GeneID	Gene.name	MIM.accession	MIM.description
ENSG00000210049	MT-TF	NA	
ENSG00000211459	MT-RNR1	NA	
ENSG00000210077	MT-TV	NA	
ENSG00000210082	MT-RNR2	NA	
ENSG00000209082	MT-TL1	NA	
ENSG00000198888	MT-ND1	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000198888	MT-ND1	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS;;MELAS SYNDROME
ENSG00000210100	MT-TI	NA	
ENSG00000210107	MT-TQ	NA	
ENSG00000210112	MT-TM	NA	
ENSG00000198763	MT-ND2	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000210117	MT-TW	NA	
ENSG00000210127	MT-TA	NA	
ENSG00000210135	MT-TN	NA	
ENSG00000210140	MT-TC	NA	
ENSG00000210144	MT-TY	NA	
ENSG00000198804	MT-CO1	500008	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL
ENSG00000198804	MT-CO1	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS;;MELAS SYNDROME
ENSG00000210151	MT-TS1	NA	
ENSG00000210154	MT-TD	NA	
ENSG00000198712	MT-CO2	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS;;MELAS SYNDROME
ENSG00000210156	MT-TK	NA	
ENSG00000228253	MT-ATP8	NA	
ENSG00000198899	MT-ATP6	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000198899	MT-ATP6	551500	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA;;NARP SYNDROME
ENSG00000198938	MT-CO3	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000198938	MT-CO3	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS;;MELAS SYNDROME
ENSG00000210164	MT-TG	NA	
ENSG00000198840	MT-ND3	NA	
ENSG00000210174	MT-TR	NA	
ENSG00000212907	MT-ND4L	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000198886	MT-ND4	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000210176	MT-TH	NA	
ENSG00000210184	MT-TS2	NA	
ENSG00000210191	MT-TL2	NA	
ENSG00000198786	MT-ND5	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000198786	MT-ND5	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS;;MELAS SYNDROME
ENSG00000198695	MT-ND6	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000198695	MT-ND6	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS;;MELAS SYNDROME
ENSG00000210194	MT-TE	NA	
ENSG00000198727	MT-CYB	535000	LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON
ENSG00000198727	MT-CYB	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS;;MELAS SYNDROME
ENSG00000210195	MT-TT	NA	
ENSG00000210196	MT-TP	NA	
ENSG00000223972	DDX11L1	NA	
ENSG00000227232	WASH7P	NA	
ENSG00000278267	MIR6859-1	NA	
ENSG00000243485	MIR1302-2HG	NA	
ENSG00000284332	MIR1302-2	NA	
ENSG00000237613	FAM138A	NA	
ENSG00000268020	OR4G4P	NA	
ENSG00000240361	OR4G11P	NA	
ENSG00000186092	OR4F5	NA	
ENSG00000238009	AL627309.1	NA	
ENSG00000239945	AL627309.3	NA	
ENSG00000233750	CICP27	NA	
ENSG00000268903	AL627309.6	NA	
ENSG00000269981	AL627309.7	NA	
ENSG00000239906	AL627309.2	NA	
ENSG00000241860	AL627309.5	NA	
ENSG00000222623	RNU6-1100P	NA	
ENSG00000241599	AL627309.4	NA	
ENSG00000279928	FO538757.1	NA	
ENSG00000279457	WASH9P	NA	
ENSG00000273874	MIR6859-2	NA	
ENSG00000228463	AP006222.1	NA	
ENSG00000286448	AP006222.2	NA	
ENSG00000236679	RPL23AP24	NA	
ENSG00000236601	AL732372.1	NA	
ENSG00000237094	AL732372.2	NA	
ENSG00000269732	WBP1LP7	NA	
ENSG00000284733	OR4F29	NA	
ENSG00000233653	CICP7	NA	
ENSG00000250575	AL732372.3	NA	
ENSG00000278757	U6	NA	
ENSG00000230021	AL669831.3	NA	
ENSG00000235146	AC114498.1	NA	
ENSG00000225972	MTND1P23	NA	
ENSG00000225630	MTND2P28	NA	
ENSG00000237973	MTCO1P12	NA	
ENSG00000278791	AC114498.2	NA	
ENSG00000229344	MTCO2P12	NA	
ENSG00000240409	MTATP8P1	NA	
ENSG00000248527	MTATP6P1	NA	
ENSG00000198744	MTCO3P12	NA	
ENSG00000268663	WBP1LP6	NA	
ENSG00000284662	OR4F16	NA	
ENSG00000229376	CICP3	NA	
ENSG00000228327	AL669831.1	NA	
ENSG00000223181	RNU6-1199P	NA	
ENSG00000229905	AL669831.2	NA	
ENSG00000237491	LINC01409	NA	
ENSG00000285268	AL669831.6	NA	
ENSG00000230092	AL669831.4	NA	
ENSG00000177757	FAM87B	NA	
ENSG00000228794	LINC01128	NA	
ENSG00000225880	LINC00115	NA	
ENSG00000288531	AL669831.7	NA	
ENSG00000230368	FAM41C	NA	
ENSG00000234711	TUBB8P11	NA	
ENSG00000283040	AL669831.5	NA	
ENSG00000272438	AL645608.6	NA	
ENSG00000230699	AL645608.2	NA	
ENSG00000241180	AL645608.4	NA	
ENSG00000223764	LINC02593	NA	
ENSG00000187634	SAMD11	NA	
ENSG00000188976	NOC2L	NA	
ENSG00000187961	KLHL17	NA	
ENSG00000187583	PLEKHN1	NA	
ENSG00000187642	PERM1	NA	
ENSG00000272512	AL645608.7	NA	
ENSG00000188290	HES4	NA	
ENSG00000187608	ISG15	616126	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38;;IMMUNODEFICIENCY 38, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;;ISG15 DEFICIENCY, AUTOSOMAL RECESSIVE
ENSG00000231702	AL645608.3	NA	
ENSG00000224969	AL645608.1	NA	
ENSG00000188157	AGRN	615120	MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8;;MYASTHENIC SYNDROME, CONGENITAL, WITH PRE- AND POSTSYNAPTIC DEFECTS; CMSPPD;;MYASTHENIC SYNDROME, CONGENITAL, DUE TO AGRIN DEFICIENCY
ENSG00000242590	AL645608.5	NA	
ENSG00000217801	AL390719.1	NA	
ENSG00000273443	AL645608.8	NA	
ENSG00000237330	RNF223	NA	
ENSG00000131591	C1orf159	NA	
ENSG00000285812	AL390719.3	NA	
ENSG00000223823	LINC01342	NA	
ENSG00000207730	MIR200B	NA	
ENSG00000207607	MIR200A	NA	
ENSG00000198976	MIR429	NA	
ENSG00000272141	AL390719.2	NA	
ENSG00000205231	TTLL10-AS1	NA	
ENSG00000162571	TTLL10	NA	
ENSG00000186891	TNFRSF18	NA	
ENSG00000186827	TNFRSF4	615593	IMMUNODEFICIENCY 16; IMD16;;OX40 DEFICIENCY
ENSG00000078808	SDF4	NA	
ENSG00000176022	B3GALT6	271640	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1;;SEMDJL
ENSG00000176022	B3GALT6	615349	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2;;EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 2, FORMERLY; EDSP2, FORMERLY
ENSG00000184163	C1QTNF12	NA	
ENSG00000260179	AL162741.1	NA	
ENSG00000160087	UBE2J2	NA	
ENSG00000230415	LINC01786	NA	
ENSG00000162572	SCNN1D	NA	
ENSG00000131584	ACAP3	NA	
ENSG00000278073	MIR6726	NA	
ENSG00000169972	PUSL1	NA	
ENSG00000127054	INTS11	NA	
ENSG00000283712	MIR6727	NA	
ENSG00000240731	AL139287.1	NA	
ENSG00000224051	CPTP	NA	
ENSG00000169962	TAS1R3	NA	
ENSG00000107404	DVL1	180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES
ENSG00000107404	DVL1	616331	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2
ENSG00000284372	MIR6808	NA	
ENSG00000162576	MXRA8	NA	
ENSG00000175756	AURKAIP1	NA	
ENSG00000223663	NDUFB4P8	NA	
ENSG00000221978	CCNL2	NA	
ENSG00000224870	MRPL20-AS1	NA	
ENSG00000242485	MRPL20	NA	
ENSG00000264293	RN7SL657P	NA	
ENSG00000272455	MRPL20-DT	NA	
ENSG00000235098	ANKRD65	NA	
ENSG00000225905	AL391244.1	NA	
ENSG00000205116	TMEM88B	NA	
ENSG00000225285	LINC01770	NA	
ENSG00000179403	VWA1	NA	
ENSG00000215915	ATAD3C	NA	
ENSG00000160072	ATAD3B	NA	
ENSG00000284740	AL645728.2	NA	
ENSG00000197785	ATAD3A	617183	HAREL-YOON SYNDROME; HAYOS
ENSG00000205090	TMEM240	607454	SPINOCEREBELLAR ATAXIA 21; SCA21
ENSG00000160075	SSU72	NA	
ENSG00000215014	AL645728.1	NA	
ENSG00000274481	AL691432.3	NA	
ENSG00000228594	FNDC10	NA	
ENSG00000286989	AL691432.4	NA	
ENSG00000272106	AL691432.2	NA	
ENSG00000197530	MIB2	NA	
ENSG00000189409	MMP23B	NA	
ENSG00000248333	CDK11B	NA	
ENSG00000272004	FO704657.1	NA	
ENSG00000189339	SLC35E2B	NA	
ENSG00000269737	AL691432.1	NA	
ENSG00000215914	MMP23A	NA	
ENSG00000008128	CDK11A	NA	
ENSG00000268575	AL031282.2	NA	
ENSG00000227775	AL031282.1	NA	
ENSG00000215790	SLC35E2A	NA	
ENSG00000008130	NADK	NA	
ENSG00000078369	GNB1	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMI /.../ELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000078369	GNB1	616973	MENTAL RETARDATION, AUTOSOMAL DOMINANT 42; MRD42
ENSG00000231050	AL109917.1	NA	
ENSG00000169885	CALML6	NA	
ENSG00000178821	TMEM52	NA	
ENSG00000142609	CFAP74	NA	
ENSG00000233542	AL391845.2	NA	
ENSG00000187730	GABRD	613060	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITY TO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GE /.../SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7, INCLUDED
ENSG00000226969	AL391845.1	NA	
ENSG00000067606	PRKCZ	NA	
ENSG00000271806	AL590822.2	NA	
ENSG00000182873	PRKCZ-AS1	NA	
ENSG00000162585	FAAP20	NA	
ENSG00000234396	AL590822.1	NA	
ENSG00000157933	SKI	182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS;;CRANIOSYNOSTOSIS WITH ARACHNODACTYLY AND ABDOMINAL HERNIAS;;MARFANOID DISORDER WITH CRANIOSYNOSTOSIS, TYPE I;;MARFANOID CRANIOSYNOSTOSIS SYNDROME
ENSG00000287356	AL590822.3	NA	
ENSG00000116151	MORN1	NA	
ENSG00000272161	AL589739.1	NA	
ENSG00000269896	AL513477.1	NA	
ENSG00000272420	AL513477.2	NA	
ENSG00000157916	RER1	NA	
ENSG00000157911	PEX10	614870	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 7, INCLUDED; CG7, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP B, INCLUDED; CGB, INCLUDED
ENSG00000157911	PEX10	614871	PEROXISOME BIOGENESIS DISORDER 6B; PBD6B
ENSG00000149527	PLCH2	NA	
ENSG00000224387	AL139246.1	NA	
ENSG00000229393	AL139246.4	NA	
ENSG00000157881	PANK4	NA	
ENSG00000197921	HES5	NA	
ENSG00000272449	AL139246.5	NA	
ENSG00000238164	TNFRSF14-AS1	NA	
ENSG00000157873	TNFRSF14	NA	
ENSG00000225931	AL139246.2	NA	
ENSG00000228037	AL139246.3	NA	
ENSG00000157870	PRXL2B	NA	
ENSG00000142606	MMEL1	NA	
ENSG00000237058	MMEL1-AS1	NA	
ENSG00000215912	TTC34	NA	
ENSG00000285945	AC242022.2	NA	
ENSG00000283259	AC242022.1	NA	
ENSG00000233234	AL592464.2	NA	
ENSG00000287396	AL592464.3	NA	
ENSG00000231630	AL592464.1	NA	
ENSG00000284745	AL589702.1	NA	
ENSG00000169717	ACTRT2	NA	
ENSG00000177133	PRDM16-DT	NA	
ENSG00000142611	PRDM16	615373	LEFT VENTRICULAR NONCOMPACTION 8; LVNC8 CARDIOMYOPATHY, DILATED, 1LL, INCLUDED; CMD1LL, INCLUDED
ENSG00000283572	MIR4251	NA	
ENSG00000226286	AL008733.1	NA	
ENSG00000279839	AL512383.1	NA	
ENSG00000272235	AL590438.1	NA	
ENSG00000287828	AL354743.2	NA	
ENSG00000286518	AL354743.1	NA	
ENSG00000130762	ARHGEF16	NA	
ENSG00000272088	AL512413.1	NA	
ENSG00000162591	MEGF6	NA	
ENSG00000207776	MIR551A	NA	
ENSG00000238260	AL513320.1	NA	
ENSG00000158109	TPRG1L	NA	
ENSG00000116213	WRAP73	NA	
ENSG00000078900	TP73	NA	
ENSG00000227589	AL136528.1	NA	
ENSG00000235131	TP73-AS2	NA	
ENSG00000227372	TP73-AS1	NA	
ENSG00000276189	AL136528.2	NA	
ENSG00000162592	CCDC27	NA	
ENSG00000235169	SMIM1	615264	BLOOD GROUP, VEL SYSTEM; VEL VEL-NULL PHENOTYPE, INCLUDED
ENSG00000130764	LRRC47	NA	
ENSG00000266075	RN7SL574P	NA	
ENSG00000272153	AL365330.1	NA	
ENSG00000116198	CEP104	616781	JOUBERT SYNDROME 25; JBTS25
ENSG00000169598	DFFB	NA	
ENSG00000198912	C1orf174	NA	
ENSG00000236423	LINC01134	NA	
ENSG00000233304	LINC01346	NA	
ENSG00000226374	LINC01345	NA	
ENSG00000284668	LINC02780	NA	
ENSG00000284703	AL805961.1	NA	
ENSG00000229280	EEF1DP6	NA	
ENSG00000235054	LINC01777	NA	
ENSG00000284694	AL355602.1	NA	
ENSG00000227169	Z98747.1	NA	
ENSG00000232596	LINC01646	NA	
ENSG00000196581	AJAP1	NA	
ENSG00000287586	Z98886.1	NA	
ENSG00000284739	BX005132.1	NA	
ENSG00000284674	LINC02781	NA	
ENSG00000231510	LINC02782	NA	
ENSG00000284616	AL139823.1	NA	
ENSG00000284692	Z98259.3	NA	
ENSG00000284666	Z98259.2	NA	
ENSG00000260972	Z98259.1	NA	
ENSG00000283356	Z97988.2	NA	
ENSG00000236948	AL365255.1	NA	
ENSG00000264341	Z97988.1	NA	
ENSG00000264101	MIR4689	NA	
ENSG00000131697	NPHP4	606966	NEPHRONOPHTHISIS 4; NPHP4;;NEPHRONOPHTHISIS 4, JUVENILE
ENSG00000131697	NPHP4	606996	SENIOR-LOKEN SYNDROME 4; SLSN4
ENSG00000069424	KCNAB2	NA	
ENSG00000116254	CHD5	NA	
ENSG00000285629	AL031847.1	NA	
ENSG00000116251	RPL22	NA	
ENSG00000226944	RNF207-AS1	NA	
ENSG00000158286	RNF207	NA	
ENSG00000116237	ICMT	NA	
ENSG00000225077	LINC00337	NA	
ENSG00000173673	HES3	NA	
ENSG00000158292	GPR153	NA	
ENSG00000097021	ACOT7	NA	
ENSG00000271746	AL031848.2	NA	
ENSG00000069812	HES2	NA	
ENSG00000187017	ESPN	609006	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36 DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, INCLUDED
ENSG00000187017	ESPN	618632	USHER SYNDROME, TYPE 1M; USH1M
ENSG00000265392	MIR4252	NA	
ENSG00000231868	AL031848.1	NA	
ENSG00000215788	TNFRSF25	NA	
ENSG00000171680	PLEKHG5	611067	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4
ENSG00000171680	PLEKHG5	615376	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE C; RI-CMTC
ENSG00000162408	NOL9	NA	
ENSG00000253022	RNU6-731P	NA	
ENSG00000229519	AL591866.1	NA	
ENSG00000173662	TAS1R1	NA	
ENSG00000204859	ZBTB48	NA	
ENSG00000162413	KLHL21	NA	
ENSG00000116273	PHF13	NA	
ENSG00000041988	THAP3	NA	
ENSG00000007923	DNAJC11	NA	
ENSG00000228750	LINC01672	NA	
ENSG00000284744	AL591163.1	NA	
ENSG00000237436	CAMTA1-DT	NA	
ENSG00000171735	CAMTA1	614756	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR
ENSG00000227950	AL590128.1	NA	
ENSG00000237365	AL512330.1	NA	
ENSG00000207056	RNU1-8P	NA	
ENSG00000237402	CAMTA1-IT1	NA	
ENSG00000237728	CAMTA1-AS2	NA	
ENSG00000225126	CAMTA1-AS1	NA	
ENSG00000270171	AL359881.3	NA	
ENSG00000270035	AL359881.2	NA	
ENSG00000269978	AL359881.1	NA	
ENSG00000049245	VAMP3	NA	
ENSG00000269925	Z98884.2	NA	
ENSG00000049246	PER3	616882	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3
ENSG00000236266	Z98884.1	NA	
ENSG00000049247	UTS2	NA	
ENSG00000049249	TNFRSF9	NA	
ENSG00000270330	AL009183.1	NA	
ENSG00000116288	PARK7	606324	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
ENSG00000200344	Y_RNA	NA	
ENSG00000284747	AL034417.4	NA	
ENSG00000284716	AL034417.3	NA	
ENSG00000116285	ERRFI1	NA	
ENSG00000238290	AL034417.2	NA	
ENSG00000232848	AL034417.1	NA	
ENSG00000229305	AL358876.1	NA	
ENSG00000227634	LINC01714	NA	
ENSG00000200975	RNU1-7P	NA	
ENSG00000233645	AL358876.2	NA	
ENSG00000251977	RNU6-991P	NA	
ENSG00000162426	SLC45A1	617532	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF
ENSG00000252254	AL356072.1	NA	
ENSG00000142599	RERE	616975	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH
ENSG00000232912	RERE-AS1	NA	
ENSG00000221083	AL096855.1	NA	
ENSG00000270282	AL096855.2	NA	
ENSG00000234619	RPL7P11	NA	
ENSG00000224315	RPL7P7	NA	
ENSG00000222511	Y_RNA	NA	
ENSG00000226545	AL357552.1	NA	
ENSG00000228423	AL357552.2	NA	
ENSG00000229716	RPL23AP19	NA	
ENSG00000074800	ENO1	NA	
ENSG00000274258	MIR6728	NA	
ENSG00000230679	ENO1-AS1	NA	
ENSG00000201725	RNU6-304P	NA	
ENSG00000238249	HMGN2P17	NA	
ENSG00000232208	AL139415.1	NA	
ENSG00000232663	AL139415.2	NA	
ENSG00000131686	CA6	NA	
ENSG00000265141	RN7SL451P	NA	
ENSG00000197241	SLC2A7	NA	
ENSG00000142583	SLC2A5	NA	
ENSG00000252404	AL158048.1	NA	
ENSG00000180758	GPR157	NA	
ENSG00000228526	MIR34AHG	NA	
ENSG00000284357	MIR34A	NA	
ENSG00000234546	LNCTAM34A	NA	
ENSG00000049239	H6PD	604931	CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1
ENSG00000171621	SPSB1	NA	
ENSG00000284652	BX323043.1	NA	
ENSG00000284693	LINC02606	NA	
ENSG00000252956	RNA5SP40	NA	
ENSG00000235263	AL928921.1	NA	
ENSG00000171612	SLC25A33	NA	
ENSG00000231181	AL954705.1	NA	
ENSG00000188807	TMEM201	NA	
ENSG00000171608	PIK3CD	615513	IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;p110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY, AND IMMUNODEFICIENCY; PASLI
ENSG00000179840	PIK3CD-AS1	NA	
ENSG00000233268	AL691449.1	NA	
ENSG00000231789	PIK3CD-AS2	NA	
ENSG00000171603	CLSTN1	NA	
ENSG00000271264	MZT1P1	NA	
ENSG00000280113	AL357140.3	NA	
ENSG00000178585	CTNNBIP1	NA	
ENSG00000223989	AL357140.1	NA	
ENSG00000285701	AL357140.4	NA	
ENSG00000162441	LZIC	NA	
ENSG00000228150	AL357140.2	NA	
ENSG00000173614	NMNAT1	608553	LEBER CONGENITAL AMAUROSIS 9; LCA9
ENSG00000202415	RN7SKP269	NA	
ENSG00000283611	TMEM274P	NA	
ENSG00000265521	MIR5697	NA	
ENSG00000241326	AL603962.1	NA	
ENSG00000162444	RBP7	NA	
ENSG00000130939	UBE4B	NA	
ENSG00000224340	AL590639.1	NA	
ENSG00000233623	PGAM1P11	NA	
ENSG00000201746	RNU6-828P	NA	
ENSG00000054523	KIF1B	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000054523	KIF1B	118210	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A1;;HEREDITARY MOTOR AND SENSORY NEUROPA /.../A1;;HMSN IIA1;;HMSN2A1
ENSG00000054523	KIF1B	256700	NEUROBLASTOMA, SUSCEPTIBILITY TO, 1; NBLST1 NEUROBLASTOMA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000264881	AL358013.1	NA	
ENSG00000199562	RNU6-37P	NA	
ENSG00000264501	RN7SL731P	NA	
ENSG00000284735	AL139424.3	NA	
ENSG00000284642	AL139424.2	NA	
ENSG00000142657	PGD	NA	
ENSG00000271989	AL139424.1	NA	
ENSG00000251503	CENPS-CORT	NA	
ENSG00000175279	CENPS	NA	
ENSG00000241563	CORT	NA	
ENSG00000160049	DFFA	NA	
ENSG00000203469	AL354956.1	NA	
ENSG00000142655	PEX14	614887	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP K, INCLUDED; CGK, INCLUDED
ENSG00000287727	AL139423.2	NA	
ENSG00000243267	RN7SL614P	NA	
ENSG00000130940	CASZ1	NA	
ENSG00000272078	AL139423.1	NA	
ENSG00000225158	HSPE1P24	NA	
ENSG00000175262	C1orf127	NA	
ENSG00000215785	CFL1P6	NA	
ENSG00000120948	TARDBP	612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED, INCLUDED;;FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED, INCLUDED;;FTLD-TDP, TAR /.../LATED, INCLUDED
ENSG00000277726	AL109811.3	NA	
ENSG00000009724	MASP2	613791	MASP2 DEFICIENCY;;LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 2; LCAPD2
ENSG00000271895	AL109811.2	NA	
ENSG00000116649	SRM	NA	
ENSG00000171824	EXOSC10	NA	
ENSG00000226849	AL109811.1	NA	
ENSG00000230337	EXOSC10-AS1	NA	
ENSG00000198793	MTOR	607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2;;CORTICAL DYSPLASIA OF TAYLOR; CDT;;FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT;;FCD2 FOCAL CORTICAL DYSPLASIA, TYPE IIA, INCLUDED; FCORD2A, INCLUDED;;FCD IIA, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR WITHOUT BAL /.../ELLS, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR, DYSPLASIA ONLY, INCLUDED; CDTD, INCLUDED;;FOCAL CORTICAL DYSPLASIA, TYPE IIB, INCLUDED; FCORD2B, INCLUDED;;FCD IIB, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR WITH BALLOON CELLS, INCLUDED; CDTBC, INCLUDED
ENSG00000198793	MTOR	616638	SMITH-KINGSMORE SYNDROME; SKS;;MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME;;MINDS SYNDROME;;MACROCEPHALY, SEIZURES, MENTAL RETARDATION, UMBILICAL HERNIA, AND FACIAL DYSMORPHISM
ENSG00000225602	MTOR-AS1	NA	
ENSG00000253086	RNU6-537P	NA	
ENSG00000171819	ANGPTL7	NA	
ENSG00000207451	RNU6-291P	NA	
ENSG00000238173	RPL39P6	NA	
ENSG00000120942	UBIAD1	121800	SCHNYDER CORNEAL DYSTROPHY; SCCD;;CORNEAL DYSTROPHY, SCHNYDER;;SCHNYDER CRYSTALLINE CORNEAL DYSTROPHY;;CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER
ENSG00000238199	UBE2V2P3	NA	
ENSG00000284646	AL031291.1	NA	
ENSG00000224338	MTCYBP45	NA	
ENSG00000204624	DISP3	NA	
ENSG00000285833	AL590989.1	NA	
ENSG00000235643	LINC01647	NA	
ENSG00000284708	AL031731.1	NA	
ENSG00000116661	FBXO2	NA	
ENSG00000132879	FBXO44	NA	
ENSG00000116663	FBXO6	NA	
ENSG00000116670	MAD2L2	617243	FANCONI ANEMIA, COMPLEMENTATION GROUP V; FANCV
ENSG00000162490	DRAXIN	NA	
ENSG00000177674	AGTRAP	NA	
ENSG00000215910	C1orf167	NA	
ENSG00000177553	C1orf167-AS1	NA	
ENSG00000177000	MTHFR	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000177000	MTHFR	188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1;;THROMBOPHILIA DUE TO FACTOR 2 DEFECT;;VENOUS THROMBOSIS;;VENOUS THROMBOEMBOLISM THROMBOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000177000	MTHFR	236250	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCY  MTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED
ENSG00000177000	MTHFR	601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS;;NTD, FOLATE-SENSITIVE  SPINA BIFIDA, FOLATE-SENSITIVE, INCLUDED
ENSG00000011021	CLCN6	NA	
ENSG00000276470	AL021155.2	NA	
ENSG00000278852	AL021155.3	NA	
ENSG00000175206	NPPA	612201	ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6
ENSG00000175206	NPPA	615745	ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL
ENSG00000275915	AL021155.1	NA	
ENSG00000120937	NPPB	NA	
ENSG00000224904	SBF1P2	NA	
ENSG00000285646	AL021155.4	NA	
ENSG00000199347	RNU5E-1	NA	
ENSG00000201801	RNU5E-4P	NA	
ENSG00000116685	KIAA2013	NA	
ENSG00000083444	PLOD1	225400	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1;;EHLERS-DANLOS SYNDROME, TYPE VI; EDS6;;EDS VI;;EHLERS-DANLOS SYNDROME, OCULAR-SCOLIOTIC TYPE;;NEVO SYNDROME;;EHLERS-DANLOS SYNDROME, TYPE VIA, FORMERLY; EDS6A, FORMERLY
ENSG00000287384	AL096840.3	NA	
ENSG00000116688	MFN2	601152	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY; HMSN6A;;HMSN VIA;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VI; HMSN6;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6A; CMT6A;;CHARCOT-MARIE-T /.../ISEASE, TYPE 6; CMT6
ENSG00000116688	MFN2	609260	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A2;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A2;;HEREDITARY MOTOR AND SENSO /.../ROPATHY IIA2; HMSN2A2;;HMSN IIA2
ENSG00000116688	MFN2	617087	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B
ENSG00000270914	AL096840.2	NA	
ENSG00000116691	MIIP	NA	
ENSG00000202461	AL096840.1	NA	
ENSG00000276869	MIR6729	NA	
ENSG00000243539	RN7SL649P	NA	
ENSG00000120949	TNFRSF8	NA	
ENSG00000201135	RNU6-777P	NA	
ENSG00000227875	RPL23AP89	NA	
ENSG00000285604	AL357835.1	NA	
ENSG00000283789	MIR7846	NA	
ENSG00000028137	TNFRSF1B	NA	
ENSG00000263676	MIR4632	NA	
ENSG00000225196	RPL10P17	NA	
ENSG00000252969	SNORA70	NA	
ENSG00000048707	VPS13D	607317	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4;;SPINOCEREBELLAR ATAXIA WITH SACCADIC INTRUSIONS; SCASI;;SPINOCEREBELLAR ATAXIA 24, FORMERLY; SCA24, FORMERLY
ENSG00000239149	SNORA59A	NA	
ENSG00000229484	LINC02766	NA	
ENSG00000162496	DHRS3	NA	
ENSG00000221340	RNU6ATAC18P	NA	
ENSG00000276830	MIR6730	NA	
ENSG00000272482	AC254633.1	NA	
ENSG00000204518	AADACL4	NA	
ENSG00000226166	AC244670.1	NA	
ENSG00000188984	AADACL3	NA	
ENSG00000157330	C1orf158	NA	
ENSG00000116726	PRAMEF12	NA	
ENSG00000116721	PRAMEF1	NA	
ENSG00000228338	LINC01784	NA	
ENSG00000239810	PRAMEF11	NA	
ENSG00000231103	PRAMEF30P	NA	
ENSG00000179172	HNRNPCL1	NA	
ENSG00000120952	PRAMEF2	NA	
ENSG00000243073	PRAMEF4	NA	
ENSG00000187545	PRAMEF10	NA	
ENSG00000204510	PRAMEF7	NA	
ENSG00000207434	RNU6-1072P	NA	
ENSG00000234064	PRAMEF29P	NA	
ENSG00000232423	PRAMEF6	NA	
ENSG00000274178	PRAMEF28P	NA	
ENSG00000274764	PRAMEF27	NA	
ENSG00000277058	HNRNPCL3	NA	
ENSG00000229571	PRAMEF25	NA	
ENSG00000277862	PRAMEF34P	NA	
ENSG00000236179	PRAMEF35P	NA	
ENSG00000275774	HNRNPCL2	NA	
ENSG00000229978	PRAMEF36P	NA	
ENSG00000233336	AC245056.1	NA	
ENSG00000280267	PRAMEF26	NA	
ENSG00000179412	HNRNPCL4	NA	
ENSG00000204505	PRAMEF9	NA	
ENSG00000279169	PRAMEF13	NA	
ENSG00000279804	PRAMEF18	NA	
ENSG00000250894	PRAMEF31P	NA	
ENSG00000270601	PRAMEF5	NA	
ENSG00000231219	PRAMEF32P	NA	
ENSG00000207511	RNU6-771P	NA	
ENSG00000182330	PRAMEF8	NA	
ENSG00000237700	PRAMEF33	NA	
ENSG00000204501	PRAMEF15	NA	
ENSG00000228229	AC243961.1	NA	
ENSG00000204481	PRAMEF14	NA	
ENSG00000204480	PRAMEF19	NA	
ENSG00000204479	PRAMEF17	NA	
ENSG00000204478	PRAMEF20	NA	
ENSG00000162494	LRRC38	NA	
ENSG00000259961	AL354712.1	NA	
ENSG00000215909	BRWD1P1	NA	
ENSG00000162493	PDPN	NA	
ENSG00000222952	RNA5SP41	NA	
ENSG00000237445	AL359771.1	NA	
ENSG00000253085	AL359771.2	NA	
ENSG00000116731	PRDM2	NA	
ENSG00000189337	KAZN	NA	
ENSG00000252151	RNU6-1265P	NA	
ENSG00000231606	AL357873.1	NA	
ENSG00000234593	KAZN-AS1	NA	
ENSG00000235829	TBCAP2	NA	
ENSG00000287756	AL031293.1	NA	
ENSG00000175147	TMEM51-AS1	NA	
ENSG00000171729	TMEM51	NA	
ENSG00000204464	C1orf195	NA	
ENSG00000215720	MFFP1	NA	
ENSG00000278480	ZBTB2P1	NA	
ENSG00000142621	FHAD1	NA	
ENSG00000233485	FHAD1-AS1	NA	
ENSG00000236045	AL031283.2	NA	
ENSG00000228140	AL031283.1	NA	
ENSG00000142634	EFHD2	NA	
ENSG00000162438	CTRC	167800	PANCREATITIS, HEREDITARY; PCTT;;HPC;;HP;;PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;PANCREATITIS, CALCIFIC, INCLUDED;;PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
ENSG00000142615	CELA2A	NA	
ENSG00000215704	CELA2B	NA	
ENSG00000132906	CASP9	NA	
ENSG00000116138	DNAJC16	NA	
ENSG00000251866	SCARNA21B	NA	
ENSG00000272510	AL121992.3	NA	
ENSG00000116771	AGMAT	NA	
ENSG00000237301	AL121992.1	NA	
ENSG00000235084	CHCHD2P6	NA	
ENSG00000252417	RNU7-179P	NA	
ENSG00000236500	CD24P1	NA	
ENSG00000197312	DDI2	NA	
ENSG00000215695	RSC1A1	NA	
ENSG00000271742	AL121992.2	NA	
ENSG00000116786	PLEKHM2	NA	
ENSG00000237938	AL450998.2	NA	
ENSG00000162461	SLC25A34	NA	
ENSG00000224459	SLC25A34-AS1	NA	
ENSG00000162460	TMEM82	NA	
ENSG00000162458	FBLIM1	NA	
ENSG00000224321	RPL12P14	NA	
ENSG00000233954	UQCRHL	NA	
ENSG00000178715	AL450998.1	NA	
ENSG00000179743	FLJ37453	NA	
ENSG00000065526	SPEN	NA	
ENSG00000270620	AL034555.1	NA	
ENSG00000116809	ZBTB17	NA	
ENSG00000234607	AL355994.4	NA	
ENSG00000231353	AL355994.1	NA	
ENSG00000275503	AL355994.5	NA	
ENSG00000224966	TBC1D3P6	NA	
ENSG00000183888	SRARP	NA	
ENSG00000233078	AL355994.3	NA	
ENSG00000173641	HSPB7	NA	
ENSG00000186510	CLCNKA	613090	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B
ENSG00000232456	AL355994.2	NA	
ENSG00000184908	CLCNKB	607364	BARTTER SYNDROME, TYPE 3; BARTS3;;BARTTER SYNDROME, CLASSIC BARTTER SYNDROME, TYPE 3, WITH HYPOCALCIURIA, INCLUDED
ENSG00000184908	CLCNKB	613090	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B
ENSG00000185519	FAM131C	NA	
ENSG00000142627	EPHA2	116600	CATARACT 6, MULTIPLE TYPES; CTRCT6;;CATARACT, POSTERIOR POLAR, 1; CTPP1;;CATARACT, AGE-RELATED CORTICAL, 2; ARCC2
ENSG00000227959	AL451042.2	NA	
ENSG00000224621	AL451042.1	NA	
ENSG00000234166	ARHGEF19-AS1	NA	
ENSG00000142632	ARHGEF19	NA	
ENSG00000237276	ANO7L1	NA	
ENSG00000288398	AL109627.1	NA	
ENSG00000132881	CPLANE2	NA	
ENSG00000233929	MT1XP1	NA	
ENSG00000037637	FBXO42	NA	
ENSG00000055070	SZRD1	NA	
ENSG00000226457	RPL22P3	NA	
ENSG00000187144	SPATA21	NA	
ENSG00000157191	NECAP2	NA	
ENSG00000226029	LINC01772	NA	
ENSG00000080947	CROCCP3	NA	
ENSG00000206652	RNU1-1	NA	
ENSG00000261135	AL137802.2	NA	
ENSG00000285853	AL137802.3	NA	
ENSG00000224174	AL137802.1	NA	
ENSG00000233421	LINC01783	NA	
ENSG00000277344	RNU1-6P	NA	
ENSG00000225710	AL355149.1	NA	
ENSG00000219481	NBPF1	NA	
ENSG00000271732	AL137798.1	NA	
ENSG00000215908	CROCCP2	NA	
ENSG00000283773	AL137798.3	NA	
ENSG00000186301	MST1P2	NA	
ENSG00000282143	AL137798.2	NA	
ENSG00000207513	RNU1-3	NA	
ENSG00000280114	AL021920.2	NA	
ENSG00000236698	EIF1AXP1	NA	
ENSG00000268869	ESPNP	NA	
ENSG00000279151	AL021920.1	NA	
ENSG00000282740	AL021920.3	NA	
ENSG00000058453	CROCC	NA	
ENSG00000227684	CROCCP4	NA	
ENSG00000207389	RNU1-4	NA	
ENSG00000186715	MST1L	NA	
ENSG00000223643	BX284668.1	NA	
ENSG00000230239	BX284668.3	NA	
ENSG00000263811	MIR3675	NA	
ENSG00000228549	BX284668.2	NA	
ENSG00000277234	RNU1-5P	NA	
ENSG00000238142	BX284668.5	NA	
ENSG00000235241	BX284668.4	NA	
ENSG00000207005	RNU1-2	NA	
ENSG00000272426	BX284668.6	NA	
ENSG00000117122	MFAP2	NA	
ENSG00000286898	AL049569.2	NA	
ENSG00000226526	AL049569.1	NA	
ENSG00000159363	ATP13A2	606693	KUFOR-RAKEB SYNDROME; KRS;;PARKINSON DISEASE 9, AUTOSOMAL RECESSIVE, JUVENILE-ONSET; PARK9;;PALLIDOPYRAMIDAL DEGENERATION WITH SUPRANUCLEAR UPGAZE PARESIS AND DEMENTIA; KRPPD
ENSG00000159363	ATP13A2	617225	SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78
ENSG00000288636	AL049569.3	NA	
ENSG00000117118	SDHB	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000117118	SDHB	115310	PARAGANGLIOMAS 4; PGL4;;CAROTID BODY TUMORS AND MULTIPLE EXTRAADRENAL PHEOCHROMOCYTOMAS;;PHEOCHROMOCYTOMA, EXTRAADRENAL, AND CERVICAL PARAGANGLIOMA;;PARAGANGLIOMAS, HEREDITARY EXTRAADRENAL;;PHEOCHROMOCYTOMA, FAMILIAL EXTRAADRENAL;;PARAGANGLIOMA, FAM /.../MALIGNANT
ENSG00000117118	SDHB	606764	GASTROINTESTINAL STROMAL TUMOR; GIST
ENSG00000117118	SDHB	606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA;;CARNEY-STRATAKIS SYNDROME;;PARAGANGLIOMA AND GASTROINTESTINAL STROMAL TUMOR
ENSG00000117115	PADI2	NA	
ENSG00000204362	LINC02783	NA	
ENSG00000282843	AL590644.1	NA	
ENSG00000142623	PADI1	NA	
ENSG00000142619	PADI3	191480	UNCOMBABLE HAIR SYNDROME 1; UHS1;;UNCOMBABLE HAIR SYNDROME; UHS;;PILI TRIANGULI ET CANALICULI
ENSG00000266634	MIR3972	NA	
ENSG00000159339	PADI4	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000276747	PADI6	617234	PREIMPLANTATION EMBRYONIC LETHALITY 2; PREMBL2
ENSG00000179051	RCC2	NA	
ENSG00000227751	RCC2-AS1	NA	
ENSG00000074964	ARHGEF10L	NA	
ENSG00000236648	LINC02810	NA	
ENSG00000117148	ACTL8	NA	
ENSG00000284653	AL357509.1	NA	
ENSG00000261781	LINC01654	NA	
ENSG00000117154	IGSF21	NA	
ENSG00000280222	AL365209.1	NA	
ENSG00000230035	IGSF21-AS1	NA	
ENSG00000225387	AL591896.1	NA	
ENSG00000179023	KLHDC7A	NA	
ENSG00000235282	DYNLL1P3	NA	
ENSG00000225478	AL031737.1	NA	
ENSG00000009709	PAX7	268220	RHABDOMYOSARCOMA 2; RMS2;;RHABDOMYOSARCOMA, ALVEOLAR; RMSA
ENSG00000009709	PAX7	618578	MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS; MYOSCO
ENSG00000179002	TAS1R2	NA	
ENSG00000159423	ALDH4A1	239510	HYPERPROLINEMIA, TYPE II; HYRPRO2;;HPII;;1-@PYRROLINE-5-CARBOXYLATE DEHYDROGENASE DEFICIENCY
ENSG00000265606	MIR4695	NA	
ENSG00000221662	MIR1290	NA	
ENSG00000169991	IFFO2	NA	
ENSG00000272084	AL137127.1	NA	
ENSG00000127481	UBR4	NA	
ENSG00000230424	EMC1-AS1	NA	
ENSG00000127463	EMC1	616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR
ENSG00000211454	AKR7L	NA	
ENSG00000053372	MRTO4	NA	
ENSG00000286064	AL035413.2	NA	
ENSG00000162482	AKR7A3	NA	
ENSG00000270728	AL035413.1	NA	
ENSG00000053371	AKR7A2	NA	
ENSG00000200403	RNU6-1099P	NA	
ENSG00000040487	SLC66A1	NA	
ENSG00000077549	CAPZB	NA	
ENSG00000240490	RN7SL277P	NA	
ENSG00000173436	MICOS10	NA	
ENSG00000201609	RNU4-28P	NA	
ENSG00000235185	AL031727.2	NA	
ENSG00000158747	NBL1	NA	
ENSG00000270136	MICOS10-NBL1	NA	
ENSG00000226396	AL031727.1	NA	
ENSG00000158748	HTR6	NA	
ENSG00000162542	TMCO4	NA	
ENSG00000178828	RNF186	NA	
ENSG00000235434	AL391883.1	NA	
ENSG00000169914	OTUD3	NA	
ENSG00000188784	PLA2G2E	NA	
ENSG00000242688	RN7SL304P	NA	
ENSG00000188257	PLA2G2A	NA	
ENSG00000127472	PLA2G5	228980	FLECK RETINA, FAMILIAL BENIGN; FRFB
ENSG00000117215	PLA2G2D	NA	
ENSG00000158786	PLA2G2F	NA	
ENSG00000227066	Z98257.1	NA	
ENSG00000187980	PLA2G2C	NA	
ENSG00000225986	UBXN10-AS1	NA	
ENSG00000162543	UBXN10	NA	
ENSG00000228105	LINC01757	NA	
ENSG00000284710	Z98257.2	NA	
ENSG00000158816	VWA5B1	NA	
ENSG00000226664	AL020998.1	NA	
ENSG00000236963	LINC01141	NA	
ENSG00000226487	AL139254.1	NA	
ENSG00000284641	AL139254.2	NA	
ENSG00000284743	AL139254.3	NA	
ENSG00000162545	CAMK2N1	NA	
ENSG00000090432	MUL1	NA	
ENSG00000215520	RPS4XP4	NA	
ENSG00000183114	FAM43B	NA	
ENSG00000158825	CDA	NA	
ENSG00000158828	PINK1	605909	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6;;PARKINSON DISEASE 6, EARLY-ONSET; PARK6  PARKINSON DISEASE 6, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED;;PARKINSON DISEASE, AUTOSOMAL RECESSIVE EARLY-ONSET, DIGENIC, PINK1/DJ1, INCLUDED
ENSG00000284005	MIR6084	NA	
ENSG00000117242	PINK1-AS	NA	
ENSG00000244038	DDOST	614507	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R
ENSG00000117245	KIF17	NA	
ENSG00000235432	AL663074.2	NA	
ENSG00000189410	SH2D5	NA	
ENSG00000233069	AL663074.1	NA	
ENSG00000127483	HP1BP3	NA	
ENSG00000075151	EIF4G3	NA	
ENSG00000251914	RNU7-200P	NA	
ENSG00000221808	MIR1256	NA	
ENSG00000233072	RPS15AP6	NA	
ENSG00000236073	AL627311.1	NA	
ENSG00000235112	HSPE1P27	NA	
ENSG00000287192	AL031005.2	NA	
ENSG00000117298	ECE1	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000117298	ECE1	613870	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD
ENSG00000236936	AL031005.1	NA	
ENSG00000231105	ECE1-AS1	NA	
ENSG00000236216	PPP1R11P1	NA	
ENSG00000228823	AL592309.1	NA	
ENSG00000236009	AL592309.2	NA	
ENSG00000227001	NBPF2P	NA	
ENSG00000187952	HS6ST1P1	NA	
ENSG00000186543	CROCCP5	NA	
ENSG00000142794	NBPF3	NA	
ENSG00000176378	PFN1P10	NA	
ENSG00000162551	ALPL	146300	HYPOPHOSPHATASIA, ADULT;;HYPOPHOSPHATASIA, MILD ODONTOHYPOPHOSPHATASIA, INCLUDED
ENSG00000162551	ALPL	241500	HYPOPHOSPHATASIA, INFANTILE;;HOPS;;PHOSPHOETHANOLAMINURIA HYPOPHOSPHATASIA, PERINATAL LETHAL, INCLUDED
ENSG00000162551	ALPL	241510	HYPOPHOSPHATASIA, CHILDHOOD
ENSG00000233431	LINC02596	NA	
ENSG00000076864	RAP1GAP	NA	
ENSG00000090686	USP48	NA	
ENSG00000231978	AL590103.1	NA	
ENSG00000187942	LDLRAD2	NA	
ENSG00000142798	HSPG2	224410	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH;;DYSSEGMENTAL DWARFISM, SILVERMAN-HANDMAKER TYPE;;ANISOSPONDYLIC CAMPTOMICROMELIC DWARFISM, SILVERMAN-HANDMAKER TYPE
ENSG00000142798	HSPG2	255800	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1;;SCHWARTZ-JAMPEL SYNDROME; SJS;;MYOTONIC MYOPATHY, DWARFISM, CHONDRODYSTROPHY, AND OCULAR AND FACIAL ABNORMALITIES;;SCHWARTZ-JAMPEL-ABERFELD SYNDROME;;SJA SYNDROME;;CHONDRODYSTROPHIC MYOTONIA
ENSG00000232037	AL590556.1	NA	
ENSG00000283234	AL590556.2	NA	
ENSG00000219073	CELA3B	NA	
ENSG00000285959	AL590556.3	NA	
ENSG00000273610	RN7SL386P	NA	
ENSG00000201919	RNU6-1022P	NA	
ENSG00000142789	CELA3A	NA	
ENSG00000278124	RN7SL186P	NA	
ENSG00000201273	RNU6-776P	NA	
ENSG00000228397	LINC01635	NA	
ENSG00000218510	LINC00339	NA	
ENSG00000070831	CDC42	616737	TAKENOUCHI-KOSAKI SYNDROME; TKS;;MACROTHROMBOCYTOPENIA AND MENTAL RETARDATION SYNDROME
ENSG00000285752	CDC42-AS1	NA	
ENSG00000285794	AL031281.1	NA	
ENSG00000230068	CDC42-IT1	NA	
ENSG00000271428	MPHOSPH6P1	NA	
ENSG00000162552	WNT4	158330	MULLERIAN APLASIA AND HYPERANDROGENISM;;MULLERIAN DUCT FAILURE AND HYPERANDROGENISM
ENSG00000162552	WNT4	611812	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL;;SERKAL SYNDROME
ENSG00000285873	AL445253.1	NA	
ENSG00000266564	MIR4418	NA	
ENSG00000234397	PPIAP34	NA	
ENSG00000279625	AL591122.1	NA	
ENSG00000184677	ZBTB40	NA	
ENSG00000237200	ZBTB40-IT1	NA	
ENSG00000070886	EPHA8	NA	
ENSG00000276835	MIR6127	NA	
ENSG00000173372	C1QA	613652	C1q DEFICIENCY; C1QD
ENSG00000159189	C1QC	613652	C1q DEFICIENCY; C1QD
ENSG00000173369	C1QB	613652	C1q DEFICIENCY; C1QD
ENSG00000133216	EPHB2	603688	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY;;PCBC;;CAPB
ENSG00000133216	EPHB2	618462	BLEEDING DISORDER, PLATELET-TYPE, 22; BDPLT22
ENSG00000265422	MIR4684	NA	
ENSG00000225952	AL512444.1	NA	
ENSG00000264014	MIR4253	NA	
ENSG00000215906	LACTBL1	NA	
ENSG00000227868	TEX46	NA	
ENSG00000004487	KDM1A	616728	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF
ENSG00000240553	AL031428.1	NA	
ENSG00000263793	MIR3115	NA	
ENSG00000266802	AL031428.2	NA	
ENSG00000169641	LUZP1	NA	
ENSG00000229010	AL161672.1	NA	
ENSG00000206935	RNU6-514P	NA	
ENSG00000252578	RNU6-135P	NA	
ENSG00000179546	HTR1D	NA	
ENSG00000215381	AL109936.2	NA	
ENSG00000261326	LINC01355	NA	
ENSG00000284726	AL109936.8	NA	
ENSG00000125944	HNRNPR	NA	
ENSG00000125945	ZNF436	NA	
ENSG00000249087	ZNF436-AS1	NA	
ENSG00000201405	AL109936.1	NA	
ENSG00000271420	AL109936.3	NA	
ENSG00000204219	TCEA3	NA	
ENSG00000232482	AL357134.1	NA	
ENSG00000088280	ASAP3	NA	
ENSG00000007968	E2F2	NA	
ENSG00000235052	AL021154.1	NA	
ENSG00000117318	ID3	NA	
ENSG00000285802	AL450043.1	NA	
ENSG00000197880	MDS2	NA	
ENSG00000229239	AL451000.1	NA	
ENSG00000142676	RPL11	612562	DIAMOND-BLACKFAN ANEMIA 7; DBA7
ENSG00000236810	ELOA-AS1	NA	
ENSG00000011007	ELOA	NA	
ENSG00000057757	PITHD1	NA	
ENSG00000011009	LYPLA2	NA	
ENSG00000117308	GALE	230350	GALACTOSE EPIMERASE DEFICIENCY;;GALE DEFICIENCY;;GALACTOSEMIA III;;UDP-GALACTOSE-4-EPIMERASE DEFICIENCY
ENSG00000117305	HMGCL	246450	3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD;;HMG-CoA LYASE DEFICIENCY;;HMGCL DEFICIENCY;;HL DEFICIENCY;;HYDROXYMETHYLGLUTARIC ACIDURIA
ENSG00000179163	FUCA1	230000	FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY
ENSG00000188822	CNR2	NA	
ENSG00000229106	BTBD6P1	NA	
ENSG00000232557	AL590609.2	NA	
ENSG00000264926	MIR378F	NA	
ENSG00000230228	H3P1	NA	
ENSG00000189266	PNRC2	NA	
ENSG00000188529	SRSF10	NA	
ENSG00000215905	AL590609.1	NA	
ENSG00000225315	AL591178.1	NA	
ENSG00000142661	MYOM3	NA	
ENSG00000230703	MYOM3-AS1	NA	
ENSG00000142677	IL22RA1	NA	
ENSG00000185436	IFNLR1	NA	
ENSG00000230023	LINC02800	NA	
ENSG00000232298	GRHL3-AS1	NA	
ENSG00000158055	GRHL3	606713	VAN DER WOUDE SYNDROME 2; VWS2
ENSG00000001460	STPG1	NA	
ENSG00000001461	NIPAL3	NA	
ENSG00000286061	RCAN3AS	NA	
ENSG00000117602	RCAN3	NA	
ENSG00000264443	NCMAP-DT	NA	
ENSG00000184454	NCMAP	NA	
ENSG00000227312	AL445686.1	NA	
ENSG00000239106	Y_RNA	NA	
ENSG00000133226	SRRM1	NA	
ENSG00000284699	AL445648.1	NA	
ENSG00000169504	CLIC4	NA	
ENSG00000238482	RNU6-1208P	NA	
ENSG00000020633	RUNX3	NA	
ENSG00000278034	MIR6731	NA	
ENSG00000229162	RUNX3-AS1	NA	
ENSG00000261025	AL445471.1	NA	
ENSG00000264371	MIR4425	NA	
ENSG00000285823	LINC02793	NA	
ENSG00000233755	AL050344.1	NA	
ENSG00000233419	IFITM3P7	NA	
ENSG00000231953	AL031432.1	NA	
ENSG00000117614	SYF2	NA	
ENSG00000284602	AL031432.4	NA	
ENSG00000284657	AL031432.5	NA	
ENSG00000117616	RSRP1	NA	
ENSG00000272432	AL031432.3	NA	
ENSG00000261349	AL031432.2	NA	
ENSG00000187010	RHD	NA	
ENSG00000224183	SDHDP6	NA	
ENSG00000259984	AL928711.1	NA	
ENSG00000183726	TMEM50A	NA	
ENSG00000188672	RHCE	617970	RH-NULL, AMORPH TYPE; RHNA
ENSG00000238084	AL031284.1	NA	
ENSG00000204178	MACO1	NA	
ENSG00000157978	LDLRAP1	603813	HYPERCHOLESTEROLEMIA, FAMILIAL, 4; FHCL4;;HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH;;HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 1, FORMERLY; ARH1, FORMERLY;;FHCB1, FORMERLY;;HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 2, FORMERLY; ARH2, FORMERLY /.../2, FORMERLY
ENSG00000225643	AL606491.1	NA	
ENSG00000117643	MAN1C1	NA	
ENSG00000233478	AL031280.1	NA	
ENSG00000162430	SELENON	255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD;;FIBER-TYPE DISPROPORTION MYOPATHY, CONGENITAL; CFTDM
ENSG00000162430	SELENON	602771	RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1;;RIGID SPINE SYNDROME; RSS;;MYOPATHY, SEPN1-RELATED;;MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE, WITH EARLY SPINE RIGIDITY; MDRS1;;MULTICORE MYOPATHY, SEVERE CLASSIC FORM;;MINICORE MYOPATHY, SEVERE CLASS /.../M;;MULTIMINICORE DISEASE, SEVERE CLASSIC FORM;;DESMIN-RELATED MYOPATHY WITH MALLORY BODIES;;MUSCULAR DYSTROPHY, CONGENITAL, EICHSFELD TYPE
ENSG00000255054	AL020996.2	NA	
ENSG00000228172	AL020996.1	NA	
ENSG00000117640	MTFR1L	NA	
ENSG00000272478	AL020996.3	NA	
ENSG00000127423	AUNIP	NA	
ENSG00000236528	AL033528.3	NA	
ENSG00000182749	PAQR7	NA	
ENSG00000207302	AL033528.1	NA	
ENSG00000117632	STMN1	NA	
ENSG00000229786	SNRPFP2	NA	
ENSG00000223624	AL033528.2	NA	
ENSG00000283938	MIR3917	NA	
ENSG00000158006	PAFAH2	NA	
ENSG00000207237	RNU6-110P	NA	
ENSG00000252190	AL592064.1	NA	
ENSG00000252691	AL592064.2	NA	
ENSG00000158008	EXTL1	NA	
ENSG00000158014	SLC30A2	608118	ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD;;ZINC DEFICIENCY, NEONATAL, DUE TO LOW BREAST MILK ZINC ZINC IN BREAST MILK, REDUCED, INCLUDED
ENSG00000284309	AL391650.2	NA	
ENSG00000158022	TRIM63	NA	
ENSG00000175087	PDIK1L	NA	
ENSG00000197245	FAM110D	NA	
ENSG00000282872	C1orf232	NA	
ENSG00000236782	AL391650.1	NA	
ENSG00000142684	ZNF593	NA	
ENSG00000142675	CNKSR1	NA	
ENSG00000188782	CATSPER4	NA	
ENSG00000236155	ZPLD2P	NA	
ENSG00000278572	AL355877.2	NA	
ENSG00000130695	CEP85	NA	
ENSG00000270733	AL355877.1	NA	
ENSG00000142669	SH3BGRL3	NA	
ENSG00000158062	UBXN11	NA	
ENSG00000169442	CD52	NA	
ENSG00000176092	CRYBG2	NA	
ENSG00000225854	AL451139.1	NA	
ENSG00000176083	ZNF683	NA	
ENSG00000131914	LIN28A	NA	
ENSG00000117682	DHDDS	613861	RETINITIS PIGMENTOSA 59; RP59 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ibb, INCLUDED; CDG1BB, INCLUDED
ENSG00000117682	DHDDS	617836	DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM
ENSG00000223583	AL513365.1	NA	
ENSG00000225891	DHDDS-AS1	NA	
ENSG00000198830	HMGN2	NA	
ENSG00000224129	DPPA2P2	NA	
ENSG00000117676	RPS6KA1	NA	
ENSG00000238705	MIR1976	NA	
ENSG00000243905	RN7SL679P	NA	
ENSG00000252802	Y_RNA	NA	
ENSG00000252429	RNU7-29P	NA	
ENSG00000229247	AL627313.1	NA	
ENSG00000238316	AL627082.2	NA	
ENSG00000235069	AL627082.1	NA	
ENSG00000260063	AL512408.1	NA	
ENSG00000117713	ARID1A	614607	COFFIN-SIRIS SYNDROME 2; CSS2;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 14; MRD14 CHROMOSOME 1p36.11 DUPLICATION SYNDROME, INCLUDED
ENSG00000060642	PIGV	239300	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1;;MABRY SYNDROME;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 2; GPIBD2
ENSG00000241188	RN7SL165P	NA	
ENSG00000287810	AL034380.2	NA	
ENSG00000204160	ZDHHC18	NA	
ENSG00000175793	SFN	NA	
ENSG00000142751	GPN2	NA	
ENSG00000226698	AL034380.1	NA	
ENSG00000198746	GPATCH3	NA	
ENSG00000090273	NUDC	NA	
ENSG00000131910	NR0B2	601665	OBESITY LEANNESS, INCLUDED
ENSG00000175707	KDF1	617337	ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12
ENSG00000172746	RPL12P13	NA	
ENSG00000224064	AL356390.1	NA	
ENSG00000225294	OSTCP2	NA	
ENSG00000253368	TRNP1	NA	
ENSG00000158246	TENT5B	NA	
ENSG00000090020	SLC9A1	616291	LICHTENSTEIN-KNORR SYNDROME; LIKNS;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 19; SCAR19
ENSG00000229985	AL590640.2	NA	
ENSG00000214973	CHCHD3P3	NA	
ENSG00000225159	NPM1P39	NA	
ENSG00000225990	SNRPEP7	NA	
ENSG00000224311	AL590640.1	NA	
ENSG00000142784	WDTC1	NA	
ENSG00000252098	Y_RNA	NA	
ENSG00000243659	FO393419.3	NA	
ENSG00000186501	TMEM222	NA	
ENSG00000206888	RNU6-48P	NA	
ENSG00000241547	ACTG1P20	NA	
ENSG00000142765	SYTL1	NA	
ENSG00000142733	MAP3K6	NA	
ENSG00000142748	FCN3	613860	FICOLIN 3 DEFICIENCY;;FCN3 DEFICIENCY;;LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 3; LCAPD3
ENSG00000174950	CD164L2	NA	
ENSG00000231207	FO393419.1	NA	
ENSG00000181773	GPR3	NA	
ENSG00000158195	WASF2	NA	
ENSG00000241169	FO393419.2	NA	
ENSG00000237429	BX293535.1	NA	
ENSG00000126705	AHDC1	615829	XIA-GIBBS SYNDROME; XIGIS;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 25; MRD25
ENSG00000000938	FGR	NA	
ENSG00000235912	AL031729.1	NA	
ENSG00000233975	LINC02574	NA	
ENSG00000126709	IFI6	NA	
ENSG00000225886	AL445490.1	NA	
ENSG00000206767	RNU6-949P	NA	
ENSG00000226662	CHMP1AP1	NA	
ENSG00000207095	RNU6-424P	NA	
ENSG00000287244	AL020997.5	NA	
ENSG00000009780	FAM76A	NA	
ENSG00000231344	AL020997.1	NA	
ENSG00000230833	RPEP3	NA	
ENSG00000117758	STX12	NA	
ENSG00000269971	AL020997.2	NA	
ENSG00000270031	AL020997.3	NA	
ENSG00000223062	RNU6-1245P	NA	
ENSG00000286433	AL020997.4	NA	
ENSG00000117751	PPP1R8	NA	
ENSG00000252947	SCARNA1	NA	
ENSG00000130775	THEMIS2	NA	
ENSG00000117748	RPA2	NA	
ENSG00000130768	SMPDL3B	NA	
ENSG00000227050	AL512288.1	NA	
ENSG00000158156	XKR8	NA	
ENSG00000158161	EYA3	NA	
ENSG00000238231	AL512288.2	NA	
ENSG00000240750	RN7SL559P	NA	
ENSG00000228589	SPCS2P4	NA	
ENSG00000228943	AL137792.2	NA	
ENSG00000214812	AL137792.1	NA	
ENSG00000253005	RNU6-176P	NA	
ENSG00000169403	PTAFR	NA	
ENSG00000126698	DNAJC8	NA	
ENSG00000130770	ATP5IF1	NA	
ENSG00000270605	AL353622.1	NA	
ENSG00000271398	AL353622.2	NA	
ENSG00000130766	SESN2	NA	
ENSG00000130772	MED18	NA	
ENSG00000204138	PHACTR4	NA	
ENSG00000206779	Y_RNA	NA	
ENSG00000229820	CR391992.1	NA	
ENSG00000221216	RNU6ATAC27P	NA	
ENSG00000180198	RCC1	NA	
ENSG00000242125	SNHG3	NA	
ENSG00000274266	SNORA73A	NA	
ENSG00000200087	SNORA73B	NA	
ENSG00000231468	PRDX3P2	NA	
ENSG00000279443	AL513497.1	NA	
ENSG00000180098	TRNAU1AP	NA	
ENSG00000197989	SNHG12	NA	
ENSG00000221539	SNORD99	NA	
ENSG00000278274	SNORA61	NA	
ENSG00000273544	SNORA44	NA	
ENSG00000274582	SNORA16A	NA	
ENSG00000280498	SNORA16A	NA	
ENSG00000120656	TAF12	NA	
ENSG00000188060	RAB42	NA	
ENSG00000229388	LINC01715	NA	
ENSG00000270103	AL360012.1	NA	
ENSG00000274978	RNU11	NA	
ENSG00000162419	GMEB1	NA	
ENSG00000252777	AL645729.1	NA	
ENSG00000198492	YTHDF2	NA	
ENSG00000116329	OPRD1	NA	
ENSG00000233427	AL009181.1	NA	
ENSG00000199756	Y_RNA	NA	
ENSG00000159023	EPB41	611804	ELLIPTOCYTOSIS 1; EL1;;ELLIPTOCYTOSIS, RHESUS-LINKED TYPE;;PROTEIN 4.1 OF ERYTHROCYTE MEMBRANE, DEFECT OF;;4.1-MINUS TRAIT;;4.1- TRAIT
ENSG00000225616	AL138785.1	NA	
ENSG00000206704	Y_RNA	NA	
ENSG00000277958	Metazoa_SRP	NA	
ENSG00000253304	TMEM200B	NA	
ENSG00000225750	AL357500.1	NA	
ENSG00000116350	SRSF4	NA	
ENSG00000277916	AL357500.2	NA	
ENSG00000116353	MECR	617282	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG;;DYSTONIA 29, CHILDHOOD-ONSET; DYT29
ENSG00000237934	AL590729.1	NA	
ENSG00000060656	PTPRU	NA	
ENSG00000230523	LINC01756	NA	
ENSG00000225011	AL671862.1	NA	
ENSG00000228176	AC092265.1	NA	
ENSG00000284676	AL645944.2	NA	
ENSG00000270927	AL645944.1	NA	
ENSG00000233399	LINC01648	NA	
ENSG00000233372	AL137076.1	NA	
ENSG00000231251	AL021921.1	NA	
ENSG00000236335	AL161638.2	NA	
ENSG00000231949	AL161638.1	NA	
ENSG00000162510	MATN1	NA	
ENSG00000186056	MATN1-AS1	NA	
ENSG00000287510	AL137857.1	NA	
ENSG00000162511	LAPTM5	NA	
ENSG00000264773	MIR4420	NA	
ENSG00000229607	AL137027.1	NA	
ENSG00000223382	LINC01778	NA	
ENSG00000222784	RN7SKP91	NA	
ENSG00000235143	AL445235.1	NA	
ENSG00000162512	SDC3	601665	OBESITY LEANNESS, INCLUDED
ENSG00000266210	RN7SL371P	NA	
ENSG00000134644	PUM1	617931	SPINOCEREBELLAR ATAXIA 47; SCA47
ENSG00000237329	AL356320.2	NA	
ENSG00000232768	AL356320.1	NA	
ENSG00000215900	SELENOWP1	NA	
ENSG00000225142	AC114495.1	NA	
ENSG00000084628	NKAIN1	NA	
ENSG00000060688	SNRNP40	NA	
ENSG00000229447	AC114495.2	NA	
ENSG00000121766	ZCCHC17	NA	
ENSG00000229044	AL451070.1	NA	
ENSG00000121769	FABP3	NA	
ENSG00000168528	SERINC2	NA	
ENSG00000215899	AC209007.1	NA	
ENSG00000206981	RNU6-40P	NA	
ENSG00000260386	LDC1P	NA	
ENSG00000265961	Y_RNA	NA	
ENSG00000284543	LINC01226	NA	
ENSG00000229167	AC114488.1	NA	
ENSG00000142910	TINAGL1	NA	
ENSG00000121764	HCRTR1	NA	
ENSG00000162517	PEF1	NA	
ENSG00000235790	PEF1-AS1	NA	
ENSG00000264078	AC114488.2	NA	
ENSG00000084636	COL16A1	NA	
ENSG00000121753	ADGRB2	NA	
ENSG00000266580	MIR4254	NA	
ENSG00000254545	AL354919.2	NA	
ENSG00000134668	SPOCD1	NA	
ENSG00000203620	AL354919.1	NA	
ENSG00000269967	AL136115.2	NA	
ENSG00000184007	PTP4A2	NA	
ENSG00000228634	AL136115.1	NA	
ENSG00000284702	AL136115.3	NA	
ENSG00000121774	KHDRBS1	NA	
ENSG00000203325	AL445248.1	NA	
ENSG00000121775	TMEM39B	NA	
ENSG00000266203	MIR5585	NA	
ENSG00000276493	Metazoa_SRP	NA	
ENSG00000025800	KPNA6	NA	
ENSG00000250135	AL049795.2	NA	
ENSG00000084652	TXLNA	NA	
ENSG00000160050	CCDC28B	209900	BARDET-BIEDL SYNDROME 1; BBS1
ENSG00000224066	AL049795.1	NA	
ENSG00000160051	IQCC	NA	
ENSG00000222046	DCDC2B	NA	
ENSG00000160055	TMEM234	NA	
ENSG00000084623	EIF3I	NA	
ENSG00000220785	MTMR9LP	NA	
ENSG00000183615	FAM167B	NA	
ENSG00000182866	LCK	615758	IMMUNODEFICIENCY 22; IMD22
ENSG00000277617	Metazoa_SRP	NA	
ENSG00000252450	Y_RNA	NA	
ENSG00000116478	HDAC1	NA	
ENSG00000175130	MARCKSL1	NA	
ENSG00000233775	AL109945.1	NA	
ENSG00000162526	TSSK3	NA	
ENSG00000225828	FAM229A	NA	
ENSG00000160058	BSDC1	NA	
ENSG00000224333	GAPDHP20	NA	
ENSG00000270850	AL356986.1	NA	
ENSG00000229259	LRRC37A12P	NA	
ENSG00000263529	RN7SL122P	NA	
ENSG00000254553	AL033529.1	NA	
ENSG00000273274	ZBTB8B	NA	
ENSG00000160062	ZBTB8A	NA	
ENSG00000176261	ZBTB8OS	NA	
ENSG00000200591	AC114489.1	NA	
ENSG00000162521	RBBP4	NA	
ENSG00000162520	SYNC	NA	
ENSG00000224409	AC114489.2	NA	
ENSG00000162522	KIAA1522	NA	
ENSG00000134684	YARS1	608323	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC;;CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE C;;DI-CMTC
ENSG00000116497	S100PBP	NA	
ENSG00000160097	FNDC5	NA	
ENSG00000121905	HPCA	224500	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2;;DYSTONIA MUSCULORUM DEFORMANS 2
ENSG00000121900	TMEM54	NA	
ENSG00000287691	AL031602.2	NA	
ENSG00000116514	RNF19B	NA	
ENSG00000278966	AL031602.1	NA	
ENSG00000217644	AL355864.1	NA	
ENSG00000239670	AL355864.2	NA	
ENSG00000236065	AL020995.1	NA	
ENSG00000004455	AK2	267500	RETICULAR DYSGENESIS;;RETICULAR DYSGENESIA;;CONGENITAL ALEUKIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH LEUKOPENIA;;DE VAAL DISEASE;;HEMATOPOIETIC HYPOPLASIA, GENERALIZED;;ALEUKOCYTOSIS
ENSG00000276645	Metazoa_SRP	NA	
ENSG00000142920	AZIN2	NA	
ENSG00000278997	AL662907.1	NA	
ENSG00000116525	TRIM62	NA	
ENSG00000279179	AL662907.2	NA	
ENSG00000284721	AL662907.3	NA	
ENSG00000160094	ZNF362	NA	
ENSG00000270115	AL513327.2	NA	
ENSG00000184389	A3GALT2	NA	
ENSG00000225313	AL513327.1	NA	
ENSG00000134686	PHC2	NA	
ENSG00000284154	MIR3605	NA	
ENSG00000222112	RN7SKP16	NA	
ENSG00000233246	PHC2-AS1	NA	
ENSG00000234512	TLR12P	NA	
ENSG00000121903	ZSCAN20	NA	
ENSG00000235907	AC115285.1	NA	
ENSG00000121904	CSMD2	NA	
ENSG00000227000	HSPD1P14	NA	
ENSG00000176256	HMGB4	NA	
ENSG00000231163	CSMD2-AS1	NA	
ENSG00000201148	RNA5SP42	NA	
ENSG00000142698	C1orf94	NA	
ENSG00000270241	AC115286.1	NA	
ENSG00000287703	AC099565.1	NA	
ENSG00000207941	MIR552	NA	
ENSG00000163866	SMIM12	NA	
ENSG00000189280	GJB5	NA	
ENSG00000189433	GJB4	617524	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2
ENSG00000255811	AL121988.1	NA	
ENSG00000188910	GJB3	133200	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1; EKVP1;;ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA; EKVP;;ERYTHROKERATODERMIA VARIABILIS; EKV;;ERYTHROKERATODERMIA, PROGRESSIVE SYMMETRIC; PSEK;;ERYTHROKERATODERMIA FIGURATA, CONGENITAL FAMILIAL, IN /.../ES;;ERYTHROKERATODERMIA VARIABILIS WITH ERYTHEMA GYRATUM REPENS GREITHER DISEASE, INCLUDED;;KERATOSIS PALMOPLANTARIS TRANSGREDIENS ET PROGREDIENS, INCLUDED
ENSG00000188910	GJB3	220290	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A DEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED
ENSG00000188910	GJB3	603324	GAP JUNCTION PROTEIN, BETA-3; GJB3;;GAP JUNCTION PROTEIN, 31-KD;;CONNEXIN 31; CX31 DEAFNESS, AUTOSOMAL RECESSIVE, INCLUDED;;DEAFNESS, AUTOSOMAL DOMINANT, WITH PERIPHERAL NEUROPATHY, INCLUDED
ENSG00000188910	GJB3	612644	DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B
ENSG00000187513	GJA4	NA	
ENSG00000230163	AL122010.1	NA	
ENSG00000116544	DLGAP3	NA	
ENSG00000284773	AC114490.3	NA	
ENSG00000241014	AC114490.1	NA	
ENSG00000271741	AC114490.2	NA	
ENSG00000243749	TMEM35B	NA	
ENSG00000163867	ZMYM6	NA	
ENSG00000197056	ZMYM1	NA	
ENSG00000233940	RPL12P45	NA	
ENSG00000228348	EFCAB14P1	NA	
ENSG00000284640	AL590434.1	NA	
ENSG00000116560	SFPQ	NA	
ENSG00000201868	Y_RNA	NA	
ENSG00000146463	ZMYM4	NA	
ENSG00000240374	RN7SL503P	NA	
ENSG00000201542	SNORA62	NA	
ENSG00000229994	RPL5P4	NA	
ENSG00000227409	ZMYM4-AS1	NA	
ENSG00000278702	Metazoa_SRP	NA	
ENSG00000142687	KIAA0319L	NA	
ENSG00000236274	AC004865.1	NA	
ENSG00000020129	NCDN	NA	
ENSG00000239636	AC004865.2	NA	
ENSG00000116819	TFAP2E	NA	
ENSG00000126067	PSMB2	NA	
ENSG00000142686	C1orf216	NA	
ENSG00000092853	CLSPN	NA	
ENSG00000232335	AL354864.1	NA	
ENSG00000134698	AGO4	NA	
ENSG00000092847	AGO1	NA	
ENSG00000271164	CFAP97P1	NA	
ENSG00000286899	AL139286.2	NA	
ENSG00000271914	AL139286.1	NA	
ENSG00000126070	AGO3	NA	
ENSG00000271554	AL138787.2	NA	
ENSG00000232862	AL138787.1	NA	
ENSG00000092850	TEKT2	NA	
ENSG00000116863	ADPRS	618170	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS
ENSG00000171812	COL8A2	136800	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, EARLY-ONSET
ENSG00000171812	COL8A2	609140	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2
ENSG00000054116	TRAPPC3	NA	
ENSG00000116871	MAP7D1	NA	
ENSG00000264592	RN7SL131P	NA	
ENSG00000054118	THRAP3	NA	
ENSG00000231849	UBE2V2P4	NA	
ENSG00000214193	SH3D21	NA	
ENSG00000142694	EVA1B	NA	
ENSG00000286379	AL591845.1	NA	
ENSG00000196182	STK40	NA	
ENSG00000181817	LSM10	NA	
ENSG00000222821	RNU4-27P	NA	
ENSG00000116885	OSCP1	NA	
ENSG00000201448	SNORA63C	NA	
ENSG00000116898	MRPS15	NA	
ENSG00000119535	CSF3R	617014	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE; SCN7
ENSG00000230214	FTLP18	NA	
ENSG00000284705	AL596257.1	NA	
ENSG00000284720	AC117945.2	NA	
ENSG00000234481	AC117945.1	NA	
ENSG00000163873	GRIK3	NA	
ENSG00000284650	AL031430.1	NA	
ENSG00000223944	AL353604.1	NA	
ENSG00000264698	MIR4255	NA	
ENSG00000207328	RNU6-636P	NA	
ENSG00000252368	RNA5SP43	NA	
ENSG00000230451	RPS29P6	NA	
ENSG00000233621	LINC01137	NA	
ENSG00000163874	ZC3H12A	NA	
ENSG00000283724	MIR6732	NA	
ENSG00000163875	MEAF6	NA	
ENSG00000263675	MIR5581	NA	
ENSG00000163877	SNIP1	614501	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED
ENSG00000232273	FTH1P1	NA	
ENSG00000237749	AL034379.1	NA	
ENSG00000163879	DNALI1	NA	
ENSG00000134697	GNL2	NA	
ENSG00000284748	AL513220.1	NA	
ENSG00000169218	RSPO1	610644	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL PALMOPLANTAR HYPERKERATOSIS AND TRUE HERMAPHRODITISM, INCLUDED
ENSG00000116922	C1orf109	NA	
ENSG00000134690	CDCA8	NA	
ENSG00000183317	EPHA10	NA	
ENSG00000200421	Y_RNA	NA	
ENSG00000214141	ACTN4P2	NA	
ENSG00000227416	AL929472.1	NA	
ENSG00000185090	MANEAL	NA	
ENSG00000233728	AL929472.3	NA	
ENSG00000196449	YRDC	NA	
ENSG00000197982	C1orf122	NA	
ENSG00000188786	MTF1	NA	
ENSG00000235673	AL929472.4	NA	
ENSG00000204084	INPP5B	NA	
ENSG00000230955	AL929472.2	NA	
ENSG00000252448	SNORA63	NA	
ENSG00000222282	RNU6-584P	NA	
ENSG00000277168	Metazoa_SRP	NA	
ENSG00000183431	SF3A3	NA	
ENSG00000212541	RNU6-510P	NA	
ENSG00000183386	FHL3	NA	
ENSG00000183520	UTP11	NA	
ENSG00000185668	POU3F1	NA	
ENSG00000224592	MIR3659HG	NA	
ENSG00000223589	AL139158.1	NA	
ENSG00000265596	MIR3659	NA	
ENSG00000284623	LINC02786	NA	
ENSG00000286552	AL390839.1	NA	
ENSG00000287987	AL390839.2	NA	
ENSG00000237290	LINC01343	NA	
ENSG00000275350	AL513479.1	NA	
ENSG00000200796	RNU6-753P	NA	
ENSG00000238063	LINC01685	NA	
ENSG00000215895	HSPA5P1	NA	
ENSG00000284632	AL354702.1	NA	
ENSG00000116954	RRAGC	NA	
ENSG00000273637	AL139260.2	NA	
ENSG00000228436	AL139260.1	NA	
ENSG00000214114	MYCBP	NA	
ENSG00000274944	AL139260.3	NA	
ENSG00000131233	GJA9	NA	
ENSG00000158315	RHBDL2	NA	
ENSG00000199963	RNU6-605P	NA	
ENSG00000207466	Y_RNA	NA	
ENSG00000235549	EIF1P2	NA	
ENSG00000174574	AKIRIN1	NA	
ENSG00000168653	NDUFS5	NA	
ENSG00000127603	MACF1	618325	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9
ENSG00000206654	RNU6-608P	NA	
ENSG00000222378	RNA5SP44	NA	
ENSG00000287422	AL442071.2	NA	
ENSG00000226438	AL442071.1	NA	
ENSG00000217897	HSPE1P8	NA	
ENSG00000183682	BMP8A	NA	
ENSG00000237624	OXCT2P1	NA	
ENSG00000243970	PPIEL	NA	
ENSG00000090621	PABPC4	NA	
ENSG00000228060	PABPC4-AS1	NA	
ENSG00000201457	SNORA55	NA	
ENSG00000163909	HEYL	NA	
ENSG00000225903	AL035404.2	NA	
ENSG00000116981	NT5C1A	NA	
ENSG00000116983	HPCAL4	NA	
ENSG00000084072	PPIE	NA	
ENSG00000225333	AL035404.1	NA	
ENSG00000252413	RNU7-121P	NA	
ENSG00000116985	BMP8B	NA	
ENSG00000198754	OXCT2	NA	
ENSG00000285905	BMP8B-AS1	NA	
ENSG00000261798	AL033527.2	NA	
ENSG00000229213	AL033527.1	NA	
ENSG00000284719	AL033527.3	NA	
ENSG00000284678	LINC02811	NA	
ENSG00000043514	TRIT1	617873	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35
ENSG00000202222	Y_RNA	NA	
ENSG00000116990	MYCL	NA	
ENSG00000236546	MYCL-AS1	NA	
ENSG00000207356	Y_RNA	NA	
ENSG00000168389	MFSD2A	616486	MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE; MCPH15
ENSG00000228477	AL663070.1	NA	
ENSG00000131236	CAP1	NA	
ENSG00000131238	PPT1	256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1;;CEROID LIPOFUSCINOSIS, NEURONAL, 1, VARIABLE AGE AT ONSET NEURONAL CEROID LIPOFUSCINOSIS, INFANTILE, INCLUDED; INCL, INCLUDED;;SANTAVUORI DISEASE, INCLUDED;;SANTAVUORI-HALTIA DISEASE, INCLUDED
ENSG00000226745	OAZ1P1	NA	
ENSG00000117000	RLF	NA	
ENSG00000207508	RNU6-1237P	NA	
ENSG00000188800	TMCO2	NA	
ENSG00000259943	AL050341.2	NA	
ENSG00000084073	ZMPSTE24	275210	RESTRICTIVE DERMOPATHY, LETHAL;;TIGHT SKIN CONTRACTURE SYNDROME, LETHAL;;HYPERKERATOSIS-CONTRACTURE SYNDROME;;FETAL HYPOKINESIA SEQUENCE DUE TO RESTRICTIVE DERMOPATHY
ENSG00000084073	ZMPSTE24	608612	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB;;LIPODYSTROPHY, TYPE B, ASSOCIATED WITH MANDIBULOACRAL DYSPLASIA
ENSG00000231296	AL050341.1	NA	
ENSG00000049089	COL9A2	600204	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2
ENSG00000049089	COL9A2	614284	STICKLER SYNDROME, TYPE V; STL5
ENSG00000227311	AL031985.2	NA	
ENSG00000084070	SMAP2	NA	
ENSG00000213172	AL031985.1	NA	
ENSG00000284677	AL031985.4	NA	
ENSG00000187801	ZFP69B	NA	
ENSG00000260920	AL031985.3	NA	
ENSG00000279667	AL603839.4	NA	
ENSG00000187815	ZFP69	NA	
ENSG00000238287	AL603839.3	NA	
ENSG00000164002	EXO5	NA	
ENSG00000227278	AL603839.1	NA	
ENSG00000238186	AL603839.2	NA	
ENSG00000117010	ZNF684	NA	
ENSG00000286838	AL356379.2	NA	
ENSG00000236505	AL356379.1	NA	
ENSG00000233910	GTF2F2P2	NA	
ENSG00000117016	RIMS3	NA	
ENSG00000287743	AL031289.2	NA	
ENSG00000237899	AL031289.1	NA	
ENSG00000272145	NFYC-AS1	NA	
ENSG00000066136	NFYC	NA	
ENSG00000198974	MIR30E	NA	
ENSG00000207962	MIR30C1	NA	
ENSG00000117013	KCNQ4	600101	DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A
ENSG00000264582	RN7SL326P	NA	
ENSG00000179862	CITED4	NA	
ENSG00000229528	AC119677.1	NA	
ENSG00000228940	AL391730.1	NA	
ENSG00000286668	AL391730.2	NA	
ENSG00000233118	UBE2V1P8	NA	
ENSG00000171793	CTPS1	615897	IMMUNODEFICIENCY 24; IMD24
ENSG00000281207	SLFNL1-AS1	NA	
ENSG00000171790	SLFNL1	NA	
ENSG00000010803	SCMH1	NA	
ENSG00000215893	RPL23AP17	NA	
ENSG00000287400	AC093151.7	NA	
ENSG00000235358	AC093151.2	NA	
ENSG00000213987	AC093151.1	NA	
ENSG00000286640	AC093151.5	NA	
ENSG00000204060	FOXO6	NA	
ENSG00000229901	FOXO6-AS1	NA	
ENSG00000252563	RNA5SP45	NA	
ENSG00000127129	EDN2	NA	
ENSG00000127124	HIVEP3	NA	
ENSG00000230881	AL445933.2	NA	
ENSG00000230638	AL445933.1	NA	
ENSG00000284895	AC119676.1	NA	
ENSG00000287587	AL158216.1	NA	
ENSG00000227538	HNRNPFP1	NA	
ENSG00000228776	AC114492.1	NA	
ENSG00000044012	GUCA2B	NA	
ENSG00000197273	GUCA2A	NA	
ENSG00000198815	FOXJ3	NA	
ENSG00000227527	AC096540.1	NA	
ENSG00000177181	RIMKLA	NA	
ENSG00000235002	AL513331.1	NA	
ENSG00000066185	ZMYND12	NA	
ENSG00000127125	PPCS	618189	CARDIOMYOPATHY, DILATED, 2C; CMD2C
ENSG00000186409	CCDC30	NA	
ENSG00000230116	RPS3AP11	NA	
ENSG00000236876	TMSB4XP1	NA	
ENSG00000200254	RNU6-536P	NA	
ENSG00000236180	AL445669.1	NA	
ENSG00000171960	PPIH	NA	
ENSG00000285728	AC098484.4	NA	
ENSG00000234917	AC098484.2	NA	
ENSG00000065978	YBX1	NA	
ENSG00000164007	CLDN19	248190	HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5;;HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA, NEPHROCALCINOSIS, AND SEVERE OCULAR INVOLVEMENT;;FHHNC WITH SEVERE OCULAR INVOLVEMENT; /.../AR COLOBOMA, BILATERAL, WITH HYPERCALCIURIA
ENSG00000117385	P3H1	610915	OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII
ENSG00000164008	C1orf50	NA	
ENSG00000283580	AC098484.3	NA	
ENSG00000228452	AC098484.1	NA	
ENSG00000274386	TMEM269	NA	
ENSG00000177868	SVBP	618569	NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY; NEDAHM
ENSG00000164010	ERMAP	111750	BLOOD GROUP--SCIANNA SYSTEM; SC;;SCIANNA BLOOD GROUP
ENSG00000164010	ERMAP	111620	RADIN BLOOD GROUP ANTIGEN; RD;;BLOOD GROUP--RADIN ANTIGEN
ENSG00000228192	AL512353.1	NA	
ENSG00000164011	ZNF691	NA	
ENSG00000233708	AL512353.2	NA	
ENSG00000237090	AL512353.3	NA	
ENSG00000225099	ATP6V1E1P1	NA	
ENSG00000117394	SLC2A1	601042	DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY
ENSG00000117394	SLC2A1	606777	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIER  GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000117394	SLC2A1	608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN;;GLUT1 DEFICIENCY SYNDROME WITH PSEUDOHYPERKALEMIA AND HEMOLYSIS;;CRYOHYDROCYTOSIS, STOMATIN-DEFICIENT, WITH MENTAL RETARDATION, SEIZURES, CATARACTS, AND MASSIVE HEPATOSPLENOMEGALY
ENSG00000117394	SLC2A1	612126	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2;;PAROXYSMAL EXERCISE-INDUCED DYSKINESIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA;;PED WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA;;PAROXYSMAL EXERTION-INDUCED DYSTONIA WITH OR WITHOUT EPILEPSY AND/O /.../LYTIC ANEMIA;;DYSTONIA 18; DYT18
ENSG00000117394	SLC2A1	614847	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12
ENSG00000284138	ATP6V0CP4	NA	
ENSG00000227533	SLC2A1-AS1	NA	
ENSG00000283973	AC099795.1	NA	
ENSG00000207256	RNU6-880P	NA	
ENSG00000283136	AL161637.2	NA	
ENSG00000277513	AL161637.1	NA	
ENSG00000186973	FAM183A	NA	
ENSG00000117395	EBNA1BP2	NA	
ENSG00000284410	MIR6733	NA	
ENSG00000243710	CFAP57	NA	
ENSG00000199240	RNA5SP46	NA	
ENSG00000179178	TMEM125	NA	
ENSG00000253313	C1orf210	NA	
ENSG00000066056	TIE1	NA	
ENSG00000117400	MPL	254450	MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED; MMM, INCLUDED
ENSG00000117400	MPL	601977	THROMBOCYTHEMIA 2; THCYT2
ENSG00000117400	MPL	604498	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT
ENSG00000287113	AL139289.2	NA	
ENSG00000234694	AL139289.1	NA	
ENSG00000117399	CDC20	NA	
ENSG00000066322	ELOVL1	618527	ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD
ENSG00000283836	MIR6734	NA	
ENSG00000159479	MED8	NA	
ENSG00000229431	MED8-AS1	NA	
ENSG00000198198	SZT2	615476	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18; EIEE18
ENSG00000229372	SZT2-AS1	NA	
ENSG00000274975	MIR6735	NA	
ENSG00000178922	HYI	NA	
ENSG00000229348	HYI-AS1	NA	
ENSG00000142949	PTPRF	616001	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2
ENSG00000284989	AL451062.3	NA	
ENSG00000066135	KDM4A	NA	
ENSG00000236200	KDM4A-AS1	NA	
ENSG00000126091	ST3GAL3	611090	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12
ENSG00000126091	ST3GAL3	615006	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15
ENSG00000229444	AL451062.1	NA	
ENSG00000283414	U6	NA	
ENSG00000233674	AL451062.2	NA	
ENSG00000283477	MIR6079	NA	
ENSG00000224751	SHMT1P1	NA	
ENSG00000117407	ARTN	NA	
ENSG00000237950	AL357079.1	NA	
ENSG00000288573	AL357079.3	NA	
ENSG00000117408	IPO13	NA	
ENSG00000285649	AL357079.2	NA	
ENSG00000132768	DPH2	NA	
ENSG00000117410	ATP6V0B	NA	
ENSG00000117411	B4GALT2	NA	
ENSG00000159214	CCDC24	NA	
ENSG00000196517	SLC6A9	617301	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE
ENSG00000230615	AL139220.2	NA	
ENSG00000227163	AL139220.1	NA	
ENSG00000271647	KRT8P47	NA	
ENSG00000239560	RN7SL479P	NA	
ENSG00000171872	KLF17	NA	
ENSG00000233514	AL356653.1	NA	
ENSG00000283039	KLF18	NA	
ENSG00000226804	AL359839.1	NA	
ENSG00000200171	Y_RNA	NA	
ENSG00000238037	OOSP1P1	NA	
ENSG00000227994	AL035417.1	NA	
ENSG00000271329	AL035417.2	NA	
ENSG00000178028	DMAP1	NA	
ENSG00000117419	ERI3	NA	
ENSG00000233602	ERI3-IT1	NA	
ENSG00000199385	RNU6-369P	NA	
ENSG00000187147	RNF220	NA	
ENSG00000263381	MIR5584	NA	
ENSG00000126106	TMEM53	NA	
ENSG00000198520	ARMH1	NA	
ENSG00000199377	RNU5F-1	NA	
ENSG00000200169	RNU5D-1	NA	
ENSG00000142945	KIF2C	NA	
ENSG00000225721	AL592166.1	NA	
ENSG00000142937	RPS8	NA	
ENSG00000264294	SNORD55	NA	
ENSG00000200913	SNORD46	NA	
ENSG00000202031	SNORD38A	NA	
ENSG00000207421	SNORD38B	NA	
ENSG00000281859	SNORD38B	NA	
ENSG00000234093	RPS15AP11	NA	
ENSG00000142959	BEST4	NA	
ENSG00000173846	PLK3	NA	
ENSG00000188396	TCTEX1D4	NA	
ENSG00000222009	BTBD19	NA	
ENSG00000117425	PTCH2	155255	MEDULLOBLASTOMA; MDB MEDULLOBLASTOMA, DESMOPLASTIC, INCLUDED;;MEDULLOBLASTOMA WITH EXTENSIVE NODULARITY, INCLUDED; MBEN, INCLUDED
ENSG00000117425	PTCH2	109400	BASAL CELL NEVUS SYNDROME; BCNS;;GORLIN SYNDROME;;GORLIN-GOLTZ SYNDROME;;NEVOID BASAL CELL CARCINOMA SYNDROME; NBCCS;;MULTIPLE BASAL CELL NEVI, ODONTOGENIC KERATOCYSTS, AND SKELETAL ANOMALIES
ENSG00000117425	PTCH2	605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1 BASAL CELL CARCINOMA, NONSYNDROMIC, INCLUDED;;BASAL CELL CARCINOMA, MULTIPLE, INCLUDED
ENSG00000202444	RNU5E-6P	NA	
ENSG00000226499	AL136380.1	NA	
ENSG00000070785	EIF2B3	603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM;;CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION; CACH;;VANISHING WHITE MATTER LEUKODYSTROPHY;;CREE LEUKOENCEPHALOPATHY; CLE VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILU /.../CLUDED;;OVARIOLEUKODYSTROPHY, INCLUDED
ENSG00000253039	RNA5SP47	NA	
ENSG00000229815	CCNB1IP1P1	NA	
ENSG00000232369	PPIAP35	NA	
ENSG00000268949	MRPS17P1	NA	
ENSG00000126107	HECTD3	NA	
ENSG00000126088	UROD	176100	PORPHYRIA CUTANEA TARDA;;PCT;;PORPHYRIA CUTANEA TARDA, TYPE II;;PCT, TYPE II;;PCT, 'FAMILIAL' TYPE;;PORPHYRIA, HEPATOCUTANEOUS TYPE;;UROPORPHYRINOGEN DECARBOXYLASE DEFICIENCY;;UROD DEFICIENCY  PORPHYRIA, HEPATOERYTHROPOIETIC, INCLUDED; HEP, INCLUDED
ENSG00000162415	ZSWIM5	NA	
ENSG00000234315	OSTCP5	NA	
ENSG00000281912	LINC01144	NA	
ENSG00000186603	HPDL	NA	
ENSG00000132781	MUTYH	608456	FAMILIAL ADENOMATOUS POLYPOSIS 2; FAP2;;COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE;;ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE
ENSG00000132781	MUTYH	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000288208	AL451136.1	NA	
ENSG00000132773	TOE1	614969	PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7
ENSG00000070759	TESK2	NA	
ENSG00000236872	PPIAP36	NA	
ENSG00000280670	CCDC163	NA	
ENSG00000132763	MMACHC	277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC;;METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblC TYPE;;METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, VITAMIN B12-RESPONSIVE;;VITAMIN B12 METABOLIC DEFECT WITH COMBINED DEFICIENCY OF METHYLMALO /.../A MUTASE AND HOMOCYSTEINE:METHYLTETRAHYDROFOLATE METHYLTRANSFERASE METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC, INCLUDED
ENSG00000117450	PRDX1	277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC;;METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblC TYPE;;METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, VITAMIN B12-RESPONSIVE;;VITAMIN B12 METABOLIC DEFECT WITH COMBINED DEFICIENCY OF METHYLMALO /.../A MUTASE AND HOMOCYSTEINE:METHYLTETRAHYDROFOLATE METHYLTRANSFERASE METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC, INCLUDED
ENSG00000234379	HMGB1P48	NA	
ENSG00000117448	AKR1A1	NA	
ENSG00000281133	AL355480.3	NA	
ENSG00000280836	AL355480.1	NA	
ENSG00000132780	NASP	NA	
ENSG00000281112	AL355480.2	NA	
ENSG00000281825	AL355480.4	NA	
ENSG00000159588	CCDC17	NA	
ENSG00000159592	GPBP1L1	NA	
ENSG00000225447	RPS15AP10	NA	
ENSG00000234329	AL604028.2	NA	
ENSG00000159596	TMEM69	NA	
ENSG00000197429	IPP	NA	
ENSG00000230896	AL604028.1	NA	
ENSG00000236111	AL603882.1	NA	
ENSG00000086015	MAST2	NA	
ENSG00000232467	TMA16P2	NA	
ENSG00000117461	PIK3R3	NA	
ENSG00000278139	P3R3URF-PIK3R3	NA	
ENSG00000226957	AL358075.1	NA	
ENSG00000233114	AL358075.3	NA	
ENSG00000227857	AL358075.2	NA	
ENSG00000117472	TSPAN1	NA	
ENSG00000250719	P3R3URF	NA	
ENSG00000085998	POMGNT1	253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMGNT1-RELATED
ENSG00000085998	POMGNT1	613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED
ENSG00000085998	POMGNT1	613157	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 15; LGMDR15;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED
ENSG00000085998	POMGNT1	617123	RETINITIS PIGMENTOSA 76; RP76
ENSG00000171357	LURAP1	NA	
ENSG00000085999	RAD54L	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000085999	RAD54L	605027	LYMPHOMA, NON-HODGKIN, FAMILIAL;;NON-HODGKIN LYMPHOMA; NHL
ENSG00000132128	LRRC41	NA	
ENSG00000173660	UQCRH	NA	
ENSG00000117481	NSUN4	NA	
ENSG00000225779	AL122001.1	NA	
ENSG00000117480	FAAH	606581	POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB;;DRUG ADDICTION, SUSCEPTIBILITY TO
ENSG00000232022	FAAHP1	NA	
ENSG00000224863	LINC01398	NA	
ENSG00000197587	DMBX1	NA	
ENSG00000282881	TMEM275	NA	
ENSG00000269956	MKNK1-AS1	NA	
ENSG00000162456	KNCN	NA	
ENSG00000079277	MKNK1	NA	
ENSG00000142961	MOB3C	NA	
ENSG00000123472	ATPAF1	NA	
ENSG00000233647	NENFP1	NA	
ENSG00000186118	TEX38	NA	
ENSG00000228237	EFCAB14-AS1	NA	
ENSG00000159658	EFCAB14	NA	
ENSG00000236476	AL593856.1	NA	
ENSG00000142973	CYP4B1	NA	
ENSG00000154198	CYP4Z2P	NA	
ENSG00000238145	AL731892.1	NA	
ENSG00000187048	CYP4A11	NA	
ENSG00000259832	CYP4A26P	NA	
ENSG00000261196	CYP4A43P	NA	
ENSG00000261593	CYP4A27P	NA	
ENSG00000261290	CYP4A44P	NA	
ENSG00000186377	CYP4X1	NA	
ENSG00000186160	CYP4Z1	NA	
ENSG00000225154	AL450996.1	NA	
ENSG00000225506	CYP4A22-AS1	NA	
ENSG00000162365	CYP4A22	NA	
ENSG00000225514	MTND1P34	NA	
ENSG00000224805	LINC00853	NA	
ENSG00000162366	PDZK1IP1	NA	
ENSG00000162367	TAL1	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMI /.../ELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000226252	AL135960.1	NA	
ENSG00000123473	STIL	612703	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7
ENSG00000162368	CMPK1	NA	
ENSG00000225762	LINC01389	NA	
ENSG00000186790	FOXE3	610256	ANTERIOR SEGMENT DYSGENESIS 2; ASGD2;;APHAKIA, CONGENITAL PRIMARY; CPAK;;CPA
ENSG00000186790	FOXE3	612968	CATARACT 34, MULTIPLE TYPES; CTRCT34;;CATARACT 34, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 3; CATC3
ENSG00000186790	FOXE3	617349	AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11
ENSG00000237424	FOXD2-AS1	NA	
ENSG00000186564	FOXD2	NA	
ENSG00000271355	AL356458.1	NA	
ENSG00000229554	RPL21P24	NA	
ENSG00000227883	ATP6V0E1P4	NA	
ENSG00000227947	LINC01738	NA	
ENSG00000269113	TRABD2B	NA	
ENSG00000223814	AL691459.1	NA	
ENSG00000225028	AC096541.1	NA	
ENSG00000226133	LINC02794	NA	
ENSG00000231413	AL356289.1	NA	
ENSG00000237180	CYP46A4P	NA	
ENSG00000242267	SKINT1L	NA	
ENSG00000279096	AL356289.2	NA	
ENSG00000223720	AL109659.1	NA	
ENSG00000117834	SLC5A9	NA	
ENSG00000272491	AL109659.2	NA	
ENSG00000279214	AL109659.3	NA	
ENSG00000132122	SPATA6	NA	
ENSG00000224986	PPP1R8P1	NA	
ENSG00000206700	RNU6-723P	NA	
ENSG00000235105	AL356968.2	NA	
ENSG00000223175	RNU4-61P	NA	
ENSG00000232514	AL356968.1	NA	
ENSG00000186094	AGBL4	NA	
ENSG00000287661	AL391844.1	NA	
ENSG00000162373	BEND5	NA	
ENSG00000286597	AL645507.1	NA	
ENSG00000229846	AC099788.1	NA	
ENSG00000230114	AGBL4-AS1	NA	
ENSG00000225623	AGBL4-IT1	NA	
ENSG00000237478	AL390023.1	NA	
ENSG00000215887	ZNF859P	NA	
ENSG00000279324	AL645730.1	NA	
ENSG00000233595	MTND2P29	NA	
ENSG00000162374	ELAVL4	NA	
ENSG00000230828	AL583843.1	NA	
ENSG00000237337	ELAVL4-AS1	NA	
ENSG00000233407	AL592182.1	NA	
ENSG00000284696	LINC02808	NA	
ENSG00000284645	AL592182.2	NA	
ENSG00000234080	AL596275.1	NA	
ENSG00000229316	HMGB1P45	NA	
ENSG00000225671	FCF1P6	NA	
ENSG00000142700	DMRTA2	NA	
ENSG00000284700	AL049637.1	NA	
ENSG00000185104	FAF1	NA	
ENSG00000225767	FAF1-AS1	NA	
ENSG00000207194	RNU6-1026P	NA	
ENSG00000230585	PHBP12	NA	
ENSG00000237130	MRPS6P2	NA	
ENSG00000123080	CDKN2C	NA	
ENSG00000265538	MIR4421	NA	
ENSG00000275816	MIR6500	NA	
ENSG00000204006	C1orf185	NA	
ENSG00000200262	Y_RNA	NA	
ENSG00000213478	CFL1P2	NA	
ENSG00000203356	LINC01562	NA	
ENSG00000123091	RNF11	NA	
ENSG00000233406	AL162430.1	NA	
ENSG00000236434	AL162430.2	NA	
ENSG00000085831	TTC39A	NA	
ENSG00000261664	TTC39A-AS1	NA	
ENSG00000085832	EPS15	NA	
ENSG00000232027	AL671986.1	NA	
ENSG00000206595	RNU6-877P	NA	
ENSG00000238140	AC104170.1	NA	
ENSG00000227070	EPS15-AS1	NA	
ENSG00000252032	RNU6-1281P	NA	
ENSG00000227742	CALR4P	NA	
ENSG00000117859	OSBPL9	NA	
ENSG00000236973	GAPDHP51	NA	
ENSG00000232846	SLC25A6P3	NA	
ENSG00000212624	AL050343.1	NA	
ENSG00000078618	NRDC	NA	
ENSG00000266993	AL050343.2	NA	
ENSG00000272175	AL050343.3	NA	
ENSG00000283899	MIR761	NA	
ENSG00000230604	TSEN15P2	NA	
ENSG00000169213	RAB3B	NA	
ENSG00000200839	RNA5SP48	NA	
ENSG00000229032	AL445685.2	NA	
ENSG00000264613	RN7SL290P	NA	
ENSG00000117862	TXNDC12	NA	
ENSG00000285839	AL445685.3	NA	
ENSG00000198841	KTI12	NA	
ENSG00000223390	AL445685.1	NA	
ENSG00000228369	TXNDC12-AS1	NA	
ENSG00000134717	BTF3L4	NA	
ENSG00000157077	ZFYVE9	NA	
ENSG00000241745	RN7SL788P	NA	
ENSG00000228407	AL139156.2	NA	
ENSG00000223429	AL139156.1	NA	
ENSG00000224255	PDCL3P6	NA	
ENSG00000236004	AL139156.3	NA	
ENSG00000237663	DNAJC19P7	NA	
ENSG00000213735	ANAPC10P1	NA	
ENSG00000154222	CC2D1B	NA	
ENSG00000272100	AL513218.1	NA	
ENSG00000287078	AL513218.2	NA	
ENSG00000224680	PLA2G12AP1	NA	
ENSG00000085840	ORC1	224690	MEIER-GORLIN SYNDROME 1; MGORS1;;EAR, PATELLA, SHORT STATURE SYNDROME; EPS;;MICROTIA, ABSENT PATELLAE, MICROGNATHIA SYNDROME;;MEIER-GORLIN SYNDROME
ENSG00000134748	PRPF38A	NA	
ENSG00000134744	TUT4	NA	
ENSG00000272371	AL591167.1	NA	
ENSG00000236290	EEF1GP7	NA	
ENSG00000116157	GPX7	NA	
ENSG00000182183	SHISAL2A	NA	
ENSG00000162377	COA7	618387	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3
ENSG00000233664	NDUFS5P3	NA	
ENSG00000239640	RN7SL62P	NA	
ENSG00000162378	ZYG11B	NA	
ENSG00000252018	RNU2-30P	NA	
ENSG00000228929	RPS13P2	NA	
ENSG00000206627	RNU6-969P	NA	
ENSG00000203995	ZYG11A	NA	
ENSG00000242391	AC099677.3	NA	
ENSG00000121310	ECHDC2	NA	
ENSG00000230953	AC099677.1	NA	
ENSG00000231866	AC099677.2	NA	
ENSG00000116171	SCP2	613724	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY; LKDMN;;STEROL CARRIER PROTEIN 2 DEFICIENCY
ENSG00000264834	AC099677.4	NA	
ENSG00000266188	AC099677.6	NA	
ENSG00000265815	AC099677.5	NA	
ENSG00000237279	H3P2	NA	
ENSG00000236360	RRAS2P1	NA	
ENSG00000226147	TUBBP10	NA	
ENSG00000174348	PODN	NA	
ENSG00000232993	AL445183.1	NA	
ENSG00000227644	HIGD1AP11	NA	
ENSG00000162383	SLC1A7	NA	
ENSG00000235563	AL445183.2	NA	
ENSG00000277397	AL606760.4	NA	
ENSG00000157184	CPT2	255110	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ADULT-ONSET;;CPT II DEFICIENCY, MYOPATHIC;;CPT2 DEFICIENCY, LATE-ONSET
ENSG00000157184	CPT2	600649	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY WITH HYPOKETOTIC HYPOGLYCEMIA;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, HEPATOCARDIOMUSCULAR;;CPT II DEFICIENCY, HEPATIC;;CPT2 DEFICIENCY, INFANTILE
ENSG00000157184	CPT2	608836	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL
ENSG00000157184	CPT2	614212	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4
ENSG00000236723	AL606760.2	NA	
ENSG00000162384	CZIB	NA	
ENSG00000259818	AL606760.3	NA	
ENSG00000162385	MAGOH	NA	
ENSG00000226754	AL606760.1	NA	
ENSG00000157193	LRP8	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000234578	AL355483.3	NA	
ENSG00000228838	AL355483.1	NA	
ENSG00000232762	AL355483.2	NA	
ENSG00000225675	LINC01771	NA	
ENSG00000285954	AC119428.2	NA	
ENSG00000226938	AC119428.1	NA	
ENSG00000230138	LINC02812	NA	
ENSG00000236253	SLC25A3P1	NA	
ENSG00000288527	AL365445.1	NA	
ENSG00000143006	DMRTB1	NA	
ENSG00000174332	GLIS1	NA	
ENSG00000239007	RNU7-95P	NA	
ENSG00000058804	NDC1	NA	
ENSG00000201003	AL049745.1	NA	
ENSG00000229687	AL049745.2	NA	
ENSG00000058799	YIPF1	NA	
ENSG00000211452	DIO1	NA	
ENSG00000081870	HSPB11	NA	
ENSG00000116212	LRRC42	NA	
ENSG00000219102	HNRNPA3P12	NA	
ENSG00000203985	LDLRAD1	NA	
ENSG00000116209	TMEM59	NA	
ENSG00000280378	AL353898.3	NA	
ENSG00000116205	TCEANC2	NA	
ENSG00000283749	MIR4781	NA	
ENSG00000225183	AL353898.1	NA	
ENSG00000279049	AL353898.2	NA	
ENSG00000256407	AL357673.1	NA	
ENSG00000157211	CDCP2	NA	
ENSG00000280425	AL357673.2	NA	
ENSG00000215883	CYB5RL	NA	
ENSG00000116221	MRPL37	NA	
ENSG00000157216	SSBP3	NA	
ENSG00000198711	SSBP3-AS1	NA	
ENSG00000225632	AL161644.1	NA	
ENSG00000232245	AL035415.1	NA	
ENSG00000287582	AC099796.2	NA	
ENSG00000235741	LINC02784	NA	
ENSG00000237173	AC099796.1	NA	
ENSG00000227453	HNRNPA1P63	NA	
ENSG00000162390	ACOT11	NA	
ENSG00000162391	FAM151A	NA	
ENSG00000230728	AL590093.1	NA	
ENSG00000184313	MROH7	NA	
ENSG00000271723	MROH7-TTC4	NA	
ENSG00000243725	TTC4	NA	
ENSG00000162396	PARS2	618437	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75
ENSG00000006555	TTC22	NA	
ENSG00000237453	AC096536.1	NA	
ENSG00000162398	LEXM	NA	
ENSG00000116133	DHCR24	602398	DESMOSTEROLOSIS
ENSG00000287724	AC096536.3	NA	
ENSG00000242396	AC096536.2	NA	
ENSG00000233203	DHCR24-DT	NA	
ENSG00000284601	AL590440.2	NA	
ENSG00000143001	TMEM61	NA	
ENSG00000233271	AL590440.1	NA	
ENSG00000162399	BSND	602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A;;BARTTER SYNDROME, NEONATAL, WITH SENSORINEURAL DEAFNESS; BSND  SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION, INCLUDED
ENSG00000169174	PCSK9	603776	HYPERCHOLESTEROLEMIA, FAMILIAL, 3; FHCL3;;HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3;;FH3 LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1, INCLUDED; LDLCQ1, INCLUDED
ENSG00000162402	USP24	NA	
ENSG00000231090	MIR4422HG	NA	
ENSG00000231095	GYG1P3	NA	
ENSG00000265822	MIR4422	NA	
ENSG00000234810	AL603840.1	NA	
ENSG00000231900	GOT2P1	NA	
ENSG00000232198	MTCO2P34	NA	
ENSG00000199831	RN7SKP291	NA	
ENSG00000252162	RNU6-830P	NA	
ENSG00000272051	Y_RNA	NA	
ENSG00000233079	LINC01755	NA	
ENSG00000230250	LINC01753	NA	
ENSG00000227104	PIGQP1	NA	
ENSG00000235612	AL353681.1	NA	
ENSG00000260971	AC119674.1	NA	
ENSG00000284686	AC119674.2	NA	
ENSG00000229871	RPSAP20	NA	
ENSG00000223956	LINC01767	NA	
ENSG00000162407	PLPP3	NA	
ENSG00000236776	RPL21P23	NA	
ENSG00000224980	RPL23AP85	NA	
ENSG00000225475	AC099789.1	NA	
ENSG00000162409	PRKAA2	NA	
ENSG00000187889	FYB2	NA	
ENSG00000229913	AL360295.1	NA	
ENSG00000157131	C8A	613790	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1;;C8 DEFICIENCY, TYPE I;;C8 ALPHA-GAMMA DEFICIENCY;;C8AG DEFICIENCY
ENSG00000021852	C8B	613789	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2;;C8 DEFICIENCY, TYPE II;;COMPLEMENT COMPONENT 8B DEFICIENCY;;C8 BETA DEFICIENCY;;C8B DEFICIENCY
ENSG00000236341	AL161740.1	NA	
ENSG00000173406	DAB1	615945	SPINOCEREBELLAR ATAXIA 37; SCA37
ENSG00000227935	AL390243.1	NA	
ENSG00000236888	RPS20P5	NA	
ENSG00000226759	DAB1-AS1	NA	
ENSG00000229887	HNRNPA1P6	NA	
ENSG00000223416	RPS26P15	NA	
ENSG00000235038	AL445193.2	NA	
ENSG00000230546	AL445193.1	NA	
ENSG00000233216	AL357373.1	NA	
ENSG00000162600	OMA1	NA	
ENSG00000286918	AL035411.3	NA	
ENSG00000270209	AL035411.2	NA	
ENSG00000264128	RN7SL713P	NA	
ENSG00000184292	TACSTD2	204870	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD;;CDGDL;;AMYLOIDOSIS, CORNEAL;;AMYLOID CORNEAL DYSTROPHY, JAPANESE TYPE;;CORNEAL DYSTROPHY, LATTICE TYPE III;;LATTICE CORNEAL DYSTROPHY, TYPE III
ENSG00000185839	AL035411.1	NA	
ENSG00000162601	MYSM1	618116	BONE MARROW FAILURE SYNDROME 4; BMFS4
ENSG00000283445	AL136985.3	NA	
ENSG00000177606	JUN	NA	
ENSG00000234807	LINC01135	NA	
ENSG00000272226	AL136985.2	NA	
ENSG00000231740	AL136985.1	NA	
ENSG00000232453	LINC02777	NA	
ENSG00000237352	LINC01358	NA	
ENSG00000228121	PHBP3	NA	
ENSG00000241042	AL592431.2	NA	
ENSG00000235215	AL592431.1	NA	
ENSG00000224609	HSD52	NA	
ENSG00000270457	AC093424.1	NA	
ENSG00000172456	FGGY	NA	
ENSG00000266150	MIR4711	NA	
ENSG00000226883	AL035416.1	NA	
ENSG00000134709	HOOK1	NA	
ENSG00000134716	CYP2J2	NA	
ENSG00000265535	RN7SL475P	NA	
ENSG00000162598	C1orf87	NA	
ENSG00000229332	PGBD4P8	NA	
ENSG00000238242	LINC02778	NA	
ENSG00000226476	LINC01748	NA	
ENSG00000231252	AC099792.1	NA	
ENSG00000162599	NFIA	613735	BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD CHROMOSOME 1p32-p31 DELETION SYNDROME, INCLUDED
ENSG00000237928	NFIA-AS2	NA	
ENSG00000237853	NFIA-AS1	NA	
ENSG00000284808	AC099791.3	NA	
ENSG00000287224	AC099791.4	NA	
ENSG00000223920	AC099791.1	NA	
ENSG00000162604	TM2D1	NA	
ENSG00000271200	AC099791.2	NA	
ENSG00000132849	PATJ	NA	
ENSG00000200575	RNU6-414P	NA	
ENSG00000212360	RNU6-1177P	NA	
ENSG00000236646	LAMTOR5P1	NA	
ENSG00000242860	RN7SL180P	NA	
ENSG00000263908	MIR3116-1	NA	
ENSG00000283690	MIR3116-2	NA	
ENSG00000234204	PIGPP2	NA	
ENSG00000234088	RPS15AP7	NA	
ENSG00000240563	L1TD1	NA	
ENSG00000237227	AL162739.1	NA	
ENSG00000200174	Y_RNA	NA	
ENSG00000132854	KANK4	NA	
ENSG00000201153	RNU6-371P	NA	
ENSG00000162607	USP1	NA	
ENSG00000116641	DOCK7	615859	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23
ENSG00000270549	AL451044.1	NA	
ENSG00000132855	ANGPTL3	605019	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2;;HYPOLIPIDEMIA, FAMILIAL, COMBINED
ENSG00000278967	AL138847.2	NA	
ENSG00000213703	AL138847.1	NA	
ENSG00000235545	AC103923.1	NA	
ENSG00000125703	ATG4C	NA	
ENSG00000234318	AC099794.1	NA	
ENSG00000237163	AC099794.2	NA	
ENSG00000229537	LINC01739	NA	
ENSG00000286455	AL162400.3	NA	
ENSG00000227485	AL162400.1	NA	
ENSG00000229225	AL162400.2	NA	
ENSG00000203605	AC096543.1	NA	
ENSG00000224209	LINC00466	NA	
ENSG00000252259	RNA5SP49	NA	
ENSG00000228734	AC096543.2	NA	
ENSG00000223683	RPSAP65	NA	
ENSG00000230798	FOXD3-AS1	NA	
ENSG00000187140	FOXD3	607836	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1;;VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 2; VAMAS2;;AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 1p-RELATED
ENSG00000275836	MIR6068	NA	
ENSG00000252784	Y_RNA	NA	
ENSG00000236674	AL049636.1	NA	
ENSG00000088035	ALG6	603147	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C;;CDG Ic; CDGIc;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE I, WITH DEFICIENT GLYCOSYLATION OF DOLICHOL-LINKED OLIGOSACCHARIDE, FORMERLY;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE  /.../MERLY; CDGS5, FORMERLY
ENSG00000142856	ITGB3BP	NA	
ENSG00000286429	BX004807.1	NA	
ENSG00000203965	EFCAB7	NA	
ENSG00000264271	RN7SL488P	NA	
ENSG00000251720	RNU7-123P	NA	
ENSG00000116652	DLEU2L	NA	
ENSG00000276884	AL109925.3	NA	
ENSG00000278287	AL109925.6	NA	
ENSG00000277565	AL109925.4	NA	
ENSG00000275823	AL109925.2	NA	
ENSG00000277689	AL109925.5	NA	
ENSG00000274199	AL109925.1	NA	
ENSG00000079739	PGM1	614921	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV
ENSG00000244256	RN7SL130P	NA	
ENSG00000185483	ROR1	617654	DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108
ENSG00000177452	AL161742.1	NA	
ENSG00000228056	CFL1P3	NA	
ENSG00000207190	RNU6-809P	NA	
ENSG00000200508	AL138793.1	NA	
ENSG00000223949	ROR1-AS1	NA	
ENSG00000284928	AL445205.1	NA	
ENSG00000177414	UBE2U	NA	
ENSG00000238653	RNU7-62P	NA	
ENSG00000158966	CACHD1	NA	
ENSG00000264470	MIR4794	NA	
ENSG00000162437	RAVER2	NA	
ENSG00000162434	JAK1	NA	
ENSG00000234784	AL606517.2	NA	
ENSG00000233877	AL606517.1	NA	
ENSG00000226891	LINC01359	NA	
ENSG00000185031	SLC2A3P2	NA	
ENSG00000272506	AL357078.2	NA	
ENSG00000212257	RNU6-1176P	NA	
ENSG00000265996	MIR3671	NA	
ENSG00000199135	MIR101-1	NA	
ENSG00000235804	AL357078.1	NA	
ENSG00000234496	MRPS21P1	NA	
ENSG00000162433	AK4	NA	
ENSG00000231622	RPS29P7	NA	
ENSG00000116675	DNAJC6	615528	PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A;;PARK19, FORMERLY PARKINSON DISEASE 19B, EARLY-ONSET, INCLUDED; PARK19B, INCLUDED
ENSG00000229294	AL139294.1	NA	
ENSG00000234144	COX6CP13	NA	
ENSG00000222624	RNU2-15P	NA	
ENSG00000213625	LEPROT	NA	
ENSG00000116678	LEPR	614963	LEPTIN RECEPTOR DEFICIENCY; LEPRD;;OBESITY, MORBID
ENSG00000237852	AC119800.1	NA	
ENSG00000224570	AC097063.1	NA	
ENSG00000285079	AL513493.1	NA	
ENSG00000239319	RN7SL854P	NA	
ENSG00000184588	PDE4B	NA	
ENSG00000227466	PDE4B-AS1	NA	
ENSG00000223152	RNU4-88P	NA	
ENSG00000118473	SGIP1	NA	
ENSG00000264720	MIR3117	NA	
ENSG00000248458	AL139147.1	NA	
ENSG00000152760	TCTEX1D1	NA	
ENSG00000172410	INSL5	NA	
ENSG00000152763	WDR78	NA	
ENSG00000231080	AL592161.1	NA	
ENSG00000198160	MIER1	NA	
ENSG00000116704	SLC35D1	269250	SCHNECKENBECKEN DYSPLASIA; SHNKND;;CHONDRODYSPLASIA, LETHAL NEONATAL, WITH SNAIL-LIKE PELVIS
ENSG00000203963	C1orf141	NA	
ENSG00000252433	AL133320.1	NA	
ENSG00000275678	AL133320.2	NA	
ENSG00000162594	IL23R	605606	PSORIASIS 7, SUSCEPTIBILITY TO; PSORS7
ENSG00000162594	IL23R	612261	INFLAMMATORY BOWEL DISEASE 17; IBD17
ENSG00000253074	RNU6-586P	NA	
ENSG00000252116	RNU4ATAC4P	NA	
ENSG00000228523	DNAJB6P4	NA	
ENSG00000081985	IL12RB2	NA	
ENSG00000142864	SERBP1	NA	
ENSG00000223263	RNU6-387P	NA	
ENSG00000235200	LINC01702	NA	
ENSG00000207504	RNU6-1031P	NA	
ENSG00000238139	AL590559.1	NA	
ENSG00000242482	RN7SL392P	NA	
ENSG00000232048	HNRNPCP9	NA	
ENSG00000116717	GADD45A	NA	
ENSG00000172380	GNG12	NA	
ENSG00000238778	RNU7-80P	NA	
ENSG00000232284	GNG12-AS1	NA	
ENSG00000235055	AL157407.1	NA	
ENSG00000162595	DIRAS3	NA	
ENSG00000228431	ARL5AP3	NA	
ENSG00000116729	WLS	NA	
ENSG00000234383	CTBP2P8	NA	
ENSG00000221203	MIR1262	NA	
ENSG00000229133	RPS7P4	NA	
ENSG00000225242	COX6B1P7	NA	
ENSG00000237622	ELOCP18	NA	
ENSG00000229440	AL139413.1	NA	
ENSG00000116745	RPE65	204100	LEBER CONGENITAL AMAUROSIS 2; LCA2;;AMAUROSIS CONGENITA OF LEBER II
ENSG00000116745	RPE65	613794	RETINITIS PIGMENTOSA 20; RP20
ENSG00000024526	DEPDC1	NA	
ENSG00000233589	AL138789.1	NA	
ENSG00000234264	DEPDC1-AS1	NA	
ENSG00000225167	TXNP2	NA	
ENSG00000285041	AL035412.1	NA	
ENSG00000285407	AL033530.1	NA	
ENSG00000285473	AL691520.1	NA	
ENSG00000223883	LINC01707	NA	
ENSG00000235446	LINC02791	NA	
ENSG00000229639	LINC01758	NA	
ENSG00000287453	AL359894.1	NA	
ENSG00000033122	LRRC7	NA	
ENSG00000270615	SGO1P1	NA	
ENSG00000287283	AL117353.1	NA	
ENSG00000240692	RN7SL538P	NA	
ENSG00000229359	PIN1P1	NA	
ENSG00000237919	LRRC7-AS1	NA	
ENSG00000066557	LRRC40	NA	
ENSG00000244389	RN7SL242P	NA	
ENSG00000116754	SRSF11	NA	
ENSG00000228988	AL353771.1	NA	
ENSG00000118454	ANKRD13C	NA	
ENSG00000197568	HHLA3	NA	
ENSG00000226088	HHLA3-AS1	NA	
ENSG00000116761	CTH	219500	CYSTATHIONINURIA;;CYSTATHIONASE DEFICIENCY
ENSG00000278636	AL354872.2	NA	
ENSG00000271992	AL354872.1	NA	
ENSG00000233020	CHORDC1P5	NA	
ENSG00000237033	CASP3P1	NA	
ENSG00000229051	LINC01788	NA	
ENSG00000226208	AL513285.1	NA	
ENSG00000050628	PTGER3	NA	
ENSG00000235782	AL031429.1	NA	
ENSG00000269933	AL031429.2	NA	
ENSG00000235079	ZRANB2-AS1	NA	
ENSG00000132485	ZRANB2	NA	
ENSG00000207721	MIR186	NA	
ENSG00000229956	ZRANB2-AS2	NA	
ENSG00000226324	AL358453.1	NA	
ENSG00000172260	NEGR1	NA	
ENSG00000231985	AL354949.1	NA	
ENSG00000271618	AL359821.1	NA	
ENSG00000228853	NEGR1-IT1	NA	
ENSG00000233994	GDI2P2	NA	
ENSG00000286863	AL513166.1	NA	
ENSG00000227207	RPL31P12	NA	
ENSG00000225087	AL583808.1	NA	
ENSG00000212366	RNU6-1246P	NA	
ENSG00000227016	LINC02796	NA	
ENSG00000285808	LINC02797	NA	
ENSG00000280317	AL732618.1	NA	
ENSG00000229636	KRT8P21	NA	
ENSG00000251825	RN7SKP19	NA	
ENSG00000233973	LINC01360	NA	
ENSG00000223479	LINC02238	NA	
ENSG00000200601	RNA5SP50	NA	
ENSG00000285778	AL591463.1	NA	
ENSG00000252005	RNU4ATAC8P	NA	
ENSG00000162620	LRRIQ3	NA	
ENSG00000254685	FPGT	NA	
ENSG00000259030	FPGT-TNNI3K	NA	
ENSG00000116783	TNNI3K	616117	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY; CCDD
ENSG00000237324	AC093158.1	NA	
ENSG00000233894	AC105271.1	NA	
ENSG00000162621	LRRC53	NA	
ENSG00000178965	ERICH3	NA	
ENSG00000234497	ERICH3-AS1	NA	
ENSG00000272864	AC135803.1	NA	
ENSG00000116791	CRYZ	NA	
ENSG00000162623	TYW3	NA	
ENSG00000229943	AC133865.1	NA	
ENSG00000261213	AC099786.3	NA	
ENSG00000224127	AC099786.1	NA	
ENSG00000162624	LHX8	NA	
ENSG00000224149	AC099786.2	NA	
ENSG00000206999	RNU6-622P	NA	
ENSG00000137968	SLC44A5	NA	
ENSG00000224493	AC093156.1	NA	
ENSG00000252338	RNU6-503P	NA	
ENSG00000213579	AL096829.1	NA	
ENSG00000230863	AL137803.1	NA	
ENSG00000117054	ACADM	201450	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD;;ACADM DEFICIENCY;;MCAD DEFICIENCY;;MCADH DEFICIENCY;;CARNITINE DEFICIENCY SECONDARY TO MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY
ENSG00000181227	DLSTP1	NA	
ENSG00000137955	RABGGTB	NA	
ENSG00000206620	SNORD45C	NA	
ENSG00000207241	SNORD45A	NA	
ENSG00000201487	SNORD45B	NA	
ENSG00000057468	MSH4	NA	
ENSG00000154007	ASB17	NA	
ENSG00000225605	AC092813.1	NA	
ENSG00000230027	AC092813.2	NA	
ENSG00000184005	ST6GALNAC3	NA	
ENSG00000223905	AC103592.1	NA	
ENSG00000272855	AC104458.1	NA	
ENSG00000226415	TPI1P1	NA	
ENSG00000199921	RNU6-161P	NA	
ENSG00000237552	LINC02567	NA	
ENSG00000117069	ST6GALNAC5	NA	
ENSG00000276081	MIR7156	NA	
ENSG00000288543	AL035409.2	NA	
ENSG00000230498	AL035409.1	NA	
ENSG00000142892	PIGK	NA	
ENSG00000226084	AC113935.1	NA	
ENSG00000228187	AC093433.1	NA	
ENSG00000287870	AC093433.2	NA	
ENSG00000154027	AK5	NA	
ENSG00000233099	AC095030.1	NA	
ENSG00000251767	RNU7-8P	NA	
ENSG00000287647	AC093575.1	NA	
ENSG00000036549	ZZZ3	NA	
ENSG00000251785	RNA5SP20	NA	
ENSG00000243437	RN7SL370P	NA	
ENSG00000077254	USP33	NA	
ENSG00000232672	ACTG1P21	NA	
ENSG00000180488	MIGA1	NA	
ENSG00000222849	RNA5SP21	NA	
ENSG00000219201	AC138392.1	NA	
ENSG00000235613	NSRP1P1	NA	
ENSG00000232015	HSPE1P25	NA	
ENSG00000235927	NEXN-AS1	NA	
ENSG00000162614	NEXN	613122	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC
ENSG00000162614	NEXN	613876	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20
ENSG00000162613	FUBP1	NA	
ENSG00000162616	DNAJB4	NA	
ENSG00000137960	GIPC2	NA	
ENSG00000273338	AC103591.3	NA	
ENSG00000285928	AC103591.4	NA	
ENSG00000213561	AC103591.2	NA	
ENSG00000251958	RNU6-1102P	NA	
ENSG00000213560	AC103591.1	NA	
ENSG00000202263	RNA5SP22	NA	
ENSG00000233333	RNFT1P2	NA	
ENSG00000237413	MGC27382	NA	
ENSG00000122420	PTGFR	NA	
ENSG00000227556	AC096531.1	NA	
ENSG00000212308	RNA5SP23	NA	
ENSG00000137959	IFI44L	NA	
ENSG00000137965	IFI44	NA	
ENSG00000238015	AC104837.2	NA	
ENSG00000235400	AC104837.1	NA	
ENSG00000162618	ADGRL4	NA	
ENSG00000230787	PSAT1P3	NA	
ENSG00000235011	AL353651.1	NA	
ENSG00000282898	AL353651.2	NA	
ENSG00000285462	LINC02792	NA	
ENSG00000232676	ADH5P2	NA	
ENSG00000285409	AC099671.1	NA	
ENSG00000235756	AC098657.1	NA	
ENSG00000260322	AC098657.2	NA	
ENSG00000277670	AC098657.3	NA	
ENSG00000236407	HMGB1P18	NA	
ENSG00000225598	AL606519.1	NA	
ENSG00000213559	HNRNPA1P64	NA	
ENSG00000227062	AL596276.1	NA	
ENSG00000234108	AL596276.2	NA	
ENSG00000224326	AL136234.1	NA	
ENSG00000234184	LINC01781	NA	
ENSG00000227937	MTND2P30	NA	
ENSG00000229752	RPL7P10	NA	
ENSG00000235089	AL357632.1	NA	
ENSG00000285179	AC093154.1	NA	
ENSG00000223026	RN7SKP247	NA	
ENSG00000117114	ADGRL2	NA	
ENSG00000224494	HNRNPA3P14	NA	
ENSG00000227288	ARID3BP1	NA	
ENSG00000227960	AL138799.1	NA	
ENSG00000234953	AL138799.3	NA	
ENSG00000242598	MED28P8	NA	
ENSG00000236676	AC117944.1	NA	
ENSG00000234683	AL138799.2	NA	
ENSG00000215875	ST13P20	NA	
ENSG00000233290	AL157944.1	NA	
ENSG00000230817	LINC01362	NA	
ENSG00000236268	LINC01361	NA	
ENSG00000285782	AC116099.1	NA	
ENSG00000231364	LINC01712	NA	
ENSG00000233008	LINC01725	NA	
ENSG00000237076	AL035706.1	NA	
ENSG00000137941	TTLL7	NA	
ENSG00000233061	TTLL7-IT1	NA	
ENSG00000229486	AC104454.1	NA	
ENSG00000285201	AC104454.2	NA	
ENSG00000271576	AL359504.1	NA	
ENSG00000142875	PRKACB	NA	
ENSG00000213540	TXN2P1	NA	
ENSG00000226970	NEDD8P1	NA	
ENSG00000199959	AL359273.1	NA	
ENSG00000203943	SAMD13	NA	
ENSG00000249237	AL359273.2	NA	
ENSG00000240520	UOX	NA	
ENSG00000137976	DNASE2B	NA	
ENSG00000285361	AL844170.1	NA	
ENSG00000117133	RPF1	NA	
ENSG00000174021	GNG5	NA	
ENSG00000285851	AL359762.3	NA	
ENSG00000122432	SPATA1	NA	
ENSG00000117151	CTBS	NA	
ENSG00000284882	AL359762.1	NA	
ENSG00000285374	AL359762.2	NA	
ENSG00000180869	LINC01555	NA	
ENSG00000232622	AC114482.1	NA	
ENSG00000117155	SSX2IP	NA	
ENSG00000285325	AC104169.1	NA	
ENSG00000171517	LPAR3	NA	
ENSG00000153898	MCOLN2	NA	
ENSG00000162643	WDR63	NA	
ENSG00000055732	MCOLN3	NA	
ENSG00000266110	MIR4423	NA	
ENSG00000280099	AL603750.1	NA	
ENSG00000097096	SYDE2	NA	
ENSG00000162642	C1orf52	NA	
ENSG00000223254	AL590113.1	NA	
ENSG00000142867	BCL10	156240	MESOTHELIOMA, MALIGNANT; MESOM
ENSG00000142867	BCL10	137245	LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE;;MALT LYMPHOMA;;GASTRIC LYMPHOMA, PRIMARY
ENSG00000142867	BCL10	273300	TESTICULAR GERM CELL TUMOR; TGCT;;MALE GERM CELL TUMOR; MGCT SEMINOMA, INCLUDED;;NONSEMINOMATOUS GERM CELL TUMORS, INCLUDED;;TERATOMA, TESTICULAR, INCLUDED;;EMBRYONAL CELL CARCINOMA, INCLUDED;;ENDODERMAL SINUS TUMOR, INCLUDED;;SPERMATOCYTIC SEMINOMA /.../UDED
ENSG00000142867	BCL10	605027	LYMPHOMA, NON-HODGKIN, FAMILIAL;;NON-HODGKIN LYMPHOMA; NHL
ENSG00000142867	BCL10	616098	IMMUNODEFICIENCY 37; IMD37
ENSG00000223653	AL078459.1	NA	
ENSG00000153904	DDAH1	NA	
ENSG00000199459	AL360219.1	NA	
ENSG00000273264	AL360219.2	NA	
ENSG00000282057	AC092807.4	NA	
ENSG00000272691	AC092807.3	NA	
ENSG00000142871	CCN1	NA	
ENSG00000199934	AC092807.1	NA	
ENSG00000230285	AC092807.2	NA	
ENSG00000117174	ZNHIT6	NA	
ENSG00000171502	COL24A1	NA	
ENSG00000201620	RNA5SP51	NA	
ENSG00000229505	AC104455.1	NA	
ENSG00000285210	LINC02795	NA	
ENSG00000122417	ODF2L	NA	
ENSG00000278281	MIR7856	NA	
ENSG00000231349	AC119749.1	NA	
ENSG00000137975	CLCA2	NA	
ENSG00000016490	CLCA1	NA	
ENSG00000016602	CLCA4	NA	
ENSG00000224466	CDCA4P2	NA	
ENSG00000236915	CLCA4-AS1	NA	
ENSG00000153923	CLCA3P	NA	
ENSG00000261737	CLCA4-AS1	NA	
ENSG00000097033	SH3GLB1	NA	
ENSG00000230721	AL049597.1	NA	
ENSG00000284846	AL355981.1	NA	
ENSG00000183291	SELENOF	NA	
ENSG00000153936	HS2ST1	NA	
ENSG00000267734	AL121989.1	NA	
ENSG00000267561	AC093155.3	NA	
ENSG00000235251	AC093155.2	NA	
ENSG00000225568	AC093155.1	NA	
ENSG00000267272	LINC01140	NA	
ENSG00000284240	LINC02801	NA	
ENSG00000143013	LMO4	NA	
ENSG00000227290	LINC01364	NA	
ENSG00000199318	RNA5SP52	NA	
ENSG00000237505	PKN2-AS1	NA	
ENSG00000279778	AL445437.1	NA	
ENSG00000270507	AL049861.1	NA	
ENSG00000286758	AL445438.1	NA	
ENSG00000239504	RN7SL583P	NA	
ENSG00000230053	AC093578.1	NA	
ENSG00000274321	AC093578.2	NA	
ENSG00000237959	RPL36AP10	NA	
ENSG00000065243	PKN2	NA	
ENSG00000207234	RNU6-125P	NA	
ENSG00000241975	ELOCP19	NA	
ENSG00000137947	GTF2B	NA	
ENSG00000235308	AL445991.1	NA	
ENSG00000137944	KYAT3	NA	
ENSG00000213516	RBMXL1	NA	
ENSG00000117226	GBP3	NA	
ENSG00000202385	Y_RNA	NA	
ENSG00000117228	GBP1	NA	
ENSG00000234518	PTGES3P1	NA	
ENSG00000162645	GBP2	NA	
ENSG00000286802	AC104459.1	NA	
ENSG00000213512	GBP7	NA	
ENSG00000162654	GBP4	NA	
ENSG00000284734	AC099063.4	NA	
ENSG00000284637	AC099063.3	NA	
ENSG00000154451	GBP5	NA	
ENSG00000237568	AC099063.1	NA	
ENSG00000238081	AC099063.2	NA	
ENSG00000233235	BX119321.1	NA	
ENSG00000183347	GBP6	NA	
ENSG00000215874	CAPNS1P1	NA	
ENSG00000225492	GBP1P1	NA	
ENSG00000286548	AL596214.1	NA	
ENSG00000197147	LRRC8B	NA	
ENSG00000288629	AC099569.1	NA	
ENSG00000231999	LRRC8C-DT	NA	
ENSG00000230735	AC093423.2	NA	
ENSG00000171488	LRRC8C	NA	
ENSG00000271949	AC093423.3	NA	
ENSG00000226394	AC093423.1	NA	
ENSG00000231613	AC099568.1	NA	
ENSG00000272931	AC099568.2	NA	
ENSG00000171492	LRRC8D	NA	
ENSG00000272672	AL391497.1	NA	
ENSG00000252797	RN7SKP272	NA	
ENSG00000228175	GEMIN8P4	NA	
ENSG00000162664	ZNF326	NA	
ENSG00000287015	AL161797.1	NA	
ENSG00000287406	AC098656.1	NA	
ENSG00000212459	RNU6-695P	NA	
ENSG00000287372	AL627316.1	NA	
ENSG00000229201	LINC02787	NA	
ENSG00000199666	SNORD3G	NA	
ENSG00000143032	BARHL2	NA	
ENSG00000287076	AC092805.1	NA	
ENSG00000233593	LINC02609	NA	
ENSG00000285532	LINC02788	NA	
ENSG00000225446	LINC01763	NA	
ENSG00000272094	AC091614.1	NA	
ENSG00000232882	PHKA1P1	NA	
ENSG00000122482	ZNF644	614167	MYOPIA 21, AUTOSOMAL DOMINANT; MYP21
ENSG00000232393	RPL5P6	NA	
ENSG00000162669	HFM1	615724	PREMATURE OVARIAN FAILURE 9; POF9
ENSG00000206817	Y_RNA	NA	
ENSG00000215873	FEN1P1	NA	
ENSG00000097046	CDC7	NA	
ENSG00000241318	WDR82P2	NA	
ENSG00000229067	AL714022.1	NA	
ENSG00000203914	HSP90B3P	NA	
ENSG00000069702	TGFBR3	NA	
ENSG00000239794	RN7SL653P	NA	
ENSG00000137948	BRDT	617644	SPERMATOGENIC FAILURE 21; SPGF21
ENSG00000172031	EPHX4	NA	
ENSG00000233228	LPCAT2BP	NA	
ENSG00000230667	SETSIP	NA	
ENSG00000189195	BTBD8	NA	
ENSG00000224678	GAPDHP46	NA	
ENSG00000233401	PRKAR1AP1	NA	
ENSG00000273487	AC104836.1	NA	
ENSG00000226773	AL663109.1	NA	
ENSG00000203910	C1orf146	NA	
ENSG00000233125	ACTBP12	NA	
ENSG00000174842	GLMN	138000	GLOMUVENOUS MALFORMATIONS; GVM;;VENOUS MALFORMATIONS WITH GLOMUS CELLS; VMGLOM;;GLOMUS TUMORS, MULTIPLE;;GLOMANGIOMAS, MULTIPLE
ENSG00000122484	RPAP2	NA	
ENSG00000242764	RN7SL824P	NA	
ENSG00000162676	GFI1	607847	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS;;NONIMMUNE CHRONIC IDIOPATHIC NEUTROPENIA OF ADULTS;;NI-CINA
ENSG00000162676	GFI1	613107	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2
ENSG00000067208	EVI5	NA	
ENSG00000223787	AL354890.1	NA	
ENSG00000229992	HMGB3P9	NA	
ENSG00000201317	RNU4-59P	NA	
ENSG00000225505	AC104332.1	NA	
ENSG00000234202	H3P3	NA	
ENSG00000223896	CCNJP2	NA	
ENSG00000122406	RPL5	612561	DIAMOND-BLACKFAN ANEMIA 6; DBA6;;AASE-SMITH SYNDROME II
ENSG00000154511	DIPK1A	NA	
ENSG00000206680	SNORD21	NA	
ENSG00000207523	SNORA66	NA	
ENSG00000207022	AL162740.1	NA	
ENSG00000229052	AL449283.1	NA	
ENSG00000252121	RNU6-970P	NA	
ENSG00000239710	RN7SL692P	NA	
ENSG00000287797	AC093577.1	NA	
ENSG00000252752	RNU6-210P	NA	
ENSG00000222664	RN7SKP123	NA	
ENSG00000251837	Y_RNA	NA	
ENSG00000143033	MTF2	NA	
ENSG00000117500	TMED5	NA	
ENSG00000122483	CCDC18	NA	
ENSG00000237003	AC126124.2	NA	
ENSG00000225297	AC126124.1	NA	
ENSG00000223745	CCDC18-AS1	NA	
ENSG00000229567	AL139421.1	NA	
ENSG00000117505	DR1	NA	
ENSG00000229635	AL137159.1	NA	
ENSG00000207379	Y_RNA	NA	
ENSG00000137942	FNBP1L	NA	
ENSG00000212601	RNA5SP53	NA	
ENSG00000137936	BCAR3	NA	
ENSG00000224093	BCAR3-AS1	NA	
ENSG00000211575	MIR760	NA	
ENSG00000260464	AL049796.1	NA	
ENSG00000067334	DNTTIP2	NA	
ENSG00000023909	GCLM	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000223490	CHCHD2P5	NA	
ENSG00000234099	MTND4P11	NA	
ENSG00000235794	MTND3P21	NA	
ENSG00000232752	MTCO3P21	NA	
ENSG00000229842	MTATP6P13	NA	
ENSG00000250890	AL117351.2	NA	
ENSG00000236689	MTCO2P21	NA	
ENSG00000226960	MTCO1P21	NA	
ENSG00000233129	AL117351.1	NA	
ENSG00000198691	ABCA4	153800	MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2;;MACULOPATHY, AGE-RELATED, 2;;MACULAR DEGENERATION, SENILE
ENSG00000198691	ABCA4	248200	STARGARDT DISEASE 1; STGD1;;STGD;;MACULAR DEGENERATION, JUVENILE;;MACULAR DYSTROPHY WITH FLECKS, TYPE 1 FUNDUS FLAVIMACULATUS, INCLUDED; FFM, INCLUDED;;RETINAL DYSTROPHY, EARLY-ONSET SEVERE, INCLUDED
ENSG00000198691	ABCA4	601718	RETINITIS PIGMENTOSA 19; RP19
ENSG00000198691	ABCA4	604116	CONE-ROD DYSTROPHY 3; CORD3
ENSG00000233482	AC093579.1	NA	
ENSG00000137962	ARHGAP29	NA	
ENSG00000264963	RN7SL440P	NA	
ENSG00000226835	ARHGAP29-AS1	NA	
ENSG00000178596	GAPDHP29	NA	
ENSG00000236098	AC097059.1	NA	
ENSG00000232918	AC118469.1	NA	
ENSG00000286692	AC118469.2	NA	
ENSG00000117528	ABCD3	616278	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5
ENSG00000117525	F3	NA	
ENSG00000223675	AC093117.1	NA	
ENSG00000224081	SLC44A3-AS1	NA	
ENSG00000232857	KATNBL1P2	NA	
ENSG00000263526	MIR378G	NA	
ENSG00000143036	SLC44A3	NA	
ENSG00000117519	CNN3	NA	
ENSG00000235501	AC105942.1	NA	
ENSG00000172339	ALG14	616227	MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15;;MYASTHENIC SYNDROME, CONGENITAL, WITHOUT TUBULAR AGGREGATES; CMSWTA
ENSG00000230427	ALG14-AS1	NA	
ENSG00000152078	TLCD4	NA	
ENSG00000271092	TLCD4-RWDD3	NA	
ENSG00000231992	AC092802.3	NA	
ENSG00000206679	Y_RNA	NA	
ENSG00000226026	AC092802.1	NA	
ENSG00000122481	RWDD3	NA	
ENSG00000228852	AC092802.2	NA	
ENSG00000287919	AC092802.4	NA	
ENSG00000228504	LINC01760	NA	
ENSG00000230434	LINC01650	NA	
ENSG00000237954	AL445218.1	NA	
ENSG00000233907	LINC01761	NA	
ENSG00000228971	LINC02607	NA	
ENSG00000271252	AL683887.1	NA	
ENSG00000237435	LINC02790	NA	
ENSG00000200800	RNU1-130P	NA	
ENSG00000231987	LINC01787	NA	
ENSG00000225923	AC092393.1	NA	
ENSG00000234422	UBE2WP1	NA	
ENSG00000228502	EEF1A1P11	NA	
ENSG00000241992	RN7SL831P	NA	
ENSG00000234226	NDUFS5P2	NA	
ENSG00000137970	RPL7P9	NA	
ENSG00000223229	RN7SKP270	NA	
ENSG00000117569	PTBP2	NA	
ENSG00000188641	DPYD	274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY;;DPD DEFICIENCY;;DPYD DEFICIENCY;;THYMINE-URACILURIA, HEREDITARY;;PYRIMIDINEMIA, FAMILIAL  5-@FLUOROURACIL TOXICITY, INCLUDED
ENSG00000232878	DPYD-AS1	NA	
ENSG00000232542	DPYD-IT1	NA	
ENSG00000228057	SEC63P1	NA	
ENSG00000226128	RPL26P9	NA	
ENSG00000230718	AC114878.1	NA	
ENSG00000235777	DPYD-AS2	NA	
ENSG00000270911	AC114878.2	NA	
ENSG00000225206	MIR137HG	NA	
ENSG00000259946	BX005019.1	NA	
ENSG00000284247	MIR2682	NA	
ENSG00000284202	MIR137	NA	
ENSG00000285922	AC104453.1	NA	
ENSG00000233557	NFU1P2	NA	
ENSG00000226053	LINC01776	NA	
ENSG00000280040	AC095031.1	NA	
ENSG00000162627	SNX7	NA	
ENSG00000117598	PLPPR5	NA	
ENSG00000232825	AL445433.2	NA	
ENSG00000227034	AL445433.1	NA	
ENSG00000117600	PLPPR4	NA	
ENSG00000233983	AL365220.1	NA	
ENSG00000224445	LINC01708	NA	
ENSG00000099260	PALMD	NA	
ENSG00000223656	HMGB3P10	NA	
ENSG00000156869	FRRS1	NA	
ENSG00000201491	RNU4-75P	NA	
ENSG00000202254	Y_RNA	NA	
ENSG00000231996	AC096949.1	NA	
ENSG00000162688	AGL	232400	GLYCOGEN STORAGE DISEASE III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCY GLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOG /.../RAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED
ENSG00000228084	AC118553.1	NA	
ENSG00000117620	SLC35A3	615553	ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES; AMRS
ENSG00000283761	AC118553.2	NA	
ENSG00000212248	RNU6-750P	NA	
ENSG00000202259	RNU6-1318P	NA	
ENSG00000156875	MFSD14A	NA	
ENSG00000241073	AC093019.2	NA	
ENSG00000156876	SASS6	616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14
ENSG00000226952	AC093019.1	NA	
ENSG00000122435	TRMT13	NA	
ENSG00000122477	LRRC39	NA	
ENSG00000137992	DBT	248600	MAPLE SYRUP URINE DISEASE; MSUD;;BRANCHED-CHAIN KETOACIDURIA;;BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY;;BCKD DEFICIENCY;;KETO ACID DECARBOXYLASE DEFICIENCY MAPLE SYRUP URINE DISEASE, CLASSIC, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTER /.../E, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTERMITTENT, INCLUDED;;MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IA, INCLUDED; MSUD1A, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IB, INCLUDED; MSUD1B, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE II, INCLUDED; MSUD2, INCLUDED
ENSG00000271415	RPL23AP90	NA	
ENSG00000225169	BRI3P1	NA	
ENSG00000285530	AL445928.2	NA	
ENSG00000230287	AL445928.1	NA	
ENSG00000224616	RTCA-AS1	NA	
ENSG00000137996	RTCA	NA	
ENSG00000207750	MIR553	NA	
ENSG00000215871	AC104457.1	NA	
ENSG00000223906	AC104457.2	NA	
ENSG00000079335	CDC14A	608653	DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32;;HEARING IMPAIRMENT INFERTILE MALE SYNDROME; HIIMS;;DEAFNESS, AUTOSOMAL RECESSIVE 105, FORMERLY; DFNB105, FORMERLY
ENSG00000234332	BCAS2P2	NA	
ENSG00000228086	AL589990.1	NA	
ENSG00000181656	GPR88	616939	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION; COCPMR
ENSG00000213421	AC099670.1	NA	
ENSG00000230402	LINC01349	NA	
ENSG00000285525	AC099670.3	NA	
ENSG00000224685	AC099670.2	NA	
ENSG00000162692	VCAM1	NA	
ENSG00000162694	EXTL2	NA	
ENSG00000273204	AC104506.1	NA	
ENSG00000162695	SLC30A7	NA	
ENSG00000230946	HNRNPA1P68	NA	
ENSG00000117543	DPH5	NA	
ENSG00000235795	AC093157.2	NA	
ENSG00000233184	AC093157.1	NA	
ENSG00000252765	AC093157.3	NA	
ENSG00000271578	AC119501.1	NA	
ENSG00000225938	AL109741.1	NA	
ENSG00000170989	S1PR1	NA	
ENSG00000228399	AL109741.2	NA	
ENSG00000173810	PPIAP7	NA	
ENSG00000231671	LINC01307	NA	
ENSG00000226715	LINC01709	NA	
ENSG00000252530	RNU6-965P	NA	
ENSG00000183298	RPSAP19	NA	
ENSG00000118733	OLFM3	NA	
ENSG00000252717	RNU6-352P	NA	
ENSG00000271277	AL356280.1	NA	
ENSG00000162699	DNAJA1P5	NA	
ENSG00000233359	AC114485.1	NA	
ENSG00000230864	AC099567.1	NA	
ENSG00000060718	COL11A1	154780	MARSHALL SYNDROME; MRSHS
ENSG00000060718	COL11A1	228520	FIBROCHONDROGENESIS 1; FBCG1
ENSG00000060718	COL11A1	603932	INTERVERTEBRAL DISC DISEASE; IDD LUMBAR DISC DISEASE, INCLUDED; LDD, INCLUDED;;LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO, INCLUDED;;LUMBAR DISC DEGENERATION, SUSCEPTIBILITY TO, INCLUDED
ENSG00000060718	COL11A1	604841	STICKLER SYNDROME, TYPE II; STL2;;STICKLER SYNDROME, VITREOUS TYPE 2;;STICKLER SYNDROME, BEADED VITREOUS TYPE
ENSG00000060718	COL11A1	618533	DEAFNESS, AUTOSOMAL DOMINANT 37; DFNA37
ENSG00000234257	SOD2P1	NA	
ENSG00000230759	AC095032.2	NA	
ENSG00000224613	AC095032.1	NA	
ENSG00000222069	RN7SKP285	NA	
ENSG00000185946	RNPC3	618160	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5
ENSG00000240038	AMY2B	NA	
ENSG00000236085	ACTG1P4	NA	
ENSG00000243480	AMY2A	NA	
ENSG00000237763	AMY1A	NA	
ENSG00000234441	AC105272.1	NA	
ENSG00000174876	AMY1B	NA	
ENSG00000227408	AMYP1	NA	
ENSG00000187733	AMY1C	NA	
ENSG00000225191	AL136455.1	NA	
ENSG00000215869	AC092506.1	NA	
ENSG00000228347	FTLP17	NA	
ENSG00000285981	AL591888.1	NA	
ENSG00000225036	CDK4P1	NA	
ENSG00000230768	LINC01676	NA	
ENSG00000227850	SEPTIN2P1	NA	
ENSG00000237897	AL512844.2	NA	
ENSG00000232952	AL512844.1	NA	
ENSG00000233047	LINC01677	NA	
ENSG00000237480	AL355306.2	NA	
ENSG00000230932	AL355306.1	NA	
ENSG00000270342	AL499605.1	NA	
ENSG00000270976	AL596327.1	NA	
ENSG00000233449	MTATP6P14	NA	
ENSG00000232551	MTCO1P14	NA	
ENSG00000237460	LINC01661	NA	
ENSG00000198890	PRMT6	NA	
ENSG00000162631	NTNG1	NA	
ENSG00000224550	AC114491.1	NA	
ENSG00000134215	VAV3	NA	
ENSG00000275455	MIR7852	NA	
ENSG00000230489	VAV3-AS1	NA	
ENSG00000226822	LINC02785	NA	
ENSG00000085491	SLC25A24	612289	FONTAINE PROGEROID SYNDROME; FPS;;GORLIN-CHAUDHRY-MOSS SYNDROME; GCMS;;PROGEROID SYNDROME, CONGENITAL, PETTY TYPE;;CRANIOFACIAL DYSOSTOSIS, HYPERTRICHOSIS, HYPOPLASIA OF LABIA MAJORA, DENTAL AND EYE ANOMALIES, PATENT DUCTUS ARTERIOSUS, AND NORMAL IN /.../ENCE
ENSG00000260879	AL359258.2	NA	
ENSG00000280186	AL359258.3	NA	
ENSG00000196427	NBPF4	NA	
ENSG00000238122	AL359258.1	NA	
ENSG00000241361	SLC25A24P1	NA	
ENSG00000243967	NBPF5P	NA	
ENSG00000238118	SLC25A24P2	NA	
ENSG00000224698	AL390038.1	NA	
ENSG00000186086	NBPF6	NA	
ENSG00000283354	AL392088.2	NA	
ENSG00000227832	ST13P21	NA	
ENSG00000226483	AL392088.1	NA	
ENSG00000162636	FAM102B	NA	
ENSG00000162639	HENMT1	NA	
ENSG00000285923	AL160171.1	NA	
ENSG00000134186	PRPF38B	NA	
ENSG00000143107	FNDC7	NA	
ENSG00000232971	AL591719.2	NA	
ENSG00000116266	STXBP3	NA	
ENSG00000228076	AL591719.1	NA	
ENSG00000162641	AKNAD1	NA	
ENSG00000203897	SPATA42	NA	
ENSG00000121957	GPSM2	604213	CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUM AND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82, FORMERLY; DFNB82, FORMERLY
ENSG00000121940	CLCC1	NA	
ENSG00000085433	WDR47	NA	
ENSG00000237349	BX679664.2	NA	
ENSG00000244716	BX679664.3	NA	
ENSG00000228665	BX679664.1	NA	
ENSG00000228054	RANP5	NA	
ENSG00000197780	TAF13	617432	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60; MRT60
ENSG00000273382	AL356488.3	NA	
ENSG00000215717	TMEM167B	NA	
ENSG00000278249	SCARNA2	NA	
ENSG00000270066	AL356488.2	NA	
ENSG00000251484	AL356488.1	NA	
ENSG00000179902	C1orf194	NA	
ENSG00000116299	ELAPOR1	NA	
ENSG00000031698	SARS1	617709	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS
ENSG00000143126	CELSR2	NA	
ENSG00000134222	PSRC1	NA	
ENSG00000221986	MYBPHL	NA	
ENSG00000134243	SORT1	613589	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6
ENSG00000143106	PSMA5	NA	
ENSG00000143028	SYPL2	NA	
ENSG00000162650	ATXN7L2	NA	
ENSG00000174151	CYB561D1	NA	
ENSG00000181754	AMIGO1	NA	
ENSG00000156097	GPR61	NA	
ENSG00000254942	AL355310.3	NA	
ENSG00000065135	GNAI3	602483	AURICULOCONDYLAR SYNDROME 1; ARCND1;;QUESTION MARK EARS SYNDROME
ENSG00000206832	RNU6V	NA	
ENSG00000225113	AL355310.1	NA	
ENSG00000284443	MIR197	NA	
ENSG00000134183	GNAT2	613856	ACHROMATOPSIA 4; ACHM4
ENSG00000116337	AMPD2	615686	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63
ENSG00000116337	AMPD2	615809	PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9
ENSG00000228703	AL355310.2	NA	
ENSG00000235045	RPL7P8	NA	
ENSG00000168765	GSTM4	NA	
ENSG00000213366	GSTM2	NA	
ENSG00000134184	GSTM1	NA	
ENSG00000260246	AC000032.1	NA	
ENSG00000134201	GSTM5	NA	
ENSG00000241720	AL158847.1	NA	
ENSG00000134202	GSTM3	NA	
ENSG00000198758	EPS8L3	612841	HYPOTRICHOSIS 5; HYPT5;;MARIE UNNA HEREDITARY HYPOTRICHOSIS 2; MUHH2
ENSG00000224927	NDUFA5P10	NA	
ENSG00000228420	LINC01768	NA	
ENSG00000235005	AL450468.1	NA	
ENSG00000261055	AL450468.2	NA	
ENSG00000184371	CSF1	NA	
ENSG00000168710	AHCYL1	NA	
ENSG00000143093	STRIP1	NA	
ENSG00000258634	AL160006.1	NA	
ENSG00000156150	ALX3	136760	FRONTONASAL DYSPLASIA 1; FND1;;FRONTORHINY;;FRONTONASAL DYSPLASIA; FND;;FRONTONASAL MALFORMATION; FNM;;MEDIAN FACIAL CLEFT SYNDROME
ENSG00000258673	LINC01397	NA	
ENSG00000186150	UBL4B	NA	
ENSG00000197106	SLC6A17	616269	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48
ENSG00000227091	AL355990.1	NA	
ENSG00000235526	AL355990.2	NA	
ENSG00000224965	LINC02586	NA	
ENSG00000116396	KCNC4	NA	
ENSG00000282852	AL137790.2	NA	
ENSG00000200536	AL137790.1	NA	
ENSG00000227963	RBM15-AS1	NA	
ENSG00000162775	RBM15	NA	
ENSG00000224699	LAMTOR5-AS1	NA	
ENSG00000168679	SLC16A4	NA	
ENSG00000273373	AL355488.1	NA	
ENSG00000134248	LAMTOR5	NA	
ENSG00000143125	PROK1	NA	
ENSG00000270380	AL358215.1	NA	
ENSG00000282887	AL358215.2	NA	
ENSG00000283999	AL358215.3	NA	
ENSG00000240194	CYMP	NA	
ENSG00000235407	CYMP-AS1	NA	
ENSG00000143105	KCNA10	NA	
ENSG00000177301	KCNA2	616366	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32
ENSG00000259834	AL365361.1	NA	
ENSG00000177272	KCNA3	NA	
ENSG00000199710	AL354713.1	NA	
ENSG00000237415	NRBF2P3	NA	
ENSG00000232791	OR11I1P	NA	
ENSG00000143119	CD53	NA	
ENSG00000261654	AL360270.2	NA	
ENSG00000232811	AL360270.1	NA	
ENSG00000121931	LRIF1	NA	
ENSG00000273010	AL360270.3	NA	
ENSG00000225672	CCNT2P1	NA	
ENSG00000252760	RNA5SP54	NA	
ENSG00000156171	DRAM2	616502	CONE-ROD DYSTROPHY 21; CORD21;;RETINAL DYSTROPHY WITH EARLY MACULAR INVOLVEMENT
ENSG00000134255	CEPT1	NA	
ENSG00000272982	AL355816.1	NA	
ENSG00000273221	AL355816.2	NA	
ENSG00000162777	DENND2D	NA	
ENSG00000064886	CHI3L2	NA	
ENSG00000236040	CHIAP1	NA	
ENSG00000203878	CHIAP2	NA	
ENSG00000134216	CHIA	NA	
ENSG00000229283	AL356387.1	NA	
ENSG00000232240	AL356387.2	NA	
ENSG00000173947	PIFO	NA	
ENSG00000234020	CHIAP3	NA	
ENSG00000236012	HIGD1AP12	NA	
ENSG00000227179	PGBP	NA	
ENSG00000085465	OVGP1	NA	
ENSG00000260948	AL390195.2	NA	
ENSG00000233337	UBE2FP3	NA	
ENSG00000243960	AL390195.1	NA	
ENSG00000116455	WDR77	NA	
ENSG00000199890	Y_RNA	NA	
ENSG00000116459	ATP5PB	NA	
ENSG00000143110	C1orf162	NA	
ENSG00000121933	TMIGD3	NA	
ENSG00000200360	RNU6-792P	NA	
ENSG00000282608	ADORA3	NA	
ENSG00000116473	RAP1A	NA	
ENSG00000231346	LINC01160	NA	
ENSG00000215867	KRT18P57	NA	
ENSG00000201028	RNU6-151P	NA	
ENSG00000197852	INKA2	NA	
ENSG00000227811	INKA2-AS1	NA	
ENSG00000284830	AL049557.1	NA	
ENSG00000064703	DDX20	NA	
ENSG00000171385	KCND3	607346	SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22
ENSG00000171385	KCND3	616399	BRUGADA SYNDROME 9; BRGDA9
ENSG00000232558	KCND3-IT1	NA	
ENSG00000237556	KCND3-AS1	NA	
ENSG00000231437	LINC01750	NA	
ENSG00000231246	LINC02884	NA	
ENSG00000234388	TXNP3	NA	
ENSG00000238761	AL591521.1	NA	
ENSG00000143079	CTTNBP2NL	NA	
ENSG00000283296	MIR4256	NA	
ENSG00000134245	WNT2B	618168	DIARRHEA 9; DIAR9
ENSG00000273483	AL354760.1	NA	
ENSG00000007341	ST7L	NA	
ENSG00000116489	CAPZA1	NA	
ENSG00000235299	MRPL53P1	NA	
ENSG00000252750	RNU7-70P	NA	
ENSG00000155363	MOV10	NA	
ENSG00000225075	AL603832.1	NA	
ENSG00000155366	RHOC	NA	
ENSG00000271810	AL603832.3	NA	
ENSG00000155367	PPM1J	NA	
ENSG00000261595	AL603832.2	NA	
ENSG00000184599	TAFA3	NA	
ENSG00000234790	NUTF2P4	NA	
ENSG00000215866	LINC01356	NA	
ENSG00000224167	LINC01357	NA	
ENSG00000228040	AL390729.1	NA	
ENSG00000155380	SLC16A1	245340	ERYTHROCYTE LACTATE TRANSPORTER DEFECT;;LACTATE TRANSPORTER DEFECT, MYOPATHY DUE TO
ENSG00000155380	SLC16A1	610021	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7;;HYPERINSULINEMIC HYPOGLYCEMIA, EXERCISE-INDUCED
ENSG00000155380	SLC16A1	616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D
ENSG00000229020	AKR7A2P1	NA	
ENSG00000226419	SLC16A1-AS1	NA	
ENSG00000287807	AL390242.1	NA	
ENSG00000238198	LRIG2-DT	NA	
ENSG00000198799	LRIG2	615112	UROFACIAL SYNDROME 2; UFS2
ENSG00000237278	RLIMP2	NA	
ENSG00000233839	AL357055.1	NA	
ENSG00000236887	AL357055.2	NA	
ENSG00000081026	MAGI3	NA	
ENSG00000232499	AL391058.1	NA	
ENSG00000238256	MTND5P20	NA	
ENSG00000116793	PHTF1	NA	
ENSG00000232450	AL133517.1	NA	
ENSG00000081019	RSBN1	NA	
ENSG00000231128	AL137856.1	NA	
ENSG00000134242	PTPN22	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000134242	PTPN22	152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED;;EXCESS LMW-DNA, INCLUDED
ENSG00000134242	PTPN22	222100	DIABETES MELLITUS, TYPE I;;DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM;;JUVENILE-ONSET DIABETES; JOD DIABETES MELLITUS, INSULIN-DEPENDENT, 1, INCLUDED; IDDM1, INCLUDED;;INSULIN-DEPENDENT DIABETES MELLITUS 1, INCLUDED
ENSG00000226167	AP4B1-AS1	NA	
ENSG00000188761	BCL2L15	NA	
ENSG00000134262	AP4B1	614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 5, FORMERLY; CPSQ5, FORMERLY
ENSG00000118655	DCLRE1B	NA	
ENSG00000235527	HIPK1-AS1	NA	
ENSG00000163349	HIPK1	NA	
ENSG00000116774	OLFML3	NA	
ENSG00000270780	AL591742.1	NA	
ENSG00000282048	AL591742.2	NA	
ENSG00000134207	SYT6	NA	
ENSG00000232895	AL121999.1	NA	
ENSG00000273698	MRPL57P1	NA	
ENSG00000271419	AL035410.2	NA	
ENSG00000197323	TRIM33	NA	
ENSG00000226984	AL035410.1	NA	
ENSG00000225650	EIF2S2P5	NA	
ENSG00000201114	Y_RNA	NA	
ENSG00000236480	PKMP1	NA	
ENSG00000116752	BCAS2	NA	
ENSG00000175984	DENND2C	NA	
ENSG00000116748	AMPD1	615511	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD;;ADENOSINE MONOPHOSPHATE DEAMINASE-1 DEFICIENCY, MYOPATHY DUE TO;;AMPD1 DEFICIENCY;;MYOADENYLATE DEAMINASE DEFICIENCY, MYOPATHY DUE TO
ENSG00000242769	RN7SL432P	NA	
ENSG00000213281	NRAS	163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM;;SFM SYNDROME;;LINEAR SEBACEOUS NEVUS SYNDROME;;SEBACEOUS NEVUS SYNDROME, LINEAR;;JADASSOHN NEVUS PHAKOMATOSIS; JNP;;NEVUS SEBACEUS OF JADASSOHN;;ORGANOID NEVUS PHAKOMATOSIS;;EPIDERMAL NEVUS SYNDROME, FORMERLY
ENSG00000213281	NRAS	162900	NEVUS, EPIDERMAL;;NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC  NEVUS SEBACEOUS, INCLUDED;;NEVUS, WOOLLY HAIR, INCLUDED
ENSG00000213281	NRAS	137550	MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS;;GIANT PIGMENTED HAIRY NEVUS; GPHN;;GIANT CONGENITAL PIGMENTED NEVUS;;PIGMENTED MOLES NEVUS SPILUS, INCLUDED;;SPITZ NEVUS, INCLUDED
ENSG00000213281	NRAS	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000213281	NRAS	188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2
ENSG00000213281	NRAS	249400	MELANOSIS, NEUROCUTANEOUS; NCMS;;NEUROMELANOSIS
ENSG00000213281	NRAS	613224	NOONAN SYNDROME 6; NS6
ENSG00000213281	NRAS	614470	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; ALPS4
ENSG00000009307	CSDE1	NA	
ENSG00000201900	RNY1P13	NA	
ENSG00000052723	SIKE1	NA	
ENSG00000227970	NR1H5P	NA	
ENSG00000198765	SYCP1	NA	
ENSG00000134200	TSHB	275100	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4;;THYROTROPIN DEFICIENCY, ISOLATED;;THYROID-STIMULATING HORMONE DEFICIENCY;;TSH DEFICIENCY;;PITUITARY CRETINISM  THYROTROPIN, BIOLOGICALLY INACTIVE, INCLUDED
ENSG00000134198	TSPAN2	NA	
ENSG00000233730	LINC01765	NA	
ENSG00000285698	AL049825.1	NA	
ENSG00000228035	NGF-AS1	NA	
ENSG00000134259	NGF	608654	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5;;HSAN V;;INSENSITIVITY TO PAIN, CONGENITAL
ENSG00000287103	AL512638.3	NA	
ENSG00000226973	AL512638.1	NA	
ENSG00000274468	AL512638.2	NA	
ENSG00000229101	ELOCP20	NA	
ENSG00000232185	CNOT7P2	NA	
ENSG00000270631	AL592436.2	NA	
ENSG00000239984	RN7SL420P	NA	
ENSG00000207502	AL592436.1	NA	
ENSG00000173218	VANGL1	182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD SPINA BIFIDA, INCLUDED
ENSG00000173218	VANGL1	600145	SACRAL DEFECT WITH ANTERIOR MENINGOCELE;;SDAM CAUDAL DYSGENESIS SYNDROME, INCLUDED;;CAUDAL REGRESSION SYNDROME, INCLUDED;;SACRAL AGENESIS, INCLUDED;;SIRENOMELIA, INCLUDED
ENSG00000118729	CASQ2	604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1;;VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP
ENSG00000118729	CASQ2	611938	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2;;VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP
ENSG00000177551	NHLH2	NA	
ENSG00000214204	HNRNPA1P43	NA	
ENSG00000228127	LINC01649	NA	
ENSG00000271143	AL357137.1	NA	
ENSG00000163393	SLC22A15	NA	
ENSG00000237993	AL365318.1	NA	
ENSG00000173212	MAB21L3	NA	
ENSG00000235933	LINC01779	NA	
ENSG00000221040	AL355538.1	NA	
ENSG00000287217	AL355538.2	NA	
ENSG00000163399	ATP1A1	618036	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2DD
ENSG00000163399	ATP1A1	618314	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2
ENSG00000203865	ATP1A1-AS1	NA	
ENSG00000212385	RNU6-817P	NA	
ENSG00000233154	LINC01762	NA	
ENSG00000230381	AL136376.1	NA	
ENSG00000200547	AL390066.1	NA	
ENSG00000224950	AL390066.2	NA	
ENSG00000286276	AL390066.3	NA	
ENSG00000116815	CD58	NA	
ENSG00000177173	NAP1L4P1	NA	
ENSG00000264419	MIR548AC	NA	
ENSG00000143061	IGSF3	149700	LACRIMAL DUCT DEFECT; LCDD;;NASOLACRIMAL DUCT OBSTRUCTION;;LACRIMAL PUNCTA, ABSENCE OF
ENSG00000211543	MIR320B1	NA	
ENSG00000203864	LINC02868	NA	
ENSG00000231072	GAPDHP64	NA	
ENSG00000223489	NEFHP1	NA	
ENSG00000116824	CD2	NA	
ENSG00000225079	FTH1P22	NA	
ENSG00000272715	AL157904.1	NA	
ENSG00000134247	PTGFRN	NA	
ENSG00000252510	RNA5SP55	NA	
ENSG00000134256	CD101	NA	
ENSG00000236137	AL445231.1	NA	
ENSG00000116830	TTF2	NA	
ENSG00000215930	MIR942	NA	
ENSG00000134253	TRIM45	NA	
ENSG00000228453	RPS15AP9	NA	
ENSG00000134258	VTCN1	NA	
ENSG00000277141	Metazoa_SRP	NA	
ENSG00000235202	LINC01525	NA	
ENSG00000271427	AL358072.1	NA	
ENSG00000198162	MAN1A2	NA	
ENSG00000279513	AL157902.2	NA	
ENSG00000226755	VPS25P1	NA	
ENSG00000236866	AL157902.1	NA	
ENSG00000183508	TENT5C	NA	
ENSG00000213262	VDAC2P3	NA	
ENSG00000212266	AL390877.1	NA	
ENSG00000270719	AL390877.2	NA	
ENSG00000228217	PNRC2P1	NA	
ENSG00000196505	GDAP2	618369	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27
ENSG00000065183	WDR3	NA	
ENSG00000155761	SPAG17	NA	
ENSG00000287980	AL391557.1	NA	
ENSG00000222209	RNA5SP56	NA	
ENSG00000226126	PSMC1P12	NA	
ENSG00000229911	AL139148.1	NA	
ENSG00000092607	TBX15	260660	COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORT STATURE;;PELVISCAPULAR DYSPLASIA
ENSG00000226172	AL139420.1	NA	
ENSG00000239216	AL139420.2	NA	
ENSG00000116874	WARS2	617710	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS
ENSG00000224238	WARS2-IT1	NA	
ENSG00000223575	RBMX2P3	NA	
ENSG00000236804	RPS3AP12	NA	
ENSG00000231365	WARS2-AS1	NA	
ENSG00000227056	RPL6P2	NA	
ENSG00000227712	AL359915.1	NA	
ENSG00000232650	LINC01780	NA	
ENSG00000194297	RNU1-75P	NA	
ENSG00000116882	HAO2	NA	
ENSG00000230921	HAO2-IT1	NA	
ENSG00000203859	HSD3B2	201810	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY;;ADRENAL HYPERPLASIA II;;3-@BETA-HSD DEFICIENCY; HSDB
ENSG00000232780	GAPDHP74	NA	
ENSG00000203858	HSD3BP2	NA	
ENSG00000235595	GAPDHP23	NA	
ENSG00000187481	HSD3BP1	NA	
ENSG00000229570	GAPDHP58	NA	
ENSG00000203857	HSD3B1	NA	
ENSG00000226443	GAPDHP32	NA	
ENSG00000249798	HSD3BP3	NA	
ENSG00000239873	GAPDHP27	NA	
ENSG00000203855	HSD3BP4	NA	
ENSG00000240244	GAPDHP33	NA	
ENSG00000260941	LINC00622	NA	
ENSG00000198857	HSD3BP5	NA	
ENSG00000143067	ZNF697	NA	
ENSG00000092621	PHGDH	256520	NEU-LAXOVA SYNDROME 1; NLS1;;NEU-LAXOVA SYNDROME; NLS
ENSG00000092621	PHGDH	601815	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD;;PHGDH DEFICIENCY
ENSG00000134240	HMGCS2	605911	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D;;MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY;;HMGCS2 DEFICIENCY
ENSG00000134193	REG4	NA	
ENSG00000215864	NBPF7	NA	
ENSG00000227205	PFN1P9	NA	
ENSG00000226446	NOTCH2P1	NA	
ENSG00000134249	ADAM30	NA	
ENSG00000134250	NOTCH2	102500	HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS
ENSG00000134250	NOTCH2	610205	ALAGILLE SYNDROME 2; ALGS2
ENSG00000273406	AC245008.1	NA	
ENSG00000207149	RNU6-465P	NA	
ENSG00000265808	SEC22B	NA	
ENSG00000274642	AC244669.2	NA	
ENSG00000277313	7SK	NA	
ENSG00000223804	AC244669.1	NA	
ENSG00000273727	U1	NA	
ENSG00000270231	NBPF8	NA	
ENSG00000270392	PFN1P2	NA	
ENSG00000275131	AC241952.1	NA	
ENSG00000273694	U2	NA	
ENSG00000275933	7SK	NA	
ENSG00000286106	NOTCH2NLR	NA	
ENSG00000273136	NBPF26	NA	
ENSG00000287979	AC253572.1	NA	
ENSG00000275538	RNVU1-19	NA	
ENSG00000263353	PPIAL4A	NA	
ENSG00000281741	AC241377.3	NA	
ENSG00000226067	LINC00623	NA	
ENSG00000277610	RNVU1-4	NA	
ENSG00000285215	AC241377.4	NA	
ENSG00000275585	AC241377.2	NA	
ENSG00000273516	U1	NA	
ENSG00000275296	AC241377.1	NA	
ENSG00000198019	FCGR1B	NA	
ENSG00000234998	AC244453.3	NA	
ENSG00000233029	AC244453.2	NA	
ENSG00000223345	H2BP1	NA	
ENSG00000227193	AC244453.1	NA	
ENSG00000213244	H3P4	NA	
ENSG00000268993	RPL22P6	NA	
ENSG00000188610	FAM72B	NA	
ENSG00000171943	SRGAP2C	NA	
ENSG00000275129	AC243994.1	NA	
ENSG00000230806	SRGAP2-AS1	NA	
ENSG00000227082	LINC02798	NA	
ENSG00000228826	AL592494.1	NA	
ENSG00000233432	MTIF2P1	NA	
ENSG00000272583	AL592494.2	NA	
ENSG00000231752	EMBP1	NA	
ENSG00000224857	LINC01691	NA	
ENSG00000276118	AC242852.1	NA	
ENSG00000277095	AC242852.2	NA	
ENSG00000277702	AC239859.5	NA	
ENSG00000252830	RNA5SP533	NA	
ENSG00000264145	AC239859.3	NA	
ENSG00000274927	AC239859.4	NA	
ENSG00000242943	NKAIN1P1	NA	
ENSG00000223495	AC239859.2	NA	
ENSG00000235887	LINC02799	NA	
ENSG00000203825	AC239859.1	NA	
ENSG00000179571	NBPF17P	NA	
ENSG00000226028	PFN1P12	NA	
ENSG00000202167	RNU1-114P	NA	
ENSG00000207349	RNVU1-17	NA	
ENSG00000252826	RNVU1-23	NA	
ENSG00000206737	RNVU1-18	NA	
ENSG00000232721	AC239800.2	NA	
ENSG00000223779	AC239800.1	NA	
ENSG00000242352	FAM91A3P	NA	
ENSG00000270962	AC239800.3	NA	
ENSG00000263590	LINC02591	NA	
ENSG00000252105	RNU1-143P	NA	
ENSG00000233430	AC239798.1	NA	
ENSG00000237503	AC239798.2	NA	
ENSG00000265531	FCGR1CP	NA	
ENSG00000234571	H2BP2	NA	
ENSG00000273213	H3-2	NA	
ENSG00000230186	AC246680.1	NA	
ENSG00000268074	RPL22P5	NA	
ENSG00000263513	FAM72C	NA	
ENSG00000270872	SRGAP2D	NA	
ENSG00000276674	IGKV1OR1-1	NA	
ENSG00000275075	AC244015.1	NA	
ENSG00000275767	AC244015.2	NA	
ENSG00000232527	LINC02802	NA	
ENSG00000276442	RNA5SP529	NA	
ENSG00000175658	DRD5P2	NA	
ENSG00000276756	AC245595.1	NA	
ENSG00000271567	PPIAL4E	NA	
ENSG00000271439	AC246785.4	NA	
ENSG00000207205	RNVU1-15	NA	
ENSG00000237343	AC246785.3	NA	
ENSG00000233586	AC246785.2	NA	
ENSG00000266338	NBPF15	NA	
ENSG00000227212	PFN1P6	NA	
ENSG00000229002	AC246785.1	NA	
ENSG00000275291	RNVU1-26	NA	
ENSG00000278099	RNVU1-2A	NA	
ENSG00000277918	RNVU1-28	NA	
ENSG00000279782	PPIAL4F	NA	
ENSG00000277199	LINC01632	NA	
ENSG00000224363	FP700111.1	NA	
ENSG00000278273	FP700107.1	NA	
ENSG00000222854	RNA5SP59	NA	
ENSG00000273825	FP700111.2	NA	
ENSG00000287607	FP700111.3	NA	
ENSG00000196369	SRGAP2B	NA	
ENSG00000271644	AC242498.1	NA	
ENSG00000215784	FAM72D	NA	
ENSG00000283752	AC241585.3	NA	
ENSG00000272419	LINC01145	NA	
ENSG00000277678	RNU1-153P	NA	
ENSG00000281571	AC241585.2	NA	
ENSG00000223612	AC241585.1	NA	
ENSG00000256374	PPIAL4D	NA	
ENSG00000271291	AC245014.2	NA	
ENSG00000276216	AC245014.3	NA	
ENSG00000207501	RNVU1-14	NA	
ENSG00000236140	AC245014.1	NA	
ENSG00000162825	NBPF20	NA	
ENSG00000234367	PFN1P3	NA	
ENSG00000270384	RNU1-154P	NA	
ENSG00000286620	AC239860.3	NA	
ENSG00000270722	RNVU1-31	NA	
ENSG00000287374	AC239860.4	NA	
ENSG00000278182	AC239860.2	NA	
ENSG00000275064	AC239860.1	NA	
ENSG00000272150	NBPF25P	NA	
ENSG00000117262	GPR89A	NA	
ENSG00000174827	PDZK1	NA	
ENSG00000117281	CD160	NA	
ENSG00000265491	RNF115	NA	
ENSG00000186141	POLR3C	NA	
ENSG00000186364	NUDT17	NA	
ENSG00000131788	PIAS3	NA	
ENSG00000278549	MIR6736	NA	
ENSG00000198483	ANKRD35	NA	
ENSG00000143127	ITGA10	NA	
ENSG00000244619	AC243547.1	NA	
ENSG00000131779	PEX11B	614920	PEROXISOME BIOGENESIS DISORDER 14B; PEX14B
ENSG00000265241	RBM8A	274000	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB
ENSG00000211451	GNRHR2	NA	
ENSG00000234222	LIX1L-AS1	NA	
ENSG00000280778	AC243547.3	NA	
ENSG00000271601	LIX1L	NA	
ENSG00000272031	ANKRD34A	NA	
ENSG00000278431	AC243547.2	NA	
ENSG00000121851	POLR3GL	NA	
ENSG00000265972	TXNIP	NA	
ENSG00000168509	HJV	602390	HEMOCHROMATOSIS, TYPE 2A; HFE2A HEMOCHROMATOSIS, TYPE 2, INCLUDED; HFE2, INCLUDED;;HEMOCHROMATOSIS, JUVENILE, INCLUDED; JH, INCLUDED
ENSG00000287190	AC239799.2	NA	
ENSG00000201558	RNVU1-6	NA	
ENSG00000233396	LINC01719	NA	
ENSG00000271425	NBPF10	NA	
ENSG00000264343	NOTCH2NLA	NA	
ENSG00000276509	AC239799.1	NA	
ENSG00000201789	RNU6-1071P	NA	
ENSG00000271121	NUDT4P2	NA	
ENSG00000277406	SEC22B4P	NA	
ENSG00000270339	PPIAL4H	NA	
ENSG00000273768	RNVU1-29	NA	
ENSG00000287978	AC245407.2	NA	
ENSG00000274428	RNVU1-25	NA	
ENSG00000277655	AC245407.1	NA	
ENSG00000276975	HYDIN2	NA	
ENSG00000274408	RNA5SP536	NA	
ENSG00000274450	AC241929.1	NA	
ENSG00000268043	NBPF12	NA	
ENSG00000244371	PFN1P8	NA	
ENSG00000234225	AC244394.2	NA	
ENSG00000227242	NBPF13P	NA	
ENSG00000225603	AC244394.1	NA	
ENSG00000201142	RNU1-151P	NA	
ENSG00000230832	AC241584.1	NA	
ENSG00000286172	RNVU1-8	NA	
ENSG00000283342	AC241584.2	NA	
ENSG00000131791	PRKAB2	NA	
ENSG00000180867	PDIA3P1	NA	
ENSG00000237188	AC242426.2	NA	
ENSG00000131781	FMO5	NA	
ENSG00000226015	CCT8P1	NA	
ENSG00000236806	RPL7AP15	NA	
ENSG00000131778	CHD1L	NA	
ENSG00000278811	LINC00624	NA	
ENSG00000213226	AC242426.1	NA	
ENSG00000226653	OR13Z1P	NA	
ENSG00000207209	AC242425.1	NA	
ENSG00000272443	OR13Z2P	NA	
ENSG00000272480	OR13Z3P	NA	
ENSG00000116128	BCL9	NA	
ENSG00000288626	AC242628.1	NA	
ENSG00000162836	ACP6	NA	
ENSG00000277762	RN7SL261P	NA	
ENSG00000227139	AC241644.1	NA	
ENSG00000265107	GJA5	108770	ATRIAL STANDSTILL 1; ATRST1;;ATRIAL CARDIOMYOPATHY WITH HEART BLOCK;;CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE
ENSG00000265107	GJA5	612474	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB
ENSG00000265107	GJA5	614049	ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11
ENSG00000274415	AC241644.3	NA	
ENSG00000234190	AC241644.2	NA	
ENSG00000223728	AC239801.1	NA	
ENSG00000121634	GJA8	116200	CATARACT 1, MULTIPLE TYPES; CTRCT1;;CATARACT 1, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, DUFFY-LINKED;;CATARACT, ZONULAR PULVERULENT, 1; CZP1; CZP; CAE1
ENSG00000121634	GJA8	612474	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB
ENSG00000188092	GPR89B	NA	
ENSG00000215859	PDZK1P1	NA	
ENSG00000273059	AC239803.1	NA	
ENSG00000274372	LINC02804	NA	
ENSG00000206791	RNU1-129P	NA	
ENSG00000206585	RNVU1-7	NA	
ENSG00000229828	PDE4DIPP1	NA	
ENSG00000263956	NBPF11	NA	
ENSG00000225080	PFN1P4	NA	
ENSG00000198658	ABHD17AP1	NA	
ENSG00000232265	LINC02805	NA	
ENSG00000227733	AC239809.3	NA	
ENSG00000238765	RNA5SP57	NA	
ENSG00000224335	AC239809.1	NA	
ENSG00000227700	AC239809.2	NA	
ENSG00000199879	RNVU1-22	NA	
ENSG00000234283	LINC01731	NA	
ENSG00000228626	AC245100.3	NA	
ENSG00000274020	LINC01138	NA	
ENSG00000238107	LINC02806	NA	
ENSG00000224481	AC245100.1	NA	
ENSG00000235988	AC245100.5	NA	
ENSG00000252744	Y_RNA	NA	
ENSG00000283676	MIR5087	NA	
ENSG00000202408	RNVU1-21	NA	
ENSG00000272824	AC245100.6	NA	
ENSG00000207340	RNVU1-1	NA	
ENSG00000252135	RNU1-155P	NA	
ENSG00000278596	MIR6077	NA	
ENSG00000238825	RNVU1-2	NA	
ENSG00000231551	AC245100.4	NA	
ENSG00000201183	RNVU1-3	NA	
ENSG00000225871	AC245100.2	NA	
ENSG00000285062	AC245100.8	NA	
ENSG00000280649	AC245100.7	NA	
ENSG00000236334	PPIAL4G	NA	
ENSG00000274210	RNVU1-27	NA	
ENSG00000270629	NBPF14	NA	
ENSG00000286019	NOTCH2NLB	NA	
ENSG00000252515	RNU6-1171P	NA	
ENSG00000177144	NUDT4B	NA	
ENSG00000275140	SEC22B3P	NA	
ENSG00000271546	AC245389.1	NA	
ENSG00000178104	PDE4DIP	NA	
ENSG00000252656	RN7SKP88	NA	
ENSG00000222788	RNU2-38P	NA	
ENSG00000254913	AC239802.1	NA	
ENSG00000255148	AC239802.2	NA	
ENSG00000254539	AC239804.1	NA	
ENSG00000269713	NBPF9	NA	
ENSG00000274019	AC239804.2	NA	
ENSG00000201699	RNVU1-24	NA	
ENSG00000274265	AC245297.3	NA	
ENSG00000215861	AC245297.1	NA	
ENSG00000272755	AC245297.2	NA	
ENSG00000273591	7SK	NA	
ENSG00000274423	SEC22B2P	NA	
ENSG00000286219	NOTCH2NLC	603472	NEURONAL INTRANUCLEAR INCLUSION DISEASE; NIID
ENSG00000286185	AC242842.3	NA	
ENSG00000271383	NBPF19	NA	
ENSG00000263464	PPIAL4C	NA	
ENSG00000277147	LINC00869	NA	
ENSG00000284964	AC242842.2	NA	
ENSG00000275557	AC242842.1	NA	
ENSG00000206828	RNVU1-30	NA	
ENSG00000284842	FAM91A2P	NA	
ENSG00000234232	AC243772.3	NA	
ENSG00000275229	RNU1-68P	NA	
ENSG00000226500	AC243772.1	NA	
ENSG00000150337	FCGR1A	NA	
ENSG00000203814	H2BC18	NA	
ENSG00000233030	AC243772.2	NA	
ENSG00000183598	H3C13	NA	
ENSG00000270882	H4C14	NA	
ENSG00000203811	H3C14	NA	
ENSG00000203812	H2AC18	NA	
ENSG00000220323	H2BC19P	NA	
ENSG00000261716	H2BC20P	NA	
ENSG00000272196	H2AC19	NA	
ENSG00000203852	H3C15	NA	
ENSG00000270276	H4C15	NA	
ENSG00000264207	AC239868.1	NA	
ENSG00000184678	H2BC21	NA	
ENSG00000184260	H2AC20	NA	
ENSG00000184270	H2AC21	NA	
ENSG00000178096	BOLA1	NA	
ENSG00000159164	SV2A	NA	
ENSG00000143368	SF3B4	154400	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1;;MANDIBULOFACIAL DYSOSTOSIS, TREACHER COLLINS TYPE, WITH LIMB ANOMALIES;;NAGER ACROFACIAL DYSOSTOSIS;;AFD, NAGER TYPE;;NAGER SYNDROME
ENSG00000014914	MTMR11	NA	
ENSG00000264522	OTUD7B	NA	
ENSG00000285184	AC244033.2	NA	
ENSG00000223945	AC244033.1	NA	
ENSG00000136631	VPS45	615285	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5
ENSG00000023902	PLEKHO1	NA	
ENSG00000285554	AC242988.2	NA	
ENSG00000266187	RN7SL480P	NA	
ENSG00000143401	ANP32E	NA	
ENSG00000222222	RNU2-17P	NA	
ENSG00000276110	AC242988.1	NA	
ENSG00000118298	CA14	NA	
ENSG00000117362	APH1A	NA	
ENSG00000118292	C1orf54	NA	
ENSG00000159208	CIART	NA	
ENSG00000266472	MRPS21	NA	
ENSG00000117360	PRPF3	601414	RETINITIS PIGMENTOSA 18; RP18
ENSG00000163125	RPRD2	NA	
ENSG00000143374	TARS2	615918	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21
ENSG00000283933	MIR6878	NA	
ENSG00000143369	ECM1	247100	LIPOID PROTEINOSIS OF URBACH AND WIETHE;;LIPOID PROTEINOSIS;;URBACH-WIETHE DISEASE;;HYALINOSIS CUTIS ET MUCOSAE
ENSG00000228126	FALEC	NA	
ENSG00000237781	ADAMTSL4-AS2	NA	
ENSG00000143382	ADAMTSL4	225100	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2
ENSG00000143382	ADAMTSL4	225200	ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL
ENSG00000264553	MIR4257	NA	
ENSG00000203804	ADAMTSL4-AS1	NA	
ENSG00000277452	RN7SL473P	NA	
ENSG00000274963	RN7SL600P	NA	
ENSG00000143384	MCL1	NA	
ENSG00000253047	AL356356.1	NA	
ENSG00000143420	ENSA	NA	
ENSG00000276103	U4	NA	
ENSG00000143457	GOLPH3L	NA	
ENSG00000143452	HORMAD1	NA	
ENSG00000206931	RNU6-1042P	NA	
ENSG00000163131	CTSS	NA	
ENSG00000236713	AL356292.1	NA	
ENSG00000143387	CTSK	265800	PYCNODYSOSTOSIS;;PYKNODYSOSTOSIS; PKND;;PYCD
ENSG00000224690	UBE2D3P3	NA	
ENSG00000143437	ARNT	NA	
ENSG00000200175	RNU6-1309P	NA	
ENSG00000224800	RPS27AP6	NA	
ENSG00000283324	CTXND2	NA	
ENSG00000229357	CYCSP51	NA	
ENSG00000143379	SETDB1	NA	
ENSG00000143418	CERS2	NA	
ENSG00000259357	AL590133.2	NA	
ENSG00000231073	AL590133.1	NA	
ENSG00000143412	ANXA9	NA	
ENSG00000143409	MINDY1	NA	
ENSG00000143363	PRUNE1	617481	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA
ENSG00000200759	RNU6-884P	NA	
ENSG00000163141	BNIPL	NA	
ENSG00000143443	C1orf56	NA	
ENSG00000197622	CDC42SE1	NA	
ENSG00000213190	MLLT11	NA	
ENSG00000143458	GABPB2	NA	
ENSG00000233717	RPS29P29	NA	
ENSG00000261168	AL592424.1	NA	
ENSG00000143434	SEMA6C	NA	
ENSG00000163154	TNFAIP8L2	NA	
ENSG00000163156	SCNM1	NA	
ENSG00000163155	LYSMD1	NA	
ENSG00000163157	TMOD4	NA	
ENSG00000163159	VPS72	NA	
ENSG00000143398	PIP5K1A	NA	
ENSG00000159352	PSMD4	NA	
ENSG00000232671	ZNF687-AS1	NA	
ENSG00000143373	ZNF687	616833	PAGET DISEASE OF BONE 6; PDB6
ENSG00000143393	PI4KB	NA	
ENSG00000265753	RN7SL444P	NA	
ENSG00000273481	AL391069.2	NA	
ENSG00000143390	RFX5	209920	BARE LYMPHOCYTE SYNDROME, TYPE II;;BLS, TYPE II;;BARE LYMPHOCYTE SYNDROME; BLS;;SEVERE COMBINED IMMUNODEFICIENCY, HLA CLASS II-NEGATIVE;;SCID, HLA CLASS II-NEGATIVE BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A, INCLUDED;;BARE LYMPHOCYT /.../ROME, TYPE II, COMPLEMENTATION GROUP B, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E, INCLUDED
ENSG00000224645	AL391069.1	NA	
ENSG00000237976	RFX5-AS1	NA	
ENSG00000143416	SELENBP1	618148	EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO;;METHANETHIOL OXIDASE DEFICIENCY;;MTO DEFICIENCY;;EXTRAORAL HALITOSIS WITH DIMETHYLSULFOXIDURIA
ENSG00000159377	PSMB4	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000143442	POGZ	616364	WHITE-SUTTON SYNDROME; WHSUS;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 37; MRD37
ENSG00000238711	RNY4P25	NA	
ENSG00000143375	CGN	NA	
ENSG00000252840	AL365436.3	NA	
ENSG00000143367	TUFT1	NA	
ENSG00000232536	AL365436.2	NA	
ENSG00000207606	MIR554	NA	
ENSG00000223861	AL365436.1	NA	
ENSG00000143376	SNX27	NA	
ENSG00000250734	AL391335.1	NA	
ENSG00000206635	RNU6-1062P	NA	
ENSG00000159409	CELF3	NA	
ENSG00000227045	AL589765.1	NA	
ENSG00000178796	RIIAD1	NA	
ENSG00000206980	RNU6-662P	NA	
ENSG00000269621	AL589765.7	NA	
ENSG00000236940	AL589765.3	NA	
ENSG00000143436	MRPL9	NA	
ENSG00000143450	OAZ3	NA	
ENSG00000249602	AL589765.4	NA	
ENSG00000232937	AL589765.2	NA	
ENSG00000268288	AL589765.5	NA	
ENSG00000182134	TDRKH	NA	
ENSG00000203288	TDRKH-AS1	NA	
ENSG00000269489	AL589765.6	NA	
ENSG00000213171	LINGO4	NA	
ENSG00000143365	RORC	616622	IMMUNODEFICIENCY 42; IMD42
ENSG00000225556	C2CD4D	NA	
ENSG00000201134	Y_RNA	NA	
ENSG00000234614	C2CD4D-AS1	NA	
ENSG00000196407	THEM5	NA	
ENSG00000159445	THEM4	NA	
ENSG00000285651	AL450992.2	NA	
ENSG00000286581	AL450992.3	NA	
ENSG00000223810	KRT8P28	NA	
ENSG00000197747	S100A10	NA	
ENSG00000229021	AL450992.1	NA	
ENSG00000240667	NBPF18P	NA	
ENSG00000163191	S100A11	NA	
ENSG00000232678	SPTLC1P4	NA	
ENSG00000285818	AL591893.1	NA	
ENSG00000182898	TCHHL1	NA	
ENSG00000159450	TCHH	617252	UNCOMBABLE HAIR SYNDROME 3; UHS3
ENSG00000226716	AL589986.1	NA	
ENSG00000233792	PUDPP2	NA	
ENSG00000215853	RPTN	NA	
ENSG00000237975	FLG-AS1	NA	
ENSG00000236427	AL589986.2	NA	
ENSG00000197915	HRNR	NA	
ENSG00000143631	FLG	146700	ICHTHYOSIS VULGARIS;;ICHTHYOSIS SIMPLEX
ENSG00000143631	FLG	605803	DERMATITIS, ATOPIC, 2; ATOD2
ENSG00000143520	FLG2	618084	PEELING SKIN SYNDROME 6; PSS6
ENSG00000183586	HMGN3P1	NA	
ENSG00000143536	CRNN	NA	
ENSG00000186207	LCE5A	NA	
ENSG00000169509	CRCT1	NA	
ENSG00000185966	LCE3E	NA	
ENSG00000163202	LCE3D	NA	
ENSG00000244057	LCE3C	NA	
ENSG00000187238	LCE3B	NA	
ENSG00000185962	LCE3A	NA	
ENSG00000226947	LCEP4	NA	
ENSG00000285753	LCEP3	NA	
ENSG00000187223	LCE2D	NA	
ENSG00000187180	LCE2C	NA	
ENSG00000159455	LCE2B	NA	
ENSG00000187173	LCE2A	NA	
ENSG00000187170	LCE4A	NA	
ENSG00000198854	C1orf68	NA	
ENSG00000229713	LCEP2	NA	
ENSG00000233819	LCEP1	NA	
ENSG00000203786	KPRP	NA	
ENSG00000240386	LCE1F	NA	
ENSG00000186226	LCE1E	NA	
ENSG00000172155	LCE1D	NA	
ENSG00000197084	LCE1C	NA	
ENSG00000196734	LCE1B	NA	
ENSG00000186844	LCE1A	NA	
ENSG00000235942	LCE6A	NA	
ENSG00000285946	AL162596.1	NA	
ENSG00000163206	SMCP	NA	
ENSG00000163207	IVL	NA	
ENSG00000224308	LINC01527	NA	
ENSG00000283227	SPRR5	NA	
ENSG00000184148	SPRR4	NA	
ENSG00000169474	SPRR1A	NA	
ENSG00000163209	SPRR3	NA	
ENSG00000234262	AL356867.1	NA	
ENSG00000252920	AL356867.2	NA	
ENSG00000169469	SPRR1B	NA	
ENSG00000163216	SPRR2D	NA	
ENSG00000241794	SPRR2A	NA	
ENSG00000196805	SPRR2B	NA	
ENSG00000203785	SPRR2E	NA	
ENSG00000244094	SPRR2F	NA	
ENSG00000229035	SPRR2C	NA	
ENSG00000159516	SPRR2G	NA	
ENSG00000229699	AL161636.1	NA	
ENSG00000203784	LELP1	NA	
ENSG00000203783	PRR9	NA	
ENSG00000230779	AL161636.2	NA	
ENSG00000203782	LORICRIN	604117	VOHWINKEL SYNDROME, VARIANT FORM;;VOHWINKEL SYNDROME WITH ICHTHYOSIS;;MUTILATING KERATODERMA WITH ICHTHYOSIS;;LORICRIN KERATODERMA
ENSG00000159527	PGLYRP3	NA	
ENSG00000163218	PGLYRP4	NA	
ENSG00000207321	RNU6-160P	NA	
ENSG00000163220	S100A9	NA	
ENSG00000163221	S100A12	NA	
ENSG00000237008	LAPTM4BP1	NA	
ENSG00000143546	S100A8	NA	
ENSG00000224784	S100A15A	NA	
ENSG00000184330	S100A7A	NA	
ENSG00000203781	S100A7P1	NA	
ENSG00000197364	S100A7L2	NA	
ENSG00000143556	S100A7	NA	
ENSG00000263841	RN7SL44P	NA	
ENSG00000238279	BX470102.1	NA	
ENSG00000197956	S100A6	NA	
ENSG00000196420	S100A5	NA	
ENSG00000196154	S100A4	NA	
ENSG00000188015	S100A3	NA	
ENSG00000196754	S100A2	NA	
ENSG00000285867	BX470102.2	NA	
ENSG00000188643	S100A16	NA	
ENSG00000189334	S100A14	NA	
ENSG00000189171	S100A13	NA	
ENSG00000271853	AL162258.1	NA	
ENSG00000160678	S100A1	NA	
ENSG00000272030	AL162258.2	NA	
ENSG00000160679	CHTOP	NA	
ENSG00000143553	SNAPIN	NA	
ENSG00000143621	ILF2	NA	
ENSG00000169418	NPR1	NA	
ENSG00000274940	MIR8083	NA	
ENSG00000242565	RN7SL372P	NA	
ENSG00000235015	GEMIN2P1	NA	
ENSG00000199565	Y_RNA	NA	
ENSG00000143624	INTS3	NA	
ENSG00000243613	AL513523.4	NA	
ENSG00000233222	AL513523.3	NA	
ENSG00000143554	SLC27A3	NA	
ENSG00000207039	Y_RNA	NA	
ENSG00000143614	GATAD2B	615074	MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18
ENSG00000231827	AL513523.2	NA	
ENSG00000223599	AL513523.1	NA	
ENSG00000236327	AL831737.1	NA	
ENSG00000284738	AL358472.5	NA	
ENSG00000198837	DENND4B	NA	
ENSG00000160741	CRTC2	NA	
ENSG00000143570	SLC39A1	NA	
ENSG00000285779	AL358472.7	NA	
ENSG00000276584	MIR6737	NA	
ENSG00000282386	AL358472.4	NA	
ENSG00000273026	AL358472.3	NA	
ENSG00000143578	CREB3L4	NA	
ENSG00000143543	JTB	NA	
ENSG00000285641	AL358472.6	NA	
ENSG00000272654	AL358472.2	NA	
ENSG00000143545	RAB13	NA	
ENSG00000177954	RPS27	617409	DIAMOND-BLACKFAN ANEMIA 17; DBA17
ENSG00000143552	NUP210L	NA	
ENSG00000231416	AL358472.1	NA	
ENSG00000200220	RNU6-179P	NA	
ENSG00000231837	RPS7P2	NA	
ENSG00000263987	MIR5698	NA	
ENSG00000143549	TPM3	255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD;;FIBER-TYPE DISPROPORTION MYOPATHY, CONGENITAL; CFTDM
ENSG00000143549	TPM3	609284	NEMALINE MYOPATHY 1; NEM1 CAP MYOPATHY 1, INCLUDED; CAPM1, INCLUDED
ENSG00000264384	RN7SL431P	NA	
ENSG00000215938	MIR190B	NA	
ENSG00000163263	C1orf189	NA	
ENSG00000143612	C1orf43	NA	
ENSG00000143569	UBAP2L	NA	
ENSG00000201129	SNORA58B	NA	
ENSG00000143575	HAX1	610738	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3;;KOSTMANN DISEASE;;AGRANULOCYTOSIS, INFANTILE
ENSG00000252682	AL354980.1	NA	
ENSG00000212292	RNU6-239P	NA	
ENSG00000222457	RNU6-121P	NA	
ENSG00000278694	AL354980.2	NA	
ENSG00000143595	AQP10	NA	
ENSG00000143515	ATP8B2	NA	
ENSG00000238365	RNU7-57P	NA	
ENSG00000237920	AL162591.1	NA	
ENSG00000226855	RPSAP17	NA	
ENSG00000228013	IL6R-AS1	NA	
ENSG00000160712	IL6R	614689	SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS;;SOLUBLE IL6R, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
ENSG00000160712	IL6R	614752	INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS;;IL6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
ENSG00000228264	PSMD8P1	NA	
ENSG00000169291	SHE	NA	
ENSG00000273110	AL162591.2	NA	
ENSG00000163239	TDRD10	NA	
ENSG00000160714	UBE2Q1	NA	
ENSG00000229780	UBE2Q1-AS1	NA	
ENSG00000286391	AL592078.2	NA	
ENSG00000160716	CHRNB2	605375	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3
ENSG00000233875	AL592078.1	NA	
ENSG00000160710	ADAR	127400	DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH;;DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1; DSH1;;RETICULATE ACROPIGMENTATION OF DOHI; RAD;;SYMMETRIC DYSCHROMATOSIS OF THE EXTREMITIES
ENSG00000160710	ADAR	615010	AICARDI-GOUTIERES SYNDROME 6; AGS6
ENSG00000287064	AL606500.1	NA	
ENSG00000143603	KCNN3	618658	ZIMMERMANN-LABAND SYNDROME 3; ZLS3
ENSG00000163344	PMVK	175800	POROKERATOSIS 1, MULTIPLE TYPES; POROK1;;POROKERATOSIS OF MIBELLI
ENSG00000270361	AL451085.1	NA	
ENSG00000163346	PBXIP1	NA	
ENSG00000268154	Metazoa_SRP	NA	
ENSG00000163348	PYGO2	NA	
ENSG00000271380	AL451085.2	NA	
ENSG00000160691	SHC1	NA	
ENSG00000173207	CKS1B	NA	
ENSG00000264349	MIR4258	NA	
ENSG00000160688	FLAD1	255100	LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD
ENSG00000163352	LENEP	NA	
ENSG00000160685	ZBTB7B	NA	
ENSG00000163354	DCST2	NA	
ENSG00000163357	DCST1	NA	
ENSG00000232093	DCST1-AS1	NA	
ENSG00000143537	ADAM15	NA	
ENSG00000243364	EFNA4	NA	
ENSG00000251246	AL691442.2	NA	
ENSG00000143590	EFNA3	NA	
ENSG00000202027	AL691442.1	NA	
ENSG00000169242	EFNA1	NA	
ENSG00000169241	SLC50A1	NA	
ENSG00000179085	DPM3	612937	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, DPM3-RELATED;;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O;;CDG Io; CDGIo;;CDG1(DPM3)
ENSG00000223452	HMGN2P18	NA	
ENSG00000163463	KRTCAP2	NA	
ENSG00000273088	AL713999.1	NA	
ENSG00000163462	TRIM46	NA	
ENSG00000185499	MUC1	174000	MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1;;MCKD;;MEDULLARY CYSTIC KIDNEY DISEASE, AUTOSOMAL DOMINANT; ADMCKD1;;POLYCYSTIC KIDNEYS, MEDULLARY TYPE
ENSG00000231064	AC234582.1	NA	
ENSG00000284586	MIR92B	NA	
ENSG00000169231	THBS3	NA	
ENSG00000173171	MTX1	NA	
ENSG00000236263	AC234582.2	NA	
ENSG00000160766	GBAP1	NA	
ENSG00000236675	MTX1P1	NA	
ENSG00000177628	GBA	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000177628	GBA	127750	DEMENTIA, LEWY BODY; DLB;;LEWY BODY DEMENTIA;;DIFFUSE LEWY BODY DISEASE DIFFUSE LEWY BODY DISEASE WITH GAZE PALSY, INCLUDED;;LEWY BODY VARIANT OF ALZHEIMER DISEASE, INCLUDED
ENSG00000177628	GBA	230800	GAUCHER DISEASE, TYPE I;;GD I;;GAUCHER DISEASE, NONCEREBRAL JUVENILE;;GLUCOCEREBROSIDASE DEFICIENCY;;ACID BETA-GLUCOSIDASE DEFICIENCY;;GBA DEFICIENCY
ENSG00000177628	GBA	230900	GAUCHER DISEASE, TYPE II;;GD II;;GAUCHER DISEASE, ACUTE NEURONOPATHIC TYPE
ENSG00000177628	GBA	231000	GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRAL  GAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;; /.../R DISEASE, NORRBOTTNIAN TYPE, INCLUDED
ENSG00000177628	GBA	231005	GAUCHER DISEASE, TYPE IIIC
ENSG00000177628	GBA	608013	GAUCHER DISEASE, PERINATAL LETHAL;;GAUCHER DISEASE, COLLODION TYPE
ENSG00000160767	FAM189B	NA	
ENSG00000116521	SCAMP3	NA	
ENSG00000176444	CLK2	NA	
ENSG00000143630	HCN3	NA	
ENSG00000143627	PKLR	102900	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES;;PYRUVATE KINASE HYPERACTIVITY
ENSG00000143627	PKLR	266200	PYRUVATE KINASE DEFICIENCY OF RED CELLS;;PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE;;PK DEFICIENCY
ENSG00000160752	FDPS	616631	POROKERATOSIS 9, MULTIPLE TYPES; POROK9
ENSG00000225855	RUSC1-AS1	NA	
ENSG00000160753	RUSC1	NA	
ENSG00000116539	ASH1L	617796	MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52
ENSG00000283701	MIR555	NA	
ENSG00000207134	RNU6-106P	NA	
ENSG00000227773	ASH1L-IT1	NA	
ENSG00000207144	RNU6-1297P	NA	
ENSG00000237872	POU5F1P4	NA	
ENSG00000235919	ASH1L-AS1	NA	
ENSG00000271267	AL353807.4	NA	
ENSG00000225082	DAP3P1	NA	
ENSG00000223503	AL353807.1	NA	
ENSG00000232519	AL353807.2	NA	
ENSG00000125459	MSTO1	617675	MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT
ENSG00000246203	AL353807.3	NA	
ENSG00000287839	AL353807.5	NA	
ENSG00000163374	YY1AP1	602531	GRANGE SYNDROME; GRNG;;ARTERIAL OCCLUSIVE DISEASE, PROGRESSIVE, WITH HYPERTENSION, HEART DEFECTS, BONE FRAGILITY, AND BRACHYSYNDACTYLY;;GRANGE OCCLUSIVE ARTERIAL SYNDROME
ENSG00000132676	DAP3	NA	
ENSG00000227673	AL162734.1	NA	
ENSG00000203761	MSTO2P	NA	
ENSG00000116580	GON4L	NA	
ENSG00000234937	AL139128.1	NA	
ENSG00000132718	SYT11	NA	
ENSG00000283442	AL139128.2	NA	
ENSG00000143622	RIT1	615355	NOONAN SYNDROME 8; NS8
ENSG00000132680	KHDC4	NA	
ENSG00000207475	SNORA80E	NA	
ENSG00000280466	SCARNA4	NA	
ENSG00000281394	SCARNA4	NA	
ENSG00000173080	RXFP4	NA	
ENSG00000116584	ARHGEF2	617523	NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM
ENSG00000277817	MIR6738	NA	
ENSG00000273002	AL355388.1	NA	
ENSG00000224276	ARHGEF2-AS1	NA	
ENSG00000285677	AL355388.2	NA	
ENSG00000163479	SSR2	NA	
ENSG00000160803	UBQLN4	NA	
ENSG00000116586	LAMTOR2	610798	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN
ENSG00000132698	RAB25	NA	
ENSG00000254726	MEX3A	NA	
ENSG00000160789	LMNA	181350	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2;;EMD2;;EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT;;SCAPULOILIOPERONEAL ATROPHY WITH CARDIOPATHY;;MUSCULAR DYSTROPHY WITH EARLY CONTRACTURES AND CARDIOMYOPATHY, AUTOSOMAL DOMIN /.../AUPTMANN-THANNHAUSER MUSCULAR DYSTROPHY;;CARDIOMYOPATHY, DILATED, WITH QUADRICEPS MYOPATHY;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B, FORMERLY; LGMD1B, FORMERLY;;MUSCULAR DYSTROPHY, PROXIMAL, TYPE 1B, FORMERLY
ENSG00000160789	LMNA	176670	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS;;PROGERIA PROGERIA SYNDROME, CHILDHOOD-ONSET, INCLUDED
ENSG00000160789	LMNA	151660	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2;;FPL2;;LIPODYSTROPHY, FAMILIAL PARTIAL, DUNNIGAN TYPE;;LIPODYSTROPHY, FAMILIAL, OF LIMBS AND LOWER TRUNK;;LIPODYSTROPHY, REVERSE PARTIAL;;LIPOATROPHIC DIABETES
ENSG00000160789	LMNA	115200	CARDIOMYOPATHY, DILATED, 1A; CMD1A;;CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 1; CDCD1;;CARDIOMYOPATHY, IDIOPATHIC DILATED;;CARDIOMYOPATHY, FAMILIAL IDIOPATHIC;;CARDIOMYOPATHY, CONGESTIVE
ENSG00000160789	LMNA	212112	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM;;MALOUF SYNDROME;;CARDIOMYOPATHY, CONGESTIVE, WITH HYPERGONADOTROPIC HYPOGONADISM;;CARDIOMYOPATHY, DILATED, WITH PREMATURE OVARIAN FAILURE;;CARDIOMYOPATHY WITH PRIMARY TESTICULAR FAILURE;; /.../ SYNDROME;;GENITAL ANOMALY WITH CARDIOMYOPATHY;;CARDIOGENITAL SYNDROME
ENSG00000160789	LMNA	248370	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA;;LIPODYSTROPHY, TYPE A, ASSOCIATED WITH MANDIBULOACRAL DYSPLASIA;;CRANIOMANDIBULAR DERMATODYSOSTOSIS MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL, INCLUDED
ENSG00000160789	LMNA	275210	RESTRICTIVE DERMOPATHY, LETHAL;;TIGHT SKIN CONTRACTURE SYNDROME, LETHAL;;HYPERKERATOSIS-CONTRACTURE SYNDROME;;FETAL HYPOKINESIA SEQUENCE DUE TO RESTRICTIVE DERMOPATHY
ENSG00000160789	LMNA	605588	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2B1;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2B1;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2B1
ENSG00000160789	LMNA	610140	HEART-HAND SYNDROME, SLOVENIAN TYPE
ENSG00000160789	LMNA	613205	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED;;MDCL
ENSG00000160789	LMNA	616516	EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3
ENSG00000196189	SEMA4A	610282	RETINITIS PIGMENTOSA 35; RP35
ENSG00000196189	SEMA4A	610283	CONE-ROD DYSTROPHY 10; CORD10
ENSG00000252236	AL135927.1	NA	
ENSG00000160785	SLC25A44	NA	
ENSG00000260238	PMF1-BGLAP	NA	
ENSG00000160783	PMF1	NA	
ENSG00000242252	BGLAP	NA	
ENSG00000160781	PAQR6	NA	
ENSG00000198952	SMG5	NA	
ENSG00000163472	TMEM79	NA	
ENSG00000198715	GLMP	NA	
ENSG00000189030	VHLL	NA	
ENSG00000163468	CCT3	NA	
ENSG00000163467	TSACC	NA	
ENSG00000132677	RHBG	NA	
ENSG00000237390	AL139130.1	NA	
ENSG00000125462	C1orf61	NA	
ENSG00000207933	MIR9-1	NA	
ENSG00000116604	MEF2D	NA	
ENSG00000206651	Y_RNA	NA	
ENSG00000260460	AL365181.1	NA	
ENSG00000183856	IQGAP3	NA	
ENSG00000187862	TTC24	NA	
ENSG00000163382	NAXE	617186	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1;;PEBEL
ENSG00000160818	GPATCH4	NA	
ENSG00000272971	AL365181.4	NA	
ENSG00000132702	HAPLN2	NA	
ENSG00000272068	AL365181.2	NA	
ENSG00000132692	BCAN	NA	
ENSG00000272405	AL365181.3	NA	
ENSG00000229953	AL590666.2	NA	
ENSG00000132688	NES	NA	
ENSG00000237588	AL590666.3	NA	
ENSG00000285570	AL590666.4	NA	
ENSG00000143320	CRABP2	NA	
ENSG00000223356	AL590666.1	NA	
ENSG00000143319	ISG20L2	NA	
ENSG00000143303	RRNAD1	NA	
ENSG00000143314	MRPL24	NA	
ENSG00000143321	HDGF	NA	
ENSG00000143294	PRCC	605074	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1
ENSG00000287624	AL590666.5	NA	
ENSG00000027869	SH2D2A	NA	
ENSG00000198400	NTRK1	256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA;;NEUROPATHY, CONGENITAL SENSORY, WITH ANHIDROSIS;;HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY IV; HSAN4;;HSAN IV;;FAMILIAL DYSAUTONOMIA, TYPE II
ENSG00000027644	INSRR	NA	
ENSG00000187800	PEAR1	NA	
ENSG00000160838	LRRC71	NA	
ENSG00000132694	ARHGEF11	NA	
ENSG00000211581	MIR765	NA	
ENSG00000266160	RN7SL612P	NA	
ENSG00000237842	SMU1P1	NA	
ENSG00000224520	KRT8P45	NA	
ENSG00000253831	ETV3L	NA	
ENSG00000117036	ETV3	NA	
ENSG00000235700	CYCSP52	NA	
ENSG00000229961	AL357143.1	NA	
ENSG00000284592	AL357143.2	NA	
ENSG00000228239	AL138900.1	NA	
ENSG00000271736	LINC02772	NA	
ENSG00000286073	AL138900.2	NA	
ENSG00000286151	AL732406.1	NA	
ENSG00000286005	AL353899.1	NA	
ENSG00000143297	FCRL5	NA	
ENSG00000163518	FCRL4	NA	
ENSG00000236731	AL135929.2	NA	
ENSG00000233712	AL135929.1	NA	
ENSG00000160856	FCRL3	NA	
ENSG00000227217	AL356276.1	NA	
ENSG00000231700	AL356276.2	NA	
ENSG00000232366	VDAC1P9	NA	
ENSG00000132704	FCRL2	NA	
ENSG00000163534	FCRL1	NA	
ENSG00000073754	CD5L	NA	
ENSG00000227425	MRPS21P2	NA	
ENSG00000236957	AL139010.1	NA	
ENSG00000183853	KIRREL1	NA	
ENSG00000226520	KIRREL1-IT1	NA	
ENSG00000288460	AL138899.3	NA	
ENSG00000231666	LINC01704	NA	
ENSG00000227295	ELL2P1	NA	
ENSG00000158473	CD1D	NA	
ENSG00000229914	AL138899.2	NA	
ENSG00000176320	AL138899.1	NA	
ENSG00000158477	CD1A	NA	
ENSG00000230942	HMGN1P5	NA	
ENSG00000158481	CD1C	NA	
ENSG00000158485	CD1B	NA	
ENSG00000158488	CD1E	NA	
ENSG00000186306	OR10T2	NA	
ENSG00000180708	OR10K2	NA	
ENSG00000203758	OR10T1P	NA	
ENSG00000236257	EI24P2	NA	
ENSG00000173285	OR10K1	NA	
ENSG00000198965	OR10R2	NA	
ENSG00000236656	AL365440.2	NA	
ENSG00000198703	OR10R3P	NA	
ENSG00000227445	OR10R1P	NA	
ENSG00000231434	AL365440.1	NA	
ENSG00000197532	OR6Y1	NA	
ENSG00000186440	OR6P1	NA	
ENSG00000279111	OR10X1	NA	
ENSG00000198967	OR10Z1	NA	
ENSG00000163554	SPTA1	130600	ELLIPTOCYTOSIS 2; EL2;;ELLIPTOCYTOSIS, RHESUS-UNLINKED TYPE
ENSG00000163554	SPTA1	266140	PYROPOIKILOCYTOSIS, HEREDITARY; HPP
ENSG00000163554	SPTA1	270970	SPHEROCYTOSIS, TYPE 3; SPH3;;SPHEROCYTOSIS, HEREDITARY, 3; HS3
ENSG00000231237	OR6K1P	NA	
ENSG00000196171	OR6K2	NA	
ENSG00000203757	OR6K3	NA	
ENSG00000180437	OR6K4P	NA	
ENSG00000226949	OR6K5P	NA	
ENSG00000197403	OR6N1	NA	
ENSG00000180433	OR6K6	NA	
ENSG00000188340	OR6N2	NA	
ENSG00000229724	OR2AQ1P	NA	
ENSG00000180409	OR10AA1P	NA	
ENSG00000163563	MNDA	NA	
ENSG00000229849	PYHIN5P	NA	
ENSG00000163564	PYHIN1	NA	
ENSG00000163565	IFI16	NA	
ENSG00000163568	AIM2	NA	
ENSG00000233473	RAD1P2	NA	
ENSG00000162706	CADM3	NA	
ENSG00000222552	RNA5SP60	NA	
ENSG00000225670	CADM3-AS1	NA	
ENSG00000213088	ACKR1	110700	BLOOD GROUP, DUFFY SYSTEM; FY;;DUFFY BLOOD GROUP SYSTEM PLASMODIUM VIVAX, RESISTANCE TO, INCLUDED
ENSG00000213088	ACKR1	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000213088	ACKR1	611862	WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1
ENSG00000215846	MPTX1	NA	
ENSG00000248642	OR10J2P	NA	
ENSG00000179639	FCER1A	NA	
ENSG00000196266	OR10J3	NA	
ENSG00000228560	AL513323.1	NA	
ENSG00000248442	OR10J7P	NA	
ENSG00000251686	OR10J8P	NA	
ENSG00000249197	OR10J9P	NA	
ENSG00000249730	OR10J4	NA	
ENSG00000196184	OR10J1	NA	
ENSG00000224943	LINC02819	NA	
ENSG00000184155	OR10J5	NA	
ENSG00000231100	AL606752.1	NA	
ENSG00000271890	OR10AE1P	NA	
ENSG00000132703	APCS	NA	
ENSG00000158731	OR10J6P	NA	
ENSG00000276632	AL445528.2	NA	
ENSG00000223603	CRPP1	NA	
ENSG00000132693	CRP	NA	
ENSG00000235226	AL445528.1	NA	
ENSG00000158716	DUSP23	NA	
ENSG00000181036	FCRL6	NA	
ENSG00000158714	SLAMF8	NA	
ENSG00000256029	AL590560.2	NA	
ENSG00000188004	SNHG28	NA	
ENSG00000212161	AL590560.1	NA	
ENSG00000243284	VSIG8	NA	
ENSG00000272668	AL590560.3	NA	
ENSG00000213085	CFAP45	NA	
ENSG00000266458	MIR4259	NA	
ENSG00000287040	AL590560.5	NA	
ENSG00000279430	AL590560.4	NA	
ENSG00000158710	TAGLN2	NA	
ENSG00000085552	IGSF9	NA	
ENSG00000162723	SLAMF9	NA	
ENSG00000224259	LINC01133	NA	
ENSG00000273933	AL513485.1	NA	
ENSG00000177807	KCNJ10	274600	PENDRED SYNDROME; PDS;;DEAFNESS WITH GOITER;;GOITER-DEAFNESS SYNDROME;;THYROID DYSHORMONOGENESIS 2B; TDH2B;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B
ENSG00000177807	KCNJ10	600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 4; NSRD4;;DILATED VESTIBULAR AQUEDUCT; DVA
ENSG00000177807	KCNJ10	612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES;;SESAME SYNDROME;;EPILEPSY, ATAXIA, SENSORINEURAL DEAFNESS, AND TUBULOPATHY;;EAST SYNDROME
ENSG00000237409	AL513302.1	NA	
ENSG00000143315	PIGM	610293	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1; GPIBD1;;PORTAL HYPERTENSION WITH SEIZURES AND/OR MACROCEPHALY;;GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; GPID
ENSG00000225279	AL121987.1	NA	
ENSG00000162728	KCNJ9	NA	
ENSG00000162729	IGSF8	NA	
ENSG00000018625	ATP1A2	104290	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1
ENSG00000018625	ATP1A2	602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2;;MHP2 MIGRAINE, FAMILIAL BASILAR, INCLUDED
ENSG00000132681	ATP1A4	NA	
ENSG00000143318	CASQ1	616231	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA
ENSG00000227741	AL121987.2	NA	
ENSG00000162734	PEA15	NA	
ENSG00000132716	DCAF8	610100	GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2
ENSG00000258465	AL139011.2	NA	
ENSG00000228606	AL139011.1	NA	
ENSG00000224261	RPSAP18	NA	
ENSG00000162735	PEX19	614886	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 14, INCLUDED;;CG14, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP J, INCLUDED;;CGJ, INCLUDED
ENSG00000122218	COPA	616414	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK
ENSG00000235082	SUMO1P3	NA	
ENSG00000202078	Y_RNA	NA	
ENSG00000162736	NCSTN	142690	ACNE INVERSA, FAMILIAL, 1; ACNINV1;;ACNE INVERSA, FAMILIAL;;HIDRADENITIS SUPPURATIVA, FAMILIAL
ENSG00000171786	NHLH1	NA	
ENSG00000201608	RNU4-42P	NA	
ENSG00000162738	VANGL2	182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD SPINA BIFIDA, INCLUDED
ENSG00000162739	SLAMF6	NA	
ENSG00000234425	AL138930.1	NA	
ENSG00000066294	CD84	NA	
ENSG00000117090	SLAMF1	NA	
ENSG00000235101	SETP9	NA	
ENSG00000228863	AL121985.1	NA	
ENSG00000117091	CD48	NA	
ENSG00000026751	SLAMF7	NA	
ENSG00000275801	AL121985.3	NA	
ENSG00000274562	AL121985.2	NA	
ENSG00000122224	LY9	NA	
ENSG00000122223	CD244	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000226003	PPIAP37	NA	
ENSG00000179914	ITLN1	NA	
ENSG00000213080	AL354714.2	NA	
ENSG00000232188	AL354714.3	NA	
ENSG00000198358	AL354714.1	NA	
ENSG00000233691	AL354714.4	NA	
ENSG00000158764	ITLN2	NA	
ENSG00000158769	F11R	NA	
ENSG00000270149	AL591806.3	NA	
ENSG00000232879	AL591806.1	NA	
ENSG00000215845	TSTD1	NA	
ENSG00000158773	USF1	602491	HYPERLIPIDEMIA, FAMILIAL COMBINED, 1; FCHL1;;HYPERLIPIDEMIA, COMBINED, 1; HYPLIP1
ENSG00000186517	ARHGAP30	NA	
ENSG00000143217	NECTIN4	613573	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1
ENSG00000228917	NECTIN4-AS1	NA	
ENSG00000162755	KLHDC9	NA	
ENSG00000143256	PFDN2	NA	
ENSG00000158793	NIT1	NA	
ENSG00000158796	DEDD	NA	
ENSG00000238934	AL591806.2	NA	
ENSG00000143222	UFC1	618076	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG
ENSG00000224985	AL590714.1	NA	
ENSG00000143258	USP21	NA	
ENSG00000143224	PPOX	176200	VARIEGATE PORPHYRIA; VP;;PORPHYRIA VARIEGATA;;PORPHYRIA, SOUTH AFRICAN TYPE;;PROTOPORPHYRINOGEN OXIDASE DEFICIENCY;;PPOX DEFICIENCY VARIEGATE PORPHYRIA, HOMOZYGOUS VARIANT, INCLUDED
ENSG00000158850	B4GALT3	NA	
ENSG00000158859	ADAMTS4	NA	
ENSG00000158864	NDUFS2	618228	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6
ENSG00000158869	FCER1G	NA	
ENSG00000158874	APOA2	143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1;;FHC; FH;;HYPERLIPOPROTEINEMIA, TYPE II;;HYPERLIPOPROTEINEMIA, TYPE IIA;;HYPER-LOW-DENSITY-LIPOPROTEINEMIA;;HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL;;LDL RECEPTOR DISORDER LOW DENSITY LIPOPROTEIN CHOLESTE /.../VEL QUANTITATIVE TRAIT LOCUS 2, INCLUDED; LDLCQ2, INCLUDED
ENSG00000158874	APOA2	107670	APOLIPOPROTEIN A-II; APOA2 APOLIPOPROTEIN A-II DEFICIENCY, INCLUDED
ENSG00000158882	TOMM40L	NA	
ENSG00000284035	MIR5187	NA	
ENSG00000143257	NR1I3	NA	
ENSG00000248485	PCP4L1	NA	
ENSG00000158887	MPZ	180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA;;ROUSSY-LEVY SYNDROME
ENSG00000158887	MPZ	145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS;;DEJERINE-SOTTAS SYNDROME; DSS;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 3; CMT3;;HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE III; HMSN3;;DEJERINE-SOTTAS NEUROPATHY; DSN
ENSG00000158887	MPZ	118200	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B;;HEREDITARY MOTOR AND SENSORY NEUROPATHY I; HMSN I;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IB; HMSN IB;;HMSN1;;HMSN1B;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1B;;CHARCOT-MARIE-TOOTH DISEASE,  /.../ERVE CONDUCTION TYPE, LINKED TO DUFFY;;PERONEAL MUSCULAR ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, WITH FOCALLY FOLDED MYELIN SHEATHS, TYPE 1B
ENSG00000158887	MPZ	607677	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2I
ENSG00000158887	MPZ	607736	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2J;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2, WITH HEARING LOSS AND PUPILLARY ABNORMALITIES
ENSG00000158887	MPZ	607791	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID;;CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE D;;DI-CMTD
ENSG00000158887	MPZ	618184	NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2
ENSG00000143252	SDHC	605373	PARAGANGLIOMAS 3; PGL3;;GLOMUS TUMORS, FAMILIAL, 3
ENSG00000143252	SDHC	606764	GASTROINTESTINAL STROMAL TUMOR; GIST
ENSG00000143252	SDHC	606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA;;CARNEY-STRATAKIS SYNDROME;;PARAGANGLIOMA AND GASTROINTESTINAL STROMAL TUMOR
ENSG00000188931	CFAP126	NA	
ENSG00000236484	RRM2P2	NA	
ENSG00000283696	AL592295.4	NA	
ENSG00000288093	AL592295.5	NA	
ENSG00000206921	RNU6-481P	NA	
ENSG00000283360	AL592295.3	NA	
ENSG00000215840	AL592295.1	NA	
ENSG00000277882	AL592295.2	NA	
ENSG00000283317	AL831711.1	NA	
ENSG00000143226	FCGR2A	152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED;;EXCESS LMW-DNA, INCLUDED
ENSG00000143226	FCGR2A	219700	CYSTIC FIBROSIS; CF;;MUCOVISCIDOSIS
ENSG00000143226	FCGR2A	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000273112	AL590385.2	NA	
ENSG00000173110	HSPA6	NA	
ENSG00000224203	RPS23P10	NA	
ENSG00000203747	FCGR3A	615707	IMMUNODEFICIENCY 20; IMD20
ENSG00000224515	AL590385.1	NA	
ENSG00000244682	FCGR2C	NA	
ENSG00000225217	HSPA7	NA	
ENSG00000231586	RPS23P9	NA	
ENSG00000162747	FCGR3B	NA	
ENSG00000072694	FCGR2B	152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED;;EXCESS LMW-DNA, INCLUDED
ENSG00000072694	FCGR2B	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000234211	AL451067.1	NA	
ENSG00000213075	RPL31P11	NA	
ENSG00000199595	Y_RNA	NA	
ENSG00000132185	FCRLA	NA	
ENSG00000162746	FCRLB	NA	
ENSG00000241347	RN7SL466P	NA	
ENSG00000081721	DUSP12	NA	
ENSG00000226889	AL359541.1	NA	
ENSG00000118217	ATF6	616517	ACHROMATOPSIA 7; ACHM7
ENSG00000229808	AL391825.1	NA	
ENSG00000162745	OLFML2B	NA	
ENSG00000227818	AL590408.1	NA	
ENSG00000198929	NOS1AP	NA	
ENSG00000285636	AL450163.1	NA	
ENSG00000266144	MIR4654	NA	
ENSG00000227094	AL512785.1	NA	
ENSG00000252262	RNA5SP61	NA	
ENSG00000207729	MIR556	NA	
ENSG00000254706	AL512785.2	NA	
ENSG00000171722	SPATA46	NA	
ENSG00000239887	C1orf226	NA	
ENSG00000198574	SH2D1B	NA	
ENSG00000227243	SLAMF6P1	NA	
ENSG00000152332	UHMK1	NA	
ENSG00000227941	UQCRBP2	NA	
ENSG00000259788	AL596325.1	NA	
ENSG00000117143	UAP1	NA	
ENSG00000272574	AL596325.2	NA	
ENSG00000162733	DDR2	271665	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE;;SMED-SL;;SMED, SHORT LIMB-HAND TYPE;;SMED, TYPE II;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-ABNORMAL CALCIFICATION TYPE;;SMED, SHORT LIMB-ABNORMAL CALCIFICATION TYPE;;SMED-SL/AC
ENSG00000162733	DDR2	618175	WARBURG-CINOTTI SYNDROME; WRCN
ENSG00000243173	RN7SL861P	NA	
ENSG00000132196	HSD17B7	NA	
ENSG00000185860	CCDC190	NA	
ENSG00000230739	AL392003.2	NA	
ENSG00000227667	AL392003.1	NA	
ENSG00000117152	RGS4	NA	
ENSG00000143248	RGS5	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000232892	RGS5-AS1	NA	
ENSG00000225755	AL451063.1	NA	
ENSG00000232995	RGS5	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000237756	AL592435.1	NA	
ENSG00000143228	NUF2	NA	
ENSG00000225122	AL603841.1	NA	
ENSG00000200327	RNA5SP62	NA	
ENSG00000212527	RNA5SP63	NA	
ENSG00000228289	AL355862.1	NA	
ENSG00000212538	U3	NA	
ENSG00000225719	NMNAT1P2	NA	
ENSG00000199849	RNU5F-6P	NA	
ENSG00000213070	HMGB3P6	NA	
ENSG00000185630	PBX1	617641	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED
ENSG00000207082	RNU6-171P	NA	
ENSG00000269887	AL391001.1	NA	
ENSG00000276359	Metazoa_SRP	NA	
ENSG00000233693	PBX1-AS1	NA	
ENSG00000271917	AL357568.1	NA	
ENSG00000201987	Y_RNA	NA	
ENSG00000225487	AL390119.1	NA	
ENSG00000201270	RNU6-755P	NA	
ENSG00000162761	LMX1A	601412	DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7
ENSG00000224702	LMX1A-AS2	NA	
ENSG00000238022	LMX1A-AS1	NA	
ENSG00000143171	RXRG	NA	
ENSG00000237463	LRRC52-AS1	NA	
ENSG00000230748	PRELID1P7	NA	
ENSG00000162763	LRRC52	NA	
ENSG00000237783	AL356441.2	NA	
ENSG00000236206	AL356441.1	NA	
ENSG00000143198	MGST3	NA	
ENSG00000143149	ALDH9A1	NA	
ENSG00000206990	AL451074.1	NA	
ENSG00000230175	AL451074.4	NA	
ENSG00000225272	AL451074.3	NA	
ENSG00000215838	AL451074.2	NA	
ENSG00000273365	AL451074.6	NA	
ENSG00000143183	TMCO1	213980	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR;;CEREBROFACIOTHORACIC DYSPLASIA
ENSG00000224358	TMCO1-AS1	NA	
ENSG00000230659	AL451074.5	NA	
ENSG00000143179	UCK2	NA	
ENSG00000236364	AL358115.1	NA	
ENSG00000283936	MIR3658	NA	
ENSG00000271527	AL606495.1	NA	
ENSG00000226292	RPS3AP10	NA	
ENSG00000207341	RNA5SP64	NA	
ENSG00000188859	FAM78B	NA	
ENSG00000203307	FAM78B-AS1	NA	
ENSG00000230898	AL596087.3	NA	
ENSG00000215952	MIR921	NA	
ENSG00000229588	AL596087.2	NA	
ENSG00000215835	AL596087.1	NA	
ENSG00000225325	AL583804.1	NA	
ENSG00000230231	FMO7P	NA	
ENSG00000234142	LINC01675	NA	
ENSG00000238087	FMO8P	NA	
ENSG00000215834	FMO9P	NA	
ENSG00000234984	FMO10P	NA	
ENSG00000232341	RPL4P2	NA	
ENSG00000232148	FMO11P	NA	
ENSG00000232223	CNN2P10	NA	
ENSG00000143157	POGK	NA	
ENSG00000152382	TADA1	NA	
ENSG00000225171	DUTP6	NA	
ENSG00000143195	ILDR2	NA	
ENSG00000143194	MAEL	NA	
ENSG00000200036	RNA5SP65	NA	
ENSG00000227907	AL158837.1	NA	
ENSG00000143167	GPA33	NA	
ENSG00000198842	DUSP27	NA	
ENSG00000213068	AL451050.1	NA	
ENSG00000231605	LINC01363	NA	
ENSG00000272205	AL451050.2	NA	
ENSG00000143190	POU2F1	NA	
ENSG00000272033	AL136984.1	NA	
ENSG00000198821	CD247	610163	IMMUNODEFICIENCY 25; IMD25;;IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA
ENSG00000287218	AL359962.3	NA	
ENSG00000233411	AL359962.1	NA	
ENSG00000273160	AL359962.2	NA	
ENSG00000227776	AKR1D1P1	NA	
ENSG00000143162	CREG1	NA	
ENSG00000231029	AL031733.1	NA	
ENSG00000241666	AL031733.2	NA	
ENSG00000198771	RCSD1	NA	
ENSG00000197965	MPZL1	NA	
ENSG00000143199	ADCY10	143870	HYPERCALCIURIA, ABSORPTIVE, 2; HCA2;;HYPERCALCIURIA, FAMILIAL IDIOPATHIC
ENSG00000250762	Z99943.2	NA	
ENSG00000232194	Z99943.1	NA	
ENSG00000143158	MPC2	NA	
ENSG00000143164	DCAF6	NA	
ENSG00000221545	MIR1255B2	NA	
ENSG00000224837	GCSHP5	NA	
ENSG00000143147	GPR161	NA	
ENSG00000143155	TIPRL	NA	
ENSG00000237049	RPL34P1	NA	
ENSG00000237131	AL021397.1	NA	
ENSG00000213064	SFT2D2	NA	
ENSG00000214262	ANKRD36BP1	NA	
ENSG00000206880	RNU6-1310P	NA	
ENSG00000143178	TBX19	201400	ACTH DEFICIENCY, ISOLATED; IAD;;ADRENOCORTICOTROPIC HORMONE DEFICIENCY
ENSG00000227722	AL022100.1	NA	
ENSG00000207974	MIR557	NA	
ENSG00000228697	AL023755.1	NA	
ENSG00000283255	AL022100.2	NA	
ENSG00000215833	QRSL1P1	NA	
ENSG00000143185	XCL2	NA	
ENSG00000227777	AL031736.1	NA	
ENSG00000143184	XCL1	NA	
ENSG00000229757	AL031736.2	NA	
ENSG00000143196	DPT	NA	
ENSG00000285622	AL135926.1	NA	
ENSG00000235736	AL031275.1	NA	
ENSG00000225826	LINC00626	NA	
ENSG00000229612	SUMO1P2	NA	
ENSG00000287831	AL135926.2	NA	
ENSG00000203601	LINC00970	NA	
ENSG00000213063	RPL29P7	NA	
ENSG00000287282	AL031726.2	NA	
ENSG00000252987	RNA5SP66	NA	
ENSG00000237707	AL031726.1	NA	
ENSG00000143153	ATP1B1	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000143156	NME7	NA	
ENSG00000235575	Z99758.1	NA	
ENSG00000117475	BLZF1	NA	
ENSG00000117477	CCDC181	NA	
ENSG00000117479	SLC19A2	249270	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA, DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUS AND SENSORINEU /.../AFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA
ENSG00000234604	AL021068.1	NA	
ENSG00000213062	Z99572.1	NA	
ENSG00000198734	F5	188055	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2;;ACTIVATED PROTEIN C RESISTANCE;;APC RESISTANCE;;THROMBOPHILIA DUE TO DEFICIENCY OF ACTIVATED PROTEIN C COFACTOR;;PROC COFACTOR DEFICIENCY;;PCCF DEFICIENCY;;THROMBOPHILIA V THROMBOPHILIA DUE /.../CTOR V LEIDEN, INCLUDED
ENSG00000198734	F5	227400	FACTOR V DEFICIENCY;;PARAHEMOPHILIA;;OWREN PARAHEMOPHILIA;;LABILE FACTOR DEFICIENCY
ENSG00000198734	F5	600880	BUDD-CHIARI SYNDROME; BDCHS MEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED; MOVC, INCLUDED
ENSG00000198734	F5	601367	STROKE, ISCHEMIC;;CEREBROVASCULAR ACCIDENT;;CEREBRAL INFARCTION
ENSG00000198734	F5	614389	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1;;RPRGL;;RPL;;ABORTION, SPONTANEOUS, RECURRENT;;FETAL LOSS, RECURRENT, SUSCEPTIBILITY TO;;MISCARRIAGE, RECURRENT;;EMBRYONIC LOSS, RECURRENT;;STILLBIRTH, RECURRENT
ENSG00000174175	SELP	NA	
ENSG00000000460	C1orf112	NA	
ENSG00000188404	SELL	NA	
ENSG00000007908	SELE	NA	
ENSG00000230704	AL021940.1	NA	
ENSG00000171806	METTL18	NA	
ENSG00000000457	SCYL3	NA	
ENSG00000239494	RN7SL333P	NA	
ENSG00000288139	AL031297.1	NA	
ENSG00000075945	KIFAP3	NA	
ENSG00000243051	RN7SL269P	NA	
ENSG00000235378	MRPS10P1	NA	
ENSG00000232959	AL356475.1	NA	
ENSG00000224896	SIGLEC30P	NA	
ENSG00000203740	METTL11B	NA	
ENSG00000283340	MIR3119-1	NA	
ENSG00000263390	MIR3119-2	NA	
ENSG00000233985	LINC01681	NA	
ENSG00000238051	ISCUP1	NA	
ENSG00000224286	LINC01142	NA	
ENSG00000226967	HAUS4P1	NA	
ENSG00000231407	GORAB-AS1	NA	
ENSG00000120370	GORAB	231070	GERODERMA OSTEODYSPLASTICUM; GO;;GERODERMIA OSTEODYSPLASTICA;;WALT DISNEY DWARFISM
ENSG00000225545	AL162399.1	NA	
ENSG00000235303	AL023495.1	NA	
ENSG00000116132	PRRX1	202650	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC;;DYSGNATHIA COMPLEX AGNATHIA-HOLOPROSENCEPHALY;;HOLOPROSENCEPHALY-AGNATHIA;;OTOCEPHALY
ENSG00000271811	Z97200.1	NA	
ENSG00000231424	BX284613.2	NA	
ENSG00000117501	MROH9	NA	
ENSG00000226552	BX284613.1	NA	
ENSG00000007933	FMO3	602079	TRIMETHYLAMINURIA; TMAU;;FISH-ODOR SYNDROME
ENSG00000221390	MIR1295A	NA	
ENSG00000283598	MIR1295B	NA	
ENSG00000117507	FMO6P	NA	
ENSG00000094963	FMO2	NA	
ENSG00000225243	AL021026.1	NA	
ENSG00000010932	FMO1	NA	
ENSG00000206692	Y_RNA	NA	
ENSG00000230547	HMGB1P11	NA	
ENSG00000076258	FMO4	NA	
ENSG00000285665	AL031274.1	NA	
ENSG00000268062	SRP14P4	NA	
ENSG00000239428	GM2AP2	NA	
ENSG00000234333	CYCSP53	NA	
ENSG00000117523	PRRC2C	NA	
ENSG00000283683	MYOCOS	NA	
ENSG00000034971	MYOC	137750	GLAUCOMA 1, OPEN ANGLE, A; GLC1A;;GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, 1; JOAG1 GLAUCOMA 1, OPEN ANGLE, L, INCLUDED; GLC1L, INCLUDED
ENSG00000233328	PFN1P1	NA	
ENSG00000230364	RPL4P3	NA	
ENSG00000117533	VAMP4	NA	
ENSG00000232261	Z98751.1	NA	
ENSG00000271459	Z98751.3	NA	
ENSG00000236741	Z98751.2	NA	
ENSG00000253060	AL135931.1	NA	
ENSG00000010165	EEF1AKNMT	605429	DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF; DFNB26M;;DFNB26, MODIFIER OF;;DFNB26, SUPPRESSOR OF;;DEAFNESS, NONSYNDROMIC, MODIFIER OF, 1; DFNM1
ENSG00000213060	AL031864.1	NA	
ENSG00000224600	AL031864.2	NA	
ENSG00000197959	DNM3	NA	
ENSG00000233540	DNM3-IT1	NA	
ENSG00000230630	DNM3OS	NA	
ENSG00000283844	MIR214	NA	
ENSG00000283152	MIR3120	NA	
ENSG00000208024	MIR199A2	NA	
ENSG00000287336	AL137157.1	NA	
ENSG00000206684	RNU6-157P	NA	
ENSG00000135845	PIGC	617816	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 62; MRT62
ENSG00000180999	C1orf105	NA	
ENSG00000094975	SUCO	NA	
ENSG00000251943	RNU6-693P	NA	
ENSG00000117560	FASLG	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000117560	FASLG	601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS;;CANALE-SMITH SYNDROME;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL DOMINANT AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, INCLUDED; ALPS1A, INCLUDED;;AUTOIMMUNE LYMPHOPROLIFERATIVE SY /.../, TYPE IB, INCLUDED; ALPS1B, INCLUDED;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000229785	SLC25A38P1	NA	
ENSG00000279061	Z98043.1	NA	
ENSG00000224228	AL031599.1	NA	
ENSG00000227177	AIMP1P2	NA	
ENSG00000224000	Z97198.1	NA	
ENSG00000120337	TNFSF18	NA	
ENSG00000230849	GOT2P2	NA	
ENSG00000226375	AL022310.1	NA	
ENSG00000117586	TNFSF4	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000232751	AL645568.3	NA	
ENSG00000231615	AL645568.2	NA	
ENSG00000203739	AL645568.1	NA	
ENSG00000117592	PRDX6	NA	
ENSG00000162753	SLC9C2	NA	
ENSG00000238272	AL139142.1	NA	
ENSG00000285777	AL139142.2	NA	
ENSG00000183831	ANKRD45	NA	
ENSG00000232113	TEX50	NA	
ENSG00000076321	KLHL20	NA	
ENSG00000225591	BX248409.1	NA	
ENSG00000200674	RN7SKP160	NA	
ENSG00000120334	CENPL	NA	
ENSG00000252357	Y_RNA	NA	
ENSG00000117593	DARS2	611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL;;MITOCHONDRIAL ASPARTYL-tRNA SYNTHETASE DEFICIENCY
ENSG00000234741	GAS5	NA	
ENSG00000270084	GAS5-AS1	NA	
ENSG00000185278	ZBTB37	NA	
ENSG00000117601	SERPINC1	613118	ANTITHROMBIN III DEFICIENCY; AT3D;;THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY; THPH7
ENSG00000252231	RNA5SP67	NA	
ENSG00000135870	RC3H1	NA	
ENSG00000200755	RNA5SP68	NA	
ENSG00000236535	RC3H1-IT1	NA	
ENSG00000224977	LINC02776	NA	
ENSG00000225713	RPL30P1	NA	
ENSG00000227373	RABGAP1L-DT	NA	
ENSG00000152061	RABGAP1L	NA	
ENSG00000237317	AL022400.1	NA	
ENSG00000203737	GPR52	NA	
ENSG00000223828	BANF1P4	NA	
ENSG00000231378	NDUFAF4P4	NA	
ENSG00000237249	Z99127.2	NA	
ENSG00000223525	RABGAP1L-IT1	NA	
ENSG00000235869	Z99127.1	NA	
ENSG00000229531	RABGAP1L-AS1	NA	
ENSG00000252552	RNU6-307P	NA	
ENSG00000287697	Z99127.3	NA	
ENSG00000116161	CACYBP	NA	
ENSG00000120333	MRPS14	618378	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38
ENSG00000206659	Y_RNA	NA	
ENSG00000181101	ENTR1P2	NA	
ENSG00000120332	TNN	NA	
ENSG00000235750	KIAA0040	NA	
ENSG00000230687	AL008626.1	NA	
ENSG00000233946	RPS29P4	NA	
ENSG00000260990	Z94057.1	NA	
ENSG00000116147	TNR	NA	
ENSG00000235628	TNR-IT1	NA	
ENSG00000224718	LINC01657	NA	
ENSG00000227740	LINC02803	NA	
ENSG00000230777	RPS29P5	NA	
ENSG00000143207	COP1	NA	
ENSG00000252906	SCARNA3	NA	
ENSG00000228686	AL590723.1	NA	
ENSG00000236021	AL591043.2	NA	
ENSG00000273629	U7	NA	
ENSG00000232463	AL359265.2	NA	
ENSG00000253025	RNU2-12P	NA	
ENSG00000227815	AL359265.1	NA	
ENSG00000231020	AL591043.1	NA	
ENSG00000225904	MORF4L1P7	NA	
ENSG00000116183	PAPPA2	NA	
ENSG00000237514	PTP4A1P7	NA	
ENSG00000286754	AL031290.1	NA	
ENSG00000152092	ASTN1	NA	
ENSG00000202609	MIR488	NA	
ENSG00000198797	BRINP2	NA	
ENSG00000224968	LINC01645	NA	
ENSG00000227579	AL136114.1	NA	
ENSG00000236720	LINC01741	NA	
ENSG00000120341	SEC16B	NA	
ENSG00000254154	CRYZL2P-SEC16B	NA	
ENSG00000242193	CRYZL2P	NA	
ENSG00000276563	AL359075.1	NA	
ENSG00000224687	RASAL2-AS1	NA	
ENSG00000075391	RASAL2	NA	
ENSG00000270575	AL160281.1	NA	
ENSG00000213058	AL365357.1	NA	
ENSG00000188585	CLEC20A	NA	
ENSG00000264809	Metazoa_SRP	NA	
ENSG00000285910	AL513013.1	NA	
ENSG00000240021	TEX35	NA	
ENSG00000213057	C1orf220	NA	
ENSG00000201347	RNA5SP69	NA	
ENSG00000273384	AL137796.1	NA	
ENSG00000266417	MIR4424	NA	
ENSG00000273062	AL449106.1	NA	
ENSG00000116191	RALGPS2	NA	
ENSG00000228196	PTPN2P1	NA	
ENSG00000201791	SNORA63	NA	
ENSG00000116194	ANGPTL1	NA	
ENSG00000116199	FAM20B	NA	
ENSG00000232750	AL139132.1	NA	
ENSG00000186283	TOR3A	NA	
ENSG00000143322	ABL2	NA	
ENSG00000234041	AL512326.5	NA	
ENSG00000231905	SETP10	NA	
ENSG00000212338	AL512326.2	NA	
ENSG00000201619	AL512326.1	NA	
ENSG00000231564	EIF4A1P11	NA	
ENSG00000225711	AL512326.3	NA	
ENSG00000223794	COX5BP8	NA	
ENSG00000228191	AL512326.4	NA	
ENSG00000057252	SOAT1	NA	
ENSG00000162779	AXDND1	NA	
ENSG00000224620	MEF2AP1	NA	
ENSG00000236539	HNRNPA1P54	NA	
ENSG00000261250	AL160286.3	NA	
ENSG00000116218	NPHS2	600995	NEPHROTIC SYNDROME, TYPE 2; NPHS2;;NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE; SRN1
ENSG00000251875	RNU5F-2P	NA	
ENSG00000227141	AL160286.1	NA	
ENSG00000261060	AL160286.2	NA	
ENSG00000162782	TDRD5	NA	
ENSG00000243062	AL359853.2	NA	
ENSG00000143340	FAM163A	NA	
ENSG00000229407	AL359853.1	NA	
ENSG00000231966	LINC02818	NA	
ENSG00000169905	TOR1AIP2	NA	
ENSG00000272906	AL353708.3	NA	
ENSG00000143337	TOR1AIP1	617072	MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES; MRRSDC;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y
ENSG00000264916	RN7SL230P	NA	
ENSG00000261831	AL353708.2	NA	
ENSG00000260360	AL353708.1	NA	
ENSG00000135837	CEP350	NA	
ENSG00000235145	RPSAP16	NA	
ENSG00000223450	AL590632.1	NA	
ENSG00000261817	AL390718.1	NA	
ENSG00000116260	QSOX1	NA	
ENSG00000121454	LHX4	262700	PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4;;PITUITARY HORMONE DEFICIENCY, COMBINED, WITH OR WITHOUT CEREBELLAR DEFECTS;;SHORT STATURE, PITUITARY AND CEREBELLAR DEFECTS, AND SMALL SELLA TURCICA
ENSG00000230124	ACBD6	NA	
ENSG00000235060	VDAC1P4	NA	
ENSG00000265435	MIR3121	NA	
ENSG00000236719	OVAAL	NA	
ENSG00000206905	Y_RNA	NA	
ENSG00000143324	XPR1	616413	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6
ENSG00000283575	U6	NA	
ENSG00000225857	LINC02816	NA	
ENSG00000135835	KIAA1614	NA	
ENSG00000243155	AL162431.1	NA	
ENSG00000232586	KIAA1614-AS1	NA	
ENSG00000251520	AL162431.2	NA	
ENSG00000270711	AL162431.3	NA	
ENSG00000135823	STX6	NA	
ENSG00000153029	MR1	NA	
ENSG00000162783	IER5	NA	
ENSG00000237292	LINC01732	NA	
ENSG00000225359	AL358393.1	NA	
ENSG00000179452	LINC01699	NA	
ENSG00000198216	CACNA1E	618285	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69
ENSG00000273573	Metazoa_SRP	NA	
ENSG00000252977	RNA5SP70	NA	
ENSG00000288574	AL161734.2	NA	
ENSG00000272880	AL161734.1	NA	
ENSG00000222397	RN7SKP229	NA	
ENSG00000287452	AL391477.1	NA	
ENSG00000179930	ZNF648	NA	
ENSG00000224810	AL355482.1	NA	
ENSG00000225982	AL355482.2	NA	
ENSG00000228918	LINC01344	NA	
ENSG00000232309	AL390856.1	NA	
ENSG00000232096	YPEL5P1	NA	
ENSG00000206764	RNU6-152P	NA	
ENSG00000228664	AL513480.1	NA	
ENSG00000231684	EIF1P3	NA	
ENSG00000135821	GLUL	610015	GLUTAMINE DEFICIENCY, CONGENITAL;;GLUTAMINE SYNTHASE DEFICIENCY, CONGENITAL SYSTEMIC
ENSG00000203730	TEDDM1	NA	
ENSG00000203729	LINC00272	NA	
ENSG00000121446	RGSL1	NA	
ENSG00000270443	AL139344.1	NA	
ENSG00000233537	TEDDM2P	NA	
ENSG00000135828	RNASEL	601518	PROSTATE CANCER, HEREDITARY, 1; HPC1;;PRCA1
ENSG00000276839	Metazoa_SRP	NA	
ENSG00000143333	RGS16	NA	
ENSG00000261504	LINC01686	NA	
ENSG00000135824	RGS8	NA	
ENSG00000227181	LINC01688	NA	
ENSG00000271269	AL353778.1	NA	
ENSG00000135838	NPL	NA	
ENSG00000287808	AL355999.1	NA	
ENSG00000135829	DHX9	NA	
ENSG00000157060	SHCBP1L	NA	
ENSG00000224040	HMGN1P4	NA	
ENSG00000285609	5S_rRNA	NA	
ENSG00000226570	AL450304.1	NA	
ENSG00000176855	KRT18P28	NA	
ENSG00000207472	RNU6-41P	NA	
ENSG00000135862	LAMC1	NA	
ENSG00000224468	LAMC1-AS1	NA	
ENSG00000058085	LAMC2	226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DIS /.../TYPE;;EPIDERMOLYSIS BULLOSA, GENERALIZED ATROPHIC BENIGN; GABEB EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT, INCLUDED;;JUNCTIONAL EPIDERMOLYSIS BULLOSA INVERSA, INCLUDED;;JEB-I, INCLUDED
ENSG00000058085	LAMC2	226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE;;JEB-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ-PEARSON TYPE;;HERLITZ-PEARSON-TYPE EPIDERMOLYSIS BULLOSA;;EPIDERMOLYSIS BULLOSA LETALIS
ENSG00000157064	NMNAT2	NA	
ENSG00000287929	AL354953.1	NA	
ENSG00000233562	RPS3AP8	NA	
ENSG00000286372	AL449223.1	NA	
ENSG00000232860	SMG7-AS1	NA	
ENSG00000116698	SMG7	NA	
ENSG00000116701	NCF2	233710	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2;;CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVE, TYPE II;;GRANULOMATOUS DISEASE, CHRONIC, DUE TO NCF2 DEFICIENCY;;NEUTROPHIL CYTOSOL FACTOR 2, DEFICIENCY OF;;N /.../EFICIENCY OF;;p67-PHOX, DEFICIENCY OF
ENSG00000286966	AL137800.1	NA	
ENSG00000162704	ARPC5	NA	
ENSG00000143344	RGL1	NA	
ENSG00000173627	APOBEC4	NA	
ENSG00000270994	AL157899.1	NA	
ENSG00000227554	AL590422.1	NA	
ENSG00000198756	COLGALT2	NA	
ENSG00000198860	TSEN15	617026	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F
ENSG00000286655	AL158011.1	NA	
ENSG00000199840	Y_RNA	NA	
ENSG00000207080	AL445228.1	NA	
ENSG00000231791	AL445228.2	NA	
ENSG00000244568	RN7SL654P	NA	
ENSG00000271387	AL445228.3	NA	
ENSG00000116667	C1orf21	NA	
ENSG00000230470	AL078645.1	NA	
ENSG00000232036	AL078645.2	NA	
ENSG00000285847	AL713852.1	NA	
ENSG00000286378	AL713852.2	NA	
ENSG00000116406	EDEM3	NA	
ENSG00000135842	NIBAN1	NA	
ENSG00000252222	RNU7-13P	NA	
ENSG00000260976	LINC01633	NA	
ENSG00000201312	RNA5SP72	NA	
ENSG00000121481	RNF2	NA	
ENSG00000232792	FTH1P25	NA	
ENSG00000121486	TRMT1L	NA	
ENSG00000116668	SWT1	NA	
ENSG00000231084	RPL22P24	NA	
ENSG00000213051	RPL5P5	NA	
ENSG00000201421	Y_RNA	NA	
ENSG00000206640	Y_RNA	NA	
ENSG00000233583	AL356273.1	NA	
ENSG00000252612	Y_RNA	NA	
ENSG00000238061	AL356273.2	NA	
ENSG00000279838	AL356273.3	NA	
ENSG00000116679	IVNS1ABP	NA	
ENSG00000273004	AL078644.1	NA	
ENSG00000261024	GS1-279B7.1	NA	
ENSG00000252407	RNU7-183P	NA	
ENSG00000270920	MCRIP2P2	NA	
ENSG00000279401	AL133383.2	NA	
ENSG00000228309	LINC01350	NA	
ENSG00000207108	Y_RNA	NA	
ENSG00000201596	Y_RNA	NA	
ENSG00000261729	AL133383.1	NA	
ENSG00000143341	HMCN1	603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1;;MACULOPATHY, AGE-RELATED, 1
ENSG00000224691	AL133553.1	NA	
ENSG00000288078	AL133553.2	NA	
ENSG00000116690	PRG4	208250	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP;;ARTHROPATHY-CAMPTODACTYLY SYNDROME;;HYPERTROPHIC SYNOVITIS, CONGENITAL FAMILIAL;;JACOBS SYNDROME;;FIBROSING SEROSITIS, FAMILIAL;;PERICARDITIS-ARTHROPATHY-CAMPTODACTYLY SYNDROME;;PAC SY /.../;;CAMPTODACTYLY-ARTHROPATHY-PERICARDITIS SYNDROME;;CAP SYNDROME
ENSG00000047410	TPR	NA	
ENSG00000202025	RNU6-1240P	NA	
ENSG00000157181	ODR4	NA	
ENSG00000229739	PDC-AS1	NA	
ENSG00000116703	PDC	NA	
ENSG00000273198	AL096803.3	NA	
ENSG00000228238	AL096803.1	NA	
ENSG00000233196	AL096803.2	NA	
ENSG00000288562	AL049198.1	NA	
ENSG00000073756	PTGS2	NA	
ENSG00000273129	PACERR	NA	
ENSG00000116711	PLA2G4A	618372	GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS; GURDP;;PHOSPHOLIPASE A2, GROUP IVA, DEFICIENCY OF
ENSG00000230426	LINC01036	NA	
ENSG00000271558	AL391813.1	NA	
ENSG00000225462	FDPSP1	NA	
ENSG00000274702	AL357559.1	NA	
ENSG00000236401	SLC4A1APP2	NA	
ENSG00000223847	AL645474.1	NA	
ENSG00000285894	AL136372.2	NA	
ENSG00000150732	AL136372.1	NA	
ENSG00000222240	RN7SKP156	NA	
ENSG00000261182	AL596211.1	NA	
ENSG00000224278	AL592447.1	NA	
ENSG00000225006	AL929288.1	NA	
ENSG00000235083	AL929288.2	NA	
ENSG00000231022	RPS3AP9	NA	
ENSG00000237283	AL691515.1	NA	
ENSG00000238054	AL691515.2	NA	
ENSG00000226486	LINC01035	NA	
ENSG00000271036	CLPTM1LP1	NA	
ENSG00000226196	GAPDHP75	NA	
ENSG00000252553	RNA5SP73	NA	
ENSG00000232212	LINC01701	NA	
ENSG00000238270	AL591504.1	NA	
ENSG00000287472	AL591504.2	NA	
ENSG00000230987	AL359976.1	NA	
ENSG00000162670	BRINP3	NA	
ENSG00000225811	AL354771.1	NA	
ENSG00000237457	LINC01351	NA	
ENSG00000241505	AL391645.1	NA	
ENSG00000231175	LINC01720	NA	
ENSG00000236025	AL139135.1	NA	
ENSG00000238108	AL139135.2	NA	
ENSG00000285638	AL138927.1	NA	
ENSG00000228020	HNRNPA1P46	NA	
ENSG00000261642	AL713866.1	NA	
ENSG00000271187	AL713866.2	NA	
ENSG00000233882	LINC01680	NA	
ENSG00000228215	LINC02770	NA	
ENSG00000223344	AL359081.1	NA	
ENSG00000150681	RGS18	NA	
ENSG00000285280	AL390957.1	NA	
ENSG00000226723	AL513175.1	NA	
ENSG00000236792	AL513175.2	NA	
ENSG00000253148	RGS21	NA	
ENSG00000236069	AL136987.1	NA	
ENSG00000090104	RGS1	NA	
ENSG00000127074	RGS13	NA	
ENSG00000231767	RPS27AP5	NA	
ENSG00000283795	MIR4426	NA	
ENSG00000228687	AL035407.2	NA	
ENSG00000226814	AL035407.1	NA	
ENSG00000116741	RGS2	NA	
ENSG00000223075	RN7SKP126	NA	
ENSG00000234473	ZNF101P2	NA	
ENSG00000116750	UCHL5	NA	
ENSG00000238754	SCARNA18B	NA	
ENSG00000116747	RO60	NA	
ENSG00000023572	GLRX2	NA	
ENSG00000134371	CDC73	145001	HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2;;HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS;;HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY; HPT-JT PARATHYROID ADENOMATOSIS, FAMILIAL CYSTIC, INCLUDED
ENSG00000134371	CDC73	145000	HYPERPARATHYROIDISM 1; HRPT1;;HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY; FIHP PARATHYROID ADENOMA, FAMILIAL, INCLUDED
ENSG00000134371	CDC73	608266	PARATHYROID CARCINOMA;;PRTC
ENSG00000221680	MIR1278	NA	
ENSG00000162630	B3GALT2	NA	
ENSG00000276735	AL390863.1	NA	
ENSG00000232077	LINC01031	NA	
ENSG00000286285	AL138778.1	NA	
ENSG00000227240	AL136456.1	NA	
ENSG00000226640	AL357793.1	NA	
ENSG00000237011	AL357793.2	NA	
ENSG00000237213	RPL23AP22	NA	
ENSG00000233057	EEF1A1P14	NA	
ENSG00000231714	AL513348.1	NA	
ENSG00000251813	RNU6-983P	NA	
ENSG00000228167	AL353072.1	NA	
ENSG00000285718	AL353072.2	NA	
ENSG00000287364	AL353709.1	NA	
ENSG00000227421	LINC01724	NA	
ENSG00000162687	KCNT2	617771	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57
ENSG00000265986	MIR4735	NA	
ENSG00000000971	CFH	126700	BASAL LAMINAR DRUSEN;;DRUSEN OF BRUCH MEMBRANE;;DRUSEN, CUTICULAR;;DRUSEN, EARLY ADULT-ONSET, GROUPED
ENSG00000000971	CFH	235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1 HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED
ENSG00000000971	CFH	609814	COMPLEMENT FACTOR H DEFICIENCY; CFHD;;FACTOR H DEFICIENCY;;CFH DEFICIENCY
ENSG00000000971	CFH	610698	MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4
ENSG00000116785	CFHR3	235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1 HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED
ENSG00000116785	CFHR3	603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1;;MACULOPATHY, AGE-RELATED, 1
ENSG00000244414	CFHR1	235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1 HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED
ENSG00000244414	CFHR1	603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1;;MACULOPATHY, AGE-RELATED, 1
ENSG00000285986	BX248415.1	NA	
ENSG00000134365	CFHR4	NA	
ENSG00000080910	CFHR2	NA	
ENSG00000273844	AL139418.1	NA	
ENSG00000134389	CFHR5	614809	CFHR5 DEFICIENCY
ENSG00000143278	F13B	613235	FACTOR XIII, B SUBUNIT, DEFICIENCY OF
ENSG00000066279	ASPM	608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5
ENSG00000235748	SEPTIN14P12	NA	
ENSG00000177888	ZBTB41	NA	
ENSG00000237861	AL513325.1	NA	
ENSG00000134376	CRB1	172870	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA
ENSG00000134376	CRB1	600105	RETINITIS PIGMENTOSA 12; RP12;;RETINITIS PIGMENTOSA WITH OR WITHOUT PARAARTERIOLAR PRESERVATION OF RETINAL PIGMENT EPITHELIUM;;RP WITH OR WITHOUT PRESERVED PARAARTERIOLE RETINAL PIGMENT EPITHELIUM;;RP WITH OR WITHOUT PPRPE
ENSG00000134376	CRB1	613835	LEBER CONGENITAL AMAUROSIS 8; LCA8
ENSG00000221879	MRPS21P3	NA	
ENSG00000230260	AL136322.1	NA	
ENSG00000213047	DENND1B	NA	
ENSG00000207139	Y_RNA	NA	
ENSG00000213046	EEF1A1P32	NA	
ENSG00000235582	AL365258.2	NA	
ENSG00000233040	FAM204BP	NA	
ENSG00000224901	AL365258.1	NA	
ENSG00000203724	C1orf53	NA	
ENSG00000143355	LHX9	NA	
ENSG00000151414	NEK7	NA	
ENSG00000232824	PRR13P1	NA	
ENSG00000287989	AL450352.1	NA	
ENSG00000151418	ATP6V1G3	NA	
ENSG00000223881	AL157402.1	NA	
ENSG00000081237	PTPRC	608971	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE;;SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE
ENSG00000081237	PTPRC	609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO;;HCV, SUSCEPTIBILITY TO HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED;;HCV, RESISTANCE TO, INCLUDED;;HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF, INCLUDED
ENSG00000261573	AL157402.2	NA	
ENSG00000236278	PEBP1P3	NA	
ENSG00000229989	MIR181A1HG	NA	
ENSG00000207975	MIR181B1	NA	
ENSG00000207759	MIR181A1	NA	
ENSG00000227747	AC096631.2	NA	
ENSG00000225172	AC096631.1	NA	
ENSG00000233410	LINC01222	NA	
ENSG00000235492	LINC01221	NA	
ENSG00000286541	AC105941.1	NA	
ENSG00000231718	LINC02789	NA	
ENSG00000228190	RPL23AP16	NA	
ENSG00000236468	AC099335.1	NA	
ENSG00000231984	AL596266.1	NA	
ENSG00000228530	AL445687.1	NA	
ENSG00000200139	RNU6-778P	NA	
ENSG00000229747	AL445687.2	NA	
ENSG00000202491	RNU6-716P	NA	
ENSG00000202329	RNU6-609P	NA	
ENSG00000116833	NR5A2	NA	
ENSG00000252860	RNU6-570P	NA	
ENSG00000229220	AC096633.1	NA	
ENSG00000233827	CCNQP1	NA	
ENSG00000203721	LINC00862	NA	
ENSG00000273093	AC097065.2	NA	
ENSG00000213045	AC097065.1	NA	
ENSG00000230623	AC104461.1	NA	
ENSG00000162702	ZNF281	NA	
ENSG00000282849	AL359834.1	NA	
ENSG00000118193	KIF14	616258	MECKEL SYNDROME 12; MKS12
ENSG00000118193	KIF14	617914	MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20
ENSG00000118197	DDX59	174300	OROFACIODIGITAL SYNDROME V; OFD5;;OFDS V;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE V;;OROFACIODIGITAL SYNDROME, THURSTON TYPE;;THURSTON SYNDROME;;POLYDACTYLY, POSTAXIAL, WITH MEDIAN CLEFT OF UPPER LIP
ENSG00000260088	DDX59-AS1	NA	
ENSG00000118200	CAMSAP2	NA	
ENSG00000231333	RPL34P6	NA	
ENSG00000170128	GPR25	NA	
ENSG00000163362	INAVA	618077	INFLAMMATORY BOWEL DISEASE 29; IBD29
ENSG00000233217	MROH3P	NA	
ENSG00000201032	RNU6-704P	NA	
ENSG00000116852	KIF21B	NA	
ENSG00000229191	AL358473.1	NA	
ENSG00000234132	AL358473.2	NA	
ENSG00000081248	CACNA1S	170400	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1;;HYPOKALEMIC PERIODIC PARALYSIS; HOKPP
ENSG00000081248	CACNA1S	188580	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1
ENSG00000081248	CACNA1S	601887	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5; MHS5
ENSG00000232237	ASCL5	NA	
ENSG00000116857	TMEM9	NA	
ENSG00000163395	IGFN1	NA	
ENSG00000229821	AC103925.1	NA	
ENSG00000081277	PKP1	604536	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME; EDSFS;;MCGRATH SYNDROME
ENSG00000118194	TNNT2	115195	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2
ENSG00000118194	TNNT2	601494	CARDIOMYOPATHY, DILATED, 1D; CMD1D;;LEFT VENTRICULAR NONCOMPACTION 6, INCLUDED; LVNC6, INCLUDED
ENSG00000118194	TNNT2	612422	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3
ENSG00000286600	AC119427.2	NA	
ENSG00000159166	LAD1	NA	
ENSG00000282221	AC119427.1	NA	
ENSG00000159173	TNNI1	NA	
ENSG00000227048	AC096677.3	NA	
ENSG00000174307	PHLDA3	NA	
ENSG00000224818	AC096677.2	NA	
ENSG00000159176	CSRP1	NA	
ENSG00000224536	AC096677.1	NA	
ENSG00000223396	RPS10P7	NA	
ENSG00000134369	NAV1	NA	
ENSG00000236390	AC092800.1	NA	
ENSG00000231871	IPO9-AS1	NA	
ENSG00000264802	MIR5191	NA	
ENSG00000235121	AL645504.1	NA	
ENSG00000200942	RNU6-501P	NA	
ENSG00000221028	MIR1231	NA	
ENSG00000198700	IPO9	NA	
ENSG00000277681	MIR6739	NA	
ENSG00000198892	SHISA4	NA	
ENSG00000223774	AL513217.1	NA	
ENSG00000163431	LMOD1	NA	
ENSG00000134375	TIMM17A	NA	
ENSG00000206637	SNORA70H	NA	
ENSG00000238003	RPL10P4	NA	
ENSG00000176393	RNPEP	NA	
ENSG00000234678	ELF3-AS1	NA	
ENSG00000275207	MIR6740	NA	
ENSG00000163435	ELF3	NA	
ENSG00000249007	AL691482.3	NA	
ENSG00000232296	AL691482.1	NA	
ENSG00000235811	AL691482.2	NA	
ENSG00000212512	Y_RNA	NA	
ENSG00000227109	CRIP1P3	NA	
ENSG00000170075	GPR37L1	NA	
ENSG00000143862	ARL8A	NA	
ENSG00000143851	PTPN7	NA	
ENSG00000243323	PTPRVP	NA	
ENSG00000133067	LGR6	NA	
ENSG00000077152	UBE2T	616435	FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT
ENSG00000077157	PPP1R12B	NA	
ENSG00000229120	CYCSP4	NA	
ENSG00000272262	RNU6-89P	NA	
ENSG00000232626	AC099336.1	NA	
ENSG00000236439	AC099336.2	NA	
ENSG00000253042	SNORA70	NA	
ENSG00000143858	SYT2	616040	MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7;;MYASTHENIC SYNDROME, PRESYNAPTIC, CONGENITAL, WITH OR WITHOUT MOTOR NEUROPATHY; MYSPC
ENSG00000226862	AC104463.2	NA	
ENSG00000225620	AC104463.1	NA	
ENSG00000117139	KDM5B	618109	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65
ENSG00000235449	AC098934.2	NA	
ENSG00000226148	SLC25A39P1	NA	
ENSG00000260021	AC098934.3	NA	
ENSG00000228288	PCAT6	NA	
ENSG00000184774	MGAT4EP	NA	
ENSG00000214796	TUBAP5	NA	
ENSG00000234996	AC098934.1	NA	
ENSG00000183155	RABIF	NA	
ENSG00000117153	KLHL12	NA	
ENSG00000230280	HNRNPA1P59	NA	
ENSG00000199471	Y_RNA	NA	
ENSG00000159346	ADIPOR1	NA	
ENSG00000159348	CYB5R1	NA	
ENSG00000234761	MGAT4FP	NA	
ENSG00000231547	AC096632.1	NA	
ENSG00000163444	TMEM183A	NA	
ENSG00000143847	PPFIA4	NA	
ENSG00000122180	MYOG	NA	
ENSG00000163485	ADORA1	NA	
ENSG00000234775	AC105940.2	NA	
ENSG00000224671	AC105940.1	NA	
ENSG00000133055	MYBPH	NA	
ENSG00000133048	CHI3L1	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000133048	CHI3L1	611960	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7
ENSG00000133063	CHIT1	614122	CHITOTRIOSIDASE DEFICIENCY; CHITD
ENSG00000236523	NPM1P40	NA	
ENSG00000231507	LINC01353	NA	
ENSG00000233791	LINC01136	NA	
ENSG00000159388	BTG2	NA	
ENSG00000202300	RNU6-487P	NA	
ENSG00000122176	FMOD	NA	
ENSG00000229652	AL359837.1	NA	
ENSG00000271588	LARP7P1	NA	
ENSG00000188783	PRELP	NA	
ENSG00000188770	OPTC	NA	
ENSG00000058668	ATP2B4	NA	
ENSG00000236035	NSA2P1	NA	
ENSG00000221643	SNORA77	NA	
ENSG00000122188	LAX1	NA	
ENSG00000058673	ZC3H11A	NA	
ENSG00000257315	ZBED6	NA	
ENSG00000288644	AC114402.3	NA	
ENSG00000227417	AC114402.2	NA	
ENSG00000223505	AC114402.1	NA	
ENSG00000182004	SNRPE	615059	HYPOTRICHOSIS 11; HYPT11
ENSG00000236430	KRT8P29	NA	
ENSG00000232917	HSPE1P6	NA	
ENSG00000237379	CBX1P3	NA	
ENSG00000286383	AC096645.1	NA	
ENSG00000176754	LINC00303	NA	
ENSG00000286572	AL592146.2	NA	
ENSG00000143842	SOX13	NA	
ENSG00000261065	AL592146.1	NA	
ENSG00000143845	ETNK2	NA	
ENSG00000230550	ERLNC1	NA	
ENSG00000143839	REN	267430	RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROME  RENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED
ENSG00000143839	REN	613092	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2;;EARLY-ONSET HYPERURICEMIA, ANEMIA, AND PROGRESSIVE KIDNEY FAILURE
ENSG00000225522	AL592114.2	NA	
ENSG00000170498	KISS1	614842	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13
ENSG00000174567	GOLT1A	NA	
ENSG00000143850	PLEKHA6	NA	
ENSG00000231691	AL592114.3	NA	
ENSG00000219133	AL592114.1	NA	
ENSG00000280924	LINC00628	NA	
ENSG00000226330	AL606489.1	NA	
ENSG00000237848	AL606489.2	NA	
ENSG00000158615	PPP1R15B	616817	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2
ENSG00000133056	PIK3C2B	NA	
ENSG00000198625	MDM4	NA	
ENSG00000236779	AL512306.1	NA	
ENSG00000200408	RNA5SP74	NA	
ENSG00000240710	AL512306.3	NA	
ENSG00000170382	LRRN2	NA	
ENSG00000240219	AL512306.2	NA	
ENSG00000228153	AL161793.1	NA	
ENSG00000252650	RNA5SP75	NA	
ENSG00000251861	AL161793.2	NA	
ENSG00000287197	AC096675.1	NA	
ENSG00000163531	NFASC	618356	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD
ENSG00000229657	AL391822.1	NA	
ENSG00000184144	CNTN2	615400	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 5; FCMTE5
ENSG00000174529	TMEM81	NA	
ENSG00000117222	RBBP5	NA	
ENSG00000271580	AL583832.1	NA	
ENSG00000236108	AC093422.3	NA	
ENSG00000133059	DSTYK	270750	SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME
ENSG00000133059	DSTYK	610805	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1; CAKUT1;;RENAL HYPODYSPLASIA, NONSYNDROMIC, 1; RHDNS1
ENSG00000213041	AC093422.1	NA	
ENSG00000133069	TMCC2	NA	
ENSG00000225063	AC093422.2	NA	
ENSG00000163545	NUAK2	NA	
ENSG00000162873	KLHDC8A	NA	
ENSG00000235363	SNRPGP10	NA	
ENSG00000226235	LEMD1-AS1	NA	
ENSG00000186007	LEMD1	NA	
ENSG00000281406	BLACAT1	NA	
ENSG00000199059	MIR135B	NA	
ENSG00000224717	LEMD1-DT	NA	
ENSG00000117266	CDK18	NA	
ENSG00000253097	RNU2-19P	NA	
ENSG00000174514	MFSD4A	NA	
ENSG00000206762	RNU6-418P	NA	
ENSG00000158711	ELK4	NA	
ENSG00000236942	AC096533.1	NA	
ENSG00000158715	SLC45A3	NA	
ENSG00000275213	Metazoa_SRP	NA	
ENSG00000069275	NUCKS1	NA	
ENSG00000201944	SNORA72	NA	
ENSG00000117280	RAB29	NA	
ENSG00000285521	AC119673.1	NA	
ENSG00000133065	SLC41A1	NA	
ENSG00000286619	AC119673.2	NA	
ENSG00000162877	PM20D1	NA	
ENSG00000174502	SLC26A9	NA	
ENSG00000227687	AL713965.1	NA	
ENSG00000276600	RAB7B	NA	
ENSG00000196188	CTSE	NA	
ENSG00000285417	BX571818.1	NA	
ENSG00000263961	RHEX	NA	
ENSG00000252692	AC244035.3	NA	
ENSG00000198049	AVPR1B	NA	
ENSG00000226780	AC244035.1	NA	
ENSG00000287432	AC244035.4	NA	
ENSG00000225483	RPL22P4	NA	
ENSG00000236889	AC244035.2	NA	
ENSG00000196550	FAM72A	NA	
ENSG00000266028	SRGAP2	NA	
ENSG00000229509	AC244023.1	NA	
ENSG00000263528	IKBKE	NA	
ENSG00000278465	MIR6769B	NA	
ENSG00000162888	C1orf147	NA	
ENSG00000261000	AC244034.2	NA	
ENSG00000266094	RASSF5	NA	
ENSG00000234981	AC244034.1	NA	
ENSG00000279946	AC244034.3	NA	
ENSG00000143486	EIF2D	NA	
ENSG00000237605	DYRK3-AS1	NA	
ENSG00000143479	DYRK3	NA	
ENSG00000162889	MAPKAPK2	NA	
ENSG00000224114	AL591846.1	NA	
ENSG00000199349	Y_RNA	NA	
ENSG00000136634	IL10	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000136634	IL10	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000136634	IL10	614395	GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS GRAFT-VERSUS-HOST DISEASE, RESISTANCE TO, INCLUDED
ENSG00000142224	IL19	NA	
ENSG00000162891	IL20	NA	
ENSG00000162892	IL24	NA	
ENSG00000162894	FCMR	NA	
ENSG00000271680	AC098935.2	NA	
ENSG00000226945	AC098935.1	NA	
ENSG00000162896	PIGR	NA	
ENSG00000162897	FCAMR	NA	
ENSG00000182795	C1orf116	NA	
ENSG00000123836	PFKFB2	NA	
ENSG00000180667	YOD1	NA	
ENSG00000123843	C4BPB	NA	
ENSG00000123838	C4BPA	NA	
ENSG00000275392	AL445493.3	NA	
ENSG00000226565	AL445493.1	NA	
ENSG00000224462	C4BPAP1	NA	
ENSG00000243636	AL445493.2	NA	
ENSG00000232621	C4BPAP2	NA	
ENSG00000237074	AL596218.1	NA	
ENSG00000196352	CD55	226300	COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE
ENSG00000196352	CD55	613793	BLOOD GROUP, CROMER SYSTEM; CROM;;CROMER BLOOD GROUP SYSTEM
ENSG00000283044	AL391597.1	NA	
ENSG00000117322	CR2	240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2;;ANTIBODY DEFICIENCY DUE TO TACI DEFECT;;HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY
ENSG00000117322	CR2	610927	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9
ENSG00000117322	CR2	614699	IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7
ENSG00000203710	CR1	607486	KNOPS BLOOD GROUP SYSTEM; KN
ENSG00000203710	CR1	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000236911	AL137789.1	NA	
ENSG00000197721	CR1L	NA	
ENSG00000244703	CD46P1	NA	
ENSG00000226289	CDCA4P3	NA	
ENSG00000274059	RNA5SP534	NA	
ENSG00000285239	AL137789.2	NA	
ENSG00000117335	CD46	612922	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2
ENSG00000234219	CDCA4P4	NA	
ENSG00000203709	MIR29B2CHG	NA	
ENSG00000284214	MIR29C	NA	
ENSG00000284203	MIR29B2	NA	
ENSG00000174059	CD34	NA	
ENSG00000285719	AL356275.1	NA	
ENSG00000284237	LINC02767	NA	
ENSG00000076356	PLXNA2	NA	
ENSG00000287220	AL590138.1	NA	
ENSG00000226843	AL606753.1	NA	
ENSG00000286198	AL606753.2	NA	
ENSG00000261453	LINC01735	NA	
ENSG00000259815	LINC02769	NA	
ENSG00000227887	RPS26P13	NA	
ENSG00000232812	LINC01717	NA	
ENSG00000236950	LINC01774	NA	
ENSG00000278684	AC104465.1	NA	
ENSG00000287046	AC092810.4	NA	
ENSG00000232537	AC092810.3	NA	
ENSG00000228081	AC092810.2	NA	
ENSG00000224540	AC092810.1	NA	
ENSG00000225712	ATP5MC2P1	NA	
ENSG00000227940	LINC01696	NA	
ENSG00000231648	LINC01698	NA	
ENSG00000230937	MIR205HG	NA	
ENSG00000284485	MIR205	NA	
ENSG00000224260	AL023754.1	NA	
ENSG00000287902	AL023754.2	NA	
ENSG00000008118	CAMK1G	NA	
ENSG00000196878	LAMB3	104530	AMELOGENESIS IMPERFECTA, TYPE IA; AI1A;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE IA
ENSG00000196878	LAMB3	226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DIS /.../TYPE;;EPIDERMOLYSIS BULLOSA, GENERALIZED ATROPHIC BENIGN; GABEB EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT, INCLUDED;;JUNCTIONAL EPIDERMOLYSIS BULLOSA INVERSA, INCLUDED;;JEB-I, INCLUDED
ENSG00000196878	LAMB3	226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE;;JEB-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ-PEARSON TYPE;;HERLITZ-PEARSON-TYPE EPIDERMOLYSIS BULLOSA;;EPIDERMOLYSIS BULLOSA LETALIS
ENSG00000283876	MIR4260	NA	
ENSG00000227591	HSD11B1-AS1	NA	
ENSG00000123689	G0S2	NA	
ENSG00000117594	HSD11B1	614662	CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2
ENSG00000236136	ADORA2BP1	NA	
ENSG00000009790	TRAF3IP3	NA	
ENSG00000162757	C1orf74	NA	
ENSG00000117595	IRF6	119500	POPLITEAL PTERYGIUM SYNDROME; PPS;;CLEFT LIP/PALATE, PARAMEDIAN MUCOUS CYSTS OF THE LOWER LIP, POPLITEAL PTERYGIUM, DIGITAL AND GENITAL ANOMALIES;;FACIOGENITOPOPLITEAL SYNDROME
ENSG00000117595	IRF6	119300	VAN DER WOUDE SYNDROME 1; VWS1;;VDWS;;LIP-PIT SYNDROME; LPS; PIT;;CLEFT LIP AND/OR PALATE WITH MUCOUS CYSTS OF LOWER LIP
ENSG00000117595	IRF6	608864	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 6
ENSG00000117597	UTP25	NA	
ENSG00000143469	SYT14	614229	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11
ENSG00000287343	AL022397.1	NA	
ENSG00000203706	SERTAD4-AS1	NA	
ENSG00000082497	SERTAD4	NA	
ENSG00000228110	ST13P19	NA	
ENSG00000233455	AL035414.1	NA	
ENSG00000054392	HHAT	NA	
ENSG00000287354	AL034351.2	NA	
ENSG00000200972	RNU5A-8P	NA	
ENSG00000287157	AL034351.1	NA	
ENSG00000270936	BPNT2P	NA	
ENSG00000143473	KCNH1	135500	ZIMMERMANN-LABAND SYNDROME 1; ZLS1;;LABAND SYNDROME;;FIBROMATOSIS, GINGIVAL, WITH ABNORMAL FINGERS, FINGERNAILS, NOSE, AND EARS, AND SPLENOMEGALY
ENSG00000143473	KCNH1	611816	TEMPLE-BARAITSER SYNDROME; TMBTS;;MENTAL RETARDATION, SEVERE, AND ABSENT NAILS OF HALLUX AND POLLEX
ENSG00000279333	AC096636.1	NA	
ENSG00000284299	AL590132.1	NA	
ENSG00000224668	IPO8P1	NA	
ENSG00000283952	AC092017.2	NA	
ENSG00000284376	AC092017.3	NA	
ENSG00000234233	KCNH1-IT1	NA	
ENSG00000234004	AC092017.1	NA	
ENSG00000226986	PRELID1P5	NA	
ENSG00000117625	RCOR3	NA	
ENSG00000082512	TRAF5	NA	
ENSG00000287033	AL590101.1	NA	
ENSG00000153363	LINC00467	NA	
ENSG00000236809	SNX25P1	NA	
ENSG00000238137	ARPC3P2	NA	
ENSG00000198570	RD3	610612	LEBER CONGENITAL AMAUROSIS 12; LCA12
ENSG00000223649	AC105275.1	NA	
ENSG00000170385	SLC30A1	NA	
ENSG00000261314	AC105275.2	NA	
ENSG00000228792	AL356310.1	NA	
ENSG00000227764	LINC01693	NA	
ENSG00000117650	NEK2	615565	RETINITIS PIGMENTOSA 67; RP67
ENSG00000224763	FDPSP8	NA	
ENSG00000231057	AC096637.2	NA	
ENSG00000226868	AC096637.1	NA	
ENSG00000123684	LPGAT1	NA	
ENSG00000241395	RN7SL344P	NA	
ENSG00000212205	Y_RNA	NA	
ENSG00000229258	LPGAT1-AS1	NA	
ENSG00000233626	AC092814.2	NA	
ENSG00000143493	INTS7	NA	
ENSG00000212187	AC092814.1	NA	
ENSG00000143476	DTL	NA	
ENSG00000220749	RPL21P28	NA	
ENSG00000264358	MIR3122	NA	
ENSG00000252879	RN7SKP98	NA	
ENSG00000229983	AL606468.1	NA	
ENSG00000226251	LINC02608	NA	
ENSG00000066027	PPP2R5A	NA	
ENSG00000230063	AL360091.2	NA	
ENSG00000234915	AL360091.3	NA	
ENSG00000225338	RPL23AP18	NA	
ENSG00000201544	SNORA16B	NA	
ENSG00000229832	AL360091.1	NA	
ENSG00000065600	PACC1	NA	
ENSG00000287445	AC092803.3	NA	
ENSG00000117691	NENF	NA	
ENSG00000224535	LINC02771	NA	
ENSG00000286213	AC092803.2	NA	
ENSG00000228067	LINC01740	NA	
ENSG00000260805	AC092803.1	NA	
ENSG00000288007	AC092803.4	NA	
ENSG00000162772	ATF3	NA	
ENSG00000235862	AL590648.2	NA	
ENSG00000162771	FAM71A	NA	
ENSG00000226036	AL590648.1	NA	
ENSG00000237980	LINC02773	NA	
ENSG00000123685	BATF3	NA	
ENSG00000117697	NSL1	NA	
ENSG00000203705	TATDN3	NA	
ENSG00000236905	AC104333.3	NA	
ENSG00000185523	SPATA45	NA	
ENSG00000198468	FLVCR1-DT	NA	
ENSG00000235182	AC104333.1	NA	
ENSG00000236317	AC104333.2	NA	
ENSG00000162769	FLVCR1	609033	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1;;PCARP
ENSG00000282718	AC104333.4	NA	
ENSG00000143494	VASH2	NA	
ENSG00000174606	ANGEL2	NA	
ENSG00000136643	RPS6KC1	NA	
ENSG00000228646	RPL31P13	NA	
ENSG00000225233	AL592402.1	NA	
ENSG00000228255	AC096639.1	NA	
ENSG00000230461	PROX1-AS1	NA	
ENSG00000281664	LINC00538	NA	
ENSG00000117707	PROX1	NA	
ENSG00000274895	AC011700.1	NA	
ENSG00000272167	AL606537.1	NA	
ENSG00000283518	LINC02775	NA	
ENSG00000143499	SMYD2	NA	
ENSG00000228470	AL929236.1	NA	
ENSG00000152104	PTPN14	613611	CHOANAL ATRESIA AND LYMPHEDEMA; CATLPH
ENSG00000213036	AL445305.1	NA	
ENSG00000215819	KRT18P12	NA	
ENSG00000117724	CENPF	243605	STROMME SYNDROME; STROMS;;JEJUNAL ATRESIA WITH MICROCEPHALY AND OCULAR ANOMALIES;;APPLE PEEL SYNDROME WITH MICROCEPHALY AND OCULAR ANOMALIES;;CILIARY DYSKINESIA, PRIMARY, 31, FORMERLY; CILD31, FORMERLY
ENSG00000250536	ABHD17AP3	NA	
ENSG00000224584	UBE2V1P13	NA	
ENSG00000185221	GAPDHP24	NA	
ENSG00000223869	AC099563.1	NA	
ENSG00000287008	AC099563.2	NA	
ENSG00000082482	KCNK2	NA	
ENSG00000232809	VDAC1P10	NA	
ENSG00000282265	AL450990.1	NA	
ENSG00000136636	KCTD3	NA	
ENSG00000042781	USH2A	276901	USHER SYNDROME, TYPE IIA; USH2A
ENSG00000042781	USH2A	613809	RETINITIS PIGMENTOSA 39; RP39
ENSG00000202498	SNORD116	NA	
ENSG00000229242	AL358452.1	NA	
ENSG00000233620	AC093581.1	NA	
ENSG00000236292	AC138024.1	NA	
ENSG00000226013	MRPS18BP1	NA	
ENSG00000196482	ESRRG	NA	
ENSG00000092978	GPATCH2	NA	
ENSG00000162814	SPATA17	NA	
ENSG00000234070	SPATA17-AS1	NA	
ENSG00000228247	UBBP2	NA	
ENSG00000231814	LINC00210	NA	
ENSG00000230714	AL355526.1	NA	
ENSG00000232100	LINC01653	NA	
ENSG00000286775	AL355526.2	NA	
ENSG00000201493	RNU1-141P	NA	
ENSG00000067533	RRP15	NA	
ENSG00000229016	AC096638.2	NA	
ENSG00000223375	AC096638.1	NA	
ENSG00000232480	TGFB2-AS1	NA	
ENSG00000092969	TGFB2	614816	LOEYS-DIETZ SYNDROME 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETAL MANIFESTATIONS
ENSG00000281453	TGFB2-OT1	NA	
ENSG00000228208	LINC02869	NA	
ENSG00000212610	U3	NA	
ENSG00000226693	NXNP1	NA	
ENSG00000225561	LINC01710	NA	
ENSG00000228063	LYPLAL1-DT	NA	
ENSG00000143353	LYPLAL1	NA	
ENSG00000225920	RIMKLBP2	NA	
ENSG00000223842	AL360093.1	NA	
ENSG00000277007	AC096642.1	NA	
ENSG00000287676	AC096642.2	NA	
ENSG00000228536	LYPLAL1-AS1	NA	
ENSG00000238232	AL356364.1	NA	
ENSG00000215817	ZC3H11B	NA	
ENSG00000196660	SLC30A10	613280	HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1;;HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS; HMDPC
ENSG00000252086	RNA5SP76	NA	
ENSG00000221673	U3	NA	
ENSG00000136628	EPRS1	617951	LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15
ENSG00000162813	BPNT1	NA	
ENSG00000067704	IARS2	616007	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS
ENSG00000207590	MIR215	NA	
ENSG00000207624	MIR194-1	NA	
ENSG00000232134	RPS15AP12	NA	
ENSG00000118873	RAB3GAP2	212720	MARTSOLF SYNDROME;;CATARACT-MENTAL RETARDATION-HYPOGONADISM
ENSG00000118873	RAB3GAP2	614225	WARBURG MICRO SYNDROME 2; WARBM2;;MICRO SYNDROME 2
ENSG00000281696	MIR664A	NA	
ENSG00000222370	SNORA36B	NA	
ENSG00000270585	AL445435.1	NA	
ENSG00000270708	KF455155.1	NA	
ENSG00000218283	MORF4L1P1	NA	
ENSG00000213033	AURKAP1	NA	
ENSG00000230318	XRCC6P3	NA	
ENSG00000232883	AL451081.2	NA	
ENSG00000226927	AL451081.1	NA	
ENSG00000260505	AC096644.3	NA	
ENSG00000235163	AC096644.2	NA	
ENSG00000234863	AC096644.1	NA	
ENSG00000226226	PRELID3BP1	NA	
ENSG00000231529	LINC02779	NA	
ENSG00000116141	MARK1	NA	
ENSG00000243872	RN7SL464P	NA	
ENSG00000233012	HDAC1P2	NA	
ENSG00000162817	C1orf115	NA	
ENSG00000117791	MTARC2	NA	
ENSG00000186205	MTARC1	NA	
ENSG00000286231	AL445423.3	NA	
ENSG00000221571	RNU6ATAC35P	NA	
ENSG00000276642	AL445423.2	NA	
ENSG00000272823	AL445423.1	NA	
ENSG00000238078	LINC01352	NA	
ENSG00000257551	HLX-AS1	NA	
ENSG00000136630	HLX	NA	
ENSG00000226211	AL445466.1	NA	
ENSG00000234754	LINC02817	NA	
ENSG00000232436	AL360013.2	NA	
ENSG00000286398	AL360013.3	NA	
ENSG00000227585	AL360013.1	NA	
ENSG00000286421	AL360013.4	NA	
ENSG00000143507	DUSP10	NA	
ENSG00000227925	LINC01655	NA	
ENSG00000200033	RNU6-403P	NA	
ENSG00000238042	LINC02257	NA	
ENSG00000228437	LINC02474	NA	
ENSG00000232679	LINC01705	NA	
ENSG00000236230	AL356108.1	NA	
ENSG00000227613	QRSL1P2	NA	
ENSG00000226643	AL513314.1	NA	
ENSG00000234419	CICP13	NA	
ENSG00000276997	AL513314.2	NA	
ENSG00000222399	RNU6-791P	NA	
ENSG00000267305	AL592148.2	NA	
ENSG00000143512	HHIPL2	NA	
ENSG00000143498	TAF1A	NA	
ENSG00000225265	TAF1A-AS1	NA	
ENSG00000154305	MIA3	NA	
ENSG00000229399	AL592148.1	NA	
ENSG00000272750	AL592148.3	NA	
ENSG00000186063	AIDA	NA	
ENSG00000162819	BROX	NA	
ENSG00000197520	FAM177B	NA	
ENSG00000287684	AL392172.1	NA	
ENSG00000154309	DISP1	NA	
ENSG00000234523	NDUFB1P2	NA	
ENSG00000287338	AL929091.1	NA	
ENSG00000187554	TLR5	601744	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1 SYSTEMIC LUPUS ERYTHEMATOSUS, RESISTANCE TO, 1, INCLUDED
ENSG00000187554	TLR5	608556	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO
ENSG00000187554	TLR5	615557	MELIOIDOSIS, SUSCEPTIBILITY TO MELIOIDOSIS, RESISTANCE TO, INCLUDED
ENSG00000236846	AL359979.2	NA	
ENSG00000226601	AL359979.1	NA	
ENSG00000143502	SUSD4	NA	
ENSG00000251789	RNU4-57P	NA	
ENSG00000178395	CCDC185	NA	
ENSG00000203697	CAPN8	NA	
ENSG00000227002	SNRPEP10	NA	
ENSG00000212398	RNU6-1248P	NA	
ENSG00000162909	CAPN2	NA	
ENSG00000143514	TP53BP2	NA	
ENSG00000227621	PHBP11	NA	
ENSG00000188460	ACTBP11	NA	
ENSG00000233771	CICP5	NA	
ENSG00000272645	GTF2IP20	NA	
ENSG00000212157	RNU6-1319P	NA	
ENSG00000185495	AC138393.1	NA	
ENSG00000278467	AC138393.3	NA	
ENSG00000229930	AC138393.2	NA	
ENSG00000252484	RN7SKP49	NA	
ENSG00000143756	FBXO28	NA	
ENSG00000236773	AC092809.3	NA	
ENSG00000143753	DEGS1	618404	LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18
ENSG00000201898	SNORA72	NA	
ENSG00000232628	AC092809.2	NA	
ENSG00000237101	AC092809.4	NA	
ENSG00000143748	NVL	NA	
ENSG00000221406	MIR320B2	NA	
ENSG00000229742	AC092809.1	NA	
ENSG00000206887	RNU6-1008P	NA	
ENSG00000143771	CNIH4	NA	
ENSG00000162923	WDR26	617616	SKRABAN-DEARDORFF SYNDROME; SKDEAS;;INTELLECTUAL DISABILITY WITH SEIZURES, ABNORMAL GAIT, AND DISTINCTIVE FACIAL FEATURES
ENSG00000266618	MIR4742	NA	
ENSG00000143786	CNIH3	NA	
ENSG00000229991	AKR1B1P1	NA	
ENSG00000233384	CNIH3-AS2	NA	
ENSG00000234247	DNAJB6P6	NA	
ENSG00000286174	AL596330.1	NA	
ENSG00000229400	CNIH3-AS1	NA	
ENSG00000225334	LINC02813	NA	
ENSG00000286719	AL391811.1	NA	
ENSG00000185842	DNAH14	NA	
ENSG00000143815	LBR	169400	PELGER-HUET ANOMALY; PHA
ENSG00000143815	LBR	215140	GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE
ENSG00000143815	LBR	613471	REYNOLDS SYNDROME;;PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA
ENSG00000143815	LBR	618019	PELGER-HUET ANOMALY WITH MILD SKELETAL ANOMALIES; PHASK;;REGRESSIVE SPONDYLOMETAPHYSEAL DYSPLASIA
ENSG00000234476	LINC02765	NA	
ENSG00000282418	AC092811.1	NA	
ENSG00000154380	ENAH	NA	
ENSG00000227496	AC099066.2	NA	
ENSG00000226349	AC099066.1	NA	
ENSG00000223306	RNU6-1304P	NA	
ENSG00000143742	SRP9	NA	
ENSG00000234112	AC099066.3	NA	
ENSG00000143819	EPHX1	607748	HYPERCHOLANEMIA, FAMILIAL; FHCA
ENSG00000242861	AL591895.1	NA	
ENSG00000196187	TMEM63A	618688	LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE; HLD19
ENSG00000243709	LEFTY1	NA	
ENSG00000255835	AL117348.2	NA	
ENSG00000143811	PYCR2	616420	LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10
ENSG00000284519	MIR6741	NA	
ENSG00000248322	AL117348.1	NA	
ENSG00000143768	LEFTY2	NA	
ENSG00000213032	NDUFA3P3	NA	
ENSG00000143751	SDE2	NA	
ENSG00000272562	AL512343.2	NA	
ENSG00000163041	H3-3A	NA	
ENSG00000225518	LINC01703	NA	
ENSG00000270598	AL512343.1	NA	
ENSG00000182827	ACBD3	NA	
ENSG00000234478	ACBD3-AS1	NA	
ENSG00000223570	AL592045.1	NA	
ENSG00000185155	MIXL1	NA	
ENSG00000183814	LIN9	NA	
ENSG00000236994	YBX1P9	NA	
ENSG00000275406	AL359742.1	NA	
ENSG00000143799	PARP1	NA	
ENSG00000270287	AL359704.1	NA	
ENSG00000229965	RPS3AP7	NA	
ENSG00000223282	RN7SKP165	NA	
ENSG00000177770	CDKN2AIPNLP1	NA	
ENSG00000287627	AL359704.2	NA	
ENSG00000203685	STUM	NA	
ENSG00000143772	ITPKB	NA	
ENSG00000228382	ITPKB-IT1	NA	
ENSG00000228548	ITPKB-AS1	NA	
ENSG00000238183	RPS27P5	NA	
ENSG00000287259	AL359732.1	NA	
ENSG00000143801	PSEN2	606889	ALZHEIMER DISEASE 4;;AD4;;ALZHEIMER DISEASE, FAMILIAL, 4
ENSG00000143801	PSEN2	613697	CARDIOMYOPATHY, DILATED, 1V; CMD1V
ENSG00000163050	COQ8A	612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9; SCAR9
ENSG00000228525	AL353689.1	NA	
ENSG00000143776	CDC42BPA	NA	
ENSG00000233706	AL353689.2	NA	
ENSG00000287532	AL353689.3	NA	
ENSG00000228625	AL451047.1	NA	
ENSG00000228729	AL627308.1	NA	
ENSG00000236636	AL627308.2	NA	
ENSG00000287525	AL627308.3	NA	
ENSG00000234277	LINC01641	NA	
ENSG00000232864	NUCKS1P1	NA	
ENSG00000242757	AL606462.1	NA	
ENSG00000224834	BTF3P9	NA	
ENSG00000237193	AL451054.2	NA	
ENSG00000278180	AL451054.3	NA	
ENSG00000237469	TUBB8P10	NA	
ENSG00000235827	TUBB8P9	NA	
ENSG00000227711	AL451054.1	NA	
ENSG00000287205	AL451054.4	NA	
ENSG00000202264	RNA5SP77	NA	
ENSG00000181450	ZNF678	NA	
ENSG00000225934	FAM133FP	NA	
ENSG00000215812	ZNF847P	NA	
ENSG00000143740	SNAP47	NA	
ENSG00000081692	JMJD4	NA	
ENSG00000230005	SNAP47-AS1	NA	
ENSG00000286389	AL731702.1	NA	
ENSG00000185888	PRSS38	NA	
ENSG00000143816	WNT9A	NA	
ENSG00000264483	MIR5008	NA	
ENSG00000233003	CICP26	NA	
ENSG00000274886	SEPTIN14P17	NA	
ENSG00000154342	WNT3A	NA	
ENSG00000276255	LINC02809	NA	
ENSG00000143761	ARF1	618185	PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8
ENSG00000284163	MIR3620	NA	
ENSG00000143793	C1orf35	NA	
ENSG00000162910	MRPL55	NA	
ENSG00000224566	FAM96AP2	NA	
ENSG00000287895	AL136379.1	NA	
ENSG00000280157	AL359510.2	NA	
ENSG00000227625	AL359510.1	NA	
ENSG00000143774	GUK1	NA	
ENSG00000198835	GJC2	608804	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1
ENSG00000198835	GJC2	613206	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44
ENSG00000198835	GJC2	613480	LYMPHATIC MALFORMATION 3; LMPHM3;;LYMPHEDEMA, HEREDITARY, IC, FORMERLY; LMPH1C, FORMERLY
ENSG00000203684	IBA57-DT	NA	
ENSG00000181873	IBA57	615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3
ENSG00000181873	IBA57	616451	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74
ENSG00000162913	OBSCN-AS1	NA	
ENSG00000154358	OBSCN	NA	
ENSG00000269934	AL353593.1	NA	
ENSG00000270110	AL353593.2	NA	
ENSG00000286773	AL353593.3	NA	
ENSG00000287315	AL670729.3	NA	
ENSG00000270104	AL670729.2	NA	
ENSG00000154370	TRIM11	NA	
ENSG00000270094	AL670729.1	NA	
ENSG00000284311	MIR6742	NA	
ENSG00000231563	AL139288.1	NA	
ENSG00000162931	TRIM17	NA	
ENSG00000168148	H3-4	NA	
ENSG00000230841	RPL23AP15	NA	
ENSG00000181218	H2AW	NA	
ENSG00000196890	H2BU1	NA	
ENSG00000266174	MIR4666A	NA	
ENSG00000181201	H2BU2P	NA	
ENSG00000279306	AL139288.2	NA	
ENSG00000168159	RNF187	NA	
ENSG00000215811	BTNL10	NA	
ENSG00000202056	RNA5SP19	NA	
ENSG00000251823	RNA5SP162	NA	
ENSG00000199352	RNA5S1	NA	
ENSG00000201588	RNA5S2	NA	
ENSG00000199337	RNA5S3	NA	
ENSG00000200381	RNA5S4	NA	
ENSG00000199396	RNA5S5	NA	
ENSG00000200624	RNA5S6	NA	
ENSG00000202521	RNA5S7	NA	
ENSG00000200343	RNA5S8	NA	
ENSG00000201321	RNA5S9	NA	
ENSG00000199910	RNA5S10	NA	
ENSG00000199334	RNA5S11	NA	
ENSG00000199270	RNA5S12	NA	
ENSG00000202526	RNA5S13	NA	
ENSG00000201355	RNA5S14	NA	
ENSG00000201925	RNA5S15	NA	
ENSG00000202257	RNA5S16	NA	
ENSG00000200370	RNA5S17	NA	
ENSG00000212237	RNA5SP18	NA	
ENSG00000183929	DUSP5P1	NA	
ENSG00000206878	AL713899.1	NA	
ENSG00000234975	FTH1P2	NA	
ENSG00000116574	RHOU	NA	
ENSG00000271475	AL078624.2	NA	
ENSG00000271399	AL078624.1	NA	
ENSG00000282111	LINC02815	NA	
ENSG00000229840	ISCA1P2	NA	
ENSG00000236975	LINC02814	NA	
ENSG00000233920	AL162595.2	NA	
ENSG00000177800	TMEM78	NA	
ENSG00000177788	AL162595.1	NA	
ENSG00000168118	RAB4A	NA	
ENSG00000237481	AL117350.1	NA	
ENSG00000154429	CCSAP	NA	
ENSG00000252506	RNU6-180P	NA	
ENSG00000252051	RN7SKP276	NA	
ENSG00000230331	AL160004.2	NA	
ENSG00000143632	ACTA1	161800	NEMALINE MYOPATHY 3; NEM3 MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS, INCLUDED;;NEMALINE MYOPATHY 3, WITH INTRANUCLEAR RODS, INCLUDED;;MYOPATHY, ACTIN, CONGENITAL, WITH CORES, INCLUDED
ENSG00000143632	ACTA1	255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD;;FIBER-TYPE DISPROPORTION MYOPATHY, CONGENITAL; CFTDM
ENSG00000143632	ACTA1	616852	MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM
ENSG00000069248	NUP133	618177	NEPHROTIC SYNDROME, TYPE 18; NPHS18
ENSG00000069248	NUP133	618349	GALLOWAY-MOWAT SYNDROME 8; GAMOS8
ENSG00000226920	AL160004.1	NA	
ENSG00000223635	AL121990.1	NA	
ENSG00000135776	ABCB10	NA	
ENSG00000199672	RNU4-21P	NA	
ENSG00000201492	RNA5SP78	NA	
ENSG00000229367	HMGN2P19	NA	
ENSG00000135801	TAF5L	NA	
ENSG00000135763	URB2	NA	
ENSG00000213028	AL354983.1	NA	
ENSG00000225984	HMGB1P26	NA	
ENSG00000227043	LINC01682	NA	
ENSG00000228058	LINC01736	NA	
ENSG00000143641	GALNT2	NA	
ENSG00000227006	AL136988.2	NA	
ENSG00000224407	AL136988.1	NA	
ENSG00000177614	PGBD5	NA	
ENSG00000282564	AL133516.1	NA	
ENSG00000232964	LINC01737	NA	
ENSG00000235817	AL158214.1	NA	
ENSG00000135775	COG2	617395	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q;;CDG IIq; CDGIIq
ENSG00000286859	AL158214.2	NA	
ENSG00000135744	AGT	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000135744	AGT	106150	ANGIOTENSINOGEN; AGT;;SERPINA8 IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO, INCLUDED;;ANGIOTENSIN I, INCLUDED;;ANGIOTENSIN II, INCLUDED
ENSG00000135744	AGT	267430	RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROME  RENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED
ENSG00000244137	AL512328.1	NA	
ENSG00000135773	CAPN9	NA	
ENSG00000202063	RNA5SP79	NA	
ENSG00000225656	AL118511.2	NA	
ENSG00000119280	C1orf198	NA	
ENSG00000223393	AL118511.1	NA	
ENSG00000288037	AL118511.4	NA	
ENSG00000287395	AL118511.3	NA	
ENSG00000240502	RN7SL837P	NA	
ENSG00000143643	TTC13	NA	
ENSG00000173409	ARV1	617020	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38
ENSG00000182118	FAM89A	NA	
ENSG00000283799	MIR1182	NA	
ENSG00000227934	AL732414.1	NA	
ENSG00000229595	AL109810.1	NA	
ENSG00000119283	TRIM67	NA	
ENSG00000235710	AL109810.2	NA	
ENSG00000143633	C1orf131	NA	
ENSG00000116906	GNPAT	222765	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2;;DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE DEFICIENCY;;DHAPAT DEFICIENCY;;GLYCERONEPHOSPHATE O-ACYLTRANSFERASE DEFICIENCY;;GNPAT DEFICIENCY;;PEROXISOMAL DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE DE /.../CY;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC, DUE TO DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE DEFICIENCY
ENSG00000222407	RNA5SP80	NA	
ENSG00000116903	EXOC8	NA	
ENSG00000010072	SPRTN	616200	RUIJS-AALFS SYNDROME; RJALS
ENSG00000287450	AL117352.1	NA	
ENSG00000135766	EGLN1	609070	HEMOGLOBIN, HIGH ALTITUDE ADAPTATION; HALAH;;HEMOGLOBIN, HIGH OXYGEN SATURATION OF
ENSG00000135766	EGLN1	609820	ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3
ENSG00000287856	AL445524.2	NA	
ENSG00000223982	SNRPD2P2	NA	
ENSG00000233461	AL445524.1	NA	
ENSG00000116918	TSNAX	NA	
ENSG00000270106	TSNAX-DISC1	NA	
ENSG00000229228	LINC00582	NA	
ENSG00000162946	DISC1	604906	SCHIZOPHRENIA 9; SCZD9;;SCHIZOPHRENIA 9 WITH OR WITHOUT AN AFFECTIVE DISORDER;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 1q42-RELATED
ENSG00000222986	RNU5A-5P	NA	
ENSG00000286071	AL136171.2	NA	
ENSG00000274121	AL136171.1	NA	
ENSG00000226758	DISC1-IT1	NA	
ENSG00000235152	AL353052.1	NA	
ENSG00000236372	AL353052.2	NA	
ENSG00000224436	BX323014.1	NA	
ENSG00000242794	RN7SL299P	NA	
ENSG00000116991	SIPA1L2	NA	
ENSG00000238382	RNU6-1211P	NA	
ENSG00000225919	LINC01745	NA	
ENSG00000236497	LINC01744	NA	
ENSG00000212916	MAP10	NA	
ENSG00000206835	RNU1-74P	NA	
ENSG00000286774	AL122003.2	NA	
ENSG00000232175	AL122003.1	NA	
ENSG00000135778	NTPCR	NA	
ENSG00000135749	PCNX2	NA	
ENSG00000231940	RPS7P3	NA	
ENSG00000251508	AL133380.1	NA	
ENSG00000143674	MAP3K21	NA	
ENSG00000252501	RNU4-77P	NA	
ENSG00000287423	AL360006.1	NA	
ENSG00000135750	KCNK1	NA	
ENSG00000265744	MIR4427	NA	
ENSG00000286109	AL357972.1	NA	
ENSG00000225486	AL663058.1	NA	
ENSG00000286666	AL663058.2	NA	
ENSG00000287921	AL713868.1	NA	
ENSG00000183780	SLC35F3	NA	
ENSG00000236101	RAC1P7	NA	
ENSG00000233332	AL122008.3	NA	
ENSG00000231272	AL122008.1	NA	
ENSG00000236244	AL122008.4	NA	
ENSG00000232166	AL122008.2	NA	
ENSG00000264377	MIR4671	NA	
ENSG00000235605	AL355472.1	NA	
ENSG00000236358	AL355472.2	NA	
ENSG00000273367	AL355472.3	NA	
ENSG00000231663	COA6-AS1	NA	
ENSG00000168275	COA6	616501	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4
ENSG00000059588	TARBP1	NA	
ENSG00000231768	LINC01354	NA	
ENSG00000286210	AL161640.2	NA	
ENSG00000287633	AL161640.3	NA	
ENSG00000230404	AL161640.1	NA	
ENSG00000212144	U8	NA	
ENSG00000168264	IRF2BP2	617765	IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14
ENSG00000228830	AL160408.2	NA	
ENSG00000224939	LINC00184	NA	
ENSG00000272362	AL160408.5	NA	
ENSG00000228044	AL160408.1	NA	
ENSG00000241475	AL160408.4	NA	
ENSG00000230628	AL160408.3	NA	
ENSG00000282097	AL160408.6	NA	
ENSG00000227630	LINC01132	NA	
ENSG00000279261	PP2672	NA	
ENSG00000286263	AL391832.4	NA	
ENSG00000201638	RNY4P16	NA	
ENSG00000239690	RN7SL668P	NA	
ENSG00000237520	AL391832.1	NA	
ENSG00000238005	AL391832.2	NA	
ENSG00000258082	AL391832.3	NA	
ENSG00000280587	LINC01348	NA	
ENSG00000233018	AL732292.1	NA	
ENSG00000273416	AL732292.2	NA	
ENSG00000173726	TOMM20	NA	
ENSG00000207181	SNORA14B	NA	
ENSG00000188739	RBM34	NA	
ENSG00000054267	ARID4B	NA	
ENSG00000263439	MIR4753	NA	
ENSG00000236863	RPL23AP23	NA	
ENSG00000152904	GGPS1	NA	
ENSG00000285053	TBCE	241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS;;HYPOPARATHYROIDISM WITH SHORT STATURE, MENTAL RETARDATION, AND SEIZURES;;SANJAD-SAKATI SYNDROME;;HYPOPARATHYROIDISM, CONGENITAL, ASSOCIATED WITH DYSMORPHISM, GROWTH RETARDATION, AND DEVELOPM /.../DELAY
ENSG00000285053	TBCE	244460	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE
ENSG00000285053	TBCE	617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO
ENSG00000227962	AL391994.1	NA	
ENSG00000230026	AL357556.1	NA	
ENSG00000285177	AL357556.4	NA	
ENSG00000284770	TBCE	241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS;;HYPOPARATHYROIDISM WITH SHORT STATURE, MENTAL RETARDATION, AND SEIZURES;;SANJAD-SAKATI SYNDROME;;HYPOPARATHYROIDISM, CONGENITAL, ASSOCIATED WITH DYSMORPHISM, GROWTH RETARDATION, AND DEVELOPM /.../DELAY
ENSG00000284770	TBCE	244460	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE
ENSG00000284770	TBCE	617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO
ENSG00000229795	RPS21P1	NA	
ENSG00000162885	B3GALNT2	615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GALNT2-RELATED
ENSG00000238236	MTCYBP14	NA	
ENSG00000235638	MTND6P14	NA	
ENSG00000231199	MTND5P19	NA	
ENSG00000226663	MTND4P10	NA	
ENSG00000231582	MTND4LP21	NA	
ENSG00000232714	MTND3P8	NA	
ENSG00000235761	MTCO3P46	NA	
ENSG00000168243	GNG4	NA	
ENSG00000270710	FO393422.1	NA	
ENSG00000227236	AL583844.1	NA	
ENSG00000143669	LYST	214500	CHEDIAK-HIGASHI SYNDROME; CHS
ENSG00000235674	LDHAP2	NA	
ENSG00000229463	LYST-AS1	NA	
ENSG00000222831	MIR1537	NA	
ENSG00000206803	RNU6-968P	NA	
ENSG00000237845	AL139161.1	NA	
ENSG00000229291	LINC02768	NA	
ENSG00000116962	NID1	NA	
ENSG00000252822	Y_RNA	NA	
ENSG00000235371	AL122018.1	NA	
ENSG00000286142	AL122018.2	NA	
ENSG00000077585	GPR137B	NA	
ENSG00000086619	ERO1B	NA	
ENSG00000222650	RNU2-70P	NA	
ENSG00000237922	AL450309.1	NA	
ENSG00000186197	EDARADD	129490	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED
ENSG00000186197	EDARADD	224900	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC; HED;;ECTODERMAL DYSPLASIA, ANHIDROTIC; EDA
ENSG00000186197	EDARADD	614940	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED
ENSG00000186197	EDARADD	614941	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC; HED;;ECTODERMAL DYSPLASIA, ANHIDROTIC; EDA
ENSG00000244457	ENO1P1	NA	
ENSG00000116977	LGALS8	NA	
ENSG00000223776	LGALS8-AS1	NA	
ENSG00000273058	AL359921.2	NA	
ENSG00000230325	AL359921.1	NA	
ENSG00000119285	HEATR1	NA	
ENSG00000077522	ACTN2	612158	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 23, WITH OR WITHOUT VENTRICULAR NONCOMPACTION, INCLUDED; CMH23, INCLUDED
ENSG00000077522	ACTN2	618654	MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES; MYOCOZ;;MULTIPLE STRUCTURED CORE DISEASE; MSCD
ENSG00000077522	ACTN2	618655	MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT; MPD6
ENSG00000116984	MTR	250940	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG;;HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblG COMPLEMENTATION TYPE;;METHYLCOBALAMIN DEFICIENCY, cblG TYPE;;METHIONINE SYNTHASE DEFICIENCY
ENSG00000116984	MTR	601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS;;NTD, FOLATE-SENSITIVE  SPINA BIFIDA, FOLATE-SENSITIVE, INCLUDED
ENSG00000226498	RPSAP21	NA	
ENSG00000237991	RPL35P1	NA	
ENSG00000244020	MT1HL1	NA	
ENSG00000288099	AL359259.1	NA	
ENSG00000198626	RYR2	600996	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 2; ARVC2
ENSG00000198626	RYR2	604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1;;VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP
ENSG00000252396	RN7SKP195	NA	
ENSG00000266262	MIR4428	NA	
ENSG00000252290	AL442065.1	NA	
ENSG00000237250	AL359924.1	NA	
ENSG00000116996	ZP4	NA	
ENSG00000243781	AL590396.1	NA	
ENSG00000283174	AL590396.3	NA	
ENSG00000283166	AL590396.2	NA	
ENSG00000283377	AL590396.4	NA	
ENSG00000270188	MTRNR2L11	NA	
ENSG00000232154	MTCYBP15	NA	
ENSG00000225723	MTND6P15	NA	
ENSG00000227860	MTND5P18	NA	
ENSG00000230019	YWHAQP9	NA	
ENSG00000234464	AL356010.2	NA	
ENSG00000232989	AL356010.1	NA	
ENSG00000252371	RNU6-725P	NA	
ENSG00000215808	LINC01139	NA	
ENSG00000231877	AL359551.1	NA	
ENSG00000215149	KRT18P32	NA	
ENSG00000224783	MIPEPP2	NA	
ENSG00000287177	AL583825.1	NA	
ENSG00000227854	AL590135.1	NA	
ENSG00000287589	AC093426.2	NA	
ENSG00000259776	AC093426.1	NA	
ENSG00000133019	CHRM3	100100	PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS
ENSG00000233355	CHRM3-AS2	NA	
ENSG00000234601	CHRM3-AS1	NA	
ENSG00000231979	AL356361.2	NA	
ENSG00000215805	AL356361.1	NA	
ENSG00000287102	AL356361.3	NA	
ENSG00000217327	RPS7P5	NA	
ENSG00000155816	FMN2	616193	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47; MRT47
ENSG00000228818	AL359918.2	NA	
ENSG00000202041	AL359918.1	NA	
ENSG00000223694	ADH5P3	NA	
ENSG00000233735	AL359918.3	NA	
ENSG00000252317	Y_RNA	NA	
ENSG00000233519	AL590490.1	NA	
ENSG00000180875	GREM2	617275	TOOTH AGENESIS, SELECTIVE, 9; STHAG9
ENSG00000224359	AL358176.1	NA	
ENSG00000226014	AL358176.2	NA	
ENSG00000231440	AL358176.4	NA	
ENSG00000228844	AL358176.3	NA	
ENSG00000251750	RNU5F-8P	NA	
ENSG00000234872	AL358176.5	NA	
ENSG00000199241	AL590965.1	NA	
ENSG00000230015	AL365184.2	NA	
ENSG00000226919	AL365184.1	NA	
ENSG00000223963	THAP12P8	NA	
ENSG00000182901	RGS7	NA	
ENSG00000215802	RFKP1	NA	
ENSG00000233615	HNRNPA1P42	NA	
ENSG00000238085	AL590682.1	NA	
ENSG00000265831	MIR3123	NA	
ENSG00000224348	AL592076.1	NA	
ENSG00000286496	AL359764.1	NA	
ENSG00000287516	AL359764.2	NA	
ENSG00000287738	AL359764.3	NA	
ENSG00000091483	FH	150800	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC;;MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATA 1, WITH OR WITHOUT RENAL CELL CARCINOMA; MCUL1;;LEIOMYOMATOSIS AND RENAL CELL CANCER, HEREDITARY; LRCC;;LEIOMYOMA, MULTIPLE CUTANEOUS; MCL
ENSG00000091483	FH	606812	FUMARASE DEFICIENCY; FMRD;;FUMARIC ACIDURIA
ENSG00000117009	KMO	NA	
ENSG00000054277	OPN3	NA	
ENSG00000203668	CHML	NA	
ENSG00000287513	AL133390.1	NA	
ENSG00000162843	WDR64	NA	
ENSG00000229022	AL365366.1	NA	
ENSG00000174371	EXO1	NA	
ENSG00000235990	RPL23AP20	NA	
ENSG00000196289	BECN2	NA	
ENSG00000213026	CFL1P4	NA	
ENSG00000197769	MAP1LC3C	NA	
ENSG00000224625	TUBB8P6	NA	
ENSG00000277099	BX571673.1	NA	
ENSG00000180287	PLD5	NA	
ENSG00000272865	AL591686.2	NA	
ENSG00000252084	RN7SKP12	NA	
ENSG00000224525	AL591686.1	NA	
ENSG00000226750	AL360271.2	NA	
ENSG00000235467	RPL10AP5	NA	
ENSG00000213690	AL360271.1	NA	
ENSG00000270859	AC099785.1	NA	
ENSG00000215800	RSL24D1P4	NA	
ENSG00000270818	AL445675.1	NA	
ENSG00000277704	AL445675.2	NA	
ENSG00000230199	AL603825.1	NA	
ENSG00000234116	AL606534.3	NA	
ENSG00000231512	SEPTIN14P21	NA	
ENSG00000278455	AL606534.5	NA	
ENSG00000253326	AL606534.4	NA	
ENSG00000214837	LINC01347	NA	
ENSG00000212230	RNU6-747P	NA	
ENSG00000143702	CEP170	NA	
ENSG00000227230	AL606534.1	NA	
ENSG00000232085	AL606534.2	NA	
ENSG00000054282	SDCCAG8	613615	SENIOR-LOKEN SYNDROME 7; SLSN7
ENSG00000054282	SDCCAG8	615993	BARDET-BIEDL SYNDROME 16; BBS16
ENSG00000224727	FCF1P7	NA	
ENSG00000265201	MIR4677	NA	
ENSG00000117020	AKT3	615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2
ENSG00000236031	AL591721.1	NA	
ENSG00000226766	FABP7P1	NA	
ENSG00000232184	AL662889.1	NA	
ENSG00000228939	AKT3-IT1	NA	
ENSG00000226828	LINC02774	NA	
ENSG00000179456	ZBTB18	612337	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22 CHROMOSOME 1q43-q44 DELETION SYNDROME, INCLUDED;;CHROMOSOME 1qter DELETION SYNDROME, INCLUDED
ENSG00000279774	AL590483.3	NA	
ENSG00000229960	AL590483.1	NA	
ENSG00000286486	AL590483.4	NA	
ENSG00000244066	RN7SL148P	NA	
ENSG00000237759	AL590483.2	NA	
ENSG00000287531	AL358177.1	NA	
ENSG00000173728	C1orf100	NA	
ENSG00000240963	AL645465.1	NA	
ENSG00000225401	TGIF2P1	NA	
ENSG00000035687	ADSS2	NA	
ENSG00000179397	CATSPERE	NA	
ENSG00000227735	CYCSP5	NA	
ENSG00000121644	DESI2	NA	
ENSG00000232059	AL451007.1	NA	
ENSG00000284188	AL451007.3	NA	
ENSG00000282317	AL451007.2	NA	
ENSG00000287601	BX323046.2	NA	
ENSG00000203667	COX20	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000153187	HNRNPU	617391	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54
ENSG00000273175	BX323046.1	NA	
ENSG00000201758	RN7SKP55	NA	
ENSG00000252073	RNU6-947P	NA	
ENSG00000272195	AL356512.1	NA	
ENSG00000203666	EFCAB2	NA	
ENSG00000252282	RNU6-1089P	NA	
ENSG00000251754	RNU6-999P	NA	
ENSG00000223353	AL589763.1	NA	
ENSG00000201170	RNU1-132P	NA	
ENSG00000162849	KIF26B	NA	
ENSG00000232192	KIF26B-AS1	NA	
ENSG00000232793	DNAJC19P8	NA	
ENSG00000238224	AC104462.2	NA	
ENSG00000231612	AC104462.1	NA	
ENSG00000185420	SMYD3	NA	
ENSG00000235096	AC118555.1	NA	
ENSG00000226876	AC092801.1	NA	
ENSG00000225222	CHCHD4P5	NA	
ENSG00000202184	RNU6-1283P	NA	
ENSG00000230184	SMYD3-IT1	NA	
ENSG00000207326	Y_RNA	NA	
ENSG00000227728	AL356583.1	NA	
ENSG00000242042	LINC01743	NA	
ENSG00000230813	AL356583.3	NA	
ENSG00000229112	AL356583.2	NA	
ENSG00000162851	TFB2M	NA	
ENSG00000162852	CNST	NA	
ENSG00000225300	AL591623.1	NA	
ENSG00000228955	AL591623.2	NA	
ENSG00000260698	AL591848.3	NA	
ENSG00000235021	AL591848.2	NA	
ENSG00000143653	SCCPDH	NA	
ENSG00000228879	AL591848.1	NA	
ENSG00000223519	KIF28P	NA	
ENSG00000260855	AL591848.4	NA	
ENSG00000227953	LINC01341	NA	
ENSG00000235386	AC113174.1	NA	
ENSG00000252011	AC113174.2	NA	
ENSG00000153207	AHCTF1	NA	
ENSG00000197472	ZNF695	NA	
ENSG00000135747	ZNF670-ZNF695	NA	
ENSG00000236775	AL512637.2	NA	
ENSG00000277462	ZNF670	NA	
ENSG00000215796	AL512637.1	NA	
ENSG00000228982	AL627095.1	NA	
ENSG00000188295	ZNF669	NA	
ENSG00000286747	AL627095.2	NA	
ENSG00000221953	C1orf229	NA	
ENSG00000226164	FGFR3P6	NA	
ENSG00000196418	ZNF124	NA	
ENSG00000224014	AL390728.3	NA	
ENSG00000215795	AL390728.2	NA	
ENSG00000259865	AL390728.6	NA	
ENSG00000227671	AL390728.4	NA	
ENSG00000283881	MIR3916	NA	
ENSG00000252516	RNA5SP82	NA	
ENSG00000232347	AL390728.5	NA	
ENSG00000214144	AL390728.1	NA	
ENSG00000235818	VN1R17P	NA	
ENSG00000197617	VN1R5	NA	
ENSG00000202079	AC104335.1	NA	
ENSG00000162714	ZNF496	NA	
ENSG00000286216	AC104335.2	NA	
ENSG00000287116	AC104335.3	NA	
ENSG00000162711	NLRP3	148200	KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH;;KERATITIS FUGAX HEREDITARIA
ENSG00000162711	NLRP3	120100	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1;;FCAS;;COLD HYPERSENSITIVITY;;COLD-INDUCED AUTOINFLAMMATORY SYNDROME, FAMILIAL;;COLD URTICARIA, FAMILIAL; FCU;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 1; CAPS1
ENSG00000162711	NLRP3	191900	MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2
ENSG00000162711	NLRP3	607115	CINCA SYNDROME; CINCA;;CHRONIC NEUROLOGIC CUTANEOUS AND ARTICULAR SYNDROME;;MULTISYSTEM INFLAMMATORY DISEASE, NEONATAL-ONSET; NOMID;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 3; CAPS3
ENSG00000162711	NLRP3	617772	DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34
ENSG00000177535	OR2B11	NA	
ENSG00000203664	OR2W5	NA	
ENSG00000169224	GCSAML	NA	
ENSG00000196242	OR2C3	NA	
ENSG00000284824	GCSAML-AS1	NA	
ENSG00000236817	AL606804.1	NA	
ENSG00000177489	OR2G2	NA	
ENSG00000177476	OR2G3	NA	
ENSG00000283369	AL606804.2	NA	
ENSG00000198452	OR14L1P	NA	
ENSG00000235749	AL390860.1	NA	
ENSG00000230411	OR3D1P	NA	
ENSG00000197437	OR13G1	NA	
ENSG00000169214	OR6F1	NA	
ENSG00000239395	AC118470.1	NA	
ENSG00000241128	OR14A2	NA	
ENSG00000153230	OR14K1	NA	
ENSG00000221888	OR1C1	NA	
ENSG00000228336	OR9H1P	NA	
ENSG00000196772	OR14A16	NA	
ENSG00000232908	HSD17B7P1	NA	
ENSG00000230576	OR6R1P	NA	
ENSG00000197591	OR11L1	NA	
ENSG00000162722	TRIM58	NA	
ENSG00000238243	OR2W3	NA	
ENSG00000177462	OR2T8	NA	
ENSG00000177275	OR2AJ1	NA	
ENSG00000226191	CLK3P2	NA	
ENSG00000224830	OR2X1P	NA	
ENSG00000279263	OR2L8	NA	
ENSG00000187080	OR2AK2	NA	
ENSG00000237492	OR2L9P	NA	
ENSG00000224227	OR2L1P	NA	
ENSG00000199442	Y_RNA	NA	
ENSG00000232215	OR2L6P	NA	
ENSG00000197454	OR2L5	NA	
ENSG00000200085	Y_RNA	NA	
ENSG00000203663	OR2L2	NA	
ENSG00000200982	Y_RNA	NA	
ENSG00000198128	OR2L3	NA	
ENSG00000197067	OR2T32P	NA	
ENSG00000196071	OR2L13	NA	
ENSG00000177233	OR2M1P	NA	
ENSG00000162727	OR2M5	NA	
ENSG00000198601	OR2M2	NA	
ENSG00000228198	OR2M3	NA	
ENSG00000171180	OR2M4	NA	
ENSG00000177212	OR2T33	NA	
ENSG00000177201	OR2T12	NA	
ENSG00000177186	OR2M7	NA	
ENSG00000177174	OR14C36	NA	
ENSG00000196944	OR2T4	NA	
ENSG00000198104	OR2T6	NA	
ENSG00000175143	OR2T1	NA	
ENSG00000227152	OR2T7	NA	
ENSG00000196240	OR2T2	NA	
ENSG00000196539	OR2T3	NA	
ENSG00000229255	AC138089.1	NA	
ENSG00000203661	OR2T5	NA	
ENSG00000271934	OR2AS2P	NA	
ENSG00000188558	OR2G6	NA	
ENSG00000224521	AC098483.1	NA	
ENSG00000227102	OR2AS1P	NA	
ENSG00000182783	OR2T29	NA	
ENSG00000183310	OR2T34	NA	
ENSG00000184022	OR2T10	NA	
ENSG00000201602	Y_RNA	NA	
ENSG00000271701	AC098483.2	NA	
ENSG00000279301	OR2T11	NA	
ENSG00000177151	OR2T35	NA	
ENSG00000187701	OR2T27	NA	
ENSG00000286015	CR589904.2	NA	
ENSG00000259823	LYPD8	NA	
ENSG00000189181	OR14I1	NA	
ENSG00000229703	LYPD9P	NA	
ENSG00000276520	CR589904.1	NA	
ENSG00000242529	AHCYP8	NA	
ENSG00000229663	DPY19L4P1	NA	
ENSG00000175137	SH3BP5L	NA	
ENSG00000264500	MIR3124	NA	
ENSG00000171161	ZNF672	NA	
ENSG00000171163	ZNF692	NA	
ENSG00000227237	AL672291.1	NA	
ENSG00000185220	PGBD2	NA	
ENSG00000200495	RNU6-1205P	NA	
ENSG00000233084	RPL23AP25	NA	
ENSG00000260370	AC215217.1	NA	
ENSG00000237297	AL713922.1	NA	
ENSG00000261456	TUBB8	616780	OOCYTE MATURATION DEFECT 2; OOMD2
ENSG00000232420	IL9RP2	NA	
ENSG00000015171	ZMYND11	616083	MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30
ENSG00000276662	AL713922.2	NA	
ENSG00000212331	RNA5SP297	NA	
ENSG00000151240	DIP2C	NA	
ENSG00000201861	RNA5SP298	NA	
ENSG00000239822	RN7SL754P	NA	
ENSG00000233021	AL669841.1	NA	
ENSG00000225140	AL358216.1	NA	
ENSG00000263511	MIR5699	NA	
ENSG00000180525	PRR26	NA	
ENSG00000231601	AL157709.1	NA	
ENSG00000107929	LARP4B	NA	
ENSG00000229869	AL359878.2	NA	
ENSG00000205740	AL359878.1	NA	
ENSG00000107937	GTPBP4	NA	
ENSG00000148377	IDI2	NA	
ENSG00000232656	IDI2-AS1	NA	
ENSG00000067064	IDI1	NA	
ENSG00000047056	WDR37	618652	NEUROOCULOCARDIOGENITOURINARY SYNDROME; NOCGUS
ENSG00000229205	LINC00200	NA	
ENSG00000185736	ADARB2	NA	
ENSG00000287043	AL392083.2	NA	
ENSG00000282390	AL392083.1	NA	
ENSG00000233052	AL513304.1	NA	
ENSG00000205696	ADARB2-AS1	NA	
ENSG00000287653	AL355597.1	NA	
ENSG00000234962	LINC00700	NA	
ENSG00000226694	AL441943.1	NA	
ENSG00000278069	MIR6072	NA	
ENSG00000252998	RNU6-889P	NA	
ENSG00000227912	AL441943.2	NA	
ENSG00000231326	LINC02662	NA	
ENSG00000212156	RNU6-576P	NA	
ENSG00000234556	LINC00701	NA	
ENSG00000234170	LINC02645	NA	
ENSG00000237500	AL713851.2	NA	
ENSG00000235281	AL713851.1	NA	
ENSG00000286858	AL355361.1	NA	
ENSG00000231743	AC026396.1	NA	
ENSG00000234182	AL731533.1	NA	
ENSG00000287560	AL731533.3	NA	
ENSG00000273001	AL731533.2	NA	
ENSG00000067057	PFKP	NA	
ENSG00000278419	AL451164.2	NA	
ENSG00000107959	PITRM1	NA	
ENSG00000237399	PITRM1-AS1	NA	
ENSG00000288566	AL451164.3	NA	
ENSG00000236968	AL451164.1	NA	
ENSG00000226762	LINC02668	NA	
ENSG00000227338	AL139280.1	NA	
ENSG00000287428	AL139280.2	NA	
ENSG00000286610	AL356433.1	NA	
ENSG00000233321	LINC02669	NA	
ENSG00000236892	AL357833.1	NA	
ENSG00000229672	AL450322.2	NA	
ENSG00000228353	AL450322.1	NA	
ENSG00000067082	KLF6	176807	PROSTATE CANCER
ENSG00000067082	KLF6	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000287175	AL513303.1	NA	
ENSG00000230573	LINC02639	NA	
ENSG00000226005	LINC02660	NA	
ENSG00000274809	MIR6078	NA	
ENSG00000227101	AC025822.1	NA	
ENSG00000236990	AC025822.2	NA	
ENSG00000233117	LINC00702	NA	
ENSG00000224382	LINC00703	NA	
ENSG00000230096	AC022535.1	NA	
ENSG00000287246	AC022535.3	NA	
ENSG00000286687	AC022535.2	NA	
ENSG00000207124	RNU6-163P	NA	
ENSG00000231298	MANCR	NA	
ENSG00000225269	LINC00705	NA	
ENSG00000287023	AC018978.1	NA	
ENSG00000165568	AKR1E2	NA	
ENSG00000151631	AKR1C6P	NA	
ENSG00000238840	U8	NA	
ENSG00000187134	AKR1C1	NA	
ENSG00000151632	AKR1C2	614279	46,XY SEX REVERSAL 8; SRXY8;;MALE PSEUDOHERMAPHRODITISM DUE TO DEFICIENCY OF TESTICULAR 17,20-DESMOLASE; TDD
ENSG00000224251	AL391427.1	NA	
ENSG00000239148	U8	NA	
ENSG00000196139	AKR1C3	NA	
ENSG00000239142	U8	NA	
ENSG00000225418	AKR1C5P	NA	
ENSG00000264006	AKR1C8P	NA	
ENSG00000198610	AKR1C4	614279	46,XY SEX REVERSAL 8; SRXY8;;MALE PSEUDOHERMAPHRODITISM DUE TO DEFICIENCY OF TESTICULAR 17,20-DESMOLASE; TDD
ENSG00000228291	ARL4AP3	NA	
ENSG00000287848	AL355303.2	NA	
ENSG00000231039	AL355303.1	NA	
ENSG00000224034	LINC02561	NA	
ENSG00000215267	AKR1C7P	NA	
ENSG00000223987	RPL26P28	NA	
ENSG00000280450	AL683826.1	NA	
ENSG00000178473	UCN3	NA	
ENSG00000178462	TUBAL3	NA	
ENSG00000173848	NET1	NA	
ENSG00000178372	CALML5	NA	
ENSG00000205488	CALML3-AS1	NA	
ENSG00000178363	CALML3	NA	
ENSG00000256462	AL732437.1	NA	
ENSG00000287566	AL732437.3	NA	
ENSG00000287235	AL732437.2	NA	
ENSG00000242147	LASTR	NA	
ENSG00000228685	AL365356.2	NA	
ENSG00000240577	RN7SL445P	NA	
ENSG00000196372	ASB13	NA	
ENSG00000108021	TASOR2	NA	
ENSG00000226647	AL365356.1	NA	
ENSG00000057608	GDI2	NA	
ENSG00000270427	NRBF2P5	NA	
ENSG00000272764	AL596094.1	NA	
ENSG00000134461	ANKRD16	NA	
ENSG00000240180	RPL12P28	NA	
ENSG00000134452	FBH1	NA	
ENSG00000232807	AL137186.2	NA	
ENSG00000134470	IL15RA	NA	
ENSG00000134460	IL2RA	601942	DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10;;INSULIN-DEPENDENT DIABETES MELLITUS 10
ENSG00000134460	IL2RA	606367	IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY
ENSG00000251922	AL137186.3	NA	
ENSG00000229664	AL137186.1	NA	
ENSG00000214015	RPL32P23	NA	
ENSG00000134453	RBM17	NA	
ENSG00000170525	PFKFB3	NA	
ENSG00000201581	RN7SKP78	NA	
ENSG00000263628	MIR3155A	NA	
ENSG00000283634	MIR3155B	NA	
ENSG00000213994	AL157395.1	NA	
ENSG00000238366	Y_RNA	NA	
ENSG00000215244	LINC02649	NA	
ENSG00000226705	SDCBPP1	NA	
ENSG00000212743	LINC02656	NA	
ENSG00000065675	PRKCQ	NA	
ENSG00000237943	PRKCQ-AS1	NA	
ENSG00000225948	LINC02648	NA	
ENSG00000285743	AL158210.1	NA	
ENSG00000223784	LINP1	NA	
ENSG00000285988	AL392086.2	NA	
ENSG00000281186	LINC00706	NA	
ENSG00000238266	LINC00707	NA	
ENSG00000285845	AL392086.1	NA	
ENSG00000287277	AL392086.3	NA	
ENSG00000223581	LINC02665	NA	
ENSG00000270811	AL590095.1	NA	
ENSG00000198879	SFMBT2	NA	
ENSG00000235141	COX6CP17	NA	
ENSG00000278982	AL139125.1	NA	
ENSG00000232591	LINC02642	NA	
ENSG00000207453	RNU6-535P	NA	
ENSG00000230121	AL445070.1	NA	
ENSG00000123243	ITIH5	NA	
ENSG00000151655	ITIH2	NA	
ENSG00000151657	KIN	NA	
ENSG00000165629	ATP5F1C	NA	
ENSG00000165632	TAF3	NA	
ENSG00000233990	AL353754.1	NA	
ENSG00000107485	GATA3	146255	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR;;HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS;;BARAKAT SYNDROME;;NEPHROSIS, NERVE DEAFNESS, AND HYPOPARATHYROIDISM
ENSG00000197308	GATA3-AS1	NA	
ENSG00000232638	AL390294.1	NA	
ENSG00000225053	PRPF38AP1	NA	
ENSG00000232170	LINC00708	NA	
ENSG00000226861	AL390835.1	NA	
ENSG00000226990	AC025946.1	NA	
ENSG00000271251	AC025946.2	NA	
ENSG00000213771	KRT8P37	NA	
ENSG00000236420	CHCHD3P1	NA	
ENSG00000212505	RNA5SP299	NA	
ENSG00000270234	AL355333.1	NA	
ENSG00000234752	LINC02676	NA	
ENSG00000223808	AC044784.1	NA	
ENSG00000230014	LINC00709	NA	
ENSG00000287120	AL138773.1	NA	
ENSG00000235838	HSP90AB7P	NA	
ENSG00000228636	LINC02663	NA	
ENSG00000224788	LINC02670	NA	
ENSG00000229919	ELOCP3	NA	
ENSG00000200849	Y_RNA	NA	
ENSG00000272436	CUX2P1	NA	
ENSG00000286439	AL354916.1	NA	
ENSG00000234306	AL583859.1	NA	
ENSG00000270111	CELF2-DT	NA	
ENSG00000279575	AL583859.2	NA	
ENSG00000287309	AL583859.3	NA	
ENSG00000228997	AL136452.1	NA	
ENSG00000225383	SFTA1P	NA	
ENSG00000048740	CELF2	NA	
ENSG00000229240	LINC00710	NA	
ENSG00000231496	AL136369.2	NA	
ENSG00000228027	AL136369.1	NA	
ENSG00000229206	AL162408.1	NA	
ENSG00000237986	CELF2-AS2	NA	
ENSG00000230322	AL136320.1	NA	
ENSG00000181800	CELF2-AS1	NA	
ENSG00000280086	AC026887.1	NA	
ENSG00000148429	USP6NL	NA	
ENSG00000271360	AL512631.2	NA	
ENSG00000271046	AL512631.1	NA	
ENSG00000134463	ECHDC3	NA	
ENSG00000148426	PROSER2	NA	
ENSG00000225778	PROSER2-AS1	NA	
ENSG00000151461	UPF2	NA	
ENSG00000251957	RNU6-1095P	NA	
ENSG00000181192	DHTKD1	204750	2-@AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD
ENSG00000181192	DHTKD1	615025	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2Q;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2Q
ENSG00000272507	RNU6-88P	NA	
ENSG00000065665	SEC61A2	NA	
ENSG00000265653	MIR548AK	NA	
ENSG00000165609	NUDT5	NA	
ENSG00000151465	CDC123	NA	
ENSG00000228302	AL512770.1	NA	
ENSG00000264036	RN7SL198P	NA	
ENSG00000183049	CAMK1D	NA	
ENSG00000252438	AL391314.1	NA	
ENSG00000252118	RNU6ATAC39P	NA	
ENSG00000285994	AL731559.1	NA	
ENSG00000263584	MIR4480	NA	
ENSG00000283699	MIR4481	NA	
ENSG00000221331	MIR548Q	NA	
ENSG00000285520	AL353586.1	NA	
ENSG00000151468	CCDC3	NA	
ENSG00000212499	RNA5SP300	NA	
ENSG00000225251	RPL5P25	NA	
ENSG00000123240	OPTN	137760	GLAUCOMA, PRIMARY OPEN ANGLE; POAG GLAUCOMA 1, OPEN ANGLE, E, INCLUDED; GLC1E, INCLUDED;;GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED
ENSG00000123240	OPTN	606657	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO;;NTG;;GLAUCOMA, NORMAL PRESSURE, SUSCEPTIBILITY TO; NPG
ENSG00000123240	OPTN	613435	AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12
ENSG00000235763	SNRPGP5	NA	
ENSG00000234175	AL355355.2	NA	
ENSG00000228330	AL355355.1	NA	
ENSG00000203414	BTBD7P1	NA	
ENSG00000237540	RPL36AP36	NA	
ENSG00000065328	MCM10	NA	
ENSG00000272055	RNU6-6P	NA	
ENSG00000165623	UCMA	NA	
ENSG00000107537	PHYH	266500	REFSUM DISEASE, CLASSIC;;REFSUM DISEASE, ADULT, 1;;PHYTANIC ACID OXIDASE DEFICIENCY;;HEREDOPATHIA ATACTICA POLYNEURITIFORMIS;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IV; HMSN4;;HMSN IV
ENSG00000226209	RBISP1	NA	
ENSG00000086475	SEPHS1	NA	
ENSG00000286514	AL355870.2	NA	
ENSG00000233256	AL355870.1	NA	
ENSG00000165626	BEND7	NA	
ENSG00000202508	Y_RNA	NA	
ENSG00000227175	AL590677.1	NA	
ENSG00000165630	PRPF18	NA	
ENSG00000227474	RPL6P24	NA	
ENSG00000282246	AL157392.5	NA	
ENSG00000239665	AL157392.3	NA	
ENSG00000151474	FRMD4A	616819	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA;;BIRK-FLUSSER SYNDROME
ENSG00000273474	AL157392.4	NA	
ENSG00000225112	AL157392.1	NA	
ENSG00000199407	RNA5SP301	NA	
ENSG00000234091	AL157392.2	NA	
ENSG00000215227	NUTF2P5	NA	
ENSG00000229751	AC044781.1	NA	
ENSG00000235410	AL157896.1	NA	
ENSG00000285671	AL139405.1	NA	
ENSG00000266321	MIR4293	NA	
ENSG00000278100	Metazoa_SRP	NA	
ENSG00000221371	MIR1265	NA	
ENSG00000065809	FAM107B	NA	
ENSG00000236495	AL158168.1	NA	
ENSG00000201766	RNA5SP302	NA	
ENSG00000237032	RPSAP7	NA	
ENSG00000185267	CDNF	NA	
ENSG00000284024	HSPA14	NA	
ENSG00000187522	HSPA14	NA	
ENSG00000272853	AC069544.1	NA	
ENSG00000152455	SUV39H2	NA	
ENSG00000152457	DCLRE1C	602450	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION;;RS-SCID;;SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE, WITH SENSITIVITY TO IONIZING RADIATION SEVERE COMBINED IMMUNODEFICIENCY, ATHABASKAN-TYPE /.../UDED; SCIDA, INCLUDED;;ATHABASKAN SEVERE COMBINED IMMUNODEFICIENCY, INCLUDED;;SEVERE COMBINED IMMUNODEFICIENCY, PARTIAL, INCLUDED
ENSG00000152457	DCLRE1C	603554	OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA
ENSG00000197889	MEIG1	NA	
ENSG00000235623	OR7E110P	NA	
ENSG00000228547	OR7E26P	NA	
ENSG00000182531	OR7E115P	NA	
ENSG00000237470	DCLRE1CP1	NA	
ENSG00000152463	OLAH	NA	
ENSG00000176244	ACBD7	NA	
ENSG00000228312	GAPDHP45	NA	
ENSG00000176236	RPP38-DT	NA	
ENSG00000152464	RPP38	NA	
ENSG00000152465	NMT2	NA	
ENSG00000206448	PPIAP30	NA	
ENSG00000228181	AL590365.1	NA	
ENSG00000148468	FAM171A1	NA	
ENSG00000232739	AL607028.1	NA	
ENSG00000077943	ITGA8	191830	RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA
ENSG00000148481	MINDY3	NA	
ENSG00000252537	AL358033.1	NA	
ENSG00000237913	FTLP19	NA	
ENSG00000201260	RNU6-1075P	NA	
ENSG00000226140	LINC02654	NA	
ENSG00000165983	PTER	NA	
ENSG00000223156	RNU2-18P	NA	
ENSG00000165985	C1QL3	NA	
ENSG00000287925	AL353576.1	NA	
ENSG00000148484	RSU1	NA	
ENSG00000225213	AC073367.1	NA	
ENSG00000275001	AL365215.1	NA	
ENSG00000286958	AL365215.2	NA	
ENSG00000107611	CUBN	261100	MEGALOBLASTIC ANEMIA 1;;MGA1;;IMERSLUND-GRASBECK SYNDROME; IGS;;PERNICIOUS ANEMIA, JUVENILE, DUE TO SELECTIVE INTESTINAL MALABSORPTION OF VITAMIN B12, WITH PROTEINURIA;;ENTEROCYTE COBALAMIN MALABSORPTION;;ENTEROCYTE INTRINSIC FACTOR RECEPTOR, DEFECT OF
ENSG00000273153	AC067747.1	NA	
ENSG00000107614	TRDMT1	NA	
ENSG00000229124	VIM-AS1	NA	
ENSG00000026025	VIM	116300	CATARACT 30, MULTIPLE TYPES; CTRCT30
ENSG00000234961	AL133415.1	NA	
ENSG00000148488	ST8SIA6	NA	
ENSG00000204832	ST8SIA6-AS1	NA	
ENSG00000251803	Y_RNA	NA	
ENSG00000236582	PRPF38AP2	NA	
ENSG00000165996	HACD1	NA	
ENSG00000280126	AC069542.2	NA	
ENSG00000260589	STAM-AS1	NA	
ENSG00000136738	STAM	NA	
ENSG00000229190	AC069542.1	NA	
ENSG00000148483	TMEM236	NA	
ENSG00000260314	MRC1	NA	
ENSG00000207938	MIR511	NA	
ENSG00000235637	AC069023.1	NA	
ENSG00000148482	SLC39A12	NA	
ENSG00000226083	SLC39A12-AS1	NA	
ENSG00000165995	CACNB2	611876	BRUGADA SYNDROME 4; BRGDA4
ENSG00000235020	AL390783.1	NA	
ENSG00000240291	AL450384.2	NA	
ENSG00000225527	AL450384.1	NA	
ENSG00000241058	NSUN6	NA	
ENSG00000165997	ARL5B	NA	
ENSG00000234244	AL512641.1	NA	
ENSG00000225509	AIFM1P1	NA	
ENSG00000234813	AL357520.1	NA	
ENSG00000204740	MALRD1	NA	
ENSG00000226255	UBE2V2P1	NA	
ENSG00000227734	AL590378.1	NA	
ENSG00000239539	HMGN1P20	NA	
ENSG00000236960	AL354695.1	NA	
ENSG00000200545	U3	NA	
ENSG00000252001	RNA5SP303	NA	
ENSG00000233968	AL157895.1	NA	
ENSG00000283456	MTND1P37	NA	
ENSG00000230818	MTND2P16	NA	
ENSG00000252832	RNU6-1212P	NA	
ENSG00000285852	AL353147.1	NA	
ENSG00000120594	PLXDC2	NA	
ENSG00000238246	AC069549.1	NA	
ENSG00000287613	AC069549.2	NA	
ENSG00000228339	AMD1P1	NA	
ENSG00000270727	AL590032.1	NA	
ENSG00000265372	MIR4675	NA	
ENSG00000078114	NEBL	NA	
ENSG00000235940	MTND1P21	NA	
ENSG00000230112	AL157398.1	NA	
ENSG00000228753	EIF4BP2	NA	
ENSG00000228219	NPM1P30	NA	
ENSG00000231920	NEBL-AS1	NA	
ENSG00000228860	AL731547.1	NA	
ENSG00000232853	LUZP4P1	NA	
ENSG00000207264	RNU6-15P	NA	
ENSG00000230109	LINC02643	NA	
ENSG00000231553	RNMTL1P1	NA	
ENSG00000278650	AL158209.2	NA	
ENSG00000273566	AL158209.1	NA	
ENSG00000199222	AL358780.1	NA	
ENSG00000204682	MIR1915HG	NA	
ENSG00000222071	MIR1915	NA	
ENSG00000180592	SKIDA1	NA	
ENSG00000078403	MLLT10	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000286881	AL358780.2	NA	
ENSG00000207347	RNU6-306P	NA	
ENSG00000223984	HNRNPRP1	NA	
ENSG00000201390	RNU6-1141P	NA	
ENSG00000136770	DNAJC1	NA	
ENSG00000252634	RN7SKP219	NA	
ENSG00000279623	AL359697.1	NA	
ENSG00000201364	RN7SKP37	NA	
ENSG00000232497	ADIPOR1P1	NA	
ENSG00000236777	AL157831.1	NA	
ENSG00000223601	EBLN1	NA	
ENSG00000260205	AL157831.2	NA	
ENSG00000227462	PSME2P6	NA	
ENSG00000286832	AL157831.3	NA	
ENSG00000279631	AL158211.5	NA	
ENSG00000261671	AL158211.1	NA	
ENSG00000233318	RPL31P45	NA	
ENSG00000148444	COMMD3	NA	
ENSG00000269897	COMMD3-BMI1	NA	
ENSG00000168283	BMI1	NA	
ENSG00000272516	AL158211.4	NA	
ENSG00000271981	AL158211.2	NA	
ENSG00000272366	AL158211.3	NA	
ENSG00000077327	SPAG6	NA	
ENSG00000233451	AL513128.1	NA	
ENSG00000286810	AL513128.3	NA	
ENSG00000285254	AL513128.2	NA	
ENSG00000150867	PIP4K2A	NA	
ENSG00000279819	AL390318.1	NA	
ENSG00000206842	RNU6-413P	NA	
ENSG00000165309	ARMC3	NA	
ENSG00000286924	AL139815.1	NA	
ENSG00000223131	RNA5SP304	NA	
ENSG00000148450	MSRB2	NA	
ENSG00000229932	YWHAZP3	NA	
ENSG00000252049	AL139281.2	NA	
ENSG00000168267	PTF1A	609069	PANCREATIC AND CEREBELLAR AGENESIS; PACA;;DIABETES MELLITUS, PERMANENT NEONATAL, WITH CEREBELLAR AGENESIS
ENSG00000168267	PTF1A	615935	PANCREATIC AGENESIS 2; PAGEN2;;PANCREATIC HYPOPLASIA, CONGENITAL 2
ENSG00000179133	C10orf67	NA	
ENSG00000227537	AL139281.1	NA	
ENSG00000224215	AL606469.1	NA	
ENSG00000264574	AL606469.2	NA	
ENSG00000165312	OTUD1	NA	
ENSG00000287124	AL512603.2	NA	
ENSG00000286442	AL512603.1	NA	
ENSG00000120549	KIAA1217	NA	
ENSG00000223928	NUP35P1	NA	
ENSG00000277563	AC063961.1	NA	
ENSG00000207930	MIR603	NA	
ENSG00000286951	AL356113.1	NA	
ENSG00000279029	AL353583.1	NA	
ENSG00000107863	ARHGAP21	NA	
ENSG00000199535	RNA5SP305	NA	
ENSG00000285750	AL157385.2	NA	
ENSG00000099256	PRTFDC1	NA	
ENSG00000228667	AL157385.1	NA	
ENSG00000240294	RN7SKP241	NA	
ENSG00000285859	AL512598.2	NA	
ENSG00000273107	AL512598.1	NA	
ENSG00000151023	ENKUR	NA	
ENSG00000185875	THNSL1	NA	
ENSG00000231422	LINC01516	NA	
ENSG00000233642	GPR158-AS1	NA	
ENSG00000151025	GPR158	NA	
ENSG00000274242	AL354976.1	NA	
ENSG00000222543	RN7SKP220	NA	
ENSG00000227465	GPN3P1	NA	
ENSG00000280809	LINC00836	NA	
ENSG00000271563	HIRAP1	NA	
ENSG00000223019	RNA5SP306	NA	
ENSG00000251711	RNU6-632P	NA	
ENSG00000226304	AL358612.1	NA	
ENSG00000095777	MYO3A	607101	DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30
ENSG00000136750	GAD2	NA	
ENSG00000284951	AL355798.1	NA	
ENSG00000077420	APBB1IP	NA	
ENSG00000199733	RNA5SP307	NA	
ENSG00000236894	AL160287.1	NA	
ENSG00000233261	FAM238A	NA	
ENSG00000234296	AL390961.1	NA	
ENSG00000231976	FAM238B	NA	
ENSG00000227932	SELENOOLP	NA	
ENSG00000279212	AL390961.3	NA	
ENSG00000148459	PDSS1	614651	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2
ENSG00000234788	HSPA8P3	NA	
ENSG00000235843	AL390961.2	NA	
ENSG00000136754	ABI1	NA	
ENSG00000223027	AL139404.1	NA	
ENSG00000206605	RNU6-946P	NA	
ENSG00000283709	FAM238C	NA	
ENSG00000107890	ANKRD26	188000	THROMBOCYTOPENIA 2; THC2;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 2
ENSG00000199855	RNU6-490P	NA	
ENSG00000136758	YME1L1	617302	OPTIC ATROPHY 11; OPA11
ENSG00000120539	MASTL	NA	
ENSG00000252639	RNU2-24P	NA	
ENSG00000107897	ACBD5	NA	
ENSG00000251839	RNU7-12P	NA	
ENSG00000262412	AL160291.1	NA	
ENSG00000230445	LRRC37A6P	NA	
ENSG00000238021	ARMC4P1	NA	
ENSG00000278830	AL355493.3	NA	
ENSG00000200369	RNU6-666P	NA	
ENSG00000215409	AL355493.1	NA	
ENSG00000207135	RNU6-452P	NA	
ENSG00000260151	LINC02673	NA	
ENSG00000213770	FAM210CP	NA	
ENSG00000237956	TRIAP1P1	NA	
ENSG00000182077	PTCHD3	NA	
ENSG00000099246	RAB18	614222	WARBURG MICRO SYNDROME 3; WARBM3;;MICRO SYNDROME 3
ENSG00000285737	LINC02680	NA	
ENSG00000150051	MKX	NA	
ENSG00000230500	MKX-AS1	NA	
ENSG00000169126	ARMC4	615451	CILIARY DYSKINESIA, PRIMARY, 23; CILD23;;CILIARY DYSKINESIA, PRIMARY, 23, WITH OR WITHOUT SITUS INVERSUS
ENSG00000251810	RN7SKP132	NA	
ENSG00000226016	RPL36AP55	NA	
ENSG00000233472	AL390866.1	NA	
ENSG00000226395	MRPS21P5	NA	
ENSG00000150054	MPP7	NA	
ENSG00000286413	AL355501.1	NA	
ENSG00000275036	MIR8086	NA	
ENSG00000282996	MPP7-DT	NA	
ENSG00000237746	ZNF101P1	NA	
ENSG00000222666	U3	NA	
ENSG00000237128	LINC02652	NA	
ENSG00000224439	RPSAP10	NA	
ENSG00000222705	RN7SKP39	NA	
ENSG00000254635	WAC-AS1	NA	
ENSG00000095787	WAC	616708	DESANTO-SHINAWI SYNDROME; DESSH;;DEVELOPMENTAL DELAY, BEHAVIORAL ABNORMALITIES, FACIAL DYSMORPHISM, AND OCULAR ABNORMALITIES  CHROMOSOME 10p12-p11 DELETION SYNDROME, INCLUDED
ENSG00000252401	RNU4ATAC6P	NA	
ENSG00000231911	TPRKBP1	NA	
ENSG00000207483	RNU6-1067P	NA	
ENSG00000095739	BAMBI	NA	
ENSG00000232624	LINC01517	NA	
ENSG00000236716	AL355376.1	NA	
ENSG00000201001	RNU6-270P	NA	
ENSG00000235824	LINC00837	NA	
ENSG00000271220	AL355376.2	NA	
ENSG00000199402	RNA5SP308	NA	
ENSG00000229605	RPL21P93	NA	
ENSG00000120563	LYZL1	NA	
ENSG00000287402	AL158167.1	NA	
ENSG00000224597	SVIL-AS1	NA	
ENSG00000274985	PTCHD3P1	NA	
ENSG00000197321	SVIL	NA	
ENSG00000207612	MIR604	NA	
ENSG00000212411	SNORD115	NA	
ENSG00000216035	MIR938	NA	
ENSG00000225976	CKS1BP2	NA	
ENSG00000222092	RNU6-908P	NA	
ENSG00000237936	AL353093.1	NA	
ENSG00000165757	JCAD	NA	
ENSG00000200887	RNU6-598P	NA	
ENSG00000230125	EEF1A1P39	NA	
ENSG00000259994	AL353796.1	NA	
ENSG00000107951	MTPAP	613672	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4
ENSG00000285824	AL353796.2	NA	
ENSG00000250833	DNM1P17	NA	
ENSG00000241621	GOLGA2P6	NA	
ENSG00000239625	RN7SL241P	NA	
ENSG00000284277	MIR7162	NA	
ENSG00000214434	NIFKP1	NA	
ENSG00000235679	AL161651.1	NA	
ENSG00000224473	CCND3P1	NA	
ENSG00000107968	MAP3K8	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000213778	HNRNPA1P32	NA	
ENSG00000287420	AL590068.4	NA	
ENSG00000228800	AL590068.1	NA	
ENSG00000239744	RN7SL63P	NA	
ENSG00000230298	AL590068.2	NA	
ENSG00000285630	AL590068.3	NA	
ENSG00000151033	LYZL2	NA	
ENSG00000234814	SVIL2P	NA	
ENSG00000230720	LINC02644	NA	
ENSG00000183621	ZNF438	NA	
ENSG00000272914	AL359532.1	NA	
ENSG00000237135	DDX10P1	NA	
ENSG00000287564	AL359546.1	NA	
ENSG00000272381	LINC02664	NA	
ENSG00000237036	ZEB1-AS1	NA	
ENSG00000252479	RNA5SP309	NA	
ENSG00000148516	ZEB1	609141	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3
ENSG00000148516	ZEB1	613270	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET
ENSG00000230397	SPTLC1P1	NA	
ENSG00000285781	AL117340.1	NA	
ENSG00000223834	AL161935.1	NA	
ENSG00000286694	AL161935.3	NA	
ENSG00000231855	AL161935.2	NA	
ENSG00000237797	MACORIS	NA	
ENSG00000222412	Y_RNA	NA	
ENSG00000165322	ARHGAP12	NA	
ENSG00000231148	HMGB1P7	NA	
ENSG00000230240	RPL34P19	NA	
ENSG00000239731	RN7SL825P	NA	
ENSG00000170759	KIF5B	NA	
ENSG00000206660	Y_RNA	NA	
ENSG00000234335	RPS4XP11	NA	
ENSG00000235113	AL161932.2	NA	
ENSG00000234811	AL161932.1	NA	
ENSG00000252482	RNU7-22P	NA	
ENSG00000217094	PPIAP31	NA	
ENSG00000233190	RPS24P13	NA	
ENSG00000227253	AL158834.2	NA	
ENSG00000120616	EPC1	NA	
ENSG00000226842	AL158834.1	NA	
ENSG00000233825	AL391839.2	NA	
ENSG00000229327	AL391839.1	NA	
ENSG00000200484	RNU6-1244P	NA	
ENSG00000286409	AL391839.3	NA	
ENSG00000216937	CCDC7	NA	
ENSG00000231245	C1DP1	NA	
ENSG00000273038	AL365203.2	NA	
ENSG00000150093	ITGB1	NA	
ENSG00000228816	AK3P5	NA	
ENSG00000229656	ITGB1-DT	NA	
ENSG00000234163	MTND4LP11	NA	
ENSG00000265319	RN7SL847P	NA	
ENSG00000229878	AL365203.1	NA	
ENSG00000235962	RPL7AP53	NA	
ENSG00000233387	IATPR	NA	
ENSG00000099250	NRP1	NA	
ENSG00000238258	AL121748.1	NA	
ENSG00000244356	RN7SL398P	NA	
ENSG00000273012	AL353600.1	NA	
ENSG00000287278	AL353600.2	NA	
ENSG00000226412	LINC02628	NA	
ENSG00000203565	AL450313.1	NA	
ENSG00000261683	LINC00838	NA	
ENSG00000226407	RPL23P11	NA	
ENSG00000223470	LINC02629	NA	
ENSG00000148498	PARD3	NA	
ENSG00000199200	Y_RNA	NA	
ENSG00000234167	ELOBP4	NA	
ENSG00000229235	RPL37P18	NA	
ENSG00000215184	RPS12P16	NA	
ENSG00000226386	PARD3-AS1	NA	
ENSG00000232525	SS18L2P1	NA	
ENSG00000223047	RNU6-847P	NA	
ENSG00000222909	RNU6-193P	NA	
ENSG00000213724	PRDX2P2	NA	
ENSG00000283000	LINC02635	NA	
ENSG00000108094	CUL2	NA	
ENSG00000266228	MIR3611	NA	
ENSG00000230534	AL392046.1	NA	
ENSG00000095794	CREM	NA	
ENSG00000253054	RNU7-77P	NA	
ENSG00000233343	ATP6V1G1P4	NA	
ENSG00000269952	AL117336.1	NA	
ENSG00000233200	LINC02634	NA	
ENSG00000253070	RNU6-794P	NA	
ENSG00000108100	CCNY	NA	
ENSG00000200097	RNU6-1167P	NA	
ENSG00000271335	AL117336.2	NA	
ENSG00000287945	AL603824.1	NA	
ENSG00000273312	AL121749.1	NA	
ENSG00000177291	GJD4	NA	
ENSG00000177283	FZD8	NA	
ENSG00000287528	AL121749.2	NA	
ENSG00000284265	MIR4683	NA	
ENSG00000226646	RPL7P37	NA	
ENSG00000280719	PCAT5	NA	
ENSG00000227313	LINC02630	NA	
ENSG00000227475	AL355300.1	NA	
ENSG00000236626	MTND5P17	NA	
ENSG00000228694	MTND4P18	NA	
ENSG00000237002	AL590730.1	NA	
ENSG00000274458	AL590730.2	NA	
ENSG00000229644	NAMPTP1	NA	
ENSG00000207271	Y_RNA	NA	
ENSG00000238176	AL390061.1	NA	
ENSG00000233533	MKNK2P1	NA	
ENSG00000225355	ARL6IP1P2	NA	
ENSG00000148513	ANKRD30A	NA	
ENSG00000206796	RNU6-811P	NA	
ENSG00000234918	AL157387.1	NA	
ENSG00000235687	LINC00993	NA	
ENSG00000244402	RN7SL314P	NA	
ENSG00000252621	Y_RNA	NA	
ENSG00000237970	TMEM161BP1	NA	
ENSG00000236313	VN1R53P	NA	
ENSG00000224920	TACC1P1	NA	
ENSG00000225276	MTND1P18	NA	
ENSG00000256892	MTRNR2L7	NA	
ENSG00000226578	AL132657.1	NA	
ENSG00000198105	ZNF248	NA	
ENSG00000260137	AL132657.2	NA	
ENSG00000225192	ZNF33BP1	NA	
ENSG00000228828	TLK2P2	NA	
ENSG00000236514	AL135791.1	NA	
ENSG00000151963	ZNF37CP	NA	
ENSG00000235197	ZNF33CP	NA	
ENSG00000175395	ZNF25	NA	
ENSG00000226447	ZNF25-DT	NA	
ENSG00000206840	Y_RNA	NA	
ENSG00000189180	ZNF33A	NA	
ENSG00000252132	RNU6-795P	NA	
ENSG00000275675	AL161931.1	NA	
ENSG00000226086	EIF3LP3	NA	
ENSG00000235964	FXYD6P2	NA	
ENSG00000075407	ZNF37A	NA	
ENSG00000283930	AL117339.4	NA	
ENSG00000272983	AL117339.3	NA	
ENSG00000225965	AL117339.1	NA	
ENSG00000224761	CCNYL4	NA	
ENSG00000226113	AL133217.1	NA	
ENSG00000234941	AL117339.2	NA	
ENSG00000099251	HSD17B7P2	NA	
ENSG00000120555	SEPTIN7P9	NA	
ENSG00000276805	AL133216.2	NA	
ENSG00000222314	RNU6-1118P	NA	
ENSG00000228882	CICP9	NA	
ENSG00000203496	AL133216.1	NA	
ENSG00000215151	ABCD1P2	NA	
ENSG00000277133	AL133173.2	NA	
ENSG00000225638	PABPC1P12	NA	
ENSG00000233867	SLC9B1P3	NA	
ENSG00000227264	ACTR3BP5	NA	
ENSG00000234541	CHEK2P5	NA	
ENSG00000227679	AL133173.1	NA	
ENSG00000233832	AL590623.1	NA	
ENSG00000229485	KSR1P1	NA	
ENSG00000237592	IGKV1OR10-1	NA	
ENSG00000271650	AL031601.1	NA	
ENSG00000274167	AL031601.2	NA	
ENSG00000228755	PABPC1P8	NA	
ENSG00000215146	BX322639.1	NA	
ENSG00000182632	CCNYL2	NA	
ENSG00000279239	AL391099.1	NA	
ENSG00000185904	LINC00839	NA	
ENSG00000234420	ZNF37BP	NA	
ENSG00000270762	FXYD6P1	NA	
ENSG00000233837	EIF3LP2	NA	
ENSG00000196693	ZNF33B	NA	
ENSG00000277479	AL022345.3	NA	
ENSG00000272319	AL022345.1	NA	
ENSG00000272387	AL022345.2	NA	
ENSG00000251783	RNU6-1170P	NA	
ENSG00000285884	AL022345.4	NA	
ENSG00000233515	LINC01518	NA	
ENSG00000232109	VN1R54P	NA	
ENSG00000231009	CUBNP1	NA	
ENSG00000234864	LINC02632	NA	
ENSG00000230425	RSU1P1	NA	
ENSG00000270552	DUXAP3	NA	
ENSG00000259869	AL022344.1	NA	
ENSG00000165733	BMS1	107600	APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC;;CONGENITAL DEFECT OF SKULL AND SCALP;;SCALP DEFECT, CONGENITAL
ENSG00000252416	RNU6-885P	NA	
ENSG00000234944	LINC02623	NA	
ENSG00000229630	LINC01264	NA	
ENSG00000263795	MIR5100	NA	
ENSG00000165731	RET	171400	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A;;PHEOCHROMOCYTOMA AND AMYLOID-PRODUCING MEDULLARY THYROID CARCINOMA;;PTC SYNDROME;;SIPPLE SYNDROME  THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED
ENSG00000165731	RET	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000165731	RET	162300	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B;;MEN IIB;;NEUROMATA, MUCOSAL, WITH ENDOCRINE TUMORS;;WAGENMANN-FROBOESE SYNDROME;;MULTIPLE ENDOCRINE NEOPLASIA, TYPE III, FORMERLY; MEN3, FORMERLY MUCOSAL NEUROMA SYNDROME, INCLUDED
ENSG00000165731	RET	155240	THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC;;FMTC;;MTC1
ENSG00000165731	RET	142623	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1;;HIRSCHSPRUNG DISEASE; HSCR;;AGANGLIONIC MEGACOLON;;MEGACOLON, AGANGLIONIC; MGC HIRSCHSPRUNG DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000165731	RET	209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS;;AUTONOMIC CONTROL, CONGENITAL FAILURE OF;;ONDINE CURSE, CONGENITAL ONDINE-HIRSCHSPRUNG DISEASE, INCLUDED; OHD, INCLUDED;;CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;;HADDAD SYNDROME, INCLUDED
ENSG00000273008	AC010864.1	NA	
ENSG00000169826	CSGALNACT2	NA	
ENSG00000198915	RASGEF1A	NA	
ENSG00000224265	LINC02633	NA	
ENSG00000285712	AC068707.1	NA	
ENSG00000221468	RNU6ATAC11P	NA	
ENSG00000150201	FXYD4	NA	
ENSG00000169813	HNRNPF	NA	
ENSG00000221400	SNORD3J	NA	
ENSG00000230555	AL450326.1	NA	
ENSG00000243660	ZNF487	NA	
ENSG00000252532	RNU7-193P	NA	
ENSG00000236114	AL450326.2	NA	
ENSG00000196793	ZNF239	NA	
ENSG00000287852	AL450326.3	NA	
ENSG00000232004	CAP1P2	NA	
ENSG00000198298	ZNF485	NA	
ENSG00000223910	ZNF32-AS3	NA	
ENSG00000237389	AL645634.2	NA	
ENSG00000238263	RPL21P88	NA	
ENSG00000169740	ZNF32	NA	
ENSG00000226245	ZNF32-AS1	NA	
ENSG00000230565	ZNF32-AS2	NA	
ENSG00000228426	AL645634.1	NA	
ENSG00000271173	AL355989.1	NA	
ENSG00000224162	UQCRHP3	NA	
ENSG00000223746	ELOCP30	NA	
ENSG00000234973	LINC02658	NA	
ENSG00000226808	LINC00840	NA	
ENSG00000226790	HNRNPA3P1	NA	
ENSG00000236769	LINC02659	NA	
ENSG00000233395	LINC00841	NA	
ENSG00000227029	AL139237.1	NA	
ENSG00000237590	AL137026.2	NA	
ENSG00000229116	AL137026.1	NA	
ENSG00000277288	LINC02881	NA	
ENSG00000287901	AL137026.3	NA	
ENSG00000107562	CXCL12	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000214089	RPL9P21	NA	
ENSG00000270767	AL356157.2	NA	
ENSG00000287173	AL356157.3	NA	
ENSG00000234580	AL356157.1	NA	
ENSG00000224812	TMEM72-AS1	NA	
ENSG00000227395	EIF2AP4	NA	
ENSG00000234504	AL353801.2	NA	
ENSG00000187783	TMEM72	NA	
ENSG00000223462	AL353801.1	NA	
ENSG00000273363	AL353801.3	NA	
ENSG00000107551	RASSF4	NA	
ENSG00000165507	DEPP1	NA	
ENSG00000165511	ZNF22-AS1	NA	
ENSG00000165512	ZNF22	NA	
ENSG00000226937	CEP164P1	NA	
ENSG00000277757	AL358394.3	NA	
ENSG00000270258	DUXAP4	NA	
ENSG00000228462	RPS19P7	NA	
ENSG00000232554	RSU1P2	NA	
ENSG00000235690	CUBNP3	NA	
ENSG00000243349	AL358394.2	NA	
ENSG00000236442	ANKRD54P1	NA	
ENSG00000230501	ANKRD30BP3	NA	
ENSG00000263476	MIR3156-1	NA	
ENSG00000227683	AL358394.1	NA	
ENSG00000275312	AL512324.1	NA	
ENSG00000278531	AL512324.3	NA	
ENSG00000207071	RNU6-1207P	NA	
ENSG00000234993	CUBNP2	NA	
ENSG00000224402	OR6D1P	NA	
ENSG00000256574	OR13A1	NA	
ENSG00000012779	ALOX5	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000231964	AL731567.1	NA	
ENSG00000165406	MARCHF8	NA	
ENSG00000172671	ZFAND4	NA	
ENSG00000230869	AGAP10P	NA	
ENSG00000237840	FAM21FP	NA	
ENSG00000228702	AL645998.1	NA	
ENSG00000172661	WASHC2C	NA	
ENSG00000270434	AC012044.1	NA	
ENSG00000231122	FAM25E	NA	
ENSG00000188234	AGAP4	NA	
ENSG00000239883	PARGP1	NA	
ENSG00000239152	RNA5SP310	NA	
ENSG00000264217	RPL35AP23	NA	
ENSG00000265354	TIMM23	NA	
ENSG00000265733	SNORA74C-1	NA	
ENSG00000266412	NCOA4	NA	
ENSG00000263639	MSMB	611928	PROSTATE CANCER, HEREDITARY, 13; HPC13
ENSG00000280012	RPL23AP61	NA	
ENSG00000264204	AGAP7P	NA	
ENSG00000263482	ANTXRLP1	NA	
ENSG00000274209	ANTXRL	NA	
ENSG00000279058	AGAP14P	NA	
ENSG00000273225	FAM25BP	NA	
ENSG00000279458	AC244230.1	NA	
ENSG00000264230	ANXA8L1	NA	
ENSG00000285402	AC244230.2	NA	
ENSG00000285294	LINC00842	NA	
ENSG00000213412	HNRNPA1P33	NA	
ENSG00000204174	NPY4R	NA	
ENSG00000204175	GPRIN2	NA	
ENSG00000204176	SYT15	NA	
ENSG00000231187	AL356056.2	NA	
ENSG00000229227	AL356056.1	NA	
ENSG00000165874	SHLD2P1	NA	
ENSG00000272430	LINC02637	NA	
ENSG00000229927	RHEBP1	NA	
ENSG00000274186	RN7SL248P	NA	
ENSG00000285662	FAM245B	NA	
ENSG00000280913	CTSLP3	NA	
ENSG00000265366	GLUD1P2	NA	
ENSG00000215097	AL731733.1	NA	
ENSG00000204177	BMS1P1	NA	
ENSG00000238405	RNA5SP311	NA	
ENSG00000243289	AGAP13P	NA	
ENSG00000150175	FRMPD2B	NA	
ENSG00000204179	PTPN20	NA	
ENSG00000266524	GDF10	NA	
ENSG00000263761	GDF2	615506	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5
ENSG00000265203	RBP3	268000	RETINITIS PIGMENTOSA; RP
ENSG00000265203	RBP3	615233	RETINITIS PIGMENTOSA 66; RP66
ENSG00000265763	ZNF488	NA	
ENSG00000265190	ANXA8	NA	
ENSG00000270369	AL591684.3	NA	
ENSG00000189090	FAM25G	NA	
ENSG00000224919	AL591684.1	NA	
ENSG00000204172	AGAP9	NA	
ENSG00000254929	AL591684.2	NA	
ENSG00000252877	RNA5SP312	NA	
ENSG00000251079	BMS1P2	NA	
ENSG00000265630	BX547991.2	NA	
ENSG00000215065	BX547991.1	NA	
ENSG00000266217	CTSLP2	NA	
ENSG00000264404	LINC02675	NA	
ENSG00000189014	SHLD2P3	NA	
ENSG00000276544	RN7SL453P	NA	
ENSG00000226964	RHEBP2	NA	
ENSG00000277758	FO681492.1	NA	
ENSG00000276850	AC245041.2	NA	
ENSG00000264717	NPY4R2	NA	
ENSG00000273760	AC245041.1	NA	
ENSG00000276430	FAM25C	NA	
ENSG00000265018	AGAP12P	NA	
ENSG00000252149	RNA5SP315	NA	
ENSG00000270025	BMS1P7	NA	
ENSG00000278561	PTPN20CP	NA	
ENSG00000170324	FRMPD2	NA	
ENSG00000285786	AC074325.1	NA	
ENSG00000225482	RPS6P14	NA	
ENSG00000107643	MAPK8	NA	
ENSG00000279822	AC016397.2	NA	
ENSG00000128805	ARHGAP22	NA	
ENSG00000248682	ARHGAP22-IT1	NA	
ENSG00000231906	AC016397.1	NA	
ENSG00000251413	AC068898.2	NA	
ENSG00000236800	AC068898.1	NA	
ENSG00000128815	WDFY4	NA	
ENSG00000228754	RPL13AP19	NA	
ENSG00000286993	AC035139.2	NA	
ENSG00000228403	AC035139.1	NA	
ENSG00000241577	AC060234.3	NA	
ENSG00000165383	LRRC18	NA	
ENSG00000233665	AC060234.2	NA	
ENSG00000226576	AC060234.1	NA	
ENSG00000264800	MIR4294	NA	
ENSG00000165633	VSTM4	NA	
ENSG00000234736	FAM170B-AS1	NA	
ENSG00000172538	FAM170B	NA	
ENSG00000204161	TMEM273	NA	
ENSG00000236208	C10orf71-AS1	NA	
ENSG00000177354	C10orf71	NA	
ENSG00000165606	DRGX	NA	
ENSG00000235939	AL138760.1	NA	
ENSG00000225830	ERCC6	133540	COCKAYNE SYNDROME B; CSB
ENSG00000225830	ERCC6	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000225830	ERCC6	214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1;;COFS SYNDROME; COFS;;PENA-SHOKEIR SYNDROME, TYPE II
ENSG00000225830	ERCC6	278800	DE SANCTIS-CACCHIONE SYNDROME
ENSG00000225830	ERCC6	600630	UV-SENSITIVE SYNDROME 1; UVSS1
ENSG00000225830	ERCC6	613761	MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5
ENSG00000225830	ERCC6	616946	PREMATURE OVARIAN FAILURE 11; POF11
ENSG00000271237	HMGB1P50	NA	
ENSG00000070748	CHAT	254210	MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6;;MYASTHENIC SYNDROME, PRESYNAPTIC, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA; CMSEA;;CONGENITAL MYASTHENIC SYNDROME TYPE Ia2, FORMERLY; CMS1A2, FORMERLY;;CMS Ia2, FORMERLY;;MYASTHENIA, FAMILIAL  /.../ILE, FORMERLY; FIM, FORMERLY;;MYASTHENIA GRAVIS, FAMILIAL INFANTILE, 2, FORMERLY; FIMG2, FORMERLY
ENSG00000187714	SLC18A3	617239	MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21
ENSG00000178645	C10orf53	NA	
ENSG00000197444	OGDHL	NA	
ENSG00000226389	MAPK6P6	NA	
ENSG00000229870	RPL21P89	NA	
ENSG00000227345	PARG	NA	
ENSG00000230166	RPL35AP24	NA	
ENSG00000204152	TIMM23B	NA	
ENSG00000178440	TIMM23B-AGAP6	NA	
ENSG00000288603	SNORA74C-2	NA	
ENSG00000222108	RNA5SP317	NA	
ENSG00000285803	AL442003.1	NA	
ENSG00000204149	AGAP6	NA	
ENSG00000235618	FAM21EP	NA	
ENSG00000226631	SLC9A3P3	NA	
ENSG00000099290	WASHC2A	NA	
ENSG00000188611	ASAH2	NA	
ENSG00000233011	SLC9A3P1	NA	
ENSG00000225137	DYNC1I2P1	NA	
ENSG00000198964	SGMS1	NA	
ENSG00000286401	AC069547.2	NA	
ENSG00000279863	AC069547.1	NA	
ENSG00000225303	AL117341.1	NA	
ENSG00000238523	RNU7-107P	NA	
ENSG00000226200	SGMS1-AS1	NA	
ENSG00000231588	SHQ1P1	NA	
ENSG00000231345	BEND3P1	NA	
ENSG00000232706	NUTM2HP	NA	
ENSG00000226168	AL589794.1	NA	
ENSG00000230011	CTSLP4	NA	
ENSG00000213667	PGGT1BP1	NA	
ENSG00000287221	AL589794.2	NA	
ENSG00000204147	ASAH2B	NA	
ENSG00000148584	A1CF	NA	
ENSG00000229711	AL512366.1	NA	
ENSG00000236944	CCDC58P2	NA	
ENSG00000261368	AL731537.2	NA	
ENSG00000185532	PRKG1	615436	AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
ENSG00000223502	AL731537.1	NA	
ENSG00000231132	AC022537.1	NA	
ENSG00000207813	MIR605	NA	
ENSG00000235279	AC069079.1	NA	
ENSG00000213659	RSU1P3	NA	
ENSG00000177613	CSTF2T	NA	
ENSG00000236671	PRKG1-AS1	NA	
ENSG00000107984	DKK1	NA	
ENSG00000213657	RPL31P44	NA	
ENSG00000227972	THAP12P3	NA	
ENSG00000231131	LNCAROD	NA	
ENSG00000165471	MBL2	NA	
ENSG00000201196	Y_RNA	NA	
ENSG00000285958	AC073174.1	NA	
ENSG00000227121	LINC02672	NA	
ENSG00000231399	SNRPEP8	NA	
ENSG00000226296	AC036101.1	NA	
ENSG00000252161	RNA5SP318	NA	
ENSG00000233805	AL365496.1	NA	
ENSG00000150275	PCDH15	601067	USHER SYNDROME, TYPE ID; USH1D USHER SYNDROME, TYPE ID/F, CDH23/PCDH15, DIGENIC, INCLUDED;;USH1D/F, CDH23/PCDH15, DIGENIC, INCLUDED
ENSG00000150275	PCDH15	602083	USHER SYNDROME, TYPE IF; USH1F
ENSG00000150275	PCDH15	609533	DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23
ENSG00000252252	RNU6-687P	NA	
ENSG00000234173	AL353784.1	NA	
ENSG00000224697	NEFMP1	NA	
ENSG00000221594	MIR548F1	NA	
ENSG00000236958	AC051618.1	NA	
ENSG00000236744	AC016822.1	NA	
ENSG00000223800	AL355314.1	NA	
ENSG00000228048	AL355314.2	NA	
ENSG00000249860	MTRNR2L5	NA	
ENSG00000236993	GAPDHP21	NA	
ENSG00000270541	AC069545.1	NA	
ENSG00000122952	ZWINT	NA	
ENSG00000287016	AC010996.1	NA	
ENSG00000238707	AC025039.1	NA	
ENSG00000264747	MIR3924	NA	
ENSG00000235810	AL731534.1	NA	
ENSG00000223841	AC006484.1	NA	
ENSG00000270192	MRPS35P3	NA	
ENSG00000232115	AC026884.1	NA	
ENSG00000151151	IPMK	NA	
ENSG00000180221	TPT1P10	NA	
ENSG00000122873	CISD1	NA	
ENSG00000228527	AC016396.1	NA	
ENSG00000261076	AC016396.2	NA	
ENSG00000072401	UBE2D1	NA	
ENSG00000108064	TFAM	617156	MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15
ENSG00000122870	BICC1	601331	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD
ENSG00000183055	FAM133CP	NA	
ENSG00000252076	RN7SKP196	NA	
ENSG00000237949	LINC00844	NA	
ENSG00000226888	RPLP1P10	NA	
ENSG00000226557	TRAF6P1	NA	
ENSG00000165443	PHYHIPL	NA	
ENSG00000148541	FAM13C	NA	
ENSG00000236556	AC025038.1	NA	
ENSG00000287969	AL355474.1	NA	
ENSG00000235469	MRPL50P4	NA	
ENSG00000235140	AC026391.1	NA	
ENSG00000165449	SLC16A9	NA	
ENSG00000227877	MRLN	NA	
ENSG00000108091	CCDC6	NA	
ENSG00000235931	LINC01553	NA	
ENSG00000151150	ANK3	615493	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37
ENSG00000232682	AL592430.1	NA	
ENSG00000202190	Y_RNA	NA	
ENSG00000282121	AL592430.2	NA	
ENSG00000122872	ARL4AP1	NA	
ENSG00000254271	ANK3-DT	NA	
ENSG00000170312	CDK1	NA	
ENSG00000072422	RHOBTB1	NA	
ENSG00000223107	RNU2-72P	NA	
ENSG00000227244	LINC00845	NA	
ENSG00000196932	TMEM26	NA	
ENSG00000237233	TMEM26-AS1	NA	
ENSG00000288052	AL356952.1	NA	
ENSG00000183346	CABCOCO1	NA	
ENSG00000272592	AL451049.1	NA	
ENSG00000233643	LINC02625	NA	
ENSG00000150347	ARID5B	NA	
ENSG00000182010	RTKN2	NA	
ENSG00000234756	LINC02621	NA	
ENSG00000288011	AC024597.1	NA	
ENSG00000240940	RN7SL591P	NA	
ENSG00000138311	ZNF365	605990	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO;;UAN;;UROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO
ENSG00000285837	AC024598.1	605990	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO;;UAN;;UROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO
ENSG00000285551	AC067752.1	NA	
ENSG00000238280	AC067751.1	NA	
ENSG00000234489	ALDH7A1P4	NA	
ENSG00000181915	ADO	NA	
ENSG00000122877	EGR2	145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS;;DEJERINE-SOTTAS SYNDROME; DSS;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 3; CMT3;;HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE III; HMSN3;;DEJERINE-SOTTAS NEUROPATHY; DSN
ENSG00000122877	EGR2	605253	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1;;NEUROPATHY, CONGENITAL HYPOMYELINATING OR AMYELINATING, AUTOSOMAL RECESSIVE;;HYPOMYELINATION, SEVERE CONGENITAL;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4E; CMT4E;;CHARCOT-MARIE-TOOTH N /.../THY, TYPE 4E NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL DOMINANT, INCLUDED
ENSG00000122877	EGR2	607678	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D;;HEREDITARY MOTOR AND SENSORY NEUROPATHY 1D;;HMSN ID;;HMSN1D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1D
ENSG00000199446	RNU6-543P	NA	
ENSG00000224301	AL590502.1	NA	
ENSG00000148572	NRBF2	NA	
ENSG00000171988	JMJD1C	NA	
ENSG00000234369	TATDN1P1	NA	
ENSG00000270421	AC022022.2	NA	
ENSG00000221063	MIR1296	NA	
ENSG00000235816	PRELID1P3	NA	
ENSG00000272767	JMJD1C-AS1	NA	
ENSG00000224412	AC022022.1	NA	
ENSG00000165476	REEP3	NA	
ENSG00000286373	AC022387.2	NA	
ENSG00000232075	MRPL35P2	NA	
ENSG00000270352	AC022387.1	NA	
ENSG00000228566	AC013287.1	NA	
ENSG00000213609	RPL7AP50	NA	
ENSG00000226426	AC012558.1	NA	
ENSG00000235489	DBF4P1	NA	
ENSG00000233900	RPL17P35	NA	
ENSG00000270648	CYP2C61P	NA	
ENSG00000216740	ANXA2P3	NA	
ENSG00000224714	LINC02671	NA	
ENSG00000270754	NEK4P3	NA	
ENSG00000282906	AL513321.2	NA	
ENSG00000227173	MYL6P3	NA	
ENSG00000233724	AL513321.1	NA	
ENSG00000235356	AL592466.1	NA	
ENSG00000228065	LINC01515	NA	
ENSG00000183230	CTNNA3	615616	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 13; ARVC13
ENSG00000273360	AC022017.1	NA	
ENSG00000277056	AL607023.1	NA	
ENSG00000198739	LRRTM3	NA	
ENSG00000225299	AL139240.1	NA	
ENSG00000226448	RPL7AP51	NA	
ENSG00000276866	MIR7151	NA	
ENSG00000213606	AKR1B10P1	NA	
ENSG00000225922	RPL21P92	NA	
ENSG00000108176	DNAJC12	617384	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4
ENSG00000212520	RNU6-1250P	NA	
ENSG00000239942	RN7SL394P	NA	
ENSG00000237141	DNAJC19P1	NA	
ENSG00000272892	AL133551.1	NA	
ENSG00000252113	RNU6-523P	NA	
ENSG00000219932	RPL12P8	NA	
ENSG00000096717	SIRT1	NA	
ENSG00000148634	HERC4	NA	
ENSG00000226318	RPS3AP38	NA	
ENSG00000266467	RN7SL220P	NA	
ENSG00000236375	POU5F1P5	NA	
ENSG00000138347	MYPN	615248	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 22, INCLUDED; CMH22, INCLUDED;;CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 4, INCLUDED; RCM4, INCLUDED
ENSG00000138347	MYPN	617336	NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11
ENSG00000222371	RN7SKP202	NA	
ENSG00000179774	ATOH7	221900	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR;;RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;;RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;;PERSISTENT FETAL VASCULATURE
ENSG00000233590	LINC02640	NA	
ENSG00000234102	KRT19P4	NA	
ENSG00000108187	PBLD	NA	
ENSG00000096746	HNRNPH3	NA	
ENSG00000204130	RUFY2	NA	
ENSG00000138346	DNA2	615156	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 6
ENSG00000138346	DNA2	615807	SECKEL SYNDROME 8; SCKL8
ENSG00000234806	RPL26P29	NA	
ENSG00000199638	RNA5SP319	NA	
ENSG00000122912	SLC25A16	NA	
ENSG00000226493	RPL26P27	NA	
ENSG00000207438	Y_RNA	NA	
ENSG00000214881	TMEM14DP	NA	
ENSG00000138336	TET1	NA	
ENSG00000213025	COX20P1	NA	
ENSG00000227583	RPS3AP37	NA	
ENSG00000260400	AL513534.2	NA	
ENSG00000270494	AL513534.3	NA	
ENSG00000060339	CCAR1	NA	
ENSG00000195401	Y_RNA	NA	
ENSG00000283551	SNORD98	NA	
ENSG00000221184	AL513534.1	NA	
ENSG00000165730	STOX1	609404	PREECLAMPSIA/ECLAMPSIA 4; PEE4
ENSG00000200218	RNU6-697P	NA	
ENSG00000285871	AL359844.1	NA	
ENSG00000107625	DDX50	NA	
ENSG00000206855	RNU6-571P	NA	
ENSG00000165732	DDX21	NA	
ENSG00000198954	KIFBP	609460	GOLDBERG-SHPRINTZEN SYNDROME; GOSHS;;GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME
ENSG00000214875	MED28P1	NA	
ENSG00000229001	ACTBP14	NA	
ENSG00000122862	SRGN	NA	
ENSG00000274008	AL442635.1	NA	
ENSG00000122958	VPS26A	NA	
ENSG00000233163	RPS12P17	NA	
ENSG00000156502	SUPV3L1	NA	
ENSG00000229261	AL596223.1	NA	
ENSG00000156510	HKDC1	NA	
ENSG00000231748	AL596223.2	NA	
ENSG00000156515	HK1	235700	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY
ENSG00000156515	HK1	605285	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4G; CMT4G;;CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4G;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, RUSSE TYPE;;CHARCOT-MARIE-TOOTH NEUROPATHY, /.../4G
ENSG00000156515	HK1	617460	RETINITIS PIGMENTOSA 79; RP79
ENSG00000156515	HK1	618547	NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA
ENSG00000229197	RPS15AP28	NA	
ENSG00000075073	TACR2	NA	
ENSG00000232734	ATP5MC1P7	NA	
ENSG00000099282	TSPAN15	NA	
ENSG00000287306	AC016821.1	NA	
ENSG00000233197	TMEM256P1	NA	
ENSG00000122859	NEUROG3	610370	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4;;ENTERIC ANENDOCRINOSIS
ENSG00000236154	AL450311.1	NA	
ENSG00000230755	MTATP6P23	NA	
ENSG00000235803	MTCO2P23	NA	
ENSG00000235524	MTCO1P23	NA	
ENSG00000231152	MTND2P15	NA	
ENSG00000226794	MTND1P20	NA	
ENSG00000171224	FAM241B	NA	
ENSG00000235645	LINC02651	NA	
ENSG00000230469	RPL5P26	NA	
ENSG00000197467	COL13A1	616720	MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19
ENSG00000224222	LINC02636	NA	
ENSG00000099284	MACROH2A2	NA	
ENSG00000042286	AIFM2	NA	
ENSG00000156521	TYSND1	NA	
ENSG00000079332	SAR1A	NA	
ENSG00000229097	CALM2P2	NA	
ENSG00000232142	RPS25P9	NA	
ENSG00000180817	PPA1	NA	
ENSG00000148734	NPFFR1	NA	
ENSG00000172731	LRRC20	NA	
ENSG00000224725	CEP57L1P1	NA	
ENSG00000148730	EIF4EBP2	NA	
ENSG00000156574	NODAL	270100	HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV
ENSG00000280401	AC022532.1	NA	
ENSG00000107719	PALD1	NA	
ENSG00000230661	YY1P1	NA	
ENSG00000180644	PRF1	603553	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2;;HPLH2;;HLH2
ENSG00000180644	PRF1	605027	LYMPHOMA, NON-HODGKIN, FAMILIAL;;NON-HODGKIN LYMPHOMA; NHL
ENSG00000180644	PRF1	609135	APLASTIC ANEMIA APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000138316	ADAMTS14	NA	
ENSG00000166220	TBATA	NA	
ENSG00000231366	RPS26P40	NA	
ENSG00000166224	SGPL1	617575	NEPHROTIC SYNDROME, TYPE 14; NPHS14
ENSG00000166228	PCBD1	264070	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D;;HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE DEFICIENCY;;HYPERPHENYLALANINEMIA WITH PRIMAPTERINURIA;;CADH DEFICIENCY;;PCBD DEFICIENCY
ENSG00000285300	AC073176.2	NA	
ENSG00000271409	AC073176.1	NA	
ENSG00000259267	LINC02622	NA	
ENSG00000107731	UNC5B	NA	
ENSG00000237512	UNC5B-AS1	NA	
ENSG00000198246	SLC29A3	602782	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME;;HISTIOCYTOSIS AND LYMPHADENOPATHY WITH OR WITHOUT CUTANEOUS, CARDIAC, AND/OR ENDOCRINE FEATURES, JOINT CONTRACTURES, AND/OR DEAFNESS;;HYPERPIGMENTATION, CUTANEOUS, WITH HYPERTRICHOSIS, HEPATOSPLENOMEGALY, /.../ ANOMALIES, AND HYPOGONADISM WITH OR WITHOUT HEARING LOSS;;H SYNDROME;;PIGMENTED HYPERTRICHOSIS WITH INSULIN-DEPENDENT DIABETES MELLITUS; PHID;;HISTIOCYTOSIS WITH JOINT CONTRACTURES AND SENSORINEURAL DEAFNESS; HJCD;;FAISALABAD HISTIOCYTOSIS;;ROSAI-DORFMAN DISEASE, FAMILIAL;;SINUS HISTIOCYTOSIS AND MASSIVE LYMPHADENOPATHY; SHML
ENSG00000279406	AL359183.1	NA	
ENSG00000107736	CDH23	601067	USHER SYNDROME, TYPE ID; USH1D USHER SYNDROME, TYPE ID/F, CDH23/PCDH15, DIGENIC, INCLUDED;;USH1D/F, CDH23/PCDH15, DIGENIC, INCLUDED
ENSG00000107736	CDH23	601386	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12
ENSG00000107736	CDH23	617540	PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5
ENSG00000223817	CDH23-AS1	NA	
ENSG00000214688	C10orf105	NA	
ENSG00000107738	VSIR	NA	
ENSG00000274824	MIR7152	NA	
ENSG00000197746	PSAP	249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY;;METACHROMATIC LEUKODYSTROPHY DUE TO CEREBROSIDE SULFATASE ACTIVATOR DEFICIENCY;;SAPOSIN B DEFICIENCY
ENSG00000197746	PSAP	610539	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY
ENSG00000197746	PSAP	611721	COMBINED SAPOSIN DEFICIENCY;;PROSAPOSIN DEFICIENCY; PSAPD;;COMBINED SAP DEFICIENCY
ENSG00000197746	PSAP	611722	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY;;SAPOSIN A DEFICIENCY
ENSG00000238446	RNU7-38P	NA	
ENSG00000230526	AC073370.1	NA	
ENSG00000122863	CHST3	143095	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD;;HUMEROSPINAL DYSOSTOSIS; HSD;;SPONDYLOEPIPHYSEAL DYSPLASIA, OMANI TYPE;;CHONDRODYSPLASIA WITH MULTIPLE DISLOCATIONS; CDMD
ENSG00000122863	CHST3	245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD;;LARSEN SYNDROME, AUTOSOMAL RECESSIVE, FORMERLY
ENSG00000272988	AC022392.1	NA	
ENSG00000107742	SPOCK2	NA	
ENSG00000138303	ASCC1	614266	BARRETT ESOPHAGUS;;BARRETT METAPLASIA  ADENOCARCINOMA OF ESOPHAGUS, INCLUDED
ENSG00000138303	ASCC1	616867	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2
ENSG00000200294	AL607035.1	NA	
ENSG00000226701	RPL15P14	NA	
ENSG00000166295	ANAPC16	NA	
ENSG00000200170	Y_RNA	NA	
ENSG00000168209	DDIT4	NA	
ENSG00000269926	DDIT4-AS1	NA	
ENSG00000148719	DNAJB12	NA	
ENSG00000107745	MICU1	615673	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS
ENSG00000202513	RNU6-805P	NA	
ENSG00000282915	AC091769.2	NA	
ENSG00000276531	AC091769.1	NA	
ENSG00000226163	AL513185.1	NA	
ENSG00000230609	AL513185.2	NA	
ENSG00000272536	RN7SL840P	NA	
ENSG00000231471	HMGN2P34	NA	
ENSG00000238215	AL513185.3	NA	
ENSG00000201881	Y_RNA	NA	
ENSG00000156026	MCU	NA	
ENSG00000266719	MIR4676	NA	
ENSG00000280166	AC016542.3	NA	
ENSG00000279502	AC016542.2	NA	
ENSG00000272627	AC016542.1	NA	
ENSG00000138315	OIT3	NA	
ENSG00000215086	NPM1P24	NA	
ENSG00000138308	PLA2G12B	NA	
ENSG00000213700	RPL17P50	NA	
ENSG00000122884	P4HA1	NA	
ENSG00000232646	AL731563.1	NA	
ENSG00000237768	AL731563.2	NA	
ENSG00000201047	Y_RNA	NA	
ENSG00000272630	AL731563.3	NA	
ENSG00000166321	NUDT13	NA	
ENSG00000272599	AC016394.1	NA	
ENSG00000221164	SNORA11F	NA	
ENSG00000122882	ECD	NA	
ENSG00000138286	FAM149B1	618763	JOUBERT SYNDROME 36; JBTS36
ENSG00000213551	DNAJC9	NA	
ENSG00000199201	Y_RNA	NA	
ENSG00000227382	EIF4A2P2	NA	
ENSG00000288559	AC016394.2	NA	
ENSG00000236756	DNAJC9-AS1	NA	
ENSG00000182180	MRPS16	610498	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2;;CORPUS CALLOSUM, AGENESIS OF, WITH DYSMORPHISM AND FATAL LACTIC ACIDOSIS
ENSG00000227540	DNAJC9-AS1	NA	
ENSG00000156042	CFAP70	618670	SPERMATOGENIC FAILURE 41; SPGF41
ENSG00000200356	RNU6-833P	NA	
ENSG00000207473	Y_RNA	NA	
ENSG00000138279	ANXA7	NA	
ENSG00000233144	AL512656.1	NA	
ENSG00000229659	RPL26P6	NA	
ENSG00000166343	MSS51	NA	
ENSG00000107758	PPP3CB	NA	
ENSG00000221817	PPP3CB-AS1	NA	
ENSG00000166348	USP54	NA	
ENSG00000207327	RNU6-883P	NA	
ENSG00000237139	RPS26P41	NA	
ENSG00000268584	AC073389.1	NA	
ENSG00000272791	AC073389.3	NA	
ENSG00000177791	MYOZ1	NA	
ENSG00000166317	SYNPO2L	NA	
ENSG00000271848	AC073389.2	NA	
ENSG00000172650	AGAP5	NA	
ENSG00000242288	BMS1P4-AGAP5	NA	
ENSG00000271816	BMS1P4	NA	
ENSG00000272140	AC022400.4	NA	
ENSG00000252072	RNA5SP320	NA	
ENSG00000242338	BMS1P4	NA	
ENSG00000250959	GLUD1P3	NA	
ENSG00000235316	DUSP8P5	NA	
ENSG00000270808	AC022400.3	NA	
ENSG00000279088	AC022400.6	NA	
ENSG00000176986	SEC24C	NA	
ENSG00000279689	AC022400.7	NA	
ENSG00000196968	FUT11	NA	
ENSG00000172586	CHCHD1	NA	
ENSG00000214655	ZSWIM8	NA	
ENSG00000280238	AC022400.8	NA	
ENSG00000272916	AC022400.5	NA	
ENSG00000272589	ZSWIM8-AS1	NA	
ENSG00000166507	NDST2	NA	
ENSG00000148660	CAMK2G	618522	INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 59
ENSG00000224195	AC022400.1	NA	
ENSG00000229990	AC022400.2	NA	
ENSG00000122861	PLAU	104300	ALZHEIMER DISEASE; AD;;PRESENILE AND SENILE DEMENTIA ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED; AD1, INCLUDED;;ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY, INCLUDED;;ALZHEIMER DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000122861	PLAU	601709	QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC
ENSG00000222047	C10orf55	NA	
ENSG00000035403	VCL	611407	CARDIOMYOPATHY, DILATED, 1W; CMD1W
ENSG00000035403	VCL	613255	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15
ENSG00000225761	AL596247.1	NA	
ENSG00000185009	AP3M1	NA	
ENSG00000156110	ADK	614300	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 8, FORMERLY; MRT8, FORMERLY
ENSG00000236900	TIMM9P1	NA	
ENSG00000214629	RPSAP6	NA	
ENSG00000213731	RAB5CP1	NA	
ENSG00000232342	AC022540.1	NA	
ENSG00000226253	MRPL35P3	NA	
ENSG00000206756	Y_RNA	NA	
ENSG00000271710	NDUFA8P1	NA	
ENSG00000214626	POLR3DP1	NA	
ENSG00000213525	FAM32CP	NA	
ENSG00000272748	AC063962.1	NA	
ENSG00000156650	KAT6B	603736	OHDO SYNDROME, SBBYS VARIANT; SBBYSS;;SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME;;YOUNG-SIMPSON SYNDROME; YSS
ENSG00000156650	KAT6B	606170	GENITOPATELLAR SYNDROME; GTPTS;;ABSENT PATELLAE, SCROTAL HYPOPLASIA, RENAL ANOMALIES, FACIAL DYSMORPHISM, AND MENTAL RETARDATION
ENSG00000234149	AC018511.2	NA	
ENSG00000227186	AC018511.1	NA	
ENSG00000188716	DUPD1	NA	
ENSG00000285810	AC018511.5	NA	
ENSG00000237882	PPIAP13	NA	
ENSG00000079393	DUSP13	NA	
ENSG00000156671	SAMD8	NA	
ENSG00000232437	RPS26P42	NA	
ENSG00000165637	VDAC2	NA	
ENSG00000165644	COMTD1	NA	
ENSG00000226051	ZNF503-AS1	NA	
ENSG00000227271	RPL39P25	NA	
ENSG00000233313	HMGA1P5	NA	
ENSG00000270087	AC010997.3	NA	
ENSG00000223428	AC010997.1	NA	
ENSG00000236797	SPA17P1	NA	
ENSG00000165655	ZNF503	NA	
ENSG00000237149	ZNF503-AS2	NA	
ENSG00000273248	AC010997.5	NA	
ENSG00000272692	AC010997.4	NA	
ENSG00000236842	AC010997.2	NA	
ENSG00000148655	LRMDA	615179	ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7
ENSG00000279814	AC010997.6	NA	
ENSG00000207583	MIR606	NA	
ENSG00000286715	AL589863.2	NA	
ENSG00000268659	AL589863.1	NA	
ENSG00000228280	AL731568.1	NA	
ENSG00000265486	RN7SL518P	NA	
ENSG00000201954	RNU6-673P	NA	
ENSG00000278992	AC012048.1	NA	
ENSG00000230575	AC013286.1	NA	
ENSG00000269256	AC024603.1	NA	
ENSG00000252888	AC013738.1	NA	
ENSG00000224948	ATP5MC1P8	NA	
ENSG00000156113	KCNMA1	609446	PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3;;GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA; GEPD
ENSG00000156113	KCNMA1	617643	CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS
ENSG00000156113	KCNMA1	618596	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 16; EIG16
ENSG00000156113	KCNMA1	618729	LIANG-WANG SYNDROME; LIWAS
ENSG00000236467	KCNMA1-AS1	NA	
ENSG00000225497	KCNMA1-AS2	NA	
ENSG00000224500	AL731575.1	NA	
ENSG00000225652	KCNMA1-AS3	NA	
ENSG00000228092	COX6CP15	NA	
ENSG00000199592	RNA5SP321	NA	
ENSG00000213514	AL731556.1	NA	
ENSG00000277981	AL731556.2	NA	
ENSG00000199664	RNU6-1266P	NA	
ENSG00000213513	IMPDH1P5	NA	
ENSG00000228748	AL450306.1	NA	
ENSG00000151208	DLG5	NA	
ENSG00000204049	AL391421.1	NA	
ENSG00000243446	RN7SL284P	NA	
ENSG00000233871	DLG5-AS1	NA	
ENSG00000234612	H2AZP5	NA	
ENSG00000274686	Metazoa_SRP	NA	
ENSG00000148606	POLR3A	264090	WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS;;PROGEROID SYNDROME, NEONATAL
ENSG00000148606	POLR3A	607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY /.../MYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM;;4H SYNDROME
ENSG00000138326	RPS24	610629	DIAMOND-BLACKFAN ANEMIA 3; DBA3
ENSG00000231957	GNAI2P2	NA	
ENSG00000283096	AL731555.1	NA	
ENSG00000282863	AC012560.1	NA	
ENSG00000230417	LINC00595	NA	
ENSG00000288090	AC010163.3	NA	
ENSG00000229543	AC010163.1	NA	
ENSG00000230229	AC010163.2	NA	
ENSG00000201393	SNORA71	NA	
ENSG00000282952	AL583852.1	NA	
ENSG00000228683	AC016820.1	NA	
ENSG00000224596	ZMIZ1-AS1	NA	
ENSG00000229569	AL356753.1	NA	
ENSG00000108175	ZMIZ1	618659	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA
ENSG00000108179	PPIF	NA	
ENSG00000165424	ZCCHC24	NA	
ENSG00000235426	AL133481.1	NA	
ENSG00000259021	TPRX1P1	NA	
ENSG00000241317	AL133481.3	NA	
ENSG00000235705	AL133481.2	NA	
ENSG00000253626	EIF5AL1	NA	
ENSG00000271985	BX248123.1	NA	
ENSG00000232965	RPS12P18	NA	
ENSG00000185303	SFTPA2	178500	PULMONARY FIBROSIS, IDIOPATHIC; IPF;;IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL;;FIBROSING ALVEOLITIS, CRYPTOGENIC;;FIBROCYSTIC PULMONARY DYSPLASIA;;INTERSTITIAL PNEUMONITIS, USUAL; UIP HAMMAN-RICH DISEASE, INCLUDED
ENSG00000219430	MBL3P	NA	
ENSG00000225827	SFTPA3P	NA	
ENSG00000122852	SFTPA1	NA	
ENSG00000226676	LINC02679	NA	
ENSG00000244733	AL132656.2	NA	
ENSG00000225484	NUTM2B-AS1	618637	OCULOPHARYNGEAL MYOPATHY WITH LEUKOENCEPHALOPATHY 1; OPML1
ENSG00000272489	AL132656.3	NA	
ENSG00000280355	AL132656.4	NA	
ENSG00000278616	BEND3P3	NA	
ENSG00000224886	AL132656.1	NA	
ENSG00000188199	NUTM2B	NA	
ENSG00000272447	AL135925.1	NA	
ENSG00000228570	NUTM2E	NA	
ENSG00000214695	NPAP1P2	NA	
ENSG00000204437	CTSLP6	NA	
ENSG00000214584	PGGT1BP2	NA	
ENSG00000283913	AL512662.2	NA	
ENSG00000283101	BMS1P21	NA	
ENSG00000242600	MBL1P	NA	
ENSG00000133661	SFTPD	NA	
ENSG00000273372	SFTPD-AS1	NA	
ENSG00000280259	AL512662.1	NA	
ENSG00000235924	ZNRF2P3	NA	
ENSG00000225100	DPY19L2P5	NA	
ENSG00000229616	AL356095.1	NA	
ENSG00000224760	C1DP3	NA	
ENSG00000236217	C1DP2	NA	
ENSG00000227515	C1DP4	NA	
ENSG00000230091	TMEM254-AS1	NA	
ENSG00000282432	AL356095.3	NA	
ENSG00000133678	TMEM254	NA	
ENSG00000279399	AL356095.2	NA	
ENSG00000230171	RPL22P18	NA	
ENSG00000189129	PLAC9	NA	
ENSG00000122359	ANXA11	617839	AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23
ENSG00000237523	LINC00857	NA	
ENSG00000234319	RPS12P2	NA	
ENSG00000234382	AL513174.1	NA	
ENSG00000234743	EIF5AP4	NA	
ENSG00000279359	AL359195.2	NA	
ENSG00000151224	MAT1A	250850	METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY;;MAT DEFICIENCY;;MAT I/III DEFICIENCY;;HYPERMETHIONINEMIA, ISOLATED PERSISTENT
ENSG00000232950	ZNF519P1	NA	
ENSG00000235858	AL359195.1	NA	
ENSG00000170788	DYDC1	NA	
ENSG00000133665	DYDC2	NA	
ENSG00000122378	PRXL2A	NA	
ENSG00000108219	TSPAN14	NA	
ENSG00000226659	AC021028.1	NA	
ENSG00000178217	SH2D4B	NA	
ENSG00000231082	LINC02655	NA	
ENSG00000233353	RPS7P9	NA	
ENSG00000233703	AC027673.1	NA	
ENSG00000231060	FARSBP1	NA	
ENSG00000227209	WARS2P1	NA	
ENSG00000226466	RPA2P2	NA	
ENSG00000287358	AL096706.1	NA	
ENSG00000185737	NRG3	NA	
ENSG00000285739	AC010157.2	NA	
ENSG00000229458	AC010157.1	NA	
ENSG00000225738	NRG3-AS1	NA	
ENSG00000207275	RNU6-441P	NA	
ENSG00000200774	RNU6-478P	NA	
ENSG00000234931	MARK2P15	NA	
ENSG00000233945	LINC02650	NA	
ENSG00000286876	AC069540.2	NA	
ENSG00000223565	AC069540.1	NA	
ENSG00000212324	RNU6-129P	NA	
ENSG00000233258	AL390786.1	NA	
ENSG00000200789	RNU1-65P	NA	
ENSG00000212769	HMGN2P8	NA	
ENSG00000271933	AL603756.1	NA	
ENSG00000165678	GHITM	NA	
ENSG00000285972	CERNA2	NA	
ENSG00000188373	C10orf99	NA	
ENSG00000148600	CDHR1	613660	CONE-ROD DYSTROPHY 15; CORD15 RETINITIS PIGMENTOSA 65, INCLUDED; RP65, INCLUDED
ENSG00000204033	LRIT2	NA	
ENSG00000148604	RGR	613769	RETINITIS PIGMENTOSA 44; RP44
ENSG00000148602	LRIT1	NA	
ENSG00000229404	LINC00858	NA	
ENSG00000107771	CCSER2	NA	
ENSG00000233189	RPL12P29	NA	
ENSG00000225423	TNPO1P1	NA	
ENSG00000225928	CACYBPP1	NA	
ENSG00000178429	RPS3AP5	NA	
ENSG00000288218	AL358787.2	NA	
ENSG00000237267	LINC01519	NA	
ENSG00000287057	AL358787.1	NA	
ENSG00000223993	LINC02647	NA	
ENSG00000224504	AC025428.1	NA	
ENSG00000230962	LINC01520	NA	
ENSG00000279910	AL731532.1	NA	
ENSG00000223064	RNU6-325P	NA	
ENSG00000280134	AL731532.2	NA	
ENSG00000234942	GRID1-AS1	NA	
ENSG00000182771	GRID1	NA	
ENSG00000278333	AC022028.3	NA	
ENSG00000270002	AC022028.2	NA	
ENSG00000252292	RN7SKP238	NA	
ENSG00000236606	AC022028.1	NA	
ENSG00000200487	RNA5SP322	NA	
ENSG00000199104	MIR346	NA	
ENSG00000287475	AL844892.2	NA	
ENSG00000286359	AL844892.1	NA	
ENSG00000062650	WAPL	NA	
ENSG00000212332	RNU6-780P	NA	
ENSG00000227896	AL731569.1	NA	
ENSG00000230507	RPL7AP8	NA	
ENSG00000122375	OPN4	NA	
ENSG00000122367	LDB3	601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C LEFT VENTRICULAR NONCOMPACTION 3, INCLUDED; LVNC3, INCLUDED;;CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 24, INCLUDED; CMH24, INCLUDED
ENSG00000122367	LDB3	609452	MYOPATHY, MYOFIBRILLAR, 4; MFM4
ENSG00000272631	AC067750.1	NA	
ENSG00000107779	BMPR1A	174900	JUVENILE POLYPOSIS SYNDROME; JPS;;POLYPOSIS, JUVENILE INTESTINAL; PJI;;JUVENILE INTESTINAL POLYPOSIS; JIP;;POLYPOSIS, FAMILIAL, OF ENTIRE GASTROINTESTINAL TRACT JUVENILE POLYPOSIS OF STOMACH, INCLUDED;;JUVENILE POLYPOSIS COLI, INCLUDED
ENSG00000107779	BMPR1A	610069	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2
ENSG00000270874	RPAP2P1	NA	
ENSG00000200176	RNU1-19P	NA	
ENSG00000173269	MMRN2	NA	
ENSG00000281974	AC025268.1	NA	
ENSG00000173267	SNCG	NA	
ENSG00000272734	ADIRF-AS1	NA	
ENSG00000148671	ADIRF	NA	
ENSG00000273413	AL136982.7	NA	
ENSG00000271880	AGAP11	NA	
ENSG00000240089	BMS1P3	NA	
ENSG00000151303	AL136982.1	NA	
ENSG00000272508	AL136982.6	NA	
ENSG00000261011	AL136982.4	NA	
ENSG00000229969	AL136982.2	NA	
ENSG00000188100	FAM25A	NA	
ENSG00000271573	AL136982.5	NA	
ENSG00000200253	RNU6-529P	NA	
ENSG00000148672	GLUD1	606762	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6;;HYPERINSULINISM-HYPERAMMONEMIA SYNDROME
ENSG00000122376	SHLD2	NA	
ENSG00000237280	AL136982.3	NA	
ENSG00000273946	RN7SL733P	NA	
ENSG00000223482	NUTM2A-AS1	NA	
ENSG00000287077	AL157893.2	NA	
ENSG00000285257	AL157893.1	NA	
ENSG00000184923	NUTM2A	NA	
ENSG00000224914	LINC00863	NA	
ENSG00000214562	NUTM2D	NA	
ENSG00000237740	NPAP1P3	NA	
ENSG00000236417	CTSLP1	NA	
ENSG00000228055	FAM245A	NA	
ENSG00000231569	AL355334.1	NA	
ENSG00000286445	AL355334.2	NA	
ENSG00000283672	MIR4678	NA	
ENSG00000107789	MINPP1	188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2
ENSG00000223761	AL138767.2	NA	
ENSG00000225913	AL138767.3	NA	
ENSG00000196566	AL138767.1	NA	
ENSG00000234192	RPS26P38	NA	
ENSG00000198682	PAPSS2	612847	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4;;SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PAKISTANI TYPE;;SEMD, PAKISTANI TYPE;;SPONDYLODYSPLASIA AND PREMATURE PUBARCHE
ENSG00000138138	ATAD1	618011	HYPEREKPLEXIA 4; HKPX4
ENSG00000223820	CFL1P1	NA	
ENSG00000243782	RN7SL78P	NA	
ENSG00000227268	KLLN	615107	COWDEN SYNDROME 4; CWS4
ENSG00000171862	PTEN	176807	PROSTATE CANCER
ENSG00000171862	PTEN	158350	COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAM;;PTEN HAMARTOMA TUMOR SYNDROME; PHTS;;PTEN HAMARTOMA TUMOR SYNDROME WITH GRANULAR CELL TUMOR;;BANNAYAN-RILEY-RUVALCABA SYNDROME; BBRS;;BANNAYAN-ZONANA SYNDROME; BZS;;RILEY-SMITH SYND /.../RUVALCABA-MYHRE-SMITH SYNDROME; RMSS;;MACROCEPHALY, PSEUDOPAPILLEDEMA, AND MULTIPLE HEMANGIOMATA;;MACROCEPHALY, MULTIPLE LIPOMAS, AND HEMANGIOMATA LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;DYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED
ENSG00000171862	PTEN	605309	MACROCEPHALY/AUTISM SYNDROME
ENSG00000171862	PTEN	607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
ENSG00000171862	PTEN	613028	GLIOMA SUSCEPTIBILITY 2; GLM2
ENSG00000224745	AC063965.2	NA	
ENSG00000213613	RPL11P3	NA	
ENSG00000200891	AC063965.1	NA	
ENSG00000227905	MED6P1	NA	
ENSG00000275015	AL353149.1	NA	
ENSG00000184719	RNLS	NA	
ENSG00000201548	AL139406.1	NA	
ENSG00000204022	LIPJ	NA	
ENSG00000237205	RPL7P34	NA	
ENSG00000182333	LIPF	NA	
ENSG00000271408	NAPGP1	NA	
ENSG00000204021	LIPK	NA	
ENSG00000226358	KRT8P38	NA	
ENSG00000204020	LIPN	613943	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8;;LAMELLAR ICHTHYOSIS, LATE-ONSET;;ICHTHYOSIS, LAMELLAR, 4, FORMERLY; LI4, FORMERLY
ENSG00000235150	RCBTB2P1	NA	
ENSG00000173239	LIPM	NA	
ENSG00000152766	ANKRD22	NA	
ENSG00000234256	PTCD2P2	NA	
ENSG00000138134	STAMBPL1	NA	
ENSG00000180139	ACTA2-AS1	NA	
ENSG00000107796	ACTA2	611788	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6;;FAMILIAL THORACIC AORTIC ANEURYSM WITH LIVEDO RETICULARIS AND IRIS FLOCCULI
ENSG00000107796	ACTA2	613834	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS;;MYDRIASIS, CONGENITAL, WITH PATENT DUCTUS ARTERIOSUS, THORACIC AORTIC ANEURYSM, AND VASCULOPATHY
ENSG00000107796	ACTA2	614042	MOYAMOYA DISEASE 5; MYMY5
ENSG00000286116	AL157394.3	NA	
ENSG00000026103	FAS	601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS;;CANALE-SMITH SYNDROME;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL DOMINANT AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, INCLUDED; ALPS1A, INCLUDED;;AUTOIMMUNE LYMPHOPROLIFERATIVE SY /.../, TYPE IB, INCLUDED; ALPS1B, INCLUDED;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000275693	AL157394.2	NA	
ENSG00000261438	AL157394.1	NA	
ENSG00000265375	MIR4679-2	NA	
ENSG00000283664	MIR4679-1	NA	
ENSG00000233292	AL513533.1	NA	
ENSG00000138135	CH25H	NA	
ENSG00000107798	LIPA	278000	LYSOSOMAL ACID LIPASE DEFICIENCY;;CHOLESTERYL ESTER STORAGE DISEASE; CESD;;LIPA DEFICIENCY;;LAL DEFICIENCY;;CHOLESTEROL ESTER HYDROLASE DEFICIENCY WOLMAN DISEASE, INCLUDED
ENSG00000119922	IFIT2	NA	
ENSG00000232110	AL353751.1	NA	
ENSG00000119917	IFIT3	NA	
ENSG00000224289	IFIT6P	NA	
ENSG00000204010	IFIT1B	NA	
ENSG00000185745	IFIT1	NA	
ENSG00000152778	IFIT5	NA	
ENSG00000152779	SLC16A12	612018	CATARACT 47; CTRCT47;;CATARACT, JUVENILE, WITH MICROCORNEA;;CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA, FORMERLY; CJMG, FORMERLY
ENSG00000234452	SLC16A12-AS1	NA	
ENSG00000152782	PANK1	NA	
ENSG00000198997	MIR107	NA	
ENSG00000249962	AL157400.5	NA	
ENSG00000232936	AL157400.2	NA	
ENSG00000225836	AL157400.1	NA	
ENSG00000235100	AL157400.3	NA	
ENSG00000240996	AL157400.4	NA	
ENSG00000138182	KIF20B	NA	
ENSG00000283578	MTND5P42	NA	
ENSG00000232229	LINC00865	NA	
ENSG00000270670	MARK2P16	NA	
ENSG00000280560	LINC01374	NA	
ENSG00000226159	LINC01375	NA	
ENSG00000228938	SNRPD2P1	NA	
ENSG00000287150	AL139340.1	NA	
ENSG00000222451	RN7SKP143	NA	
ENSG00000236373	LINC02653	NA	
ENSG00000224750	AL391704.1	NA	
ENSG00000238291	AL391704.2	NA	
ENSG00000283053	AL390862.1	NA	
ENSG00000148680	HTR7	NA	
ENSG00000148688	RPP30	NA	
ENSG00000222305	AL590622.1	NA	
ENSG00000148677	ANKRD1	NA	
ENSG00000201604	RNU6-740P	NA	
ENSG00000225519	AL365434.1	NA	
ENSG00000273124	AL365434.2	NA	
ENSG00000224851	LINC00502	NA	
ENSG00000220585	DDX18P6	NA	
ENSG00000234043	NUDT9P1	NA	
ENSG00000286981	AL731553.1	NA	
ENSG00000180628	PCGF5	NA	
ENSG00000165338	HECTD2	NA	
ENSG00000271385	AL161798.1	NA	
ENSG00000223876	RPS27P1	NA	
ENSG00000119938	PPP1R3C	NA	
ENSG00000213449	GAPDHP28	NA	
ENSG00000228759	FAF2P1	NA	
ENSG00000228701	TNKS2-AS1	NA	
ENSG00000107854	TNKS2	NA	
ENSG00000180581	SRP9P1	NA	
ENSG00000273497	AL359198.2	NA	
ENSG00000174721	FGFBP3	NA	
ENSG00000272817	AL359198.1	NA	
ENSG00000095564	BTAF1	NA	
ENSG00000107864	CPEB3	NA	
ENSG00000252993	AL365398.1	NA	
ENSG00000214549	SDHCP2	NA	
ENSG00000213484	EIF4A1P8	NA	
ENSG00000221042	AL158040.1	NA	
ENSG00000105988	NHP2P1	NA	
ENSG00000199881	Y_RNA	NA	
ENSG00000198060	MARCHF5	NA	
ENSG00000202297	RNY3P12	NA	
ENSG00000232709	MARK2P9	NA	
ENSG00000286795	AL161652.1	NA	
ENSG00000119912	IDE	NA	
ENSG00000138160	KIF11	152950	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR;;MICROCEPHALY, LYMPHEDEMA, CHORIORETINAL DYSPLASIA SYNDROME;;MLCRD SYNDROME;;MICROCEPHALY AND CHORIORETINOPATHY WITH OR WITHOUT MENTAL RETARDATION, AUTOSOMAL DO /.../;;CDMMR SYNDROME;;LYMPHEDEMA, MICROCEPHALY, CHORIORETINOPATHY SYNDROME;;LYMPHEDEMA AND RETINAL FOLDS WITH MICROCEPHALY AND MICROPHTHALMOS
ENSG00000184111	RPL11P4	NA	
ENSG00000264313	RN7SL644P	NA	
ENSG00000236493	EIF2S2P3	NA	
ENSG00000152804	HHEX	NA	
ENSG00000201412	Y_RNA	NA	
ENSG00000138190	EXOC6	NA	
ENSG00000225118	AL392103.1	NA	
ENSG00000226425	AL358613.1	NA	
ENSG00000187553	CYP26C1	614974	FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4
ENSG00000285846	AL358613.3	NA	
ENSG00000279607	AL358613.2	NA	
ENSG00000095596	CYP26A1	NA	
ENSG00000232805	NIP7P1	NA	
ENSG00000237417	XRCC6P1	NA	
ENSG00000213432	RPL17P34	NA	
ENSG00000138119	MYOF	NA	
ENSG00000138180	CEP55	236500	MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH;;HYDRANENCEPHALY WITH RENAL APLASIA-DYSPLASIA
ENSG00000212396	RNA5SP323	NA	
ENSG00000186188	FFAR4	607514	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10;;OBESITY, SUSCEPTIBILITY TO
ENSG00000138207	RBP4	615147	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS
ENSG00000138207	RBP4	616428	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10; MCOPCB10
ENSG00000095464	PDE6C	613093	CONE DYSTROPHY 4; COD4 ACHROMATOPSIA 5, INCLUDED; ACHM5, INCLUDED
ENSG00000148690	FRA10AC1	NA	
ENSG00000108231	LGI1	600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1;;EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT; ADLTE;;EPILEPSY, PARTIAL, WITH AUDITORY FEATURES; ADPEAF
ENSG00000280660	AL157396.1	NA	
ENSG00000280485	AL358154.1	NA	
ENSG00000227995	RAB11AP1	NA	
ENSG00000176273	SLC35G1	NA	
ENSG00000180764	PIPSL	NA	
ENSG00000138193	PLCE1	610725	NEPHROTIC SYNDROME, TYPE 3; NPHS3;;NEPHROTIC SYNDROME, EARLY-ONSET, TYPE 3
ENSG00000232913	PLCE1-AS2	NA	
ENSG00000231575	AL139118.1	NA	
ENSG00000234724	HDAC1P1	NA	
ENSG00000206631	RNU6-657P	NA	
ENSG00000228553	AL389885.1	NA	
ENSG00000268894	PLCE1-AS1	NA	
ENSG00000273450	AL139124.1	NA	
ENSG00000173145	NOC3L	NA	
ENSG00000108239	TBC1D12	NA	
ENSG00000119969	HELLS	616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4
ENSG00000244332	AL138759.1	NA	
ENSG00000235746	CTBP2P2	NA	
ENSG00000108242	CYP2C18	NA	
ENSG00000276490	AL583836.1	NA	
ENSG00000165841	CYP2C19	609535	DRUG METABOLISM, POOR, CYP2C19-RELATED MEPHENYTOIN, POOR METABOLISM OF, INCLUDED;;OMEPRAZOLE, POOR METABOLISM OF, INCLUDED;;PROGUANIL, POOR METABOLISM OF, INCLUDED;;CLOPIDOGREL, POOR METABOLISM OF, INCLUDED
ENSG00000230338	MTND4P19	NA	
ENSG00000235199	CYP2C58P	NA	
ENSG00000225354	RPL7AP52	NA	
ENSG00000138109	CYP2C9	122700	COUMARIN RESISTANCE;;COUMARIN, POOR METABOLISM OF;;WARFARIN RESISTANCE  COUMARIN SENSITIVITY, INCLUDED;;WARFARIN SENSITIVITY, INCLUDED
ENSG00000233377	MTND4P20	NA	
ENSG00000228460	CYP2C59P	NA	
ENSG00000260863	CYP2C60P	NA	
ENSG00000237885	AL359672.1	NA	
ENSG00000138115	CYP2C8	618018	DRUG METABOLISM, ALTERED, CYP2C8-RELATED
ENSG00000231829	AL157834.1	NA	
ENSG00000288526	AL157834.4	NA	
ENSG00000274691	AL157834.3	NA	
ENSG00000225533	PAWRP1	NA	
ENSG00000173124	ACSM6	NA	
ENSG00000234026	AL157834.2	NA	
ENSG00000107438	PDLIM1	NA	
ENSG00000095637	SORBS1	NA	
ENSG00000214362	RPS3AP36	NA	
ENSG00000059573	ALDH18A1	219150	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A;;DE BARSY SYNDROME A;;CUTIS LAXA, CORNEAL CLOUDING, AND MENTAL RETARDATION;;PROGEROID SYNDROME OF DE BARSY
ENSG00000059573	ALDH18A1	601162	SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A;;CATARACTS WITH MOTOR NEURONOPATHY, SHORT STATURE, AND SKELETAL ABNORMALITIES;;SPASTIC PARAPARESIS WITH AMYOTROPHY, CATARACTS, AND GASTROESOPHAGEAL REFLUX
ENSG00000059573	ALDH18A1	616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B
ENSG00000059573	ALDH18A1	616603	CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3
ENSG00000119977	TCTN3	258860	OROFACIODIGITAL SYNDROME IV; OFD4;;OFDS IV;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE IV;;OFD SYNDROME WITH TIBIAL DEFECTS;;MOHR-MAJEWSKI SYNDROME;;OFD SYNDROME, BARAITSER-BURN TYPE;;BARAITSER-BURN SYNDROME
ENSG00000119977	TCTN3	614815	JOUBERT SYNDROME 18; JBTS18
ENSG00000138185	ENTPD1	615683	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64
ENSG00000226688	ENTPD1-AS1	NA	
ENSG00000240527	AL365273.1	NA	
ENSG00000270099	AL365273.2	NA	
ENSG00000188649	CC2D2B	NA	
ENSG00000227805	RPL21P90	NA	
ENSG00000107443	CCNJ	NA	
ENSG00000266407	MIR3157	NA	
ENSG00000200728	RNU6-271P	NA	
ENSG00000287009	AC021037.1	NA	
ENSG00000177853	ZNF518A	NA	
ENSG00000095585	BLNK	613502	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO BLNK DEFECT
ENSG00000229417	NPM1P25	NA	
ENSG00000229418	AL136181.1	NA	
ENSG00000107447	DNTT	NA	
ENSG00000197430	OPALIN	NA	
ENSG00000095587	TLL2	NA	
ENSG00000077147	TM9SF3	NA	
ENSG00000235677	NPM1P26	NA	
ENSG00000155629	PIK3AP1	NA	
ENSG00000202047	RNA5SP324	NA	
ENSG00000227032	RPS2P36	NA	
ENSG00000207287	RNU6-1274P	NA	
ENSG00000236552	RPL13AP5	NA	
ENSG00000207976	MIR607	NA	
ENSG00000196233	LCOR	NA	
ENSG00000232875	HMGN2P35	NA	
ENSG00000187122	SLIT1	NA	
ENSG00000234855	SLIT1-AS1	NA	
ENSG00000269891	ARHGAP19-SLIT1	NA	
ENSG00000286683	AL512424.1	NA	
ENSG00000213390	ARHGAP19	NA	
ENSG00000231398	AL359385.1	NA	
ENSG00000277308	Metazoa_SRP	NA	
ENSG00000237169	RPL12P27	NA	
ENSG00000165879	FRAT1	NA	
ENSG00000181274	FRAT2	NA	
ENSG00000225850	AL355490.1	NA	
ENSG00000052749	RRP12	NA	
ENSG00000231508	RPL34P20	NA	
ENSG00000231970	AL355490.2	NA	
ENSG00000200737	Y_RNA	NA	
ENSG00000171314	PGAM1	NA	
ENSG00000171311	EXOSC1	NA	
ENSG00000171307	ZDHHC16	NA	
ENSG00000155229	MMS19	NA	
ENSG00000165886	UBTD1	NA	
ENSG00000165887	ANKRD2	NA	
ENSG00000241935	HOGA1	613616	HYPEROXALURIA, PRIMARY, TYPE III; HP3
ENSG00000249967	AL355315.1	NA	
ENSG00000203942	C10orf62	NA	
ENSG00000171160	MORN4	NA	
ENSG00000155252	PI4K2A	NA	
ENSG00000119986	AVPI1	NA	
ENSG00000155254	MARVELD1	NA	
ENSG00000155256	ZFYVE27	610244	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33
ENSG00000120057	SFRP5	NA	
ENSG00000227356	LINC00866	NA	
ENSG00000155265	GOLGA7B	NA	
ENSG00000095713	CRTAC1	NA	
ENSG00000278752	AL355301.1	NA	
ENSG00000166024	R3HCC1L	NA	
ENSG00000138131	LOXL4	NA	
ENSG00000230928	AL139241.1	NA	
ENSG00000119943	PYROXD2	NA	
ENSG00000284415	MIR1287	NA	
ENSG00000107521	HPS1	203300	HERMANSKY-PUDLAK SYNDROME 1; HPS1;;ALBINISM WITH HEMORRHAGIC DIATHESIS AND PIGMENTED RETICULOENDOTHELIAL CELLS;;DELTA STORAGE POOL DISEASE
ENSG00000264610	MIR4685	NA	
ENSG00000287261	AL139243.1	NA	
ENSG00000172987	HPSE2	236730	UROFACIAL SYNDROME 1; UFS1;;UROFACIAL SYNDROME; UFS;;OCHOA SYNDROME;;HYDRONEPHROSIS WITH PECULIAR FACIAL EXPRESSION;;INVERTED SMILE AND OCCULT NEUROPATHIC BLADDER;;FACIAL PALSY, PARTIAL, WITH URINARY ABNORMALITIES
ENSG00000274056	MIR6507	NA	
ENSG00000236818	ARL5AP2	NA	
ENSG00000234109	RPL7P36	NA	
ENSG00000119946	CNNM1	NA	
ENSG00000120053	GOT1	614419	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1;;ASTQTL1
ENSG00000224934	AL391684.1	NA	
ENSG00000257582	LINC01475	NA	
ENSG00000228778	AL513542.1	NA	
ENSG00000119919	NKX2-3	NA	
ENSG00000155287	SLC25A28	NA	
ENSG00000260475	AL353719.1	NA	
ENSG00000229278	AL133353.1	NA	
ENSG00000285932	AL133353.2	NA	
ENSG00000198018	ENTPD7	NA	
ENSG00000233690	EBAG9P1	NA	
ENSG00000119929	CUTC	NA	
ENSG00000014919	COX15	256000	LEIGH SYNDROME; LS;;NECROTIZING ENCEPHALOPATHY, INFANTILE SUBACUTE, OF LEIGH; SNE LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHON /.../COMPLEX III DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX V DEFICIENCY, INCLUDED
ENSG00000014919	COX15	615119	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2
ENSG00000023839	ABCC2	237500	DUBIN-JOHNSON SYNDROME; DJS;;HYPERBILIRUBINEMIA, DUBIN-JOHNSON TYPE; HBLRDJ;;HYPERBILIRUBINEMIA II
ENSG00000227351	NANOGP6	NA	
ENSG00000107554	DNMBP	618415	CATARACT 48; CTRCT48
ENSG00000227695	DNMBP-AS1	NA	
ENSG00000120054	CPN1	212070	CARBOXYPEPTIDASE N DEFICIENCY
ENSG00000283232	CYP2C23P	NA	
ENSG00000232230	TPM4P1	NA	
ENSG00000270623	SPCS2P2	NA	
ENSG00000107566	ERLIN1	615681	SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE; SPG62
ENSG00000213341	CHUK	613630	FETAL ENCASEMENT SYNDROME;;COCOON SYNDROME
ENSG00000236308	AL138921.2	NA	
ENSG00000227492	AL138921.1	NA	
ENSG00000095485	CWF19L1	616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17
ENSG00000212464	SNORA12	NA	
ENSG00000230224	PHBP9	NA	
ENSG00000207362	RNU6-422P	NA	
ENSG00000196072	BLOC1S2	NA	
ENSG00000107593	PKD2L1	NA	
ENSG00000231188	AL139819.1	NA	
ENSG00000099194	SCD	NA	
ENSG00000235823	OLMALINC	NA	
ENSG00000212325	Y_RNA	NA	
ENSG00000075290	WNT8B	NA	
ENSG00000075826	SEC31B	NA	
ENSG00000255339	AL133352.1	NA	
ENSG00000166136	NDUFB8	618252	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32
ENSG00000166135	HIF1AN	NA	
ENSG00000274660	Metazoa_SRP	NA	
ENSG00000075891	PAX2	120330	PAPILLORENAL SYNDROME; PAPRS;;RENAL-COLOBOMA SYNDROME;;OPTIC NERVE COLOBOMA WITH RENAL DISEASE;;COLOBOMA OF OPTIC NERVE WITH RENAL DISEASE;;OPTIC COLOBOMA, VESICOURETERAL REFLUX, AND RENAL ANOMALIES;;RENAL-COLOBOMA SYNDROME WITH MACULAR ABNORMALITIE /.../GENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH OR WITHOUT OCULAR ABNORMALITIES;;CAKUT WITH OR WITHOUT OCULAR ABNORMALITIES
ENSG00000075891	PAX2	616002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 7
ENSG00000222072	Y_RNA	NA	
ENSG00000272572	AL138762.1	NA	
ENSG00000119906	SLF2	NA	
ENSG00000273476	AL133215.3	NA	
ENSG00000055950	MRPL43	NA	
ENSG00000095539	SEMA4G	NA	
ENSG00000207551	MIR608	NA	
ENSG00000236662	AL133215.1	NA	
ENSG00000107815	TWNK	271245	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7;;SPINOCEREBELLAR ATAXIA, INFANTILE-ONSET; IOSCA;;OPHTHALMOPLEGIA, HYPOTONIA, ATAXIA, HYPOACUSIS, AND ATHETOSIS;;OHAHA SYNDROME;;SPINOCEREBELLAR ATAXIA, INFANTILE, WITH SENSORY NEUR /.../;;SPINOCEREBELLAR ATAXIA 8, FORMERLY; SCA8, FORMERLY
ENSG00000107815	TWNK	607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO;;SENSORY ATAXIC NEUROPATHY WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA WITH EPILEPSY, INCLUDED; SCAE, INCLUDED;;EPILEPSY, PROGRESSIVE MYOCLONIC, WITH /.../RY ATAXIC NEUROPATHY, INCLUDED;;EPILEPSY, PROGRESSIVE MYOCLONIC, 5, FORMERLY; EPM5, FORMERLY
ENSG00000107815	TWNK	609286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 3
ENSG00000107815	TWNK	616138	PERRAULT SYNDROME 5; PRLTS5
ENSG00000107816	LZTS2	NA	
ENSG00000186862	PDZD7	276901	USHER SYNDROME, TYPE IIA; USH2A
ENSG00000186862	PDZD7	605472	USHER SYNDROME, TYPE IIC; USH2C USHER SYNDROME, TYPE IIC, GPR98/PDZD7, DIGENIC, INCLUDED;;USHER SYNDROME, TYPE IIB, FORMERLY, INCLUDED; USH2B, FORMERLY, INCLUDED
ENSG00000186862	PDZD7	618003	DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57
ENSG00000107819	SFXN3	NA	
ENSG00000273162	AL133215.2	NA	
ENSG00000107821	KAZALD1	NA	
ENSG00000236311	TLX1NB	NA	
ENSG00000107807	TLX1	NA	
ENSG00000237579	LINC01514	NA	
ENSG00000270973	SMARCE1P7	NA	
ENSG00000138136	LBX1	NA	
ENSG00000227128	LBX1-AS1	NA	
ENSG00000229649	LINC02681	NA	
ENSG00000222238	RNU2-43P	NA	
ENSG00000225208	AL133387.1	NA	
ENSG00000230967	AL133387.2	NA	
ENSG00000166167	BTRC	NA	
ENSG00000222414	RNU2-59P	NA	
ENSG00000166171	DPCD	NA	
ENSG00000166169	POLL	NA	
ENSG00000263436	MIR3158-1	NA	
ENSG00000283558	MIR3158-2	NA	
ENSG00000107829	FBXW4	NA	
ENSG00000222051	RNU6-1165P	NA	
ENSG00000286489	AC010789.2	NA	
ENSG00000224817	AC010789.1	NA	
ENSG00000107831	FGF8	612702	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6
ENSG00000107833	NPM3	NA	
ENSG00000198408	OGA	NA	
ENSG00000226009	KCNIP2-AS1	NA	
ENSG00000120049	KCNIP2	NA	
ENSG00000120029	ARMH3	NA	
ENSG00000274742	Metazoa_SRP	NA	
ENSG00000222430	Y_RNA	NA	
ENSG00000166189	HPS6	614075	HERMANSKY-PUDLAK SYNDROME 6; HPS6
ENSG00000224302	AL500527.1	NA	
ENSG00000229629	AL500527.2	NA	
ENSG00000198728	LDB1	NA	
ENSG00000148840	PPRC1	NA	
ENSG00000166197	NOLC1	NA	
ENSG00000119915	ELOVL3	NA	
ENSG00000107859	PITX3	107250	ANTERIOR SEGMENT DYSGENESIS 1; ASGD1;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD;;ANTERIOR SEGMENT OCULAR DYSGENESIS; ASOD
ENSG00000107859	PITX3	610623	CATARACT 11, MULTIPLE TYPES; CTRCT11;;CATARACT, POSTERIOR POLAR, 4; CTPP4;;CPP4 CATARACT 11 WITH MICROPHTHALMIA AND NEURODEVELOPMENTAL ABNORMALITIES, INCLUDED
ENSG00000107862	GBF1	NA	
ENSG00000077150	NFKB2	615577	IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10;;IMMUNODEFICIENCY, COMMON VARIABLE, WITH CENTRAL ADRENAL INSUFFICIENCY;;DEFICIT IN ANTERIOR PITUITARY FUNCTION AND VARIABLE IMMUNODEFICIENCY; DAVID
ENSG00000059915	PSD	NA	
ENSG00000107872	FBXL15	NA	
ENSG00000107874	CUEDC2	NA	
ENSG00000202569	MIR146B	NA	
ENSG00000269609	RPARP-AS1	NA	
ENSG00000120055	C10orf95	NA	
ENSG00000138111	MFSD13A	NA	
ENSG00000138107	ACTR1A	NA	
ENSG00000273262	AL121928.1	NA	
ENSG00000107882	SUFU	155255	MEDULLOBLASTOMA; MDB MEDULLOBLASTOMA, DESMOPLASTIC, INCLUDED;;MEDULLOBLASTOMA WITH EXTENSIVE NODULARITY, INCLUDED; MBEN, INCLUDED
ENSG00000107882	SUFU	109400	BASAL CELL NEVUS SYNDROME; BCNS;;GORLIN SYNDROME;;GORLIN-GOLTZ SYNDROME;;NEVOID BASAL CELL CARCINOMA SYNDROME; NBCCS;;MULTIPLE BASAL CELL NEVI, ODONTOGENIC KERATOCYSTS, AND SKELETAL ANOMALIES
ENSG00000107882	SUFU	607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
ENSG00000107882	SUFU	617757	JOUBERT SYNDROME 32; JBTS32
ENSG00000228657	RPL23AP58	NA	
ENSG00000207029	RNU6-43P	NA	
ENSG00000272933	AL391121.1	NA	
ENSG00000171206	TRIM8	NA	
ENSG00000138175	ARL3	618161	JOUBERT SYNDROME 35; JBTS35
ENSG00000138175	ARL3	618173	RETINITIS PIGMENTOSA 83; RP83
ENSG00000156398	SFXN2	NA	
ENSG00000166272	WBP1L	NA	
ENSG00000252994	RNU6-1231P	NA	
ENSG00000148795	CYP17A1	202110	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA V;;17-@ALPHA-HYDROXYLASE DEFICIENCY 17,20-@LYASE DEFICIENCY, ISOLATED, INCLUDED;;17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE, INCLUDED;; /.../PHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL, INCLUDED
ENSG00000213061	PFN1P11	NA	
ENSG00000236937	PTGES3P4	NA	
ENSG00000282772	AL358790.1	NA	
ENSG00000166275	BORCS7	NA	
ENSG00000270316	BORCS7-ASMT	NA	
ENSG00000283337	U6	NA	
ENSG00000214435	AS3MT	NA	
ENSG00000235266	RPL22P17	NA	
ENSG00000286575	AL356608.3	NA	
ENSG00000272912	AL356608.1	NA	
ENSG00000148842	CNNM2	613882	HYPOMAGNESEMIA 6, RENAL; HOMG6
ENSG00000148842	CNNM2	616418	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1; HOMGSMR1;;HOMGSMR
ENSG00000278498	AL356608.2	NA	
ENSG00000076685	NT5C2	613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45
ENSG00000237827	RPS15AP29	NA	
ENSG00000213277	MARCKSL1P1	NA	
ENSG00000229256	ST13P13	NA	
ENSG00000235376	RPEL1	NA	
ENSG00000148798	INA	NA	
ENSG00000156374	PCGF6	NA	
ENSG00000212413	RNU11-3P	NA	
ENSG00000148835	TAF5	NA	
ENSG00000173915	ATP5MD	618683	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6
ENSG00000283867	MIR1307	NA	
ENSG00000148843	PDCD11	NA	
ENSG00000138172	CALHM2	NA	
ENSG00000273485	AL139339.2	NA	
ENSG00000234699	AL139339.1	NA	
ENSG00000185933	CALHM1	NA	
ENSG00000183128	CALHM3	NA	
ENSG00000235470	NEURL1-AS1	NA	
ENSG00000107954	NEURL1	NA	
ENSG00000226431	AL121929.1	NA	
ENSG00000287419	AL121929.3	NA	
ENSG00000107957	SH3PXD2A	NA	
ENSG00000273108	AL121929.2	NA	
ENSG00000222503	Y_RNA	NA	
ENSG00000280693	SH3PXD2A-AS1	NA	
ENSG00000260461	AL133355.1	NA	
ENSG00000107960	STN1	617341	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2; CRMCC2
ENSG00000065613	SLK	NA	
ENSG00000266754	RN7SL524P	NA	
ENSG00000065618	COL17A1	122400	EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED;;CORNEAL EROSIONS, RECURRING HEREDITARY
ENSG00000065618	COL17A1	226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DIS /.../TYPE;;EPIDERMOLYSIS BULLOSA, GENERALIZED ATROPHIC BENIGN; GABEB EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT, INCLUDED;;JUNCTIONAL EPIDERMOLYSIS BULLOSA INVERSA, INCLUDED;;JEB-I, INCLUDED
ENSG00000283788	MIR936	NA	
ENSG00000156384	SFR1	NA	
ENSG00000197748	CFAP43	236690	HYDROCEPHALUS, NORMAL-PRESSURE, 1; HYDNP1
ENSG00000197748	CFAP43	617592	SPERMATOGENIC FAILURE 19; SPGF19
ENSG00000208033	MIR609	NA	
ENSG00000148834	GSTO1	NA	
ENSG00000266852	MIR4482	NA	
ENSG00000065621	GSTO2	NA	
ENSG00000148841	ITPRIP	NA	
ENSG00000270075	AL162742.1	NA	
ENSG00000287779	AL162742.2	NA	
ENSG00000228261	ITPRIP-AS1	NA	
ENSG00000231233	CFAP58-DT	NA	
ENSG00000120051	CFAP58	NA	
ENSG00000225768	LINC02620	NA	
ENSG00000237761	AL161646.1	NA	
ENSG00000156395	SORCS3	NA	
ENSG00000226387	SORCS3-AS1	NA	
ENSG00000229466	LINC02627	NA	
ENSG00000207068	RNU6-463P	NA	
ENSG00000233477	PPIAP38	NA	
ENSG00000213260	YWHAZP5	NA	
ENSG00000287732	AL731574.1	NA	
ENSG00000286609	AL589166.1	NA	
ENSG00000229775	LINC02624	NA	
ENSG00000215002	RPL23AP59	NA	
ENSG00000108018	SORCS1	NA	
ENSG00000287047	AL133395.1	NA	
ENSG00000200626	RNA5SP325	NA	
ENSG00000200079	RNA5SP326	NA	
ENSG00000229981	LINC01435	NA	
ENSG00000234544	PTGES3P5	NA	
ENSG00000203434	AL353740.1	NA	
ENSG00000223381	LINC02661	NA	
ENSG00000224498	MAPKAPK5P1	NA	
ENSG00000222436	RN7SKP278	NA	
ENSG00000252574	RNU5B-6P	NA	
ENSG00000200217	RNU6-839P	NA	
ENSG00000232728	PHB2P1	NA	
ENSG00000237242	BTF3P15	NA	
ENSG00000270333	AL390123.1	NA	
ENSG00000270294	XIAPP1	NA	
ENSG00000224907	RPL21P91	NA	
ENSG00000108039	XPNPEP1	NA	
ENSG00000272160	RNU4-5P	NA	
ENSG00000203876	ADD3-AS1	NA	
ENSG00000148700	ADD3	617008	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3
ENSG00000226734	SNRPGP12	NA	
ENSG00000119950	MXI1	176807	PROSTATE CANCER
ENSG00000228417	AL360182.2	NA	
ENSG00000214067	AL360182.1	NA	
ENSG00000119953	SMNDC1	NA	
ENSG00000273143	AL355512.1	NA	
ENSG00000237642	HMGB3P5	NA	
ENSG00000138166	DUSP5	NA	
ENSG00000233518	RPL7P35	NA	
ENSG00000108055	SMC3	610759	CORNELIA DE LANGE SYNDROME 3; CDLS3
ENSG00000223302	Y_RNA	NA	
ENSG00000203867	RBM20	613172	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD
ENSG00000252036	RN7SKP288	NA	
ENSG00000199364	RNA5SP327	NA	
ENSG00000232470	AL136368.1	NA	
ENSG00000203497	PDCD4-AS1	NA	
ENSG00000150593	PDCD4	NA	
ENSG00000284482	MIR4680	NA	
ENSG00000214413	BBIP1	615995	BARDET-BIEDL SYNDROME 18; BBS18
ENSG00000278601	AL158163.2	NA	
ENSG00000270589	AL158163.1	NA	
ENSG00000108061	SHOC2	607721	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1;;NSLH;;TOSTI SYNDROME
ENSG00000234118	RPL13AP6	NA	
ENSG00000221214	MIR548E	NA	
ENSG00000150594	ADRA2A	NA	
ENSG00000213247	AL355863.1	NA	
ENSG00000237618	BTBD7P2	NA	
ENSG00000227851	AC021035.1	NA	
ENSG00000230809	RPS6P15	NA	
ENSG00000287231	AL136119.1	NA	
ENSG00000119927	GPAM	NA	
ENSG00000119913	TECTB	NA	
ENSG00000276857	MIR6715A	NA	
ENSG00000283688	MIR6715B	NA	
ENSG00000243316	GUCY2GP	NA	
ENSG00000197142	ACSL5	NA	
ENSG00000232934	AL157786.1	NA	
ENSG00000023041	ZDHHC6	NA	
ENSG00000151532	VTI1A	NA	
ENSG00000234017	AC022018.1	NA	
ENSG00000264763	MIR4295	NA	
ENSG00000233340	AL139120.1	NA	
ENSG00000285676	AL158212.5	NA	
ENSG00000260917	AL158212.3	NA	
ENSG00000279315	AL158212.4	NA	
ENSG00000225292	AL158212.1	NA	
ENSG00000148737	TCF7L2	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000233547	AL158212.2	NA	
ENSG00000227560	RPS15AP30	NA	
ENSG00000238380	RNU7-165P	NA	
ENSG00000286289	AL133482.1	NA	
ENSG00000230018	PPIAP39	NA	
ENSG00000148702	HABP2	188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1;;THROMBOPHILIA DUE TO FACTOR 2 DEFECT;;VENOUS THROMBOSIS;;VENOUS THROMBOEMBOLISM THROMBOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000148702	HABP2	616535	THYROID CANCER, NONMEDULLARY, 5; NMTC5
ENSG00000197893	NRAP	NA	
ENSG00000165806	CASP7	NA	
ENSG00000234393	AL592546.2	NA	
ENSG00000148735	PLEKHS1	NA	
ENSG00000283656	MIR4483	NA	
ENSG00000212589	AL592546.1	NA	
ENSG00000198924	DCLRE1A	NA	
ENSG00000196865	NHLRC2	618278	FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA
ENSG00000287857	AL592546.3	NA	
ENSG00000043591	ADRB1	109630	BETA-1-ADRENERGIC RECEPTOR; ADRB1;;ADRB1R;;B1AR CONGESTIVE HEART FAILURE AND BETA-BLOCKER RESPONSE, MODIFIER OF, INCLUDED
ENSG00000043591	ADRB1	607276	RESTING HEART RATE, VARIATION IN;;RHR
ENSG00000043591	ADRB1	618591	SHORT SLEEP, FAMILIAL NATURAL, 2; FNSS2
ENSG00000285540	AC022023.2	NA	
ENSG00000253066	RNU6-709P	NA	
ENSG00000226582	UBE2V1P5	NA	
ENSG00000165813	CCDC186	NA	
ENSG00000273904	AC022023.1	NA	
ENSG00000284442	MIR2110	NA	
ENSG00000095627	TDRD1	NA	
ENSG00000165816	VWA2	NA	
ENSG00000230165	AURKAP2	NA	
ENSG00000275024	AC005383.1	NA	
ENSG00000169129	AFAP1L2	NA	
ENSG00000242912	RN7SL384P	NA	
ENSG00000279796	AL133384.2	NA	
ENSG00000099204	ABLIM1	NA	
ENSG00000229668	AL133384.1	NA	
ENSG00000228169	PPIAP19	NA	
ENSG00000228484	AL137025.1	NA	
ENSG00000215760	TAF9BP2	NA	
ENSG00000151553	FAM160B1	NA	
ENSG00000226428	RPL15P13	NA	
ENSG00000165832	TRUB1	NA	
ENSG00000252611	RNU6-1121P	NA	
ENSG00000236799	LINC02626	NA	
ENSG00000107518	ATRNL1	NA	
ENSG00000285582	AC016042.1	NA	
ENSG00000270965	NTAN1P1	NA	
ENSG00000151892	GFRA1	NA	
ENSG00000285587	AC012470.1	NA	
ENSG00000182645	CCDC172	NA	
ENSG00000205433	SNRPGP6	NA	
ENSG00000203837	PNLIPRP3	NA	
ENSG00000227096	HMGB3P8	NA	
ENSG00000200935	RNU6-1090P	NA	
ENSG00000175535	PNLIP	614338	PANCREATIC LIPASE DEFICIENCY; PNLIPD;;LIPASE, CONGENITAL ABSENCE OF PANCREATIC;;PL DEFICIENCY PANCREATIC COLIPASE DEFICIENCY, INCLUDED;;COLIPASE, CONGENITAL ABSENCE OF PANCREATIC, INCLUDED;;LIPASE AND COLIPASE, DEFICIENCY OF, INCLUDED;;LIPASE AND CO /.../, CONGENITAL ABSENCE OF PANCREATIC, INCLUDED
ENSG00000232091	PNLIPP1	NA	
ENSG00000187021	PNLIPRP1	NA	
ENSG00000266200	PNLIPRP2	NA	
ENSG00000165863	C10orf82	NA	
ENSG00000232767	AC016825.1	NA	
ENSG00000165868	HSPA12A	NA	
ENSG00000228195	RPL5P27	NA	
ENSG00000188316	ENO4	131375	ENOLASE, SPERM SPECIFIC; ENO4
ENSG00000187164	SHTN1	NA	
ENSG00000287655	AC023283.1	NA	
ENSG00000235742	AC012308.1	NA	
ENSG00000148704	VAX1	614402	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11
ENSG00000234474	MIR3663HG	NA	
ENSG00000266782	MIR3663	NA	
ENSG00000236171	RPL12P26	NA	
ENSG00000186795	KCNK18	613656	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13
ENSG00000225936	AL731557.1	NA	
ENSG00000165646	SLC18A2	618049	PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2
ENSG00000277879	AL391988.1	NA	
ENSG00000165650	PDZD8	NA	
ENSG00000258114	AC005871.2	NA	
ENSG00000229847	EMX2OS	NA	
ENSG00000170370	EMX2	269160	SCHIZENCEPHALY
ENSG00000235198	AC005871.1	NA	
ENSG00000288172	AL356419.1	NA	
ENSG00000234952	LINC02674	NA	
ENSG00000263041	AL513324.1	NA	
ENSG00000107560	RAB11FIP2	NA	
ENSG00000231104	AC022395.1	NA	
ENSG00000177640	CASC2	NA	
ENSG00000238276	AL354863.1	NA	
ENSG00000165669	FAM204A	NA	
ENSG00000232139	LINC00867	NA	
ENSG00000234309	SLC25A18P1	NA	
ENSG00000119973	PRLHR	NA	
ENSG00000225155	TOMM22P5	NA	
ENSG00000151893	CACUL1	NA	
ENSG00000277687	AL139407.1	NA	
ENSG00000229272	AL157388.1	NA	
ENSG00000236058	RPL17P36	NA	
ENSG00000213574	LDHAP5	NA	
ENSG00000188613	NANOS1	615413	SPERMATOGENIC FAILURE 12; SPGF12
ENSG00000107581	EIF3A	NA	
ENSG00000207468	SNORA19	NA	
ENSG00000222588	AL355598.1	NA	
ENSG00000271343	AL355598.2	NA	
ENSG00000119979	DENND10	NA	
ENSG00000183605	SFXN4	615578	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18
ENSG00000165672	PRDX3	NA	
ENSG00000198873	GRK5	NA	
ENSG00000228485	GRK5-IT1	NA	
ENSG00000242853	RN7SL749P	NA	
ENSG00000236426	AL583824.1	NA	
ENSG00000265719	MIR4681	NA	
ENSG00000148908	RGS10	NA	
ENSG00000271353	AC012468.1	NA	
ENSG00000151923	TIAL1	NA	
ENSG00000234569	RAD1P1	NA	
ENSG00000227437	RPS8P4	NA	
ENSG00000151929	BAG3	612954	MYOPATHY, MYOFIBRILLAR, 6; MFM6
ENSG00000151929	BAG3	613881	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH
ENSG00000232823	TXNP1	NA	
ENSG00000198825	INPP5F	NA	
ENSG00000242818	RN7SL846P	NA	
ENSG00000270300	PHACTR2P1	NA	
ENSG00000282413	AL133461.1	NA	
ENSG00000197771	MCMBP	NA	
ENSG00000107651	SEC23IP	NA	
ENSG00000265370	MIR4682	NA	
ENSG00000180230	NACAP2	NA	
ENSG00000223455	AL355298.1	NA	
ENSG00000220842	RPL21P16	NA	
ENSG00000234522	AC073587.1	NA	
ENSG00000203805	PLPP4	NA	
ENSG00000177234	LINC01561	NA	
ENSG00000274461	AC023282.1	NA	
ENSG00000227165	WDR11-AS1	NA	
ENSG00000287936	AL391425.1	NA	
ENSG00000120008	WDR11	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000120008	WDR11	614858	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14
ENSG00000271670	AC010998.2	NA	
ENSG00000227307	AC010998.1	NA	
ENSG00000278484	AC010998.3	NA	
ENSG00000236762	RPL19P16	NA	
ENSG00000227143	LINC01153	NA	
ENSG00000222979	RN7SKP167	NA	
ENSG00000066468	FGFR2	149730	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD;;LADD SYNDROME;;LEVY-HOLLISTER SYNDROME
ENSG00000066468	FGFR2	123790	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS;;BEARE-STEVENSON SYNDROME;;CUTIS GYRATA SYNDROME OF BEARE AND STEVENSON
ENSG00000066468	FGFR2	123500	CROUZON SYNDROME;;CRANIOFACIAL DYSOSTOSIS, TYPE I; CFD1;;CROUZON CRANIOFACIAL DYSOSTOSIS
ENSG00000066468	FGFR2	123150	JACKSON-WEISS SYNDROME; JWS;;CRANIOSYNOSTOSIS, MIDFACIAL HYPOPLASIA, AND FOOT ABNORMALITIES
ENSG00000066468	FGFR2	101600	PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROME CRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED
ENSG00000066468	FGFR2	101400	SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLY SAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND P /.../3, FORMERLY, INCLUDED; BPES3, FORMERLY, INCLUDED
ENSG00000066468	FGFR2	101200	APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS I APERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED
ENSG00000066468	FGFR2	207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2;;TRAPEZOIDOCEPHALY-SYNOSTOSIS SYNDROME;;MULTISYNOSTOTIC OSTEODYSGENESIS WITH LONG BONE FRACTURES;;OSTEODYSGENESIS, MULTISYNOSTOTIC, WITH FRACTURES
ENSG00000066468	FGFR2	609579	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION
ENSG00000066468	FGFR2	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000066468	FGFR2	614592	BENT BONE DYSPLASIA SYNDROME; BBDS
ENSG00000223432	AC009988.1	NA	
ENSG00000223540	RPS15AP5	NA	
ENSG00000224250	AC025947.1	NA	
ENSG00000107669	ATE1	NA	
ENSG00000201884	Y_RNA	NA	
ENSG00000226864	ATE1-AS1	NA	
ENSG00000273767	AL731566.1	NA	
ENSG00000276742	AL731566.3	NA	
ENSG00000107672	NSMCE4A	NA	
ENSG00000273891	AL731566.2	NA	
ENSG00000138162	TACC2	NA	
ENSG00000285715	AC063960.1	NA	
ENSG00000285973	AC063960.2	NA	
ENSG00000138152	BTBD16	NA	
ENSG00000202245	RNU6-728P	NA	
ENSG00000107679	PLEKHA1	NA	
ENSG00000265442	MIR3941	NA	
ENSG00000285955	BX842242.1	NA	
ENSG00000254636	ARMS2	613778	MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8
ENSG00000166033	HTRA1	600142	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL;;MAEDA SYNDROME;;SUBCORTICAL VASCULAR ENCEPHALOPATHY, PROGRESSIVE;;CEREBROVASCULAR DISEASE WITH THIN SKIN, ALOPECIA, AND DISC DISEASE
ENSG00000166033	HTRA1	610149	MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7 MACULAR DEGENERATION, AGE-RELATED, NEOVASCULAR TYPE, SUSCEPTIBILITY TO, INCLUDED;;MACULAR DEGENERATION, AGE-RELATED, WET TYPE, SUSCEPTIBILITY TO, INCLUDED
ENSG00000166033	HTRA1	616779	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2
ENSG00000187908	DMBT1	NA	
ENSG00000286114	AL603764.1	NA	
ENSG00000286135	AL603764.2	NA	
ENSG00000183559	C10orf120	NA	
ENSG00000176584	DMBT1L1	NA	
ENSG00000138161	CUZD1	NA	
ENSG00000286088	AC073585.1	NA	
ENSG00000213185	FAM24B	NA	
ENSG00000255624	C10orf88B	NA	
ENSG00000203795	FAM24A	NA	
ENSG00000119965	C10orf88	NA	
ENSG00000179988	PSTK	NA	
ENSG00000095574	IKZF5	NA	
ENSG00000196177	ACADSB	610006	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY;;2-@METHYLBUTYRYL GLYCINURIA;;SHORT/BRANCHED-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY; SBCADD
ENSG00000188620	HMX3	NA	
ENSG00000188816	HMX2	NA	
ENSG00000154473	BUB3	NA	
ENSG00000227586	RPS26P39	NA	
ENSG00000270902	AL160290.2	NA	
ENSG00000230131	LINC02641	NA	
ENSG00000225152	AL160290.1	NA	
ENSG00000286344	AL357127.2	NA	
ENSG00000234542	AL357127.1	NA	
ENSG00000154478	GPR26	NA	
ENSG00000121898	CPXM2	NA	
ENSG00000231138	AC009987.1	NA	
ENSG00000234677	AC068058.1	NA	
ENSG00000287768	BX469938.1	NA	
ENSG00000213438	YBX2P1	NA	
ENSG00000232334	AL683842.1	NA	
ENSG00000182022	CHST15	NA	
ENSG00000065154	OAT	258870	GYRATE ATROPHY OF CHOROID AND RETINA; GACR;;HYPERORNITHINEMIA WITH GYRATE ATROPHY OF CHOROID AND RETINA; HOGA;;GYRATE ATROPHY;;ORNITHINE AMINOTRANSFERASE DEFICIENCY;;OAT DEFICIENCY;;ORNITHINE KETO ACID AMINOTRANSFERASE DEFICIENCY;;OKT DEFICIENCY;;OR /.../E-DELTA-AMINOTRANSFERASE DEFICIENCY
ENSG00000229544	NKX1-2	NA	
ENSG00000271434	AL445237.1	NA	
ENSG00000107902	LHPP	NA	
ENSG00000229455	RPS10P18	NA	
ENSG00000258539	AC068896.1	NA	
ENSG00000189319	FAM53B	NA	
ENSG00000278831	AL513190.1	NA	
ENSG00000233334	FAM53B-AS1	NA	
ENSG00000203791	EEF1AKMT2	NA	
ENSG00000199466	Y_RNA	NA	
ENSG00000165660	ABRAXAS2	NA	
ENSG00000207494	Y_RNA	NA	
ENSG00000214807	NPM1P31	NA	
ENSG00000249456	AL731577.2	NA	
ENSG00000019995	ZRANB1	NA	
ENSG00000226899	AL731577.1	NA	
ENSG00000175029	CTBP2	NA	
ENSG00000273599	AL731571.1	NA	
ENSG00000264572	MIR4296	NA	
ENSG00000282787	AL157888.1	NA	
ENSG00000214298	MRPS21P6	NA	
ENSG00000233135	RPS27P18	NA	
ENSG00000237675	TEX36-AS1	NA	
ENSG00000175018	TEX36	NA	
ENSG00000214297	ALDOAP2	NA	
ENSG00000228021	AL158835.1	NA	
ENSG00000224023	EDRF1-DT	NA	
ENSG00000280561	AL158835.3	NA	
ENSG00000234134	AL158835.2	NA	
ENSG00000107938	EDRF1	NA	
ENSG00000236991	EDRF1-AS1	NA	
ENSG00000154485	MMP21	616749	HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7
ENSG00000188690	UROS	263700	PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP;;GUNTHER DISEASE;;UROPORPHYRINOGEN III SYNTHASE DEFICIENCY;;UROS DEFICIENCY
ENSG00000265092	MIR4484	NA	
ENSG00000107949	BCCIP	NA	
ENSG00000089876	DHX32	NA	
ENSG00000277371	Metazoa_SRP	NA	
ENSG00000222629	RNU2-42P	NA	
ENSG00000203780	FANK1	NA	
ENSG00000234016	GNG10P1	NA	
ENSG00000233409	FANK1-AS1	NA	
ENSG00000148848	ADAM12	NA	
ENSG00000222740	RNA5SP328	NA	
ENSG00000213170	SAR1AP2	NA	
ENSG00000287609	AL589787.2	NA	
ENSG00000235180	LINC00601	NA	
ENSG00000154493	C10orf90	NA	
ENSG00000287326	AL589787.1	NA	
ENSG00000199321	AL512272.1	NA	
ENSG00000150760	DOCK1	NA	
ENSG00000223528	AL359094.1	NA	
ENSG00000232935	AL359094.2	NA	
ENSG00000188916	INSYN2A	NA	
ENSG00000214285	NPS	NA	
ENSG00000279725	AL391005.1	NA	
ENSG00000186766	FOXI2	NA	
ENSG00000270778	BUB1P1	NA	
ENSG00000180745	CLRN3	NA	
ENSG00000132334	PTPRE	NA	
ENSG00000232259	AL158166.2	NA	
ENSG00000227076	AL158166.1	NA	
ENSG00000287427	AL390236.1	NA	
ENSG00000148773	MKI67	NA	
ENSG00000280953	LINC01163	NA	
ENSG00000234640	AL390763.1	NA	
ENSG00000224190	LINC02667	NA	
ENSG00000232985	AL355537.1	NA	
ENSG00000287361	AL355537.2	NA	
ENSG00000225424	AL391869.1	NA	
ENSG00000285615	AL359508.1	NA	
ENSG00000170430	MGMT	NA	
ENSG00000287466	AL355531.1	NA	
ENSG00000237224	AL157832.2	NA	
ENSG00000227374	AL157832.1	NA	
ENSG00000283141	LINC02666	NA	
ENSG00000108001	EBF3	617330	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS
ENSG00000275327	AL354950.2	NA	
ENSG00000266676	MIR4297	NA	
ENSG00000275005	AL354950.1	NA	
ENSG00000287997	AL354950.3	NA	
ENSG00000237489	C10orf143	NA	
ENSG00000277218	AL139123.1	NA	
ENSG00000233122	CTAGE7P	NA	
ENSG00000233319	PPIAP32	NA	
ENSG00000108010	GLRX3	NA	
ENSG00000236303	LINC02646	NA	
ENSG00000276375	AL157712.1	NA	
ENSG00000222997	Y_RNA	NA	
ENSG00000285529	AC016816.1	NA	
ENSG00000264803	MIR378C	NA	
ENSG00000176769	TCERG1L	NA	
ENSG00000230098	TCERG1L-AS1	NA	
ENSG00000189275	LINC01164	NA	
ENSG00000286295	AL450307.1	NA	
ENSG00000280446	AL607033.1	NA	
ENSG00000283095	FP565171.1	NA	
ENSG00000175470	PPP2R2D	NA	
ENSG00000176171	BNIP3	NA	
ENSG00000277959	AL162274.2	NA	
ENSG00000273521	AL162274.1	NA	
ENSG00000279982	AL162274.3	NA	
ENSG00000188385	JAKMIP3	NA	
ENSG00000235010	AL512622.1	NA	
ENSG00000151640	DPYSL4	NA	
ENSG00000165752	STK32C	NA	
ENSG00000148814	LRRC27	NA	
ENSG00000171813	PWWP2B	NA	
ENSG00000231705	AL451069.2	NA	
ENSG00000234311	AL451069.3	NA	
ENSG00000180066	LINC02870	NA	
ENSG00000226900	AL451069.1	NA	
ENSG00000229081	LINC01165	NA	
ENSG00000068383	INPP5A	NA	
ENSG00000148826	NKX6-2	617560	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8
ENSG00000171811	CFAP46	NA	
ENSG00000232903	LINC01166	NA	
ENSG00000224758	LINC01167	NA	
ENSG00000240707	LINC01168	NA	
ENSG00000197177	ADGRA1	NA	
ENSG00000256925	ADGRA1-AS1	NA	
ENSG00000235264	RPL5P28	NA	
ENSG00000171798	KNDC1	NA	
ENSG00000171794	UTF1	NA	
ENSG00000151650	VENTX	NA	
ENSG00000166917	MIR202HG	NA	
ENSG00000284219	MIR202	NA	
ENSG00000273980	AL592071.1	NA	
ENSG00000151651	ADAM8	NA	
ENSG00000130640	TUBGCP2	618737	PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES; PAMDDFS
ENSG00000235245	AL360181.2	NA	
ENSG00000198546	ZNF511	NA	
ENSG00000283496	ZNF511-PRAP1	NA	
ENSG00000130643	CALY	NA	
ENSG00000230306	BANF1P2	NA	
ENSG00000226699	AL360181.1	NA	
ENSG00000165828	PRAP1	NA	
ENSG00000148803	FUOM	NA	
ENSG00000127884	ECHS1	616277	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D
ENSG00000265395	MIR3944	NA	
ENSG00000274685	AL360181.4	NA	
ENSG00000148832	PAOX	NA	
ENSG00000254536	AL360181.3	NA	
ENSG00000148824	MTG1	NA	
ENSG00000203772	SPRN	NA	
ENSG00000273327	OR6L2P	NA	
ENSG00000214279	SCART1	NA	
ENSG00000273336	OR7M1P	NA	
ENSG00000130649	CYP2E1	NA	
ENSG00000278518	AL161645.1	NA	
ENSG00000286789	AL161645.2	NA	
ENSG00000171772	SYCE1	616947	PREMATURE OVARIAN FAILURE 12; POF12
ENSG00000171772	SYCE1	616950	SPERMATOGENIC FAILURE 15; SPGF15
ENSG00000288107	AL731769.2	NA	
ENSG00000233685	OR6L1P	NA	
ENSG00000287327	AL731769.1	NA	
ENSG00000225899	FRG2B	NA	
ENSG00000213543	RARRES2P2	NA	
ENSG00000233435	AGGF1P2	NA	
ENSG00000230468	CLUHP5	NA	
ENSG00000279626	DUX4L28	NA	
ENSG00000280337	DUX4L25	NA	
ENSG00000274599	DUX4L24	NA	
ENSG00000276964	DUX4L23	NA	
ENSG00000277274	DUX4L22	NA	
ENSG00000275610	DUX4L21	NA	
ENSG00000276164	DUX4L20	NA	
ENSG00000237635	DUX4L29	NA	
ENSG00000278664	DUX4L10	NA	
ENSG00000278761	DUX4L11	NA	
ENSG00000278790	DUX4L12	NA	
ENSG00000276046	DUX4L13	NA	
ENSG00000276904	DUX4L14	NA	
ENSG00000278641	DUX4L15	NA	
ENSG00000213147	RPL23AP60	NA	
ENSG00000282875	BX322534.1	NA	
ENSG00000253826	WBP1LP10	NA	
ENSG00000224777	OR4F2P	NA	
ENSG00000254468	AC069287.1	NA	
ENSG00000270921	CICP23	NA	
ENSG00000230724	LINC01001	NA	
ENSG00000255229	AC069287.3	NA	
ENSG00000222225	RNU6-447P	NA	
ENSG00000177951	BET1L	NA	
ENSG00000188076	SCGB1C1	NA	
ENSG00000177947	ODF3	NA	
ENSG00000254559	AC069287.2	NA	
ENSG00000177963	RIC8A	NA	
ENSG00000283920	MIR6743	NA	
ENSG00000142082	SIRT3	NA	
ENSG00000185627	PSMD13	NA	
ENSG00000277290	AC136475.10	NA	
ENSG00000174885	NLRP6	NA	
ENSG00000255026	AC136475.3	NA	
ENSG00000142102	PGGHG	NA	
ENSG00000206013	IFITM5	610967	OSTEOGENESIS IMPERFECTA, TYPE V; OI5;;OI, TYPE V
ENSG00000255533	AC136475.6	NA	
ENSG00000185201	IFITM2	NA	
ENSG00000254910	AC136475.2	NA	
ENSG00000185885	IFITM1	NA	
ENSG00000251661	AC136475.1	NA	
ENSG00000142089	IFITM3	614680	INFLUENZA, SEVERE, SUSCEPTIBILITY TO
ENSG00000255089	AC136475.4	NA	
ENSG00000270105	AC136475.8	NA	
ENSG00000270030	AC136475.7	NA	
ENSG00000255328	AC136475.5	NA	
ENSG00000270972	AC136475.9	NA	
ENSG00000182272	B4GALNT4	NA	
ENSG00000184363	PKP3	NA	
ENSG00000185187	SIGIRR	NA	
ENSG00000185101	ANO9	NA	
ENSG00000243562	RN7SL838P	NA	
ENSG00000174915	PTDSS2	NA	
ENSG00000255237	AC138230.1	NA	
ENSG00000023191	RNH1	NA	
ENSG00000288033	AC137894.3	NA	
ENSG00000254739	AC137894.1	NA	
ENSG00000174775	HRAS	163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM;;SFM SYNDROME;;LINEAR SEBACEOUS NEVUS SYNDROME;;SEBACEOUS NEVUS SYNDROME, LINEAR;;JADASSOHN NEVUS PHAKOMATOSIS; JNP;;NEVUS SEBACEUS OF JADASSOHN;;ORGANOID NEVUS PHAKOMATOSIS;;EPIDERMAL NEVUS SYNDROME, FORMERLY
ENSG00000174775	HRAS	162900	NEVUS, EPIDERMAL;;NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC  NEVUS SEBACEOUS, INCLUDED;;NEVUS, WOOLLY HAIR, INCLUDED
ENSG00000174775	HRAS	137550	MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS;;GIANT PIGMENTED HAIRY NEVUS; GPHN;;GIANT CONGENITAL PIGMENTED NEVUS;;PIGMENTED MOLES NEVUS SPILUS, INCLUDED;;SPITZ NEVUS, INCLUDED
ENSG00000174775	HRAS	109800	BLADDER CANCER
ENSG00000174775	HRAS	188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2
ENSG00000174775	HRAS	218040	COSTELLO SYNDROME; CSTLO;;FACIOCUTANEOSKELETAL SYNDROME;;FCS SYNDROME  MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES, INCLUDED; CMEMS, INCLUDED
ENSG00000161328	LRRC56	618254	CILIARY DYSKINESIA, PRIMARY, 39; CILD39;;CILIARY DYSKINESIA, PRIMARY, 39, WITH OR WITHOUT SITUS INVERSUS
ENSG00000185522	LMNTD2	NA	
ENSG00000254815	LMNTD2-AS1	NA	
ENSG00000099849	RASSF7	NA	
ENSG00000247095	MIR210HG	NA	
ENSG00000199038	MIR210	NA	
ENSG00000070047	PHRF1	NA	
ENSG00000185507	IRF7	616345	IMMUNODEFICIENCY 39; IMD39
ENSG00000099834	CDHR5	NA	
ENSG00000070031	SCT	NA	
ENSG00000069696	DRD4	143465	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD;;HYPERACTIVITY OF CHILDHOOD
ENSG00000177030	DEAF1	615828	MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24
ENSG00000177030	DEAF1	617171	DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; DYSEIDD
ENSG00000255158	AC131934.1	NA	
ENSG00000177106	EPS8L2	617637	DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106
ENSG00000177042	TMEM80	NA	
ENSG00000269915	AP006621.4	NA	
ENSG00000177156	TALDO1	606003	TRANSALDOLASE DEFICIENCY;;EYAID SYNDROME;;TALDO DEFICIENCY
ENSG00000177225	GATD1	NA	
ENSG00000255284	AP006621.3	NA	
ENSG00000279672	AP006621.5	NA	
ENSG00000255142	AP006621.2	NA	
ENSG00000184524	CEND1	NA	
ENSG00000177542	SLC25A22	609304	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3
ENSG00000177595	PIDD1	NA	
ENSG00000177600	RPLP2	NA	
ENSG00000199785	SNORA52	NA	
ENSG00000177666	PNPLA2	610717	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM;;NEUTRAL LIPID STORAGE DISEASE WITHOUT ICHTHYOSIS
ENSG00000255108	AP006621.1	NA	
ENSG00000177685	CRACR2B	NA	
ENSG00000177697	CD151	179620	RAPH BLOOD GROUP SYSTEM;;MER2 BLOOD CELL ANTIGEN EXPRESSION; MER2
ENSG00000177697	CD151	609057	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS
ENSG00000177700	POLR2L	NA	
ENSG00000214063	TSPAN4	NA	
ENSG00000250397	AP006623.1	NA	
ENSG00000177830	CHID1	NA	
ENSG00000183020	AP2A2	NA	
ENSG00000222561	RNU6-1025P	NA	
ENSG00000184956	MUC6	NA	
ENSG00000254872	LINC02688	NA	
ENSG00000198788	MUC2	NA	
ENSG00000215182	MUC5AC	NA	
ENSG00000286275	AC061979.1	NA	
ENSG00000117983	MUC5B	178500	PULMONARY FIBROSIS, IDIOPATHIC; IPF;;IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL;;FIBROSING ALVEOLITIS, CRYPTOGENIC;;FIBROCYSTIC PULMONARY DYSPLASIA;;INTERSTITIAL PNEUMONITIS, USUAL; UIP HAMMAN-RICH DISEASE, INCLUDED
ENSG00000255177	MUC5B-AS1	NA	
ENSG00000275669	MIR6744	NA	
ENSG00000078902	TOLLIP	NA	
ENSG00000255153	TOLLIP-AS1	NA	
ENSG00000287935	AC136297.1	NA	
ENSG00000285985	LINC02689	NA	
ENSG00000174672	BRSK2	NA	
ENSG00000285581	AC091196.1	NA	
ENSG00000182208	MOB2	NA	
ENSG00000184545	DUSP8	NA	
ENSG00000233930	KRTAP5-AS1	NA	
ENSG00000205869	KRTAP5-1	NA	
ENSG00000205867	KRTAP5-2	NA	
ENSG00000196224	KRTAP5-3	NA	
ENSG00000241598	KRTAP5-4	NA	
ENSG00000185940	KRTAP5-5	NA	
ENSG00000231487	AP006285.1	NA	
ENSG00000205866	FAM99A	NA	
ENSG00000205865	FAM99B	NA	
ENSG00000227306	LINC02708	NA	
ENSG00000205864	KRTAP5-6	NA	
ENSG00000244242	IFITM10	NA	
ENSG00000250644	AC068580.4	NA	
ENSG00000117984	CTSD	610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCY  NEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED
ENSG00000235027	AC068580.3	NA	
ENSG00000229512	AC068580.1	NA	
ENSG00000287484	AC068580.5	NA	
ENSG00000230834	AC068580.2	NA	
ENSG00000230980	RPL36AP39	NA	
ENSG00000230080	AC139143.1	NA	
ENSG00000149043	SYT8	NA	
ENSG00000130598	TNNI2	601680	ARTHROGRYPOSIS, DISTAL, TYPE 2B1; DA2B1;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE 2B;;SHELDON-HALL SYNDROME; SHS;;FREEMAN-SHELDON SYNDROME VARIANT; FSSV;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE II, WITH CRANIOFACIAL ABNORMALITIES
ENSG00000130592	LSP1	NA	
ENSG00000264493	MIR4298	NA	
ENSG00000249086	AC051649.1	NA	
ENSG00000284594	MIR7847	NA	
ENSG00000283787	PRR33	NA	
ENSG00000229671	LINC01150	NA	
ENSG00000130595	TNNT3	618435	ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2
ENSG00000214026	MRPL23	NA	
ENSG00000226416	MRPL23-AS1	NA	
ENSG00000232987	LINC01219	NA	
ENSG00000130600	H19	180860	SILVER-RUSSELL SYNDROME; SRS;;RUSSELL-SILVER SYNDROME; RSS;;SILVER-RUSSELL DWARFISM
ENSG00000130600	H19	130650	BECKWITH-WIEDEMANN SYNDROME; BWS;;EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;;EMG SYNDROME;;WIEDEMANN-BECKWITH SYNDROME; WBS BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
ENSG00000130600	H19	194070	WILMS TUMOR 1; WT1;;NEPHROBLASTOMA
ENSG00000130600	H19	194071	WILMS TUMOR 2; WT2
ENSG00000275266	AC051649.3	NA	
ENSG00000284010	MIR675	NA	
ENSG00000274866	AC051649.2	NA	
ENSG00000284779	AC132217.2	NA	
ENSG00000167244	IGF2	180860	SILVER-RUSSELL SYNDROME; SRS;;RUSSELL-SILVER SYNDROME; RSS;;SILVER-RUSSELL DWARFISM
ENSG00000167244	IGF2	130650	BECKWITH-WIEDEMANN SYNDROME; BWS;;EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;;EMG SYNDROME;;WIEDEMANN-BECKWITH SYNDROME; WBS BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
ENSG00000167244	IGF2	194070	WILMS TUMOR 1; WT1;;NEPHROBLASTOMA
ENSG00000167244	IGF2	616489	GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF
ENSG00000240801	AC132217.1	NA	
ENSG00000129965	INS-IGF2	NA	
ENSG00000207805	MIR483	NA	
ENSG00000099869	IGF2-AS	NA	
ENSG00000254647	INS	125852	DIABETES MELLITUS, INSULIN-DEPENDENT, 2;;INSULIN-DEPENDENT DIABETES MELLITUS 2; IDDM2
ENSG00000254647	INS	606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM;;DIABETES MELLITUS, PERMANENT, OF INFANCY; PDMI DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED;;DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES, INCLUDED; DEND, INCLUDED
ENSG00000254647	INS	613370	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10
ENSG00000254647	INS	616214	HYPERPROINSULINEMIA
ENSG00000180176	TH	605407	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY
ENSG00000265258	MIR4686	NA	
ENSG00000183734	ASCL2	NA	
ENSG00000110665	C11orf21	NA	
ENSG00000064201	TSPAN32	NA	
ENSG00000207308	RNU6-878P	NA	
ENSG00000238184	CD81-AS1	NA	
ENSG00000236264	RPL26P30	NA	
ENSG00000199550	Y_RNA	NA	
ENSG00000110651	CD81	613496	IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6;;ANTIBODY DEFICIENCY DUE TO CD81 DEFECT
ENSG00000184281	TSSC4	NA	
ENSG00000070985	TRPM5	NA	
ENSG00000230483	AC124057.1	NA	
ENSG00000053918	KCNQ1	130650	BECKWITH-WIEDEMANN SYNDROME; BWS;;EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;;EMG SYNDROME;;WIEDEMANN-BECKWITH SYNDROME; WBS BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
ENSG00000053918	KCNQ1	192500	LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVAL LONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO,  /.../ED
ENSG00000053918	KCNQ1	220400	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1;;DEAFNESS, CONGENITAL, AND FUNCTIONAL HEART DISEASE;;PROLONGED QT INTERVAL IN EKG AND SUDDEN DEATH;;CARDIOAUDITORY SYNDROME OF JERVELL AND LANGE-NIELSEN;;SURDO-CARDIAC SYNDROME
ENSG00000053918	KCNQ1	607554	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3
ENSG00000053918	KCNQ1	609621	SHORT QT SYNDROME 2; SQT2
ENSG00000269821	KCNQ1OT1	130650	BECKWITH-WIEDEMANN SYNDROME; BWS;;EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;;EMG SYNDROME;;WIEDEMANN-BECKWITH SYNDROME; WBS BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
ENSG00000275666	AC021424.1	NA	
ENSG00000276105	AC021424.3	NA	
ENSG00000276494	AC021424.4	NA	
ENSG00000276015	AC021424.2	NA	
ENSG00000236041	COX6CP18	NA	
ENSG00000229414	KCNQ1-AS1	NA	
ENSG00000237941	KCNQ1DN	NA	
ENSG00000274740	AC013791.1	NA	
ENSG00000129757	CDKN1C	130650	BECKWITH-WIEDEMANN SYNDROME; BWS;;EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;;EMG SYNDROME;;WIEDEMANN-BECKWITH SYNDROME; WBS BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
ENSG00000129757	CDKN1C	614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE;;IMAGE SYNDROME
ENSG00000254827	SLC22A18AS	NA	
ENSG00000110628	SLC22A18	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000110628	SLC22A18	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000110628	SLC22A18	268210	RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1;;RHABDOMYOSARCOMA 1; RMS1;;RHABDOMYOSARCOMA CHROMOSOMAL REGION; RMSCR
ENSG00000181649	PHLDA2	NA	
ENSG00000205531	NAP1L4	NA	
ENSG00000207008	SNORA54	NA	
ENSG00000183562	AC131971.1	NA	
ENSG00000110619	CARS1	NA	
ENSG00000247473	CARS1-AS1	NA	
ENSG00000201616	RNU1-91P	NA	
ENSG00000285644	AC108448.3	NA	
ENSG00000236710	AC108448.2	NA	
ENSG00000021762	OSBPL5	NA	
ENSG00000234791	AC108448.1	NA	
ENSG00000182170	MRGPRG	NA	
ENSG00000236301	MRGPRG-AS1	NA	
ENSG00000184350	MRGPRE	NA	
ENSG00000224513	AC109309.1	NA	
ENSG00000236987	NDUFA5P8	NA	
ENSG00000276951	AC109309.2	NA	
ENSG00000232390	NDUFA5P1	NA	
ENSG00000273813	AC123788.2	NA	
ENSG00000254592	AC123788.1	NA	
ENSG00000005801	ZNF195	NA	
ENSG00000223756	TSSC2	NA	
ENSG00000189398	OR7E12P	NA	
ENSG00000166492	FAM86GP	NA	
ENSG00000284605	AC127526.3	NA	
ENSG00000254757	AC127526.1	NA	
ENSG00000287906	AC127526.5	NA	
ENSG00000255367	AC127526.2	NA	
ENSG00000287312	AC127526.4	NA	
ENSG00000255522	SNRPCP5	NA	
ENSG00000237226	RPS3AP39	NA	
ENSG00000223688	RPS24P14	NA	
ENSG00000284639	AP006294.2	NA	
ENSG00000230851	AP006294.1	NA	
ENSG00000238161	OR7E117P	NA	
ENSG00000182048	TRPC2	NA	
ENSG00000167311	ART5	NA	
ENSG00000129744	ART1	NA	
ENSG00000201279	Y_RNA	NA	
ENSG00000200201	Y_RNA	NA	
ENSG00000129749	CHRNA10	NA	
ENSG00000110713	NUP98	NA	
ENSG00000251934	RNU6-1143P	NA	
ENSG00000238304	RNU7-50P	NA	
ENSG00000148985	PGAP2	614207	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 17; MRT17;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 21; MRT21;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 8; GPIBD8
ENSG00000177105	RHOG	NA	
ENSG00000228661	AC090587.1	NA	
ENSG00000167323	STIM1	185070	STORMORKEN SYNDROME; STRMK;;THROMBOCYTOPATHY, ASPLENIA, AND MIOSIS;;YORK PLATELET SYNDROME; YPS
ENSG00000167323	STIM1	160565	MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY
ENSG00000167323	STIM1	612783	IMMUNODEFICIENCY 10; IMD10;;IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2;;STIM1 DEFICIENCY
ENSG00000229368	AC090587.2	NA	
ENSG00000284525	MIR4687	NA	
ENSG00000230593	PPIAP40	NA	
ENSG00000206976	AC087441.1	NA	
ENSG00000255232	AC087441.3	NA	
ENSG00000255141	HNRNPA1P76	NA	
ENSG00000224555	AC087441.2	NA	
ENSG00000240385	RPS29P20	NA	
ENSG00000167325	RRM1	NA	
ENSG00000255276	RRM1-AS1	NA	
ENSG00000231548	OR55B1P	NA	
ENSG00000254480	LINC02749	NA	
ENSG00000255387	AC015689.1	NA	
ENSG00000284018	SSU72P5	NA	
ENSG00000284306	SSU72P2	NA	
ENSG00000236175	SSU72P6	NA	
ENSG00000283873	SSU72P4	NA	
ENSG00000284546	SSU72P3	NA	
ENSG00000284438	SSU72P7	NA	
ENSG00000221996	OR52B4	NA	
ENSG00000175800	OR52B3P	NA	
ENSG00000132109	TRIM21	NA	
ENSG00000225101	OR52K3P	NA	
ENSG00000237272	OR51R1P	NA	
ENSG00000171999	OR52P2P	NA	
ENSG00000181963	OR52K2	NA	
ENSG00000196778	OR52K1	NA	
ENSG00000167333	TRIM68	NA	
ENSG00000226616	OR52M2P	NA	
ENSG00000197790	OR52M1	NA	
ENSG00000171987	C11orf40	NA	
ENSG00000226288	OR52I2	NA	
ENSG00000232268	OR52I1	NA	
ENSG00000197428	OR51D1	NA	
ENSG00000180785	OR51E1	NA	
ENSG00000180723	OR51A9P	NA	
ENSG00000167332	OR51E2	NA	
ENSG00000197674	OR51C1P	NA	
ENSG00000167346	MMP26	NA	
ENSG00000272634	OR51F5P	NA	
ENSG00000272664	OR51C4P	NA	
ENSG00000271602	KRT8P49	NA	
ENSG00000272559	OR51F3P	NA	
ENSG00000273051	OR51F4P	NA	
ENSG00000201980	AC103710.1	NA	
ENSG00000280021	OR51F1	NA	
ENSG00000176951	OR51N1P	NA	
ENSG00000231070	OR52Y1P	NA	
ENSG00000279270	OR52R1	NA	
ENSG00000176925	OR51F2	NA	
ENSG00000197984	OR51A8P	NA	
ENSG00000176922	OR51S1	NA	
ENSG00000176904	OR51H1	NA	
ENSG00000198217	OR51H2P	NA	
ENSG00000176900	OR51T1	NA	
ENSG00000197023	OR51A6P	NA	
ENSG00000176895	OR51A7	NA	
ENSG00000176893	OR51G2	NA	
ENSG00000278870	OR51G1	NA	
ENSG00000227023	OR51A3P	NA	
ENSG00000205497	OR51A4	NA	
ENSG00000205496	OR51A2	NA	
ENSG00000225003	OR51A5P	NA	
ENSG00000176798	OR51L1	NA	
ENSG00000224300	OR51P1P	NA	
ENSG00000230261	OR52J2P	NA	
ENSG00000205495	OR52J3	NA	
ENSG00000176787	OR52E2	NA	
ENSG00000273085	OR52E1	NA	
ENSG00000237354	OR52S1P	NA	
ENSG00000226157	OR52E3P	NA	
ENSG00000203560	OR52J1P	NA	
ENSG00000236897	AC113331.1	NA	
ENSG00000205494	OR52A4P	NA	
ENSG00000171944	OR52A5	NA	
ENSG00000182070	OR52A1	NA	
ENSG00000176752	OR51A1P	NA	
ENSG00000176748	OR52Z1	NA	
ENSG00000176742	OR51V1	NA	
ENSG00000224091	AC104389.2	NA	
ENSG00000285498	AC104389.7	NA	
ENSG00000221031	AC104389.1	NA	
ENSG00000244734	HBB	141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1;;HEMOGLOBIN F, HEREDITARY PERSISTENCE OF; HPFH;;HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, HB GENE CLUSTER-RELATED DELTA-BETA THALASSEMIA, INCLUDED
ENSG00000244734	HBB	140700	HEINZ BODY ANEMIAS
ENSG00000244734	HBB	603902	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, IRISH OR WEATHERALL TYPE
ENSG00000244734	HBB	603903	SICKLE CELL ANEMIA
ENSG00000244734	HBB	604131	ALPHA-THALASSEMIA
ENSG00000244734	HBB	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000244734	HBB	613985	BETA-THALASSEMIA
ENSG00000244734	HBB	617971	METHEMOGLOBINEMIA, BETA TYPE
ENSG00000244734	HBB	617980	ERYTHROCYTOSIS, FAMILIAL, 6; ECYT6;;ERYTHROCYTOSIS, BETA-GLOBIN TYPE;;POLYCYTHEMIA, BETA-GLOBIN TYPE
ENSG00000223609	HBD	NA	
ENSG00000229988	HBBP1	NA	
ENSG00000260629	BGLT3	NA	
ENSG00000213934	HBG1	141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1;;HEMOGLOBIN F, HEREDITARY PERSISTENCE OF; HPFH;;HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, HB GENE CLUSTER-RELATED DELTA-BETA THALASSEMIA, INCLUDED
ENSG00000284931	AC104389.6	NA	
ENSG00000196565	HBG2	141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1;;HEMOGLOBIN F, HEREDITARY PERSISTENCE OF; HPFH;;HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, HB GENE CLUSTER-RELATED DELTA-BETA THALASSEMIA, INCLUDED
ENSG00000196565	HBG2	613977	CYANOSIS, TRANSIENT NEONATAL; TNCY
ENSG00000239920	AC104389.5	NA	
ENSG00000213931	HBE1	NA	
ENSG00000229093	OR51AB1P	NA	
ENSG00000183251	OR51B4	NA	
ENSG00000167355	OR51B5	NA	
ENSG00000223735	OR51B3P	NA	
ENSG00000279012	OR51B2	NA	
ENSG00000236359	OR51B8P	NA	
ENSG00000176239	OR51B6	NA	
ENSG00000230087	AC104389.3	NA	
ENSG00000236248	AC104389.4	NA	
ENSG00000184698	OR51M1	NA	
ENSG00000184321	OR51J1	NA	
ENSG00000167360	OR51Q1	NA	
ENSG00000248424	OR51K1P	NA	
ENSG00000167359	OR51I1	NA	
ENSG00000187918	OR51I2	NA	
ENSG00000230484	OR51A10P	NA	
ENSG00000181609	OR52D1	NA	
ENSG00000175520	UBQLN3	NA	
ENSG00000175518	UBQLNL	NA	
ENSG00000224295	OLFM5P	NA	
ENSG00000249633	OR52V1P	NA	
ENSG00000181616	OR52H1	NA	
ENSG00000248553	OR52H2P	NA	
ENSG00000231049	OR52B5P	NA	
ENSG00000233646	OR52T1P	NA	
ENSG00000229534	HNRNPA1P53	NA	
ENSG00000187747	OR52B6	NA	
ENSG00000121236	TRIM6	NA	
ENSG00000258588	TRIM6-TRIM34	NA	
ENSG00000258659	TRIM34	NA	
ENSG00000132256	TRIM5	NA	
ENSG00000132274	TRIM22	NA	
ENSG00000232381	OR52U1P	NA	
ENSG00000181109	OR52P1P	NA	
ENSG00000181023	OR56B1	NA	
ENSG00000181074	OR52N4	NA	
ENSG00000181017	OR56B2P	NA	
ENSG00000181009	OR52N5	NA	
ENSG00000181001	OR52N1	NA	
ENSG00000236965	OR52N3P	NA	
ENSG00000180988	OR52N2	NA	
ENSG00000205409	OR52E6	NA	
ENSG00000183269	OR52E8	NA	
ENSG00000233563	OR52E7P	NA	
ENSG00000180974	OR52E4	NA	
ENSG00000277932	OR52E5	NA	
ENSG00000277514	OR52Q1P	NA	
ENSG00000184478	OR56A3	NA	
ENSG00000188691	OR56A5	NA	
ENSG00000183313	OR52L1	NA	
ENSG00000254831	KRT18P58	NA	
ENSG00000183389	OR56A4	NA	
ENSG00000202147	RNA5SP329	NA	
ENSG00000180934	OR56A1	NA	
ENSG00000255481	OR56A7P	NA	
ENSG00000262980	OR52L2P	NA	
ENSG00000234895	OR52X1P	NA	
ENSG00000180919	OR56B4	NA	
ENSG00000254444	AC022762.1	NA	
ENSG00000180913	OR56B3P	NA	
ENSG00000180909	OR52B1P	NA	
ENSG00000255307	OR52B2	NA	
ENSG00000175485	OR52W1	NA	
ENSG00000267940	AC022762.2	NA	
ENSG00000180878	C11orf42	NA	
ENSG00000051009	FAM160A2	NA	
ENSG00000132259	CNGA4	NA	
ENSG00000110148	CCKBR	NA	
ENSG00000270435	AC068733.2	NA	
ENSG00000170955	CAVIN3	NA	
ENSG00000282556	AC068733.3	NA	
ENSG00000254443	AC068733.1	NA	
ENSG00000166311	SMPD1	257200	NIEMANN-PICK DISEASE, TYPE A;;SPHINGOMYELIN LIPIDOSIS;;SPHINGOMYELINASE DEFICIENCY NIEMANN-PICK DISEASE, INTERMEDIATE, PROTRACTED NEUROVISCERAL, INCLUDED
ENSG00000166311	SMPD1	607616	NIEMANN-PICK DISEASE, TYPE B NIEMANN-PICK DISEASE, TYPE E, INCLUDED;;NIEMANN-PICK DISEASE, TYPE F, INCLUDED;;NIEMANN-PICK DISEASE, INTERMEDIATE, WITH VISCERAL INVOLVEMENT AND RAPID PROGRESSION, INCLUDED
ENSG00000166313	APBB1	NA	
ENSG00000110169	HPX	NA	
ENSG00000110171	TRIM3	NA	
ENSG00000132254	ARFIP2	NA	
ENSG00000283977	AC084337.2	NA	
ENSG00000132286	TIMM10B	NA	
ENSG00000254595	AC084337.1	NA	
ENSG00000179532	DNHD1	NA	
ENSG00000132275	RRP8	NA	
ENSG00000254400	AC091564.2	NA	
ENSG00000166333	ILK	NA	
ENSG00000166337	TAF10	NA	
ENSG00000254641	AC091564.3	NA	
ENSG00000285338	AC091564.7	NA	
ENSG00000166340	TPP1	204500	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2;;CEROID LIPOFUSCINOSIS, NEURONAL, 2, VARIABLE AGE AT ONSET;;JANSKY-BIELSCHOWSKY DISEASE NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, INCLUDED; LINCL, INCLUDED
ENSG00000166340	TPP1	609270	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7
ENSG00000255680	AC091564.6	NA	
ENSG00000166341	DCHS1	601390	VAN MALDERGEM SYNDROME 1; VMLDS1;;CEREBROFACIOARTICULAR SYNDROME
ENSG00000166341	DCHS1	607829	MITRAL VALVE PROLAPSE 2; MVP2;;MITRAL VALVE PROLAPSE, MYXOMATOUS 2; MMVP2;;MYXOMATOUS MITRAL VALVE PROLAPSE 2
ENSG00000255390	AC091564.4	NA	
ENSG00000255410	AC091564.5	NA	
ENSG00000158042	MRPL17	NA	
ENSG00000241678	AC091564.1	NA	
ENSG00000254838	GVINP1	NA	
ENSG00000254781	GVINP2	NA	
ENSG00000188124	OR2AG2	NA	
ENSG00000279486	OR2AG1	NA	
ENSG00000184933	OR6A2	NA	
ENSG00000283415	AC087280.2	NA	
ENSG00000254712	AC087280.1	NA	
ENSG00000166363	OR10A5	NA	
ENSG00000170790	OR10A2	NA	
ENSG00000170782	OR10A4	NA	
ENSG00000166368	OR2D2	NA	
ENSG00000178358	OR2D3	NA	
ENSG00000149054	ZNF215	NA	
ENSG00000149050	ZNF214	NA	
ENSG00000158077	NLRP14	NA	
ENSG00000170748	RBMXL2	NA	
ENSG00000255179	AC027804.1	NA	
ENSG00000221703	MIR302E	NA	
ENSG00000170743	SYT9	NA	
ENSG00000251364	AC107884.1	NA	
ENSG00000183801	OLFML1	NA	
ENSG00000166387	PPFIBP2	NA	
ENSG00000254864	AC107884.2	NA	
ENSG00000166394	CYB5R2	NA	
ENSG00000183378	OVCH2	NA	
ENSG00000275612	AC104237.2	NA	
ENSG00000276668	AC104237.3	NA	
ENSG00000271758	AC044810.3	NA	
ENSG00000254707	AC104237.1	NA	
ENSG00000176716	OR10AB1P	NA	
ENSG00000227892	OR5P4P	NA	
ENSG00000254951	AC044810.2	NA	
ENSG00000166408	OR5P1P	NA	
ENSG00000241008	AC044810.1	NA	
ENSG00000183303	OR5P2	NA	
ENSG00000182334	OR5P3	NA	
ENSG00000170688	OR5E1P	NA	
ENSG00000252769	RNU6-943P	NA	
ENSG00000279000	OR10A6	NA	
ENSG00000170683	OR10A3	NA	
ENSG00000182261	NLRP10	NA	
ENSG00000175390	EIF3F	618295	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 67
ENSG00000254642	COX6CP5	NA	
ENSG00000255420	CASC23	NA	
ENSG00000166402	TUB	616188	RETINAL DYSTROPHY AND OBESITY; RDOB
ENSG00000254921	AC116456.1	NA	
ENSG00000248332	TUB-AS1	NA	
ENSG00000279391	AC116456.2	NA	
ENSG00000166405	RIC3	NA	
ENSG00000246820	RIC3-DT	NA	
ENSG00000166407	LMO1	NA	
ENSG00000130413	STK33	NA	
ENSG00000252778	AP006442.1	NA	
ENSG00000166436	TRIM66	NA	
ENSG00000254900	AC091053.2	NA	
ENSG00000166441	RPL27A	NA	
ENSG00000200983	SNORA3A	NA	
ENSG00000212607	SNORA3B	NA	
ENSG00000166444	DENND2B	NA	
ENSG00000254665	AC091053.1	NA	
ENSG00000255159	AC026894.1	NA	
ENSG00000252905	RNA5SP330	NA	
ENSG00000202276	Y_RNA	NA	
ENSG00000166452	AKIP1	NA	
ENSG00000176029	C11orf16	NA	
ENSG00000176009	ASCL3	NA	
ENSG00000223080	Y_RNA	NA	
ENSG00000175348	TMEM9B	NA	
ENSG00000254860	TMEM9B-AS1	NA	
ENSG00000175352	NRIP3	NA	
ENSG00000253973	AC079296.1	NA	
ENSG00000175356	SCUBE2	NA	
ENSG00000286935	AC079296.2	NA	
ENSG00000264984	MIR5691	NA	
ENSG00000213538	KRT8P41	NA	
ENSG00000184014	DENND5A	617281	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49
ENSG00000255097	AP006259.1	NA	
ENSG00000273725	Metazoa_SRP	NA	
ENSG00000166471	TMEM41B	NA	
ENSG00000254884	PRR13P2	NA	
ENSG00000205339	IPO7	NA	
ENSG00000201998	SNORA23	NA	
ENSG00000254397	AC132192.1	NA	
ENSG00000268403	AC132192.2	NA	
ENSG00000166478	ZNF143	NA	
ENSG00000166483	WEE1	NA	
ENSG00000238387	AC122179.1	NA	
ENSG00000243964	RPL23AP65	NA	
ENSG00000255463	AC011979.2	NA	
ENSG00000239470	AC011979.1	NA	
ENSG00000133789	SWAP70	NA	
ENSG00000201564	RN7SKP50	NA	
ENSG00000245522	LINC02709	NA	
ENSG00000246273	SBF2-AS1	NA	
ENSG00000133812	SBF2	604563	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2;;CHARCOT-MARIE-TOOTH DISEASE, WITH FOCALLY FOLDED MYELIN SHEATHS, AUTOSOMAL RECESSIVE, TYPE 4B2;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4B2  CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2, WITH EARLY-ONSET GLAUCOMA /.../UDED;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4B2, WITH EARLY-ONSET GLAUCOMA, INCLUDED
ENSG00000255476	AC011092.2	NA	
ENSG00000252568	RNU7-28P	NA	
ENSG00000254765	AC011092.1	NA	
ENSG00000286561	AC011092.3	NA	
ENSG00000254865	AC100763.1	NA	
ENSG00000254719	AC080023.2	NA	
ENSG00000254554	AC080023.1	NA	
ENSG00000148926	ADM	NA	
ENSG00000133805	AMPD3	612874	ERYTHROCYTE AMP DEAMINASE DEFICIENCY
ENSG00000221574	RNU6ATAC33P	NA	
ENSG00000255823	MTRNR2L8	NA	
ENSG00000283813	MIR4485	NA	
ENSG00000110315	RNF141	NA	
ENSG00000177112	IRAG1-AS1	NA	
ENSG00000133800	LYVE1	NA	
ENSG00000072952	IRAG1	NA	
ENSG00000206858	Y_RNA	NA	
ENSG00000198730	CTR9	NA	
ENSG00000110321	EIF4G2	NA	
ENSG00000238622	SNORD97	NA	
ENSG00000246308	AC116535.1	NA	
ENSG00000236287	ZBED5	NA	
ENSG00000247271	ZBED5-AS1	NA	
ENSG00000250041	AC069360.1	NA	
ENSG00000254401	LINC02752	NA	
ENSG00000254957	AC111188.1	NA	
ENSG00000270897	AC111188.2	NA	
ENSG00000255123	MTND5P21	NA	
ENSG00000255260	KC877392.1	NA	
ENSG00000110328	GALNT18	NA	
ENSG00000254598	CSNK2A3	NA	
ENSG00000255351	AC023946.1	NA	
ENSG00000255462	AC104031.1	NA	
ENSG00000266645	MIR4299	NA	
ENSG00000280288	AC131935.2	NA	
ENSG00000255309	AC131935.1	NA	
ENSG00000286959	AC104383.1	NA	
ENSG00000278529	MIR8070	NA	
ENSG00000170242	USP47	NA	
ENSG00000255492	H3P33	NA	
ENSG00000050165	DKK3	NA	
ENSG00000254486	LINC02547	NA	
ENSG00000254991	AC124276.1	NA	
ENSG00000255400	AC124276.2	NA	
ENSG00000133816	MICAL2	NA	
ENSG00000275373	MIR6124	NA	
ENSG00000254680	AC079329.1	NA	
ENSG00000254983	AC025300.1	NA	
ENSG00000197702	PARVA	NA	
ENSG00000254847	AC009806.1	NA	
ENSG00000286521	AC107881.1	NA	
ENSG00000187079	TEAD1	108985	SVEINSSON CHORIORETINAL ATROPHY; SCRA;;ATROPHIA AREATA; AA;;PERIPAPILLARY CHORIORETINAL DEGENERATION, ICELANDIC TYPE;;HELICOIDAL PERIPAPILLARY CHORIORETINAL DEGENERATION; HPCD
ENSG00000254688	AC013549.3	NA	
ENSG00000255067	AC013549.4	NA	
ENSG00000252329	AC013549.2	NA	
ENSG00000203258	AC013549.1	NA	
ENSG00000251381	LINC00958	NA	
ENSG00000254670	RASSF10-DT	NA	
ENSG00000189431	RASSF10	NA	
ENSG00000255558	AC013762.1	NA	
ENSG00000255018	AC022878.1	NA	
ENSG00000133794	ARNTL	NA	
ENSG00000222162	RN7SKP151	NA	
ENSG00000148925	BTBD10	NA	
ENSG00000287548	AC021269.3	NA	
ENSG00000254583	AC021269.1	NA	
ENSG00000255401	AC021269.2	NA	
ENSG00000152266	PTH	146200	HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH;;HYPOPARATHYROIDISM, AUTOSOMAL DOMINANT HYPOPARATHYROIDISM, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000228901	HMGN2P36	NA	
ENSG00000197601	FAR1	616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD
ENSG00000254791	FAR1-IT1	NA	
ENSG00000240454	RPL39P26	NA	
ENSG00000200685	Y_RNA	NA	
ENSG00000255075	CENPUP1	NA	
ENSG00000255088	AC013828.1	NA	
ENSG00000255411	LINC02548	NA	
ENSG00000254927	AC027779.1	NA	
ENSG00000254930	LINC02545	NA	
ENSG00000201856	RNA5SP331	NA	
ENSG00000254438	LINC02683	NA	
ENSG00000262655	SPON1	NA	
ENSG00000212365	RNA5SP332	NA	
ENSG00000254418	SPON1-AS1	NA	
ENSG00000133818	RRAS2	618624	NOONAN SYNDROME 12; NS12
ENSG00000255074	AC018523.1	NA	
ENSG00000129083	COPB1	NA	
ENSG00000251991	RNU7-49P	NA	
ENSG00000256206	AC018523.2	NA	
ENSG00000129084	PSMA1	NA	
ENSG00000152270	PDE3B	NA	
ENSG00000255040	MORF4L1P3	NA	
ENSG00000186104	CYP2R1	600081	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B;;VITAMIN D-DEPENDENT RICKETS, TYPE 1B;;25-@HYDROXYVITAMIN D3 DEFICIENCY, SELECTIVE;;PSEUDOVITAMIN D3 DEFICIENCY RICKETS DUE TO 25-HYDROXYLASE DEFICIENCY
ENSG00000175868	CALCB	NA	
ENSG00000253179	CALCP	NA	
ENSG00000110680	CALCA	NA	
ENSG00000250640	OR7E41P	NA	
ENSG00000188487	INSC	NA	
ENSG00000253072	AC104361.1	NA	
ENSG00000254946	LINC02751	NA	
ENSG00000254789	AC073172.1	NA	
ENSG00000254695	AC087379.2	NA	
ENSG00000254645	AC087379.1	NA	
ENSG00000286960	AC009869.1	NA	
ENSG00000254661	LINC02682	NA	
ENSG00000110693	SOX6	NA	
ENSG00000284094	MIR6073	NA	
ENSG00000254878	AC103794.1	NA	
ENSG00000213785	AKR1B1P3	NA	
ENSG00000241943	RN7SL188P	NA	
ENSG00000110696	C11orf58	NA	
ENSG00000166689	PLEKHA7	NA	
ENSG00000199883	RN7SKP90	NA	
ENSG00000244398	AC116533.1	NA	
ENSG00000184669	OR7E14P	NA	
ENSG00000110700	RPS13	NA	
ENSG00000272034	SNORD14A	NA	
ENSG00000201403	SNORD14B	NA	
ENSG00000011405	PIK3C2A	618440	OCULOSKELETODENTAL SYNDROME; OCSKD;;CATARACTS, EARLY-ONSET, WITH SKELETAL AND DENTAL ANOMALIES
ENSG00000201586	RNU6-593P	NA	
ENSG00000240808	AC126389.1	NA	
ENSG00000213779	AC107956.2	NA	
ENSG00000070081	NUCB2	NA	
ENSG00000197149	AC107956.1	NA	
ENSG00000285545	AC124798.2	NA	
ENSG00000188211	NCR3LG1	NA	
ENSG00000260196	AC124798.1	NA	
ENSG00000187486	KCNJ11	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000187486	KCNJ11	601820	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPERINSULINEMIC HYPOGLYCEMIA, PERSISTENT;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;HYPERINSULINISM, NEONATAL;;HY /.../ULINISM, CONGENITAL;;HYPERINSULINISM, FAMILIAL;;NESIDIOBLASTOSIS
ENSG00000187486	KCNJ11	606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM;;DIABETES MELLITUS, PERMANENT, OF INFANCY; PDMI DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED;;DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES, INCLUDED; DEND, INCLUDED
ENSG00000187486	KCNJ11	610582	DIABETES MELLITUS, TRANSIENT NEONATAL, 3;;TNDM3 DIABETES MELLITUS, TYPE II, AUTOSOMAL DOMINANT, INCLUDED
ENSG00000187486	KCNJ11	616329	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13;;MODY, TYPE 13
ENSG00000006071	ABCC8	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000006071	ABCC8	240800	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH;;LEUCINE-SENSITIVE HYPOGLYCEMIA OF INFANCY
ENSG00000006071	ABCC8	256450	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS /.../RINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL
ENSG00000006071	ABCC8	606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM;;DIABETES MELLITUS, PERMANENT, OF INFANCY; PDMI DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED;;DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES, INCLUDED; DEND, INCLUDED
ENSG00000006071	ABCC8	610374	DIABETES MELLITUS, TRANSIENT NEONATAL, 2;;TNDM2
ENSG00000255035	SDHCP4	NA	
ENSG00000287898	AC124798.3	NA	
ENSG00000006611	USH1C	276900	USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESS USHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORME /.../NCLUDED
ENSG00000006611	USH1C	276904	USHER SYNDROME, TYPE IC; USH1C;;USHER SYNDROME, TYPE I, ACADIAN VARIETY
ENSG00000006611	USH1C	602092	DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A;;DEAFNESS, AUTOSOMAL RECESSIVE 18; DFNB18
ENSG00000188162	OTOG	614945	DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B
ENSG00000254586	AC124301.1	NA	
ENSG00000255335	LINC02729	NA	
ENSG00000129152	MYOD1	NA	
ENSG00000129159	KCNC1	616187	EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7
ENSG00000129158	SERGEF	NA	
ENSG00000255448	AC055860.1	NA	
ENSG00000129167	TPH1	NA	
ENSG00000166788	SAAL1	NA	
ENSG00000255254	HIGD1AP5	NA	
ENSG00000166787	SAA3P	NA	
ENSG00000179826	MRGPRX3	NA	
ENSG00000255470	AC090099.1	NA	
ENSG00000285562	AC090099.2	NA	
ENSG00000254857	MRGPRX12P	NA	
ENSG00000179817	MRGPRX4	NA	
ENSG00000255138	GLTPP1	NA	
ENSG00000254546	MRGPRX13P	NA	
ENSG00000189332	SLC25A51P4	NA	
ENSG00000148965	SAA4	NA	
ENSG00000255071	SAA2-SAA4	NA	
ENSG00000134339	SAA2	NA	
ENSG00000200336	RNA5SP333	NA	
ENSG00000212789	ST13P5	NA	
ENSG00000173432	SAA1	NA	
ENSG00000201695	RNA5SP334	NA	
ENSG00000110756	HPS5	614074	HERMANSKY-PUDLAK SYNDROME 5; HPS5
ENSG00000110768	GTF2H1	NA	
ENSG00000264603	MIR3159	NA	
ENSG00000134333	LDHA	612933	GLYCOGEN STORAGE DISEASE XI; GSD11;;GSD XI;;LACTATE DEHYDROGENASE A DEFICIENCY
ENSG00000256006	AC084117.1	NA	
ENSG00000166796	LDHC	NA	
ENSG00000256734	AC027544.3	NA	
ENSG00000166800	LDHAL6A	NA	
ENSG00000074319	TSG101	NA	
ENSG00000256464	YWHABP2	NA	
ENSG00000256588	AC027544.2	NA	
ENSG00000256361	AC027544.1	NA	
ENSG00000151116	UEVLD	NA	
ENSG00000274589	Metazoa_SRP	NA	
ENSG00000247595	SPTY2D1OS	NA	
ENSG00000256282	AC112694.1	NA	
ENSG00000279837	AC112694.2	NA	
ENSG00000179119	SPTY2D1	NA	
ENSG00000257043	SRSF3P1	NA	
ENSG00000151117	TMEM86A	NA	
ENSG00000179057	IGSF22	NA	
ENSG00000254966	AC103974.1	NA	
ENSG00000110786	PTPN5	NA	
ENSG00000286998	AC103974.2	NA	
ENSG00000276789	MRGPRX8P	NA	
ENSG00000254529	MRGPRX7P	NA	
ENSG00000255511	AC023078.2	NA	
ENSG00000254541	MRGPRX6P	NA	
ENSG00000255536	MRGPRX5P	NA	
ENSG00000170255	MRGPRX1	NA	
ENSG00000255244	AC023078.1	NA	
ENSG00000254738	MRGPRX11P	NA	
ENSG00000254720	MRGPRX10P	NA	
ENSG00000255424	MRGPRX9P	NA	
ENSG00000183695	MRGPRX2	NA	
ENSG00000177054	ZDHHC13	NA	
ENSG00000129170	CSRP3	607482	CARDIOMYOPATHY, DILATED, 1M; CMD1M
ENSG00000129170	CSRP3	612124	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12
ENSG00000255308	CSRP3-AS1	NA	
ENSG00000129173	E2F8	NA	
ENSG00000254544	PCNAP4	NA	
ENSG00000255160	AC009652.1	NA	
ENSG00000166833	NAV2	NA	
ENSG00000255270	NAV2-IT1	NA	
ENSG00000200687	RNA5SP335	NA	
ENSG00000255043	NAV2-AS5	NA	
ENSG00000254622	NAV2-AS4	NA	
ENSG00000265210	MIR4486	NA	
ENSG00000207407	AC023950.1	NA	
ENSG00000270607	AC009549.1	NA	
ENSG00000264309	MIR4694	NA	
ENSG00000254542	NAV2-AS3	NA	
ENSG00000254453	NAV2-AS2	NA	
ENSG00000254894	NAV2-AS1	NA	
ENSG00000279266	AC068860.1	NA	
ENSG00000109851	DBX1	NA	
ENSG00000109854	HTATIP2	NA	
ENSG00000185238	PRMT3	NA	
ENSG00000255291	HMGB1P40	NA	
ENSG00000286382	AC090707.2	NA	
ENSG00000165970	SLC6A5	614618	HYPEREKPLEXIA 3; HKPX3
ENSG00000165973	NELL1	NA	
ENSG00000254906	AC090707.1	NA	
ENSG00000201059	RNA5SP336	NA	
ENSG00000254816	AC090857.1	NA	
ENSG00000255167	AC090857.2	NA	
ENSG00000225477	AC099730.1	NA	
ENSG00000252816	RNA5SP337	NA	
ENSG00000287753	AC130307.1	NA	
ENSG00000171714	ANO5	166260	GNATHODIAPHYSEAL DYSPLASIA; GDD;;OSTEOGENESIS IMPERFECTA WITH UNUSUAL SKELETAL LESIONS;;GNATHODIAPHYSEAL SCLEROSIS
ENSG00000171714	ANO5	611307	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L
ENSG00000171714	ANO5	613319	MIYOSHI MUSCULAR DYSTROPHY 3; MMD3;;MIYOSHI MYOPATHY 3
ENSG00000287962	AC116534.1	NA	
ENSG00000254820	AC107882.1	NA	
ENSG00000255372	AC107886.1	NA	
ENSG00000254768	AC104009.1	NA	
ENSG00000091664	SLC17A6	NA	
ENSG00000254540	AC040936.1	NA	
ENSG00000255323	LINC01495	NA	
ENSG00000255357	AC055878.1	NA	
ENSG00000183161	FANCF	603467	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF
ENSG00000148935	GAS2	NA	
ENSG00000222427	RNA5SP338	NA	
ENSG00000198168	SVIP	NA	
ENSG00000246225	AC006299.1	NA	
ENSG00000255359	CCDC179	NA	
ENSG00000255418	LINC02718	NA	
ENSG00000271491	AC100767.2	NA	
ENSG00000255293	WIZP1	NA	
ENSG00000275868	MIR8054	NA	
ENSG00000254564	AC100767.1	NA	
ENSG00000254465	THAP12P4	NA	
ENSG00000240881	AC068472.1	NA	
ENSG00000255193	LINC02726	NA	
ENSG00000254861	AC100768.1	NA	
ENSG00000252519	RNU6-783P	NA	
ENSG00000277803	AC099842.1	NA	
ENSG00000254594	LINC02686	NA	
ENSG00000207252	Y_RNA	NA	
ENSG00000187398	LUZP2	NA	
ENSG00000255489	AC115990.1	NA	
ENSG00000255368	AC087373.1	NA	
ENSG00000240298	RPL36AP40	NA	
ENSG00000255454	AC100770.1	NA	
ENSG00000254456	LINC02699	NA	
ENSG00000254754	AC013799.1	NA	
ENSG00000255086	AC024341.1	NA	
ENSG00000134343	ANO3	615034	DYSTONIA 24; DYT24
ENSG00000287227	AC021698.1	NA	
ENSG00000254819	ANO3-AS1	NA	
ENSG00000255505	AC079064.1	NA	
ENSG00000169550	MUC15	NA	
ENSG00000148942	SLC5A12	NA	
ENSG00000176971	FIBIN	NA	
ENSG00000129151	BBOX1	NA	
ENSG00000254560	BBOX1-AS1	NA	
ENSG00000109881	CCDC34	NA	
ENSG00000205213	LGR4	615311	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17;;BONE MINERAL DENSITY, LOW, SUSCEPTIBILITY TO
ENSG00000254862	LGR4-AS1	NA	
ENSG00000242527	AC100771.1	NA	
ENSG00000148943	LIN7C	NA	
ENSG00000245573	BDNF-AS	NA	
ENSG00000278483	MIR8087	NA	
ENSG00000212289	RNA5SP339	NA	
ENSG00000240036	AC104563.1	NA	
ENSG00000254934	LINC00678	NA	
ENSG00000176697	BDNF	NA	
ENSG00000255496	AC103796.1	NA	
ENSG00000177447	CBX3P1	NA	
ENSG00000224411	HSP90AA2P	NA	
ENSG00000255094	AC090159.1	NA	
ENSG00000121621	KIF18A	NA	
ENSG00000207874	MIR610	NA	
ENSG00000169519	METTL15	NA	
ENSG00000271332	AC023206.1	NA	
ENSG00000222385	RN7SKP158	NA	
ENSG00000238149	AC104978.1	NA	
ENSG00000273912	MIR8068	NA	
ENSG00000254606	AC013714.1	NA	
ENSG00000248990	LINC02758	NA	
ENSG00000249867	LINC02742	NA	
ENSG00000272882	OR2BH1P	NA	
ENSG00000254526	AC090791.1	NA	
ENSG00000255450	AC110056.1	NA	
ENSG00000254530	LINC02755	NA	
ENSG00000255281	AC090124.2	NA	
ENSG00000255227	AC090124.1	NA	
ENSG00000255029	AC110058.1	NA	
ENSG00000255117	LINC02546	NA	
ENSG00000255047	HNRNPRP2	NA	
ENSG00000254734	AC107973.1	NA	
ENSG00000243505	RN7SL240P	NA	
ENSG00000240554	RPL7AP58	NA	
ENSG00000261340	LINC01616	NA	
ENSG00000182255	KCNA4	618284	MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS
ENSG00000254532	AL358944.1	NA	
ENSG00000255288	AL358944.2	NA	
ENSG00000131808	FSHB	229070	HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24;;FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED
ENSG00000152219	ARL14EP	NA	
ENSG00000242353	RPL12P30	NA	
ENSG00000066382	MPPED2	NA	
ENSG00000255480	AL353699.1	NA	
ENSG00000254489	MPPED2-AS1	NA	
ENSG00000287373	AL122014.1	NA	
ENSG00000170959	DCDC1	NA	
ENSG00000255370	CYCSP25	NA	
ENSG00000255525	AL137804.1	NA	
ENSG00000170946	DNAJC24	NA	
ENSG00000148950	IMMP1L	NA	
ENSG00000109911	ELP4	617141	ANIRIDIA 2; AN2
ENSG00000228061	AC131571.1	NA	
ENSG00000007372	PAX6	165550	OPTIC NERVE HYPOPLASIA, BILATERAL OPTIC NERVE APLASIA, BILATERAL, INCLUDED
ENSG00000007372	PAX6	148190	KERATITIS, HEREDITARY
ENSG00000007372	PAX6	136520	FOVEAL HYPOPLASIA 1; FVH1;;FOVEAL HYPOPLASIA 1 WITH OR WITHOUT ANTERIOR SEGMENT ANOMALIES AND/OR CATARACT
ENSG00000007372	PAX6	120430	COLOBOMA OF OPTIC NERVE OPTIC NERVE HEAD PITS, BILATERAL CONGENITAL, INCLUDED;;MORNING GLORY DISC ANOMALY, INCLUDED
ENSG00000007372	PAX6	120200	COLOBOMA, OCULAR, AUTOSOMAL DOMINANT;;COLOBOMA, UVEORETINAL;;COLOBOMA OF IRIS, CHOROID, AND RETINA; COI
ENSG00000007372	PAX6	106210	ANIRIDIA 1; AN1;;AN;;ANIRIDIA II, FORMERLY; AN2, FORMERLY CATARACT, CONGENITAL, WITH LATE-ONSET CORNEAL DYSTROPHY, INCLUDED
ENSG00000007372	PAX6	194072	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME
ENSG00000007372	PAX6	604229	ANTERIOR SEGMENT DYSGENESIS 5; ASGD5
ENSG00000281880	PAUPAR	NA	
ENSG00000285283	AL035078.4	NA	
ENSG00000254584	AL035078.1	NA	
ENSG00000254836	AL035078.3	NA	
ENSG00000254627	AL035078.2	NA	
ENSG00000212551	U3	NA	
ENSG00000255490	EIF4A2P5	NA	
ENSG00000049449	RCN1	NA	
ENSG00000255252	AL078612.1	NA	
ENSG00000227160	THEM7P	NA	
ENSG00000255375	AL078612.2	NA	
ENSG00000184937	WT1	156240	MESOTHELIOMA, MALIGNANT; MESOM
ENSG00000184937	WT1	136680	FRASIER SYNDROME
ENSG00000184937	WT1	106210	ANIRIDIA 1; AN1;;AN;;ANIRIDIA II, FORMERLY; AN2, FORMERLY CATARACT, CONGENITAL, WITH LATE-ONSET CORNEAL DYSTROPHY, INCLUDED
ENSG00000184937	WT1	194070	WILMS TUMOR 1; WT1;;NEPHROBLASTOMA
ENSG00000184937	WT1	194072	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME
ENSG00000184937	WT1	194080	DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES
ENSG00000184937	WT1	256370	NEPHROTIC SYNDROME, TYPE 4; NPHS4
ENSG00000184937	WT1	608978	MEACHAM SYNDROME
ENSG00000183242	WT1-AS	NA	
ENSG00000278822	AL049692.6	NA	
ENSG00000273677	AL049692.1	NA	
ENSG00000278045	AL049692.5	NA	
ENSG00000276530	AL049692.3	NA	
ENSG00000273908	AL049692.2	NA	
ENSG00000277119	AL049692.4	NA	
ENSG00000149100	EIF3M	NA	
ENSG00000270903	HNRNPA3P9	NA	
ENSG00000186714	CCDC73	NA	
ENSG00000244535	AL049714.1	NA	
ENSG00000135378	PRRG4	NA	
ENSG00000060749	QSER1	NA	
ENSG00000200615	Y_RNA	NA	
ENSG00000121690	DEPDC7	NA	
ENSG00000176148	TCP11L1	NA	
ENSG00000213713	PIGCP1	NA	
ENSG00000280798	LINC00294	NA	
ENSG00000176102	CSTF3	NA	
ENSG00000247151	CSTF3-DT	NA	
ENSG00000206808	Y_RNA	NA	
ENSG00000241950	RPL29P23	NA	
ENSG00000200485	Y_RNA	NA	
ENSG00000241255	AL136126.1	NA	
ENSG00000110422	HIPK3	NA	
ENSG00000110427	KIAA1549L	NA	
ENSG00000254537	AL137161.1	NA	
ENSG00000255207	AL133399.1	NA	
ENSG00000255202	AL049629.1	NA	
ENSG00000205177	C11orf91	NA	
ENSG00000284969	AL049629.2	NA	
ENSG00000085063	CD59	612300	HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59;;CD59 DEFICIENCY
ENSG00000110429	FBXO3	NA	
ENSG00000254508	FBXO3-DT	NA	
ENSG00000255272	AC113192.3	NA	
ENSG00000255161	AC113192.2	NA	
ENSG00000255169	LINC02722	NA	
ENSG00000254619	AC113192.1	NA	
ENSG00000255133	LINC02721	NA	
ENSG00000135363	LMO2	NA	
ENSG00000184566	AC132216.1	NA	
ENSG00000286626	AC090469.1	NA	
ENSG00000135387	CAPRIN1	NA	
ENSG00000135372	NAT10	NA	
ENSG00000166016	ABTB2	NA	
ENSG00000201867	Y_RNA	NA	
ENSG00000254708	AL139174.1	NA	
ENSG00000220204	AL035079.1	NA	
ENSG00000216708	CIR1P3	NA	
ENSG00000121691	CAT	614097	ACATALASEMIA;;ACATALASIA;;CATALASE DEFICIENCY
ENSG00000135374	ELF5	NA	
ENSG00000255271	AL137224.1	NA	
ENSG00000255427	LINC02707	NA	
ENSG00000135373	EHF	NA	
ENSG00000271369	AC087783.1	NA	
ENSG00000270491	AL359999.1	NA	
ENSG00000149089	APIP	NA	
ENSG00000110435	PDHX	245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD;;LACTIC ACIDEMIA DUE TO DEFECT IN LIPOYL-CONTAINING COMPONENT X OF THE PYRUVATE DEHYDROGENASE COMPLEX
ENSG00000251862	MIR1343	NA	
ENSG00000255521	AL356215.1	NA	
ENSG00000026508	CD44	609027	BLOOD GROUP, INDIAN SYSTEM; IN;;INDIAN BLOOD GROUP SYSTEM; IN
ENSG00000255443	CD44-AS1	NA	
ENSG00000251194	AL133330.1	NA	
ENSG00000110436	SLC1A2	617105	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41
ENSG00000255004	AL133330.2	NA	
ENSG00000215380	AC090625.1	NA	
ENSG00000255542	AC090625.2	NA	
ENSG00000149090	PAMR1	NA	
ENSG00000254669	AL135934.1	NA	
ENSG00000179431	FJX1	NA	
ENSG00000254686	AL138812.1	NA	
ENSG00000166326	TRIM44	617142	ANIRIDIA 3; AN3
ENSG00000285705	AC090692.2	NA	
ENSG00000186082	KRT18P14	NA	
ENSG00000285740	AC090692.3	NA	
ENSG00000254919	AC090692.1	NA	
ENSG00000179241	LDLRAD3	NA	
ENSG00000254672	AL136146.1	NA	
ENSG00000255256	AL136146.2	NA	
ENSG00000241228	RPL12P31	NA	
ENSG00000263389	MIR3973	NA	
ENSG00000280321	AC129502.1	NA	
ENSG00000110442	COMMD9	NA	
ENSG00000135362	PRR5L	NA	
ENSG00000254566	AC087277.1	NA	
ENSG00000255186	AC087277.2	NA	
ENSG00000255060	AC009656.1	NA	
ENSG00000175104	TRAF6	NA	
ENSG00000280331	AC061999.1	NA	
ENSG00000166349	RAG1	233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG
ENSG00000166349	RAG1	601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE;;SCID, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE
ENSG00000166349	RAG1	603554	OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA
ENSG00000166349	RAG1	609889	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY
ENSG00000175097	RAG2	233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG
ENSG00000175097	RAG2	601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE;;SCID, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE
ENSG00000175097	RAG2	603554	OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA
ENSG00000166352	IFTAP	NA	
ENSG00000254498	AC104042.1	NA	
ENSG00000251838	AC061997.1	NA	
ENSG00000242834	RPL7AP56	NA	
ENSG00000254516	LINC02760	NA	
ENSG00000279004	AC103798.1	NA	
ENSG00000254784	LRRC6P1	NA	
ENSG00000255477	AC021713.1	NA	
ENSG00000255175	LINC02759	NA	
ENSG00000254562	LINC01493	NA	
ENSG00000285751	AC021723.2	NA	
ENSG00000240975	AC021723.1	NA	
ENSG00000201591	RNU6-99P	NA	
ENSG00000270588	AC021749.1	NA	
ENSG00000255347	AC021820.1	NA	
ENSG00000279675	AC080100.1	NA	
ENSG00000148948	LRRC4C	NA	
ENSG00000206806	Y_RNA	NA	
ENSG00000254579	AC090720.1	NA	
ENSG00000252922	RNU6-365P	NA	
ENSG00000255132	AC090138.1	NA	
ENSG00000255388	LINC02741	NA	
ENSG00000242729	AC021006.1	NA	
ENSG00000255563	AC021006.2	NA	
ENSG00000255171	LINC01499	NA	
ENSG00000254668	AC023442.1	NA	
ENSG00000255279	AC023442.3	NA	
ENSG00000254822	AC023442.2	NA	
ENSG00000255300	LINC02745	NA	
ENSG00000255109	LINC02740	NA	
ENSG00000254914	AC109810.1	NA	
ENSG00000271028	AC009643.2	NA	
ENSG00000254725	AC009643.1	NA	
ENSG00000251557	HNRNPKP3	NA	
ENSG00000166181	API5	NA	
ENSG00000254907	AC087276.2	NA	
ENSG00000252652	Y_RNA	NA	
ENSG00000052841	TTC17	NA	
ENSG00000255340	AC087276.3	NA	
ENSG00000254577	AC087276.1	NA	
ENSG00000252355	RN7SKP287	NA	
ENSG00000254463	PPIAP41	NA	
ENSG00000213697	CTBP2P6	NA	
ENSG00000283217	AC068205.1	NA	
ENSG00000211568	MIR670	NA	
ENSG00000235661	MIR670HG	NA	
ENSG00000283341	AC068205.2	NA	
ENSG00000199077	MIR129-2	NA	
ENSG00000149084	HSD17B12	NA	
ENSG00000283393	AC068205.3	NA	
ENSG00000243721	RPL23AP63	NA	
ENSG00000254512	PHBP2	NA	
ENSG00000283483	AC068205.4	NA	
ENSG00000246250	AC087521.2	NA	
ENSG00000283375	AC087521.4	NA	
ENSG00000166199	ALKBH3	NA	
ENSG00000213693	SEC14L1P1	NA	
ENSG00000244926	ALKBH3-AS1	NA	
ENSG00000254409	AC087521.3	NA	
ENSG00000187479	C11orf96	NA	
ENSG00000244953	AC087521.1	NA	
ENSG00000205126	ACCSL	NA	
ENSG00000110455	ACCS	NA	
ENSG00000255165	AC134775.1	NA	
ENSG00000151348	EXT2	133701	EXOSTOSES, MULTIPLE, TYPE II; EXT2
ENSG00000151348	EXT2	616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS
ENSG00000052850	ALX4	609597	PARIETAL FORAMINA 2; PFM2
ENSG00000052850	ALX4	613451	FRONTONASAL DYSPLASIA 2; FND2
ENSG00000052850	ALX4	615529	CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5
ENSG00000255451	AC010768.4	NA	
ENSG00000255106	AC010768.3	NA	
ENSG00000085117	CD82	NA	
ENSG00000254693	AC010768.1	NA	
ENSG00000255092	AC010768.2	NA	
ENSG00000244267	RPL34P22	NA	
ENSG00000275725	AC104010.1	NA	
ENSG00000255079	LINC02704	NA	
ENSG00000255032	TSPAN18-AS1	NA	
ENSG00000157570	TSPAN18	NA	
ENSG00000175274	TP53I11	NA	
ENSG00000254654	LINC02685	NA	
ENSG00000287984	AC068858.1	NA	
ENSG00000019485	PRDM11	NA	
ENSG00000254664	AC103681.2	NA	
ENSG00000019505	SYT13	NA	
ENSG00000254497	AC103681.1	NA	
ENSG00000254427	LINC02696	NA	
ENSG00000255267	LINC02687	NA	
ENSG00000255041	AC103855.3	NA	
ENSG00000286418	AC018716.2	NA	
ENSG00000254651	AC018716.1	NA	
ENSG00000254746	AC103855.2	NA	
ENSG00000255519	AC103855.4	NA	
ENSG00000254514	AC103855.1	NA	
ENSG00000175264	CHST1	NA	
ENSG00000255091	AC087442.1	NA	
ENSG00000276639	MIR7154	NA	
ENSG00000254519	AC044839.1	NA	
ENSG00000255426	AC044839.2	NA	
ENSG00000255226	LINC02690	NA	
ENSG00000205106	LINC02716	NA	
ENSG00000181830	SLC35C1	266265	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C;;CDG IIc; CDGIIc;;LEUKOCYTE ADHESION DEFICIENCY, TYPE II; LAD2;;RAMBAM-HASHARON SYNDROME; RHS
ENSG00000255447	AC044839.3	NA	
ENSG00000121671	CRY2	NA	
ENSG00000121653	MAPK8IP1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000255498	AC068385.1	NA	
ENSG00000234776	C11orf94	NA	
ENSG00000121680	PEX16	614876	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 9, INCLUDED; CG9, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP D, INCLUDED; CGD, INCLUDED
ENSG00000121680	PEX16	614877	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B
ENSG00000165905	LARGE2	NA	
ENSG00000135365	PHF21A	618725	INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES; IDDBCS
ENSG00000254653	AC024475.1	NA	
ENSG00000255314	AC024475.3	NA	
ENSG00000254871	AC024475.2	NA	
ENSG00000255269	LINC02710	NA	
ENSG00000254639	AC116021.1	NA	
ENSG00000255007	LINC02489	NA	
ENSG00000157613	CREB3L1	616229	OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16;;OI, TYPE XVI CHROMOSOME 11p11.2 DELETION SYNDROME, 91.3-KB, INCLUDED
ENSG00000149091	DGKZ	NA	
ENSG00000264102	MIR4688	NA	
ENSG00000110492	MDK	NA	
ENSG00000180720	CHRM4	NA	
ENSG00000110497	AMBRA1	NA	
ENSG00000244313	AC024293.1	NA	
ENSG00000265014	MIR3160-1	NA	
ENSG00000283497	MIR3160-2	NA	
ENSG00000285658	AC127035.1	NA	
ENSG00000180423	HARBI1	NA	
ENSG00000175224	ATG13	NA	
ENSG00000175220	ARHGAP1	NA	
ENSG00000175213	ZNF408	616468	EXUDATIVE VITREORETINOPATHY 6; EVR6
ENSG00000175213	ZNF408	616469	RETINITIS PIGMENTOSA 72; RP72
ENSG00000180210	F2	188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1;;THROMBOPHILIA DUE TO FACTOR 2 DEFECT;;VENOUS THROMBOSIS;;VENOUS THROMBOEMBOLISM THROMBOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000180210	F2	601367	STROKE, ISCHEMIC;;CEREBROVASCULAR ACCIDENT;;CEREBRAL INFARCTION
ENSG00000180210	F2	613679	PROTHROMBIN DEFICIENCY, CONGENITAL;;HYPOPROTHROMBINEMIA DYSPROTHROMBINEMIA, INCLUDED
ENSG00000180210	F2	614390	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2
ENSG00000175216	CKAP5	NA	
ENSG00000263540	MIR5582	NA	
ENSG00000252427	AC115088.1	NA	
ENSG00000212135	SNORD67	NA	
ENSG00000247675	LRP4-AS1	NA	
ENSG00000134569	LRP4	212780	CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII
ENSG00000134569	LRP4	614305	SCLEROSTEOSIS 2; SOST2
ENSG00000134569	LRP4	616304	MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17
ENSG00000286450	AC021573.1	NA	
ENSG00000149179	C11orf49	NA	
ENSG00000271350	AC103792.1	NA	
ENSG00000255520	AC090589.2	NA	
ENSG00000149182	ARFGAP2	NA	
ENSG00000270060	AC090589.3	NA	
ENSG00000165912	PACSIN3	NA	
ENSG00000275208	MIR6745	NA	
ENSG00000243802	AC090589.1	NA	
ENSG00000134574	DDB2	278740	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E;;XPE;;XP, GROUP E;;XERODERMA PIGMENTOSUM V; XP5
ENSG00000256897	AC018410.1	NA	
ENSG00000134575	ACP2	200950	ACID PHOSPHATASE DEFICIENCY
ENSG00000025434	NR1H3	NA	
ENSG00000110514	MADD	NA	
ENSG00000256746	MADD-AS1	NA	
ENSG00000283338	AC090582.1	NA	
ENSG00000134571	MYBPC3	115197	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4, SUSCEPTIBILITY TO, INCLUDED
ENSG00000134571	MYBPC3	615396	LEFT VENTRICULAR NONCOMPACTION 10; LVNC10 CARDIOMYOPATHY, DILATED, 1MM, INCLUDED; CMD1MM, INCLUDED
ENSG00000066336	SPI1	NA	
ENSG00000255197	AC090559.1	NA	
ENSG00000264583	MIR4487	NA	
ENSG00000165915	SLC39A13	612350	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3; EDSSPD3;;SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE; SCD-EDS
ENSG00000165916	PSMC3	NA	
ENSG00000165917	RAPSN	616326	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11;;MYASTHENIC SYNDROME, CONGENITAL, Ie, FORMERLY; CMS1E, FORMERLY;;CMS Ie, FORMERLY
ENSG00000165917	RAPSN	618388	FETAL AKINESIA DEFORMATION SEQUENCE 2; FADS2
ENSG00000149187	CELF1	NA	
ENSG00000270072	AC090559.2	NA	
ENSG00000265559	RN7SL652P	NA	
ENSG00000213619	NDUFS3	618230	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8
ENSG00000110536	PTPMT1	NA	
ENSG00000123444	KBTBD4	NA	
ENSG00000200376	RNU5E-10P	NA	
ENSG00000231880	KF459542.1	NA	
ENSG00000196666	FAM180B	NA	
ENSG00000172247	C1QTNF4	NA	
ENSG00000109919	MTCH2	NA	
ENSG00000165923	AGBL2	NA	
ENSG00000109920	FNBP4	NA	
ENSG00000200090	Y_RNA	NA	
ENSG00000030066	NUP160	618178	NEPHROTIC SYNDROME, TYPE 19; NPHS19
ENSG00000271543	AC021443.1	NA	
ENSG00000252941	RNA5SP340	NA	
ENSG00000252874	Y_RNA	NA	
ENSG00000271557	YPEL5P2	NA	
ENSG00000254780	AC023232.1	NA	
ENSG00000149177	PTPRJ	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000254879	PTPRJ-AS1	NA	
ENSG00000263693	MIR3161	NA	
ENSG00000175619	OR4B1	NA	
ENSG00000255514	OR4B2P	NA	
ENSG00000172208	OR4X2	NA	
ENSG00000176567	OR4X1	NA	
ENSG00000176555	OR4S1	NA	
ENSG00000176547	OR4C3	NA	
ENSG00000197161	OR4C4P	NA	
ENSG00000176540	OR4C5	NA	
ENSG00000182565	OR4C2P	NA	
ENSG00000184789	OR4C10P	NA	
ENSG00000254925	OR4C9P	NA	
ENSG00000255215	OR4R1P	NA	
ENSG00000237388	OR4A47	NA	
ENSG00000255113	OR4A48P	NA	
ENSG00000255304	OR4A46P	NA	
ENSG00000254832	OR4A40P	NA	
ENSG00000255534	OR4A43P	NA	
ENSG00000213607	OR4A45P	NA	
ENSG00000255297	OR4A41P	NA	
ENSG00000254674	OR4A42P	NA	
ENSG00000255053	OR4A44P	NA	
ENSG00000255551	AC027369.6	NA	
ENSG00000254728	AC027369.3	NA	
ENSG00000254920	AC027369.4	NA	
ENSG00000255527	AC027369.5	NA	
ENSG00000249910	TRIM51CP	NA	
ENSG00000254517	AC027369.2	NA	
ENSG00000220948	TRIM51GP	NA	
ENSG00000254764	TRIM53CP	NA	
ENSG00000205044	AC027369.1	NA	
ENSG00000182053	TRIM49B	NA	
ENSG00000288434	AC084851.4	NA	
ENSG00000214891	TRIM64C	NA	
ENSG00000276637	AC084851.3	NA	
ENSG00000254801	AC084851.1	NA	
ENSG00000229361	UBTFL7	NA	
ENSG00000255452	AC084851.2	NA	
ENSG00000254412	AC118273.1	NA	
ENSG00000255338	AC118273.2	NA	
ENSG00000254993	TRIM77BP	NA	
ENSG00000254567	UBTFL9	NA	
ENSG00000086205	FOLH1	NA	
ENSG00000255532	AC118942.1	NA	
ENSG00000123447	TYRL	NA	
ENSG00000254496	CBX3P8	NA	
ENSG00000226268	AC135977.1	NA	
ENSG00000205035	AC136759.1	NA	
ENSG00000254487	AC130364.1	NA	
ENSG00000255268	AC130364.2	NA	
ENSG00000219061	TRIM51FP	NA	
ENSG00000265973	AP006587.5	NA	
ENSG00000288177	AP006587.6	NA	
ENSG00000255550	AP006587.4	NA	
ENSG00000255214	AP006587.3	NA	
ENSG00000255190	TRIM51DP	NA	
ENSG00000254800	AP006587.1	NA	
ENSG00000255111	AP006587.2	NA	
ENSG00000254408	OR4A1P	NA	
ENSG00000254472	OR4A49P	NA	
ENSG00000254637	OR4A18P	NA	
ENSG00000254940	OR4A19P	NA	
ENSG00000254624	OR4R3P	NA	
ENSG00000258817	OR4C13	NA	
ENSG00000221954	OR4C12	NA	
ENSG00000283605	OR4C48P	NA	
ENSG00000260811	OR4C45	NA	
ENSG00000260595	OR4C49P	NA	
ENSG00000255199	GTF2IP11	NA	
ENSG00000255442	AC109635.4	NA	
ENSG00000287538	AC109635.7	NA	
ENSG00000286983	AC109635.6	NA	
ENSG00000236919	AC109635.1	NA	
ENSG00000255500	AC109635.5	NA	
ENSG00000255042	AC109635.3	NA	
ENSG00000255001	AC109635.2	NA	
ENSG00000254518	LINC02750	NA	
ENSG00000254840	AC024405.2	NA	
ENSG00000214883	AC024405.1	NA	
ENSG00000237610	OR4C50P	NA	
ENSG00000185926	OR4C46	NA	
ENSG00000255312	OR4C7P	NA	
ENSG00000255560	OR4R2P	NA	
ENSG00000254769	OR4A4P	NA	
ENSG00000254464	OR4A3P	NA	
ENSG00000227547	OR4A2P	NA	
ENSG00000225997	OR4A8	NA	
ENSG00000255349	OR4A7P	NA	
ENSG00000221840	OR4A5	NA	
ENSG00000255078	OR4A6P	NA	
ENSG00000150244	TRIM48	NA	
ENSG00000255543	AP005597.4	NA	
ENSG00000255283	AP005597.3	NA	
ENSG00000255110	AP005597.2	NA	
ENSG00000166007	TRIM51HP	NA	
ENSG00000254828	AP005597.1	NA	
ENSG00000254663	OR4A11P	NA	
ENSG00000254723	OR4A12P	NA	
ENSG00000181961	OR4A16	NA	
ENSG00000181958	OR4A15	NA	
ENSG00000254891	OR4A9P	NA	
ENSG00000255077	OR4X7P	NA	
ENSG00000255493	OR4A10P	NA	
ENSG00000255196	OR4A17P	NA	
ENSG00000181950	OR4A13P	NA	
ENSG00000255294	OR4A50P	NA	
ENSG00000181943	OR4A21P	NA	
ENSG00000254576	OR4C1P	NA	
ENSG00000233301	OR4C14P	NA	
ENSG00000181939	OR4C15	NA	
ENSG00000279514	OR4C16	NA	
ENSG00000172188	OR4C11	NA	
ENSG00000181927	OR4P4	NA	
ENSG00000174982	OR4S2	NA	
ENSG00000181903	OR4C6	NA	
ENSG00000254841	OR4V1P	NA	
ENSG00000188439	OR4P1P	NA	
ENSG00000254804	AP006437.1	NA	
ENSG00000254457	OR5D2P	NA	
ENSG00000186886	OR5D3P	NA	
ENSG00000181837	OR5D17P	NA	
ENSG00000279761	OR5D13	NA	
ENSG00000255019	OR5D15P	NA	
ENSG00000186113	OR5D14	NA	
ENSG00000279395	OR5L1	NA	
ENSG00000186119	OR5D18	NA	
ENSG00000205030	OR5L2	NA	
ENSG00000205029	OR5D16	NA	
ENSG00000186124	OR9M1P	NA	
ENSG00000255204	AC036111.2	NA	
ENSG00000255499	AC036111.3	NA	
ENSG00000254547	AC036111.1	NA	
ENSG00000124900	TRIM51	NA	
ENSG00000227806	OR5W1P	NA	
ENSG00000187612	OR5W2	NA	
ENSG00000167825	OR5I1	NA	
ENSG00000255416	OR10AF1P	NA	
ENSG00000254807	OR10AK1P	NA	
ENSG00000174970	OR10AG1	NA	
ENSG00000214880	OR7E5P	NA	
ENSG00000149133	OR5F1	NA	
ENSG00000182365	OR5F2P	NA	
ENSG00000181785	OR5AS1	NA	
ENSG00000184741	OR5AQ1P	NA	
ENSG00000181780	OR5J1P	NA	
ENSG00000225538	OR5BE1P	NA	
ENSG00000172154	OR8I2	NA	
ENSG00000254524	OR8I4P	NA	
ENSG00000181767	OR8H2	NA	
ENSG00000255140	OR5BN2P	NA	
ENSG00000181761	OR8H3	NA	
ENSG00000254848	OR5BN1P	NA	
ENSG00000167822	OR8J3	NA	
ENSG00000254947	OR8K4P	NA	
ENSG00000181752	OR8K5	NA	
ENSG00000255217	OR5J7P	NA	
ENSG00000174957	OR5J2	NA	
ENSG00000230213	OR8V1P	NA	
ENSG00000213604	AC022882.1	NA	
ENSG00000254658	OR8J2	NA	
ENSG00000181718	OR5T2	NA	
ENSG00000172489	OR5T3	NA	
ENSG00000181698	OR5T1	NA	
ENSG00000181693	OR8H1	NA	
ENSG00000255461	OR8I1P	NA	
ENSG00000280314	OR8K3	NA	
ENSG00000254722	FAM8A2P	NA	
ENSG00000255134	OR8K2P	NA	
ENSG00000150261	OR8K1	NA	
ENSG00000172487	OR8J1	NA	
ENSG00000242208	RPL5P29	NA	
ENSG00000172199	OR8U1	NA	
ENSG00000254903	OR8L1P	NA	
ENSG00000255466	OR5AL2P	NA	
ENSG00000272987	OR5AL1	NA	
ENSG00000279961	OR5R1	NA	
ENSG00000230416	OR5M4P	NA	
ENSG00000284732	AP002512.3	NA	
ENSG00000150269	OR5M9	NA	
ENSG00000174937	OR5M3	NA	
ENSG00000254752	OR5M2P	NA	
ENSG00000181371	OR5M8	NA	
ENSG00000254411	AP002512.1	NA	
ENSG00000254490	OR5M7P	NA	
ENSG00000254660	AP002512.2	NA	
ENSG00000254603	OR5M6P	NA	
ENSG00000185701	OR5M5P	NA	
ENSG00000255223	OR5M11	NA	
ENSG00000254834	OR5M10	NA	
ENSG00000166693	OR5M13P	NA	
ENSG00000255012	OR5M1	NA	
ENSG00000255172	OR5AM1P	NA	
ENSG00000197866	OR5M12P	NA	
ENSG00000254795	OR5AP1P	NA	
ENSG00000172464	OR5AP2	NA	
ENSG00000172459	OR5AR1	NA	
ENSG00000232511	OR2AH1P	NA	
ENSG00000238041	AP004245.1	NA	
ENSG00000174914	OR9G1	NA	
ENSG00000254953	AP001803.1	NA	
ENSG00000181325	OR9G3P	NA	
ENSG00000172457	OR9G4	NA	
ENSG00000274770	MIR6128	NA	
ENSG00000286704	AP001803.3	NA	
ENSG00000254825	OR9G2P	NA	
ENSG00000181296	OR5G1P	NA	
ENSG00000255485	OR5G4P	NA	
ENSG00000205025	OR5G5P	NA	
ENSG00000241356	OR5G3	NA	
ENSG00000255433	LINC02735	NA	
ENSG00000274150	FADS2B	NA	
ENSG00000181282	OR5AK3P	NA	
ENSG00000181273	OR5AK2	NA	
ENSG00000255083	OR5AK1P	NA	
ENSG00000273228	OR5BQ1P	NA	
ENSG00000283307	OR5AK4P	NA	
ENSG00000272676	OR5AO1P	NA	
ENSG00000273255	OR5BP1P	NA	
ENSG00000183908	LRRC55	NA	
ENSG00000134817	APLNR	NA	
ENSG00000149115	TNKS1BP1	NA	
ENSG00000254662	AP000781.1	NA	
ENSG00000149136	SSRP1	NA	
ENSG00000109991	P2RX3	NA	
ENSG00000156575	PRG3	NA	
ENSG00000186652	PRG2	NA	
ENSG00000254979	AP000781.2	NA	
ENSG00000134802	SLC43A3	NA	
ENSG00000252070	RNA5SP341	NA	
ENSG00000222998	RN7SKP259	NA	
ENSG00000186907	RTN4RL2	NA	
ENSG00000255301	AP002893.1	NA	
ENSG00000149150	SLC43A1	NA	
ENSG00000265566	RN7SL605P	NA	
ENSG00000134809	TIMM10	NA	
ENSG00000214872	SMTNL1	NA	
ENSG00000156587	UBE2L6	NA	
ENSG00000240371	RPS4XP13	NA	
ENSG00000149131	SERPING1	120790	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
ENSG00000149131	SERPING1	106100	ANGIOEDEMA, HEREDITARY, TYPE I; HAE1;;ANGIONEUROTIC EDEMA, HEREDITARY; HANE;;C1 ESTERASE INHIBITOR, DEFICIENCY OF ANGIOEDEMA, HEREDITARY, TYPE II, INCLUDED; HAE2, INCLUDED
ENSG00000254602	AP000662.1	NA	
ENSG00000208009	MIR130A	NA	
ENSG00000166793	YPEL4	NA	
ENSG00000172409	CLP1	615803	PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10
ENSG00000156599	ZDHHC5	NA	
ENSG00000156603	MED19	NA	
ENSG00000288534	AP001931.2	NA	
ENSG00000213593	TMX2	618730	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY; NEDMCMS;;VANDERVORE-SCHOT SYNDROME
ENSG00000213592	PPIAP42	NA	
ENSG00000211450	SELENOH	NA	
ENSG00000254732	AP001931.1	NA	
ENSG00000233436	BTBD18	NA	
ENSG00000198561	CTNND1	617681	BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2
ENSG00000255303	OR5BA1P	NA	
ENSG00000255266	AP003484.1	NA	
ENSG00000180714	OR5AZ1P	NA	
ENSG00000254749	OR5BD1P	NA	
ENSG00000254601	CYCSP26	NA	
ENSG00000186509	OR9Q1	NA	
ENSG00000200817	RNU6-899P	NA	
ENSG00000279051	OR6Q1	NA	
ENSG00000236541	VN2R9P	NA	
ENSG00000255146	AP004247.2	NA	
ENSG00000254853	AP004247.1	NA	
ENSG00000255131	OR9L1P	NA	
ENSG00000272685	OR9I3P	NA	
ENSG00000172377	OR9I1	NA	
ENSG00000186508	OR9I2P	NA	
ENSG00000272569	OR5BL1P	NA	
ENSG00000186513	OR9Q2	NA	
ENSG00000197887	OR1S2	NA	
ENSG00000280204	OR1S1	NA	
ENSG00000180475	OR10Q1	NA	
ENSG00000254589	EIF4A2P3	NA	
ENSG00000172772	OR10W1	NA	
ENSG00000272900	OR10Q2P	NA	
ENSG00000255218	OR5BC1P	NA	
ENSG00000255431	OR5B19P	NA	
ENSG00000255096	OR5B10P	NA	
ENSG00000255333	AP000435.1	NA	
ENSG00000197786	OR5B17	NA	
ENSG00000233499	OR5B1P	NA	
ENSG00000273408	OR5B15P	NA	
ENSG00000172769	OR5B3	NA	
ENSG00000172365	OR5B2	NA	
ENSG00000172362	OR5B12	NA	
ENSG00000285895	AP003557.2	NA	
ENSG00000255299	AP003557.1	NA	
ENSG00000198283	OR5B21	NA	
ENSG00000110031	LPXN	NA	
ENSG00000186660	ZFP91	NA	
ENSG00000255073	ZFP91-CNTF	NA	
ENSG00000269570	AP001350.1	NA	
ENSG00000242689	CNTF	NA	
ENSG00000280010	AP001350.2	NA	
ENSG00000149124	GLYAT	NA	
ENSG00000197254	AP000445.1	NA	
ENSG00000254926	AP000445.2	NA	
ENSG00000255265	TMA16P1	NA	
ENSG00000156689	GLYATL2	NA	
ENSG00000254717	GLYATL1P2	NA	
ENSG00000166840	GLYATL1	NA	
ENSG00000255523	AP001652.1	NA	
ENSG00000255240	AP001636.3	NA	
ENSG00000254877	AP001636.2	NA	
ENSG00000255189	GLYATL1P1	NA	
ENSG00000254786	AP001636.1	NA	
ENSG00000254399	GLYATL1P4	NA	
ENSG00000255151	GLYATL1B	NA	
ENSG00000189057	FAM111B	615704	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP;;POIKILODERMA, HEREDITARY SCLEROSING, WITH TENDON AND PULMONARY INVOLVEMENT
ENSG00000245571	FAM111A-DT	NA	
ENSG00000255381	AP001258.1	NA	
ENSG00000166801	FAM111A	127000	KENNY-CAFFEY SYNDROME, TYPE 2; KCS2;;DWARFISM, CORTICAL THICKENING OF TUBULAR BONES, AND TRANSIENT HYPOCALCEMIA;;KENNY SYNDROME
ENSG00000166801	FAM111A	602361	GRACILE BONE DYSPLASIA; GCLEB;;SKELETAL DYSPLASIA, LETHAL, WITH GRACILE BONES;;OSTEOCRANIOSPLENIC SYNDROME;;OSTEOCRANIOSTENOSIS;;HABRODYSPLASIA
ENSG00000110042	DTX4	NA	
ENSG00000197629	MPEG1	NA	
ENSG00000263999	RN7SL42P	NA	
ENSG00000225802	WARS1P1	NA	
ENSG00000254799	SLC25A47P1	NA	
ENSG00000214797	AP002358.1	NA	
ENSG00000254704	AP002358.2	NA	
ENSG00000263944	RN7SL435P	NA	
ENSG00000235678	OR5AN2P	NA	
ENSG00000255386	OR5BR1P	NA	
ENSG00000176495	OR5AN1	NA	
ENSG00000198261	OR5BB1P	NA	
ENSG00000172324	OR5A2	NA	
ENSG00000172320	OR5A1	NA	
ENSG00000166884	OR4D6	NA	
ENSG00000254466	OR4D10	NA	
ENSG00000204989	OR4D8P	NA	
ENSG00000176200	OR4D11	NA	
ENSG00000172742	OR4D9	NA	
ENSG00000254770	OR4D7P	NA	
ENSG00000287264	AP003778.1	NA	
ENSG00000255008	LINC02739	NA	
ENSG00000255139	AP000442.1	NA	
ENSG00000110048	OSBP	NA	
ENSG00000264559	MIR3162	NA	
ENSG00000166889	PATL1	NA	
ENSG00000255355	AP000640.2	NA	
ENSG00000223223	RN7SKP192	NA	
ENSG00000172289	OR10V1	NA	
ENSG00000166900	STX3	NA	
ENSG00000254403	OR10Y1P	NA	
ENSG00000254743	OR10V3P	NA	
ENSG00000255538	OR10V2P	NA	
ENSG00000254477	AP000640.1	NA	
ENSG00000234964	FABP5P7	NA	
ENSG00000166902	MRPL16	NA	
ENSG00000134812	CBLIF	261000	INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR
ENSG00000134827	TCN1	NA	
ENSG00000285231	OOSP3	NA	
ENSG00000270929	SRD5A3P1	NA	
ENSG00000284873	OOSP1	NA	
ENSG00000214788	AP000790.1	NA	
ENSG00000285010	OOSP4A	NA	
ENSG00000255393	OOSP4B	NA	
ENSG00000149507	OOSP2	NA	
ENSG00000149516	MS4A3	NA	
ENSG00000255331	AP000790.2	NA	
ENSG00000149534	MS4A2	147050	IgE RESPONSIVENESS, ATOPIC; IGER;;IMMUNOGLOBULIN E, BASIC LEVEL OF, IN SERUM;;IgE, LEVEL OF; IGEL;;IgE RESPONSE UNDERLYING ALLERGIC ASTHMA AND RHINITIS IgE, ELEVATED LEVEL OF, INCLUDED;;ATOPY, SUSCEPTIBILITY TO, INCLUDED;;ATOPIC HYPERSENSITIVITY, INCLUDED
ENSG00000254952	LINC02705	NA	
ENSG00000110077	MS4A6A	NA	
ENSG00000110079	MS4A4A	NA	
ENSG00000214787	MS4A4E	NA	
ENSG00000275344	MIR6503	NA	
ENSG00000166926	MS4A6E	NA	
ENSG00000166927	MS4A7	NA	
ENSG00000166928	MS4A14	NA	
ENSG00000166930	MS4A5	NA	
ENSG00000156738	MS4A1	613495	IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5;;ANTIBODY DEFICIENCY DUE TO CD20 DEFECT
ENSG00000071203	MS4A12	NA	
ENSG00000204979	MS4A13	NA	
ENSG00000283601	MS4A19P	NA	
ENSG00000181995	LINC00301	NA	
ENSG00000166959	MS4A8	NA	
ENSG00000214782	MS4A18	NA	
ENSG00000166961	MS4A15	NA	
ENSG00000172689	MS4A10	NA	
ENSG00000255845	AP000777.1	NA	
ENSG00000255959	AP000777.2	NA	
ENSG00000256813	AP000777.3	NA	
ENSG00000110104	CCDC86	NA	
ENSG00000183134	PTGDR2	NA	
ENSG00000149506	ZP1	615774	OOCYTE MATURATION DEFECT 1; OOMD1;;OOMD
ENSG00000110107	PRPF19	NA	
ENSG00000257052	AP003721.4	NA	
ENSG00000256944	AP003721.3	NA	
ENSG00000110108	TMEM109	NA	
ENSG00000256196	AP003721.1	NA	
ENSG00000006118	TMEM132A	NA	
ENSG00000110446	SLC15A3	NA	
ENSG00000013725	CD6	NA	
ENSG00000207153	RNU6-933P	NA	
ENSG00000256733	AP003721.2	NA	
ENSG00000110448	CD5	NA	
ENSG00000167987	VPS37C	NA	
ENSG00000279549	AP000437.1	NA	
ENSG00000229859	PGA3	169710	PEPSINOGEN 3, GROUP I; PGA3;;PEPSINOGEN I--SECOND LOCUS
ENSG00000229183	PGA4	NA	
ENSG00000256220	AP003037.1	NA	
ENSG00000256713	PGA5	NA	
ENSG00000167992	VWCE	NA	
ENSG00000167986	DDB1	NA	
ENSG00000149476	TKFC	618805	TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME; TKFCD
ENSG00000162144	CYB561A3	NA	
ENSG00000279246	AP003108.3	NA	
ENSG00000149483	TMEM138	614465	JOUBERT SYNDROME 16; JBTS16
ENSG00000187049	TMEM216	603194	MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2
ENSG00000187049	TMEM216	608091	JOUBERT SYNDROME 2; JBTS2;;CEREBELLOOCULORENAL SYNDROME 2; CORS2
ENSG00000149532	CPSF7	NA	
ENSG00000279632	AP003108.4	NA	
ENSG00000256591	AP003108.2	NA	
ENSG00000167985	SDHAF2	601650	PARAGANGLIOMAS 2; PGL2;;GLOMUS TUMORS, FAMILIAL, 2
ENSG00000240823	RN7SL23P	NA	
ENSG00000162148	PPP1R32	NA	
ENSG00000255931	AP003108.1	NA	
ENSG00000266006	MIR4488	NA	
ENSG00000204950	LRRC10B	NA	
ENSG00000011347	SYT7	NA	
ENSG00000279878	AP003108.5	NA	
ENSG00000256443	AP003559.1	NA	
ENSG00000250230	AP002754.1	NA	
ENSG00000243742	RPLP0P2	NA	
ENSG00000255947	AP002754.2	NA	
ENSG00000134780	DAGLA	NA	
ENSG00000124915	MYRF-AS1	NA	
ENSG00000124920	MYRF	618113	ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV;;ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE SPLENIAL LESION; MERS
ENSG00000124920	MYRF	618280	CARDIAC-UROGENITAL SYNDROME; CUGS
ENSG00000134825	TMEM258	NA	
ENSG00000284108	MIR611	NA	
ENSG00000168496	FEN1	NA	
ENSG00000134824	FADS2	NA	
ENSG00000149485	FADS1	NA	
ENSG00000284416	MIR1908	NA	
ENSG00000221968	FADS3	NA	
ENSG00000277892	MIR6746	NA	
ENSG00000167994	RAB3IL1	NA	
ENSG00000200898	RNU6-1243P	NA	
ENSG00000167995	BEST1	153700	MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2;;VITELLIFORM MACULAR DYSTROPHY, EARLY-ONSET;;VITELLIFORM MACULAR DYSTROPHY, JUVENILE-ONSET;;BEST MACULAR DYSTROPHY; BMD;;MACULAR DEGENERATION, POLYMORPHIC VITELLINE;;BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL
ENSG00000167995	BEST1	193220	VITREORETINOCHOROIDOPATHY; VRCP;;VITREORETINOCHOROIDOPATHY, AUTOSOMAL DOMINANT; ADVIRC;;VITREORETINOCHOROIDOPATHY WITH MICROCORNEA, GLAUCOMA, AND CATARACT;;VITREORETINOCHOROIDOPATHY, AUTOSOMAL DOMINANT, WITH NANOPHTHALMOS MICROCORNEA, ROD-CONE DYSTR /.../CATARACT, AND POSTERIOR STAPHYLOMA, INCLUDED; MRCS, INCLUDED
ENSG00000167995	BEST1	611809	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB
ENSG00000167995	BEST1	613194	RETINITIS PIGMENTOSA 50; RP50 RETINITIS PIGMENTOSA, CONCENTRIC, INCLUDED
ENSG00000167996	FTH1	615517	HEMOCHROMATOSIS, TYPE 5; HFE5;;IRON OVERLOAD, AUTOSOMAL DOMINANT
ENSG00000279491	AP003733.3	NA	
ENSG00000244176	AP003733.1	NA	
ENSG00000255553	LINC02733	NA	
ENSG00000254424	AP003733.2	NA	
ENSG00000285656	AP002793.1	NA	
ENSG00000149503	INCENP	NA	
ENSG00000236607	EEF1DP8	NA	
ENSG00000168515	SCGB1D1	NA	
ENSG00000124939	SCGB2A1	NA	
ENSG00000254404	AP003306.1	NA	
ENSG00000124935	SCGB1D2	NA	
ENSG00000110484	SCGB2A2	NA	
ENSG00000197745	SCGB1D4	NA	
ENSG00000255213	NPM1P35	NA	
ENSG00000255118	AP003306.2	NA	
ENSG00000162174	ASRGL1	NA	
ENSG00000254454	RCC2P6	NA	
ENSG00000255126	AP003064.1	NA	
ENSG00000149021	SCGB1A1	NA	
ENSG00000255446	AP003064.2	NA	
ENSG00000124942	AHNAK	NA	
ENSG00000250659	AP001363.1	NA	
ENSG00000257058	AP001363.2	NA	
ENSG00000254772	EEF1G	NA	
ENSG00000255508	AP002990.1	NA	
ENSG00000276102	MIR6747	NA	
ENSG00000149016	TUT1	NA	
ENSG00000149480	MTA2	NA	
ENSG00000149499	EML3	NA	
ENSG00000254964	AP001458.1	NA	
ENSG00000149489	ROM1	268000	RETINITIS PIGMENTOSA; RP
ENSG00000149489	ROM1	608133	RETINITIS PIGMENTOSA 7; RP7 RETINITIS PIGMENTOSA 7, DIGENIC, INCLUDED;;LEBER CONGENITAL AMAUROSIS 18, INCLUDED; LCA18, INCLUDED
ENSG00000149541	B3GAT3	245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD;;LARSEN SYNDROME, AUTOSOMAL RECESSIVE, FORMERLY
ENSG00000089597	GANAB	600666	POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD3;;POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE III; APKD3
ENSG00000185085	INTS5	NA	
ENSG00000255432	AP001458.2	NA	
ENSG00000162194	LBHD1	NA	
ENSG00000278615	C11orf98	NA	
ENSG00000214756	CSKMT	NA	
ENSG00000206597	SNORA57	NA	
ENSG00000204922	UQCC3	616111	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9; MC3DN9
ENSG00000162191	UBXN1	NA	
ENSG00000177363	LRRN4CL	NA	
ENSG00000234857	HNRNPUL2-BSCL2	NA	
ENSG00000168000	BSCL2	269700	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2;;BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 2;;SEIP SYNDROME;;BERARDINELLI SYNDROME;;LIPODYSTROPHY, TOTAL, AND ACROMEGALOID GIGANTISM;;LIPOATROPHIC DIABETES, CONGENITAL;;LIPODYSTROPHY, BERARD /.../-SEIP CONGENITAL, TYPE 2;;BRUNZELL SYNDROME, BSCL2-RELATED
ENSG00000168000	BSCL2	270685	SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17;;SPASTIC PARAPLEGIA WITH AMYOTROPHY OF HANDS AND FEET;;SILVER SYNDROME;;SILVER SPASTIC PARAPLEGIA SYNDROME
ENSG00000168000	BSCL2	600794	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A;;HMN VA;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V; HMN5;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; DHMN5A;;DHMN VA;;SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VA; DSMAVA;;SPINAL MUSCULAR ATRO /.../ISTAL, TYPE V; DSMAV;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH UPPER LIMB PREDOMINANCE
ENSG00000168000	BSCL2	615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD
ENSG00000162188	GNG3	NA	
ENSG00000214753	HNRNPUL2	NA	
ENSG00000162222	TTC9C	NA	
ENSG00000185670	ZBTB3	NA	
ENSG00000168002	POLR2G	NA	
ENSG00000267811	AP001160.2	NA	
ENSG00000162227	TAF6L	NA	
ENSG00000168569	TMEM223	NA	
ENSG00000269176	AP001160.3	NA	
ENSG00000185475	TMEM179B	NA	
ENSG00000284535	MIR6748	NA	
ENSG00000162231	NXF1	NA	
ENSG00000274066	MIR6514	NA	
ENSG00000162236	STX5	NA	
ENSG00000269463	AP001160.4	NA	
ENSG00000252361	RNU6-118P	NA	
ENSG00000256690	AP001160.1	NA	
ENSG00000283268	TEX54	NA	
ENSG00000133316	WDR74	NA	
ENSG00000222328	RNU2-2P	NA	
ENSG00000255717	SNHG1	NA	
ENSG00000277194	SNORD22	NA	
ENSG00000277846	SNORD30	NA	
ENSG00000278527	SNORD22	NA	
ENSG00000274544	SNORD28	NA	
ENSG00000275996	SNORD27	NA	
ENSG00000276788	SNORD26	NA	
ENSG00000275043	SNORD25	NA	
ENSG00000168003	SLC3A2	NA	
ENSG00000168539	CHRM1	NA	
ENSG00000257002	AP000438.1	NA	
ENSG00000241082	RN7SL259P	NA	
ENSG00000197901	SLC22A6	NA	
ENSG00000285388	AP000438.2	NA	
ENSG00000149452	SLC22A8	NA	
ENSG00000256041	AP001858.2	NA	
ENSG00000253547	AP001858.1	NA	
ENSG00000197658	SLC22A24	NA	
ENSG00000239924	RPL29P22	NA	
ENSG00000184999	SLC22A10	NA	
ENSG00000196600	SLC22A25	NA	
ENSG00000256863	AP001880.2	NA	
ENSG00000256847	CCND2P1	NA	
ENSG00000256181	AP001880.1	NA	
ENSG00000149742	SLC22A9	NA	
ENSG00000168004	PLAAT5	NA	
ENSG00000275598	AP000484.1	NA	
ENSG00000287412	AP001591.1	NA	
ENSG00000133317	LGALS12	NA	
ENSG00000133321	PLAAT4	NA	
ENSG00000133328	PLAAT2	NA	
ENSG00000176485	PLAAT3	NA	
ENSG00000203520	AP000753.1	NA	
ENSG00000184743	ATL3	615632	NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F;;HSN IF
ENSG00000270269	IMMP1LP1	NA	
ENSG00000256789	AP000753.2	NA	
ENSG00000133318	RTN3	NA	
ENSG00000271100	AP000753.3	NA	
ENSG00000188070	C11orf95	NA	
ENSG00000264519	RN7SL596P	NA	
ENSG00000168005	SPINDOC	NA	
ENSG00000256280	AP006289.1	NA	
ENSG00000072518	MARK2	NA	
ENSG00000202089	RNU6-1306P	NA	
ENSG00000167771	RCOR2	NA	
ENSG00000110583	NAA40	NA	
ENSG00000207200	RNU6-45P	NA	
ENSG00000176340	COX8A	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000256100	AP000721.1	NA	
ENSG00000167770	OTUB1	NA	
ENSG00000133315	MACROD1	NA	
ENSG00000256824	AP000721.2	NA	
ENSG00000256481	AP006333.2	NA	
ENSG00000126500	FLRT1	NA	
ENSG00000256341	AP006333.1	NA	
ENSG00000168439	STIP1	NA	
ENSG00000149781	FERMT3	612840	LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3;;LEUKOCYTE ADHESION DEFICIENCY 3;;LEUKOCYTE ADHESION DEFICIENCY 1 VARIANT; LAD1V;;INTEGRIN ACTIVATION DEFICIENCY DISEASE; IADD
ENSG00000149743	TRPT1	NA	
ENSG00000149761	NUDT22	NA	
ENSG00000256116	AP001453.2	NA	
ENSG00000110011	DNAJC4	NA	
ENSG00000173511	VEGFB	NA	
ENSG00000173486	FKBP2	NA	
ENSG00000286264	AP001453.4	NA	
ENSG00000173457	PPP1R14B	NA	
ENSG00000256940	PPP1R14B-AS1	NA	
ENSG00000257086	AP001453.3	NA	
ENSG00000149782	PLCB3	NA	
ENSG00000002330	BAD	NA	
ENSG00000173264	GPR137	NA	
ENSG00000182450	KCNK4	618381	FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG
ENSG00000257069	KCNK4-TEX40	NA	
ENSG00000207024	AP001453.1	NA	
ENSG00000219435	CATSPERZ	NA	
ENSG00000173153	ESRRA	NA	
ENSG00000173113	TRMT112	NA	
ENSG00000126432	PRDX5	NA	
ENSG00000236935	AP003774.2	NA	
ENSG00000168071	CCDC88B	NA	
ENSG00000278359	MIR7155	NA	
ENSG00000162302	RPS6KA4	NA	
ENSG00000221273	MIR1237	NA	
ENSG00000231680	LINC02723	NA	
ENSG00000231492	AP003774.1	NA	
ENSG00000181908	LINC02724	NA	
ENSG00000286816	AP005273.2	NA	
ENSG00000232500	AP005273.1	NA	
ENSG00000237363	AP006288.1	NA	
ENSG00000168065	SLC22A11	NA	
ENSG00000197891	SLC22A12	220150	HYPOURICEMIA, RENAL, 1; RHUC1;;DALMATIAN HYPOURICEMIA;;RENAL HYPOURICEMIA
ENSG00000110076	NRXN2	NA	
ENSG00000237410	NRXN2-AS1	NA	
ENSG00000068831	RASGRP2	615888	BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18
ENSG00000068976	PYGM	232600	GLYCOGEN STORAGE DISEASE V; GSD5;;GSD V;;MCARDLE DISEASE;;MYOPHOSPHORYLASE DEFICIENCY;;MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY;;PYGM DEFICIENCY
ENSG00000168066	SF1	NA	
ENSG00000269038	AP001462.1	NA	
ENSG00000168067	MAP4K2	NA	
ENSG00000133895	MEN1	131100	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1;;MEN I;;ENDOCRINE ADENOMATOSIS, MULTIPLE;;MEA I;;WERMER SYNDROME MEN1 SOMATIC MUTATIONS, INCLUDED
ENSG00000171219	CDC42BPG	NA	
ENSG00000110047	EHD1	NA	
ENSG00000230835	AP001187.1	NA	
ENSG00000229719	MIR194-2HG	NA	
ENSG00000283926	MIR192	NA	
ENSG00000284155	MIR194-2	NA	
ENSG00000110046	ATG2A	NA	
ENSG00000274986	MIR6750	NA	
ENSG00000274314	MIR6749	NA	
ENSG00000068971	PPP2R5B	NA	
ENSG00000149735	GPHA2	NA	
ENSG00000168070	MAJIN	NA	
ENSG00000168062	BATF2	NA	
ENSG00000213465	ARL2	NA	
ENSG00000273003	ARL2-SNX15	NA	
ENSG00000278851	MIR6879	NA	
ENSG00000270775	AP000436.1	NA	
ENSG00000110025	SNX15	NA	
ENSG00000168061	SAC3D1	NA	
ENSG00000168060	NAALADL1	NA	
ENSG00000146670	CDCA5	NA	
ENSG00000162300	ZFPL1	NA	
ENSG00000187066	TMEM262	NA	
ENSG00000149823	VPS51	618606	PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13
ENSG00000254501	AP003068.1	NA	
ENSG00000149809	TM7SF2	NA	
ENSG00000174276	ZNHIT2	NA	
ENSG00000255173	AP003068.3	NA	
ENSG00000278952	AP003068.4	NA	
ENSG00000149806	FAU	NA	
ENSG00000162298	SYVN1	NA	
ENSG00000149792	MRPL49	NA	
ENSG00000284489	MIR6751	NA	
ENSG00000254455	HIGD1AP10	NA	
ENSG00000222477	RNU2-23P	NA	
ENSG00000255058	PDCL2P2	NA	
ENSG00000204710	SPDYC	NA	
ENSG00000255200	PGAM1P8	NA	
ENSG00000254614	AP003068.2	NA	
ENSG00000014216	CAPN1	616907	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76
ENSG00000197847	SLC22A20P	NA	
ENSG00000287821	AP000944.6	NA	
ENSG00000014138	POLA2	NA	
ENSG00000285816	AP000944.5	NA	
ENSG00000287917	AP000944.7	NA	
ENSG00000149798	CDC42EP2	NA	
ENSG00000133884	DPF2	618027	COFFIN-SIRIS SYNDROME 7; CSS7
ENSG00000173825	TIGD3	NA	
ENSG00000255478	AP000944.1	NA	
ENSG00000162241	SLC25A45	NA	
ENSG00000126391	FRMD8	NA	
ENSG00000245532	NEAT1	NA	
ENSG00000278144	AP000944.4	NA	
ENSG00000278050	AP000944.3	NA	
ENSG00000277599	AP000944.2	NA	
ENSG00000283791	MIR612	NA	
ENSG00000275948	AP000769.4	NA	
ENSG00000173727	AP000769.1	NA	
ENSG00000279243	LINC02736	NA	
ENSG00000286756	AP000769.6	NA	
ENSG00000251562	MALAT1	NA	
ENSG00000270117	AP000769.2	NA	
ENSG00000278217	AP000769.5	NA	
ENSG00000274072	AP000769.3	NA	
ENSG00000270526	SNRPGP19	NA	
ENSG00000142186	SCYL1	616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21, WITH HEPATOPATHY;;CHOLESTASIS, LOW GGT, ACUTE LIVER FAILURE, AND NEURODEGENERATION SYNDROME; CALFAN
ENSG00000168056	LTBP3	601216	DENTAL ANOMALIES AND SHORT STATURE; DASS;;VERLOES-BOURGUIGNON SYNDROME; VBS;;PLATYSPONDYLY WITH AMELOGENESIS IMPERFECTA;;TOOTH AGENESIS, SELECTIVE, 6, FORMERLY; STHAG6, FORMERLY
ENSG00000168056	LTBP3	617809	GELEOPHYSIC DYSPLASIA 3; GPHYSD3
ENSG00000279093	AP001362.1	NA	
ENSG00000260233	ZNRD2-AS1	NA	
ENSG00000173465	ZNRD2	NA	
ENSG00000176973	FAM89B	NA	
ENSG00000173442	EHBP1L1	NA	
ENSG00000173338	KCNK7	NA	
ENSG00000173327	MAP3K11	NA	
ENSG00000197136	PCNX3	NA	
ENSG00000266041	MIR4690	NA	
ENSG00000213445	SIPA1	NA	
ENSG00000265874	MIR4489	NA	
ENSG00000173039	RELA	618287	MUCOCUTANEOUS ULCERATION, CHRONIC; CMCU
ENSG00000285533	RELA-DT	NA	
ENSG00000239356	RN7SL309P	NA	
ENSG00000172977	KAT5	NA	
ENSG00000172922	RNASEH2C	610329	AICARDI-GOUTIERES SYNDROME 3; AGS3
ENSG00000214659	KRT8P26	NA	
ENSG00000255557	AP001266.2	NA	
ENSG00000254470	AP5B1	NA	
ENSG00000172818	OVOL1	NA	
ENSG00000255120	OVOL1-AS1	NA	
ENSG00000255404	AP001266.1	NA	
ENSG00000172757	CFL1	NA	
ENSG00000172803	SNX32	NA	
ENSG00000172732	MUS81	NA	
ENSG00000172638	EFEMP2	614437	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B
ENSG00000172543	CTSW	NA	
ENSG00000172500	FIBP	617107	THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS
ENSG00000175602	CCDC85B	NA	
ENSG00000175592	FOSL1	NA	
ENSG00000175573	C11orf68	NA	
ENSG00000175550	DRAP1	NA	
ENSG00000175513	TSGA10IP	NA	
ENSG00000175467	SART1	NA	
ENSG00000254867	AP006287.1	NA	
ENSG00000175376	EIF1AD	NA	
ENSG00000175334	BANF1	614008	NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS;;PROGERIA SYNDROME, CHILDHOOD-ONSET, WITH OSTEOLYSIS; PSCOO
ENSG00000175315	CST6	618535	ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15
ENSG00000175294	CATSPER1	612997	SPERMATOGENIC FAILURE 7; SPGF7;;MALE INFERTILITY, NONSYNDROMIC, AUTOSOMAL RECESSIVE; MIAR
ENSG00000175229	GAL3ST3	NA	
ENSG00000286459	AP006287.3	NA	
ENSG00000087365	SF3B2	NA	
ENSG00000255038	AP006287.2	NA	
ENSG00000175115	PACS1	615009	SCHUURS-HOEIJMAKERS SYNDROME; SHMS;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 17; MRD17
ENSG00000255320	AP000759.1	NA	
ENSG00000174996	KLC2	609541	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN
ENSG00000254461	AP001107.4	NA	
ENSG00000254855	AP001107.8	NA	
ENSG00000254762	AP001107.7	NA	
ENSG00000174903	RAB1B	NA	
ENSG00000245156	AP001107.1	NA	
ENSG00000254452	AP001107.2	NA	
ENSG00000174871	CNIH2	NA	
ENSG00000174851	YIF1A	NA	
ENSG00000179292	TMEM151A	NA	
ENSG00000254458	AP001107.3	NA	
ENSG00000174807	CD248	NA	
ENSG00000174791	RIN1	NA	
ENSG00000254756	AP001107.6	NA	
ENSG00000174744	BRMS1	NA	
ENSG00000174684	B4GAT1	615287	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GNT1-RELATED
ENSG00000255468	AP001107.9	NA	
ENSG00000174669	SLC29A2	NA	
ENSG00000276918	AP001107.10	NA	
ENSG00000254736	BRD9P1	NA	
ENSG00000202317	RNU1-84P	NA	
ENSG00000254510	AP001107.5	NA	
ENSG00000174576	NPAS4	NA	
ENSG00000201733	AP002748.1	NA	
ENSG00000174547	MRPL11	NA	
ENSG00000254596	AP002748.3	NA	
ENSG00000174516	PELI3	NA	
ENSG00000255517	AP002748.4	NA	
ENSG00000254986	DPP3	NA	
ENSG00000256349	AP002748.5	NA	
ENSG00000174483	BBS1	209900	BARDET-BIEDL SYNDROME 1; BBS1
ENSG00000286688	AP002748.6	NA	
ENSG00000174165	ZDHHC24	NA	
ENSG00000248746	ACTN3	617749	ACTN3 DEFICIENCY;;ALPHA-ACTININ-3 DEFICIENCY SPRINTING PERFORMANCE, INCLUDED
ENSG00000250105	AP002748.2	NA	
ENSG00000174080	CTSF	615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13;;CEROID LIPOFUSCINOSIS, NEURONAL, 13, KUFS TYPE
ENSG00000182791	CCDC87	NA	
ENSG00000173992	CCS	NA	
ENSG00000199325	RNU4-39P	NA	
ENSG00000248643	RBM14-RBM4	NA	
ENSG00000239306	RBM14	NA	
ENSG00000173933	RBM4	NA	
ENSG00000173914	RBM4B	NA	
ENSG00000173898	SPTBN2	600224	SPINOCEREBELLAR ATAXIA 5; SCA5
ENSG00000173898	SPTBN2	615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14;;CEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, SPECTRIN-ASSOCIATED, 1; SPARCA1
ENSG00000239553	RN7SL12P	NA	
ENSG00000173715	C11orf80	618432	HYDATIDIFORM MOLE, RECURRENT, 4; HYDM4
ENSG00000213409	C1QBPP2	NA	
ENSG00000254984	FTLP6	NA	
ENSG00000173653	RCE1	NA	
ENSG00000173599	PC	266150	PYRUVATE CARBOXYLASE DEFICIENCY;;PC DEFICIENCY;;ATAXIA WITH LACTIC ACIDOSIS II;;LEIGH NECROTIZING ENCEPHALOPATHY DUE TO PYRUVATE CARBOXYLASE DEFICIENCY;;LEIGH SYNDROME DUE TO PYRUVATE CARBOXYLASE DEFICIENCY
ENSG00000173621	LRFN4	NA	
ENSG00000239099	RNU7-23P	NA	
ENSG00000266423	MIR3163	NA	
ENSG00000173237	C11orf86	NA	
ENSG00000173227	SYT12	NA	
ENSG00000283326	MIR6860	NA	
ENSG00000173156	RHOD	NA	
ENSG00000173120	KDM2A	NA	
ENSG00000179038	AP001885.1	NA	
ENSG00000287934	AP001885.3	NA	
ENSG00000173020	GRK2	NA	
ENSG00000172932	ANKRD13D	NA	
ENSG00000172830	SSH3	NA	
ENSG00000287851	AP001885.2	NA	
ENSG00000172613	RAD9A	NA	
ENSG00000175482	POLD4	NA	
ENSG00000256514	AP003419.1	NA	
ENSG00000274251	AP003419.2	NA	
ENSG00000201684	RN7SKP239	NA	
ENSG00000175505	CLCF1	610313	CRISPONI/COLD-INDUCED SWEATING SYNDROME 2; CISS2
ENSG00000275484	AP003419.3	NA	
ENSG00000253024	RNU6-1238P	NA	
ENSG00000172531	PPP1CA	NA	
ENSG00000175463	TBC1D10C	NA	
ENSG00000172508	CARNS1	NA	
ENSG00000175634	RPS6KB2	NA	
ENSG00000255949	RPS6KB2-AS1	NA	
ENSG00000213402	PTPRCAP	NA	
ENSG00000172725	CORO1B	NA	
ENSG00000175514	GPR152	NA	
ENSG00000175544	CABP4	610427	CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B, FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE, FORMERLY
ENSG00000172663	TMEM134	NA	
ENSG00000110711	AIP	102200	PITUITARY ADENOMA 1, MULTIPLE TYPES; PITA1;;SOMATOTROPINOMA, FAMILIAL ISOLATED; FIS;;ISOLATED FAMILIAL SOMATOTROPINOMA; IFS;;SOMATOTROPHINOMA, FAMILIAL;;ACROMEGALY DUE TO PITUITARY ADENOMA 1;;PAGH1 PITUITARY ADENOMA PREDISPOSITION, INCLUDED; PAP, IN /.../;;PITUITARY ADENOMA, FAMILIAL ISOLATED, INCLUDED; FIPA, INCLUDED
ENSG00000110711	AIP	219090	PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4;;CUSHING DISEASE, PITUITARY
ENSG00000276769	MIR6752	NA	
ENSG00000110697	PITPNM1	NA	
ENSG00000167797	CDK2AP2	NA	
ENSG00000167791	CABP2	614899	DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93
ENSG00000283257	AP001184.1	NA	
ENSG00000084207	GSTP1	NA	
ENSG00000184224	C11orf72	NA	
ENSG00000255119	AP003385.3	NA	
ENSG00000167792	NDUFV1	618225	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4
ENSG00000231793	DOC2GP	NA	
ENSG00000167799	NUDT8	NA	
ENSG00000167800	TBX10	NA	
ENSG00000132744	ACY3	NA	
ENSG00000227834	AP003385.1	NA	
ENSG00000132746	ALDH3B2	NA	
ENSG00000239559	RPL37P2	NA	
ENSG00000184795	UNC93B5	NA	
ENSG00000235855	OR7E145P	NA	
ENSG00000254447	OR7E11P	NA	
ENSG00000285537	AP003385.5	NA	
ENSG00000254883	AP003385.2	NA	
ENSG00000255147	AP003385.4	NA	
ENSG00000227620	ALG1L8P	NA	
ENSG00000160172	FAM86C2P	NA	
ENSG00000273819	ENPP7P7	NA	
ENSG00000254792	AP003716.1	NA	
ENSG00000251637	LINC02754	NA	
ENSG00000206587	RNU6-46P	NA	
ENSG00000243672	RPS3AP40	NA	
ENSG00000254610	AC004923.1	NA	
ENSG00000254850	AC004923.2	NA	
ENSG00000255230	AC004923.3	NA	
ENSG00000255554	OR7E1P	NA	
ENSG00000110057	UNC93B1	610551	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1; IIAE1;;HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1
ENSG00000006534	ALDH3B1	NA	
ENSG00000255306	AC004923.4	NA	
ENSG00000110717	NDUFS8	618222	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2
ENSG00000284293	MIR7113	NA	
ENSG00000284435	MIR4691	NA	
ENSG00000110719	TCIRG1	259700	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1;;OSTEOPETROSIS, INFANTILE MALIGNANT 1;;MARBLE BONES, AUTOSOMAL RECESSIVE;;ALBERS-SCHONBERG DISEASE, AUTOSOMAL RECESSIVE
ENSG00000275022	MIR6753	NA	
ENSG00000255031	AP002807.1	NA	
ENSG00000110721	CHKA	NA	
ENSG00000255236	AP002992.1	NA	
ENSG00000110066	KMT5B	617788	MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51
ENSG00000171067	C11orf24	NA	
ENSG00000286369	AP002813.1	NA	
ENSG00000162337	LRP5	166710	OSTEOPOROSIS;;BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS; BMND;;OSTEOPOROSIS, POSTMENOPAUSAL;;OSTEOPOROSIS, INVOLUTIONAL  FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED
ENSG00000162337	LRP5	144750	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT;;HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS;;OSTEOSCLEROSIS, AUTOSOMAL DOMINANT
ENSG00000162337	LRP5	133780	EXUDATIVE VITREORETINOPATHY 1; EVR1;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;;FEVR, AUTOSOMAL DOMINANT;;CRISWICK-SCHEPENS SYNDROME RETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED
ENSG00000162337	LRP5	259770	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG;;OPS;;OSTEOGENESIS IMPERFECTA, OCULAR FORM
ENSG00000162337	LRP5	601813	EXUDATIVE VITREORETINOPATHY 4; EVR4
ENSG00000162337	LRP5	601884	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1 HIGH BONE MASS, INCLUDED; HBM, INCLUDED;;OSTEOPOROSIS, SUSCEPTIBILITY TO, INCLUDED
ENSG00000162337	LRP5	607634	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1;;OSTEOPETROSIS, AUTOSOMAL DOMINANT, TYPE I
ENSG00000162337	LRP5	607636	VAN BUCHEM DISEASE, TYPE 2;;VBCH2
ENSG00000162337	LRP5	617875	POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4
ENSG00000110075	PPP6R3	NA	
ENSG00000254856	NDUFA3P2	NA	
ENSG00000260808	AP003096.1	NA	
ENSG00000069482	GAL	616461	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8
ENSG00000132749	TESMIN	NA	
ENSG00000110090	CPT1A	255120	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY;;CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY;;CPT I DEFICIENCY;;CPT DEFICIENCY, HEPATIC, TYPE I
ENSG00000250508	LINC02701	NA	
ENSG00000197345	MRPL21	NA	
ENSG00000132740	IGHMBP2	604320	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1;;SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1; SMARD1;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VI; DHMN6;;HMN6;;HMN VI;;SEVERE INFANTILE AXONAL NEUROPATHY WITH RESPIRATORY FAI /.../SIANRF;;NEURONOPATHY, SEVERE INFANTILE AXONAL, WITH RESPIRATORY FAILURE;;SPINAL MUSCULAR ATROPHY, DIAPHRAGMATIC
ENSG00000132740	IGHMBP2	616155	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2S;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2S
ENSG00000255741	AP000808.1	NA	
ENSG00000172938	MRGPRD	NA	
ENSG00000261625	AP003071.4	NA	
ENSG00000261276	AP003071.3	NA	
ENSG00000172935	MRGPRF	NA	
ENSG00000256508	MRGPRF-AS1	NA	
ENSG00000162341	TPCN2	612267	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10;;SKIN/HAIR/EYE PIGMENTATION 10, BLOND/BROWN HAIR
ENSG00000287725	AP003071.5	NA	
ENSG00000265539	MIR3164	NA	
ENSG00000260895	AP003071.1	NA	
ENSG00000261070	AP003071.2	NA	
ENSG00000284713	SMIM38	NA	
ENSG00000172927	MYEOV	NA	
ENSG00000213275	IFITM9P	NA	
ENSG00000260877	AP005233.2	NA	
ENSG00000259854	AP005233.1	NA	
ENSG00000255980	AP000439.2	NA	
ENSG00000255606	AP000439.1	NA	
ENSG00000261347	AP000439.3	NA	
ENSG00000255774	LINC02747	NA	
ENSG00000285094	LINC01488	NA	
ENSG00000110092	CCND1	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000110092	CCND1	193300	VON HIPPEL-LINDAU SYNDROME; VHLS;;VHL VON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED
ENSG00000110092	CCND1	254500	MYELOMA, MULTIPLE AMYLOIDOSIS, SYSTEMIC, INCLUDED; AL, INCLUDED;;AL AMYLOIDOSIS, INCLUDED
ENSG00000149716	LTO1	NA	
ENSG00000162344	FGF19	NA	
ENSG00000256441	DNAJB6P5	NA	
ENSG00000075388	FGF4	NA	
ENSG00000186895	FGF3	610706	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM
ENSG00000260348	AP007216.1	NA	
ENSG00000260679	AP007216.2	NA	
ENSG00000255191	AP003555.2	NA	
ENSG00000254605	AP003555.1	NA	
ENSG00000248844	LINC02753	NA	
ENSG00000254417	LINC02584	NA	
ENSG00000202070	RNU6-1175P	NA	
ENSG00000131620	ANO1	NA	
ENSG00000255143	AP000879.2	NA	
ENSG00000254902	ANO1-AS1	NA	
ENSG00000168040	FADD	613759	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS;;FADD DEFICIENCY
ENSG00000254721	AP000879.1	NA	
ENSG00000131626	PPFIA1	NA	
ENSG00000255329	H2AZP4	NA	
ENSG00000254604	AP002336.2	NA	
ENSG00000221333	MIR548K	NA	
ENSG00000254484	AP002336.1	NA	
ENSG00000255539	AP002336.3	NA	
ENSG00000254495	AP000487.2	NA	
ENSG00000246889	AP000487.1	NA	
ENSG00000085733	CTTN	NA	
ENSG00000162105	SHANK2	613436	AUTISM, SUSCEPTIBILITY TO, 17; AUTS17
ENSG00000227726	AP001271.1	NA	
ENSG00000279459	AP001271.2	NA	
ENSG00000226627	SHANK2-AS1	NA	
ENSG00000236262	SHANK2-AS2	NA	
ENSG00000207196	Y_RNA	NA	
ENSG00000280089	AP000590.1	NA	
ENSG00000171671	SHANK2-AS3	NA	
ENSG00000263744	MIR3664	NA	
ENSG00000286708	AP003783.1	NA	
ENSG00000172900	ACTE1P	NA	
ENSG00000172893	DHCR7	270400	SMITH-LEMLI-OPITZ SYNDROME; SLOS;;SLO SYNDROME;;RSH SYNDROME;;RUTLEDGE LETHAL MULTIPLE CONGENITAL ANOMALY SYNDROME;;POLYDACTYLY, SEX REVERSAL, RENAL HYPOPLASIA, AND UNILOBAR LUNG;;LETHAL ACRODYSGENITAL SYNDROME
ENSG00000254682	AP002387.1	NA	
ENSG00000172890	NADSYN1	NA	
ENSG00000278349	MIR6754	NA	
ENSG00000254924	AP000867.2	NA	
ENSG00000244411	KRTAP5-7	NA	
ENSG00000241233	KRTAP5-8	NA	
ENSG00000254997	KRTAP5-9	NA	
ENSG00000286948	AP000867.5	NA	
ENSG00000204572	KRTAP5-10	NA	
ENSG00000248903	AP000867.1	NA	
ENSG00000204571	KRTAP5-11	NA	
ENSG00000249387	KRTAP5-14P	NA	
ENSG00000184055	OR7E87P	NA	
ENSG00000255562	UNC93B6	NA	
ENSG00000255261	OR7E4P	NA	
ENSG00000255415	AP000867.3	NA	
ENSG00000284625	AP000867.4	NA	
ENSG00000239481	RPS3AP41	NA	
ENSG00000248671	ALG1L9P	NA	
ENSG00000254805	SNRPCP14	NA	
ENSG00000254972	AP003498.1	NA	
ENSG00000255319	ENPP7P8	NA	
ENSG00000285933	AP003498.2	NA	
ENSG00000158483	FAM86C1P	NA	
ENSG00000254978	ALG1L9P	NA	
ENSG00000214534	ZNF705E	NA	
ENSG00000184276	DEFB108B	NA	
ENSG00000252902	RNA5SP342	NA	
ENSG00000255157	DEFB130C	NA	
ENSG00000254469	AP002495.1	NA	
ENSG00000225805	DEFB131B	NA	
ENSG00000228915	OR7E128P	NA	
ENSG00000254593	OR7E126P	NA	
ENSG00000137522	RNF121	NA	
ENSG00000255296	AP002490.2	NA	
ENSG00000137496	IL18BP	618549	HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO; FVH
ENSG00000137497	NUMA1	612376	ACUTE PROMYELOCYTIC LEUKEMIA; APL;;LEUKEMIA, ACUTE PROMYELOCYTIC
ENSG00000251143	AP002490.1	NA	
ENSG00000207012	RNU6-72P	NA	
ENSG00000263742	MIR3165	NA	
ENSG00000284922	AP000812.5	611451	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63
ENSG00000184154	LRTOMT	611451	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63
ENSG00000149357	LAMTOR1	NA	
ENSG00000284844	AP000812.4	NA	
ENSG00000110200	ANAPC15	NA	
ENSG00000110203	FOLR3	NA	
ENSG00000257075	RPEP6	NA	
ENSG00000256518	AP000812.3	NA	
ENSG00000204971	AP000812.1	NA	
ENSG00000255860	AP000812.2	NA	
ENSG00000110195	FOLR1	613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY
ENSG00000165457	FOLR2	NA	
ENSG00000165458	INPPL1	258480	OPSISMODYSPLASIA; OPSMD
ENSG00000165462	PHOX2A	602078	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2;;FEOM2 LOCUS;;FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, AUTOSOMAL RECESSIVE
ENSG00000228286	AP000593.2	NA	
ENSG00000285864	AP000593.4	NA	
ENSG00000213365	AP000593.1	NA	
ENSG00000162129	CLPB	616271	3-@METHYLGLUTACONIC ACIDURIA, TYPE VII; MGCA7;;3-@METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN
ENSG00000255843	AP000593.3	NA	
ENSG00000256739	AP002892.2	NA	
ENSG00000255672	AP002892.1	NA	
ENSG00000256403	AP003785.1	NA	
ENSG00000237408	ART2BP	NA	
ENSG00000238048	ART2P	NA	
ENSG00000276109	AP005019.2	NA	
ENSG00000274664	AP005019.1	NA	
ENSG00000227467	LINC01537	NA	
ENSG00000186642	PDE2A	NA	
ENSG00000256633	PDE2A-AS2	NA	
ENSG00000272036	MIR139	NA	
ENSG00000251919	RNU7-105P	NA	
ENSG00000255808	PDE2A-AS1	NA	
ENSG00000186635	ARAP1	NA	
ENSG00000256007	ARAP1-AS1	NA	
ENSG00000286555	AP003065.1	NA	
ENSG00000245148	ARAP1-AS2	NA	
ENSG00000244134	RPS12P20	NA	
ENSG00000214530	STARD10	NA	
ENSG00000202522	Y_RNA	NA	
ENSG00000265064	MIR4692	NA	
ENSG00000285693	AP002381.2	NA	
ENSG00000168010	ATG16L2	NA	
ENSG00000137478	FCHSD2	NA	
ENSG00000206638	RNU6-672P	NA	
ENSG00000234751	AP002381.1	NA	
ENSG00000256568	AP002761.2	NA	
ENSG00000215841	AP002761.1	NA	
ENSG00000175591	P2RY2	NA	
ENSG00000260401	AP002761.4	NA	
ENSG00000256347	OR8R1P	NA	
ENSG00000171631	P2RY6	NA	
ENSG00000257038	AP002761.3	NA	
ENSG00000110237	ARHGEF17	NA	
ENSG00000054967	RELT	618386	AMELOGENESIS IMPERFECTA, TYPE IIIC; AI3C;;AMELOGENESIS IMPERFECTA, HYPOCALCIFICATION TYPE, AUTOSOMAL RECESSIVE
ENSG00000256928	AP000763.4	NA	
ENSG00000054965	FAM168A	NA	
ENSG00000256448	AP000763.3	NA	
ENSG00000255786	AP000763.1	NA	
ENSG00000256148	AP000763.2	NA	
ENSG00000231726	HMGN2P38	NA	
ENSG00000270323	AP000860.1	NA	
ENSG00000021300	PLEKHB1	NA	
ENSG00000175582	RAB6A	NA	
ENSG00000255928	AP002993.1	NA	
ENSG00000256034	AP002770.1	NA	
ENSG00000175581	MRPL48	NA	
ENSG00000199975	RN7SKP243	NA	
ENSG00000256681	CCDC58P5	NA	
ENSG00000181924	COA4	NA	
ENSG00000175575	PAAF1	NA	
ENSG00000256898	AP002770.2	NA	
ENSG00000187726	DNAJB13	617091	CILIARY DYSKINESIA, PRIMARY, 34; CILD34;;CILIARY DYSKINESIA, PRIMARY, 34, WITHOUT SITUS INVERSUS
ENSG00000255847	AP003717.1	NA	
ENSG00000175567	UCP2	607447	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4;;OBESITY, SUSCEPTIBILITY TO
ENSG00000287425	AP003717.4	NA	
ENSG00000256189	AP003717.2	NA	
ENSG00000256723	AP003717.3	NA	
ENSG00000175564	UCP3	601665	OBESITY LEANNESS, INCLUDED
ENSG00000168014	C2CD3	615948	OROFACIODIGITAL SYNDROME XIV; OFD14
ENSG00000256098	AP002392.1	NA	
ENSG00000214517	PPME1	NA	
ENSG00000284736	RNA5SP343	NA	
ENSG00000280269	AP000577.2	NA	
ENSG00000149380	P4HA3	NA	
ENSG00000206913	AP000577.1	NA	
ENSG00000246211	P4HA3-AS1	NA	
ENSG00000165434	PGM2L1	NA	
ENSG00000212961	HNRNPA1P40	NA	
ENSG00000254631	AP001372.1	NA	
ENSG00000255440	AP001085.1	NA	
ENSG00000264402	MIR548AL	NA	
ENSG00000175538	KCNE3	613119	BRUGADA SYNDROME 6; BRGDA6
ENSG00000254928	AP001372.3	NA	
ENSG00000255444	CYCSP27	NA	
ENSG00000254974	AP001372.4	NA	
ENSG00000175536	LIPT2	617668	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA;;LIPOYLTRANSFERASE 2 DEFICIENCY; LIPT2D
ENSG00000254837	AP001372.2	NA	
ENSG00000077514	POLD3	NA	
ENSG00000254500	RANP3	NA	
ENSG00000223202	RN7SKP297	NA	
ENSG00000054938	CHRDL2	NA	
ENSG00000279353	AP001324.3	NA	
ENSG00000265902	MIR4696	NA	
ENSG00000241097	AP001324.2	NA	
ENSG00000227615	AP001324.1	NA	
ENSG00000166439	RNF169	NA	
ENSG00000166435	XRRA1	NA	
ENSG00000278879	AP000560.1	NA	
ENSG00000242999	RN7SL239P	NA	
ENSG00000241170	AP001992.1	NA	
ENSG00000286943	AP001992.2	NA	
ENSG00000118363	SPCS2	NA	
ENSG00000200152	RNU6-216P	NA	
ENSG00000162139	NEU3	NA	
ENSG00000284722	AP003175.1	NA	
ENSG00000234611	OR2AT2P	NA	
ENSG00000213333	NPM1P50	NA	
ENSG00000171561	OR2AT4	NA	
ENSG00000255395	AP001972.4	NA	
ENSG00000137491	SLCO2B1	NA	
ENSG00000254475	OR2AT1P	NA	
ENSG00000255136	AP001972.3	NA	
ENSG00000255460	ZDHHC20P3	NA	
ENSG00000261594	TPBGL	NA	
ENSG00000137486	ARRB1	NA	
ENSG00000254429	AP001972.1	NA	
ENSG00000279117	AP001972.5	NA	
ENSG00000254963	AP001972.2	NA	
ENSG00000199090	MIR326	NA	
ENSG00000149273	RPS3	NA	
ENSG00000206941	SNORD15A	NA	
ENSG00000207445	SNORD15B	NA	
ENSG00000149243	KLHL35	NA	
ENSG00000158555	GDPD5	NA	
ENSG00000254460	AP002815.1	NA	
ENSG00000149257	SERPINH1	610504	PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
ENSG00000149257	SERPINH1	613848	OSTEOGENESIS IMPERFECTA, TYPE X; OI10;;OI, TYPE X
ENSG00000255326	AP001922.5	NA	
ENSG00000171533	MAP6	NA	
ENSG00000255434	AP001922.6	NA	
ENSG00000254630	AP001922.2	NA	
ENSG00000255280	AP001922.4	NA	
ENSG00000166391	MOGAT2	NA	
ENSG00000263993	RN7SL786P	NA	
ENSG00000247867	AP001922.1	NA	
ENSG00000062282	DGAT2	NA	
ENSG00000254826	AP001922.3	NA	
ENSG00000254814	AP003031.3	NA	
ENSG00000255507	UVRAG-DT	NA	
ENSG00000198382	UVRAG	NA	
ENSG00000200256	AP003031.2	NA	
ENSG00000199362	AP003031.1	NA	
ENSG00000255255	PPP1R1AP1	NA	
ENSG00000255081	AP003168.2	NA	
ENSG00000223013	RNA5SP344	NA	
ENSG00000254915	AP003168.1	NA	
ENSG00000255421	AP002340.1	NA	
ENSG00000085741	WNT11	NA	
ENSG00000254933	AP000785.1	NA	
ENSG00000255362	LINC02761	NA	
ENSG00000137492	THAP12	NA	
ENSG00000179240	GVQW3	NA	
ENSG00000201756	Y_RNA	NA	
ENSG00000255135	AP002360.1	NA	
ENSG00000158636	EMSY	NA	
ENSG00000254755	AP001189.2	NA	
ENSG00000255363	LINC02757	NA	
ENSG00000255479	AP001189.5	NA	
ENSG00000254810	AP001189.3	NA	
ENSG00000236304	AP001189.1	NA	
ENSG00000137507	LRRC32	NA	
ENSG00000254975	AP001189.4	NA	
ENSG00000204529	GUCY2EP	NA	
ENSG00000254632	AP003119.1	NA	
ENSG00000182704	TSKU	NA	
ENSG00000255100	AP003119.2	NA	
ENSG00000261578	AP003119.3	NA	
ENSG00000078124	ACER3	617762	LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO
ENSG00000254988	AP002498.1	NA	
ENSG00000198488	B3GNT6	NA	
ENSG00000149260	CAPN5	193235	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI;;PROLIFERATIVE VITREORETINOPATHY; PVR;;VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY, AUTOSOMAL DOMINANT; ADNIV
ENSG00000254550	OMP	NA	
ENSG00000137474	MYO7A	276900	USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESS USHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORME /.../NCLUDED
ENSG00000137474	MYO7A	600060	DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 2; NSRD2
ENSG00000137474	MYO7A	601317	DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11
ENSG00000178795	GDPD4	NA	
ENSG00000224829	TOMM20P1	NA	
ENSG00000149269	PAK1	618158	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD
ENSG00000268635	AP003680.1	NA	
ENSG00000074201	CLNS1A	NA	
ENSG00000238880	RNU7-59P	NA	
ENSG00000178301	AQP11	NA	
ENSG00000048649	RSF1	NA	
ENSG00000206816	Y_RNA	NA	
ENSG00000254985	RSF1-IT2	NA	
ENSG00000227376	FTH1P16	NA	
ENSG00000255409	RSF1-IT1	NA	
ENSG00000219529	AP000580.1	NA	
ENSG00000087884	AAMDC	NA	
ENSG00000254459	AP002812.2	NA	
ENSG00000254691	AP002812.3	NA	
ENSG00000255449	AP002812.5	NA	
ENSG00000241782	AP002812.1	NA	
ENSG00000149262	INTS4	NA	
ENSG00000255115	AP002812.4	NA	
ENSG00000254829	AP003032.2	NA	
ENSG00000151364	KCTD14	NA	
ENSG00000259112	NDUFC2-KCTD14	NA	
ENSG00000254675	AP003032.1	NA	
ENSG00000151365	THRSP	NA	
ENSG00000151366	NDUFC2	NA	
ENSG00000159063	ALG8	608104	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H;;CDG Ih; CDGIh
ENSG00000159063	ALG8	617874	POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3
ENSG00000252494	RNU6-126P	NA	
ENSG00000246174	KCTD21-AS1	NA	
ENSG00000188997	KCTD21	NA	
ENSG00000118369	USP35	NA	
ENSG00000033327	GAB2	NA	
ENSG00000288538	AP002985.1	NA	
ENSG00000254420	AP003086.1	NA	
ENSG00000288393	AP003086.3	NA	
ENSG00000254649	AP003086.2	NA	
ENSG00000251323	LINC02728	NA	
ENSG00000137513	NARS2	616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24
ENSG00000137513	NARS2	618434	DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94
ENSG00000255084	AP003110.1	NA	
ENSG00000252033	RNU6-311P	NA	
ENSG00000254697	COPS8P3	NA	
ENSG00000149256	TENM4	616736	TREMOR, HEREDITARY ESSENTIAL, 5; ETM5
ENSG00000254563	AP002768.1	NA	
ENSG00000255345	AP002957.1	NA	
ENSG00000254885	AP001547.1	NA	
ENSG00000211997	MIR708	NA	
ENSG00000266570	MIR5579	NA	
ENSG00000255209	AP001978.1	NA	
ENSG00000279295	AP001541.1	NA	
ENSG00000254471	AP001284.1	NA	
ENSG00000254434	AP006295.1	NA	
ENSG00000200146	RNU6-544P	NA	
ENSG00000255014	ARL6IP1P3	NA	
ENSG00000255178	LINC02720	NA	
ENSG00000254437	AP003398.1	NA	
ENSG00000285568	AP003398.2	NA	
ENSG00000287912	AP003464.1	NA	
ENSG00000254747	MTND4LP18	NA	
ENSG00000255316	MTND6P25	NA	
ENSG00000245832	MIR4300HG	NA	
ENSG00000270701	AP002802.2	NA	
ENSG00000264110	MIR4300	NA	
ENSG00000254511	AP002802.1	NA	
ENSG00000255246	AP000793.1	NA	
ENSG00000227097	RPS28P7	NA	
ENSG00000182103	FAM181B	NA	
ENSG00000255382	LINC02734	NA	
ENSG00000255063	AP001646.2	NA	
ENSG00000137509	PRCP	NA	
ENSG00000254441	AP001646.1	NA	
ENSG00000165490	DDIAS	NA	
ENSG00000242279	AP000893.1	NA	
ENSG00000254698	AP000893.2	NA	
ENSG00000137502	RAB30	NA	
ENSG00000254522	AP001767.1	NA	
ENSG00000207221	SNORA70E	NA	
ENSG00000246067	RAB30-DT	NA	
ENSG00000255503	AP001767.3	NA	
ENSG00000279900	AP001767.4	NA	
ENSG00000255010	AP001767.2	NA	
ENSG00000254965	C1DP5	NA	
ENSG00000255051	BCAS2P1	NA	
ENSG00000165494	PCF11	NA	
ENSG00000254676	AP000873.4	NA	
ENSG00000247137	AP000873.2	NA	
ENSG00000269939	PCF11-AS1	NA	
ENSG00000137494	ANKRD42	NA	
ENSG00000255541	AP000873.5	NA	
ENSG00000254551	AP000873.3	NA	
ENSG00000241020	AP000873.1	NA	
ENSG00000137500	CCDC90B	NA	
ENSG00000255234	AP000446.1	NA	
ENSG00000255003	CYCSP28	NA	
ENSG00000274004	AP000446.2	NA	
ENSG00000150672	DLG2	NA	
ENSG00000255311	DLG2-AS2	NA	
ENSG00000254629	AP002370.1	NA	
ENSG00000250257	LDHAL6DP	NA	
ENSG00000254713	HNRNPA1P72	NA	
ENSG00000240174	AP000852.1	NA	
ENSG00000254787	AP001825.1	NA	
ENSG00000274006	AP001825.2	NA	
ENSG00000276179	AP001825.3	NA	
ENSG00000255555	AP000857.2	NA	
ENSG00000255396	AP000857.1	NA	
ENSG00000213305	HNRNPCP6	NA	
ENSG00000254684	AP002803.1	NA	
ENSG00000254897	AP003035.1	NA	
ENSG00000206583	RNU6-1292P	NA	
ENSG00000171204	TMEM126B	618250	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29
ENSG00000171202	TMEM126A	612989	OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7
ENSG00000137504	CREBZF	NA	
ENSG00000179071	CCDC89	NA	
ENSG00000137501	SYTL2	NA	
ENSG00000279742	AP000974.1	NA	
ENSG00000150676	CCDC83	NA	
ENSG00000255005	AP003128.1	NA	
ENSG00000254479	SLC25A1P1	NA	
ENSG00000073921	PICALM	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000200877	RNU6-560P	NA	
ENSG00000254699	LINC02695	NA	
ENSG00000254502	AP003097.1	NA	
ENSG00000276669	Metazoa_SRP	NA	
ENSG00000074266	EED	617561	COHEN-GIBSON SYNDROME; COGIS
ENSG00000283744	MIR6755	NA	
ENSG00000254783	AP003084.1	NA	
ENSG00000255222	SETP17	NA	
ENSG00000149196	HIKESHI	616881	LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13
ENSG00000239856	RN7SL225P	NA	
ENSG00000149201	CCDC81	NA	
ENSG00000254733	AP001831.1	NA	
ENSG00000254727	PTP4A1P6	NA	
ENSG00000278989	AP001148.1	NA	
ENSG00000151376	ME3	NA	
ENSG00000254731	AP003059.1	NA	
ENSG00000255250	AP003059.2	NA	
ENSG00000150687	PRSS23	NA	
ENSG00000271318	MOB4P2	NA	
ENSG00000197882	OR7E13P	NA	
ENSG00000269895	AP000654.1	NA	
ENSG00000255203	OR7E2P	NA	
ENSG00000255471	AP001528.1	NA	
ENSG00000280339	AP001528.2	NA	
ENSG00000174804	FZD4	133780	EXUDATIVE VITREORETINOPATHY 1; EVR1;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;;FEVR, AUTOSOMAL DOMINANT;;CRISWICK-SCHEPENS SYNDROME RETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED
ENSG00000246523	FZD4-DT	NA	
ENSG00000254748	HNRNPCP8	NA	
ENSG00000166575	TMEM135	NA	
ENSG00000254843	XIAPP2	NA	
ENSG00000279836	AP002967.1	NA	
ENSG00000213287	AP001102.1	NA	
ENSG00000270510	AP000811.1	NA	
ENSG00000254582	PSMA2P1	NA	
ENSG00000255391	AP003497.1	NA	
ENSG00000279701	AP003497.2	NA	
ENSG00000278929	AP001784.1	NA	
ENSG00000223015	RNU6-1135P	NA	
ENSG00000283412	U6	NA	
ENSG00000255183	LINC02711	NA	
ENSG00000279341	AP000756.1	NA	
ENSG00000254650	MTCYBP41	NA	
ENSG00000255022	AP000676.2	NA	
ENSG00000279793	AP000676.3	NA	
ENSG00000285835	AP000676.5	NA	
ENSG00000280307	AP000676.4	NA	
ENSG00000254794	AP000676.1	NA	
ENSG00000255516	AP005436.3	NA	
ENSG00000255102	AP005436.1	NA	
ENSG00000255241	AP005436.2	NA	
ENSG00000206690	Y_RNA	NA	
ENSG00000123892	RAB38	NA	
ENSG00000279733	AP001642.1	NA	
ENSG00000266581	MIR3166	NA	
ENSG00000109861	CTSC	170650	PERIODONTITIS, AGGRESSIVE, 1;;PERIODONTITIS, JUVENILE; JPD; JP;;PERIODONTITIS, PREPUBERTAL; PPP
ENSG00000109861	CTSC	245000	PAPILLON-LEFEVRE SYNDROME; PALS;;PLS;;KERATOSIS PALMOPLANTARIS WITH PERIODONTOPATHIA
ENSG00000109861	CTSC	245010	HAIM-MUNK SYNDROME; HMS;;KERATOSIS PALMOPLANTARIS WITH PERIODONTOPATHIA AND ONYCHOGRYPOSIS;;COCHIN JEWISH DISORDER
ENSG00000249489	GAPDHP70	NA	
ENSG00000288018	AP003120.1	NA	
ENSG00000168959	GRM5	NA	
ENSG00000255082	GRM5-AS1	NA	
ENSG00000207113	RNU6-16P	NA	
ENSG00000077498	TYR	203100	ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A;;OCULOCUTANEOUS ALBINISM, TYPE I; OCA1;;ALBINISM I;;OCULOCUTANEOUS ALBINISM, TYROSINASE-NEGATIVE; ATN
ENSG00000077498	TYR	601800	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3;;SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;;SKIN/HAIR/EYE PIGMENTATION 3, FRECKLING;;SKIN/HAIR/EYE PIGMENTATION 3, BLUE/GREEN EYE COLOR;;EYE COLOR 1; EYCL1;;EYE COLOR, GREEN/BLUE; GEY MELANOMA,  /.../OUS MALIGNANT, SUSCEPTIBILITY TO, 8, INCLUDED
ENSG00000077498	TYR	606952	ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISM ALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED
ENSG00000197692	CBX3P7	NA	
ENSG00000279297	AP000720.1	NA	
ENSG00000279603	AP000720.2	NA	
ENSG00000086991	NOX4	NA	
ENSG00000255295	H3P34	NA	
ENSG00000279248	AP003400.4	NA	
ENSG00000279697	AP003400.5	NA	
ENSG00000255429	AP003400.1	NA	
ENSG00000279045	AP003400.2	NA	
ENSG00000279056	AP003400.3	NA	
ENSG00000280201	AP003400.6	NA	
ENSG00000134612	FOLH1B	NA	
ENSG00000255385	UBTFL10	NA	
ENSG00000279163	AP003122.6	NA	
ENSG00000214414	TRIM77	NA	
ENSG00000255486	AP003122.4	NA	
ENSG00000255540	AP003122.5	NA	
ENSG00000234376	UBTFL2	NA	
ENSG00000254971	AP003122.2	NA	
ENSG00000255170	AP003122.3	NA	
ENSG00000204456	AP003122.1	NA	
ENSG00000254751	TRIM64DP	NA	
ENSG00000255162	AP004833.2	NA	
ENSG00000255285	AP004833.3	NA	
ENSG00000168930	TRIM49	NA	
ENSG00000250946	AP004833.1	NA	
ENSG00000166013	TRIM53BP	NA	
ENSG00000204455	TRIM51BP	NA	
ENSG00000254558	AP005435.1	NA	
ENSG00000189253	TRIM64B	NA	
ENSG00000255235	AP005435.4	NA	
ENSG00000254617	AP005435.2	NA	
ENSG00000254785	AP005435.3	NA	
ENSG00000255055	MTND1P35	NA	
ENSG00000223417	TRIM49D1	NA	
ENSG00000233802	TRIM49D2	NA	
ENSG00000254818	AP004607.3	NA	
ENSG00000278837	AP004607.9	NA	
ENSG00000255360	AP004607.8	NA	
ENSG00000254655	AP004607.1	NA	
ENSG00000204450	TRIM64	NA	
ENSG00000255305	AP004607.7	NA	
ENSG00000237706	TRIM51EP	NA	
ENSG00000225581	TRIM53AP	NA	
ENSG00000255184	AP004607.6	NA	
ENSG00000204449	TRIM49C	NA	
ENSG00000254803	AP004607.2	NA	
ENSG00000254916	AP004607.4	NA	
ENSG00000223709	TRIM64EP	NA	
ENSG00000255011	AP004607.5	NA	
ENSG00000254888	AP000827.1	NA	
ENSG00000255009	UBTFL1	NA	
ENSG00000254436	AP000648.2	NA	
ENSG00000286665	AP000648.9	NA	
ENSG00000207299	AP000648.1	NA	
ENSG00000279299	AP000648.3	NA	
ENSG00000077616	NAALAD2	NA	
ENSG00000280385	AP000648.4	NA	
ENSG00000110172	CHORDC1	NA	
ENSG00000280367	AP002364.1	NA	
ENSG00000261645	DISC1FP1	NA	
ENSG00000214391	TUBAP2	NA	
ENSG00000266703	MIR4490	NA	
ENSG00000280430	AP002782.1	NA	
ENSG00000221586	MIR1261	NA	
ENSG00000280085	AP001002.3	NA	
ENSG00000279209	AP001002.1	NA	
ENSG00000279438	AP001002.2	NA	
ENSG00000254677	OSBPL9P2	NA	
ENSG00000255070	OSBPL9P3	NA	
ENSG00000255187	LINC02748	NA	
ENSG00000280124	AP003485.2	NA	
ENSG00000278980	AP003485.1	NA	
ENSG00000280093	AP002791.1	NA	
ENSG00000255332	LINC02756	NA	
ENSG00000254961	TUBB4BP4	NA	
ENSG00000278859	AP002799.1	NA	
ENSG00000242248	RPL7AP57	NA	
ENSG00000235547	NDUFB11P1	NA	
ENSG00000165323	FAT3	NA	
ENSG00000249255	PGAM1P9	NA	
ENSG00000254705	AP000722.1	NA	
ENSG00000244244	RPS3AP42	NA	
ENSG00000255506	AP003718.1	NA	
ENSG00000282916	LINC02746	NA	
ENSG00000255127	AP003171.2	NA	
ENSG00000255287	SNRPGP16	NA	
ENSG00000254874	AP003171.1	NA	
ENSG00000134640	MTNR1B	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000242807	RPL26P31	NA	
ENSG00000278892	AP002371.1	NA	
ENSG00000279304	AP003072.4	NA	
ENSG00000180773	SLC36A4	NA	
ENSG00000255445	AP003072.2	NA	
ENSG00000280379	AP003072.5	NA	
ENSG00000279269	AP003072.3	NA	
ENSG00000233737	AP003072.1	NA	
ENSG00000255233	AP003969.1	NA	
ENSG00000279684	AP003969.2	NA	
ENSG00000165325	DEUP1	NA	
ENSG00000166002	SMCO4	NA	
ENSG00000234106	SRP14P2	NA	
ENSG00000240202	RN7SL223P	NA	
ENSG00000279454	AP003499.5	NA	
ENSG00000278953	AP003499.4	NA	
ENSG00000255515	AP003499.1	NA	
ENSG00000166004	CEP295	NA	
ENSG00000199875	Y_RNA	NA	
ENSG00000254911	SCARNA9	NA	
ENSG00000275146	AP003499.3	NA	
ENSG00000273885	AP003499.2	NA	
ENSG00000279696	AP001273.1	NA	
ENSG00000166012	TAF1D	NA	
ENSG00000207112	SNORA25	NA	
ENSG00000206799	SNORA32	NA	
ENSG00000202314	SNORD6	NA	
ENSG00000206834	SNORA1	NA	
ENSG00000207304	SNORA8	NA	
ENSG00000239195	SNORD5	NA	
ENSG00000207145	SNORA18	NA	
ENSG00000284458	MIR1304	NA	
ENSG00000210825	SNORA40	NA	
ENSG00000182919	C11orf54	NA	
ENSG00000284057	AP001273.2	NA	
ENSG00000042429	MED17	613668	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY
ENSG00000214376	VSTM5	NA	
ENSG00000206911	Y_RNA	NA	
ENSG00000255995	AP002795.1	NA	
ENSG00000256752	HPRT1P3	NA	
ENSG00000181333	HEPHL1	261990	ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD;;PILI TORTI AND DEVELOPMENTAL DELAY
ENSG00000227593	PHBP16	NA	
ENSG00000110218	PANX1	618550	OOCYTE MATURATION DEFECT 7; OOMD7
ENSG00000250519	AP002784.1	NA	
ENSG00000256745	AP002784.2	NA	
ENSG00000183560	IZUMO1R	NA	
ENSG00000123901	GPR83	NA	
ENSG00000020922	MRE11	604391	ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1;;ATLD
ENSG00000221230	MIR548L	NA	
ENSG00000255893	AP000786.1	NA	
ENSG00000168876	ANKRD49	NA	
ENSG00000257057	C11orf97	NA	
ENSG00000134627	PIWIL4	NA	
ENSG00000196371	FUT4	NA	
ENSG00000255929	AP000943.2	NA	
ENSG00000280167	AP000943.3	NA	
ENSG00000233536	AP000943.1	NA	
ENSG00000255666	LINC02700	NA	
ENSG00000166025	AMOTL1	NA	
ENSG00000256469	AP002383.2	NA	
ENSG00000213368	ST13P11	NA	
ENSG00000150316	CWC15	NA	
ENSG00000186280	KDM4D	NA	
ENSG00000255653	AP002383.1	NA	
ENSG00000235268	KDM4E	NA	
ENSG00000274486	AP002383.5	NA	
ENSG00000256779	AP002383.3	NA	
ENSG00000257012	AP002383.4	NA	
ENSG00000255855	KDM4F	NA	
ENSG00000277984	AP001264.1	NA	
ENSG00000263465	SRSF8	NA	
ENSG00000149218	ENDOD1	NA	
ENSG00000270689	BUD13P1	NA	
ENSG00000270578	AP000787.2	NA	
ENSG00000245552	AP000787.1	NA	
ENSG00000149212	SESN3	NA	
ENSG00000282834	AP000787.3	NA	
ENSG00000250390	AP001790.1	NA	
ENSG00000285842	AP000820.2	NA	
ENSG00000255605	AP000820.1	NA	
ENSG00000273600	AP001877.1	NA	
ENSG00000077458	FAM76B	NA	
ENSG00000166037	CEP57	614114	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2
ENSG00000087053	MTMR2	601382	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1;;CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, WITH FOCALLY FOLDED MYELIN SHEATHS, AUTOSOMAL RECESSIVE, TYPE 4B1;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4B1;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B; CMT4B
ENSG00000222578	RNA5SP345	NA	
ENSG00000242993	AP000870.1	NA	
ENSG00000184384	MAML2	NA	
ENSG00000285921	AP000779.1	NA	
ENSG00000266192	MIR1260B	NA	
ENSG00000149231	CCDC82	NA	
ENSG00000183340	JRKL	NA	
ENSG00000255679	JRKL-AS1	NA	
ENSG00000200411	RNA5SP346	NA	
ENSG00000256684	LINC02737	NA	
ENSG00000254587	AP003066.1	NA	
ENSG00000255376	AP003066.2	NA	
ENSG00000255205	MED28P5	NA	
ENSG00000270753	AP001836.1	NA	
ENSG00000255039	LINC02553	NA	
ENSG00000199315	RNA5SP347	NA	
ENSG00000255502	LINC02713	NA	
ENSG00000254555	AP003730.1	NA	
ENSG00000255380	AP001317.1	NA	
ENSG00000254939	AP003038.1	NA	
ENSG00000254599	AP003715.1	NA	
ENSG00000254830	AP002428.1	NA	
ENSG00000149972	CNTN5	NA	
ENSG00000223269	RN7SKP53	NA	
ENSG00000255547	RPA2P3	NA	
ENSG00000242165	RN7SL222P	NA	
ENSG00000255059	PPIAP43	NA	
ENSG00000248027	ARHGAP42-AS1	NA	
ENSG00000165895	ARHGAP42	NA	
ENSG00000200047	RN7SKP115	NA	
ENSG00000082175	PGR	264080	PROGESTERONE RESISTANCE;;PSEUDOCORPUS LUTEUM INSUFFICIENCY
ENSG00000282728	PGR-AS1	NA	
ENSG00000255504	AP001533.1	NA	
ENSG00000137672	TRPC6	603965	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 2
ENSG00000263885	MIR3920	NA	
ENSG00000254506	AP003080.1	NA	
ENSG00000254534	AP000776.1	NA	
ENSG00000187151	ANGPTL5	NA	
ENSG00000110318	CEP126	NA	
ENSG00000137691	CFAP300	618063	CILIARY DYSKINESIA, PRIMARY, 38; CILD38;;CILIARY DYSKINESIA, PRIMARY, 38, WITH OR WITHOUT SITUS INVERSUS
ENSG00000274097	RNA5SP535	NA	
ENSG00000260008	AP001527.1	NA	
ENSG00000277459	AP001527.2	NA	
ENSG00000137693	YAP1	120433	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1
ENSG00000254422	AP000942.2	NA	
ENSG00000243777	AP000942.1	NA	
ENSG00000270868	AP000942.3	NA	
ENSG00000271600	AP000942.4	NA	
ENSG00000212466	RNU6-952P	NA	
ENSG00000288528	AP000942.5	NA	
ENSG00000023445	BIRC3	NA	
ENSG00000110330	BIRC2	NA	
ENSG00000152558	TMEM123	NA	
ENSG00000255337	AP001830.1	NA	
ENSG00000255482	AP001830.2	NA	
ENSG00000137673	MMP7	NA	
ENSG00000137674	MMP20	612529	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2;;AMELOGENESIS IMPERFECTA, PIGMENTED HYPOMATURATION TYPE, 2
ENSG00000256916	AP000851.1	NA	
ENSG00000281655	AP000851.2	NA	
ENSG00000137675	MMP27	NA	
ENSG00000118113	MMP8	NA	
ENSG00000255282	WTAPP1	NA	
ENSG00000225678	AP000619.1	NA	
ENSG00000256254	AP000619.3	NA	
ENSG00000166670	MMP10	NA	
ENSG00000196611	MMP1	226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RE /.../E EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATA VARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000196611	MMP1	606963	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SEVERE EARLY-ONSET, INCLUDED;;COPD, SEVERE EARLY-ONSET, INCLUDED;;PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, RATE OF DECLINE OF LUNG FUNCTION IN, INCLUDED
ENSG00000256035	AP000619.2	NA	
ENSG00000149968	MMP3	614466	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6
ENSG00000262406	MMP12	NA	
ENSG00000255469	BOLA3P1	NA	
ENSG00000238562	RNU7-159P	NA	
ENSG00000137745	MMP13	250400	METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST;;METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE
ENSG00000137745	MMP13	602111	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE;;SEMD, MISSOURI TYPE  METAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED
ENSG00000276521	AP001486.3	NA	
ENSG00000239861	AP001486.1	NA	
ENSG00000137692	DCUN1D5	NA	
ENSG00000260966	AP001486.2	NA	
ENSG00000187240	DYNC2H1	613091	SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3;;ASPHYXIATING THORACIC DYSTROPHY 3; ATD3;;SHORT RIB-POLYDACTYLY SYNDROME, TYPE I; SRPS1;;SALDINO-NOONAN SYNDROME;;POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE I;;SHORT RIB-POLYDAC /.../YNDROME, TYPE III; SRPS3;;VERMA-NAUMOFF SYNDROME;;POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE III;;SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIB; SRPS2B
ENSG00000285878	AP002961.1	NA	
ENSG00000254895	MTCO3P15	NA	
ENSG00000254931	MTATP6P15	NA	
ENSG00000255417	MTCO2P15	NA	
ENSG00000255350	MTCO1P15	NA	
ENSG00000254565	MTND2P26	NA	
ENSG00000253245	MTND1P36	NA	
ENSG00000254824	AP003461.1	NA	
ENSG00000254987	AP002989.1	NA	
ENSG00000264200	MIR4693	NA	
ENSG00000170962	PDGFD	NA	
ENSG00000255548	AP003043.1	NA	
ENSG00000170967	DDI1	NA	
ENSG00000280773	AP003304.1	NA	
ENSG00000256422	LINC02552	NA	
ENSG00000270449	AP001485.1	NA	
ENSG00000254569	AP002004.1	NA	
ENSG00000204403	CASP12	NA	
ENSG00000235505	CASP4LP	NA	
ENSG00000196954	CASP4	NA	
ENSG00000284715	AP001153.1	NA	
ENSG00000137757	CASP5	NA	
ENSG00000137752	CASP1	NA	
ENSG00000204397	CARD16	NA	
ENSG00000288255	AP001153.2	NA	
ENSG00000254750	CASP1P2	NA	
ENSG00000255221	CARD17	NA	
ENSG00000255430	CASP1P1	NA	
ENSG00000255501	CARD18	NA	
ENSG00000254767	OR2AL1P	NA	
ENSG00000255336	AP003181.1	NA	
ENSG00000278640	Metazoa_SRP	NA	
ENSG00000152578	GRIA4	617864	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA
ENSG00000255403	AP000641.1	NA	
ENSG00000222663	RNU4-55P	NA	
ENSG00000252081	RNU6-277P	NA	
ENSG00000285813	AP000813.1	NA	
ENSG00000170903	MSANTD4	NA	
ENSG00000182359	KBTBD3	NA	
ENSG00000149313	AASDHPPT	NA	
ENSG00000254433	AP001001.1	NA	
ENSG00000287846	AP001001.2	NA	
ENSG00000254580	LINC02719	NA	
ENSG00000286345	AP002001.3	NA	
ENSG00000254811	AP002001.1	NA	
ENSG00000255065	AP002001.2	NA	
ENSG00000287802	AP003173.1	NA	
ENSG00000152402	GUCY1A2	NA	
ENSG00000274584	AP001282.2	NA	
ENSG00000213252	AP001282.1	NA	
ENSG00000255353	AP003057.1	NA	
ENSG00000261098	AP000766.1	NA	
ENSG00000152404	CWF19L2	NA	
ENSG00000225215	SMARCE1P1	NA	
ENSG00000137760	ALKBH8	618504	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 71
ENSG00000270969	AP001823.1	NA	
ENSG00000110675	ELMOD1	NA	
ENSG00000255483	AP000889.2	NA	
ENSG00000254758	AP000889.1	NA	
ENSG00000170290	SLN	NA	
ENSG00000254702	AP002353.1	NA	
ENSG00000110660	SLC35F2	NA	
ENSG00000240652	AP001024.1	NA	
ENSG00000179331	RAB39A	NA	
ENSG00000288012	AP003307.1	NA	
ENSG00000166266	CUL5	NA	
ENSG00000200855	Y_RNA	NA	
ENSG00000255467	AP002433.1	NA	
ENSG00000075239	ACAT1	203750	ALPHA-METHYLACETOACETIC ACIDURIA;;2-@METHYL-3-HYDROXYBUTYRIC ACIDEMIA;;BETA-KETOTHIOLASE DEFICIENCY;;MITOCHONDRIAL ACETOACETYL-CoA THIOLASE DEFICIENCY;;MAT DEFICIENCY;;T2 DEFICIENCY;;3-@OXOTHIOLASE DEFICIENCY;;3-@KETOTHIOLASE DEFICIENCY;;3-@KTD DEFICIENCY
ENSG00000285696	AP002433.2	NA	
ENSG00000149308	NPAT	NA	
ENSG00000149311	ATM	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000149311	ATM	208900	ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROME AT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDE /.../, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED
ENSG00000206967	AP001925.1	NA	
ENSG00000166323	C11orf65	NA	
ENSG00000178202	POGLUT3	NA	
ENSG00000110723	EXPH5	615028	EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE; EBNS
ENSG00000178105	DDX10	NA	
ENSG00000240698	RPS2P39	NA	
ENSG00000254730	AP002453.1	NA	
ENSG00000255379	CYCSP29	NA	
ENSG00000203334	AP003027.1	NA	
ENSG00000255528	AP003123.1	NA	
ENSG00000201243	RNU6-654P	NA	
ENSG00000200613	RNA5SP349	NA	
ENSG00000264997	SNORD39	NA	
ENSG00000255028	AP003049.2	NA	
ENSG00000185742	C11orf87	NA	
ENSG00000254890	AP003049.1	NA	
ENSG00000254482	AP003102.1	NA	
ENSG00000254659	LINC02715	NA	
ENSG00000137710	RDX	611022	DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24
ENSG00000254798	TFAMP2	NA	
ENSG00000287245	AP001981.2	NA	
ENSG00000224776	RPSAP50	NA	
ENSG00000270423	AP001981.1	NA	
ENSG00000255210	AP001889.1	NA	
ENSG00000149289	ZC3H12C	NA	
ENSG00000254416	LINC02732	NA	
ENSG00000137714	FDX1	NA	
ENSG00000137727	ARHGAP20	NA	
ENSG00000233497	HNRNPA1P60	NA	
ENSG00000255149	AP002963.1	NA	
ENSG00000287556	AP003973.4	NA	
ENSG00000200168	RNA5SP350	NA	
ENSG00000271390	AP003973.2	NA	
ENSG00000271584	LINC02550	NA	
ENSG00000287028	AP003973.3	NA	
ENSG00000239354	RPS17P15	NA	
ENSG00000270202	AP003973.1	NA	
ENSG00000150750	C11orf53	NA	
ENSG00000196167	COLCA1	NA	
ENSG00000214290	COLCA2	NA	
ENSG00000288097	AP002448.1	NA	
ENSG00000264032	MIR4491	NA	
ENSG00000110777	POU2AF1	NA	
ENSG00000253099	RNU2-60P	NA	
ENSG00000255428	AP002008.3	NA	
ENSG00000255093	AP002008.2	NA	
ENSG00000137707	BTG4	NA	
ENSG00000286028	AP002008.4	NA	
ENSG00000207811	MIR34B	NA	
ENSG00000207562	MIR34C	NA	
ENSG00000254980	AP002008.1	NA	
ENSG00000183644	C11orf88	NA	
ENSG00000204381	LAYN	NA	
ENSG00000170145	SIK2	NA	
ENSG00000235286	AP000925.1	NA	
ENSG00000223324	RN7SKP273	NA	
ENSG00000137713	PPP2R1B	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000254990	AP001781.1	NA	
ENSG00000086848	ALG9	263210	GILLESSEN-KAESBACH-NISHIMURA SYNDROME; GIKANIS;;POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE, WITH MICROBRACHYCEPHALY, HYPERTELORISM, AND BRACHYMELIA
ENSG00000086848	ALG9	608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L;;CDG Il; CDGIl
ENSG00000258529	AP001781.2	NA	
ENSG00000254450	ALG9-IT1	NA	
ENSG00000254949	GNG5P3	NA	
ENSG00000255561	FDXACB1	NA	
ENSG00000137720	C11orf1	NA	
ENSG00000176343	RPL37AP8	NA	
ENSG00000109846	CRYAB	608810	MYOPATHY, MYOFIBRILLAR, 2; MFM2;;MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;;MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;;ALPHA-B CRYSTALLINOPATHY;;MYOPATHY, MYOFIBRILLAR, WITH OR WITHOUT CATARACT AND/OR CARDIOMYOPATHY
ENSG00000109846	CRYAB	613763	CATARACT 16, MULTIPLE TYPES; CTRCT16;;CATARACT, POSTERIOR POLAR, 2; CTPP2;;CATARACT, CONGENITAL LAMELLAR
ENSG00000109846	CRYAB	613869	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED;;MFM, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED
ENSG00000109846	CRYAB	615184	CARDIOMYOPATHY, DILATED, 1II; CMD1II
ENSG00000170276	HSPB2	NA	
ENSG00000254445	HSPB2-C11orf52	NA	
ENSG00000149300	C11orf52	NA	
ENSG00000150764	DIXDC1	NA	
ENSG00000238965	RNA5SP351	NA	
ENSG00000255286	AP000907.1	NA	
ENSG00000255334	AP000907.2	NA	
ENSG00000150768	DLAT	245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD;;LACTIC ACIDEMIA DUE TO DEFECT OF E2 LIPOYL TRANSACETYLASE OF THE PYRUVATE DEHYDROGENASE COMPLEX
ENSG00000230911	PPIHP1	NA	
ENSG00000238444	RNU6-893P	NA	
ENSG00000271025	AP000907.3	NA	
ENSG00000150773	PIH1D2	NA	
ENSG00000150776	NKAPD1	NA	
ENSG00000150779	TIMM8B	NA	
ENSG00000204370	SDHD	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000204370	SDHD	168000	PARAGANGLIOMAS 1; PGL1;;PARAGANGLIOMAS, FAMILIAL, 1;;PARAGANGLIOMATA; PGL;;GLOMUS TUMORS, FAMILIAL, 1;;CHEMODECTOMAS;;CAROTID BODY TUMORS; CBT1;;GLOMUS JUGULARE TUMORS;;PARAGANGLIOMA, CAROTID BODY;;PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1 PARAGANGL /.../WITH SENSORINEURAL HEARING LOSS, INCLUDED
ENSG00000204370	SDHD	252011	MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY
ENSG00000204370	SDHD	606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA;;CARNEY-STRATAKIS SYNDROME;;PARAGANGLIOMA AND GASTROINTESTINAL STROMAL TUMOR
ENSG00000255292	AP002884.2	NA	
ENSG00000150782	IL18	NA	
ENSG00000254638	AP002884.1	NA	
ENSG00000150783	TEX12	NA	
ENSG00000197580	BCO2	NA	
ENSG00000214264	KCTD9P4	NA	
ENSG00000255231	MRPS36P4	NA	
ENSG00000243930	RPS12P21	NA	
ENSG00000150787	PTS	261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A;;HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO PTS DEFICIENCY;;6-@PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY;;PTS DEFICIENCY  HYPERPHENYLALANINEMIA, BH4-DEFICIENT, DUE TO PARTIAL PTS /.../IENCY, INCLUDED
ENSG00000243250	RPS6P16	NA	
ENSG00000188771	PLET1	NA	
ENSG00000268472	AP002884.3	NA	
ENSG00000213234	ST13P10	NA	
ENSG00000250303	LINC02762	NA	
ENSG00000206772	RNU6-44P	NA	
ENSG00000254968	LINC02763	NA	
ENSG00000213233	RPL23AP62	NA	
ENSG00000255484	LINC02764	NA	
ENSG00000212397	AP003063.1	NA	
ENSG00000285769	AP003100.2	NA	
ENSG00000287006	AP003100.3	NA	
ENSG00000254626	AP003100.1	NA	
ENSG00000288070	AC016902.1	NA	
ENSG00000247416	AP000802.1	NA	
ENSG00000149294	NCAM1	NA	
ENSG00000238998	RNU7-187P	NA	
ENSG00000227487	NCAM1-AS1	NA	
ENSG00000255129	AP000880.1	NA	
ENSG00000149292	TTC12	618801	CILIARY DYSKINESIA, PRIMARY, 45; CILD45;;CILIARY DYSKINESIA, PRIMARY, 45, WITHOUT SITUS INVERSUS
ENSG00000270179	AP002840.2	NA	
ENSG00000170209	ANKK1	NA	
ENSG00000256757	AP002840.1	NA	
ENSG00000149295	DRD2	NA	
ENSG00000265140	MIR4301	NA	
ENSG00000166682	TMPRSS5	NA	
ENSG00000256091	MTRF1LP1	NA	
ENSG00000086827	ZW10	NA	
ENSG00000243353	RPS29P19	NA	
ENSG00000257070	AP003170.5	NA	
ENSG00000256603	AP003170.4	NA	
ENSG00000228607	CLDN25	NA	
ENSG00000256167	ATF4P4	NA	
ENSG00000255870	AP003170.2	NA	
ENSG00000257101	LRRC37A13P	NA	
ENSG00000048028	USP28	NA	
ENSG00000256452	AP003170.3	NA	
ENSG00000255710	AP003170.1	NA	
ENSG00000201687	RNU6-1107P	NA	
ENSG00000149305	HTR3B	NA	
ENSG00000166736	HTR3A	NA	
ENSG00000109906	ZBTB16	612447	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION
ENSG00000286463	AP002755.1	NA	
ENSG00000256947	AP002518.2	NA	
ENSG00000166741	NNMT	NA	
ENSG00000256195	AP002518.1	NA	
ENSG00000180425	C11orf71	NA	
ENSG00000076053	RBM7	NA	
ENSG00000255663	AP002373.1	NA	
ENSG00000076043	REXO2	NA	
ENSG00000256533	AP002373.2	NA	
ENSG00000255982	NXPE2P1	NA	
ENSG00000270204	AC020549.3	NA	
ENSG00000095110	NXPE1	NA	
ENSG00000238724	AC020549.1	NA	
ENSG00000137634	NXPE4	NA	
ENSG00000256674	AC020549.2	NA	
ENSG00000204361	NXPE2	NA	
ENSG00000252870	AP003179.1	NA	
ENSG00000182985	CADM1	NA	
ENSG00000287897	AP000465.1	NA	
ENSG00000256972	AP000462.3	NA	
ENSG00000255580	AP000462.1	NA	
ENSG00000256315	AP000462.2	NA	
ENSG00000256281	AP003174.2	NA	
ENSG00000257087	AP003174.3	NA	
ENSG00000255903	RPL12P46	NA	
ENSG00000255689	AP003174.1	NA	
ENSG00000239153	AP000997.1	NA	
ENSG00000255599	AP000997.2	NA	
ENSG00000260254	AP000997.3	NA	
ENSG00000279771	AP000997.4	NA	
ENSG00000256717	LINC02698	NA	
ENSG00000279818	AP002991.1	NA	
ENSG00000288020	AP002991.2	NA	
ENSG00000246100	LINC00900	NA	
ENSG00000257067	LINC02703	NA	
ENSG00000244259	AP000797.2	NA	
ENSG00000239600	AP000797.1	NA	
ENSG00000236437	LINC02151	NA	
ENSG00000278945	AP000770.1	NA	
ENSG00000237937	LINC02702	NA	
ENSG00000137656	BUD13	NA	
ENSG00000226645	AP006216.1	NA	
ENSG00000109917	ZPR1	NA	
ENSG00000110243	APOA5	145750	HYPERTRIGLYCERIDEMIA, FAMILIAL
ENSG00000110243	APOA5	144650	HYPERLIPOPROTEINEMIA, TYPE V;;HYPERLIPIDEMIA, TYPE V;;HYPERCHYLOMICRONEMIA, LATE-ONSET;;HYPERCHYLOMICRONEMIA WITH HYPERPREBETALIPOPROTEINEMIA, FAMILIAL;;HYPERLIPEMIA, MIXED;;HYPERLIPEMIA, COMBINED FAT AND CARBOHYDRATE-INDUCED
ENSG00000236267	AP006216.2	NA	
ENSG00000285513	AP006216.3	NA	
ENSG00000110244	APOA4	NA	
ENSG00000110245	APOC3	614028	APOLIPOPROTEIN C-III DEFICIENCY;;HYPERALPHALIPOPROTEINEMIA 2; HALP2
ENSG00000118137	APOA1	105200	AMYLOIDOSIS, FAMILIAL VISCERAL;;AMYLOIDOSIS VIII;;OSTERTAG TYPE AMYLOIDOSIS;;GERMAN TYPE AMYLOIDOSIS;;AMYLOIDOSIS, FAMILIAL RENAL;;AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC
ENSG00000118137	APOA1	618463	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2;;APOLIPOPROTEIN A-I DEFICIENCY;;HIGH DENSITY LIPOPROTEIN DEFICIENCY COMBINED APOLIPOPROTEIN A-I AND C-III DEFICIENCY, INCLUDED
ENSG00000235910	APOA1-AS	NA	
ENSG00000160584	SIK3	618162	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK;;IMMUNOOSSEOUS DYSPLASIA, KRAKOW TYPE
ENSG00000200537	RNY4P6	NA	
ENSG00000234268	AP000936.3	NA	
ENSG00000224077	AP000936.1	NA	
ENSG00000225236	AP000936.2	NA	
ENSG00000254851	AP005018.2	NA	
ENSG00000254678	AP005018.1	NA	
ENSG00000168092	PAFAH1B2	NA	
ENSG00000149577	SIDT2	NA	
ENSG00000149591	TAGLN	NA	
ENSG00000160613	PCSK7	NA	
ENSG00000280143	AP000892.4	NA	
ENSG00000167257	RNF214	NA	
ENSG00000252992	AP000892.2	NA	
ENSG00000186318	BACE1	NA	
ENSG00000278768	BACE1-AS	NA	
ENSG00000276505	AP000892.3	NA	
ENSG00000110274	CEP164	614845	NEPHRONOPHTHISIS 15; NPHP15
ENSG00000250699	AP000892.1	NA	
ENSG00000271412	PRR13P3	NA	
ENSG00000177103	DSCAML1	NA	
ENSG00000279586	AP000711.1	NA	
ENSG00000270403	AP001554.1	NA	
ENSG00000137731	FXYD2	154020	HYPOMAGNESEMIA 2, RENAL; HOMG2;;MAGNESIUM WASTING, RENAL;;MAGNESIUM LOSS, ISOLATED RENAL
ENSG00000254844	AP000757.2	NA	
ENSG00000255245	FXYD6-FXYD2	NA	
ENSG00000254528	AP000757.1	NA	
ENSG00000137726	FXYD6	NA	
ENSG00000137747	TMPRSS13	NA	
ENSG00000110324	IL10RA	613148	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28;;INFLAMMATORY BOWEL DISEASE, EARLY-ONSET, AUTOSOMAL RECESSIVE
ENSG00000255274	SMIM35	NA	
ENSG00000272075	RN7SL828P	NA	
ENSG00000137648	TMPRSS4	NA	
ENSG00000177098	SCN4B	611819	LONG QT SYNDROME 10; LQT10 ATRIAL FIBRILLATION, FAMILIAL, 17, INCLUDED; ATFB17, INCLUDED
ENSG00000149575	SCN2B	615378	ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14
ENSG00000160593	JAML	NA	
ENSG00000255163	HSPE1P18	NA	
ENSG00000160588	MPZL3	NA	
ENSG00000149573	MPZL2	618145	DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111
ENSG00000280032	AP002800.1	NA	
ENSG00000198851	CD3E	615615	IMMUNODEFICIENCY 18; IMD18;;CD3-EPSILON DEFICIENCY IMMUNODEFICIENCY 18, SEVERE COMBINED IMMUNODEFICIENCY VARIANT, INCLUDED;;IMMUNODEFICIENCY 18, SCID VARIANT, INCLUDED
ENSG00000254992	AP001582.1	NA	
ENSG00000167286	CD3D	615617	IMMUNODEFICIENCY 19; IMD19;;CD3-DELTA DEFICIENCY;;SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE
ENSG00000160654	CD3G	615607	IMMUNODEFICIENCY 17; IMD17;;CD3-GAMMA DEFICIENCY;;SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE
ENSG00000110344	UBE4A	NA	
ENSG00000254873	AP001267.1	NA	
ENSG00000285827	AP001267.5	NA	
ENSG00000167283	ATP5MG	NA	
ENSG00000269944	AP001267.4	NA	
ENSG00000255384	AP001267.2	NA	
ENSG00000118058	KMT2A	159555	LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A;;MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA GENE; MLL; MLL1;;TRITHORAX, DROSOPHILA, HOMOLOG OF; TRX1;;HRX;;MYELOID/LYMPHOID LEUKEMIA GENE;;MIXED LINEAGE LEUKEMIA GENE;;ALL1 GENE; ALL1;;CXXC FINGER PROTEIN  /.../C7 MIXED LINEAGE LEUKEMIA, INCLUDED;;MLL/AF4 FUSION GENE, INCLUDED;;MLL/ENL FUSION GENE, INCLUDED;;MLL/AF9 FUSION GENE, INCLUDED;;MLL/GMPS FUSION GENE, INCLUDED;;MLL/FBP17 FUSION GENE, INCLUDED;;MLL/LPP FUSION GENE, INCLUDED;;MLL/GPH FUSION GENE, INCLUDED;;MLL/PNUTL1 FUSION GENE, INCLUDED;;MLL/CDK6 FUSION GENE, INCLUDED;;MLL/LASP1 FUSION GENE, INCLUDED;;MLL/GRAF FUSION GENE, INCLUDED;;MLL/ABI1 FUSION GENE, INCLUDED;;MLL/LAF4 FUSION GENE, INCLUDED;;MLL/CBL FUSION GENE, INCLUDED;;MLL/LARG FUSION GENE, INCLUDED;;MLL/AF10 FUSION GENE, INCLUDED;;MLL/AF15q14 FUSION GENE, INCLUDED;;MLL/AF6 FUSION GENE, INCLUDED;;MLL/CIP29 FUSION GENE, INCLUDED;;MLL/SEPT6 FUSION GENE, INCLUDED;;MLL/MAML2 FUSION GENE, INCLUDED;;MLL/KIAA1524 FUSION GENE, INCLUDED
ENSG00000118058	KMT2A	605130	WIEDEMANN-STEINER SYNDROME; WDSTS;;HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY
ENSG00000255435	AP001267.3	NA	
ENSG00000172425	TTC36	NA	
ENSG00000149582	TMEM25	NA	
ENSG00000118096	IFT46	NA	
ENSG00000243431	RPL5P30	NA	
ENSG00000095139	ARCN1	617164	SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD
ENSG00000207185	RNU6-1157P	NA	
ENSG00000019144	PHLDB1	NA	
ENSG00000255176	AP000941.1	NA	
ENSG00000284246	MIR6716	NA	
ENSG00000118094	TREH	612119	TREHALASE DEFICIENCY;;TREHALOSE INTOLERANCE
ENSG00000255239	TREHP1	NA	
ENSG00000255422	AP002954.1	NA	
ENSG00000207462	RNU6-376P	NA	
ENSG00000287238	AP002954.2	NA	
ENSG00000110367	DDX6	618653	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES; IDDILF
ENSG00000278376	AP004609.3	NA	
ENSG00000254478	AP004609.2	NA	
ENSG00000254621	SETP16	NA	
ENSG00000201535	Y_RNA	NA	
ENSG00000160683	CXCR5	NA	
ENSG00000245869	AP004609.1	NA	
ENSG00000186174	BCL9L	NA	
ENSG00000264211	MIR4492	NA	
ENSG00000110375	UPK2	NA	
ENSG00000239726	RN7SL688P	NA	
ENSG00000222529	Y_RNA	NA	
ENSG00000176302	FOXR1	NA	
ENSG00000280502	Metazoa_SRP	NA	
ENSG00000283691	Y_RNA	NA	
ENSG00000255121	CCDC84-DT	NA	
ENSG00000186166	CCDC84	NA	
ENSG00000240970	RPL23AP64	NA	
ENSG00000254428	AP003392.1	NA	
ENSG00000254909	AP003392.2	NA	
ENSG00000118181	RPS25	NA	
ENSG00000196655	TRAPPC4	618741	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY; NEDESBA
ENSG00000283704	AP003392.11	NA	
ENSG00000137700	SLC37A4	232220	GLYCOGEN STORAGE DISEASE Ib; GSD1B;;GSD Ib;;GLUCOSE-6-PHOSPHATE TRANSPORT DEFECT
ENSG00000137700	SLC37A4	232240	GLYCOGEN STORAGE DISEASE Ic; GSD1C;;GSD Ic  GLYCOGEN STORAGE DISEASE Id, INCLUDED; GSD1D, INCLUDED
ENSG00000149428	HYOU1	233600	IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59;;GRANULOCYTOPENIA WITH IMMUNOGLOBULIN ABNORMALITY
ENSG00000255114	AP003392.3	NA	
ENSG00000271751	AP003392.4	NA	
ENSG00000272186	AP003392.5	NA	
ENSG00000160695	VPS11	616683	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12
ENSG00000256269	HMBS	176000	PORPHYRIA, ACUTE INTERMITTENT; AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCY PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTE /.../, INCLUDED; PORC, INCLUDED
ENSG00000188486	H2AX	NA	
ENSG00000172269	DPAGT1	608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J;;CDG Ij; CDGIj
ENSG00000172269	DPAGT1	614750	MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13;;MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2; CMSTA2
ENSG00000172375	C2CD2L	NA	
ENSG00000172273	HINFP	NA	
ENSG00000172350	ABCG4	NA	
ENSG00000160703	NLRX1	NA	
ENSG00000172367	PDZD3	NA	
ENSG00000248712	CCDC153	NA	
ENSG00000110395	CBL	607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML;;LEUKEMIA, JUVENILE MYELOMONOCYTIC  LEUKEMIA, CHRONIC MYELOMONOCYTIC, INCLUDED; CMML, INCLUDED
ENSG00000110395	CBL	613563	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL;;CBL SYNDROME;;CBL MUTATION-ASSOCIATED SYNDROME
ENSG00000222249	RNU6-262P	NA	
ENSG00000076706	MCAM	NA	
ENSG00000284148	MIR6756	NA	
ENSG00000252119	AP002956.1	NA	
ENSG00000173456	RNF26	NA	
ENSG00000245385	AP003396.1	NA	
ENSG00000235718	MFRP	609549	NANOPHTHALMOS 2; NNO2;;NANOPHTHALMIA 2;;NANOPHTHALMOS, AUTOSOMAL RECESSIVE
ENSG00000235718	MFRP	611040	MICROPHTHALMIA, ISOLATED 5; MCOP5;;MICROPHTHALMIA, POSTERIOR, WITH RETINITIS PIGMENTOSA, FOVEOSCHISIS, AND OPTIC DISC DRUSEN
ENSG00000223953	C1QTNF5	605670	LATE-ONSET RETINAL DEGENERATION; LORD;;RETINAL DEGENERATION, LATE-ONSET, AUTOSOMAL DOMINANT
ENSG00000036672	USP2	NA	
ENSG00000245248	USP2-AS1	NA	
ENSG00000254740	AP003396.3	NA	
ENSG00000254590	AP003396.2	NA	
ENSG00000254892	AP003396.4	NA	
ENSG00000154096	THY1	NA	
ENSG00000263873	THY1-AS1	NA	
ENSG00000255377	DUXAP5	NA	
ENSG00000230716	KRT8P7	NA	
ENSG00000254561	AP003393.1	NA	
ENSG00000110400	NECTIN1	225060	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1;;ZLOTOGORA-OGUR SYNDROME;;ECTODERMAL DYSPLASIA, MARGARITA ISLAND TYPE;;ECTODERMAL DYSPLASIA, TYPE 4; ED4;;ECTODERMAL DYSPLASIA, CLEFT LIP AND PALATE, MENTAL RETARDATION, AND SYNDACTYLY OROFACIAL /.../ 7, INCLUDED; OFC7, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 7, INCLUDED
ENSG00000199217	RNU6-1123P	NA	
ENSG00000255247	NECTIN1-AS1	NA	
ENSG00000254854	AP003390.1	NA	
ENSG00000254406	AP001994.1	NA	
ENSG00000287545	AP001994.2	NA	
ENSG00000288047	AP001994.3	NA	
ENSG00000286992	AP001360.3	NA	
ENSG00000254863	LINC02744	NA	
ENSG00000255216	AP001360.1	NA	
ENSG00000286731	AP001360.2	NA	
ENSG00000137699	TRIM29	NA	
ENSG00000176984	AP000679.1	NA	
ENSG00000184232	OAF	NA	
ENSG00000137709	POU2F3	NA	
ENSG00000259541	AP001150.1	NA	
ENSG00000181264	TLCD5	NA	
ENSG00000196914	ARHGEF12	NA	
ENSG00000274303	AP000659.1	NA	
ENSG00000149403	GRIK4	NA	
ENSG00000255006	ELOCP22	NA	
ENSG00000250493	AP004147.1	NA	
ENSG00000254735	HMGB1P42	NA	
ENSG00000154114	TBCEL	NA	
ENSG00000285509	TBCEL-TECTA	NA	
ENSG00000109927	TECTA	601543	DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12;;DEAFNESS, AUTOSOMAL DOMINANT 8; DFNA8
ENSG00000109927	TECTA	603629	DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21
ENSG00000254515	AP001124.1	NA	
ENSG00000244400	RPS4XP12	NA	
ENSG00000109929	SC5D	607330	LATHOSTEROLOSIS;;STEROL C5-DESATURASE DEFICIENCY;;SC5D DEFICIENCY
ENSG00000232460	BMPR1AP2	NA	
ENSG00000271022	AP002365.1	NA	
ENSG00000246790	AP000977.1	NA	
ENSG00000137642	SORL1	NA	
ENSG00000286044	AP001977.1	NA	
ENSG00000286023	AP001924.1	NA	
ENSG00000252556	RNU6-256P	NA	
ENSG00000286497	AP001924.2	NA	
ENSG00000255248	MIR100HG	NA	
ENSG00000207971	MIR125B1	NA	
ENSG00000259571	BLID	NA	
ENSG00000198975	MIRLET7A2	NA	
ENSG00000207994	MIR100	NA	
ENSG00000255015	AP000755.1	NA	
ENSG00000255219	AP000755.2	NA	
ENSG00000252776	RNU4ATAC10P	NA	
ENSG00000253035	RNU4ATAC5P	NA	
ENSG00000223265	RNU6-592P	NA	
ENSG00000254572	GLULP3	NA	
ENSG00000254935	AP002469.1	NA	
ENSG00000154127	UBASH3B	NA	
ENSG00000286341	AP002762.3	NA	
ENSG00000239079	AP002762.1	NA	
ENSG00000285909	AP002762.2	NA	
ENSG00000109943	CRTAM	NA	
ENSG00000109944	JHY	NA	
ENSG00000199709	RNU4-23P	NA	
ENSG00000254944	ATP5PBP5	NA	
ENSG00000188909	BSX	NA	
ENSG00000213184	AP003040.1	NA	
ENSG00000243669	RPL34P23	NA	
ENSG00000244641	RPS26P43	NA	
ENSG00000233541	RPL31P47	NA	
ENSG00000109971	HSPA8	NA	
ENSG00000200879	SNORD14E	NA	
ENSG00000207118	SNORD14D	NA	
ENSG00000202252	SNORD14C	NA	
ENSG00000288061	AP000926.2	NA	
ENSG00000166250	CLMP	615237	CONGENITAL SHORT BOWEL SYNDROME; CSBS
ENSG00000255342	AP000926.1	NA	
ENSG00000254710	AP001970.1	NA	
ENSG00000200496	U8	NA	
ENSG00000254823	LINC02727	NA	
ENSG00000254407	PHBP17	NA	
ENSG00000023171	GRAMD1B	NA	
ENSG00000265357	MIR4493	NA	
ENSG00000254449	SF3A3P2	NA	
ENSG00000166257	SCN3B	613120	BRUGADA SYNDROME 7; BRGDA7 ATRIAL FIBRILLATION, FAMILIAL, 16, INCLUDED; ATFB16, INCLUDED
ENSG00000254467	AP002765.1	NA	
ENSG00000166261	ZNF202	NA	
ENSG00000221931	OR6X1	NA	
ENSG00000200197	RNU1-21P	NA	
ENSG00000196099	OR6M1	NA	
ENSG00000254613	OR6M2P	NA	
ENSG00000254430	OR6M3P	NA	
ENSG00000204300	TMEM225	NA	
ENSG00000181518	OR8D4	NA	
ENSG00000171014	OR4D5	NA	
ENSG00000181499	OR6T1	NA	
ENSG00000196248	OR10S1	NA	
ENSG00000198674	OR10G6	NA	
ENSG00000226461	OR10G5P	NA	
ENSG00000254737	OR10G4	NA	
ENSG00000236981	OR10G9	NA	
ENSG00000234560	OR10G8	NA	
ENSG00000182634	OR10G7	NA	
ENSG00000213182	OR10D5P	NA	
ENSG00000186268	OR10D4P	NA	
ENSG00000213181	OR10N1P	NA	
ENSG00000110002	VWA5A	NA	
ENSG00000196403	OR10D1P	NA	
ENSG00000197309	OR10D3	NA	
ENSG00000239426	OR8F1P	NA	
ENSG00000255425	OR8G3P	NA	
ENSG00000181214	OR8G2P	NA	
ENSG00000276316	OR8G7P	NA	
ENSG00000197849	OR8G1	NA	
ENSG00000255298	OR8G5	NA	
ENSG00000255116	SLC5A4P1	NA	
ENSG00000196341	OR8D1	NA	
ENSG00000279116	OR8D2	NA	
ENSG00000254976	OR8B7P	NA	
ENSG00000255225	OR8B6P	NA	
ENSG00000255030	OR8B5P	NA	
ENSG00000227737	OR8B1P	NA	
ENSG00000229254	OR8C1P	NA	
ENSG00000284680	OR8B2	NA	
ENSG00000284609	OR8B3	NA	
ENSG00000255048	OR8X1P	NA	
ENSG00000285561	AP001804.1	NA	
ENSG00000280090	OR8B4	NA	
ENSG00000197125	OR8B8	NA	
ENSG00000255510	OR8A2P	NA	
ENSG00000229386	OR8B9P	NA	
ENSG00000254646	OR8B10P	NA	
ENSG00000255315	OR8A3P	NA	
ENSG00000254937	AP000916.1	NA	
ENSG00000170953	OR8B12	NA	
ENSG00000196119	OR8A1	NA	
ENSG00000255341	OR8Q1P	NA	
ENSG00000154143	PANX3	NA	
ENSG00000154144	TBRG1	NA	
ENSG00000110013	SIAE	613551	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6
ENSG00000200278	RNA5SP352	NA	
ENSG00000064199	SPA17	NA	
ENSG00000154146	NRGN	NA	
ENSG00000255045	AP000866.5	NA	
ENSG00000019102	VSIG2	NA	
ENSG00000149564	ESAM	NA	
ENSG00000250073	AP000866.2	NA	
ENSG00000120458	MSANTD2	NA	
ENSG00000279342	AP000866.6	NA	
ENSG00000254509	AP000866.3	NA	
ENSG00000245498	AP000866.1	NA	
ENSG00000254941	AP000866.4	NA	
ENSG00000154134	ROBO3	607313	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1; HGPPS1;;HGPPS OPHTHALMOPLEGIA, PROGRESSIVE EXTERNAL, AND SCOLIOSIS, INCLUDED
ENSG00000254568	AP003501.1	NA	
ENSG00000154133	ROBO4	618496	AORTIC VALVE DISEASE 3; AOVD3
ENSG00000254943	AP003501.2	NA	
ENSG00000165478	HEPACAM	604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE
ENSG00000165478	HEPACAM	613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A
ENSG00000165478	HEPACAM	613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B
ENSG00000221932	HEPN1	NA	
ENSG00000285825	CCDC15-DT	NA	
ENSG00000149548	CCDC15	NA	
ENSG00000134955	SLC37A2	NA	
ENSG00000150433	TMEM218	NA	
ENSG00000187686	KRT18P59	NA	
ENSG00000255475	AP001007.2	NA	
ENSG00000254880	PKNOX2-AS1	NA	
ENSG00000165495	PKNOX2	NA	
ENSG00000259290	AP001007.3	NA	
ENSG00000254932	AP001007.1	NA	
ENSG00000222844	RNU6-321P	NA	
ENSG00000149557	FEZ1	NA	
ENSG00000255537	AP000708.1	NA	
ENSG00000149547	EI24	NA	
ENSG00000222297	RNU6-1156P	NA	
ENSG00000134910	STT3A	615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W;;CDG Iw; CDGIw
ENSG00000149554	CHEK1	NA	
ENSG00000252255	RNU2-35P	NA	
ENSG00000134940	ACRV1	NA	
ENSG00000171053	PATE1	NA	
ENSG00000196844	PATE2	NA	
ENSG00000236027	PATE3	NA	
ENSG00000237353	PATE4	NA	
ENSG00000260209	AP000842.3	NA	
ENSG00000198331	HYLS1	236680	HYDROLETHALUS SYNDROME 1; HLS1
ENSG00000110060	PUS3	617051	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55; MRT55
ENSG00000255027	AP000842.2	NA	
ENSG00000109832	DDX25	NA	
ENSG00000254790	AP000842.1	NA	
ENSG00000283703	VSIG10L2	NA	
ENSG00000064309	CDON	614226	HOLOPROSENCEPHALY 11; HPE11
ENSG00000254759	NAP1L1P1	NA	
ENSG00000261257	AP000821.1	NA	
ENSG00000287666	AP000821.2	NA	
ENSG00000254833	AP001893.3	NA	
ENSG00000254771	AP001893.2	NA	
ENSG00000165526	RPUSD4	NA	
ENSG00000254694	AP001893.1	NA	
ENSG00000197798	FAM118B	NA	
ENSG00000222067	RNU4-86P	NA	
ENSG00000240098	RN7SL351P	NA	
ENSG00000182934	SRPRA	NA	
ENSG00000110074	FOXRED1	618241	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19
ENSG00000243607	RPL35AP26	NA	
ENSG00000150455	TIRAP	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000150455	TIRAP	610799	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1 INVASIVE PNEUMOCOCCAL DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000150455	TIRAP	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000150455	TIRAP	614382	BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1 BACTEREMIA, RESISTANCE TO, INCLUDED
ENSG00000254905	AP001318.1	NA	
ENSG00000255062	AP001318.2	NA	
ENSG00000110063	DCPS	616459	AL-RAQAD SYNDROME; ARS
ENSG00000280832	GSEC	NA	
ENSG00000110080	ST3GAL4	NA	
ENSG00000278215	AP001318.3	NA	
ENSG00000149571	KIRREL3	NA	
ENSG00000257271	KIRREL3-AS1	NA	
ENSG00000254607	AP001783.1	NA	
ENSG00000254938	AP002833.1	NA	
ENSG00000279358	AP002833.3	NA	
ENSG00000254960	KIRREL3-AS2	NA	
ENSG00000266215	MIR3167	NA	
ENSG00000255317	AP002833.2	NA	
ENSG00000218109	KIRREL3-AS3	NA	
ENSG00000255087	AP001993.1	NA	
ENSG00000272642	AP003121.1	NA	
ENSG00000273409	LINC02712	NA	
ENSG00000222774	RN7SKP121	NA	
ENSG00000223315	RN7SKP279	NA	
ENSG00000254591	AP003532.1	NA	
ENSG00000254612	DNAJB6P1	NA	
ENSG00000273415	LINC02725	NA	
ENSG00000272575	LINC02098	NA	
ENSG00000134954	ETS1	NA	
ENSG00000276176	MIR6090	NA	
ENSG00000254588	ETS1-AS1	NA	
ENSG00000245008	AP001122.1	NA	
ENSG00000151702	FLI1	617443	BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21
ENSG00000254703	SENCR	NA	
ENSG00000151704	KCNJ1	241200	BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2;;HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 2, ANTENATAL;;HYPERPROSTAGLANDIN E SYNDROME 2
ENSG00000255369	AP000920.1	NA	
ENSG00000120457	KCNJ5	613485	LONG QT SYNDROME 13; LQT13
ENSG00000120457	KCNJ5	613677	HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3;;FH III
ENSG00000174370	C11orf45	NA	
ENSG00000120471	TP53AIP1	NA	
ENSG00000134909	ARHGAP32	NA	
ENSG00000212597	RNU6-876P	NA	
ENSG00000206847	AP000751.1	NA	
ENSG00000199260	RNU6-874P	NA	
ENSG00000255259	ZNF123P	NA	
ENSG00000043039	BARX2	NA	
ENSG00000240121	RPS27P20	NA	
ENSG00000281386	AP003500.1	NA	
ENSG00000281097	LINC01395	NA	
ENSG00000287426	AP003327.2	NA	
ENSG00000255188	AP003327.1	NA	
ENSG00000151715	TMEM45B	NA	
ENSG00000170322	NFRKB	NA	
ENSG00000170325	PRDM10	NA	
ENSG00000233220	LINC00167	NA	
ENSG00000255057	AP003041.1	NA	
ENSG00000255262	ELOBP2	NA	
ENSG00000255535	AP003041.2	NA	
ENSG00000084234	APLP2	NA	
ENSG00000244451	RPL34P21	NA	
ENSG00000274197	U4	NA	
ENSG00000149418	ST14	602400	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11;;ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE; ARIH;;ICHTHYOSIS AND FOLLICULAR ATROPHODERMA WITH HYPOTRICHOSIS AND HYPOHIDROSIS; IFAH
ENSG00000196323	ZBTB44	NA	
ENSG00000255358	NDUFAF2P2	NA	
ENSG00000255220	DDX18P5	NA	
ENSG00000272412	RN7SL778P	NA	
ENSG00000175773	ZBTB44-DT	NA	
ENSG00000134917	ADAMTS8	NA	
ENSG00000166106	ADAMTS15	NA	
ENSG00000255155	AP004371.1	NA	
ENSG00000236616	BAK1P2	NA	
ENSG00000274999	MIR8052	NA	
ENSG00000175728	LINC02873	NA	
ENSG00000288013	AP003486.2	NA	
ENSG00000255352	PPP1R10P1	NA	
ENSG00000254842	LINC02551	NA	
ENSG00000255455	AP003486.1	NA	
ENSG00000120451	SNX19	NA	
ENSG00000242673	RN7SL167P	NA	
ENSG00000236129	AP002856.3	NA	
ENSG00000227125	AP002856.1	NA	
ENSG00000237612	AP002856.4	NA	
ENSG00000231698	AP002856.2	NA	
ENSG00000182667	NTM	NA	
ENSG00000252351	RNU6ATAC12P	NA	
ENSG00000237654	AP003025.1	NA	
ENSG00000285980	AP003025.2	NA	
ENSG00000224795	NTM-AS1	NA	
ENSG00000271624	AP004372.1	NA	
ENSG00000238117	AP000844.2	NA	
ENSG00000224700	AP000844.1	NA	
ENSG00000238262	NTM-IT	NA	
ENSG00000279090	AP000843.1	NA	
ENSG00000183715	OPCML	167000	OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED
ENSG00000283489	U6	NA	
ENSG00000279497	AP003784.1	NA	
ENSG00000255371	OPCML-IT2	NA	
ENSG00000279711	AP004782.1	NA	
ENSG00000279189	AP003972.1	NA	
ENSG00000254896	OPCML-IT1	NA	
ENSG00000287068	AP004606.1	NA	
ENSG00000255258	LINC02743	NA	
ENSG00000166118	SPATA19	NA	
ENSG00000213153	AP001979.1	NA	
ENSG00000080854	IGSF9B	NA	
ENSG00000284020	MIR4697	NA	
ENSG00000255406	LINC02730	NA	
ENSG00000204241	LINC02731	NA	
ENSG00000254648	AP000911.1	NA	
ENSG00000166086	JAM3	613730	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC
ENSG00000254481	PTP4A2P2	NA	
ENSG00000151503	NCAPD3	617984	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22
ENSG00000254616	AP001775.1	NA	
ENSG00000255348	AP001775.2	NA	
ENSG00000151502	VPS26B	NA	
ENSG00000151500	THYN1	NA	
ENSG00000151498	ACAD8	611283	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY; IBDD;;IBD DEFICIENCY;;ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8, DEFICIENCY OF;;ACAD8 DEFICIENCY
ENSG00000166105	GLB1L3	NA	
ENSG00000254442	AP000859.1	NA	
ENSG00000149328	GLB1L2	NA	
ENSG00000109956	B3GAT1	NA	
ENSG00000255545	AP004608.1	NA	
ENSG00000254573	AP004550.1	NA	
ENSG00000286374	AP001999.3	NA	
ENSG00000254989	AP001999.1	NA	
ENSG00000285640	AP001999.2	NA	
ENSG00000255344	LINC02706	NA	
ENSG00000251226	LINC02714	NA	
ENSG00000287251	AP003062.2	NA	
ENSG00000255327	LINC02697	NA	
ENSG00000279046	AP003062.1	NA	
ENSG00000285735	LINC02717	NA	
ENSG00000255512	LINC02684	NA	
ENSG00000256263	DDX11L8	NA	
ENSG00000226210	WASH8P	NA	
ENSG00000249054	FAM138D	NA	
ENSG00000120645	IQSEC3	NA	
ENSG00000256948	AC026369.3	NA	
ENSG00000249695	AC026369.1	NA	
ENSG00000256694	AC026369.2	NA	
ENSG00000256540	AC007406.3	NA	
ENSG00000111181	SLC6A12	NA	
ENSG00000255671	AC007406.1	NA	
ENSG00000256577	AC007406.4	NA	
ENSG00000010379	SLC6A13	NA	
ENSG00000255746	AC007406.2	NA	
ENSG00000261799	AC007406.5	NA	
ENSG00000073614	KDM5A	NA	
ENSG00000120647	CCDC77	NA	
ENSG00000139044	B4GALNT3	NA	
ENSG00000171840	NINJ2	NA	
ENSG00000256020	AC006205.2	NA	
ENSG00000238370	RNU7-103P	NA	
ENSG00000255825	AC006205.1	NA	
ENSG00000177406	NINJ2-AS1	NA	
ENSG00000256672	LINC02455	NA	
ENSG00000060237	WNK1	201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A;;HSAN IIA;;NEUROPATHY, HEREDITARY SENSORY, TYPE IIA; HSN2A;;HSN IIA;;ACROOSTEOLYSIS, NEUROGENIC;;ACROOSTEOLYSIS, GIACCAI TYPE;;NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL RECESSI /.../RVAN DISEASE;;NEUROPATHY, PROGRESSIVE SENSORY, OF CHILDREN;;NEUROPATHY, CONGENITAL SENSORY
ENSG00000060237	WNK1	614492	PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C
ENSG00000221439	RNU4ATAC16P	NA	
ENSG00000285704	AC004765.1	NA	
ENSG00000002016	RAD52	NA	
ENSG00000250132	AC004803.1	NA	
ENSG00000082805	ERC1	NA	
ENSG00000275811	HTR1DP1	NA	
ENSG00000249028	AC004672.1	NA	
ENSG00000267285	AC004672.2	NA	
ENSG00000249628	LINC00942	NA	
ENSG00000111186	WNT5B	NA	
ENSG00000171823	FBXL14	NA	
ENSG00000266043	MIR3649	NA	
ENSG00000006831	ADIPOR2	NA	
ENSG00000271500	AC005183.1	NA	
ENSG00000285627	AC005343.1	NA	
ENSG00000243663	RPS4XP14	NA	
ENSG00000151062	CACNA2D4	610478	RETINAL CONE DYSTROPHY 4; RCD4
ENSG00000287698	AC005343.4	NA	
ENSG00000166159	LRTM2	NA	
ENSG00000256706	AC005342.2	NA	
ENSG00000235049	LINC00940	NA	
ENSG00000151065	DCP1B	NA	
ENSG00000151067	CACNA1C	601005	TIMOTHY SYNDROME; TS;;LONG QT SYNDROME WITH SYNDACTYLY
ENSG00000151067	CACNA1C	611875	BRUGADA SYNDROME 3; BRGDA3
ENSG00000151067	CACNA1C	618447	LONG QT SYNDROME 8; LQT8
ENSG00000203593	AC005342.1	NA	
ENSG00000256837	CACNA1C-IT1	NA	
ENSG00000256257	CACNA1C-IT2	NA	
ENSG00000278255	AC005344.1	NA	
ENSG00000256025	CACNA1C-AS4	NA	
ENSG00000256721	CACNA1C-IT3	NA	
ENSG00000285555	AC005293.1	NA	
ENSG00000285734	AC005414.1	NA	
ENSG00000256769	CACNA1C-AS3	NA	
ENSG00000203648	AC007618.1	NA	
ENSG00000256271	CACNA1C-AS2	NA	
ENSG00000246627	CACNA1C-AS1	NA	
ENSG00000256150	ITFG2-AS1	NA	
ENSG00000283587	AC092471.2	NA	
ENSG00000274659	LINC02371	NA	
ENSG00000256902	IQSEC3P1	NA	
ENSG00000255669	AC092471.1	NA	
ENSG00000224438	RPL23AP14	NA	
ENSG00000256030	CBX3P4	NA	
ENSG00000004478	FKBP4	NA	
ENSG00000258325	ITFG2-AS1	NA	
ENSG00000258092	AC005841.1	NA	
ENSG00000111203	ITFG2	NA	
ENSG00000053702	NRIP2	NA	
ENSG00000283297	TEX52	NA	
ENSG00000111206	FOXM1	NA	
ENSG00000171792	RHNO1	NA	
ENSG00000078246	TULP3	NA	
ENSG00000278356	AC005911.1	NA	
ENSG00000252996	RNU6-1315P	NA	
ENSG00000197905	TEAD4	NA	
ENSG00000250899	AC125807.2	NA	
ENSG00000234589	AC125807.1	NA	
ENSG00000011105	TSPAN9	NA	
ENSG00000278469	Metazoa_SRP	NA	
ENSG00000256197	TSPAN9-IT1	NA	
ENSG00000275850	AC005912.2	NA	
ENSG00000227081	AC005912.1	NA	
ENSG00000250770	AC005865.1	NA	
ENSG00000287712	AC005865.2	NA	
ENSG00000236908	LINC02827	NA	
ENSG00000257048	LINC02417	NA	
ENSG00000111218	PRMT8	NA	
ENSG00000256691	AC005908.2	NA	
ENSG00000243507	AC005908.1	NA	
ENSG00000287243	THCAT155	NA	
ENSG00000130038	CRACR2A	NA	
ENSG00000280202	AC005831.1	NA	
ENSG00000222338	RNU6-174P	NA	
ENSG00000283138	AC006207.1	NA	
ENSG00000111224	PARP11	NA	
ENSG00000118976	OTUD4P1	NA	
ENSG00000256862	PARP11-AS1	NA	
ENSG00000256969	AC084375.1	NA	
ENSG00000256356	HSPA8P5	NA	
ENSG00000242444	AC007207.1	NA	
ENSG00000255920	CCND2-AS1	NA	
ENSG00000118971	CCND2	615938	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3
ENSG00000285901	AC008012.1	NA	
ENSG00000078237	TIGAR	NA	
ENSG00000213970	AC006122.1	NA	
ENSG00000118972	FGF23	193100	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR;;VITAMIN D-RESISTANT RICKETS, AUTOSOMAL DOMINANT;;HYPOPHOSPHATEMIA, AUTOSOMAL DOMINANT
ENSG00000118972	FGF23	617993	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2; HFTC2
ENSG00000111241	FGF6	NA	
ENSG00000047621	C12orf4	618221	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66
ENSG00000111247	RAD51AP1	NA	
ENSG00000010219	DYRK4	NA	
ENSG00000256748	AC005832.2	NA	
ENSG00000272921	AC005832.4	NA	
ENSG00000111254	AKAP3	NA	
ENSG00000256799	AC005832.3	NA	
ENSG00000256381	AC005832.1	NA	
ENSG00000139180	NDUFA9	618247	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26
ENSG00000255639	AC005833.1	NA	
ENSG00000255474	GAU1	NA	
ENSG00000130035	GALNT8	NA	
ENSG00000256988	AC005833.2	NA	
ENSG00000151079	KCNA6	NA	
ENSG00000255608	AC006063.1	NA	
ENSG00000286866	AC006063.3	NA	
ENSG00000287835	AC006063.4	NA	
ENSG00000256654	AC005906.2	NA	
ENSG00000111262	KCNA1	160120	EPISODIC ATAXIA, TYPE 1; EA1;;EPISODIC ATAXIA WITH MYOKYMIA; EAM;;ATAXIA, EPISODIC, WITH MYOKYMIA; AEM; AEMK;;PAROXYSMAL ATAXIA WITH NEUROMYOTONIA, HEREDITARY;;MYOKYMIA WITH PERIODIC ATAXIA MYOKYMIA 1, INCLUDED;;CONTINUOUS MUSCLE FIBER ACTIVITY, HER /.../Y, INCLUDED;;ISAACS-MERTENS SYNDROME, INCLUDED;;MYOKYMIA 1 WITH OR WITHOUT HYPOMAGNESEMIA, INCLUDED
ENSG00000284513	AC006063.2	NA	
ENSG00000255996	AC005906.1	NA	
ENSG00000130037	KCNA5	612240	ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7
ENSG00000285523	AC005906.3	NA	
ENSG00000256115	LINC02443	NA	
ENSG00000256417	AC006206.2	NA	
ENSG00000256146	AC006206.1	NA	
ENSG00000256218	AC007848.2	NA	
ENSG00000255983	AC007848.1	NA	
ENSG00000185652	NTF3	NA	
ENSG00000047617	ANO2	NA	
ENSG00000255973	AC137627.1	NA	
ENSG00000110799	VWF	193400	VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1
ENSG00000110799	VWF	277480	VON WILLEBRAND DISEASE, TYPE 3; VWD3;;VON WILLEBRAND DISEASE, TYPE III;;VWD, TYPE 3
ENSG00000110799	VWF	613554	VON WILLEBRAND DISEASE, TYPE 2; VWD2;;VON WILLEBRAND DISEASE, TYPE II;;VWD, TYPE 2 VON WILLEBRAND DISEASE, TYPE 2A, INCLUDED; VWD2A, INCLUDED;;VON WILLEBRAND DISEASE, TYPE 2B, INCLUDED; VWD2B, INCLUDED;;VON WILLEBRAND DISEASE, TYPE 2M, INCLUDED; VWD /.../CLUDED;;VON WILLEBRAND DISEASE, TYPE 2N, INCLUDED; VWD2N, INCLUDED
ENSG00000240533	RN7SL69P	NA	
ENSG00000255775	AC005845.1	NA	
ENSG00000010278	CD9	NA	
ENSG00000202318	AC006057.1	NA	
ENSG00000256103	ATP5MFP5	NA	
ENSG00000008323	PLEKHG6	NA	
ENSG00000067182	TNFRSF1A	142680	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT; FPF;;HIBERNIAN FEVER, FAMILIAL; FHF;;FAMILIAL HIBERNIAN FEVER;;TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME; TRAPS;;TNF RECEPTOR-ASSOCIATED PERIODIC SYNDROME
ENSG00000067182	TNFRSF1A	614810	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5
ENSG00000265388	RN7SL391P	NA	
ENSG00000111319	SCNN1A	264350	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE
ENSG00000111319	SCNN1A	613021	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2;;CYSTIC FIBROSIS-LIKE SYNDROME
ENSG00000111319	SCNN1A	618126	LIDDLE SYNDROME 3; LIDLS3
ENSG00000111321	LTBR	NA	
ENSG00000256433	AC005840.2	NA	
ENSG00000213942	AC005840.1	NA	
ENSG00000224906	SRP14P1	NA	
ENSG00000215039	CD27-AS1	NA	
ENSG00000139193	CD27	615122	LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2;;CD27 DEFICIENCY
ENSG00000139192	TAPBPL	NA	
ENSG00000139190	VAMP1	108600	SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1
ENSG00000139190	VAMP1	618323	MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25
ENSG00000276718	AC005840.4	NA	
ENSG00000256913	AC005840.3	NA	
ENSG00000111639	MRPL51	NA	
ENSG00000010292	NCAPD2	617983	MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21
ENSG00000239002	SCARNA10	NA	
ENSG00000276232	AC006064.5	NA	
ENSG00000255966	AC006064.3	NA	
ENSG00000111640	GAPDH	NA	
ENSG00000269968	AC006064.4	NA	
ENSG00000010295	IFFO1	NA	
ENSG00000245667	AC006064.1	NA	
ENSG00000111641	NOP2	NA	
ENSG00000285238	AC006064.6	NA	
ENSG00000111642	CHD4	617159	SIFRIM-HITZ-WEISS SYNDROME; SIHIWES;;SIFRIM-HITZ-WEISS MULTIPLE CONGENITAL ANOMALIES-MENTAL RETARDATION SYNDROME
ENSG00000247853	AC006064.2	NA	
ENSG00000251898	SCARNA11	NA	
ENSG00000184574	LPAR5	NA	
ENSG00000111644	ACRBP	NA	
ENSG00000111653	ING4	NA	
ENSG00000219410	AC125494.1	NA	
ENSG00000126746	ZNF384	NA	
ENSG00000139200	PIANP	NA	
ENSG00000252186	RNU6-781P	NA	
ENSG00000270068	AC125494.3	NA	
ENSG00000111652	COPS7A	NA	
ENSG00000269892	AC125494.2	NA	
ENSG00000089693	MLF2	NA	
ENSG00000159335	PTMS	NA	
ENSG00000089692	LAG3	NA	
ENSG00000244532	RN7SL380P	NA	
ENSG00000010610	CD4	613949	OKT4 EPITOPE DEFICIENCY;;T4 EPITOPE DEFICIENCY
ENSG00000250510	GPR162	NA	
ENSG00000110811	P3H3	NA	
ENSG00000111664	GNB3	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000111664	GNB3	617024	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H
ENSG00000111665	CDCA3	NA	
ENSG00000111667	USP5	NA	
ENSG00000111669	TPI1	615512	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID
ENSG00000111671	SPSB2	NA	
ENSG00000240370	RPL13P5	NA	
ENSG00000010626	LRRC23	NA	
ENSG00000248593	DSTNP2	NA	
ENSG00000275703	U47924.3	NA	
ENSG00000111674	ENO2	NA	
ENSG00000111676	ATN1	125370	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA;;MYOCLONIC EPILEPSY WITH CHOREOATHETOSIS;;NAITO-OYANAGI DISEASE; NOD;;HAW RIVER SYNDROME; HRS;;ATAXIA, CHOREA, SEIZURES, AND DEMENTIA
ENSG00000111676	ATN1	618494	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA
ENSG00000111678	C12orf57	218340	TEMTAMY SYNDROME; TEMTYS;;MENTAL RETARDATION WITH OR WITHOUT CRANIOFACIAL DYSMORPHISM, OCULAR COLOBOMA, OR ABNORMAL CORPUS CALLOSUM
ENSG00000272173	U47924.2	NA	
ENSG00000238923	RNU7-1	NA	
ENSG00000111679	PTPN6	NA	
ENSG00000257084	MIR200CHG	NA	
ENSG00000207713	MIR200C	NA	
ENSG00000207708	MIR141	NA	
ENSG00000271969	U47924.1	NA	
ENSG00000215021	PHB2	NA	
ENSG00000238795	SCARNA12	NA	
ENSG00000126749	EMG1	211180	BOWEN-CONRADI SYNDROME; BWCNS;;BOWEN HUTTERITE SYNDROME, FORMERLY
ENSG00000111684	LPCAT3	NA	
ENSG00000182326	C1S	613783	COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY
ENSG00000182326	C1S	617174	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2
ENSG00000239701	AC006512.1	NA	
ENSG00000257078	AC006512.2	NA	
ENSG00000159403	C1R	130080	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1;;EHLERS-DANLOS SYNDROME, TYPE VIII; EDS8;;EDS VIII;;EHLERS-DANLOS SYNDROME, PERIODONTITIS TYPE;;EHLERS-DANLOS SYNDROME, PERIODONTOSIS TYPE
ENSG00000139178	C1RL	NA	
ENSG00000205885	C1RL-AS1	NA	
ENSG00000139194	RBP5	NA	
ENSG00000200345	RNU6-485P	NA	
ENSG00000256967	AC018653.3	NA	
ENSG00000139182	CLSTN3	NA	
ENSG00000285770	AC018653.4	NA	
ENSG00000255572	AC018653.1	NA	
ENSG00000139197	PEX5	202370	PEROXISOME BIOGENESIS DISORDER 2B; PBD2B
ENSG00000139197	PEX5	214110	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 2, INCLUDED; CG2, INCLUDED
ENSG00000139197	PEX5	616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5
ENSG00000256480	AC018653.2	NA	
ENSG00000215009	ACSM4	NA	
ENSG00000177675	CD163L1	NA	
ENSG00000255836	AC131206.1	NA	
ENSG00000177575	CD163	NA	
ENSG00000235868	GAPDHP31	NA	
ENSG00000256331	NIFKP3	NA	
ENSG00000255977	AC006927.1	NA	
ENSG00000284327	AC006927.2	NA	
ENSG00000284591	AC006927.4	NA	
ENSG00000284522	AC006927.3	NA	
ENSG00000285142	AC006927.5	NA	
ENSG00000111701	APOBEC1	NA	
ENSG00000184344	GDF3	613702	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3
ENSG00000184344	GDF3	613703	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6
ENSG00000184344	GDF3	613704	MICROPHTHALMIA, ISOLATED 7; MCOP7
ENSG00000187569	DPPA3	NA	
ENSG00000198178	CLEC4C	NA	
ENSG00000205857	NANOGNB	NA	
ENSG00000201549	Y_RNA	NA	
ENSG00000111704	NANOG	NA	
ENSG00000199912	Y_RNA	NA	
ENSG00000173262	SLC2A14	NA	
ENSG00000287713	AC006517.2	NA	
ENSG00000201663	Y_RNA	NA	
ENSG00000278459	Metazoa_SRP	NA	
ENSG00000241828	AC006517.1	NA	
ENSG00000255885	AC124891.1	NA	
ENSG00000176654	NANOGP1	NA	
ENSG00000255356	AC007536.1	NA	
ENSG00000059804	SLC2A3	NA	
ENSG00000288043	AC006511.6	NA	
ENSG00000206636	Y_RNA	NA	
ENSG00000240739	AC006511.1	NA	
ENSG00000282080	AC006511.4	NA	
ENSG00000255964	HSPD1P12	NA	
ENSG00000255581	AC006511.2	NA	
ENSG00000065970	FOXJ2	NA	
ENSG00000171860	C3AR1	NA	
ENSG00000089818	NECAP1	615833	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21
ENSG00000279865	AC006511.3	NA	
ENSG00000284697	AC006511.5	NA	
ENSG00000111729	CLEC4A	NA	
ENSG00000235602	POU5F1P3	NA	
ENSG00000284393	AC092111.3	NA	
ENSG00000256171	GCSHP4	NA	
ENSG00000196946	ZNF705A	NA	
ENSG00000226711	FAM66C	NA	
ENSG00000244050	DEFB109F	NA	
ENSG00000276417	AC092111.2	NA	
ENSG00000275367	AC092111.1	NA	
ENSG00000171847	FAM90A1	NA	
ENSG00000254016	ALG1L10P	NA	
ENSG00000164845	FAM86FP	NA	
ENSG00000215241	LINC02449	NA	
ENSG00000286895	AC092745.5	NA	
ENSG00000256589	ENPP7P5	NA	
ENSG00000286504	AC092745.4	NA	
ENSG00000226091	LINC00937	NA	
ENSG00000256552	AC092745.2	NA	
ENSG00000256101	AC092745.1	NA	
ENSG00000277952	AC092745.3	NA	
ENSG00000242661	RPS3AP43	NA	
ENSG00000284687	AC092865.4	NA	
ENSG00000284673	AC092865.3	NA	
ENSG00000256136	AC092865.2	NA	
ENSG00000238152	OR7E140P	NA	
ENSG00000214487	OR7E148P	NA	
ENSG00000177586	OR7E149P	NA	
ENSG00000205846	CLEC6A	NA	
ENSG00000243830	AC092865.1	NA	
ENSG00000201780	RNU6-275P	NA	
ENSG00000166527	CLEC4D	NA	
ENSG00000246115	SUPT4H1P2	NA	
ENSG00000166523	CLEC4E	NA	
ENSG00000255801	AC092746.1	NA	
ENSG00000238943	Y_RNA	NA	
ENSG00000252727	AC092184.1	NA	
ENSG00000111732	AICDA	605258	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2;;HYPER-IgM SYNDROME 2
ENSG00000280345	AC092184.2	NA	
ENSG00000255967	HADHAP2	NA	
ENSG00000197614	MFAP5	616166	AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9;;AORTIC ANEURYSM, THORACIC, WITH OR WITHOUT AORTIC DISSECTION
ENSG00000255829	AC092490.2	NA	
ENSG00000256004	AC092490.3	NA	
ENSG00000166532	RIMKLB	NA	
ENSG00000244131	RPSAP51	NA	
ENSG00000256661	A2ML1-AS1	NA	
ENSG00000249790	AC092490.1	NA	
ENSG00000256904	A2ML1-AS2	NA	
ENSG00000166535	A2ML1	166760	OTITIS MEDIA, SUSCEPTIBILITY TO; OMS;;OTITIS MEDIA, CHRONIC/RECURRENT;;COME/ROM
ENSG00000282022	AC006581.2	NA	
ENSG00000111752	PHC1	615414	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11
ENSG00000003056	M6PR	NA	
ENSG00000139187	KLRG1	NA	
ENSG00000257105	AC006581.1	NA	
ENSG00000213049	HNRNPA1P34	NA	
ENSG00000255776	VDAC2P2	NA	
ENSG00000214851	LINC00612	NA	
ENSG00000245105	A2M-AS1	NA	
ENSG00000175899	A2M	104300	ALZHEIMER DISEASE; AD;;PRESENILE AND SENILE DEMENTIA ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED; AD1, INCLUDED;;ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY, INCLUDED;;ALZHEIMER DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000256937	KRT17P8	NA	
ENSG00000256720	BTG1P1	NA	
ENSG00000126838	PZP	NA	
ENSG00000256817	TPT1P12	NA	
ENSG00000256069	A2MP1	NA	
ENSG00000283429	MIR1244-3	NA	
ENSG00000231503	PTMAP4	NA	
ENSG00000237248	LINC00987	NA	
ENSG00000256427	AC010175.1	NA	
ENSG00000111788	AC009533.1	NA	
ENSG00000212440	SNORA75	NA	
ENSG00000255753	AC009533.2	NA	
ENSG00000286911	AC009533.3	NA	
ENSG00000260423	LINC02367	NA	
ENSG00000287577	AC009533.4	NA	
ENSG00000256673	AC141557.1	NA	
ENSG00000278635	AC141557.2	NA	
ENSG00000214826	DDX12P	NA	
ENSG00000212432	SNORA75	NA	
ENSG00000284634	AC092821.3	NA	
ENSG00000214776	AC092821.1	NA	
ENSG00000256975	AC092821.2	NA	
ENSG00000111796	KLRB1	NA	
ENSG00000212345	RNU6-700P	NA	
ENSG00000233719	GOT2P3	NA	
ENSG00000272917	AC010186.4	NA	
ENSG00000256442	AC010186.1	NA	
ENSG00000256594	AC010186.2	NA	
ENSG00000257027	AC010186.3	NA	
ENSG00000069493	CLEC2D	NA	
ENSG00000213443	AC007068.1	NA	
ENSG00000256582	LINC02390	NA	
ENSG00000184293	CLECL1	NA	
ENSG00000110848	CD69	NA	
ENSG00000256912	GCNAP1	NA	
ENSG00000150045	KLRF1	NA	
ENSG00000110852	CLEC2B	NA	
ENSG00000255882	AC091814.1	NA	
ENSG00000256797	KLRF2	NA	
ENSG00000188393	CLEC2A	NA	
ENSG00000225231	LINC02470	NA	
ENSG00000231560	CLEC12A-AS1	NA	
ENSG00000172322	CLEC12A	NA	
ENSG00000165682	CLEC1B	NA	
ENSG00000256660	CLEC12B	NA	
ENSG00000256803	AC024224.2	NA	
ENSG00000197992	CLEC9A	NA	
ENSG00000256626	AC024224.1	NA	
ENSG00000150048	CLEC1A	614079	ASPERGILLOSIS, SUSCEPTIBILITY TO
ENSG00000223042	RN7SKP161	NA	
ENSG00000255734	HNRNPABP1	NA	
ENSG00000172243	CLEC7A	613108	CANDIDIASIS, FAMILIAL, 4; CANDF4;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS
ENSG00000172243	CLEC7A	614079	ASPERGILLOSIS, SUSCEPTIBILITY TO
ENSG00000173391	OLR1	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000165685	TMEM52B	NA	
ENSG00000139112	GABARAPL1	NA	
ENSG00000255958	GABARAPL1-AS1	NA	
ENSG00000134539	KLRD1	NA	
ENSG00000256288	LINC02617	NA	
ENSG00000256155	LINC02598	NA	
ENSG00000245648	AC022075.1	NA	
ENSG00000255819	KLRC4-KLRK1	NA	
ENSG00000213809	KLRK1	NA	
ENSG00000183542	KLRC4	NA	
ENSG00000255641	AC068775.1	NA	
ENSG00000205810	KLRC3	NA	
ENSG00000205809	KLRC2	NA	
ENSG00000134545	KLRC1	NA	
ENSG00000180574	EIF2S3B	NA	
ENSG00000257016	SLC25A39P2	NA	
ENSG00000256039	LINC02446	NA	
ENSG00000256667	KLRA1P	NA	
ENSG00000111196	MAGOHB	NA	
ENSG00000060140	STYK1	NA	
ENSG00000060138	YBX3	NA	
ENSG00000256888	LINC02366	NA	
ENSG00000235930	HSPE1P12	NA	
ENSG00000121377	TAS2R7	NA	
ENSG00000121314	TAS2R8	NA	
ENSG00000121381	TAS2R9	NA	
ENSG00000231887	PRH1	NA	
ENSG00000121318	TAS2R10	NA	
ENSG00000256651	AC006518.1	NA	
ENSG00000111215	PRR4	NA	
ENSG00000275778	AC018630.2	NA	
ENSG00000256682	AC006518.2	NA	
ENSG00000212128	TAS2R13	NA	
ENSG00000134551	PRH2	NA	
ENSG00000212127	TAS2R14	NA	
ENSG00000212125	TAS2R15P	NA	
ENSG00000212126	TAS2R50	NA	
ENSG00000255837	TAS2R20	NA	
ENSG00000212124	TAS2R19	NA	
ENSG00000256436	TAS2R31	NA	
ENSG00000256019	TAS2R63P	NA	
ENSG00000226761	TAS2R46	NA	
ENSG00000256274	TAS2R64P	NA	
ENSG00000255374	TAS2R43	NA	
ENSG00000256400	AC018630.1	NA	
ENSG00000256188	TAS2R30	NA	
ENSG00000256981	AC134349.2	NA	
ENSG00000256712	AC134349.1	NA	
ENSG00000256537	SMIM10L1	NA	
ENSG00000186136	TAS2R42	NA	
ENSG00000256657	AC244131.1	NA	
ENSG00000275119	AC244131.2	NA	
ENSG00000197870	PRB3	NA	
ENSG00000230657	PRB4	NA	
ENSG00000251655	PRB1	NA	
ENSG00000121335	PRB2	NA	
ENSG00000255790	AC078950.1	NA	
ENSG00000237303	HIGD1AP8	NA	
ENSG00000278654	AC007450.4	NA	
ENSG00000277705	AC007450.3	NA	
ENSG00000270863	DDX55P1	NA	
ENSG00000274551	AC007450.2	NA	
ENSG00000256237	AC007450.1	NA	
ENSG00000251747	RNU7-60P	NA	
ENSG00000247157	LINC01252	NA	
ENSG00000139083	ETV6	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000139083	ETV6	616216	THROMBOCYTOPENIA 5; THC5;;THROMBOCYTOPENIA 5 WITH INCREASED SUSCEPTIBILITY TO MALIGNANCY;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 5
ENSG00000121380	BCL2L14	NA	
ENSG00000198134	PTMAP9	NA	
ENSG00000283475	MIR1244-4	NA	
ENSG00000070018	LRP6	610947	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2
ENSG00000070018	LRP6	616724	TOOTH AGENESIS, SELECTIVE, 7; STHAG7
ENSG00000242405	AC007537.1	NA	
ENSG00000199551	RNU6-545P	NA	
ENSG00000270857	AC007621.1	NA	
ENSG00000207010	RNU6-318P	NA	
ENSG00000111261	MANSC1	NA	
ENSG00000243141	RPL23AP66	NA	
ENSG00000205791	LOH12CR2	NA	
ENSG00000165714	BORCS5	NA	
ENSG00000271370	AC007619.2	NA	
ENSG00000111266	DUSP16	NA	
ENSG00000255670	AC007619.1	NA	
ENSG00000240424	AC092824.1	NA	
ENSG00000111269	CREBL2	NA	
ENSG00000271215	RPL21P136	NA	
ENSG00000275963	AC008115.4	NA	
ENSG00000183150	GPR19	NA	
ENSG00000257004	AC008115.2	NA	
ENSG00000111276	CDKN1B	610755	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4
ENSG00000275560	AC008115.3	NA	
ENSG00000256658	AC008115.1	NA	
ENSG00000178878	APOLD1	NA	
ENSG00000207983	MIR613	NA	
ENSG00000270296	STX8P1	NA	
ENSG00000213782	DDX47	NA	
ENSG00000242329	AC007215.1	NA	
ENSG00000241352	AC007688.2	NA	
ENSG00000234498	RPL13AP20	NA	
ENSG00000013588	GPRC5A	NA	
ENSG00000283759	MIR614	NA	
ENSG00000247498	GPRC5D-AS1	NA	
ENSG00000111291	GPRC5D	NA	
ENSG00000256011	AC007688.3	NA	
ENSG00000221611	AC007688.1	NA	
ENSG00000013583	HEBP1	NA	
ENSG00000183935	HTR7P1	NA	
ENSG00000255621	AC023790.2	NA	
ENSG00000243129	AC023790.1	NA	
ENSG00000084444	FAM234B	NA	
ENSG00000111305	GSG1	NA	
ENSG00000134531	EMP1	NA	
ENSG00000286869	AC022276.1	NA	
ENSG00000180861	LINC01559	NA	
ENSG00000273079	GRIN2B	613970	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6
ENSG00000273079	GRIN2B	616139	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27
ENSG00000201476	RNA5SP353	NA	
ENSG00000201909	RNU6-590P	NA	
ENSG00000256306	AC007527.1	NA	
ENSG00000277935	AC007527.2	NA	
ENSG00000287928	AC007535.1	NA	
ENSG00000200475	RN7SKP162	NA	
ENSG00000256346	AC092470.1	NA	
ENSG00000227760	AC135001.1	NA	
ENSG00000256084	AC092112.1	NA	
ENSG00000255763	MRPS18CP4	NA	
ENSG00000251908	RNU6-491P	NA	
ENSG00000255749	GNAI2P1	NA	
ENSG00000244573	RPL30P11	NA	
ENSG00000171681	ATF7IP	NA	
ENSG00000121316	PLBD1	NA	
ENSG00000255649	AC008114.1	NA	
ENSG00000200830	RN7SKP134	NA	
ENSG00000256751	PLBD1-AS1	NA	
ENSG00000070019	GUCY2C	614616	DIARRHEA 6; DIAR6
ENSG00000070019	GUCY2C	614665	MECONIUM ILEUS
ENSG00000214772	AC010168.1	NA	
ENSG00000261324	AC010168.2	NA	
ENSG00000197837	H4-16	NA	
ENSG00000246705	H2AJ	NA	
ENSG00000084463	WBP11	NA	
ENSG00000182993	C12orf60	NA	
ENSG00000179256	SMCO3	NA	
ENSG00000286107	AC007655.2	NA	
ENSG00000111339	ART4	616060	BLOOD GROUP, DOMBROCK SYSTEM; DO;;DOMBROCK BLOOD GROUP SYSTEM
ENSG00000256339	AC007655.1	NA	
ENSG00000111341	MGP	245150	KEUTEL SYNDROME; KTLS;;PULMONIC STENOSIS, BRACHYTELEPHALANGISM, AND CALCIFICATION OF CARTILAGES
ENSG00000139055	ERP27	NA	
ENSG00000111348	ARHGDIB	NA	
ENSG00000139053	PDE6H	610024	RETINAL CONE DYSTROPHY 3A; RCD3A;;CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES, PDE6H-RELATED  ACHROMATOPSIA 6, INCLUDED; ACHM6, INCLUDED
ENSG00000255727	LINC01489	NA	
ENSG00000134533	RERG	NA	
ENSG00000256650	RERG-IT1	NA	
ENSG00000255660	RERG-AS1	NA	
ENSG00000256283	METTL8P1	NA	
ENSG00000151490	PTPRO	614196	NEPHROTIC SYNDROME, TYPE 6; NPHS6
ENSG00000243916	AC092183.1	NA	
ENSG00000151491	EPS8	615974	DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102
ENSG00000200105	RNU6-251P	NA	
ENSG00000255565	AC073651.1	NA	
ENSG00000256627	AC073651.2	NA	
ENSG00000023734	STRAP	NA	
ENSG00000023697	DERA	NA	
ENSG00000256134	EGLN3P1	NA	
ENSG00000188991	SLC15A5	NA	
ENSG00000008394	MGST1	NA	
ENSG00000256238	SUPT16HP1	NA	
ENSG00000286303	AC007528.1	NA	
ENSG00000256450	AC007552.1	NA	
ENSG00000048540	LMO3	NA	
ENSG00000256564	AC007552.2	NA	
ENSG00000283240	AC007529.2	NA	
ENSG00000255871	AC007529.1	NA	
ENSG00000256211	AC023512.1	NA	
ENSG00000213235	EEF1A1P16	NA	
ENSG00000287455	AC092793.1	NA	
ENSG00000212358	RNU6-837P	NA	
ENSG00000285724	AC092110.1	NA	
ENSG00000242991	RPL7P40	NA	
ENSG00000256896	PSMC1P8	NA	
ENSG00000256756	TIMM17BP1	NA	
ENSG00000256389	AC048352.1	NA	
ENSG00000256994	LINC02378	NA	
ENSG00000283665	MIR3974	NA	
ENSG00000206662	Y_RNA	NA	
ENSG00000111404	RERGL	NA	
ENSG00000139144	PIK3C2G	NA	
ENSG00000255892	NDFIP1P1	NA	
ENSG00000255960	AC092851.1	NA	
ENSG00000256138	ZKSCAN7P1	NA	
ENSG00000139151	PLCZ1	617214	SPERMATOGENIC FAILURE 17; SPGF17;;MALE INFERTILITY DUE TO OOCYTE ACTIVATION FAILURE
ENSG00000255993	PSMC1P9	NA	
ENSG00000255648	AC087242.1	NA	
ENSG00000177938	CAPZA3	NA	
ENSG00000227525	RPL7P6	NA	
ENSG00000256844	MEF2BNBP1	NA	
ENSG00000052126	PLEKHA5	NA	
ENSG00000253284	AC092828.1	NA	
ENSG00000240993	RN7SL459P	NA	
ENSG00000243854	RN7SL67P	NA	
ENSG00000139154	AEBP2	NA	
ENSG00000255909	PDCD5P1	NA	
ENSG00000271462	AC091805.2	NA	
ENSG00000200247	RNU6-254P	NA	
ENSG00000245205	EEF1A1P4	NA	
ENSG00000240328	AC091805.1	NA	
ENSG00000287074	AC137561.1	NA	
ENSG00000200885	RNU1-146P	NA	
ENSG00000255910	AC024901.1	NA	
ENSG00000256849	TCP1P3	NA	
ENSG00000256287	LINC02398	NA	
ENSG00000287075	AC126468.1	NA	
ENSG00000256499	LINC02468	NA	
ENSG00000256879	AC129102.1	NA	
ENSG00000172572	PDE3A	112410	HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME
ENSG00000131982	UBE2L2	NA	
ENSG00000256663	AC112777.1	NA	
ENSG00000139155	SLCO1C1	NA	
ENSG00000111700	SLCO1B3	237450	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR;;ROTOR SYNDROME
ENSG00000257046	SLCO1B3-SLCO1B7	NA	
ENSG00000256157	AC011604.1	NA	
ENSG00000205754	SLCO1B7	NA	
ENSG00000257062	AC022335.1	NA	
ENSG00000134538	SLCO1B1	237450	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR;;ROTOR SYNDROME
ENSG00000084453	SLCO1A2	NA	
ENSG00000121351	IAPP	NA	
ENSG00000121350	PYROXD1	617258	MYOPATHY, MYOFIBRILLAR, 8; MFM8
ENSG00000256021	ELOCP31	NA	
ENSG00000004700	RECQL	NA	
ENSG00000111711	GOLT1B	NA	
ENSG00000134548	SPX	NA	
ENSG00000111713	GYS2	240600	GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A;;GSD 0a;;HYPOGLYCEMIA WITH DEFICIENCY OF GLYCOGEN SYNTHETASE IN THE LIVER;;LIVER GLYCOGEN SYNTHASE DEFICIENCY;;LIVER GLYCOGEN STORAGE DISEASE 0
ENSG00000285854	AC010197.2	NA	
ENSG00000111716	LDHB	614128	LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD
ENSG00000256615	AC010197.1	NA	
ENSG00000255644	AC010185.1	NA	
ENSG00000121361	KCNJ8	NA	
ENSG00000069431	ABCC9	239850	CANTU SYNDROME;;HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA
ENSG00000069431	ABCC9	608569	CARDIOMYOPATHY, DILATED, 1O; CMD1O;;CARDIOMYOPATHY, DILATED, WITH VENTRICULAR TACHYCARDIA
ENSG00000069431	ABCC9	614050	ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12
ENSG00000257022	AC008250.1	NA	
ENSG00000275567	AC008250.2	NA	
ENSG00000255627	AC092862.1	NA	
ENSG00000111726	CMAS	NA	
ENSG00000111728	ST8SIA1	NA	
ENSG00000274624	AC007671.1	NA	
ENSG00000283582	SULT6B2P	NA	
ENSG00000212172	RNU1-149P	NA	
ENSG00000256714	AC087318.1	NA	
ENSG00000250166	AC053513.1	NA	
ENSG00000111731	C2CD5	NA	
ENSG00000256973	AC053513.2	NA	
ENSG00000256371	LRRC34P1	NA	
ENSG00000256774	AC087241.1	NA	
ENSG00000257023	AC087241.2	NA	
ENSG00000139163	ETNK1	NA	
ENSG00000256995	AC084816.1	NA	
ENSG00000241451	RPS27P22	NA	
ENSG00000256923	AC084819.1	NA	
ENSG00000256353	AC087258.1	NA	
ENSG00000256321	AC087235.2	NA	
ENSG00000115934	AC087235.1	NA	
ENSG00000134532	SOX5	616803	LAMB-SHAFFER SYNDROME; LAMSHF
ENSG00000256473	AC087260.1	NA	
ENSG00000216192	MIR920	NA	
ENSG00000256120	SOX5-AS1	NA	
ENSG00000197503	LINC00477	NA	
ENSG00000256852	KNOP1P1	NA	
ENSG00000244662	AC087312.1	NA	
ENSG00000255745	AC023796.1	NA	
ENSG00000240481	RN7SL38P	NA	
ENSG00000060982	BCAT1	NA	
ENSG00000256482	AC023796.2	NA	
ENSG00000278969	AC026310.3	NA	
ENSG00000255921	AC026310.2	NA	
ENSG00000213736	AC026310.1	NA	
ENSG00000226397	C12orf77	NA	
ENSG00000118308	IRAG2	NA	
ENSG00000258546	CENPUP2	NA	
ENSG00000258449	AC023510.1	NA	
ENSG00000276842	AC023510.2	NA	
ENSG00000118307	CASC1	NA	
ENSG00000205707	ETFRF1	NA	
ENSG00000133703	KRAS	163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM;;SFM SYNDROME;;LINEAR SEBACEOUS NEVUS SYNDROME;;SEBACEOUS NEVUS SYNDROME, LINEAR;;JADASSOHN NEVUS PHAKOMATOSIS; JNP;;NEVUS SEBACEUS OF JADASSOHN;;ORGANOID NEVUS PHAKOMATOSIS;;EPIDERMAL NEVUS SYNDROME, FORMERLY
ENSG00000133703	KRAS	137215	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR, INCLUDED; LBC, INCLUDED;;GASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE, INCLUDED
ENSG00000133703	KRAS	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000133703	KRAS	109800	BLADDER CANCER
ENSG00000133703	KRAS	108010	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN;;BAVM;;CEREBRAL ARTERIOVENOUS MALFORMATIONS INTRACRANIAL HEMORRHAGE IN BRAIN ARTERIOVENOUS MALFORMATIONS, SUSCEPTIBILITY TO, INCLUDED
ENSG00000133703	KRAS	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000133703	KRAS	260350	PANCREATIC CANCER;;PANCREATIC CARCINOMA;;PANCREATIC ACINAR CARCINOMA
ENSG00000133703	KRAS	600268	OCULOECTODERMAL SYNDROME; OES;;APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS
ENSG00000133703	KRAS	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000133703	KRAS	609942	NOONAN SYNDROME 3; NS3
ENSG00000133703	KRAS	614470	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; ALPS4
ENSG00000133703	KRAS	615278	CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2
ENSG00000274987	AC092794.1	NA	
ENSG00000275197	AC092794.2	NA	
ENSG00000278743	AC087239.1	NA	
ENSG00000201439	RNU4-67P	NA	
ENSG00000241846	AC092451.1	NA	
ENSG00000152936	LMNTD1	NA	
ENSG00000279173	AC092451.2	NA	
ENSG00000256079	FAM133GP	NA	
ENSG00000255988	TUBB4BP1	NA	
ENSG00000257009	AC022367.1	NA	
ENSG00000222950	RN7SKP262	NA	
ENSG00000256686	AC019209.3	NA	
ENSG00000255725	TDGP1	NA	
ENSG00000256440	AC019209.2	NA	
ENSG00000283603	MIR4302	NA	
ENSG00000256256	AC019209.1	NA	
ENSG00000246695	RASSF8-AS1	NA	
ENSG00000123094	RASSF8	NA	
ENSG00000123095	BHLHE41	612975	SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1;;SHORT SLEEP PHENOTYPE
ENSG00000123096	SSPN	NA	
ENSG00000256894	AC022509.3	NA	
ENSG00000286752	AC022509.5	NA	
ENSG00000256234	AC022509.2	NA	
ENSG00000255750	AC022509.1	NA	
ENSG00000278095	AC022509.4	NA	
ENSG00000288532	AC055720.3	NA	
ENSG00000255858	AC055720.1	NA	
ENSG00000255968	AC024145.1	NA	
ENSG00000123104	ITPR2	106190	ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD;;DANN-EPSTEIN-SOHAR SYNDROME
ENSG00000256185	AC055720.2	NA	
ENSG00000212549	RNA5SP354	NA	
ENSG00000234428	AC023051.1	NA	
ENSG00000256640	AC023051.2	NA	
ENSG00000064102	INTS13	NA	
ENSG00000111790	FGFR1OP2	NA	
ENSG00000064115	TM7SF3	NA	
ENSG00000247903	AC024896.1	NA	
ENSG00000152944	MED21	NA	
ENSG00000275764	AC092747.4	NA	
ENSG00000214700	C12orf71	NA	
ENSG00000271418	AC092747.3	NA	
ENSG00000256226	AC092747.1	NA	
ENSG00000256625	AC092747.2	NA	
ENSG00000211455	STK38L	NA	
ENSG00000029153	ARNTL2	NA	
ENSG00000245311	ARNTL2-AS1	NA	
ENSG00000165935	SMCO2	NA	
ENSG00000257037	RARS1P1	NA	
ENSG00000110841	PPFIBP1	NA	
ENSG00000248100	AC087257.1	NA	
ENSG00000256056	AC087257.2	NA	
ENSG00000256557	AC009509.4	NA	
ENSG00000256377	AC009509.2	NA	
ENSG00000174236	REP15	NA	
ENSG00000276261	AC009509.5	NA	
ENSG00000230519	HMGB1P49	NA	
ENSG00000256504	AC009509.3	NA	
ENSG00000061794	MRPS35	NA	
ENSG00000252585	AC009509.1	NA	
ENSG00000205693	MANSC4	NA	
ENSG00000087448	KLHL42	NA	
ENSG00000256747	AC009511.2	NA	
ENSG00000256512	AC009511.1	NA	
ENSG00000201612	RN7SKP15	NA	
ENSG00000257042	AC008011.2	NA	
ENSG00000274075	AC009511.3	NA	
ENSG00000256378	AC008011.1	NA	
ENSG00000087494	PTHLH	613382	BRACHYDACTYLY, TYPE E2; BDE2
ENSG00000123106	CCDC91	NA	
ENSG00000247934	AC022364.1	NA	
ENSG00000255951	AC022364.2	NA	
ENSG00000278733	AC022079.2	NA	
ENSG00000273989	AC022079.1	NA	
ENSG00000252237	RNU4-54P	NA	
ENSG00000202187	RNA5SP355	NA	
ENSG00000244712	AC084754.1	NA	
ENSG00000256513	AC022081.1	NA	
ENSG00000278687	AC024255.1	NA	
ENSG00000257258	AC012150.1	NA	
ENSG00000064763	FAR2	NA	
ENSG00000275278	AC012150.2	NA	
ENSG00000275476	AC009318.4	NA	
ENSG00000257176	AC009318.1	NA	
ENSG00000274315	AC009318.3	NA	
ENSG00000273680	AC009318.2	NA	
ENSG00000087502	ERGIC2	NA	
ENSG00000257599	OVCH1-AS1	NA	
ENSG00000187950	OVCH1	NA	
ENSG00000133687	TMTC1	NA	
ENSG00000257456	AC009320.1	NA	
ENSG00000242986	RPL21P99	NA	
ENSG00000286566	AC023511.3	NA	
ENSG00000276431	AC023511.2	NA	
ENSG00000257262	AC023511.1	NA	
ENSG00000257756	LINC02386	NA	
ENSG00000284682	AC078776.2	NA	
ENSG00000251781	RNA5SP356	NA	
ENSG00000257932	AC078776.1	NA	
ENSG00000258202	AC026371.1	NA	
ENSG00000133704	IPO8	NA	
ENSG00000285870	AC012673.1	NA	
ENSG00000110888	CAPRIN2	NA	
ENSG00000246331	AC010198.1	NA	
ENSG00000235884	LINC00941	NA	
ENSG00000285517	AC010198.2	NA	
ENSG00000258118	PPIAP44	NA	
ENSG00000110900	TSPAN11	NA	
ENSG00000226472	AC008013.1	NA	
ENSG00000256984	AC008013.2	NA	
ENSG00000245614	DDX11-AS1	NA	
ENSG00000013573	DDX11	613398	WARSAW BREAKAGE SYNDROME; WABS
ENSG00000212533	SNORA75	NA	
ENSG00000270926	AC008013.3	NA	
ENSG00000177359	AC024940.1	NA	
ENSG00000270766	AC024940.4	NA	
ENSG00000243517	AC024940.2	NA	
ENSG00000270395	MREGP1	NA	
ENSG00000275097	AC024940.5	NA	
ENSG00000139146	SINHCAF	NA	
ENSG00000256176	AC024940.3	NA	
ENSG00000177340	FLJ13224	NA	
ENSG00000256232	LINC02387	NA	
ENSG00000283256	U6	NA	
ENSG00000170456	DENND5B	NA	
ENSG00000200388	RNU6-618P	NA	
ENSG00000275769	AC068792.1	NA	
ENSG00000203437	AC022080.1	NA	
ENSG00000256159	AC022080.2	NA	
ENSG00000201228	Y_RNA	NA	
ENSG00000225349	ANKRD49P2	NA	
ENSG00000255867	DENND5B-AS1	NA	
ENSG00000252390	RNU5F-4P	NA	
ENSG00000231788	RPL31P50	NA	
ENSG00000233381	AK4P3	NA	
ENSG00000287388	AC068774.1	NA	
ENSG00000139160	ETFBKMT	NA	
ENSG00000151743	AMN1	NA	
ENSG00000276058	STMN1P1	NA	
ENSG00000276900	AC023157.2	NA	
ENSG00000256843	AC023157.1	NA	
ENSG00000223722	IFITM3P2	NA	
ENSG00000188375	H3-5	NA	
ENSG00000252421	RNU6-1069P	NA	
ENSG00000252204	AC023050.2	NA	
ENSG00000256372	AC023050.3	NA	
ENSG00000255760	LINC02422	NA	
ENSG00000256465	AC023050.4	NA	
ENSG00000244436	AC023050.1	NA	
ENSG00000242314	RPL12P32	NA	
ENSG00000256987	AC023050.5	NA	
ENSG00000174718	RESF1	NA	
ENSG00000276136	AC016957.2	NA	
ENSG00000257094	AC016957.1	NA	
ENSG00000257852	AC048344.2	NA	
ENSG00000271357	AC048344.3	NA	
ENSG00000257530	AC048344.1	NA	
ENSG00000151746	BICD1	NA	
ENSG00000277342	AC048344.4	NA	
ENSG00000258134	AC016954.1	NA	
ENSG00000274964	AC026356.1	NA	
ENSG00000276115	AC026356.2	NA	
ENSG00000207176	Y_RNA	NA	
ENSG00000139132	FGD4	609311	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H;;CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4H;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4H;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4H
ENSG00000253063	RNU6-494P	NA	
ENSG00000087470	DNM1L	610708	OPTIC ATROPHY 5; OPA5
ENSG00000087470	DNM1L	614388	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1;;EMPF
ENSG00000257643	AC084824.2	NA	
ENSG00000201563	Y_RNA	NA	
ENSG00000276148	AC084824.5	NA	
ENSG00000257511	AC084824.1	NA	
ENSG00000139131	YARS2	613561	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2
ENSG00000274105	AC084824.3	NA	
ENSG00000275854	AC084824.4	NA	
ENSG00000286950	AC087588.3	NA	
ENSG00000057294	PKP2	609040	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 9; ARVC9
ENSG00000274976	AC087588.2	NA	
ENSG00000244743	AC087588.1	NA	
ENSG00000257316	AC087311.1	NA	
ENSG00000257435	AC087311.2	NA	
ENSG00000110975	SYT10	NA	
ENSG00000259937	AC023158.1	NA	
ENSG00000273853	AC023158.2	NA	
ENSG00000256070	AC016956.1	NA	
ENSG00000212475	RNU6-400P	NA	
ENSG00000270807	AC024153.1	NA	
ENSG00000207026	RNU6-472P	NA	
ENSG00000201624	Y_RNA	NA	
ENSG00000245482	AC046130.1	NA	
ENSG00000139133	ALG10	NA	
ENSG00000256538	AC046130.2	NA	
ENSG00000255628	AC140847.1	NA	
ENSG00000256986	AC140847.3	NA	
ENSG00000250788	TUBB8P4	NA	
ENSG00000255652	AC140847.2	NA	
ENSG00000272435	RNA5SP357	NA	
ENSG00000258794	DUX4L27	NA	
ENSG00000256614	AK6P1	NA	
ENSG00000258368	ZNF970P	NA	
ENSG00000257173	AK6P2	NA	
ENSG00000258278	CLUHP8	NA	
ENSG00000274293	AC079460.1	NA	
ENSG00000287442	AC079460.2	NA	
ENSG00000199843	RNA5SP358	NA	
ENSG00000201708	RNA5SP359	NA	
ENSG00000254381	TUBB8P5	NA	
ENSG00000257292	AC117372.1	NA	
ENSG00000258360	NF1P12	NA	
ENSG00000253016	Y_RNA	NA	
ENSG00000175548	ALG10B	613688	LONG QT SYNDROME 2; LQT2 LONG QT SYNDROME 2, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/3, DIGENIC, INCLUDED; LQT2/3, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/5, DIGENIC /.../UDED; LQT2/5, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/9, DIGENIC, INCLUDED; LQT2/9, DIGENIC, INCLUDED
ENSG00000257645	AC087897.1	NA	
ENSG00000258119	AC087897.2	NA	
ENSG00000139117	CPNE8	NA	
ENSG00000257718	CPNE8-AS1	NA	
ENSG00000257586	AC018448.2	NA	
ENSG00000257237	AC018448.1	NA	
ENSG00000258144	LINC02406	NA	
ENSG00000270718	AC084373.1	NA	
ENSG00000139116	KIF21A	135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1;;OPHTHALMOPLEGIA, CONGENITAL;;BLEPHAROPTOSIS WITH ABSENT EYE MOVEMENTS;;FEOM1 LOCUS FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B, INCLUDED; CFEOM3B, INCLUDED
ENSG00000286576	AC121334.4	NA	
ENSG00000255991	AC121334.1	NA	
ENSG00000270273	AC121334.2	NA	
ENSG00000173208	ABCD2	NA	
ENSG00000285732	AC121334.3	NA	
ENSG00000180116	C12orf40	NA	
ENSG00000151229	SLC2A13	NA	
ENSG00000199571	AC121336.1	NA	
ENSG00000229014	RPL30P13	NA	
ENSG00000260943	LINC02555	NA	
ENSG00000223914	LINC02471	NA	
ENSG00000225342	LRRK2-DT	NA	
ENSG00000188906	LRRK2	607060	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8
ENSG00000229899	AC084290.1	NA	
ENSG00000205592	MUC19	NA	
ENSG00000258167	AC107023.1	NA	
ENSG00000207492	RNU6-713P	NA	
ENSG00000018236	CNTN1	612540	MYOPATHY, CONGENITAL, COMPTON-NORTH; MYPCN
ENSG00000257680	AC016144.1	NA	
ENSG00000274682	AC015540.1	NA	
ENSG00000165966	PDZRN4	NA	
ENSG00000257228	AC090531.1	NA	
ENSG00000252364	RNA5SP360	NA	
ENSG00000258239	MTND2P17	NA	
ENSG00000257858	MTND1P24	NA	
ENSG00000257784	LINC02400	NA	
ENSG00000257239	AC090630.1	NA	
ENSG00000257128	AC006197.1	NA	
ENSG00000286591	AC006197.2	NA	
ENSG00000271379	AC023513.1	NA	
ENSG00000151233	GXYLT1	NA	
ENSG00000015153	YAF2	NA	
ENSG00000134283	PPHLN1	NA	
ENSG00000257674	AC020629.1	NA	
ENSG00000139168	ZCRB1	NA	
ENSG00000278520	MIR7851	NA	
ENSG00000252917	SNORA74	NA	
ENSG00000274943	AC079684.1	NA	
ENSG00000199886	RNU6-249P	NA	
ENSG00000257376	AC079601.2	NA	
ENSG00000207142	Y_RNA	NA	
ENSG00000139174	PRICKLE1	612437	EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B
ENSG00000257225	AC079601.1	NA	
ENSG00000258068	AC079600.3	NA	
ENSG00000257510	LINC02402	NA	
ENSG00000257687	AC079600.2	NA	
ENSG00000257405	AC079600.1	NA	
ENSG00000257164	LINC02451	NA	
ENSG00000240759	RPS27P21	NA	
ENSG00000257114	LINC02450	NA	
ENSG00000271272	AC068802.1	NA	
ENSG00000257849	AC012038.2	NA	
ENSG00000257373	AC012038.1	NA	
ENSG00000257927	MRPS36P5	NA	
ENSG00000258331	LINC02461	NA	
ENSG00000173157	ADAMTS20	NA	
ENSG00000241251	AC090525.1	NA	
ENSG00000257813	AC090525.2	NA	
ENSG00000271508	AC090525.3	NA	
ENSG00000257907	EEF1A1P17	NA	
ENSG00000129317	PUS7L	NA	
ENSG00000257896	AC093012.1	NA	
ENSG00000198001	IRAK4	607676	IRAK4 DEFICIENCY;;IRAK4D
ENSG00000198001	IRAK4	610799	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1 INVASIVE PNEUMOCOCCAL DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000151239	TWF1	NA	
ENSG00000139173	TMEM117	NA	
ENSG00000258212	ZNF75BP	NA	
ENSG00000257947	AC025030.2	NA	
ENSG00000257864	AC025030.1	NA	
ENSG00000275286	AC025253.1	NA	
ENSG00000286671	AC025253.2	NA	
ENSG00000184613	NELL2	NA	
ENSG00000201788	Y_RNA	NA	
ENSG00000185610	DBX2	NA	
ENSG00000257319	AC008127.1	NA	
ENSG00000257331	RACGAP1P	NA	
ENSG00000257572	AC008127.2	NA	
ENSG00000199556	RNA5SP361	NA	
ENSG00000287386	AC009248.3	NA	
ENSG00000134297	PLEKHA8P1	NA	
ENSG00000257738	AC009248.1	NA	
ENSG00000177119	ANO6	262890	SCOTT SYNDROME; SCTS;;BLEEDING DISORDER, PLATELET-TYPE, 7; BDPLT7;;BLEEDING ABNORMALITY DUE TO DEFICIENCY OF PLATELET BINDING OF FACTOR X;;PROTHROMBIN CONVERSION DEFECT, FAMILIAL;;PROTHROMBIN CONSUMPTION DEFICIENCY;;PROTHROMBIN CONSUMPTION INHIBITOR /.../LIAL
ENSG00000278351	AC009248.2	NA	
ENSG00000257368	AC063924.1	NA	
ENSG00000257657	AC079950.1	NA	
ENSG00000283545	U6	NA	
ENSG00000273015	AC008124.1	NA	
ENSG00000189079	ARID2	617808	COFFIN-SIRIS SYNDROME 6; CSS6
ENSG00000278475	AC009464.1	NA	
ENSG00000265093	RN7SL246P	NA	
ENSG00000270429	KNOP1P2	NA	
ENSG00000139218	SCAF11	NA	
ENSG00000239397	AC084878.1	NA	
ENSG00000111371	SLC38A1	NA	
ENSG00000274591	AC025031.3	NA	
ENSG00000134294	SLC38A2	NA	
ENSG00000258096	AC025031.2	NA	
ENSG00000257261	AC008014.1	NA	
ENSG00000257496	AC025031.1	NA	
ENSG00000275481	AC025031.4	NA	
ENSG00000278896	AC025031.5	NA	
ENSG00000272369	AC008035.1	NA	
ENSG00000272963	OR7A19P	NA	
ENSG00000271642	MARK3P1	NA	
ENSG00000139209	SLC38A4	NA	
ENSG00000274723	AC079906.1	NA	
ENSG00000139211	AMIGO2	NA	
ENSG00000179715	PCED1B	NA	
ENSG00000258352	IFITM3P6	NA	
ENSG00000263838	MIR4698	NA	
ENSG00000247774	PCED1B-AS1	NA	
ENSG00000258181	AC008083.3	NA	
ENSG00000257925	AC008083.2	NA	
ENSG00000276454	AC008083.4	NA	
ENSG00000258116	PPIAP45	NA	
ENSG00000199566	AC008083.1	NA	
ENSG00000257924	LINC02416	NA	
ENSG00000264906	MIR4494	NA	
ENSG00000257906	LINC02156	NA	
ENSG00000258369	ADI1P3	NA	
ENSG00000257807	AC003686.1	NA	
ENSG00000257905	AC004486.1	NA	
ENSG00000005175	RPAP3	NA	
ENSG00000276390	AC004241.3	NA	
ENSG00000257433	AC004241.1	NA	
ENSG00000111405	ENDOU	NA	
ENSG00000280054	AC004241.5	NA	
ENSG00000274902	AC004241.2	NA	
ENSG00000079337	RAPGEF3	NA	
ENSG00000211584	SLC48A1	NA	
ENSG00000277173	AC004241.4	NA	
ENSG00000061273	HDAC7	NA	
ENSG00000268069	AC004466.1	NA	
ENSG00000276691	AC004466.3	NA	
ENSG00000274737	AC004466.2	NA	
ENSG00000257488	LINC02354	NA	
ENSG00000111424	VDR	277440	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A;;VITAMIN D-DEPENDENT RICKETS, TYPE 2A, WITH OR WITHOUT ALOPECIA;;RICKETS, HEREDITARY VITAMIN D-RESISTANT; HVDRR;;GENERALIZED RESISTANCE TO 1,25-DIHYDROXYVITAMIN D;;VITAMIN D-RESISTANT RICKETS WITH END-ORG /.../ESPONSIVENESS TO 1,25-DIHYDROXYCHOLECALCIFEROL;;PSEUDOVITAMIN D-DEFICIENCY, TYPE IIA;;PDDR IIA;;HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS;;RICKETS-ALOPECIA SYNDROME
ENSG00000205537	AC121338.1	NA	
ENSG00000278385	AC121338.2	NA	
ENSG00000279840	AC004801.7	NA	
ENSG00000134291	TMEM106C	NA	
ENSG00000139219	COL2A1	184255	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF;;SPONDYLOMETAPHYSEAL DYSPLASIA, SUTCLIFFE TYPE
ENSG00000139219	COL2A1	184250	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DY /.../A; SMD;;SEMDC
ENSG00000139219	COL2A1	183900	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC;;SED CONGENITA;;SPONDYLOEPIPHYSEAL DYSPLASIA, CONGENITAL TYPE
ENSG00000139219	COL2A1	156550	KNIEST DYSPLASIA
ENSG00000139219	COL2A1	151210	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT;;LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, TORRANCE TYPE;;THANATOPHORIC DYSPLASIA, TORRANCE VARIANT PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, LUTON TYPE, INCLUDED; PLSDL, INCLUDED;;TH /.../HORIC DYSPLASIA, LUTON VARIANT, INCLUDED
ENSG00000139219	COL2A1	150600	LEGG-CALVE-PERTHES DISEASE; LCPD;;LCP;;LEGG-PERTHES DISEASE;;PERTHES DISEASE
ENSG00000139219	COL2A1	132450	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS; EDMMD
ENSG00000139219	COL2A1	120140	COLLAGEN, TYPE II, ALPHA-1; COL2A1;;COLLAGEN, TYPE II;;COLLAGEN OF CARTILAGE CHONDROCALCIN, INCLUDED;;VITREORETINOPATHY WITH PHALANGEAL EPIPHYSEAL DYSPLASIA, INCLUDED
ENSG00000139219	COL2A1	108300	STICKLER SYNDROME, TYPE I; STL1;;STICKLER SYNDROME, VITREOUS TYPE 1;;STICKLER SYNDROME, MEMBRANOUS VITREOUS TYPE;;ARTHROOPHTHALMOPATHY, HEREDITARY PROGRESSIVE; AOM
ENSG00000139219	COL2A1	200610	ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLY HYPOCHONDROGENESIS, INCLUDED
ENSG00000139219	COL2A1	271700	SPONDYLOPERIPHERAL DYSPLASIA;;SPONDYLOPERIPHERAL DYSPLASIA WITH SHORT ULNA
ENSG00000139219	COL2A1	604864	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA; OSCDP;;NAMAQUALAND HIP DYSPLASIA; NHD
ENSG00000139219	COL2A1	608805	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1; ANFH1;;FEMORAL HEAD, AVASCULAR NECROSIS OF; ANFH;;FEMORAL HEAD, ASEPTIC NECROSIS OF;;ISCHEMIC NECROSIS OF FEMORAL HEAD;;OSTEONECROSIS OF FEMORAL HEAD
ENSG00000139219	COL2A1	609162	CZECH DYSPLASIA;;CZECH DYSPLASIA, METATARSAL TYPE;;PSEUDORHEUMATOID DYSPLASIA, PROGRESSIVE, WITH HYPOPLASTIC TOES;;SPONDYLOEPIPHYSEAL DYSPLASIA WITH PRECOCIOUS OSTEOARTHRITIS
ENSG00000139219	COL2A1	609508	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR;;STICKLER SYNDROME, TYPE I, PREDOMINANTLY OCULAR;;STICKLER SYNDROME, ATYPICAL  RHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED; DRRD, INCLUDED
ENSG00000139219	COL2A1	616583	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE; SEDSTN;;SED, STANESCU TYPE
ENSG00000258203	AC004801.5	NA	
ENSG00000257985	AC004801.4	NA	
ENSG00000257955	AC004801.3	NA	
ENSG00000276814	AC004801.6	NA	
ENSG00000079387	SENP1	NA	
ENSG00000240399	AC004801.2	NA	
ENSG00000222635	RNU6-1203P	NA	
ENSG00000226138	AC004801.1	NA	
ENSG00000152556	PFKM	232800	GLYCOGEN STORAGE DISEASE VII; GSD7;;GSD VII;;MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY;;PFKM DEFICIENCY;;TARUI DISEASE
ENSG00000275770	MIR6505	NA	
ENSG00000177981	ASB8	NA	
ENSG00000274124	AC074029.3	NA	
ENSG00000258051	AC074029.2	NA	
ENSG00000257885	PHBP18	NA	
ENSG00000257848	AC074029.1	NA	
ENSG00000177875	CCDC184	NA	
ENSG00000279875	AC074029.4	NA	
ENSG00000269514	AC024257.3	NA	
ENSG00000172640	OR10AD1	NA	
ENSG00000258234	AC024257.1	NA	
ENSG00000275228	AC024257.5	NA	
ENSG00000187166	H1-7	NA	
ENSG00000258273	AC024257.2	NA	
ENSG00000167528	ZNF641	NA	
ENSG00000257735	AC090115.1	NA	
ENSG00000257763	OR5BK1P	NA	
ENSG00000273765	AC024257.4	NA	
ENSG00000258024	OR5BT1P	NA	
ENSG00000257792	OR5BJ1P	NA	
ENSG00000273434	OR8S21P	NA	
ENSG00000226413	OR8T1P	NA	
ENSG00000139223	ANP32D	NA	
ENSG00000177627	C12orf54	NA	
ENSG00000258121	AC089987.2	NA	
ENSG00000240443	RPS10P20	NA	
ENSG00000197376	AC089987.1	NA	
ENSG00000284723	OR8S1	NA	
ENSG00000198678	OR5BS1P	NA	
ENSG00000167531	LALBA	NA	
ENSG00000224709	OR11M1P	NA	
ENSG00000139620	KANSL2	NA	
ENSG00000221491	SNORA2C	NA	
ENSG00000281842	MIR1291	NA	
ENSG00000206612	SNORA2A	NA	
ENSG00000207313	SNORA2B	NA	
ENSG00000129315	CCNT1	NA	
ENSG00000257987	TEX49	NA	
ENSG00000257653	AC117498.1	NA	
ENSG00000174233	ADCY6	616287	LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8
ENSG00000264201	MIR4701	NA	
ENSG00000257660	ADCY6-DT	NA	
ENSG00000271547	AC117498.2	NA	
ENSG00000207467	Y_RNA	NA	
ENSG00000167535	CACNB3	NA	
ENSG00000174243	DDX23	NA	
ENSG00000172602	RND1	NA	
ENSG00000199394	RNU6-600P	NA	
ENSG00000239617	AC073610.1	NA	
ENSG00000272822	AC073610.2	NA	
ENSG00000139537	CCDC65	615504	CILIARY DYSKINESIA, PRIMARY, 27; CILD27;;CILIARY DYSKINESIA, PRIMARY, 27, WITHOUT SITUS INVERSUS
ENSG00000134285	FKBP11	NA	
ENSG00000134287	ARF3	NA	
ENSG00000169884	WNT10B	225300	SPLIT-HAND/FOOT MALFORMATION 6; SHFM6;;ECTRODACTYLY, AUTOSOMAL RECESSIVE
ENSG00000169884	WNT10B	617073	TOOTH AGENESIS, SELECTIVE, 8; STHAG8
ENSG00000200303	RNU6-940P	NA	
ENSG00000125084	WNT1	615220	OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV
ENSG00000125084	WNT1	615221	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16;;OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO
ENSG00000181418	DDN	NA	
ENSG00000258283	AC011603.4	NA	
ENSG00000257913	DDN-AS1	NA	
ENSG00000181929	PRKAG1	NA	
ENSG00000167548	KMT2D	147920	KABUKI SYNDROME 1; KABUK1;;KABUKI SYNDROME;;KABUKI MAKE-UP SYNDROME; KMS;;NIIKAWA-KUROKI SYNDROME
ENSG00000167550	RHEBL1	NA	
ENSG00000277672	AC011603.5	NA	
ENSG00000139549	DHH	233420	46,XY SEX REVERSAL 7; SRXY7;;46,XY SEX REVERSAL, PARTIAL OR COMPLETE, DHH-RELATED;;46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, DHH-RELATED;;GONADAL DYSGENESIS, XY, MALE-LIMITED; GDXYM
ENSG00000139549	DHH	607080	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY
ENSG00000257346	AC011603.2	NA	
ENSG00000139636	LMBR1L	NA	
ENSG00000123416	TUBA1B	NA	
ENSG00000258017	AC011603.3	NA	
ENSG00000200309	AC011603.1	NA	
ENSG00000167552	TUBA1A	611603	LISSENCEPHALY 3; LIS3
ENSG00000167553	TUBA1C	NA	
ENSG00000274017	AC010173.2	NA	
ENSG00000258101	AC010173.1	NA	
ENSG00000258232	AC125611.3	NA	
ENSG00000258334	AC125611.4	NA	
ENSG00000135406	PRPH	105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1;;AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS;;AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED;;AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED
ENSG00000135451	TROAP	NA	
ENSG00000186897	C1QL4	NA	
ENSG00000178401	DNAJC22	NA	
ENSG00000123352	SPATS2	NA	
ENSG00000257954	AC125611.2	NA	
ENSG00000257464	AC125611.1	NA	
ENSG00000287537	AC020612.4	NA	
ENSG00000135519	KCNH3	NA	
ENSG00000187778	MCRS1	NA	
ENSG00000110844	PRPF40B	NA	
ENSG00000257964	AC020612.3	NA	
ENSG00000135436	FAM186B	NA	
ENSG00000199237	RNU6-834P	NA	
ENSG00000258284	POLR2KP1	NA	
ENSG00000257243	AC020612.1	NA	
ENSG00000258104	HIGD1AP9	NA	
ENSG00000161791	FMNL3	NA	
ENSG00000139644	TMBIM6	NA	
ENSG00000257570	AC020612.2	NA	
ENSG00000257730	LSM6P2	NA	
ENSG00000167566	NCKAP5L	NA	
ENSG00000258057	BCDIN3D-AS1	NA	
ENSG00000186666	BCDIN3D	NA	
ENSG00000257253	AC131157.1	NA	
ENSG00000242041	RPL35AP28	NA	
ENSG00000135472	FAIM2	NA	
ENSG00000257771	LINC02395	NA	
ENSG00000258135	LINC02396	NA	
ENSG00000167580	AQP2	125800	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL;;DIABETES INSIPIDUS, NEPHROGENIC, TYPE II
ENSG00000257588	AC025154.2	NA	
ENSG00000257378	AC025154.1	NA	
ENSG00000161798	AQP5	600231	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB
ENSG00000086159	AQP6	NA	
ENSG00000161800	RACGAP1	NA	
ENSG00000110881	ASIC1	NA	
ENSG00000066117	SMARCD1	618779	COFFIN-SIRIS SYNDROME 11; CSS11
ENSG00000167588	GPD1	614480	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI
ENSG00000178449	COX14	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000272368	AC074032.1	NA	
ENSG00000139624	CERS5	NA	
ENSG00000050405	LIMA1	618079	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8; LDLCQ8
ENSG00000257298	AC008147.2	NA	
ENSG00000257531	AC008147.3	NA	
ENSG00000257256	AC008147.1	NA	
ENSG00000221604	MIR1293	NA	
ENSG00000212496	RNU6-1093P	NA	
ENSG00000278842	AC008147.4	NA	
ENSG00000185958	FAM186A	NA	
ENSG00000244266	AC090058.1	NA	
ENSG00000161813	LARP4	NA	
ENSG00000066084	DIP2B	136630	MENTAL RETARDATION, FRA12A TYPE
ENSG00000207136	RNU6-769P	NA	
ENSG00000200183	RNU6-238P	NA	
ENSG00000200428	Y_RNA	NA	
ENSG00000271018	AC013244.1	NA	
ENSG00000123268	ATF1	NA	
ENSG00000271490	AC013244.2	NA	
ENSG00000243075	RN7SL519P	NA	
ENSG00000186452	TMPRSS12	NA	
ENSG00000271621	AC013244.3	NA	
ENSG00000185432	METTL7A	NA	
ENSG00000274156	AC008121.2	NA	
ENSG00000199740	Y_RNA	NA	
ENSG00000271596	AC008121.1	NA	
ENSG00000214511	HIGD1C	NA	
ENSG00000274797	AC008121.3	NA	
ENSG00000110911	SLC11A2	206100	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1
ENSG00000272028	RNU6-87P	NA	
ENSG00000199903	RNU6-1273P	NA	
ENSG00000050426	LETMD1	NA	
ENSG00000110925	CSRNP2	NA	
ENSG00000135457	TFCP2	NA	
ENSG00000244540	AC087884.1	NA	
ENSG00000257246	PHBP19	NA	
ENSG00000200953	Y_RNA	NA	
ENSG00000199824	RNU6-199P	NA	
ENSG00000184271	POU6F1	NA	
ENSG00000278126	AC139768.1	NA	
ENSG00000183283	DAZAP2	NA	
ENSG00000170545	SMAGP	NA	
ENSG00000110934	BIN2	NA	
ENSG00000139610	CELA1	NA	
ENSG00000139629	GALNT6	NA	
ENSG00000050438	SLC4A8	NA	
ENSG00000271065	AC107031.1	NA	
ENSG00000196876	SCN8A	614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT
ENSG00000196876	SCN8A	614558	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13
ENSG00000196876	SCN8A	617080	SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 5; BFIC5
ENSG00000196876	SCN8A	618364	MYOCLONUS, FAMILIAL, 2; MYOCL2
ENSG00000257851	HNRNPA3P10	NA	
ENSG00000260122	AC068987.1	NA	
ENSG00000284730	TMDD1	NA	
ENSG00000260473	AC068987.2	NA	
ENSG00000261308	FIGNL2	NA	
ENSG00000261586	AC068987.3	NA	
ENSG00000259887	FIGNL2-DT	NA	
ENSG00000167612	ANKRD33	NA	
ENSG00000258021	AC025259.2	NA	
ENSG00000139567	ACVRL1	600376	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2 PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED
ENSG00000135503	ACVR1B	NA	
ENSG00000206992	RNU6-574P	NA	
ENSG00000161835	TAMALIN	NA	
ENSG00000123358	NR4A1	NA	
ENSG00000259884	NR4A1AS	NA	
ENSG00000123395	ATG101	NA	
ENSG00000257663	AC025259.1	NA	
ENSG00000284791	SMIM41	NA	
ENSG00000257542	OR7E47P	NA	
ENSG00000257989	AC078864.1	NA	
ENSG00000258279	LINC00592	NA	
ENSG00000167767	KRT80	NA	
ENSG00000257137	LINC02874	NA	
ENSG00000257649	METTL7AP1	NA	
ENSG00000135480	KRT7	NA	
ENSG00000257671	KRT7-AS	NA	
ENSG00000170442	KRT86	158000	MONILETHRIX; MNLIX
ENSG00000135477	KRT87P	NA	
ENSG00000284883	AC021066.2	NA	
ENSG00000257830	AC021066.1	NA	
ENSG00000285102	AC021066.3	NA	
ENSG00000205426	KRT81	158000	MONILETHRIX; MNLIX
ENSG00000287051	AC121757.2	NA	
ENSG00000257829	AC121757.1	NA	
ENSG00000170523	KRT83	158000	MONILETHRIX; MNLIX
ENSG00000170523	KRT83	617756	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5; EKVP5
ENSG00000274928	KRT89P	NA	
ENSG00000135443	KRT85	602032	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4;;ECTODERMAL DYSPLASIA, 'PURE' HAIR/NAIL TYPE
ENSG00000161849	KRT84	NA	
ENSG00000258253	AC078865.1	NA	
ENSG00000161850	KRT82	NA	
ENSG00000257500	AC055736.1	NA	
ENSG00000257844	KRT90P	NA	
ENSG00000170454	KRT75	612318	PSEUDOFOLLICULITIS BARBAE;;PFB;;PILI INCARNATI;;INGROWN HAIRS
ENSG00000185479	KRT6B	615728	PACHYONYCHIA CONGENITA 4; PC4
ENSG00000170465	KRT6C	615735	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD
ENSG00000205420	KRT6A	615726	PACHYONYCHIA CONGENITA 3; PC3
ENSG00000186081	KRT5	179850	DOWLING-DEGOS DISEASE 1; DDD1;;DDD;;RETICULAR PIGMENT ANOMALY OF FLEXURES
ENSG00000186081	KRT5	131960	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBSMP;;SPECKLED HYPERPIGMENTATION WITH PUNCTATE PALMOPLANTAR KERATOSES AND CHILDHOOD BLISTERING
ENSG00000186081	KRT5	131900	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED;;EBS, GENERALIZED;;EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE
ENSG00000186081	KRT5	131800	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED;;EPIDERMOLYSIS BULLOSA SIMPLEX, WEBER-COCKAYNE TYPE;;EPIDERMOLYSIS BULLOSA OF HANDS AND FEET;;EBS, ACRAL FORM
ENSG00000186081	KRT5	131760	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM;;EPIDERMOLYSIS BULLOSA HERPETIFORMIS, DOWLING-MEARA TYPE;;EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE
ENSG00000186081	KRT5	601001	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1
ENSG00000186081	KRT5	609352	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA
ENSG00000139648	KRT71	615896	HYPOTRICHOSIS 13; HYPT13;;HYPOTRICHOSIS WITH WOOLLY HAIR
ENSG00000170484	KRT74	194300	WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH
ENSG00000170484	KRT74	613981	HYPOTRICHOSIS 3; HYPT3;;HYPOTRICHOSIS SIMPLEX OF THE SCALP 2; HTSS2
ENSG00000170484	KRT74	614929	ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7
ENSG00000170486	KRT72	NA	
ENSG00000257495	KRT73-AS1	NA	
ENSG00000186049	KRT73	NA	
ENSG00000258120	KRT128P	NA	
ENSG00000172867	KRT2	146800	ICHTHYOSIS BULLOSA OF SIEMENS; IBS;;ICHTHYOSIS, BULLOUS TYPE ICHTHYOSIS EXFOLIATIVA, INCLUDED
ENSG00000167768	KRT1	146590	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM
ENSG00000167768	KRT1	144200	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK;;PPKE;;KERATODERMA, EPIDERMOLYTIC PALMOPLANTAR;;PALMOPLANTAR KERATODERMA, VORNER TYPE;;HYPERKERATOSIS, LOCALIZED EPIDERMOLYTIC;;KERATOSIS PALMARIS ET PLANTARIS FAMILIARIS;;TYLOSIS;;KERATOSIS OF GREITHER  /.../LANTAR KERATODERMA, EPIDERMOLYTIC, WITH KNUCKLE PADS, INCLUDED
ENSG00000167768	KRT1	113800	EPIDERMOLYTIC HYPERKERATOSIS; EHK;;BULLOUS ERYTHRODERMA ICHTHYOSIFORMIS CONGENITA OF BROCQ;;BULLOUS CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; BCIE;;BULLOUS ICHTHYOSIFORM ERYTHRODERMA; BIE;;EPIDERMOLYTIC ICHTHYOSIS EPIDERMOLYTIC HYPERKERATOSIS, LATE-ONS /.../CLUDED
ENSG00000167768	KRT1	600962	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK;;PPKNE;;NONEPIDERMOLYTIC PALMOPLANTAR KERATODERMA;;KERATODERMA, NONEPIDERMOLYTIC PALMOPLANTAR;;TYLOSIS
ENSG00000167768	KRT1	607602	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS;;CIEHK;;EPIDERMOLYTIC ICHTHYOSIS, ANNULAR; AEI
ENSG00000167768	KRT1	607654	KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3;;STRIATE PALMOPLANTAR KERATODERMA III; SPPK3;;KERATODERMA, PALMOPLANTAR, STRIATE FORM III; KPPS3
ENSG00000189182	KRT77	NA	
ENSG00000257700	AC055716.3	NA	
ENSG00000257402	KRT126P	NA	
ENSG00000258036	KRT125P	NA	
ENSG00000257616	AC055716.2	NA	
ENSG00000257343	AC055716.1	NA	
ENSG00000257675	BTBD10P1	NA	
ENSG00000257125	KRT127P	NA	
ENSG00000258071	ARL2BPP2	NA	
ENSG00000185069	KRT76	NA	
ENSG00000257404	AC107016.2	NA	
ENSG00000186442	KRT3	618767	CORNEAL DYSTROPHY, MEESMANN, 2; MECD2
ENSG00000170477	KRT4	193900	WHITE SPONGE NEVUS 1; WSN1;;WHITE SPONGE NEVUS OF CANNON;;LEUKOKERATOSIS, HEREDITARY MUCOSAL
ENSG00000185640	KRT79	NA	
ENSG00000257389	AC107016.1	NA	
ENSG00000170423	KRT78	NA	
ENSG00000241146	RPL7P41	NA	
ENSG00000170421	KRT8	118900	CIRRHOSIS, FAMILIAL
ENSG00000170421	KRT8	215600	CIRRHOSIS, FAMILIAL CIRRHOSIS, FAMILIAL, WITH PULMONARY HYPERTENSION, INCLUDED;;INDIAN CHILDHOOD CIRRHOSIS, INCLUDED; ICC, INCLUDED;;SEN SYNDROME, INCLUDED;;COPPER-OVERLOAD CIRRHOSIS, INCLUDED;;ENDEMIC TYROLEAN INFANTILE CIRRHOSIS, INCLUDED; ETIC, I /.../D;;COPPER TOXICOSIS, IDIOPATHIC, INCLUDED; ICT, INCLUDED;;CIRRHOSIS, CRYPTOGENIC, INCLUDED;;CIRRHOSIS, NONCRYPTOGENIC, SUSCEPTIBILITY TO, INCLUDED
ENSG00000111057	KRT18	118900	CIRRHOSIS, FAMILIAL
ENSG00000111057	KRT18	215600	CIRRHOSIS, FAMILIAL CIRRHOSIS, FAMILIAL, WITH PULMONARY HYPERTENSION, INCLUDED;;INDIAN CHILDHOOD CIRRHOSIS, INCLUDED; ICC, INCLUDED;;SEN SYNDROME, INCLUDED;;COPPER-OVERLOAD CIRRHOSIS, INCLUDED;;ENDEMIC TYROLEAN INFANTILE CIRRHOSIS, INCLUDED; ETIC, I /.../D;;COPPER TOXICOSIS, IDIOPATHIC, INCLUDED; ICT, INCLUDED;;CIRRHOSIS, CRYPTOGENIC, INCLUDED;;CIRRHOSIS, NONCRYPTOGENIC, SUSCEPTIBILITY TO, INCLUDED
ENSG00000063046	EIF4B	NA	
ENSG00000257475	AC068888.2	NA	
ENSG00000257337	AC068888.1	NA	
ENSG00000111077	TNS2	NA	
ENSG00000278108	MIR6757	NA	
ENSG00000167778	SPRYD3	NA	
ENSG00000167779	IGFBP6	NA	
ENSG00000167780	SOAT2	NA	
ENSG00000258074	VTI1BP3	NA	
ENSG00000238669	RNU6-333P	NA	
ENSG00000258016	HIGD1AP1	NA	
ENSG00000257790	EIF4A1P4	NA	
ENSG00000139631	CSAD	NA	
ENSG00000257808	AC073573.1	NA	
ENSG00000139651	ZNF740	NA	
ENSG00000139626	ITGB7	NA	
ENSG00000172819	RARG	NA	
ENSG00000283536	AC021072.1	NA	
ENSG00000182544	MFSD5	NA	
ENSG00000135476	ESPL1	NA	
ENSG00000123349	PFDN5	NA	
ENSG00000257605	MYG1-AS1	NA	
ENSG00000139637	MYG1	NA	
ENSG00000094914	AAAS	231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASI /.../CRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMA  ACHALASIA-ALACRIMA SYNDROME, INCLUDED
ENSG00000170374	SP7	613849	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12;;OI, TYPE XII
ENSG00000185591	SP1	NA	
ENSG00000135409	AMHR2	261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS;;PSEUDOHERMAPHRODITISM, MALE INTERNAL;;HERNIA UTERI INGUINALE;;PERSISTENT OVIDUCT SYNDROME;;FEMALE GENITAL DUCTS IN OTHERWISE NORMAL MALE
ENSG00000205352	PRR13	NA	
ENSG00000257379	AC023509.1	NA	
ENSG00000197111	PCBP2	NA	
ENSG00000282977	PCBP2-OT1	NA	
ENSG00000273658	AC023509.4	NA	
ENSG00000139625	MAP3K12	NA	
ENSG00000270175	AC023509.3	NA	
ENSG00000139546	TARBP2	NA	
ENSG00000267281	ATF7-NPFF	NA	
ENSG00000139574	NPFF	NA	
ENSG00000170653	ATF7	NA	
ENSG00000257550	AC023509.2	NA	
ENSG00000285692	AC023509.6	NA	
ENSG00000275488	AC023509.5	NA	
ENSG00000135390	ATP5MC2	NA	
ENSG00000213470	AC073594.1	NA	
ENSG00000012822	CALCOCO1	NA	
ENSG00000286069	AC076968.2	NA	
ENSG00000260492	CISTR	NA	
ENSG00000260030	AC076968.1	NA	
ENSG00000253053	RN7SKP289	NA	
ENSG00000249641	HOXC13-AS	NA	
ENSG00000123364	HOXC13	614931	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE; ECTD9
ENSG00000123407	HOXC12	NA	
ENSG00000228630	HOTAIR	NA	
ENSG00000275589	AC012531.5	NA	
ENSG00000277994	AC012531.7	NA	
ENSG00000274817	AC012531.4	NA	
ENSG00000277129	AC012531.6	NA	
ENSG00000123388	HOXC11	NA	
ENSG00000251151	HOXC-AS3	NA	
ENSG00000180818	HOXC10	NA	
ENSG00000273049	AC012531.3	NA	
ENSG00000197757	HOXC6	NA	
ENSG00000207924	MIR196A2	NA	
ENSG00000250133	HOXC-AS2	NA	
ENSG00000273046	AC012531.2	NA	
ENSG00000180806	HOXC9	NA	
ENSG00000250451	HOXC-AS1	NA	
ENSG00000037965	HOXC8	NA	
ENSG00000198353	HOXC4	NA	
ENSG00000260597	AC012531.1	NA	
ENSG00000172789	HOXC5	NA	
ENSG00000207571	MIR615	NA	
ENSG00000248265	FLJ12825	NA	
ENSG00000250654	AC023794.3	NA	
ENSG00000249388	AC023794.2	NA	
ENSG00000250432	FAM242C	NA	
ENSG00000202146	Y_RNA	NA	
ENSG00000123415	SMUG1	NA	
ENSG00000250742	LINC02381	NA	
ENSG00000260470	AC023794.5	NA	
ENSG00000257534	AC023794.4	NA	
ENSG00000248576	AC023794.1	NA	
ENSG00000094916	CBX5	NA	
ENSG00000283803	MIR3198-2	NA	
ENSG00000241785	RN7SL390P	NA	
ENSG00000257596	SCAT2	NA	
ENSG00000258344	AC078778.1	NA	
ENSG00000135486	HNRNPA1	615424	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3;;MULTISYSTEM PROTEINOPATHY 3; MSP3
ENSG00000135486	HNRNPA1	615426	AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20
ENSG00000123405	NFE2	NA	
ENSG00000111481	COPZ1	NA	
ENSG00000207381	RNU6-950P	NA	
ENSG00000199122	MIR148B	NA	
ENSG00000264028	RN7SL744P	NA	
ENSG00000258137	AC079313.2	NA	
ENSG00000258086	AC079313.1	NA	
ENSG00000139572	GPR84	NA	
ENSG00000161642	ZNF385A	NA	
ENSG00000161638	ITGA5	NA	
ENSG00000257477	LINC01154	NA	
ENSG00000170627	GTSF1	NA	
ENSG00000123338	NCKAP1L	NA	
ENSG00000257824	AC068789.1	NA	
ENSG00000123360	PDE1B	NA	
ENSG00000135447	PPP1R1A	NA	
ENSG00000257780	GLYCAM1	NA	
ENSG00000135413	LACRT	NA	
ENSG00000161634	DCD	NA	
ENSG00000257634	AC079310.1	NA	
ENSG00000270858	VDAC1P5	NA	
ENSG00000172551	MUCL1	NA	
ENSG00000135426	TESPA1	NA	
ENSG00000257870	AC027287.2	NA	
ENSG00000123307	NEUROD4	NA	
ENSG00000196534	OR9K1P	NA	
ENSG00000257350	AC027287.1	NA	
ENSG00000170605	OR9K2	NA	
ENSG00000224622	OR9R1P	NA	
ENSG00000227423	OR10U1P	NA	
ENSG00000179919	OR10A7	NA	
ENSG00000197706	OR6C74	NA	
ENSG00000213451	OR6C69P	NA	
ENSG00000205331	OR6C72P	NA	
ENSG00000188324	OR6C6	NA	
ENSG00000230307	OR6C5P	NA	
ENSG00000205330	OR6C1	NA	
ENSG00000205329	OR6C3	NA	
ENSG00000257757	OR6C7P	NA	
ENSG00000187857	OR6C75	NA	
ENSG00000203408	OR6C71P	NA	
ENSG00000233606	OR6C66P	NA	
ENSG00000257414	OR6C73P	NA	
ENSG00000205328	OR6C65	NA	
ENSG00000179899	PHC1P1	NA	
ENSG00000185821	OR6C76	NA	
ENSG00000258763	AC122685.1	NA	
ENSG00000179695	OR6C2	NA	
ENSG00000184954	OR6C70	NA	
ENSG00000205327	OR6C68	NA	
ENSG00000234670	OR6C64P	NA	
ENSG00000179626	OR6C4	NA	
ENSG00000179615	OR2AP1	NA	
ENSG00000272937	OR6U2P	NA	
ENSG00000175398	OR10P1	NA	
ENSG00000258921	AC009779.5	NA	
ENSG00000272837	OR10AE3P	NA	
ENSG00000258907	AC009779.4	NA	
ENSG00000270458	AC009779.6	NA	
ENSG00000170439	METTL7B	NA	
ENSG00000135424	ITGA7	613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY;;MYOPATHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY
ENSG00000258311	AC009779.3	NA	
ENSG00000135441	BLOC1S1	NA	
ENSG00000135437	RDH5	136880	FUNDUS ALBIPUNCTATUS RETINITIS PUNCTATA ALBESCENS, INCLUDED
ENSG00000135404	CD63	NA	
ENSG00000258056	AC009779.2	NA	
ENSG00000258045	Metazoa_SRP	NA	
ENSG00000257384	AC009779.1	NA	
ENSG00000135414	GDF11	NA	
ENSG00000205323	SARNP	NA	
ENSG00000257390	AC023055.1	NA	
ENSG00000257509	AC073487.1	NA	
ENSG00000123353	ORMDL2	NA	
ENSG00000135392	DNAJC14	NA	
ENSG00000182796	TMEM198B	NA	
ENSG00000123342	MMP19	611543	CAVITARY OPTIC DISC ANOMALIES; CODA
ENSG00000257966	OLA1P3	NA	
ENSG00000257569	GSTP1P1	NA	
ENSG00000170473	PYM1	NA	
ENSG00000065357	DGKA	NA	
ENSG00000273973	AC025162.2	NA	
ENSG00000185664	PMEL	NA	
ENSG00000123374	CDK2	NA	
ENSG00000258554	AC025162.1	NA	
ENSG00000111540	RAB5B	NA	
ENSG00000237493	AC034102.1	NA	
ENSG00000139531	SUOX	272300	SULFITE OXIDASE DEFICIENCY, ISOLATED; ISOD;;SULFOCYSTEINURIA
ENSG00000123411	IKZF4	NA	
ENSG00000273890	AC034102.8	NA	
ENSG00000257449	AC034102.3	NA	
ENSG00000197728	RPS26	613309	DIAMOND-BLACKFAN ANEMIA 10; DBA10
ENSG00000065361	ERBB3	133180	ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK;;DI GUGLIELMO DISEASE, FAMILIAL;;LEUKEMIA, ACUTE MYELOGENOUS, M6
ENSG00000065361	ERBB3	607598	LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2;;MULTIPLE CONTRACTURE SYNDROME, ISRAELI BEDOUIN TYPE A
ENSG00000257411	AC034102.2	NA	
ENSG00000170515	PA2G4	NA	
ENSG00000257553	AC034102.4	NA	
ENSG00000229117	RPL41	NA	
ENSG00000139641	ESYT1	NA	
ENSG00000135482	ZC3H10	NA	
ENSG00000258345	AC034102.7	NA	
ENSG00000258317	AC034102.6	NA	
ENSG00000257809	AC034102.5	NA	
ENSG00000196465	MYL6B	NA	
ENSG00000092841	MYL6	NA	
ENSG00000139613	SMARCC2	618362	COFFIN-SIRIS SYNDROME 8; CSS8
ENSG00000258199	AC073896.4	NA	
ENSG00000181852	RNF41	NA	
ENSG00000139579	NABP2	NA	
ENSG00000139540	SLC39A5	615946	MYOPIA 24, AUTOSOMAL DOMINANT; MYP24
ENSG00000139645	ANKRD52	NA	
ENSG00000135469	COQ10A	NA	
ENSG00000258260	AC073896.5	NA	
ENSG00000062485	CS	NA	
ENSG00000144785	AC073896.1	NA	
ENSG00000257303	AC073896.2	NA	
ENSG00000257740	AC073896.3	NA	
ENSG00000257727	CNPY2	NA	
ENSG00000135473	PAN2	NA	
ENSG00000110944	IL23A	NA	
ENSG00000170581	STAT2	616636	IMMUNODEFICIENCY 44; IMD44
ENSG00000252206	RNU7-40P	NA	
ENSG00000175336	APOF	NA	
ENSG00000274823	APONP	NA	
ENSG00000259099	AC025574.1	NA	
ENSG00000276272	AC024884.2	NA	
ENSG00000274569	AC024884.1	NA	
ENSG00000111602	TIMELESS	NA	
ENSG00000135517	MIP	615274	CATARACT 15, MULTIPLE TYPES; CTRCT15
ENSG00000285528	AC097104.1	NA	
ENSG00000176422	SPRYD4	NA	
ENSG00000135423	GLS2	NA	
ENSG00000257576	HSPD1P4	NA	
ENSG00000076067	RBMS2	NA	
ENSG00000201579	RNU6-343P	NA	
ENSG00000076108	BAZ2A	NA	
ENSG00000110955	ATP5F1B	NA	
ENSG00000207031	SNORD59A	NA	
ENSG00000110958	PTGES3	NA	
ENSG00000241217	RN7SL809P	NA	
ENSG00000196531	NACA	NA	
ENSG00000285625	AC117378.1	NA	
ENSG00000198056	PRIM1	NA	
ENSG00000025423	HSD17B6	NA	
ENSG00000258679	AC121758.2	NA	
ENSG00000273536	AC121758.4	NA	
ENSG00000258816	AC121758.3	NA	
ENSG00000212383	AC121758.1	NA	
ENSG00000170426	SDR9C7	617574	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13
ENSG00000278400	AC026120.2	NA	
ENSG00000139547	RDH16	NA	
ENSG00000278399	AC026120.1	NA	
ENSG00000287715	AC026120.3	NA	
ENSG00000166856	GPR182	NA	
ENSG00000166860	ZBTB39	NA	
ENSG00000166863	TAC3	614839	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10
ENSG00000166866	MYO1A	NA	
ENSG00000166881	NEMP1	NA	
ENSG00000166886	NAB2	NA	
ENSG00000166888	STAT6	NA	
ENSG00000123384	LRP1	604093	KERATOSIS PILARIS ATROPHICANS; KPA
ENSG00000259125	LRP1-AS	NA	
ENSG00000221365	MIR1228	NA	
ENSG00000182379	NXPH4	NA	
ENSG00000276727	AC137834.2	NA	
ENSG00000182199	SHMT2	NA	
ENSG00000185633	NDUFA4L2	NA	
ENSG00000185482	STAC3	255995	MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB;;NATIVE AMERICAN MYOPATHY; NAM;;MYOPATHY, CONGENITAL, WITH MYOPATHIC FACIES, SCOLIOSIS, AND MALIGNANT HYPERTHERMIA
ENSG00000258830	AC137834.1	NA	
ENSG00000179912	R3HDM2	NA	
ENSG00000201198	RNU6-879P	NA	
ENSG00000258001	AC126614.1	NA	
ENSG00000175189	INHBC	NA	
ENSG00000139269	INHBE	NA	
ENSG00000287200	AC022506.2	NA	
ENSG00000111087	GLI1	174400	POLYDACTYLY, PREAXIAL I; PPD1;;POLYDACTYLY, PREAXIAL;;THUMB POLYDACTYLY THENAR HYPOPLASIA, INCLUDED;;FROMONT ANOMALY, INCLUDED
ENSG00000111087	GLI1	618123	POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8
ENSG00000123329	ARHGAP9	NA	
ENSG00000166986	MARS1	615486	INTERSTITIAL LUNG AND LIVER DISEASE; ILLD;;PULMONARY ALVEOLAR PROTEINOSIS, REUNION ISLAND;;INFANTILE LIVER FAILURE SYNDROME 2, FORMERLY; ILFS2, FORMERLY
ENSG00000166986	MARS1	616280	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2U;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2U
ENSG00000284152	MIR6758	NA	
ENSG00000175197	DDIT3	NA	
ENSG00000285133	AC022506.1	NA	
ENSG00000208028	MIR616	NA	
ENSG00000166987	MBD6	NA	
ENSG00000175203	DCTN2	NA	
ENSG00000155980	KIF5A	604187	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY
ENSG00000155980	KIF5A	617235	MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY
ENSG00000155980	KIF5A	617921	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25; ALS25
ENSG00000166908	PIP4K2C	NA	
ENSG00000178498	DTX3	NA	
ENSG00000240771	ARHGEF25	NA	
ENSG00000224713	AC025165.1	NA	
ENSG00000287908	AC025165.6	NA	
ENSG00000135502	SLC26A10	NA	
ENSG00000135454	B4GALNT1	609195	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26
ENSG00000242990	RPL13AP23	NA	
ENSG00000135506	OS9	NA	
ENSG00000257342	AC025165.2	NA	
ENSG00000135439	AGAP2	NA	
ENSG00000255737	AGAP2-AS1	NA	
ENSG00000135452	TSPAN31	NA	
ENSG00000135446	CDK4	609048	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3
ENSG00000283621	MIR6759	NA	
ENSG00000139266	MARCHF9	NA	
ENSG00000111012	CYP27B1	264700	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A;;VITAMIN D-DEPENDENT RICKETS, TYPE 1A;;1@-ALPHA, 25-HYDROXYVITAMIN D3 DEFICIENCY, SELECTIVE;;25-@HYDROXYCHOLECALCIFEROL-1-HYDROXYLASE DEFICIENCY;;1-@ALPHA-HYDROXYLASE DEFICIENCY;;VITAMIN D D /.../NCY, TYPE 1; VDD1;;PSEUDOVITAMIN D-DEFICIENCY RICKETS, TYPE IA; PDDR1A;;PDDR IA
ENSG00000037897	METTL1	NA	
ENSG00000123427	EEF1AKMT3	NA	
ENSG00000257921	AC025165.3	NA	
ENSG00000123297	TSFM	610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3;;ENCEPHALOMYOPATHY, RESPIRATORY FAILURE, AND LACTIC ACIDOSIS;;CONCENTRIC CARDIOMYOPATHY, HYPOTONIA, AND LACTIC ACIDOSIS
ENSG00000135407	AVIL	618594	NEPHROTIC SYNDROME, TYPE 21; NPHS21
ENSG00000270039	AC025165.5	NA	
ENSG00000206749	RNU6-1083P	NA	
ENSG00000269903	AC025165.4	NA	
ENSG00000175215	CTDSP2	NA	
ENSG00000207789	MIR26A2	NA	
ENSG00000257953	AC083805.2	NA	
ENSG00000245651	AC083805.1	NA	
ENSG00000273805	AC083805.3	NA	
ENSG00000166896	ATP23	NA	
ENSG00000257698	GIHCG	NA	
ENSG00000257159	AC084033.1	NA	
ENSG00000222210	RN7SKP65	NA	
ENSG00000257668	AC084033.2	NA	
ENSG00000257541	LINC02403	NA	
ENSG00000279134	AC090643.1	NA	
ENSG00000279411	AC090643.2	NA	
ENSG00000241423	RPL21P103	NA	
ENSG00000258133	AC025578.1	NA	
ENSG00000258231	AC020637.1	NA	
ENSG00000257259	LINC02388	NA	
ENSG00000139263	LRIG3	NA	
ENSG00000257443	AC068305.2	NA	
ENSG00000244390	RPS6P22	NA	
ENSG00000257288	AC068305.1	NA	
ENSG00000286351	AC046129.1	NA	
ENSG00000286279	AC108721.2	NA	
ENSG00000258214	AC108721.1	NA	
ENSG00000212599	RNU6-279P	NA	
ENSG00000251931	RNU6-871P	NA	
ENSG00000257230	LINC02448	NA	
ENSG00000202471	RNU4-20P	NA	
ENSG00000118596	SLC16A7	NA	
ENSG00000257146	AC079905.2	NA	
ENSG00000237176	AC079905.1	NA	
ENSG00000257294	AC080011.1	NA	
ENSG00000287014	AC087883.2	NA	
ENSG00000258184	AC087883.1	NA	
ENSG00000252607	Y_RNA	NA	
ENSG00000251822	AC090022.1	NA	
ENSG00000257865	AC090022.2	NA	
ENSG00000257308	AC090017.1	NA	
ENSG00000258336	DUX4L52	NA	
ENSG00000286402	AC090629.1	NA	
ENSG00000198673	TAFA2	NA	
ENSG00000242922	RPL21P104	NA	
ENSG00000257528	KRT8P19	NA	
ENSG00000213363	RPS3P6	NA	
ENSG00000257880	AC078789.1	NA	
ENSG00000258316	KLF17P1	NA	
ENSG00000135655	USP15	NA	
ENSG00000284360	MIR6125	NA	
ENSG00000200814	RNU6-595P	NA	
ENSG00000275881	Metazoa_SRP	NA	
ENSG00000061987	MON2	NA	
ENSG00000257568	AC079035.1	NA	
ENSG00000202034	RNU6-399P	NA	
ENSG00000221949	LINC01465	NA	
ENSG00000257354	AC048341.1	NA	
ENSG00000199179	MIRLET7I	NA	
ENSG00000275180	AC048341.2	NA	
ENSG00000111110	PPM1H	NA	
ENSG00000241941	RPL32P26	NA	
ENSG00000213352	GAPDHP44	NA	
ENSG00000200296	RNU1-83P	NA	
ENSG00000252660	Y_RNA	NA	
ENSG00000139239	RPL14P1	NA	
ENSG00000257779	AC078814.2	NA	
ENSG00000250517	LDHAL6CP	NA	
ENSG00000257235	AC078814.1	NA	
ENSG00000257664	RSL24D1P5	NA	
ENSG00000166148	AVPR1A	NA	
ENSG00000279444	AC135584.1	NA	
ENSG00000257332	HNRNPA1P69	NA	
ENSG00000258117	AC026116.1	NA	
ENSG00000177990	DPY19L2	613958	SPERMATOGENIC FAILURE 9; SPGF9;;GLOBOZOOSPERMIA, COMPLETE;;GLOBOZOOSPERMIA, TOTAL
ENSG00000249753	AC084357.2	NA	
ENSG00000257005	AC027667.1	NA	
ENSG00000255583	AC084357.3	NA	
ENSG00000240027	AC084357.1	NA	
ENSG00000118600	RXYLT1	615041	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, TMEM5-RELATED
ENSG00000255850	RXYLT1-AS1	NA	
ENSG00000255642	PABPC1P4	NA	
ENSG00000196935	SRGAP1	188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2
ENSG00000242087	RPL36AP41	NA	
ENSG00000256571	AC079866.2	NA	
ENSG00000256399	AC079866.1	NA	
ENSG00000255780	AC020611.1	NA	
ENSG00000255886	AC020611.2	NA	
ENSG00000287618	AC025576.3	NA	
ENSG00000255817	AC025576.2	NA	
ENSG00000255629	AC025576.1	NA	
ENSG00000174206	C12orf66	NA	
ENSG00000212298	RNU6-1009P	NA	
ENSG00000243024	AC012158.1	NA	
ENSG00000251788	RNU5A-7P	NA	
ENSG00000185306	C12orf56	NA	
ENSG00000256192	AC012158.2	NA	
ENSG00000256293	AC135279.3	NA	
ENSG00000238440	AC135279.1	NA	
ENSG00000184575	XPOT	NA	
ENSG00000255566	AC135279.2	NA	
ENSG00000277895	AC135279.4	NA	
ENSG00000183735	TBK1	616439	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4
ENSG00000183735	TBK1	617900	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8;;HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 6
ENSG00000153179	RASSF3	NA	
ENSG00000256199	AC078962.2	NA	
ENSG00000223294	SNORD83	NA	
ENSG00000256670	AC078962.4	NA	
ENSG00000266016	MIR548Z	NA	
ENSG00000207546	MIR548C	NA	
ENSG00000225195	AC078962.1	NA	
ENSG00000256314	AC078962.3	NA	
ENSG00000280320	AC025262.2	NA	
ENSG00000280181	AC025262.1	NA	
ENSG00000135677	GNS	252940	MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY
ENSG00000111490	TBC1D30	NA	
ENSG00000288591	AC078815.1	NA	
ENSG00000286682	AC025262.3	NA	
ENSG00000243020	RPL7P39	NA	
ENSG00000255693	LINC02389	NA	
ENSG00000248995	LINC02231	NA	
ENSG00000221564	RNU6ATAC42P	NA	
ENSG00000198671	AC135895.1	NA	
ENSG00000156076	WIF1	NA	
ENSG00000207099	RNU6-166P	NA	
ENSG00000255700	APOOP3	NA	
ENSG00000174106	LEMD3	166700	BUSCHKE-OLLENDORFF SYNDROME; BOS;;DERMATOOSTEOPOIKILOSIS;;DERMATOFIBROSIS, DISSEMINATED, WITH OSTEOPOIKILOSIS;;DERMATOFIBROSIS LENTICULARIS DISSEMINATA WITH OSTEOPOIKILOSIS;;OSTEOPATHIA CONDENSANS DISSEMINATA  OSTEOPOIKILOSIS, ISOLATED, INCLUDED;;DE /.../IBROSIS LENTICULARIS DISSEMINATA, ISOLATED, INCLUDED;;OSTEOPOIKILOSIS WITH MELORHEOSTOSIS, INCLUDED
ENSG00000276853	AC026124.2	NA	
ENSG00000174099	MSRB3	613718	DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74
ENSG00000250280	AC026124.1	NA	
ENSG00000215208	KRT18P60	NA	
ENSG00000250748	AC025419.1	NA	
ENSG00000255866	AC090023.1	NA	
ENSG00000256268	LINC02454	NA	
ENSG00000256915	AC090023.2	NA	
ENSG00000213344	PCNPP3	NA	
ENSG00000241749	RPSAP52	NA	
ENSG00000149948	HMGA2	150699	LEIOMYOMA, UTERINE; UL
ENSG00000277945	AC107308.1	NA	
ENSG00000197301	HMGA2-AS1	NA	
ENSG00000256083	AC090673.1	NA	
ENSG00000276878	MIR6074	NA	
ENSG00000256259	LINC02425	NA	
ENSG00000213343	RPL21P18	NA	
ENSG00000251857	RNA5SP362	NA	
ENSG00000139233	LLPH	NA	
ENSG00000228144	AC078927.1	NA	
ENSG00000239335	LLPH-DT	NA	
ENSG00000155957	TMBIM4	NA	
ENSG00000090376	IRAK3	611064	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5;;ASRT5
ENSG00000225422	RBMS1P1	NA	
ENSG00000284011	MIR6502	NA	
ENSG00000256072	AC078889.1	NA	
ENSG00000256777	PDCL3P7	NA	
ENSG00000222744	RN7SKP166	NA	
ENSG00000127311	HELB	NA	
ENSG00000155974	GRIP1	617667	FRASER SYNDROME 3; FRASRS3
ENSG00000256285	OSBPL9P5	NA	
ENSG00000256420	OSBPL9P4	NA	
ENSG00000257083	AC073530.1	NA	
ENSG00000279310	AC073530.2	NA	
ENSG00000255976	RAB11AP2	NA	
ENSG00000237766	GGTA2P	NA	
ENSG00000111530	CAND1	NA	
ENSG00000286563	AC078983.1	NA	
ENSG00000256037	MRPL40P1	NA	
ENSG00000256355	NTAN1P3	NA	
ENSG00000256172	LINC02420	NA	
ENSG00000203585	LINC02408	NA	
ENSG00000256077	LINC02442	NA	
ENSG00000127334	DYRK2	NA	
ENSG00000235872	AC078777.1	NA	
ENSG00000255970	LINC02421	NA	
ENSG00000279505	AC022513.1	NA	
ENSG00000255772	LINC01479	NA	
ENSG00000256835	AC005294.1	NA	
ENSG00000255733	IFNG-AS1	NA	
ENSG00000244432	RPL39P28	NA	
ENSG00000236946	HNRNPA1P70	NA	
ENSG00000256708	AC007458.1	NA	
ENSG00000111537	IFNG	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000111537	IFNG	609135	APLASTIC ANEMIA APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000111537	IFNG	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000111537	IFNG	609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO;;HCV, SUSCEPTIBILITY TO HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED;;HCV, RESISTANCE TO, INCLUDED;;HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF, INCLUDED
ENSG00000111537	IFNG	613254	TUBEROUS SCLEROSIS 2; TSC2 TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF, INCLUDED
ENSG00000111536	IL26	NA	
ENSG00000127318	IL22	NA	
ENSG00000111554	MDM1	NA	
ENSG00000251301	LINC02384	NA	
ENSG00000256273	AC022511.1	NA	
ENSG00000273824	AC008033.3	NA	
ENSG00000256075	AC008033.1	NA	
ENSG00000256917	AC008033.2	NA	
ENSG00000240087	RPSAP12	NA	
ENSG00000274459	Metazoa_SRP	NA	
ENSG00000127314	RAP1B	NA	
ENSG00000234040	RPL10P12	NA	
ENSG00000206650	SNORA70G	NA	
ENSG00000234925	ATP5PDP4	NA	
ENSG00000247363	AC090061.1	NA	
ENSG00000241825	RPL7P42	NA	
ENSG00000111581	NUP107	616730	NEPHROTIC SYNDROME, TYPE 11; NPHS11
ENSG00000111581	NUP107	618078	OVARIAN DYSGENESIS 6; ODG6
ENSG00000111581	NUP107	618348	GALLOWAY-MOWAT SYNDROME 7; GAMOS7
ENSG00000233560	KRT8P39	NA	
ENSG00000175782	SLC35E3	NA	
ENSG00000256678	AC025423.3	NA	
ENSG00000135679	MDM2	614401	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS
ENSG00000135679	MDM2	618681	LESSEL-KUBISCH SYNDROME; LSKB
ENSG00000256325	AC025423.1	NA	
ENSG00000257181	AC025423.4	NA	
ENSG00000256664	AC025423.2	NA	
ENSG00000135678	CPM	NA	
ENSG00000252770	RNU7-4P	NA	
ENSG00000257289	AC025423.5	NA	
ENSG00000257336	PRELID2P1	NA	
ENSG00000258140	AC127894.1	NA	
ENSG00000111605	CPSF6	NA	
ENSG00000283476	MIR1279	NA	
ENSG00000257818	C1GALT1P1	NA	
ENSG00000274979	AC020656.2	NA	
ENSG00000090382	LYZ	105200	AMYLOIDOSIS, FAMILIAL VISCERAL;;AMYLOIDOSIS VIII;;OSTERTAG TYPE AMYLOIDOSIS;;GERMAN TYPE AMYLOIDOSIS;;AMYLOIDOSIS, FAMILIAL RENAL;;AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC
ENSG00000257764	AC020656.1	NA	
ENSG00000127337	YEATS4	NA	
ENSG00000266185	RN7SL804P	NA	
ENSG00000241765	RPS26P45	NA	
ENSG00000257507	LINC02373	NA	
ENSG00000166225	FRS2	NA	
ENSG00000264405	MIR3913-1	NA	
ENSG00000283677	MIR3913-2	NA	
ENSG00000166226	CCT2	NA	
ENSG00000198812	LRRC10	NA	
ENSG00000127325	BEST3	NA	
ENSG00000279551	AC025263.3	NA	
ENSG00000247131	AC025263.1	NA	
ENSG00000127328	RAB3IP	NA	
ENSG00000258052	AC025263.2	NA	
ENSG00000166268	MYRFL	NA	
ENSG00000257815	PRANCR	NA	
ENSG00000257241	AC078922.1	NA	
ENSG00000257139	LINC02821	NA	
ENSG00000287132	AC092881.2	NA	
ENSG00000111596	CNOT2	618608	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES; IDNADFS CHROMOSOME 12q15 DELETION SYNDROME, INCLUDED
ENSG00000279530	AC092881.1	NA	
ENSG00000135643	KCNMB4	NA	
ENSG00000222405	RNU4-65P	NA	
ENSG00000258168	AC025569.1	NA	
ENSG00000127329	PTPRB	NA	
ENSG00000277247	AC083809.1	NA	
ENSG00000153233	PTPRR	NA	
ENSG00000257302	FAHD2P1	NA	
ENSG00000207387	Y_RNA	NA	
ENSG00000257265	AC123905.1	NA	
ENSG00000257454	AC025575.1	NA	
ENSG00000258053	AC025575.2	NA	
ENSG00000127324	TSPAN8	NA	
ENSG00000139292	LGR5	NA	
ENSG00000277223	AC090116.1	NA	
ENSG00000288530	AC078860.3	NA	
ENSG00000257761	AC078860.2	NA	
ENSG00000133858	ZFC3H1	NA	
ENSG00000212461	AC078860.1	NA	
ENSG00000173451	THAP2	NA	
ENSG00000258064	AC073612.1	NA	
ENSG00000139291	TMEM19	NA	
ENSG00000257515	AC011601.1	NA	
ENSG00000080371	RAB21	NA	
ENSG00000257410	AC089984.1	NA	
ENSG00000257991	AC089984.3	NA	
ENSG00000121749	TBC1D15	NA	
ENSG00000257802	AC089984.2	NA	
ENSG00000139287	TPH2	608516	MAJOR DEPRESSIVE DISORDER; MDD;;UNIPOLAR DEPRESSION SEASONAL AFFECTIVE DISORDER, INCLUDED; SAD, INCLUDED
ENSG00000139287	TPH2	613003	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7;;ADHD7
ENSG00000258115	AC090109.1	NA	
ENSG00000072657	TRHDE	NA	
ENSG00000236333	TRHDE-AS1	NA	
ENSG00000257287	H3P35	NA	
ENSG00000257723	CHCHD3P2	NA	
ENSG00000258235	AC133480.1	NA	
ENSG00000258294	AC090503.2	NA	
ENSG00000258123	LINC02444	NA	
ENSG00000257682	AC090503.1	NA	
ENSG00000243164	AC087879.1	NA	
ENSG00000252415	RNU6-1012P	NA	
ENSG00000257750	LINC02445	NA	
ENSG00000201809	U8	NA	
ENSG00000251138	LINC02882	NA	
ENSG00000257587	AC136188.1	NA	
ENSG00000258332	LINC02394	NA	
ENSG00000258320	AC090502.3	NA	
ENSG00000257183	AC090502.2	NA	
ENSG00000257113	AC090502.1	NA	
ENSG00000257364	VENTXP3	NA	
ENSG00000253719	ATXN7L3B	NA	
ENSG00000257386	AC025257.1	NA	
ENSG00000257323	AC123904.2	NA	
ENSG00000188646	AC123904.1	NA	
ENSG00000257998	AC123904.3	NA	
ENSG00000257434	AC073525.1	NA	
ENSG00000166006	KCNC2	NA	
ENSG00000254451	CAPS2-AS1	NA	
ENSG00000258112	CCNG2P1	NA	
ENSG00000180881	CAPS2	NA	
ENSG00000257823	AC092552.1	NA	
ENSG00000273987	AC121761.2	NA	
ENSG00000173401	GLIPR1L1	NA	
ENSG00000180481	GLIPR1L2	NA	
ENSG00000139278	GLIPR1	NA	
ENSG00000257497	AC121761.1	NA	
ENSG00000111615	KRR1	NA	
ENSG00000258077	AC078923.1	NA	
ENSG00000257777	AC022507.1	NA	
ENSG00000286259	AC078820.2	NA	
ENSG00000258245	RPL10P13	NA	
ENSG00000251893	SNORA70	NA	
ENSG00000258088	AC078820.1	NA	
ENSG00000258091	AC011611.6	NA	
ENSG00000243420	RN7SL734P	NA	
ENSG00000257329	AC011611.2	NA	
ENSG00000198923	AC011611.1	NA	
ENSG00000139289	PHLDA1	NA	
ENSG00000257453	AC011611.3	NA	
ENSG00000257839	AC011611.4	NA	
ENSG00000187109	NAP1L1	NA	
ENSG00000257941	AC011611.5	NA	
ENSG00000258304	AC233290.2	NA	
ENSG00000257872	AC233290.1	NA	
ENSG00000252858	RNU6-1271P	NA	
ENSG00000257219	LNCOG	NA	
ENSG00000223273	RN7SKP172	NA	
ENSG00000179941	BBS10	615987	BARDET-BIEDL SYNDROME 10; BBS10
ENSG00000091039	OSBPL8	NA	
ENSG00000257526	AC107032.2	NA	
ENSG00000287030	AC107032.3	NA	
ENSG00000213272	RPL7AP9	NA	
ENSG00000271142	YWHAQP7	NA	
ENSG00000243071	AC107032.1	NA	
ENSG00000241045	RPL7P43	NA	
ENSG00000258090	AC093014.1	NA	
ENSG00000186908	ZDHHC17	NA	
ENSG00000175183	CSRP2	NA	
ENSG00000257910	AC124784.1	NA	
ENSG00000257199	AC025161.1	NA	
ENSG00000165891	E2F7	NA	
ENSG00000286476	AC079030.1	NA	
ENSG00000257677	LINC02464	NA	
ENSG00000067798	NAV3	NA	
ENSG00000257835	AC073591.1	NA	
ENSG00000258066	AC138331.1	NA	
ENSG00000258225	AC073571.1	NA	
ENSG00000257220	PRXL2AP1	NA	
ENSG00000258220	LINC02424	NA	
ENSG00000258084	AC128707.1	NA	
ENSG00000257879	AC130415.1	NA	
ENSG00000257165	AC079362.1	NA	
ENSG00000257564	AC068993.1	NA	
ENSG00000257948	AC068993.2	NA	
ENSG00000067715	SYT1	618218	BAKER-GORDON SYNDROME; BAGOS;;NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENT AND ABNORMAL ELECTROENCEPHALOGRAM; NEDIMAE
ENSG00000257191	AC090709.1	NA	
ENSG00000257894	AC027288.3	NA	
ENSG00000221788	MIR1252	NA	
ENSG00000257604	AC027288.2	NA	
ENSG00000257474	AC027288.1	NA	
ENSG00000257956	NOP56P3	NA	
ENSG00000177425	PAWR	NA	
ENSG00000258048	AC073569.2	NA	
ENSG00000058272	PPP1R12A	618820	GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME; GUBS
ENSG00000277130	AC073569.3	NA	
ENSG00000258044	AC073569.1	NA	
ENSG00000201942	RNA5SP363	NA	
ENSG00000257557	PPP1R12A-AS1	NA	
ENSG00000271496	SNRPGP20	NA	
ENSG00000239473	RPL7P38	NA	
ENSG00000238842	RNU7-106P	NA	
ENSG00000165899	OTOGL	614944	DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B
ENSG00000230291	AC078817.1	NA	
ENSG00000222880	RN7SKP261	NA	
ENSG00000139304	PTPRQ	613391	DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A;;DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84;;DEAFNESS, AUTOSOMAL RECESSIVE 84A, WITH VESTIBULAR DYSFUNCTION
ENSG00000139304	PTPRQ	617663	DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73
ENSG00000257786	AKIRIN1P1	NA	
ENSG00000257429	AC074031.1	NA	
ENSG00000111046	MYF6	NA	
ENSG00000111049	MYF5	618155	OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA
ENSG00000257741	LINC01490	NA	
ENSG00000111052	LIN7A	NA	
ENSG00000207763	MIR617	NA	
ENSG00000258215	AC078886.1	NA	
ENSG00000208022	MIR618	NA	
ENSG00000111058	ACSS3	NA	
ENSG00000258026	AC078955.1	NA	
ENSG00000265227	MIR4699	NA	
ENSG00000139220	PPFIA2	NA	
ENSG00000257467	PPFIA2-AS1	NA	
ENSG00000258162	AC069228.1	NA	
ENSG00000258375	AC079363.1	NA	
ENSG00000257609	AC091515.1	NA	
ENSG00000257747	LINC02426	NA	
ENSG00000258193	AC011602.1	NA	
ENSG00000133773	CCDC59	NA	
ENSG00000127720	METTL25	NA	
ENSG00000257875	AC089998.3	NA	
ENSG00000258170	AC089998.4	NA	
ENSG00000257837	AC089998.2	NA	
ENSG00000257431	AC089998.1	NA	
ENSG00000286043	AC091214.1	NA	
ENSG00000179104	TMTC2	NA	
ENSG00000252220	RNU6-977P	NA	
ENSG00000213270	RPL6P25	NA	
ENSG00000258338	AC090680.1	NA	
ENSG00000257124	AC093025.1	NA	
ENSG00000285191	AC090679.3	NA	
ENSG00000257729	AC090679.2	NA	
ENSG00000221148	AC090679.1	NA	
ENSG00000258358	AC087888.1	NA	
ENSG00000257296	AC093027.1	NA	
ENSG00000072041	SLC6A15	NA	
ENSG00000258073	AC128657.1	NA	
ENSG00000231738	TSPAN19	NA	
ENSG00000133640	LRRIQ1	NA	
ENSG00000180318	ALX1	613456	FRONTONASAL DYSPLASIA 3; FND3
ENSG00000258815	LINC02820	NA	
ENSG00000257855	AC126471.1	NA	
ENSG00000258206	AC137768.1	NA	
ENSG00000198774	RASSF9	NA	
ENSG00000133636	NTS	NA	
ENSG00000182050	MGAT4C	NA	
ENSG00000258178	AC016993.1	NA	
ENSG00000257897	AC139697.1	NA	
ENSG00000258185	AC010196.1	NA	
ENSG00000280049	AC079597.1	NA	
ENSG00000242850	RPL23AP68	NA	
ENSG00000258205	AC079598.4	NA	
ENSG00000257648	CYCSP30	NA	
ENSG00000258173	AC079598.2	NA	
ENSG00000258128	MKRN9P	NA	
ENSG00000257912	LINC02258	NA	
ENSG00000257940	AC079598.1	NA	
ENSG00000258179	AC079598.3	NA	
ENSG00000240721	RPS4XP15	NA	
ENSG00000165805	C12orf50	NA	
ENSG00000133641	C12orf29	NA	
ENSG00000198707	CEP290	610188	JOUBERT SYNDROME 5; JBTS5
ENSG00000198707	CEP290	610189	SENIOR-LOKEN SYNDROME 6; SLSN6
ENSG00000198707	CEP290	611134	MECKEL SYNDROME, TYPE 4; MKS4;;MECKEL-GRUBER SYNDROME, TYPE 4  MECKEL-LIKE CEREBRORENODIGITAL SYNDROME, INCLUDED
ENSG00000198707	CEP290	611755	LEBER CONGENITAL AMAUROSIS 10; LCA10
ENSG00000198707	CEP290	615991	BARDET-BIEDL SYNDROME 14; BBS14
ENSG00000252747	RNA5SP364	NA	
ENSG00000257752	AC091516.1	NA	
ENSG00000139324	TMTC3	617255	LISSENCEPHALY 8; LIS8
ENSG00000199245	Y_RNA	NA	
ENSG00000049130	KITLG	145250	HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH;;MELANOSIS UNIVERSALIS HEREDITARIA; MUH;;HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2, FORMERLY; FPH2, FORMERLY
ENSG00000049130	KITLG	611664	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7;;SKIN/HAIR/EYE PIGMENTATION 7, BLOND/BROWN HAIR;;SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN
ENSG00000049130	KITLG	616697	DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69;;DEAFNESS, CONGENITAL, UNILATERAL OR ASYMMETRIC; DCUA
ENSG00000281333	AC024941.2	NA	
ENSG00000252850	RNU1-117P	NA	
ENSG00000278011	AC024941.1	NA	
ENSG00000246363	LINC02458	NA	
ENSG00000257629	AC006199.1	NA	
ENSG00000238302	RNU7-120P	NA	
ENSG00000257820	MRPS6P4	NA	
ENSG00000139318	DUSP6	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000139318	DUSP6	615269	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19
ENSG00000274021	AC024909.1	NA	
ENSG00000286608	AC010201.3	NA	
ENSG00000271327	AC010201.2	NA	
ENSG00000271259	AC010201.1	NA	
ENSG00000139323	POC1B	615973	CONE-ROD DYSTROPHY 20; CORD20
ENSG00000226982	CENPCP1	NA	
ENSG00000259075	POC1B-GALNT4	NA	
ENSG00000257594	GALNT4	NA	
ENSG00000270344	POC1B-AS1	NA	
ENSG00000279939	AC025034.2	NA	
ENSG00000258302	AC025034.1	NA	
ENSG00000070961	ATP2B1	NA	
ENSG00000271614	ATP2B1-AS1	NA	
ENSG00000258216	AC009522.1	NA	
ENSG00000252207	RNA5SP365	NA	
ENSG00000257480	MRPL2P1	NA	
ENSG00000252823	RNU6-148P	NA	
ENSG00000258290	BRWD1P2	NA	
ENSG00000257725	LINC02399	NA	
ENSG00000257194	AC126178.1	NA	
ENSG00000258183	LINC02392	NA	
ENSG00000286021	LINC02822	NA	
ENSG00000288102	AC112481.2	NA	
ENSG00000257995	AC084365.1	NA	
ENSG00000257787	AC112481.1	NA	
ENSG00000197651	CCER1	NA	
ENSG00000196243	LINC00615	NA	
ENSG00000083782	EPYC	NA	
ENSG00000139330	KERA	217300	CORNEA PLANA 2, AUTOSOMAL RECESSIVE; CNA2
ENSG00000139329	LUM	NA	
ENSG00000011465	DCN	610048	CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY
ENSG00000258148	AC007115.1	NA	
ENSG00000258100	LINC02823	NA	
ENSG00000286049	AC090016.1	NA	
ENSG00000274647	AC126175.1	NA	
ENSG00000277738	AC126175.2	NA	
ENSG00000258125	AC025254.1	NA	
ENSG00000258224	AC090049.2	NA	
ENSG00000257893	LINC02404	NA	
ENSG00000257863	AC090049.1	NA	
ENSG00000257242	LINC01619	NA	
ENSG00000286907	AC123512.1	NA	
ENSG00000287714	AC025164.2	NA	
ENSG00000133639	BTG1	NA	
ENSG00000245904	AC025164.1	NA	
ENSG00000239201	RPL21P106	NA	
ENSG00000199895	Y_RNA	NA	
ENSG00000277851	LINC02391	NA	
ENSG00000205057	CLLU1-AS1	NA	
ENSG00000257127	CLLU1	NA	
ENSG00000266923	AC063949.2	NA	
ENSG00000205056	LINC02397	NA	
ENSG00000258262	AC063949.1	NA	
ENSG00000187510	PLEKHG7	NA	
ENSG00000102189	EEA1	NA	
ENSG00000258012	AC026111.1	NA	
ENSG00000257195	HNRNPA1P50	NA	
ENSG00000202534	RNU6-1329P	NA	
ENSG00000257345	LINC02413	NA	
ENSG00000257322	AC138123.1	NA	
ENSG00000207365	Y_RNA	NA	
ENSG00000270506	AC021646.1	NA	
ENSG00000256393	RPL41P5	NA	
ENSG00000257746	AC138123.2	NA	
ENSG00000257210	NACAP8	NA	
ENSG00000258171	LINC02412	NA	
ENSG00000201502	AC126172.1	NA	
ENSG00000257512	AC124947.2	NA	
ENSG00000257252	AC124947.1	NA	
ENSG00000173598	NUDT4	NA	
ENSG00000177889	UBE2N	NA	
ENSG00000200011	Y_RNA	NA	
ENSG00000198015	MRPL42	NA	
ENSG00000243015	RN7SL737P	NA	
ENSG00000258271	AC025260.1	NA	
ENSG00000246985	SOCS2-AS1	NA	
ENSG00000120833	SOCS2	NA	
ENSG00000186076	AC012085.1	NA	
ENSG00000169372	CRADD	614499	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34
ENSG00000258274	AC012085.2	NA	
ENSG00000264978	RN7SL630P	NA	
ENSG00000258303	AC012464.2	NA	
ENSG00000257283	AC012464.1	NA	
ENSG00000271382	AC012464.3	NA	
ENSG00000223126	RN7SKP263	NA	
ENSG00000257360	AC123567.1	NA	
ENSG00000136040	PLXNC1	NA	
ENSG00000258035	AC123567.2	NA	
ENSG00000287237	AC073655.3	NA	
ENSG00000258172	AC073655.1	NA	
ENSG00000258365	AC073655.2	NA	
ENSG00000173588	CEP83	615862	NEPHRONOPHTHISIS 18; NPHP18
ENSG00000244391	RN7SL330P	NA	
ENSG00000213250	RBMS2P1	NA	
ENSG00000278916	CEP83-DT	NA	
ENSG00000257400	AC023161.1	NA	
ENSG00000244091	RN7SL483P	NA	
ENSG00000258357	NSA2P2	NA	
ENSG00000236349	SUCLG2P2	NA	
ENSG00000266099	MIR5700	NA	
ENSG00000057704	TMCC3	NA	
ENSG00000283818	MIR7844	NA	
ENSG00000257847	LSM3P2	NA	
ENSG00000216306	KRT19P2	NA	
ENSG00000283998	MIR492	NA	
ENSG00000184752	NDUFA12	618244	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23
ENSG00000120798	NR2C1	NA	
ENSG00000180263	FGD6	NA	
ENSG00000257121	AC126615.2	NA	
ENSG00000237774	AC126615.1	NA	
ENSG00000028203	VEZT	NA	
ENSG00000202470	Y_RNA	NA	
ENSG00000257666	CBX3P5	NA	
ENSG00000212535	RNU6-808P	NA	
ENSG00000199172	MIR331	NA	
ENSG00000265917	MIR3685	NA	
ENSG00000257943	AC084879.1	NA	
ENSG00000258313	AC084879.2	NA	
ENSG00000222544	RNU6-735P	NA	
ENSG00000241556	AC018475.1	NA	
ENSG00000111142	METAP2	NA	
ENSG00000136014	USP44	NA	
ENSG00000257150	PGAM1P5	NA	
ENSG00000212448	Y_RNA	NA	
ENSG00000074527	NTN4	NA	
ENSG00000258343	AC090001.1	NA	
ENSG00000199506	RNU6-247P	NA	
ENSG00000258292	LINC02410	NA	
ENSG00000139343	SNRPF	NA	
ENSG00000165972	CCDC38	NA	
ENSG00000285030	AC090001.2	NA	
ENSG00000139344	AMDHD1	NA	
ENSG00000084110	HAL	235800	HISTIDINEMIA;;HISTIDINE AMMONIA-LYASE DEFICIENCY;;HAL DEFICIENCY;;HISTIDASE DEFICIENCY;;HIS DEFICIENCY
ENSG00000257878	AC007298.2	NA	
ENSG00000111144	LTA4H	NA	
ENSG00000257715	AC007298.1	NA	
ENSG00000258251	YPEL5P3	NA	
ENSG00000277062	RN7SL88P	NA	
ENSG00000283422	LINC02452	NA	
ENSG00000111145	ELK3	NA	
ENSG00000258177	AC008149.1	NA	
ENSG00000287454	AC008149.2	NA	
ENSG00000059758	CDK17	NA	
ENSG00000201435	RNU4-24P	NA	
ENSG00000257169	AC125612.1	NA	
ENSG00000258272	AC007513.1	NA	
ENSG00000252827	RN7SKP11	NA	
ENSG00000188596	CFAP54	NA	
ENSG00000258846	EEF1A1P33	NA	
ENSG00000139350	NEDD1	NA	
ENSG00000202368	Y_RNA	NA	
ENSG00000258131	AC007656.2	NA	
ENSG00000257470	AC007656.1	NA	
ENSG00000279190	AC007656.3	NA	
ENSG00000286434	AC007656.4	NA	
ENSG00000257920	LINC02409	NA	
ENSG00000255794	RMST	NA	
ENSG00000221479	MIR1251	NA	
ENSG00000273942	AC007351.2	NA	
ENSG00000274230	AC007351.3	NA	
ENSG00000275231	AC007351.4	NA	
ENSG00000273570	AC007351.1	NA	
ENSG00000275971	AC018659.4	NA	
ENSG00000274819	AC018659.3	NA	
ENSG00000251844	AC018659.1	NA	
ENSG00000278802	AC018659.7	NA	
ENSG00000276398	AC018659.5	NA	
ENSG00000279798	AC018659.8	NA	
ENSG00000207586	MIR135A2	NA	
ENSG00000277081	AC018659.6	NA	
ENSG00000257157	AC018659.2	NA	
ENSG00000257501	AC007424.1	NA	
ENSG00000206899	RNU6-36P	NA	
ENSG00000265861	MIR4495	NA	
ENSG00000263890	MIR4303	NA	
ENSG00000258312	AC016152.1	NA	
ENSG00000257580	AC008055.1	NA	
ENSG00000201296	RNU4-41P	NA	
ENSG00000286056	AC008055.2	NA	
ENSG00000227825	SLC9A7P1	NA	
ENSG00000245017	LINC02453	NA	
ENSG00000257167	TMPO-AS1	NA	
ENSG00000120802	TMPO	NA	
ENSG00000225185	PPIAP8	NA	
ENSG00000075415	SLC25A3	610773	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY;;MPCD
ENSG00000212443	SNORA53	NA	
ENSG00000166130	IKBIP	NA	
ENSG00000120868	APAF1	NA	
ENSG00000185046	ANKS1B	NA	
ENSG00000258204	AC008126.1	NA	
ENSG00000257458	AC069437.1	NA	
ENSG00000202324	RNA5SP366	NA	
ENSG00000258039	AC117377.1	NA	
ENSG00000180219	FAM71C	NA	
ENSG00000287675	AC078916.1	NA	
ENSG00000214203	RPS4XP1	NA	
ENSG00000279148	AC126474.1	NA	
ENSG00000111647	UHRF1BP1L	NA	
ENSG00000280088	AC126474.2	NA	
ENSG00000257696	AC010203.2	NA	
ENSG00000238105	GOLGA2P5	NA	
ENSG00000266610	RN7SL176P	NA	
ENSG00000257489	AC010203.1	NA	
ENSG00000221476	MIR1827	NA	
ENSG00000075089	ACTR6	NA	
ENSG00000166153	DEPDC4	NA	
ENSG00000206790	Y_RNA	NA	
ENSG00000136021	SCYL2	618766	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM; AMCNACC;;ZAIN SYNDROME
ENSG00000179520	SLC17A8	605583	DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25
ENSG00000012504	NR1H4	617049	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5; PFIC5
ENSG00000271177	AC010200.2	NA	
ENSG00000139354	GAS2L3	NA	
ENSG00000257803	AC010200.1	NA	
ENSG00000151572	ANO4	NA	
ENSG00000257325	AC138360.1	NA	
ENSG00000258007	AC063947.1	NA	
ENSG00000258033	AC063947.2	NA	
ENSG00000256870	SLC5A8	NA	
ENSG00000207414	RNU6-768P	NA	
ENSG00000241744	AC079953.1	NA	
ENSG00000120800	UTP20	NA	
ENSG00000120805	ARL1	NA	
ENSG00000257543	AC063948.1	NA	
ENSG00000222890	RNU6-1068P	NA	
ENSG00000239413	RPS27P23	NA	
ENSG00000206929	Y_RNA	NA	
ENSG00000202249	RNU5E-5P	NA	
ENSG00000252366	RNA5SP367	NA	
ENSG00000166211	SPIC	NA	
ENSG00000196091	MYBPC1	614335	ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B
ENSG00000196091	MYBPC1	614915	LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4
ENSG00000196091	MYBPC1	618524	MYOPATHY, CONGENITAL, WITH TREMOR; MYOTREM;;MYOGENIC TREMOR
ENSG00000257514	AC117505.1	NA	
ENSG00000274560	AC010205.1	NA	
ENSG00000111666	CHPT1	NA	
ENSG00000199933	RNY1P16	NA	
ENSG00000139351	SYCP3	270960	SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARREST PREGNANCY LOSS, RECURRENT, 4, INCLUDED; RPRGL4, INCLUDED
ENSG00000111670	GNPTAB	252500	MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD
ENSG00000111670	GNPTAB	252600	MUCOLIPIDOSIS III ALPHA/BETA;;ML III ALPHA/BETA;;MUCOLIPIDOSIS IIIA; ML IIIA;;MUCOLIPIDOSIS III;;ML III;;PSEUDO-HURLER POLYDYSTROPHY MUCOLIPIDOSIS III ALPHA/BETA, ATYPICAL, INCLUDED
ENSG00000222255	RNU6-101P	NA	
ENSG00000258230	AC063950.1	NA	
ENSG00000201168	RNA5SP368	NA	
ENSG00000222932	RNU6-172P	NA	
ENSG00000223046	RNA5SP369	NA	
ENSG00000252863	RNU6-1183P	NA	
ENSG00000258153	HSPE1P4	NA	
ENSG00000136048	DRAM1	NA	
ENSG00000257202	AC084398.2	NA	
ENSG00000241917	AC084398.1	NA	
ENSG00000258308	AC079907.2	NA	
ENSG00000258288	NENFP2	NA	
ENSG00000120860	WASHC3	NA	
ENSG00000257222	AC079907.1	NA	
ENSG00000075188	NUP37	618179	MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24
ENSG00000185480	PARPBP	NA	
ENSG00000183395	PMCH	NA	
ENSG00000281344	HELLPAR	NA	
ENSG00000264554	RN7SL793P	NA	
ENSG00000258142	AC093023.1	NA	
ENSG00000283052	LINC02456	NA	
ENSG00000017427	IGF1	608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION
ENSG00000257254	AC010202.1	NA	
ENSG00000258169	LINC00485	NA	
ENSG00000171759	PAH	261600	PHENYLKETONURIA; PKU;;PHENYLALANINE HYDROXYLASE DEFICIENCY;;PAH DEFICIENCY;;OLIGOPHRENIA PHENYLPYRUVICA;;FOLLING DISEASE HYPERPHENYLALANINEMIA, NON-PKU MILD, INCLUDED;;HPA, NON-PKU MILD, INCLUDED;;PHENYLKETONURIA, MATERNAL, INCLUDED
ENSG00000282964	AC026108.1	NA	
ENSG00000139352	ASCL1	209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS;;AUTONOMIC CONTROL, CONGENITAL FAILURE OF;;ONDINE CURSE, CONGENITAL ONDINE-HIRSCHSPRUNG DISEASE, INCLUDED; OHD, INCLUDED;;CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;;HADDAD SYNDROME, INCLUDED
ENSG00000288092	AC026108.2	NA	
ENSG00000257703	AC068643.1	NA	
ENSG00000257860	AC068643.2	NA	
ENSG00000179088	C12orf42	NA	
ENSG00000257415	AC084364.1	NA	
ENSG00000257994	AC084364.2	NA	
ENSG00000286197	AC084364.3	NA	
ENSG00000257762	LINC02401	NA	
ENSG00000136011	STAB2	NA	
ENSG00000212594	U8	NA	
ENSG00000257737	AC025265.2	NA	
ENSG00000257766	AC025265.3	NA	
ENSG00000257681	AC025265.1	NA	
ENSG00000111696	NT5DC3	NA	
ENSG00000257754	AC012555.2	NA	
ENSG00000257327	AC012555.1	NA	
ENSG00000214198	TTC41P	NA	
ENSG00000166598	HSP90B1	NA	
ENSG00000284503	MIR3652	NA	
ENSG00000204954	C12orf73	NA	
ENSG00000139372	TDG	NA	
ENSG00000120820	GLT8D2	NA	
ENSG00000216285	AC078819.1	NA	
ENSG00000111727	HCFC2	NA	
ENSG00000120837	NFYB	NA	
ENSG00000199415	RNA5SP370	NA	
ENSG00000257193	LINC02385	NA	
ENSG00000286258	AC089983.2	NA	
ENSG00000198431	TXNRD1	NA	
ENSG00000257732	AC089983.1	NA	
ENSG00000213442	RPL18AP3	NA	
ENSG00000255150	EID3	NA	
ENSG00000171310	CHST11	618167	OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD
ENSG00000258111	AC079316.1	NA	
ENSG00000279176	AC079316.2	NA	
ENSG00000264295	MIR3922	NA	
ENSG00000136052	SLC41A2	NA	
ENSG00000222579	Y_RNA	NA	
ENSG00000286410	AC089985.1	NA	
ENSG00000257758	KRT18P20	NA	
ENSG00000151131	C12orf45	NA	
ENSG00000136010	ALDH1L2	NA	
ENSG00000136051	WASHC4	615817	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43
ENSG00000136044	APPL2	NA	
ENSG00000235162	C12orf75	NA	
ENSG00000286903	AC078874.1	NA	
ENSG00000257642	KCCAT198	NA	
ENSG00000286520	AC079851.1	NA	
ENSG00000257859	CASC18	NA	
ENSG00000257773	ST13P3	NA	
ENSG00000257890	AC011595.2	NA	
ENSG00000074590	NUAK1	NA	
ENSG00000257438	AC011595.1	NA	
ENSG00000257611	AC010182.1	NA	
ENSG00000136026	CKAP4	NA	
ENSG00000258355	AC079174.1	NA	
ENSG00000277715	AC079174.2	NA	
ENSG00000238609	RNU7-94P	NA	
ENSG00000166046	TCP11L2	NA	
ENSG00000013503	POLR3B	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000013503	POLR3B	607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY /.../MYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM;;4H SYNDROME
ENSG00000013503	POLR3B	614381	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8
ENSG00000257545	AC079385.1	NA	
ENSG00000111783	RFX4	NA	
ENSG00000257711	AC079385.2	NA	
ENSG00000257918	AC079385.3	NA	
ENSG00000111785	RIC8B	NA	
ENSG00000287957	AC007695.1	NA	
ENSG00000257119	EEF1B2P4	NA	
ENSG00000240631	RPL30P12	NA	
ENSG00000260329	AC007541.1	NA	
ENSG00000151135	TMEM263	NA	
ENSG00000120832	MTERF2	NA	
ENSG00000008405	CRY1	614163	DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD
ENSG00000257548	AC078929.1	NA	
ENSG00000286678	AC007649.1	NA	
ENSG00000257444	SETP7	NA	
ENSG00000151136	BTBD11	NA	
ENSG00000200897	AC009774.1	NA	
ENSG00000222302	RNA5SP371	NA	
ENSG00000257579	AC007540.1	NA	
ENSG00000222160	Y_RNA	NA	
ENSG00000136045	PWP1	NA	
ENSG00000240441	AC007622.1	NA	
ENSG00000110851	PRDM4	NA	
ENSG00000258136	AC007622.2	NA	
ENSG00000187855	ASCL4	NA	
ENSG00000257398	AC126177.3	NA	
ENSG00000257951	AC126177.5	NA	
ENSG00000257392	AC126177.2	NA	
ENSG00000257426	AC126177.4	NA	
ENSG00000258072	AC126177.6	NA	
ENSG00000257129	AC126177.1	NA	
ENSG00000075035	WSCD2	NA	
ENSG00000257281	AC009729.1	NA	
ENSG00000174600	CMKLR1	NA	
ENSG00000247213	LINC01498	NA	
ENSG00000198855	FICD	NA	
ENSG00000075856	SART3	NA	
ENSG00000287202	AC008119.1	NA	
ENSG00000136003	ISCU	255125	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML;;MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE;;MYOPATHY WITH DEFICIENCY OF SUCCINATE DEHYDROGENASE AND ACONITASE;;MYOGLOBINURIA DUE TO ABNORMAL GLYCOLYSIS
ENSG00000183160	TMEM119	NA	
ENSG00000110876	SELPLG	NA	
ENSG00000257221	AC007569.1	NA	
ENSG00000284388	MIR4496	NA	
ENSG00000110880	CORO1C	NA	
ENSG00000238457	RNU7-169P	NA	
ENSG00000200060	Y_RNA	NA	
ENSG00000273499	AC087893.1	NA	
ENSG00000084112	SSH1	NA	
ENSG00000280110	AC087893.3	NA	
ENSG00000274598	AC087893.2	NA	
ENSG00000207622	MIR619	NA	
ENSG00000110887	DAO	NA	
ENSG00000166111	SVOP	NA	
ENSG00000201324	RNU6-361P	NA	
ENSG00000279630	AC190387.1	NA	
ENSG00000135093	USP30	NA	
ENSG00000256262	USP30-AS1	NA	
ENSG00000212138	RNA5SP372	NA	
ENSG00000189046	ALKBH2	NA	
ENSG00000076248	UNG	608106	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5;;HYPER-IgM SYNDROME 5
ENSG00000256139	AC007637.1	NA	
ENSG00000076555	ACACB	NA	
ENSG00000139445	FOXN4	NA	
ENSG00000174527	MYO1H	NA	
ENSG00000256560	LINC01486	NA	
ENSG00000255655	AC007570.1	NA	
ENSG00000110906	KCTD10	NA	
ENSG00000151148	UBE3B	244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS;;BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME; BPIDS
ENSG00000139428	MMAB	251110	METHYLMALONIC ACIDURIA, cblB TYPE;;METHYLMALONIC ACIDEMIA, cblB TYPE;;METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblB TYPE
ENSG00000200274	RNU4-32P	NA	
ENSG00000110921	MVK	175900	POROKERATOSIS 3, MULTIPLE TYPES; POROK3;;POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1; DSAP1
ENSG00000110921	MVK	260920	HYPER-IgD SYNDROME; HIDS;;HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME;;PERIODIC FEVER, DUTCH TYPE
ENSG00000110921	MVK	610377	MEVALONIC ACIDURIA; MEVA
ENSG00000200794	RN7SKP250	NA	
ENSG00000139438	FAM222A	NA	
ENSG00000255650	FAM222A-AS1	NA	
ENSG00000111199	TRPV4	184252	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK;;SMD, KOZLOWSKI TYPE
ENSG00000111199	TRPV4	184095	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE;;SED, MAROTEAUX TYPE;;PSEUDO-MORQUIO SYNDROME, TYPE 2
ENSG00000111199	TRPV4	181405	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA;;AMYOTROPHY, NEUROGENIC SCAPULOPERONEAL, NEW ENGLAND TYPE
ENSG00000111199	TRPV4	168400	PARASTREMMATIC DWARFISM
ENSG00000111199	TRPV4	156530	METATROPIC DYSPLASIA;;METATROPIC DWARFISM
ENSG00000111199	TRPV4	113500	BRACHYOLMIA TYPE 3; BCYM3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA
ENSG00000111199	TRPV4	600175	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; DHMN8;;SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES
ENSG00000111199	TRPV4	606071	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C;;HMSN IIC;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2C; CMT2C;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2C
ENSG00000111199	TRPV4	606835	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB
ENSG00000111199	TRPV4	613508	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1 HYPONATREMIA, INCLUDED
ENSG00000111199	TRPV4	617383	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2; ANFH2
ENSG00000263510	MIR4497	NA	
ENSG00000139433	GLTP	NA	
ENSG00000256351	AC007834.2	NA	
ENSG00000241413	RN7SL441P	NA	
ENSG00000249094	AC007834.1	NA	
ENSG00000139437	TCHP	NA	
ENSG00000139436	GIT2	NA	
ENSG00000277299	AC084876.1	NA	
ENSG00000280426	AC084876.2	NA	
ENSG00000076513	ANKRD13A	NA	
ENSG00000174456	C12orf76	NA	
ENSG00000277595	AC007546.1	NA	
ENSG00000286220	AC007546.3	NA	
ENSG00000279360	AC007546.2	NA	
ENSG00000122970	IFT81	617895	SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19
ENSG00000174437	ATP2A2	124200	DARIER-WHITE DISEASE; DAR;;KERATOSIS FOLLICULARIS;;DARIER DISEASE; DD  DARIER DISEASE, ACRAL HEMORRHAGIC TYPE, INCLUDED;;DARIER DISEASE, SEGMENTAL, INCLUDED
ENSG00000174437	ATP2A2	101900	ACROKERATOSIS VERRUCIFORMIS; AKV;;HOPF DISEASE
ENSG00000276956	RN7SL769P	NA	
ENSG00000196510	ANAPC7	NA	
ENSG00000258210	AC144548.1	NA	
ENSG00000258011	HMGA1P3	NA	
ENSG00000111229	ARPC3	NA	
ENSG00000111231	GPN3	NA	
ENSG00000241680	RPL31P49	NA	
ENSG00000204856	FAM216A	NA	
ENSG00000111237	VPS29	NA	
ENSG00000202335	AC002350.1	NA	
ENSG00000278993	AC002350.2	NA	
ENSG00000151164	RAD9B	NA	
ENSG00000196850	PPTC7	NA	
ENSG00000204852	TCTN1	614173	JOUBERT SYNDROME 13; JBTS13
ENSG00000263537	RN7SL387P	NA	
ENSG00000122986	HVCN1	NA	
ENSG00000186298	PPP1CC	NA	
ENSG00000279925	AC144522.1	NA	
ENSG00000257268	AC002375.1	NA	
ENSG00000241286	RPL29P25	NA	
ENSG00000173093	CCDC63	NA	
ENSG00000111245	MYL2	608758	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10;;CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 2
ENSG00000185847	LINC01405	NA	
ENSG00000258240	AC002351.1	NA	
ENSG00000111249	CUX2	618141	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67
ENSG00000273700	MIR6760	NA	
ENSG00000253080	RNA5SP373	NA	
ENSG00000198324	PHETA1	NA	
ENSG00000257595	LINC02356	NA	
ENSG00000257539	HSPA8P14	NA	
ENSG00000111252	SH2B3	133100	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN
ENSG00000111252	SH2B3	187950	THROMBOCYTHEMIA 1; THCYT1;;THROMBOCYTOSIS 1
ENSG00000111252	SH2B3	254450	MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED; MMM, INCLUDED
ENSG00000204842	ATXN2	183090	SPINOCEREBELLAR ATAXIA 2; SCA2;;SPINOCEREBELLAR ATROPHY II;;OLIVOPONTOCEREBELLAR ATROPHY, HOLGUIN TYPE;;OLIVOPONTOCEREBELLAR ATROPHY II; OPCA2;;SPINOCEREBELLAR ATAXIA, CUBAN TYPE;;CEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS;;WADIA-SWAMI SYNDROME /.../OCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 13, INCLUDED; ALS13, INCLUDED
ENSG00000204842	ATXN2	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000272215	U7	NA	
ENSG00000238168	IFITM3P5	NA	
ENSG00000258099	ATXN2-AS	NA	
ENSG00000089234	BRAP	NA	
ENSG00000258359	PCNPP1	NA	
ENSG00000111271	ACAD10	NA	
ENSG00000257767	AC002996.1	NA	
ENSG00000111275	ALDH2	100650	ALDEHYDE DEHYDROGENASE 2 FAMILY; ALDH2;;ALDEHYDE DEHYDROGENASE 2;;ALDH, LIVER MITOCHONDRIAL;;ACETALDEHYDE DEHYDROGENASE 2 SUBLINGUAL NITROGLYCERIN, SUSCEPTIBILITY TO POOR RESPONSE TO, INCLUDED;;ALDH2/HMGIC FUSION GENE, INCLUDED;;ESOPHAGEAL CANCER, A /.../-RELATED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000111275	ALDH2	610251	ALCOHOL SENSITIVITY, ACUTE HANGOVER, SUSCEPTIBILITY TO, INCLUDED
ENSG00000274697	MIR6761	NA	
ENSG00000234608	MAPKAPK5-AS1	NA	
ENSG00000089022	MAPKAPK5	NA	
ENSG00000244060	RPS2P41	NA	
ENSG00000229186	ADAM1A	NA	
ENSG00000226469	ADAM1B	NA	
ENSG00000198270	TMEM116	NA	
ENSG00000258373	SLC25A3P2	NA	
ENSG00000257624	AC004024.1	NA	
ENSG00000089248	ERP29	NA	
ENSG00000274227	AC073575.2	NA	
ENSG00000111300	NAA25	NA	
ENSG00000266370	MIR3657	NA	
ENSG00000258323	AC073575.1	NA	
ENSG00000200688	Y_RNA	NA	
ENSG00000135148	TRAFD1	NA	
ENSG00000200135	Y_RNA	NA	
ENSG00000173064	HECTD4	NA	
ENSG00000283793	MIR6861	NA	
ENSG00000257494	AC004217.1	NA	
ENSG00000201428	RN7SKP71	NA	
ENSG00000213152	RPL7AP60	NA	
ENSG00000257658	AC004217.2	NA	
ENSG00000089009	RPL6	NA	
ENSG00000179295	PTPN11	163950	NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPE PTERYGIUM COLLI SYNDROME, INCLUDED
ENSG00000179295	PTPN11	156250	METACHONDROMATOSIS; METCDS
ENSG00000179295	PTPN11	151100	LEOPARD SYNDROME 1; LPRD1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME
ENSG00000179295	PTPN11	607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML;;LEUKEMIA, JUVENILE MYELOMONOCYTIC  LEUKEMIA, CHRONIC MYELOMONOCYTIC, INCLUDED; CMML, INCLUDED
ENSG00000089169	RPH3A	NA	
ENSG00000283507	MIR1302-1	NA	
ENSG00000089127	OAS1	NA	
ENSG00000257452	AC004551.1	NA	
ENSG00000111331	OAS3	NA	
ENSG00000111335	OAS2	NA	
ENSG00000258159	IMMP1LP2	NA	
ENSG00000242461	RPS15AP32	NA	
ENSG00000135144	DTX1	NA	
ENSG00000111344	RASAL1	NA	
ENSG00000186710	CFAP73	NA	
ENSG00000199899	Y_RNA	NA	
ENSG00000123064	DDX54	NA	
ENSG00000276908	MIR7106	NA	
ENSG00000201208	Y_RNA	NA	
ENSG00000139405	RITA1	NA	
ENSG00000257286	AC089999.1	NA	
ENSG00000166578	IQCD	NA	
ENSG00000186815	TPCN1	NA	
ENSG00000277566	AC089999.2	NA	
ENSG00000274822	MIR6762	NA	
ENSG00000089060	SLC8B1	NA	
ENSG00000151176	PLBD2	NA	
ENSG00000135094	SDS	NA	
ENSG00000139410	SDSL	NA	
ENSG00000089116	LHX5	NA	
ENSG00000257935	LHX5-AS1	NA	
ENSG00000249550	LINC01234	NA	
ENSG00000257231	DYNLL1P4	NA	
ENSG00000122965	RBM19	NA	
ENSG00000287229	AC009731.1	NA	
ENSG00000257359	AC073863.1	NA	
ENSG00000257603	AC010183.1	NA	
ENSG00000257997	AC010183.2	NA	
ENSG00000257300	HAUS8P1	NA	
ENSG00000257915	GLULP5	NA	
ENSG00000257476	LINC02459	NA	
ENSG00000089225	TBX5	142900	HOLT-ORAM SYNDROME; HOS;;HOS1;;HEART-HAND SYNDROME;;ATRIODIGITAL DYSPLASIA
ENSG00000255399	TBX5-AS1	NA	
ENSG00000222982	RN7SKP216	NA	
ENSG00000255830	AC069240.1	NA	
ENSG00000258244	OSTF1P1	NA	
ENSG00000258254	AC010177.2	NA	
ENSG00000199220	AC010177.1	NA	
ENSG00000135111	TBX3	181450	ULNAR-MAMMARY SYNDROME; UMS;;PALLISTER ULNAR-MAMMARY SYNDROME;;SCHINZEL SYNDROME
ENSG00000257817	AC026765.3	NA	
ENSG00000287982	AC026765.4	NA	
ENSG00000252459	AC026765.1	NA	
ENSG00000257517	AC026765.2	NA	
ENSG00000283459	AC009804.2	NA	
ENSG00000274879	AC009804.1	NA	
ENSG00000257958	AC008125.1	NA	
ENSG00000257519	AC078880.1	NA	
ENSG00000271579	AC078880.3	NA	
ENSG00000276308	AC078880.4	NA	
ENSG00000276972	AC078880.5	NA	
ENSG00000257726	AC078880.2	NA	
ENSG00000258108	AC009803.2	NA	
ENSG00000257407	AC009803.1	NA	
ENSG00000241656	UBA52P7	NA	
ENSG00000240205	RN7SL865P	NA	
ENSG00000257781	AC009387.1	NA	
ENSG00000257683	LINC02463	NA	
ENSG00000200112	AC012157.1	NA	
ENSG00000286991	AC012157.3	NA	
ENSG00000123066	MED13L	608808	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1;;D-TGA
ENSG00000123066	MED13L	616789	MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD
ENSG00000258034	AC012157.2	NA	
ENSG00000200665	RNU6-1188P	NA	
ENSG00000207967	MIR620	NA	
ENSG00000257979	SNRPGP18	NA	
ENSG00000258337	AC130895.1	NA	
ENSG00000286354	AC079384.2	NA	
ENSG00000258346	AC079384.1	NA	
ENSG00000264037	MIR4472-2	NA	
ENSG00000258018	LINC02457	NA	
ENSG00000196668	LINC00173	NA	
ENSG00000258102	MAP1LC3B2	NA	
ENSG00000275898	AC125603.4	NA	
ENSG00000258249	AC125603.3	NA	
ENSG00000257883	AC125603.2	NA	
ENSG00000257654	AC125603.1	NA	
ENSG00000111412	C12orf49	NA	
ENSG00000135119	RNFT2	NA	
ENSG00000239374	AC090013.1	NA	
ENSG00000201382	RNU6-558P	NA	
ENSG00000275467	AC083806.3	NA	
ENSG00000135116	HRK	NA	
ENSG00000240100	AC083806.1	NA	
ENSG00000174989	FBXW8	NA	
ENSG00000274554	AC083806.2	NA	
ENSG00000257279	AC127164.1	NA	
ENSG00000277840	AC026368.1	NA	
ENSG00000088992	TESC	NA	
ENSG00000258285	TESC-AS1	NA	
ENSG00000135108	FBXO21	NA	
ENSG00000089250	NOS1	NA	
ENSG00000257465	ELOCP32	NA	
ENSG00000255686	AC073864.1	NA	
ENSG00000171435	KSR2	NA	
ENSG00000256071	AC084291.1	NA	
ENSG00000111445	RFC5	NA	
ENSG00000277873	AC131159.2	NA	
ENSG00000176871	WSB2	NA	
ENSG00000276292	AC131159.1	NA	
ENSG00000176834	VSIG10	NA	
ENSG00000274859	AC131238.1	NA	
ENSG00000089220	PEBP1	NA	
ENSG00000135090	TAOK3	NA	
ENSG00000240342	RPS2P5	NA	
ENSG00000270482	AC026367.1	NA	
ENSG00000111707	SUDS3	NA	
ENSG00000275759	AC026367.3	NA	
ENSG00000275409	AC026367.2	NA	
ENSG00000255714	LINC02460	NA	
ENSG00000241590	RPL17P37	NA	
ENSG00000256750	LINC02423	NA	
ENSG00000255618	LINC02440	NA	
ENSG00000255814	LINC02439	NA	
ENSG00000199809	RNA5SP374	NA	
ENSG00000256149	AC087863.2	NA	
ENSG00000201042	AC087863.1	NA	
ENSG00000139767	SRRM4	NA	
ENSG00000286233	AC087885.1	NA	
ENSG00000244112	RN7SL508P	NA	
ENSG00000257095	AC084361.1	NA	
ENSG00000152137	HSPB8	158590	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A;;HMN IIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; DHMN2A;;SPINAL MUSCULAR ATROPHY, DISTAL, ADULT, AUTOSOMAL DOMINANT, IIA;;CHARCOT-MARIE-TOOTH DISEASE, SPINAL, IIA
ENSG00000152137	HSPB8	608673	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2L;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2L
ENSG00000256884	AC084880.4	NA	
ENSG00000256609	AC084880.3	NA	
ENSG00000213144	AC084880.1	NA	
ENSG00000256311	AC084880.2	NA	
ENSG00000281196	LINC00934	NA	
ENSG00000183273	CCDC60	NA	
ENSG00000248636	AC002070.1	NA	
ENSG00000224982	TMEM233	NA	
ENSG00000252886	RN7SKP197	NA	
ENSG00000111725	PRKAB1	NA	
ENSG00000122966	CIT	617090	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17
ENSG00000255692	AC002563.1	NA	
ENSG00000283768	MIR1178	NA	
ENSG00000226729	RPL35AP30	NA	
ENSG00000135127	BICDL1	NA	
ENSG00000278250	Metazoa_SRP	NA	
ENSG00000255575	AC004812.1	NA	
ENSG00000111737	RAB35	NA	
ENSG00000277283	AC004812.2	NA	
ENSG00000089154	GCN1	NA	
ENSG00000266704	MIR4498	NA	
ENSG00000089157	RPLP0	NA	
ENSG00000255857	PXN-AS1	NA	
ENSG00000089159	PXN	NA	
ENSG00000286067	AC004263.2	NA	
ENSG00000275936	AC004263.1	NA	
ENSG00000240925	RPS20P31	NA	
ENSG00000123009	NME2P1	NA	
ENSG00000202538	RNU4-2	NA	
ENSG00000200795	RNU4-1	NA	
ENSG00000089163	SIRT4	NA	
ENSG00000252659	RNU6-1088P	NA	
ENSG00000170890	PLA2G1B	NA	
ENSG00000135097	MSI1	NA	
ENSG00000239881	RPS27P25	NA	
ENSG00000256695	AC003982.1	NA	
ENSG00000111775	COX6A1	616039	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID
ENSG00000111780	AL021546.1	NA	
ENSG00000170855	TRIAP1	NA	
ENSG00000257218	GATC	NA	
ENSG00000219355	RPL31P52	NA	
ENSG00000111786	SRSF9	NA	
ENSG00000088986	DYNLL1	NA	
ENSG00000248008	NRAV	NA	
ENSG00000278344	AC063943.2	NA	
ENSG00000110871	COQ5	NA	
ENSG00000222601	AC063943.1	NA	
ENSG00000241030	RPL29P24	NA	
ENSG00000022840	RNF10	NA	
ENSG00000288623	AC063943.3	NA	
ENSG00000167272	POP5	NA	
ENSG00000242137	RPL11P5	NA	
ENSG00000256008	AC125616.1	NA	
ENSG00000157782	CABP1	NA	
ENSG00000110917	MLEC	NA	
ENSG00000256364	AC069234.2	NA	
ENSG00000277423	AC069234.5	NA	
ENSG00000276188	AC069234.4	NA	
ENSG00000175970	UNC119B	NA	
ENSG00000256569	AC069234.3	NA	
ENSG00000284143	MIR4700	NA	
ENSG00000122971	ACADS	201470	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD;;ACADS DEFICIENCY;;LIPID-STORAGE MYOPATHY SECONDARY TO SHORT-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY;;SCADH DEFICIENCY;;SCAD DEFICIENCY
ENSG00000255946	AC069234.1	NA	
ENSG00000157837	SPPL3	NA	
ENSG00000213137	ARF1P2	NA	
ENSG00000286493	AC069214.1	NA	
ENSG00000231313	CLIC1P1	NA	
ENSG00000244585	RPL12P33	NA	
ENSG00000241388	HNF1A-AS1	NA	
ENSG00000135100	HNF1A	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC;;HYPERNEPHROMA;;ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
ENSG00000135100	HNF1A	142330	HEPATIC ADENOMAS, FAMILIAL;;LIVER CELL ADENOMAS, FAMILIAL
ENSG00000135100	HNF1A	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000135100	HNF1A	222100	DIABETES MELLITUS, TYPE I;;DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM;;JUVENILE-ONSET DIABETES; JOD DIABETES MELLITUS, INSULIN-DEPENDENT, 1, INCLUDED; IDDM1, INCLUDED;;INSULIN-DEPENDENT DIABETES MELLITUS 1, INCLUDED
ENSG00000135100	HNF1A	600496	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3;;MODY, TYPE 3
ENSG00000135100	HNF1A	612520	DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20
ENSG00000157895	C12orf43	NA	
ENSG00000135114	OASL	NA	
ENSG00000283542	OASL2P	NA	
ENSG00000256963	AC079602.2	NA	
ENSG00000279001	AC079602.3	NA	
ENSG00000201945	SNORA70	NA	
ENSG00000223538	AC079602.1	NA	
ENSG00000089041	P2RX7	NA	
ENSG00000286248	AC069209.2	NA	
ENSG00000274029	AC069209.1	NA	
ENSG00000135124	P2RX4	NA	
ENSG00000110931	CAMKK2	NA	
ENSG00000089053	ANAPC5	NA	
ENSG00000258435	AC048337.1	NA	
ENSG00000170633	RNF34	NA	
ENSG00000089094	KDM2B	NA	
ENSG00000284402	MIR7107	NA	
ENSG00000256742	KDM2B-DT	NA	
ENSG00000252393	RNU6-1004P	NA	
ENSG00000276045	ORAI1	612782	IMMUNODEFICIENCY 9; IMD9;;IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 1
ENSG00000276045	ORAI1	615883	MYOPATHY, TUBULAR AGGREGATE, 2; TAM2
ENSG00000139714	MORN3	NA	
ENSG00000286586	AC084018.3	NA	
ENSG00000188735	TMEM120B	NA	
ENSG00000139725	RHOF	NA	
ENSG00000212694	LINC01089	NA	
ENSG00000272849	AC084018.1	NA	
ENSG00000274292	AC084018.2	NA	
ENSG00000139718	SETD1B	NA	
ENSG00000158104	HPD	140350	HAWKINSINURIA
ENSG00000158104	HPD	276710	TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY
ENSG00000256811	AC079360.1	NA	
ENSG00000278084	AC069503.3	NA	
ENSG00000287493	AC069503.4	NA	
ENSG00000110801	PSMD9	NA	
ENSG00000256950	AC069503.2	NA	
ENSG00000283389	Metazoa_SRP	NA	
ENSG00000239082	RNU7-170P	NA	
ENSG00000158023	CFAP251	618152	SPERMATOGENIC FAILURE 33; SPGF33
ENSG00000255856	AC069503.1	NA	
ENSG00000110987	BCL7A	NA	
ENSG00000256546	AC156455.1	NA	
ENSG00000175727	MLXIP	NA	
ENSG00000158113	LRRC43	NA	
ENSG00000204671	IL31	NA	
ENSG00000176383	B3GNT4	NA	
ENSG00000284934	AC048338.2	NA	
ENSG00000184047	DIABLO	614152	DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64
ENSG00000256861	AC048338.1	NA	
ENSG00000139719	VPS33A	617303	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS
ENSG00000130779	CLIP1	NA	
ENSG00000214760	RPL21P1	NA	
ENSG00000257097	CLIP1-AS1	NA	
ENSG00000033030	ZCCHC8	618674	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 5; PFBMFT5
ENSG00000252192	AC127002.1	NA	
ENSG00000275265	AC127002.2	NA	
ENSG00000111011	RSRC2	NA	
ENSG00000184445	KNTC1	NA	
ENSG00000255972	AC026333.1	NA	
ENSG00000274191	AC026333.4	NA	
ENSG00000256249	AC026333.3	NA	
ENSG00000182782	HCAR2	NA	
ENSG00000255398	HCAR3	NA	
ENSG00000196917	HCAR1	NA	
ENSG00000256044	AC026333.2	NA	
ENSG00000139726	DENR	NA	
ENSG00000206914	Y_RNA	NA	
ENSG00000130783	CCDC62	NA	
ENSG00000130787	HIP1R	NA	
ENSG00000139722	VPS37B	NA	
ENSG00000256152	AC027290.1	NA	
ENSG00000280138	AC027290.2	NA	
ENSG00000150967	ABCB9	NA	
ENSG00000111325	OGFOD2	NA	
ENSG00000256028	AC026362.1	NA	
ENSG00000182196	ARL6IP4	NA	
ENSG00000090975	PITPNM2	NA	
ENSG00000265526	MIR4304	NA	
ENSG00000251497	PITPNM2-AS1	NA	
ENSG00000280381	AC026362.2	NA	
ENSG00000051825	MPHOSPH9	NA	
ENSG00000280120	AC073857.1	NA	
ENSG00000130921	C12orf65	613559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7
ENSG00000130921	C12orf65	615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55
ENSG00000111328	CDK2AP1	NA	
ENSG00000269980	AC068768.1	NA	
ENSG00000199845	RNA5SP375	NA	
ENSG00000139697	SBNO1	NA	
ENSG00000207189	Y_RNA	NA	
ENSG00000256092	SBNO1-AS1	NA	
ENSG00000284425	MIR8072	NA	
ENSG00000183955	KMT5A	NA	
ENSG00000150977	RILPL2	NA	
ENSG00000270445	AC145423.1	NA	
ENSG00000184209	SNRNP35	NA	
ENSG00000188026	RILPL1	NA	
ENSG00000274427	AC145423.2	NA	
ENSG00000278112	AC145423.3	NA	
ENSG00000266655	MIR3908	NA	
ENSG00000247373	TMED2-DT	NA	
ENSG00000086598	TMED2	NA	
ENSG00000111364	DDX55	NA	
ENSG00000206897	SNORA9B	NA	
ENSG00000111361	EIF2B1	603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM;;CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION; CACH;;VANISHING WHITE MATTER LEUKODYSTROPHY;;CREE LEUKOENCEPHALOPATHY; CLE VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILU /.../CLUDED;;OVARIOLEUKODYSTROPHY, INCLUDED
ENSG00000111358	GTF2H3	NA	
ENSG00000279953	AC117503.3	NA	
ENSG00000278861	AC117503.2	NA	
ENSG00000168778	TCTN2	613885	MECKEL SYNDROME, TYPE 8; MKS8
ENSG00000168778	TCTN2	616654	JOUBERT SYNDROME 24; JBTS24
ENSG00000255839	AC117503.1	NA	
ENSG00000185344	ATP6V0A2	219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A;;ARCL2;;CUTIS LAXA WITH CONGENITAL DISORDER OF GLYCOSYLATION;;CUTIS LAXA WITH GROWTH AND DEVELOPMENTAL DELAY;;CUTIS LAXA, DEBRE TYPE;;CUTIS LAXA WITH BONE DYSTROPHY;;CUTIS LAXA WITH JOINT LAXITY AND  /.../ED DEVELOPMENT
ENSG00000185344	ATP6V0A2	278250	WRINKLY SKIN SYNDROME; WSS
ENSG00000286092	AC117503.5	NA	
ENSG00000239215	RPL27P12	NA	
ENSG00000280300	AC117503.4	NA	
ENSG00000197653	DNAH10	NA	
ENSG00000119242	CCDC92	NA	
ENSG00000250091	DNAH10OS	NA	
ENSG00000270130	AC068790.7	NA	
ENSG00000270048	AC068790.4	NA	
ENSG00000269997	AC068790.3	NA	
ENSG00000269938	AC068790.2	NA	
ENSG00000270061	AC068790.5	NA	
ENSG00000270095	AC068790.6	NA	
ENSG00000179195	ZNF664	NA	
ENSG00000274874	AC068790.8	NA	
ENSG00000178882	RFLNA	NA	
ENSG00000256827	AC068790.1	NA	
ENSG00000275389	AC068790.9	NA	
ENSG00000256596	AC026358.1	NA	
ENSG00000196498	NCOR2	NA	
ENSG00000275967	MIR6880	NA	
ENSG00000255965	AC073916.1	NA	
ENSG00000214650	AC073592.1	NA	
ENSG00000279527	AC073592.7	NA	
ENSG00000279071	AC073592.3	NA	
ENSG00000280354	AC073592.9	NA	
ENSG00000279121	AC073592.5	NA	
ENSG00000279334	AC073592.6	NA	
ENSG00000280097	AC073592.8	NA	
ENSG00000278973	AC073592.2	NA	
ENSG00000280444	AC073592.10	NA	
ENSG00000279087	AC073592.4	NA	
ENSG00000279931	AC073593.1	NA	
ENSG00000073060	SCARB1	610762	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6
ENSG00000287242	AC073593.2	NA	
ENSG00000252008	RNU6-927P	NA	
ENSG00000150991	UBC	NA	
ENSG00000265345	MIR5188	NA	
ENSG00000241129	RPL22P19	NA	
ENSG00000150990	DHX37	618731	NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES; NEDBAVC
ENSG00000184992	BRI3BP	NA	
ENSG00000280634	THRIL	NA	
ENSG00000256093	AC122688.1	NA	
ENSG00000081760	AACS	NA	
ENSG00000279233	AC122688.3	NA	
ENSG00000256814	AC122688.2	NA	
ENSG00000287240	AC122688.5	NA	
ENSG00000280117	AC122688.4	NA	
ENSG00000139364	TMEM132B	NA	
ENSG00000279462	AC093028.1	NA	
ENSG00000280125	AC005252.2	NA	
ENSG00000286209	AC005252.4	NA	
ENSG00000280415	AC005252.3	NA	
ENSG00000271184	AC005252.1	NA	
ENSG00000249267	LINC00939	NA	
ENSG00000275212	LINC02826	NA	
ENSG00000284848	LINC02359	NA	
ENSG00000280364	AC005858.2	NA	
ENSG00000280398	AC005858.3	NA	
ENSG00000280272	AC005858.1	NA	
ENSG00000286386	AC005888.1	NA	
ENSG00000255595	AC007368.1	NA	
ENSG00000256494	LINC02825	NA	
ENSG00000214043	LINC02347	NA	
ENSG00000256125	AC005868.1	NA	
ENSG00000255853	AC006065.1	NA	
ENSG00000256310	NDUFA5P6	NA	
ENSG00000256732	AC006065.4	NA	
ENSG00000255900	AC006065.2	NA	
ENSG00000255944	AC006065.3	NA	
ENSG00000278866	AC006065.5	NA	
ENSG00000279171	AC006065.6	NA	
ENSG00000255998	LINC02824	NA	
ENSG00000189238	LINC00943	NA	
ENSG00000256128	LINC00944	NA	
ENSG00000255923	AC078878.1	NA	
ENSG00000249873	LINC02372	NA	
ENSG00000256286	AC078878.2	NA	
ENSG00000257021	HSPE1P20	NA	
ENSG00000249345	LINC02405	NA	
ENSG00000256001	AC079949.1	NA	
ENSG00000286016	AC079949.3	NA	
ENSG00000286791	AC079949.5	NA	
ENSG00000278266	AC079949.2	NA	
ENSG00000287339	AC079949.6	NA	
ENSG00000256292	LINC02376	NA	
ENSG00000256496	AC073913.1	NA	
ENSG00000253089	RNU1-104P	NA	
ENSG00000256362	LINC02375	NA	
ENSG00000256502	AC073913.2	NA	
ENSG00000280024	AC048347.1	NA	
ENSG00000287365	AC068787.4	NA	
ENSG00000279952	AC068787.1	NA	
ENSG00000287112	AC068787.3	NA	
ENSG00000286922	AC068787.2	NA	
ENSG00000287622	AC068787.5	NA	
ENSG00000255945	AC025252.1	NA	
ENSG00000199584	Y_RNA	NA	
ENSG00000257035	AC025252.2	NA	
ENSG00000256022	LINC02411	NA	
ENSG00000288523	AC025160.1	NA	
ENSG00000286662	AC087894.3	NA	
ENSG00000279475	AC087894.2	NA	
ENSG00000255757	AC087894.1	NA	
ENSG00000256597	LINC02393	NA	
ENSG00000256193	LINC00507	NA	
ENSG00000256971	LINC00508	NA	
ENSG00000256643	LINC02441	NA	
ENSG00000287311	AC140121.1	NA	
ENSG00000256551	LINC02369	NA	
ENSG00000256659	LINC02368	NA	
ENSG00000276487	AC061709.2	NA	
ENSG00000265061	AC061709.1	NA	
ENSG00000181234	TMEM132C	NA	
ENSG00000279180	AC061709.3	NA	
ENSG00000265635	MIR3612	NA	
ENSG00000257025	AC023595.1	NA	
ENSG00000256630	AC090424.1	NA	
ENSG00000139370	SLC15A4	NA	
ENSG00000279500	AC108704.2	NA	
ENSG00000274695	AC108704.1	NA	
ENSG00000151948	GLT1D1	NA	
ENSG00000255838	AC069262.1	NA	
ENSG00000256581	NLRP9P1	NA	
ENSG00000151952	TMEM132D	NA	
ENSG00000249196	TMEM132D-AS1	NA	
ENSG00000277217	AC107033.1	NA	
ENSG00000256699	TMEM132D-AS2	NA	
ENSG00000280051	AC079456.1	NA	
ENSG00000256085	AC130404.1	NA	
ENSG00000286246	AC130404.2	NA	
ENSG00000256137	AC117373.1	NA	
ENSG00000286394	AC117373.2	NA	
ENSG00000280196	AC055717.3	NA	
ENSG00000251536	AC055717.1	NA	
ENSG00000261650	AC055717.2	NA	
ENSG00000214039	LINC02418	NA	
ENSG00000256298	AC135388.1	NA	
ENSG00000256906	LINC02419	NA	
ENSG00000279193	AC026336.4	NA	
ENSG00000276122	AC026336.3	NA	
ENSG00000250208	FZD10-AS1	NA	
ENSG00000280405	AC026336.5	NA	
ENSG00000111432	FZD10	NA	
ENSG00000242963	AC026336.1	NA	
ENSG00000259862	AC026336.2	NA	
ENSG00000125207	PIWIL1	NA	
ENSG00000279343	AC127071.1	NA	
ENSG00000279478	AC127071.2	NA	
ENSG00000060709	RIMBP2	NA	
ENSG00000256064	AC063926.1	NA	
ENSG00000279905	AC063926.3	NA	
ENSG00000279146	AC063926.2	NA	
ENSG00000256343	AC095350.1	NA	
ENSG00000279650	AC073912.3	NA	
ENSG00000111450	STX2	NA	
ENSG00000256250	AC073912.1	NA	
ENSG00000256299	AC073912.2	NA	
ENSG00000222438	RNU6-1077P	NA	
ENSG00000132341	RAN	NA	
ENSG00000206850	Y_RNA	NA	
ENSG00000111452	ADGRD1	NA	
ENSG00000279940	AC073862.3	NA	
ENSG00000279976	AC073862.4	NA	
ENSG00000280200	AC073862.5	NA	
ENSG00000256204	AC073862.1	NA	
ENSG00000279581	AC073862.2	NA	
ENSG00000280002	AC078925.4	NA	
ENSG00000256151	ADGRD1-AS1	NA	
ENSG00000279128	AC078925.2	NA	
ENSG00000279993	AC078925.3	NA	
ENSG00000256810	AC078925.1	NA	
ENSG00000204603	LINC01257	NA	
ENSG00000280217	AC126564.1	NA	
ENSG00000226356	RPS6P20	NA	
ENSG00000279746	AC092850.1	NA	
ENSG00000248703	LINC02415	NA	
ENSG00000212251	RNA5SP376	NA	
ENSG00000286462	AC092850.2	NA	
ENSG00000230294	LINC02370	NA	
ENSG00000287792	AC140118.2	NA	
ENSG00000256484	AC140118.1	NA	
ENSG00000280319	AC073578.4	NA	
ENSG00000275232	AC073578.2	NA	
ENSG00000287136	AC073578.5	NA	
ENSG00000256209	AC073578.1	NA	
ENSG00000279388	AC073578.3	NA	
ENSG00000255704	AC140063.1	NA	
ENSG00000279455	AC117500.5	NA	
ENSG00000256258	AC117500.3	NA	
ENSG00000256424	LINC02414	NA	
ENSG00000287639	AC117500.6	NA	
ENSG00000279153	AC117500.4	NA	
ENSG00000212154	RNA5SP377	NA	
ENSG00000249926	AC117500.1	NA	
ENSG00000243499	RPS6P21	NA	
ENSG00000061936	SFSWAP	NA	
ENSG00000255933	AC117500.2	NA	
ENSG00000200516	RNA5SP378	NA	
ENSG00000200483	RNU6-1017P	NA	
ENSG00000198598	MMP17	NA	
ENSG00000256955	AC131009.2	NA	
ENSG00000177169	ULK1	NA	
ENSG00000279283	AC131009.4	NA	
ENSG00000255992	AC131009.1	NA	
ENSG00000177192	PUS1	600462	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1;;MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA
ENSG00000273568	AC131009.3	NA	
ENSG00000183495	EP400	NA	
ENSG00000208892	SNORA49	NA	
ENSG00000257000	AC137590.1	NA	
ENSG00000274670	AC137590.2	NA	
ENSG00000185684	EP400P1	NA	
ENSG00000279640	AC138466.5	NA	
ENSG00000256804	AC138466.2	NA	
ENSG00000185163	DDX51	NA	
ENSG00000184967	NOC4L	NA	
ENSG00000276693	AC138466.3	NA	
ENSG00000256576	LINC02361	NA	
ENSG00000256312	AC138466.1	NA	
ENSG00000182870	GALNT9	NA	
ENSG00000279480	AC138466.4	NA	
ENSG00000256943	AC148477.3	NA	
ENSG00000256542	AC148477.2	NA	
ENSG00000278872	AC148477.5	NA	
ENSG00000277011	AC148477.4	NA	
ENSG00000255916	AC148477.1	NA	
ENSG00000279113	AC148477.7	NA	
ENSG00000286008	AC148477.10	NA	
ENSG00000279704	AC148477.8	NA	
ENSG00000279023	AC148477.6	NA	
ENSG00000280150	AC148477.9	NA	
ENSG00000274373	AC148476.1	NA	
ENSG00000256783	AC079031.1	NA	
ENSG00000256875	AC079031.2	NA	
ENSG00000112787	FBRSL1	NA	
ENSG00000280287	AC131212.3	NA	
ENSG00000279700	AC131212.2	NA	
ENSG00000277052	MIR6763	NA	
ENSG00000277186	AC131212.1	NA	
ENSG00000204583	LRCOL1	NA	
ENSG00000187848	P2RX2	608224	DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41
ENSG00000280311	AC131212.4	NA	
ENSG00000177084	POLE	615083	COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12;;COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 12q24
ENSG00000177084	POLE	615139	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS
ENSG00000177084	POLE	618336	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI;;IMAGEI SYNDROME
ENSG00000176894	PXMP2	NA	
ENSG00000256632	AC135586.2	NA	
ENSG00000247077	PGAM5	NA	
ENSG00000201469	RNA5SP379	NA	
ENSG00000176915	ANKLE2	616681	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16
ENSG00000256108	AC135586.1	NA	
ENSG00000090615	GOLGA3	NA	
ENSG00000072609	CHFR	NA	
ENSG00000232888	RPS11P5	NA	
ENSG00000252079	RNU6-327P	NA	
ENSG00000278949	AC127070.4	NA	
ENSG00000236617	AC127070.1	NA	
ENSG00000255703	AC127070.3	NA	
ENSG00000250790	AC127070.2	NA	
ENSG00000196458	ZNF605	NA	
ENSG00000256563	NANOGNBP2	NA	
ENSG00000198393	ZNF26	NA	
ENSG00000252269	RNU4ATAC12P	NA	
ENSG00000246394	ZNF84-DT	NA	
ENSG00000255807	PTP4A1P2	NA	
ENSG00000198040	ZNF84	NA	
ENSG00000279466	AC073911.1	NA	
ENSG00000279817	AC073911.2	NA	
ENSG00000196387	ZNF140	NA	
ENSG00000214029	ZNF891	NA	
ENSG00000271963	AC026786.2	NA	
ENSG00000240991	RPL23AP67	NA	
ENSG00000256223	ZNF10	NA	
ENSG00000256825	AC026786.1	NA	
ENSG00000090612	ZNF268	NA	
ENSG00000255919	AC226150.1	NA	
ENSG00000227059	ANHX	NA	
ENSG00000239190	RNU6-717P	NA	
ENSG00000238443	Y_RNA	NA	
ENSG00000279924	AL356585.4	NA	
ENSG00000279516	FAM230C	NA	
ENSG00000279081	AL356585.1	NA	
ENSG00000284679	AL356585.10	NA	
ENSG00000280208	GGT4P	NA	
ENSG00000279124	AL356585.2	NA	
ENSG00000279730	KMT5AP1	NA	
ENSG00000279231	AL356585.3	NA	
ENSG00000268486	FO681491.1	NA	
ENSG00000276183	U6	NA	
ENSG00000215604	ZNF962P	NA	
ENSG00000270496	BNIP3P7	NA	
ENSG00000231238	LINC00349	NA	
ENSG00000233905	LONRF2P2	NA	
ENSG00000229788	LINC00388	NA	
ENSG00000235876	FEM1AP4	NA	
ENSG00000231914	LINC00387	NA	
ENSG00000226361	TERF1P5	NA	
ENSG00000228797	FAM207BP	NA	
ENSG00000230931	GXYLT1P1	NA	
ENSG00000204718	CNN2P12	NA	
ENSG00000227784	ZNF965P	NA	
ENSG00000244155	CYP4F34P	NA	
ENSG00000227568	SNX18P26	NA	
ENSG00000225016	LINC00328-2P	NA	
ENSG00000206192	ANKRD20A9P	NA	
ENSG00000242756	RHOT1P3	NA	
ENSG00000223024	RNU6-55P	NA	
ENSG00000206787	RNU6-76P	NA	
ENSG00000235500	SNX19P2	NA	
ENSG00000226250	LINC00408	NA	
ENSG00000231358	AL355516.1	NA	
ENSG00000226057	PHF2P2	NA	
ENSG00000232685	LINC00442	NA	
ENSG00000229375	USP24P1	NA	
ENSG00000187721	GTF2IP3	NA	
ENSG00000226619	AL137001.1	NA	
ENSG00000287861	AL137001.2	NA	
ENSG00000252287	RNA5SP24	NA	
ENSG00000224778	CENPIP1	NA	
ENSG00000234894	AL139327.2	NA	
ENSG00000229147	SMPD4P2	NA	
ENSG00000278337	AL139327.3	NA	
ENSG00000198033	TUBA3C	NA	
ENSG00000121388	AL139327.1	NA	
ENSG00000227879	PSPC1P1	NA	
ENSG00000237636	ANKRD26P3	NA	
ENSG00000215349	MRPL3P1	NA	
ENSG00000236834	LINC00421	NA	
ENSG00000224976	PARP4P2	NA	
ENSG00000231184	CCNQP3	NA	
ENSG00000229791	AL356259.1	NA	
ENSG00000237164	SLC25A15P2	NA	
ENSG00000132958	TPTE2	NA	
ENSG00000223625	CYCSP32	NA	
ENSG00000232894	MRPS31P2	NA	
ENSG00000215572	ESRRAP1	NA	
ENSG00000225316	LINC00350	NA	
ENSG00000238132	CASC4P1	NA	
ENSG00000196199	MPHOSPH8	NA	
ENSG00000226352	PSPC1-AS2	NA	
ENSG00000121390	PSPC1	NA	
ENSG00000275014	RN7SL166P	NA	
ENSG00000233469	ST6GALNAC4P1	NA	
ENSG00000132950	ZMYM5	NA	
ENSG00000223576	AL355001.1	NA	
ENSG00000275964	AL355001.2	NA	
ENSG00000121741	ZMYM2	NA	
ENSG00000237672	KRR1P1	NA	
ENSG00000279951	AL138688.2	NA	
ENSG00000236076	LINC01072	NA	
ENSG00000121743	GJA3	601885	CATARACT 14, MULTIPLE TYPES; CTRCT14;;CATARACT, ZONULAR PULVERULENT 3; CZP3;;CAE3
ENSG00000226633	PPIAP28	NA	
ENSG00000260131	LINC00556	NA	
ENSG00000165474	GJB2	149200	BART-PUMPHREY SYNDROME; BAPS;;KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS
ENSG00000165474	GJB2	148350	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS
ENSG00000165474	GJB2	148210	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT; KIDAD;;KID SYNDROME, AUTOSOMAL DOMINANT
ENSG00000165474	GJB2	124500	VOHWINKEL SYNDROME; VOWNKL;;DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF FINGERS AND TOES;;MUTILATING KERATODERMA;;KERATODERMA HEREDITARIUM MUTILANS; KHM
ENSG00000165474	GJB2	220290	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A DEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED
ENSG00000165474	GJB2	304400	DEAFNESS, X-LINKED 2; DFNX2;;DEAFNESS, CONDUCTIVE, WITH STAPES FIXATION;;DEAFNESS 3, CONDUCTIVE, WITH STAPES FIXATION; DFN3;;PERILYMPHATIC GUSHER-DEAFNESS SYNDROME;;DEAFNESS, MIXED, WITH PERILYMPHATIC GUSHER;;NANCE DEAFNESS;;SENSORINEURAL DEAFNESS,  /.../ND, WITH OR WITHOUT A CONDUCTIVE COMPONENT, ASSOCIATED WITH A UNIQUE DEVELOPMENTAL ABNORMALITY OF THE EAR
ENSG00000165474	GJB2	601544	DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A
ENSG00000165474	GJB2	602540	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME
ENSG00000279065	AL138688.1	NA	
ENSG00000121742	GJB6	129500	CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY
ENSG00000121742	GJB6	220290	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A DEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED
ENSG00000121742	GJB6	304400	DEAFNESS, X-LINKED 2; DFNX2;;DEAFNESS, CONDUCTIVE, WITH STAPES FIXATION;;DEAFNESS 3, CONDUCTIVE, WITH STAPES FIXATION; DFN3;;PERILYMPHATIC GUSHER-DEAFNESS SYNDROME;;DEAFNESS, MIXED, WITH PERILYMPHATIC GUSHER;;NANCE DEAFNESS;;SENSORINEURAL DEAFNESS,  /.../ND, WITH OR WITHOUT A CONDUCTIVE COMPONENT, ASSOCIATED WITH A UNIQUE DEVELOPMENTAL ABNORMALITY OF THE EAR
ENSG00000121742	GJB6	612643	DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B
ENSG00000121742	GJB6	612645	DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B
ENSG00000165475	CRYL1	NA	
ENSG00000263978	MIR4499	NA	
ENSG00000277020	AL590096.1	NA	
ENSG00000032742	IFT88	NA	
ENSG00000238286	SLC35E1P1	NA	
ENSG00000222726	RNU2-7P	NA	
ENSG00000278291	AL161772.1	NA	
ENSG00000172458	IL17D	NA	
ENSG00000279135	AL512652.2	NA	
ENSG00000150456	EEF1AKMT1	NA	
ENSG00000233524	RANP8	NA	
ENSG00000275485	AL512652.1	NA	
ENSG00000132953	XPO4	NA	
ENSG00000236704	CNOT4P1	NA	
ENSG00000233780	HNRNPA1P30	NA	
ENSG00000234363	PPIAP27	NA	
ENSG00000213621	RPSAP54	NA	
ENSG00000150457	LATS2	NA	
ENSG00000233851	LATS2-AS1	NA	
ENSG00000201821	RNU4-9P	NA	
ENSG00000180172	RPS12P23	NA	
ENSG00000225585	IPPKP1	NA	
ENSG00000275689	AL161613.1	NA	
ENSG00000252128	SNORD27	NA	
ENSG00000150459	SAP18	NA	
ENSG00000165480	SKA3	NA	
ENSG00000173141	MRPL57	NA	
ENSG00000271250	AL158032.1	NA	
ENSG00000233405	LINC01046	NA	
ENSG00000235438	ESRRAP2	NA	
ENSG00000277077	AL158032.2	NA	
ENSG00000233325	MIPEPP3	NA	
ENSG00000224429	LINC00539	NA	
ENSG00000215571	GRK6P1	NA	
ENSG00000180776	ZDHHC20	NA	
ENSG00000235076	GAPDHP52	NA	
ENSG00000222747	RNA5SP25	NA	
ENSG00000236953	ZDHHC20-IT1	NA	
ENSG00000226908	H2BP6	NA	
ENSG00000165487	MICU2	NA	
ENSG00000230022	FNTAP2	NA	
ENSG00000207518	RNU6-59P	NA	
ENSG00000226525	RPS7P10	NA	
ENSG00000102678	FGF9	612961	MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3
ENSG00000244197	RN7SL766P	NA	
ENSG00000226722	LINC00424	NA	
ENSG00000276476	LINC00540	NA	
ENSG00000237175	NME1P1	NA	
ENSG00000226118	MTND3P1	NA	
ENSG00000287357	AL512484.1	NA	
ENSG00000232187	FTH1P7	NA	
ENSG00000225777	DDX39AP1	NA	
ENSG00000253094	AL162853.1	NA	
ENSG00000237952	RPL7AP73	NA	
ENSG00000226507	IPMKP1	NA	
ENSG00000231650	RFESDP1	NA	
ENSG00000262619	LINC00621	NA	
ENSG00000230535	BASP1P1	NA	
ENSG00000234685	NUS1P2	NA	
ENSG00000262198	AL157931.1	NA	
ENSG00000283075	AL157931.2	NA	
ENSG00000233440	HMGA1P6	NA	
ENSG00000207157	RNY3P4	NA	
ENSG00000229483	LINC00362	NA	
ENSG00000102683	SGCG	253700	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECO /.../;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICAN TYPE; SCARMD;;MAGHREBIAN MYOPATHY
ENSG00000252952	RNU6-58P	NA	
ENSG00000235205	TATDN2P3	NA	
ENSG00000236803	SDAD1P4	NA	
ENSG00000151835	SACS	270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS;;SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE; SPAX6;;CHARLEVOIX-SAGUENAY SPASTIC ATAXIA;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY; ARSACS
ENSG00000232163	RPLP1P13	NA	
ENSG00000229558	SACS-AS1	NA	
ENSG00000232977	LINC00327	NA	
ENSG00000227893	LINC00352	NA	
ENSG00000127863	TNFRSF19	NA	
ENSG00000027001	MIPEP	617228	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31
ENSG00000232102	MTCO3P2	NA	
ENSG00000205861	PCOTH	NA	
ENSG00000205863	C1QTNF9B	NA	
ENSG00000196593	ANKRD20A19P	NA	
ENSG00000287530	AL445985.1	NA	
ENSG00000273167	AL359736.1	NA	
ENSG00000182957	SPATA13	NA	
ENSG00000228741	SPATA13	NA	
ENSG00000225674	IPO7P2	NA	
ENSG00000252695	MIR2276	NA	
ENSG00000227213	SPATA13-AS1	NA	
ENSG00000240654	C1QTNF9	NA	
ENSG00000240868	C1QTNF9-AS1	NA	
ENSG00000277040	AL359736.2	NA	
ENSG00000234627	NUS1P3	NA	
ENSG00000261498	LINC00566	NA	
ENSG00000233545	CYCSP33	NA	
ENSG00000205822	TPTE2P6	NA	
ENSG00000102699	PARP4	NA	
ENSG00000288103	AL359538.4	NA	
ENSG00000287376	AL359538.3	NA	
ENSG00000244615	PSPC1P2	NA	
ENSG00000243008	AL359538.1	NA	
ENSG00000285228	AL359538.2	NA	
ENSG00000075673	ATP12A	NA	
ENSG00000207474	RNY1P7	NA	
ENSG00000225404	RPL26P34	NA	
ENSG00000285806	AL391560.1	NA	
ENSG00000231417	IRX1P1	NA	
ENSG00000287887	AL391560.2	NA	
ENSG00000226695	ANKRD20A10P	NA	
ENSG00000132972	RNF17	NA	
ENSG00000151849	CENPJ	608393	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6
ENSG00000151849	CENPJ	613676	SECKEL SYNDROME 4; SCKL4
ENSG00000253771	TPTE2P1	NA	
ENSG00000273628	AL354798.1	NA	
ENSG00000251299	SLC25A15P3	NA	
ENSG00000232858	RPL34P27	NA	
ENSG00000269099	LSP1P1	NA	
ENSG00000276958	AL590099.1	NA	
ENSG00000151846	PABPC3	NA	
ENSG00000279695	AL359757.2	NA	
ENSG00000165566	AMER2	NA	
ENSG00000238169	LINC01053	NA	
ENSG00000234056	LINC00463	NA	
ENSG00000279550	AL359757.1	NA	
ENSG00000225105	LINC01076	NA	
ENSG00000235315	RPL23AP69	NA	
ENSG00000139505	MTMR6	NA	
ENSG00000260509	AL590787.1	NA	
ENSG00000139496	NUP58	NA	
ENSG00000234152	ELOBP1	NA	
ENSG00000132932	ATP8A2	615268	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 4
ENSG00000199767	RNU6-78P	NA	
ENSG00000180803	AL157366.1	NA	
ENSG00000242381	RN7SL741P	NA	
ENSG00000223158	RNY1P3	NA	
ENSG00000180730	SHISA2	NA	
ENSG00000231983	LINC00415	NA	
ENSG00000233963	ATP8A2P3	NA	
ENSG00000234706	PRUNEP1	NA	
ENSG00000127870	RNF6	133239	ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED;;ESCC, SUSCEPTIBILITY TO, INCLUDED;;AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO, INCLUDED;;GASTRIC CARDIA ADENOCARCINOMA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000277368	AL138966.2	NA	
ENSG00000271559	AL138966.1	NA	
ENSG00000227882	THAP12P6	NA	
ENSG00000132964	CDK8	618748	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES; IDDHBA
ENSG00000278413	AL159159.1	NA	
ENSG00000285929	AL353789.1	NA	
ENSG00000132970	WASF3	NA	
ENSG00000234031	RPS3AP44	NA	
ENSG00000237001	WASF3-AS1	NA	
ENSG00000285935	AL159978.1	NA	
ENSG00000132975	GPR12	NA	
ENSG00000230256	FGFR1OP2P1	NA	
ENSG00000283579	AL160035.1	NA	
ENSG00000223782	RPS21P8	NA	
ENSG00000218198	RPS20P32	NA	
ENSG00000152484	USP12	NA	
ENSG00000278496	AL158062.1	NA	
ENSG00000232162	USP12-AS1	NA	
ENSG00000230641	USP12-AS2	NA	
ENSG00000275294	LINC02340	NA	
ENSG00000234772	LINC00412	NA	
ENSG00000122026	RPL21	615885	HYPOTRICHOSIS 12; HYPT12
ENSG00000207500	SNORD102	NA	
ENSG00000207051	SNORA27	NA	
ENSG00000122035	RASL11A	NA	
ENSG00000252247	RNU6-70P	NA	
ENSG00000229609	LINC01079	NA	
ENSG00000201242	RNY1P1	NA	
ENSG00000122034	GTF3A	NA	
ENSG00000122033	MTIF3	NA	
ENSG00000252499	RNU6-63P	NA	
ENSG00000139517	LNX2	NA	
ENSG00000186184	POLR1D	613717	TREACHER COLLINS SYNDROME 2; TCS2
ENSG00000273552	AL136439.1	NA	
ENSG00000226703	NPM1P4	NA	
ENSG00000169840	GSX1	NA	
ENSG00000247381	PLUT	NA	
ENSG00000207330	RNU6-73P	NA	
ENSG00000139515	PDX1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000139515	PDX1	260370	PANCREATIC AGENESIS 1; PAGEN1;;PAGEN;;PANCREATIC HYPOPLASIA, CONGENITAL
ENSG00000139515	PDX1	606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM;;DIABETES MELLITUS, PERMANENT, OF INFANCY; PDMI DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED;;DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES, INCLUDED; DEND, INCLUDED
ENSG00000139515	PDX1	606392	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4;;MODY, TYPE 4
ENSG00000180389	ATP5F1EP2	NA	
ENSG00000260704	LINC00543	NA	
ENSG00000165556	CDX2	NA	
ENSG00000183463	URAD	NA	
ENSG00000242360	RN7SL272P	NA	
ENSG00000122025	FLT3	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000122025	FLT3	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMI /.../ELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000271026	KATNBL1P1	NA	
ENSG00000235115	CHCHD2P8	NA	
ENSG00000261485	PAN3-AS1	NA	
ENSG00000152520	PAN3	NA	
ENSG00000232587	EEF1A1P3	NA	
ENSG00000200840	RNU6-82P	NA	
ENSG00000102755	FLT1	NA	
ENSG00000279393	AL139005.1	NA	
ENSG00000235472	EIF4A1P7	NA	
ENSG00000273964	Y_RNA	NA	
ENSG00000132963	POMP	601952	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA; KLICK;;KLICK SYNDROME
ENSG00000132963	POMP	618048	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2
ENSG00000139508	SLC46A3	NA	
ENSG00000202237	RNU6-53P	NA	
ENSG00000233588	CYP51A1P2	NA	
ENSG00000277227	AL359741.1	NA	
ENSG00000236339	POM121L13P	NA	
ENSG00000132938	MTUS2	NA	
ENSG00000236758	MTUS2-AS2	NA	
ENSG00000223460	GAPDHP69	NA	
ENSG00000270680	AL596092.1	NA	
ENSG00000179141	MTUS2-AS1	NA	
ENSG00000139514	SLC7A1	NA	
ENSG00000122042	UBL3	NA	
ENSG00000278172	Metazoa_SRP	NA	
ENSG00000236258	TIMM8BP1	NA	
ENSG00000224329	LINC00297	NA	
ENSG00000224405	LINC00572	NA	
ENSG00000122043	LINC00544	NA	
ENSG00000266505	AL354674.1	NA	
ENSG00000224511	LINC00365	NA	
ENSG00000232117	LINC00384	NA	
ENSG00000232643	LINC00385	NA	
ENSG00000279499	AL157770.1	NA	
ENSG00000102781	KATNAL1	NA	
ENSG00000252928	RNU6-64P	NA	
ENSG00000215049	PRDX2P1	NA	
ENSG00000236463	LINC00427	NA	
ENSG00000238121	LINC00426	NA	
ENSG00000279149	AL356750.1	NA	
ENSG00000285773	AL161893.1	NA	
ENSG00000225039	LINC01058	NA	
ENSG00000236444	UBE2L5	NA	
ENSG00000189403	HMGB1	NA	
ENSG00000285840	AL353648.1	NA	
ENSG00000213411	RBM22P2	NA	
ENSG00000232489	MFAP1P1	NA	
ENSG00000224117	PTPN2P2	NA	
ENSG00000132952	USPL1	NA	
ENSG00000275788	Metazoa_SRP	NA	
ENSG00000132965	ALOX5AP	601367	STROKE, ISCHEMIC;;CEREBROVASCULAR ACCIDENT;;CEREBRAL INFARCTION
ENSG00000237879	LINC00398	NA	
ENSG00000236094	LINC00545	NA	
ENSG00000224743	TEX26-AS1	NA	
ENSG00000102802	MEDAG	NA	
ENSG00000175664	TEX26	NA	
ENSG00000238185	AL353680.1	NA	
ENSG00000230403	LINC01066	NA	
ENSG00000286286	AL158065.1	NA	
ENSG00000231894	WDR95P	NA	
ENSG00000120694	HSPH1	NA	
ENSG00000187676	B3GLCT	261540	PETERS-PLUS SYNDROME; PTRPLS;;KRAUSE-KIVLIN SYNDROME;;PETERS ANOMALY WITH SHORT-LIMB DWARFISM
ENSG00000229427	ANKRD26P4	NA	
ENSG00000278305	AL161616.2	NA	
ENSG00000277319	AL161616.1	NA	
ENSG00000133105	RXFP2	NA	
ENSG00000287904	AL138708.1	NA	
ENSG00000073910	FRY	NA	
ENSG00000229715	EEF1DP3	NA	
ENSG00000279314	AC002525.1	NA	
ENSG00000278732	Metazoa_SRP	NA	
ENSG00000237637	FRY-AS1	NA	
ENSG00000189167	ZAR1L	NA	
ENSG00000139618	BRCA2	176807	PROSTATE CANCER
ENSG00000139618	BRCA2	155255	MEDULLOBLASTOMA; MDB MEDULLOBLASTOMA, DESMOPLASTIC, INCLUDED;;MEDULLOBLASTOMA WITH EXTENSIVE NODULARITY, INCLUDED; MBEN, INCLUDED
ENSG00000139618	BRCA2	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000139618	BRCA2	194070	WILMS TUMOR 1; WT1;;NEPHROBLASTOMA
ENSG00000139618	BRCA2	605724	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1;;FAD1
ENSG00000139618	BRCA2	612555	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2 BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2, INCLUDED;;OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2, INCLUDED
ENSG00000139618	BRCA2	613029	GLIOMA SUSCEPTIBILITY 3; GLM3
ENSG00000139618	BRCA2	613347	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;;PNCA2
ENSG00000215515	IFIT1P1	NA	
ENSG00000139597	N4BP2L1	NA	
ENSG00000212293	AL137247.1	NA	
ENSG00000270008	AL137247.2	NA	
ENSG00000244754	N4BP2L2	NA	
ENSG00000229800	ATP8A2P2	NA	
ENSG00000281026	N4BP2L2-IT2	NA	
ENSG00000083642	PDS5B	NA	
ENSG00000207325	RNY1P4	NA	
ENSG00000277151	AL138820.1	NA	
ENSG00000226968	LINC00423	NA	
ENSG00000227604	TOMM22P3	NA	
ENSG00000133116	KL	617994	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3; HFTC3
ENSG00000133121	STARD13	NA	
ENSG00000230300	STARD13-IT1	NA	
ENSG00000236581	STARD13-AS	NA	
ENSG00000287274	AL627232.1	NA	
ENSG00000227911	LINC02344	NA	
ENSG00000285621	AL138999.2	NA	
ENSG00000277386	AL138999.1	NA	
ENSG00000230490	AL139383.1	NA	
ENSG00000234535	AL161719.1	NA	
ENSG00000232986	AL139081.1	NA	
ENSG00000286779	AL139081.2	NA	
ENSG00000133119	RFC3	NA	
ENSG00000252397	RNU5A-4P	NA	
ENSG00000276672	AL161891.1	NA	
ENSG00000280431	AL160394.2	NA	
ENSG00000227254	VDAC1P12	NA	
ENSG00000199196	AL160394.1	NA	
ENSG00000278477	AL356321.1	NA	
ENSG00000271850	LINC02343	NA	
ENSG00000225179	LINC00457	NA	
ENSG00000271901	AL161716.1	NA	
ENSG00000231910	GAMTP2	NA	
ENSG00000273886	Metazoa_SRP	NA	
ENSG00000261728	AL138690.1	NA	
ENSG00000172915	NBEA	NA	
ENSG00000232795	SCAND3P1	NA	
ENSG00000234835	PHBP13	NA	
ENSG00000180660	MAB21L1	618479	CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG
ENSG00000287650	AL390071.1	NA	
ENSG00000236036	LINC00445	NA	
ENSG00000133083	DCLK1	NA	
ENSG00000120669	SOHLH2	NA	
ENSG00000250709	CCDC169-SOHLH2	NA	
ENSG00000242715	CCDC169	NA	
ENSG00000207203	RNU6-71P	NA	
ENSG00000133104	SPART	275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE
ENSG00000120664	SPART-AS1	NA	
ENSG00000133101	CCNA1	NA	
ENSG00000223383	H2ACP1	NA	
ENSG00000180440	SERTM1	NA	
ENSG00000235306	GAPDHP34	NA	
ENSG00000223543	TCEAL4P1	NA	
ENSG00000215486	ARL2BPP3	NA	
ENSG00000271337	NDE1P2	NA	
ENSG00000133111	RFXAP	209920	BARE LYMPHOCYTE SYNDROME, TYPE II;;BLS, TYPE II;;BARE LYMPHOCYTE SYNDROME; BLS;;SEVERE COMBINED IMMUNODEFICIENCY, HLA CLASS II-NEGATIVE;;SCID, HLA CLASS II-NEGATIVE BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A, INCLUDED;;BARE LYMPHOCYT /.../ROME, TYPE II, COMPLEMENTATION GROUP B, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E, INCLUDED
ENSG00000120693	SMAD9	615342	PULMONARY HYPERTENSION, PRIMARY, 2; PPH2
ENSG00000236711	SMAD9-IT1	NA	
ENSG00000228825	LAMTOR3P1	NA	
ENSG00000232378	RPL29P28	NA	
ENSG00000226161	EIF4A1P5	NA	
ENSG00000120697	ALG5	NA	
ENSG00000120699	EXOSC8	616081	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C;;HYPOMYELINATION WITH SPINAL MUSCULAR ATROPHY AND CEREBELLAR HYPOPLASIA
ENSG00000102710	SUPT20H	NA	
ENSG00000180138	CSNK1A1L	NA	
ENSG00000274549	AL356274.1	NA	
ENSG00000279511	AL356274.2	NA	
ENSG00000202395	RN7SKP1	NA	
ENSG00000230283	RPS12P24	NA	
ENSG00000230390	LINC01048	NA	
ENSG00000275226	LINC00547	NA	
ENSG00000133110	POSTN	NA	
ENSG00000133107	TRPC4	NA	
ENSG00000199276	RNA5SP26	NA	
ENSG00000287477	AL356495.1	NA	
ENSG00000274317	LINC02334	NA	
ENSG00000228036	HSPD1P9	NA	
ENSG00000223685	LINC00571	NA	
ENSG00000120686	UFM1	617899	LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14
ENSG00000279025	AL356863.1	NA	
ENSG00000236354	LINC00437	NA	
ENSG00000229437	LINC00366	NA	
ENSG00000234701	PRDX3P3	NA	
ENSG00000150893	FREM2	123570	CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED; CRYPTOP;;ANKYLOBLEPHARON, SIMPLE;;CRYPTOPHTHALMOS WITH MICROPHTHALMIA AND PETERS ANOMALY
ENSG00000150893	FREM2	617666	FRASER SYNDROME 2; FRASRS2
ENSG00000252795	RNU6-56P	NA	
ENSG00000225350	FREM2-AS1	NA	
ENSG00000225221	PLA2G12AP2	NA	
ENSG00000235550	ANKRD26P2	NA	
ENSG00000133115	STOML3	NA	
ENSG00000120685	PROSER1	NA	
ENSG00000188811	NHLRC3	NA	
ENSG00000273507	AL354809.1	NA	
ENSG00000214823	NXT1P1	NA	
ENSG00000183722	LHFPL6	NA	
ENSG00000133103	COG6	614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L;;CDG IIl; CDGIIl
ENSG00000133103	COG6	615328	SHAHEEN SYNDROME; SHNS
ENSG00000264171	MIR4305	NA	
ENSG00000200526	RNY4P14	NA	
ENSG00000224351	CDKN2AIPNLP3	NA	
ENSG00000270444	AZU1P1	NA	
ENSG00000212553	SNORD116	NA	
ENSG00000215483	LINC00598	NA	
ENSG00000230710	LINC00332	NA	
ENSG00000271429	RPL17P51	NA	
ENSG00000207458	RNY3P9	NA	
ENSG00000252812	RN7SKP2	NA	
ENSG00000288542	AL133318.1	NA	
ENSG00000150907	FOXO1	268220	RHABDOMYOSARCOMA 2; RMS2;;RHABDOMYOSARCOMA, ALVEOLAR; RMSA
ENSG00000229456	RLIMP1	NA	
ENSG00000211491	MIR320D1	NA	
ENSG00000102738	MRPS31	NA	
ENSG00000277794	Metazoa_SRP	NA	
ENSG00000102743	SLC25A15	238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; HHHS;;HHH SYNDROME; HHH;;ORNITHINE TRANSLOCASE DEFICIENCY
ENSG00000207652	MIR621	NA	
ENSG00000168852	TPTE2P5	NA	
ENSG00000176268	CYCSP34	NA	
ENSG00000287837	AL590064.1	NA	
ENSG00000239827	SUGT1P3	NA	
ENSG00000120690	ELF1	NA	
ENSG00000229473	RGS17P1	NA	
ENSG00000120688	WBP4	NA	
ENSG00000264226	MIR3168	NA	
ENSG00000244264	RN7SL597P	NA	
ENSG00000165572	KBTBD6	NA	
ENSG00000278390	AL354696.2	NA	
ENSG00000215482	CALM2P3	NA	
ENSG00000120696	KBTBD7	NA	
ENSG00000225133	MORF4L1P4	NA	
ENSG00000120662	MTRF1	NA	
ENSG00000277662	AL354696.1	NA	
ENSG00000231404	RAC1P3	NA	
ENSG00000172766	NAA16	NA	
ENSG00000223280	RNU6-57P	NA	
ENSG00000214222	TUBBP2	NA	
ENSG00000205240	OR7E36P	NA	
ENSG00000234655	OR7E155P	NA	
ENSG00000215480	OR7E37P	NA	
ENSG00000102760	RGCC	NA	
ENSG00000288600	AL354833.2	NA	
ENSG00000288598	AL354833.1	NA	
ENSG00000102763	VWA8	NA	
ENSG00000284584	MIR5006	NA	
ENSG00000241406	RN7SL515P	NA	
ENSG00000206962	RNU6-74P	NA	
ENSG00000229696	KARS1P1	NA	
ENSG00000278338	VWA8-AS1	NA	
ENSG00000226093	RPS28P8	NA	
ENSG00000102780	DGKH	NA	
ENSG00000231530	AL157932.1	NA	
ENSG00000237263	MAPK6P3	NA	
ENSG00000270809	CHCHD2P11	NA	
ENSG00000234213	FHP1	NA	
ENSG00000023516	AKAP11	NA	
ENSG00000283554	LINC02341	NA	
ENSG00000233259	FABP3P2	NA	
ENSG00000120659	TNFSF11	259710	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM
ENSG00000179813	FAM216B	NA	
ENSG00000271216	LINC01050	NA	
ENSG00000229546	LINC00428	NA	
ENSG00000133106	EPSTI1	NA	
ENSG00000238025	ZDHHC4P1	NA	
ENSG00000120675	DNAJC15	NA	
ENSG00000229928	LINC00400	NA	
ENSG00000276569	AL138709.1	NA	
ENSG00000120658	ENOX1	NA	
ENSG00000232540	RPL36P19	NA	
ENSG00000238189	ENOX1-AS2	NA	
ENSG00000233821	ENOX1-AS1	NA	
ENSG00000287842	AL161714.1	NA	
ENSG00000287029	AL162713.2	NA	
ENSG00000270522	AL162713.1	NA	
ENSG00000151773	CCDC122	NA	
ENSG00000274001	AL512506.1	NA	
ENSG00000179630	LACC1	618795	JUVENILE ARTHRITIS; JUVAR
ENSG00000281883	AL512506.3	NA	
ENSG00000280060	AL512506.2	NA	
ENSG00000233725	NRAD1	NA	
ENSG00000179611	DGKZP1	NA	
ENSG00000226519	LINC00390	NA	
ENSG00000227258	SMIM2-AS1	NA	
ENSG00000139656	SMIM2	NA	
ENSG00000235285	SMIM2-IT1	NA	
ENSG00000276854	AL589745.2	NA	
ENSG00000276319	MIR8079	NA	
ENSG00000230731	AL589745.1	NA	
ENSG00000277831	AL138960.1	NA	
ENSG00000151778	SERP2	NA	
ENSG00000237361	TUSC8	NA	
ENSG00000102804	TSC22D1	NA	
ENSG00000280357	AL138960.2	NA	
ENSG00000225727	AL139184.1	NA	
ENSG00000278156	TSC22D1-AS1	NA	
ENSG00000230793	SMARCE1P5	NA	
ENSG00000237585	LINC00407	NA	
ENSG00000276527	AL356515.1	NA	
ENSG00000235097	LINC00330	NA	
ENSG00000083635	NUFIP1	NA	
ENSG00000223732	AL359706.1	NA	
ENSG00000133114	GPALPP1	NA	
ENSG00000265802	RN7SL49P	NA	
ENSG00000223341	RN7SKP3	NA	
ENSG00000188342	GTF2F2	NA	
ENSG00000271818	RN7SKP4	NA	
ENSG00000277358	AL138693.1	NA	
ENSG00000180332	KCTD4	NA	
ENSG00000270381	AL138963.2	NA	
ENSG00000133112	TPT1	NA	
ENSG00000253051	SNORA31B	NA	
ENSG00000199477	SNORA31	NA	
ENSG00000273149	AL138963.3	NA	
ENSG00000170919	TPT1-AS1	NA	
ENSG00000228886	AL138963.1	NA	
ENSG00000214455	RCN1P2	NA	
ENSG00000174032	SLC25A30	NA	
ENSG00000251015	SLC25A30-AS1	NA	
ENSG00000229303	PPIAP25	NA	
ENSG00000136152	COG3	NA	
ENSG00000165837	ERICH6B	NA	
ENSG00000200709	RNA5SP27	NA	
ENSG00000232786	TIMM9P3	NA	
ENSG00000228869	COX4I1P2	NA	
ENSG00000235366	LINC01055	NA	
ENSG00000237876	AKR1B1P4	NA	
ENSG00000174015	CBY2	NA	
ENSG00000274357	Metazoa_SRP	NA	
ENSG00000215475	SIAH3	NA	
ENSG00000123200	ZC3H13	NA	
ENSG00000235903	CPB2-AS1	NA	
ENSG00000080618	CPB2	NA	
ENSG00000136167	LCP1	NA	
ENSG00000240767	RN7SL288P	NA	
ENSG00000173988	LRRC63	NA	
ENSG00000252854	RN7SKP5	NA	
ENSG00000251106	ABITRAMP1	NA	
ENSG00000287863	AL139801.1	NA	
ENSG00000261097	LINC00563	NA	
ENSG00000102445	RUBCNL	NA	
ENSG00000223336	RNU2-6P	NA	
ENSG00000252385	RNU6-68P	NA	
ENSG00000241353	PPP1R2P4	NA	
ENSG00000231817	LINC01198	NA	
ENSG00000285576	AL138686.2	NA	
ENSG00000227019	OR7E101P	NA	
ENSG00000277228	AL138686.1	NA	
ENSG00000205105	COX17P1	NA	
ENSG00000230243	FKBP1AP3	NA	
ENSG00000136141	LRCH1	NA	
ENSG00000278462	AL359880.1	NA	
ENSG00000139684	ESD	NA	
ENSG00000102468	HTR2A	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000102468	HTR2A	164230	OBSESSIVE-COMPULSIVE DISORDER; OCD
ENSG00000102468	HTR2A	103780	ALCOHOL DEPENDENCE;;ALCOHOLISM ALCOHOL DEPENDENCE, PROTECTION AGAINST, INCLUDED;;AERODIGESTIVE TRACT CANCER, SQUAMOUS CELL, ALCOHOL-RELATED, PROTECTION AGAINST, INCLUDED
ENSG00000102468	HTR2A	606788	ANOREXIA NERVOSA, SUSCEPTIBILITY TO; ANON;;AN ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1, INCLUDED; ANON1, INCLUDED
ENSG00000102468	HTR2A	608516	MAJOR DEPRESSIVE DISORDER; MDD;;UNIPOLAR DEPRESSION SEASONAL AFFECTIVE DISORDER, INCLUDED; SAD, INCLUDED
ENSG00000224517	HTR2A-AS1	NA	
ENSG00000234590	GNG5P5	NA	
ENSG00000244521	RN7SL700P	NA	
ENSG00000136143	SUCLA2	612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5;;MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM, WITH OR WITHOUT METHYLMALONIC ACIDURIA, AUTOSOMAL RECESSIVE, SUCLA2-RELATED
ENSG00000234145	NAP1L4P3	NA	
ENSG00000229423	RPL27AP8	NA	
ENSG00000228573	AL138962.1	NA	
ENSG00000260388	LINC00562	NA	
ENSG00000287456	AL157369.1	NA	
ENSG00000227848	SUCLA2-AS1	NA	
ENSG00000136159	NUDT15	616903	THIOPURINES, POOR METABOLISM OF, 2; THPM2;;NUDT15 DEFICIENCY
ENSG00000276968	AL158196.1	NA	
ENSG00000136146	MED4	NA	
ENSG00000229111	MED4-AS1	NA	
ENSG00000224510	POLR2KP2	NA	
ENSG00000136156	ITM2B	176500	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1;;DEMENTIA, FAMILIAL BRITISH; FBD;;PRESENILE DEMENTIA WITH SPASTIC ATAXIA;;CEREBRAL AMYLOID ANGIOPATHY, BRITISH TYPE
ENSG00000136156	ITM2B	117300	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2;;DEMENTIA, FAMILIAL DANISH; FDD;;FAMILIAL DANISH DEMENTIA;;CEREBELLAR ATAXIA, CATARACT, DEAFNESS, AND DEMENTIA OR PSYCHOSIS;;HEREDOPATHIA OPHTHALMOOTOENCEPHALICA; HOOE
ENSG00000136156	ITM2B	616079	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA
ENSG00000231473	RB1-DT	NA	
ENSG00000139687	RB1	182280	SMALL CELL CANCER OF THE LUNG;;SCLC1;;SCLC; SCCL
ENSG00000139687	RB1	180200	RETINOBLASTOMA; RB1;;RB
ENSG00000139687	RB1	109800	BLADDER CANCER
ENSG00000139687	RB1	259500	OSTEOGENIC SARCOMA;;OSTEOSARCOMA; OSRC
ENSG00000238086	PPP1R26P1	NA	
ENSG00000177197	PCNPP5	NA	
ENSG00000277684	AL392048.1	NA	
ENSG00000139679	LPAR6	278150	HYPOTRICHOSIS 8; HYPT8;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 3; LAH3 WOOLLY HAIR, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT HYPOTRICHOSIS, INCLUDED; ARWH1, INCLUDED
ENSG00000277233	AL136960.1	NA	
ENSG00000136161	RCBTB2	NA	
ENSG00000287599	AL157813.2	NA	
ENSG00000274929	AL157813.1	NA	
ENSG00000233456	LINC01077	NA	
ENSG00000233610	LINC00462	NA	
ENSG00000152207	CYSLTR2	NA	
ENSG00000225131	PSME2P2	NA	
ENSG00000275202	AL161421.1	NA	
ENSG00000102531	FNDC3A	NA	
ENSG00000201662	RNU6-60P	NA	
ENSG00000223724	RAD17P2	NA	
ENSG00000199788	RNY3P2	NA	
ENSG00000235957	COX7CP1	NA	
ENSG00000231665	OGFOD1P1	NA	
ENSG00000102539	MLNR	NA	
ENSG00000274351	AL137000.1	NA	
ENSG00000102543	CDADC1	NA	
ENSG00000102547	CAB39L	NA	
ENSG00000136169	SETDB2	NA	
ENSG00000236577	SNRPGP14	NA	
ENSG00000136147	PHF11	NA	
ENSG00000136144	RCBTB1	617175	RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA
ENSG00000176882	AL135901.1	NA	
ENSG00000152213	ARL11	NA	
ENSG00000123179	EBPL	NA	
ENSG00000102753	KPNA3	NA	
ENSG00000276436	AL136301.1	NA	
ENSG00000222148	RNY4P30	NA	
ENSG00000181358	CTAGE10P	NA	
ENSG00000200064	RNY4P9	NA	
ENSG00000123178	SPRYD7	NA	
ENSG00000231607	DLEU2	NA	
ENSG00000204977	TRIM13	NA	
ENSG00000264864	MIR3613	NA	
ENSG00000198553	KCNRG	NA	
ENSG00000277913	AL137060.9	NA	
ENSG00000277066	AL137060.7	NA	
ENSG00000208006	MIR16-1	NA	
ENSG00000283785	MIR15A	NA	
ENSG00000274878	AL137060.4	NA	
ENSG00000273612	AL137060.2	NA	
ENSG00000277752	AL137060.8	NA	
ENSG00000275559	AL137060.5	NA	
ENSG00000176124	DLEU1	NA	
ENSG00000276089	AL137060.6	NA	
ENSG00000214359	RPL18P10	NA	
ENSG00000273541	AL137060.1	NA	
ENSG00000274270	AL137060.3	NA	
ENSG00000232150	ST13P4	NA	
ENSG00000223676	RPL34P26	NA	
ENSG00000286191	AL158195.1	NA	
ENSG00000186047	DLEU7	NA	
ENSG00000200711	RNA5SP28	NA	
ENSG00000233672	RNASEH2B-AS1	NA	
ENSG00000136104	RNASEH2B	610181	AICARDI-GOUTIERES SYNDROME 2; AGS2
ENSG00000123201	GUCY1B2	NA	
ENSG00000222920	RNA5SP29	NA	
ENSG00000226792	C13orf42	NA	
ENSG00000214878	RPL5P31	NA	
ENSG00000274652	AL157817.1	NA	
ENSG00000271242	PRELID3BP2	NA	
ENSG00000150510	FAM124A	NA	
ENSG00000253309	SERPINE3	NA	
ENSG00000266072	MIR5693	NA	
ENSG00000102786	INTS6	NA	
ENSG00000236778	INTS6-AS1	NA	
ENSG00000224892	RPS4XP16	NA	
ENSG00000243900	RN7SL320P	NA	
ENSG00000229906	SNRPGP11	NA	
ENSG00000266611	MIR4703	NA	
ENSG00000252141	RNU6-65P	NA	
ENSG00000139668	WDFY2	NA	
ENSG00000206920	RNY1P6	NA	
ENSG00000242893	RN7SL413P	NA	
ENSG00000224451	ATP5PBP1	NA	
ENSG00000285444	AL162377.3	NA	
ENSG00000102796	DHRS12	NA	
ENSG00000231856	AL162377.1	NA	
ENSG00000281106	TMEM272	NA	
ENSG00000123171	CCDC70	NA	
ENSG00000232872	CTAGE3P	NA	
ENSG00000279677	AL162377.2	NA	
ENSG00000123191	ATP7B	277900	WILSON DISEASE; WND;;WD;;HEPATOLENTICULAR DEGENERATION
ENSG00000236044	FABP5P2	NA	
ENSG00000253710	ALG11	613661	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P
ENSG00000253797	UTP14C	NA	
ENSG00000197168	NEK5	NA	
ENSG00000273523	AL139082.1	NA	
ENSG00000136098	NEK3	NA	
ENSG00000217576	AL158066.1	NA	
ENSG00000243406	MRPS31P5	NA	
ENSG00000285160	AL139082.2	NA	
ENSG00000285323	AL158066.2	NA	
ENSG00000272281	TPTE2P2	NA	
ENSG00000271564	LINC02333	NA	
ENSG00000136114	THSD1	618734	ANEURYSM, INTRACRANIAL BERRY, 12; ANIB12
ENSG00000199605	RNY4P24	NA	
ENSG00000136100	VPS36	NA	
ENSG00000278238	AL359513.1	NA	
ENSG00000136108	CKAP2	NA	
ENSG00000235660	LINC00345	NA	
ENSG00000244471	AL137058.1	NA	
ENSG00000280296	AL137058.3	NA	
ENSG00000273784	AL137058.2	NA	
ENSG00000250299	MRPS31P4	NA	
ENSG00000139675	HNRNPA1L2	NA	
ENSG00000273723	SUGT1-DT	NA	
ENSG00000165416	SUGT1	NA	
ENSG00000136110	CNMD	NA	
ENSG00000211579	MIR759	NA	
ENSG00000150276	PPIAP26	NA	
ENSG00000136099	PCDH8	NA	
ENSG00000102837	OLFM4	NA	
ENSG00000237092	LINC01065	NA	
ENSG00000279325	AL136359.1	NA	
ENSG00000225510	PCDH8P1	NA	
ENSG00000287722	AL356295.1	NA	
ENSG00000241613	RN7SL618P	NA	
ENSG00000287247	AL450423.2	NA	
ENSG00000273919	AL450423.1	NA	
ENSG00000274316	ZNF646P1	NA	
ENSG00000261517	LINC00558	NA	
ENSG00000234787	LINC00458	NA	
ENSG00000271652	AL356052.1	NA	
ENSG00000283126	MIR1297	NA	
ENSG00000136149	RPL13AP25	NA	
ENSG00000287460	AL442636.1	NA	
ENSG00000286537	AL512655.1	NA	
ENSG00000277047	AL390964.1	NA	
ENSG00000278630	LINC02335	NA	
ENSG00000275071	AL139038.1	NA	
ENSG00000264387	MIR5007	NA	
ENSG00000274090	AL354821.1	NA	
ENSG00000228611	HNF4GP1	NA	
ENSG00000286709	AL138997.1	NA	
ENSG00000228319	SPATA2P1	NA	
ENSG00000201665	RN7SKP6	NA	
ENSG00000204919	PRR20A	NA	
ENSG00000229665	PRR20C	NA	
ENSG00000204918	PRR20B	NA	
ENSG00000227151	PRR20D	NA	
ENSG00000234278	PRR20E	NA	
ENSG00000271140	PRR20FP	NA	
ENSG00000230009	MTCO2P3	NA	
ENSG00000234421	SLC25A5P4	NA	
ENSG00000225352	RPL31P53	NA	
ENSG00000118946	PCDH17	NA	
ENSG00000278722	AL445288.1	NA	
ENSG00000202422	RNA5SP30	NA	
ENSG00000277448	LINC02338	NA	
ENSG00000232954	LINC00374	NA	
ENSG00000276208	AL161423.1	NA	
ENSG00000222733	RNY4P29	NA	
ENSG00000214335	CTAGE16P	NA	
ENSG00000223717	DNAJA1P1	NA	
ENSG00000214281	HMGN2P39	NA	
ENSG00000232647	POLR3KP1	NA	
ENSG00000288015	AL159156.1	NA	
ENSG00000271190	RPP40P2	NA	
ENSG00000239003	RNU7-88P	NA	
ENSG00000139734	DIAPH3	609129	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1;;AUDITORY NEUROPATHY, NONSYNDROMIC DOMINANT; NSDAN
ENSG00000227528	DIAPH3-AS1	NA	
ENSG00000265745	RN7SL375P	NA	
ENSG00000223815	DIAPH3-AS2	NA	
ENSG00000202151	RNY4P28	NA	
ENSG00000227336	LINC00434	NA	
ENSG00000238213	TARDBPP2	NA	
ENSG00000277549	AL359920.1	NA	
ENSG00000083544	TDRD3	NA	
ENSG00000223076	RNA5SP31	NA	
ENSG00000225249	LINC00378	NA	
ENSG00000236608	EIF4A1P6	NA	
ENSG00000279657	AL161901.1	NA	
ENSG00000206854	RNY3P5	NA	
ENSG00000227510	LINC01442	NA	
ENSG00000266663	MIR3169	NA	
ENSG00000280165	PCDH20	NA	
ENSG00000197991	AL592490.1	NA	
ENSG00000279797	LINC02339	NA	
ENSG00000234033	RAC1P8	NA	
ENSG00000270856	AL353765.1	NA	
ENSG00000229578	LINC00358	NA	
ENSG00000230142	LINC01075	NA	
ENSG00000227611	LINC01074	NA	
ENSG00000229307	LINC00459	NA	
ENSG00000232105	RPL32P28	NA	
ENSG00000276586	AL356102.1	NA	
ENSG00000271465	SQSTM1P1	NA	
ENSG00000286469	AL445668.1	NA	
ENSG00000228669	LINC00448	NA	
ENSG00000273550	AL354810.1	NA	
ENSG00000227564	LINC00376	NA	
ENSG00000287996	AL359208.1	NA	
ENSG00000231061	LINC00395	NA	
ENSG00000274052	OR7E156P	NA	
ENSG00000285764	AL445989.2	NA	
ENSG00000237378	AL445989.1	NA	
ENSG00000202478	RNU6-81P	NA	
ENSG00000213232	PPP1R2P10	NA	
ENSG00000287128	AL445238.2	NA	
ENSG00000227674	LINC00355	NA	
ENSG00000219926	OR7E104P	NA	
ENSG00000285566	AL445238.1	NA	
ENSG00000237849	NFYAP1	NA	
ENSG00000214269	LGMNP1	NA	
ENSG00000214266	STARP1	NA	
ENSG00000236565	HNRNPA3P5	NA	
ENSG00000234767	LINC01052	NA	
ENSG00000286395	AL158038.1	NA	
ENSG00000263581	MIR548X2	NA	
ENSG00000263561	MIR4704	NA	
ENSG00000235737	TRIM60P19	NA	
ENSG00000184226	PCDH9	NA	
ENSG00000234527	PCDH9-AS1	NA	
ENSG00000238500	RNU7-87P	NA	
ENSG00000228842	PCDH9-AS2	NA	
ENSG00000225263	PCDH9-AS3	NA	
ENSG00000233840	PCDH9-AS4	NA	
ENSG00000285588	AL160254.1	NA	
ENSG00000214263	RPSAP53	NA	
ENSG00000230040	LINC00364	NA	
ENSG00000287876	AL512452.1	NA	
ENSG00000271287	BCRP9	NA	
ENSG00000227969	NPM1P22	NA	
ENSG00000231667	OR7E111P	NA	
ENSG00000226537	OR7E33P	NA	
ENSG00000286820	AL590027.1	NA	
ENSG00000234765	ELL2P3	NA	
ENSG00000229910	HNRNPA1P18	NA	
ENSG00000236433	RPL37P21	NA	
ENSG00000230405	RPS3AP52	NA	
ENSG00000229824	RPL12P34	NA	
ENSG00000243671	RN7SL761P	NA	
ENSG00000281778	LINC00550	NA	
ENSG00000280580	LINC02342	NA	
ENSG00000232380	ZDHHC20P4	NA	
ENSG00000225501	SNRPFP3	NA	
ENSG00000235221	LINC00383	NA	
ENSG00000224640	SRSF1P1	NA	
ENSG00000150361	KLHL1	NA	
ENSG00000207495	RNY3P10	NA	
ENSG00000232314	PSMC1P13	NA	
ENSG00000230223	ATXN8OS	NA	
ENSG00000288330	AL160391.1	NA	
ENSG00000202433	RNU6-54P	NA	
ENSG00000276841	AL445264.1	NA	
ENSG00000226554	MTCL1P1	NA	
ENSG00000226846	LINC00348	NA	
ENSG00000225801	RABEPKP1	NA	
ENSG00000276644	DACH1	NA	
ENSG00000236534	H3P36	NA	
ENSG00000237816	RPL21P109	NA	
ENSG00000233460	RPL35AP31	NA	
ENSG00000232881	RPS10P21	NA	
ENSG00000212377	AL139003.1	NA	
ENSG00000227952	RPL18AP17	NA	
ENSG00000251715	AL139003.2	NA	
ENSG00000278113	AL356754.2	NA	
ENSG00000199282	AL356754.1	NA	
ENSG00000226617	RPL21P110	NA	
ENSG00000206922	RNU6-80P	NA	
ENSG00000204899	MZT1	NA	
ENSG00000136122	BORA	NA	
ENSG00000083520	DIS3	NA	
ENSG00000083535	PIBF1	617767	JOUBERT SYNDROME 33; JBTS33
ENSG00000199381	RNU6-79P	NA	
ENSG00000232041	PSMD10P3	NA	
ENSG00000102554	KLF5	NA	
ENSG00000236972	FABP5P1	NA	
ENSG00000200267	RNU6-66P	NA	
ENSG00000201253	RNU4-10P	NA	
ENSG00000206697	RNY1P8	NA	
ENSG00000279754	AL162376.1	NA	
ENSG00000229708	MARK2P12	NA	
ENSG00000224853	LINC00393	NA	
ENSG00000228295	LINC00392	NA	
ENSG00000118922	KLF12	NA	
ENSG00000280348	AL138713.1	NA	
ENSG00000279463	AL159972.1	NA	
ENSG00000235532	LINC00402	NA	
ENSG00000286330	AL353660.1	NA	
ENSG00000206617	RNY1P5	NA	
ENSG00000232701	RPL21P108	NA	
ENSG00000177596	AL355390.1	NA	
ENSG00000226240	LINC00381	NA	
ENSG00000281167	AL355390.2	NA	
ENSG00000236678	LINC00347	NA	
ENSG00000225944	RIOK3P1	NA	
ENSG00000206812	RNU6-38P	NA	
ENSG00000226665	SSR1P2	NA	
ENSG00000214249	CTAGE11P	NA	
ENSG00000223880	LINC01078	NA	
ENSG00000136111	TBC1D4	616087	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5; NIDDM5
ENSG00000225203	AL139230.1	NA	
ENSG00000188243	COMMD6	NA	
ENSG00000118939	UCHL3	NA	
ENSG00000261553	AL137782.1	NA	
ENSG00000261105	LMO7-AS1	NA	
ENSG00000136153	LMO7	NA	
ENSG00000228444	AL137244.1	NA	
ENSG00000230902	FAM204CP	NA	
ENSG00000178734	LMO7DN	NA	
ENSG00000223458	LMO7DN-IT1	NA	
ENSG00000261206	LINC00561	NA	
ENSG00000224933	LINC01034	NA	
ENSG00000243274	RN7SL571P	NA	
ENSG00000285572	AL136441.1	NA	
ENSG00000287018	AL161717.1	NA	
ENSG00000284809	AL365394.1	NA	
ENSG00000178695	KCTD12	NA	
ENSG00000278727	AC000403.1	NA	
ENSG00000118903	BTF3P11	NA	
ENSG00000102794	ACOD1	NA	
ENSG00000233873	RPL7P44	NA	
ENSG00000228002	DHX9P1	NA	
ENSG00000102805	CLN5	256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSET  NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED
ENSG00000283208	AC001226.2	NA	
ENSG00000005812	FBXL3	606220	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS;;MENTAL RETARDATION, SHORT STATURE, FACIAL ANOMALIES, AND JOINT DISLOCATIONS
ENSG00000236051	MYCBP2-AS1	NA	
ENSG00000274898	AC001226.1	NA	
ENSG00000005810	MYCBP2	NA	
ENSG00000229521	MYCBP2-AS2	NA	
ENSG00000285714	AL159158.1	NA	
ENSG00000136155	SCEL	NA	
ENSG00000287270	AL137140.1	NA	
ENSG00000224347	SCEL-AS1	NA	
ENSG00000206800	RNY3P7	NA	
ENSG00000227922	SPTLC1P5	NA	
ENSG00000285746	AL450447.1	NA	
ENSG00000139737	SLAIN1	NA	
ENSG00000266325	MIR3665	NA	
ENSG00000225579	EDNRB-AS1	NA	
ENSG00000136160	EDNRB	277580	WAARDENBURG SYNDROME, TYPE 4A; WS4A;;WAARDENBURG SYNDROME, TYPE IVA;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4A;;WAARDENBURG-SHAH SYNDROME;;SHAH-WAARDENBURG SYNDROME;;WS4
ENSG00000136160	EDNRB	600155	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2
ENSG00000136160	EDNRB	600501	ABCD SYNDROME; ABCDS;;ALBINISM, BLACK LOCK, CELL MIGRATION DISORDER OF THE NEUROCYTES OF THE GUT, AND DEAFNESS
ENSG00000234377	OBI1-AS1	NA	
ENSG00000233379	AL139002.1	NA	
ENSG00000243035	RN7SL810P	NA	
ENSG00000236133	LINC01069	NA	
ENSG00000229249	LINC00446	NA	
ENSG00000235625	AL138957.1	NA	
ENSG00000271386	SRGNP1	NA	
ENSG00000200686	RNY3P3	NA	
ENSG00000229865	RPL31P54	NA	
ENSG00000224686	ELOCP23	NA	
ENSG00000271776	AL445209.1	NA	
ENSG00000152192	POU4F1	NA	
ENSG00000152193	OBI1	NA	
ENSG00000237109	RPL21P111	NA	
ENSG00000225427	LINC00331	NA	
ENSG00000215357	HSPD1P8	NA	
ENSG00000230584	CCT5P2	NA	
ENSG00000236277	NIPA2P5	NA	
ENSG00000226670	BCAS2P3	NA	
ENSG00000139746	RBM26	NA	
ENSG00000252496	RNA5SP33	NA	
ENSG00000227354	RBM26-AS1	NA	
ENSG00000232132	NDFIP2-AS1	NA	
ENSG00000102471	NDFIP2	NA	
ENSG00000227676	LINC01068	NA	
ENSG00000285902	AL136442.1	NA	
ENSG00000229011	LINC01038	NA	
ENSG00000229175	LINC00382	NA	
ENSG00000284196	AL158064.1	NA	
ENSG00000281721	LINC01080	NA	
ENSG00000285684	AL137781.1	NA	
ENSG00000136158	SPRY2	616818	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3; IGAN3
ENSG00000202398	RNU6-61P	NA	
ENSG00000227862	HNRNPA1P31	NA	
ENSG00000226683	PWWP2AP1	NA	
ENSG00000286746	AL590807.1	NA	
ENSG00000231222	ARF4P4	NA	
ENSG00000229246	LINC00377	NA	
ENSG00000270415	DPPA3P3	NA	
ENSG00000260094	LINC00564	NA	
ENSG00000229309	AL353633.1	NA	
ENSG00000222486	RNU6-77P	NA	
ENSG00000237148	HIGD1AP2	NA	
ENSG00000214182	PTMAP5	NA	
ENSG00000286385	AL445255.1	NA	
ENSG00000237099	GYG1P2	NA	
ENSG00000270400	AL512782.1	NA	
ENSG00000222791	RNU6-67P	NA	
ENSG00000286446	AL353688.1	NA	
ENSG00000178235	SLITRK1	137580	GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDER CHRONIC MOTOR TICS, INCLUDED
ENSG00000178235	SLITRK1	613229	TRICHOTILLOMANIA; TTM
ENSG00000285680	AL355481.1	NA	
ENSG00000215037	VENTXP2	NA	
ENSG00000286284	AL590681.1	NA	
ENSG00000224188	UBE2D3P4	NA	
ENSG00000285742	AL445604.1	NA	
ENSG00000288016	AL162493.1	NA	
ENSG00000228597	MTND4P1	NA	
ENSG00000232447	MTND5P3	NA	
ENSG00000233349	LINC00333	NA	
ENSG00000288038	AL445588.1	NA	
ENSG00000287438	AL356313.1	NA	
ENSG00000226370	LINC00375	NA	
ENSG00000286906	AL160154.1	NA	
ENSG00000226317	LINC00351	NA	
ENSG00000285834	AL356413.1	NA	
ENSG00000184564	SLITRK6	221200	DEAFNESS AND MYOPIA; DFNMYP
ENSG00000278580	AL162373.1	NA	
ENSG00000228241	MOB1AP1	NA	
ENSG00000232252	AL354994.1	NA	
ENSG00000283371	FO624990.1	NA	
ENSG00000277914	DDX6P2	NA	
ENSG00000287880	AL445207.1	NA	
ENSG00000231879	TXNL1P1	NA	
ENSG00000233528	LINC00430	NA	
ENSG00000228074	UBBP5	NA	
ENSG00000228473	LIN28AP2	NA	
ENSG00000285699	AL360267.2	NA	
ENSG00000232636	AL360267.1	NA	
ENSG00000228824	MIR4500HG	NA	
ENSG00000272515	AL355578.1	NA	
ENSG00000266052	MIR4500	NA	
ENSG00000165300	SLITRK5	NA	
ENSG00000277640	AL445647.2	NA	
ENSG00000223404	LINC00397	NA	
ENSG00000272046	AL445647.1	NA	
ENSG00000232204	TET1P1	NA	
ENSG00000231019	LINC00373	NA	
ENSG00000225289	RPL29P29	NA	
ENSG00000285811	AL355677.1	NA	
ENSG00000229443	LINC00433	NA	
ENSG00000286422	AL445984.2	NA	
ENSG00000283130	AL445984.1	NA	
ENSG00000261666	LINC00560	NA	
ENSG00000233211	GRPEL2P1	NA	
ENSG00000288552	AL162573.1	NA	
ENSG00000234660	LINC00440	NA	
ENSG00000232225	LINC01047	NA	
ENSG00000227247	TRIM60P13	NA	
ENSG00000225530	SP3P	NA	
ENSG00000271395	LINC02336	NA	
ENSG00000226037	LINC01040	NA	
ENSG00000236176	LINC00353	NA	
ENSG00000234227	RPL7L1P1	NA	
ENSG00000200733	AL355821.1	NA	
ENSG00000215418	PEX12P1	NA	
ENSG00000261446	LINC00559	NA	
ENSG00000252696	RNA5SP34	NA	
ENSG00000235879	FAR1P1	NA	
ENSG00000224419	KRT18P27	NA	
ENSG00000283783	MIR622	NA	
ENSG00000234384	LINC01049	NA	
ENSG00000251753	RNU6-75P	NA	
ENSG00000231674	LINC00410	NA	
ENSG00000227983	BRK1P2	NA	
ENSG00000234625	LINC00380	NA	
ENSG00000229557	LINC00379	NA	
ENSG00000214178	PPIAP23	NA	
ENSG00000215417	MIR17HG	614326	FEINGOLD SYNDROME 2; FGLDS2;;BRACHYDACTYLY WITH SHORT STATURE AND MICROCEPHALY
ENSG00000284536	MIR17	NA	
ENSG00000283815	MIR18A	NA	
ENSG00000284204	MIR19A	NA	
ENSG00000283762	MIR20A	NA	
ENSG00000284375	MIR19B1	NA	
ENSG00000283705	MIR92A1	NA	
ENSG00000179399	GPC5	NA	
ENSG00000282864	AL356118.1	NA	
ENSG00000282997	AL162456.1	NA	
ENSG00000252508	RNU4ATAC3P	NA	
ENSG00000229287	FABP5P4	NA	
ENSG00000282865	AL157815.1	NA	
ENSG00000232885	GPC5-AS2	NA	
ENSG00000283097	AL159152.1	NA	
ENSG00000236240	GPC5-IT1	NA	
ENSG00000263741	MIR548AS	NA	
ENSG00000287159	AL356737.2	NA	
ENSG00000282993	AL356737.1	NA	
ENSG00000235984	GPC5-AS1	NA	
ENSG00000232849	LINC00363	NA	
ENSG00000288001	AL354811.2	NA	
ENSG00000278177	AL354811.1	NA	
ENSG00000183098	GPC6	258315	OMODYSPLASIA 1; OMOD1;;OMODYSPLASIA, GENERALIZED FORM;;OMODYSPLASIA, AUTOSOMAL RECESSIVE;;MICROMELIC DYSPLASIA, CONGENITAL, WITH DISLOCATION OF RADIUS
ENSG00000286843	AL160159.1	NA	
ENSG00000235784	HNRNPA1P29	NA	
ENSG00000224394	GPC6-AS2	NA	
ENSG00000212559	RNA5SP35	NA	
ENSG00000236520	GPC6-AS1	NA	
ENSG00000080166	DCT	NA	
ENSG00000088451	TGDS	616145	CATEL-MANZKE SYNDROME; CATMANS;;HYPERPHALANGY-CLINODACTYLY OF INDEX FINGER WITH PIERRE ROBIN SYNDROME;;PIERRE ROBIN SYNDROME WITH HYPERPHALANGY AND CLINODACTYLY;;INDEX FINGER ANOMALY WITH PIERRE ROBIN SYNDROME;;PALATODIGITAL SYNDROME, CATEL-MANZKE T /.../ICROGNATHIA DIGITAL SYNDROME
ENSG00000152749	GPR180	NA	
ENSG00000222129	RNA5SP36	NA	
ENSG00000238230	LINC00391	NA	
ENSG00000274168	RN7SL585P	NA	
ENSG00000227640	SOX21-AS1	NA	
ENSG00000125285	SOX21	NA	
ENSG00000235768	BRD7P5	NA	
ENSG00000237924	RPL21P112	NA	
ENSG00000260962	LINC00557	NA	
ENSG00000287635	AL139381.1	NA	
ENSG00000252335	RNU6-62P	NA	
ENSG00000125257	ABCC4	NA	
ENSG00000223298	RNY3P8	NA	
ENSG00000200211	RNY4P27	NA	
ENSG00000271492	MEMO1P5	NA	
ENSG00000134873	CLDN10	617671	HELIX SYNDROME; HELIX;;HYPOHIDROSIS, ELECTROLYTE IMBALANCE, LACRIMAL GLAND DYSFUNCTION, ICHTHYOSIS, AND XEROSTOMIA
ENSG00000223392	CLDN10-AS1	NA	
ENSG00000134874	DZIP1	NA	
ENSG00000247400	DNAJC3-DT	NA	
ENSG00000102580	DNAJC3	616192	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD
ENSG00000229622	MTND5P2	NA	
ENSG00000227714	MTND6P18	NA	
ENSG00000232373	MTCYBP3	NA	
ENSG00000276809	AL138955.1	NA	
ENSG00000102595	UGGT2	NA	
ENSG00000226977	HMGN1P24	NA	
ENSG00000185352	HS6ST3	NA	
ENSG00000242614	RN7SL164P	NA	
ENSG00000283487	MIR4501	NA	
ENSG00000233273	AMMECR1LP1	NA	
ENSG00000235137	HSP90AB6P	NA	
ENSG00000234267	TULP3P1	NA	
ENSG00000272329	AL353581.1	NA	
ENSG00000222472	RN7SKP7	NA	
ENSG00000165621	OXGR1	NA	
ENSG00000233124	LINC00456	NA	
ENSG00000139793	MBNL2	NA	
ENSG00000286334	AL161430.1	NA	
ENSG00000202290	RNA5SP37	NA	
ENSG00000286416	AL442067.3	NA	
ENSG00000125249	RAP2A	NA	
ENSG00000276573	AL442067.1	NA	
ENSG00000276704	AL442067.2	NA	
ENSG00000271625	PSMA6P4	NA	
ENSG00000226134	AL359502.1	NA	
ENSG00000286544	AL359502.2	NA	
ENSG00000233291	RPL7AP61	NA	
ENSG00000270725	AL356580.1	NA	
ENSG00000065150	IPO5	NA	
ENSG00000232217	FTLP8	NA	
ENSG00000152767	FARP1	NA	
ENSG00000139797	RNF113B	NA	
ENSG00000222969	RN7SKP8	NA	
ENSG00000263399	MIR3170	NA	
ENSG00000269189	AL445223.1	NA	
ENSG00000269599	AL161896.1	NA	
ENSG00000231194	FARP1-AS1	NA	
ENSG00000102572	STK24	NA	
ENSG00000271437	AL356423.1	NA	
ENSG00000224418	STK24-AS1	NA	
ENSG00000217686	NUS1P4	NA	
ENSG00000233549	CYCSP35	NA	
ENSG00000233662	CALM2P4	NA	
ENSG00000243366	RN7SL60P	NA	
ENSG00000088386	SLC15A1	NA	
ENSG00000088387	DOCK9	NA	
ENSG00000229918	DOCK9-AS1	NA	
ENSG00000275919	AL161420.1	NA	
ENSG00000231981	RPL7L1P12	NA	
ENSG00000207298	RNU6-83P	NA	
ENSG00000260992	DOCK9-DT	NA	
ENSG00000230871	RPS6P23	NA	
ENSG00000228889	UBAC2-AS1	NA	
ENSG00000234005	GAPDHP22	NA	
ENSG00000134882	UBAC2	NA	
ENSG00000201793	RN7SKP9	NA	
ENSG00000218502	H2AZP3	NA	
ENSG00000125245	GPR18	NA	
ENSG00000169508	GPR183	NA	
ENSG00000207719	MIR623	NA	
ENSG00000228808	HMGB3P4	NA	
ENSG00000238241	CCR12P	NA	
ENSG00000285448	AL136961.1	NA	
ENSG00000125304	TM9SF2	NA	
ENSG00000280734	LINC01232	NA	
ENSG00000280710	AL139035.1	NA	
ENSG00000203441	LINC00449	NA	
ENSG00000234168	LINC01039	NA	
ENSG00000234239	CFL1P8	NA	
ENSG00000287746	AL139035.2	NA	
ENSG00000125246	CLYBL	NA	
ENSG00000263615	MIR4306	NA	
ENSG00000227659	CLYBL-AS2	NA	
ENSG00000234303	CLYBL-AS1	NA	
ENSG00000201245	AL137139.1	NA	
ENSG00000288581	AL137139.3	NA	
ENSG00000286757	AL137139.2	NA	
ENSG00000139800	ZIC5	NA	
ENSG00000288060	AL355338.1	NA	
ENSG00000043355	ZIC2	609637	HOLOPROSENCEPHALY 5; HPE5
ENSG00000260738	LINC00554	NA	
ENSG00000225999	NDUFA12P1	NA	
ENSG00000274605	PCCA-DT	NA	
ENSG00000236554	ASNSP3	NA	
ENSG00000175198	PCCA	606054	PROPIONIC ACIDEMIA;;PROPIONYL-CoA CARBOXYLASE DEFICIENCY;;PCC DEFICIENCY;;GLYCINEMIA, KETOTIC;;HYPERGLYCINEMIA WITH KETOACIDOSIS AND LEUKOPENIA;;KETOTIC HYPERGLYCINEMIA
ENSG00000228501	RPL15P18	NA	
ENSG00000270632	AL356575.1	NA	
ENSG00000287330	AL353697.1	NA	
ENSG00000234650	PCCA-AS1	NA	
ENSG00000134864	GGACT	NA	
ENSG00000224356	AL356966.1	NA	
ENSG00000280169	AL136526.1	NA	
ENSG00000234354	RPS26P47	NA	
ENSG00000125247	TMTC4	NA	
ENSG00000237082	COX5BP6	NA	
ENSG00000233009	NALCN-AS1	NA	
ENSG00000214051	ARF4P3	NA	
ENSG00000229599	LINC00411	NA	
ENSG00000102452	NALCN	615419	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1;;IHPRF
ENSG00000102452	NALCN	616266	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD
ENSG00000198542	ITGBL1	NA	
ENSG00000102466	FGF14	609307	SPINOCEREBELLAR ATAXIA 27; SCA27;;CEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, FGF14-RELATED
ENSG00000276012	AL160153.1	NA	
ENSG00000201155	RNU1-24P	NA	
ENSG00000215399	HMGB3P7	NA	
ENSG00000265164	MIR2681	NA	
ENSG00000229975	LIPT1P1	NA	
ENSG00000201690	RNY1P2	NA	
ENSG00000264482	MIR4705	NA	
ENSG00000236860	RPL39P29	NA	
ENSG00000243319	FGF14-IT1	NA	
ENSG00000279702	AL356266.1	NA	
ENSG00000234445	FGF14-AS1	NA	
ENSG00000272143	FGF14-AS2	NA	
ENSG00000261057	LINC00555	NA	
ENSG00000276957	AL158063.1	NA	
ENSG00000134900	TPP2	NA	
ENSG00000139780	METTL21C	NA	
ENSG00000175820	CCDC168	NA	
ENSG00000231633	LINC00283	NA	
ENSG00000286312	AL157769.1	NA	
ENSG00000151287	TEX30	NA	
ENSG00000134901	POGLUT2	NA	
ENSG00000270181	BIVM-ERCC5	NA	
ENSG00000134897	BIVM	NA	
ENSG00000134899	ERCC5	278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG;;XP, GROUP G; XPGC;;XERODERMA PIGMENTOSUM VII; XP7 XERODERMA PIGMENTOSUM, TYPE G/COCKAYNE SYNDROME, INCLUDED; XPG/CS, INCLUDED
ENSG00000134899	ERCC5	616570	CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3
ENSG00000250878	METTL21EP	NA	
ENSG00000272542	AL137246.1	NA	
ENSG00000278445	AL137246.2	NA	
ENSG00000125255	SLC10A2	613291	BILE ACID MALABSORPTION, PRIMARY; PBAM
ENSG00000285789	AL162717.1	NA	
ENSG00000234551	LINC01309	NA	
ENSG00000230474	ATP6V1G1P7	NA	
ENSG00000287734	AL136524.1	NA	
ENSG00000225823	RPL7P45	NA	
ENSG00000286929	AL138954.1	NA	
ENSG00000232307	DAOA-AS1	NA	
ENSG00000275968	AL359751.2	NA	
ENSG00000275502	AL359751.1	NA	
ENSG00000182346	DAOA	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000280455	AL359745.1	NA	
ENSG00000226620	LINC00343	NA	
ENSG00000252550	AL138701.1	NA	
ENSG00000287923	AL138701.2	NA	
ENSG00000222682	RNA5SP38	NA	
ENSG00000286780	AL139379.1	NA	
ENSG00000233532	LINC00460	NA	
ENSG00000174418	RPL35P9	NA	
ENSG00000125266	EFNB2	NA	
ENSG00000284966	AL138689.2	NA	
ENSG00000274204	AL138689.1	NA	
ENSG00000134884	ARGLU1	NA	
ENSG00000272274	LINC00551	NA	
ENSG00000230156	LINC00443	NA	
ENSG00000227590	ATP5MC1P5	NA	
ENSG00000287546	AL163534.1	NA	
ENSG00000278698	AL162574.2	NA	
ENSG00000174408	PPIAP24	NA	
ENSG00000277863	AL162574.1	NA	
ENSG00000279157	AL162574.3	NA	
ENSG00000285643	AL354741.1	NA	
ENSG00000204442	FAM155A	NA	
ENSG00000201847	SNORD31B	NA	
ENSG00000276740	AL445649.1	NA	
ENSG00000221650	MIR1267	NA	
ENSG00000227248	FAM155A-IT1	NA	
ENSG00000286343	AL359436.1	NA	
ENSG00000274718	AL136964.1	NA	
ENSG00000174405	LIG4	254500	MYELOMA, MULTIPLE AMYLOIDOSIS, SYSTEMIC, INCLUDED; AL, INCLUDED;;AL AMYLOIDOSIS, INCLUDED
ENSG00000174405	LIG4	606593	LIG4 SYNDROME
ENSG00000139826	ABHD13	NA	
ENSG00000102524	TNFSF13B	NA	
ENSG00000277246	AL157762.1	NA	
ENSG00000223177	RNA5SP39	NA	
ENSG00000283384	AL138694.1	NA	
ENSG00000232087	HCFC2P1	NA	
ENSG00000041515	MYO16	NA	
ENSG00000229938	MYO16-AS2	NA	
ENSG00000236242	MYO16-AS1	NA	
ENSG00000275216	AL161431.1	NA	
ENSG00000223617	LINC00370	NA	
ENSG00000236053	LINC01067	NA	
ENSG00000229792	LINC00399	NA	
ENSG00000285534	AL163541.1	NA	
ENSG00000234854	LINC00676	NA	
ENSG00000185950	IRS2	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000275741	AL162497.1	NA	
ENSG00000275248	AL355810.1	NA	
ENSG00000201161	RN7SKP10	NA	
ENSG00000274331	AL355974.1	NA	
ENSG00000275830	AL390755.1	NA	
ENSG00000276269	AL355974.2	NA	
ENSG00000231428	LINC00396	NA	
ENSG00000265885	RN7SL783P	NA	
ENSG00000279965	AL390755.2	NA	
ENSG00000287575	AL390755.3	NA	
ENSG00000187498	COL4A1	180000	RETINAL ARTERIES, TORTUOSITY OF; RATOR;;RETINAL HEMORRHAGE WITH VASCULAR TORTUOSITY
ENSG00000187498	COL4A1	175780	BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1;;HEMIPLEGIA, INFANTILE, WITH PORENCEPHALY;;BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE;;RETINAL ARTERIOLAR TORTUOSITY, INFANTILE HEMIPARESIS, AND LEUKOENCEPHALOPATHY, AUTOSOMAL DOMI /.../BRAIN SMALL VESSEL DISEASE WITH AXENFELD-RIEGER ANOMALY;;LEUKOENCEPHALOPATHY WITH AXENFELD-RIEGER ANOMALY;;PORENCEPHALY, TYPE 1, FORMERLY; T1P, FORMERLY;;PORENCEPHALY, TYPE 1, AUTOSOMAL DOMINANT, FORMERLY; ADT1P, FORMERLY;;PORENCEPHALY 1, FORMERLY; POREN1, FORMERLY
ENSG00000187498	COL4A1	611773	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC
ENSG00000187498	COL4A1	614519	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH;;STROKE, HEMORRHAGIC, SUSCEPTIBILITY TO
ENSG00000187498	COL4A1	618564	MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL;;DEMENTIA, HEREDITARY MULTI-INFARCT, SWEDISH TYPE
ENSG00000279237	AL161773.1	NA	
ENSG00000134871	COL4A2	614483	BRAIN SMALL VESSEL DISEASE 2; BSVD2;;PORENCEPHALY 2, FORMERLY; POREN2, FORMERLY
ENSG00000134871	COL4A2	614519	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH;;STROKE, HEMORRHAGIC, SUSCEPTIBILITY TO
ENSG00000276765	MIR8073	NA	
ENSG00000224821	COL4A2-AS2	NA	
ENSG00000232814	COL4A2-AS1	NA	
ENSG00000139832	RAB20	NA	
ENSG00000275880	AL139385.1	NA	
ENSG00000213995	NAXD	618321	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2
ENSG00000134905	CARS2	616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27
ENSG00000153487	ING1	275355	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC
ENSG00000225239	RPL21P107	NA	
ENSG00000259831	LINC00567	NA	
ENSG00000255874	PRECSIT	NA	
ENSG00000088448	ANKRD10	NA	
ENSG00000229152	ANKRD10-IT1	NA	
ENSG00000277767	AL442128.2	NA	
ENSG00000227105	PARP1P1	NA	
ENSG00000275989	AL442128.1	NA	
ENSG00000225760	LINC00431	NA	
ENSG00000225870	LINC00368	NA	
ENSG00000286824	AL353704.2	NA	
ENSG00000235875	ARHGEF7-AS2	NA	
ENSG00000102606	ARHGEF7	NA	
ENSG00000233644	ARHGEF7-IT1	NA	
ENSG00000227352	ARHGEF7-AS1	NA	
ENSG00000285856	AL353704.1	NA	
ENSG00000274614	AL390754.1	NA	
ENSG00000153495	TEX29	NA	
ENSG00000204398	AL359649.1	NA	
ENSG00000215881	LINC02337	NA	
ENSG00000226903	LINC00354	NA	
ENSG00000200072	AL138691.1	NA	
ENSG00000224243	SOX1-OT	NA	
ENSG00000182968	SOX1	NA	
ENSG00000260385	AL356961.1	NA	
ENSG00000229520	LINC00404	NA	
ENSG00000260102	LINC01070	NA	
ENSG00000260343	LINC01043	NA	
ENSG00000223626	LINC01044	NA	
ENSG00000153498	SPACA7	NA	
ENSG00000126216	TUBGCP3	NA	
ENSG00000277159	AL139384.2	NA	
ENSG00000197595	ATP11AUN	NA	
ENSG00000274922	AL139384.1	NA	
ENSG00000068650	ATP11A	NA	
ENSG00000232684	ATP11A-AS1	NA	
ENSG00000277545	AL356752.1	NA	
ENSG00000126217	MCF2L	NA	
ENSG00000267868	AL356740.1	NA	
ENSG00000235280	MCF2L-AS1	NA	
ENSG00000269356	AL356740.2	NA	
ENSG00000269376	AL356740.3	NA	
ENSG00000057593	F7	227500	FACTOR VII DEFICIENCY;;F7 DEFICIENCY;;HYPOPROCONVERTINEMIA
ENSG00000057593	F7	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000126218	F10	227600	FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY
ENSG00000231882	F10-AS1	NA	
ENSG00000230371	KARS1P2	NA	
ENSG00000283828	AL137002.2	NA	
ENSG00000126231	PROZ	614024	PROTEIN Z DEFICIENCY
ENSG00000269125	AL137002.1	NA	
ENSG00000126226	PCID2	NA	
ENSG00000139842	CUL4A	NA	
ENSG00000277942	MIR8075	NA	
ENSG00000232662	LDHBP1	NA	
ENSG00000185896	LAMP1	NA	
ENSG00000139835	GRTP1	NA	
ENSG00000276434	AL136221.1	NA	
ENSG00000225083	GRTP1-AS1	NA	
ENSG00000153531	ADPRHL1	NA	
ENSG00000150401	DCUN1D2	NA	
ENSG00000233613	DCUN1D2-AS	NA	
ENSG00000202347	RNU1-16P	NA	
ENSG00000150403	TMCO3	NA	
ENSG00000276916	AL442125.2	NA	
ENSG00000276248	AL442125.1	NA	
ENSG00000198176	TFDP1	NA	
ENSG00000186009	ATP4B	NA	
ENSG00000185974	GRK1	613411	OGUCHI DISEASE 2;;NIGHT BLINDNESS, CONGENITAL STATIONARY, OGUCHI TYPE 2; CSNBO2
ENSG00000279770	LINC00552	NA	
ENSG00000184497	TMEM255B	NA	
ENSG00000233695	GAS6-AS1	NA	
ENSG00000183087	GAS6	NA	
ENSG00000272695	GAS6-DT	NA	
ENSG00000237699	BX072579.1	NA	
ENSG00000226921	LINC00454	NA	
ENSG00000229373	LINC00452	NA	
ENSG00000274766	BX072579.2	NA	
ENSG00000260910	LINC00565	NA	
ENSG00000283199	C13orf46	NA	
ENSG00000185989	RASA3	NA	
ENSG00000232487	RASA3-IT1	NA	
ENSG00000283361	CFAP97D2	NA	
ENSG00000283347	AL160396.1	NA	
ENSG00000130177	CDC16	NA	
ENSG00000264539	MIR548AR	NA	
ENSG00000265450	MIR4502	NA	
ENSG00000285672	AL160396.2	NA	
ENSG00000169062	UPF3A	NA	
ENSG00000226158	CLCP2	NA	
ENSG00000198824	CHAMP1	616579	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40
ENSG00000229723	LINC01054	NA	
ENSG00000260615	RPL23AP97	NA	
ENSG00000283274	5_8S_rRNA	NA	
ENSG00000215398	CR383658.1	NA	
ENSG00000206906	RNU6-458P	NA	
ENSG00000257171	CR383658.2	NA	
ENSG00000257356	BNIP3P6	NA	
ENSG00000257959	CR383656.10	NA	
ENSG00000257721	CR383656.7	NA	
ENSG00000258367	CR383656.13	NA	
ENSG00000257825	CR383656.9	NA	
ENSG00000257115	OR11H12	NA	
ENSG00000257672	CR383656.6	NA	
ENSG00000258233	ARHGAP42P5	NA	
ENSG00000257504	LINC02297	NA	
ENSG00000257644	CR383656.5	NA	
ENSG00000257175	CR383656.1	NA	
ENSG00000258364	CR383656.12	NA	
ENSG00000257731	CR383656.8	NA	
ENSG00000258076	CR383656.11	NA	
ENSG00000257558	CR383656.3	NA	
ENSG00000239200	RPL22P20	NA	
ENSG00000257635	CR383656.4	NA	
ENSG00000257224	CR383656.2	NA	
ENSG00000277529	NF1P10	NA	
ENSG00000277367	AL929601.4	NA	
ENSG00000278143	NF1P7	NA	
ENSG00000257853	MED15P1	NA	
ENSG00000257891	AL929601.1	NA	
ENSG00000258265	AL929601.2	NA	
ENSG00000222036	POTEM	NA	
ENSG00000275563	AL929601.3	NA	
ENSG00000212612	RNU6-1239P	NA	
ENSG00000258314	AL589182.1	NA	
ENSG00000274369	GRAMD4P4	NA	
ENSG00000225210	DUXAP9	NA	
ENSG00000286614	AL589182.3	NA	
ENSG00000277128	AL589743.4	NA	
ENSG00000277710	NBEAP5	NA	
ENSG00000278594	AL589182.2	NA	
ENSG00000196143	OR11H13P	NA	
ENSG00000271632	AL589743.3	NA	
ENSG00000277252	AL589743.5	NA	
ENSG00000258781	AL589743.2	NA	
ENSG00000285990	AL589743.6	NA	
ENSG00000257310	AL589743.1	NA	
ENSG00000277156	TOMM40P1	NA	
ENSG00000244306	DUXAP10	NA	
ENSG00000228294	BMS1P17	NA	
ENSG00000287515	AL929602.1	NA	
ENSG00000274827	LINC01297	NA	
ENSG00000278301	GRAMD4P3	NA	
ENSG00000187537	POTEG	NA	
ENSG00000276888	AL512624.2	NA	
ENSG00000212516	RNU6-1268P	NA	
ENSG00000257162	MED15P6	NA	
ENSG00000258027	NF1P4	NA	
ENSG00000273639	AL512310.11	NA	
ENSG00000274649	AL512624.1	NA	
ENSG00000278184	NF1P11	NA	
ENSG00000257432	AL512310.3	NA	
ENSG00000273558	AL512310.10	NA	
ENSG00000258324	AL512310.8	NA	
ENSG00000257493	AL512310.4	NA	
ENSG00000257751	AL512310.5	NA	
ENSG00000257846	AL512310.6	NA	
ENSG00000259069	AL512310.9	NA	
ENSG00000257884	AL512310.7	NA	
ENSG00000257395	AL512310.2	NA	
ENSG00000258080	ARHGAP42P4	NA	
ENSG00000257142	AL512310.1	NA	
ENSG00000258453	OR11H2	NA	
ENSG00000176294	OR4N2	NA	
ENSG00000258438	OR11K2P	NA	
ENSG00000182652	OR4Q3	NA	
ENSG00000176312	OR4H12P	NA	
ENSG00000176299	OR4M1	NA	
ENSG00000258564	OR4N1P	NA	
ENSG00000228304	OR4K6P	NA	
ENSG00000176290	OR4K3	NA	
ENSG00000165762	OR4K2	NA	
ENSG00000258541	OR4K4P	NA	
ENSG00000259016	AL391156.1	NA	
ENSG00000176281	OR4K5	NA	
ENSG00000155249	OR4K1	NA	
ENSG00000258822	OR4K16P	NA	
ENSG00000169488	OR4K15	NA	
ENSG00000196383	OR4Q2	NA	
ENSG00000169484	OR4K14	NA	
ENSG00000176253	OR4K13	NA	
ENSG00000258899	OR4U1P	NA	
ENSG00000176246	OR4L1	NA	
ENSG00000252999	RNA5SP380	NA	
ENSG00000258641	OR4T1P	NA	
ENSG00000176230	OR4K17	NA	
ENSG00000184394	OR4N5	NA	
ENSG00000259074	PSMB7P1	NA	
ENSG00000259095	GTF2IP22	NA	
ENSG00000258468	OR11G1P	NA	
ENSG00000284742	OR11P1P	NA	
ENSG00000196832	OR11G2	NA	
ENSG00000258625	OR11H5P	NA	
ENSG00000176219	OR11H6	NA	
ENSG00000258806	OR11H7	NA	
ENSG00000176198	OR11H4	NA	
ENSG00000136319	TTC5	NA	
ENSG00000258768	AL356019.2	NA	
ENSG00000258459	AL356019.1	NA	
ENSG00000100814	CCNB1IP1	NA	
ENSG00000287735	AL355075.6	NA	
ENSG00000222489	SNORA79B	NA	
ENSG00000238344	SNORD126	NA	
ENSG00000259001	AL355075.4	NA	
ENSG00000277209	RPPH1	NA	
ENSG00000129484	PARP2	NA	
ENSG00000254846	AL355075.1	NA	
ENSG00000129566	TEP1	NA	
ENSG00000200225	RNA5SP382	NA	
ENSG00000185271	KLHL33	NA	
ENSG00000259162	AL355075.5	NA	
ENSG00000092094	OSGEP	617729	GALLOWAY-MOWAT SYNDROME 3; GAMOS3
ENSG00000258515	AL355075.2	NA	
ENSG00000100823	APEX1	NA	
ENSG00000165782	PIP4P1	NA	
ENSG00000198805	PNP	613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY;;NUCLEOSIDE PHOSPHORYLASE DEFICIENCY
ENSG00000258908	AL355075.3	NA	
ENSG00000182545	RNASE10	NA	
ENSG00000258456	PTCD2P1	NA	
ENSG00000258863	SETP1	NA	
ENSG00000188655	RNASE9	NA	
ENSG00000259060	AL163195.3	NA	
ENSG00000173464	RNASE11	NA	
ENSG00000258573	AL163195.2	NA	
ENSG00000258436	RNASE12	NA	
ENSG00000239327	AL163195.1	NA	
ENSG00000181803	OR6S1	NA	
ENSG00000199461	AL163636.1	NA	
ENSG00000214274	ANG	611895	AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9
ENSG00000258818	RNASE4	NA	
ENSG00000259171	AL163636.2	NA	
ENSG00000258451	EGILA	NA	
ENSG00000259144	RANBP20P	NA	
ENSG00000258963	EDDM3DP	NA	
ENSG00000181562	EDDM3A	NA	
ENSG00000181552	EDDM3B	NA	
ENSG00000169413	RNASE6	NA	
ENSG00000258810	AL133371.2	NA	
ENSG00000129538	RNASE1	NA	
ENSG00000259130	AL133371.3	NA	
ENSG00000258642	AL133371.1	NA	
ENSG00000169397	RNASE3	NA	
ENSG00000258918	AL355922.4	NA	
ENSG00000258772	AL355922.3	NA	
ENSG00000136315	AL355922.1	NA	
ENSG00000169385	RNASE2	NA	
ENSG00000243817	RN7SL189P	NA	
ENSG00000258599	AL355922.2	NA	
ENSG00000165792	METTL17	NA	
ENSG00000258471	AL161668.3	NA	
ENSG00000165794	SLC39A2	NA	
ENSG00000165795	NDRG2	NA	
ENSG00000284122	MIR6717	NA	
ENSG00000179636	TPPP2	NA	
ENSG00000258604	AL161668.4	NA	
ENSG00000255472	AL161668.2	NA	
ENSG00000206150	RNASE13	NA	
ENSG00000165799	RNASE7	NA	
ENSG00000173431	RNASE8	NA	
ENSG00000165801	ARHGEF40	NA	
ENSG00000165804	ZNF219	NA	
ENSG00000232070	TMEM253	NA	
ENSG00000178107	AL161668.1	NA	
ENSG00000258722	CKAP2P1	NA	
ENSG00000200102	RNU6-252P	NA	
ENSG00000169327	OR5AU1	NA	
ENSG00000259102	SMARCE1P3	NA	
ENSG00000258906	AL157687.1	NA	
ENSG00000258441	LINC00641	NA	
ENSG00000092199	HNRNPC	NA	
ENSG00000092200	RPGRIP1	608194	CONE-ROD DYSTROPHY 13; CORD13
ENSG00000092200	RPGRIP1	613826	LEBER CONGENITAL AMAUROSIS 6; LCA6
ENSG00000092201	SUPT16H	NA	
ENSG00000260830	AL135744.1	NA	
ENSG00000100888	CHD8	615032	AUTISM, SUSCEPTIBILITY TO, 18; AUTS18
ENSG00000199436	SNORD9	NA	
ENSG00000200785	SNORD8	NA	
ENSG00000241035	AL161747.1	NA	
ENSG00000258870	EIF4EBP1P1	NA	
ENSG00000274475	RN7SL650P	NA	
ENSG00000129472	RAB2B	NA	
ENSG00000092203	TOX4	NA	
ENSG00000165819	METTL3	NA	
ENSG00000165821	SALL2	216820	COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE
ENSG00000257096	AL161747.2	NA	
ENSG00000256737	RBBP4P5	NA	
ENSG00000169208	OR10G3	NA	
ENSG00000256081	AC243972.2	NA	
ENSG00000273586	OR10G1P	NA	
ENSG00000256385	UBE2NP1	NA	
ENSG00000255569	TRAV1-1	NA	
ENSG00000255582	OR10G2	NA	
ENSG00000256553	TRAV1-2	NA	
ENSG00000255664	ARL6IP1P1	NA	
ENSG00000221977	OR4E2	NA	
ENSG00000276240	OR4E1	NA	
ENSG00000256350	AC243972.3	NA	
ENSG00000211776	TRAV2	NA	
ENSG00000248358	AC243972.1	NA	
ENSG00000211777	TRAV3	NA	
ENSG00000211778	TRAV4	NA	
ENSG00000211779	TRAV5	NA	
ENSG00000240954	RPL4P1	NA	
ENSG00000211780	TRAV6	NA	
ENSG00000211781	TRAV7	NA	
ENSG00000211782	TRAV8-1	NA	
ENSG00000211783	TRAV9-1	NA	
ENSG00000211784	TRAV10	NA	
ENSG00000256474	TRAV11	NA	
ENSG00000211785	TRAV12-1	NA	
ENSG00000211786	TRAV8-2	NA	
ENSG00000211787	TRAV8-3	NA	
ENSG00000211788	TRAV13-1	NA	
ENSG00000211789	TRAV12-2	NA	
ENSG00000211790	TRAV8-4	NA	
ENSG00000256379	TRAV8-5	NA	
ENSG00000211791	TRAV13-2	NA	
ENSG00000211792	TRAV14DV4	NA	
ENSG00000211793	TRAV9-2	NA	
ENSG00000258482	TRAV15	NA	
ENSG00000258557	AC245505.1	NA	
ENSG00000211794	TRAV12-3	NA	
ENSG00000211795	TRAV8-6	NA	
ENSG00000211796	TRAV16	NA	
ENSG00000211797	TRAV17	NA	
ENSG00000211798	TRAV18	NA	
ENSG00000211799	TRAV19	NA	
ENSG00000258705	AC245505.2	NA	
ENSG00000211800	TRAV20	NA	
ENSG00000211801	TRAV21	NA	
ENSG00000276428	AC245505.3	NA	
ENSG00000211802	TRAV22	NA	
ENSG00000211803	TRAV23DV6	NA	
ENSG00000211804	TRDV1	NA	
ENSG00000211805	TRAV24	NA	
ENSG00000211806	TRAV25	NA	
ENSG00000211807	TRAV26-1	NA	
ENSG00000211808	TRAV8-7	NA	
ENSG00000211809	TRAV27	NA	
ENSG00000258835	TRAV28	NA	
ENSG00000211810	TRAV29DV5	NA	
ENSG00000259092	TRAV30	NA	
ENSG00000249048	TRAV31	NA	
ENSG00000258905	TRAV32	NA	
ENSG00000258812	TRAV33	NA	
ENSG00000251002	AC244502.1	NA	
ENSG00000211812	TRAV26-2	NA	
ENSG00000211813	TRAV34	NA	
ENSG00000211814	TRAV35	NA	
ENSG00000211815	TRAV36DV7	NA	
ENSG00000259068	TRAV37	NA	
ENSG00000211816	TRAV38-1	NA	
ENSG00000211817	TRAV38-2DV8	NA	
ENSG00000211818	TRAV39	NA	
ENSG00000211819	TRAV40	NA	
ENSG00000211820	TRAV41	NA	
ENSG00000256221	AC244502.2	NA	
ENSG00000259042	AC244502.3	NA	
ENSG00000211821	TRDV2	NA	
ENSG00000223997	TRDD1	NA	
ENSG00000237235	TRDD2	NA	
ENSG00000228985	TRDD3	NA	
ENSG00000211825	TRDJ1	NA	
ENSG00000211826	TRDJ4	NA	
ENSG00000211827	TRDJ2	NA	
ENSG00000211828	TRDJ3	NA	
ENSG00000211829	TRDC	NA	
ENSG00000256590	TRDV3	NA	
ENSG00000211831	TRAJ61	NA	
ENSG00000249446	TRAJ60	NA	
ENSG00000211832	TRAJ59	NA	
ENSG00000211833	TRAJ58	NA	
ENSG00000211834	TRAJ57	NA	
ENSG00000211835	TRAJ56	NA	
ENSG00000250688	TRAJ55	NA	
ENSG00000211836	TRAJ54	NA	
ENSG00000211837	TRAJ53	NA	
ENSG00000211838	TRAJ52	NA	
ENSG00000248366	TRAJ51	NA	
ENSG00000211839	TRAJ50	NA	
ENSG00000211840	TRAJ49	NA	
ENSG00000211841	TRAJ48	NA	
ENSG00000211842	TRAJ47	NA	
ENSG00000211843	TRAJ46	NA	
ENSG00000211844	TRAJ45	NA	
ENSG00000211845	TRAJ44	NA	
ENSG00000211846	TRAJ43	NA	
ENSG00000211847	TRAJ42	NA	
ENSG00000211848	TRAJ41	NA	
ENSG00000211849	TRAJ40	NA	
ENSG00000211850	TRAJ39	NA	
ENSG00000211851	TRAJ38	NA	
ENSG00000278661	TRAJ37	NA	
ENSG00000276699	TRAJ36	NA	
ENSG00000211854	TRAJ35	NA	
ENSG00000211855	TRAJ34	NA	
ENSG00000211856	TRAJ33	NA	
ENSG00000211857	TRAJ32	NA	
ENSG00000211858	TRAJ31	NA	
ENSG00000211859	TRAJ30	NA	
ENSG00000211860	TRAJ29	NA	
ENSG00000211861	TRAJ28	NA	
ENSG00000211862	TRAJ27	NA	
ENSG00000211863	TRAJ26	NA	
ENSG00000211864	TRAJ25	NA	
ENSG00000211865	TRAJ24	NA	
ENSG00000211866	TRAJ23	NA	
ENSG00000211867	TRAJ22	NA	
ENSG00000211868	TRAJ21	NA	
ENSG00000211869	TRAJ20	NA	
ENSG00000211870	TRAJ19	NA	
ENSG00000211871	TRAJ18	NA	
ENSG00000211872	TRAJ17	NA	
ENSG00000211873	TRAJ16	NA	
ENSG00000211875	TRAJ14	NA	
ENSG00000211876	TRAJ13	NA	
ENSG00000211877	TRAJ12	NA	
ENSG00000211878	TRAJ11	NA	
ENSG00000211879	TRAJ10	NA	
ENSG00000211880	TRAJ9	NA	
ENSG00000211881	TRAJ8	NA	
ENSG00000211882	TRAJ7	NA	
ENSG00000211883	TRAJ6	NA	
ENSG00000211884	TRAJ5	NA	
ENSG00000211885	TRAJ4	NA	
ENSG00000211886	TRAJ3	NA	
ENSG00000211887	TRAJ2	NA	
ENSG00000211888	TRAJ1	NA	
ENSG00000277734	TRAC	NA	
ENSG00000259054	LINC02332	NA	
ENSG00000259003	AC243965.1	NA	
ENSG00000129562	DAD1	NA	
ENSG00000275552	AC243965.2	NA	
ENSG00000100439	ABHD4	NA	
ENSG00000255804	OR6J1	NA	
ENSG00000242061	AL160314.1	NA	
ENSG00000258458	AL160314.2	NA	
ENSG00000235213	OR6E1P	NA	
ENSG00000258823	AL160314.3	NA	
ENSG00000212302	AL135998.2	NA	
ENSG00000155463	OXA1L	NA	
ENSG00000155465	SLC7A7	222700	LYSINURIC PROTEIN INTOLERANCE; LPI;;DIBASIC AMINO ACIDURIA II
ENSG00000172590	MRPL52	NA	
ENSG00000157227	MMP14	277950	WINCHESTER SYNDROME; WNCHRS
ENSG00000212335	AL135998.3	NA	
ENSG00000199716	AL135998.1	NA	
ENSG00000197324	LRP10	NA	
ENSG00000139890	REM2	NA	
ENSG00000100461	RBM23	NA	
ENSG00000237054	PRMT5-AS1	NA	
ENSG00000100462	PRMT5	NA	
ENSG00000257285	AL132780.1	NA	
ENSG00000092036	HAUS4	NA	
ENSG00000259132	AL132780.3	NA	
ENSG00000284118	MIR4707	NA	
ENSG00000129474	AJUBA	NA	
ENSG00000258457	AL132780.2	NA	
ENSG00000100802	C14orf93	NA	
ENSG00000280129	AL132780.5	NA	
ENSG00000100804	PSMB5	NA	
ENSG00000279656	AL132780.4	NA	
ENSG00000222028	PSMB11	NA	
ENSG00000139880	CDH24	NA	
ENSG00000100813	ACIN1	NA	
ENSG00000179933	C14orf119	NA	
ENSG00000283654	LMLN2	NA	
ENSG00000092067	CEBPE	245480	SPECIFIC GRANULE DEFICIENCY 1; SGD1;;LACTOFERRIN-DEFICIENT NEUTROPHILS;;NEUTROPHIL LACTOFERRIN DEFICIENCY
ENSG00000092068	SLC7A8	NA	
ENSG00000202229	RNU6-1138P	NA	
ENSG00000215277	RNF212B	NA	
ENSG00000240131	AL049829.1	NA	
ENSG00000252347	RNU6-1046P	NA	
ENSG00000215271	HOMEZ	NA	
ENSG00000270433	H3P37	NA	
ENSG00000235194	PPP1R3E	NA	
ENSG00000129473	BCL2L2	NA	
ENSG00000258643	BCL2L2-PABPN1	NA	
ENSG00000100836	PABPN1	164300	OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL
ENSG00000092096	SLC22A17	NA	
ENSG00000100842	EFS	NA	
ENSG00000259018	AL049829.2	NA	
ENSG00000166090	IL25	NA	
ENSG00000166091	CMTM5	NA	
ENSG00000197616	MYH6	192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC
ENSG00000197616	MYH6	613251	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14
ENSG00000197616	MYH6	613252	CARDIOMYOPATHY, DILATED, 1EE; CMD1EE
ENSG00000197616	MYH6	614089	ATRIAL SEPTAL DEFECT 3; ASD3
ENSG00000197616	MYH6	614090	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3
ENSG00000199157	MIR208A	NA	
ENSG00000092054	MYH7	181430	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM;;SCAPULOPERONEAL MUSCULAR DYSTROPHY; SPMD;;SCAPULOPERONEAL SYNDROME, MYOPATHIC TYPE
ENSG00000092054	MYH7	160500	MYOPATHY, DISTAL, 1; MPD1;;MYOPATHY, LATE DISTAL HEREDITARY;;LAING DISTAL MYOPATHY;;MYOPATHY, DISTAL, EARLY-ONSET, AUTOSOMAL DOMINANT
ENSG00000092054	MYH7	192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC
ENSG00000092054	MYH7	255160	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE
ENSG00000092054	MYH7	255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD;;FIBER-TYPE DISPROPORTION MYOPATHY, CONGENITAL; CFTDM
ENSG00000092054	MYH7	608358	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT;;MYOPATHY WITH LYSIS OF TYPE I MYOFIBRILS
ENSG00000092054	MYH7	613426	CARDIOMYOPATHY, DILATED, 1S; CMD1S LEFT VENTRICULAR NONCOMPACTION 5, INCLUDED; LVNC5, INCLUDED
ENSG00000258444	AL132855.1	NA	
ENSG00000215991	MIR208B	NA	
ENSG00000129460	NGDN	NA	
ENSG00000157306	ZFHX2-AS1	NA	
ENSG00000136367	ZFHX2	147430	MARSILI SYNDROME; MARSIS;;INSENSITIVITY TO PAIN, CONGENITAL, AUTOSOMAL DOMINANT;;CONGENITAL ANALGESIA, AUTOSOMAL DOMINANT
ENSG00000273618	AL135999.2	NA	
ENSG00000259431	THTPA	NA	
ENSG00000213983	AP1G2	NA	
ENSG00000258727	AL135999.1	NA	
ENSG00000092051	JPH4	NA	
ENSG00000274002	AL135999.3	NA	
ENSG00000100867	DHRS2	NA	
ENSG00000258464	AL160237.1	NA	
ENSG00000259043	BRD7P1	NA	
ENSG00000270618	AL160237.3	NA	
ENSG00000222931	RN7SKP205	NA	
ENSG00000258887	AL160237.2	NA	
ENSG00000285727	AL136419.2	NA	
ENSG00000259334	LINC00596	NA	
ENSG00000215256	DHRS4-AS1	NA	
ENSG00000157326	DHRS4	NA	
ENSG00000187630	DHRS4L2	NA	
ENSG00000285467	AL136419.1	NA	
ENSG00000286931	AL136419.3	NA	
ENSG00000225766	DHRS4L1	NA	
ENSG00000186648	CARMIL3	NA	
ENSG00000100884	CPNE6	NA	
ENSG00000129535	NRL	613750	RETINITIS PIGMENTOSA 27; RP27 RETINAL DEGENERATION, AUTOSOMAL RECESSIVE, CLUMPED PIGMENT TYPE, INCLUDED
ENSG00000100889	PCK2	261650	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL; PCKDM;;PCK2 DEFICIENCY;;PEPCK2 DEFICIENCY
ENSG00000100897	DCAF11	NA	
ENSG00000259371	AL136295.3	NA	
ENSG00000139914	FITM1	NA	
ENSG00000092010	PSME1	NA	
ENSG00000100908	EMC9	NA	
ENSG00000259321	AL136295.2	NA	
ENSG00000100911	PSME2	NA	
ENSG00000283856	MIR7703	NA	
ENSG00000092098	RNF31	NA	
ENSG00000259529	AL136295.5	NA	
ENSG00000199804	RNA5SP383	NA	
ENSG00000213928	IRF9	618648	IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD65
ENSG00000100918	REC8	NA	
ENSG00000196497	IPO4	NA	
ENSG00000259522	AL136295.4	NA	
ENSG00000287765	AL136295.17	NA	
ENSG00000100926	TM9SF1	NA	
ENSG00000254692	AL136295.1	NA	
ENSG00000276698	AL136295.6	NA	
ENSG00000278784	AL136295.7	NA	
ENSG00000139908	TSSK4	NA	
ENSG00000254505	CHMP4A	NA	
ENSG00000260669	AL096870.2	NA	
ENSG00000213920	MDP1	NA	
ENSG00000255526	NEDD8-MDP1	NA	
ENSG00000129559	NEDD8	NA	
ENSG00000100938	GMPR2	NA	
ENSG00000092330	TINF2	127550	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE
ENSG00000092330	TINF2	268130	REVESZ SYNDROME;;DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 5; DKCA5;;EXUDATIVE RETINOPATHY WITH BONE MARROW FAILURE
ENSG00000092330	TINF2	613990	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3
ENSG00000092295	TGM1	242300	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1;;ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION;;COLLODION BABY, SELF-HEALING; SHCB;;ICHTHYOSIS CONGENITA;;LAMELLAR EXFOLIATION OF NEWBORN;;DESQUAMATION OF NEWBORN;; /.../ION FETUS;;ICHTHYOSIS CONGENITA II; ICR2;;ICHTHYOSIS, LAMELLAR, 1, FORMERLY; LI1, FORMERLY
ENSG00000100949	RABGGTA	NA	
ENSG00000288044	AL096870.10	NA	
ENSG00000286825	AL096870.8	NA	
ENSG00000157379	DHRS1	NA	
ENSG00000196943	NOP9	NA	
ENSG00000136305	CIDEB	NA	
ENSG00000213906	LTB4R2	NA	
ENSG00000213903	LTB4R	NA	
ENSG00000129467	ADCY4	NA	
ENSG00000258973	AL096870.1	NA	
ENSG00000129465	RIPK3	NA	
ENSG00000283290	AL096870.3	NA	
ENSG00000100968	NFATC4	NA	
ENSG00000205978	NYNRIN	NA	
ENSG00000139899	CBLN3	NA	
ENSG00000100441	KHNYN	NA	
ENSG00000100445	SDR39U1	NA	
ENSG00000258744	AL132800.1	NA	
ENSG00000092009	CMA1	NA	
ENSG00000100448	CTSG	NA	
ENSG00000258657	AL136018.1	NA	
ENSG00000100450	GZMH	NA	
ENSG00000100453	GZMB	NA	
ENSG00000168952	STXBP6	NA	
ENSG00000288100	AL161663.2	NA	
ENSG00000287481	AL161663.1	NA	
ENSG00000258098	LINC02286	NA	
ENSG00000257179	HMGN2P6	NA	
ENSG00000258275	OR7K1P	NA	
ENSG00000257976	AL079352.1	NA	
ENSG00000257986	LINC02306	NA	
ENSG00000212270	AL359396.1	NA	
ENSG00000279521	AL359396.2	NA	
ENSG00000285633	AL132633.1	NA	
ENSG00000257503	CYB5AP5	NA	
ENSG00000139910	NOVA1	NA	
ENSG00000262119	AL079343.1	NA	
ENSG00000257842	LINC02588	NA	
ENSG00000258081	AL110292.1	NA	
ENSG00000257845	LINC02294	NA	
ENSG00000257185	LINC02293	NA	
ENSG00000286479	AL132718.1	NA	
ENSG00000257612	MIR4307HG	NA	
ENSG00000265165	MIR4307	NA	
ENSG00000258932	AL390334.1	NA	
ENSG00000258548	LINC00645	NA	
ENSG00000264657	MIR3171	NA	
ENSG00000197358	BNIP3P1	NA	
ENSG00000257869	AL139023.1	NA	
ENSG00000240179	RPL26P3	NA	
ENSG00000258175	LINC02300	NA	
ENSG00000257662	EIF4A1P12	NA	
ENSG00000258282	BTF3P2	NA	
ENSG00000257126	FOXG1-AS1	NA	
ENSG00000288572	AL049777.1	NA	
ENSG00000288617	AL049777.2	NA	
ENSG00000176165	FOXG1	613454	RETT SYNDROME, CONGENITAL VARIANT
ENSG00000186960	LINC01551	NA	
ENSG00000257056	LINC02282	NA	
ENSG00000257748	LINC02281	NA	
ENSG00000258038	LINC02327	NA	
ENSG00000258065	AL122126.2	NA	
ENSG00000257523	LINC02326	NA	
ENSG00000207164	AL122126.1	NA	
ENSG00000258028	AL135878.1	NA	
ENSG00000252065	RNU6-864P	NA	
ENSG00000257522	AL133166.1	NA	
ENSG00000258107	AL158058.1	NA	
ENSG00000286040	AL158058.2	NA	
ENSG00000212518	RNU11-5P	NA	
ENSG00000184304	PRKD1	617364	CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA; CHDED
ENSG00000257120	AL356756.1	NA	
ENSG00000252686	RNU6-1234P	NA	
ENSG00000287142	AL355053.1	NA	
ENSG00000257904	AL133372.3	NA	
ENSG00000248975	AL133372.2	NA	
ENSG00000240201	AL133372.1	NA	
ENSG00000279032	AL079305.1	NA	
ENSG00000257636	G2E3-AS1	NA	
ENSG00000278587	AL117355.1	NA	
ENSG00000258350	SYF2P1	NA	
ENSG00000092140	G2E3	NA	
ENSG00000092108	SCFD1	NA	
ENSG00000258648	UBE2CP1	NA	
ENSG00000258558	AL121852.1	NA	
ENSG00000243855	RPL12P5	NA	
ENSG00000240513	AL049830.2	NA	
ENSG00000213867	AL049830.1	NA	
ENSG00000100473	COCH	601369	DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9
ENSG00000100473	COCH	618094	DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110
ENSG00000258525	AL049830.3	NA	
ENSG00000196792	STRN3	NA	
ENSG00000258886	HIGD1AP17	NA	
ENSG00000207952	MIR624	NA	
ENSG00000258968	AL049830.4	NA	
ENSG00000100478	AP4S1	614067	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 6, FORMERLY; CPSQ6, FORMERLY
ENSG00000092148	HECTD1	NA	
ENSG00000258640	RPL21P5	NA	
ENSG00000207440	RNU6-541P	NA	
ENSG00000202402	Y_RNA	NA	
ENSG00000257831	AL136418.1	NA	
ENSG00000199291	Y_RNA	NA	
ENSG00000129493	HEATR5A	NA	
ENSG00000283016	AL139353.3	NA	
ENSG00000203546	AL139353.1	NA	
ENSG00000250365	AL139353.2	NA	
ENSG00000129480	DTD2	NA	
ENSG00000239323	AL163973.1	NA	
ENSG00000214943	GPR33	NA	
ENSG00000151413	NUBPL	618242	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21
ENSG00000258196	AL163973.3	NA	
ENSG00000257155	AL163973.2	NA	
ENSG00000223087	RNU6-602P	NA	
ENSG00000207412	RNU6-455P	NA	
ENSG00000257472	AL355112.1	NA	
ENSG00000258474	LINC02313	NA	
ENSG00000275002	AL352984.2	NA	
ENSG00000258386	AL352984.1	NA	
ENSG00000258655	ARHGAP5-AS1	NA	
ENSG00000100852	ARHGAP5	NA	
ENSG00000285608	AL161665.1	NA	
ENSG00000286527	AL161665.2	NA	
ENSG00000201654	RNU6-7	NA	
ENSG00000202337	RNU6-8	NA	
ENSG00000258619	AL136298.2	NA	
ENSG00000259086	KIAA1143P1	NA	
ENSG00000151320	AKAP6	NA	
ENSG00000258580	AL136298.1	NA	
ENSG00000278746	RN7SL660P	NA	
ENSG00000259045	MTCO1P2	NA	
ENSG00000280281	AL049781.1	NA	
ENSG00000151322	NPAS3	NA	
ENSG00000287153	AL161851.1	NA	
ENSG00000287777	AL161851.2	NA	
ENSG00000129521	EGLN3	NA	
ENSG00000258897	EGLN3-AS1	NA	
ENSG00000223593	AL356806.1	NA	
ENSG00000165389	SPTSSA	NA	
ENSG00000237450	RPL23AP71	NA	
ENSG00000129518	EAPP	NA	
ENSG00000279423	AL445363.3	NA	
ENSG00000259002	AL445363.1	NA	
ENSG00000206596	RNU1-27P	NA	
ENSG00000206588	RNU1-28P	NA	
ENSG00000259135	AL445363.2	NA	
ENSG00000129515	SNX6	NA	
ENSG00000240463	RPS19P3	NA	
ENSG00000275978	Metazoa_SRP	NA	
ENSG00000253003	RNU6-1261P	NA	
ENSG00000241582	RPL23AP8	NA	
ENSG00000165410	CFL2	610687	NEMALINE MYOPATHY 7; NEM7
ENSG00000243824	RPL12P6	NA	
ENSG00000198604	BAZ1A	NA	
ENSG00000251726	RNU7-41P	NA	
ENSG00000258738	AL121603.2	NA	
ENSG00000258704	SRP54-AS1	NA	
ENSG00000258493	AL121603.1	NA	
ENSG00000226677	IGBP1P1	NA	
ENSG00000100883	SRP54	260400	SHWACHMAN-DIAMOND SYNDROME 1; SDS1;;SHWACHMAN-DIAMOND SYNDROME; SDS;;PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION;;SHWACHMAN-BODIAN SYNDROME;;LIPOMATOSIS OF PANCREAS, CONGENITAL
ENSG00000100883	SRP54	618752	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8;;NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT, WITH OR WITHOUT PANCREATIC DYSFUNCTION AND/OR NEUROLOGIC ABNORMALITIES;;SHWACHMAN-DIAMOND SYNDROME-LIKE; SDSL
ENSG00000151327	FAM177A1	NA	
ENSG00000092020	PPP2R3C	618419	GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM
ENSG00000092020	PPP2R3C	618420	SPERMATOGENIC FAILURE 36; SPGF36
ENSG00000279434	AL049776.1	NA	
ENSG00000100890	PRORP	NA	
ENSG00000258790	AL121594.1	NA	
ENSG00000241052	RPL23AP70	NA	
ENSG00000259090	SEPTIN7P1	NA	
ENSG00000282625	MRPL57P8	NA	
ENSG00000282308	DPRXP3	NA	
ENSG00000256243	RPL7AP3	NA	
ENSG00000240392	RPL9P3	NA	
ENSG00000100902	PSMA6	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000258860	AL133163.2	NA	
ENSG00000240023	AL133163.1	NA	
ENSG00000100906	NFKBIA	612132	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2; EDAID2;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY 2;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNODEFICIENCY 2;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT
ENSG00000259022	DNAJC8P1	NA	
ENSG00000259017	AL133163.3	NA	
ENSG00000259105	RPS3AP4	NA	
ENSG00000258783	KRT18P6	NA	
ENSG00000168348	INSM2	NA	
ENSG00000174373	RALGAPA1	618797	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION; NEDHRIT
ENSG00000253059	AL137818.1	NA	
ENSG00000257957	QRSL1P3	NA	
ENSG00000258938	AL162311.3	NA	
ENSG00000258300	NUTF2P2	NA	
ENSG00000100916	BRMS1L	NA	
ENSG00000257272	AL162311.1	NA	
ENSG00000257307	AL162311.2	NA	
ENSG00000258342	AL133304.3	NA	
ENSG00000257614	AL133304.1	NA	
ENSG00000257720	ILF2P2	NA	
ENSG00000257826	AL133304.2	NA	
ENSG00000257585	LINC00609	NA	
ENSG00000259104	PTCSC3	NA	
ENSG00000258844	AL162511.1	NA	
ENSG00000252312	RN7SKP21	NA	
ENSG00000151332	MBIP	NA	
ENSG00000283098	AL132857.1	NA	
ENSG00000188831	DPPA3P2	NA	
ENSG00000238540	RNU7-93P	NA	
ENSG00000257520	SFTA3	NA	
ENSG00000229415	SFTA3	NA	
ENSG00000136352	NKX2-1	118700	CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA
ENSG00000136352	NKX2-1	188550	THYROID CANCER, NONMEDULLARY, 1; NMTC1;;PAPILLARY CARCINOMA OF THYROID; PACT; PTC; TPC;;FAMILIAL NONMEDULLARY THYROID CANCER, PAPILLARY;;NONMEDULLARY THYROID CARCINOMA, PAPILLARY
ENSG00000136352	NKX2-1	610978	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP;;BRAIN-LUNG-THYROID SYNDROME
ENSG00000253563	NKX2-1-AS1	NA	
ENSG00000258467	PHKBP2	NA	
ENSG00000243730	RPL29P3	NA	
ENSG00000136327	NKX2-8	NA	
ENSG00000201395	RN7SKP257	NA	
ENSG00000258661	AL079303.1	NA	
ENSG00000198807	PAX9	604625	TOOTH AGENESIS, SELECTIVE, 3; STHAG3;;HYPODONTIA/OLIGODONTIA 3
ENSG00000183032	SLC25A21	618811	MITOCHONDRIAL DNA DEPLETION SYNDROME 18; MTDPS18
ENSG00000258690	AL162464.2	NA	
ENSG00000258601	AL162464.1	NA	
ENSG00000266327	MIR4503	NA	
ENSG00000258827	AL079304.1	NA	
ENSG00000258708	SLC25A21-AS1	NA	
ENSG00000252746	RNU6-273P	NA	
ENSG00000151338	MIPOL1	NA	
ENSG00000207046	RNU6-886P	NA	
ENSG00000259087	AL121790.2	NA	
ENSG00000258414	AL121790.1	NA	
ENSG00000129514	FOXA1	NA	
ENSG00000139865	TTC6	NA	
ENSG00000200385	AL136296.1	NA	
ENSG00000201431	RNU6-1277P	NA	
ENSG00000259091	LINC00517	NA	
ENSG00000258696	AL359233.1	NA	
ENSG00000259048	AL392023.2	NA	
ENSG00000258649	AL392023.1	NA	
ENSG00000139874	SSTR1	NA	
ENSG00000176435	CLEC14A	NA	
ENSG00000259072	AL355835.1	NA	
ENSG00000271468	AL357094.1	NA	
ENSG00000258948	KRT8P1	NA	
ENSG00000259070	LINC00639	NA	
ENSG00000258680	AL132994.1	NA	
ENSG00000270713	AL132994.2	NA	
ENSG00000199285	Y_RNA	NA	
ENSG00000100934	SEC23A	607812	CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD;;BOYADJIEV-JABS SYNDROME
ENSG00000259121	AL109628.1	NA	
ENSG00000258651	SEC23A-AS1	NA	
ENSG00000258591	PPIAP4	NA	
ENSG00000092208	GEMIN2	NA	
ENSG00000182400	TRAPPC6B	617862	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA
ENSG00000285830	AL109628.2	NA	
ENSG00000241984	RPL7AP2	NA	
ENSG00000259083	AL132639.3	NA	
ENSG00000100941	PNN	NA	
ENSG00000258671	AL132639.1	NA	
ENSG00000270503	YTHDF2P1	NA	
ENSG00000150527	MIA2	NA	
ENSG00000258940	AL132639.2	NA	
ENSG00000271424	AL157791.2	NA	
ENSG00000259100	AL157791.1	NA	
ENSG00000165355	FBXO33	NA	
ENSG00000258526	AL049828.1	NA	
ENSG00000286123	AL049828.2	NA	
ENSG00000286099	AL390800.1	NA	
ENSG00000251363	LINC02315	NA	
ENSG00000258385	AL391516.1	NA	
ENSG00000279972	AL356596.1	NA	
ENSG00000258901	AL121821.3	NA	
ENSG00000258636	AL121821.2	NA	
ENSG00000251858	AL121821.1	NA	
ENSG00000165379	LRFN5	NA	
ENSG00000258536	FKBP1BP1	NA	
ENSG00000259149	AL445074.1	NA	
ENSG00000258394	AL442163.1	NA	
ENSG00000258850	AL450442.1	NA	
ENSG00000258505	AL442163.2	NA	
ENSG00000258622	AL442163.3	NA	
ENSG00000258934	AL356800.1	NA	
ENSG00000259047	AL163153.1	NA	
ENSG00000258406	AL445383.1	NA	
ENSG00000259051	HNRNPUP1	NA	
ENSG00000286464	AL583809.1	NA	
ENSG00000258828	KRT8P2	NA	
ENSG00000258387	AL358913.1	NA	
ENSG00000258894	ARHGAP16P	NA	
ENSG00000258969	LINC02307	NA	
ENSG00000259019	EIF4BP1	NA	
ENSG00000259137	AL109766.1	NA	
ENSG00000259148	YWHAZP1	NA	
ENSG00000259126	AL161752.1	NA	
ENSG00000258487	LINC02277	NA	
ENSG00000189139	FSCB	NA	
ENSG00000258747	AL356022.1	NA	
ENSG00000258998	LINC02302	NA	
ENSG00000259000	DOCK11P1	NA	
ENSG00000258633	AL049870.2	NA	
ENSG00000258509	AL049870.1	NA	
ENSG00000259046	AL049870.4	NA	
ENSG00000179476	C14orf28	NA	
ENSG00000258949	AL049870.3	NA	
ENSG00000179454	KLHL28	NA	
ENSG00000198718	TOGARAM1	NA	
ENSG00000278147	AL121809.2	NA	
ENSG00000249163	AL121809.1	NA	
ENSG00000185246	PRPF39	NA	
ENSG00000212615	SNORD58	NA	
ENSG00000239043	SNORD127	NA	
ENSG00000100442	FKBP3	NA	
ENSG00000187790	FANCM	618086	SPERMATOGENIC FAILURE 28; SPGF28
ENSG00000187790	FANCM	618096	PREMATURE OVARIAN FAILURE 15; POF15
ENSG00000129534	MIS18BP1	NA	
ENSG00000199739	RNU6-552P	NA	
ENSG00000258608	DNAJC19P9	NA	
ENSG00000260046	AL162632.3	NA	
ENSG00000257900	AL162632.1	NA	
ENSG00000258746	AL162632.2	NA	
ENSG00000258845	AL139354.1	NA	
ENSG00000258616	LINC02303	NA	
ENSG00000258700	LINC00871	NA	
ENSG00000165496	RPL10L	NA	
ENSG00000139915	MDGA2	NA	
ENSG00000251735	AL359951.1	NA	
ENSG00000258392	RPA2P1	NA	
ENSG00000244053	RPL13AP2	NA	
ENSG00000214903	RPS15AP3	NA	
ENSG00000263945	MIR548Y	NA	
ENSG00000259129	LINC00648	NA	
ENSG00000259117	AL121576.1	NA	
ENSG00000258639	AL359212.1	NA	
ENSG00000286595	AL512358.1	NA	
ENSG00000287492	AL512358.2	NA	
ENSG00000270359	AL358335.3	NA	
ENSG00000207366	RNU6-297P	NA	
ENSG00000258751	AL358335.2	NA	
ENSG00000258750	AL358335.1	NA	
ENSG00000242417	RPL18P1	NA	
ENSG00000258381	AL512360.1	NA	
ENSG00000258868	AL110505.1	NA	
ENSG00000258401	AL512361.1	NA	
ENSG00000252424	RNA5SP384	NA	
ENSG00000213741	RPS29	615909	DIAMOND-BLACKFAN ANEMIA 13; DBA13
ENSG00000244270	RPL32P29	NA	
ENSG00000276168	RN7SL1	NA	
ENSG00000252919	Y_RNA	NA	
ENSG00000165501	LRR1	NA	
ENSG00000258568	RHOQP1	NA	
ENSG00000278009	AL139099.3	NA	
ENSG00000165502	RPL36AL	NA	
ENSG00000168282	MGAT2	212066	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A;;CDG IIa; CDGIIa;;ALKURAYA SYNDROME;;MENTAL RETARDATION, GROWTH RETARDATION, PROMINENT COLUMELLA, AND OPEN MOUTH;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE II, FORMERLY; CDGS2, FORMERLY
ENSG00000258377	AL139099.1	NA	
ENSG00000165506	DNAAF2	612518	CILIARY DYSKINESIA, PRIMARY, 10; CILD10;;CILIARY DYSKINESIA, PRIMARY, 10, WITH OR WITHOUT SITUS INVERSUS
ENSG00000258450	AL139099.2	NA	
ENSG00000100479	POLE2	NA	
ENSG00000259155	AL591767.3	NA	
ENSG00000258462	AL591767.2	NA	
ENSG00000221114	RNU6ATAC30P	NA	
ENSG00000197776	KLHDC1	NA	
ENSG00000258400	AL591767.1	NA	
ENSG00000165516	KLHDC2	NA	
ENSG00000165525	NEMF	NA	
ENSG00000277634	Y_RNA	NA	
ENSG00000252474	RNU6-539P	NA	
ENSG00000278771	RN7SL3	NA	
ENSG00000282885	AL627171.2	NA	
ENSG00000274012	RN7SL2	NA	
ENSG00000278002	AL627171.1	NA	
ENSG00000165527	ARF6	NA	
ENSG00000251929	RNU6-189P	NA	
ENSG00000274704	Metazoa_SRP	NA	
ENSG00000214900	LINC01588	NA	
ENSG00000278038	MIR6076	NA	
ENSG00000270788	PDLIM1P1	NA	
ENSG00000243038	AL117692.1	NA	
ENSG00000201358	RN7SKP193	NA	
ENSG00000251792	Y_RNA	NA	
ENSG00000100483	VCPKMT	NA	
ENSG00000100485	SOS2	616559	NOONAN SYNDROME 9; NS9
ENSG00000087299	L2HGDH	236792	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA;;L-2-HYDROXYGLUTARIC ACIDEMIA
ENSG00000264712	MIR4504	NA	
ENSG00000125375	DMAC2L	NA	
ENSG00000259071	AL359397.2	NA	
ENSG00000100490	CDKL1	NA	
ENSG00000258857	AL359397.1	NA	
ENSG00000012983	MAP4K5	NA	
ENSG00000259113	AL118556.2	NA	
ENSG00000201573	AL118556.1	NA	
ENSG00000273675	AL118556.3	NA	
ENSG00000198513	ATL1	182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1
ENSG00000198513	ATL1	613708	NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D
ENSG00000258577	SNRPGP1	NA	
ENSG00000151748	SAV1	NA	
ENSG00000243103	RN7SL452P	NA	
ENSG00000269906	AL606834.1	NA	
ENSG00000258491	ZFP64P1	NA	
ENSG00000100503	NIN	614851	SECKEL SYNDROME 7; SCKL7
ENSG00000270062	AL606834.2	NA	
ENSG00000258843	AL133485.2	NA	
ENSG00000285747	AL133485.3	NA	
ENSG00000252945	AL133485.1	NA	
ENSG00000258687	AL358334.1	NA	
ENSG00000100504	PYGL	232700	GLYCOGEN STORAGE DISEASE VI; GSD6;;GSD VI;;HERS DISEASE;;PHOSPHORYLASE DEFICIENCY GLYCOGEN-STORAGE DISEASE OF LIVER
ENSG00000131969	ABHD12B	NA	
ENSG00000258745	AL358334.3	NA	
ENSG00000258711	AL358334.2	NA	
ENSG00000100505	TRIM9	NA	
ENSG00000287990	AL358334.4	NA	
ENSG00000259055	AL591770.1	NA	
ENSG00000139921	TMX1	NA	
ENSG00000201376	SNORA70	NA	
ENSG00000201820	Y_RNA	NA	
ENSG00000258955	LINC00519	NA	
ENSG00000258479	LINC00640	NA	
ENSG00000258942	AL358332.1	NA	
ENSG00000258808	LINC02310	NA	
ENSG00000258893	SETP2	NA	
ENSG00000258537	FRMD6-AS2	NA	
ENSG00000139926	FRMD6	NA	
ENSG00000252400	RNU6-1291P	NA	
ENSG00000277050	AL122125.1	NA	
ENSG00000273888	FRMD6-AS1	NA	
ENSG00000251756	RNA5SP385	NA	
ENSG00000207004	RNU6-301P	NA	
ENSG00000259111	AL079307.2	NA	
ENSG00000258423	OR7E105P	NA	
ENSG00000258550	OR7E106P	NA	
ENSG00000258535	AL079307.1	NA	
ENSG00000258849	OR7E159P	NA	
ENSG00000259157	AL079307.3	NA	
ENSG00000186469	GNG2	NA	
ENSG00000258928	AL358333.2	NA	
ENSG00000259007	AL358333.3	NA	
ENSG00000258854	AL358333.1	NA	
ENSG00000087302	RTRAF	NA	
ENSG00000087303	NID2	NA	
ENSG00000258694	LINC02319	NA	
ENSG00000258981	COX5AP2	NA	
ENSG00000258440	AL118557.1	NA	
ENSG00000168229	PTGDR	607277	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1;;ASRT1;;AS1
ENSG00000261208	AL365475.1	NA	
ENSG00000125384	PTGER2	208550	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE;;ASA TRIAD ASTHMA, ASPIRIN-INDUCED, SUSCEPTIBILITY TO, INCLUDED;;ASTHMA AND NASAL POLYPS, INCLUDED
ENSG00000087301	TXNDC16	NA	
ENSG00000180998	GPR137C	NA	
ENSG00000197930	ERO1A	NA	
ENSG00000258757	AL133453.1	NA	
ENSG00000100519	PSMC6	NA	
ENSG00000198252	STYX	NA	
ENSG00000100522	GNPNAT1	NA	
ENSG00000259049	AL139317.3	NA	
ENSG00000285664	AL139317.5	NA	
ENSG00000258698	AL139317.1	NA	
ENSG00000258802	AL139317.2	NA	
ENSG00000073712	FERMT2	NA	
ENSG00000271075	AL139317.4	NA	
ENSG00000288045	AL352979.4	NA	
ENSG00000258503	AL352979.1	NA	
ENSG00000258993	AL352979.3	NA	
ENSG00000100523	DDHD1	609340	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28
ENSG00000258985	AL352979.2	NA	
ENSG00000258731	AL356020.1	NA	
ENSG00000237356	AL365295.1	NA	
ENSG00000286730	AL365295.2	NA	
ENSG00000225680	AL163953.1	NA	
ENSG00000226132	RPS3AP46	NA	
ENSG00000235269	LINC02331	NA	
ENSG00000231922	AL138479.1	NA	
ENSG00000266431	MIR5580	NA	
ENSG00000125378	BMP4	600625	OROFACIAL CLEFT 11; OFC11;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 11 CLEFT LIP, CONGENITAL HEALED, INCLUDED;;CONGENITAL HEALED CLEFT LIP, INCLUDED; CHCL, INCLUDED
ENSG00000125378	BMP4	607932	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6;;MICROPHTHALMIA AND PITUITARY ANOMALIES;;MICROPHTHALMIA WITH BRAIN AND DIGIT DEVELOPMENTAL ANOMALIES;;ANOPHTHALMIA, CLINICAL, WITH MICROGNATHIA, MALFORMED EARS, DIGITAL ANOMALIES, AND ABNORMAL EXTERNAL GENITALIA
ENSG00000287156	AL138479.2	NA	
ENSG00000224004	ATP5F1CP1	NA	
ENSG00000100526	CDKN3	NA	
ENSG00000100528	CNIH1	NA	
ENSG00000258753	AL359792.1	NA	
ENSG00000197045	GMFB	NA	
ENSG00000100532	CGRRF1	NA	
ENSG00000020577	SAMD4A	NA	
ENSG00000285774	AL133444.1	NA	
ENSG00000131979	GCH1	128230	DYSTONIA, DOPA-RESPONSIVE; DRD;;DYSTONIA 5; DYT5;;DYSTONIA, PROGRESSIVE, WITH DIURNAL VARIATION;;DYSTONIA-PARKINSONISM WITH DIURNAL FLUCTUATION;;SEGAWA SYNDROME, AUTOSOMAL DOMINANT;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL DOMINANT;;DOPA-RESPONSIVE DYST /.../AUTOSOMAL DOMINANT
ENSG00000131979	GCH1	233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B;;HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO GTP CYCLOHYDROLASE I DEFICIENCY;;GTP CYCLOHYDROLASE I DEFICIENCY  DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSO /.../CESSIVE, INCLUDED
ENSG00000252019	RNU6ATAC9P	NA	
ENSG00000265432	MIR4308	NA	
ENSG00000258872	FDPSP3	NA	
ENSG00000198554	WDHD1	NA	
ENSG00000233924	RPSAP13	NA	
ENSG00000180008	SOCS4	NA	
ENSG00000168175	MAPK1IP1L	NA	
ENSG00000131981	LGALS3	NA	
ENSG00000126787	DLGAP5	NA	
ENSG00000258050	AL139316.1	NA	
ENSG00000279392	AL158801.5	NA	
ENSG00000271180	AL158801.4	NA	
ENSG00000258413	AL158801.2	NA	
ENSG00000178974	FBXO34	NA	
ENSG00000239686	AL158801.1	NA	
ENSG00000278818	Metazoa_SRP	NA	
ENSG00000258469	CHMP4BP1	NA	
ENSG00000258455	AL158801.3	NA	
ENSG00000126775	ATG14	NA	
ENSG00000259318	AL356801.1	NA	
ENSG00000182521	TBPL2	NA	
ENSG00000239199	RPL21P6	NA	
ENSG00000186615	KTN1-AS1	NA	
ENSG00000213641	RPL7AP4	NA	
ENSG00000271484	ABI1P1	NA	
ENSG00000126777	KTN1	NA	
ENSG00000200742	Y_RNA	NA	
ENSG00000258784	AL355773.1	NA	
ENSG00000177350	RPL13AP3	NA	
ENSG00000258791	LINC00520	NA	
ENSG00000259868	AL163952.1	NA	
ENSG00000277763	AL138995.1	NA	
ENSG00000139946	PELI2	NA	
ENSG00000259483	AL355073.1	NA	
ENSG00000275569	AL355073.2	NA	
ENSG00000259719	LINC02284	NA	
ENSG00000070269	TMEM260	617478	STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME; SHDRA
ENSG00000258803	AL355103.1	NA	
ENSG00000258428	AL161757.2	NA	
ENSG00000259133	AL161757.5	NA	
ENSG00000242995	AL161757.1	NA	
ENSG00000258703	AL161757.3	NA	
ENSG00000165588	OTX2	610125	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5 RETINAL DYSTROPHY, EARLY-ONSET, WITH OR WITHOUT PITUITARY DYSFUNCTION, INCLUDED
ENSG00000165588	OTX2	613986	PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6
ENSG00000248550	OTX2-AS1	NA	
ENSG00000258776	AL161757.4	NA	
ENSG00000243801	RN7SL461P	NA	
ENSG00000200818	RNU6-1204P	NA	
ENSG00000286257	AL137100.3	NA	
ENSG00000243388	RPL3P3	NA	
ENSG00000258758	AL137100.1	NA	
ENSG00000259136	AL137100.2	NA	
ENSG00000258592	AL391152.1	NA	
ENSG00000070367	EXOC5	NA	
ENSG00000053770	AP5M1	NA	
ENSG00000286355	AL355834.2	NA	
ENSG00000259008	AL355834.1	NA	
ENSG00000139977	NAA30	NA	
ENSG00000100557	CCDC198	NA	
ENSG00000151812	SLC35F4	NA	
ENSG00000259039	AL161804.1	NA	
ENSG00000258856	AL136520.1	NA	
ENSG00000252837	RN7SKP99	NA	
ENSG00000259969	AL049838.1	NA	
ENSG00000139971	ARMH4	NA	
ENSG00000258836	AL121579.2	NA	
ENSG00000243023	UBA52P3	NA	
ENSG00000243700	RN7SL598P	NA	
ENSG00000258519	AL121579.1	NA	
ENSG00000131966	ACTR10	NA	
ENSG00000100567	PSMA3	NA	
ENSG00000258682	AL132989.1	NA	
ENSG00000257621	PSMA3-AS1	NA	
ENSG00000180189	HMGB1P14	NA	
ENSG00000279636	LINC00216	NA	
ENSG00000252782	RNU6-341P	NA	
ENSG00000032219	ARID4A	NA	
ENSG00000258658	AL139021.3	NA	
ENSG00000196860	TOMM20L	NA	
ENSG00000258378	AL139021.2	NA	
ENSG00000100575	TIMM9	NA	
ENSG00000100578	KIAA0586	616490	JOUBERT SYNDROME 23; JBTS23
ENSG00000100578	KIAA0586	616546	SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14
ENSG00000252198	AL139021.1	NA	
ENSG00000258650	HSBP1P1	NA	
ENSG00000258900	HNRNPCP1	NA	
ENSG00000239510	RPL9P5	NA	
ENSG00000165617	DACT1	617466	TOWNES-BROCKS SYNDROME 2; TBS2
ENSG00000258583	LINC01500	NA	
ENSG00000213598	AL049873.1	NA	
ENSG00000258734	AL049873.2	NA	
ENSG00000258685	AL359219.1	NA	
ENSG00000258996	PPIAP5	NA	
ENSG00000100592	DAAM1	NA	
ENSG00000181619	GPR135	NA	
ENSG00000126790	L3HYPDH	NA	
ENSG00000258782	AL121694.1	NA	
ENSG00000050130	JKAMP	NA	
ENSG00000151838	CCDC175	NA	
ENSG00000139970	RTN1	NA	
ENSG00000263629	MIR5586	NA	
ENSG00000261120	AL133299.1	NA	
ENSG00000131951	LRRC9	NA	
ENSG00000258553	AL157911.1	NA	
ENSG00000126773	PCNX4	NA	
ENSG00000100612	DHRS7	NA	
ENSG00000258896	SCOCP1	NA	
ENSG00000258563	PSMA3P	NA	
ENSG00000242135	RPL17P2	NA	
ENSG00000254718	AL157756.1	NA	
ENSG00000100614	PPM1A	NA	
ENSG00000258556	LINC02322	NA	
ENSG00000179008	C14orf39	NA	
ENSG00000258427	RBM8B	NA	
ENSG00000259169	GNRHR2P1	NA	
ENSG00000258692	SALL4P7	NA	
ENSG00000184302	SIX6	206900	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3;;MICROPHTHALMIA AND ESOPHAGEAL ATRESIA SYNDROME;;ANOPHTHALMIA, CLINICAL, WITH ASSOCIATED ANOMALIES;;ANOPHTHALMIA-ESOPHAGEAL-GENITAL SYNDROME;;AEG SYNDROME OPTIC NERVE HYPOPLASIA AND ABNORMALITIES OF THE CENTRAL NE /.../SYSTEM, INCLUDED
ENSG00000184302	SIX6	212550	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD
ENSG00000258670	AL049874.3	NA	
ENSG00000258764	AL049874.4	NA	
ENSG00000244756	AL049874.2	NA	
ENSG00000241354	AL049874.1	NA	
ENSG00000258952	SALRNA1	NA	
ENSG00000126778	SIX1	113650	BRANCHIOOTORENAL SYNDROME 1; BOR1;;BRANCHIOOTORENAL DYSPLASIA;;MELNICK-FRASER SYNDROME
ENSG00000126778	SIX1	605192	DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23
ENSG00000126778	SIX1	608389	BRANCHIOOTIC SYNDROME 3; BOS3;;BO SYNDROME 3
ENSG00000100625	SIX4	NA	
ENSG00000020426	MNAT1	NA	
ENSG00000258445	AL132777.1	NA	
ENSG00000258892	AL160236.2	NA	
ENSG00000258485	SRMP2	NA	
ENSG00000126814	TRMT5	616539	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26
ENSG00000258656	AL160236.1	NA	
ENSG00000206870	RNU6-398P	NA	
ENSG00000139974	SLC38A6	NA	
ENSG00000027075	PRKCH	601367	STROKE, ISCHEMIC;;CEREBROVASCULAR ACCIDENT;;CEREBRAL INFARCTION
ENSG00000182107	TMEM30B	NA	
ENSG00000247287	AL359220.1	NA	
ENSG00000258989	AL355916.3	NA	
ENSG00000258926	AL355916.2	NA	
ENSG00000250548	LINC01303	NA	
ENSG00000232774	AL355916.1	NA	
ENSG00000258777	HIF1A-AS1	NA	
ENSG00000100644	HIF1A	NA	
ENSG00000258667	HIF1A-AS3	NA	
ENSG00000258964	AL137129.1	NA	
ENSG00000023608	SNAPC1	NA	
ENSG00000279633	AL137918.1	NA	
ENSG00000139973	SYT16	NA	
ENSG00000258956	COX4I1P1	NA	
ENSG00000258842	AL390816.1	NA	
ENSG00000258903	AL390816.2	NA	
ENSG00000186369	LINC00643	NA	
ENSG00000259142	LINC00644	NA	
ENSG00000270852	AL390816.3	NA	
ENSG00000258638	AL389895.1	NA	
ENSG00000258877	ATP5F1AP4	NA	
ENSG00000140015	KCNH5	NA	
ENSG00000259093	AL137191.1	NA	
ENSG00000258995	PARP1P2	NA	
ENSG00000126785	RHOJ	NA	
ENSG00000258943	AL049871.1	NA	
ENSG00000179600	GPHB5	NA	
ENSG00000154001	PPP2R5E	NA	
ENSG00000252800	AL132992.1	NA	
ENSG00000261242	AL136038.5	NA	
ENSG00000205767	AL136038.2	NA	
ENSG00000270878	AL136038.6	NA	
ENSG00000140006	WDR89	NA	
ENSG00000258800	AL136038.4	NA	
ENSG00000258645	HSPE1P2	NA	
ENSG00000202490	RNU6-597P	NA	
ENSG00000206822	AL136038.3	NA	
ENSG00000207172	RNU6-1162P	NA	
ENSG00000274015	AL136038.7	NA	
ENSG00000200693	AL136038.1	NA	
ENSG00000126821	SGPP1	NA	
ENSG00000258778	AL161670.2	NA	
ENSG00000252749	RNU7-116P	NA	
ENSG00000054654	SYNE2	612999	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5
ENSG00000258411	AL161670.1	NA	
ENSG00000270912	RPS28P1	NA	
ENSG00000202182	AL162832.1	NA	
ENSG00000140009	ESR2	618187	OVARIAN DYSGENESIS 8; ODG8
ENSG00000221537	MIR548H1	NA	
ENSG00000214770	AL161756.1	NA	
ENSG00000234911	TEX21P	NA	
ENSG00000284664	AL161756.3	NA	
ENSG00000271511	AL161756.2	NA	
ENSG00000100714	MTHFD1	601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS;;NTD, FOLATE-SENSITIVE  SPINA BIFIDA, FOLATE-SENSITIVE, INCLUDED
ENSG00000100714	MTHFD1	617780	COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH;;METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1 DEFICIENCY
ENSG00000258824	AL122035.1	NA	
ENSG00000272909	AL122035.2	NA	
ENSG00000089775	ZBTB25	NA	
ENSG00000179841	AKAP5	NA	
ENSG00000126804	ZBTB1	NA	
ENSG00000259116	AL049869.3	NA	
ENSG00000259160	AL049869.4	NA	
ENSG00000126803	HSPA2	NA	
ENSG00000165807	PPP1R36	NA	
ENSG00000259076	AL049869.2	NA	
ENSG00000259010	AL049869.1	NA	
ENSG00000126822	PLEKHG3	NA	
ENSG00000070182	SPTB	616649	SPHEROCYTOSIS, TYPE 2; SPH2;;SPHEROCYTOSIS, HEREDITARY, 2; HS2
ENSG00000070182	SPTB	617948	ELLIPTOCYTOSIS 3; EL3 ANEMIA, PERINATAL HEMOLYTIC, FATAL OR NEAR-FATAL, INCLUDED
ENSG00000284269	MIR7855	NA	
ENSG00000252497	RPPH1-2P	NA	
ENSG00000258289	CHURC1	NA	
ENSG00000125954	CHURC1-FNTB	NA	
ENSG00000176153	GPX2	NA	
ENSG00000139998	RAB15	NA	
ENSG00000257365	FNTB	NA	
ENSG00000272158	AL139022.2	NA	
ENSG00000125952	MAX	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000266531	MIR4706	NA	
ENSG00000259118	AL139022.1	NA	
ENSG00000222985	RNU2-14P	NA	
ENSG00000255002	LINC02324	NA	
ENSG00000258878	AL355076.3	NA	
ENSG00000258760	AL355076.2	NA	
ENSG00000258613	RPL21P7	NA	
ENSG00000214759	AL355076.1	NA	
ENSG00000259078	PTBP1P	NA	
ENSG00000266740	MIR4708	NA	
ENSG00000033170	FUT8	618005	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1;;CDGF
ENSG00000276116	FUT8-AS1	NA	
ENSG00000180662	RPL21P8	NA	
ENSG00000207781	MIR625	NA	
ENSG00000258980	EIF1AXP2	NA	
ENSG00000258629	AL391261.1	NA	
ENSG00000258960	AL391261.3	NA	
ENSG00000258847	AL391261.2	NA	
ENSG00000277651	AL391261.4	NA	
ENSG00000224861	YBX1P1	NA	
ENSG00000258502	LINC02290	NA	
ENSG00000200860	Y_RNA	NA	
ENSG00000258561	AL359232.1	NA	
ENSG00000287833	AL157997.1	NA	
ENSG00000196553	CCDC196	NA	
ENSG00000171723	GPHN	149400	HYPEREKPLEXIA 1; HKPX1;;STARTLE DISEASE, FAMILIAL;;STARTLE REACTION, EXAGGERATED;;EXAGGERATED STARTLE REACTION;;STHE;;STIFF-BABY SYNDROME;;STIFF-MAN SYNDROME, CONGENITAL;;STIFF-PERSON SYNDROME, CONGENITAL;;KOK DISEASE
ENSG00000171723	GPHN	615501	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC
ENSG00000258796	AL133241.1	NA	
ENSG00000258490	AL049835.1	NA	
ENSG00000172717	FAM71D	NA	
ENSG00000258988	AL135978.1	NA	
ENSG00000072415	MPP5	NA	
ENSG00000286319	AL135978.2	NA	
ENSG00000100554	ATP6V1D	NA	
ENSG00000199755	Y_RNA	NA	
ENSG00000134001	EIF2S1	NA	
ENSG00000100558	PLEK2	NA	
ENSG00000265993	MIR5694	NA	
ENSG00000198133	TMEM229B	NA	
ENSG00000054690	PLEKHH1	NA	
ENSG00000100564	PIGH	618010	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17
ENSG00000259502	AL132640.1	NA	
ENSG00000259648	AL132640.2	NA	
ENSG00000281228	AL132640.3	NA	
ENSG00000201529	Y_RNA	NA	
ENSG00000081181	ARG2	NA	
ENSG00000286861	AL049779.4	NA	
ENSG00000100568	VTI1B	NA	
ENSG00000258626	COX7A2P1	NA	
ENSG00000272253	RNA5SP386	NA	
ENSG00000258466	AL049779.1	NA	
ENSG00000072042	RDH11	616108	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS
ENSG00000139988	RDH12	612712	LEBER CONGENITAL AMAUROSIS 13; LCA13 RETINITIS PIGMENTOSA 53, INCLUDED; RP53, INCLUDED
ENSG00000241542	RN7SL369P	NA	
ENSG00000258618	RPL21P9	NA	
ENSG00000072121	ZFYVE26	270700	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME
ENSG00000271697	AL049779.3	NA	
ENSG00000239820	RN7SL213P	NA	
ENSG00000258759	AL049779.2	NA	
ENSG00000182185	RAD51B	NA	
ENSG00000274666	AL133370.2	NA	
ENSG00000258837	AL133370.1	NA	
ENSG00000244677	RN7SL706P	NA	
ENSG00000243546	RN7SL108P	NA	
ENSG00000240210	AL122013.1	NA	
ENSG00000258477	PPIAP6	NA	
ENSG00000287385	AL121820.3	NA	
ENSG00000259038	AL121820.2	NA	
ENSG00000258623	AL121820.1	NA	
ENSG00000242941	RPL12P7	NA	
ENSG00000287167	AL133313.1	NA	
ENSG00000287913	AL132986.1	NA	
ENSG00000207089	RNU6-921P	NA	
ENSG00000185650	ZFP36L1	NA	
ENSG00000270975	MAGOH3P	NA	
ENSG00000258565	BLZF2P	NA	
ENSG00000072110	ACTN1	615193	BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15;;MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, ACTN1-RELATED
ENSG00000258967	HMGN1P3	NA	
ENSG00000258531	BANF1P1	NA	
ENSG00000259062	ACTN1-AS1	NA	
ENSG00000242293	RPS29P1	NA	
ENSG00000139990	DCAF5	NA	
ENSG00000259165	DDX18P1	NA	
ENSG00000206768	Y_RNA	NA	
ENSG00000276063	AL391262.1	NA	
ENSG00000258957	AL359317.2	NA	
ENSG00000081177	EXD2	NA	
ENSG00000258520	AL359317.1	NA	
ENSG00000100626	GALNT16	NA	
ENSG00000280073	AL157996.1	NA	
ENSG00000100632	ERH	NA	
ENSG00000029364	SLC39A9	NA	
ENSG00000286424	AL157996.2	NA	
ENSG00000175985	PLEKHD1	NA	
ENSG00000244237	AL133445.1	NA	
ENSG00000267909	CCDC177	NA	
ENSG00000287310	AL133445.3	NA	
ENSG00000100647	SUSD6	NA	
ENSG00000273797	AL133445.2	NA	
ENSG00000100650	SRSF5	NA	
ENSG00000100652	SLC10A1	NA	
ENSG00000221060	AL157789.1	NA	
ENSG00000198732	SMOC1	206920	MICROPHTHALMIA WITH LIMB ANOMALIES; MLA;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS
ENSG00000242071	RPL7AP6	NA	
ENSG00000100678	SLC8A3	NA	
ENSG00000258422	AL160191.1	NA	
ENSG00000274330	AL160191.3	NA	
ENSG00000270610	AL160191.2	NA	
ENSG00000235812	ADAM21P1	NA	
ENSG00000259033	AL356804.1	NA	
ENSG00000133983	COX16	NA	
ENSG00000258644	SYNJ2BP-COX16	NA	
ENSG00000222640	RNU2-51P	NA	
ENSG00000213463	SYNJ2BP	NA	
ENSG00000257759	AL357153.2	NA	
ENSG00000139985	ADAM21	NA	
ENSG00000259158	ADAM20P1	NA	
ENSG00000252263	RNU6-659P	NA	
ENSG00000134007	ADAM20	NA	
ENSG00000274397	AL357153.4	NA	
ENSG00000133997	MED6	NA	
ENSG00000259115	AL357153.3	NA	
ENSG00000258951	KRT18P7	NA	
ENSG00000245466	AL357153.1	NA	
ENSG00000240837	RN7SL77P	NA	
ENSG00000133985	TTC9	NA	
ENSG00000258689	LINC01269	NA	
ENSG00000006432	MAP3K9	NA	
ENSG00000259153	AC004816.1	NA	
ENSG00000275630	AC004816.2	NA	
ENSG00000258431	AC004825.1	NA	
ENSG00000274818	AC004825.2	NA	
ENSG00000100731	PCNX1	NA	
ENSG00000287643	AC004825.3	NA	
ENSG00000258930	AC005230.1	NA	
ENSG00000258966	GTF3AP2	NA	
ENSG00000258571	PTTG4P	NA	
ENSG00000269927	AC004817.3	NA	
ENSG00000286423	AC004817.5	NA	
ENSG00000259907	AC004817.2	NA	
ENSG00000258517	AC004817.1	NA	
ENSG00000269945	AC004817.4	NA	
ENSG00000259146	AC005476.2	NA	
ENSG00000197555	SIPA1L1	NA	
ENSG00000259079	AC005476.1	NA	
ENSG00000207444	SNORD56B	NA	
ENSG00000242330	RN7SL683P	NA	
ENSG00000285612	AC004974.1	NA	
ENSG00000285518	AC004900.1	NA	
ENSG00000266869	AC005993.1	NA	
ENSG00000182732	RGS6	NA	
ENSG00000200298	Y_RNA	NA	
ENSG00000286333	AC004828.2	NA	
ENSG00000273830	MIR7843	NA	
ENSG00000258871	AC004828.1	NA	
ENSG00000205683	DPF3	NA	
ENSG00000285936	AL392024.1	NA	
ENSG00000206751	Y_RNA	NA	
ENSG00000119599	DCAF4	NA	
ENSG00000176043	AC007160.1	NA	
ENSG00000259015	AL442663.4	NA	
ENSG00000239544	AL442663.1	NA	
ENSG00000165861	ZFYVE1	NA	
ENSG00000241487	RN7SL586P	NA	
ENSG00000258813	AL442663.3	NA	
ENSG00000119707	RBM25	NA	
ENSG00000258448	AL442663.2	NA	
ENSG00000080815	PSEN1	172700	PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS
ENSG00000080815	PSEN1	600274	FRONTOTEMPORAL DEMENTIA; FTD;;FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU INCLUSIONS;;FTLD WITH TAU INCLUSIONS;;DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM;;FRONTOTEMPORAL DEMENTIA WITH PARKINSONISM;;FRONTOTEMPORAL LOBE DEMENTIA; FLDEM;;FTDP17;;MULTI /.../STEM TAUOPATHY WITH PRESENILE DEMENTIA; MSTD;;DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX; DDPAC;;WILHELMSEN-LYNCH DISEASE; WLD;;PALLIDOPONTONIGRAL DEGENERATION; PPND PICK COMPLEX, INCLUDED
ENSG00000080815	PSEN1	607822	ALZHEIMER DISEASE 3; AD;;ALZHEIMER DISEASE 3, EARLY-ONSET;;ALZHEIMER DISEASE, FAMILIAL, 3 ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES, INCLUDED;;ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND APRAXIA, I /.../D
ENSG00000080815	PSEN1	613694	CARDIOMYOPATHY, DILATED, 1U; CMD1U
ENSG00000080815	PSEN1	613737	ACNE INVERSA, FAMILIAL, 3; ACNINV3
ENSG00000259109	AC004858.1	NA	
ENSG00000100767	PAPLN	NA	
ENSG00000258376	AC004846.1	NA	
ENSG00000252839	RNU6-419P	NA	
ENSG00000258944	AC004846.2	NA	
ENSG00000133961	NUMB	NA	
ENSG00000285006	AC005280.3	NA	
ENSG00000284930	AC005280.2	NA	
ENSG00000251393	AC005280.1	NA	
ENSG00000187105	HEATR4	NA	
ENSG00000170468	RIOX1	NA	
ENSG00000258443	AC005225.1	NA	
ENSG00000258695	AC005225.3	NA	
ENSG00000184227	ACOT1	NA	
ENSG00000258408	NT5CP2	NA	
ENSG00000258603	AC005225.2	NA	
ENSG00000119673	ACOT2	NA	
ENSG00000258524	NT5CP1	NA	
ENSG00000279026	AC005225.4	NA	
ENSG00000177465	ACOT4	NA	
ENSG00000205669	ACOT6	NA	
ENSG00000258972	NDUFB8P1	NA	
ENSG00000119661	DNAL1	614017	CILIARY DYSKINESIA, PRIMARY, 16; CILD16;;CILIARY DYSKINESIA, PRIMARY, 16, WITH OR WITHOUT SITUS INVERSUS
ENSG00000251907	RNU6-240P	NA	
ENSG00000258660	AC006146.1	NA	
ENSG00000176903	PNMA1	NA	
ENSG00000156030	MIDEAS	NA	
ENSG00000264741	MIR4505	NA	
ENSG00000259065	AC005520.2	NA	
ENSG00000258586	LINC02274	NA	
ENSG00000270576	AC005520.4	NA	
ENSG00000140043	PTGR2	NA	
ENSG00000258653	AC005520.1	NA	
ENSG00000223300	Y_RNA	NA	
ENSG00000273711	AC005520.5	NA	
ENSG00000119725	ZNF410	NA	
ENSG00000258891	AC005480.1	NA	
ENSG00000270140	AC005520.3	NA	
ENSG00000199472	Y_RNA	NA	
ENSG00000156050	FAM161B	NA	
ENSG00000119723	COQ6	614650	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6
ENSG00000187097	ENTPD5	NA	
ENSG00000279461	AC005480.2	NA	
ENSG00000119636	BBOF1	NA	
ENSG00000119711	ALDH6A1	614105	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD;;MMSDH DEFICIENCY
ENSG00000205659	LIN52	NA	
ENSG00000239910	RN7SL530P	NA	
ENSG00000258513	AC006349.1	NA	
ENSG00000119614	VSX2	610092	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3;;MICROPHTHALMIA, COLOBOMATOUS, ISOLATED 3  MICROPHTHALMIA, CATARACTS, AND IRIS ABNORMALITIES, INCLUDED
ENSG00000119614	VSX2	610093	MICROPHTHALMIA, ISOLATED 2; MCOP2;;ANOPHTHALMIA, CLINICAL, ISOLATED
ENSG00000119688	ABCD4	614857	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ
ENSG00000258559	AC005519.1	NA	
ENSG00000133980	VRTN	NA	
ENSG00000258737	SUB1P2	NA	
ENSG00000177776	RPS2P2	NA	
ENSG00000183379	SYNDIG1L	NA	
ENSG00000270000	AC005479.2	NA	
ENSG00000259005	AC005479.1	NA	
ENSG00000119655	NPC2	607625	NIEMANN-PICK DISEASE, TYPE C2; NPC2
ENSG00000283944	MIR4709	NA	
ENSG00000258769	RAP1AP	NA	
ENSG00000165898	ISCA2	616370	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4
ENSG00000119681	LTBP2	251750	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA
ENSG00000119681	LTBP2	600975	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B;;GLAUCOMA, PRIMARY CONGENITAL, TYPE B;;GLC3, TYPE B
ENSG00000119681	LTBP2	613086	GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D
ENSG00000119681	LTBP2	614819	WEILL-MARCHESANI SYNDROME 3; WMS3
ENSG00000258425	AC013451.1	NA	
ENSG00000258976	AC013451.2	NA	
ENSG00000119682	AREL1	NA	
ENSG00000258439	AC007956.2	NA	
ENSG00000222604	AC007956.1	NA	
ENSG00000119616	FCF1	NA	
ENSG00000119596	YLPM1	NA	
ENSG00000119608	PROX2	NA	
ENSG00000258587	AC006530.1	NA	
ENSG00000119689	DLST	618475	PARAGANGLIOMAS 7; PGL7
ENSG00000198208	RPS6KL1	NA	
ENSG00000119630	PGF	NA	
ENSG00000119718	EIF2B2	603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM;;CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION; CACH;;VANISHING WHITE MATTER LEUKODYSTROPHY;;CREE LEUKOENCEPHALOPATHY; CLE VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILU /.../CLUDED;;OVARIOLEUKODYSTROPHY, INCLUDED
ENSG00000258646	AL049780.1	NA	
ENSG00000279594	AL049780.3	NA	
ENSG00000119684	MLH3	608089	ENDOMETRIAL CANCER
ENSG00000119684	MLH3	614385	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7
ENSG00000206924	RNU6-689P	NA	
ENSG00000119640	ACYP1	NA	
ENSG00000119703	ZC2HC1C	NA	
ENSG00000119638	NEK9	614262	ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG
ENSG00000119638	NEK9	617022	LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10
ENSG00000119638	NEK9	617025	NEVUS COMEDONICUS; NC
ENSG00000258978	HIF1AP1	NA	
ENSG00000259138	AL049780.2	NA	
ENSG00000170348	TMED10	NA	
ENSG00000273565	AL691403.2	NA	
ENSG00000252013	RNU4ATAC14P	NA	
ENSG00000258740	AL691403.1	NA	
ENSG00000258820	AF111167.1	NA	
ENSG00000283519	U2	NA	
ENSG00000170345	FOS	NA	
ENSG00000119660	DPPA5P4	NA	
ENSG00000259687	LINC01220	NA	
ENSG00000259319	AF111167.2	NA	
ENSG00000140044	JDP2	NA	
ENSG00000156127	BATF	NA	
ENSG00000224721	AC007182.1	NA	
ENSG00000119686	FLVCR2	225790	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH;;HYDRANENCEPHALY, FOWLER TYPE;;FOWLER SYNDROME;;HYDROCEPHALY/HYDRANENCEPHALY DUE TO CEREBRAL VASCULOPATHY;;ENCEPHALOCLASTIC PROLIFERATIVE VASCULOPATHY; EPV
ENSG00000242951	AC007182.2	NA	
ENSG00000201096	RNA5SP387	NA	
ENSG00000280494	AC007182.3	NA	
ENSG00000119685	TTLL5	615860	CONE-ROD DYSTROPHY 19; CORD19
ENSG00000133935	ERG28	NA	
ENSG00000259103	AF107885.2	NA	
ENSG00000242488	AF107885.1	NA	
ENSG00000119650	IFT43	614099	CRANIOECTODERMAL DYSPLASIA 3; CED3
ENSG00000119650	IFT43	617866	SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18
ENSG00000119650	IFT43	617871	RETINITIS PIGMENTOSA 81; RP81
ENSG00000119699	TGFB3	107970	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1; ARVC1 UHL ANOMALY, INCLUDED;;CARDIOMYOPATHY, RIGHT VENTRICULAR DILATED, INCLUDED
ENSG00000119699	TGFB3	615582	LOEYS-DIETZ SYNDROME 5; LDS5;;RIENHOFF SYNDROME; RNHF
ENSG00000258876	TGFB3-AS1	NA	
ENSG00000258578	AC008015.1	NA	
ENSG00000283629	AC016526.4	NA	
ENSG00000089916	GPATCH2L	NA	
ENSG00000258454	AC016526.2	NA	
ENSG00000280078	AC016526.3	NA	
ENSG00000258402	AC016526.1	NA	
ENSG00000119715	ESRRB	608565	DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35
ENSG00000259124	AC008050.1	NA	
ENSG00000271423	CYCSP1	NA	
ENSG00000242952	RPSAP3	NA	
ENSG00000258566	AC007376.1	NA	
ENSG00000258569	AC007376.2	NA	
ENSG00000071246	VASH1	NA	
ENSG00000259081	AF111169.3	NA	
ENSG00000258610	AF111169.1	NA	
ENSG00000258301	VASH1-AS1	NA	
ENSG00000013523	ANGEL1	NA	
ENSG00000286437	AF111169.4	NA	
ENSG00000100565	LRRC74A	NA	
ENSG00000241081	RPL22P2	NA	
ENSG00000223174	RN7SKP17	NA	
ENSG00000259058	AF111169.2	NA	
ENSG00000285966	AC007686.4	NA	
ENSG00000258602	LINC01629	NA	
ENSG00000266553	RN7SL356P	NA	
ENSG00000243225	AC007686.1	NA	
ENSG00000119669	IRF2BPL	618088	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS
ENSG00000273729	AC007686.3	NA	
ENSG00000246548	LINC02288	NA	
ENSG00000258473	AC007686.2	NA	
ENSG00000258819	LINC02289	NA	
ENSG00000287004	AC007686.5	NA	
ENSG00000198894	CIPC	NA	
ENSG00000259164	AC007375.2	NA	
ENSG00000165548	TMEM63C	NA	
ENSG00000177108	ZDHHC22	NA	
ENSG00000269883	AC007375.3	NA	
ENSG00000258552	FAM204DP	NA	
ENSG00000201384	AC007375.1	NA	
ENSG00000165553	NGB	NA	
ENSG00000221754	MIR1260A	NA	
ENSG00000009830	POMT2	236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED;;HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA;;HARD SYNDROME;;CEREBROOCULAR DYSPLA /.../SCULAR DYSTROPHY SYNDROME;;COD-MD SYNDROME
ENSG00000009830	POMT2	613150	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED
ENSG00000009830	POMT2	613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2; MDDGB2;;MUSCULAR DYSTROPHY, CONGENITAL, POMT2-RELATED
ENSG00000009830	POMT2	613158	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 14; LGMDR14;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2N; LGMD2N;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED
ENSG00000100577	GSTZ1	617596	MALEYLACETOACETATE ISOMERASE DEFICIENCY; MAAID;;MAAI DEFICIENCY;;HYPERSUCCINYLACETONEMIA, MILD; MHSA;;BENIGN HYPERSUCCINYLACETONEMIA; BHSA
ENSG00000100580	TMED8	NA	
ENSG00000258510	AC007954.1	NA	
ENSG00000100583	SAMD15	NA	
ENSG00000165555	NOXRED1	NA	
ENSG00000151445	VIPAS39	613404	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2
ENSG00000100591	AHSA1	NA	
ENSG00000212371	AF111168.1	NA	
ENSG00000100593	ISM2	NA	
ENSG00000100596	SPTLC2	613640	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C;;HSAN IC;;NEUROPATHY, HEREDITARY SENSORY, TYPE IC; HSN1C;;HSN IC
ENSG00000240233	RN7SL587P	NA	
ENSG00000258668	COX6CP11	NA	
ENSG00000100601	ALKBH1	NA	
ENSG00000239272	RPL21P10	NA	
ENSG00000258917	ZMYND19P1	NA	
ENSG00000119705	SLIRP	NA	
ENSG00000100603	SNW1	NA	
ENSG00000197734	C14orf178	NA	
ENSG00000063761	ADCK1	NA	
ENSG00000199440	AC008372.1	NA	
ENSG00000258421	FXNP1	NA	
ENSG00000021645	NRXN3	NA	
ENSG00000199454	RNA5SP388	NA	
ENSG00000239438	RPS26P48	NA	
ENSG00000258723	AF099810.1	NA	
ENSG00000258719	AC009396.2	NA	
ENSG00000258874	AC009396.3	NA	
ENSG00000258478	AC009396.1	NA	
ENSG00000258829	AC026888.1	NA	
ENSG00000258419	AC022469.1	NA	
ENSG00000258662	AC022469.2	NA	
ENSG00000259106	AC008056.2	NA	
ENSG00000287118	AC008056.3	NA	
ENSG00000258637	AC008056.1	NA	
ENSG00000258416	AF123462.1	NA	
ENSG00000211448	DIO2	NA	
ENSG00000258766	DIO2-AS1	NA	
ENSG00000100629	CEP128	NA	
ENSG00000258452	AC022404.1	NA	
ENSG00000165409	TSHR	275200	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1;;THYROTROPIN RESISTANCE;;THYROID-STIMULATING HORMONE, RESISTANCE TO; RTSH;;TSH RESISTANCE;;HYPOTHYROIDISM, NONAUTOIMMUNE;;HYPOTHYROIDISM, CONGENITAL, DUE TO TSH RESISTANCE;;HYPOTHYROIDISM DUE TO UNRE /.../VENESS TO THYROTROPIN
ENSG00000165409	TSHR	603372	THYROID-STIMULATING HORMONE RECEPTOR; TSHR;;THYROTROPIN RECEPTOR;;LGR3 THYROID ADENOMA, HYPERFUNCTIONING, INCLUDED;;THYROID CARCINOMA WITH THYROTOXICOSIS, INCLUDED
ENSG00000165409	TSHR	603373	HYPERTHYROIDISM, FAMILIAL GESTATIONAL
ENSG00000165409	TSHR	609152	HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT
ENSG00000258915	BHLHB9P1	NA	
ENSG00000271705	RPL17P3	NA	
ENSG00000271656	AC007262.1	NA	
ENSG00000284959	AC007262.2	NA	
ENSG00000259167	NMNAT1P1	NA	
ENSG00000286686	AL136040.2	NA	
ENSG00000165417	GTF2A1	NA	
ENSG00000221303	SNORA79	NA	
ENSG00000273783	AL136040.1	NA	
ENSG00000205579	DYNLL1P1	NA	
ENSG00000270343	UNGP3	NA	
ENSG00000140022	STON2	NA	
ENSG00000242163	AL121769.1	NA	
ENSG00000258605	DYNLL1P2	NA	
ENSG00000258675	LINC02308	NA	
ENSG00000071537	SEL1L	NA	
ENSG00000258977	LINC01467	NA	
ENSG00000258841	EEF1A1P2	NA	
ENSG00000258718	LINC02311	NA	
ENSG00000259035	AL355838.1	NA	
ENSG00000241891	RPL9P6	NA	
ENSG00000258501	EIF3LP1	NA	
ENSG00000276782	Metazoa_SRP	NA	
ENSG00000258743	LINC02301	NA	
ENSG00000259032	ENSAP2	NA	
ENSG00000258683	AL355095.1	NA	
ENSG00000258600	AL359238.1	NA	
ENSG00000258426	AL162872.1	NA	
ENSG00000252369	RNU7-51P	NA	
ENSG00000238561	RNU6ATAC28P	NA	
ENSG00000258549	AL161713.1	NA	
ENSG00000258532	LINC02305	NA	
ENSG00000285826	AL356807.1	NA	
ENSG00000258762	MTND4P33	NA	
ENSG00000258923	MTND5P35	NA	
ENSG00000259012	MTCYBP27	NA	
ENSG00000251895	RNU6-976P	NA	
ENSG00000258506	AL163642.1	NA	
ENSG00000271712	AL163642.2	NA	
ENSG00000259044	AL357172.1	NA	
ENSG00000258902	AL049775.2	NA	
ENSG00000258814	LINC02329	NA	
ENSG00000259107	LINC00911	NA	
ENSG00000205562	AL049775.1	NA	
ENSG00000258945	AL049775.3	NA	
ENSG00000185070	FLRT2	NA	
ENSG00000258733	LINC02328	NA	
ENSG00000258912	LINC02316	NA	
ENSG00000286582	AL161753.1	NA	
ENSG00000258994	LINC02309	NA	
ENSG00000258804	LINC01148	NA	
ENSG00000259061	AL358292.1	NA	
ENSG00000258496	AL352955.1	NA	
ENSG00000258958	AL157688.1	NA	
ENSG00000258859	LINC02296	NA	
ENSG00000259028	AL135746.1	NA	
ENSG00000258770	LINC02330	NA	
ENSG00000258807	AL359237.1	NA	
ENSG00000259077	AL136501.1	NA	
ENSG00000054983	GALC	245200	KRABBE DISEASE;;GLOBOID CELL LEUKODYSTROPHY; GLD; GCL;;GLOBOID CELL LEUKOENCEPHALOPATHY;;GALACTOSYLCERAMIDE BETA-GALACTOSIDASE DEFICIENCY;;GALACTOCEREBROSIDASE DEFICIENCY;;GALC DEFICIENCY
ENSG00000259096	SHLD2P2	NA	
ENSG00000252783	RNU6-835P	NA	
ENSG00000140030	GPR65	NA	
ENSG00000258407	AL157955.1	NA	
ENSG00000258826	LINC01147	NA	
ENSG00000258867	LINC01146	NA	
ENSG00000258975	AL133279.2	NA	
ENSG00000259998	AL133279.3	NA	
ENSG00000258538	AL133279.1	NA	
ENSG00000100433	KCNK10	NA	
ENSG00000042317	SPATA7	604232	LEBER CONGENITAL AMAUROSIS 3; LCA3 RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED, INCLUDED
ENSG00000070778	PTPN21	NA	
ENSG00000258983	AL162171.2	NA	
ENSG00000222990	RNU4-22P	NA	
ENSG00000258789	AL162171.1	NA	
ENSG00000100722	ZC3H14	617125	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56; MRT56
ENSG00000278576	AL162171.3	NA	
ENSG00000165521	EML5	NA	
ENSG00000274492	AL121768.1	NA	
ENSG00000200653	RNU4-92P	NA	
ENSG00000165533	TTC8	613464	RETINITIS PIGMENTOSA 51; RP51
ENSG00000165533	TTC8	615985	BARDET-BIEDL SYNDROME 8; BBS8
ENSG00000207342	AL133238.1	NA	
ENSG00000283627	AL137785.1	NA	
ENSG00000258990	MPPE1P1	NA	
ENSG00000053254	FOXN3	NA	
ENSG00000277801	AL138478.1	NA	
ENSG00000259151	CAP2P1	NA	
ENSG00000258752	AL357093.2	NA	
ENSG00000258699	AL357093.1	NA	
ENSG00000258380	AL356805.1	NA	
ENSG00000259053	AL137230.2	NA	
ENSG00000258920	FOXN3-AS1	NA	
ENSG00000259073	FOXN3-AS2	NA	
ENSG00000201027	RN7SKP107	NA	
ENSG00000258792	AL137230.1	NA	
ENSG00000252655	Y_RNA	NA	
ENSG00000200312	RN7SKP255	NA	
ENSG00000259050	CHORDC2P	NA	
ENSG00000140025	EFCAB11	NA	
ENSG00000230997	RAB42P1	NA	
ENSG00000042088	TDP1	607250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1
ENSG00000152315	KCNK13	NA	
ENSG00000258544	GLRXP2	NA	
ENSG00000201351	Y_RNA	NA	
ENSG00000100764	PSMC1	NA	
ENSG00000119720	NRDE2	NA	
ENSG00000287437	AL161662.1	NA	
ENSG00000242571	RPL21P11	NA	
ENSG00000275198	AL512791.2	NA	
ENSG00000198668	CALM1	614916	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4
ENSG00000198668	CALM1	616247	LONG QT SYNDROME 14; LQT14
ENSG00000258424	AL512791.1	NA	
ENSG00000258678	LINC02317	NA	
ENSG00000233208	LINC00642	NA	
ENSG00000259789	AL096869.3	NA	
ENSG00000165914	TTC7B	NA	
ENSG00000258935	AL096869.1	NA	
ENSG00000259163	AL096869.2	NA	
ENSG00000258437	AL139193.1	NA	
ENSG00000258716	AL139193.2	NA	
ENSG00000287663	AL122020.2	NA	
ENSG00000213315	AL122020.1	NA	
ENSG00000258884	LINC02321	NA	
ENSG00000100784	RPS6KA5	NA	
ENSG00000133943	DGLUCY	NA	
ENSG00000252644	RNU7-30P	NA	
ENSG00000221102	SNORA11B	NA	
ENSG00000119714	GPR68	617217	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6; AI2A6
ENSG00000258875	AL135818.1	NA	
ENSG00000260810	AL135818.2	NA	
ENSG00000286607	AL135818.3	NA	
ENSG00000015133	CCDC88C	236600	HYDROCEPHALUS, CONGENITAL, 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY;;HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1, FORMERLY
ENSG00000015133	CCDC88C	616053	SPINOCEREBELLAR ATAXIA 40; SCA40
ENSG00000258798	AL133153.2	NA	
ENSG00000258446	AL133153.1	NA	
ENSG00000100796	PPP4R3A	NA	
ENSG00000278342	AL133373.1	NA	
ENSG00000279286	AL133373.2	NA	
ENSG00000133962	CATSPERB	NA	
ENSG00000268295	POLR3GP1	NA	
ENSG00000258774	NANOGP7	NA	
ENSG00000258962	AL121839.1	NA	
ENSG00000275154	U3	NA	
ENSG00000260711	AL121839.2	NA	
ENSG00000165929	TC2N	NA	
ENSG00000140092	FBLN5	219100	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE
ENSG00000140092	FBLN5	608895	NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION; HNARMD MACULAR DEGENERATION, AGE-RELATED, 3, INCLUDED; ARMD3, INCLUDED
ENSG00000140092	FBLN5	614434	CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2
ENSG00000100815	TRIP11	184260	ODONTOCHONDRODYSPLASIA; ODCD;;SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA;;GOLDBLATT SYNDROME
ENSG00000100815	TRIP11	200600	ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE
ENSG00000259020	AL049872.1	NA	
ENSG00000066427	ATXN3	109150	MACHADO-JOSEPH DISEASE; MJD;;SPINOCEREBELLAR ATAXIA 3; SCA3;;SPINOCEREBELLAR ATROPHY III;;AZOREAN NEUROLOGIC DISEASE;;SPINOPONTINE ATROPHY;;NIGROSPINODENTATAL DEGENERATION
ENSG00000183648	NDUFB1	NA	
ENSG00000165934	CPSF2	NA	
ENSG00000258481	AL133240.1	NA	
ENSG00000201097	RNU6-366P	NA	
ENSG00000286630	AL133240.2	NA	
ENSG00000140090	SLC24A4	210750	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6;;SKIN/HAIR/EYE PIGMENTATION 6, BLOND/BROWN HAIR;;SKIN/HAIR/EYE PIGMENTATION 6, BLUE/GREEN EYES
ENSG00000140090	SLC24A4	615887	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5
ENSG00000100599	RIN3	NA	
ENSG00000100600	LGMN	NA	
ENSG00000066455	GOLGA5	NA	
ENSG00000258742	LINC02833	NA	
ENSG00000258499	LINC02287	NA	
ENSG00000100604	CHGA	NA	
ENSG00000100605	ITPK1	NA	
ENSG00000258730	ITPK1-AS1	NA	
ENSG00000258595	AL110118.1	NA	
ENSG00000165943	MOAP1	NA	
ENSG00000153485	TMEM251	NA	
ENSG00000259066	AL110118.2	NA	
ENSG00000170270	GON7	NA	
ENSG00000012963	UBR7	NA	
ENSG00000240096	AL132838.1	NA	
ENSG00000011114	BTBD7	NA	
ENSG00000241499	AL132838.2	NA	
ENSG00000133958	UNC79	NA	
ENSG00000278396	AL122023.1	NA	
ENSG00000187581	COX8C	NA	
ENSG00000202306	Y_RNA	NA	
ENSG00000252720	RNU6-1258P	NA	
ENSG00000277826	AL157858.2	NA	
ENSG00000175785	PRIMA1	NA	
ENSG00000279593	AL132642.2	NA	
ENSG00000258584	FAM181A-AS1	NA	
ENSG00000140067	FAM181A	NA	
ENSG00000100628	ASB2	NA	
ENSG00000258987	AL132642.1	NA	
ENSG00000265768	MIR4506	NA	
ENSG00000175699	CCDC197	NA	
ENSG00000089723	OTUB2	NA	
ENSG00000089737	DDX24	NA	
ENSG00000165948	IFI27L1	NA	
ENSG00000165949	IFI27	NA	
ENSG00000119632	IFI27L2	NA	
ENSG00000119698	PPP4R4	NA	
ENSG00000140093	SERPINA10	NA	
ENSG00000170099	SERPINA6	611489	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY;;CBG DEFICIENCY;;TRANSCORTIN DEFICIENCY  CORTICOSTEROID-BINDING GLOBULIN, ELEVATED, INCLUDED
ENSG00000258597	SERPINA2	107410	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE; SERPINA2P;;PROTEASE INHIBITOR 1-LIKE; PIL;;ANTITRYPSIN-RELATED PROTEIN; ATR;;ALPHA-1-ANTITRYPSIN-RELATED GENE SEQUENCE; ARGS;;SERPINA2
ENSG00000197249	SERPINA1	613490	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD
ENSG00000256357	AL132708.1	NA	
ENSG00000186910	SERPINA11	NA	
ENSG00000170054	SERPINA9	NA	
ENSG00000165953	SERPINA12	NA	
ENSG00000287668	AL132990.1	NA	
ENSG00000100665	SERPINA4	NA	
ENSG00000188488	SERPINA5	NA	
ENSG00000273259	AL049839.2	NA	
ENSG00000288028	AL049839.3	NA	
ENSG00000196136	SERPINA3	NA	
ENSG00000258805	ADIPOR1P2	NA	
ENSG00000187483	SERPINA13P	NA	
ENSG00000259140	AL049839.1	NA	
ENSG00000239269	RPSAP4	NA	
ENSG00000133937	GSC	602471	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES; SAMS
ENSG00000285205	AL121612.2	NA	
ENSG00000240914	RPL15P2	NA	
ENSG00000274379	AL121612.1	NA	
ENSG00000258933	LINC02279	NA	
ENSG00000258866	AL390254.1	NA	
ENSG00000100697	DICER1	180295	RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2
ENSG00000100697	DICER1	138800	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1;;GOITER, NONTOXIC, WITH INTRATHYROIDAL CALCIFICATION;;MULTINODULAR GOITER, ADOLESCENT;;EUTHYROID GOITER;;SIMPLE GOITER
ENSG00000100697	DICER1	601200	PLEUROPULMONARY BLASTOMA; PPB;;PPB FAMILIAL TUMOR AND DYSPLASIA SYNDROME; PPBFTDS
ENSG00000100697	DICER1	618272	GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW;;GLOW SYNDROME
ENSG00000264607	MIR3173	NA	
ENSG00000235706	DICER1-AS1	NA	
ENSG00000165959	CLMN	NA	
ENSG00000259143	AL356017.1	NA	
ENSG00000258615	AL117187.1	NA	
ENSG00000287111	AL117187.2	NA	
ENSG00000258630	LINC02292	NA	
ENSG00000176438	SYNE3	NA	
ENSG00000258572	AL133467.1	NA	
ENSG00000247092	SNHG10	NA	
ENSG00000252481	SCARNA13	NA	
ENSG00000182512	GLRX5	616859	SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA; SPAHGC
ENSG00000182512	GLRX5	616860	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3
ENSG00000258390	LINC02318	NA	
ENSG00000258927	AL133467.2	NA	
ENSG00000270038	AL133467.4	NA	
ENSG00000187621	TCL6	NA	
ENSG00000275033	AL133467.5	NA	
ENSG00000259084	AL133467.3	NA	
ENSG00000277468	AL133467.6	NA	
ENSG00000213231	TCL1B	NA	
ENSG00000100721	TCL1A	NA	
ENSG00000257275	AL139020.1	NA	
ENSG00000258516	AL133167.1	NA	
ENSG00000250366	TUNAR	NA	
ENSG00000271358	AL137190.1	NA	
ENSG00000227051	C14orf132	NA	
ENSG00000168398	BDKRB2	NA	
ENSG00000258691	AL355102.2	NA	
ENSG00000258412	AL355102.1	NA	
ENSG00000258788	CKS1BP1	NA	
ENSG00000259036	AL355102.5	NA	
ENSG00000100739	BDKRB1	NA	
ENSG00000258793	AL355102.4	NA	
ENSG00000258729	AL355102.3	NA	
ENSG00000066739	ATG2B	NA	
ENSG00000100744	GSKIP	NA	
ENSG00000222276	RNU2-33P	NA	
ENSG00000140057	AK7	617965	SPERMATOGENIC FAILURE 27; SPGF27
ENSG00000259059	PEBP1P1	NA	
ENSG00000240051	RPL23AP10	NA	
ENSG00000260806	AL163051.1	NA	
ENSG00000090060	PAPOLA	NA	
ENSG00000258702	AL137786.1	NA	
ENSG00000223299	RN7SKP108	NA	
ENSG00000287350	AL137786.2	NA	
ENSG00000258979	LINC02299	NA	
ENSG00000287772	AL137786.3	NA	
ENSG00000100749	VRK1	607596	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A;;PCH1;;PONTOCEREBELLAR HYPOPLASIA WITH INFANTILE SPINAL MUSCULAR ATROPHY;;PONTOCEREBELLAR HYPOPLASIA WITH ANTERIOR HORN CELL DISEASE
ENSG00000225163	LINC00618	NA	
ENSG00000280070	AL049833.3	NA	
ENSG00000288034	AL049833.4	NA	
ENSG00000259026	AL049833.2	NA	
ENSG00000258393	AL049833.1	NA	
ENSG00000259110	LINC02304	NA	
ENSG00000285584	AL158800.1	NA	
ENSG00000246084	LINC02325	NA	
ENSG00000197176	LINC02291	NA	
ENSG00000287501	AL163872.1	NA	
ENSG00000258869	LINC02312	NA	
ENSG00000258379	AL355097.1	NA	
ENSG00000246223	LINC01550	NA	
ENSG00000259097	AL163932.1	NA	
ENSG00000258511	LINC02295	NA	
ENSG00000241757	RN7SL714P	NA	
ENSG00000258795	AL132719.1	NA	
ENSG00000176605	C14orf177	NA	
ENSG00000237342	AL132796.1	NA	
ENSG00000278990	AL132796.3	NA	
ENSG00000259119	AL132796.2	NA	
ENSG00000232573	RPL3P4	NA	
ENSG00000234648	AL162151.2	NA	
ENSG00000287991	AL162151.3	NA	
ENSG00000229402	AL162151.1	NA	
ENSG00000127152	BCL11B	617237	IMMUNODEFICIENCY 49; IMD49;;SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WITH INTELLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WIT /.../LLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES
ENSG00000127152	BCL11B	618092	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA
ENSG00000235785	AL109767.1	NA	
ENSG00000258383	AL132819.1	NA	
ENSG00000183576	SETD3	NA	
ENSG00000272439	RNU6-91P	NA	
ENSG00000090061	CCNK	618147	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF CHROMOSOME 14q32 DELETION SYNDROME, INCLUDED
ENSG00000205476	CCDC85C	NA	
ENSG00000258749	AL110504.1	NA	
ENSG00000200506	Y_RNA	NA	
ENSG00000247970	AL160313.1	NA	
ENSG00000182218	HHIPL1	NA	
ENSG00000036530	CYP46A1	NA	
ENSG00000258672	AL160313.2	NA	
ENSG00000066629	EML1	600348	BAND HETEROTOPIA; BH
ENSG00000199836	RNU1-47P	NA	
ENSG00000271198	VDAC3P1	NA	
ENSG00000196405	EVL	NA	
ENSG00000242888	AL133368.1	NA	
ENSG00000258693	AL133368.2	NA	
ENSG00000258560	AL157912.1	NA	
ENSG00000265154	MIR151B	NA	
ENSG00000199082	MIR342	NA	
ENSG00000168350	DEGS2	NA	
ENSG00000258982	AL133523.1	NA	
ENSG00000100811	YY1	617557	GABRIELE-DE VRIES SYNDROME; GADEVS
ENSG00000258904	AL157871.5	NA	
ENSG00000283840	MIR6764	NA	
ENSG00000259052	AL157871.6	NA	
ENSG00000197119	SLC25A29	NA	
ENSG00000258504	AL157871.1	NA	
ENSG00000198984	MIR345	NA	
ENSG00000243976	RN7SL523P	NA	
ENSG00000140107	SLC25A47	NA	
ENSG00000258666	AL157871.4	NA	
ENSG00000140105	WARS1	617721	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; DHMN9
ENSG00000258521	AL157871.2	NA	
ENSG00000258581	AL157871.3	NA	
ENSG00000176473	WDR25	NA	
ENSG00000258620	AL135838.1	NA	
ENSG00000258500	AL845552.1	NA	
ENSG00000253075	RN7SKP92	NA	
ENSG00000183092	BEGAIN	NA	
ENSG00000259031	AL845552.2	NA	
ENSG00000258576	AL163974.1	NA	
ENSG00000196273	LINC00523	NA	
ENSG00000258717	AL132711.1	NA	
ENSG00000185559	DLK1	NA	
ENSG00000214548	MEG3	NA	
ENSG00000266461	MIR2392	NA	
ENSG00000275161	AL117190.5	NA	
ENSG00000274884	AL117190.3	NA	
ENSG00000276919	AL117190.7	NA	
ENSG00000258663	AL117190.2	NA	
ENSG00000258399	AL117190.1	NA	
ENSG00000211574	MIR770	NA	
ENSG00000207989	MIR493	NA	
ENSG00000199151	MIR337	NA	
ENSG00000283159	MIR665	NA	
ENSG00000254656	RTL1	NA	
ENSG00000208001	MIR431	NA	
ENSG00000207569	MIR433	NA	
ENSG00000207608	MIR127	NA	
ENSG00000272458	MIR432	NA	
ENSG00000207942	MIR136	NA	
ENSG00000225746	MEG8	NA	
ENSG00000276225	AL117190.6	NA	
ENSG00000275662	SNORD112	NA	
ENSG00000275134	AL117190.4	NA	
ENSG00000199005	MIR370	NA	
ENSG00000202191	SNORD113-1	NA	
ENSG00000212384	SNORD113-2	NA	
ENSG00000201700	SNORD113-3	NA	
ENSG00000201672	SNORD113-4	NA	
ENSG00000272474	SNORD113-5	NA	
ENSG00000200215	SNORD113-6	NA	
ENSG00000200632	SNORD113-7	NA	
ENSG00000200367	SNORD113-8	NA	
ENSG00000201950	SNORD113-9	NA	
ENSG00000199575	SNORD114-1	NA	
ENSG00000200823	SNORD114-2	NA	
ENSG00000201839	SNORD114-3	NA	
ENSG00000200832	SNORD114-4	NA	
ENSG00000199798	SNORD114-5	NA	
ENSG00000200150	AL132709.1	NA	
ENSG00000201263	SNORD114-6	NA	
ENSG00000199390	SNORD114-7	NA	
ENSG00000201240	SNORD114-9	NA	
ENSG00000200279	SNORD114-10	NA	
ENSG00000200608	SNORD114-11	NA	
ENSG00000202270	SNORD114-12	NA	
ENSG00000201247	SNORD114-13	NA	
ENSG00000199593	SNORD114-14	NA	
ENSG00000201557	SNORD114-15	NA	
ENSG00000199914	SNORD114-16	NA	
ENSG00000201569	SNORD114-17	NA	
ENSG00000202142	SNORD114-18	NA	
ENSG00000199942	SNORD114-19	NA	
ENSG00000201500	AL132709.3	NA	
ENSG00000201036	AL132709.2	NA	
ENSG00000201710	AL132709.4	NA	
ENSG00000202048	SNORD114-20	NA	
ENSG00000272344	SNORD114-21	NA	
ENSG00000202293	SNORD114-22	NA	
ENSG00000200406	SNORD114-23	NA	
ENSG00000201899	SNORD114-24	NA	
ENSG00000200612	SNORD114-25	NA	
ENSG00000200413	SNORD114-26	NA	
ENSG00000200636	SNORD114-27	NA	
ENSG00000200480	SNORD114-28	NA	
ENSG00000201689	SNORD114-29	NA	
ENSG00000201318	SNORD114-30	NA	
ENSG00000200089	SNORD114-31	NA	
ENSG00000222095	AL132709.5	NA	
ENSG00000222185	AL132709.6	NA	
ENSG00000199088	MIR379	NA	
ENSG00000199109	MIR411	NA	
ENSG00000207749	MIR299	NA	
ENSG00000198982	MIR380	NA	
ENSG00000221745	MIR1197	NA	
ENSG00000199069	MIR323A	NA	
ENSG00000211582	MIR758	NA	
ENSG00000207761	MIR329-1	NA	
ENSG00000207762	MIR329-2	NA	
ENSG00000194717	MIR494	NA	
ENSG00000221036	MIR1193	NA	
ENSG00000212040	MIR543	NA	
ENSG00000207743	MIR495	NA	
ENSG00000283279	MIR376C	NA	
ENSG00000283561	MIR376A2	NA	
ENSG00000207934	MIR654	NA	
ENSG00000283556	MIR376B	NA	
ENSG00000283588	MIR376A1	NA	
ENSG00000215957	MIR300	NA	
ENSG00000221525	MIR1185-1	NA	
ENSG00000221614	MIR1185-2	NA	
ENSG00000258861	MIR381HG	NA	
ENSG00000199020	MIR381	NA	
ENSG00000207754	MIR487B	NA	
ENSG00000202560	MIR539	NA	
ENSG00000216099	MIR889	NA	
ENSG00000207587	MIR544A	NA	
ENSG00000207646	MIR655	NA	
ENSG00000207742	MIR487A	NA	
ENSG00000283170	MIR382	NA	
ENSG00000207993	MIR134	NA	
ENSG00000276352	MIR668	NA	
ENSG00000208027	MIR485	NA	
ENSG00000208004	MIR323B	NA	
ENSG00000207978	MIR154	NA	
ENSG00000207961	MIR496	NA	
ENSG00000199015	MIR377	NA	
ENSG00000216179	MIR541	NA	
ENSG00000199107	MIR409	NA	
ENSG00000199012	MIR412	NA	
ENSG00000199025	MIR369	NA	
ENSG00000199092	MIR410	NA	
ENSG00000207959	MIR656	NA	
ENSG00000223403	MEG9	NA	
ENSG00000230805	AL132709.7	NA	
ENSG00000288302	AL132709.8	NA	
ENSG00000259004	LINC02285	NA	
ENSG00000286551	AL355836.3	NA	
ENSG00000277754	AL355836.2	NA	
ENSG00000288252	AL355836.5	NA	
ENSG00000288245	AL355836.4	NA	
ENSG00000258681	AL355836.1	NA	
ENSG00000258497	AL359682.1	NA	
ENSG00000258460	AL355096.1	NA	
ENSG00000259023	LINC00524	NA	
ENSG00000259082	LINC02314	NA	
ENSG00000259166	AL049836.2	NA	
ENSG00000258498	DIO3OS	NA	
ENSG00000283857	MIR1247	NA	
ENSG00000197406	DIO3	NA	
ENSG00000258919	AL049836.1	NA	
ENSG00000258404	LINC02320	NA	
ENSG00000241494	AL355032.1	NA	
ENSG00000258512	LINC00239	NA	
ENSG00000078304	PPP2R5C	NA	
ENSG00000259088	AL137779.2	NA	
ENSG00000207208	RNU6-790P	NA	
ENSG00000256705	AL137779.1	NA	
ENSG00000259161	AL137779.3	NA	
ENSG00000271780	AL118558.3	NA	
ENSG00000272444	AL118558.4	NA	
ENSG00000197102	DYNC1H1	158600	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1;;SMALED;;SPINAL MUSCULAR ATROPHY, CHILDHOOD, PROXIMAL, AUTOSOMAL DOMINANT;;SPINAL MUSCULAR ATROPHY, JUVENILE, PROXIMAL, AUTOSOMAL DOMINANT;;KUGELBERG-WELANDER SYNDR /.../UTOSOMAL DOMINANT
ENSG00000197102	DYNC1H1	614228	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2O;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2O
ENSG00000197102	DYNC1H1	614563	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 13, WITH NEURONAL MIGRATION DEFECTS
ENSG00000259013	AL118558.2	NA	
ENSG00000258959	AL118558.1	NA	
ENSG00000240457	RN7SL472P	NA	
ENSG00000080824	HSP90AA1	NA	
ENSG00000140153	WDR20	NA	
ENSG00000080823	MOK	NA	
ENSG00000022976	ZNF839	NA	
ENSG00000100865	CINP	NA	
ENSG00000196663	TECPR2	615031	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49
ENSG00000212330	RNU6-244P	NA	
ENSG00000156381	ANKRD9	NA	
ENSG00000266015	MIR4309	NA	
ENSG00000259230	LINC02323	NA	
ENSG00000239224	RN7SL546P	NA	
ENSG00000089902	RCOR1	NA	
ENSG00000230988	RPL23AP11	NA	
ENSG00000202459	Y_RNA	NA	
ENSG00000259508	AL132801.1	NA	
ENSG00000131323	TRAF3	614849	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5; IIAE5;;HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 3
ENSG00000206969	RNU6-1316P	NA	
ENSG00000166126	AMN	261100	MEGALOBLASTIC ANEMIA 1;;MGA1;;IMERSLUND-GRASBECK SYNDROME; IGS;;PERNICIOUS ANEMIA, JUVENILE, DUE TO SELECTIVE INTESTINAL MALABSORPTION OF VITAMIN B12, WITH PROTEINURIA;;ENTEROCYTE COBALAMIN MALABSORPTION;;ENTEROCYTE INTRINSIC FACTOR RECEPTOR, DEFECT OF
ENSG00000198752	CDC42BPB	NA	
ENSG00000259515	AL117209.1	NA	
ENSG00000213176	RPL13P6	NA	
ENSG00000283071	LBHD2	NA	
ENSG00000259444	AL161669.1	NA	
ENSG00000205436	EXOC3L4	NA	
ENSG00000288610	AL161669.4	NA	
ENSG00000259717	LINC00677	NA	
ENSG00000185215	TNFAIP2	NA	
ENSG00000259374	NDUFB4P11	NA	
ENSG00000259535	RPL21P12	NA	
ENSG00000259525	GCSHP2	NA	
ENSG00000251533	LINC00605	NA	
ENSG00000270705	AL161669.2	NA	
ENSG00000278071	AL161669.3	NA	
ENSG00000242837	RPL21P13	NA	
ENSG00000270938	RAP2CP1	NA	
ENSG00000240624	AL138976.1	NA	
ENSG00000259775	AL138976.2	NA	
ENSG00000100664	EIF5	NA	
ENSG00000272533	SNORA28	NA	
ENSG00000259428	HMGB3P26	NA	
ENSG00000243904	RPSAP5	NA	
ENSG00000075413	MARK3	618283	VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB
ENSG00000244691	RPL10AP1	NA	
ENSG00000166165	CKB	NA	
ENSG00000260285	AL133367.1	NA	
ENSG00000166166	TRMT61A	NA	
ENSG00000252469	RNU7-160P	NA	
ENSG00000258851	AL139300.2	NA	
ENSG00000166170	BAG5	NA	
ENSG00000126214	KLC1	NA	
ENSG00000256053	COA8	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000256500	AL139300.1	NA	
ENSG00000201184	RNU4-68P	NA	
ENSG00000246451	AL049840.2	NA	
ENSG00000270108	AL049840.7	NA	
ENSG00000269910	AL049840.4	NA	
ENSG00000269940	AL049840.5	NA	
ENSG00000269958	AL049840.6	NA	
ENSG00000126215	XRCC3	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000126215	XRCC3	613972	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6
ENSG00000100711	ZFYVE21	NA	
ENSG00000253096	AL049840.3	NA	
ENSG00000088808	PPP1R13B	NA	
ENSG00000270591	AL049840.8	NA	
ENSG00000202275	AL049840.1	NA	
ENSG00000258735	LINC00637	NA	
ENSG00000258534	AL132712.1	NA	
ENSG00000287346	AL132712.2	NA	
ENSG00000156411	ATP5MPL	NA	
ENSG00000156414	TDRD9	618110	SPERMATOGENIC FAILURE 30; SPGF30
ENSG00000227729	RD3L	NA	
ENSG00000242894	RN7SL634P	NA	
ENSG00000166183	ASPG	NA	
ENSG00000207568	MIR203A	NA	
ENSG00000283165	MIR203B	NA	
ENSG00000258748	AL359399.1	NA	
ENSG00000066735	KIF26A	NA	
ENSG00000258913	LINC02691	NA	
ENSG00000288459	AL512357.2	NA	
ENSG00000258598	AL512357.1	NA	
ENSG00000222761	RNU6-684P	NA	
ENSG00000213159	CEND1P1	NA	
ENSG00000258986	TMEM179	NA	
ENSG00000184601	C14orf180	NA	
ENSG00000259037	BX927359.1	NA	
ENSG00000258736	AL583722.2	NA	
ENSG00000260792	LINC02280	NA	
ENSG00000265291	MIR4710	NA	
ENSG00000203485	INF2	613237	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 5
ENSG00000203485	INF2	614455	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE;;CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS
ENSG00000258858	AL583722.3	NA	
ENSG00000185100	ADSS1	617030	MYOPATHY, DISTAL, 5; MPD5
ENSG00000184990	SIVA1	NA	
ENSG00000258430	AL583722.1	NA	
ENSG00000142208	AKT1	176920	PROTEUS SYNDROME;;GIGANTISM, PARTIAL, OF HANDS AND FEET, NEVI, HEMIHYPERTROPHY, AND MACROCEPHALY ELATTOPROTEUS SYNDROME, INCLUDED
ENSG00000142208	AKT1	167000	OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED
ENSG00000142208	AKT1	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000142208	AKT1	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000142208	AKT1	615109	COWDEN SYNDROME 6; CWS6
ENSG00000179627	ZBTB42	616248	LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6
ENSG00000279140	AL590326.1	NA	
ENSG00000258701	LINC00638	NA	
ENSG00000239365	RPS26P49	NA	
ENSG00000196183	RPS2P4	NA	
ENSG00000258811	AL583810.2	NA	
ENSG00000258593	AL583810.1	NA	
ENSG00000099814	CEP170B	NA	
ENSG00000259067	AL583810.3	NA	
ENSG00000166428	PLD4	NA	
ENSG00000185567	AHNAK2	NA	
ENSG00000140104	CLBA1	NA	
ENSG00000170779	CDCA4	NA	
ENSG00000183484	GPR132	NA	
ENSG00000257556	LINC02298	NA	
ENSG00000286636	AL512356.4	NA	
ENSG00000280244	AL512356.3	NA	
ENSG00000258154	AL512356.2	NA	
ENSG00000287459	AL512356.5	NA	
ENSG00000184916	JAG2	NA	
ENSG00000273778	MIR6765	NA	
ENSG00000257622	AL512356.1	NA	
ENSG00000183828	NUDT14	NA	
ENSG00000185024	BRF1	616202	CEREBELLOFACIODENTAL SYNDROME; CFDS;;CEREBELLAR-FACIAL-DENTAL SYNDROME
ENSG00000184887	BTBD6	NA	
ENSG00000179364	PACS2	618067	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66
ENSG00000279495	AL928654.4	NA	
ENSG00000242085	RPS20P33	NA	
ENSG00000226174	TEX22	NA	
ENSG00000251602	AL928654.1	NA	
ENSG00000182979	MTA1	NA	
ENSG00000257270	AL928654.2	NA	
ENSG00000182809	CRIP2	NA	
ENSG00000213145	CRIP1	NA	
ENSG00000257341	AL928654.3	NA	
ENSG00000185347	TEDC1	NA	
ENSG00000184986	TMEM121	NA	
ENSG00000230157	ATP5MC1P1	NA	
ENSG00000234402	ELK2BP	NA	
ENSG00000211890	IGHA2	NA	
ENSG00000211891	IGHE	NA	
ENSG00000211892	IGHG4	NA	
ENSG00000274172	MIR8071-1	NA	
ENSG00000211893	IGHG2	NA	
ENSG00000277030	MIR8071-2	NA	
ENSG00000253364	COPDA1	NA	
ENSG00000253755	IGHGP	NA	
ENSG00000213140	ELK2AP	NA	
ENSG00000211895	IGHA1	NA	
ENSG00000253692	IGHEP1	NA	
ENSG00000211896	IGHG1	NA	
ENSG00000211897	IGHG3	NA	
ENSG00000270371	AL122127.1	NA	
ENSG00000211898	IGHD	NA	
ENSG00000211899	IGHM	NA	
ENSG00000265612	MIR4539	NA	
ENSG00000264024	MIR4507	NA	
ENSG00000263413	MIR4538	NA	
ENSG00000264781	MIR4537	NA	
ENSG00000211900	IGHJ6	NA	
ENSG00000237111	IGHJ3P	NA	
ENSG00000242472	IGHJ5	NA	
ENSG00000240041	IGHJ4	NA	
ENSG00000242887	IGHJ3	NA	
ENSG00000237547	IGHJ2P	NA	
ENSG00000211904	IGHJ2	NA	
ENSG00000211905	IGHJ1	NA	
ENSG00000236597	IGHD7-27	NA	
ENSG00000227335	IGHJ1P	NA	
ENSG00000211907	IGHD1-26	NA	
ENSG00000225825	IGHD6-25	NA	
ENSG00000211909	IGHD5-24	NA	
ENSG00000227196	IGHD4-23	NA	
ENSG00000211911	IGHD3-22	NA	
ENSG00000211912	IGHD2-21	NA	
ENSG00000244620	AC246787.2	NA	
ENSG00000237020	IGHD1-20	NA	
ENSG00000211914	IGHD6-19	NA	
ENSG00000211915	IGHD5-18	NA	
ENSG00000227800	IGHD4-17	NA	
ENSG00000211917	IGHD3-16	NA	
ENSG00000211918	IGHD2-15	NA	
ENSG00000227108	IGHD1-14	NA	
ENSG00000211920	IGHD6-13	NA	
ENSG00000211921	IGHD5-12	NA	
ENSG00000232543	IGHD4-11	NA	
ENSG00000211923	IGHD3-10	NA	
ENSG00000211924	IGHD3-9	NA	
ENSG00000211925	IGHD2-8	NA	
ENSG00000237197	IGHD1-7	NA	
ENSG00000228131	IGHD6-6	NA	
ENSG00000211928	IGHD5-5	NA	
ENSG00000233655	IGHD4-4	NA	
ENSG00000211930	IGHD3-3	NA	
ENSG00000211931	IGHD2-2	NA	
ENSG00000226777	FAM30A	NA	
ENSG00000236170	IGHD1-1	NA	
ENSG00000211933	IGHV6-1	NA	
ENSG00000254279	IGHVII-1-1	NA	
ENSG00000271968	ADAM6	NA	
ENSG00000225200	AC246787.1	NA	
ENSG00000211934	IGHV1-2	NA	
ENSG00000253780	IGHVIII-2-1	NA	
ENSG00000211935	IGHV1-3	NA	
ENSG00000276775	IGHV4-4	NA	
ENSG00000282122	IGHV7-4-1	NA	
ENSG00000211937	IGHV2-5	NA	
ENSG00000253387	IGHVIII-5-1	NA	
ENSG00000254053	IGHVIII-5-2	NA	
ENSG00000253763	IGHV3-6	NA	
ENSG00000211938	IGHV3-7	NA	
ENSG00000282639	IGHV3-64D	NA	
ENSG00000282651	IGHV5-10-1	NA	
ENSG00000211941	IGHV3-11	NA	
ENSG00000254215	IGHVIII-11-1	NA	
ENSG00000254174	IGHV1-12	NA	
ENSG00000211942	IGHV3-13	NA	
ENSG00000253412	IGHVIII-13-1	NA	
ENSG00000253709	IGHV1-14	NA	
ENSG00000211943	IGHV3-15	NA	
ENSG00000253458	IGHVII-15-1	NA	
ENSG00000211944	IGHV3-16	NA	
ENSG00000283948	IGHVIII-16-1	NA	
ENSG00000254046	IGHV1-17	NA	
ENSG00000273894	SLC20A1P2	NA	
ENSG00000211945	IGHV1-18	NA	
ENSG00000253883	IGHV3-19	NA	
ENSG00000271201	AC247036.1	NA	
ENSG00000211946	IGHV3-20	NA	
ENSG00000211947	IGHV3-21	NA	
ENSG00000253957	IGHV3-22	NA	
ENSG00000253345	IGHVII-22-1	NA	
ENSG00000254045	IGHVIII-22-2	NA	
ENSG00000211949	IGHV3-23	NA	
ENSG00000211950	IGHV1-24	NA	
ENSG00000238275	HOMER2P2	NA	
ENSG00000276210	LINC00226	NA	
ENSG00000253441	IGHV3-25	NA	
ENSG00000253367	IGHVIII-25-1	NA	
ENSG00000211951	IGHV2-26	NA	
ENSG00000253462	IGHVIII-26-1	NA	
ENSG00000253482	IGHVII-26-2	NA	
ENSG00000254326	IGHV7-27	NA	
ENSG00000211952	IGHV4-28	NA	
ENSG00000253149	IGHVII-28-1	NA	
ENSG00000254289	IGHV3-32	NA	
ENSG00000270550	IGHV3-30	NA	
ENSG00000253491	IGHVII-30-1	NA	
ENSG00000253587	IGHV3-30-2	NA	
ENSG00000231475	IGHV4-31	NA	
ENSG00000283607	IGHVII-30-21	NA	
ENSG00000270474	IGHV3-29	NA	
ENSG00000211955	IGHV3-33	NA	
ENSG00000254203	IGHVII-33-1	NA	
ENSG00000253440	IGHV3-33-2	NA	
ENSG00000211956	IGHV4-34	NA	
ENSG00000253325	IGHV7-34-1	NA	
ENSG00000211957	IGHV3-35	NA	
ENSG00000253240	IGHV3-36	NA	
ENSG00000253359	IGHV3-37	NA	
ENSG00000211958	IGHV3-38	NA	
ENSG00000253989	IGHVIII-38-1	NA	
ENSG00000211959	IGHV4-39	NA	
ENSG00000253467	IGHV7-40	NA	
ENSG00000228757	AC244452.1	NA	
ENSG00000253294	IGHVII-40-1	NA	
ENSG00000278473	IGHV3-41	NA	
ENSG00000228966	HOMER2P1	NA	
ENSG00000254228	IGHV3-42	NA	
ENSG00000232216	IGHV3-43	NA	
ENSG00000283195	IGHVII-43-1	NA	
ENSG00000283562	IGHVIII-44	NA	
ENSG00000283464	AC244452.3	NA	
ENSG00000270816	LINC00221	NA	
ENSG00000253465	IGHVIV-44-1	NA	
ENSG00000253895	IGHVII-44-2	NA	
ENSG00000211961	IGHV1-45	NA	
ENSG00000211962	IGHV1-46	NA	
ENSG00000253808	IGHVII-46-1	NA	
ENSG00000229092	IGHV3-47	NA	
ENSG00000253862	IGHVIII-47-1	NA	
ENSG00000211964	IGHV3-48	NA	
ENSG00000211965	IGHV3-49	NA	
ENSG00000253386	IGHVII-49-1	NA	
ENSG00000253241	IGHV3-50	NA	
ENSG00000211966	IGHV5-51	NA	
ENSG00000254167	IGHV8-51-1	NA	
ENSG00000253941	IGHVII-51-2	NA	
ENSG00000253545	IGHV3-52	NA	
ENSG00000211967	IGHV3-53	NA	
ENSG00000253714	IGHVII-53-1	NA	
ENSG00000275475	IGHV3-54	NA	
ENSG00000254395	IGHV4-55	NA	
ENSG00000253131	IGHV7-56	NA	
ENSG00000253759	IGHV3-57	NA	
ENSG00000211968	IGHV1-58	NA	
ENSG00000224373	IGHV4-59	NA	
ENSG00000253742	IGHV3-60	NA	
ENSG00000199480	RNA5SP389	NA	
ENSG00000254329	IGHVII-60-1	NA	
ENSG00000211970	IGHV4-61	NA	
ENSG00000253132	IGHV3-62	NA	
ENSG00000253747	IGHVII-62-1	NA	
ENSG00000253936	IGHV3-63	NA	
ENSG00000223648	IGHV3-64	NA	
ENSG00000253209	IGHV3-65	NA	
ENSG00000253169	IGHVII-65-1	NA	
ENSG00000211972	IGHV3-66	NA	
ENSG00000253274	IGHV1-67	NA	
ENSG00000223506	SLC20A1P1	NA	
ENSG00000253820	IGHVII-67-1	NA	
ENSG00000254036	IGHVIII-67-2	NA	
ENSG00000253635	IGHVIII-67-3	NA	
ENSG00000254052	IGHVIII-67-4	NA	
ENSG00000253703	IGHV1-68	NA	
ENSG00000211973	IGHV1-69	NA	
ENSG00000211974	IGHV2-70D	NA	
ENSG00000282600	IGHV3-69-1	NA	
ENSG00000281990	IGHV1-69-2	NA	
ENSG00000283571	AC245369.1	NA	
ENSG00000280411	IGHV1-69D	NA	
ENSG00000274576	IGHV2-70	NA	
ENSG00000254056	IGHV3-71	NA	
ENSG00000225698	IGHV3-72	NA	
ENSG00000211976	IGHV3-73	NA	
ENSG00000224650	IGHV3-74	NA	
ENSG00000254134	IGHVII-74-1	NA	
ENSG00000254176	IGHV3-75	NA	
ENSG00000253247	IGHV3-76	NA	
ENSG00000253310	IGHVIII-76-1	NA	
ENSG00000265929	MIR5195	NA	
ENSG00000211978	IGHV5-78	NA	
ENSG00000253674	IGHVII-78-1	NA	
ENSG00000275747	IGHV3-79	NA	
ENSG00000283906	IGHV4-80	NA	
ENSG00000211979	IGHV7-81	NA	
ENSG00000253303	IGHVIII-82	NA	
ENSG00000215567	AC138701.1	NA	
ENSG00000201241	RNU6-978P	NA	
ENSG00000258463	AC138701.2	NA	
ENSG00000274347	AC127381.2	NA	
ENSG00000188403	IGHV1OR15-9	NA	
ENSG00000258706	SLC20A1P3	NA	
ENSG00000259337	IGHV1OR15-2	NA	
ENSG00000259490	IGHV3OR15-7	NA	
ENSG00000270961	IGHD5OR15-5A	NA	
ENSG00000271317	IGHD4OR15-4A	NA	
ENSG00000282520	IGHD3OR15-3A	NA	
ENSG00000282599	IGHD2OR15-2A	NA	
ENSG00000271336	IGHD1OR15-1A	NA	
ENSG00000277988	FAM30B	NA	
ENSG00000259769	AC127381.1	NA	
ENSG00000258397	BCAR1P1	NA	
ENSG00000239471	RN7SL584P	NA	
ENSG00000258410	AC087386.1	NA	
ENSG00000278935	AC087386.2	NA	
ENSG00000258780	BMS1P15	NA	
ENSG00000258628	AC126603.1	NA	
ENSG00000259156	CHEK2P2	NA	
ENSG00000287122	AC026495.2	NA	
ENSG00000258654	AC026495.1	NA	
ENSG00000180229	HERC2P3	NA	
ENSG00000258488	AC023310.1	NA	
ENSG00000277322	GOLGA6L6	NA	
ENSG00000258797	AC023310.3	NA	
ENSG00000181984	GOLGA8CP	NA	
ENSG00000278497	RN7SL759P	NA	
ENSG00000258916	SPATA31E2P	NA	
ENSG00000258707	AC023310.2	NA	
ENSG00000270685	IGHV1OR15-6	NA	
ENSG00000258590	NBEAP1	NA	
ENSG00000278626	AC023310.4	NA	
ENSG00000279628	AC131280.1	NA	
ENSG00000260409	AC012414.4	NA	
ENSG00000238478	RNU6-498P	NA	
ENSG00000259383	AC012414.2	NA	
ENSG00000259443	AC012414.3	NA	
ENSG00000258420	LONRF2P3	NA	
ENSG00000274499	AC012414.6	NA	
ENSG00000259089	GRAMD4P5	NA	
ENSG00000259214	AC012414.1	NA	
ENSG00000265322	MIR3118-2	NA	
ENSG00000230031	POTEB2	NA	
ENSG00000238489	RNU6-749P	NA	
ENSG00000261048	AC012414.5	NA	
ENSG00000261554	AC037471.2	NA	
ENSG00000258799	ZNF519P2	NA	
ENSG00000270831	NF1P1	NA	
ENSG00000266545	MIR5701-1	NA	
ENSG00000258710	LINC01193	NA	
ENSG00000258855	OR11J2P	NA	
ENSG00000258494	OR11J5P	NA	
ENSG00000270824	IGHD5OR15-5B	NA	
ENSG00000270451	IGHD4OR15-4B	NA	
ENSG00000282089	IGHD3OR15-3B	NA	
ENSG00000282268	IGHD2OR15-2B	NA	
ENSG00000270185	IGHD1OR15-1B	NA	
ENSG00000259698	FAM30C	NA	
ENSG00000259025	AC037471.1	NA	
ENSG00000258771	BCAR1P2	NA	
ENSG00000243059	RN7SL400P	NA	
ENSG00000260986	AC126335.1	NA	
ENSG00000279595	AC126335.2	NA	
ENSG00000258684	BMS1P16	NA	
ENSG00000258883	AC068446.3	NA	
ENSG00000237161	AC068446.1	NA	
ENSG00000247765	AC068446.2	NA	
ENSG00000207289	RNU6-1235P	NA	
ENSG00000280881	AC060814.4	NA	
ENSG00000280703	AC060814.3	NA	
ENSG00000258415	LONRF2P4	NA	
ENSG00000268531	AC060814.2	NA	
ENSG00000258712	CXADRP2	NA	
ENSG00000258767	AC060814.1	NA	
ENSG00000258848	GRAMD4P6	NA	
ENSG00000278522	POTEB3	NA	
ENSG00000277243	MIR3118-3	NA	
ENSG00000275174	U6	NA	
ENSG00000281347	NF1P9	NA	
ENSG00000277841	MIR5701-2	NA	
ENSG00000287345	AC183088.3	NA	
ENSG00000284834	AC183088.2	NA	
ENSG00000284788	AC183088.1	NA	
ENSG00000280709	LINC02203	NA	
ENSG00000284988	LINC02203	NA	
ENSG00000279639	AC135068.5	NA	
ENSG00000259324	OR11K1P	NA	
ENSG00000285491	AC135068.11	NA	
ENSG00000285116	AC135068.10	NA	
ENSG00000182974	AC135068.1	NA	
ENSG00000279408	AC135068.3	NA	
ENSG00000279445	AC135068.4	NA	
ENSG00000281113	AC135068.7	NA	
ENSG00000281087	AC135068.6	NA	
ENSG00000281179	AC135068.8	NA	
ENSG00000281550	AC135068.9	NA	
ENSG00000278263	AC135068.2	NA	
ENSG00000280655	AC134981.1	NA	
ENSG00000265793	MIR3118-4	NA	
ENSG00000233917	POTEB	NA	
ENSG00000200790	RNU6-631P	NA	
ENSG00000258585	ZNF519P3	NA	
ENSG00000258997	NF1P2	NA	
ENSG00000264902	MIR5701-3	NA	
ENSG00000283524	OR11J7P	NA	
ENSG00000285405	OR11J6P	NA	
ENSG00000284500	AC134980.2	NA	
ENSG00000258721	OR11H3P	NA	
ENSG00000285472	AC134980.3	NA	
ENSG00000283680	AC134980.1	NA	
ENSG00000285135	OR4Q1P	NA	
ENSG00000284892	OR4H6P	NA	
ENSG00000274102	OR4M2	NA	
ENSG00000183706	OR4N4	NA	
ENSG00000259435	OR4N3P	NA	
ENSG00000260739	AC010760.1	NA	
ENSG00000223877	RPS8P10	NA	
ENSG00000270505	IGHV1OR15-1	NA	
ENSG00000271288	IGHV1OR15-3	NA	
ENSG00000259261	IGHV4OR15-8	NA	
ENSG00000270356	IGHV1OR15-4	NA	
ENSG00000271507	AC025884.3	NA	
ENSG00000221641	MIR1268A	NA	
ENSG00000259098	AC025884.2	NA	
ENSG00000258732	AC025884.1	NA	
ENSG00000274835	AC100757.2	NA	
ENSG00000273679	AC100757.1	NA	
ENSG00000274279	SPATA31E3P	NA	
ENSG00000185182	GOLGA8EP	NA	
ENSG00000274568	RN7SL545P	NA	
ENSG00000275363	AC100757.3	NA	
ENSG00000277865	GOLGA6L22	NA	
ENSG00000281909	HERC2P7	NA	
ENSG00000276550	HERC2P2	NA	
ENSG00000277561	GOLGA8IP	NA	
ENSG00000277515	RN7SL495P	NA	
ENSG00000276141	WHAMMP3	NA	
ENSG00000277435	AC138649.2	NA	
ENSG00000283273	AC138649.5	NA	
ENSG00000277867	AC138649.4	NA	
ENSG00000275325	PDCD6IPP1	NA	
ENSG00000277755	AC138649.3	NA	
ENSG00000274253	AC138649.1	NA	
ENSG00000259425	AC011767.1	NA	
ENSG00000170113	NIPA1	600363	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 3; FSP3
ENSG00000140157	NIPA2	NA	
ENSG00000273749	CYFIP1	NA	
ENSG00000275835	TUBGCP5	NA	
ENSG00000276172	ELMO2P1	NA	
ENSG00000273976	GOLGA6L1	NA	
ENSG00000277505	AC116165.1	NA	
ENSG00000175676	GOLGA8DP	NA	
ENSG00000273981	RN7SL106P	NA	
ENSG00000274099	ABCB10P1	NA	
ENSG00000278541	AC116165.2	NA	
ENSG00000276941	MIR4509-1	NA	
ENSG00000278552	AC116165.3	NA	
ENSG00000259414	AC242376.1	NA	
ENSG00000274471	HERC2P7	NA	
ENSG00000273756	AC100756.3	NA	
ENSG00000260399	AC100756.1	NA	
ENSG00000261739	GOLGA8S	NA	
ENSG00000278222	RN7SL536P	NA	
ENSG00000286598	AC100756.4	NA	
ENSG00000261418	AC100756.2	NA	
ENSG00000174450	GOLGA6L2	NA	
ENSG00000265673	MIR4508	NA	
ENSG00000179455	MKRN3	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000179455	MKRN3	615346	PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2
ENSG00000260978	AC126407.1	NA	
ENSG00000254585	MAGEL2	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000254585	MAGEL2	615547	SCHAAF-YANG SYNDROME; SHFYNG;;PRADER-WILLI-LIKE SYNDROME; PWLS
ENSG00000182636	NDN	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000286973	AC087490.1	NA	
ENSG00000206616	RNU6-741P	NA	
ENSG00000260232	PWRN4	NA	
ENSG00000259905	PWRN1	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000260551	PWRN2	NA	
ENSG00000260780	AC087463.1	NA	
ENSG00000260959	AC087463.2	NA	
ENSG00000287888	AC087463.3	NA	
ENSG00000286110	AC090983.2	NA	
ENSG00000185823	NPAP1	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000128739	SNRPN	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000128739	SNRPN	209850	AUTISM;;AUTISTIC DISORDER AUTISM, SUSCEPTIBILITY TO, 1, INCLUDED; AUTS1, INCLUDED;;AUTISM SPECTRUM DISORDER, INCLUDED; ASD, INCLUDED
ENSG00000280118	AC090983.1	NA	
ENSG00000241061	RPL5P1	NA	
ENSG00000242088	AC090602.1	NA	
ENSG00000273173	SNURF	NA	
ENSG00000214265	AC124312.1	NA	
ENSG00000224078	SNHG14	NA	
ENSG00000276314	SNORD107	NA	
ENSG00000279192	PWAR5	NA	
ENSG00000276610	SNORD64	NA	
ENSG00000239014	SNORD108	NA	
ENSG00000257647	AC124312.2	NA	
ENSG00000274640	SNORD109A	NA	
ENSG00000207063	SNORD116-1	NA	
ENSG00000207001	SNORD116-2	NA	
ENSG00000207014	SNORD116-3	NA	
ENSG00000275529	SNORD116-4	NA	
ENSG00000207191	SNORD116-5	NA	
ENSG00000207442	SNORD116-6	NA	
ENSG00000207133	SNORD116-7	NA	
ENSG00000207093	SNORD116-8	NA	
ENSG00000206727	SNORD116-9	NA	
ENSG00000200661	SNORD116-10	NA	
ENSG00000206609	SNORD116-11	NA	
ENSG00000207197	SNORD116-12	NA	
ENSG00000207137	SNORD116-13	NA	
ENSG00000206621	SNORD116-14	NA	
ENSG00000207174	SNORD116-15	NA	
ENSG00000207263	SNORD116-16	NA	
ENSG00000206656	SNORD116-17	NA	
ENSG00000206688	SNORD116-18	NA	
ENSG00000207460	SNORD116-19	NA	
ENSG00000261069	AC124312.3	NA	
ENSG00000278715	SNORD116-20	NA	
ENSG00000277785	SNORD116-21	NA	
ENSG00000275127	SNORD116-22	NA	
ENSG00000287482	AC124312.5	NA	
ENSG00000207375	SNORD116-23	NA	
ENSG00000279735	AC124312.4	NA	
ENSG00000207279	SNORD116-24	NA	
ENSG00000252326	SNORD116-25	NA	
ENSG00000251815	SNORD116-26	NA	
ENSG00000251896	SNORD116-27	NA	
ENSG00000278123	SNORD116-28	NA	
ENSG00000207245	SNORD116-29	NA	
ENSG00000252277	SNORD116-30	NA	
ENSG00000279050	PWAR1	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000212428	AC124303.1	NA	
ENSG00000270814	DMAC1P1	NA	
ENSG00000201831	SNORD115-1	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000199712	SNORD115-2	NA	
ENSG00000199970	SNORD115-3	NA	
ENSG00000200680	SNORD115-4	NA	
ENSG00000200503	SNORD115-5	NA	
ENSG00000200812	SNORD115-6	NA	
ENSG00000278089	SNORD115-7	NA	
ENSG00000200726	SNORD115-8	NA	
ENSG00000199782	SNORD115-9	NA	
ENSG00000201943	SNORD115-10	NA	
ENSG00000200486	SNORD115-11	NA	
ENSG00000199453	SNORD115-12	NA	
ENSG00000273835	SNORD115-13	NA	
ENSG00000199960	SNORD115-14	NA	
ENSG00000201679	SNORD115-15	NA	
ENSG00000200757	SNORD115-16	NA	
ENSG00000201482	SNORD115-17	NA	
ENSG00000200163	SNORD115-18	NA	
ENSG00000199968	SNORD115-19	NA	
ENSG00000201969	SNORD115-20	NA	
ENSG00000199833	SNORD115-21	NA	
ENSG00000201326	SNORD115-22	NA	
ENSG00000201331	SNORD115-23	NA	
ENSG00000200398	SNORD115-24	NA	
ENSG00000199489	SNORD115-25	NA	
ENSG00000275524	SNORD115-26	NA	
ENSG00000201300	SNORD115-27	NA	
ENSG00000200801	SNORD115-28	NA	
ENSG00000199704	SNORD115-29	NA	
ENSG00000200987	SNORD115-30	NA	
ENSG00000202188	SNORD115-31	NA	
ENSG00000200949	SNORD115-32	NA	
ENSG00000200593	SNORD115-33	NA	
ENSG00000199311	SNORD115-34	NA	
ENSG00000201992	SNORD115-35	NA	
ENSG00000202499	SNORD115-36	NA	
ENSG00000200638	SNORD115-37	NA	
ENSG00000201907	SNORD115-38	NA	
ENSG00000200564	SNORD115-39	NA	
ENSG00000272460	SNORD115-40	NA	
ENSG00000200478	SNORD115-41	NA	
ENSG00000201143	SNORD115-42	NA	
ENSG00000202373	SNORD115-43	NA	
ENSG00000202261	SNORD115-44	NA	
ENSG00000280234	AC124303.2	NA	
ENSG00000212380	SNORD115-45	NA	
ENSG00000276844	SNORD115-46	NA	
ENSG00000212528	SNORD115-47	NA	
ENSG00000201634	SNORD115-48	NA	
ENSG00000239169	SNORD109B	NA	
ENSG00000114062	UBE3A	105830	ANGELMAN SYNDROME; AS;;HAPPY PUPPET SYNDROME, FORMERLY ANGELMAN SYNDROME CHROMOSOME REGION, INCLUDED; ANCR, INCLUDED
ENSG00000261529	AC100774.1	NA	
ENSG00000235731	LINC02250	NA	
ENSG00000223628	AC023449.1	NA	
ENSG00000206190	ATP10A	NA	
ENSG00000222123	RNA5SP390	NA	
ENSG00000266517	MIR4715	NA	
ENSG00000259011	AC016266.1	NA	
ENSG00000206187	LINC02346	NA	
ENSG00000258965	AC044913.2	NA	
ENSG00000212604	AC044913.1	NA	
ENSG00000258931	AC100836.1	NA	
ENSG00000259150	LINC00929	NA	
ENSG00000286884	AC012060.1	NA	
ENSG00000235160	LINC02248	NA	
ENSG00000287280	AC009878.2	NA	
ENSG00000166206	GABRB3	612269	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5
ENSG00000166206	GABRB3	617113	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43; EIEE43
ENSG00000278840	AC009878.1	NA	
ENSG00000235518	AC011196.1	NA	
ENSG00000242793	AC135999.1	NA	
ENSG00000186297	GABRA5	618559	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 79; EIEE79
ENSG00000259122	TVP23BP1	NA	
ENSG00000182256	GABRG3	NA	
ENSG00000228740	GABRG3-AS1	NA	
ENSG00000214254	AC136896.1	NA	
ENSG00000200326	RNA5SP391	NA	
ENSG00000258624	SERPINE4P	NA	
ENSG00000261426	AC144833.1	NA	
ENSG00000258970	AC104002.1	NA	
ENSG00000259152	AC104002.2	NA	
ENSG00000259168	AC104002.3	NA	
ENSG00000258594	AC021979.1	NA	
ENSG00000287922	AC021979.3	NA	
ENSG00000258853	AC021979.2	NA	
ENSG00000104044	OCA2	203200	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2;;OCULOCUTANEOUS ALBINISM, TYPE II;;OCULOCUTANEOUS ALBINISM, TYROSINASE-POSITIVE;;ALBINISM II ALBINISM, BROWN OCULOCUTANEOUS, INCLUDED; BOCA, INCLUDED;;BROWN OCULOCUTANEOUS ALBINISM, INCLUDED
ENSG00000104044	OCA2	227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR;;EYE COLOR, BROWN/BLUE;;EYE COLOR, BLUE/NONBLUE;;EYE C /.../; EYCL3;;BROWN EYE COLOR 2; BEY2;;HAIR COLOR 3; HCL3
ENSG00000232394	AC090696.1	NA	
ENSG00000228992	RPL5P32	NA	
ENSG00000128731	HERC2	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000128731	HERC2	227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR;;EYE COLOR, BROWN/BLUE;;EYE COLOR, BLUE/NONBLUE;;EYE C /.../; EYCL3;;BROWN EYE COLOR 2; BEY2;;HAIR COLOR 3; HCL3
ENSG00000128731	HERC2	615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38
ENSG00000256338	RPL41P2	NA	
ENSG00000261401	AC091304.3	NA	
ENSG00000261561	AC091304.5	NA	
ENSG00000237850	AC091304.1	NA	
ENSG00000261497	AC091304.4	NA	
ENSG00000153684	GOLGA8F	NA	
ENSG00000276891	RN7SL238P	NA	
ENSG00000261524	ABCB10P3	NA	
ENSG00000276928	AC091304.9	NA	
ENSG00000274532	AC091304.6	NA	
ENSG00000266039	MIR4509-2	NA	
ENSG00000284628	AC091304.10	NA	
ENSG00000260159	AC091304.2	NA	
ENSG00000261365	AC138749.4	NA	
ENSG00000263964	MIR4509-3	NA	
ENSG00000274814	AC138749.5	NA	
ENSG00000260053	ABCB10P4	NA	
ENSG00000183629	GOLGA8G	NA	
ENSG00000276955	Metazoa_SRP	NA	
ENSG00000261041	AC138749.3	NA	
ENSG00000227717	AC138749.1	NA	
ENSG00000260444	AC138749.2	NA	
ENSG00000261581	HERC2P11	NA	
ENSG00000206149	HERC2P9	NA	
ENSG00000254398	AC055876.2	NA	
ENSG00000188626	GOLGA8M	NA	
ENSG00000274632	RN7SL719P	NA	
ENSG00000261480	GOLGA8M	NA	
ENSG00000248334	WHAMMP2	NA	
ENSG00000260844	AC055876.4	NA	
ENSG00000232431	AC055876.1	NA	
ENSG00000256951	AC055876.3	NA	
ENSG00000261377	PDCD6IPP2	NA	
ENSG00000271616	AC055876.5	NA	
ENSG00000261649	GOLGA6L7	NA	
ENSG00000270301	AC174071.1	NA	
ENSG00000287894	AC174469.1	NA	
ENSG00000034053	APBA2	NA	
ENSG00000259277	AC127522.1	NA	
ENSG00000104059	FAM189A1	NA	
ENSG00000259299	AC061965.2	NA	
ENSG00000252868	AC061965.1	NA	
ENSG00000185115	NSMCE3	617241	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS
ENSG00000259690	AC107980.1	NA	
ENSG00000259814	AC102941.1	NA	
ENSG00000259300	TUBBP8	NA	
ENSG00000287334	AC102941.2	NA	
ENSG00000256802	AC022613.1	NA	
ENSG00000104067	TJP1	NA	
ENSG00000259644	AC022613.3	NA	
ENSG00000234664	HMGN2P5	NA	
ENSG00000259523	AC022613.2	NA	
ENSG00000259749	NCAPGP2	NA	
ENSG00000259647	AC111152.2	NA	
ENSG00000260174	AC111152.3	NA	
ENSG00000229389	AC111152.1	NA	
ENSG00000179938	GOLGA8J	NA	
ENSG00000273818	RN7SL673P	NA	
ENSG00000261792	DNM1P28	NA	
ENSG00000178081	ULK4P3	NA	
ENSG00000207432	U8	NA	
ENSG00000261247	GOLGA8T	NA	
ENSG00000277637	RN7SL469P	NA	
ENSG00000260897	DNM1P30	NA	
ENSG00000261747	AC120045.2	NA	
ENSG00000259906	AC120045.1	NA	
ENSG00000225930	LINC02249	NA	
ENSG00000259993	AC135731.1	NA	
ENSG00000206972	RNU6-17P	NA	
ENSG00000270955	AC135731.2	NA	
ENSG00000279417	AC019322.4	NA	
ENSG00000238783	Y_RNA	NA	
ENSG00000166664	CHRFAM7A	NA	
ENSG00000263070	AC019322.1	NA	
ENSG00000238519	U8	NA	
ENSG00000274966	AC019322.3	NA	
ENSG00000186399	GOLGA8R	NA	
ENSG00000274424	RN7SL196P	NA	
ENSG00000271333	AC019322.2	NA	
ENSG00000215302	AC127502.1	NA	
ENSG00000270055	AC127502.2	NA	
ENSG00000283345	AC127502.3	NA	
ENSG00000260784	AC026150.3	NA	
ENSG00000260693	AC026150.2	NA	
ENSG00000178115	GOLGA8Q	NA	
ENSG00000277031	RN7SL796P	NA	
ENSG00000259890	DNM1P50	NA	
ENSG00000260128	ULK4P2	NA	
ENSG00000207430	AC026150.1	NA	
ENSG00000261794	GOLGA8H	NA	
ENSG00000270016	AC026150.4	NA	
ENSG00000277467	RN7SL628P	NA	
ENSG00000269930	AC091057.4	NA	
ENSG00000247728	AC091057.3	NA	
ENSG00000285077	ARHGAP11B	NA	
ENSG00000284906	AC091057.6	NA	
ENSG00000285035	AC091057.7	NA	
ENSG00000187951	AC091057.1	NA	
ENSG00000206846	AC091057.2	NA	
ENSG00000284783	AC091057.5	NA	
ENSG00000103832	GOLGA8UP	NA	
ENSG00000278696	RN7SL82P	NA	
ENSG00000259845	HERC2P10	NA	
ENSG00000260382	AC087481.1	NA	
ENSG00000198690	FAN1	614817	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN
ENSG00000261628	AC087481.2	NA	
ENSG00000166912	MTMR10	NA	
ENSG00000212526	RNU6-466P	NA	
ENSG00000259720	AC009562.1	NA	
ENSG00000134160	TRPM1	613216	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE
ENSG00000207702	MIR211	NA	
ENSG00000259448	LINC02352	NA	
ENSG00000259772	AC012236.1	NA	
ENSG00000169926	KLF13	612001	CHROMOSOME 15q13.3 DELETION SYNDROME;;CHROMOSOME 15q13.3 MICRODELETION SYNDROME
ENSG00000259179	UBE2CP4	NA	
ENSG00000259696	AC104759.1	NA	
ENSG00000169918	OTUD7A	NA	
ENSG00000259358	AC026951.1	NA	
ENSG00000277500	AC026951.2	NA	
ENSG00000175344	CHRNA7	612001	CHROMOSOME 15q13.3 DELETION SYNDROME;;CHROMOSOME 15q13.3 MICRODELETION SYNDROME
ENSG00000206849	AC079969.1	NA	
ENSG00000201084	AC068448.1	NA	
ENSG00000279912	AC068448.2	NA	
ENSG00000271078	AC139426.3	NA	
ENSG00000207257	RNU6-18P	NA	
ENSG00000260211	AC139426.1	NA	
ENSG00000260642	AC139426.2	NA	
ENSG00000288627	AC139426.4	NA	
ENSG00000261491	DNM1P31	NA	
ENSG00000249931	GOLGA8K	NA	
ENSG00000275776	RN7SL185P	NA	
ENSG00000215304	AC135983.2	NA	
ENSG00000261279	ULK4P1	NA	
ENSG00000206987	AC135983.1	NA	
ENSG00000261708	DNM1P32	NA	
ENSG00000206127	GOLGA8O	NA	
ENSG00000274076	RN7SL539P	NA	
ENSG00000270789	AC135983.6	NA	
ENSG00000261375	AC135983.5	NA	
ENSG00000254912	AC135983.4	NA	
ENSG00000223509	AC135983.3	NA	
ENSG00000261064	LINC02256	NA	
ENSG00000276724	AC123768.3	NA	
ENSG00000262728	AC123768.2	NA	
ENSG00000232653	GOLGA8N	NA	
ENSG00000277464	RN7SL286P	NA	
ENSG00000244952	AC123768.1	NA	
ENSG00000198826	ARHGAP11A	NA	
ENSG00000285948	AC123768.4	NA	
ENSG00000166922	SCG5	NA	
ENSG00000241818	SCG5-AS1	NA	
ENSG00000259721	AC090877.2	NA	
ENSG00000166923	GREM1	NA	
ENSG00000248905	FMN1	NA	
ENSG00000259392	AC090877.1	NA	
ENSG00000212415	AC018515.1	NA	
ENSG00000259686	HNRNPA1P71	NA	
ENSG00000279958	AC019278.1	NA	
ENSG00000215296	TMCO5B	NA	
ENSG00000259446	AC055874.1	NA	
ENSG00000198838	RYR3	NA	
ENSG00000200008	AC087638.1	NA	
ENSG00000276702	AC010809.3	NA	
ENSG00000259408	AC010809.2	NA	
ENSG00000259287	AC010809.1	NA	
ENSG00000169857	AVEN	NA	
ENSG00000184984	CHRM5	NA	
ENSG00000278472	AC009268.2	NA	
ENSG00000287840	AC009268.3	NA	
ENSG00000259505	AC009268.1	NA	
ENSG00000134153	EMC7	NA	
ENSG00000243094	AC079203.1	NA	
ENSG00000182405	PGBD4	NA	
ENSG00000134152	KATNBL1	NA	
ENSG00000128463	EMC4	NA	
ENSG00000140199	SLC12A6	218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUS CALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY
ENSG00000259468	AC079203.2	NA	
ENSG00000207091	AC021822.1	NA	
ENSG00000182117	NOP10	224230	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1
ENSG00000184507	NUTM1	NA	
ENSG00000176454	LPCAT4	NA	
ENSG00000259904	ACTG1P15	NA	
ENSG00000175265	GOLGA8A	NA	
ENSG00000221649	MIR1233-1	NA	
ENSG00000260639	AC025678.1	NA	
ENSG00000261081	AC025678.2	NA	
ENSG00000279092	AC025678.3	NA	
ENSG00000259917	HNRNPLP2	NA	
ENSG00000261559	FSCN1P1	NA	
ENSG00000278582	AC027139.2	NA	
ENSG00000215252	GOLGA8B	NA	
ENSG00000221065	MIR1233-2	NA	
ENSG00000259892	AC027139.1	NA	
ENSG00000252425	AC100834.1	NA	
ENSG00000261304	LINC02252	NA	
ENSG00000287973	AC100834.2	NA	
ENSG00000159248	GJD2	NA	
ENSG00000250007	AC087457.1	NA	
ENSG00000159251	ACTC1	612098	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11
ENSG00000159251	ACTC1	612794	ATRIAL SEPTAL DEFECT 5; ASD5
ENSG00000159251	ACTC1	613424	CARDIOMYOPATHY, DILATED, 1R; CMD1R LEFT VENTRICULAR NONCOMPACTION 4, INCLUDED; LVNC4, INCLUDED
ENSG00000259751	AC018868.2	NA	
ENSG00000021776	AQR	NA	
ENSG00000231409	AC018868.1	NA	
ENSG00000198146	ZNF770	NA	
ENSG00000279364	AC114546.3	NA	
ENSG00000259181	AC114546.1	NA	
ENSG00000280396	AC114546.4	NA	
ENSG00000259587	AC114546.2	NA	
ENSG00000259665	AC021231.3	NA	
ENSG00000255192	NANOGP8	NA	
ENSG00000259397	AC021231.2	NA	
ENSG00000259336	AC021231.1	NA	
ENSG00000259592	PRELID1P4	NA	
ENSG00000259516	ANP32AP1	NA	
ENSG00000134146	DPH6	NA	
ENSG00000259710	NUTF2P6	NA	
ENSG00000259585	RBM17P4	NA	
ENSG00000265102	MIR3942	NA	
ENSG00000259688	AC019288.1	NA	
ENSG00000259411	HNRNPA1P45	NA	
ENSG00000248079	DPH6-DT	NA	
ENSG00000259217	AC068867.1	NA	
ENSG00000259245	LINC02853	NA	
ENSG00000265098	MIR4510	NA	
ENSG00000259639	AC021351.1	NA	
ENSG00000259395	AC087516.1	NA	
ENSG00000259737	AC087516.2	NA	
ENSG00000270500	COX6CP4	NA	
ENSG00000186073	C15orf41	615631	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib
ENSG00000261635	AC103988.1	NA	
ENSG00000261315	LARP4P	NA	
ENSG00000260582	TPST2P1	NA	
ENSG00000261191	AC013640.1	NA	
ENSG00000223518	CSNK1A1P1	NA	
ENSG00000212511	U3	NA	
ENSG00000259280	AC018563.1	NA	
ENSG00000134138	MEIS2	600987	CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR;;CARDIAC MALFORMATION, CLEFT LIP/PALATE, MICROCEPHALY, AND DIGITAL ANOMALIES
ENSG00000277202	MIR8063	NA	
ENSG00000206676	Y_RNA	NA	
ENSG00000259460	AC078909.1	NA	
ENSG00000274444	AC078909.2	NA	
ENSG00000274216	Metazoa_SRP	NA	
ENSG00000259434	AC068875.1	NA	
ENSG00000270304	AC087283.1	NA	
ENSG00000243122	AC016304.1	NA	
ENSG00000166069	TMCO5A	NA	
ENSG00000259225	LINC02345	NA	
ENSG00000236914	LINC01852	NA	
ENSG00000259380	AC087473.1	NA	
ENSG00000166068	SPRED1	611431	LEGIUS SYNDROME; LGSS;;NEUROFIBROMATOSIS TYPE 1-LIKE SYNDROME; NFLS
ENSG00000171262	FAM98B	NA	
ENSG00000259192	AC109631.1	NA	
ENSG00000172575	RASGRP1	618534	IMMUNODEFICIENCY 64; IMD64
ENSG00000286786	AC116158.3	NA	
ENSG00000259326	AC116158.1	NA	
ENSG00000259598	AC116158.2	NA	
ENSG00000175779	LINC02694	NA	
ENSG00000259731	AC022929.1	NA	
ENSG00000274281	AC022929.2	NA	
ENSG00000259345	AC013652.1	NA	
ENSG00000259278	AC087878.1	NA	
ENSG00000259423	AC113146.1	NA	
ENSG00000175746	C15orf54	NA	
ENSG00000259390	AC022196.1	NA	
ENSG00000259447	AC013652.2	NA	
ENSG00000259269	AC109630.1	NA	
ENSG00000137801	THBS1	NA	
ENSG00000276107	AC037198.1	NA	
ENSG00000278621	AC037198.2	NA	
ENSG00000150667	FSIP1	NA	
ENSG00000259580	AC023908.2	NA	
ENSG00000261136	AC023908.3	NA	
ENSG00000166073	GPR176	NA	
ENSG00000259432	AC023908.1	NA	
ENSG00000246863	GPR176-DT	NA	
ENSG00000200305	Y_RNA	NA	
ENSG00000128829	EIF2AK4	234810	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2;;HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY
ENSG00000259389	H3P38	NA	
ENSG00000140319	SRP14	NA	
ENSG00000248508	SRP14-AS1	NA	
ENSG00000259584	AC021755.2	NA	
ENSG00000275636	AC021755.3	NA	
ENSG00000104081	BMF	NA	
ENSG00000259409	BMF-AS1	NA	
ENSG00000259239	AC021755.1	NA	
ENSG00000156970	BUB1B	176430	PREMATURE CHROMATID SEPARATION TRAIT; PCS;;TOTAL PREMATURE CHROMATID SEPARATION TRAIT
ENSG00000156970	BUB1B	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000156970	BUB1B	257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME
ENSG00000137843	PAK6	NA	
ENSG00000259288	BUB1B-PAK6	NA	
ENSG00000273786	AC020658.4	NA	
ENSG00000260648	AC020658.3	NA	
ENSG00000279537	AC020658.7	NA	
ENSG00000176753	C15orf56	NA	
ENSG00000279409	AC020658.6	NA	
ENSG00000137841	PLCB2	NA	
ENSG00000230778	ANKRD63	NA	
ENSG00000273855	AC020658.5	NA	
ENSG00000259307	PLCB2-AS1	NA	
ENSG00000244705	AC020658.1	NA	
ENSG00000259198	AC020658.2	NA	
ENSG00000259330	INAFM2	NA	
ENSG00000188549	CCDC9B	NA	
ENSG00000252714	RNA5SP392	NA	
ENSG00000233041	PHGR1	NA	
ENSG00000140323	DISP2	NA	
ENSG00000259368	AC013356.4	NA	
ENSG00000128944	KNSTRN	NA	
ENSG00000128928	IVD	243500	ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY
ENSG00000140320	BAHD1	NA	
ENSG00000259364	AC013356.3	NA	
ENSG00000259211	AC013356.2	NA	
ENSG00000169105	CHST14	601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1;;EDSMC;;ADDUCTED THUMB, CLUBFOOT, AND PROGRESSIVE JOINT AND SKIN LAXITY SYNDROME;;EHLERS-DANLOS SYNDROME, TYPE VIB, FORMERLY; EDS6B, FORMERLY;;ADDUCTED THUMB-CLUBFOOT SYNDROME; ATCS;;DUNDAR /.../OME;;ARTHROGRYPOSIS, DISTAL, WITH PECULIAR FACIES AND HYDRONEPHROSIS
ENSG00000244251	AC013356.1	NA	
ENSG00000259536	AC091045.1	NA	
ENSG00000128891	CCDC32	NA	
ENSG00000223313	RNU6-516P	NA	
ENSG00000166133	RPUSD2	NA	
ENSG00000203573	Metazoa_SRP	NA	
ENSG00000137812	KNL1	604321	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4
ENSG00000265814	RN7SL376P	NA	
ENSG00000259254	AC022405.1	NA	
ENSG00000245849	RAD51-AS1	NA	
ENSG00000051180	RAD51	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000051180	RAD51	614508	MIRROR MOVEMENTS 2; MRMV2
ENSG00000051180	RAD51	617244	FANCONI ANEMIA, COMPLEMENTATION GROUP R; FANCR
ENSG00000137824	RMDN3	NA	
ENSG00000271236	SUMO2P15	NA	
ENSG00000137880	GCHFR	NA	
ENSG00000104129	DNAJC17	NA	
ENSG00000188277	C15orf62	NA	
ENSG00000166140	ZFYVE19	NA	
ENSG00000166143	PPP1R14D	NA	
ENSG00000261183	SPINT1-AS1	NA	
ENSG00000166145	SPINT1	NA	
ENSG00000104140	RHOV	NA	
ENSG00000274798	AC025166.1	NA	
ENSG00000104142	VPS18	NA	
ENSG00000251161	AC020661.1	NA	
ENSG00000128917	DLL4	616589	ADAMS-OLIVER SYNDROME 6; AOS6
ENSG00000259405	ISCA1P4	NA	
ENSG00000128965	CHAC1	NA	
ENSG00000128908	INO80	NA	
ENSG00000259617	AC020661.3	NA	
ENSG00000259463	AC020661.2	NA	
ENSG00000259521	INO80-AS1	NA	
ENSG00000280036	AC020661.4	NA	
ENSG00000259547	CYCSP2	NA	
ENSG00000283133	AC021753.1	NA	
ENSG00000157021	CIBAR1P1	NA	
ENSG00000178997	EXD1	NA	
ENSG00000240847	RN7SL497P	NA	
ENSG00000187446	CHP1	618438	SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9
ENSG00000247556	OIP5-AS1	NA	
ENSG00000285920	AC087721.2	NA	
ENSG00000104147	OIP5	NA	
ENSG00000137804	NUSAP1	NA	
ENSG00000259396	AC087721.1	NA	
ENSG00000137806	NDUFAF1	618234	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11
ENSG00000137815	RTF1	NA	
ENSG00000200407	RNU6-1169P	NA	
ENSG00000137825	ITPKA	NA	
ENSG00000062524	LTK	NA	
ENSG00000103932	RPAP1	NA	
ENSG00000259838	ELOCP2	NA	
ENSG00000092445	TYRO3	NA	
ENSG00000260926	AC016134.1	NA	
ENSG00000174197	MGA	NA	
ENSG00000207766	MIR626	NA	
ENSG00000270702	AC073657.2	NA	
ENSG00000260814	AC073657.1	NA	
ENSG00000137802	MAPKBP1	617271	NEPHRONOPHTHISIS 20; NPHP20
ENSG00000250379	AC020659.2	NA	
ENSG00000243789	JMJD7	NA	
ENSG00000168970	JMJD7-PLA2G4B	NA	
ENSG00000243708	PLA2G4B	NA	
ENSG00000137877	SPTBN5	NA	
ENSG00000200293	RNA5SP393	NA	
ENSG00000264850	MIR4310	NA	
ENSG00000174171	AC020659.1	NA	
ENSG00000103966	EHD4	NA	
ENSG00000278493	AC039056.2	NA	
ENSG00000259883	EHD4-AS1	NA	
ENSG00000246740	PLA2G4E-AS1	NA	
ENSG00000188089	PLA2G4E	NA	
ENSG00000257797	AC039056.1	NA	
ENSG00000159337	PLA2G4D	NA	
ENSG00000168907	PLA2G4F	NA	
ENSG00000166887	VPS39	NA	
ENSG00000207712	MIR627	NA	
ENSG00000261002	AC036103.1	NA	
ENSG00000103978	TMEM87A	NA	
ENSG00000214013	GANC	NA	
ENSG00000260571	BNIP3P5	NA	
ENSG00000258461	AC012651.1	NA	
ENSG00000092529	CAPN3	253600	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2; LGMD2;;MUSCULAR DYSTROPHY, PELVOFEMORAL;;LEYDEN-MOEBIUS MUSCULAR DYSTROPHY;;CALPAINOPATHY MYOS /.../EOSINOPHILIC, INCLUDED
ENSG00000092529	CAPN3	618129	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1I; LGMD1I
ENSG00000103994	ZNF106	NA	
ENSG00000201077	RNU6-188P	NA	
ENSG00000092531	SNAP23	NA	
ENSG00000261684	AC018362.1	NA	
ENSG00000285942	AC018362.3	NA	
ENSG00000180979	LRRC57	NA	
ENSG00000137814	HAUS2	NA	
ENSG00000261822	AC018362.2	NA	
ENSG00000260490	MYL12BP1	NA	
ENSG00000159433	STARD9	NA	
ENSG00000260282	EIF4EBP2P2	NA	
ENSG00000140326	CDAN1	224120	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I
ENSG00000278769	AC090510.3	NA	
ENSG00000274403	AC090510.2	NA	
ENSG00000128881	TTBK2	604432	SPINOCEREBELLAR ATAXIA 11; SCA11
ENSG00000246283	AC090510.1	NA	
ENSG00000286877	AC090510.4	NA	
ENSG00000260799	KRT8P50	NA	
ENSG00000254793	FDPSP4	NA	
ENSG00000159459	UBR1	243800	JOHANSON-BLIZZARD SYNDROME; JBS;;NASAL ALAR HYPOPLASIA, HYPOTHYROIDISM, PANCREATIC ACHYLIA, AND CONGENITAL DEAFNESS
ENSG00000285080	AC068724.4	NA	
ENSG00000281269	AC068724.3	NA	
ENSG00000205871	RPS3AP47	NA	
ENSG00000137842	TMEM62	NA	
ENSG00000260928	SPCS2P1	NA	
ENSG00000285117	AC068724.5	NA	
ENSG00000261687	AC068724.2	NA	
ENSG00000166946	CCNDBP1	NA	
ENSG00000166947	EPB42	612690	SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5
ENSG00000104055	TGM5	609796	PEELING SKIN SYNDROME 2; PSS2;;ACRAL PEELING SKIN SYNDROME; APSS;;PEELING SKIN SYNDROME, ACRAL TYPE
ENSG00000202211	AC068724.1	NA	
ENSG00000261679	ATP5PDP1	NA	
ENSG00000159495	TGM7	NA	
ENSG00000260406	AC009852.1	NA	
ENSG00000168806	LCMT2	NA	
ENSG00000168803	ADAL	NA	
ENSG00000140265	ZSCAN29	NA	
ENSG00000137822	TUBGCP4	616335	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3
ENSG00000243871	RN7SL487P	NA	
ENSG00000067369	TP53BP1	NA	
ENSG00000166963	MAP1A	NA	
ENSG00000168781	PPIP5K1	NA	
ENSG00000237289	CKMT1B	NA	
ENSG00000242866	STRC	603720	DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16
ENSG00000242866	STRC	611102	DEAFNESS-INFERTILITY SYNDROME; DIS;;DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY;;CHROMOSOME 15q15.3 DELETION SYNDROME
ENSG00000242866	STRC	612997	SPERMATOGENIC FAILURE 7; SPGF7;;MALE INFERTILITY, NONSYNDROMIC, AUTOSOMAL RECESSIVE; MIAR
ENSG00000222398	RNU6-554P	NA	
ENSG00000284772	AC011330.3	NA	
ENSG00000166762	CATSPER2	611102	DEAFNESS-INFERTILITY SYNDROME; DIS;;DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY;;CHROMOSOME 15q15.3 DELETION SYNDROME
ENSG00000166762	CATSPER2	612997	SPERMATOGENIC FAILURE 7; SPGF7;;MALE INFERTILITY, NONSYNDROMIC, AUTOSOMAL RECESSIVE; MIAR
ENSG00000206991	RNU6-610P	NA	
ENSG00000275601	AC011330.2	NA	
ENSG00000224677	PDIA3P2	NA	
ENSG00000249839	AC011330.1	NA	
ENSG00000223572	CKMT1A	NA	
ENSG00000166763	STRCP1	NA	
ENSG00000201136	RNU6-353P	NA	
ENSG00000205771	CATSPER2P1	NA	
ENSG00000206589	RNU6-354P	NA	
ENSG00000167004	PDIA3	NA	
ENSG00000128886	ELL3	NA	
ENSG00000262560	AC018512.1	NA	
ENSG00000140264	SERF2	NA	
ENSG00000221792	MIR1282	NA	
ENSG00000184716	SERINC4	NA	
ENSG00000242028	HYPK	NA	
ENSG00000140259	MFAP1	NA	
ENSG00000092470	WDR76	NA	
ENSG00000200391	AC023356.1	NA	
ENSG00000171877	FRMD5	NA	
ENSG00000227973	PIN4P1	NA	
ENSG00000185607	ACTBP7	NA	
ENSG00000224055	GAPDHP55	NA	
ENSG00000166734	GOLM2	NA	
ENSG00000250130	AC090519.1	NA	
ENSG00000259499	AC090519.2	NA	
ENSG00000259595	AC025043.1	NA	
ENSG00000137770	CTDSPL2	NA	
ENSG00000259335	HNRNPMP1	NA	
ENSG00000259563	AC025430.1	NA	
ENSG00000179523	EIF3J-DT	NA	
ENSG00000104131	EIF3J	NA	
ENSG00000259659	AC009996.1	NA	
ENSG00000104133	SPG11	602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5
ENSG00000104133	SPG11	604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM;;HSP-TCC
ENSG00000104133	SPG11	616668	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2X;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2X
ENSG00000229474	PATL2	617743	OOCYTE MATURATION DEFECT 4; OOMD4
ENSG00000206957	Y_RNA	NA	
ENSG00000166710	B2M	105200	AMYLOIDOSIS, FAMILIAL VISCERAL;;AMYLOIDOSIS VIII;;OSTERTAG TYPE AMYLOIDOSIS;;GERMAN TYPE AMYLOIDOSIS;;AMYLOIDOSIS, FAMILIAL RENAL;;AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC
ENSG00000166710	B2M	241600	IMMUNODEFICIENCY 43; IMD43;;BETA-2-MICROGLOBULIN DEFICIENCY;;B2M DEFICIENCY;;HYPOPROTEINEMIA, HYPERCATABOLIC
ENSG00000185880	TRIM69	NA	
ENSG00000276121	AC122108.2	NA	
ENSG00000259479	SORD2P	NA	
ENSG00000259187	AC122108.1	NA	
ENSG00000238845	Y_RNA	NA	
ENSG00000212424	RNU1-119P	NA	
ENSG00000259742	AC090888.3	NA	
ENSG00000259231	AC090888.1	NA	
ENSG00000252117	RNU6-1108P	NA	
ENSG00000167014	TERB2	NA	
ENSG00000252475	RNU6-1332P	NA	
ENSG00000259304	AC090888.2	NA	
ENSG00000252288	RNU6-966P	NA	
ENSG00000212550	RNU1-78P	NA	
ENSG00000140263	SORD	NA	
ENSG00000259418	AC091117.2	NA	
ENSG00000252171	Y_RNA	NA	
ENSG00000259352	AC091117.1	NA	
ENSG00000140279	DUOX2	607200	THYROID DYSHORMONOGENESIS 6; TDH6;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 6;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 6
ENSG00000140274	DUOXA2	274900	THYROID DYSHORMONOGENESIS 5; TDH5;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 5
ENSG00000140254	DUOXA1	NA	
ENSG00000137857	DUOX1	NA	
ENSG00000259539	AC051619.5	NA	
ENSG00000138606	SHF	NA	
ENSG00000259519	AC051619.3	NA	
ENSG00000259932	AC051619.6	NA	
ENSG00000260035	AC051619.7	NA	
ENSG00000279014	AC051619.9	NA	
ENSG00000261709	AC051619.8	NA	
ENSG00000259338	H3P39	NA	
ENSG00000259520	AC051619.4	NA	
ENSG00000137860	SLC28A2	NA	
ENSG00000285597	AC051619.10	NA	
ENSG00000235390	AC051619.1	NA	
ENSG00000259433	AC051619.2	NA	
ENSG00000238941	RNU6-953P	NA	
ENSG00000171766	GATM	612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3;;ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY;;AGAT DEFICIENCY;;GATM DEFICIENCY;;CREATINE DEFICIENCY SYNDROME DUE TO AGAT DEFICIENCY
ENSG00000275672	AC025580.3	NA	
ENSG00000171763	SPATA5L1	NA	
ENSG00000166920	C15orf48	NA	
ENSG00000259342	AC025580.1	NA	
ENSG00000284386	MIR147B	NA	
ENSG00000259354	AC025580.2	NA	
ENSG00000104154	SLC30A4	NA	
ENSG00000179362	HMGN2P46	NA	
ENSG00000207516	SNORA41B	NA	
ENSG00000259681	AC090527.2	NA	
ENSG00000259427	DPPA5P2	NA	
ENSG00000275709	AC090527.4	NA	
ENSG00000104164	BLOC1S6	614171	HERMANSKY-PUDLAK SYNDROME 9; HPS9
ENSG00000260170	AC090527.3	NA	
ENSG00000200419	AC090527.1	NA	
ENSG00000137767	SQOR	NA	
ENSG00000273972	AC068722.2	NA	
ENSG00000259200	AC068722.1	NA	
ENSG00000259743	AC068714.1	NA	
ENSG00000287020	AC091074.3	NA	
ENSG00000259593	MTND5P40	NA	
ENSG00000238819	AC091074.1	NA	
ENSG00000285934	AC091074.2	NA	
ENSG00000287704	AC012405.1	NA	
ENSG00000238456	RNU6-1014P	NA	
ENSG00000259255	AC073941.1	NA	
ENSG00000223308	RN7SKP101	NA	
ENSG00000259509	AC073941.2	NA	
ENSG00000284540	AC066615.1	NA	
ENSG00000137872	SEMA6D	NA	
ENSG00000222343	RN7SKP139	NA	
ENSG00000259554	AC084882.1	NA	
ENSG00000259221	AC023905.1	NA	
ENSG00000259360	AC009558.1	NA	
ENSG00000259740	AC009558.2	NA	
ENSG00000259588	AC012050.1	NA	
ENSG00000213862	AC044787.1	NA	
ENSG00000259572	LINC01491	NA	
ENSG00000259754	AC092078.2	NA	
ENSG00000259730	AC092078.1	NA	
ENSG00000287439	AC092078.3	NA	
ENSG00000188467	SLC24A5	113750	ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4, INCLUDED; SHEP4, INCLUDED;;SKIN/HAIR/EYE PIGMENTATION 4, FAIR/DARK SKIN, INCLUDED
ENSG00000104177	MYEF2	NA	
ENSG00000233932	CTXN2	NA	
ENSG00000074803	SLC12A1	601678	BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1;;HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 1, ANTENATAL;;HYPERPROSTAGLANDIN E SYNDROME 1
ENSG00000259235	AC066612.1	NA	
ENSG00000259385	AC066612.2	NA	
ENSG00000259488	AC023355.1	NA	
ENSG00000202542	Y_RNA	NA	
ENSG00000128951	DUT	NA	
ENSG00000166147	FBN1	184900	STIFF SKIN SYNDROME; SSKS
ENSG00000166147	FBN1	154700	MARFAN SYNDROME; MFS;;MARFAN SYNDROME, TYPE I; MFS1
ENSG00000166147	FBN1	129600	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1
ENSG00000166147	FBN1	102370	ACROMICRIC DYSPLASIA; ACMICD
ENSG00000166147	FBN1	604308	MASS SYNDROME;;MASS PHENOTYPE;;OVERLAP CONNECTIVE TISSUE DISEASE; OCTD
ENSG00000166147	FBN1	608328	WEILL-MARCHESANI SYNDROME 2; WMS2;;WEILL-MARCHESANI SYNDROME, AUTOSOMAL DOMINANT;;SPHEROPHAKIA-BRACHYMORPHIA SYNDROME;;MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL;;GLAUCOMA-LENS ECTOPIA-MICROSPHEROPHAKIA-STIFFNESS-SHORTNESS SYNDROME; GEMSS
ENSG00000166147	FBN1	614185	GELEOPHYSIC DYSPLASIA 2; GPHYSD2
ENSG00000166147	FBN1	616914	MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME; MFLS;;MARFAN LIPODYSTROPHY SYNDROME;;MARFANOID-PROGEROID SYNDROME;;MARFAN-PROGEROID-LIPODYSTROPHY SYNDROME
ENSG00000286947	AC022467.2	NA	
ENSG00000274654	AC022467.1	NA	
ENSG00000259705	AC084757.3	NA	
ENSG00000273925	AC084757.4	NA	
ENSG00000103995	CEP152	613823	SECKEL SYNDROME 5; SCKL5
ENSG00000103995	CEP152	614852	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9
ENSG00000259216	AC084757.1	NA	
ENSG00000259469	AC084757.2	NA	
ENSG00000259670	AC012379.1	NA	
ENSG00000259700	AC012379.2	NA	
ENSG00000185634	SHC4	NA	
ENSG00000255302	EID1	NA	
ENSG00000259602	AC091073.1	NA	
ENSG00000259500	KRT8P24	NA	
ENSG00000138593	SECISBP2L	NA	
ENSG00000207105	Y_RNA	NA	
ENSG00000265942	RN7SL577P	NA	
ENSG00000259656	AC013452.2	NA	
ENSG00000166200	COPS2	NA	
ENSG00000200120	Y_RNA	NA	
ENSG00000156958	GALK2	NA	
ENSG00000259467	NDUFAF4P1	NA	
ENSG00000264210	MIR4716	NA	
ENSG00000259545	AC013452.1	NA	
ENSG00000243338	RN7SL307P	NA	
ENSG00000166262	FAM227B	NA	
ENSG00000275580	AC022306.2	NA	
ENSG00000276593	AC022306.3	NA	
ENSG00000259531	AC022306.1	NA	
ENSG00000140285	FGF7	NA	
ENSG00000104047	DTWD1	NA	
ENSG00000259388	AC025040.2	NA	
ENSG00000104043	ATP8B4	NA	
ENSG00000259188	AC025040.1	NA	
ENSG00000201086	RNA5SP394	NA	
ENSG00000140284	SLC27A2	NA	
ENSG00000200605	Y_RNA	NA	
ENSG00000140287	HDC	137580	GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDER CHRONIC MOTOR TICS, INCLUDED
ENSG00000241175	RN7SL494P	NA	
ENSG00000104064	GABPB1	NA	
ENSG00000271819	RNU6-94P	NA	
ENSG00000285410	GABPB1-IT1	NA	
ENSG00000244879	GABPB1-AS1	NA	
ENSG00000259715	AC022087.1	NA	
ENSG00000284284	MIR4712	NA	
ENSG00000259465	AHCYP7	NA	
ENSG00000138592	USP8	219090	PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4;;CUSHING DISEASE, PITUITARY
ENSG00000252376	RNA5SP395	NA	
ENSG00000242737	AC012170.1	NA	
ENSG00000170236	USP50	NA	
ENSG00000092439	TRPM7	105500	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1;;AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX OF GUAM;;GUAM DISEASE;;ALS-PDC
ENSG00000259684	AC084756.1	NA	
ENSG00000288645	AC084756.2	NA	
ENSG00000243027	RN7SL354P	NA	
ENSG00000138600	SPPL2A	NA	
ENSG00000279665	AC012100.3	NA	
ENSG00000259773	AC012100.2	NA	
ENSG00000241130	AC012100.1	NA	
ENSG00000273674	AC021752.1	NA	
ENSG00000081014	AP4E1	184450	STUTTERING, FAMILIAL PERSISTENT, 1; STUT1;;STAMMERING
ENSG00000081014	AP4E1	613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY
ENSG00000259378	DCAF13P3	NA	
ENSG00000259240	MIR4713HG	NA	
ENSG00000183578	TNFAIP8L3	NA	
ENSG00000259204	AC073964.1	NA	
ENSG00000137869	CYP19A1	139300	AROMATASE EXCESS SYNDROME; AEXS;;AROMATASE ACTIVITY, INCREASED  GYNECOMASTIA, FAMILIAL, DUE TO INCREASED AROMATASE ACTIVITY, INCLUDED;;GYNECOMASTIA, HEREDITARY, INCLUDED
ENSG00000137869	CYP19A1	613546	AROMATASE DEFICIENCY;;PSEUDOHERMAPHRODITISM, FEMALE, DUE TO PLACENTAL AROMATASE DEFICIENCY
ENSG00000266593	MIR4713	NA	
ENSG00000259701	AC020891.3	NA	
ENSG00000283614	MIR7973-2	NA	
ENSG00000278098	MIR7973-1	NA	
ENSG00000259306	AC020891.2	NA	
ENSG00000186417	GLDN	617194	LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11
ENSG00000270378	AC020891.4	NA	
ENSG00000259194	AC020891.1	NA	
ENSG00000259678	AC066613.2	NA	
ENSG00000104093	DMXL2	616113	POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS
ENSG00000104093	DMXL2	617605	DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71
ENSG00000104093	DMXL2	618663	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 81; EIEE81
ENSG00000259668	AC066613.1	NA	
ENSG00000104112	SCG3	NA	
ENSG00000259241	AC020892.1	NA	
ENSG00000259296	AC020892.2	NA	
ENSG00000140280	LYSMD2	NA	
ENSG00000128872	TMOD2	NA	
ENSG00000259377	AC026770.1	NA	
ENSG00000138594	TMOD3	NA	
ENSG00000274954	AC090971.6	NA	
ENSG00000277677	AC090971.7	NA	
ENSG00000259632	AC090971.5	NA	
ENSG00000207484	AC090971.1	NA	
ENSG00000259201	AC090971.3	NA	
ENSG00000272337	RNU6-90P	NA	
ENSG00000259185	AC090971.2	NA	
ENSG00000259556	AC090971.4	NA	
ENSG00000166477	LEO1	NA	
ENSG00000069956	MAPK6	NA	
ENSG00000259438	MAPK6-DT	NA	
ENSG00000274528	AC090970.2	NA	
ENSG00000259398	AC090970.1	NA	
ENSG00000259712	AC023906.5	NA	
ENSG00000259178	AC023906.2	NA	
ENSG00000242327	AC023906.1	NA	
ENSG00000137875	BCL2L10	NA	
ENSG00000069966	GNB5	617173	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA
ENSG00000069966	GNB5	617182	LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI
ENSG00000259327	AC023906.3	NA	
ENSG00000259709	AC023906.4	NA	
ENSG00000206995	Y_RNA	NA	
ENSG00000259577	CERNA1	NA	
ENSG00000128833	MYO5C	NA	
ENSG00000221052	MIR1266	NA	
ENSG00000197535	MYO5A	214450	GRISCELLI SYNDROME, TYPE 1; GS1;;GRISCELLI SYNDROME WITH NEUROLOGIC IMPAIRMENT;;PARTIAL ALBINISM AND PRIMARY NEUROLOGIC DISEASE WITHOUT HEMOPHAGOCYTIC SYNDROME;;GRISCELLI SYNDROME, CUTANEOUS AND NEUROLOGIC TYPE
ENSG00000231169	EEF1B2P1	NA	
ENSG00000128989	ARPP19	NA	
ENSG00000260618	AC025917.1	NA	
ENSG00000047346	FAM214A	NA	
ENSG00000259935	AC009754.1	NA	
ENSG00000287500	AC009754.2	NA	
ENSG00000169856	ONECUT1	NA	
ENSG00000259203	AC016044.1	NA	
ENSG00000214896	RPSAP55	NA	
ENSG00000259612	EEF1A1P22	NA	
ENSG00000259237	LINC02490	NA	
ENSG00000287596	AC066614.1	NA	
ENSG00000166415	WDR72	613211	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3
ENSG00000252066	RNU2-53P	NA	
ENSG00000206641	RNU6-449P	NA	
ENSG00000259301	AC084759.1	NA	
ENSG00000280362	AC084759.3	NA	
ENSG00000259669	AC084759.2	NA	
ENSG00000137766	UNC13C	NA	
ENSG00000259619	AC010867.1	NA	
ENSG00000259550	HNRNPA1P74	NA	
ENSG00000260937	AC025272.1	NA	
ENSG00000279145	AC011912.1	NA	
ENSG00000137876	RSL24D1	NA	
ENSG00000069974	RAB27A	607624	GRISCELLI SYNDROME, TYPE 2; GS2;;GRISCELLI SYNDROME WITH HEMOPHAGOCYTIC SYNDROME;;PARTIAL ALBINISM AND IMMUNODEFICIENCY SYNDROME;;PAID SYNDROME
ENSG00000276533	AC018926.2	NA	
ENSG00000225973	PIGBOS1	NA	
ENSG00000069943	PIGB	618580	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 80; EIEE80;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 20; GPIBD20
ENSG00000260916	CCPG1	NA	
ENSG00000274765	AC018926.1	NA	
ENSG00000277548	AC018926.3	NA	
ENSG00000261771	DNAAF4-CCPG1	NA	
ENSG00000283891	MIR628	NA	
ENSG00000261652	C15orf65	NA	
ENSG00000256061	DNAAF4	127700	DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1;;WORD-BLINDNESS, CONGENITAL;;READING DISABILITY, SPECIFIC, 1 DYSLEXIA, SUSCEPTIBILITY TO, 4, INCLUDED; DYX4, INCLUDED;;DYSLEXIA, SUSCEPTIBILITY TO, 7, INCLUDED; DYX7, INCLUDED
ENSG00000256061	DNAAF4	615482	CILIARY DYSKINESIA, PRIMARY, 25; CILD25;;CILIARY DYSKINESIA, PRIMARY, 25, WITH OR WITHOUT SITUS INVERSUS
ENSG00000260036	AC013355.1	NA	
ENSG00000171016	PYGO1	NA	
ENSG00000285805	AC012378.2	NA	
ENSG00000166450	PRTG	NA	
ENSG00000259180	AC012378.1	NA	
ENSG00000259369	AC009997.1	NA	
ENSG00000069869	NEDD4	NA	
ENSG00000230183	CNOT6LP1	NA	
ENSG00000239703	RN7SL568P	NA	
ENSG00000261333	CD24P2	NA	
ENSG00000181827	RFX7	NA	
ENSG00000261072	AC084783.1	NA	
ENSG00000151575	TEX9	NA	
ENSG00000275417	AC068726.1	NA	
ENSG00000199784	RNU6-1287P	NA	
ENSG00000261174	HMGB1P33	NA	
ENSG00000259941	AC084782.1	NA	
ENSG00000261823	AC084782.2	NA	
ENSG00000138587	MNS1	NA	
ENSG00000277245	AC084782.3	NA	
ENSG00000260392	AC090518.1	NA	
ENSG00000137871	ZNF280D	NA	
ENSG00000276696	Y_RNA	NA	
ENSG00000285253	AC090517.4	NA	
ENSG00000274667	AC090517.2	NA	
ENSG00000279683	AC090517.3	NA	
ENSG00000285331	AC090517.5	NA	
ENSG00000225625	AC090517.1	NA	
ENSG00000276524	AC010999.2	NA	
ENSG00000275343	AC010999.1	NA	
ENSG00000140262	TCF12	615314	CRANIOSYNOSTOSIS 3; CRS3
ENSG00000260689	HNRNPA3P11	NA	
ENSG00000239035	SNORD13D	NA	
ENSG00000247982	LINC00926	NA	
ENSG00000260172	LINC01413	NA	
ENSG00000260870	NDUFB10P1	NA	
ENSG00000128849	CGNL1	NA	
ENSG00000252984	RNU6-844P	NA	
ENSG00000261489	AC025271.3	NA	
ENSG00000261265	AC025271.2	NA	
ENSG00000276772	AC025271.4	NA	
ENSG00000240874	AC025271.1	NA	
ENSG00000263155	MYZAP	NA	
ENSG00000137878	GCOM1	NA	
ENSG00000255529	POLR2M	NA	
ENSG00000261219	AC090651.1	NA	
ENSG00000128918	ALDH1A2	NA	
ENSG00000259477	AC012653.1	NA	
ENSG00000274719	AC012653.2	NA	
ENSG00000259285	AC025431.1	NA	
ENSG00000103569	AQP9	NA	
ENSG00000259651	MTCO3P23	NA	
ENSG00000259626	MTND3P12	NA	
ENSG00000259600	AC066616.2	NA	
ENSG00000259379	MTND5P32	NA	
ENSG00000259671	MTCYBP23	NA	
ENSG00000240934	AC066616.1	NA	
ENSG00000166035	LIPC	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000166035	LIPC	612797	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12
ENSG00000166035	LIPC	614025	HEPATIC LIPASE DEFICIENCY;;LIPC DEFICIENCY;;HL DEFICIENCY
ENSG00000259293	LIPC-AS1	NA	
ENSG00000277229	AC084781.1	NA	
ENSG00000277790	AC084781.2	NA	
ENSG00000259476	AC018904.2	NA	
ENSG00000259250	AC018904.1	NA	
ENSG00000137845	ADAM10	615537	RETICULATE ACROPIGMENTATION OF KITAMURA; RAK;;ACROPIGMENTATIO RETICULARIS;;RETICULATE PIGMENTATION OF KITAMURA; RPK;;KITAMURA RETICULATE ACROPIGMENTATION
ENSG00000137845	ADAM10	615590	ALZHEIMER DISEASE 18; AD18;;ALZHEIMER DISEASE 18, LATE-ONSET
ENSG00000270986	HMGB1P51	NA	
ENSG00000182625	AC091046.1	NA	
ENSG00000282100	HSP90AB4P	NA	
ENSG00000199730	RN7SKP95	NA	
ENSG00000278513	AC091046.2	NA	
ENSG00000286897	AC090515.6	NA	
ENSG00000259173	AC090515.3	NA	
ENSG00000200318	U3	NA	
ENSG00000245975	AC090515.2	NA	
ENSG00000128923	MINDY2	NA	
ENSG00000259402	AC090515.5	NA	
ENSG00000259353	AC090515.4	NA	
ENSG00000259738	ZNF444P1	NA	
ENSG00000157450	RNF111	NA	
ENSG00000242747	AC090515.1	NA	
ENSG00000137776	SLTM	NA	
ENSG00000225798	AC025918.1	NA	
ENSG00000259393	AC025918.2	NA	
ENSG00000241640	AC092757.1	NA	
ENSG00000157456	CCNB2	NA	
ENSG00000277144	AC092757.3	NA	
ENSG00000259732	AC092757.2	NA	
ENSG00000157483	MYO1E	614131	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 6
ENSG00000253030	MIR2116	NA	
ENSG00000171989	LDHAL6B	NA	
ENSG00000200070	RNU4-80P	NA	
ENSG00000259771	AC092756.1	NA	
ENSG00000199512	RNU6-212P	NA	
ENSG00000259735	AC092868.2	NA	
ENSG00000157470	FAM81A	NA	
ENSG00000259750	NSA2P4	NA	
ENSG00000259674	AC092868.1	NA	
ENSG00000200252	Y_RNA	NA	
ENSG00000243780	AC092754.2	NA	
ENSG00000240238	AC092754.1	NA	
ENSG00000201704	RNA5SP396	NA	
ENSG00000140297	GCNT3	NA	
ENSG00000140307	GTF2A2	NA	
ENSG00000227161	AC092755.1	NA	
ENSG00000140299	BNIP2	NA	
ENSG00000259657	PIGHP1	NA	
ENSG00000259238	AC092755.2	NA	
ENSG00000234797	RPS3AP6	NA	
ENSG00000286495	AC092079.2	NA	
ENSG00000259601	AC092079.1	NA	
ENSG00000259573	NMNAT1P5	NA	
ENSG00000171956	FOXB1	NA	
ENSG00000259558	MESTP2	NA	
ENSG00000259223	AC009654.1	NA	
ENSG00000287915	AC037433.1	NA	
ENSG00000182718	ANXA2	NA	
ENSG00000240163	AC087385.1	NA	
ENSG00000242667	AC087385.2	NA	
ENSG00000273721	AC087385.3	NA	
ENSG00000128915	ICE2	NA	
ENSG00000245534	RORA-AS1	NA	
ENSG00000069667	RORA	618060	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA
ENSG00000259274	AC107241.1	NA	
ENSG00000259513	CYCSP38	NA	
ENSG00000273958	AC009560.1	NA	
ENSG00000286457	AC009560.3	NA	
ENSG00000287508	AC009560.4	NA	
ENSG00000277413	AC009560.2	NA	
ENSG00000259482	RORA-AS2	NA	
ENSG00000212625	RNA5SP397	NA	
ENSG00000259591	AC022898.1	NA	
ENSG00000273792	AC022898.2	NA	
ENSG00000259481	AC012404.1	NA	
ENSG00000259575	AC012404.2	NA	
ENSG00000276473	AC107905.1	NA	
ENSG00000259616	AC104574.2	NA	
ENSG00000259530	AC104574.1	NA	
ENSG00000259675	AC018618.1	NA	
ENSG00000271195	AC018618.2	NA	
ENSG00000259284	LINC02349	NA	
ENSG00000259564	AC009554.1	NA	
ENSG00000129003	VPS13C	616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23
ENSG00000285863	AC009554.2	NA	
ENSG00000259251	AC104590.1	NA	
ENSG00000198535	C2CD4A	NA	
ENSG00000259466	NPM1P47	NA	
ENSG00000205502	C2CD4B	NA	
ENSG00000259697	AC126323.2	NA	
ENSG00000166104	AC126323.1	NA	
ENSG00000259878	AC126323.3	NA	
ENSG00000276713	Metazoa_SRP	NA	
ENSG00000260062	GOLGA2P11	NA	
ENSG00000260375	AC126323.4	NA	
ENSG00000261296	AC126323.6	NA	
ENSG00000260957	AC126323.5	NA	
ENSG00000277919	MIR8067	NA	
ENSG00000275451	MIR6085	NA	
ENSG00000259557	HMGN1P26	NA	
ENSG00000274340	AC032011.1	NA	
ENSG00000171914	TLN2	NA	
ENSG00000259458	MGC15885	NA	
ENSG00000259756	AC100839.1	NA	
ENSG00000211137	MIR190A	NA	
ENSG00000259370	AC103740.1	NA	
ENSG00000259727	AC103740.2	NA	
ENSG00000259394	AC079328.1	NA	
ENSG00000140416	TPM1	115196	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3
ENSG00000140416	TPM1	611878	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y LEFT VENTRICULAR NONCOMPACTION 9, INCLUDED; LVNC9, INCLUDED
ENSG00000259498	TPM1-AS	NA	
ENSG00000259627	AC079328.2	NA	
ENSG00000259672	AC087612.1	NA	
ENSG00000103642	LACTB	NA	
ENSG00000185088	RPS27L	NA	
ENSG00000166128	RAB8B	NA	
ENSG00000138613	APH1B	NA	
ENSG00000074410	CA12	143860	HYPERCHLORHIDROSIS, ISOLATED; HYCHL
ENSG00000259459	LINC02568	NA	
ENSG00000259268	AC007950.1	NA	
ENSG00000276651	AC007950.2	NA	
ENSG00000140455	USP3	NA	
ENSG00000259248	USP3-AS1	NA	
ENSG00000197361	FBXL22	NA	
ENSG00000103657	HERC1	617011	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR
ENSG00000259589	AC073167.1	NA	
ENSG00000199156	MIR422A	NA	
ENSG00000275785	AC015914.2	NA	
ENSG00000035664	DAPK2	NA	
ENSG00000259351	AC015914.1	NA	
ENSG00000166797	CIAO2A	NA	
ENSG00000028528	SNX1	NA	
ENSG00000201071	AC100840.1	NA	
ENSG00000157734	SNX22	NA	
ENSG00000166794	PPIB	259440	OSTEOGENESIS IMPERFECTA, TYPE IX; OI9;;OI, TYPE IX
ENSG00000169118	CSNK1G1	NA	
ENSG00000259316	AC087632.2	NA	
ENSG00000252774	AC087632.1	NA	
ENSG00000166803	PCLAF	NA	
ENSG00000103671	TRIP4	616866	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1;;SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES
ENSG00000103671	TRIP4	617066	MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC
ENSG00000206781	AC091231.1	NA	
ENSG00000180357	ZNF609	NA	
ENSG00000259682	AC091231.2	NA	
ENSG00000248415	GAPDHP61	NA	
ENSG00000243403	AC090543.2	NA	
ENSG00000239465	AC090543.1	NA	
ENSG00000207223	Y_RNA	NA	
ENSG00000207162	RNU6-549P	NA	
ENSG00000180304	OAZ2	NA	
ENSG00000265967	AC100830.3	NA	
ENSG00000264937	AC100830.2	NA	
ENSG00000259635	AC100830.1	NA	
ENSG00000166831	RBPMS2	NA	
ENSG00000221033	MIR1272	NA	
ENSG00000140451	PIF1	NA	
ENSG00000241839	PLEKHO2	NA	
ENSG00000249240	AC069368.1	NA	
ENSG00000287494	AC069368.2	NA	
ENSG00000166839	ANKDD1A	NA	
ENSG00000275332	AC103691.2	NA	
ENSG00000274383	AC103691.1	NA	
ENSG00000090487	SPG21	248900	MAST SYNDROME;;SPASTIC PARAPLEGIA 21, AUTOSOMAL RECESSIVE; SPG21
ENSG00000103707	MTFMT	614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15
ENSG00000103707	MTFMT	618248	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27
ENSG00000270218	AC013553.2	NA	
ENSG00000186198	SLC51B	NA	
ENSG00000277351	AC013553.3	NA	
ENSG00000103710	RASL12	NA	
ENSG00000234438	KBTBD13	609273	NEMALINE MYOPATHY 6; NEM6
ENSG00000278737	AC013553.4	NA	
ENSG00000246922	UBAP1L	NA	
ENSG00000259258	AC013553.1	NA	
ENSG00000090470	PDCD7	NA	
ENSG00000166855	CLPX	618015	PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2
ENSG00000138615	CILP	603932	INTERVERTEBRAL DISC DISEASE; IDD LUMBAR DISC DISEASE, INCLUDED; LDD, INCLUDED;;LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO, INCLUDED;;LUMBAR DISC DEGENERATION, SUSCEPTIBILITY TO, INCLUDED
ENSG00000279268	AC068213.1	NA	
ENSG00000201709	RNU6-686P	NA	
ENSG00000138617	PARP16	NA	
ENSG00000206903	SNORA24B	NA	
ENSG00000199568	RNU5A-1	NA	
ENSG00000259346	AC105129.2	NA	
ENSG00000200156	RNU5B-1	NA	
ENSG00000174498	IGDCC3	NA	
ENSG00000103742	IGDCC4	NA	
ENSG00000074603	DPP8	NA	
ENSG00000270690	AC105129.3	NA	
ENSG00000259232	AC105129.1	NA	
ENSG00000252217	Y_RNA	NA	
ENSG00000074696	HACD3	NA	
ENSG00000207449	RNU6-19P	NA	
ENSG00000138614	INTS14	NA	
ENSG00000074621	SLC24A1	613830	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE
ENSG00000275638	AC011939.3	NA	
ENSG00000174485	DENND4A	NA	
ENSG00000238311	SNORD13E	NA	
ENSG00000264737	MIR4511	NA	
ENSG00000103769	RAB11A	NA	
ENSG00000261544	AC011939.2	NA	
ENSG00000259924	AC011939.1	NA	
ENSG00000249271	HNRNPA1P44	NA	
ENSG00000283249	AC084854.1	NA	
ENSG00000157890	MEGF11	NA	
ENSG00000263512	MIR4311	NA	
ENSG00000261318	AC055855.2	NA	
ENSG00000166938	DIS3L	NA	
ENSG00000260773	AC055855.1	NA	
ENSG00000075131	TIPIN	NA	
ENSG00000252712	SCARNA14	NA	
ENSG00000223271	Y_RNA	NA	
ENSG00000240821	RPL9P25	NA	
ENSG00000169032	MAP2K1	163950	NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPE PTERYGIUM COLLI SYNDROME, INCLUDED
ENSG00000169032	MAP2K1	615279	CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3
ENSG00000261102	ATP5MFP6	NA	
ENSG00000243404	RPL35AP32	NA	
ENSG00000261351	AC116913.1	NA	
ENSG00000174446	SNAPC5	NA	
ENSG00000266589	MIR4512	NA	
ENSG00000174444	RPL4	NA	
ENSG00000199574	SNORD18C	NA	
ENSG00000280554	AC116913.2	NA	
ENSG00000202529	SNORD18B	NA	
ENSG00000199673	SNORD16	NA	
ENSG00000200623	SNORD18A	NA	
ENSG00000174442	ZWILCH	NA	
ENSG00000188501	LCTL	NA	
ENSG00000259471	LINC01169	NA	
ENSG00000137834	SMAD6	614823	AORTIC VALVE DISEASE 2; AOVD2;;BICUSPID AORTIC VALVE;;AORTIC VALVE STENOSIS
ENSG00000137834	SMAD6	617439	CRANIOSYNOSTOSIS 7; CRS7;;CRANIOSYNOSTOSIS 7, DIGENIC;;CRS7, DIGENIC
ENSG00000274995	AC013564.1	NA	
ENSG00000270490	AC110048.1	NA	
ENSG00000277152	AC110048.2	NA	
ENSG00000259437	AC093334.1	NA	
ENSG00000259289	LINC02206	NA	
ENSG00000259347	AC087482.1	NA	
ENSG00000259246	HMGN2P47	NA	
ENSG00000166949	SMAD3	613795	LOEYS-DIETZ SYNDROME 3; LDS3;;ANEURYSMS-OSTEOARTHRITIS SYNDROME;;LOEYS-DIETZ SYNDROME WITH OSTEOARTHRITIS;;LOEYS-DIETZ SYNDROME, TYPE 1C, FORMERLY; LDS1C, FORMERLY
ENSG00000259202	AC012568.1	NA	
ENSG00000103591	AAGAB	148600	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A;;PALMOPLANTAR KERATODERMA, PUNCTATE TYPE I; PPKP1;;KPPP1;;KERATODERMIA PALMOPLANTARIS PAPULOSA, BUSCHKE-FISCHER-BRAUER TYPE;;KERATOSIS PALMOPLANTARIS PAPULOSA
ENSG00000242634	RPS24P16	NA	
ENSG00000103599	IQCH	NA	
ENSG00000259673	IQCH-AS1	NA	
ENSG00000189227	C15orf61	NA	
ENSG00000270964	AC016355.1	NA	
ENSG00000137764	MAP2K5	NA	
ENSG00000259512	HNRNPA1P5	NA	
ENSG00000188779	SKOR1	NA	
ENSG00000259410	AC009292.2	NA	
ENSG00000245719	AC009292.1	NA	
ENSG00000206625	RNU6-1	NA	
ENSG00000261702	AC022254.1	NA	
ENSG00000260109	AC135628.1	NA	
ENSG00000033800	PIAS1	NA	
ENSG00000260007	AC107871.1	NA	
ENSG00000129007	CALML4	NA	
ENSG00000128973	CLN6	204300	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A
ENSG00000128973	CLN6	601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6;;CEROID LIPOFUSCINOSIS, NEURONAL, 6, VARIABLE AGE AT ONSET;;NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, VARIANT; vLINCL;;CEROID LIPOFUSCINOSIS, NEURONAL, 6 (Kufs type);;CEROID LIPOFUSCINOSIS, NEURONAL, 4A /.../SOMAL RECESSIVE, FORMERLY; CLN4A, FORMERLY
ENSG00000260602	HMGN2P40	NA	
ENSG00000260657	AC107871.2	NA	
ENSG00000169018	FEM1B	NA	
ENSG00000137809	ITGA11	NA	
ENSG00000286770	AC100825.1	NA	
ENSG00000103647	CORO2B	NA	
ENSG00000271232	CARS1P1	NA	
ENSG00000140350	ANP32A	NA	
ENSG00000265195	MIR4312	NA	
ENSG00000258484	SPESP1	NA	
ENSG00000259286	AC087639.1	NA	
ENSG00000285919	AC087639.2	NA	
ENSG00000137808	AC027088.1	NA	
ENSG00000255346	NOX5	NA	
ENSG00000288068	AC027088.5	NA	
ENSG00000273851	AC027088.4	NA	
ENSG00000259265	AC027088.3	NA	
ENSG00000259222	AC027088.2	NA	
ENSG00000212766	EWSAT1	NA	
ENSG00000138604	GLCE	NA	
ENSG00000261634	AC026992.2	NA	
ENSG00000259504	AC026992.1	NA	
ENSG00000137819	PAQR5	NA	
ENSG00000259645	AC027237.4	NA	
ENSG00000259426	AC027237.3	NA	
ENSG00000207395	Y_RNA	NA	
ENSG00000137807	KIF23	NA	
ENSG00000259191	AC027237.1	NA	
ENSG00000137818	RPLP1	NA	
ENSG00000207119	U3	NA	
ENSG00000259215	AC027237.2	NA	
ENSG00000245750	DRAIC	NA	
ENSG00000259457	AC100826.1	NA	
ENSG00000259496	AC021818.2	NA	
ENSG00000259309	AC021818.1	NA	
ENSG00000140332	TLE3	NA	
ENSG00000207965	MIR629	NA	
ENSG00000200216	RNU6-745P	NA	
ENSG00000259252	AC026583.1	NA	
ENSG00000259503	AC048383.1	NA	
ENSG00000259473	LINC02205	NA	
ENSG00000287741	AC009434.1	NA	
ENSG00000280639	LINC02204	NA	
ENSG00000259227	AC087699.1	NA	
ENSG00000281264	SALRNA3	NA	
ENSG00000280515	SALRNA2	NA	
ENSG00000137831	UACA	NA	
ENSG00000259532	AC009269.2	NA	
ENSG00000274297	AC009269.5	NA	
ENSG00000259624	AC009269.3	NA	
ENSG00000259452	AC009269.1	NA	
ENSG00000235420	RPL29P30	NA	
ENSG00000166173	LARP6	NA	
ENSG00000259744	AC009269.4	NA	
ENSG00000137821	LRRC49	NA	
ENSG00000259470	KRT8P9	NA	
ENSG00000129028	THAP10	NA	
ENSG00000242276	RPL5P3	NA	
ENSG00000187720	THSD4	NA	
ENSG00000225362	CT62	NA	
ENSG00000259964	THSD4-AS1	NA	
ENSG00000259781	HMGB1P6	NA	
ENSG00000260586	AC064799.2	NA	
ENSG00000212664	AC064799.1	NA	
ENSG00000278408	AC108861.1	NA	
ENSG00000278570	NR2E3	268100	ENHANCED S-CONE SYNDROME; ESCS GOLDMANN-FAVRE SYNDROME, INCLUDED;;RETINOSCHISIS WITH EARLY HEMERALOPIA, INCLUDED;;FAVRE HYALOIDEORETINAL DEGENERATION, INCLUDED
ENSG00000278570	NR2E3	611131	RETINITIS PIGMENTOSA 37; RP37
ENSG00000260037	AC104938.1	NA	
ENSG00000066933	MYO9A	618198	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24
ENSG00000200873	RNA5SP399	NA	
ENSG00000261632	AC022872.1	NA	
ENSG00000260576	EIF5A2P1	NA	
ENSG00000222094	RNU2-65P	NA	
ENSG00000166192	SENP8	NA	
ENSG00000243568	AC020779.1	NA	
ENSG00000260173	AC020779.2	NA	
ENSG00000175318	GRAMD2A	NA	
ENSG00000067225	PKM	NA	
ENSG00000137817	PARP6	NA	
ENSG00000273025	AC009690.3	NA	
ENSG00000261460	AC009690.2	NA	
ENSG00000140488	CELF6	NA	
ENSG00000260729	AC009690.1	NA	
ENSG00000213614	HEXA	272800	TAY-SACHS DISEASE; TSD;;GM2-GANGLIOSIDOSIS, TYPE I;;B VARIANT GM2-GANGLIOSIDOSIS;;HEXOSAMINIDASE A DEFICIENCY;;HEXA DEFICIENCY TAY-SACHS DISEASE, JUVENILE, INCLUDED;;HEXOSAMINIDASE A DEFICIENCY, ADULT TYPE, INCLUDED;;GM2-GANGLIOSIDOSIS, ADULT CHRONI /.../, INCLUDED;;GM2-GANGLIOSIDOSIS, VARIANT B1, INCLUDED;;TAY-SACHS DISEASE, VARIANT B1, INCLUDED;;TAY-SACHS DISEASE, PSEUDO-AB VARIANT, INCLUDED
ENSG00000260339	HEXA-AS1	NA	
ENSG00000243007	RPL12P35	NA	
ENSG00000187806	TMEM202	NA	
ENSG00000261423	TMEM202-AS1	NA	
ENSG00000271072	PHBP20	NA	
ENSG00000261187	AC079322.1	NA	
ENSG00000166233	ARIH1	NA	
ENSG00000283798	MIR630	NA	
ENSG00000260534	AC100827.3	NA	
ENSG00000278313	AC100827.5	NA	
ENSG00000260144	AC100827.2	NA	
ENSG00000259783	LINC02259	NA	
ENSG00000260672	AC100827.4	NA	
ENSG00000259909	AC100827.1	NA	
ENSG00000215186	GOLGA6B	NA	
ENSG00000274350	RN7SL853P	NA	
ENSG00000175202	HIGD2B	NA	
ENSG00000261281	AC009712.1	NA	
ENSG00000140463	BBS4	615982	BARDET-BIEDL SYNDROME 4; BBS4
ENSG00000159322	ADPGK	NA	
ENSG00000260898	ADPGK-AS1	NA	
ENSG00000285729	AC103874.1	NA	
ENSG00000259259	NPM1P42	NA	
ENSG00000067141	NEO1	NA	
ENSG00000259691	FKBP1AP2	NA	
ENSG00000259440	NPM1P43	NA	
ENSG00000259528	AC068397.1	NA	
ENSG00000138622	HCN4	163800	SICK SINUS SYNDROME 2; SSS2;;SICK SINUS SYNDROME 2 WITH OR WITHOUT CARDIAC NONCOMPACTION AND/OR ASCENDING AORTA DILATION;;ATRIAL FIBRILLATION WITH BRADYARRHYTHMIA;;SINUS NODE DISEASE, FAMILIAL, AUTOSOMAL DOMINANT;;SINUS BRADYCARDIA SYNDROME, FAMILIA /.../OSOMAL DOMINANT
ENSG00000138622	HCN4	613123	BRUGADA SYNDROME 8; BRGDA8
ENSG00000259650	AC068397.2	NA	
ENSG00000183324	REC114	NA	
ENSG00000259186	MRPS15P1	NA	
ENSG00000156642	NPTN	NA	
ENSG00000281183	NPTN-IT1	NA	
ENSG00000103855	CD276	NA	
ENSG00000276807	AC022188.1	NA	
ENSG00000205363	INSYN1	NA	
ENSG00000260469	INSYN1-AS1	NA	
ENSG00000260624	AC018943.1	NA	
ENSG00000167139	TBC1D21	NA	
ENSG00000261801	LOXL1-AS1	NA	
ENSG00000129038	LOXL1	177650	EXFOLIATION SYNDROME; XFS;;EXFOLIATION GLAUCOMA; XFG;;PSEUDOEXFOLIATION GLAUCOMA; PEXG;;PSEUDOEXFOLIATION OF THE LENS;;PSEUDOEXFOLIATION SYNDROME; PEXS
ENSG00000067221	STOML1	NA	
ENSG00000140464	PML	NA	
ENSG00000287543	AC013486.1	NA	
ENSG00000260096	DNM1P33	NA	
ENSG00000159289	GOLGA6A	NA	
ENSG00000278604	RN7SL429P	NA	
ENSG00000214702	COMMD4P2	NA	
ENSG00000167178	ISLR2	NA	
ENSG00000248540	AC010931.1	NA	
ENSG00000261543	AC010931.2	NA	
ENSG00000278348	Metazoa_SRP	NA	
ENSG00000129009	ISLR	NA	
ENSG00000137868	STRA6	601186	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9;;ANOPHTHALMIA, CLINICAL, WITH MILD FACIAL DYSMORPHISM AND VARIABLE MALFORMATIONS OF THE LUNG, HEART, AND DIAPHRAGM;;ANOPHTHALMIA/MICROPHTHALMIA AND PULMONARY HYPOPLASIA;;PULMONARY HYPOPLASIA-DIAPHRAGMATIC HERNIA-A /.../ALMIA-CARDIAC DEFECT; PDAC;;SPEAR SYNDROME;;MATTHEW-WOOD SYNDROME;;PULMONARY AGENESIS, MICROPHTHALMIA, AND DIAPHRAGMATIC DEFECT; PMD MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 8, INCLUDED; MCOPCB8, INCLUDED
ENSG00000140481	CCDC33	NA	
ENSG00000280309	AC023300.3	NA	
ENSG00000261384	AC023300.1	NA	
ENSG00000277749	AC023300.2	NA	
ENSG00000140459	CYP11A1	613743	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE;;P450scc DEFICIENCY
ENSG00000260266	PPIAP46	NA	
ENSG00000261821	AC090826.1	NA	
ENSG00000274937	AC090826.2	NA	
ENSG00000277718	LINC02255	NA	
ENSG00000138623	SEMA7A	614745	BLOOD GROUP, JOHN MILTON HAGEN SYSTEM; JMH;;JOHN MILTON HAGEN BLOOD GROUP SYSTEM;;JMH BLOOD GROUP SYSTEM
ENSG00000277391	MIR6881	NA	
ENSG00000286696	AC090826.3	NA	
ENSG00000138629	UBL7	NA	
ENSG00000247240	UBL7-AS1	NA	
ENSG00000260103	AC012435.2	NA	
ENSG00000261775	AC012435.3	NA	
ENSG00000212279	AC012435.1	NA	
ENSG00000179361	ARID3B	NA	
ENSG00000179335	CLK3	NA	
ENSG00000275527	AC100835.2	NA	
ENSG00000260919	AC100835.1	NA	
ENSG00000179151	EDC3	616460	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50
ENSG00000140465	CYP1A1	NA	
ENSG00000140505	CYP1A2	124060	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2;;CYTOCHROME P-450, AROMATIC COMPOUND-INDUCIBLE;;DIOXIN-INDUCIBLE P3-450  PHENACETIN METABOLISM, DEFECT IN, INCLUDED;;PHENACETIN O-DEETHYLASE, DEFICIENCY OF, INCLUDED
ENSG00000103653	CSK	NA	
ENSG00000264386	MIR4513	NA	
ENSG00000140506	LMAN1L	NA	
ENSG00000261606	AC091230.1	NA	
ENSG00000213578	CPLX3	NA	
ENSG00000140474	ULK3	NA	
ENSG00000275411	MIR6882	NA	
ENSG00000140497	SCAMP2	NA	
ENSG00000178802	MPI	602579	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B;;CDG Ib; CDGIb;;CDG, GASTROINTESTINAL TYPE;;MANNOSEPHOSPHATE ISOMERASE DEFICIENCY;;MPI DEFICIENCY;;PROTEIN-LOSING ENTEROPATHY-HEPATIC FIBROSIS SYNDROME;;SAGUENAY-LAC SAINT-JEAN SYNDROME;;SLSJ SYNDROME
ENSG00000178761	FAM219B	NA	
ENSG00000178741	COX5A	NA	
ENSG00000178718	RPP25	NA	
ENSG00000198794	SCAMP5	NA	
ENSG00000261813	AC015720.2	NA	
ENSG00000199580	Y_RNA	NA	
ENSG00000260483	AC015720.1	NA	
ENSG00000138621	PPCDC	NA	
ENSG00000260152	AC113208.2	NA	
ENSG00000203411	Metazoa_SRP	NA	
ENSG00000252722	AC113208.1	NA	
ENSG00000240366	RPL36AP45	NA	
ENSG00000167173	C15orf39	NA	
ENSG00000261779	AC113208.4	NA	
ENSG00000287926	AC113208.5	NA	
ENSG00000260660	AC113208.3	NA	
ENSG00000260104	AC068338.1	NA	
ENSG00000261205	NIFKP4	NA	
ENSG00000167195	GOLGA6C	NA	
ENSG00000277295	RN7SL489P	NA	
ENSG00000140478	GOLGA6D	NA	
ENSG00000275992	RN7SL327P	NA	
ENSG00000260357	DNM1P34	NA	
ENSG00000259790	ANP32BP1	NA	
ENSG00000140365	COMMD4	NA	
ENSG00000275645	AC068338.3	NA	
ENSG00000140398	NEIL1	NA	
ENSG00000140400	MAN2C1	NA	
ENSG00000284343	MIR631	NA	
ENSG00000260274	AC068338.2	NA	
ENSG00000169375	SIN3A	613406	WITTEVEEN-KOLK SYNDROME; WITKOS CHROMOSOME 15q24 DELETION SYNDROME, INCLUDED;;CHROMOSOME 15q24 DUPLICATION SYNDROME, INCLUDED
ENSG00000241890	RPL13P4	NA	
ENSG00000261714	AC105137.1	NA	
ENSG00000276744	AC105137.2	NA	
ENSG00000169410	PTPN9	NA	
ENSG00000260165	AC105036.2	NA	
ENSG00000259931	AC105036.1	NA	
ENSG00000260269	AC105036.3	NA	
ENSG00000169371	SNUPN	NA	
ENSG00000260235	AC105020.3	NA	
ENSG00000260206	AC105020.2	NA	
ENSG00000177971	IMP3	NA	
ENSG00000275454	AC105020.6	NA	
ENSG00000274515	AC105020.5	NA	
ENSG00000173548	SNX33	NA	
ENSG00000173546	CSPG4	NA	
ENSG00000260892	AC105020.4	NA	
ENSG00000203392	AC105020.1	NA	
ENSG00000182950	ODF3L1	NA	
ENSG00000246877	DNM1P35	NA	
ENSG00000260288	AC019294.2	NA	
ENSG00000260815	PPIAP47	NA	
ENSG00000261043	AC019294.3	NA	
ENSG00000284385	MIR4313	NA	
ENSG00000187812	AC019294.1	NA	
ENSG00000241807	RN7SL319P	NA	
ENSG00000261820	DNM1P49	NA	
ENSG00000140367	UBE2Q2	NA	
ENSG00000266308	RN7SL510P	NA	
ENSG00000167196	FBXO22	NA	
ENSG00000169752	NRG4	NA	
ENSG00000260685	AC027104.1	NA	
ENSG00000169758	TMEM266	NA	
ENSG00000259422	AC091100.1	NA	
ENSG00000140374	ETFA	231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD;;GLUTARIC ACIDEMIA II; GA2;;GLUTARIC ACIDURIA II;;GA II;;ETHYLMALONIC-ADIPICACIDURIA; EMA GLUTARIC ACIDEMIA IIA, INCLUDED; GA2A, INCLUDED;;ETFA DEFICIENCY, INCLUDED;;GLUTARIC ACIDEMIA IIB, INCLUDED; G /.../NCLUDED;;ETFB DEFICIENCY, INCLUDED;;GLUTARIC ACIDEMIA IIC, INCLUDED; GA2C, INCLUDED;;ETFDH DEFICIENCY, INCLUDED
ENSG00000196274	Metazoa_SRP	NA	
ENSG00000259581	TYRO3P	NA	
ENSG00000287503	AC027243.3	NA	
ENSG00000159556	ISL2	NA	
ENSG00000259514	AC027243.1	NA	
ENSG00000270036	AC027243.2	NA	
ENSG00000140386	SCAPER	618195	INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP
ENSG00000261232	AC090751.1	NA	
ENSG00000266449	MIR3713	NA	
ENSG00000201510	RN7SKP217	NA	
ENSG00000117906	RCN2	NA	
ENSG00000243365	RN7SL278P	NA	
ENSG00000259565	KRT8P23	NA	
ENSG00000140368	PSTPIP1	604416	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE;;PAPA SYNDROME; PAPAS;;FAMILIAL RECURRENT ARTHRITIS; FRA
ENSG00000140391	TSPAN3	NA	
ENSG00000259652	AC090181.1	NA	
ENSG00000278991	AC090181.3	NA	
ENSG00000269951	AC090181.2	NA	
ENSG00000173517	PEAK1	NA	
ENSG00000259722	AC087465.1	NA	
ENSG00000230459	AC060773.1	NA	
ENSG00000140382	HMG20A	NA	
ENSG00000279033	AC090984.1	NA	
ENSG00000259362	AC046168.1	NA	
ENSG00000259420	AC046168.2	NA	
ENSG00000169783	LINGO1	618103	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64
ENSG00000259666	LINGO1-AS1	NA	
ENSG00000259281	LINGO1-AS2	NA	
ENSG00000280359	AC105133.2	NA	
ENSG00000259213	AC105133.1	NA	
ENSG00000260139	CSPG4P13	NA	
ENSG00000260776	AC104758.2	NA	
ENSG00000261244	AC104758.3	NA	
ENSG00000242066	RN7SL214P	NA	
ENSG00000214646	COMMD4P1	NA	
ENSG00000261403	AC104758.4	NA	
ENSG00000261143	ADAMTS7P3	NA	
ENSG00000167202	TBC1D2B	NA	
ENSG00000259792	AC104758.1	NA	
ENSG00000183476	SH2D7	NA	
ENSG00000199633	AC090260.1	NA	
ENSG00000136425	CIB2	609439	DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48
ENSG00000136425	CIB2	614869	USHER SYNDROME, TYPE IJ; USH1J
ENSG00000166411	IDH3A	NA	
ENSG00000260988	AC090260.2	NA	
ENSG00000103740	ACSBG1	NA	
ENSG00000259708	AC090607.3	NA	
ENSG00000140403	DNAJA4	NA	
ENSG00000140395	WDR61	NA	
ENSG00000272418	AC090607.4	NA	
ENSG00000259562	AC090607.2	NA	
ENSG00000259322	AC090607.1	NA	
ENSG00000277482	AC090607.5	NA	
ENSG00000279694	AC011270.2	NA	
ENSG00000166426	CRABP1	NA	
ENSG00000259413	AC011270.1	NA	
ENSG00000136381	IREB2	618451	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA
ENSG00000259474	AC027228.1	NA	
ENSG00000188266	HYKK	NA	
ENSG00000279373	AC027228.3	NA	
ENSG00000041357	PSMA4	NA	
ENSG00000169684	CHRNA5	612052	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3;;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO  LUNG CANCER SUSCEPTIBILITY 2, INCLUDED; LNCR2, INCLUDED
ENSG00000261762	AC027228.2	NA	
ENSG00000080644	CHRNA3	191800	BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK;;URINARY BLADDER, ATONY OF
ENSG00000080644	CHRNA3	612052	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3;;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO  LUNG CANCER SUSCEPTIBILITY 2, INCLUDED; LNCR2, INCLUDED
ENSG00000279421	AC067863.2	NA	
ENSG00000117971	CHRNB4	NA	
ENSG00000259555	AC067863.1	NA	
ENSG00000261303	AC022748.2	NA	
ENSG00000213307	RPL18P11	NA	
ENSG00000273512	AC022748.3	NA	
ENSG00000238166	AC022748.1	NA	
ENSG00000136378	ADAMTS7	NA	
ENSG00000185787	MORF4L1	NA	
ENSG00000288561	AC103975.1	NA	
ENSG00000243711	RPL21P116	NA	
ENSG00000252061	RNU6-415P	NA	
ENSG00000279235	AC011944.2	NA	
ENSG00000103811	CTSH	NA	
ENSG00000058335	RASGRF1	NA	
ENSG00000177699	AC011944.1	NA	
ENSG00000259234	ANKRD34C-AS1	NA	
ENSG00000207695	MIR184	614303	EDICT SYNDROME; EDICT;;ENDOTHELIAL DYSTROPHY, IRIS HYPOPLASIA, CONGENITAL CATARACT, AND STROMAL THINNING SYNDROME;;KERATOCONUS WITH CATARACT; KTCNCT;;KERATOCONUS, FAMILIAL, WITH EARLY-ONSET ANTERIOR POLAR CATARACT
ENSG00000259419	HNRNPCP3	NA	
ENSG00000235711	ANKRD34C	NA	
ENSG00000166557	TMED3	NA	
ENSG00000287408	AC027811.1	NA	
ENSG00000169330	MINAR1	NA	
ENSG00000259493	AC023968.2	NA	
ENSG00000259208	AC023968.1	NA	
ENSG00000260674	AC026826.3	NA	
ENSG00000213527	AC026826.1	NA	
ENSG00000259229	AC026826.2	NA	
ENSG00000252995	RNU6-667P	NA	
ENSG00000259548	AC021483.1	NA	
ENSG00000136371	MTHFS	618367	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM
ENSG00000261229	AC021483.2	NA	
ENSG00000259332	ST20-MTHFS	NA	
ENSG00000279394	AC015871.4	NA	
ENSG00000286813	AC015871.6	NA	
ENSG00000180953	ST20	NA	
ENSG00000288592	AC015871.7	NA	
ENSG00000278600	AC015871.3	NA	
ENSG00000259642	ST20-AS1	NA	
ENSG00000288604	AC015871.8	NA	
ENSG00000259770	AC015871.1	NA	
ENSG00000140379	BCL2A1	NA	
ENSG00000271364	AC015871.2	NA	
ENSG00000279719	AC015871.5	NA	
ENSG00000279705	AC092701.1	NA	
ENSG00000275460	Metazoa_SRP	NA	
ENSG00000086666	ZFAND6	NA	
ENSG00000103876	FAH	276700	TYROSINEMIA, TYPE I; TYRSN1;;HEPATORENAL TYROSINEMIA;;FUMARYLACETOACETASE DEFICIENCY;;FAH DEFICIENCY
ENSG00000259967	AC087761.1	NA	
ENSG00000259417	CTXND1	NA	
ENSG00000259361	LINC00927	NA	
ENSG00000259495	AC016705.2	NA	
ENSG00000172379	ARNT2	615926	WEBB-DATTANI SYNDROME; WEDAS;;HYPOTHALAMO-PITUITARY-FRONTOTEMPORAL HYPOPLASIA WITH VISUAL AND RENAL ANOMALIES
ENSG00000258010	AC016705.1	NA	
ENSG00000287813	AC016705.3	NA	
ENSG00000259175	AC108451.1	NA	
ENSG00000270919	AC108451.2	NA	
ENSG00000284059	MIR5572	NA	
ENSG00000222139	RNU6-380P	NA	
ENSG00000136379	ABHD17C	NA	
ENSG00000271983	AC023302.1	NA	
ENSG00000287108	AC023302.2	NA	
ENSG00000103888	CEMIP	NA	
ENSG00000208003	MIR549A	NA	
ENSG00000259546	AC027808.1	NA	
ENSG00000259649	AC027808.2	NA	
ENSG00000117899	MESD	618644	OSTEOGENESIS IMPERFECTA, TYPE XX; OI20
ENSG00000260619	AC068870.1	NA	
ENSG00000265855	MIR4514	NA	
ENSG00000277782	AC068870.2	NA	
ENSG00000140406	TLNRD1	NA	
ENSG00000288625	AC068870.4	NA	
ENSG00000156206	CFAP161	NA	
ENSG00000279834	AC068870.3	NA	
ENSG00000259461	ANP32BP3	NA	
ENSG00000172349	IL16	NA	
ENSG00000271725	AC103858.1	NA	
ENSG00000172345	STARD5	NA	
ENSG00000286488	AC103858.3	NA	
ENSG00000259343	TMC3-AS1	NA	
ENSG00000188869	TMC3	NA	
ENSG00000273920	AC103858.2	NA	
ENSG00000284709	KF456110.1	NA	
ENSG00000275995	AC109809.1	NA	
ENSG00000259543	AC060809.1	NA	
ENSG00000259594	AC023034.1	NA	
ENSG00000259692	AC104041.1	NA	
ENSG00000259622	AC026956.1	NA	
ENSG00000183496	MEX3B	NA	
ENSG00000259518	LINC01583	NA	
ENSG00000287872	AC026956.2	NA	
ENSG00000140598	EFL1	617941	SHWACHMAN-DIAMOND SYNDROME 2; SDS2
ENSG00000212170	RNU1-77P	NA	
ENSG00000285974	AC026624.1	NA	
ENSG00000188659	SAXO2	NA	
ENSG00000274376	ADAMTS7P1	NA	
ENSG00000278662	GOLGA6L10	NA	
ENSG00000259429	UBE2Q2P2	NA	
ENSG00000237550	AC243919.1	NA	
ENSG00000278202	AC243919.2	NA	
ENSG00000197978	GOLGA6L9	NA	
ENSG00000275695	UBE2Q2P6	NA	
ENSG00000276710	CSPG4P10	NA	
ENSG00000278603	AC245033.3	NA	
ENSG00000255769	GOLGA2P10	NA	
ENSG00000277741	GOLGA6L17P	NA	
ENSG00000259637	DNM1P38	NA	
ENSG00000284803	AC245033.4	NA	
ENSG00000182774	RPS17	612527	DIAMOND-BLACKFAN ANEMIA 4; DBA4
ENSG00000260836	AC245033.1	NA	
ENSG00000278013	AC245033.2	NA	
ENSG00000214575	CPEB1	NA	
ENSG00000259462	CPEB1-AS1	NA	
ENSG00000103723	AP3B2	617276	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48; EIEE48
ENSG00000259707	AC105339.4	NA	
ENSG00000228141	AC105339.1	NA	
ENSG00000259315	ACTG1P17	NA	
ENSG00000279758	AC105339.5	NA	
ENSG00000259442	AC105339.3	NA	
ENSG00000286817	AC105339.6	NA	
ENSG00000250988	SNHG21	NA	
ENSG00000252690	AC105339.2	NA	
ENSG00000186628	FSD2	NA	
ENSG00000277864	SCARNA15	NA	
ENSG00000156232	WHAMM	NA	
ENSG00000103942	HOMER2	616707	DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68
ENSG00000259805	AC022558.2	NA	
ENSG00000169612	RAMAC	NA	
ENSG00000169609	C15orf40	NA	
ENSG00000260608	AC024270.4	NA	
ENSG00000064726	BTBD1	NA	
ENSG00000273747	AC022558.3	NA	
ENSG00000259767	AC022558.1	NA	
ENSG00000260351	AC024270.2	NA	
ENSG00000259308	AC024270.1	NA	
ENSG00000263643	MIR4515	NA	
ENSG00000286872	AC024270.5	NA	
ENSG00000136404	TM6SF1	NA	
ENSG00000166503	HDGFL3	NA	
ENSG00000260579	AC024270.3	NA	
ENSG00000259986	AC103876.1	NA	
ENSG00000169594	BNC1	618723	PREMATURE OVARIAN FAILURE 16; POF16
ENSG00000140600	SH3GL3	NA	
ENSG00000156218	ADAMTSL3	NA	
ENSG00000212374	RNU6-401P	NA	
ENSG00000261665	TUBAP4	NA	
ENSG00000200444	RNU6-1339P	NA	
ENSG00000274128	AC027807.2	NA	
ENSG00000259609	AC027807.1	NA	
ENSG00000259404	EFL1P1	NA	
ENSG00000280038	DNM1P41	NA	
ENSG00000259694	AC136698.1	NA	
ENSG00000259511	UBE2Q2L	NA	
ENSG00000259726	CSPG4P11	NA	
ENSG00000225151	GOLGA2P7	NA	
ENSG00000278422	RN7SL331P	NA	
ENSG00000184206	GOLGA6L4	NA	
ENSG00000259633	UBE2Q2P8	NA	
ENSG00000259683	AC243562.2	NA	
ENSG00000244056	RN7SL417P	NA	
ENSG00000259570	AC243562.1	NA	
ENSG00000235370	DNM1P51	NA	
ENSG00000272887	CSPG4P5	NA	
ENSG00000259538	UBE2Q2P11	NA	
ENSG00000259774	AC243562.3	NA	
ENSG00000278785	AC243562.4	NA	
ENSG00000197627	UBE2Q2P12	NA	
ENSG00000259551	AC048382.4	NA	
ENSG00000259302	AC048382.3	NA	
ENSG00000230373	GOLGA6L5P	NA	
ENSG00000259244	AC048382.2	NA	
ENSG00000189136	UBE2Q2P1	NA	
ENSG00000259728	LINC00933	NA	
ENSG00000275120	AC048382.5	NA	
ENSG00000176371	ZSCAN2	NA	
ENSG00000256278	AC048382.1	NA	
ENSG00000276278	AC048382.6	NA	
ENSG00000176700	SCAND2P	NA	
ENSG00000254779	EGLN1P1	NA	
ENSG00000177082	WDR73	251300	GALLOWAY-MOWAT SYNDROME 1; GAMOS1;;MICROCEPHALY, HIATAL HERNIA, AND NEPHROTIC SYNDROME;;GALLOWAY SYNDROME;;NEPHROSIS-NEURONAL DYSMIGRATION SYNDROME;;NEPHROSIS-MICROCEPHALY SYNDROME;;CEREBELLAR ATAXIA WITH MENTAL RETARDATION, OPTIC ATROPHY, AND SKIN  /.../ALITIES; CAMOS;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5, FORMERLY; SCAR5, FORMERLY
ENSG00000277578	Metazoa_SRP	NA	
ENSG00000197696	NMB	NA	
ENSG00000140612	SEC11A	NA	
ENSG00000259654	AC115102.1	NA	
ENSG00000285667	AC012291.3	NA	
ENSG00000166716	ZNF592	NA	
ENSG00000259415	AC012291.2	NA	
ENSG00000136383	ALPK3	618052	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27
ENSG00000200991	AC012291.1	NA	
ENSG00000156222	SLC28A1	618477	URIDINE-CYTIDINEURIA; URCTU
ENSG00000286505	AC087468.2	NA	
ENSG00000207037	RNU6-339P	NA	
ENSG00000212388	RNU6-796P	NA	
ENSG00000271044	AC087468.1	NA	
ENSG00000073417	PDE8A	NA	
ENSG00000259270	AC044860.2	NA	
ENSG00000229212	AC044860.1	NA	
ENSG00000259449	NIFKP8	NA	
ENSG00000259295	CSPG4P12	NA	
ENSG00000277582	RN7SL428P	NA	
ENSG00000188388	GOLGA6L3	NA	
ENSG00000218052	ADAMTS7P4	NA	
ENSG00000259317	AC044860.3	NA	
ENSG00000170776	AKAP13	NA	
ENSG00000284160	MIR7706	NA	
ENSG00000251891	RNU7-79P	NA	
ENSG00000259630	AC104046.1	NA	
ENSG00000259375	AC087286.3	NA	
ENSG00000259367	AC087286.2	NA	
ENSG00000259276	AC087286.1	NA	
ENSG00000202081	RNU6-1280P	NA	
ENSG00000259453	AC087286.4	NA	
ENSG00000259544	AC021739.3	NA	
ENSG00000259407	AC021739.2	NA	
ENSG00000259762	AC021739.4	NA	
ENSG00000259416	LINC02883	NA	
ENSG00000183655	KLHL25	NA	
ENSG00000221634	MIR1276	NA	
ENSG00000259195	AC021739.1	NA	
ENSG00000252931	RNU6-231P	NA	
ENSG00000264406	MIR548AP	NA	
ENSG00000259608	AC104229.1	NA	
ENSG00000260477	LINC01584	NA	
ENSG00000273540	AGBL1	615523	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8
ENSG00000252964	RNA5SP400	NA	
ENSG00000261077	AC016180.2	NA	
ENSG00000200206	AC016180.1	NA	
ENSG00000260125	AGBL1-AS1	NA	
ENSG00000259734	AC012229.1	NA	
ENSG00000259636	AC016987.2	NA	
ENSG00000259620	AC016987.1	NA	
ENSG00000259761	AC078905.1	NA	
ENSG00000259560	AC020687.1	NA	
ENSG00000207150	RNU6-185P	NA	
ENSG00000259527	LINC00052	NA	
ENSG00000287391	AC103871.1	NA	
ENSG00000140538	NTRK3	NA	
ENSG00000259183	MED28P6	NA	
ENSG00000260305	NTRK3-AS1	NA	
ENSG00000259494	MRPL46	NA	
ENSG00000173867	AC013489.1	NA	
ENSG00000181991	MRPS11	NA	
ENSG00000279945	AC013489.3	NA	
ENSG00000140543	DET1	NA	
ENSG00000259569	AC013489.2	NA	
ENSG00000249487	LINC01586	NA	
ENSG00000221630	MIR1179	NA	
ENSG00000207703	MIR7-2	NA	
ENSG00000283484	MIR3529	NA	
ENSG00000181026	AEN	NA	
ENSG00000172183	ISG20	NA	
ENSG00000259676	AC103982.1	NA	
ENSG00000157766	ACAN	165800	SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD;;OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS; OD
ENSG00000157766	ACAN	608361	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE; SEDK
ENSG00000157766	ACAN	612813	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG;;SEMD, AGGRECAN TYPE
ENSG00000140511	HAPLN3	NA	
ENSG00000140545	MFGE8	NA	
ENSG00000259350	AC067805.1	NA	
ENSG00000259489	KRT18P47	NA	
ENSG00000261549	AC107954.1	NA	
ENSG00000260275	AC013565.2	NA	
ENSG00000260123	AC013565.1	NA	
ENSG00000261407	AC013565.3	NA	
ENSG00000140526	ABHD2	NA	
ENSG00000239151	RNU7-195P	NA	
ENSG00000259699	HMGB1P8	NA	
ENSG00000259948	AC124068.1	NA	
ENSG00000140522	RLBP1	136880	FUNDUS ALBIPUNCTATUS RETINITIS PUNCTATA ALBESCENS, INCLUDED
ENSG00000140522	RLBP1	607475	BOTHNIA RETINAL DYSTROPHY;;VASTERBOTTEN DYSTROPHY
ENSG00000140522	RLBP1	607476	NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD
ENSG00000140525	FANCI	609053	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI
ENSG00000140521	POLG	157640	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 1
ENSG00000140521	POLG	203700	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A;;ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC CIRRHOSIS;;ALPERS PROGRESSIVE INFANTILE POLIODYSTROPHY;;ALPERS SYNDROME;;ALPERS-HUTTENLOCHER SYNDROME;;NEURONAL DEGENERA /.../F CHILDHOOD WITH LIVER DISEASE, PROGRESSIVE; PNDC
ENSG00000140521	POLG	258450	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 1
ENSG00000140521	POLG	603041	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1;;MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, TYMP-RELATED;;MNGIE, TYMP-RELATED;;MYONEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME;;POLYNEUROPATHY, OPHTHALMOPLEGIA, LEUKOENCE /.../ATHY, AND INTESTINAL PSEUDOOBSTRUCTION;;POLIP SYNDROME
ENSG00000140521	POLG	607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO;;SENSORY ATAXIC NEUROPATHY WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA WITH EPILEPSY, INCLUDED; SCAE, INCLUDED;;EPILEPSY, PROGRESSIVE MYOCLONIC, WITH /.../RY ATAXIC NEUROPATHY, INCLUDED;;EPILEPSY, PROGRESSIVE MYOCLONIC, 5, FORMERLY; EPM5, FORMERLY
ENSG00000140521	POLG	613662	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B;;MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, POLG-RELATED;;MNGIE, POLG-RELATED
ENSG00000275101	MIR6766	NA	
ENSG00000261441	AC124068.2	NA	
ENSG00000279708	AC133637.1	NA	
ENSG00000287717	AC133637.2	NA	
ENSG00000255571	MIR9-3HG	NA	
ENSG00000284329	MIR9-3	NA	
ENSG00000140519	RHCG	NA	
ENSG00000259218	LINC00928	NA	
ENSG00000261478	AC013391.3	NA	
ENSG00000259713	AC013391.2	NA	
ENSG00000140534	TICRR	NA	
ENSG00000259615	AC013391.1	NA	
ENSG00000166813	KIF7	200990	ACROCALLOSAL SYNDROME; ACLS;;HALLUX DUPLICATION, POSTAXIAL POLYDACTYLY, AND ABSENCE OF CORPUS CALLOSUM;;SCHINZEL ACROCALLOSAL SYNDROME JOUBERT SYNDROME 12, INCLUDED; JBTS12, INCLUDED;;JOUBERT SYNDROME 12/15, DIGENIC, INCLUDED
ENSG00000166813	KIF7	607131	AL-GAZALI-BAKALINOVA SYNDROME; AGBK;;MACROCEPHALY WITH MULTIPLE EPIPHYSEAL DYSPLASIA AND DISTINCTIVE FACIES; MMEDF
ENSG00000166813	KIF7	614120	HYDROLETHALUS SYNDROME 2; HLS2
ENSG00000166819	PLIN1	613877	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS
ENSG00000166821	PEX11A	NA	
ENSG00000241362	RPL36AP43	NA	
ENSG00000140527	WDR93	NA	
ENSG00000259561	AC079075.1	NA	
ENSG00000206590	RNU6-132P	NA	
ENSG00000166823	MESP1	NA	
ENSG00000259441	MRPL15P1	NA	
ENSG00000188095	MESP2	277300	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1;;VERTEBRAL ANOMALIES;;JARCHO-LEVIN SYNDROME;;SPONDYLOTHORACIC DYSPLASIA;;COSTOVERTEBRAL DYSPLASIA;;SPONDYLOTHORACIC DYSOSTOSIS
ENSG00000188095	MESP2	608681	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2
ENSG00000166825	ANPEP	NA	
ENSG00000157823	AP3S2	NA	
ENSG00000250021	ARPIN-AP3S2	NA	
ENSG00000264966	MIR5094	NA	
ENSG00000259677	AC027176.2	NA	
ENSG00000264796	MIR5009	NA	
ENSG00000212420	RNU6-1111P	NA	
ENSG00000242498	ARPIN	NA	
ENSG00000252645	RNU7-111P	NA	
ENSG00000259273	AC027176.1	NA	
ENSG00000280377	AC027176.3	NA	
ENSG00000140548	ZNF710	NA	
ENSG00000265871	MIR3174	NA	
ENSG00000273691	AC087284.1	NA	
ENSG00000259291	ZNF710-AS1	NA	
ENSG00000276376	U7	NA	
ENSG00000182054	IDH2	613657	D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2
ENSG00000259685	IDH2-DT	NA	
ENSG00000185033	SEMA4B	NA	
ENSG00000240470	RN7SL346P	NA	
ENSG00000225193	RPS12P26	NA	
ENSG00000185043	CIB1	618267	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3
ENSG00000183208	GDPGP1	NA	
ENSG00000284626	AC091167.7	NA	
ENSG00000213471	TTLL13P	NA	
ENSG00000261147	AC091167.2	NA	
ENSG00000182768	NGRN	NA	
ENSG00000275674	AC091167.6	NA	
ENSG00000228998	AC091167.1	NA	
ENSG00000270322	AC091167.3	NA	
ENSG00000275345	AC091167.5	NA	
ENSG00000271396	AC091167.4	NA	
ENSG00000214433	GOLGA2P8	NA	
ENSG00000275803	RN7SL736P	NA	
ENSG00000279980	GABARAPL3	NA	
ENSG00000238244	GABARAPL3	NA	
ENSG00000196391	ZNF774	NA	
ENSG00000259262	NDUFA3P4	NA	
ENSG00000140575	IQGAP1	NA	
ENSG00000259177	AC018946.1	NA	
ENSG00000140577	CRTC3	NA	
ENSG00000259212	AC103739.1	NA	
ENSG00000259314	AC103739.2	NA	
ENSG00000259736	CRTC3-AS1	NA	
ENSG00000285560	AC103739.3	NA	
ENSG00000259746	HSPE1P3	NA	
ENSG00000278370	AC021422.1	NA	
ENSG00000245479	LINC01585	NA	
ENSG00000197299	BLM	210900	BLOOM SYNDROME; BLM;;BS; BLS;;MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 1; MGRISCE1
ENSG00000200677	SNORD18	NA	
ENSG00000287061	AC124248.2	NA	
ENSG00000259704	AC124248.1	NA	
ENSG00000241869	RN7SL363P	NA	
ENSG00000140564	FURIN	NA	
ENSG00000182511	FES	NA	
ENSG00000196547	MAN2A2	NA	
ENSG00000259661	AC068831.3	NA	
ENSG00000184508	HDDC3	NA	
ENSG00000140553	UNC45A	NA	
ENSG00000258384	RCCD1-AS1	NA	
ENSG00000166965	RCCD1	NA	
ENSG00000198901	PRC1	NA	
ENSG00000284946	AC068831.6	NA	
ENSG00000258725	PRC1-AS1	NA	
ENSG00000200142	Y_RNA	NA	
ENSG00000184056	VPS33B	208085	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1;;ARC SYNDROME; ARCS
ENSG00000214432	VPS33B-DT	NA	
ENSG00000278514	AC068831.5	NA	
ENSG00000258542	AC068831.1	NA	
ENSG00000275929	AC068831.4	NA	
ENSG00000258665	AC068831.2	NA	
ENSG00000285661	AC127520.1	NA	
ENSG00000185518	SV2B	NA	
ENSG00000285883	AC123784.1	NA	
ENSG00000258551	CRAT37	NA	
ENSG00000258954	AC107958.3	NA	
ENSG00000258765	AC107958.2	NA	
ENSG00000258540	AC107958.1	NA	
ENSG00000259057	THRAP3P2	NA	
ENSG00000176463	SLCO3A1	NA	
ENSG00000260661	AC116903.2	NA	
ENSG00000258761	AC116903.1	NA	
ENSG00000258726	DUXAP6	NA	
ENSG00000258925	NPM1P5	NA	
ENSG00000140557	ST8SIA2	NA	
ENSG00000239197	AC090985.1	NA	
ENSG00000258739	ENO1P2	NA	
ENSG00000259170	AC090985.2	NA	
ENSG00000183643	C15orf32	NA	
ENSG00000258647	LINC00930	NA	
ENSG00000258676	AC091544.2	NA	
ENSG00000260337	AC091544.4	NA	
ENSG00000271763	AC091544.5	NA	
ENSG00000185442	FAM174B	NA	
ENSG00000259064	AC091544.3	NA	
ENSG00000275965	AC091544.7	NA	
ENSG00000272298	AC091544.6	NA	
ENSG00000253954	HMGN1P38	NA	
ENSG00000258741	H2AZ2P1	NA	
ENSG00000240484	AC091544.1	NA	
ENSG00000258562	AC106028.1	NA	
ENSG00000260361	AC106028.3	NA	
ENSG00000258527	ASB9P1	NA	
ENSG00000258922	AC106028.2	NA	
ENSG00000274215	AC106028.4	NA	
ENSG00000272888	LINC01578	NA	
ENSG00000279765	AC013394.1	NA	
ENSG00000173575	CHD2	615369	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC
ENSG00000284324	MIR3175	NA	
ENSG00000182175	RGMA	NA	
ENSG00000258611	YBX2P2	NA	
ENSG00000285663	AC108457.1	NA	
ENSG00000257060	AC091078.1	NA	
ENSG00000258888	AC112693.1	NA	
ENSG00000258971	AC112693.2	NA	
ENSG00000258909	AC091078.2	NA	
ENSG00000258787	SEPHS1P2	NA	
ENSG00000258631	AC110023.1	NA	
ENSG00000258754	LINC01579	NA	
ENSG00000258627	AC103996.1	NA	
ENSG00000258476	LINC02207	NA	
ENSG00000259123	AC103996.3	NA	
ENSG00000258831	AC103996.2	NA	
ENSG00000258785	LINC01580	NA	
ENSG00000259724	LINC01581	NA	
ENSG00000258895	AC104390.1	NA	
ENSG00000258570	H3P40	NA	
ENSG00000140563	MCTP2	NA	
ENSG00000258632	AC135626.1	NA	
ENSG00000287328	AC135626.2	NA	
ENSG00000287950	AC009432.2	NA	
ENSG00000285866	LINC02852	NA	
ENSG00000259331	AC009432.1	NA	
ENSG00000286917	AC022308.1	NA	
ENSG00000277654	AC087633.2	NA	
ENSG00000270017	AC107976.1	NA	
ENSG00000258433	AC087633.1	NA	
ENSG00000258773	AC087636.1	NA	
ENSG00000248441	LINC01197	NA	
ENSG00000273923	AC104260.1	NA	
ENSG00000280304	AC104260.2	NA	
ENSG00000285700	AC104260.3	NA	
ENSG00000259134	LINC00924	NA	
ENSG00000258489	AC027013.1	NA	
ENSG00000275016	AC015574.1	NA	
ENSG00000222076	RNU2-3P	NA	
ENSG00000275443	AC012409.2	NA	
ENSG00000259702	AC024337.1	NA	
ENSG00000273771	AC024337.2	NA	
ENSG00000247809	NR2F2-AS1	NA	
ENSG00000280048	AC012409.5	NA	
ENSG00000277135	AC012409.3	NA	
ENSG00000259359	AC012409.1	NA	
ENSG00000278146	AC012409.4	NA	
ENSG00000259763	LINC02157	NA	
ENSG00000280291	AC016251.1	NA	
ENSG00000185551	NR2F2	615779	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4
ENSG00000283888	MIR1469	NA	
ENSG00000275322	AC103746.1	NA	
ENSG00000259275	AC087477.2	NA	
ENSG00000259614	AC087477.6	NA	
ENSG00000259542	AC087477.5	NA	
ENSG00000259312	AC087477.3	NA	
ENSG00000250825	PGAM1P12	NA	
ENSG00000242295	AC087477.1	NA	
ENSG00000259534	AC087477.4	NA	
ENSG00000222617	RN7SKP254	NA	
ENSG00000274079	Metazoa_SRP	NA	
ENSG00000259340	AC110588.1	NA	
ENSG00000214424	FAM149B1P1	NA	
ENSG00000259282	SPATA8-AS1	NA	
ENSG00000185594	SPATA8	NA	
ENSG00000223120	RN7SKP181	NA	
ENSG00000259485	LINC02253	NA	
ENSG00000259403	AC020704.1	NA	
ENSG00000259664	LINC02254	NA	
ENSG00000242863	RN7SL677P	NA	
ENSG00000251729	RNA5SP401	NA	
ENSG00000279091	AC026523.2	NA	
ENSG00000259582	AC026523.1	NA	
ENSG00000287267	AC026523.3	NA	
ENSG00000287321	AC026523.4	NA	
ENSG00000251209	LINC00923	NA	
ENSG00000259870	AC024651.2	NA	
ENSG00000287000	AC024651.3	NA	
ENSG00000140450	ARRDC4	NA	
ENSG00000259478	AC024651.1	NA	
ENSG00000258483	LINC02251	NA	
ENSG00000283372	U6	NA	
ENSG00000259199	AC022523.1	NA	
ENSG00000222361	RNU6-1186P	NA	
ENSG00000259611	LINC01582	NA	
ENSG00000259320	AC022523.3	NA	
ENSG00000259266	AC022523.2	NA	
ENSG00000259041	AC015722.1	NA	
ENSG00000274312	AC015722.2	NA	
ENSG00000277987	LINC02351	NA	
ENSG00000283597	FAM169B	NA	
ENSG00000259507	AC103968.1	NA	
ENSG00000259424	IRAIN	NA	
ENSG00000140443	IGF1R	270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES;;SOMATOMEDIN, END-ORGAN INSENSITIVITY TO;;SOMATOMEDIN-C, RESISTANCE TO;;IGF-I RESISTANCE INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO, DUE TO INCREASED BINDING PROTEIN, INCLUDED
ENSG00000278022	AC118658.1	NA	
ENSG00000264480	MIR4714	NA	
ENSG00000287191	AC055807.1	NA	
ENSG00000259621	AC069029.1	NA	
ENSG00000259475	AC036108.1	NA	
ENSG00000183571	PGPEP1L	NA	
ENSG00000278090	LUNAR1	NA	
ENSG00000182253	SYNM	NA	
ENSG00000261054	AC036108.2	NA	
ENSG00000103852	TTC23	NA	
ENSG00000261616	AC036108.3	NA	
ENSG00000259921	AC022819.1	NA	
ENSG00000168904	LRRC28	NA	
ENSG00000259706	HSP90B2P	NA	
ENSG00000259228	HNRNPA1P62	NA	
ENSG00000259257	AC037479.1	NA	
ENSG00000259590	LINC02244	NA	
ENSG00000259760	AC015660.2	NA	
ENSG00000274294	AC015660.3	NA	
ENSG00000259341	AC015660.1	NA	
ENSG00000286893	AC015660.5	NA	
ENSG00000279846	AC015660.4	NA	
ENSG00000241562	RPL7P5	NA	
ENSG00000068305	MEF2A	608320	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1;;CORONARY ARTERY DISEASE WITH MYOCARDIAL INFARCTION
ENSG00000201724	Y_RNA	NA	
ENSG00000183060	LYSMD4	NA	
ENSG00000182397	DNM1P46	NA	
ENSG00000259655	AC090825.2	NA	
ENSG00000241588	RN7SL484P	NA	
ENSG00000259363	AC090825.1	NA	
ENSG00000254744	AC084855.1	NA	
ENSG00000140470	ADAMTS17	613195	WEILL-MARCHESANI SYNDROME 4; WMS4;;WEILL-MARCHESANI-LIKE SYNDROME; WMSL
ENSG00000259219	AC084855.2	NA	
ENSG00000252957	RNA5SP402	NA	
ENSG00000259356	AC022710.1	NA	
ENSG00000189419	SPATA41	NA	
ENSG00000259430	CERS3-AS1	NA	
ENSG00000154227	CERS3	615023	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9
ENSG00000270127	AC027020.2	NA	
ENSG00000251819	RNU6-322P	NA	
ENSG00000259205	PRKXP1	NA	
ENSG00000259540	AC027020.1	NA	
ENSG00000140471	LINS1	614340	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27
ENSG00000200095	RNU6-181P	NA	
ENSG00000183475	ASB7	NA	
ENSG00000212306	Y_RNA	NA	
ENSG00000259381	AC090695.1	NA	
ENSG00000259579	AC087762.1	NA	
ENSG00000279588	AC087762.2	NA	
ENSG00000259586	AC015712.3	NA	
ENSG00000232386	AC015712.1	NA	
ENSG00000272808	AC015712.6	NA	
ENSG00000259604	AC015712.4	NA	
ENSG00000272639	AC015712.5	NA	
ENSG00000184254	ALDH1A3	615113	MICROPHTHALMIA, ISOLATED 8; MCOP8
ENSG00000278456	AC015712.7	NA	
ENSG00000259583	AC015712.2	NA	
ENSG00000154237	LRRK1	NA	
ENSG00000259376	AC090907.1	NA	
ENSG00000259755	AC090907.2	NA	
ENSG00000287892	AC090907.3	NA	
ENSG00000259365	AC019254.2	NA	
ENSG00000259182	AC019254.1	NA	
ENSG00000131873	CHSY1	605282	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS;;PREAXIAL BRACHYDACTYLY SYNDROME, TEMTAMY TYPE
ENSG00000131871	SELENOS	NA	
ENSG00000131876	SNRPA1	NA	
ENSG00000259172	AC023024.1	NA	
ENSG00000140479	PCSK6	NA	
ENSG00000279970	AC023024.2	NA	
ENSG00000259764	PCSK6-AS1	NA	
ENSG00000274139	AC090164.2	NA	
ENSG00000277210	AC090164.3	NA	
ENSG00000282793	AC090164.4	NA	
ENSG00000259464	SNRPCP18	NA	
ENSG00000259695	AC090164.1	NA	
ENSG00000286733	LINC02348	NA	
ENSG00000184277	TM2D3	NA	
ENSG00000252614	RNU6-807P	NA	
ENSG00000185418	TARS3	NA	
ENSG00000259658	AC027559.1	NA	
ENSG00000259660	DNM1P47	NA	
ENSG00000259236	GOLGA8VP	NA	
ENSG00000240927	RN7SL209P	NA	
ENSG00000184140	OR4F6	NA	
ENSG00000182854	OR4F15	NA	
ENSG00000232459	OR4F14P	NA	
ENSG00000214344	OR4F13P	NA	
ENSG00000257109	OR4F28P	NA	
ENSG00000259454	WBP1LP5	NA	
ENSG00000259646	AC140725.2	NA	
ENSG00000177693	OR4F4	NA	
ENSG00000183909	OR4G2P	NA	
ENSG00000275771	OR4G6P	NA	
ENSG00000248893	FAM138E	NA	
ENSG00000259553	AC140725.1	NA	
ENSG00000284557	MIR1302-10	NA	
ENSG00000185596	WASH3P	NA	
ENSG00000275449	MIR6859-3	NA	
ENSG00000248472	DDX11L9	NA	
ENSG00000233614	DDX11L10	NA	
ENSG00000234769	WASH4P	NA	
ENSG00000278739	MIR6859-4	NA	
ENSG00000260803	Z84723.1	NA	
ENSG00000231439	WASIR2	NA	
ENSG00000226942	IL9RP3	NA	
ENSG00000161980	POLR3K	NA	
ENSG00000161981	SNRNP25	NA	
ENSG00000007384	RHBDF1	NA	
ENSG00000278995	Z69720.2	NA	
ENSG00000103152	MPG	NA	
ENSG00000103148	NPRL3	617118	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3
ENSG00000269482	Z69720.1	NA	
ENSG00000228779	Z69666.1	NA	
ENSG00000130656	HBZ	NA	
ENSG00000206177	HBM	NA	
ENSG00000206178	HBZP1	NA	
ENSG00000225323	Z84721.2	NA	
ENSG00000188536	HBA2	140700	HEINZ BODY ANEMIAS
ENSG00000188536	HBA2	604131	ALPHA-THALASSEMIA
ENSG00000188536	HBA2	613978	HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONAL  HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED
ENSG00000188536	HBA2	617981	ERYTHROCYTOSIS, FAMILIAL, 7; ECYT7;;ERYTHROCYTOSIS, ALPHA-GLOBIN TYPE;;POLYCYTHEMIA, ALPHA-GLOBIN TYPE
ENSG00000206172	HBA1	140700	HEINZ BODY ANEMIAS
ENSG00000206172	HBA1	604131	ALPHA-THALASSEMIA
ENSG00000206172	HBA1	613978	HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONAL  HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED
ENSG00000206172	HBA1	617973	METHEMOGLOBINEMIA, ALPHA TYPE
ENSG00000206172	HBA1	617981	ERYTHROCYTOSIS, FAMILIAL, 7; ECYT7;;ERYTHROCYTOSIS, ALPHA-GLOBIN TYPE;;POLYCYTHEMIA, ALPHA-GLOBIN TYPE
ENSG00000207243	Z84721.1	NA	
ENSG00000086506	HBQ1	NA	
ENSG00000268836	Z69706.1	NA	
ENSG00000007392	LUC7L	NA	
ENSG00000206168	Z69890.1	NA	
ENSG00000167930	FAM234A	NA	
ENSG00000076344	RGS11	NA	
ENSG00000286901	Z69667.1	NA	
ENSG00000242173	ARHGDIG	NA	
ENSG00000185615	PDIA2	NA	
ENSG00000103126	AXIN1	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000103126	AXIN1	607864	CAUDAL DUPLICATION ANOMALY
ENSG00000086504	MRPL28	NA	
ENSG00000129925	PGAP6	NA	
ENSG00000236829	Z97634.1	NA	
ENSG00000103202	NME4	NA	
ENSG00000242612	DECR2	NA	
ENSG00000276984	AL023881.1	NA	
ENSG00000090565	RAB11FIP3	NA	
ENSG00000201034	Y_RNA	NA	
ENSG00000230428	AL049542.1	NA	
ENSG00000277142	LINC00235	NA	
ENSG00000103326	CAPN15	NA	
ENSG00000266124	MIR5587	NA	
ENSG00000266235	MIR3176	NA	
ENSG00000261691	Z97986.1	NA	
ENSG00000161992	PRR35	NA	
ENSG00000007541	PIGQ	618548	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 77; EIEE77;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 19; GPIBD19
ENSG00000257108	NHLRC4	NA	
ENSG00000282907	Z98883.1	NA	
ENSG00000197562	RAB40C	NA	
ENSG00000127578	WFIKKN1	NA	
ENSG00000130731	METTL26	NA	
ENSG00000172366	MCRIP2	NA	
ENSG00000228201	AL022341.1	NA	
ENSG00000161996	WDR90	NA	
ENSG00000262528	AL022341.2	NA	
ENSG00000140983	RHOT2	NA	
ENSG00000103269	RHBDL1	NA	
ENSG00000260394	LINC02867	NA	
ENSG00000279441	Z92544.2	NA	
ENSG00000103266	STUB1	615768	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16
ENSG00000103266	STUB1	618093	SPINOCEREBELLAR ATAXIA 48; SCA48
ENSG00000161999	JMJD8	NA	
ENSG00000127580	WDR24	NA	
ENSG00000261659	Z92544.1	NA	
ENSG00000127585	FBXL16	NA	
ENSG00000279255	Z97653.2	NA	
ENSG00000259840	Z97653.1	NA	
ENSG00000103260	METRN	NA	
ENSG00000103254	ANTKMT	NA	
ENSG00000162004	CCDC78	614807	MYOPATHY, CENTRONUCLEAR, 4; CNM4
ENSG00000103253	HAGHL	NA	
ENSG00000103245	CIAO3	NA	
ENSG00000102854	MSLN	NA	
ENSG00000279136	AL031258.1	NA	
ENSG00000162006	MSLNL	NA	
ENSG00000207579	MIR662	NA	
ENSG00000007376	RPUSD1	NA	
ENSG00000127586	CHTF18	NA	
ENSG00000127588	GNG13	NA	
ENSG00000287855	AL023882.1	NA	
ENSG00000275438	AL031008.1	NA	
ENSG00000103227	LMF1	246650	LIPASE DEFICIENCY, COMBINED;;LIPOPROTEIN LIPASE DEFICIENCY WITH HEPATIC TRIGLYCERIDE LIPASE DEFICIENCY;;LPL AND HTGL DEFICIENCY;;LPL AND HL DEFICIENCY
ENSG00000260022	AL031716.1	NA	
ENSG00000260316	AL008727.1	NA	
ENSG00000260439	LMF1-AS1	NA	
ENSG00000276931	AC009041.3	NA	
ENSG00000260807	CEROX1	NA	
ENSG00000005513	SOX8	NA	
ENSG00000260496	AC009041.1	NA	
ENSG00000261713	SSTR5-AS1	NA	
ENSG00000261720	AC009041.2	NA	
ENSG00000162009	SSTR5	182455	SOMATOSTATIN RECEPTOR 5; SSTR5 SOMATOSTATIN ANALOG, RESISTANCE TO, INCLUDED
ENSG00000184471	C1QTNF8	NA	
ENSG00000260702	AL031713.1	NA	
ENSG00000260532	AL031598.1	NA	
ENSG00000273551	AC120498.8	NA	
ENSG00000196557	CACNA1H	611942	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 6, INCLUDED; EIG6, INCLUDED
ENSG00000196557	CACNA1H	617027	HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4;;FH IV;;ALDOSTERONISM, PRIMARY, AND HYPERTENSION
ENSG00000260403	AC120498.3	NA	
ENSG00000259910	AC120498.1	NA	
ENSG00000261294	AC120498.6	NA	
ENSG00000116176	TPSG1	NA	
ENSG00000277010	AC120498.10	NA	
ENSG00000197253	TPSB2	NA	
ENSG00000172236	TPSAB1	NA	
ENSG00000095917	TPSD1	NA	
ENSG00000260182	AC120498.2	NA	
ENSG00000196364	PRSS29P	NA	
ENSG00000261564	AC120498.7	NA	
ENSG00000260991	AC120498.5	NA	
ENSG00000260284	TPSP2	NA	
ENSG00000260710	AC120498.4	NA	
ENSG00000274751	AC120498.9	NA	
ENSG00000103275	UBE2I	NA	
ENSG00000261505	AL031714.1	NA	
ENSG00000219274	RPS20P2	NA	
ENSG00000007516	BAIAP3	NA	
ENSG00000007520	TSR3	NA	
ENSG00000090581	GNPTG	252605	MUCOLIPIDOSIS III GAMMA;;ML III GAMMA;;MUCOLIPIDOSIS III, COMPLEMENTATION GROUP C;;MUCOLIPIDOSIS IIIC;;ML IIIC;;MUCOLIPIDOSIS III, IRANIAN VARIANT FORM;;MUCOLIPIDOSIS III, VARIANT FORM
ENSG00000260425	AL031709.1	NA	
ENSG00000059145	UNKL	NA	
ENSG00000260132	AL032819.1	NA	
ENSG00000174109	C16orf91	NA	
ENSG00000284395	PERCC1	618662	DIARRHEA 11, MALABSORPTIVE, CONGENITAL; DIAR11;;INTRACTABLE DIARRHEA OF INFANCY SYNDROME; IDIS
ENSG00000197599	CCDC154	NA	
ENSG00000279930	AL032819.2	NA	
ENSG00000103249	CLCN7	166600	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2;;OSTEOPETROSIS, AUTOSOMAL DOMINANT, TYPE II;;MARBLE BONES, AUTOSOMAL DOMINANT;;OSTEOSCLEROSIS FRAGILIS GENERALISATA;;ALBERS-SCHONBERG DISEASE, AUTOSOMAL DOMINANT
ENSG00000103249	CLCN7	611490	OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4;;OSTEOPETROSIS, INFANTILE MALIGNANT 2
ENSG00000103249	CLCN7	618541	HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD
ENSG00000261641	AL031600.3	NA	
ENSG00000260051	AL031600.1	NA	
ENSG00000261430	AL031600.2	NA	
ENSG00000219027	RPS3AP2	NA	
ENSG00000251692	PTX4	NA	
ENSG00000100726	TELO2	616954	YOU-HOOVER-FONG SYNDROME; YHFS
ENSG00000187535	IFT140	266920	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9;;MAINZER-SALDINO SYNDROME; MZSDS;;CONORENAL SYNDROME;;RENAL DYSPLASIA, RETINAL PIGMENTARY DYSTROPHY, CEREBELLAR ATAXIA, AND SKELETAL DYSPLASIA
ENSG00000187535	IFT140	617781	RETINITIS PIGMENTOSA 80; RP80
ENSG00000260646	AL031705.1	NA	
ENSG00000131634	TMEM204	NA	
ENSG00000280062	AL031719.1	NA	
ENSG00000280231	AL031719.2	NA	
ENSG00000280327	Z97633.1	NA	
ENSG00000260954	AL133297.1	NA	
ENSG00000260989	AL133297.2	NA	
ENSG00000007545	CRAMP1	NA	
ENSG00000226890	Z97652.1	NA	
ENSG00000261732	AL031708.1	NA	
ENSG00000206053	JPT2	NA	
ENSG00000278987	AL031009.1	NA	
ENSG00000138834	MAPK8IP3	618443	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA
ENSG00000275092	AL031710.2	NA	
ENSG00000261399	AL031710.1	NA	
ENSG00000265820	MIR3177	NA	
ENSG00000261207	AL031717.1	NA	
ENSG00000103024	NME3	NA	
ENSG00000074071	MRPS34	617664	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32
ENSG00000197774	EME2	NA	
ENSG00000162032	SPSB3	NA	
ENSG00000095906	NUBP2	NA	
ENSG00000099769	IGFALS	615961	ACID-LABILE SUBUNIT DEFICIENCY; ACLSD
ENSG00000063854	HAGH	614033	HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY;;GLYOXALASE II DEFICIENCY
ENSG00000180185	FAHD1	NA	
ENSG00000162039	MEIOB	617706	SPERMATOGENIC FAILURE 22; SPGF22
ENSG00000260541	AL031722.1	NA	
ENSG00000281219	LINC00254	NA	
ENSG00000259947	LINC02124	NA	
ENSG00000162040	HS3ST6	NA	
ENSG00000198736	MSRB1	NA	
ENSG00000140986	RPL3L	NA	
ENSG00000140990	NDUFB10	NA	
ENSG00000140988	RPS2	NA	
ENSG00000206811	SNORA10	NA	
ENSG00000207405	SNORA64	NA	
ENSG00000255513	AC005363.1	NA	
ENSG00000255198	SNHG9	NA	
ENSG00000273587	SNORA78	NA	
ENSG00000179580	RNF151	NA	
ENSG00000277602	AC005363.2	NA	
ENSG00000183751	TBL3	NA	
ENSG00000196408	NOXO1	NA	
ENSG00000127554	GFER	613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED
ENSG00000261790	AC005606.2	NA	
ENSG00000127561	SYNGR3	NA	
ENSG00000260107	AC005606.1	NA	
ENSG00000167962	ZNF598	NA	
ENSG00000183971	NPW	NA	
ENSG00000265386	RN7SL219P	NA	
ENSG00000065054	SLC9A3R2	NA	
ENSG00000065057	NTHL1	616415	FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3
ENSG00000103197	TSC2	606690	LYMPHANGIOLEIOMYOMATOSIS; LAM;;LYMPHANGIOMYOMATOSIS
ENSG00000103197	TSC2	607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2;;CORTICAL DYSPLASIA OF TAYLOR; CDT;;FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT;;FCD2 FOCAL CORTICAL DYSPLASIA, TYPE IIA, INCLUDED; FCORD2A, INCLUDED;;FCD IIA, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR WITHOUT BAL /.../ELLS, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR, DYSPLASIA ONLY, INCLUDED; CDTD, INCLUDED;;FOCAL CORTICAL DYSPLASIA, TYPE IIB, INCLUDED; FCORD2B, INCLUDED;;FCD IIB, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR WITH BALLOON CELLS, INCLUDED; CDTBC, INCLUDED
ENSG00000103197	TSC2	613254	TUBEROUS SCLEROSIS 2; TSC2 TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF, INCLUDED
ENSG00000008710	PKD1	173900	POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD1;;POLYCYSTIC KIDNEY DISEASE, ADULT; ADPKD;;POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE I; APKD1;;POTTER TYPE III POLYCYSTIC KIDNEY DISEASE, FORMERLY
ENSG00000221656	MIR1225	NA	
ENSG00000259933	AC009065.2	NA	
ENSG00000261123	AC009065.5	NA	
ENSG00000284008	MIR6511B1	NA	
ENSG00000261240	AC009065.6	NA	
ENSG00000260447	AC009065.3	NA	
ENSG00000200059	Y_RNA	NA	
ENSG00000265867	MIR4516	NA	
ENSG00000264397	MIR3180-5	NA	
ENSG00000167964	RAB26	NA	
ENSG00000260260	SNHG19	NA	
ENSG00000206630	SNORD60	NA	
ENSG00000281010	AC009065.9	NA	
ENSG00000131653	TRAF7	618164	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD
ENSG00000167971	CASKIN1	NA	
ENSG00000167965	MLST8	NA	
ENSG00000182685	BRICD5	NA	
ENSG00000184207	PGP	NA	
ENSG00000261532	AC009065.7	NA	
ENSG00000167967	E4F1	NA	
ENSG00000259780	AC009065.1	NA	
ENSG00000167968	DNASE1L2	NA	
ENSG00000167969	ECI1	NA	
ENSG00000261663	AC009065.8	NA	
ENSG00000205937	RNPS1	NA	
ENSG00000260778	AC009065.4	NA	
ENSG00000266643	MIR3677	NA	
ENSG00000284346	MIR940	NA	
ENSG00000264004	MIR4717	NA	
ENSG00000167972	ABCA3	610921	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 3;;INTERSTITIAL LUNG DISEASE DUE TO ABCA3 DEFICIENCY
ENSG00000243445	AC106820.1	NA	
ENSG00000238098	ABCA17P	NA	
ENSG00000162063	CCNF	NA	
ENSG00000285970	AC106820.6	NA	
ENSG00000283180	MIR6767	NA	
ENSG00000260095	AC106820.3	NA	
ENSG00000260874	AC106820.5	NA	
ENSG00000162062	TEDC2	NA	
ENSG00000274805	MIR6768	NA	
ENSG00000259895	AC106820.2	NA	
ENSG00000162068	NTN3	NA	
ENSG00000162065	TBC1D24	220500	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS;;DOOR SYNDROME;;DIGITORENOCEREBRAL SYNDROME;;DRC SYNDROME;;BRACHYDACTYLY DUE TO ABSENCE OF DISTAL PHALANGES;;ERONEN SYNDROME
ENSG00000162065	TBC1D24	605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME;;EIM
ENSG00000162065	TBC1D24	608105	EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC;;RE-PED-WC
ENSG00000162065	TBC1D24	614617	DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86
ENSG00000162065	TBC1D24	615338	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16
ENSG00000162065	TBC1D24	616044	DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65
ENSG00000260293	AC106820.4	NA	
ENSG00000260272	AC093525.2	NA	
ENSG00000185883	ATP6V0C	NA	
ENSG00000259784	AC093525.1	NA	
ENSG00000279520	AC093525.8	NA	
ENSG00000162066	AMDHD2	NA	
ENSG00000205923	CEMP1	NA	
ENSG00000266232	MIR3178	NA	
ENSG00000140992	PDPK1	NA	
ENSG00000261613	AC093525.6	NA	
ENSG00000261288	AC093525.5	NA	
ENSG00000269937	AC093525.7	NA	
ENSG00000261140	AC093525.4	NA	
ENSG00000260436	AC093525.3	NA	
ENSG00000279568	AC093525.9	NA	
ENSG00000280402	AC093525.10	NA	
ENSG00000279162	AC141586.5	NA	
ENSG00000261093	AC141586.3	NA	
ENSG00000215154	AC141586.1	NA	
ENSG00000205918	PDPK2P	NA	
ENSG00000279057	AC141586.4	NA	
ENSG00000260176	AC141586.2	NA	
ENSG00000260565	ERVK13-1	NA	
ENSG00000167977	KCTD5	NA	
ENSG00000279901	AC092117.2	NA	
ENSG00000172382	PRSS27	NA	
ENSG00000205913	SRRM2-AS1	NA	
ENSG00000167978	SRRM2	NA	
ENSG00000103363	ELOB	NA	
ENSG00000276791	AC092117.1	NA	
ENSG00000103355	PRSS33	NA	
ENSG00000221719	SNORA3C	NA	
ENSG00000215148	PRSS41	NA	
ENSG00000007038	PRSS21	NA	
ENSG00000262154	EIF1P4	NA	
ENSG00000162078	ZG16B	NA	
ENSG00000172460	PRSS30P	NA	
ENSG00000005001	PRSS22	NA	
ENSG00000263325	AC003965.2	NA	
ENSG00000263280	AC003965.1	NA	
ENSG00000162076	FLYWCH2	NA	
ENSG00000059122	FLYWCH1	NA	
ENSG00000262959	RPL23AP86	NA	
ENSG00000262482	AC004034.1	NA	
ENSG00000131650	KREMEN2	NA	
ENSG00000127564	PKMYT1	NA	
ENSG00000162073	PAQR4	NA	
ENSG00000274367	AC004233.3	NA	
ENSG00000262152	LINC00514	NA	
ENSG00000262362	AC004233.1	NA	
ENSG00000272079	AC004233.2	NA	
ENSG00000213937	CLDN9	NA	
ENSG00000184697	CLDN6	NA	
ENSG00000006327	TNFRSF12A	NA	
ENSG00000103145	HCFC1R1	NA	
ENSG00000131652	THOC6	613680	BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS;;MICROCEPHALY, MENTAL RETARDATION, AND DISTINCTIVE FACIES, WITH CARDIAC AND GENITOURINARY MALFORMATIONS
ENSG00000162069	BICDL2	NA	
ENSG00000205890	AC108134.1	NA	
ENSG00000261971	MMP25-AS1	NA	
ENSG00000008516	MMP25	NA	
ENSG00000008517	IL32	NA	
ENSG00000252561	RNU1-125P	NA	
ENSG00000262370	AC108134.3	NA	
ENSG00000200204	RNU1-22P	NA	
ENSG00000130182	ZSCAN10	NA	
ENSG00000263072	ZNF213-AS1	NA	
ENSG00000263011	AC108134.4	NA	
ENSG00000122386	ZNF205	NA	
ENSG00000085644	ZNF213	NA	
ENSG00000228146	CASP16P	NA	
ENSG00000261889	AC108134.2	NA	
ENSG00000262521	AJ003147.1	NA	
ENSG00000262668	AJ003147.2	NA	
ENSG00000168124	OR1F1	NA	
ENSG00000203581	OR1F2P	NA	
ENSG00000010539	ZNF200	NA	
ENSG00000103313	MEFV	134610	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT
ENSG00000103313	MEFV	249100	FAMILIAL MEDITERRANEAN FEVER; FMF;;FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL RECESSIVE;;POLYSEROSITIS, RECURRENT;;POLYSEROSITIS, FAMILIAL PAROXYSMAL
ENSG00000281005	LINC00921	NA	
ENSG00000006194	ZNF263	NA	
ENSG00000279330	AJ003147.3	NA	
ENSG00000279031	AC004232.2	NA	
ENSG00000140993	TIGD7	NA	
ENSG00000162086	ZNF75A	NA	
ENSG00000262899	AC004232.1	NA	
ENSG00000262316	AC025283.1	NA	
ENSG00000168158	OR2C1	NA	
ENSG00000285329	AC025283.2	NA	
ENSG00000262118	MTCO1P28	NA	
ENSG00000263177	MTND1P8	NA	
ENSG00000232196	MTRNR2L4	NA	
ENSG00000140987	ZSCAN32	NA	
ENSG00000103343	ZNF174	NA	
ENSG00000167981	ZNF597	NA	
ENSG00000122390	NAA60	NA	
ENSG00000263212	AC004224.2	NA	
ENSG00000273776	MIR6126	NA	
ENSG00000215131	C16orf90	NA	
ENSG00000240311	AC004224.1	NA	
ENSG00000103351	CLUAP1	NA	
ENSG00000278942	AC004494.2	NA	
ENSG00000167984	NLRC3	NA	
ENSG00000262312	AC004494.1	NA	
ENSG00000261938	AC006111.1	NA	
ENSG00000188827	SLX4	613951	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP
ENSG00000213918	DNASE1	152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED;;EXCESS LMW-DNA, INCLUDED
ENSG00000263235	AC006111.2	NA	
ENSG00000126602	TRAP1	NA	
ENSG00000276754	AC006111.3	NA	
ENSG00000005339	CREBBP	180849	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1;;RSTS;;RUBINSTEIN SYNDROME;;BROAD THUMBS AND GREAT TOES, CHARACTERISTIC FACIES, AND MENTAL RETARDATION;;BROAD THUMB-HALLUX SYNDROME
ENSG00000005339	CREBBP	618332	MENKE-HENNEKAM SYNDROME 1; MKHK1
ENSG00000262516	AC007151.1	NA	
ENSG00000262185	LINC02861	NA	
ENSG00000162104	ADCY9	NA	
ENSG00000263159	AC005736.1	NA	
ENSG00000262471	AC009171.1	NA	
ENSG00000263105	AC009171.2	NA	
ENSG00000185739	SRL	NA	
ENSG00000262468	LINC01569	NA	
ENSG00000090447	TFAP4	NA	
ENSG00000126603	GLIS2	611498	NEPHRONOPHTHISIS 7; NPHP7
ENSG00000262686	GLIS2-AS1	NA	
ENSG00000217930	PAM16	613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM;;CHONDRODYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE
ENSG00000262712	AC012676.1	NA	
ENSG00000103426	CORO7-PAM16	NA	
ENSG00000280063	AC012676.5	NA	
ENSG00000262246	CORO7	NA	
ENSG00000168140	VASN	NA	
ENSG00000103423	DNAJA3	NA	
ENSG00000277170	AC012676.3	NA	
ENSG00000277440	AC012676.4	NA	
ENSG00000275515	AC012676.2	NA	
ENSG00000153406	NMRAL1	NA	
ENSG00000103415	HMOX2	NA	
ENSG00000089486	CDIP1	NA	
ENSG00000278434	AC023830.3	NA	
ENSG00000205832	C16orf96	NA	
ENSG00000261789	AC023830.2	NA	
ENSG00000261612	SUB1P3	NA	
ENSG00000153443	UBALD1	NA	
ENSG00000102858	MGRN1	NA	
ENSG00000263955	RN7SL850P	NA	
ENSG00000261442	AC023830.1	NA	
ENSG00000278700	Metazoa_SRP	NA	
ENSG00000276641	MIR6769A	NA	
ENSG00000168101	NUDT16L1	NA	
ENSG00000168096	ANKS3	NA	
ENSG00000266994	AC020663.1	NA	
ENSG00000166246	C16orf71	NA	
ENSG00000103199	ZNF500	NA	
ENSG00000276096	Metazoa_SRP	NA	
ENSG00000140623	SEPTIN12	614822	SPERMATOGENIC FAILURE 10; SPGF10;;SPERMATOGENIC FAILURE WITH DEFECTIVE SPERM ANNULUS
ENSG00000285952	AC020663.4	NA	
ENSG00000267795	SMIM22	NA	
ENSG00000267077	AC020663.2	NA	
ENSG00000067836	ROGDI	226750	KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME
ENSG00000140632	GLYR1	NA	
ENSG00000275056	AC020663.3	NA	
ENSG00000118900	UBN1	NA	
ENSG00000118898	PPL	NA	
ENSG00000103184	SEC14L5	NA	
ENSG00000267072	NAGPA-AS1	NA	
ENSG00000103174	NAGPA	NA	
ENSG00000033011	ALG1	608540	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K;;CDG Ik; CDGIk
ENSG00000153446	C16orf89	NA	
ENSG00000260882	AC026458.1	NA	
ENSG00000118894	EEF2KMT	NA	
ENSG00000267070	AC026458.2	NA	
ENSG00000285567	AC074051.4	NA	
ENSG00000273963	ENPP7P14	NA	
ENSG00000260431	AC074051.1	NA	
ENSG00000261811	LINC02164	NA	
ENSG00000078328	RBFOX1	NA	
ENSG00000260817	AC074051.2	NA	
ENSG00000242278	RPS3AP48	NA	
ENSG00000267182	SNRPCP20	NA	
ENSG00000261007	AC074051.3	NA	
ENSG00000260338	LINC01570	NA	
ENSG00000273648	MIR8065	NA	
ENSG00000270440	AC012175.1	NA	
ENSG00000280000	AC009135.2	NA	
ENSG00000257180	AC009135.1	NA	
ENSG00000286635	AC006112.1	NA	
ENSG00000260835	AC007223.1	NA	
ENSG00000278975	AC007012.2	NA	
ENSG00000259963	AC007012.1	NA	
ENSG00000252080	RNU7-99P	NA	
ENSG00000200869	RNU6-457P	NA	
ENSG00000212189	RNU6-328P	NA	
ENSG00000240419	AC022206.1	NA	
ENSG00000287340	AC007222.2	NA	
ENSG00000283584	AC007222.1	NA	
ENSG00000261198	AC005774.2	NA	
ENSG00000252138	AC005774.1	NA	
ENSG00000260289	AC093515.1	NA	
ENSG00000260003	AC018767.2	NA	
ENSG00000261319	LINC02152	NA	
ENSG00000260058	AC018767.3	NA	
ENSG00000259819	AC018767.1	NA	
ENSG00000260379	AC074052.1	NA	
ENSG00000261066	AC074052.2	NA	
ENSG00000232258	TMEM114	NA	
ENSG00000287522	AC138420.1	NA	
ENSG00000067365	METTL22	NA	
ENSG00000279357	AC007224.2	NA	
ENSG00000183044	ABAT	613163	GABA-TRANSAMINASE DEFICIENCY
ENSG00000243954	RN7SL743P	NA	
ENSG00000238417	RNU7-63P	NA	
ENSG00000260764	AC007224.1	NA	
ENSG00000184857	TMEM186	NA	
ENSG00000140650	PMM2	212065	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A;;CDG Ia; CDGIa;;JAEKEN SYNDROME;;PHOSPHOMANNOMUTASE 2 DEFICIENCY;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE Ia, FORMERLY
ENSG00000260350	AC012173.1	NA	
ENSG00000260276	AC022167.2	NA	
ENSG00000153048	CARHSP1	NA	
ENSG00000259939	AC022167.1	NA	
ENSG00000261481	AC022167.4	NA	
ENSG00000283516	LITAFD	NA	
ENSG00000187555	USP7	NA	
ENSG00000260979	AC022167.3	NA	
ENSG00000261392	AC087190.2	NA	
ENSG00000182831	C16orf72	NA	
ENSG00000263244	AC087190.3	NA	
ENSG00000260349	AC087190.1	NA	
ENSG00000220793	RPL21P119	NA	
ENSG00000261617	LINC02177	NA	
ENSG00000260071	AC012178.1	NA	
ENSG00000261397	LINC01177	NA	
ENSG00000261075	LINC01195	NA	
ENSG00000283003	AC007221.1	NA	
ENSG00000200468	RNA5SP403	NA	
ENSG00000252927	RNA5SP404	NA	
ENSG00000260362	AC007218.1	NA	
ENSG00000183454	GRIN2A	245570	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD;;APHASIA, ACQUIRED, WITH EPILEPSY LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED;;CONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLU /.../SWSS, INCLUDED;;ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED;;BENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED
ENSG00000283221	AC007218.2	NA	
ENSG00000287830	AC007218.3	NA	
ENSG00000261810	AC133565.1	NA	
ENSG00000261647	IMPDH1P11	NA	
ENSG00000285543	AC022168.1	NA	
ENSG00000266439	RN7SL493P	NA	
ENSG00000166669	ATF7IP2	NA	
ENSG00000260756	AC131649.1	NA	
ENSG00000279662	AC131649.2	NA	
ENSG00000199482	RNU6-633P	NA	
ENSG00000260468	LINC01290	NA	
ENSG00000213853	EMP2	615861	NEPHROTIC SYNDROME, TYPE 10; NPHS10
ENSG00000256013	AC027277.1	NA	
ENSG00000260310	AC027277.2	NA	
ENSG00000153060	TEKT5	NA	
ENSG00000263279	AC007595.1	NA	
ENSG00000263241	MTCYBP33	NA	
ENSG00000262107	MTND6P33	NA	
ENSG00000261904	MTND5P33	NA	
ENSG00000262322	MTND4P34	NA	
ENSG00000262259	MTND4LP24	NA	
ENSG00000263196	MTND3P13	NA	
ENSG00000262158	MTCO3P24	NA	
ENSG00000262381	MTATP6P24	NA	
ENSG00000103274	NUBP1	NA	
ENSG00000166676	TVP23A	NA	
ENSG00000262488	AC133065.2	NA	
ENSG00000262151	AC133065.1	NA	
ENSG00000179583	CIITA	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000179583	CIITA	209920	BARE LYMPHOCYTE SYNDROME, TYPE II;;BLS, TYPE II;;BARE LYMPHOCYTE SYNDROME; BLS;;SEVERE COMBINED IMMUNODEFICIENCY, HLA CLASS II-NEGATIVE;;SCID, HLA CLASS II-NEGATIVE BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A, INCLUDED;;BARE LYMPHOCYT /.../ROME, TYPE II, COMPLEMENTATION GROUP B, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E, INCLUDED
ENSG00000182108	DEXI	NA	
ENSG00000280153	AC133065.3	NA	
ENSG00000038532	CLEC16A	NA	
ENSG00000229917	RPL7P46	NA	
ENSG00000274038	AC007014.2	NA	
ENSG00000262020	AC007014.1	NA	
ENSG00000287121	AC007220.2	NA	
ENSG00000263033	AC007220.1	NA	
ENSG00000263179	HNRNPCP4	NA	
ENSG00000175643	RMI2	NA	
ENSG00000185338	SOCS1	NA	
ENSG00000178279	TNP2	NA	
ENSG00000178257	PRM3	NA	
ENSG00000212228	AC009121.2	NA	
ENSG00000122304	PRM2	NA	
ENSG00000175646	PRM1	NA	
ENSG00000287429	AC009121.5	NA	
ENSG00000221801	MIR548H2	NA	
ENSG00000199668	AC009121.1	NA	
ENSG00000263080	AC009121.4	NA	
ENSG00000262703	AC009121.3	NA	
ENSG00000188897	AC099489.1	NA	
ENSG00000262636	AC099489.2	NA	
ENSG00000262999	AC099489.3	NA	
ENSG00000189067	LITAF	601098	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C;;CMT, SLOW NERVE CONDUCTION TYPE C;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1C;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE IC; HMSN1C;;HMSN IC
ENSG00000184602	SNN	NA	
ENSG00000153066	TXNDC11	NA	
ENSG00000262420	AC007613.1	NA	
ENSG00000122299	ZC3H7A	NA	
ENSG00000274505	AC007613.2	NA	
ENSG00000277369	AC010654.1	NA	
ENSG00000262117	BCAR4	NA	
ENSG00000171490	RSL1D1	NA	
ENSG00000263307	AC007216.4	NA	
ENSG00000103342	GSPT1	NA	
ENSG00000261560	AC007216.3	NA	
ENSG00000260318	COX6CP1	NA	
ENSG00000261216	AC007216.2	NA	
ENSG00000277458	AC007216.5	NA	
ENSG00000234719	NPIPB2	NA	
ENSG00000048462	TNFRSF17	NA	
ENSG00000260224	UBL5P4	NA	
ENSG00000048471	SNX29	NA	
ENSG00000260488	AC007216.1	NA	
ENSG00000241641	RPS23P6	NA	
ENSG00000175604	AC007601.1	NA	
ENSG00000261293	AC007601.2	NA	
ENSG00000238685	AC092365.1	NA	
ENSG00000261394	AC007598.2	NA	
ENSG00000260723	AC007598.1	NA	
ENSG00000278979	AC007598.3	NA	
ENSG00000260601	AC131391.1	NA	
ENSG00000259876	AC010333.1	NA	
ENSG00000259899	AC010333.2	NA	
ENSG00000274834	AC010333.3	NA	
ENSG00000103381	CPPED1	NA	
ENSG00000264733	MIR4718	NA	
ENSG00000260378	AC109597.1	NA	
ENSG00000261158	AC109597.2	NA	
ENSG00000199474	AC092324.1	NA	
ENSG00000241932	AC092324.2	NA	
ENSG00000237515	SHISA9	NA	
ENSG00000262116	AC009134.1	NA	
ENSG00000262801	U91319.1	NA	
ENSG00000262011	AC003009.1	NA	
ENSG00000262235	TMF1P1	NA	
ENSG00000262267	U95743.1	NA	
ENSG00000175595	ERCC4	278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF;;XP, GROUP F;;XERODERMA PIGMENTOSUM VI; XP6  XERODERMA PIGMENTOSUM, TYPE F/COCKAYNE SYNDROME, INCLUDED; XPF/CS, INCLUDED
ENSG00000175595	ERCC4	610965	XFE PROGEROID SYNDROME; XFEPS;;XPF-ERCC1 PROGEROID SYNDROME
ENSG00000175595	ERCC4	615272	FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ
ENSG00000242307	RPS26P52	NA	
ENSG00000262732	AC010401.1	NA	
ENSG00000263234	AC010401.2	NA	
ENSG00000262097	LINC02185	NA	
ENSG00000261856	LINC02186	NA	
ENSG00000186260	MRTFB	NA	
ENSG00000276564	AC130650.2	NA	
ENSG00000262529	AC130650.1	NA	
ENSG00000262470	TVP23CP2	NA	
ENSG00000201075	Y_RNA	NA	
ENSG00000262454	MIR193BHG	NA	
ENSG00000207639	MIR193B	NA	
ENSG00000199130	MIR365A	NA	
ENSG00000260009	LINC02130	NA	
ENSG00000263257	AC040173.1	NA	
ENSG00000140694	PARN	616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6
ENSG00000140694	PARN	616371	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4
ENSG00000242430	RN7SL274P	NA	
ENSG00000103429	BFAR	NA	
ENSG00000238964	RNU7-125P	NA	
ENSG00000069764	PLA2G10	NA	
ENSG00000261523	AC009167.1	NA	
ENSG00000224712	NPIPA3	NA	
ENSG00000254609	AC136443.1	NA	
ENSG00000261695	AC136443.4	NA	
ENSG00000254852	NPIPA2	NA	
ENSG00000255037	AC136443.2	NA	
ENSG00000255277	ABCC6P2	NA	
ENSG00000103512	NOMO1	NA	
ENSG00000270734	AC136443.5	NA	
ENSG00000257264	AC136443.3	NA	
ENSG00000284305	MIR3179-1	NA	
ENSG00000263918	MIR3670-1	NA	
ENSG00000258354	AC138932.2	NA	
ENSG00000265537	MIR3180-1	NA	
ENSG00000183458	AC138932.1	NA	
ENSG00000207425	Y_RNA	NA	
ENSG00000183426	NPIPA1	NA	
ENSG00000275259	MIR6511A1	NA	
ENSG00000278265	MIR6770-1	NA	
ENSG00000273804	AC138932.4	NA	
ENSG00000179889	PDXDC1	NA	
ENSG00000261819	AC138932.3	NA	
ENSG00000238728	MIR1972-1	NA	
ENSG00000275910	AC138932.5	NA	
ENSG00000157045	NTAN1	NA	
ENSG00000085721	RRN3	NA	
ENSG00000260735	AC139256.1	NA	
ENSG00000188599	NPIPP1	NA	
ENSG00000270580	PKD1P6-NPIPP1	NA	
ENSG00000250251	PKD1P6	NA	
ENSG00000283346	MIR6511B2	NA	
ENSG00000207294	Y_RNA	NA	
ENSG00000264115	MIR3180-4	NA	
ENSG00000257391	AC126763.1	NA	
ENSG00000277770	AC137803.1	NA	
ENSG00000183793	NPIPA5	NA	
ENSG00000261130	AC140504.1	NA	
ENSG00000156968	MPV17L	NA	
ENSG00000166780	BMERB1	NA	
ENSG00000166783	MARF1	NA	
ENSG00000257769	AC026401.1	NA	
ENSG00000284184	MIR6506	NA	
ENSG00000072864	NDE1	605013	MICROHYDRANENCEPHALY; MHAC;;HYDRANENCEPHALY AND MICROCEPHALY
ENSG00000072864	NDE1	614019	LISSENCEPHALY 4; LIS4;;LISSENCEPHALY 4 WITH MICROCEPHALY
ENSG00000283736	MIR484	NA	
ENSG00000262380	AC026401.2	NA	
ENSG00000280206	AC026401.3	NA	
ENSG00000133392	MYH11	132900	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4;;FAA4;;AORTIC ANEURYSM/AORTIC DISSECTION AND PATENT DUCTUS ARTERIOSUS
ENSG00000263335	AF001548.2	NA	
ENSG00000263065	AF001548.1	NA	
ENSG00000280429	AF001548.3	NA	
ENSG00000133393	CEP20	NA	
ENSG00000206778	RNU6-213P	NA	
ENSG00000262171	AC130651.1	NA	
ENSG00000215003	RPL15P20	NA	
ENSG00000103222	ABCC1	NA	
ENSG00000241067	RPL17P40	NA	
ENSG00000091262	ABCC6	177850	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE PSEUDOXANTHOMA ELASTICUM, HETEROZYGOUS, INCLUDED
ENSG00000091262	ABCC6	264800	PSEUDOXANTHOMA ELASTICUM; PXE;;GRONBLAD-STRANDBERG SYNDROME PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF, INCLUDED;;PXE, MODIFIER OF SEVERITY OF, INCLUDED
ENSG00000091262	ABCC6	614473	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
ENSG00000262332	AC136624.1	NA	
ENSG00000103226	NOMO3	NA	
ENSG00000263029	AC136624.3	NA	
ENSG00000262848	AC136624.2	NA	
ENSG00000257381	MIR3179-2	NA	
ENSG00000264722	MIR3670-2	NA	
ENSG00000257366	AC138969.3	NA	
ENSG00000265373	MIR3180-2	NA	
ENSG00000244257	PKD1P1	NA	
ENSG00000206706	Y_RNA	NA	
ENSG00000183889	AC138969.1	NA	
ENSG00000278221	MIR6511A2	NA	
ENSG00000277698	MIR6770-2	NA	
ENSG00000277920	AC138969.4	NA	
ENSG00000227827	AC138969.2	NA	
ENSG00000276311	MIR6511A3	NA	
ENSG00000214967	NPIPA7	NA	
ENSG00000261181	AC136619.1	NA	
ENSG00000260126	AC136431.1	NA	
ENSG00000261362	AC136619.2	NA	
ENSG00000287905	AC136431.2	NA	
ENSG00000279729	AC092326.1	NA	
ENSG00000261748	AC098965.1	NA	
ENSG00000279490	AC109446.4	NA	
ENSG00000260675	AC109446.2	NA	
ENSG00000260405	AC109446.1	NA	
ENSG00000103489	XYLT1	264800	PSEUDOXANTHOMA ELASTICUM; PXE;;GRONBLAD-STRANDBERG SYNDROME PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF, INCLUDED;;PXE, MODIFIER OF SEVERITY OF, INCLUDED
ENSG00000103489	XYLT1	615777	DESBUQUOIS DYSPLASIA 2; DBQD2;;BARATELA-SCOTT SYNDROME
ENSG00000261448	AC109446.3	NA	
ENSG00000279410	AC099494.1	NA	
ENSG00000279415	AC099494.2	NA	
ENSG00000279620	AC099494.3	NA	
ENSG00000286849	AC009152.6	NA	
ENSG00000275927	AC009152.1	NA	
ENSG00000285850	AC009152.3	NA	
ENSG00000260945	AC109495.1	NA	
ENSG00000261555	AC025277.1	NA	
ENSG00000228071	RPL7P47	NA	
ENSG00000259929	AC010601.1	NA	
ENSG00000280283	AC010601.2	NA	
ENSG00000260242	AC091489.1	NA	
ENSG00000260933	AC091489.2	NA	
ENSG00000278994	AC008785.1	NA	
ENSG00000276484	AC126755.4	NA	
ENSG00000214940	NPIPA8	NA	
ENSG00000285628	AC126755.6	NA	
ENSG00000205746	AC126755.1	NA	
ENSG00000273613	MIR6511A4	NA	
ENSG00000277647	AC126755.5	NA	
ENSG00000233024	NPIPA9	NA	
ENSG00000254681	PKD1P5	NA	
ENSG00000275391	MIR6770-3	NA	
ENSG00000206927	Y_RNA	NA	
ENSG00000257563	AC126755.3	NA	
ENSG00000266291	MIR3180-3	NA	
ENSG00000265776	MIR3670-3	NA	
ENSG00000257527	AC126755.2	NA	
ENSG00000266454	MIR3179-3	NA	
ENSG00000185164	NOMO2	NA	
ENSG00000274025	MIR3670-4	NA	
ENSG00000277014	MIR3179-4	NA	
ENSG00000262974	AC136618.2	NA	
ENSG00000260550	AC136618.1	NA	
ENSG00000256340	ABCC6P1	NA	
ENSG00000134419	RPS15A	618313	DIAMOND-BLACKFAN ANEMIA 20; DBA20
ENSG00000260342	AC138811.2	NA	
ENSG00000170540	ARL6IP1	615685	SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61
ENSG00000260017	AC138811.1	NA	
ENSG00000157106	SMG1	NA	
ENSG00000260352	AC092287.1	NA	
ENSG00000170537	TMC7	NA	
ENSG00000207167	RNU6-1340P	NA	
ENSG00000261465	AC099518.4	NA	
ENSG00000261357	AC099518.2	NA	
ENSG00000167186	COQ7	616733	COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8
ENSG00000260430	AC099518.1	NA	
ENSG00000278389	AC099518.6	NA	
ENSG00000205730	ITPRIPL2	NA	
ENSG00000261427	AC099518.3	NA	
ENSG00000261759	AC099518.5	NA	
ENSG00000103528	SYT17	NA	
ENSG00000286790	AC010494.1	NA	
ENSG00000261210	CLEC19A	NA	
ENSG00000259871	AC130456.1	NA	
ENSG00000285869	LINC02858	NA	
ENSG00000259925	AC130456.2	NA	
ENSG00000280265	AC130456.7	NA	
ENSG00000103534	TMC5	NA	
ENSG00000260681	AC130456.4	NA	
ENSG00000260592	AC130456.3	NA	
ENSG00000222750	RNU4-46P	NA	
ENSG00000260934	AC130456.5	NA	
ENSG00000006007	GDE1	NA	
ENSG00000279747	AC130456.6	NA	
ENSG00000103540	CCP110	NA	
ENSG00000103544	VPS35L	NA	
ENSG00000276571	AC002550.2	NA	
ENSG00000103550	KNOP1	NA	
ENSG00000261312	AC002550.1	NA	
ENSG00000174628	IQCK	NA	
ENSG00000261195	AC027130.1	NA	
ENSG00000261939	LARP7P2	NA	
ENSG00000167191	GPRC5B	NA	
ENSG00000180269	GPR139	NA	
ENSG00000277211	AC092132.2	NA	
ENSG00000263253	AC092132.1	NA	
ENSG00000227624	SNRPEP3	NA	
ENSG00000169347	GP2	NA	
ENSG00000169344	UMOD	162000	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1;;HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE; HNFJ;;FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY; FJHN;;NEPHROPATHY, FAMILIAL, WITH GOUT;;GOUTY NEPHROPATHY, FAMILIAL JUVENILE
ENSG00000169344	UMOD	603860	MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2;;MEDULLARY CYSTIC KIDNEY DISEASE 2, AUTOSOMAL DOMINANT; ADMCKD2
ENSG00000169344	UMOD	609886	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA
ENSG00000169340	PDILT	NA	
ENSG00000263237	AC106796.1	NA	
ENSG00000183549	ACSM5	NA	
ENSG00000262995	AC137056.1	NA	
ENSG00000183747	ACSM2A	NA	
ENSG00000280306	AC137056.2	NA	
ENSG00000066813	ACSM2B	NA	
ENSG00000260201	AC141273.1	NA	
ENSG00000260762	ACSM5P1	NA	
ENSG00000005187	ACSM3	NA	
ENSG00000275315	AC141273.3	NA	
ENSG00000274730	AC141273.2	NA	
ENSG00000166743	ACSM1	NA	
ENSG00000066654	THUMPD1	NA	
ENSG00000283399	AC004381.3	NA	
ENSG00000285303	AC004381.4	NA	
ENSG00000260510	AC004381.1	NA	
ENSG00000196678	ERI2	NA	
ENSG00000200893	RNU6-944P	NA	
ENSG00000005189	REXO5	NA	
ENSG00000275908	AC004381.2	NA	
ENSG00000188215	DCUN1D3	NA	
ENSG00000102897	LYRM1	NA	
ENSG00000158486	DNAH3	NA	
ENSG00000263331	AC008551.1	NA	
ENSG00000011638	TMEM159	NA	
ENSG00000262983	AF001550.1	NA	
ENSG00000103310	ZP2	618353	OOCYTE MATURATION DEFECT 6; OOMD6
ENSG00000175311	ANKS4B	NA	
ENSG00000103316	CRYM	616357	DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40
ENSG00000283421	AF001550.2	NA	
ENSG00000189149	CRYM-AS1	NA	
ENSG00000257403	AC008740.1	NA	
ENSG00000158482	SNX29P1	NA	
ENSG00000276548	AC008740.2	NA	
ENSG00000169246	NPIPB3	NA	
ENSG00000180747	SMG1P3	NA	
ENSG00000265462	MIR3680-1	NA	
ENSG00000287809	AC005632.6	NA	
ENSG00000258186	SLC7A5P2	NA	
ENSG00000273956	AC005632.5	NA	
ENSG00000257639	AC005632.2	NA	
ENSG00000271609	AC005632.4	NA	
ENSG00000252798	AC005632.1	NA	
ENSG00000197006	METTL9	NA	
ENSG00000261596	AC005632.3	NA	
ENSG00000140749	IGSF6	NA	
ENSG00000207248	RNU6-1005P	NA	
ENSG00000207042	RNU6-196P	NA	
ENSG00000155719	OTOA	607039	DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
ENSG00000260306	AC092375.2	NA	
ENSG00000248124	RRN3P1	NA	
ENSG00000276721	AC092375.3	NA	
ENSG00000185864	NPIPB4	NA	
ENSG00000185710	SMG1P4	NA	
ENSG00000257408	AC092375.1	NA	
ENSG00000274460	AC092119.2	NA	
ENSG00000140740	UQCRC2	615160	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5
ENSG00000155714	PDZD9	NA	
ENSG00000260395	AC092119.1	NA	
ENSG00000275445	AC092119.3	NA	
ENSG00000185716	MOSMO	NA	
ENSG00000260277	AC009019.1	NA	
ENSG00000175267	VWA3A	NA	
ENSG00000183921	SDR42E2	NA	
ENSG00000287739	AC009019.2	NA	
ENSG00000103319	EEF2K	NA	
ENSG00000261113	AC009034.1	NA	
ENSG00000058600	POLR3E	NA	
ENSG00000286808	AC092338.3	NA	
ENSG00000140743	CDR2	NA	
ENSG00000260635	AC092338.1	NA	
ENSG00000260790	AC092338.2	NA	
ENSG00000230872	MFSD13B	NA	
ENSG00000257122	RRN3P3	NA	
ENSG00000237296	SMG1P1	NA	
ENSG00000243716	NPIPB5	NA	
ENSG00000277041	AC106788.1	NA	
ENSG00000257838	OTOAP1	NA	
ENSG00000260973	AC009021.2	NA	
ENSG00000260905	AC009021.1	NA	
ENSG00000283213	AC130466.1	NA	
ENSG00000122254	HS3ST2	NA	
ENSG00000261090	AC127459.2	NA	
ENSG00000103404	USP31	NA	
ENSG00000260566	AC127459.1	NA	
ENSG00000280400	AC127459.3	NA	
ENSG00000285613	AC099482.2	NA	
ENSG00000166828	SCNN1G	264350	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE
ENSG00000166828	SCNN1G	613071	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3;;CYSTIC FIBROSIS-LIKE SYNDROME
ENSG00000166828	SCNN1G	618114	LIDDLE SYNDROME 2; LIDLS2
ENSG00000260741	AC099482.1	NA	
ENSG00000168447	SCNN1B	177200	LIDDLE SYNDROME 1; LIDLS1;;LIDDLE SYNDROME; LIDLS;;PSEUDOALDOSTERONISM;;PSEUDOHYPERALDOSTERONISM
ENSG00000168447	SCNN1B	211400	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1;;CYSTIC FIBROSIS-LIKE SYNDROME
ENSG00000168447	SCNN1B	264350	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE
ENSG00000168434	COG7	608779	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E;;CDG IIe; CDGIIe
ENSG00000280039	RN7SKP23	NA	
ENSG00000212593	AC008915.1	NA	
ENSG00000259782	AC008915.2	NA	
ENSG00000260136	AC008915.3	NA	
ENSG00000103365	GGA2	NA	
ENSG00000261528	CCNYL7	NA	
ENSG00000103356	EARS2	614924	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12;;LEUKOENCEPHALOPATHY WITH THALAMUS AND BRAINSTEM INVOLVEMENT AND HIGH LACTATE; LTBL
ENSG00000260247	SUB1P4	NA	
ENSG00000103353	UBFD1	NA	
ENSG00000260751	AC008870.2	NA	
ENSG00000004779	NDUFAB1	NA	
ENSG00000083093	PALB2	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000083093	PALB2	610832	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN
ENSG00000083093	PALB2	613348	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;;PNCA3
ENSG00000261723	AC008870.4	NA	
ENSG00000166847	DCTN5	NA	
ENSG00000260482	AC008870.1	NA	
ENSG00000166851	PLK1	NA	
ENSG00000261266	AC008870.3	NA	
ENSG00000134398	ERN2	NA	
ENSG00000278912	AC008870.5	NA	
ENSG00000261583	AC012317.1	NA	
ENSG00000279756	AC012317.2	NA	
ENSG00000166869	CHP2	NA	
ENSG00000166501	PRKCB	NA	
ENSG00000279276	AC130454.1	NA	
ENSG00000279202	AC130448.1	NA	
ENSG00000274466	MIR1273H	NA	
ENSG00000279554	AC130448.2	NA	
ENSG00000260264	LINC02194	NA	
ENSG00000006116	CACNG3	NA	
ENSG00000201541	AC004125.1	NA	
ENSG00000239081	RNU7-24P	NA	
ENSG00000260072	AC008938.1	NA	
ENSG00000122257	RBBP6	NA	
ENSG00000090905	TNRC6A	618074	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 6; FAME6;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 6; BAFME6;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 6; FCMTE6
ENSG00000224310	LINC01567	NA	
ENSG00000261669	AC008731.1	NA	
ENSG00000158865	SLC5A11	NA	
ENSG00000140750	ARHGAP17	NA	
ENSG00000260714	AC133552.1	NA	
ENSG00000262587	AC133552.2	NA	
ENSG00000262155	LINC02175	NA	
ENSG00000271105	SCML2P2	NA	
ENSG00000263326	AC133552.4	NA	
ENSG00000260448	LCMT1-AS1	NA	
ENSG00000262700	AC133552.3	NA	
ENSG00000275494	AC133552.5	NA	
ENSG00000205629	LCMT1	NA	
ENSG00000260034	LCMT1-AS2	NA	
ENSG00000266166	RN7SL557P	NA	
ENSG00000103375	AQP8	NA	
ENSG00000155592	ZKSCAN2	NA	
ENSG00000259955	AC008741.1	NA	
ENSG00000274925	ZKSCAN2-DT	NA	
ENSG00000261636	LINC02191	NA	
ENSG00000260690	CYCSP39	NA	
ENSG00000182601	HS3ST4	NA	
ENSG00000285882	AC093516.1	NA	
ENSG00000260255	AC093524.1	NA	
ENSG00000265005	MIR548W	NA	
ENSG00000199929	RNA5SP405	NA	
ENSG00000230330	HMGN2P3	NA	
ENSG00000237140	HSPE1P16	NA	
ENSG00000231876	AC009158.1	NA	
ENSG00000228480	AC130464.1	NA	
ENSG00000286712	AC002331.1	NA	
ENSG00000236481	LINC02195	NA	
ENSG00000260580	AC009035.1	NA	
ENSG00000234186	C16orf82	NA	
ENSG00000261482	AC092725.1	NA	
ENSG00000261557	EEF1A1P38	NA	
ENSG00000261045	LINC02129	NA	
ENSG00000155666	KDM8	NA	
ENSG00000259940	AC109449.1	NA	
ENSG00000169189	NSMCE1	NA	
ENSG00000245888	NSMCE1-DT	NA	
ENSG00000274092	AC106739.1	NA	
ENSG00000077238	IL4R	147050	IgE RESPONSIVENESS, ATOPIC; IGER;;IMMUNOGLOBULIN E, BASIC LEVEL OF, IN SERUM;;IgE, LEVEL OF; IGEL;;IgE RESPONSE UNDERLYING ALLERGIC ASTHMA AND RHINITIS IgE, ELEVATED LEVEL OF, INCLUDED;;ATOPY, SUSCEPTIBILITY TO, INCLUDED;;ATOPIC HYPERSENSITIVITY, INCLUDED
ENSG00000077238	IL4R	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000103522	IL21R	147050	IgE RESPONSIVENESS, ATOPIC; IGER;;IMMUNOGLOBULIN E, BASIC LEVEL OF, IN SERUM;;IgE, LEVEL OF; IGEL;;IgE RESPONSE UNDERLYING ALLERGIC ASTHMA AND RHINITIS IgE, ELEVATED LEVEL OF, INCLUDED;;ATOPY, SUSCEPTIBILITY TO, INCLUDED;;ATOPIC HYPERSENSITIVITY, INCLUDED
ENSG00000103522	IL21R	615207	IMMUNODEFICIENCY 56; IMD56;;IL21R IMMUNODEFICIENCY
ENSG00000259954	IL21R-AS1	NA	
ENSG00000077235	GTF3C1	NA	
ENSG00000047578	KIAA0556	616784	JOUBERT SYNDROME 26; JBTS26
ENSG00000261736	AC002551.1	NA	
ENSG00000261329	AC016597.1	NA	
ENSG00000273553	AC016597.2	NA	
ENSG00000201371	Y_RNA	NA	
ENSG00000169181	GSG1L	NA	
ENSG00000212382	RNU6-159P	NA	
ENSG00000207266	RNU6-1241P	NA	
ENSG00000169180	XPO6	NA	
ENSG00000260452	TPRKBP2	NA	
ENSG00000200652	AC136611.1	NA	
ENSG00000200138	RNY1P10	NA	
ENSG00000250982	GAPDHP35	NA	
ENSG00000283662	AC138904.3	NA	
ENSG00000188322	SBK1	NA	
ENSG00000246465	AC138904.1	NA	
ENSG00000288630	AC009093.11	NA	
ENSG00000277191	AC138904.2	NA	
ENSG00000198156	NPIPB6	NA	
ENSG00000271623	AC138894.3	NA	
ENSG00000205609	EIF3CL	NA	
ENSG00000275429	MIR6862-1	NA	
ENSG00000261089	CDC37P2	NA	
ENSG00000275654	AC138894.4	NA	
ENSG00000270118	AC138894.2	NA	
ENSG00000261832	AC138894.1	NA	
ENSG00000233232	NPIPB7	NA	
ENSG00000188603	CLN3	204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3;;NEURONAL CEROID LIPOFUSCINOSIS, JUVENILE; JNCL;;BATTEN DISEASE;;VOGT-SPIELMEYER DISEASE;;SPIELMEYER-SJOGREN DISEASE
ENSG00000184730	APOBR	NA	
ENSG00000197272	IL27	NA	
ENSG00000176046	NUPR1	NA	
ENSG00000271495	AC020765.1	NA	
ENSG00000275441	AC020765.2	NA	
ENSG00000176476	SGF29	NA	
ENSG00000197165	SULT1A2	NA	
ENSG00000278665	AC020765.3	NA	
ENSG00000278725	AC020765.4	NA	
ENSG00000196502	SULT1A1	NA	
ENSG00000285020	AC020765.5	NA	
ENSG00000255524	NPIPB8	NA	
ENSG00000261419	AC145285.4	NA	
ENSG00000184110	EIF3C	NA	
ENSG00000259982	CDC37P1	NA	
ENSG00000278340	MIR6862-2	NA	
ENSG00000270424	AC145285.5	NA	
ENSG00000196993	NPIPB9	NA	
ENSG00000278528	AC145285.7	NA	
ENSG00000251417	AC145285.2	NA	
ENSG00000240634	AC145285.1	NA	
ENSG00000260796	AC145285.3	NA	
ENSG00000275807	AC145285.6	NA	
ENSG00000168488	ATXN2L	NA	
ENSG00000260570	AC133550.2	NA	
ENSG00000178952	TUFM	610678	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4
ENSG00000283845	MIR4721	NA	
ENSG00000178188	SH2B1	NA	
ENSG00000261766	AC133550.3	NA	
ENSG00000196296	ATP2A1	601003	BRODY MYOPATHY
ENSG00000260442	ATP2A1-AS1	NA	
ENSG00000252461	AC133550.1	NA	
ENSG00000177548	RABEP2	NA	
ENSG00000177455	CD19	240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2;;ANTIBODY DEFICIENCY DUE TO TACI DEFECT;;HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY
ENSG00000177455	CD19	613493	IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3;;ANTIBODY DEFICIENCY DUE TO CD19 DEFECT
ENSG00000176953	NFATC2IP	NA	
ENSG00000260853	AC109460.2	NA	
ENSG00000284541	MIR4517	NA	
ENSG00000260367	AC109460.1	NA	
ENSG00000169682	SPNS1	NA	
ENSG00000261067	AC109460.3	NA	
ENSG00000213658	LAT	617514	IMMUNODEFICIENCY 52; IMD52
ENSG00000261552	AC109460.4	NA	
ENSG00000196796	NPIPB10P	NA	
ENSG00000260908	AC009093.3	NA	
ENSG00000103472	RRN3P2	NA	
ENSG00000284671	AC009093.9	NA	
ENSG00000284649	AC009093.8	NA	
ENSG00000284685	AC009093.10	NA	
ENSG00000260517	AC009093.2	NA	
ENSG00000279106	AC009093.7	NA	
ENSG00000259807	AC009093.1	NA	
ENSG00000273582	AC009093.5	NA	
ENSG00000260953	AC009093.4	NA	
ENSG00000277999	AC009093.6	NA	
ENSG00000198106	AC025279.1	NA	
ENSG00000260413	AC025279.2	NA	
ENSG00000271699	SNX29P2	NA	
ENSG00000278078	AC025279.3	NA	
ENSG00000254206	NPIPB11	NA	
ENSG00000254634	SMG1P6	NA	
ENSG00000288632	AC133555.6	NA	
ENSG00000183336	BOLA2	NA	
ENSG00000261740	BOLA2-SMG1P6	NA	
ENSG00000260335	AC133555.4	NA	
ENSG00000181625	SLX1B	NA	
ENSG00000260280	SLX1B-SULT1A4	NA	
ENSG00000213648	SULT1A4	NA	
ENSG00000258150	AC133555.3	NA	
ENSG00000279228	AC133555.5	NA	
ENSG00000257691	AC133555.2	NA	
ENSG00000257506	AC133555.1	NA	
ENSG00000169203	NPIPB12	NA	
ENSG00000205534	SMG1P2	NA	
ENSG00000279583	AC009086.2	NA	
ENSG00000266758	MIR3680-2	NA	
ENSG00000260727	SLC7A5P1	NA	
ENSG00000260133	CA5AP1	NA	
ENSG00000260514	AC009086.1	NA	
ENSG00000197471	SPN	NA	
ENSG00000103485	QPRT	NA	
ENSG00000222375	RN7SKP127	NA	
ENSG00000185905	C16orf54	NA	
ENSG00000260719	AC009133.3	NA	
ENSG00000174992	ZG16	NA	
ENSG00000079616	KIF22	603546	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2; SEMDJL2;;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, HALL TYPE;;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, LEPTODACTYLIC TYPE;;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPL /.../OCATIONS, HALL TYPE
ENSG00000275857	AC009133.4	NA	
ENSG00000103495	MAZ	NA	
ENSG00000259952	AC009133.2	NA	
ENSG00000238045	AC009133.1	NA	
ENSG00000280607	AC009133.5	NA	
ENSG00000167371	PRRT2	128200	EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10
ENSG00000167371	PRRT2	602066	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC
ENSG00000167371	PRRT2	605751	SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2
ENSG00000280893	AC009133.6	NA	
ENSG00000280789	PAGR1	NA	
ENSG00000281348	AC120114.4	NA	
ENSG00000013364	MVP	NA	
ENSG00000103502	CDIPT	NA	
ENSG00000278713	AC120114.2	NA	
ENSG00000214725	CDIPTOSP	NA	
ENSG00000174938	SEZ6L2	NA	
ENSG00000174939	ASPHD1	NA	
ENSG00000174943	KCTD13	NA	
ENSG00000279789	AC120114.3	NA	
ENSG00000247735	AC120114.1	NA	
ENSG00000149932	TMEM219	NA	
ENSG00000149930	TAOK2	NA	
ENSG00000149929	HIRIP3	NA	
ENSG00000169592	INO80E	NA	
ENSG00000149927	DOC2A	NA	
ENSG00000167194	C16orf92	NA	
ENSG00000149926	TLCD3B	NA	
ENSG00000285043	AC093512.2	NA	
ENSG00000149925	ALDOA	611881	GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY
ENSG00000274904	AC093512.1	NA	
ENSG00000149923	PPP4C	NA	
ENSG00000149922	TBX6	122600	SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5;;SCOLIOSIS, CONGENITAL, WITH OR WITHOUT RIB ANOMALIES;;TACS;;SPONDYLOCOSTAL DYSPLASIA;;SPONDYLOTHORACIC DYSOSTOSIS;;COSTOVERTEBRAL SEGMENTATION ANOMALIES
ENSG00000090238	YPEL3	NA	
ENSG00000250616	AC012645.1	NA	
ENSG00000102886	GDPD3	NA	
ENSG00000261367	AC012645.2	NA	
ENSG00000275371	AC012645.4	NA	
ENSG00000102882	MAPK3	NA	
ENSG00000102879	CORO1A	615401	IMMUNODEFICIENCY 8; IMD8
ENSG00000261416	AC012645.3	NA	
ENSG00000169627	BOLA2B	NA	
ENSG00000132207	SLX1A	NA	
ENSG00000213599	SLX1A-SULT1A3	NA	
ENSG00000261052	SULT1A3	NA	
ENSG00000258130	AC106782.1	NA	
ENSG00000278887	AC106782.6	NA	
ENSG00000261444	AC106782.3	NA	
ENSG00000261203	AC106782.2	NA	
ENSG00000198064	NPIPB13	NA	
ENSG00000183604	SMG1P5	NA	
ENSG00000273724	AC106782.4	NA	
ENSG00000169217	CD2BP2	NA	
ENSG00000260219	CD2BP2-DT	NA	
ENSG00000169221	TBC1D10B	NA	
ENSG00000274653	AC106782.5	NA	
ENSG00000180209	MYLPF	NA	
ENSG00000180035	ZNF48	NA	
ENSG00000180096	SEPTIN1	NA	
ENSG00000280137	AC116348.4	NA	
ENSG00000179965	ZNF771	NA	
ENSG00000199787	SNORA80C	NA	
ENSG00000179958	DCTPP1	NA	
ENSG00000179918	SEPHS2	NA	
ENSG00000202476	Y_RNA	NA	
ENSG00000222701	Y_RNA	NA	
ENSG00000005844	ITGAL	NA	
ENSG00000261346	AC116348.3	NA	
ENSG00000260487	AC116348.1	NA	
ENSG00000251706	RNU7-61P	NA	
ENSG00000261332	AC116348.2	NA	
ENSG00000266305	MIR4518	NA	
ENSG00000169957	ZNF768	NA	
ENSG00000261459	AC002310.4	NA	
ENSG00000278922	AC002310.5	NA	
ENSG00000169955	ZNF747	NA	
ENSG00000235560	AC002310.1	NA	
ENSG00000260494	AC002310.3	NA	
ENSG00000169951	ZNF764	NA	
ENSG00000229809	ZNF688	NA	
ENSG00000239791	AC002310.2	NA	
ENSG00000197162	ZNF785	NA	
ENSG00000260167	AC093249.2	NA	
ENSG00000261588	AC093249.4	NA	
ENSG00000156853	ZNF689	NA	
ENSG00000260678	AC093249.3	NA	
ENSG00000261680	AC093249.5	NA	
ENSG00000260113	AC093249.1	NA	
ENSG00000156858	PRR14	NA	
ENSG00000156860	FBRS	NA	
ENSG00000252074	RNU6-416P	NA	
ENSG00000261840	AC093249.6	NA	
ENSG00000080603	SRCAP	136140	FLOATING-HARBOR SYNDROME; FLHS
ENSG00000222287	RNU6-1043P	NA	
ENSG00000282034	AC106886.6	NA	
ENSG00000206755	SNORA30	NA	
ENSG00000281991	TMEM265	NA	
ENSG00000260899	AC106886.2	NA	
ENSG00000156873	PHKG2	613027	GLYCOGEN STORAGE DISEASE IXc; GSD9C;;GSD IXc
ENSG00000196118	CCDC189	NA	
ENSG00000103549	RNF40	NA	
ENSG00000280211	AC106886.5	NA	
ENSG00000102870	ZNF629	NA	
ENSG00000274848	AC106886.4	NA	
ENSG00000260082	AC106886.1	NA	
ENSG00000274678	AC106886.3	NA	
ENSG00000099385	BCL7C	NA	
ENSG00000260083	MIR762HG	NA	
ENSG00000265991	MIR4519	NA	
ENSG00000262721	AC135048.2	NA	
ENSG00000211591	MIR762	NA	
ENSG00000150281	CTF1	NA	
ENSG00000230447	CTF2P	NA	
ENSG00000260852	FBXL19-AS1	NA	
ENSG00000099364	FBXL19	NA	
ENSG00000261487	AC135048.1	NA	
ENSG00000175938	ORAI3	NA	
ENSG00000275263	AC135048.3	NA	
ENSG00000099381	SETD1A	618832	EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEDD
ENSG00000279196	AC135048.4	NA	
ENSG00000099377	HSD3B7	607765	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1;;3-@BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE DEFICIENCY
ENSG00000099365	STX1B	616172	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9;;GEFS+, TYPE 9; GEFS+9
ENSG00000103496	STX4	NA	
ENSG00000260911	AC135050.3	NA	
ENSG00000232748	AC135050.1	NA	
ENSG00000167394	ZNF668	NA	
ENSG00000261124	AC135050.4	NA	
ENSG00000167395	ZNF646	NA	
ENSG00000151006	PRSS53	NA	
ENSG00000255439	AC135050.2	NA	
ENSG00000167397	VKORC1	122700	COUMARIN RESISTANCE;;COUMARIN, POOR METABOLISM OF;;WARFARIN RESISTANCE  COUMARIN SENSITIVITY, INCLUDED;;WARFARIN SENSITIVITY, INCLUDED
ENSG00000167397	VKORC1	607473	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2
ENSG00000280160	AC135050.7	NA	
ENSG00000103507	BCKDK	614923	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY
ENSG00000103510	KAT8	NA	
ENSG00000262766	AC135050.5	NA	
ENSG00000278133	AC135050.6	NA	
ENSG00000261385	AC009088.3	NA	
ENSG00000052344	PRSS8	NA	
ENSG00000178226	PRSS36	NA	
ENSG00000263343	AC009088.4	NA	
ENSG00000262366	NDUFA3P6	NA	
ENSG00000089280	FUS	608030	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6
ENSG00000089280	FUS	614782	TREMOR, HEREDITARY ESSENTIAL, 4; ETM4
ENSG00000260304	AC009088.2	NA	
ENSG00000260060	AC009088.1	NA	
ENSG00000103490	PYCARD	NA	
ENSG00000261359	PYCARD-AS1	NA	
ENSG00000177238	TRIM72	NA	
ENSG00000169900	PYDC1	NA	
ENSG00000169896	ITGAM	NA	
ENSG00000140678	ITGAX	NA	
ENSG00000261245	AC093520.2	NA	
ENSG00000156886	ITGAD	NA	
ENSG00000260757	AC093520.1	NA	
ENSG00000156885	COX6A2	NA	
ENSG00000277543	AC026471.5	NA	
ENSG00000176723	ZNF843	NA	
ENSG00000261474	AC026471.4	NA	
ENSG00000260267	AC026471.1	NA	
ENSG00000140691	ARMC5	615954	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2;;PRIMARY MACRONODULAR ADRENAL HYPERPLASIA
ENSG00000280132	AC026471.6	NA	
ENSG00000140682	TGFB1I1	NA	
ENSG00000140675	SLC5A2	233100	RENAL GLUCOSURIA; GLYS;;GLYS1;;GLYCOSURIA, RENAL
ENSG00000140688	RUSF1	NA	
ENSG00000260740	AC026471.3	NA	
ENSG00000260625	AC026471.2	NA	
ENSG00000169877	AHSP	NA	
ENSG00000261475	LINC02190	NA	
ENSG00000261648	AC106730.1	NA	
ENSG00000213547	VN1R64P	NA	
ENSG00000260883	VN1R65P	NA	
ENSG00000261741	FRG2KP	NA	
ENSG00000278885	AC106730.2	NA	
ENSG00000261614	YBX3P1	NA	
ENSG00000260010	ZNF720P1	NA	
ENSG00000237185	VN1R66P	NA	
ENSG00000260631	RBM22P12	NA	
ENSG00000260472	AC074050.1	NA	
ENSG00000260568	AC074050.2	NA	
ENSG00000131797	CLUHP3	NA	
ENSG00000276867	AC074050.4	NA	
ENSG00000261731	AC074050.3	NA	
ENSG00000197302	ZNF720	NA	
ENSG00000259810	AC002519.1	NA	
ENSG00000260722	VN1R67P	NA	
ENSG00000261457	AC002519.2	NA	
ENSG00000180663	VN1R3	NA	
ENSG00000261284	RBM22P13	NA	
ENSG00000259874	AC034105.2	NA	
ENSG00000185947	ZNF267	NA	
ENSG00000259950	AC034105.3	NA	
ENSG00000261289	AC034105.5	NA	
ENSG00000197476	AC034105.1	NA	
ENSG00000260218	AC034105.4	NA	
ENSG00000260628	AC142381.3	NA	
ENSG00000261727	AC142381.4	NA	
ENSG00000261704	IGHV1OR16-1	NA	
ENSG00000223931	AC142381.1	NA	
ENSG00000260048	IGHV1OR16-3	NA	
ENSG00000270472	IGHV3OR16-9	NA	
ENSG00000230267	HERC2P4	NA	
ENSG00000260584	AC142381.2	NA	
ENSG00000286473	AC133485.7	NA	
ENSG00000279997	AC133485.6	NA	
ENSG00000260847	AC133485.5	NA	
ENSG00000260649	AC133485.4	NA	
ENSG00000260540	ABHD17AP8	NA	
ENSG00000260344	AC133485.1	NA	
ENSG00000260575	AC133485.3	NA	
ENSG00000205456	TP53TG3D	NA	
ENSG00000260402	AC133485.2	NA	
ENSG00000259822	AC140878.1	NA	
ENSG00000261127	AC133548.2	NA	
ENSG00000260516	AC133548.1	NA	
ENSG00000260327	ACTR3BP3	NA	
ENSG00000260866	AC138915.2	NA	
ENSG00000260307	PABPC1P13	NA	
ENSG00000261541	AC138915.3	NA	
ENSG00000260662	AC138915.1	NA	
ENSG00000261233	ABCD1P3	NA	
ENSG00000259966	AC137800.1	NA	
ENSG00000262187	AC137800.2	NA	
ENSG00000261111	AC133569.1	NA	
ENSG00000261569	AC138907.7	NA	
ENSG00000261263	AC138907.5	NA	
ENSG00000260311	AC138907.1	NA	
ENSG00000183632	TP53TG3	NA	
ENSG00000260974	AC138907.3	NA	
ENSG00000261391	AC138907.6	NA	
ENSG00000260864	ABHD17AP7	NA	
ENSG00000260845	AC138907.2	NA	
ENSG00000261108	AC138907.4	NA	
ENSG00000260644	HERC2P5	NA	
ENSG00000278950	AC138907.8	NA	
ENSG00000279780	AC138907.9	NA	
ENSG00000279795	AC138907.10	NA	
ENSG00000260158	AC137761.1	NA	
ENSG00000261719	AC137761.2	NA	
ENSG00000259934	AC142086.2	NA	
ENSG00000259303	IGHV2OR16-5	NA	
ENSG00000260047	BCAP31P2	NA	
ENSG00000214617	SLC6A10P	NA	
ENSG00000214614	AC142086.1	NA	
ENSG00000261834	IGHV3OR16-15	NA	
ENSG00000270864	IGHV3OR16-6	NA	
ENSG00000277304	AC142086.6	NA	
ENSG00000260610	AC142086.3	NA	
ENSG00000261259	AC142086.5	NA	
ENSG00000259852	IGHV1OR16-2	NA	
ENSG00000233732	IGHV3OR16-10	NA	
ENSG00000260921	AC142086.4	NA	
ENSG00000259997	IGHV1OR16-4	NA	
ENSG00000271130	IGHV3OR16-8	NA	
ENSG00000260141	AC145350.2	NA	
ENSG00000260900	AC145350.3	NA	
ENSG00000261599	HERC2P8	NA	
ENSG00000261682	AC145350.4	NA	
ENSG00000259800	AC145350.1	NA	
ENSG00000261536	ABHD17AP9	NA	
ENSG00000260414	AC138869.1	NA	
ENSG00000260419	AC138869.2	NA	
ENSG00000205457	TP53TG3C	NA	
ENSG00000260827	AC138869.3	NA	
ENSG00000261507	AC141257.2	NA	
ENSG00000275034	TP53TG3E	NA	
ENSG00000282973	AC141257.3	NA	
ENSG00000261509	TP53TG3B	NA	
ENSG00000261009	AC141257.1	NA	
ENSG00000283110	AC141257.4	NA	
ENSG00000278848	TP53TG3F	NA	
ENSG00000282927	AC136944.6	NA	
ENSG00000262090	AC136944.5	NA	
ENSG00000260626	AC136944.1	NA	
ENSG00000261200	AC136944.2	NA	
ENSG00000261466	AC136944.4	NA	
ENSG00000261405	AC136944.3	NA	
ENSG00000259882	AC142384.1	NA	
ENSG00000260518	BMS1P8	NA	
ENSG00000282924	AC136428.4	NA	
ENSG00000261580	ENPP7P13	NA	
ENSG00000260308	AC136428.2	NA	
ENSG00000270467	IGHV3OR16-12	NA	
ENSG00000261153	AC136428.3	NA	
ENSG00000271178	IGHV3OR16-13	NA	
ENSG00000259680	AC136428.1	NA	
ENSG00000270924	AC140658.6	NA	
ENSG00000271691	AC140658.7	NA	
ENSG00000260312	AC140658.2	NA	
ENSG00000270318	IGHV3OR16-11	NA	
ENSG00000260525	AC140658.3	NA	
ENSG00000260781	ARHGAP23P1	NA	
ENSG00000271620	IGHV3OR16-7	NA	
ENSG00000261607	AC140658.4	NA	
ENSG00000259842	IGHV3OR16-16	NA	
ENSG00000205452	AC140658.1	NA	
ENSG00000270401	AC140658.5	NA	
ENSG00000198555	AC133561.1	NA	
ENSG00000261217	BCAP31P1	NA	
ENSG00000259990	AC133561.2	NA	
ENSG00000283065	AC133561.4	NA	
ENSG00000261197	AC133561.3	NA	
ENSG00000262561	AC136932.1	NA	
ENSG00000261440	DUX4L45	NA	
ENSG00000260087	PCMTD1P2	NA	
ENSG00000259987	DUX4L46	NA	
ENSG00000260207	DUX4L47	NA	
ENSG00000256642	LINC00273	NA	
ENSG00000200434	RNA5-8SP2	NA	
ENSG00000279800	BCLAF1P2	NA	
ENSG00000284209	FP325313.1	NA	
ENSG00000288300	FP325313.3	NA	
ENSG00000286968	FP325313.2	NA	
ENSG00000279165	AC135776.4	NA	
ENSG00000287353	AC135776.5	NA	
ENSG00000260854	LINC02184	NA	
ENSG00000179755	AC135776.1	NA	
ENSG00000261566	AC135776.2	NA	
ENSG00000262885	AC135776.3	NA	
ENSG00000216671	CCNYL3	NA	
ENSG00000278138	CLUHP11	NA	
ENSG00000261053	NAMPTP3	NA	
ENSG00000260809	VPS35P1	NA	
ENSG00000259979	VN1R68P	NA	
ENSG00000260724	VN1R69P	NA	
ENSG00000261800	AC023824.5	NA	
ENSG00000280180	AC023824.6	NA	
ENSG00000261461	UBE2MP1	NA	
ENSG00000261608	SLC25A1P4	NA	
ENSG00000260073	AC023824.1	NA	
ENSG00000260590	AC023824.2	NA	
ENSG00000261398	AC023824.4	NA	
ENSG00000260958	AC023824.3	NA	
ENSG00000261274	TP53TG3GP	NA	
ENSG00000260967	RARRES2P5	NA	
ENSG00000260984	FGFR3P5	NA	
ENSG00000259897	FRG2JP	NA	
ENSG00000261010	RARRES2P6	NA	
ENSG00000261752	AGGF1P8	NA	
ENSG00000260846	FRG2HP	NA	
ENSG00000261486	RARRES2P9	NA	
ENSG00000260427	AGGF1P9	NA	
ENSG00000260480	C2orf69P4	NA	
ENSG00000259841	LINC01566	NA	
ENSG00000260291	FRG2GP	NA	
ENSG00000261689	AGGF1P4	NA	
ENSG00000260598	FRG2IP	NA	
ENSG00000260812	RARRES2P7	NA	
ENSG00000260680	AGGF1P5	NA	
ENSG00000261299	C2orf69P3	NA	
ENSG00000278681	AC018558.4	NA	
ENSG00000214581	ZNF971P	NA	
ENSG00000287163	AC018558.6	NA	
ENSG00000261711	FRG2DP	NA	
ENSG00000260153	RARRES2P10	NA	
ENSG00000259836	AGGF1P6	NA	
ENSG00000261350	AC018558.2	NA	
ENSG00000260341	C2orf69P2	NA	
ENSG00000261445	AC018558.3	NA	
ENSG00000287448	AC018558.7	NA	
ENSG00000260857	AC018558.1	NA	
ENSG00000269622	TP53TG3HP	NA	
ENSG00000282946	AC018558.5	NA	
ENSG00000259996	RARRES2P8	NA	
ENSG00000260994	AGGF1P7	NA	
ENSG00000261046	C2orf69P1	NA	
ENSG00000260134	C1QL1P1	NA	
ENSG00000260746	KIF18BP1	NA	
ENSG00000259791	AC092325.1	NA	
ENSG00000260522	AC106785.1	NA	
ENSG00000251915	RNA5SP406	NA	
ENSG00000222207	RNA5SP407	NA	
ENSG00000251924	RNA5SP408	NA	
ENSG00000252624	RNA5SP409	NA	
ENSG00000261122	LINC02167	NA	
ENSG00000252094	RNA5SP410	NA	
ENSG00000276599	RNA5SP411	NA	
ENSG00000277004	RNA5SP412	NA	
ENSG00000252182	RNA5SP413	NA	
ENSG00000274228	RNA5SP414	NA	
ENSG00000253055	RNA5SP415	NA	
ENSG00000252647	RNA5SP416	NA	
ENSG00000252268	RNA5SP417	NA	
ENSG00000251760	RNA5SP418	NA	
ENSG00000251717	RNA5SP419	NA	
ENSG00000252806	RNA5SP420	NA	
ENSG00000252673	RNA5SP421	NA	
ENSG00000252587	RNA5SP422	NA	
ENSG00000252936	RNA5SP423	NA	
ENSG00000260611	AC106785.2	NA	
ENSG00000261620	HMGN2P41	NA	
ENSG00000261515	VN1R70P	NA	
ENSG00000261782	AC116553.1	NA	
ENSG00000279666	AC116553.2	NA	
ENSG00000261084	PPP1R1AP2	NA	
ENSG00000261239	ANKRD26P1	NA	
ENSG00000199448	RNU6-845P	NA	
ENSG00000261356	AC092368.2	NA	
ENSG00000260251	AC092368.1	NA	
ENSG00000171241	SHCBP1	NA	
ENSG00000261512	AC092368.3	NA	
ENSG00000259856	RAB43P1	NA	
ENSG00000260909	AC012186.1	NA	
ENSG00000069329	VPS35	614203	PARKINSON DISEASE 17; PARK17
ENSG00000261131	AC012186.2	NA	
ENSG00000280376	AC012186.3	NA	
ENSG00000091651	ORC6	613803	MEIER-GORLIN SYNDROME 3; MGORS3
ENSG00000140795	MYLK3	NA	
ENSG00000260782	AC007225.1	NA	
ENSG00000155330	C16orf87	NA	
ENSG00000260889	CKBP1	NA	
ENSG00000261725	AC007225.2	NA	
ENSG00000166123	GPT2	616281	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49
ENSG00000069345	DNAJA2	NA	
ENSG00000261173	AC018845.3	NA	
ENSG00000259821	AC018845.1	NA	
ENSG00000259983	AC018845.2	NA	
ENSG00000171208	NETO2	NA	
ENSG00000260281	ITFG1-AS1	NA	
ENSG00000239840	RPL23AP72	NA	
ENSG00000129636	ITFG1	NA	
ENSG00000260744	AC007494.2	NA	
ENSG00000279509	AC007494.3	NA	
ENSG00000260012	AC007494.1	NA	
ENSG00000261369	AC007533.1	NA	
ENSG00000222767	Y_RNA	NA	
ENSG00000288601	5S_rRNA	NA	
ENSG00000102893	PHKB	261750	GLYCOGEN STORAGE DISEASE IXb; GSD9B;;GSD IXb;;GLYCOGENOSIS OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE;;PHOSPHORYLASE KINASE DEFICIENCY OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE
ENSG00000222268	RNA5SP425	NA	
ENSG00000262038	AC007599.2	NA	
ENSG00000259866	AC007599.1	NA	
ENSG00000261336	EIF4BP5	NA	
ENSG00000259918	NDUFA5P11	NA	
ENSG00000261231	LINC02133	NA	
ENSG00000260497	AC141846.1	NA	
ENSG00000261325	LINC02192	NA	
ENSG00000260450	LINC02134	NA	
ENSG00000288026	AC096996.3	NA	
ENSG00000261017	AC096996.1	NA	
ENSG00000140798	ABCC12	NA	
ENSG00000261538	AC096996.2	NA	
ENSG00000121270	ABCC11	117800	APOCRINE GLAND SECRETION, VARIATION IN;;EAR WAX, WET/DRY; EWWD;;WET WAX; WW;;CERUMEN, VARIATION IN;;AXILLARY ODOR, VARIATION IN;;COLOSTRUM SECRETION, VARIATION IN
ENSG00000102910	LONP2	NA	
ENSG00000240793	UBA52P8	NA	
ENSG00000280067	AC023818.1	NA	
ENSG00000196470	SIAH1	NA	
ENSG00000275909	Metazoa_SRP	NA	
ENSG00000261802	AC026470.3	NA	
ENSG00000260688	AC026470.1	NA	
ENSG00000260347	MOCS1P1	NA	
ENSG00000102921	N4BP1	NA	
ENSG00000261267	AC026470.2	NA	
ENSG00000243609	RPS2P44	NA	
ENSG00000260033	AC023813.2	NA	
ENSG00000259912	AC023813.1	NA	
ENSG00000260086	AC007611.1	NA	
ENSG00000260052	AC023813.3	NA	
ENSG00000272545	AC023813.4	NA	
ENSG00000260726	KLF8P1	NA	
ENSG00000222170	RNU6-257P	NA	
ENSG00000260184	AC023827.1	NA	
ENSG00000260067	MTND4LP25	NA	
ENSG00000287469	AC044798.3	NA	
ENSG00000261421	AC044798.1	NA	
ENSG00000261815	AC044798.2	NA	
ENSG00000102924	CBLN1	NA	
ENSG00000279249	AC007614.1	NA	
ENSG00000280189	AC007614.2	NA	
ENSG00000166152	C16orf78	NA	
ENSG00000262950	AC007861.1	NA	
ENSG00000263110	AC007861.2	NA	
ENSG00000261623	LINC02179	NA	
ENSG00000102935	ZNF423	614844	NEPHRONOPHTHISIS 14; NPHP14 JOUBERT SYNDROME 19, INCLUDED; JBTS19, INCLUDED
ENSG00000260089	ADAM3B	NA	
ENSG00000260024	MRPS21P7	NA	
ENSG00000280131	AC027348.2	NA	
ENSG00000259978	MRPS21P8	NA	
ENSG00000275155	AC027348.1	NA	
ENSG00000279842	AC007603.2	NA	
ENSG00000261751	AC007603.1	NA	
ENSG00000244551	RPL34P29	NA	
ENSG00000283365	AC007603.3	NA	
ENSG00000205423	CNEP1R1	NA	
ENSG00000259843	AC007610.1	NA	
ENSG00000261835	AC007610.3	NA	
ENSG00000273829	Metazoa_SRP	NA	
ENSG00000260298	ACTG1P16	NA	
ENSG00000155393	HEATR3	NA	
ENSG00000279356	AC007610.4	NA	
ENSG00000202124	RNY4P3	NA	
ENSG00000260381	AC007610.2	NA	
ENSG00000287444	AC007610.5	NA	
ENSG00000260031	RPL10P14	NA	
ENSG00000252526	SNORA70	NA	
ENSG00000121274	TENT4B	NA	
ENSG00000121281	ADCY7	NA	
ENSG00000274969	MIR6771	NA	
ENSG00000166164	BRD7	NA	
ENSG00000261393	AC007493.2	NA	
ENSG00000261092	LINC02178	NA	
ENSG00000260573	AC007493.1	NA	
ENSG00000140807	NKD1	NA	
ENSG00000260029	AC007608.2	NA	
ENSG00000278909	AC007608.4	NA	
ENSG00000205414	AC007608.1	NA	
ENSG00000260249	AC007608.3	NA	
ENSG00000167208	SNX20	NA	
ENSG00000167207	NOD2	186580	BLAU SYNDROME; BLAUS;;SARCOIDOSIS, EARLY-ONSET; EOS;;GRANULOMATOSIS, FAMILIAL JUVENILE SYSTEMIC;;ARTHROCUTANEOUVEAL GRANULOMATOSIS; ACUG;;JABS SYNDROME;;GRANULOMATOUS INFLAMMATORY ARTHRITIS, DERMATITIS, AND UVEITIS, FAMILIAL;;GRANULOMATOSIS, FAMILIA /.../U TYPE
ENSG00000167207	NOD2	266600	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1; IBD1 REGIONAL ENTERITIS, INCLUDED;;CROHN DISEASE, INCLUDED;;ULCERATIVE COLITIS, INCLUDED;;CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED
ENSG00000167207	NOD2	617321	YAO SYNDROME; YAOS
ENSG00000270120	AC007728.3	NA	
ENSG00000261644	AC007728.2	NA	
ENSG00000083799	CYLD	132700	CYLINDROMATOSIS, FAMILIAL;;ANCELL-SPIEGLER CYLINDROMAS;;'TURBAN TUMOR' SYNDROME;;CYLINDROMAS, DERMAL ECCRINE
ENSG00000083799	CYLD	601606	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1;;MFT1;;EPITHELIOMA ADENOIDES CYSTICUM OF BROOKE; EAC;;EPITHELIOMA, HEREDITARY MULTIPLE BENIGN CYSTIC;;BROOKE-FORDYCE TRICHOEPITHELIOMAS
ENSG00000083799	CYLD	605041	BROOKE-SPIEGLER SYNDROME; BRSS;;BSS;;SPIEGLER-BROOKE SYNDROME; SBS
ENSG00000264947	MIR3181	NA	
ENSG00000260616	AC007728.1	NA	
ENSG00000261703	LINC02168	NA	
ENSG00000261241	LINC02128	NA	
ENSG00000260042	AC025810.1	NA	
ENSG00000199771	RNA5SP426	NA	
ENSG00000261637	LINC02127	NA	
ENSG00000260605	AC027688.1	NA	
ENSG00000260620	AC027688.2	NA	
ENSG00000287718	AC009166.3	NA	
ENSG00000261282	SOD1P2	NA	
ENSG00000103449	SALL1	107480	TOWNES-BROCKS SYNDROME 1; TBS1;;RENAL-EAR-ANAL-RADIAL SYNDROME;;REAR SYNDROME;;ANUS, IMPERFORATE, WITH HAND, FOOT, AND EAR ANOMALIES;;DEAFNESS, SENSORINEURAL, WITH IMPERFORATE ANUS AND THUMB ANOMALIES TOWNES-BROCKS-BRANCHIOOTORENAL-LIKE SYNDROME, INCLUDED
ENSG00000261238	AC009166.1	NA	
ENSG00000285367	AC087564.1	NA	
ENSG00000280344	AC009166.2	NA	
ENSG00000287256	AC137494.1	NA	
ENSG00000261047	AC137527.1	NA	
ENSG00000260818	UNGP1	NA	
ENSG00000260850	AC007344.1	NA	
ENSG00000224578	HNRNPA1P48	NA	
ENSG00000223168	RN7SKP142	NA	
ENSG00000260057	LINC01571	NA	
ENSG00000261190	C16orf97	NA	
ENSG00000261749	LINC02180	NA	
ENSG00000261470	AC009039.1	NA	
ENSG00000279779	AC009039.2	NA	
ENSG00000260268	LINC00919	NA	
ENSG00000260975	AC007333.2	NA	
ENSG00000260478	AC007333.1	NA	
ENSG00000260887	CASC22	NA	
ENSG00000103460	TOX3	NA	
ENSG00000279427	AC007490.1	NA	
ENSG00000249231	CASC16	NA	
ENSG00000285800	AC026462.5	NA	
ENSG00000260963	AC026462.3	NA	
ENSG00000260393	AC026462.2	NA	
ENSG00000261261	AC026462.4	NA	
ENSG00000234337	AC026462.1	NA	
ENSG00000260326	PHBP21	NA	
ENSG00000260258	AC007346.1	NA	
ENSG00000260939	AC007346.2	NA	
ENSG00000277639	AC007906.2	NA	
ENSG00000177200	CHD9	NA	
ENSG00000261291	AC007906.1	NA	
ENSG00000280227	AC079416.4	NA	
ENSG00000261056	AC079416.2	NA	
ENSG00000279589	AC079416.3	NA	
ENSG00000238645	AC079416.1	NA	
ENSG00000202193	RNA5SP427	NA	
ENSG00000259962	AC007342.2	NA	
ENSG00000260078	AC007342.3	NA	
ENSG00000261804	AC007342.4	NA	
ENSG00000262714	AC007342.5	NA	
ENSG00000279741	AC007342.8	NA	
ENSG00000280027	AC007342.9	NA	
ENSG00000103479	RBL2	NA	
ENSG00000252569	RNU6-1153P	NA	
ENSG00000259926	AC007342.1	NA	
ENSG00000279344	AC007342.6	NA	
ENSG00000279722	AC007342.7	NA	
ENSG00000166971	AKTIP	NA	
ENSG00000287909	AC007497.2	NA	
ENSG00000103494	RPGRIP1L	216360	COACH SYNDROME;;CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULAR COLOBOMA, AND HEPATIC FIBROSIS;;JOUBERT SYNDROME WITH CONGENITAL HEPATIC FIBROSIS
ENSG00000103494	RPGRIP1L	611560	JOUBERT SYNDROME 7; JBTS7
ENSG00000103494	RPGRIP1L	611561	MECKEL SYNDROME, TYPE 5; MKS5
ENSG00000275191	AC007497.1	NA	
ENSG00000140718	FTO	612460	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14;;OBESITY, SUSCEPTIBILITY TO
ENSG00000140718	FTO	612938	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD
ENSG00000261630	AC007496.2	NA	
ENSG00000280392	AC007496.3	NA	
ENSG00000260194	AC007496.1	NA	
ENSG00000261049	AC007347.1	NA	
ENSG00000280454	AC007347.2	NA	
ENSG00000259759	AC007907.1	NA	
ENSG00000259517	LINC02169	NA	
ENSG00000177508	IRX3	NA	
ENSG00000283689	AC018553.2	NA	
ENSG00000277559	AC018553.1	NA	
ENSG00000261803	LINC02140	NA	
ENSG00000287885	AC018553.3	NA	
ENSG00000286845	AC007343.1	NA	
ENSG00000283304	LINC02183	NA	
ENSG00000283258	AC007491.1	NA	
ENSG00000245694	CRNDE	NA	
ENSG00000286357	AC106742.1	NA	
ENSG00000176842	IRX5	611174	HAMAMY SYNDROME; HMMS;;HYPERTELORISM, SEVERE, WITH MIDFACE PROMINENCE, MYOPIA, MENTAL RETARDATION, AND BONE FRAGILITY
ENSG00000259711	AC106738.1	NA	
ENSG00000259725	AC106738.2	NA	
ENSG00000260147	MTND5P34	NA	
ENSG00000285775	AC109136.1	NA	
ENSG00000259283	AC109462.1	NA	
ENSG00000239555	RN7SL841P	NA	
ENSG00000283423	AC109462.3	NA	
ENSG00000159387	IRX6	NA	
ENSG00000263207	AC109462.2	NA	
ENSG00000240760	RPL31P56	NA	
ENSG00000087245	MMP2	259600	MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA;;TORG SYNDROME;;NODULOSIS-ARTHROPATHY-OSTEOLYSIS SYNDROME;;NAO SYNDROME;;AL-AQEEL SEWAIRI SYNDROME;;OSTEOLYSIS, HEREDITARY MULTICENTRIC;;TORG-WINCHESTER SYNDROME, FORMERLY
ENSG00000274508	AC007336.2	NA	
ENSG00000260135	MMP2-AS1	NA	
ENSG00000279030	AC007336.3	NA	
ENSG00000087253	LPCAT2	NA	
ENSG00000261997	AC007336.1	NA	
ENSG00000256812	CAPNS2	NA	
ENSG00000103546	SLC6A2	604715	ORTHOSTATIC INTOLERANCE;;NEUROCIRCULATORY ASTHENIA;;MITRAL VALVE PROLAPSE SYNDROME;;IRRITABLE HEART;;SOLDIERS HEART
ENSG00000278928	AC136621.1	NA	
ENSG00000260765	CES1P2	NA	
ENSG00000228695	CES1P1	NA	
ENSG00000198848	CES1	618057	DRUG METABOLISM, ALTERED, CES1-RELATED CARBOXYLESTERASE 1 DEFICIENCY, INCLUDED;;MONOCYTE ESTERASE DEFICIENCY, INCLUDED
ENSG00000159398	CES5A	NA	
ENSG00000246379	AC040168.1	NA	
ENSG00000279523	AC040168.2	NA	
ENSG00000260041	AC007495.1	NA	
ENSG00000087258	GNAO1	615473	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17
ENSG00000087258	GNAO1	617493	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM
ENSG00000261439	DKFZP434H168	NA	
ENSG00000265281	MIR3935	NA	
ENSG00000287866	AC009102.4	NA	
ENSG00000260198	AC009102.1	NA	
ENSG00000279764	AC009102.3	NA	
ENSG00000272372	AC009102.2	NA	
ENSG00000159461	AMFR	NA	
ENSG00000260621	AC092140.1	NA	
ENSG00000167005	NUDT21	NA	
ENSG00000087263	OGFOD1	NA	
ENSG00000274031	AC092140.2	NA	
ENSG00000125124	BBS2	615981	BARDET-BIEDL SYNDROME 2; BBS2
ENSG00000125124	BBS2	616562	RETINITIS PIGMENTOSA 74; RP74
ENSG00000102891	MT4	NA	
ENSG00000087250	MT3	NA	
ENSG00000125148	MT2A	NA	
ENSG00000260823	AC026461.3	NA	
ENSG00000260549	MT1L	NA	
ENSG00000169715	MT1E	NA	
ENSG00000205364	MT1M	NA	
ENSG00000255986	MT1JP	NA	
ENSG00000205362	MT1A	NA	
ENSG00000205361	MT1DP	NA	
ENSG00000205360	MT1CP	NA	
ENSG00000259923	AC026461.2	NA	
ENSG00000169688	MT1B	NA	
ENSG00000198417	MT1F	NA	
ENSG00000125144	MT1G	NA	
ENSG00000205358	MT1H	NA	
ENSG00000275691	AC026461.4	NA	
ENSG00000187193	MT1X	NA	
ENSG00000259827	AC026461.1	NA	
ENSG00000261429	DPPA2P4	NA	
ENSG00000261302	AC106779.1	NA	
ENSG00000102900	NUP93	616892	NEPHROTIC SYNDROME, TYPE 12; NPHS12
ENSG00000207649	MIR138-2	NA	
ENSG00000070915	SLC12A3	263800	GITELMAN SYNDROME; GTLMNS;;HYPOMAGNESEMIA-HYPOKALEMIA, PRIMARY RENOTUBULAR, WITH HYPOCALCIURIA;;POTASSIUM AND MAGNESIUM DEPLETION
ENSG00000283471	MIR6863	NA	
ENSG00000243988	RPS24P17	NA	
ENSG00000051108	HERPUD1	NA	
ENSG00000261270	AC012181.2	NA	
ENSG00000261114	AC012181.1	NA	
ENSG00000087237	CETP	143470	HYPERALPHALIPOPROTEINEMIA 1; HALP1;;CHOLESTEROL ESTER TRANSFER PROTEIN DEFICIENCY;;CETP DEFICIENCY  HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 10, INCLUDED;;HDLCQ10, INCLUDED
ENSG00000140853	NLRC5	NA	
ENSG00000259922	AC023825.1	NA	
ENSG00000260145	AC023825.2	NA	
ENSG00000260148	AC009090.2	NA	
ENSG00000140848	CPNE2	NA	
ENSG00000279019	AC009090.4	NA	
ENSG00000279803	AC009090.5	NA	
ENSG00000172775	PSME3IP1	NA	
ENSG00000285979	AC009090.6	NA	
ENSG00000159579	RSPRY1	616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA;;SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PROGRESSIVE, WITH SHORT STATURE, FACIAL DYSMORPHISM, SHORT FOURTH METATARSALS, AND MENTAL RETARDATION, WITH OR WITHOUT CRANIOSYNOSTOSIS
ENSG00000102931	ARL2BP	615434	RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS; RP82
ENSG00000276663	AC009090.3	NA	
ENSG00000260038	AC009090.1	NA	
ENSG00000102934	PLLP	NA	
ENSG00000260965	RPL23AP91	NA	
ENSG00000271456	AC108081.1	NA	
ENSG00000102962	CCL22	NA	
ENSG00000006210	CX3CL1	NA	
ENSG00000102970	CCL17	NA	
ENSG00000005194	CIAPIN1	NA	
ENSG00000088682	COQ9	614654	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5
ENSG00000260345	AC009052.1	NA	
ENSG00000102978	POLR2C	NA	
ENSG00000125170	DOK4	NA	
ENSG00000135736	CCDC102A	NA	
ENSG00000159618	ADGRG5	NA	
ENSG00000260828	HMGB3P32	NA	
ENSG00000205336	ADGRG1	606854	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP;;CEREBELLAR ATAXIA WITH NEURONAL MIGRATION DEFECT
ENSG00000205336	ADGRG1	615752	POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR;;PMGR
ENSG00000261633	AC018552.3	NA	
ENSG00000182885	ADGRG3	NA	
ENSG00000260467	AC018552.2	NA	
ENSG00000159625	DRC7	NA	
ENSG00000260438	AC018552.1	NA	
ENSG00000140854	KATNB1	616212	LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6
ENSG00000140859	KIFC3	NA	
ENSG00000276166	AC092118.2	NA	
ENSG00000274816	MIR6772	NA	
ENSG00000187185	AC092118.1	NA	
ENSG00000206833	RNU6-20P	NA	
ENSG00000070729	CNGB1	613767	RETINITIS PIGMENTOSA 45; RP45
ENSG00000159648	TEPP	NA	
ENSG00000166188	ZNF319	NA	
ENSG00000103005	USB1	604173	POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE
ENSG00000102996	MMP15	NA	
ENSG00000207173	Y_RNA	NA	
ENSG00000261151	AC012182.1	NA	
ENSG00000070761	CFAP20	NA	
ENSG00000260545	AC026771.1	NA	
ENSG00000260927	AC009107.2	NA	
ENSG00000070770	CSNK2A2	NA	
ENSG00000260867	AC009107.1	NA	
ENSG00000240863	RN7SL645P	NA	
ENSG00000103021	CCDC113	NA	
ENSG00000103023	PRSS54	NA	
ENSG00000181938	GINS3	NA	
ENSG00000212379	RNU6-269P	NA	
ENSG00000261078	AC009118.1	NA	
ENSG00000252271	RNU6-1110P	NA	
ENSG00000276131	AC009118.2	NA	
ENSG00000260186	LINC02137	NA	
ENSG00000103034	NDRG4	NA	
ENSG00000200556	RNU6-103P	NA	
ENSG00000103037	SETD6	NA	
ENSG00000125107	CNOT1	618500	HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12
ENSG00000276259	AC009118.3	NA	
ENSG00000207493	SNORA46	NA	
ENSG00000281910	SNORA50A	NA	
ENSG00000206952	SNORA50A	NA	
ENSG00000260865	AC010287.1	NA	
ENSG00000103042	SLC38A7	NA	
ENSG00000279889	AC012183.1	NA	
ENSG00000125166	GOT2	618721	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 82; EIEE82;;GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL, DEFICIENCY OF;;GOT2 DEFICIENCY
ENSG00000245768	AC106793.1	NA	
ENSG00000200424	RNU6-1155P	NA	
ENSG00000244003	RN7SL143P	NA	
ENSG00000260451	GEMIN8P2	NA	
ENSG00000242423	RPL12P36	NA	
ENSG00000261638	AC092378.1	NA	
ENSG00000275808	Metazoa_SRP	NA	
ENSG00000244043	RPS27P27	NA	
ENSG00000261144	AC092121.1	NA	
ENSG00000200062	RNU4-58P	NA	
ENSG00000270222	DUXAP11	NA	
ENSG00000260240	APOOP5	NA	
ENSG00000261807	LINC02141	NA	
ENSG00000261278	AC009094.1	NA	
ENSG00000261436	AC009081.2	NA	
ENSG00000261590	AC018554.1	NA	
ENSG00000278499	NPAP1L	NA	
ENSG00000261310	AC009081.1	NA	
ENSG00000259844	GNPATP	NA	
ENSG00000261178	AC009169.1	NA	
ENSG00000224631	RPS27AP16	NA	
ENSG00000286653	AC092125.2	NA	
ENSG00000150394	CDH8	NA	
ENSG00000260600	AC092125.1	NA	
ENSG00000201289	RN7SKP76	NA	
ENSG00000260115	AC012174.1	NA	
ENSG00000207441	RNU6-21P	NA	
ENSG00000280261	AC009161.2	NA	
ENSG00000237901	AC009161.1	NA	
ENSG00000231589	AC009110.1	NA	
ENSG00000260332	AC010546.1	NA	
ENSG00000261502	AC040174.1	NA	
ENSG00000269986	AC040174.2	NA	
ENSG00000261199	UBE2FP2	NA	
ENSG00000260658	AC138305.1	NA	
ENSG00000241808	RPS15AP34	NA	
ENSG00000261743	AC138305.2	NA	
ENSG00000279225	AC138305.3	NA	
ENSG00000259864	AC018846.1	NA	
ENSG00000261014	LINC02165	NA	
ENSG00000261653	AC092337.1	NA	
ENSG00000260715	AC093536.2	NA	
ENSG00000261028	AC012322.1	NA	
ENSG00000260668	AC093536.1	NA	
ENSG00000259846	AC092131.1	NA	
ENSG00000260187	PPIAP48	NA	
ENSG00000260068	AC009101.1	NA	
ENSG00000140937	CDH11	211380	ELSAHY-WATERS SYNDROME; ESWS;;BRACHIOSKELETOGENITAL SYNDROME;;BSG SYNDROME;;HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARING LOSS
ENSG00000278893	AC010533.1	NA	
ENSG00000259847	LINC02126	NA	
ENSG00000260834	AC009055.2	NA	
ENSG00000260364	AC009055.1	NA	
ENSG00000261742	LINC00922	NA	
ENSG00000261818	AC092138.2	NA	
ENSG00000260004	AC092138.1	NA	
ENSG00000260695	AC022164.1	NA	
ENSG00000261234	AC025281.1	NA	
ENSG00000201999	RNA5SP428	NA	
ENSG00000286928	AC012325.1	NA	
ENSG00000179776	CDH5	NA	
ENSG00000246898	LINC00920	NA	
ENSG00000166546	BEAN1	117210	SPINOCEREBELLAR ATAXIA 31; SCA31;;SPINOCEREBELLAR ATAXIA, 16q22-LINKED
ENSG00000260146	AC132186.1	NA	
ENSG00000261656	BEAN1-AS1	NA	
ENSG00000260851	AC010542.3	NA	
ENSG00000166548	TK2	609560	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2;;MITOCHONDRIAL DNA DEPLETION MYOPATHY, TK2-RELATED
ENSG00000166548	TK2	617069	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3; PEOB3;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 3
ENSG00000260755	AC010542.2	NA	
ENSG00000261519	AC010542.4	NA	
ENSG00000275745	Y_RNA	NA	
ENSG00000217555	CKLF	NA	
ENSG00000254788	CKLF-CMTM1	NA	
ENSG00000277978	AC010542.5	NA	
ENSG00000089505	CMTM1	NA	
ENSG00000140932	CMTM2	NA	
ENSG00000260650	AC010542.1	NA	
ENSG00000140931	CMTM3	NA	
ENSG00000183723	CMTM4	NA	
ENSG00000135720	DYNC1LI2	NA	
ENSG00000260465	AC018557.1	NA	
ENSG00000287965	AC018557.3	NA	
ENSG00000260558	AC018557.2	NA	
ENSG00000246777	AC044802.1	NA	
ENSG00000249961	TERB1	NA	
ENSG00000159593	NAE1	NA	
ENSG00000258122	AC044802.2	NA	
ENSG00000168748	CA7	NA	
ENSG00000172840	PDP2	NA	
ENSG00000166589	CDH16	NA	
ENSG00000166592	RRAD	NA	
ENSG00000166595	CIAO2B	NA	
ENSG00000172831	CES2	NA	
ENSG00000265408	AC009084.1	NA	
ENSG00000280416	AC009084.3	NA	
ENSG00000172828	CES3	NA	
ENSG00000172824	CES4A	NA	
ENSG00000280334	AC009084.2	NA	
ENSG00000265918	RN7SL543P	NA	
ENSG00000067955	CBFB	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000125149	C16orf70	NA	
ENSG00000237172	B3GNT9	NA	
ENSG00000102871	TRADD	NA	
ENSG00000135722	FBXL8	NA	
ENSG00000265690	AC074143.1	NA	
ENSG00000102878	HSF4	116800	CATARACT 5, MULTIPLE TYPES; CTRCT5;;CATARACT, LAMELLAR;;CATARACT, MARNER TYPE; CAM; CTM
ENSG00000140939	NOL3	614937	MYOCLONUS, FAMILIAL, 1; MYOCL1;;MYOCLONUS, FAMILIAL CORTICAL; FCM
ENSG00000196123	KIAA0895L	NA	
ENSG00000179044	EXOC3L1	NA	
ENSG00000205250	E2F4	NA	
ENSG00000102890	ELMO3	NA	
ENSG00000207948	MIR328	NA	
ENSG00000280163	AC040160.2	NA	
ENSG00000125122	LRRC29	NA	
ENSG00000168701	TMEM208	NA	
ENSG00000135723	FHOD1	NA	
ENSG00000135740	SLC9A5	NA	
ENSG00000262691	AC040160.1	NA	
ENSG00000196155	PLEKHG4	NA	
ENSG00000168676	KCTD19	NA	
ENSG00000201201	RN7SKP118	NA	
ENSG00000159708	LRRC36	NA	
ENSG00000159713	TPPP3	NA	
ENSG00000239194	RNU1-123P	NA	
ENSG00000159714	ZDHHC1	NA	
ENSG00000176387	HSD11B2	218030	APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
ENSG00000261320	AC009061.1	NA	
ENSG00000159720	ATP6V0D1	NA	
ENSG00000270049	AC009061.2	NA	
ENSG00000159723	AGRP	601665	OBESITY LEANNESS, INCLUDED
ENSG00000276075	AC027682.6	NA	
ENSG00000039523	RIPOR1	NA	
ENSG00000261396	AC027682.5	NA	
ENSG00000259945	AC027682.2	NA	
ENSG00000260894	AC027682.3	NA	
ENSG00000261386	AC027682.4	NA	
ENSG00000280214	AC027682.7	NA	
ENSG00000259804	AC027682.1	NA	
ENSG00000102974	CTCF	615502	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21
ENSG00000237718	AC009095.1	NA	
ENSG00000159753	CARMIL2	618131	IMMUNODEFICIENCY 58; IMD58
ENSG00000102977	ACD	616553	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7, INCLUDED; DKCB7, INCLUDED
ENSG00000102981	PARD6A	NA	
ENSG00000124074	ENKD1	NA	
ENSG00000159761	C16orf86	NA	
ENSG00000141098	GFOD2	NA	
ENSG00000141084	RANBP10	NA	
ENSG00000270165	AC010530.1	NA	
ENSG00000102904	TSNAXIP1	NA	
ENSG00000102901	CENPT	618702	SHORT STATURE AND MICROCEPHALY WITH GENITAL ANOMALIES; SSMGA
ENSG00000168286	THAP11	NA	
ENSG00000102898	NUTF2	NA	
ENSG00000262141	AC040162.2	NA	
ENSG00000038358	EDC4	NA	
ENSG00000263126	AC040162.3	NA	
ENSG00000188038	NRN1L	NA	
ENSG00000159792	PSKH1	NA	
ENSG00000141086	CTRL	NA	
ENSG00000261884	AC040162.1	NA	
ENSG00000205220	PSMB10	NA	
ENSG00000213398	LCAT	136120	FISH-EYE DISEASE; FED;;DYSLIPOPROTEINEMIC CORNEAL DYSTROPHY;;ALPHA-LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY;;ALPHA-LCAT DEFICIENCY;;LCATA DEFICIENCY
ENSG00000213398	LCAT	245900	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY;;LCAT DEFICIENCY;;NORUM DISEASE
ENSG00000124067	SLC12A4	NA	
ENSG00000141096	DPEP3	NA	
ENSG00000167261	DPEP2	NA	
ENSG00000167264	DUS2	NA	
ENSG00000262962	KARS1P3	NA	
ENSG00000263201	DPEP2NB	NA	
ENSG00000202336	RNU6-359P	NA	
ENSG00000182810	DDX28	NA	
ENSG00000261864	AC130462.3	NA	
ENSG00000072736	NFATC3	NA	
ENSG00000201850	AC130462.1	NA	
ENSG00000212445	AC130462.2	NA	
ENSG00000262514	AC020978.6	NA	
ENSG00000279621	AC020978.8	NA	
ENSG00000240435	RPS12P27	NA	
ENSG00000260891	AC020978.3	NA	
ENSG00000263276	AC020978.7	NA	
ENSG00000262160	AC020978.5	NA	
ENSG00000103067	ESRP2	NA	
ENSG00000284259	MIR6773	NA	
ENSG00000261469	AC020978.4	NA	
ENSG00000103066	PLA2G15	NA	
ENSG00000260441	AC020978.2	NA	
ENSG00000103064	SLC7A6	NA	
ENSG00000252026	RNU6-1262P	NA	
ENSG00000103061	SLC7A6OS	NA	
ENSG00000279649	AC020978.9	NA	
ENSG00000132600	PRMT7	617157	SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS
ENSG00000259797	AC020978.1	NA	
ENSG00000222177	RNU4-30P	NA	
ENSG00000103056	SMPD3	NA	
ENSG00000279693	AC099521.3	NA	
ENSG00000287760	AC099521.4	NA	
ENSG00000274698	AC099521.2	NA	
ENSG00000199263	AC099521.1	NA	
ENSG00000241334	RPL35AP33	NA	
ENSG00000184939	ZFP90	NA	
ENSG00000201164	RNU4-36P	NA	
ENSG00000260084	AC126773.3	NA	
ENSG00000275383	AC126773.6	NA	
ENSG00000252040	AC126773.1	NA	
ENSG00000252640	AC126773.2	NA	
ENSG00000062038	CDH3	225280	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME; EEMS;;EEM SYNDROME
ENSG00000062038	CDH3	601553	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD;;HYPOTRICHOSIS WITH CONE-ROD DYSTROPHY
ENSG00000260577	AC126773.4	NA	
ENSG00000260860	AC126773.5	NA	
ENSG00000261395	HSPE1P5	NA	
ENSG00000039068	CDH1	176807	PROSTATE CANCER
ENSG00000039068	CDH1	167000	OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED
ENSG00000039068	CDH1	137215	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR, INCLUDED; LBC, INCLUDED;;GASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE, INCLUDED
ENSG00000039068	CDH1	119580	BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1;;BLEPHAROCHEILODONTIC SYNDROME; BCDS;;BCD SYNDROME;;CLEFTING, ECTROPION, AND CONICAL TEETH;;ECTROPION, INFERIOR, WITH CLEFT LIP AND/OR PALATE;;ELSCHNIG SYNDROME;;LAGOPHTHALMIA WITH BILATERAL CLEFT LIP AND PALATE
ENSG00000039068	CDH1	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000039068	CDH1	608089	ENDOMETRIAL CANCER
ENSG00000200558	RNA5SP429	NA	
ENSG00000260798	AC099314.1	NA	
ENSG00000260459	FTLP14	NA	
ENSG00000103047	TANGO6	NA	
ENSG00000199979	Y_RNA	NA	
ENSG00000275504	U7	NA	
ENSG00000260999	AC009137.1	NA	
ENSG00000266801	AC009137.2	NA	
ENSG00000202497	RNU6-898P	NA	
ENSG00000271129	AC009027.1	NA	
ENSG00000244378	RPS2P45	NA	
ENSG00000103044	HAS3	NA	
ENSG00000286140	DERPC	NA	
ENSG00000168802	CHTF8	NA	
ENSG00000141076	UTP4	NA	
ENSG00000207083	RNU6-22P	NA	
ENSG00000168807	SNTB2	NA	
ENSG00000200164	Y_RNA	NA	
ENSG00000265113	AC026474.1	NA	
ENSG00000260914	AC026464.4	NA	
ENSG00000132612	VPS4A	NA	
ENSG00000213380	COG8	611182	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H;;CDG IIh; CDGIIh
ENSG00000258429	PDF	NA	
ENSG00000272617	AC026464.6	NA	
ENSG00000260371	AC026464.3	NA	
ENSG00000259900	AC026464.1	NA	
ENSG00000132603	NIP7	NA	
ENSG00000157315	TMED6	NA	
ENSG00000132604	TERF2	NA	
ENSG00000103018	CYB5B	NA	
ENSG00000261527	AC026464.5	NA	
ENSG00000260108	AC026464.2	NA	
ENSG00000102908	NFAT5	NA	
ENSG00000223109	MIR1538	NA	
ENSG00000274093	AC009032.1	NA	
ENSG00000260772	AC012321.1	NA	
ENSG00000181019	NQO1	125860	NAD(P)H DEHYDROGENASE, QUINONE 1; NQO1;;NAD(P)H:MENADIONE OXIDOREDUCTASE 1, DIOXIN-INDUCIBLE 1; NMOR1;;DIAPHORASE 4; DIA4;;DT DIAPHORASE; DTD BENZENE TOXICITY, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, POST-CHEMOTHERAPY, SUSCEPTIBILITY TO, INCLUDED;;BR /.../ANCER, POST-CHEMOTHERAPY SURVIVAL IN, INCLUDED
ENSG00000261602	AC092115.2	NA	
ENSG00000262136	AC092115.3	NA	
ENSG00000141101	NOB1	NA	
ENSG00000260290	AC092115.1	NA	
ENSG00000198373	WWP2	NA	
ENSG00000252443	SNORA62	NA	
ENSG00000208017	MIR140	618618	SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE; SEDN
ENSG00000157322	CLEC18A	NA	
ENSG00000277003	AC026468.1	NA	
ENSG00000196696	PDXDC2P-NPIPB14P	NA	
ENSG00000226232	NPIPB14P	NA	
ENSG00000255185	PDXDC2P	NA	
ENSG00000239118	MIR1972-2	NA	
ENSG00000241183	AC009022.1	NA	
ENSG00000090857	PDPR	NA	
ENSG00000247228	AC009060.1	NA	
ENSG00000157335	CLEC18C	NA	
ENSG00000261145	AC009060.2	NA	
ENSG00000261556	SMG1P7	NA	
ENSG00000223496	EXOSC6	NA	
ENSG00000090861	AARS1	613287	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2N;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2N
ENSG00000090861	AARS1	616339	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29
ENSG00000265648	RN7SL279P	NA	
ENSG00000157349	DDX19B	NA	
ENSG00000260537	AC012184.2	NA	
ENSG00000261777	AC012184.3	NA	
ENSG00000168872	DDX19A	NA	
ENSG00000285710	AC012184.4	NA	
ENSG00000157350	ST3GAL2	NA	
ENSG00000260111	AC012184.1	NA	
ENSG00000240043	RPS27P26	NA	
ENSG00000200153	RNU6-23P	NA	
ENSG00000157353	FCSK	618324	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2
ENSG00000103051	COG4	613489	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J;;CDG IIj; CDGIIj
ENSG00000103051	COG4	618150	SAUL-WILSON SYNDROME; SWILS;;MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA
ENSG00000189091	SF3B3	NA	
ENSG00000221514	SNORD111B	NA	
ENSG00000221066	SNORD111	NA	
ENSG00000157368	IL34	NA	
ENSG00000132613	MTSS2	NA	
ENSG00000279569	AC020763.4	NA	
ENSG00000103043	VAC14	617054	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC;;LENK-PLOSKI SYNDROME
ENSG00000279412	AC020763.3	NA	
ENSG00000260156	AC020763.1	NA	
ENSG00000214353	VAC14-AS1	NA	
ENSG00000279815	AC020763.5	NA	
ENSG00000279122	AC020763.2	NA	
ENSG00000279123	AC027281.1	NA	
ENSG00000157423	HYDIN	608647	CILIARY DYSKINESIA, PRIMARY, 5; CILD5;;CILIARY DYSKINESIA, PRIMARY, 5, WITHOUT SITUS INVERSUS
ENSG00000221725	RNU6ATAC25P	NA	
ENSG00000259833	AC138625.2	NA	
ENSG00000259798	AC138625.1	NA	
ENSG00000180917	CMTR2	NA	
ENSG00000261260	AC106736.1	NA	
ENSG00000172137	CALB2	NA	
ENSG00000261348	LINC02136	NA	
ENSG00000262120	AC010547.6	NA	
ENSG00000260734	TLE7	NA	
ENSG00000262008	AC010547.5	NA	
ENSG00000167377	ZNF23	NA	
ENSG00000261611	AC010547.4	NA	
ENSG00000247324	AC010547.1	NA	
ENSG00000157429	ZNF19	NA	
ENSG00000260520	AC010547.3	NA	
ENSG00000140835	CHST4	NA	
ENSG00000260015	AC010547.2	NA	
ENSG00000252339	RNU6-1061P	NA	
ENSG00000260886	TAT-AS1	NA	
ENSG00000198650	TAT	276600	TYROSINEMIA, TYPE II; TYRSN2;;RICHNER-HANHART SYNDROME;;TYROSINE AMINOTRANSFERASE DEFICIENCY;;TAT DEFICIENCY;;TYROSINE TRANSAMINASE DEFICIENCY;;KERATOSIS PALMOPLANTARIS WITH CORNEAL DYSTROPHY;;OREGON TYPE TYROSINEMIA;;TYROSINOSIS, OCULOCUTANEOUS TYPE
ENSG00000260593	AC009097.2	NA	
ENSG00000140832	MARVELD3	NA	
ENSG00000040199	PHLPP2	NA	
ENSG00000260185	AC009097.1	NA	
ENSG00000199301	RNU6-208P	NA	
ENSG00000263666	SNORA70D	NA	
ENSG00000261513	AC009097.4	NA	
ENSG00000260612	AC009097.3	NA	
ENSG00000166747	AP1G1	NA	
ENSG00000223224	SNORD71	NA	
ENSG00000283057	AC010653.3	NA	
ENSG00000262140	AC010653.1	NA	
ENSG00000224470	ATXN1L	NA	
ENSG00000182149	IST1	NA	
ENSG00000102984	ZNF821	NA	
ENSG00000279592	AC010653.2	NA	
ENSG00000261765	AC009127.1	NA	
ENSG00000277481	PKD1L3	NA	
ENSG00000242176	RPL39P31	NA	
ENSG00000263311	AC009127.2	NA	
ENSG00000263232	ATP5F1AP3	NA	
ENSG00000102967	DHODH	263750	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME
ENSG00000140830	TXNL4B	NA	
ENSG00000257017	HP	614081	ANHAPTOGLOBINEMIA; AHP;;AHAPTOGLOBINEMIA  HYPOHAPTOGLOBINEMIA, INCLUDED
ENSG00000261701	HPR	NA	
ENSG00000260252	AC009087.1	NA	
ENSG00000140829	DHX38	618220	RETINITIS PIGMENTOSA 84; RP84
ENSG00000118557	PMFBP1	618112	SPERMATOGENIC FAILURE 31; SPGF31
ENSG00000261673	AC009075.1	NA	
ENSG00000261008	LINC01572	NA	
ENSG00000261774	AC009075.2	NA	
ENSG00000283564	U6	NA	
ENSG00000260664	AC004158.1	NA	
ENSG00000259768	AC004943.2	NA	
ENSG00000238731	RNU7-90P	NA	
ENSG00000261764	KRT18P18	NA	
ENSG00000279206	AC004943.3	NA	
ENSG00000140836	ZFHX3	176807	PROSTATE CANCER
ENSG00000259209	AC004943.1	NA	
ENSG00000251868	RNU7-71P	NA	
ENSG00000279757	AC132068.1	NA	
ENSG00000280092	AC002044.3	NA	
ENSG00000272330	AC002044.1	NA	
ENSG00000279591	AC002044.2	NA	
ENSG00000271009	AC116667.1	NA	
ENSG00000260880	HCCAT5	NA	
ENSG00000284675	AC116667.2	NA	
ENSG00000261227	AC140912.1	NA	
ENSG00000279120	AC009033.1	NA	
ENSG00000258779	LINC01568	NA	
ENSG00000260848	AC092114.1	NA	
ENSG00000283457	AC087565.2	NA	
ENSG00000259817	AC087565.1	NA	
ENSG00000284670	AC092128.1	NA	
ENSG00000261404	AC138627.1	NA	
ENSG00000279420	AC138627.2	NA	
ENSG00000279100	AC009120.6	NA	
ENSG00000260471	PPIAP49	NA	
ENSG00000261248	AC009120.4	NA	
ENSG00000275236	AC009120.5	NA	
ENSG00000103035	PSMD7	NA	
ENSG00000259972	AC009120.2	NA	
ENSG00000239763	AC009120.1	NA	
ENSG00000260884	AC009120.3	NA	
ENSG00000214331	AC009053.1	NA	
ENSG00000261079	AC009053.2	NA	
ENSG00000196436	NPIPB15	NA	
ENSG00000276822	AC009053.4	NA	
ENSG00000140839	CLEC18B	NA	
ENSG00000261170	AC009053.3	NA	
ENSG00000090863	GLG1	NA	
ENSG00000251794	RNU6-237P	NA	
ENSG00000207525	Y_RNA	NA	
ENSG00000240861	AC009153.1	NA	
ENSG00000270945	HSPE1P7	NA	
ENSG00000168411	RFWD3	617784	FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW
ENSG00000262904	TMPOP2	NA	
ENSG00000168404	MLKL	NA	
ENSG00000103089	FA2H	612319	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35;;FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION; FAHN;;LEUKODYSTROPHY, DYSMYELINATING, AND SPASTIC PARAPARESIS WITH OR WITHOUT DYSTONIA
ENSG00000261458	AC009132.1	NA	
ENSG00000103091	WDR59	NA	
ENSG00000186187	ZNRF1	NA	
ENSG00000247033	AC099508.1	NA	
ENSG00000166816	LDHD	245450	D-LACTIC ACIDURIA; DLACD
ENSG00000261058	AC099508.2	NA	
ENSG00000184517	ZFP1	NA	
ENSG00000213318	AC009078.1	NA	
ENSG00000168928	CTRB2	NA	
ENSG00000168925	CTRB1	NA	
ENSG00000240338	AC009078.2	NA	
ENSG00000050820	BCAR1	NA	
ENSG00000280152	AC009078.3	NA	
ENSG00000252101	RNU6-758P	NA	
ENSG00000153774	CFDP1	NA	
ENSG00000259999	AC009054.1	NA	
ENSG00000261783	AC009054.2	NA	
ENSG00000252122	AC009163.2	NA	
ENSG00000261717	AC009163.5	NA	
ENSG00000274220	AC009163.7	NA	
ENSG00000166822	TMEM170A	NA	
ENSG00000261476	AC009163.4	NA	
ENSG00000183196	CHST6	217800	MACULAR DYSTROPHY, CORNEAL; MCD;;CORNEAL DYSTROPHY, MACULAR TYPE;;GROENOUW TYPE II CORNEAL DYSTROPHY;;MACULAR CORNEAL DYSTROPHY, TYPE I;;MCDC1, FORMERLY  MACULAR CORNEAL DYSTROPHY, TYPE II, INCLUDED
ENSG00000203472	AC009163.1	NA	
ENSG00000273971	AC009163.6	NA	
ENSG00000262583	TMEM231P1	NA	
ENSG00000260092	AC009163.3	NA	
ENSG00000135702	CHST5	NA	
ENSG00000205084	TMEM231	614970	JOUBERT SYNDROME 20; JBTS20
ENSG00000205084	TMEM231	615397	MECKEL SYNDROME, TYPE 11; MKS11
ENSG00000259992	AC025287.1	NA	
ENSG00000276408	AC025287.2	NA	
ENSG00000034713	GABARAPL2	NA	
ENSG00000276523	AC025287.3	NA	
ENSG00000065457	ADAT1	NA	
ENSG00000065427	KARS1	613641	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB
ENSG00000065427	KARS1	613916	DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89
ENSG00000287194	AC025287.5	NA	
ENSG00000166848	TERF2IP	NA	
ENSG00000284484	AC025287.4	NA	
ENSG00000282757	DUXB	NA	
ENSG00000240199	RN7SL520P	NA	
ENSG00000261424	ATP5PBP7	NA	
ENSG00000283755	CPHXL	NA	
ENSG00000261313	AC105430.1	NA	
ENSG00000199299	RNA5SP430	NA	
ENSG00000260223	AC099511.1	NA	
ENSG00000260983	AC010528.1	NA	
ENSG00000244485	RPL18P13	NA	
ENSG00000286841	AC010528.2	NA	
ENSG00000152910	CNTNAP4	NA	
ENSG00000287694	AC106741.1	NA	
ENSG00000252814	RN7SKP233	NA	
ENSG00000252022	SNORD33	NA	
ENSG00000273659	AC108125.1	NA	
ENSG00000250514	LINC02125	NA	
ENSG00000259995	AC106729.1	NA	
ENSG00000266426	MIR4719	NA	
ENSG00000260797	AC106734.1	NA	
ENSG00000279856	AC106733.1	NA	
ENSG00000103111	MON1B	NA	
ENSG00000205078	SYCE1L	NA	
ENSG00000261063	AC009139.2	NA	
ENSG00000226348	VN2R10P	NA	
ENSG00000260922	AC009139.1	NA	
ENSG00000140873	ADAMTS18	615458	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT
ENSG00000260701	AC025284.1	NA	
ENSG00000261154	LINC02131	NA	
ENSG00000278862	AC092724.1	NA	
ENSG00000140876	NUDT7	NA	
ENSG00000261707	AC092134.1	NA	
ENSG00000285538	AC092134.3	NA	
ENSG00000171724	VAT1L	NA	
ENSG00000278926	AC092134.2	NA	
ENSG00000261330	PPIAP50	NA	
ENSG00000261540	AC079414.1	NA	
ENSG00000166509	CLEC3A	NA	
ENSG00000260731	KRT8P22	NA	
ENSG00000261776	AC079414.2	NA	
ENSG00000186153	WWOX	133239	ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED;;ESCC, SUSCEPTIBILITY TO, INCLUDED;;AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO, INCLUDED;;GASTRIC CARDIA ADENOCARCINOMA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000186153	WWOX	614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY
ENSG00000186153	WWOX	616211	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28
ENSG00000276007	AC079414.3	NA	
ENSG00000279991	AC009044.1	NA	
ENSG00000260969	WWOX-AS1	NA	
ENSG00000287106	AC106743.1	NA	
ENSG00000260014	LSM3P5	NA	
ENSG00000260733	AC046158.1	NA	
ENSG00000279887	AC046158.4	NA	
ENSG00000261837	AC046158.2	NA	
ENSG00000279129	AC046158.3	NA	
ENSG00000286894	AC009141.1	NA	
ENSG00000243101	RPS3P7	NA	
ENSG00000280115	AC136603.1	NA	
ENSG00000280190	AC027279.4	NA	
ENSG00000260816	AC027279.1	NA	
ENSG00000279732	AC027279.3	NA	
ENSG00000261537	AC027279.2	NA	
ENSG00000280274	AC009145.4	NA	
ENSG00000260694	AC009145.3	NA	
ENSG00000260479	AC009145.1	NA	
ENSG00000260511	AC009145.2	NA	
ENSG00000277954	AC092376.2	NA	
ENSG00000285918	AC092376.3	NA	
ENSG00000261722	AC092376.1	NA	
ENSG00000222244	RNA5SP431	NA	
ENSG00000261472	AC084064.1	NA	
ENSG00000178573	MAF	601088	AYME-GRIPP SYNDROME; AYGRP;;CATARACTS, CONGENITAL, WITH SENSORINEURAL DEAFNESS, DOWN SYNDROME-LIKE FACIAL APPEARANCE, SHORT STATURE, AND MENTAL RETARDATION
ENSG00000178573	MAF	610202	CATARACT 21, MULTIPLE TYPES; CTRCT21;;CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, CONGENITAL, CERULEAN TYPE, 4; CCA4;;CATARACT, PULVERULENT, JUVENILE-ONSET
ENSG00000277214	AC009159.2	NA	
ENSG00000278058	AC009159.3	NA	
ENSG00000275040	AC009159.1	NA	
ENSG00000279378	AC009159.4	NA	
ENSG00000260876	LINC01229	NA	
ENSG00000261390	MAFTRR	NA	
ENSG00000261082	LINC01228	NA	
ENSG00000260237	AC092130.1	NA	
ENSG00000260706	AC022166.1	NA	
ENSG00000259867	AC105411.1	NA	
ENSG00000261376	AC022166.2	NA	
ENSG00000168589	DYNLRB2	NA	
ENSG00000260183	AC108097.1	NA	
ENSG00000260737	LINC01227	NA	
ENSG00000166446	CDYL2	NA	
ENSG00000260064	AC092332.1	NA	
ENSG00000260594	AC099313.1	NA	
ENSG00000260896	ARLNC1	NA	
ENSG00000286221	AC009070.1	NA	
ENSG00000103121	CMC2	NA	
ENSG00000278985	AC092718.7	NA	
ENSG00000166451	CENPN	NA	
ENSG00000260213	AC092718.2	NA	
ENSG00000284512	AC092718.8	NA	
ENSG00000261061	AC092718.4	NA	
ENSG00000166454	ATMIN	NA	
ENSG00000166455	C16orf46	NA	
ENSG00000260643	AC092718.3	NA	
ENSG00000261141	AC092718.5	NA	
ENSG00000261838	AC092718.6	NA	
ENSG00000245059	AC092718.1	NA	
ENSG00000140905	GCSH	605899	GLYCINE ENCEPHALOPATHY; GCE;;HYPERGLYCINEMIA, NONKETOTIC; NKH HYPERGLYCINEMIA, TRANSIENT NEONATAL, INCLUDED; TNH, INCLUDED
ENSG00000166473	PKD1L2	NA	
ENSG00000252608	RNU6-1191P	NA	
ENSG00000286759	AC092718.9	NA	
ENSG00000135697	BCO1	115300	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT; HCVAD CAROTENOIDS, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1, INCLUDED
ENSG00000280182	AC131888.1	NA	
ENSG00000260495	AC009148.1	NA	
ENSG00000261609	GAN	256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN
ENSG00000284473	MIR4720	NA	
ENSG00000153815	CMIP	NA	
ENSG00000279021	AC092139.1	NA	
ENSG00000260229	PPIAP51	NA	
ENSG00000279476	AC092139.2	NA	
ENSG00000277255	MIR7854	NA	
ENSG00000275109	MIR6504	NA	
ENSG00000279681	AC092135.2	NA	
ENSG00000279294	AC092135.1	NA	
ENSG00000279841	AC092135.3	NA	
ENSG00000261218	AC099524.1	NA	
ENSG00000197943	PLCG2	614468	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3;;ANTIBODY DEFICIENCY AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; PLAID;;FAMILIAL ATYPICAL COLD URTICARIA; FACU
ENSG00000197943	PLCG2	614878	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION; APLAID;;AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED
ENSG00000260682	RN7SKP176	NA	
ENSG00000276519	AC092142.2	NA	
ENSG00000184860	SDR42E1	NA	
ENSG00000086696	HSD17B2	NA	
ENSG00000261235	AC092142.1	NA	
ENSG00000260161	MTCYBP28	NA	
ENSG00000135698	MPHOSPH6	NA	
ENSG00000261029	AC138304.1	NA	
ENSG00000251888	RN7SKP190	NA	
ENSG00000259873	AC009117.1	NA	
ENSG00000261285	AC009117.2	NA	
ENSG00000140945	CDH13	NA	
ENSG00000277387	MIR8058	NA	
ENSG00000280044	AC099506.2	NA	
ENSG00000260862	AC099506.1	NA	
ENSG00000286528	AC099506.3	NA	
ENSG00000263360	RN7SL134P	NA	
ENSG00000260832	AC125793.1	NA	
ENSG00000261410	AC009142.1	NA	
ENSG00000263785	MIR3182	NA	
ENSG00000261103	AC009063.3	NA	
ENSG00000288554	AC009063.4	NA	
ENSG00000260788	AC009063.2	NA	
ENSG00000259914	AC009063.1	NA	
ENSG00000260228	AC009119.1	NA	
ENSG00000230989	HSBP1	NA	
ENSG00000103150	MLYCD	248360	MALONYL-CoA DECARBOXYLASE DEFICIENCY
ENSG00000260932	AC009119.2	NA	
ENSG00000140961	OSGIN1	NA	
ENSG00000103154	NECAB2	NA	
ENSG00000166558	SLC38A8	609218	FOVEAL HYPOPLASIA 2; FVH2;;FOVEAL HYPOPLASIA 2 WITH OR WITHOUT OPTIC NERVE MISROUTING AND/OR ANTERIOR SEGMENT DYSGENESIS;;FOVEAL HYPOPLASIA 2 WITH OPTIC NERVE DECUSSATION DEFECTS AND ANTERIOR SEGMENT DYSGENESIS WITHOUT ALBINISM; FHONDA
ENSG00000199350	RNA5SP432	NA	
ENSG00000285792	AC040169.4	NA	
ENSG00000140943	MBTPS1	618392	SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF;;SED WITH ELEVATED BLOOD LYSOSOMAL ENZYMES
ENSG00000274677	AC040169.3	NA	
ENSG00000260018	AC040169.1	NA	
ENSG00000260410	AC040169.2	NA	
ENSG00000103160	HSDL1	NA	
ENSG00000154099	DNAAF1	613193	CILIARY DYSKINESIA, PRIMARY, 13; CILD13;;CILIARY DYSKINESIA, PRIMARY, 13, WITH OR WITHOUT SITUS INVERSUS
ENSG00000103168	TAF1C	NA	
ENSG00000140955	ADAD2	NA	
ENSG00000250685	AC009123.1	NA	
ENSG00000168418	KCNG4	NA	
ENSG00000260858	AC010551.3	NA	
ENSG00000201361	RNA5SP433	NA	
ENSG00000103175	WFDC1	NA	
ENSG00000260530	AC010551.2	NA	
ENSG00000260504	AC010551.1	NA	
ENSG00000064270	ATP2C2	NA	
ENSG00000261286	ATP2C2-AS1	NA	
ENSG00000140950	MEAK7	NA	
ENSG00000261243	AC022165.1	NA	
ENSG00000103187	COTL1	NA	
ENSG00000261471	AC092145.1	NA	
ENSG00000135686	KLHL36	NA	
ENSG00000103194	USP10	NA	
ENSG00000285848	AC025280.3	NA	
ENSG00000103196	CRISPLD2	NA	
ENSG00000260859	AC025280.1	NA	
ENSG00000279622	AC025280.2	NA	
ENSG00000260340	LINC02176	NA	
ENSG00000153786	ZDHHC7	NA	
ENSG00000135709	KIAA0513	NA	
ENSG00000153789	CIBAR2	NA	
ENSG00000278214	LINC02139	NA	
ENSG00000275088	AC026469.1	NA	
ENSG00000131149	GSE1	NA	
ENSG00000287787	AC092275.1	NA	
ENSG00000270313	COX6CP16	NA	
ENSG00000179219	LINC00311	NA	
ENSG00000266307	MIR5093	NA	
ENSG00000287946	AC092377.1	NA	
ENSG00000278716	AC133540.1	NA	
ENSG00000270124	AC092127.2	NA	
ENSG00000260417	AC092127.1	NA	
ENSG00000263968	RN7SL381P	NA	
ENSG00000131153	GINS2	NA	
ENSG00000154102	C16orf74	NA	
ENSG00000275393	AC018695.6	NA	
ENSG00000287125	AC018695.9	NA	
ENSG00000283416	MIR1910	NA	
ENSG00000269898	AC018695.2	NA	
ENSG00000131148	EMC8	NA	
ENSG00000252311	RNU1-103P	NA	
ENSG00000270184	AC018695.4	NA	
ENSG00000270159	AC018695.3	NA	
ENSG00000131143	COX4I1	NA	
ENSG00000270698	AC018695.5	NA	
ENSG00000214259	AC018695.1	NA	
ENSG00000286510	AC018695.8	NA	
ENSG00000279907	AC018695.7	NA	
ENSG00000140968	IRF8	226990	IMMUNODEFICIENCY 32B; IMD32B;;IMMUNODEFICIENCY 32B, MONOCYTE, DENDRITIC CELL, AND NATURAL KILLER CELL DEFICIENCY, AUTOSOMAL RECESSIVE;;IRF8 DEFICIENCY, AUTOSOMAL RECESSIVE;;EPSTEIN-BARR VIRUS, SUSCEPTIBILITY TO CHRONIC INFECTION BY
ENSG00000140968	IRF8	614893	IMMUNODEFICIENCY 32A; IMD32A;;IMMUNODEFICIENCY 32A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT;;IRF8 DEFICIENCY, AUTOSOMAL DOMINANT;;CD11C-POSITIVE/CD1C-POSITIVE DENDRITIC CELL DEFICIENCY, AUTOSOMAL DOMINANT
ENSG00000274134	MIR6774	NA	
ENSG00000285163	AC092723.5	NA	
ENSG00000268804	LINC02132	NA	
ENSG00000285040	AC092723.4	NA	
ENSG00000269667	AC092723.1	NA	
ENSG00000285012	AC092723.3	NA	
ENSG00000279604	AC092723.2	NA	
ENSG00000261177	AC135012.1	NA	
ENSG00000268078	AC135012.2	NA	
ENSG00000268505	AC135012.3	NA	
ENSG00000269186	LINC01082	NA	
ENSG00000268754	LINC01081	NA	
ENSG00000199949	Y_RNA	NA	
ENSG00000268532	LINC02135	NA	
ENSG00000168367	LINC00917	NA	
ENSG00000269826	AC092327.2	NA	
ENSG00000268473	AC092327.1	NA	
ENSG00000268388	FENDRR	NA	
ENSG00000103241	FOXF1	265380	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV;;ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS AND OTHER CONGENITAL ANOMALIES
ENSG00000270020	AC009108.3	NA	
ENSG00000243697	AC009108.1	NA	
ENSG00000103248	MTHFSD	NA	
ENSG00000280278	FLJ30679	NA	
ENSG00000260944	FOXC2-AS1	NA	
ENSG00000176692	FOXC2	153400	LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST;;LYMPHEDEMA WITH DISTICHIASIS LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS, INCLUDED
ENSG00000176678	FOXL1	NA	
ENSG00000279142	AC009108.4	NA	
ENSG00000260387	AC009108.2	NA	
ENSG00000261161	AC009154.1	NA	
ENSG00000274478	AC009154.2	NA	
ENSG00000261175	LINC02188	NA	
ENSG00000260026	LINC02189	NA	
ENSG00000287010	AC130467.1	NA	
ENSG00000287161	AC093519.2	NA	
ENSG00000260795	AC093519.1	NA	
ENSG00000232190	LINC02181	NA	
ENSG00000261363	AC106745.1	NA	
ENSG00000260456	C16orf95	NA	
ENSG00000285527	AC136285.3	NA	
ENSG00000261095	AC136285.1	NA	
ENSG00000261651	AC136285.2	NA	
ENSG00000261697	AC010531.4	NA	
ENSG00000243705	AC010531.2	NA	
ENSG00000280419	AC010531.8	NA	
ENSG00000131152	AC010531.1	NA	
ENSG00000270006	AC010531.6	NA	
ENSG00000103264	FBXO31	615979	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45
ENSG00000270082	AC010531.7	NA	
ENSG00000269901	AC010531.5	NA	
ENSG00000140941	MAP1LC3B	NA	
ENSG00000261592	AC010531.3	NA	
ENSG00000140948	ZCCHC14	NA	
ENSG00000276393	AC105429.2	NA	
ENSG00000276337	AC105429.1	NA	
ENSG00000288568	AC092720.3	NA	
ENSG00000260750	AC092720.1	NA	
ENSG00000269935	AC092720.2	NA	
ENSG00000154118	JPH3	606438	HUNTINGTON DISEASE-LIKE 2; HDL2
ENSG00000277504	AC010536.3	NA	
ENSG00000226180	AC010536.1	NA	
ENSG00000104731	KLHDC4	NA	
ENSG00000260671	AC010536.2	NA	
ENSG00000260498	AC126696.3	NA	
ENSG00000260177	AC126696.1	NA	
ENSG00000103257	SLC7A5	NA	
ENSG00000278598	MIR6775	NA	
ENSG00000260466	AC126696.2	NA	
ENSG00000174990	CA5A	615751	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD
ENSG00000270385	AC133539.1	NA	
ENSG00000260443	AC127455.1	NA	
ENSG00000172530	BANP	NA	
ENSG00000261193	AC134312.4	NA	
ENSG00000260166	AC134312.3	NA	
ENSG00000205037	AC134312.1	NA	
ENSG00000260162	AC134312.2	NA	
ENSG00000261327	AC134312.5	NA	
ENSG00000260420	LINC02182	NA	
ENSG00000261816	AC134312.6	NA	
ENSG00000261273	AC138512.1	NA	
ENSG00000225614	ZNF469	229200	BRITTLE CORNEA SYNDROME 1; BCS1;;FRAGILITAS OCULI WITH JOINT HYPEREXTENSIBILITY;;CORNEAL FRAGILITY, KERATOGLOBUS, BLUE SCLERAE, JOINT HYPEREXTENSIBILITY;;DYSGENESIS MESODERMALIS CORNEAE ET SCLERAE;;EHLERS-DANLOS SYNDROME, TYPE VIB, FORMERLY; EDS6B,  /.../LY
ENSG00000179588	ZFPM1	NA	
ENSG00000263456	MIR5189	NA	
ENSG00000261744	AC116552.1	NA	
ENSG00000158545	ZC3H18	NA	
ENSG00000124391	IL17C	NA	
ENSG00000051523	CYBA	233690	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE;;CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE;;CGD DUE TO DEFICIENCY OF THE ALPHA SUBUNIT OF CYTOCHROME b;;CYBA DEFICIENCY
ENSG00000167508	MVD	614714	POROKERATOSIS 7, MULTIPLE TYPES; POROK7
ENSG00000260630	SNAI3-AS1	NA	
ENSG00000185669	SNAI3	NA	
ENSG00000158717	RNF166	NA	
ENSG00000259813	AC138028.3	NA	
ENSG00000174177	CTU2	618142	MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG
ENSG00000278341	AC138028.6	NA	
ENSG00000103335	PIEZO1	194380	DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1;;DEHYDRATED HEREDITARY STOMATOCYTOSIS; DHS;;XEROCYTOSIS, HEREDITARY;;DESICCYTOSIS, HEREDITARY;;PSEUDOHYPERKALEMIA, FAMILIAL, 1, DUE TO RED CELL LE /.../HK1;;PSEUDOHYPERKALEMIA EDINBURGH
ENSG00000103335	PIEZO1	616843	LYMPHATIC MALFORMATION 6; LMPHM6;;GENERALIZED LYMPHATIC DYSPLASIA OF FOTIOU;;LYMPHEDEMA, HEREDITARY, III, FORMERLY; LMPH3, FORMERLY
ENSG00000284585	MIR4722	NA	
ENSG00000260121	AC138028.4	NA	
ENSG00000224888	AC138028.2	NA	
ENSG00000260617	AC138028.5	NA	
ENSG00000182376	AC138028.1	NA	
ENSG00000167513	CDT1	613804	MEIER-GORLIN SYNDROME 4; MGORS4
ENSG00000198931	APRT	614723	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD;;APRT DEFICIENCY;;UROLITHIASIS, 2,8-@DIHYDROXYADENINE;;UROLITHIASIS, DHA;;NEPHROLITHIASIS, DHA
ENSG00000141012	GALNS	253000	MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A;;MORQUIO SYNDROME A;;MPS IVA;;MORQUIO A DISEASE;;GALACTOSAMINE-6-SULFATASE DEFICIENCY;;GALNS DEFICIENCY
ENSG00000167515	TRAPPC2L	618331	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB
ENSG00000205022	PABPN1L	NA	
ENSG00000129993	CBFA2T3	NA	
ENSG00000259881	AC092384.2	NA	
ENSG00000261226	AC092384.3	NA	
ENSG00000205018	AC092384.1	NA	
ENSG00000259989	AC135782.2	NA	
ENSG00000256982	AC135782.1	NA	
ENSG00000176715	ACSF3	614265	COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA
ENSG00000261546	AC135782.3	NA	
ENSG00000180422	LINC00304	NA	
ENSG00000205015	LINC02138	NA	
ENSG00000129910	CDH15	612580	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3
ENSG00000259803	SLC22A31	NA	
ENSG00000259877	AC009113.1	NA	
ENSG00000170100	ZNF778	NA	
ENSG00000260659	AC009113.2	NA	
ENSG00000167522	ANKRD11	148050	KBG SYNDROME; KBGS;;MACRODONTIA, MENTAL RETARDATION, CHARACTERISTIC FACIES, SHORT STATURE, AND SKELETAL ANOMALIES
ENSG00000268218	AC137932.3	NA	
ENSG00000260279	AC137932.1	NA	
ENSG00000261253	AC137932.2	NA	
ENSG00000261692	AC092120.1	NA	
ENSG00000287351	AC092120.3	NA	
ENSG00000252887	RNU6-430P	NA	
ENSG00000270832	AC092120.2	NA	
ENSG00000197912	SPG7	607259	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7
ENSG00000261118	AC092123.1	NA	
ENSG00000167526	RPL13	618728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE; SEMDIST
ENSG00000200084	SNORD68	NA	
ENSG00000178773	CPNE7	NA	
ENSG00000015413	DPEP1	NA	
ENSG00000131165	CHMP1A	614961	PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8
ENSG00000167523	SPATA33	NA	
ENSG00000275734	AC010538.1	NA	
ENSG00000185324	CDK10	617694	AL KAISSI SYNDROME; ALKAS;;GROWTH RETARDATION, SPINE MALFORMATION, DYSMORPHIC FACIES, AND DEVELOPMENTAL DELAY
ENSG00000260259	LINC02166	NA	
ENSG00000158792	SPATA2L	NA	
ENSG00000075399	VPS9D1	NA	
ENSG00000261373	VPS9D1-AS1	NA	
ENSG00000158805	ZNF276	NA	
ENSG00000187741	FANCA	227650	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA;;FANCONI ANEMIA; FA FANCONI ANEMIA, ESTREN-DAMESHEK VARIANT, INCLUDED;;ESTREN-DAMESHEK VARIANT OF FANCONI ANEMIA, INCLUDED;;ESTREN-DAMESHEK VARIANT OF FANCONI PANCYTOPENIA, INCLUDED
ENSG00000204991	SPIRE2	NA	
ENSG00000141002	TCF25	NA	
ENSG00000267048	AC092143.3	NA	
ENSG00000258839	MC1R	203200	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2;;OCULOCUTANEOUS ALBINISM, TYPE II;;OCULOCUTANEOUS ALBINISM, TYROSINASE-POSITIVE;;ALBINISM II ALBINISM, BROWN OCULOCUTANEOUS, INCLUDED; BOCA, INCLUDED;;BROWN OCULOCUTANEOUS ALBINISM, INCLUDED
ENSG00000258839	MC1R	266300	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2;;RED HAIR COLOR; RHC;;BLOND HAIR/FAIR SKIN;;RHA;;HAIR COLOR 2; HCL2  UV-INDUCED SKIN DAMAGE, SUSCEPTIBILITY TO, INCLUDED
ENSG00000258839	MC1R	613098	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC
ENSG00000258839	MC1R	613099	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5
ENSG00000198211	AC092143.1	NA	
ENSG00000259006	AC092143.2	NA	
ENSG00000258947	TUBB3	600638	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A;;FEOM3 LOCUS
ENSG00000258947	TUBB3	614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1
ENSG00000140995	DEF8	NA	
ENSG00000177946	CENPBD1	NA	
ENSG00000223959	AFG3L1P	NA	
ENSG00000003249	DBNDD1	NA	
ENSG00000141013	GAS8	616726	CILIARY DYSKINESIA, PRIMARY, 33; CILD33;;CILIARY DYSKINESIA, PRIMARY, 33, WITHOUT SITUS INVERSUS
ENSG00000221819	GAS8-AS1	NA	
ENSG00000222019	URAHP	NA	
ENSG00000126856	PRDM7	NA	
ENSG00000261812	TUBB8P7	NA	
ENSG00000260528	FAM157C	NA	
ENSG00000260507	AC133919.1	NA	
ENSG00000261172	AC133919.2	NA	
ENSG00000222359	RNU6-355P	NA	
ENSG00000260923	LINC02193	NA	
ENSG00000277349	AC133919.3	NA	
ENSG00000280279	AC240565.2	NA	
ENSG00000280136	AC240565.1	NA	
ENSG00000277613	U6	NA	
ENSG00000268320	SCGB1C2	NA	
ENSG00000272636	DOC2B	NA	
ENSG00000273172	LINC02091	NA	
ENSG00000181031	RPH3AL	NA	
ENSG00000262920	AC129507.4	NA	
ENSG00000262061	AC129507.1	NA	
ENSG00000262294	AC129507.2	NA	
ENSG00000262558	AC129507.3	NA	
ENSG00000241525	AC141424.1	NA	
ENSG00000187624	C17orf97	NA	
ENSG00000183688	RFLNB	NA	
ENSG00000263015	AC015853.2	NA	
ENSG00000141252	VPS53	615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E
ENSG00000263300	AC015853.3	NA	
ENSG00000262905	AC015853.1	NA	
ENSG00000262708	AC027455.1	NA	
ENSG00000244097	RPS4XP17	NA	
ENSG00000167695	TLCD3A	NA	
ENSG00000179409	GEMIN4	617913	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR
ENSG00000231784	DBIL5P	NA	
ENSG00000167699	GLOD4	NA	
ENSG00000262228	AC087392.3	NA	
ENSG00000171861	MRM3	NA	
ENSG00000262434	AC087392.4	NA	
ENSG00000277491	AC087392.5	NA	
ENSG00000167693	NXN	618529	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2
ENSG00000262133	AC087392.2	NA	
ENSG00000262003	AC087392.1	NA	
ENSG00000263017	AC036164.1	NA	
ENSG00000177370	TIMM22	NA	
ENSG00000159842	ABR	NA	
ENSG00000264429	MIR3183	NA	
ENSG00000278794	Metazoa_SRP	NA	
ENSG00000275997	AC016292.2	NA	
ENSG00000235361	AC016292.1	NA	
ENSG00000262213	AC144836.1	NA	
ENSG00000205899	BHLHA9	607539	CAMPTOSYNPOLYDACTYLY, COMPLEX; CCSPD;;CAMPTOPOLYDACTYLY, DISORGANIZATION TYPE
ENSG00000205899	BHLHA9	609432	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD;;SYNDACTYLY, MALIK-PERCIN TYPE;;SYNDACTYLY, TYPE IX
ENSG00000184811	TRARG1	NA	
ENSG00000108953	YWHAE	NA	
ENSG00000280408	AC032044.2	NA	
ENSG00000167193	CRK	NA	
ENSG00000262777	AC032044.1	NA	
ENSG00000197879	MYO1C	NA	
ENSG00000132376	INPP5K	617404	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID
ENSG00000236618	PITPNA-AS1	NA	
ENSG00000174238	PITPNA	NA	
ENSG00000167703	SLC43A2	NA	
ENSG00000243704	RN7SL105P	NA	
ENSG00000074660	SCARF1	NA	
ENSG00000167705	RILP	NA	
ENSG00000174231	PRPF8	600059	RETINITIS PIGMENTOSA 13; RP13
ENSG00000277597	AC130343.2	NA	
ENSG00000185561	TLCD2	NA	
ENSG00000186594	MIR22HG	NA	
ENSG00000283824	MIR22	NA	
ENSG00000167716	WDR81	610185	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 2
ENSG00000167716	WDR81	617967	HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3;;HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 3, FORMERLY
ENSG00000262791	AC130343.1	NA	
ENSG00000167711	SERPINF2	262850	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY;;ANTIPLASMIN DEFICIENCY;;PLASMIN INHIBITOR DEFICIENCY
ENSG00000132386	SERPINF1	613982	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6
ENSG00000186532	SMYD4	NA	
ENSG00000132383	RPA1	NA	
ENSG00000108958	AC130689.1	NA	
ENSG00000185924	RTN4RL1	NA	
ENSG00000262445	AC099684.2	NA	
ENSG00000228133	AC099684.1	NA	
ENSG00000262869	AC099684.3	NA	
ENSG00000108963	DPH1	616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR; DEDSSH;;LOUCKS-INNES SYNDROME
ENSG00000287553	AC090617.10	NA	
ENSG00000262664	OVCA2	NA	
ENSG00000262533	AC090617.3	NA	
ENSG00000263050	AC090617.5	NA	
ENSG00000267200	MIR132	NA	
ENSG00000267195	MIR212	NA	
ENSG00000177374	HIC1	NA	
ENSG00000070366	SMG6	NA	
ENSG00000280333	AC090617.9	NA	
ENSG00000262810	AC090617.4	NA	
ENSG00000279040	AC090617.6	NA	
ENSG00000279562	AC090617.8	NA	
ENSG00000279340	AC090617.7	NA	
ENSG00000262402	MCUR1P1	NA	
ENSG00000265777	RN7SL624P	NA	
ENSG00000236838	AC090617.2	NA	
ENSG00000236457	AC090617.1	NA	
ENSG00000225084	AL450226.1	NA	
ENSG00000278941	SMG6-IT1	NA	
ENSG00000280242	AL450226.2	NA	
ENSG00000167720	SRR	NA	
ENSG00000262333	HNRNPA1P16	NA	
ENSG00000167721	TSR1	NA	
ENSG00000275084	SNORD91B	NA	
ENSG00000212163	SNORD91A	NA	
ENSG00000141258	SGSM2	NA	
ENSG00000274758	AC006435.3	NA	
ENSG00000263345	AC006435.2	NA	
ENSG00000070444	MNT	NA	
ENSG00000262456	AC006435.1	NA	
ENSG00000127804	METTL16	NA	
ENSG00000279872	AC006435.4	NA	
ENSG00000280280	AC006435.5	NA	
ENSG00000243049	RN7SL33P	NA	
ENSG00000262953	EIF4A1P9	NA	
ENSG00000007168	PAFAH1B1	607432	LISSENCEPHALY 1; LIS1;;LISSENCEPHALY SEQUENCE, ISOLATED; ILS;;LISSENCEPHALY, CLASSIC SUBCORTICAL LAMINAR HETEROTOPIA, INCLUDED; SCLH, INCLUDED;;SUBCORTICAL BAND HETEROTOPIA, INCLUDED; SBH, INCLUDED
ENSG00000262480	SAMD11P1	NA	
ENSG00000279432	AC015799.1	NA	
ENSG00000239884	RN7SL608P	NA	
ENSG00000272770	AC005696.2	NA	
ENSG00000272911	AC005696.3	NA	
ENSG00000132361	CLUH	NA	
ENSG00000273606	MIR6776	NA	
ENSG00000262050	AC005696.1	NA	
ENSG00000277200	AC005696.4	NA	
ENSG00000261963	CCDC92B	NA	
ENSG00000221200	MIR1253	NA	
ENSG00000272920	hsa-mir-1253	NA	
ENSG00000132359	RAP1GAP2	NA	
ENSG00000262884	AC015921.1	NA	
ENSG00000262628	OR1D5	NA	
ENSG00000184166	OR1D2	NA	
ENSG00000142163	OR1E3	NA	
ENSG00000183024	OR1G1	NA	
ENSG00000261848	AC090282.1	NA	
ENSG00000262085	OR1P1	NA	
ENSG00000172150	OR1A2	NA	
ENSG00000172146	OR1A1	NA	
ENSG00000255095	OR1D4	NA	
ENSG00000262106	OR1D3P	NA	
ENSG00000221882	OR3A2	NA	
ENSG00000180090	OR3A1	NA	
ENSG00000180068	OR3A4P	NA	
ENSG00000285760	AC087498.1	NA	
ENSG00000267129	OR1AC1P	NA	
ENSG00000180042	OR1R1P	NA	
ENSG00000180016	OR1E1	NA	
ENSG00000159961	OR3A3	NA	
ENSG00000127780	OR1E2	NA	
ENSG00000280268	AC025125.1	NA	
ENSG00000141255	SPATA22	NA	
ENSG00000108381	ASPA	271900	CANAVAN DISEASE;;CANAVAN-VAN BOGAERT-BERTRAND DISEASE;;SPONGY DEGENERATION OF CENTRAL NERVOUS SYSTEM;;ASPARTOACYLASE DEFICIENCY;;ASPA DEFICIENCY;;ASP DEFICIENCY;;AMINOACYLASE 2 DEFICIENCY;;ACY2 DEFICIENCY
ENSG00000167723	TRPV3	614594	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES;;OLMSTED SYNDROME; OLMS
ENSG00000167723	TRPV3	616400	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2
ENSG00000196689	TRPV1	NA	
ENSG00000263338	AC027796.5	NA	
ENSG00000262304	AC027796.3	NA	
ENSG00000040531	CTNS	219750	CYSTINOSIS, ADULT NONNEPHROPATHIC;;CYSTINOSIS, OCULAR NONNEPHROPATHIC;;CYSTINOSIS, BENIGN NONNEPHROPATHIC
ENSG00000040531	CTNS	219800	CYSTINOSIS, NEPHROPATHIC; CTNS;;LYSOSOMAL CYSTINE TRANSPORT PROTEIN, DEFECT OF;;CYSTINOSIN, DEFECT OF  CYSTINOSIS, INFANTILE NEPHROPATHIC, INCLUDED;;CYSTINOSIS, ATYPICAL NEPHROPATHIC, INCLUDED
ENSG00000040531	CTNS	219900	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE;;CYSTINOSIS, INTERMEDIATE
ENSG00000261916	AC027796.1	NA	
ENSG00000197417	SHPK	617213	SEDOHEPTULOKINASE DEFICIENCY; SHPKD
ENSG00000262248	AC027796.2	NA	
ENSG00000262903	AC027796.4	NA	
ENSG00000213977	TAX1BP3	NA	
ENSG00000257950	P2RX5-TAX1BP3	NA	
ENSG00000240898	AC132942.1	NA	
ENSG00000127774	EMC6	NA	
ENSG00000083454	P2RX5	NA	
ENSG00000083457	ITGAE	NA	
ENSG00000262692	AC116914.2	NA	
ENSG00000177602	HASPIN	NA	
ENSG00000262358	AC116914.1	NA	
ENSG00000074356	NCBP3	NA	
ENSG00000004660	CAMKK1	NA	
ENSG00000108405	P2RX1	NA	
ENSG00000074370	ATP2A3	NA	
ENSG00000263312	LINC01975	NA	
ENSG00000074755	ZZEF1	NA	
ENSG00000252456	RNA5SP434	NA	
ENSG00000167740	CYB5D2	NA	
ENSG00000185722	ANKFY1	NA	
ENSG00000263165	AC087292.1	NA	
ENSG00000251812	Y_RNA	NA	
ENSG00000263219	RYKP1	NA	
ENSG00000274363	AC087742.1	NA	
ENSG00000132388	UBE2G1	NA	
ENSG00000261868	MFSD1P1	NA	
ENSG00000263882	RN7SL774P	NA	
ENSG00000182557	SPNS3	NA	
ENSG00000262823	AC127521.1	NA	
ENSG00000229782	AC118754.1	NA	
ENSG00000183018	SPNS2	618457	DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115
ENSG00000132382	MYBBP1A	NA	
ENSG00000167741	GGT6	NA	
ENSG00000262921	AC118754.2	NA	
ENSG00000262519	TXNP4	NA	
ENSG00000188176	SMTNL2	NA	
ENSG00000261863	LINC01996	NA	
ENSG00000222429	RNU6-955P	NA	
ENSG00000161905	ALOX15	NA	
ENSG00000141456	PELP1	NA	
ENSG00000235085	AC091153.2	NA	
ENSG00000244184	AC091153.3	NA	
ENSG00000213939	AC091153.1	NA	
ENSG00000141480	ARRB2	NA	
ENSG00000161920	MED11	NA	
ENSG00000261898	AC091153.4	NA	
ENSG00000161921	CXCL16	NA	
ENSG00000141497	ZMYND15	615842	SPERMATOGENIC FAILURE 14; SPGF14
ENSG00000142484	TM4SF5	NA	
ENSG00000182853	VMO1	NA	
ENSG00000182327	GLTPD2	NA	
ENSG00000280254	AC233723.2	NA	
ENSG00000142507	PSMB6	NA	
ENSG00000262165	AC233723.1	NA	
ENSG00000129219	PLD2	NA	
ENSG00000141503	MINK1	NA	
ENSG00000230201	ATP6V0CP1	NA	
ENSG00000264113	RN7SL784P	NA	
ENSG00000108556	CHRNE	605809	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A;;CONGENITAL MYASTHENIC SYNDROME TYPE Ia1, FORMERLY; CMS1A1, FORMERLY;;CMS Ia1, FORMERLY
ENSG00000108556	CHRNE	608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C;;MYASTHENIC SYNDROME, CONGENITAL, TYPE Id; CMS1D, FORMERLY;;CMS Id, FORMERLY;;MYASTHENIA, FAMILIAL INFANTILE, 1, FORMERLY; FIM1, FORMERLY
ENSG00000108556	CHRNE	616324	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B
ENSG00000205710	C17orf107	NA	
ENSG00000185245	GP1BA	177820	PSEUDO-VON WILLEBRAND DISEASE; VWDP;;BLEEDING DISORDER, PLATELET-TYPE, 3; BDPLT3;;VON WILLEBRAND DISEASE, PLATELET-TYPE
ENSG00000185245	GP1BA	153670	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2
ENSG00000185245	GP1BA	231200	BERNARD-SOULIER SYNDROME; BSS;;BLEEDING DISORDER, PLATELET-TYPE, 1; BDPLT1;;PLATELET GLYCOPROTEIN Ib DEFICIENCY;;GLYCOPROTEIN Ib, PLATELET, DEFICIENCY OF;;VON WILLEBRAND FACTOR RECEPTOR DEFICIENCY BERNARD-SOULIER SYNDROME, TYPE A1, INCLUDED;;BERNARD /.../ER SYNDROME, TYPE B, INCLUDED;;BERNARD-SOULIER SYNDROME, TYPE C, INCLUDED
ENSG00000185245	GP1BA	258660	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO;;NAION, SUSCEPTIBILITY TO;;OPTIC NEUROPATHY, ANTERIOR ISCHEMIC, SUSCEPTIBILITY TO
ENSG00000108528	SLC25A11	618464	PARAGANGLIOMAS 6; PGL6
ENSG00000108523	RNF167	NA	
ENSG00000108518	PFN1	614808	AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18
ENSG00000108515	ENO3	612932	GLYCOGEN STORAGE DISEASE XIII; GSD13;;GSD XIII;;ENOLASE 3 DEFICIENCY;;ENOLASE-BETA DEFICIENCY
ENSG00000091640	SPAG7	NA	
ENSG00000108509	CAMTA2	NA	
ENSG00000262429	AC004771.3	NA	
ENSG00000274300	MIR6864	NA	
ENSG00000278517	MIR6865	NA	
ENSG00000234203	AC004771.1	NA	
ENSG00000262678	AC004771.4	NA	
ENSG00000262227	AC004771.2	NA	
ENSG00000196388	INCA1	NA	
ENSG00000129250	KIF1C	611302	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2
ENSG00000227495	KIF1C-AS1	NA	
ENSG00000132517	SLC52A1	615026	RIBOFLAVIN DEFICIENCY; RBFVD
ENSG00000262495	AC012146.2	NA	
ENSG00000262693	AC012146.3	NA	
ENSG00000180787	ZFP3	NA	
ENSG00000167840	ZNF232	NA	
ENSG00000234327	AC012146.1	NA	
ENSG00000129204	USP6	NA	
ENSG00000262855	AC012146.4	NA	
ENSG00000180626	ZNF594	NA	
ENSG00000261879	AC087500.1	NA	
ENSG00000161929	SCIMP	NA	
ENSG00000263164	AC087500.2	NA	
ENSG00000029725	RABEP1	NA	
ENSG00000108559	NUP88	618393	FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4
ENSG00000263220	AC015727.1	NA	
ENSG00000129197	RPAIN	NA	
ENSG00000263272	AC004148.1	NA	
ENSG00000108561	C1QBP	617713	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33
ENSG00000005100	DHX33	NA	
ENSG00000262099	DHX33-DT	NA	
ENSG00000072849	DERL2	NA	
ENSG00000167842	MIS12	NA	
ENSG00000091592	NLRP1	606579	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1;;VITILIGO; VTLG;;SYSTEMIC LUPUS ERYTHEMATOSUS, VITILIGO-RELATED; SLEV1
ENSG00000091592	NLRP1	615225	PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC;;CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA, FORMERLY; CIDED, FORMERLY
ENSG00000091592	NLRP1	617388	AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK
ENSG00000091592	NLRP1	618803	RESPIRATORY PAPILLOMATOSIS, JUVENILE RECURRENT, CONGENITAL; JRRP
ENSG00000286190	AC055839.2	NA	
ENSG00000282980	AC055839.1	NA	
ENSG00000286356	AC135726.1	NA	
ENSG00000262961	AC006236.1	NA	
ENSG00000284837	AC007846.1	NA	
ENSG00000285471	AC007846.2	NA	
ENSG00000179314	WSCD1	NA	
ENSG00000262231	AC104770.1	NA	
ENSG00000206618	RNU6-1264P	NA	
ENSG00000262609	BTF3P14	NA	
ENSG00000285593	AC055872.2	NA	
ENSG00000129221	AIPL1	268000	RETINITIS PIGMENTOSA; RP
ENSG00000129221	AIPL1	604393	LEBER CONGENITAL AMAUROSIS 4; LCA4 RETINITIS PIGMENTOSA, JUVENILE, AIPL1-RELATED, INCLUDED;;CONE-ROD DYSTROPHY, AIPL1-RELATED, INCLUDED
ENSG00000262818	AC055872.1	NA	
ENSG00000129195	PIMREG	NA	
ENSG00000091622	PITPNM3	600977	CONE-ROD DYSTROPHY 5; CORD5
ENSG00000274860	Metazoa_SRP	NA	
ENSG00000198920	KIAA0753	617127	OROFACIODIGITAL SYNDROME XV; OFD15;;OFDS XV;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE XV
ENSG00000200914	RNA5SP435	NA	
ENSG00000282936	AC004706.3	NA	
ENSG00000129235	TXNDC17	NA	
ENSG00000108590	MED31	NA	
ENSG00000256806	C17orf100	NA	
ENSG00000261996	AC004706.1	NA	
ENSG00000264468	MIR4520-1	NA	
ENSG00000283301	MIR4520-2	NA	
ENSG00000274114	ALOX15P1	NA	
ENSG00000141485	SLC13A5	615905	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25
ENSG00000262990	AC004706.2	NA	
ENSG00000244283	RPL23AP73	NA	
ENSG00000132530	XAF1	NA	
ENSG00000279296	PRAL	NA	
ENSG00000177294	FBXO39	NA	
ENSG00000167858	TEKT1	NA	
ENSG00000262943	ALOX12P2	NA	
ENSG00000215067	ALOX12-AS1	NA	
ENSG00000262503	AC027763.1	NA	
ENSG00000263316	AC027763.2	NA	
ENSG00000267047	AC040977.2	NA	
ENSG00000262089	AC040977.1	NA	
ENSG00000108839	ALOX12	NA	
ENSG00000219200	RNASEK	NA	
ENSG00000161939	RNASEK-C17orf49	NA	
ENSG00000258315	C17orf49	NA	
ENSG00000267532	MIR497HG	NA	
ENSG00000284112	MIR195	NA	
ENSG00000284027	MIR497	NA	
ENSG00000161940	BCL6B	NA	
ENSG00000174327	SLC16A13	NA	
ENSG00000174326	SLC16A11	NA	
ENSG00000262067	AC120057.1	NA	
ENSG00000132514	CLEC10A	NA	
ENSG00000161944	ASGR2	NA	
ENSG00000213876	RPL7AP64	NA	
ENSG00000141505	ASGR1	NA	
ENSG00000132535	DLG4	618793	INTELLECTUAL DEVELOPMENTAL DISORDER 62; MRD62;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 62
ENSG00000279812	AC120057.4	NA	
ENSG00000072778	ACADVL	201475	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD;;VLCAD DEFICIENCY
ENSG00000199053	MIR324	NA	
ENSG00000004975	DVL2	NA	
ENSG00000040633	PHF23	NA	
ENSG00000170296	GABARAP	NA	
ENSG00000262526	AC120057.2	NA	
ENSG00000279641	AC120057.3	NA	
ENSG00000175826	CTDNEP1	NA	
ENSG00000262302	AC003688.1	NA	
ENSG00000170291	ELP5	NA	
ENSG00000181885	CLDN7	NA	
ENSG00000202251	Y_RNA	NA	
ENSG00000181856	SLC2A4	NA	
ENSG00000263342	AC003688.2	NA	
ENSG00000006047	YBX2	NA	
ENSG00000132507	EIF5A	NA	
ENSG00000132522	GPS2	NA	
ENSG00000261915	AC026954.2	NA	
ENSG00000215041	NEURL4	NA	
ENSG00000224647	AC026954.1	NA	
ENSG00000072818	ACAP1	NA	
ENSG00000213859	KCTD11	NA	
ENSG00000263171	AC026954.3	NA	
ENSG00000182896	TMEM95	NA	
ENSG00000174292	TNK1	NA	
ENSG00000187838	PLSCR3	NA	
ENSG00000262481	TMEM256-PLSCR3	NA	
ENSG00000205544	TMEM256	NA	
ENSG00000169992	NLGN2	NA	
ENSG00000262880	AC113189.2	NA	
ENSG00000181323	SPEM1	NA	
ENSG00000184560	SPEM2	NA	
ENSG00000283439	SPEM3	NA	
ENSG00000286007	AC113189.9	NA	
ENSG00000181284	TMEM102	NA	
ENSG00000262624	AC113189.1	NA	
ENSG00000161958	FGF11	NA	
ENSG00000263301	AC113189.3	NA	
ENSG00000272884	AC113189.4	NA	
ENSG00000170175	CHRNB1	616313	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A
ENSG00000170175	CHRNB1	616314	MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C
ENSG00000174282	ZBTB4	NA	
ENSG00000259224	SLC35G6	NA	
ENSG00000181222	POLR2A	618603	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES; NEDHIB
ENSG00000201489	AC016876.1	NA	
ENSG00000239697	TNFSF12	NA	
ENSG00000248871	TNFSF12-TNFSF13	NA	
ENSG00000276384	AC016876.4	NA	
ENSG00000161955	TNFSF13	NA	
ENSG00000161956	SENP3	NA	
ENSG00000277957	SENP3-EIF4A1	NA	
ENSG00000161960	EIF4A1	NA	
ENSG00000264772	AC016876.3	NA	
ENSG00000209582	SNORA48	NA	
ENSG00000238917	SNORD10	NA	
ENSG00000277985	SNORA67	NA	
ENSG00000129226	CD68	NA	
ENSG00000233223	AC016876.2	NA	
ENSG00000129255	MPDU1	609180	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F;;CDG If; CDGIf
ENSG00000129194	SOX15	NA	
ENSG00000129245	FXR2	NA	
ENSG00000129214	SHBG	NA	
ENSG00000141504	SAT2	NA	
ENSG00000129244	ATP1B2	NA	
ENSG00000141510	TP53	151623	LI-FRAUMENI SYNDROME; LFS;;SARCOMA FAMILY SYNDROME OF LI AND FRAUMENI;;SBLA SYNDROME LI-FRAUMENI-LIKE SYNDROME, INCLUDED; LFL, INCLUDED
ENSG00000141510	TP53	137800	GLIOMA SUSCEPTIBILITY 1; GLM1 GLIOMA OF BRAIN, FAMILIAL, INCLUDED; GLM, INCLUDED;;GLIOBLASTOMA MULTIFORME, INCLUDED; GBM, INCLUDED;;ASTROCYTOMA, INCLUDED;;OLIGODENDROGLIOMA, INCLUDED;;EPENDYMOMA, INCLUDED;;SUBEPENDYMOMA, INCLUDED
ENSG00000141510	TP53	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000141510	TP53	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000141510	TP53	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000141510	TP53	202300	ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC ADRENOCORTICAL CARCINOMA, PEDIATRIC, INCLUDED
ENSG00000141510	TP53	259500	OSTEOGENIC SARCOMA;;OSTEOSARCOMA; OSRC
ENSG00000141510	TP53	260350	PANCREATIC CANCER;;PANCREATIC CARCINOMA;;PANCREATIC ACINAR CARCINOMA
ENSG00000141510	TP53	260500	PAPILLOMA OF CHOROID PLEXUS; CPP;;CHOROID PLEXUS PAPILLOMA CHOROID PLEXUS CARCINOMA, INCLUDED; CPC, INCLUDED
ENSG00000141510	TP53	607107	NASOPHARYNGEAL CARCINOMA;;NPCA;;NPC;;NASOPHARYNGEAL CANCER NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NPCA1, INCLUDED
ENSG00000141510	TP53	614740	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7
ENSG00000141510	TP53	618165	BONE MARROW FAILURE SYNDROME 5; BMFS5
ENSG00000141499	WRAP53	613988	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3; DKCB3
ENSG00000108947	EFNB3	NA	
ENSG00000183914	DNAH2	NA	
ENSG00000240480	RPL29P2	NA	
ENSG00000132510	KDM6B	618505	NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA
ENSG00000167874	TMEM88	NA	
ENSG00000183011	NAA38	NA	
ENSG00000182224	CYB5D1	NA	
ENSG00000280046	AC104581.4	NA	
ENSG00000170004	CHD3	618205	SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS;;INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SPEECH DELAY, AND DYSMORPHIC FACIES; IDDMSF
ENSG00000252835	SCARNA21	NA	
ENSG00000179859	RNF227	NA	
ENSG00000170049	KCNAB3	NA	
ENSG00000262730	AC104581.2	NA	
ENSG00000170043	TRAPPC1	NA	
ENSG00000170037	CNTROB	NA	
ENSG00000262492	AC104581.1	NA	
ENSG00000132518	GUCY2D	204000	LEBER CONGENITAL AMAUROSIS 1; LCA1;;AMAUROSIS CONGENITA OF LEBER I;;LCA;;RETINAL BLINDNESS, CONGENITAL; CRB
ENSG00000132518	GUCY2D	215500	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1;;CHOROIDAL DYSTROPHY, CENTRAL AREOLAR; CACD;;CHOROIDAL SCLEROSIS
ENSG00000132518	GUCY2D	601777	CONE-ROD DYSTROPHY 6; CORD6;;RETINAL CONE DYSTROPHY 2; RCD2
ENSG00000132518	GUCY2D	618555	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I; CSNB1I
ENSG00000279174	AC104581.3	NA	
ENSG00000179593	ALOX15B	NA	
ENSG00000263427	AC129492.2	NA	
ENSG00000275011	AC129492.6	NA	
ENSG00000179477	ALOX12B	242100	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2;;COLLODION BABY, SELF-HEALING;;ICHTHYOSIFORM ERYTHRODERMA, NONBULLOUS CONGENITAL, 1, FORMERLY; NCIE1, FORMERLY;;ICHTHYOSIFORM ERYTHRODERMA, BROCQ CONGENITAL, NONBULLOUS FORM, FORMERLY
ENSG00000214999	AC129492.1	NA	
ENSG00000264005	MIR4314	NA	
ENSG00000179148	ALOXE3	242100	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2;;COLLODION BABY, SELF-HEALING;;ICHTHYOSIFORM ERYTHRODERMA, NONBULLOUS CONGENITAL, 1, FORMERLY; NCIE1, FORMERLY;;ICHTHYOSIFORM ERYTHRODERMA, BROCQ CONGENITAL, NONBULLOUS FORM, FORMERLY
ENSG00000179148	ALOXE3	606545	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3; ARCI3;;COLLODION BABY, SELF-HEALING;;ICHTHYOSIS, LAMELLAR, 5, FORMERLY; LI5, FORMERLY
ENSG00000179111	HES7	613686	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4
ENSG00000179094	PER1	NA	
ENSG00000284117	MIR6883	NA	
ENSG00000263620	AC129492.3	NA	
ENSG00000220205	VAMP2	618760	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM
ENSG00000179029	TMEM107	617562	MECKEL SYNDROME 13; MKS13 JOUBERT SYNDROME 29, INCLUDED; JBTS29, INCLUDED
ENSG00000179029	TMEM107	617563	OROFACIODIGITAL SYNDROME XVI; OFD16;;OFDS XVI;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE XVI
ENSG00000200463	SNORD118	614561	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC;;LABRUNE SYNDROME
ENSG00000266824	AC129492.4	NA	
ENSG00000283160	MIR4521	NA	
ENSG00000196544	BORCS6	NA	
ENSG00000279152	AC129492.7	NA	
ENSG00000271002	AC129492.5	NA	
ENSG00000178999	AURKB	NA	
ENSG00000178977	LINC00324	NA	
ENSG00000178971	CTC1	612199	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1; CRMCC1;;CRMCC;;COATS PLUS SYNDROME
ENSG00000178921	PFAS	NA	
ENSG00000269947	AC135178.6	NA	
ENSG00000125434	SLC25A35	NA	
ENSG00000108961	RANGRF	NA	
ENSG00000271029	AC135178.7	NA	
ENSG00000198844	ARHGEF15	NA	
ENSG00000226871	AC135178.2	NA	
ENSG00000212206	AC135178.1	NA	
ENSG00000266279	AC135178.5	NA	
ENSG00000184650	ODF4	NA	
ENSG00000184619	KRBA2	NA	
ENSG00000265749	AC135178.4	NA	
ENSG00000263809	AC135178.3	NA	
ENSG00000161970	RPL26	614900	DIAMOND-BLACKFAN ANEMIA 11; DBA11
ENSG00000189051	RNF222	NA	
ENSG00000166579	NDEL1	NA	
ENSG00000133026	MYH10	NA	
ENSG00000252363	RNU7-43P	NA	
ENSG00000270606	PPIAP52	NA	
ENSG00000244604	AC025518.1	NA	
ENSG00000161973	CCDC42	NA	
ENSG00000183318	SPDYE4	NA	
ENSG00000185156	MFSD6L	NA	
ENSG00000276231	PIK3R6	NA	
ENSG00000141506	PIK3R5	615217	ATAXIA-OCULOMOTOR APRAXIA 3; AOA3
ENSG00000266389	AC002091.2	NA	
ENSG00000265975	AC002091.1	NA	
ENSG00000065320	NTN1	618264	MIRROR MOVEMENTS 4; MRMV4
ENSG00000262966	AC005695.1	NA	
ENSG00000273816	AC005695.3	NA	
ENSG00000170310	STX8	NA	
ENSG00000263708	AC005695.2	NA	
ENSG00000225751	AC087501.1	NA	
ENSG00000262815	AC087501.2	NA	
ENSG00000263051	AC087501.3	NA	
ENSG00000271851	AC087501.4	NA	
ENSG00000166596	CFAP52	NA	
ENSG00000241654	RPL19P18	NA	
ENSG00000265349	AC118755.2	NA	
ENSG00000154914	USP43	NA	
ENSG00000262296	AC118755.1	NA	
ENSG00000282882	AC027045.2	NA	
ENSG00000184544	DHRS7C	NA	
ENSG00000278944	AC027045.1	NA	
ENSG00000214978	GSG1L2	NA	
ENSG00000283025	AC027045.3	NA	
ENSG00000065325	GLP2R	NA	
ENSG00000265593	NPM1P45	NA	
ENSG00000109047	RCVRN	NA	
ENSG00000007237	GAS7	NA	
ENSG00000242692	RPS27AP1	NA	
ENSG00000273388	AC005291.2	NA	
ENSG00000006788	MYH13	NA	
ENSG00000264067	AC005291.1	NA	
ENSG00000272975	MYHAS	NA	
ENSG00000272736	AC005323.2	NA	
ENSG00000133020	MYH8	158300	ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7;;TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME;;MOUTH, INABILITY TO OPEN COMPLETELY, AND SHORT FINGER-FLEXOR TENDONS;;HECHT SYNDROME
ENSG00000133020	MYH8	608837	CARNEY COMPLEX VARIANT
ENSG00000264424	MYH4	NA	
ENSG00000109061	MYH1	NA	
ENSG00000125414	MYH2	605637	MYOPATHY, PROXIMAL, WITH OPHTHALMOPLEGIA; MYPOP;;MYOPATHY WITH CONGENITAL JOINT CONTRACTURES, OPHTHALMOPLEGIA, AND RIMMED VACUOLES;;INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT, FORMERLY; IBM3, FORMERLY
ENSG00000214970	AC005323.1	NA	
ENSG00000109063	MYH3	178110	CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A; CPSFS1A;;CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A;;MULTIPLE PTERYGIUM SYNDROME, AUTOSOMAL DOMINANT;;PTERYGIUM SYNDROME, MULTIPLE; AUTOSOMAL DOMINAN /.../HROGRYPOSIS, DISTAL, TYPE 8, FORMERLY; DA8, FORMERLY
ENSG00000109063	MYH3	193700	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A;;FREEMAN-SHELDON SYNDROME; FSS;;WHISTLING FACE-WINDMILL VANE HAND SYNDROME;;CRANIOCARPOTARSAL DYSTROPHY;;CRANIOCARPOTARSAL DYSPLASIA
ENSG00000109063	MYH3	618436	ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3
ENSG00000109063	MYH3	618469	CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B; CPSFS1B;;CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B
ENSG00000261433	AC002347.1	NA	
ENSG00000133028	SCO1	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000263388	AC002347.2	NA	
ENSG00000170222	ADPRM	NA	
ENSG00000187824	TMEM220	NA	
ENSG00000264176	MAGOH2P	NA	
ENSG00000263400	TMEM220-AS1	NA	
ENSG00000285220	AC015908.7	NA	
ENSG00000264016	AC015908.3	NA	
ENSG00000240813	AC015908.1	NA	
ENSG00000266114	AC015908.4	NA	
ENSG00000284876	AC015908.6	NA	
ENSG00000263429	TMEM238L	NA	
ENSG00000279542	AC015908.5	NA	
ENSG00000233670	PIRT	NA	
ENSG00000263508	AC015908.2	NA	
ENSG00000207242	RNU6-1065P	NA	
ENSG00000244753	RPL15P21	NA	
ENSG00000243346	RN7SL601P	NA	
ENSG00000285541	AC005548.1	NA	
ENSG00000188803	SHISA6	NA	
ENSG00000264727	AC005725.1	NA	
ENSG00000007174	DNAH9	618300	CILIARY DYSKINESIA, PRIMARY, 40; CILD40;;CILIARY DYSKINESIA, PRIMARY, 40, WITH OR WITHOUT SITUS INVERSUS
ENSG00000263684	AC005209.1	NA	
ENSG00000266368	AC005410.2	NA	
ENSG00000154957	ZNF18	NA	
ENSG00000241185	AC005410.1	NA	
ENSG00000065559	MAP2K4	NA	
ENSG00000252707	RNU11-2P	NA	
ENSG00000266297	MIR744	NA	
ENSG00000263648	AC005244.1	NA	
ENSG00000265400	AC005244.2	NA	
ENSG00000286617	AC084167.1	NA	
ENSG00000179136	LINC00670	NA	
ENSG00000287462	AC068442.1	NA	
ENSG00000141052	MYOCD	618719	MEGABLADDER, CONGENITAL; MGBL
ENSG00000227274	MYOCD-AS1	NA	
ENSG00000265489	AC005358.1	NA	
ENSG00000006740	ARHGAP44	NA	
ENSG00000265503	MIR1269B	NA	
ENSG00000280168	AC005274.1	NA	
ENSG00000277621	AC005277.2	NA	
ENSG00000263707	AC005277.1	NA	
ENSG00000006744	ELAC2	614731	PROSTATE CANCER, HEREDITARY, 2; HPC2
ENSG00000006744	ELAC2	615440	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17
ENSG00000273098	AC005303.1	NA	
ENSG00000234634	LINC02093	NA	
ENSG00000153976	HS3ST3A1	NA	
ENSG00000221698	MIR548H3	NA	
ENSG00000236088	COX10-AS1	NA	
ENSG00000265494	AC005304.2	NA	
ENSG00000233852	AC005304.1	NA	
ENSG00000266744	AC005304.3	NA	
ENSG00000141028	CDRT15P1	NA	
ENSG00000006695	COX10	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000006695	COX10	256000	LEIGH SYNDROME; LS;;NECROTIZING ENCEPHALOPATHY, INFANTILE SUBACUTE, OF LEIGH; SNE LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHON /.../COMPLEX III DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX V DEFICIENCY, INCLUDED
ENSG00000252305	AC005389.1	NA	
ENSG00000223510	CDRT15	NA	
ENSG00000262786	AC005224.1	NA	
ENSG00000125430	HS3ST3B1	NA	
ENSG00000266709	AC005224.3	NA	
ENSG00000266378	AC005224.2	NA	
ENSG00000230647	AC022816.1	NA	
ENSG00000230897	RPS18P12	NA	
ENSG00000226130	AC013248.1	NA	
ENSG00000205325	AC005863.1	NA	
ENSG00000238212	LINC02096	NA	
ENSG00000226156	RPL23AP76	NA	
ENSG00000232058	AC005772.1	NA	
ENSG00000259944	CDRT7	NA	
ENSG00000287307	AC005772.2	NA	
ENSG00000265163	CDRT8	NA	
ENSG00000109099	PMP22	180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA;;ROUSSY-LEVY SYNDROME
ENSG00000109099	PMP22	162500	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP;;POLYNEUROPATHY, FAMILIAL RECURRENT;;TOMACULOUS NEUROPATHY
ENSG00000109099	PMP22	145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS;;DEJERINE-SOTTAS SYNDROME; DSS;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 3; CMT3;;HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE III; HMSN3;;DEJERINE-SOTTAS NEUROPATHY; DSN
ENSG00000109099	PMP22	139393	GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS;;POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, ACUTE; AIDP  POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC, INCLUDED; CIDP, INCLUDED
ENSG00000109099	PMP22	118300	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E
ENSG00000109099	PMP22	118220	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IA; HMSN IA;;HMSN1A;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1A;;CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, WITH FOCALLY FOLDED MYELIN SHEATHS, TYPE 1A
ENSG00000265110	MIR4731	NA	
ENSG00000279660	AC005703.5	NA	
ENSG00000265445	AC005703.2	NA	
ENSG00000286792	AC005703.6	NA	
ENSG00000237377	AC005703.1	NA	
ENSG00000125409	TEKT3	NA	
ENSG00000200437	RNU6-799P	NA	
ENSG00000279567	AC005703.4	NA	
ENSG00000266667	AC005703.3	NA	
ENSG00000239888	RN7SL792P	NA	
ENSG00000239704	CDRT4	NA	
ENSG00000259024	TVP23C-CDRT4	NA	
ENSG00000175106	TVP23C	NA	
ENSG00000234324	RPL9P2	NA	
ENSG00000223878	PPIAP53	NA	
ENSG00000266538	AC005838.2	NA	
ENSG00000241322	CDRT1	NA	
ENSG00000251537	AC005324.3	NA	
ENSG00000252129	SNORA74	NA	
ENSG00000223544	AC005838.1	NA	
ENSG00000221926	TRIM16	NA	
ENSG00000266261	AC005324.5	NA	
ENSG00000108452	ZNF29P	NA	
ENSG00000187607	ZNF286A	NA	
ENSG00000255104	AC005324.4	NA	
ENSG00000233966	UBE2SP1	NA	
ENSG00000214946	TBC1D26	NA	
ENSG00000233002	AC005324.1	NA	
ENSG00000267227	AC005324.6	NA	
ENSG00000233193	AC005324.2	NA	
ENSG00000227255	CDRT15P2	NA	
ENSG00000235430	ZSWIM5P1	NA	
ENSG00000251829	RNA5SP436	NA	
ENSG00000227018	IL6STP1	NA	
ENSG00000179277	MEIS3P1	NA	
ENSG00000265519	AC015922.2	NA	
ENSG00000276855	AC015922.3	NA	
ENSG00000233090	AC015922.1	NA	
ENSG00000237057	LINC02087	NA	
ENSG00000227790	SPECC1P1	NA	
ENSG00000170425	ADORA2B	NA	
ENSG00000214941	ZSWIM7	NA	
ENSG00000011295	TTC19	615157	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2
ENSG00000275413	AC002553.2	NA	
ENSG00000141027	NCOR1	NA	
ENSG00000227782	AC002553.1	NA	
ENSG00000243686	RPLP1P11	NA	
ENSG00000233979	RPL22P21	NA	
ENSG00000252383	RNU6-314P	NA	
ENSG00000199674	RNU6-862P	NA	
ENSG00000239221	RN7SL442P	NA	
ENSG00000108474	PIGL	280000	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME;;CHIME SYNDROME;;ZUNICH NEUROECTODERMAL SYNDROME;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 5; GPIBD5
ENSG00000221355	MIR1288	NA	
ENSG00000166582	CENPV	NA	
ENSG00000170315	UBB	NA	
ENSG00000265401	AC093484.3	NA	
ENSG00000265095	FTLP12	NA	
ENSG00000264739	AC093484.2	NA	
ENSG00000187688	TRPV2	NA	
ENSG00000239203	AC093484.1	NA	
ENSG00000175061	SNHG29	NA	
ENSG00000277108	SNORD49B	NA	
ENSG00000277370	SNORD49A	NA	
ENSG00000266651	AC093484.4	NA	
ENSG00000277512	SNORD65	NA	
ENSG00000181350	LRRC75A	NA	
ENSG00000286743	AC127540.2	NA	
ENSG00000141040	ZNF287	NA	
ENSG00000266803	AC127540.1	NA	
ENSG00000235554	AC005822.1	NA	
ENSG00000197566	ZNF624	NA	
ENSG00000264765	AC098850.2	NA	
ENSG00000264359	NEK4P2	NA	
ENSG00000231458	RNASEH1P2	NA	
ENSG00000170160	CCDC144A	NA	
ENSG00000266302	AC098850.3	NA	
ENSG00000252446	RNU6-405P	NA	
ENSG00000276088	RN7SL620P	NA	
ENSG00000226478	UPF3AP1	NA	
ENSG00000188933	USP32P1	NA	
ENSG00000266129	SRP68P1	NA	
ENSG00000272815	AC098850.4	NA	
ENSG00000264673	AC098850.1	NA	
ENSG00000288235	FAM106C	NA	
ENSG00000264729	AC022596.1	NA	
ENSG00000264892	NOS2P4	NA	
ENSG00000226145	KRT16P6	NA	
ENSG00000227300	KRT16P2	NA	
ENSG00000131885	KRT17P1	NA	
ENSG00000205312	KRT17P4	NA	
ENSG00000229749	COTL1P1	NA	
ENSG00000283033	AC022596.2	NA	
ENSG00000265853	AL353996.1	NA	
ENSG00000128438	TBC1D27P	NA	
ENSG00000240505	TNFRSF13B	240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2;;ANTIBODY DEFICIENCY DUE TO TACI DEFECT;;HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY
ENSG00000240505	TNFRSF13B	609529	IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2;;IMMUNOGLOBULIN A, SELECTIVE DEFICIENCY OF, TACI-RELATED;;IgA, SELECTIVE DEFICIENCY OF, TACI-RELATED
ENSG00000230709	AC104024.1	NA	
ENSG00000230969	LINC02090	NA	
ENSG00000260328	AC104024.2	NA	
ENSG00000287114	AC104024.3	NA	
ENSG00000287910	AC104024.4	NA	
ENSG00000133030	MPRIP	NA	
ENSG00000225442	MPRIP-AS1	NA	
ENSG00000263624	AC055811.1	NA	
ENSG00000206859	RNU6-767P	NA	
ENSG00000243370	RN7SL775P	NA	
ENSG00000278864	AC055811.4	NA	
ENSG00000179598	PLD6	NA	
ENSG00000264187	AC055811.2	NA	
ENSG00000154803	FLCN	173600	PNEUMOTHORAX, PRIMARY SPONTANEOUS;;PSP
ENSG00000154803	FLCN	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC;;HYPERNEPHROMA;;ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
ENSG00000154803	FLCN	135150	BIRT-HOGG-DUBE SYNDROME; BHD;;HORNSTEIN-KNICKENBERG SYNDROME;;FIBROFOLLICULOMAS WITH TRICHODISCOMAS AND ACROCHORDONS
ENSG00000154803	FLCN	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000154803	FLCN	610883	POTOCKI-LUPSKI SYNDROME; PTLS;;CHROMOSOME 17p11.2 DUPLICATION SYNDROME
ENSG00000266498	AC055811.3	NA	
ENSG00000226359	ACTG1P24	NA	
ENSG00000141030	COPS3	NA	
ENSG00000205309	NT5M	NA	
ENSG00000215030	RPL13P12	NA	
ENSG00000227158	AC073621.2	NA	
ENSG00000230865	TSEN15P1	NA	
ENSG00000201741	AC073621.1	NA	
ENSG00000141026	MED9	NA	
ENSG00000108551	RASD1	NA	
ENSG00000286430	AC020558.6	NA	
ENSG00000133027	PEMT	NA	
ENSG00000265511	AC020558.2	NA	
ENSG00000206730	RNU6-468P	NA	
ENSG00000264666	AC020558.1	NA	
ENSG00000279200	AC020558.5	NA	
ENSG00000223979	SMCR2	NA	
ENSG00000273948	AC020558.3	NA	
ENSG00000274836	AC020558.4	NA	
ENSG00000108557	RAI1	182290	SMITH-MAGENIS SYNDROME; SMS;;CHROMOSOME 17p11.2 DELETION SYNDROME SMITH-MAGENIS SYNDROME CHROMOSOME REGION, INCLUDED; SMCR, INCLUDED
ENSG00000237328	RAI1-AS1	NA	
ENSG00000226746	SMCR5	NA	
ENSG00000264167	AC122129.2	NA	
ENSG00000072310	SREBF1	NA	
ENSG00000274111	MIR6777	NA	
ENSG00000207839	MIR33B	NA	
ENSG00000175662	TOM1L2	NA	
ENSG00000197815	AC122129.1	NA	
ENSG00000171962	DRC3	NA	
ENSG00000171953	ATPAF2	604273	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATPAF2 TYPE
ENSG00000230273	AC087163.1	NA	
ENSG00000232344	AC087163.2	NA	
ENSG00000280198	AC087163.3	NA	
ENSG00000141034	GID4	NA	
ENSG00000108591	DRG2	NA	
ENSG00000279428	AC087164.2	NA	
ENSG00000091536	MYO15A	600316	DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 3; NSRD3
ENSG00000266677	AC087164.1	NA	
ENSG00000091542	ALKBH5	NA	
ENSG00000131899	LLGL1	NA	
ENSG00000177731	FLII	NA	
ENSG00000177427	MIEF2	NA	
ENSG00000260647	AC127537.1	NA	
ENSG00000177302	TOP3A	618097	MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2
ENSG00000177302	TOP3A	618098	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 5
ENSG00000228000	RPL7AP65	NA	
ENSG00000237382	RPL21P121	NA	
ENSG00000176994	SMCR8	NA	
ENSG00000176974	SHMT1	NA	
ENSG00000283772	MIR6778	NA	
ENSG00000214860	EVPLL	NA	
ENSG00000264177	AL353997.2	NA	
ENSG00000267441	AL353997.3	NA	
ENSG00000275206	AL353997.5	NA	
ENSG00000204471	TBC1D3P4	NA	
ENSG00000220161	LINC02076	NA	
ENSG00000205266	KRT17P5	NA	
ENSG00000266162	YWHAEP2	NA	
ENSG00000186831	KRT17P2	NA	
ENSG00000214856	KRT16P1	NA	
ENSG00000229526	KRT16P4	NA	
ENSG00000227919	AL353997.1	NA	
ENSG00000267492	AL353997.4	NA	
ENSG00000230662	TNPO1P2	NA	
ENSG00000171916	LGALS9C	NA	
ENSG00000167494	NOS2P2	NA	
ENSG00000273018	FAM106A	NA	
ENSG00000233327	USP32P2	NA	
ENSG00000227689	SRP68P2	NA	
ENSG00000154874	CCDC144B	NA	
ENSG00000227077	AC107983.1	NA	
ENSG00000276532	AC026271.4	NA	
ENSG00000189375	TBC1D28	NA	
ENSG00000262262	AC026271.2	NA	
ENSG00000287058	AC026271.5	NA	
ENSG00000174977	AC026271.1	NA	
ENSG00000249459	ZNF286B	NA	
ENSG00000240445	FOXO3B	NA	
ENSG00000224126	UBE2SP2	NA	
ENSG00000108448	TRIM16L	NA	
ENSG00000265693	AC026271.3	NA	
ENSG00000171931	FBXW10	NA	
ENSG00000171928	TVP23B	NA	
ENSG00000265478	AC107982.3	NA	
ENSG00000250111	AC107982.1	NA	
ENSG00000141127	PRPSAP2	NA	
ENSG00000274747	RN7SL627P	NA	
ENSG00000264273	AC107982.2	NA	
ENSG00000235672	AC090286.3	NA	
ENSG00000212618	AC090286.2	NA	
ENSG00000154025	SLC5A10	NA	
ENSG00000196893	AC090286.1	NA	
ENSG00000188522	FAM83G	NA	
ENSG00000263045	AC090286.4	NA	
ENSG00000154016	GRAP	618456	DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114
ENSG00000279825	AC003957.1	NA	
ENSG00000265185	SNORD3B-1	NA	
ENSG00000262074	SNORD3B-2	NA	
ENSG00000230197	AC007952.3	NA	
ENSG00000265746	KYNUP2	NA	
ENSG00000263394	AC007952.7	NA	
ENSG00000228157	AC007952.2	NA	
ENSG00000262202	AC007952.4	NA	
ENSG00000277947	SNORD3D	NA	
ENSG00000281000	SNORD3D	NA	
ENSG00000189152	GRAPL	NA	
ENSG00000262319	AC007952.6	NA	
ENSG00000266664	AC007952.9	NA	
ENSG00000197665	AC007952.1	NA	
ENSG00000262292	AC007952.5	NA	
ENSG00000266311	AC007952.8	NA	
ENSG00000261987	KYNUP1	NA	
ENSG00000263934	SNORD3A	NA	
ENSG00000264940	SNORD3C	NA	
ENSG00000236022	AC106017.1	NA	
ENSG00000263206	KYNUP3	NA	
ENSG00000072134	EPN2	NA	
ENSG00000281856	AC106017.2	NA	
ENSG00000235397	EPN2-AS1	NA	
ENSG00000108641	B9D1	614209	MECKEL SYNDROME, TYPE 9; MKS9
ENSG00000108641	B9D1	617120	JOUBERT SYNDROME 27; JBTS27
ENSG00000221540	MIR1180	NA	
ENSG00000286799	AC124066.1	NA	
ENSG00000166484	MAPK7	NA	
ENSG00000166482	MFAP4	NA	
ENSG00000287196	AC004448.5	NA	
ENSG00000128482	RNF112	NA	
ENSG00000265126	AC004448.3	NA	
ENSG00000235979	AC004448.2	NA	
ENSG00000227078	LINC02094	NA	
ENSG00000283675	AC004448.4	NA	
ENSG00000189343	RPS2P46	NA	
ENSG00000231477	AC004448.1	NA	
ENSG00000142494	SLC47A1	NA	
ENSG00000228331	RPL17P43	NA	
ENSG00000266079	SNORA59B	NA	
ENSG00000262769	AC025627.1	NA	
ENSG00000228983	SLC47A1P1	NA	
ENSG00000263107	AC025627.2	NA	
ENSG00000266179	AC025627.3	NA	
ENSG00000271900	AC025627.4	NA	
ENSG00000227225	MTND1P14	NA	
ENSG00000242752	NMTRQ-TTG12-1	NA	
ENSG00000228725	MTND2P12	NA	
ENSG00000224254	MTCO1P39	NA	
ENSG00000231625	SLC47A1P2	NA	
ENSG00000072210	ALDH3A2	270200	SJOGREN-LARSSON SYNDROME; SLS;;ICHTHYOSIS, SPASTIC NEUROLOGIC DISORDER, AND OLIGOPHRENIA;;FATTY ALCOHOL:NAD+ OXIDOREDUCTASE DEFICIENCY;;FATTY ALDEHYDE DEHYDROGENASE DEFICIENCY;;FALDH DEFICIENCY
ENSG00000264932	AC115989.1	NA	
ENSG00000275982	AC115989.2	NA	
ENSG00000252349	AC005722.2	NA	
ENSG00000180638	SLC47A2	NA	
ENSG00000262681	AC005722.3	NA	
ENSG00000264785	AC005722.4	NA	
ENSG00000108602	ALDH3A1	NA	
ENSG00000230607	AC005722.1	NA	
ENSG00000083290	ULK2	NA	
ENSG00000231096	NDUFB4P3	NA	
ENSG00000279251	AC015726.3	NA	
ENSG00000276406	AC015726.2	NA	
ENSG00000270091	AC015726.1	NA	
ENSG00000108599	AKAP10	115080	CARDIAC CONDUCTION DEFECT SUDDEN CARDIAC DEATH, INCLUDED; SCD, INCLUDED;;FAMILIAL SUDDEN DEATH, INCLUDED
ENSG00000266126	AC005730.3	NA	
ENSG00000261033	AC005730.2	NA	
ENSG00000128487	SPECC1	NA	
ENSG00000225681	AC005730.1	NA	
ENSG00000225014	KCTD9P1	NA	
ENSG00000212186	RNU6-258P	NA	
ENSG00000263494	AC004702.1	NA	
ENSG00000252971	RNU6-1057P	NA	
ENSG00000154898	CCDC144CP	NA	
ENSG00000276577	RNU6-467P	NA	
ENSG00000266839	AC008088.1	NA	
ENSG00000278701	Metazoa_SRP	NA	
ENSG00000214832	UPF3AP2	NA	
ENSG00000189423	USP32P3	NA	
ENSG00000237911	SRP68P3	NA	
ENSG00000287490	AC015818.9	NA	
ENSG00000287751	AC015818.10	NA	
ENSG00000230528	NOS2P3	NA	
ENSG00000170298	LGALS9B	NA	
ENSG00000229586	TNPO1P3	NA	
ENSG00000263976	YWHAEP3	NA	
ENSG00000230088	KRT16P5	NA	
ENSG00000214822	KRT16P3	NA	
ENSG00000266925	AC015818.7	NA	
ENSG00000231645	KRT17P6	NA	
ENSG00000205215	KRT17P7	NA	
ENSG00000266042	AC015818.6	NA	
ENSG00000260907	AC015818.2	NA	
ENSG00000265916	AC015818.5	NA	
ENSG00000235203	TBC1D3P3	NA	
ENSG00000267075	AC015818.8	NA	
ENSG00000230339	AC015818.1	NA	
ENSG00000263946	AC015818.3	NA	
ENSG00000235323	COTL1P2	NA	
ENSG00000264422	AC015818.4	NA	
ENSG00000214819	CDRT15L2	NA	
ENSG00000231258	ZSWIM5P2	NA	
ENSG00000188013	MEIS3P2	NA	
ENSG00000232889	AC087499.3	NA	
ENSG00000226096	AC087499.1	NA	
ENSG00000235546	AC087499.4	NA	
ENSG00000227685	LINC02088	NA	
ENSG00000266364	AC087499.7	NA	
ENSG00000236504	AC087499.5	NA	
ENSG00000264874	AC087499.6	NA	
ENSG00000226521	AC087499.2	NA	
ENSG00000187870	RNFT1P3	NA	
ENSG00000218454	HNRNPA1P19	NA	
ENSG00000213671	OLA1P2	NA	
ENSG00000226549	SCDP1	NA	
ENSG00000264215	AC126365.1	NA	
ENSG00000264662	AC126365.2	NA	
ENSG00000226981	ABHD17AP6	NA	
ENSG00000205212	CCDC144NL	NA	
ENSG00000266369	AC090774.2	NA	
ENSG00000233098	CCDC144NL-AS1	NA	
ENSG00000252483	RNU6-1178P	NA	
ENSG00000265790	RNASEH1P1	NA	
ENSG00000265099	AC090774.1	NA	
ENSG00000244456	SPECC1P2	NA	
ENSG00000264660	AC107926.1	NA	
ENSG00000266009	AC087393.3	NA	
ENSG00000263729	AC087393.1	NA	
ENSG00000124422	USP22	NA	
ENSG00000263986	AC087393.2	NA	
ENSG00000236819	LINC01563	NA	
ENSG00000109016	DHRS7B	NA	
ENSG00000178307	TMEM11	NA	
ENSG00000235530	AC087294.1	NA	
ENSG00000263815	RN7SL426P	NA	
ENSG00000274180	NATD1	NA	
ENSG00000266563	EIF1P5	NA	
ENSG00000034152	MAP2K3	NA	
ENSG00000184185	KCNJ12	NA	
ENSG00000212719	LINC02693	NA	
ENSG00000287671	AC068418.3	NA	
ENSG00000265881	PDLIM1P2	NA	
ENSG00000265043	AC068418.2	NA	
ENSG00000264023	AC068418.1	NA	
ENSG00000244582	RPL21P120	NA	
ENSG00000265265	AC233702.5	NA	
ENSG00000266466	AC233702.7	NA	
ENSG00000266673	AC233702.8	NA	
ENSG00000266050	AC233702.6	NA	
ENSG00000264245	AC233702.3	NA	
ENSG00000263375	AC233702.2	NA	
ENSG00000260157	AC233702.1	NA	
ENSG00000264617	AC233702.4	NA	
ENSG00000274748	AC233702.9	NA	
ENSG00000260458	KCNJ18	613239	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2
ENSG00000283566	AC243725.1	NA	
ENSG00000265233	ABBA01006766.1	NA	
ENSG00000265019	NCOR1P2	NA	
ENSG00000263563	UBBP4	NA	
ENSG00000263725	FTLP13	NA	
ENSG00000263609	LINC02002	NA	
ENSG00000264956	AC138761.1	NA	
ENSG00000266691	AC138761.2	NA	
ENSG00000178130	FAM27E5	NA	
ENSG00000266806	AC087575.1	NA	
ENSG00000276399	FLJ36000	NA	
ENSG00000261020	AC132825.3	NA	
ENSG00000266885	AC132825.4	NA	
ENSG00000283879	AC132825.5	NA	
ENSG00000266529	MTCYBP13	NA	
ENSG00000256618	MTRNR2L1	NA	
ENSG00000243655	AC132825.2	NA	
ENSG00000264168	MTND1P15	NA	
ENSG00000263914	MTND2P13	NA	
ENSG00000240103	AC132825.1	NA	
ENSG00000241225	NMTRS-TGA3-1	NA	
ENSG00000263483	MTATP6P3	NA	
ENSG00000264316	MTCO3P13	NA	
ENSG00000284300	AC132825.7	NA	
ENSG00000284328	AC132825.8	NA	
ENSG00000284263	AC132825.6	NA	
ENSG00000275480	AC131055.2	NA	
ENSG00000264930	AC131055.1	NA	
ENSG00000264970	AC131274.3	NA	
ENSG00000264262	AC131274.1	NA	
ENSG00000264431	AC131274.2	NA	
ENSG00000263433	AC069061.1	NA	
ENSG00000264734	AC069061.2	NA	
ENSG00000264172	PDLIM1P3	NA	
ENSG00000266736	GTF2IP6	NA	
ENSG00000264837	VN1R71P	NA	
ENSG00000265646	TUFMP1	NA	
ENSG00000285822	AC129926.2	NA	
ENSG00000265246	AC129926.1	NA	
ENSG00000239223	RPL34P31	NA	
ENSG00000213664	RPS16P8	NA	
ENSG00000265453	AC026254.1	NA	
ENSG00000263583	MIR4522	NA	
ENSG00000109046	WSB1	NA	
ENSG00000266313	AC026254.2	NA	
ENSG00000265683	SYPL1P2	NA	
ENSG00000266356	AC090615.1	NA	
ENSG00000266433	TBC1D3P5	NA	
ENSG00000141068	KSR1	NA	
ENSG00000265801	AC069366.2	NA	
ENSG00000263368	AC069366.1	NA	
ENSG00000266853	ITM2BP1	NA	
ENSG00000266728	AC015688.4	NA	
ENSG00000266872	AC015688.6	NA	
ENSG00000168961	LGALS9	NA	
ENSG00000265788	NOS2P1	NA	
ENSG00000265041	AC015688.3	NA	
ENSG00000266771	AC015688.5	NA	
ENSG00000264240	CPDP1	NA	
ENSG00000264689	AC015688.2	NA	
ENSG00000263604	AC015688.1	NA	
ENSG00000265833	AC130289.1	NA	
ENSG00000266416	AC130289.2	NA	
ENSG00000266786	LGALS9DP	NA	
ENSG00000007171	NOS2	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000266202	AC005697.1	NA	
ENSG00000266527	AC005697.2	NA	
ENSG00000232859	LYRM9	NA	
ENSG00000260019	LINC01992	NA	
ENSG00000286589	AC005697.3	NA	
ENSG00000251818	AC090287.1	NA	
ENSG00000266190	AC090287.2	NA	
ENSG00000202389	SNORA70	NA	
ENSG00000087095	NLK	NA	
ENSG00000252283	AC100852.1	NA	
ENSG00000240873	RPS29P22	NA	
ENSG00000287721	AC061975.8	NA	
ENSG00000267644	AC061975.7	NA	
ENSG00000237575	PYY2	NA	
ENSG00000267259	ERVE-1	NA	
ENSG00000266830	AC061975.6	NA	
ENSG00000265060	PPY2P	NA	
ENSG00000263788	AC061975.2	NA	
ENSG00000264486	AC061975.4	NA	
ENSG00000260777	AC061975.1	NA	
ENSG00000266306	AC061975.5	NA	
ENSG00000264029	AC061975.3	NA	
ENSG00000265480	KRT18P55	NA	
ENSG00000109084	TMEM97	NA	
ENSG00000109083	IFT20	NA	
ENSG00000109079	TNFAIP1	NA	
ENSG00000004142	POLDIP2	NA	
ENSG00000244045	TMEM199	616829	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P;;CDG IIp; CDGIIp
ENSG00000258924	AC002094.1	NA	
ENSG00000284532	MIR4723	NA	
ENSG00000265618	AC002094.2	NA	
ENSG00000274529	SEBOX	NA	
ENSG00000273171	AC002094.3	NA	
ENSG00000004139	SARM1	NA	
ENSG00000109072	VTN	NA	
ENSG00000277450	AC002094.4	NA	
ENSG00000279532	AC002094.5	NA	
ENSG00000076351	SLC46A1	229050	FOLATE MALABSORPTION, HEREDITARY
ENSG00000265254	AC015917.2	NA	
ENSG00000265541	H3P41	NA	
ENSG00000263870	AC015917.1	NA	
ENSG00000258472	AC005726.1	NA	
ENSG00000263266	RPS7P1	NA	
ENSG00000007216	SLC13A2	NA	
ENSG00000109101	FOXN1	601705	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY; TIDAND
ENSG00000109101	FOXN1	618806	T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT; TLIND
ENSG00000109103	UNC119	604011	UNC119 LIPID-BINDING CHAPERONE; UNC119;;UNC119, C. ELEGANS, HOMOLOG OF;;HUMAN RETINAL GENE 4; HRG4 CONE-ROD DYSTROPHY, INCLUDED
ENSG00000109103	UNC119	615518	IMMUNODEFICIENCY 13; IMD13;;IDIOPATHIC CD4 LYMPHOPENIA; ICL
ENSG00000087111	PIGS	618143	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18
ENSG00000109107	ALDOC	NA	
ENSG00000265168	AC005726.3	NA	
ENSG00000076382	SPAG5	NA	
ENSG00000227543	SPAG5-AS1	NA	
ENSG00000167524	RSKR	NA	
ENSG00000265287	AC005726.4	NA	
ENSG00000007202	KIAA0100	NA	
ENSG00000264044	AC005726.2	NA	
ENSG00000132581	SDF2	NA	
ENSG00000240494	RPS12P28	NA	
ENSG00000109111	SUPT6H	NA	
ENSG00000265205	AC010761.3	NA	
ENSG00000167525	PROCA1	NA	
ENSG00000109113	RAB34	NA	
ENSG00000198242	RPL23A	NA	
ENSG00000238423	SNORD42B	NA	
ENSG00000264577	AC010761.1	NA	
ENSG00000238578	SNORD4A	NA	
ENSG00000238649	SNORD42A	NA	
ENSG00000238597	SNORD4B	NA	
ENSG00000160606	TLCD1	NA	
ENSG00000160602	NEK8	613824	NEPHRONOPHTHISIS 9; NPHP9
ENSG00000160602	NEK8	615415	RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2
ENSG00000267729	AC010761.6	NA	
ENSG00000265073	AC010761.2	NA	
ENSG00000076604	TRAF4	NA	
ENSG00000265474	AC010761.4	NA	
ENSG00000265840	AC010761.5	NA	
ENSG00000173065	FAM222B	NA	
ENSG00000243053	RPL31P58	NA	
ENSG00000238516	Y_RNA	NA	
ENSG00000264138	AC024267.2	NA	
ENSG00000132591	ERAL1	617565	PERRAULT SYNDROME 6; PRLTS6
ENSG00000264066	AC024267.1	NA	
ENSG00000284565	MIR451A	NA	
ENSG00000283364	MIR451B	NA	
ENSG00000283819	MIR144	NA	
ENSG00000284085	MIR4732	NA	
ENSG00000132589	FLOT2	NA	
ENSG00000264304	AC024267.3	NA	
ENSG00000266642	AC024267.6	NA	
ENSG00000167536	DHRS13	NA	
ENSG00000109118	PHF12	NA	
ENSG00000265845	AC024267.4	NA	
ENSG00000265908	AC024267.5	NA	
ENSG00000179761	PIPOX	NA	
ENSG00000063015	SEZ6	NA	
ENSG00000263613	AC024619.2	NA	
ENSG00000238007	AC024619.1	NA	
ENSG00000263781	AC024619.4	NA	
ENSG00000196535	MYO18A	NA	
ENSG00000221995	TIAF1	NA	
ENSG00000263709	AC024619.3	NA	
ENSG00000264050	AC005412.1	NA	
ENSG00000178082	TWF1P1	NA	
ENSG00000108255	CRYBA1	600881	CATARACT 10, MULTIPLE TYPES; CTRCT10;;CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS
ENSG00000108256	NUFIP2	NA	
ENSG00000239256	RPL35AP35	NA	
ENSG00000266111	AC068025.2	NA	
ENSG00000264808	AC068025.1	NA	
ENSG00000222363	RNU4-34P	NA	
ENSG00000160551	TAOK1	NA	
ENSG00000284162	MIR4523	NA	
ENSG00000253064	RNU6-711P	NA	
ENSG00000202205	RNU6-1034P	NA	
ENSG00000168792	ABHD15	NA	
ENSG00000264031	ABHD15-AS1	NA	
ENSG00000167543	TP53I13	NA	
ENSG00000264290	AC104564.3	NA	
ENSG00000108262	GIT1	NA	
ENSG00000198720	ANKRD13B	NA	
ENSG00000264647	AC104564.4	NA	
ENSG00000167549	CORO6	NA	
ENSG00000264007	AC104564.2	NA	
ENSG00000141298	SSH2	NA	
ENSG00000263370	AC104564.1	NA	
ENSG00000222858	RNU6-920P	NA	
ENSG00000265625	AC104564.5	NA	
ENSG00000240531	RPL21P123	NA	
ENSG00000263657	AC023389.1	NA	
ENSG00000265713	AC023389.2	NA	
ENSG00000252657	SNORA70	NA	
ENSG00000240074	RPL9P30	NA	
ENSG00000263477	AC104982.2	NA	
ENSG00000239129	AC104982.1	NA	
ENSG00000176927	EFCAB5	NA	
ENSG00000264435	AC104982.3	NA	
ENSG00000207011	RNY4P13	NA	
ENSG00000267482	AC104996.3	NA	
ENSG00000265289	AC104996.1	NA	
ENSG00000266876	AC104996.2	NA	
ENSG00000265394	AC104984.2	NA	
ENSG00000126653	NSRP1	NA	
ENSG00000266919	hsa-mir-423	NA	
ENSG00000283935	MIR423	NA	
ENSG00000284399	MIR3184	NA	
ENSG00000265739	AC104984.3	NA	
ENSG00000266987	AC104984.5	NA	
ENSG00000108576	SLC6A4	164230	OBSESSIVE-COMPULSIVE DISORDER; OCD
ENSG00000108576	SLC6A4	607834	ANXIETY HARM AVOIDANCE, INCLUDED
ENSG00000264125	AC104984.1	NA	
ENSG00000266120	AC104984.4	NA	
ENSG00000252112	SNORD63	NA	
ENSG00000108578	BLMH	NA	
ENSG00000222679	RNU6-1267P	NA	
ENSG00000182271	TMIGD1	NA	
ENSG00000207132	Y_RNA	NA	
ENSG00000201255	RNU6-990P	NA	
ENSG00000108582	CPD	NA	
ENSG00000108587	GOSR1	NA	
ENSG00000264958	ALOX12P1	NA	
ENSG00000263860	AC011840.3	NA	
ENSG00000279431	AC011840.5	NA	
ENSG00000266733	TBC1D29P	NA	
ENSG00000266775	AC011840.4	NA	
ENSG00000259928	AC011840.2	NA	
ENSG00000231870	KRT17P3	NA	
ENSG00000231421	AC011840.1	NA	
ENSG00000214719	AC005562.1	NA	
ENSG00000248121	SMURF2P1	NA	
ENSG00000273609	AC005562.2	NA	
ENSG00000264943	SH3GL1P2	NA	
ENSG00000250462	LRRC37BP1	NA	
ENSG00000241631	RN7SL316P	NA	
ENSG00000264538	SUZ12P1	NA	
ENSG00000279337	AC127024.7	NA	
ENSG00000265443	AC127024.3	NA	
ENSG00000263603	AC127024.2	NA	
ENSG00000280069	AC127024.8	NA	
ENSG00000176390	CRLF3	NA	
ENSG00000265791	AC127024.4	NA	
ENSG00000266490	AC127024.5	NA	
ENSG00000276250	AC127024.6	NA	
ENSG00000242439	AC127024.1	NA	
ENSG00000176208	ATAD5	NA	
ENSG00000265334	AC130324.2	NA	
ENSG00000212190	RNU6-298P	NA	
ENSG00000263531	AC130324.1	NA	
ENSG00000172171	TEFM	NA	
ENSG00000275185	AC130324.3	NA	
ENSG00000184060	ADAP2	NA	
ENSG00000230113	AC138207.1	NA	
ENSG00000266274	RN7SL138P	NA	
ENSG00000265743	AC138207.5	NA	
ENSG00000286194	AC138207.9	NA	
ENSG00000181481	RNF135	NA	
ENSG00000264456	AC138207.4	NA	
ENSG00000264743	DPRXP4	NA	
ENSG00000266340	AC138207.7	NA	
ENSG00000264148	AC138207.3	NA	
ENSG00000266865	AC138207.8	NA	
ENSG00000265798	AC138207.6	NA	
ENSG00000264107	AC138207.2	NA	
ENSG00000265444	MIR4733	NA	
ENSG00000196712	NF1	162210	NEUROFIBROMATOSIS, FAMILIAL SPINAL;;FSNF
ENSG00000196712	NF1	162200	NEUROFIBROMATOSIS, TYPE I; NF1;;NEUROFIBROMATOSIS, PERIPHERAL TYPE;;VON RECKLINGHAUSEN DISEASE
ENSG00000196712	NF1	193520	WATSON SYNDROME; WTSN;;PULMONIC STENOSIS WITH CAFE-AU-LAIT SPOTS;;CAFE-AU-LAIT SPOTS WITH PULMONIC STENOSIS
ENSG00000196712	NF1	601321	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS;;NOONAN-NEUROFIBROMATOSIS SYNDROME;;NEUROFIBROMATOSIS WITH NOONAN PHENOTYPE
ENSG00000196712	NF1	607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML;;LEUKEMIA, JUVENILE MYELOMONOCYTIC  LEUKEMIA, CHRONIC MYELOMONOCYTIC, INCLUDED; CMML, INCLUDED
ENSG00000266371	AC079915.1	NA	
ENSG00000126861	OMG	NA	
ENSG00000185862	EVI2B	NA	
ENSG00000265118	AC134669.1	NA	
ENSG00000126860	EVI2A	NA	
ENSG00000263535	AK4P1	NA	
ENSG00000131242	RAB11FIP4	NA	
ENSG00000239595	RN7SL79P	NA	
ENSG00000264862	RN7SL45P	NA	
ENSG00000278977	AC003101.3	NA	
ENSG00000284424	MIR4724	NA	
ENSG00000207614	MIR193A	NA	
ENSG00000278546	AC003101.2	NA	
ENSG00000221038	RNU6ATAC7P	NA	
ENSG00000228768	AC003101.1	NA	
ENSG00000265976	MIR4725	NA	
ENSG00000283978	MIR365B	NA	
ENSG00000266877	AC007923.3	NA	
ENSG00000266448	AC007923.2	NA	
ENSG00000202026	RNU6-1134P	NA	
ENSG00000265863	GPR160P2	NA	
ENSG00000263567	AC007923.1	NA	
ENSG00000265046	AC004253.2	NA	
ENSG00000172301	COPRS	NA	
ENSG00000108651	UTP6	NA	
ENSG00000263990	AC004253.1	NA	
ENSG00000178691	SUZ12	618786	IMAGAWA-MATSUMOTO SYNDROME; IMMAS
ENSG00000253058	RNA5SP437	NA	
ENSG00000264300	AC090616.3	NA	
ENSG00000185158	LRRC37B	NA	
ENSG00000264497	AC090616.4	NA	
ENSG00000266777	SH3GL1P1	NA	
ENSG00000278867	AC090616.6	NA	
ENSG00000264164	AC090616.2	NA	
ENSG00000266379	AC090616.5	NA	
ENSG00000263369	AC090616.1	NA	
ENSG00000265574	WDR45BP1	NA	
ENSG00000277511	AC116407.2	NA	
ENSG00000214708	AC116407.1	NA	
ENSG00000126858	RHOT1	NA	
ENSG00000265293	ARGFXP2	NA	
ENSG00000280033	AC116407.4	NA	
ENSG00000280020	AC116407.3	NA	
ENSG00000266282	UBL5P2	NA	
ENSG00000287506	AC026620.2	NA	
ENSG00000141314	RHBDL3	NA	
ENSG00000263674	AC026620.1	NA	
ENSG00000265794	AC005899.4	NA	
ENSG00000108666	C17orf75	NA	
ENSG00000265139	AC005899.3	NA	
ENSG00000263749	OOSP1P2	NA	
ENSG00000283774	MIR632	NA	
ENSG00000010244	ZNF207	NA	
ENSG00000274341	AC005899.6	NA	
ENSG00000278668	AC005899.7	NA	
ENSG00000266385	AC005899.5	NA	
ENSG00000279762	AC005899.8	NA	
ENSG00000264083	AC005899.1	NA	
ENSG00000264373	AC005899.2	NA	
ENSG00000108671	PSMD11	NA	
ENSG00000202100	Y_RNA	NA	
ENSG00000176749	CDK5R1	NA	
ENSG00000176658	MYO1D	NA	
ENSG00000266718	AC079336.5	NA	
ENSG00000280245	AC079336.7	NA	
ENSG00000265222	AC079336.2	NA	
ENSG00000263717	AC079336.1	NA	
ENSG00000279781	AC079336.6	NA	
ENSG00000266599	AC079336.4	NA	
ENSG00000265337	AC079336.3	NA	
ENSG00000264458	AC025211.1	NA	
ENSG00000201178	Y_RNA	NA	
ENSG00000226377	AC084809.1	NA	
ENSG00000236377	AC084809.2	NA	
ENSG00000006042	TMEM98	615972	NANOPHTHALMOS 4; NNO4;;NANOPHTHALMIA 4
ENSG00000141316	SPACA3	NA	
ENSG00000108684	ASIC2	NA	
ENSG00000264598	AC003687.1	NA	
ENSG00000280349	AC008133.2	NA	
ENSG00000266535	AC008133.1	NA	
ENSG00000265544	AA06	NA	
ENSG00000265697	AC011824.3	NA	
ENSG00000265125	AC011824.2	NA	
ENSG00000265115	AC011824.1	NA	
ENSG00000264643	AC024614.1	NA	
ENSG00000265689	AC024614.2	NA	
ENSG00000283381	AC024614.3	NA	
ENSG00000283417	AC024614.4	NA	
ENSG00000279668	AC024610.2	NA	
ENSG00000265356	AC004147.4	NA	
ENSG00000263435	AC024610.1	NA	
ENSG00000279674	AC123769.1	NA	
ENSG00000226049	TLK2P1	NA	
ENSG00000263485	AC004147.1	NA	
ENSG00000265775	AC004147.5	NA	
ENSG00000252370	RNA5SP438	NA	
ENSG00000264791	AC004147.3	NA	
ENSG00000263571	AC004147.2	NA	
ENSG00000261156	LINC01989	NA	
ENSG00000264990	AC005549.1	NA	
ENSG00000108691	CCL2	182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD SPINA BIFIDA, INCLUDED
ENSG00000108691	CCL2	158105	CHEMOKINE, CC MOTIF, LIGAND 2; CCL2;;SMALL INDUCIBLE CYTOKINE A2; SCYA2;;MONOCYTE CHEMOTACTIC PROTEIN 1; MCP1;;MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR; MCAF CORONARY ARTERY DISEASE, MODIFIER OF, INCLUDED;;CORONARY ARTERY DISEASE, DEVELOPMENT OF,  /.../, INCLUDED
ENSG00000108691	CCL2	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000108691	CCL2	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000108688	CCL7	NA	
ENSG00000172156	CCL11	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000172156	CCL11	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000108700	CCL8	NA	
ENSG00000265614	AC011193.2	NA	
ENSG00000181374	CCL13	NA	
ENSG00000108702	CCL1	NA	
ENSG00000225582	AC011193.1	NA	
ENSG00000197322	C17orf102	NA	
ENSG00000181291	TMEM132E	618481	DEAFNESS, AUTOSOMAL RECESSIVE 99; DFNB99
ENSG00000278860	AC005691.1	NA	
ENSG00000264174	AC005552.1	NA	
ENSG00000264622	AC022903.1	NA	
ENSG00000132141	CCT6B	NA	
ENSG00000285559	AC022903.2	NA	
ENSG00000198783	ZNF830	NA	
ENSG00000005156	LIG3	NA	
ENSG00000092871	RFFL	NA	
ENSG00000267618	AC004223.3	NA	
ENSG00000273687	AC004223.4	NA	
ENSG00000267457	AC004223.2	NA	
ENSG00000243423	AC004223.1	NA	
ENSG00000185379	RAD51D	614291	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4
ENSG00000253084	RNU6-840P	NA	
ENSG00000252328	Vault	NA	
ENSG00000073598	FNDC8	NA	
ENSG00000073536	NLE1	NA	
ENSG00000141161	UNC45B	616279	CATARACT 43; CTRCT43
ENSG00000267782	AC022916.4	NA	
ENSG00000266981	AC022916.2	NA	
ENSG00000267744	AC022916.3	NA	
ENSG00000164729	SLC35G3	NA	
ENSG00000266947	AC022916.1	NA	
ENSG00000166750	SLFN5	NA	
ENSG00000267364	AC022706.1	NA	
ENSG00000267271	AC060766.2	NA	
ENSG00000172716	SLFN11	NA	
ENSG00000267315	AC060766.3	NA	
ENSG00000267711	AC060766.6	NA	
ENSG00000267547	AC060766.4	NA	
ENSG00000267745	AC060766.7	NA	
ENSG00000267648	AC060766.5	NA	
ENSG00000267102	AC060766.1	NA	
ENSG00000172123	SLFN12	NA	
ENSG00000154760	SLFN13	NA	
ENSG00000267312	AC015911.4	NA	
ENSG00000205045	SLFN12L	NA	
ENSG00000267554	AC015911.8	NA	
ENSG00000286065	AC015911.11	NA	
ENSG00000267349	AC015911.5	NA	
ENSG00000267046	E2F3P1	NA	
ENSG00000267369	AC015911.7	NA	
ENSG00000267074	AC015911.3	NA	
ENSG00000255987	TOMM20P2	NA	
ENSG00000286030	AC015911.10	NA	
ENSG00000267035	AC015911.2	NA	
ENSG00000236320	SLFN14	616913	BLEEDING DISORDER, PLATELET-TYPE, 20; BDPLT20
ENSG00000267359	AC015911.6	NA	
ENSG00000267625	AC015911.9	NA	
ENSG00000242660	AC015911.1	NA	
ENSG00000267321	SNHG30	NA	
ENSG00000207297	SNORD7	NA	
ENSG00000108733	PEX12	266510	PEROXISOME BIOGENESIS DISORDER 3B; PBD3B
ENSG00000108733	PEX12	614859	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 3, INCLUDED; CG3, INCLUDED
ENSG00000006125	AP2B1	NA	
ENSG00000267592	AC004134.1	NA	
ENSG00000270647	TAF15	612237	CHONDROSARCOMA, EXTRASKELETAL MYXOID;;EMC
ENSG00000270885	RASL10B	NA	
ENSG00000270765	GAS2L2	618449	CILIARY DYSKINESIA, PRIMARY, 41; CILD41
ENSG00000271447	MMP28	NA	
ENSG00000271392	AC006237.1	NA	
ENSG00000270806	C17orf50	NA	
ENSG00000270829	AC015849.2	NA	
ENSG00000270871	AC015849.3	NA	
ENSG00000270894	AC015849.4	NA	
ENSG00000270379	HEATR9	NA	
ENSG00000271268	AC015849.6	NA	
ENSG00000270240	AC015849.1	NA	
ENSG00000271503	CCL5	NA	
ENSG00000271394	7SK	NA	
ENSG00000270977	AC015849.5	NA	
ENSG00000271013	LRRC37A9P	NA	
ENSG00000278023	RDM1	NA	
ENSG00000275722	LYZL6	NA	
ENSG00000273736	AC244100.1	NA	
ENSG00000275152	CCL16	NA	
ENSG00000276409	CCL14	NA	
ENSG00000275688	CCL15-CCL14	NA	
ENSG00000275431	AC244100.2	NA	
ENSG00000275718	CCL15	NA	
ENSG00000275944	AC244100.3	NA	
ENSG00000278690	AC244100.4	NA	
ENSG00000274736	CCL23	NA	
ENSG00000275385	CCL18	NA	
ENSG00000277089	AC243829.4	NA	
ENSG00000277632	CCL3	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000275302	CCL4	NA	
ENSG00000276014	RN7SL301P	NA	
ENSG00000276241	AC243829.2	NA	
ENSG00000282738	AC243829.7	NA	
ENSG00000274808	TBC1D3B	NA	
ENSG00000274767	AC243829.1	NA	
ENSG00000276085	CCL3L3	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276070	CCL4L2	NA	
ENSG00000278097	AC243829.5	NA	
ENSG00000276755	AC243829.3	NA	
ENSG00000278395	AC243829.6	NA	
ENSG00000274933	TBC1D3I	NA	
ENSG00000261499	AC233699.1	NA	
ENSG00000265889	Y_RNA	NA	
ENSG00000260287	TBC1D3G	NA	
ENSG00000274226	TBC1D3H	NA	
ENSG00000277029	RNU6-1192P	NA	
ENSG00000275954	TBC1D3F	NA	
ENSG00000274658	TBC1D3J	NA	
ENSG00000273611	ZNHIT3	260565	PEHO SYNDROME; PEHO;;PROGRESSIVE ENCEPHALOPATHY WITH EDEMA, HYPSARRHYTHMIA, AND OPTIC ATROPHY;;INFANTILE CEREBELLOOPTIC ATROPHY
ENSG00000274164	RNA5SP439	NA	
ENSG00000278259	MYO19	NA	
ENSG00000277161	PIGW	616025	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11;;HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 5; HPMRS5
ENSG00000278311	GGNBP2	NA	
ENSG00000274756	AC243732.1	NA	
ENSG00000278535	DHRS11	NA	
ENSG00000278619	MRM1	NA	
ENSG00000275720	AC243830.2	NA	
ENSG00000276508	AC243830.3	NA	
ENSG00000275613	AC243830.1	NA	
ENSG00000277268	LHX1-DT	NA	
ENSG00000273706	LHX1	NA	
ENSG00000276707	AC243773.1	NA	
ENSG00000275700	AATF	NA	
ENSG00000277911	AC243773.2	NA	
ENSG00000277589	AC244093.4	NA	
ENSG00000276326	MIR2909	NA	
ENSG00000277579	AC244093.3	NA	
ENSG00000278638	AC244093.5	NA	
ENSG00000278540	ACACA	613933	ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD;;ACACA DEFICIENCY;;ACC1 DEFICIENCY
ENSG00000274308	AC244093.1	NA	
ENSG00000275029	HMGB1P24	NA	
ENSG00000276810	AC244093.2	NA	
ENSG00000278505	C17orf78	NA	
ENSG00000276054	AC243654.3	NA	
ENSG00000276234	TADA2A	NA	
ENSG00000273965	AC243654.1	NA	
ENSG00000275839	AC243654.2	NA	
ENSG00000276023	DUSP14	NA	
ENSG00000275066	SYNRG	NA	
ENSG00000277688	AC243585.2	NA	
ENSG00000278053	DDX52	NA	
ENSG00000274620	MIR378J	NA	
ENSG00000277501	AC243571.2	NA	
ENSG00000274244	AC243585.1	NA	
ENSG00000275410	HNF1B	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC;;HYPERNEPHROMA;;ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
ENSG00000275410	HNF1B	137920	RENAL CYSTS AND DIABETES SYNDROME; RCAD;;MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 5; MODY5;;HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, ATYPICAL;;FJHN, ATYPICAL;;GLOMERULOCYSTIC KIDNEY DISEASE, HYPOPLASTIC TYPE;;GLOMERULOCYSTIC KIDNEY, FAMILIAL  /.../ASTIC;;CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH DIABETES;;CAKUT WITH DIABETES
ENSG00000275410	HNF1B	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000275173	AC243571.1	NA	
ENSG00000276715	YWHAEP7	NA	
ENSG00000277341	RNU6-489P	NA	
ENSG00000273513	TBC1D3K	NA	
ENSG00000277488	5S_rRNA	NA	
ENSG00000274512	TBC1D3L	NA	
ENSG00000274419	TBC1D3D	NA	
ENSG00000278299	TBC1D3C	NA	
ENSG00000274615	AC233968.1	NA	
ENSG00000275006	Y_RNA	NA	
ENSG00000278599	TBC1D3E	NA	
ENSG00000274663	RNA5SP526	NA	
ENSG00000274611	TBC1D3	NA	
ENSG00000274487	NPEPPSP1	NA	
ENSG00000274284	Y_RNA	NA	
ENSG00000278845	MRPL45	NA	
ENSG00000277399	GPR179	614565	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE
ENSG00000274211	SOCS7	NA	
ENSG00000275832	ARHGAP23	NA	
ENSG00000276170	AC244153.1	NA	
ENSG00000277363	SRCIN1	NA	
ENSG00000274996	AC006449.1	NA	
ENSG00000273604	EPOP	NA	
ENSG00000279119	AC006449.7	NA	
ENSG00000275238	MIR4734	NA	
ENSG00000277969	AC006449.6	NA	
ENSG00000275532	AC006449.2	NA	
ENSG00000275023	MLLT6	NA	
ENSG00000275665	AC006449.3	NA	
ENSG00000273627	MIR4726	NA	
ENSG00000277972	CISD3	NA	
ENSG00000276036	RNA5SP440	NA	
ENSG00000277258	PCGF2	618371	TURNPENNY-FRY SYNDROME; TPFS;;NEUROCARDIOSKELETAL SYNDROME
ENSG00000277182	AC006449.5	NA	
ENSG00000277791	PSMB3	NA	
ENSG00000274607	RNU6-866P	NA	
ENSG00000276293	PIP4K2B	NA	
ENSG00000273559	CWC25	NA	
ENSG00000274054	MIR4727	NA	
ENSG00000275489	C17orf98	NA	
ENSG00000125691	RPL23	NA	
ENSG00000252699	SNORA21B	NA	
ENSG00000199293	SNORA21	NA	
ENSG00000244086	AC110749.1	NA	
ENSG00000002834	LASP1	NA	
ENSG00000263466	AC006441.1	NA	
ENSG00000277057	MIR6779	NA	
ENSG00000265784	AC006441.3	NA	
ENSG00000263874	LINC00672	NA	
ENSG00000204952	FBXO47	NA	
ENSG00000265428	AC006441.2	NA	
ENSG00000266588	AC006441.4	NA	
ENSG00000277426	AC006441.5	NA	
ENSG00000266013	LINC02079	NA	
ENSG00000214553	LRRC37A11P	NA	
ENSG00000266048	AC091178.1	NA	
ENSG00000263818	RDM1P5	NA	
ENSG00000161381	PLXDC1	NA	
ENSG00000286443	AC091178.2	NA	
ENSG00000141748	ARL5C	NA	
ENSG00000280177	AC004408.2	NA	
ENSG00000266101	AC004408.1	NA	
ENSG00000067191	CACNB1	NA	
ENSG00000108298	RPL19	NA	
ENSG00000141750	STAC2	NA	
ENSG00000265460	AC015910.1	NA	
ENSG00000108306	FBXL20	NA	
ENSG00000266469	AC005288.1	NA	
ENSG00000125686	MED1	NA	
ENSG00000167258	CDK12	NA	
ENSG00000222777	RNU6-233P	NA	
ENSG00000273576	AC009283.1	NA	
ENSG00000171532	NEUROD2	618374	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72
ENSG00000214546	AC087491.1	NA	
ENSG00000131771	PPP1R1B	NA	
ENSG00000131748	STARD3	NA	
ENSG00000173991	TCAP	601954	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7; LGMDR7;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G
ENSG00000173991	TCAP	607487	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25
ENSG00000141744	PNMT	NA	
ENSG00000161395	PGAP3	615716	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 10; GPIBD10
ENSG00000141736	ERBB2	137800	GLIOMA SUSCEPTIBILITY 1; GLM1 GLIOMA OF BRAIN, FAMILIAL, INCLUDED; GLM, INCLUDED;;GLIOBLASTOMA MULTIFORME, INCLUDED; GBM, INCLUDED;;ASTROCYTOMA, INCLUDED;;OLIGODENDROGLIOMA, INCLUDED;;EPENDYMOMA, INCLUDED;;SUBEPENDYMOMA, INCLUDED
ENSG00000141736	ERBB2	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000141736	ERBB2	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000265178	MIR4728	NA	
ENSG00000141741	MIEN1	NA	
ENSG00000141738	GRB7	NA	
ENSG00000161405	IKZF3	NA	
ENSG00000264663	KRT8P34	NA	
ENSG00000226117	AC090844.1	NA	
ENSG00000186075	ZPBP2	NA	
ENSG00000073605	GSDMB	NA	
ENSG00000172057	ORMDL3	NA	
ENSG00000264968	AC090844.2	NA	
ENSG00000204913	LRRC3C	NA	
ENSG00000167914	GSDMA	NA	
ENSG00000108344	PSMD3	NA	
ENSG00000265799	AC090844.3	NA	
ENSG00000108342	CSF3	NA	
ENSG00000008838	MED24	NA	
ENSG00000283721	MIR6884	NA	
ENSG00000238793	SNORD124	NA	
ENSG00000126351	THRA	614450	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6
ENSG00000126368	NR1D1	NA	
ENSG00000279199	AC068669.1	NA	
ENSG00000188895	MSL1	NA	
ENSG00000108349	CASC3	NA	
ENSG00000284144	MIR6866	NA	
ENSG00000108352	RAPGEFL1	NA	
ENSG00000274621	MIR6867	NA	
ENSG00000171475	WIPF2	NA	
ENSG00000094804	CDC6	613805	MEIER-GORLIN SYNDROME 5; MGORS5
ENSG00000131759	RARA	612376	ACUTE PROMYELOCYTIC LEUKEMIA; APL;;LEUKEMIA, ACUTE PROMYELOCYTIC
ENSG00000287644	AC080112.4	NA	
ENSG00000265666	RARA-AS1	NA	
ENSG00000278918	AC080112.3	NA	
ENSG00000183153	GJD3	NA	
ENSG00000266208	AC080112.1	NA	
ENSG00000264655	PPIAP54	NA	
ENSG00000252618	RNA5SP441	NA	
ENSG00000278346	AC080112.2	NA	
ENSG00000131747	TOP2A	NA	
ENSG00000222881	Y_RNA	NA	
ENSG00000240125	RPL23AP75	NA	
ENSG00000141753	IGFBP4	NA	
ENSG00000279806	AC018629.1	NA	
ENSG00000131746	TNS4	NA	
ENSG00000266088	AC004585.1	NA	
ENSG00000126353	CCR7	NA	
ENSG00000279775	AC004585.2	NA	
ENSG00000073584	SMARCE1	607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
ENSG00000073584	SMARCE1	616938	COFFIN-SIRIS SYNDROME 5; CSS5
ENSG00000264058	AC073508.2	NA	
ENSG00000278834	AC073508.3	NA	
ENSG00000213424	KRT222	NA	
ENSG00000224244	AC073508.1	NA	
ENSG00000167916	KRT24	NA	
ENSG00000229028	KRT223P	NA	
ENSG00000204897	KRT25	616760	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3; ARWH3;;WOOLLY HAIR, AUTOSOMAL RECESSIVE 3, WITH HYPOTRICHOSIS
ENSG00000186393	KRT26	NA	
ENSG00000171446	KRT27	NA	
ENSG00000173908	KRT28	NA	
ENSG00000264488	AC090283.1	NA	
ENSG00000186395	KRT10	113800	EPIDERMOLYTIC HYPERKERATOSIS; EHK;;BULLOUS ERYTHRODERMA ICHTHYOSIFORMIS CONGENITA OF BROCQ;;BULLOUS CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; BCIE;;BULLOUS ICHTHYOSIFORM ERYTHRODERMA; BIE;;EPIDERMOLYTIC ICHTHYOSIS EPIDERMOLYTIC HYPERKERATOSIS, LATE-ONS /.../CLUDED
ENSG00000186395	KRT10	607602	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS;;CIEHK;;EPIDERMOLYTIC ICHTHYOSIS, ANNULAR; AEI
ENSG00000186395	KRT10	609165	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE;;ICHTHYOSIS WITH CONFETTI; IWC;;ICHTHYOSIS VARIEGATA  ERYTHROKERATODERMA, RETICULAR, INCLUDED;;AARAU DISEASE, INCLUDED
ENSG00000167920	TMEM99	NA	
ENSG00000265359	AC004231.3	NA	
ENSG00000187242	KRT12	122100	CORNEAL DYSTROPHY, MEESMANN, 1; MECD1;;CORNEAL DYSTROPHY, MEESMANN EPITHELIAL; MECD;;MEESMANN CORNEAL DYSTROPHY;;CORNEAL DYSTROPHY, JUVENILE EPITHELIAL, OF MEESMANN
ENSG00000171431	KRT20	NA	
ENSG00000234477	AC004231.1	NA	
ENSG00000108244	KRT23	NA	
ENSG00000196859	KRT39	NA	
ENSG00000204889	KRT40	NA	
ENSG00000212899	KRTAP3-3	NA	
ENSG00000212900	KRTAP3-2	NA	
ENSG00000226776	KRTAP3-4P	NA	
ENSG00000212901	KRTAP3-1	NA	
ENSG00000221852	KRTAP1-5	NA	
ENSG00000204887	KRTAP1-4	NA	
ENSG00000221880	KRTAP1-3	NA	
ENSG00000188581	KRTAP1-1	NA	
ENSG00000212725	KRTAP2-1	NA	
ENSG00000214518	KRTAP2-2	NA	
ENSG00000212724	KRTAP2-3	NA	
ENSG00000213417	KRTAP2-4	NA	
ENSG00000237230	KRTAP2-5P	NA	
ENSG00000240871	KRTAP4-7	NA	
ENSG00000287602	AC100808.1	NA	
ENSG00000204880	KRTAP4-8	NA	
ENSG00000241241	KRTAP4-16	NA	
ENSG00000212722	KRTAP4-9	NA	
ENSG00000212721	KRTAP4-11	NA	
ENSG00000213416	KRTAP4-12	NA	
ENSG00000198090	KRTAP4-6	NA	
ENSG00000198271	KRTAP4-5	NA	
ENSG00000171396	KRTAP4-4	NA	
ENSG00000196156	KRTAP4-3	NA	
ENSG00000244537	KRTAP4-2	NA	
ENSG00000198443	KRTAP4-1	NA	
ENSG00000251439	KRTAP4-17P	NA	
ENSG00000240542	KRTAP9-1	NA	
ENSG00000248807	KRTAP9-12P	NA	
ENSG00000239886	KRTAP9-2	NA	
ENSG00000204873	KRTAP9-3	NA	
ENSG00000187272	KRTAP9-8	NA	
ENSG00000241595	KRTAP9-4	NA	
ENSG00000198083	KRTAP9-9	NA	
ENSG00000212659	KRTAP9-6	NA	
ENSG00000229351	KRTAP9-11P	NA	
ENSG00000180386	KRTAP9-7	NA	
ENSG00000237183	KRTAP9-10P	NA	
ENSG00000212658	KRTAP29-1	NA	
ENSG00000212657	KRTAP16-1	NA	
ENSG00000186860	KRTAP17-1	NA	
ENSG00000233014	TBC1D3P7	NA	
ENSG00000108516	AC003958.1	NA	
ENSG00000006059	KRT33A	NA	
ENSG00000131738	KRT33B	NA	
ENSG00000131737	KRT34	NA	
ENSG00000094796	KRT31	NA	
ENSG00000234859	AC003958.2	NA	
ENSG00000225438	KRT41P	NA	
ENSG00000108417	KRT37	NA	
ENSG00000171360	KRT38	NA	
ENSG00000236473	KRT43P	NA	
ENSG00000108759	KRT32	NA	
ENSG00000223125	RNU2-32P	NA	
ENSG00000197079	KRT35	NA	
ENSG00000126337	KRT36	NA	
ENSG00000171401	KRT13	615785	WHITE SPONGE NEVUS 2; WSN2
ENSG00000229732	AC019349.1	NA	
ENSG00000171346	KRT15	NA	
ENSG00000283796	MIR6510	NA	
ENSG00000171345	KRT19	NA	
ENSG00000226629	LINC00974	NA	
ENSG00000171403	KRT9	144200	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK;;PPKE;;KERATODERMA, EPIDERMOLYTIC PALMOPLANTAR;;PALMOPLANTAR KERATODERMA, VORNER TYPE;;HYPERKERATOSIS, LOCALIZED EPIDERMOLYTIC;;KERATOSIS PALMARIS ET PLANTARIS FAMILIARIS;;TYLOSIS;;KERATOSIS OF GREITHER  /.../LANTAR KERATODERMA, EPIDERMOLYTIC, WITH KNUCKLE PADS, INCLUDED
ENSG00000186847	KRT14	161000	NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME; NFJS;;NAEGELI SYNDROME;;NFJ SYNDROME
ENSG00000186847	KRT14	131900	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED;;EBS, GENERALIZED;;EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE
ENSG00000186847	KRT14	131800	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED;;EPIDERMOLYSIS BULLOSA SIMPLEX, WEBER-COCKAYNE TYPE;;EPIDERMOLYSIS BULLOSA OF HANDS AND FEET;;EBS, ACRAL FORM
ENSG00000186847	KRT14	131760	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM;;EPIDERMOLYSIS BULLOSA HERPETIFORMIS, DOWLING-MEARA TYPE;;EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE
ENSG00000186847	KRT14	125595	DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR
ENSG00000186847	KRT14	601001	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1
ENSG00000186832	KRT16	167200	PACHYONYCHIA CONGENITA 1; PC1;;PACHYONYCHIA CONGENITA, JADASSOHN-LEWANDOWSKY TYPE, FORMERLY;;JADASSOHN-LEWANDOWSKY SYNDROME, FORMERLY
ENSG00000186832	KRT16	613000	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1; FNEPPK1;;PPKFNE;;FOCAL NONEPIDERMOLYTIC PALMOPLANTAR KERATODERMA;;KERATODERMA, FOCAL NONEPIDERMOLYTIC PALMOPLANTAR
ENSG00000128422	KRT17	184500	STEATOCYSTOMA MULTIPLEX;;SEBACEOUS CYSTS, MULTIPLE
ENSG00000128422	KRT17	167210	PACHYONYCHIA CONGENITA 2; PC2;;PACHYONYCHIA CONGENITA, JACKSON-LAWLER TYPE, FORMERLY
ENSG00000214514	KRT42P	NA	
ENSG00000278954	AC130686.1	NA	
ENSG00000173812	EIF1	NA	
ENSG00000184502	GAST	NA	
ENSG00000173805	HAP1	NA	
ENSG00000201920	RNA5SP442	NA	
ENSG00000239542	RN7SL399P	NA	
ENSG00000173801	JUP	601214	NAXOS DISEASE; NXD;;CARDIOMYOPATHY, ARRHYTHMOGENIC RIGHT VENTRICULAR, WITH SKIN, HAIR, AND NAIL ABNORMALITIES;;MAL DE NAXOS;;KERATOSIS PALMOPLANTARIS WITH ARRHYTHMOGENIC CARDIOMYOPATHY;;WOOLLY HAIR, PALMOPLANTAR KERATODERMA, AND CARDIAC ABNORMALITIE /.../MOPLANTAR KERATODERMA WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY AND WOOLLY HAIR
ENSG00000173801	JUP	611528	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 12; ARVC12
ENSG00000141696	P3H4	NA	
ENSG00000141756	FKBP10	259450	BRUCK SYNDROME 1; BRKS1;;KUSKOKWIM DISEASE;;ARTHROGRYPOSIS-LIKE DISORDER
ENSG00000141756	FKBP10	610968	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11;;OI, TYPE XI
ENSG00000141698	NT5C3B	NA	
ENSG00000161594	KLHL10	615081	SPERMATOGENIC FAILURE 11; SPGF11
ENSG00000259623	AC125257.1	NA	
ENSG00000178502	KLHL11	NA	
ENSG00000131473	ACLY	NA	
ENSG00000274630	AC125257.2	NA	
ENSG00000204815	TTC25	617092	CILIARY DYSKINESIA, PRIMARY, 35; CILD35;;CILIARY DYSKINESIA, PRIMARY, 35, WITH OR WITHOUT SITUS INVERSUS
ENSG00000173786	CNP	NA	
ENSG00000168259	DNAJC7	NA	
ENSG00000168256	NKIRAS2	NA	
ENSG00000187595	ZNF385C	NA	
ENSG00000267221	C17orf113	NA	
ENSG00000108771	DHX58	NA	
ENSG00000108773	KAT2A	NA	
ENSG00000267261	AC099811.2	NA	
ENSG00000260325	HSPB9	NA	
ENSG00000108774	RAB5C	NA	
ENSG00000267658	AC099811.3	NA	
ENSG00000089558	KCNH4	NA	
ENSG00000161610	HCRT	161400	NARCOLEPSY 1; NRCLP1;;NARCOLEPTIC SYNDROME 1 CATAPLEXY, INCLUDED
ENSG00000167925	GHDC	NA	
ENSG00000173757	STAT5B	245590	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY;;LARON SYNDROME DUE TO POSTRECEPTOR DEFECT;;GROWTH HORMONE INSENSITIVITY DUE TO POSTRECEPTOR DEFECT
ENSG00000280295	AC099811.6	NA	
ENSG00000267758	AC099811.4	NA	
ENSG00000236194	AC099811.1	NA	
ENSG00000278829	AC099811.5	NA	
ENSG00000126561	STAT5A	NA	
ENSG00000168610	STAT3	147060	HYPER-IgE RECURRENT INFECTION SYNDROME 1, AUTOSOMAL DOMINANT; HIES1;;HYPER-IgE SYNDROME, AUTOSOMAL DOMINANT;;HIES, AUTOSOMAL DOMINANT;;JOB SYNDROME
ENSG00000168610	STAT3	615952	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1
ENSG00000177469	CAVIN1	613327	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4;;BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 4, WITH MUSCULAR DYSTROPHY;;LIPODYSTROPHY, BERARDINELLI-SEIP CONGENITAL, TYPE 4, WITH MUSCULAR DYSTROPHY
ENSG00000238704	RNU7-97P	NA	
ENSG00000033627	ATP6V0A1	NA	
ENSG00000264314	MIR548AT	NA	
ENSG00000267222	AC107993.1	NA	
ENSG00000267632	AC067852.3	NA	
ENSG00000283929	MIR5010	NA	
ENSG00000267185	PTP4A2P1	NA	
ENSG00000108784	NAGLU	252920	MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B;;MPS IIIB;;SANFILIPPO SYNDROME B;;N-ACETYL-ALPHA-D-GLUCOSAMINIDASE DEFICIENCY;;NAGLU DEFICIENCY
ENSG00000108784	NAGLU	616491	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2V;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2V
ENSG00000266929	AC067852.1	NA	
ENSG00000108785	HSD17B1P1	NA	
ENSG00000266962	AC067852.2	NA	
ENSG00000108786	HSD17B1	NA	
ENSG00000068120	COASY	615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6
ENSG00000068120	COASY	618266	PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12
ENSG00000108788	MLX	NA	
ENSG00000131470	PSMC3IP	614324	OVARIAN DYSGENESIS 3; ODG3
ENSG00000287710	AC067852.5	NA	
ENSG00000141699	RETREG3	NA	
ENSG00000280183	AC067852.4	NA	
ENSG00000131462	TUBG1	615412	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4
ENSG00000267189	ATP5MGP7	NA	
ENSG00000267132	HMGB3P27	NA	
ENSG00000037042	TUBG2	NA	
ENSG00000068137	PLEKHH3	NA	
ENSG00000184451	CCR10	NA	
ENSG00000267042	AC100793.2	NA	
ENSG00000108797	CNTNAP1	616286	LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7
ENSG00000108797	CNTNAP1	618186	NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3
ENSG00000267765	AC100793.3	NA	
ENSG00000108799	EZH1	NA	
ENSG00000275273	MIR6780A	NA	
ENSG00000239671	AC100793.1	NA	
ENSG00000273650	AC100793.4	NA	
ENSG00000214578	HMGN2P15	NA	
ENSG00000197291	RAMP2-AS1	NA	
ENSG00000131477	RAMP2	NA	
ENSG00000131475	VPS25	NA	
ENSG00000126562	WNK4	614491	PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B
ENSG00000183978	COA3	NA	
ENSG00000176563	CNTD1	NA	
ENSG00000126581	BECN1	NA	
ENSG00000278447	MIR6781	NA	
ENSG00000131467	PSME3	NA	
ENSG00000131480	AOC2	NA	
ENSG00000131471	AOC3	NA	
ENSG00000260105	AOC4P	NA	
ENSG00000213373	LINC00671	NA	
ENSG00000252039	RNU6-287P	NA	
ENSG00000131482	G6PC	232200	GLYCOGEN STORAGE DISEASE Ia; GSD1A;;GSD Ia;;GLYCOGEN STORAGE DISEASE I; GSD1;;VON GIERKE DISEASE;;HEPATORENAL FORM OF GLYCOGEN STORAGE DISEASE;;GLUCOSE-6-PHOSPHATASE DEFICIENCY;;HEPATORENAL GLYCOGENOSIS
ENSG00000212149	AC055866.1	NA	
ENSG00000266967	AARSD1	NA	
ENSG00000108825	PTGES3L-AARSD1	NA	
ENSG00000267060	PTGES3L	NA	
ENSG00000198863	RUNDC1	NA	
ENSG00000131469	RPL27	617408	DIAMOND-BLACKFAN ANEMIA 16; DBA16
ENSG00000068079	IFI35	NA	
ENSG00000108828	VAT1	NA	
ENSG00000108830	RND2	NA	
ENSG00000012048	BRCA1	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000012048	BRCA1	604370	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1 BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED;;OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED
ENSG00000012048	BRCA1	614320	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4
ENSG00000012048	BRCA1	617883	FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS
ENSG00000240828	RPL21P4	NA	
ENSG00000198496	NBR2	NA	
ENSG00000285057	AC135721.2	NA	
ENSG00000267681	AC135721.1	NA	
ENSG00000267002	AC060780.1	NA	
ENSG00000267595	AC060780.3	NA	
ENSG00000267340	AC060780.2	NA	
ENSG00000188554	NBR1	NA	
ENSG00000184988	TMEM106A	NA	
ENSG00000236383	CCDC200	NA	
ENSG00000274585	RNU2-1	NA	
ENSG00000275616	U2	NA	
ENSG00000273709	U2	NA	
ENSG00000274432	U2	NA	
ENSG00000278048	U2	NA	
ENSG00000276596	U2	NA	
ENSG00000277903	U2	NA	
ENSG00000278774	U2	NA	
ENSG00000274862	U2	NA	
ENSG00000274062	U2	NA	
ENSG00000274452	U2	NA	
ENSG00000275219	U2	NA	
ENSG00000278591	U2	NA	
ENSG00000188825	LINC00910	NA	
ENSG00000279602	AC109326.1	NA	
ENSG00000277084	RNU2-4P	NA	
ENSG00000252882	RNU6-1137P	NA	
ENSG00000175906	ARL4D	NA	
ENSG00000251763	RNU6-470P	NA	
ENSG00000267151	MIR2117HG	NA	
ENSG00000284344	MIR2117	NA	
ENSG00000252279	RNU6-406P	NA	
ENSG00000252729	RNU6-971P	NA	
ENSG00000237888	AC087650.1	NA	
ENSG00000067596	DHX8	NA	
ENSG00000175832	ETV4	NA	
ENSG00000278109	Metazoa_SRP	NA	
ENSG00000005102	MEOX1	214300	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2;;KFS, AUTOSOMAL RECESSIVE;;CERVICAL VERTEBRAL FUSION, AUTOSOMAL RECESSIVE
ENSG00000267440	LINC02594	NA	
ENSG00000267253	WHSC1L2P	NA	
ENSG00000167941	SOST	122860	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD
ENSG00000167941	SOST	239100	VAN BUCHEM DISEASE; VBCH;;HYPEROSTOSIS CORTICALIS GENERALISATA;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE
ENSG00000167941	SOST	269500	SCLEROSTEOSIS 1; SOST1;;SOST;;CORTICAL HYPEROSTOSIS WITH SYNDACTYLY
ENSG00000108861	DUSP3	NA	
ENSG00000231256	CFAP97D1	NA	
ENSG00000267604	AC003098.1	NA	
ENSG00000161647	MPP3	NA	
ENSG00000161649	CD300LG	NA	
ENSG00000108852	MPP2	NA	
ENSG00000282199	AC007993.3	NA	
ENSG00000267496	FAM215A	NA	
ENSG00000267166	AC007993.1	NA	
ENSG00000267420	AC007993.2	NA	
ENSG00000261514	LINC01976	NA	
ENSG00000108849	PPY	NA	
ENSG00000131096	PYY	NA	
ENSG00000161653	NAGS	237310	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD;;HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY;;N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY;;NAGS DEFICIENCY
ENSG00000091947	TMEM101	NA	
ENSG00000221044	U3	NA	
ENSG00000161654	LSM12	NA	
ENSG00000141349	G6PC3	612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4 DURSUN SYNDROME, INCLUDED;;PULMONARY ARTERIAL HYPERTENSION, LEUKOPENIA, AND ATRIAL SEPTAL DEFECT, INCLUDED
ENSG00000108840	HDAC5	NA	
ENSG00000267638	AC023855.1	NA	
ENSG00000212446	RNU6-131P	NA	
ENSG00000125319	HROB	NA	
ENSG00000161664	ASB16	NA	
ENSG00000267080	ASB16-AS1	NA	
ENSG00000168591	TMUB2	NA	
ENSG00000087152	ATXN7L3	NA	
ENSG00000267394	AC004596.1	NA	
ENSG00000108312	UBTF	617672	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA
ENSG00000275107	MIR6782	NA	
ENSG00000260793	AC003102.1	NA	
ENSG00000267691	SHC1P2	NA	
ENSG00000004939	SLC4A1	185020	CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE
ENSG00000004939	SLC4A1	179800	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT;;RTA, DISTAL TYPE, AUTOSOMAL DOMINANT;;RENAL TUBULAR ACIDOSIS I;;RTA, CLASSIC TYPE;;RTA, GRADIENT TYPE
ENSG00000004939	SLC4A1	166900	OVALOCYTOSIS, SOUTHEAST ASIAN; SAO;;OVALOCYTOSIS, MALAYSIAN-MELANESIAN-FILIPINO TYPE;;ELLIPTOCYTOSIS 4; EL4;;ELLIPTOCYTOSIS, STOMATOCYTIC HEREDITARY;;HE, STOMATOCYTIC
ENSG00000004939	SLC4A1	112050	BLOOD GROUP--WRIGHT ANTIGEN; WR;;WRIGHT BLOOD GROUP ANTIGEN
ENSG00000004939	SLC4A1	112010	BLOOD GROUP--WALDNER TYPE; WD;;WALDNER BLOOD GROUP ANTIGEN
ENSG00000004939	SLC4A1	110500	BLOOD GROUP, DIEGO SYSTEM; DI;;DIEGO BLOOD GROUP SYSTEM
ENSG00000004939	SLC4A1	109270	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1;;BAND 3 OF RED CELL MEMBRANE; BND3;;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;;ERYTHROID PROTEIN BAND 3; EPB3;;ANION EXCHANGE PROTEIN 1; AE1 ACANTHOCYTOSIS, ONE FORM OF, INCLUDED
ENSG00000004939	SLC4A1	601550	BLOOD GROUP--SWANN SYSTEM; SW;;SWANN BLOOD GROUP
ENSG00000004939	SLC4A1	601551	BLOOD GROUP--FROESE;;FR;;FROESE BLOOD GROUP ANTIGEN
ENSG00000004939	SLC4A1	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000004939	SLC4A1	611590	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA;;RTA, DISTAL, AUTOSOMAL RECESSIVE, WITH HEMOLYTIC ANEMIA  RENAL TUBULAR ACIDOSIS, DISTAL, WITH NORMAL RED CELL MORPHOLOGY, INCLUDED
ENSG00000004939	SLC4A1	612653	SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4
ENSG00000285486	AC003043.2	NA	
ENSG00000239702	RN7SL507P	NA	
ENSG00000267750	RUNDC3A-AS1	NA	
ENSG00000221496	U3	NA	
ENSG00000252628	RNU6-453P	NA	
ENSG00000108309	RUNDC3A	NA	
ENSG00000013306	SLC25A39	NA	
ENSG00000267211	AC003043.1	NA	
ENSG00000030582	GRN	607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED;;FTLD-TDP, GRN-RELATED;;FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED;;FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS; FTLDU;;FRONTOTEMPORAL DEME /.../UBIQUITIN-POSITIVE; FTDU;;DEMENTIA, HEREDITARY DYSPHASIC DISINHIBITION; HDDD APHASIA, PRIMARY PROGRESSIVE, INCLUDED; PPA, INCLUDED
ENSG00000030582	GRN	614706	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11
ENSG00000161682	FAM171A2	NA	
ENSG00000267634	RPL7L1P5	NA	
ENSG00000005961	ITGA2B	187800	BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16;;GLANZMANN THROMBASTHENIA, AUTOSOMAL DOMINANT;;THROMBASTHENIA OF GLANZMANN AND NAEGELI, AUTOSOMAL DOMINANT
ENSG00000005961	ITGA2B	273800	GLANZMANN THROMBASTHENIA; GT;;BLEEDING DISORDER, PLATELET-TYPE, 2; BDPLT2;;THROMBASTHENIA OF GLANZMANN AND NAEGELI;;PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY;;GP IIb-IIIa COMPLEX, DEFICIENCY OF;;PLATELET FIBRINOGEN RECEPTOR, DEFICIENCY OF;;GLYCOPROT /.../MPLEX IIb-IIIa, DEFICIENCY OF
ENSG00000186566	GPATCH8	NA	
ENSG00000240589	RN7SL258P	NA	
ENSG00000283045	AC103703.1	NA	
ENSG00000180340	FZD2	164745	OMODYSPLASIA 2; OMOD2;;OMODYSPLASIA, AUTOSOMAL DOMINANT
ENSG00000271222	AC091152.3	NA	
ENSG00000267384	SMCO4P1	NA	
ENSG00000266979	LINC01180	NA	
ENSG00000180336	MEIOC	NA	
ENSG00000180329	CCDC43	NA	
ENSG00000267160	AC091152.2	NA	
ENSG00000279879	AC091152.4	NA	
ENSG00000161692	DBF4B	NA	
ENSG00000264251	RN7SL819P	NA	
ENSG00000240305	AC091152.1	NA	
ENSG00000073670	ADAM11	NA	
ENSG00000267505	AC005180.2	NA	
ENSG00000267405	AC005180.1	NA	
ENSG00000182963	GJC1	NA	
ENSG00000131097	HIGD1B	NA	
ENSG00000108883	EFTUD2	610536	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA;;MANDIBULOFACIAL DYSOSTOSIS WITH MICROCEPHALY; MFDM;;GROWTH AND MENTAL RETARDATION, MANDIBULOFACIAL DYSOSTOSIS, MICROCEPHALY, AND CLEFT PALATE
ENSG00000264540	RN7SL405P	NA	
ENSG00000167131	CCDC103	614679	CILIARY DYSKINESIA, PRIMARY, 17; CILD17;;CILIARY DYSKINESIA, PRIMARY, 17, WITH OR WITHOUT SITUS INVERSUS
ENSG00000214447	FAM187A	NA	
ENSG00000131095	GFAP	203450	ALEXANDER DISEASE; ALXDRD
ENSG00000186185	KIF18B	NA	
ENSG00000278223	MIR6783	NA	
ENSG00000267334	AC015936.1	NA	
ENSG00000131094	C1QL1	NA	
ENSG00000267788	AC015936.2	NA	
ENSG00000172992	DCAKD	NA	
ENSG00000136448	NMT1	NA	
ENSG00000200888	Y_RNA	NA	
ENSG00000161714	PLCD3	NA	
ENSG00000277249	MIR6784	NA	
ENSG00000181513	ACBD4	NA	
ENSG00000276728	AC142472.1	NA	
ENSG00000186834	HEXIM1	NA	
ENSG00000224505	AC138150.1	NA	
ENSG00000168517	HEXIM2	NA	
ENSG00000267288	AC138150.2	NA	
ENSG00000267121	AC008105.3	NA	
ENSG00000184922	FMNL1	NA	
ENSG00000233175	AC008105.1	NA	
ENSG00000233483	AC008105.2	NA	
ENSG00000267278	MAP3K14-AS1	NA	
ENSG00000184361	SPATA32	NA	
ENSG00000006062	MAP3K14	NA	
ENSG00000199953	RNA5SP443	NA	
ENSG00000267446	AC003070.2	NA	
ENSG00000159314	ARHGAP27	NA	
ENSG00000267344	AC003070.1	NA	
ENSG00000225190	PLEKHM1	611497	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6;;OSTEOPETROSIS, AUTOSOMAL RECESSIVE, INTERMEDIATE FORM
ENSG00000225190	PLEKHM1	618107	OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3
ENSG00000236234	AC091132.2	NA	
ENSG00000284055	MIR4315-1	NA	
ENSG00000214425	LRRC37A4P	NA	
ENSG00000278770	Metazoa_SRP	NA	
ENSG00000266918	AC091132.3	NA	
ENSG00000131484	AC091132.1	NA	
ENSG00000267198	AC091132.4	NA	
ENSG00000267246	AC091132.5	NA	
ENSG00000266504	RDM1P1	NA	
ENSG00000264070	DND1P1	NA	
ENSG00000285668	AC126544.2	NA	
ENSG00000280022	AC126544.1	NA	
ENSG00000263503	MAPK8IP1P2	NA	
ENSG00000204652	RPS26P8	NA	
ENSG00000204650	LINC02210	NA	
ENSG00000263715	LINC02210-CRHR1	NA	
ENSG00000265547	AC217774.1	NA	
ENSG00000265964	AC217774.2	NA	
ENSG00000120088	CRHR1	NA	
ENSG00000264589	MAPT-AS1	NA	
ENSG00000185294	SPPL2C	NA	
ENSG00000186868	MAPT	172700	PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS
ENSG00000186868	MAPT	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000186868	MAPT	260540	PARKINSON-DEMENTIA SYNDROME SUPRANUCLEAR PALSY, PROGRESSIVE, 1, ATYPICAL, INCLUDED;;STEELE-RICHARDSON-OLSZEWSKI SYNDROME, ATYPICAL, INCLUDED
ENSG00000186868	MAPT	600274	FRONTOTEMPORAL DEMENTIA; FTD;;FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU INCLUSIONS;;FTLD WITH TAU INCLUSIONS;;DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM;;FRONTOTEMPORAL DEMENTIA WITH PARKINSONISM;;FRONTOTEMPORAL LOBE DEMENTIA; FLDEM;;FTDP17;;MULTI /.../STEM TAUOPATHY WITH PRESENILE DEMENTIA; MSTD;;DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX; DDPAC;;WILHELMSEN-LYNCH DISEASE; WLD;;PALLIDOPONTONIGRAL DEGENERATION; PPND PICK COMPLEX, INCLUDED
ENSG00000186868	MAPT	601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1;;PSP;;STEELE-RICHARDSON-OLSZEWSKI SYNDROME
ENSG00000279685	MAPT-IT1	NA	
ENSG00000262881	CR936218.2	NA	
ENSG00000274883	CR936218.3	NA	
ENSG00000256762	STH	NA	
ENSG00000120071	KANSL1	610443	KOOLEN-DE VRIES SYNDROME; KDVS;;CHROMOSOME 17q21.31 DELETION SYNDROME;;MICRODELETION 17q21.31 SYNDROME
ENSG00000262372	CR936218.1	NA	
ENSG00000214401	KANSL1-AS1	NA	
ENSG00000238723	AC217773.1	NA	
ENSG00000262500	MAPK8IP1P1	NA	
ENSG00000262539	AC005829.2	NA	
ENSG00000261575	AC005829.1	NA	
ENSG00000228696	ARL17B	NA	
ENSG00000176681	LRRC37A	NA	
ENSG00000265411	RN7SL656P	NA	
ENSG00000260075	NSFP1	NA	
ENSG00000266497	RDM1P2	NA	
ENSG00000238083	LRRC37A2	NA	
ENSG00000185829	ARL17A	NA	
ENSG00000265315	RN7SL199P	NA	
ENSG00000232300	FAM215B	NA	
ENSG00000073969	NSF	NA	
ENSG00000213326	RPS7P11	NA	
ENSG00000108379	WNT3	273395	TETRAAMELIA SYNDROME 1; TETAMS1;;TETRAAMELIA SYNDROME, AUTOSOMAL RECESSIVE
ENSG00000158955	WNT9B	NA	
ENSG00000262031	LINC01974	NA	
ENSG00000261886	AC005670.1	NA	
ENSG00000210709	RNU6ATAC3P	NA	
ENSG00000108433	GOSR2	614018	EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6
ENSG00000262633	AC005670.2	NA	
ENSG00000264999	MIR5089	NA	
ENSG00000179673	RPRML	NA	
ENSG00000263142	LRRC37A17P	NA	
ENSG00000262879	AC005670.3	NA	
ENSG00000277198	RN7SL270P	NA	
ENSG00000004897	CDC27	NA	
ENSG00000239291	AC002558.1	NA	
ENSG00000262265	AC002558.3	NA	
ENSG00000261872	AC002558.2	NA	
ENSG00000198336	MYL4	617280	ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18
ENSG00000259207	ITGB3	187800	BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16;;GLANZMANN THROMBASTHENIA, AUTOSOMAL DOMINANT;;THROMBASTHENIA OF GLANZMANN AND NAEGELI, AUTOSOMAL DOMINANT
ENSG00000259207	ITGB3	273800	GLANZMANN THROMBASTHENIA; GT;;BLEEDING DISORDER, PLATELET-TYPE, 2; BDPLT2;;THROMBASTHENIA OF GLANZMANN AND NAEGELI;;PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY;;GP IIb-IIIa COMPLEX, DEFICIENCY OF;;PLATELET FIBRINOGEN RECEPTOR, DEFICIENCY OF;;GLYCOPROT /.../MPLEX IIb-IIIa, DEFICIENCY OF
ENSG00000259207	ITGB3	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000259753	AC068234.1	NA	
ENSG00000238419	RNU7-186P	NA	
ENSG00000276790	AC068234.2	NA	
ENSG00000263293	THCAT158	NA	
ENSG00000178852	EFCAB13	NA	
ENSG00000253347	AC040934.1	NA	
ENSG00000228782	MRPL45P2	NA	
ENSG00000141279	NPEPPS	NA	
ENSG00000206734	Y_RNA	NA	
ENSG00000263766	AC025682.1	NA	
ENSG00000108424	KPNB1	NA	
ENSG00000264558	AC015674.1	NA	
ENSG00000198933	TBKBP1	NA	
ENSG00000073861	TBX21	208550	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE;;ASA TRIAD ASTHMA, ASPIRIN-INDUCED, SUSCEPTIBILITY TO, INCLUDED;;ASTHMA AND NASAL POLYPS, INCLUDED
ENSG00000006025	OSBPL7	NA	
ENSG00000159111	MRPL10	NA	
ENSG00000141294	LRRC46	NA	
ENSG00000141295	SCRN2	NA	
ENSG00000189120	SP6	NA	
ENSG00000264243	AC018521.3	NA	
ENSG00000266821	AC018521.7	NA	
ENSG00000264920	AC018521.5	NA	
ENSG00000167182	SP2	NA	
ENSG00000234494	SP2-AS1	NA	
ENSG00000266601	AC018521.6	NA	
ENSG00000108439	PNPO	610090	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD;;PNPO DEFICIENCY;;SEIZURES, PYRIDOXINE-RESISTANT, PLP-SENSITIVE;;EPILEPTIC ENCEPHALOPATHY, NEONATAL, PNPO-RELATED
ENSG00000263798	AC018521.1	NA	
ENSG00000264019	AC018521.2	NA	
ENSG00000167183	PRR15L	NA	
ENSG00000108465	CDK5RAP3	NA	
ENSG00000264701	AC018521.4	NA	
ENSG00000005243	COPZ2	NA	
ENSG00000207947	MIR152	NA	
ENSG00000263412	NFE2L1-DT	NA	
ENSG00000082641	NFE2L1	NA	
ENSG00000266341	AC004477.1	NA	
ENSG00000278765	AC004477.2	NA	
ENSG00000108468	CBX1	NA	
ENSG00000206954	RNU6-1201P	NA	
ENSG00000002919	SNX11	NA	
ENSG00000141293	SKAP1	NA	
ENSG00000221739	MIR1203	NA	
ENSG00000263787	SKAP1-AS1	NA	
ENSG00000207306	RNU6-1152P	NA	
ENSG00000235300	THRA1/BTR	NA	
ENSG00000266222	AC036222.2	NA	
ENSG00000200538	U3	NA	
ENSG00000264451	AC036222.1	NA	
ENSG00000206805	Y_RNA	NA	
ENSG00000120094	HOXB1	614744	FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3
ENSG00000173917	HOXB2	NA	
ENSG00000230148	HOXB-AS1	NA	
ENSG00000120093	HOXB3	NA	
ENSG00000233101	HOXB-AS3	NA	
ENSG00000239552	HOXB-AS2	NA	
ENSG00000182742	HOXB4	NA	
ENSG00000257178	AC103702.1	NA	
ENSG00000284038	MIR10A	NA	
ENSG00000120075	HOXB5	NA	
ENSG00000108511	HOXB6	NA	
ENSG00000260027	HOXB7	NA	
ENSG00000120068	HOXB8	NA	
ENSG00000170689	HOXB9	NA	
ENSG00000242207	HOXB-AS4	NA	
ENSG00000210741	MIR196A1	NA	
ENSG00000272763	AC103702.2	NA	
ENSG00000244649	LINC02086	NA	
ENSG00000244559	AC091179.2	NA	
ENSG00000242067	RPL9P28	NA	
ENSG00000241788	COX6B1P2	NA	
ENSG00000159182	PRAC1	NA	
ENSG00000229637	PRAC2	NA	
ENSG00000273750	AC091179.3	NA	
ENSG00000277542	AC091179.4	NA	
ENSG00000263602	MIR3185	NA	
ENSG00000159184	HOXB13	610997	PROSTATE CANCER, HEREDITARY, 9; HPC9
ENSG00000242407	AC091179.1	NA	
ENSG00000170703	TTLL6	NA	
ENSG00000244514	RN7SL125P	NA	
ENSG00000136436	CALCOCO2	NA	
ENSG00000248278	SUMO2P17	NA	
ENSG00000212565	AC068531.1	NA	
ENSG00000248895	AC068531.2	NA	
ENSG00000159199	ATP5MC1	NA	
ENSG00000270781	AC091133.6	NA	
ENSG00000159202	UBE2Z	NA	
ENSG00000159210	SNF8	NA	
ENSG00000230532	AC091133.1	NA	
ENSG00000200903	RNU1-42P	NA	
ENSG00000238804	AC091133.2	NA	
ENSG00000159224	GIP	NA	
ENSG00000250838	AC091133.3	NA	
ENSG00000159217	IGF2BP1	NA	
ENSG00000251461	AC091133.4	NA	
ENSG00000255851	Metazoa_SRP	NA	
ENSG00000252636	RNU6-826P	NA	
ENSG00000251550	AC091133.5	NA	
ENSG00000248883	B4GALNT2P1	NA	
ENSG00000167080	B4GALNT2	NA	
ENSG00000240995	AC069454.1	NA	
ENSG00000167083	GNGT2	NA	
ENSG00000108798	ABI3	NA	
ENSG00000173868	PHOSPHO1	NA	
ENSG00000177369	FLJ40194	NA	
ENSG00000273500	MIR6129	NA	
ENSG00000198740	ZNF652	NA	
ENSG00000248714	AC091180.2	NA	
ENSG00000262039	AC091180.5	NA	
ENSG00000250948	AC091180.4	NA	
ENSG00000186244	AC091180.1	NA	
ENSG00000167085	PHB	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000250186	AC091180.3	NA	
ENSG00000207127	Y_RNA	NA	
ENSG00000229944	EIF4EP2	NA	
ENSG00000249497	LINC02075	NA	
ENSG00000279036	AC015656.1	NA	
ENSG00000064300	NGFR	NA	
ENSG00000249906	AC006487.1	NA	
ENSG00000277478	MIR6165	NA	
ENSG00000250310	AC006487.2	NA	
ENSG00000182575	NXPH3	NA	
ENSG00000121067	SPOP	618828	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND DYSMORPHIC FACIES; NEDMIDF
ENSG00000121067	SPOP	618829	NEURODEVELOPMENTAL DISORDER WITH RELATIVE MACROCEPHALY AND WITH OR WITHOUT CARDIAC OR ENDOCRINE ANOMALIES; NEDMACE
ENSG00000121073	SLC35B1	NA	
ENSG00000250751	AC015795.1	NA	
ENSG00000121104	FAM117A	NA	
ENSG00000136504	KAT7	NA	
ENSG00000235183	SRP14P3	NA	
ENSG00000262837	AC027801.5	NA	
ENSG00000176358	TAC4	NA	
ENSG00000204584	AC027801.1	NA	
ENSG00000248954	AC027801.2	NA	
ENSG00000254039	AC027801.4	NA	
ENSG00000249176	AC027801.3	NA	
ENSG00000199492	RNU6-1313P	NA	
ENSG00000108813	DLX4	616788	OROFACIAL CLEFT 15; OFC15
ENSG00000064195	DLX3	104510	AMELOGENESIS IMPERFECTA, TYPE IV; AI4;;AMELOGENESIS IMPERFECTA, HYPOMATURATION-HYPOPLASTIC TYPE, WITH TAURODONTISM; AIHHT
ENSG00000064195	DLX3	190320	TRICHODENTOOSSEOUS SYNDROME; TDO;;TDO SYNDROME
ENSG00000248172	AC009720.1	NA	
ENSG00000246640	PICART1	NA	
ENSG00000005884	ITGA3	614748	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB
ENSG00000276851	AC002401.4	NA	
ENSG00000005882	PDK2	NA	
ENSG00000275025	AC002401.3	NA	
ENSG00000250282	AC002401.2	NA	
ENSG00000167100	SAMD14	NA	
ENSG00000108819	PPP1R9B	NA	
ENSG00000236472	AC002401.1	NA	
ENSG00000253730	AC015909.2	NA	
ENSG00000261959	AC015909.3	NA	
ENSG00000108823	SGCA	608099	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY
ENSG00000188662	H1-9P	NA	
ENSG00000108821	COL1A1	166710	OSTEOPOROSIS;;BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS; BMND;;OSTEOPOROSIS, POSTMENOPAUSAL;;OSTEOPOROSIS, INVOLUTIONAL  FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED
ENSG00000108821	COL1A1	166220	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4;;OI, TYPE IV;;OSTEOGENESIS IMPERFECTA WITH NORMAL SCLERAE
ENSG00000108821	COL1A1	166210	OSTEOGENESIS IMPERFECTA, TYPE II; OI2;;OI, TYPE II;;OSTEOGENESIS IMPERFECTA CONGENITA, PERINATAL LETHAL FORM;;OSTEOGENESIS IMPERFECTA CONGENITA; OIC;;VROLIK TYPE OF OSTEOGENESIS IMPERFECTA
ENSG00000108821	COL1A1	166200	OSTEOGENESIS IMPERFECTA, TYPE I; OI1;;OI, TYPE I;;OSTEOGENESIS IMPERFECTA TARDA;;OSTEOGENESIS IMPERFECTA WITH BLUE SCLERAE
ENSG00000108821	COL1A1	130060	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1;;EHLERS-DANLOS SYNDROME, TYPE VIIA, AUTOSOMAL DOMINANT; EDS7A;;EDS VIIA;;ARTHROCHALASIS MULTIPLEX CONGENITA;;EDS VII, MUTANT PROCOLLAGEN TYPE
ENSG00000108821	COL1A1	120150	COLLAGEN, TYPE I, ALPHA-1; COL1A1;;COLLAGEN OF SKIN, TENDON, AND BONE, ALPHA-1 CHAIN COL1A1/PDGFB FUSION GENE, INCLUDED;;OI/EDS COMBINED SYNDROME, INCLUDED
ENSG00000108821	COL1A1	114000	CAFFEY DISEASE; CAFYD;;INFANTILE CORTICAL HYPEROSTOSIS
ENSG00000108821	COL1A1	259420	OSTEOGENESIS IMPERFECTA, TYPE III; OI3;;OI, TYPE III;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
ENSG00000249406	AC015909.1	NA	
ENSG00000263176	AC015909.4	NA	
ENSG00000249838	SUMO2P7	NA	
ENSG00000167105	TMEM92	NA	
ENSG00000251179	TMEM92-AS1	NA	
ENSG00000015532	XYLT2	264800	PSEUDOXANTHOMA ELASTICUM; PXE;;GRONBLAD-STRANDBERG SYNDROME PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF, INCLUDED;;PXE, MODIFIER OF SEVERITY OF, INCLUDED
ENSG00000015532	XYLT2	605822	SPONDYLOOCULAR SYNDROME; SOS
ENSG00000279792	AC015909.5	NA	
ENSG00000108826	MRPL27	NA	
ENSG00000154920	EME1	NA	
ENSG00000108829	LRRC59	NA	
ENSG00000206824	Y_RNA	NA	
ENSG00000253102	AC004707.1	NA	
ENSG00000167107	ACSF2	NA	
ENSG00000262759	MRPS21P9	NA	
ENSG00000136457	CHAD	NA	
ENSG00000275897	AC021491.4	NA	
ENSG00000136444	RSAD1	NA	
ENSG00000249451	AC021491.1	NA	
ENSG00000136449	MYCBPAP	NA	
ENSG00000250286	AC021491.2	NA	
ENSG00000049283	EPN3	NA	
ENSG00000006282	SPATA20	NA	
ENSG00000250107	CACNA1G-AS1	NA	
ENSG00000006283	CACNA1G	616795	SPINOCEREBELLAR ATAXIA 42; SCA42
ENSG00000006283	CACNA1G	618087	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND
ENSG00000250976	AC021491.3	NA	
ENSG00000251239	AC004590.1	NA	
ENSG00000108846	ABCC3	NA	
ENSG00000154945	ANKRD40	NA	
ENSG00000262967	AC005921.2	NA	
ENSG00000201340	Y_RNA	NA	
ENSG00000108848	LUC7L3	NA	
ENSG00000278963	AC005921.3	NA	
ENSG00000167117	ANKRD40CL	NA	
ENSG00000278672	MIR8059	NA	
ENSG00000285829	AC005921.4	NA	
ENSG00000248702	AC005921.1	NA	
ENSG00000173714	WFIKKN2	NA	
ENSG00000261976	AC091062.1	NA	
ENSG00000243521	RPL5P33	NA	
ENSG00000141232	TOB1	NA	
ENSG00000229980	TOB1-AS1	NA	
ENSG00000262006	AC005920.4	NA	
ENSG00000247011	AC005920.1	NA	
ENSG00000251665	AC005920.3	NA	
ENSG00000008294	SPAG9	NA	
ENSG00000249870	AC005920.2	NA	
ENSG00000239672	NME1	NA	
ENSG00000011052	NME1-NME2	NA	
ENSG00000243678	NME2	NA	
ENSG00000011258	MBTD1	NA	
ENSG00000279089	AC005839.1	NA	
ENSG00000264895	AC006141.1	NA	
ENSG00000011260	UTP18	NA	
ENSG00000249383	LINC02071	NA	
ENSG00000249982	AC005823.2	NA	
ENSG00000249658	AC005823.1	NA	
ENSG00000267452	LINC02073	NA	
ENSG00000187504	RPL7P48	NA	
ENSG00000154975	CA10	NA	
ENSG00000279743	AC002090.1	NA	
ENSG00000263317	LINC01982	NA	
ENSG00000226364	LINC02089	NA	
ENSG00000227011	LINC02876	NA	
ENSG00000262902	MTCO1P40	NA	
ENSG00000285939	AC034268.2	NA	
ENSG00000263252	AC005341.1	NA	
ENSG00000262271	AC090079.1	NA	
ENSG00000262518	AC090079.2	NA	
ENSG00000262384	AC034268.1	NA	
ENSG00000233380	RPS2P48	NA	
ENSG00000141200	KIF2B	NA	
ENSG00000263189	AC023934.1	NA	
ENSG00000261965	ISCA1P3	NA	
ENSG00000288036	AC015943.1	NA	
ENSG00000263199	AC005951.1	NA	
ENSG00000263125	ARL2BPP8	NA	
ENSG00000251809	RN7SKP14	NA	
ENSG00000141198	TOM1L1	NA	
ENSG00000166260	COX11	NA	
ENSG00000279059	AC007485.2	NA	
ENSG00000275710	AC007485.1	NA	
ENSG00000166263	STXBP4	NA	
ENSG00000108924	HLF	NA	
ENSG00000263096	AC007638.2	NA	
ENSG00000262079	AC007638.1	NA	
ENSG00000108960	MMD	NA	
ENSG00000261873	SMIM36	NA	
ENSG00000236319	AC105021.1	NA	
ENSG00000262135	GARS1P1	NA	
ENSG00000200107	RNU6-1249P	NA	
ENSG00000166292	TMEM100	NA	
ENSG00000141179	PCTP	NA	
ENSG00000262052	AC090618.1	NA	
ENSG00000153930	ANKFN1	NA	
ENSG00000261882	AC006600.1	NA	
ENSG00000279606	AC006600.2	NA	
ENSG00000243058	RPL39P33	NA	
ENSG00000183691	NOG	186570	TARSAL-CARPAL COALITION SYNDROME; TCC SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED
ENSG00000183691	NOG	186500	MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME
ENSG00000183691	NOG	185800	SYMPHALANGISM, PROXIMAL, 1A; SYM1A;;SYM1;;CUSHING SYMPHALANGISM;;HEREDITARY ABSENCE OF THE PROXIMAL INTERPHALANGEAL JOINTS
ENSG00000183691	NOG	184460	STAPES ANKYLOSIS WITH BROAD THUMBS AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, AND SYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM
ENSG00000183691	NOG	611377	BRACHYDACTYLY, TYPE B2; BDB2
ENSG00000214226	C17orf67	NA	
ENSG00000283209	AC106858.1	NA	
ENSG00000153933	DGKE	615008	NEPHROTIC SYNDROME, TYPE 7; NPHS7;;NEPHROTIC SYNDROME, TYPE 7, WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS  HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 7, INCLUDED; AHUS7, INCLUDED;;AHUS, SUSCEPTIBILITY TO, 7, INCLUDED
ENSG00000121060	TRIM25	NA	
ENSG00000212469	RNU6-1158P	NA	
ENSG00000262408	AC015912.2	NA	
ENSG00000262112	AC015912.1	NA	
ENSG00000284542	MIR3614	NA	
ENSG00000274213	AC015912.3	NA	
ENSG00000121058	COIL	NA	
ENSG00000262298	AC004584.1	NA	
ENSG00000262623	AC004584.2	NA	
ENSG00000121064	SCPEP1	NA	
ENSG00000263120	AC004584.3	NA	
ENSG00000261192	RNF126P1	NA	
ENSG00000263004	AC007114.1	NA	
ENSG00000121057	AKAP1	NA	
ENSG00000263089	AC007114.2	NA	
ENSG00000285785	AC003950.1	NA	
ENSG00000286732	AC091181.2	NA	
ENSG00000153944	MSI2	NA	
ENSG00000279555	AC091181.1	NA	
ENSG00000279281	AC015883.1	NA	
ENSG00000266100	AC007431.2	NA	
ENSG00000280028	AC007431.3	NA	
ENSG00000263499	AC007431.1	NA	
ENSG00000242889	RN7SL449P	NA	
ENSG00000238447	RNU7-134P	NA	
ENSG00000166329	CCDC182	NA	
ENSG00000265542	AC015845.2	NA	
ENSG00000222976	RN7SKP94	NA	
ENSG00000181610	MRPS23	NA	
ENSG00000180891	CUEDC1	NA	
ENSG00000264914	AC015845.1	NA	
ENSG00000278642	AC015813.4	NA	
ENSG00000136451	VEZF1	NA	
ENSG00000280233	AC015813.7	NA	
ENSG00000266086	AC015813.2	NA	
ENSG00000264112	AC015813.1	NA	
ENSG00000136450	SRSF1	NA	
ENSG00000279069	AC015813.5	NA	
ENSG00000285930	AC015813.8	NA	
ENSG00000266290	AC015813.3	NA	
ENSG00000264364	DYNLL2	NA	
ENSG00000279207	AC015813.6	NA	
ENSG00000141194	OR4D1	NA	
ENSG00000229590	MSX2P1	NA	
ENSG00000255713	OR4D2	NA	
ENSG00000121053	EPX	261500	EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD;;EOSINOPHIL PEROXIDASE DEFICIENCY, PARTIAL;;PEROXIDASE AND PHOSPHOLIPID DEFICIENCY IN EOSINOPHILS;;PRESENTEY ANOMALY
ENSG00000278627	AC005962.1	NA	
ENSG00000011143	MKS1	249000	MECKEL SYNDROME, TYPE 1; MKS1;;MECKEL-GRUBER SYNDROME, TYPE 1;;MECKEL SYNDROME; MKS;;MES;;DYSENCEPHALIA SPLANCHNOCYSTICA;;GRUBER SYNDROME;;MECKEL-GRUBER SYNDROME
ENSG00000011143	MKS1	615990	BARDET-BIEDL SYNDROME 13; BBS13
ENSG00000011143	MKS1	617121	JOUBERT SYNDROME 28; JBTS28
ENSG00000167419	LPO	NA	
ENSG00000287337	AC005962.2	NA	
ENSG00000286788	AC004687.3	NA	
ENSG00000005381	MPO	104300	ALZHEIMER DISEASE; AD;;PRESENILE AND SENILE DEMENTIA ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED; AD1, INCLUDED;;ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY, INCLUDED;;ALZHEIMER DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000005381	MPO	254600	MYELOPEROXIDASE DEFICIENCY; MPOD;;MPO DEFICIENCY
ENSG00000005379	TSPOAP1	NA	
ENSG00000265148	TSPOAP1-AS1	NA	
ENSG00000265206	AC004687.1	NA	
ENSG00000284353	MIR142	NA	
ENSG00000264399	MIR4736	NA	
ENSG00000213246	SUPT4H1	NA	
ENSG00000285897	AC004687.2	NA	
ENSG00000108375	RNF43	617108	SESSILE SERRATED POLYPOSIS CANCER SYNDROME; SSPCS
ENSG00000176160	HSF5	NA	
ENSG00000266648	SETP3	NA	
ENSG00000108389	MTMR4	NA	
ENSG00000264672	SEPTIN4-AS1	NA	
ENSG00000108387	SEPTIN4	NA	
ENSG00000121101	TEX14	617707	SPERMATOGENIC FAILURE 23; SPGF23
ENSG00000212195	U3	NA	
ENSG00000266826	AC011195.2	NA	
ENSG00000199426	RNU1-108P	NA	
ENSG00000266561	AC011195.1	NA	
ENSG00000206917	RNU1-52P	NA	
ENSG00000200997	RNVU1-34	NA	
ENSG00000108384	RAD51C	613390	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO
ENSG00000108384	RAD51C	613399	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3 BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3, INCLUDED;;OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3, INCLUDED
ENSG00000274198	AC025521.1	NA	
ENSG00000175175	PPM1E	NA	
ENSG00000276601	Metazoa_SRP	NA	
ENSG00000251865	RNU6-518P	NA	
ENSG00000241462	AC100832.1	NA	
ENSG00000275680	Metazoa_SRP	NA	
ENSG00000263938	AC100832.2	NA	
ENSG00000108395	TRIM37	253250	MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME
ENSG00000263558	RN7SL716P	NA	
ENSG00000224738	AC099850.1	NA	
ENSG00000182628	SKA2	NA	
ENSG00000252212	RNU2-58P	NA	
ENSG00000211514	MIR454	NA	
ENSG00000207996	MIR301A	NA	
ENSG00000068489	PRR11	NA	
ENSG00000266537	SPDYE22P	NA	
ENSG00000265303	AC099850.2	NA	
ENSG00000265415	AC099850.3	NA	
ENSG00000167447	SMG8	NA	
ENSG00000153982	GDPD1	NA	
ENSG00000207235	Y_RNA	NA	
ENSG00000271063	SNRPGP17	NA	
ENSG00000175155	YPEL2	NA	
ENSG00000278863	AC091059.2	NA	
ENSG00000263857	MIR4729	NA	
ENSG00000266002	AC091059.1	NA	
ENSG00000265313	LINC01476	NA	
ENSG00000200889	RNU4-13P	NA	
ENSG00000108406	DHX40	NA	
ENSG00000273702	AC091271.1	NA	
ENSG00000141367	CLTC	617854	MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56
ENSG00000141378	PTRH2	616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD
ENSG00000062716	VMP1	NA	
ENSG00000267637	AC040904.1	NA	
ENSG00000284190	MIR21	NA	
ENSG00000201524	RNU6-450P	NA	
ENSG00000108423	TUBD1	NA	
ENSG00000270264	NDUFB8P2	NA	
ENSG00000108443	RPS6KB1	NA	
ENSG00000241913	RPS29P21	NA	
ENSG00000267318	AC005702.1	NA	
ENSG00000189050	RNFT1	NA	
ENSG00000267104	TBC1D3P1-DHX40P1	NA	
ENSG00000267302	RNFT1-DT	NA	
ENSG00000266992	DHX40P1	NA	
ENSG00000238283	TBC1D3P1	NA	
ENSG00000287664	AC005702.5	NA	
ENSG00000275860	AC005702.4	NA	
ENSG00000274378	AC005702.3	NA	
ENSG00000068097	HEATR6	NA	
ENSG00000264049	MIR4737	NA	
ENSG00000267526	AC005702.2	NA	
ENSG00000267416	AC025048.4	NA	
ENSG00000261040	WFDC21P	NA	
ENSG00000280852	AC025048.6	NA	
ENSG00000267295	AC025048.3	NA	
ENSG00000267248	AC025048.2	NA	
ENSG00000277532	AC025048.5	NA	
ENSG00000286435	AC025048.7	NA	
ENSG00000267095	AC025048.1	NA	
ENSG00000167434	CA4	600852	RETINITIS PIGMENTOSA 17; RP17
ENSG00000170832	USP32	NA	
ENSG00000252577	SCARNA20	NA	
ENSG00000241157	AC104763.1	NA	
ENSG00000275562	AC104763.2	NA	
ENSG00000271626	H3P42	NA	
ENSG00000141371	C17orf64	NA	
ENSG00000213228	RPL12P38	NA	
ENSG00000062725	APPBP2	NA	
ENSG00000270553	AC011921.3	NA	
ENSG00000259349	AC011921.1	NA	
ENSG00000267678	AC011921.2	NA	
ENSG00000267772	LINC01999	NA	
ENSG00000266943	RPSAP66	NA	
ENSG00000170836	PPM1D	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000170836	PPM1D	617450	JANSEN-DE VRIES SYNDROME; JDVS;;INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD, FORMERLY; IDDGIP, FORMERLY
ENSG00000200013	RNU6-623P	NA	
ENSG00000141376	BCAS3	NA	
ENSG00000239932	RN7SL606P	NA	
ENSG00000224011	AC110602.1	NA	
ENSG00000252534	Y_RNA	NA	
ENSG00000267083	KRT18P61	NA	
ENSG00000254114	HMGN1P28	NA	
ENSG00000264322	RN7SL448P	NA	
ENSG00000267207	AC005884.1	NA	
ENSG00000267449	AC005884.2	NA	
ENSG00000227694	RPL23AP74	NA	
ENSG00000286997	AC005856.1	NA	
ENSG00000273982	AC005746.3	NA	
ENSG00000267131	AC005746.2	NA	
ENSG00000266934	AC005746.1	NA	
ENSG00000267280	TBX2-AS1	NA	
ENSG00000121068	TBX2	618223	VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD
ENSG00000187013	LINC02875	NA	
ENSG00000121075	TBX4	147891	ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION; ICPPS;;SMALL PATELLA SYNDROME; SPS;;PATELLA APLASIA, COXA VARA, AND TARSAL SYNOSTOSIS;;ISCHIOPATELLAR DYSPLASIA;;COXOPODOPATELLAR SYNDROME;;SCOTT-TAOR SYNDROME
ENSG00000121075	TBX4	601360	AMELIA, POSTERIOR, WITH PELVIC AND PULMONARY HYPOPLASIA SYNDROME; PAPPAS;;AMELIA, AUTOSOMAL RECESSIVE
ENSG00000267137	AC005901.1	NA	
ENSG00000253506	NACA2	NA	
ENSG00000136492	BRIP1	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000136492	BRIP1	609054	FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ
ENSG00000108506	INTS2	NA	
ENSG00000202361	Y_RNA	NA	
ENSG00000108510	MED13	618009	INTELLECTUAL DEVELOPMENTAL DISORDER 61; MRD61;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 61
ENSG00000279133	AC018628.1	NA	
ENSG00000242398	RN7SL800P	NA	
ENSG00000285879	AC018628.2	NA	
ENSG00000200842	Y_RNA	NA	
ENSG00000207123	Y_RNA	NA	
ENSG00000266066	POLRMTP1	NA	
ENSG00000266365	AC053481.3	NA	
ENSG00000266647	AC053481.4	NA	
ENSG00000188755	TBC1D3P2	NA	
ENSG00000263887	AC053481.2	NA	
ENSG00000242123	AC053481.1	NA	
ENSG00000172421	EFCAB3	NA	
ENSG00000239809	AC008026.2	NA	
ENSG00000251981	RNU7-52P	NA	
ENSG00000239527	RPS23P7	NA	
ENSG00000087995	METTL2A	NA	
ENSG00000146872	TLK2	618050	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57
ENSG00000239246	AC008026.1	NA	
ENSG00000264546	AC008026.3	NA	
ENSG00000277463	AC080038.2	NA	
ENSG00000274565	AC080038.1	NA	
ENSG00000011028	MRC2	NA	
ENSG00000207382	Y_RNA	NA	
ENSG00000279713	AC080038.3	NA	
ENSG00000199697	RNU6-446P	NA	
ENSG00000265702	AC005821.1	NA	
ENSG00000173838	MARCHF10	NA	
ENSG00000287457	AC005821.2	NA	
ENSG00000265000	MARCHF10-DT	NA	
ENSG00000264907	PRELID3BP3	NA	
ENSG00000283538	AC005972.3	NA	
ENSG00000207552	MIR633	NA	
ENSG00000265262	TRMT112P3	NA	
ENSG00000270324	AC005972.1	NA	
ENSG00000272164	AC005972.2	NA	
ENSG00000170921	TANC2	NA	
ENSG00000272383	AC006270.2	NA	
ENSG00000264513	AC006270.1	NA	
ENSG00000264529	DNAJB6P8	NA	
ENSG00000233635	AC015923.1	NA	
ENSG00000263501	AC005828.2	NA	
ENSG00000271919	AC005828.7	NA	
ENSG00000226797	AC005828.1	NA	
ENSG00000263644	AC005828.3	NA	
ENSG00000271749	AC005828.6	NA	
ENSG00000265282	AC005828.4	NA	
ENSG00000008283	CYB561	618182	ORTHOSTATIC HYPOTENSION 2; ORTHYP2
ENSG00000265971	AC005828.5	NA	
ENSG00000228979	PPIAP55	NA	
ENSG00000159640	ACE	106180	ANGIOTENSIN I-CONVERTING ENZYME; ACE;;ACE1;;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;;KININASE II ANGIOTENSIN I-CONVERTING ENZYME, PLASMA LEVEL OF, INCLUDED;;ANGIOTENSIN I-CONVERTING ENZYME, BENIGN SERUM INCREASE, INCLUDED;;IgA NEPHROPATHY, PROGRESSION T /.../L FAILURE IN, SUSCEPTIBILITY TO, INCLUDED;;ANGIOTENSIN I-CONVERTING ENZYME, TESTICULAR, INCLUDED
ENSG00000159640	ACE	267430	RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROME  RENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED
ENSG00000159640	ACE	612624	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3;;NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO;;END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO
ENSG00000159640	ACE	614519	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH;;STROKE, HEMORRHAGIC, SUSCEPTIBILITY TO
ENSG00000264813	AC113554.1	NA	
ENSG00000224353	ACE3P	NA	
ENSG00000173826	KCNH6	NA	
ENSG00000136485	DCAF7	NA	
ENSG00000200560	RNU6-288P	NA	
ENSG00000136463	TACO1	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000270587	AC046185.2	NA	
ENSG00000198909	MAP3K3	NA	
ENSG00000263883	EEF1DP7	NA	
ENSG00000266173	STRADA	611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE;;PMSE SYNDROME
ENSG00000136490	LIMD2	NA	
ENSG00000279369	AC046185.3	NA	
ENSG00000125695	AC046185.1	NA	
ENSG00000108588	CCDC47	618268	TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS
ENSG00000198231	DDX42	NA	
ENSG00000108592	FTSJ3	NA	
ENSG00000087191	PSMC5	NA	
ENSG00000108604	SMARCD2	617475	SPECIFIC GRANULE DEFICIENCY 2; SGD2
ENSG00000240280	TCAM1P	NA	
ENSG00000213218	CSH2	NA	
ENSG00000136487	GH2	NA	
ENSG00000259533	AC040958.1	NA	
ENSG00000136488	CSH1	NA	
ENSG00000259333	AC127029.1	NA	
ENSG00000204414	CSHL1	NA	
ENSG00000259384	GH1	173100	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2;;IGHD II;;GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL DOMINANT;;PITUITARY DWARFISM DUE TO ISOLATED GROWTH HORMONE DEFICIENCY, AUTOSOMAL DOMINANT
ENSG00000259384	GH1	262400	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A;;IGHD IA;;GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL RECESSIVE;;ILLIG-TYPE GROWTH HORMONE DEFICIENCY;;PRIMORDIAL DWARFISM;;SEXUAL ATELEIOTIC DWARFISM;;PITUITARY DWARFISM I
ENSG00000259384	GH1	262650	KOWARSKI SYNDROME;;BIODEFECTIVE GROWTH HORMONE;;PITUITARY DWARFISM WITH NORMAL IMMUNOREACTIVE GROWTH HORMONE AND LOW SOMATOMEDIN
ENSG00000259384	GH1	612781	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB
ENSG00000285947	AC127029.3	NA	
ENSG00000007312	CD79B	612692	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT
ENSG00000007314	SCN4A	170500	HYPERKALEMIC PERIODIC PARALYSIS; HYPP;;ADYNAMIA EPISODICA HEREDITARIA WITH OR WITHOUT MYOTONIA;;GAMSTORP DISEASE NORMOKALEMIC PERIODIC PARALYSIS, POTASSIUM-SENSITIVE, INCLUDED
ENSG00000007314	SCN4A	170400	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1;;HYPOKALEMIC PERIODIC PARALYSIS; HOKPP
ENSG00000007314	SCN4A	168300	PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC;;PARALYSIS PERIODICA PARAMYOTONICA  PARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED
ENSG00000007314	SCN4A	608390	MYOTONIA, POTASSIUM-AGGRAVATED;;MYOTONIA FLUCTUANS;;MYOTONIA PERMANENS;;SODIUM CHANNEL MUSCLE DISEASE;;MYOTONIA CONGENITA, ACETAZOLAMIDE-RESPONSIVE;;MYOTONIA CONGENITA, ATYPICAL LARYNGOSPASM, SEVERE NEONATAL EPISODIC, INCLUDED; SNEL, INCLUDED
ENSG00000007314	SCN4A	613345	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2
ENSG00000007314	SCN4A	614198	MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16;;MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE
ENSG00000263489	AC127029.2	NA	
ENSG00000264954	PRR29-AS1	NA	
ENSG00000224383	PRR29	NA	
ENSG00000108622	ICAM2	NA	
ENSG00000178607	ERN1	NA	
ENSG00000286629	AC005803.1	NA	
ENSG00000266402	SNHG25	NA	
ENSG00000199753	SNORD104	NA	
ENSG00000281311	AC025362.1	NA	
ENSG00000277887	SNORA50C	NA	
ENSG00000136478	TEX2	NA	
ENSG00000256358	RPL31P57	NA	
ENSG00000261371	PECAM1	NA	
ENSG00000239823	Y_RNA	NA	
ENSG00000265031	AC234063.1	NA	
ENSG00000271605	MILR1	NA	
ENSG00000256525	POLG2	610131	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 4
ENSG00000256525	POLG2	618528	MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16
ENSG00000256826	ATP5MFP4	NA	
ENSG00000108654	DDX5	NA	
ENSG00000284564	MIR3064	NA	
ENSG00000284368	MIR5047	NA	
ENSG00000258890	CEP95	NA	
ENSG00000108854	SMURF2	NA	
ENSG00000271779	AC009994.1	NA	
ENSG00000270714	MICOS10P2	NA	
ENSG00000215769	ARHGAP27P1-BPTFP1-KPNA2P3	NA	
ENSG00000266820	KPNA2P3	NA	
ENSG00000265298	AC132812.1	NA	
ENSG00000263647	BPTFP1	NA	
ENSG00000265982	AC103810.3	NA	
ENSG00000214176	PLEKHM1P1	NA	
ENSG00000278581	MIR6080	NA	
ENSG00000284172	MIR4315-2	NA	
ENSG00000252242	RNU7-115P	NA	
ENSG00000272400	AC103810.9	NA	
ENSG00000176809	LRRC37A3	NA	
ENSG00000264840	RN7SL404P	NA	
ENSG00000272134	AC103810.6	NA	
ENSG00000272220	AC103810.7	NA	
ENSG00000265218	AC103810.2	NA	
ENSG00000266644	AC103810.5	NA	
ENSG00000271974	RDM1P4	NA	
ENSG00000264057	AC103810.1	NA	
ENSG00000266155	AC103810.4	NA	
ENSG00000280299	AC037487.4	NA	
ENSG00000272346	AC103810.8	NA	
ENSG00000265912	AC037487.1	NA	
ENSG00000272006	AC037487.3	NA	
ENSG00000232457	SLC16A6P1	NA	
ENSG00000214174	AMZ2P1	NA	
ENSG00000120063	GNA13	NA	
ENSG00000266598	AC037487.2	NA	
ENSG00000108370	RGS9	608415	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS;;BRADYOPSIA
ENSG00000265883	AC060771.1	NA	
ENSG00000263520	LINC02563	NA	
ENSG00000168646	AXIN2	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000168646	AXIN2	608615	OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS;;TOOTH AGENESIS-COLORECTAL CANCER SYNDROME
ENSG00000266076	AC004805.1	NA	
ENSG00000154240	CEP112	NA	
ENSG00000271587	AC004805.3	NA	
ENSG00000270870	AC004805.2	NA	
ENSG00000266707	PSMD7P1	NA	
ENSG00000091583	APOH	NA	
ENSG00000252653	RNA5SP444	NA	
ENSG00000284242	AC009452.1	NA	
ENSG00000154229	PRKCA	NA	
ENSG00000244044	RN7SL735P	NA	
ENSG00000264630	PRKCA-AS1	NA	
ENSG00000252685	RNU6-928P	NA	
ENSG00000251698	RNA5SP445	NA	
ENSG00000229330	AC006947.1	NA	
ENSG00000207943	MIR634	NA	
ENSG00000075429	CACNG5	NA	
ENSG00000251764	RNA5SP446	NA	
ENSG00000075461	CACNG4	NA	
ENSG00000264491	AC005544.1	NA	
ENSG00000265664	AC005544.2	NA	
ENSG00000108878	CACNG1	NA	
ENSG00000198265	HELZ	NA	
ENSG00000264421	AC007448.3	NA	
ENSG00000213180	RPL36AP48	NA	
ENSG00000285877	AC007448.5	NA	
ENSG00000266473	AC007448.4	NA	
ENSG00000200619	RNA5SP447	NA	
ENSG00000207410	AC007448.1	NA	
ENSG00000264093	AC007448.2	NA	
ENSG00000197170	PSMD12	617516	STANKIEWICZ-ISIDOR SYNDROME; STISS
ENSG00000154217	PITPNC1	NA	
ENSG00000201547	Y_RNA	NA	
ENSG00000244610	RN7SL756P	NA	
ENSG00000263690	MIR548D2	NA	
ENSG00000207688	MIR548AA2	NA	
ENSG00000264754	AC110921.1	NA	
ENSG00000279917	AC079331.2	NA	
ENSG00000279361	AC079331.1	NA	
ENSG00000288109	AC079331.3	NA	
ENSG00000130935	NOL11	NA	
ENSG00000200394	SNORA38B	NA	
ENSG00000266858	RPSAP67	NA	
ENSG00000213179	RPL17P41	NA	
ENSG00000171634	BPTF	617755	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL
ENSG00000266717	AC134407.1	NA	
ENSG00000279573	AC134407.2	NA	
ENSG00000279880	AC134407.3	NA	
ENSG00000265052	RN7SL622P	NA	
ENSG00000186665	C17orf58	NA	
ENSG00000182481	KPNA2	NA	
ENSG00000266117	FBXO36P1	NA	
ENSG00000265055	AC145343.1	NA	
ENSG00000237854	LINC00674	NA	
ENSG00000267023	LRRC37A16P	NA	
ENSG00000278730	AC005332.6	NA	
ENSG00000274561	AC005332.3	NA	
ENSG00000277476	AC005332.5	NA	
ENSG00000267352	SH3GL1P3	NA	
ENSG00000267708	RDM1P3	NA	
ENSG00000278740	AC005332.7	NA	
ENSG00000267731	AC005332.2	NA	
ENSG00000267472	ARHGAP27P2	NA	
ENSG00000274712	AC005332.4	NA	
ENSG00000196704	AMZ2	NA	
ENSG00000265100	AC005332.1	NA	
ENSG00000141337	ARSG	618144	USHER SYNDROME, TYPE IV; USH4
ENSG00000108932	SLC16A6	NA	
ENSG00000267009	AC007780.1	NA	
ENSG00000070540	WIPI1	NA	
ENSG00000207561	MIR635	NA	
ENSG00000108946	PRKAR1A	160980	CARNEY COMPLEX, TYPE 1; CNC1;;CARNEY MYXOMA-ENDOCRINE COMPLEX;;CARNEY SYNDROME; CAR;;MYXOMA, SPOTTY PIGMENTATION, AND ENDOCRINE OVERACTIVITY;;NAME SYNDROME;;LAMB SYNDROME
ENSG00000108946	PRKAR1A	101800	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR
ENSG00000108946	PRKAR1A	255960	MYXOMA, INTRACARDIAC;;ATRIAL MYXOMA, FAMILIAL
ENSG00000108946	PRKAR1A	610489	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1;;PIGMENTED MICRONODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1;;CUSHING SYNDROME, ADRENAL, DUE TO PPNAD1;;ADRENOCORTICAL NODULAR DYSPLASIA, PRIMARY
ENSG00000108950	FAM20A	204690	AMELOGENESIS IMPERFECTA, TYPE IG; AI1G;;ENAMEL-RENAL SYNDROME; ERS;;ENAMEL-RENAL-GINGIVAL SYNDROME;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, WITH NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME; AIGFS
ENSG00000267461	AC079210.1	NA	
ENSG00000267659	LINC01482	NA	
ENSG00000283376	AC011591.2	NA	
ENSG00000267250	AC011591.1	NA	
ENSG00000141338	ABCA8	NA	
ENSG00000231749	ABCA9-AS1	NA	
ENSG00000154258	ABCA9	NA	
ENSG00000154262	ABCA6	NA	
ENSG00000267361	SEC24AP1	NA	
ENSG00000265331	MIR4524B	NA	
ENSG00000283385	MIR4524A	NA	
ENSG00000154263	ABCA10	NA	
ENSG00000278873	PRO1804	NA	
ENSG00000285931	AC005495.1	NA	
ENSG00000154265	ABCA5	135400	HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3;;FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS;;CHROMOSOME 17q24.2-q24.3 DELETION SYNDROME;;CHROMOSOME 17q24.2-q24.3 DUPLICATION SYNDROME;;MICRODELETION 17q24.2-q24.3 S /.../E;;MICRODUPLICATION 17q24.2-q24.3 SYNDROME;;HYPERTRICHOSIS TERMINALIS, GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA
ENSG00000267203	SNRPGP4	NA	
ENSG00000252352	AC115085.1	NA	
ENSG00000108984	MAP2K6	NA	
ENSG00000278972	AC015920.1	NA	
ENSG00000267653	AC002546.1	NA	
ENSG00000227517	LINC01483	NA	
ENSG00000267184	AC002545.1	NA	
ENSG00000237560	LINC01497	NA	
ENSG00000199801	Y_RNA	NA	
ENSG00000230258	AC005208.1	NA	
ENSG00000267603	LINC01028	NA	
ENSG00000153822	KCNJ16	NA	
ENSG00000267365	KCNJ2-AS1	NA	
ENSG00000123700	KCNJ2	170390	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS;;ANDERSEN SYNDROME;;LONG QT SYNDROME 7; LQT7;;ANDERSEN-TAWIL SYNDROME; ATS;;PERIODIC PARALYSIS, POTASSIUM-SENSITIVE CARDIODYSRHYTHMIC TYPE
ENSG00000123700	KCNJ2	609622	SHORT QT SYNDROME 3; SQT3
ENSG00000123700	KCNJ2	613980	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9
ENSG00000267170	CALM2P1	NA	
ENSG00000267109	AC011990.1	NA	
ENSG00000267471	AC005771.1	NA	
ENSG00000271239	AC007423.1	NA	
ENSG00000271101	AC005181.1	NA	
ENSG00000260785	CASC17	NA	
ENSG00000238759	RNU7-155P	NA	
ENSG00000225818	AC118653.1	NA	
ENSG00000228118	MYL6P5	NA	
ENSG00000286387	AC007432.1	NA	
ENSG00000283517	AC005144.1	NA	
ENSG00000228639	ROCR	NA	
ENSG00000256124	LINC01152	NA	
ENSG00000288605	AC007461.1	NA	
ENSG00000234899	SOX9-AS1	NA	
ENSG00000226101	LINC02097	NA	
ENSG00000125398	SOX9	114290	CAMPOMELIC DYSPLASIA;;CMPD;;CMD1; CMPD1;;CMPD1/SRA1 CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, INCLUDED;;ACAMPOMELIC CAMPOMELIC DYSPLASIA, INCLUDED;;ACAMPOMELIC CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, INCLUDED;;CAMPTOMELIC DYSPLASIA /.../UDED
ENSG00000227036	LINC00511	NA	
ENSG00000264026	LINC02003	NA	
ENSG00000263680	AC007639.1	NA	
ENSG00000243514	RPL32P33	NA	
ENSG00000263893	AC080037.2	NA	
ENSG00000133195	SLC39A11	NA	
ENSG00000200783	RN7SKP180	NA	
ENSG00000252274	AC080037.1	NA	
ENSG00000264196	AC011120.1	NA	
ENSG00000266501	AC025198.1	NA	
ENSG00000265469	POLR3KP2	NA	
ENSG00000264860	AC097641.1	NA	
ENSG00000180616	SSTR2	NA	
ENSG00000166685	COG1	611209	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G;;CDG IIg; CDGIIg;;CDGII/COG1 CEREBROCOSTOMANDIBULAR-LIKE SYNDROME
ENSG00000277728	AC097641.2	NA	
ENSG00000133193	FAM104A	NA	
ENSG00000141219	C17orf80	NA	
ENSG00000265010	AC087301.1	NA	
ENSG00000187959	CPSF4L	NA	
ENSG00000179604	CDC42EP4	NA	
ENSG00000069188	SDK2	NA	
ENSG00000264985	AC124804.1	NA	
ENSG00000264750	AC032019.1	NA	
ENSG00000265935	AC032019.2	NA	
ENSG00000263574	AC125421.1	NA	
ENSG00000177338	LINC00469	NA	
ENSG00000234721	LINC02092	NA	
ENSG00000265927	AC125421.2	NA	
ENSG00000266765	AC137735.1	NA	
ENSG00000288006	AC137735.3	NA	
ENSG00000285648	AC137735.2	NA	
ENSG00000266357	LINC02074	NA	
ENSG00000172809	RPL38	NA	
ENSG00000246731	MGC16275	NA	
ENSG00000141540	TTYH2	NA	
ENSG00000264272	AC100786.1	NA	
ENSG00000171595	DNAI2	612444	CILIARY DYSKINESIA, PRIMARY, 9; CILD9;;CILIARY DYSKINESIA, PRIMARY, 9, WITH OR WITHOUT SITUS INVERSUS
ENSG00000266106	AC103809.1	NA	
ENSG00000196169	KIF19	NA	
ENSG00000204347	BTBD17	NA	
ENSG00000257008	GPR142	NA	
ENSG00000200021	RNA5SP448	NA	
ENSG00000170412	GPRC5C	NA	
ENSG00000167851	CD300A	NA	
ENSG00000178789	CD300LB	NA	
ENSG00000167850	CD300C	NA	
ENSG00000236770	AC079325.1	NA	
ENSG00000284690	CD300H	NA	
ENSG00000204345	CD300LD	NA	
ENSG00000182352	C17orf77	NA	
ENSG00000261222	AC064805.1	NA	
ENSG00000186407	CD300E	NA	
ENSG00000264659	AC064805.2	NA	
ENSG00000172794	RAB37	NA	
ENSG00000186074	CD300LF	NA	
ENSG00000266036	AC016888.1	NA	
ENSG00000284186	MIR3615	NA	
ENSG00000109062	SLC9A3R1	612287	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2
ENSG00000109065	NAT9	NA	
ENSG00000109066	TMEM104	NA	
ENSG00000161509	GRIN2C	NA	
ENSG00000161513	FDXR	617717	AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA
ENSG00000172782	FADS6	NA	
ENSG00000182040	USH1G	606943	USHER SYNDROME, TYPE IG; USH1G
ENSG00000183034	OTOP2	NA	
ENSG00000182938	OTOP3	NA	
ENSG00000167861	HID1	NA	
ENSG00000263586	HID1-AS1	NA	
ENSG00000109089	CDR2L	NA	
ENSG00000167862	MRPL58	NA	
ENSG00000252545	RNU6-362P	NA	
ENSG00000180901	KCTD2	NA	
ENSG00000167863	ATP5PD	NA	
ENSG00000239607	RN7SL573P	NA	
ENSG00000270993	AC111186.1	NA	
ENSG00000232724	TRIM80P	NA	
ENSG00000170190	SLC16A5	NA	
ENSG00000206713	Y_RNA	NA	
ENSG00000125449	ARMC7	NA	
ENSG00000125458	NT5C	NA	
ENSG00000279035	AC022211.4	NA	
ENSG00000189159	JPT1	NA	
ENSG00000265800	AC022211.3	NA	
ENSG00000263786	AC022211.1	NA	
ENSG00000252042	Y_RNA	NA	
ENSG00000188612	SUMO2	NA	
ENSG00000125450	NUP85	618176	NEPHROTIC SYNDROME, TYPE 17; NPHS17
ENSG00000125447	GGA3	NA	
ENSG00000125445	MRPS7	617872	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34
ENSG00000125457	MIF4GD	NA	
ENSG00000263843	AC022211.2	NA	
ENSG00000125454	SLC25A19	607196	MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3
ENSG00000125454	SLC25A19	613710	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY
ENSG00000177885	GRB2	NA	
ENSG00000228007	AC011933.1	NA	
ENSG00000265987	AC011933.4	NA	
ENSG00000264853	AC011933.2	NA	
ENSG00000265342	AC011933.3	NA	
ENSG00000264511	MIR3678	NA	
ENSG00000223217	RNU6-938P	NA	
ENSG00000202332	Y_RNA	NA	
ENSG00000177728	TMEM94	618316	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF
ENSG00000284595	MIR6785	NA	
ENSG00000177303	CASKIN2	NA	
ENSG00000182173	TSEN54	225753	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4;;ENCEPHALOPATHY, FATAL INFANTILE, WITH OLIVOPONTOCEREBELLAR HYPOPLASIA
ENSG00000182173	TSEN54	277470	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A;;PCH2;;PONTOCEREBELLAR HYPOPLASIA WITH PROGRESSIVE CEREBRAL ATROPHY;;VOLENDAM NEURODEGENERATIVE DISEASE
ENSG00000182173	TSEN54	610204	PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5;;OLIVOPONTOCEREBELLAR HYPOPLASIA, FETAL-ONSET
ENSG00000073350	LLGL2	NA	
ENSG00000266714	MYO15B	NA	
ENSG00000108469	RECQL5	NA	
ENSG00000204323	SMIM5	NA	
ENSG00000259120	SMIM6	NA	
ENSG00000161526	SAP30BP	NA	
ENSG00000264829	AC087749.2	NA	
ENSG00000264270	AC087749.1	NA	
ENSG00000132470	ITGB4	131800	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED;;EPIDERMOLYSIS BULLOSA SIMPLEX, WEBER-COCKAYNE TYPE;;EPIDERMOLYSIS BULLOSA OF HANDS AND FEET;;EBS, ACRAL FORM
ENSG00000132470	ITGB4	226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DIS /.../TYPE;;EPIDERMOLYSIS BULLOSA, GENERALIZED ATROPHIC BENIGN; GABEB EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT, INCLUDED;;JUNCTIONAL EPIDERMOLYSIS BULLOSA INVERSA, INCLUDED;;JEB-I, INCLUDED
ENSG00000132470	ITGB4	226730	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIA CUTI /.../ENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA
ENSG00000108479	GALK1	230200	GALACTOKINASE DEFICIENCY;;GALK DEFICIENCY;;GALACTOSEMIA II
ENSG00000132475	H3-3B	NA	
ENSG00000283853	MIR4738	NA	
ENSG00000132478	UNK	NA	
ENSG00000266980	AC087289.1	NA	
ENSG00000092929	UNC13D	608898	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3
ENSG00000132471	WBP2	617639	DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107
ENSG00000132481	TRIM47	NA	
ENSG00000267801	AC087289.5	NA	
ENSG00000141569	TRIM65	NA	
ENSG00000267342	AC087289.2	NA	
ENSG00000204316	MRPL38	NA	
ENSG00000267426	AC087289.3	NA	
ENSG00000188878	FBF1	NA	
ENSG00000161533	ACOX1	264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY
ENSG00000267615	AC087289.4	NA	
ENSG00000261408	TEN1-CDK3	NA	
ENSG00000257949	TEN1	NA	
ENSG00000250506	CDK3	NA	
ENSG00000167880	EVPL	NA	
ENSG00000167881	SRP68	NA	
ENSG00000186919	ZACN	NA	
ENSG00000182687	GALR2	NA	
ENSG00000182473	EXOC7	NA	
ENSG00000279382	AC018665.1	NA	
ENSG00000275360	MIR6868	NA	
ENSG00000129654	FOXJ1	618699	CILIARY DYSKINESIA, PRIMARY, 43; CILD43;;CILIARY DYSKINESIA, PRIMARY, 43, WITH OR WITHOUT SITUS INVERSUS
ENSG00000267128	RNF157-AS1	NA	
ENSG00000141576	RNF157	NA	
ENSG00000267376	ATP5MGP6	NA	
ENSG00000228218	ATF4P3	NA	
ENSG00000185262	UBALD2	NA	
ENSG00000129646	QRICH2	618341	SPERMATOGENIC FAILURE 35; SPGF35
ENSG00000161542	PRPSAP1	NA	
ENSG00000251779	AC090699.1	NA	
ENSG00000207169	RNU6-24P	NA	
ENSG00000267518	AC090699.2	NA	
ENSG00000176170	SPHK1	NA	
ENSG00000175931	UBE2O	NA	
ENSG00000242931	RPL7P49	NA	
ENSG00000129673	AANAT	NA	
ENSG00000129667	RHBDF2	148500	TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;PALMOPLANTAR KERATODERMA WITH ESOPHAGEAL CANCER;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER
ENSG00000161544	CYGB	NA	
ENSG00000214140	PRCD	610599	RETINITIS PIGMENTOSA 36; RP36
ENSG00000267546	AC015802.4	NA	
ENSG00000267543	AC015802.3	NA	
ENSG00000272386	AC015802.5	NA	
ENSG00000163597	SNHG16	NA	
ENSG00000274091	SNORD1C	NA	
ENSG00000199961	SNORD1B	NA	
ENSG00000278261	SNORD1A	NA	
ENSG00000284526	AC015802.6	NA	
ENSG00000070731	ST6GALNAC2	NA	
ENSG00000267078	AC015802.1	NA	
ENSG00000267084	AC015802.2	NA	
ENSG00000286750	AC015802.7	NA	
ENSG00000070526	ST6GALNAC1	NA	
ENSG00000199735	RNU6-227P	NA	
ENSG00000261335	AC005837.1	NA	
ENSG00000182534	MXRA7	NA	
ENSG00000212418	RNY4P36	NA	
ENSG00000277382	AC005837.4	NA	
ENSG00000070495	JMJD6	NA	
ENSG00000274051	AC005837.3	NA	
ENSG00000181038	METTL23	615942	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44; MRT44
ENSG00000267168	AC005837.2	NA	
ENSG00000161547	SRSF2	NA	
ENSG00000092931	MFSD11	NA	
ENSG00000283805	MIR636	NA	
ENSG00000200257	RNU6-97P	NA	
ENSG00000267065	LINC02080	NA	
ENSG00000287836	AC016168.4	NA	
ENSG00000267535	LINC00868	NA	
ENSG00000167889	MGAT5B	NA	
ENSG00000267568	AC016168.2	NA	
ENSG00000267521	AC016168.1	NA	
ENSG00000280122	AC016168.3	NA	
ENSG00000276202	Metazoa_SRP	NA	
ENSG00000234912	SNHG20	NA	
ENSG00000129657	SEC14L1	NA	
ENSG00000275143	SCARNA16	NA	
ENSG00000284250	MIR6516	NA	
ENSG00000222808	RNU4-47P	NA	
ENSG00000262870	CYCSP40	NA	
ENSG00000263718	SEPTIN9-DT	NA	
ENSG00000265121	AC068594.1	NA	
ENSG00000184640	SEPTIN9	162100	AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS
ENSG00000266998	AC111182.1	NA	
ENSG00000287257	AC111182.2	NA	
ENSG00000264060	MIR4316	NA	
ENSG00000200651	AC111170.1	NA	
ENSG00000279801	AC111170.4	NA	
ENSG00000267263	AC111170.3	NA	
ENSG00000267016	AC111170.2	NA	
ENSG00000267665	AC021683.3	NA	
ENSG00000267506	AC021683.2	NA	
ENSG00000286534	AC021683.6	NA	
ENSG00000267466	AC021683.1	NA	
ENSG00000279572	AC021683.4	NA	
ENSG00000285535	AC021683.5	NA	
ENSG00000267790	LINC01987	NA	
ENSG00000204283	LINC01973	NA	
ENSG00000238898	RNU1-80P	NA	
ENSG00000078687	TNRC6C	NA	
ENSG00000279600	AC015804.1	NA	
ENSG00000267463	UBE2V2P2	NA	
ENSG00000238658	RNU6-625P	NA	
ENSG00000141524	TMC6	226400	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1;;EPIDERMODYSPLASIA VERRUCIFORMIS; EV
ENSG00000204282	TNRC6C-AS1	NA	
ENSG00000167895	TMC8	618231	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 2; EV2
ENSG00000187997	C17orf99	NA	
ENSG00000267679	EIF5AP2	NA	
ENSG00000108639	SYNGR2	NA	
ENSG00000167900	TK1	NA	
ENSG00000183077	AFMID	NA	
ENSG00000267624	AC087645.1	NA	
ENSG00000089685	BIRC5	NA	
ENSG00000204278	TMEM235	NA	
ENSG00000283914	AC087645.4	NA	
ENSG00000267676	THA1P	NA	
ENSG00000279886	AC087645.3	NA	
ENSG00000204277	LINC01993	NA	
ENSG00000267737	AC087645.2	NA	
ENSG00000184557	SOCS3	NA	
ENSG00000266970	AC061992.2	NA	
ENSG00000243870	RN7SL236P	NA	
ENSG00000087157	PGS1	NA	
ENSG00000200063	AC061992.1	NA	
ENSG00000187775	DNAH17	618643	SPERMATOGENIC FAILURE 39; SPGF39
ENSG00000267432	DNAH17-AS1	NA	
ENSG00000267770	AC016182.1	NA	
ENSG00000243426	RN7SL454P	NA	
ENSG00000267123	SCAT1	NA	
ENSG00000108669	CYTH1	NA	
ENSG00000279570	AC099804.1	NA	
ENSG00000252391	RNU6-638P	NA	
ENSG00000055483	USP36	NA	
ENSG00000287539	AC022966.2	NA	
ENSG00000267355	RPL9P29	NA	
ENSG00000035862	TIMP2	NA	
ENSG00000267601	AC022966.1	NA	
ENSG00000178404	CEP295NL	NA	
ENSG00000279339	AC100788.2	NA	
ENSG00000267491	AC100788.1	NA	
ENSG00000108679	LGALS3BP	NA	
ENSG00000171302	CANT1	251450	DESBUQUOIS DYSPLASIA 1; DBQD1;;DESBUQUOIS SYNDROME;;MICROMELIC DWARFISM WITH VERTEBRAL AND METAPHYSEAL ABNORMALITIES AND ADVANCED CARPOTARSAL OSSIFICATION DESBUQUOIS DYSPLASIA, KIM VARIANT, INCLUDED
ENSG00000171302	CANT1	617719	EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7
ENSG00000265096	C1QTNF1-AS1	NA	
ENSG00000173918	C1QTNF1	NA	
ENSG00000167280	ENGASE	NA	
ENSG00000167281	RBFOX3	NA	
ENSG00000266711	AC021534.1	NA	
ENSG00000263278	AC233701.1	NA	
ENSG00000266665	MIR4739	NA	
ENSG00000267719	LINC02078	NA	
ENSG00000182156	ENPP7	NA	
ENSG00000173894	CBX2	613080	46,XY SEX REVERSAL 5; SRXY5;;46,XY SEX REVERSAL, CBX2-RELATED;;46,XY GONADAL DYSGENESIS, COMPLETE, CBX2-RELATED;;SEX REVERSAL, XY, CBX2-RELATED;;DISORDER OF SEX DEVELOPMENT, 46,XY, CBX2-RELATED
ENSG00000141570	CBX8	NA	
ENSG00000262768	AC100791.2	NA	
ENSG00000262772	LINC01977	NA	
ENSG00000141582	CBX4	NA	
ENSG00000262343	AC100791.1	NA	
ENSG00000262585	LINC01979	NA	
ENSG00000262188	LINC01978	NA	
ENSG00000167291	TBC1D16	NA	
ENSG00000275516	AC100791.3	NA	
ENSG00000262172	AC116025.2	NA	
ENSG00000261978	AC116025.1	NA	
ENSG00000141519	CCDC40	613808	CILIARY DYSKINESIA, PRIMARY, 15; CILD15;;CILIARY DYSKINESIA, PRIMARY, 15, WITH OR WITHOUT SITUS INVERSUS
ENSG00000265561	MIR1268B	NA	
ENSG00000171298	GAA	232300	GLYCOGEN STORAGE DISEASE II; GSD2;;GSD II; ACID ALPHA-GLUCOSIDASE DEFICIENCY;;GAA DEFICIENCY;;POMPE DISEASE;;GLYCOGENOSIS, GENERALIZED, CARDIAC FORM;;CARDIOMEGALIA GLYCOGENICA DIFFUSA;;ACID MALTASE DEFICIENCY; AMD;;ALPHA-1,4-GLUCOSIDASE DEFICIENCY
ENSG00000141543	EIF4A3	268305	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES;;RICHIERI-COSTA-PEREIRA SYNDROME; RCPS
ENSG00000279259	AC087741.3	NA	
ENSG00000275479	AC087741.2	NA	
ENSG00000141527	CARD14	173200	PITYRIASIS RUBRA PILARIS; PRP
ENSG00000141527	CARD14	602723	PSORIASIS 2; PSORS2
ENSG00000262580	AC087741.1	NA	
ENSG00000181523	SGSH	252900	MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A;;MPS IIIA;;SANFILIPPO SYNDROME A;;HEPARAN SULFATE SULFATASE DEFICIENCY;;SULFAMIDASE DEFICIENCY
ENSG00000181045	SLC26A11	NA	
ENSG00000173821	RNF213	607151	MOYAMOYA DISEASE 2; MYMY2
ENSG00000262979	AC124319.1	NA	
ENSG00000276863	AC124319.2	NA	
ENSG00000280248	AC124319.3	NA	
ENSG00000263069	RNF213-AS1	NA	
ENSG00000173818	ENDOV	NA	
ENSG00000264961	MIR4730	NA	
ENSG00000260369	AC120024.1	NA	
ENSG00000279273	AC120024.4	NA	
ENSG00000171246	NPTX1	NA	
ENSG00000262000	AC120024.2	NA	
ENSG00000271340	AC120024.3	NA	
ENSG00000213128	RPL32P31	NA	
ENSG00000141564	RPTOR	NA	
ENSG00000232083	RPL31P7	NA	
ENSG00000262833	AC016245.1	NA	
ENSG00000287403	AC016245.2	NA	
ENSG00000262313	AC127496.3	NA	
ENSG00000262662	AC127496.4	NA	
ENSG00000261924	AC127496.1	NA	
ENSG00000240270	RPL12P37	NA	
ENSG00000176108	CHMP6	NA	
ENSG00000263218	AC127496.6	NA	
ENSG00000280351	AC127496.7	NA	
ENSG00000262873	AC127496.5	NA	
ENSG00000262098	AC127496.2	NA	
ENSG00000226137	BAIAP2-DT	NA	
ENSG00000175866	BAIAP2	NA	
ENSG00000181409	AATK	NA	
ENSG00000207736	MIR657	NA	
ENSG00000211563	MIR3065	NA	
ENSG00000283604	MIR338	NA	
ENSG00000221025	MIR1250	NA	
ENSG00000263167	AC115099.1	NA	
ENSG00000225180	PVALEF	NA	
ENSG00000141577	CEP131	NA	
ENSG00000262115	AC027601.2	NA	
ENSG00000167302	TEPSIN	NA	
ENSG00000260005	AC027601.1	NA	
ENSG00000224877	NDUFAF8	618776	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34; MC1DN34
ENSG00000157637	SLC38A10	NA	
ENSG00000276101	AC027601.3	NA	
ENSG00000279187	AC027601.4	NA	
ENSG00000185168	LINC00482	NA	
ENSG00000185332	TMEM105	NA	
ENSG00000287431	AC027601.5	NA	
ENSG00000263154	AC110285.3	NA	
ENSG00000262223	AC110285.1	NA	
ENSG00000274833	AC110285.5	NA	
ENSG00000262877	AC110285.2	NA	
ENSG00000266074	BAHCC1	NA	
ENSG00000279692	AC110285.6	NA	
ENSG00000266392	MIR4740	NA	
ENSG00000266189	MIR3186	NA	
ENSG00000263271	AC110285.4	NA	
ENSG00000278200	LINC01971	NA	
ENSG00000184009	ACTG1	604717	DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20;;DFNA26
ENSG00000184009	ACTG1	614583	BARAITSER-WINTER SYNDROME 2; BRWS2
ENSG00000229848	AC139149.1	NA	
ENSG00000186765	FSCN2	607921	RETINITIS PIGMENTOSA 30; RP30 MACULAR DEGENERATION, INCLUDED
ENSG00000185504	FAAP100	NA	
ENSG00000182446	NPLOC4	NA	
ENSG00000207021	AC137896.1	NA	
ENSG00000182612	TSPAN10	NA	
ENSG00000185527	PDE6G	268000	RETINITIS PIGMENTOSA; RP
ENSG00000185527	PDE6G	613582	RETINITIS PIGMENTOSA 57; RP57
ENSG00000204237	OXLD1	NA	
ENSG00000185298	CCDC137	NA	
ENSG00000214087	ARL16	NA	
ENSG00000185359	HGS	NA	
ENSG00000277784	MIR6786	NA	
ENSG00000275902	AC139530.3	NA	
ENSG00000262049	AC139530.1	NA	
ENSG00000262814	MRPL12	NA	
ENSG00000262660	AC139530.2	NA	
ENSG00000183048	SLC25A10	NA	
ENSG00000215644	GCGR	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000225663	MCRIP1	NA	
ENSG00000182676	PPP1R27	NA	
ENSG00000185624	P4HB	112240	COLE-CARPENTER SYNDROME 1; CLCRP1;;BONE FRAGILITY WITH CRANIOSYNOSTOSIS, OCULAR PROPTOSIS, HYDROCEPHALUS, AND DISTINCTIVE FACIAL FEATURES
ENSG00000262831	AC145207.3	NA	
ENSG00000278876	AC145207.9	NA	
ENSG00000141522	ARHGDIA	615244	NEPHROTIC SYNDROME, TYPE 8; NPHS8
ENSG00000262413	AC145207.2	NA	
ENSG00000263731	AC145207.5	NA	
ENSG00000263859	AC145207.6	NA	
ENSG00000183684	ALYREF	NA	
ENSG00000141552	ANAPC11	NA	
ENSG00000183979	NPB	NA	
ENSG00000185813	PCYT2	618770	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE; SPG82
ENSG00000187531	SIRT7	NA	
ENSG00000197063	MAFG	NA	
ENSG00000264769	AC145207.8	NA	
ENSG00000265688	MAFG-DT	NA	
ENSG00000183010	PYCR1	612940	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B;;CUTIS LAXA WITH PROGEROID FEATURES
ENSG00000183010	PYCR1	614438	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B
ENSG00000263585	AC145207.4	NA	
ENSG00000185105	MYADML2	NA	
ENSG00000235296	AC145207.1	NA	
ENSG00000185269	NOTUM	NA	
ENSG00000264735	AC145207.7	NA	
ENSG00000169696	ASPSCR1	606243	ALVEOLAR SOFT PART SARCOMA; ASPS
ENSG00000169689	CENPX	NA	
ENSG00000169683	LRRC45	NA	
ENSG00000169750	RAC3	618577	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF
ENSG00000169738	DCXR	260800	PENTOSURIA; PNTSU;;L-XYLULOSURIA;;XYLITOL DEHYDROGENASE DEFICIENCY;;L-XYLULOSE REDUCTASE DEFICIENCY
ENSG00000279372	AC137723.1	NA	
ENSG00000264569	DCXR-DT	NA	
ENSG00000169733	RFNG	NA	
ENSG00000169727	GPS1	NA	
ENSG00000169718	DUS1L	NA	
ENSG00000169710	FASN	NA	
ENSG00000176155	CCDC57	NA	
ENSG00000265678	AC129510.1	NA	
ENSG00000266654	AC129510.2	NA	
ENSG00000264548	AC132872.2	NA	
ENSG00000141526	SLC16A3	NA	
ENSG00000284574	MIR6787	NA	
ENSG00000141551	CSNK1D	615224	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2
ENSG00000275888	AC132872.3	NA	
ENSG00000280407	AC132872.4	NA	
ENSG00000287737	AC132872.5	NA	
ENSG00000265692	LINC01970	NA	
ENSG00000260563	AC132872.1	NA	
ENSG00000173762	CD7	NA	
ENSG00000141574	SECTM1	NA	
ENSG00000182459	TEX19	NA	
ENSG00000278964	AC132938.5	NA	
ENSG00000181408	UTS2R	NA	
ENSG00000260011	AC132938.2	NA	
ENSG00000181396	OGFOD3	NA	
ENSG00000264812	AC132938.3	NA	
ENSG00000201239	AC132938.1	NA	
ENSG00000169660	HEXD	NA	
ENSG00000279066	HEXD-IT1	NA	
ENSG00000178927	CYBC1	NA	
ENSG00000287193	AC132938.7	NA	
ENSG00000265458	AC132938.4	NA	
ENSG00000141562	NARF	NA	
ENSG00000279744	AC132938.6	NA	
ENSG00000266445	NARF-AS1	NA	
ENSG00000266236	NARF-IT1	NA	
ENSG00000141568	FOXK2	NA	
ENSG00000265136	AC124283.4	NA	
ENSG00000262652	AC124283.3	NA	
ENSG00000262147	AC124283.2	NA	
ENSG00000261845	AC124283.1	NA	
ENSG00000141580	WDR45B	617977	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS;;ELHATTAB-ALKURAYA SYNDROME
ENSG00000279613	AC124283.5	NA	
ENSG00000141542	RAB40B	NA	
ENSG00000266107	MIR4525	NA	
ENSG00000263063	AC024361.2	NA	
ENSG00000141560	FN3KRP	NA	
ENSG00000263321	AC024361.3	NA	
ENSG00000167363	FN3K	NA	
ENSG00000262410	AC024361.1	NA	
ENSG00000141556	TBCD	617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT
ENSG00000263098	AC068014.1	NA	
ENSG00000141579	ZNF750	610227	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS
ENSG00000262663	AC087222.1	NA	
ENSG00000175711	B3GNTL1	NA	
ENSG00000262339	AC130371.1	NA	
ENSG00000176845	METRNL	NA	
ENSG00000274370	AC130371.2	NA	
ENSG00000261888	AC144831.1	NA	
ENSG00000279143	AC139099.3	NA	
ENSG00000262898	AC139099.2	NA	
ENSG00000262094	AC139099.1	NA	
ENSG00000232938	RPL23AP87	NA	
ENSG00000262352	LINC02564	NA	
ENSG00000263305	AP005530.1	NA	
ENSG00000262181	AP001005.1	NA	
ENSG00000173213	TUBB8B	NA	
ENSG00000282965	AP001005.3	NA	
ENSG00000262081	IL9RP4	NA	
ENSG00000274446	AP001005.2	NA	
ENSG00000263006	ROCK1P1	NA	
ENSG00000277521	MIR8078	NA	
ENSG00000101557	USP14	NA	
ENSG00000079134	THOC1	NA	
ENSG00000263884	AP000845.1	NA	
ENSG00000158270	COLEC12	NA	
ENSG00000264514	AP000915.1	NA	
ENSG00000265477	AP000915.2	NA	
ENSG00000264265	LINC01925	NA	
ENSG00000177143	CETN1	NA	
ENSG00000222174	RN7SKP146	NA	
ENSG00000079101	CLUL1	NA	
ENSG00000288533	AP001178.4	NA	
ENSG00000176912	TYMSOS	NA	
ENSG00000266456	AP001178.3	NA	
ENSG00000263727	AP001178.1	NA	
ENSG00000176890	TYMS	NA	
ENSG00000132199	ENOSF1	NA	
ENSG00000265490	AP001178.2	NA	
ENSG00000176105	YES1	NA	
ENSG00000266171	AP001020.3	NA	
ENSG00000264339	AP001020.1	NA	
ENSG00000264635	AP001020.2	NA	
ENSG00000206687	RNU1-109P	NA	
ENSG00000273355	AP000894.4	NA	
ENSG00000266575	BOLA2P1	NA	
ENSG00000264179	AP000894.1	NA	
ENSG00000265671	AP000894.3	NA	
ENSG00000265179	AP000894.2	NA	
ENSG00000141433	ADCYAP1	NA	
ENSG00000259837	LINC01904	NA	
ENSG00000272461	AP005328.1	NA	
ENSG00000263551	AP000829.1	NA	
ENSG00000263505	AP005265.1	NA	
ENSG00000266251	COX6CP3	NA	
ENSG00000132204	LINC00470	NA	
ENSG00000199197	RN7SKP72	NA	
ENSG00000263396	AP005119.1	NA	
ENSG00000265417	AP005119.2	NA	
ENSG00000266602	AP005262.1	NA	
ENSG00000266450	AC019183.1	NA	
ENSG00000264080	AP005057.1	NA	
ENSG00000263745	AP005230.1	NA	
ENSG00000264189	AIDAP3	NA	
ENSG00000286975	AP005136.4	NA	
ENSG00000101574	METTL4	NA	
ENSG00000238575	AP005136.1	NA	
ENSG00000266783	AP005136.3	NA	
ENSG00000264150	AP005136.2	NA	
ENSG00000080986	NDC80	NA	
ENSG00000235422	KATNBL1P3	NA	
ENSG00000202224	Y_RNA	NA	
ENSG00000200875	RNU6-340P	NA	
ENSG00000266405	CBX3P2	NA	
ENSG00000101596	SMCHD1	158901	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B
ENSG00000101596	SMCHD1	603457	BOSMA ARHINIA MICROPHTHALMIA SYNDROME; BAMS;;ARHINIA, CHOANAL ATRESIA, MICROPHTHALMIA, AND HYPOGONADOTROPIC HYPOGONADISM
ENSG00000266049	AP001011.1	NA	
ENSG00000207034	Y_RNA	NA	
ENSG00000132205	EMILIN2	NA	
ENSG00000101577	LPIN2	609628	MAJEED SYNDROME; MJDS;;CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS, CONGENITAL DYSERYTHROPOIETIC ANEMIA, AND NEUTROPHILIC DERMATOSIS
ENSG00000272625	AP000919.3	NA	
ENSG00000263606	CHORDC1P4	NA	
ENSG00000265907	AP000919.1	NA	
ENSG00000266397	AP000919.2	NA	
ENSG00000264186	SNRPCP4	NA	
ENSG00000277447	AP005431.1	NA	
ENSG00000252258	SNORA70	NA	
ENSG00000101605	MYOM1	NA	
ENSG00000252353	RNU7-25P	NA	
ENSG00000265399	AP005329.2	NA	
ENSG00000272688	AP005329.3	NA	
ENSG00000101608	MYL12A	NA	
ENSG00000264235	AP005329.1	NA	
ENSG00000118680	MYL12B	NA	
ENSG00000266578	AP001025.1	NA	
ENSG00000259256	LINC01895	NA	
ENSG00000240364	RPL31P59	NA	
ENSG00000265243	IGLJCOR18	NA	
ENSG00000243720	RPL21P127	NA	
ENSG00000177426	TGIF1	142946	HOLOPROSENCEPHALY 4; HPE4
ENSG00000263460	BOD1P1	NA	
ENSG00000266835	GAPLINC	NA	
ENSG00000170579	DLGAP1	NA	
ENSG00000241223	RN7SL39P	NA	
ENSG00000266373	AP002472.1	NA	
ENSG00000177337	DLGAP1-AS1	NA	
ENSG00000262001	DLGAP1-AS2	NA	
ENSG00000266401	AP002478.1	NA	
ENSG00000266513	AP002478.2	NA	
ENSG00000263724	DLGAP1-AS3	NA	
ENSG00000275518	MIR6718	NA	
ENSG00000207278	RNU6-831P	NA	
ENSG00000263878	DLGAP1-AS4	NA	
ENSG00000250933	GAPDHP66	NA	
ENSG00000261520	DLGAP1-AS5	NA	
ENSG00000264246	AP005208.1	NA	
ENSG00000265545	AP005403.1	NA	
ENSG00000266268	AP005203.1	NA	
ENSG00000264775	PPIAP14	NA	
ENSG00000265514	LINC01892	NA	
ENSG00000215368	BOD1P2	NA	
ENSG00000231824	AKAIN1	NA	
ENSG00000266153	AP005380.1	NA	
ENSG00000285575	AP001496.4	NA	
ENSG00000265091	AP001496.2	NA	
ENSG00000264575	LINC00526	NA	
ENSG00000263753	LINC00667	NA	
ENSG00000265188	AP001496.3	NA	
ENSG00000198081	ZBTB14	NA	
ENSG00000264254	AP001496.1	NA	
ENSG00000266288	AP005671.1	NA	
ENSG00000082397	EPB41L3	NA	
ENSG00000265316	AP005059.2	NA	
ENSG00000264000	AP005059.1	NA	
ENSG00000261738	MIR3976HG	NA	
ENSG00000272380	MIR3976	NA	
ENSG00000206432	TMEM200C	NA	
ENSG00000264449	AP001021.1	NA	
ENSG00000266846	AP001021.3	NA	
ENSG00000154655	L3MBTL4	NA	
ENSG00000265487	AP001021.2	NA	
ENSG00000200637	RNU5F-3P	NA	
ENSG00000264707	L3MBTL4-AS1	NA	
ENSG00000283532	MIR4317	NA	
ENSG00000279885	AP005060.1	NA	
ENSG00000199272	RNU6-349P	NA	
ENSG00000235552	RPL6P27	NA	
ENSG00000266065	AP005202.2	NA	
ENSG00000265944	LINC01387	NA	
ENSG00000265174	AP005202.1	NA	
ENSG00000243591	RN7SL282P	NA	
ENSG00000261627	AP005205.1	NA	
ENSG00000279479	AP005205.3	NA	
ENSG00000266441	AP005205.2	NA	
ENSG00000088756	ARHGAP28	NA	
ENSG00000287834	AP005210.2	NA	
ENSG00000263797	AP005210.1	NA	
ENSG00000265933	LINC00668	NA	
ENSG00000264127	SCML2P1	NA	
ENSG00000251897	RNU6-916P	NA	
ENSG00000101680	LAMA1	615960	PORETTI-BOLTSHAUSER SYNDROME; PTBHS
ENSG00000265069	AP002409.1	NA	
ENSG00000264475	AP005062.1	NA	
ENSG00000263716	SLC25A51P2	NA	
ENSG00000206422	LRRC30	NA	
ENSG00000212626	AP005270.1	NA	
ENSG00000286126	AP001095.1	NA	
ENSG00000173482	PTPRM	NA	
ENSG00000266767	AP000897.2	NA	
ENSG00000264596	AP000897.1	NA	
ENSG00000199856	U3	NA	
ENSG00000286627	AP005900.1	NA	
ENSG00000286649	AC006566.2	NA	
ENSG00000273368	AC006566.1	NA	
ENSG00000266149	AP001094.3	NA	
ENSG00000265413	AP001094.2	NA	
ENSG00000263970	AP001094.1	NA	
ENSG00000266613	COP1P1	NA	
ENSG00000242985	RN7SL50P	NA	
ENSG00000229442	THEMIS3P	NA	
ENSG00000225212	AKR1B1P6	NA	
ENSG00000206418	RAB12	NA	
ENSG00000266708	AP001793.1	NA	
ENSG00000263935	TOMM20P3	NA	
ENSG00000265962	GACAT2	NA	
ENSG00000168502	MTCL1	NA	
ENSG00000252319	Y_RNA	NA	
ENSG00000272788	AP000864.1	NA	
ENSG00000287719	AP001531.1	NA	
ENSG00000286765	AP005899.2	NA	
ENSG00000242058	RPS4XP19	NA	
ENSG00000178127	NDUFV2	618229	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7
ENSG00000265257	AP005263.1	NA	
ENSG00000263847	AP005899.1	NA	
ENSG00000266053	NDUFV2-AS1	NA	
ENSG00000101745	ANKRD12	NA	
ENSG00000200883	Y_RNA	NA	
ENSG00000207092	Y_RNA	NA	
ENSG00000273284	AP001033.2	NA	
ENSG00000264964	AP001033.1	NA	
ENSG00000128791	TWSG1	NA	
ENSG00000287509	AP001033.3	NA	
ENSG00000273335	AP005432.2	NA	
ENSG00000017797	RALBP1	NA	
ENSG00000266805	AP005432.1	NA	
ENSG00000251994	RNU2-27P	NA	
ENSG00000154845	PPP4R1	NA	
ENSG00000266541	AP001381.1	NA	
ENSG00000263627	PPP4R1-AS1	NA	
ENSG00000212572	RNU6-903P	NA	
ENSG00000285594	LINC02856	NA	
ENSG00000264644	KRT18P8	NA	
ENSG00000168461	RAB31	NA	
ENSG00000266891	AP000902.1	NA	
ENSG00000266127	ZNF415P1	NA	
ENSG00000242651	RN7SL862P	NA	
ENSG00000285653	AC006238.2	NA	
ENSG00000252680	RNA5SP449	NA	
ENSG00000265564	PIGPP4	NA	
ENSG00000168454	TXNDC2	NA	
ENSG00000272799	AC006238.1	NA	
ENSG00000101558	VAPA	NA	
ENSG00000223138	RNA5SP450	NA	
ENSG00000265554	AP005271.1	NA	
ENSG00000287065	AP005209.2	NA	
ENSG00000264876	AP005209.1	NA	
ENSG00000266102	AP006219.1	NA	
ENSG00000286499	AP006219.2	NA	
ENSG00000260913	LINC01254	NA	
ENSG00000287563	AP006219.3	NA	
ENSG00000154856	APCDD1	605389	HYPOTRICHOSIS 1; HYPT1;;HYPOTRICHOSIS SIMPLEX, GENERALIZED, HEREDITARY; HHS;;HTS
ENSG00000134265	NAPG	NA	
ENSG00000265728	AP001099.1	NA	
ENSG00000266604	LINC01887	NA	
ENSG00000264503	AP001180.3	NA	
ENSG00000264311	CCDC58P1	NA	
ENSG00000264072	AP001180.2	NA	
ENSG00000266470	AP001180.5	NA	
ENSG00000265038	PMM2P1	NA	
ENSG00000260779	AP001180.1	NA	
ENSG00000154864	PIEZO2	114300	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3;;GORDON SYNDROME;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA;;CAMPTODACTYLY, CLEFT PALATE, AND CLUBFOOT
ENSG00000154864	PIEZO2	108145	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB
ENSG00000154864	PIEZO2	248700	MARDEN-WALKER SYNDROME; MWKS;;MWS
ENSG00000154864	PIEZO2	617146	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT
ENSG00000264843	AP001180.4	NA	
ENSG00000264714	KIAA0895LP1	NA	
ENSG00000274838	MIR6788	NA	
ENSG00000263952	AP005120.1	NA	
ENSG00000263682	AP005139.1	NA	
ENSG00000267051	AP005229.1	NA	
ENSG00000273119	AP005229.2	NA	
ENSG00000267564	AP001109.1	NA	
ENSG00000267425	LINC01928	NA	
ENSG00000267252	LINC01255	NA	
ENSG00000267371	AP001017.1	NA	
ENSG00000236396	SLC35G4	NA	
ENSG00000267794	AP001120.4	NA	
ENSG00000257513	NPIPB1P	NA	
ENSG00000267143	AP001120.2	NA	
ENSG00000267773	AP001120.3	NA	
ENSG00000283492	MIR7153	NA	
ENSG00000260759	AP001120.1	NA	
ENSG00000141404	GNAL	615073	DYSTONIA 25; DYT25
ENSG00000267333	ASNSP6	NA	
ENSG00000286812	AP001120.5	NA	
ENSG00000267455	AP005137.1	NA	
ENSG00000255112	CHMP1B	NA	
ENSG00000267165	CHMP1B-AS1	NA	
ENSG00000272703	AP005137.2	NA	
ENSG00000154889	MPPE1	NA	
ENSG00000273141	AP001269.4	NA	
ENSG00000267079	AP001269.2	NA	
ENSG00000267661	AP001269.3	NA	
ENSG00000141401	IMPA2	NA	
ENSG00000266955	AP001269.1	NA	
ENSG00000267480	AP001542.3	NA	
ENSG00000266995	AP001542.1	NA	
ENSG00000267292	AP001542.2	NA	
ENSG00000212712	AP002414.1	NA	
ENSG00000267533	AP002414.4	NA	
ENSG00000256616	AP002414.2	NA	
ENSG00000267722	AP002414.5	NA	
ENSG00000267478	AP002414.3	NA	
ENSG00000181626	ANKRD62	NA	
ENSG00000200827	RNU6-324P	NA	
ENSG00000267162	SDHDP1	NA	
ENSG00000267116	AP005264.2	NA	
ENSG00000279285	AP005264.6	NA	
ENSG00000267643	AP005264.4	NA	
ENSG00000267733	AP005264.5	NA	
ENSG00000267076	CCDC58P3	NA	
ENSG00000267247	AP005264.3	NA	
ENSG00000267663	PPIAP56	NA	
ENSG00000176194	CIDEA	NA	
ENSG00000280302	AP005264.7	NA	
ENSG00000267069	AP005264.1	NA	
ENSG00000199702	RNU6-170P	NA	
ENSG00000176014	TUBB6	617732	FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD
ENSG00000141385	AFG3L2	610246	SPINOCEREBELLAR ATAXIA 28; SCA28
ENSG00000141385	AFG3L2	614487	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5
ENSG00000251937	RNU7-129P	NA	
ENSG00000141391	PRELID3A	NA	
ENSG00000267108	AP001029.1	NA	
ENSG00000267199	AP001029.2	NA	
ENSG00000134278	SPIRE1	NA	
ENSG00000267515	AP001029.3	NA	
ENSG00000128789	PSMG2	NA	
ENSG00000101624	CEP76	NA	
ENSG00000267249	AP005482.2	NA	
ENSG00000266961	AP005482.1	NA	
ENSG00000260302	LINC01882	NA	
ENSG00000201466	Y_RNA	NA	
ENSG00000175354	PTPN2	NA	
ENSG00000267570	STK25P1	NA	
ENSG00000267336	EIF4A2P1	NA	
ENSG00000085415	SEH1L	NA	
ENSG00000266969	AP002449.1	NA	
ENSG00000101639	CEP192	NA	
ENSG00000267656	AP001357.2	NA	
ENSG00000267032	AP001357.1	NA	
ENSG00000267286	AP001198.2	NA	
ENSG00000267239	AP001198.1	NA	
ENSG00000168675	LDLRAD4	NA	
ENSG00000267177	AP002505.1	NA	
ENSG00000279020	C18orf15	NA	
ENSG00000286926	AP002505.3	NA	
ENSG00000279275	AP002505.2	NA	
ENSG00000267393	AP002439.1	NA	
ENSG00000267690	LDLRAD4-AS1	NA	
ENSG00000266146	MIR5190	NA	
ENSG00000267694	AP005131.5	NA	
ENSG00000267529	AP005131.4	NA	
ENSG00000267702	AP005131.6	NA	
ENSG00000267366	AP005131.2	NA	
ENSG00000267136	AP005131.1	NA	
ENSG00000272746	AP005131.7	NA	
ENSG00000267503	AP005131.3	NA	
ENSG00000263527	MIR4526	NA	
ENSG00000266954	AP001010.1	NA	
ENSG00000177150	FAM210A	NA	
ENSG00000279962	AP001525.1	NA	
ENSG00000242707	RN7SL362P	NA	
ENSG00000101654	RNMT	NA	
ENSG00000176136	MC5R	NA	
ENSG00000185231	MC2R	202200	GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE
ENSG00000243779	AP001086.1	NA	
ENSG00000279352	AC006557.6	NA	
ENSG00000270469	AC006557.5	NA	
ENSG00000175322	ZNF519	NA	
ENSG00000267756	AC006557.4	NA	
ENSG00000267150	AC006557.1	NA	
ENSG00000267356	AC006557.3	NA	
ENSG00000267704	FRG2LP	NA	
ENSG00000267324	AC006557.2	NA	
ENSG00000175319	NF1P5	NA	
ENSG00000186481	ANKRD20A5P	NA	
ENSG00000212329	RNU6-316P	NA	
ENSG00000266145	RHOT1P1	NA	
ENSG00000283294	AP005212.4	NA	
ENSG00000274214	AP005212.2	NA	
ENSG00000265787	CYP4F35P	NA	
ENSG00000277743	AP005212.3	NA	
ENSG00000265437	AP005212.1	NA	
ENSG00000187589	TERF1P2	NA	
ENSG00000265296	FEM1AP2	NA	
ENSG00000286593	AP006261.1	NA	
ENSG00000266605	LONRF2P1	NA	
ENSG00000265766	CXADRP3	NA	
ENSG00000266242	GRAMD4P7	NA	
ENSG00000183206	POTEC	NA	
ENSG00000200132	RNU6-1021P	NA	
ENSG00000265340	OR4K7P	NA	
ENSG00000266693	OR4K8P	NA	
ENSG00000264570	SNX19P3	NA	
ENSG00000273732	VN1R74P	NA	
ENSG00000276318	GTF2IP8	NA	
ENSG00000180777	ANKRD30B	NA	
ENSG00000200645	RNU6-1210P	NA	
ENSG00000265737	AP006565.1	NA	
ENSG00000265499	MIR3156-2	NA	
ENSG00000265786	LINC01906	NA	
ENSG00000264061	FGF7P1	NA	
ENSG00000263618	AP005121.1	NA	
ENSG00000266554	LINC01443	NA	
ENSG00000264301	LINC01444	NA	
ENSG00000263821	AP005121.2	NA	
ENSG00000279042	AP005242.4	NA	
ENSG00000266522	AP005242.2	NA	
ENSG00000278923	AP005242.3	NA	
ENSG00000263635	AP005242.1	NA	
ENSG00000286815	AP005242.5	NA	
ENSG00000264880	AP005901.2	NA	
ENSG00000287723	AP005901.6	NA	
ENSG00000286293	AP005901.5	NA	
ENSG00000265015	AP005901.3	NA	
ENSG00000265631	BNIP3P3	NA	
ENSG00000266818	AP005901.4	NA	
ENSG00000215512	AP005901.1	NA	
ENSG00000222087	RNU6-721P	NA	
ENSG00000067900	ROCK1	NA	
ENSG00000244527	AC022795.1	NA	
ENSG00000251886	RNU6-120P	NA	
ENSG00000263748	EXOGP1	NA	
ENSG00000265984	AC022809.1	NA	
ENSG00000141449	GREB1L	617805	RENAL HYPODYSPLASIA/APLASIA 3; RHDA3
ENSG00000265948	AC015878.2	NA	
ENSG00000265751	AC015878.1	NA	
ENSG00000221139	AC011774.1	NA	
ENSG00000141446	ESCO1	NA	
ENSG00000167088	SNRPD1	NA	
ENSG00000158201	ABHD3	NA	
ENSG00000264188	AC106037.2	NA	
ENSG00000265656	AC106037.3	NA	
ENSG00000221493	MIR320C1	NA	
ENSG00000101752	MIB1	615092	LEFT VENTRICULAR NONCOMPACTION 7; LVNC7
ENSG00000252677	AC106037.1	NA	
ENSG00000200750	Y_RNA	NA	
ENSG00000242971	RN7SL233P	NA	
ENSG00000199977	SNORA73	NA	
ENSG00000265142	MIR133A1HG	NA	
ENSG00000283927	MIR133A1	NA	
ENSG00000284453	MIR1-2	NA	
ENSG00000243303	AC103987.1	NA	
ENSG00000264149	AC103987.2	NA	
ENSG00000252325	RNU6-1038P	NA	
ENSG00000264289	AC103987.3	NA	
ENSG00000222520	RNA5SP451	NA	
ENSG00000265758	LINC01900	NA	
ENSG00000263588	AC091043.1	NA	
ENSG00000221363	RNU6ATAC20P	NA	
ENSG00000266010	GATA6-AS1	NA	
ENSG00000141448	GATA6	187500	TETRALOGY OF FALLOT; TOF
ENSG00000141448	GATA6	217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM TRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED /.../RRUPTED AORTIC ARCH, INCLUDED
ENSG00000141448	GATA6	600001	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA;;PANCREATIC HYPOPLASIA, CONGENITAL, WITH DIABETES MELLITUS AND CONGENITAL HEART DISEASE;;PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS; PACHD
ENSG00000141448	GATA6	614474	ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5
ENSG00000141448	GATA6	614475	ATRIAL SEPTAL DEFECT 9; ASD9
ENSG00000264012	AC091588.1	NA	
ENSG00000201852	RNU6-702P	NA	
ENSG00000266283	AC091588.3	NA	
ENSG00000264825	AC091588.2	NA	
ENSG00000273348	AC027449.1	NA	
ENSG00000212710	CTAGE1	NA	
ENSG00000270855	AC099849.1	NA	
ENSG00000239490	RPS4XP18	NA	
ENSG00000206827	RNU6-1032P	NA	
ENSG00000265943	AC090912.1	NA	
ENSG00000266850	AC090912.2	NA	
ENSG00000101773	RBBP8	251255	JAWAD SYNDROME; JWDS;;KELLY SYNDROME;;MICROCEPHALY WITH MENTAL RETARDATION AND DIGITAL ANOMALIES
ENSG00000101773	RBBP8	606744	SECKEL SYNDROME 2; SCKL2;;SECKEL-TYPE DWARFISM 2;;MICROCEPHALIC PRIMORDIAL DWARFISM 2
ENSG00000273232	AC090912.3	NA	
ENSG00000265939	UBE2CP2	NA	
ENSG00000284331	MIR4741	NA	
ENSG00000242182	RN7SL745P	NA	
ENSG00000223023	Y_RNA	NA	
ENSG00000134508	CABLES1	NA	
ENSG00000134490	TMEM241	NA	
ENSG00000266495	AC011731.1	NA	
ENSG00000101782	RIOK3	NA	
ENSG00000199357	Y_RNA	NA	
ENSG00000283084	AC026634.1	NA	
ENSG00000141452	RMC1	NA	
ENSG00000141458	NPC1	257220	NIEMANN-PICK DISEASE, TYPE C1; NPC1;;NIEMANN-PICK DISEASE, TYPE C; NPC;;NIEMANN-PICK DISEASE WITH CHOLESTEROL ESTERIFICATION BLOCK;;NIEMANN-PICK DISEASE, SUBACUTE JUVENILE FORM;;NIEMANN-PICK DISEASE, CHRONIC NEURONOPATHIC FORM;;NIEMANN-PICK DISEASE  /.../T SPHINGOMYELINASE DEFICIENCY;;NEUROVISCERAL STORAGE DISEASE WITH VERTICAL SUPRANUCLEAR OPHTHALMOPLEGIA NIEMANN-PICK DISEASE, TYPE D, INCLUDED;;NIEMANN-PICK DISEASE, NOVA SCOTIAN TYPE, INCLUDED
ENSG00000199366	Y_RNA	NA	
ENSG00000154065	ANKRD29	NA	
ENSG00000267752	RPS10P27	NA	
ENSG00000053747	LAMA3	226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DIS /.../TYPE;;EPIDERMOLYSIS BULLOSA, GENERALIZED ATROPHIC BENIGN; GABEB EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT, INCLUDED;;JUNCTIONAL EPIDERMOLYSIS BULLOSA INVERSA, INCLUDED;;JEB-I, INCLUDED
ENSG00000053747	LAMA3	226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE;;JEB-HERLITZ TYPE;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ-PEARSON TYPE;;HERLITZ-PEARSON-TYPE EPIDERMOLYSIS BULLOSA;;EPIDERMOLYSIS BULLOSA LETALIS
ENSG00000053747	LAMA3	245660	LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS;;LOGIC SYNDROME
ENSG00000267301	RPL23AP77	NA	
ENSG00000265752	AC010754.1	NA	
ENSG00000168234	TTC39C	NA	
ENSG00000264745	TTC39C-AS1	NA	
ENSG00000265204	AC090772.2	NA	
ENSG00000264924	AC090772.1	NA	
ENSG00000206863	RNU5A-6P	NA	
ENSG00000279332	AC090772.4	NA	
ENSG00000154040	CABYR	NA	
ENSG00000265750	AC090772.3	NA	
ENSG00000141447	OSBPL1A	NA	
ENSG00000199874	RNA5SP452	NA	
ENSG00000273524	Metazoa_SRP	NA	
ENSG00000206766	RNU6-435P	NA	
ENSG00000212051	MIR320C2	NA	
ENSG00000264365	AC023983.1	NA	
ENSG00000273321	AC023983.2	NA	
ENSG00000154059	IMPACT	NA	
ENSG00000199636	Y_RNA	NA	
ENSG00000265094	AC007922.2	NA	
ENSG00000134489	HRH4	NA	
ENSG00000264695	AC007922.1	NA	
ENSG00000287611	AC007922.4	NA	
ENSG00000266489	AC007922.3	NA	
ENSG00000266181	EIF4A3P1	NA	
ENSG00000265485	LINC01915	NA	
ENSG00000266520	RAC1P1	NA	
ENSG00000266809	PPIAP57	NA	
ENSG00000266573	AC018697.1	NA	
ENSG00000264345	LINC01894	NA	
ENSG00000229248	WBP2P1	NA	
ENSG00000265552	AC104961.1	NA	
ENSG00000198795	ZNF521	NA	
ENSG00000285595	AC105114.2	NA	
ENSG00000279439	AC105114.1	NA	
ENSG00000264434	AC110603.1	NA	
ENSG00000242216	RN7SL97P	NA	
ENSG00000264193	AC027229.1	NA	
ENSG00000141380	SS18	NA	
ENSG00000243925	RPS24P18	NA	
ENSG00000154611	PSMA8	NA	
ENSG00000188985	DHFRP1	NA	
ENSG00000266227	NPM1P2	NA	
ENSG00000141384	TAF4B	615841	SPERMATOGENIC FAILURE 13; SPGF13
ENSG00000263829	SINHCAFP1	NA	
ENSG00000266237	AC121320.1	NA	
ENSG00000264911	AC022069.1	NA	
ENSG00000207160	RNU6-1289P	NA	
ENSG00000263862	LINC01543	NA	
ENSG00000134504	KCTD1	181270	SCALP-EAR-NIPPLE SYNDROME; SENS;;FINLAY-MARKS SYNDROME;;SEN SYNDROME
ENSG00000277534	AC007996.1	NA	
ENSG00000275805	AC090206.1	NA	
ENSG00000276221	MIR8057	NA	
ENSG00000263846	CIAPIN1P	NA	
ENSG00000260372	AQP4-AS1	NA	
ENSG00000263677	AC012588.1	NA	
ENSG00000265369	PCAT18	NA	
ENSG00000275900	AC012588.2	NA	
ENSG00000263382	AC018371.1	NA	
ENSG00000266184	AC018371.2	NA	
ENSG00000171885	AQP4	NA	
ENSG00000154080	CHST9	NA	
ENSG00000266549	AC023575.1	NA	
ENSG00000265374	LINC01908	NA	
ENSG00000264151	AC090403.1	NA	
ENSG00000264790	AC021382.1	NA	
ENSG00000244329	UBA52P9	NA	
ENSG00000263611	AC068408.1	NA	
ENSG00000265097	RBM22P1	NA	
ENSG00000263405	PA2G4P3	NA	
ENSG00000286465	AC068408.2	NA	
ENSG00000286426	AC090936.1	NA	
ENSG00000170558	CDH2	NA	
ENSG00000227279	AC110015.1	NA	
ENSG00000274578	AC006249.1	NA	
ENSG00000265994	AC090365.1	NA	
ENSG00000266296	ARIH2P1	NA	
ENSG00000271238	AC023932.1	NA	
ENSG00000251719	RNU6-408P	NA	
ENSG00000266479	AC105245.1	NA	
ENSG00000265980	AC074237.1	NA	
ENSG00000264587	AC117569.1	NA	
ENSG00000287803	AC117569.2	NA	
ENSG00000286605	AC115100.1	NA	
ENSG00000283218	MIR302F	NA	
ENSG00000266196	AC090506.1	NA	
ENSG00000279734	AC090506.2	NA	
ENSG00000265670	AC016382.1	NA	
ENSG00000251702	RNU6-857P	NA	
ENSG00000134762	DSC3	613102	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES
ENSG00000134755	DSC2	610476	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 11; ARVC11  ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11, AND MILD PALMOPLANTAR KERATODERMA WITH OR WITHOUT WOOLLY HAIR, INCLUDED
ENSG00000265888	DSCAS	NA	
ENSG00000134765	DSC1	NA	
ENSG00000263698	AC012417.1	NA	
ENSG00000134760	DSG1	148700	PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1;;KERATOSIS PALMOPLANTARIS STRIATA I;;STRIATE PALMOPLANTAR KERATODERMA I; SPPK1;;KERATODERMA, PALMOPLANTAR, STRIATE FORM I; KPPS1
ENSG00000134760	DSG1	615508	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE;;SEVERE DERMATITIS, MULTIPLE ALLERGIES, AND METABOLIC WASTING SYNDROME;;SAM SYNDROME
ENSG00000266729	DSG1-AS1	NA	
ENSG00000207019	RNU6-167P	NA	
ENSG00000175065	DSG4	607903	HYPOTRICHOSIS 6; HYPT6;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 1; LAH1;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE; LAH;;HTL;;MONILETHRIX-LIKE HYPOTRICHOSIS
ENSG00000207240	AC021549.1	NA	
ENSG00000134757	DSG3	NA	
ENSG00000266521	AC021549.2	NA	
ENSG00000046604	DSG2	610193	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 10; ARVC10
ENSG00000046604	DSG2	612877	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB
ENSG00000264859	DSG2-AS1	NA	
ENSG00000118271	TTR	145680	HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC; DTTRH;;HYPERTHYROXINEMIA, DYSPREALBUMINEMIC;;DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA;;EUTHRYROIDAL HYPERTHYROXINEMIA 2
ENSG00000118271	TTR	115430	CARPAL TUNNEL SYNDROME; CTS1;;CTS;;AMYOTROPHY, THENAR, OF CARPAL ORIGIN
ENSG00000118271	TTR	105210	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED;;HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED;;TRANSTHYRETIN AMYLOIDOSIS;;AMYLOID POLYNEUROPATHY, FAMILIAL; FAP AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED, INCLUDED;;AMYLOID CARDIOMYOPATHY, TRA /.../ETIN-RELATED, INCLUDED
ENSG00000118276	B4GALT6	NA	
ENSG00000259985	AC017100.1	NA	
ENSG00000200472	RN7SKP44	NA	
ENSG00000265158	LRRC37A7P	NA	
ENSG00000263772	AC017100.2	NA	
ENSG00000141437	SLC25A52	NA	
ENSG00000153339	TRAPPC8	NA	
ENSG00000263924	AC022960.1	NA	
ENSG00000276486	AC022960.3	NA	
ENSG00000276282	AC022960.2	NA	
ENSG00000222320	RNU6-1050P	NA	
ENSG00000263823	AC009831.1	NA	
ENSG00000265273	PGDP1	NA	
ENSG00000266105	AC009831.2	NA	
ENSG00000280380	AC009831.4	NA	
ENSG00000101695	RNF125	616260	TENORIO SYNDROME; TNORS;;OVERGROWTH, MACROCEPHALY, AND INTELLECTUAL DISABILITY SYNDROME
ENSG00000263917	AC011825.3	NA	
ENSG00000274275	AC009831.3	NA	
ENSG00000214917	AC011825.1	NA	
ENSG00000265008	AC011825.4	NA	
ENSG00000134758	RNF138	NA	
ENSG00000263393	AC011825.2	NA	
ENSG00000141441	GAREM1	NA	
ENSG00000199373	RNA5SP453	NA	
ENSG00000141434	MEP1B	NA	
ENSG00000265279	CLUHP6	NA	
ENSG00000263904	AC015563.1	NA	
ENSG00000222395	Y_RNA	NA	
ENSG00000264982	AC015563.2	NA	
ENSG00000215492	HNRNPA1P7	NA	
ENSG00000285095	AC025887.2	NA	
ENSG00000260389	WBP11P1	NA	
ENSG00000287994	AC009835.1	NA	
ENSG00000263688	AC025887.1	NA	
ENSG00000197705	KLHL14	NA	
ENSG00000228835	AC012123.1	NA	
ENSG00000243355	AC012123.2	NA	
ENSG00000263765	AC090371.2	NA	
ENSG00000166960	CCDC178	NA	
ENSG00000263450	AC090371.1	NA	
ENSG00000267642	AC091198.1	NA	
ENSG00000141431	ASXL3	615485	BAINBRIDGE-ROPERS SYNDROME; BRPS
ENSG00000101746	NOL4	NA	
ENSG00000199204	Y_RNA	NA	
ENSG00000280406	AC104985.3	NA	
ENSG00000267746	AC104985.1	NA	
ENSG00000278052	AC104985.2	NA	
ENSG00000134769	DTNA	604169	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1;;LEFT VENTRICULAR NONCOMPACTION 1 WITH OR WITHOUT CONGENITAL HEART DEFECTS
ENSG00000267585	AC013290.1	NA	
ENSG00000268873	AC022601.1	NA	
ENSG00000278464	AC068506.1	NA	
ENSG00000166974	MAPRE2	616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2
ENSG00000280096	AC015967.2	NA	
ENSG00000274400	AC015967.1	NA	
ENSG00000186812	ZNF397	NA	
ENSG00000186814	ZSCAN30	NA	
ENSG00000279989	AC011815.3	NA	
ENSG00000274184	AC011815.2	NA	
ENSG00000268573	AC011815.1	NA	
ENSG00000257267	ZNF271P	NA	
ENSG00000274918	AC116447.1	NA	
ENSG00000172466	ZNF24	NA	
ENSG00000186496	ZNF396	NA	
ENSG00000239683	AC007998.1	NA	
ENSG00000275512	AC007998.4	NA	
ENSG00000267583	AC007998.3	NA	
ENSG00000267140	AC007998.2	NA	
ENSG00000153391	INO80C	NA	
ENSG00000279074	AC007998.5	NA	
ENSG00000141429	GALNT1	NA	
ENSG00000283514	MIR3975	NA	
ENSG00000266965	AC090220.1	NA	
ENSG00000267397	AC090229.1	NA	
ENSG00000267797	NRBF2P1	NA	
ENSG00000207797	MIR187	NA	
ENSG00000265641	MIR3929	NA	
ENSG00000267627	AC118757.1	NA	
ENSG00000278986	AC091060.1	NA	
ENSG00000141428	C18orf21	NA	
ENSG00000141425	RPRD1A	NA	
ENSG00000141424	SLC39A6	NA	
ENSG00000134759	ELP2	617270	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58
ENSG00000260552	AC023043.1	NA	
ENSG00000075643	MOCOS	603592	XANTHINURIA, TYPE II; XAN2;;XANTHINE DEHYDROGENASE AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF
ENSG00000274849	AC023043.4	NA	
ENSG00000267404	AC023043.2	NA	
ENSG00000267456	AC023043.3	NA	
ENSG00000134775	FHOD3	NA	
ENSG00000286890	AC055840.1	NA	
ENSG00000134779	TPGS2	NA	
ENSG00000150477	KIAA1328	NA	
ENSG00000267039	AC016493.1	NA	
ENSG00000267651	AC015961.1	NA	
ENSG00000101489	CELF4	NA	
ENSG00000267707	AC015961.2	NA	
ENSG00000267202	AC090386.1	NA	
ENSG00000279678	AC090386.2	NA	
ENSG00000279543	AC129908.1	NA	
ENSG00000285940	AC009899.1	NA	
ENSG00000266530	MIR4318	NA	
ENSG00000243516	RPL12P40	NA	
ENSG00000286716	AC108452.1	NA	
ENSG00000268566	AC100781.1	NA	
ENSG00000222704	RN7SKP182	NA	
ENSG00000253038	RNU6-706P	NA	
ENSG00000267374	MIR924HG	NA	
ENSG00000283458	AC011139.1	NA	
ENSG00000175886	RPL7AP66	NA	
ENSG00000283615	MIR924	NA	
ENSG00000286559	AC099845.1	NA	
ENSG00000283645	MIR5583-2	NA	
ENSG00000266148	MIR5583-1	NA	
ENSG00000212354	RNU6-1242P	NA	
ENSG00000267413	LINC01901	NA	
ENSG00000283503	LINC01902	NA	
ENSG00000279034	AC011266.1	NA	
ENSG00000261715	LINC01477	NA	
ENSG00000267664	RPL17P45	NA	
ENSG00000286844	AC068688.1	NA	
ENSG00000286328	AC079052.1	NA	
ENSG00000267313	KC6	NA	
ENSG00000267652	NPM1P1	NA	
ENSG00000225253	AC011225.1	NA	
ENSG00000078142	PIK3C3	NA	
ENSG00000276174	AC087683.2	NA	
ENSG00000267088	AC087683.1	NA	
ENSG00000287007	AC087683.3	NA	
ENSG00000267586	LINC00907	NA	
ENSG00000253040	RNA5SP454	NA	
ENSG00000286976	AC084335.1	NA	
ENSG00000152214	RIT2	NA	
ENSG00000287209	AC100779.1	NA	
ENSG00000132872	SYT4	NA	
ENSG00000278933	AC022743.1	NA	
ENSG00000267716	AC083760.1	NA	
ENSG00000202060	RNA5SP455	NA	
ENSG00000285550	AC110014.1	NA	
ENSG00000267337	LINC01478	NA	
ENSG00000267573	KRT8P5	NA	
ENSG00000277899	MLECP1	NA	
ENSG00000267414	SETBP1-DT	NA	
ENSG00000152217	SETBP1	269150	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME;;SGS
ENSG00000152217	SETBP1	616078	MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29
ENSG00000280365	AC021766.1	NA	
ENSG00000265957	MIR4319	NA	
ENSG00000279319	AC105074.1	NA	
ENSG00000267101	AC090376.1	NA	
ENSG00000132874	SLC14A2	NA	
ENSG00000267097	SLC14A2-AS1	NA	
ENSG00000266988	AC021517.1	NA	
ENSG00000285790	AC021517.2	NA	
ENSG00000267354	AC091151.2	NA	
ENSG00000287943	AC091151.7	NA	
ENSG00000267193	AC091151.1	NA	
ENSG00000266968	AC023421.1	NA	
ENSG00000288545	AC023421.2	NA	
ENSG00000141469	SLC14A1	111000	BLOOD GROUP, KIDD SYSTEM; JK;;KIDD BLOOD GROUP SYSTEM
ENSG00000267558	AC087685.1	NA	
ENSG00000197046	SIGLEC15	NA	
ENSG00000152223	EPG5	242840	VICI SYNDROME; VICIS;;IMMUNODEFICIENCY WITH CLEFT LIP/PALATE, CATARACT, HYPOPIGMENTATION, AND ABSENT CORPUS CALLOSUM
ENSG00000152229	PSTPIP2	NA	
ENSG00000222179	RN7SKP26	NA	
ENSG00000267293	AC012569.1	NA	
ENSG00000252034	RNY4P37	NA	
ENSG00000152234	ATP5F1A	615228	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5A1 TYPE
ENSG00000152234	ATP5F1A	616045	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22; COXPD22
ENSG00000152240	HAUS1	NA	
ENSG00000251939	RNU6-1278P	NA	
ENSG00000152242	C18orf25	NA	
ENSG00000141622	RNF165	NA	
ENSG00000279829	AC015959.1	NA	
ENSG00000285993	AC018931.1	NA	
ENSG00000167210	LOXHD1	613079	DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77
ENSG00000101638	ST8SIA5	NA	
ENSG00000240983	AC090311.1	NA	
ENSG00000270112	AC090241.2	NA	
ENSG00000274776	AC090241.3	NA	
ENSG00000078043	PIAS2	NA	
ENSG00000267587	AC090241.1	NA	
ENSG00000279354	AC090373.1	NA	
ENSG00000167216	KATNAL2	NA	
ENSG00000288616	ELOA3D	NA	
ENSG00000275553	ELOA3C	NA	
ENSG00000288607	ELOA3B	NA	
ENSG00000288631	ELOA3	NA	
ENSG00000206181	ELOA2	NA	
ENSG00000280212	AC012254.5	NA	
ENSG00000266957	AC012254.1	NA	
ENSG00000267724	AC012254.3	NA	
ENSG00000167220	HDHD2	NA	
ENSG00000267228	AC012254.2	NA	
ENSG00000267800	AC012254.4	NA	
ENSG00000134049	IER3IP1	614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS
ENSG00000215474	SKOR2	NA	
ENSG00000201825	RNU6-1131P	NA	
ENSG00000287673	AC051635.1	NA	
ENSG00000267761	MIR4527HG	NA	
ENSG00000266582	MIR4527	NA	
ENSG00000279367	AC102797.2	NA	
ENSG00000261307	AC102797.1	NA	
ENSG00000267156	TPMTP1	NA	
ENSG00000267187	AC026898.1	NA	
ENSG00000175387	SMAD2	NA	
ENSG00000267541	MTCO2P2	NA	
ENSG00000279707	AC120349.3	NA	
ENSG00000269365	AC120349.1	NA	
ENSG00000279366	AC120349.2	NA	
ENSG00000184828	ZBTB7C	NA	
ENSG00000278891	AC105101.1	NA	
ENSG00000286583	AC105101.2	NA	
ENSG00000206944	RNU6-708P	NA	
ENSG00000280197	C18orf12	NA	
ENSG00000200872	RNA5SP456	NA	
ENSG00000277907	AC024288.1	NA	
ENSG00000266984	POLR3GP2	NA	
ENSG00000134030	CTIF	NA	
ENSG00000278983	AC048380.2	NA	
ENSG00000279629	AC048380.3	NA	
ENSG00000266276	MIR4743	NA	
ENSG00000267762	AC048380.1	NA	
ENSG00000279250	AC022919.1	NA	
ENSG00000267764	AC093567.1	NA	
ENSG00000101665	SMAD7	612229	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3;;COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 18
ENSG00000266905	AC114684.1	NA	
ENSG00000280335	AC016866.3	NA	
ENSG00000264269	AC016866.1	NA	
ENSG00000141627	DYM	223800	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC
ENSG00000141627	DYM	607326	SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC
ENSG00000263849	MIR4744	NA	
ENSG00000265128	AC016866.2	NA	
ENSG00000266696	AC044840.1	NA	
ENSG00000263895	AC100778.1	NA	
ENSG00000287518	AC100778.4	NA	
ENSG00000264971	PRR13P4	NA	
ENSG00000177576	C18orf32	NA	
ENSG00000215472	RPL17-C18orf32	NA	
ENSG00000263916	AC100778.2	NA	
ENSG00000265496	AC100778.3	NA	
ENSG00000284239	MIR1539	NA	
ENSG00000265681	RPL17	NA	
ENSG00000202093	SNORD58C	NA	
ENSG00000206602	SNORD58A	NA	
ENSG00000271982	SNORD58B	NA	
ENSG00000265182	SRP72P1	NA	
ENSG00000264464	LINC02837	NA	
ENSG00000101670	LIPG	NA	
ENSG00000267444	SMUG1P1	NA	
ENSG00000267674	AC090227.3	NA	
ENSG00000167315	ACAA2	NA	
ENSG00000266997	AC090227.2	NA	
ENSG00000267322	SNHG22	NA	
ENSG00000251992	SCARNA17	NA	
ENSG00000252139	AC090227.1	NA	
ENSG00000167306	MYO5B	251850	DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2;;MICROVILLUS INCLUSION DISEASE; MVID;;MICROVILLUS ATROPHY, CONGENITAL;;DAVIDSON DISEASE;;CONGENITAL FAMILIAL PROTRACTED DIARRHEA WITH ENTEROCYTE BRUSH-BORDER ABNORMALITIES
ENSG00000201668	Y_RNA	NA	
ENSG00000200527	RNA5SP457	NA	
ENSG00000267196	AC091044.1	NA	
ENSG00000267511	ADAD1P2	NA	
ENSG00000267591	AC105224.1	NA	
ENSG00000283343	MIR4320	NA	
ENSG00000240663	RN7SL310P	NA	
ENSG00000172361	CFAP53	614779	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6
ENSG00000277310	AC090246.1	NA	
ENSG00000141644	MBD1	NA	
ENSG00000154832	CXXC1	NA	
ENSG00000267695	AC105227.1	NA	
ENSG00000274930	AC105227.2	NA	
ENSG00000251997	RNA5SP458	NA	
ENSG00000154839	SKA1	NA	
ENSG00000239780	RPLP0P11	NA	
ENSG00000141639	MAPK4	NA	
ENSG00000287381	AC012433.2	NA	
ENSG00000267713	AC012433.1	NA	
ENSG00000134042	MRO	NA	
ENSG00000267233	HNRNPA3P16	NA	
ENSG00000239689	RPL17P46	NA	
ENSG00000082212	ME2	NA	
ENSG00000200752	Y_RNA	NA	
ENSG00000141642	ELAC1	NA	
ENSG00000267699	AC091551.1	NA	
ENSG00000141646	SMAD4	175050	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT;;JP/HHT SYNDROME;;JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA;;JPS/HHT;;TELANGIECTASIA, HEREDITARY HEMORRHAGIC, WITH JUVENILE POLYPOSIS COLI;;POLYPOSIS, GENERA /.../JUVENILE, WITH PULMONARY ARTERIOVENOUS MALFORMATION
ENSG00000141646	SMAD4	174900	JUVENILE POLYPOSIS SYNDROME; JPS;;POLYPOSIS, JUVENILE INTESTINAL; PJI;;JUVENILE INTESTINAL POLYPOSIS; JIP;;POLYPOSIS, FAMILIAL, OF ENTIRE GASTROINTESTINAL TRACT JUVENILE POLYPOSIS OF STOMACH, INCLUDED;;JUVENILE POLYPOSIS COLI, INCLUDED
ENSG00000141646	SMAD4	139210	MYHRE SYNDROME; MYHRS;;GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE;;LARYNGOTRACHEAL STENOSIS, ARTHROPATHY, PROGNATHISM, AND SHORT STATURE; LAPS SYNDROME
ENSG00000141646	SMAD4	260350	PANCREATIC CANCER;;PANCREATIC CARCINOMA;;PANCREATIC ACINAR CARCINOMA
ENSG00000267717	SRSF10P1	NA	
ENSG00000176624	MEX3C	NA	
ENSG00000207154	RNU1-46P	NA	
ENSG00000227115	LINC01630	NA	
ENSG00000266201	SS18L2P2	NA	
ENSG00000266003	AC109315.1	NA	
ENSG00000265402	RSL24D1P9	NA	
ENSG00000265712	AC027216.1	NA	
ENSG00000215457	RPS8P3	NA	
ENSG00000286283	AC016383.3	NA	
ENSG00000285695	AC016383.2	NA	
ENSG00000266335	AC016383.1	NA	
ENSG00000187323	DCC	157600	MIRROR MOVEMENTS 1; MRMV1;;MIRROR MOVEMENTS 1 AND/OR AGENESIS OF THE CORPUS CALLOSUM;;MIRROR MOVEMENTS, CONGENITAL;;BIMANUAL SYNERGIA
ENSG00000187323	DCC	133239	ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED;;ESCC, SUSCEPTIBILITY TO, INCLUDED;;AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO, INCLUDED;;GASTRIC CARDIA ADENOCARCINOMA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000187323	DCC	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000187323	DCC	617542	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2;;DEVELOPMENTAL SPLIT-BRAIN SYNDROME
ENSG00000280098	AC011155.1	NA	
ENSG00000273762	VN1R76P	NA	
ENSG00000263872	MIR4528	NA	
ENSG00000260433	LINC01917	NA	
ENSG00000263438	LINC01919	NA	
ENSG00000242945	RPL29P32	NA	
ENSG00000264296	AC090666.1	NA	
ENSG00000134046	MBD2	NA	
ENSG00000207233	SNORA37	NA	
ENSG00000277324	AC093462.1	NA	
ENSG00000101751	POLI	NA	
ENSG00000174448	STARD6	NA	
ENSG00000166845	C18orf54	NA	
ENSG00000264350	SNRPGP2	NA	
ENSG00000283613	CUPIN1P	NA	
ENSG00000264564	AC090897.1	NA	
ENSG00000267428	AC091135.1	NA	
ENSG00000288484	AC091135.2	NA	
ENSG00000178690	DYNAP	NA	
ENSG00000041353	RAB27B	NA	
ENSG00000267524	RPSAP57	NA	
ENSG00000267311	AC007673.1	NA	
ENSG00000267112	AC098848.1	NA	
ENSG00000166510	CCDC68	NA	
ENSG00000267647	MAP1LC3P	NA	
ENSG00000267013	LINC01929	NA	
ENSG00000252437	RNA5SP459	NA	
ENSG00000196628	TCF4	610954	PITT-HOPKINS SYNDROME; PTHS;;ENCEPHALOPATHY, SEVERE EPILEPTIC, WITH AUTONOMIC DYSFUNCTION;;MENTAL RETARDATION, SYNDROMAL, WITH INTERMITTENT HYPERVENTILATION
ENSG00000196628	TCF4	613267	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3;;FCD2 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET
ENSG00000267028	TCF4-AS1	NA	
ENSG00000264571	MIR4529	NA	
ENSG00000267402	TCF4-AS2	NA	
ENSG00000267284	AC022031.2	NA	
ENSG00000242320	RPL21P126	NA	
ENSG00000267325	LINC01415	NA	
ENSG00000267172	AC022031.1	NA	
ENSG00000287944	AC027584.1	NA	
ENSG00000260930	LINC01416	NA	
ENSG00000267327	AC009271.1	NA	
ENSG00000206129	AC006305.1	NA	
ENSG00000287248	AC009271.2	NA	
ENSG00000267057	LINC01905	NA	
ENSG00000267399	AC006305.2	NA	
ENSG00000201816	SNORA73	NA	
ENSG00000267712	LINC01539	NA	
ENSG00000267732	AC006305.3	NA	
ENSG00000091164	TXNL1	NA	
ENSG00000091157	WDR7	NA	
ENSG00000206865	Y_RNA	NA	
ENSG00000267146	AC012301.1	NA	
ENSG00000212539	U3	NA	
ENSG00000267225	WDR7-OT1	NA	
ENSG00000286777	AC012301.2	NA	
ENSG00000258609	LINC-ROR	NA	
ENSG00000267789	AC100775.1	NA	
ENSG00000228075	BOD1L2	NA	
ENSG00000267726	LINC02565	NA	
ENSG00000202240	RNU6-737P	NA	
ENSG00000177511	ST8SIA3	NA	
ENSG00000277837	AC090340.1	NA	
ENSG00000119547	ONECUT2	NA	
ENSG00000066926	FECH	177000	PROTOPORPHYRIA, ERYTHROPOIETIC, 1; EPP1;;PROTOPORPHYRIA, ERYTHROPOIETIC; EPP;;ERYTHROHEPATIC PROTOPORPHYRIA;;HEME SYNTHETASE DEFICIENCY;;FERROCHELATASE DEFICIENCY
ENSG00000278703	AC100847.1	NA	
ENSG00000134440	NARS1	NA	
ENSG00000267040	AC027097.1	NA	
ENSG00000267787	AC027097.2	NA	
ENSG00000081923	ATP8B1	147480	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1;;CHOLESTASIS, PREGNANCY-RELATED, 1
ENSG00000081923	ATP8B1	211600	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1;;BYLER DISEASE
ENSG00000081923	ATP8B1	243300	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1;;SUMMERSKILL SYNDROME
ENSG00000202159	RNU6-742P	NA	
ENSG00000231544	RSL24D1P11	NA	
ENSG00000267209	LINC01897	NA	
ENSG00000235028	HMGN1P30	NA	
ENSG00000049759	NEDD4L	617201	PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7
ENSG00000267743	AC107896.1	NA	
ENSG00000267504	AC090236.2	NA	
ENSG00000267396	AC090236.1	NA	
ENSG00000267675	AC105105.2	NA	
ENSG00000267391	MIR122HG	NA	
ENSG00000284440	MIR122	NA	
ENSG00000207778	MIR3591	NA	
ENSG00000276403	AC105105.4	NA	
ENSG00000198796	ALPK2	NA	
ENSG00000274354	AC105105.3	NA	
ENSG00000267257	AC105105.1	NA	
ENSG00000267579	AC104971.2	NA	
ENSG00000252284	SNORA108	NA	
ENSG00000239659	RPL9P31	NA	
ENSG00000275418	AC104971.3	NA	
ENSG00000267226	AC104971.1	NA	
ENSG00000172175	MALT1	615468	IMMUNODEFICIENCY 12; IMD12
ENSG00000267476	AC104365.2	NA	
ENSG00000266946	MRPL37P1	NA	
ENSG00000267705	AC104365.4	NA	
ENSG00000267501	AC104365.3	NA	
ENSG00000201598	RNU6-219P	NA	
ENSG00000267593	LINC01926	NA	
ENSG00000199713	AC104365.1	NA	
ENSG00000074657	ZNF532	NA	
ENSG00000251870	RNU2-69P	NA	
ENSG00000224367	OACYLP	NA	
ENSG00000267215	AC040963.1	NA	
ENSG00000166562	SEC11C	NA	
ENSG00000134443	GRP	NA	
ENSG00000134438	RAX	611038	MICROPHTHALMIA, ISOLATED 3; MCOP3
ENSG00000166569	CPLX4	NA	
ENSG00000074695	LMAN1	227300	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1;;FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY I; FMFD1;;FMFD I;;MULTIPLE COAGULATION FACTOR DEFICIENCY I; MCFD1
ENSG00000267677	AC016229.2	NA	
ENSG00000183287	CCBE1	235510	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1;;HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME;;LYMPHATIC DYSPLASIA, GENERALIZED
ENSG00000267000	AC016229.1	NA	
ENSG00000267061	AC090213.1	NA	
ENSG00000267269	AC010776.1	NA	
ENSG00000267774	AC010776.2	NA	
ENSG00000273664	AC010776.3	NA	
ENSG00000224161	RPS26P54	NA	
ENSG00000267486	GLUD1P4	NA	
ENSG00000267669	AC098847.1	NA	
ENSG00000141682	PMAIP1	NA	
ENSG00000267066	AC107990.1	NA	
ENSG00000267497	NFE2L3P1	NA	
ENSG00000239398	RN7SL342P	NA	
ENSG00000256704	ENTR1P1	NA	
ENSG00000267462	AC090377.1	NA	
ENSG00000267742	SINHCAFP2	NA	
ENSG00000252555	RNU6-567P	NA	
ENSG00000267686	AC090771.2	NA	
ENSG00000242060	RPS3AP49	NA	
ENSG00000202468	RNU4-17P	NA	
ENSG00000267620	AC090771.1	NA	
ENSG00000267401	AC090621.1	NA	
ENSG00000285681	AC091576.1	NA	
ENSG00000166603	MC4R	618406	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20;;OBESITY;;MELANOCORTIN 4 RECEPTOR DEFICIENCY;;MC4R DEFICIENCY OBESITY, RESISTANCE TO, INCLUDED
ENSG00000267400	AC010928.2	NA	
ENSG00000266915	MRPS5P4	NA	
ENSG00000267687	AC010928.3	NA	
ENSG00000267382	AC010928.1	NA	
ENSG00000267098	AC113137.1	NA	
ENSG00000267153	CTBP2P3	NA	
ENSG00000267513	HMGN1P31	NA	
ENSG00000101542	CDH20	NA	
ENSG00000206769	RNU6-116P	NA	
ENSG00000243256	RPL30P14	NA	
ENSG00000267316	AC090409.2	NA	
ENSG00000267279	AC090409.1	NA	
ENSG00000267175	AC105094.2	NA	
ENSG00000267038	AC105094.1	NA	
ENSG00000260440	LINC01544	NA	
ENSG00000176641	RNF152	NA	
ENSG00000197563	PIGN	614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 3; GPIBD3
ENSG00000267597	RPIAP1	NA	
ENSG00000134444	RELCH	NA	
ENSG00000266900	AC027514.1	NA	
ENSG00000267560	AC027514.2	NA	
ENSG00000141655	TNFRSF11A	174810	FAMILIAL EXPANSILE OSTEOLYSIS; FEO;;POLYOSTOTIC OSTEOLYTIC DYSPLASIA, HEREDITARY EXPANSILE; HEPOD;;MCCABE DISEASE;;EXPANSILE OSTEOLYSIS, FAMILIAL; EOF
ENSG00000141655	TNFRSF11A	602080	PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2
ENSG00000141655	TNFRSF11A	612301	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7;;OSTEOPETROSIS, OSTEOCLAST-POOR, WITH HYPOGAMMAGLOBULINEMIA
ENSG00000199867	Y_RNA	NA	
ENSG00000267341	AC100843.1	NA	
ENSG00000241088	RPL17P44	NA	
ENSG00000267487	AC100843.2	NA	
ENSG00000266920	ACTBP9	NA	
ENSG00000141664	ZCCHC2	NA	
ENSG00000278017	AC064801.1	NA	
ENSG00000279236	AC064801.2	NA	
ENSG00000243549	RN7SL705P	NA	
ENSG00000081913	PHLPP1	NA	
ENSG00000206746	RNU6-142P	NA	
ENSG00000171791	BCL2	151430	B-CELL CLL/LYMPHOMA 2; BCL2;;ONCOGENE B-CELL LEUKEMIA 2 LEUKEMIA/LYMPHOMA, B-CELL, 2, INCLUDED
ENSG00000267766	AC022726.1	NA	
ENSG00000283125	AC022726.2	NA	
ENSG00000119537	KDSR	617526	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4
ENSG00000267390	AC036176.1	NA	
ENSG00000119541	VPS4B	NA	
ENSG00000267430	AC036176.2	NA	
ENSG00000206075	SERPINB5	NA	
ENSG00000269989	AC036176.3	NA	
ENSG00000214318	ATP5MC1P6	NA	
ENSG00000166634	SERPINB12	NA	
ENSG00000197641	SERPINB13	NA	
ENSG00000206073	SERPINB4	NA	
ENSG00000206072	SERPINB11	NA	
ENSG00000057149	SERPINB3	NA	
ENSG00000166396	SERPINB7	615598	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN
ENSG00000197632	SERPINB2	NA	
ENSG00000242550	SERPINB10	NA	
ENSG00000221887	HMSD	NA	
ENSG00000283667	AC009802.1	NA	
ENSG00000166401	SERPINB8	617115	PEELING SKIN SYNDROME 5; PSS5
ENSG00000267134	LINC01924	NA	
ENSG00000237314	RPL12P39	NA	
ENSG00000179676	LINC00305	NA	
ENSG00000266952	LINC01538	NA	
ENSG00000275448	AC027506.1	NA	
ENSG00000286800	AC090348.1	NA	
ENSG00000263863	AC007948.1	NA	
ENSG00000264131	AC007631.1	NA	
ENSG00000264232	LINC01916	NA	
ENSG00000265217	AC090358.1	NA	
ENSG00000081138	CDH7	NA	
ENSG00000263720	AC023394.2	NA	
ENSG00000263622	AC023394.1	NA	
ENSG00000264685	PRPF19P1	NA	
ENSG00000071991	CDH19	NA	
ENSG00000238680	RNU6-1037P	NA	
ENSG00000263354	MIR5011	NA	
ENSG00000264054	RPL31P9	NA	
ENSG00000265936	AC091042.1	NA	
ENSG00000260578	AC110597.1	NA	
ENSG00000171451	DSEL	NA	
ENSG00000263424	AC110597.3	NA	
ENSG00000265533	AC114689.3	NA	
ENSG00000264040	AC022662.1	NA	
ENSG00000263594	AC022655.1	NA	
ENSG00000265472	AC022655.2	NA	
ENSG00000264104	AC114689.1	NA	
ENSG00000265555	LINC01903	NA	
ENSG00000265240	AC114689.2	NA	
ENSG00000264634	AC100844.1	NA	
ENSG00000264869	AC068112.1	NA	
ENSG00000287907	AC005909.2	NA	
ENSG00000264699	LINC01912	NA	
ENSG00000260747	AC022968.1	NA	
ENSG00000265425	AC005909.1	NA	
ENSG00000263355	AKR1B10P2	NA	
ENSG00000264697	AC067819.1	NA	
ENSG00000166479	TMX3	NA	
ENSG00000150636	CCDC102B	NA	
ENSG00000276092	AC040896.1	NA	
ENSG00000263637	AC022035.1	NA	
ENSG00000207072	RNU6-39P	NA	
ENSG00000264444	SDHCP1	NA	
ENSG00000264472	AC096708.2	NA	
ENSG00000273584	AC096708.3	NA	
ENSG00000264236	AC096708.1	NA	
ENSG00000264705	AC090337.1	NA	
ENSG00000285748	AC090337.2	NA	
ENSG00000278532	AC026585.1	NA	
ENSG00000206052	DOK6	NA	
ENSG00000264845	AC119868.1	NA	
ENSG00000265643	AC119868.2	NA	
ENSG00000279221	AC068254.2	NA	
ENSG00000266840	AC068254.1	NA	
ENSG00000150637	CD226	NA	
ENSG00000176225	RTTN	614833	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP;;POLYMICROGYRIA WITH SEIZURES; PMGYS
ENSG00000287646	AC021701.1	NA	
ENSG00000170677	SOCS6	NA	
ENSG00000266258	LINC01909	NA	
ENSG00000266304	LIVAR	NA	
ENSG00000266278	LINC01910	NA	
ENSG00000265698	LARP7P3	NA	
ENSG00000214255	RPS2P6	NA	
ENSG00000278971	AC091305.1	NA	
ENSG00000286642	AC091646.1	NA	
ENSG00000239748	RN7SL795P	NA	
ENSG00000263417	GTSCR1	NA	
ENSG00000265781	AC090415.2	NA	
ENSG00000265639	AC090415.1	NA	
ENSG00000287693	AC091691.3	NA	
ENSG00000265484	AC091691.2	NA	
ENSG00000263733	AC091691.1	NA	
ENSG00000260676	LINC01541	NA	
ENSG00000264388	AC090312.1	NA	
ENSG00000265946	AC090312.2	NA	
ENSG00000265352	LINC01899	NA	
ENSG00000260457	AC027458.1	NA	
ENSG00000265995	AC069114.1	NA	
ENSG00000271313	AC069114.2	NA	
ENSG00000141668	CBLN2	NA	
ENSG00000264315	HNRNPA1P11	NA	
ENSG00000166342	NETO1	NA	
ENSG00000265579	AC023301.1	NA	
ENSG00000252598	RNA5SP460	NA	
ENSG00000263750	MIR548AV	NA	
ENSG00000263958	AC091138.1	NA	
ENSG00000263711	LINC02864	NA	
ENSG00000261780	LINC02582	NA	
ENSG00000265380	AC079070.1	NA	
ENSG00000241866	RN7SL401P	NA	
ENSG00000263655	AC090125.1	NA	
ENSG00000278902	AC010947.1	NA	
ENSG00000287314	AC090125.2	NA	
ENSG00000141665	FBXO15	NA	
ENSG00000075336	TIMM21	NA	
ENSG00000260569	AC090398.1	NA	
ENSG00000243856	RN7SL551P	NA	
ENSG00000166347	CYB5A	250790	METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG;;ISOLATED 17,20-LYASE DEFICIENCY, PURE;;METHEMOGLOBINEMIA TYPE IV, FORMERLY;;METHEMOGLOBINEMIA DUE TO DEFICIENCY OF CYTOCHROME b5, FORMERLY
ENSG00000286529	AC090398.2	NA	
ENSG00000206043	C18orf63	NA	
ENSG00000235297	FAUP1	NA	
ENSG00000259779	LINC01922	NA	
ENSG00000187773	DIPK1C	NA	
ENSG00000287689	AC009704.3	NA	
ENSG00000133313	CNDP2	NA	
ENSG00000276934	AC009704.2	NA	
ENSG00000150656	CNDP1	NA	
ENSG00000264340	AC009704.1	NA	
ENSG00000264247	LINC00909	NA	
ENSG00000215421	ZNF407	NA	
ENSG00000278607	AC015819.2	NA	
ENSG00000273669	AC015819.1	NA	
ENSG00000283452	AC015819.4	NA	
ENSG00000278911	AC015819.3	NA	
ENSG00000285915	AC015819.5	NA	
ENSG00000180011	ZADH2	NA	
ENSG00000179981	TSHZ1	607842	AURAL ATRESIA, CONGENITAL; CAA;;AURAL ATRESIA, CONGENITAL, WITH HYPOSMIA
ENSG00000276993	AC116003.3	NA	
ENSG00000264116	AC116003.1	NA	
ENSG00000206026	SMIM21	NA	
ENSG00000266774	AC116003.2	NA	
ENSG00000287281	AC012101.2	NA	
ENSG00000286603	AC012101.1	NA	
ENSG00000287295	AC090812.1	NA	
ENSG00000287993	AC090338.1	NA	
ENSG00000261194	LINC01898	NA	
ENSG00000266460	AC021506.1	NA	
ENSG00000275827	AC021506.2	NA	
ENSG00000264108	AC090457.1	NA	
ENSG00000263547	AC011095.1	NA	
ENSG00000266743	AC103808.6	NA	
ENSG00000264260	LINC01893	NA	
ENSG00000264595	AC103808.2	NA	
ENSG00000266014	AC103808.4	NA	
ENSG00000265717	AC103808.3	NA	
ENSG00000264212	AC103808.1	NA	
ENSG00000266614	AC103808.5	NA	
ENSG00000101493	ZNF516	NA	
ENSG00000263982	AC009716.1	NA	
ENSG00000280205	AC009716.2	NA	
ENSG00000265778	AC018413.1	NA	
ENSG00000275763	ZNF516-DT	NA	
ENSG00000266256	LINC00683	NA	
ENSG00000286090	AC034110.1	NA	
ENSG00000266312	LINC01927	NA	
ENSG00000276397	LINC01879	NA	
ENSG00000265934	ARL2BPP1	NA	
ENSG00000265836	CCND3P2	NA	
ENSG00000265626	AC139085.1	NA	
ENSG00000264278	ZNF236-DT	NA	
ENSG00000252097	RNU6-346P	NA	
ENSG00000278107	AC027575.2	NA	
ENSG00000130856	ZNF236	NA	
ENSG00000244229	RPL26P35	NA	
ENSG00000275355	Metazoa_SRP	NA	
ENSG00000265261	AC027575.1	NA	
ENSG00000266844	AC093330.1	NA	
ENSG00000197971	MBP	NA	
ENSG00000279811	AC093330.2	NA	
ENSG00000287680	AC093330.3	NA	
ENSG00000275178	AC018529.1	NA	
ENSG00000279433	AC018529.3	NA	
ENSG00000278330	AC018529.2	NA	
ENSG00000265844	AC100863.1	NA	
ENSG00000166573	GALR1	NA	
ENSG00000264015	AC124254.2	NA	
ENSG00000199392	AC124254.1	NA	
ENSG00000264736	BDP1P	NA	
ENSG00000264693	AC123786.1	NA	
ENSG00000271702	AC123786.2	NA	
ENSG00000286727	AC123786.3	NA	
ENSG00000252260	RNA5SP461	NA	
ENSG00000265843	LINC01029	NA	
ENSG00000264334	AC134978.1	NA	
ENSG00000199728	RNU6-655P	NA	
ENSG00000266213	AC107892.1	NA	
ENSG00000265644	AC087399.1	NA	
ENSG00000265378	AC012572.1	NA	
ENSG00000201723	Y_RNA	NA	
ENSG00000266273	AC044873.1	NA	
ENSG00000266586	AC091027.2	NA	
ENSG00000265101	AC091027.1	NA	
ENSG00000287758	AC091027.3	NA	
ENSG00000263146	LINC01896	NA	
ENSG00000256463	SALL3	NA	
ENSG00000166377	ATP9B	NA	
ENSG00000279416	AC099689.1	NA	
ENSG00000267655	AC125437.1	NA	
ENSG00000279474	AC125437.2	NA	
ENSG00000286245	AC125437.3	NA	
ENSG00000267628	AC104423.1	NA	
ENSG00000267015	AC023090.1	NA	
ENSG00000279077	AC023090.2	NA	
ENSG00000131196	NFATC1	NA	
ENSG00000279637	AC018445.3	NA	
ENSG00000286186	AC018445.5	NA	
ENSG00000275186	AC018445.1	NA	
ENSG00000279981	AC018445.4	NA	
ENSG00000279397	AC018445.2	NA	
ENSG00000286296	AC018445.6	NA	
ENSG00000267287	AC068473.3	NA	
ENSG00000267409	AC068473.4	NA	
ENSG00000178412	AC068473.1	NA	
ENSG00000274828	AC068473.5	NA	
ENSG00000060069	CTDP1	604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN;;CATARACT, CONGENITAL, WITH FACIAL DYSMORPHISM AND NEUROPATHY
ENSG00000266901	AC068473.2	NA	
ENSG00000266924	AC021594.1	NA	
ENSG00000267780	AC021594.2	NA	
ENSG00000178342	KCNG2	NA	
ENSG00000278075	AC114341.1	NA	
ENSG00000122490	SLC66A2	NA	
ENSG00000287879	AC114341.2	NA	
ENSG00000226742	HSBP1L1	NA	
ENSG00000141759	TXNL4A	608572	BURN-MCKEOWN SYNDROME; BMKS;;OCULOOTOFACIAL DYSPLASIA; OOFD
ENSG00000267127	AC090360.1	NA	
ENSG00000101546	RBFA	NA	
ENSG00000261126	RBFADN	NA	
ENSG00000266909	SLC25A6P4	NA	
ENSG00000101544	ADNP2	NA	
ENSG00000267270	PARD6G-AS1	NA	
ENSG00000178184	PARD6G	NA	
ENSG00000278000	AC139100.2	NA	
ENSG00000267251	AC139100.1	NA	
ENSG00000282458	WASH5P	NA	
ENSG00000282542	AC008993.1	NA	
ENSG00000282798	AC008993.2	NA	
ENSG00000282807	AC008993.3	NA	
ENSG00000283801	MIR1302-11	NA	
ENSG00000282591	FAM138F	NA	
ENSG00000282137	OR4G3P	NA	
ENSG00000267310	OR4G1P	NA	
ENSG00000176695	OR4F17	NA	
ENSG00000267792	WBP1LP11	NA	
ENSG00000266971	OR4F8P	NA	
ENSG00000282535	AC092192.1	NA	
ENSG00000281379	SEPTIN14P19	NA	
ENSG00000282059	CICP19	NA	
ENSG00000282416	AC092299.1	NA	
ENSG00000282051	AC010507.1	NA	
ENSG00000282508	LINC01002	NA	
ENSG00000282339	AC010507.2	NA	
ENSG00000222329	RNU6-1076P	NA	
ENSG00000282393	AC016588.2	NA	
ENSG00000141934	PLPP2	NA	
ENSG00000105556	MIER2	NA	
ENSG00000267124	AC016588.1	NA	
ENSG00000105549	THEG	NA	
ENSG00000286667	AC010641.2	NA	
ENSG00000267443	AC010641.1	NA	
ENSG00000183186	C2CD4C	NA	
ENSG00000129946	SHC2	NA	
ENSG00000252539	RNA5SP462	NA	
ENSG00000181781	ODF3L2	NA	
ENSG00000099866	MADCAM1	NA	
ENSG00000266933	AC005775.1	NA	
ENSG00000141933	TPGS1	NA	
ENSG00000099804	CDC34	NA	
ENSG00000197540	GZMM	NA	
ENSG00000267751	AC009005.1	NA	
ENSG00000172270	BSG	111380	BLOOD GROUP--OK; OK
ENSG00000099822	HCN2	NA	
ENSG00000267036	AC005559.1	NA	
ENSG00000099821	POLRMT	NA	
ENSG00000261204	AC004449.1	NA	
ENSG00000070388	FGF22	NA	
ENSG00000070423	RNF126	NA	
ENSG00000267666	AC004156.1	NA	
ENSG00000070404	FSTL3	NA	
ENSG00000185198	PRSS57	NA	
ENSG00000213726	RPS2P52	NA	
ENSG00000099864	PALM	NA	
ENSG00000099812	MISP	NA	
ENSG00000272473	AC006273.1	NA	
ENSG00000267530	LINC01836	NA	
ENSG00000011304	PTBP1	NA	
ENSG00000284361	MIR4745	NA	
ENSG00000129951	PLPPR3	NA	
ENSG00000263414	MIR3187	NA	
ENSG00000172232	AZU1	NA	
ENSG00000196415	PRTN3	NA	
ENSG00000197561	ELANE	162800	CYCLIC NEUTROPENIA;;CYCLIC HEMATOPOIESIS
ENSG00000197561	ELANE	202700	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1
ENSG00000197766	CFD	613912	COMPLEMENT FACTOR D DEFICIENCY; CFDD;;FACTOR D DEFICIENCY
ENSG00000175221	MED16	NA	
ENSG00000207507	RNU6-9	NA	
ENSG00000198858	R3HDM4	NA	
ENSG00000116014	KISS1R	176400	PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1
ENSG00000116014	KISS1R	614837	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8
ENSG00000116017	ARID3A	NA	
ENSG00000267159	AC005379.1	NA	
ENSG00000275162	AC005391.1	NA	
ENSG00000065268	WDR18	NA	
ENSG00000266990	AC004528.1	NA	
ENSG00000116032	GRIN3B	NA	
ENSG00000182087	TMEM259	NA	
ENSG00000274177	AC004528.2	NA	
ENSG00000207357	RNU6-2	NA	
ENSG00000064666	CNN2	NA	
ENSG00000279753	AC011558.1	NA	
ENSG00000064687	ABCA7	608907	ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9;;ALZHEIMER DISEASE 9, LATE-ONSET
ENSG00000180448	ARHGAP45	NA	
ENSG00000099817	POLR2E	NA	
ENSG00000167468	GPX4	250220	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS;;SEDAGHATIAN CHONDRODYSPLASIA;;METAPHYSEAL CHONDRODYSPLASIA, CONGENITAL LETHAL
ENSG00000064932	SBNO2	NA	
ENSG00000118046	STK11	175200	PEUTZ-JEGHERS SYNDROME; PJS;;POLYPOSIS, HAMARTOMATOUS INTESTINAL;;POLYPS-AND-SPOTS SYNDROME
ENSG00000118046	STK11	260350	PANCREATIC CANCER;;PANCREATIC CARCINOMA;;PANCREATIC ACINAR CARCINOMA
ENSG00000118046	STK11	273300	TESTICULAR GERM CELL TUMOR; TGCT;;MALE GERM CELL TUMOR; MGCT SEMINOMA, INCLUDED;;NONSEMINOMATOUS GERM CELL TUMORS, INCLUDED;;TERATOMA, TESTICULAR, INCLUDED;;EMBRYONAL CELL CARCINOMA, INCLUDED;;ENDODERMAL SINUS TUMOR, INCLUDED;;SPERMATOCYTIC SEMINOMA /.../UDED
ENSG00000267736	HMGB2P1	NA	
ENSG00000099625	CBARP	NA	
ENSG00000267778	AC004221.1	NA	
ENSG00000099624	ATP5F1D	618120	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5F1D TYPE
ENSG00000167470	MIDN	NA	
ENSG00000099622	CIRBP	NA	
ENSG00000267493	CIRBP-AS1	NA	
ENSG00000228300	FAM174C	NA	
ENSG00000099617	EFNA2	NA	
ENSG00000240846	RPS15P9	NA	
ENSG00000267372	AC005330.1	NA	
ENSG00000160953	PWWP3A	NA	
ENSG00000279488	AC004623.1	NA	
ENSG00000267755	AC005329.2	NA	
ENSG00000115286	NDUFS7	618224	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3
ENSG00000280486	AC005329.3	NA	
ENSG00000248015	AC005329.1	NA	
ENSG00000130005	GAMT	612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2;;GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY;;GAMT DEFICIENCY;;CREATINE DEFICIENCY SYNDROME DUE TO GAMT DEFICIENCY
ENSG00000071626	DAZAP1	NA	
ENSG00000115268	RPS15	NA	
ENSG00000268798	AC027307.3	NA	
ENSG00000115266	APC2	617169	SOTOS SYNDROME 3; SOTOS3
ENSG00000115266	APC2	618677	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10; CDCBM10
ENSG00000267317	AC027307.2	NA	
ENSG00000119559	C19orf25	NA	
ENSG00000115257	PCSK4	NA	
ENSG00000115255	REEP6	617304	RETINITIS PIGMENTOSA 77; RP77
ENSG00000185761	ADAMTSL5	NA	
ENSG00000185988	PLK5	NA	
ENSG00000267092	AC027307.1	NA	
ENSG00000181588	MEX3D	NA	
ENSG00000239367	RN7SL477P	NA	
ENSG00000071655	MBD3	NA	
ENSG00000279009	AC005943.2	NA	
ENSG00000267059	AC005943.1	NA	
ENSG00000127540	UQCR11	NA	
ENSG00000071564	TCF3	616941	AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT; AGM8;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO TCF3 DEFECT
ENSG00000252933	RNU6-1223P	NA	
ENSG00000275642	Metazoa_SRP	NA	
ENSG00000267073	AC005256.1	NA	
ENSG00000205922	ONECUT3	NA	
ENSG00000130270	ATP8B3	NA	
ENSG00000079313	REXO1	NA	
ENSG00000267007	AC012615.2	NA	
ENSG00000284216	MIR1909	NA	
ENSG00000267244	AC012615.6	NA	
ENSG00000267125	AC012615.3	NA	
ENSG00000129911	KLF16	NA	
ENSG00000267141	AC012615.4	NA	
ENSG00000261526	AC012615.1	NA	
ENSG00000267232	AC012615.5	NA	
ENSG00000129968	ABHD17A	NA	
ENSG00000227500	SCAMP4	NA	
ENSG00000213638	ADAT3	615286	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36
ENSG00000133275	CSNK1G2	NA	
ENSG00000180846	CSNK1G2-AS1	NA	
ENSG00000133243	BTBD2	NA	
ENSG00000267283	AC005306.1	NA	
ENSG00000279653	AC004678.2	NA	
ENSG00000275468	AC004678.1	NA	
ENSG00000267180	AC007136.1	NA	
ENSG00000099875	MKNK2	NA	
ENSG00000172081	MOB3A	NA	
ENSG00000099840	IZUMO4	NA	
ENSG00000065000	AP3D1	617050	HERMANSKY-PUDLAK SYNDROME 10; HPS10
ENSG00000104885	DOT1L	NA	
ENSG00000267122	AC004490.1	NA	
ENSG00000104886	PLEKHJ1	NA	
ENSG00000221411	MIR1227	NA	
ENSG00000284129	MIR6789	NA	
ENSG00000104897	SF3A2	NA	
ENSG00000104899	AMH	261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS;;PSEUDOHERMAPHRODITISM, MALE INTERNAL;;HERNIA UTERI INGUINALE;;PERSISTENT OVIDUCT SYNDROME;;FEMALE GENITAL DUCTS IN OTHERWISE NORMAL MALE
ENSG00000284272	MIR4321	NA	
ENSG00000167476	JSRP1	NA	
ENSG00000104904	OAZ1	NA	
ENSG00000273734	AC005258.1	NA	
ENSG00000188305	PEAK3	NA	
ENSG00000220008	LINGO3	NA	
ENSG00000288156	AC104530.1	NA	
ENSG00000286880	AC005258.2	NA	
ENSG00000130332	LSM7	NA	
ENSG00000005206	SPPL2B	NA	
ENSG00000178297	TMPRSS9	NA	
ENSG00000099800	TIMM13	NA	
ENSG00000176619	LMNB2	608709	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE
ENSG00000176619	LMNB2	616540	EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9
ENSG00000283728	MIR7108	NA	
ENSG00000267201	LINC01775	NA	
ENSG00000099860	GADD45B	NA	
ENSG00000252962	RNU6-993P	NA	
ENSG00000176533	GNG7	NA	
ENSG00000105694	ELOCP28	NA	
ENSG00000263974	RN7SL121P	NA	
ENSG00000267412	AC092068.2	NA	
ENSG00000277904	MIR7850	NA	
ENSG00000267214	AC092068.1	NA	
ENSG00000267749	AC092068.3	NA	
ENSG00000276097	AC006538.3	NA	
ENSG00000176490	DIRAS1	NA	
ENSG00000267001	AC006538.2	NA	
ENSG00000286460	AC006538.4	NA	
ENSG00000261342	AC006538.1	NA	
ENSG00000141873	SLC39A3	NA	
ENSG00000104969	SGTA	NA	
ENSG00000172009	THOP1	NA	
ENSG00000172006	ZNF554	NA	
ENSG00000186300	ZNF555	NA	
ENSG00000267063	AC006130.1	NA	
ENSG00000287766	AC006130.3	NA	
ENSG00000172000	ZNF556	NA	
ENSG00000267398	AC006130.2	NA	
ENSG00000266938	AC119403.2	NA	
ENSG00000171970	ZNF57	NA	
ENSG00000253392	AC119403.1	NA	
ENSG00000175691	ZNF77	NA	
ENSG00000279452	AC006277.1	NA	
ENSG00000104953	TLE6	616814	PREIMPLANTATION EMBRYONIC LETHALITY 1; PREMBL1;;PREMBL
ENSG00000065717	TLE2	NA	
ENSG00000267469	AC005944.1	NA	
ENSG00000104964	TLE5	NA	
ENSG00000088256	GNA11	145981	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2;;FAMILIAL BENIGN HYPERCALCEMIA, TYPE II; FBH2;;HYPERCALCEMIA, FAMILIAL BENIGN, TYPE II
ENSG00000088256	GNA11	615361	HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2
ENSG00000267139	AC005262.2	NA	
ENSG00000267688	KF456478.1	NA	
ENSG00000266944	AC005262.1	NA	
ENSG00000060558	GNA15	NA	
ENSG00000267551	AC005264.1	NA	
ENSG00000125910	S1PR4	NA	
ENSG00000125912	NCLN	NA	
ENSG00000161082	CELF5	NA	
ENSG00000267448	AC010649.1	NA	
ENSG00000141905	NFIC	NA	
ENSG00000280103	AC007792.1	NA	
ENSG00000279599	AC005514.1	NA	
ENSG00000095932	SMIM24	NA	
ENSG00000284638	AC005551.1	NA	
ENSG00000129932	DOHH	NA	
ENSG00000105325	FZR1	NA	
ENSG00000252408	AC005787.1	NA	
ENSG00000161091	MFSD12	NA	
ENSG00000183397	C19orf71	NA	
ENSG00000267436	AC005786.3	NA	
ENSG00000267231	AC005786.2	NA	
ENSG00000279590	AC005786.4	NA	
ENSG00000266959	AC005786.1	NA	
ENSG00000064961	HMG20B	NA	
ENSG00000179855	GIPC3	601869	DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15;;DEAFNESS, AUTOSOMAL RECESSIVE 72; DFNB72;;DEAFNESS, AUTOSOMAL RECESSIVE 95; DFNB95
ENSG00000006638	TBXA2R	614009	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13;;BLEEDING DISORDER, SUSCEPTIBILITY TO, DUE TO DEFECTIVE PLATELET THROMBOXANE A2 RECEPTOR
ENSG00000226800	CACTIN-AS1	NA	
ENSG00000105298	CACTIN	NA	
ENSG00000186111	PIP5K1C	611369	LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3;;MULTIPLE CONTRACTURE SYNDROME, ISRAELI BEDOUIN TYPE B
ENSG00000267304	AC004637.1	NA	
ENSG00000105289	TJP3	NA	
ENSG00000011132	APBA3	NA	
ENSG00000267205	AC005954.2	NA	
ENSG00000267138	AC005954.1	NA	
ENSG00000183617	MRPL54	NA	
ENSG00000173976	RAX2	610381	CONE-ROD DYSTROPHY 11; CORD11
ENSG00000173976	RAX2	613757	MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6
ENSG00000267148	AC005777.1	NA	
ENSG00000007264	MATK	NA	
ENSG00000105278	ZFR2	NA	
ENSG00000266989	FTLP5	NA	
ENSG00000167654	ATCAY	601238	CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY
ENSG00000266627	RN7SL202P	NA	
ENSG00000077009	NMRK2	NA	
ENSG00000167657	DAPK3	NA	
ENSG00000283928	MIR637	NA	
ENSG00000167658	EEF2	609306	SPINOCEREBELLAR ATAXIA 26; SCA26
ENSG00000206775	SNORD37	NA	
ENSG00000105229	PIAS4	NA	
ENSG00000178951	ZBTB7A	NA	
ENSG00000268670	AC016586.1	NA	
ENSG00000126934	MAP2K2	615280	CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4
ENSG00000278007	Metazoa_SRP	NA	
ENSG00000060566	CREB3L3	NA	
ENSG00000077463	SIRT6	NA	
ENSG00000089847	ANKRD24	NA	
ENSG00000105246	EBI3	NA	
ENSG00000280247	AC005578.1	NA	
ENSG00000105248	YJU2	NA	
ENSG00000105251	SHD	NA	
ENSG00000167664	TMIGD2	NA	
ENSG00000105255	FSD1	NA	
ENSG00000178078	STAP2	NA	
ENSG00000269425	AC104521.1	NA	
ENSG00000008382	MPND	NA	
ENSG00000269807	AC007292.3	NA	
ENSG00000267938	EIF1P6	NA	
ENSG00000269318	AC007292.2	NA	
ENSG00000141985	SH3GL1	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000267980	AC007292.1	NA	
ENSG00000167670	CHAF1A	NA	
ENSG00000267255	AC011498.3	NA	
ENSG00000167671	UBXN6	NA	
ENSG00000266437	MIR4746	NA	
ENSG00000267030	AC011498.2	NA	
ENSG00000280239	AC011498.7	NA	
ENSG00000267769	AC011498.6	NA	
ENSG00000267011	AC011498.1	NA	
ENSG00000167674	HDGFL2	NA	
ENSG00000167676	PLIN4	NA	
ENSG00000214456	PLIN5	NA	
ENSG00000267385	AC011498.4	NA	
ENSG00000171236	LRG1	NA	
ENSG00000167680	SEMA6B	NA	
ENSG00000267408	AC011498.5	NA	
ENSG00000185361	TNFAIP8L1	NA	
ENSG00000074842	MYDGF	NA	
ENSG00000268565	AC005339.1	NA	
ENSG00000142002	DPP9	NA	
ENSG00000205790	DPP9-AS1	NA	
ENSG00000287884	AC005594.1	NA	
ENSG00000176840	MIR7-3HG	NA	
ENSG00000207630	MIR7-3	NA	
ENSG00000268536	AC005523.1	NA	
ENSG00000141965	FEM1A	NA	
ENSG00000269604	AC005523.2	NA	
ENSG00000127666	TICAM1	614850	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6; IIAE6;;HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4
ENSG00000267484	AC027319.1	NA	
ENSG00000105355	PLIN3	NA	
ENSG00000205784	ARRDC5	NA	
ENSG00000276043	UHRF1	NA	
ENSG00000263409	MIR4747	NA	
ENSG00000127663	KDM4B	NA	
ENSG00000105426	PTPRS	NA	
ENSG00000267550	AC022517.1	NA	
ENSG00000239524	RPL32P34	NA	
ENSG00000274447	AC005790.1	NA	
ENSG00000105428	ZNRF4	NA	
ENSG00000223573	TINCR	NA	
ENSG00000233270	SNRPEP4	NA	
ENSG00000130254	SAFB2	NA	
ENSG00000160633	SAFB	NA	
ENSG00000130255	RPL36	NA	
ENSG00000174917	MICOS13	618329	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37
ENSG00000167733	HSD11B1L	NA	
ENSG00000196365	LONP1	600373	CODAS SYNDROME;;CEREBRAL, OCULAR, DENTAL, AURICULAR, AND SKELETAL ANOMALIES SYNDROME
ENSG00000174898	CATSPERD	NA	
ENSG00000212123	PRR22	NA	
ENSG00000267157	AC011499.1	NA	
ENSG00000141994	DUS3L	NA	
ENSG00000171119	NRTN	NA	
ENSG00000156413	FUT6	613852	FUCOSYLTRANSFERASE 6 DEFICIENCY
ENSG00000171124	FUT3	111100	FUCOSYLTRANSFERASE 3; FUT3;;LEWIS ENZYME  BLOOD GROUP--LEWIS SYSTEM, INCLUDED; Le, INCLUDED;;Les, INCLUDED
ENSG00000267709	AC024592.2	NA	
ENSG00000130383	FUT5	NA	
ENSG00000267740	AC024592.3	NA	
ENSG00000174886	NDUFA11	618236	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14
ENSG00000266941	AC024592.1	NA	
ENSG00000267314	AC104532.1	NA	
ENSG00000187650	VMAC	NA	
ENSG00000267571	AC104532.2	NA	
ENSG00000105519	CAPS	NA	
ENSG00000031823	RANBP3	NA	
ENSG00000266983	AC011444.1	NA	
ENSG00000087903	RFX2	NA	
ENSG00000267262	AC011444.2	NA	
ENSG00000267589	AC011444.4	NA	
ENSG00000267299	AC011444.3	NA	
ENSG00000130377	ACSBG2	NA	
ENSG00000267415	AC011471.1	NA	
ENSG00000284490	AC011471.4	NA	
ENSG00000130382	MLLT1	NA	
ENSG00000267563	AC011471.2	NA	
ENSG00000280394	AC011471.3	NA	
ENSG00000167769	ACER1	NA	
ENSG00000269802	AC011491.3	NA	
ENSG00000125656	CLPP	614129	PERRAULT SYNDROME 3; PRLTS3;;DEAFNESS, AUTOSOMAL RECESSIVE 81, FORMERLY; DFNB81, FORMERLY
ENSG00000125652	ALKBH7	NA	
ENSG00000125650	PSPN	NA	
ENSG00000125651	GTF2F1	NA	
ENSG00000269444	AC011491.2	NA	
ENSG00000274390	MIR6885	NA	
ENSG00000273758	MIR6790	NA	
ENSG00000214347	AC011491.1	NA	
ENSG00000088247	KHSRP	NA	
ENSG00000284159	MIR3940	NA	
ENSG00000181240	SLC25A41	NA	
ENSG00000125648	SLC25A23	NA	
ENSG00000130545	CRB3	NA	
ENSG00000205744	DENND1C	NA	
ENSG00000275234	AC010503.5	NA	
ENSG00000104833	TUBB4A	128101	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4;;WHISPERING DYSPHONIA, HEREDITARY;;DYSTONIA MUSCULORUM DEFORMANS 4
ENSG00000104833	TUBB4A	612438	LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIA AND CEREBELLUM; HABC
ENSG00000268203	AC010503.3	NA	
ENSG00000268191	AC010503.2	NA	
ENSG00000125657	TNFSF9	NA	
ENSG00000268742	AC010503.4	NA	
ENSG00000269546	CLIC4P2	NA	
ENSG00000199223	AC010503.1	NA	
ENSG00000125726	CD70	618261	LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3;;CD70 DEFICIENCY
ENSG00000268785	RPL7P50	NA	
ENSG00000125735	TNFSF14	NA	
ENSG00000125730	C3	611378	MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9
ENSG00000125730	C3	612925	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5
ENSG00000125730	C3	613779	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D;;C3 DEFICIENCY, AUTOSOMAL RECESSIVE
ENSG00000276980	AC008760.2	NA	
ENSG00000125734	GPR108	NA	
ENSG00000283950	MIR6791	NA	
ENSG00000125733	TRIP10	NA	
ENSG00000269680	AC008760.1	NA	
ENSG00000125731	SH2D3A	NA	
ENSG00000141968	VAV1	NA	
ENSG00000174837	ADGRE1	NA	
ENSG00000280091	AC020895.2	NA	
ENSG00000269385	AC020895.1	NA	
ENSG00000276568	Metazoa_SRP	NA	
ENSG00000268758	ADGRE4P	NA	
ENSG00000268845	AC025278.1	NA	
ENSG00000269761	AC025278.2	NA	
ENSG00000283679	AC025278.3	NA	
ENSG00000196589	MBD3L2B	NA	
ENSG00000237247	MBD3L5	NA	
ENSG00000205718	MBD3L4	NA	
ENSG00000230522	MBD3L2	NA	
ENSG00000182315	MBD3L3	NA	
ENSG00000130544	ZNF557	NA	
ENSG00000171105	INSR	246200	DONOHUE SYNDROME;;LEPRECHAUNISM  INSULIN RECEPTOR, DEFECT IN, INCLUDED
ENSG00000171105	INSR	262190	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES;;RABSON-MENDENHALL SYNDROME;;MENDENHALL SYNDROME
ENSG00000171105	INSR	609968	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5
ENSG00000171105	INSR	610549	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS;;INSULIN RECEPTOR, DEFECT IN, WITH INSULIN-RESISTANT DIABETES MELLITUS AND ACANTHOSIS NIGRICANS;;DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS, TYPE A;;IRAN, TYPE A
ENSG00000263264	AC119396.1	NA	
ENSG00000268861	AC008878.3	NA	
ENSG00000267852	AC119396.2	NA	
ENSG00000104880	ARHGEF18	617433	RETINITIS PIGMENTOSA 78; RP78
ENSG00000104883	PEX11G	NA	
ENSG00000198723	TEX45	NA	
ENSG00000267952	AC008878.1	NA	
ENSG00000198816	ZNF358	NA	
ENSG00000269371	AC008878.4	NA	
ENSG00000090674	MCOLN1	252650	MUCOLIPIDOSIS IV; ML4;;ML IV;;SIALOLIPIDOSIS
ENSG00000268614	AC008878.2	NA	
ENSG00000032444	PNPLA6	215470	BOUCHER-NEUHAUSER SYNDROME; BNHS;;SPINOCEREBELLAR ATAXIA, HYPOGONADOTROPIC HYPOGONADISM, AND CHORIORETINAL DYSTROPHY
ENSG00000032444	PNPLA6	245800	LAURENCE-MOON SYNDROME; LNMS
ENSG00000032444	PNPLA6	275400	OLIVER-MCFARLANE SYNDROME; OMCS;;TRICHOMEGALY WITH MENTAL RETARDATION, DWARFISM, AND PIGMENTARY DEGENERATION OF RETINA;;EYELASHES, LONG, WITH MENTAL RETARDATION
ENSG00000032444	PNPLA6	612020	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND
ENSG00000076826	CAMSAP3	NA	
ENSG00000273657	MIR6792	NA	
ENSG00000076924	XAB2	NA	
ENSG00000229833	PET100	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000268400	AC008763.2	NA	
ENSG00000174788	PCP2	NA	
ENSG00000268204	AC008763.1	NA	
ENSG00000076944	STXBP2	613101	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5
ENSG00000269228	RPS27AP19	NA	
ENSG00000104918	RETN	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000183019	MCEMP1	NA	
ENSG00000269711	AC008763.3	NA	
ENSG00000181029	TRAPPC5	NA	
ENSG00000104921	FCER2	NA	
ENSG00000182566	CLEC4G	NA	
ENSG00000090659	CD209	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000090659	CD209	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000090659	CD209	614371	DENGUE VIRUS, SUSCEPTIBILITY TO DENGUE FEVER, SUSCEPTIBILITY TO, INCLUDED;;DENGUE FEVER, PROTECTION AGAINST, INCLUDED;;DENGUE HEMORRHAGIC FEVER, SUSCEPTIBILITY TO, INCLUDED;;DENGUE SHOCK SYNDROME, SUSCEPTIBILITY TO, INCLUDED
ENSG00000242636	RPL21P129	NA	
ENSG00000104938	CLEC4M	NA	
ENSG00000268297	CLEC4GP1	NA	
ENSG00000269763	EXOSC3P2	NA	
ENSG00000142459	EVI5L	NA	
ENSG00000183248	PRR36	NA	
ENSG00000268120	AC010336.3	NA	
ENSG00000269153	LYPLA2P2	NA	
ENSG00000285674	5S_rRNA	NA	
ENSG00000171017	LRRC8E	NA	
ENSG00000214248	AC010336.1	NA	
ENSG00000076984	MAP2K7	NA	
ENSG00000268149	AC010336.4	NA	
ENSG00000260001	TGFBR3L	NA	
ENSG00000260500	AC010336.2	NA	
ENSG00000104976	SNAPC2	NA	
ENSG00000178531	CTXN1	NA	
ENSG00000269139	AC010336.5	NA	
ENSG00000104980	TIMM44	NA	
ENSG00000286138	AC010336.7	NA	
ENSG00000066044	ELAVL1	NA	
ENSG00000269813	AC010336.6	NA	
ENSG00000267939	AC008946.1	NA	
ENSG00000131142	CCL25	NA	
ENSG00000142449	FBN3	NA	
ENSG00000269651	AC022146.1	NA	
ENSG00000090661	CERS4	NA	
ENSG00000271717	AC022146.2	NA	
ENSG00000167775	CD320	613646	METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT;;METHYLMALONIC ACIDEMIA, TCblR TYPE
ENSG00000167774	AC010323.1	NA	
ENSG00000267855	NDUFA7	NA	
ENSG00000233927	RPS28	606164	DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15
ENSG00000186994	KANK3	NA	
ENSG00000268884	AC010323.2	NA	
ENSG00000167772	ANGPTL4	615881	PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL
ENSG00000269386	RAB11B-AS1	NA	
ENSG00000265390	MIR4999	NA	
ENSG00000185236	RAB11B	617807	NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW
ENSG00000099785	MARCHF2	NA	
ENSG00000268931	AC136469.1	NA	
ENSG00000279827	AC136469.2	NA	
ENSG00000099783	HNRNPM	NA	
ENSG00000133246	PRAM1	NA	
ENSG00000133250	ZNF414	NA	
ENSG00000142347	MYO1F	NA	
ENSG00000268618	AC092316.1	NA	
ENSG00000142303	ADAMTS10	277600	WEILL-MARCHESANI SYNDROME 1; WMS1;;WEILL-MARCHESANI SYNDROME, AUTOSOMAL RECESSIVE;;SPHEROPHAKIA-BRACHYMORPHIA SYNDROME;;MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL
ENSG00000267986	AC130469.1	NA	
ENSG00000268480	NFILZ	NA	
ENSG00000279426	AC243312.1	NA	
ENSG00000181786	ACTL9	NA	
ENSG00000181733	OR2Z1	NA	
ENSG00000269244	RPL23AP78	NA	
ENSG00000268922	AC012616.1	NA	
ENSG00000167785	ZNF558	NA	
ENSG00000269300	AC008734.1	NA	
ENSG00000170948	MBD3L1	NA	
ENSG00000269400	AC008734.2	NA	
ENSG00000181143	MUC16	NA	
ENSG00000267332	BOLA3P2	NA	
ENSG00000267154	OR1M4P	NA	
ENSG00000170929	OR1M1	NA	
ENSG00000170923	OR7G2	NA	
ENSG00000161807	OR7G1	NA	
ENSG00000275787	OR7G15P	NA	
ENSG00000170920	OR7G3	NA	
ENSG00000130803	ZNF317	NA	
ENSG00000188000	OR7D2	NA	
ENSG00000267418	ELOCP29	NA	
ENSG00000267775	OR7E16P	NA	
ENSG00000187847	OR7E25P	NA	
ENSG00000174667	OR7D4	NA	
ENSG00000188314	OR7D1P	NA	
ENSG00000237521	OR7E24	NA	
ENSG00000180926	OR7E18P	NA	
ENSG00000225980	OR7E19P	NA	
ENSG00000226480	OR7H1P	NA	
ENSG00000196110	ZNF699	NA	
ENSG00000267510	AC011451.1	NA	
ENSG00000188321	ZNF559	NA	
ENSG00000270011	ZNF559-ZNF177	NA	
ENSG00000270614	AC011451.2	NA	
ENSG00000188629	ZNF177	NA	
ENSG00000283108	AC011451.3	NA	
ENSG00000174652	ZNF266	NA	
ENSG00000287275	AC011451.4	NA	
ENSG00000198028	ZNF560	NA	
ENSG00000267273	AC008567.2	NA	
ENSG00000287960	AC008567.3	NA	
ENSG00000260112	AC008567.1	NA	
ENSG00000130818	ZNF426	NA	
ENSG00000278611	ZNF426-DT	NA	
ENSG00000197961	ZNF121	NA	
ENSG00000171469	ZNF561	NA	
ENSG00000267106	ZNF561-AS1	NA	
ENSG00000171466	ZNF562	NA	
ENSG00000239830	RPS4XP22	NA	
ENSG00000224689	ZNF812P	NA	
ENSG00000277587	AC008759.3	NA	
ENSG00000267490	AC008759.1	NA	
ENSG00000267612	AC008759.2	NA	
ENSG00000196605	ZNF846	NA	
ENSG00000267370	AC008752.4	NA	
ENSG00000267741	UBE2L4	NA	
ENSG00000266950	AC008752.2	NA	
ENSG00000127452	FBXL12	NA	
ENSG00000200237	AC008752.1	NA	
ENSG00000267119	RPL10P15	NA	
ENSG00000198258	UBL5	NA	
ENSG00000267289	AC008752.3	NA	
ENSG00000127445	PIN1	NA	
ENSG00000105088	OLFM2	NA	
ENSG00000080573	COL5A3	NA	
ENSG00000267650	AC008742.1	NA	
ENSG00000080511	RDH8	NA	
ENSG00000167798	C3P1	NA	
ENSG00000266204	MIR5589	NA	
ENSG00000130813	SHFL	NA	
ENSG00000267387	AC020931.1	NA	
ENSG00000130812	ANGPTL6	NA	
ENSG00000243207	PPAN-P2RY11	NA	
ENSG00000130810	PPAN	NA	
ENSG00000209645	SNORD105	NA	
ENSG00000238531	SNORD105B	NA	
ENSG00000244165	P2RY11	NA	
ENSG00000130811	EIF3G	NA	
ENSG00000130816	DNMT1	604121	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN
ENSG00000130816	DNMT1	614116	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E;;HSN IE;;NEUROPATHY, HEREDITARY SENSORY, WITH HEARING LOSS AND DEMENTIA
ENSG00000267534	S1PR2	610419	DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68
ENSG00000264266	MIR4322	NA	
ENSG00000105364	MRPL4	NA	
ENSG00000266978	AC011511.2	NA	
ENSG00000267105	AC011511.3	NA	
ENSG00000090339	ICAM1	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000267607	AC011511.5	NA	
ENSG00000105371	ICAM4	111250	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW;;LANDSTEINER-WIENER BLOOD GROUP SYSTEM
ENSG00000105376	ICAM5	NA	
ENSG00000220201	ZGLP1	NA	
ENSG00000167807	AC011511.1	NA	
ENSG00000267673	FDX2	251900	MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL
ENSG00000267303	AC011511.4	NA	
ENSG00000161847	RAVER1	NA	
ENSG00000274425	AC114271.1	NA	
ENSG00000076662	ICAM3	NA	
ENSG00000105397	TYK2	611521	IMMUNODEFICIENCY 35; IMD35;;TYROSINE KINASE 2 DEFICIENCY;;TYK2 DEFICIENCY;;HYPER-IgE SYNDROME WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;;HIES WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE
ENSG00000105401	CDC37	NA	
ENSG00000284268	MIR1181	NA	
ENSG00000065989	PDE4A	NA	
ENSG00000079999	KEAP1	NA	
ENSG00000267197	AC011461.1	NA	
ENSG00000180739	S1PR5	NA	
ENSG00000130734	ATG4D	NA	
ENSG00000238364	RNU7-140P	NA	
ENSG00000221410	MIR1238	NA	
ENSG00000129347	KRI1	NA	
ENSG00000129355	CDKN2D	NA	
ENSG00000129354	AP1M2	NA	
ENSG00000271010	AC011475.1	NA	
ENSG00000129353	SLC44A2	NA	
ENSG00000267100	ILF3-DT	NA	
ENSG00000129351	ILF3	NA	
ENSG00000213339	QTRT1	NA	
ENSG00000079805	DNM2	160150	MYOPATHY, CENTRONUCLEAR, 1; CNM1;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT;;MYOTUBULAR MYOPATHY, AUTOSOMAL DOMINANT
ENSG00000079805	DNM2	606482	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE B;;DI-CMTB;;CMTDI1 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2M, INCLUDED; CMT2M, INCLUDED;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTO /.../DOMINANT, TYPE 2M, INCLUDED;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2M, INCLUDED;;CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B, WITH NEUTROPENIA, INCLUDED;;CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE B, WITH NEUTROPENIA, INCLUDED
ENSG00000079805	DNM2	615368	LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5;;MYOPATHY, CENTRONUCLEAR, LETHAL, AUTOSOMAL RECESSIVE
ENSG00000207972	MIR638	NA	
ENSG00000265879	MIR4748	NA	
ENSG00000207752	MIR199A1	NA	
ENSG00000275640	MIR6793	NA	
ENSG00000099203	TMED1	NA	
ENSG00000214212	C19orf38	NA	
ENSG00000267544	AC007229.1	NA	
ENSG00000142453	CARM1	NA	
ENSG00000130733	YIPF2	NA	
ENSG00000142444	TIMM29	NA	
ENSG00000127616	SMARCA4	613325	RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2
ENSG00000127616	SMARCA4	614609	COFFIN-SIRIS SYNDROME 4; CSS4;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 16; MRD16
ENSG00000266936	AC011442.1	NA	
ENSG00000276757	RN7SL192P	NA	
ENSG00000278643	AC006127.1	NA	
ENSG00000130164	LDLR	143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1;;FHC; FH;;HYPERLIPOPROTEINEMIA, TYPE II;;HYPERLIPOPROTEINEMIA, TYPE IIA;;HYPER-LOW-DENSITY-LIPOPROTEINEMIA;;HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL;;LDL RECEPTOR DISORDER LOW DENSITY LIPOPROTEIN CHOLESTE /.../VEL QUANTITATIVE TRAIT LOCUS 2, INCLUDED; LDLCQ2, INCLUDED
ENSG00000284553	MIR6886	NA	
ENSG00000161888	SPC24	NA	
ENSG00000197256	KANK2	616099	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH
ENSG00000197256	KANK2	617783	NEPHROTIC SYNDROME, TYPE 16; NPHS16
ENSG00000130158	DOCK6	614219	ADAMS-OLIVER SYNDROME 2; AOS2
ENSG00000267082	AC011472.1	NA	
ENSG00000279807	AC011472.5	NA	
ENSG00000273733	AC011472.4	NA	
ENSG00000130173	ANGPTL8	NA	
ENSG00000130167	TSPAN16	NA	
ENSG00000267174	AC011472.2	NA	
ENSG00000105514	RAB3D	NA	
ENSG00000267576	AC011472.3	NA	
ENSG00000105518	TMEM205	NA	
ENSG00000183401	CCDC159	NA	
ENSG00000105520	PLPPR2	NA	
ENSG00000267277	AC024575.1	NA	
ENSG00000173928	SWSAP1	NA	
ENSG00000187266	EPOR	133100	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN
ENSG00000205517	RGL3	NA	
ENSG00000202357	Y_RNA	NA	
ENSG00000198003	CCDC151	616037	CILIARY DYSKINESIA, PRIMARY, 30; CILD30;;CILIARY DYSKINESIA, PRIMARY, 30, WITH OR WITHOUT SITUS INVERSUS
ENSG00000130175	PRKCSH	174050	POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1
ENSG00000196361	ELAVL3	NA	
ENSG00000267477	AC008481.3	NA	
ENSG00000161914	ZNF653	NA	
ENSG00000274713	MIR7974	NA	
ENSG00000130159	ECSIT	NA	
ENSG00000244080	RN7SL833P	NA	
ENSG00000213304	AC008481.2	NA	
ENSG00000213303	AC008481.1	NA	
ENSG00000130176	CNN1	NA	
ENSG00000130165	ELOF1	NA	
ENSG00000198551	ZNF627	NA	
ENSG00000102575	ACP5	607944	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI;;SPENCD;;COMBINED IMMUNODEFICIENCY WITH AUTOIMMUNITY AND SPONDYLOMETAPHYSEAL DYSPLASIA;;ROIFMAN IMMUNOSKELETAL SYNDROME
ENSG00000249840	GAPDHP76	NA	
ENSG00000197332	AC008543.1	NA	
ENSG00000267500	ZNF887P	NA	
ENSG00000214223	HNRNPA1P10	NA	
ENSG00000267343	ZNF833P	NA	
ENSG00000197933	ZNF823	NA	
ENSG00000266922	AC008543.3	NA	
ENSG00000220949	AC008543.2	NA	
ENSG00000197044	ZNF441	NA	
ENSG00000267646	AC008543.5	NA	
ENSG00000177599	ZNF491	NA	
ENSG00000171295	ZNF440	NA	
ENSG00000267089	AC008543.4	NA	
ENSG00000171291	ZNF439	NA	
ENSG00000278897	AC020951.1	NA	
ENSG00000198429	ZNF69	NA	
ENSG00000196757	ZNF700	NA	
ENSG00000267179	AC008770.2	NA	
ENSG00000267274	AC008770.3	NA	
ENSG00000197054	ZNF763	NA	
ENSG00000219665	ZNF433-AS1	NA	
ENSG00000286098	AC008770.4	NA	
ENSG00000252060	RNA5SP464	NA	
ENSG00000197647	ZNF433	NA	
ENSG00000257355	AC008770.1	NA	
ENSG00000212497	RNA5SP465	NA	
ENSG00000257446	ZNF878	NA	
ENSG00000223547	ZNF844	NA	
ENSG00000252546	RNA5SP466	NA	
ENSG00000286132	AC022415.2	NA	
ENSG00000199444	Y_RNA	NA	
ENSG00000214189	ZNF788P	NA	
ENSG00000132010	ZNF20	NA	
ENSG00000237273	RSL24D1P8	NA	
ENSG00000212576	RNA5SP467	NA	
ENSG00000213297	ZNF625-ZNF20	NA	
ENSG00000242615	AC022415.1	NA	
ENSG00000257591	ZNF625	NA	
ENSG00000196646	ZNF136	NA	
ENSG00000234773	AC012618.3	NA	
ENSG00000197857	ZNF44	NA	
ENSG00000213293	AC012618.1	NA	
ENSG00000234750	AC012618.2	NA	
ENSG00000188868	ZNF563	NA	
ENSG00000198342	ZNF442	NA	
ENSG00000231361	RPS29P23	NA	
ENSG00000268744	AC008758.4	NA	
ENSG00000248406	AC008758.3	NA	
ENSG00000196466	ZNF799	NA	
ENSG00000268870	AC008758.5	NA	
ENSG00000180855	ZNF443	NA	
ENSG00000269755	AC008758.6	NA	
ENSG00000234848	AC008758.2	NA	
ENSG00000242852	ZNF709	NA	
ENSG00000196826	AC008758.1	NA	
ENSG00000236483	MTND2P40	NA	
ENSG00000232579	MTCO1P27	NA	
ENSG00000230321	MTCO2P27	NA	
ENSG00000234003	MTATP6P27	NA	
ENSG00000235686	PPIAP20	NA	
ENSG00000249709	ZNF564	NA	
ENSG00000269693	AC010422.6	NA	
ENSG00000269560	AC010422.4	NA	
ENSG00000230310	AC010422.1	NA	
ENSG00000213290	PGK1P2	NA	
ENSG00000188033	ZNF490	NA	
ENSG00000173875	ZNF791	NA	
ENSG00000178464	RPL10P16	NA	
ENSG00000269242	AC010422.3	NA	
ENSG00000104774	MAN2B1	248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA;;ALPHA-MANNOSIDOSIS;;LYSOSOMAL ALPHA-D-MANNOSIDASE DEFICIENCY;;ALPHA-MANNOSIDASE B DEFICIENCY
ENSG00000269590	AC010422.5	NA	
ENSG00000123154	WDR83	NA	
ENSG00000285589	AC010422.8	NA	
ENSG00000105583	WDR83OS	NA	
ENSG00000285583	AC010422.7	NA	
ENSG00000095059	DHPS	618480	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI
ENSG00000268945	AC010422.2	NA	
ENSG00000283980	GNG14	NA	
ENSG00000132004	FBXW9	NA	
ENSG00000267791	AC018761.4	NA	
ENSG00000105576	TNPO2	NA	
ENSG00000209702	SNORD41	NA	
ENSG00000267004	AC018761.1	NA	
ENSG00000123144	TRIR	NA	
ENSG00000198356	GET3	NA	
ENSG00000039987	BEST2	NA	
ENSG00000095066	HOOK2	NA	
ENSG00000267212	AC018761.3	NA	
ENSG00000263800	MIR5684	NA	
ENSG00000171223	JUNB	NA	
ENSG00000167815	PRDX2	NA	
ENSG00000267062	AC018761.2	NA	
ENSG00000284491	THSD8	NA	
ENSG00000104889	RNASEH2A	610333	AICARDI-GOUTIERES SYNDROME 4; AGS4
ENSG00000132026	RTBDN	NA	
ENSG00000267424	AC020934.1	NA	
ENSG00000105613	MAST1	618273	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM
ENSG00000276181	MIR6794	NA	
ENSG00000105612	DNASE2	NA	
ENSG00000267735	AC020934.2	NA	
ENSG00000105610	KLF1	111150	BLOOD GROUP--LUTHERAN INHIBITOR; INLU;;DOMINANT LU (a-b-) PHENOTYPE
ENSG00000105610	KLF1	613566	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6;;HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, KLF1-RELATED
ENSG00000105610	KLF1	613673	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4;;CDA, TYPE IV
ENSG00000105607	GCDH	231670	GLUTARIC ACIDEMIA I; GA1;;GLUTARIC ACIDURIA I;;GA I;;GLUTARYL-CoA DEHYDROGENASE DEFICIENCY
ENSG00000240616	RPS6P25	NA	
ENSG00000161860	SYCE2	NA	
ENSG00000266721	MIR5695	NA	
ENSG00000179115	FARSA	NA	
ENSG00000266975	FARSA-AS1	NA	
ENSG00000179218	CALR	187950	THROMBOCYTHEMIA 1; THCYT1;;THROMBOCYTOSIS 1
ENSG00000179218	CALR	254450	MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED; MMM, INCLUDED
ENSG00000274417	MIR6515	NA	
ENSG00000267458	AC092069.1	NA	
ENSG00000179262	RAD23A	NA	
ENSG00000179271	GADD45GIP1	NA	
ENSG00000179284	DAND5	NA	
ENSG00000008441	NFIX	602535	MARSHALL-SMITH SYNDROME; MRSHSS
ENSG00000008441	NFIX	614753	SOTOS SYNDROME 2; SOTOS2;;MALAN SYNDROME
ENSG00000267417	AC138474.1	NA	
ENSG00000267610	AC007787.1	NA	
ENSG00000279044	AC007787.2	NA	
ENSG00000104903	LYL1	NA	
ENSG00000104907	TRMT1	618302	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 68
ENSG00000160877	NACC1	617393	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM
ENSG00000266897	AC005546.1	NA	
ENSG00000267512	AC011446.1	NA	
ENSG00000104915	STX10	NA	
ENSG00000160888	IER2	NA	
ENSG00000287296	AC011446.3	NA	
ENSG00000267598	AC011446.2	NA	
ENSG00000213253	RPL12P42	NA	
ENSG00000141837	CACNA1A	183086	SPINOCEREBELLAR ATAXIA 6; SCA6
ENSG00000141837	CACNA1A	141500	MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1 MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA, INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED
ENSG00000141837	CACNA1A	108500	EPISODIC ATAXIA, TYPE 2; EA2;;ATAXIA, EPISODIC, WITH NYSTAGMUS;;EPISODIC ATAXIA, NYSTAGMUS-ASSOCIATED;;CEREBELLOPATHY, HEREDITARY PAROXYSMAL;;ATAXIA, FAMILIAL PAROXYSMAL;;ACETAZOLAMIDE-RESPONSIVE HEREDITARY PAROXYSMAL CEREBELLAR ATAXIA; APCA;;CEREBE /.../TAXIA, PAROXYSMAL, ACETAZOLAMIDE-RESPONSIVE; CAPA
ENSG00000141837	CACNA1A	617106	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42
ENSG00000104957	CCDC130	NA	
ENSG00000037757	MRI1	NA	
ENSG00000267633	AC008686.1	NA	
ENSG00000104979	C19orf53	NA	
ENSG00000132003	ZSWIM4	NA	
ENSG00000267582	AC020916.2	NA	
ENSG00000266770	RN7SL619P	NA	
ENSG00000267519	AC020916.1	NA	
ENSG00000284387	MIR24-2	NA	
ENSG00000207808	MIR27A	NA	
ENSG00000207980	MIR23A	NA	
ENSG00000187556	NANOS3	NA	
ENSG00000207613	MIR181C	NA	
ENSG00000207585	MIR181D	NA	
ENSG00000132016	C19orf57	NA	
ENSG00000132024	CC2D1A	608443	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3
ENSG00000132000	PODNL1	NA	
ENSG00000132017	DCAF15	NA	
ENSG00000132005	RFX1	NA	
ENSG00000275091	AC022098.4	NA	
ENSG00000171136	RLN3	NA	
ENSG00000267670	AC022098.2	NA	
ENSG00000104998	IL27RA	NA	
ENSG00000187867	PALM3	NA	
ENSG00000228887	EEF1DP1	NA	
ENSG00000141854	MISP3	NA	
ENSG00000284081	MIR1199	NA	
ENSG00000188032	C19orf67	NA	
ENSG00000141858	SAMD1	NA	
ENSG00000072062	PRKACA	615830	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4;;CUSHING SYNDROME, ADRENAL, DUE TO PPNAD4;;CHROMOSOME 19p13 DUPLICATION SYNDROME  ACTH-INDEPENDENT ADRENAL CUSHING SYNDROME, SOMATIC, INCLUDED
ENSG00000267783	AC022098.3	NA	
ENSG00000105011	ASF1B	NA	
ENSG00000267169	AC022098.1	NA	
ENSG00000072071	ADGRL1	NA	
ENSG00000240803	RN7SL231P	NA	
ENSG00000287254	AC011509.3	NA	
ENSG00000267723	AC011509.2	NA	
ENSG00000267406	AC011509.1	NA	
ENSG00000266913	LINC01841	NA	
ENSG00000267147	LINC01842	NA	
ENSG00000123146	ADGRE5	NA	
ENSG00000267379	AC008569.1	NA	
ENSG00000123136	DDX39A	NA	
ENSG00000123143	PKN1	NA	
ENSG00000267474	AC008569.2	NA	
ENSG00000160951	PTGER1	NA	
ENSG00000123159	GIPC1	NA	
ENSG00000224543	SNRPGP15	NA	
ENSG00000132002	DNAJB1	NA	
ENSG00000099797	TECR	614020	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14
ENSG00000283822	MIR639	NA	
ENSG00000099795	NDUFB7	NA	
ENSG00000187912	CLEC17A	NA	
ENSG00000243488	RN7SL337P	NA	
ENSG00000243066	RN7SL842P	NA	
ENSG00000131355	ADGRE3	NA	
ENSG00000269378	AC022149.1	NA	
ENSG00000275432	AC022149.2	NA	
ENSG00000160961	ZNF333	NA	
ENSG00000127507	ADGRE2	125630	VIBRATORY URTICARIA; VBU;;DERMODISTORTIVE URTICARIA; DDU;;VIBRATORY ANGIOEDEMA
ENSG00000127530	OR7C1	NA	
ENSG00000256210	AC005255.1	NA	
ENSG00000188269	OR7A5	NA	
ENSG00000127515	OR7A10	NA	
ENSG00000269552	OR7A8P	NA	
ENSG00000172148	OR7A2P	NA	
ENSG00000185385	OR7A17	NA	
ENSG00000269678	OR7A18P	NA	
ENSG00000268834	OR7A1P	NA	
ENSG00000269787	OR7A3P	NA	
ENSG00000198367	OR7A11P	NA	
ENSG00000176923	OR7A15P	NA	
ENSG00000127529	OR7C2	NA	
ENSG00000105143	SLC1A6	NA	
ENSG00000160994	CCDC105	NA	
ENSG00000105141	CASP14	617320	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12; ARCI12
ENSG00000094661	OR1I1	NA	
ENSG00000105137	SYDE1	NA	
ENSG00000105135	ILVBL	NA	
ENSG00000268564	AC003956.1	NA	
ENSG00000267961	OR10B1P	NA	
ENSG00000252661	RNU6-782P	NA	
ENSG00000074181	NOTCH3	130720	LATERAL MENINGOCELE SYNDROME; LMNS;;LMS;;LEHMAN SYNDROME
ENSG00000074181	NOTCH3	125310	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1;;CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL
ENSG00000074181	NOTCH3	615293	MYOFIBROMATOSIS, INFANTILE, 2; IMF2
ENSG00000275711	MIR6795	NA	
ENSG00000269635	AC004257.1	NA	
ENSG00000105131	EPHX3	NA	
ENSG00000141867	BRD4	NA	
ENSG00000270802	AC005776.1	NA	
ENSG00000273218	AC005776.2	NA	
ENSG00000105127	AKAP8	NA	
ENSG00000268189	AC005785.1	NA	
ENSG00000011243	AKAP8L	NA	
ENSG00000279203	AC005785.2	NA	
ENSG00000279716	AC006128.1	NA	
ENSG00000011451	WIZ	NA	
ENSG00000269782	MIR1470	NA	
ENSG00000105122	RASAL3	NA	
ENSG00000161031	PGLYRP2	NA	
ENSG00000171954	CYP4F22	604777	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5;;ICHTHYOSIS, NONLAMELLAR AND NONERYTHRODERMIC, CONGENITAL, AUTOSOMAL RECESSIVE; NNCI;;ICHTHYOSIS CONGENITA III;;ICHTHYOSIS, LAMELLAR, 3, FORMERLY; LI3, FORMERLY
ENSG00000269765	AC011492.1	NA	
ENSG00000269516	CYP4F23P	NA	
ENSG00000267135	AD000091.1	NA	
ENSG00000225067	RPL23AP2	NA	
ENSG00000266951	AC093072.1	NA	
ENSG00000186526	CYP4F8	NA	
ENSG00000186529	CYP4F3	NA	
ENSG00000267241	CYP4F10P	NA	
ENSG00000186204	CYP4F12	NA	
ENSG00000171942	OR10H2	NA	
ENSG00000171936	OR10H3	NA	
ENSG00000267594	CYP4F24P	NA	
ENSG00000268673	AC004597.1	NA	
ENSG00000172519	OR10H5	NA	
ENSG00000186723	OR10H1	NA	
ENSG00000267235	ZNF861P	NA	
ENSG00000288618	AC004510.2	NA	
ENSG00000267308	LINC01764	NA	
ENSG00000214049	UCA1	NA	
ENSG00000273782	AC004510.1	NA	
ENSG00000267453	CLEC4O	NA	
ENSG00000273330	CYP4F36P	NA	
ENSG00000186115	CYP4F2	NA	
ENSG00000267218	AC005336.2	NA	
ENSG00000279717	AC005336.3	NA	
ENSG00000267056	AC005336.1	NA	
ENSG00000171903	CYP4F11	NA	
ENSG00000176231	OR10H4	NA	
ENSG00000267392	CYP4F9P	NA	
ENSG00000205396	LINC00661	NA	
ENSG00000280412	AC004790.2	NA	
ENSG00000167459	LINC00905	NA	
ENSG00000267609	SNX33P1	NA	
ENSG00000277766	AC004790.1	NA	
ENSG00000267450	OR1AB1P	NA	
ENSG00000267517	LINC01855	NA	
ENSG00000167460	TPM4	NA	
ENSG00000279198	AC008894.3	NA	
ENSG00000267373	AC008894.1	NA	
ENSG00000167461	RAB8A	NA	
ENSG00000269243	AC008894.2	NA	
ENSG00000196684	HSH2D	NA	
ENSG00000141977	CIB3	NA	
ENSG00000105058	FAM32A	NA	
ENSG00000267033	AC020911.1	NA	
ENSG00000275901	Metazoa_SRP	NA	
ENSG00000287961	AC020911.3	NA	
ENSG00000072958	AP1M1	NA	
ENSG00000267275	AC020911.2	NA	
ENSG00000127528	KLF2	NA	
ENSG00000277825	AC020917.3	NA	
ENSG00000127527	EPS15L1	NA	
ENSG00000280332	AC020917.4	NA	
ENSG00000240418	AC020917.1	NA	
ENSG00000267703	AC020917.2	NA	
ENSG00000269058	CALR3	NA	
ENSG00000141979	AC008764.1	NA	
ENSG00000105072	C19orf44	NA	
ENSG00000085872	CHERP	NA	
ENSG00000240106	RN7SL146P	NA	
ENSG00000269399	AC008764.6	NA	
ENSG00000127526	SLC35E1	NA	
ENSG00000268309	AC008764.3	NA	
ENSG00000269085	AC008764.5	NA	
ENSG00000279529	AC008764.8	NA	
ENSG00000105085	MED26	NA	
ENSG00000268790	AC008764.4	NA	
ENSG00000269578	AC008764.7	NA	
ENSG00000279748	AC008764.9	NA	
ENSG00000279977	AC008764.10	NA	
ENSG00000268087	AC008764.2	NA	
ENSG00000269427	AC024075.3	NA	
ENSG00000214046	SMIM7	NA	
ENSG00000269044	AC024075.2	NA	
ENSG00000267904	AC024075.1	NA	
ENSG00000072954	TMEM38A	NA	
ENSG00000269419	AC008737.2	NA	
ENSG00000188039	NWD1	NA	
ENSG00000269799	AC008737.3	NA	
ENSG00000127511	SIN3B	NA	
ENSG00000268743	AC008737.1	NA	
ENSG00000127533	F2RL3	NA	
ENSG00000160111	CPAMD8	617319	ANTERIOR SEGMENT DYSGENESIS 8; ASGD8
ENSG00000264250	RN7SL835P	NA	
ENSG00000263595	RN7SL823P	NA	
ENSG00000268985	AC020908.2	NA	
ENSG00000131351	HAUS8	NA	
ENSG00000268289	AC020908.1	NA	
ENSG00000099331	MYO9B	609753	CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4;;GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 4
ENSG00000269066	AC020908.3	NA	
ENSG00000268056	AC020913.1	NA	
ENSG00000269836	AC020913.3	NA	
ENSG00000269480	AC020913.2	NA	
ENSG00000053501	USE1	NA	
ENSG00000099330	OCEL1	NA	
ENSG00000160113	NR2F6	NA	
ENSG00000269095	AC010646.1	NA	
ENSG00000130307	USHBP1	NA	
ENSG00000105393	BABAM1	NA	
ENSG00000269307	AC010463.1	NA	
ENSG00000160117	ANKLE1	NA	
ENSG00000127220	ABHD8	NA	
ENSG00000130312	MRPL34	NA	
ENSG00000269815	AC010463.3	NA	
ENSG00000130311	DDA1	NA	
ENSG00000074855	ANO8	NA	
ENSG00000130299	GTPBP3	616198	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23
ENSG00000130300	PLVAP	618183	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10
ENSG00000269350	AC010463.2	NA	
ENSG00000269720	CCDC194	NA	
ENSG00000130303	BST2	NA	
ENSG00000282851	BISPR	NA	
ENSG00000141971	MVB12A	NA	
ENSG00000269481	AC010319.4	NA	
ENSG00000254503	AC010319.1	NA	
ENSG00000269053	AC010319.3	NA	
ENSG00000188051	TMEM221	NA	
ENSG00000269035	AC010319.2	NA	
ENSG00000269736	AC010319.5	NA	
ENSG00000171773	NXNL1	NA	
ENSG00000130304	SLC27A1	NA	
ENSG00000269439	AC010618.3	NA	
ENSG00000130313	PGLS	NA	
ENSG00000269161	AC010618.2	NA	
ENSG00000167483	NIBAN3	NA	
ENSG00000130309	COLGALT1	618360	BRAIN SMALL VESSEL DISEASE 3; BSVD3
ENSG00000243771	AC010618.1	NA	
ENSG00000130477	UNC13A	NA	
ENSG00000269752	AC008761.2	NA	
ENSG00000279300	AC008761.3	NA	
ENSG00000130479	MAP1S	NA	
ENSG00000268112	AC008761.1	NA	
ENSG00000130475	FCHO1	NA	
ENSG00000179913	B3GNT3	NA	
ENSG00000248099	INSL3	219050	CRYPTORCHIDISM, UNILATERAL OR BILATERAL;;UNDESCENDED TESTIS
ENSG00000105639	JAK3	600802	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE
ENSG00000105640	RPL18A	NA	
ENSG00000207166	SNORA68	NA	
ENSG00000279617	AC005796.1	NA	
ENSG00000105641	SLC5A5	274400	THYROID DYSHORMONOGENESIS 1; TDH1;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 1;;IODINE ACCUMULATION, TRANSPORT, OR TRAPPING DEFECT
ENSG00000007080	CCDC124	NA	
ENSG00000105642	KCNN1	NA	
ENSG00000252591	RNA5SP468	NA	
ENSG00000105643	ARRDC2	NA	
ENSG00000279172	AC020904.3	NA	
ENSG00000273654	AC020904.2	NA	
ENSG00000268623	AC020904.1	NA	
ENSG00000243455	RPS18P13	NA	
ENSG00000096996	IL12RB1	614891	IMMUNODEFICIENCY 30; IMD30;;IL12RB1 DEFICIENCY
ENSG00000099308	MAST3	NA	
ENSG00000269145	AC007192.2	NA	
ENSG00000268173	AC007192.1	NA	
ENSG00000105647	PIK3R2	603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME; MPPH;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT
ENSG00000216490	IFI30	NA	
ENSG00000254858	MPV17L2	NA	
ENSG00000105649	RAB3A	NA	
ENSG00000268650	AC005759.1	NA	
ENSG00000285188	AC008397.2	NA	
ENSG00000105650	PDE4C	NA	
ENSG00000284797	AC008397.1	NA	
ENSG00000130518	IQCN	NA	
ENSG00000130522	JUND	NA	
ENSG00000267959	MIR3188	NA	
ENSG00000241464	RPL39P38	NA	
ENSG00000130520	LSM4	NA	
ENSG00000239821	RN7SL513P	NA	
ENSG00000130517	PGPEP1	NA	
ENSG00000130513	GDF15	NA	
ENSG00000264175	MIR3189	NA	
ENSG00000175489	LRRC25	NA	
ENSG00000130511	SSBP4	NA	
ENSG00000105655	ISYNA1	NA	
ENSG00000268199	AC010335.1	NA	
ENSG00000105656	ELL	NA	
ENSG00000280121	AC010335.3	NA	
ENSG00000279262	AC010335.2	NA	
ENSG00000268938	AC005387.1	NA	
ENSG00000105701	FKBP8	NA	
ENSG00000269191	AC005387.2	NA	
ENSG00000105700	KXD1	NA	
ENSG00000268030	AC005253.1	NA	
ENSG00000268983	AC005253.2	NA	
ENSG00000221983	UBA52	NA	
ENSG00000006016	CRLF1	272430	CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1;;CRISPONI SYNDROME;;SOHAR-CRISPONI SYNDROME;;MUSCLE CONTRACTIONS, TETANOFORM, WITH CHARACTERISTIC FACE, CAMPTODACTYLY, HYPERTHERMIA, AND SUDDEN DEATH
ENSG00000006015	REX1BD	NA	
ENSG00000105696	TMEM59L	NA	
ENSG00000263490	RN7SL155P	NA	
ENSG00000167487	KLHL26	NA	
ENSG00000105662	CRTC1	NA	
ENSG00000105664	COMP	177170	PSEUDOACHONDROPLASIA; PSACH;;PSEUDOACHONDROPLASTIC DYSPLASIA;;SPONDYLOEPIPHYSEAL DYSPLASIA, PSEUDOACHONDROPLASTIC
ENSG00000105664	COMP	132400	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1;;MULTIPLE EPIPHYSEAL DYSPLASIA, COMP-RELATED EPIPHYSEAL DYSPLASIA, FAIRBANK TYPE, INCLUDED;;EPIPHYSEAL DYSPLASIA, RIBBING TYPE, INCLUDED
ENSG00000005007	UPF1	NA	
ENSG00000130283	GDF1	208530	RIGHT ATRIAL ISOMERISM; RAI;;RIGHT ISOMERISM;;ASPLENIA WITH CARDIOVASCULAR ANOMALIES;;IVEMARK SYNDROME POLYSPLENIA SYNDROME, INCLUDED;;POLYASPLENIA, INCLUDED;;HETEROTAXY, VISCEROATRIAL, AUTOSOMAL RECESSIVE, INCLUDED;;VAH, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000130283	GDF1	613854	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6;;TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3, FORMERLY; DTGA3, FORMERLY
ENSG00000223802	CERS1	616230	EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8
ENSG00000269694	AC005197.1	NA	
ENSG00000105669	COPE	NA	
ENSG00000268193	AC002985.1	NA	
ENSG00000105671	DDX49	NA	
ENSG00000051128	HOMER3	NA	
ENSG00000269019	HOMER3-AS1	NA	
ENSG00000241172	RN7SL70P	NA	
ENSG00000064607	SUGP2	NA	
ENSG00000105676	ARMC6	NA	
ENSG00000181035	SLC25A42	618416	METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN
ENSG00000064545	TMEM161A	NA	
ENSG00000213999	MEF2B	NA	
ENSG00000064489	BORCS8-MEF2B	NA	
ENSG00000254901	BORCS8	NA	
ENSG00000064490	RFXANK	209920	BARE LYMPHOCYTE SYNDROME, TYPE II;;BLS, TYPE II;;BARE LYMPHOCYTE SYNDROME; BLS;;SEVERE COMBINED IMMUNODEFICIENCY, HLA CLASS II-NEGATIVE;;SCID, HLA CLASS II-NEGATIVE BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A, INCLUDED;;BARE LYMPHOCYT /.../ROME, TYPE II, COMPLEMENTATION GROUP B, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D, INCLUDED;;BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E, INCLUDED
ENSG00000184162	NR2C2AP	NA	
ENSG00000130287	NCAN	NA	
ENSG00000252973	RNU6-1028P	NA	
ENSG00000267629	AC138430.1	NA	
ENSG00000187664	HAPLN4	NA	
ENSG00000280282	AC138430.2	NA	
ENSG00000213996	TM6SF2	NA	
ENSG00000105705	SUGP1	NA	
ENSG00000129933	MAU2	NA	
ENSG00000167491	GATAD2A	NA	
ENSG00000267234	AC092067.1	NA	
ENSG00000207821	MIR640	NA	
ENSG00000178093	TSSK6	NA	
ENSG00000186010	NDUFA13	607464	THYROID CARCINOMA, HURTHLE CELL;;HURTHLE CELL THYROID NEOPLASIA
ENSG00000186010	NDUFA13	618249	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28
ENSG00000258674	AC011448.1	NA	
ENSG00000250067	YJEFN3	NA	
ENSG00000160161	CILP2	NA	
ENSG00000105717	PBX4	NA	
ENSG00000267178	PHF5CP	NA	
ENSG00000259242	AC002306.1	NA	
ENSG00000064547	LPAR2	NA	
ENSG00000089639	GMIP	NA	
ENSG00000105726	ATP13A1	NA	
ENSG00000181896	ZNF101	NA	
ENSG00000271283	AC011458.2	NA	
ENSG00000270402	AC011458.1	NA	
ENSG00000105708	ZNF14	NA	
ENSG00000275540	AC011477.6	NA	
ENSG00000286080	AC011477.7	NA	
ENSG00000271499	AC011477.5	NA	
ENSG00000266904	LINC00663	NA	
ENSG00000287533	AC011477.8	NA	
ENSG00000267581	AC011477.3	NA	
ENSG00000267693	AC011477.4	NA	
ENSG00000267419	ZNF56	NA	
ENSG00000081665	ZNF506	NA	
ENSG00000267481	AC011477.1	NA	
ENSG00000270325	BNIP3P9	NA	
ENSG00000256771	ZNF253	NA	
ENSG00000270270	BNIP3P10	NA	
ENSG00000267565	AC011477.2	NA	
ENSG00000184635	ZNF93	NA	
ENSG00000273791	AC007204.1	NA	
ENSG00000274800	AC007204.2	NA	
ENSG00000197124	ZNF682	NA	
ENSG00000268070	AC006539.2	NA	
ENSG00000274033	AC006539.3	NA	
ENSG00000269154	BNIP3P13	NA	
ENSG00000213988	ZNF90	NA	
ENSG00000240673	AC006539.1	NA	
ENSG00000274612	AC011447.5	NA	
ENSG00000267383	AC011447.3	NA	
ENSG00000224864	AC011447.1	NA	
ENSG00000267220	AC011447.2	NA	
ENSG00000270716	BNIP3P15	NA	
ENSG00000256229	ZNF486	NA	
ENSG00000267641	BNIP3P16	NA	
ENSG00000267771	AC011447.4	NA	
ENSG00000279039	AC011447.6	NA	
ENSG00000280079	AC011447.7	NA	
ENSG00000271524	BNIP3P17	NA	
ENSG00000268620	AC078899.3	NA	
ENSG00000213985	AC078899.1	NA	
ENSG00000269055	BNIP3P18	NA	
ENSG00000269274	AC078899.4	NA	
ENSG00000271638	BNIP3P19	NA	
ENSG00000276294	AC078899.5	NA	
ENSG00000231205	ZNF826P	NA	
ENSG00000271704	BNIP3P20	NA	
ENSG00000268461	AC078899.2	NA	
ENSG00000238517	MIR1270	NA	
ENSG00000268174	BNIP3P22	NA	
ENSG00000269043	AC008554.1	NA	
ENSG00000268335	BNIP3P23	NA	
ENSG00000237440	ZNF737	NA	
ENSG00000269110	AC010636.2	NA	
ENSG00000268272	VN1R78P	NA	
ENSG00000268560	AC010636.1	NA	
ENSG00000188171	ZNF626	NA	
ENSG00000280171	AC010329.5	NA	
ENSG00000269779	AC010329.2	NA	
ENSG00000268416	AC010329.1	NA	
ENSG00000269885	VN1R79P	NA	
ENSG00000160229	ZNF66	NA	
ENSG00000269040	BNIP3P24	NA	
ENSG00000269373	AC008739.2	NA	
ENSG00000105750	ZNF85	NA	
ENSG00000279404	AC008739.5	NA	
ENSG00000269012	KRT18P40	NA	
ENSG00000268326	AC008739.1	NA	
ENSG00000118620	ZNF430	NA	
ENSG00000271598	AC008739.3	NA	
ENSG00000268598	VN1R80P	NA	
ENSG00000160352	ZNF714	NA	
ENSG00000201035	RNA5SP469	NA	
ENSG00000268357	VN1R81P	NA	
ENSG00000196705	ZNF431	NA	
ENSG00000240522	RPL7AP10	NA	
ENSG00000268995	VN1R82P	NA	
ENSG00000268892	AC010620.1	NA	
ENSG00000269839	AC010620.2	NA	
ENSG00000242291	RPL36AP51	NA	
ENSG00000268747	AC022432.1	NA	
ENSG00000268521	VN1R83P	NA	
ENSG00000182141	ZNF708	NA	
ENSG00000268322	BNIP3P25	NA	
ENSG00000172687	ZNF738	NA	
ENSG00000268731	AC010615.3	NA	
ENSG00000213976	AC010615.1	NA	
ENSG00000196268	ZNF493	NA	
ENSG00000269237	AC010615.4	NA	
ENSG00000268119	AC010615.2	NA	
ENSG00000268658	LINC00664	NA	
ENSG00000197013	ZNF429	NA	
ENSG00000268705	BNIP3P26	NA	
ENSG00000268081	AC123912.1	NA	
ENSG00000268555	AC123912.4	NA	
ENSG00000268240	AC123912.2	NA	
ENSG00000274503	AC123912.6	NA	
ENSG00000271182	AC123912.5	NA	
ENSG00000268278	AC123912.3	NA	
ENSG00000268433	MTDHP3	NA	
ENSG00000268535	MTDHP4	NA	
ENSG00000268117	VN1R84P	NA	
ENSG00000197020	ZNF100	NA	
ENSG00000269845	CCNYL6	NA	
ENSG00000268184	AC092364.1	NA	
ENSG00000269136	BRI3BPP1	NA	
ENSG00000198521	ZNF43	NA	
ENSG00000268438	BNIP3P27	NA	
ENSG00000160321	ZNF208	NA	
ENSG00000269615	MTDHP2	NA	
ENSG00000279377	AC003973.2	NA	
ENSG00000271095	BNIP3P28	NA	
ENSG00000269504	AC003973.1	NA	
ENSG00000197134	ZNF257	NA	
ENSG00000269742	BNIP3P29	NA	
ENSG00000269505	ZNF92P2	NA	
ENSG00000268116	AC073539.2	NA	
ENSG00000268140	PCGF7P	NA	
ENSG00000269575	MTDHP5	NA	
ENSG00000269345	VN1R85P	NA	
ENSG00000196109	ZNF676	NA	
ENSG00000268079	BNIP3P30	NA	
ENSG00000282732	AC073539.7	NA	
ENSG00000267872	AC073539.1	NA	
ENSG00000268597	AC073539.3	NA	
ENSG00000196350	ZNF729	NA	
ENSG00000270191	BNIP3P31	NA	
ENSG00000268685	AC011494.1	NA	
ENSG00000236312	RPL34P34	NA	
ENSG00000197360	ZNF98	NA	
ENSG00000269796	AC011516.1	NA	
ENSG00000268830	BNIP3P32	NA	
ENSG00000270947	AC025811.1	NA	
ENSG00000268717	BNIP3P33	NA	
ENSG00000269138	ZNF209P	NA	
ENSG00000270317	AC004004.1	NA	
ENSG00000286157	AC011467.6	NA	
ENSG00000260599	AC011467.1	NA	
ENSG00000269364	LINC01233	NA	
ENSG00000207397	RNU6-1179P	NA	
ENSG00000271149	AC011467.5	NA	
ENSG00000269332	GOLGA2P9	NA	
ENSG00000240713	RN7SL860P	NA	
ENSG00000268823	AC011467.3	NA	
ENSG00000269025	AC011467.4	NA	
ENSG00000269316	RAD54L2P1	NA	
ENSG00000268038	LINC01785	NA	
ENSG00000268589	AC011467.2	NA	
ENSG00000229676	ZNF492	NA	
ENSG00000268981	AC024563.1	NA	
ENSG00000198153	ZNF849P	NA	
ENSG00000241282	RPL34P33	NA	
ENSG00000270475	AC024563.2	NA	
ENSG00000268789	VN1R87P	NA	
ENSG00000213973	ZNF99	NA	
ENSG00000279966	AC008626.2	NA	
ENSG00000270518	AC008626.1	NA	
ENSG00000269509	BNIP3P34	NA	
ENSG00000268696	ZNF723	NA	
ENSG00000271655	BNIP3P35	NA	
ENSG00000268541	VN1R88P	NA	
ENSG00000268296	AC022145.1	NA	
ENSG00000269458	AC022145.2	NA	
ENSG00000269067	ZNF728	NA	
ENSG00000271661	BNIP3P36	NA	
ENSG00000261558	LINC01859	NA	
ENSG00000261615	LINC01858	NA	
ENSG00000269543	AC074135.2	NA	
ENSG00000267886	AC074135.1	NA	
ENSG00000183850	ZNF730	NA	
ENSG00000270479	BNIP3P37	NA	
ENSG00000268105	AC124856.1	NA	
ENSG00000267920	SNX6P1	NA	
ENSG00000269471	AC092329.2	NA	
ENSG00000196081	ZNF724	NA	
ENSG00000283201	AC092329.3	NA	
ENSG00000268469	BNIP3P38	NA	
ENSG00000269837	IPO5P1	NA	
ENSG00000269107	AC092329.1	NA	
ENSG00000284428	AC092329.4	NA	
ENSG00000268794	VN1R90P	NA	
ENSG00000268148	VN1R91P	NA	
ENSG00000167232	ZNF91	NA	
ENSG00000267934	AC010300.1	NA	
ENSG00000269431	BNIP3P8	NA	
ENSG00000268992	CDC42EP3P1	NA	
ENSG00000269416	LINC01224	NA	
ENSG00000268908	VN1R92P	NA	
ENSG00000275201	AC074140.1	NA	
ENSG00000268100	ZNF725P	NA	
ENSG00000197372	ZNF675	NA	
ENSG00000268455	AC073544.1	NA	
ENSG00000240231	RPS27P29	NA	
ENSG00000269320	VN1R93P	NA	
ENSG00000196172	ZNF681	NA	
ENSG00000233836	AC139769.1	NA	
ENSG00000269662	BNIP3P39	NA	
ENSG00000267924	AC139769.2	NA	
ENSG00000225178	RPSAP58	NA	
ENSG00000277493	AC139769.3	NA	
ENSG00000287399	AC011503.4	NA	
ENSG00000213967	ZNF726	NA	
ENSG00000269289	AC011503.1	NA	
ENSG00000269397	AC011503.2	NA	
ENSG00000269421	AC011503.3	NA	
ENSG00000201966	RNA5-8SP4	NA	
ENSG00000268362	AC092279.1	NA	
ENSG00000213096	ZNF254	NA	
ENSG00000279425	AC092279.2	NA	
ENSG00000268058	BNIP3P40	NA	
ENSG00000276030	AC073534.2	NA	
ENSG00000268442	AC073534.1	NA	
ENSG00000267696	ERVK-28	NA	
ENSG00000279882	AC112702.1	NA	
ENSG00000261824	LINC00662	NA	
ENSG00000261770	AC006504.1	NA	
ENSG00000267575	AC006504.5	NA	
ENSG00000281468	AC006504.7	NA	
ENSG00000267264	AC006504.3	NA	
ENSG00000267323	SLC25A1P5	NA	
ENSG00000266977	AC006504.2	NA	
ENSG00000267389	AC006504.4	NA	
ENSG00000267623	AC005357.2	NA	
ENSG00000267768	AC006504.6	NA	
ENSG00000267630	AC005758.1	NA	
ENSG00000266906	AC005357.1	NA	
ENSG00000267509	AC010511.1	NA	
ENSG00000266928	AC020905.1	NA	
ENSG00000267320	AC005580.1	NA	
ENSG00000267238	AC093074.1	NA	
ENSG00000260725	AC005307.1	NA	
ENSG00000283403	AC005394.2	NA	
ENSG00000267243	AC005381.1	NA	
ENSG00000266893	AC005394.1	NA	
ENSG00000267423	AC005616.1	NA	
ENSG00000267537	AC079466.2	NA	
ENSG00000266976	AC079466.1	NA	
ENSG00000283269	AC005524.1	NA	
ENSG00000267799	MAN1A2P1	NA	
ENSG00000267617	AC007795.1	NA	
ENSG00000267339	LINC00906	NA	
ENSG00000267683	AC008991.1	NA	
ENSG00000267027	AC011524.1	NA	
ENSG00000267240	AC011524.2	NA	
ENSG00000252272	RNA5SP470	NA	
ENSG00000267014	LINC01532	NA	
ENSG00000288017	AC011505.1	NA	
ENSG00000169021	UQCRFS1	618775	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10; MC3DN10
ENSG00000267498	AC007786.1	NA	
ENSG00000276251	AC007786.2	NA	
ENSG00000276631	AC007786.3	NA	
ENSG00000241604	RN7SL340P	NA	
ENSG00000287272	AC007786.4	NA	
ENSG00000264515	AC011474.1	NA	
ENSG00000267574	AC011474.3	NA	
ENSG00000266248	AC011474.2	NA	
ENSG00000279387	AC011474.4	NA	
ENSG00000187135	VSTM2B	NA	
ENSG00000105171	POP4	NA	
ENSG00000166289	PLEKHF1	NA	
ENSG00000131943	C19orf12	614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4;;MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION; MPAN
ENSG00000131943	C19orf12	615043	SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43
ENSG00000286867	AC008798.3	NA	
ENSG00000105173	CCNE1	NA	
ENSG00000286538	AC008798.2	NA	
ENSG00000267433	AC008798.1	NA	
ENSG00000278895	AC008507.3	NA	
ENSG00000267258	PPIAP58	NA	
ENSG00000105176	URI1	NA	
ENSG00000242100	RPL9P32	NA	
ENSG00000267006	AC008507.2	NA	
ENSG00000267692	TAF9P3	NA	
ENSG00000266910	AC008507.1	NA	
ENSG00000287859	AC008507.4	NA	
ENSG00000288072	AC008507.5	NA	
ENSG00000267223	AC005597.1	NA	
ENSG00000198597	ZNF536	NA	
ENSG00000280061	AC011504.1	NA	
ENSG00000267760	AC011478.1	NA	
ENSG00000267081	AC011507.1	NA	
ENSG00000261316	LINC01834	NA	
ENSG00000267378	AC020897.1	NA	
ENSG00000284430	AC020912.1	NA	
ENSG00000121297	TSHZ3	NA	
ENSG00000267777	LINC01791	NA	
ENSG00000267662	AC025809.1	NA	
ENSG00000278875	AC025809.2	NA	
ENSG00000267636	AC008992.1	NA	
ENSG00000267599	AC008794.1	NA	
ENSG00000267407	LINC02841	NA	
ENSG00000261400	AC011525.1	NA	
ENSG00000267465	AC011525.2	NA	
ENSG00000252780	RNA5SP471	NA	
ENSG00000201894	RNU6-967P	NA	
ENSG00000267489	LINC01837	NA	
ENSG00000267779	LINC01533	NA	
ENSG00000267204	LINC01782	NA	
ENSG00000267133	AC011518.1	NA	
ENSG00000286041	AC074139.1	NA	
ENSG00000200738	RNA5SP472	NA	
ENSG00000168813	ZNF507	NA	
ENSG00000267213	AC007773.1	NA	
ENSG00000178904	DPY19L3	NA	
ENSG00000105185	PDCD5	NA	
ENSG00000105186	ANKRD27	NA	
ENSG00000201388	SNORA68B	NA	
ENSG00000242325	RPS12P31	NA	
ENSG00000242436	RN7SL789P	NA	
ENSG00000267557	AC008474.1	NA	
ENSG00000186326	RGS9BP	608415	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS;;BRADYOPSIA
ENSG00000267475	AC008736.1	NA	
ENSG00000213965	NUDT19	NA	
ENSG00000267567	AC008736.2	NA	
ENSG00000173809	TDRD12	NA	
ENSG00000267245	AC008805.1	NA	
ENSG00000021488	SLC7A9	220100	CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLY CYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, /.../A/B, INCLUDED
ENSG00000267555	AC008805.2	NA	
ENSG00000201967	RN7SKP22	NA	
ENSG00000121289	CEP89	NA	
ENSG00000239988	RPL31P60	NA	
ENSG00000131944	FAAP24	NA	
ENSG00000131941	RHPN2	NA	
ENSG00000267611	AC008521.1	NA	
ENSG00000267725	AC008521.2	NA	
ENSG00000076650	GPATCH1	NA	
ENSG00000166359	WDR88	NA	
ENSG00000130881	LRP3	NA	
ENSG00000267054	AC008738.1	NA	
ENSG00000273420	AC008738.7	NA	
ENSG00000130876	SLC7A10	NA	
ENSG00000267714	AC008738.4	NA	
ENSG00000270212	AC008738.6	NA	
ENSG00000245848	CEBPA	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000267580	AC008738.3	NA	
ENSG00000267727	AC008738.5	NA	
ENSG00000267296	CEBPA-DT	NA	
ENSG00000267130	AC008738.2	NA	
ENSG00000243864	RPS3AP50	NA	
ENSG00000266899	AKR1B1P7	NA	
ENSG00000153879	CEBPG	NA	
ENSG00000124299	PEPD	170100	PROLIDASE DEFICIENCY
ENSG00000266985	AC010485.1	NA	
ENSG00000232429	RPL21P131	NA	
ENSG00000124302	CHST8	616265	PEELING SKIN SYNDROME 3; PSS3
ENSG00000153885	KCTD15	NA	
ENSG00000277013	AC008556.1	NA	
ENSG00000240626	RN7SL150P	NA	
ENSG00000287526	AC016587.1	NA	
ENSG00000239253	RPS4XP23	NA	
ENSG00000249987	RPS4XP20	NA	
ENSG00000186008	RPS4XP21	NA	
ENSG00000270849	CHCHD2P3	NA	
ENSG00000257103	LSM14A	NA	
ENSG00000166398	GARRE1	NA	
ENSG00000257074	RPL29P33	NA	
ENSG00000267219	AC010504.1	NA	
ENSG00000105220	GPI	613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY
ENSG00000266953	AC092073.1	NA	
ENSG00000126249	PDCD2L	NA	
ENSG00000264317	RN7SL154P	NA	
ENSG00000267024	AC008747.1	NA	
ENSG00000126261	UBA2	NA	
ENSG00000142279	WTIP	NA	
ENSG00000239210	RPS26P55	NA	
ENSG00000248830	ZNF807P	NA	
ENSG00000268751	SCGB1B2P	NA	
ENSG00000205209	SCGB2B2	NA	
ENSG00000271049	AC020910.4	NA	
ENSG00000252230	AC020910.1	NA	
ENSG00000268683	AC020910.2	NA	
ENSG00000279971	AC020910.7	NA	
ENSG00000269811	SCGB2B3P	NA	
ENSG00000279329	AC020910.6	NA	
ENSG00000089335	ZNF302	NA	
ENSG00000274104	AC020910.5	NA	
ENSG00000197841	ZNF181	NA	
ENSG00000153896	ZNF599	NA	
ENSG00000270281	AC020910.3	NA	
ENSG00000267767	LINC01801	NA	
ENSG00000261754	AC008555.1	NA	
ENSG00000271666	AC008555.5	NA	
ENSG00000269086	AC008555.2	NA	
ENSG00000271109	AC008555.4	NA	
ENSG00000270624	AC008555.3	NA	
ENSG00000271171	LINC00904	NA	
ENSG00000269037	LINC01838	NA	
ENSG00000270876	ZNF30-AS1	NA	
ENSG00000168661	ZNF30	NA	
ENSG00000280106	AC008555.6	NA	
ENSG00000180884	ZNF792	NA	
ENSG00000089351	GRAMD1A	NA	
ENSG00000269303	AC020907.3	NA	
ENSG00000271032	AC020907.4	NA	
ENSG00000105711	SCN1B	604233	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1
ENSG00000105711	SCN1B	612838	BRUGADA SYNDROME 5; BRGDA5 CARDIAC CONDUCTION DEFECT, NONSPECIFIC, INCLUDED
ENSG00000105711	SCN1B	615377	ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13
ENSG00000105711	SCN1B	617350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52
ENSG00000105707	HPN	NA	
ENSG00000227392	HPN-AS1	NA	
ENSG00000179066	AC020907.1	NA	
ENSG00000285526	AC020907.6	NA	
ENSG00000089356	FXYD3	NA	
ENSG00000284065	MIR6887	NA	
ENSG00000153902	LGI4	617468	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT; AMCNMY
ENSG00000279619	AC020907.5	NA	
ENSG00000221857	AC020907.2	NA	
ENSG00000266964	FXYD1	NA	
ENSG00000221946	FXYD7	NA	
ENSG00000089327	FXYD5	NA	
ENSG00000177558	FAM187B	NA	
ENSG00000262497	FAM187B2P	NA	
ENSG00000105699	LSR	NA	
ENSG00000271366	AC002128.2	NA	
ENSG00000268947	AC002128.1	NA	
ENSG00000105698	USF2	NA	
ENSG00000105697	HAMP	613313	HEMOCHROMATOSIS, TYPE 2B; HFE2B
ENSG00000105695	MAG	616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75
ENSG00000012124	CD22	NA	
ENSG00000269553	U62631.1	NA	
ENSG00000284034	MIR5196	NA	
ENSG00000126266	FFAR1	NA	
ENSG00000185897	FFAR3	NA	
ENSG00000126251	GPR42	NA	
ENSG00000268222	EEF1A1P7	NA	
ENSG00000205786	LINC01531	NA	
ENSG00000283479	AC002511.3	NA	
ENSG00000264400	RN7SL491P	NA	
ENSG00000233214	AC002511.2	NA	
ENSG00000232680	AC002511.1	NA	
ENSG00000126262	FFAR2	NA	
ENSG00000188508	KRTDAP	NA	
ENSG00000161249	DMKN	NA	
ENSG00000189001	SBSN	NA	
ENSG00000105679	GAPDHS	NA	
ENSG00000236144	TMEM147-AS1	NA	
ENSG00000105677	TMEM147	NA	
ENSG00000105675	ATP4A	NA	
ENSG00000283907	AD000090.1	NA	
ENSG00000283758	PMIS2	NA	
ENSG00000224910	LINC01766	NA	
ENSG00000267626	AC002115.1	NA	
ENSG00000249115	HAUS5	NA	
ENSG00000126254	RBM42	NA	
ENSG00000105672	ETV2	NA	
ENSG00000126267	COX6B1	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000105668	UPK1A	NA	
ENSG00000226510	UPK1A-AS1	NA	
ENSG00000267190	TYMSP2	NA	
ENSG00000011590	ZBTB32	NA	
ENSG00000272333	KMT2B	617284	DYSTONIA 28, CHILDHOOD-ONSET; DYT28
ENSG00000126246	IGFLR1	NA	
ENSG00000267120	AD000671.2	NA	
ENSG00000161265	U2AF1L4	NA	
ENSG00000205155	PSENEN	613736	ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2
ENSG00000188223	AD000671.1	NA	
ENSG00000267439	AD000671.3	NA	
ENSG00000267796	LIN37	NA	
ENSG00000267328	AC002398.2	NA	
ENSG00000004776	HSPB6	NA	
ENSG00000167595	PROSER3	NA	
ENSG00000267049	AC002398.1	NA	
ENSG00000004777	ARHGAP33	NA	
ENSG00000225872	LINC01529	NA	
ENSG00000250799	PRODH2	NA	
ENSG00000161270	NPHS1	256300	NEPHROTIC SYNDROME, TYPE 1; NPHS1;;FINNISH CONGENITAL NEPHROSIS; CNF;;NEPHROTIC SYNDROME, CONGENITAL
ENSG00000126259	KIRREL2	NA	
ENSG00000105290	APLP1	NA	
ENSG00000243968	RN7SL402P	NA	
ENSG00000167604	NFKBID	NA	
ENSG00000280194	AD000864.1	NA	
ENSG00000126264	HCST	NA	
ENSG00000011600	TYROBP	221770	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1; PLOSL1;;PLOSL;;NASU-HAKOLA DISEASE; NHD;;PRESENILE DEMENTIA WITH BONE CYSTS;;DEMENTIA, PREFRONTAL, WITH BONE CYSTS;;DEMENTIA, PROGRESSIVE, WITH LIPOMEMBRANOUS POLYCYSTIC /.../DYSPLASIA;;BRAIN-BONE-FAT DISEASE
ENSG00000126243	LRFN3	NA	
ENSG00000267786	AF038458.3	NA	
ENSG00000267113	AF038458.1	NA	
ENSG00000267388	AF038458.2	NA	
ENSG00000205138	SDHAF1	252011	MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY
ENSG00000181392	SYNE4	615540	DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76
ENSG00000248101	AC002116.1	NA	
ENSG00000239382	ALKBH6	NA	
ENSG00000267698	AC002116.2	NA	
ENSG00000105270	CLIP3	NA	
ENSG00000161277	THAP8	NA	
ENSG00000075702	WDR62	604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2
ENSG00000280023	AD000813.1	NA	
ENSG00000105261	OVOL3	NA	
ENSG00000105258	POLR2I	NA	
ENSG00000105254	TBCB	NA	
ENSG00000279504	AD001527.2	NA	
ENSG00000126247	CAPNS1	NA	
ENSG00000270760	AD001527.1	NA	
ENSG00000161281	COX7A1	NA	
ENSG00000267005	AC002984.1	NA	
ENSG00000196357	ZNF565	NA	
ENSG00000200179	Y_RNA	NA	
ENSG00000167635	ZNF146	NA	
ENSG00000232677	LINC00665	NA	
ENSG00000267053	AC092296.2	NA	
ENSG00000142065	ZFP14	NA	
ENSG00000266973	AC092296.1	NA	
ENSG00000267363	AC092296.4	NA	
ENSG00000181007	ZFP82	NA	
ENSG00000267142	AC092296.3	NA	
ENSG00000186017	ZNF566	NA	
ENSG00000267309	AC092295.2	NA	
ENSG00000267091	CTBP2P7	NA	
ENSG00000254004	ZNF260	NA	
ENSG00000228629	AC092295.1	NA	
ENSG00000186020	ZNF529	NA	
ENSG00000233527	ZNF529-AS1	NA	
ENSG00000161298	ZNF382	NA	
ENSG00000197808	ZNF461	NA	
ENSG00000276071	AC074138.1	NA	
ENSG00000225975	LINC01534	NA	
ENSG00000189042	ZNF567	NA	
ENSG00000267041	ZNF850	NA	
ENSG00000267260	AC020928.1	NA	
ENSG00000267353	AC020928.2	NA	
ENSG00000267254	ZNF790-AS1	NA	
ENSG00000197863	ZNF790	NA	
ENSG00000251247	ZNF345	NA	
ENSG00000206669	Y_RNA	NA	
ENSG00000185869	ZNF829	NA	
ENSG00000243297	RPL31P61	NA	
ENSG00000198453	ZNF568	NA	
ENSG00000197050	ZNF420	NA	
ENSG00000275547	AC010632.3	NA	
ENSG00000267345	AC010632.1	NA	
ENSG00000267672	AC010632.2	NA	
ENSG00000267360	AC012309.1	NA	
ENSG00000196967	ZNF585A	NA	
ENSG00000267437	AC012309.2	NA	
ENSG00000245680	ZNF585B	NA	
ENSG00000188283	ZNF383	NA	
ENSG00000267605	AC016590.1	NA	
ENSG00000226686	LINC01535	NA	
ENSG00000286449	AC016590.4	NA	
ENSG00000181666	ZNF875	NA	
ENSG00000276846	AC016590.3	NA	
ENSG00000267682	AC016590.2	NA	
ENSG00000189164	ZNF527	NA	
ENSG00000279936	AC008806.1	NA	
ENSG00000196437	ZNF569	NA	
ENSG00000171827	ZNF570	NA	
ENSG00000266916	ZNF793-AS1	NA	
ENSG00000267115	AC022148.2	NA	
ENSG00000188227	ZNF793	NA	
ENSG00000180458	AC022148.1	NA	
ENSG00000267470	ZNF571-AS1	NA	
ENSG00000171817	ZNF540	NA	
ENSG00000180479	ZNF571	NA	
ENSG00000120784	ZFP30	NA	
ENSG00000196381	ZNF781	NA	
ENSG00000267552	AC093227.2	NA	
ENSG00000267319	SELENOKP1	NA	
ENSG00000198182	ZNF607	NA	
ENSG00000267152	AC093227.1	NA	
ENSG00000287496	AC093227.3	NA	
ENSG00000189144	ZNF573	NA	
ENSG00000267422	AC016582.2	NA	
ENSG00000267640	AC016582.3	NA	
ENSG00000225868	AC016582.1	NA	
ENSG00000171804	WDR87	NA	
ENSG00000105738	SIPA1L3	616851	CATARACT 45; CTRCT45
ENSG00000268051	AC008395.1	NA	
ENSG00000268764	AC011465.1	NA	
ENSG00000269653	AC011479.3	NA	
ENSG00000268499	AC011479.2	NA	
ENSG00000275132	RN7SL663P	NA	
ENSG00000011332	DPF1	NA	
ENSG00000167642	SPINT2	270420	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES; DIAR3;;SODIUM DIARRHEA, CONGENITAL; CSD;;DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, SYNDROMIC
ENSG00000167641	PPP1R14A	NA	
ENSG00000267748	AC011479.1	NA	
ENSG00000286037	AC011479.4	NA	
ENSG00000200209	Y_RNA	NA	
ENSG00000167645	YIF1B	NA	
ENSG00000167644	C19orf33	NA	
ENSG00000099337	KCNK6	NA	
ENSG00000099338	CATSPERG	NA	
ENSG00000266963	AC005625.1	NA	
ENSG00000099341	PSMD8	NA	
ENSG00000179168	GGN	NA	
ENSG00000267090	AC005789.1	NA	
ENSG00000188766	SPRED3	NA	
ENSG00000130244	FAM98C	NA	
ENSG00000171777	RASGRP4	NA	
ENSG00000196218	RYR1	145600	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MH KING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED
ENSG00000196218	RYR1	117000	CENTRAL CORE DISEASE OF MUSCLE; CCD;;CCO MINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DIS /.../CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED; CNMDU1, INCLUDED
ENSG00000196218	RYR1	255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD;;FIBER-TYPE DISPROPORTION MYOPATHY, CONGENITAL; CFTDM
ENSG00000196218	RYR1	255320	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA
ENSG00000269445	AC067969.2	NA	
ENSG00000268055	AC067969.1	NA	
ENSG00000104814	MAP4K1	NA	
ENSG00000267291	AC008649.1	NA	
ENSG00000178982	EIF3K	NA	
ENSG00000130402	ACTN4	603278	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 1
ENSG00000267375	AC008649.2	NA	
ENSG00000182472	CAPN12	NA	
ENSG00000267892	AC022144.1	NA	
ENSG00000205076	LGALS7	NA	
ENSG00000178934	LGALS7B	NA	
ENSG00000207296	RNU6-140P	NA	
ENSG00000171747	LGALS4	NA	
ENSG00000104823	ECH1	NA	
ENSG00000268083	AC008982.1	NA	
ENSG00000268756	AC104534.1	NA	
ENSG00000104824	HNRNPL	NA	
ENSG00000269688	AC008982.2	NA	
ENSG00000187994	RINL	NA	
ENSG00000269050	AC011455.1	NA	
ENSG00000068903	SIRT2	NA	
ENSG00000104825	NFKBIB	NA	
ENSG00000262484	CCER2	NA	
ENSG00000104835	SARS2	613845	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS;;HUPRA SYNDROME
ENSG00000269547	AC011455.2	NA	
ENSG00000128626	MRPS12	NA	
ENSG00000269486	ERVK9-11	NA	
ENSG00000269190	FBXO17	NA	
ENSG00000287271	AC011455.6	NA	
ENSG00000161243	FBXO27	NA	
ENSG00000267992	AC010605.1	NA	
ENSG00000183760	ACP7	NA	
ENSG00000130669	PAK4	NA	
ENSG00000269172	AC011443.1	NA	
ENSG00000188505	NCCRP1	NA	
ENSG00000179751	SYCN	NA	
ENSG00000268510	IFNL3P1	NA	
ENSG00000197110	IFNL3	609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO;;HCV, SUSCEPTIBILITY TO HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED;;HCV, RESISTANCE TO, INCLUDED;;HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF, INCLUDED
ENSG00000272395	IFNL4	NA	
ENSG00000213926	MSRB1P1	NA	
ENSG00000272311	IFNL4P1	NA	
ENSG00000183709	IFNL2	NA	
ENSG00000182393	IFNL1	NA	
ENSG00000128011	LRFN1	NA	
ENSG00000130755	GMFG	NA	
ENSG00000269246	AC011445.1	NA	
ENSG00000179134	SAMD4B	NA	
ENSG00000241983	RN7SL566P	NA	
ENSG00000006712	PAF1	NA	
ENSG00000063322	MED29	NA	
ENSG00000128016	ZFP36	NA	
ENSG00000266559	MIR4530	NA	
ENSG00000090924	PLEKHG2	616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD
ENSG00000105193	RPS16	NA	
ENSG00000196235	SUPT5H	NA	
ENSG00000105197	TIMM50	617698	3-@METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9
ENSG00000090932	DLL3	277300	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1;;VERTEBRAL ANOMALIES;;JARCHO-LEVIN SYNDROME;;SPONDYLOTHORACIC DYSPLASIA;;COSTOVERTEBRAL DYSPLASIA;;SPONDYLOTHORACIC DYSOSTOSIS
ENSG00000186838	SELENOV	NA	
ENSG00000176401	EID2B	NA	
ENSG00000269792	AC011500.3	NA	
ENSG00000269584	TDGF1P7	NA	
ENSG00000176396	EID2	NA	
ENSG00000269588	AC011500.2	NA	
ENSG00000269188	AC011500.1	NA	
ENSG00000244253	RPS29P24	NA	
ENSG00000243581	RPS29P25	NA	
ENSG00000239320	RPS29P26	NA	
ENSG00000105198	LGALS13	NA	
ENSG00000269519	AC005176.2	NA	
ENSG00000268153	AC005176.1	NA	
ENSG00000268243	RPS29P30	NA	
ENSG00000249861	LGALS16	NA	
ENSG00000226025	LGALS17A	NA	
ENSG00000269460	AC005515.1	NA	
ENSG00000268088	AC093063.1	NA	
ENSG00000240320	RPS29P27	NA	
ENSG00000006659	LGALS14	NA	
ENSG00000278813	AC006133.1	NA	
ENSG00000105205	CLC	NA	
ENSG00000213921	LEUTX	NA	
ENSG00000276445	AC005393.1	NA	
ENSG00000105204	DYRK1B	615812	ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3;;CENTRAL OBESITY, TYPE 2 DIABETES, HYPERTENSION, AND EARLY-ONSET CORONARY ARTERY DISEASE
ENSG00000277759	MIR6719	NA	
ENSG00000105202	FBL	NA	
ENSG00000275395	FCGBP	NA	
ENSG00000187534	PRR13P5	NA	
ENSG00000013275	PSMC4	NA	
ENSG00000187187	ZNF546	NA	
ENSG00000269069	AC007842.1	NA	
ENSG00000128000	ZNF780B	NA	
ENSG00000269749	AC005614.2	NA	
ENSG00000197782	ZNF780A	NA	
ENSG00000269296	AC005614.1	NA	
ENSG00000230086	VN1R96P	NA	
ENSG00000130758	MAP3K10	NA	
ENSG00000174521	TTC9B	NA	
ENSG00000105219	CCNP	NA	
ENSG00000105221	AKT2	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000105221	AKT2	240900	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH
ENSG00000205041	AC118344.1	NA	
ENSG00000207631	MIR641	NA	
ENSG00000206674	RNU6-945P	NA	
ENSG00000160392	C19orf47	NA	
ENSG00000207281	Y_RNA	NA	
ENSG00000206925	Y_RNA	NA	
ENSG00000105223	PLD3	617770	SPINOCEREBELLAR ATAXIA 46; SCA46;;SPINOCEREBELLAR ATAXIA, 46, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY
ENSG00000279759	AC118344.2	NA	
ENSG00000275652	MIR6796	NA	
ENSG00000160396	HIPK4	NA	
ENSG00000105227	PRX	145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS;;DEJERINE-SOTTAS SYNDROME; DSS;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 3; CMT3;;HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE III; HMSN3;;DEJERINE-SOTTAS NEUROPATHY; DSN
ENSG00000105227	PRX	614895	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F
ENSG00000197019	SERTAD1	NA	
ENSG00000277453	AC010271.2	NA	
ENSG00000167565	SERTAD3	NA	
ENSG00000268366	AC010271.1	NA	
ENSG00000090013	BLVRB	NA	
ENSG00000277510	AC010271.3	NA	
ENSG00000160460	SPTBN4	617519	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND;;MYOPATHY, CONGENITAL, WITH NEUROPATHY AND DEAFNESS; CMND
ENSG00000160410	SHKBP1	NA	
ENSG00000090006	LTBP4	613177	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C;;CUTIS LAXA WITH SEVERE PULMONARY, GASTROINTESTINAL, AND URINARY ABNORMALITIES;;URBAN-RIFKIN-DAVIS SYNDROME; URDS
ENSG00000105245	NUMBL	NA	
ENSG00000123815	COQ8B	615573	NEPHROTIC SYNDROME, TYPE 9; NPHS9
ENSG00000223284	RNU6-195P	NA	
ENSG00000086544	ITPKC	611775	KAWASAKI DISEASE;;KD;;MUCOCUTANEOUS LYMPH NODE SYNDROME;;INFANTILE POLYARTERITIS
ENSG00000188493	C19orf54	NA	
ENSG00000077312	SNRPA	NA	
ENSG00000268975	MIA-RAB4B	NA	
ENSG00000261857	MIA	NA	
ENSG00000167578	RAB4B	NA	
ENSG00000171570	RAB4B-EGLN2	NA	
ENSG00000282951	AC008537.4	NA	
ENSG00000269858	EGLN2	NA	
ENSG00000268797	AC008537.1	NA	
ENSG00000233622	CYP2T1P	NA	
ENSG00000237118	CYP2F2P	NA	
ENSG00000269843	AC008537.2	NA	
ENSG00000279108	AC008537.3	NA	
ENSG00000255974	CYP2A6	122720	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6;;COUMARIN 7-HYDROXYLASE;;CYTOCHROME P450, PHENOBARBITAL-INDUCIBLE; P450PB;;CYP2A3, FORMERLY TEGAFUR, POOR METABOLISM OF, INCLUDED
ENSG00000255974	CYP2A6	122700	COUMARIN RESISTANCE;;COUMARIN, POOR METABOLISM OF;;WARFARIN RESISTANCE  COUMARIN SENSITIVITY, INCLUDED;;WARFARIN SENSITIVITY, INCLUDED
ENSG00000255974	CYP2A6	188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO;;CIGARETTE HABITUATION, SUSCEPTIBILITY TO;;SMOKING HABIT, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO;;NICOTINE ADDICTION, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, PROTECTION AGAINST
ENSG00000255974	CYP2A6	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000198077	CYP2A7	NA	
ENSG00000130612	CYP2G1P	NA	
ENSG00000198251	CYP2A7P2	NA	
ENSG00000256612	CYP2B7P	NA	
ENSG00000269353	AC092071.1	NA	
ENSG00000197408	CYP2B6	614546	EFAVIRENZ, POOR METABOLISM OF EFAVIRENZ CENTRAL NERVOUS SYSTEM TOXICITY, SUSCEPTIBILITY TO, INCLUDED
ENSG00000213908	CYP2A7P1	NA	
ENSG00000268101	CYP2G2P	NA	
ENSG00000271299	AC008962.1	NA	
ENSG00000197838	CYP2A13	NA	
ENSG00000197446	CYP2F1	NA	
ENSG00000268529	CYP2T3P	NA	
ENSG00000224476	RPL36P16	NA	
ENSG00000264423	RN7SL718P	NA	
ENSG00000167600	CYP2S1	NA	
ENSG00000167601	AXL	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000269652	AC011510.1	NA	
ENSG00000105323	HNRNPUL1	NA	
ENSG00000239868	RN7SL34P	NA	
ENSG00000105329	TGFB1	131300	CAMURATI-ENGELMANN DISEASE; CAEND;;CED;;ENGELMANN DISEASE;;DIAPHYSEAL DYSPLASIA 1, PROGRESSIVE; DPD1;;PROGRESSIVE DIAPHYSEAL DYSPLASIA; PDD
ENSG00000105329	TGFB1	219700	CYSTIC FIBROSIS; CF;;MUCOVISCIDOSIS
ENSG00000105329	TGFB1	618213	INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE
ENSG00000286177	AC011462.5	NA	
ENSG00000142039	CCDC97	NA	
ENSG00000255730	AC011462.1	NA	
ENSG00000142046	TMEM91	NA	
ENSG00000123810	B9D2	614175	MECKEL SYNDROME, TYPE 10; MKS10 JOUBERT SYNDROME 34, INCLUDED; JBTS34, INCLUDED
ENSG00000277744	AC011462.4	NA	
ENSG00000077348	EXOSC5	NA	
ENSG00000248098	BCKDHA	248600	MAPLE SYRUP URINE DISEASE; MSUD;;BRANCHED-CHAIN KETOACIDURIA;;BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY;;BCKD DEFICIENCY;;KETO ACID DECARBOXYLASE DEFICIENCY MAPLE SYRUP URINE DISEASE, CLASSIC, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTER /.../E, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTERMITTENT, INCLUDED;;MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IA, INCLUDED; MSUD1A, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IB, INCLUDED; MSUD1B, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE II, INCLUDED; MSUD2, INCLUDED
ENSG00000268987	AC011462.3	NA	
ENSG00000268475	AC011462.2	NA	
ENSG00000177191	B3GNT8	NA	
ENSG00000105341	DMAC2	NA	
ENSG00000277136	AC011526.1	NA	
ENSG00000204978	ERICH4	NA	
ENSG00000267107	PCAT19	NA	
ENSG00000268034	AC243960.2	NA	
ENSG00000269800	PLEKHA3P1	NA	
ENSG00000268355	AC243960.3	NA	
ENSG00000270164	LINC01480	NA	
ENSG00000268027	AC243960.1	NA	
ENSG00000007129	CEACAM21	NA	
ENSG00000280014	AC243960.7	NA	
ENSG00000239736	CEACAMP3	NA	
ENSG00000269266	DNAJC19P2	NA	
ENSG00000105352	CEACAM4	NA	
ENSG00000268997	DNAJC19P3	NA	
ENSG00000269354	AC243960.5	NA	
ENSG00000268582	AC243960.4	NA	
ENSG00000007306	CEACAM7	NA	
ENSG00000105388	CEACAM5	NA	
ENSG00000267881	AC243967.1	NA	
ENSG00000086548	CEACAM6	NA	
ENSG00000268833	AC243967.2	NA	
ENSG00000170956	CEACAM3	NA	
ENSG00000269119	HNRNPA1P52	NA	
ENSG00000278239	AC243967.3	NA	
ENSG00000273111	LYPD4	NA	
ENSG00000142025	DMRTC2	NA	
ENSG00000105372	RPS19	105650	DIAMOND-BLACKFAN ANEMIA 1; DBA1;;DBA;;BLACKFAN-DIAMOND SYNDROME; BDS;;ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND;;ANEMIA, CONGENITAL ERYTHROID HYPOPLASTIC;;RED CELL APLASIA, PURE, HEREDITARY;;AREGENERATIVE ANEMIA, CHRONIC CONGENITAL;;ER /.../ENESIS IMPERFECTA;;AASE-SMITH SYNDROME II;;AASE SYNDROME
ENSG00000276926	MIR6797	NA	
ENSG00000105369	CD79A	613501	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79A DEFECT
ENSG00000076928	ARHGEF1	618459	IMMUNODEFICIENCY 62; IMD62
ENSG00000268041	ERFL	NA	
ENSG00000105404	RABAC1	NA	
ENSG00000285505	AC010616.1	NA	
ENSG00000105409	ATP1A3	128235	DYSTONIA 12; DYT12;;DYSTONIA-PARKINSONISM, RAPID-ONSET; RDP
ENSG00000105409	ATP1A3	601338	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS
ENSG00000105409	ATP1A3	614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2
ENSG00000105737	GRIK5	NA	
ENSG00000105732	ZNF574	NA	
ENSG00000028277	POU2F2	NA	
ENSG00000254887	AC010247.1	NA	
ENSG00000266226	MIR4323	NA	
ENSG00000259436	AC010247.2	NA	
ENSG00000160570	DEDD2	NA	
ENSG00000167625	ZNF526	NA	
ENSG00000105723	GSK3A	NA	
ENSG00000268643	AC006486.1	NA	
ENSG00000279539	AC006486.2	NA	
ENSG00000105722	ERF	600775	CRANIOSYNOSTOSIS 4; CRS4
ENSG00000105722	ERF	617180	CHITAYAT SYNDROME; CHYTS
ENSG00000079432	CIC	617600	MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45
ENSG00000079462	PAFAH1B3	NA	
ENSG00000188368	PRR19	NA	
ENSG00000167619	TMEM145	NA	
ENSG00000105429	MEGF8	614976	CARPENTER SYNDROME 2; CRPT2
ENSG00000277533	MIR8077	NA	
ENSG00000105427	CNFN	NA	
ENSG00000213904	LIPE-AS1	NA	
ENSG00000079435	LIPE	615980	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH LIPE MUTATIONS
ENSG00000268605	AC011497.1	NA	
ENSG00000189377	CXCL17	NA	
ENSG00000253048	RNU4-60P	NA	
ENSG00000269374	AC011497.2	NA	
ENSG00000079385	CEACAM1	NA	
ENSG00000230558	CEACAMP2	NA	
ENSG00000124469	CEACAM8	NA	
ENSG00000233681	CEACAMP1	NA	
ENSG00000231561	CEACAMP5	NA	
ENSG00000243167	RPS10P28	NA	
ENSG00000221826	PSG3	NA	
ENSG00000124467	PSG8	NA	
ENSG00000238092	CEACAMP6	NA	
ENSG00000225877	PSG8-AS1	NA	
ENSG00000248257	PSG10P	NA	
ENSG00000231924	PSG1	NA	
ENSG00000170848	PSG6	NA	
ENSG00000221878	PSG7	NA	
ENSG00000227349	CEACAMP7	NA	
ENSG00000282943	AC004784.1	NA	
ENSG00000243130	PSG11	NA	
ENSG00000236932	CEACAMP8	NA	
ENSG00000242221	PSG2	NA	
ENSG00000230529	CEACAMP9	NA	
ENSG00000227606	AC005392.1	NA	
ENSG00000204941	PSG5	NA	
ENSG00000243137	PSG4	NA	
ENSG00000241104	CEACAMP10	NA	
ENSG00000183668	PSG9	NA	
ENSG00000236123	CEACAMP11	NA	
ENSG00000230681	CEACAMP4	NA	
ENSG00000231412	AC005392.2	NA	
ENSG00000204936	CD177	NA	
ENSG00000272396	AC005392.3	NA	
ENSG00000204933	CD177P1	NA	
ENSG00000131126	TEX101	NA	
ENSG00000124466	LYPD3	NA	
ENSG00000176531	PHLDB3	NA	
ENSG00000105755	ETHE1	602473	ENCEPHALOPATHY, ETHYLMALONIC; EE
ENSG00000176472	ZNF575	NA	
ENSG00000073050	XRCC1	617633	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26
ENSG00000269177	L34079.2	NA	
ENSG00000268361	L34079.1	NA	
ENSG00000269583	L34079.3	NA	
ENSG00000234465	PINLYP	NA	
ENSG00000167378	IRGQ	NA	
ENSG00000124444	ZNF576	NA	
ENSG00000226763	SRRM5	NA	
ENSG00000131116	ZNF428	NA	
ENSG00000105767	CADM4	NA	
ENSG00000011422	PLAUR	NA	
ENSG00000239948	RN7SL368P	NA	
ENSG00000283525	AC005622.1	NA	
ENSG00000124449	IRGC	NA	
ENSG00000105771	SMG9	616920	HEART AND BRAIN MALFORMATION SYNDROME; HBMS
ENSG00000104783	KCNN4	616689	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2;;XEROCYTOSIS GARDOS;;DESICCYTOSIS GARDOS
ENSG00000159871	LYPD5	NA	
ENSG00000268601	AC115522.1	NA	
ENSG00000167637	ZNF283	NA	
ENSG00000176222	ZNF404	NA	
ENSG00000278917	AC006213.6	NA	
ENSG00000267058	AC006213.2	NA	
ENSG00000286613	AC006213.7	NA	
ENSG00000267191	AC006213.3	NA	
ENSG00000124459	ZNF45	NA	
ENSG00000159905	ZNF221	NA	
ENSG00000204920	ZNF155	NA	
ENSG00000277806	AC006213.4	NA	
ENSG00000278492	AC006213.5	NA	
ENSG00000266921	AC006213.1	NA	
ENSG00000159882	ZNF230	NA	
ENSG00000267144	AC067968.2	NA	
ENSG00000159885	ZNF222	NA	
ENSG00000267022	AC067968.1	NA	
ENSG00000178386	ZNF223	NA	
ENSG00000186026	ZNF284	NA	
ENSG00000253021	RNU6-902P	NA	
ENSG00000267680	ZNF224	NA	
ENSG00000186019	AC021092.1	NA	
ENSG00000256294	ZNF225	NA	
ENSG00000263002	ZNF234	NA	
ENSG00000287035	AC138470.2	NA	
ENSG00000167380	ZNF226	NA	
ENSG00000131115	ZNF227	NA	
ENSG00000159917	ZNF235	NA	
ENSG00000279103	AC138470.1	NA	
ENSG00000159915	ZNF233	NA	
ENSG00000270679	AC138473.1	NA	
ENSG00000267590	NDUFA3P1	NA	
ENSG00000062370	ZNF112	NA	
ENSG00000267173	AC245748.1	NA	
ENSG00000267508	ZNF285	NA	
ENSG00000267188	AC245748.2	NA	
ENSG00000278318	ZNF229	NA	
ENSG00000176761	ZNF285B	NA	
ENSG00000167384	ZNF180	NA	
ENSG00000273777	CEACAM20	NA	
ENSG00000267614	AC245748.3	NA	
ENSG00000230666	CEACAM22P	NA	
ENSG00000224366	AC243964.1	NA	
ENSG00000216588	IGSF23	NA	
ENSG00000266903	AC243964.3	NA	
ENSG00000073008	PVR	NA	
ENSG00000283673	MIR4531	NA	
ENSG00000186567	CEACAM19	NA	
ENSG00000279095	AC243964.4	NA	
ENSG00000213892	CEACAM16	614614	DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B
ENSG00000213892	CEACAM16	618410	DEAFNESS, AUTOSOMAL RECESSIVE 113; DFNB113
ENSG00000252200	AC243964.2	NA	
ENSG00000069399	BCL3	NA	
ENSG00000284258	MIR8085	NA	
ENSG00000253027	SNORA70	NA	
ENSG00000236807	AC092066.1	NA	
ENSG00000142273	CBLC	NA	
ENSG00000285128	AC092306.1	NA	
ENSG00000187244	BCAM	111200	BLOOD GROUP--LUTHERAN SYSTEM; LU AUBERGER SYSTEM, INCLUDED; AU, INCLUDED
ENSG00000187244	BCAM	247420	LUTHERAN NULL;;RECESSIVE LU (a-b-) PHENOTYPE
ENSG00000130202	NECTIN2	NA	
ENSG00000267282	AC011481.2	NA	
ENSG00000130204	TOMM40	NA	
ENSG00000130203	APOE	104310	ALZHEIMER DISEASE 2; AD2;;ALZHEIMER DISEASE 2, LATE-ONSET;;ALZHEIMER DISEASE ASSOCIATED WITH APOE4
ENSG00000130203	APOE	269600	SEA-BLUE HISTIOCYTE DISEASE;;SEA-BLUE HISTIOCYTOSIS;;HISTIOCYTOSIS, SEA-BLUE
ENSG00000130203	APOE	603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1;;MACULOPATHY, AGE-RELATED, 1
ENSG00000130203	APOE	606889	ALZHEIMER DISEASE 4;;AD4;;ALZHEIMER DISEASE, FAMILIAL, 4
ENSG00000130203	APOE	611771	LIPOPROTEIN GLOMERULOPATHY; LPG
ENSG00000130203	APOE	617347	HYPERLIPOPROTEINEMIA, TYPE III;;APOLIPOPROTEIN E, DEFICIENCY OR DEFECT OF;;DYSBETALIPOPROTEINEMIA DUE TO DEFECT IN APOLIPOPROTEIN E-d;;FAMILIAL HYPERBETA- AND PREBETALIPOPROTEINEMIA;;FAMILIAL HYPERCHOLESTEROLEMIA WITH HYPERLIPEMIA;;HYPERLIPEMIA WITH /.../IAL HYPERCHOLESTEROLEMIC XANTHOMATOSIS;;BROAD-BETALIPOPROTEINEMIA;;FLOATING-BETALIPOPROTEINEMIA CORONARY ARTERY DISEASE, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5, INCLUDED; LDLCQ5, INCLUDED
ENSG00000280087	AC011481.3	NA	
ENSG00000130208	APOC1	NA	
ENSG00000214855	APOC1P1	NA	
ENSG00000267467	APOC4	NA	
ENSG00000224916	APOC4-APOC2	NA	
ENSG00000234906	APOC2	207750	APOLIPOPROTEIN C-II DEFICIENCY;;HYPERLIPOPROTEINEMIA, TYPE IB;;C-II ANAPOLIPOPROTEINEMIA;;APOC2 DEFICIENCY
ENSG00000267114	AC011481.1	NA	
ENSG00000104853	CLPTM1	NA	
ENSG00000104856	RELB	617585	IMMUNODEFICIENCY 53; IMD53
ENSG00000104859	CLASRP	NA	
ENSG00000207003	RNU6-611P	NA	
ENSG00000170684	ZNF296	NA	
ENSG00000267348	GEMIN7-AS1	NA	
ENSG00000142252	GEMIN7	NA	
ENSG00000007047	MARK4	NA	
ENSG00000104866	PPP1R37	NA	
ENSG00000267346	EIF5AP3	NA	
ENSG00000267044	AC005757.1	NA	
ENSG00000179846	NKPD1	NA	
ENSG00000007255	TRAPPC6A	NA	
ENSG00000189114	BLOC1S3	614077	HERMANSKY-PUDLAK SYNDROME 8; HPS8
ENSG00000283632	EXOC3L2	NA	
ENSG00000104879	CKM	NA	
ENSG00000242675	RPS16P9	NA	
ENSG00000104892	KLC3	NA	
ENSG00000104884	ERCC2	278730	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD;;XP, GROUP D; XPDC;;XERODERMA PIGMENTOSUM IV;;XP4 XERODERMA PIGMENTOSUM VIII, FORMERLY; XP8, FORMERLY;;XP, GROUP H, FORMERLY; XPH, FORMERLY
ENSG00000104884	ERCC2	601675	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1;;TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP;;ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION;;TAY SYNDROME;;TRICHOTHIODYSTROPHY WITH CONGENITAL ICHTHYOSIS; ICHTHYOSIS, CON /.../L, WITH TRICHOTHIODYSTROPHY;;PIBIDS SYNDROME
ENSG00000104884	ERCC2	610756	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2
ENSG00000104881	PPP1R13L	NA	
ENSG00000117877	CD3EAP	NA	
ENSG00000012061	ERCC1	610758	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4
ENSG00000275726	MIR6088	NA	
ENSG00000125740	FOSB	NA	
ENSG00000125744	RTN2	604805	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12
ENSG00000213889	PPM1N	NA	
ENSG00000125753	VASP	NA	
ENSG00000125741	OPA3	165300	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3;;OPTIC ATROPHY AND CATARACT, AUTOSOMAL DOMINANT
ENSG00000125741	OPA3	258501	3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE; /.../ AUTOSOMAL RECESSIVE
ENSG00000177464	GPR4	NA	
ENSG00000125746	EML2	NA	
ENSG00000284544	MIR330	NA	
ENSG00000267757	EML2-AS1	NA	
ENSG00000241226	RN7SL836P	NA	
ENSG00000010310	GIPR	NA	
ENSG00000207773	MIR642A	NA	
ENSG00000283212	MIR642B	NA	
ENSG00000125743	SNRPD2	NA	
ENSG00000011478	QPCTL	NA	
ENSG00000177051	FBXO46	NA	
ENSG00000279407	AC007191.1	NA	
ENSG00000237452	BHMG1	NA	
ENSG00000177045	SIX5	610896	BRANCHIOOTORENAL SYNDROME 2; BOR2
ENSG00000259605	AC074212.1	NA	
ENSG00000267395	DM1-AS	NA	
ENSG00000104936	DMPK	160900	MYOTONIC DYSTROPHY 1; DM1;;DYSTROPHIA MYOTONICA 1;;DYSTROPHIA MYOTONICA; DM;;STEINERT DISEASE
ENSG00000268434	AC011530.1	NA	
ENSG00000185800	DMWD	NA	
ENSG00000104941	RSPH6A	NA	
ENSG00000125755	SYMPK	NA	
ENSG00000269148	AC092301.1	NA	
ENSG00000170608	FOXA3	NA	
ENSG00000170604	IRF2BP1	NA	
ENSG00000176182	MYPOP	NA	
ENSG00000188425	NANOS2	NA	
ENSG00000104967	NOVA2	NA	
ENSG00000104983	CCDC61	NA	
ENSG00000211580	MIR769	NA	
ENSG00000008438	PGLYRP1	NA	
ENSG00000268401	AC007785.3	NA	
ENSG00000204869	IGFL4	NA	
ENSG00000204866	IGFL2	NA	
ENSG00000267922	AC007785.1	NA	
ENSG00000268053	AC007785.2	NA	
ENSG00000188624	IGFL3	NA	
ENSG00000259339	TGIF1P1	NA	
ENSG00000269729	AC006262.2	NA	
ENSG00000268621	IGFL2-AS1	NA	
ENSG00000268879	IGFL1P1	NA	
ENSG00000268460	AC006262.1	NA	
ENSG00000269637	RPL12P41	NA	
ENSG00000269745	AC006262.3	NA	
ENSG00000188293	IGFL1	NA	
ENSG00000277748	AC006262.4	NA	
ENSG00000268238	IGFL1P2	NA	
ENSG00000124440	HIF3A	NA	
ENSG00000199796	RNU6-924P	NA	
ENSG00000269124	AC007193.2	NA	
ENSG00000011485	PPP5C	NA	
ENSG00000268810	AC007193.1	NA	
ENSG00000269151	AC007193.3	NA	
ENSG00000169515	CCDC8	614205	THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3
ENSG00000277531	PNMA8C	NA	
ENSG00000182013	PNMA8A	NA	
ENSG00000230510	PPP5D1	NA	
ENSG00000204851	PNMA8B	NA	
ENSG00000204850	AC011484.1	NA	
ENSG00000278797	AC011551.1	NA	
ENSG00000249210	GAPDHP38	NA	
ENSG00000160014	CALM3	618782	LONG QT SYNDROME 16; LQT16 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC 6, INCLUDED; CPVT6, INCLUDED
ENSG00000269292	AC093503.1	NA	
ENSG00000160013	PTGIR	NA	
ENSG00000167414	GNG8	NA	
ENSG00000279161	AC093503.2	NA	
ENSG00000197380	DACT3	NA	
ENSG00000245598	DACT3-AS1	NA	
ENSG00000105287	PRKD2	NA	
ENSG00000243560	RN7SL364P	NA	
ENSG00000211513	MIR320E	NA	
ENSG00000090372	STRN4	NA	
ENSG00000269487	AC008635.2	NA	
ENSG00000222614	AC008635.1	NA	
ENSG00000181027	FKRP	236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED;;HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA;;HARD SYNDROME;;CEREBROOCULAR DYSPLA /.../SCULAR DYSTROPHY SYNDROME;;COD-MD SYNDROME
ENSG00000181027	FKRP	606612	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED
ENSG00000181027	FKRP	607155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 9; LGMDR9;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I; LGMD2I;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, FRKP-RELATED
ENSG00000181027	FKRP	613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKRP-RELATED
ENSG00000105281	SLC1A5	NA	
ENSG00000275719	AC008622.2	NA	
ENSG00000275862	AC008622.3	NA	
ENSG00000269576	HNRNPMP2	NA	
ENSG00000269014	AC008622.1	NA	
ENSG00000042753	AP2S1	600740	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3;;FAMILIAL BENIGN HYPERCALCEMIA, TYPE III; FBH3;;HYPERCALCEMIA, FAMILIAL BENIGN, TYPE III;;HYPERCALCEMIA, FAMILIAL BENIGN, OKLAHOMA TYPE
ENSG00000160007	ARHGAP35	NA	
ENSG00000279948	AC008895.1	NA	
ENSG00000130751	NPAS1	NA	
ENSG00000130748	TMEM160	NA	
ENSG00000130749	ZC3H4	NA	
ENSG00000142230	SAE1	NA	
ENSG00000105327	BBC3	NA	
ENSG00000265134	MIR3190	NA	
ENSG00000284411	MIR3191	NA	
ENSG00000286669	AC008532.1	NA	
ENSG00000105321	CCDC9	NA	
ENSG00000257704	INAFM1	NA	
ENSG00000197405	C5AR1	NA	
ENSG00000134830	C5AR2	NA	
ENSG00000134815	DHX34	NA	
ENSG00000105419	MEIS3	NA	
ENSG00000118160	SLC8A2	NA	
ENSG00000287896	AC073548.2	NA	
ENSG00000118162	KPTN	615637	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41
ENSG00000268061	NAPA-AS1	NA	
ENSG00000105402	NAPA	NA	
ENSG00000279861	AC073548.1	NA	
ENSG00000118156	ZNF541	NA	
ENSG00000276588	RN7SL322P	NA	
ENSG00000268746	AC010519.1	NA	
ENSG00000277383	AC010331.1	NA	
ENSG00000063169	BICRA	NA	
ENSG00000269806	BICRA-AS1	NA	
ENSG00000278999	AC008985.1	NA	
ENSG00000024422	EHD2	NA	
ENSG00000105373	NOP53	NA	
ENSG00000221803	SNORD23	NA	
ENSG00000269656	NOP53-AS1	NA	
ENSG00000178980	SELENOW	NA	
ENSG00000213035	RPL23AP80	NA	
ENSG00000271150	AC008745.1	NA	
ENSG00000178928	TPRX1	NA	
ENSG00000105392	CRX	120970	CONE-ROD DYSTROPHY 2; CORD2;;CONE-ROD DYSTROPHY; CORD;;CONE-ROD RETINAL DYSTROPHY; CRD; CRD2;;RETINAL CONE-ROD DYSTROPHY; RCRD2
ENSG00000105392	CRX	268000	RETINITIS PIGMENTOSA; RP
ENSG00000105392	CRX	613829	LEBER CONGENITAL AMAUROSIS 7; LCA7
ENSG00000259009	TPRX2P	NA	
ENSG00000259108	LINC01595	NA	
ENSG00000105398	SULT2A1	NA	
ENSG00000188334	BSPH1	NA	
ENSG00000169393	ELSPBP1	NA	
ENSG00000105507	CABP5	NA	
ENSG00000105499	PLA2G4C	NA	
ENSG00000269420	PLA2G4C-AS1	NA	
ENSG00000105486	LIG1	NA	
ENSG00000269534	AC011466.3	NA	
ENSG00000269321	AC011466.2	NA	
ENSG00000185453	ZSWIM9	NA	
ENSG00000105483	CARD8	NA	
ENSG00000280353	AC011466.4	NA	
ENSG00000268583	AC011466.1	NA	
ENSG00000268001	CARD8-AS1	NA	
ENSG00000268186	ZNF114-AS1	NA	
ENSG00000178150	ZNF114	NA	
ENSG00000105479	CCDC114	615067	CILIARY DYSKINESIA, PRIMARY, 20; CILD20;;CILIARY DYSKINESIA, PRIMARY, 20, WITH OR WITHOUT SITUS INVERSUS
ENSG00000142227	EMP3	NA	
ENSG00000161558	TMEM143	NA	
ENSG00000105467	SYNGR4	NA	
ENSG00000105438	KDELR1	NA	
ENSG00000105464	GRIN2D	617162	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46
ENSG00000105447	GRWD1	NA	
ENSG00000182324	KCNJ14	NA	
ENSG00000268530	AC008403.2	NA	
ENSG00000268465	AC008403.1	NA	
ENSG00000105443	CYTH2	NA	
ENSG00000142235	LMTK3	NA	
ENSG00000287603	AC008403.3	NA	
ENSG00000088002	SULT2B1	617571	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14
ENSG00000105523	FAM83E	NA	
ENSG00000177202	SPACA4	NA	
ENSG00000063177	RPL18	618310	DIAMOND-BLACKFAN ANEMIA 18; DBA18
ENSG00000268093	AC022154.1	NA	
ENSG00000063176	SPHK2	NA	
ENSG00000105516	DBP	NA	
ENSG00000063180	CA11	NA	
ENSG00000232871	SEC1P	NA	
ENSG00000142233	NTN5	NA	
ENSG00000176920	FUT2	612542	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1
ENSG00000176920	FUT2	616754	BOMBAY PHENOTYPE PARA-BOMBAY PHENOTYPE, INCLUDED;;REUNION VARIANT, INCLUDED;;BOMBAY PHENOTYPE, DIGENIC, INCLUDED
ENSG00000176909	MAMSTR	NA	
ENSG00000105538	RASIP1	NA	
ENSG00000182264	IZUMO1	NA	
ENSG00000174951	FUT1	616754	BOMBAY PHENOTYPE PARA-BOMBAY PHENOTYPE, INCLUDED;;REUNION VARIANT, INCLUDED;;BOMBAY PHENOTYPE, DIGENIC, INCLUDED
ENSG00000105550	FGF21	NA	
ENSG00000206758	RNU6-317P	NA	
ENSG00000105552	BCAT2	NA	
ENSG00000286024	AC026803.3	NA	
ENSG00000087076	HSD17B14	NA	
ENSG00000105559	PLEKHA4	NA	
ENSG00000087074	PPP1R15A	NA	
ENSG00000104804	TULP2	NA	
ENSG00000104805	NUCB1	NA	
ENSG00000235191	NUCB1-AS1	NA	
ENSG00000260366	AC026803.1	NA	
ENSG00000104808	DHDH	NA	
ENSG00000087088	BAX	NA	
ENSG00000267898	AC026803.2	NA	
ENSG00000087086	FTL	600886	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT; HRFTC;;HYPERFERRITINEMIA-CATARACT SYNDROME;;HYPERFERRITINEMIA, HEREDITARY, WITH CONGENITAL CATARACTS; HHCS
ENSG00000087086	FTL	606159	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3;;NEUROFERRITINOPATHY;;BASAL GANGLIA DISEASE, ADULT-ONSET
ENSG00000087086	FTL	615604	L-FERRITIN DEFICIENCY; LFTD
ENSG00000104812	GYS1	611556	GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B;;GSD 0b;;MUSCLE GLYCOGEN STORAGE DISEASE 0;;MUSCLE GLYCOGEN SYNTHASE DEFICIENCY
ENSG00000183207	RUVBL2	NA	
ENSG00000273898	MIR6798	NA	
ENSG00000104826	LHB	228300	HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23;;PASQUALINI SYNDROME;;FERTILE EUNUCH SYNDROME
ENSG00000268655	AC008687.4	NA	
ENSG00000104827	CGB3	NA	
ENSG00000267335	AC008687.1	NA	
ENSG00000267019	NTF6A	NA	
ENSG00000267099	NTF6G	NA	
ENSG00000104818	CGB2	NA	
ENSG00000267631	CGB1	NA	
ENSG00000267685	NTF6B	NA	
ENSG00000268669	AC008687.5	NA	
ENSG00000189052	CGB5	NA	
ENSG00000213030	CGB8	NA	
ENSG00000269706	AC008687.6	NA	
ENSG00000196337	CGB7	NA	
ENSG00000283663	AC008687.8	NA	
ENSG00000283251	AC008687.7	NA	
ENSG00000268108	AC008687.2	NA	
ENSG00000225950	NTF4	613100	GLAUCOMA 1, OPEN ANGLE, O; GLC1O
ENSG00000268287	AC008687.3	NA	
ENSG00000104848	KCNA7	NA	
ENSG00000265675	RN7SL708P	NA	
ENSG00000104852	SNRNP70	NA	
ENSG00000104863	LIN7B	NA	
ENSG00000221916	C19orf73	NA	
ENSG00000177380	PPFIA3	NA	
ENSG00000130528	HRC	NA	
ENSG00000130529	TRPM4	604559	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B;;PFHBIB
ENSG00000130529	TRPM4	618531	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6; EKVP6
ENSG00000269009	SLC6A21P	NA	
ENSG00000235555	SUMO1P4	NA	
ENSG00000063127	SLC6A16	NA	
ENSG00000265407	MIR4324	NA	
ENSG00000197813	AC011450.1	NA	
ENSG00000104894	CD37	NA	
ENSG00000074219	TEAD2	NA	
ENSG00000268157	AC010524.1	NA	
ENSG00000104901	DKKL1	NA	
ENSG00000268686	AC010643.1	NA	
ENSG00000161609	KASH5	NA	
ENSG00000142538	PTH2	NA	
ENSG00000261949	GFY	NA	
ENSG00000104888	SLC17A7	NA	
ENSG00000104872	PIH1D1	NA	
ENSG00000161618	ALDH16A1	NA	
ENSG00000269469	AC010619.1	NA	
ENSG00000090554	FLT3LG	NA	
ENSG00000273189	AC010619.2	NA	
ENSG00000142541	RPL13A	NA	
ENSG00000201675	SNORD32A	NA	
ENSG00000199631	SNORD33	NA	
ENSG00000202503	SNORD34	NA	
ENSG00000200259	SNORD35A	NA	
ENSG00000142534	RPS11	NA	
ENSG00000200530	SNORD35B	NA	
ENSG00000207782	MIR150	NA	
ENSG00000268681	COX6CP7	NA	
ENSG00000104870	FCGRT	NA	
ENSG00000142552	RCN3	NA	
ENSG00000142546	NOSIP	NA	
ENSG00000207073	Y_RNA	NA	
ENSG00000126460	PRRG2	NA	
ENSG00000126464	PRR12	NA	
ENSG00000268636	AC011495.2	NA	
ENSG00000126458	RRAS	NA	
ENSG00000126461	SCAF1	NA	
ENSG00000126456	IRF3	616532	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7;;HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 5
ENSG00000126453	BCL2L12	NA	
ENSG00000126457	PRMT1	NA	
ENSG00000274306	MIR5088	NA	
ENSG00000224420	ADM5	NA	
ENSG00000268677	AC011495.3	NA	
ENSG00000169169	CPT1C	616282	SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73
ENSG00000243829	AC011495.1	NA	
ENSG00000126467	TSKS	NA	
ENSG00000206599	RNU6-841P	NA	
ENSG00000196961	AP2A1	NA	
ENSG00000276270	MIR6799	NA	
ENSG00000010361	FUZ	182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD SPINA BIFIDA, INCLUDED
ENSG00000269194	AC006942.1	NA	
ENSG00000104973	MED25	605589	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2B2;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2B2;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2B2;;ARCMT2B
ENSG00000104973	MED25	616449	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS
ENSG00000284114	MIR6800	NA	
ENSG00000268006	PTOV1-AS1	NA	
ENSG00000104960	PTOV1	NA	
ENSG00000268047	AC018766.1	NA	
ENSG00000265954	MIR4749	NA	
ENSG00000269352	PTOV1-AS2	NA	
ENSG00000039650	PNKP	613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10; EIEE10
ENSG00000039650	PNKP	616267	ATAXIA-OCULOMOTOR APRAXIA 4; AOA4
ENSG00000204673	AKT1S1	NA	
ENSG00000104946	TBC1D17	NA	
ENSG00000284394	MIR4750	NA	
ENSG00000104951	IL4I1	NA	
ENSG00000213024	NUP62	271930	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL
ENSG00000269179	AC011452.2	NA	
ENSG00000283842	MIR4751	NA	
ENSG00000161640	SIGLEC11	NA	
ENSG00000221125	AC011452.1	NA	
ENSG00000161643	SIGLEC16	NA	
ENSG00000105053	VRK3	NA	
ENSG00000276729	AC011452.3	NA	
ENSG00000142528	ZNF473	NA	
ENSG00000269091	AC010624.3	NA	
ENSG00000204666	AC010624.1	NA	
ENSG00000269540	AC010624.4	NA	
ENSG00000267890	AC010624.2	NA	
ENSG00000287001	AC010624.5	NA	
ENSG00000161652	IZUMO2	NA	
ENSG00000105357	MYH14	600652	DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A;;DEAFNESS, AUTOSOMAL DOMINANT 4; DFNA4
ENSG00000105357	MYH14	614369	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH
ENSG00000276002	Metazoa_SRP	NA	
ENSG00000267815	AC008655.1	NA	
ENSG00000131398	KCNC3	605259	SPINOCEREBELLAR ATAXIA 13; SCA13
ENSG00000131408	NR1H2	NA	
ENSG00000131401	NAPSB	NA	
ENSG00000131400	NAPSA	NA	
ENSG00000269392	AC008655.2	NA	
ENSG00000062822	POLD1	612591	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10;;COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 19q
ENSG00000062822	POLD1	615381	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL
ENSG00000142539	AC020909.1	NA	
ENSG00000269404	SPIB	NA	
ENSG00000086967	MYBPC2	NA	
ENSG00000142530	FAM71E1	NA	
ENSG00000161671	EMC10	NA	
ENSG00000268854	AC020909.3	NA	
ENSG00000268518	AC020909.2	NA	
ENSG00000161677	JOSD2	NA	
ENSG00000204653	ASPDH	NA	
ENSG00000131409	LRRC4B	NA	
ENSG00000268231	AC008743.1	NA	
ENSG00000213023	SYT3	NA	
ENSG00000235034	C19orf81	NA	
ENSG00000161681	SHANK1	NA	
ENSG00000105472	CLEC11A	NA	
ENSG00000269565	GPR32P1	NA	
ENSG00000142511	GPR32	NA	
ENSG00000261341	AC010325.1	NA	
ENSG00000142513	ACP4	617297	AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J
ENSG00000268375	AC010325.2	NA	
ENSG00000167747	C19orf48	NA	
ENSG00000221381	SNORD88B	NA	
ENSG00000221241	SNORD88A	NA	
ENSG00000220988	SNORD88C	NA	
ENSG00000284711	AC010325.3	NA	
ENSG00000180279	LINC01869	NA	
ENSG00000167748	KLK1	615953	KALLIKREIN, DECREASED URINARY ACTIVITY OF
ENSG00000174562	KLK15	NA	
ENSG00000267968	AC011523.1	NA	
ENSG00000142515	KLK3	NA	
ENSG00000167751	KLK2	NA	
ENSG00000197588	KLKP1	NA	
ENSG00000167749	KLK4	204700	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1;;AMELOGENESIS IMPERFECTA, PIGMENTED HYPOMATURATION TYPE, 1
ENSG00000228674	PPIAP59	NA	
ENSG00000167754	KLK5	NA	
ENSG00000269495	AC011483.2	NA	
ENSG00000167755	KLK6	NA	
ENSG00000279676	AC011483.3	NA	
ENSG00000267879	AC011483.1	NA	
ENSG00000169035	KLK7	NA	
ENSG00000129455	KLK8	NA	
ENSG00000269741	AC011473.4	NA	
ENSG00000213022	KLK9	NA	
ENSG00000129451	KLK10	NA	
ENSG00000268739	AC011473.2	NA	
ENSG00000167757	KLK11	NA	
ENSG00000186474	KLK12	NA	
ENSG00000268906	AC011473.3	NA	
ENSG00000268390	AC011473.1	NA	
ENSG00000167759	KLK13	NA	
ENSG00000129437	KLK14	NA	
ENSG00000142544	CTU1	NA	
ENSG00000268581	SIGLEC18P	NA	
ENSG00000129450	SIGLEC9	NA	
ENSG00000267990	AC063977.2	NA	
ENSG00000168995	SIGLEC7	NA	
ENSG00000267895	AC063977.1	NA	
ENSG00000269072	AC063977.6	NA	
ENSG00000269681	AC063977.7	NA	
ENSG00000171101	SIGLEC17P	NA	
ENSG00000268336	SIGLEC20P	NA	
ENSG00000268652	AC063977.4	NA	
ENSG00000269253	SIGLEC21P	NA	
ENSG00000278617	MIR8074	NA	
ENSG00000268849	SIGLEC22P	NA	
ENSG00000105383	CD33	NA	
ENSG00000179213	SIGLECL1	NA	
ENSG00000268595	AC063977.3	NA	
ENSG00000268318	LINC01872	NA	
ENSG00000269021	AC063977.5	NA	
ENSG00000142549	IGLON5	NA	
ENSG00000186806	VSIG10L	NA	
ENSG00000267905	AC008750.2	NA	
ENSG00000267984	AC008750.3	NA	
ENSG00000105379	ETFB	231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD;;GLUTARIC ACIDEMIA II; GA2;;GLUTARIC ACIDURIA II;;GA II;;ETHYLMALONIC-ADIPICACIDURIA; EMA GLUTARIC ACIDEMIA IIA, INCLUDED; GA2A, INCLUDED;;ETFA DEFICIENCY, INCLUDED;;GLUTARIC ACIDEMIA IIB, INCLUDED; G /.../NCLUDED;;ETFB DEFICIENCY, INCLUDED;;GLUTARIC ACIDEMIA IIC, INCLUDED; GA2C, INCLUDED;;ETFDH DEFICIENCY, INCLUDED
ENSG00000269403	AC008750.7	NA	
ENSG00000268520	AC008750.4	NA	
ENSG00000160318	CLDND2	NA	
ENSG00000105374	NKG7	NA	
ENSG00000105370	LIM2	615277	CATARACT 19, MULTIPLE TYPES; CTRCT19
ENSG00000262874	C19orf84	NA	
ENSG00000268889	AC008750.6	NA	
ENSG00000268144	NIFKP6	NA	
ENSG00000142512	SIGLEC10	NA	
ENSG00000254760	AC008750.1	NA	
ENSG00000255441	SIGLEC10-AS1	NA	
ENSG00000268711	AC008750.5	NA	
ENSG00000269181	AC020914.5	NA	
ENSG00000105366	SIGLEC8	NA	
ENSG00000268957	AC020914.3	NA	
ENSG00000213822	CEACAM18	NA	
ENSG00000254521	SIGLEC12	NA	
ENSG00000268839	AC020914.2	NA	
ENSG00000269580	SIGLEC27P	NA	
ENSG00000105492	SIGLEC6	NA	
ENSG00000268777	AC020914.1	NA	
ENSG00000269130	AC020914.4	NA	
ENSG00000268267	SIGLEC29P	NA	
ENSG00000105497	ZNF175	NA	
ENSG00000269388	AC018755.3	NA	
ENSG00000267808	AC018755.1	NA	
ENSG00000105501	SIGLEC5	NA	
ENSG00000268500	AC018755.2	NA	
ENSG00000244071	RPL9P33	NA	
ENSG00000273837	AC018755.4	NA	
ENSG00000254415	SIGLEC14	NA	
ENSG00000243469	RPL7P51	NA	
ENSG00000269959	SPACA6P-AS	NA	
ENSG00000182310	SPACA6	NA	
ENSG00000207550	MIR99B	NA	
ENSG00000198972	MIRLET7E	NA	
ENSG00000208008	MIR125A	NA	
ENSG00000105509	HAS1	NA	
ENSG00000171051	FPR1	NA	
ENSG00000171049	FPR2	NA	
ENSG00000286236	AC018755.5	NA	
ENSG00000187474	FPR3	NA	
ENSG00000161551	ZNF577	NA	
ENSG00000268316	AC006272.1	NA	
ENSG00000269483	AC006272.2	NA	
ENSG00000283236	AC074141.1	NA	
ENSG00000268095	ZNF649-AS1	NA	
ENSG00000198093	ZNF649	NA	
ENSG00000283285	AC011460.1	NA	
ENSG00000176024	ZNF613	NA	
ENSG00000269235	ZNF350-AS1	NA	
ENSG00000256683	ZNF350	NA	
ENSG00000197619	ZNF615	NA	
ENSG00000142556	ZNF614	NA	
ENSG00000256087	ZNF432	NA	
ENSG00000275055	AC011468.5	NA	
ENSG00000260160	AC011468.1	NA	
ENSG00000197608	ZNF841	NA	
ENSG00000270248	AC011468.4	NA	
ENSG00000204611	ZNF616	NA	
ENSG00000267827	AC011468.2	NA	
ENSG00000268458	AC011468.3	NA	
ENSG00000243680	RPL37P23	NA	
ENSG00000196267	ZNF836	NA	
ENSG00000267927	AC010320.1	NA	
ENSG00000105568	PPP2R1A	616362	MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36
ENSG00000274380	MIR6801	NA	
ENSG00000268015	AC010320.2	NA	
ENSG00000277562	AC010320.5	NA	
ENSG00000207265	Y_RNA	NA	
ENSG00000196214	ZNF766	NA	
ENSG00000208002	MIR643	NA	
ENSG00000269102	AC010320.3	NA	
ENSG00000198464	ZNF480	NA	
ENSG00000269535	AC010320.4	NA	
ENSG00000167554	ZNF610	NA	
ENSG00000221923	ZNF880	NA	
ENSG00000269834	ZNF528-AS1	NA	
ENSG00000277977	AC010332.1	NA	
ENSG00000167555	ZNF528	NA	
ENSG00000269776	DPPA5P1	NA	
ENSG00000198633	ZNF534	NA	
ENSG00000258405	ZNF578	NA	
ENSG00000288253	AC010332.3	NA	
ENSG00000278543	AC010332.2	NA	
ENSG00000269349	AC022150.3	NA	
ENSG00000198482	ZNF808	NA	
ENSG00000167562	ZNF701	NA	
ENSG00000242255	RPL39P34	NA	
ENSG00000268886	AC022150.1	NA	
ENSG00000123870	ZNF137P	NA	
ENSG00000167766	ZNF83	NA	
ENSG00000268970	AC022150.2	NA	
ENSG00000269825	AC022150.4	NA	
ENSG00000213020	ZNF611	NA	
ENSG00000189190	ZNF600	NA	
ENSG00000198538	ZNF28	NA	
ENSG00000255875	AC008813.1	NA	
ENSG00000204604	ZNF468	NA	
ENSG00000182986	ZNF320	NA	
ENSG00000283695	AC010487.2	NA	
ENSG00000213793	ZNF888	NA	
ENSG00000269646	AC010487.1	NA	
ENSG00000221874	ZNF816-ZNF321P	NA	
ENSG00000213801	ZNF321P	NA	
ENSG00000180257	ZNF816	NA	
ENSG00000269082	AC010328.3	NA	
ENSG00000242779	ZNF702P	NA	
ENSG00000268282	AC010328.2	NA	
ENSG00000267943	AC010328.1	NA	
ENSG00000269526	ERVV-1	NA	
ENSG00000268964	ERVV-2	NA	
ENSG00000170949	ZNF160	NA	
ENSG00000170954	ZNF415	NA	
ENSG00000197937	ZNF347	NA	
ENSG00000197497	ZNF665	NA	
ENSG00000268842	AC092070.1	NA	
ENSG00000269001	AC092070.2	NA	
ENSG00000267809	NDUFV2P1	NA	
ENSG00000197928	ZNF677	NA	
ENSG00000269288	AC092070.3	NA	
ENSG00000196131	VN1R2	NA	
ENSG00000228567	VN1R4	NA	
ENSG00000269758	AC092070.4	NA	
ENSG00000189348	FAM90A27P	NA	
ENSG00000163098	BIRC8	NA	
ENSG00000269118	FAM90A28P	NA	
ENSG00000174677	VN1R6P	NA	
ENSG00000213799	ZNF845	NA	
ENSG00000203326	ZNF525	NA	
ENSG00000241069	AC125388.1	NA	
ENSG00000196417	ZNF765	NA	
ENSG00000239912	RPL39P36	NA	
ENSG00000249435	AC022137.2	NA	
ENSG00000241015	TPM3P9	NA	
ENSG00000286261	AC022137.3	NA	
ENSG00000287608	AC022137.4	NA	
ENSG00000160336	ZNF761	NA	
ENSG00000198346	ZNF813	NA	
ENSG00000250731	TPM3P6	NA	
ENSG00000241434	AC022137.1	NA	
ENSG00000213777	AC011487.1	NA	
ENSG00000274892	AC011487.4	NA	
ENSG00000130844	ZNF331	NA	
ENSG00000268864	AC011487.2	NA	
ENSG00000269608	AC011487.3	NA	
ENSG00000242668	RN7SL317P	NA	
ENSG00000204595	DPRX	NA	
ENSG00000200393	RNU6-698P	NA	
ENSG00000270347	AC011453.2	NA	
ENSG00000207645	MIR512-1	NA	
ENSG00000207644	MIR512-2	NA	
ENSG00000221017	MIR1323	NA	
ENSG00000207869	MIR498	NA	
ENSG00000207599	MIR520E	NA	
ENSG00000207616	MIR515-1	NA	
ENSG00000207810	MIR519E	NA	
ENSG00000283540	MIR520F	NA	
ENSG00000207615	MIR515-2	NA	
ENSG00000207788	MIR519C	NA	
ENSG00000221421	MIR1283-1	NA	
ENSG00000207594	MIR520A	NA	
ENSG00000207580	MIR526B	NA	
ENSG00000207825	MIR519B	NA	
ENSG00000207711	MIR525	NA	
ENSG00000283455	MIR523	NA	
ENSG00000207706	MIR518F	NA	
ENSG00000207722	MIR520B	NA	
ENSG00000207862	MIR518B	NA	
ENSG00000207629	MIR526A1	NA	
ENSG00000207738	MIR520C	NA	
ENSG00000283490	MIR518C	NA	
ENSG00000283289	MIR524	NA	
ENSG00000207734	MIR517A	NA	
ENSG00000207981	MIR519D	NA	
ENSG00000207549	MIR521-2	NA	
ENSG00000251843	RNU6-803P	NA	
ENSG00000207735	MIR520D	NA	
ENSG00000207837	MIR517B	NA	
ENSG00000207799	MIR520G	NA	
ENSG00000207925	MIR516B2	NA	
ENSG00000211532	MIR526A2	NA	
ENSG00000207987	MIR518E	NA	
ENSG00000207803	MIR518A1	NA	
ENSG00000252734	RNU6-980P	NA	
ENSG00000283330	MIR518D	NA	
ENSG00000207946	MIR516B1	NA	
ENSG00000207699	MIR518A2	NA	
ENSG00000207838	MIR517C	NA	
ENSG00000207861	MIR520H	NA	
ENSG00000252025	RNU6-982P	NA	
ENSG00000207634	MIR521-1	NA	
ENSG00000252191	RNU6-751P	NA	
ENSG00000283685	MIR522	NA	
ENSG00000207992	MIR519A1	NA	
ENSG00000207979	MIR527	NA	
ENSG00000207767	MIR516A1	NA	
ENSG00000221548	MIR1283-2	NA	
ENSG00000252063	RNU6-1041P	NA	
ENSG00000207620	MIR516A2	NA	
ENSG00000269842	AC011453.1	NA	
ENSG00000284362	MIR519A2	NA	
ENSG00000252979	RNU6-165P	NA	
ENSG00000237589	HMGN1P32	NA	
ENSG00000229000	SEPTIN7P8	NA	
ENSG00000238150	AC008753.1	NA	
ENSG00000269877	AC008753.3	NA	
ENSG00000199031	MIR371A	NA	
ENSG00000284568	MIR371B	NA	
ENSG00000199095	MIR372	NA	
ENSG00000199143	MIR373	NA	
ENSG00000269564	AC008753.2	NA	
ENSG00000142405	NLRP12	611762	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2
ENSG00000228323	MYADM-AS1	NA	
ENSG00000179820	MYADM	NA	
ENSG00000232220	AC008440.1	NA	
ENSG00000126583	PRKCG	605361	SPINOCEREBELLAR ATAXIA 14; SCA14
ENSG00000105605	CACNG7	NA	
ENSG00000142408	CACNG8	NA	
ENSG00000284583	MIR935	NA	
ENSG00000130433	CACNG6	NA	
ENSG00000276206	AC012314.9	NA	
ENSG00000189068	VSTM1	NA	
ENSG00000248385	TARM1	NA	
ENSG00000170909	OSCAR	NA	
ENSG00000170906	NDUFA3	NA	
ENSG00000105619	TFPT	NA	
ENSG00000105618	PRPF31	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000237017	AC245052.4	NA	
ENSG00000088038	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000105617	LENG1	NA	
ENSG00000167608	TMC4	NA	
ENSG00000125505	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000170892	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000223660	AC245052.1	NA	
ENSG00000170889	RPS9	NA	
ENSG00000224579	AC245052.2	NA	
ENSG00000204577	LILRB3	NA	
ENSG00000269524	AC245052.7	NA	
ENSG00000235081	AC245052.3	NA	
ENSG00000244482	LILRA6	NA	
ENSG00000249189	AC245052.6	NA	
ENSG00000105609	LILRB5	NA	
ENSG00000212314	RNU6-1307P	NA	
ENSG00000240296	AC245052.5	NA	
ENSG00000131042	LILRB2	NA	
ENSG00000264703	MIR4752	NA	
ENSG00000240197	AC245884.5	NA	
ENSG00000276758	AC245884.12	NA	
ENSG00000251431	AC245884.7	NA	
ENSG00000234436	AC245884.2	NA	
ENSG00000187116	LILRA5	NA	
ENSG00000275210	AC245884.11	NA	
ENSG00000249654	VN1R104P	NA	
ENSG00000250507	AC245884.6	NA	
ENSG00000239961	LILRA4	NA	
ENSG00000167613	LAIR1	NA	
ENSG00000237955	AC245884.4	NA	
ENSG00000167614	TTYH1	NA	
ENSG00000227407	AC245884.1	NA	
ENSG00000268496	AC245884.9	NA	
ENSG00000269873	AC245884.10	NA	
ENSG00000267838	AC245884.8	NA	
ENSG00000226696	LENG8-AS1	NA	
ENSG00000235681	AC245884.3	NA	
ENSG00000167615	LENG8	NA	
ENSG00000275183	LENG9	NA	
ENSG00000167617	CDC42EP5	NA	
ENSG00000167618	LAIR2	NA	
ENSG00000213016	AC245036.1	NA	
ENSG00000104970	KIR3DX1	NA	
ENSG00000235181	AC245036.2	NA	
ENSG00000239998	LILRA2	NA	
ENSG00000269271	AC245036.5	NA	
ENSG00000104974	LILRA1	NA	
ENSG00000238094	AC245036.4	NA	
ENSG00000104972	LILRB1	NA	
ENSG00000224730	LILRB1-AS1	NA	
ENSG00000186818	LILRB4	NA	
ENSG00000277636	MIR8061	NA	
ENSG00000242856	VN1R105P	NA	
ENSG00000237323	AC245036.3	NA	
ENSG00000225370	AC243962.1	NA	
ENSG00000186152	LILRP1	NA	
ENSG00000228790	AC245128.2	NA	
ENSG00000170858	LILRP2	NA	
ENSG00000242019	KIR3DL3	NA	
ENSG00000215765	AC245128.1	NA	
ENSG00000243772	KIR2DL3	NA	
ENSG00000242473	KIR2DP1	NA	
ENSG00000125498	KIR2DL1	NA	
ENSG00000264257	KIR3DP1	NA	
ENSG00000189013	KIR2DL4	NA	
ENSG00000167633	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000221957	KIR2DS4	NA	
ENSG00000240403	KIR3DL2	NA	
ENSG00000199308	RNU6-222P	NA	
ENSG00000186431	FCAR	NA	
ENSG00000268734	AC245128.3	NA	
ENSG00000189430	NCR1	NA	
ENSG00000167634	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000275012	AC011476.8	NA	
ENSG00000022556	NLRP2	NA	
ENSG00000243494	AC011476.1	NA	
ENSG00000267265	AC011476.3	NA	
ENSG00000088053	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000267149	AC011476.2	NA	
ENSG00000160439	RDH13	NA	
ENSG00000131037	EPS8L1	NA	
ENSG00000125503	PPP1R12C	NA	
ENSG00000287170	AC010327.8	NA	
ENSG00000267507	AC010327.3	NA	
ENSG00000275863	MIR7975	NA	
ENSG00000105048	TNNT1	605355	NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY
ENSG00000129991	TNNI3	115210	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1;;RCM
ENSG00000129991	TNNI3	611880	CARDIOMYOPATHY, DILATED, 2A; CMD2A;;CARDIOMYOPATHY, DILATED, AUTOSOMAL RECESSIVE;;CARDIOMYOPATHY, CONGESTIVE, AUTOSOMAL RECESSIVE
ENSG00000129991	TNNI3	613286	CARDIOMYOPATHY, DILATED, 1FF; CMD1FF
ENSG00000129991	TNNI3	613690	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7
ENSG00000267110	AC010327.2	NA	
ENSG00000167646	DNAAF3	606763	CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS
ENSG00000267577	AC010327.4	NA	
ENSG00000239137	AC010327.1	NA	
ENSG00000129990	SYT5	NA	
ENSG00000080031	PTPRH	NA	
ENSG00000286230	AC010327.7	NA	
ENSG00000267649	AC010327.5	NA	
ENSG00000180089	TMEM86B	NA	
ENSG00000276570	AC010327.6	NA	
ENSG00000105063	PPP6R1	NA	
ENSG00000275519	MIR6804	NA	
ENSG00000278328	MIR6802	NA	
ENSG00000278264	MIR6803	NA	
ENSG00000133265	HSPBP1	NA	
ENSG00000160469	BRSK1	NA	
ENSG00000268729	AC020922.2	NA	
ENSG00000180061	TMEM150B	NA	
ENSG00000276831	AC020922.4	NA	
ENSG00000133247	KMT5C	NA	
ENSG00000160471	COX6B2	NA	
ENSG00000267706	AC020922.1	NA	
ENSG00000180043	FAM71E2	NA	
ENSG00000095752	IL11	NA	
ENSG00000160472	TMEM190	NA	
ENSG00000269275	AC020922.3	NA	
ENSG00000233493	TMEM238	NA	
ENSG00000108107	RPL28	NA	
ENSG00000284029	MIR6805	NA	
ENSG00000108106	UBE2S	NA	
ENSG00000187902	SHISA7	NA	
ENSG00000063241	ISOC2	NA	
ENSG00000283567	C19orf85	NA	
ENSG00000279063	AC008735.5	NA	
ENSG00000269859	AC008735.3	NA	
ENSG00000197483	ZNF628	NA	
ENSG00000090971	NAT14	NA	
ENSG00000179954	SSC5D	NA	
ENSG00000187550	SBK2	NA	
ENSG00000231274	SBK3	NA	
ENSG00000218891	ZNF579	NA	
ENSG00000179943	FIZ1	NA	
ENSG00000171443	ZNF524	NA	
ENSG00000261221	ZNF865	NA	
ENSG00000276488	AC008735.4	NA	
ENSG00000179922	ZNF784	NA	
ENSG00000213015	ZNF580	NA	
ENSG00000171425	ZNF581	NA	
ENSG00000173581	CCDC106	NA	
ENSG00000063244	U2AF2	NA	
ENSG00000267523	AC008735.2	NA	
ENSG00000267096	AC008735.1	NA	
ENSG00000063245	EPN1	NA	
ENSG00000267117	AC010525.1	NA	
ENSG00000267689	AC010525.2	NA	
ENSG00000268593	AC008749.1	NA	
ENSG00000185792	NLRP9	NA	
ENSG00000222524	RN7SKP109	NA	
ENSG00000223638	RFPL4A	NA	
ENSG00000229292	RFPL4AL1	NA	
ENSG00000255238	RFPL4AP1	NA	
ENSG00000179873	NLRP11	NA	
ENSG00000160505	NLRP4	NA	
ENSG00000173572	NLRP13	NA	
ENSG00000179709	NLRP8	NA	
ENSG00000171487	NLRP5	NA	
ENSG00000267522	LINC01864	NA	
ENSG00000142409	ZNF787	NA	
ENSG00000223060	Y_RNA	NA	
ENSG00000279959	AC024580.2	NA	
ENSG00000167685	ZNF444	NA	
ENSG00000279794	AC024580.1	NA	
ENSG00000197487	GALP	NA	
ENSG00000197213	ZSCAN5B	NA	
ENSG00000204532	ZSCAN5C	NA	
ENSG00000242411	AC011506.1	NA	
ENSG00000131848	ZSCAN5A	NA	
ENSG00000267908	ZSCAN5DP	NA	
ENSG00000267710	EDDM13	NA	
ENSG00000267298	AC006116.6	NA	
ENSG00000267549	AC006116.8	NA	
ENSG00000200646	AC006116.1	NA	
ENSG00000213014	VN2R17P	NA	
ENSG00000266907	AC006116.2	NA	
ENSG00000267145	AC006116.4	NA	
ENSG00000266932	AC006116.3	NA	
ENSG00000267429	AC006116.7	NA	
ENSG00000267606	AC006116.9	NA	
ENSG00000240225	ZNF542P	NA	
ENSG00000018869	ZNF582	NA	
ENSG00000285996	AC006116.10	NA	
ENSG00000267781	SLC25A36P1	NA	
ENSG00000267192	AC006116.5	NA	
ENSG00000267454	ZNF582-AS1	NA	
ENSG00000198440	ZNF583	NA	
ENSG00000198046	ZNF667	NA	
ENSG00000166770	ZNF667-AS1	NA	
ENSG00000279405	AC004696.2	NA	
ENSG00000276578	AC004696.1	NA	
ENSG00000196263	ZNF471	NA	
ENSG00000267224	AC005498.1	NA	
ENSG00000267421	AC005498.2	NA	
ENSG00000196867	ZFP28	NA	
ENSG00000269696	AC005498.3	NA	
ENSG00000197016	ZNF470	NA	
ENSG00000268847	SIGLEC31P	NA	
ENSG00000197951	ZNF71	NA	
ENSG00000269793	ZIM2-AS1	NA	
ENSG00000268182	SMIM17	NA	
ENSG00000127903	ZNF835	NA	
ENSG00000286125	AC006115.2	NA	
ENSG00000268067	OR5AH1P	NA	
ENSG00000269699	ZIM2	NA	
ENSG00000268407	AC006115.1	NA	
ENSG00000198300	PEG3	NA	
ENSG00000268654	MIMT1	NA	
ENSG00000274777	AC004792.1	NA	
ENSG00000269786	AC044792.1	NA	
ENSG00000268483	RPL7AP69	NA	
ENSG00000274219	AC025588.4	NA	
ENSG00000131864	USP29	NA	
ENSG00000141946	ZIM3	NA	
ENSG00000270293	AC025588.2	NA	
ENSG00000270790	AC025588.3	NA	
ENSG00000258873	DUXA	NA	
ENSG00000268379	AC025588.1	NA	
ENSG00000083844	ZNF264	NA	
ENSG00000105146	AURKC	243060	SPERMATOGENIC FAILURE 5; SPGF5;;MALE INFERTILITY WITH LARGE-HEADED, MULTIFLAGELLAR, POLYPLOID SPERMATOZOA;;INFERTILITY ASSOCIATED WITH MULTITAILED SPERMATOZOA AND EXCESSIVE DNA
ENSG00000204524	ZNF805	NA	
ENSG00000268713	AC005261.3	NA	
ENSG00000267871	ZNF460-AS1	NA	
ENSG00000197714	ZNF460	NA	
ENSG00000279541	AC005261.5	NA	
ENSG00000268205	AC005261.1	NA	
ENSG00000268723	AC005261.4	NA	
ENSG00000178229	ZNF543	NA	
ENSG00000268678	AC005261.2	NA	
ENSG00000131845	ZNF304	NA	
ENSG00000152433	ZNF547	NA	
ENSG00000256060	TRAPPC2B	NA	
ENSG00000268133	AC003002.1	NA	
ENSG00000188785	ZNF548	NA	
ENSG00000269533	AC003002.3	NA	
ENSG00000268533	AC003002.2	NA	
ENSG00000186272	ZNF17	NA	
ENSG00000186230	ZNF749	NA	
ENSG00000268163	AC004076.1	NA	
ENSG00000276449	AC004076.2	NA	
ENSG00000178201	VN1R1	NA	
ENSG00000268545	VN1R107P	NA	
ENSG00000197128	ZNF772	NA	
ENSG00000268266	AC003005.2	NA	
ENSG00000105136	ZNF419	NA	
ENSG00000268107	AC003005.1	NA	
ENSG00000152439	ZNF773	NA	
ENSG00000121406	ZNF549	NA	
ENSG00000251369	ZNF550	NA	
ENSG00000083817	ZNF416	NA	
ENSG00000171649	ZIK1	NA	
ENSG00000183647	ZNF530	NA	
ENSG00000204519	ZNF551	NA	
ENSG00000213762	ZNF134	NA	
ENSG00000268392	AC003682.1	NA	
ENSG00000121417	ZNF211	NA	
ENSG00000269097	TPRG1LP1	NA	
ENSG00000180532	ZSCAN4	NA	
ENSG00000269026	AC003006.1	NA	
ENSG00000179909	ZNF154	NA	
ENSG00000083814	ZNF671	NA	
ENSG00000152443	ZNF776	NA	
ENSG00000083828	ZNF586	NA	
ENSG00000178935	ZNF552	NA	
ENSG00000268750	AC010522.1	NA	
ENSG00000269343	ZNF587B	NA	
ENSG00000269304	FKBP1AP1	NA	
ENSG00000204514	ZNF814	NA	
ENSG00000198466	ZNF587	NA	
ENSG00000269867	AC010326.3	NA	
ENSG00000270804	AC010326.4	NA	
ENSG00000269476	AC010326.2	NA	
ENSG00000173480	ZNF417	NA	
ENSG00000196724	ZNF418	NA	
ENSG00000152454	ZNF256	NA	
ENSG00000243234	AC010326.1	NA	
ENSG00000177025	C19orf18	NA	
ENSG00000166704	ZNF606	NA	
ENSG00000176593	AC008969.1	NA	
ENSG00000235974	VN2R19P	NA	
ENSG00000286949	AC008969.2	NA	
ENSG00000152467	ZSCAN1	NA	
ENSG00000268660	LETM1P2	NA	
ENSG00000270837	HNRNPDLP4	NA	
ENSG00000176293	ZNF135	NA	
ENSG00000243642	RN7SL526P	NA	
ENSG00000121413	ZSCAN18	NA	
ENSG00000181894	ZNF329	NA	
ENSG00000268293	AC008751.1	NA	
ENSG00000286632	AC008751.3	NA	
ENSG00000269236	AC008751.2	NA	
ENSG00000171606	ZNF274	NA	
ENSG00000213013	RPS15AP36	NA	
ENSG00000268866	AC020915.3	NA	
ENSG00000198131	ZNF544	NA	
ENSG00000283515	AC020915.4	NA	
ENSG00000268516	AC020915.2	NA	
ENSG00000268201	AC020915.1	NA	
ENSG00000278129	ZNF8	NA	
ENSG00000267216	ZNF8-ERVK3-1	NA	
ENSG00000142396	ERVK3-1	NA	
ENSG00000283103	AC010642.2	NA	
ENSG00000269794	AC010642.1	NA	
ENSG00000182318	ZSCAN22	NA	
ENSG00000277588	MIR6806	NA	
ENSG00000121410	A1BG	NA	
ENSG00000268230	AC012313.3	NA	
ENSG00000268895	A1BG-AS1	NA	
ENSG00000279611	AC012313.10	NA	
ENSG00000174586	ZNF497	NA	
ENSG00000268049	AC012313.2	NA	
ENSG00000269054	AC012313.6	NA	
ENSG00000252211	RNA5SP473	NA	
ENSG00000152475	ZNF837	NA	
ENSG00000083845	RPS5	NA	
ENSG00000266640	MIR4754	NA	
ENSG00000269855	RNF225	NA	
ENSG00000268307	LINC02560	NA	
ENSG00000171574	ZNF584	NA	
ENSG00000232098	AC012313.1	NA	
ENSG00000268543	AC012313.4	NA	
ENSG00000268912	AC012313.5	NA	
ENSG00000131849	ZNF132	NA	
ENSG00000269473	AC012313.8	NA	
ENSG00000249471	ZNF324B	NA	
ENSG00000083812	ZNF324	NA	
ENSG00000083838	ZNF446	NA	
ENSG00000269106	AC012313.7	NA	
ENSG00000083807	SLC27A5	NA	
ENSG00000252334	RNU6-1337P	NA	
ENSG00000265272	RN7SL693P	NA	
ENSG00000273901	AC012313.9	NA	
ENSG00000119574	ZBTB45	NA	
ENSG00000264910	RN7SL525P	NA	
ENSG00000130726	TRIM28	NA	
ENSG00000275924	MIR6807	NA	
ENSG00000130724	CHMP2A	NA	
ENSG00000130725	UBE2M	NA	
ENSG00000267858	MZF1-AS1	NA	
ENSG00000099326	MZF1	NA	
ENSG00000213753	CENPBD1P1	NA	
ENSG00000286104	AC016629.3	NA	
ENSG00000269032	AC016629.1	NA	
ENSG00000269600	AC016629.2	NA	
ENSG00000184731	FAM110C	NA	
ENSG00000227061	AC079779.1	NA	
ENSG00000035115	SH3YL1	NA	
ENSG00000143727	ACP1	NA	
ENSG00000233684	LINC01865	NA	
ENSG00000189292	ALKAL2	NA	
ENSG00000228643	AC079779.2	NA	
ENSG00000235779	AC079779.3	NA	
ENSG00000277997	AC079779.4	NA	
ENSG00000236856	AC105393.2	NA	
ENSG00000226277	AC105393.1	NA	
ENSG00000223985	LINC01874	NA	
ENSG00000284452	AC093326.2	NA	
ENSG00000225942	LINC01875	NA	
ENSG00000233633	AC093326.1	NA	
ENSG00000151353	TMEM18	NA	
ENSG00000233296	TMEM18-DT	NA	
ENSG00000280360	AC092159.3	NA	
ENSG00000233970	AC092159.2	NA	
ENSG00000227713	AC092159.1	NA	
ENSG00000272342	LINC01115	NA	
ENSG00000231173	AC116609.2	NA	
ENSG00000223751	AC116609.1	NA	
ENSG00000237667	LINC01115	NA	
ENSG00000228799	LINC01939	NA	
ENSG00000234796	AC113607.1	NA	
ENSG00000235688	SNTG2-AS1	NA	
ENSG00000172554	SNTG2	NA	
ENSG00000235403	AC114808.1	NA	
ENSG00000236665	AC114808.2	NA	
ENSG00000233553	AC108462.1	NA	
ENSG00000231482	AC105450.1	NA	
ENSG00000115705	TPO	274500	THYROID DYSHORMONOGENESIS 2A; TDH2A;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2A;;IODIDE PEROXIDASE DEFICIENCY;;THYROID PEROXIDASE DEFICIENCY
ENSG00000228613	AC141930.1	NA	
ENSG00000283766	AC141930.2	NA	
ENSG00000203635	AC144450.1	NA	
ENSG00000130508	PXDN	269400	ANTERIOR SEGMENT DYSGENESIS 7; ASGD7;;CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;;SCLEROCORNEA WITH OTHER OCULAR ANOMALIES
ENSG00000186487	MYT1L	616521	MENTAL RETARDATION, AUTOSOMAL DOMINANT 39; MRD39;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 39, AND OBESITY CHROMOSOME 2p25.3 DELETION SYNDROME, INCLUDED;;CHROMOSOME 2p25.3 DUPLICATION SYNDROME, INCLUDED
ENSG00000284600	AC093390.2	NA	
ENSG00000232057	AC093390.1	NA	
ENSG00000225619	MYT1L-AS1	NA	
ENSG00000234929	AC018685.2	NA	
ENSG00000287583	AC018685.3	NA	
ENSG00000237720	AC011995.2	NA	
ENSG00000227364	AC018685.1	NA	
ENSG00000228391	AC011995.1	NA	
ENSG00000234423	LINC01250	NA	
ENSG00000236760	AC019118.2	NA	
ENSG00000226649	AC019118.1	NA	
ENSG00000032389	EIPR1	NA	
ENSG00000224885	EIPR1-IT1	NA	
ENSG00000171853	TRAPPC12	617669	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS
ENSG00000225234	TRAPPC12-AS1	NA	
ENSG00000271868	AC114810.1	NA	
ENSG00000182551	ADI1	NA	
ENSG00000235078	AC231981.1	NA	
ENSG00000242282	AC108488.1	NA	
ENSG00000286905	AC108488.2	NA	
ENSG00000171865	RNASEH1	616479	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 2
ENSG00000234171	RNASEH1-AS1	NA	
ENSG00000287126	AC108488.3	NA	
ENSG00000171863	RPS7	612563	DIAMOND-BLACKFAN ANEMIA 8; DBA8
ENSG00000118004	COLEC11	265050	3MC SYNDROME 2; 3MC2;;PTOSIS OF EYELIDS WITH DIASTASIS RECTI AND HIP DYSPLASIA;;OCULO-SKELETAL-ABDOMINAL SYNDROME;;OSA SYNDROME;;CARNEVALE SYNDROME, FORMERLY
ENSG00000237370	AC010907.2	NA	
ENSG00000188765	TMSB4XP2	NA	
ENSG00000151360	ALLC	612396	ALLANTOICASE; ALLC
ENSG00000232718	GAPDHP48	NA	
ENSG00000224661	AC010907.1	NA	
ENSG00000214866	DCDC2C	NA	
ENSG00000237401	LINC01304	NA	
ENSG00000229550	AC012445.1	NA	
ENSG00000231821	NPM1P48	NA	
ENSG00000231532	LINC01249	NA	
ENSG00000252238	AC092169.1	NA	
ENSG00000207192	RNU6-649P	NA	
ENSG00000228585	AC073143.1	NA	
ENSG00000232835	AC107057.1	NA	
ENSG00000224128	LINC01248	NA	
ENSG00000230090	AC108025.1	NA	
ENSG00000176887	SOX11	615866	COFFIN-SIRIS SYNDROME 9; CSS9;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 27; MRD27
ENSG00000242540	AC010729.2	NA	
ENSG00000236106	AC010729.1	NA	
ENSG00000237266	LINC01810	NA	
ENSG00000232044	SILC1	NA	
ENSG00000276733	MIR7158	NA	
ENSG00000234275	AC017053.1	NA	
ENSG00000227007	LINC01247	NA	
ENSG00000226488	LINC01824	NA	
ENSG00000231610	PIK3CDP1	NA	
ENSG00000236172	MIR7515HG	NA	
ENSG00000286851	AC097517.1	NA	
ENSG00000283394	MIR7515	NA	
ENSG00000205837	LINC00487	NA	
ENSG00000225964	NRIR	NA	
ENSG00000134326	CMPK2	NA	
ENSG00000134321	RSAD2	NA	
ENSG00000271947	AC017076.1	NA	
ENSG00000228203	RNF144A-AS1	NA	
ENSG00000151692	RNF144A	NA	
ENSG00000223884	AC068481.1	NA	
ENSG00000223145	RN7SKP112	NA	
ENSG00000272002	AC010904.2	NA	
ENSG00000213774	AC010904.1	NA	
ENSG00000229727	AC013460.1	NA	
ENSG00000221255	RNU6ATAC37P	NA	
ENSG00000287119	AC092580.4	NA	
ENSG00000230515	AC092580.2	NA	
ENSG00000235576	LINC01871	NA	
ENSG00000232979	AC092580.3	NA	
ENSG00000229405	AC092580.1	NA	
ENSG00000226506	AC007463.1	NA	
ENSG00000235665	LINC00298	NA	
ENSG00000286857	AC007463.2	NA	
ENSG00000236790	LINC00299	NA	
ENSG00000229740	U91324.1	NA	
ENSG00000236008	LINC01814	NA	
ENSG00000285591	AC092617.1	NA	
ENSG00000231083	AC011747.1	NA	
ENSG00000225642	SNRPEP5	NA	
ENSG00000235092	ID2-AS1	NA	
ENSG00000115738	ID2	NA	
ENSG00000134313	KIDINS220	617296	SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO
ENSG00000143797	MBOAT2	NA	
ENSG00000230886	HMGB1P25	NA	
ENSG00000223640	RPL30P3	NA	
ENSG00000242136	AC093904.2	NA	
ENSG00000261104	AC093904.4	NA	
ENSG00000244310	AC093904.3	NA	
ENSG00000240980	AC093904.1	NA	
ENSG00000151693	ASAP2	NA	
ENSG00000213772	EIF1P7	NA	
ENSG00000119185	ITGB1BP1	NA	
ENSG00000119203	CPSF3	NA	
ENSG00000134330	IAH1	NA	
ENSG00000151694	ADAM17	614328	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1
ENSG00000239300	AC080162.1	NA	
ENSG00000271855	AC073195.1	NA	
ENSG00000134308	YWHAQ	NA	
ENSG00000207086	Y_RNA	NA	
ENSG00000240687	AC082651.1	NA	
ENSG00000244260	AC082651.4	NA	
ENSG00000200034	RNU4-73P	NA	
ENSG00000240960	AC082651.2	NA	
ENSG00000243491	AC082651.3	NA	
ENSG00000115750	TAF1B	NA	
ENSG00000269973	AC010969.2	NA	
ENSG00000287305	AC010969.3	NA	
ENSG00000134317	GRHL1	NA	
ENSG00000188525	AC010969.1	NA	
ENSG00000260476	AC104794.4	NA	
ENSG00000260077	AC104794.3	NA	
ENSG00000172059	KLF11	610508	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7
ENSG00000271787	AC104794.5	NA	
ENSG00000205795	CYS1	NA	
ENSG00000233502	AC104794.2	NA	
ENSG00000212558	AC104794.1	NA	
ENSG00000171848	RRM2	NA	
ENSG00000206647	AC007240.1	NA	
ENSG00000265418	MIR4261	NA	
ENSG00000264030	RN7SL66P	NA	
ENSG00000285872	AC007240.3	NA	
ENSG00000206898	AC007240.2	NA	
ENSG00000115756	HPCAL1	NA	
ENSG00000115758	ODC1	NA	
ENSG00000206633	SNORA80B	NA	
ENSG00000257135	ODC1-DT	NA	
ENSG00000115761	NOL10	NA	
ENSG00000234818	AC007314.1	NA	
ENSG00000243819	RN7SL832P	NA	
ENSG00000277446	Metazoa_SRP	NA	
ENSG00000236162	AC092687.2	NA	
ENSG00000143882	ATP6V1C2	NA	
ENSG00000239053	RNU7-138P	NA	
ENSG00000272275	AC092687.3	NA	
ENSG00000143870	PDIA6	NA	
ENSG00000238962	RNU7-176P	NA	
ENSG00000271952	LINC01954	NA	
ENSG00000232056	AC092687.1	NA	
ENSG00000270488	AC079587.1	NA	
ENSG00000162975	KCNF1	NA	
ENSG00000226080	RPL6P4	NA	
ENSG00000145063	AC062028.1	NA	
ENSG00000150873	C2orf50	NA	
ENSG00000162976	SLC66A3	NA	
ENSG00000134318	ROCK2	NA	
ENSG00000207267	RNU6-1081P	NA	
ENSG00000230154	AIDAP1	NA	
ENSG00000226961	PPIAP60	NA	
ENSG00000230952	AC099344.1	NA	
ENSG00000224177	LINC00570	NA	
ENSG00000231403	AC099344.2	NA	
ENSG00000285569	AC099344.3	NA	
ENSG00000169016	E2F6	NA	
ENSG00000196208	GREB1	NA	
ENSG00000201610	RNA5SP84	NA	
ENSG00000264010	MIR4429	NA	
ENSG00000251718	RNU2-13P	NA	
ENSG00000285626	5S_rRNA	NA	
ENSG00000239899	RN7SL674P	NA	
ENSG00000169006	NTSR2	NA	
ENSG00000230044	CDK8P1	NA	
ENSG00000276411	AC106875.2	NA	
ENSG00000134324	LPIN1	268200	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE;;MYOGLOBINURIA, FAMILIAL PAROXYSMAL PARALYTIC;;RHABDOMYOLYSIS, ACUTE RECURRENT
ENSG00000228496	AC106875.1	NA	
ENSG00000203643	AC012456.1	NA	
ENSG00000230790	AC012456.2	NA	
ENSG00000265056	MIR548S	NA	
ENSG00000224184	MIR3681HG	NA	
ENSG00000265172	MIR4262	NA	
ENSG00000238503	SNORD18	NA	
ENSG00000264089	MIR3681	NA	
ENSG00000207183	RNU6-843P	NA	
ENSG00000223360	AC096559.1	NA	
ENSG00000286427	AC009486.2	NA	
ENSG00000261117	AC009486.1	NA	
ENSG00000071575	TRIB2	NA	
ENSG00000264370	MIR3125	NA	
ENSG00000225649	AC064875.1	NA	
ENSG00000285876	AC093912.1	NA	
ENSG00000229370	AC073062.1	NA	
ENSG00000230448	LINC00276	NA	
ENSG00000227718	AC016730.1	NA	
ENSG00000251859	RNU6-1288P	NA	
ENSG00000237261	Metazoa_SRP	NA	
ENSG00000228505	AC011897.1	NA	
ENSG00000162981	LRATD1	NA	
ENSG00000287291	AC068286.2	NA	
ENSG00000235127	AC068286.1	NA	
ENSG00000151779	NBAS	614800	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH;;SOPH SYNDROME
ENSG00000151779	NBAS	616483	INFANTILE LIVER FAILURE SYNDROME 2; ILFS2
ENSG00000229087	RPS26P18	NA	
ENSG00000234022	AC008278.2	NA	
ENSG00000079785	DDX1	NA	
ENSG00000224194	AC008278.1	NA	
ENSG00000231031	LINC01804	NA	
ENSG00000237326	AC113608.1	NA	
ENSG00000202160	RNU5E-7P	NA	
ENSG00000214657	RPLP1P5	NA	
ENSG00000238371	AC010145.2	NA	
ENSG00000233718	MYCNOS	NA	
ENSG00000223850	MYCNUT	NA	
ENSG00000134323	MYCN	164280	FEINGOLD SYNDROME 1; FGLDS1;;FEINGOLD SYNDROME;;OCULODIGITOESOPHAGODUODENAL SYNDROME; ODED;;ODED SYNDROME;;MICROCEPHALY-OCULO-DIGITO-ESOPHAGEAL-DUODENAL SYNDROME; MODED;;DIGITAL ANOMALIES WITH SHORT PALPEBRAL FISSURES AND ATRESIA OF ESOPHAGUS OR DUO /.../;MICROCEPHALY, MENTAL RETARDATION, AND TRACHEOESOPHAGEAL FISTULA SYNDROME;;MMT SYNDROME;;MICROCEPHALY AND DIGITAL ABNORMALITIES WITH NORMAL INTELLIGENCE
ENSG00000243541	RN7SL104P	NA	
ENSG00000226764	AC010145.1	NA	
ENSG00000236289	GACAT3	NA	
ENSG00000236989	AC130710.1	NA	
ENSG00000271315	AC174048.1	NA	
ENSG00000251704	AC142283.1	NA	
ENSG00000226041	AC010745.1	NA	
ENSG00000228876	AC010745.2	NA	
ENSG00000231266	AC010745.3	NA	
ENSG00000285354	AC010745.5	NA	
ENSG00000232444	AC010745.4	NA	
ENSG00000224400	AC010880.1	NA	
ENSG00000237633	AC104623.1	NA	
ENSG00000279663	AC104623.2	NA	
ENSG00000197872	CYRIA	NA	
ENSG00000223536	AC008164.1	NA	
ENSG00000224604	AC008069.1	NA	
ENSG00000237670	LINC01866	NA	
ENSG00000222842	RN7SKP168	NA	
ENSG00000214843	ZFYVE9P2	NA	
ENSG00000236348	PSMC1P10	NA	
ENSG00000214842	RAD51AP2	NA	
ENSG00000163032	VSNL1	NA	
ENSG00000163029	SMC6	NA	
ENSG00000178295	GEN1	NA	
ENSG00000151379	MSGN1	NA	
ENSG00000170745	KCNS3	NA	
ENSG00000212455	AC079802.1	NA	
ENSG00000287881	AC079148.3	NA	
ENSG00000287849	AC079148.2	NA	
ENSG00000260331	AC079148.1	NA	
ENSG00000240857	RDH14	NA	
ENSG00000250741	NT5C1B-RDH14	NA	
ENSG00000185013	NT5C1B	NA	
ENSG00000207170	RNU6-1215P	NA	
ENSG00000224626	AC106053.1	NA	
ENSG00000287284	AC130814.1	NA	
ENSG00000236204	LINC01376	NA	
ENSG00000266738	MIR4757	NA	
ENSG00000143867	OSR1	NA	
ENSG00000234597	AC010096.1	NA	
ENSG00000237992	LINC01808	NA	
ENSG00000235911	AC019055.1	NA	
ENSG00000213403	CISD1P1	NA	
ENSG00000228784	LINC00954	NA	
ENSG00000183891	TTC32	NA	
ENSG00000271991	AC013400.1	NA	
ENSG00000118965	WDR35	613610	CRANIOECTODERMAL DYSPLASIA 2; CED2
ENSG00000118965	WDR35	614091	SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7;;SHORT RIB-POLYDACTYLY SYNDROME, TYPE V; SRPS5 SHORT-RIB THORACIC DYSPLASIA 7/20 WITH POLYDACTYLY, DIGENIC, INCLUDED; SRTD7/20, INCLUDED
ENSG00000227210	AC079145.1	NA	
ENSG00000132031	MATN3	140600	OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2;;OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS;;OADIP;;DIPOA;;HAND OSTEOARTHRITIS; HOA  HEBERDEN NODES, INCLUDED
ENSG00000132031	MATN3	607078	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5;;MULTIPLE EPIPHYSEAL DYSPLASIA, MATN3-RELATED;;MICROEPIPHYSEAL DYSPLASIA, BILATERAL HEREDITARY; BHMED
ENSG00000132031	MATN3	608728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED;;SEMD, MATN3-RELATED
ENSG00000068697	LAPTM4A	NA	
ENSG00000223734	LAPTM4A-DT	NA	
ENSG00000234378	AC098828.1	NA	
ENSG00000213729	RPS16P2	NA	
ENSG00000266059	RN7SL140P	NA	
ENSG00000200763	RNU6-961P	NA	
ENSG00000115884	SDC1	NA	
ENSG00000235411	DRG1P1	NA	
ENSG00000238735	RNU7-113P	NA	
ENSG00000055917	PUM2	NA	
ENSG00000232800	SLC7A15P	NA	
ENSG00000212171	RNA5SP86	NA	
ENSG00000143878	RHOB	NA	
ENSG00000228950	AC023137.1	NA	
ENSG00000200829	Y_RNA	NA	
ENSG00000227047	AC012065.1	NA	
ENSG00000279307	NDUFAF2P1	NA	
ENSG00000118960	HS1BP3	NA	
ENSG00000269976	AC012065.2	NA	
ENSG00000231948	HS1BP3-IT1	NA	
ENSG00000233416	RPS25P3	NA	
ENSG00000143869	GDF7	NA	
ENSG00000270100	AC012065.3	NA	
ENSG00000118961	LDAH	NA	
ENSG00000236436	LINC02850	NA	
ENSG00000261012	AC115619.1	NA	
ENSG00000084674	APOB	144010	HYPERCHOLESTEROLEMIA, FAMILIAL, 2; FCHL2;;HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B;;APOLIPOPROTEIN B-100, FAMILIAL LIGAND-DEFECTIVE;;HYPERCHOLESTEROLEMIA, FAMILIAL, DUE TO LIGAND-DEFECTIVE APOLIPOPROTEIN B;;APOLIPOPROTEIN B-100, FAMILIAL DEFECTIVE
ENSG00000084674	APOB	615558	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1;;HYPOBETALIPOPROTEINEMIA, FAMILIAL; FHBL;;ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA;;HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4, IN /.../; LDLCQ4, INCLUDED
ENSG00000280390	AC010872.1	NA	
ENSG00000287956	AC010872.2	NA	
ENSG00000218819	TDRD15	NA	
ENSG00000271629	AC067959.1	NA	
ENSG00000233005	AC018742.1	NA	
ENSG00000231204	AC011752.1	NA	
ENSG00000270654	NUTF2P8	NA	
ENSG00000235537	AC009411.2	NA	
ENSG00000228538	AC009411.1	NA	
ENSG00000229621	LINC01822	NA	
ENSG00000264192	RN7SL117P	NA	
ENSG00000228999	AC096570.1	NA	
ENSG00000223691	AC068044.1	NA	
ENSG00000234189	AC099799.1	NA	
ENSG00000206882	RNA5SP87	NA	
ENSG00000234207	LINC01830	NA	
ENSG00000233587	LINC01884	NA	
ENSG00000222616	RN7SKP27	NA	
ENSG00000232451	AC018467.1	NA	
ENSG00000223530	AC012506.1	NA	
ENSG00000233714	AC012506.3	NA	
ENSG00000223634	AC012506.2	NA	
ENSG00000235497	AC012506.4	NA	
ENSG00000119771	KLHL29	NA	
ENSG00000224361	AC011239.1	NA	
ENSG00000279526	AC011239.2	NA	
ENSG00000283031	AC009242.1	NA	
ENSG00000119778	ATAD2B	NA	
ENSG00000224464	PGAM1P6	NA	
ENSG00000238111	RPS13P4	NA	
ENSG00000173960	UBXN2A	NA	
ENSG00000234946	SDHCP3	NA	
ENSG00000243847	RN7SL610P	NA	
ENSG00000205639	MFSD2B	NA	
ENSG00000163026	WDCP	NA	
ENSG00000222940	RNU6-370P	NA	
ENSG00000119782	FKBP1B	NA	
ENSG00000115128	SF3B6	NA	
ENSG00000219626	FAM228B	NA	
ENSG00000115129	TP53I3	NA	
ENSG00000176732	PFN4	NA	
ENSG00000276087	AC008073.3	NA	
ENSG00000232642	AC008073.2	NA	
ENSG00000186453	FAM228A	NA	
ENSG00000223754	AC008073.1	NA	
ENSG00000198399	ITSN2	NA	
ENSG00000242628	AC009228.1	NA	
ENSG00000251805	AC009228.2	NA	
ENSG00000232963	HMGN2P20	NA	
ENSG00000233747	RPL36AP13	NA	
ENSG00000286829	AC093798.1	NA	
ENSG00000084676	NCOA1	NA	
ENSG00000202430	RNA5SP88	NA	
ENSG00000206732	RNU6-936P	NA	
ENSG00000184924	PTRHD1	NA	
ENSG00000138092	CENPO	NA	
ENSG00000138031	ADCY3	617885	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19;;OBESITY, SUSCEPTIBILITY TO
ENSG00000271936	AC012073.1	NA	
ENSG00000115137	DNAJC27	NA	
ENSG00000237953	RPS13P5	NA	
ENSG00000202479	SNORD14	NA	
ENSG00000224165	DNAJC27-AS1	NA	
ENSG00000286645	AC013267.1	NA	
ENSG00000207069	Y_RNA	NA	
ENSG00000084710	EFR3B	NA	
ENSG00000276653	RN7SL856P	NA	
ENSG00000229593	SUCLA2P3	NA	
ENSG00000115138	POMC	601665	OBESITY LEANNESS, INCLUDED
ENSG00000115138	POMC	609734	OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH;;PROOPIOMELANOCORTIN DEFICIENCY
ENSG00000230452	LINC01381	NA	
ENSG00000119772	DNMT3A	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000119772	DNMT3A	615879	TATTON-BROWN-RAHMAN SYNDROME; TBRS
ENSG00000119772	DNMT3A	618724	HEYN-SPROUL-JACKSON SYNDROME; HESJAS;;MICROCEPHALY, SHORT STATURE, AND IMPAIRED INTELLECTUAL DEVELOPMENT
ENSG00000221445	MIR1301	NA	
ENSG00000235072	ARNILA	NA	
ENSG00000138101	DTNB	NA	
ENSG00000224220	DTNB-AS1	NA	
ENSG00000201160	Y_RNA	NA	
ENSG00000143970	ASXL2	617190	SHASHI-PENA SYNDROME; SHAPNS
ENSG00000187536	TPM3P7	NA	
ENSG00000217643	PTGES3P2	NA	
ENSG00000218682	AC064847.1	NA	
ENSG00000217718	NDUFB4P4	NA	
ENSG00000084731	KIF3C	NA	
ENSG00000237629	UQCRHP2	NA	
ENSG00000268412	TRMT112P6	NA	
ENSG00000084733	RAB10	NA	
ENSG00000199872	RNU6-942P	NA	
ENSG00000235440	RPS2P15	NA	
ENSG00000231655	EMP2P1	NA	
ENSG00000214465	SMARCE1P6	NA	
ENSG00000227133	AC011742.1	NA	
ENSG00000237951	PPIL1P1	NA	
ENSG00000157833	GAREM2	NA	
ENSG00000084754	HADHA	609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD;;TRIFUNCTIONAL PROTEIN DEFICIENCY TRIFUNCTIONAL PROTEIN DEFICIENCY WITH MYOPATHY AND NEUROPATHY, INCLUDED
ENSG00000084754	HADHA	609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY
ENSG00000138029	HADHB	609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD;;TRIFUNCTIONAL PROTEIN DEFICIENCY TRIFUNCTIONAL PROTEIN DEFICIENCY WITH MYOPATHY AND NEUROPATHY, INCLUDED
ENSG00000286707	AC010896.1	NA	
ENSG00000173567	ADGRF3	NA	
ENSG00000138018	SELENOI	618768	SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81
ENSG00000157856	DRC1	615294	CILIARY DYSKINESIA, PRIMARY, 21; CILD21;;CILIARY DYSKINESIA, PRIMARY, 21, WITHOUT SITUS INVERSUS
ENSG00000115155	OTOF	601071	DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 9; NSRD9 AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1, INCLUDED; AUNB1, INCLUDED;;AUDITORY NEUROPATHY, NONSYNDROMIC RECESSIVE, INCLUDED; NSRAN, INCLUDED
ENSG00000173557	FAM166C	NA	
ENSG00000157884	CIB4	NA	
ENSG00000225378	AC015977.1	NA	
ENSG00000225024	RPL37P11	NA	
ENSG00000171303	KCNK3	615344	PULMONARY HYPERTENSION, PRIMARY, 4; PPH4
ENSG00000213699	SLC35F6	NA	
ENSG00000115163	CENPA	NA	
ENSG00000145835	CDKN2AIPNLP2	NA	
ENSG00000157851	DPYSL5	NA	
ENSG00000230286	AC013472.1	NA	
ENSG00000084764	MAPRE3	NA	
ENSG00000205500	MAPRE3-AS1	NA	
ENSG00000119777	TMEM214	NA	
ENSG00000084693	AGBL5	617023	RETINITIS PIGMENTOSA 75; RP75
ENSG00000231636	AGBL5-AS1	NA	
ENSG00000272056	AC013472.2	NA	
ENSG00000229122	AGBL5-IT1	NA	
ENSG00000272148	AC013403.2	NA	
ENSG00000228474	OST4	NA	
ENSG00000138080	EMILIN1	NA	
ENSG00000138030	KHK	229800	FRUCTOSURIA, ESSENTIAL;;HEPATIC FRUCTOKINASE DEFICIENCY;;KETOHEXOKINASE DEFICIENCY
ENSG00000138028	CGREF1	NA	
ENSG00000143994	ABHD1	NA	
ENSG00000138073	PREB	NA	
ENSG00000186143	PRR30	NA	
ENSG00000163792	TCF23	NA	
ENSG00000236099	AC013403.1	NA	
ENSG00000138074	SLC5A6	NA	
ENSG00000138085	ATRAID	NA	
ENSG00000084774	CAD	616457	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50;;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iz, FORMERLY; CDG1Z, FORMERLY
ENSG00000115194	SLC30A3	NA	
ENSG00000163793	DNAJC5G	NA	
ENSG00000138100	TRIM54	NA	
ENSG00000163794	UCN	NA	
ENSG00000115204	MPV17	256810	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6;;NAVAJO NEUROHEPATOPATHY; NNH;;NAVAJO NEUROPATHY; NN NAVAJO FAMILIAL NEUROGENIC ARTHROPATHY, INCLUDED
ENSG00000115204	MPV17	618400	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2EE
ENSG00000115207	GTF3C2	NA	
ENSG00000234945	GTF3C2-AS1	NA	
ENSG00000234072	AC074117.1	NA	
ENSG00000115211	EIF2B4	603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM;;CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION; CACH;;VANISHING WHITE MATTER LEUKODYSTROPHY;;CREE LEUKOENCEPHALOPATHY; CLE VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILU /.../CLUDED;;OVARIOLEUKODYSTROPHY, INCLUDED
ENSG00000115234	SNX17	NA	
ENSG00000163795	ZNF513	613617	RETINITIS PIGMENTOSA 58; RP58
ENSG00000115241	PPM1G	NA	
ENSG00000213453	FTH1P3	NA	
ENSG00000115216	NRBP1	NA	
ENSG00000157992	KRTCAP3	NA	
ENSG00000138002	IFT172	615630	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10
ENSG00000138002	IFT172	616394	RETINITIS PIGMENTOSA 71; RP71
ENSG00000235267	AC074117.2	NA	
ENSG00000200003	RNU6-986P	NA	
ENSG00000115226	FNDC4	NA	
ENSG00000084734	GCKR	613463	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5
ENSG00000221843	C2orf16	NA	
ENSG00000243943	ZNF512	NA	
ENSG00000259080	AC074091.2	NA	
ENSG00000176714	CCDC121	NA	
ENSG00000198522	GPN1	NA	
ENSG00000206731	AC074091.1	NA	
ENSG00000119760	SUPT7L	NA	
ENSG00000163798	SLC4A1AP	NA	
ENSG00000205334	LINC01460	NA	
ENSG00000243147	MRPL33	NA	
ENSG00000171174	RBKS	NA	
ENSG00000158019	BABAM2	NA	
ENSG00000270846	MYG1P1	NA	
ENSG00000265321	MIR4263	NA	
ENSG00000270528	FAM133EP	NA	
ENSG00000277035	AC096552.1	NA	
ENSG00000223522	AC093690.1	NA	
ENSG00000225991	RPL23AP34	NA	
ENSG00000229951	FLJ31356	NA	
ENSG00000075426	FOSL2	NA	
ENSG00000270640	AC104695.3	NA	
ENSG00000270210	AC104695.2	NA	
ENSG00000227938	AC104695.1	NA	
ENSG00000163803	PLB1	NA	
ENSG00000242915	SNRPGP7	NA	
ENSG00000230730	AC074011.1	NA	
ENSG00000222232	RNA5SP89	NA	
ENSG00000226833	AC092164.1	NA	
ENSG00000213639	PPP1CB	617506	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2
ENSG00000163806	SPDYA	NA	
ENSG00000273233	AC097724.1	NA	
ENSG00000171103	TRMT61B	NA	
ENSG00000163811	WDR43	NA	
ENSG00000264994	SNORD92	NA	
ENSG00000265145	SNORD53	NA	
ENSG00000222224	Y_RNA	NA	
ENSG00000265706	SNORD53B	NA	
ENSG00000189350	TOGARAM2	NA	
ENSG00000200283	Y_RNA	NA	
ENSG00000179270	PCARE	613428	RETINITIS PIGMENTOSA 54; RP54
ENSG00000229224	AC105398.1	NA	
ENSG00000115295	CLIP4	NA	
ENSG00000171094	ALK	613014	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3
ENSG00000286963	AC074096.1	NA	
ENSG00000242699	RN7SL516P	NA	
ENSG00000288553	AC106870.3	NA	
ENSG00000230737	AC106870.2	NA	
ENSG00000197644	AC106870.1	NA	
ENSG00000233862	AC016907.2	NA	
ENSG00000225943	AC016907.1	NA	
ENSG00000119801	YPEL5	NA	
ENSG00000207187	SNORA10B	NA	
ENSG00000231712	H3P5	NA	
ENSG00000213626	LBH	NA	
ENSG00000287658	AC109642.1	NA	
ENSG00000235997	LINC01936	NA	
ENSG00000280154	AC073255.1	NA	
ENSG00000172954	LCLAT1	NA	
ENSG00000278908	AC132154.1	NA	
ENSG00000162949	CAPN13	NA	
ENSG00000230118	AC092569.1	NA	
ENSG00000285984	AC009301.1	NA	
ENSG00000158089	GALNT14	NA	
ENSG00000234579	AC009305.1	NA	
ENSG00000214711	CAPN14	NA	
ENSG00000201671	RNA5SP90	NA	
ENSG00000013016	EHD3	NA	
ENSG00000213620	AL121657.1	NA	
ENSG00000158125	XDH	278300	XANTHINURIA, TYPE I; XAN1;;XANTHINE DEHYDROGENASE DEFICIENCY;;XDH DEFICIENCY;;XANTHINE OXIDASE DEFICIENCY
ENSG00000277893	SRD5A2	264600	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH;;MALE PSEUDOHERMAPHRODITISM DUE TO 5-ALPHA-REDUCTASE DEFICIENCY;;FAMILIAL INCOMPLETE MALE PSEUDOHERMAPHRODITISM, TYPE 2 MICROPENIS, INCLUDED
ENSG00000228563	AL133247.1	NA	
ENSG00000270422	AL133247.2	NA	
ENSG00000223647	LINC01946	NA	
ENSG00000237007	KRT18P52	NA	
ENSG00000242272	AK2P2	NA	
ENSG00000273165	AL121652.1	NA	
ENSG00000162959	MEMO1	NA	
ENSG00000162961	DPY30	NA	
ENSG00000271228	AL121655.1	NA	
ENSG00000021574	SPAST	182601	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2
ENSG00000272716	AL121658.1	NA	
ENSG00000152683	SLC30A6	NA	
ENSG00000229816	DDX50P1	NA	
ENSG00000201113	RNU6-647P	NA	
ENSG00000091106	NLRC4	616050	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC
ENSG00000091106	NLRC4	616115	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4
ENSG00000119820	YIPF4	NA	
ENSG00000272754	AL133245.1	NA	
ENSG00000115760	BIRC6	NA	
ENSG00000230046	BIRC6-AS1	NA	
ENSG00000276334	AL133243.2	NA	
ENSG00000276517	AL133243.3	NA	
ENSG00000207653	MIR558	NA	
ENSG00000274159	AL133243.1	NA	
ENSG00000279897	BIRC6-AS2	NA	
ENSG00000279544	AL133243.4	NA	
ENSG00000018699	TTC27	NA	
ENSG00000265057	MIR4765	NA	
ENSG00000230876	LINC00486	NA	
ENSG00000236854	LINC00486	NA	
ENSG00000206951	Y_RNA	NA	
ENSG00000049323	LTBP1	NA	
ENSG00000223951	H2ACP2	NA	
ENSG00000285577	AC019127.1	NA	
ENSG00000212204	RNA5SP91	NA	
ENSG00000252246	RNA5SP92	NA	
ENSG00000283591	MIR4430	NA	
ENSG00000152689	RASGRP3	NA	
ENSG00000237133	RASGRP3-AS1	NA	
ENSG00000119812	FAM98A	NA	
ENSG00000286415	AC017050.1	NA	
ENSG00000238038	ATP6V0E1P3	NA	
ENSG00000187999	HNRNPA1P61	NA	
ENSG00000228262	LINC01320	NA	
ENSG00000239649	MYADML	NA	
ENSG00000235064	SLC25A5P2	NA	
ENSG00000237790	LINC01318	NA	
ENSG00000285754	AC008170.1	NA	
ENSG00000272027	AC073218.1	NA	
ENSG00000232153	AC012593.2	NA	
ENSG00000226994	AC012593.1	NA	
ENSG00000264352	RN7SL602P	NA	
ENSG00000237320	AC019064.1	NA	
ENSG00000196085	SMIM7P1	NA	
ENSG00000288535	AC013442.1	NA	
ENSG00000265301	MIR548AD	NA	
ENSG00000207255	RNU6-1117P	NA	
ENSG00000229013	AC083939.1	NA	
ENSG00000234587	MRPL50P1	NA	
ENSG00000233752	RPL21P36	NA	
ENSG00000260025	CRIM1-DT	NA	
ENSG00000150938	CRIM1	NA	
ENSG00000273090	AC007378.1	NA	
ENSG00000171055	FEZ2	NA	
ENSG00000270677	AC007363.1	NA	
ENSG00000205221	VIT	NA	
ENSG00000115808	STRN	NA	
ENSG00000279519	AC007382.1	NA	
ENSG00000252756	RNU6-577P	NA	
ENSG00000008869	HEATR5B	NA	
ENSG00000152133	GPATCH11	NA	
ENSG00000055332	EIF2AK2	NA	
ENSG00000224891	ARL14EPP1	NA	
ENSG00000138068	SULT6B1	NA	
ENSG00000233159	RPL31P16	NA	
ENSG00000218739	CEBPZOS	NA	
ENSG00000115816	CEBPZ	NA	
ENSG00000272054	AC007390.1	NA	
ENSG00000003509	NDUFAF7	NA	
ENSG00000115825	PRKD3	NA	
ENSG00000232028	AC007391.1	NA	
ENSG00000207364	RNU6-939P	NA	
ENSG00000285925	AC007391.2	NA	
ENSG00000115828	QPCT	NA	
ENSG00000253078	RNU6-1116P	NA	
ENSG00000287316	AC007391.3	NA	
ENSG00000236213	AC006369.1	NA	
ENSG00000163171	CDC42EP3	NA	
ENSG00000236572	AC006369.2	NA	
ENSG00000225402	AC010878.1	NA	
ENSG00000237803	LINC00211	NA	
ENSG00000115841	RMDN2	NA	
ENSG00000235848	RMDN2-AS1	NA	
ENSG00000138061	CYP1B1	231300	GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A;;GLAUCOMA, CONGENITAL; GLC3;;BUPHTHALMOS GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED;;GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, INCLUDED
ENSG00000138061	CYP1B1	600975	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B;;GLAUCOMA, PRIMARY CONGENITAL, TYPE B;;GLC3, TYPE B
ENSG00000138061	CYP1B1	617315	ANTERIOR SEGMENT DYSGENESIS 6; ASGD6
ENSG00000232973	CYP1B1-AS1	NA	
ENSG00000280276	AC009229.4	NA	
ENSG00000229160	AC009229.2	NA	
ENSG00000199603	RNU6-951P	NA	
ENSG00000273006	AC009229.3	NA	
ENSG00000227292	AC009229.1	NA	
ENSG00000227770	RPL7P12	NA	
ENSG00000213594	GAPDHP25	NA	
ENSG00000119787	ATL2	NA	
ENSG00000231367	LINC02613	NA	
ENSG00000287313	AC016995.1	NA	
ENSG00000235009	LINC01883	NA	
ENSG00000213553	RPLP0P6	NA	
ENSG00000271443	AC011247.2	NA	
ENSG00000143889	HNRNPLL	NA	
ENSG00000235586	AC011247.1	NA	
ENSG00000143891	GALM	NA	
ENSG00000232518	AC074366.1	NA	
ENSG00000115875	SRSF7	NA	
ENSG00000152147	GEMIN6	NA	
ENSG00000227238	TTC39DP	NA	
ENSG00000232114	NPLP1	NA	
ENSG00000163214	DHX57	NA	
ENSG00000223922	ASS1P2	NA	
ENSG00000225284	AC018693.1	NA	
ENSG00000188010	MORN2	NA	
ENSG00000207295	RNU6-851P	NA	
ENSG00000214694	ARHGEF33	NA	
ENSG00000265905	RN7SL96P	NA	
ENSG00000269210	AC019171.1	NA	
ENSG00000115904	SOS1	135300	FIBROMATOSIS, GINGIVAL, 1; GINGF1;;GINGF;;GGF1;;FIBROMATOSIS, GINGIVAL, HEREDITARY; HGF
ENSG00000115904	SOS1	610733	NOONAN SYNDROME 4; NS4
ENSG00000229692	SOS1-IT1	NA	
ENSG00000206985	RNU6-198P	NA	
ENSG00000225900	HSPE1P13	NA	
ENSG00000202309	Y_RNA	NA	
ENSG00000205111	CDKL4	NA	
ENSG00000011566	MAP4K3	NA	
ENSG00000252473	AC007684.1	NA	
ENSG00000273035	AC007684.2	NA	
ENSG00000231312	MAP4K3-DT	NA	
ENSG00000152154	TMEM178A	NA	
ENSG00000138050	THUMPD2	NA	
ENSG00000227028	SLC8A1-AS1	NA	
ENSG00000235653	AC007253.1	NA	
ENSG00000183023	SLC8A1	NA	
ENSG00000287255	AC007877.1	NA	
ENSG00000285898	AC007317.1	NA	
ENSG00000287468	AC007317.2	NA	
ENSG00000233128	LINC01794	NA	
ENSG00000237442	HNRNPA1P57	NA	
ENSG00000287145	AC009413.1	NA	
ENSG00000236090	LDHAP3	NA	
ENSG00000236533	RPS12P4	NA	
ENSG00000207218	Y_RNA	NA	
ENSG00000214691	LINC01913	NA	
ENSG00000223245	RNU4-63P	NA	
ENSG00000234362	LINC01914	NA	
ENSG00000205086	C2orf91	NA	
ENSG00000226398	AC013480.1	NA	
ENSG00000162878	PKDCC	618821	RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES; RLSDF
ENSG00000224875	EML4-AS1	NA	
ENSG00000143924	EML4	NA	
ENSG00000115944	COX7A2L	NA	
ENSG00000221300	AC025750.2	NA	
ENSG00000171126	KCNG3	NA	
ENSG00000232526	VDAC1P13	NA	
ENSG00000236913	RPS13P3	NA	
ENSG00000057935	MTA3	NA	
ENSG00000273913	Metazoa_SRP	NA	
ENSG00000215263	AC025750.1	NA	
ENSG00000226523	AC074375.1	NA	
ENSG00000200550	RNU6-137P	NA	
ENSG00000162881	OXER1	NA	
ENSG00000162882	HAAO	617660	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1;;CONGENITAL NAD DEFICIENCY DISORDER 1;;3-@HYDROXYANTHRANILIC ACIDEMIA
ENSG00000226491	FTOP1	NA	
ENSG00000232202	CHORDC1P1	NA	
ENSG00000224739	AC016735.1	NA	
ENSG00000231826	LINC01819	NA	
ENSG00000233978	LINC02590	NA	
ENSG00000207087	RNU6-242P	NA	
ENSG00000230587	LINC02580	NA	
ENSG00000286796	AC010883.2	NA	
ENSG00000287387	AC010883.3	NA	
ENSG00000152518	ZFP36L2	NA	
ENSG00000279873	LINC01126	NA	
ENSG00000234936	AC010883.1	NA	
ENSG00000115970	THADA	NA	
ENSG00000252804	RNU6-958P	NA	
ENSG00000264071	RN7SL531P	NA	
ENSG00000207411	Y_RNA	NA	
ENSG00000152527	PLEKHH2	NA	
ENSG00000223658	C1GALT1C1L	NA	
ENSG00000229695	AC011242.1	NA	
ENSG00000252490	RN7SKP66	NA	
ENSG00000138036	DYNC2LI1	617088	SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15
ENSG00000138075	ABCG5	618666	SITOSTEROLEMIA 2; STSL2
ENSG00000143921	ABCG8	210250	SITOSTEROLEMIA 1; STSL1;;STSL;;PHYTOSTEROLEMIA MACROTHROMBOCYTOPENIA/STOMATOCYTOSIS, MEDITERRANEAN, INCLUDED
ENSG00000143921	ABCG8	611465	GALLBLADDER DISEASE 4; GBD4
ENSG00000138095	LRPPRC	220111	LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC;;CYTOCHROME c OXIDASE DEFICIENCY, FRENCH CANADIAN TYPE;;COX DEFICIENCY, FRENCH CANADIAN TYPE;;COX DEFICIENCY, SAGUENAY-LAC-SAINT-JEAN TYPE;;LEIGH SYNDROME, SAGUENAY-LAC-SAINT-JEAN TYPE
ENSG00000200924	RNU6-1048P	NA	
ENSG00000264047	RN7SL455P	NA	
ENSG00000219391	AC019129.1	NA	
ENSG00000252599	RNU6-566P	NA	
ENSG00000224637	PDSS1P2	NA	
ENSG00000273106	AC019129.2	NA	
ENSG00000138032	PPM1B	NA	
ENSG00000285542	AC013717.1	NA	
ENSG00000226972	RPL12P19	NA	
ENSG00000138079	SLC3A1	220100	CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLY CYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, /.../A/B, INCLUDED
ENSG00000138078	PREPL	616224	MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22;;PREPL DEFICIENCY
ENSG00000143919	CAMKMT	NA	
ENSG00000259439	LINC01833	NA	
ENSG00000278957	AC012354.9	NA	
ENSG00000274520	AC012354.2	NA	
ENSG00000277311	AC012354.7	NA	
ENSG00000276229	AC012354.5	NA	
ENSG00000277809	AC012354.8	NA	
ENSG00000276048	AC012354.4	NA	
ENSG00000274547	AC012354.3	NA	
ENSG00000276670	AC012354.6	NA	
ENSG00000236502	SIX3-AS1	NA	
ENSG00000138083	SIX3	157170	HOLOPROSENCEPHALY 2; HPE2
ENSG00000138083	SIX3	269160	SCHIZENCEPHALY
ENSG00000225156	AC012354.1	NA	
ENSG00000231848	KRTCAP2P1	NA	
ENSG00000170577	SIX2	NA	
ENSG00000231156	AC093702.1	NA	
ENSG00000205054	LINC01121	NA	
ENSG00000231054	AC093833.1	NA	
ENSG00000286728	AC009236.2	NA	
ENSG00000286519	AC009236.1	NA	
ENSG00000068784	SRBD1	NA	
ENSG00000239396	RN7SL414P	NA	
ENSG00000171132	PRKCE	NA	
ENSG00000228481	PRKCE-AS1	NA	
ENSG00000233829	RPL26P15	NA	
ENSG00000232696	AC017006.2	NA	
ENSG00000231336	AC017006.1	NA	
ENSG00000233335	RPL36AP14	NA	
ENSG00000278764	Metazoa_SRP	NA	
ENSG00000116016	EPAS1	611783	ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4
ENSG00000228100	LINC01820	NA	
ENSG00000187600	LINC02583	NA	
ENSG00000284608	AC016912.2	NA	
ENSG00000253515	AC016912.1	NA	
ENSG00000241791	RN7SL817P	NA	
ENSG00000284701	TMEM247	NA	
ENSG00000250565	ATP6V1E2	NA	
ENSG00000119729	RHOQ	NA	
ENSG00000250116	RHOQ-AS1	NA	
ENSG00000151665	PIGF	NA	
ENSG00000119878	CRIPT	615789	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF
ENSG00000279254	AC020604.1	NA	
ENSG00000222005	LINC01118	NA	
ENSG00000171150	SOCS5	NA	
ENSG00000239332	LINC01119	NA	
ENSG00000226548	AC016722.1	NA	
ENSG00000228925	AC016722.2	NA	
ENSG00000180398	MCFD2	613625	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2
ENSG00000068724	TTC7A	243150	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID;;INTESTINAL ATRESIA, MULTIPLE AND/OR INFLAMMATORY BOWEL DISEASE WITH OR WITHOUT IMMUNODEFICIENCY;;INTESTINAL ATRESIA, MULTIPLE; MINAT;;FAMILIAL INTESTINAL POLYATRESIA SYNDROME; FIPA
ENSG00000272814	AC093732.2	NA	
ENSG00000233845	AC093732.1	NA	
ENSG00000239605	STPG4	NA	
ENSG00000273269	AC073283.3	NA	
ENSG00000225187	AC073283.1	NA	
ENSG00000143933	CALM2	616249	LONG QT SYNDROME 15; LQT15
ENSG00000234690	EPCAM-DT	NA	
ENSG00000226087	AC073283.2	NA	
ENSG00000236824	BCYRN1	NA	
ENSG00000119888	EPCAM	613217	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5;;ENTEROPATHY, CONGENITAL TUFTING; CTE;;INTESTINAL EPITHELIAL CELL DYSPLASIA
ENSG00000119888	EPCAM	613244	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8
ENSG00000222685	RN7SKP119	NA	
ENSG00000207923	MIR559	NA	
ENSG00000277396	Metazoa_SRP	NA	
ENSG00000095002	MSH2	158320	MUIR-TORRE SYNDROME; MRTES;;CUTANEOUS SEBACEOUS NEOPLASMS AND KERATOACANTHOMAS, MULTIPLE, WITH GASTROINTESTINAL AND OTHER CARCINOMAS
ENSG00000095002	MSH2	120435	LYNCH SYNDROME I;;COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1; HNPCC1;;COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1; FCC1;;COCA1 LYNCH SYNDROME II, INCLUDED
ENSG00000095002	MSH2	276300	MISMATCH REPAIR CANCER SYNDROME; MMRCS;;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME; CMMRDS;;MISMATCH REPAIR DEFICIENCY;;MMR DEFICIENCY;;CHILDHOOD CANCER SYNDROME;;BRAIN TUMOR-POLYPOSIS SYNDROME 1; BTPS1;;BTP1 SYNDROME;;TURCOT SYNDROME
ENSG00000184261	KCNK12	NA	
ENSG00000235760	MSH2-OT1	NA	
ENSG00000230979	AC079250.1	NA	
ENSG00000116062	MSH6	276300	MISMATCH REPAIR CANCER SYNDROME; MMRCS;;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME; CMMRDS;;MISMATCH REPAIR DEFICIENCY;;MMR DEFICIENCY;;CHILDHOOD CANCER SYNDROME;;BRAIN TUMOR-POLYPOSIS SYNDROME 1; BTPS1;;BTP1 SYNDROME;;TURCOT SYNDROME
ENSG00000116062	MSH6	608089	ENDOMETRIAL CANCER
ENSG00000116062	MSH6	614350	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5
ENSG00000224443	NME2P2	NA	
ENSG00000224058	AC006509.1	NA	
ENSG00000283502	AC006509.2	NA	
ENSG00000138081	FBXO11	618089	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA
ENSG00000235369	RPL36AP15	NA	
ENSG00000236549	RPS27AP7	NA	
ENSG00000233230	AC079807.1	NA	
ENSG00000230773	AC092650.1	NA	
ENSG00000226473	PPIAP62	NA	
ENSG00000275423	VN1R18P	NA	
ENSG00000201010	RN7SKP224	NA	
ENSG00000170802	FOXN2	NA	
ENSG00000251889	RNU4-49P	NA	
ENSG00000272663	AC093635.1	NA	
ENSG00000162869	PPP1R21	NA	
ENSG00000202227	RNU6-282P	NA	
ENSG00000243244	STON1	NA	
ENSG00000068781	STON1-GTF2A1L	NA	
ENSG00000242441	GTF2A1L	NA	
ENSG00000279956	AC073082.1	NA	
ENSG00000239995	TPT1P11	NA	
ENSG00000138039	LHCGR	176410	PRECOCIOUS PUBERTY, MALE-LIMITED;;SEXUAL PRECOCITY, FAMILIAL, GONADOTROPIN-INDEPENDENT;;TESTOTOXICOSIS, FAMILIAL LEYDIG CELL ADENOMA, SOMATIC, WITH MALE-LIMITED PRECOCIOUS PUBERTY, INCLUDED
ENSG00000138039	LHCGR	238320	LEYDIG CELL HYPOPLASIA, TYPE I;;LEYDIG CELL HYPOPLASIA WITH MALE PSEUDOHERMAPHRODITISM;;HYPERGONADOTROPIC HYPOGONADISM, MALE, DUE TO LHCGR DEFECT;;LEYDIG CELL HYPOPLASIA, COMPLETE;;LEYDIG CELL AGENESIS  LEYDIG CELL HYPOPLASIA, TYPE II, INCLUDED;;LEY /.../LL HYPOPLASIA, PARTIAL, INCLUDED;;LUTEINIZING HORMONE RESISTANCE, FEMALE, INCLUDED
ENSG00000232285	ELOBP3	NA	
ENSG00000282890	AC009975.1	NA	
ENSG00000214602	CTBP2P5	NA	
ENSG00000170820	FSHR	233300	OVARIAN DYSGENESIS 1; ODG1;;OVARIAN DYSGENESIS, HYPERGONADOTROPIC, AUTOSOMAL RECESSIVE;;OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH NORMAL KARYOTYPE;;GONADAL DYSGENESIS, XX TYPE;;XX GONADAL DYSGENESIS; XXGD;;OVARIAN FAILURE, HYPERGONADOTROPIC
ENSG00000170820	FSHR	276400	TWINNING, DIZYGOTIC OVARIAN RESPONSE TO FSH STIMULATION, INCLUDED
ENSG00000170820	FSHR	608115	OVARIAN HYPERSTIMULATION SYNDROME; OHSS;;OVARIAN HYPERSTIMULATION SYNDROME, FAMILIAL GESTATIONAL SPONTANEOUS
ENSG00000212036	MIR548BA	NA	
ENSG00000282998	AC009975.2	NA	
ENSG00000206915	RNU6-439P	NA	
ENSG00000282828	AC009971.1	NA	
ENSG00000234253	RPL7P13	NA	
ENSG00000212580	AC078994.1	NA	
ENSG00000179915	NRXN1	614325	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2
ENSG00000179915	NRXN1	614332	CHROMOSOME 2p16.3 DELETION SYNDROME SCHIZOPHRENIA 17, INCLUDED; SCZD17, INCLUDED
ENSG00000285548	AC068725.1	NA	
ENSG00000230327	MTCO1P42	NA	
ENSG00000283058	AC009234.1	NA	
ENSG00000216191	MIR8485	NA	
ENSG00000238165	AC007560.1	NA	
ENSG00000286412	AC007682.1	NA	
ENSG00000231918	AC007402.1	NA	
ENSG00000287867	AC007402.2	NA	
ENSG00000224344	KNOP1P3	NA	
ENSG00000223710	CRYGGP	NA	
ENSG00000230840	AC097463.1	NA	
ENSG00000226366	CCDC12P1	NA	
ENSG00000287344	AC079304.1	NA	
ENSG00000236538	ZNF863P	NA	
ENSG00000202195	Y_RNA	NA	
ENSG00000225444	LINC01867	NA	
ENSG00000225842	GGCTP3	NA	
ENSG00000236837	AC139712.1	NA	
ENSG00000204993	CRTC1P1	NA	
ENSG00000233083	FTH1P6	NA	
ENSG00000264975	MIR4431	NA	
ENSG00000228033	AC010967.1	NA	
ENSG00000232604	AC010967.2	NA	
ENSG00000232668	AC010967.3	NA	
ENSG00000251942	AC069157.2	NA	
ENSG00000223897	AC069157.1	NA	
ENSG00000115239	ASB3	NA	
ENSG00000207456	RNU6-997P	NA	
ENSG00000143942	CHAC2	NA	
ENSG00000068912	ERLEC1	NA	
ENSG00000265452	MIR3682	NA	
ENSG00000119737	GPR75	NA	
ENSG00000068878	PSME4	NA	
ENSG00000170634	ACYP2	NA	
ENSG00000235937	RPL21P30	NA	
ENSG00000233266	HMGB1P31	NA	
ENSG00000241114	AC008280.1	NA	
ENSG00000272156	AC008280.2	NA	
ENSG00000252934	RNU7-172P	NA	
ENSG00000178021	TSPYL6	NA	
ENSG00000177994	C2orf73	NA	
ENSG00000115306	SPTBN1	NA	
ENSG00000228108	AC092839.1	NA	
ENSG00000237887	RPL23AP32	NA	
ENSG00000234943	AC092839.2	NA	
ENSG00000238018	AC093110.1	NA	
ENSG00000214595	EML6	NA	
ENSG00000231334	EML6-AS1	NA	
ENSG00000285519	AC104781.1	NA	
ENSG00000252507	RNU7-81P	NA	
ENSG00000115310	RTN4	NA	
ENSG00000200086	RNU6-433P	NA	
ENSG00000162994	CLHC1	NA	
ENSG00000203327	AC012358.1	NA	
ENSG00000227799	CDPF1P1	NA	
ENSG00000143947	RPS27A	NA	
ENSG00000085760	MTIF2	NA	
ENSG00000162997	PRORSD1P	NA	
ENSG00000240401	AC012358.3	NA	
ENSG00000206964	AC012358.2	NA	
ENSG00000115355	CCDC88A	617507	PEHO-LIKE SYNDROME; PEHOL;;PROGRESSIVE ENCEPHALOPATHY WITH EDEMA, HYPSARRHYTHMIA, AND OPTIC ATROPHY-LIKE SYNDROME
ENSG00000233594	BTF3P5	NA	
ENSG00000238619	RNU6-775P	NA	
ENSG00000238493	RNU6-221P	NA	
ENSG00000239189	RNU6-634P	NA	
ENSG00000163001	CFAP36	NA	
ENSG00000275052	PPP4R3B	NA	
ENSG00000212175	AC015982.1	NA	
ENSG00000272606	AC015982.2	NA	
ENSG00000138035	PNPT1	614932	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13
ENSG00000138035	PNPT1	614934	DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70
ENSG00000115380	EFEMP1	126600	DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD;;DOYNE HONEYCOMB DEGENERATION OF RETINA; DHD MALATTIA LEVENTINESE, INCLUDED; MLVT, INCLUDED;;DRUSEN, RADIAL, AUTOSOMAL DOMINANT, INCLUDED
ENSG00000202344	RN7SKP208	NA	
ENSG00000272180	AC011306.1	NA	
ENSG00000226702	MIR217HG	NA	
ENSG00000207548	MIR217	NA	
ENSG00000207798	MIR216A	NA	
ENSG00000211520	MIR216B	NA	
ENSG00000229805	LINC01813	NA	
ENSG00000271894	AC007744.1	NA	
ENSG00000233251	AC007743.1	NA	
ENSG00000055813	CCDC85A	NA	
ENSG00000199395	RNA5SP93	NA	
ENSG00000231570	PPIAP63	NA	
ENSG00000271115	EIF2S2P7	NA	
ENSG00000285755	AC132153.1	NA	
ENSG00000270569	AC068276.1	NA	
ENSG00000212168	AC073875.1	NA	
ENSG00000271615	ACTG1P22	NA	
ENSG00000028116	VRK2	NA	
ENSG00000287875	AC068193.1	NA	
ENSG00000115392	FANCL	614083	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL
ENSG00000273063	AC007250.1	NA	
ENSG00000233426	EIF3FP3	NA	
ENSG00000225226	LINC01795	NA	
ENSG00000233723	LINC01122	NA	
ENSG00000231043	AC007238.1	NA	
ENSG00000285673	AC007092.1	NA	
ENSG00000222030	LINC01793	NA	
ENSG00000271955	AC007100.1	NA	
ENSG00000233891	AC007179.2	NA	
ENSG00000231815	AC007179.1	NA	
ENSG00000270447	AC007179.3	NA	
ENSG00000200101	RNU6-508P	NA	
ENSG00000252726	RNA5SP94	NA	
ENSG00000286604	AC007100.2	NA	
ENSG00000285611	AC007132.1	NA	
ENSG00000228590	MIR4432HG	NA	
ENSG00000287640	AC007381.1	NA	
ENSG00000200807	RNU1-32P	NA	
ENSG00000266078	MIR4432	NA	
ENSG00000119866	BCL11A	617101	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN;;DIAS-LOGAN SYNDROME;;INTELLECTUAL DEVELOPMENTAL DISORDER WITH HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN
ENSG00000233953	AC009970.1	NA	
ENSG00000242158	RN7SL361P	NA	
ENSG00000271134	IFITM3P9	NA	
ENSG00000213495	RPL26P13	NA	
ENSG00000252718	RNU6-612P	NA	
ENSG00000271707	ATP1B3P1	NA	
ENSG00000115421	PAPOLG	NA	
ENSG00000228414	LINC01185	NA	
ENSG00000241524	RN7SL632P	NA	
ENSG00000237024	RPL21P33	NA	
ENSG00000162924	REL	NA	
ENSG00000201076	RNU4-51P	NA	
ENSG00000267520	AC010733.1	NA	
ENSG00000237522	NONOP2	NA	
ENSG00000232713	RPS12P3	NA	
ENSG00000162927	PUS10	NA	
ENSG00000222251	RNA5SP95	NA	
ENSG00000162928	PEX13	614883	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 13, INCLUDED; CG13, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP H, INCLUDED; CGH, INCLUDED
ENSG00000162928	PEX13	614885	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B
ENSG00000162929	KIAA1841	NA	
ENSG00000274769	AC016747.4	NA	
ENSG00000212978	AC016747.1	NA	
ENSG00000237651	C2orf74	NA	
ENSG00000271889	AC016747.2	NA	
ENSG00000173209	AHSA2P	NA	
ENSG00000115464	USP34	NA	
ENSG00000273302	AC016747.3	NA	
ENSG00000271146	AC018889.1	NA	
ENSG00000234624	AC016894.1	NA	
ENSG00000206937	SNORA70B	NA	
ENSG00000270820	AC016727.1	NA	
ENSG00000082898	XPO1	NA	
ENSG00000285857	AC016727.3	NA	
ENSG00000271243	AC016727.2	NA	
ENSG00000226884	RPS29P10	NA	
ENSG00000206973	RNU6-1145P	NA	
ENSG00000213486	AC108039.1	NA	
ENSG00000227361	RPS24P7	NA	
ENSG00000229831	AC108039.2	NA	
ENSG00000170264	FAM161A	606068	RETINITIS PIGMENTOSA 28; RP28
ENSG00000230702	RPL31P30	NA	
ENSG00000277498	AC107081.2	NA	
ENSG00000115484	CCT4	NA	
ENSG00000236498	AC107081.1	NA	
ENSG00000286360	AC107081.3	NA	
ENSG00000173163	COMMD1	NA	
ENSG00000278523	Y_RNA	NA	
ENSG00000229839	AC018462.1	NA	
ENSG00000242735	RPSAP26	NA	
ENSG00000271657	AC018462.2	NA	
ENSG00000170340	B3GNT2	NA	
ENSG00000266097	MIR5192	NA	
ENSG00000239958	RN7SL51P	NA	
ENSG00000270335	AC093159.2	NA	
ENSG00000228541	AC093159.1	NA	
ENSG00000241625	RN7SL18P	NA	
ENSG00000186889	TMEM17	NA	
ENSG00000233702	RPL37P13	NA	
ENSG00000229503	RPL21P37	NA	
ENSG00000226622	AC092155.1	NA	
ENSG00000232144	PSAT1P2	NA	
ENSG00000230595	RSL24D1P2	NA	
ENSG00000115504	EHBP1	611868	PROSTATE CANCER, HEREDITARY, 12; HPC12
ENSG00000252436	Y_RNA	NA	
ENSG00000286524	AC092567.2	NA	
ENSG00000226605	AC092567.1	NA	
ENSG00000237162	RPS20P9	NA	
ENSG00000231609	AC007098.1	NA	
ENSG00000115507	OTX1	NA	
ENSG00000270437	AC009501.1	NA	
ENSG00000286480	AC009501.2	NA	
ENSG00000232403	RPL27P5	NA	
ENSG00000242412	DBIL5P2	NA	
ENSG00000143951	WDPCP	217085	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP
ENSG00000143951	WDPCP	615992	BARDET-BIEDL SYNDROME 15; BBS15
ENSG00000283636	Metazoa_SRP	NA	
ENSG00000233716	MTFR2P1	NA	
ENSG00000279485	AC016734.1	NA	
ENSG00000014641	MDH1	NA	
ENSG00000228305	PRELID1P6	NA	
ENSG00000229920	RPS4XP5	NA	
ENSG00000234488	RPL27P6	NA	
ENSG00000228872	CSP1	NA	
ENSG00000229221	HNRNPA1P66	NA	
ENSG00000169764	UGP2	618744	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 83; EIEE83;;BARAKAT-PERENTHALER SYNDROME
ENSG00000251775	AC114748.1	NA	
ENSG00000143952	VPS54	NA	
ENSG00000228079	AC012368.2	NA	
ENSG00000197329	PELI1	NA	
ENSG00000225889	AC012368.1	NA	
ENSG00000230923	LINC00309	NA	
ENSG00000270354	AC012368.3	NA	
ENSG00000238012	AC114752.1	NA	
ENSG00000238201	AC114752.2	NA	
ENSG00000264297	MIR4433B	NA	
ENSG00000283222	MIR4433A	NA	
ENSG00000236148	RPL23AP37	NA	
ENSG00000223935	LGALSL-DT	NA	
ENSG00000237217	AC008074.1	NA	
ENSG00000119862	LGALSL	NA	
ENSG00000223863	LINC01805	NA	
ENSG00000260101	AC008074.2	NA	
ENSG00000119844	AFTPH	NA	
ENSG00000283204	MIR4434	NA	
ENSG00000252414	RNU6-100P	NA	
ENSG00000233694	LINC02579	NA	
ENSG00000179833	SERTAD2	NA	
ENSG00000226756	AC007365.1	NA	
ENSG00000227791	RPS10P9	NA	
ENSG00000275588	RN7SL341P	NA	
ENSG00000199964	Y_RNA	NA	
ENSG00000287123	AC007880.1	NA	
ENSG00000234572	LINC01800	NA	
ENSG00000237638	LINC02245	NA	
ENSG00000244534	RN7SL211P	NA	
ENSG00000227394	RPL11P1	NA	
ENSG00000115902	SLC1A4	616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM
ENSG00000252892	RNU6-548P	NA	
ENSG00000232613	LINC02576	NA	
ENSG00000011523	CEP68	NA	
ENSG00000138069	RAB1A	NA	
ENSG00000272025	SNORA74	NA	
ENSG00000273763	AC007318.1	NA	
ENSG00000172974	VDAC2P5	NA	
ENSG00000138071	ACTR2	NA	
ENSG00000198369	SPRED2	NA	
ENSG00000232693	AC012370.1	NA	
ENSG00000204929	AC007389.1	NA	
ENSG00000234255	AC012370.2	NA	
ENSG00000237979	DNAJB12P1	NA	
ENSG00000223739	RPS15AP15	NA	
ENSG00000243029	RN7SL635P	NA	
ENSG00000251900	VTRNA2-2P	NA	
ENSG00000235725	AC007389.2	NA	
ENSG00000281920	AC007389.3	NA	
ENSG00000214533	KRT18P33	NA	
ENSG00000280257	AC007741.1	NA	
ENSG00000227293	AC118345.1	NA	
ENSG00000225815	AC092669.1	NA	
ENSG00000264525	MIR4778	NA	
ENSG00000232164	LINC01873	NA	
ENSG00000226819	MEIS1-AS3	NA	
ENSG00000143995	MEIS1	NA	
ENSG00000230749	MEIS1-AS2	NA	
ENSG00000232046	LINC01798	NA	
ENSG00000237179	LINC01797	NA	
ENSG00000224071	DNMT3AP1	NA	
ENSG00000230355	AC009474.1	NA	
ENSG00000230525	LINC01799	NA	
ENSG00000232688	LINC01628	NA	
ENSG00000223859	AC007403.1	NA	
ENSG00000235885	LINC01828	NA	
ENSG00000236780	LINC01829	NA	
ENSG00000236605	AC023115.1	NA	
ENSG00000143971	ETAA1	NA	
ENSG00000224173	LINC02831	NA	
ENSG00000235495	AC007422.1	NA	
ENSG00000286002	AC010987.1	NA	
ENSG00000237013	LINC01812	NA	
ENSG00000235968	FBXL12P1	NA	
ENSG00000197223	C1D	NA	
ENSG00000284932	AC017083.4	NA	
ENSG00000243667	WDR92	NA	
ENSG00000236259	PPIAP64	NA	
ENSG00000273398	AC017083.3	NA	
ENSG00000115946	PNO1	NA	
ENSG00000221823	PPP3R1	NA	
ENSG00000273275	AC017083.2	NA	
ENSG00000273064	AC017083.1	NA	
ENSG00000119865	CNRIP1	NA	
ENSG00000203395	AC015969.1	NA	
ENSG00000115956	PLEK	NA	
ENSG00000229462	AC127383.1	NA	
ENSG00000204923	FBXO48	NA	
ENSG00000169621	APLF	NA	
ENSG00000214525	AC130709.1	NA	
ENSG00000169618	PROKR1	NA	
ENSG00000163219	ARHGAP25	NA	
ENSG00000228329	LINC01890	NA	
ENSG00000237576	LINC01888	NA	
ENSG00000163217	BMP10	NA	
ENSG00000283586	GKN3P	NA	
ENSG00000183607	GKN2	NA	
ENSG00000169605	GKN1	NA	
ENSG00000169604	ANTXR1	230740	GAPO SYNDROME; GAPOS;;GROWTH RETARDATION, ALOPECIA, PSEUDOANODONTIA, AND OPTIC ATROPHY
ENSG00000169604	ANTXR1	602089	HEMANGIOMA, CAPILLARY INFANTILE;;HCI;;HEMANGIOMA, HEREDITARY CAPILLARY
ENSG00000286347	AC114802.1	NA	
ENSG00000266649	MIR3126	NA	
ENSG00000251850	RNA5SP96	NA	
ENSG00000199460	RNU6-1216P	NA	
ENSG00000271597	AC112230.1	NA	
ENSG00000198380	GFPT1	608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C;;MYASTHENIC SYNDROME, CONGENITAL, TYPE Id; CMS1D, FORMERLY;;CMS Id, FORMERLY;;MYASTHENIA, FAMILIAL INFANTILE, 1, FORMERLY; FIM1, FORMERLY
ENSG00000198380	GFPT1	610542	MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12;;MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1
ENSG00000252250	Y_RNA	NA	
ENSG00000169599	NFU1	605711	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1;;MMDS
ENSG00000115977	AAK1	NA	
ENSG00000244236	RN7SL604P	NA	
ENSG00000207016	SNORA36C	NA	
ENSG00000232228	RPL36AP16	NA	
ENSG00000229948	B3GALNT1P1	NA	
ENSG00000196975	ANXA4	NA	
ENSG00000231024	AC092431.1	NA	
ENSG00000087338	GMCL1	NA	
ENSG00000275381	AC019206.1	NA	
ENSG00000270723	RPL23AP92	NA	
ENSG00000124380	SNRNP27	NA	
ENSG00000059728	MXD1	NA	
ENSG00000244617	ASPRV1	NA	
ENSG00000179818	PCBP1-AS1	NA	
ENSG00000263669	RN7SL470P	NA	
ENSG00000169564	PCBP1	NA	
ENSG00000233060	AC016700.1	NA	
ENSG00000225392	MRPL36P1	NA	
ENSG00000231327	LINC01816	NA	
ENSG00000115998	C2orf42	NA	
ENSG00000116001	TIA1	604454	WELANDER DISTAL MYOPATHY; WDM;;MUSCULAR DYSTROPHY, DISTAL, LATE-ONSET, AUTOSOMAL DOMINANT;;MYOPATHY, DISTAL, SWEDISH
ENSG00000221238	MIR1285-2	NA	
ENSG00000231414	RPL39P15	NA	
ENSG00000116005	PCYOX1	NA	
ENSG00000143977	SNRPG	NA	
ENSG00000035141	FAM136A	NA	
ENSG00000233849	AC022201.2	NA	
ENSG00000235289	BRD7P6	NA	
ENSG00000229229	AC022201.1	NA	
ENSG00000163235	TGFA	NA	
ENSG00000224606	TGFA-IT1	NA	
ENSG00000075340	ADD2	NA	
ENSG00000286979	AC005234.2	NA	
ENSG00000235035	AC005234.1	NA	
ENSG00000183733	FIGLA	612310	PREMATURE OVARIAN FAILURE 6; POF6
ENSG00000228034	HMGN2P21	NA	
ENSG00000152672	CLEC4F	NA	
ENSG00000231386	MOB4P1	NA	
ENSG00000116031	CD207	613393	BIRBECK GRANULE DEFICIENCY;;BIRBECK GRANULES, ABSENCE OF
ENSG00000237751	LINC01143	NA	
ENSG00000277764	AC007040.3	NA	
ENSG00000116035	VAX2	NA	
ENSG00000116039	ATP6V1B1	267300	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PROGRESSIVE NERVE DEAFNESS;;RENAL TUBULAR ACIDOSIS WITH PROGRESSIVE NERVE DEAFNESS;;RTA WITH PROGRESSIVE NERVE DEAFNESS
ENSG00000258881	AC007040.2	NA	
ENSG00000239322	ATP6V1B1-AS1	NA	
ENSG00000226186	ELOCP21	NA	
ENSG00000241159	RN7SL160P	NA	
ENSG00000144031	ANKRD53	NA	
ENSG00000144043	TEX261	NA	
ENSG00000228384	AC007040.1	NA	
ENSG00000236469	AC007881.2	NA	
ENSG00000205847	OR7E91P	NA	
ENSG00000234485	OR7E46P	NA	
ENSG00000234896	OR7E62P	NA	
ENSG00000124357	NAGK	NA	
ENSG00000272735	AC007881.3	NA	
ENSG00000124370	MCEE	251120	METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLY  METHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASE DEFICIENCY, INCLUDED
ENSG00000288065	AC007881.4	NA	
ENSG00000124383	MPHOSPH10	NA	
ENSG00000233870	AC007881.1	NA	
ENSG00000124374	PAIP2B	NA	
ENSG00000075292	ZNF638	NA	
ENSG00000281195	AC007878.1	NA	
ENSG00000200779	RNU6-105P	NA	
ENSG00000135636	DYSF	253601	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 3; LGMD3
ENSG00000135636	DYSF	254130	MIYOSHI MUSCULAR DYSTROPHY 1; MMD1;;MIYOSHI MYOPATHY;;MUSCULAR DYSTROPHY, DISTAL, LATE-ONSET, AUTOSOMAL RECESSIVE
ENSG00000135636	DYSF	606768	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT
ENSG00000233971	RPS20P10	NA	
ENSG00000003137	CYP26B1	614416	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA
ENSG00000144036	EXOC6B	618395	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3
ENSG00000228568	RPS15AP13	NA	
ENSG00000222536	RNU2-39P	NA	
ENSG00000212378	AC092630.1	NA	
ENSG00000116096	SPR	612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY; SRD;;SPR DEFICIENCY
ENSG00000135638	EMX1	NA	
ENSG00000278060	AC012366.1	NA	
ENSG00000144040	SFXN5	NA	
ENSG00000135631	RAB11FIP5	NA	
ENSG00000272702	AC010913.1	NA	
ENSG00000214513	NOTO	NA	
ENSG00000135632	SMYD5	NA	
ENSG00000135617	PRADC1	NA	
ENSG00000135624	CCT7	NA	
ENSG00000163013	FBXO41	NA	
ENSG00000135625	EGR4	NA	
ENSG00000252988	RNU6-111P	NA	
ENSG00000287435	AC069404.1	NA	
ENSG00000285068	AC074008.2	NA	
ENSG00000214484	RPSAP28	NA	
ENSG00000116127	ALMS1	203800	ALSTROM SYNDROME; ALMS;;ALSS
ENSG00000230002	ALMS1-IT1	NA	
ENSG00000284902	AC074008.1	NA	
ENSG00000144035	NAT8	NA	
ENSG00000163016	ALMS1P1	NA	
ENSG00000204872	NAT8B	NA	
ENSG00000144034	TPRKB	617731	GALLOWAY-MOWAT SYNDROME 5; GAMOS5
ENSG00000273245	AC092653.1	NA	
ENSG00000280037	AC092653.2	NA	
ENSG00000144048	DUSP11	NA	
ENSG00000187833	C2orf78	NA	
ENSG00000287250	AC073046.4	NA	
ENSG00000124356	STAMBP	614261	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP
ENSG00000286244	AC073046.3	NA	
ENSG00000271536	AC073046.2	NA	
ENSG00000163017	ACTG2	155310	VISCERAL MYOPATHY; VSCM;;MEGADUODENUM AND/OR MEGACYSTIS;;INFANTILE VISCERAL MYOPATHY;;PSEUDOOBSTRUCTION, IDIOPATHIC INTESTINAL
ENSG00000114956	DGUOK	251880	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3
ENSG00000114956	DGUOK	617068	PORTAL HYPERTENSION, NONCIRRHOTIC; NCPH
ENSG00000114956	DGUOK	617070	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4; PEOB4;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 4
ENSG00000237883	DGUOK-AS1	NA	
ENSG00000201876	RNA5SP97	NA	
ENSG00000235499	AC073046.1	NA	
ENSG00000187605	TET3	618798	BECK-FAHRNER SYNDROME; BEFAHRS
ENSG00000279181	AC110801.1	NA	
ENSG00000257800	FNBP1P1	NA	
ENSG00000217702	AC073263.1	NA	
ENSG00000163170	BOLA3	614299	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2
ENSG00000225439	BOLA3-AS1	NA	
ENSG00000114978	MOB1A	NA	
ENSG00000279201	AC073263.3	NA	
ENSG00000279070	AC073263.2	NA	
ENSG00000065911	MTHFD2	NA	
ENSG00000264324	AC006030.1	NA	
ENSG00000188687	SLC4A5	NA	
ENSG00000229798	KRT18P26	NA	
ENSG00000252214	RNU6-542P	NA	
ENSG00000234632	NECAP1P2	NA	
ENSG00000225658	TAF13P2	NA	
ENSG00000204843	DCTN1	168605	PERRY SYNDROME;;PARKINSONISM WITH ALVEOLAR HYPOVENTILATION AND MENTAL DEPRESSION
ENSG00000204843	DCTN1	105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1;;AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS;;AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED;;AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED
ENSG00000204843	DCTN1	607641	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B;;HMN VIIB;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB;;DHMN7B;;NEUROPATHY, DISTAL HEREDITARY MOTOR, WITH VOCAL CORD PARALYSIS, TYPE VIIB;;LOWER MOTOR NEURON DISEASE, DYNACTIN TYPE
ENSG00000237737	DCTN1-AS1	NA	
ENSG00000159239	AC005041.1	NA	
ENSG00000234521	AC005041.2	NA	
ENSG00000284308	C2orf81	NA	
ENSG00000286623	AC005041.4	NA	
ENSG00000233155	HMGA1P8	NA	
ENSG00000005448	WDR54	NA	
ENSG00000114993	RTKN	NA	
ENSG00000115274	INO80B	NA	
ENSG00000274049	INO80B-WBP1	NA	
ENSG00000239779	WBP1	NA	
ENSG00000115275	MOGS	606056	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B;;CDG IIb; CDGIIb;;GLUCOSIDASE I DEFICIENCY
ENSG00000286883	AC005041.5	NA	
ENSG00000204822	MRPL53	NA	
ENSG00000135637	CCDC142	NA	
ENSG00000115282	TTC31	NA	
ENSG00000179528	LBX2	NA	
ENSG00000272183	AC005041.3	NA	
ENSG00000257702	LBX2-AS1	NA	
ENSG00000115289	PCGF1	NA	
ENSG00000115297	TLX2	NA	
ENSG00000144045	DQX1	NA	
ENSG00000115307	AUP1	NA	
ENSG00000115317	HTRA2	610297	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13
ENSG00000115317	HTRA2	617248	3-@METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8
ENSG00000115318	LOXL3	NA	
ENSG00000115325	DOK1	NA	
ENSG00000159374	M1AP	NA	
ENSG00000233872	TOR1BP1	NA	
ENSG00000108442	TVP23BP2	NA	
ENSG00000135622	SEMA4F	NA	
ENSG00000287687	AC007387.2	NA	
ENSG00000224646	RPS28P5	NA	
ENSG00000286739	AC007387.1	NA	
ENSG00000272711	AC019069.1	NA	
ENSG00000159399	HK2	NA	
ENSG00000204792	LINC01291	NA	
ENSG00000236209	AC104135.1	NA	
ENSG00000230836	LINC01293	NA	
ENSG00000115350	POLE4	NA	
ENSG00000115353	TACR1	NA	
ENSG00000263909	MIR5000	NA	
ENSG00000270571	AC007681.1	NA	
ENSG00000236167	GAPDHP57	NA	
ENSG00000115363	EVA1A	NA	
ENSG00000237293	AC007099.2	NA	
ENSG00000238410	AC007099.3	NA	
ENSG00000231172	AC007099.1	NA	
ENSG00000230477	AC005034.1	NA	
ENSG00000221638	U3	NA	
ENSG00000270696	AC005034.3	NA	
ENSG00000115364	MRPL19	NA	
ENSG00000226247	SUPT4H1P1	NA	
ENSG00000005436	GCFC2	NA	
ENSG00000271452	AC005034.5	NA	
ENSG00000270462	AC005034.2	NA	
ENSG00000286045	AC005034.6	NA	
ENSG00000270996	AC005034.4	NA	
ENSG00000287474	AC110614.1	NA	
ENSG00000233107	SUCLA2P2	NA	
ENSG00000287172	AC073091.1	NA	
ENSG00000287749	AC073091.2	NA	
ENSG00000228209	PNPP1	NA	
ENSG00000271356	USP21P2	NA	
ENSG00000200488	RN7SKP203	NA	
ENSG00000251947	RN7SKP164	NA	
ENSG00000287026	AC068616.2	NA	
ENSG00000287130	AC068616.3	NA	
ENSG00000286202	AC068616.1	NA	
ENSG00000176204	LRRTM4	NA	
ENSG00000200028	RNA5SP98	NA	
ENSG00000287025	AC079117.1	NA	
ENSG00000234653	LRRTM4-AS1	NA	
ENSG00000286932	AC013716.1	NA	
ENSG00000227088	AC012494.1	NA	
ENSG00000230968	AC084149.1	NA	
ENSG00000237077	RPL38P2	NA	
ENSG00000233605	LINC01851	NA	
ENSG00000229494	AC012494.2	NA	
ENSG00000214429	CYCSP6	NA	
ENSG00000270470	AC064872.1	NA	
ENSG00000234877	AC092660.1	NA	
ENSG00000286260	AC092604.1	NA	
ENSG00000202423	RNU6-827P	NA	
ENSG00000200048	RNU6-812P	NA	
ENSG00000143954	REG3G	NA	
ENSG00000172023	REG1B	NA	
ENSG00000115386	REG1A	NA	
ENSG00000204787	REG1CP	NA	
ENSG00000172016	REG3A	NA	
ENSG00000224879	AC011754.1	NA	
ENSG00000066032	CTNNA2	618174	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9
ENSG00000286227	AC011754.2	NA	
ENSG00000229385	CTNNA2-AS1	NA	
ENSG00000277171	AC010975.1	NA	
ENSG00000230237	GNA13P1	NA	
ENSG00000252031	RNU6-561P	NA	
ENSG00000266436	MIR4264	NA	
ENSG00000276917	MIR8080	NA	
ENSG00000224731	AC016716.1	NA	
ENSG00000223427	RBM7P1	NA	
ENSG00000162951	LRRTM1	NA	
ENSG00000237031	AC008067.1	NA	
ENSG00000230975	AC012355.1	NA	
ENSG00000234429	ANKRD11P1	NA	
ENSG00000231722	CHMP4AP1	NA	
ENSG00000235519	LINC01815	NA	
ENSG00000200890	RNA5SP99	NA	
ENSG00000233444	AC013262.1	NA	
ENSG00000242118	RN7SL201P	NA	
ENSG00000231781	AC079896.1	NA	
ENSG00000229560	LYARP1	NA	
ENSG00000252897	RNU6-685P	NA	
ENSG00000201311	Y_RNA	NA	
ENSG00000237498	AC010105.1	NA	
ENSG00000226860	RBX1P1	NA	
ENSG00000226700	MTND4P25	NA	
ENSG00000225045	MTND5P27	NA	
ENSG00000224695	MTND6P7	NA	
ENSG00000227789	MTCYBP7	NA	
ENSG00000286211	AC098817.1	NA	
ENSG00000168129	DHFRP3	NA	
ENSG00000223977	AC138623.1	NA	
ENSG00000232548	LINC01809	NA	
ENSG00000224627	RPL37P10	NA	
ENSG00000199295	RNU6-1312P	NA	
ENSG00000228225	CRLF3P3	NA	
ENSG00000228902	ST6GALNAC2P1	NA	
ENSG00000182814	FUNDC2P2	NA	
ENSG00000228272	AC106874.1	NA	
ENSG00000163541	SUCLG1	245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY
ENSG00000115423	DNAH6	NA	
ENSG00000259056	DUXAP1	NA	
ENSG00000235847	LDHAP7	NA	
ENSG00000186854	TRABD2A	NA	
ENSG00000276362	AC010087.1	NA	
ENSG00000213400	RPL12P18	NA	
ENSG00000034510	TMSB10	NA	
ENSG00000213399	RPS2P17	NA	
ENSG00000287625	AC022210.1	NA	
ENSG00000176407	KCMF1	NA	
ENSG00000260840	LINC01964	NA	
ENSG00000235463	AC078974.1	NA	
ENSG00000225787	LSM3P3	NA	
ENSG00000152284	TCF7L1	NA	
ENSG00000231134	TCF7L1-IT1	NA	
ENSG00000200701	RNU6-674P	NA	
ENSG00000230299	SNRPEP11	NA	
ENSG00000246575	AC093162.1	NA	
ENSG00000152291	TGOLN2	NA	
ENSG00000239143	Y_RNA	NA	
ENSG00000270532	PEBP1P2	NA	
ENSG00000042445	RETSAT	NA	
ENSG00000115459	ELMOD3	615429	DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88
ENSG00000271014	AC062037.1	NA	
ENSG00000202382	Y_RNA	NA	
ENSG00000278590	RN7SL113P	NA	
ENSG00000273196	AC062037.2	NA	
ENSG00000042493	CAPG	NA	
ENSG00000286011	AC062037.3	NA	
ENSG00000152292	SH2D6	NA	
ENSG00000207207	Y_RNA	NA	
ENSG00000244399	RN7SL251P	NA	
ENSG00000199936	Y_RNA	NA	
ENSG00000229648	RPSAP22	NA	
ENSG00000286532	PARTICL	NA	
ENSG00000168906	MAT2A	NA	
ENSG00000115486	GGCX	277450	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1;;VKCFD;;VITAMIN K-DEPENDENT COAGULATION DEFECT;;FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY III;;FMFD III;;MULTIPLE COAGULATION FACTOR DEFICIENCY III; MCFD3;;FACTORS II, VII /.../AND X, COMBINED DEFICIENCY OF;;GLUTAMIC ACID, DEFICIENT GAMMA-CARBOXYLATION OF
ENSG00000115486	GGCX	610842	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY;;PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY
ENSG00000118640	VAMP8	NA	
ENSG00000276281	RN7SL126P	NA	
ENSG00000168899	VAMP5	NA	
ENSG00000168894	RNF181	NA	
ENSG00000168890	TMEM150A	NA	
ENSG00000168883	USP39	NA	
ENSG00000168887	C2orf68	NA	
ENSG00000168878	SFTPB	265120	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 1;;INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN B DEFICIENCY;;INTERSTITIAL LUNG DISEASE, NONSPECIFIC, DUE TO SURFACTANT PROTEIN B DEFICIENCY
ENSG00000115523	GNLY	NA	
ENSG00000203363	GPR160P1	NA	
ENSG00000199687	RNU1-38P	NA	
ENSG00000168874	ATOH8	NA	
ENSG00000278783	MIR6071	NA	
ENSG00000229498	AC105053.1	NA	
ENSG00000252321	RN7SKP83	NA	
ENSG00000115525	ST3GAL5	609056	SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS;;AMISH INFANTILE EPILEPSY SYNDROME;;EPILEPSY SYNDROME, INFANTILE-ONSET SYMPTOMATIC;;GM3 SYNTHASE DEFICIENCY;;SALT AND PEPPER MENTAL RETARDATION SYNDROME
ENSG00000232504	ST3GAL5-AS1	NA	
ENSG00000272564	AC012511.1	NA	
ENSG00000287628	AC012511.2	NA	
ENSG00000068654	POLR1A	616462	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN
ENSG00000132300	PTCD3	NA	
ENSG00000208772	SNORD94	NA	
ENSG00000132305	IMMT	NA	
ENSG00000200241	AC009309.1	NA	
ENSG00000265420	MIR4779	NA	
ENSG00000273080	AC009309.2	NA	
ENSG00000132313	MRPL35	NA	
ENSG00000068615	REEP1	610250	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31
ENSG00000068615	REEP1	614751	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B;;HMN VB;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; DHMN5B;;DHMN VB;;SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VB; DSMAVB
ENSG00000202537	AC009408.1	NA	
ENSG00000251974	AC009408.2	NA	
ENSG00000115548	KDM3A	NA	
ENSG00000115561	CHMP3	NA	
ENSG00000249884	RNF103-CHMP3	NA	
ENSG00000200563	RNU6-640P	NA	
ENSG00000228363	AC015971.1	NA	
ENSG00000239305	RNF103	NA	
ENSG00000153561	RMND5A	NA	
ENSG00000153563	CD8A	608957	CD8 DEFICIENCY, FAMILIAL
ENSG00000172116	CD8B	NA	
ENSG00000233673	ANAPC1P1	NA	
ENSG00000213605	AC111200.1	NA	
ENSG00000187627	RGPD1	NA	
ENSG00000231351	WBP1P1	NA	
ENSG00000226114	NDUFB4P5	NA	
ENSG00000183281	PLGLB1	NA	
ENSG00000285793	ANAPC1P2	NA	
ENSG00000231259	ANAPC1P2	NA	
ENSG00000266931	AC092651.1	NA	
ENSG00000287931	AC092651.2	NA	
ENSG00000230395	ANAPC1P3	NA	
ENSG00000204745	AC083899.1	NA	
ENSG00000264793	MIR4771-1	NA	
ENSG00000233671	CENPNP1	NA	
ENSG00000281477	LINC01955	NA	
ENSG00000271097	DBF4P3	NA	
ENSG00000287763	AC068279.2	NA	
ENSG00000233999	IGKV3OR2-268	NA	
ENSG00000224881	AC068279.1	NA	
ENSG00000280721	LINC01943	NA	
ENSG00000222041	CYTOR	NA	
ENSG00000284879	AC133644.2	NA	
ENSG00000273445	AC133644.1	NA	
ENSG00000214354	PAFAH1B1P1	NA	
ENSG00000265507	MIR4435-1	NA	
ENSG00000225933	RPS14P5	NA	
ENSG00000234231	ANAPC1P4	NA	
ENSG00000125551	PLGLB2	NA	
ENSG00000185304	RGPD2	NA	
ENSG00000229604	MTATP8P2	NA	
ENSG00000225428	NDUFB4P7	NA	
ENSG00000233205	WBP1P2	NA	
ENSG00000275597	ANAPC1P5	NA	
ENSG00000288437	AC108479.2	NA	
ENSG00000222724	RNU2-63P	NA	
ENSG00000287670	AC108479.1	NA	
ENSG00000172086	KRCC1	NA	
ENSG00000115593	SMYD1	NA	
ENSG00000265003	MIR4780	NA	
ENSG00000163586	FABP1	NA	
ENSG00000144115	THNSL2	NA	
ENSG00000232508	MRPL45P1	NA	
ENSG00000283262	U6	NA	
ENSG00000212133	RNU6-1168P	NA	
ENSG00000252395	RNU6-1007P	NA	
ENSG00000224291	RPL38P6	NA	
ENSG00000214336	FOXI3	NA	
ENSG00000172073	TEX37	NA	
ENSG00000225420	AC104134.1	NA	
ENSG00000172071	EIF2AK3	226980	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS;;MED-IDDM SYNDROME;;IDDM-MED SYNDROME;;WOLCOTT-RALLISON SYNDROME
ENSG00000234028	EIF2AK3-DT	NA	
ENSG00000287686	AC062029.1	NA	
ENSG00000153574	RPIA	608611	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD
ENSG00000230006	ANKRD36BP2	NA	
ENSG00000283270	AC244205.2	NA	
ENSG00000240040	AC244205.1	NA	
ENSG00000265510	MIR4436A	NA	
ENSG00000211592	IGKC	NA	
ENSG00000211593	IGKJ5	NA	
ENSG00000211594	IGKJ4	NA	
ENSG00000211595	IGKJ3	NA	
ENSG00000211596	IGKJ2	NA	
ENSG00000211597	IGKJ1	NA	
ENSG00000211598	IGKV4-1	NA	
ENSG00000211599	IGKV5-2	NA	
ENSG00000197794	IGKV7-3	NA	
ENSG00000225136	PGBD4P5	NA	
ENSG00000253435	IGKV2-4	NA	
ENSG00000243466	IGKV1-5	NA	
ENSG00000239855	IGKV1-6	NA	
ENSG00000243063	IGKV3-7	NA	
ENSG00000240671	IGKV1-8	NA	
ENSG00000241755	IGKV1-9	NA	
ENSG00000253278	IGKV2-10	NA	
ENSG00000241351	IGKV3-11	NA	
ENSG00000243290	IGKV1-12	NA	
ENSG00000253497	IGKV1-13	NA	
ENSG00000253265	IGKV2-14	NA	
ENSG00000244437	IGKV3-15	NA	
ENSG00000240864	IGKV1-16	NA	
ENSG00000240382	IGKV1-17	NA	
ENSG00000254157	IGKV2-18	NA	
ENSG00000253732	IGKV2-19	NA	
ENSG00000239951	IGKV3-20	NA	
ENSG00000211611	IGKV6-21	NA	
ENSG00000253578	IGKV1-22	NA	
ENSG00000253625	IGKV2-23	NA	
ENSG00000241294	IGKV2-24	NA	
ENSG00000253202	IGKV3-25	NA	
ENSG00000254098	IGKV2-26	NA	
ENSG00000277852	AC244255.1	NA	
ENSG00000244575	IGKV1-27	NA	
ENSG00000244116	IGKV2-28	NA	
ENSG00000253998	IGKV2-29	NA	
ENSG00000243238	IGKV2-30	NA	
ENSG00000253158	IGKV3-31	NA	
ENSG00000253870	IGKV1-32	NA	
ENSG00000242076	IGKV1-33	NA	
ENSG00000253860	IGKV3-34	NA	
ENSG00000253461	IGKV1-35	NA	
ENSG00000253487	IGKV2-36	NA	
ENSG00000239862	IGKV1-37	NA	
ENSG00000253592	IGKV2-38	NA	
ENSG00000242371	IGKV1-39	NA	
ENSG00000273962	IGKV2-40	NA	
ENSG00000283427	AC006453.3	NA	
ENSG00000283196	LSP1P5	NA	
ENSG00000276861	5S_rRNA	NA	
ENSG00000283132	AC006453.1	NA	
ENSG00000283214	AC006453.2	NA	
ENSG00000283659	AC006453.4	NA	
ENSG00000251039	IGKV2D-40	NA	
ENSG00000251546	IGKV1D-39	NA	
ENSG00000254009	IGKV2D-38	NA	
ENSG00000250036	IGKV1D-37	NA	
ENSG00000253127	IGKV2D-36	NA	
ENSG00000232747	IGKV1D-35	NA	
ENSG00000253501	IGKV3D-34	NA	
ENSG00000239975	IGKV1D-33	NA	
ENSG00000253191	IGKV1D-32	NA	
ENSG00000253999	IGKV3D-31	NA	
ENSG00000239571	IGKV2D-30	NA	
ENSG00000243264	IGKV2D-29	NA	
ENSG00000242534	IGKV2D-28	NA	
ENSG00000224607	IGKV1D-27	NA	
ENSG00000211623	IGKV2D-26	NA	
ENSG00000254097	IGKV3D-25	NA	
ENSG00000241566	IGKV2D-24	NA	
ENSG00000254345	IGKV2D-23	NA	
ENSG00000253365	IGKV1D-22	NA	
ENSG00000225523	IGKV6D-21	NA	
ENSG00000211625	IGKV3D-20	NA	
ENSG00000253765	IGKV2D-19	NA	
ENSG00000254220	IGKV2D-18	NA	
ENSG00000211626	IGKV6D-41	NA	
ENSG00000242766	IGKV1D-17	NA	
ENSG00000241244	IGKV1D-16	NA	
ENSG00000224041	IGKV3D-15	NA	
ENSG00000254292	IGKV2D-14	NA	
ENSG00000276566	IGKV1D-13	NA	
ENSG00000278857	IGKV1D-12	NA	
ENSG00000211632	IGKV3D-11	NA	
ENSG00000253906	IGKV2D-10	NA	
ENSG00000211633	IGKV1D-42	NA	
ENSG00000242580	IGKV1D-43	NA	
ENSG00000239819	IGKV1D-8	NA	
ENSG00000228325	IGKV3D-7	NA	
ENSG00000275490	AC233263.2	NA	
ENSG00000270999	IGKV1OR2-118	NA	
ENSG00000265897	AC233263.1	NA	
ENSG00000281904	AC233263.6	NA	
ENSG00000230964	AC233266.1	NA	
ENSG00000261600	AC233266.2	NA	
ENSG00000278131	AC116050.1	NA	
ENSG00000143429	LSP1P4	NA	
ENSG00000222835	RNA5SP100	NA	
ENSG00000184303	DRD5P1	NA	
ENSG00000230572	AC027612.2	NA	
ENSG00000271627	NKAIN1P2	NA	
ENSG00000223703	AC027612.1	NA	
ENSG00000232531	KMT5AP2	NA	
ENSG00000286698	AC027612.3	NA	
ENSG00000236969	GGT8P	NA	
ENSG00000235235	IGKV1OR2-1	NA	
ENSG00000214330	ABCD1P5	NA	
ENSG00000237085	AC127391.1	NA	
ENSG00000227497	PABPC1P6	NA	
ENSG00000214329	SLC9B1P2	NA	
ENSG00000226481	ACTR3BP2	NA	
ENSG00000234898	CHEK2P3	NA	
ENSG00000235147	AC128677.1	NA	
ENSG00000223816	IGKV1OR2-2	NA	
ENSG00000286156	AC026273.1	NA	
ENSG00000261522	AL845331.2	NA	
ENSG00000259916	AL845331.1	NA	
ENSG00000237383	CNN2P11	NA	
ENSG00000227265	GXYLT1P7	NA	
ENSG00000213355	CNN2P8	NA	
ENSG00000234837	AC073464.2	NA	
ENSG00000223564	CYP4F32P	NA	
ENSG00000232502	AC073464.1	NA	
ENSG00000235571	SNX18P14	NA	
ENSG00000229089	ANKRD20A8P	NA	
ENSG00000212140	RNU6-1320P	NA	
ENSG00000278631	SOWAHCP5	NA	
ENSG00000259848	AC097374.1	NA	
ENSG00000163060	TEKT4	NA	
ENSG00000237055	MTCO1P48	NA	
ENSG00000232128	MTCO3P45	NA	
ENSG00000233158	RPS24P6	NA	
ENSG00000231331	AC103563.3	NA	
ENSG00000232594	AC103563.4	NA	
ENSG00000233105	AC103563.5	NA	
ENSG00000224585	AC103563.1	NA	
ENSG00000233447	AC103563.6	NA	
ENSG00000235186	AC103563.8	NA	
ENSG00000277591	RN7SL575P	NA	
ENSG00000233850	AC103563.7	NA	
ENSG00000172005	MAL	NA	
ENSG00000231062	AC103563.2	NA	
ENSG00000287362	AC103563.9	NA	
ENSG00000144029	MRPS5	NA	
ENSG00000144026	ZNF514	NA	
ENSG00000275111	ZNF2	NA	
ENSG00000275768	SLC2AXP1	NA	
ENSG00000233757	AC092835.1	NA	
ENSG00000155066	PROM2	NA	
ENSG00000115041	KCNIP3	NA	
ENSG00000235129	FABP7P2	NA	
ENSG00000115042	FAHD2A	NA	
ENSG00000248821	AC009238.3	NA	
ENSG00000233275	AC009238.2	NA	
ENSG00000227120	AC009238.1	NA	
ENSG00000204705	UBTFL5	NA	
ENSG00000277747	AC133104.2	NA	
ENSG00000234903	AC133104.1	NA	
ENSG00000144010	TRIM43B	NA	
ENSG00000238162	AC009237.11	NA	
ENSG00000223917	AC009237.1	NA	
ENSG00000237308	AC009237.10	NA	
ENSG00000224719	AC009237.2	NA	
ENSG00000226185	TRIM64FP	NA	
ENSG00000272913	AC009237.14	NA	
ENSG00000229689	AC009237.3	NA	
ENSG00000236431	AC009237.8	NA	
ENSG00000273305	AC009237.15	NA	
ENSG00000233037	AC009237.5	NA	
ENSG00000168992	OR7E102P	NA	
ENSG00000232717	TRIM51JP	NA	
ENSG00000274028	AC009237.16	NA	
ENSG00000230083	AC009237.4	NA	
ENSG00000144015	TRIM43	NA	
ENSG00000236026	AC009237.7	NA	
ENSG00000271003	AC009237.13	NA	
ENSG00000270193	AC009237.12	NA	
ENSG00000204699	UBTFL3	NA	
ENSG00000275497	AC009237.17	NA	
ENSG00000235959	AC009237.6	NA	
ENSG00000236750	AC009237.9	NA	
ENSG00000235584	AC008268.1	NA	
ENSG00000237510	GPAT2P1	NA	
ENSG00000232931	LINC00342	NA	
ENSG00000174501	ANKRD36C	NA	
ENSG00000275961	RN7SL210P	NA	
ENSG00000231584	FAHD2CP	NA	
ENSG00000186281	GPAT2	NA	
ENSG00000274286	ADRA2B	NA	
ENSG00000188886	ASTL	NA	
ENSG00000158050	DUSP2	NA	
ENSG00000228873	AC012307.1	NA	
ENSG00000084090	STARD7	607876	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME
ENSG00000204685	STARD7-AS1	NA	
ENSG00000135956	TMEM127	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000144021	CIAO1	NA	
ENSG00000144028	SNRNP200	610359	RETINITIS PIGMENTOSA 33; RP33
ENSG00000230747	AC021188.1	NA	
ENSG00000198885	ITPRIPL1	NA	
ENSG00000121152	NCAPH	617985	MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23
ENSG00000163121	NEURL3	NA	
ENSG00000235480	AC013270.1	NA	
ENSG00000196843	ARID5A	NA	
ENSG00000114982	KANSL3	NA	
ENSG00000249715	FER1L5	NA	
ENSG00000114988	LMAN2L	616887	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52; MRT52
ENSG00000158158	CNNM4	217080	JALILI SYNDROME;;CONE-ROD DYSTROPHY AND AMELOGENESIS IMPERFECTA
ENSG00000264157	MIR3127	NA	
ENSG00000273265	CNNM3-DT	NA	
ENSG00000168763	CNNM3	NA	
ENSG00000163126	ANKRD23	NA	
ENSG00000213337	ANKRD39	NA	
ENSG00000168758	SEMA4C	NA	
ENSG00000168754	FAM178B	NA	
ENSG00000286654	AC092636.1	NA	
ENSG00000274206	Metazoa_SRP	NA	
ENSG00000252845	RNA5SP101	NA	
ENSG00000275094	AC079395.3	NA	
ENSG00000273634	AC079395.2	NA	
ENSG00000248134	AC079395.1	NA	
ENSG00000144188	TRIM43CP	NA	
ENSG00000230343	AC018892.1	NA	
ENSG00000236847	AC018892.2	NA	
ENSG00000270748	IGKV2OR2-1	NA	
ENSG00000271402	IGKV2OR2-2	NA	
ENSG00000204670	IGKV1OR2-3	NA	
ENSG00000188383	GPAT2P2	NA	
ENSG00000144199	FAHD2B	NA	
ENSG00000279791	AC018892.3	NA	
ENSG00000275655	RN7SL313P	NA	
ENSG00000135976	ANKRD36	NA	
ENSG00000277701	AC159540.2	NA	
ENSG00000237837	AC159540.1	NA	
ENSG00000271351	IGKV1OR2-9	NA	
ENSG00000276050	IGKV2OR2-10	NA	
ENSG00000271015	IGKV2OR2-7D	NA	
ENSG00000270252	IGKV3OR2-5	NA	
ENSG00000271569	IGKV1OR2-6	NA	
ENSG00000270450	IGKV2OR2-7	NA	
ENSG00000278537	IGKV2OR2-8	NA	
ENSG00000270187	IGKV1OR2-11	NA	
ENSG00000230606	AC092683.1	NA	
ENSG00000278766	AC092683.2	NA	
ENSG00000196912	ANKRD36B	NA	
ENSG00000235833	AC017099.1	NA	
ENSG00000286036	AC017099.2	NA	
ENSG00000228970	UBTFL6	NA	
ENSG00000135940	COX5B	NA	
ENSG00000115073	ACTR1B	NA	
ENSG00000228486	C2orf92	NA	
ENSG00000201806	RNU4-8P	NA	
ENSG00000115085	ZAP70	269840	IMMUNODEFICIENCY 48; IMD48;;SELECTIVE T-CELL DEFECT; STCD
ENSG00000115085	ZAP70	617006	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2
ENSG00000075568	TMEM131	NA	
ENSG00000235734	HMGN1P36	NA	
ENSG00000238719	RNU7-96P	NA	
ENSG00000168658	VWA3B	616948	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22; SCAR22
ENSG00000231635	ATP5F1BP1	NA	
ENSG00000222000	AC092675.1	NA	
ENSG00000144191	CNGA3	216900	ACHROMATOPSIA 2; ACHM2;;COLORBLINDNESS, TOTAL;;ROD MONOCHROMATISM 2;;ROD MONOCHROMACY 2; RMCH2
ENSG00000227987	AC092675.2	NA	
ENSG00000040933	INPP4A	NA	
ENSG00000183513	COA5	616500	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3; CEMCOX3
ENSG00000115446	UNC50	NA	
ENSG00000071073	MGAT4A	NA	
ENSG00000236564	YWHAQP5	NA	
ENSG00000226791	LINC02611	NA	
ENSG00000201070	RNU4-84P	NA	
ENSG00000196872	CRACDL	NA	
ENSG00000238830	RNU7-46P	NA	
ENSG00000135951	TSGA10	617961	SPERMATOGENIC FAILURE 26; SPGF26
ENSG00000231822	SMC3P1	NA	
ENSG00000241962	AC079447.1	NA	
ENSG00000273045	C2orf15	NA	
ENSG00000144182	LIPT1	616299	LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D
ENSG00000273155	AC092587.1	NA	
ENSG00000158411	MITD1	NA	
ENSG00000185414	MRPL30	NA	
ENSG00000185674	LYG2	NA	
ENSG00000144214	LYG1	NA	
ENSG00000115514	TXNDC9	NA	
ENSG00000158417	EIF5B	NA	
ENSG00000135945	REV1	NA	
ENSG00000273306	AC018690.1	NA	
ENSG00000144218	AFF3	NA	
ENSG00000230393	AC092667.1	NA	
ENSG00000232084	LINC01104	NA	
ENSG00000170500	LONRF2	NA	
ENSG00000269383	CYCSP7	NA	
ENSG00000270699	AC012493.1	NA	
ENSG00000115526	CHST10	NA	
ENSG00000238029	RALBP1P2	NA	
ENSG00000204640	NMS	NA	
ENSG00000204637	ARPP19P2	NA	
ENSG00000115539	PDCL3	NA	
ENSG00000227259	HMGN2P22	NA	
ENSG00000234988	LINC01849	NA	
ENSG00000287832	AC092845.1	NA	
ENSG00000226034	NANOGNBP1	NA	
ENSG00000234169	LINC01868	NA	
ENSG00000228488	AC092168.1	NA	
ENSG00000286737	AC092168.3	NA	
ENSG00000170485	NPAS2	NA	
ENSG00000232034	AC092168.2	NA	
ENSG00000230140	NPAS2-AS1	NA	
ENSG00000223947	AC016738.1	NA	
ENSG00000071082	RPL31	NA	
ENSG00000204634	TBC1D8	NA	
ENSG00000271532	BBIP1P1	NA	
ENSG00000272902	TBC1D8-AS1	NA	
ENSG00000158435	CNOT11	NA	
ENSG00000163162	RNF149	NA	
ENSG00000212283	SNORD89	NA	
ENSG00000264857	MIR5696	NA	
ENSG00000175874	CREG2	NA	
ENSG00000226058	AC092570.1	NA	
ENSG00000196460	RFX8	NA	
ENSG00000223826	LINC01870	NA	
ENSG00000237549	RPS6P3	NA	
ENSG00000232556	PRCPP1	NA	
ENSG00000286047	AC093894.1	NA	
ENSG00000286101	AC093894.2	NA	
ENSG00000071054	MAP4K4	NA	
ENSG00000281162	LINC01127	NA	
ENSG00000115590	IL1R2	NA	
ENSG00000287771	AC007271.1	NA	
ENSG00000115594	IL1R1	NA	
ENSG00000226925	IL1R1-AS1	NA	
ENSG00000115598	IL1RL2	NA	
ENSG00000205716	FAM183DP	NA	
ENSG00000115602	IL1RL1	NA	
ENSG00000115604	IL18R1	NA	
ENSG00000236785	SDR42E1P5	NA	
ENSG00000115607	IL18RAP	NA	
ENSG00000264764	MIR4772	NA	
ENSG00000236525	AC007278.2	NA	
ENSG00000234389	AC007278.1	NA	
ENSG00000180251	SLC9A4	NA	
ENSG00000115616	SLC9A2	NA	
ENSG00000135953	MFSD9	NA	
ENSG00000170417	TMEM182	NA	
ENSG00000277527	LINC01796	NA	
ENSG00000224095	LINC01935	NA	
ENSG00000227680	AC108051.1	NA	
ENSG00000229209	AC073987.1	NA	
ENSG00000227623	AC010881.1	NA	
ENSG00000286290	AC011593.1	NA	
ENSG00000236596	CRLF3P1	NA	
ENSG00000221849	AC018880.1	NA	
ENSG00000231723	CAPZBP1	NA	
ENSG00000232597	AC013727.1	NA	
ENSG00000236141	AC013727.2	NA	
ENSG00000256637	LINC01965	NA	
ENSG00000273515	AC013727.3	NA	
ENSG00000228968	AC096554.1	NA	
ENSG00000233955	AHCYP3	NA	
ENSG00000227157	AC068535.1	NA	
ENSG00000225765	LINC01831	NA	
ENSG00000287793	AC068535.2	NA	
ENSG00000235597	LINC01102	NA	
ENSG00000234781	LINC01103	NA	
ENSG00000231626	AC013402.2	NA	
ENSG00000236109	AC013402.3	NA	
ENSG00000288565	AC068057.3	NA	
ENSG00000230690	AC013402.1	NA	
ENSG00000225669	RPL23AP27	NA	
ENSG00000228528	AC068057.1	NA	
ENSG00000279904	AC068057.2	NA	
ENSG00000207249	SNORA72	NA	
ENSG00000233639	PANTR1	NA	
ENSG00000234177	LINC01114	NA	
ENSG00000213301	HMGB3P11	NA	
ENSG00000269707	AC018730.1	NA	
ENSG00000198914	POU3F3	618604	SNIJDERS BLOK-FISHER SYNDROME; SNIBFIS
ENSG00000229743	LINC01159	NA	
ENSG00000287135	AC010884.1	NA	
ENSG00000224509	MRPS9-AS2	NA	
ENSG00000135972	MRPS9	NA	
ENSG00000231851	MRPS9-AS1	NA	
ENSG00000226508	LINC01918	NA	
ENSG00000135973	GPR45	NA	
ENSG00000272861	AC012360.2	NA	
ENSG00000135966	TGFBRAP1	NA	
ENSG00000235319	AC012360.1	NA	
ENSG00000272994	AC012360.3	NA	
ENSG00000135974	C2orf49	NA	
ENSG00000115641	FHL2	NA	
ENSG00000238273	AC108058.1	NA	
ENSG00000287036	AC018802.1	NA	
ENSG00000287308	AC018802.2	NA	
ENSG00000071051	NCK2	NA	
ENSG00000235522	AC010978.1	NA	
ENSG00000234162	AC009505.1	NA	
ENSG00000119147	ECRG4	NA	
ENSG00000115652	UXS1	NA	
ENSG00000233339	AC018878.1	NA	
ENSG00000273595	AC092106.1	NA	
ENSG00000213295	RPL22P10	NA	
ENSG00000224061	SRSF3P4	NA	
ENSG00000230353	RPS21P2	NA	
ENSG00000233939	RPL27AP4	NA	
ENSG00000227513	ILRUNP1	NA	
ENSG00000229682	AC114755.1	NA	
ENSG00000235486	ANAPC1P6	NA	
ENSG00000240935	PLGLA	NA	
ENSG00000153165	RGPD3	NA	
ENSG00000237666	AC097527.1	NA	
ENSG00000254126	CD8B2	NA	
ENSG00000232001	AC108868.2	NA	
ENSG00000231505	AC108868.1	NA	
ENSG00000214199	EEF1A1P12	NA	
ENSG00000144057	ST6GAL2	NA	
ENSG00000238250	ST6GAL2-IT1	NA	
ENSG00000227294	AC016994.1	NA	
ENSG00000286218	AC005040.2	NA	
ENSG00000229360	PPP1R2P5	NA	
ENSG00000226905	AC005040.1	NA	
ENSG00000229457	LINC01789	NA	
ENSG00000225588	AC096669.1	NA	
ENSG00000237880	LINC01885	NA	
ENSG00000224568	LINC01886	NA	
ENSG00000286769	AC064869.1	NA	
ENSG00000232991	GACAT1	NA	
ENSG00000230651	RGPD4-AS1	NA	
ENSG00000196862	RGPD4	NA	
ENSG00000233494	AC009963.2	NA	
ENSG00000227270	AC009963.1	NA	
ENSG00000237745	RPL22P8	NA	
ENSG00000235325	SRSF3P5	NA	
ENSG00000115665	SLC5A7	158580	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY
ENSG00000115665	SLC5A7	617143	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20
ENSG00000231221	LINC01593	NA	
ENSG00000229890	ACTP1	NA	
ENSG00000225328	LINC01594	NA	
ENSG00000236877	SETD6P1	NA	
ENSG00000196228	SULT1C3	NA	
ENSG00000227597	WASF1P1	NA	
ENSG00000198203	SULT1C2	NA	
ENSG00000261209	SULT1C2P2	NA	
ENSG00000237223	SULT1C2P1	NA	
ENSG00000271070	GMCL1P2	NA	
ENSG00000198075	SULT1C4	NA	
ENSG00000271284	SMIM12P1	NA	
ENSG00000135968	GCC2	NA	
ENSG00000214184	GCC2-AS1	NA	
ENSG00000169756	LIMS1	NA	
ENSG00000228763	LIMS1-AS1	NA	
ENSG00000233648	AC010095.1	NA	
ENSG00000235644	RPL10P5	NA	
ENSG00000153201	RANBP2	608033	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE
ENSG00000163006	CCDC138	NA	
ENSG00000227470	RPL39P16	NA	
ENSG00000135960	EDAR	129490	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED
ENSG00000135960	EDAR	224900	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC; HED;;ECTODERMAL DYSPLASIA, ANHIDROTIC; EDA
ENSG00000135960	EDAR	612630	HAIR MORPHOLOGY 1; HRM1;;HAIR THICKNESS, VARIATION IN
ENSG00000277628	Metazoa_SRP	NA	
ENSG00000259863	SH3RF3-AS1	NA	
ENSG00000172985	SH3RF3	NA	
ENSG00000264934	MIR4265	NA	
ENSG00000228551	SNRPGP9	NA	
ENSG00000265965	MIR4266	NA	
ENSG00000186522	SEPTIN10	NA	
ENSG00000237916	RPL37P12	NA	
ENSG00000230696	AC011753.2	NA	
ENSG00000198142	SOWAHC	NA	
ENSG00000230603	AC011753.1	NA	
ENSG00000231099	BMS1P19	NA	
ENSG00000233307	SRSF3P6	NA	
ENSG00000233707	RPL22P11	NA	
ENSG00000282033	AC074387.1	NA	
ENSG00000015568	RGPD5	NA	
ENSG00000256977	LIMS3	NA	
ENSG00000284337	AC013271.1	NA	
ENSG00000186148	AC013268.1	NA	
ENSG00000283684	AC013268.5	NA	
ENSG00000240069	GPAA1P1	NA	
ENSG00000225108	ZBTB45P1	NA	
ENSG00000204588	LINC01123	NA	
ENSG00000235721	AC013268.3	NA	
ENSG00000229730	AC013268.2	NA	
ENSG00000283283	AC013268.4	NA	
ENSG00000265682	MIR4267	NA	
ENSG00000144063	MALL	NA	
ENSG00000264979	MIR4436B1	NA	
ENSG00000144061	NPHP1	256100	NEPHRONOPHTHISIS 1; NPHP1;;NEPHRONOPHTHISIS, FAMILIAL JUVENILE;;NPH1
ENSG00000144061	NPHP1	266900	SENIOR-LOKEN SYNDROME 1; SLSN1;;SENIOR-LOKEN SYNDROME;;LOKEN-SENIOR SYNDROME;;RENAL-RETINAL SYNDROME;;JUVENILE NEPHRONOPHTHISIS WITH LEBER AMAUROSIS;;RENAL DYSPLASIA AND RETINAL APLASIA
ENSG00000144061	NPHP1	609583	JOUBERT SYNDROME 4; JBTS4
ENSG00000233370	ACTR1AP1	NA	
ENSG00000175701	MTLN	NA	
ENSG00000261760	AC140479.3	NA	
ENSG00000282304	AC140479.4	NA	
ENSG00000282785	AC140479.5	NA	
ENSG00000263881	MIR4436B2	NA	
ENSG00000283167	AC140479.6	NA	
ENSG00000226991	AC140479.1	NA	
ENSG00000230650	AC140479.2	NA	
ENSG00000175772	LINC01106	NA	
ENSG00000226065	ZBTB45P2	NA	
ENSG00000230596	GPAA1P2	NA	
ENSG00000273471	AC112229.4	NA	
ENSG00000184115	AC112229.1	NA	
ENSG00000257207	AC112229.3	NA	
ENSG00000256671	LIMS4	NA	
ENSG00000227574	AC112229.2	NA	
ENSG00000231583	AC108938.1	NA	
ENSG00000183054	RGPD6	NA	
ENSG00000231536	AC226101.1	NA	
ENSG00000216867	RPL22P12	NA	
ENSG00000169679	BUB1	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000235881	AC114776.1	NA	
ENSG00000153093	ACOXL	NA	
ENSG00000236330	RPL5P9	NA	
ENSG00000172965	MIR4435-2HG	NA	
ENSG00000204581	ACOXL-AS1	NA	
ENSG00000153094	BCL2L11	NA	
ENSG00000230499	AC108463.2	NA	
ENSG00000227992	AC108463.1	NA	
ENSG00000271590	AC108463.3	NA	
ENSG00000229118	AC068491.2	NA	
ENSG00000270190	AC068491.3	NA	
ENSG00000226928	RPS14P4	NA	
ENSG00000266139	MIR4435-2	NA	
ENSG00000223973	AC068491.1	NA	
ENSG00000285016	AC017002.3	NA	
ENSG00000280878	AC017002.2	NA	
ENSG00000240350	SOCAR	NA	
ENSG00000271635	DBF4P2	NA	
ENSG00000225744	AC017002.1	NA	
ENSG00000153107	ANAPC1	618625	ROTHMUND-THOMSON SYNDROME, TYPE 1; RTS1;;POIKILODERMA ATROPHICANS AND CATARACT
ENSG00000237583	RPL34P8	NA	
ENSG00000227842	AC093166.1	NA	
ENSG00000228615	CENPNP2	NA	
ENSG00000266063	MIR4771-2	NA	
ENSG00000230958	AC093166.2	NA	
ENSG00000236307	EEF1E1P1	NA	
ENSG00000153208	MERTK	613862	RETINITIS PIGMENTOSA 38; RP38;;ROD-CONE DYSTROPHY, CHILDHOOD-ONSET
ENSG00000240183	RN7SL297P	NA	
ENSG00000225496	RTRAFP1	NA	
ENSG00000232277	SLC30A6P1	NA	
ENSG00000286904	AC093675.1	NA	
ENSG00000153214	TMEM87B	NA	
ENSG00000287141	AC093675.2	NA	
ENSG00000144152	FBLN7	NA	
ENSG00000278962	AC092645.1	NA	
ENSG00000144161	ZC3H8	NA	
ENSG00000286545	AC092645.2	NA	
ENSG00000188177	ZC3H6	NA	
ENSG00000235258	NDUFB4P6	NA	
ENSG00000236555	AC115115.1	NA	
ENSG00000169629	RGPD8	NA	
ENSG00000283698	VINAC1P	NA	
ENSG00000114999	TTL	NA	
ENSG00000125630	POLR1B	NA	
ENSG00000207383	Y_RNA	NA	
ENSG00000125611	CHCHD5	NA	
ENSG00000243389	AC012442.2	NA	
ENSG00000228251	AC012442.1	NA	
ENSG00000231747	AC079922.1	NA	
ENSG00000237753	AC079922.2	NA	
ENSG00000144136	SLC20A1	NA	
ENSG00000144130	NT5DC4	NA	
ENSG00000169607	CKAP2L	272440	FILIPPI SYNDROME; FLPIS;;SYNDACTYLY, TYPE I, WITH MICROCEPHALY AND MENTAL RETARDATION;;SCOTT CRANIODIGITAL SYNDROME WITH MENTAL RETARDATION
ENSG00000115008	IL1A	NA	
ENSG00000287937	AC079753.2	NA	
ENSG00000125538	IL1B	137215	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR, INCLUDED; LBC, INCLUDED;;GASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE, INCLUDED
ENSG00000280228	AC079753.1	NA	
ENSG00000180152	XIAPP3	NA	
ENSG00000125571	IL37	NA	
ENSG00000227368	CDK8P2	NA	
ENSG00000136688	IL36G	NA	
ENSG00000236124	HMGN2P23	NA	
ENSG00000232090	POLR2DP1	NA	
ENSG00000136694	IL36A	NA	
ENSG00000136696	IL36B	NA	
ENSG00000136695	IL36RN	614204	PSORIASIS 14, PUSTULAR; PSORS14;;INTERLEUKIN 36 RECEPTOR ANTAGONIST DEFICIENCY; DITRA;;GENERALIZED PUSTULAR PSORIASIS; GPP;;PSORP;;ACRODERMATITIS CONTINUA OF HALLOPEAU;;PALMOPLANTAR PUSTULOSIS
ENSG00000136697	IL1F10	NA	
ENSG00000201805	RNU6-1180P	NA	
ENSG00000136689	IL1RN	137215	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSE BREAST CANCER, LOBULAR, INCLUDED; LBC, INCLUDED;;GASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE, INCLUDED
ENSG00000136689	IL1RN	612628	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4;;NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO
ENSG00000136689	IL1RN	612852	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP;;INTERLEUKIN 1 RECEPTOR ANTAGONIST DEFICIENCY; DIRA
ENSG00000125637	PSD4	NA	
ENSG00000234174	AC016683.1	NA	
ENSG00000189223	PAX8-AS1	NA	
ENSG00000125618	PAX8	218700	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2;;THYROID DYSGENESIS;;THYROID AGENESIS;;THYROID HYPOPLASIA;;THYROID, ECTOPIC;;HYPOTHYROIDISM, CONGENITAL, DUE TO THYROID DYSGENESIS;;HYPOTHYROIDISM, ATHYREOTIC;;ATHYREOTIC HYPOTHYROIDISM;;RESISTANCE T /.../OTROPIN; RTSH;;THYROTROPIN RESISTANCE
ENSG00000234997	AC016745.1	NA	
ENSG00000231292	IGKV1OR2-108	NA	
ENSG00000272563	AC016745.2	NA	
ENSG00000136682	CBWD2	NA	
ENSG00000184492	FOXD4L1	NA	
ENSG00000234148	LINC01961	NA	
ENSG00000231943	PGM5P4-AS1	NA	
ENSG00000225398	PGM5P4	NA	
ENSG00000226516	FAM138B	NA	
ENSG00000287165	AL078621.2	NA	
ENSG00000221055	MIR1302-3	NA	
ENSG00000146556	WASH2P	NA	
ENSG00000236397	DDX11L2	NA	
ENSG00000279267	AL078621.1	NA	
ENSG00000240356	RPL23AP7	NA	
ENSG00000144134	RABL2A	NA	
ENSG00000144158	SNRPA1P1	NA	
ENSG00000175509	ACRP1	NA	
ENSG00000233479	AC017074.2	NA	
ENSG00000227359	AC017074.1	NA	
ENSG00000202427	RNU6-744P	NA	
ENSG00000115084	SLC35F5	NA	
ENSG00000265429	MIR4782	NA	
ENSG00000244063	AC104653.2	NA	
ENSG00000228857	AC104653.1	NA	
ENSG00000270019	AC110769.2	NA	
ENSG00000115091	ACTR3	NA	
ENSG00000279957	AC110769.3	NA	
ENSG00000234199	LINC01191	NA	
ENSG00000243179	AC110769.1	NA	
ENSG00000212182	U3	NA	
ENSG00000286513	AC010982.2	NA	
ENSG00000235242	AC010982.1	NA	
ENSG00000231926	SEPHS1P7	NA	
ENSG00000222923	RNU2-41P	NA	
ENSG00000175497	DPP10	NA	
ENSG00000231538	DPP10-AS3	NA	
ENSG00000235717	DPP10-AS2	NA	
ENSG00000286776	AC093610.1	NA	
ENSG00000235026	DPP10-AS1	NA	
ENSG00000230391	RPSAP23	NA	
ENSG00000287451	AC016721.1	NA	
ENSG00000271667	AC104408.1	NA	
ENSG00000224869	AC062016.1	NA	
ENSG00000226341	MTCYBP39	NA	
ENSG00000235871	AC062016.2	NA	
ENSG00000230158	MTND1P28	NA	
ENSG00000230950	MTND2P21	NA	
ENSG00000228898	MTCO1P43	NA	
ENSG00000239185	RNU7-190P	NA	
ENSG00000227291	AC092170.1	NA	
ENSG00000286370	AC064856.1	NA	
ENSG00000238207	AC009312.1	NA	
ENSG00000088205	DDX18	NA	
ENSG00000236255	AC009404.1	NA	
ENSG00000125631	HTR5BP	NA	
ENSG00000125633	CCDC93	NA	
ENSG00000224967	AC009303.1	NA	
ENSG00000235066	AC009303.2	NA	
ENSG00000272895	AC009303.3	NA	
ENSG00000279227	AC009303.4	NA	
ENSG00000243510	RN7SL111P	NA	
ENSG00000125629	INSIG2	NA	
ENSG00000226856	THORLNC	NA	
ENSG00000258910	LINC01956	NA	
ENSG00000163064	EN1	NA	
ENSG00000019169	MARCO	NA	
ENSG00000259094	AC013457.1	NA	
ENSG00000144119	C1QL2	NA	
ENSG00000264833	RN7SL468P	NA	
ENSG00000115107	STEAP3	615234	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2
ENSG00000229867	STEAP3-AS1	NA	
ENSG00000186132	C2orf76	NA	
ENSG00000155368	DBI	NA	
ENSG00000171227	TMEM37	NA	
ENSG00000080293	SCTR	NA	
ENSG00000231013	SCTR-AS1	NA	
ENSG00000163075	CFAP221	NA	
ENSG00000144120	TMEM177	NA	
ENSG00000229326	RPL17P15	NA	
ENSG00000088179	PTPN4	NA	
ENSG00000233741	RPL27P7	NA	
ENSG00000115109	EPB41L5	NA	
ENSG00000224789	AC012363.1	NA	
ENSG00000202046	Y_RNA	NA	
ENSG00000236878	MTATP6P26	NA	
ENSG00000227788	MTCO3P43	NA	
ENSG00000233286	MTND3P10	NA	
ENSG00000243104	MTND4LP14	NA	
ENSG00000234065	MTND4P26	NA	
ENSG00000223549	MTND5P28	NA	
ENSG00000226479	TMEM185B	NA	
ENSG00000144118	RALB	NA	
ENSG00000235840	AC012363.2	NA	
ENSG00000163083	INHBB	NA	
ENSG00000280409	LINC01101	NA	
ENSG00000237614	AC073257.2	NA	
ENSG00000232140	AC073257.1	NA	
ENSG00000201006	AC018866.1	NA	
ENSG00000229774	AC018866.2	NA	
ENSG00000074047	GLI2	610829	HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES
ENSG00000074047	GLI2	615849	CULLER-JONES SYNDROME; CJS;;PALLISTER-HALL SYNDROME 2, FORMERLY; PHS2, FORMERLY
ENSG00000271709	AC017033.1	NA	
ENSG00000201584	AC016764.1	NA	
ENSG00000234455	AC067960.1	NA	
ENSG00000236145	AC079988.1	NA	
ENSG00000115112	TFCP2L1	NA	
ENSG00000232723	RPS17P7	NA	
ENSG00000074054	CLASP1	NA	
ENSG00000265451	AC012447.1	NA	
ENSG00000264229	RNU4ATAC	210710	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1;;MOPD I; MOPD;;OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I;;BRACHYMELIC PRIMORDIAL DWARFISM;;TAYBI-LINDER SYNDROME; TALS;;CEPHALOSKELETAL DYSPLASIA;;LOW-BIRTH-WEIGHT DWARFISM WITH SKEL /.../YSPLASIA
ENSG00000264229	RNU4ATAC	616651	ROIFMAN SYNDROME; RFMN;;SPONDYLOEPIPHYSEAL DYSPLASIA, RETINAL DYSTROPHY, AND ANTIBODY DEFICIENCY
ENSG00000222467	AC079449.1	NA	
ENSG00000236859	NIFK-AS1	NA	
ENSG00000230993	RPL12P15	NA	
ENSG00000279721	AC018737.2	NA	
ENSG00000213239	NPM1P32	NA	
ENSG00000155438	NIFK	NA	
ENSG00000211460	TSN	NA	
ENSG00000270798	AC018737.1	NA	
ENSG00000224655	LINC01823	NA	
ENSG00000286481	AC011246.1	NA	
ENSG00000287871	AC073632.1	NA	
ENSG00000237856	AC062020.1	NA	
ENSG00000232740	LINC01826	NA	
ENSG00000287854	AC073409.2	NA	
ENSG00000226708	AC073409.1	NA	
ENSG00000235640	ELOAP1	NA	
ENSG00000227738	PSMD14P1	NA	
ENSG00000279874	AC064859.1	NA	
ENSG00000223118	RN7SKP102	NA	
ENSG00000228400	AC079154.1	NA	
ENSG00000155052	CNTNAP5	NA	
ENSG00000238046	MTND5P22	NA	
ENSG00000286384	AC019159.2	NA	
ENSG00000270815	AC019159.1	NA	
ENSG00000252674	RNA5SP102	NA	
ENSG00000206726	RNU6-259P	NA	
ENSG00000286206	AC097499.2	NA	
ENSG00000235491	LINC01889	NA	
ENSG00000224410	AC097499.1	NA	
ENSG00000226813	LINC01941	NA	
ENSG00000286515	AC142116.2	NA	
ENSG00000235774	AC023347.1	NA	
ENSG00000236655	SLC6A14P3	NA	
ENSG00000213236	YWHAZP2	NA	
ENSG00000288524	AC013474.2	NA	
ENSG00000136732	GYPC	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000136732	GYPC	616089	BLOOD GROUP, GERBICH SYSTEM; GE;;GERBICH BLOOD GROUP SYSTEM
ENSG00000235128	AC013474.1	NA	
ENSG00000206963	RNU6-675P	NA	
ENSG00000237524	TEX51	NA	
ENSG00000238788	RNU7-182P	NA	
ENSG00000260634	AC012508.2	NA	
ENSG00000286971	AC012508.3	NA	
ENSG00000260163	AC012508.1	NA	
ENSG00000136717	BIN1	255200	MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE
ENSG00000286400	AC110926.1	NA	
ENSG00000237630	NIFKP9	NA	
ENSG00000186684	CYP27C1	NA	
ENSG00000226789	WBP11P2	NA	
ENSG00000163161	ERCC3	610651	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB;;XP, GROUP B; XPBC  XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME, INCLUDED;;XPB/CS, INCLUDED
ENSG00000163161	ERCC3	616390	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE; TTD2
ENSG00000286145	AC068282.1	NA	
ENSG00000169967	MAP3K2	NA	
ENSG00000200250	RNU6-1147P	NA	
ENSG00000236682	MAP3K2-DT	NA	
ENSG00000287742	AC068282.2	NA	
ENSG00000115718	PROC	176860	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3;;PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT;;PROC DEFICIENCY, AUTOSOMAL DOMINANT PROTEIN C DEFICIENCY, ACQUIRED, INCLUDED
ENSG00000115718	PROC	612304	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4;;PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE;;PROC DEFICIENCY, AUTOSOMAL RECESSIVE
ENSG00000264075	MIR4783	NA	
ENSG00000163166	IWS1	NA	
ENSG00000231731	AC010976.1	NA	
ENSG00000202429	RNU4-48P	NA	
ENSG00000169994	MYO7B	NA	
ENSG00000272789	AC010976.2	NA	
ENSG00000072163	LIMS2	616827	MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE; MDRCMTT;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W
ENSG00000144230	GPR17	NA	
ENSG00000136709	WDR33	NA	
ENSG00000173349	SFT2D3	NA	
ENSG00000201470	RNY4P7	NA	
ENSG00000200390	Y_RNA	NA	
ENSG00000274010	ZFP91P1	NA	
ENSG00000144231	POLR2D	NA	
ENSG00000202532	RNU6-395P	NA	
ENSG00000244563	RPS26P19	NA	
ENSG00000273950	Metazoa_SRP	NA	
ENSG00000144233	AMMECR1L	NA	
ENSG00000272667	AC012306.2	NA	
ENSG00000286873	AC012306.3	NA	
ENSG00000204399	AC012306.1	NA	
ENSG00000136715	SAP130	NA	
ENSG00000234044	AC108059.2	NA	
ENSG00000200432	Y_RNA	NA	
ENSG00000136731	UGGT1	NA	
ENSG00000229173	SRMP3	NA	
ENSG00000232101	AC108059.1	NA	
ENSG00000229758	DYNLT3P2	NA	
ENSG00000185631	RPL14P6	NA	
ENSG00000238180	RPL21P34	NA	
ENSG00000136720	HS6ST1	614880	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15
ENSG00000252742	Y_RNA	NA	
ENSG00000238379	RNA5SP103	NA	
ENSG00000227653	ISCA1P6	NA	
ENSG00000237532	AC012451.1	NA	
ENSG00000238277	AC068483.1	NA	
ENSG00000204460	LINC01854	NA	
ENSG00000233428	PPIAP65	NA	
ENSG00000229536	LINC02572	NA	
ENSG00000286957	AC079776.5	NA	
ENSG00000214100	PLAC9P1	NA	
ENSG00000237574	LINC01856	NA	
ENSG00000234559	RPL22P7	NA	
ENSG00000225449	RAB6C-AS1	NA	
ENSG00000222014	RAB6C	NA	
ENSG00000284619	AC079776.3	NA	
ENSG00000286026	AC079776.4	NA	
ENSG00000250207	AC079776.2	NA	
ENSG00000217289	AC079776.1	NA	
ENSG00000231147	ARHGAP42P2	NA	
ENSG00000180178	FAR2P1	NA	
ENSG00000286058	AC018865.2	NA	
ENSG00000231240	KLF2P1	NA	
ENSG00000248313	CYP4F27P	NA	
ENSG00000196604	POTEF	NA	
ENSG00000228471	AC018865.1	NA	
ENSG00000224087	POTEF-AS1	NA	
ENSG00000252223	RNU6-1049P	NA	
ENSG00000223760	MED15P9	NA	
ENSG00000152076	CCDC74B	NA	
ENSG00000136699	SMPD4	618622	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES; NEDMABA
ENSG00000152082	MZT2B	NA	
ENSG00000152086	TUBA3E	NA	
ENSG00000227632	AC018804.1	NA	
ENSG00000230756	RHOQP3	NA	
ENSG00000213225	NOC2LP1	NA	
ENSG00000234398	AC134915.1	NA	
ENSG00000236595	MED15P5	NA	
ENSG00000237722	MTND1P29	NA	
ENSG00000231954	MTND2P22	NA	
ENSG00000236211	MTCO1P7	NA	
ENSG00000230496	MTCO2P7	NA	
ENSG00000232990	MTATP6P7	NA	
ENSG00000249997	MTCO3P7	NA	
ENSG00000283940	AC068137.1	NA	
ENSG00000284171	AC068137.2	NA	
ENSG00000230548	MTND4P27	NA	
ENSG00000234934	MTND5P29	NA	
ENSG00000248136	MTND6P8	NA	
ENSG00000233550	MTCYBP8	NA	
ENSG00000226915	RPL19P4	NA	
ENSG00000271435	TEKT4P3	NA	
ENSG00000224352	AC132479.1	NA	
ENSG00000136710	CCDC115	616828	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O;;CDG IIo; CDGIIo
ENSG00000136718	IMP4	NA	
ENSG00000072135	PTPN18	NA	
ENSG00000178162	FAR2P2	NA	
ENSG00000230646	KLF2P2	NA	
ENSG00000239402	CYP4F62P	NA	
ENSG00000196834	POTEI	NA	
ENSG00000251973	RNU6-473P	NA	
ENSG00000225819	AC013269.2	NA	
ENSG00000274711	Metazoa_SRP	NA	
ENSG00000152093	CFC1B	NA	
ENSG00000225341	AC013269.1	NA	
ENSG00000184761	PRSS40B	NA	
ENSG00000183292	PRSS40A	NA	
ENSG00000232408	AC140481.2	NA	
ENSG00000136698	CFC1	605376	HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2;;HTX
ENSG00000277668	AC140481.3	NA	
ENSG00000222038	POTEJ	NA	
ENSG00000251757	RNU6-848P	NA	
ENSG00000214081	CYP4F30P	NA	
ENSG00000282944	AC140481.4	NA	
ENSG00000240253	FAR2P3	NA	
ENSG00000223349	KLF2P3	NA	
ENSG00000173302	GPR148	NA	
ENSG00000229797	AC140481.1	NA	
ENSG00000178171	AMER3	NA	
ENSG00000232503	CYCSP8	NA	
ENSG00000233221	AC133785.1	NA	
ENSG00000136002	ARHGEF4	NA	
ENSG00000281159	AC112786.1	NA	
ENSG00000281516	AC112786.2	NA	
ENSG00000284479	SMIM39	NA	
ENSG00000152102	FAM168B	NA	
ENSG00000115762	PLEKHB2	NA	
ENSG00000230450	NEK2P4	NA	
ENSG00000225448	AC009477.1	NA	
ENSG00000236956	NF1P8	NA	
ENSG00000285819	AC131180.1	NA	
ENSG00000248796	MED15P8	NA	
ENSG00000188219	POTEE	NA	
ENSG00000212199	RNU6-127P	NA	
ENSG00000231431	FAR2P4	NA	
ENSG00000236516	KLF2P4	NA	
ENSG00000284604	AC073869.5	NA	
ENSG00000227817	ARHGAP42P1	NA	
ENSG00000284706	AC073869.7	NA	
ENSG00000224425	SSBP3P2	NA	
ENSG00000233087	RAB6D	NA	
ENSG00000283303	AC073869.3	NA	
ENSG00000233285	MTCYBP10	NA	
ENSG00000227275	MTND6P10	NA	
ENSG00000235080	MTND5P23	NA	
ENSG00000231777	MTND4P21	NA	
ENSG00000284003	AC073869.4	NA	
ENSG00000283865	MTND3P18	NA	
ENSG00000227661	MTCO3P18	NA	
ENSG00000236590	MTATP6P4	NA	
ENSG00000234480	MTCO2P18	NA	
ENSG00000237910	MTCO1P18	NA	
ENSG00000234939	MTND2P18	NA	
ENSG00000234576	MTND1P26	NA	
ENSG00000226831	MED15P3	NA	
ENSG00000276460	AC073869.2	NA	
ENSG00000223631	LINC01120	NA	
ENSG00000284659	AC073869.6	NA	
ENSG00000214077	GNAQP1	NA	
ENSG00000217950	NOC2LP2	NA	
ENSG00000232742	RHOQP2	NA	
ENSG00000273073	AC073869.1	NA	
ENSG00000173272	MZT2A	NA	
ENSG00000075886	TUBA3D	617928	KERATOCONUS 9; KTCN9
ENSG00000284149	MIR4784	NA	
ENSG00000152117	SMPD4BP	NA	
ENSG00000163040	CCDC74A	NA	
ENSG00000224679	MED15P4	NA	
ENSG00000286208	AC093838.1	NA	
ENSG00000204434	POTEKP	NA	
ENSG00000251956	RNU6-617P	NA	
ENSG00000224559	LINC01087	NA	
ENSG00000270930	GRAMD4P8	NA	
ENSG00000287151	C2orf27A	NA	
ENSG00000197927	C2orf27A	NA	
ENSG00000288031	AC093838.2	NA	
ENSG00000213222	TOMM40P4	NA	
ENSG00000287071	AC093724.1	NA	
ENSG00000186825	C2orf27B	NA	
ENSG00000274353	AC103564.3	NA	
ENSG00000229203	AC103564.1	NA	
ENSG00000232760	AC103564.2	NA	
ENSG00000244337	AJ239322.2	NA	
ENSG00000235615	AJ239322.1	NA	
ENSG00000236485	LINC01945	NA	
ENSG00000287414	AC093787.2	NA	
ENSG00000226886	AC093787.1	NA	
ENSG00000271179	AC098826.3	NA	
ENSG00000225594	AC098826.1	NA	
ENSG00000227745	AC098826.2	NA	
ENSG00000163046	ANKRD30BL	NA	
ENSG00000239108	RNU6-1132P	NA	
ENSG00000202174	RNA5-8SP5	NA	
ENSG00000221288	MIR663B	NA	
ENSG00000233786	CDC27P1	NA	
ENSG00000230803	AC097532.1	NA	
ENSG00000018607	ZNF806	NA	
ENSG00000272769	AC097532.2	NA	
ENSG00000286833	AC097532.3	NA	
ENSG00000230992	FAM201B	NA	
ENSG00000252705	RNU6-175P	NA	
ENSG00000183840	GPR39	NA	
ENSG00000232349	YBX1P7	NA	
ENSG00000200718	RN7SKP103	NA	
ENSG00000150551	LYPD1	NA	
ENSG00000230065	AC010974.1	NA	
ENSG00000176771	NCKAP5	NA	
ENSG00000286068	AC010974.2	NA	
ENSG00000228721	AC016909.1	NA	
ENSG00000233729	NCKAP5-AS1	NA	
ENSG00000279512	AC011755.1	NA	
ENSG00000226953	NCKAP5-AS2	NA	
ENSG00000252688	RNU6-579P	NA	
ENSG00000222068	RN7SKP154	NA	
ENSG00000232474	NCKAP5-IT1	NA	
ENSG00000223430	AC011243.1	NA	
ENSG00000200708	RN7SKP93	NA	
ENSG00000286697	AC092623.1	NA	
ENSG00000152127	MGAT5	NA	
ENSG00000263813	MIR3679	NA	
ENSG00000222921	RNA5SP104	NA	
ENSG00000234060	EDDM3CP	NA	
ENSG00000152128	TMEM163	NA	
ENSG00000287463	AC110620.2	NA	
ENSG00000224043	CCNT2-AS1	NA	
ENSG00000234682	VDAC2P4	NA	
ENSG00000228098	AC110620.1	NA	
ENSG00000153086	ACMSD	NA	
ENSG00000263783	MIR5590	NA	
ENSG00000082258	CCNT2	NA	
ENSG00000176601	MAP3K19	NA	
ENSG00000115839	RAB3GAP1	600118	WARBURG MICRO SYNDROME 1; WARBM1;;MICRO SYNDROME
ENSG00000208308	SNORA40B	NA	
ENSG00000121988	ZRANB3	NA	
ENSG00000235651	G3BP1P1	NA	
ENSG00000048991	R3HDM1	NA	
ENSG00000201308	RNU6-512P	NA	
ENSG00000207654	MIR128-1	NA	
ENSG00000144224	UBXN4	NA	
ENSG00000115850	LCT	223000	LACTASE DEFICIENCY, CONGENITAL;;ALACTASIA, CONGENITAL;;DISACCHARIDE INTOLERANCE II
ENSG00000200664	Y_RNA	NA	
ENSG00000226806	LCT-AS1	NA	
ENSG00000076003	MCM6	223100	LACTOSE INTOLERANCE, ADULT TYPE;;HYPOLACTASIA, ADULT TYPE;;ADULT LACTASE DEFICIENCY;;DISACCHARIDE INTOLERANCE III LACTASE PERSISTENCE, INCLUDED
ENSG00000214070	MANEALP1	NA	
ENSG00000115866	DARS1	615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY
ENSG00000231890	DARS-AS1	NA	
ENSG00000237262	AC068492.1	NA	
ENSG00000121966	CXCR4	193670	WHIM SYNDROME; WHIMS;;WARTS, HYPOGAMMAGLOBULINEMIA, INFECTIONS, AND MYELOKATHEXIS SYNDROME
ENSG00000227347	HNRNPKP2	NA	
ENSG00000279024	AC112255.1	NA	
ENSG00000230037	UBBP1	NA	
ENSG00000251976	RN7SKP141	NA	
ENSG00000229568	SMC4P1	NA	
ENSG00000144229	THSD7B	NA	
ENSG00000212425	RNA5SP105	NA	
ENSG00000222394	Y_RNA	NA	
ENSG00000150540	HNMT	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000150540	HNMT	616739	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51; MRT51
ENSG00000224231	LINC01832	NA	
ENSG00000233045	RPL15P5	NA	
ENSG00000234645	YWHAEP5	NA	
ENSG00000237939	IDI1P1	NA	
ENSG00000232915	RNF14P1	NA	
ENSG00000228043	AC114763.1	NA	
ENSG00000230569	AC114763.2	NA	
ENSG00000144228	SPOPL	NA	
ENSG00000241772	AC092620.1	NA	
ENSG00000260059	AC092620.2	NA	
ENSG00000237772	LINC02631	NA	
ENSG00000144227	NXPH2	NA	
ENSG00000222826	RN7SKP286	NA	
ENSG00000229104	YY1P2	NA	
ENSG00000232992	AHCYP4	NA	
ENSG00000287147	AC023468.1	NA	
ENSG00000286778	AC013265.1	NA	
ENSG00000226939	AC062021.1	NA	
ENSG00000229131	AC016710.1	NA	
ENSG00000206901	SNORA72	NA	
ENSG00000235232	MRPS18BP2	NA	
ENSG00000228374	RPL9P13	NA	
ENSG00000223554	AC078851.1	NA	
ENSG00000240977	RN7SL283P	NA	
ENSG00000224028	LINC01853	NA	
ENSG00000227149	MTCO1P44	NA	
ENSG00000231567	MTND2P19	NA	
ENSG00000223921	MTND1P27	NA	
ENSG00000168702	LRP1B	NA	
ENSG00000277306	AC092156.1	NA	
ENSG00000283506	MIR7157	NA	
ENSG00000236440	COPRSP1	NA	
ENSG00000238065	LRRC57P1	NA	
ENSG00000201892	Y_RNA	NA	
ENSG00000252015	RNU6-904P	NA	
ENSG00000233329	RPS16P3	NA	
ENSG00000244125	AC078882.1	NA	
ENSG00000228134	UBE2V1P14	NA	
ENSG00000229781	RRN3P4	NA	
ENSG00000115919	KYNU	236800	HYDROXYKYNURENINURIA;;XANTHURENIC ACIDURIA;;KYNURENINASE DEFICIENCY, PARTIAL
ENSG00000115919	KYNU	617661	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2;;CONGENITAL NAD DEFICIENCY DISORDER 2;;KYNURENINASE DEFICIENCY, COMPLETE
ENSG00000270390	SFXN4P1	NA	
ENSG00000075884	ARHGAP15	NA	
ENSG00000224288	MTCYBP11	NA	
ENSG00000226839	MTND6P11	NA	
ENSG00000224852	MTND5P24	NA	
ENSG00000232772	MTND4P22	NA	
ENSG00000236300	MTND4LP12	NA	
ENSG00000227557	MTND3P9	NA	
ENSG00000225476	MTCO3P5	NA	
ENSG00000284167	MTATP6P5	NA	
ENSG00000231766	MTCO2P5	NA	
ENSG00000257284	AC013437.1	NA	
ENSG00000228655	AC079793.1	NA	
ENSG00000283994	AC092652.2	NA	
ENSG00000231758	ARHGAP15-AS1	NA	
ENSG00000257277	AC092652.1	NA	
ENSG00000257226	AC079584.2	NA	
ENSG00000236356	AC079584.1	NA	
ENSG00000200287	Y_RNA	NA	
ENSG00000232377	AC016910.1	NA	
ENSG00000121964	GTDC1	NA	
ENSG00000169554	ZEB2	235730	MOWAT-WILSON SYNDROME; MOWS;;MICROCEPHALY, MENTAL RETARDATION, AND DISTINCT FACIAL FEATURES, WITH OR WITHOUT HIRSCHSPRUNG DISEASE;;HIRSCHSPRUNG DISEASE-MENTAL RETARDATION SYNDROME
ENSG00000283118	AC009951.5	NA	
ENSG00000279166	AC009951.4	NA	
ENSG00000238057	ZEB2-AS1	NA	
ENSG00000275372	AC009951.2	NA	
ENSG00000273537	AC009951.1	NA	
ENSG00000277444	AC009951.3	NA	
ENSG00000287115	AC009951.6	NA	
ENSG00000232606	LINC01412	NA	
ENSG00000226674	TEX41	NA	
ENSG00000234940	AC023128.1	NA	
ENSG00000276706	AC023128.2	NA	
ENSG00000235352	SGCEP1	NA	
ENSG00000268580	LINC01966	NA	
ENSG00000235435	AC096666.1	NA	
ENSG00000214064	RPL6P5	NA	
ENSG00000225107	AC092484.1	NA	
ENSG00000286225	AC079163.2	NA	
ENSG00000226218	AC079163.1	NA	
ENSG00000234119	METAP2P1	NA	
ENSG00000233842	AC079248.1	NA	
ENSG00000279876	AC079248.2	NA	
ENSG00000251905	RNU7-2P	NA	
ENSG00000230559	RPL17P12	NA	
ENSG00000227134	OTX2P2	NA	
ENSG00000198526	PABPC1P2	NA	
ENSG00000271583	AC103881.1	NA	
ENSG00000231040	LINC01911	NA	
ENSG00000227902	AC062032.1	NA	
ENSG00000287847	AC018678.1	NA	
ENSG00000207225	RNU6-692P	NA	
ENSG00000207161	Y_RNA	NA	
ENSG00000202074	RNU6-715P	NA	
ENSG00000253083	RNA5SP106	NA	
ENSG00000229143	AC009480.2	NA	
ENSG00000121989	ACVR2A	NA	
ENSG00000212389	RNU6-1275P	NA	
ENSG00000223911	AC009480.1	NA	
ENSG00000115947	ORC4	613800	MEIER-GORLIN SYNDROME 2; MGORS2
ENSG00000204406	MBD5	156200	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1 CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED
ENSG00000281469	AC019226.1	NA	
ENSG00000281772	AC019226.2	NA	
ENSG00000212181	AC019070.1	NA	
ENSG00000224007	USP12P2	NA	
ENSG00000232238	RPS29P8	NA	
ENSG00000135999	EPC2	NA	
ENSG00000222126	RNU2-9P	NA	
ENSG00000223962	UBBP3	NA	
ENSG00000231079	KIF5C-AS1	NA	
ENSG00000228848	RPS20P13	NA	
ENSG00000226340	USP8P2	NA	
ENSG00000168280	KIF5C	615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2
ENSG00000286167	AC105402.1	NA	
ENSG00000150556	LYPD6B	NA	
ENSG00000228236	TXNP5	NA	
ENSG00000286335	AC009230.1	NA	
ENSG00000224337	FAM8A3P	NA	
ENSG00000187123	LYPD6	NA	
ENSG00000223604	RPL17P13	NA	
ENSG00000168288	MMADHC	277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD;;METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblD TYPE;;METHYLMALONIC ACIDURIA, cblH TYPE, FORMERLY;;METHYLMALONIC ACIDEMIA, cblH TYPE, FORMERLY HOMOCYSTINURIA, cblD TYPE, VARIANT 1, INCLUDE /.../HYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2, INCLUDED
ENSG00000231969	MMADHC-DT	NA	
ENSG00000207270	RNU6-601P	NA	
ENSG00000162947	LINC01931	NA	
ENSG00000286081	AC016682.1	NA	
ENSG00000230645	LINC01818	NA	
ENSG00000231420	LINC01817	NA	
ENSG00000115963	RND3	NA	
ENSG00000236049	LINC01920	NA	
ENSG00000237220	AC104777.2	NA	
ENSG00000232359	AC104777.1	NA	
ENSG00000224048	LINC02612	NA	
ENSG00000228064	AC023469.2	NA	
ENSG00000222031	AC023469.1	NA	
ENSG00000236885	AC018731.1	NA	
ENSG00000213201	FABP5P10	NA	
ENSG00000184898	RBM43	NA	
ENSG00000123609	NMI	NA	
ENSG00000123610	TNFAIP6	NA	
ENSG00000283569	MIR4773-2	NA	
ENSG00000264684	MIR4773-1	NA	
ENSG00000242113	RN7SL124P	NA	
ENSG00000080345	RIF1	NA	
ENSG00000183091	NEB	256030	NEMALINE MYOPATHY 2; NEM2
ENSG00000162980	ARL5A	NA	
ENSG00000288066	AC097448.1	NA	
ENSG00000283228	AC068547.1	NA	
ENSG00000182389	CACNB4	607682	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6, INCLUDED
ENSG00000182389	CACNB4	613855	EPISODIC ATAXIA, TYPE 5; EA5
ENSG00000225214	AC079790.1	NA	
ENSG00000115145	STAM2	NA	
ENSG00000234272	RPL30P2	NA	
ENSG00000286234	AC079790.2	NA	
ENSG00000199884	Y_RNA	NA	
ENSG00000157827	FMNL2	NA	
ENSG00000213197	NUDCP1	NA	
ENSG00000287085	AC012066.1	NA	
ENSG00000270776	AC012443.1	NA	
ENSG00000286207	AC012443.2	NA	
ENSG00000196504	PRPF40A	NA	
ENSG00000177917	ARL6IP6	NA	
ENSG00000234932	AC009969.1	NA	
ENSG00000226213	UBQLN4P2	NA	
ENSG00000214025	ATP5PBP4	NA	
ENSG00000224612	AC011901.1	NA	
ENSG00000226338	AC079150.1	NA	
ENSG00000227708	LINC01850	NA	
ENSG00000214024	RPL23AP29	NA	
ENSG00000242575	AC012501.3	NA	
ENSG00000227400	AC012501.2	NA	
ENSG00000200377	AC012501.1	NA	
ENSG00000177519	RPRM	NA	
ENSG00000236917	DNAJA1P2	NA	
ENSG00000144278	GALNT13	NA	
ENSG00000230251	PHBP4	NA	
ENSG00000224675	AC009227.1	NA	
ENSG00000238004	AC009227.2	NA	
ENSG00000223290	RNA5SP107	NA	
ENSG00000287900	AC061961.1	NA	
ENSG00000162989	KCNJ3	NA	
ENSG00000228837	CBX3P6	NA	
ENSG00000230991	AC092625.1	NA	
ENSG00000223197	RNU6-1001P	NA	
ENSG00000232982	MTCO1P45	NA	
ENSG00000229701	MTND2P20	NA	
ENSG00000227682	ATP5F1AP2	NA	
ENSG00000233709	MTND4P28	NA	
ENSG00000233039	MTND5P30	NA	
ENSG00000233248	MTND6P9	NA	
ENSG00000229935	MTCYBP9	NA	
ENSG00000206718	RNU6-546P	NA	
ENSG00000286679	AC073225.1	NA	
ENSG00000226383	LINC01876	NA	
ENSG00000235548	HEBP2P1	NA	
ENSG00000282440	AC074099.1	NA	
ENSG00000153234	NR4A2	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000115159	GPD2	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000283436	LINC01958	NA	
ENSG00000238069	RPLP0P7	NA	
ENSG00000287048	AC096589.2	NA	
ENSG00000286889	AC096589.1	NA	
ENSG00000286530	AC108057.1	NA	
ENSG00000213194	CDK7P1	NA	
ENSG00000136542	GALNT5	NA	
ENSG00000222404	RN7SKP281	NA	
ENSG00000136541	ERMN	NA	
ENSG00000230562	FAM133DP	NA	
ENSG00000115165	CYTIP	NA	
ENSG00000123612	ACVR1C	NA	
ENSG00000234584	AC019186.1	NA	
ENSG00000115170	ACVR1	135100	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP
ENSG00000007001	UPP2	NA	
ENSG00000270557	AC013731.1	NA	
ENSG00000251980	RNU6-436P	NA	
ENSG00000271320	AC091488.1	NA	
ENSG00000228937	MTA3P1	NA	
ENSG00000212410	RNU6-932P	NA	
ENSG00000231158	PTP4A1P1	NA	
ENSG00000237327	UPP2-IT1	NA	
ENSG00000227480	CCDC148-AS1	NA	
ENSG00000153237	CCDC148	NA	
ENSG00000234890	HNRNPDLP2	NA	
ENSG00000243723	RN7SL393P	NA	
ENSG00000144283	PKP4	NA	
ENSG00000227331	RPL7AP22	NA	
ENSG00000204380	PKP4-AS1	NA	
ENSG00000228586	AC005042.1	NA	
ENSG00000231675	AC005042.2	NA	
ENSG00000163331	DAPL1	NA	
ENSG00000286621	AC064843.1	NA	
ENSG00000243792	OR7E89P	NA	
ENSG00000251491	OR7E28P	NA	
ENSG00000188668	OR7E90P	NA	
ENSG00000222300	RNU2-21P	NA	
ENSG00000115183	TANC1	NA	
ENSG00000213189	BTF3L4P2	NA	
ENSG00000202029	RNU6-580P	NA	
ENSG00000226878	GSTM3P2	NA	
ENSG00000275141	MIR6888	NA	
ENSG00000196151	WDSUB1	NA	
ENSG00000123636	BAZ2B	NA	
ENSG00000223642	AC008277.1	NA	
ENSG00000270893	AC008277.2	NA	
ENSG00000225369	CAPZA1P2	NA	
ENSG00000207117	Y_RNA	NA	
ENSG00000224152	AC009506.1	NA	
ENSG00000226266	AC009961.1	NA	
ENSG00000230783	RPS3AP13	NA	
ENSG00000136536	MARCHF7	NA	
ENSG00000241399	CD302	NA	
ENSG00000248672	LY75-CD302	NA	
ENSG00000287091	AC009961.3	NA	
ENSG00000054219	LY75	NA	
ENSG00000227055	AC009961.2	NA	
ENSG00000153246	PLA2R1	NA	
ENSG00000115221	ITGB6	616221	AMELOGENESIS IMPERFECTA, TYPE IH; AI1H
ENSG00000285155	AC092153.1	NA	
ENSG00000285373	LINC02478	NA	
ENSG00000153250	RBMS1	NA	
ENSG00000283734	MIR4785	NA	
ENSG00000279844	AC096656.1	NA	
ENSG00000244372	RN7SL423P	NA	
ENSG00000232337	AC009313.2	NA	
ENSG00000224467	AC009313.1	NA	
ENSG00000136560	TANK	NA	
ENSG00000235724	AC009299.2	NA	
ENSG00000227403	LINC01806	NA	
ENSG00000225813	AC009299.1	NA	
ENSG00000115233	PSMD14	NA	
ENSG00000232320	MXRA7P1	NA	
ENSG00000271924	RNA5SP108	NA	
ENSG00000136535	TBR1	606053	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS;;PHRASE SPEECH DELAY, AUTISM-RELATED;;AUTISM-RELATED SPEECH DELAY;;AUTISM, SUSCEPTIBILITY TO, 5, FORMERLY; AUTS5, FORMERLY
ENSG00000224076	AC009487.1	NA	
ENSG00000251621	AC009487.2	NA	
ENSG00000144290	SLC4A10	NA	
ENSG00000280105	AC009487.3	NA	
ENSG00000226121	AHCTF1P1	NA	
ENSG00000238570	AC092654.1	NA	
ENSG00000226946	AC062022.1	NA	
ENSG00000288091	AC062022.2	NA	
ENSG00000235716	KRT18P46	NA	
ENSG00000234732	RPEP5	NA	
ENSG00000197635	DPP4	NA	
ENSG00000230918	DPP4-DT	NA	
ENSG00000231445	TIMM8AP1	NA	
ENSG00000224674	EIF3EP2	NA	
ENSG00000233397	AC008063.1	NA	
ENSG00000115263	GCG	NA	
ENSG00000236841	AC007750.1	NA	
ENSG00000078098	FAP	NA	
ENSG00000115267	IFIH1	182250	SINGLETON-MERTEN SYNDROME 1; SGMRT1
ENSG00000115267	IFIH1	615846	AICARDI-GOUTIERES SYNDROME 7; AGS7
ENSG00000115271	GCA	NA	
ENSG00000184611	KCNH7	NA	
ENSG00000212312	RNA5SP109	NA	
ENSG00000237750	KCNH7-AS1	NA	
ENSG00000230282	RPL7P61	NA	
ENSG00000200902	RNU6-627P	NA	
ENSG00000182263	FIGN	NA	
ENSG00000237844	AC016766.1	NA	
ENSG00000226847	PRPS1P1	NA	
ENSG00000229641	CYP2C56P	NA	
ENSG00000115290	GRB14	NA	
ENSG00000277998	AC107075.1	NA	
ENSG00000082438	COBLL1	NA	
ENSG00000224331	AC019181.1	NA	
ENSG00000206869	SNORA70F	NA	
ENSG00000236283	AC019197.1	NA	
ENSG00000199508	RNA5SP110	NA	
ENSG00000223318	RNA5SP111	NA	
ENSG00000169507	SLC38A11	NA	
ENSG00000153253	SCN3A	617935	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4
ENSG00000153253	SCN3A	617938	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62
ENSG00000136531	SCN2A	607745	SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 3; BFIC3;;SEIZURES, BENIGN FAMILIAL NEONATAL-INFANTILE; BFNIS
ENSG00000136531	SCN2A	613721	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11
ENSG00000233204	MAPRE1P3	NA	
ENSG00000288089	AC011303.1	NA	
ENSG00000178662	CSRNP3	NA	
ENSG00000115339	GALNT3	211900	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1;;TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL; HFTC;;CALCINOSIS, TUMORAL, WITH HYPERPHOSPHATEMIA;;TUMORAL CALCINOSIS, PRIMARY HYPERPHOSPHATEMIC; PHPTC;;LIPOCALCINOGRANULOMATOSIS;;TEUTSCHLA /.../DISEASE, FAMILIAL;;MORBUS TEUTSCHLAENDER;;HYPEROSTOSIS-HYPERPHOSPHATEMIA SYNDROME; HHS;;HYPEROSTOSIS WITH HYPERPHOSPHATEMIA;;CORTICAL HYPEROSTOSIS WITH HYPERPHOSPHATEMIA
ENSG00000235192	AC009495.3	NA	
ENSG00000229195	AC009495.1	NA	
ENSG00000232411	AC009495.2	NA	
ENSG00000123607	TTC21B	613819	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4;;ASPHYXIATING THORACIC DYSTROPHY 4; ATD4
ENSG00000123607	TTC21B	613820	NEPHRONOPHTHISIS 12; NPHP12 JOUBERT SYNDROME 11, INCLUDED; JBTS11, INCLUDED
ENSG00000224490	TTC21B-AS1	NA	
ENSG00000236107	SCN1A-AS1	NA	
ENSG00000144285	SCN1A	604403	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2  FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED
ENSG00000144285	SCN1A	607208	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;DRAVET SYNDROME;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI
ENSG00000144285	SCN1A	609634	MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3
ENSG00000238813	AC010127.1	NA	
ENSG00000222376	RN7SKP152	NA	
ENSG00000169432	SCN9A	167400	PAROXYSMAL EXTREME PAIN DISORDER;;PEXPD; PEPD;;PAIN, SUBMANDIBULAR, OCULAR, AND RECTAL, WITH FLUSHING;;RECTAL PAIN, FAMILIAL
ENSG00000169432	SCN9A	133020	ERYTHERMALGIA, PRIMARY;;ERYTHROMELALGIA, PRIMARY;;ERYTHROMELALGIA, FAMILIAL NEUROPATHY, SMALL FIBER, INCLUDED; SFNP, INCLUDED
ENSG00000169432	SCN9A	201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A;;HSAN IIA;;NEUROPATHY, HEREDITARY SENSORY, TYPE IIA; HSN2A;;HSN IIA;;ACROOSTEOLYSIS, NEUROGENIC;;ACROOSTEOLYSIS, GIACCAI TYPE;;NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL RECESSI /.../RVAN DISEASE;;NEUROPATHY, PROGRESSIVE SENSORY, OF CHILDREN;;NEUROPATHY, CONGENITAL SENSORY
ENSG00000169432	SCN9A	243000	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP;;INSENSITIVITY TO PAIN, CHANNELOPATHY-ASSOCIATED;;CONGENITAL ANALGESIA, AUTOSOMAL RECESSIVE;;ASYMBOLIA FOR PAIN NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IID, INCLUDED; HSAN2D, INCLUDED
ENSG00000169432	SCN9A	607208	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;DRAVET SYNDROME;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI
ENSG00000169432	SCN9A	613863	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7 FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED
ENSG00000136546	SCN7A	NA	
ENSG00000283657	AC074101.1	NA	
ENSG00000163092	XIRP2	NA	
ENSG00000225182	AC092601.1	NA	
ENSG00000254552	XIRP2-AS1	NA	
ENSG00000228222	AC073050.1	NA	
ENSG00000238357	RNU7-148P	NA	
ENSG00000214211	CTAGE14P	NA	
ENSG00000235335	B3GALT1-AS1	NA	
ENSG00000172318	B3GALT1	NA	
ENSG00000198648	STK39	NA	
ENSG00000238259	PHF5GP	NA	
ENSG00000241074	RN7SL813P	NA	
ENSG00000172292	CERS6	NA	
ENSG00000265694	MIR4774	NA	
ENSG00000199348	RNU6-766P	NA	
ENSG00000227617	CERS6-AS1	NA	
ENSG00000163072	NOSTRIN	NA	
ENSG00000152253	SPC25	NA	
ENSG00000152254	G6PC2	NA	
ENSG00000073734	ABCB11	601847	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2
ENSG00000073734	ABCB11	605479	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2
ENSG00000073737	DHRS9	NA	
ENSG00000235321	AC007556.1	NA	
ENSG00000235995	UBE2V1P6	NA	
ENSG00000081479	LRP2	222448	DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM, MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA
ENSG00000251569	AC093899.2	NA	
ENSG00000163093	BBS5	615983	BARDET-BIEDL SYNDROME 5; BBS5
ENSG00000239474	KLHL41	615731	NEMALINE MYOPATHY 9; NEM9
ENSG00000138399	FASTKD1	NA	
ENSG00000229827	AC093899.1	NA	
ENSG00000138398	PPIG	NA	
ENSG00000154479	CCDC173	NA	
ENSG00000226072	AC016772.1	NA	
ENSG00000144362	PHOSPHO2	NA	
ENSG00000213160	KLHL23	NA	
ENSG00000206961	AC009967.1	NA	
ENSG00000231550	PTCHD3P2	NA	
ENSG00000214369	CYB5AP2	NA	
ENSG00000138385	SSB	NA	
ENSG00000138382	METTL5	618665	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72; MRT72;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 72
ENSG00000144357	UBR3	NA	
ENSG00000227176	NSA2P5	NA	
ENSG00000252807	RNU6-1006P	NA	
ENSG00000071909	MYO3B	NA	
ENSG00000231898	MYO3B-AS1	NA	
ENSG00000214821	HMGB1P4	NA	
ENSG00000213981	AC007277.1	NA	
ENSG00000275414	AC007277.2	NA	
ENSG00000234350	AC007405.1	NA	
ENSG00000222033	LINC01124	NA	
ENSG00000204335	SP5	NA	
ENSG00000128692	EIF2S2P4	NA	
ENSG00000239467	AC007405.3	NA	
ENSG00000222509	Y_RNA	NA	
ENSG00000204334	ERICH2	NA	
ENSG00000128683	GAD1	603513	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1
ENSG00000235934	AC007405.2	NA	
ENSG00000286611	AC007405.4	NA	
ENSG00000286115	AC010092.1	NA	
ENSG00000115806	GORASP2	NA	
ENSG00000198586	TLK1	NA	
ENSG00000123600	METTL8	NA	
ENSG00000224553	RPS26P20	NA	
ENSG00000115827	DCAF17	241080	WOODHOUSE-SAKATI SYNDROME; WDSKS;;HYPOGONADISM, ALOPECIA, DIABETES MELLITUS, MENTAL RETARDATION, DEAFNESS, AND EXTRAPYRAMIDAL SYNDROME;;EXTRAPYRAMIDAL DISORDER, PROGRESSIVE, WITH PRIMARY HYPOGONADISM, MENTAL RETARDATION, AND ALOPECIA
ENSG00000228507	DAP3P2	NA	
ENSG00000234061	AC007969.1	NA	
ENSG00000233762	RPS15P4	NA	
ENSG00000071967	CYBRD1	NA	
ENSG00000233934	RPL21P38	NA	
ENSG00000077380	DYNC1I2	618492	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA
ENSG00000115840	SLC25A12	612949	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39; EIEE39;;HYPOMYELINATION, GLOBAL CEREBRAL;;ASPARTATE-GLUTAMATE CARRIER 1 DEFICIENCY;;AGC1 DEFICIENCY
ENSG00000252779	RNU6-182P	NA	
ENSG00000128708	HAT1	NA	
ENSG00000172878	METAP1D	NA	
ENSG00000144355	DLX1	NA	
ENSG00000115844	DLX2	NA	
ENSG00000236651	DLX2-DT	NA	
ENSG00000232555	AC104088.1	NA	
ENSG00000288048	AC104088.3	NA	
ENSG00000286557	AC104088.2	NA	
ENSG00000278924	AC078883.3	NA	
ENSG00000091409	ITGA6	226730	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIA CUTI /.../ENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA
ENSG00000226963	AC078883.2	NA	
ENSG00000232788	ITGA6-AS1	NA	
ENSG00000225205	AC078883.1	NA	
ENSG00000152256	PDK1	NA	
ENSG00000199866	Y_RNA	NA	
ENSG00000230104	AC018712.1	NA	
ENSG00000228016	RAPGEF4-AS1	NA	
ENSG00000239041	AC018712.2	NA	
ENSG00000091428	RAPGEF4	NA	
ENSG00000232292	ALDH7A1P2	NA	
ENSG00000091436	MAP3K20	616890	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP
ENSG00000091436	MAP3K20	617760	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6
ENSG00000238133	MAP3K20-AS1	NA	
ENSG00000231735	RPS2P18	NA	
ENSG00000236391	AC092573.1	NA	
ENSG00000144354	CDCA7	616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3
ENSG00000213148	JPT1P1	NA	
ENSG00000236832	CBY1P1	NA	
ENSG00000226131	PPIAP66	NA	
ENSG00000237016	AC013410.1	NA	
ENSG00000237617	AC013410.2	NA	
ENSG00000270460	AC106900.1	NA	
ENSG00000234415	RPL5P7	NA	
ENSG00000172845	SP3	NA	
ENSG00000271151	AC016737.1	NA	
ENSG00000273258	AC016737.2	NA	
ENSG00000260868	LINC01960	NA	
ENSG00000235414	RPSAP24	NA	
ENSG00000138430	OLA1	NA	
ENSG00000270799	AC013467.1	NA	
ENSG00000243770	RN7SL65P	NA	
ENSG00000201088	Y_RNA	NA	
ENSG00000227180	LRRC2P1	NA	
ENSG00000237804	HNRNPA1P39	NA	
ENSG00000231453	LINC01305	NA	
ENSG00000280414	AC018470.1	NA	
ENSG00000217236	SP9	NA	
ENSG00000138433	CIR1	NA	
ENSG00000144306	SCRN3	NA	
ENSG00000163328	GPR155	NA	
ENSG00000226853	AC010894.1	NA	
ENSG00000179997	RPA3P1	NA	
ENSG00000279884	AC010894.4	NA	
ENSG00000236449	AC010894.2	NA	
ENSG00000206965	RNU6-5P	NA	
ENSG00000115935	WIPF1	614493	WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY
ENSG00000237798	AC010894.3	NA	
ENSG00000235655	H3P6	NA	
ENSG00000138435	CHRNA1	253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE
ENSG00000138435	CHRNA1	601462	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa, FORMERLY; CMS2A, FORMERLY;;CMS IIa, FORMERLY
ENSG00000138435	CHRNA1	608930	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B
ENSG00000128656	CHN1	604356	DUANE RETRACTION SYNDROME 2; DURS2
ENSG00000212167	RNU6-763P	NA	
ENSG00000199827	RNU6-1290P	NA	
ENSG00000227187	RPL21P31	NA	
ENSG00000115966	ATF2	NA	
ENSG00000277948	AC007435.1	NA	
ENSG00000215973	MIR933	NA	
ENSG00000229750	AC096649.1	NA	
ENSG00000154518	ATP5MC3	NA	
ENSG00000200121	Y_RNA	NA	
ENSG00000233131	RPS15AP14	NA	
ENSG00000229066	AC093459.1	NA	
ENSG00000223976	EXTL2P1	NA	
ENSG00000235047	AC016751.2	NA	
ENSG00000229779	AC016751.1	NA	
ENSG00000144320	LNPK	618090	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC
ENSG00000174279	EVX2	NA	
ENSG00000128714	HOXD13	186300	SYNDACTYLY, TYPE V; SDTY5;;SYNDACTYLY WITH METACARPAL AND METATARSAL FUSION
ENSG00000128714	HOXD13	186000	SYNPOLYDACTYLY 1; SPD1;;SYNDACTYLY, TYPE II; SDTY2
ENSG00000128714	HOXD13	113300	BRACHYDACTYLY, TYPE E1; BDE1;;BRACHYDACTYLY, TYPE E; BDE
ENSG00000128714	HOXD13	113200	BRACHYDACTYLY, TYPE D; BDD;;STUB THUMB
ENSG00000128714	HOXD13	610713	BRACHYDACTYLY-SYNDACTYLY SYNDROME; BDSD BRACHYDACTYLY-SYNDACTYLY-OLIGODACTYLY SYNDROME, INCLUDED; BDSDO, INCLUDED
ENSG00000170178	HOXD12	NA	
ENSG00000128713	HOXD11	NA	
ENSG00000128710	HOXD10	192950	VERTICAL TALUS, CONGENITAL; CVT;;ROCKER-BOTTOM FOOT;;PES VALGUS, CONGENITAL CONVEX
ENSG00000237380	HOXD-AS2	NA	
ENSG00000128709	HOXD9	NA	
ENSG00000175879	HOXD8	NA	
ENSG00000128652	HOXD3	NA	
ENSG00000207744	MIR10B	NA	
ENSG00000170166	HOXD4	NA	
ENSG00000224189	HAGLR	NA	
ENSG00000272729	AC009336.1	NA	
ENSG00000226363	HAGLROS	NA	
ENSG00000128645	HOXD1	NA	
ENSG00000283880	MIR7704	NA	
ENSG00000279160	AC009336.2	NA	
ENSG00000218175	AC016739.1	NA	
ENSG00000230384	RPSAP25	NA	
ENSG00000128654	MTX2	NA	
ENSG00000237260	PPIAP67	NA	
ENSG00000224577	LINC01117	NA	
ENSG00000229434	AC017048.1	NA	
ENSG00000236231	AC017048.2	NA	
ENSG00000283203	MIR1246	NA	
ENSG00000272551	AC017048.3	NA	
ENSG00000163364	LINC01116	NA	
ENSG00000252027	RNU6ATAC14P	NA	
ENSG00000230552	AC092162.2	NA	
ENSG00000237053	FUCA1P1	NA	
ENSG00000223777	AC092162.1	NA	
ENSG00000279205	AC092162.3	NA	
ENSG00000227098	AC073636.1	NA	
ENSG00000206866	RNU6-187P	NA	
ENSG00000236501	AC074286.1	NA	
ENSG00000229337	AC079305.2	NA	
ENSG00000251746	RNA5SP112	NA	
ENSG00000226273	STUB1P1	NA	
ENSG00000201102	Y_RNA	NA	
ENSG00000213069	KRT8P40	NA	
ENSG00000170144	HNRNPA3	NA	
ENSG00000284252	MIR4444-1	NA	
ENSG00000116044	NFE2L2	617744	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH
ENSG00000225808	DNAJC19P5	NA	
ENSG00000265396	MIR3128	NA	
ENSG00000222043	AC079305.1	NA	
ENSG00000213963	AC019080.1	NA	
ENSG00000271825	AC019080.3	NA	
ENSG00000271996	AC019080.4	NA	
ENSG00000278418	MIR6512	NA	
ENSG00000280374	AC019080.5	NA	
ENSG00000237178	H3P7	NA	
ENSG00000238295	AC019080.2	NA	
ENSG00000018510	AGPS	600121	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3;;ALKYLDIHYDROXYACETONEPHOSPHATE SYNTHASE DEFICIENCY;;ALKYLGLYCERONE-PHOSPHATE SYNTHASE DEFICIENCY;;AGPS DEFICIENCY
ENSG00000196659	TTC30B	NA	
ENSG00000237655	AC073834.1	NA	
ENSG00000197557	TTC30A	NA	
ENSG00000128655	PDE11A	610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2;;PIGMENTED MICRONODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2;;CUSHING SYNDROME, ADRENAL, DUE TO PPNAD2
ENSG00000284741	PDE11A	610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2;;PIGMENTED MICRONODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2;;CUSHING SYNDROME, ADRENAL, DUE TO PPNAD2
ENSG00000229941	PDE11A-AS1	NA	
ENSG00000236664	AC011998.2	NA	
ENSG00000213962	API5P2	NA	
ENSG00000229744	SDHDP5	NA	
ENSG00000206788	RNU6-629P	NA	
ENSG00000249909	CYCTP	NA	
ENSG00000227241	AC011998.1	NA	
ENSG00000155636	RBM45	NA	
ENSG00000223096	RNU5E-9P	NA	
ENSG00000079156	OSBPL6	NA	
ENSG00000223960	CHROMR	NA	
ENSG00000180228	PRKRA	612067	DYSTONIA 16; DYT16
ENSG00000204311	PJVK	610220	DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59
ENSG00000238082	NUDCP2	NA	
ENSG00000079150	FKBP7	NA	
ENSG00000116095	PLEKHA3	NA	
ENSG00000237298	TTN-AS1	NA	
ENSG00000155657	TTN	600334	TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD;;TARDIVE TIBIAL MUSCULAR DYSTROPHY;;UDD MYOPATHY
ENSG00000155657	TTN	603689	MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9;;HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF;;MYOPATHY, PROXIMAL, WITH EARLY RESPIRATORY MUSCLE INVOLVEMENT; MPRM;;EDSTROM MYOPATHY;;MYOPATHY, DISTAL, WITH EARLY RESPIRATO /.../LURE, AUTOSOMAL DOMINANT
ENSG00000155657	TTN	604145	CARDIOMYOPATHY, DILATED, 1G; CMD1G
ENSG00000155657	TTN	608807	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J
ENSG00000155657	TTN	611705	SALIH MYOPATHY; SALMY;;MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; EOMFC
ENSG00000155657	TTN	613765	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9
ENSG00000270956	AC009948.2	NA	
ENSG00000270277	AC009948.1	NA	
ENSG00000279598	AC009948.3	NA	
ENSG00000271011	AC010680.3	NA	
ENSG00000270574	AC010680.2	NA	
ENSG00000271141	AC010680.4	NA	
ENSG00000271401	AC010680.5	NA	
ENSG00000267784	AC010680.1	NA	
ENSG00000287149	AC092640.1	NA	
ENSG00000163492	CCDC141	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000238542	RNU7-104P	NA	
ENSG00000231541	RPS6P2	NA	
ENSG00000187231	SESTD1	NA	
ENSG00000237477	AC093911.1	NA	
ENSG00000237964	RAD52P1	NA	
ENSG00000144331	ZNF385B	NA	
ENSG00000213126	TXNL4AP1	NA	
ENSG00000221240	MIR1258	NA	
ENSG00000280636	AC096587.2	NA	
ENSG00000202216	AC096587.1	NA	
ENSG00000163510	CWC22	NA	
ENSG00000270289	AC012669.1	NA	
ENSG00000225258	AC009478.1	NA	
ENSG00000281131	SCHLAP1	NA	
ENSG00000279559	AC104820.1	NA	
ENSG00000226564	FTH1P20	NA	
ENSG00000236667	RPL27AP3	NA	
ENSG00000170035	UBE2E3	NA	
ENSG00000236153	AC104076.1	NA	
ENSG00000238171	AC068196.1	NA	
ENSG00000234663	LINC01934	NA	
ENSG00000266705	MIR4437	NA	
ENSG00000226681	AC020595.1	NA	
ENSG00000115232	ITGA4	NA	
ENSG00000188452	CERKL	608380	RETINITIS PIGMENTOSA 26; RP26
ENSG00000162992	NEUROD1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000162992	NEUROD1	606394	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6;;MODY, TYPE 6
ENSG00000234595	AC013733.2	NA	
ENSG00000225570	AC013733.1	NA	
ENSG00000223873	SAP18P2	NA	
ENSG00000221023	RNU6ATAC19P	NA	
ENSG00000260742	AC009962.1	NA	
ENSG00000138434	ITPRID2	NA	
ENSG00000150722	PPP1R1C	NA	
ENSG00000213958	KRT18P29	NA	
ENSG00000222418	RNA5SP113	NA	
ENSG00000115252	PDE1A	NA	
ENSG00000287536	AC012500.1	NA	
ENSG00000242121	RN7SL267P	NA	
ENSG00000077232	DNAJC10	NA	
ENSG00000232430	RPL31P15	NA	
ENSG00000212404	Y_RNA	NA	
ENSG00000162998	FRZB	165720	OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1;;OA;;OSTEOARTHROSIS;;OSTEOARTHRITIS OF HIP, FEMALE-SPECIFIC, SUSCEPTIBILITY TO
ENSG00000207178	RNU6-1122P	NA	
ENSG00000061676	NCKAP1	NA	
ENSG00000202141	Y_RNA	NA	
ENSG00000221498	AC064871.1	NA	
ENSG00000231203	KRT8P10	NA	
ENSG00000162999	DUSP19	NA	
ENSG00000224643	AC064871.2	NA	
ENSG00000163002	NUP35	NA	
ENSG00000272800	AC021851.1	NA	
ENSG00000287621	AC021851.2	NA	
ENSG00000213120	LIN28AP1	NA	
ENSG00000177855	CACYBPP2	NA	
ENSG00000286879	AC093639.3	NA	
ENSG00000234172	AC093639.1	NA	
ENSG00000286807	AC093639.2	NA	
ENSG00000286152	AC096555.1	NA	
ENSG00000286980	AC020584.1	NA	
ENSG00000266808	MIR548AE1	NA	
ENSG00000283839	AC096667.1	NA	
ENSG00000170396	ZNF804A	NA	
ENSG00000237824	RPL23AP33	NA	
ENSG00000286797	AC009315.1	NA	
ENSG00000225406	ELF2P4	NA	
ENSG00000231646	FSIP2-AS1	NA	
ENSG00000212581	U8	NA	
ENSG00000226747	FSIP2-AS2	NA	
ENSG00000188738	FSIP2	618153	SPERMATOGENIC FAILURE 34; SPGF34
ENSG00000287129	AC097500.1	NA	
ENSG00000224019	RPL21P32	NA	
ENSG00000237877	LINC01473	NA	
ENSG00000226410	AC104058.1	NA	
ENSG00000232568	RPL23AP35	NA	
ENSG00000259915	AC017071.1	NA	
ENSG00000227692	MED28P3	NA	
ENSG00000065548	ZC3H15	NA	
ENSG00000224323	DPRXP1	NA	
ENSG00000138448	ITGAV	NA	
ENSG00000227227	AC017101.1	NA	
ENSG00000144369	FAM171B	NA	
ENSG00000163012	ZSWIM2	NA	
ENSG00000226553	IMPDH1P7	NA	
ENSG00000224063	AC007319.1	NA	
ENSG00000222845	RN7SKP42	NA	
ENSG00000199626	RNU6-989P	NA	
ENSG00000064989	CALCRL	618773	LYMPHATIC MALFORMATION 8; LMPHM8
ENSG00000231739	GAPDHP59	NA	
ENSG00000003436	TFPI	NA	
ENSG00000231689	LINC01090	NA	
ENSG00000235616	ST13P2	NA	
ENSG00000213115	AC104131.1	NA	
ENSG00000200650	RNA5SP114	NA	
ENSG00000144366	GULP1	NA	
ENSG00000207951	MIR561	NA	
ENSG00000223523	AC092598.1	NA	
ENSG00000174325	DIRC1	NA	
ENSG00000168542	COL3A1	130050	EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC;;EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT; EDS4;;EDS IV;;EHLERS-DANLOS SYNDROME, ARTERIAL TYPE;;EHLERS-DANLOS SYNDROME, ECCHYMOTIC TYPE;;EHLERS-DANLOS SYNDROME, SACK-BARABAS TYPE
ENSG00000168542	COL3A1	618343	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV
ENSG00000221502	MIR1245A	NA	
ENSG00000283238	MIR1245B	NA	
ENSG00000284180	MIR3606	NA	
ENSG00000204262	COL5A2	130010	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2;;EHLERS-DANLOS SYNDROME, TYPE II, FORMERLY; EDS2, FORMERLY;;EHLERS DANLOS SYNDROME, MILD CLASSIC TYPE, FORMERLY;;EDS II, FORMERLY;;EHLERS DANLOS SYNDROME, MITIS TYPE, FORMERLY
ENSG00000228073	AC133106.1	NA	
ENSG00000264725	MIR3129	NA	
ENSG00000213601	KRT18P19	NA	
ENSG00000115368	WDR75	NA	
ENSG00000233996	KDM3AP1	NA	
ENSG00000287418	AC013439.1	NA	
ENSG00000138449	SLC40A1	606069	HEMOCHROMATOSIS, TYPE 4; HFE4;;HEMOCHROMATOSIS, AUTOSOMAL DOMINANT;;HEMOCHROMATOSIS DUE TO DEFECT IN FERROPORTIN
ENSG00000276828	AC012488.1	NA	
ENSG00000138381	ASNSD1	NA	
ENSG00000286053	ASDURF	NA	
ENSG00000286165	AC012488.2	NA	
ENSG00000151687	ANKAR	NA	
ENSG00000128694	OSGEPL1	NA	
ENSG00000253559	OSGEPL1-AS1	NA	
ENSG00000273240	AC013468.1	NA	
ENSG00000128699	ORMDL1	NA	
ENSG00000064933	PMS1	120435	LYNCH SYNDROME I;;COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1; HNPCC1;;COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1; FCC1;;COCA1 LYNCH SYNDROME II, INCLUDED
ENSG00000187699	C2orf88	NA	
ENSG00000223824	TERF1P6	NA	
ENSG00000204253	HNRNPCP2	NA	
ENSG00000213110	RNF11P1	NA	
ENSG00000138379	MSTN	614160	MUSCLE HYPERTROPHY; MSLHP
ENSG00000198130	HIBCH	250620	3-@HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD;;BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY;;HIBCH DEFICIENCY;;METHACRYLIC ACIDURIA;;METHACRYLIC ACID TOXICITY;;VALINE METABOLIC DEFECT
ENSG00000151689	INPP1	NA	
ENSG00000151690	MFSD6	NA	
ENSG00000272979	AC093388.1	NA	
ENSG00000189362	NEMP2	NA	
ENSG00000233654	AC108047.1	NA	
ENSG00000251935	RN7SKP179	NA	
ENSG00000284052	AC006460.2	NA	
ENSG00000138386	NAB1	NA	
ENSG00000228509	AC006460.1	NA	
ENSG00000235852	AC005540.1	NA	
ENSG00000115419	GLS	618328	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71;;GLUTAMINASE DEFICIENCY WITH NEONATAL EPILEPTIC ENCEPHALOPATHY
ENSG00000115419	GLS	618339	INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID
ENSG00000115419	GLS	618412	GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG;;GLUTAMINASE DEFICIENCY WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND PROGRESSIVE ATAXIA
ENSG00000115415	STAT1	613796	IMMUNODEFICIENCY 31B; IMD31B;;IMMUNODEFICIENCY 31B, MYCOBACTERIAL AND VIRAL INFECTIONS, AUTOSOMAL RECESSIVE;;STAT1 DEFICIENCY, AUTOSOMAL RECESSIVE
ENSG00000115415	STAT1	614162	IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT
ENSG00000115415	STAT1	614892	IMMUNODEFICIENCY 31A; IMD31A;;IMMUNODEFICIENCY 31A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT;;STAT1 DEFICIENCY, AUTOSOMAL DOMINANT
ENSG00000229023	RAB1AP1	NA	
ENSG00000230686	AC067945.1	NA	
ENSG00000231858	AC067945.2	NA	
ENSG00000138378	STAT4	612253	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11
ENSG00000288064	AC067945.3	NA	
ENSG00000207402	RNU6-959P	NA	
ENSG00000280083	AC079777.1	NA	
ENSG00000230611	HMGB1P27	NA	
ENSG00000227542	AC092614.1	NA	
ENSG00000128641	MYO1B	NA	
ENSG00000252130	RNU6-1045P	NA	
ENSG00000173559	NABP1	NA	
ENSG00000274845	AC114778.1	NA	
ENSG00000288582	AC098872.2	NA	
ENSG00000225884	AC098872.1	NA	
ENSG00000168497	CAVIN2	NA	
ENSG00000233766	CAVIN2-AS1	NA	
ENSG00000213946	DNAJB1P1	NA	
ENSG00000144339	TMEFF2	NA	
ENSG00000229395	AC062039.1	NA	
ENSG00000232227	AC013401.1	NA	
ENSG00000227418	PCGEM1	NA	
ENSG00000226242	RPS17P8	NA	
ENSG00000278406	AC013401.2	NA	
ENSG00000286358	AC096647.1	NA	
ENSG00000232658	SLC44A3P1	NA	
ENSG00000235218	DNAJC17P1	NA	
ENSG00000224219	SEC61GP1	NA	
ENSG00000286868	AC074290.1	NA	
ENSG00000260142	AC068135.2	NA	
ENSG00000224670	AC068135.1	NA	
ENSG00000215043	GLULP6	NA	
ENSG00000236695	HNRNPA1P47	NA	
ENSG00000225539	LINC01821	NA	
ENSG00000225394	AC106883.1	NA	
ENSG00000286539	AC073973.1	NA	
ENSG00000276123	Metazoa_SRP	NA	
ENSG00000252517	AC006196.1	NA	
ENSG00000230173	LINC01790	NA	
ENSG00000235056	AC010983.1	NA	
ENSG00000224099	AC104823.1	NA	
ENSG00000271893	AC064834.1	NA	
ENSG00000202206	RNU6-169P	NA	
ENSG00000223466	LINC01825	NA	
ENSG00000234919	LINC01827	NA	
ENSG00000196950	SLC39A10	NA	
ENSG00000213107	AHCYP5	NA	
ENSG00000201813	RNU6-915P	NA	
ENSG00000118997	DNAH7	NA	
ENSG00000203435	E2F3P2	NA	
ENSG00000227878	AC114760.1	NA	
ENSG00000081320	STK17B	NA	
ENSG00000272211	AC114760.2	NA	
ENSG00000138411	HECW2	617268	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL
ENSG00000229056	HECW2-AS1	NA	
ENSG00000276200	RN7SL820P	NA	
ENSG00000282836	AC068544.2	NA	
ENSG00000144395	CCDC150	NA	
ENSG00000252923	AC068544.1	NA	
ENSG00000119041	GTF3C3	NA	
ENSG00000187944	C2orf66	NA	
ENSG00000280176	AC012486.1	NA	
ENSG00000197121	PGAP1	615802	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 9; GPIBD9
ENSG00000065413	ANKRD44	NA	
ENSG00000225636	HNRNPA3P15	NA	
ENSG00000224442	RPL4P7	NA	
ENSG00000231621	ANKRD44-AS1	NA	
ENSG00000236977	ANKRD44-IT1	NA	
ENSG00000230482	ATP5MC2P3	NA	
ENSG00000225979	AC010746.2	NA	
ENSG00000213104	NPM1P46	NA	
ENSG00000115524	SF3B1	614286	MYELODYSPLASTIC SYNDROME; MDS;;MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED
ENSG00000202434	AC010746.1	NA	
ENSG00000206836	RNU6-1029P	NA	
ENSG00000115520	COQ10B	NA	
ENSG00000144381	HSPD1	605280	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13
ENSG00000144381	HSPD1	612233	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4;;MITOCHONDRIAL HSP60 CHAPERONOPATHY;;MITCHAP60 DISEASE
ENSG00000115541	HSPE1	NA	
ENSG00000270757	HSPE1-MOB4	NA	
ENSG00000115540	MOB4	NA	
ENSG00000231699	AC020550.1	NA	
ENSG00000162944	RFTN2	NA	
ENSG00000287858	AC020550.2	NA	
ENSG00000222017	AC011997.1	NA	
ENSG00000247626	MARS2	611390	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL
ENSG00000247626	MARS2	616430	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25
ENSG00000152430	BOLL	NA	
ENSG00000115896	PLCL1	NA	
ENSG00000286020	AC011997.2	NA	
ENSG00000237035	AC020719.1	NA	
ENSG00000236653	LINC01923	NA	
ENSG00000225421	AC019330.1	NA	
ENSG00000231557	AC020718.1	NA	
ENSG00000230407	AC018717.1	NA	
ENSG00000238698	RNU7-147P	NA	
ENSG00000119042	SATB2	612313	GLASS SYNDROME; GLASS;;CHROMOSOME 2q32-q33 DELETION SYNDROME
ENSG00000257045	AC016746.1	NA	
ENSG00000225953	SATB2-AS1	NA	
ENSG00000238217	LINC01877	NA	
ENSG00000213938	SEPHS1P6	NA	
ENSG00000226124	FTCDNL1	NA	
ENSG00000232732	AC097717.1	NA	
ENSG00000227004	AC108032.1	NA	
ENSG00000240302	RN7SL717P	NA	
ENSG00000178074	C2orf69	NA	
ENSG00000162971	TYW5	NA	
ENSG00000162972	MAIP1	NA	
ENSG00000287027	AC004464.1	NA	
ENSG00000196141	SPATS2L	NA	
ENSG00000201649	RNY4P34	NA	
ENSG00000287299	AC012459.1	NA	
ENSG00000155729	KCTD18	NA	
ENSG00000163535	SGO2	NA	
ENSG00000138356	AOX1	NA	
ENSG00000244301	AOX3P	NA	
ENSG00000284084	AOX3P-AOX2P	NA	
ENSG00000237166	LINC01792	NA	
ENSG00000243478	AOX2P	NA	
ENSG00000201737	RNU1-133P	NA	
ENSG00000230408	BZW1-AS1	NA	
ENSG00000082153	BZW1	NA	
ENSG00000207116	RNU6-31P	NA	
ENSG00000224346	BICD1P1	NA	
ENSG00000223092	RNA5SP115	NA	
ENSG00000013441	CLK1	NA	
ENSG00000252759	Y_RNA	NA	
ENSG00000240344	PPIL3	NA	
ENSG00000201499	RNU6-312P	NA	
ENSG00000196290	NIF3L1	NA	
ENSG00000252916	RNU6-762P	NA	
ENSG00000115942	ORC2	NA	
ENSG00000183308	AC005037.1	NA	
ENSG00000155744	FAM126B	NA	
ENSG00000225695	HNRNPA1P35	NA	
ENSG00000226658	RPL23AP30	NA	
ENSG00000119013	NDUFB3	618246	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25
ENSG00000252148	RNU6-1206P	NA	
ENSG00000273975	Metazoa_SRP	NA	
ENSG00000232719	AC007272.1	NA	
ENSG00000224672	RPL17P10	NA	
ENSG00000003402	CFLAR	NA	
ENSG00000232133	IMPDH1P10	NA	
ENSG00000226312	CFLAR-AS1	NA	
ENSG00000238829	RNU7-45P	NA	
ENSG00000235579	RPL38P5	NA	
ENSG00000234431	AC007283.1	NA	
ENSG00000003400	CASP10	603909	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE II; ALPS2
ENSG00000003400	CASP10	605027	LYMPHOMA, NON-HODGKIN, FAMILIAL;;NON-HODGKIN LYMPHOMA; NHL
ENSG00000003400	CASP10	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000227348	MTND5P25	NA	
ENSG00000225796	MTND4P23	NA	
ENSG00000235318	MTND4LP13	NA	
ENSG00000064012	CASP8	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000064012	CASP8	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000064012	CASP8	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000064012	CASP8	607271	CASPASE 8 DEFICIENCY;;CEDS;;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIB; ALPS2B
ENSG00000155749	FLACC1	NA	
ENSG00000115993	TRAK2	NA	
ENSG00000082146	STRADB	NA	
ENSG00000213090	SCYL2P1	NA	
ENSG00000202008	Y_RNA	NA	
ENSG00000155754	C2CD6	NA	
ENSG00000234842	MTCO2P16	NA	
ENSG00000224299	MTATP6P16	NA	
ENSG00000227736	MTCO3P16	NA	
ENSG00000224590	MTND3P16	NA	
ENSG00000234731	MTND4LP16	NA	
ENSG00000249177	MTND4P29	NA	
ENSG00000227841	MTND5P31	NA	
ENSG00000155755	TMEM237	614424	JOUBERT SYNDROME 14; JBTS14
ENSG00000241790	ENO1P4	NA	
ENSG00000287133	AC007279.1	NA	
ENSG00000082126	MPP4	NA	
ENSG00000222972	RNU6-651P	NA	
ENSG00000003393	ALS2	205100	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2;;ALS, JUVENILE; ALSJ
ENSG00000003393	ALS2	606353	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ;;PLS, JUVENILE
ENSG00000003393	ALS2	607225	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP
ENSG00000230799	RPS2P16	NA	
ENSG00000138395	CDK15	NA	
ENSG00000202137	Y_RNA	NA	
ENSG00000231124	UBE2V1P11	NA	
ENSG00000212184	RNU6-440P	NA	
ENSG00000273209	AC069148.1	NA	
ENSG00000155760	FZD7	NA	
ENSG00000182329	KIAA2012	NA	
ENSG00000222035	KIAA2012-AS1	NA	
ENSG00000287041	AC079354.2	NA	
ENSG00000231903	AC079354.1	NA	
ENSG00000227890	PSMA2P3	NA	
ENSG00000223825	DAZAP2P1	NA	
ENSG00000116030	SUMO1	613705	OROFACIAL CLEFT 10; OFC10;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 10
ENSG00000224463	RPL39P14	NA	
ENSG00000055044	NOP58	NA	
ENSG00000212534	SNORD70	NA	
ENSG00000212309	SNORD70B	NA	
ENSG00000271852	SNORD11B	NA	
ENSG00000238317	SNORD11	NA	
ENSG00000286223	AC064836.3	NA	
ENSG00000264275	RN7SL753P	NA	
ENSG00000226261	PIMREGP1	NA	
ENSG00000272966	AC064836.1	NA	
ENSG00000242696	RN7SL40P	NA	
ENSG00000273456	AC064836.2	NA	
ENSG00000204217	BMPR2	178600	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAH PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PR /.../ 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA, INCLUDED;;PPH1 WITH HHT, INCLUDED
ENSG00000204217	BMPR2	265450	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1;;PVOD
ENSG00000270915	H3P8	NA	
ENSG00000236047	RPL13AP12	NA	
ENSG00000223619	MTCO1P17	NA	
ENSG00000233888	MTCO2P17	NA	
ENSG00000235433	MTATP6P17	NA	
ENSG00000237542	MTCO3P17	NA	
ENSG00000233134	MTND3P17	NA	
ENSG00000241221	MTND4LP17	NA	
ENSG00000227454	MTND4P30	NA	
ENSG00000233311	MTCO1P54	NA	
ENSG00000138439	FAM117B	NA	
ENSG00000163596	ICA1L	NA	
ENSG00000240761	AC098831.1	NA	
ENSG00000233579	KRT8P15	NA	
ENSG00000138442	WDR12	NA	
ENSG00000138380	CARF	NA	
ENSG00000232479	KRT8P52	NA	
ENSG00000270664	AC010900.1	NA	
ENSG00000144426	NBEAL1	NA	
ENSG00000232994	RPL7P14	NA	
ENSG00000202059	AC023271.1	NA	
ENSG00000228513	AC023271.2	NA	
ENSG00000225124	RPL23AP36	NA	
ENSG00000204196	RPL12P16	NA	
ENSG00000119004	CYP20A1	NA	
ENSG00000264041	RN7SL670P	NA	
ENSG00000238285	MRPL50P2	NA	
ENSG00000138443	ABI2	NA	
ENSG00000256458	AC080075.1	NA	
ENSG00000173166	RAPH1	NA	
ENSG00000233459	AC125238.2	NA	
ENSG00000233031	AC125238.1	NA	
ENSG00000178562	CD28	NA	
ENSG00000224791	KRT18P39	NA	
ENSG00000213925	NPM1P33	NA	
ENSG00000206970	RNU6-474P	NA	
ENSG00000163599	CTLA4	152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED;;EXCESS LMW-DNA, INCLUDED
ENSG00000163599	CTLA4	140300	HASHIMOTO THYROIDITIS;;HT;;HASHIMOTO STRUMA;;HYPOTHYROIDISM, AUTOIMMUNE  THYROID AUTOANTIBODIES, INCLUDED
ENSG00000163599	CTLA4	601388	DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12;;INSULIN-DEPENDENT DIABETES MELLITUS 12
ENSG00000163599	CTLA4	609755	CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3;;GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 3
ENSG00000163599	CTLA4	616100	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5;;CTLA4 HAPLOINSUFFICIENCY WITH AUTOIMMUNE INFILTRATION; CHAI
ENSG00000163600	ICOS	240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2;;ANTIBODY DEFICIENCY DUE TO TACI DEFECT;;HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY
ENSG00000163600	ICOS	607594	IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECT IMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED
ENSG00000235951	AC009965.2	NA	
ENSG00000234714	AC009965.1	NA	
ENSG00000237271	AC009498.1	NA	
ENSG00000236681	DSTNP5	NA	
ENSG00000225304	AC106901.1	NA	
ENSG00000236634	AC016903.1	NA	
ENSG00000237843	AC016903.2	NA	
ENSG00000116117	PARD3B	NA	
ENSG00000287524	AC007736.1	NA	
ENSG00000223890	AC008171.1	NA	
ENSG00000118257	NRP2	NA	
ENSG00000225216	AC007362.1	NA	
ENSG00000201875	RN7SKP178	NA	
ENSG00000213739	PPIAP68	NA	
ENSG00000225610	AC007679.1	NA	
ENSG00000114933	INO80D	NA	
ENSG00000252485	Vault	NA	
ENSG00000207386	Y_RNA	NA	
ENSG00000237041	RPL27P8	NA	
ENSG00000227946	AC007383.1	NA	
ENSG00000023228	NDUFS1	618226	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5
ENSG00000231955	AC007383.2	NA	
ENSG00000237580	GCSHP3	NA	
ENSG00000114942	EEF1B2	NA	
ENSG00000277502	AC007383.3	NA	
ENSG00000281780	snoZ196	NA	
ENSG00000207047	SNORD51	NA	
ENSG00000207406	SNORA41	NA	
ENSG00000183671	GPR1	NA	
ENSG00000279220	GPR1-AS	NA	
ENSG00000222496	RN7SKP200	NA	
ENSG00000159186	ATP5POP1	NA	
ENSG00000224070	HMGN1P6	NA	
ENSG00000252716	RN7SKP260	NA	
ENSG00000204186	ZDBF2	NA	
ENSG00000180105	ACER2P1	NA	
ENSG00000234491	HNRNPA1P51	NA	
ENSG00000114948	ADAM23	NA	
ENSG00000228577	AC010731.1	NA	
ENSG00000231653	AC010731.2	NA	
ENSG00000235118	FAM237A	NA	
ENSG00000232125	DYTN	NA	
ENSG00000213083	VPS26CP1	NA	
ENSG00000207319	Y_RNA	NA	
ENSG00000138400	MDH1B	NA	
ENSG00000118246	FASTKD2	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY;;CYTOCHROME c OXIDASE DEFICIENCY;;COX DEFICIENCY
ENSG00000283469	MIR3130-1	NA	
ENSG00000263468	MIR3130-2	NA	
ENSG00000229321	AC008269.1	NA	
ENSG00000260171	AC008269.2	NA	
ENSG00000144410	CPO	NA	
ENSG00000118263	KLF7	NA	
ENSG00000253008	MIR2355	NA	
ENSG00000237892	KLF7-IT1	NA	
ENSG00000229647	MYOSLID	NA	
ENSG00000277590	MIR7845	NA	
ENSG00000224342	AC007879.1	NA	
ENSG00000234902	AC007879.3	NA	
ENSG00000286568	AC007879.5	NA	
ENSG00000225916	AC007879.2	NA	
ENSG00000240440	AC007879.4	NA	
ENSG00000223725	AC009226.1	NA	
ENSG00000225064	LINC01802	NA	
ENSG00000221628	MIR1302-4	NA	
ENSG00000118260	CREB1	612160	HISTIOCYTOMA, ANGIOMATOID FIBROUS
ENSG00000144401	METTL21A	NA	
ENSG00000223433	RPS29P9	NA	
ENSG00000224137	LINC01857	NA	
ENSG00000199251	RNU6-664P	NA	
ENSG00000213082	PPP1R14BP2	NA	
ENSG00000200764	Y_RNA	NA	
ENSG00000163249	CCNYL1	NA	
ENSG00000272851	AC096772.1	NA	
ENSG00000284079	MIR4775	NA	
ENSG00000163251	FZD5	NA	
ENSG00000178385	PLEKHM3	NA	
ENSG00000225111	AC083900.1	NA	
ENSG00000212246	RNU6-360P	NA	
ENSG00000185078	RPL9P14	NA	
ENSG00000251941	RNA5SP116	NA	
ENSG00000224839	RPL12P17	NA	
ENSG00000229150	CRYGEP	NA	
ENSG00000118231	CRYGD	115700	CATARACT 4, MULTIPLE TYPES; CTRCT4;;CATARACT 4, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, CRYSTALLINE ACULEIFORM; CACA;;CATARACT, CONGENITAL, CERULEAN TYPE, 3; CCA3;;CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL; PCC;;CATARACT, PUNCTATE,  /.../SSIVE JUVENILE-ONSET
ENSG00000163254	CRYGC	604307	CATARACT 2, MULTIPLE TYPES; CTRCT2;;CATARACT 2, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, COPPOCK-LIKE; CCL
ENSG00000224529	AC093698.1	NA	
ENSG00000182187	CRYGB	615188	CATARACT 39, MULTIPLE TYPES; CTRCT39
ENSG00000168582	CRYGA	NA	
ENSG00000188674	C2orf80	NA	
ENSG00000233869	RPSAP27	NA	
ENSG00000228111	TPT1P2	NA	
ENSG00000138413	IDH1	137800	GLIOMA SUSCEPTIBILITY 1; GLM1 GLIOMA OF BRAIN, FAMILIAL, INCLUDED; GLM, INCLUDED;;GLIOBLASTOMA MULTIFORME, INCLUDED; GBM, INCLUDED;;ASTROCYTOMA, INCLUDED;;OLIGODENDROGLIOMA, INCLUDED;;EPENDYMOMA, INCLUDED;;SUBEPENDYMOMA, INCLUDED
ENSG00000231908	IDH1-AS1	NA	
ENSG00000115020	PIKFYVE	121850	CORNEAL DYSTROPHY, FLECK;;CFD;;FLECK CORNEAL DYSTROPHY; FCD;;CORNEAL DYSTROPHY, FRANCOIS-NEETENS SPECKLED OR FLECKED
ENSG00000228380	MYL6BP1	NA	
ENSG00000144407	PTH2R	NA	
ENSG00000213081	ARPC1BP1	NA	
ENSG00000227430	H3P9	NA	
ENSG00000231896	AC019185.1	NA	
ENSG00000232409	AC019185.2	NA	
ENSG00000287662	AC109824.1	NA	
ENSG00000202164	RNA5SP117	NA	
ENSG00000235864	HSPA8P6	NA	
ENSG00000232799	CRYGFP	NA	
ENSG00000240286	MEAF6P1	NA	
ENSG00000229670	PKP4P1	NA	
ENSG00000286249	AC016743.1	NA	
ENSG00000078018	MAP2	NA	
ENSG00000222317	RNA5SP118	NA	
ENSG00000144406	UNC80	616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2
ENSG00000237194	SNAI1P1	NA	
ENSG00000197713	RPE	NA	
ENSG00000144445	KANSL1L	NA	
ENSG00000272807	AC007038.1	NA	
ENSG00000229127	KANSL1L-AS1	NA	
ENSG00000231063	RPL6P6	NA	
ENSG00000279317	AC006994.1	NA	
ENSG00000115361	ACADL	NA	
ENSG00000199203	Y_RNA	NA	
ENSG00000168530	MYL1	618414	MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA
ENSG00000234281	LANCL1-AS1	NA	
ENSG00000115365	LANCL1	NA	
ENSG00000021826	CPS1	237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY
ENSG00000021826	CPS1	615371	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN
ENSG00000280837	CPS1-IT1	NA	
ENSG00000271074	AC012491.1	NA	
ENSG00000231017	RPS27P10	NA	
ENSG00000178568	ERBB4	615515	AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19
ENSG00000199585	RNA5SP119	NA	
ENSG00000232631	MTND2P23	NA	
ENSG00000236007	MTCO1P46	NA	
ENSG00000221782	MIR548F2	NA	
ENSG00000273118	AC093865.1	NA	
ENSG00000234308	LINC01878	NA	
ENSG00000231254	PCED1CP	NA	
ENSG00000223373	AC108066.1	NA	
ENSG00000266354	MIR4776-1	NA	
ENSG00000283637	MIR4776-2	NA	
ENSG00000286965	AC108066.2	NA	
ENSG00000030419	IKZF2	NA	
ENSG00000270659	AC079610.1	NA	
ENSG00000236193	LINC01953	NA	
ENSG00000272519	AC079610.2	NA	
ENSG00000196096	SPAG16-DT	NA	
ENSG00000144451	SPAG16	NA	
ENSG00000265734	MIR4438	NA	
ENSG00000197585	AC068051.1	NA	
ENSG00000213917	RPL5P8	NA	
ENSG00000174453	VWC2L	NA	
ENSG00000224257	VWC2L-IT1	NA	
ENSG00000177261	ENSAP3	NA	
ENSG00000138376	BARD1	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000229267	SNHG31	NA	
ENSG00000207274	SNORA70I	NA	
ENSG00000230076	RPL10P6	NA	
ENSG00000144452	ABCA12	242500	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'
ENSG00000144452	ABCA12	601277	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY
ENSG00000227769	AC072062.1	NA	
ENSG00000286836	AC092844.1	NA	
ENSG00000237571	LINC02862	NA	
ENSG00000138363	ATIC	608688	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY;;ATIC DEFICIENCY;;AICA-RIBOSURIA DUE TO ATIC DEFICIENCY
ENSG00000115414	FN1	184255	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF;;SPONDYLOMETAPHYSEAL DYSPLASIA, SUTCLIFFE TYPE
ENSG00000115414	FN1	601894	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY
ENSG00000230695	AC012462.3	NA	
ENSG00000225166	AC012462.1	NA	
ENSG00000228618	AC012462.2	NA	
ENSG00000234938	AC012668.2	NA	
ENSG00000237525	AC012668.3	NA	
ENSG00000227981	AC012668.1	NA	
ENSG00000235770	LINC00607	NA	
ENSG00000230838	LINC01614	NA	
ENSG00000216721	AC093850.1	NA	
ENSG00000227824	AC122136.1	NA	
ENSG00000226276	AC093382.1	NA	
ENSG00000118242	MREG	NA	
ENSG00000115425	PECR	NA	
ENSG00000163449	TMEM169	NA	
ENSG00000079246	XRCC5	NA	
ENSG00000232970	POLHP1	NA	
ENSG00000236478	AC012513.2	NA	
ENSG00000279348	AC012513.3	NA	
ENSG00000260804	LINC01963	NA	
ENSG00000144583	MARCHF4	NA	
ENSG00000231092	AC012513.1	NA	
ENSG00000233581	AC069155.1	NA	
ENSG00000207303	Y_RNA	NA	
ENSG00000235042	AC098820.1	NA	
ENSG00000138375	SMARCAL1	242900	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD;;IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE
ENSG00000232485	RPL37A-DT	NA	
ENSG00000241520	AC098820.2	NA	
ENSG00000197756	RPL37A	NA	
ENSG00000224391	LINC01280	NA	
ENSG00000225794	AC073321.1	NA	
ENSG00000235444	PSMB3P2	NA	
ENSG00000115457	IGFBP2	NA	
ENSG00000115461	IGFBP5	NA	
ENSG00000236886	AC007563.2	NA	
ENSG00000237930	RPL31P14	NA	
ENSG00000222832	RNA5SP120	NA	
ENSG00000229352	AC007563.1	NA	
ENSG00000234588	FABP5P14	NA	
ENSG00000286601	AC007563.3	NA	
ENSG00000231597	AC007557.2	NA	
ENSG00000118245	TNP1	NA	
ENSG00000223874	LINC01921	NA	
ENSG00000237479	AC007557.4	NA	
ENSG00000227021	AC007557.1	NA	
ENSG00000236295	AC007557.3	NA	
ENSG00000259855	AC007749.1	NA	
ENSG00000287498	AC007749.2	NA	
ENSG00000251982	RN7SKP43	NA	
ENSG00000233143	DIRC3-AS1	NA	
ENSG00000278004	AC009492.1	NA	
ENSG00000231672	DIRC3	NA	
ENSG00000224414	AC010886.1	NA	
ENSG00000231035	RPL7L1P9	NA	
ENSG00000079308	TNS1	NA	
ENSG00000275458	MIR6809	NA	
ENSG00000223923	AC010136.1	NA	
ENSG00000188282	RUFY4	NA	
ENSG00000229754	CXCR2P1	NA	
ENSG00000180871	CXCR2	NA	
ENSG00000163464	CXCR1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000224159	HMGB1P9	NA	
ENSG00000163466	ARPC2	NA	
ENSG00000261338	AC021016.1	NA	
ENSG00000179921	GPBAR1	NA	
ENSG00000127837	AAMP	NA	
ENSG00000127838	PNKD	118800	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1;;PAROXYSMAL DYSTONIC CHOREOATHETOSIS; PDC;;CHOREOATHETOSIS, FAMILIAL PAROXYSMAL; FPD1;;MOUNT-REBACK SYNDROME;;CHOREOATHETOSIS, NONKINESIGENIC;;DYSTONIA 8; DYT8
ENSG00000135926	TMBIM1	NA	
ENSG00000284173	MIR6513	NA	
ENSG00000237281	CATIP-AS2	NA	
ENSG00000278524	MIR6810	NA	
ENSG00000230580	RPL19P5	NA	
ENSG00000158428	CATIP	NA	
ENSG00000225062	CATIP-AS1	NA	
ENSG00000018280	SLC11A1	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000018280	SLC11A1	610446	BURULI ULCER, SUSCEPTIBILITY TO;;MYCOBACTERIUM ULCERANS, SUSCEPTIBILITY TO
ENSG00000144579	CTDSP1	NA	
ENSG00000273361	AC021016.2	NA	
ENSG00000199121	MIR26B	NA	
ENSG00000127831	VIL1	NA	
ENSG00000135913	USP37	NA	
ENSG00000222714	RN7SKP38	NA	
ENSG00000144580	CNOT9	NA	
ENSG00000207393	RNU6-136P	NA	
ENSG00000115556	PLCD4	NA	
ENSG00000273466	AC012510.1	NA	
ENSG00000115568	ZNF142	618425	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM
ENSG00000074582	BCS1L	124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1
ENSG00000074582	BCS1L	256000	LEIGH SYNDROME; LS;;NECROTIZING ENCEPHALOPATHY, INFANTILE SUBACUTE, OF LEIGH; SNE LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHON /.../COMPLEX III DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX V DEFICIENCY, INCLUDED
ENSG00000074582	BCS1L	262000	BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD
ENSG00000074582	BCS1L	603358	GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTIC ACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME
ENSG00000163481	RNF25	NA	
ENSG00000163482	STK36	NA	
ENSG00000135912	TTLL4	NA	
ENSG00000135929	CYP27A1	213700	CEREBROTENDINOUS XANTHOMATOSIS; CTX;;CEREBRAL CHOLESTERINOSIS
ENSG00000286154	AC009974.2	NA	
ENSG00000272555	AC009974.1	NA	
ENSG00000115592	PRKAG3	604976	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-3; PRKAG3 GLYCOGEN CONTENT IN SKELETAL MUSCLE, INCREASED, INCLUDED
ENSG00000283639	MIR9500	NA	
ENSG00000232625	RPL23AP31	NA	
ENSG00000115596	WNT6	NA	
ENSG00000135925	WNT10A	150400	TOOTH AGENESIS, SELECTIVE, 4; STHAG4;;TOOTH AGENESIS, SELECTIVE, 4, WITH OR WITHOUT ECTODERMAL DYSPLASIA;;LATERAL INCISORS, ABSENCE OF;;LATERAL INCISORS, PEGGED OR MISSING;;SUCCEDANEOUS TEETH, AGENESIS OF
ENSG00000135925	WNT10A	224750	SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS;;KERATOSIS PALMOPLANTARIS WITH CYSTIC EYELIDS, HYPODONTIA, AND HYPOTRICHOSIS;;ECCRINE TUMORS WITH ECTODERMAL DYSPLASIA
ENSG00000135925	WNT10A	257980	ODONTOONYCHODERMAL DYSPLASIA; OODD
ENSG00000228135	LINC01494	NA	
ENSG00000200029	RNU6-642P	NA	
ENSG00000235024	AC097468.2	NA	
ENSG00000224928	KRT8P30	NA	
ENSG00000171450	CDK5R2	NA	
ENSG00000236445	LINC00608	NA	
ENSG00000163497	FEV	NA	
ENSG00000163499	CRYBA2	115900	CATARACT 42; CTRCT42
ENSG00000198973	MIR375	NA	
ENSG00000224090	AC097468.1	NA	
ENSG00000181378	CFAP65	618664	SPERMATOGENIC FAILURE 40; SPGF40
ENSG00000163501	IHH	112500	BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY
ENSG00000163501	IHH	607778	ACROCAPITOFEMORAL DYSPLASIA; ACFD
ENSG00000264755	MIR3131	NA	
ENSG00000286606	AC097468.3	NA	
ENSG00000187736	NHEJ1	611291	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION;;SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE, WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO I /.../G RADIATION;;NHEJ1 SYNDROME  SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION DUE TO NHEJ1 DEFICIENCY, INCLUDED;;SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE, AND SENSITIVITY TO IONIZING RADIATION DUE TO NHEJ1 DEFICIENCY, INCLUDED
ENSG00000280537	AC068946.1	NA	
ENSG00000240317	RN7SL764P	NA	
ENSG00000213901	SLC23A3	NA	
ENSG00000115649	CNPPD1	NA	
ENSG00000144567	RETREG2	NA	
ENSG00000158552	ZFAND2B	NA	
ENSG00000287529	AC068946.3	NA	
ENSG00000115657	ABCB6	111600	BLOOD GROUP, LANGEREIS SYSTEM; LAN
ENSG00000115657	ABCB6	609153	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2;;PSEUDOHYPERKALEMIA LILLE;;PSEUDOHYPERKALEMIA FALKIRK;;PSEUDOHYPERKALEMIA CHISWICK;;PSEUDOHYPERKALEMIA CARDIFF;;PSEUDOHYPERKALEMIA EAST LONDON;;CRYOHYDROCYTOSIS, MILD
ENSG00000115657	ABCB6	614497	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7
ENSG00000115657	ABCB6	615402	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3
ENSG00000284820	AC068946.2	NA	
ENSG00000198925	ATG9A	NA	
ENSG00000163516	ANKZF1	NA	
ENSG00000163521	GLB1L	NA	
ENSG00000115661	STK16	NA	
ENSG00000127824	TUBA4A	616208	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22
ENSG00000243910	TUBA4B	NA	
ENSG00000135924	DNAJB2	614881	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5
ENSG00000054356	PTPRN	NA	
ENSG00000207647	MIR153-1	NA	
ENSG00000230432	AC114803.1	NA	
ENSG00000182698	RESP18	NA	
ENSG00000232789	AC053503.2	NA	
ENSG00000123992	DNPEP	NA	
ENSG00000229525	AC053503.1	NA	
ENSG00000175084	DES	181400	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK;;KAESER SYNDROME;;STARK-KAESER SYNDROME;;SCAPULOPERONEAL SYNDROME, NEUROGENIC TYPE, OF KAESER
ENSG00000175084	DES	601419	MYOPATHY, MYOFIBRILLAR, 1; MFM1;;MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED;;DESMINOPATHY, PRIMARY;;DESMIN-RELATED MYOPATHY; DRM;;MYOFIBRILLAR MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;;DESMIN-RELATED MYOPATHY WITH ARRHYTHMOGENIC RIG /.../TRICULAR CARDIOMYOPATHY;;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 7, FORMERLY; ARVD7, FORMERLY;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 7, FORMERLY; ARVC7, FORMERLY;;INCLUSION BODY MYOPATHY 1, AUTOSOMAL DOMINANT, FORMERLY; IBM1, FORMERLY;;CARDIOMYOPATHY, DILATED, 1F AND LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1D, FORMERLY;;CMD1F AND LGMD1D, FORMERLY;;CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT AND MUSCULAR DYSTROPHY; CDCD3, FORMERLY;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R, FORMERLY; LGMD2R, FORMERLY
ENSG00000175084	DES	604765	CARDIOMYOPATHY, DILATED, 1I; CMD1I
ENSG00000234638	AC053503.3	NA	
ENSG00000280323	AC053503.5	NA	
ENSG00000072195	SPEG	615959	MYOPATHY, CENTRONUCLEAR, 5; CNM5
ENSG00000227432	ASIC4-AS1	NA	
ENSG00000286143	AC053503.6	NA	
ENSG00000286095	SPEGNB	NA	
ENSG00000268603	AC053503.4	NA	
ENSG00000144591	GMPPA	615510	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR
ENSG00000072182	ASIC4	NA	
ENSG00000123989	CHPF	NA	
ENSG00000188760	TMEM198	NA	
ENSG00000268896	AC009955.3	NA	
ENSG00000265252	MIR3132	NA	
ENSG00000124006	OBSL1	612921	THREE M SYNDROME 2; 3M2;;3@M SYNDROME 2
ENSG00000269068	AC009955.4	NA	
ENSG00000123999	INHA	NA	
ENSG00000222678	RN7SKP213	NA	
ENSG00000144589	STK11IP	NA	
ENSG00000228973	AC009955.1	NA	
ENSG00000114923	SLC4A3	NA	
ENSG00000267919	AC009955.2	NA	
ENSG00000231802	DNAJB6P3	NA	
ENSG00000227308	LINC02832	NA	
ENSG00000223903	RPL23P4	NA	
ENSG00000228909	LINC01803	NA	
ENSG00000286199	AC008281.1	NA	
ENSG00000266518	MIR4268	NA	
ENSG00000225911	AC009310.1	NA	
ENSG00000239498	AC019211.1	NA	
ENSG00000235337	AC093083.1	NA	
ENSG00000236451	AC067956.1	NA	
ENSG00000224819	AC093843.1	NA	
ENSG00000286272	AC093843.2	NA	
ENSG00000232089	AC011233.1	NA	
ENSG00000286170	AC011233.2	NA	
ENSG00000116106	EPHA4	NA	
ENSG00000226726	TMEM256P2	NA	
ENSG00000272944	AC079834.1	NA	
ENSG00000230406	RPL23P5	NA	
ENSG00000234446	AC068489.1	NA	
ENSG00000233868	LLPHP3	NA	
ENSG00000226666	HSPA9P1	NA	
ENSG00000226331	RPL23AP28	NA	
ENSG00000135903	PAX3	148820	WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME
ENSG00000135903	PAX3	122880	CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS
ENSG00000135903	PAX3	193500	WAARDENBURG SYNDROME, TYPE 1; WS1;;WAARDENBURG SYNDROME WITH DYSTOPIA CANTHORUM
ENSG00000135903	PAX3	268220	RHABDOMYOSARCOMA 2; RMS2;;RHABDOMYOSARCOMA, ALVEOLAR; RMSA
ENSG00000163081	CCDC140	NA	
ENSG00000237732	CT75	NA	
ENSG00000200822	AC010980.1	NA	
ENSG00000163082	SGPP2	NA	
ENSG00000228670	NANOGP2	NA	
ENSG00000202016	RNU6-619P	NA	
ENSG00000234285	GAPDHP49	NA	
ENSG00000116120	FARSB	613658	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC;;RAJAB SYNDROME;;DEVELOPMENTAL DELAY, SMALL STATURE, MICROCEPHALY, AND BRAIN CALCIFICATIONS, FORMERLY;;NEURODEVELOPMENTAL DISORDER WITH BRAIN, LIVER, AND LUNG ABNORMALITIES, FORMERLY; /.../LA, FORMERLY
ENSG00000124003	MOGAT1	NA	
ENSG00000233751	RRAS2P2	NA	
ENSG00000203531	AC104772.1	NA	
ENSG00000235225	RPL31P17	NA	
ENSG00000123983	ACSL3	NA	
ENSG00000224121	ATG12P2	NA	
ENSG00000234193	ACSL3-AS1	NA	
ENSG00000278083	AC013476.1	NA	
ENSG00000152049	KCNE4	NA	
ENSG00000243125	RN7SL807P	NA	
ENSG00000233299	HIGD1AP4	NA	
ENSG00000231189	AC013448.1	NA	
ENSG00000235610	AC013448.2	NA	
ENSG00000171951	SCG2	NA	
ENSG00000226539	MLXP1	NA	
ENSG00000152056	AP1S3	616106	PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15
ENSG00000286239	AC093884.1	NA	
ENSG00000085449	WDFY1	NA	
ENSG00000135900	MRPL44	615395	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16
ENSG00000228802	AC073641.1	NA	
ENSG00000135919	SERPINE2	NA	
ENSG00000224826	USP21P1	NA	
ENSG00000228681	AC008072.1	NA	
ENSG00000124019	FAM124B	NA	
ENSG00000274629	AC073052.1	NA	
ENSG00000036257	CUL3	614496	PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E
ENSG00000228446	ANKRD49P1	NA	
ENSG00000283428	CCDC195	NA	
ENSG00000135905	DOCK10	NA	
ENSG00000263828	MIR4439	NA	
ENSG00000144460	NYAP2	NA	
ENSG00000228206	AC016717.1	NA	
ENSG00000273301	AC016717.2	NA	
ENSG00000279015	AC016717.3	NA	
ENSG00000230621	AC068138.1	NA	
ENSG00000235070	AC062015.1	NA	
ENSG00000263363	MIR5702	NA	
ENSG00000169047	IRS1	147545	INSULIN RECEPTOR SUBSTRATE 1; IRS1 CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO, INCLUDED
ENSG00000169047	IRS1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000272622	AC010735.2	NA	
ENSG00000261379	AC010735.1	NA	
ENSG00000144468	RHBDD1	NA	
ENSG00000212391	AC073149.1	NA	
ENSG00000081052	COL4A4	141200	HEMATURIA, BENIGN FAMILIAL; BFH;;THIN-BASEMENT-MEMBRANE NEPHROPATHY;;THIN MEMBRANE NEPHROPATHY; TMN
ENSG00000081052	COL4A4	203780	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2
ENSG00000169031	COL4A3	141200	HEMATURIA, BENIGN FAMILIAL; BFH;;THIN-BASEMENT-MEMBRANE NEPHROPATHY;;THIN MEMBRANE NEPHROPATHY; TMN
ENSG00000169031	COL4A3	104200	ALPORT SYNDROME 3, AUTOSOMAL DOMINANT; ATS3
ENSG00000169031	COL4A3	203780	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2
ENSG00000236432	MFF-DT	NA	
ENSG00000168958	MFF	617086	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2
ENSG00000168955	TM4SF20	615432	SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5
ENSG00000284629	SCYGR1	NA	
ENSG00000284092	MIR5703	NA	
ENSG00000173744	AGFG1	NA	
ENSG00000285843	SCYGR9	NA	
ENSG00000284643	SCYGR2	NA	
ENSG00000284622	SCYGR10	NA	
ENSG00000042304	C2orf83	NA	
ENSG00000284704	SCYGR3	NA	
ENSG00000236116	AC064853.1	NA	
ENSG00000284631	SCYGR4	NA	
ENSG00000284667	SCYGR5	NA	
ENSG00000135917	SLC19A3	607483	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2;;BASAL GANGLIA DISEASE, BIOTIN-RESPONSIVE; BBGD;;BTBGD;;ENCEPHALOPATHY, THIAMINE-RESPONSIVE
ENSG00000284725	SCYGR6	NA	
ENSG00000284718	SCYGR7	NA	
ENSG00000284635	SCYGR8	NA	
ENSG00000252346	RNA5SP121	NA	
ENSG00000226718	SNRPGP8	NA	
ENSG00000229172	AC073065.1	NA	
ENSG00000115009	CCL20	NA	
ENSG00000183514	TDGF1P2	NA	
ENSG00000123977	DAW1	NA	
ENSG00000272237	AC073065.2	NA	
ENSG00000153820	SPHKAP	NA	
ENSG00000200281	RNU6-624P	NA	
ENSG00000203387	SNF8P1	NA	
ENSG00000286772	AC009410.1	NA	
ENSG00000232023	LINC01807	NA	
ENSG00000228226	AC012070.1	NA	
ENSG00000237322	RPL7L1P10	NA	
ENSG00000153823	PID1	NA	
ENSG00000226297	RPL17P14	NA	
ENSG00000253006	RN7SKP283	NA	
ENSG00000187957	DNER	NA	
ENSG00000287791	AC008273.1	NA	
ENSG00000238782	RNU7-9P	NA	
ENSG00000235993	AC007559.1	NA	
ENSG00000153827	TRIP12	617752	MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49
ENSG00000222344	RNU6-613P	NA	
ENSG00000153832	FBXO36	NA	
ENSG00000252333	RNU6-964P	NA	
ENSG00000231534	FBXO36-IT1	NA	
ENSG00000206725	RNU6-1027P	NA	
ENSG00000163053	SLC16A14	NA	
ENSG00000199400	RNY4P19	NA	
ENSG00000225963	AC009950.1	NA	
ENSG00000283451	AC009950.2	NA	
ENSG00000135899	SP110	235550	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI
ENSG00000135899	SP110	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000079263	SP140	NA	
ENSG00000185404	SP140L	NA	
ENSG00000279964	AC009949.1	NA	
ENSG00000067066	SP100	NA	
ENSG00000243650	RN7SL834P	NA	
ENSG00000250011	HMGB1P3	NA	
ENSG00000235419	AC010149.1	NA	
ENSG00000183022	TPM3P8	NA	
ENSG00000283202	AC010149.2	NA	
ENSG00000199791	RNU6-451P	NA	
ENSG00000226125	LINC01907	NA	
ENSG00000135932	CAB39	NA	
ENSG00000237758	BANF1P3	NA	
ENSG00000201044	RNU6-268P	NA	
ENSG00000270891	AC012507.2	NA	
ENSG00000135916	ITM2C	NA	
ENSG00000232520	GCSIR	NA	
ENSG00000135898	GPR55	NA	
ENSG00000230385	AC012507.1	NA	
ENSG00000283164	AC012507.3	NA	
ENSG00000235013	COX20P2	NA	
ENSG00000238062	SPATA3-AS1	NA	
ENSG00000173699	SPATA3	NA	
ENSG00000204128	C2orf72	NA	
ENSG00000261829	AC009407.1	NA	
ENSG00000173692	PSMD1	NA	
ENSG00000135914	HTR2B	NA	
ENSG00000201574	RNU1-93P	NA	
ENSG00000135931	ARMC9	617622	JOUBERT SYNDROME 30; JBTS30
ENSG00000237039	RPS28P4	NA	
ENSG00000263641	MIR4777	NA	
ENSG00000224376	AC017104.1	NA	
ENSG00000156966	B3GNT7	NA	
ENSG00000172799	ZBTB8OSP2	NA	
ENSG00000230047	HIGD2AP1	NA	
ENSG00000233538	AC017104.2	NA	
ENSG00000115053	NCL	NA	
ENSG00000206885	SNORA75	NA	
ENSG00000207280	SNORD20	NA	
ENSG00000202400	SNORD82	NA	
ENSG00000283312	AC017104.3	NA	
ENSG00000283491	AC017104.4	NA	
ENSG00000223198	RNU2-22P	NA	
ENSG00000181798	LINC00471	NA	
ENSG00000286942	AC017104.5	NA	
ENSG00000171596	NMUR1	NA	
ENSG00000231494	RPL21P35	NA	
ENSG00000228884	RPL23AP26	NA	
ENSG00000286399	AC104634.1	NA	
ENSG00000177673	TEX44	NA	
ENSG00000239202	RN7SL499P	NA	
ENSG00000187514	PTMA	NA	
ENSG00000277986	AC073476.3	NA	
ENSG00000284378	MIR1244-1	NA	
ENSG00000156973	PDE6D	615665	JOUBERT SYNDROME 22; JBTS22
ENSG00000281072	AC073476.4	NA	
ENSG00000144524	COPS7B	NA	
ENSG00000237641	RPL28P2	NA	
ENSG00000261096	AC073476.2	NA	
ENSG00000260622	AC073476.1	NA	
ENSG00000222246	MIR1471	NA	
ENSG00000163273	NPPC	NA	
ENSG00000144535	DIS3L2	267000	PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR
ENSG00000227033	AC019130.1	NA	
ENSG00000207626	MIR562	NA	
ENSG00000251485	NRBF2P6	NA	
ENSG00000230122	ECEL1P3	NA	
ENSG00000275157	AC068134.3	NA	
ENSG00000163283	ALPP	NA	
ENSG00000224516	AC068134.1	NA	
ENSG00000244280	ECEL1P2	NA	
ENSG00000163286	ALPG	NA	
ENSG00000204121	ECEL1P1	NA	
ENSG00000237087	AC068134.2	NA	
ENSG00000223788	DIS3L2P1	NA	
ENSG00000163295	ALPI	NA	
ENSG00000171551	ECEL1	615065	ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D
ENSG00000237412	PRSS56	613517	MICROPHTHALMIA, ISOLATED 6; MCOP6;;MICROPHTHALMIA, POSTERIOR NONSYNDROMIC
ENSG00000135902	CHRND	253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE
ENSG00000135902	CHRND	616321	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A
ENSG00000135902	CHRND	616322	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B
ENSG00000135902	CHRND	616323	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C
ENSG00000196811	CHRNG	253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE
ENSG00000196811	CHRNG	265000	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE
ENSG00000221944	TIGD1	NA	
ENSG00000284407	MIR5001	NA	
ENSG00000135930	EIF4E2	NA	
ENSG00000237126	AC073254.1	NA	
ENSG00000115468	EFHD1	NA	
ENSG00000244384	RN7SL359P	NA	
ENSG00000204120	GIGYF2	607688	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK11
ENSG00000213055	EEF1B2P7	NA	
ENSG00000241409	AC064852.1	NA	
ENSG00000115474	KCNJ13	193230	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD;;SNOWFLAKE VITREORETINAL DEGENERATION
ENSG00000115474	KCNJ13	614186	LEBER CONGENITAL AMAUROSIS 16; LCA16
ENSG00000252452	RNU6-107P	NA	
ENSG00000199781	Y_RNA	NA	
ENSG00000182600	SNORC	NA	
ENSG00000066248	NGEF	NA	
ENSG00000222001	AC106876.1	NA	
ENSG00000115488	NEU2	NA	
ENSG00000168918	INPP5D	NA	
ENSG00000263941	RN7SL32P	NA	
ENSG00000085978	ATG16L1	611081	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10; IBD10
ENSG00000252010	SCARNA5	NA	
ENSG00000251791	SCARNA6	NA	
ENSG00000130561	SAG	258100	OGUCHI DISEASE 1;;NIGHT BLINDNESS, CONGENITAL STATIONARY, OGUCHI TYPE 1; CSNBO1
ENSG00000130561	SAG	613758	RETINITIS PIGMENTOSA 47; RP47
ENSG00000259793	AC013726.1	NA	
ENSG00000077044	DGKD	NA	
ENSG00000201013	Y_RNA	NA	
ENSG00000085982	USP40	NA	
ENSG00000271639	PPFIA1P1	NA	
ENSG00000228949	UGT1A12P	NA	
ENSG00000227846	UGT1A11P	NA	
ENSG00000242366	UGT1A8	NA	
ENSG00000242515	UGT1A10	NA	
ENSG00000234143	UGT1A13P	NA	
ENSG00000241119	UGT1A9	NA	
ENSG00000244122	UGT1A7	NA	
ENSG00000167165	UGT1A6	NA	
ENSG00000224814	AC114812.2	NA	
ENSG00000240224	UGT1A5	NA	
ENSG00000244474	UGT1A4	NA	
ENSG00000233445	RPL17P11	NA	
ENSG00000243135	UGT1A3	NA	
ENSG00000248114	AC114812.3	NA	
ENSG00000227802	DNAJB3	NA	
ENSG00000228445	UGT1A2P	NA	
ENSG00000248705	AC114812.4	NA	
ENSG00000178836	AC114812.1	NA	
ENSG00000241635	UGT1A1	143500	GILBERT SYNDROME;;HYPERBILIRUBINEMIA, GILBERT TYPE; HBLRG;;HYPERBILIRUBINEMIA, ARIAS TYPE;;HYPERBILIRUBINEMIA I
ENSG00000241635	UGT1A1	218800	CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME
ENSG00000241635	UGT1A1	237900	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN;;LUCEY-DRISCOLL SYNDROME  BREAST MILK JAUNDICE, INCLUDED
ENSG00000241635	UGT1A1	601816	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1
ENSG00000241635	UGT1A1	606785	CRIGLER-NAJJAR SYNDROME, TYPE II;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE II; HBLRCN2
ENSG00000185038	MROH2A	NA	
ENSG00000123485	HJURP	NA	
ENSG00000224287	MSL3P1	NA	
ENSG00000279809	AC005538.2	NA	
ENSG00000144481	TRPM8	NA	
ENSG00000237581	AC005538.1	NA	
ENSG00000286059	AC005538.3	NA	
ENSG00000072080	SPP2	NA	
ENSG00000279218	AC006037.2	NA	
ENSG00000226442	AC006037.1	NA	
ENSG00000261298	AC122134.1	NA	
ENSG00000237784	RPS20P12	NA	
ENSG00000288040	AC097713.2	NA	
ENSG00000228162	AC097713.1	NA	
ENSG00000231682	LINC01891	NA	
ENSG00000232690	HSPE1P9	NA	
ENSG00000188042	ARL4C	NA	
ENSG00000280744	LINC01173	NA	
ENSG00000278593	AC104394.1	NA	
ENSG00000235726	AC010148.1	NA	
ENSG00000130147	SH3BP4	NA	
ENSG00000226542	AC114814.1	NA	
ENSG00000231032	CEP19P1	NA	
ENSG00000235293	AC114814.2	NA	
ENSG00000157985	AGAP1	NA	
ENSG00000235529	AGAP1-IT1	NA	
ENSG00000222007	AC064874.1	NA	
ENSG00000228499	TMSB10P1	NA	
ENSG00000238812	RNU7-127P	NA	
ENSG00000264676	RN7SL204P	NA	
ENSG00000207049	Y_RNA	NA	
ENSG00000168505	GBX2	NA	
ENSG00000233611	AC019068.1	NA	
ENSG00000182177	ASB18	NA	
ENSG00000200745	RNU1-31P	NA	
ENSG00000132321	IQCA1	NA	
ENSG00000270540	AC093915.1	NA	
ENSG00000232893	IQCA1-AS1	NA	
ENSG00000231546	RPL3P5	NA	
ENSG00000144476	ACKR3	NA	
ENSG00000232328	AC084030.1	NA	
ENSG00000227252	AC012063.1	NA	
ENSG00000202341	RNU6-1051P	NA	
ENSG00000124835	AC105760.1	NA	
ENSG00000198612	COPS8	NA	
ENSG00000224844	AC107079.1	NA	
ENSG00000224132	AC112715.1	NA	
ENSG00000163359	COL6A3	158810	BETHLEM MYOPATHY 1; BTHLM1;;BETHLEM MYOPATHY;;MYOPATHY, BENIGN CONGENITAL, WITH CONTRACTURES;;MUSCULAR DYSTROPHY, BENIGN CONGENITAL;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 5; LGMDD5
ENSG00000163359	COL6A3	254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1;;ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD;;MUSCULAR DYSTROPHY, SCLEROATONIC;;ULLRICH DISEASE;;ULLRICH SCLEROATONIC MUSCULAR DYSTROPHY;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 22; LGMDR22
ENSG00000163359	COL6A3	616411	DYSTONIA 27; DYT27
ENSG00000222022	AC112721.1	NA	
ENSG00000222032	AC112721.2	NA	
ENSG00000115648	MLPH	609227	GRISCELLI SYNDROME, TYPE 3; GS3
ENSG00000277842	MIR6811	NA	
ENSG00000222449	RNU6-1140P	NA	
ENSG00000071677	PRLH	NA	
ENSG00000124839	RAB17	NA	
ENSG00000234949	AC104667.2	NA	
ENSG00000227107	AC104667.1	NA	
ENSG00000124831	LRRFIP1	NA	
ENSG00000286864	AC012076.1	NA	
ENSG00000177483	RBM44	NA	
ENSG00000132329	RAMP1	NA	
ENSG00000263723	SNORD39	NA	
ENSG00000184182	UBE2F	NA	
ENSG00000258984	UBE2F-SCLY	NA	
ENSG00000251971	RNU6-1333P	NA	
ENSG00000132330	SCLY	NA	
ENSG00000144488	ESPNL	NA	
ENSG00000168427	KLHL30	NA	
ENSG00000279484	KLHL30-AS1	NA	
ENSG00000178752	ERFE	NA	
ENSG00000132323	ILKAP	NA	
ENSG00000186235	LINC02610	NA	
ENSG00000225057	AC012485.1	NA	
ENSG00000144485	HES6	NA	
ENSG00000132326	PER2	604348	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1
ENSG00000283635	AC012485.3	NA	
ENSG00000232306	AC012485.2	NA	
ENSG00000204104	TRAF3IP1	616629	SENIOR-LOKEN SYNDROME 9; SLSN9
ENSG00000202099	RNU6-234P	NA	
ENSG00000065802	ASB1	NA	
ENSG00000229915	AC016999.1	NA	
ENSG00000274346	AC016999.2	NA	
ENSG00000225493	LINC01107	NA	
ENSG00000234279	LINC01937	NA	
ENSG00000286160	AC113618.2	NA	
ENSG00000224252	AC113618.1	NA	
ENSG00000286748	AC145625.2	NA	
ENSG00000226992	AC145625.1	NA	
ENSG00000233608	TWIST2	200110	ABLEPHARON-MACROSTOMIA SYNDROME; AMS
ENSG00000233608	TWIST2	209885	BARBER-SAY SYNDROME; BBRSAY;;BSS;;HYPERTRICHOSIS, ATROPHIC SKIN, ECTROPION, AND MACROSTOMIA
ENSG00000233608	TWIST2	227260	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3;;SETLEIS SYNDROME;;BITEMPORAL FORCEPS MARKS SYNDROME;;FACIAL ECTODERMAL DYSPLASIA;;FOCAL FACIAL DERMAL DYSPLASIA, TYPE II, FORMERLY
ENSG00000227744	LINC01940	NA	
ENSG00000068024	HDAC4	NA	
ENSG00000266109	MIR4440	NA	
ENSG00000264810	MIR4441	NA	
ENSG00000286307	AC017028.1	NA	
ENSG00000287405	AC017028.2	NA	
ENSG00000265215	MIR4269	NA	
ENSG00000264292	MIR2467	NA	
ENSG00000222020	HDAC4-AS1	NA	
ENSG00000286525	AC023787.2	NA	
ENSG00000288082	AC023787.3	NA	
ENSG00000286188	AC023787.1	NA	
ENSG00000196758	AC079612.1	NA	
ENSG00000227459	AC079612.2	NA	
ENSG00000259889	AC093802.2	NA	
ENSG00000220256	AC093802.1	NA	
ENSG00000130414	NDUFA10	618243	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22
ENSG00000264279	MIR4786	NA	
ENSG00000182083	OR6B2	NA	
ENSG00000178586	OR6B3	NA	
ENSG00000231278	OR9S24P	NA	
ENSG00000213048	OR5S1P	NA	
ENSG00000172428	COPS9	NA	
ENSG00000178602	OTOS	NA	
ENSG00000286325	AC124861.3	NA	
ENSG00000286183	AC124861.2	NA	
ENSG00000227479	AC124861.1	NA	
ENSG00000276366	U3	NA	
ENSG00000063660	GPC1	NA	
ENSG00000218416	AC110619.1	NA	
ENSG00000207611	MIR149	NA	
ENSG00000144504	ANKMY1	NA	
ENSG00000287049	AC124862.1	NA	
ENSG00000188542	DUSP28	NA	
ENSG00000142327	RNPEPL1	NA	
ENSG00000260942	CAPN10-DT	NA	
ENSG00000142330	CAPN10	601283	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1;;NONINSULIN-DEPENDENT DIABETES MELLITUS 1
ENSG00000178623	GPR35	NA	
ENSG00000276949	AC011298.3	NA	
ENSG00000185176	AQP12B	NA	
ENSG00000219159	AC011298.1	NA	
ENSG00000184945	AQP12A	NA	
ENSG00000274977	AC011298.2	NA	
ENSG00000130294	KIF1A	201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A;;HSAN IIA;;NEUROPATHY, HEREDITARY SENSORY, TYPE IIA; HSN2A;;HSN IIA;;ACROOSTEOLYSIS, NEUROGENIC;;ACROOSTEOLYSIS, GIACCAI TYPE;;NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL RECESSI /.../RVAN DISEASE;;NEUROPATHY, PROGRESSIVE SENSORY, OF CHILDREN;;NEUROPATHY, CONGENITAL SENSORY
ENSG00000130294	KIF1A	610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30
ENSG00000130294	KIF1A	614213	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C
ENSG00000130294	KIF1A	614255	NESCAV SYNDROME; NESCAVS;;NEURODEGENERATION AND SPASTICITY WITH OR WITHOUT CEREBELLAR ATROPHY OR CORTICAL VISUAL IMPAIRMENT;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 9, FORMERLY; MRD9, FORMERLY
ENSG00000172482	AGXT	259900	HYPEROXALURIA, PRIMARY, TYPE I; HP1;;OXALOSIS I;;GLYCOLIC ACIDURIA;;ALANINE-GLYOXYLATE AMINOTRANSFERASE DEFICIENCY;;PEROXISOMAL ALANINE:GLYOXYLATE AMINOTRANSFERASE DEFICIENCY;;HEPATIC AGT DEFICIENCY;;SERINE:PYRUVATE AMINOTRANSFERASE DEFICIENCY
ENSG00000172478	MAB21L4	NA	
ENSG00000226321	CROCC2	NA	
ENSG00000233392	AC104809.2	NA	
ENSG00000223991	AC104809.1	NA	
ENSG00000162804	SNED1	NA	
ENSG00000229996	AC093585.1	NA	
ENSG00000225521	AC005237.1	NA	
ENSG00000122085	MTERF4	NA	
ENSG00000115687	PASK	NA	
ENSG00000235861	AC005237.2	NA	
ENSG00000115685	PPP1R7	NA	
ENSG00000146205	ANO7	NA	
ENSG00000115677	HDLBP	NA	
ENSG00000168385	SEPTIN2	NA	
ENSG00000286588	AC104841.1	NA	
ENSG00000223374	AC005104.1	NA	
ENSG00000006607	FARP2	NA	
ENSG00000288080	AC005104.2	NA	
ENSG00000263752	MIR3133	NA	
ENSG00000224232	KCTD5P1	NA	
ENSG00000115694	STK25	NA	
ENSG00000234235	BOK-AS1	NA	
ENSG00000176720	BOK	NA	
ENSG00000273113	AC133528.1	NA	
ENSG00000176946	THAP4	NA	
ENSG00000207186	RNA5SP122	NA	
ENSG00000168397	ATG4B	NA	
ENSG00000168393	DTYMK	NA	
ENSG00000168395	ING5	NA	
ENSG00000235351	AC114730.3	NA	
ENSG00000180902	D2HGDH	600721	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1;;D2HGA
ENSG00000215692	AC114730.1	NA	
ENSG00000234793	AC114730.2	NA	
ENSG00000154252	GAL3ST2	NA	
ENSG00000215023	AC131097.1	NA	
ENSG00000224272	AC131097.2	NA	
ENSG00000204099	NEU4	NA	
ENSG00000235151	AC131097.3	NA	
ENSG00000188389	PDCD1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000188389	PDCD1	605218	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2
ENSG00000188011	RTP5	NA	
ENSG00000233806	LINC01237	NA	
ENSG00000216921	FAM240C	NA	
ENSG00000237940	LINC01238	NA	
ENSG00000280119	AC093642.2	NA	
ENSG00000226423	AC093642.1	NA	
ENSG00000287971	AC093642.5	NA	
ENSG00000232002	LINC01880	NA	
ENSG00000261186	LINC01238	NA	
ENSG00000220804	LINC01881	NA	
ENSG00000224160	CICP10	NA	
ENSG00000244528	SEPTIN14P2	NA	
ENSG00000271153	RPL23AP88	NA	
ENSG00000178591	DEFB125	NA	
ENSG00000125788	DEFB126	NA	
ENSG00000088782	DEFB127	NA	
ENSG00000185982	DEFB128	NA	
ENSG00000125903	DEFB129	NA	
ENSG00000186458	DEFB132	NA	
ENSG00000272874	AL034548.1	NA	
ENSG00000196476	C20orf96	NA	
ENSG00000247315	ZCCHC3	NA	
ENSG00000286158	AL034548.2	NA	
ENSG00000225377	NRSN2-AS1	NA	
ENSG00000177732	SOX12	NA	
ENSG00000125841	NRSN2	NA	
ENSG00000101255	TRIB3	NA	
ENSG00000125826	RBCK1	615895	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1;;POLYGLUCOSAN BODY MYOPATHY, EARLY-ONSET, WITH OR WITHOUT IMMUNODEFICIENCY; PBMEI
ENSG00000125875	TBC1D20	615663	WARBURG MICRO SYNDROME 4; WARBM4
ENSG00000206797	Y_RNA	NA	
ENSG00000101266	CSNK2A1	617062	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS
ENSG00000125878	TCF15	NA	
ENSG00000271303	SRXN1	NA	
ENSG00000270299	AL121758.1	NA	
ENSG00000215397	SCRT2	NA	
ENSG00000101276	SLC52A3	211500	FAZIO-LONDE DISEASE;;BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD
ENSG00000101276	SLC52A3	211530	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1;;BULBAR PALSY, PROGRESSIVE, WITH SENSORINEURAL DEAFNESS;;PONTOBULBAR PALSY WITH DEAFNESS
ENSG00000125898	FAM110A	NA	
ENSG00000101278	RPS10P5	NA	
ENSG00000101280	ANGPT4	NA	
ENSG00000101282	RSPO4	206800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4;;ANONYCHIA/HYPONYCHIA CONGENITA;;ANONYCHIA TOTALIS
ENSG00000286787	AL110114.1	NA	
ENSG00000125818	PSMF1	NA	
ENSG00000215388	ACTG1P3	NA	
ENSG00000125895	TMEM74B	NA	
ENSG00000274269	AL031665.1	NA	
ENSG00000215595	C20orf202	NA	
ENSG00000244588	RAD21L1	NA	
ENSG00000101298	SNPH	NA	
ENSG00000125775	SDCBP2	NA	
ENSG00000274322	AL136531.2	NA	
ENSG00000280162	AL136531.3	NA	
ENSG00000234684	SDCBP2-AS1	NA	
ENSG00000229728	AL136531.1	NA	
ENSG00000088832	FKBP1A	NA	
ENSG00000284436	MIR6869	NA	
ENSG00000088833	NSFL1C	NA	
ENSG00000196209	SIRPB2	NA	
ENSG00000242324	AL049634.1	NA	
ENSG00000252103	RNU6-917P	NA	
ENSG00000125900	SIRPD	NA	
ENSG00000260861	AL049634.2	NA	
ENSG00000101307	SIRPB1	NA	
ENSG00000271523	AL049634.3	NA	
ENSG00000089012	SIRPG	NA	
ENSG00000237914	SIRPG-AS1	NA	
ENSG00000223750	SIRPB3P	NA	
ENSG00000242348	RN7SL561P	NA	
ENSG00000236550	AL109809.3	NA	
ENSG00000234282	AL109809.2	NA	
ENSG00000286288	AL109809.4	NA	
ENSG00000271461	CKAP2LP1	NA	
ENSG00000232528	AL109809.1	NA	
ENSG00000276649	AL117335.1	NA	
ENSG00000198053	SIRPA	NA	
ENSG00000233896	PDYN-AS1	NA	
ENSG00000101327	PDYN	610245	SPINOCEREBELLAR ATAXIA 23; SCA23
ENSG00000227663	RPL7P2	NA	
ENSG00000125834	STK35	NA	
ENSG00000286108	AL359916.1	NA	
ENSG00000287213	AL121899.3	NA	
ENSG00000287561	AL121899.4	NA	
ENSG00000226644	AL121899.1	NA	
ENSG00000286022	AL121899.2	NA	
ENSG00000125780	TGM3	617251	UNCOMBABLE HAIR SYNDROME 2; UHS2
ENSG00000166948	TGM6	613908	SPINOCEREBELLAR ATAXIA 35; SCA35
ENSG00000207305	Y_RNA	NA	
ENSG00000125835	SNRPB	117650	CEREBROCOSTOMANDIBULAR SYNDROME; CCMS;;RIB GAP DEFECTS WITH MICROGNATHIA
ENSG00000256566	AL049650.1	NA	
ENSG00000088876	ZNF343	NA	
ENSG00000149488	TMC2	NA	
ENSG00000101361	NOP56	614153	SPINOCEREBELLAR ATAXIA 36; SCA36
ENSG00000284481	MIR1292	NA	
ENSG00000221116	SNORD110	NA	
ENSG00000271798	SNORA51	NA	
ENSG00000212498	SNORD86	NA	
ENSG00000229686	SNORD56	NA	
ENSG00000226572	SNORD57	NA	
ENSG00000101365	IDH3B	612572	RETINITIS PIGMENTOSA 46; RP46;;RETINITIS PIGMENTOSA, AUTOSOMAL RECESSIVE, IDH3B-RELATED
ENSG00000228293	AL049712.1	NA	
ENSG00000088881	EBF4	NA	
ENSG00000226217	RPL19P1	NA	
ENSG00000088882	CPXM1	NA	
ENSG00000241690	AL035460.1	NA	
ENSG00000258713	C20orf141	NA	
ENSG00000198326	TMEM239	NA	
ENSG00000132635	PCED1A	NA	
ENSG00000215305	VPS16	NA	
ENSG00000132670	PTPRA	NA	
ENSG00000125787	GNRH2	NA	
ENSG00000125901	MRPS26	NA	
ENSG00000101405	OXT	NA	
ENSG00000101200	AVP	125700	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL;;DIABETES INSIPIDUS, PRIMARY CENTRAL; CDI;;DIABETES INSIPIDUS, CRANIAL TYPE
ENSG00000263905	RN7SL555P	NA	
ENSG00000235958	UBOX5-AS1	NA	
ENSG00000185019	UBOX5	NA	
ENSG00000215251	FASTKD5	NA	
ENSG00000088899	LZTS3	NA	
ENSG00000198171	DDRGK1	602557	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH;;SEMD, SHOHAT TYPE
ENSG00000125877	ITPA	613850	INOSINE TRIPHOSPHATASE DEFICIENCY;;INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE DEFICIENCY
ENSG00000125877	ITPA	616647	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35; EIEE35
ENSG00000088836	SLC4A11	217400	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD;;CDPD1;;CORNEAL DYSTROPHY AND SENSORINEURAL DEAFNESS;;HARBOYAN SYNDROME
ENSG00000088836	SLC4A11	217700	CORNEAL ENDOTHELIAL DYSTROPHY; CHED;;CORNEAL DYSTROPHY, CONGENITAL HEREDITARY ENDOTHELIAL;;CONGENITAL HEREDITARY ENDOTHELIAL DYSTROPHY OF CORNEA;;CORNEAL ENDOTHELIAL DYSTROPHY 2, AUTOSOMAL RECESSIVE, FORMERLY; CHED2, FORMERLY
ENSG00000088836	SLC4A11	613268	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET
ENSG00000277287	AL109976.1	NA	
ENSG00000088854	C20orf194	NA	
ENSG00000201294	RNU6-1019P	NA	
ENSG00000226632	UBE2V1P1	NA	
ENSG00000201346	U3	NA	
ENSG00000288577	AL117334.1	NA	
ENSG00000225116	AL353193.1	NA	
ENSG00000088812	ATRN	NA	
ENSG00000230568	SF3A3P1	NA	
ENSG00000125861	GFRA4	NA	
ENSG00000149451	ADAM33	NA	
ENSG00000088827	SIGLEC1	NA	
ENSG00000132622	HSPA12B	NA	
ENSG00000101220	C20orf27	NA	
ENSG00000101222	SPEF1	NA	
ENSG00000125817	CENPB	NA	
ENSG00000101224	CDC25B	NA	
ENSG00000275491	LINC01730	NA	
ENSG00000274949	AL109804.1	NA	
ENSG00000125843	AP5S1	NA	
ENSG00000088888	MAVS	NA	
ENSG00000229539	PANK2-AS1	NA	
ENSG00000125779	PANK2	234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1;;PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PKAN;;PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET;;HALLERVORDEN-SPATZ DISEASE
ENSG00000125779	PANK2	607236	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION;;HARP SYNDROME
ENSG00000199024	MIR103A2	NA	
ENSG00000283320	MIR103B2	NA	
ENSG00000275582	AL031670.1	NA	
ENSG00000101236	RNF24	NA	
ENSG00000226608	FTLP3	NA	
ENSG00000215063	RPL21P2	NA	
ENSG00000205300	AL356414.1	NA	
ENSG00000088826	SMOX	NA	
ENSG00000230176	LINC01433	NA	
ENSG00000171873	ADRA1D	NA	
ENSG00000236387	AL139350.1	NA	
ENSG00000238282	AL121781.1	NA	
ENSG00000228210	AL121916.1	NA	
ENSG00000226948	RPS4XP2	NA	
ENSG00000171867	PRNP	137440	GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIF /.../CEPHALOPATHY;;PRION DEMENTIA CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED
ENSG00000171867	PRNP	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000171867	PRNP	245300	KURU, SUSCEPTIBILITY TO
ENSG00000171867	PRNP	600072	FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL
ENSG00000171867	PRNP	603218	HUNTINGTON DISEASE-LIKE 1; HDL1;;HUNTINGTON-LIKE NEURODEGENERATIVE DISORDER 1; HLN1;;HUNTINGTON-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL DOMINANT;;PRION DISEASE, EARLY-ONSET, WITH PROMINENT PSYCHIATRIC FEATURES
ENSG00000171867	PRNP	606688	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES
ENSG00000171864	PRND	NA	
ENSG00000180259	PRNT	NA	
ENSG00000231071	IDI1P3	NA	
ENSG00000278595	AL133396.1	NA	
ENSG00000101265	RASSF2	NA	
ENSG00000089057	SLC23A2	NA	
ENSG00000252096	AL389886.1	NA	
ENSG00000234573	AL121890.1	NA	
ENSG00000277087	AL121890.3	NA	
ENSG00000276768	AL121890.2	NA	
ENSG00000278816	AL121890.5	NA	
ENSG00000277425	AL121890.4	NA	
ENSG00000089063	TMEM230	NA	
ENSG00000212536	RNA5SP474	NA	
ENSG00000252367	Y_RNA	NA	
ENSG00000132646	PCNA	615919	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2
ENSG00000212517	AL121924.1	NA	
ENSG00000101290	CDS2	NA	
ENSG00000225022	UBE2D3P1	NA	
ENSG00000101292	PROKR2	244200	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3
ENSG00000266908	AL121757.2	NA	
ENSG00000200313	RNA5-8SP7	NA	
ENSG00000276688	AL121757.3	NA	
ENSG00000226995	LINC00658	NA	
ENSG00000230563	AL121757.1	NA	
ENSG00000205181	LINC00654	NA	
ENSG00000225640	LINC01729	NA	
ENSG00000225831	RPS18P1	NA	
ENSG00000235820	AL109935.1	NA	
ENSG00000125772	GPCPD1	NA	
ENSG00000233578	EIF4EP1	NA	
ENSG00000171984	SHLD1	NA	
ENSG00000202380	RNU1-55P	NA	
ENSG00000089199	CHGB	NA	
ENSG00000215589	KANK1P1	NA	
ENSG00000089195	TRMT6	NA	
ENSG00000125885	MCM8	612885	PREMATURE OVARIAN FAILURE 10; POF10 MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3, INCLUDED; MENOQ3, INCLUDED
ENSG00000286235	AL035461.3	NA	
ENSG00000207380	Y_RNA	NA	
ENSG00000231961	AL035461.1	NA	
ENSG00000278719	MCM8-AS1	NA	
ENSG00000275632	AL035461.2	NA	
ENSG00000263755	RN7SL498P	NA	
ENSG00000088766	CRLS1	NA	
ENSG00000125872	LRRN4	NA	
ENSG00000278192	AL118505.1	NA	
ENSG00000101311	FERMT1	173650	KINDLER SYNDROME; KNDLRS;;POIKILODERMA, HEREDITARY ACROKERATOTIC;;BULLOUS ACROKERATOTIC POIKILODERMA OF KINDLER AND WEARY;;POIKILODERMA, CONGENITAL, WITH BULLAE, WEARY TYPE
ENSG00000233402	TARDBPP1	NA	
ENSG00000234241	AL109618.1	NA	
ENSG00000271565	AL109618.2	NA	
ENSG00000276915	AL109618.3	NA	
ENSG00000229876	CASC20	NA	
ENSG00000228482	LINC01713	NA	
ENSG00000125845	BMP2	112600	BRACHYDACTYLY, TYPE A2; BDA2;;BRACHYMESOPHALANGY II;;MOHR-WRIEDT TYPE BRACHYDACTYLY
ENSG00000125845	BMP2	235200	HEMOCHROMATOSIS, TYPE 1; HFE1;;HEMOCHROMATOSIS; HFE;;HEMOCHROMATOSIS, HEREDITARY; HH
ENSG00000125845	BMP2	617877	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC
ENSG00000232271	AL096799.1	NA	
ENSG00000228888	LINC01428	NA	
ENSG00000238102	AL080248.1	NA	
ENSG00000261249	LINC01751	NA	
ENSG00000224711	LINC01706	NA	
ENSG00000278159	MIR8062	NA	
ENSG00000240584	RN7SL547P	NA	
ENSG00000215586	AL031679.1	NA	
ENSG00000277315	AL021879.1	NA	
ENSG00000101323	HAO1	NA	
ENSG00000125827	TMX4	NA	
ENSG00000229766	AL021396.1	NA	
ENSG00000182621	PLCB1	613722	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12
ENSG00000226262	PHKBP1	NA	
ENSG00000225479	PLCB1-IT1	NA	
ENSG00000201348	RNU105B	NA	
ENSG00000228438	AL445567.1	NA	
ENSG00000276385	AL445567.2	NA	
ENSG00000275222	Metazoa_SRP	NA	
ENSG00000101333	PLCB4	614669	AURICULOCONDYLAR SYNDROME 2; ARCND2
ENSG00000225988	LAMP5-AS1	NA	
ENSG00000125869	LAMP5	NA	
ENSG00000101349	PAK5	NA	
ENSG00000286740	AL353612.2	NA	
ENSG00000232738	AL353612.1	NA	
ENSG00000286470	AL034427.1	NA	
ENSG00000243961	PARAL1	NA	
ENSG00000132623	ANKEF1	NA	
ENSG00000227906	SNAP25-AS1	NA	
ENSG00000276525	Metazoa_SRP	NA	
ENSG00000230506	AL354824.1	NA	
ENSG00000232448	AL354824.2	NA	
ENSG00000132639	SNAP25	616330	MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18;;MYASTHENIC SYNDROME, CONGENITAL, 18, WITH INTELLECTUAL DISABILITY AND ATAXIA
ENSG00000286936	AL023913.1	NA	
ENSG00000237005	HIGD1AP15	NA	
ENSG00000214835	RPL23AP6	NA	
ENSG00000230750	SDAD1P2	NA	
ENSG00000125863	MKKS	236700	MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION; HMCS;;KAUFMAN-MCKUSICK SYNDROME
ENSG00000125863	MKKS	605231	BARDET-BIEDL SYNDROME 6; BBS6
ENSG00000285508	AL034430.1	NA	
ENSG00000285723	AL034430.2	NA	
ENSG00000149346	SLX4IP	NA	
ENSG00000235036	AL035456.1	NA	
ENSG00000101384	JAG1	118450	ALAGILLE SYNDROME 1; ALGS1;;ALAGILLE SYNDROME; ALGS;;ALAGILLE-WATSON SYNDROME; AWS;;CHOLESTASIS WITH PERIPHERAL PULMONARY STENOSIS;;ARTERIOHEPATIC DYSPLASIA; AHD;;HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC
ENSG00000101384	JAG1	187500	TETRALOGY OF FALLOT; TOF
ENSG00000101384	JAG1	617992	DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON; DCHE
ENSG00000273745	MIR6870	NA	
ENSG00000270792	AL050403.2	NA	
ENSG00000224961	LINC01752	NA	
ENSG00000234900	AL135937.1	NA	
ENSG00000232900	AL050403.1	NA	
ENSG00000217809	FAT1P1	NA	
ENSG00000125899	LINC02871	NA	
ENSG00000270777	AL158042.1	NA	
ENSG00000230990	AL049649.1	NA	
ENSG00000235544	RPS11P1	NA	
ENSG00000282478	AL109837.2	NA	
ENSG00000287754	AL109837.3	NA	
ENSG00000271397	AL109837.1	NA	
ENSG00000237256	PGAM3P	NA	
ENSG00000261411	AL161938.1	NA	
ENSG00000228422	LINC00687	NA	
ENSG00000222281	RN7SKP111	NA	
ENSG00000271298	AL080274.1	NA	
ENSG00000132640	BTBD3	NA	
ENSG00000236526	AL035448.1	NA	
ENSG00000235292	AL109838.1	NA	
ENSG00000230437	AL136460.1	NA	
ENSG00000235698	PA2G4P2	NA	
ENSG00000233048	LINC01722	NA	
ENSG00000269931	AL078623.1	NA	
ENSG00000286087	AL133331.1	NA	
ENSG00000234265	LINC01723	NA	
ENSG00000172296	SPTLC3	NA	
ENSG00000271426	AL109983.1	NA	
ENSG00000101230	ISM1	NA	
ENSG00000226263	ISM1-AS1	NA	
ENSG00000225956	AL050320.1	NA	
ENSG00000278153	AL121782.1	NA	
ENSG00000089123	TASP1	NA	
ENSG00000236811	GAPDHP2	NA	
ENSG00000089048	ESF1	NA	
ENSG00000101247	NDUFAF5	618238	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16
ENSG00000101251	SEL1L2	NA	
ENSG00000212247	RNU6-278P	NA	
ENSG00000172264	MACROD2	NA	
ENSG00000230935	RPS3P1	NA	
ENSG00000234187	AIMP1P1	NA	
ENSG00000239923	RN7SL864P	NA	
ENSG00000125848	FLRT3	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000125848	FLRT3	615271	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21
ENSG00000199570	RNU6-228P	NA	
ENSG00000287062	AL121582.1	NA	
ENSG00000227563	RNF11P2	NA	
ENSG00000227927	MACROD2-IT1	NA	
ENSG00000213950	RPS10P2	NA	
ENSG00000235914	MACROD2-AS1	NA	
ENSG00000237832	AL138808.1	NA	
ENSG00000199803	RNU6-1159P	NA	
ENSG00000201180	RNU6-115P	NA	
ENSG00000222500	RNA5SP475	NA	
ENSG00000225181	AL121584.1	NA	
ENSG00000224274	ENSAP1	NA	
ENSG00000286546	AL079338.1	NA	
ENSG00000287410	AL161941.1	NA	
ENSG00000225622	PPIAP17	NA	
ENSG00000089177	KIF16B	NA	
ENSG00000273998	AL049794.1	NA	
ENSG00000275728	AL049794.2	NA	
ENSG00000226229	RPLP0P1	NA	
ENSG00000200494	Y_RNA	NA	
ENSG00000235208	AL135938.1	NA	
ENSG00000228809	AL034428.1	NA	
ENSG00000125870	SNRPB2	NA	
ENSG00000125879	OTOR	NA	
ENSG00000236985	AL121892.1	NA	
ENSG00000212165	U3	NA	
ENSG00000251955	RNU6-27P	NA	
ENSG00000220540	AL359511.1	NA	
ENSG00000238833	RNU1-131P	NA	
ENSG00000286571	AL359511.2	NA	
ENSG00000287241	AL359511.3	NA	
ENSG00000125851	PCSK2	NA	
ENSG00000232241	DYNLT3P1	NA	
ENSG00000125864	BFSP1	611391	CATARACT 33, MULTIPLE TYPES; CTRCT33
ENSG00000232333	RPS27AP2	NA	
ENSG00000277373	AL132765.2	NA	
ENSG00000125868	DSTN	NA	
ENSG00000202260	RN7SKP69	NA	
ENSG00000230495	AL132765.1	NA	
ENSG00000125844	RRBP1	NA	
ENSG00000125888	BANF2	NA	
ENSG00000233625	AL035045.1	NA	
ENSG00000212555	RNU6-192P	NA	
ENSG00000089006	SNX5	NA	
ENSG00000125850	OVOL2	122000	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1;;POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY; PPCD;;CORNEAL DYSTROPHY, HEREDITARY POLYMORPHOUS POSTERIOR;;MAUMENEE CORNEAL DYSTROPHY;;CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT, FORMERLY; CHE /.../RMERLY
ENSG00000212232	SNORD17	NA	
ENSG00000125871	MGME1	615084	MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11
ENSG00000218902	PTMAP3	NA	
ENSG00000229262	AL160411.1	NA	
ENSG00000227343	RPL15P1	NA	
ENSG00000252597	RNU7-137P	NA	
ENSG00000207282	Y_RNA	NA	
ENSG00000232838	PET117	NA	
ENSG00000149474	KAT14	NA	
ENSG00000232943	GGCTP2	NA	
ENSG00000266720	RN7SL14P	NA	
ENSG00000252635	RNU2-56P	NA	
ENSG00000287954	AL049646.3	NA	
ENSG00000125846	ZNF133	NA	
ENSG00000230010	AL049646.1	NA	
ENSG00000199719	RN7SKP74	NA	
ENSG00000237259	AL049646.2	NA	
ENSG00000237282	LINC00851	NA	
ENSG00000089091	DZANK1	NA	
ENSG00000236474	GCNT1P1	NA	
ENSG00000252422	RNA5SP476	NA	
ENSG00000132664	POLR3F	NA	
ENSG00000265137	MIR3192	NA	
ENSG00000225419	RPL21P3	NA	
ENSG00000089050	RBBP9	NA	
ENSG00000214612	RPS19P1	NA	
ENSG00000101310	SEC23B	224100	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE II;;CDA II;;DYSERYTHROPOIETIC ANEMIA, HEMPAS TYPE;;HEREDITARY ERYTHROBLASTIC MULTINUCLEARITY WITH POSITIVE ACIDIFIED-SERUM TEST; HEMPAS
ENSG00000101310	SEC23B	616858	COWDEN SYNDROME 7; CWS7
ENSG00000232388	SMIM26	NA	
ENSG00000284776	AL121900.1	NA	
ENSG00000125821	DTD1	NA	
ENSG00000243702	RN7SL638P	NA	
ENSG00000221806	RNU6ATAC34P	NA	
ENSG00000232136	DUXAP7	NA	
ENSG00000233993	DTD1-AS1	NA	
ENSG00000233324	EEF1A1P34	NA	
ENSG00000179935	LINC00652	NA	
ENSG00000273148	LINC00653	NA	
ENSG00000149443	SCP2D1-AS1	NA	
ENSG00000132631	SCP2D1	NA	
ENSG00000274863	AL135936.1	NA	
ENSG00000287430	AL136090.2	NA	
ENSG00000185052	SLC24A3	NA	
ENSG00000235996	AL136090.1	NA	
ENSG00000179447	AL049647.1	NA	
ENSG00000232675	AL121830.1	NA	
ENSG00000268628	AL121761.1	NA	
ENSG00000132669	RIN2	613075	MACS SYNDROME;;MACROCEPHALY, ALOPECIA, CUTIS LAXA, AND SCOLIOSIS;;TALL FOREHEAD, SPARSE HAIR, SKIN HYPEREXTENSIBILITY, AND SCOLIOSIS
ENSG00000236992	RPL12P12	NA	
ENSG00000173418	NAA20	NA	
ENSG00000101343	CRNKL1	NA	
ENSG00000089101	CFAP61	NA	
ENSG00000241054	AL035454.1	NA	
ENSG00000225417	AL049648.1	NA	
ENSG00000229500	RPL17P1	NA	
ENSG00000243810	CFAP61-AS1	NA	
ENSG00000264879	RN7SL690P	NA	
ENSG00000280229	AL161658.1	NA	
ENSG00000173404	INSM1	NA	
ENSG00000188559	RALGAPA2	NA	
ENSG00000213384	EIF4E2P1	NA	
ENSG00000270793	LLPHP1	NA	
ENSG00000278525	RN7SL607P	NA	
ENSG00000225803	MRPS11P1	NA	
ENSG00000234104	AL133465.1	NA	
ENSG00000225127	LINC00237	NA	
ENSG00000283405	AL121759.2	NA	
ENSG00000235065	RPL24P2	NA	
ENSG00000088970	KIZ	615780	RETINITIS PIGMENTOSA 69; RP69
ENSG00000199509	RNA5SP477	NA	
ENSG00000228604	AL121759.1	NA	
ENSG00000232712	KIZ-AS1	NA	
ENSG00000214535	RPS15AP1	NA	
ENSG00000226875	ZNF877P	NA	
ENSG00000275457	AL117332.1	NA	
ENSG00000088930	XRN2	NA	
ENSG00000125816	NKX2-4	NA	
ENSG00000225280	AL158013.1	NA	
ENSG00000223128	RN7SKP140	NA	
ENSG00000226405	AL133325.1	NA	
ENSG00000278041	AL133325.3	NA	
ENSG00000227693	GSTM3P1	NA	
ENSG00000125820	NKX2-2	NA	
ENSG00000258197	NKX2-2-AS1	NA	
ENSG00000233492	AL133325.2	NA	
ENSG00000279082	LINC01727	NA	
ENSG00000280350	LINC01726	NA	
ENSG00000278410	AL121590.1	NA	
ENSG00000125813	PAX1	615560	OTOFACIOCERVICAL SYNDROME 2; OTFCS2;;OFC2
ENSG00000233015	SLC25A6P1	NA	
ENSG00000227063	RPL41P1	NA	
ENSG00000238034	AL109807.1	NA	
ENSG00000234435	LINC01432	NA	
ENSG00000234862	AL035258.1	NA	
ENSG00000225321	LINC01427	NA	
ENSG00000225170	AL049737.1	NA	
ENSG00000270838	AL121912.1	NA	
ENSG00000204684	AL133464.1	NA	
ENSG00000259974	LINC00261	NA	
ENSG00000125798	FOXA2	NA	
ENSG00000237396	LNCNEF	NA	
ENSG00000230400	LINC01747	NA	
ENSG00000283072	AL158175.1	NA	
ENSG00000215553	KRT18P3	NA	
ENSG00000213882	CYB5AP4	NA	
ENSG00000228935	AL353132.1	NA	
ENSG00000230492	AL049651.1	NA	
ENSG00000234646	AL049651.2	NA	
ENSG00000132671	SSTR4	NA	
ENSG00000178726	THBD	612926	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6
ENSG00000178726	THBD	614486	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12
ENSG00000279447	AL118508.3	NA	
ENSG00000125810	CD93	NA	
ENSG00000233746	LINC00656	NA	
ENSG00000279164	AL118508.2	NA	
ENSG00000201527	RNA5SP478	NA	
ENSG00000230387	AL118508.1	NA	
ENSG00000277901	AL390037.1	NA	
ENSG00000234832	NXT1-AS1	NA	
ENSG00000132661	NXT1	NA	
ENSG00000232645	LINC01431	NA	
ENSG00000125812	GZF1	617662	JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM
ENSG00000125814	NAPB	NA	
ENSG00000201728	RNA5SP479	NA	
ENSG00000125823	CSTL1	NA	
ENSG00000125831	CST11	NA	
ENSG00000273838	AL096677.1	NA	
ENSG00000200208	Y_RNA	NA	
ENSG00000226344	CST12P	NA	
ENSG00000260202	AL109954.1	NA	
ENSG00000276638	AL109954.2	NA	
ENSG00000125815	CST8	NA	
ENSG00000204663	CST13P	NA	
ENSG00000204662	CST9LP1	NA	
ENSG00000101435	CST9L	NA	
ENSG00000204658	CST9LP2	NA	
ENSG00000173335	CST9	NA	
ENSG00000101439	CST3	105150	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, ICELANDIC TYPE;;AMYLOIDOSIS VI;;HEREDITARY CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS; HCHWA;;CEREBRAL HEMORRHAGE, HEREDITARY, WITH AMYLOIDOSIS
ENSG00000101439	CST3	611953	MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11
ENSG00000270001	AL121894.2	NA	
ENSG00000225056	AL121894.1	NA	
ENSG00000286117	AL121894.3	NA	
ENSG00000101441	CST4	NA	
ENSG00000232595	CST2P1	NA	
ENSG00000286270	AL591074.2	NA	
ENSG00000170373	CST1	NA	
ENSG00000277975	CSTP2	NA	
ENSG00000230908	AL591074.1	NA	
ENSG00000170369	CST2	NA	
ENSG00000170367	CST5	NA	
ENSG00000228476	CSTP1	NA	
ENSG00000236168	AL133466.1	NA	
ENSG00000149435	GGTLC1	NA	
ENSG00000167390	POM121L3P	NA	
ENSG00000230133	LINC01721	NA	
ENSG00000236151	AL110503.1	NA	
ENSG00000200231	RNU1-23P	NA	
ENSG00000232200	AL158090.1	NA	
ENSG00000234069	GAPDHP53	NA	
ENSG00000101463	SYNDIG1	NA	
ENSG00000228539	AL157413.1	NA	
ENSG00000231015	AL049594.1	NA	
ENSG00000274173	AL035661.1	NA	
ENSG00000077984	CST7	NA	
ENSG00000101474	APMAP	NA	
ENSG00000207355	RNU6-1257P	NA	
ENSG00000286444	AL035661.2	NA	
ENSG00000154930	ACSS1	NA	
ENSG00000275358	AL080312.2	NA	
ENSG00000100987	VSX1	148300	KERATOCONUS 1; KTCN1
ENSG00000100987	VSX1	614195	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS
ENSG00000225069	AL080312.1	NA	
ENSG00000230725	AL035252.2	NA	
ENSG00000225344	AL035252.1	NA	
ENSG00000286472	AL035252.5	NA	
ENSG00000197586	ENTPD6	NA	
ENSG00000202414	Y_RNA	NA	
ENSG00000279322	AL035252.4	NA	
ENSG00000277938	AL035252.3	NA	
ENSG00000274414	AL121772.1	NA	
ENSG00000100994	PYGB	NA	
ENSG00000274507	AL121772.2	NA	
ENSG00000276952	AL121772.3	NA	
ENSG00000100997	ABHD12	612674	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC
ENSG00000227379	PPIAP2	NA	
ENSG00000101003	GINS1	617827	IMMUNODEFICIENCY 55; IMD55
ENSG00000101004	NINL	NA	
ENSG00000251883	RNU6ATAC17P	NA	
ENSG00000170191	NANP	NA	
ENSG00000213742	ZNF337-AS1	NA	
ENSG00000242236	RN7SL594P	NA	
ENSG00000236542	MED28P7	NA	
ENSG00000130684	ZNF337	NA	
ENSG00000278383	AL031673.1	NA	
ENSG00000226465	AL390198.1	NA	
ENSG00000230772	VN1R108P	NA	
ENSG00000175170	FAM182B	NA	
ENSG00000275048	BSNDP1	NA	
ENSG00000250090	AL390198.2	NA	
ENSG00000274973	BSNDP2	NA	
ENSG00000228593	CFTRP1	NA	
ENSG00000226203	LINC01733	NA	
ENSG00000125804	FAM182A	NA	
ENSG00000231081	AL078587.1	NA	
ENSG00000287569	AL078587.2	NA	
ENSG00000204556	AL450124.1	NA	
ENSG00000277508	BSNDP3	NA	
ENSG00000240108	NCOR1P1	NA	
ENSG00000230440	AL391119.1	NA	
ENSG00000287211	AL121904.2	NA	
ENSG00000227195	MIR663AHG	NA	
ENSG00000238129	AL121904.1	NA	
ENSG00000284419	MIR663A	NA	
ENSG00000282826	FRG1CP	NA	
ENSG00000282870	FRG1DP	NA	
ENSG00000283568	5_8S_rRNA	NA	
ENSG00000283069	DUX4L32	NA	
ENSG00000282949	PCMTD1P7	NA	
ENSG00000282894	DUX4L33	NA	
ENSG00000282935	DUX4L34	NA	
ENSG00000282842	FRG2EP	NA	
ENSG00000283123	RARRES2P11	NA	
ENSG00000282968	AGGF1P10	NA	
ENSG00000282911	DUX4L35	NA	
ENSG00000282995	FRG1EP	NA	
ENSG00000287889	FAM242B	NA	
ENSG00000283592	Y_RNA	NA	
ENSG00000282921	CFTRP2	NA	
ENSG00000283291	5_8S_rRNA	NA	
ENSG00000283005	CDC27P3	NA	
ENSG00000283433	RNA5SP532	NA	
ENSG00000283020	DUX4L37	NA	
ENSG00000204555	CFTRP3	NA	
ENSG00000205611	LINC01597	NA	
ENSG00000286483	AL121762.1	NA	
ENSG00000287288	AL121762.2	NA	
ENSG00000200325	Y_RNA	NA	
ENSG00000231934	FAM242A	NA	
ENSG00000149531	FRG1BP	NA	
ENSG00000238151	MLLT10P1	NA	
ENSG00000275877	5_8S_rRNA	NA	
ENSG00000283443	AC018688.1	NA	
ENSG00000277112	ANKRD20A21P	NA	
ENSG00000274385	U6	NA	
ENSG00000275305	RNA5SP528	NA	
ENSG00000215547	DEFB115	NA	
ENSG00000215546	DKKL1P1	NA	
ENSG00000224628	AL121723.1	NA	
ENSG00000215545	DEFB116	NA	
ENSG00000237929	RPL31P3	NA	
ENSG00000236121	HAUS6P2	NA	
ENSG00000252649	RNA5SP480	NA	
ENSG00000212717	DEFB117	NA	
ENSG00000131068	DEFB118	NA	
ENSG00000212134	AL031650.1	NA	
ENSG00000180483	DEFB119	NA	
ENSG00000204548	DEFB121	NA	
ENSG00000204547	DEFB122	NA	
ENSG00000180424	DEFB123	NA	
ENSG00000180383	DEFB124	NA	
ENSG00000088320	REM1	NA	
ENSG00000233354	LINC00028	NA	
ENSG00000101294	HM13	NA	
ENSG00000274364	AL110115.1	NA	
ENSG00000101898	MCTS2P	NA	
ENSG00000235313	HM13-IT1	NA	
ENSG00000230613	HM13-AS1	NA	
ENSG00000278276	AL110115.2	NA	
ENSG00000201770	RNU6-384P	NA	
ENSG00000125968	ID1	NA	
ENSG00000264395	MIR3193	NA	
ENSG00000131055	COX4I2	612714	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS
ENSG00000171552	BCL2L1	NA	
ENSG00000236559	BCL2L1-AS1	NA	
ENSG00000281376	ABALON	NA	
ENSG00000088325	TPX2	NA	
ENSG00000230801	AL160175.1	NA	
ENSG00000101306	MYLK2	192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC
ENSG00000179772	FOXS1	NA	
ENSG00000149599	DUSP15	NA	
ENSG00000131044	TTLL9	NA	
ENSG00000199497	RNU1-94P	NA	
ENSG00000088356	PDRG1	NA	
ENSG00000260903	XKR7	NA	
ENSG00000278012	AL031658.2	NA	
ENSG00000226239	AL031658.1	NA	
ENSG00000252623	RNA5SP481	NA	
ENSG00000101331	CCM2L	NA	
ENSG00000212571	RNA5SP482	NA	
ENSG00000101336	HCK	NA	
ENSG00000101337	TM9SF4	NA	
ENSG00000275576	AL049539.1	NA	
ENSG00000224452	RSL24D1P6	NA	
ENSG00000235217	TSPY26P	NA	
ENSG00000126003	PLAGL2	NA	
ENSG00000101346	POFUT1	615327	DOWLING-DEGOS DISEASE 2; DDD2
ENSG00000284125	MIR1825	NA	
ENSG00000287850	AL121897.1	NA	
ENSG00000101350	KIF3B	NA	
ENSG00000277692	AL121583.1	NA	
ENSG00000171456	ASXL1	605039	BOHRING-OPITZ SYNDROME; BOPS;;BOS;;C-LIKE SYNDROME;;OPITZ TRIGONOCEPHALY-LIKE SYNDROME;;BOHRING SYNDROME
ENSG00000171456	ASXL1	614286	MYELODYSPLASTIC SYNDROME; MDS;;MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED
ENSG00000197183	NOL4L	NA	
ENSG00000236772	AL034550.1	NA	
ENSG00000286311	AL034550.3	NA	
ENSG00000277301	AL034550.2	NA	
ENSG00000233293	AL133343.2	NA	
ENSG00000204393	NOL4L-DT	NA	
ENSG00000228156	AL133343.1	NA	
ENSG00000198547	C20orf203	NA	
ENSG00000285382	FO393400.1	NA	
ENSG00000175730	BAK1P1	NA	
ENSG00000149600	COMMD7	NA	
ENSG00000088305	DNMT3B	242860	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1;;IMMUNE DEFICIENCY, VARIABLE, WITH CENTROMERIC INSTABILITY OF CHROMOSOMES 1, 9, AND 16;;CENTROMERIC INSTABILITY, IMMUNODEFICIENCY SYNDROME; CIID;;IMMUNODEFICIENCY SYNDROME, V /.../E
ENSG00000101367	MAPRE1	NA	
ENSG00000260536	AL035071.2	NA	
ENSG00000260257	AL035071.1	NA	
ENSG00000215529	EFCAB8	NA	
ENSG00000167098	SUN5	617187	SPERMATOGENIC FAILURE 16; SPGF16;;ACEPHALIC SPERMATOZOA SYNDROME
ENSG00000078898	BPIFB2	NA	
ENSG00000167104	BPIFB6	NA	
ENSG00000214245	PUDPP3	NA	
ENSG00000186190	BPIFB3	NA	
ENSG00000186191	BPIFB4	NA	
ENSG00000131050	BPIFA2	NA	
ENSG00000237662	SOCS2P1	NA	
ENSG00000183566	BPIFA4P	NA	
ENSG00000224876	AL121901.1	NA	
ENSG00000131059	BPIFA3	NA	
ENSG00000198183	BPIFA1	NA	
ENSG00000233106	RPL12P3	NA	
ENSG00000125999	BPIFB1	NA	
ENSG00000233146	BPIFB5P	NA	
ENSG00000125997	BPIFB9P	NA	
ENSG00000101391	CDK5RAP1	NA	
ENSG00000101400	SNTA1	612955	LONG QT SYNDROME 12; LQT12
ENSG00000078699	CBFA2T2	NA	
ENSG00000275223	AL121906.2	NA	
ENSG00000125967	NECAB3	NA	
ENSG00000149609	C20orf144	NA	
ENSG00000182584	ACTL10	NA	
ENSG00000271803	AL121906.1	NA	
ENSG00000101412	E2F1	NA	
ENSG00000101417	PXMP4	NA	
ENSG00000229188	AL050349.1	NA	
ENSG00000131061	ZNF341	618282	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3
ENSG00000230837	RPL31P2	NA	
ENSG00000230753	ZNF341-AS1	NA	
ENSG00000101421	CHMP4B	605387	CATARACT 31, MULTIPLE TYPES; CTRCT31;;CATARACT, POSTERIOR POLAR, 3; CTPP3; CPP3
ENSG00000214200	TPM3P2	NA	
ENSG00000228958	PIGPP3	NA	
ENSG00000285230	RALY-AS1	NA	
ENSG00000125970	RALY	NA	
ENSG00000228386	AL031668.1	NA	
ENSG00000264616	MIR4755	NA	
ENSG00000125977	EIF2S2	NA	
ENSG00000225246	RPS2P1	NA	
ENSG00000287853	AL031668.2	NA	
ENSG00000101440	ASIP	611742	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9;;SKIN/HAIR/EYE PIGMENTATION 9, DARK/LIGHT HAIR;;SKIN/HAIR/EYE PIGMENTATION 9, BROWN/NONBROWN EYES;;SKIN/HAIR/EYE PIGMENTATION 9, RED/NONRED HAIR;;SKIN/HAIR/EYE PIGMENTATION 9, FRECKLING/SUNBURN
ENSG00000214185	XPOTP1	NA	
ENSG00000250917	AL035458.2	NA	
ENSG00000236456	AL035458.1	NA	
ENSG00000101444	AHCY	613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY
ENSG00000272945	AL356299.2	NA	
ENSG00000234087	AL356299.1	NA	
ENSG00000078747	ITCH	613385	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD
ENSG00000201498	Y_RNA	NA	
ENSG00000234933	CDC42P1	NA	
ENSG00000236388	ITCH-AS1	NA	
ENSG00000231795	ITCH-IT1	NA	
ENSG00000207997	MIR644A	NA	
ENSG00000181741	FDX1P1	NA	
ENSG00000277558	AL109923.1	NA	
ENSG00000125971	DYNLRB1	NA	
ENSG00000206582	Y_RNA	NA	
ENSG00000101460	MAP1LC3A	NA	
ENSG00000101464	PIGU	618590	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 21; GPIBD21;;NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS
ENSG00000231034	AL118520.1	NA	
ENSG00000198646	NCOA6	NA	
ENSG00000078804	TP53INP2	NA	
ENSG00000286803	AL109824.1	NA	
ENSG00000225336	HMGB3P1	NA	
ENSG00000131067	GGT7	NA	
ENSG00000131069	ACSS2	NA	
ENSG00000100983	GSS	231900	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE
ENSG00000100983	GSS	266130	GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD;;5-@OXOPROLINURIA;;PYROGLUTAMIC ACIDURIA
ENSG00000078814	MYH7B	NA	
ENSG00000207635	MIR499A	NA	
ENSG00000283441	MIR499B	NA	
ENSG00000100991	TRPC4AP	NA	
ENSG00000202150	RNU6-407P	NA	
ENSG00000088298	EDEM2	NA	
ENSG00000201151	AL135844.1	NA	
ENSG00000101000	PROCR	NA	
ENSG00000278367	AL356652.1	NA	
ENSG00000200301	RNA5SP483	NA	
ENSG00000126005	MMP24OS	NA	
ENSG00000229230	MT1P3	NA	
ENSG00000125966	MMP24	NA	
ENSG00000279253	AL121753.2	NA	
ENSG00000261582	AL121753.1	NA	
ENSG00000242372	EIF6	NA	
ENSG00000235214	FAM83C-AS1	NA	
ENSG00000125998	FAM83C	NA	
ENSG00000101019	UQCC1	NA	
ENSG00000204183	GDF5-AS1	NA	
ENSG00000125965	GDF5	113100	BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE
ENSG00000125965	GDF5	112600	BRACHYDACTYLY, TYPE A2; BDA2;;BRACHYMESOPHALANGY II;;MOHR-WRIEDT TYPE BRACHYDACTYLY
ENSG00000125965	GDF5	200700	CHONDRODYSPLASIA, GREBE TYPE;;ACHONDROGENESIS, BRAZILIAN;;GREBE CHONDRODYSPLASIA;;GREBE DYSPLASIA;;ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;;ACHONDROGENESIS, TYPE II, FORMERLY
ENSG00000125965	GDF5	201250	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE; AMDH;;ACROMESOMELIC DWARFISM
ENSG00000125965	GDF5	228900	DU PAN SYNDROME; DUPANS;;FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY
ENSG00000125965	GDF5	610017	MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2
ENSG00000125965	GDF5	612400	OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5;;OSTEOARTHRITIS OF HIP
ENSG00000125965	GDF5	615072	BRACHYDACTYLY, TYPE A1, C; BDA1C
ENSG00000125965	GDF5	615298	SYMPHALANGISM, PROXIMAL, 1B; SYM1B
ENSG00000221763	MIR1289-1	NA	
ENSG00000126001	CEP250	618358	CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2
ENSG00000230155	CEP250-AS1	NA	
ENSG00000242507	FO393401.1	NA	
ENSG00000125975	C20orf173	NA	
ENSG00000125991	ERGIC3	NA	
ENSG00000224497	RPL36P4	NA	
ENSG00000088340	FER1L4	NA	
ENSG00000227401	RPL37P1	NA	
ENSG00000061656	SPAG4	NA	
ENSG00000214078	CPNE1	NA	
ENSG00000272897	AL109827.1	NA	
ENSG00000222460	RN7SKP271	NA	
ENSG00000252549	RNU6-759P	NA	
ENSG00000244462	RBM12	617629	SCHIZOPHRENIA 19; SCZD19;;SCHIZOPHRENIA 19 WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000244005	NFS1	NA	
ENSG00000125995	ROMO1	NA	
ENSG00000131051	RBM39	NA	
ENSG00000225357	RPF2P1	NA	
ENSG00000283527	U6	NA	
ENSG00000025293	PHF20	NA	
ENSG00000234274	COX7BP2	NA	
ENSG00000199676	Y_RNA	NA	
ENSG00000219608	HIGD1AP16	NA	
ENSG00000201221	RNU4-40P	NA	
ENSG00000207053	RNU6-937P	NA	
ENSG00000171222	SCAND1	NA	
ENSG00000149646	CNBD2	NA	
ENSG00000260032	NORAD	NA	
ENSG00000234139	AL035420.1	NA	
ENSG00000277235	AL035420.3	NA	
ENSG00000231470	HMGB3P2	NA	
ENSG00000237063	AL035420.2	NA	
ENSG00000088367	EPB41L1	614257	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11
ENSG00000232406	AL121895.1	NA	
ENSG00000278035	AL121895.2	NA	
ENSG00000131043	AAR2	NA	
ENSG00000080845	DLGAP4	NA	
ENSG00000232907	DLGAP4-AS1	NA	
ENSG00000101335	MYL9	NA	
ENSG00000273986	Metazoa_SRP	NA	
ENSG00000118707	TGIF2	NA	
ENSG00000259399	TGIF2-RAB5IF	NA	
ENSG00000101084	RAB5IF	NA	
ENSG00000101082	SLA2	NA	
ENSG00000227688	HNRNPA3P2	NA	
ENSG00000101079	NDRG3	NA	
ENSG00000202255	Y_RNA	NA	
ENSG00000149636	DSN1	NA	
ENSG00000149639	SOGA1	NA	
ENSG00000242509	RN7SL156P	NA	
ENSG00000101342	TLDC2	NA	
ENSG00000101347	SAMHD1	612952	AICARDI-GOUTIERES SYNDROME 5; AGS5
ENSG00000101347	SAMHD1	614415	CHILBLAIN LUPUS 2; CHBL2
ENSG00000080839	RBL1	NA	
ENSG00000231241	RPS3AP3	NA	
ENSG00000226144	RPS27AP3	NA	
ENSG00000269846	AL136172.1	NA	
ENSG00000101353	MROH8	NA	
ENSG00000236159	AL031659.1	NA	
ENSG00000118705	RPN2	NA	
ENSG00000118702	GHRH	NA	
ENSG00000101363	MANBAL	NA	
ENSG00000286240	AL034422.1	NA	
ENSG00000197122	SRC	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000197122	SRC	616937	THROMBOCYTOPENIA 6; THC6;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 6
ENSG00000213979	RPL7AP14	NA	
ENSG00000166619	BLCAP	NA	
ENSG00000053438	NNAT	NA	
ENSG00000276603	AL109614.1	NA	
ENSG00000235044	PPIAP3	NA	
ENSG00000274469	LINC01746	NA	
ENSG00000228234	GLRXP1	NA	
ENSG00000225759	LINC00489	NA	
ENSG00000204117	AL162293.1	NA	
ENSG00000132792	CTNNBL1	NA	
ENSG00000132821	VSTM2L	NA	
ENSG00000199683	RN7SKP185	NA	
ENSG00000101407	TTI1	NA	
ENSG00000101413	RPRD1B	NA	
ENSG00000264767	RN7SL237P	NA	
ENSG00000277550	AL031651.1	NA	
ENSG00000198959	TGM2	NA	
ENSG00000149633	KIAA1755	NA	
ENSG00000277829	AL031651.2	NA	
ENSG00000285144	AL359555.3	NA	
ENSG00000285347	AL359555.4	NA	
ENSG00000285100	AL359555.2	NA	
ENSG00000206249	AL359555.1	NA	
ENSG00000101425	BPI	NA	
ENSG00000129988	LBP	NA	
ENSG00000275285	AL391095.2	NA	
ENSG00000224635	AL391095.1	NA	
ENSG00000275401	AL391095.3	NA	
ENSG00000196756	SNHG17	NA	
ENSG00000277034	SNORA71	NA	
ENSG00000235408	SNORA71B	NA	
ENSG00000225091	SNORA71A	NA	
ENSG00000201512	SNORA71C	NA	
ENSG00000200354	SNORA71D	NA	
ENSG00000201811	SNORA71	NA	
ENSG00000174365	SNHG11	NA	
ENSG00000274309	SNORA71E	NA	
ENSG00000199266	SNORA60	NA	
ENSG00000170471	RALGAPB	NA	
ENSG00000275453	MIR548O2	NA	
ENSG00000231307	RPS3P2	NA	
ENSG00000182035	ADIG	NA	
ENSG00000124143	ARHGAP40	NA	
ENSG00000213959	AL035419.1	NA	
ENSG00000277965	Metazoa_SRP	NA	
ENSG00000101438	SLC32A1	NA	
ENSG00000101442	ACTR5	NA	
ENSG00000199691	RN7SKP173	NA	
ENSG00000101445	PPP1R16B	NA	
ENSG00000240474	RN7SL116P	NA	
ENSG00000101447	FAM83D	NA	
ENSG00000274825	AL023803.2	NA	
ENSG00000261431	AL023803.1	NA	
ENSG00000101452	DHX35	NA	
ENSG00000277581	AL023803.3	NA	
ENSG00000223864	NPM1P19	NA	
ENSG00000230324	LINC01734	NA	
ENSG00000287983	AL035251.1	NA	
ENSG00000224357	ATG3P1	NA	
ENSG00000275337	RN7SL680P	NA	
ENSG00000286083	AL132981.1	NA	
ENSG00000229976	AL118523.1	NA	
ENSG00000234878	HSPE1P1	NA	
ENSG00000237767	LINC01370	NA	
ENSG00000233415	AL133419.1	NA	
ENSG00000223410	AL009050.1	NA	
ENSG00000204103	MAFB	166300	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO;;OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH OR WITHOUT NEPHROPATHY;;MULTICENTRIC OSTEOLYSIS, AUTOSOMAL DOMINANT
ENSG00000204103	MAFB	617041	DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3
ENSG00000229771	AL035665.1	NA	
ENSG00000286972	AL035665.2	NA	
ENSG00000238908	RNA5SP484	NA	
ENSG00000222612	RNU2-52P	NA	
ENSG00000198900	TOP1	NA	
ENSG00000226648	PLCG1-AS1	NA	
ENSG00000124181	PLCG1	NA	
ENSG00000276169	MIR6871	NA	
ENSG00000174306	ZHX3	NA	
ENSG00000272407	AL022394.1	NA	
ENSG00000242748	RPL23AP81	NA	
ENSG00000263989	RN7SL615P	NA	
ENSG00000235102	ADI1P1	NA	
ENSG00000132793	LPIN3	NA	
ENSG00000183798	EMILIN3	NA	
ENSG00000229398	AL031667.1	NA	
ENSG00000124177	CHD6	NA	
ENSG00000235088	AL031667.2	NA	
ENSG00000273951	AL031667.3	NA	
ENSG00000232493	RPL12P11	NA	
ENSG00000252386	RNU6-1018P	NA	
ENSG00000212224	AL133229.1	NA	
ENSG00000225458	AL049812.2	NA	
ENSG00000223651	AL049812.1	NA	
ENSG00000228959	AL049812.3	NA	
ENSG00000196090	PTPRT	NA	
ENSG00000229892	AL035666.1	NA	
ENSG00000229042	AL031656.1	NA	
ENSG00000227599	PTPRT-AS1	NA	
ENSG00000223190	RN7SKP100	NA	
ENSG00000233508	AL021395.1	NA	
ENSG00000240639	RN7SL666P	NA	
ENSG00000226038	PPIAP21	NA	
ENSG00000252193	AL021395.2	NA	
ENSG00000237555	AL031681.2	NA	
ENSG00000201021	RNU6-743P	NA	
ENSG00000233711	EIF4EBP2P1	NA	
ENSG00000206998	AL031681.1	NA	
ENSG00000124193	SRSF6	NA	
ENSG00000288000	AL031681.3	NA	
ENSG00000201372	RNU6-1251P	NA	
ENSG00000185513	L3MBTL1	NA	
ENSG00000234271	Z98752.2	NA	
ENSG00000277611	Z98752.3	NA	
ENSG00000226143	Z98752.1	NA	
ENSG00000101049	SGK2	NA	
ENSG00000282876	Z98752.4	NA	
ENSG00000101052	IFT52	617102	SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16
ENSG00000215467	RPL27AP	NA	
ENSG00000101057	MYBL2	NA	
ENSG00000124196	GTSF1L	NA	
ENSG00000206801	RNU6-639P	NA	
ENSG00000233277	LINC01728	NA	
ENSG00000124191	TOX2	NA	
ENSG00000241229	RN7SL443P	NA	
ENSG00000149596	JPH2	613873	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17
ENSG00000287570	AL035447.1	NA	
ENSG00000132823	OSER1	NA	
ENSG00000223891	OSER1-DT	NA	
ENSG00000124194	GDAP1L1	NA	
ENSG00000197296	FITM2	618635	SIDDIQI SYNDROME; SIDDIS;;DEAFNESS, DYSTONIA, DEVELOPMENTAL DELAY, AND POOR GROWTH
ENSG00000101074	R3HDML	NA	
ENSG00000201363	AL117382.1	NA	
ENSG00000226812	AL117382.2	NA	
ENSG00000101076	HNF4A	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000101076	HNF4A	125850	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1;;MODY, TYPE 1;;MILD JUVENILE DIABETES MELLITUS
ENSG00000101076	HNF4A	616026	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4;;FRTS4 WITH MODY
ENSG00000229005	HNF4A-AS1	NA	
ENSG00000233376	AL117382.3	NA	
ENSG00000266151	MIR3646	NA	
ENSG00000168746	LINC01620	NA	
ENSG00000226243	RPL37AP1	NA	
ENSG00000124120	TTPAL	NA	
ENSG00000132824	SERINC3	NA	
ENSG00000168734	PKIG	NA	
ENSG00000196839	ADA	102700	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY;;SCID DUE TO ADA DEFICIENCY;;ADA-SCID;;SCID DUE TO ADA DEFICIENCY, EARLY-ONSET SCID DUE TO ADA DEFICIENC /.../AYED ONSET, INCLUDED;;SCID DUE TO ADA DEFICIENCY, LATE-ONSET, INCLUDED;;ADENOSINE DEAMINASE DEFICIENCY, PARTIAL, INCLUDED;;PARTIAL ADA DEFICIENCY, INCLUDED
ENSG00000283440	LINC01260	NA	
ENSG00000132832	AL139352.1	NA	
ENSG00000244558	KCNK15-AS1	NA	
ENSG00000064205	CCN5	NA	
ENSG00000124249	KCNK15	NA	
ENSG00000276223	AL118522.1	NA	
ENSG00000101098	RIMS4	NA	
ENSG00000277708	PGBD4P2	NA	
ENSG00000286100	AL008725.1	NA	
ENSG00000166913	YWHAB	NA	
ENSG00000101104	PABPC1L	NA	
ENSG00000025772	TOMM34	NA	
ENSG00000227477	STK4-AS1	NA	
ENSG00000101109	STK4	614868	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC;;STK4 DEFICIENCY;;MST1 DEFICIENCY
ENSG00000252021	Y_RNA	NA	
ENSG00000124134	KCNS1	NA	
ENSG00000175121	WFDC5	NA	
ENSG00000168703	WFDC12	NA	
ENSG00000283142	AL049767.1	NA	
ENSG00000124102	PI3	NA	
ENSG00000124233	SEMG1	NA	
ENSG00000124157	SEMG2	NA	
ENSG00000233352	AL035660.1	NA	
ENSG00000243995	AL035660.2	NA	
ENSG00000124107	SLPI	NA	
ENSG00000124159	MATN4	NA	
ENSG00000124232	RBPJL	NA	
ENSG00000124145	SDC4	NA	
ENSG00000275894	AL021578.1	NA	
ENSG00000204070	SYS1	NA	
ENSG00000254806	SYS1-DBNDD2	NA	
ENSG00000124251	TP53TG5	NA	
ENSG00000232880	NDUFB4P10	NA	
ENSG00000244274	DBNDD2	NA	
ENSG00000124155	PIGT	615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 7; GPIBD7
ENSG00000124155	PIGT	615399	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2
ENSG00000273555	MIR6812	NA	
ENSG00000277022	AL031663.3	NA	
ENSG00000101443	WFDC2	NA	
ENSG00000237464	AL031663.2	NA	
ENSG00000237068	RPL5P2	NA	
ENSG00000101446	SPINT3	NA	
ENSG00000249139	EPPIN-WFDC6	NA	
ENSG00000243543	WFDC6	NA	
ENSG00000232135	AL031663.1	NA	
ENSG00000229900	HSPD1P21	NA	
ENSG00000101448	EPPIN	NA	
ENSG00000158901	WFDC8	NA	
ENSG00000201923	RNA5SP485	NA	
ENSG00000230860	CCNB1IP1P2	NA	
ENSG00000180205	WFDC9	NA	
ENSG00000180305	WFDC10A	NA	
ENSG00000235508	RPS2P7	NA	
ENSG00000180083	WFDC11	NA	
ENSG00000182931	WFDC10B	NA	
ENSG00000168634	WFDC13	NA	
ENSG00000266071	MIR3617	NA	
ENSG00000149651	SPINT4	NA	
ENSG00000226188	HNRNPA1P3	NA	
ENSG00000124116	WFDC3	NA	
ENSG00000168630	SPINT5P	NA	
ENSG00000221046	RNU6ATAC38P	NA	
ENSG00000101457	DNTTIP1	NA	
ENSG00000175063	UBE2C	NA	
ENSG00000101470	TNNC2	NA	
ENSG00000124104	SNX21	NA	
ENSG00000101473	ACOT8	NA	
ENSG00000277051	Metazoa_SRP	NA	
ENSG00000132801	ZSWIM3	NA	
ENSG00000168612	ZSWIM1	NA	
ENSG00000149634	SPATA25	NA	
ENSG00000124257	NEURL2	NA	
ENSG00000064601	CTSA	256540	GALACTOSIALIDOSIS; GSL;;GOLDBERG SYNDROME;;NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY;;NEURAMINIDASE/BETA-GALACTOSIDASE EXPRESSION; NGBE;;LYSOSOMAL PROTECTIVE PROTEIN DEFICIENCY;;CATHEPSIN A DEFICIENCY;;PROTECTIVE PROTEIN/CATHEPSIN  /.../CIENCY;;PPCA DEFICIENCY
ENSG00000271984	AL008726.1	NA	
ENSG00000100979	PLTP	172425	PHOSPHOLIPID TRANSFER PROTEIN; PLTP;;LIPID TRANSFER PROTEIN II  HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 9, INCLUDED; HDLCQ9, INCLUDED
ENSG00000285796	AL162458.1	NA	
ENSG00000100982	PCIF1	NA	
ENSG00000198026	ZNF335	615095	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10
ENSG00000235525	FTLP1	NA	
ENSG00000100985	MMP9	613073	METAPHYSEAL ANADYSPLASIA 2; MANDP2
ENSG00000204044	SLC12A5-AS1	NA	
ENSG00000124140	SLC12A5	616645	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34
ENSG00000124140	SLC12A5	616685	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14
ENSG00000124160	NCOA5	NA	
ENSG00000213820	RPL13P2	NA	
ENSG00000101017	CD40	606843	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3;;HYPER-IgM SYNDROME 3
ENSG00000229957	AL031687.1	NA	
ENSG00000149654	CDH22	NA	
ENSG00000080189	SLC35C2	NA	
ENSG00000273828	AL133227.1	NA	
ENSG00000062598	ELMO2	606893	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS;;VASCULAR MALFORMATION OSSEOUS; VMOS;;HEMANGIOMA, INTRAOSSEOUS
ENSG00000215452	ZNF663P	NA	
ENSG00000283757	AL031686.1	NA	
ENSG00000225849	MKRN7P	NA	
ENSG00000184617	ZNF840P	NA	
ENSG00000198185	ZNF334	NA	
ENSG00000149635	OCSTAMP	NA	
ENSG00000158296	SLC13A3	618384	LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK
ENSG00000273893	AL133520.1	NA	
ENSG00000172315	TP53RK	617730	GALLOWAY-MOWAT SYNDROME 4; GAMOS4
ENSG00000271784	AL031055.1	NA	
ENSG00000197496	SLC2A10	208050	ARTERIAL TORTUOSITY SYNDROME; ATORS;;ATS;;ARTERIAL TORTUOSITY
ENSG00000222874	RN7SKP33	NA	
ENSG00000235922	AL354766.1	NA	
ENSG00000064655	EYA2	NA	
ENSG00000236028	AL354766.2	NA	
ENSG00000226769	GAPDHP54	NA	
ENSG00000239783	AL121776.1	NA	
ENSG00000215450	AL022342.1	NA	
ENSG00000264901	MIR3616	NA	
ENSG00000101040	ZMYND8	NA	
ENSG00000267882	AL031666.2	NA	
ENSG00000273451	AL031666.3	NA	
ENSG00000231119	AL031666.1	NA	
ENSG00000224565	LINC01754	NA	
ENSG00000234075	RPL35AP	NA	
ENSG00000202186	RNU6-497P	NA	
ENSG00000201742	RNU6-563P	NA	
ENSG00000124151	NCOA3	NA	
ENSG00000229853	AL034418.1	NA	
ENSG00000196562	SULF2	NA	
ENSG00000255438	AL354813.1	NA	
ENSG00000238950	RNU7-173P	NA	
ENSG00000215448	SRMP1	NA	
ENSG00000251770	RNA5SP486	NA	
ENSG00000238785	RNU7-92P	NA	
ENSG00000234967	AL357558.2	NA	
ENSG00000228503	AL357558.1	NA	
ENSG00000287443	AL357558.3	NA	
ENSG00000237423	LINC01522	NA	
ENSG00000229522	LINC01523	NA	
ENSG00000286179	AL139351.2	NA	
ENSG00000287335	AL139351.3	NA	
ENSG00000276923	AL139351.1	NA	
ENSG00000287107	AL136102.1	NA	
ENSG00000288083	AL121888.2	NA	
ENSG00000286063	AL121888.1	NA	
ENSG00000235621	LINC00494	NA	
ENSG00000236874	AL137078.1	NA	
ENSG00000274261	AL137078.2	NA	
ENSG00000281365	AL049541.1	NA	
ENSG00000281460	AL049541.2	NA	
ENSG00000238452	RNU7-144P	NA	
ENSG00000124126	PREX1	NA	
ENSG00000286159	AL035106.1	NA	
ENSG00000278231	AL133342.1	NA	
ENSG00000124198	ARFGEF2	608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM;;PERIVENTRICULAR NODULAR HETEROTOPIA 2; PVNH2;;HETEROTOPIA, PERIVENTRICULAR, AUTOSOMAL RECESSIVE
ENSG00000230758	SNAP23P1	NA	
ENSG00000227431	CSE1L-AS1	NA	
ENSG00000124207	CSE1L	NA	
ENSG00000124214	STAU1	NA	
ENSG00000226284	ARPC3P1	NA	
ENSG00000124228	DDX27	NA	
ENSG00000124201	ZNFX1	NA	
ENSG00000177410	ZFAS1	NA	
ENSG00000277830	AL049766.2	NA	
ENSG00000209042	SNORD12C	NA	
ENSG00000274760	AL049766.1	NA	
ENSG00000222365	SNORD12B	NA	
ENSG00000277967	AL049766.3	NA	
ENSG00000212304	SNORD12	NA	
ENSG00000158445	KCNB1	616056	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26
ENSG00000283529	AL035685.1	NA	
ENSG00000124212	PTGIS	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000158470	B4GALT5	NA	
ENSG00000276031	RN7SL197P	NA	
ENSG00000231878	SNRPFP1	NA	
ENSG00000252540	RNU6-919P	NA	
ENSG00000197818	SLC9A8	NA	
ENSG00000237788	AL162615.1	NA	
ENSG00000158480	SPATA2	NA	
ENSG00000199490	Y_RNA	NA	
ENSG00000269103	Metazoa_SRP	NA	
ENSG00000124226	RNF114	NA	
ENSG00000229222	KRT18P4	NA	
ENSG00000206710	RNU6-147P	NA	
ENSG00000124216	SNAI1	NA	
ENSG00000231265	TRERNA1	NA	
ENSG00000124208	TMEM189-UBE2V1	NA	
ENSG00000244687	UBE2V1	NA	
ENSG00000240849	TMEM189	NA	
ENSG00000237595	LINC01275	NA	
ENSG00000231742	LINC01273	NA	
ENSG00000234698	AL161937.1	NA	
ENSG00000277449	CEBPB-AS1	NA	
ENSG00000172216	CEBPB	NA	
ENSG00000224397	PELATON	NA	
ENSG00000203999	LINC01270	NA	
ENSG00000233077	LINC01271	NA	
ENSG00000244376	RN7SL636P	NA	
ENSG00000231715	COX6CP2	NA	
ENSG00000196396	PTPN1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000239742	RN7SL672P	NA	
ENSG00000201501	Y_RNA	NA	
ENSG00000232043	AL133230.1	NA	
ENSG00000208018	MIR645	NA	
ENSG00000042062	RIPOR3	NA	
ENSG00000221091	MIR1302-5	NA	
ENSG00000231302	RPL36P2	NA	
ENSG00000234693	RIPOR3-AS1	NA	
ENSG00000124171	PARD6B	NA	
ENSG00000124243	BCAS4	NA	
ENSG00000230043	TMSB4XP6	NA	
ENSG00000101126	ADNP	615873	HELSMOORTEL-VAN DER AA SYNDROME; HVDAS;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 28; MRD28
ENSG00000228663	PSMD10P1	NA	
ENSG00000259456	ADNP-AS1	NA	
ENSG00000000419	DPM1	608799	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E;;CDG Ie; CDGIe
ENSG00000124217	MOCS3	NA	
ENSG00000232358	AL050404.1	NA	
ENSG00000026559	KCNG1	NA	
ENSG00000279835	AL121785.1	NA	
ENSG00000228820	RPSAP1	NA	
ENSG00000101096	NFATC2	NA	
ENSG00000266761	MIR3194	NA	
ENSG00000054793	ATP9A	NA	
ENSG00000215444	AL138807.1	NA	
ENSG00000101115	SALL4	147750	IVIC SYNDROME;;RADIAL RAY DEFECTS, HEARING IMPAIRMENT, EXTERNAL OPHTHALMOPLEGIA, AND THROMBOCYTOPENIA;;OCULOOTORADIAL SYNDROME; OORS
ENSG00000101115	SALL4	607323	DUANE-RADIAL RAY SYNDROME; DRRS;;OKIHIRO SYNDROME;;DUANE ANOMALY WITH RADIAL RAY ABNORMALITIES AND DEAFNESS;;DR SYNDROME;;ACRORENOOCULAR SYNDROME
ENSG00000227964	LINC01429	NA	
ENSG00000252467	RNU6-347P	NA	
ENSG00000252654	RNU7-6P	NA	
ENSG00000020256	ZFP64	NA	
ENSG00000287511	AL109984.1	NA	
ENSG00000233347	ERP29P1	NA	
ENSG00000234948	LINC01524	NA	
ENSG00000225785	AL109610.1	NA	
ENSG00000275958	AL049765.2	NA	
ENSG00000232465	AL049765.1	NA	
ENSG00000234821	MRPS33P4	NA	
ENSG00000232294	AL031674.1	NA	
ENSG00000286250	AL161945.1	NA	
ENSG00000232286	AL121902.1	NA	
ENSG00000230636	RPL36P1	NA	
ENSG00000182463	TSHZ2	NA	
ENSG00000199218	RN7SKP184	NA	
ENSG00000286865	AL391097.3	NA	
ENSG00000223492	AL391097.1	NA	
ENSG00000227705	AL391097.2	NA	
ENSG00000271774	AL109930.1	NA	
ENSG00000231703	AL354993.1	NA	
ENSG00000224530	PPIAP10	NA	
ENSG00000259723	AL354993.2	NA	
ENSG00000206959	Y_RNA	NA	
ENSG00000197670	AL157838.1	NA	
ENSG00000171940	ZNF217	NA	
ENSG00000235415	AC005808.1	NA	
ENSG00000238468	RNU7-14P	NA	
ENSG00000287886	AC005914.1	NA	
ENSG00000225563	AC006076.1	NA	
ENSG00000241721	SUMO1P1	NA	
ENSG00000064787	BCAS1	NA	
ENSG00000236352	AC005220.1	NA	
ENSG00000265595	MIR4756	NA	
ENSG00000019186	CYP24A1	143880	HYPERCALCEMIA, INFANTILE, 1; HCINF1;;HYPERCALCEMIA, IDIOPATHIC, OF INFANCY
ENSG00000286587	AL133335.2	NA	
ENSG00000101132	PFDN4	NA	
ENSG00000286229	AL133335.1	NA	
ENSG00000101134	DOK5	NA	
ENSG00000252089	RNU4ATAC7P	NA	
ENSG00000185834	RPL12P4	NA	
ENSG00000235166	LINC01440	NA	
ENSG00000224008	LINC01441	NA	
ENSG00000275923	AL160413.1	NA	
ENSG00000287478	AL109829.1	NA	
ENSG00000286006	AL109828.1	NA	
ENSG00000054803	CBLN4	NA	
ENSG00000222118	RNA5SP487	NA	
ENSG00000124089	MC3R	602025	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9;;OBESITY, SUSCEPTIBILITY TO
ENSG00000235594	AL139824.2	NA	
ENSG00000230843	AL139824.1	NA	
ENSG00000124098	FAM210B	NA	
ENSG00000087586	AURKA	NA	
ENSG00000101138	CSTF1	NA	
ENSG00000087589	CASS4	NA	
ENSG00000228601	RPL39P	NA	
ENSG00000022277	RTF2	NA	
ENSG00000124091	GCNT7	NA	
ENSG00000124103	FAM209A	NA	
ENSG00000280387	AL109806.1	NA	
ENSG00000213714	FAM209B	NA	
ENSG00000287079	AL109806.2	NA	
ENSG00000225657	LINC01716	NA	
ENSG00000214541	RPS4XP3	NA	
ENSG00000087510	TFAP2C	NA	
ENSG00000252091	RNU6-1146P	NA	
ENSG00000241821	RN7SL170P	NA	
ENSG00000237000	PTMAP6	NA	
ENSG00000231604	AL133232.1	NA	
ENSG00000207158	RNU6-929P	NA	
ENSG00000231078	AL157414.2	NA	
ENSG00000203266	AL157414.1	NA	
ENSG00000288086	AL157414.4	NA	
ENSG00000280220	AL157414.3	NA	
ENSG00000101144	BMP7	NA	
ENSG00000235032	BMP7-AS1	NA	
ENSG00000226308	AL122058.1	NA	
ENSG00000252064	Y_RNA	NA	
ENSG00000266666	MIR4325	NA	
ENSG00000231005	RPL39P39	NA	
ENSG00000054796	SPO11	NA	
ENSG00000101146	RAE1	NA	
ENSG00000228995	MTND1P9	NA	
ENSG00000256222	MTRNR2L3	NA	
ENSG00000218018	RBM38-AS1	NA	
ENSG00000132819	RBM38	NA	
ENSG00000286052	AL109955.1	NA	
ENSG00000124097	HMGB1P1	NA	
ENSG00000124092	CTCFL	NA	
ENSG00000124253	PCK1	261680	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC;;PCK1 DEFICIENCY, CYTOSOLIC;;PEPCK DEFICIENCY, CYTOSOLIC
ENSG00000227297	AL035541.1	NA	
ENSG00000124256	ZBP1	NA	
ENSG00000124225	PMEPA1	NA	
ENSG00000278709	NKILA	NA	
ENSG00000263453	AL162291.1	NA	
ENSG00000203971	AL354984.1	NA	
ENSG00000275852	LINC01742	NA	
ENSG00000225708	AL354984.2	NA	
ENSG00000270411	AL354984.3	NA	
ENSG00000124237	C20orf85	NA	
ENSG00000124227	ANKRD60	NA	
ENSG00000124224	PPP4R1L	NA	
ENSG00000124209	RAB22A	NA	
ENSG00000124164	VAPB	182980	SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK;;FINKEL LATE-ADULT TYPE SMA;;SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANT
ENSG00000124164	VAPB	608627	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8
ENSG00000198768	APCDD1L	NA	
ENSG00000231290	APCDD1L-DT	NA	
ENSG00000254620	AL050327.1	NA	
ENSG00000268941	LINC01711	NA	
ENSG00000124222	STX16	603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B;;PHP IB
ENSG00000254995	STX16-NPEPL1	NA	
ENSG00000215440	NPEPL1	NA	
ENSG00000254419	AL139349.1	NA	
ENSG00000237121	PIEZO1P2	NA	
ENSG00000270279	AL132655.3	NA	
ENSG00000268649	AL132655.2	NA	
ENSG00000284040	MIR296	NA	
ENSG00000216031	MIR298	NA	
ENSG00000235590	GNAS-AS1	603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B;;PHP IB
ENSG00000268333	AL132655.1	NA	
ENSG00000087460	GNAS	174800	MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROME POLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED
ENSG00000087460	GNAS	166350	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH;;ECTOPIC OSSIFICATION, FAMILIAL;;OSTEOMA CUTIS
ENSG00000087460	GNAS	103580	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE
ENSG00000087460	GNAS	219080	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1;;ACTH-INDEPENDENT MACRONODULAR ADRENOCORTICAL HYPERPLASIA;;ADRENOCORTICOTROPIC HORMONE-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA;;CORTICOTROPIN-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA /.../ING SYNDROME, ADRENAL, DUE TO AIMAH
ENSG00000087460	GNAS	603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B;;PHP IB
ENSG00000087460	GNAS	612462	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC
ENSG00000087460	GNAS	612463	PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE
ENSG00000087460	GNAS	617686	PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3
ENSG00000276859	AL132655.7	NA	
ENSG00000276722	AL132655.6	NA	
ENSG00000274491	AL132655.4	NA	
ENSG00000275069	AL132655.5	NA	
ENSG00000225806	AL121917.1	NA	
ENSG00000270951	AL121917.2	NA	
ENSG00000285091	AL109840.2	NA	
ENSG00000284985	AL109840.1	NA	
ENSG00000101158	NELFCD	NA	
ENSG00000101160	CTSZ	NA	
ENSG00000101162	TUBB1	613112	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED
ENSG00000124172	ATP5F1E	614053	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE
ENSG00000101166	PRELID3B	NA	
ENSG00000232925	MRPS16P2	NA	
ENSG00000124203	ZNF831	NA	
ENSG00000124205	EDN3	209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS;;AUTONOMIC CONTROL, CONGENITAL FAILURE OF;;ONDINE CURSE, CONGENITAL ONDINE-HIRSCHSPRUNG DISEASE, INCLUDED; OHD, INCLUDED;;CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;;HADDAD SYNDROME, INCLUDED
ENSG00000124205	EDN3	613265	WAARDENBURG SYNDROME, TYPE 4B; WS4B;;WAARDENBURG SYNDROME, TYPE 4B, WITH HIRSCHSPRUNG DISEASE;;WAARDENBURG SYNDROME, TYPE IVB
ENSG00000124205	EDN3	613712	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4
ENSG00000225129	AL035250.1	NA	
ENSG00000230352	AL035250.2	NA	
ENSG00000286309	AL160410.1	NA	
ENSG00000233686	PIEZO1P1	NA	
ENSG00000287752	AL389889.2	NA	
ENSG00000227282	AL389889.1	NA	
ENSG00000087495	PHACTR3	NA	
ENSG00000238194	PHACTR3-AS1	NA	
ENSG00000238777	RNU7-141P	NA	
ENSG00000196074	SYCP2	258150	SPERMATOGENIC FAILURE 1; SPGF1;;OLIGOSYNAPTIC INFERTILITY;;OLIGOCHIASMATIC INFERTILITY
ENSG00000196227	FAM217B	NA	
ENSG00000132825	PPP1R3D	NA	
ENSG00000124215	CDH26	NA	
ENSG00000176659	C20orf197	NA	
ENSG00000276093	AL132822.1	NA	
ENSG00000228340	MIR646HG	NA	
ENSG00000207802	MIR646	NA	
ENSG00000229690	MTCO2P1	NA	
ENSG00000266140	MIR4533	NA	
ENSG00000265617	MIR548AG2	NA	
ENSG00000276627	AL117372.1	NA	
ENSG00000261035	AL139348.1	NA	
ENSG00000229755	AL121910.1	NA	
ENSG00000229606	LINC01718	NA	
ENSG00000179242	CDH4	NA	
ENSG00000286232	AL365229.1	NA	
ENSG00000276786	BX640515.1	NA	
ENSG00000277270	AL160412.1	NA	
ENSG00000179253	AL162457.1	NA	
ENSG00000225106	AL162457.2	NA	
ENSG00000130699	TAF4	NA	
ENSG00000284193	MIR1257	NA	
ENSG00000235018	AL137077.1	NA	
ENSG00000265306	MIR3195	NA	
ENSG00000283078	AL137077.2	NA	
ENSG00000149657	LSM14B	NA	
ENSG00000101182	PSMA7	NA	
ENSG00000184402	SS18L1	NA	
ENSG00000101181	MTG2	NA	
ENSG00000101180	HRH3	NA	
ENSG00000130703	OSBPL2	616340	DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67
ENSG00000130706	ADRM1	NA	
ENSG00000226332	AL354836.1	NA	
ENSG00000130702	LAMA5	NA	
ENSG00000284074	MIR4758	NA	
ENSG00000228812	LAMA5-AS1	NA	
ENSG00000273619	AL121832.2	NA	
ENSG00000171858	RPS21	NA	
ENSG00000149679	CABLES2	NA	
ENSG00000275437	AL121832.3	NA	
ENSG00000130701	RBBP8NL	NA	
ENSG00000233017	AL121832.1	NA	
ENSG00000130700	GATA5	617912	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5
ENSG00000272050	AL499627.2	NA	
ENSG00000260542	AL499627.1	NA	
ENSG00000174403	MIR1-1HG-AS1	NA	
ENSG00000174407	MIR1-1HG	NA	
ENSG00000199017	MIR1-1	NA	
ENSG00000284508	MIR133A2	NA	
ENSG00000226094	RPL7P3	NA	
ENSG00000264490	BX640514.1	NA	
ENSG00000273812	BX640514.2	NA	
ENSG00000232121	AL450469.2	NA	
ENSG00000229882	AL450469.1	NA	
ENSG00000167046	AL357033.1	NA	
ENSG00000101187	SLCO4A1	NA	
ENSG00000277496	AL357033.4	NA	
ENSG00000276317	AL357033.3	NA	
ENSG00000232803	SLCO4A1-AS1	NA	
ENSG00000237687	LINC00686	NA	
ENSG00000101188	NTSR1	NA	
ENSG00000223669	AL357033.2	NA	
ENSG00000228705	LINC00659	NA	
ENSG00000101189	MRGBP	NA	
ENSG00000229873	OGFR-AS1	NA	
ENSG00000060491	OGFR	NA	
ENSG00000092758	COL9A3	600969	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3 EPIPHYSEAL DYSPLASIA, MULTIPLE, 3, WITH MYOPATHY, INCLUDED
ENSG00000092758	COL9A3	603932	INTERVERTEBRAL DISC DISEASE; IDD LUMBAR DISC DISEASE, INCLUDED; LDD, INCLUDED;;LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO, INCLUDED;;LUMBAR DISC DEGENERATION, SUSCEPTIBILITY TO, INCLUDED
ENSG00000101190	TCFL5	NA	
ENSG00000233838	DPH3P1	NA	
ENSG00000236527	ARF4P2	NA	
ENSG00000101191	DIDO1	NA	
ENSG00000273759	AL117379.1	NA	
ENSG00000101193	GID8	NA	
ENSG00000101194	SLC17A9	616063	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8
ENSG00000125533	BHLHE23	NA	
ENSG00000272259	LINC01749	NA	
ENSG00000125514	LINC00029	NA	
ENSG00000237119	LINC01056	NA	
ENSG00000231133	HAR1B	NA	
ENSG00000274915	AL096828.4	NA	
ENSG00000225978	HAR1A	NA	
ENSG00000287324	AL096828.6	NA	
ENSG00000260416	AL096828.2	NA	
ENSG00000286628	AL096828.5	NA	
ENSG00000231977	AL096828.1	NA	
ENSG00000207598	MIR124-3	NA	
ENSG00000149658	YTHDF1	NA	
ENSG00000273821	AL096828.3	NA	
ENSG00000101197	BIRC7	NA	
ENSG00000266463	MIR3196	NA	
ENSG00000101198	NKAIN4	NA	
ENSG00000275620	FLJ16779	NA	
ENSG00000101199	ARFGAP1	NA	
ENSG00000266104	MIR4326	NA	
ENSG00000101203	COL20A1	NA	
ENSG00000222439	RNU6-994P	NA	
ENSG00000101204	CHRNA4	188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO;;CIGARETTE HABITUATION, SUSCEPTIBILITY TO;;SMOKING HABIT, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO;;NICOTINE ADDICTION, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, PROTECTION AGAINST
ENSG00000101204	CHRNA4	600513	EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1
ENSG00000203900	AL121827.1	NA	
ENSG00000075043	KCNQ2	121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1 EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED
ENSG00000075043	KCNQ2	613720	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7
ENSG00000280936	AL353658.1	NA	
ENSG00000226390	KCNQ2-AS1	NA	
ENSG00000101210	EEF1A2	616393	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38;;PSYCHOMOTOR RETARDATION, EPILEPSY, AND LANGUAGE DISABILITY SYNDROME; PRELDS
ENSG00000101210	EEF1A2	616409	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33
ENSG00000230226	AL121829.1	NA	
ENSG00000125534	PPDPF	NA	
ENSG00000101213	PTK6	NA	
ENSG00000125508	SRMS	NA	
ENSG00000275812	AL121829.2	NA	
ENSG00000125531	FNDC11	NA	
ENSG00000130589	HELZ2	NA	
ENSG00000101216	GMEB2	NA	
ENSG00000232442	MHENCR	NA	
ENSG00000197457	STMN3	NA	
ENSG00000258366	RTEL1	615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 4, INCLUDED; DKCA4, INCLUDED
ENSG00000258366	RTEL1	616373	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3
ENSG00000026036	RTEL1-TNFRSF6B	NA	
ENSG00000243509	TNFRSF6B	NA	
ENSG00000101246	ARFRP1	NA	
ENSG00000197114	ZGPAT	NA	
ENSG00000273154	AL121845.3	NA	
ENSG00000274501	AL121845.4	NA	
ENSG00000203896	LIME1	NA	
ENSG00000273047	AL121845.2	NA	
ENSG00000125520	SLC2A4RG	NA	
ENSG00000130584	ZBTB46	NA	
ENSG00000229299	AL121845.1	NA	
ENSG00000231208	ZBTB46-AS1	NA	
ENSG00000279610	C20orf181	NA	
ENSG00000268858	AL118506.1	NA	
ENSG00000183260	ABHD16B	NA	
ENSG00000101150	TPD52L2	NA	
ENSG00000101152	DNAJC5	162350	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B;;KUFS DISEASE, AUTOSOMAL DOMINANT;;CEROID LIPOFUSCINOSIS, NEURONAL, PARRY TYPE
ENSG00000199805	RNU1-134P	NA	
ENSG00000283206	MIR941-1	NA	
ENSG00000216141	MIR941-2	NA	
ENSG00000283513	MIR941-3	NA	
ENSG00000216195	MIR941-4	NA	
ENSG00000275842	MIR941-5	NA	
ENSG00000198276	UCKL1	NA	
ENSG00000284433	MIR1914	NA	
ENSG00000207554	MIR647	NA	
ENSG00000280213	UCKL1-AS1	NA	
ENSG00000196700	ZNF512B	NA	
ENSG00000130590	SAMD10	NA	
ENSG00000101161	PRPF6	613983	RETINITIS PIGMENTOSA 60; RP60
ENSG00000196421	C20orf204	NA	
ENSG00000203883	SOX18	137940	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS;;GLOMERULONEPHRITIS WITH SPARSE HAIR AND TELANGIECTASES;;TELANGIECTATIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
ENSG00000203883	SOX18	607823	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS
ENSG00000171703	TCEA2	NA	
ENSG00000237371	AL355803.1	NA	
ENSG00000171700	RGS19	NA	
ENSG00000274034	MIR6813	NA	
ENSG00000125510	OPRL1	NA	
ENSG00000171695	LKAAEAR1	NA	
ENSG00000286999	AL121581.2	NA	
ENSG00000196132	MYT1	NA	
ENSG00000125522	NPBWR2	NA	
ENSG00000203880	PCMTD2	NA	
ENSG00000278171	AL137028.2	NA	
ENSG00000232852	CICP4	NA	
ENSG00000149656	LINC00266-1	NA	
ENSG00000274727	AL137028.1	NA	
ENSG00000279493	FP565260.4	NA	
ENSG00000277117	FP565260.3	NA	
ENSG00000279687	FP565260.5	NA	
ENSG00000280071	GATD3B	NA	
ENSG00000276612	FP565260.2	NA	
ENSG00000275464	FP565260.1	NA	
ENSG00000280433	FP565260.6	NA	
ENSG00000279669	AC079801.1	NA	
ENSG00000279094	LINC01670	NA	
ENSG00000274333	CU633967.1	NA	
ENSG00000277777	Y_RNA	NA	
ENSG00000279186	FP236315.2	NA	
ENSG00000279784	FP236315.3	NA	
ENSG00000279064	FP236315.1	NA	
ENSG00000274559	CU639417.1	NA	
ENSG00000280013	CU639417.3	NA	
ENSG00000279769	CU639417.2	NA	
ENSG00000280191	LINC01669	NA	
ENSG00000280095	CU639417.4	NA	
ENSG00000280179	CU639417.5	NA	
ENSG00000275993	SIK1B	NA	
ENSG00000288187	CU633906.5	NA	
ENSG00000274790	Y_RNA	NA	
ENSG00000275496	CU633906.1	NA	
ENSG00000280019	CU633906.4	NA	
ENSG00000279709	CU633906.3	NA	
ENSG00000278903	CU633906.2	NA	
ENSG00000276902	Y_RNA	NA	
ENSG00000274276	CBSL	NA	
ENSG00000275895	U2AF1L5	NA	
ENSG00000280346	FP236240.3	NA	
ENSG00000279226	FP236240.2	NA	
ENSG00000278927	FP236240.1	NA	
ENSG00000276076	CRYAA2	NA	
ENSG00000280145	CU638689.4	NA	
ENSG00000278878	CU638689.1	NA	
ENSG00000279788	CU638689.3	NA	
ENSG00000279728	CU638689.2	NA	
ENSG00000280164	CU638689.5	NA	
ENSG00000279998	FP475955.3	NA	
ENSG00000278955	FP475955.1	NA	
ENSG00000284550	MIR8069-1	NA	
ENSG00000280172	FP475955.4	NA	
ENSG00000279751	FP475955.2	NA	
ENSG00000280018	CU634019.5	NA	
ENSG00000279477	CU634019.4	NA	
ENSG00000278884	CU634019.2	NA	
ENSG00000277067	CU634019.1	NA	
ENSG00000274046	Y_RNA	NA	
ENSG00000280330	CTBP2P10	NA	
ENSG00000279303	CU634019.3	NA	
ENSG00000279647	CU633904.2	NA	
ENSG00000279895	CU633904.3	NA	
ENSG00000276077	CU633904.1	NA	
ENSG00000274484	Y_RNA	NA	
ENSG00000279177	CTBP2P9	NA	
ENSG00000276546	Y_RNA	NA	
ENSG00000277991	FP236241.1	NA	
ENSG00000273590	SMIM11B	NA	
ENSG00000277277	FAM243B	NA	
ENSG00000278961	SMIM34B	NA	
ENSG00000276289	KCNE1B	NA	
ENSG00000273614	CU633980.1	NA	
ENSG00000279967	FP671120.5	NA	
ENSG00000278996	FP671120.4	NA	
ENSG00000275950	MIR6724-1	NA	
ENSG00000275664	FP671120.1	NA	
ENSG00000275708	MIR3648-1	NA	
ENSG00000277437	FP671120.2	NA	
ENSG00000280800	FP671120.6	NA	
ENSG00000278233	RNA5-8SN2	NA	
ENSG00000286155	FP671120.10	NA	
ENSG00000286252	FP671120.11	NA	
ENSG00000286057	FP671120.9	NA	
ENSG00000286012	FP671120.8	NA	
ENSG00000274060	MIR6724-2	NA	
ENSG00000277671	FP671120.3	NA	
ENSG00000281383	FP671120.7	NA	
ENSG00000277739	5_8S_rRNA	NA	
ENSG00000280441	FP236383.3	NA	
ENSG00000277379	MIR6724-3	NA	
ENSG00000274868	FP236383.1	NA	
ENSG00000280614	FP236383.4	NA	
ENSG00000275215	RNA5-8SN3	NA	
ENSG00000286267	FP236383.13	NA	
ENSG00000286146	FP236383.9	NA	
ENSG00000286054	FP236383.7	NA	
ENSG00000286178	FP236383.12	NA	
ENSG00000275692	MIR6724-4	NA	
ENSG00000278775	FP236383.2	NA	
ENSG00000281181	FP236383.5	NA	
ENSG00000278189	RNA5-8SN1	NA	
ENSG00000286149	FP236383.11	NA	
ENSG00000286032	FP236383.6	NA	
ENSG00000286091	FP236383.8	NA	
ENSG00000286148	FP236383.10	NA	
ENSG00000279990	RPSAP68	NA	
ENSG00000279615	CR381572.2	NA	
ENSG00000279167	CR381572.1	NA	
ENSG00000279579	LINC01666	NA	
ENSG00000286033	CR381670.2	NA	
ENSG00000279213	SNX18P10	NA	
ENSG00000280243	MTCO1P1	NA	
ENSG00000278931	CR381670.1	NA	
ENSG00000264462	MIR3648-2	NA	
ENSG00000264063	CR392039.1	NA	
ENSG00000279501	CR392039.4	NA	
ENSG00000279414	CR392039.3	NA	
ENSG00000280436	CR392039.5	NA	
ENSG00000188681	TEKT4P2	NA	
ENSG00000279720	SOWAHCP2	NA	
ENSG00000279381	CR392039.2	NA	
ENSG00000278932	CR381653.1	NA	
ENSG00000279718	SNX18P12	NA	
ENSG00000279208	CR381653.2	NA	
ENSG00000279864	NCOR1P4	NA	
ENSG00000279211	AC124864.1	NA	
ENSG00000286103	AC124864.2	NA	
ENSG00000275631	U1	NA	
ENSG00000280081	LINC01667	NA	
ENSG00000279783	AC018692.2	NA	
ENSG00000264002	RN7SL52P	NA	
ENSG00000252199	SNORA70	NA	
ENSG00000279321	AC018692.1	NA	
ENSG00000270533	CR382285.1	NA	
ENSG00000280372	CR382285.2	NA	
ENSG00000279851	CR382287.2	NA	
ENSG00000279062	CR382287.1	NA	
ENSG00000277693	AP003900.1	NA	
ENSG00000275945	EIF3FP1	NA	
ENSG00000275592	VN1R7P	NA	
ENSG00000278106	AF254983.2	NA	
ENSG00000187172	BAGE2	NA	
ENSG00000273840	AF254983.1	NA	
ENSG00000274391	TPTE	NA	
ENSG00000278678	CYCSP41	NA	
ENSG00000273872	SLC25A15P4	NA	
ENSG00000276556	AF254982.1	NA	
ENSG00000277282	IGHV1OR21-1	NA	
ENSG00000229306	AP001464.1	NA	
ENSG00000224309	ANKRD30BP2	NA	
ENSG00000207097	RNU6-614P	NA	
ENSG00000168122	ZNF355P	NA	
ENSG00000237202	AJ239321.1	NA	
ENSG00000280108	AJ239318.1	NA	
ENSG00000185390	FGF7P2	NA	
ENSG00000175302	ANKRD30BP1	NA	
ENSG00000266211	MIR3156-3	NA	
ENSG00000226930	GTF2IP2	NA	
ENSG00000219280	VN1R8P	NA	
ENSG00000228159	LINC01674	NA	
ENSG00000228184	SNX19P1	NA	
ENSG00000179381	OR4K11P	NA	
ENSG00000218549	OR4K12P	NA	
ENSG00000166351	POTED	NA	
ENSG00000207476	RNU6-286P	NA	
ENSG00000266299	MIR3118-1	NA	
ENSG00000278381	AL050303.2	NA	
ENSG00000227874	GRAMD4P1	NA	
ENSG00000214319	CXADRP1	NA	
ENSG00000279773	AL050303.3	NA	
ENSG00000273692	LONRF2P5	NA	
ENSG00000278618	MIR8069-2	NA	
ENSG00000229231	FEM1AP1	NA	
ENSG00000224922	AL050303.1	NA	
ENSG00000173231	TERF1P1	NA	
ENSG00000232797	FAM207CP	NA	
ENSG00000224860	GXYLT1P2	NA	
ENSG00000215562	CNN2P7	NA	
ENSG00000234538	ZNF114P1	NA	
ENSG00000228314	CYP4F29P	NA	
ENSG00000230965	SNX18P13	NA	
ENSG00000215559	ANKRD20A11P	NA	
ENSG00000203616	RHOT1P2	NA	
ENSG00000223287	RNU6-954P	NA	
ENSG00000183249	NF1P3	NA	
ENSG00000233442	PPP6R2P1	NA	
ENSG00000275170	FRG2MP	NA	
ENSG00000224905	AP001347.1	NA	
ENSG00000249493	ANKRD20A18P	NA	
ENSG00000201812	RNA5SP488	NA	
ENSG00000277572	AP001347.2	NA	
ENSG00000188992	LIPI	NA	
ENSG00000240755	ERLEC1P1	NA	
ENSG00000185272	RBM11	NA	
ENSG00000243064	ABCC13	NA	
ENSG00000155304	HSPA13	NA	
ENSG00000155307	SAMSN1	NA	
ENSG00000223662	SAMSN1-AS1	NA	
ENSG00000232884	AF127936.1	NA	
ENSG00000228600	POLR2CP1	NA	
ENSG00000225502	GAPDHP16	NA	
ENSG00000235609	AF127577.4	NA	
ENSG00000281903	LINC02246	NA	
ENSG00000226406	RBMX2P1	NA	
ENSG00000235277	AF127577.3	NA	
ENSG00000180530	NRIP1	618270	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3; CAKUT3
ENSG00000229047	AF127577.1	NA	
ENSG00000231201	AF127577.2	NA	
ENSG00000279390	AF127577.6	NA	
ENSG00000236471	AF127577.5	NA	
ENSG00000288536	AF222684.1	NA	
ENSG00000288555	AF222685.1	NA	
ENSG00000288578	AF130248.1	NA	
ENSG00000280082	AF246928.1	NA	
ENSG00000229425	AJ009632.2	NA	
ENSG00000224524	CYCSP42	NA	
ENSG00000224247	AJ009632.1	NA	
ENSG00000212564	RNU6-1326P	NA	
ENSG00000226298	RAD23BP3	NA	
ENSG00000155313	USP25	NA	
ENSG00000234159	RBPMSLP	NA	
ENSG00000215386	MIR99AHG	NA	
ENSG00000252273	RNU6-426P	NA	
ENSG00000214976	VDAC2P1	NA	
ENSG00000224602	RPS26P5	NA	
ENSG00000201025	SNORD74B	NA	
ENSG00000270071	AP001172.1	NA	
ENSG00000270139	AP001172.2	NA	
ENSG00000287066	AP000962.3	NA	
ENSG00000280432	AP000962.2	NA	
ENSG00000207638	MIR99A	NA	
ENSG00000199030	MIRLET7C	NA	
ENSG00000269950	AP000962.1	NA	
ENSG00000207863	MIR125B2	NA	
ENSG00000239023	RNU1-98P	NA	
ENSG00000237735	AF130359.1	NA	
ENSG00000232886	AF212831.1	NA	
ENSG00000225735	NEK4P1	NA	
ENSG00000278181	AP000457.1	NA	
ENSG00000252462	RNU6-113P	NA	
ENSG00000232560	LINC01549	NA	
ENSG00000226580	RPL39P40	NA	
ENSG00000266195	RN7SL163P	NA	
ENSG00000154639	CXADR	NA	
ENSG00000232260	BTF3L4P1	NA	
ENSG00000200754	Y_RNA	NA	
ENSG00000199962	Y_RNA	NA	
ENSG00000154640	BTG3	NA	
ENSG00000280594	BTG3-AS1	NA	
ENSG00000226956	AP000432.1	NA	
ENSG00000279648	AP000432.2	NA	
ENSG00000240770	C21orf91-OT1	NA	
ENSG00000154642	C21orf91	NA	
ENSG00000154645	CHODL	NA	
ENSG00000244676	AL109761.1	NA	
ENSG00000231755	CHODL-AS1	NA	
ENSG00000215369	RPL37P3	NA	
ENSG00000227330	AF130417.1	NA	
ENSG00000154646	TMPRSS15	226200	ENTEROKINASE DEFICIENCY;;ENTEROPEPTIDASE DEFICIENCY
ENSG00000228708	AL109763.1	NA	
ENSG00000224141	MIR548XHG	NA	
ENSG00000230233	AF240627.1	NA	
ENSG00000265841	MIR548X	NA	
ENSG00000198618	PPIAP22	NA	
ENSG00000279156	AL157359.3	NA	
ENSG00000232193	AL157359.2	NA	
ENSG00000226204	AL157359.1	NA	
ENSG00000235965	AP000431.2	NA	
ENSG00000229289	AP000431.1	NA	
ENSG00000226818	SLC6A6P1	NA	
ENSG00000231620	AP000855.1	NA	
ENSG00000212609	RNU1-139P	NA	
ENSG00000230198	RPL37P4	NA	
ENSG00000271486	NIPA2P3	NA	
ENSG00000229336	SREK1IP1P1	NA	
ENSG00000215353	C1QBPP1	NA	
ENSG00000233480	LINC01683	NA	
ENSG00000233236	LINC02573	NA	
ENSG00000251851	RNU6-772P	NA	
ENSG00000252963	RN7SKP147	NA	
ENSG00000233676	FDPSP6	NA	
ENSG00000234439	KRT18P2	NA	
ENSG00000233206	RPS3AP1	NA	
ENSG00000276738	AP001506.1	NA	
ENSG00000224924	LINC00320	NA	
ENSG00000215351	PPIAP1	NA	
ENSG00000154654	NCAM2	NA	
ENSG00000226771	AP001136.1	NA	
ENSG00000234730	AP001117.1	NA	
ENSG00000237527	AF241725.1	NA	
ENSG00000238265	LINC00317	NA	
ENSG00000233997	LINC01425	NA	
ENSG00000227075	AP000472.1	NA	
ENSG00000233215	LINC01687	NA	
ENSG00000184856	LINC00308	NA	
ENSG00000234340	AP000705.2	NA	
ENSG00000231136	AP000705.1	NA	
ENSG00000202339	RNU4-45P	NA	
ENSG00000226043	AP000561.1	NA	
ENSG00000223488	MAPK6P2	NA	
ENSG00000234034	AP000959.1	NA	
ENSG00000225906	AP000949.1	NA	
ENSG00000230972	AP001116.1	NA	
ENSG00000275469	MIR6130	NA	
ENSG00000219368	ZNF299P	NA	
ENSG00000231058	MSANTD2P1	NA	
ENSG00000286222	AP001255.1	NA	
ENSG00000223078	RNU2-55P	NA	
ENSG00000228592	D21S2088E	NA	
ENSG00000223822	EEF1A1P1	NA	
ENSG00000237569	TUBAP	NA	
ENSG00000199698	Y_RNA	NA	
ENSG00000227716	AP000459.1	NA	
ENSG00000288094	AP000961.1	NA	
ENSG00000287612	AP000474.2	NA	
ENSG00000231986	AP000474.1	NA	
ENSG00000235564	AP000477.2	NA	
ENSG00000287801	AP000477.3	NA	
ENSG00000226996	AP000477.1	NA	
ENSG00000224018	AP000470.1	NA	
ENSG00000224832	LINC01689	NA	
ENSG00000237484	LINC01684	NA	
ENSG00000226983	LINC01692	NA	
ENSG00000227090	AP000402.1	NA	
ENSG00000230379	AP000146.1	NA	
ENSG00000237444	AP001342.1	NA	
ENSG00000244278	AP000235.1	NA	
ENSG00000232512	AP000233.2	NA	
ENSG00000274662	RN7SKP236	NA	
ENSG00000223870	AP000233.1	NA	
ENSG00000222042	AP001341.1	NA	
ENSG00000238627	RNA5SP489	NA	
ENSG00000213885	RPL13AP7	NA	
ENSG00000279534	AP001340.1	NA	
ENSG00000185433	LINC00158	NA	
ENSG00000229962	AP000221.1	NA	
ENSG00000234883	MIR155HG	NA	
ENSG00000283904	MIR155	NA	
ENSG00000260583	AP000223.1	NA	
ENSG00000154719	MRPL39	NA	
ENSG00000154721	JAM2	618824	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE; IBGC8
ENSG00000237731	RNGTTP1	NA	
ENSG00000287109	AP000224.1	NA	
ENSG00000227054	FDX1P2	NA	
ENSG00000154723	ATP5PF	NA	
ENSG00000154727	GABPA	NA	
ENSG00000235514	LLPHP2	NA	
ENSG00000142192	APP	104300	ALZHEIMER DISEASE; AD;;PRESENILE AND SENILE DEMENTIA ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED; AD1, INCLUDED;;ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY, INCLUDED;;ALZHEIMER DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000142192	APP	605714	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT; HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP- /.../D, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT
ENSG00000233783	AP001442.1	NA	
ENSG00000251972	RNU6-123P	NA	
ENSG00000224541	AP001439.1	NA	
ENSG00000273492	AP000229.1	NA	
ENSG00000206802	RNU6-926P	NA	
ENSG00000286902	AP001595.2	NA	
ENSG00000229025	AP001595.1	NA	
ENSG00000232692	AP001596.1	NA	
ENSG00000197934	CYYR1-AS1	NA	
ENSG00000273115	AP001596.2	NA	
ENSG00000166265	CYYR1	NA	
ENSG00000154734	ADAMTS1	NA	
ENSG00000223563	AP001599.1	NA	
ENSG00000154736	ADAMTS5	NA	
ENSG00000266133	MIR4759	NA	
ENSG00000215326	GPX1P2	NA	
ENSG00000231236	AP001605.1	NA	
ENSG00000236332	AP001604.1	NA	
ENSG00000233300	EIF4A1P1	NA	
ENSG00000217026	RPL10P1	NA	
ENSG00000219592	NCSTNP1	NA	
ENSG00000234052	LINC01673	NA	
ENSG00000225298	LINC00113	NA	
ENSG00000234083	AJ006995.1	NA	
ENSG00000178457	LINC00314	NA	
ENSG00000232079	LINC01697	NA	
ENSG00000236532	LINC01695	NA	
ENSG00000232855	AF165147.1	NA	
ENSG00000226935	LINC00161	NA	
ENSG00000283300	U6	NA	
ENSG00000156239	N6AMT1	NA	
ENSG00000215005	HSPD1P7	NA	
ENSG00000215317	THUMPD1P1	NA	
ENSG00000198862	LTN1	NA	
ENSG00000176054	RPL23P2	NA	
ENSG00000156253	RWDD2B	NA	
ENSG00000273254	AF129075.2	NA	
ENSG00000156256	USP16	NA	
ENSG00000156261	CCT8	NA	
ENSG00000231125	AF129075.1	NA	
ENSG00000286018	AF129075.3	NA	
ENSG00000156265	MAP3K7CL	NA	
ENSG00000232687	RPL12P9	NA	
ENSG00000201984	Y_RNA	NA	
ENSG00000212479	U3	NA	
ENSG00000224649	AF124730.1	NA	
ENSG00000215533	LINC00189	NA	
ENSG00000156273	BACH1	NA	
ENSG00000236056	GAPDHP14	NA	
ENSG00000248476	BACH1-IT1	NA	
ENSG00000273017	AP000240.1	NA	
ENSG00000232118	BACH1-AS1	NA	
ENSG00000228817	BACH1-IT2	NA	
ENSG00000234293	BACH1-IT3	NA	
ENSG00000171189	GRIK1	NA	
ENSG00000273464	AP000238.1	NA	
ENSG00000174680	GRIK1-AS1	NA	
ENSG00000259981	AF096876.1	NA	
ENSG00000156282	CLDN17	NA	
ENSG00000227342	LINC00307	NA	
ENSG00000156284	CLDN8	NA	
ENSG00000225267	RPL8P2	NA	
ENSG00000188694	KRTAP24-1	NA	
ENSG00000232263	KRTAP25-1	NA	
ENSG00000197683	KRTAP26-1	NA	
ENSG00000206107	KRTAP27-1	NA	
ENSG00000186980	KRTAP23-1	NA	
ENSG00000250973	KRTAP13-6P	NA	
ENSG00000182816	KRTAP13-2	NA	
ENSG00000265007	MIR4327	NA	
ENSG00000198390	KRTAP13-1	NA	
ENSG00000240432	KRTAP13-3	NA	
ENSG00000186971	KRTAP13-4	NA	
ENSG00000233640	KRTAP13-5P	NA	
ENSG00000186970	KRTAP15-1	NA	
ENSG00000184351	KRTAP19-1	NA	
ENSG00000186965	KRTAP19-2	NA	
ENSG00000244025	KRTAP19-3	NA	
ENSG00000186967	KRTAP19-4	NA	
ENSG00000186977	KRTAP19-5	NA	
ENSG00000237841	KRTAP19-9P	NA	
ENSG00000235312	KRTAP19-10P	NA	
ENSG00000218125	AP000567.1	NA	
ENSG00000236612	KRTAP19-11P	NA	
ENSG00000186925	KRTAP19-6	NA	
ENSG00000244362	KRTAP19-7	NA	
ENSG00000206106	KRTAP22-2	NA	
ENSG00000212938	KRTAP6-3	NA	
ENSG00000186930	KRTAP6-2	NA	
ENSG00000186924	KRTAP22-1	NA	
ENSG00000184724	KRTAP6-1	NA	
ENSG00000244624	KRTAP20-1	NA	
ENSG00000206105	KRTAP20-4	NA	
ENSG00000184032	KRTAP20-2	NA	
ENSG00000206104	KRTAP20-3	NA	
ENSG00000231068	KRTAP21-3	NA	
ENSG00000236400	KRTAP21-4P	NA	
ENSG00000187026	KRTAP21-2	NA	
ENSG00000187005	KRTAP21-1	NA	
ENSG00000238257	AP000244.1	NA	
ENSG00000233036	KRTAP8-2P	NA	
ENSG00000227840	KRTAP8-3P	NA	
ENSG00000183640	KRTAP8-1	NA	
ENSG00000274749	KRTAP7-1	NA	
ENSG00000182591	KRTAP11-1	NA	
ENSG00000156299	TIAM1	NA	
ENSG00000206102	KRTAP19-8	NA	
ENSG00000228941	UBE3AP2	NA	
ENSG00000286643	AP000248.1	NA	
ENSG00000237325	AP000563.1	NA	
ENSG00000237594	AP000251.1	NA	
ENSG00000230870	FBXW11P1	NA	
ENSG00000234509	AP000253.1	NA	
ENSG00000142168	SOD1	105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1;;AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS;;AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED;;AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED
ENSG00000142168	SOD1	618598	SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP;;SOD1 DEFICIENCY, AUTOSOMAL RECESSIVE
ENSG00000238390	AP000254.1	NA	
ENSG00000273271	AP000254.2	NA	
ENSG00000156304	SCAF4	NA	
ENSG00000229046	HMGN1P2	NA	
ENSG00000273091	AP000255.1	NA	
ENSG00000234107	TPT1P1	NA	
ENSG00000142149	HUNK	NA	
ENSG00000237138	HUNK-AS1	NA	
ENSG00000230323	LINC00159	NA	
ENSG00000261610	AP000265.1	NA	
ENSG00000159055	MIS18A	NA	
ENSG00000227256	MIS18A-AS1	NA	
ENSG00000170262	MRAP	607398	GLUCOCORTICOID DEFICIENCY 2; GCCD2;;FAMILIAL GLUCOCORTICOID DEFICIENCY 2; FGD2
ENSG00000232623	MRAP-AS1	NA	
ENSG00000142207	URB1	NA	
ENSG00000200792	SNORA80A	NA	
ENSG00000256073	URB1-AS1	NA	
ENSG00000265590	CFAP298-TCP10L	NA	
ENSG00000166979	EVA1C	NA	
ENSG00000229007	EXOSC3P1	NA	
ENSG00000242220	TCP10L	NA	
ENSG00000252045	AP000272.1	NA	
ENSG00000252950	RNA5SP490	NA	
ENSG00000159079	CFAP298	615500	CILIARY DYSKINESIA, PRIMARY, 26; CILD26;;CILIARY DYSKINESIA, PRIMARY, 26, WITH OR WITHOUT SITUS INVERSUS
ENSG00000228433	OR7E23P	NA	
ENSG00000238220	AP000275.1	NA	
ENSG00000159082	SYNJ1	615530	PARKINSON DISEASE 20, EARLY-ONSET; PARK20
ENSG00000159082	SYNJ1	617389	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53
ENSG00000238197	PAXBP1-AS1	NA	
ENSG00000159086	PAXBP1	NA	
ENSG00000205930	C21orf62-AS1	NA	
ENSG00000279690	AP000280.1	NA	
ENSG00000205929	C21orf62	NA	
ENSG00000224427	AP000281.1	NA	
ENSG00000207098	SNORA70	NA	
ENSG00000232360	AP000281.2	NA	
ENSG00000227757	AP000282.1	NA	
ENSG00000228961	LINC01690	NA	
ENSG00000205927	OLIG2	NA	
ENSG00000232539	LINC00945	NA	
ENSG00000184221	OLIG1	NA	
ENSG00000226527	AP000289.1	NA	
ENSG00000226433	AP000290.1	NA	
ENSG00000229086	LINC01548	NA	
ENSG00000249624	AP000295.1	NA	
ENSG00000159110	IFNAR2	610424	HEPATITIS B VIRUS, SUSCEPTIBILITY TO;;HBV, SUSCEPTIBILITY TO  HEPATITIS B VIRUS, RESISTANCE TO, INCLUDED;;HBV, RESISTANCE TO, INCLUDED
ENSG00000159110	IFNAR2	616669	IMMUNODEFICIENCY 45; IMD45
ENSG00000223799	IL10RB-DT	NA	
ENSG00000243646	IL10RB	610424	HEPATITIS B VIRUS, SUSCEPTIBILITY TO;;HBV, SUSCEPTIBILITY TO  HEPATITIS B VIRUS, RESISTANCE TO, INCLUDED;;HBV, RESISTANCE TO, INCLUDED
ENSG00000243646	IL10RB	612567	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25;;INFLAMMATORY BOWEL DISEASE, EARLY-ONSET, AUTOSOMAL RECESSIVE
ENSG00000142166	IFNAR1	NA	
ENSG00000226501	USF1P1	NA	
ENSG00000159128	IFNGR2	614889	IMMUNODEFICIENCY 28; IMD28;;IMMUNODEFICIENCY 28, MYCOBACTERIOSIS;;IFNGR2 DEFICIENCY
ENSG00000142188	TMEM50B	NA	
ENSG00000215088	RPS5P3	NA	
ENSG00000231355	AP000302.1	NA	
ENSG00000177692	DNAJC28	NA	
ENSG00000159131	GART	NA	
ENSG00000233956	BTF3P6	NA	
ENSG00000159140	SON	617140	ZTTK SYNDROME; ZTTKS;;ZHU-TOKITA-TAKENOUCHI-KIM SYNDROME;;ZTTK MULTIPLE CONGENITAL ANOMALIES-MENTAL RETARDATION SYNDROME
ENSG00000284448	MIR6501	NA	
ENSG00000159147	DONSON	251230	MICROCEPHALY-MICROMELIA SYNDROME; MIMIS
ENSG00000159147	DONSON	617604	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA
ENSG00000249209	AP000311.1	NA	
ENSG00000205758	CRYZL1	NA	
ENSG00000205726	ITSN1	NA	
ENSG00000241837	ATP5PO	NA	
ENSG00000237945	LINC00649	NA	
ENSG00000244294	RN7SL740P	NA	
ENSG00000273102	AP000569.1	NA	
ENSG00000243927	MRPS6	NA	
ENSG00000198743	SLC5A3	NA	
ENSG00000272657	AP000317.2	NA	
ENSG00000224598	RPS5P2	NA	
ENSG00000227456	LINC00310	NA	
ENSG00000214955	AP000317.1	NA	
ENSG00000225555	AP000320.1	NA	
ENSG00000159197	KCNE2	611493	ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4
ENSG00000159197	KCNE2	613693	LONG QT SYNDROME 6; LQT6 LONG QT SYNDROME 6, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 3/6, DIGENIC, INCLUDED; LQT3/6, DIGENIC, INCLUDED
ENSG00000205670	SMIM11A	NA	
ENSG00000222018	FAM243A	NA	
ENSG00000273104	AP000322.2	NA	
ENSG00000243627	SMIM34A	NA	
ENSG00000272958	AP000322.1	NA	
ENSG00000180509	KCNE1	612347	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2
ENSG00000180509	KCNE1	613695	LONG QT SYNDROME 5; LQT5 LONG QT SYNDROME 5, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 2/5, DIGENIC, INCLUDED; LQT2/5, DIGENIC, INCLUDED
ENSG00000221398	AP000324.1	NA	
ENSG00000159200	RCAN1	NA	
ENSG00000159212	CLIC6	NA	
ENSG00000230978	LINC00160	NA	
ENSG00000234380	LINC01426	NA	
ENSG00000159216	RUNX1	601399	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM;;PLATELET DISORDER, ASPIRIN-LIKE;;THROMBOCYTOPENIA, FAMILIAL, WITH PROPENSITY TO ACUTE MYELOGENOUS LEUKEMIA; FPD/AML
ENSG00000159216	RUNX1	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000286153	AP000331.1	NA	
ENSG00000234703	AF015262.1	NA	
ENSG00000223671	RPL34P3	NA	
ENSG00000231300	EZH2P1	NA	
ENSG00000230794	AF015720.1	NA	
ENSG00000211590	MIR802	NA	
ENSG00000229761	RPS20P1	NA	
ENSG00000234008	PPP1R2P2	NA	
ENSG00000231106	LINC01436	NA	
ENSG00000214914	RPL23AP3	NA	
ENSG00000185917	SETD4	NA	
ENSG00000189089	RIMKLBP1	NA	
ENSG00000236677	SETD4-AS1	NA	
ENSG00000200213	RNU6-992P	NA	
ENSG00000230212	AP000688.1	NA	
ENSG00000159228	CBR1	NA	
ENSG00000236119	AP000688.3	NA	
ENSG00000233393	AP000688.2	NA	
ENSG00000226054	MEMO1P1	NA	
ENSG00000236830	CBR3-AS1	NA	
ENSG00000214889	RPS9P1	NA	
ENSG00000159231	CBR3	NA	
ENSG00000142197	DOP1B	NA	
ENSG00000228149	RPL3P1	NA	
ENSG00000214867	SRSF9P1	NA	
ENSG00000273199	AP000692.2	NA	
ENSG00000159256	MORC3	NA	
ENSG00000228107	AP000692.1	NA	
ENSG00000159259	CHAF1B	NA	
ENSG00000224421	ATP5MFP1	NA	
ENSG00000230479	AP000695.1	NA	
ENSG00000233818	AP000695.2	NA	
ENSG00000159261	CLDN14	614035	DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29
ENSG00000279365	AP000695.3	NA	
ENSG00000223741	PSMD4P1	NA	
ENSG00000286517	AP000696.2	NA	
ENSG00000286852	AP000696.3	NA	
ENSG00000231324	AP000696.1	NA	
ENSG00000224269	AP000697.1	NA	
ENSG00000159263	SIM2	NA	
ENSG00000159267	HLCS	253270	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY;;HLCS DEFICIENCY;;MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL FORM;;MULTIPLE CARBOXYLASE DEFICIENCY, EARLY ONSET
ENSG00000237646	HLCS-IT1	NA	
ENSG00000199806	RNA5SP491	NA	
ENSG00000270652	DPRXP5	NA	
ENSG00000224790	AP000704.2	NA	
ENSG00000207416	AP000704.1	NA	
ENSG00000215734	MRPL20P1	NA	
ENSG00000183145	RIPPLY3	NA	
ENSG00000212136	RNU6-696P	NA	
ENSG00000185808	PIGP	617599	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 14; GPIBD14
ENSG00000182670	TTC3	NA	
ENSG00000270116	AP001429.1	NA	
ENSG00000228677	TTC3-AS1	NA	
ENSG00000230366	DSCR9	NA	
ENSG00000263969	RN7SL678P	NA	
ENSG00000157538	VPS26C	NA	
ENSG00000242553	AP001432.1	NA	
ENSG00000272948	AP001412.1	NA	
ENSG00000287637	AP001437.2	NA	
ENSG00000273210	AP001437.1	NA	
ENSG00000157540	DYRK1A	614104	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7
ENSG00000286717	AP001407.1	NA	
ENSG00000157542	KCNJ6	614098	KEPPEN-LUBINSKY SYNDROME; KPLBS
ENSG00000233213	KCNJ6-AS1	NA	
ENSG00000184029	DSCR4	NA	
ENSG00000223608	DSCR4-IT1	NA	
ENSG00000198054	DSCR8	NA	
ENSG00000157551	KCNJ15	NA	
ENSG00000270835	AP001425.1	NA	
ENSG00000233316	DSCR10	NA	
ENSG00000226012	AP001434.1	NA	
ENSG00000231123	SPATA20P1	NA	
ENSG00000231231	LINC01423	NA	
ENSG00000157554	ERG	NA	
ENSG00000231480	SNRPGP13	NA	
ENSG00000287470	AP001037.1	NA	
ENSG00000223806	LINC00114	NA	
ENSG00000157557	ETS2	NA	
ENSG00000205622	AP001042.1	NA	
ENSG00000229986	AP001042.2	NA	
ENSG00000287082	AP001042.3	NA	
ENSG00000229925	AP001043.1	NA	
ENSG00000272015	SNORA62	NA	
ENSG00000227721	RPSAP64	NA	
ENSG00000232837	LINC01700	NA	
ENSG00000235888	AF064858.1	NA	
ENSG00000288266	AF064858.3	NA	
ENSG00000237609	AF064858.2	NA	
ENSG00000228861	RPL23AP12	NA	
ENSG00000235701	PCBP2P1	NA	
ENSG00000276873	AF129408.2	NA	
ENSG00000183527	PSMG1	NA	
ENSG00000185658	BRWD1	NA	
ENSG00000272991	AF129408.1	NA	
ENSG00000232608	TIMM9P2	NA	
ENSG00000237373	BRWD1-IT1	NA	
ENSG00000229623	METTL21AP1	NA	
ENSG00000255568	BRWD1-AS2	NA	
ENSG00000238141	BRWD1-AS1	NA	
ENSG00000205581	HMGN1	NA	
ENSG00000252915	Y_RNA	NA	
ENSG00000227406	RNF6P1	NA	
ENSG00000182093	GET1	NA	
ENSG00000285815	GET1-SH3BGR	NA	
ENSG00000157578	LCA5L	NA	
ENSG00000185437	SH3BGR	NA	
ENSG00000275523	MIR6508	NA	
ENSG00000235808	MYL6P2	NA	
ENSG00000228349	RPS26P4	NA	
ENSG00000235012	JCADP1	NA	
ENSG00000183778	B3GALT5	NA	
ENSG00000184809	B3GALT5-AS1	NA	
ENSG00000225330	AF064860.1	NA	
ENSG00000231713	AF064860.2	NA	
ENSG00000183067	IGSF5	NA	
ENSG00000183036	PCP4	NA	
ENSG00000171587	DSCAM	NA	
ENSG00000263973	MIR4760	NA	
ENSG00000235123	DSCAM-AS1	NA	
ENSG00000207147	AF064863.1	NA	
ENSG00000233756	DSCAM-IT1	NA	
ENSG00000288069	AF064866.1	NA	
ENSG00000230859	YRDCP3	NA	
ENSG00000286425	AL773573.1	NA	
ENSG00000226496	LINC00323	NA	
ENSG00000263681	MIR3197	NA	
ENSG00000182240	BACE2	NA	
ENSG00000280109	PLAC4	NA	
ENSG00000224388	BACE2-IT1	NA	
ENSG00000183844	FAM3B	NA	
ENSG00000183486	MX2	NA	
ENSG00000157601	MX1	NA	
ENSG00000228318	AP001610.2	NA	
ENSG00000184012	TMPRSS2	NA	
ENSG00000207503	AP001610.1	NA	
ENSG00000232806	AP001610.3	NA	
ENSG00000223400	AP006748.1	NA	
ENSG00000286027	PCSEAT	NA	
ENSG00000227702	LINC00111	NA	
ENSG00000236384	LINC00479	NA	
ENSG00000232401	LINC00112	NA	
ENSG00000183421	RIPK4	214350	CHAND SYNDROME; CHANDS;;CURLY HAIR-ANKYLOBLEPHARON-NAIL DYSPLASIA SYNDROME
ENSG00000183421	RIPK4	263650	BARTSOCAS-PAPAS SYNDROME; BPS;;POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE;;PTERYGIUM, POPLITEAL, LETHAL TYPE;;MULTIPLE PTERYGIUM SYNDROME, ASLAN TYPE
ENSG00000236883	AP001615.1	NA	
ENSG00000275166	MIR6814	NA	
ENSG00000141956	PRDM15	NA	
ENSG00000236545	AP001619.2	NA	
ENSG00000227698	AP001619.1	NA	
ENSG00000251778	AP001619.3	NA	
ENSG00000157617	C2CD2	NA	
ENSG00000173276	ZBTB21	NA	
ENSG00000237232	ZNF295-AS1	NA	
ENSG00000177398	UMODL1	NA	
ENSG00000184385	UMODL1-AS1	NA	
ENSG00000160179	ABCG1	NA	
ENSG00000223262	RNA5SP492	NA	
ENSG00000160180	TFF3	NA	
ENSG00000160181	TFF2	NA	
ENSG00000160182	TFF1	NA	
ENSG00000160183	TMPRSS3	601072	DEAFNESS, AUTOSOMAL RECESSIVE 8; DFNB8;;DEAFNESS, AUTOSOMAL RECESSIVE 10; DFNB10;;DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8; DFNB8;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 8; NSRD8
ENSG00000160185	UBASH3A	NA	
ENSG00000252619	RNU6-1149P	NA	
ENSG00000160188	RSPH1	615481	CILIARY DYSKINESIA, PRIMARY, 24; CILD24;;CILIARY DYSKINESIA, PRIMARY, 24, WITHOUT SITUS INVERSUS
ENSG00000160190	SLC37A1	NA	
ENSG00000239930	AP001625.3	NA	
ENSG00000231867	AP001625.1	NA	
ENSG00000235772	AP001625.2	NA	
ENSG00000225431	LINC01671	NA	
ENSG00000235023	AP001626.1	NA	
ENSG00000160191	PDE9A	NA	
ENSG00000225731	PDE9A-AS1	NA	
ENSG00000283051	LINC01668	NA	
ENSG00000233754	AP001628.2	NA	
ENSG00000225218	AP001628.1	NA	
ENSG00000160193	WDR4	618346	MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB
ENSG00000160193	WDR4	618347	GALLOWAY-MOWAT SYNDROME 6; GAMOS6
ENSG00000160194	NDUFV3	NA	
ENSG00000233056	ERVH48-1	NA	
ENSG00000264580	MIR5692B	NA	
ENSG00000224100	AP001630.1	NA	
ENSG00000160199	PKNOX1	NA	
ENSG00000160200	CBS	236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY;;HOMOCYSTINURIA WITH OR WITHOUT RESPONSE TO PYRIDOXINE;;CYSTATHIONINE BETA-SYNTHASE DEFICIENCY;;CBS DEFICIENCY HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED, INCLUDED
ENSG00000160201	U2AF1	NA	
ENSG00000286549	AP001631.2	NA	
ENSG00000232777	MRPL51P2	NA	
ENSG00000236663	FRGCA	NA	
ENSG00000228120	AP001631.1	NA	
ENSG00000160202	CRYAA	604219	CATARACT 9, MULTIPLE TYPES; CTRCT9;;CATARACT 9, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, AUTOSOMAL DOMINANT;;CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 1; CATC1
ENSG00000237864	LINC00322	NA	
ENSG00000237989	LINC01679	NA	
ENSG00000225637	AP001046.1	NA	
ENSG00000142178	SIK1	616341	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30
ENSG00000188660	LINC00319	NA	
ENSG00000185186	LINC00313	NA	
ENSG00000223975	AP001048.1	NA	
ENSG00000160207	HSF2BP	NA	
ENSG00000214326	RPL31P1	NA	
ENSG00000234289	H2BS1	NA	
ENSG00000278433	MIR6070	NA	
ENSG00000160208	RRP1B	NA	
ENSG00000160209	PDXK	618511	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C;;HMSN VIC;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6C; CMT6C
ENSG00000160221	GATD3A	NA	
ENSG00000281420	AP001052.1	NA	
ENSG00000287507	AP001053.1	NA	
ENSG00000160213	CSTB	254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG;;ULD;;EPILEPSY, PROGRESSIVE MYOCLONIC, 1A; EPM1A;;EPILEPSY, PROGRESSIVE MYOCLONIC, 1; EPM1;;PROGRESSIVE MYOCLONIC EPILEPSY; PME;;BALTIC MYOCLONIC EPILEPSY
ENSG00000234030	TMEM97P1	NA	
ENSG00000160214	RRP1	NA	
ENSG00000215458	AATBC	NA	
ENSG00000226543	MYL6P1	NA	
ENSG00000160216	AGPAT3	NA	
ENSG00000199598	RNU6-859P	NA	
ENSG00000288593	AP001054.1	NA	
ENSG00000252606	RNU6-1150P	NA	
ENSG00000160218	TRAPPC10	NA	
ENSG00000213440	H2AZP1	NA	
ENSG00000241945	PWP2	NA	
ENSG00000225331	LINC01678	NA	
ENSG00000285413	AP001056.2	NA	
ENSG00000237604	AP001056.1	NA	
ENSG00000232124	AP001057.1	NA	
ENSG00000160223	ICOSLG	NA	
ENSG00000278158	AP001059.2	NA	
ENSG00000275799	AP001059.1	NA	
ENSG00000142182	DNMT3L	NA	
ENSG00000232010	DNMT3L-AS1	NA	
ENSG00000160224	AIRE	240300	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1;;APS I;;AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL DYSTROPHY; APECED;;AUTOIMMUNE POLYGLANDULAR SYNDROME, TYPE I;;POLYGLANDULAR AUTOIMMUNE SYN /.../ TYPE I;;PGA I;;HYPOADRENOCORTICISM WITH HYPOPARATHYROIDISM AND SUPERFICIAL MONILIASIS AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I, AUTOSOMAL DOMINANT, INCLUDED;;POLYGLANDULAR DEFICIENCY SYNDROME, PERSIAN-JEWISH TYPE, INCLUDED
ENSG00000141959	PFKL	NA	
ENSG00000241728	AP001062.3	NA	
ENSG00000160226	CFAP410	602271	SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX;;SMD, AXIAL;;AXIAL SMD
ENSG00000160226	CFAP410	617547	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS
ENSG00000184441	AP001062.1	NA	
ENSG00000232969	AP001062.2	NA	
ENSG00000260256	AP001063.1	NA	
ENSG00000142185	TRPM2	NA	
ENSG00000230061	TRPM2-AS	NA	
ENSG00000266692	AP001065.2	NA	
ENSG00000264452	AP001065.1	NA	
ENSG00000229356	LRRC3-DT	NA	
ENSG00000160233	LRRC3	NA	
ENSG00000224747	MTCYBP21	NA	
ENSG00000223431	MTND6P21	NA	
ENSG00000227999	MTND5P1	NA	
ENSG00000274225	AP001065.3	NA	
ENSG00000228709	LINC02575	NA	
ENSG00000277352	AP001065.4	NA	
ENSG00000175894	TSPEAR	614861	DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98
ENSG00000175894	TSPEAR	618180	ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14
ENSG00000235890	TSPEAR-AS1	NA	
ENSG00000182912	TSPEAR-AS2	NA	
ENSG00000287088	AP001066.1	NA	
ENSG00000215455	KRTAP10-1	NA	
ENSG00000205445	KRTAP10-2	NA	
ENSG00000212935	KRTAP10-3	NA	
ENSG00000215454	KRTAP10-4	NA	
ENSG00000241123	KRTAP10-5	NA	
ENSG00000188155	KRTAP10-6	NA	
ENSG00000272804	KRTAP10-7	NA	
ENSG00000187766	KRTAP10-8	NA	
ENSG00000221837	KRTAP10-9	NA	
ENSG00000221859	KRTAP10-10	NA	
ENSG00000243489	KRTAP10-11	NA	
ENSG00000212933	KRTAP12-4	NA	
ENSG00000205439	KRTAP12-3	NA	
ENSG00000221864	KRTAP12-2	NA	
ENSG00000229880	IMMTP1	NA	
ENSG00000187175	KRTAP12-1	NA	
ENSG00000276647	KRTAP12-6P	NA	
ENSG00000189169	KRTAP10-12	NA	
ENSG00000236382	KRTAP10-13P	NA	
ENSG00000184787	UBE2G2	NA	
ENSG00000184900	SUMO3	NA	
ENSG00000236519	LINC01424	NA	
ENSG00000160255	ITGB2	116920	LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD;;LAD1;;LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN 1 IMMUNODEFICIENCY;;LFA1 IMMUNODEFICIENCY
ENSG00000183255	PTTG1IP	NA	
ENSG00000227039	ITGB2-AS1	NA	
ENSG00000273027	AL844908.2	NA	
ENSG00000183250	LINC01547	NA	
ENSG00000272825	AL844908.1	NA	
ENSG00000160256	FAM207A	NA	
ENSG00000276529	AP001505.1	NA	
ENSG00000234880	LINC00163	NA	
ENSG00000261706	LINC00165	NA	
ENSG00000275874	PICSAR	NA	
ENSG00000235374	SSR4P1	NA	
ENSG00000197381	ADARB1	NA	
ENSG00000267857	AL133499.1	NA	
ENSG00000182586	LINC00334	NA	
ENSG00000186866	POFUT2	NA	
ENSG00000223768	LINC00205	NA	
ENSG00000286262	BX322557.2	NA	
ENSG00000184274	LINC00315	NA	
ENSG00000229382	BX322557.1	NA	
ENSG00000237664	LINC00316	NA	
ENSG00000228930	MTCO1P3	NA	
ENSG00000228355	BX322559.1	NA	
ENSG00000273796	BX322562.1	NA	
ENSG00000182871	COL18A1	267750	KNOBLOCH SYNDROME 1; KNO1;;KNO;;RETINAL DETACHMENT AND OCCIPITAL ENCEPHALOCELE
ENSG00000224574	COL18A1-AS2	NA	
ENSG00000183535	COL18A1-AS1	NA	
ENSG00000275167	MIR6815	NA	
ENSG00000173638	SLC19A1	NA	
ENSG00000233922	LINC01694	NA	
ENSG00000286082	AL133493.1	NA	
ENSG00000286594	AL133493.2	NA	
ENSG00000183570	PCBP3	NA	
ENSG00000275139	AL133492.1	NA	
ENSG00000205424	PCBP3-AS1	NA	
ENSG00000286886	AJ011931.2	NA	
ENSG00000276633	AJ011931.1	NA	
ENSG00000280604	AJ239328.1	NA	
ENSG00000274248	AJ011932.1	NA	
ENSG00000142156	COL6A1	158810	BETHLEM MYOPATHY 1; BTHLM1;;BETHLEM MYOPATHY;;MYOPATHY, BENIGN CONGENITAL, WITH CONTRACTURES;;MUSCULAR DYSTROPHY, BENIGN CONGENITAL;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 5; LGMDD5
ENSG00000142156	COL6A1	254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1;;ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD;;MUSCULAR DYSTROPHY, SCLEROATONIC;;ULLRICH DISEASE;;ULLRICH SCLEROATONIC MUSCULAR DYSTROPHY;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 22; LGMDR22
ENSG00000224413	AP001476.1	NA	
ENSG00000228235	AP001476.3	NA	
ENSG00000226115	AP001476.2	NA	
ENSG00000233767	PSMA6P3	NA	
ENSG00000227438	AP001471.1	NA	
ENSG00000142173	COL6A2	158810	BETHLEM MYOPATHY 1; BTHLM1;;BETHLEM MYOPATHY;;MYOPATHY, BENIGN CONGENITAL, WITH CONTRACTURES;;MUSCULAR DYSTROPHY, BENIGN CONGENITAL;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 5; LGMDD5
ENSG00000142173	COL6A2	254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1;;ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD;;MUSCULAR DYSTROPHY, SCLEROATONIC;;ULLRICH DISEASE;;ULLRICH SCLEROATONIC MUSCULAR DYSTROPHY;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 22; LGMDR22
ENSG00000142173	COL6A2	255600	MYOSCLEROSIS, AUTOSOMAL RECESSIVE;;MYOPATHY, MYOSCLEROTIC;;MYOSCLEROSIS, CONGENITAL, OF LOWENTHAL
ENSG00000160282	FTCD	229100	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY;;FORMIMINOTRANSFERASE DEFICIENCY;;FORMIMINOGLUTAMIC ACIDURIA;;FIGLU-URIA
ENSG00000237338	FTCD-AS1	NA	
ENSG00000160284	SPATC1L	NA	
ENSG00000228404	AP001468.1	NA	
ENSG00000160285	LSS	616509	CATARACT 44; CTRCT44;;CATARACT 44 AND HYPOTRICHOSIS
ENSG00000160285	LSS	618275	HYPOTRICHOSIS 14; HYPT14
ENSG00000160285	LSS	618840	ALOPECIA-MENTAL RETARDATION SYNDROME 4; APMR4
ENSG00000223901	AP001469.1	NA	
ENSG00000215424	MCM3AP-AS1	NA	
ENSG00000160294	MCM3AP	618124	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID
ENSG00000228137	AP001469.2	NA	
ENSG00000239415	AP001469.3	NA	
ENSG00000182362	YBEY	NA	
ENSG00000160298	C21orf58	NA	
ENSG00000160299	PCNT	210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2;;MOPD II;;OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II
ENSG00000286224	AP000471.1	NA	
ENSG00000225043	RPL18AP2	NA	
ENSG00000160305	DIP2A	NA	
ENSG00000223692	DIP2A-IT1	NA	
ENSG00000202239	RNU6-396P	NA	
ENSG00000160307	S100B	NA	
ENSG00000160310	PRMT2	NA	
ENSG00000230982	DSTNP1	NA	
ENSG00000212932	RPL23AP4	NA	
ENSG00000277248	U2	NA	
ENSG00000283047	FRG1FP	NA	
ENSG00000279973	CU104787.1	NA	
ENSG00000226444	ACTR3BP6	NA	
ENSG00000276871	5_8S_rRNA	NA	
ENSG00000288262	CT867976.1	NA	
ENSG00000286406	AC138776.1	NA	
ENSG00000283023	FRG1GP	NA	
ENSG00000276138	U6	NA	
ENSG00000280341	AP000542.3	NA	
ENSG00000236235	AP000542.1	NA	
ENSG00000279442	AP000542.2	NA	
ENSG00000184624	ZNF72P	NA	
ENSG00000236097	BNIP3P2	NA	
ENSG00000236831	YME1L1P1	NA	
ENSG00000130538	OR11H1	NA	
ENSG00000237299	AP000534.2	NA	
ENSG00000235759	ARHGAP42P3	NA	
ENSG00000233408	AP000534.1	NA	
ENSG00000215268	AP000533.2	NA	
ENSG00000213727	AP000533.1	NA	
ENSG00000230643	AP000533.3	NA	
ENSG00000230471	AP000532.2	NA	
ENSG00000231565	NEK2P2	NA	
ENSG00000226474	AP000532.1	NA	
ENSG00000224435	NF1P6	NA	
ENSG00000234381	MED15P7	NA	
ENSG00000198062	POTEH	NA	
ENSG00000236666	POTEH-AS1	NA	
ENSG00000212216	RNU6-816P	NA	
ENSG00000241838	AP000529.1	NA	
ENSG00000225255	PSLNR	NA	
ENSG00000235992	GRAMD4P2	NA	
ENSG00000206195	DUXAP8	NA	
ENSG00000271127	AP000526.1	NA	
ENSG00000232775	BMS1P22	NA	
ENSG00000272872	AP000525.1	NA	
ENSG00000271672	DUXAP8	NA	
ENSG00000223875	NBEAP3	NA	
ENSG00000215270	TOMM40P2	NA	
ENSG00000229286	AP000522.1	NA	
ENSG00000233866	AC145543.1	NA	
ENSG00000278188	U6	NA	
ENSG00000225293	ABCD1P4	NA	
ENSG00000226160	AC137499.1	NA	
ENSG00000229658	PABPC1P9	NA	
ENSG00000227367	SLC9B1P4	NA	
ENSG00000280263	ACTR3BP2	NA	
ENSG00000235969	CHEK2P4	NA	
ENSG00000273362	AP000547.2	NA	
ENSG00000233995	AP000547.1	NA	
ENSG00000239435	KCNMB3P1	NA	
ENSG00000198445	CCT8L2	NA	
ENSG00000287285	AP000547.4	NA	
ENSG00000240122	FABP5P11	NA	
ENSG00000100181	TPTEP1	NA	
ENSG00000283633	AP000547.3	NA	
ENSG00000267338	AP000365.1	NA	
ENSG00000249288	SLC25A15P5	NA	
ENSG00000249263	PARP4P3	NA	
ENSG00000189295	ANKRD62P1-PARP4P3	NA	
ENSG00000259271	ANKRD62P1	NA	
ENSG00000273244	AC005301.1	NA	
ENSG00000241717	VWFP1	NA	
ENSG00000288024	AC005301.2	NA	
ENSG00000235343	LINC01665	NA	
ENSG00000172967	XKR3	NA	
ENSG00000229027	HSFY1P1	NA	
ENSG00000234121	GPM6BP3	NA	
ENSG00000283535	AC007064.4	NA	
ENSG00000237835	AC007064.3	NA	
ENSG00000220248	ZNF402P	NA	
ENSG00000237689	AC007064.2	NA	
ENSG00000228122	MTND1P17	NA	
ENSG00000237358	AC007064.1	NA	
ENSG00000225480	AC006548.1	NA	
ENSG00000230481	IGKV1OR22-5	NA	
ENSG00000253691	IGKV2OR22-4	NA	
ENSG00000253460	IGKV2OR22-3	NA	
ENSG00000254264	IGKV3OR22-2	NA	
ENSG00000253481	IGKV1OR22-1	NA	
ENSG00000285045	AC006548.3	NA	
ENSG00000215568	GAB4	NA	
ENSG00000270226	AC006548.2	NA	
ENSG00000276400	VN1R9P	NA	
ENSG00000237438	CECR7	NA	
ENSG00000273203	AC006946.2	NA	
ENSG00000183307	TMEM121B	NA	
ENSG00000273442	AC006946.3	NA	
ENSG00000177663	IL17RA	613953	IMMUNODEFICIENCY 51; IMD51;;CANDIDIASIS, FAMILIAL, 5, FORMERLY; CANDF5, FORMERLY
ENSG00000235328	AC006946.1	NA	
ENSG00000235478	LINC01664	NA	
ENSG00000069998	HDHD5	NA	
ENSG00000185837	HDHD5-AS1	NA	
ENSG00000093072	ADA2	182410	SNEDDON SYNDROME; SNDNS;;LIVEDO RETICULARIS AND CEREBROVASCULAR ACCIDENTS
ENSG00000093072	ADA2	615688	VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS;;POLYARTERITIS NODOSA, CHILDHOOD-ONSET; PAN;;ADENOSINE DEAMINASE 2 DEFICIENCY; DADA2
ENSG00000236325	AC005300.1	NA	
ENSG00000203416	FAM32BP	NA	
ENSG00000241832	CECR3	NA	
ENSG00000231004	CECR9	NA	
ENSG00000239547	RN7SL843P	NA	
ENSG00000099954	CECR2	NA	
ENSG00000229492	FO681548.1	NA	
ENSG00000232305	CLCP1	NA	
ENSG00000228045	DNAJA1P6	NA	
ENSG00000286195	AC007666.2	NA	
ENSG00000182902	SLC25A18	NA	
ENSG00000236754	AC007666.1	NA	
ENSG00000131100	ATP6V1E1	617402	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C
ENSG00000099968	BCL2L13	NA	
ENSG00000015475	BID	NA	
ENSG00000264757	MIR3198-1	NA	
ENSG00000269220	LINC00528	NA	
ENSG00000243156	MICAL3	NA	
ENSG00000093100	AC016026.1	NA	
ENSG00000286990	AC016026.2	NA	
ENSG00000207780	MIR648	NA	
ENSG00000235445	AC016027.3	NA	
ENSG00000234913	AC016027.2	NA	
ENSG00000237446	RHEBP3	NA	
ENSG00000235295	LINC01634	NA	
ENSG00000225335	AC016027.1	NA	
ENSG00000215193	PEX26	614872	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 8, INCLUDED; CG8, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A, INCLUDED; CGA, INCLUDED
ENSG00000215193	PEX26	614873	PEROXISOME BIOGENESIS DISORDER 7B; PBD7B
ENSG00000236890	AC016027.5	NA	
ENSG00000235617	AC016027.4	NA	
ENSG00000225225	ARL2BPP10	NA	
ENSG00000183785	TUBA8	613180	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8; CDCBM8;;POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA
ENSG00000280007	AC008079.1	NA	
ENSG00000184979	USP18	617397	PSEUDO-TORCH SYNDROME 2; PTORCH2
ENSG00000187979	FAM230D	NA	
ENSG00000276160	GGTLC5P	NA	
ENSG00000274044	FAM230J	NA	
ENSG00000276874	AC011718.1	NA	
ENSG00000275060	PPP1R26P3	NA	
ENSG00000277870	FAM230A	NA	
ENSG00000277017	AC023490.2	NA	
ENSG00000278044	AC023490.4	NA	
ENSG00000274252	GGTLC3	NA	
ENSG00000275319	Metazoa_SRP	NA	
ENSG00000277690	AC023490.3	NA	
ENSG00000278558	TMEM191B	NA	
ENSG00000274602	PI4KAP1	NA	
ENSG00000274625	AC023490.1	NA	
ENSG00000222630	RN7SKP131	NA	
ENSG00000275793	RIMBP3	NA	
ENSG00000275362	Metazoa_SRP	NA	
ENSG00000278110	SUSD2P2	NA	
ENSG00000286175	AC023490.5	NA	
ENSG00000273907	CA15P2	NA	
ENSG00000273643	PPP1R26P2	NA	
ENSG00000278008	PPP1R26P4	NA	
ENSG00000182824	FAM230E	NA	
ENSG00000197421	GGT3P	NA	
ENSG00000239989	AC008132.2	NA	
ENSG00000234764	E2F6P1	NA	
ENSG00000161103	AC008132.1	NA	
ENSG00000215544	BCRP7	NA	
ENSG00000276095	FAM230F	NA	
ENSG00000279987	AC008103.1	NA	
ENSG00000183628	DGCR6	192430	VELOCARDIOFACIAL SYNDROME;;CHROMOSOME 22q11.2 DELETION SYNDROME;;VCF SYNDROME; VCFS;;SHPRINTZEN VCF SYNDROME
ENSG00000283809	AC007326.4	NA	
ENSG00000100033	PRODH	239500	HYPERPROLINEMIA, TYPE I; HYRPRO1;;HPI;;PROLINE OXIDASE DEFICIENCY
ENSG00000100033	PRODH	600850	SCHIZOPHRENIA 4; SCZD4;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 22q11-RELATED
ENSG00000284294	AC007326.5	NA	
ENSG00000280418	AC007326.2	NA	
ENSG00000273032	DGCR5	NA	
ENSG00000283583	AC007326.3	NA	
ENSG00000237517	DGCR5	NA	
ENSG00000271275	AC007326.1	NA	
ENSG00000283366	AC000095.2	NA	
ENSG00000270393	AC000095.1	NA	
ENSG00000286025	AC000095.3	NA	
ENSG00000241527	CA15P1	NA	
ENSG00000070413	DGCR2	192430	VELOCARDIOFACIAL SYNDROME;;CHROMOSOME 22q11.2 DELETION SYNDROME;;VCF SYNDROME; VCFS;;SHPRINTZEN VCF SYNDROME
ENSG00000206739	AC004461.1	NA	
ENSG00000273311	DGCR11	NA	
ENSG00000237347	AC004461.2	NA	
ENSG00000281530	AC004461.3	NA	
ENSG00000223461	AC004471.1	NA	
ENSG00000272682	AC004471.2	NA	
ENSG00000231086	TSSK1A	NA	
ENSG00000100056	ESS2	192430	VELOCARDIOFACIAL SYNDROME;;CHROMOSOME 22q11.2 DELETION SYNDROME;;VCF SYNDROME; VCFS;;SHPRINTZEN VCF SYNDROME
ENSG00000206203	TSSK2	NA	
ENSG00000063515	GSC2	NA	
ENSG00000260924	LINC01311	NA	
ENSG00000100075	SLC25A1	615182	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD
ENSG00000100075	SLC25A1	618197	MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23
ENSG00000070371	CLTCL1	NA	
ENSG00000286367	AC000072.1	NA	
ENSG00000230194	AC000081.1	NA	
ENSG00000251940	AC000081.2	NA	
ENSG00000233471	KRT18P62	NA	
ENSG00000287146	AC000085.1	NA	
ENSG00000100084	HIRA	NA	
ENSG00000128191	DGCR8	192430	VELOCARDIOFACIAL SYNDROME;;CHROMOSOME 22q11.2 DELETION SYNDROME;;VCF SYNDROME; VCFS;;SHPRINTZEN VCF SYNDROME
ENSG00000242259	C22orf39	NA	
ENSG00000244296	RN7SL168P	NA	
ENSG00000185608	MRPL40	NA	
ENSG00000185065	AC000068.1	NA	
ENSG00000070010	UFD1	NA	
ENSG00000273300	AC000068.3	NA	
ENSG00000273212	AC000068.2	NA	
ENSG00000093009	CDC45	617063	MEIER-GORLIN SYNDROME 7; MGORS7
ENSG00000287652	AC000082.1	NA	
ENSG00000184113	CLDN5	NA	
ENSG00000281548	LINC00895	NA	
ENSG00000230485	AC000077.1	NA	
ENSG00000225007	AC000067.1	NA	
ENSG00000184702	SEPTIN5	NA	
ENSG00000284874	AC000093.1	NA	
ENSG00000203618	GP1BB	231200	BERNARD-SOULIER SYNDROME; BSS;;BLEEDING DISORDER, PLATELET-TYPE, 1; BDPLT1;;PLATELET GLYCOPROTEIN Ib DEFICIENCY;;GLYCOPROTEIN Ib, PLATELET, DEFICIENCY OF;;VON WILLEBRAND FACTOR RECEPTOR DEFICIENCY BERNARD-SOULIER SYNDROME, TYPE A1, INCLUDED;;BERNARD /.../ER SYNDROME, TYPE B, INCLUDED;;BERNARD-SOULIER SYNDROME, TYPE C, INCLUDED
ENSG00000184058	TBX1	187500	TETRALOGY OF FALLOT; TOF
ENSG00000184058	TBX1	188400	DIGEORGE SYNDROME; DGS;;CHROMOSOME 22q11.2 DELETION SYNDROME;;HYPOPLASIA OF THYMUS AND PARATHYROIDS;;THIRD AND FOURTH PHARYNGEAL POUCH SYNDROME DIGEORGE SYNDROME CHROMOSOME REGION, INCLUDED; DGCR, INCLUDED;;TAKAO VCF SYNDROME, INCLUDED;;CATCH22, INCLUDED
ENSG00000184058	TBX1	192430	VELOCARDIOFACIAL SYNDROME;;CHROMOSOME 22q11.2 DELETION SYNDROME;;VCF SYNDROME; VCFS;;SHPRINTZEN VCF SYNDROME
ENSG00000184058	TBX1	217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM TRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED /.../RRUPTED AORTIC ARCH, INCLUDED
ENSG00000185838	GNB1L	NA	
ENSG00000235776	AC000089.1	NA	
ENSG00000215012	RTL10	NA	
ENSG00000184470	TXNRD2	617825	GLUCOCORTICOID DEFICIENCY 5; GCCD5
ENSG00000232926	AC000078.1	NA	
ENSG00000093010	COMT	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000093010	COMT	167870	PANIC DISORDER 1; PAND1;;PANIC DISORDER SUSCEPTIBILITY LOCUS, CHROMOSOME 13q-RELATED  PANIC DISORDER WITH BLADDER CONDITIONS, INCLUDED;;PANIC DISORDER WITH JOINT LAXITY, INCLUDED
ENSG00000093010	COMT	116790	CATECHOL-O-METHYLTRANSFERASE; COMT CATECHOL-O-METHYLTRANSFERASE ACTIVITY, LOW, IN RED CELLS, INCLUDED
ENSG00000284031	MIR4761	NA	
ENSG00000099889	ARVCF	NA	
ENSG00000183597	TANGO2	616878	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN
ENSG00000208023	MIR185	NA	
ENSG00000236540	AC006547.1	NA	
ENSG00000268292	AC006547.3	NA	
ENSG00000277950	Metazoa_SRP	NA	
ENSG00000284140	MIR3618	NA	
ENSG00000284464	MIR1306	NA	
ENSG00000243762	AC006547.2	NA	
ENSG00000099899	TRMT2A	NA	
ENSG00000278278	MIR6816	NA	
ENSG00000099901	RANBP1	NA	
ENSG00000264346	SNORA77B	NA	
ENSG00000099904	ZDHHC8	NA	
ENSG00000234409	CCDC188	NA	
ENSG00000249923	AC007663.2	NA	
ENSG00000236499	LINC00896	NA	
ENSG00000040608	RTN4R	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000221039	MIR1286	NA	
ENSG00000161132	AC007663.1	NA	
ENSG00000128185	DGCR6L	NA	
ENSG00000273343	AC007663.4	NA	
ENSG00000273139	AC007663.3	NA	
ENSG00000188280	FAM230G	NA	
ENSG00000235578	AC007731.2	NA	
ENSG00000287446	AC007731.5	NA	
ENSG00000161133	USP41	NA	
ENSG00000185252	ZNF74	NA	
ENSG00000207343	RNU6-225P	NA	
ENSG00000244486	SCARF2	600920	VAN DEN ENDE-GUPTA SYNDROME; VDEGS;;MARDEN-WALKER-LIKE SYNDROME WITHOUT PSYCHOMOTOR RETARDATION;;BLEPHAROPHIMOSIS, ARACHNODACTYLY, AND CONGENITAL CONTRACTURES
ENSG00000277971	AC007731.4	NA	
ENSG00000099910	KLHL22	NA	
ENSG00000215493	AC007731.1	NA	
ENSG00000255156	RNY1P9	NA	
ENSG00000201916	Y_RNA	NA	
ENSG00000242876	RN7SL812P	NA	
ENSG00000236670	KRT18P5	NA	
ENSG00000099917	MED15	NA	
ENSG00000236003	AC007731.3	NA	
ENSG00000250261	CCDC74BP1	NA	
ENSG00000223553	SMPD4P1	NA	
ENSG00000276427	IGLL4P	NA	
ENSG00000238125	SLC9A3P2	NA	
ENSG00000229107	ABHD17AP4	NA	
ENSG00000217261	POM121L4P	NA	
ENSG00000235062	BCRP5	NA	
ENSG00000226287	TMEM191A	NA	
ENSG00000241973	PI4KA	616531	POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA
ENSG00000099937	SERPIND1	612356	HEPARIN COFACTOR II DEFICIENCY;;THROMBOPHILIA DUE TO HEPARIN COFACTOR II DEFICIENCY; THPH10;;HCF II DEFICIENCY;;HCF2 DEFICIENCY
ENSG00000099940	SNAP29	609528	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME;;CEDNIK SYNDROME
ENSG00000272600	AC007308.1	NA	
ENSG00000099942	CRKL	NA	
ENSG00000237476	LINC01637	NA	
ENSG00000183773	AIFM3	NA	
ENSG00000285314	AC002470.2	NA	
ENSG00000272829	AC002470.1	NA	
ENSG00000099949	LZTR1	615670	SCHWANNOMATOSIS 2; SWNTS2
ENSG00000099949	LZTR1	616564	NOONAN SYNDROME 10; NS10
ENSG00000184436	THAP7	NA	
ENSG00000230513	THAP7-AS1	NA	
ENSG00000284060	AC002472.2	NA	
ENSG00000161149	TUBA3FP	NA	
ENSG00000099957	P2RX6	NA	
ENSG00000284130	AC002472.3	NA	
ENSG00000099960	SLC7A4	NA	
ENSG00000226872	AC002472.1	NA	
ENSG00000207575	MIR649	NA	
ENSG00000206145	P2RX6P	NA	
ENSG00000187905	LRRC74B	NA	
ENSG00000249680	TUBA3GP	NA	
ENSG00000284665	AC002472.4	NA	
ENSG00000169668	BCRP2	NA	
ENSG00000197210	AP000550.1	NA	
ENSG00000239511	POM121L7P	NA	
ENSG00000224688	E2F6P2	NA	
ENSG00000215498	FAM230B	NA	
ENSG00000234503	AP000550.2	NA	
ENSG00000283972	AP000550.4	NA	
ENSG00000133475	GGT2	NA	
ENSG00000283145	AP000550.3	NA	
ENSG00000226885	E2F6P3	NA	
ENSG00000229266	POM121L8P	NA	
ENSG00000169662	BCRP6	NA	
ENSG00000206142	FAM230H	NA	
ENSG00000237407	AP000552.2	NA	
ENSG00000232771	PPP1R26P5	NA	
ENSG00000279920	LINC01651	NA	
ENSG00000286102	AP000552.4	NA	
ENSG00000226534	AP000552.1	NA	
ENSG00000273846	Metazoa_SRP	NA	
ENSG00000274600	RIMBP3B	NA	
ENSG00000200057	RN7SKP63	NA	
ENSG00000252020	AP000552.3	NA	
ENSG00000275840	Metazoa_SRP	NA	
ENSG00000169635	HIC2	NA	
ENSG00000276800	Metazoa_SRP	NA	
ENSG00000206140	TMEM191C	NA	
ENSG00000183506	PI4KAP2	NA	
ENSG00000252143	AP000557.1	NA	
ENSG00000222352	RN7SKP221	NA	
ENSG00000183246	RIMBP3C	NA	
ENSG00000185651	UBE2L3	NA	
ENSG00000275293	Metazoa_SRP	NA	
ENSG00000161179	YDJC	NA	
ENSG00000161180	CCDC116	NA	
ENSG00000273342	AP000553.3	NA	
ENSG00000128228	SDF2L1	NA	
ENSG00000207751	AP000553.1	NA	
ENSG00000212102	MIR301B	NA	
ENSG00000283871	MIR130B	NA	
ENSG00000284630	AP000553.5	NA	
ENSG00000284651	AP000553.6	NA	
ENSG00000284654	AP000553.7	NA	
ENSG00000284621	AP000553.4	NA	
ENSG00000272954	AP000553.2	NA	
ENSG00000100023	PPIL2	NA	
ENSG00000100027	YPEL1	NA	
ENSG00000286365	AP000553.9	NA	
ENSG00000244671	RN7SL280P	NA	
ENSG00000286127	AP000553.8	NA	
ENSG00000100030	MAPK1	NA	
ENSG00000200985	RNA5SP493	NA	
ENSG00000225544	AC245452.1	NA	
ENSG00000100034	PPM1F	NA	
ENSG00000224086	PPM1F-AS1	NA	
ENSG00000100038	TOP3B	NA	
ENSG00000197549	PRAMENP	NA	
ENSG00000253239	IGLVI-70	NA	
ENSG00000211637	IGLV4-69	NA	
ENSG00000254355	IGLVI-68	NA	
ENSG00000278657	AC245452.4	NA	
ENSG00000211642	IGLV10-54	NA	
ENSG00000249333	AC245452.3	NA	
ENSG00000253794	IGLV10-67	NA	
ENSG00000228161	AC245452.2	NA	
ENSG00000253874	IGLVIV-66-1	NA	
ENSG00000254075	IGLVV-66	NA	
ENSG00000254161	IGLVIV-65	NA	
ENSG00000253242	IGLVIV-64	NA	
ENSG00000253752	IGLVI-63	NA	
ENSG00000253823	IGLV1-62	NA	
ENSG00000275361	AC245517.5	NA	
ENSG00000211638	IGLV8-61	NA	
ENSG00000225741	AC245517.1	NA	
ENSG00000263366	ABHD17AP5	NA	
ENSG00000236118	AC245517.4	NA	
ENSG00000233720	AC245517.3	NA	
ENSG00000211639	IGLV4-60	NA	
ENSG00000227710	AC245517.2	NA	
ENSG00000224465	SOCS2P2	NA	
ENSG00000254308	IGLVIV-59	NA	
ENSG00000253637	IGLVV-58	NA	
ENSG00000236323	BMP6P1	NA	
ENSG00000211640	IGLV6-57	NA	
ENSG00000253126	IGLVI-56	NA	
ENSG00000211641	IGLV11-55	NA	
ENSG00000253935	IGLVIV-53	NA	
ENSG00000228050	TOP3BP1	NA	
ENSG00000234726	AC245060.3	NA	
ENSG00000169575	VPREB1	NA	
ENSG00000279278	AC245060.6	NA	
ENSG00000274422	AC245060.5	NA	
ENSG00000234630	AC245060.2	NA	
ENSG00000286129	AC245060.7	NA	
ENSG00000272779	AC245060.4	NA	
ENSG00000211643	IGLV5-52	NA	
ENSG00000211644	IGLV1-51	NA	
ENSG00000211645	IGLV1-50	NA	
ENSG00000225724	ASH2LP3	NA	
ENSG00000223350	IGLV9-49	NA	
ENSG00000232515	AC245060.1	NA	
ENSG00000211647	IGLV5-48	NA	
ENSG00000211648	IGLV1-47	NA	
ENSG00000237428	ASH2LP2	NA	
ENSG00000211649	IGLV7-46	NA	
ENSG00000232603	AC245291.3	NA	
ENSG00000211650	IGLV5-45	NA	
ENSG00000211651	IGLV1-44	NA	
ENSG00000211652	IGLV7-43	NA	
ENSG00000254175	IGLVI-42	NA	
ENSG00000254073	IGLVVII-41-1	NA	
ENSG00000253818	IGLV1-41	NA	
ENSG00000211653	IGLV1-40	NA	
ENSG00000224144	ASH2LP1	NA	
ENSG00000253889	IGLVI-38	NA	
ENSG00000211654	IGLV5-37	NA	
ENSG00000211655	IGLV1-36	NA	
ENSG00000230821	AC245291.2	NA	
ENSG00000253631	IGLV7-35	NA	
ENSG00000226595	AC245291.1	NA	
ENSG00000275004	ZNF280B	NA	
ENSG00000169548	ZNF280A	NA	
ENSG00000185686	PRAME	NA	
ENSG00000220891	LL22NC03-63E9.3	NA	
ENSG00000253120	IGLV2-34	NA	
ENSG00000211656	IGLV2-33	NA	
ENSG00000211657	IGLV3-32	NA	
ENSG00000253920	IGLV3-31	NA	
ENSG00000253329	IGLV3-30	NA	
ENSG00000215456	BCRP4	NA	
ENSG00000286941	AC244250.4	NA	
ENSG00000183169	POM121L1P	NA	
ENSG00000100121	GGTLC2	NA	
ENSG00000253338	IGLV3-29	NA	
ENSG00000253451	IGLV2-28	NA	
ENSG00000211658	IGLV3-27	NA	
ENSG00000253913	IGLV3-26	NA	
ENSG00000253779	IGLVVI-25-1	NA	
ENSG00000211659	IGLV3-25	NA	
ENSG00000232350	AC244250.2	NA	
ENSG00000223999	AC244250.1	NA	
ENSG00000253822	IGLV3-24	NA	
ENSG00000211660	IGLV2-23	NA	
ENSG00000253546	IGLVVI-22-1	NA	
ENSG00000211661	IGLV3-22	NA	
ENSG00000211662	IGLV3-21	NA	
ENSG00000254240	IGLVI-20	NA	
ENSG00000211663	IGLV3-19	NA	
ENSG00000278667	AC244250.3	NA	
ENSG00000211664	IGLV2-18	NA	
ENSG00000253152	IGLV3-17	NA	
ENSG00000211665	IGLV3-16	NA	
ENSG00000253786	IGLV3-15	NA	
ENSG00000211666	IGLV2-14	NA	
ENSG00000253590	IGLV3-13	NA	
ENSG00000211667	IGLV3-12	NA	
ENSG00000231392	AC244157.1	NA	
ENSG00000275772	AC244157.2	NA	
ENSG00000211668	IGLV2-11	NA	
ENSG00000274381	AC245028.3	NA	
ENSG00000211669	IGLV3-10	NA	
ENSG00000226477	AC245028.1	NA	
ENSG00000211670	IGLV3-9	NA	
ENSG00000278196	IGLV2-8	NA	
ENSG00000284049	MIR650	NA	
ENSG00000237127	AC245028.2	NA	
ENSG00000254077	IGLV3-7	NA	
ENSG00000253448	IGLV3-6	NA	
ENSG00000253234	IGLV2-5	NA	
ENSG00000226420	IGLV3-4	NA	
ENSG00000211672	IGLV4-3	NA	
ENSG00000253963	IGLV3-2	NA	
ENSG00000211673	IGLV3-1	NA	
ENSG00000264824	MIR5571	NA	
ENSG00000254709	IGLL5	NA	
ENSG00000211674	IGLJ1	NA	
ENSG00000211675	IGLC1	NA	
ENSG00000211676	IGLJ2	NA	
ENSG00000211677	IGLC2	NA	
ENSG00000211678	IGLJ3	NA	
ENSG00000211679	IGLC3	NA	
ENSG00000211680	IGLJ4	NA	
ENSG00000254029	IGLC4	NA	
ENSG00000211681	IGLJ5	NA	
ENSG00000254030	IGLC5	NA	
ENSG00000211682	IGLJ6	NA	
ENSG00000222037	IGLC6	NA	
ENSG00000211684	IGLJ7	NA	
ENSG00000211685	IGLC7	NA	
ENSG00000237472	AC245054.2	NA	
ENSG00000223679	AC245054.1	NA	
ENSG00000100218	RSPH14	NA	
ENSG00000128266	GNAZ	NA	
ENSG00000283438	Metazoa_SRP	NA	
ENSG00000275635	U7	NA	
ENSG00000100228	RAB36	NA	
ENSG00000186716	BCR	608232	LEUKEMIA, CHRONIC MYELOID; CML;;LEUKEMIA, CHRONIC MYELOGENOUS LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATANIB, INCLUDED;;LEUKEMIA, CHRONIC MYELOID, ATYPICAL, INCLUDED; ACML, INCLUDED
ENSG00000186716	BCR	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMI /.../ELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000236794	BCRP8	NA	
ENSG00000240160	RN7SL263P	NA	
ENSG00000230701	FBXW4P1	NA	
ENSG00000214526	AP000343.1	NA	
ENSG00000236611	LINC02556	NA	
ENSG00000215478	CES5AP1	NA	
ENSG00000133519	ZDHHC8P1	NA	
ENSG00000248409	AP000344.2	NA	
ENSG00000234928	LINC01659	NA	
ENSG00000227755	AP000344.1	NA	
ENSG00000178248	FAM230I	NA	
ENSG00000287864	AP000345.3	NA	
ENSG00000225413	LINC02557	NA	
ENSG00000280623	PCAT14	NA	
ENSG00000224277	AP000345.1	NA	
ENSG00000128322	IGLL1	613500	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGLL1 DEFECT
ENSG00000272733	AP000345.2	NA	
ENSG00000278655	AP000346.4	NA	
ENSG00000189269	DRICH1	NA	
ENSG00000275609	AP000346.3	NA	
ENSG00000211683	AP000346.1	NA	
ENSG00000228315	GUSBP11	NA	
ENSG00000234353	AP000346.2	NA	
ENSG00000244723	ASLP1	NA	
ENSG00000272578	AP000347.1	NA	
ENSG00000159496	RGL4	NA	
ENSG00000187792	ZNF70	NA	
ENSG00000128218	VPREB3	NA	
ENSG00000169314	C22orf15	NA	
ENSG00000250479	CHCHD10	615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ
ENSG00000250479	CHCHD10	615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2
ENSG00000250479	CHCHD10	616209	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD
ENSG00000099953	MMP11	NA	
ENSG00000099956	SMARCB1	162091	SCHWANNOMATOSIS 1; SWNTS1;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS
ENSG00000099956	SMARCB1	609322	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1;;BRAIN TUMOR, POSTERIOR FOSSA, OF INFANCY, FAMILIAL MALIGNANT RHABDOID TUMOR, SOMATIC, INCLUDED;;RHABDOID TUMOR, INCLUDED; RDT, INCLUDED;;TERATOID TUMOR, ATYPICAL, INCLUDED;;AT/RT, INCLUDED
ENSG00000099956	SMARCB1	614608	COFFIN-SIRIS SYNDROME 3; CSS3;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 15; MRD15
ENSG00000099958	DERL3	NA	
ENSG00000272973	AP000350.5	NA	
ENSG00000133460	SLC2A11	NA	
ENSG00000251357	AP000350.4	NA	
ENSG00000279467	AP000350.7	NA	
ENSG00000244425	RN7SL268P	NA	
ENSG00000240972	MIF	604302	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE;;SYSTEMIC JUVENILE RHEUMATOID ARTHRITIS
ENSG00000218537	MIF-AS1	NA	
ENSG00000273295	AP000350.6	NA	
ENSG00000225282	AP000350.2	NA	
ENSG00000206090	AP000350.1	NA	
ENSG00000231271	AP000350.3	NA	
ENSG00000133433	GSTT2B	NA	
ENSG00000228039	AC253536.2	NA	
ENSG00000099974	DDTL	NA	
ENSG00000272787	AC253536.6	NA	
ENSG00000099977	DDT	NA	
ENSG00000285762	AC253536.7	NA	
ENSG00000224205	AC253536.1	NA	
ENSG00000250470	AC253536.5	NA	
ENSG00000099984	GSTT2	NA	
ENSG00000276950	GSTT4	NA	
ENSG00000235689	AC253536.4	NA	
ENSG00000099991	CABIN1	NA	
ENSG00000232545	AC253536.3	NA	
ENSG00000099994	SUSD2	NA	
ENSG00000099998	GGT5	NA	
ENSG00000230712	GGTLC4P	NA	
ENSG00000128262	POM121L9P	NA	
ENSG00000225098	BCRP1	NA	
ENSG00000215464	AP000354.1	NA	
ENSG00000100014	SPECC1L	145420	HYPERTELORISM, TEEBI TYPE; TBHS;;BRACHYCEPHALOFRONTONASAL DYSPLASIA
ENSG00000100014	SPECC1L	145410	OPITZ GBBB SYNDROME, TYPE II; GBBB2;;OPITZ GBBB SYNDROME, AUTOSOMAL DOMINANT;;HYPERTELORISM WITH ESOPHAGEAL ABNORMALITY AND HYPOSPADIAS;;G SYNDROME;;HYPOSPADIAS-DYSPHAGIA SYNDROME;;OPITZ-FRIAS SYNDROME;;OPITZ-G SYNDROME, TYPE II; OGS2;;TELECANTHUS W /.../SOCIATED ABNORMALITIES;;BBB SYNDROME;;HYPERTELORISM-HYPOSPADIAS SYNDROME;;TELECANTHUS-HYPOSPADIAS SYNDROME;;OPITZ BBBG SYNDROME;;GBBB SYNDROME;;OPITZ OCULOGENITOLARYNGEAL SYNDROME, TYPE II;;CHROMOSOME 22q11.2 DELETION SYNDROME, OPITZ PHENOTYPE
ENSG00000100014	SPECC1L	600251	FACIAL CLEFTING, OBLIQUE, 1; OBLFC1;;OCULOMAXILLOFACIAL DYSPLASIA WITH OBLIQUE FACIAL CLEFTS
ENSG00000258555	SPECC1L-ADORA2A	NA	
ENSG00000128271	ADORA2A	NA	
ENSG00000178803	ADORA2A-AS1	NA	
ENSG00000100024	UPB1	613161	BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D
ENSG00000228923	AP000355.1	NA	
ENSG00000138867	GUCD1	NA	
ENSG00000100028	SNRPD3	NA	
ENSG00000286070	AP000356.5	NA	
ENSG00000178026	LRRC75B	NA	
ENSG00000100031	GGT1	231950	GLUTATHIONURIA;;GAMMA-GLUTAMYLTRANSPEPTIDASE DEFICIENCY;;GGT DEFICIENCY;;GTG DEFICIENCY;;GAMMA-GLUTAMYLTRANSFERASE DEFICIENCY
ENSG00000230947	AP000356.1	NA	
ENSG00000215481	BCRP3	NA	
ENSG00000284233	AP000356.4	NA	
ENSG00000284128	AP000356.3	NA	
ENSG00000284070	AP000356.2	NA	
ENSG00000224124	POM121L10P	NA	
ENSG00000224806	ARL5AP4	NA	
ENSG00000224334	AP000357.1	NA	
ENSG00000282012	AP000357.2	NA	
ENSG00000237601	AP000358.1	NA	
ENSG00000182351	CRIP1P4	NA	
ENSG00000184571	PIWIL3	NA	
ENSG00000167037	SGSM1	NA	
ENSG00000199783	AL049759.1	NA	
ENSG00000206069	TMEM211	NA	
ENSG00000197077	KIAA1671	NA	
ENSG00000279085	AL022323.2	NA	
ENSG00000279548	AL022323.4	NA	
ENSG00000279006	AL022323.1	NA	
ENSG00000279110	AL022323.3	NA	
ENSG00000203280	KIAA1671-AS1	NA	
ENSG00000271181	Z99916.2	NA	
ENSG00000100053	CRYBB3	609741	CATARACT 22, MULTIPLE TYPES; CTRCT22;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 2; CATCN2
ENSG00000236641	Z99916.1	NA	
ENSG00000244752	CRYBB2	601547	CATARACT 3, MULTIPLE TYPES; CTRCT3;;CATARACT 3, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, CONGENITAL, CERULEAN TYPE, 2; CCA2
ENSG00000279298	Z99916.3	NA	
ENSG00000233577	AL022332.1	NA	
ENSG00000285968	AL022324.4	NA	
ENSG00000285690	AL022332.2	NA	
ENSG00000206066	IGLL3P	NA	
ENSG00000230637	AL022324.1	NA	
ENSG00000231466	AL022324.2	NA	
ENSG00000100068	LRP5L	NA	
ENSG00000272942	AL022324.3	NA	
ENSG00000272798	AL008721.1	NA	
ENSG00000271138	IGLVIVOR22-1	NA	
ENSG00000100058	CRYBB2P1	NA	
ENSG00000277872	MIR6817	NA	
ENSG00000272977	AL008721.2	NA	
ENSG00000234884	AL022329.1	NA	
ENSG00000100077	GRK3	NA	
ENSG00000237387	AL022329.2	NA	
ENSG00000224003	YES1P1	NA	
ENSG00000222585	RNA5SP494	NA	
ENSG00000133454	MYO18B	616549	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4
ENSG00000278960	AL022329.3	NA	
ENSG00000231933	MYO18B-AS1	NA	
ENSG00000232464	Z98949.2	NA	
ENSG00000223056	RN7SKP169	NA	
ENSG00000232050	Z98949.1	NA	
ENSG00000236464	LINC02559	NA	
ENSG00000229770	AL022337.1	NA	
ENSG00000100095	SEZ6L	NA	
ENSG00000224192	SEZ6L-AS1	NA	
ENSG00000252267	RNA5SP495	NA	
ENSG00000230203	Z99714.1	NA	
ENSG00000128203	ASPHD2	NA	
ENSG00000100099	HPS4	614073	HERMANSKY-PUDLAK SYNDROME 4; HPS4
ENSG00000100104	SRRD	NA	
ENSG00000100109	TFIP11	NA	
ENSG00000261188	Z95115.1	NA	
ENSG00000128294	TPST2	NA	
ENSG00000221760	MIR548J	NA	
ENSG00000213707	HMGB1P10	NA	
ENSG00000286326	Z95115.2	NA	
ENSG00000100122	CRYBB1	611544	CATARACT 17, MULTIPLE TYPES; CTRCT17;;CATARACT 17, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 3; CATCN3
ENSG00000196431	CRYBA4	610425	CATARACT 23, MULTIPLE TYPES; CTRCT23;;CATARACT 23, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA
ENSG00000226912	ISCA2P1	NA	
ENSG00000225783	MIAT	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000278404	Z99774.5	NA	
ENSG00000206028	Z99774.1	NA	
ENSG00000277941	Z99774.4	NA	
ENSG00000275942	Z99774.2	NA	
ENSG00000244625	MIATNB	NA	
ENSG00000276991	Z99774.3	NA	
ENSG00000223704	LINC01422	NA	
ENSG00000231369	Z97353.1	NA	
ENSG00000235271	Z97353.2	NA	
ENSG00000279440	AL008638.3	NA	
ENSG00000200443	RNU6-1066P	NA	
ENSG00000279914	AL008638.5	NA	
ENSG00000279848	AL008638.4	NA	
ENSG00000236858	AL008638.2	NA	
ENSG00000280025	AL008638.6	NA	
ENSG00000231405	AL008638.1	NA	
ENSG00000238195	AL021153.1	NA	
ENSG00000233521	LINC01638	NA	
ENSG00000233574	AL020994.3	NA	
ENSG00000223726	AL020994.1	NA	
ENSG00000226741	LINC02554	NA	
ENSG00000230051	AL020994.2	NA	
ENSG00000280445	AL049536.1	NA	
ENSG00000287034	AL050402.2	NA	
ENSG00000227880	AL050402.1	NA	
ENSG00000224027	AL133456.1	NA	
ENSG00000227838	AL121885.2	NA	
ENSG00000231495	AL121885.3	NA	
ENSG00000226169	AL121885.1	NA	
ENSG00000169184	MN1	607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
ENSG00000169184	MN1	618774	CEBALID SYNDROME; CEBALID;;CRANIOFACIAL DEFECTS, DYSMORPHIC EARS, STRUCTURAL BRAIN ABNORMALITIES, EXPRESSIVE LANGUAGE DELAY, AND IMPAIRED INTELLECTUAL DEVELOPMENT
ENSG00000180957	PITPNB	NA	
ENSG00000235954	TTC28-AS1	NA	
ENSG00000277460	AL031591.2	NA	
ENSG00000264073	MIR3199-1	NA	
ENSG00000283225	MIR3199-2	NA	
ENSG00000276150	AL031591.1	NA	
ENSG00000100154	TTC28	NA	
ENSG00000274342	AL033538.1	NA	
ENSG00000276675	AL033538.2	NA	
ENSG00000239249	RN7SL757P	NA	
ENSG00000201209	SNORD42	NA	
ENSG00000199797	Y_RNA	NA	
ENSG00000276162	MIR5739	NA	
ENSG00000266503	RN7SL162P	NA	
ENSG00000183765	CHEK2	176807	PROSTATE CANCER
ENSG00000183765	CHEK2	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000183765	CHEK2	259500	OSTEOGENIC SARCOMA;;OSTEOSARCOMA; OSRC
ENSG00000183765	CHEK2	604373	CHECKPOINT KINASE 2; CHEK2;;CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF;;CHK2;;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53;;CDS1, S. POMBE, HOMOLOG OF BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO, INCLUDED;;HBCC, SUSCEPTIBILITY TO, INCLUDED
ENSG00000183765	CHEK2	609265	LI-FRAUMENI SYNDROME 2; LFS2
ENSG00000100209	HSCB	NA	
ENSG00000159873	CCDC117	NA	
ENSG00000100219	XBP1	612371	MAJOR AFFECTIVE DISORDER 7; MAFD7;;BIPOLAR AFFECTIVE DISORDER
ENSG00000226471	Z93930.2	NA	
ENSG00000272858	Z93930.3	NA	
ENSG00000224256	Z93930.1	NA	
ENSG00000183579	ZNRF3	NA	
ENSG00000235786	ZNRF3-IT1	NA	
ENSG00000177993	ZNRF3-AS1	NA	
ENSG00000100249	C22orf31	NA	
ENSG00000183762	KREMEN1	617392	ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13
ENSG00000226772	AL021393.1	NA	
ENSG00000200871	RNU6-810P	NA	
ENSG00000251952	RNU6-1219P	NA	
ENSG00000186998	EMID1	NA	
ENSG00000100263	RHBDD3	NA	
ENSG00000237015	AL031186.1	NA	
ENSG00000182944	EWSR1	612219	EWING SARCOMA; ES NEUROEPITHELIOMA, PERIPHERAL, INCLUDED; PNE, INCLUDED;;ASKIN TUMOR, INCLUDED
ENSG00000185340	GAS2L1	NA	
ENSG00000100276	RASL10A	NA	
ENSG00000273216	AC002059.1	NA	
ENSG00000100280	AP1B1	242150	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KIDAR;;ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS;;KID SYNDROME, AUTOSOMAL RECESSIVE;;DESMONS SYNDROME
ENSG00000280968	AC002059.2	NA	
ENSG00000239127	SNORD125	NA	
ENSG00000285697	AC002059.3	NA	
ENSG00000242156	AC000041.1	NA	
ENSG00000278292	RFPL4AP6	NA	
ENSG00000225465	RFPL1S	NA	
ENSG00000128250	RFPL1	NA	
ENSG00000100285	NEFH	105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1;;AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS;;AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED;;AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED
ENSG00000100285	NEFH	616924	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2CC
ENSG00000282816	AC000035.1	NA	
ENSG00000100296	THOC5	NA	
ENSG00000234208	AC005529.1	NA	
ENSG00000184117	NIPSNAP1	NA	
ENSG00000186575	NF2	162091	SCHWANNOMATOSIS 1; SWNTS1;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS
ENSG00000186575	NF2	101000	NEUROFIBROMATOSIS, TYPE II; NF2;;NEUROFIBROMATOSIS, CENTRAL TYPE;;ACOUSTIC SCHWANNOMAS, BILATERAL;;BILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF;;ACOUSTIC NEURINOMA, BILATERAL; ACN
ENSG00000186575	NF2	607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
ENSG00000233010	RPEP4	NA	
ENSG00000232396	AC004882.1	NA	
ENSG00000239446	AC004882.2	NA	
ENSG00000100314	CABP7	NA	
ENSG00000100319	ZMAT5	NA	
ENSG00000200976	Y_RNA	NA	
ENSG00000287967	AC004882.3	NA	
ENSG00000184076	UQCR10	NA	
ENSG00000100325	ASCC2	NA	
ENSG00000100330	MTMR3	NA	
ENSG00000207455	RNU6-331P	NA	
ENSG00000279159	AC003681.1	NA	
ENSG00000275818	MIR6818	NA	
ENSG00000227117	HORMAD2-AS1	NA	
ENSG00000227201	CNN2P1	NA	
ENSG00000176635	HORMAD2	NA	
ENSG00000226573	AC003071.1	NA	
ENSG00000225971	RPS3AP51	NA	
ENSG00000225676	AC002378.1	NA	
ENSG00000232530	LIF-AS1	NA	
ENSG00000128342	LIF	NA	
ENSG00000268812	AC004264.1	NA	
ENSG00000099985	OSM	NA	
ENSG00000279699	AC004264.2	NA	
ENSG00000239282	CASTOR1	NA	
ENSG00000248751	AC004997.1	NA	
ENSG00000099992	TBC1D10A	NA	
ENSG00000099995	SF3A1	NA	
ENSG00000187860	CCDC157	NA	
ENSG00000099999	RNF215	NA	
ENSG00000100003	SEC14L2	NA	
ENSG00000249590	AC004832.3	NA	
ENSG00000273350	AC004832.5	NA	
ENSG00000222915	RNU6-564P	NA	
ENSG00000272689	AC004832.4	NA	
ENSG00000242114	MTFP1	NA	
ENSG00000273428	AC004832.6	NA	
ENSG00000230137	AC004832.2	NA	
ENSG00000100012	SEC14L3	NA	
ENSG00000181123	AC004832.1	NA	
ENSG00000214161	SDC4P	NA	
ENSG00000133488	SEC14L4	NA	
ENSG00000214491	SEC14L6	NA	
ENSG00000225774	SIRPAP1	NA	
ENSG00000128242	GAL3ST1	NA	
ENSG00000100029	PES1	NA	
ENSG00000223831	AC005006.1	NA	
ENSG00000185339	TCN2	275350	TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY
ENSG00000100036	SLC35E4	NA	
ENSG00000167065	DUSP18	NA	
ENSG00000250318	AC003072.1	NA	
ENSG00000288153	AC003072.2	NA	
ENSG00000184792	OSBP2	NA	
ENSG00000264661	MIR3200	NA	
ENSG00000237977	EIF4HP2	NA	
ENSG00000235989	MORC2-AS1	NA	
ENSG00000133422	MORC2	616688	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2Z;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2Z
ENSG00000253352	TUG1	NA	
ENSG00000276664	AC004542.5	NA	
ENSG00000276057	AC004542.4	NA	
ENSG00000276965	AC004542.6	NA	
ENSG00000275307	AC004542.3	NA	
ENSG00000269987	AC004542.2	NA	
ENSG00000269972	AC004542.1	NA	
ENSG00000278920	AC005005.4	NA	
ENSG00000240186	RN7SL633P	NA	
ENSG00000183963	SMTN	NA	
ENSG00000273387	AC005005.3	NA	
ENSG00000198832	SELENOM	NA	
ENSG00000235573	AC005005.2	NA	
ENSG00000185133	INPP5J	NA	
ENSG00000100078	PLA2G3	NA	
ENSG00000214125	AC005005.1	NA	
ENSG00000264141	MIR3928	NA	
ENSG00000138942	RNF185	NA	
ENSG00000254835	RNF185-AS1	NA	
ENSG00000182541	LIMK2	NA	
ENSG00000199695	RNU6-1128P	NA	
ENSG00000202019	Y_RNA	NA	
ENSG00000100100	PIK3IP1	NA	
ENSG00000228839	PIK3IP1-DT	NA	
ENSG00000212542	RNA5SP496	NA	
ENSG00000100105	PATZ1	NA	
ENSG00000213888	LINC01521	NA	
ENSG00000206615	RNU6-338P	NA	
ENSG00000185721	DRG1	NA	
ENSG00000184708	EIF4ENIF1	NA	
ENSG00000240591	AL096701.3	NA	
ENSG00000199248	RNU6-28P	NA	
ENSG00000198089	SFI1	NA	
ENSG00000287817	AL096701.4	NA	
ENSG00000233733	H2AZP6	NA	
ENSG00000229169	AL096701.2	NA	
ENSG00000214093	AL096701.1	NA	
ENSG00000241878	PISD	NA	
ENSG00000284082	MIR7109	NA	
ENSG00000183530	PRR14L	NA	
ENSG00000100150	DEPDC5	604364	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1;;EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF
ENSG00000285404	Z82190.2	NA	
ENSG00000242251	RN7SL20P	NA	
ENSG00000236132	AL022331.1	NA	
ENSG00000252909	RNU6-201P	NA	
ENSG00000227813	Z82190.1	NA	
ENSG00000128254	C22orf24	NA	
ENSG00000128245	YWHAH	NA	
ENSG00000227519	AL008719.1	NA	
ENSG00000230866	LINC02558	NA	
ENSG00000240647	RN7SL305P	NA	
ENSG00000232346	Z74021.1	NA	
ENSG00000100170	SLC5A1	606824	GLUCOSE/GALACTOSE MALABSORPTION; GGM;;MONOSACCHARIDE MALABSORPTION; GM
ENSG00000234479	AP1B1P1	NA	
ENSG00000237439	Z83839.1	NA	
ENSG00000232707	AP1B1P2	NA	
ENSG00000239674	Z83839.2	NA	
ENSG00000205856	C22orf42	NA	
ENSG00000230120	AL008723.1	NA	
ENSG00000275656	AL008723.3	NA	
ENSG00000128253	RFPL2	NA	
ENSG00000254127	IGLCOR22-1	NA	
ENSG00000242082	SLC5A4-AS1	NA	
ENSG00000100191	SLC5A4	NA	
ENSG00000214076	CPSF1P1	NA	
ENSG00000273325	AL008723.2	NA	
ENSG00000234626	AL021937.3	NA	
ENSG00000128276	RFPL3	NA	
ENSG00000271093	IGLCOR22-2	NA	
ENSG00000205853	RFPL3S	NA	
ENSG00000274617	AL021937.6	NA	
ENSG00000274170	AL021937.5	NA	
ENSG00000230736	AL021937.1	NA	
ENSG00000243519	IGLVIVOR22-2	NA	
ENSG00000241954	AL021937.4	NA	
ENSG00000232218	AL021937.2	NA	
ENSG00000100220	RTCB	NA	
ENSG00000100124	ANKRD54	NA	
ENSG00000184459	BPIFC	NA	
ENSG00000100225	FBXO7	260300	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15;;PARKINSONIAN-PYRAMIDAL SYNDROME; PKPS;;PALLIDOPYRAMIDAL SYNDROME;;PALLIDO-PYRAMIDAL SYNDROME
ENSG00000185666	SYN3	NA	
ENSG00000236054	Z82246.1	NA	
ENSG00000251890	RNA5SP497	NA	
ENSG00000229673	Z73495.1	NA	
ENSG00000100234	TIMP3	136900	SORSBY FUNDUS DYSTROPHY; SFD;;FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY;;MACULAR DYSTROPHY, HEMORRHAGIC
ENSG00000228194	Z83846.1	NA	
ENSG00000231253	LINC01640	NA	
ENSG00000228622	Z82198.1	NA	
ENSG00000233632	Z82198.3	NA	
ENSG00000133424	LARGE1	236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED;;HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA;;HARD SYNDROME;;CEREBROOCULAR DYSPLA /.../SCULAR DYSTROPHY SYNDROME;;COD-MD SYNDROME
ENSG00000133424	LARGE1	608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6;;MUSCULAR DYSTROPHY, CONGENITAL, LARGE-RELATED;;MUSCULAR DYSTROPHY, CONGENITAL, TYPE 1D; MDC1D
ENSG00000133424	LARGE1	613154	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED
ENSG00000232073	Z82198.2	NA	
ENSG00000230741	Z82173.1	NA	
ENSG00000266012	MIR4764	NA	
ENSG00000253007	SNORA50B	NA	
ENSG00000281295	Z69713.1	NA	
ENSG00000232081	LARGE-IT1	NA	
ENSG00000224973	LARGE-AS1	NA	
ENSG00000273082	Z73429.1	NA	
ENSG00000236052	LINC01643	NA	
ENSG00000224404	Z68323.1	NA	
ENSG00000235485	AL021877.1	NA	
ENSG00000280356	AL021877.2	NA	
ENSG00000234891	Z82196.1	NA	
ENSG00000237316	Z82196.2	NA	
ENSG00000286592	LINC02885	NA	
ENSG00000175329	ISX	NA	
ENSG00000233080	LINC01399	NA	
ENSG00000273068	Z99755.2	NA	
ENSG00000238153	Z99755.1	NA	
ENSG00000238584	RNU7-167P	NA	
ENSG00000100281	HMGXB4	NA	
ENSG00000273176	AL008635.1	NA	
ENSG00000100284	TOM1	NA	
ENSG00000266320	MIR3909	NA	
ENSG00000274280	MIR6069	NA	
ENSG00000282602	Z82244.2	NA	
ENSG00000282041	Z82244.1	NA	
ENSG00000100292	HMOX1	606963	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SEVERE EARLY-ONSET, INCLUDED;;COPD, SEVERE EARLY-ONSET, INCLUDED;;PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, RATE OF DECLINE OF LUNG FUNCTION IN, INCLUDED
ENSG00000100292	HMOX1	614034	HEME OXYGENASE 1 DEFICIENCY; HMOX1D
ENSG00000100345	MYH9	155100	MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS;;BLEEDING DISORDER, PLATELET-TYPE, 6; BDPLT6;;MAY-HEGGLIN ANOMALY; MHA;;DOHLE LEUKOCYTE INCLUSIONS WITH GIANT PLATELETS;;MACROTHROMBOCYT /.../ WITH LEUKOCYTE INCLUSIONS;;GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA;;SEBASTIAN SYNDROME; SBS;;SEBASTIAN PLATELET SYNDROME;;MACROTHROMBOCYTOPENIA WITH DISPERSED LEUKOCYTIC INCLUSIONS;;EPSTEIN SYNDROME; EPSTNS;;MACROTHROMBOCYTOPENIA, NEPHRITIS, AND DEAFNESS;;MACROTHROMBOCYTOPENIA, NEPHRITIS, DEAFNESS, AND LEUKOCYTE INCLUSIONS;;FECHTNER SYNDROME; FTNS;;MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS;;ALPORT SYNDROME WITH MACROTHROMBOCYTOPENIA, FORMERLY; APSM, FORMERLY
ENSG00000100345	MYH9	603622	DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17 COCHLEOSACCULAR DEGENERATION, INCLUDED
ENSG00000100297	MCM5	617564	MEIER-GORLIN SYNDROME 8; MGORS8
ENSG00000233388	AL022334.1	NA	
ENSG00000273044	AL022334.2	NA	
ENSG00000100302	RASD2	NA	
ENSG00000198125	MB	NA	
ENSG00000268818	AL049747.1	NA	
ENSG00000221963	APOL6	NA	
ENSG00000228587	AL049748.1	NA	
ENSG00000226336	MRPS16P3	NA	
ENSG00000128313	APOL5	NA	
ENSG00000100320	RBFOX2	NA	
ENSG00000237406	NDUFA9P1	NA	
ENSG00000279652	Z82217.1	NA	
ENSG00000279927	Z95114.4	NA	
ENSG00000279217	Z95114.1	NA	
ENSG00000279714	Z95114.2	NA	
ENSG00000279805	Z95114.3	NA	
ENSG00000128284	APOL3	NA	
ENSG00000233764	MTCO1P20	NA	
ENSG00000231576	MTCO2P20	NA	
ENSG00000237948	MTATP6P20	NA	
ENSG00000225557	MTCO3P20	NA	
ENSG00000237129	MTCYBP34	NA	
ENSG00000229088	MTND1P10	NA	
ENSG00000100336	APOL4	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000128335	APOL2	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000100342	APOL1	612551	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4;;END-STAGE RENAL DISEASE, NONDIABETIC, SUSCEPTIBILITY TO, INCLUDED
ENSG00000278420	MIR6819	NA	
ENSG00000287269	Z82215.1	NA	
ENSG00000223695	FO393418.1	NA	
ENSG00000237668	RPS15AP38	NA	
ENSG00000252225	Y_RNA	NA	
ENSG00000228719	AL022313.2	NA	
ENSG00000100348	TXN2	616811	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29
ENSG00000100350	FOXRED2	NA	
ENSG00000100353	EIF3D	NA	
ENSG00000100106	TRIOBP	609823	DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28
ENSG00000188078	AL022313.1	NA	
ENSG00000229971	AL022313.3	NA	
ENSG00000261675	AL022313.4	NA	
ENSG00000166862	CACNG2	614256	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10
ENSG00000234688	AL049749.1	NA	
ENSG00000287773	Z80897.2	NA	
ENSG00000100360	IFT27	615996	BARDET-BIEDL SYNDROME 19; BBS19
ENSG00000286485	Z80897.1	NA	
ENSG00000100362	PVALB	NA	
ENSG00000234979	Z82185.1	NA	
ENSG00000183822	NCF4-AS1	NA	
ENSG00000100365	NCF4	613960	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III; CDG3;;CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVE, TYPE III;;GRANULOMATOUS DISEASE, CHRONIC, DUE TO NCF4 DEFICIENCY
ENSG00000100368	CSF2RB	614370	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5;;PULMONARY ALVEOLAR PROTEINOSIS 5;;PAP DUE TO CSF2RB DEFICIENCY;;CSF2RB DEFICIENCY
ENSG00000232254	CSF2RBP1	NA	
ENSG00000215403	LL22NC01-81G9.3	NA	
ENSG00000185264	TEX33	NA	
ENSG00000128311	TST	NA	
ENSG00000252412	Z73420.1	NA	
ENSG00000128309	MPST	NA	
ENSG00000287236	Z73420.2	NA	
ENSG00000100379	KCTD17	616398	DYSTONIA 26, MYOCLONIC; DYT26
ENSG00000201078	RN7SKP214	NA	
ENSG00000187045	TMPRSS6	206200	IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA;;ANEMIA, HYPOCHROMIC MICROCYTIC, WITH DEFECT IN IRON METABOLISM;;IRON-HANDLING DISORDER, HEREDITARY;;PSEUDO-IRON-DEFICIENCY ANEMIA
ENSG00000231467	AL022314.1	NA	
ENSG00000100385	IL2RB	618495	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63;;INTERLEUKIN 2 RECEPTOR, BETA, DEFICIENCY OF;;IL2RB DEFICIENCY;;CD122 DEFICIENCY
ENSG00000235237	Z82188.2	NA	
ENSG00000133466	C1QTNF6	NA	
ENSG00000278195	SSTR3	NA	
ENSG00000226233	Z82188.1	NA	
ENSG00000128340	RAC2	608203	NEUTROPHIL IMMUNODEFICIENCY SYNDROME
ENSG00000100055	CYTH4	NA	
ENSG00000243902	ELFN2	NA	
ENSG00000237862	Z94160.1	NA	
ENSG00000166897	ELFN2	NA	
ENSG00000272694	Z94160.2	NA	
ENSG00000100060	MFNG	NA	
ENSG00000100065	CARD10	NA	
ENSG00000225867	AL022315.1	NA	
ENSG00000128283	CDC42EP1	NA	
ENSG00000100079	LGALS2	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000273866	Metazoa_SRP	NA	
ENSG00000100083	GGA1	NA	
ENSG00000100092	SH3BP1	NA	
ENSG00000285304	Z83844.2	NA	
ENSG00000233360	PDXP-DT	NA	
ENSG00000241360	PDXP	NA	
ENSG00000241333	RN7SL385P	NA	
ENSG00000100097	LGALS1	NA	
ENSG00000273899	NOL12	NA	
ENSG00000100101	Z83844.1	NA	
ENSG00000189060	H1-0	NA	
ENSG00000100116	GCAT	NA	
ENSG00000128310	GALR3	NA	
ENSG00000284197	MIR658	NA	
ENSG00000207696	MIR659	NA	
ENSG00000100129	EIF3L	NA	
ENSG00000279738	AL022311.1	NA	
ENSG00000207227	RNU6-900P	NA	
ENSG00000100139	MICALL1	NA	
ENSG00000278948	AL031587.5	NA	
ENSG00000128346	C22orf23	NA	
ENSG00000272582	AL031587.3	NA	
ENSG00000100142	POLR2F	NA	
ENSG00000284289	MIR6820	NA	
ENSG00000100146	SOX10	609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH;;WAARDENBURG-SHAH SYNDROME, NEUROLOGIC VARIANT
ENSG00000100146	SOX10	611584	WAARDENBURG SYNDROME, TYPE 2E; WS2E;;HYPOGONADOTROPIC HYPOGONADISM WITH ANOSMIA AND DEAFNESS, WITH OR WITHOUT HYPOPIGMENTATION;;WAARDENBURG SYNDROME, TYPE 2E, WITH OR WITHOUT NEUROLOGIC INVOLVEMENT;;WS2E, WITH OR WITHOUT NEUROLOGIC INVOLVEMENT;;WAAR /.../G SYNDROME, TYPE IIE
ENSG00000100146	SOX10	613266	WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC
ENSG00000284266	MIR4534	NA	
ENSG00000222044	AL031587.1	NA	
ENSG00000273214	AL031587.4	NA	
ENSG00000100151	PICK1	NA	
ENSG00000233739	AL031587.2	NA	
ENSG00000100156	SLC16A8	NA	
ENSG00000128298	BAIAP2L2	NA	
ENSG00000272720	AL022322.1	NA	
ENSG00000184381	PLA2G6	256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A;;NEURODEGENERATION, PLA2G6-ASSOCIATED; PLAN;;NEUROAXONAL DYSTROPHY, INFANTILE; INAD; INAD1;;SEITELBERGER DISEASE
ENSG00000184381	PLA2G6	610217	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B;;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION, PLA2G6-RELATED;;NEUROAXONAL DYSTROPHY, ATYPICAL  KARAK SYNDROME, INCLUDED
ENSG00000184381	PLA2G6	612953	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14;;DYSTONIA-PARKINSONISM, ADULT-ONSET
ENSG00000279080	AL022322.2	NA	
ENSG00000185022	MAFF	NA	
ENSG00000198792	TMEM184B	NA	
ENSG00000235246	AL020993.1	NA	
ENSG00000241693	RN7SL704P	NA	
ENSG00000277385	Metazoa_SRP	NA	
ENSG00000213923	CSNK1E	NA	
ENSG00000283900	TPTEP2-CSNK1E	NA	
ENSG00000244627	TPTEP2	NA	
ENSG00000229955	Z98749.1	NA	
ENSG00000286144	Z97056.2	NA	
ENSG00000228620	Z97056.1	NA	
ENSG00000168135	KCNJ4	NA	
ENSG00000286440	Z97056.3	NA	
ENSG00000100196	KDELR3	NA	
ENSG00000100201	DDX17	NA	
ENSG00000100206	DMC1	NA	
ENSG00000224279	RPS29P31	NA	
ENSG00000184949	FAM227A	NA	
ENSG00000100211	CBY1	NA	
ENSG00000230912	AL021707.4	NA	
ENSG00000228274	AL021707.2	NA	
ENSG00000287219	AL021707.9	NA	
ENSG00000100216	TOMM22	NA	
ENSG00000100221	JOSD1	NA	
ENSG00000100226	GTPBP1	NA	
ENSG00000229598	PRDX3P1	NA	
ENSG00000100242	SUN2	NA	
ENSG00000244491	AL021707.5	NA	
ENSG00000230149	AL021707.3	NA	
ENSG00000273096	AL021707.8	NA	
ENSG00000225450	AL021707.1	NA	
ENSG00000272669	AL021707.6	NA	
ENSG00000273076	AL021707.7	NA	
ENSG00000100246	DNAL4	616059	MIRROR MOVEMENTS 3; MRMV3
ENSG00000221890	NPTXR	NA	
ENSG00000183741	CBX6	NA	
ENSG00000288106	AL022318.5	NA	
ENSG00000235209	AL022318.1	NA	
ENSG00000128383	APOBEC3A	NA	
ENSG00000179750	APOBEC3B	NA	
ENSG00000249310	APOBEC3B-AS1	NA	
ENSG00000244509	APOBEC3C	NA	
ENSG00000284554	AL022318.4	NA	
ENSG00000243811	APOBEC3D	NA	
ENSG00000128394	APOBEC3F	NA	
ENSG00000259421	AL022318.2	NA	
ENSG00000239713	APOBEC3G	NA	
ENSG00000225720	AL031846.1	NA	
ENSG00000100298	APOBEC3H	NA	
ENSG00000100307	CBX7	NA	
ENSG00000226024	COX5BP7	NA	
ENSG00000279833	AL031846.2	NA	
ENSG00000227009	FUNDC2P4	NA	
ENSG00000100311	PDGFB	213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1;;PRIMARY FAMILIAL BRAIN CALCIFICATION; PFBC;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL; BSPDC;;STRIOPALLIDODENTATE CALCINOSIS, AUTOSOMAL DOMINANT, ADULT-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLER /.../IDIOPATHIC, ADULT-ONSET;;FERROCALCINOSIS, CEREBROVASCULAR;;FAHR DISEASE, FAMILIAL, FORMERLY;;BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3, FORMERLY; IBGC3, FORMERLY;;BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2, FORMERLY; IBGC2, FORMERLY
ENSG00000100311	PDGFB	607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
ENSG00000100311	PDGFB	607907	DERMATOFIBROSARCOMA PROTUBERANS; DFSP;;GIANT CELL FIBROBLASTOMA
ENSG00000100311	PDGFB	615483	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5
ENSG00000284633	AL031590.1	NA	
ENSG00000224794	AL022326.1	NA	
ENSG00000100316	RPL3	NA	
ENSG00000209480	SNORD83B	NA	
ENSG00000209482	SNORD83A	NA	
ENSG00000263764	SNORD43	NA	
ENSG00000100321	SYNGR1	NA	
ENSG00000280216	AL022326.2	NA	
ENSG00000100324	TAB1	NA	
ENSG00000128268	MGAT3	NA	
ENSG00000227188	MGAT3-AS1	NA	
ENSG00000100335	MIEF1	NA	
ENSG00000285025	AL022312.1	NA	
ENSG00000128272	ATF4	NA	
ENSG00000187051	RPS19BP1	NA	
ENSG00000100346	CACNA1I	NA	
ENSG00000176177	ENTHD1	NA	
ENSG00000235647	MTFR2P2	NA	
ENSG00000238875	RN7SKP210	NA	
ENSG00000226085	UQCRFS1P1	NA	
ENSG00000100351	GRAP2	NA	
ENSG00000225528	Z82206.1	NA	
ENSG00000133477	FAM83F	NA	
ENSG00000261202	Z83847.1	NA	
ENSG00000100354	TNRC6B	NA	
ENSG00000228599	RPL7P52	NA	
ENSG00000239900	ADSL	103050	ADENYLOSUCCINASE DEFICIENCY; ADSLD;;ADENYLOSUCCINATE LYASE DEFICIENCY;;ADSL DEFICIENCY
ENSG00000284431	AL022238.3	NA	
ENSG00000100300	TSPO	NA	
ENSG00000100359	SGSM3	NA	
ENSG00000229999	SGSM3-AS1	NA	
ENSG00000196588	MRTFA	NA	
ENSG00000272834	AL022238.2	NA	
ENSG00000227413	AL022238.1	NA	
ENSG00000232564	MRTFA-AS1	NA	
ENSG00000172912	COX6B1P3	NA	
ENSG00000230071	RPL4P6	NA	
ENSG00000231907	GAPDHP37	NA	
ENSG00000128285	MCHR1	NA	
ENSG00000100372	SLC25A17	NA	
ENSG00000230769	Z98048.1	NA	
ENSG00000233603	JTBP1	NA	
ENSG00000266594	MIR4766	NA	
ENSG00000100380	ST13	NA	
ENSG00000196236	XPNPEP3	613159	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1
ENSG00000172404	DNAJB7	NA	
ENSG00000273979	Metazoa_SRP	NA	
ENSG00000200683	RNU6-379P	NA	
ENSG00000100387	RBX1	NA	
ENSG00000222698	Y_RNA	NA	
ENSG00000237214	AL080243.2	NA	
ENSG00000199515	Y_RNA	NA	
ENSG00000213857	AL080243.1	NA	
ENSG00000284015	MIR1281	NA	
ENSG00000100393	EP300	180849	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1;;RSTS;;RUBINSTEIN SYNDROME;;BROAD THUMBS AND GREAT TOES, CHARACTERISTIC FACIES, AND MENTAL RETARDATION;;BROAD THUMB-HALLUX SYNDROME
ENSG00000100393	EP300	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000100393	EP300	613684	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2
ENSG00000100393	EP300	618333	MENKE-HENNEKAM SYNDROME 2; MKHK2
ENSG00000252859	RNU6-375P	NA	
ENSG00000232754	AL035658.1	NA	
ENSG00000231993	EP300-AS1	NA	
ENSG00000215771	LRRC37A14P	NA	
ENSG00000100395	L3MBTL2	NA	
ENSG00000235513	L3MBTL2-AS1	NA	
ENSG00000100399	CHADL	NA	
ENSG00000100401	RANGAP1	NA	
ENSG00000274552	MIR6889	NA	
ENSG00000100403	ZC3H7B	NA	
ENSG00000167074	TEF	NA	
ENSG00000199865	RNU6-495P	NA	
ENSG00000273424	AL008582.1	NA	
ENSG00000183864	TOB2	NA	
ENSG00000100410	PHF5A	NA	
ENSG00000100412	ACO2	614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD
ENSG00000100412	ACO2	616289	OPTIC ATROPHY 9; OPA9
ENSG00000100413	POLR3H	NA	
ENSG00000286491	AL023553.1	NA	
ENSG00000172346	CSDC2	NA	
ENSG00000100417	PMM1	NA	
ENSG00000100227	POLDIP3	NA	
ENSG00000100418	DESI1	NA	
ENSG00000196419	XRCC6	NA	
ENSG00000200332	Y_RNA	NA	
ENSG00000100138	SNU13	NA	
ENSG00000285531	Z83840.1	NA	
ENSG00000207457	RNU6-476P	NA	
ENSG00000184208	C22orf46	NA	
ENSG00000167077	MEI1	618431	HYDATIDIFORM MOLE, RECURRENT, 3; HYDM3
ENSG00000231261	HMGN2P10	NA	
ENSG00000252603	RNU6ATAC22P	NA	
ENSG00000206813	Y_RNA	NA	
ENSG00000100147	CCDC134	NA	
ENSG00000184068	SREBF2-AS1	NA	
ENSG00000198911	SREBF2	NA	
ENSG00000207932	MIR33A	NA	
ENSG00000234965	SHISA8	NA	
ENSG00000159958	TNFRSF13C	240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2;;ANTIBODY DEFICIENCY DUE TO TACI DEFECT;;HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY
ENSG00000159958	TNFRSF13C	613494	IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4;;ANTIBODY DEFICIENCY DUE TO BAFFR DEFECT
ENSG00000283829	MIR378I	NA	
ENSG00000100162	CENPM	NA	
ENSG00000205704	LINC00634	NA	
ENSG00000100167	SEPTIN3	NA	
ENSG00000224883	Z99716.1	NA	
ENSG00000183066	WBP2NL	NA	
ENSG00000215347	SLC25A5P1	NA	
ENSG00000198951	NAGA	609241	SCHINDLER DISEASE, TYPE I;;NEUROAXONAL DYSTROPHY, SCHINDLER TYPE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE I;;NAGA DEFICIENCY, TYPE I  ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE III, INCLUDED;;NAGA DEFICIENCY, TYPE III, INCLUDED;;SCHIN /.../ISEASE, TYPE III, INCLUDED
ENSG00000198951	NAGA	609242	KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II
ENSG00000286659	Z99716.2	NA	
ENSG00000177096	PHETA2	NA	
ENSG00000238498	SNORD13P1	NA	
ENSG00000183172	SMDT1	NA	
ENSG00000184983	NDUFA6	618253	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33
ENSG00000270083	AL021878.2	NA	
ENSG00000237037	NDUFA6-DT	NA	
ENSG00000213790	OLA1P1	NA	
ENSG00000100197	CYP2D6	608902	DRUG METABOLISM, POOR, CYP2D6-RELATED DRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED;;DEBRISOQUINE, POOR METABOLISM OF, INCLUDED;;DEBRISOQUINE, ULTRARAPID METABOLISM OF, INCLUDED;;SPARTEINE, POOR METABOLISM OF, INCLUDED;;NORTRIPTYLINE, POOR M /.../ISM OF, INCLUDED;;CODEINE, ULTRARAPID METABOLISM OF, INCLUDED
ENSG00000227370	AC254562.1	NA	
ENSG00000232710	AC254562.2	NA	
ENSG00000281538	AC254562.3	NA	
ENSG00000205702	CYP2D7	NA	
ENSG00000226450	CYP2D8P	NA	
ENSG00000100207	TCF20	618430	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA
ENSG00000182057	OGFRP1	NA	
ENSG00000229891	LINC01315	NA	
ENSG00000235568	NFAM1	NA	
ENSG00000230107	AL022316.1	NA	
ENSG00000172250	SERHL	NA	
ENSG00000189306	RRP7A	NA	
ENSG00000183569	SERHL2	NA	
ENSG00000182841	RRP7BP	NA	
ENSG00000202058	RN7SKP80	NA	
ENSG00000251913	RNU6-513P	NA	
ENSG00000270022	Z93241.1	NA	
ENSG00000276027	RNU12	NA	
ENSG00000100243	CYB5R3	250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE;;NADH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY;;NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY;;METHEMOGLOBINEMIA, CONGENITAL, AUTOSOMAL RECESSIVE METHEMOGLOBINEMIA, TYPE I, INCLUDED;;METHE /.../INEMIA, TYPE II, INCLUDED;;NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY, TYPE I, INCLUDED;;NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY, TYPE II, INCLUDED
ENSG00000249222	ATP5MGL	NA	
ENSG00000128274	A4GALT	111400	BLOOD GROUP, P1PK SYSTEM P(1) PHENOTYPE, INCLUDED;;P(2) PHENOTYPE, INCLUDED;;P1(k) PHENOTYPE, INCLUDED;;P2(k) PHENOTYPE, INCLUDED;;p PHENOTYPE, INCLUDED;;NOR POLYAGGLUTINATION SYNDROME, INCLUDED
ENSG00000200448	Y_RNA	NA	
ENSG00000234009	RPL5P34	NA	
ENSG00000229608	GOLGA2P4	NA	
ENSG00000274717	AL049757.1	NA	
ENSG00000242247	ARFGAP3	NA	
ENSG00000100266	PACSIN2	NA	
ENSG00000226989	AL049758.1	NA	
ENSG00000100271	TTLL1	NA	
ENSG00000230319	AL022476.1	NA	
ENSG00000234735	AL022237.1	NA	
ENSG00000100290	BIK	NA	
ENSG00000100294	MCAT	NA	
ENSG00000100304	TTLL12	NA	
ENSG00000159307	SCUBE1	NA	
ENSG00000236272	SCUBE1-AS2	NA	
ENSG00000234892	Z82214.1	NA	
ENSG00000203527	SCUBE1-AS1	NA	
ENSG00000236117	LINC01639	NA	
ENSG00000186732	MPPED1	NA	
ENSG00000286801	BX546033.1	NA	
ENSG00000223843	EFCAB6-AS1	NA	
ENSG00000186976	EFCAB6	NA	
ENSG00000233157	Z97055.1	NA	
ENSG00000180150	HMGN2P9	NA	
ENSG00000261251	Z97055.2	NA	
ENSG00000130540	SULT4A1	NA	
ENSG00000100341	PNPLA5	NA	
ENSG00000100344	PNPLA3	NA	
ENSG00000100347	SAMM50	NA	
ENSG00000224856	AL035398.1	NA	
ENSG00000188677	PARVB	NA	
ENSG00000279175	AL033543.1	NA	
ENSG00000280434	AL031595.3	NA	
ENSG00000138964	PARVG	NA	
ENSG00000279933	AL031595.1	NA	
ENSG00000280011	AL031595.2	NA	
ENSG00000138944	SHISAL1	NA	
ENSG00000220702	Z85994.1	NA	
ENSG00000236079	Z85994.2	NA	
ENSG00000232655	LINC01656	NA	
ENSG00000228807	MRPS18CP6	NA	
ENSG00000279642	AL023973.1	NA	
ENSG00000188636	RTL6	NA	
ENSG00000215333	KRT18P23	NA	
ENSG00000187012	LINC00207	NA	
ENSG00000234300	LINC00229	NA	
ENSG00000231801	ANP32BP2	NA	
ENSG00000186654	PRR5	NA	
ENSG00000248405	PRR5-ARHGAP8	NA	
ENSG00000241484	ARHGAP8	NA	
ENSG00000056487	PHF21B	NA	
ENSG00000223730	Z83838.1	NA	
ENSG00000230922	AL079301.1	NA	
ENSG00000226328	NUP50-DT	NA	
ENSG00000273243	Z82243.1	NA	
ENSG00000093000	NUP50	NA	
ENSG00000273353	AL008718.3	NA	
ENSG00000100364	KIAA0930	NA	
ENSG00000221598	MIR1249	NA	
ENSG00000273287	AL008718.2	NA	
ENSG00000213752	AL008718.1	NA	
ENSG00000100373	UPK3A	NA	
ENSG00000100376	FAM118A	NA	
ENSG00000077935	SMC1B	NA	
ENSG00000128408	RIBC2	NA	
ENSG00000232363	AL021391.1	NA	
ENSG00000077942	FBLN1	608180	SYNPOLYDACTYLY 2; SPD2;;SYNPOLYDACTYLY, 3/3-PRIME/4, ASSOCIATED WITH METACARPAL AND METATARSAL SYNOSTOSES
ENSG00000238120	LINC01589	NA	
ENSG00000251985	RNU6-1161P	NA	
ENSG00000280383	Z95331.1	NA	
ENSG00000130638	ATXN10	603516	SPINOCEREBELLAR ATAXIA 10; SCA10
ENSG00000264160	MIR4762	NA	
ENSG00000235347	Z84478.1	NA	
ENSG00000279954	BX324167.2	NA	
ENSG00000235091	BX324167.1	NA	
ENSG00000188064	WNT7B	NA	
ENSG00000280424	BX537318.2	NA	
ENSG00000273145	BX537318.1	NA	
ENSG00000231711	LINC00899	NA	
ENSG00000182257	PRR34	NA	
ENSG00000273289	AL121672.3	NA	
ENSG00000241990	PRR34-AS1	NA	
ENSG00000197182	MIRLET7BHG	NA	
ENSG00000231010	AL121672.1	NA	
ENSG00000235159	AL121672.2	NA	
ENSG00000266533	MIR3619	NA	
ENSG00000283990	MIRLET7A3	NA	
ENSG00000284175	MIR4763	NA	
ENSG00000284520	MIRLET7B	NA	
ENSG00000186951	PPARA	170998	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA;;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR HYPERAPOBETALIPOPROTEINEMIA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000280384	FP325332.1	NA	
ENSG00000205643	CDPF1	NA	
ENSG00000130943	PKDREJ	NA	
ENSG00000075234	TTC38	NA	
ENSG00000277232	GTSE1-DT	NA	
ENSG00000075218	GTSE1	NA	
ENSG00000100416	TRMU	580000	DEAFNESS, AMINOGLYCOSIDE-INDUCED;;DEAFNESS, STREPTOMYCIN-INDUCED;;STREPTOMYCIN OTOTOXICITY
ENSG00000100416	TRMU	613070	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT
ENSG00000075275	CELSR1	NA	
ENSG00000230634	AL031597.1	NA	
ENSG00000234869	AL021392.1	NA	
ENSG00000075240	GRAMD4	NA	
ENSG00000100422	CERK	NA	
ENSG00000260708	AL118516.1	NA	
ENSG00000054611	TBC1D22A	NA	
ENSG00000280080	TBC1D22A-AS1	NA	
ENSG00000278881	FP325331.1	NA	
ENSG00000280312	Z83836.1	NA	
ENSG00000224715	Z82186.1	NA	
ENSG00000218357	LINC01644	NA	
ENSG00000205634	LINC00898	NA	
ENSG00000224271	AL117329.1	NA	
ENSG00000232897	AL117329.2	NA	
ENSG00000279712	FP325330.3	NA	
ENSG00000235154	FP325330.1	NA	
ENSG00000278890	FP325330.2	NA	
ENSG00000238192	BX284656.2	NA	
ENSG00000229275	BX284656.1	NA	
ENSG00000285707	AL008720.1	NA	
ENSG00000266508	MIR3201	NA	
ENSG00000288540	AL008720.2	NA	
ENSG00000285855	Z72006.1	NA	
ENSG00000233179	Z82249.1	NA	
ENSG00000287225	Z84468.2	NA	
ENSG00000219438	TAFA5	NA	
ENSG00000281732	Z84468.1	NA	
ENSG00000266887	MIR4535	NA	
ENSG00000205632	LINC01310	NA	
ENSG00000286381	AL078622.1	NA	
ENSG00000285623	Z82202.2	NA	
ENSG00000226142	RPL35P8	NA	
ENSG00000280199	Z82202.1	NA	
ENSG00000285722	AC207130.1	NA	
ENSG00000188511	C22orf34	NA	
ENSG00000280224	AL008636.1	NA	
ENSG00000279597	AL031593.1	NA	
ENSG00000264139	MIR3667	NA	
ENSG00000212939	Z97192.1	NA	
ENSG00000213279	Z97192.2	NA	
ENSG00000235111	Z97192.3	NA	
ENSG00000286393	Z97192.4	NA	
ENSG00000226954	AL023802.1	NA	
ENSG00000223142	RN7SKP252	NA	
ENSG00000214727	RPL5P35	NA	
ENSG00000100425	BRD1	NA	
ENSG00000279345	Z98885.3	NA	
ENSG00000236867	Z98885.1	NA	
ENSG00000260613	Z98885.2	NA	
ENSG00000229409	AL117328.1	NA	
ENSG00000277771	Metazoa_SRP	NA	
ENSG00000279494	AL117328.2	NA	
ENSG00000100426	ZBED4	NA	
ENSG00000182858	ALG12	607143	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G;;CDG Ig; CDGIg
ENSG00000273192	AL671710.1	NA	
ENSG00000184164	CRELD2	NA	
ENSG00000278869	BX539320.1	NA	
ENSG00000198355	PIM3	NA	
ENSG00000276753	MIR6821	NA	
ENSG00000188263	IL17REL	NA	
ENSG00000138892	TTLL8	NA	
ENSG00000100427	MLC1	604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE
ENSG00000073146	MOV10L1	NA	
ENSG00000280395	AL034546.1	NA	
ENSG00000073150	PANX2	NA	
ENSG00000170638	TRABD	NA	
ENSG00000273188	AL022328.3	NA	
ENSG00000273253	AL022328.4	NA	
ENSG00000073169	SELENOO	NA	
ENSG00000272836	AL022328.1	NA	
ENSG00000273137	AL022328.2	NA	
ENSG00000128159	TUBGCP6	251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1
ENSG00000100429	HDAC10	NA	
ENSG00000188130	MAPK12	NA	
ENSG00000185386	MAPK11	NA	
ENSG00000196576	PLXNB2	NA	
ENSG00000205593	DENND6B	NA	
ENSG00000227484	CR559946.1	NA	
ENSG00000279182	CR559946.2	NA	
ENSG00000100239	PPP6R2	NA	
ENSG00000100241	SBF1	615284	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3
ENSG00000128165	ADM2	NA	
ENSG00000100253	MIOX	NA	
ENSG00000100258	LMF2	NA	
ENSG00000025770	NCAPH2	NA	
ENSG00000284194	SCO2	604377	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1;;CYTOCHROME c OXIDASE DEFICIENCY, FATAL INFANTILE, WITH CARDIOENCEPHALOMYOPATHY
ENSG00000284194	SCO2	608908	MYOPIA 6; MYP6
ENSG00000272821	U62317.1	NA	
ENSG00000025708	TYMP	603041	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1;;MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, TYMP-RELATED;;MNGIE, TYMP-RELATED;;MYONEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME;;POLYNEUROPATHY, OPHTHALMOPLEGIA, LEUKOENCE /.../ATHY, AND INTESTINAL PSEUDOOBSTRUCTION;;POLIP SYNDROME
ENSG00000177989	ODF3B	NA	
ENSG00000273272	U62317.3	NA	
ENSG00000272666	KLHDC7B-DT	NA	
ENSG00000130487	KLHDC7B	NA	
ENSG00000217442	SYCE3	NA	
ENSG00000205560	CPT1B	NA	
ENSG00000254413	CHKB-CPT1B	NA	
ENSG00000100288	CHKB	602541	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES
ENSG00000205559	CHKB-DT	NA	
ENSG00000272940	U62317.2	NA	
ENSG00000008735	MAPK8IP2	NA	
ENSG00000100299	ARSA	250100	METACHROMATIC LEUKODYSTROPHY; MLD;;METACHROMATIC LEUKOENCEPHALOPATHY;;CEREBRAL SCLEROSIS, DIFFUSE, METACHROMATIC FORM;;SULFATIDE LIPIDOSIS;;ARYLSULFATASE A DEFICIENCY;;ARSA DEFICIENCY;;CEREBROSIDE SULFATASE DEFICIENCY PSEUDOARYLSULFATASE A DEFICIENC /.../LUDED;;METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE, INCLUDED;;METACHROMATIC LEUKODYSTROPHY, JUVENILE, INCLUDED;;METACHROMATIC LEUKODYSTROPHY, ADULT, INCLUDED
ENSG00000212569	AC000050.1	NA	
ENSG00000286508	AC000050.3	NA	
ENSG00000251322	SHANK3	NA	
ENSG00000206841	RNU6-409P	NA	
ENSG00000225929	AC000036.1	NA	
ENSG00000100312	ACR	NA	
ENSG00000254499	AC002056.2	NA	
ENSG00000213683	AC002056.1	NA	
ENSG00000184319	RPL23AP82	NA	
ENSG00000079974	RABL2B	NA	
ENSG00000223587	LINC01986	NA	
ENSG00000224918	AC066595.1	NA	
ENSG00000224318	CHL1-AS2	NA	
ENSG00000287140	AC066595.2	NA	
ENSG00000134121	CHL1	NA	
ENSG00000252017	RNU6-1194P	NA	
ENSG00000231660	RPS8P6	NA	
ENSG00000234661	CHL1-AS1	NA	
ENSG00000287505	AC087428.1	NA	
ENSG00000224957	LINC01266	NA	
ENSG00000238075	RPSAP32	NA	
ENSG00000224239	AC090044.1	NA	
ENSG00000235158	AC087430.1	NA	
ENSG00000244169	RN7SL120P	NA	
ENSG00000134115	CNTN6	NA	
ENSG00000232563	CRB3P1	NA	
ENSG00000184423	RPL23AP38	NA	
ENSG00000214074	RPL23AP39	NA	
ENSG00000214073	RPL21P17	NA	
ENSG00000225044	AC018814.1	NA	
ENSG00000223040	RN7SKP144	NA	
ENSG00000144619	CNTN4	NA	
ENSG00000227588	CNTN4-AS2	NA	
ENSG00000286363	AC087427.1	NA	
ENSG00000230398	HINT2P1	NA	
ENSG00000225310	DNAJC19P4	NA	
ENSG00000237990	CNTN4-AS1	NA	
ENSG00000091181	IL5RA	NA	
ENSG00000253049	AC024060.1	NA	
ENSG00000072756	TRNT1	616084	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD
ENSG00000072756	TRNT1	616959	RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM
ENSG00000113851	CRBN	607417	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2A; MRT2A
ENSG00000271870	AC024060.2	NA	
ENSG00000223727	AC034195.1	NA	
ENSG00000144455	SUMF1	272200	MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE
ENSG00000175928	LRRN1	NA	
ENSG00000287720	AC023480.1	NA	
ENSG00000229241	PNPT1P1	NA	
ENSG00000286579	AC023483.1	NA	
ENSG00000170364	SETMAR	NA	
ENSG00000234325	MRPS10P2	NA	
ENSG00000231249	ITPR1-DT	NA	
ENSG00000150995	ITPR1	117360	SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT; CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV
ENSG00000150995	ITPR1	206700	GILLESPIE SYNDROME; GLSP;;ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION
ENSG00000150995	ITPR1	606658	SPINOCEREBELLAR ATAXIA 15; SCA15;;SPINOCEREBELLAR ATAXIA 16, FORMERLY; SCA16, FORMERLY
ENSG00000235947	EGOT	NA	
ENSG00000275981	AC018816.2	NA	
ENSG00000235978	AC018816.1	NA	
ENSG00000235831	BHLHE40-AS1	NA	
ENSG00000134107	BHLHE40	NA	
ENSG00000230182	RNF10P1	NA	
ENSG00000224082	UBTFL8	NA	
ENSG00000207283	AC090955.1	NA	
ENSG00000237566	AC090955.2	NA	
ENSG00000134108	ARL8B	NA	
ENSG00000233912	AC026202.2	NA	
ENSG00000268509	AC026202.3	NA	
ENSG00000134109	EDEM1	NA	
ENSG00000265180	MIR4790	NA	
ENSG00000241227	RN7SL553P	NA	
ENSG00000230944	AC026202.1	NA	
ENSG00000229642	AC087857.1	NA	
ENSG00000226022	AC026167.1	NA	
ENSG00000232958	AC027119.1	NA	
ENSG00000189229	AC069277.1	NA	
ENSG00000226258	GRM7-AS3	NA	
ENSG00000223719	AC069277.2	NA	
ENSG00000196277	GRM7	NA	
ENSG00000236152	MRPS36P1	NA	
ENSG00000237665	GRM7-AS2	NA	
ENSG00000288030	AC066585.1	NA	
ENSG00000236202	GRM7-AS1	NA	
ENSG00000270207	AC077690.1	NA	
ENSG00000227110	LMCD1-AS1	NA	
ENSG00000228351	AC018832.1	NA	
ENSG00000231401	AC023481.1	NA	
ENSG00000253081	RNU4ATAC17P	NA	
ENSG00000071282	LMCD1	NA	
ENSG00000224884	AC034187.1	NA	
ENSG00000125046	SSUH2	NA	
ENSG00000215160	OR7E122P	NA	
ENSG00000182533	CAV3	123320	CREATINE PHOSPHOKINASE, ELEVATED SERUM;;CPK, ELEVATED SERUM;;HYPERCKEMIA, IDIOPATHIC
ENSG00000182533	CAV3	192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC
ENSG00000182533	CAV3	606072	RIPPLING MUSCLE DISEASE 2; RMD2;;RIPPLING MUSCLE DISEASE; RMD;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C, FORMERLY; LGMD1C, FORMERLY
ENSG00000182533	CAV3	611818	LONG QT SYNDROME 9; LQT9;;LONG QT SYNDROME 9, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 2/9, DIGENIC, INCLUDED; LQT2/9, DIGENIC, INCLUDED
ENSG00000182533	CAV3	614321	MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT
ENSG00000180914	OXTR	NA	
ENSG00000070950	RAD18	NA	
ENSG00000281863	AC034186.2	NA	
ENSG00000199815	AC034186.1	NA	
ENSG00000196220	SRGAP3	NA	
ENSG00000224808	SRGAP3-AS1	NA	
ENSG00000287623	AC037193.1	NA	
ENSG00000228723	SRGAP3-AS2	NA	
ENSG00000227929	SRGAP3-AS3	NA	
ENSG00000235830	SRGAP3-AS4	NA	
ENSG00000254485	AC026191.1	NA	
ENSG00000214041	PGAM1P4	NA	
ENSG00000206573	THUMPD3-AS1	NA	
ENSG00000134077	THUMPD3	NA	
ENSG00000168137	SETD5	615761	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23
ENSG00000156959	LHFPL4	NA	
ENSG00000235338	DUSP5P2	NA	
ENSG00000163719	MTMR14	160150	MYOPATHY, CENTRONUCLEAR, 1; CNM1;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT;;MYOTUBULAR MYOPATHY, AUTOSOMAL DOMINANT
ENSG00000287878	AC022382.2	NA	
ENSG00000144550	CPNE9	NA	
ENSG00000156983	BRPF1	617333	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP
ENSG00000114026	OGG1	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC;;HYPERNEPHROMA;;ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
ENSG00000134072	CAMK1	NA	
ENSG00000171148	TADA3	NA	
ENSG00000241553	ARPC4	NA	
ENSG00000250151	ARPC4-TTLL3	NA	
ENSG00000214021	TTLL3	NA	
ENSG00000269886	AC022382.1	NA	
ENSG00000156990	RPUSD3	NA	
ENSG00000187288	CIDEC	615238	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS
ENSG00000171135	JAGN1	616022	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6
ENSG00000163701	IL17RE	NA	
ENSG00000163702	IL17RC	616445	CANDIDIASIS, FAMILIAL, 9; CANDF9
ENSG00000212327	RNU6-882P	NA	
ENSG00000288550	AC018809.3	NA	
ENSG00000163703	CRELD1	606217	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2 ATRIOVENTRICULAR SEPTAL DEFECT, PARTIAL, WITH HETEROTAXY SYNDROME, INCLUDED
ENSG00000269894	AC018809.1	NA	
ENSG00000163704	PRRT3	NA	
ENSG00000230082	PRRT3-AS1	NA	
ENSG00000269982	AC018809.2	NA	
ENSG00000125037	EMC3	NA	
ENSG00000180385	EMC3-AS1	NA	
ENSG00000232901	CYCSP10	NA	
ENSG00000206567	AC022007.1	NA	
ENSG00000186162	CIDECP1	NA	
ENSG00000144554	FANCD2	227646	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4
ENSG00000201182	RNU6-670P	NA	
ENSG00000229217	CYCSP11	NA	
ENSG00000163705	FANCD2OS	NA	
ENSG00000254999	BRK1	NA	
ENSG00000134086	VHL	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000134086	VHL	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC;;HYPERNEPHROMA;;ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
ENSG00000134086	VHL	193300	VON HIPPEL-LINDAU SYNDROME; VHLS;;VHL VON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED
ENSG00000134086	VHL	263400	ERYTHROCYTOSIS, FAMILIAL, 2, AUTOSOMAL RECESSIVE; ECYT2;;POLYCYTHEMIA, VHL-DEPENDENT POLYCYTHEMIA, CHUVASH TYPE, INCLUDED
ENSG00000287086	AC034193.1	NA	
ENSG00000134070	IRAK2	NA	
ENSG00000157014	TATDN2	NA	
ENSG00000272410	AC022384.1	NA	
ENSG00000231177	LINC00852	NA	
ENSG00000157017	GHRL	601665	OBESITY LEANNESS, INCLUDED
ENSG00000240288	GHRLOS	NA	
ENSG00000276678	AC022384.2	NA	
ENSG00000157020	SEC13	NA	
ENSG00000157087	ATP2B2	601386	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12
ENSG00000264534	MIR378B	NA	
ENSG00000216135	MIR885	NA	
ENSG00000236999	ATP2B2-IT1	NA	
ENSG00000224771	ATP2B2-IT2	NA	
ENSG00000226567	LINC00606	NA	
ENSG00000230599	AC018495.1	NA	
ENSG00000132164	SLC6A11	NA	
ENSG00000286962	AC027128.1	NA	
ENSG00000157103	SLC6A1	616421	MYOCLONIC-ATONIC EPILEPSY; MAE
ENSG00000232287	SLC6A1-AS1	NA	
ENSG00000287964	AC066580.1	NA	
ENSG00000196639	HRH1	NA	
ENSG00000285906	AC083855.2	NA	
ENSG00000213964	CHCHD4P4	NA	
ENSG00000197548	ATG7	NA	
ENSG00000226621	AC083855.1	NA	
ENSG00000235240	AC026185.1	NA	
ENSG00000270531	AC022001.1	NA	
ENSG00000144560	VGLL4	NA	
ENSG00000271716	AC022001.2	NA	
ENSG00000272483	AC022001.3	NA	
ENSG00000144559	TAMM41	NA	
ENSG00000230342	FANCD2P2	NA	
ENSG00000224263	CYCSP12	NA	
ENSG00000225275	NUP210P2	NA	
ENSG00000231897	MARK2P14	NA	
ENSG00000251038	AC090958.1	NA	
ENSG00000263988	RN7SL147P	NA	
ENSG00000157152	SYN2	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000226642	ACTG1P12	NA	
ENSG00000157150	TIMP4	NA	
ENSG00000233026	MTCO1P5	NA	
ENSG00000236062	GSTM5P1	NA	
ENSG00000132170	PPARG	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000132170	PPARG	601665	OBESITY LEANNESS, INCLUDED
ENSG00000132170	PPARG	604367	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS
ENSG00000132170	PPARG	609338	CAROTID INTIMAL MEDIAL THICKNESS 1;;CIMT1;;INTIMAL MEDIAL THICKNESS OF INTERNAL CAROTID ARTERY
ENSG00000225026	AC091492.1	NA	
ENSG00000154743	TSEN2	612389	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B
ENSG00000200114	RNA5SP123	NA	
ENSG00000251774	RNU6-377P	NA	
ENSG00000225526	MKRN2OS	NA	
ENSG00000075975	MKRN2	NA	
ENSG00000274514	Metazoa_SRP	NA	
ENSG00000132155	RAF1	611553	NOONAN SYNDROME 5; NS5
ENSG00000132155	RAF1	611554	LEOPARD SYNDROME 2; LPRD2
ENSG00000132155	RAF1	615916	CARDIOMYOPATHY, DILATED, 1NN; CMD1NN
ENSG00000233252	CRIP1P1	NA	
ENSG00000088726	TMEM40	NA	
ENSG00000213943	KRT18P17	NA	
ENSG00000144712	CAND2	NA	
ENSG00000272263	AC034198.2	NA	
ENSG00000144713	RPL32	NA	
ENSG00000207496	SNORA7A	NA	
ENSG00000250939	AC034198.1	NA	
ENSG00000232746	LINC02022	NA	
ENSG00000144711	IQSEC1	618687	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES; IDDSSBA
ENSG00000231362	AC069271.1	NA	
ENSG00000132182	NUP210	NA	
ENSG00000238138	AC027124.2	NA	
ENSG00000223398	AC027124.1	NA	
ENSG00000244502	HDAC11-AS1	NA	
ENSG00000163517	HDAC11	NA	
ENSG00000163520	FBLN2	NA	
ENSG00000224514	LINC00620	NA	
ENSG00000154764	WNT7A	228930	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY;;FUHRMANN SYNDROME
ENSG00000154764	WNT7A	276820	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME
ENSG00000233121	VN1R20P	NA	
ENSG00000275340	FGD5P1	NA	
ENSG00000180438	TPRXL	NA	
ENSG00000287059	AC090004.2	NA	
ENSG00000224752	VN1R21P	NA	
ENSG00000163528	CHCHD4	NA	
ENSG00000170876	TMEM43	604400	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 5; ARVC5
ENSG00000170876	TMEM43	614302	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7
ENSG00000268279	AC090004.1	NA	
ENSG00000228242	AC093495.1	NA	
ENSG00000154767	XPC	278720	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC;;XPCC;;XP, GROUP C;;XERODERMA PIGMENTOSUM III; XP3
ENSG00000170860	LSM3	NA	
ENSG00000255021	AC093496.1	NA	
ENSG00000251576	LINC01267	NA	
ENSG00000199609	RNA5SP124	NA	
ENSG00000131389	SLC6A6	NA	
ENSG00000144596	GRIP2	NA	
ENSG00000207163	RNU6-905P	NA	
ENSG00000234123	RHBDF1P1	NA	
ENSG00000283392	AC090952.2	NA	
ENSG00000235629	AC090952.1	NA	
ENSG00000154781	CCDC174	616816	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR
ENSG00000131379	C3orf20	NA	
ENSG00000230172	AC090957.1	NA	
ENSG00000285969	AC087591.1	NA	
ENSG00000260902	LINC02011	NA	
ENSG00000154783	FGD5	NA	
ENSG00000225733	FGD5-AS1	NA	
ENSG00000177463	NR2C2	NA	
ENSG00000131368	MRPS25	NA	
ENSG00000131381	RBSN	NA	
ENSG00000228874	AC090954.1	NA	
ENSG00000227578	RPS3AP53	NA	
ENSG00000230524	COL6A4P1	NA	
ENSG00000131375	CAPN7	NA	
ENSG00000224660	SH3BP5-AS1	NA	
ENSG00000131370	SH3BP5	NA	
ENSG00000201162	RNU6-454P	NA	
ENSG00000226427	HMGN2P7	NA	
ENSG00000206562	METTL6	NA	
ENSG00000144597	EAF1	NA	
ENSG00000206926	RNU6-1024P	NA	
ENSG00000249786	EAF1-AS1	NA	
ENSG00000206561	COLQ	603034	MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5;;ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY; EAD;;ENGEL CONGENITAL MYASTHENIC SYNDROME;;MYASTHENIC SYNDROME, CONGENITAL, ENGEL TYPE;;CONGENITAL MYASTHENIC SYNDROME TYPE Ic, FORMERLY; CMS1C, FORMERLY;;CMS Ic, FORMERLY
ENSG00000263573	MIR4270	NA	
ENSG00000288077	AC027129.1	NA	
ENSG00000241064	RN7SL110P	NA	
ENSG00000131373	HACL1	NA	
ENSG00000169814	BTD	253260	BIOTINIDASE DEFICIENCY;;BTD DEFICIENCY;;MULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET;;MULTIPLE CARBOXYLASE DEFICIENCY, JUVENILE-ONSET
ENSG00000206560	ANKRD28	NA	
ENSG00000264354	MIR3134	NA	
ENSG00000279465	AC090950.2	NA	
ENSG00000270409	AC090950.1	NA	
ENSG00000263740	RN7SL4P	NA	
ENSG00000287042	AC090945.1	NA	
ENSG00000207815	MIR563	NA	
ENSG00000224728	IMPDH1P8	NA	
ENSG00000286689	AC090946.1	NA	
ENSG00000131386	GALNT15	NA	
ENSG00000285654	AC090953.2	NA	
ENSG00000154813	DPH3	NA	
ENSG00000154814	OXNAD1	NA	
ENSG00000270739	AC090953.1	NA	
ENSG00000131378	RFTN1	NA	
ENSG00000271964	AC090948.1	NA	
ENSG00000272498	AC090948.2	NA	
ENSG00000272529	AC090948.3	NA	
ENSG00000287377	AC090948.4	NA	
ENSG00000288050	AC010727.1	NA	
ENSG00000233570	LINC00690	NA	
ENSG00000269391	AC010139.1	NA	
ENSG00000092345	DAZL	NA	
ENSG00000229271	AC091493.1	NA	
ENSG00000224039	CDYLP1	NA	
ENSG00000154822	PLCL2	NA	
ENSG00000283885	MIR3714	NA	
ENSG00000226441	PLCL2-AS1	NA	
ENSG00000285731	AC090644.1	NA	
ENSG00000131374	TBC1D5	NA	
ENSG00000231780	AC090960.1	NA	
ENSG00000227309	AC140076.1	NA	
ENSG00000271841	RNU7-10P	NA	
ENSG00000233133	AC104451.1	NA	
ENSG00000286352	AC104451.2	NA	
ENSG00000213383	AC104297.1	NA	
ENSG00000214286	PDCL3P3	NA	
ENSG00000226238	AC132807.1	NA	
ENSG00000274840	AC132807.2	NA	
ENSG00000182568	SATB1	NA	
ENSG00000272477	AC144521.1	NA	
ENSG00000228956	SATB1-AS1	NA	
ENSG00000236570	RAD23BP1	NA	
ENSG00000251761	RNU6-138P	NA	
ENSG00000183960	KCNH8	NA	
ENSG00000271898	MIR4791	NA	
ENSG00000287069	AC061958.1	NA	
ENSG00000163576	EFHB	NA	
ENSG00000232953	HSPA8P18	NA	
ENSG00000144566	RAB5A	NA	
ENSG00000183977	PP2D1	NA	
ENSG00000201545	RNU4-85P	NA	
ENSG00000230697	SAP18P3	NA	
ENSG00000229468	RPL39P18	NA	
ENSG00000114166	KAT2B	NA	
ENSG00000266745	MIR3135A	NA	
ENSG00000129810	SGO1	616201	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID
ENSG00000231304	SGO1-AS1	NA	
ENSG00000199577	RNU6-822P	NA	
ENSG00000261734	AC116096.1	NA	
ENSG00000206807	RNU6-815P	NA	
ENSG00000282987	AC099753.1	NA	
ENSG00000236380	VENTXP7	NA	
ENSG00000151789	ZNF385D	NA	
ENSG00000225542	ZNF385D-AS1	NA	
ENSG00000223351	ZNF385D-AS2	NA	
ENSG00000132967	HMGB1P5	NA	
ENSG00000234723	AC092421.1	NA	
ENSG00000271235	AC114477.1	NA	
ENSG00000226183	RANP7	NA	
ENSG00000231915	SALL4P5	NA	
ENSG00000215016	RPL24P7	NA	
ENSG00000233153	UBE2E2-AS1	NA	
ENSG00000182247	UBE2E2	NA	
ENSG00000206728	Y_RNA	NA	
ENSG00000228171	AC121251.1	NA	
ENSG00000252562	RNU6-922P	NA	
ENSG00000212269	RNU6-788P	NA	
ENSG00000223791	UBE2E1-AS1	NA	
ENSG00000170142	UBE2E1	NA	
ENSG00000231395	ARL4AP4	NA	
ENSG00000197885	NKIRAS1	NA	
ENSG00000174748	RPL15	615550	DIAMOND-BLACKFAN ANEMIA 12; DBA12
ENSG00000174738	NR1D2	NA	
ENSG00000224074	LINC00691	NA	
ENSG00000242109	NPM1P23	NA	
ENSG00000151090	THRB	145650	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH;;HYPERTHYROIDISM, FAMILIAL, DUE TO INAPPROPRIATE THYROTROPIN SECRETION
ENSG00000151090	THRB	188570	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH;;GTHR;;THYROID HORMONE UNRESPONSIVENESS;;HYPERTHYROXINEMIA, FAMILIAL EUTHYROID, SECONDARY TO PITUITARY AND PERIPHERAL RESISTANCE TO THYROID HORMONES
ENSG00000151090	THRB	274300	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH;;GTHR;;THYROID HORMONE UNRESPONSIVENESS;;REFETOFF SYNDROME
ENSG00000229756	RPL31P20	NA	
ENSG00000224822	THRB-IT1	NA	
ENSG00000228791	THRB-AS1	NA	
ENSG00000272554	AC012087.2	NA	
ENSG00000265028	AC012087.1	NA	
ENSG00000233544	EIF3KP2	NA	
ENSG00000237838	AC092422.1	NA	
ENSG00000244404	RN7SL216P	NA	
ENSG00000201713	RNA5SP125	NA	
ENSG00000077092	RARB	615524	MICROPHTHALMIA, SYNDROMIC 12; MCOPS12;;MICROPHTHALMIA WITH OR WITHOUT PULMONARY HYPOPLASIA, DIAPHRAGMATIC HERNIA, AND/OR CARDIAC DEFECTS
ENSG00000213877	CFL1P7	NA	
ENSG00000201962	RNA5SP126	NA	
ENSG00000229421	H3P10	NA	
ENSG00000272166	AC093416.1	NA	
ENSG00000077097	TOP2B	NA	
ENSG00000275227	AC093416.2	NA	
ENSG00000283971	MIR4442	NA	
ENSG00000238225	CRIP1P2	NA	
ENSG00000151092	NGLY1	615273	CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG;;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iv, FORMERLY; CDG1V, FORMERLY
ENSG00000213872	AC092798.1	NA	
ENSG00000213871	TAF9BP1	NA	
ENSG00000151093	OXSM	NA	
ENSG00000230891	LINC00692	NA	
ENSG00000234158	RPEP2	NA	
ENSG00000237603	HMGB3P12	NA	
ENSG00000230465	VENTXP4	NA	
ENSG00000225386	AC099754.1	NA	
ENSG00000179796	LRRC3B	NA	
ENSG00000163491	NEK10	618781	CILIARY DYSKINESIA, PRIMARY, 44; CILD44;;CILIARY DYSKINESIA, PRIMARY, 44, WITHOUT SITUS INVERSUS
ENSG00000224237	MICOS10P3	NA	
ENSG00000207251	RNU6-342P	NA	
ENSG00000287348	AC099535.2	NA	
ENSG00000033867	SLC4A7	NA	
ENSG00000227523	RPS20P15	NA	
ENSG00000230807	AC099535.1	NA	
ENSG00000201033	RNU1-96P	NA	
ENSG00000232167	AC137675.1	NA	
ENSG00000238912	Y_RNA	NA	
ENSG00000223968	AC098614.1	NA	
ENSG00000271943	AC098614.2	NA	
ENSG00000232766	KIAA1143P2	NA	
ENSG00000272282	LINC02084	NA	
ENSG00000163508	EOMES	NA	
ENSG00000225548	LINC01980	NA	
ENSG00000229243	LINC01981	NA	
ENSG00000235493	LINC01967	NA	
ENSG00000187118	CMC1	NA	
ENSG00000163512	AZI2	NA	
ENSG00000206559	ZCWPW2	NA	
ENSG00000283563	AC098650.1	NA	
ENSG00000234048	FAM96AP1	NA	
ENSG00000230480	AC093142.1	NA	
ENSG00000144642	RBMS3	NA	
ENSG00000235904	RBMS3-AS3	NA	
ENSG00000215004	MESTP4	NA	
ENSG00000226216	RPS12P5	NA	
ENSG00000203506	RBMS3-AS2	NA	
ENSG00000227795	MTND4LP9	NA	
ENSG00000235593	RBMS3-AS1	NA	
ENSG00000287774	AC025614.2	NA	
ENSG00000199927	AC025614.1	NA	
ENSG00000281710	U3	NA	
ENSG00000227260	LINC01985	NA	
ENSG00000227549	AC116035.1	NA	
ENSG00000163513	TGFBR2	133239	ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED;;ESCC, SUSCEPTIBILITY TO, INCLUDED;;AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO, INCLUDED;;GASTRIC CARDIA ADENOCARCINOMA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000163513	TGFBR2	610168	LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY
ENSG00000163513	TGFBR2	614331	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6;;COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6
ENSG00000224618	AC096921.1	NA	
ENSG00000261468	AC096921.2	NA	
ENSG00000144644	GADL1	NA	
ENSG00000265376	MIR466	NA	
ENSG00000213854	CNN2P6	NA	
ENSG00000222983	RNA5SP127	NA	
ENSG00000230111	H3P11	NA	
ENSG00000227339	THRAP3P1	NA	
ENSG00000163527	STT3B	615597	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X;;CDG Ix; CDGIx
ENSG00000144645	OSBPL10	NA	
ENSG00000232490	OSBPL10-AS1	NA	
ENSG00000223965	ZNF587P1	NA	
ENSG00000197385	ZNF860	NA	
ENSG00000235670	RPL21P40	NA	
ENSG00000201701	AC094019.1	NA	
ENSG00000252398	Y_RNA	NA	
ENSG00000251590	NIFKP7	NA	
ENSG00000152642	GPD1L	611777	BRUGADA SYNDROME 2; BRGDA2
ENSG00000236732	AC094019.2	NA	
ENSG00000237433	RPSAP11	NA	
ENSG00000261572	AC097639.1	NA	
ENSG00000170293	CMTM8	NA	
ENSG00000270377	AC097639.2	NA	
ENSG00000234737	KRT18P15	NA	
ENSG00000153551	CMTM7	NA	
ENSG00000091317	CMTM6	NA	
ENSG00000276147	MIR548AY	NA	
ENSG00000213849	AC104306.1	NA	
ENSG00000144635	DYNC1LI1	NA	
ENSG00000226955	AC104306.2	NA	
ENSG00000231552	IGBP1P3	NA	
ENSG00000237676	RPL30P4	NA	
ENSG00000182973	CNOT10	NA	
ENSG00000251224	CNOT10-AS1	NA	
ENSG00000213842	SUGT1P2	NA	
ENSG00000227337	RPL23AP43	NA	
ENSG00000206557	TRIM71	618667	HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1; HYDCC1
ENSG00000183813	CCR4	NA	
ENSG00000170266	GLB1	230500	GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCY GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC  /.../EMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED
ENSG00000170266	GLB1	230600	GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2  GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED
ENSG00000170266	GLB1	230650	GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3
ENSG00000170266	GLB1	253010	MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B;;MORQUIO SYNDROME B;;MPS IVB
ENSG00000223899	SEC13P1	NA	
ENSG00000235424	SUMO2P10	NA	
ENSG00000188167	TMPPE	NA	
ENSG00000275090	RN7SL296P	NA	
ENSG00000170275	CRTAP	610682	OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY
ENSG00000272149	AC112211.1	NA	
ENSG00000173705	SUSD5	NA	
ENSG00000230119	AC123900.1	NA	
ENSG00000153558	FBXL2	NA	
ENSG00000153560	UBP1	NA	
ENSG00000252700	RNU7-110P	NA	
ENSG00000202175	RNA5SP128	NA	
ENSG00000163539	CLASP2	NA	
ENSG00000238008	COX6CP10	NA	
ENSG00000228112	AC112220.1	NA	
ENSG00000227707	SDAD1P3	NA	
ENSG00000271643	AC112220.2	NA	
ENSG00000170248	PDCD6IP	NA	
ENSG00000226320	LINC01811	NA	
ENSG00000287981	AC123023.2	NA	
ENSG00000236452	AC123023.1	NA	
ENSG00000227498	AC018359.1	NA	
ENSG00000287641	AC007483.1	NA	
ENSG00000235534	FECHP1	NA	
ENSG00000228767	KRT8P18	NA	
ENSG00000212442	RNU6-243P	NA	
ENSG00000172995	ARPP21	NA	
ENSG00000230830	ARPP21-AS1	NA	
ENSG00000207625	MIR128-2	NA	
ENSG00000226489	AC104308.1	NA	
ENSG00000236158	RFC3P1	NA	
ENSG00000144681	STAC	NA	
ENSG00000231382	NBPF21P	NA	
ENSG00000201315	RN7SKP227	NA	
ENSG00000163673	DCLK3	NA	
ENSG00000230067	HSPD1P6	NA	
ENSG00000279727	LINC02033	NA	
ENSG00000281100	AC105749.1	NA	
ENSG00000168016	TRANK1	NA	
ENSG00000234073	AC011816.1	NA	
ENSG00000210181	RNU6ATAC4P	NA	
ENSG00000272334	AC011816.2	NA	
ENSG00000236165	PRADC1P1	NA	
ENSG00000178567	EPM2AIP1	NA	
ENSG00000076242	MLH1	158320	MUIR-TORRE SYNDROME; MRTES;;CUTANEOUS SEBACEOUS NEOPLASMS AND KERATOACANTHOMAS, MULTIPLE, WITH GASTROINTESTINAL AND OTHER CARCINOMAS
ENSG00000076242	MLH1	276300	MISMATCH REPAIR CANCER SYNDROME; MMRCS;;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME; CMMRDS;;MISMATCH REPAIR DEFICIENCY;;MMR DEFICIENCY;;CHILDHOOD CANCER SYNDROME;;BRAIN TUMOR-POLYPOSIS SYNDROME 1; BTPS1;;BTP1 SYNDROME;;TURCOT SYNDROME
ENSG00000076242	MLH1	609310	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2;;COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; FCC2;;COCA2
ENSG00000224858	RPL29P11	NA	
ENSG00000093167	LRRFIP2	NA	
ENSG00000206645	Y_RNA	NA	
ENSG00000225558	UBE2D3P2	NA	
ENSG00000199594	RNU6-1301P	NA	
ENSG00000224080	UBE2FP1	NA	
ENSG00000271993	AC126118.1	NA	
ENSG00000231449	AC097359.1	NA	
ENSG00000271653	AC097359.3	NA	
ENSG00000270194	AC097359.2	NA	
ENSG00000144674	GOLGA4	NA	
ENSG00000230409	TCEA1P2	NA	
ENSG00000222208	RNA5SP129	NA	
ENSG00000198590	C3orf35	NA	
ENSG00000144668	ITGA9	NA	
ENSG00000239105	RNU7-73P	NA	
ENSG00000235257	ITGA9-AS1	NA	
ENSG00000235482	RPL21P135	NA	
ENSG00000236411	NDUFAF4P3	NA	
ENSG00000144677	CTDSPL	NA	
ENSG00000199075	MIR26A1	NA	
ENSG00000136059	VILL	NA	
ENSG00000187091	PLCD1	151600	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3;;LEUKONYCHIA TOTALIS AND/OR PARTIALIS;;PORCELAIN NAILS LEUKONYCHIA STRIATUS, INCLUDED;;LEUKONYCHIA PUNCTATA, INCLUDED
ENSG00000200579	AC144536.1	NA	
ENSG00000008226	DLEC1	NA	
ENSG00000231668	PPP2R2DP1	NA	
ENSG00000060971	ACAA1	NA	
ENSG00000201965	AP006309.1	NA	
ENSG00000172936	MYD88	153600	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1 MACROGLOBULINEMIA, WALDENSTROM, SOMATIC, INCLUDED
ENSG00000172936	MYD88	612260	MYD88 DEFICIENCY; MYD88D;;PYOGENIC BACTERIAL INFECTIONS, RECURRENT, DUE TO MYD88 DEFICIENCY;;RECURRENT PYOGENIC BACTERIAL INFECTIONS DUE TO MYD88 DEFICIENCY
ENSG00000172939	OXSR1	NA	
ENSG00000172940	SLC22A13	NA	
ENSG00000237982	AP006193.1	NA	
ENSG00000144671	SLC22A14	NA	
ENSG00000199514	RNU6-235P	NA	
ENSG00000230123	DLEC1P1	NA	
ENSG00000093217	XYLB	NA	
ENSG00000229589	ACVR2B-AS1	NA	
ENSG00000114739	ACVR2B	613751	HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4
ENSG00000157036	EXOG	NA	
ENSG00000207512	AP006241.1	NA	
ENSG00000230683	DDTP1	NA	
ENSG00000232439	RPL18AP7	NA	
ENSG00000183873	SCN5A	113900	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A;;PFHBIA;;HEART BLOCK, PROGRESSIVE FAMILIAL, TYPE I; PFHBI;;LENEGRE-LEV DISEASE;;CARDIAC CONDUCTION DEFECT, PROGRESSIVE; PCCD;;BUNDLE BRANCH BLOCK;;HEREDITARY BUNDLE BRANCH SYSTEM DEFECT; HBBD HEART B /.../NONPROGRESSIVE, INCLUDED;;CARDIAC CONDUCTION DEFECT, NONPROGRESSIVE, INCLUDED
ENSG00000183873	SCN5A	272120	SUDDEN INFANT DEATH SYNDROME;;SIDS
ENSG00000183873	SCN5A	601144	BRUGADA SYNDROME 1; BRGDA1;;RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION, AND SUDDEN DEATH SYNDROME;;SUDDEN UNEXPLAINED NOCTURNAL DEATH SYNDROME; SUNDS CARDIAC CONDUCTION DEFECT, NONSPECIFIC, INCLUDED
ENSG00000183873	SCN5A	601154	CARDIOMYOPATHY, DILATED, 1E; CMD1E;;CARDIOMYOPATHY, DILATED, WITH CONDUCTION DISORDER AND ARRHYTHMIA;;CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 2; CDCD2
ENSG00000183873	SCN5A	603829	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1;;VF;;IVF VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, INCLUDED
ENSG00000183873	SCN5A	603830	LONG QT SYNDROME 3; LQT3 LONG QT SYNDROME 3, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 2/3, DIGENIC, INCLUDED; LQT2/3, DIGENIC, INCLUDED;;LONG QT SYNDROME 3/6, DIGENIC, INCLUDED; LQT3/6, DIGENIC, INCLUDED
ENSG00000183873	SCN5A	608567	SICK SINUS SYNDROME 1; SSS1;;SINUS RHYTHM, CONGENITAL ABSENCE OF;;SINUS NODE DISEASE, FAMILIAL, AUTOSOMAL RECESSIVE;;SICK SINUS SYNDROME, CONGENITAL;;SINUS BRADYCARDIA SYNDROME, FAMILIAL
ENSG00000183873	SCN5A	614022	ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10
ENSG00000185313	SCN10A	615551	EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2
ENSG00000231243	AC116038.1	NA	
ENSG00000168356	SCN11A	615548	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7;;HSAN VII;;INSENSITIVITY TO PAIN, CONGENITAL, WITH GASTROINTESTINAL DYSFUNCTION AND HYPERHIDROSIS
ENSG00000168356	SCN11A	615552	EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3
ENSG00000206708	RNU6-1227P	NA	
ENSG00000114742	WDR48	NA	
ENSG00000114745	GORASP1	NA	
ENSG00000168026	TTC21A	618429	SPERMATOGENIC FAILURE 37; SPGF37
ENSG00000284158	MIR6822	NA	
ENSG00000144655	CSRNP1	NA	
ENSG00000284669	AC092053.3	NA	
ENSG00000283849	AC092053.2	NA	
ENSG00000214305	Metazoa_SRP	NA	
ENSG00000287620	AC092053.4	NA	
ENSG00000168334	XIRP1	NA	
ENSG00000287995	AC092053.6	NA	
ENSG00000215034	DSTNP4	NA	
ENSG00000287958	AC092053.5	NA	
ENSG00000168329	CX3CR1	607339	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1;;CHDS1
ENSG00000168329	CX3CR1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000168329	CX3CR1	613784	MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12
ENSG00000270367	AC092053.1	NA	
ENSG00000287780	AC104850.2	NA	
ENSG00000179934	CCR8	NA	
ENSG00000228168	HNRNPA1P21	NA	
ENSG00000238267	AC104850.1	NA	
ENSG00000223668	EEF1A1P24	NA	
ENSG00000144659	SLC25A38	205950	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2
ENSG00000168028	RPSA	271400	ASPLENIA, ISOLATED CONGENITAL; ICAS;;HYPOSPLENIA, ISOLATED CONGENITAL;;SPLENIC HYPOPLASIA;;ASPLENIA, FAMILIAL
ENSG00000206760	SNORA6	NA	
ENSG00000202363	SNORA62	NA	
ENSG00000286996	AC099332.2	NA	
ENSG00000286781	AC099332.1	NA	
ENSG00000168314	MOBP	NA	
ENSG00000285885	AC092058.1	NA	
ENSG00000230757	NFU1P1	NA	
ENSG00000170011	MYRIP	NA	
ENSG00000201570	RNU4-56P	NA	
ENSG00000280739	EIF1B-AS1	NA	
ENSG00000265327	RN7SL411P	NA	
ENSG00000202517	AC099331.1	NA	
ENSG00000114784	EIF1B	NA	
ENSG00000223797	ENTPD3-AS1	NA	
ENSG00000230274	PGAM1P3	NA	
ENSG00000168032	ENTPD3	NA	
ENSG00000188846	RPL14	NA	
ENSG00000177873	ZNF619	NA	
ENSG00000177842	ZNF620	NA	
ENSG00000199906	RNU5B-2P	NA	
ENSG00000172888	ZNF621	NA	
ENSG00000234067	RPL5P10	NA	
ENSG00000226845	EEF1GP3	NA	
ENSG00000226302	AC122683.1	NA	
ENSG00000229072	HMGN2P24	NA	
ENSG00000231873	AC099560.1	NA	
ENSG00000234287	AC099560.2	NA	
ENSG00000287415	AC099541.2	NA	
ENSG00000233096	AC099541.1	NA	
ENSG00000233919	AC009743.1	NA	
ENSG00000275256	MRPS31P1	NA	
ENSG00000168036	CTNNB1	167000	OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED
ENSG00000168036	CTNNB1	155255	MEDULLOBLASTOMA; MDB MEDULLOBLASTOMA, DESMOPLASTIC, INCLUDED;;MEDULLOBLASTOMA WITH EXTENSIVE NODULARITY, INCLUDED; MBEN, INCLUDED
ENSG00000168036	CTNNB1	132600	PILOMATRIXOMA;;PILOMATRICOMA; PTR;;EPITHELIOMA CALCIFICANS OF MALHERBE
ENSG00000168036	CTNNB1	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000168036	CTNNB1	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000168036	CTNNB1	615075	NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 19, FORMERLY; MRD19, FORMERLY
ENSG00000168036	CTNNB1	617572	EXUDATIVE VITREORETINOPATHY 7; EVR7
ENSG00000168038	ULK4	NA	
ENSG00000252409	AC099537.1	NA	
ENSG00000222942	RN7SKP58	NA	
ENSG00000223513	ATP6V0E1P2	NA	
ENSG00000251986	Y_RNA	NA	
ENSG00000212145	U8	NA	
ENSG00000234270	RPL36P20	NA	
ENSG00000235339	GEMIN2P2	NA	
ENSG00000182606	TRAK1	618201	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68
ENSG00000229339	AC093414.1	NA	
ENSG00000234562	TPMTP2	NA	
ENSG00000222872	RNU4-78P	NA	
ENSG00000187094	CCK	NA	
ENSG00000281160	AC018358.1	NA	
ENSG00000231280	SALL4P6	NA	
ENSG00000229572	EIF4BP4	NA	
ENSG00000157093	LYZL4	NA	
ENSG00000235787	AC092047.1	NA	
ENSG00000114812	VIPR1	NA	
ENSG00000232354	VIPR1-AS1	NA	
ENSG00000093183	SEC22C	NA	
ENSG00000008324	SS18L2	NA	
ENSG00000114857	NKTR	NA	
ENSG00000230084	AC006059.1	NA	
ENSG00000114853	ZBTB47	NA	
ENSG00000287629	AC006059.5	NA	
ENSG00000240203	RN7SL567P	NA	
ENSG00000157119	KLHL40	615348	NEMALINE MYOPATHY 8; NEM8
ENSG00000010282	HHATL	NA	
ENSG00000285539	AC006059.3	NA	
ENSG00000230970	HHATL-AS1	NA	
ENSG00000280571	AC006059.2	NA	
ENSG00000244607	CCDC13	NA	
ENSG00000287417	AC006059.4	NA	
ENSG00000173811	CCDC13-AS1	NA	
ENSG00000225611	LINC02158	NA	
ENSG00000181061	HIGD1A	NA	
ENSG00000235288	AC099329.1	NA	
ENSG00000144648	ACKR2	NA	
ENSG00000273328	AC099329.2	NA	
ENSG00000273291	AC092042.3	NA	
ENSG00000240747	KRBOX1	NA	
ENSG00000180432	CYP8B1	NA	
ENSG00000236459	HNRNPA1P22	NA	
ENSG00000182983	ZNF662	NA	
ENSG00000206552	KRBOX1-AS1	NA	
ENSG00000144649	GASK1A	NA	
ENSG00000232375	AC092042.2	NA	
ENSG00000144647	POMGNT2	614830	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, GTDC2-RELATED
ENSG00000144647	POMGNT2	618135	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 24; LGMDR24;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT2-RELATED
ENSG00000227245	AC092042.1	NA	
ENSG00000285766	AC092042.4	NA	
ENSG00000163788	SNRK	NA	
ENSG00000241939	RN7SL517P	NA	
ENSG00000234617	SNRK-AS1	NA	
ENSG00000160746	ANO10	613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10
ENSG00000251811	Y_RNA	NA	
ENSG00000223916	AC097638.1	NA	
ENSG00000011198	ABHD5	275630	CHANARIN-DORFMAN SYNDROME; CDS;;NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS; NLSDI;;TRIGLYCERIDE STORAGE DISEASE WITH IMPAIRED LONG-CHAIN FATTY ACID OXIDATION;;ICHTHYOTIC NEUTRAL LIPID STORAGE DISEASE;;DORFMAN-CHANARIN SYNDROME; DCS;;CHANARIN-DORF /.../SEASE;;ICHTHYOSIFORM ERYTHRODERMA WITH LEUKOCYTE VACUOLATION
ENSG00000235886	AC006055.1	NA	
ENSG00000271192	AC006058.2	NA	
ENSG00000272121	AC006058.3	NA	
ENSG00000252980	RNU6-367P	NA	
ENSG00000207954	MIR138-1	NA	
ENSG00000280435	AC006058.4	NA	
ENSG00000261786	AC006058.1	NA	
ENSG00000173769	TOPAZ1	NA	
ENSG00000271937	AC104187.1	NA	
ENSG00000179152	TCAIM	NA	
ENSG00000225873	C3orf86	NA	
ENSG00000283036	LINC01988	NA	
ENSG00000185219	ZNF445	NA	
ENSG00000178917	ZNF852	NA	
ENSG00000214825	EI24P3	NA	
ENSG00000277509	AC099669.1	NA	
ENSG00000196345	ZKSCAN7	NA	
ENSG00000236869	ZKSCAN7-AS1	NA	
ENSG00000144792	ZNF660	NA	
ENSG00000214820	MPRIPP1	NA	
ENSG00000186448	ZNF197	NA	
ENSG00000233509	ZNF197-AS1	NA	
ENSG00000169981	ZNF35	NA	
ENSG00000272077	AC124045.1	NA	
ENSG00000235805	SOCS5P3	NA	
ENSG00000196653	ZNF502	NA	
ENSG00000186446	ZNF501	NA	
ENSG00000163807	KIAA1143	NA	
ENSG00000163808	KIF15	NA	
ENSG00000284498	MIR564	NA	
ENSG00000169964	TMEM42	NA	
ENSG00000163810	TGM4	NA	
ENSG00000235845	AC098649.1	NA	
ENSG00000163812	ZDHHC3	NA	
ENSG00000227123	RPL12P44	NA	
ENSG00000075914	EXOSC7	NA	
ENSG00000163815	CLEC3B	NA	
ENSG00000252410	RNU5B-3P	NA	
ENSG00000163814	CDCP1	NA	
ENSG00000224094	RPS24P8	NA	
ENSG00000249992	TMEM158	NA	
ENSG00000202268	U3	NA	
ENSG00000011376	LARS2	615300	PERRAULT SYNDROME 4; PRLTS4
ENSG00000011376	LARS2	617021	HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA
ENSG00000232455	LARS2-AS1	NA	
ENSG00000144791	LIMD1	NA	
ENSG00000230530	LIMD1-AS1	NA	
ENSG00000211456	SACM1L	NA	
ENSG00000244357	RN7SL145P	NA	
ENSG00000279017	AC098476.1	NA	
ENSG00000163817	SLC6A20	138500	HYPERGLYCINURIA;;GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS;;GLYCINURIA WITH OR WITHOUT OXALATE NEPHROLITHIASIS;;IMINOGLYCINURIA TYPE II
ENSG00000163817	SLC6A20	242600	IMINOGLYCINURIA
ENSG00000163818	LZTFL1	615994	BARDET-BIEDL SYNDROME 17; BBS17
ENSG00000285788	AC099782.2	NA	
ENSG00000236930	AC099782.1	NA	
ENSG00000173585	CCR9	NA	
ENSG00000201635	Y_RNA	NA	
ENSG00000163820	FYCO1	610019	CATARACT 18; CTRCT18;;CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2; CATC2
ENSG00000172215	CXCR6	NA	
ENSG00000173578	XCR1	NA	
ENSG00000226933	NRBF2P2	NA	
ENSG00000229515	FLT1P1	NA	
ENSG00000183625	CCR3	NA	
ENSG00000163823	CCR1	NA	
ENSG00000236736	UQCRC2P1	NA	
ENSG00000121807	CCR2	NA	
ENSG00000223552	CCR5AS	NA	
ENSG00000160791	CCR5	609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO;;HCV, SUSCEPTIBILITY TO HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED;;HCV, RESISTANCE TO, INCLUDED;;HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF, INCLUDED
ENSG00000160791	CCR5	610379	WEST NILE VIRUS, SUSCEPTIBILITY TO;;WNV, SUSCEPTIBILITY TO
ENSG00000160791	CCR5	612522	DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22
ENSG00000121797	CCRL2	NA	
ENSG00000283646	LINC02009	NA	
ENSG00000012223	LTF	NA	
ENSG00000163825	RTP3	NA	
ENSG00000163827	LRRC2	NA	
ENSG00000268324	LRRC2-AS1	NA	
ENSG00000241186	TDGF1	187395	TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1;;CRIPTO GROWTH FACTOR; CRGF  FOREBRAIN DEFECTS, INCLUDED
ENSG00000283877	AC104304.2	NA	
ENSG00000283473	FAM240A	NA	
ENSG00000286570	AC104304.3	NA	
ENSG00000251967	AC104304.1	NA	
ENSG00000178038	ALS2CL	NA	
ENSG00000181585	TMIE	600971	DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6
ENSG00000206549	AC109583.1	NA	
ENSG00000283706	PRSS50	NA	
ENSG00000261603	PRSS46P	NA	
ENSG00000188086	PRSS45P	NA	
ENSG00000284672	AC109583.4	NA	
ENSG00000286651	PRSS43P	NA	
ENSG00000238013	AC109583.2	NA	
ENSG00000226074	PRSS44P	NA	
ENSG00000178055	PRSS42P	NA	
ENSG00000160808	MYL3	608751	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8;;CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 1
ENSG00000160801	PTH1R	156400	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE; MCDJ;;METAPHYSEAL CHONDRODYSPLASIA, MURK JANSEN TYPE
ENSG00000160801	PTH1R	125350	FAILURE OF TOOTH ERUPTION, PRIMARY; PFE;;PRIMARY FAILURE OF TOOTH ERUPTION, NONSYNDROMIC;;PRIMARY RETENTION OF TEETH;;UNERUPTED SECOND PRIMARY MOLAR;;POSTERIOR OPENBITE MALOCCLUSION, FAMILIAL;;DENTAL NONERUPTION
ENSG00000160801	PTH1R	215045	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD
ENSG00000160801	PTH1R	600002	EIKEN SYNDROME;;EIKEN SKELETAL DYSPLASIA;;BONE MODELING DEFECT OF HANDS AND FEET
ENSG00000273682	AC109583.3	NA	
ENSG00000160799	CCDC12	NA	
ENSG00000160796	NBEAL2	139090	GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY
ENSG00000236409	NRADDP	NA	
ENSG00000181555	SETD2	616831	LUSCAN-LUMISH SYNDROME; LLS
ENSG00000275940	MRPL57P3	NA	
ENSG00000227398	KIF9-AS1	NA	
ENSG00000088727	KIF9	NA	
ENSG00000239128	SNORD13P3	NA	
ENSG00000114648	KLHL18	NA	
ENSG00000280173	AC104447.1	NA	
ENSG00000260236	AC099778.1	NA	
ENSG00000076201	PTPN23	NA	
ENSG00000114650	SCAP	NA	
ENSG00000276925	AC099778.2	NA	
ENSG00000163832	ELP6	NA	
ENSG00000271161	BOLA2P2	NA	
ENSG00000244732	RN7SL870P	NA	
ENSG00000114646	CSPG5	NA	
ENSG00000173473	SMARCC1	NA	
ENSG00000214773	AC112512.1	NA	
ENSG00000235695	HIGD2AP2	NA	
ENSG00000132153	DHX30	617804	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL
ENSG00000274420	AC026318.1	NA	
ENSG00000221585	MIR1226	NA	
ENSG00000047849	MAP4	NA	
ENSG00000199591	Y_RNA	NA	
ENSG00000224895	VPS26BP1	NA	
ENSG00000270285	AC124916.2	NA	
ENSG00000265078	RN7SL664P	NA	
ENSG00000236768	AC124916.1	NA	
ENSG00000164045	CDC25A	NA	
ENSG00000235627	SNRPFP4	NA	
ENSG00000253056	RNU7-128P	NA	
ENSG00000231884	NDUFB1P1	NA	
ENSG00000265483	MIR4443	NA	
ENSG00000164047	CAMP	NA	
ENSG00000164048	ZNF589	NA	
ENSG00000229759	MRPS18AP1	NA	
ENSG00000199476	Y_RNA	NA	
ENSG00000172113	NME6	NA	
ENSG00000228638	FCF1P2	NA	
ENSG00000229453	SPINK8	NA	
ENSG00000252466	MIR2115	NA	
ENSG00000164049	FBXW12	NA	
ENSG00000277483	RN7SL321P	NA	
ENSG00000164050	PLXNB1	NA	
ENSG00000164051	CCDC51	NA	
ENSG00000232112	TMA7	NA	
ENSG00000244380	AC134772.1	NA	
ENSG00000164053	ATRIP	NA	
ENSG00000213689	TREX1	152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED;;EXCESS LMW-DNA, INCLUDED
ENSG00000213689	TREX1	192315	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL;;CEREBRORETINAL VASCULOPATHY, HEREDITARY; CRV;;RETINOPATHY, VASCULAR, WITH CEREBRAL AND RENAL INVOLVEMENT AND RAYNAUD AND MIGRAINE PHENOMENA
ENSG00000213689	TREX1	225750	AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROME AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMIN /.../NCLUDED
ENSG00000213689	TREX1	610448	CHILBLAIN LUPUS 1; CHBL1
ENSG00000164054	SHISA5	NA	
ENSG00000114268	PFKFB4	NA	
ENSG00000278799	MIR6823	NA	
ENSG00000145040	UCN2	NA	
ENSG00000114270	COL7A1	132000	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, BART TYPE
ENSG00000114270	COL7A1	131850	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, PRETIBIAL;;DEB, PRETIBIAL;;EPIDERMOLYSIS BULLOSA, PRETIBIAL
ENSG00000114270	COL7A1	131750	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL DOMINANT;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, COCKAYNE-TOURAINE TYPE; EBDCT;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, PASINI TYPE;;ALBOPAPULOID DOMINAN /.../ROPHIC EPIDERMOLYSIS BULLOSA; EBDD EPIDERMOLYSIS BULLOSA DYSTROPHICA WITH SUBCORNEAL CLEAVAGE, INCLUDED; EBDSC, INCLUDED
ENSG00000114270	COL7A1	131705	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, NEONATAL FORM;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, NEONATAL
ENSG00000114270	COL7A1	226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RE /.../E EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATA VARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000114270	COL7A1	604129	EPIDERMOLYSIS BULLOSA PRURIGINOSA;;DYSTROPHIC EPIDERMOLYSIS BULLOSA PRURIGINOSA;;DEB, PRURIGINOSA
ENSG00000114270	COL7A1	607523	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8;;TOENAIL DYSTROPHY, ISOLATED
ENSG00000284251	MIR711	NA	
ENSG00000010256	UQCRC1	NA	
ENSG00000183396	TMEM89	NA	
ENSG00000225697	SLC26A6	NA	
ENSG00000284364	MIR6824	NA	
ENSG00000008300	CELSR3	NA	
ENSG00000284575	MIR4793	NA	
ENSG00000213672	NCKIPSD	NA	
ENSG00000228350	LINC02585	NA	
ENSG00000271973	AC141002.1	NA	
ENSG00000068745	IP6K2	NA	
ENSG00000114302	PRKAR2A	NA	
ENSG00000224424	PRKAR2A-AS1	NA	
ENSG00000178537	SLC25A20	212138	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD;;CACT DEFICIENCY
ENSG00000221883	ARIH2OS	NA	
ENSG00000177479	ARIH2	NA	
ENSG00000235236	AC137630.2	NA	
ENSG00000223343	AC137630.1	NA	
ENSG00000273211	AC137630.4	NA	
ENSG00000178467	P4HTM	618493	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA
ENSG00000285416	AC137630.5	NA	
ENSG00000178252	WDR6	NA	
ENSG00000178149	DALRD3	NA	
ENSG00000199032	MIR425	NA	
ENSG00000178057	NDUFAF3	618240	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18
ENSG00000207605	MIR191	NA	
ENSG00000178035	IMPDH2	617995	IMPDH2 ENZYME ACTIVITY, VARIATION IN; IMPDH2V
ENSG00000272434	AC137630.3	NA	
ENSG00000198218	QRICH1	617982	VERVERI-BRADY SYNDROME; VERBRAS
ENSG00000241461	RN7SL182P	NA	
ENSG00000172053	QARS1	615760	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA
ENSG00000284488	MIR6890	NA	
ENSG00000172046	USP19	NA	
ENSG00000172037	LAMB2	609049	PIERSON SYNDROME;;MICROCORIA-CONGENITAL NEPHROTIC SYNDROME
ENSG00000172037	LAMB2	614199	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5
ENSG00000270441	AC135506.1	NA	
ENSG00000177352	CCDC71	NA	
ENSG00000185909	KLHDC8B	236000	LYMPHOMA, HODGKIN, CLASSIC; CHL;;HODGKIN DISEASE
ENSG00000236980	C3orf84	NA	
ENSG00000173421	IHO1	NA	
ENSG00000270538	AC121247.2	NA	
ENSG00000225399	AC121247.1	NA	
ENSG00000188315	C3orf62	NA	
ENSG00000199546	Y_RNA	NA	
ENSG00000264633	MIR4271	NA	
ENSG00000114316	USP4	NA	
ENSG00000233276	GPX1	614164	GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD
ENSG00000067560	RHOA	618727	ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES; EDFAOB
ENSG00000235908	RHOA-IT1	NA	
ENSG00000145022	TCTA	NA	
ENSG00000283189	AC104452.1	NA	
ENSG00000145020	AMT	605899	GLYCINE ENCEPHALOPATHY; GCE;;HYPERGLYCINEMIA, NONKETOTIC; NKH HYPERGLYCINEMIA, TRANSIENT NEONATAL, INCLUDED; TNH, INCLUDED
ENSG00000145029	NICN1	NA	
ENSG00000201301	RNA5SP130	NA	
ENSG00000173402	DAG1	613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 16; LGMDR16;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2P; LGMD2P;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, DAG1-RELATED
ENSG00000173402	DAG1	616538	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE BRAIN DISEASE, DAG1-RELATED
ENSG00000226913	BSN-DT	NA	
ENSG00000164061	BSN	NA	
ENSG00000235120	BSN-AS1	NA	
ENSG00000164062	APEH	NA	
ENSG00000173531	MST1	NA	
ENSG00000259970	AC099668.1	NA	
ENSG00000164068	RNF123	NA	
ENSG00000176020	AMIGO3	NA	
ENSG00000173540	GMPPB	615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, GMPPB-RELATED
ENSG00000173540	GMPPB	615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14;;MUSCULAR DYSTROPHY, CONGENITAL, GMPPB-RELATED
ENSG00000173540	GMPPB	615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 19; LGMDR19;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2T; LGMD2T;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, GMPPB-RELATED
ENSG00000176095	IP6K1	NA	
ENSG00000239576	COX6CP14	NA	
ENSG00000244730	AC139451.1	NA	
ENSG00000187492	CDHR4	NA	
ENSG00000185614	INKA1	NA	
ENSG00000182179	UBA7	NA	
ENSG00000283726	MIR5193	NA	
ENSG00000183763	TRAIP	616777	SECKEL SYNDROME 9; SCKL9
ENSG00000164076	CAMKV	NA	
ENSG00000264706	RN7SL217P	NA	
ENSG00000234667	ACTBP13	NA	
ENSG00000164078	MST1R	617075	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3; NPCA3
ENSG00000230698	AC105935.2	NA	
ENSG00000228008	AC105935.1	NA	
ENSG00000164077	MON1A	NA	
ENSG00000004534	RBM6	NA	
ENSG00000003756	RBM5	NA	
ENSG00000281691	RBM5-AS1	NA	
ENSG00000235016	SEMA3F-AS1	NA	
ENSG00000001617	SEMA3F	NA	
ENSG00000207922	AC104450.1	NA	
ENSG00000114349	GNAT1	610444	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3;;NIGHT BLINDNESS, CONGENITAL STATIONARY, NOUGARET TYPE
ENSG00000114349	GNAT1	616389	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G
ENSG00000188338	SLC38A3	NA	
ENSG00000114353	GNAI2	192605	VENTRICULAR TACHYCARDIA, FAMILIAL;;VENTRICULAR TACHYCARDIA, FAMILIAL POLYMORPHIC
ENSG00000275334	MIR5787	NA	
ENSG00000213600	U73169.1	NA	
ENSG00000230454	U73166.1	NA	
ENSG00000232352	SEMA3B-AS1	NA	
ENSG00000012171	SEMA3B	NA	
ENSG00000283848	MIR6872	NA	
ENSG00000179564	LSMEM2	NA	
ENSG00000214706	IFRD2	NA	
ENSG00000186792	HYAL3	NA	
ENSG00000243477	NAA80	NA	
ENSG00000114378	HYAL1	601492	MUCOPOLYSACCHARIDOSIS, TYPE IX; MPS9;;MPS IX;;HYALURONIDASE DEFICIENCY
ENSG00000068001	HYAL2	NA	
ENSG00000114383	TUSC2	NA	
ENSG00000068028	RASSF1	NA	
ENSG00000281358	RASSF1-AS1	NA	
ENSG00000235058	ZMYND10-AS1	NA	
ENSG00000004838	ZMYND10	615444	CILIARY DYSKINESIA, PRIMARY, 22; CILD22;;CILIARY DYSKINESIA, PRIMARY, 22, WITH OR WITHOUT SITUS INVERSUS
ENSG00000114388	NPRL2	617116	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2
ENSG00000114395	CYB561D2	NA	
ENSG00000272104	Z84492.1	NA	
ENSG00000126062	TMEM115	NA	
ENSG00000007402	CACNA2D2	618501	CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD
ENSG00000271858	CYB561D2	NA	
ENSG00000202322	RNA5SP131	NA	
ENSG00000088543	C3orf18	NA	
ENSG00000114735	HEMK1	NA	
ENSG00000280382	AC096920.1	NA	
ENSG00000114737	CISH	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000114737	CISH	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000114737	CISH	614383	BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2
ENSG00000114738	MAPKAPK3	617111	MACULAR DYSTROPHY, PATTERNED, 3; MDPT3;;MARTINIQUE CRINKLED RETINAL PIGMENT EPITHELIOPATHY
ENSG00000273356	LINC02019	NA	
ENSG00000088538	DOCK3	618292	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA
ENSG00000272543	MIR4787	NA	
ENSG00000228337	PPIAP69	NA	
ENSG00000213587	AC126120.1	NA	
ENSG00000235278	ZNF652P1	NA	
ENSG00000240959	ST13P14	NA	
ENSG00000145050	MANF	NA	
ENSG00000259956	RBM15B	NA	
ENSG00000145041	DCAF1	NA	
ENSG00000164080	RAD54L2	NA	
ENSG00000221015	RNU6ATAC29P	NA	
ENSG00000164081	TEX264	NA	
ENSG00000288063	AC099050.1	NA	
ENSG00000201595	RNA5SP132	NA	
ENSG00000164082	GRM2	NA	
ENSG00000214686	IQCF6	NA	
ENSG00000285749	AC097636.1	NA	
ENSG00000173389	IQCF1	NA	
ENSG00000224792	IQCF4P	NA	
ENSG00000229972	IQCF3	NA	
ENSG00000184345	IQCF2	NA	
ENSG00000241789	RN7SL504P	NA	
ENSG00000235455	IQCF5-AS1	NA	
ENSG00000214681	IQCF5	NA	
ENSG00000287707	AC115284.4	NA	
ENSG00000114767	RRP9	NA	
ENSG00000041880	PARP3	NA	
ENSG00000280422	AC115284.2	NA	
ENSG00000180929	GPR62	NA	
ENSG00000090097	PCBP4	NA	
ENSG00000272762	AC115284.1	NA	
ENSG00000114779	ABHD14B	NA	
ENSG00000248487	ABHD14A	NA	
ENSG00000114786	ABHD14A-ACY1	NA	
ENSG00000243989	ACY1	609924	AMINOACYLASE 1 DEFICIENCY; ACY1D
ENSG00000162244	RPL29	NA	
ENSG00000285685	AC115284.3	NA	
ENSG00000164086	DUSP7	NA	
ENSG00000164087	POC1A	614813	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT;;SOFT SYNDROME
ENSG00000286419	AC097637.3	NA	
ENSG00000242849	ALDOAP1	NA	
ENSG00000023330	ALAS1	NA	
ENSG00000280003	AC097637.2	NA	
ENSG00000239732	TLR9	NA	
ENSG00000173366	AC097637.1	NA	
ENSG00000247596	TWF2	NA	
ENSG00000243224	AC006252.1	NA	
ENSG00000164088	PPM1M	NA	
ENSG00000164091	WDR82	NA	
ENSG00000199150	MIRLET7G	NA	
ENSG00000168237	GLYCTK	220120	D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY
ENSG00000242797	GLYCTK-AS1	NA	
ENSG00000207926	MIR135A1	NA	
ENSG00000114841	DNAH1	617576	SPERMATOGENIC FAILURE 18; SPGF18
ENSG00000114841	DNAH1	617577	CILIARY DYSKINESIA, PRIMARY, 37; CILD37;;CILIARY DYSKINESIA, PRIMARY, 37, WITH OR WITHOUT SITUS INVERSUS
ENSG00000239557	AC092045.1	NA	
ENSG00000163930	BAP1	614327	TUMOR PREDISPOSITION SYNDROME; TPDS
ENSG00000010318	PHF7	NA	
ENSG00000010319	SEMA3G	NA	
ENSG00000114854	TNNC1	611879	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z
ENSG00000114854	TNNC1	613243	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13
ENSG00000010322	NISCH	NA	
ENSG00000010327	STAB1	NA	
ENSG00000168268	NT5DC2	NA	
ENSG00000168273	SMIM4	NA	
ENSG00000163939	PBRM1	NA	
ENSG00000252768	RNU6-856P	NA	
ENSG00000221518	RNU6ATAC16P	NA	
ENSG00000163938	GNL3	NA	
ENSG00000280904	AC104446.3	NA	
ENSG00000252787	AC104446.1	NA	
ENSG00000212493	SNORD19	NA	
ENSG00000238862	SNORD19B	NA	
ENSG00000222345	SNORD19C	NA	
ENSG00000212452	SNORD69	NA	
ENSG00000016864	GLT8D1	NA	
ENSG00000114902	SPCS1	NA	
ENSG00000114904	NEK4	NA	
ENSG00000275956	AC104446.2	NA	
ENSG00000270941	AC006254.2	NA	
ENSG00000271137	AC006254.3	NA	
ENSG00000055957	ITIH1	NA	
ENSG00000162267	ITIH3	NA	
ENSG00000055955	ITIH4	NA	
ENSG00000243696	AC006254.1	NA	
ENSG00000239799	ITIH4-AS1	NA	
ENSG00000272573	MUSTN1	NA	
ENSG00000248592	STIMATE-MUSTN1	NA	
ENSG00000213533	STIMATE	NA	
ENSG00000275789	MIR8064	NA	
ENSG00000279144	AC099667.1	NA	
ENSG00000163935	SFMBT1	NA	
ENSG00000272305	AC096887.1	NA	
ENSG00000280417	AC096887.2	NA	
ENSG00000242142	SERBP1P3	NA	
ENSG00000163933	RFT1	612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N;;CDG In; CDGIn
ENSG00000163932	PRKCD	615559	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3;;IMMUNODEFICIENCY, COMMON VARIABLE, 9, FORMERLY; CVID9, FORMERLY
ENSG00000286531	AC097015.1	NA	
ENSG00000163931	TKT	617044	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD;;TRANSKETOLASE DEFICIENCY
ENSG00000272886	DCP1A	NA	
ENSG00000274967	Y_RNA	NA	
ENSG00000157388	CACNA1D	614896	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD
ENSG00000157388	CACNA1D	615474	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA
ENSG00000207109	SNORD38C	NA	
ENSG00000212608	AC112218.1	NA	
ENSG00000227224	AC092035.1	NA	
ENSG00000251987	SNORD63	NA	
ENSG00000271916	AC012467.1	NA	
ENSG00000016391	CHDH	NA	
ENSG00000056736	IL17RB	NA	
ENSG00000271976	AC012467.2	NA	
ENSG00000113812	ACTR8	NA	
ENSG00000113811	SELENOK	NA	
ENSG00000288029	AC115282.2	NA	
ENSG00000242983	CABYRP1	NA	
ENSG00000286353	AC115282.1	NA	
ENSG00000157445	CACNA2D3	NA	
ENSG00000229806	RPS15P5	NA	
ENSG00000265992	ESRG	NA	
ENSG00000243715	CACNA2D3-AS1	NA	
ENSG00000144771	LRTM1	NA	
ENSG00000239991	AC092059.1	NA	
ENSG00000243572	LINC02017	NA	
ENSG00000240708	LINC02030	NA	
ENSG00000242568	AC121764.2	NA	
ENSG00000242775	AC121764.3	NA	
ENSG00000114251	WNT5A	180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES
ENSG00000244586	WNT5A-AS1	NA	
ENSG00000242317	AC121764.1	NA	
ENSG00000187672	ERC2	NA	
ENSG00000240777	AC025572.1	NA	
ENSG00000281708	ERC2-IT1	NA	
ENSG00000264013	MIR3938	NA	
ENSG00000200379	RN7SKP45	NA	
ENSG00000200238	RNA5SP133	NA	
ENSG00000180376	CCDC66	NA	
ENSG00000163946	TASOR	NA	
ENSG00000163947	ARHGEF3	NA	
ENSG00000240198	ARHGEF3-AS1	NA	
ENSG00000186451	SPATA12	NA	
ENSG00000272202	AC097358.2	NA	
ENSG00000144730	IL17RD	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000144730	IL17RD	615267	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18
ENSG00000229863	AC097358.1	NA	
ENSG00000163666	HESX1	182230	SEPTOOPTIC DYSPLASIA;;DE MORSIER SYNDROME PITUITARY HORMONE DEFICIENCY, COMBINED, 5, INCLUDED; CPHD5, INCLUDED;;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES, INCLUDED
ENSG00000157500	APPL1	616511	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14
ENSG00000239388	ASB14	NA	
ENSG00000286952	AC093928.1	NA	
ENSG00000174844	DNAH12	NA	
ENSG00000212392	Y_RNA	NA	
ENSG00000206918	RNU6-1181P	NA	
ENSG00000239831	RNF7P1	NA	
ENSG00000237186	AC092418.1	NA	
ENSG00000202428	RNU6-108P	NA	
ENSG00000206815	RNU6-483P	NA	
ENSG00000287502	AC092418.2	NA	
ENSG00000174840	PDE12	NA	
ENSG00000168374	ARF4	NA	
ENSG00000272146	ARF4-AS1	NA	
ENSG00000210841	RNU6ATAC26P	NA	
ENSG00000174839	DENND6A	NA	
ENSG00000239801	DENND6A-AS1	NA	
ENSG00000241933	DENND6A-DT	NA	
ENSG00000163681	SLMAP	NA	
ENSG00000270772	PDHA1P1	NA	
ENSG00000213509	PPIAP16	NA	
ENSG00000136068	FLNB	150250	LARSEN SYNDROME; LRS
ENSG00000136068	FLNB	112310	BOOMERANG DYSPLASIA; BOOMD
ENSG00000136068	FLNB	108721	ATELOSTEOGENESIS, TYPE III; AO3;;AOIII
ENSG00000136068	FLNB	108720	ATELOSTEOGENESIS, TYPE I; AO1;;AOI;;GIANT CELL CHONDRODYSPLASIA;;SPONDYLOHUMEROFEMORAL HYPOPLASIA
ENSG00000136068	FLNB	272460	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT;;SPONDYLOCARPOTARSAL SYNDROME;;SYNSPONDYLISM, CONGENITAL;;VERTEBRAL FUSION WITH CARPAL COALITION;;SCOLIOSIS, CONGENITAL, WITH UNILATERAL UNSEGMENTED BAR
ENSG00000244161	FLNB-AS1	NA	
ENSG00000283148	AC137936.1	NA	
ENSG00000283511	AC137936.2	NA	
ENSG00000163687	DNASE1L3	614420	SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16
ENSG00000163686	ABHD6	NA	
ENSG00000255154	HTD2	NA	
ENSG00000163684	RPP14	NA	
ENSG00000273493	AC098479.1	NA	
ENSG00000168297	PXK	NA	
ENSG00000275607	AC135507.2	NA	
ENSG00000168291	PDHB	614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD
ENSG00000272182	AC135507.1	NA	
ENSG00000272360	AC116036.2	NA	
ENSG00000168301	KCTD6	NA	
ENSG00000168306	ACOX2	617308	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6
ENSG00000236722	AC116036.1	NA	
ENSG00000168309	FAM107A	NA	
ENSG00000243384	AC119424.1	NA	
ENSG00000244383	FAM3D-AS1	NA	
ENSG00000198643	FAM3D	NA	
ENSG00000163689	CFAP20DC	NA	
ENSG00000242428	CFAP20DC-AS1	NA	
ENSG00000243295	AC126121.3	NA	
ENSG00000243903	AC138057.1	NA	
ENSG00000242545	AC126121.2	NA	
ENSG00000241804	AC126121.1	NA	
ENSG00000277592	Metazoa_SRP	NA	
ENSG00000189283	FHIT	NA	
ENSG00000287649	AC093418.1	NA	
ENSG00000240097	AC104164.2	NA	
ENSG00000281426	MIR548BB	NA	
ENSG00000232407	PPIAP70	NA	
ENSG00000225673	AC104164.1	NA	
ENSG00000244183	PPIAP71	NA	
ENSG00000212211	U3	NA	
ENSG00000144724	PTPRG	NA	
ENSG00000252420	Y_RNA	NA	
ENSG00000226360	RPL10AP6	NA	
ENSG00000252184	RNU2-10P	NA	
ENSG00000237456	AC104849.1	NA	
ENSG00000241472	PTPRG-AS1	NA	
ENSG00000114405	C3orf14	NA	
ENSG00000153266	FEZF2	NA	
ENSG00000163618	CADPS	NA	
ENSG00000225662	AC012519.1	NA	
ENSG00000244632	RN7SL863P	NA	
ENSG00000252449	RNU6-139P	NA	
ENSG00000226082	AC096915.1	NA	
ENSG00000244342	LINC00698	NA	
ENSG00000242841	KRT8P35	NA	
ENSG00000240359	UBL5P3	NA	
ENSG00000163630	SYNPR	NA	
ENSG00000241359	SYNPR-AS1	NA	
ENSG00000252301	RNA5SP134	NA	
ENSG00000188817	SNTN	NA	
ENSG00000224479	AC104162.1	NA	
ENSG00000163632	C3orf49	NA	
ENSG00000163634	THOC7	NA	
ENSG00000240549	THOC7-AS1	NA	
ENSG00000163635	ATXN7	164500	SPINOCEREBELLAR ATAXIA 7; SCA7;;OLIVOPONTOCEREBELLAR ATROPHY III; OPCA3;;OPCA III;;OPCA WITH RETINAL DEGENERATION;;OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA;;AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II;;ADCA, TYPE II
ENSG00000280620	SCAANT1	NA	
ENSG00000239653	PSMD6-AS2	NA	
ENSG00000271843	AC012557.1	NA	
ENSG00000163636	PSMD6	NA	
ENSG00000243410	PSMD6-AS1	NA	
ENSG00000272181	AC012557.2	NA	
ENSG00000241111	PRICKLE2-AS1	NA	
ENSG00000200222	U3	NA	
ENSG00000189196	LINC00994	NA	
ENSG00000163637	PRICKLE2	NA	
ENSG00000241572	PRICKLE2-AS1	NA	
ENSG00000241101	PRICKLE2-AS2	NA	
ENSG00000239926	PRDX3P4	NA	
ENSG00000226017	PRICKLE2-AS3	NA	
ENSG00000244564	PRICKLE2-DT	NA	
ENSG00000212340	RNU6-739P	NA	
ENSG00000163638	ADAMTS9	NA	
ENSG00000241158	ADAMTS9-AS1	NA	
ENSG00000241684	ADAMTS9-AS2	NA	
ENSG00000243149	LINC02040	NA	
ENSG00000151276	MAGI1	NA	
ENSG00000270059	AC121493.1	NA	
ENSG00000244226	ILF2P1	NA	
ENSG00000223409	RPL17P17	NA	
ENSG00000272610	MAGI1-IT1	NA	
ENSG00000240175	MAGI1-AS1	NA	
ENSG00000202071	Y_RNA	NA	
ENSG00000203647	AC106827.1	NA	
ENSG00000144741	SLC25A26	616794	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28
ENSG00000206759	RNU6-787P	NA	
ENSG00000241587	RN7SL482P	NA	
ENSG00000144749	LRIG1	NA	
ENSG00000271174	AC104440.1	NA	
ENSG00000214560	RPL21P41	NA	
ENSG00000288039	AC098969.2	NA	
ENSG00000285738	AC098969.1	NA	
ENSG00000287873	AC020655.1	NA	
ENSG00000163376	KBTBD8	NA	
ENSG00000283298	MIR4272	NA	
ENSG00000241884	AC114401.1	NA	
ENSG00000172340	SUCLG2	NA	
ENSG00000242510	NDUFB4P1	NA	
ENSG00000241316	SUCLG2-AS1	NA	
ENSG00000183662	TAFA1	NA	
ENSG00000214552	COPS8P2	NA	
ENSG00000240568	AC107626.1	NA	
ENSG00000286967	AC104167.1	NA	
ENSG00000244640	AC096922.1	NA	
ENSG00000241506	PSMC1P1	NA	
ENSG00000163377	TAFA4	NA	
ENSG00000252828	RNA5SP135	NA	
ENSG00000163378	EOGT	615297	ADAMS-OLIVER SYNDROME 4; AOS4
ENSG00000244513	AC109587.1	NA	
ENSG00000144747	TMF1	NA	
ENSG00000265355	MIR3136	NA	
ENSG00000144744	UBA3	NA	
ENSG00000144746	ARL6IP5	NA	
ENSG00000163380	LMOD3	616165	NEMALINE MYOPATHY 10; NEM10
ENSG00000114541	FRMD4B	NA	
ENSG00000239263	RBM43P1	NA	
ENSG00000240265	AC099328.1	NA	
ENSG00000240842	AC099328.2	NA	
ENSG00000241667	AC104445.1	NA	
ENSG00000187098	MITF	103500	TIETZ ALBINISM-DEAFNESS SYNDROME; TADS;;TIETZ SYNDROME;;ALBINISM-DEAFNESS OF TIETZ;;HYPOPIGMENTATION/DEAFNESS OF TIETZ
ENSG00000187098	MITF	193510	WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2
ENSG00000187098	MITF	614456	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8;;MELANOMA AND RENAL CELL CARCINOMA, SUSCEPTIBILITY TO
ENSG00000187098	MITF	617306	COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD
ENSG00000241665	RN7SL418P	NA	
ENSG00000240405	SAMMSON	NA	
ENSG00000271034	AC139700.1	NA	
ENSG00000242728	UQCRHP4	NA	
ENSG00000242120	MDFIC2	NA	
ENSG00000287487	AC104633.1	NA	
ENSG00000287669	AC104633.2	NA	
ENSG00000240156	COX6CP6	NA	
ENSG00000243873	HMGB1P36	NA	
ENSG00000206939	RNU6-281P	NA	
ENSG00000114861	FOXP1	613670	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES
ENSG00000285708	AC097634.4	NA	
ENSG00000244203	FOXP1-AS1	NA	
ENSG00000221264	MIR1284	NA	
ENSG00000274387	AC097634.2	NA	
ENSG00000242094	FOXP1-IT1	NA	
ENSG00000277855	AC097634.3	NA	
ENSG00000270562	AC097634.1	NA	
ENSG00000163412	EIF4E3	NA	
ENSG00000170837	GPR27	NA	
ENSG00000163421	PROK2	610628	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4
ENSG00000287131	AC096970.1	NA	
ENSG00000239250	RN7SL271P	NA	
ENSG00000241163	LINC00877	NA	
ENSG00000244130	UBE2Q2P9	NA	
ENSG00000273461	AC105265.2	NA	
ENSG00000276471	AC105265.3	NA	
ENSG00000239350	AC105265.1	NA	
ENSG00000242609	CCDC137P	NA	
ENSG00000243083	LINC00870	NA	
ENSG00000272774	AC112219.2	NA	
ENSG00000242618	AC112219.1	NA	
ENSG00000287882	AC134508.2	NA	
ENSG00000260670	AC134508.1	NA	
ENSG00000163602	RYBP	NA	
ENSG00000244345	AC104435.2	NA	
ENSG00000199469	RNU1-62P	NA	
ENSG00000239568	AC104435.1	NA	
ENSG00000222838	RNA5SP136	NA	
ENSG00000287595	AC097369.2	NA	
ENSG00000144736	SHQ1	NA	
ENSG00000241537	AC134050.1	NA	
ENSG00000240135	PSMD12P1	NA	
ENSG00000271266	LAPTM4BP2	NA	
ENSG00000172986	GXYLT2	NA	
ENSG00000276890	Metazoa_SRP	NA	
ENSG00000242960	FTH1P23	NA	
ENSG00000163605	PPP4R2	NA	
ENSG00000238959	RNU7-19P	NA	
ENSG00000255423	EBLN2	NA	
ENSG00000252651	RNU6-557P	NA	
ENSG00000223247	RNU2-64P	NA	
ENSG00000182921	CCDC75P1	NA	
ENSG00000252937	RNU6-1270P	NA	
ENSG00000121440	PDZRN3	NA	
ENSG00000239119	RNU7-119P	NA	
ENSG00000239677	PDZRN3-AS1	NA	
ENSG00000278934	AC117489.1	NA	
ENSG00000242364	AC108725.1	NA	
ENSG00000242741	LINC02005	NA	
ENSG00000278554	Metazoa_SRP	NA	
ENSG00000239454	LINC02047	NA	
ENSG00000223738	AC016930.1	NA	
ENSG00000213452	AKR1B1P2	NA	
ENSG00000113805	CNTN3	NA	
ENSG00000241022	NIPA2P2	NA	
ENSG00000242638	RN7SL294P	NA	
ENSG00000266780	MIR4444-2	NA	
ENSG00000287398	AC117481.1	NA	
ENSG00000213300	HNRNPA3P6	NA	
ENSG00000228868	MYLKP1	NA	
ENSG00000243674	OR7E66P	NA	
ENSG00000179799	OR7E22P	NA	
ENSG00000230655	OR7E55P	NA	
ENSG00000244699	AC139453.2	NA	
ENSG00000240665	LSP1P2	NA	
ENSG00000242953	AC139453.1	NA	
ENSG00000238278	ALG1L6P	NA	
ENSG00000244026	FAM86DP	NA	
ENSG00000272690	LINC02018	NA	
ENSG00000239959	ENPP7P2	NA	
ENSG00000243794	SNRPCP10	NA	
ENSG00000272710	AC133041.1	NA	
ENSG00000244674	RPS3AP15	NA	
ENSG00000239383	AC108724.1	NA	
ENSG00000244222	OR7E121P	NA	
ENSG00000172971	UNC93B3	NA	
ENSG00000243422	RPL23AP49	NA	
ENSG00000282912	AC108724.2	NA	
ENSG00000282511	CLUHP10	NA	
ENSG00000283894	MIR1324	NA	
ENSG00000241532	AGGF1P3	NA	
ENSG00000241622	RARRES2P1	NA	
ENSG00000172969	FRG2C	NA	
ENSG00000236138	DUX4L26	NA	
ENSG00000242516	LINC00960	NA	
ENSG00000227124	ZNF717	NA	
ENSG00000266396	MIR4273	NA	
ENSG00000185008	ROBO2	610878	VESICOURETERAL REFLUX 2; VUR2
ENSG00000222883	Y_RNA	NA	
ENSG00000240809	AC026877.1	NA	
ENSG00000199520	RNU6-386P	NA	
ENSG00000213450	VDAC1P7	NA	
ENSG00000287567	AC133040.1	NA	
ENSG00000206891	RNU6-217P	NA	
ENSG00000244461	LINC02077	NA	
ENSG00000240573	AC117462.1	NA	
ENSG00000243957	RN7SL647P	NA	
ENSG00000222574	RN7SKP61	NA	
ENSG00000240241	AC108752.1	NA	
ENSG00000239226	MRPS17P3	NA	
ENSG00000169855	ROBO1	NA	
ENSG00000240752	AC055731.1	NA	
ENSG00000240964	RN7SL751P	NA	
ENSG00000288105	AC117461.1	NA	
ENSG00000265193	MIR3923	NA	
ENSG00000243877	HMGB1P38	NA	
ENSG00000271389	OSBPL9P1	NA	
ENSG00000239699	HNRNPA3P8	NA	
ENSG00000242586	AC108740.1	NA	
ENSG00000286329	AC108690.1	NA	
ENSG00000242828	AC068756.1	NA	
ENSG00000242781	LINC02050	NA	
ENSG00000243694	LINC02027	NA	
ENSG00000242145	AC099542.2	NA	
ENSG00000241593	AC099542.1	NA	
ENSG00000287053	AC107302.2	NA	
ENSG00000244281	AC107302.1	NA	
ENSG00000114480	GBE1	232500	GLYCOGEN STORAGE DISEASE IV; GSD4;;GSD IV;;GLYCOGEN BRANCHING ENZYME DEFICIENCY;;GBE1 DEFICIENCY;;ANDERSEN DISEASE;;BRANCHER DEFICIENCY;;GLYCOGENOSIS IV;;AMYLOPECTINOSIS;;CIRRHOSIS, FAMILIAL, WITH DEPOSITION OF ABNORMAL GLYCOGEN  GSD IV, CLASSIC HEP /.../INCLUDED;;GSD IV, NONPROGRESSIVE HEPATIC, INCLUDED;;GSD IV, NEUROMUSCULAR FORM, FATAL PERINATAL, INCLUDED;;GSD IV, NEUROMUSCULAR FORM, CONGENITAL, INCLUDED;;GSD IV, NEUROMUSCULAR FORM, CHILDHOOD, INCLUDED;;GSD IV, NEUROMUSCULAR FORM, ADULT, WITH ISOLATED MYOPATHY, INCLUDED
ENSG00000114480	GBE1	263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN;;POLYGLUCOSAN BODY DISEASE, ADULT FORM; APBD
ENSG00000222389	RNU2-28P	NA	
ENSG00000241319	SETP6	NA	
ENSG00000240404	AC017015.1	NA	
ENSG00000242190	AC017015.2	NA	
ENSG00000242009	AC129807.1	NA	
ENSG00000239440	LINC02008	NA	
ENSG00000241367	RPL7AP23	NA	
ENSG00000241095	CYP51A1P1	NA	
ENSG00000288004	AC023503.1	NA	
ENSG00000286567	AC092825.1	NA	
ENSG00000242195	SRRM1P2	NA	
ENSG00000287158	AC117464.1	NA	
ENSG00000242641	LINC00971	NA	
ENSG00000241776	AC117482.1	NA	
ENSG00000242339	LINC02025	NA	
ENSG00000287273	AC132660.2	NA	
ENSG00000175161	CADM2	NA	
ENSG00000264084	MIR5688	NA	
ENSG00000241648	CADM2-AS2	NA	
ENSG00000239519	CADM2-AS1	NA	
ENSG00000243915	THAP12P2	NA	
ENSG00000201410	AC107024.1	NA	
ENSG00000239767	AC108733.1	NA	
ENSG00000251773	RNU6-1129P	NA	
ENSG00000222934	RN7SKP284	NA	
ENSG00000241328	LINC02070	NA	
ENSG00000277746	AC108706.1	NA	
ENSG00000206538	VGLL3	NA	
ENSG00000241293	PPATP1	NA	
ENSG00000281392	LINC00506	NA	
ENSG00000264119	MIR4795	NA	
ENSG00000083937	CHMP2B	600795	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3;;DMT1; DEM;;DEMENTIA, FAMILIAL NONSPECIFIC
ENSG00000083937	CHMP2B	614696	AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED
ENSG00000064835	POU1F1	613038	PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1
ENSG00000239829	KRT8P25	NA	
ENSG00000240902	APOOP2	NA	
ENSG00000240255	PSMC1P6	NA	
ENSG00000239572	AC108749.1	NA	
ENSG00000200703	RNU6-873P	NA	
ENSG00000221059	RNU6ATAC6P	NA	
ENSG00000179097	HTR1F	NA	
ENSG00000163320	CGGBP1	NA	
ENSG00000175105	ZNF654	NA	
ENSG00000241535	CBX5P1	NA	
ENSG00000179021	C3orf38	NA	
ENSG00000242159	ABCF2P1	NA	
ENSG00000283434	CSNKA2IP	NA	
ENSG00000207316	Y_RNA	NA	
ENSG00000242365	NDUFA5P5	NA	
ENSG00000242705	ICE2P2	NA	
ENSG00000241861	GAPDHP50	NA	
ENSG00000044524	EPHA3	NA	
ENSG00000285780	AC109129.1	NA	
ENSG00000240951	MTCO2P6	NA	
ENSG00000240309	MTCO1P6	NA	
ENSG00000212598	U3	NA	
ENSG00000222490	RNU6-712P	NA	
ENSG00000189002	PROS2P	NA	
ENSG00000271024	HSPE1P19	NA	
ENSG00000283367	ABBA01000933.1	NA	
ENSG00000283544	ABBA01000935.2	NA	
ENSG00000251727	RNU6-488P	NA	
ENSG00000184500	PROS1	612336	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5
ENSG00000184500	PROS1	614514	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6
ENSG00000201339	Y_RNA	NA	
ENSG00000200366	RNU6-511P	NA	
ENSG00000169379	ARL13B	612291	JOUBERT SYNDROME 8; JBTS8
ENSG00000239614	HMGN1P7	NA	
ENSG00000178750	STX19	NA	
ENSG00000178700	DHFR2	NA	
ENSG00000178694	NSUN3	NA	
ENSG00000242457	RBBP4P2	NA	
ENSG00000178660	ARMC10P1	NA	
ENSG00000234629	WDR82P1	NA	
ENSG00000242911	AC140059.1	NA	
ENSG00000239589	LINC00879	NA	
ENSG00000244048	RPS18P6	NA	
ENSG00000244681	MTHFD2P1	NA	
ENSG00000286516	AC106719.1	NA	
ENSG00000271671	AC107304.1	NA	
ENSG00000243547	HNRNPKP4	NA	
ENSG00000278103	MIR8060	NA	
ENSG00000241815	AC107015.1	NA	
ENSG00000199286	RNU6-1094P	NA	
ENSG00000269028	MTRNR2L12	NA	
ENSG00000218754	RPL18AP8	NA	
ENSG00000241018	RCC2P5	NA	
ENSG00000176243	CDV3P1	NA	
ENSG00000286447	AC109782.1	NA	
ENSG00000080224	EPHA6	NA	
ENSG00000251172	AC117470.1	NA	
ENSG00000261292	AC110491.1	NA	
ENSG00000113966	ARL6	268000	RETINITIS PIGMENTOSA; RP
ENSG00000113966	ARL6	600151	BARDET-BIEDL SYNDROME 3; BBS3
ENSG00000113966	ARL6	613575	RETINITIS PIGMENTOSA 55; RP55
ENSG00000282527	AC110491.3	NA	
ENSG00000080200	CRYBG3	NA	
ENSG00000279658	AC110491.2	NA	
ENSG00000170854	RIOX2	NA	
ENSG00000285614	AC026100.1	NA	
ENSG00000183185	GABRR3	NA	
ENSG00000250750	OR5BM1P	NA	
ENSG00000213439	OR5AC1	NA	
ENSG00000196578	OR5AC2	NA	
ENSG00000249225	AC117460.1	NA	
ENSG00000251090	OR5AC4P	NA	
ENSG00000248365	POU5F1P7	NA	
ENSG00000231192	OR5H1	NA	
ENSG00000236032	OR5H14	NA	
ENSG00000233412	OR5H15	NA	
ENSG00000249321	OR5H5P	NA	
ENSG00000249975	OR5H3P	NA	
ENSG00000248507	OR5H4P	NA	
ENSG00000251088	AC117473.1	NA	
ENSG00000187900	OR5H7P	NA	
ENSG00000230301	OR5H6	NA	
ENSG00000197938	OR5H2	NA	
ENSG00000232535	OR5H8	NA	
ENSG00000196098	OR5K4	NA	
ENSG00000206536	OR5K3	NA	
ENSG00000244653	UBFD1P1	NA	
ENSG00000232382	OR5K1	NA	
ENSG00000231861	OR5K2	NA	
ENSG00000080822	CLDND1	NA	
ENSG00000285635	AC021660.3	NA	
ENSG00000248839	AC021660.2	NA	
ENSG00000250562	RPL38P4	NA	
ENSG00000154165	GPR15	NA	
ENSG00000286602	AC021660.4	NA	
ENSG00000080819	CPOX	121300	COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCY  HARDEROPORPHYRIA, INCLUDED
ENSG00000240827	AC021660.1	NA	
ENSG00000244153	WWP1P1	NA	
ENSG00000239445	ST3GAL6-AS1	NA	
ENSG00000064225	ST3GAL6	NA	
ENSG00000249274	PDLIM1P4	NA	
ENSG00000057019	DCBLD2	NA	
ENSG00000206712	RNU6-26P	NA	
ENSG00000239462	AC091212.1	NA	
ENSG00000207331	RNU6-1263P	NA	
ENSG00000240476	LINC00973	NA	
ENSG00000275108	U7	NA	
ENSG00000241305	ACTG1P13	NA	
ENSG00000240572	AC107297.1	NA	
ENSG00000243296	AC078828.1	NA	
ENSG00000243089	AC107029.1	NA	
ENSG00000244464	AC107029.2	NA	
ENSG00000144810	COL8A1	NA	
ENSG00000273374	AC069222.1	NA	
ENSG00000184220	CMSS1	NA	
ENSG00000168386	FILIP1L	NA	
ENSG00000264897	MIR3921	NA	
ENSG00000287378	AC129803.1	NA	
ENSG00000235156	TMEM30CP	NA	
ENSG00000277000	DUSP12P1	NA	
ENSG00000243974	VTI1BP1	NA	
ENSG00000036054	TBC1D23	617695	PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11
ENSG00000114021	NIT2	NA	
ENSG00000154174	TOMM70	NA	
ENSG00000206535	LNP1	NA	
ENSG00000181458	TMEM45A	NA	
ENSG00000144820	ADGRG7	NA	
ENSG00000252989	AC069223.1	NA	
ENSG00000243495	GMFBP1	NA	
ENSG00000114354	TFG	604484	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, PROXIMAL TYPE, FORMERLY; HMSNP, FORMERLY
ENSG00000114354	TFG	615658	SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57
ENSG00000154175	ABI3BP	NA	
ENSG00000213431	AC080014.1	NA	
ENSG00000201642	RNU6-865P	NA	
ENSG00000242573	ACTR3P3	NA	
ENSG00000081148	IMPG2	613581	RETINITIS PIGMENTOSA 56; RP56
ENSG00000081148	IMPG2	616152	MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5
ENSG00000138468	SENP7	NA	
ENSG00000241738	ZNF90P1	NA	
ENSG00000232830	AC110994.2	NA	
ENSG00000282978	AC110994.3	NA	
ENSG00000201554	AC110994.1	NA	
ENSG00000175841	FAM172BP	NA	
ENSG00000174173	TRMT10C	616974	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30; COXPD30
ENSG00000081154	PCNP	NA	
ENSG00000242299	AC073861.1	NA	
ENSG00000243396	AC084198.3	NA	
ENSG00000252348	RNU6-1256P	NA	
ENSG00000212319	AC084198.2	NA	
ENSG00000201511	AC084198.1	NA	
ENSG00000066422	ZBTB11	618383	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 69
ENSG00000201121	RNY1P12	NA	
ENSG00000256628	ZBTB11-AS1	NA	
ENSG00000114391	RPL24	NA	
ENSG00000286699	AC084198.4	NA	
ENSG00000244119	PDCL3P4	NA	
ENSG00000182504	CEP97	NA	
ENSG00000144815	NXPE3	NA	
ENSG00000249474	AC020651.1	NA	
ENSG00000144802	NFKBIZ	NA	
ENSG00000287682	AC020651.2	NA	
ENSG00000214407	LINC02085	NA	
ENSG00000202177	Y_RNA	NA	
ENSG00000241280	AC106712.1	NA	
ENSG00000170044	ZPLD1	NA	
ENSG00000241754	AC063938.1	NA	
ENSG00000201065	RNU6-461P	NA	
ENSG00000201922	RNU1-43P	NA	
ENSG00000236691	NDUFA4P2	NA	
ENSG00000265328	MIR548AB	NA	
ENSG00000240107	AC046144.1	NA	
ENSG00000243195	TUBBP11	NA	
ENSG00000214405	RAP1BP2	NA	
ENSG00000243635	AC091804.1	NA	
ENSG00000170017	ALCAM	NA	
ENSG00000114423	CBLB	NA	
ENSG00000287421	AC131237.1	NA	
ENSG00000244652	AC079382.1	NA	
ENSG00000286854	AC079382.2	NA	
ENSG00000242759	LINC00882	NA	
ENSG00000200610	Y_RNA	NA	
ENSG00000288557	AC080097.1	NA	
ENSG00000200361	Y_RNA	NA	
ENSG00000239997	FCF1P3	NA	
ENSG00000241787	MTND4P16	NA	
ENSG00000239632	MTND4LP3	NA	
ENSG00000242214	MTND3P6	NA	
ENSG00000242836	MTCO3P35	NA	
ENSG00000249580	MTATP6P22	NA	
ENSG00000243658	MTND5P16	NA	
ENSG00000240034	MTND6P6	NA	
ENSG00000250630	MTCO1P35	NA	
ENSG00000239586	MTND1P16	NA	
ENSG00000240796	MTND2P14	NA	
ENSG00000252626	RNU6-1308P	NA	
ENSG00000286956	AC117435.1	NA	
ENSG00000239455	AC074043.1	NA	
ENSG00000243701	DUBR	NA	
ENSG00000239828	AC063944.1	NA	
ENSG00000241218	CSP2	NA	
ENSG00000272597	AC063944.2	NA	
ENSG00000138483	CCDC54	NA	
ENSG00000273125	LINC01990	NA	
ENSG00000114439	BBX	NA	
ENSG00000240423	LINC00636	NA	
ENSG00000241469	LINC00635	NA	
ENSG00000279277	AC012020.1	NA	
ENSG00000196776	CD47	NA	
ENSG00000271856	LINC01215	NA	
ENSG00000114446	IFT57	617927	OROFACIODIGITAL SYNDROME XVIII; OFD18;;OFDS XVIII;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE XVIII
ENSG00000114455	HHLA2	NA	
ENSG00000243188	HNRNPA1P17	NA	
ENSG00000144821	MYH15	NA	
ENSG00000241634	AC069499.1	NA	
ENSG00000163507	CIP2A	NA	
ENSG00000202379	SNORA70	NA	
ENSG00000276763	AC069499.2	NA	
ENSG00000198919	DZIP3	NA	
ENSG00000241777	AC092185.1	NA	
ENSG00000163515	RETNLB	NA	
ENSG00000163519	TRAT1	NA	
ENSG00000138472	GUCA1C	NA	
ENSG00000114487	MORC1	NA	
ENSG00000221633	U3	NA	
ENSG00000239314	MORC1-AS1	NA	
ENSG00000241224	C3orf85	NA	
ENSG00000261364	AC063923.2	NA	
ENSG00000214381	LINC00488	NA	
ENSG00000252889	RNU6-1236P	NA	
ENSG00000239288	AC063923.1	NA	
ENSG00000163530	DPPA2	NA	
ENSG00000277635	Metazoa_SRP	NA	
ENSG00000121570	DPPA4	NA	
ENSG00000241257	AC124945.1	NA	
ENSG00000244561	AC092905.1	NA	
ENSG00000230618	H3P12	NA	
ENSG00000228980	LINC01205	NA	
ENSG00000244196	PPIAP15	NA	
ENSG00000265956	MIR4445	NA	
ENSG00000242029	AC078980.1	NA	
ENSG00000271249	DIMT1P1	NA	
ENSG00000214380	NFYBP1	NA	
ENSG00000243945	AC078918.1	NA	
ENSG00000240895	AC117430.1	NA	
ENSG00000221206	RNU6ATAC15P	NA	
ENSG00000244722	RPSAP29	NA	
ENSG00000201426	Y_RNA	NA	
ENSG00000242242	NECTIN3-AS1	NA	
ENSG00000177707	NECTIN3	NA	
ENSG00000153283	CD96	211750	C SYNDROME;;OPITZ TRIGONOCEPHALY SYNDROME;;TRIGONOCEPHALY SYNDROME
ENSG00000239311	AC092916.1	NA	
ENSG00000244142	ATP6V0CP2	NA	
ENSG00000240787	AC092916.2	NA	
ENSG00000177494	ZBED2	NA	
ENSG00000244720	NT5C3AP2	NA	
ENSG00000240891	PLCXD2	NA	
ENSG00000240766	PLCXD2-AS1	NA	
ENSG00000144824	PHLDB2	NA	
ENSG00000286492	AC117509.1	NA	
ENSG00000144827	ABHD10	NA	
ENSG00000144834	TAGLN3	NA	
ENSG00000239439	RFKP2	NA	
ENSG00000176040	TMPRSS7	NA	
ENSG00000114529	C3orf52	NA	
ENSG00000207940	MIR567	NA	
ENSG00000174500	GCSAM	NA	
ENSG00000261488	TBILA	NA	
ENSG00000172139	SLC9C1	NA	
ENSG00000244144	AC128688.1	NA	
ENSG00000239482	AC112487.1	NA	
ENSG00000283669	AC112487.2	NA	
ENSG00000091972	CD200	NA	
ENSG00000243081	AC092894.1	NA	
ENSG00000186265	BTLA	NA	
ENSG00000242525	OR7E100P	NA	
ENSG00000279349	AC092692.1	NA	
ENSG00000144848	ATG3	NA	
ENSG00000138459	SLC35A5	NA	
ENSG00000091986	CCDC80	NA	
ENSG00000242308	AC048334.1	NA	
ENSG00000240893	LINC02042	NA	
ENSG00000242770	CD200R1L-AS1	NA	
ENSG00000206531	CD200R1L	NA	
ENSG00000163606	CD200R1	NA	
ENSG00000272844	AC074044.1	NA	
ENSG00000163607	GTPBP8	NA	
ENSG00000163608	NEPRO	NA	
ENSG00000240057	AC078785.1	NA	
ENSG00000243483	AC078785.3	NA	
ENSG00000241219	AC078785.2	NA	
ENSG00000243795	LINC02044	NA	
ENSG00000144857	BOC	NA	
ENSG00000288079	AC026329.1	NA	
ENSG00000206530	CFAP44	617593	SPERMATOGENIC FAILURE 20; SPGF20
ENSG00000240751	AC026348.1	NA	
ENSG00000285943	AC112128.1	NA	
ENSG00000243849	CFAP44-AS1	NA	
ENSG00000275670	MIR8076	NA	
ENSG00000163611	SPICE1	NA	
ENSG00000072858	SIDT1	NA	
ENSG00000239453	SIDT1-AS1	NA	
ENSG00000265253	MIR4446	NA	
ENSG00000241529	RN7SL767P	NA	
ENSG00000176542	USF3	NA	
ENSG00000121579	NAA50	NA	
ENSG00000239280	AC108693.1	NA	
ENSG00000114573	ATP6V1A	617403	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D
ENSG00000114573	ATP6V1A	618012	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3
ENSG00000242659	AC108693.2	NA	
ENSG00000178075	GRAMD1C	NA	
ENSG00000240776	AC079944.1	NA	
ENSG00000241889	AC079944.2	NA	
ENSG00000240375	VPS26AP1	NA	
ENSG00000273394	AC128687.2	NA	
ENSG00000184307	ZDHHC23	NA	
ENSG00000163617	CCDC191	NA	
ENSG00000270880	AC128687.1	NA	
ENSG00000287805	AC128687.3	NA	
ENSG00000285836	AC092896.1	NA	
ENSG00000151576	QTRT2	NA	
ENSG00000240912	H2BP3	NA	
ENSG00000151577	DRD3	181500	SCHIZOPHRENIA; SCZD;;SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000151577	DRD3	190300	TREMOR, HEREDITARY ESSENTIAL, 1; ETM1;;TREMOR, FAMILIAL ESSENTIAL, 1; FET1
ENSG00000241490	AC093010.1	NA	
ENSG00000240487	FAM214BP1	NA	
ENSG00000174255	ZNF80	NA	
ENSG00000181847	TIGIT	NA	
ENSG00000181722	ZBTB20	259050	PRIMROSE SYNDROME; PRIMS;;OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND BONY CHANGES
ENSG00000259976	AC093010.2	NA	
ENSG00000284134	MIR568	NA	
ENSG00000241560	ZBTB20-AS1	NA	
ENSG00000242290	ZBTB20-AS5	NA	
ENSG00000241295	ZBTB20-AS2	NA	
ENSG00000264623	MIR4796	NA	
ENSG00000239946	ZBTB20-AS3	NA	
ENSG00000240002	YBX1P3	NA	
ENSG00000242767	ZBTB20-AS4	NA	
ENSG00000242880	AC026341.1	NA	
ENSG00000244157	EIF4E2P2	NA	
ENSG00000287795	AC026341.2	NA	
ENSG00000288074	AC026341.3	NA	
ENSG00000172020	GAP43	NA	
ENSG00000241596	AC092468.1	NA	
ENSG00000185565	LSAMP	NA	
ENSG00000243359	RN7SL815P	NA	
ENSG00000240922	LSAMP-AS1	NA	
ENSG00000241397	LINC00903	NA	
ENSG00000241156	RN7SL582P	NA	
ENSG00000198406	BZW1P2	NA	
ENSG00000243197	TUSC7	NA	
ENSG00000278072	AC108713.1	NA	
ENSG00000265433	MIR4447	NA	
ENSG00000274732	AC069504.1	NA	
ENSG00000242385	LINC00901	NA	
ENSG00000200372	RNU5E-8P	NA	
ENSG00000243014	PTMAP8	NA	
ENSG00000206889	RNU6-1200P	NA	
ENSG00000239268	AC092691.1	NA	
ENSG00000240393	AC092691.2	NA	
ENSG00000241213	LINC02024	NA	
ENSG00000242816	AC092691.3	NA	
ENSG00000243276	AC068633.1	NA	
ENSG00000286660	AC068633.2	NA	
ENSG00000144847	IGSF11	NA	
ENSG00000239877	IGSF11-AS1	NA	
ENSG00000163424	TEX55	NA	
ENSG00000251012	AC083800.1	NA	
ENSG00000114638	UPK1B	NA	
ENSG00000121578	B4GALT4	NA	
ENSG00000240254	B4GALT4-AS1	NA	
ENSG00000031081	ARHGAP31	100300	ADAMS-OLIVER SYNDROME 1; AOS1;;AOS;;ABSENCE DEFECT OF LIMBS, SCALP, AND SKULL;;CONGENITAL SCALP DEFECTS WITH DISTAL LIMB REDUCTION ANOMALIES;;APLASIA CUTIS CONGENITA WITH TERMINAL TRANSVERSE LIMB DEFECTS APLASIA CUTIS CONGENITA, CONGENITAL HEART DEF /.../ND FRONTONASAL CYSTS, INCLUDED
ENSG00000242829	RPS26P21	NA	
ENSG00000241155	ARHGAP31-AS1	NA	
ENSG00000207310	RNU6-1127P	NA	
ENSG00000176142	TMEM39A	NA	
ENSG00000163389	POGLUT1	615696	DOWLING-DEGOS DISEASE 4; DDD4
ENSG00000163389	POGLUT1	617232	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21; LGMDR21;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z; LGMD2Z
ENSG00000272662	AC073352.1	NA	
ENSG00000113845	TIMMDC1	618251	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31
ENSG00000121594	CD80	NA	
ENSG00000272967	AC073352.2	NA	
ENSG00000144843	ADPRH	NA	
ENSG00000144837	PLA1A	NA	
ENSG00000242052	RPL10P7	NA	
ENSG00000121577	POPDC2	NA	
ENSG00000138495	COX17	NA	
ENSG00000286584	AC023494.1	NA	
ENSG00000183833	CFAP91	NA	
ENSG00000285585	AC069444.2	NA	
ENSG00000239994	AC069444.1	NA	
ENSG00000144852	NR1I2	NA	
ENSG00000240471	PHBP8	NA	
ENSG00000082701	GSK3B	NA	
ENSG00000239835	AC092910.1	NA	
ENSG00000241546	AC092910.2	NA	
ENSG00000242622	AC092910.3	NA	
ENSG00000244308	RN7SL762P	NA	
ENSG00000244139	RN7SL397P	NA	
ENSG00000175697	GPR156	NA	
ENSG00000206721	Y_RNA	NA	
ENSG00000240882	AC063952.2	NA	
ENSG00000163428	LRRC58	NA	
ENSG00000240661	AC063952.1	NA	
ENSG00000282950	AC063952.4	NA	
ENSG00000242613	AC063952.3	NA	
ENSG00000163430	FSTL1	NA	
ENSG00000284121	MIR198	NA	
ENSG00000286735	AC126182.3	NA	
ENSG00000240774	AC126182.1	NA	
ENSG00000244441	AC126182.2	NA	
ENSG00000065518	NDUFB4	NA	
ENSG00000113924	HGD	203500	ALKAPTONURIA; AKU;;HOMOGENTISIC ACID OXIDASE DEFICIENCY
ENSG00000144840	RABL3	618680	PANCREATIC CANCER, SUSCEPTIBILITY TO, 5; PNCA5
ENSG00000240452	MTCO1P29	NA	
ENSG00000243257	MTCO2P29	NA	
ENSG00000153767	GTF2E1	NA	
ENSG00000213371	NAP1L1P3	NA	
ENSG00000286827	AC072026.2	NA	
ENSG00000243593	LINC02049	NA	
ENSG00000287366	AC072026.3	NA	
ENSG00000145087	STXBP5L	NA	
ENSG00000270782	AC072026.1	NA	
ENSG00000264477	MIR5682	NA	
ENSG00000243813	AC078857.1	NA	
ENSG00000242103	AC079841.1	NA	
ENSG00000287022	AC079841.2	NA	
ENSG00000051341	POLQ	NA	
ENSG00000242445	RPL7AP11	NA	
ENSG00000186103	ARGFX	NA	
ENSG00000163833	FBXO40	NA	
ENSG00000180353	HCLS1	NA	
ENSG00000243544	RN7SL172P	NA	
ENSG00000222057	RNU4-62P	NA	
ENSG00000173230	GOLGB1	NA	
ENSG00000173226	IQCB1	609254	SENIOR-LOKEN SYNDROME 5; SLSN5
ENSG00000145088	EAF2	NA	
ENSG00000163406	SLC15A2	NA	
ENSG00000145103	ILDR1	609646	DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42
ENSG00000202388	Y_RNA	NA	
ENSG00000114013	CD86	NA	
ENSG00000287977	AC068630.1	NA	
ENSG00000036828	CASR	145980	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1;;HHC; FHH;;FHH1;;FAMILIAL BENIGN HYPERCALCEMIA 1; FBH1;;HYPERCALCEMIA, FAMILIAL BENIGN HYPOCALCIURIC HYPERCALCEMIA, ACQUIRED, INCLUDED
ENSG00000036828	CASR	239200	HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT;;NSPH; NHPT;;HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY
ENSG00000036828	CASR	601198	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1; HYPOC1;;HYPERCALCIURIC HYPOCALCEMIA;;HYPOCALCEMIA, FAMILIAL HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME, INCLUDED
ENSG00000036828	CASR	612899	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8
ENSG00000240236	HNRNPA1P23	NA	
ENSG00000121552	CSTA	607936	PEELING SKIN SYNDROME 4; PSS4;;ICHTHYOSIS BULLOSA OF SIEMENS-LIKE;;ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE; AREI
ENSG00000160124	CCDC58	NA	
ENSG00000114023	FAM162A	NA	
ENSG00000196981	WDR5B	NA	
ENSG00000272758	AC083798.2	NA	
ENSG00000242531	AC083798.1	NA	
ENSG00000114030	KPNA1	NA	
ENSG00000275348	AC096861.1	NA	
ENSG00000287207	AC096861.2	NA	
ENSG00000138496	PARP9	NA	
ENSG00000163840	DTX3L	NA	
ENSG00000173200	PARP15	NA	
ENSG00000243918	EIF4BP8	NA	
ENSG00000173193	PARP14	NA	
ENSG00000169087	HSPBAP1	NA	
ENSG00000138463	SLC49A4	NA	
ENSG00000273033	LINC02035	NA	
ENSG00000082684	SEMA5B	NA	
ENSG00000065485	PDIA5	NA	
ENSG00000284421	MIR7110	NA	
ENSG00000121542	SEC22A	NA	
ENSG00000273454	AC112503.2	NA	
ENSG00000173175	ADCY5	606703	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM
ENSG00000272678	AC112503.1	NA	
ENSG00000206527	HACD2	NA	
ENSG00000239523	MYLK-AS1	NA	
ENSG00000065534	MYLK	613780	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7;;AORTIC DISSECTION, FAMILIAL, WITH OR WITHOUT AORTIC ANEURYSM
ENSG00000250174	MYLK-AS2	NA	
ENSG00000273123	AC020634.2	NA	
ENSG00000207002	AC020634.1	NA	
ENSG00000175455	CCDC14	NA	
ENSG00000065371	ROPN1	NA	
ENSG00000160145	KALRN	NA	
ENSG00000266383	MIR5002	NA	
ENSG00000240622	RPL7P15	NA	
ENSG00000276656	MIR6083	NA	
ENSG00000252751	RNU6-143P	NA	
ENSG00000260391	AC022336.2	NA	
ENSG00000114491	UMPS	258900	OROTIC ACIDURIA;;OROTIC ACIDURIA I;;OROTATE PHOSPHORIBOSYLTRANSFERASE AND OROTIDYLIC DECARBOXYLASE DEFICIENCY;;OPRT AND ODC DEFICIENCY;;OROTIDYLIC PYROPHOSPHORYLASE AND OROTIDYLIC DECARBOXYLASE DEFICIENCY;;URIDINE MONOPHOSPHATE SYNTHASE DEFICIENCY;; /.../NTHASE DEFICIENCY;;UMPS DEFICIENCY OROTIC ACIDURIA WITHOUT MEGALOBLASTIC ANEMIA, INCLUDED; OAWA, INCLUDED
ENSG00000265981	MIR544B	NA	
ENSG00000242199	AC022336.1	NA	
ENSG00000082781	ITGB5	NA	
ENSG00000244286	ITGB5-AS1	NA	
ENSG00000280042	AC022336.3	NA	
ENSG00000276626	7SK	NA	
ENSG00000243986	ENO1P3	NA	
ENSG00000173702	MUC13	NA	
ENSG00000173706	HEG1	NA	
ENSG00000252642	RNA5SP137	NA	
ENSG00000288022	AC117488.1	NA	
ENSG00000221955	SLC12A8	NA	
ENSG00000199327	RNU6-230P	NA	
ENSG00000264986	MIR5092	NA	
ENSG00000163848	ZNF148	617260	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF
ENSG00000229048	DUTP1	NA	
ENSG00000243508	DNAJB6P7	NA	
ENSG00000252953	RNU6-232P	NA	
ENSG00000114520	SNX4	NA	
ENSG00000201800	Y_RNA	NA	
ENSG00000252965	Y_RNA	NA	
ENSG00000144909	OSBPL11	NA	
ENSG00000243072	AF186996.3	NA	
ENSG00000242001	AF186996.2	NA	
ENSG00000234458	OR7E130P	NA	
ENSG00000243429	OR7E29P	NA	
ENSG00000228963	OR7E93P	NA	
ENSG00000239978	OR7E53P	NA	
ENSG00000179170	OR7E97P	NA	
ENSG00000239432	AF186996.1	NA	
ENSG00000284624	AC092902.4	NA	
ENSG00000284660	AC092902.5	NA	
ENSG00000272840	AC092902.2	NA	
ENSG00000239804	AC092902.1	NA	
ENSG00000221737	MIR548I1	NA	
ENSG00000242229	RPS3AP14	NA	
ENSG00000287617	AC092902.6	NA	
ENSG00000241346	SNRPCP11	NA	
ENSG00000241288	LINC02614	NA	
ENSG00000241278	ENPP7P4	NA	
ENSG00000248787	AC092903.2	NA	
ENSG00000171084	FAM86JP	NA	
ENSG00000189366	ALG1L	NA	
ENSG00000241439	AC092903.1	NA	
ENSG00000114547	ROPN1B	NA	
ENSG00000114544	SLC41A3	NA	
ENSG00000248607	AC117422.1	NA	
ENSG00000250012	AC079848.1	NA	
ENSG00000144908	ALDH1L1	NA	
ENSG00000250218	ALDH1L1-AS1	NA	
ENSG00000272020	RNU1-30P	NA	
ENSG00000246022	ALDH1L1-AS2	NA	
ENSG00000287232	AC079848.2	NA	
ENSG00000250934	AC016924.1	NA	
ENSG00000251448	AC063919.1	NA	
ENSG00000287440	AC063919.2	NA	
ENSG00000163884	KLF15	NA	
ENSG00000249833	CCDC37-DT	NA	
ENSG00000163885	CFAP100	NA	
ENSG00000279328	AC073439.1	NA	
ENSG00000070476	ZXDC	NA	
ENSG00000159650	UROC1	276880	UROCANASE DEFICIENCY; UROCD
ENSG00000180767	CHST13	NA	
ENSG00000180697	C3orf22	NA	
ENSG00000201968	RNA5SP138	NA	
ENSG00000288436	AC024558.2	NA	
ENSG00000197763	TXNRD3	NA	
ENSG00000248557	AC024558.1	NA	
ENSG00000198284	NUP210P1	NA	
ENSG00000248850	AC078867.1	NA	
ENSG00000159685	CHCHD6	NA	
ENSG00000249558	RCC2P4	NA	
ENSG00000280053	AC011199.1	NA	
ENSG00000114554	PLXNA1	NA	
ENSG00000287784	AC112482.2	NA	
ENSG00000214324	C3orf56	NA	
ENSG00000212556	Y_RNA	NA	
ENSG00000243016	AC112482.1	NA	
ENSG00000201288	RNU6-1047P	NA	
ENSG00000286919	AC133681.1	NA	
ENSG00000239620	PRR20G	NA	
ENSG00000244215	LINC02016	NA	
ENSG00000239921	LINC01471	NA	
ENSG00000240562	AC016968.1	NA	
ENSG00000282975	LINC02034	NA	
ENSG00000163870	TPRA1	NA	
ENSG00000282860	AC084035.1	NA	
ENSG00000275067	MIR6825	NA	
ENSG00000276083	MIR7976	NA	
ENSG00000073111	MCM2	616968	DEAFNESS, AUTOSOMAL DOMINANT 70; DFNA70
ENSG00000285600	AC023593.1	NA	
ENSG00000114631	PODXL2	NA	
ENSG00000114626	ABTB1	NA	
ENSG00000074416	MGLL	NA	
ENSG00000287143	AC117480.1	NA	
ENSG00000187715	KBTBD12	NA	
ENSG00000201210	RNA5SP139	NA	
ENSG00000058262	SEC61A1	617056	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4
ENSG00000175792	RUVBL1	NA	
ENSG00000222627	RNU2-37P	NA	
ENSG00000239608	RUVBL1-AS1	NA	
ENSG00000212344	RNU6-823P	NA	
ENSG00000132394	EEFSEC	NA	
ENSG00000285619	AL449214.1	NA	
ENSG00000179407	DNAJB8	NA	
ENSG00000242049	DNAJB8-AS1	NA	
ENSG00000179348	GATA2	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000179348	GATA2	614038	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA;;EMBERGER SYNDROME
ENSG00000179348	GATA2	614172	IMMUNODEFICIENCY 21; IMD21;;DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY; DCML;;MONOCYTOPENIA AND MYCOBACTERIAL INFECTION SYNDROME; MONOMAC;;MONOCYTOPENIA WITH SUSCEPTIBILITY TO MYCOBACTERIAL, FUNGAL, AND PAPILLOM /.../ INFECTIONS AND MYELODYSPLASIA;;COMBINED IMMUNODEFICIENCY WITH SUSCEPTIBILITY TO MYCOBACTERIAL, VIRAL, AND FUNGAL INFECTIONS;;GATA2 DEFICIENCY
ENSG00000179348	GATA2	614286	MYELODYSPLASTIC SYNDROME; MDS;;MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED
ENSG00000244300	GATA2-AS1	NA	
ENSG00000239405	TMED10P2	NA	
ENSG00000286806	AC080005.1	NA	
ENSG00000198685	LINC01565	NA	
ENSG00000163902	RPN1	NA	
ENSG00000277250	AC079945.2	NA	
ENSG00000242551	POU5F1P6	NA	
ENSG00000075785	RAB7A	600882	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B;;CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2B;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2B;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IIB; HMSN IIB;;HMSN2B
ENSG00000207130	AC079945.1	NA	
ENSG00000239503	MARK2P8	NA	
ENSG00000242992	FTH1P4	NA	
ENSG00000244232	RN7SL698P	NA	
ENSG00000239483	RPS15AP16	NA	
ENSG00000244065	MARK2P17	NA	
ENSG00000243022	MARK3P3	NA	
ENSG00000242062	MARK2P6	NA	
ENSG00000261159	AC112484.3	NA	
ENSG00000231305	AC112484.1	NA	
ENSG00000250796	AC112484.2	NA	
ENSG00000287110	AC112484.5	NA	
ENSG00000177646	ACAD9	611126	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20;;MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY;;ACYL-CoA DEHYDROGENASE 9 DEFICIENCY;;ACAD9 DEFICIENCY
ENSG00000114656	CFAP92	NA	
ENSG00000279507	AC112484.4	NA	
ENSG00000114654	EFCC1	NA	
ENSG00000249505	AC108673.1	NA	
ENSG00000169704	GP9	231200	BERNARD-SOULIER SYNDROME; BSS;;BLEEDING DISORDER, PLATELET-TYPE, 1; BDPLT1;;PLATELET GLYCOPROTEIN Ib DEFICIENCY;;GLYCOPROTEIN Ib, PLATELET, DEFICIENCY OF;;VON WILLEBRAND FACTOR RECEPTOR DEFICIENCY BERNARD-SOULIER SYNDROME, TYPE A1, INCLUDED;;BERNARD /.../ER SYNDROME, TYPE B, INCLUDED;;BERNARD-SOULIER SYNDROME, TYPE C, INCLUDED
ENSG00000172780	RAB43	NA	
ENSG00000261796	ISY1-RAB43	NA	
ENSG00000273174	AC108673.2	NA	
ENSG00000240682	ISY1	NA	
ENSG00000273437	AC108673.3	NA	
ENSG00000169714	CNBP	602668	MYOTONIC DYSTROPHY 2; DM2;;DYSTROPHIA MYOTONICA 2;;PROXIMAL MYOTONIC MYOPATHY; PROMM;;MYOTONIC MYOPATHY, PROXIMAL;;RICKER SYNDROME
ENSG00000241673	RPS27P12	NA	
ENSG00000181789	COPG1	NA	
ENSG00000278658	MIR6826	NA	
ENSG00000286729	AC137695.3	NA	
ENSG00000183624	HMCES	NA	
ENSG00000184897	H1-10	NA	
ENSG00000206417	H1-10-AS1	NA	
ENSG00000248916	NUP210P3	NA	
ENSG00000270492	AC137695.1	NA	
ENSG00000270773	AC137695.2	NA	
ENSG00000244932	AL449212.1	NA	
ENSG00000251474	RPL32P3	NA	
ENSG00000207088	SNORA7B	NA	
ENSG00000172771	EFCAB12	NA	
ENSG00000129071	MBD4	NA	
ENSG00000163913	IFT122	218330	CRANIOECTODERMAL DYSPLASIA 1; CED1;;SENSENBRENNER SYNDROME;;LEVIN SYNDROME I
ENSG00000163914	RHO	136880	FUNDUS ALBIPUNCTATUS RETINITIS PUNCTATA ALBESCENS, INCLUDED
ENSG00000163914	RHO	610445	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1;;NIGHT BLINDNESS, CONGENITAL STATIONARY, RHODOPSIN-RELATED
ENSG00000163914	RHO	613731	RETINITIS PIGMENTOSA 4; RP4;;RETINITIS PIGMENTOSA, RHODOPSIN-RELATED
ENSG00000178804	H1-8	NA	
ENSG00000004399	PLXND1	NA	
ENSG00000239437	RN7SL752P	NA	
ENSG00000248659	AC023162.1	NA	
ENSG00000172765	TMCC1	NA	
ENSG00000202412	RNY3P13	NA	
ENSG00000283509	U6	NA	
ENSG00000203644	AC083799.1	NA	
ENSG00000271270	TMCC1-AS1	NA	
ENSG00000250643	AC083906.3	NA	
ENSG00000170893	TRH	275120	THYROTROPIN-RELEASING HORMONE DEFICIENCY;;TRH DEFICIENCY;;HYPOTHALAMIC HYPOTHYROIDISM
ENSG00000248459	AC083906.1	NA	
ENSG00000284731	AC083906.5	NA	
ENSG00000249869	AC083906.2	NA	
ENSG00000180770	OR7E129P	NA	
ENSG00000251178	OR7E21P	NA	
ENSG00000251610	AC083906.4	NA	
ENSG00000251287	ALG1L2	NA	
ENSG00000248243	LINC02014	NA	
ENSG00000253540	FAM86HP	NA	
ENSG00000249846	LINC02021	NA	
ENSG00000248618	ENPP7P3	NA	
ENSG00000288111	AC130888.1	NA	
ENSG00000250580	SNRPCP8	NA	
ENSG00000228252	COL6A4P2	NA	
ENSG00000249253	AC093004.1	NA	
ENSG00000172752	COL6A5	NA	
ENSG00000206384	COL6A6	NA	
ENSG00000196455	PIK3R4	NA	
ENSG00000222783	RN7SKP212	NA	
ENSG00000285631	AC097105.1	NA	
ENSG00000232829	GSTO3P	NA	
ENSG00000017260	ATP2C1	169600	BENIGN CHRONIC PEMPHIGUS; BCPM;;PEMPHIGUS, BENIGN FAMILIAL;;HAILEY-HAILEY DISEASE; HHD
ENSG00000284095	AC055733.5	NA	
ENSG00000250592	AC055733.2	NA	
ENSG00000252894	AC055733.4	NA	
ENSG00000249098	AC055733.1	NA	
ENSG00000251579	AC055733.3	NA	
ENSG00000034533	ASTE1	NA	
ENSG00000114670	NEK11	NA	
ENSG00000250129	AC116424.1	NA	
ENSG00000201550	RNU6-726P	NA	
ENSG00000250608	AC010210.1	NA	
ENSG00000246082	NUDT16P1	NA	
ENSG00000198585	NUDT16	NA	
ENSG00000261167	AC107027.3	NA	
ENSG00000114686	MRPL3	614582	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9
ENSG00000249020	SNORA58	NA	
ENSG00000248468	AC107027.1	NA	
ENSG00000248530	BCL2L12P1	NA	
ENSG00000196353	CPNE4	NA	
ENSG00000251447	AC107027.2	NA	
ENSG00000265859	MIR5704	NA	
ENSG00000240854	PSMC2P1	NA	
ENSG00000242899	RPL7P16	NA	
ENSG00000014257	ACP3	NA	
ENSG00000240890	AC020633.1	NA	
ENSG00000213264	NIP7P2	NA	
ENSG00000138246	DNAJC13	NA	
ENSG00000240303	ACAD11	NA	
ENSG00000274810	NPHP3-ACAD11	NA	
ENSG00000129048	ACKR4	NA	
ENSG00000251614	HSPA8P19	NA	
ENSG00000081307	UBA5	617132	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44; EIEE44
ENSG00000081307	UBA5	617133	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24
ENSG00000113971	NPHP3	208540	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1;;RHPD
ENSG00000113971	NPHP3	267010	MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME
ENSG00000113971	NPHP3	604387	NEPHRONOPHTHISIS 3; NPHP3;;NPH3
ENSG00000248724	NPHP3-AS1	NA	
ENSG00000249725	AC079942.1	NA	
ENSG00000144868	TMEM108	NA	
ENSG00000251011	TMEM108-AS1	NA	
ENSG00000170819	BFSP2	611597	CATARACT 12, MULTIPLE TYPES; CTRCT12
ENSG00000249820	AC055753.1	NA	
ENSG00000249993	BFSP2-AS1	NA	
ENSG00000214301	AC022296.2	NA	
ENSG00000272832	AC022296.4	NA	
ENSG00000250983	AC022296.3	NA	
ENSG00000201827	AC022296.1	NA	
ENSG00000091527	CDV3	NA	
ENSG00000163781	TOPBP1	NA	
ENSG00000242337	INHCAP	NA	
ENSG00000252641	RNU6-678P	NA	
ENSG00000201394	RNA5SP140	NA	
ENSG00000091513	TF	209300	ATRANSFERRINEMIA;;HYPOTRANSFERRINEMIA, FAMILIAL  TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1, INCLUDED; TFQTL1, INCLUDED
ENSG00000244062	AC080128.1	NA	
ENSG00000144867	SRPRB	NA	
ENSG00000285908	AC080128.2	NA	
ENSG00000154917	RAB6B	NA	
ENSG00000288547	C3orf36	NA	
ENSG00000174640	SLCO2A1	614441	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2;;PACHYDERMOPERIOSTOSIS, AUTOSOMAL RECESSIVE;;PDP, AUTOSOMAL RECESSIVE
ENSG00000243832	LINC02000	NA	
ENSG00000163785	RYK	NA	
ENSG00000231845	HMGB3P14	NA	
ENSG00000240006	LINC02004	NA	
ENSG00000260633	AC010207.1	NA	
ENSG00000214289	RPL39P5	NA	
ENSG00000114019	AMOTL2	NA	
ENSG00000277723	MIR6827	NA	
ENSG00000248377	HMGN1P9	NA	
ENSG00000214288	HMGB3P13	NA	
ENSG00000284561	MIR4788	NA	
ENSG00000129055	ANAPC13	NA	
ENSG00000182923	CEP63	614728	SECKEL SYNDROME 6; SCKL6
ENSG00000249691	AC026117.1	NA	
ENSG00000154928	EPHB1	NA	
ENSG00000174611	KY	617114	MYOPATHY, MYOFIBRILLAR, 7; MFM7
ENSG00000286982	AC016931.1	NA	
ENSG00000253087	RNU6-1174P	NA	
ENSG00000201413	RNA5SP141	NA	
ENSG00000240086	AC092969.1	NA	
ENSG00000242222	AC092989.1	NA	
ENSG00000241905	NDUFS6P1	NA	
ENSG00000073711	PPP2R3A	NA	
ENSG00000227267	AC072039.1	NA	
ENSG00000273455	AC072039.2	NA	
ENSG00000174579	MSL2	NA	
ENSG00000241438	TDGF1P6	NA	
ENSG00000244740	AC092991.1	NA	
ENSG00000114054	PCCB	606054	PROPIONIC ACIDEMIA;;PROPIONYL-CoA CARBOXYLASE DEFICIENCY;;PCC DEFICIENCY;;GLYCINEMIA, KETOTIC;;HYPERGLYCINEMIA WITH KETOACIDOSIS AND LEUKOPENIA;;KETOTIC HYPERGLYCINEMIA
ENSG00000118007	STAG1	617635	MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47
ENSG00000200571	RNU6-1284P	NA	
ENSG00000244101	HMGN1P10	NA	
ENSG00000252914	RNU6-789P	NA	
ENSG00000240695	AC117382.1	NA	
ENSG00000261758	AC117382.2	NA	
ENSG00000286915	AC096992.3	NA	
ENSG00000242968	AC096992.1	NA	
ENSG00000168917	SLC35G2	NA	
ENSG00000239213	NCK1-DT	NA	
ENSG00000273486	AC096992.2	NA	
ENSG00000158092	NCK1	NA	
ENSG00000214283	RAD51AP1P1	NA	
ENSG00000174564	IL20RB	NA	
ENSG00000249407	IL20RB-AS1	NA	
ENSG00000201325	RNA5SP142	NA	
ENSG00000243886	AC117440.1	NA	
ENSG00000242070	NPM1P17	NA	
ENSG00000168875	SOX14	NA	
ENSG00000239513	LINC01210	NA	
ENSG00000261146	AC007159.1	NA	
ENSG00000241478	HSPA8P9	NA	
ENSG00000066405	CLDN18	NA	
ENSG00000272609	AC016252.1	NA	
ENSG00000158163	DZIP1L	617610	POLYCYSTIC KIDNEY DISEASE 5; PKD5
ENSG00000240668	KRT8P36	NA	
ENSG00000118017	A4GNT	NA	
ENSG00000286396	AC023049.1	NA	
ENSG00000138231	DBR1	NA	
ENSG00000114098	ARMC8	NA	
ENSG00000181322	NME9	NA	
ENSG00000158186	MRAS	618499	NOONAN SYNDROME 11; NS11
ENSG00000158220	ESYT3	NA	
ENSG00000280399	AC022497.1	NA	
ENSG00000114107	CEP70	NA	
ENSG00000158234	FAIM	NA	
ENSG00000174715	PPIAP72	NA	
ENSG00000051382	PIK3CB	NA	
ENSG00000239207	GAPDHP39	NA	
ENSG00000242321	RPL23AP40	NA	
ENSG00000241429	EEF1A1P25	NA	
ENSG00000242244	ATP5MC1P3	NA	
ENSG00000244578	LINC01391	NA	
ENSG00000183770	FOXL2	110100	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES BPES, TYPE I, INCLUDED;;BPES WITH OVARIAN FAILURE, INCLUDED;;BPES, TYPE II, INCLUDED;;BPES WITHOUT OVARIAN FAILURE, INCLUDED;;BPES WITH DUANE RETRACTION SYNDROME, INCLUDED
ENSG00000183770	FOXL2	608996	PREMATURE OVARIAN FAILURE 3; POF3
ENSG00000206262	FOXL2NB	NA	
ENSG00000206260	PRR23A	NA	
ENSG00000175110	MRPS22	611719	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5
ENSG00000175110	MRPS22	618117	OVARIAN DYSGENESIS 7; ODG7
ENSG00000184814	PRR23B	NA	
ENSG00000233701	PRR23C	NA	
ENSG00000251137	RPL7L1P7	NA	
ENSG00000232416	BPESC1	NA	
ENSG00000281473	PISRT1	NA	
ENSG00000276304	AC119740.1	NA	
ENSG00000286988	AC024933.2	NA	
ENSG00000272656	AC024933.1	NA	
ENSG00000184432	COPB2	617800	MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19
ENSG00000283418	U6	NA	
ENSG00000248932	AC046134.2	NA	
ENSG00000114113	RBP2	NA	
ENSG00000248790	AC097103.1	NA	
ENSG00000178631	ACTG1P1	NA	
ENSG00000114115	RBP1	NA	
ENSG00000163864	NMNAT3	NA	
ENSG00000214280	AC046134.1	NA	
ENSG00000201600	RN7SKP124	NA	
ENSG00000244692	RN7SL724P	NA	
ENSG00000261763	AC110716.2	NA	
ENSG00000250543	AC110716.1	NA	
ENSG00000251471	AC016933.1	NA	
ENSG00000250161	TRMT112P5	NA	
ENSG00000158258	CLSTN2	NA	
ENSG00000249290	AC010181.1	NA	
ENSG00000251058	AC010181.2	NA	
ENSG00000250433	CLSTN2-AS1	NA	
ENSG00000249305	AC048346.1	NA	
ENSG00000155890	TRIM42	NA	
ENSG00000261826	AC121333.1	NA	
ENSG00000224085	RPL23AP41	NA	
ENSG00000114120	SLC25A36	NA	
ENSG00000248773	AC108727.1	NA	
ENSG00000175093	SPSB4	NA	
ENSG00000251270	AC108727.2	NA	
ENSG00000155893	PXYLP1	NA	
ENSG00000287155	AC022215.2	NA	
ENSG00000241400	AC022215.1	NA	
ENSG00000249417	AC117383.1	NA	
ENSG00000249540	AC117383.2	NA	
ENSG00000177311	ZBTB38	NA	
ENSG00000288585	AC010184.1	NA	
ENSG00000215606	KRT18P35	NA	
ENSG00000155903	RASA2	NA	
ENSG00000250170	RASA2-IT1	NA	
ENSG00000249986	YWHAQP6	NA	
ENSG00000242104	LINC02618	NA	
ENSG00000241899	TPT1P3	NA	
ENSG00000241526	AC112771.1	NA	
ENSG00000114125	RNF7	NA	
ENSG00000285558	AC112504.2	NA	
ENSG00000114124	GRK7	NA	
ENSG00000286822	AC112504.3	NA	
ENSG00000228398	HMGN2P25	NA	
ENSG00000069849	ATP1B3	NA	
ENSG00000200389	RNU6-509P	NA	
ENSG00000244124	ATP1B3-AS1	NA	
ENSG00000279147	AC112504.1	NA	
ENSG00000114126	TFDP2	NA	
ENSG00000233597	AC133435.1	NA	
ENSG00000206604	RNU6-425P	NA	
ENSG00000175066	GK5	NA	
ENSG00000114127	XRN1	NA	
ENSG00000251804	RNU6-1294P	NA	
ENSG00000202125	RNU1-100P	NA	
ENSG00000175054	ATR	210600	SECKEL SYNDROME 1; SCKL1;;SCKL;;SECKEL-TYPE DWARFISM;;NANOCEPHALIC DWARFISM;;MICROCEPHALIC PRIMORDIAL DWARFISM I;;BIRD-HEADED DWARFISM
ENSG00000175054	ATR	614564	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS;;TELANGIECTASIA, CUTANEOUS, AND CANCER SYNDROME, FAMILIAL
ENSG00000242479	AC109992.1	NA	
ENSG00000244327	AC109992.2	NA	
ENSG00000242390	RPL6P9	NA	
ENSG00000252745	RNA5SP143	NA	
ENSG00000120756	PLS1	618787	DEAFNESS, AUTOSOMAL DOMINANT 76; DFNA76
ENSG00000239641	PLS1-AS1	NA	
ENSG00000199319	RN7SKP25	NA	
ENSG00000287045	AC072028.1	NA	
ENSG00000144935	TRPC1	NA	
ENSG00000251787	RNU7-47P	NA	
ENSG00000163710	PCOLCE2	NA	
ENSG00000240950	AC021074.1	NA	
ENSG00000243818	AC021074.3	NA	
ENSG00000188582	PAQR9	NA	
ENSG00000241592	AC021074.2	NA	
ENSG00000241570	PAQR9-AS1	NA	
ENSG00000163714	U2SURP	NA	
ENSG00000268129	AC026304.1	NA	
ENSG00000243733	AC018450.2	NA	
ENSG00000175040	CHST2	NA	
ENSG00000241679	AC018450.1	NA	
ENSG00000244171	PBX2P1	NA	
ENSG00000181804	SLC9A9	613410	AUTISM, SUSCEPTIBILITY TO, 16; AUTS16;;AUTISM WITH OR WITHOUT SEIZURES
ENSG00000240888	AC131210.1	NA	
ENSG00000240012	SLC9A9-AS1	NA	
ENSG00000244493	SLC9A9-AS2	NA	
ENSG00000243033	GAPDHP47	NA	
ENSG00000243759	ST13P15	NA	
ENSG00000248374	AC073358.1	NA	
ENSG00000235110	AC107421.1	NA	
ENSG00000181744	DIPK2A	NA	
ENSG00000222778	RNA5SP144	NA	
ENSG00000280397	AC011592.1	NA	
ENSG00000244024	LARP7P4	NA	
ENSG00000241695	GM2AP1	NA	
ENSG00000239797	RPL21P39	NA	
ENSG00000244358	AC055758.2	NA	
ENSG00000240095	AC055758.1	NA	
ENSG00000261051	AC107021.2	NA	
ENSG00000243415	AC107021.1	NA	
ENSG00000240032	LNCSRLR	NA	
ENSG00000152952	PLOD2	609220	BRUCK SYNDROME 2; BRKS2;;OSTEOGENESIS IMPERFECTA WITH CONGENITAL JOINT CONTRACTURES
ENSG00000114698	PLSCR4	NA	
ENSG00000243596	AC130509.1	NA	
ENSG00000241358	AC069528.1	NA	
ENSG00000163746	PLSCR2	NA	
ENSG00000279320	AC069528.2	NA	
ENSG00000188313	PLSCR1	NA	
ENSG00000199812	RNU6-428P	NA	
ENSG00000231213	PLSCR5	NA	
ENSG00000241457	PLSCR5-AS1	NA	
ENSG00000243620	AC092957.1	NA	
ENSG00000242671	LINC02010	NA	
ENSG00000207156	RNU6-505P	NA	
ENSG00000239412	RPL21P71	NA	
ENSG00000174963	ZIC4	NA	
ENSG00000241202	ZIC4-AS1	NA	
ENSG00000152977	ZIC1	616602	CRANIOSYNOSTOSIS 6; CRS6
ENSG00000152977	ZIC1	618736	STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS; BAIDCS
ENSG00000240804	NPM1P28	NA	
ENSG00000239661	AC092925.1	NA	
ENSG00000239922	AC092958.1	NA	
ENSG00000285798	AC092958.4	NA	
ENSG00000241131	LINC02032	NA	
ENSG00000285660	AC092958.3	NA	
ENSG00000241792	AC092958.2	NA	
ENSG00000244650	AC025566.1	NA	
ENSG00000205412	HNRNPA1P20	NA	
ENSG00000243347	LINC02045	NA	
ENSG00000242440	LINC02046	NA	
ENSG00000285557	AC069410.1	NA	
ENSG00000241993	RPL38P1	NA	
ENSG00000144891	AGTR1	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000144891	AGTR1	267430	RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROME  RENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED
ENSG00000153002	CPB1	NA	
ENSG00000244089	HMGB1P30	NA	
ENSG00000240521	AC092979.1	NA	
ENSG00000163751	CPA3	NA	
ENSG00000287198	AC092979.2	NA	
ENSG00000241627	UBQLN4P1	NA	
ENSG00000163754	GYG1	613507	GLYCOGEN STORAGE DISEASE XV; GSD15;;GSD XV;;GLYCOGENIN DEFICIENCY;;GYG1 DEFICIENCY
ENSG00000163754	GYG1	616199	POLYGLUCOSAN BODY MYOPATHY 2; PGBM2
ENSG00000071794	HLTF	NA	
ENSG00000239718	HLTF-AS1	NA	
ENSG00000201031	AC021059.1	NA	
ENSG00000240511	MED28P2	NA	
ENSG00000163755	HPS3	614072	HERMANSKY-PUDLAK SYNDROME 3; HPS3
ENSG00000047457	CP	604290	ACERULOPLASMINEMIA HYPOCERULOPLASMINEMIA, INCLUDED;;CERULOPLASMIN DEFICIENCY, INCLUDED;;HEMOSIDEROSIS, SYSTEMIC, DUE TO ACERULOPLASMINEMIA, INCLUDED
ENSG00000286714	AC093001.2	NA	
ENSG00000240216	CPHL1P	NA	
ENSG00000244468	AC093001.1	NA	
ENSG00000163762	TM4SF18	NA	
ENSG00000243822	AC073522.1	NA	
ENSG00000169908	TM4SF1	NA	
ENSG00000240541	TM4SF1-AS1	NA	
ENSG00000243885	AC108751.4	NA	
ENSG00000240246	AC108751.2	NA	
ENSG00000241929	AC108751.3	NA	
ENSG00000282502	FKBP1AP4	NA	
ENSG00000239408	AC108751.1	NA	
ENSG00000169903	TM4SF4	NA	
ENSG00000244503	AC108751.5	NA	
ENSG00000018408	WWTR1	NA	
ENSG00000252581	RNU6-1098P	NA	
ENSG00000241985	WWTR1-IT1	NA	
ENSG00000241313	WWTR1-AS1	NA	
ENSG00000114744	COMMD2	NA	
ENSG00000206199	ANKUB1	NA	
ENSG00000251854	RNU6-507P	NA	
ENSG00000082996	RNF13	618379	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73
ENSG00000252172	RNU6-720P	NA	
ENSG00000239351	NPM1P29	NA	
ENSG00000070087	PFN2	NA	
ENSG00000242791	AC117395.1	NA	
ENSG00000224831	TMEM183B	NA	
ENSG00000182000	PPIAP73	NA	
ENSG00000241947	HNRNPA1P24	NA	
ENSG00000243944	AC117386.2	NA	
ENSG00000240477	AC022494.1	NA	
ENSG00000243321	LINC01998	NA	
ENSG00000241143	RPL32P9	NA	
ENSG00000241048	AC117386.1	NA	
ENSG00000244541	LINC01213	NA	
ENSG00000278234	U2	NA	
ENSG00000243550	LINC01214	NA	
ENSG00000286501	AC018545.1	NA	
ENSG00000196428	TSC22D2	NA	
ENSG00000120742	SERP1	NA	
ENSG00000144895	EIF2A	NA	
ENSG00000198843	SELENOT	NA	
ENSG00000271711	AC069236.1	NA	
ENSG00000163645	ERICH6	NA	
ENSG00000240137	ERICH6-AS1	NA	
ENSG00000244668	SNRPCP3	NA	
ENSG00000287688	AC011317.1	NA	
ENSG00000181788	SIAH2	NA	
ENSG00000244265	SIAH2-AS1	NA	
ENSG00000239265	CLRN1-AS1	NA	
ENSG00000214237	MINDY4B	NA	
ENSG00000260234	AC020636.2	NA	
ENSG00000243273	AC020636.1	NA	
ENSG00000163646	CLRN1	268000	RETINITIS PIGMENTOSA; RP
ENSG00000163646	CLRN1	276902	USHER SYNDROME, TYPE IIIA; USH3A;;USHER SYNDROME, TYPE III; USH3
ENSG00000163646	CLRN1	614180	RETINITIS PIGMENTOSA 61; RP61
ENSG00000276055	AC108726.1	NA	
ENSG00000144893	MED12L	NA	
ENSG00000199994	RNA5SP145	NA	
ENSG00000174946	GPR171	NA	
ENSG00000174944	P2RY14	NA	
ENSG00000239570	SETP11	NA	
ENSG00000286273	AC078816.1	NA	
ENSG00000138271	GPR87	NA	
ENSG00000181631	P2RY13	NA	
ENSG00000169313	P2RY12	609821	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8;;BLEEDING DISORDER DUE TO P2RY12 DEFECT
ENSG00000152580	IGSF10	NA	
ENSG00000242810	MRPL42P6	NA	
ENSG00000242119	AC117454.1	NA	
ENSG00000264330	MIR5186	NA	
ENSG00000241151	LINC02066	NA	
ENSG00000197953	AADACL2	NA	
ENSG00000242908	AADACL2-AS1	NA	
ENSG00000242097	AC068647.1	NA	
ENSG00000240602	AADACP1	NA	
ENSG00000250271	AC068647.2	NA	
ENSG00000114771	AADAC	NA	
ENSG00000198829	SUCNR1	NA	
ENSG00000239941	AC108718.1	NA	
ENSG00000152601	MBNL1	NA	
ENSG00000229619	MBNL1-AS1	NA	
ENSG00000221962	TMEM14EP	NA	
ENSG00000201217	Y_RNA	NA	
ENSG00000243305	AC026347.1	NA	
ENSG00000244545	AC092924.1	NA	
ENSG00000287706	AC092924.2	NA	
ENSG00000242561	ATP5MGP5	NA	
ENSG00000169860	P2RY1	NA	
ENSG00000241810	HMGN2P13	NA	
ENSG00000241671	AC117394.1	NA	
ENSG00000244268	AC117394.2	NA	
ENSG00000181467	RAP2B	NA	
ENSG00000265813	RN7SL300P	NA	
ENSG00000241220	AC078788.1	NA	
ENSG00000241912	AC078788.2	NA	
ENSG00000238755	LINC02006	NA	
ENSG00000237787	LINC02877	NA	
ENSG00000207323	RNU6-901P	NA	
ENSG00000200162	Y_RNA	NA	
ENSG00000243486	AC068985.1	NA	
ENSG00000201398	U8	NA	
ENSG00000240068	RPL21P42	NA	
ENSG00000243069	ARHGEF26-AS1	NA	
ENSG00000114790	ARHGEF26	NA	
ENSG00000174953	DHX36	NA	
ENSG00000271922	AC134026.1	NA	
ENSG00000279305	AC134026.2	NA	
ENSG00000174948	GPR149	NA	
ENSG00000240048	DDX50P2	NA	
ENSG00000243861	AC092994.1	NA	
ENSG00000243154	SYPL1P1	NA	
ENSG00000242151	DYNLL1P5	NA	
ENSG00000240601	RPL9P15	NA	
ENSG00000243969	AC073359.2	NA	
ENSG00000243953	AC073359.1	NA	
ENSG00000196549	MME	617017	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2T;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2T
ENSG00000196549	MME	617018	SPINOCEREBELLAR ATAXIA 43; SCA43
ENSG00000240666	MME-AS1	NA	
ENSG00000241336	LINC01487	NA	
ENSG00000240045	STRIT1	NA	
ENSG00000242790	AC104831.1	NA	
ENSG00000239443	PABPC1P10	NA	
ENSG00000114805	PLCH1	NA	
ENSG00000248772	AC108729.3	NA	
ENSG00000243518	AC108729.2	NA	
ENSG00000242152	AC108729.1	NA	
ENSG00000272096	RN7SL715P	NA	
ENSG00000239508	PLCH1-AS1	NA	
ENSG00000242925	PLCH1-AS2	NA	
ENSG00000239212	RPL6P7	NA	
ENSG00000214919	AC104472.1	NA	
ENSG00000241307	AC104472.2	NA	
ENSG00000174928	C3orf33	NA	
ENSG00000284952	AC104472.3	NA	
ENSG00000169359	SLC33A1	612539	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42
ENSG00000169359	SLC33A1	614482	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND
ENSG00000286585	AC104472.4	NA	
ENSG00000163655	GMPS	NA	
ENSG00000288032	AC104472.5	NA	
ENSG00000240489	SETP14	NA	
ENSG00000174930	VN2R1P	NA	
ENSG00000169282	KCNAB1	NA	
ENSG00000242017	ALG1L15P	NA	
ENSG00000242537	MRE11P1	NA	
ENSG00000287916	AC091607.2	NA	
ENSG00000227709	AC091607.1	NA	
ENSG00000240596	KCNAB1-AS2	NA	
ENSG00000242370	KCNAB1-AS1	NA	
ENSG00000272990	AC084036.1	NA	
ENSG00000114850	SSR3	NA	
ENSG00000243926	TIPARP-AS1	NA	
ENSG00000163659	TIPARP	NA	
ENSG00000174912	METTL15P1	NA	
ENSG00000240875	LINC00886	NA	
ENSG00000230457	PA2G4P4	NA	
ENSG00000197980	LEKR1	NA	
ENSG00000241879	KLF3P2	NA	
ENSG00000239706	AC117392.1	NA	
ENSG00000222499	RN7SKP177	NA	
ENSG00000243629	LINC00880	NA	
ENSG00000241544	LINC02029	NA	
ENSG00000241135	LINC00881	NA	
ENSG00000163660	CCNL1	NA	
ENSG00000201778	Y_RNA	NA	
ENSG00000244515	KRT18P34	NA	
ENSG00000241770	AC104411.1	NA	
ENSG00000222675	RNA5SP146	NA	
ENSG00000243176	AC092944.1	NA	
ENSG00000270981	AC092944.2	NA	
ENSG00000286361	AC092944.3	NA	
ENSG00000197415	VEPH1	NA	
ENSG00000163661	PTX3	NA	
ENSG00000174899	SLC66A1L	NA	
ENSG00000286892	AC084212.1	NA	
ENSG00000242536	AC079943.2	NA	
ENSG00000251751	RN7SKP46	NA	
ENSG00000239716	AC079943.1	NA	
ENSG00000168779	SHOX2	NA	
ENSG00000174891	RSRC1	618402	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 70
ENSG00000241723	AC074276.1	NA	
ENSG00000277143	AC074276.2	NA	
ENSG00000243314	AC106707.2	NA	
ENSG00000243150	AC106707.1	NA	
ENSG00000178053	MLF1	NA	
ENSG00000243025	MTAPP1	NA	
ENSG00000243165	AC025033.1	NA	
ENSG00000168827	GFM1	609060	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE
ENSG00000079257	LXN	NA	
ENSG00000272087	AC080013.4	NA	
ENSG00000118849	RARRES1	NA	
ENSG00000118855	MFSD1	NA	
ENSG00000240207	AC080013.1	NA	
ENSG00000243675	AC080013.2	NA	
ENSG00000271778	AC080013.3	NA	
ENSG00000272247	AC080013.5	NA	
ENSG00000232374	GPR79	NA	
ENSG00000279311	AC092999.1	NA	
ENSG00000283154	IQCJ-SCHIP1	NA	
ENSG00000214216	IQCJ	NA	
ENSG00000263634	MIR3919	NA	
ENSG00000244249	AC063955.1	NA	
ENSG00000286913	AC092943.2	NA	
ENSG00000243116	AC092943.1	NA	
ENSG00000241211	IQCJ-SCHIP1-AS1	NA	
ENSG00000252763	RNU2-31P	NA	
ENSG00000151967	SCHIP1	NA	
ENSG00000244040	IL12A-AS1	NA	
ENSG00000168811	IL12A	NA	
ENSG00000242107	LINC01100	NA	
ENSG00000184100	BRD7P2	NA	
ENSG00000180044	C3orf80	NA	
ENSG00000248710	AC079594.2	NA	
ENSG00000068885	IFT80	611263	SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2;;ASPHYXIATING THORACIC DYSTROPHY 2; ATD2
ENSG00000243687	AC079594.1	NA	
ENSG00000113810	SMC4	NA	
ENSG00000207779	MIR15B	NA	
ENSG00000198987	MIR16-2	NA	
ENSG00000213186	TRIM59	NA	
ENSG00000244009	B3GAT3P1	NA	
ENSG00000238427	RNU7-136P	NA	
ENSG00000186432	KPNA4	NA	
ENSG00000238741	SCARNA7	NA	
ENSG00000229320	KRT8P12	NA	
ENSG00000242285	RPL6P8	NA	
ENSG00000179674	ARL14	NA	
ENSG00000207084	SNORA72	NA	
ENSG00000260572	AC069224.1	NA	
ENSG00000163590	PPM1L	NA	
ENSG00000169255	B3GALNT1	111400	BLOOD GROUP, P1PK SYSTEM P(1) PHENOTYPE, INCLUDED;;P(2) PHENOTYPE, INCLUDED;;P1(k) PHENOTYPE, INCLUDED;;P2(k) PHENOTYPE, INCLUDED;;p PHENOTYPE, INCLUDED;;NOR POLYAGGLUTINATION SYNDROME, INCLUDED
ENSG00000169255	B3GALNT1	615021	BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB
ENSG00000169251	NMD3	NA	
ENSG00000271052	AC108738.1	NA	
ENSG00000240138	EEF1GP4	NA	
ENSG00000243838	PSMC1P7	NA	
ENSG00000196542	SPTSSB	NA	
ENSG00000240567	LINC02067	NA	
ENSG00000269888	AC112491.1	NA	
ENSG00000234851	RPL23AP42	NA	
ENSG00000182447	OTOL1	NA	
ENSG00000288087	AC112770.1	NA	
ENSG00000240354	AC131211.1	NA	
ENSG00000241874	TOMM22P6	NA	
ENSG00000243044	AC128716.1	NA	
ENSG00000241168	AC128685.1	NA	
ENSG00000241369	LINC01192	NA	
ENSG00000244571	RPS6P4	NA	
ENSG00000240792	AC079910.1	NA	
ENSG00000238924	RNU7-82P	NA	
ENSG00000214210	AC084017.1	NA	
ENSG00000221251	MIR1263	NA	
ENSG00000241636	LINC01323	NA	
ENSG00000241767	LINC01324	NA	
ENSG00000090402	SI	222900	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID;;DISACCHARIDE INTOLERANCE I;;SUCROSE-ISOMALTOSE MALABSORPTION, CONGENITAL;;SUCROSE INTOLERANCE, CONGENITAL;;SI DEFICIENCY
ENSG00000200052	Y_RNA	NA	
ENSG00000239205	LINC02023	NA	
ENSG00000121871	SLITRK3	NA	
ENSG00000244128	LINC01322	NA	
ENSG00000114200	BCHE	617936	BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED;;ACHOLINESTERASEMIA;;PSEUDOCHOLINESTERASE DEFICIENCY SUXAMETHONIUM SENSITIVITY, INCLUDED;;APNEA, POSTANESTHETIC, INCLUDED;;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE, INCLUDED;;HYPOCHO /.../ERASEMIA, FLUORIDE-RESISTANT, JAPANESE TYPE, INCLUDED
ENSG00000242178	MTND4P17	NA	
ENSG00000240084	MTND4LP10	NA	
ENSG00000240824	MTND3P7	NA	
ENSG00000242456	MTCO3P38	NA	
ENSG00000242326	MCUR1P2	NA	
ENSG00000244429	AC104629.1	NA	
ENSG00000244321	LINC01326	NA	
ENSG00000274149	AC072046.2	NA	
ENSG00000251759	RN7SKP298	NA	
ENSG00000224962	PSAT1P4	NA	
ENSG00000240458	AC072046.1	NA	
ENSG00000231516	CBX1P5	NA	
ENSG00000240033	AC069439.2	NA	
ENSG00000239227	AC069439.1	NA	
ENSG00000220343	PPIAP74	NA	
ENSG00000169064	ZBBX	NA	
ENSG00000241669	LINC01327	NA	
ENSG00000114204	SERPINI2	NA	
ENSG00000174776	WDR49	NA	
ENSG00000114209	PDCD10	603285	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3
ENSG00000241120	HMGN1P8	NA	
ENSG00000163536	SERPINI1	604218	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB;;ENCEPHALOPATHY, FAMILIAL, WITH COLLINS BODIES
ENSG00000287319	AC079822.1	NA	
ENSG00000244227	LRRC77P	NA	
ENSG00000244706	AC026353.1	NA	
ENSG00000239238	MEMO1P3	NA	
ENSG00000242036	AC128713.1	NA	
ENSG00000241203	HMGN2P26	NA	
ENSG00000173905	GOLIM4	NA	
ENSG00000286994	AC069243.1	NA	
ENSG00000206120	EGFEM1P	NA	
ENSG00000241882	AC124893.1	NA	
ENSG00000222357	RNU2-20P	NA	
ENSG00000207717	MIR551B	NA	
ENSG00000226765	RPSAP33	NA	
ENSG00000231688	RPL21P43	NA	
ENSG00000242268	LINC02082	NA	
ENSG00000272797	AC092954.1	NA	
ENSG00000273177	AC092954.2	NA	
ENSG00000241383	LINC01997	NA	
ENSG00000085276	MECOM	616738	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2
ENSG00000241479	MECOM-AS1	NA	
ENSG00000213178	RPL22P1	NA	
ENSG00000242795	AC007849.1	NA	
ENSG00000244381	AC007849.2	NA	
ENSG00000206777	RNU6-637P	NA	
ENSG00000270141	TERC	NA	
ENSG00000277925	Telomerase-vert	NA	
ENSG00000184378	ACTRT3	NA	
ENSG00000269889	AC078802.1	NA	
ENSG00000085274	MYNN	NA	
ENSG00000269984	AC078795.1	NA	
ENSG00000171757	LRRC34	NA	
ENSG00000270135	AC078795.3	NA	
ENSG00000270096	AC078795.2	NA	
ENSG00000188306	LRRIQ4	NA	
ENSG00000114248	LRRC31	NA	
ENSG00000240128	KRT18P43	NA	
ENSG00000187033	SAMD7	NA	
ENSG00000244039	AC008040.2	NA	
ENSG00000239219	AC008040.1	NA	
ENSG00000244193	AC008040.3	NA	
ENSG00000008952	SEC62	NA	
ENSG00000240373	SEC62-AS1	NA	
ENSG00000173890	GPR160	NA	
ENSG00000201342	RNU4-38P	NA	
ENSG00000242583	KMT5AP3	NA	
ENSG00000173889	PHC3	NA	
ENSG00000199536	RNU6-315P	NA	
ENSG00000163558	PRKCI	NA	
ENSG00000200118	Y_RNA	NA	
ENSG00000239628	AC073288.1	NA	
ENSG00000136603	SKIL	NA	
ENSG00000242578	AC073288.2	NA	
ENSG00000285218	AC026316.4	NA	
ENSG00000013297	CLDN11	NA	
ENSG00000283474	MIR6828	NA	
ENSG00000285051	SLC7A14-AS1	NA	
ENSG00000013293	SLC7A14	615725	RETINITIS PIGMENTOSA 68; RP68
ENSG00000241416	KRT8P13	NA	
ENSG00000213174	AC026316.1	NA	
ENSG00000244738	AC026316.3	NA	
ENSG00000286695	AC026316.5	NA	
ENSG00000239739	AC026316.2	NA	
ENSG00000163584	RPL22L1	NA	
ENSG00000163577	EIF5A2	NA	
ENSG00000286856	AC061708.1	NA	
ENSG00000240704	KLF7P1	NA	
ENSG00000199488	RNU1-70P	NA	
ENSG00000163581	SLC2A2	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000163581	SLC2A2	227810	FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE  /.../RANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI
ENSG00000154310	TNIK	617028	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54; MRT54
ENSG00000207963	MIR569	NA	
ENSG00000222506	Y_RNA	NA	
ENSG00000240497	AC092919.1	NA	
ENSG00000279673	AC092919.2	NA	
ENSG00000207114	RNU6-348P	NA	
ENSG00000234594	AC008134.1	NA	
ENSG00000075651	PLD1	212093	CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD
ENSG00000234717	TMEM212-AS1	NA	
ENSG00000186329	TMEM212	NA	
ENSG00000235943	TMEM212-IT1	NA	
ENSG00000287899	AC055714.1	NA	
ENSG00000075420	FNDC3B	NA	
ENSG00000237483	RPS27AP8	NA	
ENSG00000243398	RN7SL141P	NA	
ENSG00000279862	AC092964.1	NA	
ENSG00000236686	BZW1P1	NA	
ENSG00000121853	GHSR	615925	GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP
ENSG00000121858	TNFSF10	NA	
ENSG00000224611	AC007919.1	NA	
ENSG00000223387	LINC02068	NA	
ENSG00000224426	SLC31A1P1	NA	
ENSG00000144959	NCEH1	NA	
ENSG00000231384	AC007919.2	NA	
ENSG00000252082	RNU6-547P	NA	
ENSG00000287012	AC108667.2	NA	
ENSG00000114346	ECT2	NA	
ENSG00000200355	SNORA72	NA	
ENSG00000201458	RNU4-4P	NA	
ENSG00000227440	ATP5MC1P4	NA	
ENSG00000237501	AC108667.1	NA	
ENSG00000144962	SPATA16	102530	SPERMATOGENIC FAILURE 6; SPGF6;;GLOBOZOOSPERMIA;;ROUND-HEADED SPERMATOZOA;;SPERMATOZOA, ROUND-HEADED;;ACROSOME MALFORMATION OF SPERMATOZOA
ENSG00000237473	AC068759.1	NA	
ENSG00000169760	NLGN1	NA	
ENSG00000237645	AC092967.1	NA	
ENSG00000228213	NLGN1-AS1	NA	
ENSG00000252982	RN7SKP234	NA	
ENSG00000232601	AC069218.2	NA	
ENSG00000213169	AC069218.1	NA	
ENSG00000177694	NAALADL2	NA	
ENSG00000253020	RN7SKP40	NA	
ENSG00000230497	EEF1B2P8	NA	
ENSG00000230292	NAALADL2-AS3	NA	
ENSG00000226779	NAALADL2-AS2	NA	
ENSG00000264974	MIR4789	NA	
ENSG00000199792	RNU6-1233P	NA	
ENSG00000288104	AC008180.2	NA	
ENSG00000201648	RNU4-91P	NA	
ENSG00000236241	AC119744.1	NA	
ENSG00000214192	UBE2V1P2	NA	
ENSG00000201452	RNU6-1317P	NA	
ENSG00000225552	NAALADL2-AS1	NA	
ENSG00000260217	AC104640.1	NA	
ENSG00000230362	ACTG1P23	NA	
ENSG00000236357	EI24P1	NA	
ENSG00000271413	AC104640.2	NA	
ENSG00000238026	AC117434.1	NA	
ENSG00000223715	LINC01208	NA	
ENSG00000283333	MIR7977	NA	
ENSG00000252302	RNA5SP147	NA	
ENSG00000228308	LINC01209	NA	
ENSG00000231888	MTND5P15	NA	
ENSG00000177565	TBL1XR1	602342	PIERPONT SYNDROME; PRPTS;;PLANTAR LIPOMATOSIS, UNUSUAL FACIES, AND DEVELOPMENTAL DELAY
ENSG00000177565	TBL1XR1	616944	MENTAL RETARDATION, AUTOSOMAL DOMINANT 41; MRD41
ENSG00000231310	TBL1XR1-AS1	NA	
ENSG00000201343	Y_RNA	NA	
ENSG00000200882	RNU6-681P	NA	
ENSG00000203645	LINC00501	NA	
ENSG00000236893	ASS1P7	NA	
ENSG00000226782	AC117465.1	NA	
ENSG00000228221	LINC00578	NA	
ENSG00000252028	RN7SKP52	NA	
ENSG00000236385	AC026355.3	NA	
ENSG00000200288	AC026355.1	NA	
ENSG00000228561	AC026355.2	NA	
ENSG00000277241	AC026355.4	NA	
ENSG00000231574	LINC02015	NA	
ENSG00000225790	AC007953.1	NA	
ENSG00000270321	AC007953.2	NA	
ENSG00000199858	RNU6-1120P	NA	
ENSG00000286003	AC110992.1	NA	
ENSG00000223930	AC117453.1	NA	
ENSG00000197584	KCNMB2	NA	
ENSG00000275163	AC117457.1	NA	
ENSG00000223941	LINC01014	NA	
ENSG00000252336	RNA5SP148	NA	
ENSG00000271131	PPIAP75	NA	
ENSG00000237978	KCNMB2-AS1	NA	
ENSG00000172667	ZMAT3	NA	
ENSG00000200616	Y_RNA	NA	
ENSG00000229102	AC076966.2	NA	
ENSG00000121879	PIK3CA	182000	KERATOSIS, SEBORRHEIC
ENSG00000121879	PIK3CA	167000	OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED
ENSG00000121879	PIK3CA	162900	NEVUS, EPIDERMAL;;NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC  NEVUS SEBACEOUS, INCLUDED;;NEVUS, WOOLLY HAIR, INCLUDED
ENSG00000121879	PIK3CA	155500	MACRODACTYLY;;MEGALODACTYLY
ENSG00000121879	PIK3CA	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000121879	PIK3CA	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000121879	PIK3CA	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000121879	PIK3CA	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000121879	PIK3CA	602501	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP;;MACROCEPHALY-CAPILLARY MALFORMATION; MCM;;MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME;;MACROCEPHALY-CUTIS MARMORATA TELANGIECTATICA CONGENITA; MCMTC;;MEGALENCEPHALY-CUTIS MARMOR /.../LANGIECTATICA CONGENITA
ENSG00000121879	PIK3CA	612918	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI;;CLOVE SYNDROME;;CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, EPIDERMAL NEVI, AND SKELETAL/SPINAL ABNORMALITIES;;CLOVES SYNDROME
ENSG00000121879	PIK3CA	613089	CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH;;CLAPO;;LOPEZ-GUTIERREZ SYNDROME
ENSG00000121879	PIK3CA	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000121879	PIK3CA	615108	COWDEN SYNDROME 5; CWS5
ENSG00000201957	AC076966.1	NA	
ENSG00000171121	KCNMB3	NA	
ENSG00000240429	LRRFIP1P1	NA	
ENSG00000121864	ZNF639	NA	
ENSG00000260743	AC007823.1	NA	
ENSG00000171109	MFN1	NA	
ENSG00000114450	GNB4	615185	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF
ENSG00000242539	AC007620.2	NA	
ENSG00000272699	AC007620.3	NA	
ENSG00000239255	AC007620.1	NA	
ENSG00000181260	MTHFD2P7	NA	
ENSG00000136518	ACTL6A	NA	
ENSG00000272910	AC090425.3	NA	
ENSG00000272660	AC090425.2	NA	
ENSG00000136522	MRPL47	NA	
ENSG00000136521	NDUFB5	NA	
ENSG00000239096	AC090425.1	NA	
ENSG00000243977	H3P13	NA	
ENSG00000058056	USP13	NA	
ENSG00000114757	PEX5L	NA	
ENSG00000270178	AC007687.1	NA	
ENSG00000243799	PEX5L-AS1	NA	
ENSG00000244302	PEX5L-AS2	NA	
ENSG00000287645	AC092939.1	NA	
ENSG00000201822	RNA5SP149	NA	
ENSG00000282327	AC134503.1	NA	
ENSG00000213158	GAPDHP36	NA	
ENSG00000239880	RALBP1P1	NA	
ENSG00000241696	LINC02053	NA	
ENSG00000201810	U8	NA	
ENSG00000239774	AC125618.1	NA	
ENSG00000199986	RNU6-486P	NA	
ENSG00000241946	AC068298.1	NA	
ENSG00000163728	TTC14	NA	
ENSG00000284862	CCDC39	613807	CILIARY DYSKINESIA, PRIMARY, 14; CILD14;;CILIARY DYSKINESIA, PRIMARY, 14, WITH OR WITHOUT SITUS INVERSUS
ENSG00000145075	CCDC39	NA	
ENSG00000243187	CCDC39-AS1	NA	
ENSG00000285336	AC108734.4	NA	
ENSG00000242811	RN7SL229P	NA	
ENSG00000242068	AC108734.3	NA	
ENSG00000241473	AC108734.2	NA	
ENSG00000239516	FLYWCH1P1	NA	
ENSG00000114416	FXR1	618822	MYOPATHY, CONGENITAL, WITH RESPIRATORY INSUFFICIENCY AND BONE FRACTURES; MYORIBF
ENSG00000114416	FXR1	618823	MYOPATHY, CONGENITAL PROXIMAL, WITH MINICORE LESIONS; MYOPMIL
ENSG00000213157	AC108734.1	NA	
ENSG00000205981	DNAJC19	610198	3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5
ENSG00000242808	SOX2-OT	NA	
ENSG00000242140	AC083904.1	NA	
ENSG00000206932	RNU6-4P	NA	
ENSG00000237806	FAUP2	NA	
ENSG00000241231	AC068308.1	NA	
ENSG00000235294	RPL7AP25	NA	
ENSG00000239381	AC125613.1	NA	
ENSG00000276074	AC125613.2	NA	
ENSG00000276690	AC117415.1	NA	
ENSG00000181449	SOX2	206900	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3;;MICROPHTHALMIA AND ESOPHAGEAL ATRESIA SYNDROME;;ANOPHTHALMIA, CLINICAL, WITH ASSOCIATED ANOMALIES;;ANOPHTHALMIA-ESOPHAGEAL-GENITAL SYNDROME;;AEG SYNDROME OPTIC NERVE HYPOPLASIA AND ABNORMALITIES OF THE CENTRAL NE /.../SYSTEM, INCLUDED
ENSG00000278026	AC117415.2	NA	
ENSG00000266317	RN7SL703P	NA	
ENSG00000199839	RNA5SP150	NA	
ENSG00000239805	AC007547.2	NA	
ENSG00000213155	AC007547.1	NA	
ENSG00000242512	LINC01206	NA	
ENSG00000252257	RN7SKP265	NA	
ENSG00000286453	AC012081.2	NA	
ENSG00000240478	AC012081.1	NA	
ENSG00000287605	AC109131.1	NA	
ENSG00000242012	AC084211.1	NA	
ENSG00000241098	LINC01994	NA	
ENSG00000244199	EIF4EP3	NA	
ENSG00000244247	LINC01995	NA	
ENSG00000287941	AC021055.1	NA	
ENSG00000228766	RPL7L1P8	NA	
ENSG00000238837	LINC02031	NA	
ENSG00000243378	AC083801.1	NA	
ENSG00000260377	AC083801.2	NA	
ENSG00000240063	AC069431.1	NA	
ENSG00000058063	ATP11B	NA	
ENSG00000270554	AC069431.2	NA	
ENSG00000273261	AC092953.2	NA	
ENSG00000043093	DCUN1D1	NA	
ENSG00000244346	AC092953.1	NA	
ENSG00000078070	MCCC1	210200	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D;;MCCD TYPE 1;;MCC1 DEFICIENCY;;3-@METHYLCROTONYLGLYCINURIA I;;METHYLCROTONYLGLYCINURIA TYPE I
ENSG00000243368	MCCC1-AS1	NA	
ENSG00000078081	LAMP3	NA	
ENSG00000053524	MCF2L2	NA	
ENSG00000176597	B3GNT5	NA	
ENSG00000202502	RNA5SP151	NA	
ENSG00000240024	LINC00888	NA	
ENSG00000201229	SNORA63D	NA	
ENSG00000253092	AC092960.2	NA	
ENSG00000199363	SNORA63E	NA	
ENSG00000251730	AC092960.1	NA	
ENSG00000271682	AC092960.3	NA	
ENSG00000172578	KLHL6	NA	
ENSG00000242522	KLHL6-AS1	NA	
ENSG00000243584	AC068769.1	NA	
ENSG00000114796	KLHL24	617294	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH
ENSG00000163872	YEATS2	615127	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 4; FCMTE4
ENSG00000233885	YEATS2-AS1	NA	
ENSG00000283765	AC131160.1	NA	
ENSG00000180834	MAP6D1	NA	
ENSG00000175193	PARL	NA	
ENSG00000234371	RPSAP31	NA	
ENSG00000263932	MIR4448	NA	
ENSG00000233441	CYP2AB1P	NA	
ENSG00000114770	ABCC5	NA	
ENSG00000223882	ABCC5-AS1	NA	
ENSG00000223529	EEF1A1P8	NA	
ENSG00000186090	HTR3D	NA	
ENSG00000178084	HTR3C	NA	
ENSG00000233576	HTR3C2P	NA	
ENSG00000207351	Y_RNA	NA	
ENSG00000238020	HTR3E-AS1	NA	
ENSG00000186038	HTR3E	NA	
ENSG00000205955	HSP90AA5P	NA	
ENSG00000273181	AC131235.3	NA	
ENSG00000272721	AC131235.2	NA	
ENSG00000145191	EIF2B5	603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM;;CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION; CACH;;VANISHING WHITE MATTER LEUKODYSTROPHY;;CREE LEUKOENCEPHALOPATHY; CLE VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILU /.../CLUDED;;OVARIOLEUKODYSTROPHY, INCLUDED
ENSG00000228205	AC131235.1	NA	
ENSG00000161202	DVL3	180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES
ENSG00000161202	DVL3	616894	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3
ENSG00000161203	AP2M1	618587	INTELLECTUAL DEVELOPMENTAL DISORDER 60 WITH SEIZURES; MRD60;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 60, WITH SEIZURES
ENSG00000161204	ABCF3	NA	
ENSG00000145198	VWA5B2	NA	
ENSG00000221120	MIR1224	NA	
ENSG00000214160	ALG3	601110	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D;;CDG Id; CDGId;;CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE IV, FORMERLY; CDGS4, FORMERLY;;CDGS, TYPE IV, FORMERLY
ENSG00000284753	EEF1AKMT4	NA	
ENSG00000284917	EEF1AKMT4-ECE2	NA	
ENSG00000163888	CAMK2N2	NA	
ENSG00000145194	ECE2	NA	
ENSG00000175166	PSMD2	NA	
ENSG00000114867	EIF4G1	614251	PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18
ENSG00000212158	SNORD66	NA	
ENSG00000175182	FAM131A	NA	
ENSG00000114859	CLCN2	605635	HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2;;FH II
ENSG00000114859	CLCN2	607628	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8, INCLUDED; EJM8, INCLUDED;;EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 2, INCLUDED; EJA2, INCLUDED
ENSG00000114859	CLCN2	615651	LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT
ENSG00000163882	POLR2H	NA	
ENSG00000090534	THPO	187950	THROMBOCYTHEMIA 1; THCYT1;;THROMBOCYTOSIS 1
ENSG00000090539	CHRD	NA	
ENSG00000224153	LINC02054	NA	
ENSG00000283625	AC128714.1	NA	
ENSG00000227509	LINC01839	NA	
ENSG00000230215	LINC01840	NA	
ENSG00000182580	EPHB3	NA	
ENSG00000177383	MAGEF1	NA	
ENSG00000272970	AC107294.2	NA	
ENSG00000229433	LINC02069	NA	
ENSG00000273403	AC107294.3	NA	
ENSG00000272922	AC107294.1	NA	
ENSG00000288576	AC107294.4	NA	
ENSG00000156931	VPS8	NA	
ENSG00000187068	C3orf70	NA	
ENSG00000223358	EHHADH-AS1	NA	
ENSG00000113790	EHHADH	615605	FANCONI RENOTUBULAR SYNDROME 3; FRTS3
ENSG00000229704	EIF2S2P2	NA	
ENSG00000264614	MIR5588	NA	
ENSG00000073803	MAP3K13	NA	
ENSG00000229638	RPL4P4	NA	
ENSG00000163900	TMEM41A	NA	
ENSG00000286086	AC099661.1	NA	
ENSG00000163898	LIPH	604379	HYPOTRICHOSIS 7; HYPT7;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 2; LAH2;;HYPOTRICHOSIS, AUTOSOMAL RECESSIVE; AH;;HYPOTRICHOSIS, TOTAL, MARI TYPE  WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS, INCLUDED; ARWH2, INCLUDED;;WH/ /.../CLUDED
ENSG00000163904	SENP2	NA	
ENSG00000236489	AC133473.1	NA	
ENSG00000073792	IGF2BP2	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000163915	IGF2BP2-AS1	NA	
ENSG00000265470	MIR548AQ	NA	
ENSG00000136527	TRA2B	NA	
ENSG00000171658	NMRAL2P	NA	
ENSG00000244405	ETV5	NA	
ENSG00000277118	Metazoa_SRP	NA	
ENSG00000234197	ETV5-AS1	NA	
ENSG00000058866	DGKG	NA	
ENSG00000234548	LINC02020	NA	
ENSG00000224406	LINC02052	NA	
ENSG00000226859	LINC02051	NA	
ENSG00000213139	CRYGS	116100	CATARACT 20, MULTIPLE TYPES; CTRCT20
ENSG00000113838	TBCCD1	NA	
ENSG00000090520	DNAJB11	618061	POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6
ENSG00000197099	AC068631.1	NA	
ENSG00000283149	AC068631.2	NA	
ENSG00000283390	AC068631.3	NA	
ENSG00000145192	AHSG	203650	ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1;;APMR;;AMR SYNDROME
ENSG00000275696	Metazoa_SRP	NA	
ENSG00000090512	FETUB	NA	
ENSG00000113905	HRG	613116	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11 THROMBOPHILIA DUE TO ELEVATED HISTIDINE-RICH GLYCOPROTEIN, INCLUDED
ENSG00000225175	AC109780.1	NA	
ENSG00000226724	AC109780.2	NA	
ENSG00000113889	KNG1	228960	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY;;HMWK DEFICIENCY;;KININOGEN DEFICIENCY, HIGH MOLECULAR WEIGHT;;FITZGERALD TRAIT  KININOGEN DEFICIENCY, TOTAL, INCLUDED;;KININOGEN DEFICIENCY, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT, INCLUDED;;FLAUJE /.../IT, INCLUDED;;WILLIAMS TRAIT, INCLUDED
ENSG00000226652	PSMD10P2	NA	
ENSG00000207505	RNU6-1105P	NA	
ENSG00000230951	GPS2P2	NA	
ENSG00000156976	EIF4A2	NA	
ENSG00000263826	AC112907.3	NA	
ENSG00000238942	SNORD2	NA	
ENSG00000200418	SNORA63B	NA	
ENSG00000283958	MIR1248	NA	
ENSG00000221420	SNORA81	NA	
ENSG00000200320	SNORA63	NA	
ENSG00000263776	SNORA4	NA	
ENSG00000163918	RFC4	NA	
ENSG00000231724	AC112907.1	NA	
ENSG00000232233	LINC02043	NA	
ENSG00000231982	AC112907.2	NA	
ENSG00000181092	ADIPOQ	612556	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1 ADIPONECTIN DEFICIENCY, INCLUDED;;HYPOADIPONECTINEMIA, INCLUDED
ENSG00000226482	ADIPOQ-AS1	NA	
ENSG00000223803	RPS20P14	NA	
ENSG00000233565	AC007690.1	NA	
ENSG00000073849	ST6GAL1	NA	
ENSG00000163923	RPL39L	NA	
ENSG00000198491	AC007920.1	NA	
ENSG00000175077	RTP1	NA	
ENSG00000127241	MASP1	257920	3MC SYNDROME 1; 3MC1;;OCULOPALATOSKELETAL SYNDROME;;CRANIOSYNOSTOSIS WITH LID ANOMALIES;;MICHELS SYNDROME, FORMERLY
ENSG00000283175	AC007920.2	NA	
ENSG00000136514	RTP4	NA	
ENSG00000280270	AC068299.2	NA	
ENSG00000239093	AC068299.1	NA	
ENSG00000228952	LINC02041	NA	
ENSG00000157005	SST	NA	
ENSG00000198471	RTP2	NA	
ENSG00000228804	AC072022.1	NA	
ENSG00000113916	BCL6	NA	
ENSG00000285938	AC072022.2	NA	
ENSG00000224049	AC108681.1	NA	
ENSG00000236864	AC068295.1	NA	
ENSG00000224187	LINC01991	NA	
ENSG00000225058	AC092941.1	NA	
ENSG00000236412	AC092941.2	NA	
ENSG00000234238	AC022498.1	NA	
ENSG00000270959	LPP-AS2	NA	
ENSG00000145012	LPP	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000279891	FLJ42393	NA	
ENSG00000224563	LPP-AS1	NA	
ENSG00000207651	MIR28	NA	
ENSG00000234076	TPRG1-AS1	NA	
ENSG00000188001	TPRG1	NA	
ENSG00000236182	AC009319.1	NA	
ENSG00000230115	TPRG1-AS2	NA	
ENSG00000073282	TP63	129400	RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE
ENSG00000073282	TP63	106260	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE; AEC;;AEC SYNDROME;;HAY-WELLS SYNDROME
ENSG00000073282	TP63	103285	ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME
ENSG00000073282	TP63	603543	LIMB-MAMMARY SYNDROME; LMS
ENSG00000073282	TP63	604292	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3;;EEC SYNDROME 3
ENSG00000073282	TP63	605289	SPLIT-HAND/FOOT MALFORMATION 4; SHFM4
ENSG00000073282	TP63	618149	OROFACIAL CLEFT 8; OFC8;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8
ENSG00000227971	AC078809.1	NA	
ENSG00000216058	MIR944	NA	
ENSG00000090530	P3H2	614292	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD
ENSG00000230077	MTAPP2	NA	
ENSG00000225764	P3H2-AS1	NA	
ENSG00000212489	RNU6-1109P	NA	
ENSG00000238077	NMNAT1P3	NA	
ENSG00000163347	CLDN1	607626	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC;;ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME;;NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME;;NISCH SYNDROME
ENSG00000113946	CLDN16	248250	HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORT OF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS HYPERCALCIURIA, CHILDHOOD, SELF-LIMITI /.../CLUDED
ENSG00000198398	TMEM207	NA	
ENSG00000196083	IL1RAP	NA	
ENSG00000231047	GCNT1P3	NA	
ENSG00000223117	RN7SKP296	NA	
ENSG00000273370	AC108747.1	NA	
ENSG00000228730	LINC02013	NA	
ENSG00000232610	CCT6P4	NA	
ENSG00000214147	AC092952.1	NA	
ENSG00000205835	GMNC	NA	
ENSG00000188729	OSTN	NA	
ENSG00000233308	OSTN-AS1	NA	
ENSG00000188958	UTS2B	NA	
ENSG00000152492	CCDC50	607453	DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44
ENSG00000223812	AC073365.1	NA	
ENSG00000253548	PYDC2	NA	
ENSG00000201860	Y_RNA	NA	
ENSG00000237653	AC026320.2	NA	
ENSG00000232353	AC026320.1	NA	
ENSG00000287178	AC026320.3	NA	
ENSG00000222583	RN7SKP222	NA	
ENSG00000114279	FGF12	617166	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47; EIEE47
ENSG00000231383	FGF12-AS1	NA	
ENSG00000230126	FGF12-AS2	NA	
ENSG00000226709	FGF12-AS3	NA	
ENSG00000238902	AC026671.1	NA	
ENSG00000200184	RNU1-20P	NA	
ENSG00000180611	MB21D2	NA	
ENSG00000232130	AC092966.1	NA	
ENSG00000236229	VEZF1P1	NA	
ENSG00000127252	PLAAT1	NA	
ENSG00000187527	ATP13A5	NA	
ENSG00000236508	ATP13A5-AS1	NA	
ENSG00000127249	ATP13A4	NA	
ENSG00000225473	ATP13A4-AS1	NA	
ENSG00000236297	AC048351.1	NA	
ENSG00000198836	OPA1	165500	OPTIC ATROPHY 1; OPA1;;OPTIC ATROPHY, JUVENILE;;KJER-TYPE OPTIC ATROPHY;;OPTIC ATROPHY, KJER TYPE; OAK
ENSG00000198836	OPA1	125250	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY;;DOMINANT OPTIC ATROPHY PLUS SYNDROME; DOA+
ENSG00000198836	OPA1	210000	BEHR SYNDROME; BEHRS;;OPTIC ATROPHY, INFANTILE HEREDITARY, WITH NEUROLOGIC ABNORMALITIES
ENSG00000198836	OPA1	606657	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO;;NTG;;GLAUCOMA, NORMAL PRESSURE, SUSCEPTIBILITY TO; NPG
ENSG00000198836	OPA1	616896	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14
ENSG00000224855	OPA1-AS1	NA	
ENSG00000207370	Y_RNA	NA	
ENSG00000243991	RN7SL447P	NA	
ENSG00000223986	AC069421.1	NA	
ENSG00000286624	AC069421.2	NA	
ENSG00000287206	AC069421.3	NA	
ENSG00000229155	LINC02038	NA	
ENSG00000214146	LINC02026	NA	
ENSG00000238043	AC024559.1	NA	
ENSG00000224403	DPPA2P3	NA	
ENSG00000230102	LINC02028	NA	
ENSG00000276407	AC024559.2	NA	
ENSG00000229964	AC080129.1	NA	
ENSG00000232874	AC080129.2	NA	
ENSG00000114315	HES1	NA	
ENSG00000242201	RN7SL215P	NA	
ENSG00000225742	LINC02036	NA	
ENSG00000238097	LINC02037	NA	
ENSG00000228271	LINC02048	NA	
ENSG00000214145	LINC00887	NA	
ENSG00000286317	AC117469.1	NA	
ENSG00000178772	CPN2	NA	
ENSG00000172061	LRRC15	NA	
ENSG00000178732	GP5	NA	
ENSG00000133657	ATP13A3	NA	
ENSG00000271483	AC108676.2	NA	
ENSG00000233058	LINC00884	NA	
ENSG00000244675	AC108676.1	NA	
ENSG00000252053	RNU6-1101P	NA	
ENSG00000232873	RPL23AP93	NA	
ENSG00000231770	TMEM44-AS1	NA	
ENSG00000145014	TMEM44	NA	
ENSG00000229334	AC046143.1	NA	
ENSG00000272707	AC046143.2	NA	
ENSG00000041802	LSG1	NA	
ENSG00000185112	FAM43A	NA	
ENSG00000233987	AC106706.1	NA	
ENSG00000287073	AC106706.2	NA	
ENSG00000237222	LINC01968	NA	
ENSG00000234805	AC090505.1	NA	
ENSG00000230401	LINC01972	NA	
ENSG00000238031	AC090505.2	NA	
ENSG00000173950	XXYLT1	NA	
ENSG00000233303	XXYLT1-AS1	NA	
ENSG00000265333	MIR3137	NA	
ENSG00000244314	RN7SL36P	NA	
ENSG00000230266	XXYLT1-AS2	NA	
ENSG00000206600	RNU6-25P	NA	
ENSG00000287005	AC090018.2	NA	
ENSG00000114331	ACAP2	NA	
ENSG00000229325	ACAP2-IT1	NA	
ENSG00000227433	AC090018.1	NA	
ENSG00000207368	Y_RNA	NA	
ENSG00000184203	PPP1R2	NA	
ENSG00000252620	RNU6ATAC24P	NA	
ENSG00000223711	AC069213.1	NA	
ENSG00000265882	RN7SL73P	NA	
ENSG00000236844	AC069213.3	NA	
ENSG00000236425	AC069213.2	NA	
ENSG00000189058	APOD	NA	
ENSG00000224769	MUC20P1	NA	
ENSG00000282206	AC233280.19	NA	
ENSG00000271662	AC233280.2	NA	
ENSG00000229178	AC233280.1	NA	
ENSG00000242086	MUC20-OT1	NA	
ENSG00000215837	SDHAP2	NA	
ENSG00000207650	MIR570	NA	
ENSG00000283426	SMBD1P	NA	
ENSG00000176945	MUC20	NA	
ENSG00000145113	MUC4	NA	
ENSG00000223783	LINC01983	NA	
ENSG00000235836	KIF3AP1	NA	
ENSG00000061938	TNK2	NA	
ENSG00000276489	MIR6829	NA	
ENSG00000286004	AC124944.3	NA	
ENSG00000224614	TNK2-AS1	NA	
ENSG00000260261	AC124944.2	NA	
ENSG00000239122	RNU2-11P	NA	
ENSG00000231443	AC124944.1	NA	
ENSG00000185485	SDHAP1	NA	
ENSG00000286168	AC024937.3	NA	
ENSG00000231464	AC024937.2	NA	
ENSG00000072274	TFRC	616740	IMMUNODEFICIENCY 46; IMD46
ENSG00000228413	AC024937.1	NA	
ENSG00000252174	RNU7-18P	NA	
ENSG00000224652	LINC00885	NA	
ENSG00000163958	ZDHHC19	NA	
ENSG00000222335	Y_RNA	NA	
ENSG00000163959	SLC51A	NA	
ENSG00000161217	PCYT1A	608940	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD
ENSG00000272741	AC069257.3	NA	
ENSG00000228028	AC069257.1	NA	
ENSG00000213123	TCTEX1D2	617405	SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17
ENSG00000237418	AC069257.2	NA	
ENSG00000273331	TM4SF19-TCTEX1D2	NA	
ENSG00000235897	TM4SF19-AS1	NA	
ENSG00000145107	TM4SF19	NA	
ENSG00000212146	RNU6-910P	NA	
ENSG00000163960	UBXN7	NA	
ENSG00000206644	RNU6-1279P	NA	
ENSG00000241868	RN7SL434P	NA	
ENSG00000243339	RN7SL738P	NA	
ENSG00000226345	AC083822.1	NA	
ENSG00000225822	UBXN7-AS1	NA	
ENSG00000225240	AC117490.1	NA	
ENSG00000163961	RNF168	611943	RIDDLE SYNDROME; RIDL;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FACIAL FEATURES, AND LEARNING DIFFICULTIES
ENSG00000273013	AC117490.2	NA	
ENSG00000214097	SMCO1	NA	
ENSG00000213358	AC092933.1	NA	
ENSG00000225770	RPS29P3	NA	
ENSG00000185798	WDR53	NA	
ENSG00000174013	FBXO45	NA	
ENSG00000286661	AC092933.2	NA	
ENSG00000232065	LINC01063	NA	
ENSG00000174004	NRROS	NA	
ENSG00000163964	PIGX	NA	
ENSG00000174007	CEP19	615703	MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF
ENSG00000201441	RNU6-646P	NA	
ENSG00000180370	PAK2	NA	
ENSG00000272359	RNU4-89P	NA	
ENSG00000206892	RNU6-42P	NA	
ENSG00000119231	SENP5	NA	
ENSG00000230732	AC016949.1	NA	
ENSG00000114503	NCBP2	NA	
ENSG00000225578	NCBP2-AS1	NA	
ENSG00000270170	NCBP2AS2	NA	
ENSG00000119227	PIGZ	NA	
ENSG00000286017	AC011322.1	NA	
ENSG00000233487	RPSAP69	NA	
ENSG00000163975	MELTF	NA	
ENSG00000228109	MELTF-AS1	NA	
ENSG00000075711	DLG1	NA	
ENSG00000265850	MIR4797	NA	
ENSG00000227375	DLG1-AS1	NA	
ENSG00000286870	AL121981.1	NA	
ENSG00000235126	AC128709.2	NA	
ENSG00000229912	AC128709.1	NA	
ENSG00000237167	AC128709.3	NA	
ENSG00000272989	LINC02012	NA	
ENSG00000161267	BDH1	NA	
ENSG00000214135	AC132008.2	NA	
ENSG00000213519	AC132008.1	NA	
ENSG00000249626	AC024560.2	NA	
ENSG00000273308	AC024560.3	NA	
ENSG00000286909	AC024560.4	NA	
ENSG00000236833	AC024560.1	NA	
ENSG00000287286	AC024560.5	NA	
ENSG00000145016	RUBCN	615705	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA
ENSG00000284146	MIR922	NA	
ENSG00000122068	FYTTD1	NA	
ENSG00000273375	AC055764.2	NA	
ENSG00000186001	LRCH3	NA	
ENSG00000234136	AC055764.1	NA	
ENSG00000234742	AC144530.1	NA	
ENSG00000114473	IQCG	NA	
ENSG00000199306	RNU6-858P	NA	
ENSG00000182899	RPL35A	612528	DIAMOND-BLACKFAN ANEMIA 5; DBA5
ENSG00000185621	LMLN	NA	
ENSG00000201622	RNU6-621P	NA	
ENSG00000286755	AC135893.1	NA	
ENSG00000232832	LMLN-AS1	NA	
ENSG00000226435	ANKRD18DP	NA	
ENSG00000212297	RNU6-821P	NA	
ENSG00000232783	FRG2FP	NA	
ENSG00000213113	TUBB8P8	NA	
ENSG00000236246	AC073135.1	NA	
ENSG00000236438	FAM157A	NA	
ENSG00000222792	RNU6-860P	NA	
ENSG00000230304	CICP6	NA	
ENSG00000226008	SEPTIN14P3	NA	
ENSG00000248302	BNIP3P41	NA	
ENSG00000272602	ZNF595	NA	
ENSG00000250238	AC253576.1	NA	
ENSG00000250312	ZNF718	NA	
ENSG00000275426	AC253576.2	NA	
ENSG00000250892	AC108475.1	NA	
ENSG00000198155	ZNF876P	NA	
ENSG00000251188	AC079140.3	NA	
ENSG00000251689	AC079140.5	NA	
ENSG00000186777	ZNF732	NA	
ENSG00000286705	AC079140.6	NA	
ENSG00000251535	AC079140.4	NA	
ENSG00000131127	ZNF141	615226	POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6
ENSG00000248564	AC079140.1	NA	
ENSG00000250321	AC079140.2	NA	
ENSG00000207642	MIR571	NA	
ENSG00000281016	AC092574.2	NA	
ENSG00000249025	ZNF519P4	NA	
ENSG00000272885	AC092574.1	NA	
ENSG00000251595	ABCA11P	NA	
ENSG00000182903	ZNF721	NA	
ENSG00000174227	PIGG	616917	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 13; GPIBD13
ENSG00000273238	TMEM271	NA	
ENSG00000283183	AC116565.1	NA	
ENSG00000133256	PDE6B	163500	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2;;NIGHT BLINDNESS, CONGENITAL STATIONARY, RAMBUSCH TYPE
ENSG00000133256	PDE6B	613801	RETINITIS PIGMENTOSA 40; RP40
ENSG00000242686	PDE6B-AS1	NA	
ENSG00000272927	AC107464.2	NA	
ENSG00000169020	ATP5ME	NA	
ENSG00000215375	MYL5	NA	
ENSG00000169026	SLC49A3	NA	
ENSG00000185619	PCGF3	NA	
ENSG00000248416	AC107464.1	NA	
ENSG00000272588	AC139887.4	NA	
ENSG00000249592	AC139887.2	NA	
ENSG00000233799	AC139887.1	NA	
ENSG00000168993	CPLX1	194190	WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME;;WITTWER SYNDROME
ENSG00000168993	CPLX1	617976	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63
ENSG00000260262	AC139887.3	NA	
ENSG00000286205	AC139887.5	NA	
ENSG00000178950	GAK	NA	
ENSG00000127419	TMEM175	NA	
ENSG00000145214	DGKQ	NA	
ENSG00000145217	SLC26A1	167030	NEPHROLITHIASIS, CALCIUM OXALATE; CAON;;KIDNEY STONES;;UROLITHIASIS, CALCIUM OXALATE
ENSG00000127415	IDUA	607014	HURLER SYNDROME;;MUCOPOLYSACCHARIDOSIS TYPE IH; MPS1-H
ENSG00000127415	IDUA	607015	HURLER-SCHEIE SYNDROME;;MUCOPOLYSACCHARIDOSIS TYPE IH/S; MPS1-HS
ENSG00000127415	IDUA	607016	SCHEIE SYNDROME;;MUCOPOLYSACCHARIDOSIS TYPE IS; MPS1-S;;MUCOPOLYSACCHARIDOSIS TYPE V, FORMERLY;;MPS V, FORMERLY; MPS5, FORMERLY
ENSG00000127418	FGFRL1	194190	WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME;;WITTWER SYNDROME
ENSG00000250259	AC019103.1	NA	
ENSG00000178222	RNF212	612042	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1
ENSG00000251639	AC092535.3	NA	
ENSG00000251652	AC092535.4	NA	
ENSG00000215367	TMED11P	NA	
ENSG00000212458	AC092535.1	NA	
ENSG00000227189	AC092535.2	NA	
ENSG00000159674	SPON2	NA	
ENSG00000273179	AC092535.5	NA	
ENSG00000280927	CTBP1-AS	NA	
ENSG00000159692	CTBP1	194190	WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME;;WITTWER SYNDROME
ENSG00000159692	CTBP1	617915	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS
ENSG00000196810	CTBP1-DT	NA	
ENSG00000090316	MAEA	NA	
ENSG00000163945	UVSSA	614640	UV-SENSITIVE SYNDROME 3; UVSS3
ENSG00000254094	AC078852.2	NA	
ENSG00000253399	AC078852.1	NA	
ENSG00000288380	AC118281.1	NA	
ENSG00000235608	NKX1-1	NA	
ENSG00000272783	AC147067.2	NA	
ENSG00000244459	AC147067.1	NA	
ENSG00000174137	FAM53A	NA	
ENSG00000207009	AC016773.1	NA	
ENSG00000163950	SLBP	NA	
ENSG00000270195	AC016773.2	NA	
ENSG00000013810	TACC3	NA	
ENSG00000168936	TMEM129	NA	
ENSG00000068078	FGFR3	162900	NEVUS, EPIDERMAL;;NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC  NEVUS SEBACEOUS, INCLUDED;;NEVUS, WOOLLY HAIR, INCLUDED
ENSG00000068078	FGFR3	149730	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD;;LADD SYNDROME;;LEVY-HOLLISTER SYNDROME
ENSG00000068078	FGFR3	146000	HYPOCHONDROPLASIA; HCH
ENSG00000068078	FGFR3	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000068078	FGFR3	109800	BLADDER CANCER
ENSG00000068078	FGFR3	100800	ACHONDROPLASIA; ACH
ENSG00000068078	FGFR3	187600	THANATOPHORIC DYSPLASIA, TYPE I; TD1;;THANATOPHORIC DYSPLASIA; TD;;THANATOPHORIC DWARFISM;;PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, SAN DIEGO TYPE;;LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, SAN DIEGO TYPE
ENSG00000068078	FGFR3	187601	THANATOPHORIC DYSPLASIA, TYPE II; TD2;;THANATOPHORIC DYSPLASIA WITH STRAIGHT FEMURS AND CLOVERLEAF SKULL;;THANATOPHORIC DYSPLASIA WITH KLEEBLATTSCHAEDEL;;CLOVERLEAF SKULL WITH THANATOPHORIC DWARFISM
ENSG00000068078	FGFR3	273300	TESTICULAR GERM CELL TUMOR; TGCT;;MALE GERM CELL TUMOR; MGCT SEMINOMA, INCLUDED;;NONSEMINOMATOUS GERM CELL TUMORS, INCLUDED;;TERATOMA, TESTICULAR, INCLUDED;;EMBRYONAL CELL CARCINOMA, INCLUDED;;ENDODERMAL SINUS TUMOR, INCLUDED;;SPERMATOCYTIC SEMINOMA /.../UDED
ENSG00000068078	FGFR3	602849	MUENKE SYNDROME; MNKES;;MUENKE NONSYNDROMIC CORONAL CRANIOSYNOSTOSIS
ENSG00000068078	FGFR3	603956	CERVICAL CANCER
ENSG00000068078	FGFR3	610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS;;CATSHL SYNDROME
ENSG00000068078	FGFR3	612247	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN;;CROUZONODERMOSKELETAL SYNDROME
ENSG00000068078	FGFR3	616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN;;SADDAN DYSPLASIA
ENSG00000168924	LETM1	194190	WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME;;WITTWER SYNDROME
ENSG00000109685	NSD2	194190	WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME;;WITTWER SYNDROME
ENSG00000249784	SCARNA22	NA	
ENSG00000185049	NELFA	NA	
ENSG00000284587	MIR943	NA	
ENSG00000243449	C4orf48	NA	
ENSG00000185818	NAT8L	614063	N-ACETYLASPARTATE DEFICIENCY; NACED;;NAA DEFICIENCY;;HYPOACETYLASPARTIA
ENSG00000130997	POLN	NA	
ENSG00000214367	HAUS3	NA	
ENSG00000249006	AL136360.1	NA	
ENSG00000250623	AL136360.2	NA	
ENSG00000249047	COX6B1P5	NA	
ENSG00000123933	MXD4	NA	
ENSG00000284276	MIR4800	NA	
ENSG00000159733	ZFYVE28	NA	
ENSG00000251148	AL158068.2	NA	
ENSG00000239247	RN7SL589P	NA	
ENSG00000249077	AL158068.1	NA	
ENSG00000206113	CFAP99	NA	
ENSG00000063978	RNF4	NA	
ENSG00000248399	AL645924.1	NA	
ENSG00000251229	AL645924.2	NA	
ENSG00000125386	FAM193A	NA	
ENSG00000248155	CR545473.1	NA	
ENSG00000206738	Y_RNA	NA	
ENSG00000168884	TNIP2	NA	
ENSG00000087266	SH3BP2	118400	CHERUBISM;;CRBM
ENSG00000087274	ADD1	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000287099	AL121750.1	NA	
ENSG00000109736	MFSD10	NA	
ENSG00000249673	NOP14-AS1	NA	
ENSG00000087269	NOP14	NA	
ENSG00000125388	GRK4	NA	
ENSG00000197386	HTT	143100	HUNTINGTON DISEASE; HD;;HUNTINGTON CHOREA
ENSG00000197386	HTT	617435	LOPES-MACIEL-RODAN SYNDROME; LOMARS
ENSG00000199335	RNU6-204P	NA	
ENSG00000251075	HTT-AS	NA	
ENSG00000278778	AL390065.2	NA	
ENSG00000274693	AL390065.1	NA	
ENSG00000188981	MSANTD1	NA	
ENSG00000159788	RGS12	NA	
ENSG00000248840	AL645949.1	NA	
ENSG00000248843	AL645949.2	NA	
ENSG00000109758	HGFAC	NA	
ENSG00000286900	AL590235.2	NA	
ENSG00000175920	DOK7	254300	MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10;;MYASTHENIA, LIMB-GIRDLE, FAMILIAL, FORMERLY; LGM, FORMERLY;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib, FORMERLY; CMS1B, FORMERLY;;CMS Ib, FORMERLY;;MYASTHENIC MYOPATHY, FORMERLY
ENSG00000175920	DOK7	618389	FETAL AKINESIA DEFORMATION SEQUENCE 3; FADS3
ENSG00000163956	LRPAP1	615431	MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23
ENSG00000270090	AL590235.1	NA	
ENSG00000216560	LINC00955	NA	
ENSG00000250681	AL121796.1	NA	
ENSG00000250632	LINC02171	NA	
ENSG00000250986	LINC02600	NA	
ENSG00000184160	ADRA2C	104250	ALPHA-2C-ADRENERGIC RECEPTOR; ADRA2C;;ALPHA-2-ADRENERGIC RECEPTOR, RENAL TYPE  CONGESTIVE HEART FAILURE AND BETA-BLOCKER RESPONSE, MODIFIER OF, INCLUDED
ENSG00000251166	OR7E163P	NA	
ENSG00000234386	OR7E162P	NA	
ENSG00000249522	AC147876.1	NA	
ENSG00000253917	AC226119.1	NA	
ENSG00000271977	AC226119.2	NA	
ENSG00000251271	ALG1L7P	NA	
ENSG00000251669	FAM86EP	NA	
ENSG00000250476	ENPP7P9	NA	
ENSG00000288589	DUS4L-BCAP29	NA	
ENSG00000284727	AC116562.3	NA	
ENSG00000243894	RPS3AP16	NA	
ENSG00000250940	AC116562.2	NA	
ENSG00000248669	AC116562.1	NA	
ENSG00000198787	OR7E103P	NA	
ENSG00000250381	UNC93B4	NA	
ENSG00000250710	OR7E99P	NA	
ENSG00000249844	OR7E43P	NA	
ENSG00000163982	OTOP1	NA	
ENSG00000132406	TMEM128	NA	
ENSG00000145220	LYAR	NA	
ENSG00000168826	ZBTB49	NA	
ENSG00000248516	AC105415.1	NA	
ENSG00000168824	NSG1	NA	
ENSG00000168818	STX18	NA	
ENSG00000248221	STX18-IT1	NA	
ENSG00000237170	RPS7P15	NA	
ENSG00000247708	STX18-AS1	NA	
ENSG00000280310	AC092437.1	NA	
ENSG00000273396	LINC01396	NA	
ENSG00000163132	MSX1	106600	TOOTH AGENESIS, SELECTIVE, 1; STHAG1;;HYPODONTIA/OLIGODONTIA 1; HYD1;;SECOND PREMOLARS AND THIRD MOLARS, ABSENCE OF;;TOOTH AGENESIS, FAMILIAL TOOTH AGENESIS, SELECTIVE, WITH OROFACIAL CLEFT, INCLUDED;;HYPODONTIA/OLIGODONTIA WITH OROFACIAL CLEFT, INCLUDED
ENSG00000163132	MSX1	189500	WITKOP SYNDROME;;ECTODERMAL DYSPLASIA 3, WITKOP TYPE; ECTD3;;ECTODERMAL DYSPLASIA 3, TOOTH/NAIL TYPE;;NAIL DYSPLASIA WITH HYPODONTIA;;TOOTH-AND-NAIL SYNDROME; TNS
ENSG00000163132	MSX1	608874	OROFACIAL CLEFT 5; OFC5;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 5
ENSG00000251587	LDHAP1	NA	
ENSG00000200761	RN7SKP113	NA	
ENSG00000170891	CYTL1	NA	
ENSG00000152953	STK32B	NA	
ENSG00000252266	AC004664.1	NA	
ENSG00000201496	RN7SKP275	NA	
ENSG00000082929	LINC01587	NA	
ENSG00000173040	EVC2	193530	WEYERS ACROFACIAL DYSOSTOSIS; WAD;;ACRODENTAL DYSOSTOSIS OF WEYERS;;CURRY-HALL SYNDROME
ENSG00000173040	EVC2	225500	ELLIS-VAN CREVELD SYNDROME; EVC;;CHONDROECTODERMAL DYSPLASIA;;MESOECTODERMAL DYSPLASIA
ENSG00000072840	EVC	193530	WEYERS ACROFACIAL DYSOSTOSIS; WAD;;ACRODENTAL DYSOSTOSIS OF WEYERS;;CURRY-HALL SYNDROME
ENSG00000072840	EVC	225500	ELLIS-VAN CREVELD SYNDROME; EVC;;CHONDROECTODERMAL DYSPLASIA;;MESOECTODERMAL DYSPLASIA
ENSG00000072832	CRMP1	NA	
ENSG00000181215	C4orf50	NA	
ENSG00000263631	MIR378D1	NA	
ENSG00000152969	JAKMIP1	NA	
ENSG00000284684	AC092442.1	NA	
ENSG00000287786	AC113615.2	NA	
ENSG00000249896	LINC02495	NA	
ENSG00000251408	AC113615.1	NA	
ENSG00000288588	AC116317.2	NA	
ENSG00000109501	WFS1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000109501	WFS1	116400	CATARACT 41; CTRCT41;;CATARACT 41, CONGENITAL NUCLEAR TYPE
ENSG00000109501	WFS1	222300	WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD
ENSG00000109501	WFS1	600965	DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6;;DEAFNESS, AUTOSOMAL DOMINANT 14; DFNA14;;DEAFNESS, AUTOSOMAL DOMINANT 38; DFNA38
ENSG00000109501	WFS1	614296	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL;;HEARING LOSS, PROGRESSIVE, WITH OPTIC ATROPHY AND/OR IMPAIRED GLUCOSE REGULATION
ENSG00000286176	AC116317.1	NA	
ENSG00000074211	PPP2R2C	NA	
ENSG00000013288	MAN2B2	NA	
ENSG00000179010	MRFAP1	NA	
ENSG00000251580	LINC02482	NA	
ENSG00000284847	AC093323.4	NA	
ENSG00000170846	AC093323.1	NA	
ENSG00000246526	LINC02481	NA	
ENSG00000279859	AC093323.2	NA	
ENSG00000163993	S100P	NA	
ENSG00000282742	AC093323.3	NA	
ENSG00000178988	MRFAP1L1	NA	
ENSG00000186222	BLOC1S4	NA	
ENSG00000287331	AC106045.1	NA	
ENSG00000170871	KIAA0232	NA	
ENSG00000132405	TBC1D14	NA	
ENSG00000287104	AC097382.3	NA	
ENSG00000187904	AC097382.1	NA	
ENSG00000202392	RN7SKP292	NA	
ENSG00000245748	AC097382.2	NA	
ENSG00000173013	CCDC96	NA	
ENSG00000173011	TADA2B	NA	
ENSG00000109519	GRPEL1	NA	
ENSG00000245468	LINC02447	NA	
ENSG00000200867	RN7SKP36	NA	
ENSG00000184985	SORCS2	NA	
ENSG00000264658	MIR4798	NA	
ENSG00000178597	PSAPL1	NA	
ENSG00000266690	MIR4274	NA	
ENSG00000272620	AFAP1-AS1	NA	
ENSG00000196526	AFAP1	NA	
ENSG00000287164	AC112254.1	NA	
ENSG00000228919	AC097381.1	NA	
ENSG00000163995	ABLIM2	NA	
ENSG00000207807	MIR95	NA	
ENSG00000273267	AC097381.3	NA	
ENSG00000251460	AC097381.2	NA	
ENSG00000250471	GMPSP1	NA	
ENSG00000125089	SH3TC1	NA	
ENSG00000170801	HTRA3	NA	
ENSG00000249145	LINC02517	NA	
ENSG00000251615	AC104825.1	NA	
ENSG00000087008	ACOX3	NA	
ENSG00000202054	RNA5SP152	NA	
ENSG00000155275	TRMT44	NA	
ENSG00000251186	AC105345.2	NA	
ENSG00000205959	AC105345.1	NA	
ENSG00000155269	GPR78	NA	
ENSG00000109625	CPZ	NA	
ENSG00000250915	AC209005.1	NA	
ENSG00000215612	HMX1	612109	OCULOAURICULAR SYNDROME; OCACS;;MICROPHTHALMIA, MICROCORNEA, ANTERIOR SEGMENT DYSGENESIS, CATARACT, OCULAR COLOBOMA, RETINAL PIGMENT EPITHELIUM ABNORMALITIES, ROD-CONE DYSTROPHY, AND ANOMALIES OF THE EXTERNAL EAR;;SCHORDERET-MUNIER-FRANCESCHETTI SYNDROME
ENSG00000258507	AC116612.1	NA	
ENSG00000197468	AC073648.1	NA	
ENSG00000249272	UNC93B8	NA	
ENSG00000250804	AC073648.3	NA	
ENSG00000249347	AC073648.2	NA	
ENSG00000284636	AC073648.6	NA	
ENSG00000271057	AC073648.5	NA	
ENSG00000251313	AC073648.4	NA	
ENSG00000288075	AC108519.1	NA	
ENSG00000250342	SNRPCP16	NA	
ENSG00000287972	AC073648.7	NA	
ENSG00000249767	ENPP7P10	NA	
ENSG00000163612	FAM86KP	NA	
ENSG00000250268	ALG1L14P	NA	
ENSG00000229924	FAM90A26	NA	
ENSG00000231396	USP17L10	NA	
ENSG00000233136	USP17L11	NA	
ENSG00000227551	USP17L12	NA	
ENSG00000232399	USP17L13	NA	
ENSG00000249482	USP17L14P	NA	
ENSG00000223569	USP17L15	NA	
ENSG00000250231	USP17L16P	NA	
ENSG00000249104	USP17L17	NA	
ENSG00000250844	USP17L18	NA	
ENSG00000248920	USP17L19	NA	
ENSG00000250745	USP17L20	NA	
ENSG00000249811	USP17L21	NA	
ENSG00000248933	USP17L22	NA	
ENSG00000250913	USP17L23	NA	
ENSG00000232264	USP17L24	NA	
ENSG00000230430	USP17L25	NA	
ENSG00000229579	USP17L26	NA	
ENSG00000227140	USP17L5	NA	
ENSG00000235780	USP17L27	NA	
ENSG00000231051	USP17L28	NA	
ENSG00000231637	USP17L29	NA	
ENSG00000251694	USP17L9P	NA	
ENSG00000228856	USP17L30	NA	
ENSG00000205946	USP17L6P	NA	
ENSG00000219492	AC116655.1	NA	
ENSG00000188438	DEFB108F	NA	
ENSG00000252307	RNA5SP153	NA	
ENSG00000232773	DEFB130D	NA	
ENSG00000186146	DEFB131A	NA	
ENSG00000248364	OR7E86P	NA	
ENSG00000284689	OR7E84P	NA	
ENSG00000250884	OR7E85P	NA	
ENSG00000251624	UNC93B7	NA	
ENSG00000249866	OR7E83P	NA	
ENSG00000249443	AC097493.2	NA	
ENSG00000284648	AC097493.3	NA	
ENSG00000242034	AC097493.1	NA	
ENSG00000221275	MIR548I2	NA	
ENSG00000244004	RPS3AP19	NA	
ENSG00000287117	AC105916.1	NA	
ENSG00000249799	SNRPCP13	NA	
ENSG00000250942	ENPP7P11	NA	
ENSG00000186234	FAM86MP	NA	
ENSG00000251087	ALG1L3P	NA	
ENSG00000203436	Metazoa_SRP	NA	
ENSG00000249563	AC098976.1	NA	
ENSG00000250425	OR7E35P	NA	
ENSG00000109667	SLC2A9	612076	HYPOURICEMIA, RENAL, 2; RHUC2 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 2, INCLUDED; UAQTL2, INCLUDED;;GOUT SUSCEPTIBILITY 2, INCLUDED; GOUT2, INCLUDED
ENSG00000169676	DRD5	143465	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD;;HYPERACTIVITY OF CHILDHOOD
ENSG00000169676	DRD5	606798	BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO
ENSG00000252002	RNA5SP154	NA	
ENSG00000249219	AC108199.1	NA	
ENSG00000250413	AC005674.1	NA	
ENSG00000261490	AC005674.2	NA	
ENSG00000071127	WDR1	NA	
ENSG00000264931	MIR3138	NA	
ENSG00000223086	RNA5SP155	NA	
ENSG00000250393	AC093664.1	NA	
ENSG00000251296	AC006499.6	NA	
ENSG00000248777	AC006499.1	NA	
ENSG00000271544	AC006499.8	NA	
ENSG00000250040	RAF1P1	NA	
ENSG00000250573	AC006499.4	NA	
ENSG00000250074	AC006499.2	NA	
ENSG00000250505	AC006499.3	NA	
ENSG00000251278	AC006499.5	NA	
ENSG00000251338	AC006499.7	NA	
ENSG00000250613	AC110768.2	NA	
ENSG00000178163	ZNF518B	NA	
ENSG00000287154	AC005599.1	NA	
ENSG00000248419	AC110768.1	NA	
ENSG00000109684	CLNK	NA	
ENSG00000249334	AC084048.1	NA	
ENSG00000283083	LINC02498	NA	
ENSG00000207716	MIR572	NA	
ENSG00000250896	RNPS1P1	NA	
ENSG00000002587	HS3ST1	NA	
ENSG00000222182	RNA5SP156	NA	
ENSG00000287778	AC006230.1	NA	
ENSG00000251152	AC025539.1	NA	
ENSG00000249631	AC005699.1	NA	
ENSG00000248300	LINC02360	NA	
ENSG00000248262	AC108037.1	NA	
ENSG00000251210	LINC02270	NA	
ENSG00000212282	RNU6-578P	NA	
ENSG00000249995	ECM1P2	NA	
ENSG00000249780	AC093809.1	NA	
ENSG00000250371	AC007370.2	NA	
ENSG00000250098	AC007370.1	NA	
ENSG00000283271	U6	NA	
ENSG00000157869	RAB28	615374	CONE-ROD DYSTROPHY 18; CORD18
ENSG00000205940	HSP90AB2P	NA	
ENSG00000286297	AC006445.3	NA	
ENSG00000281202	LINC01097	NA	
ENSG00000109705	NKX3-2	613330	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD
ENSG00000246095	LINC01096	NA	
ENSG00000038219	BOD1L1	NA	
ENSG00000266240	MIR5091	NA	
ENSG00000249148	AC006445.2	NA	
ENSG00000242209	AC006445.1	NA	
ENSG00000250634	LINC01182	NA	
ENSG00000250497	AC007126.1	NA	
ENSG00000224569	AC095052.1	NA	
ENSG00000248698	LINC01085	NA	
ENSG00000249988	AC092546.1	NA	
ENSG00000251679	AC073848.1	NA	
ENSG00000287360	AC006296.3	NA	
ENSG00000251412	AC006296.2	NA	
ENSG00000248425	AC006296.1	NA	
ENSG00000248360	LINC00504	NA	
ENSG00000251252	MTND2P31	NA	
ENSG00000202449	SNORA63	NA	
ENSG00000247624	CPEB2-DT	NA	
ENSG00000137449	CPEB2	NA	
ENSG00000249252	C1QTNF7-AS1	NA	
ENSG00000199420	RN7SKP170	NA	
ENSG00000163145	C1QTNF7	NA	
ENSG00000251379	AC099550.1	NA	
ENSG00000048342	CC2D2A	216360	COACH SYNDROME;;CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULAR COLOBOMA, AND HEPATIC FIBROSIS;;JOUBERT SYNDROME WITH CONGENITAL HEPATIC FIBROSIS
ENSG00000048342	CC2D2A	612284	MECKEL SYNDROME, TYPE 6; MKS6
ENSG00000048342	CC2D2A	612285	JOUBERT SYNDROME 9; JBTS9 JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED
ENSG00000249930	AC007016.1	NA	
ENSG00000273133	AC116651.1	NA	
ENSG00000118564	FBXL5	NA	
ENSG00000237765	FAM200B	NA	
ENSG00000288606	AC114744.2	NA	
ENSG00000109743	BST1	NA	
ENSG00000214846	AC114744.1	NA	
ENSG00000248188	AC005798.1	NA	
ENSG00000004468	CD38	NA	
ENSG00000251644	HPRT1P1	NA	
ENSG00000137440	FGFBP1	NA	
ENSG00000137441	FGFBP2	NA	
ENSG00000007062	PROM1	603786	STARGARDT DISEASE 4; STGD4
ENSG00000007062	PROM1	608051	MACULAR DYSTROPHY, RETINAL, 2; MCDR2
ENSG00000007062	PROM1	612095	RETINITIS PIGMENTOSA 41; RP41;;RETINAL DEGENERATION, AUTOSOMAL RECESSIVE, PROMININ-RELATED
ENSG00000007062	PROM1	612657	CONE-ROD DYSTROPHY 12; CORD12
ENSG00000286280	AC108063.2	NA	
ENSG00000169762	TAPT1	616897	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG
ENSG00000249234	AC108063.1	NA	
ENSG00000263327	TAPT1-AS1	NA	
ENSG00000242358	RPS21P4	NA	
ENSG00000248851	AC006427.1	NA	
ENSG00000286888	AC006427.2	NA	
ENSG00000249506	ZEB2P1	NA	
ENSG00000248138	AC097515.1	NA	
ENSG00000169744	LDB2	NA	
ENSG00000287081	AC104656.1	NA	
ENSG00000249998	AC106894.1	NA	
ENSG00000251212	MTND5P4	NA	
ENSG00000250819	LINC02493	NA	
ENSG00000206780	SNORA75B	NA	
ENSG00000215278	RPS7P6	NA	
ENSG00000151552	QDPR	261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C;;HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO DHPR DEFICIENCY;;DIHYDROPTERIDINE REDUCTASE DEFICIENCY;;DHPR DEFICIENCY;;QUINOID DIHYDROPTERIDINE REDUCTASE DEFICIENCY;;QDPR DEFICIENCY
ENSG00000249581	CLRN2	NA	
ENSG00000249488	NACAP5	NA	
ENSG00000283219	AC006160.2	NA	
ENSG00000002549	LAP3	NA	
ENSG00000249502	AC006160.1	NA	
ENSG00000118579	MED28	NA	
ENSG00000047662	FAM184B	NA	
ENSG00000163257	DCAF16	NA	
ENSG00000109805	NCAPG	NA	
ENSG00000178177	LCORL	NA	
ENSG00000235413	KRT18P63	NA	
ENSG00000286046	AC093898.1	NA	
ENSG00000251048	AC093871.1	NA	
ENSG00000279918	AC006840.1	NA	
ENSG00000248238	LINC02438	NA	
ENSG00000251816	RNA5SP157	NA	
ENSG00000279379	AC024595.1	NA	
ENSG00000248515	AC024230.1	NA	
ENSG00000249441	AC110767.1	NA	
ENSG00000241612	AC114728.1	NA	
ENSG00000250611	AC098862.1	NA	
ENSG00000145147	SLIT2	NA	
ENSG00000248228	SLIT2-IT1	NA	
ENSG00000207732	MIR218-1	NA	
ENSG00000163138	PACRGL	NA	
ENSG00000185774	KCNIP4	NA	
ENSG00000272995	AC097505.1	NA	
ENSG00000250243	AC110296.1	NA	
ENSG00000283281	MIR7978	NA	
ENSG00000286318	AC096576.6	NA	
ENSG00000250092	AC096576.3	NA	
ENSG00000242768	AC096576.1	NA	
ENSG00000248343	AC096576.2	NA	
ENSG00000280650	KCNIP4-IT1	NA	
ENSG00000250039	AC096719.1	NA	
ENSG00000239001	RNU6-420P	NA	
ENSG00000152990	ADGRA3	NA	
ENSG00000244538	AC098583.1	NA	
ENSG00000251516	AC098583.2	NA	
ENSG00000249948	GBA3	NA	
ENSG00000237350	CDC42P6	NA	
ENSG00000248837	AC097512.1	NA	
ENSG00000249547	AC092440.1	NA	
ENSG00000251220	RFPL4AP3	NA	
ENSG00000250137	AC093607.1	NA	
ENSG00000251292	ERVH-1	NA	
ENSG00000109819	PPARGC1A	NA	
ENSG00000249453	AC092834.1	NA	
ENSG00000109606	DHX15	NA	
ENSG00000207697	MIR573	NA	
ENSG00000243005	RN7SL16P	NA	
ENSG00000249256	ATP5MGP3	NA	
ENSG00000261121	LINC02473	NA	
ENSG00000251638	AC006390.1	NA	
ENSG00000248444	HNRNPA1P65	NA	
ENSG00000109610	SOD3	NA	
ENSG00000181982	CCDC149	NA	
ENSG00000153012	LGI2	NA	
ENSG00000109618	SEPSECS	613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D;;CEREBELLOCEREBRAL ATROPHY, PROGRESSIVE; PCCA
ENSG00000281501	SEPSECS-AS1	NA	
ENSG00000038210	PI4K2B	NA	
ENSG00000271172	AC104662.1	NA	
ENSG00000278135	U2	NA	
ENSG00000168228	ZCCHC4	NA	
ENSG00000053900	ANAPC4	NA	
ENSG00000249320	AC133963.2	NA	
ENSG00000248608	AC133963.1	NA	
ENSG00000248545	AC105290.1	NA	
ENSG00000238632	RNU7-126P	NA	
ENSG00000228154	AC092436.1	NA	
ENSG00000157765	SLC34A2	265100	PULMONARY ALVEOLAR MICROLITHIASIS; PULAM
ENSG00000242640	RPS29P11	NA	
ENSG00000249277	AC092436.2	NA	
ENSG00000250050	MTND4P9	NA	
ENSG00000248133	MTND4LP22	NA	
ENSG00000251353	MTND3P5	NA	
ENSG00000248654	MTCO3P44	NA	
ENSG00000091490	SEL1L3	NA	
ENSG00000250541	AC092436.3	NA	
ENSG00000250317	SMIM20	NA	
ENSG00000251009	AC133961.1	NA	
ENSG00000283314	LINC02357	NA	
ENSG00000248452	AC097714.1	NA	
ENSG00000168214	RBPJ	614814	ADAMS-OLIVER SYNDROME 3; AOS3
ENSG00000163394	CCKAR	NA	
ENSG00000109680	TBC1D19	NA	
ENSG00000200999	AC107390.1	NA	
ENSG00000109689	STIM2	NA	
ENSG00000240005	STIM2-AS1	NA	
ENSG00000248340	PIMREGP4	NA	
ENSG00000251080	AC024132.2	NA	
ENSG00000205830	AC024132.1	NA	
ENSG00000249699	LINC02261	NA	
ENSG00000222206	Y_RNA	NA	
ENSG00000251325	AC024132.3	NA	
ENSG00000250858	IGBP1P5	NA	
ENSG00000287389	AC007106.2	NA	
ENSG00000251410	AC007106.1	NA	
ENSG00000286321	AC093791.2	NA	
ENSG00000250038	AC093791.1	NA	
ENSG00000250064	AC097480.1	NA	
ENSG00000286141	AC097480.2	NA	
ENSG00000243548	RN7SL101P	NA	
ENSG00000283275	MIR4275	NA	
ENSG00000250927	MESTP3	NA	
ENSG00000250190	LINC02364	NA	
ENSG00000276507	AC068944.2	NA	
ENSG00000249228	AC068944.1	NA	
ENSG00000248176	AC109349.1	NA	
ENSG00000248338	LINC02472	NA	
ENSG00000251373	AC092593.2	NA	
ENSG00000251113	AC092593.1	NA	
ENSG00000283666	U6	NA	
ENSG00000249542	EEF1A1P21	NA	
ENSG00000249564	AC097510.1	NA	
ENSG00000244031	RPS3AP17	NA	
ENSG00000248281	AC106868.1	NA	
ENSG00000286596	AC098595.1	NA	
ENSG00000169851	PCDH7	NA	
ENSG00000249678	AC097716.1	NA	
ENSG00000250624	MTCYBP43	NA	
ENSG00000251182	LINC02497	NA	
ENSG00000251434	AC104071.1	NA	
ENSG00000249882	LINC02501	NA	
ENSG00000251129	LINC02506	NA	
ENSG00000286212	AC097654.1	NA	
ENSG00000251329	LINC02353	NA	
ENSG00000286784	AC116611.1	NA	
ENSG00000250076	AC017013.1	NA	
ENSG00000287968	AC093606.1	NA	
ENSG00000249452	AC093878.1	NA	
ENSG00000249766	AC097535.2	NA	
ENSG00000248417	AC097535.1	NA	
ENSG00000288321	AC079772.1	NA	
ENSG00000250954	AC016687.3	NA	
ENSG00000250723	AC016687.2	NA	
ENSG00000239983	AC016687.1	NA	
ENSG00000248685	LINC02484	NA	
ENSG00000287320	AC110790.1	NA	
ENSG00000250597	AC093689.1	NA	
ENSG00000275250	AC093913.1	NA	
ENSG00000238694	AC020589.1	NA	
ENSG00000250416	SEC63P2	NA	
ENSG00000206665	RNU6-573P	NA	
ENSG00000047365	ARAP2	NA	
ENSG00000248466	AC098827.1	NA	
ENSG00000247193	AC104078.1	NA	
ENSG00000197057	DTHD1	NA	
ENSG00000251438	AC104078.2	NA	
ENSG00000283207	MIR1255B1	NA	
ENSG00000248215	LINC02505	NA	
ENSG00000251588	AC125336.1	NA	
ENSG00000287416	AC093746.1	NA	
ENSG00000261761	LINC02616	NA	
ENSG00000247810	AL136537.1	NA	
ENSG00000264319	MIR4801	NA	
ENSG00000174145	NWD2	NA	
ENSG00000154274	C4orf19	NA	
ENSG00000288073	AC022463.1	NA	
ENSG00000248936	AC027607.1	NA	
ENSG00000181826	RELL1	NA	
ENSG00000207075	Y_RNA	NA	
ENSG00000239532	AC108022.1	NA	
ENSG00000169299	PGM2	NA	
ENSG00000279386	AC021106.3	NA	
ENSG00000249863	AC021106.1	NA	
ENSG00000065882	TBC1D1	NA	
ENSG00000250254	PTTG2	NA	
ENSG00000251332	AC021106.2	NA	
ENSG00000249649	MRPS33P2	NA	
ENSG00000287659	AC098680.2	NA	
ENSG00000251642	AC098680.1	NA	
ENSG00000248227	LINC02513	NA	
ENSG00000280015	AC024023.1	NA	
ENSG00000249534	LINC01258	NA	
ENSG00000249667	LINC01259	NA	
ENSG00000251635	LINC02278	NA	
ENSG00000231160	KLF3-AS1	NA	
ENSG00000271958	AC021860.1	NA	
ENSG00000109787	KLF3	NA	
ENSG00000222230	RNA5SP158	NA	
ENSG00000174123	TLR10	NA	
ENSG00000174125	TLR1	613223	LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5 LEPROSY, PROTECTION AGAINST, INCLUDED
ENSG00000174130	TLR6	NA	
ENSG00000197712	FAM114A1	NA	
ENSG00000207944	MIR574	NA	
ENSG00000121895	TMEM156	NA	
ENSG00000109790	KLHL5	NA	
ENSG00000249207	AC079921.1	NA	
ENSG00000249685	AC079921.2	NA	
ENSG00000157796	WDR19	614376	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5;;ASPHYXIATING THORACIC DYSTROPHY 5; ATD5
ENSG00000157796	WDR19	614377	NEPHRONOPHTHISIS 13; NPHP13
ENSG00000157796	WDR19	614378	CRANIOECTODERMAL DYSPLASIA 4; CED4
ENSG00000157796	WDR19	616307	SENIOR-LOKEN SYNDROME 8; SLSN8
ENSG00000035928	RFC1	614575	CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS
ENSG00000206675	RNU6-32P	NA	
ENSG00000222592	RNU6-887P	NA	
ENSG00000134962	KLB	NA	
ENSG00000264621	MIR5591	NA	
ENSG00000238797	AC021148.2	NA	
ENSG00000163682	RPL9	NA	
ENSG00000121897	LIAS	614462	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS;;PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD
ENSG00000224097	AC021148.1	NA	
ENSG00000109814	UGDH	618792	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84; EIEE84;;JAMUAR SYNDROME
ENSG00000249348	UGDH-AS1	NA	
ENSG00000287262	AC021148.3	NA	
ENSG00000163683	SMIM14	NA	
ENSG00000286349	AC108471.3	NA	
ENSG00000252796	RNU7-11P	NA	
ENSG00000255458	AC108471.2	NA	
ENSG00000078140	UBE2K	NA	
ENSG00000252975	Y_RNA	NA	
ENSG00000249019	AC108471.1	NA	
ENSG00000243260	RN7SL558P	NA	
ENSG00000180610	ZBTB12BP	NA	
ENSG00000121892	PDS5A	NA	
ENSG00000271278	ELOCP33	NA	
ENSG00000252970	RNA5SP159	NA	
ENSG00000250568	AC098591.3	NA	
ENSG00000231707	PABPC1P1	NA	
ENSG00000249064	KRT18P25	NA	
ENSG00000205794	AC098591.2	NA	
ENSG00000078177	N4BP2	NA	
ENSG00000200455	RNU6-1112P	NA	
ENSG00000201863	AC098591.1	NA	
ENSG00000248977	AC095057.1	NA	
ENSG00000260296	AC095057.3	NA	
ENSG00000286089	AC095057.4	NA	
ENSG00000168421	RHOH	618307	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4
ENSG00000250338	AC095057.2	NA	
ENSG00000249241	LINC02265	NA	
ENSG00000174343	CHRNA9	NA	
ENSG00000239010	RNU7-74P	NA	
ENSG00000163694	RBM47	NA	
ENSG00000250893	AC098869.2	NA	
ENSG00000242197	AC098869.1	NA	
ENSG00000263642	MIR4802	NA	
ENSG00000287182	AC131953.2	NA	
ENSG00000179299	NSUN7	NA	
ENSG00000248780	ARL4AP2	NA	
ENSG00000163697	APBB2	NA	
ENSG00000250906	AC131953.1	NA	
ENSG00000207195	Y_RNA	NA	
ENSG00000201736	RNA5SP160	NA	
ENSG00000199790	RNU6-836P	NA	
ENSG00000207198	RNU6-1195P	NA	
ENSG00000251173	UCHL1-AS1	NA	
ENSG00000154277	UCHL1	613643	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK5
ENSG00000154277	UCHL1	615491	SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79;;NEURODEGENERATION WITH OPTIC ATROPHY, CHILDHOOD-ONSET; NDGOA
ENSG00000207481	Y_RNA	NA	
ENSG00000064042	LIMCH1	NA	
ENSG00000239627	RPL12P20	NA	
ENSG00000287762	AC108050.1	NA	
ENSG00000249216	AC105389.2	NA	
ENSG00000249081	OR5M14P	NA	
ENSG00000109132	PHOX2B	209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS;;AUTONOMIC CONTROL, CONGENITAL FAILURE OF;;ONDINE CURSE, CONGENITAL ONDINE-HIRSCHSPRUNG DISEASE, INCLUDED; OHD, INCLUDED;;CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;;HADDAD SYNDROME, INCLUDED
ENSG00000109132	PHOX2B	613013	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2 NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE, INCLUDED
ENSG00000250467	PHOX2B-AS1	NA	
ENSG00000249122	AC105389.1	NA	
ENSG00000200338	RNU1-49P	NA	
ENSG00000249745	HMGB1P28	NA	
ENSG00000245870	LINC00682	NA	
ENSG00000249771	AC108210.1	NA	
ENSG00000249887	AC108210.2	NA	
ENSG00000109133	TMEM33	NA	
ENSG00000182308	DCAF4L1	NA	
ENSG00000272862	AC106052.1	NA	
ENSG00000014824	SLC30A9	617595	BIRK-LANDAU-PEREZ SYNDROME; BILAPES
ENSG00000249212	ATP1B1P1	NA	
ENSG00000188848	BEND4	NA	
ENSG00000285454	AC111006.1	NA	
ENSG00000250781	AC024022.1	NA	
ENSG00000178343	SHISA3	NA	
ENSG00000124406	ATP8A1	NA	
ENSG00000240167	RPS7P7	NA	
ENSG00000248283	CCNL2P1	NA	
ENSG00000260519	AC096734.2	NA	
ENSG00000251517	AC096734.1	NA	
ENSG00000252595	RN7SKP82	NA	
ENSG00000215203	GRXCR1	613285	DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25
ENSG00000248939	AC111198.1	NA	
ENSG00000250657	AC097451.1	NA	
ENSG00000277096	AC098590.2	NA	
ENSG00000213851	AC098590.1	NA	
ENSG00000248143	LINC02383	NA	
ENSG00000251501	AC114774.1	NA	
ENSG00000239464	RN7SL691P	NA	
ENSG00000286891	AC080132.1	NA	
ENSG00000239679	RN7SL193P	NA	
ENSG00000124399	NDUFB4P12	NA	
ENSG00000250863	AC114757.1	NA	
ENSG00000251350	LINC02475	NA	
ENSG00000183783	KCTD8	NA	
ENSG00000251159	AC093852.1	NA	
ENSG00000177752	YIPF7	NA	
ENSG00000151806	GUF1	617065	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40; EIEE40
ENSG00000163281	GNPDA2	NA	
ENSG00000273369	AC096586.2	NA	
ENSG00000272936	AC096586.1	NA	
ENSG00000249729	AC093755.1	NA	
ENSG00000248987	PRDX4P1	NA	
ENSG00000275959	AC108467.2	NA	
ENSG00000248744	AC108467.1	NA	
ENSG00000248320	THAP12P9	NA	
ENSG00000224560	AC108043.1	NA	
ENSG00000200720	RNU6-931P	NA	
ENSG00000222257	RN7SKP199	NA	
ENSG00000163285	GABRG1	NA	
ENSG00000260878	AC104072.1	NA	
ENSG00000151834	GABRA2	103780	ALCOHOL DEPENDENCE;;ALCOHOLISM ALCOHOL DEPENDENCE, PROTECTION AGAINST, INCLUDED;;AERODIGESTIVE TRACT CANCER, SQUAMOUS CELL, ALCOHOL-RELATED, PROTECTION AGAINST, INCLUDED
ENSG00000151834	GABRA2	618557	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 78; EIEE78
ENSG00000249330	AC095060.1	NA	
ENSG00000252243	RNU6-412P	NA	
ENSG00000249936	RAC1P2	NA	
ENSG00000170516	COX7B2	NA	
ENSG00000109158	GABRA4	NA	
ENSG00000163288	GABRB1	617153	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45; EIEE45
ENSG00000260918	AC107398.3	NA	
ENSG00000169019	COMMD8	NA	
ENSG00000282904	AC107398.4	NA	
ENSG00000286294	AC107398.5	NA	
ENSG00000145246	ATP10D	NA	
ENSG00000242431	AC107398.1	NA	
ENSG00000248254	AC107398.2	NA	
ENSG00000145244	CORIN	614595	PREECLAMPSIA/ECLAMPSIA 5; PEE5
ENSG00000277388	MIR8053	NA	
ENSG00000242262	AC092597.1	NA	
ENSG00000282917	AC107068.2	NA	
ENSG00000259959	AC107068.1	NA	
ENSG00000170448	NFXL1	NA	
ENSG00000163293	NIPAL1	NA	
ENSG00000198515	CNGA1	268000	RETINITIS PIGMENTOSA; RP
ENSG00000198515	CNGA1	613756	RETINITIS PIGMENTOSA 49; RP49
ENSG00000074966	TXK	NA	
ENSG00000200269	RNU6-838P	NA	
ENSG00000283499	AC079118.2	NA	
ENSG00000135605	TEC	NA	
ENSG00000202014	AC079118.1	NA	
ENSG00000109171	SLAIN2	NA	
ENSG00000145248	SLC10A4	NA	
ENSG00000182223	ZAR1	NA	
ENSG00000075539	FRYL	NA	
ENSG00000251722	RNU5E-3P	NA	
ENSG00000109180	OCIAD1	NA	
ENSG00000248256	OCIAD1-AS1	NA	
ENSG00000145247	OCIAD2	NA	
ENSG00000252913	RNU6-158P	NA	
ENSG00000251334	AC020593.1	NA	
ENSG00000109182	CWH43	NA	
ENSG00000225455	TPI1P4	NA	
ENSG00000249828	AC118282.3	NA	
ENSG00000249079	AC118282.2	NA	
ENSG00000280043	AC118282.4	NA	
ENSG00000250016	SNX18P23	NA	
ENSG00000237961	AC118282.1	NA	
ENSG00000268736	MTCO3P39	NA	
ENSG00000248946	MTND3P22	NA	
ENSG00000248583	AC119751.3	NA	
ENSG00000251056	ANKRD20A17P	NA	
ENSG00000250769	AC119751.5	NA	
ENSG00000248532	AC119751.2	NA	
ENSG00000269848	AC119751.8	NA	
ENSG00000268967	AC119751.7	NA	
ENSG00000268391	MTCO3P42	NA	
ENSG00000232471	AC119751.1	NA	
ENSG00000251630	AC119751.6	NA	
ENSG00000251539	SNX18P24	NA	
ENSG00000250753	AC119751.4	NA	
ENSG00000249337	SNX18P25	NA	
ENSG00000109184	DCUN1D4	NA	
ENSG00000250473	DUTP7	NA	
ENSG00000272576	AC027271.1	NA	
ENSG00000243929	AC104784.1	NA	
ENSG00000188993	LRRC66	NA	
ENSG00000163069	SGCB	604286	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E
ENSG00000251040	LINC02480	NA	
ENSG00000163071	SPATA18	NA	
ENSG00000287999	AC097522.2	NA	
ENSG00000251286	AC097522.1	NA	
ENSG00000199924	RNU6-1252P	NA	
ENSG00000109189	USP46	NA	
ENSG00000248866	USP46-DT	NA	
ENSG00000260120	AC104066.4	NA	
ENSG00000226950	DANCR	NA	
ENSG00000250302	LINC01618	NA	
ENSG00000264585	MIR4449	NA	
ENSG00000286161	AC104066.5	NA	
ENSG00000212588	SNORA26	NA	
ENSG00000248375	AC104066.3	NA	
ENSG00000226887	ERVMER34-1	NA	
ENSG00000212490	AC104066.2	NA	
ENSG00000199901	AC104066.1	NA	
ENSG00000128045	RASL11B	NA	
ENSG00000184178	SCFD2	NA	
ENSG00000248115	AC023154.1	NA	
ENSG00000207385	RNU6-310P	NA	
ENSG00000145216	FIP1L1	NA	
ENSG00000282278	AC058822.1	NA	
ENSG00000072201	LNX1	NA	
ENSG00000250930	LNX1-AS1	NA	
ENSG00000173966	AC095040.1	NA	
ENSG00000248494	LNX1-AS2	NA	
ENSG00000249341	AC124017.1	NA	
ENSG00000249706	AC105384.1	NA	
ENSG00000250815	AC105384.2	NA	
ENSG00000229585	RPL21P44	NA	
ENSG00000272650	AC110792.3	NA	
ENSG00000109220	CHIC2	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000269506	AC110792.2	NA	
ENSG00000287534	AC110792.4	NA	
ENSG00000251105	AC110792.1	NA	
ENSG00000250147	MORF4L2P1	NA	
ENSG00000180613	GSX2	618646	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2;;SPASTIC TETRAPARESIS, DYSTONIA, DEVELOPMENTAL DELAY, AND STRUCTURAL ABNORMALITIES OF THE BASAL GANGLIA
ENSG00000242670	RPL22P13	NA	
ENSG00000134853	PDGFRA	175510	GIST-PLUS SYNDROME; GISTPS;;POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL, FORMERLY
ENSG00000134853	PDGFRA	607685	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES
ENSG00000248184	LINC02283	NA	
ENSG00000248518	AC098587.1	NA	
ENSG00000251264	AC098868.1	NA	
ENSG00000250456	LINC02260	NA	
ENSG00000157404	KIT	172800	PIEBALD TRAIT; PBT;;PIEBALDISM
ENSG00000157404	KIT	154800	MASTOCYTOSIS, CUTANEOUS; MASTC;;URTICARIA PIGMENTOSA;;MASTOCYTOSIS, MACULOPAPULAR CUTANEOUS;;MASTOCYTOSIS, DIFFUSE CUTANEOUS MASTOCYTOSIS, SYSTEMIC, INCLUDED; MASTSYS, INCLUDED;;MASTOCYTOSIS, INDOLENT, INCLUDED;;MASTOCYTOSIS WITH ASSOCIATED HEMATOLO /.../SORDER, INCLUDED;;MAST CELL LEUKEMIA, INCLUDED
ENSG00000157404	KIT	273300	TESTICULAR GERM CELL TUMOR; TGCT;;MALE GERM CELL TUMOR; MGCT SEMINOMA, INCLUDED;;NONSEMINOMATOUS GERM CELL TUMORS, INCLUDED;;TERATOMA, TESTICULAR, INCLUDED;;EMBRYONAL CELL CARCINOMA, INCLUDED;;ENDODERMAL SINUS TUMOR, INCLUDED;;SPERMATOCYTIC SEMINOMA /.../UDED
ENSG00000157404	KIT	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000157404	KIT	606764	GASTROINTESTINAL STROMAL TUMOR; GIST
ENSG00000249727	AC097494.1	NA	
ENSG00000251256	LINC02358	NA	
ENSG00000248317	AC111194.1	NA	
ENSG00000244422	RPL38P3	NA	
ENSG00000252815	RNU6-410P	NA	
ENSG00000250646	AC111194.2	NA	
ENSG00000244034	RN7SL424P	NA	
ENSG00000128052	KDR	602089	HEMANGIOMA, CAPILLARY INFANTILE;;HCI;;HEMANGIOMA, HEREDITARY CAPILLARY
ENSG00000287060	AC021220.2	NA	
ENSG00000239545	RN7SL822P	NA	
ENSG00000250812	AC021220.1	NA	
ENSG00000206839	RNU6-746P	NA	
ENSG00000250464	LRRC34P2	NA	
ENSG00000128039	SRD5A3	612379	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q;;COLOBOMA, OCULAR, WITH ICHTHYOSIS, BRAIN MALFORMATIONS, AND ENDOCRINE ABNORMALITIES;;CDG Iq; CDGIq
ENSG00000128039	SRD5A3	612713	KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE
ENSG00000251111	FCF1P8	NA	
ENSG00000249700	SRD5A3-AS1	NA	
ENSG00000273257	AC069200.1	NA	
ENSG00000134851	TMEM165	614727	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K;;CDG IIk; CDGIIk
ENSG00000239040	Y_RNA	NA	
ENSG00000134852	CLOCK	NA	
ENSG00000238585	Y_RNA	NA	
ENSG00000223305	RN7SKP30	NA	
ENSG00000272969	AC024243.1	NA	
ENSG00000163440	PDCL2	NA	
ENSG00000109255	NMU	NA	
ENSG00000251923	RNU6-276P	NA	
ENSG00000250821	EXOC1L	NA	
ENSG00000090989	EXOC1	NA	
ENSG00000202358	RNU6-652P	NA	
ENSG00000286599	AC110611.1	NA	
ENSG00000287382	AC110611.2	NA	
ENSG00000174799	CEP135	614673	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8
ENSG00000109265	CRACD	NA	
ENSG00000200741	RNA5SP161	NA	
ENSG00000252489	RNU6-197P	NA	
ENSG00000286093	AC022267.1	NA	
ENSG00000250324	MRPL22P1	NA	
ENSG00000157426	AASDH	NA	
ENSG00000242083	RPL7AP31	NA	
ENSG00000269921	AC068620.1	NA	
ENSG00000128059	PPAT	NA	
ENSG00000270147	AC068620.2	NA	
ENSG00000283156	AC068620.3	NA	
ENSG00000128050	PAICS	NA	
ENSG00000174780	SRP72	614675	BONE MARROW FAILURE SYNDROME 1; BMFS1
ENSG00000196503	ARL9	NA	
ENSG00000249693	THEGL	NA	
ENSG00000248590	GLDCP1	NA	
ENSG00000171476	HOPX	NA	
ENSG00000280285	AC108215.1	NA	
ENSG00000241250	RPL17P20	NA	
ENSG00000227040	AC022483.1	NA	
ENSG00000240545	RN7SL492P	NA	
ENSG00000265894	RN7SL357P	NA	
ENSG00000128040	SPINK2	618091	SPERMATOGENIC FAILURE 29; SPGF29
ENSG00000278226	AC022483.3	NA	
ENSG00000251799	AC022483.2	NA	
ENSG00000084093	REST	612431	DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27
ENSG00000084093	REST	616806	WILMS TUMOR 6; WT6;;WILMS TUMOR, SUSCEPTIBILITY TO
ENSG00000084093	REST	617626	FIBROMATOSIS, GINGIVAL, 5; GINGF5;;GGF5;;FIBROMATOSIS, GINGIVAL, HEREDITARY, 5; HGF5
ENSG00000269949	AC069307.1	NA	
ENSG00000084092	NOA1	NA	
ENSG00000047315	POLR2B	NA	
ENSG00000251703	RNU6-998P	NA	
ENSG00000163453	IGFBP7	614224	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS
ENSG00000250384	UBE2CP3	NA	
ENSG00000245067	IGFBP7-AS1	NA	
ENSG00000287369	AC111197.1	NA	
ENSG00000250192	AC105390.1	NA	
ENSG00000243920	RPS26P24	NA	
ENSG00000248505	LINC02380	NA	
ENSG00000251459	AC013724.1	NA	
ENSG00000251049	AC107396.1	NA	
ENSG00000250333	AC093725.2	NA	
ENSG00000249831	AC093725.1	NA	
ENSG00000285998	AC104790.1	NA	
ENSG00000248660	SRIP1	NA	
ENSG00000249105	AC096725.1	NA	
ENSG00000250340	LINC02494	NA	
ENSG00000250078	AC019133.1	NA	
ENSG00000251339	AC017091.1	NA	
ENSG00000249382	LINC02619	NA	
ENSG00000251266	LINC02429	NA	
ENSG00000250375	AC097501.1	NA	
ENSG00000286097	AC108517.2	NA	
ENSG00000249111	AC108517.1	NA	
ENSG00000199780	Y_RNA	NA	
ENSG00000249392	AC096588.1	NA	
ENSG00000249892	AC093857.1	NA	
ENSG00000201676	Y_RNA	NA	
ENSG00000201775	RNU6-1325P	NA	
ENSG00000287174	AC092596.1	NA	
ENSG00000283043	AC097655.1	NA	
ENSG00000249066	LINC02496	NA	
ENSG00000248237	AC105420.1	NA	
ENSG00000265829	MIR548AG1	NA	
ENSG00000240152	LINC02271	NA	
ENSG00000150471	ADGRL3	NA	
ENSG00000241261	RPL17P19	NA	
ENSG00000205682	AC020741.1	NA	
ENSG00000226439	AC108161.1	NA	
ENSG00000202169	Y_RNA	NA	
ENSG00000248692	ADGRL3-AS1	NA	
ENSG00000225405	RPS15AP17	NA	
ENSG00000241344	RPL21P47	NA	
ENSG00000250249	AC105313.1	NA	
ENSG00000288567	AC074087.2	NA	
ENSG00000248847	AC074087.1	NA	
ENSG00000248336	HMGN1P11	NA	
ENSG00000180673	EXOC5P1	NA	
ENSG00000251055	AC097491.1	NA	
ENSG00000231442	LARP1BP1	NA	
ENSG00000250775	AC093730.1	NA	
ENSG00000205678	TECRL	614021	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3
ENSG00000252104	RNU6-191P	NA	
ENSG00000250768	DPP3P1	NA	
ENSG00000251430	MTCO3P27	NA	
ENSG00000251385	MTCYBP16	NA	
ENSG00000249893	MTND6P16	NA	
ENSG00000250169	MTND5P13	NA	
ENSG00000248259	MTND4LP31	NA	
ENSG00000249045	MTND3P24	NA	
ENSG00000248328	MTCO3P28	NA	
ENSG00000244669	AC104689.1	NA	
ENSG00000286664	AC104689.2	NA	
ENSG00000250125	LINC02232	NA	
ENSG00000248447	AC107058.1	NA	
ENSG00000248998	EFL1P2	NA	
ENSG00000249351	AC096754.1	NA	
ENSG00000285711	LINC02835	NA	
ENSG00000145242	EPHA5	NA	
ENSG00000243199	AC115223.1	NA	
ENSG00000250846	EPHA5-AS1	NA	
ENSG00000248479	AC104137.1	NA	
ENSG00000222765	RNU2-40P	NA	
ENSG00000251527	AC097110.1	NA	
ENSG00000249413	AC116049.1	NA	
ENSG00000272304	AC096721.1	NA	
ENSG00000236562	IFITM3P1	NA	
ENSG00000287383	AC110809.1	NA	
ENSG00000221563	MIR1269A	NA	
ENSG00000244099	RPS23P3	NA	
ENSG00000252890	RNU6-699P	NA	
ENSG00000250075	AC104806.2	NA	
ENSG00000206629	RNU1-63P	NA	
ENSG00000274759	RNA5SP527	NA	
ENSG00000250030	AC104806.1	NA	
ENSG00000145241	CENPC	NA	
ENSG00000035720	STAP1	NA	
ENSG00000279464	AC096720.2	NA	
ENSG00000033178	UBA6	NA	
ENSG00000270257	AC096720.1	NA	
ENSG00000248049	UBA6-AS1	NA	
ENSG00000250656	ST3GAL1P1	NA	
ENSG00000270228	AC079880.1	NA	
ENSG00000270292	AC079880.2	NA	
ENSG00000109163	GNRHR	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000202374	SNORA62	NA	
ENSG00000232398	TMPRSS11CP	NA	
ENSG00000153802	TMPRSS11D	NA	
ENSG00000187054	TMPRSS11A	NA	
ENSG00000229009	TMPRSS11GP	NA	
ENSG00000207428	RNU6-95P	NA	
ENSG00000227725	GCOM2	NA	
ENSG00000283131	MTND2P41	NA	
ENSG00000198092	TMPRSS11F	NA	
ENSG00000215127	SYT14P1	NA	
ENSG00000250426	FTLP10	NA	
ENSG00000250026	TMPRSS11BNL	NA	
ENSG00000185873	TMPRSS11B	NA	
ENSG00000250642	AC098799.3	NA	
ENSG00000248639	AC098799.1	NA	
ENSG00000249531	AC098799.2	NA	
ENSG00000248122	APOOP4	NA	
ENSG00000083896	YTHDC1	NA	
ENSG00000162840	MT2P1	NA	
ENSG00000087128	TMPRSS11E	NA	
ENSG00000250566	UGT2B29P	NA	
ENSG00000197888	UGT2B17	612560	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
ENSG00000249472	AC147055.2	NA	
ENSG00000251101	AC147055.4	NA	
ENSG00000251074	AC147055.3	NA	
ENSG00000196620	UGT2B15	NA	
ENSG00000248635	AC147055.1	NA	
ENSG00000250376	AC093720.1	NA	
ENSG00000251236	AC021146.8	NA	
ENSG00000109181	UGT2B10	NA	
ENSG00000251424	AC021146.9	NA	
ENSG00000249235	AC021146.4	NA	
ENSG00000251529	AC021146.11	NA	
ENSG00000248547	AC021146.2	NA	
ENSG00000248613	AC021146.3	NA	
ENSG00000272626	AC021146.12	NA	
ENSG00000249985	AC021146.6	NA	
ENSG00000198277	AC021146.1	NA	
ENSG00000135220	UGT2A3	NA	
ENSG00000251498	AC021146.10	NA	
ENSG00000249735	AC021146.5	NA	
ENSG00000250277	AC021146.7	NA	
ENSG00000251685	UGT2B27P	NA	
ENSG00000249890	AC107401.1	NA	
ENSG00000250919	UGT2B26P	NA	
ENSG00000171234	UGT2B7	NA	
ENSG00000248763	AC111000.2	NA	
ENSG00000251284	AC111000.5	NA	
ENSG00000250100	AC111000.3	NA	
ENSG00000251427	AC111000.6	NA	
ENSG00000196472	AC111000.1	NA	
ENSG00000250696	AC111000.4	NA	
ENSG00000213759	UGT2B11	NA	
ENSG00000268803	AC114797.1	NA	
ENSG00000249763	AC114786.1	NA	
ENSG00000135226	UGT2B28	NA	
ENSG00000251691	AC114786.3	NA	
ENSG00000250612	AC114786.2	NA	
ENSG00000268209	AC114786.4	NA	
ENSG00000215110	UGT2B25P	NA	
ENSG00000248824	AC108078.1	NA	
ENSG00000249956	UGT2B24P	NA	
ENSG00000250828	AC108078.3	NA	
ENSG00000249686	AC108078.2	NA	
ENSG00000156096	UGT2B4	NA	
ENSG00000248886	UGT2A3P7	NA	
ENSG00000251177	AC093829.1	NA	
ENSG00000173610	UGT2A1	NA	
ENSG00000271271	UGT2A2	NA	
ENSG00000173597	SULT1B1	NA	
ENSG00000236959	SULT1D1P	NA	
ENSG00000284695	AC108941.2	NA	
ENSG00000109193	SULT1E1	NA	
ENSG00000251489	AC108941.1	NA	
ENSG00000126545	CSN1S1	NA	
ENSG00000135222	CSN2	NA	
ENSG00000126549	STATH	NA	
ENSG00000205649	HTN3	NA	
ENSG00000126550	HTN1	NA	
ENSG00000234124	CSN1S2AP	NA	
ENSG00000187533	PRR27	NA	
ENSG00000109205	ODAM	NA	
ENSG00000181617	FDCSP	NA	
ENSG00000171209	CSN3	NA	
ENSG00000145309	CABS1	NA	
ENSG00000109208	SMR3A	NA	
ENSG00000171201	SMR3B	NA	
ENSG00000171199	OPRPN	NA	
ENSG00000171195	MUC7	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000187689	AMTN	617607	AMELOGENESIS IMPERFECTA, TYPE IIIB; AI3B
ENSG00000178522	AMBN	616270	AMELOGENESIS IMPERFECTA, TYPE IF; AI1F;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE IF; AI1F
ENSG00000132464	ENAM	104500	AMELOGENESIS IMPERFECTA, TYPE IB; AI1B;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC LOCAL, AUTOSOMAL DOMINANT;;AIH2;;ENAMEL HYPOPLASIA, HEREDITARY LOCALIZED
ENSG00000132464	ENAM	204650	AMELOGENESIS IMPERFECTA, TYPE IC; AI1C;;AMELOGENESIS IMPERFECTA, LOCAL HYPOPLASTIC TYPE, AUTOSOMAL RECESSIVE;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, WITH OR WITHOUT OPEN-BITE MALOCCLUSION, AUTOSOMAL RECESSIVE
ENSG00000286848	AC009570.2	NA	
ENSG00000132465	JCHAIN	NA	
ENSG00000132467	UTP3	NA	
ENSG00000207448	RNU6-520P	NA	
ENSG00000207058	RNU6-784P	NA	
ENSG00000272986	AC009570.1	NA	
ENSG00000018189	RUFY3	NA	
ENSG00000132463	GRSF1	NA	
ENSG00000283313	AC021989.1	NA	
ENSG00000207007	RNU6-891P	NA	
ENSG00000173542	MOB1B	NA	
ENSG00000156136	DCK	NA	
ENSG00000080493	SLC4A4	604278	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION;;RTA, PROXIMAL, AUTOSOMAL RECESSIVE
ENSG00000249170	AC096713.1	NA	
ENSG00000270098	LDHAL6EP	NA	
ENSG00000145321	GC	NA	
ENSG00000222236	RNA5SP163	NA	
ENSG00000248567	AC068721.1	NA	
ENSG00000056291	NPFFR2	NA	
ENSG00000156140	ADAMTS3	618154	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3
ENSG00000250877	AC095056.1	NA	
ENSG00000270665	HNRNPA1P67	NA	
ENSG00000252955	RNU4ATAC9P	NA	
ENSG00000210839	RNU6ATAC5P	NA	
ENSG00000163626	COX18	NA	
ENSG00000132466	ANKRD17	NA	
ENSG00000248641	HMGA1P2	NA	
ENSG00000250220	AC053527.2	NA	
ENSG00000221639	AC053527.1	NA	
ENSG00000249976	AC108157.1	NA	
ENSG00000163631	ALB	615999	HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC; FDAH;;FDH;;EUTHYROID HYPERTHYROXINEMIA 1
ENSG00000163631	ALB	616000	ANALBUMINEMIA; ANALBA
ENSG00000081051	AFP	615969	ALPHA-FETOPROTEIN DEFICIENCY; AFPD
ENSG00000081051	AFP	615970	ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF; HPAFP
ENSG00000079557	AFM	NA	
ENSG00000250436	LINC02499	NA	
ENSG00000249970	AC074250.1	NA	
ENSG00000169435	RASSF6	NA	
ENSG00000228277	UMLILO	NA	
ENSG00000169429	CXCL8	NA	
ENSG00000249051	AC112518.1	NA	
ENSG00000124875	CXCL6	NA	
ENSG00000250550	PPBPP1	NA	
ENSG00000109272	PF4V1	NA	
ENSG00000163739	CXCL1	NA	
ENSG00000249920	HNRNPA1P55	NA	
ENSG00000250339	CXCL1P1	NA	
ENSG00000163737	PF4	NA	
ENSG00000163736	PPBP	NA	
ENSG00000163735	CXCL5	NA	
ENSG00000287037	AC097709.1	NA	
ENSG00000244194	RN7SL218P	NA	
ENSG00000163734	CXCL3	NA	
ENSG00000248848	PPBPP2	NA	
ENSG00000288019	AC093677.3	NA	
ENSG00000251017	AC093677.1	NA	
ENSG00000081041	CXCL2	NA	
ENSG00000163738	MTHFD2L	NA	
ENSG00000269559	AC093677.2	NA	
ENSG00000182585	EPGN	NA	
ENSG00000124882	EREG	NA	
ENSG00000250532	AC021180.1	NA	
ENSG00000109321	AREG	NA	
ENSG00000249942	AC239584.1	NA	
ENSG00000174808	BTC	NA	
ENSG00000287375	AC098825.1	NA	
ENSG00000250356	HSPE1P23	NA	
ENSG00000169116	PARM1	NA	
ENSG00000249717	PARM1-AS1	NA	
ENSG00000248165	AC110760.1	NA	
ENSG00000260265	LINC02562	NA	
ENSG00000250315	AC110760.2	NA	
ENSG00000250560	AC093870.1	NA	
ENSG00000251185	AC025244.1	NA	
ENSG00000251454	AC025244.2	NA	
ENSG00000251383	LINC02483	NA	
ENSG00000248646	AC096759.1	NA	
ENSG00000250735	AC096759.2	NA	
ENSG00000163743	RCHY1	NA	
ENSG00000174796	THAP6	NA	
ENSG00000174792	ODAPH	614832	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4
ENSG00000138769	CDKL2	NA	
ENSG00000138757	G3BP2	NA	
ENSG00000201644	Y_RNA	NA	
ENSG00000138768	USO1	NA	
ENSG00000229717	AC110615.1	NA	
ENSG00000222644	RNU2-16P	NA	
ENSG00000156194	PPEF2	NA	
ENSG00000138744	NAAA	NA	
ENSG00000198301	SDAD1	NA	
ENSG00000245928	SDAD1-AS1	NA	
ENSG00000138755	CXCL9	NA	
ENSG00000156219	ART3	NA	
ENSG00000169245	CXCL10	NA	
ENSG00000169248	CXCL11	NA	
ENSG00000225846	AC112719.1	NA	
ENSG00000138750	NUP54	NA	
ENSG00000286074	AC110795.1	NA	
ENSG00000138760	SCARB2	254900	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4;;ACTION MYOCLONUS-RENAL FAILURE SYNDROME; AMRF;;MYOCLONUS-NEPHROPATHY SYNDROME
ENSG00000189157	FAM47E	NA	
ENSG00000287401	AC034139.1	NA	
ENSG00000272414	FAM47E-STBD1	NA	
ENSG00000118804	STBD1	NA	
ENSG00000163749	CCDC158	NA	
ENSG00000249858	SNX5P1	NA	
ENSG00000212368	RNU6-1000P	NA	
ENSG00000240426	AC096743.2	NA	
ENSG00000199857	AC096743.1	NA	
ENSG00000138771	SHROOM3	NA	
ENSG00000249278	AC112249.1	NA	
ENSG00000207307	RNU6-145P	NA	
ENSG00000263445	MIR4450	NA	
ENSG00000283682	MIR548AH	NA	
ENSG00000233860	SHROOM3-AS1	NA	
ENSG00000224218	AC107072.1	NA	
ENSG00000270244	AC104687.2	NA	
ENSG00000242727	AC104687.1	NA	
ENSG00000186212	SOWAHB	NA	
ENSG00000138758	SEPTIN11	NA	
ENSG00000234036	TXNP6	NA	
ENSG00000118816	CCNI	NA	
ENSG00000214062	RPL7P17	NA	
ENSG00000271676	AC104771.1	NA	
ENSG00000201641	RNU6-1187P	NA	
ENSG00000138764	CCNG2	NA	
ENSG00000270669	AC008638.3	NA	
ENSG00000250006	AC008638.2	NA	
ENSG00000248831	AC008638.1	NA	
ENSG00000249036	AC092674.1	NA	
ENSG00000156234	CXCL13	NA	
ENSG00000221711	AC104701.1	NA	
ENSG00000138767	CNOT6L	NA	
ENSG00000169288	MRPL1	NA	
ENSG00000250214	AC112225.1	NA	
ENSG00000248926	AC114801.2	NA	
ENSG00000248956	HMGB1P44	NA	
ENSG00000248640	HNRNPA1P56	NA	
ENSG00000248128	AC114801.1	NA	
ENSG00000249072	AC114801.3	NA	
ENSG00000138759	FRAS1	219000	FRASER SYNDROME 1; FRASRS1;;FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONS;;CRYPTOPHTHALMOS-SYNDACTYLY SYNDROME
ENSG00000249565	SERBP1P5	NA	
ENSG00000248117	MICOS10P4	NA	
ENSG00000138772	ANXA3	NA	
ENSG00000200998	Y_RNA	NA	
ENSG00000251442	LINC01094	NA	
ENSG00000251019	HIGD1AP13	NA	
ENSG00000287632	AC112253.1	NA	
ENSG00000239793	AC098818.1	NA	
ENSG00000260278	AC098818.2	NA	
ENSG00000138756	BMP2K	NA	
ENSG00000266270	AC098818.3	NA	
ENSG00000163291	PAQR3	NA	
ENSG00000242175	RN7SL127P	NA	
ENSG00000249307	LINC01088	NA	
ENSG00000156269	NAA11	NA	
ENSG00000196475	GK2	600148	GLYCEROL KINASE 2; GK2;;GLYCEROL KINASE, TESTICULAR, TYPE A; GKTA;;GLYCEROL KINASE PSEUDOGENE 2; GKP2
ENSG00000250334	LINC00989	NA	
ENSG00000249646	OR7E94P	NA	
ENSG00000251399	AC092542.1	NA	
ENSG00000248408	LINC02469	NA	
ENSG00000251321	PCAT4	NA	
ENSG00000212620	SNORA75	NA	
ENSG00000163297	ANTXR2	228600	HYALINE FIBROMATOSIS SYNDROME; HFS;;HYALINOSIS, SYSTEMIC
ENSG00000236530	KPNA2P1	NA	
ENSG00000244002	RPSAP39	NA	
ENSG00000248719	AC021127.1	NA	
ENSG00000152784	PRDM8	616640	EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10
ENSG00000138675	FGF5	190330	TRICHOMEGALY; TCMGLY;;EYELASHES, LONG
ENSG00000197826	CFAP299	NA	
ENSG00000232327	AC105917.1	NA	
ENSG00000152785	BMP3	NA	
ENSG00000138669	PRKG2	NA	
ENSG00000251059	PRKG2-AS1	NA	
ENSG00000207065	RNU5A-2P	NA	
ENSG00000138670	RASGEF1B	NA	
ENSG00000248282	MTCYBP44	NA	
ENSG00000248448	COX5BP1	NA	
ENSG00000252762	AC021863.1	NA	
ENSG00000248543	NPM1P41	NA	
ENSG00000250826	HNRNPA3P13	NA	
ENSG00000202485	RNU6-499P	NA	
ENSG00000234568	BIN2P1	NA	
ENSG00000284516	VAMP9P	NA	
ENSG00000273156	AC124016.2	NA	
ENSG00000138668	HNRNPD	NA	
ENSG00000272677	AC124016.1	NA	
ENSG00000250325	IGBP1P4	NA	
ENSG00000202440	SNORD42	NA	
ENSG00000152795	HNRNPDL	609115	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3; LGMDD3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1G; LGMD1G
ENSG00000145293	ENOPH1	NA	
ENSG00000249242	TMEM150C	NA	
ENSG00000214988	RPL7AP26	NA	
ENSG00000227304	AC067942.1	NA	
ENSG00000249960	AC067942.3	NA	
ENSG00000248113	AC067942.2	NA	
ENSG00000231782	LINC00575	NA	
ENSG00000286490	AC067942.4	NA	
ENSG00000145284	SCD5	NA	
ENSG00000270480	AC073413.1	NA	
ENSG00000207746	MIR575	NA	
ENSG00000270842	AC073413.2	NA	
ENSG00000138674	SEC31A	618651	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA, OPTIC ATROPHY, SEIZURES, AND STRUCTURAL BRAIN ANOMALIES; NEDSOSB
ENSG00000251022	THAP9-AS1	NA	
ENSG00000168152	THAP9	NA	
ENSG00000189308	LIN54	NA	
ENSG00000199530	Y_RNA	NA	
ENSG00000251874	RNU6-615P	NA	
ENSG00000138663	COPS4	NA	
ENSG00000286035	AC073840.1	NA	
ENSG00000145287	PLAC8	NA	
ENSG00000250057	AC114781.2	NA	
ENSG00000250677	AC114781.3	NA	
ENSG00000248401	AC114781.1	NA	
ENSG00000173085	COQ2	146500	MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1;;MSA1, SUSCEPTIBILITY TO AUTONOMIC FAILURE, PURE, INCLUDED;;HYPOTENSION, ORTHOSTATIC, INCLUDED
ENSG00000173085	COQ2	607426	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1;;CoQ10 DEFICIENCY, PRIMARY, 1;;UBIQUINONE DEFICIENCY 1;;COENZYME Q DEFICIENCY 1;;CoQ DEFICIENCY 1
ENSG00000173083	HPSE	NA	
ENSG00000274154	AC114781.5	NA	
ENSG00000251647	AC114781.4	NA	
ENSG00000163312	HELQ	NA	
ENSG00000163319	MRPS18C	NA	
ENSG00000163322	ABRAXAS1	NA	
ENSG00000213608	SLC25A14P1	NA	
ENSG00000239525	RPL30P5	NA	
ENSG00000138678	GPAT3	NA	
ENSG00000201633	Y_RNA	NA	
ENSG00000249171	AC021192.1	NA	
ENSG00000250546	AC079160.1	NA	
ENSG00000200108	RNU6-774P	NA	
ENSG00000214980	AC025538.1	NA	
ENSG00000248749	AC104063.1	NA	
ENSG00000163623	NKX6-1	NA	
ENSG00000258013	RPL3P13	NA	
ENSG00000163624	CDS1	NA	
ENSG00000163625	WDFY3	617520	MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18
ENSG00000239466	RN7SL552P	NA	
ENSG00000251260	WDFY3-AS1	NA	
ENSG00000252062	RNU6-469P	NA	
ENSG00000180769	WDFY3-AS2	NA	
ENSG00000286189	AC108021.1	NA	
ENSG00000201901	RN7SKP48	NA	
ENSG00000248725	AC097488.1	NA	
ENSG00000138639	ARHGAP24	NA	
ENSG00000266421	MIR4451	NA	
ENSG00000109339	MAPK10	NA	
ENSG00000250062	MAPK10-AS1	NA	
ENSG00000252757	RN7SKP96	NA	
ENSG00000266515	MIR4452	NA	
ENSG00000163629	PTPN13	NA	
ENSG00000145283	SLC10A6	NA	
ENSG00000243312	AC093827.1	NA	
ENSG00000163633	C4orf36	NA	
ENSG00000250202	AC093827.2	NA	
ENSG00000285458	AC093827.5	NA	
ENSG00000251411	AC093827.3	NA	
ENSG00000284968	AC093827.4	NA	
ENSG00000172493	AFF1	NA	
ENSG00000235043	TECRP1	NA	
ENSG00000145332	KLHL8	NA	
ENSG00000248196	AC092658.1	NA	
ENSG00000248180	GAPDHP60	NA	
ENSG00000250572	AC108516.1	NA	
ENSG00000263981	MIR5705	NA	
ENSG00000170509	HSD17B13	NA	
ENSG00000255723	AC108516.2	NA	
ENSG00000198189	HSD17B11	NA	
ENSG00000240966	RN7SL681P	NA	
ENSG00000249262	AC112250.1	NA	
ENSG00000170502	NUDT9	NA	
ENSG00000272856	AC112250.2	NA	
ENSG00000152583	SPARCL1	NA	
ENSG00000249001	AC093895.1	NA	
ENSG00000152591	DSPP	125500	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III;;DGI-III;;BRANDYWINE TYPE DENTINOGENESIS IMPERFECTA
ENSG00000152591	DSPP	125490	DENTINOGENESIS IMPERFECTA 1; DGI1;;OPALESCENT DENTIN;;DENTINOGENESIS IMPERFECTA WITHOUT OSTEOGENESIS IMPERFECTA;;OPALESCENT TEETH WITHOUT OSTEOGENESIS IMPERFECTA;;DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II;;DGI-II;;CAPDEPONT TEETH
ENSG00000152591	DSPP	125420	DENTIN DYSPLASIA, TYPE II; DTDP2;;DENTIN DYSPLASIA, SHIELDS TYPE II;;CORONAL DENTIN DYSPLASIA;;ANOMALOUS DYSPLASIA OF DENTIN;;PULPAL DYSPLASIA;;PULP STONES
ENSG00000152591	DSPP	605594	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1;;DFNA39/DENTINOGENESIS IMPERFECTA 1 SYNDROME;;DFNA39/DGI1 SYNDROME;;DGI1/DFNA39 SYNDROME
ENSG00000152592	DMP1	241520	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1;;ARHR;;HYPOPHOSPHATEMIA, AUTOSOMAL RECESSIVE; ARHP
ENSG00000200024	Y_RNA	NA	
ENSG00000249973	CHCHD2P7	NA	
ENSG00000029559	IBSP	NA	
ENSG00000152595	MEPE	NA	
ENSG00000183199	HSP90AB3P	NA	
ENSG00000286618	AC131944.1	NA	
ENSG00000118785	SPP1	NA	
ENSG00000202000	RNU1-36P	NA	
ENSG00000118762	PKD2	613095	POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2;;POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE II; APKD2
ENSG00000118777	ABCG2	138900	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1;;GOUT SUSCEPTIBILITY 1; GOUT1
ENSG00000118777	ABCG2	614490	BLOOD GROUP, JUNIOR SYSTEM; JR
ENSG00000241853	AC097484.1	NA	
ENSG00000201707	RNU6-818P	NA	
ENSG00000221440	RNU6ATAC31P	NA	
ENSG00000251285	AC097484.2	NA	
ENSG00000199326	RNU6-1298P	NA	
ENSG00000163644	PPM1K	615135	MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV
ENSG00000200469	RNU6-112P	NA	
ENSG00000246375	PPM1K-DT	NA	
ENSG00000207480	Y_RNA	NA	
ENSG00000287181	AC107067.2	NA	
ENSG00000286978	AC107067.1	NA	
ENSG00000138642	HERC6	NA	
ENSG00000138646	HERC5	NA	
ENSG00000249934	NCOA4P2	NA	
ENSG00000145337	PYURF	NA	
ENSG00000255072	PIGY	616809	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6; HPMRS6;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 12; GPIBD12
ENSG00000287542	AC098582.1	NA	
ENSG00000285122	PIGY-DT	NA	
ENSG00000249755	AC083829.1	NA	
ENSG00000252322	RN7SKP244	NA	
ENSG00000138641	HERC3	NA	
ENSG00000207524	RNU6-33P	NA	
ENSG00000177432	NAP1L5	NA	
ENSG00000248019	FAM13A-AS1	NA	
ENSG00000278151	AC108065.2	NA	
ENSG00000276003	AC108065.1	NA	
ENSG00000138640	FAM13A	NA	
ENSG00000180346	TIGD2	NA	
ENSG00000270720	AC104785.1	NA	
ENSG00000212226	RNU6-907P	NA	
ENSG00000185477	GPRIN3	NA	
ENSG00000251095	AC093866.1	NA	
ENSG00000288563	AC097478.4	NA	
ENSG00000145335	SNCA	168601	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1;;PARKINSON DISEASE 1, AUTOSOMAL DOMINANT LEWY BODY ATYPICAL PARKINSON DISEASE, INCLUDED
ENSG00000145335	SNCA	127750	DEMENTIA, LEWY BODY; DLB;;LEWY BODY DEMENTIA;;DIFFUSE LEWY BODY DISEASE DIFFUSE LEWY BODY DISEASE WITH GAZE PALSY, INCLUDED;;LEWY BODY VARIANT OF ALZHEIMER DISEASE, INCLUDED
ENSG00000145335	SNCA	605543	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4;;PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY
ENSG00000274238	AC097478.1	NA	
ENSG00000277695	AC097478.3	NA	
ENSG00000276542	AC097478.2	NA	
ENSG00000247775	SNCA-AS1	NA	
ENSG00000138722	MMRN1	NA	
ENSG00000287239	AC105445.1	NA	
ENSG00000184305	CCSER1	NA	
ENSG00000252087	RN7SKP248	NA	
ENSG00000251401	AC093729.1	NA	
ENSG00000187653	TMSB4XP8	NA	
ENSG00000248984	AC004054.1	NA	
ENSG00000249049	AC074124.1	NA	
ENSG00000279013	AC110774.1	NA	
ENSG00000249891	KRT19P6	NA	
ENSG00000249052	AC093810.1	NA	
ENSG00000248817	PMPCAP1	NA	
ENSG00000287392	AC097520.2	NA	
ENSG00000280056	AC097520.1	NA	
ENSG00000249152	LNCPRESS2	NA	
ENSG00000248511	AC112695.1	NA	
ENSG00000152208	GRID2	616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18
ENSG00000251449	MTND1P19	NA	
ENSG00000249239	AC095059.2	NA	
ENSG00000248627	AC095059.1	NA	
ENSG00000248750	AC020699.1	NA	
ENSG00000250908	AC110800.1	NA	
ENSG00000252342	RNA5SP164	NA	
ENSG00000172238	ATOH1	NA	
ENSG00000246541	AC096746.1	NA	
ENSG00000250897	HMGB3P15	NA	
ENSG00000163104	SMARCAD1	181600	HURIEZ SYNDROME; HRZ;;SCLEROTYLOSIS;;SCLEROATROPHIC AND KERATOTIC DERMATOSIS OF LIMBS
ENSG00000163104	SMARCAD1	136000	ADERMATOGLYPHIA; ADERM;;FINGERPRINTS, ABSENCE OF
ENSG00000163104	SMARCAD1	129200	BASAN SYNDROME;;ADERMATOGLYPHIA WITH CONGENITAL FACIAL MILIA AND ACRAL BLISTERS, DIGITAL CONTRACTURES, AND NAIL ABNORMALITIES;;ECTODERMAL DYSPLASIA, ABSENT DERMATOGLYPHIC PATTERN, CHANGES IN NAILS, AND SIMIAN CREASE
ENSG00000163106	HPGDS	NA	
ENSG00000287552	AC109925.2	NA	
ENSG00000241103	AC109925.1	NA	
ENSG00000163110	PDLIM5	NA	
ENSG00000249951	AC108067.1	NA	
ENSG00000249599	BMPR1B-DT	NA	
ENSG00000138696	BMPR1B	112600	BRACHYDACTYLY, TYPE A2; BDA2;;BRACHYMESOPHALANGY II;;MOHR-WRIEDT TYPE BRACHYDACTYLY
ENSG00000138696	BMPR1B	609441	ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD;;CHONDRODYSPLASIA, ACROMESOMELIC, WITH OR WITHOUT GENITAL ANOMALIES
ENSG00000138696	BMPR1B	616849	BRACHYDACTYLY, TYPE A1, D; BDA1D
ENSG00000182168	UNC5C	NA	
ENSG00000271474	AC106881.1	NA	
ENSG00000242936	RPL30P6	NA	
ENSG00000163114	PDHA2	NA	
ENSG00000200622	RNU6-1059P	NA	
ENSG00000201744	RNU6-34P	NA	
ENSG00000250655	AC096661.1	NA	
ENSG00000248510	LINC02267	NA	
ENSG00000201640	RN7SKP28	NA	
ENSG00000287841	AC096585.1	NA	
ENSG00000236764	COX7A2P2	NA	
ENSG00000253170	AC108515.1	NA	
ENSG00000163116	STPG2	NA	
ENSG00000254044	AC034154.1	NA	
ENSG00000251620	STPG2-AS1	NA	
ENSG00000250293	CRYZP2	NA	
ENSG00000242697	RPL5P12	NA	
ENSG00000214904	DUTP8	NA	
ENSG00000214559	AC019077.1	NA	
ENSG00000138698	RAP1GDS1	NA	
ENSG00000242318	AC058823.1	NA	
ENSG00000168785	TSPAN5	NA	
ENSG00000251523	AC108159.1	NA	
ENSG00000260641	AC114811.2	NA	
ENSG00000249764	AC114811.1	NA	
ENSG00000227118	BTF3P13	NA	
ENSG00000151247	EIF4E	615091	AUTISM, SUSCEPTIBILITY TO, 19; AUTS19
ENSG00000249055	TBCAP3	NA	
ENSG00000263923	AC019131.1	NA	
ENSG00000214886	FAM177A1P1	NA	
ENSG00000287512	AC019131.3	NA	
ENSG00000252548	RNU7-149P	NA	
ENSG00000251437	NDUFS5P4	NA	
ENSG00000164024	METAP1	NA	
ENSG00000265213	MIR3684	NA	
ENSG00000250496	ABT1P1	NA	
ENSG00000272777	AC019131.2	NA	
ENSG00000197894	ADH5	NA	
ENSG00000246090	AP002026.1	NA	
ENSG00000198099	ADH4	NA	
ENSG00000249065	PCNAP1	NA	
ENSG00000172955	ADH6	NA	
ENSG00000187758	ADH1A	NA	
ENSG00000196616	ADH1B	103780	ALCOHOL DEPENDENCE;;ALCOHOLISM ALCOHOL DEPENDENCE, PROTECTION AGAINST, INCLUDED;;AERODIGESTIVE TRACT CANCER, SQUAMOUS CELL, ALCOHOL-RELATED, PROTECTION AGAINST, INCLUDED
ENSG00000248144	ADH1C	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000248144	ADH1C	103780	ALCOHOL DEPENDENCE;;ALCOHOLISM ALCOHOL DEPENDENCE, PROTECTION AGAINST, INCLUDED;;AERODIGESTIVE TRACT CANCER, SQUAMOUS CELL, ALCOHOL-RELATED, PROTECTION AGAINST, INCLUDED
ENSG00000196344	ADH7	NA	
ENSG00000250300	AP001960.1	NA	
ENSG00000138813	C4orf17	NA	
ENSG00000145331	TRMT10A	616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1;;MSSGM
ENSG00000138823	MTTP	200100	ABETALIPOPROTEINEMIA; ABL;;ACANTHOCYTOSIS;;BASSEN-KORNZWEIG SYNDROME;;MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN DEFICIENCY;;MTP DEFICIENCY
ENSG00000138823	MTTP	605552	ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1;;METABOLIC SYNDROME X ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 1, INCLUDED;;METABOLIC SYNDROME, PROTECTION AGAINST, INCLUDED
ENSG00000248676	AC083902.1	NA	
ENSG00000248713	C4orf54	NA	
ENSG00000070190	DAPP1	NA	
ENSG00000279913	AP001962.1	NA	
ENSG00000109270	LAMTOR3	NA	
ENSG00000164031	DNAJB14	NA	
ENSG00000279098	AC097460.2	NA	
ENSG00000164032	H2AZ1	NA	
ENSG00000245322	H2AZ1-DT	NA	
ENSG00000250403	AC097460.1	NA	
ENSG00000248820	DYNLL1P6	NA	
ENSG00000145358	DDIT4L	NA	
ENSG00000249710	AP001961.1	NA	
ENSG00000164035	EMCN	NA	
ENSG00000286150	AC097459.1	NA	
ENSG00000250223	LINC01216	NA	
ENSG00000251219	LINC01217	NA	
ENSG00000251636	LINC01218	NA	
ENSG00000138814	PPP3CA	617711	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1
ENSG00000138814	PPP3CA	618265	ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID
ENSG00000273882	MIR8066	NA	
ENSG00000221265	MIR1255A	NA	
ENSG00000254531	FLJ20021	NA	
ENSG00000153064	BANK1	NA	
ENSG00000286124	AC084277.1	NA	
ENSG00000199529	RNU6-462P	NA	
ENSG00000251149	MTND5P5	NA	
ENSG00000251309	AP002075.1	NA	
ENSG00000138821	SLC39A8	616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N;;CDG IIn; CDGIIn
ENSG00000241144	RN7SL728P	NA	
ENSG00000248161	AC098487.1	NA	
ENSG00000251572	AF213884.2	NA	
ENSG00000260651	AF213884.3	NA	
ENSG00000109320	NFKB1	616576	IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12;;NFKB1 DEFICIENCY
ENSG00000109323	MANBA	248510	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB;;BETA-MANNOSIDOSIS;;LYSOSOMAL BETA-MANNOSIDASE DEFICIENCY;;BETA-MANNOSIDASE DEFICIENCY
ENSG00000241981	AF213884.1	NA	
ENSG00000230069	LRRC37A15P	NA	
ENSG00000248971	KRT8P46	NA	
ENSG00000224207	AC018797.1	NA	
ENSG00000251288	AC018797.2	NA	
ENSG00000109332	UBE2D3	NA	
ENSG00000286242	AC018797.3	NA	
ENSG00000246560	UBE2D3-AS1	NA	
ENSG00000252739	RNU7-151P	NA	
ENSG00000145354	CISD2	604928	WOLFRAM SYNDROME 2; WFS2
ENSG00000164037	SLC9B1	NA	
ENSG00000250651	PABPC1P7	NA	
ENSG00000249283	ACTR3BP4	NA	
ENSG00000164038	SLC9B2	NA	
ENSG00000164039	BDH2	NA	
ENSG00000138778	CENPE	616051	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13
ENSG00000248740	LINC02428	NA	
ENSG00000251577	AC105460.2	NA	
ENSG00000250920	AC105460.1	NA	
ENSG00000251571	DDX3P3	NA	
ENSG00000169836	TACR3	614840	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11
ENSG00000286291	AC004047.1	NA	
ENSG00000252460	RNU6-635P	NA	
ENSG00000249614	LINC02503	NA	
ENSG00000251170	AC004052.1	NA	
ENSG00000168772	CXXC4	NA	
ENSG00000245384	CXXC4-AS1	NA	
ENSG00000250670	AC004063.1	NA	
ENSG00000248242	AC004053.1	NA	
ENSG00000244470	AC105918.1	NA	
ENSG00000248373	AC096577.1	NA	
ENSG00000251906	RNU6-351P	NA	
ENSG00000276992	AC096577.2	NA	
ENSG00000251473	AC004069.2	NA	
ENSG00000252136	AC004069.3	NA	
ENSG00000251259	AC004069.1	NA	
ENSG00000168769	TET2	614286	MYELODYSPLASTIC SYNDROME; MDS;;MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED
ENSG00000251586	TET2-AS1	NA	
ENSG00000243383	RN7SL89P	NA	
ENSG00000138777	PPA2	617222	SUDDEN CARDIAC FAILURE, INFANTILE; SCFI
ENSG00000138777	PPA2	617223	SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED; SCFAI
ENSG00000200917	RNU6-553P	NA	
ENSG00000249264	EEF1A1P9	NA	
ENSG00000216425	PIMREGP2	NA	
ENSG00000250922	ATP5F1EP1	NA	
ENSG00000250522	AC004066.1	NA	
ENSG00000236699	ARHGEF38	NA	
ENSG00000249885	ARHGEF38-IT1	NA	
ENSG00000248778	AC105391.1	NA	
ENSG00000138785	INTS12	NA	
ENSG00000138780	GSTCD	NA	
ENSG00000251175	GSTCD-AS1	NA	
ENSG00000168743	NPNT	NA	
ENSG00000250740	AC109361.2	NA	
ENSG00000249635	AC109361.1	NA	
ENSG00000145348	TBCK	616900	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3
ENSG00000164022	AIMP1	260600	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3
ENSG00000250298	GIMD1	NA	
ENSG00000249613	LINC02173	NA	
ENSG00000286147	AC092445.1	NA	
ENSG00000248915	ACTR6P1	NA	
ENSG00000155011	DKK2	NA	
ENSG00000213522	RAC1P5	NA	
ENSG00000251081	AC104663.1	NA	
ENSG00000252470	RNU6-551P	NA	
ENSG00000138801	PAPSS1	NA	
ENSG00000164023	SGMS2	126550	CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL;;DOUGHNUT LESIONS OF SKULL, FAMILIAL CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY AND SPONDYLOMETAPHYSEAL DYSPLASIA, INCLUDED; CDLSMD, INCLUDED
ENSG00000245293	CYP2U1-AS1	NA	
ENSG00000222691	RNU6-733P	NA	
ENSG00000155016	CYP2U1	615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56
ENSG00000249604	AC096564.1	NA	
ENSG00000138796	HADH	231530	3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;HADH DEFICIENCY;;SCHAD DEFICIENCY, FORMERLY
ENSG00000138796	HADH	609975	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4
ENSG00000138795	LEF1	153245	LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1;;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1, ALPHA;;TCF1-ALPHA  SEBACEOUS TUMORS, SOMATIC, INCLUDED
ENSG00000232021	LEF1-AS1	NA	
ENSG00000239939	RPSAP34	NA	
ENSG00000278589	ZACNP1	NA	
ENSG00000250485	EXOC7P1	NA	
ENSG00000234492	RPL34-DT	NA	
ENSG00000109475	RPL34	NA	
ENSG00000198856	OSTC	NA	
ENSG00000206601	RNU6-431P	NA	
ENSG00000286136	AC107071.1	NA	
ENSG00000164089	ETNPPL	NA	
ENSG00000249257	AC097473.1	NA	
ENSG00000250185	RCC2P8	NA	
ENSG00000188517	COL25A1	616219	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5
ENSG00000246774	COL25A1-DT	NA	
ENSG00000249465	RBMXP4	NA	
ENSG00000247950	SEC24B-AS1	NA	
ENSG00000138802	SEC24B	NA	
ENSG00000243227	RN7SL55P	NA	
ENSG00000207988	MIR576	NA	
ENSG00000225094	SETP20	NA	
ENSG00000249965	CDC42P4	NA	
ENSG00000005059	MCUB	NA	
ENSG00000248785	HIGD1AP14	NA	
ENSG00000138794	CASP6	NA	
ENSG00000273447	AC004067.1	NA	
ENSG00000123739	PLA2G12A	NA	
ENSG00000285330	AC126283.2	NA	
ENSG00000205403	CFI	610984	COMPLEMENT FACTOR I DEFICIENCY; CFID;;COMPLEMENT COMPONENT 3 INACTIVATOR DEFICIENCY;;C3 INACTIVATOR DEFICIENCY
ENSG00000205403	CFI	612923	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3
ENSG00000205403	CFI	615439	MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13
ENSG00000272795	AC126283.1	NA	
ENSG00000109534	GAR1	NA	
ENSG00000180245	RRH	NA	
ENSG00000183423	LRIT3	615058	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F
ENSG00000249681	KRT19P3	NA	
ENSG00000138798	EGF	611718	HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC
ENSG00000207260	RNU6-35P	NA	
ENSG00000170522	ELOVL6	NA	
ENSG00000263940	RN7SL275P	NA	
ENSG00000248200	AC093770.1	NA	
ENSG00000166530	HSBP1P2	NA	
ENSG00000250594	RNF14P2	NA	
ENSG00000212160	RNU6-205P	NA	
ENSG00000250304	ZBED1P1	NA	
ENSG00000138792	ENPEP	NA	
ENSG00000251464	RPL7L1P13	NA	
ENSG00000251046	ZNF969P	NA	
ENSG00000199894	AC093872.1	NA	
ENSG00000250511	AC098798.1	NA	
ENSG00000250103	PANCR	NA	
ENSG00000164093	PITX2	180550	RING DERMOID OF CORNEA; RDC
ENSG00000164093	PITX2	180500	AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1;;RIEGER SYNDROME, TYPE 1;;RIEG;;RGS
ENSG00000164093	PITX2	137600	ANTERIOR SEGMENT DYSGENESIS 4; ASGD4;;IRIDOGONIODYSGENESIS, TYPE 2; IRID2;;IRIDOGONIODYSGENESIS SYNDROME; IGDS;;IRIS HYPOPLASIA WITH EARLY-ONSET GLAUCOMA, AUTOSOMAL DOMINANT; IHGA
ENSG00000249519	LINC01438	NA	
ENSG00000215961	MIR297	NA	
ENSG00000251483	LYPLA1P2	NA	
ENSG00000251312	AC004062.1	NA	
ENSG00000200963	RNU6-289P	NA	
ENSG00000241722	AC083795.1	NA	
ENSG00000248656	AC083795.2	NA	
ENSG00000250855	AC139718.2	NA	
ENSG00000248432	AC139718.1	NA	
ENSG00000249815	AC004704.1	NA	
ENSG00000250556	CCDC34P1	NA	
ENSG00000250307	TUBB8P3	NA	
ENSG00000240459	AC093663.1	NA	
ENSG00000174749	FAM241A	NA	
ENSG00000243280	AC093663.2	NA	
ENSG00000260526	AC109347.1	NA	
ENSG00000138660	AP1AR	NA	
ENSG00000272567	AC109347.2	NA	
ENSG00000145365	TIFA	NA	
ENSG00000073331	ALPK1	NA	
ENSG00000251441	RTEL1P1	NA	
ENSG00000248697	TOX4P1	NA	
ENSG00000178403	NEUROG2	NA	
ENSG00000249509	NEUROG2-AS1	NA	
ENSG00000248439	RPL23AP94	NA	
ENSG00000138658	ZGRF1	NA	
ENSG00000250966	H3P14	NA	
ENSG00000174720	LARP7	615071	ALAZAMI SYNDROME; ALAZS;;FACIAL DYSMORPHISM, INTELLECTUAL DISABILITY, AND PRIMORDIAL DWARFISM
ENSG00000249532	MIR302CHG	NA	
ENSG00000199169	MIR367	NA	
ENSG00000199145	MIR302D	NA	
ENSG00000207927	MIR302A	NA	
ENSG00000199102	MIR302C	NA	
ENSG00000284463	MIR302B	NA	
ENSG00000220924	OSTCP4	NA	
ENSG00000250046	AC106864.1	NA	
ENSG00000248633	WRBP1	NA	
ENSG00000241002	AC017007.3	NA	
ENSG00000202536	Y_RNA	NA	
ENSG00000241741	RPL7AP30	NA	
ENSG00000250500	AC017007.4	NA	
ENSG00000145362	ANK2	600919	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED;;ANKYRIN-B SYNDROME LONG QT SYNDROME 4, INCLUDED; LQT4, INCLUDED
ENSG00000234841	AC017007.2	NA	
ENSG00000251126	AC017007.5	NA	
ENSG00000228814	AC017007.1	NA	
ENSG00000248152	ANK2-AS1	NA	
ENSG00000249373	AC093879.1	NA	
ENSG00000283193	MIR1243	NA	
ENSG00000275810	MIR8082	NA	
ENSG00000196656	AC004057.1	NA	
ENSG00000239279	RN7SL184P	NA	
ENSG00000206820	RNU1-138P	NA	
ENSG00000145349	CAMK2D	NA	
ENSG00000250229	AC111193.1	NA	
ENSG00000180801	ARSJ	NA	
ENSG00000249304	AC104779.1	NA	
ENSG00000248716	AC093815.1	NA	
ENSG00000174607	UGT8	NA	
ENSG00000207931	MIR577	NA	
ENSG00000250215	CIR1P2	NA	
ENSG00000240637	RN7SL808P	NA	
ENSG00000138653	NDST4	NA	
ENSG00000251308	MRPS33P3	NA	
ENSG00000250693	RPF2P2	NA	
ENSG00000248488	PGAM4P2	NA	
ENSG00000250363	KRT18P21	NA	
ENSG00000249259	AC027613.1	NA	
ENSG00000250442	EIF3KP3	NA	
ENSG00000250627	TTC39CP1	NA	
ENSG00000270394	MTRNR2L13	NA	
ENSG00000284253	MIR1973	NA	
ENSG00000250272	TRMT112P1	NA	
ENSG00000248139	CUL4AP1	NA	
ENSG00000250791	AC106892.1	NA	
ENSG00000213493	ACTN4P1	NA	
ENSG00000287845	AC093765.5	NA	
ENSG00000287520	AC093765.4	NA	
ENSG00000287290	AC093765.3	NA	
ENSG00000286637	AC093765.2	NA	
ENSG00000201752	RNU6-119P	NA	
ENSG00000271053	AC093765.1	NA	
ENSG00000174599	TRAM1L1	NA	
ENSG00000223605	AC107399.1	NA	
ENSG00000224932	LINC02262	NA	
ENSG00000228358	LINC02263	NA	
ENSG00000236922	LINC01378	NA	
ENSG00000237684	RPSAP35	NA	
ENSG00000213492	NT5C3AP1	NA	
ENSG00000286269	AC092661.1	NA	
ENSG00000229565	LINC02264	NA	
ENSG00000164100	NDST3	NA	
ENSG00000251463	FKBP4P1	NA	
ENSG00000269893	SNHG8	NA	
ENSG00000275994	SNORA24	NA	
ENSG00000164099	PRSS12	249500	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1
ENSG00000230671	NDUFS5P5	NA	
ENSG00000273716	AC092670.1	NA	
ENSG00000154608	CEP170P1	NA	
ENSG00000260404	AC110079.1	NA	
ENSG00000223225	RNU6-1054P	NA	
ENSG00000248213	CICP16	NA	
ENSG00000251155	SEPTIN14P4	NA	
ENSG00000281731	METTL14-DT	NA	
ENSG00000145388	METTL14	NA	
ENSG00000150961	SEC24D	616294	COLE-CARPENTER SYNDROME 2; CLCRP2
ENSG00000172403	SYNPO2	NA	
ENSG00000249002	AC096745.1	NA	
ENSG00000172399	MYOZ2	613838	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16
ENSG00000178636	AC092656.1	NA	
ENSG00000145390	USP53	NA	
ENSG00000164096	C4orf3	NA	
ENSG00000145384	FABP2	NA	
ENSG00000250412	KLHL2P1	NA	
ENSG00000201186	RNU4-33P	NA	
ENSG00000249244	AC110373.1	NA	
ENSG00000283050	GTF2IP12	NA	
ENSG00000260091	AC093752.3	NA	
ENSG00000223208	RNU6-1217P	NA	
ENSG00000245958	AC093752.1	NA	
ENSG00000250950	AC093752.2	NA	
ENSG00000138735	PDE5A	NA	
ENSG00000221245	AC080089.1	NA	
ENSG00000286241	AC080089.2	NA	
ENSG00000250772	LINC01365	NA	
ENSG00000250183	AC097173.1	NA	
ENSG00000250392	LINC02502	NA	
ENSG00000200553	Y_RNA	NA	
ENSG00000253825	AC097173.2	NA	
ENSG00000164109	MAD2L1	NA	
ENSG00000250938	AC073475.1	NA	
ENSG00000250219	LTV1P1	NA	
ENSG00000225665	SAR1AP3	NA	
ENSG00000249409	AC025741.1	NA	
ENSG00000138738	PRDM5	614170	BRITTLE CORNEA SYNDROME 2; BCS2
ENSG00000212359	RNU6-550P	NA	
ENSG00000251609	SETP12	NA	
ENSG00000173376	NDNF	618841	HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25
ENSG00000223006	RN7SKP137	NA	
ENSG00000250344	AC105254.1	NA	
ENSG00000271302	AC105254.2	NA	
ENSG00000050730	TNIP3	NA	
ENSG00000252183	RNU6-948P	NA	
ENSG00000186867	QRFPR	NA	
ENSG00000207148	Y_RNA	NA	
ENSG00000213480	AC093816.1	NA	
ENSG00000224062	TUBB4BP5	NA	
ENSG00000164111	ANXA5	614391	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3
ENSG00000164112	TMEM155	NA	
ENSG00000226757	PP12613	NA	
ENSG00000123737	EXOSC9	618065	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D
ENSG00000145386	CCNA2	NA	
ENSG00000138686	BBS7	615984	BARDET-BIEDL SYNDROME 7; BBS7
ENSG00000261501	AC079341.1	NA	
ENSG00000138741	TRPC3	616410	SPINOCEREBELLAR ATAXIA 41; SCA41
ENSG00000237868	AC097533.1	NA	
ENSG00000241037	RN7SL335P	NA	
ENSG00000138688	KIAA1109	617822	ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS
ENSG00000164113	ADAD1	NA	
ENSG00000109471	IL2	NA	
ENSG00000138684	IL21	615767	IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11;;IL21 DEFICIENCY
ENSG00000227145	IL21-AS1	NA	
ENSG00000287692	AC053545.1	NA	
ENSG00000224786	CETN4P	NA	
ENSG00000181004	BBS12	615989	BARDET-BIEDL SYNDROME 12; BBS12
ENSG00000244083	AC021205.2	NA	
ENSG00000138685	FGF2	NA	
ENSG00000240775	AC021205.1	NA	
ENSG00000273007	AC021205.3	NA	
ENSG00000170917	NUDT6	NA	
ENSG00000145375	SPATA5	616577	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS
ENSG00000250322	AC026402.1	NA	
ENSG00000287951	AC026402.2	NA	
ENSG00000164056	SPRY1	NA	
ENSG00000249125	AC093821.1	NA	
ENSG00000249464	LINC01091	NA	
ENSG00000251526	LINC02435	NA	
ENSG00000226655	AC096732.1	NA	
ENSG00000228489	RPL21P50	NA	
ENSG00000250458	AC093767.1	NA	
ENSG00000286700	AC108075.1	NA	
ENSG00000250484	PPIAP76	NA	
ENSG00000249837	AC121154.1	NA	
ENSG00000286734	AC133530.1	NA	
ENSG00000248506	AC097474.1	NA	
ENSG00000248565	TECRP2	NA	
ENSG00000261083	LINC02516	NA	
ENSG00000151458	ANKRD50	NA	
ENSG00000196159	FAT4	615546	VAN MALDERGEM SYNDROME 2; VMLDS2
ENSG00000196159	FAT4	616006	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2
ENSG00000201297	AC079835.1	NA	
ENSG00000283550	MIR2054	NA	
ENSG00000250149	AC104664.1	NA	
ENSG00000251436	NUP58P1	NA	
ENSG00000249555	TMEM248P1	NA	
ENSG00000251649	LINC02379	NA	
ENSG00000251005	H3P15	NA	
ENSG00000286251	AC097528.1	NA	
ENSG00000223620	RBM48P1	NA	
ENSG00000199862	Y_RNA	NA	
ENSG00000250945	AC096773.1	NA	
ENSG00000248491	AC093772.1	NA	
ENSG00000287101	AC093772.2	NA	
ENSG00000248209	AC097462.1	NA	
ENSG00000249795	AC097462.2	NA	
ENSG00000287021	AC097462.3	NA	
ENSG00000164066	INTU	617925	SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20
ENSG00000164066	INTU	617926	OROFACIODIGITAL SYNDROME XVII; OFD17;;OFDS XVII;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE XVII
ENSG00000151475	SLC25A31	NA	
ENSG00000164070	HSPA4L	NA	
ENSG00000282855	AC093591.3	NA	
ENSG00000244021	AC093591.1	NA	
ENSG00000261668	AC093591.2	NA	
ENSG00000142731	PLK4	616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2
ENSG00000251821	RNU6-583P	NA	
ENSG00000164073	MFSD8	610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7
ENSG00000164073	MFSD8	616170	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD
ENSG00000164074	ABHD18	NA	
ENSG00000138709	LARP1B	NA	
ENSG00000241651	AC099340.1	NA	
ENSG00000248394	FOSL1P1	NA	
ENSG00000164040	PGRMC2	NA	
ENSG00000251432	LINC02615	NA	
ENSG00000273077	AC110609.1	NA	
ENSG00000248187	AC078850.1	NA	
ENSG00000248802	AC078850.2	NA	
ENSG00000280711	JADRR	NA	
ENSG00000077684	JADE1	NA	
ENSG00000151466	SCLT1	NA	
ENSG00000275647	AC093783.1	NA	
ENSG00000281369	AC093826.2	NA	
ENSG00000151470	C4orf33	NA	
ENSG00000251345	AC093826.1	NA	
ENSG00000248958	ZSWIM5P3	NA	
ENSG00000251195	AC105417.1	NA	
ENSG00000250193	AC082650.1	NA	
ENSG00000287748	AC082650.2	NA	
ENSG00000246876	LINC02466	NA	
ENSG00000249618	LINC02465	NA	
ENSG00000234125	EEF1GP8	NA	
ENSG00000251326	LINC02479	NA	
ENSG00000248877	PGBD4P4	NA	
ENSG00000249018	GAPDHP56	NA	
ENSG00000280059	AC093831.2	NA	
ENSG00000250503	AC093831.1	NA	
ENSG00000287924	AC093902.1	NA	
ENSG00000250213	AC025554.1	NA	
ENSG00000206782	RNU6-224P	NA	
ENSG00000250102	LINC02377	NA	
ENSG00000248715	AC105424.1	NA	
ENSG00000241392	RN7SL205P	NA	
ENSG00000251676	SNHG27	NA	
ENSG00000252014	SNORA70	NA	
ENSG00000249416	AC107393.1	NA	
ENSG00000184139	RPL7AP28	NA	
ENSG00000251555	AC096711.2	NA	
ENSG00000251598	AC093916.1	NA	
ENSG00000249463	AC096711.1	NA	
ENSG00000251051	ELL2P2	NA	
ENSG00000248369	AC114741.1	NA	
ENSG00000251398	LINC01256	NA	
ENSG00000249038	AARS1P1	NA	
ENSG00000251488	AC115622.1	NA	
ENSG00000249513	AC110751.1	NA	
ENSG00000250241	AC105383.1	NA	
ENSG00000248735	R3HDM2P1	NA	
ENSG00000138650	PCDH10	NA	
ENSG00000286467	AC108052.1	NA	
ENSG00000250191	AC105252.1	NA	
ENSG00000251199	AC015631.1	NA	
ENSG00000251388	AC079380.1	NA	
ENSG00000286253	AC096763.1	NA	
ENSG00000254535	PABPC4L	NA	
ENSG00000248191	PES1P1	NA	
ENSG00000251291	LINC02462	NA	
ENSG00000249000	AC093722.1	NA	
ENSG00000249847	AC104619.2	NA	
ENSG00000251228	AC104619.4	NA	
ENSG00000241411	AC104619.1	NA	
ENSG00000250144	AC104619.3	NA	
ENSG00000248434	AC107463.1	NA	
ENSG00000248456	LINC02485	NA	
ENSG00000283432	U6	NA	
ENSG00000250834	KRT18P54	NA	
ENSG00000248104	TARS2P1	NA	
ENSG00000250865	AC105362.1	NA	
ENSG00000248330	LINC00613	NA	
ENSG00000207322	RNU1-89P	NA	
ENSG00000251492	AC104136.1	NA	
ENSG00000261166	AC073429.2	NA	
ENSG00000251567	AC018680.1	NA	
ENSG00000250665	AC073429.1	NA	
ENSG00000249311	TERF1P3	NA	
ENSG00000279749	AC093875.1	NA	
ENSG00000248869	LINC02511	NA	
ENSG00000250341	LINC02510	NA	
ENSG00000250813	SERF1AP1	NA	
ENSG00000251440	STMN1P2	NA	
ENSG00000213448	RPS23P2	NA	
ENSG00000189184	PCDH18	NA	
ENSG00000251632	LINC02172	NA	
ENSG00000280352	AC116563.2	NA	
ENSG00000250126	AC116563.1	NA	
ENSG00000250777	AC131956.2	NA	
ENSG00000287441	AC131956.3	NA	
ENSG00000250034	AC131956.1	NA	
ENSG00000287144	AC097511.1	NA	
ENSG00000248307	LINC00616	NA	
ENSG00000250033	SLC7A11-AS1	NA	
ENSG00000151012	SLC7A11	NA	
ENSG00000249091	AC093903.1	NA	
ENSG00000248397	LINC00498	NA	
ENSG00000251372	LINC00499	NA	
ENSG00000249381	LINC00500	NA	
ENSG00000248305	AC105416.1	NA	
ENSG00000248795	AC098859.1	NA	
ENSG00000250977	AC098859.2	NA	
ENSG00000250501	AC093766.1	NA	
ENSG00000250195	AC109927.1	NA	
ENSG00000250577	AC109927.2	NA	
ENSG00000151014	NOCT	NA	
ENSG00000109381	ELF2	NA	
ENSG00000252503	RNU6-531P	NA	
ENSG00000240723	RN7SL382P	NA	
ENSG00000179967	PPP1R14BP3	NA	
ENSG00000276396	AC024032.2	NA	
ENSG00000265892	RN7SL311P	NA	
ENSG00000207384	AC024032.1	NA	
ENSG00000252362	RNU6-506P	NA	
ENSG00000206722	RNU6-1074P	NA	
ENSG00000137463	MGARP	NA	
ENSG00000109390	NDUFC1	NA	
ENSG00000164134	NAA15	617787	MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50
ENSG00000200520	RNU6-1214P	NA	
ENSG00000273247	AC097376.3	NA	
ENSG00000248863	AC097376.2	NA	
ENSG00000239005	AC097376.1	NA	
ENSG00000172007	RAB33B	615222	SMITH-MCCORT DYSPLASIA 2; SMC2
ENSG00000145391	SETD7	NA	
ENSG00000249302	FTH1P24	NA	
ENSG00000272717	AC112236.2	NA	
ENSG00000286896	AC112236.3	NA	
ENSG00000261268	AC112236.1	NA	
ENSG00000085871	MGST2	NA	
ENSG00000201533	RN7SKP237	NA	
ENSG00000178458	H3P16	NA	
ENSG00000196782	MAML3	NA	
ENSG00000286320	AC108053.1	NA	
ENSG00000252233	RN7SKP253	NA	
ENSG00000250698	AC131182.1	NA	
ENSG00000153130	SCOC	NA	
ENSG00000196951	SCOC-AS1	NA	
ENSG00000249754	NDUFB4P9	NA	
ENSG00000241923	RPL14P3	NA	
ENSG00000153132	CLGN	NA	
ENSG00000205301	MGAT4D	NA	
ENSG00000280262	AC093671.1	NA	
ENSG00000179387	ELMOD2	NA	
ENSG00000109424	UCP1	NA	
ENSG00000287449	AC108019.2	NA	
ENSG00000242102	RN7SL152P	NA	
ENSG00000248621	AC108019.1	NA	
ENSG00000109436	TBC1D9	NA	
ENSG00000249661	TNRC18P1	NA	
ENSG00000207155	RNY1P14	NA	
ENSG00000248335	AC096733.1	NA	
ENSG00000273472	AC096733.2	NA	
ENSG00000222613	Y_RNA	NA	
ENSG00000170153	RNF150	NA	
ENSG00000109445	ZNF330	NA	
ENSG00000248747	AC107220.1	NA	
ENSG00000248810	LINC02432	NA	
ENSG00000250189	AC097504.1	NA	
ENSG00000272632	AC097504.2	NA	
ENSG00000250141	LINC02276	NA	
ENSG00000164136	IL15	NA	
ENSG00000109452	INPP4B	NA	
ENSG00000242134	RPL5P13	NA	
ENSG00000250835	LSM3P4	NA	
ENSG00000251248	AC139720.2	NA	
ENSG00000249806	AC139720.1	NA	
ENSG00000250326	AC104596.1	NA	
ENSG00000251300	AC104596.2	NA	
ENSG00000170185	USP38	NA	
ENSG00000250969	AC097658.2	NA	
ENSG00000200049	Y_RNA	NA	
ENSG00000109458	GAB1	605428	DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26
ENSG00000265623	MIR3139	NA	
ENSG00000228981	AC097658.1	NA	
ENSG00000286771	AC097658.3	NA	
ENSG00000243175	RPSAP36	NA	
ENSG00000250540	AC104685.1	NA	
ENSG00000153147	SMARCA5	NA	
ENSG00000245112	SMARCA5-AS1	NA	
ENSG00000248924	AC139713.1	NA	
ENSG00000251600	AC107223.1	NA	
ENSG00000236296	GUSBP5	NA	
ENSG00000183090	FREM3	NA	
ENSG00000250345	AC104090.1	NA	
ENSG00000197465	GYPE	NA	
ENSG00000249741	AC093890.1	NA	
ENSG00000250361	GYPB	111740	BLOOD GROUP, Ss; Ss;;Ss BLOOD GROUP
ENSG00000250361	GYPB	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000286055	AC093890.2	NA	
ENSG00000170180	GYPA	111300	BLOOD GROUP, MN; MN;;MN BLOOD GROUP BLOOD GROUP, MNSs SYSTEM, INCLUDED;;MNSs BLOOD GROUP SYSTEM, INCLUDED;;MNS BLOOD GROUP SYSTED, INCLUDED
ENSG00000170180	GYPA	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000285783	AC098588.3	NA	
ENSG00000285713	AC098588.2	NA	
ENSG00000261129	AC106871.1	NA	
ENSG00000250504	KRT18P51	NA	
ENSG00000248890	HHIP-AS1	NA	
ENSG00000164161	HHIP	NA	
ENSG00000273621	AC098588.1	NA	
ENSG00000164162	ANAPC10	NA	
ENSG00000249193	HSPD1P5	NA	
ENSG00000250406	AC109811.1	NA	
ENSG00000251452	AC109811.2	NA	
ENSG00000222594	RN7SKP235	NA	
ENSG00000164163	ABCE1	NA	
ENSG00000164164	OTUD4	NA	
ENSG00000238713	Y_RNA	NA	
ENSG00000240992	RPS23P4	NA	
ENSG00000272727	LINC02266	NA	
ENSG00000251333	RTN3P1	NA	
ENSG00000278943	AC079228.1	NA	
ENSG00000286420	AC093796.1	NA	
ENSG00000248745	NMNAT1P4	NA	
ENSG00000170365	SMAD1	NA	
ENSG00000250582	SMAD1-AS2	NA	
ENSG00000250902	SMAD1-AS1	NA	
ENSG00000151611	MMAA	251100	METHYLMALONIC ACIDURIA, cblA TYPE;;METHYLMALONIC ACIDEMIA, cblA TYPE;;METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblA TYPE
ENSG00000249245	NCOA4P3	NA	
ENSG00000248356	AC093864.1	NA	
ENSG00000237136	C4orf51	NA	
ENSG00000151612	ZNF827	NA	
ENSG00000279481	AC104791.2	NA	
ENSG00000251687	AC104791.1	NA	
ENSG00000201314	Y_RNA	NA	
ENSG00000260303	AC108206.1	NA	
ENSG00000248809	LINC01095	NA	
ENSG00000164167	LSM6	NA	
ENSG00000279845	AC097372.2	NA	
ENSG00000250673	REELD1	NA	
ENSG00000280250	AC097372.3	NA	
ENSG00000251010	AC097372.1	NA	
ENSG00000120519	SLC10A7	618363	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS
ENSG00000278438	MIR7849	NA	
ENSG00000207182	RNU1-44P	NA	
ENSG00000151615	POU4F2	NA	
ENSG00000137473	TTC29	618745	SPERMATOGENIC FAILURE 42; SPGF42
ENSG00000248764	AC092435.2	NA	
ENSG00000248346	AC092435.1	NA	
ENSG00000260090	AC092435.3	NA	
ENSG00000279376	AC092435.4	NA	
ENSG00000286371	AC097450.1	NA	
ENSG00000221369	MIR548G	NA	
ENSG00000241281	AC010683.1	NA	
ENSG00000249004	PRMT5P1	NA	
ENSG00000151617	EDNRA	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000151617	EDNRA	616367	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA
ENSG00000280219	AC093908.1	NA	
ENSG00000251254	GTF2F2P1	NA	
ENSG00000251688	LINC02507	NA	
ENSG00000251298	AC093835.1	NA	
ENSG00000164168	TMEM184C	NA	
ENSG00000164169	PRMT9	NA	
ENSG00000071205	ARHGAP10	NA	
ENSG00000252951	RNA5SP165	NA	
ENSG00000264274	MIR4799	NA	
ENSG00000240014	RN7SL254P	NA	
ENSG00000270387	AC115621.1	NA	
ENSG00000151623	NR3C2	177735	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT
ENSG00000151623	NR3C2	605115	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY
ENSG00000250354	AC069272.1	NA	
ENSG00000287292	AC002460.2	NA	
ENSG00000251418	ASS1P8	NA	
ENSG00000201846	RNA5SP166	NA	
ENSG00000250357	AC108935.1	NA	
ENSG00000225176	ATP5MGP4	NA	
ENSG00000279016	AC093648.1	NA	
ENSG00000249317	AC002460.1	NA	
ENSG00000239168	RNU7-197P	NA	
ENSG00000249752	AC108156.1	NA	
ENSG00000250252	LINC02430	NA	
ENSG00000248210	LINC02355	NA	
ENSG00000234828	IQCM	NA	
ENSG00000287565	AC108168.1	NA	
ENSG00000250905	AC093893.1	NA	
ENSG00000251482	AKIRIN2P1	NA	
ENSG00000202331	RNA5SP167	NA	
ENSG00000207121	RNU6-1230P	NA	
ENSG00000250704	AC105343.1	NA	
ENSG00000286711	AC105343.2	NA	
ENSG00000170390	DCLK2	NA	
ENSG00000238721	RNU7-194P	NA	
ENSG00000198589	LRBA	614700	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8
ENSG00000248521	AC092612.1	NA	
ENSG00000249690	AC110813.1	NA	
ENSG00000181541	MAB21L2	615877	MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS;;MICROPHTHALMIA AND/OR COLOBOMA WITH OR WITHOUT RHIZOMELIC SKELETAL DYSPLASIA;;MICROPHTHALMIA, SYNDROMIC 14; MCOPS14
ENSG00000183432	ZBTB8OSP1	NA	
ENSG00000252451	RNA5SP168	NA	
ENSG00000235606	AK4P6	NA	
ENSG00000145425	RPS3A	NA	
ENSG00000201264	SNORD73B	NA	
ENSG00000109686	SH3D19	NA	
ENSG00000208797	SNORD73A	NA	
ENSG00000270681	AC095055.1	NA	
ENSG00000249012	AC104819.1	NA	
ENSG00000189099	PRSS48	NA	
ENSG00000250350	AC104819.2	NA	
ENSG00000252544	RNU6-1282P	NA	
ENSG00000270265	AC104819.3	NA	
ENSG00000251611	FAM160A1-DT	NA	
ENSG00000164142	FAM160A1	NA	
ENSG00000253019	RN7SKP35	NA	
ENSG00000059691	GATB	NA	
ENSG00000251455	AC092611.1	NA	
ENSG00000249184	AC107074.1	NA	
ENSG00000286761	AC112242.2	NA	
ENSG00000249708	AC112242.1	NA	
ENSG00000249818	AC097375.2	NA	
ENSG00000248991	AC097375.1	NA	
ENSG00000286066	AC097375.4	NA	
ENSG00000251249	AC097375.3	NA	
ENSG00000253077	RNA5SP169	NA	
ENSG00000286720	AC097375.5	NA	
ENSG00000245954	LINC02273	NA	
ENSG00000287504	AC079340.3	NA	
ENSG00000250706	AC079340.1	NA	
ENSG00000251377	AC079340.2	NA	
ENSG00000244544	RN7SL446P	NA	
ENSG00000270302	AC080078.1	NA	
ENSG00000270883	AC080078.2	NA	
ENSG00000109670	FBXW7	NA	
ENSG00000270751	FBXW7-AS1	NA	
ENSG00000287555	AC023424.2	NA	
ENSG00000264678	MIR3140	NA	
ENSG00000268471	MIR4453HG	NA	
ENSG00000283792	MIR4453	NA	
ENSG00000243417	RPS3AP18	NA	
ENSG00000240669	AC023424.1	NA	
ENSG00000170006	TMEM154	NA	
ENSG00000248571	AC106882.1	NA	
ENSG00000169989	TIGD4	NA	
ENSG00000164144	ARFIP1	NA	
ENSG00000250980	NSA2P6	NA	
ENSG00000231841	FAM192BP	NA	
ENSG00000287642	AC093599.2	NA	
ENSG00000137460	FHDC1	NA	
ENSG00000249022	AC093599.1	NA	
ENSG00000109654	TRIM2	615490	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2R;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2R
ENSG00000288637	AC013477.2	NA	
ENSG00000252030	RNU6-1196P	NA	
ENSG00000201786	AC013477.1	NA	
ENSG00000213406	ANXA2P1	NA	
ENSG00000121211	MND1	NA	
ENSG00000243883	RN7SL419P	NA	
ENSG00000121210	TMEM131L	NA	
ENSG00000287216	AC106865.2	NA	
ENSG00000250771	AC106865.1	NA	
ENSG00000248208	WDR45P1	NA	
ENSG00000137462	TLR2	246300	LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3
ENSG00000137462	TLR2	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000145428	RNF175	NA	
ENSG00000249309	AC020703.1	NA	
ENSG00000145423	SFRP2	NA	
ENSG00000280241	AC079298.3	NA	
ENSG00000197410	DCHS2	NA	
ENSG00000278981	AC079298.1	NA	
ENSG00000280005	AC079298.2	NA	
ENSG00000249200	AC110775.1	NA	
ENSG00000250609	AC110753.1	NA	
ENSG00000171566	PLRG1	NA	
ENSG00000200350	RNU6-1285P	NA	
ENSG00000248611	AC107385.1	NA	
ENSG00000171564	FGB	202400	AFIBRINOGENEMIA, CONGENITAL HYPOFIBRINOGENEMIA, CONGENITAL, INCLUDED
ENSG00000171564	FGB	616004	DYSFIBRINOGENEMIA, CONGENITAL HYPODYSFIBRINOGENEMIA, CONGENITAL, INCLUDED
ENSG00000171560	FGA	105200	AMYLOIDOSIS, FAMILIAL VISCERAL;;AMYLOIDOSIS VIII;;OSTERTAG TYPE AMYLOIDOSIS;;GERMAN TYPE AMYLOIDOSIS;;AMYLOIDOSIS, FAMILIAL RENAL;;AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC
ENSG00000171560	FGA	202400	AFIBRINOGENEMIA, CONGENITAL HYPOFIBRINOGENEMIA, CONGENITAL, INCLUDED
ENSG00000171560	FGA	616004	DYSFIBRINOGENEMIA, CONGENITAL HYPODYSFIBRINOGENEMIA, CONGENITAL, INCLUDED
ENSG00000171557	FGG	202400	AFIBRINOGENEMIA, CONGENITAL HYPOFIBRINOGENEMIA, CONGENITAL, INCLUDED
ENSG00000171557	FGG	616004	DYSFIBRINOGENEMIA, CONGENITAL HYPODYSFIBRINOGENEMIA, CONGENITAL, INCLUDED
ENSG00000287770	AC107385.2	NA	
ENSG00000121207	LRAT	268000	RETINITIS PIGMENTOSA; RP
ENSG00000121207	LRAT	613341	LEBER CONGENITAL AMAUROSIS 14; LCA14 RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED
ENSG00000249074	NDUFB2P1	NA	
ENSG00000249041	AC009567.1	NA	
ENSG00000249692	AC009567.2	NA	
ENSG00000151962	RBM46	NA	
ENSG00000222582	RNU2-66P	NA	
ENSG00000252604	RNU2-44P	NA	
ENSG00000250910	AC097467.3	NA	
ENSG00000250538	AC104407.1	NA	
ENSG00000185149	NPY2R	NA	
ENSG00000249924	AC097467.1	NA	
ENSG00000164114	MAP9	NA	
ENSG00000250205	YWHAEP4	NA	
ENSG00000250398	AC097467.2	NA	
ENSG00000271606	AC097467.4	NA	
ENSG00000287730	AC097526.1	NA	
ENSG00000249247	MTCYBP17	NA	
ENSG00000249770	MTND6P17	NA	
ENSG00000248748	MTND5P9	NA	
ENSG00000248548	MTND4P8	NA	
ENSG00000249127	MTND3P3	NA	
ENSG00000249698	MTCO3P9	NA	
ENSG00000248420	MTATP6P9	NA	
ENSG00000249386	MTCO2P9	NA	
ENSG00000251223	MTCO1P9	NA	
ENSG00000248907	MTND2P33	NA	
ENSG00000251407	MTND1P22	NA	
ENSG00000251244	AC107208.1	NA	
ENSG00000164116	GUCY1A1	615750	MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA; MYMY6
ENSG00000260244	AC104083.1	NA	
ENSG00000061918	GUCY1B1	NA	
ENSG00000256394	ASIC5	NA	
ENSG00000151790	TDO2	600627	HYPERTRYPTOPHANEMIA; HYPTRP;;HYPERTRYPTOPHANEMIA, FAMILIAL
ENSG00000256043	CTSO	NA	
ENSG00000249013	FTH1P21	NA	
ENSG00000251511	AC096736.3	NA	
ENSG00000251283	LINC02272	NA	
ENSG00000249479	AC096736.2	NA	
ENSG00000248912	AC096736.1	NA	
ENSG00000145431	PDGFC	NA	
ENSG00000248629	AC092608.1	NA	
ENSG00000280284	AC092608.3	NA	
ENSG00000278880	AC092608.2	NA	
ENSG00000250622	AC093325.1	NA	
ENSG00000252350	RPPH1-3P	NA	
ENSG00000252524	Y_RNA	NA	
ENSG00000109738	GLRB	614619	HYPEREKPLEXIA 2; HKPX2
ENSG00000199859	RNU6-582P	NA	
ENSG00000120251	GRIA2	NA	
ENSG00000249819	AC112240.1	NA	
ENSG00000286133	AC093817.2	NA	
ENSG00000234111	LINC02433	NA	
ENSG00000249275	AC093817.1	NA	
ENSG00000200521	Y_RNA	NA	
ENSG00000249627	AC017037.1	NA	
ENSG00000279703	AC017037.3	NA	
ENSG00000286862	AC017037.5	NA	
ENSG00000287226	AC084740.1	NA	
ENSG00000279994	AC017037.4	NA	
ENSG00000250475	AC017037.2	NA	
ENSG00000279139	AC098679.2	NA	
ENSG00000280140	AC098679.3	NA	
ENSG00000164125	GASK1B	NA	
ENSG00000248429	FAM198B-AS1	NA	
ENSG00000287822	AC098679.5	NA	
ENSG00000251073	NUDT19P5	NA	
ENSG00000250604	AC098679.1	NA	
ENSG00000164124	TMEM144	NA	
ENSG00000286558	AC098679.4	NA	
ENSG00000251429	AIDAP2	NA	
ENSG00000171509	RXFP1	NA	
ENSG00000199634	RNU4-79P	NA	
ENSG00000248387	AC121161.1	NA	
ENSG00000249901	AC121161.2	NA	
ENSG00000205208	C4orf46	NA	
ENSG00000171503	ETFDH	231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD;;GLUTARIC ACIDEMIA II; GA2;;GLUTARIC ACIDURIA II;;GA II;;ETHYLMALONIC-ADIPICACIDURIA; EMA GLUTARIC ACIDEMIA IIA, INCLUDED; GA2A, INCLUDED;;ETFA DEFICIENCY, INCLUDED;;GLUTARIC ACIDEMIA IIB, INCLUDED; G /.../NCLUDED;;ETFB DEFICIENCY, INCLUDED;;GLUTARIC ACIDEMIA IIC, INCLUDED; GA2C, INCLUDED;;ETFDH DEFICIENCY, INCLUDED
ENSG00000271817	U3	NA	
ENSG00000171497	PPID	NA	
ENSG00000052795	FNIP2	NA	
ENSG00000206703	RNU6-128P	NA	
ENSG00000164123	C4orf45	NA	
ENSG00000274535	SNORD39	NA	
ENSG00000248988	AC093700.1	NA	
ENSG00000249367	FABP5P12	NA	
ENSG00000206978	Y_RNA	NA	
ENSG00000109756	RAPGEF2	618075	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 7; FAME7;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 7; BAFME7;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 7; FCMTE7
ENSG00000264105	MIR3688-1	NA	
ENSG00000283379	MIR3688-2	NA	
ENSG00000248552	AC074344.1	NA	
ENSG00000250180	AC074344.2	NA	
ENSG00000250488	LINC02233	NA	
ENSG00000250997	AC093853.1	NA	
ENSG00000249425	LINC02477	NA	
ENSG00000242635	RPS14P7	NA	
ENSG00000249568	AC104793.1	NA	
ENSG00000168843	FSTL5	NA	
ENSG00000249419	AC023136.1	NA	
ENSG00000251253	MTHFD2P4	NA	
ENSG00000248396	TOMM22P4	NA	
ENSG00000248431	AC021134.1	NA	
ENSG00000287072	AC021134.2	NA	
ENSG00000251123	AC084752.1	NA	
ENSG00000283468	MIR4454	NA	
ENSG00000250027	AC022272.1	NA	
ENSG00000145414	NAF1	NA	
ENSG00000250547	AC079238.1	NA	
ENSG00000164128	NPY1R	NA	
ENSG00000164129	NPY5R	NA	
ENSG00000227283	RPL35AP12	NA	
ENSG00000151005	TKTL2	NA	
ENSG00000198498	TMA16	NA	
ENSG00000145416	MARCHF1	NA	
ENSG00000273449	AC093788.1	NA	
ENSG00000253001	RN7SKP105	NA	
ENSG00000177803	AC112247.1	NA	
ENSG00000250746	AC105250.1	NA	
ENSG00000248546	ANP32C	NA	
ENSG00000251162	AC074198.1	NA	
ENSG00000223037	RNU6-284P	NA	
ENSG00000248162	CHORDC1P3	NA	
ENSG00000248771	SMIM31	NA	
ENSG00000201050	RNU6-668P	NA	
ENSG00000248329	APELA	NA	
ENSG00000250227	TRIM60P14	NA	
ENSG00000244146	AC106872.3	NA	
ENSG00000285563	AC106872.12	NA	
ENSG00000221891	FAM218BP	NA	
ENSG00000270960	AC106872.10	NA	
ENSG00000248645	AC106872.5	NA	
ENSG00000121089	NACA3P	NA	
ENSG00000236941	AC106872.1	NA	
ENSG00000183439	TRIM61	NA	
ENSG00000250486	FAM218A	NA	
ENSG00000248229	AC106872.4	NA	
ENSG00000250887	AC106872.9	NA	
ENSG00000250712	AC106872.8	NA	
ENSG00000240674	AC106872.2	NA	
ENSG00000176979	TRIM60	NA	
ENSG00000276623	AC106872.11	NA	
ENSG00000250430	AC106872.7	NA	
ENSG00000249617	AC106872.6	NA	
ENSG00000250374	TRIM75P	NA	
ENSG00000170088	TMEM192	NA	
ENSG00000109466	KLHL2	NA	
ENSG00000200974	RNU4-87P	NA	
ENSG00000229894	GK3P	NA	
ENSG00000052802	MSMO1	616834	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD;;SC4MOL DEFICIENCY
ENSG00000109472	CPE	NA	
ENSG00000207559	MIR578	NA	
ENSG00000251596	HADHAP1	NA	
ENSG00000248287	SCGB1D5P	NA	
ENSG00000248327	NOL8P1	NA	
ENSG00000287424	AC080079.2	NA	
ENSG00000250725	AC080079.1	NA	
ENSG00000249500	LINC01179	NA	
ENSG00000038295	TLL1	613087	ATRIAL SEPTAL DEFECT 6; ASD6
ENSG00000252959	RNA5SP170	NA	
ENSG00000206711	Y_RNA	NA	
ENSG00000249675	AC097487.1	NA	
ENSG00000196104	SPOCK3	NA	
ENSG00000212373	RNA5SP171	NA	
ENSG00000250150	AC079349.1	NA	
ENSG00000240772	RN7SL776P	NA	
ENSG00000248913	PHBP14	NA	
ENSG00000222721	RN7SKP188	NA	
ENSG00000270336	AC105148.1	NA	
ENSG00000248601	AC116634.1	NA	
ENSG00000109511	ANXA10	NA	
ENSG00000287188	AC068989.1	NA	
ENSG00000137628	DDX60	NA	
ENSG00000181381	DDX60L	NA	
ENSG00000207171	AC079926.1	NA	
ENSG00000129116	PALLD	606856	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1;;PNCA1
ENSG00000229226	BTF3L4P4	NA	
ENSG00000249623	PALLD-AS1	NA	
ENSG00000206613	RNU6-1336P	NA	
ENSG00000214676	RPL9P16	NA	
ENSG00000249609	AC080188.1	NA	
ENSG00000279384	AC080188.2	NA	
ENSG00000145439	CBR4	NA	
ENSG00000201176	RNU6-853P	NA	
ENSG00000201818	RNY4P17	NA	
ENSG00000251445	AC021151.1	NA	
ENSG00000154447	SH3RF1	NA	
ENSG00000214671	RPL6P12	NA	
ENSG00000251171	AC096741.1	NA	
ENSG00000137601	NEK1	263520	SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6;;SHORT RIB-POLYDACTYLY SYNDROME, TYPE II;;SRPS, TYPE II;;MAJEWSKI SYNDROME;;SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA; SRPS2A;;POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II
ENSG00000137601	NEK1	617892	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24
ENSG00000286302	AC084724.1	NA	
ENSG00000109572	CLCN3	NA	
ENSG00000056050	HPF1	NA	
ENSG00000229204	PTGES3P3	NA	
ENSG00000248625	AC079768.1	NA	
ENSG00000287660	AC079768.3	NA	
ENSG00000288003	AC079768.4	NA	
ENSG00000248319	LINC02275	NA	
ENSG00000287298	AC079768.2	NA	
ENSG00000251200	AC084866.2	NA	
ENSG00000249955	AC084866.1	NA	
ENSG00000198948	MFAP3L	NA	
ENSG00000109576	AADAT	NA	
ENSG00000248822	APOBEC3AP1	NA	
ENSG00000248739	AC069306.1	NA	
ENSG00000250266	LINC01612	NA	
ENSG00000251061	LINC02512	NA	
ENSG00000250082	AC074255.1	NA	
ENSG00000181359	HSP90AA6P	NA	
ENSG00000250968	LINC02382	NA	
ENSG00000249943	AC097486.1	NA	
ENSG00000251961	RNU6ATAC13P	NA	
ENSG00000286580	AC034159.2	NA	
ENSG00000248872	LINC02431	NA	
ENSG00000249525	AC034159.1	NA	
ENSG00000248755	AC092639.1	NA	
ENSG00000278502	MIR6082	NA	
ENSG00000248339	LINC02504	NA	
ENSG00000287210	AC074254.2	NA	
ENSG00000249297	LINC02174	NA	
ENSG00000251176	AC074254.1	NA	
ENSG00000174473	GALNTL6	NA	
ENSG00000248637	AC108064.1	NA	
ENSG00000245213	AC105285.1	NA	
ENSG00000241652	RN7SL253P	NA	
ENSG00000109586	GALNT7	NA	
ENSG00000221296	MIR548T	NA	
ENSG00000248774	AC097534.1	NA	
ENSG00000164104	HMGB2	NA	
ENSG00000272870	SAP30-DT	NA	
ENSG00000164105	SAP30	NA	
ENSG00000164106	SCRG1	NA	
ENSG00000288025	AC093849.4	NA	
ENSG00000242882	RPL5P11	NA	
ENSG00000286226	AC093849.3	NA	
ENSG00000252898	RNU6-1096P	NA	
ENSG00000261646	AC093849.1	NA	
ENSG00000286039	AC093849.2	NA	
ENSG00000164107	HAND2	NA	
ENSG00000237125	HAND2-AS1	NA	
ENSG00000234801	MORF4	NA	
ENSG00000213370	RANP6	NA	
ENSG00000250708	LINC02269	NA	
ENSG00000250043	AC106895.1	NA	
ENSG00000251216	AC106895.2	NA	
ENSG00000248174	LINC02268	NA	
ENSG00000250957	AC012055.1	NA	
ENSG00000251213	AC012055.2	NA	
ENSG00000164117	FBXO8	NA	
ENSG00000164118	CEP44	NA	
ENSG00000249875	AC116616.1	NA	
ENSG00000265846	MIR4276	NA	
ENSG00000164120	HPGD	119900	DIGITAL CLUBBING, ISOLATED CONGENITAL;;CLUBBING OF DIGITS;;ACROPACHY, HEREDITARY
ENSG00000164120	HPGD	259100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1;;PHO, AUTOSOMAL RECESSIVE;;PACHYDERMOPERIOSTOSIS, AUTOSOMAL RECESSIVE;;PDP, AUTOSOMAL RECESSIVE;;TOURAINE-SOLENTE-GOLE SYNDROME  CRANIOOSTEOARTHROPATHY, INCLUDED; COA, INCLUDED;; /.../AL IDIOPATHIC OSTEOARTHROPATHY OF CHILDHOOD, INCLUDED;;CURRARINO IDIOPATHIC OSTEOARTHROPATHY, INCLUDED; CIO, INCLUDED
ENSG00000251584	AC096751.2	NA	
ENSG00000250596	AC096751.1	NA	
ENSG00000145451	GLRA3	NA	
ENSG00000168594	ADAM29	NA	
ENSG00000250200	AC105914.1	NA	
ENSG00000250431	AC105914.2	NA	
ENSG00000249411	AC022325.1	NA	
ENSG00000286494	AC022325.2	NA	
ENSG00000249284	AC095050.2	NA	
ENSG00000248551	AC095050.1	NA	
ENSG00000249945	AC131094.1	NA	
ENSG00000251174	TSEN2P1	NA	
ENSG00000248574	ADAM20P2	NA	
ENSG00000150625	GPM6A	NA	
ENSG00000249106	AC097537.1	NA	
ENSG00000248249	AC110794.1	NA	
ENSG00000250372	MARK2P4	NA	
ENSG00000150627	WDR17	NA	
ENSG00000201516	AC093605.1	NA	
ENSG00000150628	SPATA4	NA	
ENSG00000164122	ASB5	NA	
ENSG00000248980	SPCS3-AS1	NA	
ENSG00000129128	SPCS3	NA	
ENSG00000248480	AC093801.2	NA	
ENSG00000248388	AC093801.1	NA	
ENSG00000150630	VEGFC	615907	LYMPHATIC MALFORMATION 4; LMPHM4;;LYMPHEDEMA, HEREDITARY, ID, FORMERLY; LMPH1D, FORMERLY
ENSG00000287544	AC097518.2	NA	
ENSG00000249458	AC092673.1	NA	
ENSG00000250263	LINC02509	NA	
ENSG00000222859	RN7SKP136	NA	
ENSG00000249008	AC097518.1	NA	
ENSG00000109674	NEIL3	NA	
ENSG00000249084	AC027627.1	NA	
ENSG00000038002	AGA	208400	ASPARTYLGLUCOSAMINURIA; AGU;;GLYCOSYLASPARAGINASE DEFICIENCY;;ASPARTYLGLUCOSAMINIDASE DEFICIENCY;;AGA DEFICIENCY;;GLYCOASPARAGINASE;;ASPARTYLGLYCOSAMINURIA
ENSG00000250131	AC078881.1	NA	
ENSG00000201931	RNA5SP172	NA	
ENSG00000251416	AC103879.1	NA	
ENSG00000231171	LINC01098	NA	
ENSG00000251504	LINC01099	NA	
ENSG00000253000	RNU1-45P	NA	
ENSG00000241877	AC095041.1	NA	
ENSG00000201727	RNA5SP173	NA	
ENSG00000212191	AC017087.1	NA	
ENSG00000250839	AC018710.1	NA	
ENSG00000250993	AC020551.1	NA	
ENSG00000248921	AC021193.1	NA	
ENSG00000287083	AC108169.1	NA	
ENSG00000287775	AC096747.1	NA	
ENSG00000251025	NDUFB5P1	NA	
ENSG00000249883	AC104803.1	NA	
ENSG00000248197	LINC00290	NA	
ENSG00000248770	AC019235.1	NA	
ENSG00000249460	LINC02500	NA	
ENSG00000225356	AC093840.1	NA	
ENSG00000286860	AC093840.2	NA	
ENSG00000287948	AC084741.1	NA	
ENSG00000251336	TEMN3-AS1	NA	
ENSG00000251742	RN7SKP13	NA	
ENSG00000177822	TENM3-AS1	NA	
ENSG00000251433	CCNHP1	NA	
ENSG00000218336	TENM3	615145	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9 MICROPHTHALMIA, SYNDROMIC 15, INCLUDED;  MCOPS15, INCLUDED;;MICROPHTHALMIA AND/OR COLOBOMA WITH DEVELOPMENTAL DELAY, INCLUDED
ENSG00000248266	AC108142.1	NA	
ENSG00000221227	MIR1305	NA	
ENSG00000252343	RNU2-34P	NA	
ENSG00000251714	RN7SKP67	NA	
ENSG00000248816	AC079226.2	NA	
ENSG00000248694	AC079226.1	NA	
ENSG00000286119	AC114798.1	NA	
ENSG00000272646	AC079766.1	NA	
ENSG00000129187	DCTD	NA	
ENSG00000286821	AC019193.4	NA	
ENSG00000250636	AC019193.1	NA	
ENSG00000230219	CIBAR1P2	NA	
ENSG00000273180	AC019193.3	NA	
ENSG00000272784	AC019193.2	NA	
ENSG00000251359	WWC2-AS2	NA	
ENSG00000151718	WWC2	NA	
ENSG00000251128	WWC2-AS1	NA	
ENSG00000177300	CLDN22	NA	
ENSG00000185758	CLDN24	NA	
ENSG00000250292	AC093844.1	NA	
ENSG00000248376	AC112698.1	NA	
ENSG00000168564	CDKN2AIP	NA	
ENSG00000213434	VTI1BP2	NA	
ENSG00000232648	AC107214.1	NA	
ENSG00000168556	ING2	NA	
ENSG00000272744	AC107214.2	NA	
ENSG00000182552	RWDD4	NA	
ENSG00000252157	RNU6-479P	NA	
ENSG00000168538	TRAPPC11	615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2S; LGMD2S
ENSG00000201433	RNU6-335P	NA	
ENSG00000251739	RNU6-1053P	NA	
ENSG00000287349	AC108477.2	NA	
ENSG00000283383	AC108477.1	NA	
ENSG00000173320	STOX2	NA	
ENSG00000248206	AC074194.1	NA	
ENSG00000283355	AC074194.2	NA	
ENSG00000250726	AC107222.1	NA	
ENSG00000164303	ENPP6	NA	
ENSG00000287433	AC107222.2	NA	
ENSG00000240159	AC079080.1	NA	
ENSG00000244512	RN7SL28P	NA	
ENSG00000227765	MYL12BP2	NA	
ENSG00000180712	LINC02363	NA	
ENSG00000249096	LINC02362	NA	
ENSG00000168310	IRF2	NA	
ENSG00000251878	SNORD79	NA	
ENSG00000270426	AC099343.2	NA	
ENSG00000271646	AC099343.3	NA	
ENSG00000286292	AC099343.4	NA	
ENSG00000271538	LINC02427	NA	
ENSG00000249056	AC099343.1	NA	
ENSG00000254233	LINC02365	NA	
ENSG00000164305	CASP3	NA	
ENSG00000164306	PRIMPOL	615420	MYOPIA 22, AUTOSOMAL DOMINANT; MYP22
ENSG00000151725	CENPU	NA	
ENSG00000151726	ACSL1	NA	
ENSG00000249138	SLED1	NA	
ENSG00000251139	AC084871.1	NA	
ENSG00000286256	AC084871.3	NA	
ENSG00000251230	MIR3945HG	NA	
ENSG00000266698	MIR3945	NA	
ENSG00000249173	LINC01093	NA	
ENSG00000251147	AC084871.2	NA	
ENSG00000263458	MIR4455	NA	
ENSG00000279460	AC112243.1	NA	
ENSG00000248517	LINC02437	NA	
ENSG00000187821	HELT	NA	
ENSG00000250754	LINC02436	NA	
ENSG00000249520	AC093824.1	NA	
ENSG00000287183	AC093824.2	NA	
ENSG00000151729	SLC25A4	609283	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 2
ENSG00000151729	SLC25A4	615418	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B
ENSG00000151729	SLC25A4	617184	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A
ENSG00000164323	CFAP97	NA	
ENSG00000109762	SNX25	NA	
ENSG00000109771	LRP2BP	NA	
ENSG00000250410	AC112722.1	NA	
ENSG00000186352	ANKRD37	NA	
ENSG00000109775	UFSP2	142669	BEUKES HIP DYSPLASIA; BHD;;HIP DYSPLASIA, BEUKES TYPE;;BEUKES FAMILIAL HIP DYSPLASIA; BFHD;;OSTEOARTHROPATHY, PREMATURE DEGENERATIVE, OF HIP
ENSG00000109775	UFSP2	617974	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR
ENSG00000207231	Y_RNA	NA	
ENSG00000205129	C4orf47	NA	
ENSG00000168491	CCDC110	NA	
ENSG00000249679	AC106897.1	NA	
ENSG00000154553	PDLIM3	NA	
ENSG00000154556	SORBS2	NA	
ENSG00000233110	AC093797.1	NA	
ENSG00000235902	AC108472.1	NA	
ENSG00000207497	Y_RNA	NA	
ENSG00000285745	AC104805.1	NA	
ENSG00000235149	AC096659.1	NA	
ENSG00000222727	RNU4-64P	NA	
ENSG00000164342	TLR3	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000164342	TLR3	613002	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2;;HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2
ENSG00000109794	FAM149A	NA	
ENSG00000253013	AC104070.1	NA	
ENSG00000250327	RPSAP70	NA	
ENSG00000251008	ORAOV1P1	NA	
ENSG00000279943	FLJ38576	NA	
ENSG00000145476	CYP4V2	210370	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD;;BIETTI CRYSTALLINE DYSTROPHY;;BIETTI TAPETORETINAL DEGENERATION WITH MARGINAL CORNEAL DYSTROPHY
ENSG00000164344	KLKB1	612423	PREKALLIKREIN DEFICIENCY;;PKK DEFICIENCY;;FLETCHER FACTOR DEFICIENCY
ENSG00000088926	F11	612416	FACTOR XI DEFICIENCY;;F11 DEFICIENCY;;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;;PTA DEFICIENCY;;ROSENTHAL SYNDROME
ENSG00000251165	F11-AS1	NA	
ENSG00000287667	AC109517.1	NA	
ENSG00000213332	SLC25A5P6	NA	
ENSG00000272297	AC018709.1	NA	
ENSG00000212387	RNU6-1055P	NA	
ENSG00000168412	MTNR1A	NA	
ENSG00000083857	FAT1	NA	
ENSG00000287169	AC107050.1	NA	
ENSG00000250829	AC108865.1	NA	
ENSG00000272218	AC108865.2	NA	
ENSG00000249539	MRPS36P2	NA	
ENSG00000249742	AC110772.1	NA	
ENSG00000250971	AC110772.2	NA	
ENSG00000287571	AC108046.1	NA	
ENSG00000249747	LINC02374	NA	
ENSG00000250658	AC097652.1	NA	
ENSG00000250042	LINC02514	NA	
ENSG00000250620	LINC02515	NA	
ENSG00000251643	AC093763.2	NA	
ENSG00000251490	AC093763.1	NA	
ENSG00000250590	LINC02492	NA	
ENSG00000249642	AC097521.1	NA	
ENSG00000249162	ADAM20P3	NA	
ENSG00000286641	AC108073.3	NA	
ENSG00000213331	AC108073.1	NA	
ENSG00000179059	ZFP42	NA	
ENSG00000179046	TRIML2	NA	
ENSG00000241011	AC108073.2	NA	
ENSG00000201085	RNU6-173P	NA	
ENSG00000184108	TRIML1	NA	
ENSG00000247130	AC138781.1	NA	
ENSG00000248370	LINC02434	NA	
ENSG00000242169	AC093789.1	NA	
ENSG00000248880	ICE2P1	NA	
ENSG00000249378	LINC01060	NA	
ENSG00000250523	AC093909.3	NA	
ENSG00000275826	AC093909.5	NA	
ENSG00000252275	RNU7-192P	NA	
ENSG00000180015	AC093909.1	NA	
ENSG00000278974	AC093909.6	NA	
ENSG00000249269	AC093909.2	NA	
ENSG00000251619	LINC02508	NA	
ENSG00000250626	AC093909.4	NA	
ENSG00000250024	AC122138.1	NA	
ENSG00000251310	AC107391.1	NA	
ENSG00000249877	AC105924.1	NA	
ENSG00000205100	HSP90AA4P	NA	
ENSG00000250739	LINC01262	NA	
ENSG00000272566	AF250324.1	NA	
ENSG00000202215	RNU1-51P	NA	
ENSG00000245685	FRG1-DT	NA	
ENSG00000250666	LINC01596	NA	
ENSG00000109536	FRG1	158900	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHY FACIO /.../OHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS AND TORTUOSITY OF RETINAL ARTERIOLES, INCLUDED
ENSG00000249462	MLLT10P2	NA	
ENSG00000271307	AF146191.1	NA	
ENSG00000251297	TUBB7P	NA	
ENSG00000199572	RNA5SP174	NA	
ENSG00000201145	RNA5SP175	NA	
ENSG00000224807	DUX4L9	NA	
ENSG00000205097	FRG2	NA	
ENSG00000250053	RARRES2P4	NA	
ENSG00000214273	AGGF1P1	NA	
ENSG00000249003	CLUHP4	NA	
ENSG00000281591	DBET	NA	
ENSG00000277162	U85056.1	NA	
ENSG00000281720	DUX4L8	NA	
ENSG00000281652	DUX4L7	NA	
ENSG00000281058	DUX4L6	NA	
ENSG00000280799	DUX4L5	NA	
ENSG00000258834	DUX4L4	NA	
ENSG00000280757	DUX4L1	NA	
ENSG00000281627	DUX4L3	NA	
ENSG00000280457	DUX4L2	NA	
ENSG00000260596	DUX4	NA	
ENSG00000261914	RPL23AP84	NA	
ENSG00000282994	AC215524.1	NA	
ENSG00000250020	AC113430.1	NA	
ENSG00000153404	PLEKHG4B	NA	
ENSG00000199540	AC010443.1	NA	
ENSG00000185028	LRRC14B	NA	
ENSG00000261434	AC021087.4	NA	
ENSG00000164366	CCDC127	NA	
ENSG00000260774	AC021087.3	NA	
ENSG00000073578	SDHA	252011	MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY
ENSG00000073578	SDHA	256000	LEIGH SYNDROME; LS;;NECROTIZING ENCEPHALOPATHY, INFANTILE SUBACUTE, OF LEIGH; SNE LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHON /.../COMPLEX III DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX V DEFICIENCY, INCLUDED
ENSG00000073578	SDHA	613642	CARDIOMYOPATHY, DILATED, 1GG; CMD1GG
ENSG00000073578	SDHA	614165	PARAGANGLIOMAS 5; PGL5
ENSG00000286001	AC021087.5	NA	
ENSG00000248925	AC021087.1	NA	
ENSG00000249915	PDCD6	NA	
ENSG00000288622	AC010442.3	NA	
ENSG00000250848	AC021087.2	NA	
ENSG00000063438	AHRR	NA	
ENSG00000286169	PDCD6-AHRR	NA	
ENSG00000214278	AC010442.1	NA	
ENSG00000250645	AC010442.2	NA	
ENSG00000221990	EXOC3-AS1	NA	
ENSG00000180104	EXOC3	NA	
ENSG00000188242	PP7080	NA	
ENSG00000066230	SLC9A3	616868	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8;;DIARRHEA, CONGENITAL SODIUM; CSD
ENSG00000225138	SLC9A3-AS1	NA	
ENSG00000250385	AC106772.2	NA	
ENSG00000264233	MIR4456	NA	
ENSG00000249650	AC106772.1	NA	
ENSG00000112877	CEP72	NA	
ENSG00000171368	TPPP	NA	
ENSG00000271781	AC026740.1	NA	
ENSG00000206077	ZDHHC11B	NA	
ENSG00000249908	BRD9P2	NA	
ENSG00000285522	AC026740.2	NA	
ENSG00000188818	ZDHHC11	NA	
ENSG00000247872	SPCS2P3	NA	
ENSG00000028310	BRD9	NA	
ENSG00000071539	TRIP13	617598	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3
ENSG00000287600	AC122719.3	NA	
ENSG00000248949	AC122719.1	NA	
ENSG00000250173	AC122719.2	NA	
ENSG00000215246	AC116351.1	NA	
ENSG00000272347	AC116351.2	NA	
ENSG00000145506	NKD2	NA	
ENSG00000113504	SLC12A7	NA	
ENSG00000263834	MIR4635	NA	
ENSG00000249201	CTD-3080P12.3	NA	
ENSG00000174358	SLC6A19	138500	HYPERGLYCINURIA;;GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS;;GLYCINURIA WITH OR WITHOUT OXALATE NEPHROLITHIASIS;;IMINOGLYCINURIA TYPE II
ENSG00000174358	SLC6A19	234500	HARTNUP DISORDER; HND;;HARTNUP DISEASE
ENSG00000174358	SLC6A19	242600	IMINOGLYCINURIA
ENSG00000164363	SLC6A18	NA	
ENSG00000287486	AC114291.1	NA	
ENSG00000164362	TERT	178500	PULMONARY FIBROSIS, IDIOPATHIC; IPF;;IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL;;FIBROSING ALVEOLITIS, CRYPTOGENIC;;FIBROCYSTIC PULMONARY DYSPLASIA;;INTERSTITIAL PNEUMONITIS, USUAL; UIP HAMMAN-RICH DISEASE, INCLUDED
ENSG00000164362	TERT	127550	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE
ENSG00000164362	TERT	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000164362	TERT	609135	APLASTIC ANEMIA APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000164362	TERT	613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 4, INCLUDED; DKCB4, INCLUDED
ENSG00000164362	TERT	614742	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1
ENSG00000164362	TERT	615134	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9
ENSG00000263670	MIR4457	NA	
ENSG00000049656	CLPTM1L	NA	
ENSG00000286388	AC026748.3	NA	
ENSG00000250584	LINC01511	NA	
ENSG00000248951	MTCO2P32	NA	
ENSG00000279908	AC026748.1	NA	
ENSG00000142319	SLC6A3	188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO;;CIGARETTE HABITUATION, SUSCEPTIBILITY TO;;SMOKING HABIT, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO;;NICOTINE ADDICTION, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, PROTECTION AGAINST
ENSG00000142319	SLC6A3	613135	PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1;;PKDYS;;DOPAMINE TRANSPORTER DEFICIENCY SYNDROME; DTDS
ENSG00000153395	LPCAT1	NA	
ENSG00000273742	MIR6075	NA	
ENSG00000251532	AC091849.2	NA	
ENSG00000185986	SDHAP3	NA	
ENSG00000271119	AC026412.3	NA	
ENSG00000248126	AC091849.1	NA	
ENSG00000188002	AC026412.1	NA	
ENSG00000232615	AC026412.2	NA	
ENSG00000288549	AC026412.4	NA	
ENSG00000263746	MIR4277	NA	
ENSG00000260066	AC112176.1	NA	
ENSG00000171421	MRPL36	NA	
ENSG00000145494	NDUFS6	618232	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9
ENSG00000249966	AC025183.1	NA	
ENSG00000250417	LINC02116	NA	
ENSG00000279222	AC025183.2	NA	
ENSG00000113430	IRX4	NA	
ENSG00000249116	IRX4-AS1	NA	
ENSG00000249326	CTD-2194D22.4	NA	
ENSG00000288108	AC126768.3	NA	
ENSG00000248994	AC124852.1	NA	
ENSG00000248597	AC126768.1	NA	
ENSG00000249731	AC126768.2	NA	
ENSG00000201026	Y_RNA	NA	
ENSG00000275733	AC092266.1	NA	
ENSG00000281560	LSINCT5	NA	
ENSG00000259757	AC091891.1	NA	
ENSG00000170561	IRX2	NA	
ENSG00000186493	C5orf38	NA	
ENSG00000249541	AC116359.1	NA	
ENSG00000248137	AC094105.1	NA	
ENSG00000248736	AC094105.2	NA	
ENSG00000249808	LINC01377	NA	
ENSG00000248118	LINC01019	NA	
ENSG00000249830	LINC02162	NA	
ENSG00000250716	LINC01017	NA	
ENSG00000170549	IRX1	NA	
ENSG00000259603	AC016595.1	NA	
ENSG00000248962	AC025773.1	NA	
ENSG00000249994	AC025187.1	NA	
ENSG00000250921	LINC02063	NA	
ENSG00000260763	AC106799.3	NA	
ENSG00000248973	AC106799.2	NA	
ENSG00000231291	AC106799.1	NA	
ENSG00000251371	AC010634.1	NA	
ENSG00000249521	LINC02114	NA	
ENSG00000248311	AC026719.1	NA	
ENSG00000249941	AC026415.1	NA	
ENSG00000251506	AC010451.3	NA	
ENSG00000250481	AC010451.1	NA	
ENSG00000215231	LINC01020	NA	
ENSG00000251426	AC010451.2	NA	
ENSG00000250529	LINC02121	NA	
ENSG00000223007	RN7SKP73	NA	
ENSG00000250579	CTD-2297D10.2	NA	
ENSG00000145536	ADAMTS16	NA	
ENSG00000250866	AC022424.1	NA	
ENSG00000251568	ALG3P1	NA	
ENSG00000286753	AC091978.1	NA	
ENSG00000248729	MTCO1P30	NA	
ENSG00000250808	MTCO2P30	NA	
ENSG00000251476	MTCO1P31	NA	
ENSG00000164151	ICE1	NA	
ENSG00000286986	AC026736.1	NA	
ENSG00000261037	AC010266.2	NA	
ENSG00000259861	AC010266.1	NA	
ENSG00000278913	AC026797.1	NA	
ENSG00000250730	HMGB3P3	NA	
ENSG00000250490	LINC02145	NA	
ENSG00000133398	MED10	NA	
ENSG00000287031	AC093307.1	NA	
ENSG00000215218	UBE2QL1	NA	
ENSG00000271230	AC027334.1	NA	
ENSG00000250056	LINC01018	NA	
ENSG00000037474	NSUN2	611091	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5
ENSG00000145545	SRD5A1	NA	
ENSG00000248677	LINC02102	NA	
ENSG00000112941	TENT4A	NA	
ENSG00000251365	LINC02236	NA	
ENSG00000272071	AC122710.2	NA	
ENSG00000283420	MIR4278	NA	
ENSG00000250974	LINC02196	NA	
ENSG00000200243	RN7SKP79	NA	
ENSG00000250060	AC122710.1	NA	
ENSG00000212258	RNA5SP176	NA	
ENSG00000287790	AC025756.1	NA	
ENSG00000286254	AC091889.1	NA	
ENSG00000237611	Metazoa_SRP	NA	
ENSG00000285689	AC091951.4	NA	
ENSG00000248775	AC091951.2	NA	
ENSG00000251250	AC091951.3	NA	
ENSG00000205976	AC091951.1	NA	
ENSG00000251678	AC027343.3	NA	
ENSG00000250668	LINC02123	NA	
ENSG00000249638	AC027343.1	NA	
ENSG00000249865	AC027343.2	NA	
ENSG00000223597	LINC02142	NA	
ENSG00000078295	ADCY2	NA	
ENSG00000250761	AC093305.1	NA	
ENSG00000215217	C5orf49	NA	
ENSG00000124275	MTRR	236270	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE;;HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE;;VITAMIN B12-RESPONSIVE HOMOCYSTINURIA, cblE TYPE;;METHYLCOBALAMIN DEFICIENCY, /.../TYPE
ENSG00000124275	MTRR	601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS;;NTD, FOLATE-SENSITIVE  SPINA BIFIDA, FOLATE-SENSITIVE, INCLUDED
ENSG00000124279	FASTKD3	NA	
ENSG00000251168	AC025174.1	NA	
ENSG00000199773	RNU1-76P	NA	
ENSG00000287947	AC116361.1	NA	
ENSG00000280338	AC091941.1	NA	
ENSG00000280251	AC091912.2	NA	
ENSG00000249486	AC091912.1	NA	
ENSG00000245729	LINC02226	NA	
ENSG00000288002	AC091912.3	NA	
ENSG00000249159	AC091965.1	NA	
ENSG00000251549	AC091965.3	NA	
ENSG00000272049	AC091965.4	NA	
ENSG00000247516	MIR4458HG	NA	
ENSG00000250037	AC091965.2	NA	
ENSG00000279075	AC091965.5	NA	
ENSG00000284000	MIR4458	NA	
ENSG00000249782	AC091953.1	NA	
ENSG00000279097	AC091953.3	NA	
ENSG00000279264	AC091953.5	NA	
ENSG00000250389	MTND6P2	NA	
ENSG00000248765	MTCYBP37	NA	
ENSG00000279002	AC091953.2	NA	
ENSG00000280373	AC091953.6	NA	
ENSG00000279125	AC091953.4	NA	
ENSG00000280438	AC091932.4	NA	
ENSG00000278877	AC091932.2	NA	
ENSG00000260981	AC091932.1	NA	
ENSG00000280185	AC091932.3	NA	
ENSG00000250198	LINC02199	NA	
ENSG00000279635	AC091895.1	NA	
ENSG00000250619	AC021088.1	NA	
ENSG00000112902	SEMA5A	NA	
ENSG00000266415	MIR4636	NA	
ENSG00000248537	AC091906.1	NA	
ENSG00000279698	AC027335.2	NA	
ENSG00000251370	SEMA5A-AS1	NA	
ENSG00000250001	AC027335.1	NA	
ENSG00000250786	SNHG18	NA	
ENSG00000239112	SNORD123	NA	
ENSG00000248525	AC026787.1	NA	
ENSG00000169777	TAS2R1	NA	
ENSG00000249781	LINC02112	NA	
ENSG00000222054	RNA5SP177	NA	
ENSG00000286556	AC091838.1	NA	
ENSG00000250814	LINC02221	NA	
ENSG00000279011	AC091905.2	NA	
ENSG00000279755	AC091905.3	NA	
ENSG00000278874	AC091905.1	NA	
ENSG00000280016	AC091905.4	NA	
ENSG00000249807	AC034229.1	NA	
ENSG00000280449	AC034229.6	NA	
ENSG00000280368	AC034229.5	NA	
ENSG00000260515	AC034229.2	NA	
ENSG00000271998	AC034229.3	NA	
ENSG00000272417	AC034229.4	NA	
ENSG00000150756	ATPSCKMT	NA	
ENSG00000248968	AC012640.1	NA	
ENSG00000150753	CCT5	256840	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE
ENSG00000271980	AC012640.4	NA	
ENSG00000271715	AC012640.3	NA	
ENSG00000164237	CMBL	NA	
ENSG00000252341	Y_RNA	NA	
ENSG00000252671	Y_RNA	NA	
ENSG00000280369	AC012640.5	NA	
ENSG00000259802	AC012640.2	NA	
ENSG00000145495	MARCHF6	613608	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3
ENSG00000250600	ROPN1L-AS1	NA	
ENSG00000145491	ROPN1L	NA	
ENSG00000277073	MIR6131	NA	
ENSG00000246016	LINC01513	NA	
ENSG00000244361	RPL30P7	NA	
ENSG00000249396	LINC02212	NA	
ENSG00000249166	AC092336.1	NA	
ENSG00000249160	LINC02213	NA	
ENSG00000280017	AC112200.2	NA	
ENSG00000279450	AC112200.1	NA	
ENSG00000164236	ANKRD33B	NA	
ENSG00000250106	ANKRD33B-AS1	NA	
ENSG00000251196	AC106760.1	NA	
ENSG00000251548	AC106760.2	NA	
ENSG00000279979	AC012629.4	NA	
ENSG00000278865	AC012629.3	NA	
ENSG00000112977	DAP	NA	
ENSG00000272324	AC012629.2	NA	
ENSG00000250576	AC012629.1	NA	
ENSG00000169862	CTNND2	NA	
ENSG00000207312	RNU6-429P	NA	
ENSG00000212305	RNU6-679P	NA	
ENSG00000248783	AC106771.1	NA	
ENSG00000248131	LINC01194	NA	
ENSG00000251112	AC106794.2	NA	
ENSG00000249053	AC106794.1	NA	
ENSG00000248457	LINC02220	NA	
ENSG00000248145	AC016553.1	NA	
ENSG00000242608	RPS23P5	NA	
ENSG00000248462	NENFP3	NA	
ENSG00000243744	AC016546.1	NA	
ENSG00000039139	DNAH5	608644	CILIARY DYSKINESIA, PRIMARY, 3; CILD3;;CILIARY DYSKINESIA, PRIMARY, 3, WITH OR WITHOUT SITUS INVERSUS
ENSG00000251423	AC016576.1	NA	
ENSG00000038382	TRIO	617061	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 44
ENSG00000038382	TRIO	618825	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY
ENSG00000287581	AC016549.1	NA	
ENSG00000145569	OTULINL	NA	
ENSG00000248791	AC010627.1	NA	
ENSG00000250526	CCT6P2	NA	
ENSG00000250182	EEF1A1P13	NA	
ENSG00000261360	AC010491.1	NA	
ENSG00000154124	OTULIN	617099	AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS;;OTULIN-RELATED AUTOINFLAMMATORY SYNDROME; ORAS;;OTULIPENIA
ENSG00000154122	ANKH	123000	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD;;CMD;;CRANIOMETAPHYSEAL DYSPLASIA, JACKSON TYPE; CMDJ
ENSG00000154122	ANKH	118600	CHONDROCALCINOSIS 2; CCAL2;;CHONDROCALCINOSIS, FAMILIAL ARTICULAR;;CALCIUM GOUT;;CALCIUM PYROPHOSPHATE ARTHROPATHY;;CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION DISEASE; CPPDD
ENSG00000286970	AC010491.2	NA	
ENSG00000249485	RBBP4P1	NA	
ENSG00000264792	MIR4637	NA	
ENSG00000272057	AC016575.1	NA	
ENSG00000249928	UQCRBP3	NA	
ENSG00000250662	HNRNPKP5	NA	
ENSG00000250247	SEPHS2P1	NA	
ENSG00000286441	AC016575.2	NA	
ENSG00000202269	U8	NA	
ENSG00000249332	LINC02149	NA	
ENSG00000248834	MARK2P5	NA	
ENSG00000286377	AC114964.2	NA	
ENSG00000248699	AC114964.1	NA	
ENSG00000183580	FBXL7	NA	
ENSG00000250250	CTD-2350J17.1	NA	
ENSG00000216077	MIR887	NA	
ENSG00000222312	RNA5SP178	NA	
ENSG00000183654	MARCHF11	NA	
ENSG00000250981	MARCHF11-AS1	NA	
ENSG00000250448	AC092335.1	NA	
ENSG00000248403	NACAP6	NA	
ENSG00000248150	LINC02150	NA	
ENSG00000249737	AC020980.1	NA	
ENSG00000173545	ZNF622	NA	
ENSG00000154153	RETREG1	201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A;;HSAN IIA;;NEUROPATHY, HEREDITARY SENSORY, TYPE IIA; HSN2A;;HSN IIA;;ACROOSTEOLYSIS, NEUROGENIC;;ACROOSTEOLYSIS, GIACCAI TYPE;;NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL RECESSI /.../RVAN DISEASE;;NEUROPATHY, PROGRESSIVE SENSORY, OF CHILDREN;;NEUROPATHY, CONGENITAL SENSORY
ENSG00000154153	RETREG1	613115	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B
ENSG00000246214	AC024588.1	NA	
ENSG00000250415	AC022113.1	NA	
ENSG00000201370	Y_RNA	NA	
ENSG00000145555	MYO10	NA	
ENSG00000253093	RNA5SP179	NA	
ENSG00000243538	RPS26P28	NA	
ENSG00000201436	RNU6-660P	NA	
ENSG00000176788	BASP1	NA	
ENSG00000215196	BASP1-AS1	NA	
ENSG00000271892	AC026790.1	NA	
ENSG00000206814	Y_RNA	NA	
ENSG00000251990	RNA5SP180	NA	
ENSG00000250816	DCAF13P2	NA	
ENSG00000252908	RNU6-1003P	NA	
ENSG00000185296	AC026785.1	NA	
ENSG00000201715	RN7SKP133	NA	
ENSG00000223361	FTH1P10	NA	
ENSG00000248223	AC026785.2	NA	
ENSG00000249199	AC026785.3	NA	
ENSG00000250822	LINC02111	NA	
ENSG00000248455	LINC02217	NA	
ENSG00000249662	LINC02218	NA	
ENSG00000268799	H3Y2	NA	
ENSG00000250667	AC106774.1	NA	
ENSG00000284373	TAF11L2	NA	
ENSG00000248205	H3P17	NA	
ENSG00000249620	H3P18	NA	
ENSG00000284439	TAF11L3	NA	
ENSG00000284283	TAF11L4	NA	
ENSG00000284234	TAF11L5	NA	
ENSG00000284042	TAF11L6	NA	
ENSG00000284465	TAF11L7	NA	
ENSG00000250088	AC233724.7	NA	
ENSG00000283967	TAF11L8	NA	
ENSG00000283988	TAF11L9	NA	
ENSG00000284356	TAF11L10	NA	
ENSG00000248422	AC233724.3	NA	
ENSG00000249282	AC233724.6	NA	
ENSG00000283740	TAF11L11	NA	
ENSG00000249156	TAF11L12	NA	
ENSG00000271296	H3P19	NA	
ENSG00000250351	H3P20	NA	
ENSG00000250386	H3P21	NA	
ENSG00000283776	TAF11L13	NA	
ENSG00000250782	TAF11L14	NA	
ENSG00000248471	AC233724.4	NA	
ENSG00000248160	AC233724.1	NA	
ENSG00000248542	AC233724.5	NA	
ENSG00000248337	AC233724.2	NA	
ENSG00000269466	H3Y1	NA	
ENSG00000274832	AC233724.8	NA	
ENSG00000250715	H3P22	NA	
ENSG00000249937	LINC02223	NA	
ENSG00000240785	RPL36AP21	NA	
ENSG00000212278	SNORD81	NA	
ENSG00000241552	RN7SL58P	NA	
ENSG00000248693	LINC02100	NA	
ENSG00000249191	UBE2V1P12	NA	
ENSG00000249927	AC025768.1	NA	
ENSG00000249285	AC114981.1	NA	
ENSG00000276764	Metazoa_SRP	NA	
ENSG00000249174	AC106744.1	NA	
ENSG00000251487	AC106744.2	NA	
ENSG00000242654	RPL32P14	NA	
ENSG00000249557	HSPD1P15	NA	
ENSG00000145526	CDH18	NA	
ENSG00000248766	AC093303.1	NA	
ENSG00000214132	AC094103.1	NA	
ENSG00000249854	CDH18-AS1	NA	
ENSG00000249490	LINC02146	NA	
ENSG00000251629	LINC02241	NA	
ENSG00000248308	AC138938.1	NA	
ENSG00000286751	AC140168.1	NA	
ENSG00000248286	AC140172.1	NA	
ENSG00000249359	AC093274.1	NA	
ENSG00000183666	GUSBP1	NA	
ENSG00000233974	AC138951.1	NA	
ENSG00000279107	AC138951.2	NA	
ENSG00000272130	AC091946.2	NA	
ENSG00000253766	AC091946.1	NA	
ENSG00000154162	CDH12	NA	
ENSG00000213430	HSPD1P1	NA	
ENSG00000253104	AC139497.1	NA	
ENSG00000168967	PMCHL1	NA	
ENSG00000287471	AC138854.1	NA	
ENSG00000249206	GCNT1P2	NA	
ENSG00000286961	AC091938.1	NA	
ENSG00000249404	AC010445.1	NA	
ENSG00000250319	AC010460.2	NA	
ENSG00000206912	Y_RNA	NA	
ENSG00000250332	AC010460.3	NA	
ENSG00000249289	AC010460.1	NA	
ENSG00000164256	PRDM9	NA	
ENSG00000248591	AC109445.1	NA	
ENSG00000249607	AC108103.1	NA	
ENSG00000248874	C5orf17	NA	
ENSG00000252083	AC026784.1	NA	
ENSG00000234865	ADH5P5	NA	
ENSG00000200600	Y_RNA	NA	
ENSG00000286134	AC114930.1	NA	
ENSG00000226432	AC010342.1	NA	
ENSG00000250694	AC010387.1	NA	
ENSG00000277455	Metazoa_SRP	NA	
ENSG00000287199	AC010387.2	NA	
ENSG00000040731	CDH10	NA	
ENSG00000251294	AC091885.2	NA	
ENSG00000249562	AC091885.1	NA	
ENSG00000286454	AC091893.2	NA	
ENSG00000250099	AC091893.1	NA	
ENSG00000286238	AC106821.2	NA	
ENSG00000248156	BTG4P1	NA	
ENSG00000223004	SNORD29	NA	
ENSG00000248908	LINC02239	NA	
ENSG00000250524	AC106821.1	NA	
ENSG00000199911	Y_RNA	NA	
ENSG00000251273	LINC02228	NA	
ENSG00000245662	LINC02211	NA	
ENSG00000285042	AC099499.2	NA	
ENSG00000251654	AC099499.1	NA	
ENSG00000260761	AC106754.1	NA	
ENSG00000279671	AC106754.2	NA	
ENSG00000248605	AC022140.1	NA	
ENSG00000279531	AC022140.2	NA	
ENSG00000201016	RNU6-374P	NA	
ENSG00000279869	AC022418.1	NA	
ENSG00000251593	MSNP1	NA	
ENSG00000286625	AC113370.1	NA	
ENSG00000222560	RNU4-43P	NA	
ENSG00000249099	AC025475.1	NA	
ENSG00000286204	AC025475.2	NA	
ENSG00000230571	AC113347.1	NA	
ENSG00000248426	AC113347.2	NA	
ENSG00000250703	AC113347.3	NA	
ENSG00000251033	AC113347.4	NA	
ENSG00000249616	CCNB3P1	NA	
ENSG00000113100	CDH9	NA	
ENSG00000207261	RNU6-738P	NA	
ENSG00000250337	PURPL	NA	
ENSG00000248490	AC113355.1	NA	
ENSG00000250079	AC093300.1	NA	
ENSG00000249785	LINC02103	NA	
ENSG00000250453	AC008825.1	NA	
ENSG00000286432	AC109472.1	NA	
ENSG00000252867	RNU6-909P	NA	
ENSG00000270495	AC008825.2	NA	
ENSG00000259786	LINC02109	NA	
ENSG00000271035	AC010385.2	NA	
ENSG00000162685	LSP1P3	NA	
ENSG00000226400	AC010385.1	NA	
ENSG00000277878	AC010385.3	NA	
ENSG00000249226	SUCLG2P4	NA	
ENSG00000252601	AC024589.2	NA	
ENSG00000248687	AC024589.1	NA	
ENSG00000270430	AC024589.3	NA	
ENSG00000286182	AC112172.2	NA	
ENSG00000248391	LINC02064	NA	
ENSG00000276098	AC027345.1	NA	
ENSG00000248418	UBL5P1	NA	
ENSG00000250984	AC108082.1	NA	
ENSG00000249744	AC010374.2	NA	
ENSG00000233787	AC010374.1	NA	
ENSG00000223136	RN7SKP207	NA	
ENSG00000280305	AC018765.1	NA	
ENSG00000250587	HPRT1P2	NA	
ENSG00000250118	AC114300.1	NA	
ENSG00000287176	AC099517.1	NA	
ENSG00000287940	AC026433.1	NA	
ENSG00000241668	RPL19P11	NA	
ENSG00000253940	AC026421.1	NA	
ENSG00000254138	AC113386.1	NA	
ENSG00000113361	CDH6	NA	
ENSG00000250482	DUX4L51	NA	
ENSG00000113360	DROSHA	NA	
ENSG00000206682	Y_RNA	NA	
ENSG00000082213	C5orf22	NA	
ENSG00000279923	AC022417.1	NA	
ENSG00000199765	RNU6-363P	NA	
ENSG00000133401	PDZD2	NA	
ENSG00000248624	AC022447.2	NA	
ENSG00000248878	AC022447.4	NA	
ENSG00000249114	AC022447.5	NA	
ENSG00000248813	AC022447.3	NA	
ENSG00000248378	AC022447.1	NA	
ENSG00000250164	AC022447.7	NA	
ENSG00000249688	AC022447.6	NA	
ENSG00000252373	RNU6-358P	NA	
ENSG00000224282	AC010469.1	NA	
ENSG00000251887	RNU6-760P	NA	
ENSG00000241739	AC010469.2	NA	
ENSG00000243914	RPL5P14	NA	
ENSG00000214108	TPT1P5	NA	
ENSG00000249774	AC025458.1	NA	
ENSG00000266243	MIR4279	NA	
ENSG00000250764	AC025178.1	NA	
ENSG00000113384	GOLPH3	NA	
ENSG00000200065	Y_RNA	NA	
ENSG00000272086	AC025181.2	NA	
ENSG00000230829	AC025181.1	NA	
ENSG00000150712	MTMR12	NA	
ENSG00000199731	RNU6-1079P	NA	
ENSG00000207052	RNU6-378P	NA	
ENSG00000056097	ZFR	NA	
ENSG00000207956	MIR579	NA	
ENSG00000249142	AC074134.1	NA	
ENSG00000113387	SUB1	NA	
ENSG00000250885	LINC02061	NA	
ENSG00000286741	AC008766.1	NA	
ENSG00000113389	NPR3	NA	
ENSG00000251062	AC025459.1	NA	
ENSG00000250697	AC010343.3	NA	
ENSG00000248279	LINC02120	NA	
ENSG00000249102	AC034223.1	NA	
ENSG00000251281	AC034223.2	NA	
ENSG00000250672	AC010343.2	NA	
ENSG00000240376	AC010343.1	NA	
ENSG00000251443	LINC02160	NA	
ENSG00000288579	AC025472.1	NA	
ENSG00000249572	AC034231.1	NA	
ENSG00000113407	TARS1	618546	TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE; TTD7
ENSG00000249360	TOMM40P3	NA	
ENSG00000250583	AC034232.1	NA	
ENSG00000151388	ADAMTS12	NA	
ENSG00000201623	RNU6-923P	NA	
ENSG00000182631	RXFP3	NA	
ENSG00000164175	SLC45A2	227240	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5;;SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR;;SKIN/HAIR/EYE PIGMENTATION 5, DARK/LIGHT EYES;;SKIN/HAIR/EYE PIGMENTATION 5, DARK/FAIR SKIN
ENSG00000164175	SLC45A2	606574	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV
ENSG00000250914	AC139783.2	NA	
ENSG00000242110	AMACR	214950	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4;;CHOLESTASIS, INTRAHEPATIC, WITH DEFECTIVE CONVERSION OF TRIHYDROXYCOPROSTANIC ACID TO CHOLIC ACID;;TRIHYDROXYCOPROSTANIC ACID IN BILE
ENSG00000242110	AMACR	614307	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD;;AMACR DEFICIENCY
ENSG00000273294	C1QTNF3-AMACR	NA	
ENSG00000250767	AC139783.1	NA	
ENSG00000082196	C1QTNF3	NA	
ENSG00000278900	AC139792.2	NA	
ENSG00000279995	AC139792.3	NA	
ENSG00000271771	AC139792.1	NA	
ENSG00000215158	AC138409.2	NA	
ENSG00000215156	AC138409.1	NA	
ENSG00000286543	AC138409.3	NA	
ENSG00000249380	AC138853.1	NA	
ENSG00000271874	AC025754.2	NA	
ENSG00000039560	RAI14	NA	
ENSG00000250234	AC025754.1	NA	
ENSG00000272323	AC026801.2	NA	
ENSG00000205838	TTC23L	NA	
ENSG00000250140	AC026801.1	NA	
ENSG00000241829	RPL21P54	NA	
ENSG00000113456	RAD1	NA	
ENSG00000113460	BRIX1	NA	
ENSG00000168724	DNAJC21	260400	SHWACHMAN-DIAMOND SYNDROME 1; SDS1;;SHWACHMAN-DIAMOND SYNDROME; SDS;;PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION;;SHWACHMAN-BODIAN SYNDROME;;LIPOMATOSIS OF PANCREAS, CONGENITAL
ENSG00000168724	DNAJC21	617052	BONE MARROW FAILURE SYNDROME 3; BMFS3
ENSG00000113492	AGXT2	210100	BETA-AMINOISOBUTYRIC ACIDURIA; BAIBA;;BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF;;BAIB URINARY EXCRETION;;HYPER-BETA-AMINOISOBUTYRIC ACIDURIA
ENSG00000113494	PRLR	615554	MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB
ENSG00000113494	PRLR	615555	HYPERPROLACTINEMIA; HPRL
ENSG00000250886	AC010368.1	NA	
ENSG00000201368	U3	NA	
ENSG00000152582	SPEF2	618751	SPERMATOGENIC FAILURE 43; SPGF43
ENSG00000238441	RNU7-130P	NA	
ENSG00000248969	AC137810.1	NA	
ENSG00000168685	IL7R	608971	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE;;SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE
ENSG00000279737	AC112204.3	NA	
ENSG00000248349	AC112204.1	NA	
ENSG00000152611	CAPSL	NA	
ENSG00000249748	AC112204.2	NA	
ENSG00000145626	UGT3A1	NA	
ENSG00000168671	UGT3A2	NA	
ENSG00000251591	AC016612.1	NA	
ENSG00000164187	LMBRD2	NA	
ENSG00000207756	MIR580	NA	
ENSG00000145604	SKP2	NA	
ENSG00000201223	RNU6-1305P	NA	
ENSG00000152620	NADK2	616034	2,4-@DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD
ENSG00000245711	NADK2-AS1	NA	
ENSG00000164188	RANBP3L	NA	
ENSG00000287634	AC114277.1	NA	
ENSG00000222178	RNA5SP181	NA	
ENSG00000242292	AC010631.1	NA	
ENSG00000079215	SLC1A3	612656	EPISODIC ATAXIA, TYPE 6; EA6
ENSG00000274441	AC008957.2	NA	
ENSG00000250155	AC008957.1	NA	
ENSG00000279400	AC008957.3	NA	
ENSG00000272103	AC026741.1	NA	
ENSG00000285967	NIPBL-DT	NA	
ENSG00000164190	NIPBL	122470	CORNELIA DE LANGE SYNDROME 1; CDLS1;;CDL; CDLS;;TYPUS DEGENERATIVUS AMSTELODAMENSIS;;DE LANGE SYNDROME;;BRACHMANN-DE LANGE SYNDROME; BDLS
ENSG00000249850	KRT18P31	NA	
ENSG00000244073	RPS4XP6	NA	
ENSG00000197603	CPLANE1	277170	OROFACIODIGITAL SYNDROME VI; OFD6;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE VI;;OFDS VI;;VARADI-PAPP SYNDROME;;VARADI SYNDROME;;POLYDACTYLY, CLEFT LIP/PALATE OR LINGUAL LUMP, AND PSYCHOMOTOR RETARDATION
ENSG00000197603	CPLANE1	614615	JOUBERT SYNDROME 17; JBTS17
ENSG00000271378	RBISP2	NA	
ENSG00000228212	OFD1P17	NA	
ENSG00000242493	RN7SL37P	NA	
ENSG00000286193	AC025449.2	NA	
ENSG00000270558	AC025449.1	NA	
ENSG00000113569	NUP155	615770	ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15
ENSG00000251880	RNU7-75P	NA	
ENSG00000250455	AC117532.1	NA	
ENSG00000082068	WDR70	NA	
ENSG00000248216	KCTD9P5	NA	
ENSG00000222743	RNU6-1190P	NA	
ENSG00000206743	RNU6-484P	NA	
ENSG00000248587	GDNF-AS1	NA	
ENSG00000168621	GDNF	171300	PHEOCHROMOCYTOMA;;PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO
ENSG00000168621	GDNF	209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS;;AUTONOMIC CONTROL, CONGENITAL FAILURE OF;;ONDINE CURSE, CONGENITAL ONDINE-HIRSCHSPRUNG DISEASE, INCLUDED; OHD, INCLUDED;;CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;;HADDAD SYNDROME, INCLUDED
ENSG00000168621	GDNF	613711	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3
ENSG00000248539	LINC02117	NA	
ENSG00000250032	AC008869.1	NA	
ENSG00000251518	LINC02110	NA	
ENSG00000248533	AC034226.1	NA	
ENSG00000248461	LINC02119	NA	
ENSG00000276332	AC010338.1	NA	
ENSG00000164318	EGFLAM	NA	
ENSG00000248730	EGFLAM-AS4	NA	
ENSG00000249071	EGFLAM-AS3	NA	
ENSG00000248572	EGFLAM-AS2	NA	
ENSG00000249491	EGFLAM-AS1	NA	
ENSG00000248234	AC091839.1	NA	
ENSG00000251257	AC010457.1	NA	
ENSG00000113594	LIFR	601559	STUVE-WIEDEMANN SYNDROME; STWS;;SWS;;SCHWARTZ-JAMPEL SYNDROME, TYPE 2; SJS2;;SCHWARTZ-JAMPEL SYNDROME, NEONATAL;;STUVE-WIEDEMANN/SCHWARTZ-JAMPEL TYPE 2 SYNDROME
ENSG00000244968	LIFR-AS1	NA	
ENSG00000265304	MIR3650	NA	
ENSG00000251189	AC010425.1	NA	
ENSG00000249740	OSMR-AS1	NA	
ENSG00000248577	AC091435.1	NA	
ENSG00000250629	AC091435.2	NA	
ENSG00000145623	OSMR	105250	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1;;AMYLOIDOSIS, PRIMARY CUTANEOUS, 1; PCA1;;PCA;;LICHEN AMYLOIDOSIS, FAMILIAL;;AMYLOIDOSIS IX;;AMYLOIDOSIS, FAMILIAL CUTANEOUS LICHEN
ENSG00000164327	RICTOR	NA	
ENSG00000249089	AIG1P1	NA	
ENSG00000286809	AC008964.1	NA	
ENSG00000082074	FYB1	273900	THROMBOCYTOPENIA 3; THC3;;THROMBOCYTOPENIA, AUTOSOMAL RECESSIVE, 3
ENSG00000251215	GOLGA5P1	NA	
ENSG00000113600	C9	613825	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D;;C9 DEFICIENCY
ENSG00000113600	C9	615591	MACULAR DEGENERATION, AGE-RELATED, 15; ARMD15
ENSG00000153071	DAB2	NA	
ENSG00000271334	LINC02104	NA	
ENSG00000251515	CCDC11P1	NA	
ENSG00000250492	INTS6P1	NA	
ENSG00000248651	GCSHP1	NA	
ENSG00000250048	LINC00603	NA	
ENSG00000249668	KRT18P56	NA	
ENSG00000250585	LINC00604	NA	
ENSG00000199361	RNU1-150P	NA	
ENSG00000287597	AC108105.1	NA	
ENSG00000283286	AC093277.1	NA	
ENSG00000285552	AC114977.1	NA	
ENSG00000285616	AC114977.2	NA	
ENSG00000113638	TTC33	NA	
ENSG00000199552	SNORA63	NA	
ENSG00000171522	PTGER4	NA	
ENSG00000132356	PRKAA1	NA	
ENSG00000212567	AC008810.1	NA	
ENSG00000145592	RPL37	NA	
ENSG00000212296	SNORD72	NA	
ENSG00000132357	CARD6	NA	
ENSG00000112936	C7	610102	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D;;C7 DEFICIENCY
ENSG00000253098	RNU7-161P	NA	
ENSG00000248120	AC114967.1	NA	
ENSG00000171495	MROH2B	NA	
ENSG00000039537	C6	612446	COMPLEMENT COMPONENT 6 DEFICIENCY; C6D;;C6 DEFICIENCY  COMPLEMENT COMPONENT 6 DEFICIENCY, SUBTOTAL, INCLUDED;;C6 DEFICIENCY, SUBTOTAL, INCLUDED
ENSG00000182836	PLCXD3	NA	
ENSG00000251478	AC008817.1	NA	
ENSG00000083720	OXCT1	245050	SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD;;SCOT DEFICIENCY;;SUCCINYL-CoA:3-KETOACID CoA-TRANSFERASE DEFICIENCY;;SUCCINYL-CoA:ACETOACETATE TRANSFERASE DEFICIENCY;;KETOACIDOSIS DUE TO SCOT DEFICIENCY
ENSG00000286164	AC034222.2	NA	
ENSG00000248668	OXCT1-AS1	NA	
ENSG00000240281	AC034222.1	NA	
ENSG00000205765	C5orf51	NA	
ENSG00000151876	FBXO4	NA	
ENSG00000239694	RPSAP38	NA	
ENSG00000199487	Y_RNA	NA	
ENSG00000249266	MTHFD2P6	NA	
ENSG00000260786	AC108099.1	NA	
ENSG00000112964	GHR	143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1;;FHC; FH;;HYPERLIPOPROTEINEMIA, TYPE II;;HYPERLIPOPROTEINEMIA, TYPE IIA;;HYPER-LOW-DENSITY-LIPOPROTEINEMIA;;HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL;;LDL RECEPTOR DISORDER LOW DENSITY LIPOPROTEIN CHOLESTE /.../VEL QUANTITATIVE TRAIT LOCUS 2, INCLUDED; LDLCQ2, INCLUDED
ENSG00000112964	GHR	262500	LARON SYNDROME;;GROWTH HORMONE INSENSITIVITY SYNDROME;;PITUITARY DWARFISM II;;GROWTH HORMONE RECEPTOR DEFICIENCY
ENSG00000112964	GHR	604271	GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP INCREASED RESPONSIVENESS TO GROWTH HORMONE, INCLUDED
ENSG00000248873	SERBP1P6	NA	
ENSG00000250860	AC093225.1	NA	
ENSG00000270513	AC113368.1	NA	
ENSG00000198865	CCDC152	NA	
ENSG00000250722	SELENOP	NA	
ENSG00000272234	AC008945.1	NA	
ENSG00000286271	AC008945.2	NA	
ENSG00000249092	PPIAP77	NA	
ENSG00000251163	PRELID3BP4	NA	
ENSG00000251656	PRELID3BP5	NA	
ENSG00000249516	PRELID3BP6	NA	
ENSG00000250711	PRELID3BP7	NA	
ENSG00000287263	AC008875.3	NA	
ENSG00000286656	AC008875.2	NA	
ENSG00000271788	AC008875.1	NA	
ENSG00000177738	AC025171.1	NA	
ENSG00000251131	AC025171.3	NA	
ENSG00000272382	AC025171.5	NA	
ENSG00000177721	ANXA2R	NA	
ENSG00000215068	AC025171.2	NA	
ENSG00000272144	AC025171.4	NA	
ENSG00000172262	ZNF131	NA	
ENSG00000278487	AC106800.4	NA	
ENSG00000177453	NIM1K	NA	
ENSG00000249779	AC106800.2	NA	
ENSG00000249888	AC106800.3	NA	
ENSG00000247763	AC106800.1	NA	
ENSG00000112972	HMGCS1	NA	
ENSG00000261604	AC114947.2	NA	
ENSG00000188850	AC114947.1	NA	
ENSG00000151882	CCL28	NA	
ENSG00000151881	TMEM267	NA	
ENSG00000249492	AC114956.2	NA	
ENSG00000172244	C5orf34	NA	
ENSG00000249855	EEF1A1P19	NA	
ENSG00000248554	C5orf34-AS1	NA	
ENSG00000248240	AC114956.1	NA	
ENSG00000172239	PAIP1	NA	
ENSG00000248092	NNT-AS1	NA	
ENSG00000279557	AC010435.1	NA	
ENSG00000249286	AMD1P3	NA	
ENSG00000112992	NNT	614736	GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4
ENSG00000224993	RPL29P12	NA	
ENSG00000249276	AC104119.1	NA	
ENSG00000212561	RNU6-381P	NA	
ENSG00000070193	FGF10	180920	APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG SALIVARY GLANDS, ABSENCE OF, INCLUDED;;PAROTID APLASIA OR HYPOPLASIA, INCLUDED
ENSG00000070193	FGF10	149730	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD;;LADD SYNDROME;;LEVY-HOLLISTER SYNDROME
ENSG00000248464	FGF10-AS1	NA	
ENSG00000249203	LINC02224	NA	
ENSG00000250418	AC093292.1	NA	
ENSG00000263556	RN7SL383P	NA	
ENSG00000251141	MRPS30-DT	NA	
ENSG00000248779	AC093297.1	NA	
ENSG00000112996	MRPS30	NA	
ENSG00000272335	AC093297.2	NA	
ENSG00000248148	AC114954.1	NA	
ENSG00000287540	AC116350.1	NA	
ENSG00000164588	HCN1	615871	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24
ENSG00000164588	HCN1	618482	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10;;GEFS+, TYPE 10; GEFS+10
ENSG00000250422	AC117529.2	NA	
ENSG00000250017	AC117529.1	NA	
ENSG00000250122	AC122694.1	NA	
ENSG00000170571	EMB	NA	
ENSG00000271455	AC112187.2	NA	
ENSG00000213956	AC112187.1	NA	
ENSG00000271752	AC112187.3	NA	
ENSG00000151883	PARP8	NA	
ENSG00000249405	AC022441.1	NA	
ENSG00000270830	AC022441.3	NA	
ENSG00000251601	AC022441.2	NA	
ENSG00000250360	AC008808.2	NA	
ENSG00000251573	LINC02106	NA	
ENSG00000248918	AC008808.1	NA	
ENSG00000207060	RNU6-480P	NA	
ENSG00000278734	AC091834.1	NA	
ENSG00000206606	RNU6-1296P	NA	
ENSG00000240627	AC026798.1	NA	
ENSG00000259663	AC010478.1	NA	
ENSG00000016082	ISL1	NA	
ENSG00000249338	HMGB1P47	NA	
ENSG00000248891	AC091860.1	NA	
ENSG00000288035	AC022433.1	NA	
ENSG00000251125	AC091860.2	NA	
ENSG00000251873	RNA5SP182	NA	
ENSG00000249270	KATNBL1P4	NA	
ENSG00000279470	AC091903.1	NA	
ENSG00000248789	LINC02118	NA	
ENSG00000244621	RPS17P11	NA	
ENSG00000250827	MFSD4BP1	NA	
ENSG00000248898	AC022126.1	NA	
ENSG00000213949	ITGA1	NA	
ENSG00000152684	PELO	NA	
ENSG00000288539	AC022133.2	NA	
ENSG00000251237	B3GNTL1P1	NA	
ENSG00000241809	AC022133.1	NA	
ENSG00000249899	AC025180.1	NA	
ENSG00000164171	ITGA2	NA	
ENSG00000286048	AC008966.3	NA	
ENSG00000272123	AC008966.2	NA	
ENSG00000164172	MOCS2	252160	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB
ENSG00000247796	AC008966.1	NA	
ENSG00000213940	AC026477.1	NA	
ENSG00000285831	AC027329.1	NA	
ENSG00000240052	AC108114.1	NA	
ENSG00000134363	FST	NA	
ENSG00000164258	NDUFS4	252010	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1;;MITOCHONDRIAL COMPLEX I DEFICIENCY;;NADH:Q(1) OXIDOREDUCTASE DEFICIENCY;;NADH-COENZYME Q REDUCTASE DEFICIENCY;;MITOCHONDRIAL NADH DEHYDROGENASE COMPONENT OF COMPLEX I, DEFICIENCY OF
ENSG00000250447	LINC02105	NA	
ENSG00000217791	ASS1P9	NA	
ENSG00000272416	AC025175.1	NA	
ENSG00000185305	ARL15	NA	
ENSG00000287087	AC025175.2	NA	
ENSG00000222960	RNU6-272P	NA	
ENSG00000207627	MIR581	NA	
ENSG00000241230	RN7SL801P	NA	
ENSG00000265421	AC016601.1	NA	
ENSG00000279638	AC008873.1	NA	
ENSG00000249069	LINC01033	NA	
ENSG00000251597	RPL37P25	NA	
ENSG00000169271	HSPB3	613376	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C;;HMN IIC;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; DHMN2C
ENSG00000178996	SNX18	NA	
ENSG00000280159	AC016583.1	NA	
ENSG00000287367	AC016583.2	NA	
ENSG00000232517	AC112198.2	NA	
ENSG00000226810	AC112198.1	NA	
ENSG00000249843	AC112198.4	NA	
ENSG00000249016	AC112198.3	NA	
ENSG00000164283	ESM1	NA	
ENSG00000240535	AC034238.1	NA	
ENSG00000113088	GZMK	NA	
ENSG00000207229	Y_RNA	NA	
ENSG00000251376	AC034238.3	NA	
ENSG00000248029	AC034238.2	NA	
ENSG00000249454	GZMAP1	NA	
ENSG00000145649	GZMA	NA	
ENSG00000164287	CDC20B	NA	
ENSG00000164294	GPX8	NA	
ENSG00000198983	MIR449A	NA	
ENSG00000207728	MIR449B	NA	
ENSG00000251856	MIR449C	NA	
ENSG00000234602	MCIDAS	618695	CILIARY DYSKINESIA, PRIMARY, 42; CILD42;;CILIARY DYSKINESIA, PRIMARY, 42, WITHOUT SITUS INVERSUS
ENSG00000152669	CCNO	615872	CILIARY DYSKINESIA, PRIMARY, 29; CILD29;;CILIARY DYSKINESIA, PRIMARY, 29, WITHOUT SITUS INVERSUS
ENSG00000251307	AC026704.1	NA	
ENSG00000067248	DHX29	NA	
ENSG00000039123	MTREX	NA	
ENSG00000271410	AC020728.1	NA	
ENSG00000067113	PLPP1	NA	
ENSG00000279883	AC010480.1	NA	
ENSG00000265135	MIR5687	NA	
ENSG00000250853	RNF138P1	NA	
ENSG00000249410	AK4P2	NA	
ENSG00000177058	SLC38A9	NA	
ENSG00000152670	DDX4	NA	
ENSG00000251368	AC016632.1	NA	
ENSG00000199322	RNA5SP183	NA	
ENSG00000248854	HNRNPH1P3	NA	
ENSG00000164509	IL31RA	613955	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2
ENSG00000134352	IL6ST	618523	HYPER-IgE RECURRENT INFECTION SYNDROME 4, AUTOSOMAL RECESSIVE; HIES4
ENSG00000262211	AC008914.1	NA	
ENSG00000264281	AC016596.2	NA	
ENSG00000249236	AC008892.1	NA	
ENSG00000227908	FLJ31104	NA	
ENSG00000238326	AC016596.1	NA	
ENSG00000164512	ANKRD55	NA	
ENSG00000253032	RNU6-299P	NA	
ENSG00000243592	RPL17P22	NA	
ENSG00000223003	RNA5SP184	NA	
ENSG00000251435	C1GALT1P2	NA	
ENSG00000212265	RNA5SP185	NA	
ENSG00000248781	PSMC1P4	NA	
ENSG00000210678	RNU6ATAC2P	NA	
ENSG00000249697	AC034245.1	NA	
ENSG00000250787	HMGN1P17	NA	
ENSG00000248727	LINC01948	NA	
ENSG00000285997	AC008391.1	NA	
ENSG00000226221	RPL26P19	NA	
ENSG00000225940	C5orf67	NA	
ENSG00000234553	AC022431.1	NA	
ENSG00000228650	AC008940.1	NA	
ENSG00000095015	MAP3K1	613762	46,XY SEX REVERSAL 6; SRXY6;;46,XY SEX REVERSAL, PARTIAL OR COMPLETE, MAP3K1-RELATED;;46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, MAP3K1-RELATED
ENSG00000237705	AC008937.2	NA	
ENSG00000225230	AC008937.1	NA	
ENSG00000155542	SETD9	NA	
ENSG00000155545	MIER3	NA	
ENSG00000271828	AC008937.3	NA	
ENSG00000235635	AC016644.1	NA	
ENSG00000233943	AC114973.1	NA	
ENSG00000248652	AC034244.1	NA	
ENSG00000250480	AC034244.2	NA	
ENSG00000207293	Y_RNA	NA	
ENSG00000062194	GPBP1	NA	
ENSG00000248586	AC025470.1	NA	
ENSG00000250961	AC025470.2	NA	
ENSG00000250308	SALL4P1	NA	
ENSG00000169067	ACTBL2	NA	
ENSG00000249436	LINCR-0003	NA	
ENSG00000287709	AC008780.1	NA	
ENSG00000249198	AC106822.1	NA	
ENSG00000249584	LINC02225	NA	
ENSG00000248132	LINC02101	NA	
ENSG00000286853	AC008786.1	NA	
ENSG00000248271	PGAM1P1	NA	
ENSG00000145632	PLK2	NA	
ENSG00000175857	GAPT	NA	
ENSG00000271257	AC008814.1	NA	
ENSG00000265699	MIR548AE2	NA	
ENSG00000250127	LINC02108	NA	
ENSG00000152932	RAB3C	NA	
ENSG00000248475	AC016642.1	NA	
ENSG00000240412	RPL5P15	NA	
ENSG00000248733	AC008852.1	NA	
ENSG00000113448	PDE4D	614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2
ENSG00000247345	AC092343.1	NA	
ENSG00000276214	AC008833.1	NA	
ENSG00000251306	NDUFB4P2	NA	
ENSG00000202601	MIR582	NA	
ENSG00000248935	AC034234.1	NA	
ENSG00000202017	RNU6-806P	NA	
ENSG00000213896	AC109486.1	NA	
ENSG00000214244	SETP21	NA	
ENSG00000152931	PART1	NA	
ENSG00000273701	AC109486.2	NA	
ENSG00000275634	AC109486.3	NA	
ENSG00000276233	AC016591.1	NA	
ENSG00000035499	DEPDC1B	NA	
ENSG00000251303	CAB39P1	NA	
ENSG00000287434	AC109133.1	NA	
ENSG00000250148	KRT8P31	NA	
ENSG00000164181	ELOVL7	NA	
ENSG00000049167	ERCC8	216400	COCKAYNE SYNDROME A; CSA
ENSG00000049167	ERCC8	614621	UV-SENSITIVE SYNDROME 2; UVSS2
ENSG00000215032	GNL3LP1	NA	
ENSG00000233847	ERCC8-AS1	NA	
ENSG00000164182	NDUFAF2	618233	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10
ENSG00000279985	AC008498.2	NA	
ENSG00000276945	AC008498.1	NA	
ENSG00000188725	SMIM15	NA	
ENSG00000251279	SMIM15-AS1	NA	
ENSG00000249279	LINC02057	NA	
ENSG00000130449	ZSWIM6	603671	ACROMELIC FRONTONASAL DYSOSTOSIS; AFND
ENSG00000130449	ZSWIM6	617865	NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA
ENSG00000251682	AC122718.2	NA	
ENSG00000250461	AC122718.1	NA	
ENSG00000213891	RPL3P6	NA	
ENSG00000178722	C5orf64	NA	
ENSG00000248529	AC026746.1	NA	
ENSG00000212215	RNU6-913P	NA	
ENSG00000251575	C5orf64-AS1	NA	
ENSG00000249878	AC026434.1	NA	
ENSG00000248199	AC008877.1	NA	
ENSG00000251983	RN7SKP157	NA	
ENSG00000068796	KIF2A	615411	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3
ENSG00000288643	AC114982.3	NA	
ENSG00000086189	DIMT1	NA	
ENSG00000086200	IPO11	NA	
ENSG00000199279	RNU6-661P	NA	
ENSG00000268942	CKS1BP3	NA	
ENSG00000241991	AC114982.2	NA	
ENSG00000240436	AC114982.1	NA	
ENSG00000186105	LRRC70	NA	
ENSG00000217416	ISCA1P1	NA	
ENSG00000249579	AC113420.1	NA	
ENSG00000248185	AC025445.1	NA	
ENSG00000287179	AC008558.1	NA	
ENSG00000178394	HTR1A	614674	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT
ENSG00000248285	AC122707.1	NA	
ENSG00000164197	RNF180	NA	
ENSG00000236068	AC091862.1	NA	
ENSG00000186479	RGS7BP	NA	
ENSG00000242547	RN7SL169P	NA	
ENSG00000201869	RNU6-294P	NA	
ENSG00000224296	MRPL49P1	NA	
ENSG00000145642	SHISAL2B	NA	
ENSG00000153006	SREK1IP1	NA	
ENSG00000153015	CWC27	250410	RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA;;METAPHYSEAL CHONDRODYSPLASIA WITH RETINITIS PIGMENTOSA
ENSG00000272370	AC092354.2	NA	
ENSG00000272354	AC092354.1	NA	
ENSG00000207439	Y_RNA	NA	
ENSG00000049192	ADAMTS6	NA	
ENSG00000248288	AC008868.1	NA	
ENSG00000250732	RPEP1	NA	
ENSG00000205644	AC025186.1	NA	
ENSG00000250081	AC025176.1	NA	
ENSG00000123219	CENPK	NA	
ENSG00000113593	PPWD1	NA	
ENSG00000113595	TRIM23	NA	
ENSG00000207352	RNU6-540P	NA	
ENSG00000113597	TRAPPC13	NA	
ENSG00000253251	SHLD3	NA	
ENSG00000197860	SGTB	NA	
ENSG00000123213	NLN	NA	
ENSG00000251648	AC008958.1	NA	
ENSG00000269961	AC010359.2	NA	
ENSG00000112851	ERBIN	NA	
ENSG00000252904	AC010359.1	NA	
ENSG00000286314	AC010359.3	NA	
ENSG00000285999	AC025442.2	NA	
ENSG00000153914	SREK1	NA	
ENSG00000253744	AC025442.1	NA	
ENSG00000248846	LINC02065	NA	
ENSG00000251391	AC092353.1	NA	
ENSG00000286062	AC092353.2	NA	
ENSG00000250313	LINC02229	NA	
ENSG00000234838	PPIAP78	NA	
ENSG00000069020	MAST4	NA	
ENSG00000248803	AC092349.1	NA	
ENSG00000249057	MAST4-IT1	NA	
ENSG00000229666	MAST4-AS1	NA	
ENSG00000134061	CD180	NA	
ENSG00000251206	AC010420.1	NA	
ENSG00000286647	AC008459.1	NA	
ENSG00000249364	AC112206.2	NA	
ENSG00000250978	AC079467.1	NA	
ENSG00000239870	AC112206.1	NA	
ENSG00000249736	LINC02242	NA	
ENSG00000249238	BCL9P1	NA	
ENSG00000250669	AC112206.4	NA	
ENSG00000249721	AC112206.3	NA	
ENSG00000250421	AC106798.1	NA	
ENSG00000249894	AC024581.1	NA	
ENSG00000273860	AC024581.2	NA	
ENSG00000253801	AC010376.1	NA	
ENSG00000252108	RNU6-1232P	NA	
ENSG00000213864	EEF1B2P2	NA	
ENSG00000253787	LINC02219	NA	
ENSG00000145675	PIK3R1	269880	SHORT SYNDROME;;SHORT STATURE, HYPEREXTENSIBILITY, HERNIA, OCULAR DEPRESSION, RIEGER ANOMALY, AND TEETHING DELAY;;LIPODYSTROPHY, PARTIAL, WITH RIEGER ANOMALY AND SHORT STATURE
ENSG00000145675	PIK3R1	615214	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO PIK3R1 DEFECT
ENSG00000145675	PIK3R1	616005	IMMUNODEFICIENCY 36; IMD36
ENSG00000251044	AC024579.1	NA	
ENSG00000250237	AC010273.3	NA	
ENSG00000248884	AC010280.2	NA	
ENSG00000248359	AC010280.1	NA	
ENSG00000249588	AC010280.3	NA	
ENSG00000249335	AC093523.1	NA	
ENSG00000250289	VWA8P1	NA	
ENSG00000212249	U8	NA	
ENSG00000250066	AC093248.1	NA	
ENSG00000276309	RN7SKP251	NA	
ENSG00000249352	LINC02198	NA	
ENSG00000249183	SUMO2P4	NA	
ENSG00000145740	SLC30A5	NA	
ENSG00000248664	AC010273.2	NA	
ENSG00000220986	AC010273.1	NA	
ENSG00000280894	SNORA50D	NA	
ENSG00000134057	CCNB1	NA	
ENSG00000280187	AC022107.1	NA	
ENSG00000153044	CENPH	NA	
ENSG00000134056	MRPS36	NA	
ENSG00000134058	CDK7	NA	
ENSG00000183323	CCDC125	NA	
ENSG00000213830	CFL1P5	NA	
ENSG00000215006	CHCHD2P2	NA	
ENSG00000271045	NDUFB9P1	NA	
ENSG00000085231	AK6	NA	
ENSG00000273841	TAF9	NA	
ENSG00000152942	RAD17	NA	
ENSG00000152939	MARVELD2	610153	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
ENSG00000244717	RPS27P14	NA	
ENSG00000249295	AC145146.1	NA	
ENSG00000266477	RN7SL616P	NA	
ENSG00000197822	OCLN	251290	PSEUDO-TORCH SYNDROME 1; PTORCH1;;PSEUDO-TORCH SYNDROME; BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA; BLCPMG
ENSG00000212260	RNU6-724P	NA	
ENSG00000183474	GTF2H2C	NA	
ENSG00000248477	NAIPP3	NA	
ENSG00000250138	AC139495.2	NA	
ENSG00000253203	GUSBP3	NA	
ENSG00000248769	AC139495.1	NA	
ENSG00000198237	AC131392.1	NA	
ENSG00000251158	AC131392.2	NA	
ENSG00000249230	CDH12P2	NA	
ENSG00000205572	SERF1B	NA	
ENSG00000205571	SMN2	253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE
ENSG00000205571	SMN2	253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3;;SMA III;;MUSCULAR ATROPHY, JUVENILE;;KUGELBERG-WELANDER SYNDROME; KWS;;SPINAL MUSCULAR ATROPHY, MILD CHILDHOOD AND ADOLESCENT FORM
ENSG00000205571	SMN2	253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2;;SMA II;;MUSCULAR ATROPHY, SPINAL, INTERMEDIATE TYPE;;MUSCULAR ATROPHY, SPINAL, INFANTILE CHRONIC FORM
ENSG00000205571	SMN2	271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4;;SPINAL MUSCULAR ATROPHY, ADULT FORM;;SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL RECESSIVE
ENSG00000285151	AC140134.1	NA	
ENSG00000179978	NAIPP2	NA	
ENSG00000253492	CDH12P3	NA	
ENSG00000254701	AC138866.2	NA	
ENSG00000253816	AC138866.1	NA	
ENSG00000226259	GTF2H2B	NA	
ENSG00000269983	AC146944.3	NA	
ENSG00000250687	NAIPP1	NA	
ENSG00000253333	AC146944.2	NA	
ENSG00000196302	AC146944.1	NA	
ENSG00000253366	GUSBP16	NA	
ENSG00000288349	AC139272.1	NA	
ENSG00000254335	CDH12P1	NA	
ENSG00000172058	SERF1A	NA	
ENSG00000172062	SMN1	253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE
ENSG00000172062	SMN1	253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3;;SMA III;;MUSCULAR ATROPHY, JUVENILE;;KUGELBERG-WELANDER SYNDROME; KWS;;SPINAL MUSCULAR ATROPHY, MILD CHILDHOOD AND ADOLESCENT FORM
ENSG00000172062	SMN1	253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2;;SMA II;;MUSCULAR ATROPHY, SPINAL, INTERMEDIATE TYPE;;MUSCULAR ATROPHY, SPINAL, INFANTILE CHRONIC FORM
ENSG00000172062	SMN1	271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4;;SPINAL MUSCULAR ATROPHY, ADULT FORM;;SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL RECESSIVE
ENSG00000285204	AC139834.1	NA	
ENSG00000249437	NAIP	NA	
ENSG00000145736	GTF2H2	NA	
ENSG00000230847	OCLNP1	NA	
ENSG00000251634	NAIPP4	NA	
ENSG00000253900	CDH12P4	NA	
ENSG00000215630	GUSBP9	NA	
ENSG00000235558	AC146949.1	NA	
ENSG00000250387	LINC02197	NA	
ENSG00000253985	AC145141.2	NA	
ENSG00000169040	PMCHL2	NA	
ENSG00000249981	AC145141.1	NA	
ENSG00000145734	BDP1	618257	DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112
ENSG00000253536	AC138832.1	NA	
ENSG00000247911	HMGN1P12	NA	
ENSG00000131844	MCCC2	210210	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D;;MCC2 DEFICIENCY;;3-@METHYLCROTONYLGLYCINURIA II;;METHYLCROTONYLGLYCINURIA, TYPE II
ENSG00000164326	CARTPT	601665	OBESITY LEANNESS, INCLUDED
ENSG00000278824	AC143336.1	NA	
ENSG00000285804	AC025774.1	NA	
ENSG00000131711	MAP1B	NA	
ENSG00000264099	MIR4803	NA	
ENSG00000113048	MRPS27	NA	
ENSG00000244748	RN7SL153P	NA	
ENSG00000049883	PTCD2	NA	
ENSG00000244061	AC093278.1	NA	
ENSG00000251108	YBX1P5	NA	
ENSG00000261269	AC093278.2	NA	
ENSG00000178175	ZNF366	NA	
ENSG00000248371	LINC02056	NA	
ENSG00000251613	AC063979.1	NA	
ENSG00000226544	RPL7P22	NA	
ENSG00000223497	H2BL1P	NA	
ENSG00000206770	Y_RNA	NA	
ENSG00000249085	AC035140.1	NA	
ENSG00000083312	TNPO1	NA	
ENSG00000263593	MIR4804	NA	
ENSG00000242602	AC008953.1	NA	
ENSG00000271926	AC008972.1	NA	
ENSG00000272081	AC008972.2	NA	
ENSG00000157107	FCHO2	NA	
ENSG00000251467	AC020893.2	NA	
ENSG00000248930	AC020893.1	NA	
ENSG00000157111	TMEM171	NA	
ENSG00000251599	AC116345.3	NA	
ENSG00000250747	AC116345.2	NA	
ENSG00000164325	TMEM174	NA	
ENSG00000287090	AC116345.4	NA	
ENSG00000249743	AC116345.1	NA	
ENSG00000251543	LINC02230	NA	
ENSG00000249149	AC099522.1	NA	
ENSG00000251493	FOXD1	NA	
ENSG00000247993	FOXD1-AS1	NA	
ENSG00000251604	LINC01385	NA	
ENSG00000251324	LINC01386	NA	
ENSG00000272525	AC099522.2	NA	
ENSG00000145741	BTF3	NA	
ENSG00000255883	FUNDC2P1	NA	
ENSG00000164331	ANKRA2	NA	
ENSG00000164338	UTP15	NA	
ENSG00000214944	ARHGEF28	NA	
ENSG00000249293	AC091868.2	NA	
ENSG00000184084	AC091868.1	NA	
ENSG00000238913	RNU7-196P	NA	
ENSG00000259968	AC093283.1	NA	
ENSG00000248474	LINC02122	NA	
ENSG00000248673	LINC01331	NA	
ENSG00000248942	LINC01335	NA	
ENSG00000244326	RN7SL814P	NA	
ENSG00000249343	LINC01333	NA	
ENSG00000250446	LINC01332	NA	
ENSG00000171617	ENC1	NA	
ENSG00000049860	HEXB	268800	SANDHOFF DISEASE;;GM2-GANGLIOSIDOSIS, TYPE II;;HEXOSAMINIDASES A AND B DEFICIENCY SANDHOFF DISEASE, ADULT TYPE, INCLUDED;;SANDHOFF DISEASE, JUVENILE TYPE, INCLUDED;;SANDHOFF DISEASE, INFANTILE TYPE, INCLUDED
ENSG00000164347	GFM2	618397	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39
ENSG00000207336	RNU6-658P	NA	
ENSG00000164346	NSA2	NA	
ENSG00000198780	FAM169A	NA	
ENSG00000199645	RNU6-1330P	NA	
ENSG00000250071	AC093214.1	NA	
ENSG00000271714	AC010501.2	NA	
ENSG00000212363	AC010501.1	NA	
ENSG00000287701	AC116337.4	NA	
ENSG00000249856	AC116337.3	NA	
ENSG00000196390	AC116337.1	NA	
ENSG00000239517	AC116337.2	NA	
ENSG00000182383	RPL27AP5	NA	
ENSG00000249157	AC093259.1	NA	
ENSG00000176928	GCNT4	NA	
ENSG00000145700	ANKRD31	NA	
ENSG00000251663	SUMO2P5	NA	
ENSG00000247372	AC008897.2	NA	
ENSG00000113161	HMGCR	142910	3-@HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR;;HMG-CoA REDUCTASE LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3, INCLUDED; LDLCQ3, INCLUDED;;STATINS, ATTENUATED CHOLESTEROL LOWERING BY, INCLUDED
ENSG00000113163	CERT1	616351	MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34
ENSG00000271815	AC008897.3	NA	
ENSG00000242198	AC008897.1	NA	
ENSG00000122008	POLK	NA	
ENSG00000251724	RNU7-175P	NA	
ENSG00000248881	AC010245.1	NA	
ENSG00000272040	AC010245.2	NA	
ENSG00000189045	ANKDD1B	NA	
ENSG00000152359	POC5	NA	
ENSG00000207333	RNU6-680P	NA	
ENSG00000251078	SLC25A5P9	NA	
ENSG00000251419	AC108120.3	NA	
ENSG00000249301	AC108120.2	NA	
ENSG00000248684	BIN2P2	NA	
ENSG00000228367	AC108120.1	NA	
ENSG00000249777	SAP18P1	NA	
ENSG00000251342	AC026774.2	NA	
ENSG00000248127	AC026774.1	NA	
ENSG00000122012	SV2C	NA	
ENSG00000252833	RNA5SP186	NA	
ENSG00000251668	AC113404.2	NA	
ENSG00000254893	AC113404.3	NA	
ENSG00000249014	HMGN2P4	NA	
ENSG00000251107	PDCD5P2	NA	
ENSG00000250348	AC113404.1	NA	
ENSG00000251235	SNRPCP2	NA	
ENSG00000145703	IQGAP2	NA	
ENSG00000250574	AC112173.1	NA	
ENSG00000249713	AC026725.1	NA	
ENSG00000164220	F2RL2	NA	
ENSG00000225407	AC025188.1	NA	
ENSG00000277188	AC025188.2	NA	
ENSG00000278237	AC025188.3	NA	
ENSG00000181104	F2R	NA	
ENSG00000164251	F2RL1	NA	
ENSG00000264391	RN7SL208P	NA	
ENSG00000171643	S100Z	NA	
ENSG00000252684	RNU6ATAC36P	NA	
ENSG00000145708	CRHBP	NA	
ENSG00000164252	AGGF1	NA	
ENSG00000285000	AC008581.2	NA	
ENSG00000132846	ZBED3	NA	
ENSG00000250615	AC008581.1	NA	
ENSG00000238961	SNORA47	NA	
ENSG00000250802	ZBED3-AS1	NA	
ENSG00000284762	AC022414.1	609161	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1; ADSD1
ENSG00000284762	AC022414.1	614190	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3;;CUSHING SYNDROME, ADRENAL, DUE TO PPNAD3
ENSG00000251566	HMGB1P35	NA	
ENSG00000113231	PDE8B	609161	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1; ADSD1
ENSG00000113231	PDE8B	614190	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3;;CUSHING SYNDROME, ADRENAL, DUE TO PPNAD3
ENSG00000251400	ALDH7A1P1	NA	
ENSG00000164253	WDR41	NA	
ENSG00000244019	RPS2P24	NA	
ENSG00000244363	RPL7P23	NA	
ENSG00000171540	OTP	NA	
ENSG00000171530	TBCA	NA	
ENSG00000213763	ACTBP2	NA	
ENSG00000253572	AC108482.1	NA	
ENSG00000287162	AC108482.2	NA	
ENSG00000132842	AP3B1	608233	HERMANSKY-PUDLAK SYNDROME 2; HPS2
ENSG00000253558	AC024568.1	NA	
ENSG00000249372	ATP6V1G1P6	NA	
ENSG00000251605	AC104108.1	NA	
ENSG00000200331	RNU6-183P	NA	
ENSG00000206714	Y_RNA	NA	
ENSG00000245556	SCAMP1-AS1	NA	
ENSG00000085365	SCAMP1	NA	
ENSG00000145685	LHFPL2	NA	
ENSG00000248909	HMGB1P21	NA	
ENSG00000254170	AC008802.1	NA	
ENSG00000254310	AC025755.1	NA	
ENSG00000113273	ARSB	253200	MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6;;MPS VI;;MAROTEAUX-LAMY SYNDROME;;ARYLSULFATASE B DEFICIENCY;;ARSB DEFICIENCY;;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY
ENSG00000132837	DMGDH	605850	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD;;DMGDH DEFICIENCY
ENSG00000214890	AC020937.1	NA	
ENSG00000132840	BHMT2	NA	
ENSG00000145692	BHMT	NA	
ENSG00000201955	RNY3P1	NA	
ENSG00000249829	AC016559.2	NA	
ENSG00000206592	AC016559.1	NA	
ENSG00000250330	AC016559.3	NA	
ENSG00000152409	JMY	NA	
ENSG00000213757	RPS3AP20	NA	
ENSG00000152413	HOMER1	NA	
ENSG00000213755	AC093270.1	NA	
ENSG00000243160	AC093270.2	NA	
ENSG00000207391	Y_RNA	NA	
ENSG00000277818	Y_RNA	NA	
ENSG00000164329	TENT2	NA	
ENSG00000164309	CMYA5	NA	
ENSG00000250258	AC008496.2	NA	
ENSG00000286818	AC008496.3	NA	
ENSG00000238254	AC008496.1	NA	
ENSG00000250888	LINC01455	NA	
ENSG00000177034	MTX3	NA	
ENSG00000113296	THBS4	NA	
ENSG00000251050	RBX1P2	NA	
ENSG00000249778	TRMT112P2	NA	
ENSG00000249825	CTD-2201I18.1	NA	
ENSG00000164300	SERINC5	NA	
ENSG00000251675	AC010260.1	NA	
ENSG00000249438	KRT18P45	NA	
ENSG00000184188	AC026410.1	NA	
ENSG00000251828	AC026410.4	NA	
ENSG00000244076	AC026410.2	NA	
ENSG00000164299	SPZ1	NA	
ENSG00000227087	RBMX2P5	NA	
ENSG00000248569	AC026410.3	NA	
ENSG00000220157	HNRNPA1P12	NA	
ENSG00000206774	RNU6-211P	NA	
ENSG00000039319	ZFYVE16	NA	
ENSG00000249042	AC008771.1	NA	
ENSG00000152380	FAM151B	NA	
ENSG00000242706	RPS27AP9	NA	
ENSG00000240003	RPL7P24	NA	
ENSG00000189127	ANKRD34B	NA	
ENSG00000251366	DBIP2	NA	
ENSG00000251221	LINC01337	NA	
ENSG00000228716	DHFR	613839	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY;;DHFR DEFICIENCY
ENSG00000249655	AC008434.1	NA	
ENSG00000271043	MTRNR2L2	NA	
ENSG00000113318	MSH3	608089	ENDOMETRIAL CANCER
ENSG00000113318	MSH3	617100	FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4
ENSG00000248967	AC022493.2	NA	
ENSG00000244630	AC022493.1	NA	
ENSG00000251450	RASGRF2-AS1	NA	
ENSG00000113319	RASGRF2	NA	
ENSG00000251001	AC026427.2	NA	
ENSG00000249772	AC026427.1	NA	
ENSG00000247572	CKMT2-AS1	NA	
ENSG00000131730	CKMT2	NA	
ENSG00000248794	AC026436.1	NA	
ENSG00000131732	ZCCHC9	NA	
ENSG00000172497	ACOT12	NA	
ENSG00000286721	AC010623.1	NA	
ENSG00000145687	SSBP2	NA	
ENSG00000287938	AC026726.2	NA	
ENSG00000249483	AC026726.1	NA	
ENSG00000214857	SEM1P1	NA	
ENSG00000152348	ATG10	NA	
ENSG00000236447	ATG10-IT1	NA	
ENSG00000251495	PPIAP11	NA	
ENSG00000248192	ATG10-AS1	NA	
ENSG00000265684	RN7SL378P	NA	
ENSG00000251374	AC010598.1	NA	
ENSG00000186468	RPS23	617412	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD;;MACINNES SYNDROME; MCINS
ENSG00000205464	ATP6AP1L	NA	
ENSG00000248393	AC026782.1	NA	
ENSG00000248870	AC026782.2	NA	
ENSG00000249100	AC008885.2	NA	
ENSG00000240411	RPL5P16	NA	
ENSG00000248105	AC008885.1	NA	
ENSG00000283359	MIR3977	NA	
ENSG00000281327	LINC01338	NA	
ENSG00000248112	AC108174.1	NA	
ENSG00000249857	AC027338.2	NA	
ENSG00000248400	ST13P12	NA	
ENSG00000249664	AC027338.1	NA	
ENSG00000271862	AC104118.1	NA	
ENSG00000174695	TMEM167A	NA	
ENSG00000238835	SCARNA18	NA	
ENSG00000152422	XRCC4	616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED
ENSG00000243385	AC094085.1	NA	
ENSG00000251552	COQ10BP2	NA	
ENSG00000251395	FTH1P9	NA	
ENSG00000038427	VCAN	143200	WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1
ENSG00000249835	VCAN-AS1	NA	
ENSG00000145681	HAPLN1	NA	
ENSG00000253073	RN7SKP295	NA	
ENSG00000206744	RNU6-620P	NA	
ENSG00000242858	AC020899.1	NA	
ENSG00000202157	RNU4-11P	NA	
ENSG00000250013	ZP3P1	NA	
ENSG00000164176	EDIL3	NA	
ENSG00000252861	RNU6-448P	NA	
ENSG00000250320	EDIL3-DT	NA	
ENSG00000214853	PPIAP79	NA	
ENSG00000249349	AC114928.1	NA	
ENSG00000248674	RBBP4P6	NA	
ENSG00000250253	AC117522.3	NA	
ENSG00000249792	AC117522.2	NA	
ENSG00000248170	AC117522.1	NA	
ENSG00000248667	AC010486.1	NA	
ENSG00000249023	AC010486.2	NA	
ENSG00000249842	AC010486.3	NA	
ENSG00000243859	RPL5P17	NA	
ENSG00000251066	AC026700.1	NA	
ENSG00000250874	AC010595.1	NA	
ENSG00000241965	RPS2P25	NA	
ENSG00000249153	AC026414.1	NA	
ENSG00000250359	PTP4A1P4	NA	
ENSG00000205449	NBPF22P	NA	
ENSG00000280009	AC020923.1	NA	
ENSG00000248195	AC016550.1	NA	
ENSG00000248363	AC016550.2	NA	
ENSG00000250124	AC016550.3	NA	
ENSG00000251585	AC026444.1	NA	
ENSG00000127184	COX7C	NA	
ENSG00000284078	SNORD138	NA	
ENSG00000207013	RNU6-804P	NA	
ENSG00000250544	LINC02059	NA	
ENSG00000248701	AC008539.1	NA	
ENSG00000242477	AC091429.1	NA	
ENSG00000249061	AC109492.1	NA	
ENSG00000233828	LINC01949	NA	
ENSG00000251951	RN7SKP34	NA	
ENSG00000265919	MIR4280	NA	
ENSG00000288569	AC008394.1	NA	
ENSG00000145715	RASA1	605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1 BASAL CELL CARCINOMA, NONSYNDROMIC, INCLUDED;;BASAL CELL CARCINOMA, MULTIPLE, INCLUDED
ENSG00000145715	RASA1	608354	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1; CMAVM1;;CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM
ENSG00000241243	RN7SL629P	NA	
ENSG00000207452	RNU6-606P	NA	
ENSG00000134480	CCNH	NA	
ENSG00000285190	AC018754.1	NA	
ENSG00000200462	RNU6-727P	NA	
ENSG00000249362	LINC02488	NA	
ENSG00000248708	LINC02144	NA	
ENSG00000287783	AC020930.1	NA	
ENSG00000287862	AC114971.1	NA	
ENSG00000164180	TMEM161B	NA	
ENSG00000247828	TMEM161B-AS1	NA	
ENSG00000207129	RNA5SP187	NA	
ENSG00000240083	RPS3AP22	NA	
ENSG00000206958	SNORA70	NA	
ENSG00000250306	AC091826.1	NA	
ENSG00000250156	LINC02060	NA	
ENSG00000245526	LINC00461	NA	
ENSG00000271904	AC091826.2	NA	
ENSG00000250705	H3P23	NA	
ENSG00000284447	MIR9-2	NA	
ENSG00000245864	MEF2C-AS2	NA	
ENSG00000250377	AC008525.1	NA	
ENSG00000250555	AC008525.2	NA	
ENSG00000081189	MEF2C	613443	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20;;MENTAL RETARDATION, STEREOTYPIC MOVEMENTS, EPILEPSY, AND/OR CEREBRAL MALFORMATIONS  CHROMOSOME 5q14.3 DELETION SYNDROME, PROXIMAL, INCLUDED
ENSG00000248309	MEF2C-AS1	NA	
ENSG00000250831	AC074131.1	NA	
ENSG00000250437	LINC02161	NA	
ENSG00000214942	AC113167.1	NA	
ENSG00000264342	MIR3660	NA	
ENSG00000248555	LINC01339	NA	
ENSG00000253321	AC099554.1	NA	
ENSG00000260871	AC093510.2	NA	
ENSG00000153140	CETN3	NA	
ENSG00000255647	AC093510.1	NA	
ENSG00000176055	MBLAC2	NA	
ENSG00000113356	POLR3G	NA	
ENSG00000176018	LYSMD3	NA	
ENSG00000164199	ADGRV1	604352	FEBRILE SEIZURES, FAMILIAL, 4; FEB4;;CONVULSIONS, FAMILIAL FEBRILE, 4
ENSG00000164199	ADGRV1	605472	USHER SYNDROME, TYPE IIC; USH2C USHER SYNDROME, TYPE IIC, GPR98/PDZD7, DIGENIC, INCLUDED;;USHER SYNDROME, TYPE IIB, FORMERLY, INCLUDED; USH2B, FORMERLY, INCLUDED
ENSG00000249514	TMEM251P1	NA	
ENSG00000248323	LUCAT1	NA	
ENSG00000285618	AC074132.1	NA	
ENSG00000212930	AC093281.1	NA	
ENSG00000251093	AC093281.2	NA	
ENSG00000199643	RNU4-90P	NA	
ENSG00000234292	AC123595.1	NA	
ENSG00000286638	AC123595.2	NA	
ENSG00000277001	Metazoa_SRP	NA	
ENSG00000240388	AC008799.1	NA	
ENSG00000241059	AC008799.2	NA	
ENSG00000113369	ARRDC3	NA	
ENSG00000281357	ARRDC3-AS1	NA	
ENSG00000251356	RAB5CP2	NA	
ENSG00000286121	AC093298.2	NA	
ENSG00000248826	PCBP2P3	NA	
ENSG00000276426	AC093298.1	NA	
ENSG00000250049	AC114316.1	NA	
ENSG00000249776	AC124854.1	NA	
ENSG00000249169	AC026780.1	NA	
ENSG00000249984	AC026780.2	NA	
ENSG00000248588	AC008517.1	NA	
ENSG00000248950	LDHBP3	NA	
ENSG00000249958	CCT7P2	NA	
ENSG00000248528	LINC02058	NA	
ENSG00000251361	AC012625.1	NA	
ENSG00000286509	AC026408.1	NA	
ENSG00000213730	POLD2P1	NA	
ENSG00000237187	NR2F1-AS1	NA	
ENSG00000175745	NR2F1	615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS
ENSG00000278905	AC106818.1	NA	
ENSG00000113391	FAM172A	NA	
ENSG00000284336	MIR2277	NA	
ENSG00000287180	AC106818.2	NA	
ENSG00000249353	NPM1P27	NA	
ENSG00000248483	POU5F2	NA	
ENSG00000272406	AC108102.1	NA	
ENSG00000287447	AC099501.1	NA	
ENSG00000251023	AC114980.1	NA	
ENSG00000286577	AC117528.1	NA	
ENSG00000185261	KIAA0825	618498	POLYDACTYLY, POSTAXIAL, TYPE A10; PAPA10
ENSG00000254132	MTND6P3	NA	
ENSG00000251544	MTND5P12	NA	
ENSG00000251340	MTCYBP35	NA	
ENSG00000232578	AC093311.1	NA	
ENSG00000270133	AC025766.1	NA	
ENSG00000133302	SLF1	NA	
ENSG00000175471	MCTP1	NA	
ENSG00000249175	AC008534.1	NA	
ENSG00000243806	RPL7P18	NA	
ENSG00000276514	AC008534.2	NA	
ENSG00000249545	MCTP1-AS1	NA	
ENSG00000153347	FAM81B	NA	
ENSG00000225165	RTRAFP2	NA	
ENSG00000198677	TTC37	222470	TRICHOHEPATOENTERIC SYNDROME 1; THES1;;THE SYNDROME;;DIARRHEA, SYNDROMIC;;DIARRHEA, FATAL INFANTILE, WITH TRICHORRHEXIS NODOSA
ENSG00000212259	RNU6-308P	NA	
ENSG00000164291	ARSK	NA	
ENSG00000178015	GPR150	NA	
ENSG00000175449	RFESD	NA	
ENSG00000145757	SPATA9	NA	
ENSG00000250240	AC008840.1	NA	
ENSG00000164292	RHOBTB3	NA	
ENSG00000173221	GLRX	NA	
ENSG00000251348	HSPD1P11	NA	
ENSG00000251000	GGCTP1	NA	
ENSG00000251409	AC008592.3	NA	
ENSG00000236882	LINC01554	NA	
ENSG00000272021	AC008592.4	NA	
ENSG00000250362	AC008592.1	NA	
ENSG00000118985	ELL2	NA	
ENSG00000251314	AC104123.1	NA	
ENSG00000250955	AC008592.2	NA	
ENSG00000213716	FABP5P5	NA	
ENSG00000250551	MIR583HG	NA	
ENSG00000207578	MIR583	NA	
ENSG00000206997	RNU6-524P	NA	
ENSG00000249746	AC099509.1	NA	
ENSG00000250158	AC099509.2	NA	
ENSG00000175426	PCSK1	600955	PROPROTEIN CONVERTASE 1/3 DEFICIENCY;;OBESITY AND ENDOCRINOPATHY DUE TO IMPAIRED PROCESSING OF PROHORMONES
ENSG00000175426	PCSK1	612362	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12;;OBESITY, SUSCEPTIBILITY TO
ENSG00000153113	CAST	616295	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS; PLACK
ENSG00000249180	AC020900.1	NA	
ENSG00000164307	ERAP1	NA	
ENSG00000248734	AC008906.1	NA	
ENSG00000272109	AC008906.2	NA	
ENSG00000247121	AC009126.1	NA	
ENSG00000164308	ERAP2	NA	
ENSG00000113441	LNPEP	NA	
ENSG00000227836	AC008850.1	NA	
ENSG00000200884	Y_RNA	NA	
ENSG00000213701	SETP22	NA	
ENSG00000251513	LIX1-AS1	NA	
ENSG00000145721	LIX1	NA	
ENSG00000058729	RIOK2	NA	
ENSG00000206698	RNU1-73P	NA	
ENSG00000286828	AC008883.3	NA	
ENSG00000248758	AC008883.1	NA	
ENSG00000251054	AC008883.2	NA	
ENSG00000249761	AC074133.1	NA	
ENSG00000251389	YTHDF1P1	NA	
ENSG00000249977	AC106748.1	NA	
ENSG00000250331	LINC01340	NA	
ENSG00000248931	MTCYBP40	NA	
ENSG00000251193	AC112203.1	NA	
ENSG00000286953	AC122697.1	NA	
ENSG00000248202	LINC02234	NA	
ENSG00000249101	AC008834.1	NA	
ENSG00000248901	LINC01846	NA	
ENSG00000249135	AC116347.2	NA	
ENSG00000238000	AC116347.1	NA	
ENSG00000176183	AC233964.1	NA	
ENSG00000250221	KRT8P32	NA	
ENSG00000250830	MRPS35P2	NA	
ENSG00000249990	MTCO2P24	NA	
ENSG00000249448	MTCO1P24	NA	
ENSG00000251102	CTBP2P4	NA	
ENSG00000251553	DDX18P4	NA	
ENSG00000174136	RGMB	NA	
ENSG00000246763	RGMB-AS1	NA	
ENSG00000279232	AC008522.1	NA	
ENSG00000250162	CSNK1A1P3	NA	
ENSG00000153922	CHD1	617682	PILAROWSKI-BJORNSSON SYNDROME; PILBOS;;DEVELOPMENTAL DELAY AND SPEECH APRAXIA WITH OR WITHOUT SEIZURES
ENSG00000222610	RNU6-402P	NA	
ENSG00000248489	LINC02062	NA	
ENSG00000200351	Y_RNA	NA	
ENSG00000241597	AC022121.1	NA	
ENSG00000249444	AC114324.2	NA	
ENSG00000206356	AC114324.1	NA	
ENSG00000227762	GUSBP8	NA	
ENSG00000249515	LINC02113	NA	
ENSG00000248236	AC008837.1	NA	
ENSG00000248928	AC008837.2	NA	
ENSG00000250391	CRLF3P2	NA	
ENSG00000249963	EEF1A1P20	NA	
ENSG00000199378	Y_RNA	NA	
ENSG00000270232	MTCYBP22	NA	
ENSG00000270230	MTND6P22	NA	
ENSG00000271687	MTND5P10	NA	
ENSG00000270906	MTND4P35	NA	
ENSG00000270350	MTND4LP5	NA	
ENSG00000271480	MTND3P19	NA	
ENSG00000270388	MTCO3P22	NA	
ENSG00000270307	MTATP6P2	NA	
ENSG00000270225	MTCO2P22	NA	
ENSG00000271207	MTCO1P22	NA	
ENSG00000274455	AC092278.1	NA	
ENSG00000207077	RNU6-1119P	NA	
ENSG00000275374	AC113385.3	NA	
ENSG00000273957	AC113385.2	NA	
ENSG00000249787	AC113385.1	NA	
ENSG00000247877	AC021086.1	NA	
ENSG00000174132	FAM174A	NA	
ENSG00000250806	AC027315.1	NA	
ENSG00000207269	RN7SKP62	NA	
ENSG00000113532	ST8SIA4	NA	
ENSG00000221263	MIR548P	NA	
ENSG00000277506	RN7SL802P	NA	
ENSG00000251261	OR7H2P	NA	
ENSG00000249495	AC117525.1	NA	
ENSG00000199786	RNA5SP188	NA	
ENSG00000248261	AC008948.1	NA	
ENSG00000173930	SLCO4C1	NA	
ENSG00000222987	RN7SKP68	NA	
ENSG00000205359	SLCO6A1	NA	
ENSG00000249017	AC094108.1	NA	
ENSG00000250958	LINC00492	NA	
ENSG00000250682	LINC00491	NA	
ENSG00000247402	AC099487.1	NA	
ENSG00000286338	AC099487.2	NA	
ENSG00000145730	PAM	NA	
ENSG00000175749	EIF3KP1	NA	
ENSG00000145723	GIN1	NA	
ENSG00000145725	PPIP5K2	618422	DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100
ENSG00000248203	AC011362.1	NA	
ENSG00000181751	MACIR	NA	
ENSG00000250567	AC010406.1	NA	
ENSG00000226926	PDZPH1P	NA	
ENSG00000248757	LINC02115	NA	
ENSG00000112874	NUDT12	NA	
ENSG00000283462	AC008505.1	NA	
ENSG00000251026	LINC02163	NA	
ENSG00000201910	RNU1-140P	NA	
ENSG00000239808	RN7SL255P	NA	
ENSG00000251574	AC099520.1	NA	
ENSG00000278958	AC091931.1	NA	
ENSG00000253776	AC099520.2	NA	
ENSG00000252881	RNU6-334P	NA	
ENSG00000253584	AC091987.1	NA	
ENSG00000232159	RAB9BP1	NA	
ENSG00000201790	RNA5SP189	NA	
ENSG00000251204	AC027313.1	NA	
ENSG00000250145	AC114940.1	NA	
ENSG00000252337	AC114940.2	NA	
ENSG00000251027	LINC01950	NA	
ENSG00000250273	PSMC1P5	NA	
ENSG00000184349	EFNA5	NA	
ENSG00000249959	AC024587.2	NA	
ENSG00000248827	AC024587.1	NA	
ENSG00000239708	RN7SL782P	NA	
ENSG00000251732	RN7SKP122	NA	
ENSG00000145743	FBXL17	NA	
ENSG00000286503	AC008462.1	NA	
ENSG00000244245	AC133134.1	NA	
ENSG00000272523	LINC01023	NA	
ENSG00000151422	FER	NA	
ENSG00000249921	AC034207.1	NA	
ENSG00000250383	AC008871.1	NA	
ENSG00000207404	Y_RNA	NA	
ENSG00000250441	AC109481.1	NA	
ENSG00000206593	RNU6-47P	NA	
ENSG00000176857	GJA1P1	NA	
ENSG00000286882	AC116428.1	NA	
ENSG00000249476	AC008467.1	NA	
ENSG00000198961	PJA2	NA	
ENSG00000248867	AC010625.1	NA	
ENSG00000251367	AC091917.3	NA	
ENSG00000248876	AC091917.2	NA	
ENSG00000248440	AC091917.1	NA	
ENSG00000214794	KRT18P42	NA	
ENSG00000271849	MAN2A1-DT	NA	
ENSG00000112893	MAN2A1	NA	
ENSG00000202512	RN7SKP230	NA	
ENSG00000249068	AC008417.1	NA	
ENSG00000254106	LINC01848	NA	
ENSG00000253224	PGAM5P1	NA	
ENSG00000186952	TMEM232	NA	
ENSG00000221436	MIR548F3	NA	
ENSG00000207177	AC008650.1	NA	
ENSG00000164209	SLC25A46	616505	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY; HMSN6B;;HMSN VIB;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6B; CMT6B
ENSG00000270779	AC008782.1	NA	
ENSG00000248966	BCLAF1P1	NA	
ENSG00000248428	AC010395.1	NA	
ENSG00000251627	AC010395.2	NA	
ENSG00000145777	TSLP	NA	
ENSG00000253613	AC008572.1	NA	
ENSG00000134987	WDR36	609887	GLAUCOMA 1, OPEN ANGLE, G; GLC1G
ENSG00000250728	AC010468.2	NA	
ENSG00000214784	RPS3AP21	NA	
ENSG00000152495	CAMK4	NA	
ENSG00000249318	AC010468.1	NA	
ENSG00000248268	AC010275.1	NA	
ENSG00000164211	STARD4	NA	
ENSG00000246859	STARD4-AS1	NA	
ENSG00000249619	HMGN1P13	NA	
ENSG00000251099	AC008967.1	NA	
ENSG00000134986	NREP	NA	
ENSG00000253057	RN7SKP57	NA	
ENSG00000249439	HMGN1P14	NA	
ENSG00000250095	NREP-AS1	NA	
ENSG00000129595	EPB41L4A	NA	
ENSG00000224032	EPB41L4A-AS1	NA	
ENSG00000238363	SNORA13	NA	
ENSG00000250882	AC010261.1	NA	
ENSG00000251187	AC010261.2	NA	
ENSG00000251076	AC104126.1	NA	
ENSG00000248350	AC010265.1	NA	
ENSG00000278921	EPB41L4A-DT	NA	
ENSG00000248430	HMGB3P16	NA	
ENSG00000251014	AC137549.1	NA	
ENSG00000250358	LINC02200	NA	
ENSG00000134982	APC	175100	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1;;ADENOMATOUS POLYPOSIS OF THE COLON; APC;;FAMILIAL POLYPOSIS OF THE COLON; FPC;;POLYPOSIS, ADENOMATOUS INTESTINAL GARDNER SYNDROME, INCLUDED; GS, INCLUDED;;BRAIN TUMOR-POLYPOSIS SYNDROME 2, INCLUDED; BTPS2, INC /.../;FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED, INCLUDED; AFAP, INCLUDED;;ADENOMATOUS POLYPOSIS COLI, ATTENUATED, INCLUDED; AAPC, INCLUDED
ENSG00000134982	APC	135290	DESMOID DISEASE, HEREDITARY; DESMD;;FIBROMATOSIS, FAMILIAL INFILTRATIVE; FIF DESMOID TUMOR CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000134982	APC	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000134982	APC	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000134982	APC	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000250045	CBX3P3	NA	
ENSG00000212370	RNU6-482P	NA	
ENSG00000258864	AC008575.1	NA	
ENSG00000153037	SRP19	NA	
ENSG00000129625	REEP5	NA	
ENSG00000249947	XBP1P1	NA	
ENSG00000212643	ZRSR2P1	NA	
ENSG00000172795	DCP2	NA	
ENSG00000171444	MCC	NA	
ENSG00000232633	AC079465.1	NA	
ENSG00000212122	TSSK1B	NA	
ENSG00000251741	RNU4ATAC13P	NA	
ENSG00000047188	YTHDC2	NA	
ENSG00000286839	AC093240.1	NA	
ENSG00000080709	KCNN2	NA	
ENSG00000222706	RN7SKP89	NA	
ENSG00000246316	AC010230.1	NA	
ENSG00000251542	LINC01957	NA	
ENSG00000251132	AC094104.2	NA	
ENSG00000250242	AC094104.1	NA	
ENSG00000152503	TRIM36	206500	ANENCEPHALY; ANPH
ENSG00000250472	TRIM36-IT1	NA	
ENSG00000249791	AC008494.2	NA	
ENSG00000164219	PGGT1B	NA	
ENSG00000271797	AC008494.3	NA	
ENSG00000243304	AC008494.1	NA	
ENSG00000164221	CCDC112	NA	
ENSG00000250197	HMGN1P15	NA	
ENSG00000249026	CTNNA1P1	NA	
ENSG00000248722	AK3P4	NA	
ENSG00000249944	AC008628.2	NA	
ENSG00000249433	AC008628.1	NA	
ENSG00000250444	CCT5P1	NA	
ENSG00000145780	FEM1C	NA	
ENSG00000243414	TICAM2	NA	
ENSG00000251201	TMED7-TICAM2	NA	
ENSG00000249249	AC010226.1	NA	
ENSG00000134970	TMED7	NA	
ENSG00000249021	AC008549.2	NA	
ENSG00000248709	AC008549.1	NA	
ENSG00000251118	H3P24	NA	
ENSG00000222598	RNU2-49P	NA	
ENSG00000129596	CDO1	NA	
ENSG00000145782	ATG12	NA	
ENSG00000177879	AP3S1	NA	
ENSG00000287148	LINCADL	NA	
ENSG00000172901	LVRN	NA	
ENSG00000248295	DDX43P1	NA	
ENSG00000268223	ARL14EPL	NA	
ENSG00000185641	AC034236.1	NA	
ENSG00000272265	AC034236.3	NA	
ENSG00000271918	AC034236.2	NA	
ENSG00000145781	COMMD10	NA	
ENSG00000212457	RNU6-644P	NA	
ENSG00000232916	HMGN2P27	NA	
ENSG00000250015	AC018752.1	NA	
ENSG00000092421	SEMA6A	NA	
ENSG00000248445	SEMA6A-AS1	NA	
ENSG00000239528	RPS14P8	NA	
ENSG00000249167	SEMA6A-AS2	NA	
ENSG00000197575	RPS17P2	NA	
ENSG00000251311	LINC02214	NA	
ENSG00000249150	AC010267.1	NA	
ENSG00000250650	AC093534.1	NA	
ENSG00000250949	AC093534.2	NA	
ENSG00000243758	RPL35AP15	NA	
ENSG00000285809	AC093295.1	NA	
ENSG00000248663	LINC00992	NA	
ENSG00000251477	AC114322.1	NA	
ENSG00000249797	LINC02147	NA	
ENSG00000249582	RPL7L1P4	NA	
ENSG00000250891	LINC02208	NA	
ENSG00000250427	LINC02148	NA	
ENSG00000249551	LINC02216	NA	
ENSG00000286745	AC114311.1	NA	
ENSG00000249128	LINC02215	NA	
ENSG00000238904	RNU7-34P	NA	
ENSG00000249426	AC093206.1	NA	
ENSG00000169570	DTWD2	NA	
ENSG00000197744	PTMAP2	NA	
ENSG00000283498	MIR1244-2	NA	
ENSG00000249494	AC008629.1	NA	
ENSG00000223179	RNU6-373P	NA	
ENSG00000250678	AC008629.2	NA	
ENSG00000250928	AC008629.3	NA	
ENSG00000172869	DMXL1	NA	
ENSG00000248885	AC118465.1	NA	
ENSG00000248979	LAMTOR3P2	NA	
ENSG00000206786	RNU6-701P	NA	
ENSG00000264536	MIR5706	NA	
ENSG00000145779	TNFAIP8	NA	
ENSG00000243333	RN7SL174P	NA	
ENSG00000202092	RNA5SP190	NA	
ENSG00000133835	HSD17B4	233400	PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS
ENSG00000133835	HSD17B4	261515	D-BIFUNCTIONAL PROTEIN DEFICIENCY;;17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV DEFICIENCY;;DBP DEFICIENCY;;PEROXISOMAL BIFUNCTIONAL ENZYME DEFICIENCY;;PBFE DEFICIENCY
ENSG00000213663	AC010409.1	NA	
ENSG00000249919	FABP5P6	NA	
ENSG00000164334	FAM170A	NA	
ENSG00000250895	AC010409.2	NA	
ENSG00000234259	AC008550.1	NA	
ENSG00000251293	AC008574.1	NA	
ENSG00000251975	RNU6-718P	NA	
ENSG00000261036	AC113418.1	NA	
ENSG00000184838	PRR16	NA	
ENSG00000270741	PRELID3BP8	NA	
ENSG00000222609	RNU4-69P	NA	
ENSG00000248927	AC114284.1	NA	
ENSG00000251135	AC008565.1	NA	
ENSG00000248853	AC113352.1	NA	
ENSG00000229855	AC008568.1	NA	
ENSG00000250847	AC010350.1	NA	
ENSG00000279860	AC008568.2	NA	
ENSG00000244088	RPL23AP44	NA	
ENSG00000213661	AC106806.1	NA	
ENSG00000249600	AC106806.2	NA	
ENSG00000181867	FTMT	NA	
ENSG00000151304	SRFBP1	NA	
ENSG00000113083	LOX	617168	AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10;;AORTIC ANEURYSM, THORACIC, WITH OR WITHOUT AORTIC DISSECTION
ENSG00000247311	AC010255.1	NA	
ENSG00000164185	ZNF474	NA	
ENSG00000250803	AC010255.3	NA	
ENSG00000249610	AC010255.2	NA	
ENSG00000272139	AC113349.2	NA	
ENSG00000064692	SNCAIP	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000249621	AC113349.1	NA	
ENSG00000249916	AC119150.1	NA	
ENSG00000287794	AC119150.2	NA	
ENSG00000250328	MGC32805	NA	
ENSG00000251538	LINC02201	NA	
ENSG00000240058	ARGFXP1	NA	
ENSG00000205302	SNX2	NA	
ENSG00000260686	AC008669.1	NA	
ENSG00000064652	SNX24	NA	
ENSG00000263432	RN7SL689P	NA	
ENSG00000168938	PPIC	NA	
ENSG00000249996	PPIC-AS1	NA	
ENSG00000276047	RN7SL711P	NA	
ENSG00000223652	AC106786.1	NA	
ENSG00000061455	PRDM6	617039	PATENT DUCTUS ARTERIOSUS 3; PDA3
ENSG00000213655	AC010493.1	NA	
ENSG00000168944	CEP120	616300	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13
ENSG00000168944	CEP120	617761	JOUBERT SYNDROME 31; JBTS31
ENSG00000250539	KRT8P33	NA	
ENSG00000249400	HMGB3P17	NA	
ENSG00000279772	AC026422.1	NA	
ENSG00000151292	CSNK1G3	NA	
ENSG00000235275	KRT18P16	NA	
ENSG00000253807	LINC01170	NA	
ENSG00000250862	HMGB1P29	NA	
ENSG00000251421	AC016556.1	NA	
ENSG00000248600	AC025465.2	NA	
ENSG00000251214	AC025465.4	NA	
ENSG00000250438	AC025465.3	NA	
ENSG00000248296	AC025465.1	NA	
ENSG00000168916	ZNF608	NA	
ENSG00000249112	AC112196.1	NA	
ENSG00000251456	AC113398.2	NA	
ENSG00000242814	AC113398.1	NA	
ENSG00000260192	LINC02240	NA	
ENSG00000248443	AC109464.1	NA	
ENSG00000249261	AC109464.2	NA	
ENSG00000288008	AC109458.2	NA	
ENSG00000250194	AC109458.1	NA	
ENSG00000250721	HMGB1P22	NA	
ENSG00000248752	AC116362.1	NA	
ENSG00000222107	RN7SKP117	NA	
ENSG00000250402	AC109471.1	NA	
ENSG00000286111	AC116362.2	NA	
ENSG00000249950	AC010587.2	NA	
ENSG00000249904	AC010587.1	NA	
ENSG00000241888	RPSAP37	NA	
ENSG00000248107	LINC02039	NA	
ENSG00000155324	GRAMD2B	NA	
ENSG00000250602	AC093535.1	NA	
ENSG00000279118	AC093535.2	NA	
ENSG00000164904	ALDH7A1	266100	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD;;PYRIDOXINE-DEPENDENT EPILEPSY; PDE;;PYRIDOXINE DEPENDENCY WITH SEIZURES;;AASA DEHYDROGENASE DEFICIENCY
ENSG00000202082	RNU6-290P	NA	
ENSG00000164902	PHAX	NA	
ENSG00000230929	AC099513.1	NA	
ENSG00000196900	TEX43	NA	
ENSG00000213630	BOLA3P3	NA	
ENSG00000249768	HSPE1P10	NA	
ENSG00000251072	LMNB1-DT	NA	
ENSG00000252185	RNU6-752P	NA	
ENSG00000113368	LMNB1	169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD;;PELIZAEUS-MERZBACHER DISEASE, AUTOSOMAL DOMINANT OR LATE-ONSET TYPE, FORMERLY
ENSG00000173926	MARCHF3	NA	
ENSG00000164241	C5orf63	NA	
ENSG00000279446	AC005915.1	NA	
ENSG00000214743	MRPS5P3	NA	
ENSG00000250080	AC011416.1	NA	
ENSG00000271585	SELENOTP2	NA	
ENSG00000250956	AC011416.2	NA	
ENSG00000283897	AC011416.3	NA	
ENSG00000145794	MEGF10	614399	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET, MILD VARIANT, INCLUDED
ENSG00000286615	AC011416.4	NA	
ENSG00000249577	AC010424.1	NA	
ENSG00000271766	AC010424.2	NA	
ENSG00000250859	HNRNPKP1	NA	
ENSG00000164244	PRRC1	NA	
ENSG00000282925	AC010424.3	NA	
ENSG00000205279	CTXN3	NA	
ENSG00000248799	AC022118.1	NA	
ENSG00000230561	CCDC192	NA	
ENSG00000251032	CUL1P1	NA	
ENSG00000250603	AC068658.1	NA	
ENSG00000245937	LINC01184	NA	
ENSG00000064651	SLC12A2	NA	
ENSG00000250329	KDELC1P1	NA	
ENSG00000138829	FBN2	121050	CONTRACTURAL ARACHNODACTYLY, CONGENITAL; CCA;;ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;;BEALS SYNDROME
ENSG00000138829	FBN2	616118	MACULAR DEGENERATION, EARLY-ONSET; EOMD
ENSG00000207290	Y_RNA	NA	
ENSG00000113396	SLC27A6	NA	
ENSG00000248634	AC008588.1	NA	
ENSG00000066583	ISOC1	NA	
ENSG00000264563	MIR4633	NA	
ENSG00000286274	AC008679.1	NA	
ENSG00000265691	MIR4460	NA	
ENSG00000249421	ADAMTS19-AS1	NA	
ENSG00000145808	ADAMTS19	NA	
ENSG00000251680	AC008591.1	NA	
ENSG00000186367	MINAR2	NA	
ENSG00000198108	CHSY3	NA	
ENSG00000221562	RNU6ATAC10P	NA	
ENSG00000199455	RNA5SP191	NA	
ENSG00000248610	HSPA8P4	NA	
ENSG00000252514	RNU7-53P	NA	
ENSG00000249312	ARL2BPP4	NA	
ENSG00000249418	AC005741.1	NA	
ENSG00000287390	AC006525.1	NA	
ENSG00000244192	AC113367.1	NA	
ENSG00000250405	AC113367.3	NA	
ENSG00000248955	AC113367.2	NA	
ENSG00000169567	HINT1	137200	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN;;GAMSTORP-WOHLFART SYNDROME;;MYOKYMIA, MYOTONIA, AND MUSCLE WASTING
ENSG00000186687	LYRM7	615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8
ENSG00000158985	CDC42SE2	NA	
ENSG00000279370	AC004777.1	NA	
ENSG00000158987	RAPGEF6	NA	
ENSG00000273217	AC008695.1	NA	
ENSG00000275939	AC008497.1	NA	
ENSG00000217128	FNIP1	NA	
ENSG00000286676	AC008695.2	NA	
ENSG00000279584	AC005593.1	NA	
ENSG00000239642	MEIKIN	NA	
ENSG00000281938	AC034228.3	NA	
ENSG00000234758	AC034228.2	NA	
ENSG00000164398	ACSL6	NA	
ENSG00000223548	ACSL6-AS1	NA	
ENSG00000231585	AC034228.1	NA	
ENSG00000164399	IL3	NA	
ENSG00000164400	CSF2	NA	
ENSG00000253067	AC034216.1	NA	
ENSG00000227616	AC063976.3	NA	
ENSG00000235775	AC063976.4	NA	
ENSG00000224015	AC063976.1	NA	
ENSG00000237714	P4HA2-AS1	NA	
ENSG00000072682	P4HA2	617238	MYOPIA 25, AUTOSOMAL DOMINANT; MYP25
ENSG00000224431	AC063976.2	NA	
ENSG00000283678	MIR6830	NA	
ENSG00000131435	PDLIM4	166710	OSTEOPOROSIS;;BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS; BMND;;OSTEOPOROSIS, POSTMENOPAUSAL;;OSTEOPOROSIS, INVOLUTIONAL  FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED
ENSG00000197208	SLC22A4	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000233006	MIR3936HG	NA	
ENSG00000263597	MIR3936	NA	
ENSG00000197375	SLC22A5	212140	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP;;SYSTEMIC CARNITINE DEFICIENCY; SCD;;CARNITINE DEFICIENCY, SYSTEMIC, DUE TO DEFECT IN RENAL REABSORPTION OF CARNITINE;;CARNITINE DEFICIENCY, PRIMARY;;CARNITINE TRANSPORTER, PLASMA-MEMBRANE, DEFICIENCY OF; /.../TINE UPTAKE DEFECT; CUD
ENSG00000197536	IRF1-AS1	NA	
ENSG00000283782	AC116366.2	NA	
ENSG00000238160	LINC02863	NA	
ENSG00000202533	Y_RNA	NA	
ENSG00000234290	AC116366.1	NA	
ENSG00000125347	IRF1	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000125347	IRF1	613659	GASTRIC CANCER GASTRIC CANCER, INTESTINAL, INCLUDED
ENSG00000113525	IL5	NA	
ENSG00000113522	RAD50	613078	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY
ENSG00000223442	TH2LCRR	NA	
ENSG00000169194	IL13	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000169194	IL13	607154	ALLERGIC RHINITIS;;ALRH
ENSG00000113520	IL4	NA	
ENSG00000230612	AC004039.1	NA	
ENSG00000131437	KIF3A	NA	
ENSG00000205089	CCNI2	NA	
ENSG00000164402	SEPTIN8	NA	
ENSG00000198944	SOWAHA	NA	
ENSG00000272203	AC004775.1	NA	
ENSG00000164403	SHROOM1	NA	
ENSG00000201274	RNA5SP192	NA	
ENSG00000164404	GDF9	618014	PREMATURE OVARIAN FAILURE 14; POF14
ENSG00000164405	UQCRQ	615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4
ENSG00000164406	LEAP2	NA	
ENSG00000072364	AFF4	616368	CHOPS SYNDROME; CHOPS;;COGNITIVE IMPAIRMENT, COARSE FACIES, HEART DEFECTS, OBESITY, PULMONARY INVOLVEMENT, SHORT STATURE, AND SKELETAL DYSPLASIA
ENSG00000235253	AC010240.2	NA	
ENSG00000202417	Y_RNA	NA	
ENSG00000225364	ATP6V0E1P1	NA	
ENSG00000272023	AC010240.3	NA	
ENSG00000229738	AC010240.1	NA	
ENSG00000199677	Y_RNA	NA	
ENSG00000155329	ZCCHC10	NA	
ENSG00000248648	AC113410.1	NA	
ENSG00000287054	AC113410.5	NA	
ENSG00000286408	AC113410.4	NA	
ENSG00000170606	HSPA4	NA	
ENSG00000279691	AC113410.3	NA	
ENSG00000251616	AC113410.2	NA	
ENSG00000248245	AC010307.2	NA	
ENSG00000240611	AC010307.1	NA	
ENSG00000053108	FSTL4	NA	
ENSG00000249478	AC010307.3	NA	
ENSG00000250244	AC010307.4	NA	
ENSG00000250409	AC010608.1	NA	
ENSG00000221287	MIR1289-2	NA	
ENSG00000280104	AC010608.3	NA	
ENSG00000279197	AC010608.2	NA	
ENSG00000251243	AC005178.1	NA	
ENSG00000249073	WSPAR	NA	
ENSG00000113583	C5orf15	NA	
ENSG00000213585	VDAC1	NA	
ENSG00000271737	AC008608.2	NA	
ENSG00000271128	AC008608.1	NA	
ENSG00000081059	TCF7	NA	
ENSG00000113558	SKP1	NA	
ENSG00000272772	AC104109.3	NA	
ENSG00000113575	PPP2CA	618354	NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA
ENSG00000273345	AC104109.4	NA	
ENSG00000266751	MIR3661	NA	
ENSG00000270177	AC104109.2	NA	
ENSG00000239615	AC104109.1	NA	
ENSG00000006837	CDKL3	NA	
ENSG00000119048	UBE2B	NA	
ENSG00000279469	AC109454.4	NA	
ENSG00000248559	AC109454.2	NA	
ENSG00000237190	CDKN2AIPNL	NA	
ENSG00000243648	AC109454.1	NA	
ENSG00000250564	AC109454.3	NA	
ENSG00000250994	AC005355.1	NA	
ENSG00000207222	RNU6-456P	NA	
ENSG00000251169	LINC01843	NA	
ENSG00000240250	RN7SL541P	NA	
ENSG00000280420	AC005355.2	NA	
ENSG00000043143	JADE2	NA	
ENSG00000152700	SAR1B	246700	CHYLOMICRON RETENTION DISEASE; CMRD;;ANDERSON DISEASE; ANDD;;LIPID TRANSPORT DEFECT OF INTESTINE;;HYPOBETALIPOPROTEINEMIA WITH ACCUMULATION OF APOLIPOPROTEIN B-LIKE PROTEIN IN INTESTINAL CELLS
ENSG00000207459	RNU6-1311P	NA	
ENSG00000113615	SEC24A	NA	
ENSG00000201298	RNU6-1164P	NA	
ENSG00000222266	RNU6-757P	NA	
ENSG00000164615	CAMLG	NA	
ENSG00000145833	DDX46	NA	
ENSG00000241179	AC010301.1	NA	
ENSG00000181904	C5orf24	NA	
ENSG00000270892	AC006077.1	NA	
ENSG00000113621	TXNDC15	NA	
ENSG00000132570	PCBD2	NA	
ENSG00000279799	AC006077.2	NA	
ENSG00000244921	MTCYBP18	NA	
ENSG00000249119	MTND6P4	NA	
ENSG00000248923	MTND5P11	NA	
ENSG00000247627	MTND4P12	NA	
ENSG00000198868	MTND4LP30	NA	
ENSG00000263963	AC008670.1	NA	
ENSG00000249192	MTND3P25	NA	
ENSG00000152705	CATSPER3	NA	
ENSG00000069011	PITX1	186550	LIEBENBERG SYNDROME; LBNBG;;SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY;;BRACHYDACTYLY WITH JOINT DYSPLASIA
ENSG00000069011	PITX1	119800	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF
ENSG00000224186	C5orf66	NA	
ENSG00000277619	AC008406.3	NA	
ENSG00000249082	C5orf66-AS1	NA	
ENSG00000248753	AC008406.2	NA	
ENSG00000248482	AC008406.1	NA	
ENSG00000249647	C5orf66-AS2	NA	
ENSG00000113648	MACROH2A1	NA	
ENSG00000270021	AC026691.1	NA	
ENSG00000251380	DCANP1	NA	
ENSG00000255833	TIFAB	NA	
ENSG00000249639	AC022092.1	NA	
ENSG00000181965	NEUROG1	NA	
ENSG00000250167	AC034206.1	NA	
ENSG00000145824	CXCL14	NA	
ENSG00000145832	SLC25A48	NA	
ENSG00000251045	SLC25A48-AS1	NA	
ENSG00000223539	AC011431.1	NA	
ENSG00000265924	MIR5692C1	NA	
ENSG00000250378	AC114296.1	NA	
ENSG00000145839	IL9	NA	
ENSG00000254239	AC002428.2	NA	
ENSG00000253927	AC002428.1	NA	
ENSG00000145826	LECT2	NA	
ENSG00000164616	FBXL21P	NA	
ENSG00000120708	TGFBI	122200	CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1;;LATTICE CORNEAL DYSTROPHY, TYPE I; LCD1;;LCD
ENSG00000120708	TGFBI	121900	CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1;;GRANULAR CORNEAL DYSTROPHY, TYPE I; GCD1;;CORNEAL DYSTROPHY, PUNCTATE OR NODULAR
ENSG00000120708	TGFBI	121820	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD;;CORNEAL DYSTROPHY, ANTERIOR BASEMENT MEMBRANE;;COGAN CORNEAL DYSTROPHY;;CORNEAL DYSTROPHY, MAP-DOT-FINGERPRINT TYPE;;CORNEAL DYSTROPHY, MICROCYSTIC
ENSG00000120708	TGFBI	602082	CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB;;THIEL-BEHNKE CORNEAL DYSTROPHY; TBCD;;CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2;;CORNEAL DYSTROPHY, HONEYCOMB-SHAPED
ENSG00000120708	TGFBI	607541	CORNEAL DYSTROPHY, AVELLINO TYPE; CDA;;ACD;;AVELLINO CORNEAL DYSTROPHY;;COMBINED GRANULAR-LATTICE CORNEAL DYSTROPHY;;GRANULAR CORNEAL DYSTROPHY, TYPE II; CGD2
ENSG00000120708	TGFBI	608470	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB;;REIS-BUCKLERS CORNEAL DYSTROPHY; RBCD;;CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1;;CORNEAL DYSTROPHY, GEOGRAPHIC;;GRANULAR CORNEAL DYSTROPHY, TYPE III
ENSG00000120708	TGFBI	608471	CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A;;LATTICE CORNEAL DYSTROPHY, TYPE IIIA
ENSG00000270123	VTRNA2-1	NA	
ENSG00000278815	Vault	NA	
ENSG00000164621	SMAD5-AS1	NA	
ENSG00000277859	AC009014.4	NA	
ENSG00000113658	SMAD5	NA	
ENSG00000275646	AC009014.2	NA	
ENSG00000277524	AC009014.3	NA	
ENSG00000274934	AC009014.1	NA	
ENSG00000271824	SMIM32	NA	
ENSG00000069018	TRPC7	NA	
ENSG00000248211	TRPC7-AS1	NA	
ENSG00000250947	TRPC7-AS2	NA	
ENSG00000279240	AC063980.1	NA	
ENSG00000248351	HSPD1P18	NA	
ENSG00000213568	HNRNPA1P13	NA	
ENSG00000249803	AC112178.1	NA	
ENSG00000250284	AC109439.1	NA	
ENSG00000248616	ANKRD49P3	NA	
ENSG00000222285	RNA5SP193	NA	
ENSG00000152377	SPOCK1	NA	
ENSG00000146021	KLHL3	614495	PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT
ENSG00000216009	MIR874	NA	
ENSG00000177733	HNRNPA0	NA	
ENSG00000287067	AC106791.3	NA	
ENSG00000270697	AC106791.2	NA	
ENSG00000226306	NPY6R	NA	
ENSG00000250159	AC106791.1	NA	
ENSG00000120729	MYOT	182920	MYOPATHY, SPHEROID BODY
ENSG00000120729	MYOT	609200	MYOPATHY, MYOFIBRILLAR, 3; MFM3;;MYOTILINOPATHY;;MYOPATHY, MYOFIBRILLAR, MYOTILIN-RELATED;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1, FORMERLY; LGMD1, FORMERLY;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A, FORMERLY; LGMD1A, FORMERLY
ENSG00000078795	PKD2L2	NA	
ENSG00000031003	FAM13B	NA	
ENSG00000246323	AC113382.1	NA	
ENSG00000250260	AC113382.2	NA	
ENSG00000222924	RNU6-1148P	NA	
ENSG00000061492	WNT8A	NA	
ENSG00000112981	NME5	NA	
ENSG00000212460	RNU6-460P	NA	
ENSG00000199880	RNU6-888P	NA	
ENSG00000112983	BRD8	NA	
ENSG00000112984	KIF20A	NA	
ENSG00000094880	CDC23	NA	
ENSG00000146013	GFRA3	NA	
ENSG00000249851	RPS27AP18	NA	
ENSG00000158402	CDC25C	NA	
ENSG00000120709	FAM53C	NA	
ENSG00000249971	AC104116.1	NA	
ENSG00000120733	KDM3B	NA	
ENSG00000132563	REEP2	615625	SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72 SPASTIC PARAPLEGIA 72, AUTOSOMAL DOMINANT, INCLUDED
ENSG00000271196	AC113403.1	NA	
ENSG00000120738	EGR1	NA	
ENSG00000241458	RPL7P19	NA	
ENSG00000120705	ETF1	NA	
ENSG00000113013	HSPA9	182170	ANEMIA, SIDEROBLASTIC, 4; SIDBA4
ENSG00000113013	HSPA9	616854	EVEN-PLUS SYNDROME; EVPLS;;EPIPHYSEAL AND VERTEBRAL DYSPLASIA, MICROTIA, AND FLAT NOSE, PLUS ASSOCIATED MALFORMATIONS
ENSG00000222937	SNORD63B	NA	
ENSG00000206989	SNORD63	NA	
ENSG00000044115	CTNNA1	608970	MACULAR DYSTROPHY, PATTERNED, 2; MDPT2;;MACULAR DYSTROPHY, BUTTERFLY-SHAPED PIGMENTARY, 2
ENSG00000232174	AC113340.1	NA	
ENSG00000238745	AC113340.2	NA	
ENSG00000253404	AC034243.1	NA	
ENSG00000146006	LRRTM2	NA	
ENSG00000120725	SIL1	248800	MARINESCO-SJOGREN SYNDROME; MSS
ENSG00000201532	RNA5SP194	NA	
ENSG00000249593	AC011405.1	NA	
ENSG00000242683	RPL12P21	NA	
ENSG00000252533	RNU6-572P	NA	
ENSG00000280987	MATR3	606070	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY; VCPDM, FORMERLY
ENSG00000281398	SNHG4	NA	
ENSG00000252213	SNORA74D	NA	
ENSG00000200959	SNORA74A	NA	
ENSG00000015479	MATR3	606070	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY; VCPDM, FORMERLY
ENSG00000199545	RNA5SP195	NA	
ENSG00000253015	RN7SKP64	NA	
ENSG00000120727	PAIP2	NA	
ENSG00000272742	AC135457.1	NA	
ENSG00000170482	SLC23A1	NA	
ENSG00000170476	MZB1	NA	
ENSG00000228672	PROB1	NA	
ENSG00000170469	SPATA24	NA	
ENSG00000170464	DNAJC18	NA	
ENSG00000279686	AC142391.1	NA	
ENSG00000200378	RNU5B-4P	NA	
ENSG00000249751	ECSCR	NA	
ENSG00000283288	SMIM33	NA	
ENSG00000184584	STING1	615934	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI
ENSG00000249689	AC138517.1	NA	
ENSG00000249215	NCOA4P4	NA	
ENSG00000286403	AC010378.1	NA	
ENSG00000131508	UBE2D2	NA	
ENSG00000207020	Y_RNA	NA	
ENSG00000275506	H3P25	NA	
ENSG00000272255	AC113361.1	NA	
ENSG00000171604	CXXC5	NA	
ENSG00000250635	CXXC5-AS1	NA	
ENSG00000249526	AC008667.1	NA	
ENSG00000200756	RNU6-236P	NA	
ENSG00000249131	PSD2-AS1	NA	
ENSG00000251387	AC008667.3	NA	
ENSG00000271792	AC008667.4	NA	
ENSG00000146005	PSD2	NA	
ENSG00000158458	NRG2	NA	
ENSG00000250692	AC008667.2	NA	
ENSG00000207317	AC010292.1	NA	
ENSG00000245146	MALINC1	NA	
ENSG00000185129	PURA	616158	MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31
ENSG00000182700	IGIP	NA	
ENSG00000254363	AC011379.2	NA	
ENSG00000120306	CYSTM1	NA	
ENSG00000250069	AC011379.1	NA	
ENSG00000113068	PFDN1	NA	
ENSG00000113070	HBEGF	NA	
ENSG00000253965	AC008438.2	NA	
ENSG00000113073	SLC4A9	NA	
ENSG00000249637	AC008438.1	NA	
ENSG00000222790	RNU4-14P	NA	
ENSG00000131503	ANKHD1	NA	
ENSG00000254996	ANKHD1-EIF4EBP3	NA	
ENSG00000200051	AC011399.1	NA	
ENSG00000213523	SRA1	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000243056	EIF4EBP3	NA	
ENSG00000113108	APBB3	NA	
ENSG00000283155	AC116353.5	NA	
ENSG00000283717	MIR6831	NA	
ENSG00000176087	SLC35A4	NA	
ENSG00000283602	AC116353.6	NA	
ENSG00000200235	AC116353.1	NA	
ENSG00000251453	HAUS1P1	NA	
ENSG00000113119	TMCO6	NA	
ENSG00000240518	AC116353.2	NA	
ENSG00000170458	CD14	NA	
ENSG00000131495	NDUFA2	618235	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13
ENSG00000113141	IK	NA	
ENSG00000284325	MIR3655	NA	
ENSG00000120314	WDR55	NA	
ENSG00000256453	DND1	NA	
ENSG00000170445	HARS1	614504	USHER SYNDROME, TYPE IIIB; USH3B
ENSG00000170445	HARS1	616625	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W; CMT2W;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2W;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2W
ENSG00000112855	HARS2	614926	PERRAULT SYNDROME 2; PRLTS2
ENSG00000146007	ZMAT2	NA	
ENSG00000199990	VTRNA1-1	NA	
ENSG00000202111	VTRNA1-2	NA	
ENSG00000202515	VTRNA1-3	NA	
ENSG00000250515	AC116353.4	NA	
ENSG00000248106	AC116353.3	NA	
ENSG00000279726	AC005609.5	NA	
ENSG00000204970	PCDHA1	NA	
ENSG00000204969	PCDHA2	NA	
ENSG00000255408	PCDHA3	NA	
ENSG00000204967	PCDHA4	NA	
ENSG00000204965	PCDHA5	NA	
ENSG00000081842	PCDHA6	NA	
ENSG00000204963	PCDHA7	NA	
ENSG00000204962	PCDHA8	NA	
ENSG00000204961	PCDHA9	NA	
ENSG00000278907	AC005609.2	NA	
ENSG00000250120	PCDHA10	NA	
ENSG00000249504	PCDHA14	NA	
ENSG00000278946	AC005609.4	NA	
ENSG00000249158	PCDHA11	NA	
ENSG00000251664	PCDHA12	NA	
ENSG00000278915	AC005609.3	NA	
ENSG00000278901	AC005609.1	NA	
ENSG00000239389	PCDHA13	NA	
ENSG00000248383	PCDHAC1	NA	
ENSG00000279028	AC010223.1	NA	
ENSG00000243232	PCDHAC2	NA	
ENSG00000279047	AC244517.5	NA	
ENSG00000171815	PCDHB1	NA	
ENSG00000279558	AC244517.9	NA	
ENSG00000112852	PCDHB2	NA	
ENSG00000272154	AC244517.2	NA	
ENSG00000113205	PCDHB3	NA	
ENSG00000272108	AC244517.1	NA	
ENSG00000081818	PCDHB4	NA	
ENSG00000113209	PCDHB5	NA	
ENSG00000280029	AC244517.11	NA	
ENSG00000113211	PCDHB6	NA	
ENSG00000255622	PCDHB17P	NA	
ENSG00000280336	AC244517.12	NA	
ENSG00000113212	PCDHB7	NA	
ENSG00000120322	PCDHB8	NA	
ENSG00000279472	AC244517.8	NA	
ENSG00000272674	PCDHB16	NA	
ENSG00000279068	AC244517.6	NA	
ENSG00000278936	AC244517.4	NA	
ENSG00000177839	PCDHB9	NA	
ENSG00000279375	AC244517.7	NA	
ENSG00000120324	PCDHB10	NA	
ENSG00000197479	PCDHB11	NA	
ENSG00000120328	PCDHB12	NA	
ENSG00000187372	PCDHB13	NA	
ENSG00000120327	PCDHB14	NA	
ENSG00000279983	AC244517.10	NA	
ENSG00000146001	PCDHB18P	NA	
ENSG00000262096	PCDHB19P	NA	
ENSG00000113248	PCDHB15	NA	
ENSG00000277795	AC244517.3	NA	
ENSG00000178913	TAF7	NA	
ENSG00000120329	SLC25A2	NA	
ENSG00000288095	AC005618.4	NA	
ENSG00000272070	AC005618.1	NA	
ENSG00000204956	PCDHGA1	NA	
ENSG00000081853	PCDHGA2	NA	
ENSG00000254245	PCDHGA3	NA	
ENSG00000254221	PCDHGB1	NA	
ENSG00000280026	AC005618.3	NA	
ENSG00000262576	PCDHGA4	NA	
ENSG00000253910	PCDHGB2	NA	
ENSG00000253485	PCDHGA5	NA	
ENSG00000262209	PCDHGB3	NA	
ENSG00000253731	PCDHGA6	NA	
ENSG00000253537	PCDHGA7	NA	
ENSG00000253953	PCDHGB4	NA	
ENSG00000253767	PCDHGA8	NA	
ENSG00000276547	PCDHGB5	NA	
ENSG00000261934	PCDHGA9	NA	
ENSG00000253305	PCDHGB6	NA	
ENSG00000253846	PCDHGA10	NA	
ENSG00000254122	PCDHGB7	NA	
ENSG00000253873	PCDHGA11	NA	
ENSG00000248449	PCDHGB8P	NA	
ENSG00000279855	AC005618.2	NA	
ENSG00000253159	PCDHGA12	NA	
ENSG00000276545	PCDHGB9P	NA	
ENSG00000273557	AC008781.2	NA	
ENSG00000240184	PCDHGC3	NA	
ENSG00000242020	RN7SL68P	NA	
ENSG00000242419	PCDHGC4	NA	
ENSG00000240764	PCDHGC5	NA	
ENSG00000131504	DIAPH1	124900	DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1;;KONIGSMARK SYNDROME;;DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA
ENSG00000131504	DIAPH1	616632	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS
ENSG00000246422	DIAPH1-AS1	NA	
ENSG00000240974	RPS27AP10	NA	
ENSG00000228737	AC008781.1	NA	
ENSG00000171720	HDAC3	NA	
ENSG00000164620	RELL2	NA	
ENSG00000197948	FCHSD1	NA	
ENSG00000120318	ARAP3	NA	
ENSG00000286736	AC005753.2	NA	
ENSG00000287527	AC005753.3	NA	
ENSG00000278925	AC005753.1	NA	
ENSG00000156453	PCDH1	NA	
ENSG00000287726	AC005740.5	NA	
ENSG00000226040	AC005740.1	NA	
ENSG00000081791	DELE1	NA	
ENSG00000113555	PCDH12	251280	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1; DMJDS1;;MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC
ENSG00000271871	AC005740.4	NA	
ENSG00000013561	RNF14	NA	
ENSG00000254099	AC005740.3	NA	
ENSG00000113552	GNPDA1	NA	
ENSG00000250347	AC005740.2	NA	
ENSG00000131507	NDFIP1	NA	
ENSG00000280047	AC091825.3	NA	
ENSG00000187678	SPRY4	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000187678	SPRY4	615266	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17
ENSG00000277968	AC091825.2	NA	
ENSG00000274721	AC091825.1	NA	
ENSG00000231185	SPRY4-AS1	NA	
ENSG00000225147	RPS12P10	NA	
ENSG00000113578	FGF1	NA	
ENSG00000261757	AC005592.1	NA	
ENSG00000236714	LINC01844	NA	
ENSG00000287203	AC005592.2	NA	
ENSG00000145819	ARHGAP26	607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML;;LEUKEMIA, JUVENILE MYELOMONOCYTIC  LEUKEMIA, CHRONIC MYELOMONOCYTIC, INCLUDED; CMML, INCLUDED
ENSG00000226272	ARHGAP26-AS1	NA	
ENSG00000285366	AC008533.1	NA	
ENSG00000230789	ARHGAP26-IT1	NA	
ENSG00000113580	NR3C1	615962	GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR;;GLUCOCORTICOID RECEPTOR DEFICIENCY;;GCCR DEFICIENCY;;GCR DEFICIENCY;;GRL DEFICIENCY;;CORTISOL RESISTANCE FROM GLUCOCORTICOID RECEPTOR DEFECT
ENSG00000231579	RPL7P21	NA	
ENSG00000279679	AC091925.2	NA	
ENSG00000279130	AC091925.1	NA	
ENSG00000249429	AC016598.1	NA	
ENSG00000251205	AC016598.2	NA	
ENSG00000253023	RNU7-156P	NA	
ENSG00000249881	AC008696.2	NA	
ENSG00000266478	MIR5197	NA	
ENSG00000225869	AC008696.1	NA	
ENSG00000158497	HMHB1	NA	
ENSG00000239390	RN7SL87P	NA	
ENSG00000145817	YIPF5	NA	
ENSG00000183775	KCTD16	NA	
ENSG00000249605	AC008652.1	NA	
ENSG00000285605	AC109441.1	NA	
ENSG00000250972	CKS1BP5	NA	
ENSG00000213488	AC008716.1	NA	
ENSG00000201423	RN7SKP246	NA	
ENSG00000251031	AC132803.1	NA	
ENSG00000249229	NAMPTP2	NA	
ENSG00000215325	ASS1P10	NA	
ENSG00000250842	AC137770.1	NA	
ENSG00000248125	AC008700.1	NA	
ENSG00000186314	PRELID2	NA	
ENSG00000249363	AC011411.1	NA	
ENSG00000204928	GRXCR2	615837	DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101
ENSG00000156463	SH3RF2	NA	
ENSG00000248493	AC005351.1	NA	
ENSG00000173261	PLAC8L1	NA	
ENSG00000251556	AC091887.1	NA	
ENSG00000133706	LARS1	615438	INFANTILE LIVER FAILURE SYNDROME 1; ILFS1
ENSG00000239602	AC091959.2	NA	
ENSG00000239317	AC091959.1	NA	
ENSG00000275740	AC091959.3	NA	
ENSG00000091009	RBM27	NA	
ENSG00000238374	RNU7-180P	NA	
ENSG00000250025	AC011396.2	NA	
ENSG00000091010	POU4F3	602459	DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15
ENSG00000271724	AC011396.3	NA	
ENSG00000248842	AC011396.1	NA	
ENSG00000113649	TCERG1	NA	
ENSG00000277568	AC011375.1	NA	
ENSG00000173250	GPR151	NA	
ENSG00000250407	AC008728.1	NA	
ENSG00000156475	PPP2R2B	604326	SPINOCEREBELLAR ATAXIA 12; SCA12
ENSG00000280646	RNA5SP196	NA	
ENSG00000241291	RN7SL791P	NA	
ENSG00000248568	KRT8P48	NA	
ENSG00000249553	PPP2R2B-IT1	NA	
ENSG00000286468	AC010251.1	NA	
ENSG00000250343	STK32A-AS1	NA	
ENSG00000169302	STK32A	NA	
ENSG00000113657	DPYSL3	NA	
ENSG00000272239	AC011373.1	NA	
ENSG00000280780	JAKMIP2-AS1	NA	
ENSG00000176049	JAKMIP2	NA	
ENSG00000287630	AC011370.1	NA	
ENSG00000164266	SPINK1	167800	PANCREATITIS, HEREDITARY; PCTT;;HPC;;HP;;PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;PANCREATITIS, CALCIFIC, INCLUDED;;PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
ENSG00000164266	SPINK1	608189	TROPICAL CALCIFIC PANCREATITIS;;TCP
ENSG00000249518	AC011352.2	NA	
ENSG00000164265	SCGB3A2	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000178776	C5orf46	NA	
ENSG00000248362	AC011352.1	NA	
ENSG00000251320	AC011352.3	NA	
ENSG00000250346	EEF1GP2	NA	
ENSG00000133710	SPINK5	256500	NETHERTON SYNDROME; NETH;;ERYTHRODERMA, ICHTHYOSIFORM, WITH HYPOTRICHOSIS AND HYPER-IgE;;NS;;NETHERTON DISEASE;;COMEL-NETHERTON SYNDROME
ENSG00000247199	AC011346.1	NA	
ENSG00000196800	SPINK14	NA	
ENSG00000178172	SPINK6	NA	
ENSG00000249503	HMGN1P16	NA	
ENSG00000248109	MARCOL	NA	
ENSG00000214510	SPINK13	NA	
ENSG00000249834	PGBD4P3	NA	
ENSG00000145879	SPINK7	NA	
ENSG00000204909	SPINK9	NA	
ENSG00000283653	AC091948.1	NA	
ENSG00000145868	FBXO38	615575	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D;;HMN IID;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;;SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT
ENSG00000274799	Metazoa_SRP	NA	
ENSG00000251330	AC114939.1	NA	
ENSG00000164270	HTR4	NA	
ENSG00000253297	AC008627.1	NA	
ENSG00000169252	ADRB2	109690	BETA-2-ADRENERGIC RECEPTOR; ADRB2;;BETA-ADRENERGIC RECEPTOR; ADRBR;;BETA-2-ADRENOCEPTOR; BAR; B2AR;;ADRB2R BETA-2-ADRENORECEPTOR AGONIST, REDUCED RESPONSE TO, INCLUDED
ENSG00000169252	ADRB2	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000169252	ADRB2	601665	OBESITY LEANNESS, INCLUDED
ENSG00000169247	SH3TC2	601596	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4C;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4C
ENSG00000169247	SH3TC2	613353	MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN;;CARPAL TUNNEL SYNDROME, SUSCEPTIBILITY TO
ENSG00000272411	AC116312.1	NA	
ENSG00000251842	RNU6-732P	NA	
ENSG00000207714	MIR584	NA	
ENSG00000250072	SH3TC2-DT	NA	
ENSG00000200161	RN7SKP145	NA	
ENSG00000173210	ABLIM3	NA	
ENSG00000248647	AC012613.1	NA	
ENSG00000253406	AC012613.2	NA	
ENSG00000157510	AFAP1L1	NA	
ENSG00000285736	AC131025.3	NA	
ENSG00000164284	GRPEL2	NA	
ENSG00000253618	GRPEL2-AS1	NA	
ENSG00000145882	PCYOX1L	NA	
ENSG00000127743	IL17B	NA	
ENSG00000253865	AC131025.1	NA	
ENSG00000249669	CARMN	NA	
ENSG00000275871	AC131025.2	NA	
ENSG00000284182	MIR143	NA	
ENSG00000276365	MIR145	NA	
ENSG00000113712	CSNK1A1	NA	
ENSG00000230551	AC021078.1	NA	
ENSG00000241112	RPL29P14	NA	
ENSG00000183111	ARHGEF37	NA	
ENSG00000222213	RNU6-588P	NA	
ENSG00000287323	AC022100.1	NA	
ENSG00000221043	U3	NA	
ENSG00000242928	RN7SL868P	NA	
ENSG00000155846	PPARGC1B	NA	
ENSG00000199047	MIR378A	NA	
ENSG00000132915	PDE6A	613810	RETINITIS PIGMENTOSA 43; RP43
ENSG00000251583	MFFP2	NA	
ENSG00000200334	Y_RNA	NA	
ENSG00000155850	SLC26A2	222600	DIASTROPHIC DYSPLASIA; DTD;;DD  DIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED
ENSG00000155850	SLC26A2	226900	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4;;MULTIPLE EPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE;;MULTIPLE EPIPHYSEAL DYSPLASIA WITH CLUBFOOT;;MULTIPLE EPIPHYSEAL DYSPLASIA WITH BILAYERED PATELLAE
ENSG00000155850	SLC26A2	256050	ATELOSTEOGENESIS, TYPE II; AO2;;AOII;;NEONATAL OSSEOUS DYSPLASIA I  DE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED
ENSG00000155850	SLC26A2	600972	ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE
ENSG00000164296	TIGD6	NA	
ENSG00000113716	HMGXB3	NA	
ENSG00000248696	AC011406.1	NA	
ENSG00000241907	RPS20P4	NA	
ENSG00000182578	CSF1R	221820	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY, ADULT-ONSET, WITH AXONAL SPHEROIDS AND PIGMENTED GLIA; ALSP;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCOR /.../ GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN
ENSG00000182578	CSF1R	618476	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS
ENSG00000214485	RPL7P1	NA	
ENSG00000199409	AC011382.1	NA	
ENSG00000113721	PDGFRB	131440	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA;;MPE; EMP;;EOSINOPHILS, MALIGNANT PROLIFERATION OF
ENSG00000113721	PDGFRB	213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1;;PRIMARY FAMILIAL BRAIN CALCIFICATION; PFBC;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL; BSPDC;;STRIOPALLIDODENTATE CALCINOSIS, AUTOSOMAL DOMINANT, ADULT-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLER /.../IDIOPATHIC, ADULT-ONSET;;FERROCALCINOSIS, CEREBROVASCULAR;;FAHR DISEASE, FAMILIAL, FORMERLY;;BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3, FORMERLY; IBGC3, FORMERLY;;BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2, FORMERLY; IBGC2, FORMERLY
ENSG00000113721	PDGFRB	228550	MYOFIBROMATOSIS, INFANTILE, 1; IMF1;;MYOFIBROMATOSIS, JUVENILE;;FIBROMATOSIS, CONGENITAL GENERALIZED; CGF
ENSG00000113721	PDGFRB	601812	PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT;;PENTTINEN SYNDROME
ENSG00000113721	PDGFRB	615007	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4
ENSG00000113721	PDGFRB	616592	KOSAKI OVERGROWTH SYNDROME; KOGS;;SKELETAL OVERGROWTH WITH FACIAL DYSMORPHISM, HYPERELASTIC SKIN, WHITE MATTER LESIONS, AND NEUROLOGIC DETERIORATION
ENSG00000113722	CDX1	NA	
ENSG00000011083	SLC6A7	NA	
ENSG00000070808	CAMK2A	617798	MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53
ENSG00000070808	CAMK2A	618095	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63
ENSG00000183876	ARSI	NA	
ENSG00000070814	TCOF1	154500	TREACHER COLLINS SYNDROME 1; TCS1;;TREACHER COLLINS-FRANCESCHETTI SYNDROME; TCOF;;TREACHER COLLINS SYNDROME; TCS;;MANDIBULOFACIAL DYSOSTOSIS; MFD1
ENSG00000019582	CD74	NA	
ENSG00000286331	AC011388.1	NA	
ENSG00000164587	RPS14	153550	CHROMOSOME 5q DELETION SYNDROME;;5q- SYNDROME;;MACROCYTIC ANEMIA, REFRACTORY, DUE TO 5q DELETION; MAR  MEGAKARYOCYTES, UNILOBULAR NUCLEATED, INCLUDED
ENSG00000254333	NDST1-AS1	NA	
ENSG00000070614	NDST1	616116	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46; MRT46
ENSG00000171992	SYNPO	NA	
ENSG00000253852	AC011383.1	NA	
ENSG00000286657	AC008453.2	NA	
ENSG00000164591	MYOZ3	NA	
ENSG00000250309	AC008453.1	NA	
ENSG00000086589	RBM22	NA	
ENSG00000132912	DCTN4	NA	
ENSG00000256235	SMIM3	NA	
ENSG00000237693	IRGM	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000237693	IRGM	612278	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19; IBD19
ENSG00000145908	ZNF300	NA	
ENSG00000197083	ZNF300P1	NA	
ENSG00000274235	AC022106.1	NA	
ENSG00000277866	AC022106.2	NA	
ENSG00000211445	GPX3	NA	
ENSG00000145901	TNIP1	NA	
ENSG00000197043	ANXA6	NA	
ENSG00000254298	AC008641.1	NA	
ENSG00000285420	PDGFRL2P	NA	
ENSG00000198624	CCDC69	NA	
ENSG00000196743	GM2A	272750	GM2-GANGLIOSIDOSIS, AB VARIANT;;HEXOSAMINIDASE ACTIVATOR DEFICIENCY;;GM2 ACTIVATOR DEFICIENCY;;AB VARIANT GM2-GANGLIOSIDOSIS;;TAY-SACHS DISEASE, AB VARIANT
ENSG00000186334	SLC36A3	NA	
ENSG00000186335	SLC36A2	138500	HYPERGLYCINURIA;;GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS;;GLYCINURIA WITH OR WITHOUT OXALATE NEPHROLITHIASIS;;IMINOGLYCINURIA TYPE II
ENSG00000186335	SLC36A2	242600	IMINOGLYCINURIA
ENSG00000270904	AC008385.1	NA	
ENSG00000253897	AC034205.2	NA	
ENSG00000253472	AC034205.1	NA	
ENSG00000271494	AC034205.3	NA	
ENSG00000123643	SLC36A1	NA	
ENSG00000200227	RNA5SP197	NA	
ENSG00000086570	FAT2	617769	SPINOCEREBELLAR ATAXIA 45; SCA45
ENSG00000271795	AC011337.1	NA	
ENSG00000276622	MIR6499	NA	
ENSG00000288081	AC011374.3	NA	
ENSG00000260581	AC011374.1	NA	
ENSG00000113140	SPARC	616507	OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17
ENSG00000249035	CLMAT3	NA	
ENSG00000222102	RN7SKP232	NA	
ENSG00000272112	AC011374.2	NA	
ENSG00000177556	ATOX1	NA	
ENSG00000253921	AC091982.1	NA	
ENSG00000213433	RPLP1P6	NA	
ENSG00000275765	AC091982.3	NA	
ENSG00000145907	G3BP1	NA	
ENSG00000145888	GLRA1	149400	HYPEREKPLEXIA 1; HKPX1;;STARTLE DISEASE, FAMILIAL;;STARTLE REACTION, EXAGGERATED;;EXAGGERATED STARTLE REACTION;;STHE;;STIFF-BABY SYNDROME;;STIFF-MAN SYNDROME, CONGENITAL;;STIFF-PERSON SYNDROME, CONGENITAL;;KOK DISEASE
ENSG00000270978	AC091982.2	NA	
ENSG00000222308	RNA5SP198	NA	
ENSG00000254226	LINC01933	NA	
ENSG00000286749	AC008571.2	NA	
ENSG00000132911	NMUR2	NA	
ENSG00000242080	AC008571.1	NA	
ENSG00000249484	LINC01470	NA	
ENSG00000155511	GRIA1	NA	
ENSG00000242976	RN7SL177P	NA	
ENSG00000251183	LINC01861	NA	
ENSG00000261382	AC091962.1	NA	
ENSG00000055147	FAM114A2	NA	
ENSG00000037749	MFAP3	NA	
ENSG00000164574	GALNT10	NA	
ENSG00000245275	SAP30L-AS1	NA	
ENSG00000253119	HNRNPA3P7	NA	
ENSG00000287695	AC008625.1	NA	
ENSG00000221430	MIR1294	NA	
ENSG00000241963	RN7SL655P	NA	
ENSG00000164576	SAP30L	NA	
ENSG00000113196	HAND1	NA	
ENSG00000254293	AC026688.2	NA	
ENSG00000253886	AC026688.1	NA	
ENSG00000253146	CIR1P1	NA	
ENSG00000264760	MIR3141	NA	
ENSG00000221552	MIR1303	NA	
ENSG00000274472	AC008379.2	NA	
ENSG00000155506	LARP1	NA	
ENSG00000272197	RN7SL803P	NA	
ENSG00000241187	AC008379.1	NA	
ENSG00000170271	FAXDC2	NA	
ENSG00000277039	AC112169.1	NA	
ENSG00000263361	MIR378H	NA	
ENSG00000155508	CNOT8	NA	
ENSG00000082516	GEMIN5	NA	
ENSG00000082515	MRPL22	NA	
ENSG00000253261	AC008410.1	NA	
ENSG00000226650	KIF4B	NA	
ENSG00000287963	AC010476.2	NA	
ENSG00000253646	AC010476.1	NA	
ENSG00000271477	AC010591.1	NA	
ENSG00000270442	AC008725.1	NA	
ENSG00000200275	RNA5SP199	NA	
ENSG00000170624	SGCD	601287	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6; LGMDR6;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F; LGMD2F
ENSG00000170624	SGCD	606685	CARDIOMYOPATHY, DILATED, 1L; CMD1L
ENSG00000286690	AC011351.1	NA	
ENSG00000253370	AC027308.1	NA	
ENSG00000254163	AC025434.1	NA	
ENSG00000199468	RNU6-556P	NA	
ENSG00000231989	PPP1R2B	NA	
ENSG00000145850	TIMD4	NA	
ENSG00000270560	APOOP1	NA	
ENSG00000113249	HAVCR1	NA	
ENSG00000135077	HAVCR2	618398	T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL
ENSG00000254246	AC011377.1	NA	
ENSG00000155868	MED7	NA	
ENSG00000113263	ITK	613011	LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1
ENSG00000170613	FAM71B	NA	
ENSG00000253980	AC010609.1	NA	
ENSG00000253653	AC009185.1	NA	
ENSG00000055163	CYFIP2	618008	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65
ENSG00000285868	AC008676.3	NA	
ENSG00000172568	FNDC9	NA	
ENSG00000251405	AC016571.1	NA	
ENSG00000248544	AC008676.1	NA	
ENSG00000135074	ADAM19	NA	
ENSG00000253155	AC008676.2	NA	
ENSG00000172548	NIPAL4	612281	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6;;ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE, NIPAL4-RELATED
ENSG00000253519	AC106801.1	NA	
ENSG00000252068	RNU6-390P	NA	
ENSG00000254336	AC008694.2	NA	
ENSG00000039600	SOX30	NA	
ENSG00000187658	C5orf52	NA	
ENSG00000253798	AC008694.1	NA	
ENSG00000113272	THG1L	618800	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28; SCAR28
ENSG00000155858	LSM11	NA	
ENSG00000253630	AC026407.1	NA	
ENSG00000113282	CLINT1	NA	
ENSG00000206819	RNU6-260P	NA	
ENSG00000244331	AC008677.2	NA	
ENSG00000222626	RNU2-48P	NA	
ENSG00000253743	MARK2P11	NA	
ENSG00000213414	AC008677.1	NA	
ENSG00000253422	AC008677.3	NA	
ENSG00000253792	AC025437.5	NA	
ENSG00000253673	AC025437.4	NA	
ENSG00000254047	AC025437.6	NA	
ENSG00000253449	AC025437.3	NA	
ENSG00000253424	AC025437.2	NA	
ENSG00000253134	AC025437.1	NA	
ENSG00000276778	LINC02227	NA	
ENSG00000254350	AC091979.1	NA	
ENSG00000272085	AC091979.2	NA	
ENSG00000254135	AC091939.1	NA	
ENSG00000164330	EBF1	NA	
ENSG00000253811	AC136424.2	NA	
ENSG00000253456	AC136424.1	NA	
ENSG00000245812	LINC02202	NA	
ENSG00000279204	AC134043.3	NA	
ENSG00000145860	RNF145	NA	
ENSG00000253256	AC134043.2	NA	
ENSG00000253315	LINC01932	NA	
ENSG00000252458	AC134043.1	NA	
ENSG00000164332	UBLCP1	NA	
ENSG00000249738	AC008691.1	NA	
ENSG00000113302	IL12B	614890	IMMUNODEFICIENCY 29; IMD29;;IL12B DEFICIENCY
ENSG00000221601	RNU4ATAC2P	NA	
ENSG00000253298	LINC01845	NA	
ENSG00000283413	AC008703.1	NA	
ENSG00000253311	LINC01847	NA	
ENSG00000170214	ADRA1B	NA	
ENSG00000248626	GAPDHP40	NA	
ENSG00000199398	Y_RNA	NA	
ENSG00000113312	TTC1	NA	
ENSG00000223908	AC068657.1	NA	
ENSG00000170234	PWWP2A	NA	
ENSG00000170231	FABP6	NA	
ENSG00000247699	FABP6-AS1	NA	
ENSG00000253772	AC112191.1	NA	
ENSG00000135083	CCNJL	NA	
ENSG00000254373	AC112191.2	NA	
ENSG00000270612	AC112191.3	NA	
ENSG00000145861	C1QTNF2	NA	
ENSG00000221886	ZBED8	NA	
ENSG00000164609	SLU7	NA	
ENSG00000164611	PTTG1	NA	
ENSG00000253522	MIR3142HG	NA	
ENSG00000265237	MIR3142	NA	
ENSG00000283733	MIR146A	NA	
ENSG00000118322	ATP10B	NA	
ENSG00000253687	AC008456.1	NA	
ENSG00000254391	AC011363.1	NA	
ENSG00000253417	LINC02159	NA	
ENSG00000145864	GABRB2	617829	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2
ENSG00000145863	GABRA6	NA	
ENSG00000253403	AC091944.1	NA	
ENSG00000118990	GLRXP3	NA	
ENSG00000022355	GABRA1	611136	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5, INCLUDED; EJM5, INCLUDED;;EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 4, INCLUDED; ECA4, INCLUDED
ENSG00000022355	GABRA1	615744	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19
ENSG00000280776	LINC01202	NA	
ENSG00000113327	GABRG2	607681	FEBRILE SEIZURES, FAMILIAL, 8; FEB8 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2, INCLUDED; ECA2, INCLUDED;;GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3, INCLUDED; GEFSP3, INCLUDED;;GEFS+, TYPE 3, INCLUDED; GEFS+3, INCLUDED
ENSG00000113327	GABRG2	618396	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74
ENSG00000254186	AC113414.1	NA	
ENSG00000201474	RNU6-164P	NA	
ENSG00000254351	ARL2BPP5	NA	
ENSG00000249449	MRPL57P6	NA	
ENSG00000250114	AC008723.1	NA	
ENSG00000113328	CCNG1	NA	
ENSG00000170584	NUDCD2	NA	
ENSG00000072571	HMMR	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000251018	HMMR-AS1	NA	
ENSG00000038274	MAT2B	NA	
ENSG00000285590	AC010291.1	NA	
ENSG00000224012	AC116917.1	NA	
ENSG00000251998	RNU6-168P	NA	
ENSG00000273569	AC008432.1	NA	
ENSG00000271679	LSM1P2	NA	
ENSG00000253331	AC008662.1	NA	
ENSG00000253538	AC008662.2	NA	
ENSG00000241956	AC109466.1	NA	
ENSG00000253236	LINC02143	NA	
ENSG00000253600	AC008446.1	NA	
ENSG00000206845	RNU6-209P	NA	
ENSG00000285549	AC091973.1	NA	
ENSG00000254066	LINC01938	NA	
ENSG00000253693	AC008415.1	NA	
ENSG00000252794	RN7SKP60	NA	
ENSG00000253512	AC008562.1	NA	
ENSG00000253946	AC008489.1	NA	
ENSG00000254252	RPL7P20	NA	
ENSG00000254171	AC114321.1	NA	
ENSG00000229119	AC026403.1	NA	
ENSG00000254130	LINC01947	NA	
ENSG00000253713	AC091819.2	NA	
ENSG00000253469	AC091819.1	NA	
ENSG00000145934	TENM2	NA	
ENSG00000254365	AC091820.2	NA	
ENSG00000254297	AC091820.1	NA	
ENSG00000253527	AC008601.1	NA	
ENSG00000254187	AC008708.2	NA	
ENSG00000253357	AC008708.1	NA	
ENSG00000253660	AC008464.1	NA	
ENSG00000253947	AC008705.2	NA	
ENSG00000253065	AC008705.1	NA	
ENSG00000253925	AC011369.1	NA	
ENSG00000279739	AC011369.2	NA	
ENSG00000253978	CTB-178M22.2	NA	
ENSG00000113645	WWC1	615602	MEMORY QUANTITATIVE TRAIT LOCUS; MEMRYQTL
ENSG00000113643	RARS1	616140	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9
ENSG00000188573	FBLL1	NA	
ENSG00000120137	PANK3	NA	
ENSG00000253861	SLC2A3P1	NA	
ENSG00000199035	MIR103A1	NA	
ENSG00000283612	MIR103B1	NA	
ENSG00000233913	RPL10P9	NA	
ENSG00000254192	AC011365.2	NA	
ENSG00000184347	SLIT3	NA	
ENSG00000254042	AC011365.1	NA	
ENSG00000207739	MIR218-2	NA	
ENSG00000202345	Y_RNA	NA	
ENSG00000248965	AC011389.2	NA	
ENSG00000279752	AC011389.3	NA	
ENSG00000248222	AC011389.1	NA	
ENSG00000207619	MIR585	NA	
ENSG00000206614	RNU6-477P	NA	
ENSG00000040275	SPDL1	NA	
ENSG00000134516	DOCK2	616433	IMMUNODEFICIENCY 40; IMD40
ENSG00000253269	AC008680.1	NA	
ENSG00000204767	INSYN2B	NA	
ENSG00000263831	MIR378E	NA	
ENSG00000168269	FOXI1	274600	PENDRED SYNDROME; PDS;;DEAFNESS WITH GOITER;;GOITER-DEAFNESS SYNDROME;;THYROID DYSHORMONOGENESIS 2B; TDH2B;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B
ENSG00000168269	FOXI1	600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 4; NSRD4;;DILATED VESTIBULAR AQUEDUCT; DVA
ENSG00000253219	KRT18P41	NA	
ENSG00000249601	LINC01187	NA	
ENSG00000234511	C5orf58	NA	
ENSG00000043462	LCP2	NA	
ENSG00000288615	AC034199.2	NA	
ENSG00000235172	LINC01366	NA	
ENSG00000250274	AC034199.1	NA	
ENSG00000182132	KCNIP1	NA	
ENSG00000145936	KCNMB1	608622	HYPERTENSION, DIASTOLIC, RESISTANCE TO
ENSG00000253647	KCNIP1-OT1	NA	
ENSG00000253858	AC008619.1	NA	
ENSG00000253591	KCNIP1-AS1	NA	
ENSG00000253348	AC008514.1	NA	
ENSG00000094755	GABRP	NA	
ENSG00000204764	RANBP17	NA	
ENSG00000244501	RN7SL623P	NA	
ENSG00000253966	AC008514.2	NA	
ENSG00000253213	USP12P1	NA	
ENSG00000275038	AC091980.2	NA	
ENSG00000164438	TLX3	NA	
ENSG00000213393	AC091980.1	NA	
ENSG00000265740	RN7SL339P	NA	
ENSG00000254256	RPSAP71	NA	
ENSG00000206909	SNORA70J	NA	
ENSG00000254012	RPL10P8	NA	
ENSG00000264249	MIR3912	NA	
ENSG00000181163	NPM1	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000156427	FGF18	NA	
ENSG00000288639	AC093246.1	NA	
ENSG00000285914	AC022440.1	NA	
ENSG00000253110	AC011410.1	NA	
ENSG00000185662	SMIM23	NA	
ENSG00000072803	FBXW11	NA	
ENSG00000072786	STK10	NA	
ENSG00000214360	EFCAB9	NA	
ENSG00000168246	UBTD2	NA	
ENSG00000212529	AC024561.1	NA	
ENSG00000253218	KLF3P1	NA	
ENSG00000174705	SH3PXD2B	249420	FRANK-TER HAAR SYNDROME; FTHS;;TER HAAR SYNDROME;;BORRONE DERMATOCARDIOSKELETAL SYNDROME;;MELNICK-NEEDLES SYNDROME, AUTOSOMAL RECESSIVE, FORMERLY
ENSG00000287814	AC011407.1	NA	
ENSG00000254299	LINC01944	NA	
ENSG00000280318	AC027309.3	NA	
ENSG00000214357	NEURL1B	NA	
ENSG00000253683	AC027309.2	NA	
ENSG00000265160	MIR5003	NA	
ENSG00000253445	AC027309.1	NA	
ENSG00000253295	AC022217.2	NA	
ENSG00000213386	AC022217.1	NA	
ENSG00000253736	AC022217.3	NA	
ENSG00000120129	DUSP1	NA	
ENSG00000206741	Y_RNA	NA	
ENSG00000270243	AC022217.4	NA	
ENSG00000253628	AC110011.1	NA	
ENSG00000113719	ERGIC1	208100	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN;;AMC, NEUROGENIC TYPE
ENSG00000204758	AC008429.1	NA	
ENSG00000254295	AC008429.3	NA	
ENSG00000037241	RPL26L1	NA	
ENSG00000253785	AC008429.2	NA	
ENSG00000113732	ATP6V0E1	NA	
ENSG00000254328	AC008429.4	NA	
ENSG00000212402	SNORA74B	NA	
ENSG00000207210	Y_RNA	NA	
ENSG00000164463	CREBRF	NA	
ENSG00000253439	CDC42P5	NA	
ENSG00000253172	AC008378.1	NA	
ENSG00000113734	BNIP1	NA	
ENSG00000254200	RPL7AP33	NA	
ENSG00000183072	NKX2-5	108900	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7;;ASD WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS
ENSG00000183072	NKX2-5	187500	TETRALOGY OF FALLOT; TOF
ENSG00000183072	NKX2-5	217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM TRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED /.../RRUPTED AORTIC ARCH, INCLUDED
ENSG00000183072	NKX2-5	225250	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5
ENSG00000183072	NKX2-5	614432	VENTRICULAR SEPTAL DEFECT 3; VSD3
ENSG00000183072	NKX2-5	614435	HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2
ENSG00000201277	Y_RNA	NA	
ENSG00000252169	RNA5SP200	NA	
ENSG00000113739	STC2	NA	
ENSG00000274994	MIR8056	NA	
ENSG00000199219	RNU6-500P	NA	
ENSG00000253968	AC016573.1	NA	
ENSG00000253141	AC008632.1	NA	
ENSG00000253768	AC008663.1	NA	
ENSG00000254164	AC008663.3	NA	
ENSG00000253955	AC008663.2	NA	
ENSG00000145919	BOD1	NA	
ENSG00000253959	LINC01863	NA	
ENSG00000253686	LINC01484	NA	
ENSG00000253428	LINC01942	NA	
ENSG00000287003	AC008674.1	NA	
ENSG00000254211	LINC01485	NA	
ENSG00000113742	CPEB4	NA	
ENSG00000185056	C5orf47	NA	
ENSG00000253109	RPL12P22	NA	
ENSG00000170091	NSG2	NA	
ENSG00000253244	AC113423.1	NA	
ENSG00000253447	AC113423.2	NA	
ENSG00000254011	AC011333.1	NA	
ENSG00000249722	AC025752.1	NA	
ENSG00000249306	LINC01411	NA	
ENSG00000213376	GAPDHP71	NA	
ENSG00000249031	SUMO2P6	NA	
ENSG00000250256	AC108112.1	NA	
ENSG00000248929	HIGD1AP3	NA	
ENSG00000120149	MSX2	168550	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD;;CLEIDOCRANIAL DYSPLASIA WITH PARIETAL FORAMINA
ENSG00000120149	MSX2	168500	PARIETAL FORAMINA 1; PFM1;;PFM;;PARIETAL FORAMINA, SYMMETRIC;;FORAMINA PARIETALIA PERMAGNA; FPP;;CATLIN MARKS;;CRANIUM BIFIDUM OCCULTUM;;CRANIUM BIFIDUM, HEREDITARY
ENSG00000120149	MSX2	604757	CRANIOSYNOSTOSIS 2; CRS2;;CRANIOSYNOSTOSIS, BOSTON-TYPE; CSB
ENSG00000251670	AC113346.2	NA	
ENSG00000266890	MIR4634	NA	
ENSG00000251144	AC113346.1	NA	
ENSG00000204754	LINC01951	NA	
ENSG00000251122	NIFKP2	NA	
ENSG00000248293	AC008413.1	NA	
ENSG00000249403	AC008413.2	NA	
ENSG00000248355	ARL2BPP6	NA	
ENSG00000184845	DRD1	NA	
ENSG00000286350	AC091393.2	NA	
ENSG00000164466	SFXN1	NA	
ENSG00000270839	AC091393.1	NA	
ENSG00000222111	RN7SKP148	NA	
ENSG00000113749	HRH2	NA	
ENSG00000200648	RNU6-226P	NA	
ENSG00000145920	CPLX2	NA	
ENSG00000280068	AC138965.3	NA	
ENSG00000250820	AC138965.2	NA	
ENSG00000051596	THOC3	NA	
ENSG00000250801	AC138965.1	NA	
ENSG00000272494	OR1X1P	NA	
ENSG00000250992	AC139491.3	NA	
ENSG00000248469	AC139491.1	NA	
ENSG00000182230	FAM153B	NA	
ENSG00000285476	AC139491.7	NA	
ENSG00000251623	AC139491.5	NA	
ENSG00000251458	AC139491.4	NA	
ENSG00000283559	AC139491.6	NA	
ENSG00000248596	AC139491.2	NA	
ENSG00000287579	AC139491.8	NA	
ENSG00000283235	AC139493.2	NA	
ENSG00000270989	AC139493.1	NA	
ENSG00000170085	SIMC1	NA	
ENSG00000251667	BRCC3P1	NA	
ENSG00000122203	KIAA1191	NA	
ENSG00000250909	AC138956.1	NA	
ENSG00000251414	AC138956.2	NA	
ENSG00000175414	ARL10	NA	
ENSG00000221464	MIR1271	NA	
ENSG00000048162	NOP16	NA	
ENSG00000146066	HIGD2A	NA	
ENSG00000175416	CLTB	NA	
ENSG00000280139	AC010297.1	NA	
ENSG00000113194	FAF2	NA	
ENSG00000146083	RNF44	NA	
ENSG00000074276	CDHR2	NA	
ENSG00000243959	RN7SL684P	NA	
ENSG00000207420	Y_RNA	NA	
ENSG00000169258	GPRIN1	NA	
ENSG00000074317	SNCB	127750	DEMENTIA, LEWY BODY; DLB;;LEWY BODY DEMENTIA;;DIFFUSE LEWY BODY DISEASE DIFFUSE LEWY BODY DISEASE WITH GAZE PALSY, INCLUDED;;LEWY BODY VARIANT OF ALZHEIMER DISEASE, INCLUDED
ENSG00000266329	MIR4281	NA	
ENSG00000175766	EIF4E1B	NA	
ENSG00000048140	TSPAN17	NA	
ENSG00000248484	AC113391.1	NA	
ENSG00000251446	AC113391.2	NA	
ENSG00000248859	LINC01574	NA	
ENSG00000113763	UNC5A	NA	
ENSG00000160883	HK3	NA	
ENSG00000087206	UIMC1	NA	
ENSG00000113761	ZNF346	NA	
ENSG00000251666	ZNF346-IT1	NA	
ENSG00000160867	FGFR4	NA	
ENSG00000165671	NSD1	117550	SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME
ENSG00000286634	AC146507.3	NA	
ENSG00000240729	AC146507.2	NA	
ENSG00000270706	PRMT1P1	NA	
ENSG00000169228	RAB24	NA	
ENSG00000213347	MXD3	NA	
ENSG00000169230	PRELID1	NA	
ENSG00000169223	LMAN2	NA	
ENSG00000239393	AC146507.1	NA	
ENSG00000169220	RGS14	NA	
ENSG00000131183	SLC34A1	612286	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1
ENSG00000131183	SLC34A1	613388	FANCONI RENOTUBULAR SYNDROME 2; FRTS2
ENSG00000131183	SLC34A1	616963	HYPERCALCEMIA, INFANTILE, 2; HCINF2
ENSG00000196570	PFN3	NA	
ENSG00000131187	F12	234000	FACTOR XII DEFICIENCY;;F12 DEFICIENCY;;HAGEMAN FACTOR DEFICIENCY;;HAF DEFICIENCY
ENSG00000131187	F12	610618	ANGIOEDEMA, HEREDITARY, TYPE III; HAE3;;HAE III;;ESTROGEN-RELATED HAE;;ESTROGEN-SENSITIVE HAE;;ANGIONEUROTIC EDEMA, HEREDITARY, WITH NORMAL C1 INHIBITOR CONCENTRATION AND FUNCTION;;HAE WITH NORMAL C1 INHIBITOR CONCENTRATION AND FUNCTION;;HEREDITARY  /.../DEMA WITH NORMAL C1 INHIBITOR ACTIVITY
ENSG00000198055	GRK6	NA	
ENSG00000246334	PRR7-AS1	NA	
ENSG00000131188	PRR7	NA	
ENSG00000113758	DBN1	NA	
ENSG00000279821	AC145098.2	NA	
ENSG00000196923	PDLIM7	NA	
ENSG00000248996	AC145098.1	NA	
ENSG00000146094	DOK3	NA	
ENSG00000183258	DDX41	616871	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF
ENSG00000146067	FAM193B	NA	
ENSG00000272459	AC139795.3	NA	
ENSG00000184840	TMED9	NA	
ENSG00000027847	B4GALT7	130070	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1;;EHLERS-DANLOS SYNDROME WITH SHORT STATURE AND LIMB ANOMALIES; EDSSLA;;PROTEODERMATAN SULFATE, DEFECTIVE BIOSYNTHESIS OF;;PDS, DEFECTIVE BIOSYNTHESIS OF;;DERMATAN SULFATE PROTEOGLYCAN;;XYLO /.../TEIN 4-BETA-GALACTOSYLTRANSFERASE DEFICIENCY;;XGPT DEFICIENCY;;GALACTOSYLTRANSFERASE I DEFICIENCY;;EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 1, FORMERLY; EDSP1, FORMERLY
ENSG00000247679	AC139795.2	NA	
ENSG00000246596	AC139795.1	NA	
ENSG00000249849	AC138819.1	NA	
ENSG00000170074	FAM153A	NA	
ENSG00000249109	AC140125.2	NA	
ENSG00000248943	AC140125.1	NA	
ENSG00000170089	AC106795.1	NA	
ENSG00000214351	OR1X5P	NA	
ENSG00000249186	AC140125.3	NA	
ENSG00000250101	AC106795.3	NA	
ENSG00000249684	AC106795.2	NA	
ENSG00000280207	AC106795.5	NA	
ENSG00000249129	SUDS3P1	NA	
ENSG00000175325	PROP1	262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM
ENSG00000204677	FAM153CP	NA	
ENSG00000218227	AC136632.1	NA	
ENSG00000145911	N4BP3	NA	
ENSG00000145916	RMND5B	NA	
ENSG00000145912	NHP2	224230	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1
ENSG00000145912	NHP2	613987	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2
ENSG00000251211	AC136632.2	NA	
ENSG00000244234	GMCL2	NA	
ENSG00000197451	HNRNPAB	NA	
ENSG00000175309	PHYKPL	615011	PHOSPHOHYDROXYLYSINURIA; PHLU
ENSG00000050767	COL23A1	NA	
ENSG00000271681	AC136601.2	NA	
ENSG00000253698	AC136601.1	NA	
ENSG00000242341	RN7SL646P	NA	
ENSG00000245688	AC008659.1	NA	
ENSG00000113240	CLK4	NA	
ENSG00000252464	RN7SKP70	NA	
ENSG00000286713	AC113348.3	NA	
ENSG00000285891	AC113348.1	NA	
ENSG00000285978	AC113348.2	NA	
ENSG00000169131	ZNF354A	NA	
ENSG00000250420	AACSP1	NA	
ENSG00000274813	AC126915.2	NA	
ENSG00000253725	AC126915.1	NA	
ENSG00000278441	AC126915.3	NA	
ENSG00000178338	ZNF354B	NA	
ENSG00000206624	RNU1-39P	NA	
ENSG00000198939	ZFP2	NA	
ENSG00000213328	AC104117.1	NA	
ENSG00000253869	PIGFP1	NA	
ENSG00000272431	AC104117.5	NA	
ENSG00000178187	ZNF454	NA	
ENSG00000254035	AC104117.3	NA	
ENSG00000113262	GRM6	257270	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B;;NIGHT BLINDNESS, CONGENITAL STATIONARY, COMPLETE, AUTOSOMAL RECESSIVE;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE
ENSG00000254158	AC104117.4	NA	
ENSG00000234284	ZNF879	NA	
ENSG00000177932	ZNF354C	NA	
ENSG00000253144	AC104117.2	NA	
ENSG00000087116	ADAMTS2	225410	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS;;DERMATOSPARAXIS;;EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EDS VIIC;;EDS7C
ENSG00000253979	AC109479.3	NA	
ENSG00000253163	AC109479.1	NA	
ENSG00000253617	AC109479.2	NA	
ENSG00000250674	AC136628.1	NA	
ENSG00000274716	U4	NA	
ENSG00000253652	AC136628.4	NA	
ENSG00000251545	AC136628.2	NA	
ENSG00000253520	AC136628.3	NA	
ENSG00000176783	RUFY1	NA	
ENSG00000249140	PRDX2P3	NA	
ENSG00000244945	RUFY1-AS1	NA	
ENSG00000169045	HNRNPH1	NA	
ENSG00000273549	Metazoa_SRP	NA	
ENSG00000204661	C5orf60	NA	
ENSG00000228259	AC136604.1	NA	
ENSG00000250999	AC136604.2	NA	
ENSG00000204659	CBY3	NA	
ENSG00000127022	CANX	NA	
ENSG00000225051	HMGB3P22	NA	
ENSG00000161021	MAML1	NA	
ENSG00000213316	LTC4S	614037	LEUKOTRIENE C4 SYNTHASE DEFICIENCY;;LTC4 SYNTHASE DEFICIENCY
ENSG00000161013	MGAT4B	NA	
ENSG00000221394	MIR1229	NA	
ENSG00000161011	SQSTM1	167250	PAGET DISEASE OF BONE 3; PDB3
ENSG00000161011	SQSTM1	616437	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3
ENSG00000161011	SQSTM1	617145	NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP
ENSG00000161011	SQSTM1	617158	MYOPATHY, DISTAL, WITH RIMMED VACUOLES; DMRV
ENSG00000161010	MRNIP	NA	
ENSG00000222448	RN7SKP150	NA	
ENSG00000252202	Y_RNA	NA	
ENSG00000245317	AC008393.1	NA	
ENSG00000197226	TBC1D9B	NA	
ENSG00000113269	RNF130	NA	
ENSG00000242979	RPS15AP18	NA	
ENSG00000249876	AC010285.2	NA	
ENSG00000249412	AC010285.1	NA	
ENSG00000285865	AC010285.3	NA	
ENSG00000198995	MIR340	NA	
ENSG00000278965	AC122713.2	NA	
ENSG00000253480	AC122713.1	NA	
ENSG00000146090	RASGEF1C	NA	
ENSG00000229721	AC104115.1	NA	
ENSG00000050748	MAPK9	NA	
ENSG00000253908	AC104115.2	NA	
ENSG00000248367	AC008610.1	NA	
ENSG00000131459	GFPT2	NA	
ENSG00000250509	AC034213.1	NA	
ENSG00000200555	RNU6-525P	NA	
ENSG00000113300	CNOT6	NA	
ENSG00000250749	AC122714.1	NA	
ENSG00000161055	SCGB3A1	NA	
ENSG00000037280	FLT4	153100	LYMPHATIC MALFORMATION 1; LMPHM1;;NONNE-MILROY LYMPHEDEMA;;MILROY DISEASE;;LYMPHEDEMA, EARLY-ONSET;;PRIMARY CONGENITAL LYMPHEDEMA; PCL;;LYMPHEDEMA, HEREDITARY, TYPE I, FORMERLY;;LYMPHEDEMA, HEREDITARY, IA, FORMERLY; LMPH1A, FORMERLY
ENSG00000037280	FLT4	602089	HEMANGIOMA, CAPILLARY INFANTILE;;HCI;;HEMANGIOMA, HEREDITARY CAPILLARY
ENSG00000037280	FLT4	618780	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7; CHTD7
ENSG00000251352	AC122714.2	NA	
ENSG00000248717	LINC02222	NA	
ENSG00000236791	OR2AI1P	NA	
ENSG00000199892	RNU1-17P	NA	
ENSG00000174339	OR2Y1	NA	
ENSG00000131446	MGAT1	NA	
ENSG00000280161	AC022413.1	NA	
ENSG00000278970	HEIH	NA	
ENSG00000245060	LINC00847	NA	
ENSG00000286128	AC022413.2	NA	
ENSG00000196670	ZFP62	NA	
ENSG00000113303	BTNL8	NA	
ENSG00000222852	Y_RNA	NA	
ENSG00000243664	RPS29P12	NA	
ENSG00000249287	AC091874.2	NA	
ENSG00000248761	AC091874.1	NA	
ENSG00000231228	ARPP19P1	NA	
ENSG00000168903	BTNL3	NA	
ENSG00000206686	RNU6-1036P	NA	
ENSG00000165810	BTNL9	NA	
ENSG00000277912	MIR8089	NA	
ENSG00000241870	AC008620.1	NA	
ENSG00000214295	FOXO1B	NA	
ENSG00000248560	AC008620.2	NA	
ENSG00000185372	OR2V1	NA	
ENSG00000182613	OR2V2	NA	
ENSG00000248473	LINC01962	NA	
ENSG00000250222	AC008443.4	NA	
ENSG00000146054	TRIM7	NA	
ENSG00000250900	AC008443.5	NA	
ENSG00000248514	AC008443.3	NA	
ENSG00000286644	AC008443.8	NA	
ENSG00000146063	TRIM41	NA	
ENSG00000264732	MIR4638	NA	
ENSG00000247049	AC008443.1	NA	
ENSG00000204628	RACK1	NA	
ENSG00000272296	SNORD96A	NA	
ENSG00000264549	SNORD95	NA	
ENSG00000233937	CTC-338M12.4	NA	
ENSG00000183718	TRIM52	NA	
ENSG00000248275	TRIM52-AS1	NA	
ENSG00000286310	AC008443.7	NA	
ENSG00000248103	AC008443.2	NA	
ENSG00000274525	AC008443.6	NA	
ENSG00000222533	RNU6-705P	NA	
ENSG00000238035	AC138035.1	NA	
ENSG00000274553	AC138035.3	NA	
ENSG00000250765	AC138035.2	NA	
ENSG00000230178	OR4F3	NA	
ENSG00000251035	WBP1LP4	NA	
ENSG00000213285	RPL23AP45	NA	
ENSG00000271530	WBP1LP12	NA	
ENSG00000220212	OR4F1P	NA	
ENSG00000217929	CICP18	NA	
ENSG00000218577	AL035696.2	NA	
ENSG00000263667	AL035696.3	NA	
ENSG00000285578	AL035696.4	NA	
ENSG00000205653	AL035696.1	NA	
ENSG00000287265	AL365272.1	NA	
ENSG00000112679	DUSP22	NA	
ENSG00000137265	IRF4	611724	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8;;SKIN/HAIR/EYE PIGMENTATION 8, BROWN HAIR;;SKIN/HAIR/EYE PIGMENTATION 8, FAIR SKIN;;SKIN/HAIR/EYE PIGMENTATION 8, BLUE/LIGHT EYE COLOR;;SKIN/HAIR/EYE PIGMENTATION 8, FRECKLING/SUNBURN
ENSG00000286364	AL512308.1	NA	
ENSG00000112685	EXOC2	NA	
ENSG00000230433	AL031770.1	NA	
ENSG00000188996	HUS1B	NA	
ENSG00000219712	AL357054.1	NA	
ENSG00000271727	AL357054.2	NA	
ENSG00000272463	AL357054.4	NA	
ENSG00000287293	AL357054.5	NA	
ENSG00000271911	AL357054.3	NA	
ENSG00000272485	AL392183.1	NA	
ENSG00000276687	AL356130.1	NA	
ENSG00000286785	LINC01622	NA	
ENSG00000270937	AL033381.2	NA	
ENSG00000176515	AL033381.1	NA	
ENSG00000286324	AL033381.3	NA	
ENSG00000164379	FOXQ1	NA	
ENSG00000281809	LINC01394	NA	
ENSG00000261730	AL034346.1	NA	
ENSG00000137273	FOXF2	NA	
ENSG00000275859	MIR6720	NA	
ENSG00000243439	RN7SL352P	NA	
ENSG00000218027	AL512329.1	NA	
ENSG00000272279	AL512329.2	NA	
ENSG00000280916	FOXCUT	NA	
ENSG00000054598	FOXC1	601631	ANTERIOR SEGMENT DYSGENESIS 3; ASGD3;;IRIDOGONIODYSGENESIS, TYPE 1; IRID1;;IRIDOGONIODYSGENESIS ANOMALY, AUTOSOMAL DOMINANT; IGDA;;IRIS HYPOPLASIA WITH GLAUCOMA;;GLAUCOMA IRIDOGONIODYSPLASIA, FAMILIAL
ENSG00000054598	FOXC1	602482	AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH CARDIAC DEFECTS AND/OR SENSORINEURAL HEARING LOSS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3
ENSG00000112699	GMDS	NA	
ENSG00000285603	AL035693.1	NA	
ENSG00000250903	GMDS-DT	NA	
ENSG00000236086	HMGN2P28	NA	
ENSG00000286512	AL031768.2	NA	
ENSG00000272465	AL031768.1	NA	
ENSG00000287903	AL359852.2	NA	
ENSG00000280423	AL359852.1	NA	
ENSG00000228718	LINC02521	NA	
ENSG00000164385	LINC01600	NA	
ENSG00000145949	MYLK4	NA	
ENSG00000124535	WRNIP1	NA	
ENSG00000021355	SERPINB1	NA	
ENSG00000230438	SERPINB9P1	NA	
ENSG00000266750	MIR4645	NA	
ENSG00000170542	SERPINB9	NA	
ENSG00000232999	AL133351.2	NA	
ENSG00000228365	AL133351.1	NA	
ENSG00000124570	SERPINB6	613453	DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91
ENSG00000244041	LINC01011	NA	
ENSG00000124588	NQO2	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000224846	NQO2-AS1	NA	
ENSG00000271361	HTATSF1P2	NA	
ENSG00000288612	AL133351.4	NA	
ENSG00000274855	AL133351.3	NA	
ENSG00000232654	FAM136BP	NA	
ENSG00000217707	SERPINB8P1	NA	
ENSG00000229282	AL031963.2	NA	
ENSG00000137275	RIPK1	618108	IMMUNODEFICIENCY 57; IMD57
ENSG00000272277	AL031963.3	NA	
ENSG00000222248	RNA5SP201	NA	
ENSG00000137274	BPHL	NA	
ENSG00000228170	AL031963.1	NA	
ENSG00000137267	TUBB2A	615763	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5
ENSG00000216819	TUBB2BP1	NA	
ENSG00000230269	LINC02525	NA	
ENSG00000137285	TUBB2B	610031	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7;;POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC; PMGYSA
ENSG00000180822	PSMG4	NA	
ENSG00000137266	SLC22A23	NA	
ENSG00000272320	AL445309.1	NA	
ENSG00000228793	AL033523.1	NA	
ENSG00000270477	AL033523.2	NA	
ENSG00000168994	PXDC1	NA	
ENSG00000270504	AL391422.4	NA	
ENSG00000219992	AL391422.1	NA	
ENSG00000238158	AL391422.3	NA	
ENSG00000233068	AL391422.2	NA	
ENSG00000145945	FAM50B	NA	
ENSG00000260604	AL590004.3	NA	
ENSG00000218472	AL590004.2	NA	
ENSG00000217135	AL590004.1	NA	
ENSG00000217566	TDGF1P4	NA	
ENSG00000216657	GLRX3P2	NA	
ENSG00000279926	AL138831.3	NA	
ENSG00000272248	AL138831.2	NA	
ENSG00000230648	AL138831.1	NA	
ENSG00000112739	PRPF4B	NA	
ENSG00000145975	FAM217A	NA	
ENSG00000185689	C6orf201	NA	
ENSG00000198721	ECI2	NA	
ENSG00000254821	AL136309.3	NA	
ENSG00000234817	ECI2-DT	NA	
ENSG00000237716	AL136309.2	NA	
ENSG00000216307	AL136309.1	NA	
ENSG00000285424	AL162718.1	NA	
ENSG00000231811	AL159166.1	NA	
ENSG00000287761	AL162718.3	NA	
ENSG00000201185	RNA5SP202	NA	
ENSG00000285694	AL162718.2	NA	
ENSG00000260239	LINC02533	NA	
ENSG00000270695	AL133393.1	NA	
ENSG00000260673	AL034376.1	NA	
ENSG00000205444	KU-MEL-3	NA	
ENSG00000217385	PSMC1P11	NA	
ENSG00000153046	CDYL	NA	
ENSG00000284823	AL356747.1	NA	
ENSG00000236336	CDYL-AS1	NA	
ENSG00000217030	AL359643.1	NA	
ENSG00000124787	RPP40	NA	
ENSG00000272142	LYRM4-AS1	NA	
ENSG00000271978	AL359643.2	NA	
ENSG00000220685	AL139094.1	NA	
ENSG00000288548	AL035653.1	NA	
ENSG00000219607	PPP1R3G	NA	
ENSG00000214113	LYRM4	615595	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19
ENSG00000265083	MIR3691	NA	
ENSG00000145982	FARS2	614946	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14
ENSG00000145982	FARS2	617046	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; SPG77
ENSG00000220446	AL121978.1	NA	
ENSG00000269985	AL021328.1	NA	
ENSG00000218574	HNRNPA1P37	NA	
ENSG00000270174	AL022097.1	NA	
ENSG00000217239	AL136968.2	NA	
ENSG00000216360	AL136968.1	NA	
ENSG00000233064	AL136307.1	NA	
ENSG00000239472	RN7SL221P	NA	
ENSG00000215057	PKMP5	NA	
ENSG00000124785	NRN1	NA	
ENSG00000124491	F13A1	188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1;;THROMBOPHILIA DUE TO FACTOR 2 DEFECT;;VENOUS THROMBOSIS;;VENOUS THROMBOEMBOLISM THROMBOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000124491	F13A1	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000124491	F13A1	613225	FACTOR XIII, A SUBUNIT, DEFICIENCY OF
ENSG00000263572	MIR7853	NA	
ENSG00000283616	MIR5683	NA	
ENSG00000216863	LY86-AS1	NA	
ENSG00000241216	SNAPC5P1	NA	
ENSG00000285717	AL162719.1	NA	
ENSG00000218868	CNN3P1	NA	
ENSG00000112799	LY86	NA	
ENSG00000261211	AL031123.2	NA	
ENSG00000279368	AL031123.3	NA	
ENSG00000226281	AL031123.1	NA	
ENSG00000287497	AL031123.4	NA	
ENSG00000288046	AL031123.5	NA	
ENSG00000224532	AL136361.1	NA	
ENSG00000219986	BTF3P7	NA	
ENSG00000223342	AL158817.1	NA	
ENSG00000240936	RN7SL554P	NA	
ENSG00000203498	AL139390.1	NA	
ENSG00000124782	RREB1	NA	
ENSG00000225092	AL355336.1	NA	
ENSG00000201483	Y_RNA	NA	
ENSG00000287002	AL589644.1	NA	
ENSG00000285771	AL139095.5	NA	
ENSG00000124783	SSR1	NA	
ENSG00000238221	AL139095.4	NA	
ENSG00000164304	CAGE1	NA	
ENSG00000219375	AL139095.1	NA	
ENSG00000220472	AL139095.2	NA	
ENSG00000230570	AL139095.3	NA	
ENSG00000124784	RIOK1	NA	
ENSG00000233503	HNRNPLP1	NA	
ENSG00000219993	AL138878.1	NA	
ENSG00000234115	AL138878.2	NA	
ENSG00000261189	AL031058.1	NA	
ENSG00000096696	DSP	605676	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK;;CARVAJAL SYNDROME;;PALMOPLANTAR KERATODERMA WITH LEFT VENTRICULAR CARDIOMYOPATHY AND WOOLLY HAIR
ENSG00000096696	DSP	607450	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8;;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 8; ARVC8
ENSG00000096696	DSP	607655	SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS
ENSG00000096696	DSP	609638	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA;;LETHAL ACANTHOLYTIC EPIDERMOLYSIS BULLOSA; LAEB
ENSG00000096696	DSP	612908	KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2;;KERATODERMA, PALMOPLANTAR, STRIATE FORM II; KPPS2;;STRIATE PALMOPLANTAR KERATODERMA II; SPPK2
ENSG00000096696	DSP	615821	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA
ENSG00000168566	SNRNP48	NA	
ENSG00000236512	AL390026.1	NA	
ENSG00000153162	BMP6	NA	
ENSG00000239264	TXNDC5	NA	
ENSG00000259040	BLOC1S5-TXNDC5	NA	
ENSG00000217746	AL096800.1	NA	
ENSG00000219294	PIP5K1P1	NA	
ENSG00000188428	BLOC1S5	NA	
ENSG00000265818	EEF1E1-BLOC1S5	NA	
ENSG00000124802	EEF1E1	NA	
ENSG00000232234	AL355499.1	NA	
ENSG00000285216	AL355499.2	NA	
ENSG00000234763	AL359378.1	NA	
ENSG00000124786	SLC35B3	NA	
ENSG00000285219	HULC	NA	
ENSG00000276019	AL161437.1	NA	
ENSG00000225775	AL137220.1	NA	
ENSG00000181355	OFCC1	NA	
ENSG00000216368	AL136226.1	NA	
ENSG00000229765	AL354868.1	NA	
ENSG00000221583	RNU6ATAC21P	NA	
ENSG00000216781	AL138885.1	NA	
ENSG00000137203	TFAP2A	113620	BRANCHIOOCULOFACIAL SYNDROME; BOFS;;BOF SYNDROME;;BRANCHIAL CLEFTS WITH CHARACTERISTIC FACIES, GROWTH RETARDATION, IMPERFORATE NASOLACRIMAL DUCT, AND PREMATURE AGING;;HEMANGIOMATOUS BRANCHIAL CLEFTS-LIP PSEUDOCLEFT SYNDROME;;LIP PSEUDOCLEFT-HEMANGIO /.../ BRANCHIAL CYST SYNDROME
ENSG00000285278	TFAP2A-AS2	NA	
ENSG00000229950	TFAP2A-AS1	NA	
ENSG00000228478	AL138885.2	NA	
ENSG00000285759	AL138885.3	NA	
ENSG00000183674	LINC00518	NA	
ENSG00000229401	MIR5689HG	NA	
ENSG00000263705	MIR5689	NA	
ENSG00000238076	MRPL48P1	NA	
ENSG00000231056	LINC02522	NA	
ENSG00000111846	GCNT2	116700	CATARACT 13 WITH ADULT i PHENOTYPE; CTRCT13
ENSG00000111846	GCNT2	110800	BLOOD GROUP, I SYSTEM; Ii;;I BLOOD GROUP SYSTEM;;Ii BLOOD GROUP SYSTEM  ADULT i PHENOTYPE, INCLUDED
ENSG00000237685	AL139039.3	NA	
ENSG00000216359	AL139039.1	NA	
ENSG00000217181	AL139039.2	NA	
ENSG00000205318	GCNT2P1	NA	
ENSG00000285763	AL358777.3	NA	
ENSG00000137434	C6orf52	NA	
ENSG00000201048	AL358777.1	NA	
ENSG00000111845	PAK1IP1	NA	
ENSG00000111843	TMEM14C	NA	
ENSG00000272097	AL024498.1	NA	
ENSG00000137210	TMEM14B	NA	
ENSG00000272162	AL024498.2	NA	
ENSG00000222383	RNA5SP203	NA	
ENSG00000111837	MAK	614181	RETINITIS PIGMENTOSA 62; RP62
ENSG00000124827	GCM2	146200	HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH;;HYPOPARATHYROIDISM, AUTOSOMAL DOMINANT HYPOPARATHYROIDISM, AUTOSOMAL RECESSIVE, INCLUDED
ENSG00000124827	GCM2	617343	HYPERPARATHYROIDISM 4; HRPT4
ENSG00000235051	AL357497.1	NA	
ENSG00000153157	SYCP2L	NA	
ENSG00000197977	ELOVL2	NA	
ENSG00000274541	AL121955.1	NA	
ENSG00000230314	ELOVL2-AS1	NA	
ENSG00000224531	SMIM13	NA	
ENSG00000244476	ERVFRD-1	NA	
ENSG00000271245	AL136139.1	NA	
ENSG00000247925	AL139807.1	NA	
ENSG00000111859	NEDD9	NA	
ENSG00000287920	AL022098.1	NA	
ENSG00000242753	AL445430.2	NA	
ENSG00000233656	AL445430.1	NA	
ENSG00000202313	RNU1-64P	NA	
ENSG00000218020	THAP12P5	NA	
ENSG00000205269	TMEM170B	NA	
ENSG00000271897	AL357518.1	NA	
ENSG00000277473	Metazoa_SRP	NA	
ENSG00000207419	AL022724.1	NA	
ENSG00000111863	ADTRP	NA	
ENSG00000287593	AL022724.3	NA	
ENSG00000234427	AL022724.2	NA	
ENSG00000215124	AMD1P4	NA	
ENSG00000225102	AL157373.1	NA	
ENSG00000229896	AL157373.2	NA	
ENSG00000095951	HIVEP1	NA	
ENSG00000078401	EDN1	131240	ENDOTHELIN 1; EDN1;;ET1 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7, INCLUDED; HDLCQ7, INCLUDED;;PREPROENDOTHELIN 1, INCLUDED
ENSG00000078401	EDN1	612798	QUESTION MARK EARS, ISOLATED; QME;;EARS, PROMINENT AND CONSTRICTED;;COSMAN DEFORMITY OF THE AURICLE;;AURICULAR CLEFT, CONGENITAL
ENSG00000078401	EDN1	615706	AURICULOCONDYLAR SYNDROME 3; ARCND3
ENSG00000218893	SUMO2P12	NA	
ENSG00000223321	RN7SKP293	NA	
ENSG00000212802	RPL15P3	NA	
ENSG00000234015	LINC02530	NA	
ENSG00000112137	PHACTR1	618298	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70
ENSG00000206702	RNU1-11P	NA	
ENSG00000215022	AL008729.1	NA	
ENSG00000145979	TBC1D7	248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH
ENSG00000272379	AL008729.2	NA	
ENSG00000145990	GFOD1	NA	
ENSG00000237786	GFOD1-AS1	NA	
ENSG00000218265	RPS4XP7	NA	
ENSG00000202351	RN7SKP204	NA	
ENSG00000124523	SIRT5	NA	
ENSG00000261071	AL441883.1	NA	
ENSG00000225921	NOL7	NA	
ENSG00000010017	RANBP9	NA	
ENSG00000286316	Z93020.1	NA	
ENSG00000050393	MCUR1	NA	
ENSG00000272209	AL023583.1	NA	
ENSG00000180537	RNF182	NA	
ENSG00000220868	MRPL35P1	NA	
ENSG00000233981	AL022396.1	NA	
ENSG00000112149	CD83	NA	
ENSG00000285639	AL133259.1	NA	
ENSG00000238987	RNU7-133P	NA	
ENSG00000286281	AL353152.2	NA	
ENSG00000230631	AL353152.1	NA	
ENSG00000226673	LINC01108	NA	
ENSG00000237346	AL080313.2	NA	
ENSG00000234540	AL080313.1	NA	
ENSG00000286277	AL009177.1	NA	
ENSG00000229646	AL109914.1	NA	
ENSG00000206960	RNU6-793P	NA	
ENSG00000234261	AL138720.1	NA	
ENSG00000216754	AL050335.1	NA	
ENSG00000242989	RN7SL332P	NA	
ENSG00000271888	AL136162.1	NA	
ENSG00000008083	JARID2	NA	
ENSG00000235488	JARID2-AS1	NA	
ENSG00000201367	RNU6-522P	NA	
ENSG00000201519	RNU6-645P	NA	
ENSG00000277411	5S_rRNA	NA	
ENSG00000047579	DTNBP1	614076	HERMANSKY-PUDLAK SYNDROME 7; HPS7
ENSG00000287626	AL021978.1	NA	
ENSG00000214027	ARPC3P5	NA	
ENSG00000232947	LINC02543	NA	
ENSG00000274212	AL365265.1	NA	
ENSG00000217585	AL021407.2	NA	
ENSG00000007944	MYLIP	NA	
ENSG00000263712	MIR4639	NA	
ENSG00000218073	AL021407.3	NA	
ENSG00000217078	AL021407.1	NA	
ENSG00000216364	MRPL42P2	NA	
ENSG00000251831	RNU6-1114P	NA	
ENSG00000207193	AL138883.1	NA	
ENSG00000137198	GMPR	NA	
ENSG00000282024	AL009031.1	NA	
ENSG00000124788	ATXN1	164400	SPINOCEREBELLAR ATAXIA 1; SCA1;;SPINOCEREBELLAR ATROPHY I;;OLIVOPONTOCEREBELLAR ATROPHY I; OPCA1;;OPCA I;;CEREBELLOPARENCHYMAL DISORDER I; CPD1;;MENZEL TYPE OPCA;;OLIVOPONTOCEREBELLAR ATROPHY IV; OPCA4;;OPCA IV;;SCHUT-HAYMAKER TYPE OPCA
ENSG00000229931	ATXN1-AS1	NA	
ENSG00000272341	AL137003.1	NA	
ENSG00000287347	AL133405.2	NA	
ENSG00000286631	AL133405.1	NA	
ENSG00000287359	AL138740.1	NA	
ENSG00000230873	STMND1	NA	
ENSG00000287559	AL136305.1	NA	
ENSG00000112183	RBM24	NA	
ENSG00000219314	AL034372.1	NA	
ENSG00000112186	CAP2	NA	
ENSG00000184612	RPL7P26	NA	
ENSG00000218359	SUMO2P13	NA	
ENSG00000286885	AL138824.1	NA	
ENSG00000137414	FAM8A1	NA	
ENSG00000124789	NUP153	NA	
ENSG00000206881	RNU6-190P	NA	
ENSG00000272269	AL138724.1	NA	
ENSG00000201415	RNA5SP204	NA	
ENSG00000201442	Y_RNA	NA	
ENSG00000137177	KIF13A	NA	
ENSG00000220920	AL023807.1	NA	
ENSG00000187566	NHLRC1	254780	MYOCLONIC EPILEPSY OF LAFORA;;MELF;;LAFORA DISEASE;;LAFORA BODY DISEASE; LBD;;EPILEPSY, PROGRESSIVE MYOCLONIC, 2A; EPM2A;;EPM2  EPILEPSY, PROGRESSIVE MYOCLONIC, 2B, INCLUDED; EPM2B, INCLUDED
ENSG00000137364	TPMT	610460	THIOPURINES, POOR METABOLISM OF, 1; THPM1;;THIOPURINE S-METHYLTRANSFERASE DEFICIENCY; TPMTD;;TPMT DEFICIENCY
ENSG00000165097	KDM1B	NA	
ENSG00000124795	DEK	NA	
ENSG00000199715	Y_RNA	NA	
ENSG00000278102	AL138825.1	NA	
ENSG00000200681	RNU6-263P	NA	
ENSG00000217414	DDX18P3	NA	
ENSG00000218976	AL138725.1	NA	
ENSG00000137393	RNF144B	NA	
ENSG00000283408	MIR548A1HG	NA	
ENSG00000207775	MIR548A1	NA	
ENSG00000217379	AL589647.1	NA	
ENSG00000231662	AL357052.1	NA	
ENSG00000228412	LNC-LBCS	NA	
ENSG00000218643	RPL5P20	NA	
ENSG00000201523	RNA5SP205	NA	
ENSG00000214012	KRT18P38	NA	
ENSG00000217314	UQCRFS1P3	NA	
ENSG00000200957	RNU6-801P	NA	
ENSG00000172201	ID4	NA	
ENSG00000287138	AL022726.1	NA	
ENSG00000229700	AL008627.1	NA	
ENSG00000172197	MBOAT1	NA	
ENSG00000227803	AL158198.1	NA	
ENSG00000287614	AL158198.2	NA	
ENSG00000286590	AL132775.1	NA	
ENSG00000287483	AL132775.2	NA	
ENSG00000112242	E2F3	NA	
ENSG00000240869	RN7SL128P	NA	
ENSG00000224707	E2F3-IT1	NA	
ENSG00000222431	RNU6-141P	NA	
ENSG00000201683	Y_RNA	NA	
ENSG00000145996	CDKAL1	NA	
ENSG00000225832	AL035090.1	NA	
ENSG00000233848	AL513188.1	NA	
ENSG00000252046	RNU6-150P	NA	
ENSG00000287404	AL451080.1	NA	
ENSG00000227089	AL031767.1	NA	
ENSG00000286368	AL031767.2	NA	
ENSG00000280989	LINC00581	NA	
ENSG00000231754	AL512380.1	NA	
ENSG00000283480	AL512380.2	NA	
ENSG00000124766	SOX4	618506	COFFIN-SIRIS SYNDROME 10; CSS10
ENSG00000220771	BOLA2P3	NA	
ENSG00000272168	CASC15	NA	
ENSG00000280443	AL136313.1	NA	
ENSG00000222515	RN7SKP240	NA	
ENSG00000260455	NBAT1	NA	
ENSG00000219404	AL359694.1	NA	
ENSG00000172179	PRL	NA	
ENSG00000112273	HDGFL1	NA	
ENSG00000228772	AL033539.1	NA	
ENSG00000286954	AL033539.2	NA	
ENSG00000233358	AL035401.1	NA	
ENSG00000218476	AL591416.1	NA	
ENSG00000207394	RNU6-1060P	NA	
ENSG00000235743	AL139231.1	NA	
ENSG00000219453	AL133270.1	NA	
ENSG00000278128	AL139093.1	NA	
ENSG00000218512	SPTLC1P2	NA	
ENSG00000220748	AL032822.1	NA	
ENSG00000219582	HNRNPA1P58	NA	
ENSG00000152954	NRSN1	NA	
ENSG00000251830	FO393410.1	NA	
ENSG00000146038	DCDC2	610212	DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66
ENSG00000146038	DCDC2	616217	NEPHRONOPHTHISIS 19; NPHP19
ENSG00000146038	DCDC2	617394	SCLEROSING CHOLANGITIS, NEONATAL; NSC
ENSG00000146049	KAAG1	NA	
ENSG00000202050	RNU6-391P	NA	
ENSG00000124532	MRS2	NA	
ENSG00000112293	GPLD1	NA	
ENSG00000112294	ALDH5A1	271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD;;SSADH DEFICIENCY;;4-@HYDROXYBUTYRIC ACIDURIA;;GABA METABOLIC DEFECT;;GAMMA-HYDROXYBUTYRIC ACIDURIA
ENSG00000137261	KIAA0319	NA	
ENSG00000218186	KRT8P43	NA	
ENSG00000111802	TDP2	616949	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23
ENSG00000112304	ACOT13	NA	
ENSG00000272345	AL031775.1	NA	
ENSG00000112308	C6orf62	NA	
ENSG00000272402	AL031775.2	NA	
ENSG00000224164	LINC02828	NA	
ENSG00000218806	AL133264.1	NA	
ENSG00000112312	GMNN	616835	MEIER-GORLIN SYNDROME 6; MGORS6
ENSG00000260286	ARMH2	NA	
ENSG00000282804	AL512428.1	NA	
ENSG00000111913	RIPOR2	616515	DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104
ENSG00000217083	MTCO2P33	NA	
ENSG00000214975	PPIAP29	NA	
ENSG00000286633	AL160400.1	NA	
ENSG00000220517	ASS1P1	NA	
ENSG00000244618	RN7SL334P	NA	
ENSG00000229313	AL133268.3	NA	
ENSG00000223623	AL133268.2	NA	
ENSG00000168405	CMAHP	NA	
ENSG00000285801	AL133268.4	NA	
ENSG00000219682	AL133268.1	NA	
ENSG00000262400	AL590084.3	NA	
ENSG00000217805	AL590084.1	NA	
ENSG00000219681	AL590084.2	NA	
ENSG00000271108	KATNBL1P5	NA	
ENSG00000216718	AL024509.2	NA	
ENSG00000213972	AL024509.1	NA	
ENSG00000079691	CARMIL1	NA	
ENSG00000207286	Y_RNA	NA	
ENSG00000207490	RNU6-987P	NA	
ENSG00000286933	AL022170.1	NA	
ENSG00000079689	SCGN	NA	
ENSG00000217408	PRELID1P2	NA	
ENSG00000164508	H2AC1	NA	
ENSG00000146047	H2BC1	NA	
ENSG00000178762	H2BC2P	NA	
ENSG00000216436	H2AC2P	NA	
ENSG00000146039	SLC17A4	NA	
ENSG00000124568	SLC17A1	NA	
ENSG00000124564	SLC17A3	612671	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4;;GOUT SUSCEPTIBILITY 4; GOUT4
ENSG00000242387	H2AC3P	NA	
ENSG00000277410	H2BP5	NA	
ENSG00000112337	SLC17A2	NA	
ENSG00000112343	TRIM38	NA	
ENSG00000272558	U91328.2	NA	
ENSG00000272462	U91328.1	NA	
ENSG00000272810	U91328.3	NA	
ENSG00000224447	H3P26	NA	
ENSG00000124610	H1-1	NA	
ENSG00000275714	H3C1	NA	
ENSG00000278637	H4C1	NA	
ENSG00000278705	H4C2	NA	
ENSG00000286522	H3C2	NA	
ENSG00000278463	H2AC4	NA	
ENSG00000276410	H2BC3	NA	
ENSG00000234816	H2AC5P	NA	
ENSG00000287080	H3C3	NA	
ENSG00000187837	H1-2	NA	
ENSG00000010704	HFE	176200	VARIEGATE PORPHYRIA; VP;;PORPHYRIA VARIEGATA;;PORPHYRIA, SOUTH AFRICAN TYPE;;PROTOPORPHYRINOGEN OXIDASE DEFICIENCY;;PPOX DEFICIENCY VARIEGATE PORPHYRIA, HOMOZYGOUS VARIANT, INCLUDED
ENSG00000010704	HFE	176100	PORPHYRIA CUTANEA TARDA;;PCT;;PORPHYRIA CUTANEA TARDA, TYPE II;;PCT, TYPE II;;PCT, 'FAMILIAL' TYPE;;PORPHYRIA, HEPATOCUTANEOUS TYPE;;UROPORPHYRINOGEN DECARBOXYLASE DEFICIENCY;;UROD DEFICIENCY  PORPHYRIA, HEPATOERYTHROPOIETIC, INCLUDED; HEP, INCLUDED
ENSG00000010704	HFE	104300	ALZHEIMER DISEASE; AD;;PRESENILE AND SENILE DEMENTIA ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED; AD1, INCLUDED;;ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY, INCLUDED;;ALZHEIMER DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000010704	HFE	235200	HEMOCHROMATOSIS, TYPE 1; HFE1;;HEMOCHROMATOSIS; HFE;;HEMOCHROMATOSIS, HEREDITARY; HH
ENSG00000010704	HFE	612635	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7;;PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;;NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;;NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO
ENSG00000010704	HFE	614193	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2
ENSG00000197061	H4C3	NA	
ENSG00000187475	H1-6	NA	
ENSG00000180596	H2BC4	NA	
ENSG00000180573	H2AC6	NA	
ENSG00000168298	H1-4	617537	RAHMAN SYNDROME; RMNS
ENSG00000158373	H2BC5	NA	
ENSG00000283064	AL353759.1	NA	
ENSG00000217159	LARP1P1	NA	
ENSG00000274290	H2BC6	NA	
ENSG00000277157	H4C4	NA	
ENSG00000216331	H1-12P	NA	
ENSG00000282988	AL031777.2	NA	
ENSG00000197409	H3C4	NA	
ENSG00000196866	H2AC7	NA	
ENSG00000277224	H2BC7	NA	
ENSG00000217275	AL031777.1	NA	
ENSG00000276966	H4C5	NA	
ENSG00000273802	H2BC8	NA	
ENSG00000277075	H2AC8	NA	
ENSG00000277720	H3C5P	NA	
ENSG00000274750	H3C6	NA	
ENSG00000218281	H2AC9P	NA	
ENSG00000124575	H1-3	NA	
ENSG00000274618	H4C6	NA	
ENSG00000275663	H4C7	NA	
ENSG00000277775	H3C7	NA	
ENSG00000275713	H2BC9	NA	
ENSG00000273983	H3C8	NA	
ENSG00000218690	H2AC10P	NA	
ENSG00000278588	H2BC10	NA	
ENSG00000158406	H4C8	NA	
ENSG00000220875	H3C9P	NA	
ENSG00000287050	AL021917.1	NA	
ENSG00000186470	BTN3A2	NA	
ENSG00000124508	BTN2A2	NA	
ENSG00000026950	BTN3A1	NA	
ENSG00000124549	BTN2A3P	NA	
ENSG00000111801	BTN3A3	NA	
ENSG00000112763	BTN2A1	NA	
ENSG00000284688	AL121936.2	NA	
ENSG00000124557	BTN1A1	NA	
ENSG00000199289	RNU6-502P	NA	
ENSG00000228223	HCG11	NA	
ENSG00000182952	HMGN4	NA	
ENSG00000284607	AL121936.1	NA	
ENSG00000146109	ABT1	NA	
ENSG00000275846	AL513548.3	NA	
ENSG00000271071	AL513548.2	NA	
ENSG00000181315	ZNF322	NA	
ENSG00000285571	AL513548.4	NA	
ENSG00000261584	AL513548.1	NA	
ENSG00000241549	GUSBP2	NA	
ENSG00000243307	POM121L6P	NA	
ENSG00000224843	LINC00240	NA	
ENSG00000272312	AL133255.1	NA	
ENSG00000287966	AL590062.1	NA	
ENSG00000220581	VN1R12P	NA	
ENSG00000216762	VN1R13P	NA	
ENSG00000219770	VN1R11P	NA	
ENSG00000222800	RNU2-62P	NA	
ENSG00000272468	AL021807.1	NA	
ENSG00000124635	H2BC11	NA	
ENSG00000196787	H2AC11	NA	
ENSG00000276180	H4C9	NA	
ENSG00000197903	H2BC12	NA	
ENSG00000274997	H2AC12	NA	
ENSG00000265565	MIR3143	NA	
ENSG00000174572	RPL10P2	NA	
ENSG00000112812	PRSS16	NA	
ENSG00000270935	AL021808.1	NA	
ENSG00000158553	POM121L2	NA	
ENSG00000220758	VN1R10P	NA	
ENSG00000204789	ZNF204P	NA	
ENSG00000124613	ZNF391	NA	
ENSG00000271755	AL031118.1	NA	
ENSG00000237154	MCFD2P1	NA	
ENSG00000096654	ZNF184	NA	
ENSG00000285849	AL021918.4	NA	
ENSG00000286652	AL021918.5	NA	
ENSG00000285703	AL021918.3	NA	
ENSG00000278332	AL021918.2	NA	
ENSG00000270666	AL021918.1	NA	
ENSG00000218347	HNRNPA1P1	NA	
ENSG00000219738	CD83P1	NA	
ENSG00000206671	RNU6-471P	NA	
ENSG00000216676	AL031229.1	NA	
ENSG00000287674	AL009179.2	NA	
ENSG00000281706	LINC01012	NA	
ENSG00000216915	GPR89P	NA	
ENSG00000287252	AL009179.1	NA	
ENSG00000218069	RSL24D1P1	NA	
ENSG00000217862	H4C10P	NA	
ENSG00000185130	H2BC13	NA	
ENSG00000196747	H2AC13	NA	
ENSG00000278828	H3C10	NA	
ENSG00000276368	H2AC14	NA	
ENSG00000273703	H2BC14	NA	
ENSG00000197238	H4C11	NA	
ENSG00000273542	H4C12	NA	
ENSG00000233822	H2BC15	NA	
ENSG00000275221	H2AC15	NA	
ENSG00000217646	H2BC16P	NA	
ENSG00000276903	H2AC16	NA	
ENSG00000184357	H1-5	NA	
ENSG00000275379	H3C11	NA	
ENSG00000275126	H4C13	NA	
ENSG00000197153	H3C12	NA	
ENSG00000278677	H2AC17	NA	
ENSG00000274641	H2BC17	NA	
ENSG00000238610	RNU7-26P	NA	
ENSG00000168131	OR2B2	NA	
ENSG00000168126	OR2W6P	NA	
ENSG00000124657	OR2B6	NA	
ENSG00000214374	RPLP2P1	NA	
ENSG00000216629	OR2W4P	NA	
ENSG00000217539	IQCB2P	NA	
ENSG00000269293	ZSCAN16-AS1	NA	
ENSG00000199851	AL121944.1	NA	
ENSG00000217315	OR2W2P	NA	
ENSG00000187763	OR2B7P	NA	
ENSG00000182477	OR2B8P	NA	
ENSG00000220721	OR1F12	NA	
ENSG00000272009	AL121944.2	NA	
ENSG00000197279	ZNF165	NA	
ENSG00000219891	ZSCAN12P1	NA	
ENSG00000219392	ZNF602P	NA	
ENSG00000196812	ZSCAN16	NA	
ENSG00000261839	AL358933.1	NA	
ENSG00000198315	ZKSCAN8	NA	
ENSG00000226314	ZNF192P1	NA	
ENSG00000280107	AL022393.1	NA	
ENSG00000216901	ZNF603P	NA	
ENSG00000218016	ZNF192P2	NA	
ENSG00000176933	TOB2P1	NA	
ENSG00000137185	ZSCAN9	NA	
ENSG00000187626	ZKSCAN4	NA	
ENSG00000189134	NKAPL	NA	
ENSG00000197062	ZSCAN26	NA	
ENSG00000276302	AL021997.3	NA	
ENSG00000137338	PGBD1	NA	
ENSG00000273712	AL021997.2	NA	
ENSG00000270326	AL021997.1	NA	
ENSG00000235109	ZSCAN31	NA	
ENSG00000189298	ZKSCAN3	NA	
ENSG00000158691	ZSCAN12	NA	
ENSG00000251877	RNU2-45P	NA	
ENSG00000187987	ZSCAN23	NA	
ENSG00000231162	COX11P1	NA	
ENSG00000219262	OR2E1P	NA	
ENSG00000287804	Z98745.2	NA	
ENSG00000286819	Z98745.1	NA	
ENSG00000198704	GPX6	NA	
ENSG00000224586	GPX5	NA	
ENSG00000232040	ZBED9	NA	
ENSG00000246350	AL049543.1	NA	
ENSG00000271440	AL121932.1	NA	
ENSG00000287279	AL121932.2	NA	
ENSG00000235570	LINC00533	NA	
ENSG00000237425	RPSAP2	NA	
ENSG00000235559	NOP56P1	NA	
ENSG00000225173	AL662890.1	NA	
ENSG00000225595	LINC01623	NA	
ENSG00000213916	RPL13P	NA	
ENSG00000233366	ZNF90P2	NA	
ENSG00000224157	HCG14	NA	
ENSG00000204713	TRIM27	NA	
ENSG00000212240	RNU6-930P	NA	
ENSG00000204709	LINC01556	NA	
ENSG00000228666	KRT18P1	NA	
ENSG00000263426	RN7SL471P	NA	
ENSG00000227214	HCG15	NA	
ENSG00000244349	AL662791.1	NA	
ENSG00000197935	ZNF311	NA	
ENSG00000223677	OR2AD1P	NA	
ENSG00000277661	AL662791.2	NA	
ENSG00000204704	OR2W1	NA	
ENSG00000236909	OR2P1P	NA	
ENSG00000228364	SAR1AP1	NA	
ENSG00000204703	OR2B3	NA	
ENSG00000204702	OR2J1	NA	
ENSG00000204701	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000227206	AL645937.2	NA	
ENSG00000203492	AL645937.1	NA	
ENSG00000284656	AL645937.4	NA	
ENSG00000204700	OR2J2	NA	
ENSG00000224233	OR2J4P	NA	
ENSG00000230598	AL645937.3	NA	
ENSG00000197171	AL672167.1	NA	
ENSG00000213911	OR2G1P	NA	
ENSG00000204697	OR2U1P	NA	
ENSG00000242524	OR2U2P	NA	
ENSG00000204695	OR14J1	NA	
ENSG00000230056	DDX6P1	NA	
ENSG00000243729	OR5V1	NA	
ENSG00000112462	OR12D3	NA	
ENSG00000280236	OR12D2	NA	
ENSG00000251608	OR12D1	NA	
ENSG00000204694	OR11A1	NA	
ENSG00000206474	OR10C1	NA	
ENSG00000277881	AL645927.1	NA	
ENSG00000204688	OR2H1	NA	
ENSG00000225797	UBDP1	NA	
ENSG00000230164	MAS1LP1	NA	
ENSG00000204687	MAS1L	NA	
ENSG00000213900	RPS17P1	NA	
ENSG00000229274	LINC02829	NA	
ENSG00000224582	LINC01015	NA	
ENSG00000229281	GPR53P	NA	
ENSG00000237988	OR2I1P	NA	
ENSG00000213886	UBD	NA	
ENSG00000204681	GABBR1	NA	
ENSG00000232173	OR2H5P	NA	
ENSG00000227609	TMEM183AP1	NA	
ENSG00000201330	SNORD32B	NA	
ENSG00000231301	RPL13AP	NA	
ENSG00000204657	OR2H2	NA	
ENSG00000235238	SUMO2P1	NA	
ENSG00000204655	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000204644	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000233916	ZDHHC20P1	NA	
ENSG00000204642	HLA-F	NA	
ENSG00000225864	AL645939.2	NA	
ENSG00000214922	HLA-F-AS1	NA	
ENSG00000239257	RPL23AP1	NA	
ENSG00000273340	MICE	NA	
ENSG00000227758	AL645939.3	NA	
ENSG00000199290	AL645939.1	NA	
ENSG00000235821	IFITM4P	NA	
ENSG00000272236	AL645939.5	NA	
ENSG00000285761	AL645939.6	NA	
ENSG00000270896	AL645939.4	NA	
ENSG00000181126	HLA-V	NA	
ENSG00000176998	HCG4	NA	
ENSG00000261548	HLA-P	NA	
ENSG00000213880	RPL7AP7	NA	
ENSG00000237042	MICG	NA	
ENSG00000204632	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000229142	HCG4P8	NA	
ENSG00000285799	AL645929.2	NA	
ENSG00000281831	HCP5B	NA	
ENSG00000230521	AL645929.1	NA	
ENSG00000206341	HLA-H	NA	
ENSG00000231130	HLA-T	NA	
ENSG00000233677	DDX39BP1	NA	
ENSG00000235963	MCCD1P1	NA	
ENSG00000227262	HCG4B	NA	
ENSG00000230795	HLA-K	NA	
ENSG00000228078	HLA-U	NA	
ENSG00000206503	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000227766	AL671277.1	NA	
ENSG00000235290	HLA-W	NA	
ENSG00000229390	MICD	NA	
ENSG00000204625	HCG9	NA	
ENSG00000238024	DDX39BP2	NA	
ENSG00000224312	MCCD1P2	NA	
ENSG00000204623	ZNRD1ASP	NA	
ENSG00000204622	HLA-J	NA	
ENSG00000237669	AL671277.2	NA	
ENSG00000232757	ETF1P1	NA	
ENSG00000278104	AL669914.3	NA	
ENSG00000275856	AL669914.2	NA	
ENSG00000066379	ZNRD1	NA	
ENSG00000278773	AL669914.4	NA	
ENSG00000204619	PPP1R11	NA	
ENSG00000204618	RNF39	NA	
ENSG00000204616	TRIM31	NA	
ENSG00000231226	TRIM31-AS1	NA	
ENSG00000252228	AL669914.1	NA	
ENSG00000204614	TRIM40	NA	
ENSG00000204613	TRIM10	NA	
ENSG00000204610	TRIM15	NA	
ENSG00000234127	TRIM26	NA	
ENSG00000233892	PAIP1P1	NA	
ENSG00000270604	HCG17	NA	
ENSG00000236475	TRIM26BP	NA	
ENSG00000243753	HLA-L	NA	
ENSG00000280128	AL662795.2	NA	
ENSG00000231074	HCG18	NA	
ENSG00000204599	TRIM39	NA	
ENSG00000248167	TRIM39-RPP21	NA	
ENSG00000241370	RPP21	NA	
ENSG00000224372	HLA-N	NA	
ENSG00000224486	AL662795.1	NA	
ENSG00000236405	UBQLN1P1	NA	
ENSG00000226577	MICC	NA	
ENSG00000286301	AL662873.1	NA	
ENSG00000229068	TMPOP1	NA	
ENSG00000224936	SUCLA2P1	NA	
ENSG00000236603	RANP1	NA	
ENSG00000204592	HLA-E	NA	
ENSG00000235781	LINC02569	NA	
ENSG00000204590	GNL1	NA	
ENSG00000204576	PRR3	NA	
ENSG00000204574	ABCF1	NA	
ENSG00000216101	MIR877	NA	
ENSG00000204569	PPP1R10	NA	
ENSG00000204568	MRPS18B	NA	
ENSG00000137343	ATAT1	NA	
ENSG00000228415	PTMAP1	NA	
ENSG00000204564	C6orf136	NA	
ENSG00000204560	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000146112	PPP1R18	NA	
ENSG00000137404	NRM	NA	
ENSG00000230449	RPL7P4	NA	
ENSG00000137337	MDC1	NA	
ENSG00000224328	MDC1-AS1	NA	
ENSG00000196230	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000196230	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000272540	AL662797.1	NA	
ENSG00000137312	FLOT1	NA	
ENSG00000201988	Y_RNA	NA	
ENSG00000272273	IER3-AS1	NA	
ENSG00000137331	IER3	NA	
ENSG00000228022	HCG20	NA	
ENSG00000263608	RN7SL353P	NA	
ENSG00000214894	LINC00243	NA	
ENSG00000237923	LINC02570	NA	
ENSG00000202241	RN7SKP186	NA	
ENSG00000237775	DDR1-DT	NA	
ENSG00000204580	DDR1	NA	
ENSG00000284370	MIR4640	NA	
ENSG00000213780	GTF2H4	NA	
ENSG00000288473	AL669830.2	NA	
ENSG00000137411	VARS2	615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
ENSG00000196260	SFTA2	NA	
ENSG00000252761	AL669830.1	NA	
ENSG00000168631	MUCL3	NA	
ENSG00000233529	HCG21	NA	
ENSG00000275906	NAPGP2	NA	
ENSG00000204544	MUC21	NA	
ENSG00000261272	MUC22	NA	
ENSG00000228789	HCG22	NA	
ENSG00000222895	RNU6-1133P	NA	
ENSG00000204542	C6orf15	NA	
ENSG00000204540	PSORS1C1	NA	
ENSG00000204539	CDSN	146520	HYPOTRICHOSIS 2; HYPT2;;HYPOTRICHOSIS SIMPLEX OF THE SCALP 1; HTSS1;;HTSS;;HYPOTRICHOSIS, SPANISH TYPE
ENSG00000204539	CDSN	270300	PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN
ENSG00000204538	PSORS1C2	NA	
ENSG00000238211	POLR2LP1	NA	
ENSG00000204536	CCHCR1	NA	
ENSG00000137310	TCF19	NA	
ENSG00000204531	POU5F1	NA	
ENSG00000204528	PSORS1C3	NA	
ENSG00000272501	AL662844.4	NA	
ENSG00000206344	HCG27	NA	
ENSG00000271821	AL662844.3	NA	
ENSG00000255726	AL662844.1	NA	
ENSG00000255899	AL662844.2	NA	
ENSG00000204525	HLA-C	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
ENSG00000204525	HLA-C	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000234745	HLA-B	142830	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B;;HLA-B HISTOCOMPATIBILITY TYPE ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO, INCLUDED;;SYNOVITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;DRUG-INDUCED LIVER INJURY DUE TO FLUCLOXACILLIN, INCLUDED
ENSG00000234745	HLA-B	106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1;;ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO;;MARIE-STRUMPELL SPONDYLITIS;;BECHTEREW SYNDROME
ENSG00000234745	HLA-B	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000214892	USP8P1	NA	
ENSG00000227939	RPL3P2	NA	
ENSG00000231402	WASF5P	NA	
ENSG00000256166	LINC02571	NA	
ENSG00000229836	AL671883.1	NA	
ENSG00000277402	MIR6891	NA	
ENSG00000271581	AL671883.2	NA	
ENSG00000228432	DHFRP2	NA	
ENSG00000285647	AL671883.3	NA	
ENSG00000201658	RNU6-283P	NA	
ENSG00000230994	FGFR3P1	NA	
ENSG00000223702	ZDHHC20P2	NA	
ENSG00000225851	HLA-S	NA	
ENSG00000272221	AL645933.2	NA	
ENSG00000204520	MICA	NA	
ENSG00000288587	AL645933.3	NA	
ENSG00000199332	Y_RNA	NA	
ENSG00000230174	LINC01149	NA	
ENSG00000233902	AL645933.1	NA	
ENSG00000206337	HCP5	NA	
ENSG00000286940	MICB-DT	NA	
ENSG00000204516	MICB	NA	
ENSG00000201680	Y_RNA	NA	
ENSG00000256851	AL663061.1	NA	
ENSG00000219797	PPIAP9	NA	
ENSG00000225499	RPL15P4	NA	
ENSG00000204511	MCCD1	NA	
ENSG00000198563	DDX39B	NA	
ENSG00000254870	ATP6V1G2-DDX39B	NA	
ENSG00000201785	SNORD117	NA	
ENSG00000265236	SNORD84	NA	
ENSG00000234006	DDX39B-AS1	NA	
ENSG00000213760	ATP6V1G2	NA	
ENSG00000204498	NFKBIL1	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000226979	LTA	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
ENSG00000226979	LTA	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000226979	LTA	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4 LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
ENSG00000232810	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000232810	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000232810	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000227507	LTB	NA	
ENSG00000204482	LST1	NA	
ENSG00000204475	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000230622	UQCRHP1	NA	
ENSG00000204472	AIF1	NA	
ENSG00000204469	PRRC2A	NA	
ENSG00000200816	SNORA38	NA	
ENSG00000274494	MIR6832	NA	
ENSG00000204463	BAG6	NA	
ENSG00000204444	APOM	NA	
ENSG00000204439	C6orf47	NA	
ENSG00000227198	C6orf47-AS1	NA	
ENSG00000204438	GPANK1	NA	
ENSG00000201207	Y_RNA	NA	
ENSG00000204435	CSNK2B	618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
ENSG00000263020	AL662899.2	NA	
ENSG00000240053	LY6G5B	NA	
ENSG00000204428	LY6G5C	NA	
ENSG00000204427	ABHD16A	NA	
ENSG00000204422	AL662899.1	NA	
ENSG00000266776	MIR4646	NA	
ENSG00000204424	LY6G6F	NA	
ENSG00000250641	LY6G6F-LY6G6D	NA	
ENSG00000255552	LY6G6E	NA	
ENSG00000244355	LY6G6D	NA	
ENSG00000204420	MPIG6B	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
ENSG00000204421	LY6G6C	NA	
ENSG00000213722	DDAH2	NA	
ENSG00000213719	CLIC1	NA	
ENSG00000204410	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000255152	MSH5-SAPCD1	NA	
ENSG00000252743	RNU6-850P	NA	
ENSG00000228727	SAPCD1	NA	
ENSG00000235663	SAPCD1-AS1	NA	
ENSG00000204396	VWA7	NA	
ENSG00000204394	VARS1	617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
ENSG00000201555	Y_RNA	NA	
ENSG00000204392	LSM2	NA	
ENSG00000204390	HSPA1L	NA	
ENSG00000204389	HSPA1A	NA	
ENSG00000204388	HSPA1B	NA	
ENSG00000285565	AL671762.1	NA	
ENSG00000204387	SNHG32	NA	
ENSG00000201823	SNORD48	NA	
ENSG00000201754	SNORD52	NA	
ENSG00000204386	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000204385	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000237080	EHMT2-AS1	NA	
ENSG00000204371	EHMT2	NA	
ENSG00000166278	C2	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D;;C2 DEFICIENCY
ENSG00000166278	C2	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000204366	ZBTB12	NA	
ENSG00000244255	AL645922.1	NA	
ENSG00000281756	C2-AS1	NA	
ENSG00000243649	CFB	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4
ENSG00000243649	CFB	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000243649	CFB	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
ENSG00000204356	NELFE	NA	
ENSG00000284446	MIR1236	NA	
ENSG00000204351	SKIV2L	614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
ENSG00000204348	DXO	NA	
ENSG00000204344	STK19	NA	
ENSG00000244731	C4A	614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM;;CHIDO/RODGERS BLOOD GROUP SYSTEM
ENSG00000244731	C4A	614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD;;C4A DEFICIENCY
ENSG00000233627	C4A-AS1	NA	
ENSG00000204338	CYP21A1P	NA	
ENSG00000248290	TNXA	NA	
ENSG00000250535	STK19B	NA	
ENSG00000224389	C4B	614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD;;C4B DEFICIENCY
ENSG00000229776	C4B-AS1	NA	
ENSG00000231852	CYP21A2	201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA III;;21-@HYDROXYLASE DEFICIENCY;;CYP21 DEFICIENCY;;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1 HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED
ENSG00000168477	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000168477	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000252512	RNA5SP206	NA	
ENSG00000284829	AL662884.2	NA	
ENSG00000286974	AL662884.5	NA	
ENSG00000213676	ATF6B	NA	
ENSG00000204315	FKBPL	NA	
ENSG00000204314	PRRT1	NA	
ENSG00000285085	AL662884.4	NA	
ENSG00000284954	AL662884.3	NA	
ENSG00000221988	PPT2	NA	
ENSG00000258388	PPT2-EGFL8	NA	
ENSG00000241404	EGFL8	NA	
ENSG00000204310	AGPAT1	NA	
ENSG00000284469	MIR6721	NA	
ENSG00000204308	RNF5	NA	
ENSG00000277264	MIR6833	NA	
ENSG00000204305	AGER	NA	
ENSG00000273333	AL662884.1	NA	
ENSG00000204304	PBX2	NA	
ENSG00000213654	GPSM3	NA	
ENSG00000204301	NOTCH4	NA	
ENSG00000225914	TSBP1-AS1	NA	
ENSG00000204296	TSBP1	NA	
ENSG00000237285	HNRNPA1P2	NA	
ENSG00000223335	RNU6-603P	NA	
ENSG00000204290	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000204287	HLA-DRA	NA	
ENSG00000196301	HLA-DRB9	NA	
ENSG00000198502	HLA-DRB5	NA	
ENSG00000251916	RNU1-61P	NA	
ENSG00000229391	HLA-DRB6	NA	
ENSG00000196126	HLA-DRB1	181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1;;SARCOIDOSIS;;BOECK SARCOID
ENSG00000196126	HLA-DRB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000196735	HLA-DQA1	NA	
ENSG00000179344	HLA-DQB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000179344	HLA-DQB1	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000223534	HLA-DQB1-AS1	NA	
ENSG00000235040	MTCO3P1	NA	
ENSG00000232080	AL662789.1	NA	
ENSG00000226030	HLA-DQB3	NA	
ENSG00000237541	HLA-DQA2	NA	
ENSG00000263649	MIR3135B	NA	
ENSG00000232629	HLA-DQB2	NA	
ENSG00000241106	HLA-DOB	NA	
ENSG00000250264	AL669918.1	NA	
ENSG00000204267	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000204264	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000204261	PSMB8-AS1	NA	
ENSG00000240065	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000168394	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000234515	PPP1R2P1	NA	
ENSG00000235301	HLA-Z	NA	
ENSG00000242574	HLA-DMB	NA	
ENSG00000248993	AL645941.2	NA	
ENSG00000204257	HLA-DMA	NA	
ENSG00000204256	BRD2	NA	
ENSG00000223837	AL645941.1	NA	
ENSG00000263756	AL645941.3	NA	
ENSG00000204252	HLA-DOA	NA	
ENSG00000231389	HLA-DPA1	NA	
ENSG00000223865	HLA-DPB1	NA	
ENSG00000224796	RPL32P1	NA	
ENSG00000231461	HLA-DPA2	NA	
ENSG00000228688	COL11A2P1	NA	
ENSG00000224557	HLA-DPB2	NA	
ENSG00000237398	HLA-DPA3	NA	
ENSG00000230313	HCG24	NA	
ENSG00000204248	COL11A2	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA;;OSMED, HETEROZYGOUS;;WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;;PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;;STICKLER SYNDROME, TYPE III, /.../RLY; STL3, FORMERLY
ENSG00000204248	COL11A2	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB;;OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA;;WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY
ENSG00000204248	COL11A2	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
ENSG00000204248	COL11A2	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
ENSG00000204248	COL11A2	614524	FIBROCHONDROGENESIS 2; FBCG2
ENSG00000204231	RXRB	NA	
ENSG00000202441	RNY4P10	NA	
ENSG00000112473	SLC39A7	NA	
ENSG00000204228	HSD17B8	NA	
ENSG00000199036	MIR219A1	NA	
ENSG00000204227	RING1	NA	
ENSG00000225463	ZNF70P1	NA	
ENSG00000223457	HTATSF1P1	NA	
ENSG00000272217	AL645940.1	NA	
ENSG00000232940	HCG25	NA	
ENSG00000223501	VPS52	NA	
ENSG00000231500	RPS18	NA	
ENSG00000235863	B3GALT4	NA	
ENSG00000227057	WDR46	NA	
ENSG00000284517	MIR6873	NA	
ENSG00000204220	PFDN6	NA	
ENSG00000284064	MIR6834	NA	
ENSG00000237441	RGL2	NA	
ENSG00000231925	TAPBP	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000236104	ZBTB22	NA	
ENSG00000204209	DAXX	NA	
ENSG00000285064	SMIM40	NA	
ENSG00000286920	SMIM40	NA	
ENSG00000229596	MYL8P	NA	
ENSG00000228285	LYPLA2P1	NA	
ENSG00000225644	RPL35AP4	NA	
ENSG00000237649	KIFC1	NA	
ENSG00000204194	RPL12P1	NA	
ENSG00000112511	PHF1	NA	
ENSG00000112514	CUTA	NA	
ENSG00000197283	SYNGAP1	612621	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5
ENSG00000274259	SYNGAP1-AS1	NA	
ENSG00000284256	MIR5004	NA	
ENSG00000213588	ZBTB9	NA	
ENSG00000204188	GGNBP1	NA	
ENSG00000242014	RN7SL26P	NA	
ENSG00000276746	Metazoa_SRP	NA	
ENSG00000030110	BAK1	NA	
ENSG00000197251	LINC00336	NA	
ENSG00000096433	ITPR3	222100	DIABETES MELLITUS, TYPE I;;DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM;;JUVENILE-ONSET DIABETES; JOD DIABETES MELLITUS, INSULIN-DEPENDENT, 1, INCLUDED; IDDM1, INCLUDED;;INSULIN-DEPENDENT DIABETES MELLITUS 1, INCLUDED
ENSG00000137288	UQCC2	615824	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7
ENSG00000266509	MIR3934	NA	
ENSG00000161896	IP6K3	NA	
ENSG00000161904	LEMD2	212500	CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY; CTRCT46;;CATARACT, JUVENILE, HUTTERITE TYPE
ENSG00000096395	MLN	NA	
ENSG00000287089	AL138889.3	NA	
ENSG00000249346	LINC01016	NA	
ENSG00000271362	AL138889.2	NA	
ENSG00000233183	AL138889.1	NA	
ENSG00000276824	MIR7159	NA	
ENSG00000221697	MIR1275	NA	
ENSG00000124493	GRM4	NA	
ENSG00000271231	KRT18P9	NA	
ENSG00000214810	CYCSP55	NA	
ENSG00000137309	HMGA1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000276404	MIR6835	NA	
ENSG00000186577	SMIM29	NA	
ENSG00000225339	AL354740.1	NA	
ENSG00000220583	RPL35P2	NA	
ENSG00000272325	NUDT3	NA	
ENSG00000270800	RPS10-NUDT3	NA	
ENSG00000124614	RPS10	613308	DIAMOND-BLACKFAN ANEMIA 9; DBA9
ENSG00000124507	PACSIN1	NA	
ENSG00000124664	SPDEF	NA	
ENSG00000196114	IFITM3P3	NA	
ENSG00000196821	ILRUN	NA	
ENSG00000216636	RPL7P25	NA	
ENSG00000265123	RN7SL200P	NA	
ENSG00000220643	AL031577.1	NA	
ENSG00000272288	AL451165.2	NA	
ENSG00000186328	AL451165.1	NA	
ENSG00000217130	AL139100.1	NA	
ENSG00000124562	SNRPC	NA	
ENSG00000065060	UHRF1BP1	NA	
ENSG00000206717	Y_RNA	NA	
ENSG00000252106	RNY3P15	NA	
ENSG00000064995	TAF11	NA	
ENSG00000064999	ANKS1A	NA	
ENSG00000187762	HSPE1P11	NA	
ENSG00000286550	AL591002.1	NA	
ENSG00000273870	AL138721.1	NA	
ENSG00000124678	TCP11	NA	
ENSG00000146197	SCUBE3	NA	
ENSG00000272374	Z97832.2	NA	
ENSG00000065029	ZNF76	NA	
ENSG00000217004	Z97832.1	NA	
ENSG00000023892	DEF6	NA	
ENSG00000112033	PPARD	NA	
ENSG00000227154	AL022721.1	NA	
ENSG00000112039	FANCE	600901	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE;;FACE
ENSG00000198755	RPL10A	NA	
ENSG00000276712	MIR7111	NA	
ENSG00000007866	TEAD3	NA	
ENSG00000112041	TULP1	600132	RETINITIS PIGMENTOSA 14; RP14
ENSG00000112041	TULP1	613843	LEBER CONGENITAL AMAUROSIS 15; LCA15 RETINITIS PIGMENTOSA, JUVENILE, TULP1-RELATED, INCLUDED
ENSG00000228559	AL033519.4	NA	
ENSG00000219023	AL033519.3	NA	
ENSG00000096060	FKBP5	608516	MAJOR DEPRESSIVE DISORDER; MDD;;UNIPOLAR DEPRESSION SEASONAL AFFECTIVE DISORDER, INCLUDED; SAD, INCLUDED
ENSG00000218749	AL033519.2	NA	
ENSG00000287458	AL033519.5	NA	
ENSG00000212579	AL033519.1	NA	
ENSG00000265527	MIR5690	NA	
ENSG00000232909	AL157823.2	NA	
ENSG00000157343	ARMC12	NA	
ENSG00000220734	AL157823.1	NA	
ENSG00000196748	CLPSL2	NA	
ENSG00000204140	CLPSL1	NA	
ENSG00000137392	CLPS	NA	
ENSG00000197753	LHFPL5	610265	DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67
ENSG00000096063	SRPK1	NA	
ENSG00000112053	SLC26A8	606766	SPERMATOGENIC FAILURE 3; SPGF3
ENSG00000271304	DPRXP2	NA	
ENSG00000112062	MAPK14	NA	
ENSG00000237719	Z95152.1	NA	
ENSG00000156711	MAPK13	NA	
ENSG00000246982	Z84485.1	NA	
ENSG00000096070	BRPF3	NA	
ENSG00000180316	PNPLA1	615024	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10
ENSG00000189325	BNIP5	NA	
ENSG00000010030	ETV7	NA	
ENSG00000224666	ETV7-AS1	NA	
ENSG00000179165	PXT1	NA	
ENSG00000112078	KCTD20	NA	
ENSG00000240733	RN7SL502P	NA	
ENSG00000112079	STK38	NA	
ENSG00000239964	RN7SL748P	NA	
ENSG00000112081	SRSF3	NA	
ENSG00000263894	MIR3925	NA	
ENSG00000238554	RNU1-88P	NA	
ENSG00000251864	Y_RNA	NA	
ENSG00000281450	PANDAR	NA	
ENSG00000213500	LAP3P2	NA	
ENSG00000124762	CDKN1A	NA	
ENSG00000285244	DINOL	NA	
ENSG00000255587	RAB44	NA	
ENSG00000220349	Z85996.1	NA	
ENSG00000124772	CPNE5	NA	
ENSG00000285888	Z85996.2	NA	
ENSG00000287891	Z85996.3	NA	
ENSG00000137168	PPIL1	NA	
ENSG00000198663	C6orf89	NA	
ENSG00000232598	AL122034.1	NA	
ENSG00000164530	PI16	NA	
ENSG00000137409	MTCH1	NA	
ENSG00000146192	FGD2	NA	
ENSG00000226976	COX6A1P2	NA	
ENSG00000216412	RPL12P2	NA	
ENSG00000137193	PIM1	NA	
ENSG00000172738	TMEM217	NA	
ENSG00000286105	AL353579.1	NA	
ENSG00000065491	TBC1D22B	NA	
ENSG00000275550	AL096712.1	NA	
ENSG00000286672	AL096712.2	NA	
ENSG00000112130	RNF8	NA	
ENSG00000239953	RN7SL273P	NA	
ENSG00000137200	CMTR1	NA	
ENSG00000198937	CCDC167	NA	
ENSG00000204110	LINC02520	NA	
ENSG00000229559	AL353597.2	NA	
ENSG00000227920	AL353597.1	NA	
ENSG00000263926	MIR4462	NA	
ENSG00000279942	AL353597.3	NA	
ENSG00000112139	MDGA1	NA	
ENSG00000225945	AL121574.1	NA	
ENSG00000156639	ZFAND3	NA	
ENSG00000243313	RN7SL285P	NA	
ENSG00000200597	RNVU1-33	NA	
ENSG00000218521	AL589655.1	NA	
ENSG00000183826	BTBD9	NA	
ENSG00000200706	AL033518.1	NA	
ENSG00000226533	BTBD9-AS1	NA	
ENSG00000199938	Y_RNA	NA	
ENSG00000217227	AL079341.1	NA	
ENSG00000124767	GLO1	NA	
ENSG00000236355	AL391415.1	NA	
ENSG00000124721	DNAH8	NA	
ENSG00000244297	RN7SL465P	NA	
ENSG00000219273	AL035555.2	NA	
ENSG00000212586	AL035555.1	NA	
ENSG00000231150	DNAH8-AS1	NA	
ENSG00000220076	AL034345.1	NA	
ENSG00000220556	AL035690.1	NA	
ENSG00000112164	GLP1R	NA	
ENSG00000112167	SAYSD1	NA	
ENSG00000217165	ANKRD18EP	NA	
ENSG00000164626	KCNK5	NA	
ENSG00000124780	KCNK17	NA	
ENSG00000095981	KCNK16	NA	
ENSG00000164627	KIF6	NA	
ENSG00000218986	AL136087.1	NA	
ENSG00000231276	E2F4P1	NA	
ENSG00000252990	RNU1-54P	NA	
ENSG00000146122	DAAM2	NA	
ENSG00000281969	AL592158.1	NA	
ENSG00000235033	DAAM2-AS1	NA	
ENSG00000124615	MOCS1	252150	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA;;SULFITE OXIDASE, XANTHINE DEHYDROGENASE, AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF
ENSG00000220586	TUBBP9	NA	
ENSG00000180211	FO393411.1	NA	
ENSG00000227131	AL139275.2	NA	
ENSG00000204091	TDRG1	NA	
ENSG00000204092	LINC00951	NA	
ENSG00000226070	AL139275.1	NA	
ENSG00000156564	LRFN2	NA	
ENSG00000252767	RNU6-250P	NA	
ENSG00000236075	AL359475.1	NA	
ENSG00000226454	AL033380.1	NA	
ENSG00000237947	AL583854.1	NA	
ENSG00000124602	UNC5CL	NA	
ENSG00000124596	OARD1	NA	
ENSG00000112212	TSPO2	NA	
ENSG00000124701	APOBEC2	NA	
ENSG00000001167	NFYA	NA	
ENSG00000287678	AL031778.1	NA	
ENSG00000161912	ADCY10P1	NA	
ENSG00000161911	TREML1	NA	
ENSG00000095970	TREM2	618193	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL2
ENSG00000112195	TREML2	NA	
ENSG00000184106	TREML3P	NA	
ENSG00000188056	TREML4	NA	
ENSG00000212176	RNA5SP207	NA	
ENSG00000225690	TREML5P	NA	
ENSG00000274256	AL391903.2	NA	
ENSG00000278745	AL391903.3	NA	
ENSG00000124731	TREM1	NA	
ENSG00000218809	AL391903.1	NA	
ENSG00000206745	RNU6-643P	NA	
ENSG00000213461	AL672212.1	NA	
ENSG00000096264	NCR2	NA	
ENSG00000279284	AL136967.1	NA	
ENSG00000280371	AL136967.2	NA	
ENSG00000234753	FOXP4-AS1	NA	
ENSG00000226917	LINC01276	NA	
ENSG00000137166	FOXP4	NA	
ENSG00000266494	MIR4641	NA	
ENSG00000112559	MDFI	NA	
ENSG00000230913	NPM1P51	NA	
ENSG00000112561	TFEB	NA	
ENSG00000231102	AL035588.1	NA	
ENSG00000096088	PGC	NA	
ENSG00000269387	AL365205.4	NA	
ENSG00000137218	FRS3	NA	
ENSG00000124593	AL365205.1	NA	
ENSG00000278224	PRICKLE4	NA	
ENSG00000214736	TOMM6	NA	
ENSG00000164663	USP49	NA	
ENSG00000268745	AL365205.3	NA	
ENSG00000206977	AL365205.2	NA	
ENSG00000227516	AL160163.1	NA	
ENSG00000124641	MED20	NA	
ENSG00000207371	Y_RNA	NA	
ENSG00000112578	BYSL	NA	
ENSG00000112576	CCND3	NA	
ENSG00000206875	RNU6-761P	NA	
ENSG00000223946	AL513008.1	NA	
ENSG00000137413	TAF8	NA	
ENSG00000261068	AL512274.1	NA	
ENSG00000188112	C6orf132	NA	
ENSG00000214732	AL096814.1	NA	
ENSG00000048545	GUCA1A	602093	CONE DYSTROPHY 3; COD3;;RETINAL CONE DYSTROPHY CONE-ROD DYSTROPHY 14, INCLUDED; CORD14, INCLUDED
ENSG00000287363	AL096814.2	NA	
ENSG00000112599	GUCA1B	613827	RETINITIS PIGMENTOSA 48; RP48
ENSG00000048544	MRPS10	NA	
ENSG00000124496	TRERF1	NA	
ENSG00000237107	AL591473.1	NA	
ENSG00000024048	UBR2	NA	
ENSG00000206848	RNU6-890P	NA	
ENSG00000112619	PRPH2	169150	MACULAR DYSTROPHY, PATTERNED, 1; MDPT1;;PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM;;MACULAR DYSTROPHY, BUTTERFLY-SHAPED PIGMENTARY;;BUTTERFLY DYSTROPHY OF RETINAL PIGMENT EPITHELIUM
ENSG00000112619	PRPH2	136880	FUNDUS ALBIPUNCTATUS RETINITIS PUNCTATA ALBESCENS, INCLUDED
ENSG00000112619	PRPH2	608133	RETINITIS PIGMENTOSA 7; RP7 RETINITIS PIGMENTOSA 7, DIGENIC, INCLUDED;;LEBER CONGENITAL AMAUROSIS 18, INCLUDED; LCA18, INCLUDED
ENSG00000112619	PRPH2	608161	MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3;;VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET; AVMD;;FOVEOMACULAR DYSTROPHY, ADULT-ONSET; AOFMD;;FOVEOMACULAR DYSTROPHY, ADULT-ONSET, WITH OR WITHOUT CHOROIDAL NEOVASCULARIZATION
ENSG00000112619	PRPH2	613105	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2;;MACULAR DYSTROPHY, PROGRESSIVE
ENSG00000213435	ATP6V0CP3	NA	
ENSG00000124659	TBCC	NA	
ENSG00000112624	BICRAL	NA	
ENSG00000146223	RPL7L1	NA	
ENSG00000221821	C6orf226	NA	
ENSG00000288010	AL035587.3	NA	
ENSG00000171611	PTCRA	NA	
ENSG00000287825	AL035587.2	NA	
ENSG00000137161	CNPY3	617929	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60
ENSG00000231113	AL035587.1	NA	
ENSG00000181524	RPL24P4	NA	
ENSG00000124713	GNMT	606664	GLYCINE N-METHYLTRANSFERASE DEFICIENCY;;GNMT DEFICIENCY
ENSG00000124587	PEX6	614862	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 4, INCLUDED; CG4, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 6, INCLUDED; CG6, INCLUDED;;PEROXISOME BIOGENESIS DISORDER,  /.../MENTATION GROUP C, INCLUDED; CGC, INCLUDED
ENSG00000124587	PEX6	614863	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B
ENSG00000124587	PEX6	616617	HEIMLER SYNDROME 2; HMLR2;;PEROXISOME BIOGENESIS DISORDER 4C; PBD4C
ENSG00000112640	PPP2R5D	616355	MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35
ENSG00000124733	MEA1	NA	
ENSG00000124702	KLHDC3	NA	
ENSG00000124541	RRP36	NA	
ENSG00000272223	AL136304.1	NA	
ENSG00000240625	RN7SL403P	NA	
ENSG00000044090	CUL7	273750	THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROME YAKUT SHORT STATURE SYNDROME, INCLUDED
ENSG00000137171	KLC4	NA	
ENSG00000288564	AL355385.2	NA	
ENSG00000112651	MRPL2	NA	
ENSG00000272170	AL355385.1	NA	
ENSG00000112655	PTK7	NA	
ENSG00000112658	SRF	NA	
ENSG00000112659	CUL9	NA	
ENSG00000245261	AL133375.1	NA	
ENSG00000112667	DNPH1	NA	
ENSG00000146216	TTBK1	NA	
ENSG00000137204	SLC22A7	NA	
ENSG00000146215	CRIP3	NA	
ENSG00000171467	ZNF318	NA	
ENSG00000219222	RPL12P47	NA	
ENSG00000220614	AL583834.1	NA	
ENSG00000179157	RPS2P28	NA	
ENSG00000226558	AL590383.1	NA	
ENSG00000287055	AL359813.1	NA	
ENSG00000287266	AL359813.2	NA	
ENSG00000124574	ABCC10	NA	
ENSG00000276770	MIR6780B	NA	
ENSG00000171462	DLK2	NA	
ENSG00000207076	RNU6-1113P	NA	
ENSG00000137221	TJAP1	NA	
ENSG00000204052	LRRC73	NA	
ENSG00000171453	POLR1C	248390	TREACHER COLLINS SYNDROME 3; TCS3;;MANDIBULOFACIAL DYSOSTOSIS, TREACHER COLLINS TYPE, AUTOSOMAL RECESSIVE
ENSG00000171453	POLR1C	616494	LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11
ENSG00000137207	YIPF3	NA	
ENSG00000271754	AL355802.3	NA	
ENSG00000124571	XPO5	NA	
ENSG00000219470	AL355802.1	NA	
ENSG00000252218	AL355802.2	NA	
ENSG00000170734	POLH	278750	XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV;;XERODERMA PIGMENTOSUM WITH NORMAL DNA REPAIR RATES;;PHOTOSENSITIVITY WITH DEFECTIVE DNA SYNTHESIS
ENSG00000203362	POLH-AS1	NA	
ENSG00000172432	GTPBP2	617988	JABERI-ELAHI SYNDROME; JABELS
ENSG00000124688	MAD2L1BP	NA	
ENSG00000172426	RSPH9	612650	CILIARY DYSKINESIA, PRIMARY, 12; CILD12;;CILIARY DYSKINESIA, PRIMARY, 12, WITHOUT SITUS INVERSUS
ENSG00000096080	MRPS18A	NA	
ENSG00000218107	AL136131.1	NA	
ENSG00000236961	AL136131.2	NA	
ENSG00000112715	VEGFA	603933	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1;;PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;;NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO  MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, INCL /.../MICROVASCULAR COMPLICATIONS OF DIABETES, PROTECTION AGAINST, INCLUDED;;NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;;END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;;PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;;NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;;NEUROPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED
ENSG00000272114	AL136131.3	NA	
ENSG00000283573	AL157371.2	NA	
ENSG00000283215	LINC02537	NA	
ENSG00000223469	AL157371.1	NA	
ENSG00000237686	AL109615.3	NA	
ENSG00000181577	C6orf223	NA	
ENSG00000231881	AL109615.2	NA	
ENSG00000183239	AL109615.1	NA	
ENSG00000287562	AL109615.4	NA	
ENSG00000180992	MRPL14	NA	
ENSG00000137216	TMEM63B	NA	
ENSG00000137225	CAPN11	NA	
ENSG00000265439	RN7SL811P	NA	
ENSG00000262179	MYMX	NA	
ENSG00000112759	SLC29A1	NA	
ENSG00000096384	HSP90AB1	NA	
ENSG00000157593	SLC35B2	NA	
ENSG00000284427	MIR4647	NA	
ENSG00000146232	NFKBIE	NA	
ENSG00000178233	TMEM151B	NA	
ENSG00000272442	AL353588.1	NA	
ENSG00000146221	TCTE1	NA	
ENSG00000124608	AARS2	614096	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE
ENSG00000124608	AARS2	615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP
ENSG00000249481	SPATS1	NA	
ENSG00000096401	CDC5L	NA	
ENSG00000266619	MIR4642	NA	
ENSG00000237530	AL136140.1	NA	
ENSG00000279076	AL136140.2	NA	
ENSG00000286417	AL133334.1	NA	
ENSG00000196284	SUPT3H	NA	
ENSG00000270900	NUDT19P4	NA	
ENSG00000276156	AL138880.2	NA	
ENSG00000277769	RBM22P4	NA	
ENSG00000219384	AL138880.1	NA	
ENSG00000207769	MIR586	NA	
ENSG00000124813	RUNX2	156510	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB
ENSG00000124813	RUNX2	119600	CLEIDOCRANIAL DYSPLASIA; CCD;;CLEIDOCRANIAL DYSOSTOSIS; CLCD CLEIDOCRANIAL DYSPLASIA, FORME FRUSTE, WITH BRACHYDACTYLY, INCLUDED;;CLEIDOCRANIAL DYSPLASIA, FORME FRUSTE, DENTAL ANOMALIES ONLY, INCLUDED
ENSG00000271857	AL096865.1	NA	
ENSG00000261080	RUNX2-AS1	NA	
ENSG00000112782	CLIC5	616042	DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103
ENSG00000212468	RNU6-754P	NA	
ENSG00000231769	AL035701.1	NA	
ENSG00000001561	ENPP4	NA	
ENSG00000112796	ENPP5	NA	
ENSG00000229349	ACTG1P9	NA	
ENSG00000172348	RCAN2	NA	
ENSG00000226541	AL359633.1	NA	
ENSG00000236466	AL035670.1	NA	
ENSG00000146233	CYP39A1	NA	
ENSG00000153291	SLC25A27	NA	
ENSG00000242973	AL591242.1	NA	
ENSG00000180113	TDRD6	NA	
ENSG00000146070	PLA2G7	147050	IgE RESPONSIVENESS, ATOPIC; IGER;;IMMUNOGLOBULIN E, BASIC LEVEL OF, IN SERUM;;IgE, LEVEL OF; IGEL;;IgE RESPONSE UNDERLYING ALLERGIC ASTHMA AND RHINITIS IgE, ELEVATED LEVEL OF, INCLUDED;;ATOPY, SUSCEPTIBILITY TO, INCLUDED;;ATOPIC HYPERSENSITIVITY, INCLUDED
ENSG00000146070	PLA2G7	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000146070	PLA2G7	614278	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD
ENSG00000230062	ANKRD66	NA	
ENSG00000236164	AL161618.1	NA	
ENSG00000112818	MEP1A	NA	
ENSG00000069122	ADGRF5	NA	
ENSG00000225730	ADGRF5-AS1	NA	
ENSG00000153292	ADGRF1	NA	
ENSG00000146072	TNFRSF21	NA	
ENSG00000271328	B3GNTL1P2	NA	
ENSG00000287485	AL451166.1	NA	
ENSG00000270761	AL355353.1	NA	
ENSG00000198087	CD2AP	607832	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO
ENSG00000199762	Y_RNA	NA	
ENSG00000216813	AL358178.1	NA	
ENSG00000164393	ADGRF2	NA	
ENSG00000153294	ADGRF4	NA	
ENSG00000252711	RN7SKP116	NA	
ENSG00000226594	AL356421.2	NA	
ENSG00000216616	AL356421.1	NA	
ENSG00000124818	OPN5	NA	
ENSG00000200340	RNU1-105P	NA	
ENSG00000244694	PTCHD4	NA	
ENSG00000286811	AL353138.1	NA	
ENSG00000226068	HNRNPA3P4	NA	
ENSG00000216835	RBMXP1	NA	
ENSG00000278736	FO393412.1	NA	
ENSG00000287137	AL391538.1	NA	
ENSG00000271162	AL022099.1	NA	
ENSG00000218337	AL589994.1	NA	
ENSG00000274867	AL589994.2	NA	
ENSG00000217631	FO393413.1	NA	
ENSG00000252457	RNU7-65P	NA	
ENSG00000277043	EEF1A1P42	NA	
ENSG00000146085	MMUT	251000	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY;;METHYLMALONIC ACIDEMIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY MMA DUE TO MCM DEFICIENCY;;METHYLMALONIC ACIDURIA, mut TYPE METHYLMALONIC ACIDURIA, mut(0) TYPE, INCLUDED;;METHYLMAL /.../CIDURIA, mut(-) TYPE, INCLUDED
ENSG00000031691	CENPQ	NA	
ENSG00000203972	GLYATL3	NA	
ENSG00000197261	C6orf141	NA	
ENSG00000216998	CYP2AC1P	NA	
ENSG00000112077	RHAG	185000	OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST;;OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE
ENSG00000112077	RHAG	268150	RH-NULL, REGULATOR TYPE; RHNR;;RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE;;RH-NULL DISEASE, REGULATOR TYPE RH-MOD, INCLUDED;;RH DEFICIENCY SYNDROME, INCLUDED
ENSG00000124490	CRISP2	NA	
ENSG00000235122	AL121974.1	NA	
ENSG00000279127	AL121950.1	NA	
ENSG00000096006	CRISP3	NA	
ENSG00000170950	PGK2	NA	
ENSG00000226707	AL359458.1	NA	
ENSG00000124812	CRISP1	NA	
ENSG00000214643	DEFB133	NA	
ENSG00000177684	DEFB114	NA	
ENSG00000214642	DEFB113	NA	
ENSG00000203970	DEFB110	NA	
ENSG00000180872	DEFB112	NA	
ENSG00000226733	AL138826.1	NA	
ENSG00000286405	AL132799.1	NA	
ENSG00000233470	AL360175.1	NA	
ENSG00000230472	AL135908.1	NA	
ENSG00000008197	TFAP2D	NA	
ENSG00000008196	TFAP2B	169100	CHAR SYNDROME; CHAR;;PATENT DUCTUS ARTERIOSUS WITH FACIAL DYSMORPHISM AND ABNORMAL FIFTH DIGITS
ENSG00000008196	TFAP2B	617035	PATENT DUCTUS ARTERIOSUS 2; PDA2
ENSG00000060303	RPS17P5	NA	
ENSG00000216913	AL049693.1	NA	
ENSG00000230204	FTH1P5	NA	
ENSG00000270306	AL158050.2	NA	
ENSG00000232702	AL158050.1	NA	
ENSG00000212532	AL365219.1	NA	
ENSG00000214641	AL445529.1	NA	
ENSG00000228689	AL355997.1	NA	
ENSG00000170927	PKHD1	263200	POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4;;POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT HEPATIC DISEASE;;POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD;;POLYCYSTIC KIDNEY AND HEPATIC DISEASE 1; PKHD1;;POLYCYSTI /.../EY DISEASE, INFANTILE, TYPE I;;PKD3, FORMERLY HEPATIC FIBROSIS, CONGENITAL, INCLUDED
ENSG00000240641	RN7SL580P	NA	
ENSG00000207604	MIR206	NA	
ENSG00000225613	LINCMD1	NA	
ENSG00000199080	MIR133B	NA	
ENSG00000112115	IL17A	NA	
ENSG00000112116	IL17F	613956	CANDIDIASIS, FAMILIAL, 6; CANDF6;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT
ENSG00000218363	SLC25A20P1	NA	
ENSG00000112118	MCM3	NA	
ENSG00000170915	PAQR8	NA	
ENSG00000096093	EFHC1	254770	EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROME MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1, INCLUDED
ENSG00000096093	EFHC1	607631	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1;;JAE1
ENSG00000065308	TRAM2	NA	
ENSG00000225791	TRAM2-AS1	NA	
ENSG00000270382	AL109918.2	NA	
ENSG00000216775	AL109918.1	NA	
ENSG00000096092	TMEM14A	NA	
ENSG00000220377	GSTA8P	NA	
ENSG00000271227	SREK1IP1P2	NA	
ENSG00000237674	GSTA7P	NA	
ENSG00000244067	GSTA2	NA	
ENSG00000217228	GSTA12P	NA	
ENSG00000243955	GSTA1	NA	
ENSG00000223622	GSTA6P	NA	
ENSG00000182793	GSTA5	NA	
ENSG00000230375	GSTA11P	NA	
ENSG00000230845	GSTA10P	NA	
ENSG00000174156	GSTA3	NA	
ENSG00000243236	GSTA9P	NA	
ENSG00000288014	AL121969.1	NA	
ENSG00000170899	GSTA4	NA	
ENSG00000202198	AL162581.1	NA	
ENSG00000283293	RN7SK	NA	
ENSG00000112144	CILK1	612651	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO
ENSG00000112144	CILK1	617924	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10
ENSG00000288614	AL031178.1	NA	
ENSG00000112146	FBXO9	NA	
ENSG00000242865	RN7SL244P	NA	
ENSG00000261745	AL512347.1	NA	
ENSG00000137270	GCM1	NA	
ENSG00000253026	RNU6-464P	NA	
ENSG00000219074	SOD1P1	NA	
ENSG00000218713	AL512378.1	NA	
ENSG00000206908	RNU1-136P	NA	
ENSG00000219163	HMGB1P20	NA	
ENSG00000012660	ELOVL5	615957	SPINOCEREBELLAR ATAXIA 38; SCA38
ENSG00000264056	MIR5685	NA	
ENSG00000217527	RPS16P5	NA	
ENSG00000271367	AL034374.1	NA	
ENSG00000219863	RPL31P28	NA	
ENSG00000218049	RPL31P33	NA	
ENSG00000218261	RPA3P2	NA	
ENSG00000271338	AL591034.1	NA	
ENSG00000253010	RN7SKP256	NA	
ENSG00000271373	NANOGP3	NA	
ENSG00000001084	GCLC	230450	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
ENSG00000001084	GCLC	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000249379	AL033397.2	NA	
ENSG00000231683	AL033397.1	NA	
ENSG00000235899	LINC01564	NA	
ENSG00000124743	KLHL31	NA	
ENSG00000227885	AL590652.1	NA	
ENSG00000137269	LRRC1	NA	
ENSG00000271218	AL033384.2	NA	
ENSG00000146147	MLIP	NA	
ENSG00000236740	AL033384.1	NA	
ENSG00000235050	MLIP-AS1	NA	
ENSG00000236996	MLIP-IT1	NA	
ENSG00000218143	ERHP2	NA	
ENSG00000287745	AL359380.1	NA	
ENSG00000137251	TINAG	NA	
ENSG00000228231	AL589946.1	NA	
ENSG00000213335	CLNS1AP1	NA	
ENSG00000216347	RPL10P10	NA	
ENSG00000220773	RPSAP44	NA	
ENSG00000220635	KRASP1	NA	
ENSG00000251946	RNU6-1023P	NA	
ENSG00000224984	AL512363.1	NA	
ENSG00000168143	FAM83B	NA	
ENSG00000261116	AL049555.1	NA	
ENSG00000137252	HCRTR2	NA	
ENSG00000187871	GFRAL	NA	
ENSG00000146151	HMGCLL1	NA	
ENSG00000220725	AL590290.1	NA	
ENSG00000112175	BMP5	NA	
ENSG00000214604	NPM1P36	NA	
ENSG00000124749	COL21A1	NA	
ENSG00000219095	DHFRP6	NA	
ENSG00000227602	AL031779.1	NA	
ENSG00000220666	RCC2P7	NA	
ENSG00000151914	DST	614653	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI
ENSG00000151914	DST	615425	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2; EBSB2
ENSG00000231441	DST-AS1	NA	
ENSG00000216854	RPL17P26	NA	
ENSG00000200224	RNU6-626P	NA	
ENSG00000151917	BEND6	NA	
ENSG00000219790	OSTCP6	NA	
ENSG00000218980	FTH1P15	NA	
ENSG00000276576	MRPL30P1	NA	
ENSG00000168116	KIAA1586	NA	
ENSG00000112200	ZNF451	NA	
ENSG00000226803	ZNF451-AS1	NA	
ENSG00000112208	BAG2	NA	
ENSG00000112210	RAB23	201000	CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II
ENSG00000146143	PRIM2	NA	
ENSG00000212017	MIR548U	NA	
ENSG00000266579	FO680682.1	NA	
ENSG00000272541	AL021368.3	NA	
ENSG00000286723	AL021368.5	NA	
ENSG00000271761	AL021368.1	NA	
ENSG00000272316	AL021368.2	NA	
ENSG00000215190	LINC00680	NA	
ENSG00000239650	GUSBP4	NA	
ENSG00000283352	AL021368.4	NA	
ENSG00000218189	POM121L14P	NA	
ENSG00000225096	AL445250.1	NA	
ENSG00000214563	GAPDHP15	NA	
ENSG00000216687	AL390237.1	NA	
ENSG00000214561	RBBP4P4	NA	
ENSG00000275046	AL603755.1	NA	
ENSG00000283453	AC244258.1	NA	
ENSG00000277172	GAPDHP41	NA	
ENSG00000275773	AL590227.1	NA	
ENSG00000287598	AL512427.2	NA	
ENSG00000274844	AL512427.1	NA	
ENSG00000276290	RBBP4P3	NA	
ENSG00000220030	AL356131.1	NA	
ENSG00000255633	MTRNR2L9	NA	
ENSG00000250686	KHDRBS2-OT1	NA	
ENSG00000112232	KHDRBS2	NA	
ENSG00000287679	AL355347.1	NA	
ENSG00000216859	DHFRP5	NA	
ENSG00000217067	AL355375.1	NA	
ENSG00000262566	AL355375.2	NA	
ENSG00000217477	AL450346.1	NA	
ENSG00000198225	FKBP1C	NA	
ENSG00000219940	SPTLC1P3	NA	
ENSG00000218520	AL450346.2	NA	
ENSG00000146166	LGSN	NA	
ENSG00000218617	AL121949.3	NA	
ENSG00000218274	AL121949.2	NA	
ENSG00000218048	AL121949.1	NA	
ENSG00000225121	EEF1B2P5	NA	
ENSG00000112245	PTP4A1	NA	
ENSG00000213312	RPL7AP34	NA	
ENSG00000266680	AL135905.1	NA	
ENSG00000285976	AL135905.2	NA	
ENSG00000262651	AL513043.1	NA	
ENSG00000213309	RPL9P18	NA	
ENSG00000118482	PHF3	NA	
ENSG00000188107	EYS	602772	RETINITIS PIGMENTOSA 25; RP25
ENSG00000218813	AL354719.1	NA	
ENSG00000236345	SCAT8	NA	
ENSG00000219653	GCNT1P4	NA	
ENSG00000232120	AL357375.1	NA	
ENSG00000217811	HNRNPDP2	NA	
ENSG00000243828	AL355357.1	NA	
ENSG00000214558	AL365217.1	NA	
ENSG00000220483	SLC25A51P1	NA	
ENSG00000233859	ADH5P4	NA	
ENSG00000218890	NUFIP1P1	NA	
ENSG00000270521	AL450336.1	NA	
ENSG00000238949	RNU7-66P	NA	
ENSG00000212229	AL591004.1	NA	
ENSG00000271111	AL365503.1	NA	
ENSG00000251965	RNA5SP208	NA	
ENSG00000201015	RNU6-280P	NA	
ENSG00000206672	Y_RNA	NA	
ENSG00000227706	AL713998.1	NA	
ENSG00000286680	AL713998.3	NA	
ENSG00000287557	AL713998.4	NA	
ENSG00000270509	AL713998.2	NA	
ENSG00000285838	AL646090.2	NA	
ENSG00000223504	AL646090.1	NA	
ENSG00000286564	AL593844.1	NA	
ENSG00000226497	LINC02549	NA	
ENSG00000288088	AL606923.2	NA	
ENSG00000218834	AL606923.1	NA	
ENSG00000230910	AL391807.1	NA	
ENSG00000135298	ADGRB3	NA	
ENSG00000168216	LMBRD1	277380	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF;;METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblF TYPE;;METHYLMALONIC ACIDURIA DUE TO VITAMIN B12-RELEASE DEFECT;;VITAMIN B12 LYSOSOMAL RELEASE DEFECT;;COBALAMIN, DEFECT IN LYSOSOMAL RELEASE /.../ITAMIN B12 STORAGE DISEASE;;COBALAMIN F DISEASE; cblF
ENSG00000219085	NPM1P37	NA	
ENSG00000219881	GAPDHP42	NA	
ENSG00000082293	COL19A1	NA	
ENSG00000216365	RPL37P15	NA	
ENSG00000112280	COL9A1	614134	STICKLER SYNDROME, TYPE IV; STL4
ENSG00000112280	COL9A1	614135	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6
ENSG00000253809	AL160262.1	NA	
ENSG00000287300	AL080275.1	NA	
ENSG00000237643	AL365226.1	NA	
ENSG00000224349	FAM135A-AS1	NA	
ENSG00000082269	FAM135A	NA	
ENSG00000238386	RNU7-48P	NA	
ENSG00000154079	SDHAF4	NA	
ENSG00000271967	AL583856.2	NA	
ENSG00000232389	AL583856.1	NA	
ENSG00000218870	SLC25A6P6	NA	
ENSG00000112305	SMAP1	NA	
ENSG00000262803	AL354943.1	NA	
ENSG00000217767	NDUFAB1P1	NA	
ENSG00000112309	B3GAT2	NA	
ENSG00000287939	AL096709.1	NA	
ENSG00000219669	BECN1P2	NA	
ENSG00000221345	U3	NA	
ENSG00000218350	LYPLA1P3	NA	
ENSG00000207180	RNU6-411P	NA	
ENSG00000232295	AL589935.1	NA	
ENSG00000287380	AL589935.3	NA	
ENSG00000276127	AL589935.2	NA	
ENSG00000119900	OGFRL1	NA	
ENSG00000269966	AL136164.2	NA	
ENSG00000230597	AL136164.1	NA	
ENSG00000233237	LINC00472	NA	
ENSG00000199094	MIR30C2	NA	
ENSG00000279289	AL136164.3	NA	
ENSG00000207827	MIR30A	NA	
ENSG00000223765	LINC01626	NA	
ENSG00000285963	AL035467.2	NA	
ENSG00000219575	AL035467.1	NA	
ENSG00000218014	KRT19P1	NA	
ENSG00000202069	RNU4-66P	NA	
ENSG00000079841	RIMS1	603649	CONE-ROD DYSTROPHY 7; CORD7
ENSG00000218732	AL035633.1	NA	
ENSG00000217483	FO393414.2	NA	
ENSG00000181514	FO393414.1	NA	
ENSG00000285844	FO393414.3	NA	
ENSG00000185760	KCNQ5	617601	MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46
ENSG00000266180	MIR4282	NA	
ENSG00000232422	KNOP1P4	NA	
ENSG00000220515	PGAM1P10	NA	
ENSG00000229154	KCNQ5-AS1	NA	
ENSG00000234025	RBPMS2P1	NA	
ENSG00000243501	AL365232.1	NA	
ENSG00000251360	KHDC1P1	NA	
ENSG00000256980	KHDC1L	NA	
ENSG00000135314	KHDC1	NA	
ENSG00000229852	AC019205.1	NA	
ENSG00000239626	RPSAP41	NA	
ENSG00000234882	EIF3EP1	NA	
ENSG00000223389	SDCBP2P1	NA	
ENSG00000226840	PAICSP3	NA	
ENSG00000203909	DPPA5	NA	
ENSG00000203908	KHDC3L	614293	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2;;HYDATIDIFORM MOLE, COMPLETE
ENSG00000203907	OOEP	NA	
ENSG00000231332	OOEP-AS1	NA	
ENSG00000235174	RPL39P3	NA	
ENSG00000224221	RPS6P8	NA	
ENSG00000080007	DDX43	NA	
ENSG00000164430	CGAS	NA	
ENSG00000135297	MTO1	614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10;;CARDIOMYOPATHY, INFANTILE HYPERTROPHIC MITOCHONDRIAL, AND LACTIC ACIDOSIS
ENSG00000207023	RNU6-975P	NA	
ENSG00000271986	RN7SL827P	NA	
ENSG00000223821	AL603910.1	NA	
ENSG00000156508	EEF1A1	NA	
ENSG00000229862	AL121972.1	NA	
ENSG00000223967	AL603910.2	NA	
ENSG00000119899	SLC17A5	269920	INFANTILE SIALIC ACID STORAGE DISEASE; ISSD;;SIALURIA, INFANTILE FORM;;N-ACETYLNEURAMINIC ACID STORAGE DISEASE;;NANA STORAGE DISEASE; NSD
ENSG00000119899	SLC17A5	604369	SALLA DISEASE; SD;;SIALURIA, FINNISH TYPE
ENSG00000218459	RPS27P15	NA	
ENSG00000231652	AL590428.1	NA	
ENSG00000156535	CD109	NA	
ENSG00000279790	AL590552.1	NA	
ENSG00000217268	TXNP7	NA	
ENSG00000223786	AL357507.1	NA	
ENSG00000217178	AL357563.1	NA	
ENSG00000272243	AL356277.3	NA	
ENSG00000218483	AL356277.1	NA	
ENSG00000224583	AL356277.2	NA	
ENSG00000219736	AL356473.1	NA	
ENSG00000111799	COL12A1	616470	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2
ENSG00000111799	COL12A1	616471	BETHLEM MYOPATHY 2; BTHLM2;;EHLERS-DANLOS SYNDROME, MYOPATHIC TYPE; EDSMYP;;EDS, MYOPATHIC TYPE
ENSG00000112695	COX7A2	NA	
ENSG00000112697	TMEM30A	NA	
ENSG00000225793	TMEM30A-DT	NA	
ENSG00000118407	FILIP1	NA	
ENSG00000203489	HMGB1P39	NA	
ENSG00000237174	AL445465.1	NA	
ENSG00000238156	AL445465.2	NA	
ENSG00000221332	U3	NA	
ENSG00000263533	MIR4463	NA	
ENSG00000217680	UBE2V1P15	NA	
ENSG00000201291	RNU1-34P	NA	
ENSG00000219722	RPL26P20	NA	
ENSG00000220730	H3P27	NA	
ENSG00000252137	RNU6-1338P	NA	
ENSG00000112701	SENP6	NA	
ENSG00000217488	AL356057.1	NA	
ENSG00000252498	RNU6-1016P	NA	
ENSG00000200091	RN7SKP163	NA	
ENSG00000285401	AL109897.1	NA	
ENSG00000196586	MYO6	606346	DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22 DEAFNESS, AUTOSOMAL DOMINANT 22, WITH HYPERTROPHIC CARDIOMYOPATHY, INCLUDED
ENSG00000196586	MYO6	607821	DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37
ENSG00000252156	RNU6-155P	NA	
ENSG00000223169	RNA5SP209	NA	
ENSG00000112706	IMPG1	616151	MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4
ENSG00000200040	Y_RNA	NA	
ENSG00000222652	RNU6-248P	NA	
ENSG00000238697	RNU6-261P	NA	
ENSG00000236635	LINC02540	NA	
ENSG00000272445	RNU6-84P	NA	
ENSG00000280511	AL591030.1	NA	
ENSG00000231762	AL590426.1	NA	
ENSG00000271945	AL355612.1	NA	
ENSG00000276064	AL365222.1	NA	
ENSG00000135312	HTR1B	NA	
ENSG00000219253	RPS6P7	NA	
ENSG00000269964	MEI4	NA	
ENSG00000230309	AL121718.1	NA	
ENSG00000229495	AL450327.1	NA	
ENSG00000146243	IRAK1BP1	NA	
ENSG00000146247	PHIP	617991	CHUNG-JANSEN SYNDROME; CHUJANS;;DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHISM; DIDOD
ENSG00000217512	AL356776.1	NA	
ENSG00000286340	AL356776.2	NA	
ENSG00000118418	HMGN3	NA	
ENSG00000270362	HMGN3-AS1	NA	
ENSG00000220154	AL355796.1	NA	
ENSG00000201464	Y_RNA	NA	
ENSG00000286042	LCAL1	NA	
ENSG00000217786	AL355379.1	NA	
ENSG00000218029	AL078601.1	NA	
ENSG00000262048	AL078601.2	NA	
ENSG00000231533	AL391840.1	NA	
ENSG00000218748	DBIP1	NA	
ENSG00000135338	LCA5	604537	LEBER CONGENITAL AMAUROSIS 5; LCA5
ENSG00000287811	AL391840.3	NA	
ENSG00000261970	AL391840.2	NA	
ENSG00000272137	AL451064.1	NA	
ENSG00000279659	AL451064.2	NA	
ENSG00000198478	SH3BGRL2	NA	
ENSG00000235357	LINC01621	NA	
ENSG00000220918	AL132875.1	NA	
ENSG00000285586	AL132875.3	NA	
ENSG00000233835	AL132875.2	NA	
ENSG00000118402	ELOVL4	133190	SPINOCEREBELLAR ATAXIA 34; SCA34;;ERYTHROKERATODERMIA WITH ATAXIA
ENSG00000118402	ELOVL4	600110	STARGARDT DISEASE 3; STGD3;;MACULAR DYSTROPHY WITH FLECKS, TYPE 3;;STARGARDT-LIKE MACULAR DYSTROPHY, AUTOSOMAL DOMINANT
ENSG00000118402	ELOVL4	614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR
ENSG00000287816	AL133475.1	NA	
ENSG00000218582	GAPDHP63	NA	
ENSG00000220311	RPL35AP18	NA	
ENSG00000112742	TTK	NA	
ENSG00000288071	AL591135.2	NA	
ENSG00000218418	AL591135.1	NA	
ENSG00000217377	AK4P5	NA	
ENSG00000083123	BCKDHB	248600	MAPLE SYRUP URINE DISEASE; MSUD;;BRANCHED-CHAIN KETOACIDURIA;;BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY;;BCKD DEFICIENCY;;KETO ACID DECARBOXYLASE DEFICIENCY MAPLE SYRUP URINE DISEASE, CLASSIC, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTER /.../E, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTERMITTENT, INCLUDED;;MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IA, INCLUDED; MSUD1A, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IB, INCLUDED; MSUD1B, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE II, INCLUDED; MSUD2, INCLUDED
ENSG00000272129	AL359715.3	NA	
ENSG00000219547	RPL17P25	NA	
ENSG00000279022	AL359715.4	NA	
ENSG00000233967	AL359715.1	NA	
ENSG00000260645	AL359715.2	NA	
ENSG00000219361	RPSAP72	NA	
ENSG00000181705	AL596028.1	NA	
ENSG00000216352	AL590824.1	NA	
ENSG00000112773	TENT5A	617952	OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18
ENSG00000226089	AL122017.1	NA	
ENSG00000277797	AL359693.1	NA	
ENSG00000212336	RNA5SP210	NA	
ENSG00000232031	AL078599.2	NA	
ENSG00000206886	SNORA70	NA	
ENSG00000219702	AL078599.1	NA	
ENSG00000224995	LINC01526	NA	
ENSG00000226453	LINC02542	NA	
ENSG00000260574	AL360157.1	NA	
ENSG00000005700	IBTK	NA	
ENSG00000223044	RNU6-130P	NA	
ENSG00000220537	AL121977.1	NA	
ENSG00000286875	AL121977.2	NA	
ENSG00000146242	TPBG	NA	
ENSG00000118420	UBE3D	NA	
ENSG00000220091	LAP3P1	NA	
ENSG00000227215	AL355613.1	NA	
ENSG00000083097	DOP1A	NA	
ENSG00000013375	PGM3	615816	IMMUNODEFICIENCY 23; IMD23;;IMMUNODEFICIENCY WITH HYPER IgE AND COGNITIVE IMPAIRMENT;;IMMUNODEFICIENCY-VASCULITIS-MYOCLONUS SYNDROME; IVMS
ENSG00000013392	RWDD2A	NA	
ENSG00000065833	ME1	NA	
ENSG00000219951	AL391416.1	NA	
ENSG00000146250	PRSS35	NA	
ENSG00000065609	SNAP91	NA	
ENSG00000237874	AL136972.1	NA	
ENSG00000287705	AL139232.1	NA	
ENSG00000203877	RIPPLY2	616566	SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6
ENSG00000065615	CYB5R4	NA	
ENSG00000228679	AL034347.1	NA	
ENSG00000230852	LINC02857	NA	
ENSG00000135324	MRAP2	615457	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18;;OBESITY, SUSCEPTIBILITY TO
ENSG00000135315	CEP162	NA	
ENSG00000231776	LINC01611	NA	
ENSG00000226309	SMARCE1P2	NA	
ENSG00000112837	TBX18	143400	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2;;URETEROPELVIC JUNCTION OBSTRUCTION; UPJO;;PELVIURETERIC JUNCTION OBSTRUCTION; PUJO;;HYDRONEPHROSIS DUE TO PUJO;;MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD
ENSG00000228290	TBX18-AS1	NA	
ENSG00000219604	AL590143.1	NA	
ENSG00000287294	AL035694.1	NA	
ENSG00000216523	AL109941.1	NA	
ENSG00000220291	AL139806.1	NA	
ENSG00000216902	AL122016.1	NA	
ENSG00000217060	AL135903.1	NA	
ENSG00000213211	KRT18P64	NA	
ENSG00000234155	LINC02535	NA	
ENSG00000216439	DUTP5	NA	
ENSG00000214460	TPT1P6	NA	
ENSG00000135318	NT5E	211800	CALCIFICATION OF JOINTS AND ARTERIES; CALJA;;ARTERIAL CALCIFICATION DUE TO DEFICIENCY OF CD73; ACDC
ENSG00000280232	AL589666.2	NA	
ENSG00000135317	SNX14	616354	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20
ENSG00000271793	AL589666.1	NA	
ENSG00000135316	SYNCRIP	NA	
ENSG00000203875	SNHG5	NA	
ENSG00000220563	PKMP3	NA	
ENSG00000275072	SNORD50B	NA	
ENSG00000217334	AL355615.1	NA	
ENSG00000198738	SMIM11P1	NA	
ENSG00000222686	RNU4-72P	NA	
ENSG00000200427	Y_RNA	NA	
ENSG00000218766	AL450338.1	NA	
ENSG00000288021	AL450338.2	NA	
ENSG00000202103	RNU4-12P	NA	
ENSG00000220069	RPL7P27	NA	
ENSG00000217272	RAB1AP2	NA	
ENSG00000220831	NDUFA5P9	NA	
ENSG00000219500	AL391417.1	NA	
ENSG00000243124	RN7SL643P	NA	
ENSG00000218561	AL353133.1	NA	
ENSG00000219190	AL353133.2	NA	
ENSG00000217769	AL157777.1	NA	
ENSG00000220240	AL157777.2	NA	
ENSG00000168830	HTR1E	NA	
ENSG00000214457	RPL7P29	NA	
ENSG00000217169	MTHFD2P2	NA	
ENSG00000217776	AL138827.1	NA	
ENSG00000252697	RN7SKP209	NA	
ENSG00000135346	CGA	NA	
ENSG00000215477	RCN1P1	NA	
ENSG00000272008	AL139274.2	NA	
ENSG00000188994	ZNF292	NA	
ENSG00000218313	AL139274.1	NA	
ENSG00000164411	GJB7	NA	
ENSG00000216990	HSPD1P10	NA	
ENSG00000111850	SMIM8	NA	
ENSG00000203872	C6orf163	NA	
ENSG00000279616	AL096817.1	NA	
ENSG00000272514	CFAP206	NA	
ENSG00000213204	AL049697.1	NA	
ENSG00000216324	AL049697.2	NA	
ENSG00000218793	AL049697.3	NA	
ENSG00000218698	ST13P16	NA	
ENSG00000164414	SLC35A1	603585	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F;;CDG IIf; CDGIIf
ENSG00000206715	RNU6-444P	NA	
ENSG00000146282	RARS2	611523	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6;;ENCEPHALOPATHY, FATAL INFANTILE, WITH MITOCHONDRIAL RESPIRATORY CHAIN DEFECTS
ENSG00000135336	ORC3	NA	
ENSG00000135334	AKIRIN2	NA	
ENSG00000238628	AL133211.1	NA	
ENSG00000207131	Y_RNA	NA	
ENSG00000240997	RN7SL183P	NA	
ENSG00000271114	AL590392.1	NA	
ENSG00000286278	AL136096.1	NA	
ENSG00000118434	SPACA1	NA	
ENSG00000118432	CNR1	NA	
ENSG00000279565	AL121835.2	NA	
ENSG00000234426	AL139042.1	NA	
ENSG00000220131	AL121835.1	NA	
ENSG00000220267	ACTBP8	NA	
ENSG00000286871	AL139090.1	NA	
ENSG00000111880	RNGTT	NA	
ENSG00000222145	SNORA73	NA	
ENSG00000280277	AL079342.3	NA	
ENSG00000220130	AL079342.1	NA	
ENSG00000220960	AL079342.2	NA	
ENSG00000223001	RNU2-61P	NA	
ENSG00000271931	AL353135.1	NA	
ENSG00000146278	PNRC1	NA	
ENSG00000264017	RN7SL336P	NA	
ENSG00000154548	SRSF12	NA	
ENSG00000288009	AL353135.2	NA	
ENSG00000146281	PM20D2	NA	
ENSG00000146276	GABRR1	NA	
ENSG00000111886	GABRR2	NA	
ENSG00000220418	TUBB3P1	NA	
ENSG00000198833	UBE2J1	NA	
ENSG00000025039	RRAGD	NA	
ENSG00000218965	NACAP7	NA	
ENSG00000135299	ANKRD6	NA	
ENSG00000239316	RN7SL11P	NA	
ENSG00000237027	AL159174.1	NA	
ENSG00000083099	LYRM2	NA	
ENSG00000112159	MDN1	NA	
ENSG00000228124	AL096678.1	NA	
ENSG00000220871	DNAJC19P6	NA	
ENSG00000217653	PIMREGP3	NA	
ENSG00000118412	CASP8AP2	NA	
ENSG00000199630	AL353692.1	NA	
ENSG00000218300	RPL22P14	NA	
ENSG00000219240	AL353692.2	NA	
ENSG00000135355	GJA10	NA	
ENSG00000252891	AL353692.3	NA	
ENSG00000112182	BACH2	618394	IMMUNODEFICIENCY 60; IMD60;;IMMUNODEFICIENCY AND AUTOIMMUNITY, BACH2-RELATED; BRIDA
ENSG00000226455	AL121787.1	NA	
ENSG00000222078	RN7SKP110	NA	
ENSG00000287789	AL158136.1	NA	
ENSG00000218730	AL117342.1	NA	
ENSG00000260271	AL132996.1	NA	
ENSG00000266760	MIR4464	NA	
ENSG00000135341	MAP3K7	157800	CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF;;MITRAL REGURGITATION, CONDUCTIVE DEAFNESS, AND FUSION OF CERVICAL VERTEBRAE AND OF CARPAL AND TARSAL BONES
ENSG00000135341	MAP3K7	617137	FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2
ENSG00000224605	AL080284.1	NA	
ENSG00000263734	MIR4643	NA	
ENSG00000224944	CASC6	NA	
ENSG00000262095	MTATP6P25	NA	
ENSG00000219087	MTND4LP19	NA	
ENSG00000220340	MTCO1P56	NA	
ENSG00000240961	RN7SL415P	NA	
ENSG00000219867	AL590635.1	NA	
ENSG00000285961	AL590814.1	NA	
ENSG00000220553	RPL5P19	NA	
ENSG00000200492	U3	NA	
ENSG00000261038	AL133457.1	NA	
ENSG00000288101	AL359987.1	NA	
ENSG00000220908	LINC02531	NA	
ENSG00000221455	U3	NA	
ENSG00000219387	ATF1P1	NA	
ENSG00000235099	AL138731.1	NA	
ENSG00000213187	COPS5P1	NA	
ENSG00000135333	EPHA7	NA	
ENSG00000287683	AL591519.1	NA	
ENSG00000288085	AL356094.2	NA	
ENSG00000280451	AL356094.1	NA	
ENSG00000252249	AL391336.2	NA	
ENSG00000229600	AL391336.1	NA	
ENSG00000231143	AL157378.1	NA	
ENSG00000220370	AL078595.1	NA	
ENSG00000279403	AL078595.3	NA	
ENSG00000270484	AL078595.2	NA	
ENSG00000216853	MTCYBP36	NA	
ENSG00000219627	CYCSP17	NA	
ENSG00000261366	MANEA-DT	NA	
ENSG00000172469	MANEA	NA	
ENSG00000219549	AL607077.1	NA	
ENSG00000287578	AL034348.1	NA	
ENSG00000219941	KRT18P50	NA	
ENSG00000172461	FUT9	NA	
ENSG00000233797	UFL1-AS1	NA	
ENSG00000242560	RN7SL797P	NA	
ENSG00000014123	UFL1	NA	
ENSG00000112214	FHL5	NA	
ENSG00000213183	RPS7P8	NA	
ENSG00000207309	RNU4-70P	NA	
ENSG00000219139	TYMSP1	NA	
ENSG00000217331	AL355143.1	NA	
ENSG00000216518	EEF1GP6	NA	
ENSG00000224384	AL033379.1	NA	
ENSG00000112218	GPR63	NA	
ENSG00000123545	NDUFAF4	618237	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15
ENSG00000263479	RN7SL509P	NA	
ENSG00000186231	KLHL32	NA	
ENSG00000146263	MMS22L	NA	
ENSG00000271860	AL589740.1	NA	
ENSG00000226207	AL080316.1	NA	
ENSG00000238367	MIR2113	NA	
ENSG00000220505	EIF4EBP2P3	NA	
ENSG00000236920	AL590727.1	NA	
ENSG00000187472	AL589826.1	NA	
ENSG00000283010	AL589826.2	NA	
ENSG00000184486	POU3F2	NA	
ENSG00000112234	FBXL4	615471	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13
ENSG00000271042	AL078603.1	NA	
ENSG00000265226	MIR548AI	NA	
ENSG00000232699	BDH2P1	NA	
ENSG00000146267	FAXC	NA	
ENSG00000132423	COQ3	NA	
ENSG00000132424	PNISR	NA	
ENSG00000228506	AL513550.1	NA	
ENSG00000123552	USP45	618513	LEBER CONGENITAL AMAUROSIS 19; LCA19
ENSG00000279170	TSTD3	NA	
ENSG00000274603	Y_RNA	NA	
ENSG00000112237	CCNC	NA	
ENSG00000219755	AL137784.1	NA	
ENSG00000112238	PRDM13	NA	
ENSG00000199303	Y_RNA	NA	
ENSG00000152034	MCHR2	NA	
ENSG00000229315	MCHR2-AS1	NA	
ENSG00000219257	NPM1P38	NA	
ENSG00000275716	AL080285.2	NA	
ENSG00000213177	PRDX2P4	NA	
ENSG00000216378	AL080285.1	NA	
ENSG00000112246	SIM1	NA	
ENSG00000228082	Z86062.2	NA	
ENSG00000112249	ASCC3	NA	
ENSG00000220695	Z86062.1	NA	
ENSG00000260000	AL133338.1	NA	
ENSG00000270987	AL133338.2	NA	
ENSG00000164418	GRIK2	611092	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6
ENSG00000218475	ACTG1P18	NA	
ENSG00000287397	AP002528.1	NA	
ENSG00000218536	AP002530.1	NA	
ENSG00000287499	AL357139.2	NA	
ENSG00000219757	AL357139.1	NA	
ENSG00000217120	Z98755.1	NA	
ENSG00000202283	AL591387.1	NA	
ENSG00000288084	AL590608.1	NA	
ENSG00000216817	R3HDM2P2	NA	
ENSG00000214428	NPM1P10	NA	
ENSG00000287616	AL357522.1	NA	
ENSG00000218173	AL356967.1	NA	
ENSG00000085382	HACE1	616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS
ENSG00000252944	RNU6-897P	NA	
ENSG00000227535	AL357315.1	NA	
ENSG00000271099	AL357315.2	NA	
ENSG00000203809	LIN28B-AS1	NA	
ENSG00000187772	LIN28B	NA	
ENSG00000212147	RNU6-1106P	NA	
ENSG00000112276	BVES	616812	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2X; LGMD2X;;CARDIAC ARRHYTHMIA WITH INCREASED SERUM CREATINE KINASE; CARICK
ENSG00000203808	BVES-AS1	NA	
ENSG00000132429	POPDC3	NA	
ENSG00000085377	PREP	NA	
ENSG00000231628	AL133406.2	NA	
ENSG00000216639	AL133406.1	NA	
ENSG00000219902	RPL35P3	NA	
ENSG00000286084	AL096794.1	NA	
ENSG00000237567	LINC02836	NA	
ENSG00000219088	Z97206.1	NA	
ENSG00000284999	AL591518.1	NA	
ENSG00000200198	RN7SKP211	NA	
ENSG00000057657	PRDM1	NA	
ENSG00000057663	ATG5	617584	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25
ENSG00000269919	AL022067.1	NA	
ENSG00000273744	U4	NA	
ENSG00000244710	RN7SL47P	NA	
ENSG00000252444	RNU6-344P	NA	
ENSG00000233941	AL356859.1	NA	
ENSG00000112297	CRYBG1	NA	
ENSG00000207499	AL109920.2	NA	
ENSG00000202386	RNA5SP211	NA	
ENSG00000282408	AL109920.3	NA	
ENSG00000200314	AL109920.1	NA	
ENSG00000130347	RTN4IP1	616732	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10
ENSG00000200295	RNU6-527P	NA	
ENSG00000130348	QRSL1	NA	
ENSG00000216977	RPL21P65	NA	
ENSG00000229654	LINC02526	NA	
ENSG00000235142	LINC02532	NA	
ENSG00000202285	RNU6-117P	NA	
ENSG00000207577	MIR587	NA	
ENSG00000272398	CD24	NA	
ENSG00000130349	MTRES1	NA	
ENSG00000178409	BEND3	NA	
ENSG00000252125	RNU6-1299P	NA	
ENSG00000164494	PDSS2	614652	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3
ENSG00000276620	AL591516.1	NA	
ENSG00000220237	RPS24P12	NA	
ENSG00000112320	SOBP	613671	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS
ENSG00000234206	AL121957.1	NA	
ENSG00000280135	AL096816.1	NA	
ENSG00000146285	SCML4	NA	
ENSG00000025796	SEC63	617004	POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS; PCLD2
ENSG00000238420	RNU6-437P	NA	
ENSG00000232778	RPL23AP50	NA	
ENSG00000272476	AL024507.2	NA	
ENSG00000224987	AL024507.1	NA	
ENSG00000253090	SNORA73	NA	
ENSG00000231112	MTHFD2P3	NA	
ENSG00000225093	RPL3P7	NA	
ENSG00000271734	Z98200.1	NA	
ENSG00000081087	OSTM1	259720	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5;;OSTEOPETROSIS, INFANTILE MALIGNANT 3
ENSG00000238490	Y_RNA	NA	
ENSG00000225174	OSTM1-AS1	NA	
ENSG00000112333	NR2E1	NA	
ENSG00000279398	AL078596.1	NA	
ENSG00000112335	SNX3	NA	
ENSG00000233511	Z98742.2	NA	
ENSG00000212525	RNA5SP212	NA	
ENSG00000286562	Z98742.4	NA	
ENSG00000230248	Z98742.1	NA	
ENSG00000206974	RNU6-1144P	NA	
ENSG00000135537	AFG1L	NA	
ENSG00000238055	Z98742.3	NA	
ENSG00000279498	AL356121.2	NA	
ENSG00000238079	AL356121.1	NA	
ENSG00000227072	AL353706.1	NA	
ENSG00000200799	RNU6-770P	NA	
ENSG00000287044	AL139106.1	NA	
ENSG00000271608	AL391646.1	NA	
ENSG00000118689	FOXO3	NA	
ENSG00000228976	SUMO2P8	NA	
ENSG00000203801	LINC00222	NA	
ENSG00000219565	ZNF259P1	NA	
ENSG00000286511	Z95118.2	NA	
ENSG00000231559	Z95118.1	NA	
ENSG00000118690	ARMC2	618433	SPERMATOGENIC FAILURE 38; SPGF38
ENSG00000218872	AL445189.1	NA	
ENSG00000228834	AL445189.2	NA	
ENSG00000230290	ARMC2-AS1	NA	
ENSG00000080546	SESN1	NA	
ENSG00000271730	AL390208.1	NA	
ENSG00000199944	RNU6-653P	NA	
ENSG00000183137	CEP57L1	NA	
ENSG00000203799	CCDC162P	NA	
ENSG00000233908	AL359711.1	NA	
ENSG00000219700	PTCHD3P3	NA	
ENSG00000201023	RNY3P11	NA	
ENSG00000218632	RPL7P28	NA	
ENSG00000135535	CD164	616969	DEAFNESS, AUTOSOMAL DOMINANT 66; DFNA66
ENSG00000260273	AL359711.2	NA	
ENSG00000185250	PPIL6	NA	
ENSG00000135587	SMPD2	NA	
ENSG00000135596	MICAL1	600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1;;EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT; ADLTE;;EPILEPSY, PARTIAL, WITH AUDITORY FEATURES; ADPEAF
ENSG00000112365	ZBTB24	614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2
ENSG00000223537	AL109947.1	NA	
ENSG00000155085	AK9	NA	
ENSG00000112367	FIG4	216340	YUNIS-VARON SYNDROME; YVS;;CLEIDOCRANIAL DYSPLASIA WITH MICROGNATHIA, ABSENT THUMBS, AND DISTAL APHALANGIA
ENSG00000112367	FIG4	611228	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J;;CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4J
ENSG00000112367	FIG4	612577	AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11
ENSG00000112367	FIG4	612691	POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP
ENSG00000146360	GPR6	NA	
ENSG00000286691	AL590009.1	NA	
ENSG00000112290	WASF1	618707	NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES; NEDALVS;;ITO-RAYMOND SYNDROME
ENSG00000168438	CDC40	NA	
ENSG00000053328	METTL24	NA	
ENSG00000287268	AL050350.1	NA	
ENSG00000203797	DDO	NA	
ENSG00000004809	SLC22A16	NA	
ENSG00000241162	RN7SL617P	NA	
ENSG00000260188	AC002464.1	NA	
ENSG00000219559	AL512430.3	NA	
ENSG00000270934	AL512430.4	NA	
ENSG00000155111	CDK19	NA	
ENSG00000213150	AL512430.1	NA	
ENSG00000217041	AL512430.2	NA	
ENSG00000219150	AL603914.1	NA	
ENSG00000200522	RNU6-957P	NA	
ENSG00000212587	SNORA40C	NA	
ENSG00000199360	RNU6-1115P	NA	
ENSG00000213149	CNN2P9	NA	
ENSG00000271607	Z84480.1	NA	
ENSG00000123505	AMD1	NA	
ENSG00000219329	AL357515.1	NA	
ENSG00000155115	GTF3C6	NA	
ENSG00000197498	RPF2	NA	
ENSG00000218803	GSTM2P1	NA	
ENSG00000112394	SLC16A10	NA	
ENSG00000200926	RNU6-960P	NA	
ENSG00000231046	AL360227.1	NA	
ENSG00000173214	MFSD4B	NA	
ENSG00000271789	AL080317.1	NA	
ENSG00000009413	REV3L	NA	
ENSG00000272356	AL080317.2	NA	
ENSG00000220392	FCF1P5	NA	
ENSG00000229276	REV3L-IT1	NA	
ENSG00000218676	BRD7P4	NA	
ENSG00000231889	TRAF3IP2-AS1	NA	
ENSG00000220506	AL136310.1	NA	
ENSG00000286616	AL008730.1	NA	
ENSG00000056972	TRAF3IP2	614070	PSORIASIS 13, SUSCEPTIBILITY TO; PSORS13
ENSG00000056972	TRAF3IP2	615527	CANDIDIASIS, FAMILIAL, 8; CANDF8;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE
ENSG00000255389	Z97989.1	NA	
ENSG00000010810	FYN	NA	
ENSG00000227012	LINC02527	NA	
ENSG00000112761	CCN6	208230	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC;;PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH PROGRESSIVE ARTHROPATHY; SEDT-PA;;PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA; PPD
ENSG00000074935	TUBE1	NA	
ENSG00000203778	FAM229B	NA	
ENSG00000112769	LAMA4	615235	CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ
ENSG00000237234	Z99289.1	NA	
ENSG00000207044	RNU6-1226P	NA	
ENSG00000270661	Z99289.2	NA	
ENSG00000271208	Z99289.3	NA	
ENSG00000226440	LAMA4-AS1	NA	
ENSG00000281613	AL365214.2	NA	
ENSG00000216663	AL365214.1	NA	
ENSG00000251258	RFPL4B	NA	
ENSG00000219773	RPSAP45	NA	
ENSG00000215807	KRT18P65	NA	
ENSG00000217770	FEM1AP3	NA	
ENSG00000286914	AL365214.3	NA	
ENSG00000232299	AL357514.1	NA	
ENSG00000225580	AL358942.1	NA	
ENSG00000271498	AL360085.1	NA	
ENSG00000201386	RNU6-1163P	NA	
ENSG00000288560	AL360015.1	NA	
ENSG00000218490	FCF1P10	NA	
ENSG00000287728	AL049695.1	NA	
ENSG00000216904	SOCS5P5	NA	
ENSG00000223811	AL589684.1	NA	
ENSG00000232316	LINC02518	NA	
ENSG00000236347	AL513123.1	NA	
ENSG00000218208	RPS27AP11	NA	
ENSG00000230943	LINC02541	NA	
ENSG00000231912	FO393415.2	NA	
ENSG00000219758	FO393415.1	NA	
ENSG00000277443	MARCKS	NA	
ENSG00000227502	MROCKI	NA	
ENSG00000175967	LINC02880	NA	
ENSG00000196591	HDAC2	NA	
ENSG00000228624	HDAC2-AS2	NA	
ENSG00000216723	NUDT19P3	NA	
ENSG00000249853	HS3ST5	NA	
ENSG00000216471	RPSAP43	NA	
ENSG00000212333	RNA5SP213	NA	
ENSG00000218089	DNAJA1P4	NA	
ENSG00000232395	AL138830.2	NA	
ENSG00000226079	AL138830.1	NA	
ENSG00000287097	AL590550.1	NA	
ENSG00000251882	RNU6-475P	NA	
ENSG00000219619	AL606845.1	NA	
ENSG00000228777	LINC02534	NA	
ENSG00000111816	FRK	NA	
ENSG00000287933	AL357141.1	NA	
ENSG00000186743	TPI1P3	NA	
ENSG00000178425	NT5DC1	NA	
ENSG00000123500	COL10A1	156500	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS;;SPONDYLOMETAPHYSEAL DYSPLASIA, JAPANESE TYPE
ENSG00000218428	NIP7P3	NA	
ENSG00000236326	AL050331.2	NA	
ENSG00000187189	TSPYL4	NA	
ENSG00000111817	DSE	615539	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2
ENSG00000233558	AL050331.1	NA	
ENSG00000189241	TSPYL1	608800	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT
ENSG00000285446	Z84488.1	NA	
ENSG00000217241	CBX3P9	NA	
ENSG00000218153	KRT18P22	NA	
ENSG00000244158	CALHM6-AS1	NA	
ENSG00000188820	CALHM6	NA	
ENSG00000234117	AL445224.1	NA	
ENSG00000173626	TRAPPC3L	NA	
ENSG00000178033	CALHM5	NA	
ENSG00000164451	CALHM4	NA	
ENSG00000111832	RWDD1	NA	
ENSG00000111834	RSPH4A	612649	CILIARY DYSKINESIA, PRIMARY, 11; CILD11;;CILIARY DYSKINESIA, PRIMARY, 11, WITHOUT SITUS INVERSUS
ENSG00000153975	ZUP1	NA	
ENSG00000196911	KPNA5	NA	
ENSG00000183807	FAM162B	NA	
ENSG00000173612	GPRC6A	NA	
ENSG00000185002	RFX6	615710	MITCHELL-RILEY SYNDROME; MTCHRS;;DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA
ENSG00000217089	RPS29P13	NA	
ENSG00000200248	RNA5SP214	NA	
ENSG00000287253	Z98880.1	NA	
ENSG00000170162	VGLL2	NA	
ENSG00000047936	ROS1	NA	
ENSG00000251814	RN7SKP18	NA	
ENSG00000222713	RN7SKP51	NA	
ENSG00000282218	AL132671.2	NA	
ENSG00000219703	RAP1BP3	NA	
ENSG00000226181	AL132671.1	NA	
ENSG00000164465	DCBLD1	NA	
ENSG00000207461	RNU6-253P	NA	
ENSG00000047932	GOPC	NA	
ENSG00000218233	NEPNP	NA	
ENSG00000153989	NUS1	617082	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa; CDG1AA
ENSG00000153989	NUS1	617831	MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55
ENSG00000196376	SLC35F1	NA	
ENSG00000230202	AL450405.1	NA	
ENSG00000216809	AL589993.1	NA	
ENSG00000111860	CEP85L	NA	
ENSG00000169075	Z99496.1	NA	
ENSG00000198523	PLN	609909	CARDIOMYOPATHY, DILATED, 1P; CMD1P
ENSG00000198523	PLN	613874	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18
ENSG00000286339	Z99496.2	NA	
ENSG00000217330	SSXP10	NA	
ENSG00000225549	SELENOKP3	NA	
ENSG00000111877	MCM9	616185	OVARIAN DYSGENESIS 4; ODG4
ENSG00000111875	ASF1A	NA	
ENSG00000253194	AL137009.1	NA	
ENSG00000111879	FAM184A	NA	
ENSG00000222649	Y_RNA	NA	
ENSG00000207982	MIR548B	NA	
ENSG00000220139	AL022722.2	NA	
ENSG00000111885	MAN1A1	NA	
ENSG00000216316	AL022722.1	NA	
ENSG00000200732	RNU6-194P	NA	
ENSG00000287100	AL078600.1	NA	
ENSG00000265725	MIR3144	NA	
ENSG00000286540	AL096854.1	NA	
ENSG00000206857	RNU6-214P	NA	
ENSG00000200310	RNA5SP215	NA	
ENSG00000216710	COX6A1P3	NA	
ENSG00000287992	AL357513.1	NA	
ENSG00000146350	TBC1D32	NA	
ENSG00000206598	RNU6-1286P	NA	
ENSG00000207403	Y_RNA	NA	
ENSG00000220447	AL139098.1	NA	
ENSG00000272714	AL139098.2	NA	
ENSG00000152661	GJA1	186100	SYNDACTYLY, TYPE III;;SDTY3;;RING AND LITTLE FINGER SYNDACTYLY;;SYNDACTYLY OF FINGERS IV AND V
ENSG00000152661	GJA1	164200	OCULODENTODIGITAL DYSPLASIA; ODDD;;ODD SYNDROME;;OCULODENTOOSSEOUS DYSPLASIA; ODOD
ENSG00000152661	GJA1	104100	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1;;PPKCA, STEVANOVIC TYPE;;KERATODERMA-HYPOTRICHOSIS-LEUKONYCHIA TOTALIS SYNDROME
ENSG00000152661	GJA1	218400	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR
ENSG00000152661	GJA1	241550	HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1;;HLHS
ENSG00000152661	GJA1	257850	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE;;ODDD, AUTOSOMAL RECESSIVE;;OCULODENTOOSSEOUS DYSPLASIA, AUTOSOMAL RECESSIVE;;ODOD, AUTOSOMAL RECESSIVE
ENSG00000152661	GJA1	600309	ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3
ENSG00000152661	GJA1	617525	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3; EKVP3
ENSG00000199458	RNU4-35P	NA	
ENSG00000219784	AL138729.1	NA	
ENSG00000201379	RNU4-76P	NA	
ENSG00000222659	RNU2-8P	NA	
ENSG00000220326	AL603865.2	NA	
ENSG00000218180	SLC25A5P7	NA	
ENSG00000219135	RPL23AP48	NA	
ENSG00000217139	AL603865.1	NA	
ENSG00000220184	HMGB3P18	NA	
ENSG00000199932	RNU1-18P	NA	
ENSG00000025156	HSF2	NA	
ENSG00000279453	Z99129.4	NA	
ENSG00000111897	SERINC1	NA	
ENSG00000275339	Z99129.1	NA	
ENSG00000135549	PKIB	NA	
ENSG00000279114	Z99129.3	NA	
ENSG00000277408	Z99129.2	NA	
ENSG00000287258	AL512283.2	NA	
ENSG00000272472	AL512283.1	NA	
ENSG00000287818	AL512283.3	NA	
ENSG00000240606	RN7SL564P	NA	
ENSG00000164434	FABP7	NA	
ENSG00000172594	SMPDL3A	NA	
ENSG00000232362	ATP5MGP2	NA	
ENSG00000285652	AL591428.1	NA	
ENSG00000146352	CLVS2	NA	
ENSG00000186439	TRDN	604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1;;VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP
ENSG00000186439	TRDN	615441	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5
ENSG00000235535	TRDN-AS1	NA	
ENSG00000285691	AL445259.1	NA	
ENSG00000285941	AL133257.1	NA	
ENSG00000188580	NKAIN2	NA	
ENSG00000237321	AL354936.1	NA	
ENSG00000236548	RNF217-AS1	NA	
ENSG00000146373	RNF217	NA	
ENSG00000111907	TPD52L1	NA	
ENSG00000111906	HDDC2	NA	
ENSG00000286299	AL121938.1	NA	
ENSG00000226409	AL450332.1	NA	
ENSG00000237742	AL365259.1	NA	
ENSG00000224506	LINC02523	NA	
ENSG00000135547	HEY2	NA	
ENSG00000111912	NCOA7	NA	
ENSG00000232131	NCOA7-AS1	NA	
ENSG00000222445	RN7SKP56	NA	
ENSG00000111911	HINT3	NA	
ENSG00000251920	RNA5SP216	NA	
ENSG00000066651	TRMT11	NA	
ENSG00000213133	PPP1R14BP5	NA	
ENSG00000286215	AL356534.1	NA	
ENSG00000203760	CENPW	NA	
ENSG00000207632	MIR588	NA	
ENSG00000201613	RNU6-200P	NA	
ENSG00000275953	AL359535.1	NA	
ENSG00000217325	PRELID1P1	NA	
ENSG00000217404	RPS4XP9	NA	
ENSG00000287731	AL035603.1	NA	
ENSG00000146374	RSPO3	NA	
ENSG00000118518	RNF146	NA	
ENSG00000093144	ECHDC1	NA	
ENSG00000251768	RNA5SP217	NA	
ENSG00000213131	YWHAZP4	NA	
ENSG00000220744	RPL5P18	NA	
ENSG00000220522	AL590002.1	NA	
ENSG00000220694	AL096711.1	NA	
ENSG00000189367	KIAA0408	NA	
ENSG00000255330	AL096711.2	NA	
ENSG00000214338	SOGA3	NA	
ENSG00000184530	C6orf58	NA	
ENSG00000219284	AL592291.1	NA	
ENSG00000218187	AL356432.1	NA	
ENSG00000260212	AL356432.3	NA	
ENSG00000219699	AL356432.2	NA	
ENSG00000281248	LINC02536	NA	
ENSG00000172673	THEMIS	NA	
ENSG00000274493	MRPS17P5	NA	
ENSG00000152894	PTPRK	NA	
ENSG00000227945	PTPRK-AS1	NA	
ENSG00000224733	AL034349.1	NA	
ENSG00000213130	EEF1DP5	NA	
ENSG00000206982	Y_RNA	NA	
ENSG00000220110	AL080315.1	NA	
ENSG00000202200	Y_RNA	NA	
ENSG00000196569	LAMA2	607855	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A;;MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY, INCLUDED
ENSG00000196569	LAMA2	618138	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23
ENSG00000220884	MESTP1	NA	
ENSG00000219642	BMPR1AP1	NA	
ENSG00000252554	RNU6-861P	NA	
ENSG00000226149	AL356124.1	NA	
ENSG00000233351	AL356124.2	NA	
ENSG00000146376	ARHGAP18	NA	
ENSG00000218689	RPL5P21	NA	
ENSG00000219666	AL451046.2	NA	
ENSG00000218725	B3GALNT2P1	NA	
ENSG00000219302	AL451046.1	NA	
ENSG00000203756	TMEM244	NA	
ENSG00000198945	L3MBTL3	NA	
ENSG00000227678	AL355581.1	NA	
ENSG00000164483	SAMD3	NA	
ENSG00000164484	TMEM200A	NA	
ENSG00000202438	Y_RNA	NA	
ENSG00000229923	AL583803.1	NA	
ENSG00000256162	SMLR1	NA	
ENSG00000079819	EPB41L2	NA	
ENSG00000118507	AKAP7	NA	
ENSG00000218857	AL137222.1	NA	
ENSG00000219776	RPL21P67	NA	
ENSG00000118520	ARG1	207800	ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY
ENSG00000112282	MED23	614249	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18
ENSG00000154269	ENPP3	NA	
ENSG00000252560	RNU4-18P	NA	
ENSG00000180658	OR2A4	NA	
ENSG00000236761	CTAGE9	NA	
ENSG00000216917	AC005587.1	NA	
ENSG00000266807	MIR548H5	NA	
ENSG00000197594	ENPP1	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000197594	ENPP1	208000	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1;;GACI;;IDIOPATHIC INFANTILE ARTERIAL CALCIFICATION; IIAC;;ARTERIAL CALCIFICATION, IDIOPATHIC INFANTILE;;ARTERIOPATHY, OCCLUSIVE INFANTILE CORONARY SCLEROSIS, MEDIAL, OF INFANCY, INCLUDED
ENSG00000197594	ENPP1	601665	OBESITY LEANNESS, INCLUDED
ENSG00000197594	ENPP1	613312	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2
ENSG00000197594	ENPP1	615522	COLE DISEASE; COLED;;GUTTATE HYPOPIGMENTATION AND PUNCTATE PALMOPLANTAR KERATODERMA WITH OR WITHOUT ECTOPIC CALCIFICATION
ENSG00000219532	SELENOKP2	NA	
ENSG00000200895	RN7SKP245	NA	
ENSG00000237115	AL139805.1	NA	
ENSG00000236673	AL117378.1	NA	
ENSG00000280058	AL117378.2	NA	
ENSG00000118523	CCN2	NA	
ENSG00000227220	AL133346.1	NA	
ENSG00000236166	AL021408.1	NA	
ENSG00000265669	MIR548AJ1	NA	
ENSG00000280155	AL021408.2	NA	
ENSG00000228495	LINC01013	NA	
ENSG00000223912	EEF1A1P36	NA	
ENSG00000079931	MOXD1	NA	
ENSG00000079950	STX7	NA	
ENSG00000225343	RPL21P66	NA	
ENSG00000237110	TAAR9	NA	
ENSG00000146385	TAAR8	NA	
ENSG00000235998	TAAR7P	NA	
ENSG00000146383	TAAR6	NA	
ENSG00000135569	TAAR5	NA	
ENSG00000237449	TAAR4P	NA	
ENSG00000286663	AL513524.1	NA	
ENSG00000179073	TAAR3P	NA	
ENSG00000146378	TAAR2	NA	
ENSG00000146399	TAAR1	NA	
ENSG00000218194	HLFP1	NA	
ENSG00000112299	VNN1	603570	VANIN 1; VNN1 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8, INCLUDED; HDLCQ8, INCLUDED
ENSG00000218991	CCNG1P1	NA	
ENSG00000093134	VNN3	NA	
ENSG00000112303	VNN2	NA	
ENSG00000234484	AL032821.1	NA	
ENSG00000271488	RBM11P1	NA	
ENSG00000146409	SLC18B1	NA	
ENSG00000112306	RPS12	NA	
ENSG00000206754	SNORD101	NA	
ENSG00000221500	SNORD100	NA	
ENSG00000200534	SNORA33	NA	
ENSG00000220557	HMGB1P13	NA	
ENSG00000279960	AL137783.1	NA	
ENSG00000231023	LINC00326	NA	
ENSG00000213122	RPL23AP46	NA	
ENSG00000286438	AL591115.1	NA	
ENSG00000220113	MTCYBP4	NA	
ENSG00000112319	EYA4	601316	DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10
ENSG00000112319	EYA4	605362	CARDIOMYOPATHY, DILATED, 1J; CMD1J;;CARDIOMYOPATHY, DILATED, WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL DOMINANT
ENSG00000223542	AL024497.1	NA	
ENSG00000234567	AL024497.2	NA	
ENSG00000227954	TARID	NA	
ENSG00000238059	HSPE1P21	NA	
ENSG00000272428	AL450270.1	NA	
ENSG00000218213	FTH1P26	NA	
ENSG00000223586	LINC01312	NA	
ENSG00000118526	TCF21	NA	
ENSG00000028839	TBPL1	NA	
ENSG00000288529	AL035699.1	NA	
ENSG00000146411	SLC2A12	NA	
ENSG00000278744	AL449363.1	NA	
ENSG00000287413	AL449363.2	NA	
ENSG00000216753	HMGA1P7	NA	
ENSG00000266875	RN7SL408P	NA	
ENSG00000118515	SGK1	NA	
ENSG00000276703	RPS29P32	NA	
ENSG00000200058	RNA5SP218	NA	
ENSG00000201309	Y_RNA	NA	
ENSG00000286887	AL355881.1	NA	
ENSG00000220378	KRT8P42	NA	
ENSG00000236700	LINC01010	NA	
ENSG00000287974	Z84486.1	NA	
ENSG00000213118	CHCHD2P4	NA	
ENSG00000231971	CT69	NA	
ENSG00000232310	AL078590.2	NA	
ENSG00000218772	FAM8A6P	NA	
ENSG00000229722	AL078590.1	NA	
ENSG00000227723	AL596188.1	NA	
ENSG00000236389	AL121970.1	NA	
ENSG00000213117	AL021939.1	NA	
ENSG00000118514	ALDH8A1	NA	
ENSG00000240056	AL445190.1	NA	
ENSG00000112339	HBS1L	NA	
ENSG00000283409	MIR3662	NA	
ENSG00000232876	AL353596.1	NA	
ENSG00000118513	MYB	NA	
ENSG00000236703	MYB-AS1	NA	
ENSG00000207689	MIR548A2	NA	
ENSG00000224374	AL023693.1	NA	
ENSG00000135541	AHI1	608629	JOUBERT SYNDROME 3; JBTS3
ENSG00000234084	AL049552.1	NA	
ENSG00000287094	AL049552.2	NA	
ENSG00000201012	Y_RNA	NA	
ENSG00000231028	LINC00271	NA	
ENSG00000226540	GAPDHP73	NA	
ENSG00000233534	AL035604.1	NA	
ENSG00000217482	HMGB1P17	NA	
ENSG00000236378	AL133319.1	NA	
ENSG00000171408	PDE7B	NA	
ENSG00000286313	AL360178.1	NA	
ENSG00000288054	AL360178.2	NA	
ENSG00000237596	AL138828.1	NA	
ENSG00000213111	COX5BP2	NA	
ENSG00000277973	AL138828.2	NA	
ENSG00000146410	MTFR2	NA	
ENSG00000029363	BCLAF1	NA	
ENSG00000216519	AL023284.1	NA	
ENSG00000260418	AL023284.4	NA	
ENSG00000135525	MAP7	NA	
ENSG00000220660	AL023284.3	NA	
ENSG00000216613	AL023284.2	NA	
ENSG00000218424	NDUFS5P1	NA	
ENSG00000271765	RN7SKP299	NA	
ENSG00000272189	AL024508.1	NA	
ENSG00000197442	MAP3K5	NA	
ENSG00000234263	MAP3K5-AS1	NA	
ENSG00000212242	RNA5SP219	NA	
ENSG00000286646	AL121933.2	NA	
ENSG00000112357	PEX7	215100	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA
ENSG00000112357	PEX7	266500	REFSUM DISEASE, CLASSIC;;REFSUM DISEASE, ADULT, 1;;PHYTANIC ACID OXIDASE DEFICIENCY;;HEREDOPATHIA ATACTICA POLYNEURITIFORMIS;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IV; HMSN4;;HMSN IV
ENSG00000112357	PEX7	614879	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B;;REFSUM DISEASE, ADULT, 2;;PEROXISOME BIOGENESIS DISORDER, PEX7-RELATED, ATYPICAL PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 11, INCLUDED; CG11, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENT /.../GROUP R, INCLUDED; CGR, INCLUDED
ENSG00000201807	AL121933.1	NA	
ENSG00000213109	AL365223.1	NA	
ENSG00000182747	SLC35D3	NA	
ENSG00000207247	Y_RNA	NA	
ENSG00000230350	RPL35AP3	NA	
ENSG00000225391	NHEG1	NA	
ENSG00000235399	AL135902.1	NA	
ENSG00000016402	IL20RA	NA	
ENSG00000164485	IL22RA2	NA	
ENSG00000027697	IFNGR1	209950	IMMUNODEFICIENCY 27A; IMD27A;;IMMUNODEFICIENCY 27A, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;;IFNGR1 DEFICIENCY, AUTOSOMAL RECESSIVE
ENSG00000027697	IFNGR1	600263	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO
ENSG00000027697	IFNGR1	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
ENSG00000027697	IFNGR1	610424	HEPATITIS B VIRUS, SUSCEPTIBILITY TO;;HBV, SUSCEPTIBILITY TO  HEPATITIS B VIRUS, RESISTANCE TO, INCLUDED;;HBV, RESISTANCE TO, INCLUDED
ENSG00000027697	IFNGR1	615978	IMMUNODEFICIENCY 27B; IMD27B;;IMMUNODEFICIENCY 27B, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT;;IFNGR1 DEFICIENCY, AUTOSOMAL DOMINANT
ENSG00000177468	OLIG3	NA	
ENSG00000213108	BTF3L4P3	NA	
ENSG00000230533	AL356234.2	NA	
ENSG00000283265	AL356234.3	NA	
ENSG00000220412	AL356234.1	NA	
ENSG00000234956	LINC02539	NA	
ENSG00000207300	Y_RNA	NA	
ENSG00000237499	WAKMAR2	NA	
ENSG00000118503	TNFAIP3	616744	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE; AISBL
ENSG00000287393	AL591468.1	NA	
ENSG00000226004	LINC02528	NA	
ENSG00000229922	LINC02865	NA	
ENSG00000219463	RPSAP42	NA	
ENSG00000112378	PERP	NA	
ENSG00000112379	ARFGEF3	NA	
ENSG00000254440	PBOV1	NA	
ENSG00000262543	SMIM28	NA	
ENSG00000218499	AL031003.1	NA	
ENSG00000215878	MARCKSL1P2	NA	
ENSG00000051620	HEBP2	NA	
ENSG00000135540	NHSL1	NA	
ENSG00000266555	MIR3145	NA	
ENSG00000274594	AL391669.1	NA	
ENSG00000216802	AL590617.1	NA	
ENSG00000225177	AL590617.2	NA	
ENSG00000279968	CCDC28A-AS1	NA	
ENSG00000024862	CCDC28A	NA	
ENSG00000203734	ECT2L	NA	
ENSG00000225415	ACKR4P1	NA	
ENSG00000220600	AL121834.1	NA	
ENSG00000135597	REPS1	617916	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7
ENSG00000146386	ABRACL	NA	
ENSG00000112406	HECA	NA	
ENSG00000231329	AL031772.1	NA	
ENSG00000272446	AL158850.1	NA	
ENSG00000164440	TXLNB	NA	
ENSG00000226571	AL592429.2	NA	
ENSG00000218565	AL592429.1	NA	
ENSG00000164442	CITED2	614431	VENTRICULAR SEPTAL DEFECT 2; VSD2
ENSG00000164442	CITED2	614433	ATRIAL SEPTAL DEFECT 8; ASD8
ENSG00000238099	LINC01625	NA	
ENSG00000219806	ATP5PBP6	NA	
ENSG00000205695	AL390205.1	NA	
ENSG00000231426	FILNC1	NA	
ENSG00000225148	AL050338.1	NA	
ENSG00000287820	AL050338.2	NA	
ENSG00000236013	AL357146.1	NA	
ENSG00000252107	RNA5SP220	NA	
ENSG00000263514	MIR3668	NA	
ENSG00000285875	AL035446.2	NA	
ENSG00000264390	MIR4465	NA	
ENSG00000217684	RPS3AP24	NA	
ENSG00000234147	AL035446.1	NA	
ENSG00000216548	AL357084.1	NA	
ENSG00000275138	AL357080.1	NA	
ENSG00000286452	AL355596.2	NA	
ENSG00000259828	AL355596.1	NA	
ENSG00000222764	RN7SKP106	NA	
ENSG00000218351	RPS3AP23	NA	
ENSG00000135577	NMBR	NA	
ENSG00000270983	AL589674.1	NA	
ENSG00000236822	NMBR-AS1	NA	
ENSG00000203733	GJE1	NA	
ENSG00000009844	VTA1	NA	
ENSG00000237494	AL360007.1	NA	
ENSG00000112414	ADGRG6	616503	LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9
ENSG00000236366	AL359313.1	NA	
ENSG00000287084	AL355337.1	NA	
ENSG00000233138	AL023584.1	NA	
ENSG00000010818	HIVEP2	616977	MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43
ENSG00000237851	AL023584.2	NA	
ENSG00000232618	AL355304.1	NA	
ENSG00000229017	LINC01277	NA	
ENSG00000227192	AL023581.2	NA	
ENSG00000146416	AIG1	NA	
ENSG00000225752	AL023581.1	NA	
ENSG00000217495	AL136116.2	NA	
ENSG00000216642	AL136116.1	NA	
ENSG00000217648	AL136116.3	NA	
ENSG00000270655	AL031320.1	NA	
ENSG00000189007	ADAT2	NA	
ENSG00000218896	TUBB8P2	NA	
ENSG00000223203	RNA5SP221	NA	
ENSG00000034693	PEX3	614882	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 12, INCLUDED; CG12, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP G, INCLUDED; CGG, INCLUDED
ENSG00000034693	PEX3	617370	PEROXISOME BIOGENESIS DISORDER 10B; PBD10B
ENSG00000278206	AL031320.2	NA	
ENSG00000229036	VDAC1P8	NA	
ENSG00000001036	FUCA2	NA	
ENSG00000112419	PHACTR2	NA	
ENSG00000235740	PHACTR2-AS1	NA	
ENSG00000257065	AL049844.1	NA	
ENSG00000135521	LTV1	NA	
ENSG00000280148	AL049844.3	NA	
ENSG00000270890	AL049844.2	NA	
ENSG00000118491	ZC2HC1B	NA	
ENSG00000118495	PLAGL1	NA	
ENSG00000283122	HYMAI	NA	
ENSG00000276680	AL109755.2	NA	
ENSG00000217231	AL109755.1	NA	
ENSG00000169976	SF3B5	NA	
ENSG00000219297	MRPL42P3	NA	
ENSG00000135604	STX11	603552	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4;;HPLH4;;HLH4
ENSG00000217027	TPT1P4	NA	
ENSG00000216475	AL024474.1	NA	
ENSG00000152818	UTRN	NA	
ENSG00000225311	AL024474.2	NA	
ENSG00000219409	AL590704.1	NA	
ENSG00000217195	AL513475.1	NA	
ENSG00000220739	AL513475.2	NA	
ENSG00000285598	AL023283.1	NA	
ENSG00000112425	EPM2A	254780	MYOCLONIC EPILEPSY OF LAFORA;;MELF;;LAFORA DISEASE;;LAFORA BODY DISEASE; LBD;;EPILEPSY, PROGRESSIVE MYOCLONIC, 2A; EPM2A;;EPM2  EPILEPSY, PROGRESSIVE MYOCLONIC, 2B, INCLUDED; EPM2B, INCLUDED
ENSG00000201119	RNU1-33P	NA	
ENSG00000217612	AL031119.1	NA	
ENSG00000270638	AL023806.1	NA	
ENSG00000270828	AL023806.2	NA	
ENSG00000288551	AL023806.5	NA	
ENSG00000288056	AL023806.4	NA	
ENSG00000280184	AL023806.3	NA	
ENSG00000118496	FBXO30	NA	
ENSG00000235652	FBXO30-DT	NA	
ENSG00000146414	SHPRH	NA	
ENSG00000152822	GRM1	614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13
ENSG00000152822	GRM1	617691	SPINOCEREBELLAR ATAXIA 44; SCA44
ENSG00000187103	FUNDC2P3	NA	
ENSG00000222971	RNA5SP222	NA	
ENSG00000216811	AL035698.1	NA	
ENSG00000118508	RAB32	NA	
ENSG00000237468	AL359547.1	NA	
ENSG00000118492	ADGB	NA	
ENSG00000273719	AL359547.2	NA	
ENSG00000207431	RNU6-906P	NA	
ENSG00000228283	KATNBL1P6	NA	
ENSG00000233452	STXBP5-AS1	NA	
ENSG00000227748	AL138916.1	NA	
ENSG00000272397	AL138916.2	NA	
ENSG00000196634	LUADT1	NA	
ENSG00000164506	STXBP5	NA	
ENSG00000273997	AL355365.1	NA	
ENSG00000220494	YAP1P1	NA	
ENSG00000203727	SAMD5	NA	
ENSG00000227681	AL033504.1	NA	
ENSG00000226249	AL365271.1	NA	
ENSG00000287976	AL445123.2	NA	
ENSG00000234675	AL445123.1	NA	
ENSG00000230205	AL359382.1	NA	
ENSG00000287473	AL359382.2	NA	
ENSG00000224658	AL513164.1	NA	
ENSG00000111961	SASH1	127500	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1
ENSG00000111961	SASH1	618373	CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK
ENSG00000207345	RNU6-1222P	NA	
ENSG00000215223	CYP51A1P3	NA	
ENSG00000217824	SNRPEP6	NA	
ENSG00000231368	RPSAP40	NA	
ENSG00000111962	UST	NA	
ENSG00000227660	UST-AS1	NA	
ENSG00000236591	AL357992.1	NA	
ENSG00000219487	AL603766.1	NA	
ENSG00000228408	AL031056.1	NA	
ENSG00000055208	TAB2	614980	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2
ENSG00000225924	TAB2-AS1	NA	
ENSG00000283608	AL031056.2	NA	
ENSG00000241391	RN7SL234P	NA	
ENSG00000216265	FABP12P1	NA	
ENSG00000177688	SUMO4	600320	DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5;;INSULIN-DEPENDENT DIABETES MELLITUS 5
ENSG00000178199	ZC3H12D	NA	
ENSG00000219553	AL031133.1	NA	
ENSG00000131013	PPIL4	NA	
ENSG00000252244	RNU7-3P	NA	
ENSG00000235168	AL078581.3	NA	
ENSG00000055211	GINM1	NA	
ENSG00000281021	AL078581.4	NA	
ENSG00000233330	AL078581.2	NA	
ENSG00000220848	RPS18P9	NA	
ENSG00000202343	AL078581.1	NA	
ENSG00000186625	KATNA1	NA	
ENSG00000207292	Y_RNA	NA	
ENSG00000131023	LATS1	NA	
ENSG00000278899	AL358852.1	NA	
ENSG00000120253	NUP43	NA	
ENSG00000120265	PCMT1	NA	
ENSG00000219433	BTBD10P2	NA	
ENSG00000231760	AL355312.2	NA	
ENSG00000285889	AL355312.4	NA	
ENSG00000164520	RAET1E	NA	
ENSG00000285991	AL355312.5	NA	
ENSG00000120256	LRP11	NA	
ENSG00000273132	AL355312.3	NA	
ENSG00000268592	RAET1E-AS1	NA	
ENSG00000217733	CCT7P1	NA	
ENSG00000223701	RAET1E-AS1	NA	
ENSG00000216906	AL355312.1	NA	
ENSG00000203722	RAET1G	NA	
ENSG00000216621	AL583835.2	NA	
ENSG00000131015	ULBP2	NA	
ENSG00000215094	AL583835.1	NA	
ENSG00000111981	ULBP1	NA	
ENSG00000219298	AL355497.1	NA	
ENSG00000231120	BTF3P10	NA	
ENSG00000218358	RAET1K	NA	
ENSG00000155918	RAET1L	NA	
ENSG00000216444	RAET1M	NA	
ENSG00000235972	AL355497.2	NA	
ENSG00000213091	PHBP1	NA	
ENSG00000131019	ULBP3	NA	
ENSG00000198729	PPP1R14C	NA	
ENSG00000238594	AL355497.3	NA	
ENSG00000201628	RNU4-7P	NA	
ENSG00000009765	IYD	274800	THYROID DYSHORMONOGENESIS 4; TDH4;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 4;;IODOTYROSINE DEHALOGENASE DEFICIENCY;;DEIODINASE DEFICIENCY
ENSG00000220598	SSR1P1	NA	
ENSG00000219622	AL451061.1	NA	
ENSG00000120278	PLEKHG1	NA	
ENSG00000232891	AL450344.3	NA	
ENSG00000224029	AL450344.1	NA	
ENSG00000226599	AL450344.2	NA	
ENSG00000213089	PDCL3P5	NA	
ENSG00000120254	MTHFD1L	NA	
ENSG00000218996	ARL4AP5	NA	
ENSG00000202119	RNU6-302P	NA	
ENSG00000232290	AL133260.2	NA	
ENSG00000223598	AL138733.1	NA	
ENSG00000219747	AL133260.1	NA	
ENSG00000231883	AL138733.2	NA	
ENSG00000238616	RNU6-300P	NA	
ENSG00000213087	AL356535.1	NA	
ENSG00000131016	AKAP12	NA	
ENSG00000252431	RNU6-1247P	NA	
ENSG00000252487	RNY4P20	NA	
ENSG00000223039	RN7SKP268	NA	
ENSG00000181472	ZBTB2	NA	
ENSG00000252615	Y_RNA	NA	
ENSG00000155906	RMND1	614922	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11;;ENCEPHALONEUROMYOPATHY, INFANTILE, DUE TO MITOCHONDRIAL TRANSLATION DEFECT
ENSG00000219395	HSPA8P15	NA	
ENSG00000146476	ARMT1	NA	
ENSG00000120262	CCDC170	NA	
ENSG00000207422	RNU6-813P	NA	
ENSG00000091831	ESR1	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000091831	ESR1	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000091831	ESR1	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000091831	ESR1	615363	ESTROGEN RESISTANCE; ESTRR;;ESTROGEN INSENSITIVITY
ENSG00000233823	AL356311.1	NA	
ENSG00000287914	AL078582.2	NA	
ENSG00000284615	AL078582.1	NA	
ENSG00000131018	SYNE1	610743	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8;;ATAXIA, RECESSIVE, OF BEAUCE;;CEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, TYPE 1; ARCA1
ENSG00000131018	SYNE1	612998	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES
ENSG00000131018	SYNE1	618484	ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM
ENSG00000234577	SYNE1-AS1	NA	
ENSG00000226193	AL049548.1	NA	
ENSG00000202044	RNA5SP223	NA	
ENSG00000233464	NANOGP11	NA	
ENSG00000120279	MYCT1	NA	
ENSG00000218792	HSPD1P16	NA	
ENSG00000146469	VIP	NA	
ENSG00000224893	LINC02840	NA	
ENSG00000217372	TUBB4BP7	NA	
ENSG00000220745	AL080276.1	NA	
ENSG00000112029	FBXO5	NA	
ENSG00000227627	AL080276.2	NA	
ENSG00000112031	MTRF1L	NA	
ENSG00000091844	RGS17	NA	
ENSG00000201939	RNA5SP224	NA	
ENSG00000213121	AL590867.1	NA	
ENSG00000218426	AL590867.2	NA	
ENSG00000237312	AL358134.1	NA	
ENSG00000222806	RNA5SP225	NA	
ENSG00000217160	MTCO2P31	NA	
ENSG00000242246	AL603908.1	NA	
ENSG00000218776	MTATP6P31	NA	
ENSG00000217044	MTCO3P31	NA	
ENSG00000220733	MTND3P20	NA	
ENSG00000220514	MTND4LP20	NA	
ENSG00000216713	MTND4P13	NA	
ENSG00000199246	RNU6-896P	NA	
ENSG00000217085	HMGB3P19	NA	
ENSG00000112038	OPRM1	NA	
ENSG00000074706	IPCEF1	NA	
ENSG00000288520	AL357075.4	NA	
ENSG00000237593	AL445220.1	NA	
ENSG00000153721	CNKSR3	NA	
ENSG00000286553	AL357075.2	NA	
ENSG00000287260	AL357075.3	NA	
ENSG00000275419	AL357075.1	NA	
ENSG00000220181	MTRES1P1	NA	
ENSG00000219146	RPS4XP8	NA	
ENSG00000231316	AL591419.1	NA	
ENSG00000205625	AL591499.1	NA	
ENSG00000213079	SCAF8	NA	
ENSG00000200594	RNU6-824P	NA	
ENSG00000146426	TIAM2	NA	
ENSG00000218757	AL121952.1	NA	
ENSG00000264814	MIR1273C	NA	
ENSG00000238963	AL121952.2	NA	
ENSG00000274451	AL136228.1	NA	
ENSG00000235381	AL596202.1	NA	
ENSG00000029639	TFB1M	NA	
ENSG00000171217	CLDN20	NA	
ENSG00000232529	AL031773.1	NA	
ENSG00000074771	NOX3	NA	
ENSG00000238789	RNU7-152P	NA	
ENSG00000287092	AL589693.1	NA	
ENSG00000221456	MIR1202	NA	
ENSG00000285797	AL512658.2	NA	
ENSG00000212295	SNORD28B	NA	
ENSG00000227360	AL512658.1	NA	
ENSG00000220347	H3P28	NA	
ENSG00000271265	AL355297.2	NA	
ENSG00000049618	ARID1B	135900	COFFIN-SIRIS SYNDROME 1; CSS1;;COFFIN-SIRIS SYNDROME; CSS;;FIFTH DIGIT SYNDROME;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 12; MRD12;;HYPERTRICHOSIS, HYPERKERATOSIS, MENTAL RETARDATION, AND DISTINCTIVE FACIAL FEATURES; HHID
ENSG00000271551	AL355297.3	NA	
ENSG00000271899	MIR4466	NA	
ENSG00000270487	AL355297.1	NA	
ENSG00000218596	AL162578.1	NA	
ENSG00000233044	AL049820.1	NA	
ENSG00000215712	TMEM242	NA	
ENSG00000217783	LDHAL6FP	NA	
ENSG00000271040	AL390955.2	NA	
ENSG00000213078	AL390955.1	NA	
ENSG00000218631	AL117344.1	NA	
ENSG00000286482	AL117344.2	NA	
ENSG00000175048	ZDHHC14	NA	
ENSG00000266617	MIR3692	NA	
ENSG00000130340	SNX9	NA	
ENSG00000234361	AL391863.2	NA	
ENSG00000229502	AL391863.1	NA	
ENSG00000236324	AL035634.1	NA	
ENSG00000220867	HSPE1P26	NA	
ENSG00000252658	RNU6-786P	NA	
ENSG00000078269	SYNJ2	NA	
ENSG00000285642	AL139330.1	NA	
ENSG00000233496	SYNJ2-IT1	NA	
ENSG00000122335	SERAC1	614739	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL;;3-@METHYLGLUTACONIC ACIDURIA WITH DYSTONIA-DEAFNESS, HEPATOPATHY, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDHEL;;3-@METHYLGLUTACONIC ACIDURIA, TYPE VI; MGCA6
ENSG00000272047	GTF2H5	616395	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA
ENSG00000130338	TULP4	NA	
ENSG00000188451	SRP72P2	NA	
ENSG00000274023	AL360169.2	NA	
ENSG00000287591	AL360169.3	NA	
ENSG00000238019	AL360169.1	NA	
ENSG00000243373	RN7SL173P	NA	
ENSG00000219188	CACYBPP3	NA	
ENSG00000146433	TMEM181	NA	
ENSG00000218226	TATDN2P2	NA	
ENSG00000278571	MIR7161	NA	
ENSG00000146425	DYNLT1	NA	
ENSG00000164674	SYTL3	NA	
ENSG00000219249	AMZ2P2	NA	
ENSG00000265558	MIR3918	NA	
ENSG00000092820	EZR	NA	
ENSG00000233893	EZR-AS1	NA	
ENSG00000243775	OSTCP1	NA	
ENSG00000285159	AL627422.2	NA	
ENSG00000203711	C6orf99	NA	
ENSG00000213076	AL627422.1	NA	
ENSG00000223191	RNU6-293P	NA	
ENSG00000130363	RSPH3	616481	CILIARY DYSKINESIA, PRIMARY, 32; CILD32;;CILIARY DYSKINESIA, PRIMARY, 32, WITHOUT SITUS INVERSUS
ENSG00000271913	AL035530.2	NA	
ENSG00000164691	TAGAP	NA	
ENSG00000226032	AL035530.1	NA	
ENSG00000285492	AL356417.3	NA	
ENSG00000224478	AL356417.1	NA	
ENSG00000233682	AL356417.2	NA	
ENSG00000164694	FNDC1	NA	
ENSG00000235086	FNDC1-IT1	NA	
ENSG00000231178	AL357832.1	NA	
ENSG00000234777	LINC02529	NA	
ENSG00000286533	AL078604.4	NA	
ENSG00000216480	AL078604.1	NA	
ENSG00000276413	AL078604.3	NA	
ENSG00000237927	AL078604.2	NA	
ENSG00000112096	SOD2	612634	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6;;NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO
ENSG00000220305	HNRNPH1P1	NA	
ENSG00000251988	RNU4ATAC18P	NA	
ENSG00000146457	WTAP	NA	
ENSG00000285427	SOD2-OT1	NA	
ENSG00000120437	ACAT2	614055	ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY; ACAT2D;;ACAT2 DEFICIENCY
ENSG00000120438	TCP1	NA	
ENSG00000207392	SNORA20	NA	
ENSG00000206910	SNORA29	NA	
ENSG00000112110	MRPL18	NA	
ENSG00000146453	PNLDC1	NA	
ENSG00000236823	AL035691.1	NA	
ENSG00000130368	MAS1	NA	
ENSG00000197081	IGF2R	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000268257	AIRN	NA	
ENSG00000213073	AL353625.1	NA	
ENSG00000175003	SLC22A1	NA	
ENSG00000216516	AL645733.1	NA	
ENSG00000112499	SLC22A2	NA	
ENSG00000230234	AL162582.1	NA	
ENSG00000146477	SLC22A3	NA	
ENSG00000287656	AL591069.1	NA	
ENSG00000213071	LPAL2	NA	
ENSG00000198670	LPA	618807	LIPOPROTEIN(a) QUANTITATIVE TRAIT LOCUS LIPOPROTEIN(a) DEFICIENCY, CONGENITAL, INCLUDED;;LIPOPROTEIN(a), ELEVATION OF, INCLUDED
ENSG00000243831	AL109933.2	NA	
ENSG00000224477	AL109933.1	NA	
ENSG00000122194	PLG	217090	PLASMINOGEN DEFICIENCY, TYPE I LIGNEOUS CONJUNCTIVITIS, INCLUDED;;DYSPLASMINOGENEMIA, INCLUDED;;PLASMINOGEN DEFICIENCY, TYPE II, INCLUDED
ENSG00000287558	AL109933.5	NA	
ENSG00000276960	AL109933.4	NA	
ENSG00000274903	AL109933.3	NA	
ENSG00000224371	AL391361.2	NA	
ENSG00000220913	AL391361.1	NA	
ENSG00000233342	AL139393.2	NA	
ENSG00000231863	AL139393.1	NA	
ENSG00000272841	AL139393.3	NA	
ENSG00000085511	MAP3K4	NA	
ENSG00000026652	AGPAT4	NA	
ENSG00000185345	PRKN	167000	OVARIAN CANCER OVARIAN CANCER, EPITHELIAL, INCLUDED
ENSG00000185345	PRKN	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000185345	PRKN	600116	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF
ENSG00000286498	AL132982.1	NA	
ENSG00000286805	AL138716.1	NA	
ENSG00000227913	KRT8P44	NA	
ENSG00000112530	PACRG	NA	
ENSG00000217557	AL590286.1	NA	
ENSG00000285610	AL590286.2	NA	
ENSG00000225437	PACRG-AS2	NA	
ENSG00000285553	AL137182.1	NA	
ENSG00000225683	PACRG-AS3	NA	
ENSG00000281692	PACRG-AS1	NA	
ENSG00000285564	AL031121.2	NA	
ENSG00000285726	AL031121.3	NA	
ENSG00000217514	AL031121.1	NA	
ENSG00000270419	CAHM	NA	
ENSG00000112531	QKI	NA	
ENSG00000228692	AL445307.1	NA	
ENSG00000235538	AL078602.1	NA	
ENSG00000285858	AL137005.1	NA	
ENSG00000266128	RN7SL366P	NA	
ENSG00000286573	AL136225.1	NA	
ENSG00000260422	Z97205.2	NA	
ENSG00000230627	Z97205.1	NA	
ENSG00000288584	Z97205.3	NA	
ENSG00000226739	AL358972.1	NA	
ENSG00000287550	AL450345.2	NA	
ENSG00000227455	AL450345.1	NA	
ENSG00000287877	AL133538.1	NA	
ENSG00000217878	AL136100.1	NA	
ENSG00000112539	C6orf118	NA	
ENSG00000112541	PDE10A	616921	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD
ENSG00000112541	PDE10A	616922	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2; ADSD2
ENSG00000199523	RNA5SP226	NA	
ENSG00000206681	RNU6-730P	NA	
ENSG00000236627	AL590302.2	NA	
ENSG00000223942	AL590302.1	NA	
ENSG00000281832	LINC00602	NA	
ENSG00000216624	GAPDHP72	NA	
ENSG00000287824	AL627443.3	NA	
ENSG00000231297	AL627443.1	NA	
ENSG00000276643	AL627443.2	NA	
ENSG00000164458	TBXT	182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD SPINA BIFIDA, INCLUDED
ENSG00000164458	TBXT	615709	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA
ENSG00000288638	AL627443.4	NA	
ENSG00000201292	RNU6-153P	NA	
ENSG00000280991	AL121956.5	NA	
ENSG00000233365	AL121956.1	NA	
ENSG00000213536	GNG5P1	NA	
ENSG00000280850	AL121956.4	NA	
ENSG00000176381	PRR18	NA	
ENSG00000287189	AL121956.6	NA	
ENSG00000198818	SFT2D1	NA	
ENSG00000233231	HNRNPA1P49	NA	
ENSG00000286760	AL022069.3	NA	
ENSG00000060762	MPC1	614741	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD
ENSG00000261420	AL022069.1	NA	
ENSG00000280057	AL022069.2	NA	
ENSG00000071242	RPS6KA2	NA	
ENSG00000232082	RPS6KA2-IT1	NA	
ENSG00000222958	MIR1913	NA	
ENSG00000235272	RAMACL	NA	
ENSG00000287690	AL023775.2	NA	
ENSG00000235008	AL023775.1	NA	
ENSG00000249141	AL159163.1	NA	
ENSG00000231654	RPS6KA2-AS1	NA	
ENSG00000026297	RNASET2	612951	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY
ENSG00000227598	Z94721.1	NA	
ENSG00000285730	Z94721.3	NA	
ENSG00000265828	MIR3939	NA	
ENSG00000213066	CEP43	NA	
ENSG00000272980	Z94721.2	NA	
ENSG00000112486	CCR6	NA	
ENSG00000284825	AL121935.1	NA	
ENSG00000284914	AL121935.2	NA	
ENSG00000166984	TCP10L2	NA	
ENSG00000120436	GPR31	NA	
ENSG00000286674	AL121935.3	NA	
ENSG00000216966	AL353747.1	NA	
ENSG00000280707	HPAT5	NA	
ENSG00000231720	AL353747.3	NA	
ENSG00000228648	AL353747.2	NA	
ENSG00000112494	UNC93A	NA	
ENSG00000120440	TTLL2	NA	
ENSG00000217447	AL021331.1	NA	
ENSG00000203690	TCP10L3	NA	
ENSG00000287297	AL356123.1	NA	
ENSG00000272549	LINC02538	NA	
ENSG00000287594	AL356123.2	NA	
ENSG00000203688	LINC02487	NA	
ENSG00000213065	AL009178.1	NA	
ENSG00000146521	LINC01558	NA	
ENSG00000269155	AL009178.2	NA	
ENSG00000285212	AL009178.3	NA	
ENSG00000198221	AFDN-DT	NA	
ENSG00000130396	AFDN	NA	
ENSG00000235994	HGC6.3	NA	
ENSG00000125337	KIF25	NA	
ENSG00000229921	KIF25-AS1	NA	
ENSG00000153303	FRMD1	NA	
ENSG00000234768	AL611929.1	NA	
ENSG00000287056	AL606970.5	NA	
ENSG00000237987	AL606970.4	NA	
ENSG00000228361	AL606970.2	NA	
ENSG00000234647	AL606970.3	NA	
ENSG00000230711	CTAGE13P	NA	
ENSG00000164488	DACT2	NA	
ENSG00000224417	AL606970.1	NA	
ENSG00000260771	AL138918.1	NA	
ENSG00000112562	SMOC2	125400	DENTIN DYSPLASIA, TYPE I; DTDP1;;DENTIN DYSPLASIA, SHIELDS TYPE I;;ROOTLESS TEETH;;RADICULAR DENTIN DYSPLASIA  DENTIN DYSPLASIA, TYPE I, WITH EXTREME MICRODONTIA AND MISSHAPEN TEETH, INCLUDED
ENSG00000235815	AL136099.1	NA	
ENSG00000280665	AL513210.2	NA	
ENSG00000225879	AL513210.1	NA	
ENSG00000285917	AL109924.4	NA	
ENSG00000279810	AL109924.3	NA	
ENSG00000229720	AL109924.1	NA	
ENSG00000234519	AL109924.2	NA	
ENSG00000286826	AL136129.1	NA	
ENSG00000223485	LINC01615	NA	
ENSG00000261039	LINC02544	NA	
ENSG00000226445	BX322234.1	NA	
ENSG00000186340	THBS2	603932	INTERVERTEBRAL DISC DISEASE; IDD LUMBAR DISC DISEASE, INCLUDED; LDD, INCLUDED;;LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO, INCLUDED;;LUMBAR DISC DEGENERATION, SUSCEPTIBILITY TO, INCLUDED
ENSG00000233085	BX322234.2	NA	
ENSG00000224999	VTA1P1	NA	
ENSG00000226194	LINC02519	NA	
ENSG00000285887	AL009176.1	NA	
ENSG00000285733	AL031315.1	NA	
ENSG00000272848	AL135910.1	NA	
ENSG00000184465	WDR27	NA	
ENSG00000185127	C6orf120	NA	
ENSG00000130024	PHF10	NA	
ENSG00000232640	AL354892.2	NA	
ENSG00000227704	AL354892.1	NA	
ENSG00000184786	TCTE3	NA	
ENSG00000130023	ERMARD	615544	PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6
ENSG00000266896	AL354892.3	NA	
ENSG00000229214	LINC00242	NA	
ENSG00000231690	LINC00574	NA	
ENSG00000236173	AL049612.1	NA	
ENSG00000287823	AL603783.1	NA	
ENSG00000288162	AL596442.4	NA	
ENSG00000287407	AL596442.3	NA	
ENSG00000232197	AL596442.1	NA	
ENSG00000273100	AL596442.2	NA	
ENSG00000218716	RPL12P23	NA	
ENSG00000230960	AL109910.1	NA	
ENSG00000271820	AL109910.2	NA	
ENSG00000227508	LINC01624	NA	
ENSG00000198719	DLL1	618709	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS
ENSG00000112584	FAM120B	NA	
ENSG00000271234	AL078605.1	NA	
ENSG00000266245	MIR4644	NA	
ENSG00000261003	AL008628.1	NA	
ENSG00000008018	PSMB1	NA	
ENSG00000112592	TBP	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000112592	TBP	607136	SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4
ENSG00000071994	PDCD2	NA	
ENSG00000287411	AL031259.1	NA	
ENSG00000230423	AL672310.1	NA	
ENSG00000217874	OR4F7P	NA	
ENSG00000273640	WBP1LP8	NA	
ENSG00000234986	AL731661.1	NA	
ENSG00000225532	AL731684.1	NA	
ENSG00000219814	RPL23AP47	NA	
ENSG00000283061	AC215522.3	NA	
ENSG00000282572	AC215522.2	NA	
ENSG00000273644	AC215522.1	NA	
ENSG00000232325	AC093627.1	NA	
ENSG00000242611	AC093627.6	NA	
ENSG00000287883	AC093627.22	NA	
ENSG00000242474	AC093627.5	NA	
ENSG00000240859	AC093627.4	NA	
ENSG00000261795	AC093627.7	NA	
ENSG00000239715	AC093627.2	NA	
ENSG00000240093	AC093627.3	NA	
ENSG00000177706	FAM20C	259775	RAINE SYNDROME; RNS;;OSTEOSCLEROTIC BONE DYSPLASIA, LETHAL
ENSG00000249852	AC145676.1	NA	
ENSG00000248767	FOXL3	NA	
ENSG00000287342	AC188616.1	NA	
ENSG00000249574	AC226118.1	NA	
ENSG00000286710	AC188617.1	NA	
ENSG00000286764	AC188617.2	NA	
ENSG00000234471	AC147651.1	NA	
ENSG00000197461	PDGFA	NA	
ENSG00000223855	HRAT92	NA	
ENSG00000188191	PRKAR1B	NA	
ENSG00000229380	PRKAR1B-AS2	NA	
ENSG00000237181	PRKAR1B-AS1	NA	
ENSG00000164818	DNAAF5	614874	CILIARY DYSKINESIA, PRIMARY, 18; CILD18;;CILIARY DYSKINESIA, PRIMARY, 18, WITH OR WITHOUT SITUS INVERSUS
ENSG00000164828	SUN1	NA	
ENSG00000239857	GET4	NA	
ENSG00000273151	AC073957.3	NA	
ENSG00000105963	ADAP1	NA	
ENSG00000240230	COX19	NA	
ENSG00000073067	CYP2W1	NA	
ENSG00000146540	C7orf50	NA	
ENSG00000199023	MIR339	NA	
ENSG00000225146	AC073957.1	NA	
ENSG00000164849	GPR146	NA	
ENSG00000257607	AC073957.2	NA	
ENSG00000224079	AC091729.1	NA	
ENSG00000226291	AC091729.2	NA	
ENSG00000164850	GPER1	NA	
ENSG00000178381	ZFAND2A	NA	
ENSG00000229043	AC091729.3	NA	
ENSG00000164853	UNCX	NA	
ENSG00000233082	AC073094.1	NA	
ENSG00000164877	MICALL2	NA	
ENSG00000225981	AC102953.1	NA	
ENSG00000273230	AC102953.2	NA	
ENSG00000164880	INTS1	618571	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES; NDCAGF
ENSG00000231927	AC093734.1	NA	
ENSG00000198517	MAFK	NA	
ENSG00000164855	TMEM184A	NA	
ENSG00000157778	PSMG3	NA	
ENSG00000230487	PSMG3-AS1	NA	
ENSG00000230444	TFAMP1	NA	
ENSG00000231476	AC074389.2	NA	
ENSG00000225968	ELFN1	NA	
ENSG00000234977	AC074389.3	NA	
ENSG00000205971	AC074389.1	NA	
ENSG00000236081	ELFN1-AS1	NA	
ENSG00000002822	MAD1L1	176807	PROSTATE CANCER
ENSG00000286192	AC069288.1	NA	
ENSG00000176349	AC104129.1	NA	
ENSG00000265089	MIR4655	NA	
ENSG00000122687	MRM2	618567	MITOCHONDRIAL DNA DEPLETION SYNDROME 17; MTDPS17
ENSG00000106268	NUDT1	NA	
ENSG00000106266	SNX8	NA	
ENSG00000284047	MIR6836	NA	
ENSG00000271098	IMMP1LP3	NA	
ENSG00000106263	EIF3B	NA	
ENSG00000230914	AC004840.1	NA	
ENSG00000271163	AC004840.2	NA	
ENSG00000136213	CHST12	NA	
ENSG00000275572	GRIFIN	NA	
ENSG00000106003	LFNG	609813	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3
ENSG00000264357	MIR4648	NA	
ENSG00000106009	BRAT1	614498	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL
ENSG00000106009	BRAT1	618056	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS
ENSG00000106012	IQCE	617642	POLYDACTYLY, POSTAXIAL, TYPE A7; PAPA7
ENSG00000136295	TTYH3	NA	
ENSG00000174945	AMZ1	NA	
ENSG00000146535	GNA12	NA	
ENSG00000231357	AC006028.1	NA	
ENSG00000198286	CARD11	615206	IMMUNODEFICIENCY 11; IMD11A;;IMMUNODEFICIENCY 11; IMD11;;CARD11 IMMUNODEFICIENCY
ENSG00000198286	CARD11	616452	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA
ENSG00000198286	CARD11	617638	IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B;;ATOPIC DERMATITIS, ELEVATED IgE, AND EOSINOPHILIA
ENSG00000237286	CARD11-AS1	NA	
ENSG00000201794	RN7SKP130	NA	
ENSG00000228334	AC024028.1	NA	
ENSG00000217455	AC073316.1	NA	
ENSG00000231892	AC073316.2	NA	
ENSG00000236708	SDK1-AS1	NA	
ENSG00000146555	SDK1	NA	
ENSG00000224593	AC092427.1	NA	
ENSG00000236510	AC011284.1	NA	
ENSG00000283991	AC017000.1	NA	
ENSG00000261809	CYP3A54P	NA	
ENSG00000286874	AC072054.1	NA	
ENSG00000164916	FOXK1	NA	
ENSG00000287665	AC092428.1	NA	
ENSG00000242802	AP5Z1	613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48
ENSG00000264474	MIR4656	NA	
ENSG00000287541	AC092610.1	NA	
ENSG00000157927	RADIL	NA	
ENSG00000206895	Y_RNA	NA	
ENSG00000218823	PAPOLB	NA	
ENSG00000213935	RPL22P16	NA	
ENSG00000136297	MMD2	NA	
ENSG00000196204	RNF216P1	NA	
ENSG00000288620	AC092032.2	NA	
ENSG00000272968	RBAK-RBAKDN	NA	
ENSG00000288633	AC092032.3	NA	
ENSG00000270822	AC092032.1	NA	
ENSG00000275328	SPDYE19P	NA	
ENSG00000146587	RBAK	NA	
ENSG00000273313	RBAKDN	NA	
ENSG00000272595	OR10AH1P	NA	
ENSG00000159904	ZNF890P	NA	
ENSG00000202039	RNU6-215P	NA	
ENSG00000157954	WIPI2	618453	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA
ENSG00000164638	SLC29A4	NA	
ENSG00000182095	TNRC18	NA	
ENSG00000241269	AC093620.1	NA	
ENSG00000188365	AC092171.1	NA	
ENSG00000272953	AC092171.4	NA	
ENSG00000234432	AC092171.3	NA	
ENSG00000273084	AC092171.5	NA	
ENSG00000155034	FBXL18	NA	
ENSG00000230733	AC092171.2	NA	
ENSG00000207973	MIR589	NA	
ENSG00000075624	ACTB	243310	BARAITSER-WINTER SYNDROME 1; BRWS1;;IRIS COLOBOMA WITH PTOSIS, HYPERTELORISM, AND MENTAL RETARDATION;;FRYNS-AFTIMOS SYNDROME;;PACHYGYRIA, MENTAL RETARDATION, EPILEPSY, AND CHARACTERISTIC FACIES;;CEREBROOCULOFACIAL LYMPHATIC SYNDROME; COFLS;;MENTAL R /.../TION WITH EPILEPSY AND CHARACTERISTIC FACIES;;CEREBROFRONTOFACIAL SYNDROME;;CHROMOSOME 7p22 DELETION SYNDROME
ENSG00000075624	ACTB	607371	DYSTONIA, JUVENILE-ONSET; DJO
ENSG00000272719	AC006483.2	NA	
ENSG00000228974	AC006483.1	NA	
ENSG00000075618	FSCN1	NA	
ENSG00000011275	RNF216	212840	GORDON HOLMES SYNDROME; GDHS;;CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA
ENSG00000237738	RNF216-IT1	NA	
ENSG00000283419	MIR6874	NA	
ENSG00000235944	ZNF815P	NA	
ENSG00000277265	RN7SL556P	NA	
ENSG00000122543	OCM	NA	
ENSG00000122674	CCZ1	NA	
ENSG00000155026	RSPH10B	NA	
ENSG00000122512	PMS2	276300	MISMATCH REPAIR CANCER SYNDROME; MMRCS;;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME; CMMRDS;;MISMATCH REPAIR DEFICIENCY;;MMR DEFICIENCY;;CHILDHOOD CANCER SYNDROME;;BRAIN TUMOR-POLYPOSIS SYNDROME 1; BTPS1;;BTP1 SYNDROME;;TURCOT SYNDROME
ENSG00000122512	PMS2	614337	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4
ENSG00000201990	Y_RNA	NA	
ENSG00000106305	AIMP2	618006	LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17
ENSG00000207217	SNORA80D	NA	
ENSG00000086232	EIF2AK1	NA	
ENSG00000157999	ANKRD61	NA	
ENSG00000240718	RN7SL851P	NA	
ENSG00000252929	RNU6-218P	NA	
ENSG00000231704	AC004895.1	NA	
ENSG00000106346	USP42	NA	
ENSG00000008256	CYTH3	NA	
ENSG00000202273	Y_RNA	NA	
ENSG00000178397	FAM220A	NA	
ENSG00000286075	AC009412.1	NA	
ENSG00000274319	RPSAP73	NA	
ENSG00000136238	RAC1	617751	MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48
ENSG00000164535	DAGLB	NA	
ENSG00000136240	KDELR2	NA	
ENSG00000231359	AC072052.1	NA	
ENSG00000215045	GRID2IP	NA	
ENSG00000136247	ZDHHC4	NA	
ENSG00000232581	AC079742.1	NA	
ENSG00000146576	C7orf26	NA	
ENSG00000236609	ZNF853	NA	
ENSG00000205903	ZNF316	NA	
ENSG00000228010	AC073343.2	NA	
ENSG00000198580	AC073343.1	NA	
ENSG00000164631	ZNF12	NA	
ENSG00000187953	PMS2CL	NA	
ENSG00000277327	SPDYE20P	NA	
ENSG00000169402	RSPH10B2	NA	
ENSG00000146574	CCZ1B	NA	
ENSG00000273252	OR7E39P	NA	
ENSG00000155070	UNC93B2	NA	
ENSG00000205897	OR7E136P	NA	
ENSG00000250561	OR7E59P	NA	
ENSG00000243531	AC079804.2	NA	
ENSG00000226943	ALG1L5P	NA	
ENSG00000241539	AC079804.1	NA	
ENSG00000242731	FAM86LP	NA	
ENSG00000287860	AC079804.3	NA	
ENSG00000266287	MIR3683	NA	
ENSG00000239696	AC092104.1	NA	
ENSG00000201218	Y_RNA	NA	
ENSG00000106392	C1GALT1	NA	
ENSG00000244167	AC005532.2	NA	
ENSG00000230825	AC005532.1	NA	
ENSG00000236712	AC079448.1	NA	
ENSG00000215018	COL28A1	NA	
ENSG00000272732	AC004982.1	NA	
ENSG00000272894	AC004982.2	NA	
ENSG00000164654	MIOS	NA	
ENSG00000272745	AC004948.1	NA	
ENSG00000106399	RPA3	NA	
ENSG00000219545	UMAD1	NA	
ENSG00000283549	AC007161.3	NA	
ENSG00000270314	AC007161.2	NA	
ENSG00000234718	AC007161.1	NA	
ENSG00000201747	RNU6-534P	NA	
ENSG00000214998	CCNB2P1	NA	
ENSG00000234141	AC006042.3	NA	
ENSG00000233108	GLCCI1-DT	NA	
ENSG00000106415	GLCCI1	614400	GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR
ENSG00000233264	AC006042.2	NA	
ENSG00000003147	ICA1	NA	
ENSG00000227719	AC006042.1	NA	
ENSG00000244239	AC007009.1	NA	
ENSG00000229970	AC007128.1	NA	
ENSG00000272328	AC007128.2	NA	
ENSG00000122584	NXPH1	NA	
ENSG00000236748	AC009500.1	NA	
ENSG00000278254	AC004852.2	NA	
ENSG00000271526	AC004852.1	NA	
ENSG00000278446	AC004852.3	NA	
ENSG00000233876	GAPDHP68	NA	
ENSG00000234710	AC060834.2	NA	
ENSG00000271077	PER3P1	NA	
ENSG00000197320	AC060834.1	NA	
ENSG00000270611	AC006363.1	NA	
ENSG00000235431	AC010991.1	NA	
ENSG00000287409	AC004936.1	NA	
ENSG00000286639	AC004879.1	NA	
ENSG00000212422	U3	NA	
ENSG00000283117	MGC4859	NA	
ENSG00000229091	HSPA8P8	NA	
ENSG00000234356	AC009945.1	NA	
ENSG00000236414	AC004415.1	NA	
ENSG00000201774	Y_RNA	NA	
ENSG00000189043	NDUFA4	NA	
ENSG00000271185	AC007029.1	NA	
ENSG00000106443	PHF14	NA	
ENSG00000230370	RPL23AP52	NA	
ENSG00000230333	AC004160.1	NA	
ENSG00000226827	NPM1P11	NA	
ENSG00000005108	THSD7A	NA	
ENSG00000230435	AC004160.2	NA	
ENSG00000235920	THRAP3P3	NA	
ENSG00000106460	TMEM106B	617964	LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16
ENSG00000146530	VWDE	NA	
ENSG00000274970	AC013470.4	NA	
ENSG00000226690	AC013470.2	NA	
ENSG00000236048	AC013470.3	NA	
ENSG00000203523	TAS2R2P	NA	
ENSG00000224667	AC013470.1	NA	
ENSG00000225606	AC005281.1	NA	
ENSG00000006747	SCIN	NA	
ENSG00000229233	AC011891.2	NA	
ENSG00000271253	AC011891.3	NA	
ENSG00000122644	ARL4A	NA	
ENSG00000199470	AC011891.1	NA	
ENSG00000229618	AC011287.1	NA	
ENSG00000222974	RN7SKP228	NA	
ENSG00000230879	RBMX2P4	NA	
ENSG00000237713	AC011287.2	NA	
ENSG00000224330	AC005019.2	NA	
ENSG00000213875	AC005019.1	NA	
ENSG00000006468	ETV1	NA	
ENSG00000252374	Y_RNA	NA	
ENSG00000223445	RPL6P21	NA	
ENSG00000136267	DGKB	NA	
ENSG00000233167	EEF1A1P26	NA	
ENSG00000226323	AC006150.1	NA	
ENSG00000225816	GTF3AP5	NA	
ENSG00000227489	AC006458.1	NA	
ENSG00000187546	AGMO	NA	
ENSG00000106511	MEOX2	NA	
ENSG00000237070	AC005550.2	NA	
ENSG00000229108	LINC02587	NA	
ENSG00000225974	AC005550.1	NA	
ENSG00000235828	RPL36AP26	NA	
ENSG00000286376	AC006041.2	NA	
ENSG00000229379	AC006041.1	NA	
ENSG00000214960	CRPPA	614643	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, ISPD-RELATED
ENSG00000214960	CRPPA	616052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 20; LGMDR20;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2U; LGMD2U
ENSG00000224683	RPL36AP29	NA	
ENSG00000229688	CRPPA-AS1	NA	
ENSG00000171243	SOSTDC1	NA	
ENSG00000272537	AC005014.3	NA	
ENSG00000205858	LRRC72	NA	
ENSG00000224280	AC005014.1	NA	
ENSG00000272361	AC005014.2	NA	
ENSG00000106524	ANKMY2	NA	
ENSG00000287799	AC005014.4	NA	
ENSG00000136261	BZW2	NA	
ENSG00000235837	AC073333.1	NA	
ENSG00000106537	TSPAN13	NA	
ENSG00000106541	AGR2	NA	
ENSG00000270593	AC073333.2	NA	
ENSG00000173467	AGR3	NA	
ENSG00000232400	RAD17P1	NA	
ENSG00000227965	AC098592.2	NA	
ENSG00000106546	AHR	618345	RETINITIS PIGMENTOSA 85; RP85
ENSG00000223867	AC098592.1	NA	
ENSG00000237773	AC073332.1	NA	
ENSG00000232841	BRWD1P3	NA	
ENSG00000278569	Metazoa_SRP	NA	
ENSG00000283321	AC019117.3	NA	
ENSG00000199473	SNORA63	NA	
ENSG00000236318	AC019117.2	NA	
ENSG00000236039	AC019117.1	NA	
ENSG00000228675	AC006482.1	NA	
ENSG00000071189	SNX13	NA	
ENSG00000279048	AC080080.1	NA	
ENSG00000236195	RNMTL1P2	NA	
ENSG00000280340	AC080080.2	NA	
ENSG00000229937	PRPS1L1	NA	
ENSG00000048052	HDAC9	NA	
ENSG00000221393	MIR1302-6	NA	
ENSG00000225000	AC010082.1	NA	
ENSG00000222164	RN7SKP266	NA	
ENSG00000226522	HDAC9-AS1	NA	
ENSG00000232492	NPM1P13	NA	
ENSG00000122691	TWIST1	180750	ROBINOW-SORAUF SYNDROME;;CRANIOSYNOSTOSIS-BIFID HALLUX SYNDROME;;ACROCEPHALOSYNDACTYLY, ROBINOW-SORAUF TYPE
ENSG00000122691	TWIST1	123100	CRANIOSYNOSTOSIS 1; CRS1;;CRS;;CRANIOSTENOSIS
ENSG00000122691	TWIST1	101400	SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLY SAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND P /.../3, FORMERLY, INCLUDED; BPES3, FORMERLY, INCLUDED
ENSG00000122691	TWIST1	617746	SWEENEY-COX SYNDROME; SWCOS
ENSG00000232821	AC003986.2	NA	
ENSG00000236536	AC003986.3	NA	
ENSG00000229533	AC003986.1	NA	
ENSG00000146618	FERD3L	NA	
ENSG00000223838	AC007091.1	NA	
ENSG00000105849	TWISTNB	NA	
ENSG00000265932	MIR3146	NA	
ENSG00000173452	TMEM196	NA	
ENSG00000237921	AC004543.1	NA	
ENSG00000243004	AC005062.1	NA	
ENSG00000213860	RPL21P75	NA	
ENSG00000267055	AC007001.1	NA	
ENSG00000183742	MACC1	NA	
ENSG00000228598	MACC1-AS1	NA	
ENSG00000233834	AC005083.1	NA	
ENSG00000226097	AC099342.1	NA	
ENSG00000271133	AC004130.2	NA	
ENSG00000105855	ITGB8	NA	
ENSG00000200753	AC004130.1	NA	
ENSG00000179460	EEF1A1P27	NA	
ENSG00000231525	AC002486.2	NA	
ENSG00000004846	ABCB5	NA	
ENSG00000223866	AC002486.1	NA	
ENSG00000164651	SP8	NA	
ENSG00000219451	RPL23P8	NA	
ENSG00000232790	LINC01162	NA	
ENSG00000234839	RPS26P30	NA	
ENSG00000285592	AC080068.1	NA	
ENSG00000243633	RN7SL542P	NA	
ENSG00000225308	ASS1P11	NA	
ENSG00000195024	RNU1-15P	NA	
ENSG00000229949	AC005094.1	NA	
ENSG00000105866	SP4	NA	
ENSG00000221783	MIR1183	NA	
ENSG00000105877	DNAH11	611884	CILIARY DYSKINESIA, PRIMARY, 7; CILD7;;CILIARY DYSKINESIA, PRIMARY, 7, WITH OR WITHOUT SITUS INVERSUS
ENSG00000164649	CDCA7L	NA	
ENSG00000136237	RAPGEF5	NA	
ENSG00000251993	RNA5SP227	NA	
ENSG00000105889	STEAP1B	NA	
ENSG00000233476	EEF1A1P6	NA	
ENSG00000232759	AC002480.1	NA	
ENSG00000232949	AC002480.2	NA	
ENSG00000179428	IL6-AS1	NA	
ENSG00000136244	IL6	148000	KAPOSI SARCOMA, SUSCEPTIBILITY TO;;MULTIPLE IDIOPATHIC PIGMENTED HEMANGIOSARCOMA, SUSCEPTIBILITY TO MULTICENTRIC CASTLEMAN DISEASE, SUSCEPTIBILITY TO, INCLUDED; MCD, INCLUDED
ENSG00000136244	IL6	108010	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN;;BAVM;;CEREBRAL ARTERIOVENOUS MALFORMATIONS INTRACRANIAL HEMORRHAGE IN BRAIN ARTERIOVENOUS MALFORMATIONS, SUSCEPTIBILITY TO, INCLUDED
ENSG00000136244	IL6	222100	DIABETES MELLITUS, TYPE I;;DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM;;JUVENILE-ONSET DIABETES; JOD DIABETES MELLITUS, INSULIN-DEPENDENT, 1, INCLUDED; IDDM1, INCLUDED;;INSULIN-DEPENDENT DIABETES MELLITUS 1, INCLUDED
ENSG00000136244	IL6	266600	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1; IBD1 REGIONAL ENTERITIS, INCLUDED;;CROHN DISEASE, INCLUDED;;ULCERATIVE COLITIS, INCLUDED;;CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED
ENSG00000136244	IL6	604302	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE;;SYSTEMIC JUVENILE RHEUMATOID ARTHRITIS
ENSG00000228803	MTCYBP42	NA	
ENSG00000234513	AC073072.1	NA	
ENSG00000196683	TOMM7	NA	
ENSG00000286703	AC005682.2	NA	
ENSG00000228649	SNHG26	NA	
ENSG00000226329	AC005682.1	NA	
ENSG00000221740	SNORD93	NA	
ENSG00000226279	RPL12P10	NA	
ENSG00000122591	FAM126A	610532	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5;;HYPOMYELINATION AND CONGENITAL CATARACT: HCC
ENSG00000230658	KLHL7-DT	NA	
ENSG00000122550	KLHL7	612943	RETINITIS PIGMENTOSA 42; RP42
ENSG00000122550	KLHL7	617055	PERCHING SYNDROME; PERCHING;;CRISPONI/COLD-INDUCED SWEATING SYNDROME 3, FORMERLY; CISS3, FORMERLY
ENSG00000230042	AK3P3	NA	
ENSG00000136243	NUP42	NA	
ENSG00000285926	AC005082.2	NA	
ENSG00000226816	AC005082.1	NA	
ENSG00000136235	GPNMB	617920	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3;;AMYLOIDOSIS CUTIS DYSCHROMICA; ACD
ENSG00000156928	MALSU1	NA	
ENSG00000136231	IGF2BP3	NA	
ENSG00000232627	AC021876.1	NA	
ENSG00000212264	SNORD65C	NA	
ENSG00000252590	RNU7-143P	NA	
ENSG00000236654	AC079780.1	NA	
ENSG00000232818	RPS2P32	NA	
ENSG00000200847	Y_RNA	NA	
ENSG00000164548	TRA2A	NA	
ENSG00000224785	AC006026.1	NA	
ENSG00000232553	CLK2P1	NA	
ENSG00000169193	CCDC126	NA	
ENSG00000227436	FCF1P1	NA	
ENSG00000228953	AC006026.2	NA	
ENSG00000188732	FAM221A	NA	
ENSG00000234286	AC006026.3	NA	
ENSG00000196335	STK31	NA	
ENSG00000234800	PCMTD1P3	NA	
ENSG00000231328	TPT1P7	NA	
ENSG00000227930	AC003087.1	NA	
ENSG00000252041	RNA5SP228	NA	
ENSG00000228944	AC004485.1	NA	
ENSG00000122585	NPY	NA	
ENSG00000287523	AC003044.1	NA	
ENSG00000206877	RNU6-1103P	NA	
ENSG00000105926	MPP6	NA	
ENSG00000271096	SUMO2P14	NA	
ENSG00000271330	AC005084.1	NA	
ENSG00000105928	GSDME	600994	DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5
ENSG00000287093	AC003093.1	NA	
ENSG00000070882	OSBPL3	NA	
ENSG00000234999	SNRPCP19	NA	
ENSG00000172115	CYCS	612004	THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4
ENSG00000153790	C7orf31	NA	
ENSG00000234406	AC004129.2	NA	
ENSG00000213798	AC004129.1	NA	
ENSG00000105954	NPVF	NA	
ENSG00000285716	AC004129.3	NA	
ENSG00000202233	U3	NA	
ENSG00000234922	TSEN15P3	NA	
ENSG00000233824	AC003985.1	NA	
ENSG00000260951	AC005100.1	NA	
ENSG00000285960	AC005100.2	NA	
ENSG00000227386	AC091705.1	NA	
ENSG00000223561	AC005165.1	NA	
ENSG00000239622	AC005165.2	NA	
ENSG00000287096	AC005165.3	NA	
ENSG00000286725	AC018706.1	NA	
ENSG00000270933	AC010719.1	NA	
ENSG00000199085	MIR148A	NA	
ENSG00000050344	NFE2L3	NA	
ENSG00000122566	HNRNPA2B1	615422	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2;;MULTISYSTEM PROTEINOPATHY 2; MSP2
ENSG00000122565	CBX3	NA	
ENSG00000285860	AC010677.2	NA	
ENSG00000232383	AC010677.1	NA	
ENSG00000086300	SNX10	615085	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8
ENSG00000225792	AC004540.2	NA	
ENSG00000214870	AC004540.1	NA	
ENSG00000122548	KIAA0087	NA	
ENSG00000280255	AC004947.2	NA	
ENSG00000233760	AC004947.1	NA	
ENSG00000286507	AC004947.3	NA	
ENSG00000222004	LINC02860	NA	
ENSG00000005020	SKAP2	NA	
ENSG00000213787	RPL7AP38	NA	
ENSG00000226059	HMGB3P20	NA	
ENSG00000214869	TPM3P4	NA	
ENSG00000213786	NHP2P2	NA	
ENSG00000105991	HOXA1	601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROME  BOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED
ENSG00000233429	HOTAIRM1	NA	
ENSG00000276528	AC004079.3	NA	
ENSG00000276771	AC004079.4	NA	
ENSG00000274864	AC004079.2	NA	
ENSG00000274396	AC004079.1	NA	
ENSG00000277694	AC004079.5	NA	
ENSG00000105996	HOXA2	612290	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE MICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED
ENSG00000105997	HOXA3	NA	
ENSG00000253552	HOXA-AS2	NA	
ENSG00000197576	HOXA4	NA	
ENSG00000273433	AC004080.6	NA	
ENSG00000254369	HOXA-AS3	NA	
ENSG00000106004	HOXA5	NA	
ENSG00000106006	HOXA6	NA	
ENSG00000272801	AC004080.5	NA	
ENSG00000122592	HOXA7	NA	
ENSG00000270182	AC004080.4	NA	
ENSG00000078399	HOXA9	NA	
ENSG00000257184	AC004080.3	NA	
ENSG00000253187	HOXA10-AS	NA	
ENSG00000283745	MIR196B	NA	
ENSG00000253293	HOXA10	NA	
ENSG00000005073	HOXA11	605432	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1; RUSAT1;;RUSAT;;THROMBOCYTOPENIA, CONGENITAL, WITH RADIOULNAR SYNOSTOSIS; CTRUS
ENSG00000240990	HOXA11-AS	NA	
ENSG00000273961	AC004080.7	NA	
ENSG00000278334	AC004080.14	NA	
ENSG00000276496	AC004080.8	NA	
ENSG00000253508	AC004080.2	NA	
ENSG00000277966	AC004080.12	NA	
ENSG00000278592	AC004080.15	NA	
ENSG00000278020	AC004080.13	NA	
ENSG00000106031	HOXA13	176305	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS;;GUTTMACHER SYNDROME
ENSG00000106031	HOXA13	140000	HAND-FOOT-GENITAL SYNDROME; HFG;;HAND-FOOT-UTERUS SYNDROME; HFU
ENSG00000243766	HOTTIP	NA	
ENSG00000276609	AC004080.9	NA	
ENSG00000278708	AC004080.16	NA	
ENSG00000277469	AC004080.10	NA	
ENSG00000277553	AC004080.11	NA	
ENSG00000286323	AC004080.17	NA	
ENSG00000253308	AC004080.1	NA	
ENSG00000253405	EVX1-AS	NA	
ENSG00000106038	EVX1	NA	
ENSG00000213783	RPL35P4	NA	
ENSG00000236569	HNRNPA1P73	NA	
ENSG00000224322	AC004009.1	NA	
ENSG00000279655	AC004009.3	NA	
ENSG00000279429	AC004009.2	NA	
ENSG00000233830	EIF4HP1	NA	
ENSG00000213781	PSMC1P2	NA	
ENSG00000235574	AC073150.1	NA	
ENSG00000106049	HIBADH	NA	
ENSG00000286478	AC007130.1	NA	
ENSG00000229893	AC005091.1	NA	
ENSG00000106052	TAX1BP1	NA	
ENSG00000153814	JAZF1	NA	
ENSG00000287489	AC004549.1	NA	
ENSG00000206623	RNU6-979P	NA	
ENSG00000234336	JAZF1-AS1	NA	
ENSG00000174495	PPIAP80	NA	
ENSG00000146592	CREB5	NA	
ENSG00000225286	AC005105.1	NA	
ENSG00000255690	TRIL	NA	
ENSG00000228421	AC005013.1	NA	
ENSG00000272568	AC005162.2	NA	
ENSG00000233517	AC005162.1	NA	
ENSG00000106066	CPVL	NA	
ENSG00000229452	CPVL-AS1	NA	
ENSG00000285412	AC005232.1	NA	
ENSG00000285162	AC004593.2	NA	
ENSG00000106069	CHN2	NA	
ENSG00000285081	AC004593.1	NA	
ENSG00000235669	CHN2-AS1	NA	
ENSG00000237065	NANOGP4	NA	
ENSG00000223813	AC007255.1	NA	
ENSG00000270196	AC007255.2	NA	
ENSG00000176532	PRR15	NA	
ENSG00000225264	ZNRF2P2	NA	
ENSG00000223437	TMSB4XP3	NA	
ENSG00000227855	DPY19L2P3	NA	
ENSG00000212024	MIR550A3	NA	
ENSG00000122574	WIPF3	NA	
ENSG00000238906	AC004912.1	NA	
ENSG00000136193	SCRN1	NA	
ENSG00000227014	FKBP14-AS1	NA	
ENSG00000106080	FKBP14	614557	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2;;EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS; EDSKMH
ENSG00000106086	PLEKHA8	NA	
ENSG00000231519	AC007285.1	NA	
ENSG00000283618	AC007036.4	NA	
ENSG00000286847	AC007036.5	NA	
ENSG00000180354	MTURN	NA	
ENSG00000230751	AC007036.2	NA	
ENSG00000251660	AC007036.3	NA	
ENSG00000225907	RPS27P16	NA	
ENSG00000227017	AC007036.1	NA	
ENSG00000180233	ZNRF2	NA	
ENSG00000207771	MIR550A1	NA	
ENSG00000283237	MIR550B1	NA	
ENSG00000281593	AC006978.2	NA	
ENSG00000235859	AC006978.1	NA	
ENSG00000281404	LINC01176	NA	
ENSG00000106100	NOD1	NA	
ENSG00000272638	AC006027.1	NA	
ENSG00000006625	GGCT	NA	
ENSG00000281039	AC005154.5	NA	
ENSG00000196295	GARS1-DT	NA	
ENSG00000244480	AC005154.2	NA	
ENSG00000264520	AC005154.4	NA	
ENSG00000226874	AC005154.1	NA	
ENSG00000263683	AC005154.3	NA	
ENSG00000106105	GARS1	600794	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A;;HMN VA;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V; HMN5;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; DHMN5A;;DHMN VA;;SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VA; DSMAVA;;SPINAL MUSCULAR ATRO /.../ISTAL, TYPE V; DSMAV;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH UPPER LIMB PREDOMINANCE
ENSG00000106105	GARS1	601472	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2D
ENSG00000106113	CRHR2	NA	
ENSG00000241644	INMT	NA	
ENSG00000223419	AC006022.1	NA	
ENSG00000254959	INMT-MINDY4	NA	
ENSG00000106125	MINDY4	NA	
ENSG00000229263	AC004691.1	NA	
ENSG00000250424	AC004691.2	NA	
ENSG00000240583	AQP1	110450	BLOOD GROUP, COLTON SYSTEM; CO;;COLTON BLOOD GROUP SYSTEM COLTON-NULL PHENOTYPE, INCLUDED
ENSG00000106128	GHRHR	618157	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV; IGHD4;;ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB, FORMERLY; IGHD1B, FORMERLY;;DWARFISM OF SINDH
ENSG00000078549	ADCYAP1R1	NA	
ENSG00000232887	AC006466.1	NA	
ENSG00000286487	AC006398.1	NA	
ENSG00000271027	AC006380.1	NA	
ENSG00000164600	NEUROD6	NA	
ENSG00000231418	AC005090.1	NA	
ENSG00000180347	ITPRID1	NA	
ENSG00000106341	PPP1R17	143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1;;FHC; FH;;HYPERLIPOPROTEINEMIA, TYPE II;;HYPERLIPOPROTEINEMIA, TYPE IIA;;HYPER-LOW-DENSITY-LIPOPROTEINEMIA;;HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL;;LDL RECEPTOR DISORDER LOW DENSITY LIPOPROTEIN CHOLESTE /.../VEL QUANTITATIVE TRAIT LOCUS 2, INCLUDED; LDLCQ2, INCLUDED
ENSG00000154678	PDE1C	618140	DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74
ENSG00000236460	SNX2P2	NA	
ENSG00000284839	AC018637.1	NA	
ENSG00000226468	AC018641.1	NA	
ENSG00000226421	SLC25A5P5	NA	
ENSG00000106355	LSM5	NA	
ENSG00000105778	AVL9	NA	
ENSG00000229358	DPY19L1P1	NA	
ENSG00000237004	ZNRF2P1	NA	
ENSG00000207573	MIR550A2	NA	
ENSG00000283461	MIR550B2	NA	
ENSG00000273014	AC018645.3	NA	
ENSG00000281332	LINC00997	NA	
ENSG00000250756	AC018645.1	NA	
ENSG00000251999	AC018645.2	NA	
ENSG00000231952	DPY19L1P2	NA	
ENSG00000272905	AC018648.1	NA	
ENSG00000170852	KBTBD2	NA	
ENSG00000205763	RP9P	NA	
ENSG00000224573	AC083863.1	NA	
ENSG00000122642	FKBP9	NA	
ENSG00000252821	RNU6-388P	NA	
ENSG00000122643	NT5C3A	266120	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO;;HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY;;PYRIMIDINE 5-PRIME NUCLEOTIDASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO;;HEMOLYTIC ANEMIA DUE TO P5N DEFICIENCY;;P5N DEFICIENCY;;UMPH1 /.../IENCY
ENSG00000229054	RPS29P14	NA	
ENSG00000241420	RN7SL505P	NA	
ENSG00000164610	RP9	180104	RETINITIS PIGMENTOSA 9; RP9
ENSG00000122507	BBS9	615986	BARDET-BIEDL SYNDROME 9; BBS9
ENSG00000228015	AC074338.1	NA	
ENSG00000222741	RNA5SP229	NA	
ENSG00000224946	AC007312.1	NA	
ENSG00000238090	AC006195.1	NA	
ENSG00000173862	AC008080.1	NA	
ENSG00000227481	AC008080.2	NA	
ENSG00000236494	AC008080.4	NA	
ENSG00000233219	AC008080.3	NA	
ENSG00000164619	BMPER	608022	DIAPHANOSPONDYLODYSOSTOSIS;;VERTEBRAL OSSIFICATION, DEFECT IN, WITH NEPHROGENIC RESTS
ENSG00000286300	AC007350.1	NA	
ENSG00000236212	AC009262.1	NA	
ENSG00000202431	RNU6-438P	NA	
ENSG00000197085	NPSR1-AS1	NA	
ENSG00000187258	NPSR1	608584	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2;;ASRT2
ENSG00000235379	RPL7P31	NA	
ENSG00000230356	NCAPD2P1	NA	
ENSG00000242653	RN7SL132P	NA	
ENSG00000251802	AC004788.1	NA	
ENSG00000173852	DPY19L1	NA	
ENSG00000221669	MIR548N	NA	
ENSG00000287249	AC005400.1	NA	
ENSG00000189212	DPY19L2P1	NA	
ENSG00000236592	S100A11P2	NA	
ENSG00000164532	TBX20	611363	ATRIAL SEPTAL DEFECT 4; ASD4
ENSG00000226063	AC009531.1	NA	
ENSG00000287651	AC007652.3	NA	
ENSG00000286526	AC007652.2	NA	
ENSG00000235464	AC007652.1	NA	
ENSG00000287032	AC018647.3	NA	
ENSG00000122557	HERPUD2	NA	
ENSG00000271122	AC018647.2	NA	
ENSG00000227544	AC018647.1	NA	
ENSG00000228878	SEPTIN7-DT	NA	
ENSG00000232736	AC007551.1	NA	
ENSG00000122545	SEPTIN7	NA	
ENSG00000274328	AC007551.2	NA	
ENSG00000200446	RNU6-1085P	NA	
ENSG00000273580	AC087072.2	NA	
ENSG00000226102	SEPTIN7P3	NA	
ENSG00000270889	AC087072.1	NA	
ENSG00000287893	AC083864.5	NA	
ENSG00000232930	AC083864.2	NA	
ENSG00000285573	AC083864.4	NA	
ENSG00000205745	AC083864.1	NA	
ENSG00000261184	AC083864.3	NA	
ENSG00000228815	MARK2P13	NA	
ENSG00000271117	AC078841.1	NA	
ENSG00000122547	EEPD1	NA	
ENSG00000228770	AC007327.1	NA	
ENSG00000229679	AC007327.2	NA	
ENSG00000234457	AC006960.1	NA	
ENSG00000260070	AC006960.3	NA	
ENSG00000164542	KIAA0895	NA	
ENSG00000201432	Y_RNA	NA	
ENSG00000011426	ANLN	616032	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 8
ENSG00000237400	AC006960.2	NA	
ENSG00000136250	AOAH	NA	
ENSG00000230539	AOAH-IT1	NA	
ENSG00000272984	AC007349.4	NA	
ENSG00000229424	AC007349.1	NA	
ENSG00000235728	AC007349.3	NA	
ENSG00000225739	NPM1P18	NA	
ENSG00000230831	AC007349.2	NA	
ENSG00000155849	ELMO1	NA	
ENSG00000221325	MIR1200	NA	
ENSG00000224101	ELMO1-AS1	NA	
ENSG00000224706	RPS17P13	NA	
ENSG00000222869	RNU6-565P	NA	
ENSG00000213744	RPS10P14	NA	
ENSG00000200113	AC078843.1	NA	
ENSG00000201566	Y_RNA	NA	
ENSG00000178503	NECAP1P1	NA	
ENSG00000187037	GPR141	NA	
ENSG00000086289	EPDR1	NA	
ENSG00000283444	GPR141BP	NA	
ENSG00000225314	AC018634.1	NA	
ENSG00000086288	NME8	610852	CILIARY DYSKINESIA, PRIMARY, 6; CILD6
ENSG00000106483	SFRP4	265900	PYLE DISEASE; PYL;;METAPHYSEAL DYSPLASIA, PYLE TYPE
ENSG00000010270	STARD3NL	NA	
ENSG00000227191	TRGC2	NA	
ENSG00000211687	TRGJ2	NA	
ENSG00000211688	TRGJP2	NA	
ENSG00000211689	TRGC1	NA	
ENSG00000211690	TRGJ1	NA	
ENSG00000211691	TRGJP	NA	
ENSG00000211692	TRGJP1	NA	
ENSG00000211693	TRGV11	NA	
ENSG00000231202	TRGVB	NA	
ENSG00000211694	TRGV10	NA	
ENSG00000231916	AC006033.1	NA	
ENSG00000211695	TRGV9	NA	
ENSG00000225992	TRGVA	NA	
ENSG00000272908	AC006033.2	NA	
ENSG00000211696	TRGV8	NA	
ENSG00000249978	TRGV7	NA	
ENSG00000226212	TRGV6	NA	
ENSG00000281103	TRG-AS1	NA	
ENSG00000228668	TRGV5P	NA	
ENSG00000211697	TRGV5	NA	
ENSG00000211698	TRGV4	NA	
ENSG00000211699	TRGV3	NA	
ENSG00000233306	TRGV2	NA	
ENSG00000211701	TRGV1	NA	
ENSG00000078053	AMPH	NA	
ENSG00000241756	RN7SL83P	NA	
ENSG00000227404	KRT8P20	NA	
ENSG00000164556	FAM183BP	NA	
ENSG00000006715	VPS41	NA	
ENSG00000106536	POU6F2	601583	WILMS TUMOR 5; WT5;;WILMS TUMOR, SUSCEPTIBILITY TO; WTSL
ENSG00000233854	POU6F2-AS2	NA	
ENSG00000206947	SNORA20B	NA	
ENSG00000224122	POU6F2-AS1	NA	
ENSG00000227172	AC011290.1	NA	
ENSG00000241127	YAE1	NA	
ENSG00000236015	AC011290.2	NA	
ENSG00000231951	AC004837.3	NA	
ENSG00000106540	AC004837.1	NA	
ENSG00000287584	AC004837.4	NA	
ENSG00000006451	RALA	NA	
ENSG00000228554	AC004837.2	NA	
ENSG00000188185	LINC00265	NA	
ENSG00000252480	RNU6-719P	NA	
ENSG00000270797	AC004987.3	NA	
ENSG00000226220	CICP22	NA	
ENSG00000237251	AC004987.2	NA	
ENSG00000231198	AC004987.1	NA	
ENSG00000233225	SSBP3P1	NA	
ENSG00000175741	RWDD4P2	NA	
ENSG00000242855	RN7SL496P	NA	
ENSG00000259826	AC072061.1	NA	
ENSG00000065883	CDK13	617360	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD
ENSG00000273444	AC006023.3	NA	
ENSG00000270577	AC006023.2	NA	
ENSG00000168303	MPLKIP	234050	TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4;;TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1;;AMISH BRITTLE HAIR BRAIN SYNDROME; ABHS;;HAIR-BRAIN SYNDROME;;BIDS SYNDROME;;POLLITT SYNDROME;;TRICHOTHIODYSTROPHY-NEUROCUTANEOUS SYNDROME
ENSG00000199273	AC006023.1	NA	
ENSG00000175600	SUGCT	231690	GLUTARIC ACIDURIA III; GA3;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY
ENSG00000248711	THUMPD3P1	NA	
ENSG00000203446	AC004988.1	NA	
ENSG00000227658	AC005160.1	NA	
ENSG00000232458	LINC01450	NA	
ENSG00000224017	LINC01449	NA	
ENSG00000122641	INHBA	NA	
ENSG00000224116	INHBA-AS1	NA	
ENSG00000106571	GLI3	175700	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS;;POLYSYNDACTYLY WITH PECULIAR SKULL SHAPE
ENSG00000106571	GLI3	174700	POLYDACTYLY, PREAXIAL IV; PPD4;;POLYSYNDACTYLY, UNCOMPLICATED CROSSED POLYDACTYLY, TYPE I, INCLUDED; CP1, INCLUDED
ENSG00000106571	GLI3	174200	POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1;;POSTAXIAL POLYDACTYLY, TYPE A; PAPA;;POLYDACTYLY, POSTAXIAL POSTAXIAL POLYDACTYLY, TYPE B, INCLUDED; PAPB, INCLUDED
ENSG00000106571	GLI3	146510	PALLISTER-HALL SYNDROME; PHS;;HYPOTHALAMIC HAMARTOBLASTOMA, HYPOPITUITARISM, IMPERFORATE ANUS, AND POSTAXIAL POLYDACTYLY
ENSG00000106571	GLI3	241800	HYPOTHALAMIC HAMARTOMAS CONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED
ENSG00000213721	HMGN2P30	NA	
ENSG00000238284	LINC01448	NA	
ENSG00000229161	TCP1P1	NA	
ENSG00000231539	AC010132.1	NA	
ENSG00000261019	AC010132.4	NA	
ENSG00000136197	C7orf25	NA	
ENSG00000256646	AC010132.3	NA	
ENSG00000106588	PSMA2	NA	
ENSG00000234983	AC010132.2	NA	
ENSG00000106591	MRPL32	NA	
ENSG00000232006	AC005537.1	NA	
ENSG00000201933	Y_RNA	NA	
ENSG00000002746	HECW1	NA	
ENSG00000181211	HECW1-IT1	NA	
ENSG00000264069	MIR3943	NA	
ENSG00000252983	RNU7-35P	NA	
ENSG00000223258	RNU6-575P	NA	
ENSG00000228680	AC004692.2	NA	
ENSG00000213717	AC004692.1	NA	
ENSG00000231638	LUARIS	NA	
ENSG00000164543	STK17A	NA	
ENSG00000106603	COA1	NA	
ENSG00000106605	BLVRA	614156	HYPERBILIVERDINEMIA; HBLVD;;GREEN JAUNDICE
ENSG00000229497	AC005189.1	NA	
ENSG00000062582	MRPS24	NA	
ENSG00000270617	URGCP-MRPS24	NA	
ENSG00000106608	URGCP	NA	
ENSG00000237972	TUBG1P	NA	
ENSG00000078967	UBE2D4	NA	
ENSG00000214783	POLR2J4	NA	
ENSG00000273432	AC004951.4	NA	
ENSG00000241057	AC004951.3	NA	
ENSG00000239556	AC004951.2	NA	
ENSG00000136206	SPDYE1	NA	
ENSG00000228434	AC004951.1	NA	
ENSG00000285596	AC017116.2	NA	
ENSG00000272655	POLR2J4	NA	
ENSG00000228903	RASA4CP	NA	
ENSG00000235314	LINC00957	NA	
ENSG00000136279	DBNL	NA	
ENSG00000284067	MIR6837	NA	
ENSG00000164708	PGAM2	261670	GLYCOGEN STORAGE DISEASE X; GSD10;;GSD X;;PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF;;MYOPATHY DUE TO PHOSPHOGLYCERATE MUTASE DEFICIENCY;;PGAMM DEFICIENCY
ENSG00000239775	AC017116.1	NA	
ENSG00000122678	POLM	NA	
ENSG00000283969	MIR6838	NA	
ENSG00000106624	AEBP1	618000	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2
ENSG00000284412	MIR4649	NA	
ENSG00000106628	POLD2	NA	
ENSG00000252848	RNA5SP230	NA	
ENSG00000106631	MYL7	NA	
ENSG00000106633	GCK	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000106633	GCK	125851	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2;;MODY, TYPE 2;;MODY, GLUCOKINASE-RELATED
ENSG00000106633	GCK	602485	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3
ENSG00000106633	GCK	606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM;;DIABETES MELLITUS, PERMANENT, OF INFANCY; PDMI DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED;;DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES, INCLUDED; DEND, INCLUDED
ENSG00000106636	YKT6	NA	
ENSG00000058404	CAMK2B	617799	MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54
ENSG00000279853	AC004453.2	NA	
ENSG00000015676	NUDCD3	NA	
ENSG00000146677	AC004453.1	NA	
ENSG00000200456	RNU6-1097P	NA	
ENSG00000225443	AC004938.1	NA	
ENSG00000015520	NPC1L1	617966	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7; LDLCQ7 EZETIMIBE, RESPONSE TO, INCLUDED
ENSG00000136271	DDX56	NA	
ENSG00000158604	TMED4	NA	
ENSG00000287574	AC004938.2	NA	
ENSG00000271586	AC011894.1	NA	
ENSG00000105953	OGDH	203740	ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY;;ALPHA-KGD DEFICIENCY;;2-@KETOGLUTARATE DEHYDROGENASE DEFICIENCY;;OXOGLUTARIC ACIDURIA
ENSG00000122515	ZMIZ2	NA	
ENSG00000228596	AC013436.1	NA	
ENSG00000196262	PPIA	NA	
ENSG00000105968	H2AZ2	NA	
ENSG00000234183	LINC01952	NA	
ENSG00000146676	PURB	NA	
ENSG00000284261	MIR4657	NA	
ENSG00000272768	AC004854.2	NA	
ENSG00000230160	AC004854.1	NA	
ENSG00000260997	AC004847.1	NA	
ENSG00000136286	MYO1G	NA	
ENSG00000232956	SNHG15	NA	
ENSG00000277184	SNORA9	NA	
ENSG00000136280	CCM2	603284	CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2
ENSG00000136274	NACAD	NA	
ENSG00000136270	TBRG4	NA	
ENSG00000206838	SNORA5A	NA	
ENSG00000201772	SNORA5C	NA	
ENSG00000200656	SNORA5B	NA	
ENSG00000122679	RAMP3	NA	
ENSG00000286738	AC073968.2	NA	
ENSG00000275295	AC073968.1	NA	
ENSG00000234359	ELK1P1	NA	
ENSG00000225537	AC073325.1	NA	
ENSG00000226999	AC073325.2	NA	
ENSG00000164742	ADCY1	610154	DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44
ENSG00000214765	SEPTIN7P2	NA	
ENSG00000272556	GTF2IP13	NA	
ENSG00000212450	RNU6-241P	NA	
ENSG00000235955	CICP20	NA	
ENSG00000226838	AC096582.1	NA	
ENSG00000251378	AC096582.2	NA	
ENSG00000202350	RNU6-326P	NA	
ENSG00000283247	CCDC201	NA	
ENSG00000146678	IGFBP1	NA	
ENSG00000146674	IGFBP3	NA	
ENSG00000237471	AC073115.2	NA	
ENSG00000229628	AC073115.1	NA	
ENSG00000233952	FTLP15	NA	
ENSG00000221971	TTC4P1	NA	
ENSG00000224547	ZNF619P1	NA	
ENSG00000229459	AC023669.1	NA	
ENSG00000237760	AC023669.2	NA	
ENSG00000240355	AC004869.2	NA	
ENSG00000230680	AC004869.1	NA	
ENSG00000224519	HMGN1P19	NA	
ENSG00000233539	AC011294.1	NA	
ENSG00000242948	EPS15P1	NA	
ENSG00000232072	AC004870.4	NA	
ENSG00000223829	AC004870.2	NA	
ENSG00000229192	AC004870.3	NA	
ENSG00000242552	MRPL42P4	NA	
ENSG00000214754	AC004870.1	NA	
ENSG00000286315	AC087175.1	NA	
ENSG00000136205	TNS3	NA	
ENSG00000236078	LINC01447	NA	
ENSG00000221845	C7orf65	NA	
ENSG00000158683	PKD1L1	617205	HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8
ENSG00000146666	LINC00525	NA	
ENSG00000136275	C7orf69	NA	
ENSG00000225507	AC069282.1	NA	
ENSG00000136273	HUS1	NA	
ENSG00000164744	SUN3	NA	
ENSG00000164746	C7orf57	NA	
ENSG00000183696	UPP1	NA	
ENSG00000179869	ABCA13	NA	
ENSG00000228173	AC091770.1	NA	
ENSG00000285536	LINC02838	NA	
ENSG00000225705	AC004899.1	NA	
ENSG00000279578	AC004899.2	NA	
ENSG00000229165	GDI2P1	NA	
ENSG00000218305	CDC14C	NA	
ENSG00000234686	AC091730.1	NA	
ENSG00000270763	DDX43P2	NA	
ENSG00000286995	AC092448.1	NA	
ENSG00000279104	AC093775.1	NA	
ENSG00000188730	VWC2	NA	
ENSG00000042813	ZPBP	NA	
ENSG00000223893	GNL2P1	NA	
ENSG00000287521	AC034148.1	NA	
ENSG00000164500	SPATA48	NA	
ENSG00000228005	AC020743.1	NA	
ENSG00000231681	AC020743.2	NA	
ENSG00000235620	AC020743.3	NA	
ENSG00000185811	IKZF1	616873	IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13
ENSG00000285165	AC124014.1	NA	
ENSG00000200815	RNU6-1091P	NA	
ENSG00000132436	FIGNL1	NA	
ENSG00000132437	DDC	608643	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY;;AADC DEFICIENCY;;DOPA DECARBOXYLASE DEFICIENCY;;DDC DEFICIENCY
ENSG00000226122	DDC-AS1	NA	
ENSG00000106070	GRB10	NA	
ENSG00000286658	AC005153.1	NA	
ENSG00000236046	AC004920.1	NA	
ENSG00000228085	AC009296.1	NA	
ENSG00000228204	AC004830.2	NA	
ENSG00000201133	AC004830.1	NA	
ENSG00000106078	COBL	NA	
ENSG00000231490	RPL7L1P2	NA	
ENSG00000227233	CICP17	NA	
ENSG00000228897	AC012441.2	NA	
ENSG00000227080	AC012441.1	NA	
ENSG00000285741	AC005999.2	NA	
ENSG00000229478	ROBO2P1	NA	
ENSG00000229403	AC005999.1	NA	
ENSG00000242650	RN7SL292P	NA	
ENSG00000286987	AC006478.1	NA	
ENSG00000287039	AC006478.2	NA	
ENSG00000233960	AC079763.1	NA	
ENSG00000253028	AC006320.1	NA	
ENSG00000286908	AC006459.1	NA	
ENSG00000234304	SGO1P2	NA	
ENSG00000223970	AC074397.1	NA	
ENSG00000221900	POM121L12	NA	
ENSG00000227344	HAUS6P1	NA	
ENSG00000271194	RNF138P2	NA	
ENSG00000199629	RNU1-14P	NA	
ENSG00000222154	RN7SKP218	NA	
ENSG00000234105	AC009468.2	NA	
ENSG00000228627	AC009468.1	NA	
ENSG00000205628	LINC01446	NA	
ENSG00000222355	RNU2-29P	NA	
ENSG00000271306	RAC1P9	NA	
ENSG00000232418	AC074348.1	NA	
ENSG00000235454	HAUS6P3	NA	
ENSG00000238131	LINC02854	NA	
ENSG00000287953	AC092848.2	NA	
ENSG00000280920	AC092848.1	NA	
ENSG00000231427	LINC01445	NA	
ENSG00000213673	SLC25A5P3	NA	
ENSG00000170419	VSTM2A	NA	
ENSG00000224223	VSTM2A-OT1	NA	
ENSG00000228735	AC011228.1	NA	
ENSG00000200471	RNU6-1125P	NA	
ENSG00000232612	RPL31P35	NA	
ENSG00000288525	AC011228.3	NA	
ENSG00000286404	AC011228.2	NA	
ENSG00000132432	SEC61G	NA	
ENSG00000234707	SEC61G-DT	NA	
ENSG00000218586	AC006971.1	NA	
ENSG00000146648	EGFR	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000146648	EGFR	616069	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2
ENSG00000224057	EGFR-AS1	NA	
ENSG00000280890	ELDR	NA	
ENSG00000237210	AC073324.1	NA	
ENSG00000230564	CALM1P2	NA	
ENSG00000230936	AC073347.1	NA	
ENSG00000132434	LANCL2	NA	
ENSG00000154978	VOPP1	NA	
ENSG00000223475	AC099681.1	NA	
ENSG00000233977	AC099681.3	NA	
ENSG00000231394	AC099681.2	NA	
ENSG00000234844	CDC42P2	NA	
ENSG00000235207	TUBBP6	NA	
ENSG00000231317	AC091812.1	NA	
ENSG00000176826	FKBP9P1	NA	
ENSG00000252857	RNU6-389P	NA	
ENSG00000275853	Metazoa_SRP	NA	
ENSG00000224971	SUMO2P3	NA	
ENSG00000237799	CICP11	NA	
ENSG00000275875	AC091812.3	NA	
ENSG00000273720	AC091812.2	NA	
ENSG00000226278	PSPHP1	NA	
ENSG00000206729	RNU6-1126P	NA	
ENSG00000154997	SEPTIN14	NA	
ENSG00000235738	AC092647.4	NA	
ENSG00000225270	CICP12	NA	
ENSG00000229762	AC092647.3	NA	
ENSG00000225018	AC092647.1	NA	
ENSG00000227499	AC092647.2	NA	
ENSG00000249773	AC092647.5	NA	
ENSG00000178665	ZNF713	NA	
ENSG00000146729	NIPSNAP2	NA	
ENSG00000239789	MRPS17	NA	
ENSG00000146733	PSPH	614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD
ENSG00000146731	CCT6A	NA	
ENSG00000206603	SNORA22B	NA	
ENSG00000207168	SNORA15	NA	
ENSG00000129103	SUMF2	NA	
ENSG00000164776	PHKG1	NA	
ENSG00000106153	CHCHD2	616710	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22
ENSG00000185290	NUPR2	NA	
ENSG00000230191	IFITM3P4	NA	
ENSG00000233028	AC006970.1	NA	
ENSG00000285670	AC006970.2	NA	
ENSG00000227491	CCNJP1	NA	
ENSG00000223559	AC073136.1	NA	
ENSG00000224155	AC073136.2	NA	
ENSG00000203462	AC093392.1	NA	
ENSG00000202296	RNU6-1335P	NA	
ENSG00000231299	SEPTIN14P24	NA	
ENSG00000225371	CICP8	NA	
ENSG00000224370	AC093392.2	NA	
ENSG00000223330	RNU6-1052P	NA	
ENSG00000232944	AC092423.1	NA	
ENSG00000237268	AC092447.7	NA	
ENSG00000278205	AC092447.10	NA	
ENSG00000225488	AC092447.4	NA	
ENSG00000226485	RBM22P3	NA	
ENSG00000261275	AC092447.8	NA	
ENSG00000231504	NMD3P2	NA	
ENSG00000223740	AC092447.3	NA	
ENSG00000233288	AC092447.5	NA	
ENSG00000224947	VN1R25P	NA	
ENSG00000213650	AC092447.2	NA	
ENSG00000234716	AC092447.6	NA	
ENSG00000213067	AC092447.1	NA	
ENSG00000271047	AC092447.9	NA	
ENSG00000287019	AC095038.5	NA	
ENSG00000229909	TRIM60P16	NA	
ENSG00000228303	AC095038.1	NA	
ENSG00000286477	AC095038.4	NA	
ENSG00000277174	AC095038.2	NA	
ENSG00000282879	AC095038.3	NA	
ENSG00000277253	AC118758.2	NA	
ENSG00000279072	AC118758.3	NA	
ENSG00000233437	AC118758.1	NA	
ENSG00000225244	AC069152.1	NA	
ENSG00000264426	MIR4283-1	NA	
ENSG00000189166	TNRC18P3	NA	
ENSG00000214668	SLC29A4P1	NA	
ENSG00000229508	PHKG1P4	NA	
ENSG00000275061	AC122133.1	NA	
ENSG00000185177	ZNF479	NA	
ENSG00000286436	AC099654.15	NA	
ENSG00000235095	AC099654.2	NA	
ENSG00000283431	AC099654.6	NA	
ENSG00000284474	AC099654.12	NA	
ENSG00000283547	AC099654.7	NA	
ENSG00000231537	MTCO3P10	NA	
ENSG00000283230	AC099654.5	NA	
ENSG00000283481	MTND4LP32	NA	
ENSG00000225295	MTND4P4	NA	
ENSG00000228440	MTND5P6	NA	
ENSG00000283311	MTND6P29	NA	
ENSG00000224880	MTCYBP29	NA	
ENSG00000224723	GUSBP10	NA	
ENSG00000230764	MTND1P4	NA	
ENSG00000237309	MTND2P6	NA	
ENSG00000236692	AC099654.3	NA	
ENSG00000284291	AC099654.11	NA	
ENSG00000284098	AC099654.9	NA	
ENSG00000283626	AC099654.8	NA	
ENSG00000228851	MTCO3P4	NA	
ENSG00000284558	AC099654.13	NA	
ENSG00000284221	AC099654.10	NA	
ENSG00000227584	MTND4P5	NA	
ENSG00000230531	MTND5P7	NA	
ENSG00000284572	AC099654.14	NA	
ENSG00000234671	MTCYBP5	NA	
ENSG00000169325	GUSBP12	NA	
ENSG00000234089	AC099654.1	NA	
ENSG00000238431	RNU7-157P	NA	
ENSG00000287517	AC099654.16	NA	
ENSG00000274299	AC099654.4	NA	
ENSG00000280225	AC237221.2	NA	
ENSG00000260653	AC237221.1	NA	
ENSG00000266168	MIR3147	NA	
ENSG00000227182	VN1R28P	NA	
ENSG00000235368	SAPCD2P2	NA	
ENSG00000182111	ZNF716	NA	
ENSG00000270957	AC092175.1	NA	
ENSG00000233601	NCOR1P3	NA	
ENSG00000243981	AC064862.6	NA	
ENSG00000270749	AC064862.7	NA	
ENSG00000229627	BSNDP4	NA	
ENSG00000230796	AC064862.1	NA	
ENSG00000237639	AC064862.5	NA	
ENSG00000233962	AC064862.2	NA	
ENSG00000236261	AC064862.4	NA	
ENSG00000234085	AC064862.3	NA	
ENSG00000227015	AC023141.4	NA	
ENSG00000232161	AC023141.8	NA	
ENSG00000230271	AC023141.5	NA	
ENSG00000250923	AC023141.12	NA	
ENSG00000224484	AC023141.2	NA	
ENSG00000236907	AC023141.9	NA	
ENSG00000250618	AC023141.11	NA	
ENSG00000224653	AC023141.3	NA	
ENSG00000223836	AC023141.1	NA	
ENSG00000237236	AC023141.10	NA	
ENSG00000231232	AC023141.6	NA	
ENSG00000231484	AC023141.7	NA	
ENSG00000271696	AC023141.13	NA	
ENSG00000233918	AC128676.1	NA	
ENSG00000207443	RNU6-417P	NA	
ENSG00000227148	AC069285.2	NA	
ENSG00000233454	AC069285.3	NA	
ENSG00000233782	ZNF90P3	NA	
ENSG00000234312	SAPCD2P4	NA	
ENSG00000231523	SEPTIN14P1	NA	
ENSG00000199231	AC069285.1	NA	
ENSG00000237572	AC092001.1	NA	
ENSG00000226075	PHKG1P1	NA	
ENSG00000244550	AC006455.8	NA	
ENSG00000240651	SEPTIN7P4	NA	
ENSG00000236638	AC006455.7	NA	
ENSG00000185037	ZNF733P	NA	
ENSG00000226587	AC006455.1	NA	
ENSG00000227298	ARAFP3	NA	
ENSG00000232165	AC006455.6	NA	
ENSG00000230000	AC006455.5	NA	
ENSG00000227545	AC006455.2	NA	
ENSG00000227923	AC006455.3	NA	
ENSG00000229301	AC006455.4	NA	
ENSG00000236284	VN1R31P	NA	
ENSG00000230361	VN1R32P	NA	
ENSG00000230600	AC073188.3	NA	
ENSG00000232817	AC073188.4	NA	
ENSG00000227305	AC073188.2	NA	
ENSG00000223889	AC073188.1	NA	
ENSG00000234387	AC073188.5	NA	
ENSG00000268181	AC073188.6	NA	
ENSG00000234467	SLC25A1P2	NA	
ENSG00000227426	VN1R33P	NA	
ENSG00000224368	ARAFP2	NA	
ENSG00000197990	ZNF734P	NA	
ENSG00000230132	AC006457.1	NA	
ENSG00000164740	SEPTIN7P5	NA	
ENSG00000228645	PHKG1P2	NA	
ENSG00000214660	SLC29A4P2	NA	
ENSG00000223566	TNRC18P2	NA	
ENSG00000265214	MIR4283-2	NA	
ENSG00000226401	AC006015.1	NA	
ENSG00000226411	AC079355.1	NA	
ENSG00000271466	CICP24	NA	
ENSG00000227397	AC079355.2	NA	
ENSG00000236574	AC092634.5	NA	
ENSG00000225451	AC092634.2	NA	
ENSG00000236299	AC092634.4	NA	
ENSG00000235720	GABPAP	NA	
ENSG00000226581	LINC02848	NA	
ENSG00000226342	NMD3P1	NA	
ENSG00000227910	AC092634.3	NA	
ENSG00000287588	AC092634.8	NA	
ENSG00000213645	SLC25A1P3	NA	
ENSG00000233173	VN1R34P	NA	
ENSG00000231264	ARAFP1	NA	
ENSG00000284534	AC092634.7	NA	
ENSG00000228660	VN1R35P	NA	
ENSG00000230639	VN1R36P	NA	
ENSG00000176232	AC092634.1	NA	
ENSG00000278577	AC092634.6	NA	
ENSG00000241149	ZNF722P	NA	
ENSG00000228564	LINC01005	NA	
ENSG00000286397	AC115220.2	NA	
ENSG00000285544	AC115220.1	NA	
ENSG00000214652	ZNF727	NA	
ENSG00000223558	TRIM60P17	NA	
ENSG00000224458	GUSBP6	NA	
ENSG00000248704	MTND4P2	NA	
ENSG00000248315	MTND4LP2	NA	
ENSG00000230052	MTND3P2	NA	
ENSG00000233385	MTCO3P8	NA	
ENSG00000227035	MTATP6P18	NA	
ENSG00000234234	MTCO2P8	NA	
ENSG00000234700	MTCO1P8	NA	
ENSG00000230252	MTND2P4	NA	
ENSG00000235646	MTND1P2	NA	
ENSG00000229881	AC091685.1	NA	
ENSG00000236976	AC091685.2	NA	
ENSG00000213643	VN1R37P	NA	
ENSG00000235227	VN1R38P	NA	
ENSG00000213644	SAPCD2P1	NA	
ENSG00000223614	ZNF735	NA	
ENSG00000197123	ZNF679	NA	
ENSG00000287699	AC073270.1	NA	
ENSG00000234444	ZNF736	NA	
ENSG00000227986	TRIM60P18	NA	
ENSG00000287985	AC073270.2	NA	
ENSG00000276650	AC022202.1	NA	
ENSG00000232727	YWHAEP1	NA	
ENSG00000223845	VN1R40P	NA	
ENSG00000228014	ZNF680P1	NA	
ENSG00000228653	HNRNPCP7	NA	
ENSG00000173041	ZNF680	NA	
ENSG00000223974	BNIP3P42	NA	
ENSG00000235349	AC016769.3	NA	
ENSG00000213642	AC016769.1	NA	
ENSG00000224669	AC016769.2	NA	
ENSG00000276475	AC016769.4	NA	
ENSG00000286456	AC016769.5	NA	
ENSG00000287317	AC016769.6	NA	
ENSG00000196247	ZNF107	NA	
ENSG00000271550	BNIP3P11	NA	
ENSG00000275667	MIR6839	NA	
ENSG00000224172	AC091799.1	NA	
ENSG00000277206	AC073349.3	NA	
ENSG00000197008	ZNF138	NA	
ENSG00000287580	AC073349.4	NA	
ENSG00000234338	AC073349.2	NA	
ENSG00000182722	SEPHS1P1	NA	
ENSG00000213640	EEF1DP4	NA	
ENSG00000287869	AC073349.5	NA	
ENSG00000198039	ZNF273	NA	
ENSG00000189316	AC073349.1	NA	
ENSG00000223476	VN1R42P	NA	
ENSG00000270948	MTDHP1	NA	
ENSG00000286342	AC073210.3	NA	
ENSG00000152926	ZNF117	NA	
ENSG00000213462	ERV3-1	NA	
ENSG00000201165	RNU6-1229P	NA	
ENSG00000234585	CCT6P3	NA	
ENSG00000239985	AC073210.2	NA	
ENSG00000207344	SNORA22C	NA	
ENSG00000207062	SNORA15B-1	NA	
ENSG00000227113	AC073210.1	NA	
ENSG00000226002	GTF2IP14	NA	
ENSG00000164669	INTS4P1	NA	
ENSG00000237026	AC104073.2	NA	
ENSG00000229064	AC104073.1	NA	
ENSG00000282381	AC104073.4	NA	
ENSG00000277544	AC104073.3	NA	
ENSG00000231556	RSL24D1P3	NA	
ENSG00000232906	AC092685.1	NA	
ENSG00000146757	ZNF92	NA	
ENSG00000238124	AC114501.3	NA	
ENSG00000226767	AC114501.1	NA	
ENSG00000235421	AC114501.2	NA	
ENSG00000230386	AC104057.1	NA	
ENSG00000272693	AC073107.1	NA	
ENSG00000273024	INTS4P2	NA	
ENSG00000228409	CCT6P1	NA	
ENSG00000206634	SNORA22	NA	
ENSG00000206785	SNORA15B-2	NA	
ENSG00000275833	AC073107.2	NA	
ENSG00000224316	GTF2IP5	NA	
ENSG00000200670	RNU6-912P	NA	
ENSG00000236529	AC093582.1	NA	
ENSG00000201560	RNU6-973P	NA	
ENSG00000196715	VKORC1L1	NA	
ENSG00000169919	GUSB	253220	MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7;;MPS VII;;SLY SYNDROME;;BETA-GLUCURONIDASE DEFICIENCY;;GUSB DEFICIENCY
ENSG00000224365	AC073261.1	NA	
ENSG00000229886	AC068533.2	NA	
ENSG00000205596	AC068533.1	NA	
ENSG00000126522	ASL	207900	ARGININOSUCCINIC ACIDURIA;;ARGININOSUCCINASE DEFICIENCY;;ARGININOSUCCINATE LYASE DEFICIENCY;;ASL DEFICIENCY;;ARGININOSUCCINIC ACID LYASE DEFICIENCY
ENSG00000249319	AC068533.4	NA	
ENSG00000241258	CRCP	NA	
ENSG00000234185	AC068533.3	NA	
ENSG00000169902	TPST1	NA	
ENSG00000252126	RNU6-313P	NA	
ENSG00000179406	LINC00174	NA	
ENSG00000251451	GTF2IP9	NA	
ENSG00000231234	SKP1P1	NA	
ENSG00000230189	AC008267.2	NA	
ENSG00000236928	AC008267.4	NA	
ENSG00000279785	AC008267.7	NA	
ENSG00000244510	AC008267.5	NA	
ENSG00000244657	AC008267.6	NA	
ENSG00000237310	GS1-124K5.4	NA	
ENSG00000179342	AC008267.1	NA	
ENSG00000234500	AC008267.3	NA	
ENSG00000229180	AC006001.3	NA	
ENSG00000275400	AC006001.4	NA	
ENSG00000232491	SAPCD2P3	NA	
ENSG00000177418	AC006001.1	NA	
ENSG00000225573	RPL35P5	NA	
ENSG00000243335	KCTD7	611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3;;CEROID LIPOFUSCINOSIS, NEURONAL, 14; CLN14
ENSG00000284461	AC027644.4	NA	
ENSG00000226824	AC006001.2	NA	
ENSG00000154710	RABGEF1	NA	
ENSG00000272831	AC027644.3	NA	
ENSG00000271064	AC027644.2	NA	
ENSG00000230583	GTF2IRD1P1	NA	
ENSG00000232546	AC027644.1	NA	
ENSG00000230295	GTF2IP23	NA	
ENSG00000212568	RNU6-1254P	NA	
ENSG00000273142	LINC02604	NA	
ENSG00000179131	AC073335.1	NA	
ENSG00000274135	AC073335.2	NA	
ENSG00000106609	TMEM248	NA	
ENSG00000275878	RN7SL43P	NA	
ENSG00000126524	SBDS	260400	SHWACHMAN-DIAMOND SYNDROME 1; SDS1;;SHWACHMAN-DIAMOND SYNDROME; SDS;;PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION;;SHWACHMAN-BODIAN SYNDROME;;LIPOMATOSIS OF PANCREAS, CONGENITAL
ENSG00000126524	SBDS	609135	APLASTIC ANEMIA APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000198874	TYW1	NA	
ENSG00000233383	AC073089.1	NA	
ENSG00000266525	MIR4650-1	NA	
ENSG00000067601	PMS2P4	NA	
ENSG00000230358	SPDYE21	NA	
ENSG00000201565	Y_RNA	NA	
ENSG00000106610	STAG3L4	NA	
ENSG00000228019	AC006480.1	NA	
ENSG00000273448	AC006480.2	NA	
ENSG00000226392	MTATP6P21	NA	
ENSG00000237466	MTCO3P41	NA	
ENSG00000233423	AC005482.1	NA	
ENSG00000223948	AC092648.1	NA	
ENSG00000225209	AC092637.1	NA	
ENSG00000236531	AC006013.1	NA	
ENSG00000232975	MTCO1P57	NA	
ENSG00000226829	AC093655.1	NA	
ENSG00000237754	AC093655.2	NA	
ENSG00000225959	MTND4P3	NA	
ENSG00000228429	AC004910.1	NA	
ENSG00000222428	RNA5SP231	NA	
ENSG00000233689	AC104688.1	NA	
ENSG00000200189	RNU6-832P	NA	
ENSG00000286466	AC069280.2	NA	
ENSG00000225718	AC092100.1	NA	
ENSG00000236839	AC069280.1	NA	
ENSG00000230654	MTCO2P25	NA	
ENSG00000229031	MTCO1P25	NA	
ENSG00000252423	RNU6-229P	NA	
ENSG00000200857	Y_RNA	NA	
ENSG00000234215	CT66	NA	
ENSG00000158321	AUTS2	615834	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26
ENSG00000236978	AC073873.1	NA	
ENSG00000185274	GALNT17	NA	
ENSG00000265878	MIR3914-1	NA	
ENSG00000283278	MIR3914-2	NA	
ENSG00000199940	RN7SKP75	NA	
ENSG00000183166	CALN1	NA	
ENSG00000201014	RNA5SP232	NA	
ENSG00000235581	AC005011.1	NA	
ENSG00000228769	ABCF2P2	NA	
ENSG00000277149	TYW1B	NA	
ENSG00000264494	MIR4650-2	NA	
ENSG00000270694	AC211469.2	NA	
ENSG00000270555	AC211469.1	NA	
ENSG00000266569	RN7SL377P	NA	
ENSG00000225648	SBDSP1	NA	
ENSG00000274656	RN7SL625P	NA	
ENSG00000179994	SPDYE7P	NA	
ENSG00000196313	POM121	NA	
ENSG00000272843	AC211476.2	NA	
ENSG00000106133	NSUN5P2	NA	
ENSG00000285886	AC211476.7	NA	
ENSG00000155428	TRIM74	NA	
ENSG00000174353	STAG3L3	NA	
ENSG00000205584	AC211476.1	NA	
ENSG00000276178	Y_RNA	NA	
ENSG00000229018	PMS2P7	NA	
ENSG00000201282	Y_RNA	NA	
ENSG00000273520	SPDYE8	NA	
ENSG00000273897	AC211476.3	NA	
ENSG00000273927	Y_RNA	NA	
ENSG00000285702	AC211476.6	NA	
ENSG00000275976	AC211476.4	NA	
ENSG00000286228	SPDYE11	NA	
ENSG00000277125	AC211476.5	NA	
ENSG00000274984	Y_RNA	NA	
ENSG00000262461	SPDYE9	NA	
ENSG00000174384	PMS2P6	NA	
ENSG00000199913	Y_RNA	NA	
ENSG00000274570	SPDYE10P	NA	
ENSG00000233369	GTF2IP4	NA	
ENSG00000233523	PHBP5	NA	
ENSG00000182487	NCF1B	NA	
ENSG00000214544	GTF2IRD2P1	NA	
ENSG00000205578	POM121B	NA	
ENSG00000130305	NSUN5	NA	
ENSG00000146755	TRIM50	NA	
ENSG00000225005	AC211485.1	NA	
ENSG00000077800	FKBP6	NA	
ENSG00000206709	RNU6-1080P	NA	
ENSG00000202035	Y_RNA	NA	
ENSG00000188763	FZD9	NA	
ENSG00000009954	BAZ1B	NA	
ENSG00000252713	RNU6-1198P	NA	
ENSG00000106635	BCL7B	NA	
ENSG00000106638	TBL2	NA	
ENSG00000009950	MLXIPL	194050	WILLIAMS-BEUREN SYNDROME; WBS;;CHROMOSOME 7q11.23 DELETION SYNDROME, 1.5- TO 1.8-MB;;WILLIAMS SYNDROME; WMS; WS
ENSG00000274080	AC005089.1	NA	
ENSG00000176428	VPS37D	NA	
ENSG00000176410	DNAJC30	NA	
ENSG00000071462	BUD23	NA	
ENSG00000106089	STX1A	NA	
ENSG00000265724	MIR4284	NA	
ENSG00000241709	RN7SL265P	NA	
ENSG00000225969	ABHD11-AS1	NA	
ENSG00000106077	ABHD11	NA	
ENSG00000165215	CLDN3	NA	
ENSG00000189143	CLDN4	NA	
ENSG00000165171	METTL27	NA	
ENSG00000175877	TMEM270	NA	
ENSG00000261467	AC099398.1	NA	
ENSG00000049540	ELN	185500	SUPRAVALVULAR AORTIC STENOSIS; SVAS;;SUPRAVALVAR AORTIC STENOSIS, EISENBERG TYPE
ENSG00000049540	ELN	123700	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1
ENSG00000049540	ELN	194050	WILLIAMS-BEUREN SYNDROME; WBS;;CHROMOSOME 7q11.23 DELETION SYNDROME, 1.5- TO 1.8-MB;;WILLIAMS SYNDROME; WMS; WS
ENSG00000232415	ELN-AS1	NA	
ENSG00000106683	LIMK1	NA	
ENSG00000106682	EIF4H	NA	
ENSG00000207741	MIR590	NA	
ENSG00000086730	LAT2	NA	
ENSG00000049541	RFC2	NA	
ENSG00000287815	AC005081.1	NA	
ENSG00000106665	CLIP2	NA	
ENSG00000006704	GTF2IRD1	NA	
ENSG00000238391	RNA5SP233	NA	
ENSG00000273069	AC211433.2	NA	
ENSG00000279005	AC211433.3	NA	
ENSG00000263001	GTF2I	NA	
ENSG00000232729	AC211433.1	NA	
ENSG00000262648	PHBP15	NA	
ENSG00000158517	NCF1	233700	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1;;CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVE, TYPE I;;GRANULOMATOUS DISEASE, CHRONIC, DUE TO NCF1 DEFICIENCY;;NEUTROPHIL CYTOSOL FACTOR 1, DEFICIENCY OF;;NCF /.../ICIENCY OF;;SOLUBLE OXIDASE COMPONENT II, DEFICIENCY OF;;SOC2, DEFICIENCY OF;;p47-PHOX, DEFICIENCY OF
ENSG00000196275	GTF2IRD2	NA	
ENSG00000277072	STAG3L2	NA	
ENSG00000184616	SPDYE12P	NA	
ENSG00000123965	PMS2P5	NA	
ENSG00000239069	Y_RNA	NA	
ENSG00000274070	CASTOR2	NA	
ENSG00000274523	RCC1L	NA	
ENSG00000277127	Metazoa_SRP	NA	
ENSG00000174428	GTF2IRD2B	NA	
ENSG00000165178	NCF1C	NA	
ENSG00000277053	GTF2IP1	NA	
ENSG00000276592	PHBP6	NA	
ENSG00000277675	AC211486.5	NA	
ENSG00000263081	AC211486.2	NA	
ENSG00000275121	AC211486.4	NA	
ENSG00000286038	SPDYE13	NA	
ENSG00000276840	PMS2P10	NA	
ENSG00000267828	Y_RNA	NA	
ENSG00000286137	SPDYE14	NA	
ENSG00000273598	AC211486.3	NA	
ENSG00000202021	Y_RNA	NA	
ENSG00000286014	SPDYE15	NA	
ENSG00000278416	PMS2P2	NA	
ENSG00000199870	Y_RNA	NA	
ENSG00000205583	STAG3L1	NA	
ENSG00000275930	Y_RNA	NA	
ENSG00000146722	AC211486.1	NA	
ENSG00000178809	TRIM73	NA	
ENSG00000223705	NSUN5P1	NA	
ENSG00000272391	POM121C	NA	
ENSG00000242073	AC211429.1	NA	
ENSG00000170092	SPDYE5	NA	
ENSG00000127957	PMS2P3	NA	
ENSG00000200874	Y_RNA	NA	
ENSG00000127946	HIP1	NA	
ENSG00000279996	AC004491.1	NA	
ENSG00000006606	CCL26	NA	
ENSG00000106178	CCL24	NA	
ENSG00000219039	AC005102.1	NA	
ENSG00000005486	RHBDD2	NA	
ENSG00000127948	POR	201750	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1
ENSG00000127948	POR	207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2;;TRAPEZOIDOCEPHALY-SYNOSTOSIS SYNDROME;;MULTISYNOSTOTIC OSTEODYSGENESIS WITH LONG BONE FRACTURES;;OSTEODYSGENESIS, MULTISYNOSTOTIC, WITH FRACTURES
ENSG00000127948	POR	613571	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY;;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY;;DISORDERED STEROIDOGENESIS DUE TO POR DEFICIENCY
ENSG00000284334	MIR4651	NA	
ENSG00000235090	RPL7L1P3	NA	
ENSG00000201643	SNORA14A	NA	
ENSG00000189077	TMEM120A	NA	
ENSG00000127952	STYXL1	NA	
ENSG00000280388	AC006330.1	NA	
ENSG00000146701	MDH2	617339	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51
ENSG00000230882	AC005077.4	NA	
ENSG00000251798	RNU6-863P	NA	
ENSG00000227038	GTF2IP7	NA	
ENSG00000224273	AC005077.2	NA	
ENSG00000213549	AC005077.1	NA	
ENSG00000228829	AC005077.3	NA	
ENSG00000177679	SRRM3	NA	
ENSG00000106211	HSPB1	606595	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2F;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2F
ENSG00000106211	HSPB1	608634	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B;;HMN IIB;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; DHMN2B
ENSG00000170027	YWHAG	617665	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56
ENSG00000213548	PPIAP81	NA	
ENSG00000146700	SSC4D	NA	
ENSG00000188372	ZP3	617712	OOCYTE MATURATION DEFECT 3; OOMD3
ENSG00000091073	DTX2	NA	
ENSG00000233980	FDPSP2	NA	
ENSG00000250614	AC005522.1	NA	
ENSG00000243566	UPK3B	NA	
ENSG00000250778	AC004980.4	NA	
ENSG00000238560	Y_RNA	NA	
ENSG00000230305	AC004980.3	NA	
ENSG00000185040	SPDYE16	NA	
ENSG00000205485	AC004980.1	NA	
ENSG00000146707	POMZP3	NA	
ENSG00000214243	AC004980.2	NA	
ENSG00000285666	AC006972.1	NA	
ENSG00000231183	AC007003.1	NA	
ENSG00000265479	DTX2P1-UPK3BP1-PMS2P11	NA	
ENSG00000231087	FDPSP7	NA	
ENSG00000225703	AC114737.2	NA	
ENSG00000186704	DTX2P1	NA	
ENSG00000242435	UPK3BP1	NA	
ENSG00000241350	PMS2P11	NA	
ENSG00000201885	AC114737.1	NA	
ENSG00000186645	SPDYE17	NA	
ENSG00000233448	PMS2P9	NA	
ENSG00000201959	AC007000.1	NA	
ENSG00000259628	AC007000.4	NA	
ENSG00000205482	SPDYE18	NA	
ENSG00000225726	AC007000.3	NA	
ENSG00000214439	FAM185BP	NA	
ENSG00000213542	AC007000.2	NA	
ENSG00000135205	CCDC146	NA	
ENSG00000127951	FGL2	NA	
ENSG00000250990	AC098851.1	NA	
ENSG00000186088	GSAP	NA	
ENSG00000273341	AC004921.1	NA	
ENSG00000237620	GCNT1P5	NA	
ENSG00000287519	AC004921.2	NA	
ENSG00000127947	PTPN12	NA	
ENSG00000214293	APTR	NA	
ENSG00000187257	RSBN1L	NA	
ENSG00000135211	TMEM60	NA	
ENSG00000006576	PHTF2	NA	
ENSG00000222432	AC073520.1	NA	
ENSG00000232756	AC004990.1	NA	
ENSG00000187391	MAGI2	617609	NEPHROTIC SYNDROME, TYPE 15; NPHS15
ENSG00000281008	AC004808.2	NA	
ENSG00000280958	AC004808.1	NA	
ENSG00000231322	RPL13AP17	NA	
ENSG00000285892	AC006043.1	NA	
ENSG00000226230	AC007237.1	NA	
ENSG00000251276	MAGI2-AS1	NA	
ENSG00000226978	MAGI2-AS2	NA	
ENSG00000212545	RNU6-337P	NA	
ENSG00000229110	AC006355.1	NA	
ENSG00000281120	AC006355.2	NA	
ENSG00000286855	AC074024.1	NA	
ENSG00000212482	RNU6-530P	NA	
ENSG00000222024	AC004945.1	NA	
ENSG00000234456	MAGI2-AS3	NA	
ENSG00000226285	NUP35P2	NA	
ENSG00000200786	RNA5SP234	NA	
ENSG00000287488	AC073048.1	NA	
ENSG00000127955	GNAI1	NA	
ENSG00000206818	RNU6-849P	NA	
ENSG00000230853	RPL10P11	NA	
ENSG00000244392	RN7SL869P	NA	
ENSG00000234223	AC003988.1	NA	
ENSG00000232667	AC004862.1	NA	
ENSG00000240347	RN7SL35P	NA	
ENSG00000135218	CD36	608404	PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY
ENSG00000135218	CD36	610938	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7
ENSG00000135218	CD36	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000223550	SNRPBP1	NA	
ENSG00000214415	GNAT3	NA	
ENSG00000229436	AC073850.1	NA	
ENSG00000075223	SEMA3C	NA	
ENSG00000279326	AC004972.1	NA	
ENSG00000237896	AC005008.2	NA	
ENSG00000226671	AC005008.1	NA	
ENSG00000223514	AC004866.1	NA	
ENSG00000224134	AC004866.2	NA	
ENSG00000232968	EIF4EP4	NA	
ENSG00000233491	AC008163.1	NA	
ENSG00000230196	DDX43P3	NA	
ENSG00000019991	HGF	608265	DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39
ENSG00000153956	CACNA2D1	NA	
ENSG00000223770	CACNA2D1-AS1	NA	
ENSG00000213530	MTHFD2P5	NA	
ENSG00000228711	AC004006.1	NA	
ENSG00000186472	PCLO	608027	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY
ENSG00000202281	RNA5SP235	NA	
ENSG00000235503	AC079799.1	NA	
ENSG00000170381	SEMA3E	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000170381	SEMA3E	214800	CHARGE SYNDROME;;CHARGE ASSOCIATION--COLOBOMA, HEART ANOMALY, CHOANAL ATRESIA, RETARDATION, GENITAL AND EAR ANOMALIES;;HALL-HITTNER SYNDROME; HHS
ENSG00000285398	AC079799.2	NA	
ENSG00000230617	AC079987.1	NA	
ENSG00000230244	RAD23BP2	NA	
ENSG00000075213	SEMA3A	614897	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16
ENSG00000227982	RPL7P30	NA	
ENSG00000235139	AC003984.1	NA	
ENSG00000235243	AC093716.1	NA	
ENSG00000232605	HMGN2P11	NA	
ENSG00000280325	AC074183.2	NA	
ENSG00000232019	AC074183.1	NA	
ENSG00000229251	HNRNPA1P8	NA	
ENSG00000153993	SEMA3D	NA	
ENSG00000224059	HSPA8P16	NA	
ENSG00000230614	DYNLL1P7	NA	
ENSG00000225128	LINC00972	NA	
ENSG00000227785	AC092013.1	NA	
ENSG00000236610	SOCS5P1	NA	
ENSG00000198822	GRM3	NA	
ENSG00000231255	AC005009.1	NA	
ENSG00000233073	GRM3-AS1	NA	
ENSG00000164659	ELAPOR2	NA	
ENSG00000261462	AC004023.1	NA	
ENSG00000224046	AC005076.1	NA	
ENSG00000135164	DMTF1	NA	
ENSG00000278236	AC005076.2	NA	
ENSG00000135185	TMEM243	NA	
ENSG00000200397	Y_RNA	NA	
ENSG00000182165	TP53TG1	NA	
ENSG00000273623	AC005045.1	NA	
ENSG00000276185	AC005045.2	NA	
ENSG00000005469	CROT	NA	
ENSG00000005471	ABCB4	600803	GALLBLADDER DISEASE 1; GBD1;;CHOLELITHIASIS, LOW PHOSPHOLIPID-ASSOCIATED; LPAC
ENSG00000005471	ABCB4	602347	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3;;MDR3 DEFICIENCY;;CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, WITH ELEVATED SERUM GAMMA-GLUTAMYLTRANSFERASE
ENSG00000005471	ABCB4	614972	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3
ENSG00000085563	ABCB1	120080	COLCHICINE RESISTANCE;;COLCHICINE SENSITIVITY; CLCS
ENSG00000085563	ABCB1	612244	INFLAMMATORY BOWEL DISEASE 13; IBD13
ENSG00000231956	HNRNPA1P9	NA	
ENSG00000105784	RUNDC3B	NA	
ENSG00000075303	SLC25A40	NA	
ENSG00000006634	DBF4	NA	
ENSG00000008277	ADAM22	617933	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61
ENSG00000075142	SRI	NA	
ENSG00000254003	AC003991.2	NA	
ENSG00000228113	AC003991.1	NA	
ENSG00000127954	STEAP4	NA	
ENSG00000233420	AC002069.2	NA	
ENSG00000225701	EIF4A1P13	NA	
ENSG00000207094	AC002069.1	NA	
ENSG00000270812	AC002069.4	NA	
ENSG00000235639	AC002069.3	NA	
ENSG00000228928	KPNA2P2	NA	
ENSG00000231763	PQLC1P1	NA	
ENSG00000237709	EEF1A1P28	NA	
ENSG00000227979	AC002127.1	NA	
ENSG00000182348	ZNF804B	NA	
ENSG00000164645	TEX47	NA	
ENSG00000227863	AC002383.1	NA	
ENSG00000239075	RNU6-274P	NA	
ENSG00000227646	STEAP2-AS1	NA	
ENSG00000238358	AC004969.1	NA	
ENSG00000235436	DPY19L2P4	NA	
ENSG00000164647	STEAP1	NA	
ENSG00000157214	STEAP2	NA	
ENSG00000105792	CFAP69	617959	SPERMATOGENIC FAILURE 24; SPGF24
ENSG00000207488	Y_RNA	NA	
ENSG00000234459	AC002064.2	NA	
ENSG00000225498	AC002064.1	NA	
ENSG00000283267	FAM237B	NA	
ENSG00000105793	GTPBP10	NA	
ENSG00000280440	AC002064.3	NA	
ENSG00000157224	CLDN12	NA	
ENSG00000273299	AC006153.1	NA	
ENSG00000058091	CDK14	NA	
ENSG00000251154	AC002456.2	NA	
ENSG00000223969	AC002456.1	NA	
ENSG00000223584	TVP23CP1	NA	
ENSG00000286411	AC002458.1	NA	
ENSG00000226254	PTP4A1P3	NA	
ENSG00000157240	FZD1	NA	
ENSG00000243144	AC079760.2	NA	
ENSG00000225843	NIPA2P1	NA	
ENSG00000235450	AC079760.1	NA	
ENSG00000223665	AC000058.1	NA	
ENSG00000127989	MTERF1	NA	
ENSG00000287672	AC003086.1	NA	
ENSG00000127914	AKAP9	611820	LONG QT SYNDROME 11; LQT11
ENSG00000001630	CYP51A1	NA	
ENSG00000285772	AC000120.3	NA	
ENSG00000285953	AC000120.4	NA	
ENSG00000188693	CYP51A1-AS1	NA	
ENSG00000240720	LRRD1	NA	
ENSG00000001631	KRIT1	116860	CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONS CEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, I /.../D;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATED WITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED
ENSG00000243107	AC000120.2	NA	
ENSG00000200769	AC000120.1	NA	
ENSG00000221520	MIR1285-1	NA	
ENSG00000001629	ANKIB1	NA	
ENSG00000230927	TMBIM7P	NA	
ENSG00000270453	AC007566.2	NA	
ENSG00000157259	GATAD1	614672	CARDIOMYOPATHY, DILATED, 2B; CMD2B
ENSG00000244055	AC007566.1	NA	
ENSG00000242950	ERVW-1	NA	
ENSG00000127980	PEX1	214100	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A;;ZS; ZWS;;CEREBROHEPATORENAL SYNDROME; CHR PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 1, INCLUDED; CG1, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP E, INCLUDED; CGE, /.../DED
ENSG00000127980	PEX1	234580	HEIMLER SYNDROME 1; HMLR1;;HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;;PEROXISOME BIOGENESIS DISORDER 1C; PBD1C
ENSG00000127980	PEX1	601539	PEROXISOME BIOGENESIS DISORDER 1B; PBD1B;;PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE);;PEROXISOME BIOGENESIS DISORDER (NALD/IRD);;ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL;;REFSUM DISEASE, INFANTILE;;INFANT /.../YTANIC ACID STORAGE DISEASE
ENSG00000127993	RBM48	NA	
ENSG00000278819	AC005156.1	NA	
ENSG00000234545	FAM133B	NA	
ENSG00000105810	CDK6	616080	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12
ENSG00000287932	AC000065.2	NA	
ENSG00000286742	AC000065.1	NA	
ENSG00000206763	RNU6-10P	NA	
ENSG00000237819	CDK6-AS1	NA	
ENSG00000266794	RN7SL7P	NA	
ENSG00000205413	SAMD9	610455	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC;;CALCINOSIS, TUMORAL, WITH NORMOPHOSPHATEMIA
ENSG00000205413	SAMD9	617053	MIRAGE SYNDROME; MIRAGE;;MYELODYSPLASIA, INFECTION, RESTRICTION OF GROWTH, ADRENAL HYPOPLASIA, GENITAL PHENOTYPES, AND ENTEROPATHY
ENSG00000177409	SAMD9L	159550	ATAXIA-PANCYTOPENIA SYNDROME; ATXPC;;MYELOCEREBELLAR DISORDER
ENSG00000188175	HEPACAM2	NA	
ENSG00000004766	VPS50	NA	
ENSG00000004948	CALCR	166710	OSTEOPOROSIS;;BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS; BMND;;OSTEOPOROSIS, POSTMENOPAUSAL;;OSTEOPOROSIS, INVOLUTIONAL  FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED
ENSG00000208014	MIR653	NA	
ENSG00000207656	MIR489	NA	
ENSG00000127928	GNGT1	NA	
ENSG00000237729	AC002075.2	NA	
ENSG00000265423	MIR4652	NA	
ENSG00000225898	AC002075.1	NA	
ENSG00000213483	NDUFAF4P2	NA	
ENSG00000105825	TFPI2	NA	
ENSG00000234695	AC002076.1	NA	
ENSG00000278388	AC002076.2	NA	
ENSG00000127920	GNG11	NA	
ENSG00000278959	AC006378.1	NA	
ENSG00000105829	BET1	NA	
ENSG00000236861	BET1-AS1	NA	
ENSG00000236453	AC003092.1	NA	
ENSG00000236938	AC003092.2	NA	
ENSG00000285090	AC002074.1	NA	
ENSG00000285964	AC002074.2	NA	
ENSG00000164692	COL1A2	166710	OSTEOPOROSIS;;BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS; BMND;;OSTEOPOROSIS, POSTMENOPAUSAL;;OSTEOPOROSIS, INVOLUTIONAL  FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED
ENSG00000164692	COL1A2	166220	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4;;OI, TYPE IV;;OSTEOGENESIS IMPERFECTA WITH NORMAL SCLERAE
ENSG00000164692	COL1A2	166210	OSTEOGENESIS IMPERFECTA, TYPE II; OI2;;OI, TYPE II;;OSTEOGENESIS IMPERFECTA CONGENITA, PERINATAL LETHAL FORM;;OSTEOGENESIS IMPERFECTA CONGENITA; OIC;;VROLIK TYPE OF OSTEOGENESIS IMPERFECTA
ENSG00000164692	COL1A2	225320	EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE; EDSCV
ENSG00000164692	COL1A2	259420	OSTEOGENESIS IMPERFECTA, TYPE III; OI3;;OI, TYPE III;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
ENSG00000164692	COL1A2	617821	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2;;EHLERS-DANLOS SYNDROME, TYPE VIIB, AUTOSOMAL DOMINANT; EDS7B;;EDS VIIB
ENSG00000222870	RNU6-1328P	NA	
ENSG00000127995	CASD1	NA	
ENSG00000127990	SGCE	159900	DYSTONIA 11, MYOCLONIC; DYT11;;MYOCLONUS-DYSTONIA SYNDROME;;MYOCLONIC DYSTONIA;;DYSTONIA, ALCOHOL-RESPONSIVE;;MYOCLONUS, HEREDITARY ESSENTIAL
ENSG00000242265	PEG10	NA	
ENSG00000232385	RPS3AP25	NA	
ENSG00000239030	RNU6-956P	NA	
ENSG00000214342	ATP5PBP2	NA	
ENSG00000230682	GRPEL2P3	NA	
ENSG00000222220	RN7SKP129	NA	
ENSG00000219807	ARF1P1	NA	
ENSG00000158528	PPP1R9A	NA	
ENSG00000271159	HINT1P2	NA	
ENSG00000231153	AC002429.1	NA	
ENSG00000236197	PPP1R9A-AS1	NA	
ENSG00000201607	RNU4-16P	NA	
ENSG00000005421	PON1	168820	PARAOXONASE 1; PON1;;PON;;PARAOXONASE, PLASMA;;ARYLESTERASE;;ESTERASE A; ESA PON1 ENZYME ACTIVITY, VARIATION IN, INCLUDED;;ORGANOPHOSPHATE POISONING, SUSCEPTIBILITY TO, INCLUDED;;CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO, INCLUDED;;CORONARY ARTERY  /.../2, SUSCEPTIBILITY TO, INCLUDED
ENSG00000005421	PON1	612633	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5;;RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO
ENSG00000237160	AC004022.2	NA	
ENSG00000228751	AC004022.1	NA	
ENSG00000105852	PON3	NA	
ENSG00000105854	PON2	NA	
ENSG00000273138	AC005021.1	NA	
ENSG00000233942	AC004012.1	NA	
ENSG00000005981	ASB4	NA	
ENSG00000279525	AC002451.2	NA	
ENSG00000231170	AC002451.1	NA	
ENSG00000004799	PDK4	NA	
ENSG00000158560	DYNC1I1	NA	
ENSG00000279067	AC002540.1	NA	
ENSG00000004864	SLC25A13	603471	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY
ENSG00000004864	SLC25A13	605814	CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CITRULLINEMIA, TYPE II, NEONATAL-ONSET, WITH OR WITHOUT FAILURE TO THRIVE AND DYSLIPIDEMIA;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD
ENSG00000208025	MIR591	NA	
ENSG00000237551	AC096775.1	NA	
ENSG00000275834	AC084368.1	NA	
ENSG00000207045	RNU6-532P	NA	
ENSG00000207115	RNU6-364P	NA	
ENSG00000252872	RNU7-188P	NA	
ENSG00000127922	SEM1	NA	
ENSG00000227284	MARK2P10	NA	
ENSG00000244318	RN7SL252P	NA	
ENSG00000231764	DLX6-AS1	NA	
ENSG00000274409	AC004774.1	NA	
ENSG00000277124	AC004774.3	NA	
ENSG00000006377	DLX6	NA	
ENSG00000274709	AC004774.2	NA	
ENSG00000105880	DLX5	220600	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE; SHFM1D;;DEAFNESS, CONGENITAL, WITH SPLIT HANDS AND FEET
ENSG00000196636	SDHAF3	NA	
ENSG00000224551	HMGB3P21	NA	
ENSG00000224475	AC073900.1	NA	
ENSG00000226046	AP1S2P1	NA	
ENSG00000199475	RN7SKP104	NA	
ENSG00000006128	TAC1	NA	
ENSG00000070669	ASNS	615574	ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD;;ASNS DEFICIENCY
ENSG00000284707	AC079781.5	NA	
ENSG00000226744	AC005326.1	NA	
ENSG00000231812	SNRPCP9	NA	
ENSG00000237818	RPS3AP29	NA	
ENSG00000231859	AC079781.1	NA	
ENSG00000232032	AC079781.2	NA	
ENSG00000284627	AC079781.4	NA	
ENSG00000232097	AC079781.3	NA	
ENSG00000238228	OR7E7P	NA	
ENSG00000266318	MIR5692A1	NA	
ENSG00000266668	MIR5692C2	NA	
ENSG00000183444	OR7E38P	NA	
ENSG00000285725	AC004967.2	NA	
ENSG00000243554	AC004967.1	NA	
ENSG00000135175	OCM2	NA	
ENSG00000277946	RN7SL478P	NA	
ENSG00000164715	LMTK2	NA	
ENSG00000180535	BHLHA15	NA	
ENSG00000205356	TECPR1	NA	
ENSG00000164713	BRI3	NA	
ENSG00000006453	BAIAP2L1	NA	
ENSG00000272950	AC093799.1	NA	
ENSG00000214389	RPS3AP26	NA	
ENSG00000213455	PPIAP82	NA	
ENSG00000223402	AC074121.1	NA	
ENSG00000106236	NPTX2	NA	
ENSG00000207204	RNU6-393P	NA	
ENSG00000166448	TMEM130	NA	
ENSG00000196367	TRRAP	618454	DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA
ENSG00000196367	TRRAP	618778	DEAFNESS, AUTOSOMAL DOMINANT 75; DFNA75
ENSG00000266019	MIR3609	NA	
ENSG00000286305	AC004893.2	NA	
ENSG00000238109	RNF14P3	NA	
ENSG00000198742	SMURF1	NA	
ENSG00000284840	AC004893.1	NA	
ENSG00000185467	KPNA7	NA	
ENSG00000002079	MYH16	NA	
ENSG00000284523	AC004834.1	NA	
ENSG00000284292	AC004922.1	NA	
ENSG00000241685	ARPC1A	NA	
ENSG00000130429	ARPC1B	617718	PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID
ENSG00000106244	PDAP1	NA	
ENSG00000106245	BUD31	NA	
ENSG00000106246	PTCD1	NA	
ENSG00000248919	ATP5MF-PTCD1	NA	
ENSG00000160917	CPSF4	NA	
ENSG00000228335	AC073063.1	NA	
ENSG00000241468	ATP5MF	NA	
ENSG00000198556	ZNF789	NA	
ENSG00000160908	ZNF394	NA	
ENSG00000196652	ZKSCAN5	NA	
ENSG00000221909	FAM200A	NA	
ENSG00000197343	ZNF655	NA	
ENSG00000272647	AC005020.2	NA	
ENSG00000244219	TMEM225B	NA	
ENSG00000197037	ZSCAN25	NA	
ENSG00000224448	AC005020.1	NA	
ENSG00000106258	CYP3A5	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000282301	CYP3A7-CYP3A51P	NA	
ENSG00000282277	CYP3A51P	NA	
ENSG00000160870	CYP3A7	NA	
ENSG00000160868	CYP3A4	NA	
ENSG00000273407	AC069294.1	NA	
ENSG00000261511	CYP3A137P	NA	
ENSG00000021461	CYP3A43	NA	
ENSG00000260445	AC011904.1	NA	
ENSG00000260524	CYP3A52P	NA	
ENSG00000244623	OR2AE1	NA	
ENSG00000146833	TRIM4	NA	
ENSG00000176402	GJC3	NA	
ENSG00000237640	AC004522.3	NA	
ENSG00000199711	Y_RNA	NA	
ENSG00000222966	AC004522.1	NA	
ENSG00000160862	AZGP1	NA	
ENSG00000286921	AC004522.4	NA	
ENSG00000214313	AZGP1P1	NA	
ENSG00000235713	AC004522.2	NA	
ENSG00000286923	AC004522.5	NA	
ENSG00000106261	ZKSCAN1	NA	
ENSG00000166529	ZSCAN21	NA	
ENSG00000166526	ZNF3	NA	
ENSG00000168090	COPS6	NA	
ENSG00000166508	MCM7	NA	
ENSG00000207547	MIR25	NA	
ENSG00000207757	MIR93	NA	
ENSG00000208036	MIR106B	NA	
ENSG00000221838	AP4M1	612936	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY
ENSG00000106290	TAF6	617126	ALAZAMI-YUAN SYNDROME; ALYUS
ENSG00000242798	AC073842.2	NA	
ENSG00000166997	CNPY4	NA	
ENSG00000214309	MBLAC1	NA	
ENSG00000235077	AC073842.1	NA	
ENSG00000214142	RPL7P60	NA	
ENSG00000188186	LAMTOR4	NA	
ENSG00000146826	MAP11	618351	MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25
ENSG00000284518	MIR4658	NA	
ENSG00000197093	GAL3ST4	NA	
ENSG00000213420	GPC2	NA	
ENSG00000066923	STAG3	615723	PREMATURE OVARIAN FAILURE 8; POF8
ENSG00000239521	CASTOR3	NA	
ENSG00000213413	PVRIG	NA	
ENSG00000214300	SPDYE3	NA	
ENSG00000078319	PMS2P1	NA	
ENSG00000201913	AC005071.1	NA	
ENSG00000242294	STAG3L5P	NA	
ENSG00000272752	STAG3L5P-PVRIG2P-PILRB	NA	
ENSG00000121716	PILRB	NA	
ENSG00000235333	PVRIG2P	NA	
ENSG00000284012	MIR6840	NA	
ENSG00000085514	PILRA	NA	
ENSG00000287631	AC005071.2	NA	
ENSG00000078487	ZCWPW1	NA	
ENSG00000146834	MEPCE	NA	
ENSG00000241357	AC092849.1	NA	
ENSG00000160813	PPP1R35	NA	
ENSG00000240211	PPP1R35-AS1	NA	
ENSG00000185955	C7orf61	NA	
ENSG00000166925	TSC22D4	NA	
ENSG00000286938	AC092849.2	NA	
ENSG00000166924	NYAP1	NA	
ENSG00000225807	AC069281.1	NA	
ENSG00000242101	RN7SL416P	NA	
ENSG00000106351	AGFG2	NA	
ENSG00000184414	IRS3P	NA	
ENSG00000205307	SAP25	NA	
ENSG00000274272	AC069281.2	NA	
ENSG00000077454	LRCH4	NA	
ENSG00000106336	FBXO24	NA	
ENSG00000224729	PCOLCE-AS1	NA	
ENSG00000106333	PCOLCE	NA	
ENSG00000106330	MOSPD3	NA	
ENSG00000106327	TFR2	604250	HEMOCHROMATOSIS, TYPE 3; HFE3;;HEMOCHROMATOSIS DUE TO DEFECT IN TRANSFERRIN RECEPTOR 2
ENSG00000077080	ACTL6B	618468	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 76; EIEE76;;DEVELOPMENTAL DELAY, EPILEPTIC ENCEPHALOPATHY, CEREBRAL ATROPHY, AND ABNORMAL MYELINATION; DECAM
ENSG00000077080	ACTL6B	618470	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD
ENSG00000172354	GNB2	NA	
ENSG00000146830	GIGYF1	NA	
ENSG00000172336	POP7	NA	
ENSG00000130427	EPO	612623	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2;;PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;;END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO
ENSG00000130427	EPO	617907	ERYTHROCYTOSIS, FAMILIAL, 5; ECYT5
ENSG00000130427	EPO	617911	DIAMOND-BLACKFAN ANEMIA-LIKE; DBAL
ENSG00000146839	ZAN	NA	
ENSG00000196411	EPHB4	617300	LYMPHATIC MALFORMATION 7; LMPHM7;;CENTRAL CONDUCTION LYMPHATIC ANOMALY;;HYDROPS FETALIS, NONIMMUNE, AND/OR ATRIAL SEPTAL DEFECT; HFASD
ENSG00000196411	EPHB4	618196	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2; CMAVM2
ENSG00000263672	RN7SL750P	NA	
ENSG00000146828	SLC12A9	NA	
ENSG00000236305	SLC12A9-AS1	NA	
ENSG00000087077	TRIP6	NA	
ENSG00000283821	MIR6875	NA	
ENSG00000087087	SRRT	NA	
ENSG00000176125	UFSP1	NA	
ENSG00000087085	ACHE	112100	YT BLOOD GROUP ANTIGEN;;CARTWRIGHT ANTIGEN
ENSG00000239825	RN7SL549P	NA	
ENSG00000235926	RPS29P15	NA	
ENSG00000169894	MUC3A	NA	
ENSG00000274993	AC254629.1	NA	
ENSG00000205277	MUC12	NA	
ENSG00000227053	MUC12-AS1	NA	
ENSG00000169876	MUC17	NA	
ENSG00000222636	RN7SKP54	NA	
ENSG00000169871	TRIM56	NA	
ENSG00000106366	SERPINE1	613329	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY;;HYPERFIBRINOLYSIS DUE TO PAI1 DEFICIENCY
ENSG00000106367	AP1S1	609313	MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK;;ERYTHROKERATODERMIA VARIABILIS 3; EKV3;;ERYTHROKERATODERMIA VARIABILIS, KAMOURASKA TYPE
ENSG00000264425	MIR4653	NA	
ENSG00000128564	VGF	NA	
ENSG00000167011	NAT16	NA	
ENSG00000106384	MOGAT3	NA	
ENSG00000205267	DGAT2L7P	NA	
ENSG00000213394	RPSAP46	NA	
ENSG00000106397	PLOD3	612394	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS;;LYSYL HYDROXYLASE 3 DEFICIENCY;;LH3 DEFICIENCY
ENSG00000106400	ZNHIT1	NA	
ENSG00000106404	CLDN15	NA	
ENSG00000214253	FIS1	NA	
ENSG00000207454	RNU6-1104P	NA	
ENSG00000278683	AC006329.1	NA	
ENSG00000214252	AZGP1P2	NA	
ENSG00000232301	LNCPRESS1	NA	
ENSG00000232445	EMSLR	NA	
ENSG00000128581	IFT22	NA	
ENSG00000160963	COL26A1	NA	
ENSG00000233683	AC004965.1	NA	
ENSG00000233123	LINC01007	NA	
ENSG00000106436	MYL10	NA	
ENSG00000257923	CUX1	618330	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI
ENSG00000259294	AC005096.1	NA	
ENSG00000272219	AC005072.1	NA	
ENSG00000261535	AC005086.2	NA	
ENSG00000280404	AC005086.5	NA	
ENSG00000280004	AC005086.4	NA	
ENSG00000279724	AC005086.3	NA	
ENSG00000252824	AC005086.1	NA	
ENSG00000278586	AC005088.1	NA	
ENSG00000160999	SH2B2	NA	
ENSG00000264675	MIR4285	NA	
ENSG00000170409	AC091390.1	NA	
ENSG00000200552	Y_RNA	NA	
ENSG00000228546	AC091390.2	NA	
ENSG00000260097	SPDYE6	NA	
ENSG00000128563	PRKRIP1	NA	
ENSG00000239969	AC091390.4	NA	
ENSG00000239486	AC091390.3	NA	
ENSG00000221510	MIR548O	NA	
ENSG00000239480	AC073517.1	NA	
ENSG00000160991	ORAI2	NA	
ENSG00000160993	ALKBH4	NA	
ENSG00000161036	LRWD1	NA	
ENSG00000284176	MIR5090	NA	
ENSG00000284596	MIR4467	NA	
ENSG00000005075	POLR2J	NA	
ENSG00000170667	RASA4B	NA	
ENSG00000168255	POLR2J3	NA	
ENSG00000284981	UPK3BL2	NA	
ENSG00000270249	AC093668.1	NA	
ENSG00000205238	SPDYE2	NA	
ENSG00000285437	POLR2J3	NA	
ENSG00000105808	RASA4	NA	
ENSG00000279168	AC105052.4	NA	
ENSG00000205236	AC105052.1	NA	
ENSG00000267368	UPK3BL1	NA	
ENSG00000267645	AC105052.3	NA	
ENSG00000173678	SPDYE2B	NA	
ENSG00000228049	POLR2J2	NA	
ENSG00000233297	RASA4DP	NA	
ENSG00000286830	AC105052.5	NA	
ENSG00000222011	FAM185A	NA	
ENSG00000213385	AC105052.2	NA	
ENSG00000161040	FBXL13	NA	
ENSG00000252643	RNU6-1136P	NA	
ENSG00000238324	RN7SKP198	NA	
ENSG00000128606	LRRC17	NA	
ENSG00000230257	NFE4	NA	
ENSG00000236226	AC073127.1	NA	
ENSG00000170632	ARMC10	NA	
ENSG00000233025	CRYZP1	NA	
ENSG00000161048	NAPEPLD	NA	
ENSG00000224415	AC007683.1	NA	
ENSG00000236848	RPL23AP95	NA	
ENSG00000279482	AC007683.2	NA	
ENSG00000170629	DPY19L2P2	NA	
ENSG00000237632	S100A11P1	NA	
ENSG00000105819	PMPCB	617954	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6
ENSG00000105821	DNAJC2	NA	
ENSG00000161057	PSMC2	NA	
ENSG00000235354	RPS29P16	NA	
ENSG00000170615	SLC26A5	613865	DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61
ENSG00000251852	Y_RNA	NA	
ENSG00000252047	Y_RNA	NA	
ENSG00000234715	AC005064.1	NA	
ENSG00000189056	RELN	257320	LISSENCEPHALY 2; LIS2;;LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE;;NORMAN-ROBERTS SYNDROME
ENSG00000189056	RELN	600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1;;EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT; ADLTE;;EPILEPSY, PARTIAL, WITH AUDITORY FEATURES; ADPEAF
ENSG00000189056	RELN	616436	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7
ENSG00000222386	RN7SKP86	NA	
ENSG00000164815	ORC5	NA	
ENSG00000187416	LHFPL3	NA	
ENSG00000197258	EIF4BP6	NA	
ENSG00000226869	LHFPL3-AS1	NA	
ENSG00000237606	AC091286.1	NA	
ENSG00000225329	LHFPL3-AS2	NA	
ENSG00000243352	RN7SL8P	NA	
ENSG00000237513	AC007384.1	NA	
ENSG00000228393	LINC01004	NA	
ENSG00000239569	KMT2E-AS1	NA	
ENSG00000005483	KMT2E	618512	O'DONNELL-LURIA-RODAN SYNDROME; ODLURO
ENSG00000272918	AC005070.3	NA	
ENSG00000135250	SRPK2	NA	
ENSG00000270764	AC005070.1	NA	
ENSG00000271482	AC005070.2	NA	
ENSG00000213361	AC004884.1	NA	
ENSG00000244490	RWDD4P1	NA	
ENSG00000242154	AC004884.2	NA	
ENSG00000201179	RNU6-1322P	NA	
ENSG00000091127	PUS7	618342	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS
ENSG00000223886	AC073073.1	NA	
ENSG00000135249	RINT1	618641	INFANTILE LIVER FAILURE SYNDROME 3; ILFS3
ENSG00000185055	EFCAB10	NA	
ENSG00000272604	AC073073.2	NA	
ENSG00000231167	YBX1P2	NA	
ENSG00000146776	ATXN7L1	NA	
ENSG00000226624	AC005099.1	NA	
ENSG00000128536	CDHR3	NA	
ENSG00000280439	AC004836.1	NA	
ENSG00000008282	SYPL1	NA	
ENSG00000242562	DCAF13P1	NA	
ENSG00000201796	RNU6-392P	NA	
ENSG00000105835	NAMPT	NA	
ENSG00000273320	AC007032.1	NA	
ENSG00000243438	LARP1BP2	NA	
ENSG00000243797	AC004917.1	NA	
ENSG00000286076	AC005050.3	NA	
ENSG00000267052	AC005050.1	NA	
ENSG00000286013	AC005050.2	NA	
ENSG00000253276	CCDC71L	NA	
ENSG00000228742	LINC02577	NA	
ENSG00000251978	RNA5SP236	NA	
ENSG00000105851	PIK3CG	NA	
ENSG00000005249	PRKAR2B	NA	
ENSG00000243193	PRKAR2B-AS1	NA	
ENSG00000105856	HBP1	NA	
ENSG00000272072	AC004492.1	NA	
ENSG00000164597	COG5	613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I;;CDG IIi; CDGIIi
ENSG00000228341	AC002381.1	NA	
ENSG00000172209	GPR22	NA	
ENSG00000105865	DUS4L	NA	
ENSG00000288558	DUS4L-BCAP29	NA	
ENSG00000272854	AC004839.2	NA	
ENSG00000075790	BCAP29	NA	
ENSG00000238832	AC004839.1	NA	
ENSG00000250474	WBP1LP2	NA	
ENSG00000225935	BANF1P5	NA	
ENSG00000233705	SLC26A4-AS1	NA	
ENSG00000091137	SLC26A4	274600	PENDRED SYNDROME; PDS;;DEAFNESS WITH GOITER;;GOITER-DEAFNESS SYNDROME;;THYROID DYSHORMONOGENESIS 2B; TDH2B;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B
ENSG00000091137	SLC26A4	600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 4; NSRD4;;DILATED VESTIBULAR AQUEDUCT; DVA
ENSG00000241764	AC002467.1	NA	
ENSG00000105879	CBLL1	NA	
ENSG00000091138	SLC26A3	214700	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL
ENSG00000229626	PIGCP2	NA	
ENSG00000091140	DLD	246900	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD;;DLD DEFICIENCY;;E3 DEFICIENCY;;LIPOAMIDE DEHYDROGENASE DEFICIENCY, LACTIC ACIDOSIS DUE TO;;MAPLE SYRUP URINE DISEASE, TYPE III
ENSG00000091136	LAMB1	615191	LISSENCEPHALY 5; LIS5
ENSG00000273055	AC005046.1	NA	
ENSG00000238297	U3	NA	
ENSG00000091128	LAMB4	NA	
ENSG00000091129	NRCAM	NA	
ENSG00000135241	PNPLA8	251950	MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA
ENSG00000231006	RPL7P32	NA	
ENSG00000177683	THAP5	NA	
ENSG00000128590	DNAJB9	NA	
ENSG00000225647	AC005487.1	NA	
ENSG00000270425	AC002487.1	NA	
ENSG00000205174	C7orf66	NA	
ENSG00000279043	AC004014.2	NA	
ENSG00000229603	AC004014.1	NA	
ENSG00000227968	BUB3P1	NA	
ENSG00000230941	AC002386.1	NA	
ENSG00000234273	AC073071.1	NA	
ENSG00000230192	AC073387.1	NA	
ENSG00000271368	AC073387.2	NA	
ENSG00000237064	EIF3IP1	NA	
ENSG00000232199	RPL3P8	NA	
ENSG00000226965	AC073114.1	NA	
ENSG00000278424	AC073114.2	NA	
ENSG00000287186	AC073326.2	NA	
ENSG00000184903	IMMP2L	NA	
ENSG00000228540	AC073326.1	NA	
ENSG00000173114	LRRN3	NA	
ENSG00000243621	AC003989.2	NA	
ENSG00000227948	AC003989.1	NA	
ENSG00000128512	DOCK4	NA	
ENSG00000287011	AC003077.1	NA	
ENSG00000225572	DOCK4-AS1	NA	
ENSG00000222346	RNA5SP237	NA	
ENSG00000234358	AC003080.1	NA	
ENSG00000198839	ZNF277	NA	
ENSG00000202406	RN7SKP187	NA	
ENSG00000226851	AC004112.1	NA	
ENSG00000230999	MTND5P8	NA	
ENSG00000232922	MTND6P24	NA	
ENSG00000236232	MTCYBP24	NA	
ENSG00000006652	IFRD1	NA	
ENSG00000180019	AC079741.1	NA	
ENSG00000288640	AC005192.1	NA	
ENSG00000288634	AC079741.2	NA	
ENSG00000181016	LSMEM1	NA	
ENSG00000182965	NPM1P14	NA	
ENSG00000223646	AC002463.1	NA	
ENSG00000225358	MIPEPP1	NA	
ENSG00000146802	TMEM168	NA	
ENSG00000164603	BMT2	NA	
ENSG00000234520	HRAT17	NA	
ENSG00000279288	AC073346.2	NA	
ENSG00000164604	GPR85	NA	
ENSG00000225457	AC073346.1	NA	
ENSG00000214194	SMIM30	NA	
ENSG00000270997	AC073137.1	NA	
ENSG00000278894	AC073348.1	NA	
ENSG00000287592	AC073348.2	NA	
ENSG00000154415	PPP1R3A	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000128573	FOXP2	602081	SPEECH-LANGUAGE DISORDER 1; SPCH1;;CHILDHOOD APRAXIA OF SPEECH; CAS;;DEVELOPMENTAL VERBAL DYSPRAXIA; DVD;;SPEECH AND LANGUAGE DISORDER WITH OROFACIAL DYSPRAXIA
ENSG00000236580	AC073626.2	NA	
ENSG00000224595	AC073626.1	NA	
ENSG00000282859	AC003992.1	NA	
ENSG00000202334	RNA5SP238	NA	
ENSG00000272230	MIR3666	NA	
ENSG00000135272	MDFIC	NA	
ENSG00000225535	LINC01393	NA	
ENSG00000233607	LINC01392	NA	
ENSG00000226962	RAC1P6	NA	
ENSG00000199764	Y_RNA	NA	
ENSG00000244565	POLR2DP2	NA	
ENSG00000202377	SNORA25B	NA	
ENSG00000242072	AC092590.1	NA	
ENSG00000240973	AC093714.1	NA	
ENSG00000243345	AC093714.2	NA	
ENSG00000199224	Y_RNA	NA	
ENSG00000105967	TFEC	NA	
ENSG00000279086	AC073130.3	NA	
ENSG00000135269	TES	NA	
ENSG00000243243	AC073130.2	NA	
ENSG00000237813	AC002066.1	NA	
ENSG00000237870	AC073130.1	NA	
ENSG00000105971	CAV2	NA	
ENSG00000213167	Metazoa_SRP	NA	
ENSG00000105974	CAV1	606721	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7;;PARTIAL LIPODYSTROPHY, CONGENITAL CATARACTS, WITH OR WITHOUT NEURODEGENERATION SYNDROME; LCCNS
ENSG00000105974	CAV1	612526	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3;;BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 3; BSCL3;;LIPODYSTROPHY, BERARDINELLI-SEIP CONGENITAL, TYPE 3
ENSG00000105974	CAV1	615343	PULMONARY HYPERTENSION, PRIMARY, 3; PPH3
ENSG00000235427	AC006159.1	NA	
ENSG00000243220	AC006159.2	NA	
ENSG00000231210	COMETT	NA	
ENSG00000105976	MET	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000105976	MET	605074	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1
ENSG00000105976	MET	607278	OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD;;OFD;;TIBIA, BOWING OF, WITH PSEUDARTHROSIS AND PECTUS EXCAVATUM
ENSG00000105976	MET	616705	DEAFNESS, AUTOSOMAL RECESSIVE 97; DFNB97
ENSG00000198898	CAPZA2	NA	
ENSG00000235945	AC002543.1	NA	
ENSG00000252115	AC002543.2	NA	
ENSG00000222150	RNA5SP239	NA	
ENSG00000227199	ST7-AS1	NA	
ENSG00000275359	AC106873.5	NA	
ENSG00000277583	AC106873.7	NA	
ENSG00000004866	ST7	NA	
ENSG00000214188	ST7-OT4	NA	
ENSG00000288635	AC106873.8	NA	
ENSG00000273596	AC106873.3	NA	
ENSG00000273571	AC106873.2	NA	
ENSG00000276100	AC106873.6	NA	
ENSG00000274606	AC106873.4	NA	
ENSG00000228368	AC106873.1	NA	
ENSG00000213050	TPM3P1	NA	
ENSG00000283923	MIR6132	NA	
ENSG00000226367	ST7-AS2	NA	
ENSG00000287829	AC002542.6	NA	
ENSG00000274344	AC002542.2	NA	
ENSG00000275054	AC002542.3	NA	
ENSG00000227532	AC002542.1	NA	
ENSG00000278526	AC002542.5	NA	
ENSG00000278482	AC002542.4	NA	
ENSG00000230785	AC006326.1	NA	
ENSG00000224042	MTND4P6	NA	
ENSG00000230605	MTCYBP6	NA	
ENSG00000105989	WNT2	NA	
ENSG00000001626	CFTR	167800	PANCREATITIS, HEREDITARY; PCTT;;HPC;;HP;;PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;PANCREATITIS, CALCIFIC, INCLUDED;;PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
ENSG00000001626	CFTR	211400	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1;;CYSTIC FIBROSIS-LIKE SYNDROME
ENSG00000001626	CFTR	219700	CYSTIC FIBROSIS; CF;;MUCOVISCIDOSIS
ENSG00000001626	CFTR	277180	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD;;CAVD VAS DEFERENS, CONGENITAL UNILATERAL APLASIA OF, INCLUDED; CUAVD, INCLUDED
ENSG00000286390	AC002465.1	NA	
ENSG00000154438	ASZ1	NA	
ENSG00000214684	ANKRD49P4	NA	
ENSG00000237974	AC000111.2	NA	
ENSG00000232661	CFTR-AS1	NA	
ENSG00000234001	AC000111.1	NA	
ENSG00000083622	AC000061.1	NA	
ENSG00000077063	CTTNBP2	NA	
ENSG00000224136	AC007568.1	NA	
ENSG00000234826	AC003084.1	NA	
ENSG00000128534	LSM8	NA	
ENSG00000106013	ANKRD7	NA	
ENSG00000287827	AC002529.1	NA	
ENSG00000229982	GTF3AP6	NA	
ENSG00000230520	AC092098.1	NA	
ENSG00000270516	AC079791.1	NA	
ENSG00000225546	LINC02476	NA	
ENSG00000271739	RNU1-29P	NA	
ENSG00000233417	AC004946.1	NA	
ENSG00000233969	AC004946.2	NA	
ENSG00000184408	KCND2	NA	
ENSG00000252023	RNU6-581P	NA	
ENSG00000231295	AC004888.1	NA	
ENSG00000106025	TSPAN12	613310	EXUDATIVE VITREORETINOPATHY 5; EVR5
ENSG00000071243	ING3	NA	
ENSG00000202225	RNA5SP240	NA	
ENSG00000106034	CPED1	NA	
ENSG00000234927	HMGN1P18	NA	
ENSG00000212628	RNA5SP241	NA	
ENSG00000207090	RNU6-517P	NA	
ENSG00000287554	AC006364.1	NA	
ENSG00000002745	WNT16	NA	
ENSG00000196937	FAM3C	NA	
ENSG00000213310	CYCSP19	NA	
ENSG00000227371	AC074085.1	NA	
ENSG00000234985	AC074085.2	NA	
ENSG00000227743	AC004875.1	NA	
ENSG00000252704	RN7SKP277	NA	
ENSG00000233272	PNPT1P2	NA	
ENSG00000106278	PTPRZ1	NA	
ENSG00000008311	AASS	238700	HYPERLYSINEMIA, TYPE I;;LYSINE:ALPHA-KETOGLUTARATE REDUCTASE DEFICIENCY;;ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE DEFICIENCY;;LYSINE INTOLERANCE;;L-LYSINE:NAD-OXIDO-REDUCTASE DEFICIENCY
ENSG00000252003	RNU7-154P	NA	
ENSG00000234418	AC015983.2	NA	
ENSG00000226636	AC006020.1	NA	
ENSG00000213302	AC015983.1	NA	
ENSG00000128610	FEZF1	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000128610	FEZF1	616030	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22
ENSG00000230316	FEZF1-AS1	NA	
ENSG00000081803	CADPS2	NA	
ENSG00000240499	AC004594.1	NA	
ENSG00000225795	AC006463.1	NA	
ENSG00000235459	RPS26P31	NA	
ENSG00000188050	RNF133	NA	
ENSG00000235631	RNF148	NA	
ENSG00000227573	AC004986.1	NA	
ENSG00000128519	TAS2R16	617956	BETA-GLUCOPYRANOSIDE TASTING; BGLPT
ENSG00000226680	AC073311.1	NA	
ENSG00000081800	SLC13A1	NA	
ENSG00000223595	LYPLA1P1	NA	
ENSG00000164675	IQUB	NA	
ENSG00000232524	AC073323.1	NA	
ENSG00000207338	RNU6-296P	NA	
ENSG00000128609	NDUFA5	NA	
ENSG00000146809	ASB15	NA	
ENSG00000230442	ASB15-AS1	NA	
ENSG00000170807	LMOD2	NA	
ENSG00000106299	WASL	NA	
ENSG00000272686	WASL-DT	NA	
ENSG00000201104	RNU6-11P	NA	
ENSG00000228211	HYAL6P	NA	
ENSG00000106302	HYAL4	NA	
ENSG00000106304	SPAM1	NA	
ENSG00000225583	AC004690.1	NA	
ENSG00000241345	AC004690.2	NA	
ENSG00000234224	TMEM229A	NA	
ENSG00000242593	AC006148.1	NA	
ENSG00000243574	AC006148.2	NA	
ENSG00000241324	AC004930.1	NA	
ENSG00000230268	SSU72P8	NA	
ENSG00000213296	AC005521.1	NA	
ENSG00000207214	RNU6-102P	NA	
ENSG00000279419	AC004925.1	NA	
ENSG00000170775	GPR37	NA	
ENSG00000275356	C7orf77	NA	
ENSG00000128513	POT1	615848	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10
ENSG00000128513	POT1	616568	GLIOMA SUSCEPTIBILITY 9; GLM9
ENSG00000224897	POT1-AS1	NA	
ENSG00000186676	EEF1GP1	NA	
ENSG00000224899	LINC02830	NA	
ENSG00000205898	AC019155.1	NA	
ENSG00000219445	AC019155.2	NA	
ENSG00000213291	AC010099.1	NA	
ENSG00000234071	AC010099.2	NA	
ENSG00000227847	PPIAP93	NA	
ENSG00000197462	AC003975.1	NA	
ENSG00000241921	AC000372.1	NA	
ENSG00000179603	GRM8	NA	
ENSG00000287702	AC002057.2	NA	
ENSG00000227249	AC000374.1	NA	
ENSG00000287568	AC002057.1	NA	
ENSG00000224981	AC000367.1	NA	
ENSG00000230820	AC000362.1	NA	
ENSG00000207692	MIR592	NA	
ENSG00000236340	GRM8-AS1	NA	
ENSG00000236105	PRELID3BP10	NA	
ENSG00000048405	ZNF800	NA	
ENSG00000279265	AC000123.2	NA	
ENSG00000224138	AC000123.1	NA	
ENSG00000280347	AC000123.3	NA	
ENSG00000226770	AC000124.1	NA	
ENSG00000179562	GCC1	NA	
ENSG00000004059	ARF5	NA	
ENSG00000106328	FSCN3	NA	
ENSG00000106331	PAX4	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000106331	PAX4	612225	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9
ENSG00000106331	PAX4	612227	DIABETES MELLITUS, KETOSIS-PRONE; KPD
ENSG00000240790	AC073934.1	NA	
ENSG00000197157	SND1	NA	
ENSG00000240579	AC006529.1	NA	
ENSG00000279078	SND1-IT1	NA	
ENSG00000128594	LRRC4	NA	
ENSG00000207588	MIR593	NA	
ENSG00000207705	MIR129-1	NA	
ENSG00000174697	LEP	614962	LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD;;OBESITY, MORBID
ENSG00000272915	AC018635.2	NA	
ENSG00000106344	RBM28	612079	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES;;ANE SYNDROME
ENSG00000242261	AC018635.1	NA	
ENSG00000238750	RNU7-27P	NA	
ENSG00000224940	PRRT4	NA	
ENSG00000106348	IMPDH1	180105	RETINITIS PIGMENTOSA 10; RP10
ENSG00000106348	IMPDH1	613837	LEBER CONGENITAL AMAUROSIS 11; LCA11
ENSG00000228700	AC010655.1	NA	
ENSG00000238590	RNU7-54P	NA	
ENSG00000273184	AC010655.4	NA	
ENSG00000135245	HILPDA	NA	
ENSG00000240758	AC010655.2	NA	
ENSG00000272601	AC010655.3	NA	
ENSG00000165055	METTL2B	NA	
ENSG00000276988	Metazoa_SRP	NA	
ENSG00000273270	AC090114.2	NA	
ENSG00000280828	AC090114.3	NA	
ENSG00000213280	AC090114.1	NA	
ENSG00000242588	AC108010.1	NA	
ENSG00000281896	AC018638.8	NA	
ENSG00000223189	RNU6-177P	NA	
ENSG00000243302	AC018638.4	NA	
ENSG00000230715	AC018638.2	NA	
ENSG00000229413	AC018638.1	NA	
ENSG00000243679	AC018638.5	NA	
ENSG00000281490	CICP14	NA	
ENSG00000271553	AC018638.7	NA	
ENSG00000241493	AC018638.3	NA	
ENSG00000205085	FAM71F2	NA	
ENSG00000271344	AC018638.6	NA	
ENSG00000239722	IMP3P2	NA	
ENSG00000201041	RNA5SP242	NA	
ENSG00000252866	RNA5SP243	NA	
ENSG00000135248	FAM71F1	NA	
ENSG00000128595	CALU	NA	
ENSG00000244218	RN7SL81P	NA	
ENSG00000128617	OPN1SW	190900	TRITANOPIA;;COLORBLINDNESS, TRITANOPIC;;BLUE COLORBLINDNESS;;COLORBLINDNESS, TRITAN; CBT
ENSG00000128596	CCDC136	NA	
ENSG00000128591	FLNC	609524	MYOPATHY, MYOFIBRILLAR, 5; MFM5;;MYOPATHY, MYOFIBRILLAR, FILAMIN C-RELATED;;FILAMINOPATHY, AUTOSOMAL DOMINANT
ENSG00000128591	FLNC	614065	MYOPATHY, DISTAL, 4; MPD4;;WILLIAMS DISTAL MYOPATHY
ENSG00000128591	FLNC	617047	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26 CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 5, INCLUDED; RCM5, INCLUDED
ENSG00000242902	FLNC-AS1	NA	
ENSG00000135253	KCP	NA	
ENSG00000128524	ATP6V1F	NA	
ENSG00000272899	ATP6V1FNB	NA	
ENSG00000224163	AC025594.1	NA	
ENSG00000128604	IRF5	612245	INFLAMMATORY BOWEL DISEASE 14; IBD14
ENSG00000128604	IRF5	612251	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10
ENSG00000275106	AC025594.2	NA	
ENSG00000064419	TNPO3	608423	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F
ENSG00000242241	RN7SL306P	NA	
ENSG00000244556	ODCP	NA	
ENSG00000230359	TPI1P2	NA	
ENSG00000242162	AC018639.1	NA	
ENSG00000241102	AC011005.2	NA	
ENSG00000241573	AC011005.3	NA	
ENSG00000240416	CYCSP20	NA	
ENSG00000230626	AC011005.1	NA	
ENSG00000158457	TSPAN33	NA	
ENSG00000200629	RNY1P11	NA	
ENSG00000128602	SMO	601707	CURRY-JONES SYNDROME; CRJS;;CRANIOFACIAL MALFORMATIONS, ASYMMETRIC, WITH POLYSYNDACTYLY AND ABNORMAL SKIN AND GUT DEVELOPMENT
ENSG00000128602	SMO	605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1 BASAL CELL CARCINOMA, NONSYNDROMIC, INCLUDED;;BASAL CELL CARCINOMA, MULTIPLE, INCLUDED
ENSG00000243230	AC011005.4	NA	
ENSG00000158467	AHCYL2	NA	
ENSG00000286722	AC009244.2	NA	
ENSG00000238072	AC009244.1	NA	
ENSG00000128578	STRIP2	NA	
ENSG00000239919	SNRPGP3	NA	
ENSG00000199846	RNU1-72P	NA	
ENSG00000240204	SMKR1	NA	
ENSG00000273329	AC078846.1	NA	
ENSG00000106459	NRF1	NA	
ENSG00000212238	RNA5SP244	NA	
ENSG00000286380	AC084864.2	NA	
ENSG00000207990	MIR182	NA	
ENSG00000199158	MIR96	613074	DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50
ENSG00000207691	MIR183	NA	
ENSG00000242078	AC084864.1	NA	
ENSG00000186591	UBE2H	NA	
ENSG00000244036	AC073320.1	NA	
ENSG00000199516	Y_RNA	NA	
ENSG00000091732	ZC3HC1	NA	
ENSG00000201109	RNA5SP245	NA	
ENSG00000128607	KLHDC10	NA	
ENSG00000229196	AC087071.1	NA	
ENSG00000146842	TMEM209	NA	
ENSG00000240571	AC087071.2	NA	
ENSG00000165120	SSMEM1	NA	
ENSG00000270992	AC024085.1	NA	
ENSG00000158516	CPA2	NA	
ENSG00000128510	CPA4	NA	
ENSG00000158525	CPA5	NA	
ENSG00000091704	CPA1	NA	
ENSG00000106477	CEP41	614464	JOUBERT SYNDROME 15; JBTS15 JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED;;JOUBERT SYNDROME 12/15, DIGENIC, INCLUDED
ENSG00000259920	AC007938.1	NA	
ENSG00000272701	MESTIT1	NA	
ENSG00000106484	MEST	NA	
ENSG00000277269	AC007938.5	NA	
ENSG00000278055	AC007938.6	NA	
ENSG00000274500	AC007938.4	NA	
ENSG00000270823	AC007938.2	NA	
ENSG00000199043	MIR335	NA	
ENSG00000158623	COPG2	NA	
ENSG00000270953	AC007938.3	NA	
ENSG00000286214	AUXG01000058.1	NA	
ENSG00000239021	RNA5SP246	NA	
ENSG00000226045	AC234644.1	NA	
ENSG00000213265	TSGA13	NA	
ENSG00000287547	AC234644.2	NA	
ENSG00000266265	KLF14	NA	
ENSG00000271522	AC016831.5	NA	
ENSG00000285106	AC016831.6	NA	
ENSG00000229858	AC016831.2	NA	
ENSG00000240680	H4P1	NA	
ENSG00000232716	AC016831.3	NA	
ENSG00000233559	LINC00513	NA	
ENSG00000284032	MIR29A	NA	
ENSG00000226380	AC016831.1	NA	
ENSG00000283797	MIR29B1	NA	
ENSG00000271204	AC016831.4	NA	
ENSG00000273319	AC058791.1	NA	
ENSG00000231721	LINC-PINT	NA	
ENSG00000199627	RNU6-1010P	NA	
ENSG00000128585	MKLN1	NA	
ENSG00000233287	AC009362.1	NA	
ENSG00000236753	MKLN1-AS	NA	
ENSG00000273489	AC008264.2	NA	
ENSG00000128567	PODXL	NA	
ENSG00000224545	AC008264.1	NA	
ENSG00000213261	EEF1B2P6	NA	
ENSG00000236238	AC093106.1	NA	
ENSG00000236395	AC093106.2	NA	
ENSG00000236281	NDUFB9P2	NA	
ENSG00000233263	CAPZA1P4	NA	
ENSG00000236386	AC009518.2	NA	
ENSG00000224865	AC009518.1	NA	
ENSG00000229532	AC105443.1	NA	
ENSG00000221866	PLXNA4	NA	
ENSG00000225144	AC018643.1	NA	
ENSG00000223436	AC011625.1	NA	
ENSG00000183470	FLJ40288	NA	
ENSG00000201009	AC009365.1	NA	
ENSG00000225881	AC009365.2	NA	
ENSG00000106554	CHCHD3	NA	
ENSG00000227197	AC009365.3	NA	
ENSG00000283041	AC008038.1	NA	
ENSG00000284135	MIR3654	NA	
ENSG00000272393	RNU6-92P	NA	
ENSG00000237821	AC083873.1	NA	
ENSG00000131558	EXOC4	NA	
ENSG00000276137	MIR6133	NA	
ENSG00000235429	AC083875.1	NA	
ENSG00000235967	COX5BP3	NA	
ENSG00000226205	RPS3AP27	NA	
ENSG00000155530	LRGUK	NA	
ENSG00000231098	AC008154.2	NA	
ENSG00000205060	SLC35B4	NA	
ENSG00000229177	AC008154.1	NA	
ENSG00000273297	AC009275.1	NA	
ENSG00000085662	AKR1B1	NA	
ENSG00000198074	AKR1B10	NA	
ENSG00000227471	AKR1B15	NA	
ENSG00000172331	BPGM	222800	ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8;;BISPHOSPHOGLYCERATE MUTASE DEFICIENCY;;BISPHOSPHOGLYCEROMUTASE DEFICIENCY;;BPGM DEFICIENCY;;DIPHOSPHOGLYCERATE MUTASE DEFICIENCY OF ERYTHROCYTE;;DPGM DEFICIENCY
ENSG00000224375	AC009276.1	NA	
ENSG00000230101	TUBB3P2	NA	
ENSG00000122786	CALD1	NA	
ENSG00000286458	AC083870.1	NA	
ENSG00000146856	AGBL3	NA	
ENSG00000122783	CYREN	NA	
ENSG00000223500	RNF14P4	NA	
ENSG00000146859	TMEM140	NA	
ENSG00000272941	AC083862.1	NA	
ENSG00000287733	AC083862.2	NA	
ENSG00000105875	WDR91	NA	
ENSG00000231794	AC009542.1	NA	
ENSG00000277138	MIR6509	NA	
ENSG00000146857	STRA8	NA	
ENSG00000276067	AC009542.2	NA	
ENSG00000080802	CNOT4	NA	
ENSG00000227073	SDHDP2	NA	
ENSG00000155561	NUP205	616893	NEPHROTIC SYNDROME, TYPE 13; NPHS13
ENSG00000271414	AC093107.2	NA	
ENSG00000223718	AC093107.1	NA	
ENSG00000243317	STMP1	NA	
ENSG00000212303	RNU6-1154P	NA	
ENSG00000164707	SLC13A4	NA	
ENSG00000273219	AC091736.1	NA	
ENSG00000189320	FAM180A	NA	
ENSG00000224746	AC015987.1	NA	
ENSG00000105887	MTPN	NA	
ENSG00000199700	RNU6-223P	NA	
ENSG00000230649	AC024084.1	NA	
ENSG00000232053	AC078845.1	NA	
ENSG00000206705	Y_RNA	NA	
ENSG00000236503	AC009784.1	NA	
ENSG00000226066	ZP3P2	NA	
ENSG00000234352	AC009264.1	NA	
ENSG00000231244	PSMC1P3	NA	
ENSG00000181072	CHRM2	NA	
ENSG00000207597	MIR490	NA	
ENSG00000223657	KRT8P51	NA	
ENSG00000224469	AC009517.1	NA	
ENSG00000105894	PTN	NA	
ENSG00000202023	SNORD81	NA	
ENSG00000231114	AC078842.2	NA	
ENSG00000228031	AC078842.1	NA	
ENSG00000157680	DGKI	NA	
ENSG00000279483	AC090498.1	NA	
ENSG00000230383	AC009245.1	NA	
ENSG00000182158	CREB3L2	NA	
ENSG00000237243	CREB3L2-AS1	NA	
ENSG00000122787	AKR1D1	235555	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2;;CHOLESTASIS WITH DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE DEFICIENCY
ENSG00000234639	AC009263.1	NA	
ENSG00000231923	AC024082.1	NA	
ENSG00000231931	AC024082.2	NA	
ENSG00000222514	RN7SKP223	NA	
ENSG00000233951	RCC2P3	NA	
ENSG00000284028	MIR4468	NA	
ENSG00000225559	AC083867.2	NA	
ENSG00000252820	Y_RNA	NA	
ENSG00000201465	AC083867.1	NA	
ENSG00000213238	AC008155.1	NA	
ENSG00000213237	PTMAP10	NA	
ENSG00000214815	IMPDH1P3	NA	
ENSG00000122779	TRIM24	NA	
ENSG00000234995	RPS3AP28	NA	
ENSG00000157703	SVOPL	NA	
ENSG00000252188	AC013429.2	NA	
ENSG00000234658	AC013429.1	NA	
ENSG00000243099	AC020983.1	NA	
ENSG00000223721	UQCRFS1P2	NA	
ENSG00000105929	ATP6V0A4	602722	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARING RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSET SENSORINEURAL HEAR /.../SS, INCLUDED
ENSG00000214128	TMEM213	NA	
ENSG00000122778	KIAA1549	618613	RETINITIS PIGMENTOSA 86; RP86
ENSG00000199646	RNU6-1272P	NA	
ENSG00000146858	ZC3HAV1L	NA	
ENSG00000105939	ZC3HAV1	NA	
ENSG00000229677	AC018644.1	NA	
ENSG00000105948	TTC26	NA	
ENSG00000239254	AC009220.2	NA	
ENSG00000271537	AC009220.3	NA	
ENSG00000228360	AC009220.1	NA	
ENSG00000271404	MZT1P2	NA	
ENSG00000157741	UBN2	NA	
ENSG00000206843	RNU6-206P	NA	
ENSG00000164898	FMC1	NA	
ENSG00000146963	LUC7L2	NA	
ENSG00000269955	FMC1-LUC7L2	NA	
ENSG00000273391	AC083880.1	NA	
ENSG00000252332	RNU6-911P	NA	
ENSG00000188883	KLRG2	NA	
ENSG00000253183	AC005531.1	NA	
ENSG00000236279	CLEC2L	NA	
ENSG00000254270	ERHP1	NA	
ENSG00000064393	HIPK2	NA	
ENSG00000059377	TBXAS1	231095	GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME
ENSG00000059378	PARP12	NA	
ENSG00000006459	KDM7A	NA	
ENSG00000251728	Y_RNA	NA	
ENSG00000260231	KDM7A-DT	NA	
ENSG00000199971	RNU6-797P	NA	
ENSG00000199283	RNU1-58P	NA	
ENSG00000270512	AC005377.1	NA	
ENSG00000241661	PPP1R2P6	NA	
ENSG00000157800	SLC37A3	NA	
ENSG00000223113	RNA5SP247	NA	
ENSG00000202472	RNA5SP248	NA	
ENSG00000146955	RAB19	NA	
ENSG00000103200	AC069335.1	NA	
ENSG00000133606	MKRN1	NA	
ENSG00000146966	DENND2A	NA	
ENSG00000201354	AC006452.1	NA	
ENSG00000285904	AC006452.2	NA	
ENSG00000240173	RN7SL771P	NA	
ENSG00000133597	ADCK2	NA	
ENSG00000090266	NDUFB2	NA	
ENSG00000240889	NDUFB2-AS1	NA	
ENSG00000157764	BRAF	163950	NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPE PTERYGIUM COLLI SYNDROME, INCLUDED
ENSG00000157764	BRAF	115150	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1;;CFC SYNDROME;;CFCS
ENSG00000157764	BRAF	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000157764	BRAF	613706	NOONAN SYNDROME 7; NS7
ENSG00000157764	BRAF	613707	LEOPARD SYNDROME 3; LPRD3
ENSG00000271932	RNU6-85P	NA	
ENSG00000271611	AC006006.1	NA	
ENSG00000242703	CCT4P1	NA	
ENSG00000090263	MRPS33	NA	
ENSG00000223212	RNU4-74P	NA	
ENSG00000261115	TMEM178B	NA	
ENSG00000261778	AC006362.1	NA	
ENSG00000261624	NDUFB10P2	NA	
ENSG00000285841	AC005692.3	NA	
ENSG00000204990	AC005692.1	NA	
ENSG00000261629	AC005692.2	NA	
ENSG00000261570	AC073878.1	NA	
ENSG00000261797	AC073878.2	NA	
ENSG00000006530	AGK	212350	SENGERS SYNDROME;;MITOCHONDRIAL DNA DEPLETION SYNDROME 10 (CARDIOMYOPATHIC TYPE); MTDPS10;;CARDIOMYOPATHY AND CATARACT
ENSG00000006530	AGK	614691	CATARACT 38; CTRCT38;;CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5; CATC5
ENSG00000244701	AC004918.1	NA	
ENSG00000257093	DENND11	NA	
ENSG00000270157	AC004918.3	NA	
ENSG00000228775	WEE2-AS1	NA	
ENSG00000214102	WEE2	617996	OOCYTE MATURATION DEFECT 5; OOMD5
ENSG00000212153	RNU1-82P	NA	
ENSG00000106028	SSBP1	NA	
ENSG00000127362	TAS2R3	NA	
ENSG00000127364	TAS2R4	NA	
ENSG00000270923	TAS2R6P	NA	
ENSG00000127366	TAS2R5	NA	
ENSG00000241926	MTCO1P55	NA	
ENSG00000224354	MTND2P5	NA	
ENSG00000239648	MTND1P3	NA	
ENSG00000240677	MYL6P4	NA	
ENSG00000165076	PRSS37	NA	
ENSG00000240031	OR9A3P	NA	
ENSG00000237621	OR9A1P	NA	
ENSG00000257335	MGAM	NA	
ENSG00000244292	OR9N1P	NA	
ENSG00000258083	OR9A4	NA	
ENSG00000258227	CLEC5A	NA	
ENSG00000257138	TAS2R38	171200	THIOUREA TASTING; THIOT PHENYLTHIOCARBAMIDE TASTING, INCLUDED;;PTC TASTING, INCLUDED;;PROPYLTHIOURACIL TASTING, INCLUDED;;PROP TASTING, INCLUDED
ENSG00000257743	MGAM2	NA	
ENSG00000240268	MOXD2P	NA	
ENSG00000258223	PRSS58	NA	
ENSG00000186163	TRY2P	NA	
ENSG00000241881	AC245088.1	NA	
ENSG00000277083	PRSS3P3	NA	
ENSG00000242736	TRBV1	NA	
ENSG00000226660	TRBV2	NA	
ENSG00000237702	TRBV3-1	NA	
ENSG00000211710	TRBV4-1	NA	
ENSG00000211734	TRBV5-1	NA	
ENSG00000211706	TRBV6-1	NA	
ENSG00000211707	TRBV7-1	NA	
ENSG00000211745	TRBV4-2	NA	
ENSG00000283063	TRBV6-2	NA	
ENSG00000282939	TRBV7-2	NA	
ENSG00000243889	TRBV8-1	NA	
ENSG00000242771	TRBV5-2	NA	
ENSG00000211713	TRBV6-4	NA	
ENSG00000211714	TRBV7-3	NA	
ENSG00000239944	TRBV8-2	NA	
ENSG00000211715	TRBV5-3	NA	
ENSG00000211716	TRBV9	NA	
ENSG00000211717	TRBV10-1	NA	
ENSG00000211720	TRBV11-1	NA	
ENSG00000244661	TRBV12-1	NA	
ENSG00000229769	TRBV10-2	NA	
ENSG00000241657	TRBV11-2	NA	
ENSG00000211739	TRBV12-2	NA	
ENSG00000211721	TRBV6-5	NA	
ENSG00000253409	TRBV7-4	NA	
ENSG00000230099	TRBV5-4	NA	
ENSG00000211724	TRBV6-6	NA	
ENSG00000227550	TRBV7-5	NA	
ENSG00000211725	TRBV5-5	NA	
ENSG00000253188	TRBV6-7	NA	
ENSG00000211727	TRBV7-6	NA	
ENSG00000211728	TRBV5-6	NA	
ENSG00000253534	TRBV6-8	NA	
ENSG00000253291	TRBV7-7	NA	
ENSG00000211731	TRBV5-7	NA	
ENSG00000278030	TRBV7-9	NA	
ENSG00000276405	TRBV13	NA	
ENSG00000275791	TRBV10-3	NA	
ENSG00000276597	TRBV11-3	NA	
ENSG00000274752	TRBV12-3	NA	
ENSG00000276953	TRBV12-4	NA	
ENSG00000275158	TRBV12-5	NA	
ENSG00000275743	TRBV14	NA	
ENSG00000276819	TRBV15	NA	
ENSG00000275243	TRBV16	NA	
ENSG00000277880	TRBV17	NA	
ENSG00000276557	TRBV18	NA	
ENSG00000211746	TRBV19	NA	
ENSG00000211747	TRBV20-1	NA	
ENSG00000251578	TRBV21-1	NA	
ENSG00000240578	TRBV22-1	NA	
ENSG00000211749	TRBV23-1	NA	
ENSG00000211750	TRBV24-1	NA	
ENSG00000270672	MTRNR2L6	NA	
ENSG00000282499	TRBV25-1	NA	
ENSG00000239992	TRBVA	NA	
ENSG00000249912	TRBV26	NA	
ENSG00000241911	TRBVB	NA	
ENSG00000211752	TRBV27	NA	
ENSG00000211753	TRBV28	NA	
ENSG00000244273	PGBD4P1	NA	
ENSG00000286831	AC244472.1	NA	
ENSG00000232869	TRBV29-1	NA	
ENSG00000204983	PRSS1	167800	PANCREATITIS, HEREDITARY; PCTT;;HPC;;HP;;PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;PANCREATITIS, CALCIFIC, INCLUDED;;PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
ENSG00000275896	PRSS2	167800	PANCREATITIS, HEREDITARY; PCTT;;HPC;;HP;;PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;PANCREATITIS, CALCIFIC, INCLUDED;;PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
ENSG00000250591	PRSS3P1	NA	
ENSG00000243661	WBP1LP1	NA	
ENSG00000282431	TRBD1	NA	
ENSG00000282320	TRBJ1-1	NA	
ENSG00000282420	TRBJ1-2	NA	
ENSG00000282133	TRBJ1-3	NA	
ENSG00000281958	TRBJ1-4	NA	
ENSG00000282173	TRBJ1-5	NA	
ENSG00000282780	TRBJ1-6	NA	
ENSG00000211751	TRBC1	NA	
ENSG00000211764	TRBJ2-1	NA	
ENSG00000211765	TRBJ2-2	NA	
ENSG00000211766	TRBJ2-2P	NA	
ENSG00000211767	TRBJ2-3	NA	
ENSG00000211768	TRBJ2-4	NA	
ENSG00000211769	TRBJ2-5	NA	
ENSG00000211770	TRBJ2-6	NA	
ENSG00000211771	TRBJ2-7	NA	
ENSG00000211772	TRBC2	NA	
ENSG00000237254	TRBV30	NA	
ENSG00000106123	EPHB6	NA	
ENSG00000165125	TRPV6	618188	HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN
ENSG00000224970	AC245427.1	NA	
ENSG00000286569	AC245427.2	NA	
ENSG00000127412	TRPV5	NA	
ENSG00000165131	LLCFC1	NA	
ENSG00000197993	KEL	110900	BLOOD GROUP--KELL SYSTEM; KEL;;BLOOD GROUP--KELL-CELLANO SYSTEM  KELL-NULL, INCLUDED;;K(0), INCLUDED;;Ko, INCLUDED
ENSG00000179468	OR9A2	NA	
ENSG00000239293	OR9P1P	NA	
ENSG00000225781	OR6V1	NA	
ENSG00000179420	OR6W1P	NA	
ENSG00000159763	PIP	NA	
ENSG00000236398	TAS2R39	NA	
ENSG00000268170	AC073342.2	NA	
ENSG00000221937	TAS2R40	NA	
ENSG00000279223	AC073342.3	NA	
ENSG00000197448	GSTK1	NA	
ENSG00000231840	AC073342.1	NA	
ENSG00000178826	TMEM139	NA	
ENSG00000106144	CASP2	NA	
ENSG00000239419	RN7SL535P	NA	
ENSG00000240322	RN7SL481P	NA	
ENSG00000231531	HINT1P1	NA	
ENSG00000188037	CLCN1	160800	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT;;THOMSEN DISEASE; THD MYOTONIA LEVIOR, INCLUDED
ENSG00000188037	CLCN1	255700	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE;;BECKER DISEASE;;MYOTONIA, GENERALIZED
ENSG00000159784	FAM131B	NA	
ENSG00000272619	AC093673.2	NA	
ENSG00000232533	AC093673.1	NA	
ENSG00000159840	ZYX	NA	
ENSG00000278449	MIR6892	NA	
ENSG00000146904	EPHA1	NA	
ENSG00000229153	EPHA1-AS1	NA	
ENSG00000234066	TAS2R62P	NA	
ENSG00000185899	TAS2R60	NA	
ENSG00000221855	TAS2R41	NA	
ENSG00000236853	OR2R1P	NA	
ENSG00000176510	OR10AC1	NA	
ENSG00000229977	AC073264.1	NA	
ENSG00000229877	PAICSP5	NA	
ENSG00000271079	CTAGE15	NA	
ENSG00000252037	RNU6-162P	NA	
ENSG00000230556	AC073264.2	NA	
ENSG00000223459	TCAF1P1	NA	
ENSG00000283537	AC073264.3	NA	
ENSG00000170379	TCAF2	NA	
ENSG00000283528	TCAF2C	NA	
ENSG00000252523	RNU6-267P	NA	
ENSG00000271321	CTAGE6	NA	
ENSG00000253882	AC099548.2	NA	
ENSG00000241136	PAICSP6	NA	
ENSG00000232145	AC099548.1	NA	
ENSG00000159860	TCAF2P1	NA	
ENSG00000198420	TCAF1	NA	
ENSG00000221910	OR2F2	NA	
ENSG00000213215	OR2F1	NA	
ENSG00000270729	CAPZA1P5	NA	
ENSG00000273377	OR2Q1P	NA	
ENSG00000242280	SLC16A1P1	NA	
ENSG00000221813	OR6B1	NA	
ENSG00000221836	OR2A5	NA	
ENSG00000221933	OR2A25	NA	
ENSG00000239967	OR2A41P	NA	
ENSG00000221858	OR2A12	NA	
ENSG00000221989	OR2A2	NA	
ENSG00000239981	OR2A15P	NA	
ENSG00000221938	OR2A14	NA	
ENSG00000273234	OR2A13P	NA	
ENSG00000183122	OR2A3P	NA	
ENSG00000240621	OR2AO1P	NA	
ENSG00000225932	CTAGE4	NA	
ENSG00000213214	ARHGEF35	NA	
ENSG00000244198	ARHGEF35-AS1	NA	
ENSG00000212807	OR2A42	NA	
ENSG00000170356	OR2A20P	NA	
ENSG00000284644	AC074386.1	NA	
ENSG00000243896	OR2A7	NA	
ENSG00000244693	CTAGE8	NA	
ENSG00000204959	ARHGEF34P	NA	
ENSG00000228960	OR2A9P	NA	
ENSG00000244479	OR2A1-AS1	NA	
ENSG00000221970	OR2A1	NA	
ENSG00000050327	ARHGEF5	NA	
ENSG00000106410	NOBOX	611548	PREMATURE OVARIAN FAILURE 5; POF5
ENSG00000242978	PPIAP83	NA	
ENSG00000221507	RNU6ATAC40P	NA	
ENSG00000196511	TPK1	614458	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5;;ENCEPHALOPATHY, EPISODIC, DUE TO THIAMINE PYROPHOSPHOKINASE DEFICIENCY
ENSG00000243746	EEF1A1P10	NA	
ENSG00000200673	RN7SKP174	NA	
ENSG00000236343	EI24P4	NA	
ENSG00000214035	AC073310.1	NA	
ENSG00000225918	RPL7P59	NA	
ENSG00000226592	AC004911.1	NA	
ENSG00000231839	DPY19L4P2	NA	
ENSG00000230746	AC006007.1	NA	
ENSG00000280144	AC073308.1	NA	
ENSG00000174469	CNTNAP2	610042	PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1;;CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME; CDFES
ENSG00000174469	CNTNAP2	612100	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15
ENSG00000274127	AC073418.1	NA	
ENSG00000274118	AC007027.1	NA	
ENSG00000236795	CNTNAP2-AS1	NA	
ENSG00000226857	DUTP3	NA	
ENSG00000232391	RANP2	NA	
ENSG00000221442	MIR548F4	NA	
ENSG00000230190	AC005518.1	NA	
ENSG00000270634	AC005518.2	NA	
ENSG00000207318	RNU6-1184P	NA	
ENSG00000251936	RNA5SP249	NA	
ENSG00000242266	RN7SL456P	NA	
ENSG00000199370	AC083849.1	NA	
ENSG00000243374	RN7SL72P	NA	
ENSG00000274133	AC083849.2	NA	
ENSG00000283504	AC006974.1	NA	
ENSG00000283648	AC006974.2	NA	
ENSG00000213210	AC005229.2	NA	
ENSG00000287636	AC005229.5	NA	
ENSG00000170279	C7orf33	NA	
ENSG00000213209	AC005229.1	NA	
ENSG00000270200	AC005229.3	NA	
ENSG00000273314	AC005229.4	NA	
ENSG00000055130	CUL1	NA	
ENSG00000106462	EZH2	277590	WEAVER SYNDROME; WVS;;WEAVER-SMITH SYNDROME; WSS
ENSG00000251712	RNU7-20P	NA	
ENSG00000275586	Metazoa_SRP	NA	
ENSG00000239468	RN7SL569P	NA	
ENSG00000286180	AC073140.2	NA	
ENSG00000286171	AC073140.1	NA	
ENSG00000252316	RNY4	NA	
ENSG00000202354	RNY3	NA	
ENSG00000201098	RNY1	NA	
ENSG00000281189	GHET1	NA	
ENSG00000155660	PDIA4	NA	
ENSG00000202528	RNU6-650P	NA	
ENSG00000234565	COX6B1P1	NA	
ENSG00000197362	ZNF786	NA	
ENSG00000204947	ZNF425	NA	
ENSG00000240877	RN7SL521P	NA	
ENSG00000197024	ZNF398	NA	
ENSG00000239719	AC004890.1	NA	
ENSG00000170265	ZNF282	NA	
ENSG00000170260	ZNF212	NA	
ENSG00000204946	ZNF783	NA	
ENSG00000271664	AC004890.3	NA	
ENSG00000244560	AC004890.2	NA	
ENSG00000231397	AC004941.2	NA	
ENSG00000215311	NPM1P12	NA	
ENSG00000228151	AC004941.1	NA	
ENSG00000261842	AC073314.1	NA	
ENSG00000196453	ZNF777	NA	
ENSG00000181220	ZNF746	NA	
ENSG00000133624	ZNF767P	NA	
ENSG00000133619	KRBA1	NA	
ENSG00000181444	ZNF467	NA	
ENSG00000197558	SSPOP	NA	
ENSG00000106479	ZNF862	NA	
ENSG00000280149	AC004877.2	NA	
ENSG00000273419	AC004877.1	NA	
ENSG00000204934	ATP6V0E2-AS1	NA	
ENSG00000171130	ATP6V0E2	NA	
ENSG00000273293	AC093458.1	NA	
ENSG00000279536	AC093458.2	NA	
ENSG00000273011	AC092681.3	NA	
ENSG00000224016	AC092681.1	NA	
ENSG00000260555	AC092681.2	NA	
ENSG00000241449	AC092666.1	NA	
ENSG00000276538	AC092666.2	NA	
ENSG00000286912	AC006008.1	NA	
ENSG00000106526	ACTR3C	NA	
ENSG00000188707	ZBED6CL	NA	
ENSG00000127399	LRRC61	NA	
ENSG00000261305	AC005586.2	NA	
ENSG00000106538	RARRES2	NA	
ENSG00000240449	AC005586.1	NA	
ENSG00000214022	REPIN1	NA	
ENSG00000196456	ZNF775	NA	
ENSG00000284048	AC073111.3	NA	
ENSG00000239377	AC073111.1	NA	
ENSG00000284691	AC073111.4	NA	
ENSG00000242258	LINC00996	NA	
ENSG00000171115	GIMAP8	NA	
ENSG00000271582	AC073111.2	NA	
ENSG00000213205	STRADBP1	NA	
ENSG00000179144	GIMAP7	NA	
ENSG00000243853	ALDH7A1P3	NA	
ENSG00000133574	GIMAP4	NA	
ENSG00000271568	AC069304.3	NA	
ENSG00000232361	AC069304.1	NA	
ENSG00000133561	GIMAP6	NA	
ENSG00000270990	AC069304.2	NA	
ENSG00000106560	GIMAP2	NA	
ENSG00000213203	GIMAP1	NA	
ENSG00000281887	GIMAP1-GIMAP5	NA	
ENSG00000196329	GIMAP5	NA	
ENSG00000177590	GIMAP3P	NA	
ENSG00000241134	BET1P1	NA	
ENSG00000106565	TMEM176B	NA	
ENSG00000002933	TMEM176A	NA	
ENSG00000002726	AOC1	NA	
ENSG00000055118	KCNH2	609620	SHORT QT SYNDROME 1; SQT1
ENSG00000055118	KCNH2	613688	LONG QT SYNDROME 2; LQT2 LONG QT SYNDROME 2, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;;LONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/3, DIGENIC, INCLUDED; LQT2/3, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/5, DIGENIC /.../UDED; LQT2/5, DIGENIC, INCLUDED;;LONG QT SYNDROME 2/9, DIGENIC, INCLUDED; LQT2/9, DIGENIC, INCLUDED
ENSG00000164867	NOS3	163729	NITRIC OXIDE SYNTHASE 3; NOS3;;NITRIC OXIDE SYNTHASE, ENDOTHELIAL; ENOS CORONARY ARTERY SPASM 1, SUSCEPTIBILITY TO, INCLUDED;;ALZHEIMER DISEASE, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED;;HYPERTENSION, PREGNANCY-INDUCED, SUSCEPTIBILITY TO, INCLUDED;;H /.../NSION RESISTANT TO CONVENTIONAL THERAPY, INCLUDED
ENSG00000164867	NOS3	145500	HYPERTENSION, ESSENTIAL;;EHT
ENSG00000164867	NOS3	104300	ALZHEIMER DISEASE; AD;;PRESENILE AND SENILE DEMENTIA ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED; AD1, INCLUDED;;ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY, INCLUDED;;ALZHEIMER DISEASE, PROTECTION AGAINST, INCLUDED
ENSG00000164867	NOS3	189800	PREECLAMPSIA/ECLAMPSIA 1; PEE1;;PREG1;;PEE;;TOXEMIA OF PREGNANCY HYPERTENSION, PREGNANCY-INDUCED, INCLUDED;;HEMOLYSIS, ELEVATED LIVER ENZYMES, AND LOW PLATELET COUNT, INCLUDED; HELLP, INCLUDED
ENSG00000164867	NOS3	601367	STROKE, ISCHEMIC;;CEREBROVASCULAR ACCIDENT;;CEREBRAL INFARCTION
ENSG00000181652	ATG9B	NA	
ENSG00000197150	ABCB8	NA	
ENSG00000243433	AC010973.1	NA	
ENSG00000213199	ASIC3	NA	
ENSG00000164885	CDK5	616342	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7
ENSG00000164889	SLC4A2	NA	
ENSG00000288608	AC010973.3	NA	
ENSG00000244151	AC010973.2	NA	
ENSG00000164896	FASTK	NA	
ENSG00000164897	TMUB1	NA	
ENSG00000133612	AGAP3	NA	
ENSG00000164900	GBX1	NA	
ENSG00000146926	ASB10	603383	GLAUCOMA 1, OPEN ANGLE, F; GLC1F;;GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET
ENSG00000278685	IQCA1L	NA	
ENSG00000285480	H2BE1	NA	
ENSG00000285292	ABCF2-H2BE1	NA	
ENSG00000033050	ABCF2	NA	
ENSG00000033100	CHPF2	NA	
ENSG00000284191	MIR671	NA	
ENSG00000082014	SMARCD3	NA	
ENSG00000272661	AC021097.1	NA	
ENSG00000243018	AC005486.1	NA	
ENSG00000013374	NUB1	NA	
ENSG00000187260	WDR86	NA	
ENSG00000243836	WDR86-AS1	NA	
ENSG00000241456	AC005996.1	NA	
ENSG00000127377	CRYGN	NA	
ENSG00000265810	MIR3907	NA	
ENSG00000241959	RN7SL76P	NA	
ENSG00000106615	RHEB	NA	
ENSG00000240132	ETF1P2	NA	
ENSG00000106617	PRKAG2	194200	WOLFF-PARKINSON-WHITE SYNDROME;;WPW SYNDROME PREEXCITATION SYNDROME, INCLUDED;;ACCESSORY ATRIOVENTRICULAR PATHWAYS, INCLUDED
ENSG00000106617	PRKAG2	261740	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL;;PHOSPHORYLASE KINASE DEFICIENCY OF HEART;;GLYCOGEN STORAGE DISEASE OF HEART
ENSG00000106617	PRKAG2	600858	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6
ENSG00000242048	AC093583.1	NA	
ENSG00000239911	PRKAG2-AS1	NA	
ENSG00000212219	RNU6-604P	NA	
ENSG00000222941	Y_RNA	NA	
ENSG00000227562	AC074257.1	NA	
ENSG00000106648	GALNTL5	NA	
ENSG00000276213	AC006017.2	NA	
ENSG00000178234	GALNT11	NA	
ENSG00000229591	AC006017.1	NA	
ENSG00000213188	YBX1P4	NA	
ENSG00000055609	KMT2C	617768	KLEEFSTRA SYNDROME 2; KLEFS2
ENSG00000270405	AC104692.2	NA	
ENSG00000204894	AC104692.1	NA	
ENSG00000241007	SEPTIN7P6	NA	
ENSG00000253088	AC005631.1	NA	
ENSG00000241735	FABP5P3	NA	
ENSG00000020219	CCT8L1P	NA	
ENSG00000261455	LINC01003	NA	
ENSG00000231139	AC104843.2	NA	
ENSG00000285912	5S_rRNA	NA	
ENSG00000225416	AC104843.1	NA	
ENSG00000212590	AC003109.1	NA	
ENSG00000196584	XRCC2	617247	FANCONI ANEMIA, COMPLEMENTATION GROUP U; FANCU
ENSG00000214003	ATP5PBP3	NA	
ENSG00000244328	RN7SL845P	NA	
ENSG00000133627	ACTR3B	NA	
ENSG00000286565	AC006348.1	NA	
ENSG00000224104	AC079809.1	NA	
ENSG00000234722	LINC01287	NA	
ENSG00000285524	AC073236.1	NA	
ENSG00000233489	PAXBP1P1	NA	
ENSG00000287744	AC005998.1	NA	
ENSG00000130226	DPP6	612956	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2
ENSG00000130226	DPP6	616311	MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33
ENSG00000226509	AC005588.1	NA	
ENSG00000270114	AC006019.3	NA	
ENSG00000203335	AC006019.1	NA	
ENSG00000233363	AC006019.2	NA	
ENSG00000286461	AC024730.1	NA	
ENSG00000236408	AC073336.1	NA	
ENSG00000214106	PAXIP1-AS2	NA	
ENSG00000157212	PAXIP1	NA	
ENSG00000272760	AC093726.1	NA	
ENSG00000273183	AC093726.2	NA	
ENSG00000273344	PAXIP1-AS1	NA	
ENSG00000220575	HTR5A-AS1	NA	
ENSG00000157219	HTR5A	NA	
ENSG00000283339	AC093726.3	NA	
ENSG00000274637	AC092628.2	NA	
ENSG00000228806	AC092628.1	NA	
ENSG00000201066	RN7SKP280	NA	
ENSG00000217825	AC099552.1	NA	
ENSG00000228521	AC099552.3	NA	
ENSG00000287865	AC099552.5	NA	
ENSG00000278998	AC099552.4	NA	
ENSG00000225612	AC099552.2	NA	
ENSG00000273117	AC144652.1	NA	
ENSG00000186480	INSIG1	NA	
ENSG00000204960	BLACE	NA	
ENSG00000218672	AC008060.1	NA	
ENSG00000260426	AC008060.4	NA	
ENSG00000288051	AC008060.5	NA	
ENSG00000236544	AC008060.3	NA	
ENSG00000164778	EN2	NA	
ENSG00000146910	CNPY1	NA	
ENSG00000283128	AC009403.2	NA	
ENSG00000227365	AC008060.2	NA	
ENSG00000287610	AC009403.3	NA	
ENSG00000216895	AC009403.1	NA	
ENSG00000184863	RBM33	NA	
ENSG00000164690	SHH	147250	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI;;INCISORS, FUSED;;FUSED INCISORS;;SINGLE UPPER CENTRAL INCISOR;;SINGLE CENTRAL MAXILLARY INCISOR SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR SYNDROME, INCLUDED;;SMMCI SYNDROME, INCLUDED
ENSG00000164690	SHH	142945	HOLOPROSENCEPHALY 3; HPE3;;HLP3
ENSG00000164690	SHH	269160	SCHIZENCEPHALY
ENSG00000164690	SHH	611638	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5
ENSG00000204876	AC021218.1	NA	
ENSG00000207061	Y_RNA	NA	
ENSG00000270584	AC093813.1	NA	
ENSG00000182648	LINC01006	NA	
ENSG00000279418	LINC00244	NA	
ENSG00000234450	AC005534.1	NA	
ENSG00000105982	RNF32	NA	
ENSG00000224903	RNF32-AS1	NA	
ENSG00000105983	LMBR1	186200	SYNDACTYLY, TYPE IV; SDTY4;;HAAS TYPE SYNDACTYLY;;POLYSYNDACTYLY, HAAS TYPE;;SD4
ENSG00000105983	LMBR1	174500	POLYDACTYLY, PREAXIAL II; PPD2;;POLYDACTYLY OF TRIPHALANGEAL THUMB;;TRIPHALANGEAL THUMB-POLYDACTYLY SYNDROME TRIPHALANGEAL THUMB WITH POLYSYNDACTYLY, INCLUDED;;TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME, INCLUDED;;TPT-PS SYNDROME, INCLUDED;;TRIPHAL /.../ THUMB, INCLUDED; TPT, INCLUDED
ENSG00000105983	LMBR1	135750	LAURIN-SANDROW SYNDROME; LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUS LAURIN-SANDROW SYND /.../SEGMENTAL, INCLUDED
ENSG00000105983	LMBR1	188740	TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY; THYP;;TIBIAL HEMIMELIA-POLYDACTYLY-TRIPHALANGEAL THUMBS WITH FIBULAR DIMELIA
ENSG00000105983	LMBR1	200500	ACHEIROPODY; ACHP;;ACHEIROPODIA;;ACHEIROPODY, BRAZILIAN TYPE
ENSG00000206938	RNU4-31P	NA	
ENSG00000230033	AC006357.1	NA	
ENSG00000146909	NOM1	NA	
ENSG00000130675	MNX1	176450	CURRARINO SYNDROME;;CURRARINO TRIAD SACRAL AGENESIS SYNDROME, INCLUDED;;SACRAL AGENESIS, HEREDITARY, WITH PRESACRAL MASS, ANTERIOR MENINGOCELE, AND/OR TERATOMA, AND ANORECTAL MALFORMATION, INCLUDED;;SCRA1, INCLUDED
ENSG00000235029	MNX1-AS2	NA	
ENSG00000243479	MNX1-AS1	NA	
ENSG00000236102	AC006967.2	NA	
ENSG00000229365	AC006967.1	NA	
ENSG00000269446	AC006967.3	NA	
ENSG00000009335	UBE3C	NA	
ENSG00000225224	RPS27AP12	NA	
ENSG00000236018	AC004898.1	NA	
ENSG00000224629	AC004975.1	NA	
ENSG00000229660	AC004975.2	NA	
ENSG00000105993	DNAJB6	603511	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1; LGMDD1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E; LGMD1E;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1D, FORMERLY; LGMD1D, FORMERLY
ENSG00000234210	AC006372.3	NA	
ENSG00000223872	AC006372.1	NA	
ENSG00000233191	AC006372.2	NA	
ENSG00000280266	AC006372.4	NA	
ENSG00000155093	PTPRN2	NA	
ENSG00000207960	MIR153-2	NA	
ENSG00000222012	AC005481.1	NA	
ENSG00000231515	AC006003.1	NA	
ENSG00000233038	PTPRN2-AS1	NA	
ENSG00000272839	AC011899.2	NA	
ENSG00000285821	AC011899.3	NA	
ENSG00000231980	AC011899.1	NA	
ENSG00000207637	MIR595	NA	
ENSG00000225365	AC078942.1	NA	
ENSG00000232715	LINC01022	NA	
ENSG00000265598	MIR5707	NA	
ENSG00000224324	THAP5P1	NA	
ENSG00000146918	NCAPG2	618460	KHAN-KHAN-KATSANIS SYNDROME; 3KS;;3K SYNDROME
ENSG00000228030	AC019084.1	NA	
ENSG00000117868	ESYT2	NA	
ENSG00000126870	WDR60	615503	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8;;SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6
ENSG00000286407	AC004863.1	NA	
ENSG00000231419	LINC00689	NA	
ENSG00000106018	VIPR2	NA	
ENSG00000287184	AC007269.1	NA	
ENSG00000229435	PIP5K1P2	NA	
ENSG00000253620	AC144568.1	NA	
ENSG00000253896	AC144568.2	NA	
ENSG00000254193	AC131281.2	NA	
ENSG00000253612	WBP1LP3	NA	
ENSG00000176269	OR4F21	NA	
ENSG00000255464	SEPTIN14P8	NA	
ENSG00000253166	AC131281.1	NA	
ENSG00000223508	RPL23AP53	NA	
ENSG00000172748	ZNF596	NA	
ENSG00000272812	AC004908.2	NA	
ENSG00000272240	AC004908.1	NA	
ENSG00000273402	AC004908.3	NA	
ENSG00000254104	AC136777.2	NA	
ENSG00000249868	AC136777.1	NA	
ENSG00000182366	FAM87A	NA	
ENSG00000147364	FBXO25	NA	
ENSG00000272293	AC083964.1	NA	
ENSG00000279852	AC083964.2	NA	
ENSG00000180190	TDRP	NA	
ENSG00000104714	ERICH1	NA	
ENSG00000254207	AC100797.1	NA	
ENSG00000198010	DLGAP2	NA	
ENSG00000282375	AC100797.4	NA	
ENSG00000282759	AC026950.2	NA	
ENSG00000282692	AC129915.3	NA	
ENSG00000254160	AC110288.1	NA	
ENSG00000275427	AF067845.2	NA	
ENSG00000260721	AF067845.1	NA	
ENSG00000282160	AF067845.5	NA	
ENSG00000281961	AF067845.4	NA	
ENSG00000253267	DLGAP2-AS1	NA	
ENSG00000283576	AC100810.6	NA	
ENSG00000254265	AC100810.2	NA	
ENSG00000182372	CLN8	600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
ENSG00000182372	CLN8	610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT;;NORTHERN EPILEPSY;;EPILEPSY, PROGRESSIVE, WITH MENTAL RETARDATION; EPMR
ENSG00000282021	AC100810.3	NA	
ENSG00000253982	AC100810.1	NA	
ENSG00000283239	KBTBD11-OT1	NA	
ENSG00000283858	MIR3674	NA	
ENSG00000287464	AC100810.7	NA	
ENSG00000207826	MIR596	NA	
ENSG00000104728	ARHGEF10	608236	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV
ENSG00000285957	AC019257.7	NA	
ENSG00000253764	AC019257.1	NA	
ENSG00000253696	KBTBD11-OT1	NA	
ENSG00000176595	KBTBD11	NA	
ENSG00000270988	AC019257.2	NA	
ENSG00000253805	AC245164.1	NA	
ENSG00000036448	MYOM2	NA	
ENSG00000273593	MIR7160	NA	
ENSG00000287970	AC245164.2	NA	
ENSG00000253444	AC245519.1	NA	
ENSG00000282686	AC245519.2	NA	
ENSG00000282142	AC245187.2	NA	
ENSG00000253855	AC245187.1	NA	
ENSG00000277526	AC245123.1	NA	
ENSG00000254319	AC246817.2	NA	
ENSG00000253853	AC246817.1	NA	
ENSG00000287740	AC115485.1	NA	
ENSG00000288580	AC023296.1	NA	
ENSG00000183117	CSMD1	NA	
ENSG00000253162	AC026991.1	NA	
ENSG00000285861	AC026991.2	NA	
ENSG00000222546	RNA5SP251	NA	
ENSG00000286934	AC027251.1	NA	
ENSG00000288110	AC010941.1	NA	
ENSG00000285977	AC022068.1	NA	
ENSG00000254244	PAICSP4	NA	
ENSG00000253262	AC019176.1	NA	
ENSG00000273876	AC019176.2	NA	
ENSG00000206661	SNORA70	NA	
ENSG00000242079	RN7SL318P	NA	
ENSG00000278256	AC007718.1	NA	
ENSG00000271248	AC091193.1	NA	
ENSG00000240486	RPL23AP54	NA	
ENSG00000253510	AC004944.1	NA	
ENSG00000254007	AC084768.1	NA	
ENSG00000275461	AC084768.2	NA	
ENSG00000253571	AC087369.1	NA	
ENSG00000286969	AC087369.2	NA	
ENSG00000222589	RN7SKP159	NA	
ENSG00000253189	AC079054.1	NA	
ENSG00000253880	AC009435.1	NA	
ENSG00000246089	AC016065.1	NA	
ENSG00000147316	MCPH1	251200	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1;;PREMATURE CHROMOSOME CONDENSATION WITH MICROCEPHALY AND MENTAL RETARDATION;;PREMATURE CHROMOSOME CONDENSATION SYNDROME;;PCC SYNDROME
ENSG00000253550	AC016065.2	NA	
ENSG00000091879	ANGPT2	NA	
ENSG00000288076	AC018398.1	NA	
ENSG00000271743	AF287957.1	NA	
ENSG00000249898	MCPH1-AS1	NA	
ENSG00000276580	MIR8055	NA	
ENSG00000155189	AGPAT5	NA	
ENSG00000266038	MIR4659A	NA	
ENSG00000283386	MIR4659B	NA	
ENSG00000287747	AF233439.2	NA	
ENSG00000275591	XKR5	NA	
ENSG00000245857	GS1-24F4.2	NA	
ENSG00000164825	DEFB1	NA	
ENSG00000250752	RPL23AP96	NA	
ENSG00000164822	DEFA6	NA	
ENSG00000254625	AF233439.1	NA	
ENSG00000164821	DEFA4	NA	
ENSG00000223629	DEFA8P	NA	
ENSG00000233238	DEFA9P	NA	
ENSG00000233531	DEFA10P	NA	
ENSG00000206047	DEFA1	NA	
ENSG00000215378	DEFT1P	NA	
ENSG00000240247	DEFA1B	NA	
ENSG00000232039	DEFT1P2	NA	
ENSG00000239839	DEFA3	NA	
ENSG00000234178	DEFA11P	NA	
ENSG00000206042	DEFA7P	NA	
ENSG00000164816	DEFA5	NA	
ENSG00000255273	AF238378.1	NA	
ENSG00000284620	AF228730.5	NA	
ENSG00000234120	AF228730.2	NA	
ENSG00000228744	RPS3AP30	NA	
ENSG00000254683	SNRPCP6	NA	
ENSG00000230106	SNRPCP15	NA	
ENSG00000214268	RPS3AP33	NA	
ENSG00000231930	AF228730.1	NA	
ENSG00000284614	AF228730.4	NA	
ENSG00000284728	AF228730.6	NA	
ENSG00000255025	AF228730.3	NA	
ENSG00000177306	OR7E125P	NA	
ENSG00000230045	FAM90A15P	NA	
ENSG00000233132	FAM90A3P	NA	
ENSG00000249005	FAM90A4P	NA	
ENSG00000223885	FAM90A13P	NA	
ENSG00000215373	FAM90A5P	NA	
ENSG00000233295	FAM90A20P	NA	
ENSG00000215374	FAM66B	NA	
ENSG00000206034	DEFB109B	NA	
ENSG00000230549	USP17L1	NA	
ENSG00000236125	USP17L4	NA	
ENSG00000235778	AC130360.1	NA	
ENSG00000215372	ZNF705G	NA	
ENSG00000215371	DEFB108C	NA	
ENSG00000177257	DEFB4B	NA	
ENSG00000255128	HSPD1P3	NA	
ENSG00000177243	DEFB103B	NA	
ENSG00000164871	SPAG11B	NA	
ENSG00000177023	DEFB104B	NA	
ENSG00000187082	DEFB106B	NA	
ENSG00000186599	DEFB105B	NA	
ENSG00000198129	DEFB107B	NA	
ENSG00000285659	AC134684.4	NA	
ENSG00000255251	PRR23D1	NA	
ENSG00000285927	AC134684.5	NA	
ENSG00000248944	FAM90A6P	NA	
ENSG00000285975	FAM90A7P	NA	
ENSG00000234749	FAM90A21P	NA	
ENSG00000285687	FAM90A22P	NA	
ENSG00000285765	FAM90A23P	NA	
ENSG00000233176	OR7E157P	NA	
ENSG00000254796	AC134684.1	NA	
ENSG00000284617	AC134684.3	NA	
ENSG00000284655	AC084121.2	NA	
ENSG00000284698	AC084121.3	NA	
ENSG00000254889	AC084121.1	NA	
ENSG00000254715	OR7E154P	NA	
ENSG00000285814	FAM90A14P	NA	
ENSG00000285913	FAM90A18P	NA	
ENSG00000285620	FAM90A16P	NA	
ENSG00000285937	FAM90A8P	NA	
ENSG00000285720	FAM90A17P	NA	
ENSG00000285657	FAM90A19P	NA	
ENSG00000285607	FAM90A9P	NA	
ENSG00000285950	FAM90A10P	NA	
ENSG00000285862	AC084121.4	NA	
ENSG00000255378	PRR23D2	NA	
ENSG00000254776	PRR23D3P	NA	
ENSG00000186572	DEFB107A	NA	
ENSG00000186562	DEFB105A	NA	
ENSG00000186579	DEFB106A	NA	
ENSG00000176782	DEFB104A	NA	
ENSG00000178287	SPAG11A	NA	
ENSG00000176797	DEFB103A	NA	
ENSG00000254543	HSPD1P2	NA	
ENSG00000171711	DEFB4A	NA	
ENSG00000215356	ZNF705B	NA	
ENSG00000229907	DEFB108A	NA	
ENSG00000225725	FAM66E	NA	
ENSG00000255211	AC130365.1	NA	
ENSG00000237038	USP17L8	NA	
ENSG00000225327	USP17L3	NA	
ENSG00000205989	DEFB109C	NA	
ENSG00000233115	FAM90A11P	NA	
ENSG00000215354	FAM90A24P	NA	
ENSG00000254229	FAM90A12P	NA	
ENSG00000227013	OR7E96P	NA	
ENSG00000253881	AC105233.1	NA	
ENSG00000284603	AC105233.3	NA	
ENSG00000284606	AC105233.4	NA	
ENSG00000284661	AC105233.5	NA	
ENSG00000255459	AC105233.2	NA	
ENSG00000221305	MIR548I3	NA	
ENSG00000244427	RPS3AP31	NA	
ENSG00000254311	SNRPCP17	NA	
ENSG00000249188	ENPP7P1	NA	
ENSG00000253893	FAM85B	NA	
ENSG00000268955	AC068020.1	NA	
ENSG00000173295	FAM86B3P	NA	
ENSG00000253981	ALG1L13P	NA	
ENSG00000275342	PRAG1	NA	
ENSG00000253505	AC103957.1	NA	
ENSG00000254153	AC103957.2	NA	
ENSG00000253343	AC114550.2	NA	
ENSG00000253774	AC114550.3	NA	
ENSG00000253130	AC114550.1	NA	
ENSG00000263616	RN7SL178P	NA	
ENSG00000286910	AC087269.3	NA	
ENSG00000253958	CLDN23	NA	
ENSG00000284717	AC087269.2	NA	
ENSG00000254367	AC087269.1	NA	
ENSG00000147324	MFHAS1	NA	
ENSG00000200713	RNU6-682P	NA	
ENSG00000270966	AC087763.1	NA	
ENSG00000233609	RPL10P19	NA	
ENSG00000207244	SNORA70	NA	
ENSG00000104626	ERI1	NA	
ENSG00000263407	MIR4660	NA	
ENSG00000239078	RNU7-55P	NA	
ENSG00000197334	Metazoa_SRP	NA	
ENSG00000173281	PPP1R3B	NA	
ENSG00000254340	AC022784.5	NA	
ENSG00000248538	AC022784.1	NA	
ENSG00000279949	AC022784.6	NA	
ENSG00000253252	AC022784.2	NA	
ENSG00000254091	AC022784.4	NA	
ENSG00000253887	AC022784.3	NA	
ENSG00000207415	RNU6-1151P	NA	
ENSG00000253735	AC021736.1	NA	
ENSG00000254237	AC021242.2	NA	
ENSG00000201815	RNU6-526P	NA	
ENSG00000249050	AC021242.1	NA	
ENSG00000272267	AC021242.3	NA	
ENSG00000173273	TNKS	NA	
ENSG00000253697	AC103834.1	NA	
ENSG00000207701	MIR597	NA	
ENSG00000253230	MIR124-1HG	NA	
ENSG00000284321	MIR124-1	NA	
ENSG00000286622	AC034111.2	NA	
ENSG00000260093	AC034111.1	NA	
ENSG00000175806	MSRA	NA	
ENSG00000285675	AC023385.1	NA	
ENSG00000285606	AC079200.1	NA	
ENSG00000249848	AC112673.1	NA	
ENSG00000261451	AC104964.2	NA	
ENSG00000253641	LINCR-0001	NA	
ENSG00000285237	AC104964.4	NA	
ENSG00000207128	RNU6-729P	NA	
ENSG00000253678	AC104964.1	NA	
ENSG00000253649	PRSS51	NA	
ENSG00000272505	AC104964.3	NA	
ENSG00000184647	PRSS55	NA	
ENSG00000183638	RP1L1	613587	OCCULT MACULAR DYSTROPHY; OCMD;;OMD
ENSG00000183638	RP1L1	618826	RETINITIS PIGMENTOSA 88; RP88
ENSG00000263762	MIR4286	NA	
ENSG00000171060	C8orf74	NA	
ENSG00000212433	RNA5SP252	NA	
ENSG00000171056	SOX7	NA	
ENSG00000258724	PINX1	NA	
ENSG00000248896	AC105001.1	NA	
ENSG00000254093	PINX1	NA	
ENSG00000283210	MIR1322	NA	
ENSG00000253695	AC011008.1	NA	
ENSG00000280294	AC011008.2	NA	
ENSG00000171044	XKR6	NA	
ENSG00000207600	MIR598	NA	
ENSG00000254839	AF131215.3	NA	
ENSG00000269918	AF131215.6	NA	
ENSG00000255310	AF131215.5	NA	
ENSG00000254936	AF131215.4	NA	
ENSG00000254556	AF131215.2	NA	
ENSG00000231965	AF131215.1	NA	
ENSG00000270076	AF131215.7	NA	
ENSG00000236827	LINC00529	NA	
ENSG00000239315	RPL19P13	NA	
ENSG00000249316	AF131216.2	NA	
ENSG00000280273	AF131216.4	NA	
ENSG00000104643	MTMR9	NA	
ENSG00000246477	AF131216.1	NA	
ENSG00000177710	SLC35G5	NA	
ENSG00000154316	TDH	NA	
ENSG00000255020	AF131216.3	NA	
ENSG00000184608	FAM167A-AS1	NA	
ENSG00000242483	RN7SL293P	NA	
ENSG00000199368	RNU6-1084P	NA	
ENSG00000154319	FAM167A	NA	
ENSG00000284957	AF131216.5	NA	
ENSG00000136573	BLK	613375	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11
ENSG00000269954	AC022239.1	NA	
ENSG00000170983	LINC00208	NA	
ENSG00000286985	AC022239.2	NA	
ENSG00000136574	GATA4	187500	TETRALOGY OF FALLOT; TOF
ENSG00000136574	GATA4	607941	ATRIAL SEPTAL DEFECT 2; ASD2
ENSG00000136574	GATA4	614429	VENTRICULAR SEPTAL DEFECT 1; VSD1
ENSG00000136574	GATA4	614430	ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4
ENSG00000136574	GATA4	615542	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD
ENSG00000255394	C8orf49	NA	
ENSG00000154328	NEIL2	NA	
ENSG00000227203	SUB1P1	NA	
ENSG00000079459	FDFT1	618156	SQUALENE SYNTHASE DEFICIENCY; SQSD;;NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS
ENSG00000255046	AC069185.1	NA	
ENSG00000164733	CTSB	148370	KERATOLYTIC WINTER ERYTHEMA; KWE;;OUDTSHOORN SKIN DISEASE
ENSG00000269899	AC025857.2	NA	
ENSG00000255144	AC025857.1	NA	
ENSG00000254948	OR7E158P	NA	
ENSG00000206014	OR7E161P	NA	
ENSG00000287755	AC107918.5	NA	
ENSG00000287798	AC107918.6	NA	
ENSG00000205884	DEFB136	NA	
ENSG00000205883	DEFB135	NA	
ENSG00000205882	DEFB134	NA	
ENSG00000255174	AC107918.3	NA	
ENSG00000254507	DEFB131E	NA	
ENSG00000284610	AC107918.4	NA	
ENSG00000255016	AC107918.2	NA	
ENSG00000254817	AC107918.1	NA	
ENSG00000254700	DEFB131C	NA	
ENSG00000233050	DEFB130B	NA	
ENSG00000252029	RNA5SP253	NA	
ENSG00000255544	DEFB108D	NA	
ENSG00000215343	ZNF705D	NA	
ENSG00000255052	FAM66D	NA	
ENSG00000254923	AC130366.1	NA	
ENSG00000226430	USP17L7	NA	
ENSG00000223443	USP17L2	NA	
ENSG00000254866	DEFB109D	NA	
ENSG00000205879	FAM90A2P	NA	
ENSG00000249889	ALG1L11P	NA	
ENSG00000186523	FAM86B1	NA	
ENSG00000255495	AC145124.1	NA	
ENSG00000254527	ENPP7P12	NA	
ENSG00000237215	DEFB131D	NA	
ENSG00000232948	DEFB130A	NA	
ENSG00000252535	RNA5SP254	NA	
ENSG00000254623	DEFB108E	NA	
ENSG00000215339	ZNF705CP	NA	
ENSG00000227888	FAM66A	NA	
ENSG00000254423	AC087203.1	NA	
ENSG00000255556	AC087203.2	NA	
ENSG00000242296	DEFB109A	NA	
ENSG00000270074	AC087203.3	NA	
ENSG00000251402	FAM90A25P	NA	
ENSG00000250794	ALG1L12P	NA	
ENSG00000145002	FAM86B2	NA	
ENSG00000255549	ENPP7P6	NA	
ENSG00000283674	AC068587.4	NA	
ENSG00000270154	AC130352.1	NA	
ENSG00000242607	RPS3AP34	NA	
ENSG00000255122	AC068587.2	NA	
ENSG00000284746	AC068587.8	NA	
ENSG00000284663	AC068587.6	NA	
ENSG00000244289	RPS3AP35	NA	
ENSG00000255253	AC068587.3	NA	
ENSG00000284724	AC068587.7	NA	
ENSG00000284613	AC068587.5	NA	
ENSG00000254581	AC068587.1	NA	
ENSG00000177400	OR7E8P	NA	
ENSG00000254917	OR7E15P	NA	
ENSG00000254724	OR7E10P	NA	
ENSG00000264512	MIR5692A2	NA	
ENSG00000154359	LONRF1	NA	
ENSG00000266206	MIR3926-1	NA	
ENSG00000283523	MIR3926-2	NA	
ENSG00000254813	AC123777.1	NA	
ENSG00000255494	LINC00681	NA	
ENSG00000250305	TRMT9B	NA	
ENSG00000251468	AC135352.1	NA	
ENSG00000206996	RNU6-842P	NA	
ENSG00000164741	DLC1	114500	COLORECTAL CANCER; CRC;;COLON CANCER
ENSG00000287134	AC106845.1	NA	
ENSG00000200630	Y_RNA	NA	
ENSG00000253932	AC019270.1	NA	
ENSG00000253257	MTND4P7	NA	
ENSG00000252179	RNA5SP255	NA	
ENSG00000164743	C8orf48	NA	
ENSG00000254491	AC022832.1	NA	
ENSG00000286798	AC022832.2	NA	
ENSG00000255457	AC022880.2	NA	
ENSG00000255413	AC022880.1	NA	
ENSG00000254753	AC022690.2	NA	
ENSG00000254425	AC022690.1	NA	
ENSG00000255437	AC023538.1	NA	
ENSG00000185053	SGCZ	NA	
ENSG00000254575	AC022039.1	NA	
ENSG00000214366	EIF4EP5	NA	
ENSG00000252264	RNU7-153P	NA	
ENSG00000206950	Y_RNA	NA	
ENSG00000252035	RNU6-397P	NA	
ENSG00000255365	AC040926.1	NA	
ENSG00000199127	MIR383	NA	
ENSG00000255076	AC084838.1	NA	
ENSG00000249368	AC103851.1	NA	
ENSG00000104723	TUSC3	611093	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 22; MRT22
ENSG00000248423	AC100850.1	NA	
ENSG00000250483	PPM1AP1	NA	
ENSG00000287476	AC018437.3	NA	
ENSG00000226836	AC018437.1	NA	
ENSG00000253648	AC018437.2	NA	
ENSG00000038945	MSR1	614266	BARRETT ESOPHAGUS;;BARRETT METAPLASIA  ADENOCARCINOMA OF ESOPHAGUS, INCLUDED
ENSG00000253951	AC087360.1	NA	
ENSG00000253934	MRPL49P2	NA	
ENSG00000253496	AC011586.2	NA	
ENSG00000253184	AC011586.1	NA	
ENSG00000264092	RN7SL474P	NA	
ENSG00000078579	FGF20	615721	RENAL HYPODYSPLASIA/APLASIA 2; RHDA2
ENSG00000155970	MICU3	NA	
ENSG00000249258	AC079193.2	NA	
ENSG00000244113	AC079193.1	NA	
ENSG00000104219	ZDHHC2	NA	
ENSG00000198791	CNOT7	NA	
ENSG00000155975	VPS37A	614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53
ENSG00000003987	MTMR7	NA	
ENSG00000214607	ADAM24P	NA	
ENSG00000003989	SLC7A2	NA	
ENSG00000279271	AP006248.2	NA	
ENSG00000280453	AP006248.5	NA	
ENSG00000279903	AP006248.3	NA	
ENSG00000279932	AP006248.4	NA	
ENSG00000104213	PDGFRL	114550	HEPATOCELLULAR CARCINOMA;;HCC;;CANCER, HEPATOCELLULAR;;LIVER CANCER;;LIVER CELL CARCINOMA; LCC;;HEPATOMA HEPATOBLASTOMA, INCLUDED;;HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
ENSG00000277466	AP006248.1	NA	
ENSG00000287303	AP006248.6	NA	
ENSG00000129422	MTUS1	NA	
ENSG00000265520	MIR548V	NA	
ENSG00000253168	AC124069.1	NA	
ENSG00000212280	RNA5SP256	NA	
ENSG00000253944	AC027117.2	NA	
ENSG00000253671	AC027117.1	NA	
ENSG00000104760	FGL1	NA	
ENSG00000253215	AC087273.1	NA	
ENSG00000254054	AC087273.2	NA	
ENSG00000078674	PCM1	NA	
ENSG00000104763	ASAH1	159950	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME;;MYOCLONUS, HEREDITARY, WITH PROGRESSIVE DISTAL MUSCULAR ATROPHY
ENSG00000104763	ASAH1	228000	FARBER LIPOGRANULOMATOSIS; FRBRL;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY
ENSG00000245281	AC124242.1	NA	
ENSG00000253384	AC124242.2	NA	
ENSG00000286542	AC124242.3	NA	
ENSG00000171428	NAT1	NA	
ENSG00000254015	MTND4LP26	NA	
ENSG00000253937	NATP	NA	
ENSG00000244593	AC025062.1	NA	
ENSG00000285624	AC025062.3	NA	
ENSG00000271654	AC025062.2	NA	
ENSG00000156006	NAT2	243400	ACETYLATION, SLOW;;SLOW ACETYLATOR PHENOTYPE;;ISONIAZID INACTIVATION, SLOW;;INH INACTIVATION, SLOW ACETYLATION, FAST, INCLUDED;;FAST ACETYLATOR PHENOTYPE, INCLUDED;;INH INACTIVATION, FAST, INCLUDED
ENSG00000156011	PSD3	NA	
ENSG00000187229	AC100800.1	NA	
ENSG00000244018	RPL35P6	NA	
ENSG00000283402	AC087821.2	NA	
ENSG00000278886	AC087821.1	NA	
ENSG00000201157	SNORA62	NA	
ENSG00000253335	AC009884.1	NA	
ENSG00000270255	AC009884.2	NA	
ENSG00000253557	AC100849.1	NA	
ENSG00000254242	AC100849.2	NA	
ENSG00000250316	AC068880.1	NA	
ENSG00000254201	AC068880.3	NA	
ENSG00000253280	AC068880.2	NA	
ENSG00000279919	AC068880.5	NA	
ENSG00000104611	SH2D4A	NA	
ENSG00000279858	AC068880.4	NA	
ENSG00000147408	CSGALNACT1	NA	
ENSG00000253270	AC090541.1	NA	
ENSG00000104613	INTS10	NA	
ENSG00000175445	LPL	144250	HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3;;FAMILIAL COMBINED HYPERLIPIDEMIA
ENSG00000175445	LPL	238600	HYPERLIPOPROTEINEMIA, TYPE I;;LIPOPROTEIN LIPASE DEFICIENCY;;LPL DEFICIENCY;;HYPERCHYLOMICRONEMIA, FAMILIAL;;HYPERLIPEMIA, IDIOPATHIC, BURGER-GRUTZ TYPE;;HYPERLIPEMIA, ESSENTIAL FAMILIAL;;LIPASE D DEFICIENCY;;LIPD DEFICIENCY;;HYPERLIPOPROTEINEMIA, T /.../;;CHYLOMICRONEMIA, FAMILIAL HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 11, INCLUDED; HDLCQ11, INCLUDED
ENSG00000253775	AC100802.1	NA	
ENSG00000242709	RPL30P9	NA	
ENSG00000036565	SLC18A1	NA	
ENSG00000147416	ATP6V1B2	124480	DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD;;DDOD SYNDROME
ENSG00000147416	ATP6V1B2	616455	ZIMMERMANN-LABAND SYNDROME 2; ZLS2
ENSG00000222267	RNU6-892P	NA	
ENSG00000061337	LZTS1	133239	ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED;;ESCC, SUSCEPTIBILITY TO, INCLUDED;;AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO, INCLUDED;;GASTRIC CARDIA ADENOCARCINOMA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000253733	LZTS1-AS1	NA	
ENSG00000274467	RNA5SP257	NA	
ENSG00000253164	AC023403.1	NA	
ENSG00000253178	AC022559.1	NA	
ENSG00000253300	AC018541.1	NA	
ENSG00000253866	TMEM97P2	NA	
ENSG00000254260	AC015468.3	NA	
ENSG00000254092	AC021613.1	NA	
ENSG00000253147	AC015468.1	NA	
ENSG00000254026	AC015468.2	NA	
ENSG00000253199	LINC02153	NA	
ENSG00000254040	AC103719.1	NA	
ENSG00000280215	AC021613.2	NA	
ENSG00000286346	AC021613.3	NA	
ENSG00000254334	AC021355.1	NA	
ENSG00000168546	GFRA2	NA	
ENSG00000273484	OR6R2P	NA	
ENSG00000147443	DOK2	NA	
ENSG00000130227	XPO7	NA	
ENSG00000158806	NPM2	NA	
ENSG00000158815	FGF17	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000158815	FGF17	615270	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20
ENSG00000158856	DMTN	NA	
ENSG00000158863	FAM160B2	NA	
ENSG00000275074	NUDT18	NA	
ENSG00000168453	HR	146550	HYPOTRICHOSIS 4; HYPT4;;MARIE UNNA HEREDITARY HYPOTRICHOSIS 1; MUHH1;;HYPOTRICHOSIS, MARIE UNNA TYPE, 1
ENSG00000168453	HR	203655	ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED
ENSG00000168453	HR	209500	ATRICHIA WITH PAPULAR LESIONS; APL;;PAPULAR ATRICHIA
ENSG00000168476	REEP4	NA	
ENSG00000168481	LGI3	NA	
ENSG00000168484	SFTPC	178500	PULMONARY FIBROSIS, IDIOPATHIC; IPF;;IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL;;FIBROSING ALVEOLITIS, CRYPTOGENIC;;FIBROCYSTIC PULMONARY DYSPLASIA;;INTERSTITIAL PNEUMONITIS, USUAL; UIP HAMMAN-RICH DISEASE, INCLUDED
ENSG00000168484	SFTPC	610913	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2;;INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN C DEFICIENCY;;DESQUAMATIVE INTERSTITIAL PNEUMONITIS DUE TO SURFACTANT PROTEIN C DEFICIENCY;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 2
ENSG00000168487	BMP1	614856	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13;;OI, TYPE XIII
ENSG00000177725	AC105206.1	NA	
ENSG00000285881	AC105206.3	NA	
ENSG00000168490	PHYHIP	NA	
ENSG00000208037	MIR320A	NA	
ENSG00000168495	POLR3D	NA	
ENSG00000254064	AC105206.2	NA	
ENSG00000197181	PIWIL2	NA	
ENSG00000104635	SLC39A14	144755	HYPEROSTOSIS CRANIALIS INTERNA; HCIN
ENSG00000104635	SLC39A14	617013	HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2
ENSG00000241026	AC105910.1	NA	
ENSG00000201761	RNU6-336P	NA	
ENSG00000120910	PPP3CC	NA	
ENSG00000251034	AC087854.1	NA	
ENSG00000254272	AC087854.2	NA	
ENSG00000120896	SORBS3	NA	
ENSG00000287467	AC037459.4	NA	
ENSG00000254230	AC037459.3	NA	
ENSG00000120913	PDLIM2	NA	
ENSG00000248235	AC037459.1	NA	
ENSG00000241852	C8orf58	NA	
ENSG00000158941	CCAR2	NA	
ENSG00000253200	AC037459.2	NA	
ENSG00000147439	BIN3	NA	
ENSG00000261026	AC105046.1	NA	
ENSG00000179388	EGR3	NA	
ENSG00000253125	AC055854.1	NA	
ENSG00000287812	AC105046.2	NA	
ENSG00000134020	PEBP4	NA	
ENSG00000248738	AC037441.1	NA	
ENSG00000253142	AC037441.2	NA	
ENSG00000240116	RN7SL303P	NA	
ENSG00000245025	AC107959.1	NA	
ENSG00000008853	RHOBTB2	618004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64
ENSG00000120889	TNFRSF10B	275355	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC
ENSG00000246130	AC107959.2	NA	
ENSG00000253616	AC107959.3	NA	
ENSG00000284948	AC107959.4	NA	
ENSG00000284956	AC107959.5	NA	
ENSG00000173535	TNFRSF10C	NA	
ENSG00000173530	TNFRSF10D	NA	
ENSG00000104689	TNFRSF10A	NA	
ENSG00000253930	TNFRSF10A-AS1	NA	
ENSG00000243265	RPL23AP55	NA	
ENSG00000246582	AC100861.1	NA	
ENSG00000250714	AC100861.2	NA	
ENSG00000147457	CHMP7	NA	
ENSG00000104679	R3HCC1	NA	
ENSG00000134013	LOXL2	NA	
ENSG00000253837	AC090197.1	NA	
ENSG00000197217	ENTPD4	NA	
ENSG00000253390	AC104561.1	NA	
ENSG00000253483	AC104561.2	NA	
ENSG00000287166	AC104561.4	NA	
ENSG00000253986	AC104561.3	NA	
ENSG00000147454	SLC25A37	NA	
ENSG00000252067	RNU4-71P	NA	
ENSG00000253488	SINHCAFP3	NA	
ENSG00000167034	NKX3-1	NA	
ENSG00000180053	NKX2-6	217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM TRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED /.../RRUPTED AORTIC ARCH, INCLUDED
ENSG00000253471	AC012574.1	NA	
ENSG00000254002	AC012574.2	NA	
ENSG00000271118	AC012119.2	NA	
ENSG00000207027	AC012119.1	NA	
ENSG00000159167	STC1	NA	
ENSG00000207201	RNU1-148P	NA	
ENSG00000253891	AC023202.1	NA	
ENSG00000042980	ADAM28	NA	
ENSG00000253535	AC120193.1	NA	
ENSG00000134028	ADAMDEC1	NA	
ENSG00000069206	ADAM7	NA	
ENSG00000253643	AC024958.1	NA	
ENSG00000272163	AF106564.1	NA	
ENSG00000104722	NEFM	NA	
ENSG00000277586	NEFL	607684	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2E
ENSG00000277586	NEFL	607734	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1F
ENSG00000277586	NEFL	617882	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG
ENSG00000283327	MIR6841	NA	
ENSG00000272157	AC107373.2	NA	
ENSG00000253832	AC107373.1	NA	
ENSG00000288055	AC107373.3	NA	
ENSG00000253670	AC073581.1	NA	
ENSG00000287185	AC041005.1	NA	
ENSG00000147459	DOCK5	NA	
ENSG00000284858	AC091185.2	NA	
ENSG00000274988	MIR6876	NA	
ENSG00000147437	GNRH1	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7;;HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH
ENSG00000147437	GNRH1	614841	HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12;;EUNUCHOIDISM, FAMILIAL HYPOGONADOTROPIC;;GONADOTROPIN DEFICIENCY, FAMILIAL IDIOPATHIC; FIGD
ENSG00000253476	AC091185.1	NA	
ENSG00000104756	KCTD9	NA	
ENSG00000184661	CDCA2	NA	
ENSG00000253100	AC009623.1	NA	
ENSG00000253342	AC009623.2	NA	
ENSG00000285890	AC009623.3	NA	
ENSG00000254178	AC090103.1	NA	
ENSG00000221818	EBF2	NA	
ENSG00000199620	RNA5SP258	NA	
ENSG00000249213	AC079097.1	NA	
ENSG00000221914	PPP2R2A	NA	
ENSG00000228451	SDAD1P1	NA	
ENSG00000104765	BNIP3L	NA	
ENSG00000253430	AC011726.1	NA	
ENSG00000251203	DNAJB6P2	NA	
ENSG00000254362	AC011726.2	NA	
ENSG00000240694	PNMA2	NA	
ENSG00000092964	DPYSL2	NA	
ENSG00000253208	AC015743.1	NA	
ENSG00000120907	ADRA1A	NA	
ENSG00000240519	AC091675.1	NA	
ENSG00000253813	COX6B1P4	NA	
ENSG00000275115	AC067904.3	NA	
ENSG00000215288	AC067904.1	NA	
ENSG00000221616	MIR548H4	NA	
ENSG00000253899	AC067904.2	NA	
ENSG00000253903	AC090150.2	NA	
ENSG00000253888	AC090150.1	NA	
ENSG00000015592	STMN4	NA	
ENSG00000104228	TRIM35	NA	
ENSG00000120899	PTK2B	NA	
ENSG00000273836	MIR6842	NA	
ENSG00000120903	CHRNA2	610353	EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4;;EPILEPSY, FAMILIAL, WITH NOCTURNAL WANDERING AND ICTAL FEAR SEIZURES, BENIGN FAMILIAL INFANTILE, 6, INCLUDED; BFIS6, INCLUDED;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 6, INCLUDED; BFIC6, INCLUDED
ENSG00000120915	EPHX2	143890	HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1;;FHC; FH;;HYPERLIPOPROTEINEMIA, TYPE II;;HYPERLIPOPROTEINEMIA, TYPE IIA;;HYPER-LOW-DENSITY-LIPOPROTEINEMIA;;HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL;;LDL RECEPTOR DISORDER LOW DENSITY LIPOPROTEIN CHOLESTE /.../VEL QUANTITATIVE TRAIT LOCUS 2, INCLUDED; LDLCQ2, INCLUDED
ENSG00000234770	GULOP	NA	
ENSG00000120885	CLU	NA	
ENSG00000284280	MIR6843	NA	
ENSG00000168077	SCARA3	NA	
ENSG00000222862	RNU6-1086P	NA	
ENSG00000253560	AC013643.1	NA	
ENSG00000279302	AC013643.3	NA	
ENSG00000265075	MIR3622B	NA	
ENSG00000284351	MIR3622A	NA	
ENSG00000253875	AC013643.2	NA	
ENSG00000147419	CCDC25	NA	
ENSG00000171320	ESCO2	268300	ROBERTS SYNDROME; RBS;;LONG BONE DEFICIENCIES ASSOCIATED WITH CLEFT LIP-PALATE
ENSG00000171320	ESCO2	269000	SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME
ENSG00000202242	RNU6-1276P	NA	
ENSG00000168078	PBK	NA	
ENSG00000253176	AC104997.1	NA	
ENSG00000168079	SCARA5	NA	
ENSG00000265847	MIR4287	NA	
ENSG00000253290	AC069113.1	NA	
ENSG00000253615	AC069113.3	NA	
ENSG00000253397	AC069113.2	NA	
ENSG00000189233	NUGGC	NA	
ENSG00000134014	ELP3	NA	
ENSG00000250516	AC021678.1	NA	
ENSG00000253907	AC021678.3	NA	
ENSG00000253690	AC021678.2	NA	
ENSG00000239198	RPL5P22	NA	
ENSG00000168081	PNOC	NA	
ENSG00000186918	ZNF395	NA	
ENSG00000214050	FBXO16	NA	
ENSG00000286804	AC025871.3	NA	
ENSG00000254370	AC025871.2	NA	
ENSG00000207361	RNU6-178P	NA	
ENSG00000253567	AC025871.1	NA	
ENSG00000104290	FZD3	NA	
ENSG00000265251	MIR4288	NA	
ENSG00000202411	RNA5SP259	NA	
ENSG00000012232	EXTL3	617425	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA
ENSG00000246339	EXTL3-AS1	NA	
ENSG00000104299	INTS9	NA	
ENSG00000254034	INTS9-AS1	NA	
ENSG00000242958	AC040975.1	NA	
ENSG00000147421	HMBOX1	NA	
ENSG00000273710	Metazoa_SRP	NA	
ENSG00000259196	HMBOX1-IT1	NA	
ENSG00000200719	RNA5SP260	NA	
ENSG00000259366	AC108449.2	NA	
ENSG00000197892	KIF13B	NA	
ENSG00000259607	AC108449.3	NA	
ENSG00000254129	AC108449.1	NA	
ENSG00000253770	HMGB1P23	NA	
ENSG00000120875	DUSP4	NA	
ENSG00000285601	AC084262.2	NA	
ENSG00000260253	AC084262.1	NA	
ENSG00000253632	AC084026.2	NA	
ENSG00000253182	AC084026.1	NA	
ENSG00000280147	AC084026.3	NA	
ENSG00000243844	RPL17P33	NA	
ENSG00000251191	LINC00589	NA	
ENSG00000253490	LINC02099	NA	
ENSG00000248964	AC131254.1	NA	
ENSG00000254086	AC131254.3	NA	
ENSG00000253604	AC131254.2	NA	
ENSG00000253279	LINC02209	NA	
ENSG00000264788	MIR3148	NA	
ENSG00000254013	MAP2K1P1	NA	
ENSG00000239175	RNU6-1218P	NA	
ENSG00000133872	SARAF	NA	
ENSG00000272256	AC044849.1	NA	
ENSG00000104660	LEPROTL1	NA	
ENSG00000241511	RPS15AP24	NA	
ENSG00000177669	MBOAT4	NA	
ENSG00000271869	AC026979.2	NA	
ENSG00000104671	DCTN6	NA	
ENSG00000253708	AC026979.1	NA	
ENSG00000285669	AC026979.4	NA	
ENSG00000272375	AC026979.3	NA	
ENSG00000248159	HSPA8P11	NA	
ENSG00000254316	AC090820.1	NA	
ENSG00000287590	AC090820.2	NA	
ENSG00000253346	AC109329.1	NA	
ENSG00000254152	PPIAP84	NA	
ENSG00000127589	TUBBP1	NA	
ENSG00000254109	RBPMS-AS1	NA	
ENSG00000157110	RBPMS	NA	
ENSG00000279041	AC102945.2	NA	
ENSG00000197265	GTF2E2	616943	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6
ENSG00000253112	AC102945.1	NA	
ENSG00000253457	SMIM18	NA	
ENSG00000254172	RNU5A-3P	NA	
ENSG00000104687	GSR	618660	HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY
ENSG00000104691	UBXN8	NA	
ENSG00000271081	AC009314.1	NA	
ENSG00000104695	PPP2CB	NA	
ENSG00000133863	TEX15	617960	SPERMATOGENIC FAILURE 25; SPGF25
ENSG00000253204	AC090281.1	NA	
ENSG00000253793	AC008066.1	NA	
ENSG00000172733	PURG	NA	
ENSG00000165392	WRN	277700	WERNER SYNDROME; WRN
ENSG00000253579	SUMO2P16	NA	
ENSG00000253961	AC009563.1	NA	
ENSG00000229211	KCTD9P6	NA	
ENSG00000253377	AC068672.2	NA	
ENSG00000254095	AC068672.3	NA	
ENSG00000253275	AC068672.1	NA	
ENSG00000287204	AC090816.1	NA	
ENSG00000222468	RNA5SP261	NA	
ENSG00000157168	NRG1	603013	SCHIZOPHRENIA 6; SCZD6;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 8p-RELATED
ENSG00000286648	AC068931.1	NA	
ENSG00000253974	NRG1-IT1	NA	
ENSG00000252261	RNA5SP262	NA	
ENSG00000200246	RNA5SP263	NA	
ENSG00000254049	NRG1-IT3	NA	
ENSG00000286131	AC083977.1	NA	
ENSG00000212407	RNU6-663P	NA	
ENSG00000247134	AC090204.1	NA	
ENSG00000254346	MTND1P6	NA	
ENSG00000254090	MTND2P32	NA	
ENSG00000253393	RANP9	NA	
ENSG00000253993	AC104027.1	NA	
ENSG00000252735	RNU6-528P	NA	
ENSG00000272338	AC067838.1	NA	
ENSG00000172728	FUT10	NA	
ENSG00000254061	AC091144.2	NA	
ENSG00000129696	TTI2	615541	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39
ENSG00000198042	MAK16	NA	
ENSG00000239039	SNORD13	NA	
ENSG00000253232	AC091144.1	NA	
ENSG00000252505	SNORA70	NA	
ENSG00000253995	RPL10P18	NA	
ENSG00000133874	RNF122	NA	
ENSG00000240189	RN7SL621P	NA	
ENSG00000133878	DUSP26	NA	
ENSG00000253642	AF279873.3	NA	
ENSG00000253684	BUD31P1	NA	
ENSG00000263794	RN7SL457P	NA	
ENSG00000253569	VENTXP5	NA	
ENSG00000240738	AF279873.2	NA	
ENSG00000188512	AF279873.1	NA	
ENSG00000254194	AF279873.4	NA	
ENSG00000254302	AC087855.2	NA	
ENSG00000253108	AC090993.1	NA	
ENSG00000254033	AC087855.1	NA	
ENSG00000215264	RPL10AP3	NA	
ENSG00000254344	LINC01288	NA	
ENSG00000243181	AC087343.1	NA	
ENSG00000287152	AC099685.1	NA	
ENSG00000156687	UNC5D	NA	
ENSG00000279099	AC090740.1	NA	
ENSG00000232024	LSM12P1	NA	
ENSG00000286693	AC105230.1	NA	
ENSG00000253452	AC124290.1	NA	
ENSG00000253524	AC124290.2	NA	
ENSG00000254309	AC124290.3	NA	
ENSG00000253504	MTCYBP19	NA	
ENSG00000254384	MTND6P19	NA	
ENSG00000253685	MTND5P41	NA	
ENSG00000253610	AP006245.1	NA	
ENSG00000206871	RNU6-533P	NA	
ENSG00000254320	AP006245.2	NA	
ENSG00000253363	AC090809.1	NA	
ENSG00000244708	RPL23P10	NA	
ENSG00000199985	RNA5SP264	NA	
ENSG00000215262	KCNU1	NA	
ENSG00000274489	AC124076.1	NA	
ENSG00000219491	TPT1P8	NA	
ENSG00000243503	AC090453.1	NA	
ENSG00000254038	AC092818.1	NA	
ENSG00000253650	SMARCE1P4	NA	
ENSG00000253123	AC091182.1	NA	
ENSG00000253746	AC091182.2	NA	
ENSG00000253161	LINC01605	NA	
ENSG00000253388	AC124067.1	NA	
ENSG00000253414	AC124067.2	NA	
ENSG00000254111	AC124067.3	NA	
ENSG00000254290	AC124067.4	NA	
ENSG00000254306	AC137579.2	NA	
ENSG00000253344	AC137579.1	NA	
ENSG00000223215	RNU6-607P	NA	
ENSG00000183779	ZNF703	NA	
ENSG00000253181	AC138356.3	NA	
ENSG00000183154	AC138356.1	NA	
ENSG00000147475	ERLIN2	611225	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18;;INTELLECTUAL DISABILITY, MOTOR DYSFUNCTION, AND JOINT CONTRACTURES; IDMDC
ENSG00000233170	AC138356.2	NA	
ENSG00000147471	PLPBP	617290	EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D
ENSG00000020181	ADGRA2	NA	
ENSG00000104221	BRF2	NA	
ENSG00000280064	AC130304.1	NA	
ENSG00000156675	RAB11FIP1	NA	
ENSG00000241032	RN7SL709P	NA	
ENSG00000169154	GOT1L1	NA	
ENSG00000285880	AC144573.1	NA	
ENSG00000188778	ADRB3	601665	OBESITY LEANNESS, INCLUDED
ENSG00000270865	RPL12P48	NA	
ENSG00000187840	EIF4EBP1	NA	
ENSG00000260949	AP006545.1	NA	
ENSG00000286677	AP006545.3	NA	
ENSG00000272128	AP006545.2	NA	
ENSG00000129691	ASH2L	NA	
ENSG00000253437	RNU6-988P	NA	
ENSG00000240015	AC084024.1	NA	
ENSG00000147465	STAR	201710	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH;;ADRENAL HYPERPLASIA I;;LIPOID HYPERPLASIA, CONGENITAL, OF ADRENAL CORTEX WITH MALE PSEUDOHERMAPHRODITISM
ENSG00000253356	AC084024.3	NA	
ENSG00000175324	LSM1	NA	
ENSG00000253739	RNU6-323P	NA	
ENSG00000156735	BAG4	NA	
ENSG00000248585	AC084024.2	NA	
ENSG00000285632	AC084024.4	NA	
ENSG00000085788	DDHD2	615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54
ENSG00000147535	PLPP5	NA	
ENSG00000147548	NSD3	NA	
ENSG00000255487	AC087362.2	NA	
ENSG00000254898	AC087362.1	NA	
ENSG00000272092	AC087623.2	NA	
ENSG00000165046	LETM2	NA	
ENSG00000077782	FGFR1	166250	OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM
ENSG00000077782	FGFR1	147950	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2;;KALLMANN SYNDROME 2; KAL2
ENSG00000077782	FGFR1	123150	JACKSON-WEISS SYNDROME; JWS;;CRANIOSYNOSTOSIS, MIDFACIAL HYPOPLASIA, AND FOOT ABNORMALITIES
ENSG00000077782	FGFR1	101600	PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROME CRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED
ENSG00000077782	FGFR1	190440	TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC
ENSG00000077782	FGFR1	613001	ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL
ENSG00000077782	FGFR1	615465	HARTSFIELD SYNDROME; HRTFDS;;HOLOPROSENCEPHALY, ECTRODACTYLY, AND BILATERAL CLEFT LIP/PALATE
ENSG00000272159	AC087623.3	NA	
ENSG00000255201	AC087623.1	NA	
ENSG00000239218	RPS20P22	NA	
ENSG00000196166	C8orf86	NA	
ENSG00000253361	AC069120.1	NA	
ENSG00000253570	RNF5P1	NA	
ENSG00000254321	AC016813.2	NA	
ENSG00000147526	TACC1	NA	
ENSG00000207258	AC016813.1	NA	
ENSG00000253586	AC067817.1	NA	
ENSG00000253829	AC067817.2	NA	
ENSG00000169499	PLEKHA2	NA	
ENSG00000253645	AC108863.1	NA	
ENSG00000169495	HTRA4	NA	
ENSG00000169490	TM2D2	NA	
ENSG00000168615	ADAM9	612775	CONE-ROD DYSTROPHY 9; CORD9
ENSG00000207199	SNORD38D	NA	
ENSG00000197140	ADAM32	NA	
ENSG00000243095	RPL3P10	NA	
ENSG00000253160	AC105185.1	NA	
ENSG00000196115	ADAM5	NA	
ENSG00000197475	ADAM3A	NA	
ENSG00000254067	AC123767.1	NA	
ENSG00000168619	ADAM18	NA	
ENSG00000104755	ADAM2	NA	
ENSG00000253332	AP005902.2	NA	
ENSG00000253233	AP005902.1	NA	
ENSG00000131203	IDO1	NA	
ENSG00000253939	AC007991.3	NA	
ENSG00000253838	AC007991.2	NA	
ENSG00000254287	AC007991.4	NA	
ENSG00000188676	IDO2	NA	
ENSG00000253790	AC007991.1	NA	
ENSG00000254143	AC022733.1	NA	
ENSG00000253381	AC087518.1	NA	
ENSG00000253665	LINC02866	NA	
ENSG00000176907	TCIM	NA	
ENSG00000253802	SIRLNT	NA	
ENSG00000253354	AC105999.1	NA	
ENSG00000272479	AC010857.1	NA	
ENSG00000165061	ZMAT4	NA	
ENSG00000254383	AC048387.1	NA	
ENSG00000206867	RNU6-356P	NA	
ENSG00000104332	SFRP1	NA	
ENSG00000263372	MIR548AO	NA	
ENSG00000239281	RPS29P2	NA	
ENSG00000253509	AC104393.1	NA	
ENSG00000206852	RNU6-895P	NA	
ENSG00000238936	SNORD65B	NA	
ENSG00000253396	AC016868.1	NA	
ENSG00000147533	GOLGA7	NA	
ENSG00000253133	AC009630.1	NA	
ENSG00000253943	KRT18P37	NA	
ENSG00000147536	GINS4	NA	
ENSG00000253174	AC009630.2	NA	
ENSG00000287535	AC009630.4	NA	
ENSG00000158669	GPAT4	NA	
ENSG00000264578	AC009630.3	NA	
ENSG00000165066	NKX6-3	NA	
ENSG00000029534	ANK1	182900	SPHEROCYTOSIS, TYPE 1; SPH1;;SPHEROCYTOSIS, HEREDITARY, 1; HS1;;SPH; HS
ENSG00000274705	MIR486-1	NA	
ENSG00000283450	MIR486-2	NA	
ENSG00000253389	AC113133.1	NA	
ENSG00000207101	Y_RNA	NA	
ENSG00000260588	AC027702.1	NA	
ENSG00000241834	RN7SL149P	NA	
ENSG00000083168	KAT6A	616268	ARBOLEDA-THAM SYNDROME; ARTHS;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 32, FORMERLY; MRD32, FORMERLY
ENSG00000238966	AC090571.1	NA	
ENSG00000244235	AC103724.1	NA	
ENSG00000253135	AC103724.2	NA	
ENSG00000271938	AC103724.4	NA	
ENSG00000261449	AC103724.3	NA	
ENSG00000070718	AP3M2	NA	
ENSG00000104368	PLAT	612348	THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR; THPH9 HYPERFIBRINOLYSIS, FAMILIAL, DUE TO INCREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR, INCLUDED
ENSG00000253408	AC083973.1	NA	
ENSG00000104365	IKBKB	615592	IMMUNODEFICIENCY 15B; IMD15B
ENSG00000104365	IKBKB	618204	IMMUNODEFICIENCY 15A; IMD15A
ENSG00000070501	POLB	NA	
ENSG00000240395	RPL5P23	NA	
ENSG00000104371	DKK4	NA	
ENSG00000078668	VDAC3	NA	
ENSG00000168575	SLC20A2	213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1;;PRIMARY FAMILIAL BRAIN CALCIFICATION; PFBC;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL; BSPDC;;STRIOPALLIDODENTATE CALCINOSIS, AUTOSOMAL DOMINANT, ADULT-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLER /.../IDIOPATHIC, ADULT-ONSET;;FERROCALCINOSIS, CEREBROVASCULAR;;FAHR DISEASE, FAMILIAL, FORMERLY;;BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3, FORMERLY; IBGC3, FORMERLY;;BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2, FORMERLY; IBGC2, FORMERLY
ENSG00000254131	AC093367.1	NA	
ENSG00000254165	AC090739.1	NA	
ENSG00000176209	SMIM19	NA	
ENSG00000147432	CHRNB3	NA	
ENSG00000255101	AC103843.1	NA	
ENSG00000255361	AC103843.2	NA	
ENSG00000147434	CHRNA6	NA	
ENSG00000131931	THAP1	602629	DYSTONIA 6, TORSION; DYT6;;TORSION DYSTONIA, ADULT-ONSET, MIXED TYPE
ENSG00000286837	AC087533.1	NA	
ENSG00000120925	RNF170	608984	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1;;ADSA
ENSG00000242719	RN7SL806P	NA	
ENSG00000284062	MIR4469	NA	
ENSG00000168172	HOOK3	NA	
ENSG00000202514	Y_RNA	NA	
ENSG00000254673	AC110275.1	NA	
ENSG00000168522	FNTA	NA	
ENSG00000200731	RNU1-124P	NA	
ENSG00000185900	POMK	615249	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMK-RELATED
ENSG00000185900	POMK	616094	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMK-RELATED
ENSG00000254198	AC113191.1	NA	
ENSG00000165102	HGSNAT	252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C;;MPS IIIC;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY
ENSG00000165102	HGSNAT	616544	RETINITIS PIGMENTOSA 73; RP73
ENSG00000253611	VN1R46P	NA	
ENSG00000253884	AC022616.6	NA	
ENSG00000255166	AC022616.8	NA	
ENSG00000253312	AC022616.4	NA	
ENSG00000253186	AC022616.3	NA	
ENSG00000253606	AFG3L2P1	NA	
ENSG00000234713	AC022616.2	NA	
ENSG00000253707	AC022616.5	NA	
ENSG00000188877	POTEA	NA	
ENSG00000238509	RNU6-104P	NA	
ENSG00000255497	AC022616.9	NA	
ENSG00000254342	AC022616.7	NA	
ENSG00000201329	AC022616.1	NA	
ENSG00000250637	AC134698.1	NA	
ENSG00000254069	AC134698.4	NA	
ENSG00000253319	AC134698.3	NA	
ENSG00000253418	SNX18P27	NA	
ENSG00000254145	AC134698.5	NA	
ENSG00000253748	CYP4F44P	NA	
ENSG00000253195	AC134698.2	NA	
ENSG00000253845	AC139365.2	NA	
ENSG00000253198	AC139365.1	NA	
ENSG00000276685	AC118650.1	NA	
ENSG00000253425	HSPA8P13	NA	
ENSG00000248498	ASNSP1	NA	
ENSG00000254070	AC104576.1	NA	
ENSG00000251470	ASNSP4	NA	
ENSG00000228984	AC021451.1	NA	
ENSG00000250857	TRIM60P15	NA	
ENSG00000286484	AC021451.2	NA	
ENSG00000286554	AC021451.3	NA	
ENSG00000253314	LINC00293	NA	
ENSG00000253828	MTND2P38	NA	
ENSG00000282321	MTND1P7	NA	
ENSG00000252594	RNU6-656P	NA	
ENSG00000254118	MTCYBP20	NA	
ENSG00000254156	MTND6P20	NA	
ENSG00000253803	AC091163.3	NA	
ENSG00000253745	AC091163.1	NA	
ENSG00000253782	AC091163.2	NA	
ENSG00000215179	MAPK6P4	NA	
ENSG00000222099	RN7SKP32	NA	
ENSG00000248347	AC120036.1	NA	
ENSG00000285992	AC120036.5	NA	
ENSG00000200986	RNU6-819P	NA	
ENSG00000188873	RPL10AP2	NA	
ENSG00000248531	NDUFA5P12	NA	
ENSG00000254348	AC120036.3	NA	
ENSG00000255366	AC120036.4	NA	
ENSG00000253502	ATP6V1G1P2	NA	
ENSG00000253817	AC120036.2	NA	
ENSG00000215177	IGLV8OR8-1	NA	
ENSG00000164808	SPIDR	NA	
ENSG00000253330	AC024451.2	NA	
ENSG00000269924	AC024451.4	NA	
ENSG00000251354	AC024451.1	NA	
ENSG00000254065	AC024451.3	NA	
ENSG00000207369	RNU6-665P	NA	
ENSG00000221869	CEBPD	NA	
ENSG00000253729	PRKDC	615966	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26
ENSG00000207450	Y_RNA	NA	
ENSG00000287959	AC021236.1	NA	
ENSG00000104738	MCM4	609981	IMMUNODEFICIENCY 54; IMD54;;NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT; NKGCD;;NATURAL KILLER CELL DEFICIENCY, FAMILIAL ISOLATED; NKCD
ENSG00000222522	RNU6-519P	NA	
ENSG00000169139	UBE2V2	NA	
ENSG00000253843	AC104989.1	NA	
ENSG00000253654	IDI1P2	NA	
ENSG00000252710	RNU6-295P	NA	
ENSG00000277418	RNA5SP531	NA	
ENSG00000224594	RPL29P19	NA	
ENSG00000279881	AC041040.1	NA	
ENSG00000253140	AC026904.1	NA	
ENSG00000253688	AC026904.2	NA	
ENSG00000253608	AC022915.2	NA	
ENSG00000233858	LINC02599	NA	
ENSG00000253702	LINC02847	NA	
ENSG00000253455	AC022915.1	NA	
ENSG00000253892	AC022915.3	NA	
ENSG00000034239	EFCAB1	NA	
ENSG00000286878	AC100805.1	NA	
ENSG00000233109	AC013701.1	NA	
ENSG00000019549	SNAI2	172800	PIEBALD TRAIT; PBT;;PIEBALDISM
ENSG00000019549	SNAI2	608890	WAARDENBURG SYNDROME, TYPE 2D; WS2D;;WAARDENBURG SYNDROME, TYPE IID
ENSG00000287788	AC013701.2	NA	
ENSG00000286701	AC044893.2	NA	
ENSG00000168333	PPDPFL	NA	
ENSG00000253474	AC044893.1	NA	
ENSG00000199640	RN7SKP294	NA	
ENSG00000254268	RFPL4AP7	NA	
ENSG00000253380	AC090155.2	NA	
ENSG00000253206	AC090155.1	NA	
ENSG00000253810	PSAT1P1	NA	
ENSG00000253484	AC113145.1	NA	
ENSG00000271148	AC023762.1	NA	
ENSG00000147481	SNTG1	NA	
ENSG00000253849	AC090539.1	NA	
ENSG00000254392	AC090539.2	NA	
ENSG00000254358	CYCSP22	NA	
ENSG00000253340	AC087272.1	NA	
ENSG00000201316	AC090919.1	NA	
ENSG00000253664	AC012413.1	NA	
ENSG00000147485	PXDNL	NA	
ENSG00000254025	BRIX1P1	NA	
ENSG00000254225	BTF3P1	NA	
ENSG00000272076	AC090186.1	NA	
ENSG00000168300	PCMTD1	NA	
ENSG00000253475	AC103769.1	NA	
ENSG00000228801	AC064807.1	NA	
ENSG00000272024	AC064807.4	NA	
ENSG00000253844	AC064807.2	NA	
ENSG00000254136	AC064807.3	NA	
ENSG00000147488	ST18	NA	
ENSG00000254314	AC021915.2	NA	
ENSG00000253551	AC021915.1	NA	
ENSG00000253924	AC103831.1	NA	
ENSG00000240534	RPL34P17	NA	
ENSG00000196711	ALKAL1	NA	
ENSG00000023287	RB1CC1	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000271555	AC113139.1	NA	
ENSG00000288611	NPBWR1	NA	
ENSG00000248911	AC009800.1	NA	
ENSG00000250494	AC009646.1	NA	
ENSG00000254687	AC009646.2	NA	
ENSG00000082556	OPRK1	NA	
ENSG00000260484	AC131902.1	NA	
ENSG00000253369	AC022034.3	NA	
ENSG00000274295	AC131902.2	NA	
ENSG00000237807	AC022034.1	NA	
ENSG00000254204	AC022034.4	NA	
ENSG00000240919	AC022034.2	NA	
ENSG00000206144	MAPK6P1	NA	
ENSG00000253668	AC103778.1	NA	
ENSG00000047249	ATP6V1H	NA	
ENSG00000147509	RGS20	NA	
ENSG00000272457	AC113194.1	NA	
ENSG00000244159	RPS27AP13	NA	
ENSG00000200528	RNU6-1331P	NA	
ENSG00000187735	TCEA1	NA	
ENSG00000253667	AC100821.1	NA	
ENSG00000260955	AC100821.2	NA	
ENSG00000120992	LYPLA1	NA	
ENSG00000254274	TDGF1P5	NA	
ENSG00000276353	Metazoa_SRP	NA	
ENSG00000137547	MRPL15	NA	
ENSG00000251835	RNU6ATAC32P	NA	
ENSG00000270980	AC060764.1	NA	
ENSG00000253840	AC044836.1	NA	
ENSG00000199212	RNU105C	NA	
ENSG00000276605	AC027250.1	NA	
ENSG00000286471	AC027250.2	NA	
ENSG00000244107	RN7SL250P	NA	
ENSG00000164736	SOX17	613674	VESICOURETERAL REFLUX 3; VUR3
ENSG00000274310	AC091076.1	NA	
ENSG00000270275	TRMT112P7	NA	
ENSG00000104237	RP1	180100	RETINITIS PIGMENTOSA 1; RP1
ENSG00000226098	SEC11B	NA	
ENSG00000253114	AC090151.1	NA	
ENSG00000286348	AC084834.1	NA	
ENSG00000206579	XKR4	NA	
ENSG00000253976	AC022679.2	NA	
ENSG00000253857	AC022679.1	NA	
ENSG00000248522	SBF1P1	NA	
ENSG00000254357	AC090200.1	NA	
ENSG00000167904	TMEM68	NA	
ENSG00000222955	RNA5SP265	NA	
ENSG00000137574	TGS1	NA	
ENSG00000254087	LYN	NA	
ENSG00000254325	AC018607.1	NA	
ENSG00000199405	SNORA1B	NA	
ENSG00000240905	RN7SL798P	NA	
ENSG00000241997	RN7SL323P	NA	
ENSG00000236814	AC046176.1	NA	
ENSG00000008988	RPS20	NA	
ENSG00000238650	SNORD54	NA	
ENSG00000253603	CERNA3	NA	
ENSG00000248578	NPM1P21	NA	
ENSG00000172680	MOS	NA	
ENSG00000221093	AC107376.1	NA	
ENSG00000181690	PLAG1	181030	SALIVARY GLAND ADENOMA, PLEOMORPHIC;;SGPA;;PSA
ENSG00000170791	CHCHD7	NA	
ENSG00000272343	AC107952.2	NA	
ENSG00000254216	AC107952.1	NA	
ENSG00000170786	SDR16C5	NA	
ENSG00000253542	SDR16C6P	NA	
ENSG00000181195	PENK	NA	
ENSG00000254254	AC012349.1	NA	
ENSG00000253541	SEPTIN10P1	NA	
ENSG00000246430	LINC00968	NA	
ENSG00000253139	AC013644.1	NA	
ENSG00000241431	RPL37P6	NA	
ENSG00000254055	AC009597.1	NA	
ENSG00000270328	AC009597.2	NA	
ENSG00000206975	RNU6-13P	NA	
ENSG00000104331	BPNT2	614078	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE;;GPAPP DEFICIENCY
ENSG00000222205	RNA5SP266	NA	
ENSG00000253301	LINC01606	NA	
ENSG00000251142	AC025674.1	NA	
ENSG00000253614	AC025674.2	NA	
ENSG00000215117	LINC00588	NA	
ENSG00000202265	RNU6-596P	NA	
ENSG00000253871	AC068075.1	NA	
ENSG00000243050	RPL30P10	NA	
ENSG00000287301	AC068075.2	NA	
ENSG00000253821	AC090796.1	NA	
ENSG00000253322	AC104051.1	NA	
ENSG00000254139	AC104051.2	NA	
ENSG00000205293	LINC01602	NA	
ENSG00000253376	AC012103.1	NA	
ENSG00000169122	FAM110B	NA	
ENSG00000253523	AC104350.1	NA	
ENSG00000253116	AC027698.1	NA	
ENSG00000242595	RPL26P26	NA	
ENSG00000288041	AC092819.3	NA	
ENSG00000253281	AC092819.1	NA	
ENSG00000286578	AC092819.2	NA	
ENSG00000215114	UBXN2B	NA	
ENSG00000250031	AC009927.1	NA	
ENSG00000167910	CYP7A1	NA	
ENSG00000254103	PPIAP85	NA	
ENSG00000137575	SDCBP	NA	
ENSG00000035681	NSMAF	NA	
ENSG00000242970	AC068522.1	NA	
ENSG00000198846	TOX	NA	
ENSG00000201231	RNU4-50P	NA	
ENSG00000254048	AC105150.1	NA	
ENSG00000167912	AC090152.1	NA	
ENSG00000206853	AC087698.1	NA	
ENSG00000201763	RNA5SP267	NA	
ENSG00000254150	AC087664.3	NA	
ENSG00000253260	AC087664.1	NA	
ENSG00000253879	AC087664.2	NA	
ENSG00000253413	AC107934.1	NA	
ENSG00000253723	AC107934.2	NA	
ENSG00000278428	AC022709.1	NA	
ENSG00000254775	AC021393.1	NA	
ENSG00000254954	SLC2A13P1	NA	
ENSG00000178538	CA8	613227	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 3
ENSG00000251396	LINC01301	NA	
ENSG00000226301	PDCL3P1	NA	
ENSG00000104388	RAB2A	NA	
ENSG00000255321	AC068389.3	NA	
ENSG00000228862	AC068389.1	NA	
ENSG00000255289	AC068389.2	NA	
ENSG00000171316	CHD7	214800	CHARGE SYNDROME;;CHARGE ASSOCIATION--COLOBOMA, HEART ANOMALY, CHOANAL ATRESIA, RETARDATION, GENITAL AND EAR ANOMALIES;;HALL-HITTNER SYNDROME; HHS
ENSG00000171316	CHD7	612370	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5
ENSG00000254432	AC113143.1	NA	
ENSG00000287975	AC113143.2	NA	
ENSG00000271377	IFITM3P8	NA	
ENSG00000254777	AC022182.1	NA	
ENSG00000255397	AC022182.3	NA	
ENSG00000254802	AC022182.2	NA	
ENSG00000177182	CLVS1	NA	
ENSG00000213881	NPM1P6	NA	
ENSG00000254222	AC023866.2	NA	
ENSG00000253711	AC023866.1	NA	
ENSG00000198363	ASPH	601552	FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB;;TRABOULSI SYNDROME;;SHAWAF-TRABOULSI SYNDROME;;ECTOPIA LENTIS, SPONTANEOUS FILTERING BLEBS, AND CRANIOFACIAL DYSMORPHISM
ENSG00000254285	KRT8P3	NA	
ENSG00000222898	RN7SKP97	NA	
ENSG00000264408	MIR4470	NA	
ENSG00000251127	AC091173.1	NA	
ENSG00000254119	LINC02842	NA	
ENSG00000253834	AC025524.1	NA	
ENSG00000253789	NARS1P2	NA	
ENSG00000254120	LINC02155	NA	
ENSG00000253544	C1GALT1P3	NA	
ENSG00000237810	AC104852.1	NA	
ENSG00000285971	AC023095.1	NA	
ENSG00000185942	NKAIN3	NA	
ENSG00000254050	AC018861.2	NA	
ENSG00000253975	AC018861.1	NA	
ENSG00000287105	AC090577.1	NA	
ENSG00000253517	XRCC6P4	NA	
ENSG00000253431	SRPK2P	NA	
ENSG00000240915	AC120042.1	NA	
ENSG00000137563	GGH	NA	
ENSG00000253121	AC120042.2	NA	
ENSG00000137561	TTPA	277460	VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED;;ATAXIA, FRIEDREICH-LIKE, WITH SELECTIVE VITAMIN E DEFICIENCY; AVED;;FRIEDREICH-LIKE ATAXIA
ENSG00000253555	AC011978.1	NA	
ENSG00000270673	YTHDF3-AS1	NA	
ENSG00000185728	YTHDF3	NA	
ENSG00000261542	AC011978.2	NA	
ENSG00000241964	RN7SL135P	NA	
ENSG00000253205	AC011124.1	NA	
ENSG00000215096	IFITM8P	NA	
ENSG00000253894	AC011124.2	NA	
ENSG00000253583	AC018953.1	NA	
ENSG00000252358	RN7SKP135	NA	
ENSG00000287844	AC018953.2	NA	
ENSG00000253554	LINC01414	NA	
ENSG00000253762	AC069133.1	NA	
ENSG00000253734	LINC01289	NA	
ENSG00000253231	COX6CP8	NA	
ENSG00000254377	MIR124-2HG	NA	
ENSG00000207816	MIR124-2	NA	
ENSG00000287615	AC012535.1	NA	
ENSG00000253750	AC090136.1	NA	
ENSG00000253800	AC090136.2	NA	
ENSG00000254102	AC090136.3	NA	
ENSG00000180828	BHLHE22	NA	
ENSG00000172817	CYP7B1	270800	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A
ENSG00000172817	CYP7B1	613812	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3
ENSG00000254330	AC104232.2	NA	
ENSG00000287998	AC104232.3	NA	
ENSG00000254006	AC104232.1	NA	
ENSG00000253493	AC087808.1	NA	
ENSG00000239261	RPL31P41	NA	
ENSG00000280725	LINC00251	NA	
ENSG00000213873	PPIAP86	NA	
ENSG00000254081	LINC01299	NA	
ENSG00000272010	AC100814.1	NA	
ENSG00000200714	Y_RNA	NA	
ENSG00000104442	ARMC1	NA	
ENSG00000066855	MTFR1	NA	
ENSG00000272155	AC055822.1	NA	
ENSG00000205268	PDE7A	NA	
ENSG00000272192	AC100812.1	NA	
ENSG00000147570	DNAJC5B	NA	
ENSG00000253190	AC084082.1	NA	
ENSG00000147573	TRIM55	NA	
ENSG00000147571	CRH	NA	
ENSG00000253138	LINC00967	NA	
ENSG00000287127	AC009879.4	NA	
ENSG00000246145	RRS1-AS1	NA	
ENSG00000179041	RRS1	NA	
ENSG00000285655	AC009879.2	NA	
ENSG00000285791	AC009879.3	NA	
ENSG00000147576	ADHFE1	NA	
ENSG00000253623	AC009879.1	NA	
ENSG00000169085	VXN	NA	
ENSG00000206949	RNU6-1324P	NA	
ENSG00000185697	MYBL1	NA	
ENSG00000175073	VCPIP1	NA	
ENSG00000201365	Y_RNA	NA	
ENSG00000288596	C8orf44	NA	
ENSG00000288602	C8orf44-SGK3	NA	
ENSG00000104205	SGK3	NA	
ENSG00000213005	PTTG3P	NA	
ENSG00000178460	MCMDC2	NA	
ENSG00000245910	SNHG6	NA	
ENSG00000254341	SNORD87	NA	
ENSG00000261787	TCF24	NA	
ENSG00000178125	PPP1R42	NA	
ENSG00000253223	AC110998.1	NA	
ENSG00000121022	COPS5	NA	
ENSG00000104218	CSPP1	615636	JOUBERT SYNDROME 21; JBTS21
ENSG00000252637	RNA5SP268	NA	
ENSG00000250869	AC087359.1	NA	
ENSG00000066777	ARFGEF1	NA	
ENSG00000287214	AC021321.2	NA	
ENSG00000271966	AC021321.1	NA	
ENSG00000241961	AC011037.1	NA	
ENSG00000165078	CPA6	614417	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5
ENSG00000165078	CPA6	614418	FEBRILE SEIZURES, FAMILIAL, 11; FEB11;;CONVULSIONS, FAMILIAL FEBRILE, 11
ENSG00000254253	NACAP10	NA	
ENSG00000255130	AC022874.1	NA	
ENSG00000255531	NDUFS5P6	NA	
ENSG00000046889	PREX2	NA	
ENSG00000255206	AC011853.2	NA	
ENSG00000254051	AC011853.1	NA	
ENSG00000252210	Y_RNA	NA	
ENSG00000253964	RPL31P40	NA	
ENSG00000248801	C8orf34-AS1	NA	
ENSG00000165084	C8orf34	NA	
ENSG00000236191	RPS15AP25	NA	
ENSG00000239184	RNA5SP269	NA	
ENSG00000254337	AC083967.1	NA	
ENSG00000253658	LINC01592	NA	
ENSG00000238808	RNU7-102P	NA	
ENSG00000254332	AF201337.1	NA	
ENSG00000253373	AC021785.1	NA	
ENSG00000253479	LINC01603	NA	
ENSG00000253216	AC022790.1	NA	
ENSG00000137573	SULF1	NA	
ENSG00000137571	SLCO5A1	NA	
ENSG00000222889	RN7SKP29	NA	
ENSG00000254557	AC091047.1	NA	
ENSG00000271113	AC079089.3	NA	
ENSG00000246528	AC079089.1	NA	
ENSG00000277740	Metazoa_SRP	NA	
ENSG00000255107	AC079089.2	NA	
ENSG00000239580	RN7SL675P	NA	
ENSG00000223293	RNA5SP270	NA	
ENSG00000280393	AC090574.1	NA	
ENSG00000247570	SDCBPP2	NA	
ENSG00000253721	SUMO2P20	NA	
ENSG00000147596	PRDM14	NA	
ENSG00000212473	RNU1-101P	NA	
ENSG00000253173	H2AZP2	NA	
ENSG00000140396	NCOA2	NA	
ENSG00000213003	BTF3P12	NA	
ENSG00000207036	RNY3P14	NA	
ENSG00000241204	AC022730.2	NA	
ENSG00000253143	AC022730.3	NA	
ENSG00000253967	AC022730.4	NA	
ENSG00000275128	RN7SL203P	NA	
ENSG00000241105	AC022730.1	NA	
ENSG00000287230	AC120194.1	NA	
ENSG00000067167	TRAM1	NA	
ENSG00000246366	LACTB2-AS1	NA	
ENSG00000147592	LACTB2	NA	
ENSG00000243532	RN7SL19P	NA	
ENSG00000221947	XKR9	NA	
ENSG00000285579	AC015687.1	NA	
ENSG00000223220	Y_RNA	NA	
ENSG00000254031	AC022858.1	NA	
ENSG00000104313	EYA1	166780	OTOFACIOCERVICAL SYNDROME 1; OTFCS;;OFC; OFC1
ENSG00000104313	EYA1	113650	BRANCHIOOTORENAL SYNDROME 1; BOR1;;BRANCHIOOTORENAL DYSPLASIA;;MELNICK-FRASER SYNDROME
ENSG00000104313	EYA1	602588	BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIA ANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED
ENSG00000253124	TRAPPC2P2	NA	
ENSG00000254277	AC009446.1	NA	
ENSG00000253287	AC104012.1	NA	
ENSG00000200191	U8	NA	
ENSG00000235531	MSC-AS1	NA	
ENSG00000178860	MSC	NA	
ENSG00000241942	RPS20P20	NA	
ENSG00000104321	TRPA1	615040	EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1
ENSG00000253317	AC078906.1	NA	
ENSG00000250979	AC022905.1	NA	
ENSG00000252509	RNA5SP271	NA	
ENSG00000212989	AC124293.1	NA	
ENSG00000254347	AC011131.1	NA	
ENSG00000182674	KCNB2	NA	
ENSG00000253226	HAUS1P3	NA	
ENSG00000278193	AC013562.2	NA	
ENSG00000253726	AC013562.1	NA	
ENSG00000253784	AC090735.1	NA	
ENSG00000260838	AC022893.2	NA	
ENSG00000147601	TERF1	NA	
ENSG00000222488	RNU6-285P	NA	
ENSG00000272254	AC022893.3	NA	
ENSG00000253636	AC022893.1	NA	
ENSG00000164764	SBSPON	NA	
ENSG00000237061	AC100823.1	NA	
ENSG00000253564	AC100823.2	NA	
ENSG00000274443	C8orf89	NA	
ENSG00000254213	PRXL2AP2	NA	
ENSG00000147604	RPL7	NA	
ENSG00000121039	RDH10	NA	
ENSG00000250295	RDH10-AS1	NA	
ENSG00000253235	AC111149.1	NA	
ENSG00000253339	AC111149.2	NA	
ENSG00000253302	STAU2-AS1	NA	
ENSG00000040341	STAU2	NA	
ENSG00000254273	AC018620.1	NA	
ENSG00000253383	AC100784.1	NA	
ENSG00000254105	VENTXP6	NA	
ENSG00000254538	AC027018.1	NA	
ENSG00000258677	AC022826.2	NA	
ENSG00000104343	UBE2W	NA	
ENSG00000253273	AC022826.1	NA	
ENSG00000272469	RN7SL760P	NA	
ENSG00000286113	AC022868.2	NA	
ENSG00000251633	GYG1P1	NA	
ENSG00000154582	ELOC	NA	
ENSG00000175606	TMEM70	614052	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, TMEM70 TYPE;;ENCEPHALOCARDIOMYOPATHY, MITOCHONDRIAL, NEONATAL, DUE TO ATP SYNTHASE DEFICIENCY
ENSG00000244295	RPS20P21	NA	
ENSG00000253833	AC022868.1	NA	
ENSG00000154589	LY96	NA	
ENSG00000212348	RNU6-1300P	NA	
ENSG00000254288	AC087672.2	NA	
ENSG00000240047	RPS3AP32	NA	
ENSG00000212485	RNU6-1197P	NA	
ENSG00000253983	AC087627.1	NA	
ENSG00000253115	AC087672.1	NA	
ENSG00000104369	JPH1	607831	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2K;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2K  CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K, INCLUDED
ENSG00000104381	GDAP1	214400	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4A;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4A
ENSG00000104381	GDAP1	607706	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, /.../OMAL RECESSIVE
ENSG00000104381	GDAP1	607831	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2K;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2K  CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K, INCLUDED
ENSG00000104381	GDAP1	608340	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA
ENSG00000253596	AC103952.2	NA	
ENSG00000207417	AC103952.1	NA	
ENSG00000266502	MIR5681A	NA	
ENSG00000283505	MIR5681B	NA	
ENSG00000254349	MIR2052HG	NA	
ENSG00000253341	AC115837.1	NA	
ENSG00000254080	AC115837.2	NA	
ENSG00000283188	MIR2052	NA	
ENSG00000253706	AC011632.1	NA	
ENSG00000253777	AC026616.1	NA	
ENSG00000137558	PI15	NA	
ENSG00000254043	AC011632.2	NA	
ENSG00000121005	CRISPLD1	NA	
ENSG00000254238	AC100782.1	NA	
ENSG00000249395	CASC9	NA	
ENSG00000253712	AC022274.1	NA	
ENSG00000253229	HIGD1AP6	NA	
ENSG00000254023	PKMP4	NA	
ENSG00000164749	HNF4G	NA	
ENSG00000287352	AC011029.1	NA	
ENSG00000222231	RNU2-54P	NA	
ENSG00000270866	AC067773.1	NA	
ENSG00000271167	LINC01109	NA	
ENSG00000254300	LINC01111	NA	
ENSG00000253661	ZFHX4-AS1	NA	
ENSG00000253681	AC013509.1	NA	
ENSG00000254305	MRPL9P1	NA	
ENSG00000091656	ZFHX4	178300	PTOSIS, HEREDITARY CONGENITAL 1; PTOS1
ENSG00000276673	AC011716.1	NA	
ENSG00000253416	AC023200.1	NA	
ENSG00000266712	MIR3149	NA	
ENSG00000164751	PEX2	614866	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 5, INCLUDED; CG5, INCLUDED;;PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 10, INCLUDED; CG10, INCLUDED;;PEROXISOME BIOGENESIS DISORDER /.../LEMENTATION GROUP F, INCLUDED; CGF, INCLUDED
ENSG00000164751	PEX2	614867	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B
ENSG00000253952	HIGD1AP18	NA	
ENSG00000254366	AC062004.1	NA	
ENSG00000254001	AC084706.1	NA	
ENSG00000254266	PKIA-AS1	NA	
ENSG00000252935	RNU6-1220P	NA	
ENSG00000171033	PKIA	NA	
ENSG00000260398	AC068700.1	NA	
ENSG00000286675	AC068700.2	NA	
ENSG00000104427	ZC2HC1A	NA	
ENSG00000104432	IL7	618309	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 5; EV5
ENSG00000254352	AC100854.1	NA	
ENSG00000253919	THAP12P7	NA	
ENSG00000285744	AC083837.1	NA	
ENSG00000261618	LINC02605	NA	
ENSG00000253659	AC138646.1	NA	
ENSG00000253391	AC100870.1	NA	
ENSG00000240540	RPL3P9	NA	
ENSG00000104435	STMN2	NA	
ENSG00000287052	AC016240.1	NA	
ENSG00000164683	HEY1	NA	
ENSG00000272138	LINC01607	NA	
ENSG00000249328	AC036214.1	NA	
ENSG00000238884	RNU7-85P	NA	
ENSG00000285758	AC036214.4	NA	
ENSG00000147586	MRPS28	NA	
ENSG00000276418	AC036214.3	NA	
ENSG00000272518	AC036214.2	NA	
ENSG00000272264	AC009686.2	NA	
ENSG00000076554	TPD52	NA	
ENSG00000254205	AC009686.1	NA	
ENSG00000241550	RN7SL41P	NA	
ENSG00000265588	MIR5708	NA	
ENSG00000241746	AC104212.3	NA	
ENSG00000253238	AC034114.2	NA	
ENSG00000213791	AC104212.2	NA	
ENSG00000206649	AC104212.1	NA	
ENSG00000253237	AC034114.1	NA	
ENSG00000252884	RNU6-1213P	NA	
ENSG00000251867	AC009812.1	NA	
ENSG00000277604	Y_RNA	NA	
ENSG00000205189	ZBTB10	NA	
ENSG00000254162	AC009812.3	NA	
ENSG00000260317	AC009812.4	NA	
ENSG00000188856	RPSAP47	NA	
ENSG00000252057	RNU7-174P	NA	
ENSG00000253760	AC009812.2	NA	
ENSG00000223327	RNU2-71P	NA	
ENSG00000254181	SLC25A51P3	NA	
ENSG00000243424	RN7SL107P	NA	
ENSG00000164684	ZNF704	NA	
ENSG00000254331	CKS1BP7	NA	
ENSG00000212429	RNU11-6P	NA	
ENSG00000243951	RN7SL308P	NA	
ENSG00000253516	HMGB1P41	NA	
ENSG00000286763	AC012533.1	NA	
ENSG00000076641	PAG1	NA	
ENSG00000254060	AC022778.1	NA	
ENSG00000254177	AC079209.2	NA	
ENSG00000253214	AC079209.1	NA	
ENSG00000254014	AC009902.1	NA	
ENSG00000253677	UBE2HP1	NA	
ENSG00000272425	AC009902.3	NA	
ENSG00000254027	AC009902.2	NA	
ENSG00000164687	FABP5	NA	
ENSG00000253859	AC018616.1	NA	
ENSG00000147588	PMP2	618279	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G
ENSG00000205186	FABP9	NA	
ENSG00000170323	FABP4	NA	
ENSG00000253374	AC023644.1	NA	
ENSG00000237264	FTH1P11	NA	
ENSG00000197416	FABP12	NA	
ENSG00000251521	IMPA1P1	NA	
ENSG00000254151	NIPA2P4	NA	
ENSG00000240427	RPS26P34	NA	
ENSG00000205184	SLC10A5P1	NA	
ENSG00000133731	IMPA1	617323	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59; MRT59
ENSG00000253598	SLC10A5	NA	
ENSG00000280193	AC132219.2	NA	
ENSG00000104231	ZFAND1	NA	
ENSG00000164695	CHMP4C	NA	
ENSG00000253334	AC132219.1	NA	
ENSG00000104497	SNX16	NA	
ENSG00000231942	HNRNPA1P36	NA	
ENSG00000254689	LINC02235	NA	
ENSG00000254394	AC060765.2	NA	
ENSG00000254123	LINC02839	NA	
ENSG00000206228	HNRNPA1P4	NA	
ENSG00000253503	AC060765.1	NA	
ENSG00000253836	AC105031.2	NA	
ENSG00000253581	AC105031.1	NA	
ENSG00000254189	AC090095.1	NA	
ENSG00000253423	AC090132.1	NA	
ENSG00000274116	AC090132.2	NA	
ENSG00000253898	LINC01419	NA	
ENSG00000254202	AC015522.1	NA	
ENSG00000254195	TPM3P3	NA	
ENSG00000253362	AC012400.1	NA	
ENSG00000184672	RALYL	NA	
ENSG00000206701	RNU6-1040P	NA	
ENSG00000253137	PSMC2P2	NA	
ENSG00000248978	AC009901.1	NA	
ENSG00000254212	AC009901.2	NA	
ENSG00000203413	ACTBP6	NA	
ENSG00000253655	JCHAINP1	NA	
ENSG00000253283	AC091175.1	NA	
ENSG00000133739	LRRCC1	NA	
ENSG00000260493	AC011773.4	NA	
ENSG00000133740	E2F5	NA	
ENSG00000254208	AC011773.1	NA	
ENSG00000176731	RBIS	NA	
ENSG00000185015	CA13	NA	
ENSG00000258256	AC011773.3	NA	
ENSG00000257962	AC011773.2	NA	
ENSG00000133742	CA1	NA	
ENSG00000164879	CA3	NA	
ENSG00000253549	CA3-AS1	NA	
ENSG00000104267	CA2	259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3;;OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS;;CARBONIC ANHYDRASE II DEFICIENCY;;GUIBAUD-VAINSEL SYNDROME;;MARBLE BRAIN DISEASE
ENSG00000254380	AC084734.1	NA	
ENSG00000253680	AC093331.1	NA	
ENSG00000270971	REXO1L8P	NA	
ENSG00000273567	REXO1L3P	NA	
ENSG00000205176	REXO1L1P	NA	
ENSG00000276006	REXO1L12P	NA	
ENSG00000275928	REXO1L11P	NA	
ENSG00000276540	REXO1L10P	NA	
ENSG00000271381	REXO1L9P	NA	
ENSG00000276998	REXO1L2P	NA	
ENSG00000274343	AC232323.1	NA	
ENSG00000270416	REXO1L4P	NA	
ENSG00000277436	REXO1L5P	NA	
ENSG00000277422	REXO1L6P	NA	
ENSG00000253154	AC100801.1	NA	
ENSG00000285768	LINC02849	NA	
ENSG00000287927	AC100801.2	NA	
ENSG00000147614	ATP6V0D2	NA	
ENSG00000227753	AC023194.1	NA	
ENSG00000243761	AC023194.2	NA	
ENSG00000147613	PSKH2	NA	
ENSG00000253675	AC023194.3	NA	
ENSG00000253699	AC084128.1	NA	
ENSG00000164893	SLC7A13	NA	
ENSG00000254231	AC103760.1	NA	
ENSG00000123124	WWP1	NA	
ENSG00000176623	RMDN1	NA	
ENSG00000250569	NTAN1P2	NA	
ENSG00000254088	SLC2A3P4	NA	
ENSG00000085719	CPNE3	NA	
ENSG00000170289	CNGB3	248200	STARGARDT DISEASE 1; STGD1;;STGD;;MACULAR DEGENERATION, JUVENILE;;MACULAR DYSTROPHY WITH FLECKS, TYPE 1 FUNDUS FLAVIMACULATUS, INCLUDED; FFM, INCLUDED;;RETINAL DYSTROPHY, EARLY-ONSET SEVERE, INCLUDED
ENSG00000170289	CNGB3	262300	ACHROMATOPSIA 3; ACHM3;;PINGELAPESE BLINDNESS;;TOTAL COLORBLINDNESS WITH MYOPIA;;ACHROMATOPSIA WITH MYOPIA;;ACHM1, FORMERLY;;ROD MONOCHROMATISM 1, FORMERLY;;ROD MONOCHROMACY 1, FORMERLY; RMCH1, FORMERLY
ENSG00000253292	MIOXP1	NA	
ENSG00000205333	GOLGA2P1	NA	
ENSG00000233915	UBE2Q2P10	NA	
ENSG00000254115	AC090572.3	NA	
ENSG00000253778	AC090572.2	NA	
ENSG00000253568	AC090572.1	NA	
ENSG00000176571	CNBD1	NA	
ENSG00000253500	AF121898.1	NA	
ENSG00000253401	VTA1P2	NA	
ENSG00000251563	IARS2P1	NA	
ENSG00000254376	SOX5P1	NA	
ENSG00000273978	AC005066.1	NA	
ENSG00000176566	DCAF4L2	NA	
ENSG00000253171	AC037450.1	NA	
ENSG00000156103	MMP16	NA	
ENSG00000253553	AC090578.1	NA	
ENSG00000251904	RNA5SP272	NA	
ENSG00000250962	AC090568.1	NA	
ENSG00000271156	AC090578.2	NA	
ENSG00000286984	AC090578.3	NA	
ENSG00000253621	RPSAP74	NA	
ENSG00000248231	KRT8P4	NA	
ENSG00000251136	AF117829.1	NA	
ENSG00000104312	RIPK2	NA	
ENSG00000253349	COX6B1P6	NA	
ENSG00000275103	AF117829.2	NA	
ENSG00000207359	RNU6-925P	NA	
ENSG00000164823	OSGIN2	NA	
ENSG00000104320	NBN	251260	NIJMEGEN BREAKAGE SYNDROME; NBS;;ATAXIA-TELANGIECTASIA VARIANT V1; AT-V1;;MICROCEPHALY WITH NORMAL INTELLIGENCE, IMMUNODEFICIENCY, AND LYMPHORETICULAR MALIGNANCIES;;SEEMANOVA SYNDROME II;;NONSYNDROMAL MICROCEPHALY, AUTOSOMAL RECESSIVE, WITH NORMAL I /.../GENCE;;IMMUNODEFICIENCY, MICROCEPHALY, AND CHROMOSOMAL INSTABILITY  BERLIN BREAKAGE SYNDROME, INCLUDED; BBS, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT V2, INCLUDED; AT-V2, INCLUDED
ENSG00000104320	NBN	609135	APLASTIC ANEMIA APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED
ENSG00000104320	NBN	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMI /.../ELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000104325	DECR1	NA	
ENSG00000104327	CALB1	NA	
ENSG00000254180	AC004083.1	NA	
ENSG00000253394	LINC00534	NA	
ENSG00000199354	RNA5SP273	NA	
ENSG00000253799	LINC01030	NA	
ENSG00000180694	TMEM64	NA	
ENSG00000246792	AC106038.1	NA	
ENSG00000254182	AC106038.2	NA	
ENSG00000123119	NECAB1	NA	
ENSG00000254251	AC103770.1	NA	
ENSG00000253250	C8orf88	NA	
ENSG00000155099	PIP4P2	NA	
ENSG00000253358	AC087439.1	NA	
ENSG00000254219	AC087439.2	NA	
ENSG00000253738	OTUD6B-AS1	NA	
ENSG00000155100	OTUD6B	617452	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA
ENSG00000214954	LRRC69	NA	
ENSG00000253525	AC104966.1	NA	
ENSG00000266194	MIR4661	NA	
ENSG00000147606	SLC26A7	NA	
ENSG00000253901	AC103409.1	NA	
ENSG00000200151	RN7SKP231	NA	
ENSG00000271202	PRR13P7	NA	
ENSG00000229182	MRPS16P1	NA	
ENSG00000079102	RUNX1T1	NA	
ENSG00000253576	AF181450.1	NA	
ENSG00000233778	AC104339.1	NA	
ENSG00000253118	AC022695.1	NA	
ENSG00000253682	AC022695.2	NA	
ENSG00000253749	AC022695.3	NA	
ENSG00000253634	AC091096.1	NA	
ENSG00000253177	AC104211.1	NA	
ENSG00000288005	AC104211.3	NA	
ENSG00000248858	FLJ46284	NA	
ENSG00000254020	AC104211.2	NA	
ENSG00000253577	AC117834.2	NA	
ENSG00000253197	AC117834.1	NA	
ENSG00000205133	TRIQK	NA	
ENSG00000251347	IRF5P1	NA	
ENSG00000277063	MIR8084	NA	
ENSG00000279847	C8orf87	NA	
ENSG00000246662	LINC00535	NA	
ENSG00000253960	AC016885.1	NA	
ENSG00000268080	AC016885.3	NA	
ENSG00000254089	AC016885.2	NA	
ENSG00000222416	RNA5SP274	NA	
ENSG00000253781	ZNF317P1	NA	
ENSG00000188343	CIBAR1	618219	POLYDACTYLY, POSTAXIAL, TYPE A9; PAPA9
ENSG00000271971	AC120053.1	NA	
ENSG00000253854	AC010834.3	NA	
ENSG00000183808	RBM12B	NA	
ENSG00000253722	AC010834.1	NA	
ENSG00000279331	RBM12B-AS1	NA	
ENSG00000253848	AC010834.2	NA	
ENSG00000164953	TMEM67	216360	COACH SYNDROME;;CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULAR COLOBOMA, AND HEPATIC FIBROSIS;;JOUBERT SYNDROME WITH CONGENITAL HEPATIC FIBROSIS
ENSG00000164953	TMEM67	602152	RHYNS SYNDROME; RHYNS;;RETINITIS PIGMENTOSA SYNDROME;;RETINITIS PIGMENTOSA, HYPOPITUITARISM, NEPHRONOPHTHISIS, AND MILD SKELETAL DYSPLASIA
ENSG00000164953	TMEM67	607361	MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3
ENSG00000164953	TMEM67	610688	JOUBERT SYNDROME 6; JBTS6
ENSG00000164953	TMEM67	613550	NEPHRONOPHTHISIS 11; NPHP11
ENSG00000164953	TMEM67	615991	BARDET-BIEDL SYNDROME 14; BBS14
ENSG00000254057	AC084346.1	NA	
ENSG00000254387	MYL12AP1	NA	
ENSG00000164951	PDP1	608782	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD;;LACTIC ACIDEMIA WITH PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY
ENSG00000264448	MIR378D2HG	NA	
ENSG00000284288	MIR378D2	NA	
ENSG00000251234	PSMA2P2	NA	
ENSG00000240509	RPL34P18	NA	
ENSG00000275386	AC105081.1	NA	
ENSG00000253585	AP003351.1	NA	
ENSG00000079112	CDH17	NA	
ENSG00000249510	AP003478.1	NA	
ENSG00000164949	GEM	NA	
ENSG00000244217	RPS4XP10	NA	
ENSG00000197275	RAD54B	605027	LYMPHOMA, NON-HODGKIN, FAMILIAL;;NON-HODGKIN LYMPHOMA; NHL
ENSG00000265817	FSBP	NA	
ENSG00000164944	VIRMA	NA	
ENSG00000254315	AC023632.5	NA	
ENSG00000253704	AC023632.2	NA	
ENSG00000253175	AC023632.1	NA	
ENSG00000254190	AC023632.3	NA	
ENSG00000254283	AC023632.4	NA	
ENSG00000261437	AC108860.2	NA	
ENSG00000104413	ESRP1	618013	DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109
ENSG00000274701	Metazoa_SRP	NA	
ENSG00000241003	AC108860.1	NA	
ENSG00000253429	AP005660.1	NA	
ENSG00000199701	Y_RNA	NA	
ENSG00000156162	DPY19L4	NA	
ENSG00000254307	AP003692.1	NA	
ENSG00000164941	INTS8	618572	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY; NEDCHS
ENSG00000175305	CCNE2	NA	
ENSG00000272509	AC087752.4	NA	
ENSG00000243979	AC087752.1	NA	
ENSG00000156170	NDUFAF6	618239	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17
ENSG00000164938	TP53INP1	NA	
ENSG00000253878	AC087752.3	NA	
ENSG00000253528	AC087752.2	NA	
ENSG00000287322	AC068189.2	NA	
ENSG00000200525	RNU6-1209P	NA	
ENSG00000245080	MIR3150BHG	NA	
ENSG00000254248	AC068189.1	NA	
ENSG00000284147	MIR3150B	NA	
ENSG00000283522	MIR3150A	NA	
ENSG00000175895	PLEKHF2	NA	
ENSG00000253773	C8orf37-AS1	NA	
ENSG00000253351	LINC01298	NA	
ENSG00000156172	C8orf37	268000	RETINITIS PIGMENTOSA; RP
ENSG00000156172	C8orf37	614500	CONE-ROD DYSTROPHY 16; CORD16;;RETINAL DYSTROPHY WITH EARLY MACULAR INVOLVEMENT RETINITIS PIGMENTOSA 64, INCLUDED; RP64, INCLUDED
ENSG00000156172	C8orf37	617406	BARDET-BIEDL SYNDROME 21; BBS21
ENSG00000253945	AC024995.1	NA	
ENSG00000253872	AC083836.1	NA	
ENSG00000202112	RNU6-690P	NA	
ENSG00000254079	SRSF3P2	NA	
ENSG00000248762	AC012339.1	NA	
ENSG00000183663	AC007992.1	NA	
ENSG00000271349	AC007992.2	NA	
ENSG00000270131	AP003465.2	NA	
ENSG00000156466	GDF6	118100	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1;;KFS;;CERVICAL VERTEBRAL FUSION, AUTOSOMAL DOMINANT
ENSG00000156466	GDF6	613094	MICROPHTHALMIA, ISOLATED 4; MCOP4
ENSG00000156466	GDF6	613703	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6
ENSG00000156466	GDF6	615360	LEBER CONGENITAL AMAUROSIS 17; LCA17
ENSG00000156466	GDF6	617898	MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4
ENSG00000156467	UQCRB	615158	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3
ENSG00000254224	AP003465.1	NA	
ENSG00000156469	MTERF3	NA	
ENSG00000156471	PTDSS1	151050	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD;;LENZ-MAJEWSKI SYNDROME
ENSG00000199732	Y_RNA	NA	
ENSG00000253105	AP003548.1	NA	
ENSG00000202095	RNU6-1172P	NA	
ENSG00000169439	SDC2	NA	
ENSG00000104324	CPQ	NA	
ENSG00000180543	TSPYL5	NA	
ENSG00000272249	AP003117.2	NA	
ENSG00000270077	AP003117.1	NA	
ENSG00000260640	AP003115.1	NA	
ENSG00000207215	SNORD3H	NA	
ENSG00000213750	AP002982.1	NA	
ENSG00000287654	AP002982.2	NA	
ENSG00000147649	MTDH	NA	
ENSG00000202399	Y_RNA	NA	
ENSG00000104341	LAPTM4B	NA	
ENSG00000270682	AP003357.1	NA	
ENSG00000270861	AP002906.1	NA	
ENSG00000253639	SUMO2P18	NA	
ENSG00000243504	RPS23P1	NA	
ENSG00000132561	MATN2	NA	
ENSG00000156482	RPL30	NA	
ENSG00000245970	AP003352.1	NA	
ENSG00000207067	SNORA72	NA	
ENSG00000252755	RNU6-703P	NA	
ENSG00000177459	ERICH5	NA	
ENSG00000132541	RIDA	NA	
ENSG00000104356	POP1	617396	ANAUXETIC DYSPLASIA 2; ANXD2
ENSG00000104361	NIPAL2	NA	
ENSG00000252558	RNU6-914P	NA	
ENSG00000104375	STK3	NA	
ENSG00000278914	AP003355.3	NA	
ENSG00000253468	AP003355.1	NA	
ENSG00000156486	KCNS2	NA	
ENSG00000272321	AP003355.2	NA	
ENSG00000207378	RNU6-748P	NA	
ENSG00000253911	AP003467.1	NA	
ENSG00000254112	AP003467.2	NA	
ENSG00000240870	RPL19P14	NA	
ENSG00000253415	AC016877.2	NA	
ENSG00000254312	MRPL57P7	NA	
ENSG00000223281	RN7SKP85	NA	
ENSG00000271930	AC016877.3	NA	
ENSG00000164920	OSR2	NA	
ENSG00000253948	VPS13B-DT	NA	
ENSG00000229625	AC016877.1	NA	
ENSG00000253180	AC104986.1	NA	
ENSG00000132549	VPS13B	216550	COHEN SYNDROME; COH1;;COH;;HYPOTONIA, OBESITY, AND PROMINENT INCISORS;;PEPPER SYNDROME;;CHS1, FORMERLY
ENSG00000253562	AC107909.2	NA	
ENSG00000253532	AC107909.1	NA	
ENSG00000236583	AP004290.1	NA	
ENSG00000237704	AP004289.2	NA	
ENSG00000225017	AP004289.1	NA	
ENSG00000206699	Y_RNA	NA	
ENSG00000207804	MIR599	NA	
ENSG00000216069	MIR875	NA	
ENSG00000243254	RN7SL350P	NA	
ENSG00000235683	AC018442.1	NA	
ENSG00000253539	AC018442.2	NA	
ENSG00000253912	AC018442.3	NA	
ENSG00000164919	COX6C	NA	
ENSG00000287952	AC105328.1	NA	
ENSG00000132554	RGS22	NA	
ENSG00000212414	SNORD77B	NA	
ENSG00000221753	AC021590.1	NA	
ENSG00000156509	FBXO43	NA	
ENSG00000147669	POLR2K	NA	
ENSG00000104450	SPAG1	615505	CILIARY DYSKINESIA, PRIMARY, 28; CILD28;;CILIARY DYSKINESIA, PRIMARY, 28, WITH OR WITHOUT SITUS INVERSUS
ENSG00000202310	Y_RNA	NA	
ENSG00000253299	AC025647.1	NA	
ENSG00000199667	Y_RNA	NA	
ENSG00000034677	RNF19A	NA	
ENSG00000253217	AP001574.1	NA	
ENSG00000253824	AP003472.1	NA	
ENSG00000265599	MIR4471	NA	
ENSG00000253842	AP003472.2	NA	
ENSG00000253666	AP000424.1	NA	
ENSG00000254364	AP000424.2	NA	
ENSG00000186106	ANKRD46	NA	
ENSG00000251013	GAPDHP62	NA	
ENSG00000174226	SNX31	NA	
ENSG00000253740	AP001205.1	NA	
ENSG00000252764	RNU6-1092P	NA	
ENSG00000070756	PABPC1	NA	
ENSG00000284570	MIR7705	NA	
ENSG00000221527	RNU6ATAC41P	NA	
ENSG00000202001	Y_RNA	NA	
ENSG00000242399	RPS20P23	NA	
ENSG00000222795	RNU4-83P	NA	
ENSG00000212994	RPS26P6	NA	
ENSG00000275041	Metazoa_SRP	NA	
ENSG00000260368	AC027373.1	NA	
ENSG00000164924	YWHAZ	NA	
ENSG00000242315	RN7SL685P	NA	
ENSG00000248599	FLJ42969	NA	
ENSG00000253395	AP003469.2	NA	
ENSG00000253737	AP003469.3	NA	
ENSG00000253355	AP003469.1	NA	
ENSG00000202360	RN7SKP249	NA	
ENSG00000261087	ZNNT1	NA	
ENSG00000120963	ZNF706	NA	
ENSG00000271882	AP001330.4	NA	
ENSG00000253942	AP001330.2	NA	
ENSG00000253679	LINC02844	NA	
ENSG00000287479	AP001330.5	NA	
ENSG00000253282	AP001330.1	NA	
ENSG00000239115	RNU7-67P	NA	
ENSG00000271560	AP001330.3	NA	
ENSG00000228224	NACA4P	NA	
ENSG00000254063	DUXAP2	NA	
ENSG00000253644	LINC02845	NA	
ENSG00000239211	RN7SL563P	NA	
ENSG00000254084	AP001208.1	NA	
ENSG00000254024	AP001207.3	NA	
ENSG00000083307	GRHL2	608641	DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28
ENSG00000083307	GRHL2	616029	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME; ECTDS
ENSG00000083307	GRHL2	618031	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4
ENSG00000253991	AP001207.2	NA	
ENSG00000253153	AP001207.1	NA	
ENSG00000104490	NCALD	NA	
ENSG00000253629	AP000426.1	NA	
ENSG00000238372	AP001329.1	NA	
ENSG00000282989	PDCL3P2	NA	
ENSG00000266756	MIR5680	NA	
ENSG00000254492	AP001328.1	NA	
ENSG00000048392	RRM2B	612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A;;MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC, WITH RENAL TUBULOPATHY, AUTOSOMAL RECESSIVE MITOCHONDRIAL DNA DEPLETION SYNDROME 8B (MNGIE T /.../INCLUDED; MTDPS8B, INCLUDED;;MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, RRM2B-RELATED, INCLUDED;;MNGIE, RRM2B-RELATED, INCLUDED
ENSG00000048392	RRM2B	613077	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 5
ENSG00000246263	UBR5-AS1	NA	
ENSG00000253328	SUMO2P19	NA	
ENSG00000104517	UBR5	NA	
ENSG00000272037	AP002907.1	NA	
ENSG00000253923	AP002981.1	NA	
ENSG00000221387	RNU6ATAC8P	NA	
ENSG00000271612	HSPE1P14	NA	
ENSG00000240724	RPS12P15	NA	
ENSG00000253633	AP002852.1	NA	
ENSG00000252593	RNU6-1224P	NA	
ENSG00000155087	ODF1	NA	
ENSG00000253382	POU5F1P2	NA	
ENSG00000155090	KLF10	NA	
ENSG00000283959	AP002851.1	NA	
ENSG00000250684	ADI1P2	NA	
ENSG00000253669	GASAL1	NA	
ENSG00000155096	AZIN1	NA	
ENSG00000253385	AP003696.1	NA	
ENSG00000253320	AZIN1-AS1	NA	
ENSG00000253263	AP003354.1	NA	
ENSG00000244052	RPL5P24	NA	
ENSG00000201216	Y_RNA	NA	
ENSG00000253663	NPM1P52	NA	
ENSG00000254236	AP003550.1	NA	
ENSG00000155097	ATP6V1C1	NA	
ENSG00000253795	MTND1P5	NA	
ENSG00000253556	MTCO1P4	NA	
ENSG00000253977	MTCO2P4	NA	
ENSG00000250929	LINC01181	NA	
ENSG00000236939	BAALC-AS2	NA	
ENSG00000164929	BAALC	NA	
ENSG00000247081	BAALC-AS1	NA	
ENSG00000265657	MIR3151	NA	
ENSG00000253851	AC025370.1	NA	
ENSG00000164930	FZD6	161050	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1;;TWENTY-NAIL DYSTROPHY;;ONYCHODYSTROPHY TOTALIS, ISOLATED;;CLAW-SHAPED NAILS;;ONYCHAUXIS, HYPONYCHIA, AND ONYCHOLYSIS;;NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10, FORMERLY; NDNC10, FORMERLY NAIL GROWT /.../LUDED
ENSG00000286337	AC025370.2	NA	
ENSG00000164932	CTHRC1	614266	BARRETT ESOPHAGUS;;BARRETT METAPLASIA  ADENOCARCINOMA OF ESOPHAGUS, INCLUDED
ENSG00000266289	AC012213.3	NA	
ENSG00000207399	RNU6-1011P	NA	
ENSG00000164933	SLC25A32	616839	EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI
ENSG00000285982	AC012213.5	NA	
ENSG00000164934	DCAF13	NA	
ENSG00000261670	AC012213.2	NA	
ENSG00000271830	AC012213.4	NA	
ENSG00000253477	AC012213.1	NA	
ENSG00000176406	RIMS2	NA	
ENSG00000255105	PTMAP15	NA	
ENSG00000254644	AC007751.1	NA	
ENSG00000239344	AC090686.1	NA	
ENSG00000147647	DPYS	222748	DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY
ENSG00000164935	DCSTAMP	NA	
ENSG00000179577	AP003471.1	NA	
ENSG00000279138	AP002847.1	NA	
ENSG00000208032	MIR548A3	NA	
ENSG00000147650	LRP12	164310	OCULOPHARYNGODISTAL MYOPATHY 1; OPDM1;;OCULOPHARYNGODISTAL MYOPATHY; OPDM;;FACIOOCULOLARYNGOPHARYNGEAL MYOPATHY WITH DISTAL AND RESPIRATORY INVOLVEMENT; FOLP-DR
ENSG00000253454	NDUFA5P2	NA	
ENSG00000169946	ZFPM2	187500	TETRALOGY OF FALLOT; TOF
ENSG00000169946	ZFPM2	610187	DIAPHRAGMATIC HERNIA 3; DIH3
ENSG00000169946	ZFPM2	616067	46,XY SEX REVERSAL 9; SRXY9;;46,XY SEX REVERSAL, ZFPM2-RELATED
ENSG00000283157	AC012564.1	NA	
ENSG00000243939	AC090142.2	NA	
ENSG00000253997	AC090142.3	NA	
ENSG00000240271	AC090142.1	NA	
ENSG00000254041	AC021546.1	NA	
ENSG00000253318	TMCC1P1	NA	
ENSG00000243171	AC041039.1	NA	
ENSG00000251003	ZFPM2-AS1	NA	
ENSG00000253420	AC103853.1	NA	
ENSG00000254141	AC103853.2	NA	
ENSG00000243601	RPL12P24	NA	
ENSG00000253526	AC090802.1	NA	
ENSG00000201627	Y_RNA	NA	
ENSG00000213708	SLC16A14P1	NA	
ENSG00000254021	AC027031.1	NA	
ENSG00000254615	AC027031.2	NA	
ENSG00000164830	OXR1	213000	CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY; CHEGDD
ENSG00000253582	AC090579.1	NA	
ENSG00000253676	TAGLN2P1	NA	
ENSG00000251892	RNU7-84P	NA	
ENSG00000174429	ABRA	NA	
ENSG00000275905	AP003789.1	NA	
ENSG00000287289	AP000428.2	NA	
ENSG00000254146	HMGB1P46	NA	
ENSG00000287208	AP000428.1	NA	
ENSG00000154188	ANGPT1	NA	
ENSG00000286766	AC091010.1	NA	
ENSG00000248838	PGAM1P13	NA	
ENSG00000287949	AC025508.1	NA	
ENSG00000200806	RNA5SP275	NA	
ENSG00000147655	RSPO2	618021	TETRAAMELIA SYNDROME 2; TETAMS2;;TETRAAMELIA SYNDROME 2 WITH PULMONARY AGENESIS
ENSG00000147655	RSPO2	618022	HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD;;HFHRTRD
ENSG00000253228	NRBF2P4	NA	
ENSG00000230948	AP001331.1	NA	
ENSG00000104408	EIF3E	NA	
ENSG00000253754	AC087620.1	NA	
ENSG00000243287	RPS17P14	NA	
ENSG00000104412	EMC2	NA	
ENSG00000253657	AC022634.1	NA	
ENSG00000253949	AC022634.2	NA	
ENSG00000164841	TMEM74	NA	
ENSG00000253580	TRMT10BP1	NA	
ENSG00000253796	AC104248.1	NA	
ENSG00000174417	TRHR	618573	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7;;THYROTROPIN-RELEASING HORMONE RESISTANCE, GENERALIZED
ENSG00000120526	NUDCD1	NA	
ENSG00000250267	AC021237.1	NA	
ENSG00000120533	ENY2	NA	
ENSG00000205038	PKHD1L1	NA	
ENSG00000254185	MAPK6P5	NA	
ENSG00000147654	EBAG9	NA	
ENSG00000147642	SYBU	NA	
ENSG00000248050	AC079061.1	NA	
ENSG00000255099	AC023245.2	NA	
ENSG00000283555	U2	NA	
ENSG00000241385	AC023245.1	NA	
ENSG00000164794	KCNV1	NA	
ENSG00000255402	AC027451.1	NA	
ENSG00000240590	RPSAP48	NA	
ENSG00000253956	AC073023.1	NA	
ENSG00000253107	AC090819.1	NA	
ENSG00000253122	AC025366.1	NA	
ENSG00000253717	AP005357.1	NA	
ENSG00000253994	NDUFB9P3	NA	
ENSG00000253877	LINC01608	NA	
ENSG00000254241	MTCO1P47	NA	
ENSG00000253103	LINC01609	NA	
ENSG00000253489	AC009930.1	NA	
ENSG00000254124	EEF1A1P37	NA	
ENSG00000253434	LINC02237	NA	
ENSG00000255033	SERPINA15P	NA	
ENSG00000253156	H2AZP7	NA	
ENSG00000287942	AC022360.1	NA	
ENSG00000222146	RNU4-37P	NA	
ENSG00000164796	CSMD3	NA	
ENSG00000286946	AC024996.1	NA	
ENSG00000230169	RPL30P16	NA	
ENSG00000238399	MIR2053	NA	
ENSG00000227514	AC107890.1	NA	
ENSG00000287819	AC055788.2	NA	
ENSG00000286937	AC055788.1	NA	
ENSG00000253207	AC103993.1	NA	
ENSG00000206719	Y_RNA	NA	
ENSG00000254339	AC064802.1	NA	
ENSG00000253499	AC025881.1	NA	
ENSG00000253756	CARS1P2	NA	
ENSG00000104447	TRPS1	190350	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1;;TRPS I
ENSG00000104447	TRPS1	190351	TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3;;SUGIO-KAJII SYNDROME
ENSG00000227170	AF178030.1	NA	
ENSG00000249917	LINC00536	NA	
ENSG00000199450	RNA5SP276	NA	
ENSG00000287826	AC090994.1	NA	
ENSG00000253672	AC105177.1	NA	
ENSG00000147677	EIF3H	NA	
ENSG00000147679	UTP23	NA	
ENSG00000164754	RAD21	611376	MUNGAN SYNDROME; MGS;;VISCERAL NEUROMYOPATHY, FAMILIAL, WITH PSEUDOOBSTRUCTION, MEGADUODENUM, BARRETT ESOPHAGUS, AND CARDIAC ABNORMALITIES;;PSEUDOOBSTRUCTION, CHRONIC IDIOPATHIC INTESTINAL, WITH BARRETT ESOPHAGUS AND CARDIAC ABNORMALITIES
ENSG00000164754	RAD21	614701	CORNELIA DE LANGE SYNDROME 4; CDLS4
ENSG00000253327	RAD21-AS1	NA	
ENSG00000283956	MIR3610	NA	
ENSG00000205002	AARD	NA	
ENSG00000164756	SLC30A8	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000244033	RN7SL228P	NA	
ENSG00000253271	AC027419.1	NA	
ENSG00000253622	AC027419.2	NA	
ENSG00000240151	RN7SL826P	NA	
ENSG00000286308	AC084114.1	NA	
ENSG00000252852	AP002848.1	NA	
ENSG00000164758	MED30	NA	
ENSG00000239917	RPS10P16	NA	
ENSG00000182197	EXT1	133700	EXOSTOSES, MULTIPLE, TYPE I; EXT1;;EXT;;MULTIPLE CARTILAGINOUS EXOSTOSES;;DIAPHYSEAL ACLASIS;;MULTIPLE OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS
ENSG00000182197	EXT1	215300	CHONDROSARCOMA
ENSG00000177570	SAMD12	601068	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 1; BAFME1;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 1; FCMTE1
ENSG00000225885	AC023590.1	NA	
ENSG00000281641	SAMD12-AS1	NA	
ENSG00000242206	RPS26P35	NA	
ENSG00000164761	TNFRSF11B	239000	PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5;;JUVENILE PAGET DISEASE; JPD;;HYPEROSTOSIS CORTICALIS DEFORMANS JUVENILIS;;HYPERPHOSPHATASIA, FAMILIAL IDIOPATHIC;;HYPERPHOSPHATASEMIA, CHRONIC CONGENITAL IDIOPATHIC;;OSTEOECTASIA, FAMILIAL
ENSG00000207334	RNU6-12P	NA	
ENSG00000254247	AC107953.1	NA	
ENSG00000184374	COLEC10	248340	3MC SYNDROME 3; 3MC3;;FACIAL CLEFTING SYNDROME, GYPSY TYPE;;MALPUECH FACIAL CLEFTING SYNDROME, FORMERLY
ENSG00000254278	AC107953.2	NA	
ENSG00000147676	MAL2	NA	
ENSG00000253972	MAL2-AS1	NA	
ENSG00000276479	MIR548AZ	NA	
ENSG00000286282	AC021733.4	NA	
ENSG00000206776	AC021733.1	NA	
ENSG00000136999	CCN3	NA	
ENSG00000253398	AC021733.2	NA	
ENSG00000254037	AC021733.3	NA	
ENSG00000136960	ENPP2	NA	
ENSG00000253495	CYCSP23	NA	
ENSG00000201896	RN7SKP153	NA	
ENSG00000064313	TAF2	615599	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40
ENSG00000286362	AP005717.2	NA	
ENSG00000136982	DSCC1	NA	
ENSG00000279347	AC021945.1	NA	
ENSG00000244642	RN7SL396P	NA	
ENSG00000245330	AP005717.1	NA	
ENSG00000155792	DEPTOR	NA	
ENSG00000202356	RNA5SP277	NA	
ENSG00000254343	AC091563.1	NA	
ENSG00000187955	COL14A1	NA	
ENSG00000172172	MRPL13	NA	
ENSG00000172167	MTBP	NA	
ENSG00000172164	SNTB1	NA	
ENSG00000250290	NCAPGP1	NA	
ENSG00000248318	AC104958.1	NA	
ENSG00000272502	AC104958.2	NA	
ENSG00000253619	AC068413.1	NA	
ENSG00000271219	AC011626.1	NA	
ENSG00000239872	RPL35AP19	NA	
ENSG00000170961	HAS2	NA	
ENSG00000248690	HAS2-AS1	NA	
ENSG00000254209	LINC02855	NA	
ENSG00000254303	AC037486.1	NA	
ENSG00000253814	MRPS36P3	NA	
ENSG00000255364	SMILR	NA	
ENSG00000253819	LINC01151	NA	
ENSG00000255325	AC108136.1	NA	
ENSG00000238901	AC100872.1	NA	
ENSG00000263443	AC100872.2	NA	
ENSG00000235165	CDK5P1	NA	
ENSG00000272384	AC016405.3	NA	
ENSG00000272043	AC016405.2	NA	
ENSG00000178764	ZHX2	NA	
ENSG00000253372	AC016405.1	NA	
ENSG00000259631	AC104316.2	NA	
ENSG00000253607	AC104316.1	NA	
ENSG00000136986	DERL1	NA	
ENSG00000156787	TBC1D31	NA	
ENSG00000253463	HMGB1P19	NA	
ENSG00000287657	AC068228.3	NA	
ENSG00000147689	FAM83A	NA	
ENSG00000221461	U3	NA	
ENSG00000253258	AC068228.1	NA	
ENSG00000253410	AC068228.2	NA	
ENSG00000204949	FAM83A-AS1	NA	
ENSG00000266324	MIR4663	NA	
ENSG00000189376	C8orf76	NA	
ENSG00000259305	ZHX1-C8orf76	NA	
ENSG00000243498	UBA52P5	NA	
ENSG00000165156	ZHX1	NA	
ENSG00000222607	RNU6-628P	NA	
ENSG00000253336	AC018992.1	NA	
ENSG00000156802	ATAD2	NA	
ENSG00000252297	RNU6-875P	NA	
ENSG00000283172	MIR548D1	NA	
ENSG00000207704	MIR548AA1	NA	
ENSG00000254388	DUTP2	NA	
ENSG00000254294	IMPDH1P6	NA	
ENSG00000156795	NTAQ1	NA	
ENSG00000278374	U4	NA	
ENSG00000156804	FBXO32	NA	
ENSG00000254113	AC090193.1	NA	
ENSG00000251840	RN7SKP155	NA	
ENSG00000253286	AC135166.1	NA	
ENSG00000175946	KLHL38	NA	
ENSG00000104537	ANXA13	NA	
ENSG00000176853	FAM91A1	NA	
ENSG00000214814	FER1L6	NA	
ENSG00000254000	AC090753.1	NA	
ENSG00000181171	FER1L6-AS1	NA	
ENSG00000254249	AC100871.2	NA	
ENSG00000253868	FER1L6-AS2	NA	
ENSG00000250727	AC100871.1	NA	
ENSG00000253885	ARF1P3	NA	
ENSG00000214803	AC090921.1	NA	
ENSG00000206724	RNU6-756P	NA	
ENSG00000253227	AC090192.2	NA	
ENSG00000237586	AC090192.1	NA	
ENSG00000164983	TMEM65	NA	
ENSG00000183665	TRMT12	NA	
ENSG00000245149	RNF139-AS1	NA	
ENSG00000170881	RNF139	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC;;HYPERNEPHROMA;;ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
ENSG00000147687	TATDN1	NA	
ENSG00000253106	AC090198.1	NA	
ENSG00000284087	MIR6844	NA	
ENSG00000147684	NDUFB9	618245	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24
ENSG00000170873	MTSS1	NA	
ENSG00000255491	AC100858.3	NA	
ENSG00000263735	MIR4662B	NA	
ENSG00000283609	MIR4662A	NA	
ENSG00000249816	LINC00964	NA	
ENSG00000250428	AC100858.1	NA	
ENSG00000255313	AC100858.2	NA	
ENSG00000286955	AC100858.4	NA	
ENSG00000180938	ZNF572	NA	
ENSG00000253513	AC009908.1	NA	
ENSG00000104549	SQLE	NA	
ENSG00000164961	WASHC5	220210	RITSCHER-SCHINZEL SYNDROME 1; RTSC1;;CRANIOCEREBELLOCARDIAC DYSPLASIA;;3@C SYNDROME;;DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT
ENSG00000164961	WASHC5	603563	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8
ENSG00000253167	WASHC5-AS1	NA	
ENSG00000156831	NSMCE2	617253	SECKEL SYNDROME 10; SCKL10
ENSG00000242170	RN7SL329P	NA	
ENSG00000254431	AC084083.1	NA	
ENSG00000173334	TRIB1	NA	
ENSG00000253111	AC091114.1	NA	
ENSG00000286122	AC016074.2	NA	
ENSG00000253470	AC016074.1	NA	
ENSG00000245164	LINC00861	NA	
ENSG00000206695	RNU6-442P	NA	
ENSG00000253651	SOD1P3	NA	
ENSG00000254227	AC024681.2	NA	
ENSG00000250563	KNOP1P5	NA	
ENSG00000253841	AC024681.1	NA	
ENSG00000248720	RFPL4AP5	NA	
ENSG00000244791	AC087667.1	NA	
ENSG00000253427	AC084116.2	NA	
ENSG00000253220	AC084116.1	NA	
ENSG00000207138	RNU6-869P	NA	
ENSG00000253530	AC084116.3	NA	
ENSG00000168672	LRATD2	NA	
ENSG00000253438	PCAT1	NA	
ENSG00000253543	AC083923.1	NA	
ENSG00000212451	RNU11-4P	NA	
ENSG00000253573	AC024382.1	NA	
ENSG00000254166	CASC19	NA	
ENSG00000282961	PRNCR1	NA	
ENSG00000224722	AC020688.1	NA	
ENSG00000287781	AC018714.2	NA	
ENSG00000246228	CASC8	NA	
ENSG00000271509	AC018714.1	NA	
ENSG00000212993	POU5F1B	NA	
ENSG00000280997	CCAT2	NA	
ENSG00000286266	AC104370.1	NA	
ENSG00000286010	AC108925.1	NA	
ENSG00000249375	CASC11	NA	
ENSG00000136997	MYC	113970	BURKITT LYMPHOMA; BL
ENSG00000249859	PVT1	NA	
ENSG00000283710	MIR1204	NA	
ENSG00000278324	AC084123.1	NA	
ENSG00000280055	TMEM75	NA	
ENSG00000221771	MIR1205	NA	
ENSG00000207110	RNVU1-32	NA	
ENSG00000283200	MIR1206	NA	
ENSG00000278275	AC103705.1	NA	
ENSG00000222501	RNU4-25P	NA	
ENSG00000221176	MIR1207	NA	
ENSG00000221261	MIR1208	NA	
ENSG00000201782	RN7SKP226	NA	
ENSG00000286034	AC100822.1	NA	
ENSG00000254275	LINC00824	NA	
ENSG00000229140	CCDC26	NA	
ENSG00000287785	AC103833.2	NA	
ENSG00000253225	AC103833.1	NA	
ENSG00000222755	RN7SKP206	NA	
ENSG00000253926	AC011257.1	NA	
ENSG00000263763	MIR3686	NA	
ENSG00000285108	AC103718.1	NA	
ENSG00000224110	MTRF1LP2	NA	
ENSG00000147697	GSDMC	NA	
ENSG00000254317	AC022973.5	NA	
ENSG00000153310	CYRIB	NA	
ENSG00000243402	AC022973.2	NA	
ENSG00000200075	AC022973.1	NA	
ENSG00000254263	AC022973.4	NA	
ENSG00000253720	AC022973.3	NA	
ENSG00000287195	AC131568.1	NA	
ENSG00000253043	RNU7-181P	NA	
ENSG00000264653	MIR5194	NA	
ENSG00000153317	ASAP1	NA	
ENSG00000200304	RNU6-1255P	NA	
ENSG00000280543	ASAP1-IT2	NA	
ENSG00000212342	AC103725.1	NA	
ENSG00000287201	AC009682.1	NA	
ENSG00000286535	AC139019.1	NA	
ENSG00000253656	AC090987.1	NA	
ENSG00000155897	ADCY8	NA	
ENSG00000253259	AC103726.1	NA	
ENSG00000253992	AC103726.2	NA	
ENSG00000253407	AC087341.1	NA	
ENSG00000253507	AC104257.1	NA	
ENSG00000252158	SNORA72	NA	
ENSG00000254255	AC060788.1	NA	
ENSG00000132294	EFR3A	NA	
ENSG00000253117	OC90	NA	
ENSG00000258417	AC100868.1	NA	
ENSG00000132297	HHLA1	NA	
ENSG00000184156	KCNQ3	121201	SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, 2; BFNC2
ENSG00000253521	HPYR1	NA	
ENSG00000129295	LRRC6	614935	CILIARY DYSKINESIA, PRIMARY, 19; CILD19;;CILIARY DYSKINESIA, PRIMARY, 19, WITH OR WITHOUT SITUS INVERSUS
ENSG00000165071	TMEM71	NA	
ENSG00000287095	AF228727.1	NA	
ENSG00000129292	PHF20L1	NA	
ENSG00000270137	AF230666.2	NA	
ENSG00000223697	AF230666.1	NA	
ENSG00000042832	TG	274700	THYROID DYSHORMONOGENESIS 3; TDH3;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 3
ENSG00000042832	TG	608175	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3
ENSG00000240237	AF305872.1	NA	
ENSG00000155926	SLA	NA	
ENSG00000276961	MIR7848	NA	
ENSG00000287736	PTCSC1	NA	
ENSG00000104415	CCN4	NA	
ENSG00000104419	NDRG1	601455	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D
ENSG00000243537	KC877373.1	NA	
ENSG00000253638	AF186190.1	NA	
ENSG00000225259	ST13P6	NA	
ENSG00000008513	ST3GAL1	NA	
ENSG00000283176	AC103706.2	NA	
ENSG00000283197	AC103706.3	NA	
ENSG00000261220	AC103706.1	NA	
ENSG00000212273	AC090821.1	NA	
ENSG00000276193	Metazoa_SRP	NA	
ENSG00000253970	MTND2P7	NA	
ENSG00000253916	MTCO1P49	NA	
ENSG00000253561	AC133634.1	NA	
ENSG00000253165	AC090821.2	NA	
ENSG00000254313	AC090821.3	NA	
ENSG00000253593	AC110741.1	NA	
ENSG00000277576	AC110741.3	NA	
ENSG00000271240	AC110741.2	NA	
ENSG00000288067	AC105180.2	NA	
ENSG00000253627	AC105180.1	NA	
ENSG00000066827	ZFAT	608175	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3
ENSG00000248492	ZFAT-AS1	NA	
ENSG00000276140	AC015599.1	NA	
ENSG00000277732	AC015599.2	NA	
ENSG00000278454	AC015599.3	NA	
ENSG00000271048	AC087045.1	NA	
ENSG00000272456	AC087045.2	NA	
ENSG00000278898	AC087045.3	NA	
ENSG00000279518	AC083843.3	NA	
ENSG00000259820	AC083843.2	NA	
ENSG00000207582	MIR30B	NA	
ENSG00000199153	MIR30D	NA	
ENSG00000253433	NCRNA00250	NA	
ENSG00000254028	AC083843.1	NA	
ENSG00000251218	AC103764.1	NA	
ENSG00000244413	RPL23AP56	NA	
ENSG00000254083	LINC01591	NA	
ENSG00000254372	AC040914.1	NA	
ENSG00000131773	KHDRBS3	NA	
ENSG00000253915	MAPRE1P1	NA	
ENSG00000199652	RNU1-35P	NA	
ENSG00000254101	LINC02055	NA	
ENSG00000286927	AC103955.1	NA	
ENSG00000285683	AC023781.1	NA	
ENSG00000206678	RNU6-144P	NA	
ENSG00000274572	ZYXP1	NA	
ENSG00000285817	AC105213.1	NA	
ENSG00000254076	AC110053.1	NA	
ENSG00000253288	AC046195.1	NA	
ENSG00000254361	AC046195.2	NA	
ENSG00000253988	AC079015.1	NA	
ENSG00000147724	FAM135B	NA	
ENSG00000169436	COL22A1	NA	
ENSG00000253432	AC027541.1	NA	
ENSG00000251744	AC100807.1	NA	
ENSG00000253783	AC100807.2	NA	
ENSG00000254258	AC087354.1	NA	
ENSG00000275078	AC090093.1	NA	
ENSG00000169427	KCNK9	612292	BIRK-BAREL SYNDROME;;BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM
ENSG00000167632	TRAPPC9	613192	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13
ENSG00000253574	AC021744.1	NA	
ENSG00000250733	C8orf17	NA	
ENSG00000274064	AC040978.1	NA	
ENSG00000282164	PEG13	NA	
ENSG00000259891	AC107375.1	NA	
ENSG00000104472	CHRAC1	NA	
ENSG00000123908	AGO2	NA	
ENSG00000279766	AC067931.1	NA	
ENSG00000280326	AC067931.2	NA	
ENSG00000280303	ERICD	NA	
ENSG00000169398	PTK2	NA	
ENSG00000254324	MIR151A	NA	
ENSG00000279786	AC105235.1	NA	
ENSG00000252864	RNA5SP278	NA	
ENSG00000253266	AC100860.1	NA	
ENSG00000105339	DENND3	NA	
ENSG00000253210	AC040970.1	NA	
ENSG00000022567	SLC45A4	NA	
ENSG00000280035	AC011676.5	NA	
ENSG00000253307	AC011676.1	NA	
ENSG00000254019	AC011676.2	NA	
ENSG00000254197	AC011676.3	NA	
ENSG00000254291	AC011676.4	NA	
ENSG00000253595	LINC01300	NA	
ENSG00000261655	AC100803.3	NA	
ENSG00000204882	GPR20	NA	
ENSG00000244998	AC100803.2	NA	
ENSG00000184489	PTP4A3	NA	
ENSG00000226807	MROH5	NA	
ENSG00000271959	AC100803.4	NA	
ENSG00000238854	AC100803.1	NA	
ENSG00000253605	HNRNPA1P38	NA	
ENSG00000287325	AC138647.2	NA	
ENSG00000226490	AC138647.1	NA	
ENSG00000287677	AC025839.1	NA	
ENSG00000221768	MIR1302-7	NA	
ENSG00000254183	AC104417.1	NA	
ENSG00000261710	AC104417.2	NA	
ENSG00000287332	AC103758.1	NA	
ENSG00000265247	MIR4472-1	NA	
ENSG00000254008	LINC00051	NA	
ENSG00000171045	TSNARE1	NA	
ENSG00000253602	RN7SL260P	NA	
ENSG00000261693	AC134682.1	NA	
ENSG00000181790	ADGRB1	NA	
ENSG00000232722	MROH4P	NA	
ENSG00000198576	ARC	NA	
ENSG00000261044	AP006547.1	NA	
ENSG00000277332	AC108002.2	NA	
ENSG00000234616	JRK	NA	
ENSG00000167653	PSCA	NA	
ENSG00000160886	LY6K	NA	
ENSG00000253741	LNCOC1	NA	
ENSG00000130193	THEM6	NA	
ENSG00000253806	AC108002.1	NA	
ENSG00000126233	SLURP1	248300	MAL DE MELEDA; MDM;;MELEDA DISEASE;;KERATOSIS PALMOPLANTARIS TRANSGREDIENS OF SIEMENS
ENSG00000197353	LYPD2	NA	
ENSG00000253196	AC083841.1	NA	
ENSG00000284505	LYNX1-SLURP2	NA	
ENSG00000283992	SLURP2	NA	
ENSG00000180155	LYNX1	NA	
ENSG00000167656	LY6D	NA	
ENSG00000253715	AC083841.2	NA	
ENSG00000283686	AC083841.4	NA	
ENSG00000253728	AC083841.3	NA	
ENSG00000104499	GML	NA	
ENSG00000253421	ZNHIT1P1	NA	
ENSG00000160882	CYP11B1	103900	HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1;;GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA;;FH I;;GLUCOCORTICOID-SUPPRESSIBLE HYPERALDOSTERONISM; GSH;;ALDOSTERONISM, SENSITIVE TO DEXAMETHASONE;;ACTH-DEPENDENT HYPERALDOSTERONISM SYNDROME
ENSG00000160882	CYP11B1	202010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA IV;;STEROID 11-BETA-HYDROXYLASE DEFICIENCY;;11-@BETA-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA, HYPERTENSIVE FORM;;P450C11B1 DEFICIENCY
ENSG00000179142	CYP11B2	203400	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18 /.../OXYLASE DEFICIENCY
ENSG00000179142	CYP11B2	610600	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY;;CMO II DEFICIENCY;;ALDOSTERONE DEFICIENCY II;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1B;;ALDOSTERONE DEFICIENCY DUE TO DEFICIENCY OF STEROID 18-OXIDASE;;STEROID 18-OXIDASE DEFICIENCY;;18-@ /.../E DEFICIENCY
ENSG00000247317	LY6E-DT	NA	
ENSG00000253971	CDC42P3	NA	
ENSG00000160932	LY6E	NA	
ENSG00000177335	C8orf31	NA	
ENSG00000250115	AK3P2	NA	
ENSG00000243328	AC083982.1	NA	
ENSG00000261667	LY6L	NA	
ENSG00000176956	LY6H	NA	
ENSG00000277494	GPIHBP1	615947	HYPERLIPOPROTEINEMIA, TYPE ID
ENSG00000181638	ZFP41	NA	
ENSG00000264668	AC138696.1	NA	
ENSG00000250571	GLI4	NA	
ENSG00000253716	MINCR	NA	
ENSG00000185730	ZNF696	NA	
ENSG00000272172	AC138696.2	NA	
ENSG00000184428	TOP1MT	NA	
ENSG00000212221	RNU6-220P	NA	
ENSG00000254389	RHPN1-AS1	NA	
ENSG00000158106	RHPN1	NA	
ENSG00000253931	AC105118.1	NA	
ENSG00000254338	MAFA-AS1	NA	
ENSG00000182759	MAFA	147630	INSULINOMATOSIS AND DIABETES MELLITUS; INSDM;;ISLET CELL ADENOMATOSIS
ENSG00000014164	ZC3H3	NA	
ENSG00000287576	AC067930.8	NA	
ENSG00000254859	AC067930.3	NA	
ENSG00000275558	RN7SKP175	NA	
ENSG00000104518	GSDMD	NA	
ENSG00000204839	MROH6	NA	
ENSG00000255050	AC067930.4	NA	
ENSG00000147813	NAPRT	NA	
ENSG00000279605	AC067930.5	NA	
ENSG00000254741	AC067930.1	NA	
ENSG00000104529	EEF1D	NA	
ENSG00000179886	TIGD5	NA	
ENSG00000104524	PYCR3	NA	
ENSG00000104522	TSTA3	NA	
ENSG00000254812	AC067930.2	NA	
ENSG00000183309	ZNF623	NA	
ENSG00000181135	ZNF707	NA	
ENSG00000181097	LINC02878	NA	
ENSG00000255181	CCDC166	NA	
ENSG00000254574	AC105219.2	NA	
ENSG00000181085	MAPK15	NA	
ENSG00000254548	AC105219.1	NA	
ENSG00000180921	FAM83H	130900	AMELOGENESIS IMPERFECTA, TYPE IIIA; AI3A;;AMELOGENESIS IMPERFECTA, TYPE III; AI3;;AMELOGENESIS IMPERFECTA, HYPOCALCIFICATION TYPE, AUTOSOMAL DOMINANT; ADHCAI;;AMELOGENESIS IMPERFECTA, HYPOMINERALIZATION TYPE
ENSG00000265660	MIR4664	NA	
ENSG00000203499	IQANK1	NA	
ENSG00000254973	AC105219.3	NA	
ENSG00000180900	SCRIB	NA	
ENSG00000284224	MIR937	NA	
ENSG00000179950	PUF60	615583	VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME
ENSG00000287222	AC234917.3	NA	
ENSG00000255343	AC234917.1	NA	
ENSG00000185189	NRBP2	NA	
ENSG00000284142	MIR6845	NA	
ENSG00000285599	AC234917.2	NA	
ENSG00000261150	EPPK1	NA	
ENSG00000288096	AC109322.2	NA	
ENSG00000178209	PLEC	131950	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE; EBSOG
ENSG00000178209	PLEC	226670	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY; EBSMD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS
ENSG00000178209	PLEC	226730	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIA CUTI /.../ENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA
ENSG00000178209	PLEC	612138	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA; EBSPA;;EBS WITH PYLORIC ATRESIA
ENSG00000178209	PLEC	613723	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMDR17;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q
ENSG00000178209	PLEC	616487	EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY; EBSND
ENSG00000207574	MIR661	NA	
ENSG00000178685	PARP10	NA	
ENSG00000178719	GRINA	NA	
ENSG00000186583	SPATC1	NA	
ENSG00000204791	SMPD5	NA	
ENSG00000178814	OPLAH	260005	5-@OXOPROLINASE DEFICIENCY; OPLAHD;;OXOPROLINURIA DUE TO 5-OXOPROLINASE DEFICIENCY
ENSG00000277888	MIR6846	NA	
ENSG00000255224	AC109322.1	NA	
ENSG00000178896	EXOSC4	NA	
ENSG00000284200	MIR6847	NA	
ENSG00000197858	GPAA1	617810	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15;;DEVELOPMENTAL DELAY, EPILEPSY, CEREBELLAR ATROPHY, AND OSTEOPENIA
ENSG00000179091	CYC1	615453	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6
ENSG00000179526	SHARPIN	NA	
ENSG00000179632	MAF1	NA	
ENSG00000179698	WDR97	NA	
ENSG00000235173	HGH1	NA	
ENSG00000227473	TSSK5P	NA	
ENSG00000179832	MROH1	NA	
ENSG00000261236	BOP1	NA	
ENSG00000284054	MIR7112	NA	
ENSG00000260428	SCX	NA	
ENSG00000185122	HSF1	NA	
ENSG00000185000	DGAT1	615863	DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7
ENSG00000254690	AC233992.1	NA	
ENSG00000284229	MIR6848	NA	
ENSG00000261678	SCRT1	NA	
ENSG00000185803	SLC52A2	614707	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2
ENSG00000261587	TMEM249	NA	
ENSG00000271698	AC233992.2	NA	
ENSG00000182325	FBXL6	NA	
ENSG00000173137	ADCK5	NA	
ENSG00000071894	CPSF1	618827	MYOPIA 27; MYP27
ENSG00000284310	MIR939	NA	
ENSG00000284139	MIR1234	NA	
ENSG00000283770	MIR6849	NA	
ENSG00000272115	AC233992.3	NA	
ENSG00000147804	SLC39A4	201100	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ
ENSG00000160948	VPS28	NA	
ENSG00000160949	TONSL	271510	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP;;SPONDYLAR AND NASAL ALTERATIONS WITH STRIATED METAPHYSES;;SPONASTRIME DYSPLASIA;;SHORT-LIMB DWARFISM WITH SADDLE NOSE, SPINAL ALTERATIONS, AND METAPHYSEAL STRIATION
ENSG00000276598	MIR6893	NA	
ENSG00000232600	TONSL-AS1	NA	
ENSG00000187954	CYHR1	NA	
ENSG00000254578	AC084125.1	NA	
ENSG00000167702	KIFC2	NA	
ENSG00000160973	FOXH1	NA	
ENSG00000160972	PPP1R16A	NA	
ENSG00000255182	AC084125.2	NA	
ENSG00000167701	GPT	NA	
ENSG00000167700	MFSD3	NA	
ENSG00000160957	RECQL4	218600	BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME
ENSG00000160957	RECQL4	266280	RAPADILINO SYNDROME
ENSG00000160957	RECQL4	268400	ROTHMUND-THOMSON SYNDROME, TYPE 2; RTS2;;ROTHMUND-THOMSON SYNDROME
ENSG00000265393	AC084125.4	NA	
ENSG00000160959	LRRC14	NA	
ENSG00000254402	LRRC24	NA	
ENSG00000213563	C8orf82	NA	
ENSG00000147799	ARHGAP39	NA	
ENSG00000255456	AC084125.3	NA	
ENSG00000274772	Metazoa_SRP	NA	
ENSG00000254533	AF186192.1	NA	
ENSG00000255085	AF186192.2	NA	
ENSG00000263612	AF186192.3	NA	
ENSG00000198169	ZNF251	NA	
ENSG00000196378	ZNF34	NA	
ENSG00000244307	RN7SL395P	NA	
ENSG00000161016	RPL8	NA	
ENSG00000283764	MIR6850	NA	
ENSG00000197363	ZNF517	NA	
ENSG00000147789	ZNF7	NA	
ENSG00000170619	COMMD5	NA	
ENSG00000286681	AF235103.3	NA	
ENSG00000196150	ZNF250	NA	
ENSG00000170631	ZNF16	NA	
ENSG00000196922	ZNF252P	NA	
ENSG00000255164	AF235103.1	NA	
ENSG00000254618	TMED10P1	NA	
ENSG00000255559	ZNF252P-AS1	NA	
ENSG00000255530	AF235103.2	NA	
ENSG00000255000	AC139103.1	NA	
ENSG00000182307	C8orf33	NA	
ENSG00000236875	DDX11L5	NA	
ENSG00000181404	WASHC1	NA	
ENSG00000227518	AL928970.1	NA	
ENSG00000283921	MIR1302-9	NA	
ENSG00000218839	FAM138C	NA	
ENSG00000284986	AL449043.2	NA	
ENSG00000277631	PGM5P3-AS1	NA	
ENSG00000227917	AL449043.1	NA	
ENSG00000231808	LINC01388	NA	
ENSG00000170122	FOXD4	NA	
ENSG00000172785	CBWD1	NA	
ENSG00000287480	AL158832.2	NA	
ENSG00000183784	DOCK8-AS1	NA	
ENSG00000107099	DOCK8	243700	HYPER-IgE RECURRENT INFECTION SYNDROME 2, AUTOSOMAL RECESSIVE; HIES2;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE
ENSG00000235880	AL158832.1	NA	
ENSG00000227155	AL161725.1	NA	
ENSG00000107104	KANK1	612900	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2
ENSG00000235330	RPL12P25	NA	
ENSG00000228115	AL161725.2	NA	
ENSG00000226403	AL392089.1	NA	
ENSG00000202172	RNU6-1327P	NA	
ENSG00000229875	EIF1P1	NA	
ENSG00000227914	AL136979.1	NA	
ENSG00000137090	DMRT1	NA	
ENSG00000064218	DMRT3	NA	
ENSG00000252991	RNU6-1073P	NA	
ENSG00000228783	H3P29	NA	
ENSG00000286684	AL358976.1	NA	
ENSG00000281769	LINC01230	NA	
ENSG00000173253	DMRT2	NA	
ENSG00000224836	AL356498.1	NA	
ENSG00000236594	RPS27AP14	NA	
ENSG00000233575	AL358934.1	NA	
ENSG00000202383	RNA5SP279	NA	
ENSG00000287465	AL358053.1	NA	
ENSG00000224092	AL591644.1	NA	
ENSG00000080503	SMARCA2	601358	NICOLAIDES-BARAITSER SYNDROME; NCBRS;;SPARSE HAIR AND MENTAL RETARDATION;;NBS
ENSG00000236199	AL359076.1	NA	
ENSG00000222973	RNU2-25P	NA	
ENSG00000264615	RN7SL592P	NA	
ENSG00000236404	VLDLR-AS1	NA	
ENSG00000231052	AL353614.1	NA	
ENSG00000147852	VLDLR	224050	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1;;CEREBELLAR HYPOPLASIA, VLDLR-ASSOCIATED;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 1;;CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETAR /.../, AUTOSOMAL RECESSIVE;;DYSEQUILIBRIUM SYNDROME; DES
ENSG00000286670	AL450467.1	NA	
ENSG00000168263	KCNV2	610356	RETINAL CONE DYSTROPHY 3B; RCD3B;;CONE DYSTROPHY WITH SUPERNORMAL ROD RESPONSES; CDSRR;;CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES, KCNV2-RELATED
ENSG00000080608	PUM3	NA	
ENSG00000236496	GPS2P1	NA	
ENSG00000229184	ATP5PDP2	NA	
ENSG00000227835	CARM1P1	NA	
ENSG00000236511	LINC01231	NA	
ENSG00000080298	RFX3	NA	
ENSG00000215297	AL354941.1	NA	
ENSG00000232104	RFX3-AS1	NA	
ENSG00000237359	AL354977.2	NA	
ENSG00000226669	AL354977.1	NA	
ENSG00000107249	GLIS3	610199	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH;;NDH SYNDROME
ENSG00000236724	AL137071.1	NA	
ENSG00000237009	GLIS3-AS1	NA	
ENSG00000230001	AL359095.1	NA	
ENSG00000228322	AL162419.1	NA	
ENSG00000200941	RNU6-694P	NA	
ENSG00000106688	SLC1A1	222730	DICARBOXYLIC AMINOACIDURIA; DCBXA;;GLUTAMATE-ASPARTATE TRANSPORT DEFECT
ENSG00000106688	SLC1A1	615232	SCHIZOPHRENIA 18; SCZD18;;SCHIZOPHRENIA 18 WITH OR WITHOUT AN AFFECTIVE DISORDER
ENSG00000106686	SPATA6L	NA	
ENSG00000225893	AL136231.1	NA	
ENSG00000205808	PLPP6	NA	
ENSG00000273061	CDC37L1-DT	NA	
ENSG00000106993	CDC37L1	NA	
ENSG00000147853	AK3	NA	
ENSG00000287759	AL353151.2	NA	
ENSG00000270639	ECM1P1	NA	
ENSG00000220105	AL353151.1	NA	
ENSG00000120158	RCL1	NA	
ENSG00000233186	KLF4P1	NA	
ENSG00000199065	MIR101-2	NA	
ENSG00000228165	AL158147.1	NA	
ENSG00000220937	HNRNPA1P41	NA	
ENSG00000096968	JAK2	133100	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN
ENSG00000096968	JAK2	254450	MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED; MMM, INCLUDED
ENSG00000096968	JAK2	263300	POLYCYTHEMIA VERA; PV;;POLYCYTHEMIA RUBRA VERA; PRV
ENSG00000096968	JAK2	600880	BUDD-CHIARI SYNDROME; BDCHS MEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED; MOVC, INCLUDED
ENSG00000096968	JAK2	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000096968	JAK2	614521	THROMBOCYTHEMIA 3; THCYT3;;THROMBOCYTOSIS 3
ENSG00000234534	CSNK1G2P1	NA	
ENSG00000182347	PDSS1P1	NA	
ENSG00000227730	MTND6P5	NA	
ENSG00000228166	MTND1P11	NA	
ENSG00000224083	MTCO1P11	NA	
ENSG00000235917	MTCO2P11	NA	
ENSG00000228097	MTATP6P11	NA	
ENSG00000237711	MTCO3P11	NA	
ENSG00000236254	MTND4P14	NA	
ENSG00000230225	MTND5P14	NA	
ENSG00000236567	TCF3P1	NA	
ENSG00000254017	IGHEP2	NA	
ENSG00000120210	INSL6	NA	
ENSG00000237553	AL133547.1	NA	
ENSG00000120211	INSL4	NA	
ENSG00000107014	RLN2	NA	
ENSG00000214195	HMGN2P31	NA	
ENSG00000107018	RLN1	NA	
ENSG00000272866	AL135786.2	NA	
ENSG00000231967	AL135786.1	NA	
ENSG00000107020	PLGRKT	NA	
ENSG00000214190	RNF152P1	NA	
ENSG00000120217	CD274	NA	
ENSG00000286162	AL162253.2	NA	
ENSG00000197646	PDCD1LG2	NA	
ENSG00000231509	AL162253.1	NA	
ENSG00000107036	RIC1	618761	CATIFA SYNDROME; CATIFA;;CLEFT LIP, CATARACT, TOOTH ABNORMALITY, IMPAIRED INTELLECTUAL DEVELOPMENT, FACIAL DYSMORPHISM, AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER
ENSG00000225408	AL136980.1	NA	
ENSG00000099219	ERMP1	NA	
ENSG00000223621	AK4P4	NA	
ENSG00000183354	KIAA2026	NA	
ENSG00000120215	MLANA	NA	
ENSG00000263575	MIR4665	NA	
ENSG00000137040	RANBP6	NA	
ENSG00000228739	AL162384.1	NA	
ENSG00000237274	GTF3AP1	NA	
ENSG00000137033	IL33	NA	
ENSG00000228132	AL360221.1	NA	
ENSG00000233846	SELENOTP1	NA	
ENSG00000170777	TPD52L3	NA	
ENSG00000147854	UHRF2	NA	
ENSG00000233367	AL133480.1	NA	
ENSG00000178445	GLDC	605899	GLYCINE ENCEPHALOPATHY; GCE;;HYPERGLYCINEMIA, NONKETOTIC; NKH HYPERGLYCINEMIA, TRANSIENT NEONATAL, INCLUDED; TNH, INCLUDED
ENSG00000264530	RN7SL25P	NA	
ENSG00000237158	AL353718.1	NA	
ENSG00000206147	RPL23AP57	NA	
ENSG00000236924	AL162411.1	NA	
ENSG00000266863	RN7SL123P	NA	
ENSG00000229057	RPS3AP54	NA	
ENSG00000231381	RNF2P1	NA	
ENSG00000232946	AL354707.2	NA	
ENSG00000229611	LINC02851	NA	
ENSG00000225489	AL354707.1	NA	
ENSG00000107077	KDM4C	NA	
ENSG00000231108	PRELID3BP11	NA	
ENSG00000256968	SNRPEP2	NA	
ENSG00000230581	ACTG1P14	NA	
ENSG00000224972	AL513412.1	NA	
ENSG00000285688	AL161443.1	NA	
ENSG00000288042	AL157703.1	NA	
ENSG00000230207	RPL4P5	NA	
ENSG00000178654	PPIAP33	NA	
ENSG00000273056	AL354694.1	NA	
ENSG00000137038	DMAC1	NA	
ENSG00000231902	AL135923.2	NA	
ENSG00000226376	AL135923.1	NA	
ENSG00000153707	PTPRD	NA	
ENSG00000235389	AL583805.2	NA	
ENSG00000212695	AL583805.1	NA	
ENSG00000239102	RNU7-185P	NA	
ENSG00000225706	PTPRD-AS1	NA	
ENSG00000234021	AL596451.1	NA	
ENSG00000212829	RPS26P3	NA	
ENSG00000265735	RN7SL5P	NA	
ENSG00000230920	AL513422.1	NA	
ENSG00000234360	AL135790.2	NA	
ENSG00000226717	PTPRD-AS2	NA	
ENSG00000232035	AL135790.1	NA	
ENSG00000227138	AL161788.1	NA	
ENSG00000230589	IMP3P1	NA	
ENSG00000270372	AL162413.1	NA	
ENSG00000234146	AKAP8P1	NA	
ENSG00000230365	AL451129.1	NA	
ENSG00000286474	AL355672.1	NA	
ENSG00000275130	AL592227.1	NA	
ENSG00000285784	AL353595.1	NA	
ENSG00000224935	AL589678.1	NA	
ENSG00000231491	JKAMPP1	NA	
ENSG00000222581	RNU2-47P	NA	
ENSG00000107165	TYRP1	203290	ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3;;OCULOCUTANEOUS ALBINISM, TYPE III;;ALBINISM III;;RUFOUS OCULOCUTANEOUS ALBINISM; ROCA;;XANTHISM
ENSG00000107165	TYRP1	612271	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11;;MELANESIAN BLOND HAIR;;SKIN/HAIR/EYE PIGMENTATION 11, BLUE/NONBLUE EYES
ENSG00000235448	LURAP1L-AS1	NA	
ENSG00000243115	RN7SL849P	NA	
ENSG00000153714	LURAP1L	NA	
ENSG00000222658	Y_RNA	NA	
ENSG00000285637	AL161449.2	NA	
ENSG00000214121	PRDX1P1	NA	
ENSG00000234586	AL161449.1	NA	
ENSG00000107186	MPDZ	615219	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2;;HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 2, FORMERLY
ENSG00000234740	AL162386.2	NA	
ENSG00000223672	AL162386.1	NA	
ENSG00000226197	AL583785.1	NA	
ENSG00000270547	LINC01235	NA	
ENSG00000288556	AL158157.1	NA	
ENSG00000205636	LINC00583	NA	
ENSG00000229268	PES1P2	NA	
ENSG00000235533	AL360089.1	NA	
ENSG00000223568	RPL3P11	NA	
ENSG00000213954	ATP5PDP3	NA	
ENSG00000147862	NFIB	618286	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID;;MACROCEPHALY, ACQUIRED, WITH MENTAL RETARDATION
ENSG00000234982	AL441963.1	NA	
ENSG00000225472	AL136366.1	NA	
ENSG00000287708	AL137017.1	NA	
ENSG00000237137	AL159169.1	NA	
ENSG00000273399	AL159169.3	NA	
ENSG00000272871	AL159169.2	NA	
ENSG00000229029	CDCA4P1	NA	
ENSG00000175893	ZDHHC21	NA	
ENSG00000147869	CER1	NA	
ENSG00000164946	FREM1	248450	MANITOBA OCULOTRICHOANAL SYNDROME; MOTA;;MARLES SYNDROME
ENSG00000164946	FREM1	608980	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR
ENSG00000164946	FREM1	614485	TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC
ENSG00000286500	AL512643.2	NA	
ENSG00000283647	AL512643.1	NA	
ENSG00000199814	RNU6-1260P	NA	
ENSG00000232000	CLCN3P1	NA	
ENSG00000214110	LDHAP4	NA	
ENSG00000215237	AL592293.1	NA	
ENSG00000234297	AL592293.2	NA	
ENSG00000251960	RNU6-559P	NA	
ENSG00000155158	TTC39B	NA	
ENSG00000215236	RPL7P33	NA	
ENSG00000164975	SNAPC3	NA	
ENSG00000251834	RNU6-319P	NA	
ENSG00000164985	PSIP1	NA	
ENSG00000278754	AL513423.1	NA	
ENSG00000240613	RN7SL98P	NA	
ENSG00000213362	FTH1P12	NA	
ENSG00000207433	RNU6-246P	NA	
ENSG00000164989	CCDC171	NA	
ENSG00000231376	HMGN2P16	NA	
ENSG00000207360	RNU6-14P	NA	
ENSG00000205549	C9orf92	NA	
ENSG00000173068	BNC2	618612	LOWER URINARY TRACT OBSTRUCTION, CONGENITAL; LUTO
ENSG00000231756	AL449983.1	NA	
ENSG00000230694	AL450003.1	NA	
ENSG00000234779	BNC2-AS1	NA	
ENSG00000233551	LSM1P1	NA	
ENSG00000237153	AL162725.2	NA	
ENSG00000285169	AL358117.1	NA	
ENSG00000241152	RN7SL720P	NA	
ENSG00000226470	RPS29P33	NA	
ENSG00000237083	AL162725.1	NA	
ENSG00000044459	CNTLN	NA	
ENSG00000224488	SAMM50P1	NA	
ENSG00000107295	SH3GL2	NA	
ENSG00000228810	PABPC1P11	NA	
ENSG00000178031	ADAMTSL1	NA	
ENSG00000227167	AL442638.1	NA	
ENSG00000264638	MIR3152	NA	
ENSG00000252960	RN7SKP258	NA	
ENSG00000236857	RAP1BP1	NA	
ENSG00000155875	SAXO1	NA	
ENSG00000236680	AL356000.1	NA	
ENSG00000155876	RRAGA	NA	
ENSG00000147874	HAUS6	NA	
ENSG00000251733	SCARNA8	NA	
ENSG00000252943	RNU6-264P	NA	
ENSG00000201118	Y_RNA	NA	
ENSG00000147872	PLIN2	NA	
ENSG00000232176	AL161909.1	NA	
ENSG00000137145	DENND4C	NA	
ENSG00000232978	AL161909.2	NA	
ENSG00000272842	AL391834.1	NA	
ENSG00000273226	AL391834.2	NA	
ENSG00000137154	RPS6	NA	
ENSG00000234853	NDUFA5P3	NA	
ENSG00000285911	AL391834.3	NA	
ENSG00000177076	ACER2	NA	
ENSG00000260912	AL158206.1	NA	
ENSG00000231909	MAP1LC3BP1	NA	
ENSG00000155886	SLC24A2	NA	
ENSG00000232158	C11orf98P1	NA	
ENSG00000286685	AL158077.2	NA	
ENSG00000276667	AL158077.1	NA	
ENSG00000261402	AL591222.1	NA	
ENSG00000270712	AL591222.2	NA	
ENSG00000277711	AL591222.3	NA	
ENSG00000237434	AL512635.1	NA	
ENSG00000171843	MLLT3	NA	
ENSG00000263790	MIR4473	NA	
ENSG00000222202	RNU4-26P	NA	
ENSG00000264941	MIR4474	NA	
ENSG00000237088	AL163193.1	NA	
ENSG00000188352	FOCAD	NA	
ENSG00000227071	FOCAD-AS1	NA	
ENSG00000207609	MIR491	NA	
ENSG00000202189	SNORA30B	NA	
ENSG00000188921	HACD4	NA	
ENSG00000230208	IFNNP1	NA	
ENSG00000171855	IFNB1	NA	
ENSG00000225027	IFNWP4	NA	
ENSG00000275980	AL390882.1	NA	
ENSG00000177047	IFNW1	NA	
ENSG00000199635	Y_RNA	NA	
ENSG00000137080	IFNA21	NA	
ENSG00000232281	IFNWP15	NA	
ENSG00000236637	IFNA4	NA	
ENSG00000226597	IFNWP9	NA	
ENSG00000214042	IFNA7	NA	
ENSG00000186803	IFNA10	NA	
ENSG00000223684	IFNWP18	NA	
ENSG00000147885	IFNA16	NA	
ENSG00000234829	IFNA17	NA	
ENSG00000232138	IFNWP5	NA	
ENSG00000228083	IFNA14	NA	
ENSG00000224416	IFNA22P	NA	
ENSG00000147873	IFNA5	NA	
ENSG00000226393	IFNA20P	NA	
ENSG00000198642	KLHL9	NA	
ENSG00000120235	IFNA6	NA	
ENSG00000233816	IFNA13	NA	
ENSG00000188379	IFNA2	NA	
ENSG00000261696	AL353732.1	NA	
ENSG00000231195	IFNA11P	NA	
ENSG00000235108	IFNA12P	NA	
ENSG00000120242	IFNA8	NA	
ENSG00000288541	AL353732.2	NA	
ENSG00000237691	IFNWP2	NA	
ENSG00000197919	IFNA1	NA	
ENSG00000171889	MIR31HG	NA	
ENSG00000238271	IFNWP19	NA	
ENSG00000184995	IFNE	NA	
ENSG00000199177	MIR31	NA	
ENSG00000264379	SNORD39	NA	
ENSG00000227443	H3P30	NA	
ENSG00000229835	KHSRPP1	NA	
ENSG00000244230	RN7SL151P	NA	
ENSG00000099810	MTAP	112250	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH;;BONE DYSPLASIA WITH MEDULLARY FIBROSARCOMA; BDMF;;BONE DYSPLASIA WITH MALIGNANT FIBROUS HISTIOCYTOMA;;MYOPATHY, LIMB-GIRDLE, WITH BONE FRAGILITY
ENSG00000264545	AL359922.1	NA	
ENSG00000229298	TUBB8P1	NA	
ENSG00000265194	AL359922.2	NA	
ENSG00000279670	AL359922.3	NA	
ENSG00000264801	ERVFRD-3	NA	
ENSG00000224854	CDKN2A-DT	NA	
ENSG00000147889	CDKN2A	155755	MELANOMA-ASTROCYTOMA SYNDROME;;MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME
ENSG00000147889	CDKN2A	155601	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2
ENSG00000147889	CDKN2A	606719	MELANOMA-PANCREATIC CANCER SYNDROME;;FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA-PANCREATIC CARCINOMA SYNDROME; FAMMMPC
ENSG00000240498	CDKN2B-AS1	NA	
ENSG00000266446	AL449423.1	NA	
ENSG00000147883	CDKN2B	NA	
ENSG00000215221	UBA52P6	NA	
ENSG00000274055	AL354709.1	NA	
ENSG00000277653	AL354709.2	NA	
ENSG00000236921	AL157937.1	NA	
ENSG00000176399	DMRTA1	NA	
ENSG00000234840	LINC01239	NA	
ENSG00000284418	AL391117.1	NA	
ENSG00000236739	CLIC4P1	NA	
ENSG00000224549	AC017067.1	NA	
ENSG00000287696	AL357614.1	NA	
ENSG00000283982	AL445623.2	NA	
ENSG00000227607	SUMO2P2	NA	
ENSG00000233906	AL445623.1	NA	
ENSG00000226626	NOP56P2	NA	
ENSG00000107105	ELAVL2	NA	
ENSG00000287843	AL161628.1	NA	
ENSG00000231460	AL365204.1	NA	
ENSG00000237414	AL365204.2	NA	
ENSG00000277608	AL365204.3	NA	
ENSG00000287139	AL513317.1	NA	
ENSG00000205442	IZUMO3	NA	
ENSG00000269957	AL353811.1	NA	
ENSG00000223088	RMRPP5	NA	
ENSG00000222693	RN7SKP120	NA	
ENSG00000287318	AL353730.1	NA	
ENSG00000198680	TUSC1	NA	
ENSG00000236306	LINC01241	NA	
ENSG00000270683	FAM71BP1	NA	
ENSG00000276759	AL353753.1	NA	
ENSG00000279256	AL442639.1	NA	
ENSG00000254261	AL451137.2	NA	
ENSG00000252580	AL451137.1	NA	
ENSG00000253400	AL356133.1	NA	
ENSG00000120159	CAAP1	NA	
ENSG00000232466	H3P31	NA	
ENSG00000240306	RN7SL100P	NA	
ENSG00000137055	PLAA	617527	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA
ENSG00000096872	IFT74	617119	BARDET-BIEDL SYNDROME 20; BBS20
ENSG00000234676	IFT74-AS1	NA	
ENSG00000184434	LRRC19	NA	
ENSG00000254396	AL355432.1	NA	
ENSG00000120156	TEK	600195	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM;;VMCM1
ENSG00000120156	TEK	600975	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B;;GLAUCOMA, PRIMARY CONGENITAL, TYPE B;;GLC3, TYPE B
ENSG00000120156	TEK	617272	GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E
ENSG00000223162	RNA5SP280	NA	
ENSG00000232867	AL355433.1	NA	
ENSG00000283945	LINC00032	NA	
ENSG00000120160	EQTN	NA	
ENSG00000120162	MOB3B	NA	
ENSG00000237734	AL163192.1	NA	
ENSG00000287355	AL451123.2	NA	
ENSG00000147896	IFNK	NA	
ENSG00000285103	AL451123.1	NA	
ENSG00000147894	C9orf72	105550	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1;;FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS;;FRONTOTEMPORAL DEMENTIA AND/OR MOTOR NEURON DISEASE; FTDMND;;AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTE /.../ DEMENTIA; ALSFTD
ENSG00000215441	CTAGE12P	NA	
ENSG00000260390	AL360014.1	NA	
ENSG00000260412	AL353746.1	NA	
ENSG00000174482	LINGO2	NA	
ENSG00000229060	AL451124.1	NA	
ENSG00000287551	AL445526.1	NA	
ENSG00000224955	KCTD10P1	NA	
ENSG00000215966	MIR876	NA	
ENSG00000215939	MIR873	NA	
ENSG00000287038	AL162388.2	NA	
ENSG00000230276	AL162388.1	NA	
ENSG00000277646	AL353684.1	NA	
ENSG00000229834	AL354676.1	NA	
ENSG00000230097	ME2P1	NA	
ENSG00000280683	LINC01242	NA	
ENSG00000232060	SLC4A1APP1	NA	
ENSG00000239792	C2orf27AP2	NA	
ENSG00000215210	RBMXP2	NA	
ENSG00000235626	KRT18P66	NA	
ENSG00000226246	KRT18P36	NA	
ENSG00000233278	RPS26P2	NA	
ENSG00000214020	FTLP4	NA	
ENSG00000228557	HSPA8P17	NA	
ENSG00000223421	AL354854.1	NA	
ENSG00000232203	SLC25A6P2	NA	
ENSG00000260720	LINC01243	NA	
ENSG00000226998	MTATP6P30	NA	
ENSG00000229080	MTCO3P30	NA	
ENSG00000235148	HMGB3P23	NA	
ENSG00000252313	RNA5SP281	NA	
ENSG00000225347	SLC25A5P8	NA	
ENSG00000122729	ACO1	NA	
ENSG00000107201	DDX58	616298	SINGLETON-MERTEN SYNDROME 2; SGMRT2
ENSG00000197579	TOPORS	609923	RETINITIS PIGMENTOSA 31; RP31
ENSG00000235453	SMIM27	NA	
ENSG00000165264	NDUFB6	NA	
ENSG00000232303	DFFBP1	NA	
ENSG00000122728	TAF1L	NA	
ENSG00000223440	AL589642.1	NA	
ENSG00000230516	AL589642.2	NA	
ENSG00000238001	SNRPCP1	NA	
ENSG00000230867	AL157884.1	NA	
ENSG00000188133	TMEM215	NA	
ENSG00000272113	Y_RNA	NA	
ENSG00000236796	AL157884.3	NA	
ENSG00000231193	AL157884.2	NA	
ENSG00000137074	APTX	208920	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH;;ATAXIA-OCULOMOTOR APRAXIA SYNDROME; AOA;;ATAXIA-OCULOMOTOR APRAXIA 1; AOA1;;ATAXIA-TELANGIECTASIA-LIKE SYNDROME;;CEREBELLAR ATAXIA, EARLY-ONSET, WITH HYPOALBUMINEMIA; EOCA-HA AT /.../ADULT-ONSET, WITH OCULOMOTOR APRAXIA, INCLUDED
ENSG00000223807	BOLA3P4	NA	
ENSG00000237437	ASS1P12	NA	
ENSG00000236184	TCEA1P4	NA	
ENSG00000225693	LAGE3P1	NA	
ENSG00000086061	DNAJA1	NA	
ENSG00000122692	SMU1	NA	
ENSG00000086062	B4GALT1	607091	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D;;CDG IId; CDGIId
ENSG00000233554	B4GALT1-AS1	NA	
ENSG00000252224	RNU4ATAC15P	NA	
ENSG00000122711	SPINK4	NA	
ENSG00000107262	BAG1	NA	
ENSG00000086065	CHMP5	NA	
ENSG00000086102	NFX1	NA	
ENSG00000200544	Y_RNA	NA	
ENSG00000165269	AQP7	614411	GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL;;GLYCEROL RELEASE DURING EXERCISE, DEFECTIVE  BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 17, INCLUDED; BMIQ17, INCLUDED
ENSG00000286322	AL356218.2	NA	
ENSG00000165272	AQP3	607457	GIL BLOOD GROUP
ENSG00000270542	AL356218.1	NA	
ENSG00000165271	NOL6	NA	
ENSG00000275651	MIR6851	NA	
ENSG00000226823	SUGT1P1	NA	
ENSG00000228072	AL139008.2	NA	
ENSG00000230453	ANKRD18B	NA	
ENSG00000225123	AL139008.1	NA	
ENSG00000234373	SNX18P7	NA	
ENSG00000226562	CYP4F26P	NA	
ENSG00000204982	PRSS3P4	NA	
ENSG00000205274	TRBV20OR9-2	NA	
ENSG00000231991	ANXA2P2	NA	
ENSG00000183938	TRBV21OR9-2	NA	
ENSG00000234122	TRBV22OR9-2	NA	
ENSG00000229063	TRBV23OR9-2	NA	
ENSG00000215206	TRBV24OR9-2	NA	
ENSG00000240215	TRBV25OR9-2	NA	
ENSG00000237984	PTENP1	NA	
ENSG00000281128	PTENP1-AS	NA	
ENSG00000231165	TRBV26OR9-2	NA	
ENSG00000260947	AL356489.2	NA	
ENSG00000287063	AL356489.3	NA	
ENSG00000227301	AL356489.1	NA	
ENSG00000287495	AL356489.4	NA	
ENSG00000235481	UBE2R2-AS1	NA	
ENSG00000233776	LINC01251	NA	
ENSG00000010438	PRSS3	NA	
ENSG00000223394	TRBV29OR9-2	NA	
ENSG00000107341	UBE2R2	NA	
ENSG00000200834	Y_RNA	NA	
ENSG00000251748	RNU4ATAC11P	NA	
ENSG00000137073	UBAP2	NA	
ENSG00000238300	SNORD121B	NA	
ENSG00000238886	SNORD121A	NA	
ENSG00000226801	OSTCP8	NA	
ENSG00000222259	RN7SKP114	NA	
ENSG00000228352	AL354989.1	NA	
ENSG00000198876	DCAF12	NA	
ENSG00000224802	TUBB4BP2	NA	
ENSG00000239392	AL354989.2	NA	
ENSG00000165006	UBAP1	618418	SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80
ENSG00000227383	AL353662.1	NA	
ENSG00000279336	AL353662.3	NA	
ENSG00000252164	RNA5SP282	NA	
ENSG00000233668	AL353662.2	NA	
ENSG00000186638	KIF24	NA	
ENSG00000222426	RNU2-50P	NA	
ENSG00000229207	SERPINH1P1	NA	
ENSG00000164978	NUDT2	NA	
ENSG00000164976	MYORG	618317	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7
ENSG00000164972	C9orf24	NA	
ENSG00000207032	Y_RNA	NA	
ENSG00000164970	FAM219A	NA	
ENSG00000122735	DNAI1	244400	CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASIS KARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED; /.../RT SYNDROME, INCLUDED
ENSG00000251697	RN7SKP24	NA	
ENSG00000168913	ENHO	NA	
ENSG00000230729	AL160270.1	NA	
ENSG00000232983	AL160270.2	NA	
ENSG00000122756	CNTFR	NA	
ENSG00000237159	CNTFR-AS1	NA	
ENSG00000164967	RPP25L	NA	
ENSG00000137100	DCTN3	NA	
ENSG00000205143	ARID3C	NA	
ENSG00000147955	SIGMAR1	605726	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE;;NEUROPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE; HMNJ;;SPINAL MUSCULAR ATROPHY, JERASH TYPE
ENSG00000147955	SIGMAR1	614373	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16
ENSG00000213930	GALT	230400	GALACTOSEMIA;;GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY;;GALT DEFICIENCY;;GALACTOSEMIA, CLASSIC GALACTOSEMIA, DUARTE VARIANT, INCLUDED
ENSG00000258728	AL162231.3	NA	
ENSG00000137070	IL11RA	614188	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA;;KREIBORG-PAKISTANI SYNDROME
ENSG00000213927	CCL27	NA	
ENSG00000261215	AL162231.4	NA	
ENSG00000187186	AL162231.1	NA	
ENSG00000230074	AL162231.2	NA	
ENSG00000172724	CCL19	NA	
ENSG00000288583	AL162231.5	NA	
ENSG00000137077	CCL21	NA	
ENSG00000205108	FAM205A	NA	
ENSG00000287368	AL589645.1	NA	
ENSG00000257198	FAM205BP	NA	
ENSG00000187791	FAM205C	NA	
ENSG00000178723	GLULP4	NA	
ENSG00000215199	YWHAZP6	NA	
ENSG00000122733	PHF24	NA	
ENSG00000281491	DNAJB5-DT	NA	
ENSG00000137094	DNAJB5	NA	
ENSG00000273597	AL355377.1	NA	
ENSG00000279489	AL355377.2	NA	
ENSG00000233148	SYF2P2	NA	
ENSG00000286782	AL355377.3	NA	
ENSG00000287868	AL355377.4	NA	
ENSG00000279608	AL353795.3	NA	
ENSG00000174038	C9orf131	NA	
ENSG00000241568	RN7SL338P	NA	
ENSG00000165280	VCP	167320	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1;;MULTISYSTEM PROTEINOPATHY 1; MSP1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, WITH PAGET DISEASE OF BONE;;PAGETOID AMYOTROPHIC LATERAL SCLEROSIS;;PAGETO /.../ROSKELETAL SYNDROME;;LOWER MOTOR NEURON DEGENERATION WITH PAGET-LIKE BONE DISEASE
ENSG00000165280	VCP	613954	AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS14
ENSG00000165280	VCP	616687	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2Y;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2Y
ENSG00000221829	FANCG	614082	FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG
ENSG00000165282	PIGO	614749	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 6; GPIBD6
ENSG00000234181	AL353795.2	NA	
ENSG00000165283	STOML2	NA	
ENSG00000005238	FAM214B	NA	
ENSG00000215198	AL353795.1	NA	
ENSG00000198722	UNC13B	NA	
ENSG00000279083	AL160274.1	NA	
ENSG00000179766	ATP8B5P	NA	
ENSG00000244213	ZFAND6P1	NA	
ENSG00000198853	RUSC2	617773	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61;;ALWADEI SYNDROME
ENSG00000287287	AL133476.1	NA	
ENSG00000235619	RPL36AP33	NA	
ENSG00000215187	FAM166B	NA	
ENSG00000227852	RPS29P17	NA	
ENSG00000288586	AL357874.3	NA	
ENSG00000107140	TESK1	NA	
ENSG00000263892	MIR4667	NA	
ENSG00000137101	CD72	NA	
ENSG00000231393	AL357874.2	NA	
ENSG00000227933	AL357874.1	NA	
ENSG00000137078	SIT1	NA	
ENSG00000269900	RMRP	250250	CARTILAGE-HAIR HYPOPLASIA; CHH;;METAPHYSEAL CHONDRODYSPLASIA, MCKUSICK TYPE
ENSG00000269900	RMRP	250460	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSIS OR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV
ENSG00000269900	RMRP	607095	ANAUXETIC DYSPLASIA 1; ANXD1;;ANAUXETIC DYSPLASIA; ANXD;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE
ENSG00000277027	RMRP	NA	
ENSG00000159884	CCDC107	NA	
ENSG00000137135	ARHGEF39	NA	
ENSG00000243136	RN7SL22P	NA	
ENSG00000107159	CA9	NA	
ENSG00000198467	TPM2	108120	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A;;ARTHROGRYPOSIS, DISTAL, TYPE 1; DA1;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE I; AMCD1 ARTHROGRYPOSIS, DISTAL, TYPE 2B4, INCLUDED; DA2B4, INCLUDED
ENSG00000198467	TPM2	255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD;;FIBER-TYPE DISPROPORTION MYOPATHY, CONGENITAL; CFTDM
ENSG00000198467	TPM2	609285	NEMALINE MYOPATHY 4; NEM4 CAP MYOPATHY 2, INCLUDED; CAPM2, INCLUDED
ENSG00000137076	TLN1	NA	
ENSG00000284195	MIR6852	NA	
ENSG00000107175	CREB3	NA	
ENSG00000273945	MIR6853	NA	
ENSG00000070610	GBA2	614409	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46
ENSG00000107185	RGP1	NA	
ENSG00000215183	MSMP	NA	
ENSG00000228843	AL133410.2	NA	
ENSG00000227388	AL133410.1	NA	
ENSG00000159899	NPR2	602875	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM;;ST. HELENA DYSPLASIA
ENSG00000159899	NPR2	615923	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM
ENSG00000159899	NPR2	616255	SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK
ENSG00000137098	SPAG8	NA	
ENSG00000137133	HINT2	NA	
ENSG00000285645	AL133410.3	NA	
ENSG00000137103	TMEM8B	NA	
ENSG00000204930	FAM221B	NA	
ENSG00000236083	OR13E1P	NA	
ENSG00000168828	OR13J1	NA	
ENSG00000233659	NDUFA5P4	NA	
ENSG00000196196	HRCT1	NA	
ENSG00000235387	SPAAR	NA	
ENSG00000287986	AL135841.1	NA	
ENSG00000225639	PGAM1P2	NA	
ENSG00000278889	OR2S2	NA	
ENSG00000228307	OR2S1P	NA	
ENSG00000213866	YBX1P10	NA	
ENSG00000179443	OR13C6P	NA	
ENSG00000243641	OR13C7	NA	
ENSG00000236110	OR2AM1P	NA	
ENSG00000122707	RECK	NA	
ENSG00000276730	AL138834.1	NA	
ENSG00000122694	GLIPR2	NA	
ENSG00000185972	CCIN	NA	
ENSG00000122705	CLTA	NA	
ENSG00000159921	GNE	269921	SIALURIA;;SIALURIA, FRENCH TYPE
ENSG00000159921	GNE	605820	NONAKA MYOPATHY; NM;;NONAKA DISTAL MYOPATHY;;MYOPATHY, DISTAL, WITH OR WITHOUT RIMMED VACUOLES;;INCLUSION BODY MYOPATHY, HEREDITARY, AUTOSOMAL RECESSIVE; HIBM;;INCLUSION BODY MYOPATHY, QUADRICEPS-SPARING; QSM;;GNE MYOPATHY;;INCLUSION BODY MYOPATHY 2 /.../SOMAL RECESSIVE, FORMERLY; IBM2, FORMERLY
ENSG00000222760	RNU4-53P	NA	
ENSG00000215283	HMGB3P24	NA	
ENSG00000137075	RNF38	NA	
ENSG00000165304	MELK	NA	
ENSG00000288571	AL442063.1	NA	
ENSG00000287514	AL450267.2	NA	
ENSG00000266255	MIR4475	NA	
ENSG00000196092	PAX5	615545	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3; ALL3
ENSG00000258885	AL450267.1	NA	
ENSG00000264922	MIR4540	NA	
ENSG00000265368	MIR4476	NA	
ENSG00000250850	AL161781.2	NA	
ENSG00000125385	AL161781.1	NA	
ENSG00000232920	LINC01400	NA	
ENSG00000260100	AL512604.3	NA	
ENSG00000281649	EBLN3P	NA	
ENSG00000233242	AL512604.2	NA	
ENSG00000147905	ZCCHC7	NA	
ENSG00000200502	Y_RNA	NA	
ENSG00000228292	AL512604.1	NA	
ENSG00000206784	Y_RNA	NA	
ENSG00000252723	RNU6-677P	NA	
ENSG00000224648	LINC01627	NA	
ENSG00000137106	GRHPR	260000	HYPEROXALURIA, PRIMARY, TYPE II; HP2;;OXALOSIS II;;GLYCERIC ACIDURIA;;GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE DEFICIENCY;;D-GLYCERATE DEHYDROGENASE DEFICIENCY
ENSG00000236156	CHCHD4P3	NA	
ENSG00000168795	ZBTB5	NA	
ENSG00000187988	KCTD9P3	NA	
ENSG00000137054	POLR1E	NA	
ENSG00000230188	AL158156.1	NA	
ENSG00000234160	AL513165.1	NA	
ENSG00000147912	FBXO10	NA	
ENSG00000256966	AL513165.2	NA	
ENSG00000175768	TOMM5	NA	
ENSG00000255872	AL138752.2	NA	
ENSG00000233111	RAB1C	NA	
ENSG00000070601	FRMPD1	NA	
ENSG00000201287	RN7SKP171	NA	
ENSG00000165275	TRMT10B	NA	
ENSG00000107371	EXOSC3	614678	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B
ENSG00000122741	DCAF10	NA	
ENSG00000232454	AL138752.1	NA	
ENSG00000226055	PAICSP1	NA	
ENSG00000122696	SLC25A51	NA	
ENSG00000213839	TMX2P1	NA	
ENSG00000107338	SHB	NA	
ENSG00000251745	RNU7-124P	NA	
ENSG00000200026	U8	NA	
ENSG00000223716	AL135785.1	NA	
ENSG00000137124	ALDH1B1	NA	
ENSG00000137142	IGFBPL1	NA	
ENSG00000283162	AL390726.5	NA	
ENSG00000225254	ARMC8P1	NA	
ENSG00000215165	TCEA1P3	NA	
ENSG00000229511	GAS2L1P1	NA	
ENSG00000237487	VN1R48P	NA	
ENSG00000243085	AL390726.1	NA	
ENSG00000176007	FAM220BP	NA	
ENSG00000273036	AL390726.4	NA	
ENSG00000283486	FAM95C	NA	
ENSG00000272934	AL390726.3	NA	
ENSG00000272904	AL390726.2	NA	
ENSG00000225345	SNX18P3	NA	
ENSG00000180071	ANKRD18A	NA	
ENSG00000204860	FAM201A	NA	
ENSG00000237557	YWHABP1	NA	
ENSG00000284612	AL591543.1	NA	
ENSG00000252725	RNU6-765P	NA	
ENSG00000283329	FAM240B	NA	
ENSG00000228467	AL845311.1	NA	
ENSG00000287838	AL953883.1	NA	
ENSG00000234680	VN2R3P	NA	
ENSG00000106714	CNTNAP3	NA	
ENSG00000226625	RBM17P1	NA	
ENSG00000271454	AL353729.2	NA	
ENSG00000243695	AL353729.1	NA	
ENSG00000278825	RN7SL640P	NA	
ENSG00000204849	SPATA31A1	NA	
ENSG00000277024	BX005214.3	NA	
ENSG00000215112	FAM74A1	NA	
ENSG00000224038	BX005214.1	NA	
ENSG00000231140	BX005214.2	NA	
ENSG00000198416	ZNF658B	NA	
ENSG00000229707	SKP1P3	NA	
ENSG00000269692	FKBP4P2	NA	
ENSG00000273994	SDR42E1P1	NA	
ENSG00000234720	ATP5F1AP8	NA	
ENSG00000226108	RAB28P1	NA	
ENSG00000232239	RBPJP5	NA	
ENSG00000278175	GLIDR	NA	
ENSG00000229273	BX664615.1	NA	
ENSG00000204837	FGF7P3	NA	
ENSG00000283886	BX664615.2	NA	
ENSG00000277774	RN7SL763P	NA	
ENSG00000252724	CR769767.2	NA	
ENSG00000232798	CR769767.1	NA	
ENSG00000284116	AL772307.1	NA	
ENSG00000184961	RPL7AP49	NA	
ENSG00000237846	AL773545.3	NA	
ENSG00000230804	C2orf27AP3	NA	
ENSG00000228136	AL773545.1	NA	
ENSG00000236966	AL773545.2	NA	
ENSG00000283211	AL773545.4	NA	
ENSG00000283246	MEP1AP1	NA	
ENSG00000183148	ANKRD20A2P	NA	
ENSG00000240240	BX664727.3	NA	
ENSG00000212441	RNU6-1269P	NA	
ENSG00000234812	BX664727.2	NA	
ENSG00000231390	SNX18P8	NA	
ENSG00000223839	FAM95B1	NA	
ENSG00000224681	BX664727.1	NA	
ENSG00000227069	CNN2P2	NA	
ENSG00000232433	GXYLT1P3	NA	
ENSG00000274157	AL591471.1	NA	
ENSG00000278122	AQP7P5	NA	
ENSG00000274067	FP885919.1	NA	
ENSG00000184906	AMYH02020865.1	NA	
ENSG00000276500	BMS1P14	NA	
ENSG00000276266	FP325318.1	NA	
ENSG00000225380	IGKV1OR9-2	NA	
ENSG00000276963	AL353626.3	NA	
ENSG00000278331	RNU6-156P	NA	
ENSG00000275390	AL353626.1	NA	
ENSG00000276868	AL353626.2	NA	
ENSG00000275377	MIR1299	NA	
ENSG00000276291	FRG1HP	NA	
ENSG00000277778	PGM5P2	NA	
ENSG00000280077	AL353763.2	NA	
ENSG00000279456	AL353763.1	NA	
ENSG00000225655	BX255923.1	NA	
ENSG00000276462	BX255923.2	NA	
ENSG00000273514	FOXD4L6	NA	
ENSG00000215126	CBWD6	NA	
ENSG00000276029	MIR4477A	NA	
ENSG00000277049	RNA5SP530	NA	
ENSG00000279561	AL845472.1	NA	
ENSG00000275450	PTGER4P2-CDK2AP2P2	NA	
ENSG00000278647	CDK2AP2P1	NA	
ENSG00000274680	MYO5BP1	NA	
ENSG00000276502	AL354718.2	NA	
ENSG00000276832	AL354718.3	NA	
ENSG00000275160	AL354718.1	NA	
ENSG00000277340	AL591926.3	NA	
ENSG00000276094	SNORA70	NA	
ENSG00000276562	RN7SL565P	NA	
ENSG00000288225	AL591926.7	NA	
ENSG00000278077	AL591926.6	NA	
ENSG00000278054	AL591926.5	NA	
ENSG00000276412	AL591926.2	NA	
ENSG00000275239	FAM242F	NA	
ENSG00000278028	Y_RNA	NA	
ENSG00000274688	AL591926.1	NA	
ENSG00000278001	AL591926.4	NA	
ENSG00000275297	AL162731.1	NA	
ENSG00000154529	CNTNAP3B	NA	
ENSG00000237207	RBM17P3	NA	
ENSG00000270909	CR788268.1	NA	
ENSG00000273717	RN7SL343P	NA	
ENSG00000185775	SPATA31A6	NA	
ENSG00000239986	AL445584.1	NA	
ENSG00000277260	FAM74A7	NA	
ENSG00000276277	AL445584.3	NA	
ENSG00000275649	AL445584.2	NA	
ENSG00000268234	FKBP4P6	NA	
ENSG00000277213	SDR42E1P2	NA	
ENSG00000234861	ATP5F1AP1	NA	
ENSG00000227353	RAB28P3	NA	
ENSG00000227924	RBPJP6	NA	
ENSG00000237357	BX088651.4	NA	
ENSG00000212952	BX088651.1	NA	
ENSG00000229311	BX088651.2	NA	
ENSG00000204816	FGF7P5	NA	
ENSG00000230245	BX088651.3	NA	
ENSG00000216829	FGF7P4	NA	
ENSG00000233424	BX664718.1	NA	
ENSG00000287276	BX664718.2	NA	
ENSG00000204818	ADGRF5P2	NA	
ENSG00000224537	MEP1AP4	NA	
ENSG00000236816	ANKRD20A7P	NA	
ENSG00000286793	CR848007.3	NA	
ENSG00000238529	RNU6-599P	NA	
ENSG00000273900	CR848007.2	NA	
ENSG00000275144	SNX18P5	NA	
ENSG00000230635	CYP4F60P	NA	
ENSG00000229079	CR848007.1	NA	
ENSG00000213816	CNN2P4	NA	
ENSG00000276128	AL591441.1	NA	
ENSG00000277737	FP325317.1	NA	
ENSG00000286506	FP325317.2	NA	
ENSG00000287800	ABBA01045074.2	NA	
ENSG00000286916	ABBA01045074.1	NA	
ENSG00000277598	BX088702.1	NA	
ENSG00000276581	SPATA31A5	NA	
ENSG00000275628	AL590491.1	NA	
ENSG00000274516	FAM74A6	NA	
ENSG00000276422	AL590491.2	NA	
ENSG00000278485	AL590491.3	NA	
ENSG00000283541	BX005040.4	NA	
ENSG00000276040	SPATA31A7	NA	
ENSG00000277412	BX005040.3	NA	
ENSG00000276149	BX005040.2	NA	
ENSG00000274583	FAM74A4	NA	
ENSG00000275676	BX005040.1	NA	
ENSG00000283378	CNTNAP3C	NA	
ENSG00000276522	RN7SL462P	NA	
ENSG00000277109	AL935212.3	NA	
ENSG00000231248	FAM242D	NA	
ENSG00000238933	Y_RNA	NA	
ENSG00000204814	AL935212.1	NA	
ENSG00000231454	AL935212.2	NA	
ENSG00000273940	RN7SL722P	NA	
ENSG00000231527	FAM27C	NA	
ENSG00000204805	AL391987.2	NA	
ENSG00000170152	AL391987.1	NA	
ENSG00000235659	AL391987.4	NA	
ENSG00000223379	AL391987.3	NA	
ENSG00000238749	Y_RNA	NA	
ENSG00000229697	FAM242E	NA	
ENSG00000276845	CR769775.1	NA	
ENSG00000284471	CR769775.2	NA	
ENSG00000231995	AL590399.4	NA	
ENSG00000231212	AL590399.3	NA	
ENSG00000236450	AL590399.6	NA	
ENSG00000252133	SNORA70	NA	
ENSG00000275230	RN7SL544P	NA	
ENSG00000204802	AL590399.1	NA	
ENSG00000227449	FGF7P6	NA	
ENSG00000233651	AL590399.5	NA	
ENSG00000226429	AL590399.2	NA	
ENSG00000224603	BX664725.1	NA	
ENSG00000232827	LINC01189	NA	
ENSG00000204801	FGF7P7	NA	
ENSG00000226007	BX005266.2	NA	
ENSG00000212951	BX005266.1	NA	
ENSG00000278213	CNTNAP3P5	NA	
ENSG00000234217	RBPJP7	NA	
ENSG00000236825	RAB28P2	NA	
ENSG00000234451	BX005266.3	NA	
ENSG00000241571	ATP5F1AP7	NA	
ENSG00000234276	SDR42E1P3	NA	
ENSG00000235256	FKBP4P7	NA	
ENSG00000238113	LINC01410	NA	
ENSG00000287168	AL512625.3	NA	
ENSG00000202474	RNA5SP283	NA	
ENSG00000229422	AL512625.2	NA	
ENSG00000184523	PTGER4P2	NA	
ENSG00000237451	CDK2AP2P2	NA	
ENSG00000234665	LERFS	NA	
ENSG00000238245	MYO5BP2	NA	
ENSG00000227582	ADGRF5P1	NA	
ENSG00000219693	FGF7P8	NA	
ENSG00000170161	AL512625.1	NA	
ENSG00000273509	CNTNAP3P1	NA	
ENSG00000244081	AL591379.2	NA	
ENSG00000198312	BMS1P9	NA	
ENSG00000182021	AL591379.1	NA	
ENSG00000176115	AQP7P4	NA	
ENSG00000237238	BMS1P10	NA	
ENSG00000186466	AQP7P1	NA	
ENSG00000228522	AL845321.1	NA	
ENSG00000233555	AL591438.1	NA	
ENSG00000234042	AL591438.2	NA	
ENSG00000268951	AL772155.3	NA	
ENSG00000224267	AL772155.1	NA	
ENSG00000225360	AL772155.2	NA	
ENSG00000228656	MYO5BP3	NA	
ENSG00000226020	CDK2AP2P3	NA	
ENSG00000239684	PTGER4P3	NA	
ENSG00000225411	CR786580.1	NA	
ENSG00000207277	RNA5SP284	NA	
ENSG00000232815	DUX4L50	NA	
ENSG00000266017	MIR4477B	NA	
ENSG00000215548	FRG1JP	NA	
ENSG00000204790	AL163540.1	NA	
ENSG00000275068	U6	NA	
ENSG00000285580	CR769776.3	NA	
ENSG00000172014	ANKRD20A4P	NA	
ENSG00000238551	RNU6-1193P	NA	
ENSG00000224185	SNX18P9	NA	
ENSG00000229156	CR769776.2	NA	
ENSG00000224106	CYP4F25P	NA	
ENSG00000224762	CR769776.1	NA	
ENSG00000235832	CNN2P3	NA	
ENSG00000235310	GXYLT1P6	NA	
ENSG00000277869	AL773524.1	NA	
ENSG00000181997	AQP7P2	NA	
ENSG00000176134	AL445665.1	NA	
ENSG00000225883	BMS1P11	NA	
ENSG00000235932	AL359955.2	NA	
ENSG00000156755	IGKV1OR-2	NA	
ENSG00000271225	BNIP3P4	NA	
ENSG00000197550	AL359955.1	NA	
ENSG00000223602	AC125634.1	NA	
ENSG00000206804	RNU6-1293P	NA	
ENSG00000287988	FO082814.1	NA	
ENSG00000224599	BMS1P12	NA	
ENSG00000236252	AL512605.1	NA	
ENSG00000267085	AL512605.2	NA	
ENSG00000204780	IGKV1OR9-1	NA	
ENSG00000204779	FOXD4L5	NA	
ENSG00000204778	CBWD4P	NA	
ENSG00000287329	FP326651.1	NA	
ENSG00000276723	Y_RNA	NA	
ENSG00000280286	FRG1KP	NA	
ENSG00000147996	CBWD5	NA	
ENSG00000184659	FOXD4L4	NA	
ENSG00000204776	IGKV1OR-3	NA	
ENSG00000237904	BX284632.2	NA	
ENSG00000235893	BX284632.1	NA	
ENSG00000231701	BMS1P13	NA	
ENSG00000279955	AC129778.1	NA	
ENSG00000279688	AQP7P3	NA	
ENSG00000274893	AL136317.2	NA	
ENSG00000273668	AL136317.1	NA	
ENSG00000275026	GXYLT1P4	NA	
ENSG00000278068	AL136317.3	NA	
ENSG00000278720	AL669942.2	NA	
ENSG00000274628	AL669942.1	NA	
ENSG00000286945	AL513478.4	NA	
ENSG00000229146	SNX18P4	NA	
ENSG00000276203	ANKRD20A3P	NA	
ENSG00000276257	AL513478.1	NA	
ENSG00000275030	RNU6-538P	NA	
ENSG00000284611	AL513478.2	NA	
ENSG00000284658	AL513478.3	NA	
ENSG00000233765	AL591479.1	NA	
ENSG00000274181	RBPJP2	NA	
ENSG00000276894	RAB28P4	NA	
ENSG00000277297	ATP5F1AP10	NA	
ENSG00000273849	SDR42E1P4	NA	
ENSG00000276457	FKBP4P8	NA	
ENSG00000274349	ZNF658	NA	
ENSG00000277490	BX664608.1	NA	
ENSG00000277350	AL353770.4	NA	
ENSG00000276039	AL353770.2	NA	
ENSG00000274355	FAM74A3	NA	
ENSG00000276348	AL353770.3	NA	
ENSG00000274820	AL353770.1	NA	
ENSG00000275969	SPATA31A3	NA	
ENSG00000276386	CNTNAP3P2	NA	
ENSG00000274852	RN7SL422P	NA	
ENSG00000277575	AL162233.1	NA	
ENSG00000273999	RBM17P2	NA	
ENSG00000276204	BX005195.1	NA	
ENSG00000276898	BX664730.1	NA	
ENSG00000275904	Y_RNA	NA	
ENSG00000274026	FAM27E3	NA	
ENSG00000286079	AL627230.3	NA	
ENSG00000278763	FAM27B	NA	
ENSG00000275493	AL627230.1	NA	
ENSG00000274098	RN7SL787P	NA	
ENSG00000278010	SNORA70	NA	
ENSG00000277618	AL627230.2	NA	
ENSG00000260691	ANKRD20A1	NA	
ENSG00000278551	RNU6-368P	NA	
ENSG00000226904	AL353608.2	NA	
ENSG00000196873	CBWD3	NA	
ENSG00000279706	AL353608.4	NA	
ENSG00000187559	FOXD4L3	NA	
ENSG00000234394	AL353608.3	NA	
ENSG00000225337	AL353608.1	NA	
ENSG00000154330	PGM5	NA	
ENSG00000224958	PGM5-AS1	NA	
ENSG00000233178	AL161457.2	NA	
ENSG00000229019	AL161457.1	NA	
ENSG00000181778	TMEM252	NA	
ENSG00000226337	TMEM252-DT	NA	
ENSG00000234506	LINC01506	NA	
ENSG00000224025	AL353616.1	NA	
ENSG00000107242	PIP5K1B	NA	
ENSG00000187866	FAM122A	NA	
ENSG00000236998	AL354794.2	NA	
ENSG00000236733	AL354794.1	NA	
ENSG00000207000	RNU6-820P	NA	
ENSG00000165059	PRKACG	616176	BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19
ENSG00000285130	AL358113.1	NA	
ENSG00000165060	FXN	229300	FRIEDREICH ATAXIA; FRDA;;FRIEDREICH ATAXIA 1; FRDA1;;FA FRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED
ENSG00000270236	AL162730.1	NA	
ENSG00000119139	TJP2	607748	HYPERCHOLANEMIA, FAMILIAL; FHCA
ENSG00000119139	TJP2	615878	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4
ENSG00000278910	BANCR	NA	
ENSG00000135063	FAM189A2	NA	
ENSG00000107282	APBA1	NA	
ENSG00000243888	AL355140.1	NA	
ENSG00000229312	AL353693.1	NA	
ENSG00000261447	AL162412.1	NA	
ENSG00000188647	PTAR1	NA	
ENSG00000225626	C9orf135-DT	NA	
ENSG00000204711	C9orf135	NA	
ENSG00000241174	RN7SL570P	NA	
ENSG00000204706	MAMDC2-AS1	NA	
ENSG00000165072	MAMDC2	NA	
ENSG00000222465	RNU2-5P	NA	
ENSG00000268364	SMC5-AS1	NA	
ENSG00000236801	RPL24P8	NA	
ENSG00000198887	SMC5	NA	
ENSG00000274421	AL162390.1	NA	
ENSG00000239180	Y_RNA	NA	
ENSG00000119138	KLF9	NA	
ENSG00000083067	TRPM3	NA	
ENSG00000272232	RN7SL726P	NA	
ENSG00000232086	AL159990.2	NA	
ENSG00000223966	AL159990.1	NA	
ENSG00000207935	MIR204	616722	RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT; RDICC
ENSG00000224437	PIGUP1	NA	
ENSG00000229814	RPL35AP21	NA	
ENSG00000135048	CEMIP2	NA	
ENSG00000271166	AL671309.1	NA	
ENSG00000107362	ABHD17B	NA	
ENSG00000200922	Y_RNA	NA	
ENSG00000155621	C9orf85	NA	
ENSG00000236060	HSPB1P1	NA	
ENSG00000204669	C9orf57	NA	
ENSG00000286823	AL583829.1	NA	
ENSG00000224820	BTF3P4	NA	
ENSG00000119125	GDA	NA	
ENSG00000235523	AL135924.2	NA	
ENSG00000233933	AL135924.1	NA	
ENSG00000252428	RNA5SP285	NA	
ENSG00000225434	LINC01504	NA	
ENSG00000107372	ZFAND5	NA	
ENSG00000230003	AL445646.1	NA	
ENSG00000225947	AL596448.1	NA	
ENSG00000165091	TMC1	600974	DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7;;DEAFNESS, AUTOSOMAL RECESSIVE 11; DFNB11
ENSG00000165091	TMC1	606705	DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36
ENSG00000236862	RPS20P24	NA	
ENSG00000229753	RPS27AP15	NA	
ENSG00000236849	LINC01474	NA	
ENSG00000165092	ALDH1A1	NA	
ENSG00000228024	CYP1D1P	NA	
ENSG00000135046	ANXA1	NA	
ENSG00000221844	DPP3P2	NA	
ENSG00000286840	AL451127.2	NA	
ENSG00000232590	AL451127.1	NA	
ENSG00000236701	AL512594.1	NA	
ENSG00000212454	RNA5SP286	NA	
ENSG00000223368	AL513124.1	NA	
ENSG00000227809	AL355674.1	NA	
ENSG00000224825	RORB-AS1	NA	
ENSG00000198963	RORB	618357	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15
ENSG00000286944	AL137018.1	NA	
ENSG00000119121	TRPM6	602014	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1;;HOMG;;HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA; HSH;;HYPOMAGNESEMIC TETANY;;HYPOMAGNESEMIA, INTESTINAL, WITH SECONDARY HYPOCALCEMIA
ENSG00000202217	RN7SKP47	NA	
ENSG00000270954	RPSAP75	NA	
ENSG00000252758	RNU6-445P	NA	
ENSG00000224297	AL158825.1	NA	
ENSG00000135045	C9orf40	NA	
ENSG00000203321	CARNMT1-AS1	NA	
ENSG00000156017	CARNMT1	NA	
ENSG00000229587	AL158825.2	NA	
ENSG00000278040	AL158825.3	NA	
ENSG00000106733	NMRK1	NA	
ENSG00000134996	OSTF1	NA	
ENSG00000200041	Y_RNA	NA	
ENSG00000212316	RNU6-1228P	NA	
ENSG00000235707	AL158073.1	NA	
ENSG00000236376	AL353780.1	NA	
ENSG00000234644	OTX2P1	NA	
ENSG00000099139	PCSK5	NA	
ENSG00000231137	RBM22P5	NA	
ENSG00000135002	RFK	NA	
ENSG00000234618	RPSAP9	NA	
ENSG00000187210	GCNT1	NA	
ENSG00000233814	H3P32	NA	
ENSG00000219149	PPIAP87	NA	
ENSG00000106772	PRUNE2	NA	
ENSG00000225937	PCA3	NA	
ENSG00000274326	AL359314.1	NA	
ENSG00000277320	AL390239.1	NA	
ENSG00000286332	AL353637.2	NA	
ENSG00000230335	DNAJB5P1	NA	
ENSG00000236604	LYPLA2P3	NA	
ENSG00000229857	AL353637.1	NA	
ENSG00000204612	FOXB2	NA	
ENSG00000232851	ATP5MFP3	NA	
ENSG00000233526	RFC5P1	NA	
ENSG00000232998	VPS13A-AS1	NA	
ENSG00000197969	VPS13A	200150	CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS
ENSG00000156049	GNA14	NA	
ENSG00000231373	GNA14-AS1	NA	
ENSG00000228248	NUTF2P3	NA	
ENSG00000201711	RNU6-1303P	NA	
ENSG00000156052	GNAQ	185300	STURGE-WEBER SYNDROME; SWS
ENSG00000156052	GNAQ	163000	CAPILLARY MALFORMATIONS, CONGENITAL; CMC;;NEVI FLAMMEI, FAMILIAL MULTIPLE;;PORT-WINE STAIN;;CAPILLARY MALFORMATIONS; CMAL
ENSG00000233457	AL353705.2	NA	
ENSG00000222452	RN7SKP59	NA	
ENSG00000233947	AL353705.3	NA	
ENSG00000228781	AL353705.1	NA	
ENSG00000234819	AL353705.4	NA	
ENSG00000148019	CEP78	617236	CONE-ROD DYSTROPHY AND HEARING LOSS 1; CRDHL1;;CRDHL
ENSG00000135069	PSAT1	610992	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD;;PSAT DEFICIENCY
ENSG00000135069	PSAT1	616038	NEU-LAXOVA SYNDROME 2; NLS2
ENSG00000270627	AL592221.1	NA	
ENSG00000237257	MTND2P8	NA	
ENSG00000226234	KRT18P24	NA	
ENSG00000260995	AL512634.1	NA	
ENSG00000186940	CHCHD2P9	NA	
ENSG00000233086	LNCARSR	NA	
ENSG00000106829	TLE4	NA	
ENSG00000270691	AL161912.3	NA	
ENSG00000238002	NPAP1P6	NA	
ENSG00000232494	AL161912.1	NA	
ENSG00000260564	AL161912.2	NA	
ENSG00000279715	AL161912.4	NA	
ENSG00000280366	AL161782.1	NA	
ENSG00000230945	LINC01507	NA	
ENSG00000236521	NPAP1P4	NA	
ENSG00000232981	MTCO1P51	NA	
ENSG00000225901	MTND2P9	NA	
ENSG00000234637	RPS19P6	NA	
ENSG00000226798	AL138749.1	NA	
ENSG00000228375	RPS20P25	NA	
ENSG00000237072	AL161727.1	NA	
ENSG00000196781	TLE1	NA	
ENSG00000233926	AL591368.1	NA	
ENSG00000207206	RNU6-1035P	NA	
ENSG00000252167	RNA5SP287	NA	
ENSG00000200969	AL158154.1	NA	
ENSG00000240632	SPATA31D5P	NA	
ENSG00000230846	AL158154.2	NA	
ENSG00000189357	SPATA31D4	NA	
ENSG00000267559	AL158154.3	NA	
ENSG00000186788	SPATA31D3	NA	
ENSG00000237770	SPATA31D2P	NA	
ENSG00000228430	AL162726.3	NA	
ENSG00000214929	SPATA31D1	NA	
ENSG00000231649	SPATA31B1P	NA	
ENSG00000230360	DDX10P2	NA	
ENSG00000235377	AL158047.1	NA	
ENSG00000225085	AL162726.1	NA	
ENSG00000228046	MTCO3P40	NA	
ENSG00000228123	AL162726.2	NA	
ENSG00000232749	AL162726.4	NA	
ENSG00000278988	AL356490.1	NA	
ENSG00000286612	AL353774.1	NA	
ENSG00000233309	RPS6P12	NA	
ENSG00000165105	RASEF	NA	
ENSG00000286451	AL499602.1	NA	
ENSG00000251776	RN7SKP242	NA	
ENSG00000273806	AL137847.3	NA	
ENSG00000229109	AL137847.1	NA	
ENSG00000172159	FRMD3	NA	
ENSG00000237529	AL137847.2	NA	
ENSG00000251752	RNU4-29P	NA	
ENSG00000199483	RNU4-15P	NA	
ENSG00000148057	IDNK	NA	
ENSG00000135018	UBQLN1	NA	
ENSG00000254473	AL354920.1	NA	
ENSG00000165113	GKAP1	NA	
ENSG00000226877	AL354733.1	NA	
ENSG00000231616	AL354733.2	NA	
ENSG00000165115	KIF27	NA	
ENSG00000165118	C9orf64	NA	
ENSG00000165119	HNRNPK	616580	AU-KLINE SYNDROME; AUKS
ENSG00000284179	MIR7-1	NA	
ENSG00000235298	AL354733.3	NA	
ENSG00000178966	RMI1	NA	
ENSG00000202523	AL732446.1	NA	
ENSG00000227463	AL390838.1	NA	
ENSG00000270166	AL390838.2	NA	
ENSG00000197506	SLC28A3	NA	
ENSG00000233262	AL356134.1	NA	
ENSG00000285987	AL157886.1	NA	
ENSG00000228095	AL354692.1	NA	
ENSG00000148053	NTRK2	613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD
ENSG00000148053	NTRK2	617830	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58
ENSG00000226590	UBE2V1P10	NA	
ENSG00000285556	AL354897.1	NA	
ENSG00000287930	AL354897.2	NA	
ENSG00000285634	AL583827.1	NA	
ENSG00000227412	STK33P1	NA	
ENSG00000135049	AGTPBP1	618276	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA
ENSG00000234424	AL353743.4	NA	
ENSG00000229454	AL157882.1	NA	
ENSG00000230303	AL353743.2	NA	
ENSG00000165121	AL353743.1	NA	
ENSG00000213711	PHBP7	NA	
ENSG00000231741	AL353743.3	NA	
ENSG00000135040	NAA35	NA	
ENSG00000135052	GOLM1	NA	
ENSG00000287333	AL161447.2	NA	
ENSG00000233713	AL161447.1	NA	
ENSG00000187753	C9orf153	NA	
ENSG00000270688	AL137849.1	NA	
ENSG00000223012	RN7SKP264	NA	
ENSG00000135070	ISCA1	617613	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5
ENSG00000083223	TUT7	NA	
ENSG00000214908	AL353678.1	NA	
ENSG00000235819	AL158828.1	NA	
ENSG00000222293	RNU2-36P	NA	
ENSG00000232211	AL353613.1	NA	
ENSG00000285686	LINC02834	NA	
ENSG00000288575	AL159996.1	NA	
ENSG00000180447	GAS1	NA	
ENSG00000226237	GAS1RR	NA	
ENSG00000269994	AL513318.2	NA	
ENSG00000231007	CDC20P1	NA	
ENSG00000224887	AL513318.1	NA	
ENSG00000204446	LINC02872	NA	
ENSG00000212421	AL136367.1	NA	
ENSG00000228373	AL353752.1	NA	
ENSG00000286842	AL353752.2	NA	
ENSG00000196730	DAPK1	NA	
ENSG00000219928	AL161787.1	NA	
ENSG00000236709	DAPK1-IT1	NA	
ENSG00000135047	CTSL	NA	
ENSG00000237747	AL160279.1	NA	
ENSG00000188029	CTSL3P	NA	
ENSG00000276478	AL772337.4	NA	
ENSG00000237743	FBP2P1	NA	
ENSG00000232743	ELF2P3	NA	
ENSG00000277357	NPAP1P7	NA	
ENSG00000234575	CTSLP8	NA	
ENSG00000233884	AL772337.2	NA	
ENSG00000214888	AL772337.1	NA	
ENSG00000234460	AL772337.3	NA	
ENSG00000177992	SPATA31E1	NA	
ENSG00000230246	SPATA31C1	NA	
ENSG00000238110	AL353572.2	NA	
ENSG00000283205	AL353572.3	NA	
ENSG00000156345	CDK20	NA	
ENSG00000271923	RNU6-86P	NA	
ENSG00000217716	RPS10P3	NA	
ENSG00000287750	AL353572.4	NA	
ENSG00000225385	AL353572.1	NA	
ENSG00000177910	SPATA31C2	NA	
ENSG00000276535	AL353726.1	NA	
ENSG00000279154	AL353726.2	NA	
ENSG00000204429	AL451142.1	NA	
ENSG00000229288	AL451142.2	NA	
ENSG00000226327	RPSAP49	NA	
ENSG00000287769	AL353748.3	NA	
ENSG00000106723	SPIN1	NA	
ENSG00000275017	AL353748.2	NA	
ENSG00000227638	HNRNPA1P14	NA	
ENSG00000231804	AL353748.1	NA	
ENSG00000130045	NXNL2	NA	
ENSG00000228189	LINC02843	NA	
ENSG00000286414	AL390791.1	NA	
ENSG00000265873	MIR4289	NA	
ENSG00000225856	PCNPP2	NA	
ENSG00000228658	AL772202.1	NA	
ENSG00000213694	S1PR3	NA	
ENSG00000148082	SHC3	NA	
ENSG00000224945	AL353150.1	NA	
ENSG00000123975	CKS2	NA	
ENSG00000265112	MIR3153	NA	
ENSG00000187742	SECISBP2	609698	THYROID HORMONE METABOLISM, ABNORMAL; THMA
ENSG00000187764	SEMA4D	NA	
ENSG00000231799	PA2G4P6	NA	
ENSG00000225460	AL590233.1	NA	
ENSG00000285907	AL161910.1	NA	
ENSG00000130222	GADD45G	NA	
ENSG00000237372	UNQ6494	NA	
ENSG00000236507	BX470209.2	NA	
ENSG00000226206	BX470209.1	NA	
ENSG00000237626	AL161629.1	NA	
ENSG00000227555	MIR4290HG	NA	
ENSG00000263967	MIR4290	NA	
ENSG00000234910	IL6RP1	NA	
ENSG00000278382	AL161629.2	NA	
ENSG00000279503	AL353649.1	NA	
ENSG00000185074	OR7E31P	NA	
ENSG00000225072	OR7E116P	NA	
ENSG00000231107	LINC01508	NA	
ENSG00000229613	LINC01501	NA	
ENSG00000165023	DIRAS2	NA	
ENSG00000236316	OR7E109P	NA	
ENSG00000270432	OR7E108P	NA	
ENSG00000165025	SYK	NA	
ENSG00000287212	AL162585.1	NA	
ENSG00000228216	AL355607.1	NA	
ENSG00000260454	AL355607.2	NA	
ENSG00000237422	AL158071.3	NA	
ENSG00000230537	AL158071.2	NA	
ENSG00000229694	LINC00484	NA	
ENSG00000235641	LINC00484	NA	
ENSG00000230147	AL158071.1	NA	
ENSG00000273381	AL158071.4	NA	
ENSG00000148090	AUH	250950	3-@METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1;;MGA, TYPE I; MGA1;;3-@METHYLGLUTACONYL-CoA HYDRATASE DEFICIENCY;;3-@MG-CoA-HYDRATASE DEFICIENCY
ENSG00000165030	NFIL3	NA	
ENSG00000233081	AL353764.1	NA	
ENSG00000169071	ROR2	113000	BRACHYDACTYLY, TYPE B1; BDB1;;BRACHYDACTYLY, TYPE B; BDB
ENSG00000169071	ROR2	268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1; RRS1;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLY ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OF PHALANGES AND METACARPALS/METATARSALS, INCLUDED /.../NOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY, INCLUDED
ENSG00000228595	PAICSP2	NA	
ENSG00000266855	MIR3910-1	NA	
ENSG00000283351	MIR3910-2	NA	
ENSG00000090054	SPTLC1	162400	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A;;HSAN IA;;HSAN1;;NEUROPATHY, HEREDITARY SENSORY, TYPE IA; HSN1A;;HSN IA;;NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL DOMINANT, TYPE 1A
ENSG00000227399	AL391219.1	NA	
ENSG00000237306	HSPE1P22	NA	
ENSG00000275756	AL354751.3	NA	
ENSG00000232179	MTATP6P29	NA	
ENSG00000228069	MTCO3P29	NA	
ENSG00000238288	MTND3P23	NA	
ENSG00000240791	MTND4LP7	NA	
ENSG00000227321	MTND4P15	NA	
ENSG00000234537	AL354751.1	NA	
ENSG00000225511	LINC00475	NA	
ENSG00000236717	AL354751.2	NA	
ENSG00000224809	BEND3P2	NA	
ENSG00000276717	PRSS47	NA	
ENSG00000236115	AL136097.2	NA	
ENSG00000196305	IARS1	NA	
ENSG00000281156	MIR3651	NA	
ENSG00000239183	SNORA84	NA	
ENSG00000198000	NOL8	NA	
ENSG00000188312	CENPP	NA	
ENSG00000229530	AL136097.1	NA	
ENSG00000106809	OGN	NA	
ENSG00000127083	OMD	NA	
ENSG00000106819	ASPN	603932	INTERVERTEBRAL DISC DISEASE; IDD LUMBAR DISC DISEASE, INCLUDED; LDD, INCLUDED;;LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO, INCLUDED;;LUMBAR DISC DEGENERATION, SUSCEPTIBILITY TO, INCLUDED
ENSG00000106819	ASPN	607850	OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3;;OSTEOARTHRITIS OF KNEE/HIP
ENSG00000106823	ECM2	NA	
ENSG00000264158	MIR4670	NA	
ENSG00000225551	AL157827.1	NA	
ENSG00000285650	AL157827.2	NA	
ENSG00000127080	IPPK	NA	
ENSG00000213669	AL137074.1	NA	
ENSG00000185963	BICD2	615290	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT; SMALED2A
ENSG00000185963	BICD2	618291	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B
ENSG00000288062	AL136981.3	NA	
ENSG00000288271	AL136981.4	NA	
ENSG00000187984	ANKRD19P	NA	
ENSG00000252772	RNU6-714P	NA	
ENSG00000226721	EEF1DP2	NA	
ENSG00000275318	AL136981.2	NA	
ENSG00000127081	ZNF484	NA	
ENSG00000226668	AL136981.1	NA	
ENSG00000232843	SNX18P2	NA	
ENSG00000188101	ALOX15P2	NA	
ENSG00000127084	FGD3	NA	
ENSG00000157303	SUSD3	NA	
ENSG00000223446	AL451065.1	NA	
ENSG00000165233	CARD19	NA	
ENSG00000131669	NINJ1	NA	
ENSG00000203364	AL390760.1	NA	
ENSG00000165238	WNK2	NA	
ENSG00000204352	C9orf129	NA	
ENSG00000200570	RNU6-829P	NA	
ENSG00000201074	AL583839.1	NA	
ENSG00000237385	AL583839.2	NA	
ENSG00000188938	FAM120AOS	NA	
ENSG00000048828	FAM120A	NA	
ENSG00000197724	PHF2	NA	
ENSG00000283146	MIR548AU	NA	
ENSG00000231990	AL442224.1	NA	
ENSG00000265347	MIR4291	NA	
ENSG00000131668	BARX1	NA	
ENSG00000235601	BARX1-DT	NA	
ENSG00000158079	PTPDC1	NA	
ENSG00000227666	CYCSP24	NA	
ENSG00000286834	AL360020.1	NA	
ENSG00000286203	AL158152.1	NA	
ENSG00000269929	MIRLET7A1HG	NA	
ENSG00000199165	MIRLET7A1	NA	
ENSG00000199072	MIRLET7F1	NA	
ENSG00000230262	LINC02603	NA	
ENSG00000199133	MIRLET7D	NA	
ENSG00000175787	ZNF169	NA	
ENSG00000237679	VDAC1P11	NA	
ENSG00000130950	NUTM2F	NA	
ENSG00000232063	AL691447.2	NA	
ENSG00000224815	AL691447.1	NA	
ENSG00000282886	PTMAP12	NA	
ENSG00000148110	MFSD14B	NA	
ENSG00000278486	YRDCP1	NA	
ENSG00000286850	AL358232.2	NA	
ENSG00000224245	AL358232.1	NA	
ENSG00000202445	RNU6-669P	NA	
ENSG00000231806	PCAT7	NA	
ENSG00000130957	FBP2	NA	
ENSG00000165140	FBP1	229700	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D
ENSG00000288023	AL157936.1	NA	
ENSG00000148120	AOPEP	NA	
ENSG00000252153	MIR2278	NA	
ENSG00000230815	AL807757.1	NA	
ENSG00000236095	AL807757.2	NA	
ENSG00000224764	AL353768.1	NA	
ENSG00000285807	AL353768.2	NA	
ENSG00000274115	MIR6081	NA	
ENSG00000207563	MIR23B	NA	
ENSG00000207864	MIR27B	NA	
ENSG00000207617	MIR3074	NA	
ENSG00000284459	MIR24-1	NA	
ENSG00000158169	FANCC	227645	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3
ENSG00000229065	AL354893.2	NA	
ENSG00000223849	AL354893.1	NA	
ENSG00000251884	RNA5SP288	NA	
ENSG00000230221	AL157384.1	NA	
ENSG00000271384	AL161729.3	NA	
ENSG00000213761	MT1P1	NA	
ENSG00000185920	PTCH1	109400	BASAL CELL NEVUS SYNDROME; BCNS;;GORLIN SYNDROME;;GORLIN-GOLTZ SYNDROME;;NEVOID BASAL CELL CARCINOMA SYNDROME; NBCCS;;MULTIPLE BASAL CELL NEVI, ODONTOGENIC KERATOCYSTS, AND SKELETAL ANOMALIES
ENSG00000185920	PTCH1	605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1 BASAL CELL CARCINOMA, NONSYNDROMIC, INCLUDED;;BASAL CELL CARCINOMA, MULTIPLE, INCLUDED
ENSG00000185920	PTCH1	610828	HOLOPROSENCEPHALY 7; HPE7
ENSG00000271314	AL161729.2	NA	
ENSG00000271155	AL161729.1	NA	
ENSG00000271659	AL161729.4	NA	
ENSG00000229345	AL392185.1	NA	
ENSG00000228142	AL354861.2	NA	
ENSG00000227358	AL354861.1	NA	
ENSG00000175611	LINC00476	NA	
ENSG00000268926	AL354861.3	NA	
ENSG00000252847	RNU2-46P	NA	
ENSG00000182150	ERCC6L2	615715	BONE MARROW FAILURE SYNDROME 2; BMFS2
ENSG00000199202	RNA5SP289	NA	
ENSG00000237631	AL161454.1	NA	
ENSG00000225194	LINC00092	NA	
ENSG00000237212	AL449403.2	NA	
ENSG00000201938	AL449403.1	NA	
ENSG00000275465	AL449403.3	NA	
ENSG00000287187	AL449403.4	NA	
ENSG00000224546	EIF4BP3	NA	
ENSG00000130948	HSD17B3	264300	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY;;17-@KETOSTEROID REDUCTASE DEFICIENCY OF TESTIS;;17-@KSR DEFICIENCY;;NEUTRAL 17-BETA-HYDROXYSTEROID OXIDOREDUCTASE DEFICIENCY;;PSEUDOHERMAPHRODITISM, MALE, WITH GYNECOMASTIA POLYCYSTIC OVARY SYNDR /.../E TO 17-KETOSTEROID REDUCTASE DEFICIENCY, INCLUDED
ENSG00000285269	AL160269.1	NA	
ENSG00000232283	HSD17B3-AS1	NA	
ENSG00000207276	RNU6-1160P	NA	
ENSG00000130958	SLC35D2	NA	
ENSG00000165244	ZNF367	NA	
ENSG00000238251	NSA2P7	NA	
ENSG00000286835	AL133477.1	NA	
ENSG00000287302	AL133477.2	NA	
ENSG00000130956	HABP4	NA	
ENSG00000081377	CDC14B	NA	
ENSG00000158122	PRXL2C	NA	
ENSG00000224848	AL589843.1	NA	
ENSG00000233820	AL589843.2	NA	
ENSG00000081386	ZNF510	NA	
ENSG00000196597	ZNF782	NA	
ENSG00000196312	MFSD14C	NA	
ENSG00000269907	PTMAP11	NA	
ENSG00000227257	AL158827.1	NA	
ENSG00000188152	NUTM2G	NA	
ENSG00000236745	YRDCP2	NA	
ENSG00000136943	CTSV	NA	
ENSG00000197214	TCEA1P1	NA	
ENSG00000228376	GAS2L1P2	NA	
ENSG00000228038	VN1R51P	NA	
ENSG00000213612	FAM220CP	NA	
ENSG00000277103	AL445670.1	NA	
ENSG00000159712	ANKRD18CP	NA	
ENSG00000252721	RNU6-798P	NA	
ENSG00000242375	AL590705.3	NA	
ENSG00000188801	ZNF322P1	NA	
ENSG00000203279	AL590705.1	NA	
ENSG00000235494	AL590705.2	NA	
ENSG00000255036	STRA6LP	NA	
ENSG00000254876	SUGT1P4-STRA6LP	NA	
ENSG00000254483	SUGT1P4	NA	
ENSG00000254633	AL512590.2	NA	
ENSG00000197816	CCDC180	NA	
ENSG00000221269	MIR1302-8	NA	
ENSG00000228957	AL512590.1	NA	
ENSG00000286375	AL512590.3	NA	
ENSG00000196116	TDRD7	613887	CATARACT 36; CTRCT36;;CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4; CATC4
ENSG00000136842	TMOD1	NA	
ENSG00000228174	AL162385.1	NA	
ENSG00000136925	TSTD2	NA	
ENSG00000136937	NCBP1	NA	
ENSG00000231521	AL162385.2	NA	
ENSG00000136936	XPA	278700	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA;;XP, GROUP A;;XERODERMA PIGMENTOSUM I; XP1
ENSG00000214417	KRT18P13	NA	
ENSG00000236130	PTCSC2	NA	
ENSG00000260677	AL445531.1	NA	
ENSG00000178919	FOXE1	241850	HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE;;BAMFORTH-LAZARUS SYNDROME
ENSG00000178919	FOXE1	616534	THYROID CANCER, NONMEDULLARY, 4; NMTC4
ENSG00000136932	TRMO	NA	
ENSG00000201830	Y_RNA	NA	
ENSG00000287070	AL499604.1	NA	
ENSG00000136929	HEMGN	NA	
ENSG00000136938	ANP32B	NA	
ENSG00000236896	AL354726.1	NA	
ENSG00000212521	RNU6-918P	NA	
ENSG00000095380	NANS	610442	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG;;SEMD, GENEVIEVE TYPE;;NANS DEFICIENCY
ENSG00000106785	TRIM14	NA	
ENSG00000274011	Metazoa_SRP	NA	
ENSG00000106789	CORO2A	NA	
ENSG00000095383	TBC1D2	NA	
ENSG00000278412	MIR6854	NA	
ENSG00000224001	AL360081.1	NA	
ENSG00000136928	GABBR2	188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO;;CIGARETTE HABITUATION, SUSCEPTIBILITY TO;;SMOKING HABIT, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO;;NICOTINE ADDICTION, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, PROTECTION AGAINST
ENSG00000136928	GABBR2	617903	NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS
ENSG00000136928	GABBR2	617904	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59
ENSG00000229897	SEPTIN7P7	NA	
ENSG00000165138	ANKS6	615382	NEPHRONOPHTHISIS 16; NPHP16
ENSG00000285706	AL807776.1	NA	
ENSG00000119514	GALNT12	608812	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1;;COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 9;;COLORECTAL ADENOMA AND CANCER, SUSCEPTIBILITY TO
ENSG00000267026	AL136084.1	NA	
ENSG00000229338	NME2P3	NA	
ENSG00000204291	COL15A1	NA	
ENSG00000270412	AL136084.2	NA	
ENSG00000106799	TGFBR1	132800	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE;;FERGUSON-SMITH-TYPE EPITHELIOMA;;ESS1, FORMERLY
ENSG00000106799	TGFBR1	609192	LOEYS-DIETZ SYNDROME 1; LDS1;;FURLONG SYNDROME;;LOEYS-DIETZ AORTIC ANEURYSM SYNDROME;;AORTIC ANEURYSM, FAMILIAL THORACIC 5; AAT5
ENSG00000252942	RNA5SP290	NA	
ENSG00000227269	AL162427.1	NA	
ENSG00000240235	RN7SL794P	NA	
ENSG00000119523	ALG2	607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I;;CDG Ii; CDGIi
ENSG00000119523	ALG2	616228	MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14;;MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 3; CMSTA3
ENSG00000106803	SEC61B	NA	
ENSG00000222337	RN7SKP225	NA	
ENSG00000255815	KRT8P11	NA	
ENSG00000271086	NAMA	NA	
ENSG00000277828	AL137067.2	NA	
ENSG00000287955	AL137067.3	NA	
ENSG00000277465	AL137067.1	NA	
ENSG00000237461	AL359710.1	NA	
ENSG00000255145	STX17-AS1	NA	
ENSG00000234860	AL162394.1	NA	
ENSG00000119508	NR4A3	612237	CHONDROSARCOMA, EXTRASKELETAL MYXOID;;EMC
ENSG00000136874	STX17	NA	
ENSG00000254571	AL358937.1	NA	
ENSG00000023318	ERP44	NA	
ENSG00000234709	UPF3AP3	NA	
ENSG00000119509	INVS	602088	NEPHRONOPHTHISIS 2; NPHP2;;NPH2
ENSG00000239908	RN7SL75P	NA	
ENSG00000238172	RPS2P35	NA	
ENSG00000270995	AL137072.1	NA	
ENSG00000231697	NANOGP5	NA	
ENSG00000136891	TEX10	NA	
ENSG00000066697	MSANTD3	NA	
ENSG00000251349	MSANTD3-TMEFF1	NA	
ENSG00000241697	TMEFF1	NA	
ENSG00000170681	CAVIN4	NA	
ENSG00000200966	RN7SKP87	NA	
ENSG00000237999	ACTG1P19	NA	
ENSG00000230161	AL162395.1	NA	
ENSG00000229541	GAPDHP26	NA	
ENSG00000148123	PLPPR1	NA	
ENSG00000238143	AL161631.1	NA	
ENSG00000253041	AL359893.2	NA	
ENSG00000227411	ACNATP	NA	
ENSG00000136881	BAAT	607748	HYPERCHOLANEMIA, FAMILIAL; FHCA
ENSG00000236763	TRMT112P4	NA	
ENSG00000230328	AL359893.1	NA	
ENSG00000234502	FYTTD1P1	NA	
ENSG00000136897	MRPL50	NA	
ENSG00000136870	ZNF189	NA	
ENSG00000136872	ALDOB	229600	FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY
ENSG00000270982	AL353621.2	NA	
ENSG00000225376	TMEM246-AS1	NA	
ENSG00000165152	PGAP4	NA	
ENSG00000233055	AL353621.1	NA	
ENSG00000155827	RNF20	NA	
ENSG00000198785	GRIN3A	NA	
ENSG00000188386	PPP3R2	NA	
ENSG00000230302	MTND3P4	NA	
ENSG00000230418	ARL2BPP7	NA	
ENSG00000238882	RNU6-329P	NA	
ENSG00000286243	AL442644.2	NA	
ENSG00000235901	AL442644.1	NA	
ENSG00000204250	LINC00587	NA	
ENSG00000232242	ZYG11AP1	NA	
ENSG00000234269	AL365396.1	NA	
ENSG00000155833	CYLC2	NA	
ENSG00000229830	AL589823.1	NA	
ENSG00000225564	LINC01492	NA	
ENSG00000226566	AL390962.1	NA	
ENSG00000253031	RNA5SP291	NA	
ENSG00000285483	AL590381.1	NA	
ENSG00000270332	SMC2-AS1	NA	
ENSG00000136824	SMC2	NA	
ENSG00000242111	TOPORSLP	NA	
ENSG00000203396	AL512646.1	NA	
ENSG00000186881	OR13F1	NA	
ENSG00000283001	AL450426.1	NA	
ENSG00000148136	OR13C4	NA	
ENSG00000204246	OR13C3	NA	
ENSG00000186943	OR13C8	NA	
ENSG00000237443	OR13D2P	NA	
ENSG00000277556	OR13C5	NA	
ENSG00000276119	OR13C2	NA	
ENSG00000136839	OR13C9	NA	
ENSG00000273423	OR13I1P	NA	
ENSG00000235248	OR13C1P	NA	
ENSG00000179055	OR13D1	NA	
ENSG00000188712	OR13D3P	NA	
ENSG00000136783	NIPSNAP3A	NA	
ENSG00000165028	NIPSNAP3B	NA	
ENSG00000165029	ABCA1	205400	TANGIER DISEASE; TGD;;HIGH DENSITY LIPOPROTEIN DEFICIENCY, TYPE 1; HDLDT1;;HIGH DENSITY LIPOPROTEIN DEFICIENCY, TANGIER TYPE;;ANALPHALIPOPROTEINEMIA
ENSG00000165029	ABCA1	604091	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1;;HYPOALPHALIPOPROTEINEMIA, FAMILIAL; FHA;;HIGH DENSITY LIPOPROTEIN DEFICIENCY; HDLD;;FAMILIAL HDL DEFICIENCY; FHD;;HDL CHOLESTEROL, LOW SERUM; HDLC HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LO /.../, INCLUDED; HDLCQ13, INCLUDED
ENSG00000226334	AL359182.1	NA	
ENSG00000230013	CT70	NA	
ENSG00000286536	AL591506.1	NA	
ENSG00000201583	RN7SKP191	NA	
ENSG00000070214	SLC44A1	NA	
ENSG00000106701	FSD1L	NA	
ENSG00000229419	RALGAPA1P1	NA	
ENSG00000228317	AL158070.1	NA	
ENSG00000106692	FKTN	236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED;;HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA;;HARD SYNDROME;;CEREBROOCULAR DYSPLA /.../SCULAR DYSTROPHY SYNDROME;;COD-MD SYNDROME
ENSG00000106692	FKTN	253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4;;FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; FCMD;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKTN-RELATED
ENSG00000106692	FKTN	611588	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 13; LGMDR13;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2M; LGMD2M
ENSG00000106692	FKTN	611615	CARDIOMYOPATHY, DILATED, 1X; CMD1X;;CARDIOMYOPATHY, DILATED, WITH MILD OR NO PROXIMAL MUSCLE WEAKNESS
ENSG00000106692	FKTN	613152	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4;;MUSCULAR DYSTROPHY, CONGENITAL, FKTN-RELATED
ENSG00000279609	AL158070.2	NA	
ENSG00000186051	TAL2	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMI /.../ELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000095209	TMEM38B	615066	OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14;;OI, TYPE XIV
ENSG00000228366	AL592437.1	NA	
ENSG00000232486	AL592437.2	NA	
ENSG00000228948	SLC25A6P5	NA	
ENSG00000234323	LINC01505	NA	
ENSG00000225002	AL732323.1	NA	
ENSG00000229297	AL451140.1	NA	
ENSG00000277889	MIR8081	NA	
ENSG00000237062	AL512649.2	NA	
ENSG00000200131	RN7SKP77	NA	
ENSG00000228143	AL512649.1	NA	
ENSG00000212276	RNA5SP292	NA	
ENSG00000148143	ZNF462	618619	WEISS-KRUSZKA SYNDROME; WSKA
ENSG00000230782	AL807761.4	NA	
ENSG00000231562	AL512593.1	NA	
ENSG00000223615	AL807761.1	NA	
ENSG00000225531	AL807761.2	NA	
ENSG00000226047	AL807761.3	NA	
ENSG00000226535	AL445487.1	NA	
ENSG00000119318	RAD23B	NA	
ENSG00000226825	LINC01509	NA	
ENSG00000287233	AL359552.1	NA	
ENSG00000213558	HMGN2P32	NA	
ENSG00000199905	RNU6-492P	NA	
ENSG00000136826	KLF4	NA	
ENSG00000236005	AL389915.1	NA	
ENSG00000227350	PPIAP88	NA	
ENSG00000202308	RNU6-996P	NA	
ENSG00000222558	RNU6-1064P	NA	
ENSG00000244104	RN7SL659P	NA	
ENSG00000231293	RPL36AP6	NA	
ENSG00000233727	AL162389.1	NA	
ENSG00000222459	RNA5SP293	NA	
ENSG00000236783	RPS15AP27	NA	
ENSG00000213557	AC068050.1	NA	
ENSG00000237360	CHCHD4P2	NA	
ENSG00000230030	AL353742.1	NA	
ENSG00000169253	AL669983.1	NA	
ENSG00000231678	AL358779.1	NA	
ENSG00000231810	RPL36AP35	NA	
ENSG00000213556	AL359692.1	NA	
ENSG00000148156	ACTL7B	NA	
ENSG00000187003	ACTL7A	NA	
ENSG00000070061	ELP1	223900	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3;;HSAN III;;DYSAUTONOMIA, FAMILIAL; DYS; FD;;RILEY-DAY SYNDROME
ENSG00000119328	ABITRAM	NA	
ENSG00000119326	CTNNAL1	NA	
ENSG00000106771	TMEM245	NA	
ENSG00000199331	AL354797.1	NA	
ENSG00000207698	MIR32	NA	
ENSG00000260230	FRRS1L	616981	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37
ENSG00000095203	EPB41L4B	NA	
ENSG00000200106	RNU6-984P	NA	
ENSG00000237124	MTND2P11	NA	
ENSG00000207329	Y_RNA	NA	
ENSG00000070159	PTPN3	NA	
ENSG00000157654	PALM2AKAP2	NA	
ENSG00000263861	MIR3927	NA	
ENSG00000213539	YBX1P6	NA	
ENSG00000232939	AL158829.1	NA	
ENSG00000228053	AL158823.1	NA	
ENSG00000188959	C9orf152	NA	
ENSG00000136810	TXN	NA	
ENSG00000204193	TXNDC8	NA	
ENSG00000165124	SVEP1	NA	
ENSG00000206658	RNU6-1039P	NA	
ENSG00000232896	AL592463.1	NA	
ENSG00000030304	MUSK	208150	FETAL AKINESIA DEFORMATION SEQUENCE 1; FADS1;;FETAL AKINESIA DEFORMATION SEQUENCE; FADS;;PENA-SHOKEIR SYNDROME, TYPE I;;FETAL AKINESIA SEQUENCE;;ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH PULMONARY HYPOPLASIA
ENSG00000030304	MUSK	616325	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9
ENSG00000223918	AL513328.1	NA	
ENSG00000198121	LPAR1	NA	
ENSG00000206923	RNU6-432P	NA	
ENSG00000207401	Y_RNA	NA	
ENSG00000212409	RNY4P18	NA	
ENSG00000227531	AL162414.1	NA	
ENSG00000274263	MIR7702	NA	
ENSG00000171133	OR2K2	NA	
ENSG00000136813	ECPAS	NA	
ENSG00000223238	RNA5SP294	NA	
ENSG00000173258	ZNF483	NA	
ENSG00000106853	PTGR1	NA	
ENSG00000224644	AL135787.1	NA	
ENSG00000204173	LRRC37A5P	NA	
ENSG00000059769	DNAJC25	NA	
ENSG00000244115	DNAJC25-GNG10	NA	
ENSG00000242616	GNG10	NA	
ENSG00000165181	SHOC1	NA	
ENSG00000224067	AL354877.1	NA	
ENSG00000206907	RNU6-1013P	NA	
ENSG00000148154	UGCG	NA	
ENSG00000266315	MIR4668	NA	
ENSG00000222356	RNU6-710P	NA	
ENSG00000259953	AL138756.1	NA	
ENSG00000106868	SUSD1	NA	
ENSG00000222327	RNU6-855P	NA	
ENSG00000200261	Y_RNA	NA	
ENSG00000225513	AL158824.1	NA	
ENSG00000119314	PTBP3	NA	
ENSG00000242256	RN7SL57P	NA	
ENSG00000199525	RNA5SP295	NA	
ENSG00000243911	RN7SL430P	NA	
ENSG00000230081	HSPE1P28	NA	
ENSG00000213529	AL359073.1	NA	
ENSG00000119471	HSDL2	NA	
ENSG00000230185	C9orf147	NA	
ENSG00000165185	KIAA1958	NA	
ENSG00000250068	AL445187.1	NA	
ENSG00000148153	INIP	NA	
ENSG00000226609	AL390067.1	NA	
ENSG00000148158	SNX30	NA	
ENSG00000119457	SLC46A2	NA	
ENSG00000271631	AL139041.1	NA	
ENSG00000228623	ZNF883	NA	
ENSG00000237906	MUPP	NA	
ENSG00000285447	ZNF883	NA	
ENSG00000136866	ZFP37	NA	
ENSG00000285115	AL162588.1	NA	
ENSG00000284763	AL449105.1	NA	
ENSG00000284962	AL449105.3	NA	
ENSG00000285076	AL449105.4	NA	
ENSG00000284867	AL449105.2	NA	
ENSG00000285370	AL449105.5	NA	
ENSG00000225684	FAM225B	NA	
ENSG00000231528	FAM225A	NA	
ENSG00000136867	SLC31A2	NA	
ENSG00000119321	FKBP15	NA	
ENSG00000136868	SLC31A1	NA	
ENSG00000176386	CDC26	NA	
ENSG00000136875	PRPF4	615922	RETINITIS PIGMENTOSA 70; RP70
ENSG00000165188	RNF183	NA	
ENSG00000148225	WDR31	NA	
ENSG00000119411	BSPRY	NA	
ENSG00000119431	HDHD3	NA	
ENSG00000148218	ALAD	612740	PORPHYRIA, ACUTE HEPATIC;;DELTA-AMINOLEVULINATE DEHYDRATASE DEFICIENCY;;ALAD DEFICIENCY;;PORPHYRIA, ALAD;;PORPHOBILINOGEN SYNTHASE DEFICIENCY;;DOSS PORPHYRIA  LEAD POISONING, SUSCEPTIBILITY TO, INCLUDED
ENSG00000148229	POLE3	NA	
ENSG00000157653	C9orf43	NA	
ENSG00000138835	RGS3	NA	
ENSG00000237073	AL162727.2	NA	
ENSG00000282897	AL162727.3	NA	
ENSG00000233817	AL162727.1	NA	
ENSG00000227482	AL157702.2	NA	
ENSG00000214669	AL157702.1	NA	
ENSG00000232905	AL162393.1	NA	
ENSG00000157657	ZNF618	NA	
ENSG00000106927	AMBP	NA	
ENSG00000136883	KIF12	NA	
ENSG00000196739	COL27A1	615155	STEEL SYNDROME; STLS;;DISLOCATED HIPS AND RADIAL HEADS, CARPAL COALITION, SCOLIOSIS, AND SHORT STATURE
ENSG00000207726	MIR455	NA	
ENSG00000229314	ORM1	NA	
ENSG00000228278	ORM2	NA	
ENSG00000106948	AKNA	NA	
ENSG00000235119	AL138895.1	NA	
ENSG00000095397	WHRN	607084	DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31;;WHIRLER, MOUSE, HOMOLOG OF
ENSG00000095397	WHRN	611383	USHER SYNDROME, TYPE IID; USH2D
ENSG00000271214	AL138895.2	NA	
ENSG00000235797	AL160275.2	NA	
ENSG00000136888	ATP6V1G1	NA	
ENSG00000157693	TMEM268	NA	
ENSG00000201749	Y_RNA	NA	
ENSG00000230054	TEX53	NA	
ENSG00000230601	TEX48	NA	
ENSG00000230284	AL160275.1	NA	
ENSG00000274919	AL390240.1	NA	
ENSG00000181634	TNFSF15	NA	
ENSG00000229817	AL133412.1	NA	
ENSG00000173077	DELEC1	NA	
ENSG00000106952	TNFSF8	NA	
ENSG00000041982	TNC	615629	DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56
ENSG00000236461	AL162425.1	NA	
ENSG00000234692	AL355601.1	NA	
ENSG00000228714	AL691420.1	NA	
ENSG00000274755	U2	NA	
ENSG00000204148	LINC00474	NA	
ENSG00000228707	AL691426.1	NA	
ENSG00000182752	PAPPA	NA	
ENSG00000226604	PAPPA-AS2	NA	
ENSG00000244757	AL137024.1	NA	
ENSG00000256040	PAPPA-AS1	NA	
ENSG00000148219	ASTN2	NA	
ENSG00000229105	ASTN2-AS1	NA	
ENSG00000230894	AL133284.1	NA	
ENSG00000119401	TRIM32	254110	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8; LGMDR8;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H;;MUSCULAR DYSTROPHY, HUTTERITE TYPE;;SARCOTUBULAR MYOPATHY
ENSG00000119401	TRIM32	615988	BARDET-BIEDL SYNDROME 11; BBS11
ENSG00000285820	AL157829.1	NA	
ENSG00000230734	RPL10P3	NA	
ENSG00000207268	SNORA70C	NA	
ENSG00000201140	RN7SKP128	NA	
ENSG00000222413	RN7SKP125	NA	
ENSG00000233516	AL445644.1	NA	
ENSG00000233569	AL161630.1	NA	
ENSG00000235133	RPL35AP22	NA	
ENSG00000285082	AL160272.2	NA	
ENSG00000136869	TLR4	NA	
ENSG00000201444	RNU6-1082P	NA	
ENSG00000284977	AL160272.1	NA	
ENSG00000231901	AL354754.1	NA	
ENSG00000234782	TPT1P9	NA	
ENSG00000225050	AL355592.1	NA	
ENSG00000235201	LINC02578	NA	
ENSG00000231166	TUBB4BP6	NA	
ENSG00000078725	BRINP1	NA	
ENSG00000260970	AC006288.1	NA	
ENSG00000261432	LINC01613	NA	
ENSG00000225960	AL441989.1	NA	
ENSG00000207814	MIR147A	NA	
ENSG00000136861	CDK5RAP2	604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3
ENSG00000106780	MEGF9	NA	
ENSG00000238181	AHCYP2	NA	
ENSG00000119402	FBXW2	NA	
ENSG00000214654	B3GNT10	NA	
ENSG00000270917	AL161911.1	NA	
ENSG00000095261	PSMD5	NA	
ENSG00000226752	CUTALP	NA	
ENSG00000119403	PHF19	NA	
ENSG00000056558	TRAF1	NA	
ENSG00000106804	C5	609536	COMPLEMENT COMPONENT 5 DEFICIENCY; C5D;;C5 DEFICIENCY
ENSG00000106804	C5	615749	ECULIZUMAB, POOR RESPONSE TO
ENSG00000119397	CNTRL	NA	
ENSG00000119396	RAB14	NA	
ENSG00000243738	RN7SL181P	NA	
ENSG00000148180	GSN	105120	AMYLOIDOSIS, FINNISH TYPE;;AMYLOIDOSIS V;;AMYLOIDOSIS, MERETOJA TYPE;;AMYLOID CRANIAL NEUROPATHY WITH LATTICE CORNEAL DYSTROPHY;;AMYLOIDOSIS DUE TO MUTANT GELSOLIN CEREBRAL AMYLOID ANGIOPATHY, GSN-RELATED, INCLUDED;;CORNEAL DYSTROPHY, LATTICE TYPE I /.../LUDED; CDL2, INCLUDED;;LATTICE CORNEAL DYSTROPHY, TYPE II, INCLUDED; LCD2, INCLUDED
ENSG00000214651	AL513122.1	NA	
ENSG00000239593	AL513122.2	NA	
ENSG00000235865	GSN-AS1	NA	
ENSG00000148175	STOM	NA	
ENSG00000227355	AL359644.1	NA	
ENSG00000204136	GGTA1P	NA	
ENSG00000240299	RN7SL187P	NA	
ENSG00000213467	HMGB1P37	NA	
ENSG00000136848	DAB2IP	NA	
ENSG00000229854	AL357936.1	NA	
ENSG00000261534	AL596244.1	NA	
ENSG00000175764	TTLL11	NA	
ENSG00000237548	TTLL11-IT1	NA	
ENSG00000266583	MIR4478	NA	
ENSG00000119421	NDUFA8	NA	
ENSG00000185681	MORN5	NA	
ENSG00000106852	LHX6	NA	
ENSG00000119446	RBM18	NA	
ENSG00000148187	MRRF	NA	
ENSG00000095303	PTGS1	NA	
ENSG00000269970	AL162424.1	NA	
ENSG00000233616	AL359636.1	NA	
ENSG00000234156	AL359636.2	NA	
ENSG00000136834	OR1J1	NA	
ENSG00000197233	OR1J2	NA	
ENSG00000239590	OR1J4	NA	
ENSG00000171505	OR1N1	NA	
ENSG00000171501	OR1N2	NA	
ENSG00000171496	OR1L8	NA	
ENSG00000228914	OR1H1P	NA	
ENSG00000165202	OR1Q1	NA	
ENSG00000280094	OR1B1	NA	
ENSG00000173679	OR1L1	NA	
ENSG00000171481	OR1L3	NA	
ENSG00000226783	TLK1P1	NA	
ENSG00000136939	OR1L4	NA	
ENSG00000171459	OR1L6	NA	
ENSG00000232387	SKA2P1	NA	
ENSG00000148215	OR5C1	NA	
ENSG00000136940	PDCL	NA	
ENSG00000165204	OR1K1	NA	
ENSG00000233425	KRT18P67	NA	
ENSG00000056586	RC3H2	NA	
ENSG00000212447	SNORD90	NA	
ENSG00000186130	ZBTB6	NA	
ENSG00000171448	ZBTB26	NA	
ENSG00000261094	AC007066.2	NA	
ENSG00000286718	AC007066.3	NA	
ENSG00000011454	RABGAP1	NA	
ENSG00000222351	RNY1P15	NA	
ENSG00000213216	AC007066.1	NA	
ENSG00000188394	GPR21	NA	
ENSG00000225078	AL365338.1	NA	
ENSG00000236901	MIR600HG	NA	
ENSG00000165209	STRBP	NA	
ENSG00000283941	MIR600	NA	
ENSG00000148204	CRB2	219730	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD
ENSG00000148204	CRB2	616220	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 9
ENSG00000119522	DENND1A	NA	
ENSG00000207991	MIR601	NA	
ENSG00000274932	MIR7150	NA	
ENSG00000237336	AL445489.1	NA	
ENSG00000230826	AL390774.2	NA	
ENSG00000229115	AL390774.1	NA	
ENSG00000234881	PIGFP2	NA	
ENSG00000106689	LHX2	NA	
ENSG00000236668	AC006450.3	NA	
ENSG00000231227	AC006450.1	NA	
ENSG00000234921	AC006450.2	NA	
ENSG00000119408	NEK6	NA	
ENSG00000235204	AL162724.2	NA	
ENSG00000227200	AL162724.1	NA	
ENSG00000136930	PSMB7	NA	
ENSG00000180264	ADGRD2	NA	
ENSG00000136931	NR5A1	612964	PREMATURE OVARIAN FAILURE 7; POF7 ADRENAL INSUFFICIENCY, NR5A1-RELATED, INCLUDED
ENSG00000136931	NR5A1	612965	46,XY SEX REVERSAL 3; SRXY3;;46,XY SEX REVERSAL, PARTIAL OR COMPLETE, NR5A1-RELATED;;46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, WITH OR WITHOUT ADRENAL FAILURE;;SEX REVERSAL, XY, WITH OR WITHOUT ADRENAL FAILURE;;DISORDER OF SEX DEVELOPMENT, 46,X /.../A1-RELATED
ENSG00000136931	NR5A1	613957	SPERMATOGENIC FAILURE 8; SPGF8
ENSG00000136931	NR5A1	617480	46,XX SEX REVERSAL 4; SRXX4;;46,XX SEX REVERSAL, SRY-NEGATIVE
ENSG00000231149	AL354979.1	NA	
ENSG00000148200	NR6A1	NA	
ENSG00000231744	AL669818.1	NA	
ENSG00000241246	RN7SL302P	NA	
ENSG00000224020	MIR181A2HG	NA	
ENSG00000207595	MIR181A2	NA	
ENSG00000207737	MIR181B2	NA	
ENSG00000236643	AL354928.1	NA	
ENSG00000185585	OLFML2A	NA	
ENSG00000136918	WDR38	NA	
ENSG00000136942	RPL35	618312	DIAMOND-BLACKFAN ANEMIA 19; DBA19
ENSG00000136950	ARPC5L	NA	
ENSG00000136935	GOLGA1	NA	
ENSG00000199313	RNU4-82P	NA	
ENSG00000173611	SCAI	NA	
ENSG00000177736	FXNP2	NA	
ENSG00000119414	PPP6C	NA	
ENSG00000232630	PRPS1P2	NA	
ENSG00000235332	RPSAP76	NA	
ENSG00000136933	RABEPK	NA	
ENSG00000044574	HSPA5	NA	
ENSG00000239705	AL354710.2	NA	
ENSG00000165219	GAPVD1	NA	
ENSG00000214593	AL354710.1	NA	
ENSG00000200554	RNU6-1020P	NA	
ENSG00000227845	AL627223.1	NA	
ENSG00000274510	Metazoa_SRP	NA	
ENSG00000287782	AL359632.1	NA	
ENSG00000119487	MAPKAP1	NA	
ENSG00000243845	RN7SL30P	NA	
ENSG00000227068	AL162584.1	NA	
ENSG00000214761	HNRNPA1P15	NA	
ENSG00000229582	AL358074.1	NA	
ENSG00000167081	PBX3	NA	
ENSG00000232413	AL589923.1	NA	
ENSG00000288537	AL162391.2	NA	
ENSG00000228392	AL162391.1	NA	
ENSG00000196814	MVB12B	NA	
ENSG00000253079	NRON	NA	
ENSG00000252985	SNORD116	NA	
ENSG00000233721	AL356309.2	NA	
ENSG00000279137	AL356309.3	NA	
ENSG00000226078	AL356309.1	NA	
ENSG00000224842	AL161908.1	NA	
ENSG00000136944	LMX1B	161200	NAIL-PATELLA SYNDROME; NPS;;NPS1;;ONYCHOOSTEODYSPLASIA;;TURNER-KIESER SYNDROME;;FONG DISEASE
ENSG00000238010	AL161908.2	NA	
ENSG00000286428	AL161731.1	NA	
ENSG00000169155	ZBTB43	NA	
ENSG00000177125	ZBTB34	NA	
ENSG00000136828	RALGPS1	NA	
ENSG00000136859	ANGPTL2	NA	
ENSG00000228487	AL450263.1	NA	
ENSG00000136895	GARNL3	NA	
ENSG00000229369	AL450263.2	NA	
ENSG00000271833	AL445222.2	NA	
ENSG00000136856	SLC2A8	NA	
ENSG00000196152	ZNF79	NA	
ENSG00000197958	RPL12	NA	
ENSG00000201302	SNORA65	NA	
ENSG00000148356	LRSAM1	614436	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2P;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2G, FORMERLY; CMT2G, FORMERLY
ENSG00000200788	AL445222.1	NA	
ENSG00000136830	NIBAN2	NA	
ENSG00000136854	STXBP1	612164	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4
ENSG00000279571	AL162426.1	NA	
ENSG00000187024	PTRH1	NA	
ENSG00000283874	MIR3911	NA	
ENSG00000160401	CFAP157	NA	
ENSG00000167094	TTC16	NA	
ENSG00000160404	TOR2A	NA	
ENSG00000095370	SH2D3C	NA	
ENSG00000286196	AL162586.2	NA	
ENSG00000136807	CDK9	NA	
ENSG00000283863	MIR3960	NA	
ENSG00000284547	MIR2861	613418	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15;;OSTEOPOROSIS, SUSCEPTIBILITY TO;;METAPHYSEAL FRACTURE, SUSCEPTIBILITY TO;;COMPRESSION FRACTURE, SUSCEPTIBILITY TO
ENSG00000136877	FPGS	NA	
ENSG00000106991	ENG	187300	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1; HHT1;;HHT;;TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASE
ENSG00000225032	AL162586.1	NA	
ENSG00000222421	Y_RNA	NA	
ENSG00000222455	RNA5SP296	NA	
ENSG00000106992	AK1	612631	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
ENSG00000257524	AL157935.2	NA	
ENSG00000263979	MIR4672	NA	
ENSG00000160408	ST6GALNAC6	NA	
ENSG00000136840	ST6GALNAC4	NA	
ENSG00000167103	PIP5KL1	NA	
ENSG00000227218	AL157935.1	NA	
ENSG00000136908	DPM2	615042	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U;;CDG Iu; CDGIu
ENSG00000167106	FAM102A	NA	
ENSG00000230848	AL360268.2	NA	
ENSG00000171169	NAIF1	NA	
ENSG00000148339	SLC25A25	NA	
ENSG00000230536	AL360268.1	NA	
ENSG00000234771	SLC25A25-AS1	NA	
ENSG00000148334	PTGES2	NA	
ENSG00000232850	PTGES2-AS1	NA	
ENSG00000148346	LCN2	NA	
ENSG00000171159	C9orf16	NA	
ENSG00000148337	CIZ1	NA	
ENSG00000106976	DNM1	616346	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31
ENSG00000207581	MIR199B	NA	
ENSG00000264823	MIR3154	NA	
ENSG00000167110	GOLGA2	NA	
ENSG00000175854	SWI5	NA	
ENSG00000167112	TRUB2	NA	
ENSG00000272696	AL359091.3	NA	
ENSG00000167113	COQ4	616276	COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7
ENSG00000167114	SLC27A4	608649	ICHTHYOSIS PREMATURITY SYNDROME; IPS;;ICHTHYOSIS CONGENITA IV
ENSG00000223551	TMSB4XP4	NA	
ENSG00000167118	URM1	NA	
ENSG00000207955	AL359091.1	NA	
ENSG00000284185	MIR219A2	NA	
ENSG00000283335	MIR219B	NA	
ENSG00000167123	CERCAM	NA	
ENSG00000273186	AL359091.4	NA	
ENSG00000228510	AL359091.2	NA	
ENSG00000136811	ODF2	NA	
ENSG00000225951	ODF2-AS1	NA	
ENSG00000119392	GLE1	253310	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1;;LCCS;;MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE
ENSG00000119392	GLE1	611890	CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD;;LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE, FORMERLY; LAAHD, FORMERLY
ENSG00000228395	AL356481.1	NA	
ENSG00000238406	RNU7-171P	NA	
ENSG00000197694	SPTAN1	613477	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5
ENSG00000280474	AL356481.2	NA	
ENSG00000280758	AL356481.3	NA	
ENSG00000119333	WDR34	615633	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11
ENSG00000227759	VTI1BP4	NA	
ENSG00000234705	HMGA1P4	NA	
ENSG00000119335	SET	618106	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58
ENSG00000160447	PKN3	NA	
ENSG00000264438	RN7SL560P	NA	
ENSG00000160446	ZDHHC12	NA	
ENSG00000223478	AL441992.1	NA	
ENSG00000160445	ZER1	NA	
ENSG00000203286	Metazoa_SRP	NA	
ENSG00000107021	TBC1D13	NA	
ENSG00000167136	ENDOG	NA	
ENSG00000198917	SPOUT1	NA	
ENSG00000286112	AL441992.2	NA	
ENSG00000171097	KYAT1	NA	
ENSG00000136802	LRRC8A	613506	AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT
ENSG00000175287	PHYHD1	NA	
ENSG00000251184	AL672142.1	NA	
ENSG00000175283	DOLK	610768	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY
ENSG00000095319	NUP188	618804	SANDESTIG-STEFANOVA SYNDROME; SANDSTEF
ENSG00000267834	AL592211.1	NA	
ENSG00000148341	SH3GLB2	NA	
ENSG00000148343	MIGA2	NA	
ENSG00000287234	AL592211.2	NA	
ENSG00000167130	DOLPP1	NA	
ENSG00000095321	CRAT	617917	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8
ENSG00000234055	AL158151.2	NA	
ENSG00000119383	PTPA	NA	
ENSG00000235007	AL158151.3	NA	
ENSG00000268707	AL158151.4	NA	
ENSG00000188483	IER5L	NA	
ENSG00000204055	AL158151.1	NA	
ENSG00000224307	AL161785.1	NA	
ENSG00000179082	C9orf106	NA	
ENSG00000268615	AL353803.5	NA	
ENSG00000233901	LINC01503	NA	
ENSG00000242281	RN7SL159P	NA	
ENSG00000236146	AL353803.3	NA	
ENSG00000230676	AL353803.2	NA	
ENSG00000226355	AL353803.1	NA	
ENSG00000204054	LINC00963	NA	
ENSG00000261334	AL353803.4	NA	
ENSG00000286078	AL391056.2	NA	
ENSG00000227619	AL391056.1	NA	
ENSG00000148335	NTMT1	NA	
ENSG00000179058	C9orf50	NA	
ENSG00000148331	ASB6	NA	
ENSG00000234789	AL590369.1	NA	
ENSG00000167157	PRRX2	NA	
ENSG00000236024	PRRX2-AS1	NA	
ENSG00000148344	PTGES	NA	
ENSG00000233909	UBE2V1P4	NA	
ENSG00000136816	TOR1B	NA	
ENSG00000136827	TOR1A	128100	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1;;DYSTONIA MUSCULORUM DEFORMANS 1;;EARLY-ONSET TORSION DYSTONIA; EOTD
ENSG00000136819	C9orf78	NA	
ENSG00000136878	USP20	NA	
ENSG00000276124	MIR6855	NA	
ENSG00000224988	AL158207.1	NA	
ENSG00000187239	FNBP1	NA	
ENSG00000230684	AL158207.2	NA	
ENSG00000270755	AL136141.1	NA	
ENSG00000148358	GPR107	NA	
ENSG00000223188	Y_RNA	NA	
ENSG00000196979	GPRACR	NA	
ENSG00000107130	NCS1	NA	
ENSG00000148357	HMCN2	NA	
ENSG00000264169	RN7SL665P	NA	
ENSG00000130707	ASS1	215700	CITRULLINEMIA, CLASSIC;;CITRULLINEMIA, TYPE I; CTLN1;;CITRULLINURIA;;ARGININOSUCCINATE SYNTHETASE DEFICIENCY;;ASS DEFICIENCY
ENSG00000107164	FUBP3	NA	
ENSG00000277713	MIR6856	NA	
ENSG00000232172	AL359092.2	NA	
ENSG00000130711	PRDM12	616488	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8;;HSAN VIII
ENSG00000130713	EXOSC2	617763	SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF
ENSG00000097007	ABL1	608232	LEUKEMIA, CHRONIC MYELOID; CML;;LEUKEMIA, CHRONIC MYELOGENOUS LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATANIB, INCLUDED;;LEUKEMIA, CHRONIC MYELOID, ATYPICAL, INCLUDED; ACML, INCLUDED
ENSG00000097007	ABL1	617602	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM
ENSG00000288570	AL359092.3	NA	
ENSG00000224797	AL359092.1	NA	
ENSG00000188710	QRFP	NA	
ENSG00000130720	FIBCD1	NA	
ENSG00000236658	AL161733.1	NA	
ENSG00000050555	LAMC3	614115	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM
ENSG00000252582	AL583807.1	NA	
ENSG00000126878	AIF1L	NA	
ENSG00000126883	NUP214	601626	LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000126883	NUP214	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMI /.../ELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
ENSG00000126883	NUP214	618426	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9
ENSG00000252622	RNU6-881P	NA	
ENSG00000236986	AL157938.2	NA	
ENSG00000246851	AL157938.3	NA	
ENSG00000226987	AL157938.1	NA	
ENSG00000126882	FAM78A	NA	
ENSG00000286547	AL157938.4	NA	
ENSG00000160539	PLPP7	NA	
ENSG00000285287	AL354855.1	NA	
ENSG00000130723	PRRC2B	NA	
ENSG00000235284	SNORD62A	NA	
ENSG00000231587	SNORD62B	NA	
ENSG00000176868	AL358781.1	NA	
ENSG00000130714	POMT1	236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED;;HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA;;HARD SYNDROME;;CEREBROOCULAR DYSPLA /.../SCULAR DYSTROPHY SYNDROME;;COD-MD SYNDROME
ENSG00000130714	POMT1	609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 11; LGMDR11;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K
ENSG00000130714	POMT1	613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1;;MUSCULAR DYSTROPHY, CONGENITAL, POMT1-RELATED
ENSG00000230289	AL358781.2	NA	
ENSG00000130717	UCK1	NA	
ENSG00000283526	PRRT1B	NA	
ENSG00000107263	RAPGEF1	NA	
ENSG00000240853	RN7SL328P	NA	
ENSG00000231018	EIF4A1P3	NA	
ENSG00000212395	AL160271.1	NA	
ENSG00000236687	AL160271.2	NA	
ENSG00000160563	MED27	NA	
ENSG00000196358	NTNG2	618718	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA; NEDBASH
ENSG00000107290	SETX	602433	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES
ENSG00000107290	SETX	606002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2; SCAN2;;ATAXIA-OCULOMOTOR APRAXIA 2; AOA2;;ATAXIA-OCULAR APRAXIA 2;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1, FORMERLY; SCAR1, FORMERLY
ENSG00000125482	TTF1	NA	
ENSG00000188523	CFAP77	NA	
ENSG00000252521	RNU5D-2P	NA	
ENSG00000125492	BARHL1	NA	
ENSG00000125485	DDX31	NA	
ENSG00000125484	GTF3C4	NA	
ENSG00000165695	AK8	NA	
ENSG00000224992	AL445645.1	NA	
ENSG00000165698	SPACA9	NA	
ENSG00000165699	TSC1	191100	TUBEROUS SCLEROSIS 1; TSC1;;TUBEROUS SCLEROSIS COMPLEX; TSC;;TUBEROSE SCLEROSIS; TS
ENSG00000165699	TSC1	606690	LYMPHANGIOLEIOMYOMATOSIS; LAM;;LYMPHANGIOMYOMATOSIS
ENSG00000165699	TSC1	607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2;;CORTICAL DYSPLASIA OF TAYLOR; CDT;;FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT;;FCD2 FOCAL CORTICAL DYSPLASIA, TYPE IIA, INCLUDED; FCORD2A, INCLUDED;;FCD IIA, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR WITHOUT BAL /.../ELLS, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR, DYSPLASIA ONLY, INCLUDED; CDTD, INCLUDED;;FOCAL CORTICAL DYSPLASIA, TYPE IIB, INCLUDED; FCORD2B, INCLUDED;;FCD IIB, INCLUDED;;CORTICAL DYSPLASIA OF TAYLOR WITH BALLOON CELLS, INCLUDED; CDTBC, INCLUDED
ENSG00000165702	GFI1B	187900	BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17;;THROMBASTHENIA-THROMBOCYTOPENIA, HEREDITARY
ENSG00000263816	MIR548AW	NA	
ENSG00000234907	AL593851.1	NA	
ENSG00000238558	RNU7-21P	NA	
ENSG00000196205	EEF1A1P5	NA	
ENSG00000148308	GTF3C5	NA	
ENSG00000273932	MIR6877	NA	
ENSG00000170835	CEL	609812	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8;;DIABETES AND PANCREATIC EXOCRINE DYSFUNCTION; DPED;;DIABETES-PANCREATIC EXOCRINE DYSFUNCTION SYNDROME
ENSG00000170827	CELP	NA	
ENSG00000160271	RALGDS	NA	
ENSG00000285245	AL162417.1	NA	
ENSG00000148288	GBGT1	NA	
ENSG00000171102	OBP2B	NA	
ENSG00000119440	LCN1P1	NA	
ENSG00000175164	ABO	616093	BLOOD GROUP, ABO SYSTEM;;ABO BLOOD GROUP SYSTEM
ENSG00000201843	Y_RNA	NA	
ENSG00000204031	LCN1P2	NA	
ENSG00000148296	SURF6	NA	
ENSG00000201451	Y_RNA	NA	
ENSG00000148297	MED22	NA	
ENSG00000230064	AL772161.1	NA	
ENSG00000148303	RPL7A	NA	
ENSG00000206611	SNORD24	NA	
ENSG00000200831	SNORD36B	NA	
ENSG00000199744	SNORD36A	NA	
ENSG00000252542	SNORD36C	NA	
ENSG00000148290	SURF1	256000	LEIGH SYNDROME; LS;;NECROTIZING ENCEPHALOPATHY, INFANTILE SUBACUTE, OF LEIGH; SNE LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHON /.../COMPLEX III DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;;LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX V DEFICIENCY, INCLUDED
ENSG00000148290	SURF1	616684	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4K;;CHARCOT-MARIE-TOOTH NEUROPATHY, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4K
ENSG00000148291	SURF2	NA	
ENSG00000148248	SURF4	NA	
ENSG00000198870	STKLD1	NA	
ENSG00000148300	REXO4	NA	
ENSG00000160323	ADAMTS13	274150	THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY; TTP;;THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY, INFANTILE- OR ADULT-ONSET;;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIA /.../HAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL
ENSG00000160325	CACFD1	NA	
ENSG00000160326	SLC2A6	NA	
ENSG00000187616	MYMK	254940	CAREY-FINEMAN-ZITER SYNDROME; CFZS;;MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN SEQUENCE
ENSG00000197859	ADAMTSL2	231050	GELEOPHYSIC DYSPLASIA 1; GPHYSD1
ENSG00000196990	FAM163B	NA	
ENSG00000261018	AC002101.1	NA	
ENSG00000123454	DBH	223360	ORTHOSTATIC HYPOTENSION 1; ORTHYP1;;DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY
ENSG00000225756	DBH-AS1	NA	
ENSG00000123453	SARDH	268900	SARCOSINEMIA; SARCOS;;HYPERSARCOSINEMIA;;SARCOSINE DEHYDROGENASE COMPLEX DEFICIENCY;;SARDH DEFICIENCY; SARDHD;;SARD DEFICIENCY
ENSG00000160293	VAV2	NA	
ENSG00000235106	BRD3OS	NA	
ENSG00000169925	BRD3	NA	
ENSG00000235138	AL445931.1	NA	
ENSG00000271525	ARF4P1	NA	
ENSG00000273249	BX649632.1	NA	
ENSG00000196363	WDR5	NA	
ENSG00000221676	RNU6ATAC	NA	
ENSG00000273473	BX649601.1	NA	
ENSG00000223729	LINC02247	NA	
ENSG00000279929	AL354796.1	NA	
ENSG00000186350	RXRA	NA	
ENSG00000263897	MIR4669	NA	
ENSG00000223795	AL669970.1	NA	
ENSG00000228877	AL669970.3	NA	
ENSG00000227150	AL669970.2	NA	
ENSG00000130635	COL5A1	130010	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2;;EHLERS-DANLOS SYNDROME, TYPE II, FORMERLY; EDS2, FORMERLY;;EHLERS DANLOS SYNDROME, MILD CLASSIC TYPE, FORMERLY;;EDS II, FORMERLY;;EHLERS DANLOS SYNDROME, MITIS TYPE, FORMERLY
ENSG00000130635	COL5A1	130000	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1;;EHLERS-DANLOS SYNDROME, TYPE I, FORMERLY; EDS1, FORMERLY;;EHLERS-DANLOS SYNDROME, SEVERE CLASSIC TYPE, FORMERLY;;EDS I, FORMERLY;;EHLERS-DANLOS SYNDROME, GRAVIS TYPE, FORMERLY
ENSG00000204011	COL5A1-AS1	NA	
ENSG00000286502	AL645768.1	NA	
ENSG00000264744	MIR3689C	NA	
ENSG00000265872	MIR3689A	NA	
ENSG00000265848	MIR3689D1	NA	
ENSG00000264163	MIR3689B	NA	
ENSG00000264136	MIR3689D2	NA	
ENSG00000266827	MIR3689E	NA	
ENSG00000266514	MIR3689F	NA	
ENSG00000232355	AL603650.1	NA	
ENSG00000160339	FCN2	NA	
ENSG00000085265	FCN1	NA	
ENSG00000236403	AL353611.1	NA	
ENSG00000279935	AL353611.2	NA	
ENSG00000130558	OLFM1	NA	
ENSG00000227958	AL390778.1	NA	
ENSG00000233936	AL390778.2	NA	
ENSG00000178243	C9orf62	NA	
ENSG00000235572	AL353615.1	NA	
ENSG00000224682	SOCS5P2	NA	
ENSG00000225361	PPP1R26-AS1	NA	
ENSG00000196422	PPP1R26	NA	
ENSG00000160345	C9orf116	NA	
ENSG00000122140	MRPS2	617950	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36
ENSG00000226706	AL161452.1	NA	
ENSG00000160349	LCN1	NA	
ENSG00000122136	OBP2A	NA	
ENSG00000122133	PAEP	NA	
ENSG00000237339	LINC01502	NA	
ENSG00000224045	PAEPP1	NA	
ENSG00000236543	AL354761.1	NA	
ENSG00000204007	GLT6D1	NA	
ENSG00000148386	LCN9	NA	
ENSG00000165643	SOHLH1	617690	OVARIAN DYSGENESIS 5; ODG5
ENSG00000165643	SOHLH1	618115	SPERMATOGENIC FAILURE 32; SPGF32
ENSG00000107147	KCNT1	614959	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14
ENSG00000107147	KCNT1	615005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5
ENSG00000130559	CAMSAP1	NA	
ENSG00000238058	AL355574.1	NA	
ENSG00000130560	UBAC1	NA	
ENSG00000148411	NACC2	NA	
ENSG00000260193	LINC02846	NA	
ENSG00000238227	TMEM250	NA	
ENSG00000275329	AL138781.1	NA	
ENSG00000107187	LHX3	221750	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3;;PITUITARY HORMONE DEFICIENCY, COMBINED, WITH RIGID CERVICAL SPINE;;DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM
ENSG00000165661	QSOX2	NA	
ENSG00000260220	CCDC187	NA	
ENSG00000279813	CR392000.1	NA	
ENSG00000283769	CR392000.2	NA	
ENSG00000262075	DKFZP434A062	NA	
ENSG00000160360	GPSM1	NA	
ENSG00000213221	DNLZ	NA	
ENSG00000187796	CARD9	212050	CANDIDIASIS, FAMILIAL, 2; CANDF2;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE;;CARD9 IMMUNODEFICIENCY
ENSG00000165684	SNAPC4	NA	
ENSG00000165689	ENTR1	NA	
ENSG00000165688	PMPCA	213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2;;CEREBELLAR HYPOPLASIA, NONPROGRESSIVE NORMAN TYPE;;CEREBELLAR GRANULAR CELL HYPOPLASIA AND MENTAL RETARDATION, CONGENITAL;;CEREBELLOPARENCHYMAL DISORDER III; CPD3;;CPD III
ENSG00000148384	INPP5E	213300	JOUBERT SYNDROME 1; JBTS1;;JOUBERT SYNDROME; JBTS;;JOUBERT-BOLTSHAUSER SYNDROME;;CEREBELLOPARENCHYMAL DISORDER IV; CPD4;;CEREBELLOOCULORENAL SYNDROME 1; CORS1
ENSG00000148384	INPP5E	610156	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS;;MORM SYNDROME
ENSG00000148396	SEC16A	NA	
ENSG00000196366	C9orf163	NA	
ENSG00000148400	NOTCH1	109730	AORTIC VALVE DISEASE 1; AOVD1;;AORTIC VALVE DISEASE; AOVD;;BICUSPID AORTIC VALVE; BAV;;AORTIC VALVE, BICUSPID;;AORTIC VALVE, CALCIFICATION OF;;AORTIC STENOSIS, CALCIFIC
ENSG00000148400	NOTCH1	616028	ADAMS-OLIVER SYNDROME 5; AOS5
ENSG00000263403	MIR4673	NA	
ENSG00000227512	AL592301.1	NA	
ENSG00000265181	MIR4674	NA	
ENSG00000237886	NALT1	NA	
ENSG00000279141	LINC01451	NA	
ENSG00000228401	AL590226.1	NA	
ENSG00000172889	EGFL7	NA	
ENSG00000199161	MIR126	NA	
ENSG00000169692	AGPAT2	608594	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1;;BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 1; BSCL1;;LIPODYSTROPHY, BERARDINELLI-SEIP CONGENITAL, TYPE 1;;BRUNZELL SYNDROME, AGPAT2-RELATED
ENSG00000165716	DIPK1B	NA	
ENSG00000233016	SNHG7	NA	
ENSG00000280496	SNORA17B	NA	
ENSG00000276161	SNORA17B	NA	
ENSG00000274998	SNORA17A	NA	
ENSG00000281808	AL355987.6	NA	
ENSG00000274356	AL355987.5	NA	
ENSG00000187922	LCN10	NA	
ENSG00000204003	AL355987.1	NA	
ENSG00000267206	LCN6	NA	
ENSG00000278756	MIR6722	NA	
ENSG00000204001	LCN8	NA	
ENSG00000177984	LCN15	NA	
ENSG00000224662	ATP6V1G1P3	NA	
ENSG00000244187	TMEM141	NA	
ENSG00000272896	AL355987.3	NA	
ENSG00000213213	CCDC183	NA	
ENSG00000273066	AL355987.4	NA	
ENSG00000272679	AL355987.2	NA	
ENSG00000228544	CCDC183-AS1	NA	
ENSG00000196642	RABL6	NA	
ENSG00000213212	NCLP1	NA	
ENSG00000265806	MIR4292	NA	
ENSG00000232434	AJM1	NA	
ENSG00000054148	PHPT1	NA	
ENSG00000177943	MAMDC4	NA	
ENSG00000107223	EDF1	NA	
ENSG00000127191	TRAF2	NA	
ENSG00000266507	MIR4479	NA	
ENSG00000213590	AL807752.1	NA	
ENSG00000260190	AL807752.5	NA	
ENSG00000159069	FBXW5	NA	
ENSG00000176919	C8G	NA	
ENSG00000184925	LCN12	NA	
ENSG00000198454	LINC02692	NA	
ENSG00000107317	PTGDS	NA	
ENSG00000284341	AL807752.7	NA	
ENSG00000214402	LCNL1	NA	
ENSG00000148362	PAXX	NA	
ENSG00000169583	CLIC3	NA	
ENSG00000107331	ABCA2	618808	INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA
ENSG00000180539	C9orf139	NA	
ENSG00000180549	FUT7	NA	
ENSG00000279073	AL807752.6	NA	
ENSG00000107281	NPDC1	NA	
ENSG00000054179	ENTPD2	NA	
ENSG00000236394	AL807752.4	NA	
ENSG00000229257	AL807752.2	NA	
ENSG00000186193	SAPCD2	NA	
ENSG00000231864	AL807752.3	NA	
ENSG00000197355	UAP1L1	NA	
ENSG00000268996	MAN1B1-DT	NA	
ENSG00000177239	MAN1B1	614202	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15
ENSG00000199411	AL929554.1	NA	
ENSG00000176978	DPP7	NA	
ENSG00000176884	GRIN1	614254	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 8, FORMERLY; MRD8, FORMERLY
ENSG00000176884	GRIN1	617820	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR
ENSG00000184709	LRRC26	NA	
ENSG00000261793	AL929554.2	NA	
ENSG00000263697	MIR3621	NA	
ENSG00000185863	TMEM210	NA	
ENSG00000176248	ANAPC2	NA	
ENSG00000176101	SSNA1	NA	
ENSG00000176058	TPRN	613307	DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79
ENSG00000187713	TMEM203	NA	
ENSG00000188566	NDOR1	NA	
ENSG00000284976	BX255925.3	NA	
ENSG00000212864	RNF208	NA	
ENSG00000197191	CYSRT1	NA	
ENSG00000233198	RNF224	NA	
ENSG00000198569	SLC34A3	241530	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH;;HYPERCALCIURIC RICKETS
ENSG00000188229	TUBB4B	617879	LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD
ENSG00000188163	FAM166A	NA	
ENSG00000275549	STPG3-AS1	NA	
ENSG00000197768	STPG3	NA	
ENSG00000188986	NELFB	NA	
ENSG00000198113	TOR4A	NA	
ENSG00000270259	BX255925.2	NA	
ENSG00000260996	BX255925.1	NA	
ENSG00000288234	BX255925.4	NA	
ENSG00000198435	NRARP	NA	
ENSG00000187609	EXD3	NA	
ENSG00000188747	NOXA1	NA	
ENSG00000188833	ENTPD8	NA	
ENSG00000165802	NSMF	614838	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9
ENSG00000284317	MIR7114	NA	
ENSG00000130653	PNPLA7	NA	
ENSG00000182154	MRPL41	NA	
ENSG00000148399	DPH7	NA	
ENSG00000165724	ZMYND19	NA	
ENSG00000197070	ARRDC1	NA	
ENSG00000283411	AL590627.3	NA	
ENSG00000203993	ARRDC1-AS1	NA	
ENSG00000181090	EHMT1	610253	KLEEFSTRA SYNDROME 1; KLEFS1;;CHROMOSOME 9q34.3 DELETION SYNDROME;;9q- SYNDROME;;9q SUBTELOMERIC DELETION SYNDROME
ENSG00000274841	AL590627.2	NA	
ENSG00000233998	SETP5	NA	
ENSG00000255585	AL590627.1	NA	
ENSG00000207693	MIR602	NA	
ENSG00000203987	AL772363.1	NA	
ENSG00000148408	CACNA1B	618497	NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH
ENSG00000276388	AL591424.2	NA	
ENSG00000229926	AL591424.1	NA	
ENSG00000159247	TUBBP5	NA	
ENSG00000278130	AL591424.3	NA	
ENSG00000237419	AL954642.1	NA	
ENSG00000233013	FAM157B	NA	
ENSG00000223256	RNU6-785P	NA	
ENSG00000250210	FO082796.1	NA	
ENSG00000286255	FO082796.2	NA	
ENSG00000281819	AC022882.2	NA	
ENSG00000263150	OR8J2	NA	
ENSG00000262851	OR5T2	NA	
ENSG00000261897	OR5T3	NA	
ENSG00000262784	OR5T1	NA	
ENSG00000262611	OR8H1	NA	
ENSG00000280712	OR8I1P	NA	
ENSG00000262755	OR8K3	NA	
ENSG00000281773	FAM8A2P	NA	
ENSG00000280617	OR8K2P	NA	
ENSG00000263328	OR8K1	NA	
ENSG00000281820	RPL5P29	NA	
ENSG00000262796	OR8J1	NA	
ENSG00000262315	OR8U8	NA	
ENSG00000281038	OR8U9	NA	
ENSG00000280577	OR8L1P	NA	
ENSG00000261958	OR9G1	NA	
ENSG00000262191	OR9G9	NA	
ENSG00000281683	AP001803.2	NA	
ENSG00000262268	OR9G3P	NA	
ENSG00000262647	OR9G4	NA	
ENSG00000281777	OR9G2P	NA	
ENSG00000281313	OR5G1P	NA	
ENSG00000281279	OR5G4P	NA	
ENSG00000262535	OR5G5P	NA	
ENSG00000281107	OR5G3	NA	
ENSG00000281839	LINC02735	NA	
ENSG00000276777	ARMC4P1	NA	
ENSG00000278036	U6	NA	
ENSG00000275336	AL355493.2	NA	
ENSG00000273501	U6	NA	
ENSG00000273681	FAM210CP	NA	
ENSG00000278364	TRIAP1P1	NA	
ENSG00000276595	PTCHD3	NA	
ENSG00000275985	ANKRD30BP3	NA	
ENSG00000278121	AL512324.2	NA	
ENSG00000282156	AL512324.4	NA	
ENSG00000275615	RNU6-1207P	NA	
ENSG00000273495	CUBNP2	NA	
ENSG00000274650	OR6D1P	NA	
ENSG00000277495	OR13A1	NA	
ENSG00000275565	ALOX5	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000276446	AL731567.2	NA	
ENSG00000278545	MARCHF8	NA	
ENSG00000282764	KSR1P1	NA	
ENSG00000282178	IGKV1OR10-1	NA	
ENSG00000282271	AL031601.3	NA	
ENSG00000282372	PABPC1P8	NA	
ENSG00000276274	RNU6-1266P	NA	
ENSG00000282534	IMPDH1P5	NA	
ENSG00000282233	AL450306.2	NA	
ENSG00000274429	DLG5	NA	
ENSG00000282690	AL391421.2	NA	
ENSG00000276516	RN7SL284P	NA	
ENSG00000282770	DLG5-AS1	NA	
ENSG00000281427	AC044810.6	NA	
ENSG00000276025	OR5P2	NA	
ENSG00000278253	OR5P3	NA	
ENSG00000280497	OR5E1P	NA	
ENSG00000281367	AC044810.5	NA	
ENSG00000278379	U6	NA	
ENSG00000276451	OR10A6	NA	
ENSG00000273953	OR10A3	NA	
ENSG00000276780	NLRP10	NA	
ENSG00000273793	DUSP8	NA	
ENSG00000281801	KRTAP5-AS1	NA	
ENSG00000276565	AP006285.2	NA	
ENSG00000278210	KRTAP5-1	NA	
ENSG00000278489	KRTAP5-2	NA	
ENSG00000275920	KRTAP5-3	NA	
ENSG00000277068	KRTAP5-4	NA	
ENSG00000277291	KRTAP5-5	NA	
ENSG00000281645	AP006285.3	NA	
ENSG00000281733	FAM99A	NA	
ENSG00000281783	FAM99B	NA	
ENSG00000281240	LINC02708	NA	
ENSG00000282076	KCNQ1	130650	BECKWITH-WIEDEMANN SYNDROME; BWS;;EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;;EMG SYNDROME;;WIEDEMANN-BECKWITH SYNDROME; WBS BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
ENSG00000282076	KCNQ1	192500	LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVAL LONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO,  /.../ED
ENSG00000282076	KCNQ1	220400	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1;;DEAFNESS, CONGENITAL, AND FUNCTIONAL HEART DISEASE;;PROLONGED QT INTERVAL IN EKG AND SUDDEN DEATH;;CARDIOAUDITORY SYNDROME OF JERVELL AND LANGE-NIELSEN;;SURDO-CARDIAC SYNDROME
ENSG00000282076	KCNQ1	607554	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3
ENSG00000282076	KCNQ1	609621	SHORT QT SYNDROME 2; SQT2
ENSG00000282441	COX6CP18	NA	
ENSG00000282343	KCNQ1-AS1	NA	
ENSG00000278855	KCNQ1DN	NA	
ENSG00000275660	AC001228.1	NA	
ENSG00000273707	CDKN1C	130650	BECKWITH-WIEDEMANN SYNDROME; BWS;;EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;;EMG SYNDROME;;WIEDEMANN-BECKWITH SYNDROME; WBS BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
ENSG00000273707	CDKN1C	614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE;;IMAGE SYNDROME
ENSG00000274454	SLC22A18AS	NA	
ENSG00000276130	SLC22A18	114480	BREAST CANCER;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
ENSG00000276130	SLC22A18	211980	LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;;ADENOCARCINOMA OF LUNG, INCLUDED;;NONSMALL CELL LUNG CANCER, INCLUDED;;LUNG CANCER, PROTECTION AGAINST, INCLUDED
ENSG00000276130	SLC22A18	268210	RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1;;RHABDOMYOSARCOMA 1; RMS1;;RHABDOMYOSARCOMA CHROMOSOMAL REGION; RMSCR
ENSG00000274538	PHLDA2	NA	
ENSG00000273562	NAP1L4	NA	
ENSG00000273525	SNORA54	NA	
ENSG00000282438	AC001228.2	NA	
ENSG00000278191	CARS1	NA	
ENSG00000282355	CARS1-AS1	NA	
ENSG00000275205	U1	NA	
ENSG00000282367	PTDSS2	NA	
ENSG00000276230	RNH1	NA	
ENSG00000282464	AC137894.2	NA	
ENSG00000276536	HRAS	163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM;;SFM SYNDROME;;LINEAR SEBACEOUS NEVUS SYNDROME;;SEBACEOUS NEVUS SYNDROME, LINEAR;;JADASSOHN NEVUS PHAKOMATOSIS; JNP;;NEVUS SEBACEUS OF JADASSOHN;;ORGANOID NEVUS PHAKOMATOSIS;;EPIDERMAL NEVUS SYNDROME, FORMERLY
ENSG00000276536	HRAS	162900	NEVUS, EPIDERMAL;;NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC  NEVUS SEBACEOUS, INCLUDED;;NEVUS, WOOLLY HAIR, INCLUDED
ENSG00000276536	HRAS	137550	MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS;;GIANT PIGMENTED HAIRY NEVUS; GPHN;;GIANT CONGENITAL PIGMENTED NEVUS;;PIGMENTED MOLES NEVUS SPILUS, INCLUDED;;SPITZ NEVUS, INCLUDED
ENSG00000276536	HRAS	109800	BLADDER CANCER
ENSG00000276536	HRAS	188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2
ENSG00000276536	HRAS	218040	COSTELLO SYNDROME; CSTLO;;FACIOCUTANEOSKELETAL SYNDROME;;FCS SYNDROME  MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES, INCLUDED; CMEMS, INCLUDED
ENSG00000273831	LRRC56	618254	CILIARY DYSKINESIA, PRIMARY, 39; CILD39;;CILIARY DYSKINESIA, PRIMARY, 39, WITH OR WITHOUT SITUS INVERSUS
ENSG00000275873	LMNTD2	NA	
ENSG00000282005	LMNTD2-AS1	NA	
ENSG00000273859	RASSF7	NA	
ENSG00000282810	MIR210HG	NA	
ENSG00000274780	PHRF1	NA	
ENSG00000276561	IRF7	616345	IMMUNODEFICIENCY 39; IMD39
ENSG00000273572	CDHR5	NA	
ENSG00000274473	SCT	NA	
ENSG00000276825	DRD4	143465	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD;;HYPERACTIVITY OF CHILDHOOD
ENSG00000282712	DEAF1	615828	MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24
ENSG00000282712	DEAF1	617171	DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; DYSEIDD
ENSG00000282598	AC138374.1	NA	
ENSG00000280759	AP2A2	NA	
ENSG00000274980	RNU6-1025P	NA	
ENSG00000277518	MUC6	NA	
ENSG00000278165	DUSP8	NA	
ENSG00000281176	KRTAP5-AS1	NA	
ENSG00000280585	KRTAP5-1	NA	
ENSG00000281533	KRTAP5-2	NA	
ENSG00000281191	KRTAP5-3	NA	
ENSG00000278620	KRTAP5-4	NA	
ENSG00000278302	KRTAP5-5	NA	
ENSG00000281111	AC130310.1	NA	
ENSG00000281261	FAM99A	NA	
ENSG00000281829	FAM99B	NA	
ENSG00000281633	LINC02708	NA	
ENSG00000277389	KRTAP5-6	NA	
ENSG00000281618	IFITM10	NA	
ENSG00000281385	AP2A2	NA	
ENSG00000276186	RNU6-1025P	NA	
ENSG00000277281	MUC6	NA	
ENSG00000281524	LINC02688	NA	
ENSG00000278466	MUC2	NA	
ENSG00000272877	DDX11L8	NA	
ENSG00000262435	WASH8P	NA	
ENSG00000262927	FAM138D	NA	
ENSG00000262607	IQSEC3	NA	
ENSG00000282676	AC026369.8	NA	
ENSG00000262226	AC026369.6	NA	
ENSG00000263137	AC026369.7	NA	
ENSG00000262016	AC026369.4	NA	
ENSG00000262193	AC026369.5	NA	
ENSG00000262349	GIHCG	NA	
ENSG00000262145	ATP23	NA	
ENSG00000262819	AC084033.4	NA	
ENSG00000262776	RN7SKP65	NA	
ENSG00000262082	AC084033.3	NA	
ENSG00000262201	LINC02403	NA	
ENSG00000273326	TAS2R7	NA	
ENSG00000272712	TAS2R8	NA	
ENSG00000273086	TAS2R9	NA	
ENSG00000263247	PRR4	NA	
ENSG00000272805	TAS2R10	NA	
ENSG00000272718	AC006518.3	NA	
ENSG00000272751	AC006518.4	NA	
ENSG00000273457	TAS2R13	NA	
ENSG00000272803	PRH2	NA	
ENSG00000261984	TAS2R14	NA	
ENSG00000273144	TAS2R15P	NA	
ENSG00000273431	TAS2R50	NA	
ENSG00000273092	TAS2R20	NA	
ENSG00000263028	TAS2R19	NA	
ENSG00000263097	TAS2R31	NA	
ENSG00000263158	TAS2R63P	NA	
ENSG00000262525	TAS2R46	NA	
ENSG00000263083	TAS2R64P	NA	
ENSG00000262612	TAS2R45	NA	
ENSG00000262293	AC242308.1	NA	
ENSG00000262829	AC242308.2	NA	
ENSG00000261936	TAS2R45	NA	
ENSG00000262111	TAS2R30	NA	
ENSG00000261853	AC134349.3	NA	
ENSG00000262531	AC134349.4	NA	
ENSG00000262986	SMIM10L1	NA	
ENSG00000262159	RPS6P22	NA	
ENSG00000262036	AC068305.3	NA	
ENSG00000262592	AC068305.4	NA	
ENSG00000274327	TAS2R7	NA	
ENSG00000277316	TAS2R8	NA	
ENSG00000273713	TAS2R9	NA	
ENSG00000277823	PRH1	NA	
ENSG00000277238	TAS2R10	NA	
ENSG00000282174	AC006518.5	NA	
ENSG00000282269	PRR4	NA	
ENSG00000277454	AC245078.1	NA	
ENSG00000282363	AC006518.6	NA	
ENSG00000277254	TAS2R13	NA	
ENSG00000275679	PRH2	NA	
ENSG00000276541	TAS2R14	NA	
ENSG00000276217	TAS2R15P	NA	
ENSG00000276167	TAS2R50	NA	
ENSG00000282612	TAS2R20	NA	
ENSG00000278307	TAS2R19	NA	
ENSG00000282256	TAS2R31	NA	
ENSG00000282293	TAS2R63P	NA	
ENSG00000278111	TAS2R46	NA	
ENSG00000282079	TAS2R64P	NA	
ENSG00000282537	TAS2R45	NA	
ENSG00000274699	TAS2R30	NA	
ENSG00000282675	AC245078.3	NA	
ENSG00000282546	AC245078.2	NA	
ENSG00000281930	SMIM10L1	NA	
ENSG00000273505	TAS2R42	NA	
ENSG00000281977	AC244131.3	NA	
ENSG00000282539	AC244131.4	NA	
ENSG00000275624	PRB3	NA	
ENSG00000274839	PRB4	NA	
ENSG00000282673	PRB1	NA	
ENSG00000262139	ANO4	NA	
ENSG00000262217	SLC5A8	NA	
ENSG00000261867	U6	NA	
ENSG00000263114	AC079953.2	NA	
ENSG00000275428	AC024940.6	NA	
ENSG00000282391	AC024940.8	NA	
ENSG00000282388	AC024940.7	NA	
ENSG00000282329	MREGP1	NA	
ENSG00000276371	SINHCAF	NA	
ENSG00000282551	AC024940.9	NA	
ENSG00000282176	FLJ13224	NA	
ENSG00000278208	AC007368.2	NA	
ENSG00000278711	AC007368.3	NA	
ENSG00000276226	LINC02825	NA	
ENSG00000275517	PRB1	NA	
ENSG00000275051	PIWIL1	NA	
ENSG00000282480	AC127071.3	NA	
ENSG00000282766	AC217627.1	NA	
ENSG00000281935	DNAH10	NA	
ENSG00000275035	CCDC92	NA	
ENSG00000281954	AC208069.1	NA	
ENSG00000282647	LINC01070	NA	
ENSG00000282706	LINC01043	NA	
ENSG00000282737	LINC01044	NA	
ENSG00000275865	SPACA7	NA	
ENSG00000282003	TUBGCP3	NA	
ENSG00000282037	GXYLT1P1	NA	
ENSG00000282611	CNN2P12	NA	
ENSG00000282352	ZNF965P	NA	
ENSG00000282782	CYP4F34P	NA	
ENSG00000282677	SNX18P26	NA	
ENSG00000282536	LINC00328-2P	NA	
ENSG00000282715	ANKRD20A9P	NA	
ENSG00000278853	RNU6-55P	NA	
ENSG00000252379	U6	NA	
ENSG00000281988	GRK1	613411	OGUCHI DISEASE 2;;NIGHT BLINDNESS, CONGENITAL STATIONARY, OGUCHI TYPE 2; CSNBO2
ENSG00000282664	LINC00552	NA	
ENSG00000282107	TMEM255B	NA	
ENSG00000282311	AL133373.4	NA	
ENSG00000280633	AL133373.3	NA	
ENSG00000274338	CATSPERB	NA	
ENSG00000281924	POLR3GP1	NA	
ENSG00000276238	NANOGP7	NA	
ENSG00000282153	AL121839.3	NA	
ENSG00000274581	U3	NA	
ENSG00000282241	AL121839.4	NA	
ENSG00000276776	TC2N	NA	
ENSG00000276342	TMEM179	NA	
ENSG00000274126	C14orf180	NA	
ENSG00000281161	BX927359.2	NA	
ENSG00000282751	ATP5MC1P1	NA	
ENSG00000282219	ELK2BP	NA	
ENSG00000276173	IGHA2	NA	
ENSG00000276192	IGHE	NA	
ENSG00000277016	IGHG4	NA	
ENSG00000274497	IGHG2	NA	
ENSG00000282430	COPDA1	NA	
ENSG00000282094	IGHGP	NA	
ENSG00000282360	ELK2AP	NA	
ENSG00000282474	AL928768.1	NA	
ENSG00000282633	IGHA1	NA	
ENSG00000281947	IGHEP1	NA	
ENSG00000277633	IGHG1	NA	
ENSG00000282184	IGHG3	NA	
ENSG00000282819	AL122127.2	NA	
ENSG00000278801	IGHD	NA	
ENSG00000282657	IGHM	NA	
ENSG00000282797	IGHJ6	NA	
ENSG00000282541	IGHJ3P	NA	
ENSG00000282615	IGHJ5	NA	
ENSG00000282065	IGHJ4	NA	
ENSG00000282471	IGHJ3	NA	
ENSG00000282778	IGHJ2P	NA	
ENSG00000282342	IGHJ2	NA	
ENSG00000282409	IGHJ1	NA	
ENSG00000282455	IGHD7-27	NA	
ENSG00000282672	IGHJ1P	NA	
ENSG00000282323	IGHD1-26	NA	
ENSG00000282724	IGHD6-25	NA	
ENSG00000282674	IGHD5-24	NA	
ENSG00000282640	IGHD4-23	NA	
ENSG00000282396	IGHD3-22	NA	
ENSG00000281984	IGHD2-21	NA	
ENSG00000282135	AC246787.4	NA	
ENSG00000282592	IGHD1-20	NA	
ENSG00000282487	IGHD6-19	NA	
ENSG00000282346	IGHD5-18	NA	
ENSG00000282274	IGHD4-17	NA	
ENSG00000282232	IGHD3-16	NA	
ENSG00000282818	IGHD2-15	NA	
ENSG00000282736	IGHD1-14	NA	
ENSG00000282042	IGHD6-13	NA	
ENSG00000282102	IGHD5-12	NA	
ENSG00000281940	IGHD4-11	NA	
ENSG00000282373	IGHD3-10	NA	
ENSG00000281939	IGHD3-9	NA	
ENSG00000282132	IGHD2-8	NA	
ENSG00000282495	IGHD1-7	NA	
ENSG00000282010	IGHD6-6	NA	
ENSG00000282769	IGHD5-5	NA	
ENSG00000282227	IGHD4-4	NA	
ENSG00000282754	IGHD3-3	NA	
ENSG00000282578	IGHD2-2	NA	
ENSG00000277059	FAM30A	NA	
ENSG00000282714	IGHD1-1	NA	
ENSG00000282745	IGHV6-1	NA	
ENSG00000282197	IGHVII-1-1	NA	
ENSG00000282626	ADAM6	NA	
ENSG00000282039	AC246787.3	NA	
ENSG00000282550	IGHV1-2	NA	
ENSG00000282108	IGHVIII-2-1	NA	
ENSG00000282213	IGHV1-3	NA	
ENSG00000282223	IGHV4-4	NA	
ENSG00000282678	AC244226.1	NA	
ENSG00000277318	IGHV2-5	NA	
ENSG00000282066	IGHVIII-5-1	NA	
ENSG00000282139	IGHVIII-5-2	NA	
ENSG00000281944	IGHV3-6	NA	
ENSG00000282211	IGHV3-7	NA	
ENSG00000282644	AC247036.4	NA	
ENSG00000282401	AC247036.3	NA	
ENSG00000282322	IGHV3-11	NA	
ENSG00000281964	IGHVIII-11-1	NA	
ENSG00000282366	IGHV1-12	NA	
ENSG00000282286	IGHV3-13	NA	
ENSG00000282569	IGHVIII-13-1	NA	
ENSG00000282796	IGHV1-14	NA	
ENSG00000282290	IGHV3-15	NA	
ENSG00000282631	IGHVII-15-1	NA	
ENSG00000282653	IGHV3-16	NA	
ENSG00000282561	IGHV1-17	NA	
ENSG00000282659	SLC20A1P2	NA	
ENSG00000282716	IGHV1-18	NA	
ENSG00000281996	IGHV3-19	NA	
ENSG00000281928	AC247036.2	NA	
ENSG00000282476	IGHV3-20	NA	
ENSG00000282281	IGHV3-21	NA	
ENSG00000282609	IGHV3-22	NA	
ENSG00000282127	IGHVII-22-1	NA	
ENSG00000282687	IGHVIII-22-2	NA	
ENSG00000281962	IGHV3-23	NA	
ENSG00000282284	IGHV1-24	NA	
ENSG00000282601	HOMER2P2	NA	
ENSG00000282710	IGHV3-25	NA	
ENSG00000281926	IGHVIII-25-1	NA	
ENSG00000282344	IGHV2-26	NA	
ENSG00000282239	IGHVIII-26-1	NA	
ENSG00000282452	IGHVII-26-2	NA	
ENSG00000282267	IGHV7-27	NA	
ENSG00000282726	IGHV4-28	NA	
ENSG00000282702	AC245166.1	NA	
ENSG00000282777	IGHV3-30	NA	
ENSG00000282136	IGHVII-30-1	NA	
ENSG00000282356	IGHV3-30-2	NA	
ENSG00000282404	AC234301.4	NA	
ENSG00000282761	AC234301.6	NA	
ENSG00000281983	IGHV3-29	NA	
ENSG00000282642	IGHV3-33	NA	
ENSG00000281959	AC234301.2	NA	
ENSG00000278082	AC234301.1	NA	
ENSG00000282595	AC234301.5	NA	
ENSG00000282150	AC234301.3	NA	
ENSG00000282552	IGHVII-33-1	NA	
ENSG00000282526	IGHV3-33-2	NA	
ENSG00000276491	IGHV4-34	NA	
ENSG00000282123	IGHV7-34-1	NA	
ENSG00000282104	IGHV3-35	NA	
ENSG00000281986	IGHV3-36	NA	
ENSG00000281973	IGHV3-37	NA	
ENSG00000282425	IGHV3-38	NA	
ENSG00000282576	IGHVIII-38-1	NA	
ENSG00000282579	IGHV4-39	NA	
ENSG00000282194	IGHV7-40	NA	
ENSG00000282533	AC244452.2	NA	
ENSG00000282292	IGHVII-40-1	NA	
ENSG00000282783	IGHV3-41	NA	
ENSG00000281971	HOMER2P1	NA	
ENSG00000282180	IGHV3-42	NA	
ENSG00000282151	IGHV3-43	NA	
ENSG00000282802	IGHVIII-44	NA	
ENSG00000282553	IGHVIV-44-1	NA	
ENSG00000281956	IGHVII-44-2	NA	
ENSG00000282776	IGHV1-45	NA	
ENSG00000282131	IGHV1-46	NA	
ENSG00000282196	IGHVII-46-1	NA	
ENSG00000282398	IGHV3-47	NA	
ENSG00000282708	IGHVIII-47-1	NA	
ENSG00000282627	IGHV3-48	NA	
ENSG00000275316	IGHV3-49	NA	
ENSG00000282465	IGHVII-49-1	NA	
ENSG00000282138	IGHV3-50	NA	
ENSG00000277574	IGHV5-51	NA	
ENSG00000282294	IGHV8-51-1	NA	
ENSG00000282312	IGHVII-51-2	NA	
ENSG00000282188	IGHV3-52	NA	
ENSG00000282593	IGHV3-53	NA	
ENSG00000281923	IGHVII-53-1	NA	
ENSG00000282383	IGHV3-54	NA	
ENSG00000282616	IGHV4-55	NA	
ENSG00000282504	IGHV7-56	NA	
ENSG00000282794	IGHV3-57	NA	
ENSG00000282337	IGHV1-58	NA	
ENSG00000282691	IGHV4-59	NA	
ENSG00000282586	IGHV3-60	NA	
ENSG00000273928	5S_rRNA	NA	
ENSG00000282082	IGHVII-60-1	NA	
ENSG00000282451	IGHV4-61	NA	
ENSG00000282414	IGHV3-62	NA	
ENSG00000282099	IGHVII-62-1	NA	
ENSG00000282560	IGHV3-63	NA	
ENSG00000274236	IGHV3-64	NA	
ENSG00000282821	IGHV3-65	NA	
ENSG00000282018	IGHVII-65-1	NA	
ENSG00000282045	IGHV3-66	NA	
ENSG00000282439	IGHV1-67	NA	
ENSG00000282117	SLC20A1P1	NA	
ENSG00000282652	IGHVII-67-1	NA	
ENSG00000282016	IGHVIII-67-2	NA	
ENSG00000282161	IGHVIII-67-3	NA	
ENSG00000282808	IGHVIII-67-4	NA	
ENSG00000282055	IGHV1-68	NA	
ENSG00000282350	IGHV1-69	NA	
ENSG00000282482	IGHV2-70D	NA	
ENSG00000282421	IGHV3-69-1	NA	
ENSG00000275148	IGHV1-69-2	NA	
ENSG00000282822	AC242528.1	NA	
ENSG00000282399	IGHV1-69D	NA	
ENSG00000282453	IGHV2-70	NA	
ENSG00000282679	IGHV3-71	NA	
ENSG00000278042	IGHV3-72	NA	
ENSG00000273539	IGHV3-73	NA	
ENSG00000282305	IGHV3-74	NA	
ENSG00000282186	IGHVII-74-1	NA	
ENSG00000276060	IGHV3-75	NA	
ENSG00000281966	IGHV3-76	NA	
ENSG00000282473	IGHVIII-76-1	NA	
ENSG00000276708	IGHV5-78	NA	
ENSG00000280805	LINC02833	NA	
ENSG00000281811	LINC02287	NA	
ENSG00000276781	CHGA	NA	
ENSG00000274958	ITPK1	NA	
ENSG00000280802	ITPK1-AS1	NA	
ENSG00000281141	AL110118.3	NA	
ENSG00000278268	MOAP1	NA	
ENSG00000275947	TMEM251	NA	
ENSG00000281847	AL110118.4	NA	
ENSG00000275619	GON7	NA	
ENSG00000278787	UBR7	NA	
ENSG00000280562	AL132838.3	NA	
ENSG00000277222	BTBD7	NA	
ENSG00000281292	AL132838.4	NA	
ENSG00000276416	UNC79	NA	
ENSG00000281396	AL122023.2	NA	
ENSG00000277018	COX8C	NA	
ENSG00000277032	Y_RNA	NA	
ENSG00000276881	RNU6-1258P	NA	
ENSG00000274710	AL157858.1	NA	
ENSG00000274089	PRIMA1	NA	
ENSG00000281432	AL132642.3	NA	
ENSG00000281032	FAM181A-AS1	NA	
ENSG00000273533	FAM181A	NA	
ENSG00000278693	ASB2	NA	
ENSG00000281498	AL132642.4	NA	
ENSG00000280668	CCDC197	NA	
ENSG00000277276	OTUB2	NA	
ENSG00000273761	DDX24	NA	
ENSG00000276880	IFI27L1	NA	
ENSG00000275214	IFI27	NA	
ENSG00000276879	IFI27L2	NA	
ENSG00000278326	PPP4R4	NA	
ENSG00000278767	SERPINA10	NA	
ENSG00000277405	SERPINA6	611489	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY;;CBG DEFICIENCY;;TRANSCORTIN DEFICIENCY  CORTICOSTEROID-BINDING GLOBULIN, ELEVATED, INCLUDED
ENSG00000274821	SERPINA2	107410	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE; SERPINA2P;;PROTEASE INHIBITOR 1-LIKE; PIL;;ANTITRYPSIN-RELATED PROTEIN; ATR;;ALPHA-1-ANTITRYPSIN-RELATED GENE SEQUENCE; ARGS;;SERPINA2
ENSG00000277377	SERPINA1	613490	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD
ENSG00000281804	AC068446.4	NA	
ENSG00000274240	AC136352.1	NA	
ENSG00000281836	AC136352.9	NA	
ENSG00000275809	U6	NA	
ENSG00000281507	AC136352.7	NA	
ENSG00000281263	AC136352.6	NA	
ENSG00000281208	LONRF2P4	NA	
ENSG00000281803	AC136352.8	NA	
ENSG00000274439	CXADRP2	NA	
ENSG00000281153	AC136352.5	NA	
ENSG00000281718	GRAMD4P6	NA	
ENSG00000278699	POTEB3	NA	
ENSG00000273624	U6	NA	
ENSG00000281688	NF1P9	NA	
ENSG00000281604	AC020679.1	NA	
ENSG00000281622	AC020679.2	NA	
ENSG00000280555	LINC02203	NA	
ENSG00000278776	AC171558.6	NA	
ENSG00000278178	AC171558.5	NA	
ENSG00000274846	AC171558.2	NA	
ENSG00000280463	AC171558.7	NA	
ENSG00000280618	CYFIP1	NA	
ENSG00000276856	TUBGCP5	NA	
ENSG00000280500	ELMO2P1	NA	
ENSG00000275009	GOLGA6L1	NA	
ENSG00000280476	AC116165.4	NA	
ENSG00000278070	GOLGA8DP	NA	
ENSG00000274040	Metazoa_SRP	NA	
ENSG00000280461	ABCB10P1	NA	
ENSG00000281012	AC116165.7	NA	
ENSG00000280679	AC116165.6	NA	
ENSG00000274700	AC091304.7	NA	
ENSG00000277278	HERC2	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000277278	HERC2	227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR;;EYE COLOR, BROWN/BLUE;;EYE COLOR, BLUE/NONBLUE;;EYE C /.../; EYCL3;;BROWN EYE COLOR 2; BEY2;;HAIR COLOR 3; HCL3
ENSG00000277278	HERC2	615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38
ENSG00000274801	AC091304.8	NA	
ENSG00000282126	AC138747.6	NA	
ENSG00000276455	AC138747.5	NA	
ENSG00000275855	AC138747.3	NA	
ENSG00000276896	GOLGA8F	NA	
ENSG00000274122	Metazoa_SRP	NA	
ENSG00000276143	AC138747.4	NA	
ENSG00000282731	AC138747.10	NA	
ENSG00000282516	AC138747.7	NA	
ENSG00000282581	AC138747.8	NA	
ENSG00000282587	AC138747.9	NA	
ENSG00000273635	AC138747.1	NA	
ENSG00000273969	AC138747.2	NA	
ENSG00000281946	AC138749.8	NA	
ENSG00000274192	ABCB10P4	NA	
ENSG00000273651	GOLGA8G	NA	
ENSG00000276767	Metazoa_SRP	NA	
ENSG00000282058	AC138749.9	NA	
ENSG00000276485	AC138749.7	NA	
ENSG00000282531	AC138749.10	NA	
ENSG00000282090	HERC2P11	NA	
ENSG00000276005	AC138749.6	NA	
ENSG00000280807	TUBGCP5	NA	
ENSG00000281725	ELMO2P1	NA	
ENSG00000278247	GOLGA6L1	NA	
ENSG00000281737	AC116165.9	NA	
ENSG00000278508	GOLGA8DP	NA	
ENSG00000277046	Metazoa_SRP	NA	
ENSG00000281173	ABCB10P1	NA	
ENSG00000280490	AC116165.5	NA	
ENSG00000281254	AC116165.8	NA	
ENSG00000281754	AC116165.10	NA	
ENSG00000277848	MEGF11	NA	
ENSG00000282280	AC087382.2	NA	
ENSG00000277844	AC087382.1	NA	
ENSG00000281422	AC136687.2	NA	
ENSG00000281537	AC136687.3	NA	
ENSG00000281846	SPATA31E3P	NA	
ENSG00000278429	GOLGA8EP	NA	
ENSG00000276377	Metazoa_SRP	NA	
ENSG00000280700	AC136687.1	NA	
ENSG00000274404	GOLGA6L22	NA	
ENSG00000281828	HERC2P7	NA	
ENSG00000280787	HERC2P2	NA	
ENSG00000281356	GOLGA8IP	NA	
ENSG00000276062	Metazoa_SRP	NA	
ENSG00000282700	AC018901.1	NA	
ENSG00000207390	Y_RNA	NA	
ENSG00000282077	PATL2	617743	OOCYTE MATURATION DEFECT 4; OOMD4
ENSG00000273686	B2M	105200	AMYLOIDOSIS, FAMILIAL VISCERAL;;AMYLOIDOSIS VIII;;OSTERTAG TYPE AMYLOIDOSIS;;GERMAN TYPE AMYLOIDOSIS;;AMYLOIDOSIS, FAMILIAL RENAL;;AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC
ENSG00000273686	B2M	241600	IMMUNODEFICIENCY 43; IMD43;;BETA-2-MICROGLOBULIN DEFICIENCY;;B2M DEFICIENCY;;HYPOPROTEINEMIA, HYPERCATABOLIC
ENSG00000278211	TRIM69	NA	
ENSG00000282195	SORD2P	NA	
ENSG00000273845	Y_RNA	NA	
ENSG00000273636	U1	NA	
ENSG00000277361	OCA2	203200	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2;;OCULOCUTANEOUS ALBINISM, TYPE II;;OCULOCUTANEOUS ALBINISM, TYROSINASE-POSITIVE;;ALBINISM II ALBINISM, BROWN OCULOCUTANEOUS, INCLUDED; BOCA, INCLUDED;;BROWN OCULOCUTANEOUS ALBINISM, INCLUDED
ENSG00000277361	OCA2	227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR;;EYE COLOR, BROWN/BLUE;;EYE COLOR, BLUE/NONBLUE;;EYE C /.../; EYCL3;;BROWN EYE COLOR 2; BEY2;;HAIR COLOR 3; HCL3
ENSG00000282545	RPL5P32	NA	
ENSG00000276802	HERC2	176270	PRADER-WILLI SYNDROME; PWS;;PRADER-LABHART-WILLI SYNDROME PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;;PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
ENSG00000276802	HERC2	227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES;;SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR;;EYE COLOR, BROWN/BLUE;;EYE COLOR, BLUE/NONBLUE;;EYE C /.../; EYCL3;;BROWN EYE COLOR 2; BEY2;;HAIR COLOR 3; HCL3
ENSG00000276802	HERC2	615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38
ENSG00000282105	RPL41P2	NA	
ENSG00000282544	AC243660.7	NA	
ENSG00000282006	AC243660.1	NA	
ENSG00000282475	AC243660.6	NA	
ENSG00000282190	AC243660.4	NA	
ENSG00000278310	GOLGA8F	NA	
ENSG00000273839	Metazoa_SRP	NA	
ENSG00000282479	ABCB10P3	NA	
ENSG00000282779	AC243660.8	NA	
ENSG00000282038	AC243660.2	NA	
ENSG00000282073	AC243660.3	NA	
ENSG00000282224	AC243660.5	NA	
ENSG00000282060	AC243913.2	NA	
ENSG00000282696	AC243913.11	NA	
ENSG00000282169	AC243913.5	NA	
ENSG00000282660	AC243913.10	NA	
ENSG00000282368	AC243913.6	NA	
ENSG00000282118	AC243913.3	NA	
ENSG00000282023	AC243913.1	NA	
ENSG00000282004	ABCB10P4	NA	
ENSG00000277090	GOLGA8G	NA	
ENSG00000278003	Metazoa_SRP	NA	
ENSG00000282145	AC243913.4	NA	
ENSG00000282444	AC243913.8	NA	
ENSG00000282422	AC243913.7	NA	
ENSG00000282567	AC243913.9	NA	
ENSG00000282417	HERC2P9	NA	
ENSG00000278186	GOLGA8M	NA	
ENSG00000275257	Metazoa_SRP	NA	
ENSG00000282540	WHAMMP2	NA	
ENSG00000282072	AC243657.1	NA	
ENSG00000282648	AC243657.3	NA	
ENSG00000282198	AC243657.2	NA	
ENSG00000282655	PDCD6IPP2	NA	
ENSG00000276495	APBA2	NA	
ENSG00000273564	FAM189A1	NA	
ENSG00000281925	AC243902.2	NA	
ENSG00000276132	AC243902.1	NA	
ENSG00000282130	NSMCE3	617241	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS
ENSG00000282503	AC243686.1	NA	
ENSG00000277401	TJP1	NA	
ENSG00000272101	AC243587.1	NA	
ENSG00000278119	GOLGA8J	NA	
ENSG00000276120	Metazoa_SRP	NA	
ENSG00000275394	U8	NA	
ENSG00000273660	Metazoa_SRP	NA	
ENSG00000276253	AC243790.1	NA	
ENSG00000277419	U6	NA	
ENSG00000275698	Y_RNA	NA	
ENSG00000275917	CHRFAM7A	NA	
ENSG00000276367	U8	NA	
ENSG00000278118	Metazoa_SRP	NA	
ENSG00000276439	Metazoa_SRP	NA	
ENSG00000275648	U8	NA	
ENSG00000277167	Metazoa_SRP	NA	
ENSG00000274734	ARHGAP11B	NA	
ENSG00000277980	Y_RNA	NA	
ENSG00000276152	Metazoa_SRP	NA	
ENSG00000276787	FAN1	NA	
ENSG00000277086	MTMR10	NA	
ENSG00000277262	U6	NA	
ENSG00000274965	TRPM1	613216	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE
ENSG00000275746	KLF13	612001	CHROMOSOME 15q13.3 DELETION SYNDROME;;CHROMOSOME 15q13.3 MICRODELETION SYNDROME
ENSG00000273538	AC243649.1	NA	
ENSG00000274542	AC243734.1	612001	CHROMOSOME 15q13.3 DELETION SYNDROME;;CHROMOSOME 15q13.3 MICRODELETION SYNDROME
ENSG00000278470	Y_RNA	NA	
ENSG00000276847	U6	NA	
ENSG00000278115	Metazoa_SRP	NA	
ENSG00000275568	ARHGAP11A	NA	
ENSG00000277614	SCG5	NA	
ENSG00000276886	GREM1	NA	
ENSG00000281976	ADAMTS7P1	NA	
ENSG00000274042	GOLGA6L10	NA	
ENSG00000282377	AC011295.2	NA	
ENSG00000275049	UBE2Q2L	NA	
ENSG00000274166	GOLGA6L10	NA	
ENSG00000282084	UBE2Q2P2	NA	
ENSG00000273673	AC011295.1	NA	
ENSG00000282814	AC010724.3	NA	
ENSG00000274320	GOLGA6L9	NA	
ENSG00000276228	UBE2Q2P6	NA	
ENSG00000282457	CSPG4P10	NA	
ENSG00000282514	AC010724.1	NA	
ENSG00000282183	GOLGA2P10	NA	
ENSG00000282209	GOLGA6L17P	NA	
ENSG00000282596	DNM1P38	NA	
ENSG00000278229	RPS17	612527	DIAMOND-BLACKFAN ANEMIA 4; DBA4
ENSG00000282755	AC010724.2	NA	
ENSG00000277445	CPEB1	NA	
ENSG00000274829	PARN	616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6
ENSG00000274829	PARN	616371	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4
ENSG00000263947	RN7SL274P	NA	
ENSG00000275618	BFAR	NA	
ENSG00000251964	U7	NA	
ENSG00000276870	PLA2G10	NA	
ENSG00000282427	AC243753.1	NA	
ENSG00000278308	NPIPA3	NA	
ENSG00000275283	Y_RNA	NA	
ENSG00000282086	PKD1P6	NA	
ENSG00000282091	AC243651.1	NA	
ENSG00000278494	RRN3	NA	
ENSG00000275779	NTAN1	NA	
ENSG00000275498	PDXDC1	NA	
ENSG00000282717	AC243651.2	NA	
ENSG00000278440	AC243791.1	NA	
ENSG00000281994	NPIPA1	NA	
ENSG00000282788	AC243791.3	NA	
ENSG00000281965	AC243791.2	NA	
ENSG00000276709	AC245049.1	NA	
ENSG00000277625	Y_RNA	NA	
ENSG00000273905	Y_RNA	NA	
ENSG00000274779	NOMO1	NA	
ENSG00000282247	AC245049.2	NA	
ENSG00000273808	ABCC6P2	NA	
ENSG00000282705	NPIPA5	NA	
ENSG00000275543	MPV17L	NA	
ENSG00000282074	AC243733.1	NA	
ENSG00000278823	BMERB1	NA	
ENSG00000277140	MARF1	NA	
ENSG00000282314	AC243742.2	NA	
ENSG00000275911	NDE1	605013	MICROHYDRANENCEPHALY; MHAC;;HYDRANENCEPHALY AND MICROCEPHALY
ENSG00000275911	NDE1	614019	LISSENCEPHALY 4; LIS4;;LISSENCEPHALY 4 WITH MICROCEPHALY
ENSG00000282255	AC243742.1	NA	
ENSG00000282638	AC243742.3	NA	
ENSG00000276480	MYH11	132900	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4;;FAA4;;AORTIC ANEURYSM/AORTIC DISSECTION AND PATENT DUCTUS ARTERIOSUS
ENSG00000282287	AC243629.2	NA	
ENSG00000282167	AC243629.1	NA	
ENSG00000276914	CEP20	NA	
ENSG00000251771	U6	NA	
ENSG00000282412	AC243629.3	NA	
ENSG00000282445	RPL15P20	NA	
ENSG00000278183	ABCC1	NA	
ENSG00000281929	RPL17P40	NA	
ENSG00000275331	ABCC6	177850	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE PSEUDOXANTHOMA ELASTICUM, HETEROZYGOUS, INCLUDED
ENSG00000275331	ABCC6	264800	PSEUDOXANTHOMA ELASTICUM; PXE;;GRONBLAD-STRANDBERG SYNDROME PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF, INCLUDED;;PXE, MODIFIER OF SEVERITY OF, INCLUDED
ENSG00000275331	ABCC6	614473	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
ENSG00000282574	AC243824.1	NA	
ENSG00000278087	NOMO3	NA	
ENSG00000282597	AC244489.4	NA	
ENSG00000282332	AC244489.3	NA	
ENSG00000282522	PKD1P1	NA	
ENSG00000277242	Y_RNA	NA	
ENSG00000273807	AC244489.1	NA	
ENSG00000277983	AC244489.2	NA	
ENSG00000282528	AC246789.1	NA	
ENSG00000282744	AC246789.2	NA	
ENSG00000281975	AC243615.1	NA	
ENSG00000282713	AC098965.2	NA	
ENSG00000281948	CES1P1	NA	
ENSG00000262243	CES1	618057	DRUG METABOLISM, ALTERED, CES1-RELATED CARBOXYLESTERASE 1 DEFICIENCY, INCLUDED;;MONOCYTE ESTERASE DEFICIENCY, INCLUDED
ENSG00000261972	CES5A	NA	
ENSG00000262788	UTP4	NA	
ENSG00000262579	U6	NA	
ENSG00000260873	SNTB2	NA	
ENSG00000262354	Y_RNA	NA	
ENSG00000274636	GLIS2	611498	NEPHRONOPHTHISIS 7; NPHP7
ENSG00000282703	GLIS2-AS1	NA	
ENSG00000282228	PAM16	613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM;;CHONDRODYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE
ENSG00000278760	CORO7-PAM16	NA	
ENSG00000282011	AC004789.1	NA	
ENSG00000282725	CORO7	NA	
ENSG00000274334	VASN	NA	
ENSG00000276726	DNAJA3	NA	
ENSG00000282450	AC012676.7	NA	
ENSG00000282590	AC012676.8	NA	
ENSG00000282374	AC012676.6	NA	
ENSG00000274684	NMRAL1	NA	
ENSG00000277424	HMOX2	NA	
ENSG00000274336	CDIP1	NA	
ENSG00000282650	MEIOB	617706	SPERMATOGENIC FAILURE 22; SPGF22
ENSG00000282469	LINC00254	NA	
ENSG00000282069	LINC02124	NA	
ENSG00000276333	HS3ST6	NA	
ENSG00000274296	DECR2	NA	
ENSG00000282201	AL023881.2	NA	
ENSG00000275338	RAB11FIP3	NA	
ENSG00000274018	Y_RNA	NA	
ENSG00000282378	AC208188.1	NA	
ENSG00000282485	LINC00235	NA	
ENSG00000282214	CAPN15	NA	
ENSG00000278006	CCL18	NA	
ENSG00000282775	AC243829.9	NA	
ENSG00000278567	CCL3	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000277943	CCL4	NA	
ENSG00000274169	RN7SL301P	NA	
ENSG00000282763	AC243829.8	NA	
ENSG00000282389	AC131056.3	NA	
ENSG00000282750	TBC1D3B	NA	
ENSG00000282229	AC131056.1	NA	
ENSG00000277796	CCL3L1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000282604	CCL4L2	NA	
ENSG00000282512	AC131056.5	NA	
ENSG00000278632	TBC1D3B	NA	
ENSG00000282319	AC131056.2	NA	
ENSG00000277768	CCL3L1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000275313	CCL4L2	NA	
ENSG00000282747	AC131056.6	NA	
ENSG00000282768	AC131056.7	NA	
ENSG00000282403	AC131056.4	NA	
ENSG00000275861	TBC1D3I	NA	
ENSG00000282235	AC240565.3	NA	
ENSG00000277660	U6	NA	
ENSG00000282518	AC240565.4	NA	
ENSG00000277730	SCGB1C2	NA	
ENSG00000272670	DOC2B	NA	
ENSG00000282365	LINC02091	NA	
ENSG00000262334	RPH3AL	NA	
ENSG00000282030	AC211856.1	NA	
ENSG00000263267	AC129507.5	NA	
ENSG00000282634	AC243301.1	NA	
ENSG00000282720	AC243301.2	NA	
ENSG00000278550	SLC43A2	NA	
ENSG00000273968	RN7SL105P	NA	
ENSG00000276336	SCARF1	NA	
ENSG00000274145	RILP	NA	
ENSG00000274442	PRPF8	600059	RETINITIS PIGMENTOSA 13; RP13
ENSG00000275246	TLCD2	NA	
ENSG00000282800	MIR22HG	NA	
ENSG00000276021	WDR81	610185	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 2
ENSG00000276021	WDR81	617967	HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3;;HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 3, FORMERLY
ENSG00000276838	SERPINF2	262850	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY;;ANTIPLASMIN DEFICIENCY;;PLASMIN INHIBITOR DEFICIENCY
ENSG00000282307	SERPINF1	613982	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6
ENSG00000263186	KRTAP16-1	NA	
ENSG00000263341	KRTAP17-1	NA	
ENSG00000262591	TBC1D3P7	NA	
ENSG00000262282	AC003958.4	NA	
ENSG00000261986	KRT33A	NA	
ENSG00000263012	KRT33B	NA	
ENSG00000262045	KRT34	NA	
ENSG00000262748	AC207056.1	NA	
ENSG00000262993	KRT31	NA	
ENSG00000262603	AC003958.5	NA	
ENSG00000262040	AC003958.3	NA	
ENSG00000263022	KRT37	NA	
ENSG00000283454	5S_rRNA	NA	
ENSG00000281837	AC217778.1	NA	
ENSG00000276836	ARHGAP27	NA	
ENSG00000281898	AC217778.2	NA	
ENSG00000277111	PLEKHM1	611497	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6;;OSTEOPETROSIS, AUTOSOMAL RECESSIVE, INTERMEDIATE FORM
ENSG00000277111	PLEKHM1	618107	OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3
ENSG00000274332	LRRC37A2	NA	
ENSG00000278357	Metazoa_SRP	NA	
ENSG00000281364	AC217769.1	NA	
ENSG00000280810	NSFP1	NA	
ENSG00000275748	ARL17B	NA	
ENSG00000278742	LRRC37A	NA	
ENSG00000278553	Metazoa_SRP	NA	
ENSG00000281642	AC127032.1	NA	
ENSG00000281815	AC127032.2	NA	
ENSG00000275867	KANSL1	610443	KOOLEN-DE VRIES SYNDROME; KDVS;;CHROMOSOME 17q21.31 DELETION SYNDROME;;MICRODELETION 17q21.31 SYNDROME
ENSG00000274754	Y_RNA	NA	
ENSG00000281569	KANSL1-AS1	NA	
ENSG00000280735	AC217779.1	NA	
ENSG00000276155	MAPT	172700	PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS
ENSG00000276155	MAPT	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000276155	MAPT	260540	PARKINSON-DEMENTIA SYNDROME SUPRANUCLEAR PALSY, PROGRESSIVE, 1, ATYPICAL, INCLUDED;;STEELE-RICHARDSON-OLSZEWSKI SYNDROME, ATYPICAL, INCLUDED
ENSG00000276155	MAPT	600274	FRONTOTEMPORAL DEMENTIA; FTD;;FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU INCLUSIONS;;FTLD WITH TAU INCLUSIONS;;DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM;;FRONTOTEMPORAL DEMENTIA WITH PARKINSONISM;;FRONTOTEMPORAL LOBE DEMENTIA; FLDEM;;FTDP17;;MULTI /.../STEM TAUOPATHY WITH PRESENILE DEMENTIA; MSTD;;DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX; DDPAC;;WILHELMSEN-LYNCH DISEASE; WLD;;PALLIDOPONTONIGRAL DEGENERATION; PPND PICK COMPLEX, INCLUDED
ENSG00000276155	MAPT	601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1;;PSP;;STEELE-RICHARDSON-OLSZEWSKI SYNDROME
ENSG00000281139	STH	NA	
ENSG00000277055	Metazoa_SRP	NA	
ENSG00000280786	BX544879.1	NA	
ENSG00000281284	MAPT-IT1	NA	
ENSG00000281578	MAPT-AS1	NA	
ENSG00000278194	SPPL2C	NA	
ENSG00000278232	CRHR1	NA	
ENSG00000281283	MAPK8IP1P1	NA	
ENSG00000281144	AC225613.1	NA	
ENSG00000275775	Y_RNA	NA	
ENSG00000281487	AC139677.3	NA	
ENSG00000281336	AC139677.2	NA	
ENSG00000281922	AC139677.4	NA	
ENSG00000281797	RDM1P2	NA	
ENSG00000275621	LRRC37A3	NA	
ENSG00000275949	AC139677.1	NA	
ENSG00000275574	Metazoa_SRP	NA	
ENSG00000281693	AC217775.1	NA	
ENSG00000278174	NSF	NA	
ENSG00000277626	WNT3	273395	TETRAAMELIA SYNDROME 1; TETAMS1;;TETRAAMELIA SYNDROME, AUTOSOMAL RECESSIVE
ENSG00000278759	TBCD	617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT
ENSG00000277033	B3GNTL1	NA	
ENSG00000281945	AC127518.1	NA	
ENSG00000275031	METRNL	NA	
ENSG00000282013	RPH3AL	NA	
ENSG00000282357	AC240137.1	NA	
ENSG00000275886	AC129507.6	NA	
ENSG00000282336	AC129507.7	NA	
ENSG00000282426	AC129507.8	NA	
ENSG00000280563	NXN	618529	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2
ENSG00000277649	TIMM22	NA	
ENSG00000278741	ABR	NA	
ENSG00000273728	Metazoa_SRP	NA	
ENSG00000281251	AC107911.1	NA	
ENSG00000281590	AC107911.2	NA	
ENSG00000280938	TRARG1	NA	
ENSG00000274474	YWHAE	NA	
ENSG00000282128	AC207965.1	NA	
ENSG00000282637	MAP3K14	NA	
ENSG00000275780	5S_rRNA	NA	
ENSG00000282563	AC003070.4	NA	
ENSG00000276907	ARHGAP27	NA	
ENSG00000281982	AC003070.3	NA	
ENSG00000276358	PLEKHM1	611497	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6;;OSTEOPETROSIS, AUTOSOMAL RECESSIVE, INTERMEDIATE FORM
ENSG00000276358	PLEKHM1	618107	OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3
ENSG00000282325	AC244207.1	NA	
ENSG00000282331	LRRC37A4P	NA	
ENSG00000275587	Metazoa_SRP	NA	
ENSG00000282727	AC244207.2	NA	
ENSG00000282491	AC243807.3	NA	
ENSG00000282002	AC243807.1	NA	
ENSG00000282614	DND1P1	NA	
ENSG00000282351	MAPK8IP1P2	NA	
ENSG00000282238	RPS26P8	NA	
ENSG00000282171	LINC02210	NA	
ENSG00000282456	LINC02210-CRHR1	NA	
ENSG00000282523	AC243807.4	NA	
ENSG00000282361	AC243807.2	NA	
ENSG00000276191	CRHR1	NA	
ENSG00000282067	MAPT-AS1	NA	
ENSG00000277106	SPPL2C	NA	
ENSG00000277956	MAPT	172700	PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS
ENSG00000277956	MAPT	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000277956	MAPT	260540	PARKINSON-DEMENTIA SYNDROME SUPRANUCLEAR PALSY, PROGRESSIVE, 1, ATYPICAL, INCLUDED;;STEELE-RICHARDSON-OLSZEWSKI SYNDROME, ATYPICAL, INCLUDED
ENSG00000277956	MAPT	600274	FRONTOTEMPORAL DEMENTIA; FTD;;FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU INCLUSIONS;;FTLD WITH TAU INCLUSIONS;;DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM;;FRONTOTEMPORAL DEMENTIA WITH PARKINSONISM;;FRONTOTEMPORAL LOBE DEMENTIA; FLDEM;;FTDP17;;MULTI /.../STEM TAUOPATHY WITH PRESENILE DEMENTIA; MSTD;;DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX; DDPAC;;WILHELMSEN-LYNCH DISEASE; WLD;;PALLIDOPONTONIGRAL DEGENERATION; PPND PICK COMPLEX, INCLUDED
ENSG00000277956	MAPT	601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1;;PSP;;STEELE-RICHARDSON-OLSZEWSKI SYNDROME
ENSG00000282620	MAPT-IT1	NA	
ENSG00000282165	AC243621.1	NA	
ENSG00000275602	Metazoa_SRP	NA	
ENSG00000278458	KANSL1	610443	KOOLEN-DE VRIES SYNDROME; KDVS;;CHROMOSOME 17q21.31 DELETION SYNDROME;;MICRODELETION 17q21.31 SYNDROME
ENSG00000282279	AC243658.1	NA	
ENSG00000282799	KANSL1-AS1	NA	
ENSG00000276222	Y_RNA	NA	
ENSG00000282723	MAPK8IP1P1	NA	
ENSG00000281927	AC243899.1	NA	
ENSG00000282032	AC243899.2	NA	
ENSG00000276276	ARL17B	NA	
ENSG00000277221	LRRC37A2	NA	
ENSG00000274171	Metazoa_SRP	NA	
ENSG00000276262	NSF	NA	
ENSG00000282733	NSFP1	NA	
ENSG00000282052	RPS7P11	NA	
ENSG00000277641	WNT3	273395	TETRAAMELIA SYNDROME 1; TETAMS1;;TETRAAMELIA SYNDROME, AUTOSOMAL RECESSIVE
ENSG00000276799	WNT9B	NA	
ENSG00000281300	NXN	618529	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2
ENSG00000278501	TIMM22	NA	
ENSG00000276016	ABR	NA	
ENSG00000275991	Metazoa_SRP	NA	
ENSG00000282649	SEPTIN9-DT	NA	
ENSG00000282753	AC068594.2	NA	
ENSG00000282302	SEPTIN9	162100	AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS
ENSG00000264450	AC004231.2	NA	
ENSG00000263243	KRT12	122100	CORNEAL DYSTROPHY, MEESMANN, 1; MECD1;;CORNEAL DYSTROPHY, MEESMANN EPITHELIAL; MECD;;MEESMANN CORNEAL DYSTROPHY;;CORNEAL DYSTROPHY, JUVENILE EPITHELIAL, OF MEESMANN
ENSG00000263057	KRT20	NA	
ENSG00000262487	AC037482.1	NA	
ENSG00000263309	KRT23	NA	
ENSG00000262164	KRT39	NA	
ENSG00000262845	KRT40	NA	
ENSG00000263101	KRTAP3-3	NA	
ENSG00000263296	KRTAP3-2	NA	
ENSG00000262616	KRTAP3-4P	NA	
ENSG00000262068	KRTAP3-1	NA	
ENSG00000261862	KRTAP1-5	NA	
ENSG00000263242	KRTAP1-4	NA	
ENSG00000262347	KRTAP1-3	NA	
ENSG00000262808	KRTAP1-1	NA	
ENSG00000261852	KRTAP2-1	NA	
ENSG00000262731	AC037482.2	NA	
ENSG00000262862	KRTAP2-3	NA	
ENSG00000263091	KRTAP2-4	NA	
ENSG00000262376	KRTAP2-5P	NA	
ENSG00000266286	AC037482.3	NA	
ENSG00000261968	KRTAP4-8	NA	
ENSG00000262520	KRTAP4-16	NA	
ENSG00000262121	KRTAP4-9	NA	
ENSG00000263229	KRTAP4-11	NA	
ENSG00000263236	KRTAP4-12	NA	
ENSG00000263090	KRTAP9-2	NA	
ENSG00000262749	KRTAP9-3	NA	
ENSG00000267208	AC209539.1	NA	
ENSG00000262512	KRTAP9-4	NA	
ENSG00000267728	KRTAP9-9	NA	
ENSG00000267635	AC209539.2	NA	
ENSG00000263103	KRTAP9-10P	NA	
ENSG00000262218	KRTAP29-1	NA	
ENSG00000262214	KRTAP9-12P	NA	
ENSG00000262573	KRTAP9-2	NA	
ENSG00000262896	KRTAP9-4	NA	
ENSG00000262594	KRTAP9-9	NA	
ENSG00000263263	KRTAP9-6	NA	
ENSG00000262946	KRTAP9-11P	NA	
ENSG00000262221	KRTAP9-7	NA	
ENSG00000263115	KRTAP9-10P	NA	
ENSG00000262542	KRTAP29-1	NA	
ENSG00000278843	MMP28	NA	
ENSG00000282384	AC015849.11	NA	
ENSG00000276833	TAF15	612237	CHONDROSARCOMA, EXTRASKELETAL MYXOID;;EMC
ENSG00000282202	AC015849.10	NA	
ENSG00000282083	AC015849.7	NA	
ENSG00000276986	HEATR9	NA	
ENSG00000282115	AC015849.8	NA	
ENSG00000282498	AC015849.12	NA	
ENSG00000274233	CCL5	NA	
ENSG00000274262	7SK	NA	
ENSG00000282124	AC015849.9	NA	
ENSG00000282486	LRRC37A9P	NA	
ENSG00000276432	RDM1	NA	
ENSG00000277042	LYZL6	NA	
ENSG00000282525	AC004675.2	NA	
ENSG00000275095	CCL16	NA	
ENSG00000277236	CCL14	NA	
ENSG00000282521	CCL15-CCL14	NA	
ENSG00000282446	AC004675.1	NA	
ENSG00000275528	CCL15	NA	
ENSG00000282588	AC069363.2	NA	
ENSG00000282071	AC069363.1	NA	
ENSG00000276114	CCL23	NA	
ENSG00000278167	CCL18	NA	
ENSG00000282721	AC069363.3	NA	
ENSG00000274221	CCL3	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000275824	CCL4	NA	
ENSG00000278781	Metazoa_SRP	NA	
ENSG00000282348	AC003976.2	NA	
ENSG00000275347	AC003976.1	NA	
ENSG00000274939	TBC1D3B	NA	
ENSG00000282231	AC233699.4	NA	
ENSG00000277336	CCL3L1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276125	CCL4L2	NA	
ENSG00000282370	AC233699.5	NA	
ENSG00000281967	AC233699.2	NA	
ENSG00000281992	AC233699.3	NA	
ENSG00000282144	TBC1D3I	NA	
ENSG00000282411	AC233699.6	NA	
ENSG00000278320	Y_RNA	NA	
ENSG00000275760	TBC1D3G	NA	
ENSG00000277974	TBC1D3H	NA	
ENSG00000278515	U6	NA	
ENSG00000282087	TBC1D3F	NA	
ENSG00000282656	TBC1D3J	NA	
ENSG00000278574	ZNHIT3	260565	PEHO SYNDROME; PEHO;;PROGRESSIVE ENCEPHALOPATHY WITH EDEMA, HYPSARRHYTHMIA, AND OPTIC ATROPHY;;INFANTILE CEREBELLOOPTIC ATROPHY
ENSG00000277395	5S_rRNA	NA	
ENSG00000278372	MYO19	NA	
ENSG00000275600	PIGW	616025	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11;;HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 5; HPMRS5
ENSG00000275099	GGNBP2	NA	
ENSG00000282707	AC003042.2	NA	
ENSG00000275397	DHRS11	NA	
ENSG00000274853	MRM1	NA	
ENSG00000282570	AC003042.1	NA	
ENSG00000282028	AC015938.1	NA	
ENSG00000282237	AC015938.2	NA	
ENSG00000281998	LHX1-DT	NA	
ENSG00000274577	LHX1	NA	
ENSG00000282454	AC023315.1	NA	
ENSG00000276072	AATF	NA	
ENSG00000282636	AC023315.2	NA	
ENSG00000282805	AC023315.3	NA	
ENSG00000282043	AC003103.1	NA	
ENSG00000282166	AC003103.2	NA	
ENSG00000275176	ACACA	613933	ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD;;ACACA DEFICIENCY;;ACC1 DEFICIENCY
ENSG00000282532	AC016482.2	NA	
ENSG00000282695	HMGB1P24	NA	
ENSG00000282489	AC016482.1	NA	
ENSG00000278145	C17orf78	NA	
ENSG00000282806	AC068400.2	NA	
ENSG00000277104	TADA2A	NA	
ENSG00000282790	AC068400.1	NA	
ENSG00000282015	AC004099.1	NA	
ENSG00000275932	DUSP14	NA	
ENSG00000274047	SYNRG	NA	
ENSG00000277594	DDX52	NA	
ENSG00000276194	HNF1B	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC;;HYPERNEPHROMA;;ADENOCARCINOMA OF KIDNEY NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
ENSG00000276194	HNF1B	137920	RENAL CYSTS AND DIABETES SYNDROME; RCAD;;MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 5; MODY5;;HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, ATYPICAL;;FJHN, ATYPICAL;;GLOMERULOCYSTIC KIDNEY DISEASE, HYPOPLASTIC TYPE;;GLOMERULOCYSTIC KIDNEY, FAMILIAL  /.../ASTIC;;CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH DIABETES;;CAKUT WITH DIABETES
ENSG00000276194	HNF1B	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM;;DIABETES MELLITUS, TYPE II; T2D;;NONINSULIN-DEPENDENT DIABETES MELLITUS;;MATURITY-ONSET DIABETES INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;;DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
ENSG00000282632	AC113211.1	NA	
ENSG00000282630	YWHAEP7	NA	
ENSG00000277891	U6	NA	
ENSG00000275153	TBC1D3K	NA	
ENSG00000276349	TBC1D3L	NA	
ENSG00000282641	AC183084.1	NA	
ENSG00000276153	Y_RNA	NA	
ENSG00000277936	MRPL45	NA	
ENSG00000276469	GPR179	614565	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE
ENSG00000274229	SOCS7	NA	
ENSG00000273780	ARHGAP23	NA	
ENSG00000282205	AC115090.1	NA	
ENSG00000273608	SRCIN1	NA	
ENSG00000282217	AC006449.8	NA	
ENSG00000277303	EPOP	NA	
ENSG00000282494	AC006449.9	NA	
ENSG00000275851	MLLT6	NA	
ENSG00000277005	AC006449.4	NA	
ENSG00000274768	CISD3	NA	
ENSG00000278779	5S_rRNA	NA	
ENSG00000278644	PCGF2	618371	TURNPENNY-FRY SYNDROME; TPFS;;NEUROCARDIOSKELETAL SYNDROME
ENSG00000282749	AC006449.10	NA	
ENSG00000275903	PSMB3	NA	
ENSG00000277546	U6	NA	
ENSG00000277292	PIP4K2B	NA	
ENSG00000276761	CWC25	NA	
ENSG00000276913	C17orf98	NA	
ENSG00000282257	AC118653.2	NA	
ENSG00000275193	MYL6P5	NA	
ENSG00000282291	SLC39A11	NA	
ENSG00000282385	AC240577.1	NA	
ENSG00000282443	AC105227.4	NA	
ENSG00000282085	AC105227.3	NA	
ENSG00000262132	RNA5SP458	NA	
ENSG00000262634	SKA1	NA	
ENSG00000262892	AC013759.1	NA	
ENSG00000282110	MAPK4	NA	
ENSG00000282433	AC012572.2	NA	
ENSG00000262104	Y_RNA	NA	
ENSG00000282429	AC208322.1	NA	
ENSG00000279612	AC231988.1	NA	
ENSG00000263322	AC110597.2	NA	
ENSG00000262102	DSEL	NA	
ENSG00000282220	AC110597.5	NA	
ENSG00000282112	AC110597.4	NA	
ENSG00000262280	LINC01896	NA	
ENSG00000263310	SALL3	NA	
ENSG00000274273	ATP9B	NA	
ENSG00000281942	AC068473.6	NA	
ENSG00000281995	AC215996.1	NA	
ENSG00000282606	AC068473.9	NA	
ENSG00000282330	AC068473.8	NA	
ENSG00000282752	CTDP1	604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN;;CATARACT, CONGENITAL, WITH FACIAL DYSMORPHISM AND NEUROPATHY
ENSG00000281949	AC068473.7	NA	
ENSG00000282658	AC012572.3	NA	
ENSG00000273770	Y_RNA	NA	
ENSG00000282765	LINC01896	NA	
ENSG00000277015	SALL3	NA	
ENSG00000282266	ATP9B	NA	
ENSG00000282460	AC099689.2	NA	
ENSG00000276806	KIR3DL3	NA	
ENSG00000278327	KIR2DL3	NA	
ENSG00000275815	KIR2DP1	NA	
ENSG00000276625	KIR2DL1	NA	
ENSG00000278833	GU182360.1	NA	
ENSG00000277850	KIR2DL4	NA	
ENSG00000275717	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000275353	KIR2DS4	NA	
ENSG00000278809	KIR3DL2	NA	
ENSG00000275671	U6	NA	
ENSG00000275136	FCAR	NA	
ENSG00000277442	NCR1	NA	
ENSG00000277570	LILRP1	NA	
ENSG00000276306	AC245128.8	NA	
ENSG00000275442	LILRP2	NA	
ENSG00000274696	KIR3DL3	NA	
ENSG00000277484	KIR2DL3	NA	
ENSG00000274851	KIR2DP1	NA	
ENSG00000274782	KIR2DL1	NA	
ENSG00000273688	KIR3DP1	NA	
ENSG00000274955	KIR2DL4	NA	
ENSG00000276379	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000278325	LILRP1	NA	
ENSG00000276974	AC245128.11	NA	
ENSG00000274826	LILRP2	NA	
ENSG00000276930	KIR3DL3	NA	
ENSG00000277317	KIR2DL3	NA	
ENSG00000273522	KIR2DP1	NA	
ENSG00000278755	KIR2DL1	NA	
ENSG00000277742	KIR3DP1	NA	
ENSG00000275699	KIR2DL4	NA	
ENSG00000275288	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000275938	KIR2DS4	NA	
ENSG00000278726	KIR3DL2	NA	
ENSG00000273929	U6	NA	
ENSG00000277028	KIR3DL3	NA	
ENSG00000273887	KIR2DL3	NA	
ENSG00000277375	KIR2DP1	NA	
ENSG00000278495	KIR2DL1	NA	
ENSG00000277691	GU182338.1	NA	
ENSG00000275317	KIR2DL4	NA	
ENSG00000275786	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276885	KIR2DS4	NA	
ENSG00000275629	KIR3DL2	NA	
ENSG00000278063	U6	NA	
ENSG00000275970	FCAR	NA	
ENSG00000276450	NCR1	NA	
ENSG00000277552	KIR3DL3	NA	
ENSG00000277885	KIR2DS2	NA	
ENSG00000276011	KIR2DL2	NA	
ENSG00000275937	KIR2DL5B	NA	
ENSG00000278306	KIR2DS3	NA	
ENSG00000275795	GU182339.2	NA	
ENSG00000276820	KIR2DL1	NA	
ENSG00000277835	KIR3DP1	NA	
ENSG00000275732	KIR2DL4	NA	
ENSG00000274465	KIR3DS1	NA	
ENSG00000278116	KIR2DL5A	NA	
ENSG00000275500	GU182339.1	NA	
ENSG00000276327	KIR2DS1	NA	
ENSG00000276882	KIR3DL2	NA	
ENSG00000274597	U6	NA	
ENSG00000276985	FCAR	NA	
ENSG00000278025	NCR1	NA	
ENSG00000277392	KIR3DL3	NA	
ENSG00000274108	KIR2DL3	NA	
ENSG00000278329	KIR2DP1	NA	
ENSG00000277356	KIR2DL1	NA	
ENSG00000275751	KIR3DP1	NA	
ENSG00000277750	KIR2DL4	NA	
ENSG00000278368	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276465	KIR2DS4	NA	
ENSG00000278710	KIR3DL2	NA	
ENSG00000277567	U6	NA	
ENSG00000276858	FCAR	NA	
ENSG00000275521	NCR1	NA	
ENSG00000274788	LILRP2	NA	
ENSG00000274480	KIR3DL3	NA	
ENSG00000275452	KIR2DS2	NA	
ENSG00000277725	KIR2DL2	NA	
ENSG00000274610	KIR3DP1	NA	
ENSG00000275237	KIR2DL4	NA	
ENSG00000276423	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000274714	KIR2DS4	NA	
ENSG00000274722	KIR3DL2	NA	
ENSG00000273752	U6	NA	
ENSG00000275269	FCAR	NA	
ENSG00000277334	NCR1	NA	
ENSG00000275433	KIR3DL3	NA	
ENSG00000273947	KIR2DL3	NA	
ENSG00000278339	KIR2DP1	NA	
ENSG00000273510	KIR2DL1	NA	
ENSG00000277560	KIR3DP1	NA	
ENSG00000276779	KIR2DL4	NA	
ENSG00000278079	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000273526	KIR2DS4	NA	
ENSG00000275416	KIR3DL2	NA	
ENSG00000278140	U6	NA	
ENSG00000273738	FCAR	NA	
ENSG00000275637	NCR1	NA	
ENSG00000273881	LILRP1	NA	
ENSG00000277940	AC245128.14	NA	
ENSG00000275289	LILRP2	NA	
ENSG00000277596	GU182343.4	NA	
ENSG00000278369	KIR2DL3	NA	
ENSG00000274707	GU182343.2	NA	
ENSG00000274563	GU182343.1	NA	
ENSG00000275059	GU182343.3	NA	
ENSG00000275080	KIR2DL1	NA	
ENSG00000275659	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000278345	GU182343.5	NA	
ENSG00000276044	KIR2DL4	NA	
ENSG00000277078	KIR2DS4	NA	
ENSG00000278474	KIR3DL2	NA	
ENSG00000276552	U6	NA	
ENSG00000274339	LILRP1	NA	
ENSG00000276808	AC245128.10	NA	
ENSG00000274861	LILRP2	NA	
ENSG00000273502	KIR3DL3	NA	
ENSG00000276218	KIR2DL3	NA	
ENSG00000274912	KIR2DP1	NA	
ENSG00000276310	KIR2DL1	NA	
ENSG00000278051	KIR3DP1	NA	
ENSG00000277362	KIR2DL4	NA	
ENSG00000273775	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276395	KIR2DS4	NA	
ENSG00000278850	KIR3DL2	NA	
ENSG00000278190	U6	NA	
ENSG00000277070	LILRP1	NA	
ENSG00000273755	LILRP2	NA	
ENSG00000274724	KIR3DL3	NA	
ENSG00000276258	GU182345.3	NA	
ENSG00000275407	GU182345.1	NA	
ENSG00000275946	GU182345.2	NA	
ENSG00000276676	GU182345.4	NA	
ENSG00000277376	KIR2DP1	NA	
ENSG00000278805	KIR2DL1	NA	
ENSG00000277176	KIR3DP1	NA	
ENSG00000274189	KIR2DL4	NA	
ENSG00000276329	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000277345	KIR2DS4	NA	
ENSG00000276424	KIR3DL2	NA	
ENSG00000277551	U6	NA	
ENSG00000277240	LILRP1	NA	
ENSG00000276324	AC245128.9	NA	
ENSG00000277963	LILRP2	NA	
ENSG00000274556	KIR3DL3	NA	
ENSG00000274830	KIR2DL3	NA	
ENSG00000273955	KIR2DP1	NA	
ENSG00000273794	KIR2DL1	NA	
ENSG00000278786	KIR3DP1	NA	
ENSG00000273575	KIR2DL4	NA	
ENSG00000274948	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000274807	KIR2DS4	NA	
ENSG00000276004	KIR3DL2	NA	
ENSG00000275021	U6	NA	
ENSG00000277894	LILRP1	NA	
ENSG00000278432	AC245128.16	NA	
ENSG00000273666	LILRP2	NA	
ENSG00000274394	KIR3DL3	NA	
ENSG00000275737	GU182347.3	NA	
ENSG00000276731	GU182347.5	NA	
ENSG00000278481	GU182347.8	NA	
ENSG00000277163	GU182347.6	NA	
ENSG00000276279	KIR2DP1	NA	
ENSG00000275522	KIR2DL1	NA	
ENSG00000278691	KIR3DP1	NA	
ENSG00000277540	KIR2DL4	NA	
ENSG00000275037	GU182347.1	NA	
ENSG00000276177	GU182347.4	NA	
ENSG00000278086	GU182347.7	NA	
ENSG00000275306	GU182347.2	NA	
ENSG00000278403	KIR3DL2	NA	
ENSG00000274623	U6	NA	
ENSG00000273670	LILRP1	NA	
ENSG00000277456	AC245128.13	NA	
ENSG00000273528	LILRP2	NA	
ENSG00000276084	KIR3DL3	NA	
ENSG00000274402	KIR2DL3	NA	
ENSG00000274476	KIR2DP1	NA	
ENSG00000277833	KIR2DL1	NA	
ENSG00000275255	KIR3DP1	NA	
ENSG00000278606	KIR2DL4	NA	
ENSG00000275486	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000275351	KIR2DS4	NA	
ENSG00000275083	KIR3DL2	NA	
ENSG00000274545	LILRP1	NA	
ENSG00000278360	AC245128.15	NA	
ENSG00000278288	LILRP2	NA	
ENSG00000278490	KIR3DL3	NA	
ENSG00000276139	GU182349.2	NA	
ENSG00000275546	GU182349.1	NA	
ENSG00000275887	KIR3DP1	NA	
ENSG00000277076	KIR2DL4	NA	
ENSG00000274146	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276209	KIR2DS4	NA	
ENSG00000278656	KIR3DL2	NA	
ENSG00000274771	U6	NA	
ENSG00000276307	LILRP1	NA	
ENSG00000273918	AC245128.4	NA	
ENSG00000273883	LILRP2	NA	
ENSG00000274763	KIR3DL3	NA	
ENSG00000275623	KIR2DL3	NA	
ENSG00000278614	KIR2DP1	NA	
ENSG00000278821	KIR2DL1	NA	
ENSG00000275593	KIR3DP1	NA	
ENSG00000278430	KIR2DL4	NA	
ENSG00000277175	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000274957	KIR2DS4	NA	
ENSG00000278361	KIR3DL2	NA	
ENSG00000277642	U6	NA	
ENSG00000275513	KIR3DL3	NA	
ENSG00000274438	GU182351.1	NA	
ENSG00000275914	GU182351.4	NA	
ENSG00000275436	GU182351.3	NA	
ENSG00000277657	GU182351.7	NA	
ENSG00000277185	GU182351.6	NA	
ENSG00000278207	KIR2DL1	NA	
ENSG00000275422	GU182351.2	NA	
ENSG00000275848	KIR2DL4	NA	
ENSG00000274920	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276254	GU182351.5	NA	
ENSG00000277271	GU182352.5	NA	
ENSG00000275062	KIR3DL3	NA	
ENSG00000275008	KIR2DL3	NA	
ENSG00000275247	GU182352.2	NA	
ENSG00000274692	KIR2DL1	NA	
ENSG00000277729	GU182352.6	NA	
ENSG00000278201	KIR2DL4	NA	
ENSG00000274283	GU182352.1	NA	
ENSG00000276686	GU182352.4	NA	
ENSG00000275599	GU182352.3	NA	
ENSG00000278304	GU182352.7	NA	
ENSG00000277982	KIR3DL2	NA	
ENSG00000278230	U6	NA	
ENSG00000276512	GU182353.3	NA	
ENSG00000274254	KIR3DL3	NA	
ENSG00000275253	GU182353.2	NA	
ENSG00000277251	GU182353.4	NA	
ENSG00000274971	GU182353.1	NA	
ENSG00000278271	KIR2DL4	NA	
ENSG00000278427	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000275731	KIR2DS4	NA	
ENSG00000275626	KIR3DL2	NA	
ENSG00000274639	KIR3DL3	NA	
ENSG00000276459	KIR2DL3	NA	
ENSG00000275225	GU182354.1	NA	
ENSG00000278248	KIR2DL1	NA	
ENSG00000275245	GU182354.2	NA	
ENSG00000275456	KIR2DL4	NA	
ENSG00000278856	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276154	KIR2DS4	NA	
ENSG00000276357	KIR3DL2	NA	
ENSG00000278411	U6	NA	
ENSG00000273546	LILRP1	NA	
ENSG00000276994	AC245128.12	NA	
ENSG00000273922	LILRP2	NA	
ENSG00000276086	KIR3DL3	NA	
ENSG00000275735	GU182355.5	NA	
ENSG00000278692	GU182355.7	NA	
ENSG00000278277	GU182355.6	NA	
ENSG00000273498	KIR2DL4	NA	
ENSG00000275608	GU182355.4	NA	
ENSG00000275596	GU182355.3	NA	
ENSG00000275047	GU182355.2	NA	
ENSG00000273603	GU182355.1	NA	
ENSG00000275511	KIR3DL2	NA	
ENSG00000275782	U6	NA	
ENSG00000274271	LILRP1	NA	
ENSG00000277267	LILRP2	NA	
ENSG00000276433	KIR3DL3	NA	
ENSG00000278152	AL133414.6	NA	
ENSG00000273661	AL133414.2	NA	
ENSG00000276518	KIR3DP1	NA	
ENSG00000274193	KIR2DL4	NA	
ENSG00000276534	AL133414.4	NA	
ENSG00000274676	AL133414.3	NA	
ENSG00000277650	AL133414.5	NA	
ENSG00000273517	AL133414.1	NA	
ENSG00000273735	KIR3DL2	NA	
ENSG00000277921	LILRP1	NA	
ENSG00000274009	AC245128.5	NA	
ENSG00000274842	LILRP2	NA	
ENSG00000276328	KIR3DL3	NA	
ENSG00000277554	KIR2DL3	NA	
ENSG00000274942	KIR2DP1	NA	
ENSG00000275276	KIR2DL1	NA	
ENSG00000274163	KIR3DP1	NA	
ENSG00000278074	KIR2DL4	NA	
ENSG00000273518	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000274406	KIR2DS4	NA	
ENSG00000275262	KIR3DL2	NA	
ENSG00000277153	RNU6-222P	NA	
ENSG00000275112	LILRP1	NA	
ENSG00000274130	AC245128.7	NA	
ENSG00000276247	LILRP2	NA	
ENSG00000277620	KIR3DL3	NA	
ENSG00000274518	GU182357.2	NA	
ENSG00000278731	GU182357.5	NA	
ENSG00000278414	GU182357.4	NA	
ENSG00000274243	GU182357.1	NA	
ENSG00000276013	GU182357.3	NA	
ENSG00000277616	KIR2DL1	NA	
ENSG00000274945	KIR2DL4	NA	
ENSG00000276501	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000274324	KIR2DS4	NA	
ENSG00000276001	LILRP1	NA	
ENSG00000274082	AC245128.6	NA	
ENSG00000276243	LILRP2	NA	
ENSG00000274786	KIR3DL3	NA	
ENSG00000276590	KIR2DL3	NA	
ENSG00000276970	GU182358.1	NA	
ENSG00000275750	KIR2DL1	NA	
ENSG00000276035	KIR3DP1	NA	
ENSG00000277964	KIR2DL4	NA	
ENSG00000277272	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000274947	KIR2DS4	NA	
ENSG00000278442	KIR3DL2	NA	
ENSG00000275168	U6	NA	
ENSG00000276099	LILRP1	NA	
ENSG00000274120	LILRP2	NA	
ENSG00000275172	KIR3DL3	NA	
ENSG00000276425	GU182359.4	NA	
ENSG00000273578	GU182359.1	NA	
ENSG00000276212	KIR3DP1	NA	
ENSG00000277355	KIR2DL4	NA	
ENSG00000276498	GU182359.5	NA	
ENSG00000276392	GU182359.3	NA	
ENSG00000277193	GU182359.6	NA	
ENSG00000275421	GU182359.2	NA	
ENSG00000278758	KIR3DL2	NA	
ENSG00000274708	U6	NA	
ENSG00000275330	VSTM1	NA	
ENSG00000276604	TARM1	NA	
ENSG00000273511	OSCAR	NA	
ENSG00000274359	NDUFA3	NA	
ENSG00000274073	TFPT	NA	
ENSG00000277154	AC012314.13	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000277114	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000277808	LENG1	NA	
ENSG00000277789	TMC4	NA	
ENSG00000276935	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000278622	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000274646	RPS9	NA	
ENSG00000277816	LILRB3	NA	
ENSG00000275116	CU457734.1	NA	
ENSG00000275584	LILRA6	NA	
ENSG00000277414	LILRB5	NA	
ENSG00000274323	U6	NA	
ENSG00000277366	CU457734.2	NA	
ENSG00000276146	LILRB2	NA	
ENSG00000276175	LILRA3	NA	
ENSG00000274914	LILRA5	NA	
ENSG00000276537	TTYH1	NA	
ENSG00000278409	CU467002.1	NA	
ENSG00000276458	LENG8	NA	
ENSG00000278312	LENG9	NA	
ENSG00000273633	CDC42EP5	NA	
ENSG00000274084	LAIR2	NA	
ENSG00000276848	KIR3DX1	NA	
ENSG00000274000	LILRA2	NA	
ENSG00000274935	LILRA1	NA	
ENSG00000274669	LILRB1	NA	
ENSG00000274101	CU234142.1	NA	
ENSG00000278555	LILRB4	NA	
ENSG00000273740	LILRP1	NA	
ENSG00000278795	LILRP2	NA	
ENSG00000278723	KIR3DL3	NA	
ENSG00000274952	KIR2DL3	NA	
ENSG00000277286	KIR2DP1	NA	
ENSG00000278738	KIR2DL1	NA	
ENSG00000277477	KIR3DP1	NA	
ENSG00000275822	AC011476.9	NA	
ENSG00000277786	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000275082	NLRP2	NA	
ENSG00000276211	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000278149	RDH13	NA	
ENSG00000275577	VSTM1	NA	
ENSG00000275384	TARM1	NA	
ENSG00000275644	OSCAR	NA	
ENSG00000276220	NDUFA3	NA	
ENSG00000276323	TFPT	NA	
ENSG00000275117	AC012314.8	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000274176	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000276774	LENG1	NA	
ENSG00000276260	AC012314.10	NA	
ENSG00000278322	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000274796	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000274626	RPS9	NA	
ENSG00000273884	LILRA3	NA	
ENSG00000278355	LILRA5	NA	
ENSG00000276798	LILRA4	NA	
ENSG00000276163	LAIR1	NA	
ENSG00000275196	KIR2DL1	NA	
ENSG00000276912	KIR3DP1	NA	
ENSG00000276979	KIR2DL4	NA	
ENSG00000275434	KIR3DS1	NA	
ENSG00000274143	KIR2DL5A	NA	
ENSG00000274739	KIR2DS3	NA	
ENSG00000278120	KIR2DS1	NA	
ENSG00000278707	KIR3DL2	NA	
ENSG00000275304	U6	NA	
ENSG00000278415	FCAR	NA	
ENSG00000278362	NCR1	NA	
ENSG00000274174	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000275796	NLRP2	NA	
ENSG00000275633	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000276826	RDH13	NA	
ENSG00000276066	VSTM1	NA	
ENSG00000277178	TARM1	NA	
ENSG00000278533	OSCAR	NA	
ENSG00000276766	NDUFA3	NA	
ENSG00000276263	TFPT	NA	
ENSG00000274651	AC012314.4	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000274941	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000276628	LENG1	NA	
ENSG00000274905	AC012314.7	NA	
ENSG00000278519	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000274078	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000277359	RPS9	NA	
ENSG00000275583	CU464060.1	NA	
ENSG00000288613	CU464060.2	NA	
ENSG00000274412	KIR2DL2	NA	
ENSG00000274921	KIR2DS4	NA	
ENSG00000274498	KIR3DP1	NA	
ENSG00000273911	KIR3DL2	NA	
ENSG00000273506	AC011476.4	NA	
ENSG00000277179	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000274638	NLRP2	NA	
ENSG00000278670	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000276341	RDH13	NA	
ENSG00000276363	VSTM1	NA	
ENSG00000276145	TARM1	NA	
ENSG00000276982	OSCAR	NA	
ENSG00000273642	NDUFA3	NA	
ENSG00000275086	TFPT	NA	
ENSG00000274894	AC012314.6	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000276082	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000275935	LENG1	NA	
ENSG00000274873	AC012314.5	NA	
ENSG00000277025	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000274672	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000275323	RPS9	NA	
ENSG00000276875	KIR3DL3	NA	
ENSG00000276468	KIR2DP1	NA	
ENSG00000275921	CU633846.1	NA	
ENSG00000277709	KIR3DL2	NA	
ENSG00000277629	AC011476.10	NA	
ENSG00000276804	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000275843	NLRP2	NA	
ENSG00000276065	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000273944	RDH13	NA	
ENSG00000276159	VSTM1	NA	
ENSG00000274889	TARM1	NA	
ENSG00000274703	OSCAR	NA	
ENSG00000278365	NDUFA3	NA	
ENSG00000276296	TFPT	NA	
ENSG00000276421	AC012314.12	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000275979	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000277457	LENG1	NA	
ENSG00000277996	AC012314.17	NA	
ENSG00000277733	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000275165	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000278081	RPS9	NA	
ENSG00000274533	KIR2DS4	NA	
ENSG00000276739	KIR3DL2	NA	
ENSG00000278296	U6	NA	
ENSG00000277824	AC011476.11	NA	
ENSG00000277776	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000275399	NLRP2	NA	
ENSG00000274566	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000275474	RDH13	NA	
ENSG00000274953	VSTM1	NA	
ENSG00000275123	TARM1	NA	
ENSG00000275551	OSCAR	NA	
ENSG00000275724	NDUFA3	NA	
ENSG00000273833	TFPT	NA	
ENSG00000277953	AC012314.16	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000273943	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000278426	LENG1	NA	
ENSG00000277667	AC012314.14	NA	
ENSG00000277923	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000273896	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000274005	RPS9	NA	
ENSG00000276572	KIR3DL3	NA	
ENSG00000275658	KIR2DL3	NA	
ENSG00000273753	KIR2DP1	NA	
ENSG00000276387	KIR2DS1	NA	
ENSG00000275838	KIR3DL2	NA	
ENSG00000273519	U6	NA	
ENSG00000273916	AC011476.5	NA	
ENSG00000277071	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000278789	NLRP2	NA	
ENSG00000274050	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000274504	RDH13	NA	
ENSG00000274887	VSTM1	NA	
ENSG00000275806	TARM1	NA	
ENSG00000277088	OSCAR	NA	
ENSG00000275605	NDUFA3	NA	
ENSG00000278161	TFPT	NA	
ENSG00000277707	AC012314.15	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000274616	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000278516	LENG1	NA	
ENSG00000274384	TMC4	NA	
ENSG00000273592	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000274129	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000274950	RPS9	NA	
ENSG00000275019	LILRB3	NA	
ENSG00000276720	CU151838.1	NA	
ENSG00000275539	LILRA6	NA	
ENSG00000273991	LILRB5	NA	
ENSG00000275889	U6	NA	
ENSG00000278137	CU151838.2	NA	
ENSG00000277751	LILRB2	NA	
ENSG00000274110	LAIR1	NA	
ENSG00000276887	TTYH1	NA	
ENSG00000278827	CU207370.1	NA	
ENSG00000274305	LENG8	NA	
ENSG00000274495	LENG9	NA	
ENSG00000273622	CDC42EP5	NA	
ENSG00000275819	LAIR2	NA	
ENSG00000276033	KIR3DX1	NA	
ENSG00000278634	LILRA2	NA	
ENSG00000277398	LILRA1	NA	
ENSG00000277807	LILRB1	NA	
ENSG00000278031	CU024913.1	NA	
ENSG00000276042	LILRB4	NA	
ENSG00000276447	LILRP1	NA	
ENSG00000276976	LILRP2	NA	
ENSG00000278729	KIR3DL3	NA	
ENSG00000277924	KIR2DL3	NA	
ENSG00000278169	KIR2DP1	NA	
ENSG00000274926	KIR2DL1	NA	
ENSG00000273880	KIR3DP1	NA	
ENSG00000274609	KIR2DL4	NA	
ENSG00000275545	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000276634	KIR2DS4	NA	
ENSG00000275566	KIR3DL2	NA	
ENSG00000276339	U6	NA	
ENSG00000275564	FCAR	NA	
ENSG00000273535	NCR1	NA	
ENSG00000278173	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000277060	NLRP2	NA	
ENSG00000278316	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000274418	RDH13	NA	
ENSG00000277607	VSTM1	NA	
ENSG00000273875	TARM1	NA	
ENSG00000278378	OSCAR	NA	
ENSG00000277722	NDUFA3	NA	
ENSG00000276022	TFPT	NA	
ENSG00000274144	AC012314.3	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000277615	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000278257	LENG1	NA	
ENSG00000278363	AC012314.18	NA	
ENSG00000274194	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000278712	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000277079	RPS9	NA	
ENSG00000277177	LILRA6	NA	
ENSG00000274311	LILRB5	NA	
ENSG00000275752	U6	NA	
ENSG00000273726	CU104682.1	NA	
ENSG00000274513	LILRB2	NA	
ENSG00000278046	LILRA3	NA	
ENSG00000275404	LILRA5	NA	
ENSG00000274185	LILRA4	NA	
ENSG00000278154	LAIR1	NA	
ENSG00000276452	LILRB1	NA	
ENSG00000276906	CU467612.1	NA	
ENSG00000278279	LILRB4	NA	
ENSG00000276526	LILRP1	NA	
ENSG00000275462	LILRP2	NA	
ENSG00000275960	KIR2DL2	NA	
ENSG00000274511	KIR3DL3	NA	
ENSG00000278300	KIR2DS2	NA	
ENSG00000278157	KIR3DP1	NA	
ENSG00000274053	AC011476.6	NA	
ENSG00000275483	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000278682	NLRP2	NA	
ENSG00000275931	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000278284	RDH13	NA	
ENSG00000275321	AC010329.3	NA	
ENSG00000280030	AC010329.4	NA	
ENSG00000275050	ZNF66	NA	
ENSG00000280428	BNIP3P24	NA	
ENSG00000274449	AC008463.2	NA	
ENSG00000274106	AC008463.1	NA	
ENSG00000278091	ZNF85	NA	
ENSG00000279318	AC008739.4	NA	
ENSG00000277976	KRT18P40	NA	
ENSG00000279974	AC008739.6	NA	
ENSG00000278780	ZNF430	NA	
ENSG00000262860	LSM14A	NA	
ENSG00000279389	GARRE1	NA	
ENSG00000262113	AC010614.1	NA	
ENSG00000276999	AC226770.1	NA	
ENSG00000280066	MTDHP4	NA	
ENSG00000279280	CCNYL6	NA	
ENSG00000280218	VN1R84P	NA	
ENSG00000274746	ZNF100	NA	
ENSG00000279112	BRI3BPP1	NA	
ENSG00000280271	AC092364.3	NA	
ENSG00000279614	AC092364.2	NA	
ENSG00000279566	ZNF43	NA	
ENSG00000282735	GARRE1	NA	
ENSG00000282746	AC010504.2	NA	
ENSG00000282019	GPI	613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY
ENSG00000274875	ZNF92P2	NA	
ENSG00000279577	AC073539.4	NA	
ENSG00000275641	PCGF7P	NA	
ENSG00000279661	MTDHP5	NA	
ENSG00000280210	VN1R85P	NA	
ENSG00000276219	ZNF676	NA	
ENSG00000279350	BNIP3P30	NA	
ENSG00000279902	AC073539.6	NA	
ENSG00000279731	AC073539.5	NA	
ENSG00000279552	ZNF729	NA	
ENSG00000279984	BNIP3P31	NA	
ENSG00000280726	AC243960.9	NA	
ENSG00000276944	AC243960.6	NA	
ENSG00000274857	PLEKHA3P1	NA	
ENSG00000281382	AC236970.1	NA	
ENSG00000280540	LINC01480	NA	
ENSG00000278565	CEACAM21	NA	
ENSG00000281556	AC243960.12	NA	
ENSG00000281224	AC243960.10	NA	
ENSG00000280470	CEACAMP3	NA	
ENSG00000281505	DNAJC19P2	NA	
ENSG00000274131	CEACAM4	NA	
ENSG00000281659	DNAJC19P3	NA	
ENSG00000280545	AC243960.8	NA	
ENSG00000281424	AC243960.11	NA	
ENSG00000280501	CEACAM7	NA	
ENSG00000278788	SBNO2	NA	
ENSG00000275962	VSTM1	NA	
ENSG00000276355	TARM1	NA	
ENSG00000275736	OSCAR	NA	
ENSG00000276061	NDUFA3	NA	
ENSG00000276504	TFPT	NA	
ENSG00000275885	PRPF31	600138	RETINITIS PIGMENTOSA 11; RP11
ENSG00000274041	AC012314.2	NA	
ENSG00000277600	CNOT3	618672	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF
ENSG00000276959	LENG1	NA	
ENSG00000273722	TMC4	NA	
ENSG00000275118	MBOAT7	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57
ENSG00000278605	TSEN34	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
ENSG00000276287	AC012314.11	NA	
ENSG00000278270	RPS9	NA	
ENSG00000273655	AC012314.1	NA	
ENSG00000274587	LILRB3	NA	
ENSG00000277190	AC010492.3	NA	
ENSG00000274345	AC010492.1	NA	
ENSG00000274148	LILRA6	NA	
ENSG00000277080	AC010492.2	NA	
ENSG00000278437	LILRB5	NA	
ENSG00000275299	U6	NA	
ENSG00000240042	AC098789.1	NA	
ENSG00000275463	LILRB2	NA	
ENSG00000275841	LILRA3	NA	
ENSG00000277961	AC010518.1	NA	
ENSG00000275951	AC008984.3	NA	
ENSG00000278402	AC008984.5	NA	
ENSG00000274113	LILRA5	NA	
ENSG00000275893	AC008984.2	NA	
ENSG00000276466	AC008984.4	NA	
ENSG00000274785	AC008984.1	NA	
ENSG00000277092	LILRA4	NA	
ENSG00000276053	LAIR1	NA	
ENSG00000276551	AC008746.5	NA	
ENSG00000275650	TTYH1	NA	
ENSG00000275137	AC008746.3	NA	
ENSG00000274045	AC008746.1	NA	
ENSG00000275797	AC008746.4	NA	
ENSG00000275470	LENG8-AS1	NA	
ENSG00000276681	LENG8	NA	
ENSG00000273574	LENG9	NA	
ENSG00000278444	CDC42EP5	NA	
ENSG00000277335	LAIR2	NA	
ENSG00000274968	AC008746.2	NA	
ENSG00000275918	KIR3DX1	NA	
ENSG00000276983	AC009892.2	NA	
ENSG00000275290	LILRA2	NA	
ENSG00000275440	AC009892.1	NA	
ENSG00000275525	LILRA1	NA	
ENSG00000278826	AC009892.3	NA	
ENSG00000277134	LILRB1	NA	
ENSG00000275274	LILRB1-AS1	NA	
ENSG00000275730	LILRB4	NA	
ENSG00000275984	AC011515.1	NA	
ENSG00000274881	LILRP1	NA	
ENSG00000274517	AC098784.1	NA	
ENSG00000273864	LILRP2	NA	
ENSG00000276196	KIR3DL3	NA	
ENSG00000274410	KIR2DL3	NA	
ENSG00000276503	KIR2DP1	NA	
ENSG00000278503	KIR2DL1	NA	
ENSG00000276041	KIR3DP1	NA	
ENSG00000274232	KIR2DL4	NA	
ENSG00000274036	KIR3DL1	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000273931	KIR2DS4	NA	
ENSG00000277181	KIR3DL2	NA	
ENSG00000273938	U6	NA	
ENSG00000274580	FCAR	NA	
ENSG00000275156	NCR1	NA	
ENSG00000274571	NLRP7	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1;;HYDATIDIFORM MOLE; HYDM;;HYDATIDIFORM MOLE, COMPLETE; CHM;;GESTATIONAL TROPHOBLASTIC DISEASE
ENSG00000273992	NLRP2	NA	
ENSG00000277439	GP6	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11;;GLYCOPROTEIN VI DEFICIENCY;;GP VI DEFICIENCY
ENSG00000274413	AC011476.7	NA	
ENSG00000276684	RDH13	NA	
ENSG00000282283	PLPPR3	NA	
ENSG00000278624	AZU1	NA	
ENSG00000277804	PRTN3	NA	
ENSG00000277571	ELANE	162800	CYCLIC NEUTROPENIA;;CYCLIC HEMATOPOIESIS
ENSG00000277571	ELANE	202700	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1
ENSG00000274619	CFD	613912	COMPLEMENT FACTOR D DEFICIENCY; CFDD;;FACTOR D DEFICIENCY
ENSG00000282092	MED16	NA	
ENSG00000281870	AC208814.1	NA	
ENSG00000280892	AL161638.3	NA	
ENSG00000281104	AL161638.4	NA	
ENSG00000276429	PLCH2	NA	
ENSG00000281225	AL139246.7	NA	
ENSG00000281274	AL139246.8	NA	
ENSG00000273494	PANK4	NA	
ENSG00000273529	HES5	NA	
ENSG00000281734	AL139246.9	NA	
ENSG00000281197	TNFRSF14-AS1	NA	
ENSG00000273936	TNFRSF14	NA	
ENSG00000280609	AL139246.6	NA	
ENSG00000281740	AL139246.10	NA	
ENSG00000275125	PRXL2B	NA	
ENSG00000277131	MMEL1	NA	
ENSG00000280645	MMEL1-AS1	NA	
ENSG00000275571	TTC34	NA	
ENSG00000275531	Metazoa_SRP	NA	
ENSG00000262767	GEMIN2P1	NA	
ENSG00000276295	Metazoa_SRP	NA	
ENSG00000262994	AC217323.1	NA	
ENSG00000262469	Y_RNA	NA	
ENSG00000262826	INTS3	NA	
ENSG00000263130	AL513523.7	NA	
ENSG00000263275	AL513523.8	NA	
ENSG00000269823	AL513523.9	NA	
ENSG00000263163	SLC27A3	NA	
ENSG00000262710	Y_RNA	NA	
ENSG00000262299	AL513523.6	NA	
ENSG00000261992	GATAD2B	615074	MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18
ENSG00000262025	AL513523.5	NA	
ENSG00000281216	KIF26B	NA	
ENSG00000280946	CR854858.2	NA	
ENSG00000276816	PRAMEF22	NA	
ENSG00000281597	CR854858.4	NA	
ENSG00000281229	CR854858.3	NA	
ENSG00000274109	HNRNPCL2	NA	
ENSG00000281711	CR854858.5	NA	
ENSG00000276299	PRAMEF25	NA	
ENSG00000273865	HNRNPCL4	NA	
ENSG00000281573	PRAMEF9	NA	
ENSG00000274107	CR854858.1	NA	
ENSG00000277853	PRAMEF18	NA	
ENSG00000281073	AC244216.1	NA	
ENSG00000276420	PRAMEF5	NA	
ENSG00000281121	AC244216.2	NA	
ENSG00000252239	U6	NA	
ENSG00000278021	PRAMEF8	NA	
ENSG00000276370	PRAMEF33	NA	
ENSG00000262734	AC217785.2	NA	
ENSG00000261905	AC217785.1	NA	
ENSG00000263231	AC217785.3	NA	
ENSG00000263037	MTX1P1	NA	
ENSG00000262446	GBA	168600	PARKINSON DISEASE, LATE-ONSET; PD;;PARK
ENSG00000262446	GBA	127750	DEMENTIA, LEWY BODY; DLB;;LEWY BODY DEMENTIA;;DIFFUSE LEWY BODY DISEASE DIFFUSE LEWY BODY DISEASE WITH GAZE PALSY, INCLUDED;;LEWY BODY VARIANT OF ALZHEIMER DISEASE, INCLUDED
ENSG00000262446	GBA	230800	GAUCHER DISEASE, TYPE I;;GD I;;GAUCHER DISEASE, NONCEREBRAL JUVENILE;;GLUCOCEREBROSIDASE DEFICIENCY;;ACID BETA-GLUCOSIDASE DEFICIENCY;;GBA DEFICIENCY
ENSG00000262446	GBA	230900	GAUCHER DISEASE, TYPE II;;GD II;;GAUCHER DISEASE, ACUTE NEURONOPATHIC TYPE
ENSG00000262446	GBA	231000	GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRAL  GAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;; /.../R DISEASE, NORRBOTTNIAN TYPE, INCLUDED
ENSG00000262446	GBA	231005	GAUCHER DISEASE, TYPE IIIC
ENSG00000262446	GBA	608013	GAUCHER DISEASE, PERINATAL LETHAL;;GAUCHER DISEASE, COLLODION TYPE
ENSG00000262666	FAM189B	NA	
ENSG00000263290	SCAMP3	NA	
ENSG00000261893	CLK2	NA	
ENSG00000263324	HCN3	NA	
ENSG00000262785	PKLR	102900	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES;;PYRUVATE KINASE HYPERACTIVITY
ENSG00000262785	PKLR	266200	PYRUVATE KINASE DEFICIENCY OF RED CELLS;;PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE;;PK DEFICIENCY
ENSG00000274870	OR2T4	NA	
ENSG00000278689	OR2T6	NA	
ENSG00000275244	OR2T1	NA	
ENSG00000281395	OR2T7	NA	
ENSG00000276821	OR2T2	NA	
ENSG00000278377	OR2T3	NA	
ENSG00000273827	OR2T5	NA	
ENSG00000263014	ATP6V1G3	NA	
ENSG00000262375	AL157402.4	NA	
ENSG00000262418	PTPRC	608971	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE;;SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE
ENSG00000262418	PTPRC	609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO;;HCV, SUSCEPTIBILITY TO HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED;;HCV, RESISTANCE TO, INCLUDED;;HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF, INCLUDED
ENSG00000262237	AL157402.3	NA	
ENSG00000262210	PEBP1P3	NA	
ENSG00000280891	AL606534.6	NA	
ENSG00000280534	LINC01347	NA	
ENSG00000280994	LINC01347	NA	
ENSG00000277580	RNU6-747P	NA	
ENSG00000276725	CEP170	NA	
ENSG00000276111	SDCCAG8	613615	SENIOR-LOKEN SYNDROME 7; SLSN7
ENSG00000276111	SDCCAG8	615993	BARDET-BIEDL SYNDROME 16; BBS16
ENSG00000275199	AKT3	615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2
ENSG00000280906	AC225099.1	NA	
ENSG00000273990	RNVU1-26	NA	
ENSG00000273757	RNVU1-2A	NA	
ENSG00000274574	U1	NA	
ENSG00000281416	AC006359.4	NA	
ENSG00000280708	AC006359.3	NA	
ENSG00000275974	PPIAL4F	NA	
ENSG00000280579	AC006359.2	NA	
ENSG00000280460	AC006359.1	NA	
ENSG00000275617	OR2T4	NA	
ENSG00000278659	OR2T6	NA	
ENSG00000273508	OR2T1	NA	
ENSG00000281489	OR2T7	NA	
ENSG00000275754	OR2T2	NA	
ENSG00000277113	OR2T3	NA	
ENSG00000281658	AC138089.2	NA	
ENSG00000275102	OR2T5	NA	
ENSG00000280815	OR2AS2P	NA	
ENSG00000262517	AL035045.2	NA	
ENSG00000262640	AC207480.1	NA	
ENSG00000262802	AL035045.3	NA	
ENSG00000280641	CDH4	NA	
ENSG00000280529	TAF4	NA	
ENSG00000277044	OPRL1	NA	
ENSG00000277339	NPBWR2	NA	
ENSG00000280695	AC226131.1	NA	
ENSG00000276876	MYT1	NA	
ENSG00000275018	AL121581.1	NA	
ENSG00000280663	PCMTD2	NA	
ENSG00000281151	KCNQ2	121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1 EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED
ENSG00000281151	KCNQ2	613720	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7
ENSG00000281914	AL353658.2	NA	
ENSG00000281651	KCNQ2-AS1	NA	
ENSG00000262510	LINC00308	NA	
ENSG00000262752	AP000705.5	NA	
ENSG00000261847	AP000705.3	NA	
ENSG00000262704	RNU4-45P	NA	
ENSG00000262476	AP000705.4	NA	
ENSG00000263141	PAXBP1	NA	
ENSG00000263140	C21orf62-AS1	NA	
ENSG00000280072	AP000280.2	NA	
ENSG00000262938	C21orf62	NA	
ENSG00000262795	IFNGR2	614889	IMMUNODEFICIENCY 28; IMD28;;IMMUNODEFICIENCY 28, MYCOBACTERIOSIS;;IFNGR2 DEFICIENCY
ENSG00000263160	TMEM50B	NA	
ENSG00000262148	RPS5P3	NA	
ENSG00000263314	AC207981.1	NA	
ENSG00000262911	DNAJC28	NA	
ENSG00000262473	GART	NA	
ENSG00000281775	FTCD	229100	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY;;FORMIMINOTRANSFERASE DEFICIENCY;;FORMIMINOGLUTAMIC ACIDURIA;;FIGLU-URIA
ENSG00000280541	FTCD-AS1	NA	
ENSG00000274679	SPATC1L	NA	
ENSG00000281753	AP001468.2	NA	
ENSG00000281289	LSS	616509	CATARACT 44; CTRCT44;;CATARACT 44 AND HYPOTRICHOSIS
ENSG00000281289	LSS	618275	HYPOTRICHOSIS 14; HYPT14
ENSG00000281289	LSS	618840	ALOPECIA-MENTAL RETARDATION SYNDROME 4; APMR4
ENSG00000281484	BTG3	NA	
ENSG00000281317	BTG3-AS1	NA	
ENSG00000280972	AP000432.4	NA	
ENSG00000280882	AP000432.3	NA	
ENSG00000280542	AC208585.1	NA	
ENSG00000280681	NEK4P1	NA	
ENSG00000280973	AP000457.2	NA	
ENSG00000272901	SMDT1	NA	
ENSG00000272765	NDUFA6	618253	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33
ENSG00000273616	NDUFA6-DT	NA	
ENSG00000272813	OLA1P1	NA	
ENSG00000262303	AL021878.1	NA	
ENSG00000263181	CYP2D7	NA	
ENSG00000262055	CYP2D8P	NA	
ENSG00000262024	TCF20	618430	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA
ENSG00000262453	AL022318.3	NA	
ENSG00000262536	AC192820.1	NA	
ENSG00000262156	APOBEC3A	NA	
ENSG00000262679	APOBEC3B-AS1	NA	
ENSG00000281145	IGLV5-45	NA	
ENSG00000274854	IGLV1-44	NA	
ENSG00000278293	IGLV7-43	NA	
ENSG00000281361	IGLVI-42	NA	
ENSG00000281536	AC009286.3	NA	
ENSG00000281074	IGLVVII-41-1	NA	
ENSG00000281565	IGLV1-41	NA	
ENSG00000274575	IGLV1-40	NA	
ENSG00000281502	ASH2LP1	NA	
ENSG00000280941	IGLVI-38	NA	
ENSG00000281471	IGLV5-37	NA	
ENSG00000273737	IGLV1-36	NA	
ENSG00000280754	AC009286.1	NA	
ENSG00000280825	IGLV7-35	NA	
ENSG00000281326	AC009286.2	NA	
ENSG00000277421	ZNF280B	NA	
ENSG00000275499	ZNF280A	NA	
ENSG00000275013	PRAME	NA	
ENSG00000281296	LL22NC03-63E9.3	NA	
ENSG00000281055	IGLV2-34	NA	
ENSG00000281345	IGLV2-33	NA	
ENSG00000280866	IGLV3-32	NA	
ENSG00000281493	IGLV3-31	NA	
ENSG00000281031	IGLV3-30	NA	
ENSG00000280984	AL049748.2	NA	
ENSG00000280782	MRPS16P3	NA	
ENSG00000277390	APOL5	NA	
ENSG00000277564	RBFOX2	NA	
ENSG00000274665	PVALB	NA	
ENSG00000281401	Z82185.2	NA	
ENSG00000281093	NCF4-AS1	NA	
ENSG00000275990	NCF4	613960	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III; CDG3;;CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVE, TYPE III;;GRANULOMATOUS DISEASE, CHRONIC, DUE TO NCF4 DEFICIENCY
ENSG00000280839	CES5AP1	NA	
ENSG00000281076	ZDHHC8P1	NA	
ENSG00000281149	AP000344.3	NA	
ENSG00000280986	LINC01659	NA	
ENSG00000281374	AP000344.4	NA	
ENSG00000274657	FAM230I	NA	
ENSG00000281077	LINC02557	NA	
ENSG00000273579	C22orf15	NA	
ENSG00000273607	CHCHD10	615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ
ENSG00000273607	CHCHD10	615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2
ENSG00000273607	CHCHD10	616209	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD
ENSG00000275365	MMP11	NA	
ENSG00000267954	AP000349.1	NA	
ENSG00000275837	SMARCB1	162091	SCHWANNOMATOSIS 1; SWNTS1;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS
ENSG00000275837	SMARCB1	609322	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1;;BRAIN TUMOR, POSTERIOR FOSSA, OF INFANCY, FAMILIAL MALIGNANT RHABDOID TUMOR, SOMATIC, INCLUDED;;RHABDOID TUMOR, INCLUDED; RDT, INCLUDED;;TERATOID TUMOR, ATYPICAL, INCLUDED;;AT/RT, INCLUDED
ENSG00000275837	SMARCB1	614608	COFFIN-SIRIS SYNDROME 3; CSS3;;MENTAL RETARDATION, AUTOSOMAL DOMINANT 15; MRD15
ENSG00000274437	DERL3	NA	
ENSG00000281354	AP000350.13	NA	
ENSG00000275744	SLC2A11	NA	
ENSG00000281287	AP000350.12	NA	
ENSG00000281180	AP000350.10	NA	
ENSG00000277187	RN7SL268P	NA	
ENSG00000276701	MIF	604302	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE;;SYSTEMIC JUVENILE RHEUMATOID ARTHRITIS
ENSG00000281335	MIF-AS1	NA	
ENSG00000281582	AP000350.14	NA	
ENSG00000281900	AP000350.15	NA	
ENSG00000281065	AP000350.9	NA	
ENSG00000280601	AP000350.8	NA	
ENSG00000278695	GSTT2B	NA	
ENSG00000281265	AP000350.11	NA	
ENSG00000275758	DDTL	NA	
ENSG00000281400	AP000351.8	NA	
ENSG00000275003	DDT	NA	
ENSG00000281722	AP000351.9	NA	
ENSG00000277897	GSTT2	NA	
ENSG00000281276	AP000351.6	NA	
ENSG00000281748	GSTT4	NA	
ENSG00000280929	AP000351.4	NA	
ENSG00000278401	AP000351.3	NA	
ENSG00000276636	AP000351.1	NA	
ENSG00000277507	AP000351.2	NA	
ENSG00000277656	GSTT1	NA	
ENSG00000281310	AP000351.7	NA	
ENSG00000280940	AP000351.5	NA	
ENSG00000281670	CABIN1	NA	
ENSG00000272835	SMDT1	NA	
ENSG00000273397	NDUFA6	618253	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33
ENSG00000280750	AL021878.3	NA	
ENSG00000280613	NDUFA6-DT	NA	
ENSG00000273194	OLA1P1	NA	
ENSG00000272532	CYP2D6	608902	DRUG METABOLISM, POOR, CYP2D6-RELATED DRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED;;DEBRISOQUINE, POOR METABOLISM OF, INCLUDED;;DEBRISOQUINE, ULTRARAPID METABOLISM OF, INCLUDED;;SPARTEINE, POOR METABOLISM OF, INCLUDED;;NORTRIPTYLINE, POOR M /.../ISM OF, INCLUDED;;CODEINE, ULTRARAPID METABOLISM OF, INCLUDED
ENSG00000281417	AC236040.3	NA	
ENSG00000272000	AC236040.1	NA	
ENSG00000280821	AC236040.2	NA	
ENSG00000274112	SMDT1	NA	
ENSG00000277365	NDUFA6	618253	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33
ENSG00000281542	AL021878.4	NA	
ENSG00000280811	NDUFA6-DT	NA	
ENSG00000278846	OLA1P1	NA	
ENSG00000275211	CYP2D6	608902	DRUG METABOLISM, POOR, CYP2D6-RELATED DRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED;;DEBRISOQUINE, POOR METABOLISM OF, INCLUDED;;DEBRISOQUINE, ULTRARAPID METABOLISM OF, INCLUDED;;SPARTEINE, POOR METABOLISM OF, INCLUDED;;NORTRIPTYLINE, POOR M /.../ISM OF, INCLUDED;;CODEINE, ULTRARAPID METABOLISM OF, INCLUDED
ENSG00000280556	BX247885.1	NA	
ENSG00000280880	BX247885.2	NA	
ENSG00000278088	CYP2D7	NA	
ENSG00000273785	CYP2D8P	NA	
ENSG00000276461	TCF20	618430	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA
ENSG00000274891	TRAPPC12	617669	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS
ENSG00000280770	AC216281.1	NA	
ENSG00000281723	AC114810.2	NA	
ENSG00000280830	ADI1	NA	
ENSG00000280733	LINC01238	NA	
ENSG00000280591	AC237191.1	NA	
ENSG00000280691	AC237191.2	NA	
ENSG00000280980	LINC01880	NA	
ENSG00000281782	AC093642.4	NA	
ENSG00000278476	RPL21P36	NA	
ENSG00000279215	CRIM1-DT	NA	
ENSG00000277354	CRIM1	NA	
ENSG00000281095	AC233263.5	NA	
ENSG00000281668	IGKV1OR2-118	NA	
ENSG00000280917	AC241851.1	NA	
ENSG00000280944	AC241851.2	NA	
ENSG00000275326	NOSTRIN	NA	
ENSG00000277909	SPC25	NA	
ENSG00000278373	G6PC2	NA	
ENSG00000276582	ABCB11	601847	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2
ENSG00000276582	ABCB11	605479	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2
ENSG00000281806	AC208876.2	NA	
ENSG00000280538	AC208876.1	NA	
ENSG00000281362	LINC01115	NA	
ENSG00000281213	LINC01238	NA	
ENSG00000281099	AC244167.1	NA	
ENSG00000281268	AC244167.2	NA	
ENSG00000280943	LINC01880	NA	
ENSG00000281519	AC093642.3	NA	
ENSG00000281078	IGKV1D-8	NA	
ENSG00000281759	AC145029.2	NA	
ENSG00000275777	IGKV3D-7	NA	
ENSG00000280768	AC145029.1	NA	
ENSG00000280572	IGKV1OR2-118	NA	
ENSG00000280569	AC233263.4	NA	
ENSG00000280491	AC233263.3	NA	
ENSG00000276734	KIF5C	615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2
ENSG00000281486	SNTG2	NA	
ENSG00000276126	GAL3ST2	NA	
ENSG00000281082	AC131097.4	NA	
ENSG00000281624	AC131097.5	NA	
ENSG00000277926	NEU4	NA	
ENSG00000281648	AC131097.6	NA	
ENSG00000276977	PDCD1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000276977	PDCD1	605218	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2
ENSG00000277949	RTP5	NA	
ENSG00000280686	LINC01237	NA	
ENSG00000281553	FAM240C	NA	
ENSG00000274392	C2orf27A	NA	
ENSG00000281848	TOMM40P4	NA	
ENSG00000274362	C2orf27B	NA	
ENSG00000281020	SNTG2	NA	
ENSG00000281232	AC108489.1	NA	
ENSG00000277603	TPO	274500	THYROID DYSHORMONOGENESIS 2A; TDH2A;;THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A;;HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2A;;IODIDE PEROXIDASE DEFICIENCY;;THYROID PEROXIDASE DEFICIENCY
ENSG00000279643	TAMM41	NA	
ENSG00000282035	AC090958.3	NA	
ENSG00000266488	AC226154.2	NA	
ENSG00000264064	AC226154.1	NA	
ENSG00000265773	NUP210P2	NA	
ENSG00000266576	MARK2P14	NA	
ENSG00000266695	AC090958.2	NA	
ENSG00000266381	Metazoa_SRP	NA	
ENSG00000262411	LINC02066	NA	
ENSG00000261846	AADACL2	NA	
ENSG00000262466	AADACL2-AS1	NA	
ENSG00000281188	AC233280.10	NA	
ENSG00000281562	AC233280.11	NA	
ENSG00000281564	AC233280.12	NA	
ENSG00000282953	MUC20-OT1	NA	
ENSG00000281334	SDHAP2	NA	
ENSG00000276583	MUC20	NA	
ENSG00000277585	MUC4	NA	
ENSG00000281157	ARHGEF26-AS1	NA	
ENSG00000277101	ARHGEF26	NA	
ENSG00000281763	DHX36	NA	
ENSG00000280611	AC128709.4	NA	
ENSG00000280749	AC231647.1	NA	
ENSG00000281360	AC231647.2	NA	
ENSG00000275544	BDH1	NA	
ENSG00000280552	AC107622.1	NA	
ENSG00000281798	AC233280.16	NA	
ENSG00000280629	AC233280.5	NA	
ENSG00000280993	MUC20-OT1	NA	
ENSG00000280909	SDHAP2	NA	
ENSG00000274843	MUC20	NA	
ENSG00000273822	MUC4	NA	
ENSG00000281246	AF186996.7	NA	
ENSG00000280982	AF186996.5	NA	
ENSG00000281785	AF186996.9	NA	
ENSG00000280597	AF186996.4	NA	
ENSG00000280996	AF186996.6	NA	
ENSG00000281363	AF186996.8	NA	
ENSG00000280813	AC092902.3	NA	
ENSG00000281743	AC233280.15	NA	
ENSG00000281094	AC233280.9	NA	
ENSG00000281794	MUC20-OT1	NA	
ENSG00000281237	SDHAP2	NA	
ENSG00000278114	MUC20	NA	
ENSG00000278468	MUC4	NA	
ENSG00000281250	LINC02054	NA	
ENSG00000281738	LINC01839	NA	
ENSG00000281821	AC233280.17	NA	
ENSG00000280865	AC233280.8	NA	
ENSG00000280482	AC233280.3	NA	
ENSG00000281603	MUC20-OT1	NA	
ENSG00000280521	SDHAP2	NA	
ENSG00000277753	MUC20	NA	
ENSG00000278303	MUC4	NA	
ENSG00000280506	AC233280.4	NA	
ENSG00000280631	AC233280.6	NA	
ENSG00000280512	MUC20-OT1	NA	
ENSG00000280912	SDHAP2	NA	
ENSG00000275501	MUC20	NA	
ENSG00000275164	MUC4	NA	
ENSG00000281583	AC233280.13	NA	
ENSG00000281654	AC233280.14	NA	
ENSG00000281915	MUC20-OT1	NA	
ENSG00000281418	SDHAP2	NA	
ENSG00000281630	MUC20	NA	
ENSG00000273984	MUC4	NA	
ENSG00000281901	AC233280.18	NA	
ENSG00000280748	AC233280.7	NA	
ENSG00000281060	MUC20-OT1	NA	
ENSG00000281687	SDHAP2	NA	
ENSG00000275430	MUC20	NA	
ENSG00000276613	MUC4	NA	
ENSG00000281617	AC073135.6	NA	
ENSG00000274706	RNU6-821P	NA	
ENSG00000281062	AC240720.1	NA	
ENSG00000281503	AC240720.2	NA	
ENSG00000281577	AC240720.3	NA	
ENSG00000276938	AC073135.4	NA	
ENSG00000281496	AC073135.5	NA	
ENSG00000278747	U6	NA	
ENSG00000267639	AC073135.3	NA	
ENSG00000267237	AC073135.2	NA	
ENSG00000262505	AC093830.1	NA	
ENSG00000262635	TDO2	600627	HYPERTRYPTOPHANEMIA; HYPTRP;;HYPERTRYPTOPHANEMIA, FAMILIAL
ENSG00000263238	CTSO	NA	
ENSG00000281758	KCNIP4	NA	
ENSG00000280838	AC210756.1	NA	
ENSG00000281559	AC096576.5	NA	
ENSG00000281470	AC096576.4	NA	
ENSG00000263270	AC093689.2	NA	
ENSG00000275272	YTHDC1	NA	
ENSG00000278061	MT2P1	NA	
ENSG00000274058	TMPRSS11E	NA	
ENSG00000281547	UGT2B29P	NA	
ENSG00000277132	UGT2B15	NA	
ENSG00000281154	AC019173.1	NA	
ENSG00000280740	AC226496.4	NA	
ENSG00000280626	AC226496.2	NA	
ENSG00000275190	UGT2B10	NA	
ENSG00000280720	AC226496.3	NA	
ENSG00000281174	AC226496.7	NA	
ENSG00000281890	AC226496.10	NA	
ENSG00000280578	AC226496.1	NA	
ENSG00000280794	AC226496.5	NA	
ENSG00000281704	AC226496.9	NA	
ENSG00000281127	AC226496.6	NA	
ENSG00000281612	AC226496.8	NA	
ENSG00000278216	UGT2A3	NA	
ENSG00000281510	AC021146.15	NA	
ENSG00000280504	AC021146.13	NA	
ENSG00000280525	AC021146.14	NA	
ENSG00000281308	UGT2B27P	NA	
ENSG00000280621	AC110772.3	NA	
ENSG00000281916	AF250324.4	NA	
ENSG00000276052	RNU1-51P	NA	
ENSG00000280716	FRG1-DT	NA	
ENSG00000281830	LINC01596	NA	
ENSG00000281122	AC108866.1	NA	
ENSG00000281482	AC093789.2	NA	
ENSG00000281800	ICE2P1	NA	
ENSG00000281580	LINC01060	NA	
ENSG00000280590	AF250324.2	NA	
ENSG00000277908	RNU1-51P	NA	
ENSG00000281543	FRG1-DT	NA	
ENSG00000281015	LINC01596	NA	
ENSG00000275145	FRG1	158900	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHY FACIO /.../OHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS AND TORTUOSITY OF RETINAL ARTERIOLES, INCLUDED
ENSG00000280930	AC226374.1	NA	
ENSG00000280732	AF146191.2	NA	
ENSG00000173876	TUBB7P	NA	
ENSG00000277584	5S_rRNA	NA	
ENSG00000275999	5S_rRNA	NA	
ENSG00000276616	DUX4L9	NA	
ENSG00000274972	FRG2	NA	
ENSG00000281409	AF146191.3	NA	
ENSG00000281610	HSP90AA4P	NA	
ENSG00000280513	LINC01262	NA	
ENSG00000280853	AF250324.3	NA	
ENSG00000274208	U1	NA	
ENSG00000281787	FRG1-DT	NA	
ENSG00000281377	LINC01596	NA	
ENSG00000273954	LINC01194	NA	
ENSG00000278019	AC245690.1	NA	
ENSG00000281703	AC245690.2	NA	
ENSG00000280638	CDH12P2	NA	
ENSG00000277429	SERF1B	NA	
ENSG00000273772	SMN2	253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE
ENSG00000273772	SMN2	253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3;;SMA III;;MUSCULAR ATROPHY, JUVENILE;;KUGELBERG-WELANDER SYNDROME; KWS;;SPINAL MUSCULAR ATROPHY, MILD CHILDHOOD AND ADOLESCENT FORM
ENSG00000273772	SMN2	253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2;;SMA II;;MUSCULAR ATROPHY, SPINAL, INTERMEDIATE TYPE;;MUSCULAR ATROPHY, SPINAL, INFANTILE CHRONIC FORM
ENSG00000273772	SMN2	271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4;;SPINAL MUSCULAR ATROPHY, ADULT FORM;;SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL RECESSIVE
ENSG00000285263	AC244635.3	NA	
ENSG00000281380	AC244635.2	NA	
ENSG00000280983	AC244635.1	NA	
ENSG00000275581	SERF1A	NA	
ENSG00000275349	SMN1	253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE
ENSG00000275349	SMN1	253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3;;SMA III;;MUSCULAR ATROPHY, JUVENILE;;KUGELBERG-WELANDER SYNDROME; KWS;;SPINAL MUSCULAR ATROPHY, MILD CHILDHOOD AND ADOLESCENT FORM
ENSG00000275349	SMN1	253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2;;SMA II;;MUSCULAR ATROPHY, SPINAL, INTERMEDIATE TYPE;;MUSCULAR ATROPHY, SPINAL, INFANTILE CHRONIC FORM
ENSG00000275349	SMN1	271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4;;SPINAL MUSCULAR ATROPHY, ADULT FORM;;SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL RECESSIVE
ENSG00000285240	AC244260.2	NA	
ENSG00000276068	NAIP	NA	
ENSG00000276910	GTF2H2	NA	
ENSG00000280518	AC244260.1	NA	
ENSG00000281650	AC243922.3	NA	
ENSG00000281425	AC243922.2	NA	
ENSG00000278562	AC243922.1	NA	
ENSG00000281321	LINC02197	NA	
ENSG00000281210	AC245931.2	NA	
ENSG00000280840	PMCHL2	NA	
ENSG00000280619	AC245931.1	NA	
ENSG00000274803	BDP1	618257	DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112
ENSG00000281742	MCCC2	210210	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D;;MCC2 DEFICIENCY;;3-@METHYLCROTONYLGLYCINURIA II;;METHYLCROTONYLGLYCINURIA, TYPE II
ENSG00000262513	AC091996.1	NA	
ENSG00000262922	RNU6-164P	NA	
ENSG00000277995	AC025771.2	NA	
ENSG00000275151	AC025771.1	NA	
ENSG00000274882	LINC02109	NA	
ENSG00000279969	AC112172.1	NA	
ENSG00000278461	MRPS36	NA	
ENSG00000277273	CDK7	NA	
ENSG00000277868	CCDC125	NA	
ENSG00000275282	CFL1P5	NA	
ENSG00000275346	CHCHD2P2	NA	
ENSG00000279830	NDUFB9P1	NA	
ENSG00000279247	AK6	NA	
ENSG00000276463	TAF9	NA	
ENSG00000276618	RAD17	NA	
ENSG00000274671	MARVELD2	610153	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
ENSG00000274567	RPS27P14	NA	
ENSG00000278096	AC142525.2	NA	
ENSG00000275420	Metazoa_SRP	NA	
ENSG00000273814	OCLN	251290	PSEUDO-TORCH SYNDROME 1; PTORCH1;;PSEUDO-TORCH SYNDROME; BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA; BLCPMG
ENSG00000277139	U6	NA	
ENSG00000280514	AC142525.4	NA	
ENSG00000275045	GTF2H2	NA	
ENSG00000274434	AC142525.1	NA	
ENSG00000278613	NAIP	NA	
ENSG00000279234	AC142525.3	NA	
ENSG00000280235	AC139494.7	NA	
ENSG00000277773	SMN2	253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE
ENSG00000277773	SMN2	253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3;;SMA III;;MUSCULAR ATROPHY, JUVENILE;;KUGELBERG-WELANDER SYNDROME; KWS;;SPINAL MUSCULAR ATROPHY, MILD CHILDHOOD AND ADOLESCENT FORM
ENSG00000277773	SMN2	253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2;;SMA II;;MUSCULAR ATROPHY, SPINAL, INTERMEDIATE TYPE;;MUSCULAR ATROPHY, SPINAL, INFANTILE CHRONIC FORM
ENSG00000277773	SMN2	271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4;;SPINAL MUSCULAR ATROPHY, ADULT FORM;;SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL RECESSIVE
ENSG00000285499	AC139494.8	NA	
ENSG00000278839	SERF1B	NA	
ENSG00000273656	AC139494.1	NA	
ENSG00000275311	AC139494.3	NA	
ENSG00000277036	AC139494.6	NA	
ENSG00000273847	AC139494.2	NA	
ENSG00000276909	AC139494.5	NA	
ENSG00000275825	AC139494.4	NA	
ENSG00000275536	AC118459.1	NA	
ENSG00000277606	GUSBP1	NA	
ENSG00000276794	AC108108.1	NA	
ENSG00000273715	AC138827.1	NA	
ENSG00000273909	AC138827.2	NA	
ENSG00000274675	GTF2H2C_2	NA	
ENSG00000274741	AC138827.3	NA	
ENSG00000277219	NAIPP4	NA	
ENSG00000273935	CDH12P4	NA	
ENSG00000273799	AC146335.1	NA	
ENSG00000275192	LINC02197	NA	
ENSG00000277680	AC139463.1	NA	
ENSG00000275396	PMCHL2	NA	
ENSG00000276297	AC138832.3	NA	
ENSG00000273873	BDP1	618257	DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112
ENSG00000274506	AC138832.2	NA	
ENSG00000274138	HMGN1P12	NA	
ENSG00000275300	MCCC2	210210	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D;;MCC2 DEFICIENCY;;3-@METHYLCROTONYLGLYCINURIA II;;METHYLCROTONYLGLYCINURIA, TYPE II
ENSG00000281464	AC106795.8	NA	
ENSG00000275495	AC114936.1	NA	
ENSG00000281081	AC114936.3	NA	
ENSG00000281048	AC114936.2	NA	
ENSG00000281513	AC114936.4	NA	
ENSG00000274681	SUDS3P1	NA	
ENSG00000280635	PROP1	262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM
ENSG00000274811	CLPTM1L	NA	
ENSG00000281736	LINC01511	NA	
ENSG00000281511	MTCO2P32	NA	
ENSG00000280841	AC026748.2	NA	
ENSG00000276996	SLC6A3	188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO;;CIGARETTE HABITUATION, SUSCEPTIBILITY TO;;SMOKING HABIT, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO;;NICOTINE ADDICTION, SUSCEPTIBILITY TO;;NICOTINE DEPENDENCE, PROTECTION AGAINST
ENSG00000276996	SLC6A3	613135	PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1;;PKDYS;;DOPAMINE TRANSPORTER DEFICIENCY SYNDROME; DTDS
ENSG00000275079	LPCAT1	NA	
ENSG00000280559	AC106795.6	NA	
ENSG00000278666	AC106795.4	NA	
ENSG00000280647	AC106795.7	NA	
ENSG00000281644	AC106795.9	NA	
ENSG00000280971	AC236592.1	NA	
ENSG00000281351	SUDS3P1	NA	
ENSG00000274382	PROP1	262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM
ENSG00000281019	AC116351.3	NA	
ENSG00000281521	AC116351.4	NA	
ENSG00000276920	NKD2	NA	
ENSG00000276482	SLC12A7	NA	
ENSG00000281036	AC109471.2	NA	
ENSG00000276134	RN7SKP117	NA	
ENSG00000281609	AC109471.3	NA	
ENSG00000281861	SLC9A3	616868	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8;;DIARRHEA, CONGENITAL SODIUM; CSD
ENSG00000280666	AC106772.3	NA	
ENSG00000280978	AC106772.4	NA	
ENSG00000280688	CEP72	NA	
ENSG00000281690	ADAMTS12	NA	
ENSG00000277091	U6	NA	
ENSG00000277069	RXFP3	NA	
ENSG00000281919	SLC45A2	227240	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5;;SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR;;SKIN/HAIR/EYE PIGMENTATION 5, DARK/LIGHT EYES;;SKIN/HAIR/EYE PIGMENTATION 5, DARK/FAIR SKIN
ENSG00000281919	SLC45A2	606574	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV
ENSG00000278697	AL078601.5	NA	
ENSG00000273605	AC209234.1	NA	
ENSG00000282623	AL078601.6	NA	
ENSG00000273741	AL078601.3	NA	
ENSG00000277783	AL078601.4	NA	
ENSG00000281421	AL513210.3	NA	
ENSG00000281625	AL354892.5	NA	
ENSG00000281410	AL354892.4	NA	
ENSG00000275368	TCTE3	NA	
ENSG00000276187	ERMARD	615544	PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6
ENSG00000281833	AL354892.6	NA	
ENSG00000280868	LINC00242	NA	
ENSG00000281305	LINC00574	NA	
ENSG00000281249	AL049612.2	NA	
ENSG00000280592	LINC01624	NA	
ENSG00000280883	AL078605.2	NA	
ENSG00000275555	DLL1	618709	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS
ENSG00000275333	FAM120B	NA	
ENSG00000281761	AL078605.3	NA	
ENSG00000280722	AL008628.2	NA	
ENSG00000281184	PSMB1	NA	
ENSG00000280737	LINC02549	NA	
ENSG00000281567	SLC25A51P1	NA	
ENSG00000277364	ADH5P4	NA	
ENSG00000280814	AL356432.5	NA	
ENSG00000280658	AL356432.4	NA	
ENSG00000281054	AL356432.6	NA	
ENSG00000281270	LINC02536	NA	
ENSG00000275122	THEMIS	NA	
ENSG00000281841	MRPS17P5	NA	
ENSG00000273993	PTPRK	NA	
ENSG00000280612	PTPRK-AS1	NA	
ENSG00000281853	AL034349.2	NA	
ENSG00000280784	AL121956.3	NA	
ENSG00000280765	AL121956.2	NA	
ENSG00000280557	GNG5P1	NA	
ENSG00000280898	AC233714.1	NA	
ENSG00000275798	AC226007.1	NA	
ENSG00000277263	AL662796.1	NA	
ENSG00000272603	NOP56P1	NA	
ENSG00000272793	CR759954.1	NA	
ENSG00000272857	LINC01623	NA	
ENSG00000272613	RPL13P	NA	
ENSG00000236614	ZNF90P2	NA	
ENSG00000234411	HCG14	NA	
ENSG00000234495	TRIM27	NA	
ENSG00000264025	U6	NA	
ENSG00000224642	HCG15	NA	
ENSG00000241408	CR759957.1	NA	
ENSG00000225351	ZNF311	NA	
ENSG00000236070	OR2AD1P	NA	
ENSG00000226463	OR2W1	NA	
ENSG00000233054	OR2B3	NA	
ENSG00000234305	OR2J1	NA	
ENSG00000226271	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000224229	CR942175.1	NA	
ENSG00000229040	CR774181.1	NA	
ENSG00000225550	OR2J2	NA	
ENSG00000226799	CR936918.1	NA	
ENSG00000230754	OR2U2P	NA	
ENSG00000237690	CR936918.2	NA	
ENSG00000236927	OR14J1	NA	
ENSG00000242289	OR5V1	NA	
ENSG00000232289	OR11A1	NA	
ENSG00000230505	OR10C1	NA	
ENSG00000229181	OR12D3	NA	
ENSG00000229125	OR2H1	NA	
ENSG00000237421	UBDP1	NA	
ENSG00000229136	MAS1LP1	NA	
ENSG00000234954	MAS1L	NA	
ENSG00000232974	RPS17P1	NA	
ENSG00000224753	LINC02829	NA	
ENSG00000235788	LINC01015	NA	
ENSG00000227576	GPR53P	NA	
ENSG00000226896	OR2I1P	NA	
ENSG00000232569	GABBR1	NA	
ENSG00000226898	UBD	NA	
ENSG00000229469	OR2H5P	NA	
ENSG00000225305	TMEM183AP1	NA	
ENSG00000265634	SNORD32B	NA	
ENSG00000224053	RPL13AP	NA	
ENSG00000224319	OR2H2	NA	
ENSG00000236971	SUMO2P1	NA	
ENSG00000234096	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000227858	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000206507	HLA-V	NA	
ENSG00000236225	HCG4	NA	
ENSG00000260538	HLA-P	NA	
ENSG00000237554	RPL7AP7	NA	
ENSG00000235714	MICG	NA	
ENSG00000276051	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000277480	HCG4P8	NA	
ENSG00000278443	CR925767.1	NA	
ENSG00000228490	CT009496.1	NA	
ENSG00000229215	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000231904	HLA-H	NA	
ENSG00000232988	HLA-T	NA	
ENSG00000235697	DDX39BP1	NA	
ENSG00000224538	MCCD1P1	NA	
ENSG00000231287	HCG4B	NA	
ENSG00000233964	HLA-K	NA	
ENSG00000227366	HLA-U	NA	
ENSG00000234831	CR759913.1	NA	
ENSG00000235144	HLA-W	NA	
ENSG00000235809	DDX39BP2	NA	
ENSG00000236203	MCCD1P2	NA	
ENSG00000236598	ZNRD1ASP	NA	
ENSG00000223798	CR759960.1	NA	
ENSG00000228524	HLA-J	NA	
ENSG00000235372	ETF1P1	NA	
ENSG00000273601	CR759960.2	NA	
ENSG00000276608	CR759960.4	NA	
ENSG00000235443	ZNRD1	NA	
ENSG00000275424	CR759960.3	NA	
ENSG00000233314	PPP1R11	NA	
ENSG00000236967	RNF39	NA	
ENSG00000224542	TRIM31	NA	
ENSG00000235722	TRIM31-AS1	NA	
ENSG00000265674	CR925727.1	NA	
ENSG00000224496	TRIM40	NA	
ENSG00000237703	TRIM10	NA	
ENSG00000235259	TRIM15	NA	
ENSG00000228881	TRIM26	NA	
ENSG00000236798	PAIP1P1	NA	
ENSG00000236729	HCG17	NA	
ENSG00000249434	TRIM26BP	NA	
ENSG00000235727	HCG18	NA	
ENSG00000230308	TRIM39	NA	
ENSG00000241779	RPP21	NA	
ENSG00000232232	HLA-N	NA	
ENSG00000229149	CR759890.1	NA	
ENSG00000223560	UBQLN1P1	NA	
ENSG00000236727	MICC	NA	
ENSG00000225382	LINC02569	NA	
ENSG00000206412	GNL1	NA	
ENSG00000227222	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000230341	PPP1R18	NA	
ENSG00000228854	NRM	NA	
ENSG00000236100	RPL7P4	NA	
ENSG00000234012	MDC1	NA	
ENSG00000231860	MDC1-AS1	NA	
ENSG00000224156	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000224156	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000223654	FLOT1	NA	
ENSG00000229767	DDR1	NA	
ENSG00000231350	MUC21	NA	
ENSG00000237108	CR759964.1	NA	
ENSG00000228147	HCG22	NA	
ENSG00000231179	MICB	NA	
ENSG00000266548	Y_RNA	NA	
ENSG00000230616	PPIAP9	NA	
ENSG00000233965	RPL15P4	NA	
ENSG00000225228	MCCD1	NA	
ENSG00000237889	DDX39B	NA	
ENSG00000265849	SNORD117	NA	
ENSG00000228978	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000228978	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000228978	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000231314	LTB	NA	
ENSG00000235915	LST1	NA	
ENSG00000236315	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000238126	UQCRHP1	NA	
ENSG00000233345	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000266231	U6	NA	
ENSG00000264619	MSH5-SAPCD1	NA	
ENSG00000227861	SAPCD1	NA	
ENSG00000236912	SAPCD1-AS1	NA	
ENSG00000238203	VWA7	NA	
ENSG00000231116	VARS1	617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
ENSG00000264393	Y_RNA	NA	
ENSG00000224979	LSM2	NA	
ENSG00000226704	HSPA1L	NA	
ENSG00000235941	HSPA1A	NA	
ENSG00000232804	HSPA1B	NA	
ENSG00000234728	SNHG32	NA	
ENSG00000263864	SNORD48	NA	
ENSG00000266300	SNORD52	NA	
ENSG00000228691	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000235336	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000232045	EHMT2	NA	
ENSG00000232266	CR936237.1	NA	
ENSG00000229341	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000229341	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000266653	5S_rRNA	NA	
ENSG00000238056	PRRT1	NA	
ENSG00000236649	PPT2	NA	
ENSG00000240389	EGFL8	NA	
ENSG00000236873	AGPAT1	NA	
ENSG00000223767	RNF5	NA	
ENSG00000231268	AGER	NA	
ENSG00000225987	PBX2	NA	
ENSG00000237052	GPSM3	NA	
ENSG00000238196	NOTCH4	NA	
ENSG00000236672	TSBP1	NA	
ENSG00000234216	HNRNPA1P2	NA	
ENSG00000266435	U6	NA	
ENSG00000235135	TSBP1-AS1	NA	
ENSG00000226127	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000227384	HLA-DRB9	NA	
ENSG00000264998	U1	NA	
ENSG00000230463	HLA-DRB3	NA	
ENSG00000237577	CR936921.1	NA	
ENSG00000226343	HLA-DQB3	NA	
ENSG00000233192	HLA-DQA2	NA	
ENSG00000230675	HLA-DQB2	NA	
ENSG00000243612	HLA-DOB	NA	
ENSG00000225967	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000230669	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000233089	PSMB8-AS1	NA	
ENSG00000242711	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000227816	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000234642	PPP1R2P1	NA	
ENSG00000237334	HLA-Z	NA	
ENSG00000242092	HLA-DMB	NA	
ENSG00000242361	HLA-DMA	NA	
ENSG00000235844	HLA-DPA1	NA	
ENSG00000236693	HLA-DPB1	NA	
ENSG00000231580	RPL32P1	NA	
ENSG00000234260	HLA-DPA2	NA	
ENSG00000227577	COL11A2P1	NA	
ENSG00000226071	HLA-DPB2	NA	
ENSG00000231895	HLA-DPA3	NA	
ENSG00000217281	LYPLA2P1	NA	
ENSG00000281185	GPX6	NA	
ENSG00000257770	GPX5	NA	
ENSG00000248496	ZBED9	NA	
ENSG00000275478	AL671879.1	NA	
ENSG00000249032	LINC00533	NA	
ENSG00000249814	RPSAP2	NA	
ENSG00000230574	NOP56P1	NA	
ENSG00000237006	AL669978.1	NA	
ENSG00000227966	LINC01623	NA	
ENSG00000226714	RPL13P	NA	
ENSG00000235184	ZNF90P2	NA	
ENSG00000230004	HCG14	NA	
ENSG00000237071	TRIM27	NA	
ENSG00000263937	U6	NA	
ENSG00000237634	LINC01556	NA	
ENSG00000233505	KRT18P1	NA	
ENSG00000263419	Metazoa_SRP	NA	
ENSG00000227380	HCG15	NA	
ENSG00000239940	AL662865.1	NA	
ENSG00000223687	ZNF311	NA	
ENSG00000227626	OR2AD1P	NA	
ENSG00000234101	OR2W1	NA	
ENSG00000274063	AL662852.3	NA	
ENSG00000225838	OR2P1P	NA	
ENSG00000226657	SAR1AP1	NA	
ENSG00000233180	OR2B3	NA	
ENSG00000234804	OR2J1	NA	
ENSG00000232178	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000232272	AL662852.2	NA	
ENSG00000224925	AL662852.1	NA	
ENSG00000231676	OR2J2	NA	
ENSG00000226610	OR2J4P	NA	
ENSG00000234092	AL662857.3	NA	
ENSG00000233950	AL662857.2	NA	
ENSG00000225150	OR2G1P	NA	
ENSG00000237366	OR2U1P	NA	
ENSG00000226844	OR2U2P	NA	
ENSG00000231279	AL662857.1	NA	
ENSG00000225291	OR14J1	NA	
ENSG00000229045	DDX6P1	NA	
ENSG00000233046	OR5V1	NA	
ENSG00000251394	OR12D3	NA	
ENSG00000235966	OR12D2	NA	
ENSG00000249030	OR12D1	NA	
ENSG00000230780	OR11A1	NA	
ENSG00000224234	OR10C1	NA	
ENSG00000235132	OR2H1	NA	
ENSG00000227228	UBDP1	NA	
ENSG00000224444	MAS1LP1	NA	
ENSG00000233141	MAS1L	NA	
ENSG00000232302	RPS17P1	NA	
ENSG00000232652	LINC02829	NA	
ENSG00000230674	LINC01015	NA	
ENSG00000237698	GPR53P	NA	
ENSG00000229467	OR2I1P	NA	
ENSG00000228913	UBD	NA	
ENSG00000232632	GABBR1	NA	
ENSG00000226796	OR2H5P	NA	
ENSG00000225248	TMEM183AP1	NA	
ENSG00000266672	SNORD32B	NA	
ENSG00000230181	RPL13AP	NA	
ENSG00000229185	OR2H2	NA	
ENSG00000223771	SUMO2P1	NA	
ENSG00000237834	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000226858	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000235507	ZDHHC20P1	NA	
ENSG00000137403	HLA-F	NA	
ENSG00000233935	AL669813.2	NA	
ENSG00000206446	HLA-F-AS1	NA	
ENSG00000241880	RPL23AP1	NA	
ENSG00000251581	MICE	NA	
ENSG00000224253	AL669813.1	NA	
ENSG00000263876	Y_RNA	NA	
ENSG00000228912	IFITM4P	NA	
ENSG00000230238	HLA-V	NA	
ENSG00000225346	HCG4	NA	
ENSG00000260055	HLA-P	NA	
ENSG00000233462	RPL7AP7	NA	
ENSG00000229995	MICG	NA	
ENSG00000230413	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000234681	HCG4P8	NA	
ENSG00000224118	AL671561.1	NA	
ENSG00000226152	AL671561.2	NA	
ENSG00000224320	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000226893	HLA-H	NA	
ENSG00000227027	HLA-T	NA	
ENSG00000233241	DDX39BP1	NA	
ENSG00000231998	MCCD1P1	NA	
ENSG00000227956	HCG4B	NA	
ENSG00000232331	HLA-K	NA	
ENSG00000223352	HLA-U	NA	
ENSG00000223708	AL645935.1	NA	
ENSG00000232011	HLA-W	NA	
ENSG00000237395	MICD	NA	
ENSG00000236579	HCG9	NA	
ENSG00000234242	DDX39BP2	NA	
ENSG00000235340	MCCD1P2	NA	
ENSG00000229653	ZNRD1ASP	NA	
ENSG00000224006	AL645935.2	NA	
ENSG00000228220	HLA-J	NA	
ENSG00000232141	ETF1P1	NA	
ENSG00000276049	AL671859.4	NA	
ENSG00000274071	AL671859.2	NA	
ENSG00000224859	ZNRD1	NA	
ENSG00000276034	AL671859.3	NA	
ENSG00000234058	PPP1R11	NA	
ENSG00000227171	RNF39	NA	
ENSG00000226402	TRIM31	NA	
ENSG00000238027	TRIM31-AS1	NA	
ENSG00000265495	AL671859.1	NA	
ENSG00000228001	TRIM40	NA	
ENSG00000237192	TRIM10	NA	
ENSG00000227147	TRIM15	NA	
ENSG00000230230	TRIM26	NA	
ENSG00000228199	PAIP1P1	NA	
ENSG00000241701	HCG17	NA	
ENSG00000223840	TRIM26BP	NA	
ENSG00000243492	HLA-L	NA	
ENSG00000228894	HCG18	NA	
ENSG00000224994	TRIM39	NA	
ENSG00000241863	RPP21	NA	
ENSG00000227334	HLA-N	NA	
ENSG00000234417	AL662831.1	NA	
ENSG00000232095	UBQLN1P1	NA	
ENSG00000233466	MICC	NA	
ENSG00000223933	TMPOP1	NA	
ENSG00000223412	SUCLA2P1	NA	
ENSG00000227703	RANP1	NA	
ENSG00000233904	HLA-E	NA	
ENSG00000223827	LINC02569	NA	
ENSG00000235986	GNL1	NA	
ENSG00000228186	PRR3	NA	
ENSG00000236149	ABCF1	NA	
ENSG00000230995	PPP1R10	NA	
ENSG00000227420	MRPS18B	NA	
ENSG00000223752	ATAT1	NA	
ENSG00000225453	PTMAP1	NA	
ENSG00000233641	C6orf136	NA	
ENSG00000233561	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000231247	PPP1R18	NA	
ENSG00000235773	NRM	NA	
ENSG00000235342	RPL7P4	NA	
ENSG00000224587	MDC1	NA	
ENSG00000236766	MDC1-AS1	NA	
ENSG00000227739	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000227739	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000232280	FLOT1	NA	
ENSG00000266119	Y_RNA	NA	
ENSG00000237155	IER3	NA	
ENSG00000263728	Metazoa_SRP	NA	
ENSG00000224641	HCG20	NA	
ENSG00000236006	AL662848.1	NA	
ENSG00000231522	LINC02570	NA	
ENSG00000265903	7SK	NA	
ENSG00000224360	DDR1-DT	NA	
ENSG00000137332	DDR1	NA	
ENSG00000236895	GTF2H4	NA	
ENSG00000285224	AL662854.1	NA	
ENSG00000236178	VARS2	615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
ENSG00000224246	SFTA2	NA	
ENSG00000266178	Y_RNA	NA	
ENSG00000232308	MUCL3	NA	
ENSG00000223454	HCG21	NA	
ENSG00000234137	MUC21	NA	
ENSG00000234063	AL663093.1	NA	
ENSG00000238234	HCG22	NA	
ENSG00000265921	U6	NA	
ENSG00000229432	C6orf15	NA	
ENSG00000235487	PSORS1C1	NA	
ENSG00000137197	CDSN	146520	HYPOTRICHOSIS 2; HYPT2;;HYPOTRICHOSIS SIMPLEX OF THE SCALP 1; HTSS1;;HTSS;;HYPOTRICHOSIS, SPANISH TYPE
ENSG00000137197	CDSN	270300	PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN
ENSG00000224544	PSORS1C2	NA	
ENSG00000226993	POLR2LP1	NA	
ENSG00000234114	CCHCR1	NA	
ENSG00000224379	TCF19	NA	
ENSG00000233911	POU5F1	NA	
ENSG00000223364	PSORS1C3	NA	
ENSG00000232758	HCG27	NA	
ENSG00000228583	AL662833.2	NA	
ENSG00000233841	HLA-C	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
ENSG00000233841	HLA-C	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000223532	HLA-B	142830	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B;;HLA-B HISTOCOMPATIBILITY TYPE ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO, INCLUDED;;SYNOVITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;DRUG-INDUCED LIVER INJURY DUE TO FLUCLOXACILLIN, INCLUDED
ENSG00000223532	HLA-B	106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1;;ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO;;MARIE-STRUMPELL SPONDYLITIS;;BECHTEREW SYNDROME
ENSG00000223532	HLA-B	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000233486	USP8P1	NA	
ENSG00000228461	RPL3P2	NA	
ENSG00000231433	WASF5P	NA	
ENSG00000225939	AL662833.1	NA	
ENSG00000230016	DHFRP2	NA	
ENSG00000264185	U6	NA	
ENSG00000223971	AL669854.1	NA	
ENSG00000232659	ZDHHC20P2	NA	
ENSG00000225145	HLA-S	NA	
ENSG00000233051	MICA	NA	
ENSG00000264692	Y_RNA	NA	
ENSG00000234858	LINC01149	NA	
ENSG00000237105	HCP5	NA	
ENSG00000264846	Y_RNA	NA	
ENSG00000234218	MICB	NA	
ENSG00000236415	PPIAP9	NA	
ENSG00000230211	RPL15P4	NA	
ENSG00000226923	MCCD1	NA	
ENSG00000225073	DDX39B	NA	
ENSG00000263359	SNORD117	NA	
ENSG00000265607	SNORD84	NA	
ENSG00000232256	DDX39B-AS1	NA	
ENSG00000227587	ATP6V1G2	NA	
ENSG00000234530	NFKBIL1	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000238130	LTA	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
ENSG00000238130	LTA	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000238130	LTA	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4 LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
ENSG00000204490	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000204490	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000204490	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000204487	LTB	NA	
ENSG00000226182	LST1	NA	
ENSG00000237808	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000227650	UQCRHP1	NA	
ENSG00000237727	AIF1	NA	
ENSG00000225164	PRRC2A	NA	
ENSG00000263879	SNORA38	NA	
ENSG00000229524	BAG6	NA	
ENSG00000224290	APOM	NA	
ENSG00000235360	C6orf47	NA	
ENSG00000235516	C6orf47-AS1	NA	
ENSG00000236011	GPANK1	NA	
ENSG00000266759	Y_RNA	NA	
ENSG00000228875	CSNK2B	618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
ENSG00000241713	LY6G5B	NA	
ENSG00000231325	LY6G5C	NA	
ENSG00000235676	ABHD16A	NA	
ENSG00000240008	LY6G6F	NA	
ENSG00000226603	LY6G6D	NA	
ENSG00000224708	LY6G6E	NA	
ENSG00000230060	MPIG6B	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
ENSG00000236183	LY6G6C	NA	
ENSG00000226634	DDAH2	NA	
ENSG00000230685	CLIC1	NA	
ENSG00000235222	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000254405	MSH5-SAPCD1	NA	
ENSG00000265409	U6	NA	
ENSG00000229176	SAPCD1	NA	
ENSG00000238017	SAPCD1-AS1	NA	
ENSG00000227144	VWA7	NA	
ENSG00000226589	VARS1	617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
ENSG00000264955	Y_RNA	NA	
ENSG00000236826	LSM2	NA	
ENSG00000236251	HSPA1L	NA	
ENSG00000237724	HSPA1A	NA	
ENSG00000224501	HSPA1B	NA	
ENSG00000226710	SNHG32	NA	
ENSG00000264202	SNORD48	NA	
ENSG00000263362	SNORD52	NA	
ENSG00000227315	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000231479	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000236759	EHMT2	NA	
ENSG00000223557	AL662834.1	NA	
ENSG00000235017	C2	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D;;C2 DEFICIENCY
ENSG00000235017	C2	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000237900	ZBTB12	NA	
ENSG00000227884	C4B-AS1	NA	
ENSG00000239754	CFB	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4
ENSG00000239754	CFB	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000239754	CFB	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
ENSG00000231044	NELFE	NA	
ENSG00000225737	SKIV2L	614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
ENSG00000225682	DXO	NA	
ENSG00000234947	STK19	NA	
ENSG00000228267	C4B	614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD;;C4B DEFICIENCY
ENSG00000236587	AL662849.1	NA	
ENSG00000233151	CYP21A2	201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA III;;21-@HYDROXYLASE DEFICIENCY;;CYP21 DEFICIENCY;;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1 HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED
ENSG00000233323	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000233323	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000265816	5S_rRNA	NA	
ENSG00000234539	ATF6B	NA	
ENSG00000230907	FKBPL	NA	
ENSG00000229071	PRRT1	NA	
ENSG00000206256	PPT2	NA	
ENSG00000254778	AL662828.1	NA	
ENSG00000242038	EGFL8	NA	
ENSG00000226467	AGPAT1	NA	
ENSG00000228405	RNF5	NA	
ENSG00000234729	AGER	NA	
ENSG00000237344	PBX2	NA	
ENSG00000233490	GPSM3	NA	
ENSG00000235396	NOTCH4	NA	
ENSG00000234280	TSBP1	NA	
ENSG00000231275	HNRNPA1P2	NA	
ENSG00000263869	U6	NA	
ENSG00000225834	TSBP1-AS1	NA	
ENSG00000224770	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000227993	HLA-DRA	NA	
ENSG00000227526	HLA-DRB9	NA	
ENSG00000265223	RNU1-79P	NA	
ENSG00000231679	HLA-DRB3	NA	
ENSG00000264909	U1	NA	
ENSG00000232156	AL662842.1	NA	
ENSG00000264259	RNU1-116P	NA	
ENSG00000206240	HLA-DRB1	181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1;;SARCOIDOSIS;;BOECK SARCOID
ENSG00000206240	HLA-DRB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000257473	HLA-DQA2	NA	
ENSG00000206237	HLA-DQB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000206237	HLA-DQB1	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000231677	HLA-DQB1-AS1	NA	
ENSG00000243252	AL731683.2	NA	
ENSG00000228845	MTCO3P1	NA	
ENSG00000232026	AL731683.1	NA	
ENSG00000224793	HLA-DQB3	NA	
ENSG00000224305	HLA-DQB2	NA	
ENSG00000241386	HLA-DOB	NA	
ENSG00000228582	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000235715	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000235540	PSMB8-AS1	NA	
ENSG00000243067	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000232367	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000236093	PPP1R2P1	NA	
ENSG00000228785	HLA-Z	NA	
ENSG00000234154	HLA-DMB	NA	
ENSG00000243719	HLA-DMA	NA	
ENSG00000234507	BRD2	NA	
ENSG00000234673	AL662845.1	NA	
ENSG00000232962	HLA-DOA	NA	
ENSG00000224103	HLA-DPA1	NA	
ENSG00000230708	HLA-DPB1	NA	
ENSG00000228579	RPL32P1	NA	
ENSG00000223990	HLA-DPA2	NA	
ENSG00000230816	COL11A2P1	NA	
ENSG00000225132	HLA-DPB2	NA	
ENSG00000227936	HLA-DPA3	NA	
ENSG00000237196	HCG24	NA	
ENSG00000227801	COL11A2	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA;;OSMED, HETEROZYGOUS;;WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;;PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;;STICKLER SYNDROME, TYPE III, /.../RLY; STL3, FORMERLY
ENSG00000227801	COL11A2	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB;;OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA;;WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY
ENSG00000227801	COL11A2	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
ENSG00000227801	COL11A2	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
ENSG00000227801	COL11A2	614524	FIBROCHONDROGENESIS 2; FBCG2
ENSG00000227322	RXRB	NA	
ENSG00000266781	Y_RNA	NA	
ENSG00000226614	SLC39A7	NA	
ENSG00000228712	HSD17B8	NA	
ENSG00000226788	RING1	NA	
ENSG00000230949	ZNF70P1	NA	
ENSG00000237536	HTATSF1P1	NA	
ENSG00000224096	HCG25	NA	
ENSG00000225590	VPS52	NA	
ENSG00000235650	RPS18	NA	
ENSG00000226936	B3GALT4	NA	
ENSG00000204221	WDR46	NA	
ENSG00000237335	PFDN6	NA	
ENSG00000224841	RGL2	NA	
ENSG00000112493	TAPBP	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000229253	ZBTB22	NA	
ENSG00000227046	DAXX	NA	
ENSG00000226575	MYL8P	NA	
ENSG00000232639	LYPLA2P1	NA	
ENSG00000230511	NOP56P1	NA	
ENSG00000235460	CR753651.1	NA	
ENSG00000225604	LINC01623	NA	
ENSG00000224158	RPL13P	NA	
ENSG00000263491	Metazoa_SRP	NA	
ENSG00000235405	HCG15	NA	
ENSG00000239675	CR759835.1	NA	
ENSG00000235178	ZNF311	NA	
ENSG00000225048	OR2AD1P	NA	
ENSG00000229328	OR2W1	NA	
ENSG00000275606	CR388407.1	NA	
ENSG00000237608	OR2P1P	NA	
ENSG00000229179	SAR1AP1	NA	
ENSG00000225736	OR2B3	NA	
ENSG00000226192	OR2J1	NA	
ENSG00000229866	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000227448	CR388415.1	NA	
ENSG00000236771	CR388415.2	NA	
ENSG00000232945	OR2J2	NA	
ENSG00000228483	OR2J4P	NA	
ENSG00000229441	CR933537.1	NA	
ENSG00000235273	CR753509.2	NA	
ENSG00000224990	OR2G1P	NA	
ENSG00000233168	OR2U1P	NA	
ENSG00000234351	OR2U2P	NA	
ENSG00000232469	CR753509.1	NA	
ENSG00000237777	OR14J1	NA	
ENSG00000228197	DDX6P1	NA	
ENSG00000242022	OR12D3	NA	
ENSG00000227446	OR12D2	NA	
ENSG00000249103	OR12D1	NA	
ENSG00000230742	OR5V1	NA	
ENSG00000234347	OR11A1	NA	
ENSG00000229412	OR10C1	NA	
ENSG00000232984	OR2H1	NA	
ENSG00000233989	UBDP1	NA	
ENSG00000229889	MAS1LP1	NA	
ENSG00000228515	MAS1L	NA	
ENSG00000223769	RPS17P1	NA	
ENSG00000232356	LINC02829	NA	
ENSG00000224446	LINC01015	NA	
ENSG00000225274	GPR53P	NA	
ENSG00000237725	OR2I1P	NA	
ENSG00000237112	GABBR1	NA	
ENSG00000231968	UBD	NA	
ENSG00000225955	OR2H5P	NA	
ENSG00000232189	TMEM183AP1	NA	
ENSG00000265926	SNORD32B	NA	
ENSG00000227961	RPL13AP	NA	
ENSG00000229680	OR2H2	NA	
ENSG00000229210	SUMO2P1	NA	
ENSG00000234623	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000223852	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000238053	ZDHHC20P1	NA	
ENSG00000235220	HLA-F	NA	
ENSG00000233617	CR753818.1	NA	
ENSG00000230017	HLA-F-AS1	NA	
ENSG00000240845	RPL23AP1	NA	
ENSG00000248230	MICE	NA	
ENSG00000235458	CR753818.2	NA	
ENSG00000264218	Y_RNA	NA	
ENSG00000228102	IFITM4P	NA	
ENSG00000223606	HLA-V	NA	
ENSG00000235317	HCG4	NA	
ENSG00000261814	HLA-P	NA	
ENSG00000227030	RPL7AP7	NA	
ENSG00000225763	MICG	NA	
ENSG00000235346	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000231430	HCG4P8	NA	
ENSG00000235536	CR388220.3	NA	
ENSG00000226517	CR388220.2	NA	
ENSG00000235657	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000227669	HLA-H	NA	
ENSG00000229293	HLA-T	NA	
ENSG00000228891	DDX39BP1	NA	
ENSG00000230357	MCCD1P1	NA	
ENSG00000231941	HCG4B	NA	
ENSG00000232708	HLA-K	NA	
ENSG00000233239	HLA-U	NA	
ENSG00000225114	CR388220.1	NA	
ENSG00000234849	HLA-W	NA	
ENSG00000226713	MICD	NA	
ENSG00000234313	HCG9	NA	
ENSG00000228458	DDX39BP2	NA	
ENSG00000231719	MCCD1P2	NA	
ENSG00000225618	ZNRD1ASP	NA	
ENSG00000227025	CR388205.1	NA	
ENSG00000234074	HLA-J	NA	
ENSG00000235764	ETF1P1	NA	
ENSG00000275415	CR388205.4	NA	
ENSG00000273764	CR388205.2	NA	
ENSG00000236949	ZNRD1	NA	
ENSG00000274401	CR388205.3	NA	
ENSG00000227720	PPP1R11	NA	
ENSG00000235022	RNF39	NA	
ENSG00000233573	TRIM31	NA	
ENSG00000232510	TRIM31-AS1	NA	
ENSG00000265138	CR753815.1	NA	
ENSG00000227458	TRIM40	NA	
ENSG00000227472	TRIM10	NA	
ENSG00000235960	TRIM15	NA	
ENSG00000226060	TRIM26	NA	
ENSG00000225109	PAIP1P1	NA	
ENSG00000241053	HCG17	NA	
ENSG00000225659	TRIM26BP	NA	
ENSG00000241166	HLA-L	NA	
ENSG00000224705	HCG18	NA	
ENSG00000232839	TRIM39	NA	
ENSG00000243009	RPP21	NA	
ENSG00000230509	HLA-N	NA	
ENSG00000235561	CR759281.1	NA	
ENSG00000232473	UBQLN1P1	NA	
ENSG00000229651	MICC	NA	
ENSG00000236369	TMPOP1	NA	
ENSG00000231157	SUCLA2P1	NA	
ENSG00000227652	RANP1	NA	
ENSG00000229252	HLA-E	NA	
ENSG00000233315	LINC02569	NA	
ENSG00000229470	GNL1	NA	
ENSG00000223887	PRR3	NA	
ENSG00000232169	ABCF1	NA	
ENSG00000227804	PPP1R10	NA	
ENSG00000233813	MRPS18B	NA	
ENSG00000229061	ATAT1	NA	
ENSG00000237156	PTMAP1	NA	
ENSG00000237012	C6orf136	NA	
ENSG00000233418	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000234000	PPP1R18	NA	
ENSG00000236843	NRM	NA	
ENSG00000233091	RPL7P4	NA	
ENSG00000225589	MDC1	NA	
ENSG00000229681	MDC1-AS1	NA	
ENSG00000235067	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000235067	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000206379	FLOT1	NA	
ENSG00000263950	Y_RNA	NA	
ENSG00000227231	IER3	NA	
ENSG00000264417	Metazoa_SRP	NA	
ENSG00000224923	HCG20	NA	
ENSG00000227596	CR388215.1	NA	
ENSG00000231733	LINC02570	NA	
ENSG00000265255	7SK	NA	
ENSG00000236492	DDR1-DT	NA	
ENSG00000230456	DDR1	NA	
ENSG00000226384	GTF2H4	NA	
ENSG00000285192	CR759747.1	NA	
ENSG00000230985	VARS2	615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
ENSG00000225454	SFTA2	NA	
ENSG00000266841	Y_RNA	NA	
ENSG00000232251	MUCL3	NA	
ENSG00000235747	HCG21	NA	
ENSG00000237962	MUC21	NA	
ENSG00000234461	CR753812.1	NA	
ENSG00000229501	HCG22	NA	
ENSG00000263467	U6	NA	
ENSG00000225543	C6orf15	NA	
ENSG00000233439	PSORS1C1	NA	
ENSG00000237123	CDSN	146520	HYPOTRICHOSIS 2; HYPT2;;HYPOTRICHOSIS SIMPLEX OF THE SCALP 1; HTSS1;;HTSS;;HYPOTRICHOSIS, SPANISH TYPE
ENSG00000237123	CDSN	270300	PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN
ENSG00000232127	PSORS1C2	NA	
ENSG00000232007	POLR2LP1	NA	
ENSG00000206355	CCHCR1	NA	
ENSG00000233890	TCF19	NA	
ENSG00000229094	POU5F1	NA	
ENSG00000231450	PSORS1C3	NA	
ENSG00000234079	HCG27	NA	
ENSG00000228469	CR388229.1	NA	
ENSG00000228299	HLA-C	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
ENSG00000228299	HLA-C	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000236374	USP8P1	NA	
ENSG00000229430	RPL3P2	NA	
ENSG00000229103	WASF5P	NA	
ENSG00000231710	CR759814.1	NA	
ENSG00000263833	Y_RNA	NA	
ENSG00000224378	MICB	NA	
ENSG00000231118	PPIAP9	NA	
ENSG00000229535	RPL15P4	NA	
ENSG00000231975	MCCD1	NA	
ENSG00000230624	DDX39B	NA	
ENSG00000266419	SNORD117	NA	
ENSG00000264591	SNORD84	NA	
ENSG00000236019	DDX39B-AS1	NA	
ENSG00000234668	ATP6V1G2	NA	
ENSG00000236196	NFKBIL1	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000223919	LTA	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
ENSG00000223919	LTA	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000223919	LTA	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4 LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
ENSG00000228849	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000228849	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000228849	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000236925	LTB	NA	
ENSG00000223465	LST1	NA	
ENSG00000237103	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000232683	UQCRHP1	NA	
ENSG00000234836	AIF1	NA	
ENSG00000231370	PRRC2A	NA	
ENSG00000266004	SNORA38	NA	
ENSG00000227761	BAG6	NA	
ENSG00000227567	APOM	NA	
ENSG00000228435	C6orf47	NA	
ENSG00000227665	C6orf47-AS1	NA	
ENSG00000233210	GPANK1	NA	
ENSG00000264353	Y_RNA	NA	
ENSG00000230700	CSNK2B	618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
ENSG00000258589	CR753842.1	NA	
ENSG00000244672	LY6G5B	NA	
ENSG00000226404	LY6G5C	NA	
ENSG00000231488	ABHD16A	NA	
ENSG00000243003	LY6G6F	NA	
ENSG00000259101	LY6G6F-LY6G6D	NA	
ENSG00000237482	LY6G6E	NA	
ENSG00000234443	LY6G6D	NA	
ENSG00000224393	MPIG6B	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
ENSG00000228859	LY6G6C	NA	
ENSG00000227317	DDAH2	NA	
ENSG00000226248	CLIC1	NA	
ENSG00000230293	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000266027	MSH5-SAPCD1	NA	
ENSG00000263896	U6	NA	
ENSG00000227074	SAPCD1	NA	
ENSG00000227856	SAPCD1-AS1	NA	
ENSG00000230048	VWA7	NA	
ENSG00000096171	VARS1	617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
ENSG00000266113	Y_RNA	NA	
ENSG00000231502	LSM2	NA	
ENSG00000234258	HSPA1L	NA	
ENSG00000234475	HSPA1A	NA	
ENSG00000231555	HSPA1B	NA	
ENSG00000229300	SNHG32	NA	
ENSG00000264086	SNORD48	NA	
ENSG00000265707	SNORD52	NA	
ENSG00000234343	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000228263	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000227333	EHMT2	NA	
ENSG00000236903	CR388202.1	NA	
ENSG00000231543	C2	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D;;C2 DEFICIENCY
ENSG00000231543	C2	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000234852	ZBTB12	NA	
ENSG00000233692	C4B-AS1	NA	
ENSG00000241534	CFB	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4
ENSG00000241534	CFB	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000241534	CFB	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
ENSG00000206268	NELFE	NA	
ENSG00000223493	SKIV2L	614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
ENSG00000236765	DXO	NA	
ENSG00000226257	STK19	NA	
ENSG00000244207	C4A	614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM;;CHIDO/RODGERS BLOOD GROUP SYSTEM
ENSG00000244207	C4A	614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD;;C4A DEFICIENCY
ENSG00000232565	C4A-AS1	NA	
ENSG00000231759	CYP21A1P	NA	
ENSG00000269167	CR753845.2	NA	
ENSG00000248352	TNXA	NA	
ENSG00000249480	STK19B	NA	
ENSG00000236625	C4B	614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD;;C4B DEFICIENCY
ENSG00000225512	CR753845.1	NA	
ENSG00000232414	CYP21A2	201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA III;;21-@HYDROXYLASE DEFICIENCY;;CYP21 DEFICIENCY;;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1 HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED
ENSG00000231608	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000231608	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000266615	5S_rRNA	NA	
ENSG00000168468	ATF6B	NA	
ENSG00000224200	FKBPL	NA	
ENSG00000225141	PRRT1	NA	
ENSG00000228116	PPT2	NA	
ENSG00000226892	TSBP1	NA	
ENSG00000230209	HNRNPA1P2	NA	
ENSG00000265351	U6	NA	
ENSG00000226228	TSBP1-AS1	NA	
ENSG00000229741	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000228987	HLA-DRA	NA	
ENSG00000237591	HLA-DRB9	NA	
ENSG00000235577	CR759837.1	NA	
ENSG00000234470	CR753841.1	NA	
ENSG00000233240	CR753309.1	NA	
ENSG00000235391	CR753841.2	NA	
ENSG00000265983	U1	NA	
ENSG00000236884	HLA-DRB1	181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1;;SARCOIDOSIS;;BOECK SARCOID
ENSG00000236884	HLA-DRB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000236418	HLA-DQA1	NA	
ENSG00000233209	HLA-DQB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000233209	HLA-DQB1	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000237455	HLA-DQB1-AS1	NA	
ENSG00000240684	CR753846.2	NA	
ENSG00000236629	MTCO3P1	NA	
ENSG00000234331	CR753846.1	NA	
ENSG00000231596	HLA-DQB3	NA	
ENSG00000223793	HLA-DQA2	NA	
ENSG00000228813	HLA-DQB2	NA	
ENSG00000243496	HLA-DOB	NA	
ENSG00000223481	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000230034	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000206232	PSMB8-AS1	NA	
ENSG00000240118	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000224212	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000227435	PPP1R2P1	NA	
ENSG00000237871	HLA-Z	NA	
ENSG00000226264	HLA-DMB	NA	
ENSG00000241394	HLA-DMA	NA	
ENSG00000230678	BRD2	NA	
ENSG00000235744	HLA-DOA	NA	
ENSG00000229685	HLA-DPA1	NA	
ENSG00000237710	HLA-DPB1	NA	
ENSG00000226879	RPL32P1	NA	
ENSG00000223894	HLA-DPA2	NA	
ENSG00000232802	COL11A2P1	NA	
ENSG00000225429	HLA-DPB2	NA	
ENSG00000223696	HLA-DPA3	NA	
ENSG00000230134	HCG24	NA	
ENSG00000230930	COL11A2	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA;;OSMED, HETEROZYGOUS;;WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;;PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;;STICKLER SYNDROME, TYPE III, /.../RLY; STL3, FORMERLY
ENSG00000230930	COL11A2	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB;;OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA;;WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY
ENSG00000230930	COL11A2	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
ENSG00000230930	COL11A2	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
ENSG00000230930	COL11A2	614524	FIBROCHONDROGENESIS 2; FBCG2
ENSG00000228333	RXRB	NA	
ENSG00000266410	Y_RNA	NA	
ENSG00000229802	SLC39A7	NA	
ENSG00000225312	HSD17B8	NA	
ENSG00000228520	RING1	NA	
ENSG00000229394	ZNF70P1	NA	
ENSG00000224052	HTATSF1P1	NA	
ENSG00000233772	HCG25	NA	
ENSG00000228425	VPS52	NA	
ENSG00000223367	RPS18	NA	
ENSG00000235155	B3GALT4	NA	
ENSG00000226916	WDR46	NA	
ENSG00000224782	PFDN6	NA	
ENSG00000237825	RGL2	NA	
ENSG00000236490	TAPBP	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000227780	ZBTB22	NA	
ENSG00000206206	DAXX	NA	
ENSG00000229342	MYL8P	NA	
ENSG00000273083	NOP56P1	NA	
ENSG00000273040	BX908720.1	NA	
ENSG00000273200	LINC01623	NA	
ENSG00000273286	RPL13P	NA	
ENSG00000237462	TRIM27	NA	
ENSG00000264777	U6	NA	
ENSG00000231041	LINC01556	NA	
ENSG00000226462	KRT18P1	NA	
ENSG00000265326	Metazoa_SRP	NA	
ENSG00000233035	HCG15	NA	
ENSG00000240111	BX927167.1	NA	
ENSG00000235589	ZNF311	NA	
ENSG00000232781	OR2AD1P	NA	
ENSG00000228652	OR2W1	NA	
ENSG00000277403	CR547123.1	NA	
ENSG00000233019	OR2P1P	NA	
ENSG00000227529	SAR1AP1	NA	
ENSG00000231319	OR2B3	NA	
ENSG00000225441	OR2J1	NA	
ENSG00000233636	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000231960	BX927132.2	NA	
ENSG00000228846	BX927132.1	NA	
ENSG00000226347	OR2J2	NA	
ENSG00000230136	OR2J4P	NA	
ENSG00000231919	BX908738.3	NA	
ENSG00000225188	BX908738.1	NA	
ENSG00000231320	OR2G1P	NA	
ENSG00000236918	OR2U1P	NA	
ENSG00000249415	OR2U2P	NA	
ENSG00000227178	BX908738.2	NA	
ENSG00000234100	OR14J1	NA	
ENSG00000225927	DDX6P1	NA	
ENSG00000243441	OR5V1	NA	
ENSG00000224487	OR12D3	NA	
ENSG00000233481	OR12D2	NA	
ENSG00000248182	OR12D1	NA	
ENSG00000237258	OR11A1	NA	
ENSG00000232397	OR10C1	NA	
ENSG00000224395	OR2H1	NA	
ENSG00000226365	UBDP1	NA	
ENSG00000230957	MAS1LP1	NA	
ENSG00000228377	MAS1L	NA	
ENSG00000228840	RPS17P1	NA	
ENSG00000228370	LINC02829	NA	
ENSG00000225426	LINC01015	NA	
ENSG00000237811	GPR53P	NA	
ENSG00000223441	OR2I1P	NA	
ENSG00000237051	GABBR1	NA	
ENSG00000224654	UBD	NA	
ENSG00000225034	OR2H5P	NA	
ENSG00000224241	TMEM183AP1	NA	
ENSG00000265663	SNORD32B	NA	
ENSG00000224146	RPL13AP	NA	
ENSG00000227044	OR2H2	NA	
ENSG00000228130	SUMO2P1	NA	
ENSG00000230885	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000232099	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000226303	ZDHHC20P1	NA	
ENSG00000237508	HLA-F	NA	
ENSG00000229573	BX927250.1	NA	
ENSG00000226378	HLA-F-AS1	NA	
ENSG00000242039	RPL23AP1	NA	
ENSG00000250154	MICE	NA	
ENSG00000228900	BX927182.1	NA	
ENSG00000264495	Y_RNA	NA	
ENSG00000233023	IFITM4P	NA	
ENSG00000224736	HLA-V	NA	
ENSG00000226379	HCG4	NA	
ENSG00000261134	HLA-P	NA	
ENSG00000233465	RPL7AP7	NA	
ENSG00000229461	MICG	NA	
ENSG00000235680	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000224801	HCG4P8	NA	
ENSG00000235498	BX927141.2	NA	
ENSG00000231197	BX927141.1	NA	
ENSG00000223463	HLA-H	NA	
ENSG00000226727	HLA-T	NA	
ENSG00000225926	DDX39BP1	NA	
ENSG00000226940	MCCD1P1	NA	
ENSG00000226563	HCG4B	NA	
ENSG00000232816	HLA-K	NA	
ENSG00000226354	HLA-U	NA	
ENSG00000231834	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000226109	CR382333.1	NA	
ENSG00000230915	HLA-W	NA	
ENSG00000230745	MICD	NA	
ENSG00000227647	HCG9	NA	
ENSG00000224362	DDX39BP2	NA	
ENSG00000231745	MCCD1P2	NA	
ENSG00000235394	ZNRD1ASP	NA	
ENSG00000225086	BX927229.1	NA	
ENSG00000223439	HLA-J	NA	
ENSG00000224108	ETF1P1	NA	
ENSG00000278049	BX927229.4	NA	
ENSG00000277415	BX927229.3	NA	
ENSG00000235176	ZNRD1	NA	
ENSG00000277085	BX927229.2	NA	
ENSG00000236560	PPP1R11	NA	
ENSG00000237733	RNF39	NA	
ENSG00000225130	TRIM31	NA	
ENSG00000237050	TRIM31-AS1	NA	
ENSG00000263589	BX927221.1	NA	
ENSG00000237046	TRIM40	NA	
ENSG00000235025	TRIM10	NA	
ENSG00000233599	TRIM15	NA	
ENSG00000231002	TRIM26	NA	
ENSG00000226175	PAIP1P1	NA	
ENSG00000240924	HCG17	NA	
ENSG00000231928	TRIM26BP	NA	
ENSG00000239618	HLA-L	NA	
ENSG00000230660	HCG18	NA	
ENSG00000226437	TRIM39	NA	
ENSG00000239865	RPP21	NA	
ENSG00000234095	HLA-N	NA	
ENSG00000236422	BX927214.1	NA	
ENSG00000231659	UBQLN1P1	NA	
ENSG00000229187	MICC	NA	
ENSG00000233700	TMPOP1	NA	
ENSG00000227754	SUCLA2P1	NA	
ENSG00000224554	RANP1	NA	
ENSG00000236632	HLA-E	NA	
ENSG00000235801	LINC02569	NA	
ENSG00000232143	GNL1	NA	
ENSG00000223766	PRR3	NA	
ENSG00000231129	ABCF1	NA	
ENSG00000231737	PPP1R10	NA	
ENSG00000226111	MRPS18B	NA	
ENSG00000235658	ATAT1	NA	
ENSG00000223851	PTMAP1	NA	
ENSG00000233164	C6orf136	NA	
ENSG00000233049	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000229998	PPP1R18	NA	
ENSG00000228867	NRM	NA	
ENSG00000226494	RPL7P4	NA	
ENSG00000228575	MDC1	NA	
ENSG00000224508	MDC1-AS1	NA	
ENSG00000232575	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000232575	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000236271	FLOT1	NA	
ENSG00000230128	IER3	NA	
ENSG00000263671	Metazoa_SRP	NA	
ENSG00000228762	HCG20	NA	
ENSG00000229170	CR847861.1	NA	
ENSG00000231854	LINC02570	NA	
ENSG00000266263	7SK	NA	
ENSG00000231444	DDR1-DT	NA	
ENSG00000234078	DDR1	NA	
ENSG00000233149	GTF2H4	NA	
ENSG00000285089	BX927194.1	NA	
ENSG00000223494	VARS2	615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
ENSG00000230072	SFTA2	NA	
ENSG00000265323	Y_RNA	NA	
ENSG00000223590	MUC21	NA	
ENSG00000231474	BX927139.1	NA	
ENSG00000237894	HCG22	NA	
ENSG00000263367	U6	NA	
ENSG00000231624	C6orf15	NA	
ENSG00000231094	PSORS1C1	NA	
ENSG00000237114	CDSN	146520	HYPOTRICHOSIS 2; HYPT2;;HYPOTRICHOSIS SIMPLEX OF THE SCALP 1; HTSS1;;HTSS;;HYPOTRICHOSIS, SPANISH TYPE
ENSG00000237114	CDSN	270300	PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN
ENSG00000234605	PSORS1C2	NA	
ENSG00000225714	POLR2LP1	NA	
ENSG00000223533	CCHCR1	NA	
ENSG00000224941	TCF19	NA	
ENSG00000230336	POU5F1	NA	
ENSG00000257215	CR847794.2	NA	
ENSG00000226422	PSORS1C3	NA	
ENSG00000238148	HCG27	NA	
ENSG00000229823	CR847794.1	NA	
ENSG00000237022	HLA-C	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
ENSG00000237022	HLA-C	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000224608	HLA-B	142830	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B;;HLA-B HISTOCOMPATIBILITY TYPE ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO, INCLUDED;;SYNOVITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;DRUG-INDUCED LIVER INJURY DUE TO FLUCLOXACILLIN, INCLUDED
ENSG00000224608	HLA-B	106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1;;ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO;;MARIE-STRUMPELL SPONDYLITIS;;BECHTEREW SYNDROME
ENSG00000224608	HLA-B	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000229265	USP8P1	NA	
ENSG00000237448	RPL3P2	NA	
ENSG00000234980	WASF5P	NA	
ENSG00000228954	BX927178.1	NA	
ENSG00000233604	DHFRP2	NA	
ENSG00000263701	U6	NA	
ENSG00000224131	CR318637.1	NA	
ENSG00000226732	ZDHHC20P2	NA	
ENSG00000228179	HLA-S	NA	
ENSG00000235233	MICA	NA	
ENSG00000266747	Y_RNA	NA	
ENSG00000231836	LINC01149	NA	
ENSG00000231372	MICB	NA	
ENSG00000229216	PPIAP9	NA	
ENSG00000236273	RPL15P4	NA	
ENSG00000238238	MCCD1	NA	
ENSG00000225859	DDX39B	NA	
ENSG00000265116	SNORD117	NA	
ENSG00000265325	SNORD84	NA	
ENSG00000231647	DDX39B-AS1	NA	
ENSG00000226850	ATP6V1G2	NA	
ENSG00000227565	NFKBIL1	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000231408	LTA	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
ENSG00000231408	LTA	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000231408	LTA	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4 LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
ENSG00000228321	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000228321	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000228321	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000223448	LTB	NA	
ENSG00000231048	LST1	NA	
ENSG00000236979	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000226618	PRRC2A	NA	
ENSG00000266847	SNORA38	NA	
ENSG00000228760	BAG6	NA	
ENSG00000231974	APOM	NA	
ENSG00000228177	C6orf47	NA	
ENSG00000233169	C6orf47-AS1	NA	
ENSG00000223932	GPANK1	NA	
ENSG00000264915	Y_RNA	NA	
ENSG00000232960	CSNK2B	618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
ENSG00000258543	CR354443.1	NA	
ENSG00000240433	LY6G5B	NA	
ENSG00000228883	LY6G5C	NA	
ENSG00000224552	ABHD16A	NA	
ENSG00000239741	LY6G6F	NA	
ENSG00000258635	LY6G6F-LY6G6D	NA	
ENSG00000236210	LY6G6E	NA	
ENSG00000225993	LY6G6D	NA	
ENSG00000228090	MPIG6B	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
ENSG00000235452	LY6G6C	NA	
ENSG00000233076	DDAH2	NA	
ENSG00000226651	CLIC1	NA	
ENSG00000230961	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000223957	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000203463	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000204364	C2	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D;;C2 DEFICIENCY
ENSG00000204364	C2	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000223747	C4B-AS1	NA	
ENSG00000204359	CFB	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4
ENSG00000204359	CFB	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000204359	CFB	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
ENSG00000236221	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000236221	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000263418	5S_rRNA	NA	
ENSG00000229488	PRRT1	NA	
ENSG00000168452	PPT2	NA	
ENSG00000243897	EGFL8	NA	
ENSG00000227642	AGPAT1	NA	
ENSG00000228907	RNF5	NA	
ENSG00000229058	AGER	NA	
ENSG00000232005	PBX2	NA	
ENSG00000236697	GPSM3	NA	
ENSG00000232339	NOTCH4	NA	
ENSG00000206245	TSBP1	NA	
ENSG00000233160	HNRNPA1P2	NA	
ENSG00000266660	U6	NA	
ENSG00000229903	TSBP1-AS1	NA	
ENSG00000225412	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000226260	HLA-DRA	NA	
ENSG00000234164	HLA-DRB9	NA	
ENSG00000223359	CR354545.1	NA	
ENSG00000265059	U1	NA	
ENSG00000224230	BX927235.1	NA	
ENSG00000266081	U1	NA	
ENSG00000227826	HLA-DRB4	NA	
ENSG00000264640	U1	NA	
ENSG00000233853	BX927235.2	NA	
ENSG00000265074	U1	NA	
ENSG00000238248	CR933540.4	NA	
ENSG00000237120	CR933540.3	NA	
ENSG00000229099	CR933540.2	NA	
ENSG00000223844	CR933540.1	NA	
ENSG00000263871	U1	NA	
ENSG00000229074	HLA-DRB1	181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1;;SARCOIDOSIS;;BOECK SARCOID
ENSG00000229074	HLA-DRB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000225890	HLA-DQA1	NA	
ENSG00000225824	HLA-DQB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000225824	HLA-DQB1	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000238226	HLA-DQB1-AS1	NA	
ENSG00000242138	BX927168.2	NA	
ENSG00000237145	MTCO3P1	NA	
ENSG00000226139	BX927168.1	NA	
ENSG00000228684	HLA-DQB3	NA	
ENSG00000231823	HLA-DQA2	NA	
ENSG00000229493	HLA-DQB2	NA	
ENSG00000206235	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000236443	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000231591	PSMB8-AS1	NA	
ENSG00000239836	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000226173	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000236488	PPP1R2P1	NA	
ENSG00000225459	HLA-Z	NA	
ENSG00000239329	HLA-DMB	NA	
ENSG00000243189	HLA-DMA	NA	
ENSG00000234704	BRD2	NA	
ENSG00000236657	BX908719.1	NA	
ENSG00000231558	HLA-DOA	NA	
ENSG00000228163	HLA-DPA1	NA	
ENSG00000229295	HLA-DPB1	NA	
ENSG00000233972	RPL32P1	NA	
ENSG00000235528	HLA-DPA2	NA	
ENSG00000226591	COL11A2P1	NA	
ENSG00000233584	HLA-DPB2	NA	
ENSG00000234372	HLA-DPA3	NA	
ENSG00000233043	HCG24	NA	
ENSG00000223699	COL11A2	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA;;OSMED, HETEROZYGOUS;;WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;;PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;;STICKLER SYNDROME, TYPE III, /.../RLY; STL3, FORMERLY
ENSG00000223699	COL11A2	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB;;OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA;;WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY
ENSG00000223699	COL11A2	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
ENSG00000223699	COL11A2	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
ENSG00000223699	COL11A2	614524	FIBROCHONDROGENESIS 2; FBCG2
ENSG00000231321	RXRB	NA	
ENSG00000265159	Y_RNA	NA	
ENSG00000227402	SLC39A7	NA	
ENSG00000228357	HSD17B8	NA	
ENSG00000235107	RING1	NA	
ENSG00000236910	ZNF70P1	NA	
ENSG00000230012	HTATSF1P1	NA	
ENSG00000231037	HCG25	NA	
ENSG00000223618	VPS52	NA	
ENSG00000235668	CR936879.1	NA	
ENSG00000234966	LINC01623	NA	
ENSG00000234904	RPL13P	NA	
ENSG00000232017	ZNF90P2	NA	
ENSG00000236835	HCG14	NA	
ENSG00000233948	TRIM27	NA	
ENSG00000263598	U6	NA	
ENSG00000237313	LINC01556	NA	
ENSG00000225567	OR2AD1P	NA	
ENSG00000228977	OR2W1	NA	
ENSG00000274733	CR933783.1	NA	
ENSG00000228635	OR2P1P	NA	
ENSG00000238070	SAR1AP1	NA	
ENSG00000233687	OR2B3	NA	
ENSG00000226931	OR2J1	NA	
ENSG00000230855	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000228698	CR759834.1	NA	
ENSG00000196231	OR2J2	NA	
ENSG00000220379	OR2J4P	NA	
ENSG00000233182	CR759834.2	NA	
ENSG00000224633	CR933842.1	NA	
ENSG00000112459	OR14J1	NA	
ENSG00000232435	DDX6P1	NA	
ENSG00000112461	OR5V1	NA	
ENSG00000204692	OR12D3	NA	
ENSG00000204690	OR12D2	NA	
ENSG00000249571	OR12D1	NA	
ENSG00000206472	OR11A1	NA	
ENSG00000204689	OR10C1	NA	
ENSG00000206471	OR2H1	NA	
ENSG00000234856	UBDP1	NA	
ENSG00000227668	MAS1LP1	NA	
ENSG00000206470	MAS1L	NA	
ENSG00000223376	RPS17P1	NA	
ENSG00000227886	LINC02829	NA	
ENSG00000233857	LINC01015	NA	
ENSG00000228993	GPR53P	NA	
ENSG00000232049	OR2I1P	NA	
ENSG00000206466	GABBR1	NA	
ENSG00000206468	UBD	NA	
ENSG00000223853	OR2H5P	NA	
ENSG00000224293	TMEM183AP1	NA	
ENSG00000265013	SNORD32B	NA	
ENSG00000231190	RPL13AP	NA	
ENSG00000206467	OR2H2	NA	
ENSG00000230888	SUMO2P1	NA	
ENSG00000232641	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000223858	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000236926	ZDHHC20P1	NA	
ENSG00000234487	HLA-F	NA	
ENSG00000249663	CR759790.1	NA	
ENSG00000228491	MICE	NA	
ENSG00000243430	CR788234.2	NA	
ENSG00000228202	CR788234.1	NA	
ENSG00000264646	Y_RNA	NA	
ENSG00000233298	IFITM4P	NA	
ENSG00000229194	HLA-V	NA	
ENSG00000224564	HCG4	NA	
ENSG00000259930	HLA-P	NA	
ENSG00000233982	RPL7AP7	NA	
ENSG00000233592	MICG	NA	
ENSG00000237216	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000232122	HCG4P8	NA	
ENSG00000234364	CT009517.2	NA	
ENSG00000225120	CT009517.1	NA	
ENSG00000247700	HLA-H	NA	
ENSG00000237098	HLA-T	NA	
ENSG00000236265	DDX39BP1	NA	
ENSG00000232649	MCCD1P1	NA	
ENSG00000227715	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000228921	CR759762.1	NA	
ENSG00000236746	HLA-W	NA	
ENSG00000235600	MICD	NA	
ENSG00000234599	HCG9	NA	
ENSG00000227389	DDX39BP2	NA	
ENSG00000236113	MCCD1P2	NA	
ENSG00000232691	ZNRD1ASP	NA	
ENSG00000223892	CR759763.1	NA	
ENSG00000226586	HLA-J	NA	
ENSG00000228765	ETF1P1	NA	
ENSG00000278347	CR759763.4	NA	
ENSG00000276640	CR759763.3	NA	
ENSG00000236808	ZNRD1	NA	
ENSG00000276594	CR759763.2	NA	
ENSG00000237403	PPP1R11	NA	
ENSG00000230332	RNF39	NA	
ENSG00000223531	TRIM31	NA	
ENSG00000225038	TRIM31-AS1	NA	
ENSG00000263517	CR759838.1	NA	
ENSG00000236399	TRIM40	NA	
ENSG00000229381	TRIM10	NA	
ENSG00000235905	TRIM15	NA	
ENSG00000231641	TRIM26	NA	
ENSG00000234574	PAIP1P1	NA	
ENSG00000230887	MICC	NA	
ENSG00000225201	HLA-E	NA	
ENSG00000234057	LINC02569	NA	
ENSG00000228581	GNL1	NA	
ENSG00000233564	PRR3	NA	
ENSG00000236342	ABCF1	NA	
ENSG00000235291	PPP1R10	NA	
ENSG00000229861	MRPS18B	NA	
ENSG00000231257	ATAT1	NA	
ENSG00000227655	PTMAP1	NA	
ENSG00000224120	C6orf136	NA	
ENSG00000231377	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000225060	PPP1R18	NA	
ENSG00000234809	NRM	NA	
ENSG00000229575	RPL7P4	NA	
ENSG00000237095	MDC1	NA	
ENSG00000233883	MDC1-AS1	NA	
ENSG00000229684	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000229684	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000224740	FLOT1	NA	
ENSG00000266523	Y_RNA	NA	
ENSG00000224862	LINC02570	NA	
ENSG00000265633	7SK	NA	
ENSG00000227422	DDR1-DT	NA	
ENSG00000223680	DDR1	NA	
ENSG00000234370	GTF2H4	NA	
ENSG00000285515	CR936875.1	NA	
ENSG00000234032	VARS2	615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
ENSG00000237814	SFTA2	NA	
ENSG00000264847	Y_RNA	NA	
ENSG00000257232	MUCL3	NA	
ENSG00000228448	HCG21	NA	
ENSG00000227506	MUC21	NA	
ENSG00000227132	CR759772.1	NA	
ENSG00000225629	HCG22	NA	
ENSG00000263474	U6	NA	
ENSG00000224105	C6orf15	NA	
ENSG00000233734	PSORS1C1	NA	
ENSG00000237165	CDSN	146520	HYPOTRICHOSIS 2; HYPT2;;HYPOTRICHOSIS SIMPLEX OF THE SCALP 1; HTSS1;;HTSS;;HYPOTRICHOSIS, SPANISH TYPE
ENSG00000237165	CDSN	270300	PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN
ENSG00000227246	PSORS1C2	NA	
ENSG00000233504	POLR2LP1	NA	
ENSG00000224180	CCHCR1	NA	
ENSG00000224472	TCF19	NA	
ENSG00000235068	POU5F1	NA	
ENSG00000258002	CR759815.2	NA	
ENSG00000230983	PSORS1C3	NA	
ENSG00000223577	HCG27	NA	
ENSG00000226408	CR759815.1	NA	
ENSG00000225691	HLA-C	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
ENSG00000225691	HLA-C	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000232126	HLA-B	142830	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B;;HLA-B HISTOCOMPATIBILITY TYPE ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO, INCLUDED;;SYNOVITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;DRUG-INDUCED LIVER INJURY DUE TO FLUCLOXACILLIN, INCLUDED
ENSG00000232126	HLA-B	106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1;;ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO;;MARIE-STRUMPELL SPONDYLITIS;;BECHTEREW SYNDROME
ENSG00000232126	HLA-B	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000226050	USP8P1	NA	
ENSG00000227656	RPL3P2	NA	
ENSG00000231309	WASF5P	NA	
ENSG00000228713	CR759828.1	NA	
ENSG00000227429	HCP5	NA	
ENSG00000263679	Y_RNA	NA	
ENSG00000238289	MICB	NA	
ENSG00000229706	PPIAP9	NA	
ENSG00000236547	RPL15P4	NA	
ENSG00000228662	MCCD1	NA	
ENSG00000229496	DDX39B	NA	
ENSG00000263625	SNORD117	NA	
ENSG00000266755	SNORD84	NA	
ENSG00000234082	DDX39B-AS1	NA	
ENSG00000230900	ATP6V1G2	NA	
ENSG00000235125	NFKBIL1	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000226275	LTA	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
ENSG00000226275	LTA	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000226275	LTA	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4 LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
ENSG00000223952	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000223952	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000223952	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000236237	LTB	NA	
ENSG00000234514	LST1	NA	
ENSG00000225211	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000235985	AIF1	NA	
ENSG00000225748	PRRC2A	NA	
ENSG00000265754	SNORA38	NA	
ENSG00000234651	BAG6	NA	
ENSG00000226215	APOM	NA	
ENSG00000226531	C6orf47	NA	
ENSG00000225390	C6orf47-AS1	NA	
ENSG00000232312	GPANK1	NA	
ENSG00000265738	Y_RNA	NA	
ENSG00000224398	CSNK2B	618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
ENSG00000241132	LY6G5B	NA	
ENSG00000237495	LY6G5C	NA	
ENSG00000236063	ABHD16A	NA	
ENSG00000240957	LY6G6F	NA	
ENSG00000236902	LY6G6D	NA	
ENSG00000235769	LY6G6E	NA	
ENSG00000237459	MPIG6B	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
ENSG00000228250	LY6G6C	NA	
ENSG00000225635	DDAH2	NA	
ENSG00000226417	CLIC1	NA	
ENSG00000227314	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000266442	MSH5-SAPCD1	NA	
ENSG00000264951	U6	NA	
ENSG00000234951	SAPCD1	NA	
ENSG00000235765	SAPCD1-AS1	NA	
ENSG00000223757	VWA7	NA	
ENSG00000224264	VARS1	617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
ENSG00000264887	Y_RNA	NA	
ENSG00000225998	LSM2	NA	
ENSG00000227129	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000229077	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000238134	EHMT2	NA	
ENSG00000233649	CR759784.1	NA	
ENSG00000226560	C2	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D;;C2 DEFICIENCY
ENSG00000226560	C2	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000234196	ZBTB12	NA	
ENSG00000223661	C4B-AS1	NA	
ENSG00000243570	CFB	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4
ENSG00000243570	CFB	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000243570	CFB	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
ENSG00000229363	NELFE	NA	
ENSG00000232616	SKIV2L	614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
ENSG00000224313	DXO	NA	
ENSG00000226033	STK19	NA	
ENSG00000224639	C4B	614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD;;C4B DEFICIENCY
ENSG00000229856	CYP21A1P	NA	
ENSG00000224140	TNXA	NA	
ENSG00000230354	STK19B	NA	
ENSG00000227746	C4A	614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM;;CHIDO/RODGERS BLOOD GROUP SYSTEM
ENSG00000227746	C4A	614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD;;C4A DEFICIENCY
ENSG00000225540	C4A-AS1	NA	
ENSG00000235134	CYP21A2	201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA III;;21-@HYDROXYLASE DEFICIENCY;;CYP21 DEFICIENCY;;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1 HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED
ENSG00000206258	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000206258	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000266726	5S_rRNA	NA	
ENSG00000228628	ATF6B	NA	
ENSG00000223666	FKBPL	NA	
ENSG00000227122	PRRT1	NA	
ENSG00000231618	PPT2	NA	
ENSG00000240592	EGFL8	NA	
ENSG00000235758	AGPAT1	NA	
ENSG00000225452	RNF5	NA	
ENSG00000230514	AGER	NA	
ENSG00000236353	PBX2	NA	
ENSG00000234243	GPSM3	NA	
ENSG00000223355	NOTCH4	NA	
ENSG00000237881	TSBP1	NA	
ENSG00000225237	HNRNPA1P2	NA	
ENSG00000264557	U6	NA	
ENSG00000230602	TSBP1-AS1	NA	
ENSG00000225845	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000230726	HLA-DRA	NA	
ENSG00000228260	HLA-DRB9	NA	
ENSG00000232441	CR788250.1	NA	
ENSG00000264893	U1	NA	
ENSG00000235074	CR788250.2	NA	
ENSG00000263971	U1	NA	
ENSG00000231021	HLA-DRB4	NA	
ENSG00000228284	HLA-DQA1	NA	
ENSG00000231286	HLA-DQB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000231286	HLA-DQB1	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000232351	HLA-DQB1-AS1	NA	
ENSG00000242044	CR933859.1	NA	
ENSG00000228025	MTCO3P1	NA	
ENSG00000226550	CR759848.1	NA	
ENSG00000234510	HLA-DQB3	NA	
ENSG00000206301	HLA-DQA2	NA	
ENSG00000228254	HLA-DQB2	NA	
ENSG00000241910	HLA-DOB	NA	
ENSG00000237599	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000226201	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000234365	PSMB8-AS1	NA	
ENSG00000240508	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000230705	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000233498	PPP1R2P1	NA	
ENSG00000226691	HLA-Z	NA	
ENSG00000242386	HLA-DMB	NA	
ENSG00000239463	HLA-DMA	NA	
ENSG00000236227	BRD2	NA	
ENSG00000237348	CR759798.1	NA	
ENSG00000230141	HLA-DOA	NA	
ENSG00000168384	HLA-DPA1	NA	
ENSG00000230763	HLA-DPB1	NA	
ENSG00000231288	RPL32P1	NA	
ENSG00000230878	HLA-DPA2	NA	
ENSG00000234249	COL11A2P1	NA	
ENSG00000223372	HLA-DPB2	NA	
ENSG00000235708	COL11A2	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA;;OSMED, HETEROZYGOUS;;WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;;PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;;STICKLER SYNDROME, TYPE III, /.../RLY; STL3, FORMERLY
ENSG00000235708	COL11A2	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB;;OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA;;WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY
ENSG00000235708	COL11A2	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
ENSG00000235708	COL11A2	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
ENSG00000235708	COL11A2	614524	FIBROCHONDROGENESIS 2; FBCG2
ENSG00000235712	RXRB	NA	
ENSG00000266464	Y_RNA	NA	
ENSG00000224399	SLC39A7	NA	
ENSG00000232357	HSD17B8	NA	
ENSG00000231115	RING1	NA	
ENSG00000237723	ZNF70P1	NA	
ENSG00000227750	HTATSF1P1	NA	
ENSG00000238064	HCG25	NA	
ENSG00000224455	VPS52	NA	
ENSG00000226225	RPS18	NA	
ENSG00000236802	B3GALT4	NA	
ENSG00000236222	WDR46	NA	
ENSG00000235692	PFDN6	NA	
ENSG00000228736	RGL2	NA	
ENSG00000206208	TAPBP	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000237056	ZBTB22	NA	
ENSG00000231617	DAXX	NA	
ENSG00000224874	MYL8P	NA	
ENSG00000205677	LYPLA2P1	NA	
ENSG00000231602	RPL35AP4	NA	
ENSG00000056678	KIFC1	NA	
ENSG00000273323	NOP56P1	NA	
ENSG00000272907	AL844539.1	NA	
ENSG00000272629	LINC01623	NA	
ENSG00000273122	RPL13P	NA	
ENSG00000229714	ZNF90P2	NA	
ENSG00000227559	HCG14	NA	
ENSG00000215641	TRIM27	NA	
ENSG00000265795	U6	NA	
ENSG00000206526	LINC01556	NA	
ENSG00000235541	KRT18P1	NA	
ENSG00000264866	Metazoa_SRP	NA	
ENSG00000225368	HCG15	NA	
ENSG00000243286	AL929561.3	NA	
ENSG00000169260	ZNF311	NA	
ENSG00000237043	OR2AD1P	NA	
ENSG00000206525	OR2W1	NA	
ENSG00000278714	AL929561.4	NA	
ENSG00000235195	OR2P1P	NA	
ENSG00000226795	SAR1AP1	NA	
ENSG00000206524	OR2B3	NA	
ENSG00000206523	OR2J1	NA	
ENSG00000206522	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000225184	AL929561.1	NA	
ENSG00000233506	AL929561.2	NA	
ENSG00000234746	OR2J2	NA	
ENSG00000218297	OR2J4P	NA	
ENSG00000235401	AL935156.1	NA	
ENSG00000224392	OR2G1P	NA	
ENSG00000251547	OR12D1	NA	
ENSG00000240130	OR5V1	NA	
ENSG00000206517	OR11A1	NA	
ENSG00000220550	OR10C1	NA	
ENSG00000206516	OR2H1	NA	
ENSG00000224044	UBDP1	NA	
ENSG00000227859	MAS1LP1	NA	
ENSG00000206515	MAS1L	NA	
ENSG00000229439	RPS17P1	NA	
ENSG00000232902	LINC02829	NA	
ENSG00000226687	LINC01015	NA	
ENSG00000224894	GPR53P	NA	
ENSG00000231973	OR2I1P	NA	
ENSG00000206511	GABBR1	NA	
ENSG00000206513	UBD	NA	
ENSG00000235630	OR2H5P	NA	
ENSG00000229737	TMEM183AP1	NA	
ENSG00000266132	SNORD32B	NA	
ENSG00000206519	RPL13AP	NA	
ENSG00000206512	OR2H2	NA	
ENSG00000234528	SUMO2P1	NA	
ENSG00000137345	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000206510	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000228371	ZDHHC20P1	NA	
ENSG00000206509	HLA-F	NA	
ENSG00000224921	AL844851.1	NA	
ENSG00000206508	HLA-F-AS1	NA	
ENSG00000239784	RPL23AP1	NA	
ENSG00000251197	MICE	NA	
ENSG00000236619	AL844851.2	NA	
ENSG00000265105	Y_RNA	NA	
ENSG00000230722	IFITM4P	NA	
ENSG00000206444	HLA-V	NA	
ENSG00000237905	HCG4	NA	
ENSG00000260638	HLA-P	NA	
ENSG00000233113	RPL7AP7	NA	
ENSG00000224355	MICG	NA	
ENSG00000206506	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000225023	HCG4P8	NA	
ENSG00000232253	BX001005.1	NA	
ENSG00000230419	AL845454.1	NA	
ENSG00000227296	HLA-H	NA	
ENSG00000229552	HLA-T	NA	
ENSG00000236441	DDX39BP1	NA	
ENSG00000229411	MCCD1P1	NA	
ENSG00000220391	HCG4B	NA	
ENSG00000224526	HLA-K	NA	
ENSG00000229428	HLA-U	NA	
ENSG00000206505	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000235952	AL845454.2	NA	
ENSG00000228029	HLA-W	NA	
ENSG00000232345	MICD	NA	
ENSG00000206504	HCG9	NA	
ENSG00000234140	DDX39BP2	NA	
ENSG00000234970	MCCD1P2	NA	
ENSG00000235814	ZNRD1ASP	NA	
ENSG00000237884	AL845454.3	NA	
ENSG00000243336	HLA-J	NA	
ENSG00000232516	ETF1P1	NA	
ENSG00000278511	AL845439.3	NA	
ENSG00000278397	AL845439.2	NA	
ENSG00000206502	ZNRD1	NA	
ENSG00000275133	AL845439.1	NA	
ENSG00000206501	PPP1R11	NA	
ENSG00000206500	RNF39	NA	
ENSG00000137397	TRIM31	NA	
ENSG00000229223	TRIM31-AS1	NA	
ENSG00000265602	BX322644.1	NA	
ENSG00000172524	TRIM40	NA	
ENSG00000137394	TRIM10	NA	
ENSG00000137384	TRIM15	NA	
ENSG00000137313	TRIM26	NA	
ENSG00000228227	PAIP1P1	NA	
ENSG00000244695	HCG17	NA	
ENSG00000235923	TRIM26BP	NA	
ENSG00000244721	HLA-L	NA	
ENSG00000234893	HCG18	NA	
ENSG00000206495	TRIM39	NA	
ENSG00000242726	RPP21	NA	
ENSG00000236688	HLA-N	NA	
ENSG00000227100	AL773535.1	NA	
ENSG00000236122	UBQLN1P1	NA	
ENSG00000237034	MICC	NA	
ENSG00000235223	TMPOP1	NA	
ENSG00000223693	SUCLA2P1	NA	
ENSG00000229038	RANP1	NA	
ENSG00000206493	HLA-E	NA	
ENSG00000236934	LINC02569	NA	
ENSG00000206492	GNL1	NA	
ENSG00000206491	PRR3	NA	
ENSG00000206490	ABCF1	NA	
ENSG00000206489	PPP1R10	NA	
ENSG00000203624	MRPS18B	NA	
ENSG00000206488	ATAT1	NA	
ENSG00000235757	PTMAP1	NA	
ENSG00000206487	C6orf136	NA	
ENSG00000206486	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000206485	PPP1R18	NA	
ENSG00000206484	NRM	NA	
ENSG00000238255	RPL7P4	NA	
ENSG00000206481	MDC1	NA	
ENSG00000227899	MDC1-AS1	NA	
ENSG00000183311	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000183311	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000206480	FLOT1	NA	
ENSG00000265955	Y_RNA	NA	
ENSG00000206478	IER3	NA	
ENSG00000264688	Metazoa_SRP	NA	
ENSG00000224133	HCG20	NA	
ENSG00000215523	AL773551.1	NA	
ENSG00000225888	LINC02570	NA	
ENSG00000264415	7SK	NA	
ENSG00000223405	DDR1-DT	NA	
ENSG00000215522	DDR1	NA	
ENSG00000221974	GTF2H4	NA	
ENSG00000285213	AL773541.1	NA	
ENSG00000206476	VARS2	615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20
ENSG00000206465	SFTA2	NA	
ENSG00000264602	Y_RNA	NA	
ENSG00000229284	MUCL3	NA	
ENSG00000230541	HCG21	NA	
ENSG00000206463	MUC21	NA	
ENSG00000229199	AL805909.1	NA	
ENSG00000227974	HCG22	NA	
ENSG00000266375	U6	NA	
ENSG00000206461	C6orf15	NA	
ENSG00000206458	PSORS1C1	NA	
ENSG00000206460	CDSN	146520	HYPOTRICHOSIS 2; HYPT2;;HYPOTRICHOSIS SIMPLEX OF THE SCALP 1; HTSS1;;HTSS;;HYPOTRICHOSIS, SPANISH TYPE
ENSG00000206460	CDSN	270300	PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN
ENSG00000206459	PSORS1C2	NA	
ENSG00000237545	POLR2LP1	NA	
ENSG00000206457	CCHCR1	NA	
ENSG00000206455	TCF19	NA	
ENSG00000206454	POU5F1	NA	
ENSG00000224744	PSORS1C3	NA	
ENSG00000220890	HCG27	NA	
ENSG00000223868	AL845458.1	NA	
ENSG00000206452	HLA-C	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
ENSG00000206452	HLA-C	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000206450	HLA-B	142830	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B;;HLA-B HISTOCOMPATIBILITY TYPE ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO, INCLUDED;;SYNOVITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;DRUG-INDUCED LIVER INJURY DUE TO FLUCLOXACILLIN, INCLUDED
ENSG00000206450	HLA-B	106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1;;ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO;;MARIE-STRUMPELL SPONDYLITIS;;BECHTEREW SYNDROME
ENSG00000206450	HLA-B	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000228904	USP8P1	NA	
ENSG00000223927	RPL3P2	NA	
ENSG00000225954	WASF5P	NA	
ENSG00000225571	AL845443.1	NA	
ENSG00000236851	DHFRP2	NA	
ENSG00000266886	U6	NA	
ENSG00000232276	AL845443.2	NA	
ENSG00000231773	ZDHHC20P2	NA	
ENSG00000237559	HLA-S	NA	
ENSG00000183214	MICA	NA	
ENSG00000265896	Y_RNA	NA	
ENSG00000265852	Y_RNA	NA	
ENSG00000206449	MICB	NA	
ENSG00000225317	PPIAP9	NA	
ENSG00000232572	RPL15P4	NA	
ENSG00000206447	MCCD1	NA	
ENSG00000215425	DDX39B	NA	
ENSG00000266295	SNORD117	NA	
ENSG00000266646	SNORD84	NA	
ENSG00000238071	DDX39B-AS1	NA	
ENSG00000206445	ATP6V1G2	NA	
ENSG00000206440	NFKBIL1	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000173503	LTA	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
ENSG00000173503	LTA	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000173503	LTA	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4 LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
ENSG00000206439	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000206439	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000206439	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000206437	LTB	NA	
ENSG00000206433	LST1	NA	
ENSG00000206430	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000229189	UQCRHP1	NA	
ENSG00000206428	AIF1	NA	
ENSG00000206427	PRRC2A	NA	
ENSG00000264153	SNORA38	NA	
ENSG00000096155	BAG6	NA	
ENSG00000206409	APOM	NA	
ENSG00000203623	C6orf47	NA	
ENSG00000224835	C6orf47-AS1	NA	
ENSG00000206408	GPANK1	NA	
ENSG00000265278	Y_RNA	NA	
ENSG00000206406	CSNK2B	618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
ENSG00000239285	LY6G5B	NA	
ENSG00000206404	LY6G5C	NA	
ENSG00000206403	ABHD16A	NA	
ENSG00000243804	LY6G6F	NA	
ENSG00000206402	LY6G6D	NA	
ENSG00000206401	LY6G6E	NA	
ENSG00000206396	MPIG6B	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
ENSG00000206398	LY6G6C	NA	
ENSG00000206395	DDAH2	NA	
ENSG00000206394	CLIC1	NA	
ENSG00000235569	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000264556	U6	NA	
ENSG00000227686	VARS1	617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
ENSG00000172850	LSM2	NA	
ENSG00000206383	HSPA1L	NA	
ENSG00000215328	HSPA1A	NA	
ENSG00000212866	HSPA1B	NA	
ENSG00000206380	SNHG32	NA	
ENSG00000265732	SNORD48	NA	
ENSG00000265156	SNORD52	NA	
ENSG00000184494	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000206338	CYP21A2	201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA III;;21-@HYDROXYLASE DEFICIENCY;;CYP21 DEFICIENCY;;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1 HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED
ENSG00000206378	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000206376	EHMT2	NA	
ENSG00000231869	AL844853.1	NA	
ENSG00000206372	C2	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D;;C2 DEFICIENCY
ENSG00000206372	C2	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000206366	ZBTB12	NA	
ENSG00000235250	C4B-AS1	NA	
ENSG00000241253	CFB	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4
ENSG00000241253	CFB	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000241253	CFB	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
ENSG00000206357	NELFE	NA	
ENSG00000206353	SKIV2L	614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
ENSG00000206346	DXO	NA	
ENSG00000206342	STK19	NA	
ENSG00000272295	AL844853.2	NA	
ENSG00000206340	C4A	614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM;;CHIDO/RODGERS BLOOD GROUP SYSTEM
ENSG00000206340	C4A	614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD;;C4A DEFICIENCY
ENSG00000230075	C4A-AS1	NA	
ENSG00000229353	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000229353	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000266035	5S_rRNA	NA	
ENSG00000206331	PRRT1	NA	
ENSG00000206329	PPT2	NA	
ENSG00000254875	AL845464.1	NA	
ENSG00000244444	EGFL8	NA	
ENSG00000206324	AGPAT1	NA	
ENSG00000183574	RNF5	NA	
ENSG00000206320	AGER	NA	
ENSG00000206315	PBX2	NA	
ENSG00000206314	GPSM3	NA	
ENSG00000206312	NOTCH4	NA	
ENSG00000206310	TSBP1	NA	
ENSG00000235171	HNRNPA1P2	NA	
ENSG00000265920	U6	NA	
ENSG00000228738	TSBP1-AS1	NA	
ENSG00000229597	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000206308	HLA-DRA	NA	
ENSG00000226035	HLA-DRB9	NA	
ENSG00000266884	U1	NA	
ENSG00000196101	HLA-DRB3	NA	
ENSG00000264389	U1	NA	
ENSG00000227442	HLA-DRB2	NA	
ENSG00000266689	U1	NA	
ENSG00000206306	HLA-DRB1	181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1;;SARCOIDOSIS;;BOECK SARCOID
ENSG00000206306	HLA-DRB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000206305	HLA-DQA1	NA	
ENSG00000206302	HLA-DQB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000206302	HLA-DQB1	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000233744	HLA-DQB1-AS1	NA	
ENSG00000240110	AL935026.1	NA	
ENSG00000229710	MTCO3P1	NA	
ENSG00000230150	AL773543.1	NA	
ENSG00000224197	HLA-DQB3	NA	
ENSG00000225103	HLA-DQA2	NA	
ENSG00000196610	HLA-DQB2	NA	
ENSG00000206299	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000206298	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000206296	PSMB8-AS1	NA	
ENSG00000243594	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000206297	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000226914	PPP1R2P1	NA	
ENSG00000233053	HLA-Z	NA	
ENSG00000241674	HLA-DMB	NA	
ENSG00000242685	HLA-DMA	NA	
ENSG00000215077	BRD2	NA	
ENSG00000228104	AL935042.1	NA	
ENSG00000206292	HLA-DOA	NA	
ENSG00000206291	HLA-DPA1	NA	
ENSG00000215048	HLA-DPB1	NA	
ENSG00000233194	RPL32P1	NA	
ENSG00000227286	HLA-DPA2	NA	
ENSG00000228164	COL11A2P1	NA	
ENSG00000234834	HLA-DPB2	NA	
ENSG00000224929	HLA-DPA3	NA	
ENSG00000238100	HCG24	NA	
ENSG00000206290	COL11A2	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA;;OSMED, HETEROZYGOUS;;WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;;PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;;STICKLER SYNDROME, TYPE III, /.../RLY; STL3, FORMERLY
ENSG00000206290	COL11A2	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB;;OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA;;WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY
ENSG00000206290	COL11A2	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
ENSG00000206290	COL11A2	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
ENSG00000206290	COL11A2	614524	FIBROCHONDROGENESIS 2; FBCG2
ENSG00000206289	RXRB	NA	
ENSG00000265071	Y_RNA	NA	
ENSG00000206288	SLC39A7	NA	
ENSG00000112474	HSD17B8	NA	
ENSG00000206287	RING1	NA	
ENSG00000231030	ZNF70P1	NA	
ENSG00000235684	HTATSF1P1	NA	
ENSG00000231343	HCG25	NA	
ENSG00000206286	VPS52	NA	
ENSG00000096150	RPS18	NA	
ENSG00000206285	B3GALT4	NA	
ENSG00000206284	WDR46	NA	
ENSG00000206283	PFDN6	NA	
ENSG00000206282	RGL2	NA	
ENSG00000206281	TAPBP	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000206280	ZBTB22	NA	
ENSG00000206279	DAXX	NA	
ENSG00000230193	MYL8P	NA	
ENSG00000232376	LYPLA2P1	NA	
ENSG00000227168	RPL35AP4	NA	
ENSG00000204197	KIFC1	NA	
ENSG00000228099	RPL12P1	NA	
ENSG00000239756	PHF1	NA	
ENSG00000248563	RPSAP2	NA	
ENSG00000248655	NOP56P1	NA	
ENSG00000233826	BX119924.1	NA	
ENSG00000229773	LINC01623	NA	
ENSG00000231746	RPL13P	NA	
ENSG00000232997	ZNF90P2	NA	
ENSG00000237010	HCG14	NA	
ENSG00000229006	TRIM27	NA	
ENSG00000266870	U6	NA	
ENSG00000233566	LINC01556	NA	
ENSG00000228990	KRT18P1	NA	
ENSG00000266191	Metazoa_SRP	NA	
ENSG00000237898	HCG15	NA	
ENSG00000241124	BX248109.1	NA	
ENSG00000233831	ZNF311	NA	
ENSG00000233650	OR2AD1P	NA	
ENSG00000227639	OR2W1	NA	
ENSG00000278450	BX248413.1	NA	
ENSG00000229100	OR2P1P	NA	
ENSG00000231592	SAR1AP1	NA	
ENSG00000226832	OR2B3	NA	
ENSG00000235632	OR2J1	NA	
ENSG00000233618	OR2J3	615082	C3HEX, ABILITY TO SMELL
ENSG00000233119	BX248093.2	NA	
ENSG00000231670	BX248093.1	NA	
ENSG00000226000	OR2J2	NA	
ENSG00000229069	OR2J4P	NA	
ENSG00000225592	BX248084.1	NA	
ENSG00000230089	BX248084.2	NA	
ENSG00000230874	OR2G1P	NA	
ENSG00000230752	OR2U1P	NA	
ENSG00000226932	OR2U2P	NA	
ENSG00000232146	BX005432.1	NA	
ENSG00000234195	OR14J1	NA	
ENSG00000227843	DDX6P1	NA	
ENSG00000227137	OR5V1	NA	
ENSG00000250364	OR12D3	NA	
ENSG00000225247	OR12D2	NA	
ENSG00000250294	OR12D1	NA	
ENSG00000223898	OR11A1	NA	
ENSG00000235441	OR10C1	NA	
ENSG00000229408	OR2H1	NA	
ENSG00000237369	UBDP1	NA	
ENSG00000237544	MAS1LP1	NA	
ENSG00000237284	MAS1L	NA	
ENSG00000231000	RPS17P1	NA	
ENSG00000225432	LINC02829	NA	
ENSG00000229383	LINC01015	NA	
ENSG00000234992	GPR53P	NA	
ENSG00000235666	SUMO2P1	NA	
ENSG00000236561	MOG	614250	NARCOLEPSY 7; NRCLP7
ENSG00000234669	ZFP57	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1;;6q24-RELATED DIABETES MELLITUS;;TNDM;;DMTN
ENSG00000229898	ZDHHC20P1	NA	
ENSG00000229698	HLA-F	NA	
ENSG00000236881	BX005428.2	NA	
ENSG00000230545	HLA-F-AS1	NA	
ENSG00000242511	RPL23AP1	NA	
ENSG00000249123	MICE	NA	
ENSG00000226267	BX005428.1	NA	
ENSG00000229942	IFITM4P	NA	
ENSG00000229529	HLA-V	NA	
ENSG00000228706	HCG4	NA	
ENSG00000260221	HLA-P	NA	
ENSG00000227326	RPL7AP7	NA	
ENSG00000229499	MICG	NA	
ENSG00000233095	HLA-G	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000230504	HCG4P8	NA	
ENSG00000236642	BX247949.1	NA	
ENSG00000226736	BX284699.1	NA	
ENSG00000237218	HLA-H	NA	
ENSG00000224693	HLA-T	NA	
ENSG00000229364	DDX39BP1	NA	
ENSG00000223860	MCCD1P1	NA	
ENSG00000236033	HCG4B	NA	
ENSG00000229959	HLA-K	NA	
ENSG00000236706	HLA-U	NA	
ENSG00000223980	HLA-A	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000231067	BX005091.1	NA	
ENSG00000234786	HLA-W	NA	
ENSG00000235380	MICD	NA	
ENSG00000237812	HCG9	NA	
ENSG00000235305	DDX39BP2	NA	
ENSG00000229034	MCCD1P2	NA	
ENSG00000196299	ZNRD1ASP	NA	
ENSG00000231385	BX005091.2	NA	
ENSG00000235309	HLA-J	NA	
ENSG00000223996	ETF1P1	NA	
ENSG00000275472	BX088647.2	NA	
ENSG00000274187	BX088647.1	NA	
ENSG00000233795	ZNRD1	NA	
ENSG00000276383	BX088647.3	NA	
ENSG00000237829	PPP1R11	NA	
ENSG00000230467	RNF39	NA	
ENSG00000224168	TRIM31	NA	
ENSG00000225732	TRIM31-AS1	NA	
ENSG00000263942	BX005441.1	NA	
ENSG00000233931	TRIM40	NA	
ENSG00000229346	TRIM10	NA	
ENSG00000224145	TRIM15	NA	
ENSG00000234046	TRIM26	NA	
ENSG00000224954	PAIP1P1	NA	
ENSG00000240833	HCG17	NA	
ENSG00000233350	TRIM26BP	NA	
ENSG00000242227	HLA-L	NA	
ENSG00000224619	HCG18	NA	
ENSG00000229929	TRIM39	NA	
ENSG00000239927	RPP21	NA	
ENSG00000234799	HLA-N	NA	
ENSG00000235877	BX294158.1	NA	
ENSG00000230441	UBQLN1P1	NA	
ENSG00000231785	MICC	NA	
ENSG00000230422	TMPOP1	NA	
ENSG00000237865	SUCLA2P1	NA	
ENSG00000137321	RANP1	NA	
ENSG00000230254	HLA-E	NA	
ENSG00000232523	LINC02569	NA	
ENSG00000226882	GNL1	NA	
ENSG00000229202	PRR3	NA	
ENSG00000225989	ABCF1	NA	
ENSG00000238104	PPP1R10	NA	
ENSG00000223775	MRPS18B	NA	
ENSG00000234549	ATAT1	NA	
ENSG00000224889	PTMAP1	NA	
ENSG00000237100	C6orf136	NA	
ENSG00000226171	DHX16	618733	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES; NMOAS
ENSG00000236428	PPP1R18	NA	
ENSG00000231135	MDC1	NA	
ENSG00000236522	MDC1-AS1	NA	
ENSG00000232421	TUBB	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1;;SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;;CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;;MICHELIN TIRE BABY SYNDROME
ENSG00000232421	TUBB	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
ENSG00000230143	FLOT1	NA	
ENSG00000263610	Y_RNA	NA	
ENSG00000235030	IER3	NA	
ENSG00000263912	Metazoa_SRP	NA	
ENSG00000238216	HCG20	NA	
ENSG00000237890	BX571801.1	NA	
ENSG00000229126	BX248321.1	NA	
ENSG00000237093	HCG22	NA	
ENSG00000266626	U6	NA	
ENSG00000234674	TCF19	NA	
ENSG00000237582	POU5F1	NA	
ENSG00000224056	PSORS1C3	NA	
ENSG00000231281	HCG27	NA	
ENSG00000229075	BX088580.1	NA	
ENSG00000206435	HLA-C	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1
ENSG00000206435	HLA-C	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO;;HIV-1, SUSCEPTIBILITY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;;HIV-1, RESISTANCE TO, INCLUDED;;ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;;AIDS, PROGRE /.../TO, INCLUDED
ENSG00000228964	HLA-B	142830	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B;;HLA-B HISTOCOMPATIBILITY TYPE ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO, INCLUDED;;SYNOVITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;DRUG-INDUCED LIVER INJURY DUE TO FLUCLOXACILLIN, INCLUDED
ENSG00000228964	HLA-B	106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1;;ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO;;MARIE-STRUMPELL SPONDYLITIS;;BECHTEREW SYNDROME
ENSG00000228964	HLA-B	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;;STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;;HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
ENSG00000225029	USP8P1	NA	
ENSG00000227672	RPL3P2	NA	
ENSG00000225403	WASF5P	NA	
ENSG00000226834	BX248310.1	NA	
ENSG00000233161	DHFRP2	NA	
ENSG00000266784	U6	NA	
ENSG00000232244	BX248310.2	NA	
ENSG00000227405	ZDHHC20P2	NA	
ENSG00000226027	HLA-S	NA	
ENSG00000231225	MICA	NA	
ENSG00000266250	Y_RNA	NA	
ENSG00000226768	LINC01149	NA	
ENSG00000230389	HCP5	NA	
ENSG00000265509	Y_RNA	NA	
ENSG00000227772	MICB	NA	
ENSG00000235596	PPIAP9	NA	
ENSG00000231623	RPL15P4	NA	
ENSG00000226841	MCCD1	NA	
ENSG00000254899	BX248516.1	NA	
ENSG00000235439	DDX39B	NA	
ENSG00000263358	SNORD117	NA	
ENSG00000263442	SNORD84	NA	
ENSG00000228245	DDX39B-AS1	NA	
ENSG00000234920	ATP6V1G2	NA	
ENSG00000236346	NFKBIL1	180300	RHEUMATOID ARTHRITIS; RA;;RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ENSG00000230279	LTA	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
ENSG00000230279	LTA	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;;MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
ENSG00000230279	LTA	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4 LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
ENSG00000230108	TNF	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1;;MGR1;;MGAU; MA;;MIGRAINE
ENSG00000230108	TNF	600807	ASTHMA, SUSCEPTIBILITY TO;;ASTHMA, BRONCHIAL;;ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO ASTHMA, PROTECTION AGAINST, INCLUDED;;ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
ENSG00000230108	TNF	611162	MALARIA, SUSCEPTIBILITY TO MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
ENSG00000238114	LTB	NA	
ENSG00000230791	LST1	NA	
ENSG00000223833	NCR3	609148	MALARIA, MILD, SUSCEPTIBILITY TO;;MALS
ENSG00000228926	UQCRHP1	NA	
ENSG00000235588	AIF1	NA	
ENSG00000231825	PRRC2A	NA	
ENSG00000263994	SNORA38	NA	
ENSG00000233348	BAG6	NA	
ENSG00000235754	APOM	NA	
ENSG00000226103	C6orf47	NA	
ENSG00000227853	C6orf47-AS1	NA	
ENSG00000228605	GPANK1	NA	
ENSG00000266716	Y_RNA	NA	
ENSG00000224774	CSNK2B	618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS
ENSG00000239497	LY6G5B	NA	
ENSG00000111971	LY6G5C	NA	
ENSG00000230475	ABHD16A	NA	
ENSG00000241822	LY6G6F	NA	
ENSG00000258880	LY6G6F-LY6G6D	NA	
ENSG00000226187	LY6G6E	NA	
ENSG00000235302	LY6G6D	NA	
ENSG00000231003	MPIG6B	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY
ENSG00000235925	LY6G6C	NA	
ENSG00000228128	DDAH2	NA	
ENSG00000223639	CLIC1	NA	
ENSG00000237333	MSH5	617442	PREMATURE OVARIAN FAILURE 13; POF13
ENSG00000263638	U6	NA	
ENSG00000255419	MSH5-SAPCD1	NA	
ENSG00000237918	SAPCD1	NA	
ENSG00000234433	VWA7	NA	
ENSG00000231945	VARS1	617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA
ENSG00000264778	Y_RNA	NA	
ENSG00000234846	NEU1	256550	NEURAMINIDASE DEFICIENCY;;SIALIDOSIS, TYPE II;;MUCOLIPIDOSIS I;;ML I;;LIPOMUCOPOLYSACCHARIDOSIS;;SIALIDASE DEFICIENCY;;GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;;NEUG DEFICIENCY;;NEURAMINIDASE 1 DEFICIENCY;;NEU DEFICIENCY;;NEU1 DEFICIENCY  SIALIDOSIS, T /.../ INCLUDED;;CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;;MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
ENSG00000232180	SLC44A4	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72
ENSG00000224143	EHMT2	NA	
ENSG00000224766	BX005460.1	NA	
ENSG00000235696	C2	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D;;C2 DEFICIENCY
ENSG00000235696	C2	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000225773	C4B-AS1	NA	
ENSG00000242335	CFB	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4
ENSG00000242335	CFB	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14 MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
ENSG00000242335	CFB	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD
ENSG00000233801	NELFE	NA	
ENSG00000228896	SKIV2L	614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2
ENSG00000234798	DXO	NA	
ENSG00000236250	STK19	NA	
ENSG00000233312	C4B_2	NA	
ENSG00000232577	BX679671.1	NA	
ENSG00000239882	CYP21A1P	NA	
ENSG00000234328	TNXA	NA	
ENSG00000248989	STK19B	NA	
ENSG00000228454	C4B	614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD;;C4B DEFICIENCY
ENSG00000238170	C4A-AS1	NA	
ENSG00000198457	CYP21A2	201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY;;ADRENAL HYPERPLASIA III;;21-@HYDROXYLASE DEFICIENCY;;CYP21 DEFICIENCY;;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1 HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED
ENSG00000236236	TNXB	606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL;;EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY;;EDS DUE TO TNX DEFICIENCY;;TNX DEFICIENCY
ENSG00000236236	TNXB	615963	VESICOURETERAL REFLUX 8; VUR8
ENSG00000235956	PRRT1	NA	
ENSG00000227600	PPT2	NA	
ENSG00000239974	EGFL8	NA	
ENSG00000228892	AGPAT1	NA	
ENSG00000227277	RNF5	NA	
ENSG00000237405	AGER	NA	
ENSG00000224952	PBX2	NA	
ENSG00000234508	GPSM3	NA	
ENSG00000234876	NOTCH4	NA	
ENSG00000232106	TSBP1	NA	
ENSG00000237295	HNRNPA1P2	NA	
ENSG00000265048	U6	NA	
ENSG00000224507	TSBP1-AS1	NA	
ENSG00000224242	BTNL2	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
ENSG00000234794	HLA-DRA	NA	
ENSG00000232705	HLA-DRB9	NA	
ENSG00000235228	BX120007.2	NA	
ENSG00000264704	U1	NA	
ENSG00000226227	BX120007.1	NA	
ENSG00000265838	U1	NA	
ENSG00000227357	HLA-DRB4	NA	
ENSG00000264960	U1	NA	
ENSG00000233697	HLA-DRB8	NA	
ENSG00000265248	U1	NA	
ENSG00000235324	BX649210.2	NA	
ENSG00000235116	BX649210.1	NA	
ENSG00000227099	HLA-DRB7	NA	
ENSG00000238101	FAM8A5P	NA	
ENSG00000266860	U1	NA	
ENSG00000228080	HLA-DRB1	181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1;;SARCOIDOSIS;;BOECK SARCOID
ENSG00000228080	HLA-DRB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000232062	HLA-DQA1	NA	
ENSG00000231939	HLA-DQB1	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS;;DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
ENSG00000231939	HLA-DQB1	123400	CREUTZFELDT-JAKOB DISEASE; CJD;;CREUTZFELDT-JAKOB DISEASE, FAMILIAL  CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;;CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
ENSG00000230414	HLA-DQB1-AS1	NA	
ENSG00000243245	BX248406.2	NA	
ENSG00000233317	MTCO3P1	NA	
ENSG00000232343	BX248406.1	NA	
ENSG00000234968	HLA-DQB3	NA	
ENSG00000231526	HLA-DQA2	NA	
ENSG00000226165	HLA-DQB2	NA	
ENSG00000239457	HLA-DOB	NA	
ENSG00000232326	TAP2	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000231631	PSMB8	256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1;;CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE;;NAKAJO-NISHIMURA SYNDROME; NKJO;;JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMI /.../ PANNICULITIS-INDUCED LIPODYSTROPHY;;JMP SYNDROME;;AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED
ENSG00000233140	PSMB8-AS1	NA	
ENSG00000243958	PSMB9	617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3, DIGENIC, INCLUDED
ENSG00000224748	TAP1	604571	BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY
ENSG00000223939	PPP1R2P1	NA	
ENSG00000228498	HLA-Z	NA	
ENSG00000241296	HLA-DMB	NA	
ENSG00000243215	HLA-DMA	NA	
ENSG00000235307	BRD2	NA	
ENSG00000225788	BX664702.1	NA	
ENSG00000232957	HLA-DOA	NA	
ENSG00000236177	HLA-DPA1	NA	
ENSG00000226826	HLA-DPB1	NA	
ENSG00000224098	RPL32P1	NA	
ENSG00000236898	HLA-DPA2	NA	
ENSG00000226513	COL11A2P1	NA	
ENSG00000168379	HLA-DPB2	NA	
ENSG00000223447	HLA-DPA3	NA	
ENSG00000232541	COL11A2	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA;;OSMED, HETEROZYGOUS;;WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;;PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;;STICKLER SYNDROME, TYPE III, /.../RLY; STL3, FORMERLY
ENSG00000232541	COL11A2	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB;;OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA;;WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY
ENSG00000232541	COL11A2	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
ENSG00000232541	COL11A2	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
ENSG00000232541	COL11A2	614524	FIBROCHONDROGENESIS 2; FBCG2
ENSG00000225696	ZNF70P1	NA	
ENSG00000234251	HTATSF1P1	NA	
ENSG00000231573	HCG25	NA	
ENSG00000236014	VPS52	NA	
ENSG00000227794	RPS18	NA	
ENSG00000229396	DAXX	NA	
ENSG00000226538	RPL35AP4	NA	
ENSG00000233450	KIFC1	NA	
ENSG00000232733	RPL12P1	NA	
ENSG00000225553	PHF1	NA	
ENSG00000226492	CUTA	NA	
ENSG00000227460	SYNGAP1	612621	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5
ENSG00000236515	ZBTB9	NA	
ENSG00000281993	AC093627.12	NA	
ENSG00000282155	AC093627.13	NA	
ENSG00000282226	AC093614.2	NA	
ENSG00000282075	AC093614.1	NA	
ENSG00000281767	AC093627.9	NA	
ENSG00000281349	AC093627.8	NA	
ENSG00000281788	AC093627.10	NA	
ENSG00000281429	FAM20C	259775	RAINE SYNDROME; RNS;;OSTEOSCLEROTIC BONE DYSPLASIA, LETHAL
ENSG00000282813	ARMC10	NA	
ENSG00000282789	CRYZP1	NA	
ENSG00000275723	NAPEPLD	NA	
ENSG00000282463	AC216130.2	NA	
ENSG00000282063	RPL23AP95	NA	
ENSG00000281979	AC216130.1	NA	
ENSG00000282026	DPY19L2P2	NA	
ENSG00000262327	AGK	212350	SENGERS SYNDROME;;MITOCHONDRIAL DNA DEPLETION SYNDROME 10 (CARDIOMYOPATHIC TYPE); MTDPS10;;CARDIOMYOPATHY AND CATARACT
ENSG00000262327	AGK	614691	CATARACT 38; CTRCT38;;CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5; CATC5
ENSG00000262671	AC004918.2	NA	
ENSG00000262599	DENND11	NA	
ENSG00000261994	WEE2-AS1	NA	
ENSG00000263042	WEE2	617996	OOCYTE MATURATION DEFECT 5; OOMD5
ENSG00000262656	U1	NA	
ENSG00000262771	SSBP1	NA	
ENSG00000282185	PTPRN2	NA	
ENSG00000281951	AC093627.11	NA	
ENSG00000282333	AC093627.15	NA	
ENSG00000282645	AC093627.19	NA	
ENSG00000282557	AC093627.17	NA	
ENSG00000282662	AC093627.20	NA	
ENSG00000282461	AC093627.16	NA	
ENSG00000282781	AC093627.21	NA	
ENSG00000282309	AC093627.14	NA	
ENSG00000282575	AC093627.18	NA	
ENSG00000282147	FAM20C	259775	RAINE SYNDROME; RNS;;OSTEOSCLEROTIC BONE DYSPLASIA, LETHAL
ENSG00000282379	DTX2	NA	
ENSG00000276184	UPK3B	NA	
ENSG00000282349	AC237298.1	NA	
ENSG00000281950	SPDYE16	NA	
ENSG00000282254	AC004980.5	NA	
ENSG00000276464	POMZP3	NA	
ENSG00000282364	AC004980.6	NA	
ENSG00000282580	AC004980.7	NA	
ENSG00000282607	MGAM	NA	
ENSG00000278563	MGAM2	NA	
ENSG00000282809	MOXD2P	NA	
ENSG00000276785	PRSS58	NA	
ENSG00000282170	TRY2P	NA	
ENSG00000282264	AC231381.1	NA	
ENSG00000282303	PRSS3P3	NA	
ENSG00000282423	TRBV1	NA	
ENSG00000282568	TRBV2	NA	
ENSG00000282624	TRBV3-1	NA	
ENSG00000282014	TRBV4-1	NA	
ENSG00000282803	TRBV5-1	NA	
ENSG00000281970	TRBV6-1	NA	
ENSG00000282225	TRBV7-1	NA	
ENSG00000282285	TRBV4-2	NA	
ENSG00000282719	TRBV6-2	NA	
ENSG00000282505	AC234635.2	NA	
ENSG00000282543	AC234635.3	NA	
ENSG00000282353	AC234635.1	NA	
ENSG00000282506	TRBV7-2	NA	
ENSG00000281952	TRBV8-1	NA	
ENSG00000282236	TRBV5-2	NA	
ENSG00000282240	TRBV6-4	NA	
ENSG00000282203	TRBV7-3	NA	
ENSG00000282529	TRBV8-2	NA	
ENSG00000282148	TRBV5-3	NA	
ENSG00000282204	TRBV9	NA	
ENSG00000282618	TRBV10-1	NA	
ENSG00000282711	TRBV11-1	NA	
ENSG00000282760	TRBV12-1	NA	
ENSG00000282007	TRBV10-2	NA	
ENSG00000282436	TRBV11-2	NA	
ENSG00000282326	TRBV12-2	NA	
ENSG00000277110	TRBV6-5	NA	
ENSG00000282756	TRBV7-4	NA	
ENSG00000282466	TRBV5-4	NA	
ENSG00000282459	TRBV6-6	NA	
ENSG00000282709	TRBV7-5	NA	
ENSG00000282577	TRBV5-5	NA	
ENSG00000282470	TRBV6-7	NA	
ENSG00000282704	TRBV7-6	NA	
ENSG00000282098	TRBV5-6	NA	
ENSG00000282134	TRBV6-8	NA	
ENSG00000282179	TRBV7-7	NA	
ENSG00000282748	TRBV5-7	NA	
ENSG00000282610	AC233282.2	NA	
ENSG00000282040	AC233282.1	NA	
ENSG00000282054	AC229888.1	NA	
ENSG00000281943	TRBV7-9	NA	
ENSG00000282407	TRBV13	NA	
ENSG00000282340	TRBV10-3	NA	
ENSG00000282242	TRBV11-3	NA	
ENSG00000282208	TRBV12-3	NA	
ENSG00000282354	TRBV12-4	NA	
ENSG00000282605	TRBV12-5	NA	
ENSG00000282252	TRBV14	NA	
ENSG00000282497	TRBV15	NA	
ENSG00000282415	TRBV16	NA	
ENSG00000282483	TRBV17	NA	
ENSG00000282771	TRBV18	NA	
ENSG00000282621	TRBV19	NA	
ENSG00000282064	TRBV20-1	NA	
ENSG00000282462	TRBV21-1	NA	
ENSG00000282036	TRBV22-1	NA	
ENSG00000282449	TRBV23-1	NA	
ENSG00000282730	TRBV24-1	NA	
ENSG00000282017	MTRNR2L6	NA	
ENSG00000281963	TRBV25-1	NA	
ENSG00000281972	TRBVA	NA	
ENSG00000281968	TRBV26	NA	
ENSG00000282047	TRBVB	NA	
ENSG00000282234	TRBV27	NA	
ENSG00000282812	TRBV28	NA	
ENSG00000282270	PGBD4P1	NA	
ENSG00000282628	TRBV29-1	NA	
ENSG00000274247	PRSS1	167800	PANCREATITIS, HEREDITARY; PCTT;;HPC;;HP;;PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;PANCREATITIS, CALCIFIC, INCLUDED;;PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
ENSG00000282295	PRSS3P1	NA	
ENSG00000282667	PRSS3P2	NA	
ENSG00000282565	AC239618.2	NA	
ENSG00000282049	PRSS2	167800	PANCREATITIS, HEREDITARY; PCTT;;HPC;;HP;;PANCREATITIS, CHRONIC PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;;PANCREATITIS, CALCIFIC, INCLUDED;;PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
ENSG00000282492	WBP1LP1	NA	
ENSG00000282253	TRBD1	NA	
ENSG00000282078	TRBJ1-1	NA	
ENSG00000281989	TRBJ1-2	NA	
ENSG00000282500	TRBJ1-3	NA	
ENSG00000282273	TRBJ1-4	NA	
ENSG00000282215	TRBJ1-5	NA	
ENSG00000281957	TRBJ1-6	NA	
ENSG00000281981	TRBC1	NA	
ENSG00000282488	TRBJ2-1	NA	
ENSG00000282272	TRBJ2-2	NA	
ENSG00000282589	TRBJ2-2P	NA	
ENSG00000282371	TRBJ2-3	NA	
ENSG00000282380	TRBJ2-4	NA	
ENSG00000282820	TRBJ2-5	NA	
ENSG00000282154	TRBJ2-6	NA	
ENSG00000282392	TRBJ2-7	NA	
ENSG00000276849	TRBC2	NA	
ENSG00000282297	TRBV30	NA	
ENSG00000275482	EPHB6	NA	
ENSG00000276971	TRPV6	618188	HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN
ENSG00000282313	AC239618.1	NA	
ENSG00000274348	TRPV5	NA	
ENSG00000275821	LLCFC1	NA	
ENSG00000276615	KEL	110900	BLOOD GROUP--KELL SYSTEM; KEL;;BLOOD GROUP--KELL-CELLANO SYSTEM  KELL-NULL, INCLUDED;;K(0), INCLUDED;;Ko, INCLUDED
ENSG00000273914	OR9A2	NA	
ENSG00000282335	OR9P1P	NA	
ENSG00000277378	OR6V1	NA	
ENSG00000274360	OR6W1P	NA	
ENSG00000282507	AC236756.1	NA	
ENSG00000278728	CNTNAP2	610042	PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1;;CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME; CDFES
ENSG00000278728	CNTNAP2	612100	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15
ENSG00000277205	U3	NA	
ENSG00000274906	Metazoa_SRP	NA	
ENSG00000282044	AC083849.4	NA	
ENSG00000281999	AC083849.3	NA	
ENSG00000282734	AF067845.6	NA	
ENSG00000281953	AF067845.3	NA	
ENSG00000281997	AC131901.1	NA	
ENSG00000282141	AC131901.2	NA	
ENSG00000282152	DLGAP2	NA	
ENSG00000282001	DLGAP2-AS1	NA	
ENSG00000282395	LINC01606	NA	
ENSG00000282061	AC025674.4	NA	
ENSG00000282027	AC025674.3	NA	
ENSG00000282106	LINC00588	NA	
ENSG00000278101	U6	NA	
ENSG00000282114	LINC00824	NA	
ENSG00000282113	AC068570.1	NA	
ENSG00000282472	AC026950.1	NA	
ENSG00000282261	AC129915.1	NA	
ENSG00000282428	AC129915.2	NA	
ENSG00000282524	AF186192.5	NA	
ENSG00000282619	AF186192.6	NA	
ENSG00000278062	ZNF251	NA	
ENSG00000282146	AF186192.4	NA	
ENSG00000280677	FAM66B	NA	
ENSG00000277802	AF252830.1	NA	
ENSG00000281561	AF252830.2	NA	
ENSG00000274195	ZNF705G	NA	
ENSG00000276378	DEFB108C	NA	
ENSG00000275444	DEFB4B	NA	
ENSG00000282496	HSPD1P3	NA	
ENSG00000273641	DEFB103B	NA	
ENSG00000274405	SPAG11B	NA	
ENSG00000277006	DEFB104B	NA	
ENSG00000275794	DEFB106B	NA	
ENSG00000274729	DEFB105B	NA	
ENSG00000277530	DEFB107B	NA	
ENSG00000274540	PRR23D1	NA	
ENSG00000280471	FAM90A6P	NA	
ENSG00000281040	FAM90A7P	NA	
ENSG00000281150	FAM90A21P	NA	
ENSG00000281407	FAM90A22P	NA	
ENSG00000281862	FAM90A23P	NA	
ENSG00000280960	OR7E157P	NA	
ENSG00000280939	AC134684.2	NA	
ENSG00000282684	ZC3H3	NA	
ENSG00000277845	RN7SKP175	NA	
ENSG00000278718	GSDMD	NA	
ENSG00000277781	MROH6	NA	
ENSG00000282613	AC067930.7	NA	
ENSG00000278488	NAPRT	NA	
ENSG00000282189	AC067930.6	NA	
ENSG00000273594	EEF1D	NA	
ENSG00000278016	TIGD5	NA	
ENSG00000276657	PYCR3	NA	
ENSG00000278243	TSTA3	NA	
ENSG00000276340	ZNF623	NA	
ENSG00000274352	ZNF707	NA	
ENSG00000277126	LINC02878	NA	
ENSG00000278749	CCDC166	NA	
ENSG00000282538	AC105219.5	NA	
ENSG00000274205	MAPK15	NA	
ENSG00000282617	AC105219.6	NA	
ENSG00000273889	FAM83H	130900	AMELOGENESIS IMPERFECTA, TYPE IIIA; AI3A;;AMELOGENESIS IMPERFECTA, TYPE III; AI3;;AMELOGENESIS IMPERFECTA, HYPOCALCIFICATION TYPE, AUTOSOMAL DOMINANT; ADHCAI;;AMELOGENESIS IMPERFECTA, HYPOMINERALIZATION TYPE
ENSG00000282685	FAM83H-AS1	NA	
ENSG00000282519	AC105219.4	NA	
ENSG00000274287	SCRIB	NA	
ENSG00000274081	PUF60	615583	VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME
ENSG00000282347	AC100797.3	NA	
ENSG00000282665	ERICH1	NA	
ENSG00000282103	DLGAP2	NA	
ENSG00000282245	AC100797.2	NA	
ENSG00000282681	LY6E-DT	NA	
ENSG00000278032	LY6E	NA	
ENSG00000278812	C8orf31	NA	
ENSG00000282669	AK3P2	NA	
ENSG00000282683	AC236721.1	NA	
ENSG00000282693	LY6L	NA	
ENSG00000274488	LY6H	NA	
ENSG00000274161	DLGAP2	NA	
ENSG00000282643	DLGAP2-AS1	NA	
ENSG00000282594	LINC01300	NA	
ENSG00000282573	AC100803.7	NA	
ENSG00000275181	GPR20	NA	
ENSG00000275575	PTP4A3	NA	
ENSG00000282181	MROH5	NA	
ENSG00000282477	AC100803.6	NA	
ENSG00000276275	AC100803.5	NA	
ENSG00000282315	HNRNPA1P38	NA	
ENSG00000282029	AC120035.1	NA	
ENSG00000282515	AC242019.1	NA	
ENSG00000282020	DLGAP2-AS1	NA	
ENSG00000282318	DLGAP2	NA	
ENSG00000282786	AF188030.1	NA	
ENSG00000278220	CLN8	600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
ENSG00000278220	CLN8	610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT;;NORTHERN EPILEPSY;;EPILEPSY, PROGRESSIVE, WITH MENTAL RETARDATION; EPMR
ENSG00000282493	AC100810.5	NA	
ENSG00000282481	AC100810.4	NA	
ENSG00000274726	ARHGEF10	608236	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV
ENSG00000282101	AC019257.4	NA	
ENSG00000282405	AC019257.6	NA	
ENSG00000282334	KBTBD11-OT1	NA	
ENSG00000282053	AC019257.3	NA	
ENSG00000273645	KBTBD11	NA	
ENSG00000282260	AC019257.5	NA	
ENSG00000282191	AC125453.1	NA	
ENSG00000274137	MYOM2	NA	
ENSG00000282484	AC022257.1	NA	
ENSG00000282263	AC133633.2	NA	
ENSG00000281936	AC133633.1	NA	
ENSG00000282397	AC104021.1	NA	
ENSG00000281980	AC246817.3	NA	
ENSG00000282435	AC246817.4	NA	
ENSG00000282661	AC246817.5	NA	
ENSG00000282230	ADAM9	612775	CONE-ROD DYSTROPHY 9; CORD9
ENSG00000275594	ADAM32	NA	
ENSG00000282698	RPL3P10	NA	
ENSG00000282490	AC245594.2	NA	
ENSG00000282250	AC245594.1	NA	
ENSG00000278548	ADAM18	NA	
ENSG00000276286	ADAM2	NA	
ENSG00000282680	AP005902.4	NA	
ENSG00000282382	AP005902.3	NA	
ENSG00000263127	RPL4P5	NA	
ENSG00000280745	AC208386.1	NA	
ENSG00000276497	APBA1	NA	
ENSG00000274039	AL355140.2	NA	
ENSG00000278608	MAMDC2	NA	
ENSG00000277409	MAMDC2-AS1	NA	
ENSG00000277517	AC212493.1	NA	
ENSG00000274806	U2	NA	
ENSG00000276374	AL451142.3	NA	
ENSG00000278688	AC215799.1	NA	
ENSG00000282008	GAPDHP26	NA	
ENSG00000276539	PLPPR1	NA	
ENSG00000282376	AL161631.2	NA	
ENSG00000276714	AL359893.3	NA	
ENSG00000282259	AC216089.2	NA	
ENSG00000282406	TRMT112P4	NA	
ENSG00000282159	AC216089.1	NA	
ENSG00000276559	BAAT	607748	HYPERCHOLANEMIA, FAMILIAL; FHCA
ENSG00000282345	FYTTD1P1	NA	
ENSG00000280741	LINC00685	NA	
ENSG00000276438	PPP2R3B	NA	
ENSG00000280593	AL732314.3	NA	
ENSG00000276895	Metazoa_SRP	NA	
ENSG00000280532	AL732314.2	NA	
ENSG00000280935	FABP5P13	NA	
ENSG00000280844	KRT18P53	NA	
ENSG00000277800	TBX22	302905	ABRUZZO-ERICKSON SYNDROME; ABERS;;CHARGE-LIKE SYNDROME, X-LINKED
ENSG00000277800	TBX22	303400	CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX
ENSG00000273850	PPP2R3B	NA	
ENSG00000280484	AL732314.1	NA	
ENSG00000280769	AL732314.5	NA	
ENSG00000280877	FABP5P13	NA	
ENSG00000281050	KRT18P53	NA	
ENSG00000278704	BX004987.1	NA	
ENSG00000277400	AC145212.1	NA	
ENSG00000274847	MAFIP	NA	
ENSG00000277428	Y_RNA	NA	
ENSG00000276256	AC011043.1	NA	
ENSG00000278198	AC011043.2	NA	
ENSG00000276932	Y_RNA	NA	
ENSG00000273496	AC011841.1	NA	
ENSG00000277630	BX072566.1	NA	
ENSG00000278793	U6	NA	
ENSG00000274202	U2	NA	
ENSG00000278384	AL354822.1	NA	
ENSG00000273748	AL592183.1	NA	
ENSG00000276197	AL592188.2	NA	
ENSG00000274917	RNA5-8SN5	NA	
ENSG00000273937	AL592188.1	NA	
ENSG00000273730	5_8S_rRNA	NA	
ENSG00000276711	U2	NA	
ENSG00000278294	5_8S_rRNA	NA	
ENSG00000278457	5S_rRNA	NA	
ENSG00000271254	AC240274.1	NA	
ENSG00000275405	U1	NA	
ENSG00000275987	U1	NA	
ENSG00000277475	AC213203.2	NA	
ENSG00000268674	AC213203.1	NA	
ENSG00000276345	AC004556.3	NA	
ENSG00000273532	AC004556.1	NA	
ENSG00000276351	AC004556.4	NA	
ENSG00000275661	AC004556.2	NA	
ENSG00000277856	AC233755.2	NA	
ENSG00000275063	AC233755.1	NA	
ENSG00000278673	AC136352.4	NA	
ENSG00000277890	U6	NA	
ENSG00000277666	AC136352.3	NA	
ENSG00000276760	AC136352.2	NA	
ENSG00000277927	U6	NA	
ENSG00000275249	AC171558.3	NA	
ENSG00000274792	AC171558.1	NA	
ENSG00000276872	AC171558.4	NA	
ENSG00000274175	AC133551.1	NA	
ENSG00000273843	AC009091.1	NA	
ENSG00000275869	AC136612.1	NA	
ENSG00000278510	AC007908.1	NA	
ENSG00000273554	AC136616.1	NA	
ENSG00000278782	AC136616.3	NA	
ENSG00000277761	AC136616.2	NA	
ENSG00000277836	AC141272.1	NA	
ENSG00000278633	AC023491.2	NA	
ENSG00000278066	AC023491.1	NA	
ENSG00000273739	AL353644.1	NA	
ENSG00000276700	RNA5-8SN4	NA	
ENSG00000276312	AL353644.2	NA	
ENSG00000275757	5_8S_rRNA	NA	
ENSG00000278573	AC007325.3	NA	
ENSG00000276017	AC007325.1	NA	
ENSG00000278817	AC007325.4	NA	
ENSG00000277196	AC007325.2	NA	
ENSG00000278625	U6	NA	
ENSG00000277374	U1	NA	
ENSG00000228572	AL954722.1	NA	
ENSG00000182378	PLCXD1	NA	
ENSG00000178605	GTPBP6	NA	
ENSG00000226179	LINC00685	NA	
ENSG00000167393	PPP2R3B	NA	
ENSG00000281849	AL732314.6	NA	
ENSG00000275287	Metazoa_SRP	NA	
ENSG00000280767	AL732314.4	NA	
ENSG00000234958	FABP5P13	NA	
ENSG00000229232	KRT18P53	NA	
ENSG00000185960	SHOX	127300	LERI-WEILL DYSCHONDROSTEOSIS; LWD;;DYSCHONDROSTEOSIS; DCO MADELUNG DEFORMITY, INCLUDED
ENSG00000185960	SHOX	249700	LANGER MESOMELIC DYSPLASIA; LMD;;DYSCHONDROSTEOSIS, HOMOZYGOUS;;MESOMELIC DWARFISM OF THE HYPOPLASTIC ULNA, FIBULA, AND MANDIBLE TYPE
ENSG00000185960	SHOX	300582	SHORT STATURE, IDIOPATHIC, X-LINKED; ISS
ENSG00000237531	AL672277.1	NA	
ENSG00000225661	RPL14P5	NA	
ENSG00000205755	CRLF2	NA	
ENSG00000198223	CSF2RA	300770	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 4;;PAP DUE TO CSF2RA DEFICIENCY;;CSF2RA DEFICIENCY
ENSG00000265658	MIR3690	NA	
ENSG00000223274	RNA5SP498	NA	
ENSG00000185291	IL3RA	NA	
ENSG00000169100	SLC25A6	NA	
ENSG00000236871	LINC00106	NA	
ENSG00000236017	ASMTL-AS1	NA	
ENSG00000169093	ASMTL	NA	
ENSG00000182162	P2RY8	NA	
ENSG00000197976	AKAP17A	NA	
ENSG00000196433	ASMT	NA	
ENSG00000223511	AL683807.1	NA	
ENSG00000234622	AL683807.2	NA	
ENSG00000169084	DHRSX	NA	
ENSG00000223571	DHRSX-IT1	NA	
ENSG00000214717	ZBED1	NA	
ENSG00000277120	MIR6089	NA	
ENSG00000223773	CD99P1	NA	
ENSG00000230542	LINC00102	NA	
ENSG00000002586	CD99	NA	
ENSG00000124343	XG	NA	
ENSG00000056998	GYG2	NA	
ENSG00000235483	GYG2-AS1	NA	
ENSG00000006756	ARSD	NA	
ENSG00000229851	ARSD-AS1	NA	
ENSG00000157399	ARSL	302950	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1;;CPXR;;CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC
ENSG00000205667	ARSH	NA	
ENSG00000062096	ARSF	NA	
ENSG00000239228	RN7SL578P	NA	
ENSG00000230249	AC112653.1	NA	
ENSG00000228459	LINC01546	NA	
ENSG00000101825	MXRA5	NA	
ENSG00000213487	ASS1P4	NA	
ENSG00000212214	SNORA48B	NA	
ENSG00000207435	RNU6-114P	NA	
ENSG00000183943	PRKX	NA	
ENSG00000207332	RNU6-146P	NA	
ENSG00000207320	Y_RNA	NA	
ENSG00000236188	PRKX-AS1	NA	
ENSG00000182888	AC007685.1	NA	
ENSG00000285756	BX890604.2	NA	
ENSG00000286431	BX842570.1	NA	
ENSG00000225722	BX890604.1	NA	
ENSG00000236513	AC074035.1	NA	
ENSG00000235039	MTND6P12	NA	
ENSG00000226313	MTCYBP12	NA	
ENSG00000238193	AC112656.1	NA	
ENSG00000201660	AC095353.1	NA	
ENSG00000236120	AC110995.1	NA	
ENSG00000146938	NLGN4X	300495	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2 MENTAL RETARDATION, X-LINKED, INCLUDED
ENSG00000146938	NLGN4X	300497	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2
ENSG00000252291	AC079173.1	NA	
ENSG00000265284	MIR4770	NA	
ENSG00000237730	AC078991.1	NA	
ENSG00000169059	VCX3A	NA	
ENSG00000130021	PUDP	NA	
ENSG00000237490	RPS27AP17	NA	
ENSG00000228550	AC073583.1	NA	
ENSG00000101846	STS	308100	ICHTHYOSIS, X-LINKED; XLI;;STEROID SULFATASE DEFICIENCY;;STS DEFICIENCY;;PLACENTAL STEROID SULFATASE DEFICIENCY;;STEROID SULFATASE DEFICIENCY DISEASE; SSDD ICHTHYOSIS, X-LINKED, COMPLICATED, INCLUDED
ENSG00000264268	MIR4767	NA	
ENSG00000279682	AC120338.1	NA	
ENSG00000182583	VCX	NA	
ENSG00000274923	AC005296.1	NA	
ENSG00000006757	PNPLA4	NA	
ENSG00000285679	AC079142.1	NA	
ENSG00000207628	MIR651	NA	
ENSG00000177504	VCX2	NA	
ENSG00000205642	VCX3B	NA	
ENSG00000287171	AC006062.1	NA	
ENSG00000011201	ANOS1	308700	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1;;KALLMANN SYNDROME 1; KAL1;;KMS;;HYPOGONADOTROPIC HYPOGONADISM AND ANOSMIA; HHA;;DYSPLASIA OLFACTOGENITALIS OF DE MORSIER;;ANOSMIC HYPOGONADISM
ENSG00000225574	DRAXINP1	NA	
ENSG00000183304	FAM9A	NA	
ENSG00000231619	AC003685.2	NA	
ENSG00000229012	AC003685.1	NA	
ENSG00000285896	AC074281.2	NA	
ENSG00000225271	AC074281.1	NA	
ENSG00000177138	FAM9B	NA	
ENSG00000200852	RNA5SP499	NA	
ENSG00000219870	BRK1P1	NA	
ENSG00000228543	AC003684.1	NA	
ENSG00000232111	AC073488.1	NA	
ENSG00000282306	AC073488.7	NA	
ENSG00000282501	AC073488.9	NA	
ENSG00000282358	AC073488.8	NA	
ENSG00000282668	AC073488.10	NA	
ENSG00000282299	AC073488.5	NA	
ENSG00000282697	AC073488.11	NA	
ENSG00000282222	AC073488.4	NA	
ENSG00000281955	AC073488.3	NA	
ENSG00000281941	AC073488.2	NA	
ENSG00000282300	AC073488.6	NA	
ENSG00000101849	TBL1X	301033	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8; CHNG8
ENSG00000101850	GPR143	300500	ALBINISM, OCULAR, TYPE I; OA1;;NETTLESHIP-FALLS TYPE OCULAR ALBINISM
ENSG00000101850	GPR143	300814	NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6
ENSG00000146950	SHROOM2	NA	
ENSG00000215319	EIF5P1	NA	
ENSG00000230326	HMGN1P33	NA	
ENSG00000206844	Y_RNA	NA	
ENSG00000234469	CLDN34	NA	
ENSG00000047644	WWC3	NA	
ENSG00000225076	WWC3-AS1	NA	
ENSG00000202469	AC002359.1	NA	
ENSG00000073464	CLCN4	300114	RAYNAUD-CLAES SYNDROME; MRXSRC;;MENTAL RETARDATION, X-LINKED 49; MRX49;;MENTAL RETARDATION, X-LINKED 15; MRX15
ENSG00000227042	AC003666.1	NA	
ENSG00000101871	MID1	300000	OPITZ GBBB SYNDROME, TYPE I; GBBB1;;OPITZ GBBB SYNDROME, X-LINKED;;OPITZ SYNDROME; OS;;OPITZ SYNDROME, X-LINKED; OSX;;OPITZ-G SYNDROME, TYPE I; OGS1;;OPITZ BBBG SYNDROME, TYPE I; BBBG1;;HYPERTELORISM WITH ESOPHAGEAL ABNORMALITY AND HYPOSPADIAS;;HYPE /.../ISM-HYPOSPADIAS SYNDROME;;TELECANTHUS-HYPOSPADIAS SYNDROME
ENSG00000207202	RNU6-800P	NA	
ENSG00000234129	AC073529.1	NA	
ENSG00000004961	HCCS	309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1;;MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME
ENSG00000207151	Y_RNA	NA	
ENSG00000047648	ARHGAP6	NA	
ENSG00000278218	AC003657.1	NA	
ENSG00000275194	AC004467.1	NA	
ENSG00000125363	AMELX	301200	AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED
ENSG00000263652	MIR548AX	NA	
ENSG00000232392	AC002366.1	NA	
ENSG00000282840	AC004554.2	NA	
ENSG00000223418	AC004554.1	NA	
ENSG00000005302	MSL3	301032	BASILICATA-AKHTAR SYNDROME; MRXSBA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BASILICATA-AKHTAR TYPE;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 36; MRXS36
ENSG00000169933	FRMPD4	300983	MENTAL RETARDATION, X-LINKED 104; MRX104
ENSG00000206792	AC002980.1	NA	
ENSG00000206795	AC002981.1	NA	
ENSG00000223487	FRMPD4-AS1	NA	
ENSG00000231211	RPL17P49	NA	
ENSG00000273800	AC119619.1	NA	
ENSG00000271814	RN7SKP290	NA	
ENSG00000101911	PRPS2	NA	
ENSG00000229083	PSMA6P2	NA	
ENSG00000230691	MRPL35P4	NA	
ENSG00000196664	TLR7	NA	
ENSG00000233338	TLR8-AS1	NA	
ENSG00000101916	TLR8	NA	
ENSG00000205542	TMSB4X	NA	
ENSG00000187268	FAM9C	NA	
ENSG00000261030	AC079171.1	NA	
ENSG00000235385	LINC02154	NA	
ENSG00000231216	GS1-600G8.3	NA	
ENSG00000123594	ATXN3L	NA	
ENSG00000235592	AC004674.1	NA	
ENSG00000226985	LINC01203	NA	
ENSG00000197582	GPX1P1	NA	
ENSG00000198759	EGFL6	NA	
ENSG00000233357	RPL30P15	NA	
ENSG00000283493	MIR6086	NA	
ENSG00000199622	RN7SKP20	NA	
ENSG00000176896	TCEANC	NA	
ENSG00000123595	RAB9A	NA	
ENSG00000196459	TRAPPC2	313400	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE
ENSG00000046651	OFD1	300209	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2
ENSG00000046651	OFD1	300424	RETINITIS PIGMENTOSA 23; RP23
ENSG00000046651	OFD1	300804	JOUBERT SYNDROME 10; JBTS10
ENSG00000046651	OFD1	311200	OROFACIODIGITAL SYNDROME I; OFD1;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE I;;OFDS I;;PAPILLON-LEAGE AND PSAUME SYNDROME
ENSG00000046653	GPM6B	NA	
ENSG00000233535	AC003035.2	NA	
ENSG00000212663	AC003035.1	NA	
ENSG00000046647	GEMIN8	NA	
ENSG00000233247	AC002524.1	NA	
ENSG00000101958	GLRA2	NA	
ENSG00000231066	NPM1P9	NA	
ENSG00000181544	FANCB	300514	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB;;FACB;;FANCONI PANCYTOPENIA, TYPE 2; FA2
ENSG00000181544	FANCB	314390	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX;;VACTERL-H, X-LINKED
ENSG00000130150	MOSPD2	NA	
ENSG00000235929	TPT1P14	NA	
ENSG00000236929	AC112498.1	NA	
ENSG00000102048	ASB9	NA	
ENSG00000165192	ASB11	NA	
ENSG00000165195	PIGA	300818	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1
ENSG00000165195	PIGA	300868	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 20; EIEE20;;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 4; GPIBD4
ENSG00000165197	VEGFD	NA	
ENSG00000087842	PIR	NA	
ENSG00000102010	BMX	NA	
ENSG00000130234	ACE2	NA	
ENSG00000285602	AC097625.1	NA	
ENSG00000225833	GS1-594A7.3	NA	
ENSG00000147003	CLTRN	NA	
ENSG00000237539	AC003669.1	NA	
ENSG00000186312	CA5BP1	NA	
ENSG00000169239	CA5B	NA	
ENSG00000279413	AC112497.2	NA	
ENSG00000200620	AC112497.1	NA	
ENSG00000281371	INE2	NA	
ENSG00000169249	ZRSR2	NA	
ENSG00000182287	AP1S2	304340	PETTIGREW SYNDROME; PGS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 5; MRXS5;;MENTAL RETARDATION, X-LINKED, WITH DANDY-WALKER MALFORMATION, BASAL GANGLIA DISEASE, AND SEIZURES;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, FRIED TYPE; MRXSF;;MENTAL RETARDAT /.../-LINKED 59; MRX59;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 21; MRXS21
ENSG00000200566	RNU5F-7P	NA	
ENSG00000226536	SETP15	NA	
ENSG00000126010	GRPR	NA	
ENSG00000238178	AC078993.1	NA	
ENSG00000182798	MAGEB17	NA	
ENSG00000215313	RPL6P30	NA	
ENSG00000235071	AC073909.1	NA	
ENSG00000239333	RN7SL658P	NA	
ENSG00000047230	CTPS2	NA	
ENSG00000265144	MIR548AM	NA	
ENSG00000169906	S100G	NA	
ENSG00000169895	SYAP1	NA	
ENSG00000238709	RNU7-56P	NA	
ENSG00000086712	TXLNG	NA	
ENSG00000230180	RPL12P49	NA	
ENSG00000102054	RBBP7	NA	
ENSG00000222736	RNU4-6P	NA	
ENSG00000223498	AL929302.1	NA	
ENSG00000199410	Y_RNA	NA	
ENSG00000169891	REPS2	NA	
ENSG00000201467	AL732371.1	NA	
ENSG00000214322	CBX1P2	NA	
ENSG00000214321	CBX1P4	NA	
ENSG00000238764	AL845433.1	NA	
ENSG00000188158	NHS	302200	CATARACT 40; CTRCT40;;CATARACT 40 WITH OR WITHOUT MICROCORNEA;;CATARACT, CONGENITAL, X-LINKED; CXN;;CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES; CCT
ENSG00000188158	NHS	302350	NANCE-HORAN SYNDROME; NHS;;CATARACT-DENTAL SYNDROME;;CATARACT, X-LINKED, WITH HUTCHINSONIAN TEETH;;MESIODENS-CATARACT SYNDROME
ENSG00000265465	MIR4768	NA	
ENSG00000235834	Z93022.1	NA	
ENSG00000230020	NHS-AS1	NA	
ENSG00000226153	Z93242.1	NA	
ENSG00000047634	SCML1	NA	
ENSG00000227873	Z93242.2	NA	
ENSG00000131831	RAI2	NA	
ENSG00000276467	Z93929.2	NA	
ENSG00000225066	Z93929.1	NA	
ENSG00000225882	LINC01456	NA	
ENSG00000177324	BEND2	NA	
ENSG00000102098	SCML2	NA	
ENSG00000235211	TMSB10P2	NA	
ENSG00000207025	Y_RNA	NA	
ENSG00000008086	CDKL5	300672	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2
ENSG00000236187	GJA6P	NA	
ENSG00000102104	RS1	312700	RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1;;XLRS1;;RS
ENSG00000086717	PPEF1	NA	
ENSG00000237221	PPEF1-AS1	NA	
ENSG00000196564	AL096700.1	NA	
ENSG00000224224	HAUS1P2	NA	
ENSG00000237836	PHKA2-AS1	NA	
ENSG00000044446	PHKA2	306000	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1;;LIVER GLYCOGENOSIS, X-LINKED, TYPE I; XLG1;;GLYCOGEN STORAGE DISEASE VIII, FORMERLY;;GSD VIII, FORMERLY; GSD8, FORMERLY GLYCOGEN STORAGE DISEASE IXa2, INCLUDED; GSD9A2, INCLUDED;;GSD IXa2, INCLUDED;;LIVER GLYCO /.../S, X-LINKED, TYPE II, INCLUDED; XLG2, INCLUDED
ENSG00000266710	RN7SL48P	NA	
ENSG00000286724	AL732509.1	NA	
ENSG00000173698	ADGRG2	300985	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX
ENSG00000131828	PDHA1	312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD;;PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY;;PYRUVATE DECARBOXYLASE DEFICIENCY;;ATAXIA, INTERMITTENT, WITH ABNORMAL PYRUVATE METABOLISM;;PDH DEFICIENCY;;ATAXIA, INTERMITTENT, WITH PYRUVATE DEHYDROGENA /.../ICIENCY;;ATAXIA WITH LACTIC ACIDOSIS I LACTIC ACIDEMIA, THIAMINE-RESPONSIVE, INCLUDED
ENSG00000180815	MAP3K15	NA	
ENSG00000202144	Y_RNA	NA	
ENSG00000275800	EIF5P2	NA	
ENSG00000147010	SH3KBP1	300310	IMMUNODEFICIENCY 61; IMD61;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2;;XLA2
ENSG00000173681	BCLAF3	NA	
ENSG00000206663	Y_RNA	NA	
ENSG00000184368	MAP7D2	NA	
ENSG00000264566	MIR23C	NA	
ENSG00000173674	EIF1AX	NA	
ENSG00000201882	AL732366.2	NA	
ENSG00000201592	AL732366.1	NA	
ENSG00000225037	EIF1AX-AS1	NA	
ENSG00000177189	RPS6KA3	300844	MENTAL RETARDATION, X-LINKED 19; MRX19
ENSG00000177189	RPS6KA3	303600	COFFIN-LOWRY SYNDROME; CLS
ENSG00000283631	AL928596.1	NA	
ENSG00000283400	AL807740.1	NA	
ENSG00000252978	RN7SKP183	NA	
ENSG00000283380	AL807742.1	NA	
ENSG00000283546	BX088723.1	NA	
ENSG00000206716	RNU6-133P	NA	
ENSG00000149970	CNKSR2	301008	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG
ENSG00000231913	RARRES2P3	NA	
ENSG00000185915	KLHL34	NA	
ENSG00000091482	SMPX	300066	DEAFNESS, X-LINKED 4; DFNX4;;DEAFNESS, X-LINKED 6, PROGRESSIVE; DFN6;;DEAFNESS, NONSYNDROMIC SENSORINEURAL PROGRESSIVE 6
ENSG00000012174	MBTPS2	300918	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED;;OLMSTED SYNDROME, X-LINKED; OLMSX
ENSG00000012174	MBTPS2	301014	OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19
ENSG00000012174	MBTPS2	308205	IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME;;ICHTHYOSIS FOLLICULARIS, ATRICHIA, AND PHOTOPHOBIA WITH OR WITHOUT BRAIN ANOMALIES, RETARDATION, ECTODERMAL DYSPLASIA, SKELETAL MALFORMATIONS, HIRSCHSPRUNG DISEASE, EAR/EYE ANOMALIES, CLEFT PALATE/CRY /.../IDISM, AND KIDNEY DYSPLASIA/HYPOPLASIA
ENSG00000012174	MBTPS2	308800	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX;;KERATOSIS FOLLICULARIS SPINULOSA DECALVANS CUM OPHIASI
ENSG00000275681	U73479.1	NA	
ENSG00000230797	YY2	NA	
ENSG00000206639	Y_RNA	NA	
ENSG00000271286	U73023.1	NA	
ENSG00000102172	SMS	309583	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR;;SNYDER-ROBINSON MENTAL RETARDATION SYNDROME; SRS
ENSG00000102174	PHEX	307800	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR
ENSG00000224204	PHEX-AS1	NA	
ENSG00000233067	PTCHD1-AS	NA	
ENSG00000288546	AC004470.2	NA	
ENSG00000175809	CBLL2	NA	
ENSG00000231846	AC092832.2	NA	
ENSG00000224396	METTL15P3	NA	
ENSG00000201095	RNU6-266P	NA	
ENSG00000231011	AC092832.1	NA	
ENSG00000237019	AC004470.1	NA	
ENSG00000184735	DDX53	NA	
ENSG00000174028	FAM3C2	NA	
ENSG00000228610	PDCL2P1	NA	
ENSG00000165186	PTCHD1	300830	AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4;;CHROMOSOME Xp22 DELETION SYNDROME
ENSG00000226774	AC073910.1	NA	
ENSG00000123131	PRDX4	NA	
ENSG00000123130	ACOT9	NA	
ENSG00000233785	AC131011.1	NA	
ENSG00000202272	Y_RNA	NA	
ENSG00000130066	SAT1	NA	
ENSG00000184831	APOO	NA	
ENSG00000238103	RPL9P7	NA	
ENSG00000165182	CXorf58	NA	
ENSG00000174010	KLHL15	300982	MENTAL RETARDATION, X-LINKED 103; MRX103
ENSG00000130741	EIF2S3	300148	MEHMO SYNDROME; MEHMO;;MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 20; MRXS20;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 25; MRXS25;;MENTAL RETARDATION, X- /.../, SYNDROMIC, BORCK TYPE; MRXSBRK
ENSG00000201407	AC079169.1	NA	
ENSG00000234230	ZFX-AS1	NA	
ENSG00000005889	ZFX	NA	
ENSG00000223611	SUPT20HL2	NA	
ENSG00000223731	SUPT20HL1	NA	
ENSG00000225071	AC004552.1	NA	
ENSG00000067992	PDK3	300905	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED DOMINANT, 6
ENSG00000214124	SNRPEP9	NA	
ENSG00000102230	PCYT1B	NA	
ENSG00000226222	H2BP7	NA	
ENSG00000236836	PCYT1B-AS1	NA	
ENSG00000236487	AC079168.1	NA	
ENSG00000101868	POLA1	301030	VAN ESCH-O'DRISCOLL SYNDROME; VEODS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, VAN ESCH-O'DRISCOLL TYPE; MRXSVEOD
ENSG00000101868	POLA1	301220	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR;;XLPDR
ENSG00000251869	SCARNA23	NA	
ENSG00000232472	EEF1B2P3	NA	
ENSG00000004848	ARX	300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME
ENSG00000004848	ARX	300215	LISSENCEPHALY, X-LINKED, 2; LISX2;;LISSENCEPHALY, X-LINKED, WITH AMBIGUOUS GENITALIA; XLAG;;XLISG  HYDRANENCEPHALY AND ABNORMAL GENITALIA, INCLUDED
ENSG00000004848	ARX	300419	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX;;MENTAL RETARDATION, X-LINKED 29; MRX29;;MENTAL RETARDATION, X-LINKED 32; MRX32;;MENTAL RETARDATION, X-LINKED 33; MRX33;;MENTAL RETARDATION, X-LINKED 38; MRX38;;MENTAL RETAR /.../, X-LINKED 43; MRX43;;MENTAL RETARDATION, X-LINKED 52; MRX52;;MENTAL RETARDATION, X-LINKED 54; MRX54;;MENTAL RETARDATION, X-LINKED 76; MRX76;;MENTAL RETARDATION, X-LINKED 87; MRX87
ENSG00000004848	ARX	308350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1;;INFANTILE SPASM SYNDROME, X-LINKED 1; ISSX1;;WEST SYNDROME, X-LINKED;;OHTAHARA SYNDROME, X-LINKED;;INFANTILE EPILEPTIC-DYSKINETIC ENCEPHALOPATHY;;XMESID
ENSG00000004848	ARX	309510	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, AND SEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36
ENSG00000214111	AC002504.1	NA	
ENSG00000240439	RN7SL91P	NA	
ENSG00000176812	AC112778.1	NA	
ENSG00000229310	RPP40P1	NA	
ENSG00000228519	AC097263.1	NA	
ENSG00000233403	AC121342.1	NA	
ENSG00000176774	MAGEB18	NA	
ENSG00000232446	AC129850.1	NA	
ENSG00000232030	MAGEB6B	NA	
ENSG00000227511	AC005297.1	NA	
ENSG00000176746	MAGEB6	NA	
ENSG00000232644	AC005297.2	NA	
ENSG00000188408	MAGEB5	NA	
ENSG00000237171	AC005297.3	NA	
ENSG00000228464	AC073614.1	NA	
ENSG00000231388	AC079178.1	NA	
ENSG00000259849	VENTXP1	NA	
ENSG00000236160	AC005345.1	NA	
ENSG00000216938	RPL7P58	NA	
ENSG00000236683	HMGA1P1	NA	
ENSG00000252491	RNU1-142P	NA	
ENSG00000242021	AC112493.1	NA	
ENSG00000228933	AC107419.1	NA	
ENSG00000233807	AC097262.1	NA	
ENSG00000252486	Y_RNA	NA	
ENSG00000235642	PTP4A1P5	NA	
ENSG00000224960	PPP4R3C	NA	
ENSG00000223391	AC006210.1	NA	
ENSG00000238247	AC006210.2	NA	
ENSG00000189186	DCAF8L2	NA	
ENSG00000177689	MAGEB10	NA	
ENSG00000229731	AC107613.1	NA	
ENSG00000226199	AC112492.2	NA	
ENSG00000232834	AC112492.4	NA	
ENSG00000228345	AC112492.3	NA	
ENSG00000233243	AC112492.5	NA	
ENSG00000224589	AC112492.1	NA	
ENSG00000226372	DCAF8L1	NA	
ENSG00000277569	MIR6134	NA	
ENSG00000223742	AC112495.1	NA	
ENSG00000169306	IL1RAPL1	300143	MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34
ENSG00000226436	H3P43	NA	
ENSG00000201666	AC121343.1	NA	
ENSG00000237994	AC003659.1	NA	
ENSG00000201356	RNA5SP500	NA	
ENSG00000227393	AL031575.1	NA	
ENSG00000264090	MIR4666B	NA	
ENSG00000227592	PIGFP3	NA	
ENSG00000270794	AC005185.1	NA	
ENSG00000099399	MAGEB2	NA	
ENSG00000198798	MAGEB3	NA	
ENSG00000120289	MAGEB4	NA	
ENSG00000214107	MAGEB1	NA	
ENSG00000276940	PLCE1P1	NA	
ENSG00000169297	NR0B1	300018	46,XY SEX REVERSAL 2; SRXY2;;46,XY SEX REVERSAL, DAX1-RELATED;;DOSAGE-SENSITIVE SEX REVERSAL; DSS
ENSG00000169297	NR0B1	300200	ADRENAL HYPOPLASIA, CONGENITAL; AHC;;ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM; AHCH;;ADDISON DISEASE, X-LINKED; AHX;;AHC WITH HHG;;CYTOMEGALIC ADRENOCORTICAL HYPOPLASIA;;AHC WITH ISOLATED GONADOTROPIN DEFICIENCY
ENSG00000120280	CXorf21	NA	
ENSG00000178556	CKS1BP6	NA	
ENSG00000232368	FTLP2	NA	
ENSG00000198814	GK	307030	GLYCEROL KINASE DEFICIENCY; GKD;;GK DEFICIENCY;;GK1 DEFICIENCY;;HYPERGLYCEROLEMIA
ENSG00000229331	GK-IT1	NA	
ENSG00000241886	AC112496.1	NA	
ENSG00000243055	GK-AS1	NA	
ENSG00000277876	AC108359.1	NA	
ENSG00000157625	TAB3	NA	
ENSG00000231542	TAB3-AS1	NA	
ENSG00000235512	TAB3-AS2	NA	
ENSG00000132446	FTHL17	NA	
ENSG00000198947	DMD	300376	MUSCULAR DYSTROPHY, BECKER TYPE; BMD;;BECKER MUSCULAR DYSTROPHY;;MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, BECKER TYPE
ENSG00000198947	DMD	302045	CARDIOMYOPATHY, DILATED, 3B; CMD3B;;CARDIOMYOPATHY, DILATED, X-LINKED; XLCM
ENSG00000198947	DMD	310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD;;DUCHENNE MUSCULAR DYSTROPHY;;MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE TYPE
ENSG00000252903	RNU6-894P	NA	
ENSG00000285900	AC079177.1	NA	
ENSG00000222922	RNA5SP501	NA	
ENSG00000236285	NPM1P8	NA	
ENSG00000263600	MIR3915	NA	
ENSG00000221348	MIR548F5	NA	
ENSG00000236828	DMD-AS3	NA	
ENSG00000226781	TBCAP1	NA	
ENSG00000215310	AL050305.1	NA	
ENSG00000287700	AL591378.1	NA	
ENSG00000233928	AL591501.1	NA	
ENSG00000185448	FAM47A	NA	
ENSG00000185638	FTH1P14	NA	
ENSG00000233571	AL592043.1	NA	
ENSG00000236072	AL592043.2	NA	
ENSG00000271136	AL592504.1	NA	
ENSG00000147027	TMEM47	NA	
ENSG00000225384	AL606662.1	NA	
ENSG00000273704	AL596245.1	NA	
ENSG00000189132	FAM47B	NA	
ENSG00000229347	AL596268.1	NA	
ENSG00000252411	RNU6-1087P	NA	
ENSG00000230227	SIAH1P1	NA	
ENSG00000233663	AL161722.1	NA	
ENSG00000271088	AL161722.3	NA	
ENSG00000233880	AL161722.2	NA	
ENSG00000189023	MAGEB16	NA	
ENSG00000271519	AL590065.1	NA	
ENSG00000165164	CFAP47	NA	
ENSG00000206733	RNU6-641P	NA	
ENSG00000229384	HMGB1P16	NA	
ENSG00000226484	AL606516.1	NA	
ENSG00000233921	RPS15AP40	NA	
ENSG00000286475	AL592156.1	NA	
ENSG00000249467	H2AL1QP	NA	
ENSG00000275314	AC006924.1	NA	
ENSG00000235510	BX842568.4	NA	
ENSG00000223723	BX842568.2	NA	
ENSG00000231069	BX842568.3	NA	
ENSG00000198173	FAM47C	NA	
ENSG00000243048	FTHL18	NA	
ENSG00000214071	BX842568.1	NA	
ENSG00000233810	MOB1AP2	NA	
ENSG00000130962	PRRG1	NA	
ENSG00000250349	AF241726.2	NA	
ENSG00000241607	AC245096.1	NA	
ENSG00000219186	FTH1P19	NA	
ENSG00000234355	FTH1P27	NA	
ENSG00000174678	FAM47DP	NA	
ENSG00000147036	LANCL3	NA	
ENSG00000047597	XK	300842	MCLEOD SYNDROME; MCLDS;;MCLEOD PHENOTYPE;;NEUROACANTHOCYTOSIS, MCLEOD TYPE MCLEOD SYNDROME WITH CHRONIC GRANULOMATOUS DISEASE, INCLUDED
ENSG00000285944	H2AL1SP	NA	
ENSG00000165168	CYBB	300645	IMMUNODEFICIENCY 34; IMD34;;IMMUNODEFICIENCY 34, MYCOBACTERIOSIS, X-LINKED;;ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2; AMCBX2
ENSG00000165168	CYBB	306400	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX;;CGD;;CYTOCHROME b-NEGATIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED;;CHRONIC GRANULOMATOUS DISEASE, X-LINKED CYTOCHROME b-POSITIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, INCLUDED;;GRANULOMATOUS DISE /.../HRONIC, X-LINKED, VARIANT, INCLUDED;;CHRONIC GRANULOMATOUS DISEASE, ATYPICAL, INCLUDED
ENSG00000165169	DYNLT3	NA	
ENSG00000206983	RNU6-49P	NA	
ENSG00000259977	AL121578.1	NA	
ENSG00000224339	SC4MOP	NA	
ENSG00000187516	H2AP	NA	
ENSG00000229674	H2AL1RP	NA	
ENSG00000147041	SYTL5	NA	
ENSG00000221466	MIR548AJ2	NA	
ENSG00000101955	SRPX	NA	
ENSG00000226679	AL606748.1	NA	
ENSG00000156313	RPGR	300029	RETINITIS PIGMENTOSA 3; RP3;;RETINITIS PIGMENTOSA 15; RP15;;CONE-ROD DEGENERATION, X-LINKED;;CHOROIDORETINAL DEGENERATION WITH RETINAL REFLEX IN HETEROZYGOUS WOMEN
ENSG00000156313	RPGR	300455	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS
ENSG00000156313	RPGR	300834	MACULAR DEGENERATION, X-LINKED ATROPHIC
ENSG00000156313	RPGR	304020	CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1 CONE DYSTROPHY 1, X-LINKED, INCLUDED; COD1, INCLUDED
ENSG00000252050	AL606748.2	NA	
ENSG00000036473	OTC	311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCY
ENSG00000227988	TDGF1P1	NA	
ENSG00000232370	AF241726.1	NA	
ENSG00000229735	FTLP16	NA	
ENSG00000233007	UBTFL11	NA	
ENSG00000156298	TSPAN7	300210	MENTAL RETARDATION, X-LINKED 58; MRX58
ENSG00000238606	RNU7-7P	NA	
ENSG00000235806	AF241728.1	NA	
ENSG00000287729	AF241728.2	NA	
ENSG00000165175	MID1IP1	NA	
ENSG00000238123	MID1IP1-AS1	NA	
ENSG00000207122	RNU6-591P	NA	
ENSG00000224610	AC108879.1	NA	
ENSG00000235304	LINC01281	NA	
ENSG00000236747	LINC01282	NA	
ENSG00000234191	LINC01283	NA	
ENSG00000263730	MIR3937	NA	
ENSG00000264618	RN7SL732P	NA	
ENSG00000228232	GAPDHP1	NA	
ENSG00000270759	AC091810.1	NA	
ENSG00000261435	AL592164.1	NA	
ENSG00000263972	MIR1587	NA	
ENSG00000214047	RPS11P7	NA	
ENSG00000285709	AL592164.2	NA	
ENSG00000223486	AC092198.1	NA	
ENSG00000183337	BCOR	300166	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2;;OCULOFACIOCARDIODENTAL SYNDROME;;OFCD SYNDROME;;MICROPHTHALMIA, CATARACTS, RADICULOMEGALY, AND SEPTAL HEART DEFECTS;;ANOP2, FORMERLY;;MAA2, FORMERLY
ENSG00000183337	BCOR	309800	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1;;LENZ MICROPHTHALMIA SYNDROME;;LENZ DYSPLASIA;;MAA, FORMERLY
ENSG00000236393	AC091806.1	NA	
ENSG00000214045	AC091807.1	NA	
ENSG00000206677	Y_RNA	NA	
ENSG00000235685	AC092473.1	NA	
ENSG00000238730	RNU7-164P	NA	
ENSG00000182220	ATP6AP2	300423	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH;;MENTAL RETARDATION, X-LINKED, WITH EPILEPSY; MRXE
ENSG00000182220	ATP6AP2	300911	PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS
ENSG00000287098	AC092473.2	NA	
ENSG00000238205	MPC1L	NA	
ENSG00000185753	CXorf38	NA	
ENSG00000180182	MED14	NA	
ENSG00000234636	MED14OS	NA	
ENSG00000270791	DPRXP6	NA	
ENSG00000214031	AC092474.1	NA	
ENSG00000237661	AC092474.2	NA	
ENSG00000238222	MKRN4P	NA	
ENSG00000232801	SDCBPP3	NA	
ENSG00000189145	AC092268.1	NA	
ENSG00000216866	RPS2P55	NA	
ENSG00000287549	AC092268.2	NA	
ENSG00000237931	CLIC4P3	NA	
ENSG00000124486	USP9X	300919	MENTAL RETARDATION, X-LINKED 99; MRX99
ENSG00000124486	USP9X	300968	MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F
ENSG00000223714	LINC02601	NA	
ENSG00000199564	RNA5SP502	NA	
ENSG00000238426	AL391647.2	NA	
ENSG00000226641	AL391647.1	NA	
ENSG00000215301	DDX3X	300958	MENTAL RETARDATION, X-LINKED 102; MRX102
ENSG00000264573	RN7SL15P	NA	
ENSG00000188937	NYX	310500	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A;;CSNB, COMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, WITH MYOPIA;;HEMERALOPIA-MYOPIA;;MYOPIA-NIGHT BLINDNESS; NBM1 NYCTALOPIA, INCLUDED
ENSG00000225238	Z93015.1	NA	
ENSG00000147044	CASK	300422	FG SYNDROME 4; FGS4 MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED
ENSG00000147044	CASK	300749	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH;;MICPCH SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, NAJM TYPE; MRXSNA
ENSG00000147044	CASK	300908	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY;;FAVISM, SUSCEPTIBILITY TO
ENSG00000233033	CASK-AS1	NA	
ENSG00000212207	RNU6-1321P	NA	
ENSG00000217624	AL627402.1	NA	
ENSG00000242559	RN7SL144P	NA	
ENSG00000171659	GPR34	NA	
ENSG00000171657	GPR82	NA	
ENSG00000229822	AL353691.1	NA	
ENSG00000237875	AL353691.2	NA	
ENSG00000251807	RNU6-202P	NA	
ENSG00000233103	AL133329.1	NA	
ENSG00000228847	ATP5MC2P4	NA	
ENSG00000212560	RNU6-630P	NA	
ENSG00000228780	Z92545.1	NA	
ENSG00000206896	RNU6-1124P	NA	
ENSG00000231772	Z93403.1	NA	
ENSG00000283737	AL023875.1	NA	
ENSG00000287223	Z94277.1	NA	
ENSG00000102055	PPP1R2C	NA	
ENSG00000270280	AL451086.1	NA	
ENSG00000224294	PINCR	NA	
ENSG00000237206	IMPDH1P4	NA	
ENSG00000285899	AL023574.1	NA	
ENSG00000231750	NANOGP10	NA	
ENSG00000189221	MAOA	300615	BRUNNER SYNDROME; BRNRS ANTISOCIAL BEHAVIOR, SUSCEPTIBILITY TO, INCLUDED
ENSG00000069535	MAOB	NA	
ENSG00000124479	NDP	305390	EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;;EVRX;;FEVR, X-LINKED; FEVRX
ENSG00000124479	NDP	310600	NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS
ENSG00000236276	NDP-AS1	NA	
ENSG00000214019	AL034370.1	NA	
ENSG00000183690	EFHC2	NA	
ENSG00000198414	TATDN2P1	NA	
ENSG00000214018	RRM2P3	NA	
ENSG00000200702	Y_RNA	NA	
ENSG00000224054	AL022163.1	NA	
ENSG00000215035	FDPSP5	NA	
ENSG00000069509	FUNDC1	NA	
ENSG00000233543	CHTF8P1	NA	
ENSG00000229168	RPL19P20	NA	
ENSG00000214016	RPSAP61	NA	
ENSG00000242065	RN7SL291P	NA	
ENSG00000189037	DUSP21	NA	
ENSG00000147050	KDM6A	147920	KABUKI SYNDROME 1; KABUK1;;KABUKI SYNDROME;;KABUKI MAKE-UP SYNDROME; KMS;;NIIKAWA-KUROKI SYNDROME
ENSG00000147050	KDM6A	300867	KABUKI SYNDROME 2; KABUK2
ENSG00000147113	DIPK2B	NA	
ENSG00000229491	AC136489.1	NA	
ENSG00000237782	AL020989.1	NA	
ENSG00000229563	LINC01204	NA	
ENSG00000214282	KRT8P14	NA	
ENSG00000204915	AC234772.1	NA	
ENSG00000270069	MIR222HG	NA	
ENSG00000207870	MIR221	NA	
ENSG00000207725	MIR222	NA	
ENSG00000269902	AC234772.2	NA	
ENSG00000231566	LINC02595	NA	
ENSG00000212347	AL031584.1	NA	
ENSG00000215286	AL031584.2	NA	
ENSG00000234613	AL031584.3	NA	
ENSG00000224701	MED28P4	NA	
ENSG00000213100	KRT18P68	NA	
ENSG00000214009	PCNAP3	NA	
ENSG00000278838	Metazoa_SRP	NA	
ENSG00000236751	LINC01186	NA	
ENSG00000229145	ACTBP1	NA	
ENSG00000286306	AL139811.3	NA	
ENSG00000231235	AL139811.2	NA	
ENSG00000235587	GAPDHP65	NA	
ENSG00000147121	KRBOX4	NA	
ENSG00000224072	AL139811.1	NA	
ENSG00000251192	ZNF674	NA	
ENSG00000199226	RNU6-50P	NA	
ENSG00000230844	ZNF674-AS1	NA	
ENSG00000277721	Metazoa_SRP	NA	
ENSG00000270499	MKI67P1	NA	
ENSG00000147119	CHST7	NA	
ENSG00000065923	SLC9A7	301024	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108;;MENTAL RETARDATION, X-LINKED 108
ENSG00000213997	PGAM1P7	NA	
ENSG00000226048	YBX1P8	NA	
ENSG00000215284	AL512633.1	NA	
ENSG00000102218	RP2	312600	RETINITIS PIGMENTOSA 2; RP2
ENSG00000204904	LINC01545	NA	
ENSG00000102221	JADE3	NA	
ENSG00000130988	RGN	NA	
ENSG00000206685	RNU6-1189P	NA	
ENSG00000201659	RNU12-2P	NA	
ENSG00000147123	NDUFB11	300952	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3;;LINEAR SKIN DEFECTS WITH CARDIOMYOPATHY AND OTHER CONGENITAL ANOMALIES
ENSG00000147123	NDUFB11	301021	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30
ENSG00000147123	NDUFB11	309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1;;MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME
ENSG00000182872	RBM10	311900	TARP SYNDROME; TARPS;;TALIPES EQUINOVARUS, ATRIAL SEPTAL DEFECT, ROBIN SEQUENCE, AND PERSISTENCE OF LEFT SUPERIOR VENA CAVA;;PIERRE ROBIN SYNDROME WITH CONGENITAL HEART MALFORMATION AND CLUBFOOT
ENSG00000237351	AL513366.1	NA	
ENSG00000130985	UBA1	301830	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED /.../ I; AMCX1
ENSG00000224975	INE1	NA	
ENSG00000102225	CDK16	NA	
ENSG00000102226	USP11	NA	
ENSG00000237623	AL591503.3	NA	
ENSG00000266158	RN7SL785P	NA	
ENSG00000203402	AL591503.1	NA	
ENSG00000147117	ZNF157	NA	
ENSG00000221459	SNORA11C	NA	
ENSG00000232009	AL591503.2	NA	
ENSG00000226556	NPM1P49	NA	
ENSG00000147124	ZNF41	NA	
ENSG00000277605	AL590283.1	NA	
ENSG00000196741	LINC01560	NA	
ENSG00000235636	NUS1P1	NA	
ENSG00000078061	ARAF	NA	
ENSG00000008056	SYN1	300491	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS
ENSG00000283743	Z84466.1	NA	
ENSG00000102265	TIMP1	NA	
ENSG00000263858	MIR4769	NA	
ENSG00000126759	CFP	312060	PROPERDIN DEFICIENCY, X-LINKED; CFPD;;PROPERDIN P FACTOR DEFICIENCY; PFD;;COMPLEMENT FACTOR PROPERDIN DEFICIENCY;;PROPERDIN DEFICIENCY, TYPE I  PROPERDIN DEFICIENCY, TYPE II, INCLUDED;;PROPERDIN DEFICIENCY, TYPE III, INCLUDED
ENSG00000126767	ELK1	NA	
ENSG00000126756	UXT	NA	
ENSG00000267064	UXT-AS1	NA	
ENSG00000187893	CXXC1P1	NA	
ENSG00000224656	AL009172.1	NA	
ENSG00000229968	AL022578.1	NA	
ENSG00000188459	WASF4P	NA	
ENSG00000197779	ZNF81	NA	
ENSG00000224401	RPL7P57	NA	
ENSG00000147118	ZNF182	NA	
ENSG00000221994	ZNF630	NA	
ENSG00000171489	SPACA5	NA	
ENSG00000277541	ZNF630-AS1	NA	
ENSG00000287757	AC244636.3	NA	
ENSG00000171483	SSX6P	NA	
ENSG00000171478	SPACA5B	NA	
ENSG00000230241	AC244636.1	NA	
ENSG00000233139	AC244636.2	NA	
ENSG00000201517	RNU6-707P	NA	
ENSG00000225198	SSXP3	NA	
ENSG00000238032	AC245047.7	NA	
ENSG00000165583	SSX5	NA	
ENSG00000234780	AC245047.5	NA	
ENSG00000252856	RNA5SP503	NA	
ENSG00000204368	AC245047.1	NA	
ENSG00000231568	AC245047.3	NA	
ENSG00000229662	AC245047.2	NA	
ENSG00000126752	SSX1	300813	SARCOMA, SYNOVIAL
ENSG00000232813	AC245047.4	NA	
ENSG00000241207	AC245047.8	NA	
ENSG00000237345	AC245047.6	NA	
ENSG00000204648	SSX9P	NA	
ENSG00000234391	AL606490.6	NA	
ENSG00000227302	SSXP9	NA	
ENSG00000230100	AL606490.3	NA	
ENSG00000270747	AL606490.9	NA	
ENSG00000165584	SSX3	NA	
ENSG00000225055	AL606490.1	NA	
ENSG00000234448	AL606490.7	NA	
ENSG00000268009	SSX4	NA	
ENSG00000269791	SSX4B	NA	
ENSG00000231603	AL606490.5	NA	
ENSG00000231489	AL606490.4	NA	
ENSG00000235350	AL606490.8	NA	
ENSG00000226971	AL606490.2	NA	
ENSG00000017483	SLC38A5	NA	
ENSG00000068438	FTSJ1	309549	MENTAL RETARDATION, X-LINKED 9; MRX9;;MENTAL RETARDATION, X-LINKED 44; MRX44
ENSG00000224292	AF196972.1	NA	
ENSG00000102312	PORCN	305600	FOCAL DERMAL HYPOPLASIA; FDH;;FODH; DHOF;;GOLTZ SYNDROME;;GOLTZ-GORLIN SYNDROME
ENSG00000147155	EBP	300960	MEND SYNDROME; MEND;;MALE EBP DISORDER WITH NEUROLOGIC DEFECTS
ENSG00000147155	EBP	302960	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2;;CDPXD; CPXD;;CONRADI-HUNERMANN SYNDROME;;HAPPLE SYNDROME;;CONRADI-HUNERMANN-HAPPLE SYNDROME
ENSG00000286268	AF196969.1	NA	
ENSG00000276823	AF196972.2	NA	
ENSG00000068354	TBC1D25	NA	
ENSG00000204620	AC115618.1	NA	
ENSG00000102317	RBM3	NA	
ENSG00000228343	AC115618.2	NA	
ENSG00000279528	AC115618.3	NA	
ENSG00000220125	MRPL32P1	NA	
ENSG00000101940	WDR13	NA	
ENSG00000231725	VN1R110P	NA	
ENSG00000015285	WAS	300299	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX;;XLN
ENSG00000015285	WAS	301000	WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2
ENSG00000015285	WAS	313900	THROMBOCYTOPENIA 1; THC1;;THC;;THROMBOCYTOPENIA, X-LINKED; XLT;;THROMBOCYTOPENIA, X-LINKED, 1 THROMBOCYTOPENIA, X-LINKED, INTERMITTENT, INCLUDED
ENSG00000101945	SUV39H1	NA	
ENSG00000232828	AC231533.1	NA	
ENSG00000206723	RNU6-1056P	NA	
ENSG00000171433	GLOD5	NA	
ENSG00000233585	AC231533.2	NA	
ENSG00000207367	RNU6-29P	NA	
ENSG00000102145	GATA1	190685	DOWN SYNDROME;;TRISOMY 21 DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDRO /.../CLUDED
ENSG00000102145	GATA1	300367	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA
ENSG00000102145	GATA1	300835	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP
ENSG00000102145	GATA1	314050	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCED GLOBIN SYNTHESIS
ENSG00000094631	HDAC6	300863	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA
ENSG00000187682	ERAS	NA	
ENSG00000102109	PCSK1N	NA	
ENSG00000102103	PQBP1	309500	RENPENNING SYNDROME 1; RENS1;;MENTAL RETARDATION, X-LINKED, RENPENNING TYPE;;SUTHERLAND-HAAN X-LINKED MENTAL RETARDATION SYNDROME; SHS;;GOLABI-ITO-HALL SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH SPASTIC DIPLEGIA;;MENTAL RETARDATION, X-LINKED, SYND /.../3; MRXS3;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 8; MRXS8;;MENTAL RETARDATION, X-LINKED 55; MRX55
ENSG00000126768	TIMM17B	NA	
ENSG00000102100	SLC35A2	300896	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M;;CDG IIm; CDGIIm;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 22; EIEE22
ENSG00000102096	PIM2	NA	
ENSG00000068308	OTUD5	NA	
ENSG00000279155	AC233300.1	NA	
ENSG00000223309	RNU6-722P	NA	
ENSG00000102057	KCND1	NA	
ENSG00000068400	GRIPAP1	NA	
ENSG00000068323	TFE3	300854	RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1
ENSG00000147144	CCDC120	NA	
ENSG00000243279	PRAF2	NA	
ENSG00000288053	AC231657.3	NA	
ENSG00000196998	WDR45	300894	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD; SENDA
ENSG00000206936	RNU4-52P	NA	
ENSG00000068394	GPKOW	NA	
ENSG00000265033	RN7SL262P	NA	
ENSG00000280116	AC231657.2	NA	
ENSG00000269313	MAGIX	NA	
ENSG00000279422	AC231657.1	NA	
ENSG00000102007	PLP2	NA	
ENSG00000012211	PRICKLE3	NA	
ENSG00000102003	SYP	300802	MENTAL RETARDATION, X-LINKED 96; MRX96
ENSG00000237341	SYP-AS1	NA	
ENSG00000102001	CACNA1F	300071	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A;;CSNB, INCOMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2
ENSG00000102001	CACNA1F	300476	CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
ENSG00000102001	CACNA1F	300600	ALAND ISLAND EYE DISEASE; AIED;;FORSIUS-ERIKSSON TYPE OCULAR ALBINISM
ENSG00000230216	HSPB1P2	NA	
ENSG00000101997	CCDC22	300963	RITSCHER-SCHINZEL SYNDROME 2; RTSC2
ENSG00000049768	FOXP3	304790	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX;;X-LINKED AUTOIMMUNITY-ALLERGIC DYSREGULATION SYNDROME; XLAAD;;IDDM-SECRETORY DIARRHEA SYNDROME; DMSD;;AUTOIMMUNITY-IMMUNODEFICIENCY SYNDROME, X-LINKED;;DIARRHEA, POLYENDOCRINO /.../ FATAL INFECTION SYNDROME, X-LINKED;;ENTEROPATHY, AUTOIMMUNE, WITH HEMOLYTIC ANEMIA AND POLYENDOCRINOPATHY;;POLYENDOCRINOPATHY, IMMUNE DYSFUNCTION, AND DIARRHEA, X-LINKED; XPID;;DIABETES MELLITUS, CONGENITAL INSULIN-DEPENDENT, WITH FATAL SECRETORY DIARRHEA;;IMMUNODEFICIENCY, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED, FORMERLY  ISLETS OF LANGERHANS, ABSENCE OF, INCLUDED
ENSG00000286181	AC232271.3	NA	
ENSG00000049769	PPP1R3F	NA	
ENSG00000270012	AC232271.1	NA	
ENSG00000286031	AC232271.2	NA	
ENSG00000215274	GAGE10	NA	
ENSG00000224659	GAGE12J	NA	
ENSG00000274274	GAGE13	NA	
ENSG00000275113	GAGE2E	NA	
ENSG00000236737	GAGE12B	NA	
ENSG00000237671	GAGE12C	NA	
ENSG00000227488	GAGE12D	NA	
ENSG00000236362	GAGE12F	NA	
ENSG00000216649	GAGE12E	NA	
ENSG00000215269	GAGE12G	NA	
ENSG00000224902	GAGE12H	NA	
ENSG00000189064	GAGE2A	NA	
ENSG00000205777	GAGE1	NA	
ENSG00000213856	VDAC1P2	NA	
ENSG00000227391	SALL1P1	NA	
ENSG00000068985	PAGE1	NA	
ENSG00000101951	PAGE4	NA	
ENSG00000234390	USP27X-AS1	NA	
ENSG00000273820	USP27X	300984	MENTAL RETARDATION, X-LINKED 105; MRX105
ENSG00000220132	AC236430.1	NA	
ENSG00000171365	CLCN5	300009	DENT DISEASE 1;;NEPHROLITHIASIS, HYPERCALCIURIC, X-LINKED;;UROLITHIASIS, HYPERCALCIURIC, X-LINKED;;NEPHROLITHIASIS 2; NPHL2
ENSG00000171365	CLCN5	300554	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE
ENSG00000171365	CLCN5	308990	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS
ENSG00000171365	CLCN5	310468	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN;;NEPHROLITHIASIS, X-LINKED RECESSIVE, TYPE 1;;UROLITHIASIS, X-LINKED RECESSIVE, TYPE 1;;NEPHROLITHIASIS 1; NPHL1
ENSG00000201341	RNU6-421P	NA	
ENSG00000207758	MIR532	NA	
ENSG00000207768	MIR188	NA	
ENSG00000207785	MIR500A	NA	
ENSG00000208015	MIR362	NA	
ENSG00000211538	MIR501	NA	
ENSG00000239057	MIR500B	NA	
ENSG00000207970	MIR660	NA	
ENSG00000272080	MIR502	NA	
ENSG00000181977	PYY3	NA	
ENSG00000202495	Y_RNA	NA	
ENSG00000147081	AKAP4	NA	
ENSG00000147082	CCNB3	NA	
ENSG00000274588	DGKK	NA	
ENSG00000158352	SHROOM4	300434	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX;;MENTAL RETARDATION, X-LINKED, STOCCO DOS SANTOS TYPE
ENSG00000222303	RNU6-935P	NA	
ENSG00000226881	H3P44	NA	
ENSG00000130385	BMP15	300510	OVARIAN DYSGENESIS 2; ODG2;;OVARIAN DYSGENESIS, HYPERGONADOTROPIC, X-LINKED;;OVARIAN FAILURE, HYPERGONADOTROPIC, DUE TO OVARIAN DYSGENESIS PREMATURE OVARIAN FAILURE 4, INCLUDED; POF4, INCLUDED
ENSG00000238190	HMGB1P15	NA	
ENSG00000227493	AC239367.1	NA	
ENSG00000230926	AC239367.2	NA	
ENSG00000230317	LINC01284	NA	
ENSG00000237926	AC239367.3	NA	
ENSG00000229151	AC233976.1	NA	
ENSG00000287767	AC233976.2	NA	
ENSG00000122824	NUDT10	NA	
ENSG00000226530	AL158055.1	NA	
ENSG00000187690	EZHIP	NA	
ENSG00000196368	NUDT11	NA	
ENSG00000234766	LINC01496	NA	
ENSG00000224109	CENPVL3	NA	
ENSG00000283093	CENPVL2	NA	
ENSG00000223591	CENPVL1	NA	
ENSG00000189369	GSPT2	NA	
ENSG00000179222	MAGED1	NA	
ENSG00000236576	AC241520.1	NA	
ENSG00000252377	RNU6-504P	NA	
ENSG00000228827	AL929410.1	NA	
ENSG00000232951	IPO7P1	NA	
ENSG00000237528	AL929410.2	NA	
ENSG00000232562	TPMTP3	NA	
ENSG00000182776	AC239585.1	NA	
ENSG00000279750	AC239585.2	NA	
ENSG00000187243	MAGED4B	NA	
ENSG00000221705	SNORA11E	NA	
ENSG00000154545	MAGED4	NA	
ENSG00000221475	SNORA11D	NA	
ENSG00000287215	AC231759.2	NA	
ENSG00000179028	AC245177.1	NA	
ENSG00000276474	AC231759.1	NA	
ENSG00000275335	MIR8088	NA	
ENSG00000155622	XAGE2	NA	
ENSG00000225957	AC231532.1	NA	
ENSG00000276897	AC231532.2	NA	
ENSG00000224556	BX510359.1	NA	
ENSG00000250084	BX510359.5	NA	
ENSG00000278358	BX510359.8	NA	
ENSG00000278160	BX510359.7	NA	
ENSG00000275643	RBM22P6	NA	
ENSG00000204379	XAGE1A	NA	
ENSG00000223395	RBM22P7	NA	
ENSG00000204382	XAGE1B	NA	
ENSG00000277289	BX510359.6	NA	
ENSG00000227058	BX510359.2	NA	
ENSG00000231593	BX510359.4	NA	
ENSG00000228771	BX510359.3	NA	
ENSG00000185319	SSXP4	NA	
ENSG00000197185	SSXP1	NA	
ENSG00000234792	AL450023.2	NA	
ENSG00000157965	SSX8P	NA	
ENSG00000187754	SSX7	NA	
ENSG00000228354	AL450023.1	NA	
ENSG00000222608	RNA5SP504	NA	
ENSG00000225508	SSXP5	NA	
ENSG00000237275	AL450023.3	NA	
ENSG00000241476	SSX2	300813	SARCOMA, SYNOVIAL
ENSG00000223958	AC244505.2	NA	
ENSG00000225397	AC244505.3	NA	
ENSG00000229826	AC244505.5	NA	
ENSG00000268447	SSX2B	NA	
ENSG00000269281	AC244505.7	NA	
ENSG00000226867	AC244505.4	NA	
ENSG00000204363	SPANXN5	NA	
ENSG00000229885	AC244505.6	NA	
ENSG00000171405	XAGE5	NA	
ENSG00000196395	AC244505.1	NA	
ENSG00000224781	EIF4A2P4	NA	
ENSG00000171402	XAGE3	NA	
ENSG00000179304	FAM156B	NA	
ENSG00000286118	AC234031.1	NA	
ENSG00000268350	FAM156A	NA	
ENSG00000184194	GPR173	NA	
ENSG00000270497	BX322635.1	NA	
ENSG00000184205	TSPYL2	NA	
ENSG00000234019	AL591212.1	NA	
ENSG00000232593	KANTR	NA	
ENSG00000235224	AL591212.2	NA	
ENSG00000231340	ACTG1P10	NA	
ENSG00000227329	AL139396.1	NA	
ENSG00000126012	KDM5C	300534	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ
ENSG00000276575	MIR6895	NA	
ENSG00000277474	MIR6894	NA	
ENSG00000235262	KDM5C-IT1	NA	
ENSG00000124313	IQSEC2	309530	MENTAL RETARDATION, X-LINKED 1; MRX1;;MRX;;MENTAL RETARDATION, X-LINKED 18; MRX18;;MENTAL RETARDATION, X-LINKED 78; MRX78
ENSG00000226299	RPSAP62	NA	
ENSG00000207408	AC245102.1	NA	
ENSG00000236571	AC245102.3	NA	
ENSG00000234413	AC245102.2	NA	
ENSG00000072501	SMC1A	300590	CORNELIA DE LANGE SYNDROME 2; CDLS2;;CORNELIA DE LANGE SYNDROME, X-LINKED;;CDLS, X-LINKED
ENSG00000278204	MIR6857	NA	
ENSG00000158423	RIBC1	NA	
ENSG00000072506	HSD17B10	300438	HSD10 MITOCHONDRIAL DISEASE; HSD10MD;;HSD17B10 DEFICIENCY;;17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY;;3-@HYDROXYACYL-CoA DEHYDROGENASE II DEFICIENCY;;2-@METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY;;MHBD DEFICIENCY;;MENTAL RETARDATI /.../LINKED, SYNDROMIC 10; MRXS10;;CHORIOATHETOSIS WITH MENTAL RETARDATION AND ABNORMAL BEHAVIOR; CAMR;;MENTAL RETARDATION WITH CHORIOATHETOSIS AND ABNORMAL BEHAVIOR
ENSG00000233250	AC233728.1	NA	
ENSG00000235416	AC233728.2	NA	
ENSG00000199422	VTRNA3-1P	NA	
ENSG00000086758	HUWE1	309590	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST;;JUBERG-MARSIDI SYNDROME; JMS;;BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH GROWTH RETARDATION, DEAFNESS, AND MICROGENITALISM;;MENTAL RETARDATION, X-LINKED, SYNDROMI /.../OKS-WISNIEWSKI-BROWN TYPE; MRXSBWB;;MENTAL RETARDATION AND MACROCEPHALY SYNDROME
ENSG00000271886	MIR98	NA	
ENSG00000208012	MIRLET7F2	NA	
